FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Kim, SJ
   Jeon, DB
   Park, JH
   Ryu, MK
   Yang, JH
   Hwang, CS
   Kim, GH
   Yoon, SM
AF Kim, So-Jung
   Jeon, Da-Bin
   Park, Jung-Ho
   Ryu, Min-Ki
   Yang, Jong-Heon
   Hwang, Chi-Sun
   Kim, Gi-Heon
   Yoon, Sung-Min
TI Nonvolatile Memory Thin-Film Transistors Using Biodegradable Chicken
   Albumen Gate Insulator and Oxide Semiconductor Channel on Eco-Friendly
   Paper Substrate
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE eco-friendly device; nonvolatile memory; paper substrate; chicken
   albumen dielectric; oxide semiconductor
AB Nonvolatile memory thin-film transistors (TFTs) fabricated on paper substrates were proposed as one of the eco-friendly electronic devices. The gate stack was composed of chicken albumen gate insulator and In-Ga-Zn-O semiconducting channel layers. All the fabrication processes were performed below 120 degrees C. To improve the process compatibility of the synthethic paper substrate, an Al2O3 thin film was introduced as adhesion and barrier layers by atomic layer deposition. The dielectric properties of biomaterial albumen gate insulator were also enhanced by the preparation of Al2O3 capping layer. The nonvolatile bistabilities were realized by the switching phenomena of residual polarization within the albumen thin film. The fabricated device exhibited a counterclockwise hysteresis with a memory window of 11.8 V, high on/off ratio of approximately 1.1 x 10(6), and high saturation mobility (mu sat) of 11.5 cm(2)/(V s). Furthermore, these device characteristics were not markedly degraded even after the delamination and under the bending situration. When the curvature radius was set as 5.3 cm, the I-ON/I-OFF ratio and mu(sat) were obtained to be 5.9 x 10(6) and 7.9 cm(2)/(V s), respectively.
C1 [Kim, So-Jung; Jeon, Da-Bin; Park, Jung-Ho; Yoon, Sung-Min] Kyung Hee Univ, Dept Adv Mat Engn Informat & Elect, Yongin 446701, Gyeonggi Do, South Korea.
   [Ryu, Min-Ki; Yang, Jong-Heon; Hwang, Chi-Sun; Kim, Gi-Heon] Elect & Telecommun Res Inst, Informat & Commun Core Technol Res Lab, Daejeon 305730, South Korea.
RP Yoon, SM (reprint author), Kyung Hee Univ, Dept Adv Mat Engn Informat & Elect, Yongin 446701, Gyeonggi Do, South Korea.
EM sungmin@khu.ac.kr
FU National Research Foundation of Korea (NRF) - Korean government (MEST)
   [2014063718]; MSIP (Ministry of Science, ICT & Future Planning), Korea
FX This research was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korean government (MEST) (2014063718). This
   research was also funded by the MSIP (Ministry of Science, ICT & Future
   Planning), Korea in the ICT R&D Program (the core technology development
   of light and space adaptable energy-saving I/O platform for future
   advertising service).
CR Chang JW, 2011, ADV MATER, V23, P4077, DOI 10.1002/adma.201102124
   Jeon DB, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.128002
   Khanna R, 2010, J VAC SCI TECHNOL B, V28, pL43, DOI 10.1116/1.3467507
   Li Y, 2012, ORG ELECTRON, V13, P815, DOI 10.1016/j.orgel.2012.01.021
   Lien DH, 2014, ACS NANO, V8, P7613, DOI 10.1021/nn501231z
   Lim W, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3309753
   Lim W, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3086394
   Lu AX, 2011, IEEE ELECTR DEVICE L, V32, P518, DOI 10.1109/LED.2011.2107550
   Martins R, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3030873
   Mazzeo AD, 2012, ADV MATER, V24, P2850, DOI 10.1002/adma.201200137
   Russo A, 2011, ADV MATER, V23, P3426, DOI 10.1002/adma.201101328
   Siegel AC, 2009, LAB CHIP, V9, P2775, DOI 10.1039/b905832j
   Yoon SM, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/24/245101
NR 13
TC 16
Z9 16
U1 3
U2 40
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAR 4
PY 2015
VL 7
IS 8
BP 4869
EP 4874
DI 10.1021/am508834y
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CG1AL
UT WOS:000353005300053
PM 25679117
DA 2018-10-19
ER

PT J
AU Pedron, S
   Becka, E
   Harley, BA
AF Pedron, Sara
   Becka, Eftalda
   Harley, Brendan A.
TI Spatially Gradated Hydrogel Platform as a 3D Engineered Tumor
   Microenvironment
SO ADVANCED MATERIALS
LA English
DT Article
ID STEM-CELL CULTURE; INVASION IN-VITRO; HYALURONIC-ACID;
   EXTRACELLULAR-MATRIX; GLIOBLASTOMA CELLS; GLIOMA INVASION; GENERATION;
   CANCER; MATRIX-METALLOPROTEINASE-9; HETEROGENEITY
AB There is an acute need for biomaterial tools that recreate the heterogeneous brain-tumor microenvironment. A microfluidic mixing tool is reported to encapsulate glioblastoma multiforme cells within miniaturized gelatin hydrogels containing overlapping patterns of tumor-inspired matrix signals. This approach permits in situ analysis of glioma cells at the molecular and genomic level as well as the potential for clinical insight.
C1 [Pedron, Sara; Becka, Eftalda] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
   [Harley, Brendan A.] Univ Illinois, Inst Genom Biol, Dept Chem & Biomol Engn, Roger Adams Lab 110, Urbana, IL 61801 USA.
RP Harley, BA (reprint author), Univ Illinois, Inst Genom Biol, Dept Chem & Biomol Engn, Roger Adams Lab 110, 600 S Mathews Ave, Urbana, IL 61801 USA.
EM bharley@illinois.edu
RI Pedron, Sara/E-6404-2015
OI Harley, Brendan/0000-0001-5458-154X
FU National Science Foundation [1254738]; Illini 4000; Department of
   Chemical & Biomolecular Engineering; Institute for Genomic Biology at
   the University of Illinois at Urbana-Champaign
FX The authors would like to acknowledge Mr. Bhushan Mahadik for assistance
   with microfluidic mixer fabrication, Harshita Polishetty for assistance
   with hydrogel fabrication, Dr. Mayandi Sivaguru (IGB, UIUC) for
   assistance with fluorescence imaging, and Prof. Paul Kenis (University
   of Illinois) for access to soft lithography facilities. This material is
   based upon work supported by the National Science Foundation under Grant
   No. 1254738. The authors are grateful for funding provided by the Illini
   4000. The authors are also grateful for additional funding provided by
   the Department of Chemical & Biomolecular Engineering and the Institute
   for Genomic Biology at the University of Illinois at Urbana-Champaign.
CR Akiyama Y, 2001, J NEURO-ONCOL, V53, P115, DOI 10.1023/A:1012297132047
   Ananthanarayanan B, 2011, BIOMATERIALS, V32, P7913, DOI 10.1016/j.biomaterials.2011.07.005
   Bexell D, 2010, MOL THER, V18, P1067, DOI 10.1038/mt.2010.58
   Binda Elena, 2012, Front Biosci (Schol Ed), V4, P1235
   Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153
   Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136
   Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287
   Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085
   Hambardzumyan D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024454
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704
   Infanger DW, 2013, ANNU REV BIOMED ENG, V15, P29, DOI 10.1146/annurev-bioeng-071811-150028
   Jackson C, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/732413
   Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b
   Kievit FM, 2010, BIOMATERIALS, V31, P5903, DOI 10.1016/j.biomaterials.2010.03.062
   Kondraganti S, 2000, CANCER RES, V60, P6851
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Mahadik BP, 2014, ADV HEALTHC MATER, V3, P449, DOI 10.1002/adhm.201300263
   MERZAK A, 1994, CANCER RES, V54, P3988
   Nakada M, 2007, CELL MOL LIFE SCI, V64, P458, DOI 10.1007/s00018-007-6342-5
   Norrby K, 2006, J CELL MOL MED, V10, P588, DOI 10.2755/jcmm010.003.01
   Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011
   Park MJ, 2002, CANCER RES, V62, P6318
   Pedron S, 2013, J BIOMED MATER RES A, V101, P3404, DOI 10.1002/jbm.a.34637
   Pedron S, 2013, BIOMATERIALS, V34, P7408, DOI 10.1016/j.biomaterials.2013.06.024
   Prestwich GD, 2007, J CELL BIOCHEM, V101, P1370, DOI 10.1002/jeb.21386
   Radotra B, 1997, J PATHOL, V181, P434
   Reynolds BA, 2009, CELL STEM CELL, V5, P466, DOI 10.1016/j.stem.2009.10.017
   Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489
   Serban MA, 2008, METHODS, V45, P93, DOI 10.1016/j.ymeth.2008.01.010
   Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110
   Tanaka S, 2013, NAT REV CLIN ONCOL, V10, P14, DOI 10.1038/nrclinonc.2012.204
   Unsgaard G, 2006, ACTA NEUROCHIR, V148, P235, DOI 10.1007/s00701-005-0688-y
   Villa-Diaz LG, 2013, STEM CELLS, V31, P1, DOI 10.1002/stem.1260
   Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126
   Wiranowska M., 2011, GLIOMA EXPLORING ITS
   Zhang W, 2003, J NEUROSURG, V99, P1039, DOI 10.3171/jns.2003.99.6.1039
NR 37
TC 35
Z9 36
U1 4
U2 104
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD MAR 4
PY 2015
VL 27
IS 9
BP 1567
EP +
DI 10.1002/adma.201404896
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CC7IO
UT WOS:000350541100011
PM 25521283
DA 2018-10-19
ER

PT J
AU Reategui, E
   Aceto, N
   Lim, EJ
   Sullivan, JP
   Jensen, AE
   Zeinali, M
   Martel, JM
   Aranyosi, AJ
   Li, W
   Castleberry, S
   Bardia, A
   Sequist, LV
   Haber, DA
   Maheswaran, S
   Hammond, PT
   Toner, M
   Stott, SL
AF Reategui, Eduardo
   Aceto, Nicola
   Lim, Eugene J.
   Sullivan, James P.
   Jensen, Anne E.
   Zeinali, Mahnaz
   Martel, Joseph M.
   Aranyosi, Alexander J.
   Li, Wei
   Castleberry, Steven
   Bardia, Aditya
   Sequist, Lecia V.
   Haber, Daniel A.
   Maheswaran, Shyamala
   Hammond, Paula T.
   Toner, Mehmet
   Stott, Shannon L.
TI Tunable Nanostructured Coating for the Capture and Selective Release of
   Viable Circulating Tumor Cells
SO ADVANCED MATERIALS
LA English
DT Article
ID BREAST-CANCER; EFFICIENT CAPTURE; MELANOMA-CELLS; WHOLE-BLOOD;
   NANOMATERIALS; METASTASIS; MUTATIONS; EGFR
AB A layer-by-layer gelatin nanocoating is presented for use as a tunable, dual response biomaterial for the capture and release of circulating tumor cells (CTCs) from cancer patient blood. The entire nanocoating can be dissolved from the surface of microfluidic devices through biologically compatible temperature shifts. Alternatively, individual CTCs can be released through locally applied mechanical stress.
C1 [Reategui, Eduardo; Lim, Eugene J.; Jensen, Anne E.; Zeinali, Mahnaz; Martel, Joseph M.; Aranyosi, Alexander J.; Toner, Mehmet; Stott, Shannon L.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Engn Med, Charlestown, MA 02129 USA.
   [Reategui, Eduardo; Martel, Joseph M.; Toner, Mehmet; Stott, Shannon L.] Harvard Univ, Sch Med, Shriners Hosp Children, Boston, MA 02114 USA.
   [Reategui, Eduardo; Martel, Joseph M.; Toner, Mehmet] Harvard Univ, Med Sch 55, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA.
   [Aceto, Nicola; Sullivan, James P.; Bardia, Aditya; Sequist, Lecia V.; Haber, Daniel A.; Maheswaran, Shyamala] Harvard Univ, Med Sch Boston, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.
   [Lim, Eugene J.] MIT, Dept Elect Engn, Cambridge, MA 02139 USA.
   [Li, Wei; Castleberry, Steven; Hammond, Paula T.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
   [Stott, Shannon L.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.
RP Stott, SL (reprint author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Engn Med, Bldg 114,16th St, Charlestown, MA 02129 USA.
EM sstott@mgh.harvard.edu
RI Li, Wei/P-3546-2016
OI Li, Wei/0000-0002-4738-1475; Aceto, Nicola/0000-0001-9579-6918;
   Reategui, Eduardo/0000-0002-8271-8205; Aranyosi,
   Alexander/0000-0002-8133-5026
FU Stand Up to Cancer; Howard Hughes Medical Institute; NIH [CA129933, P41
   EB002503-11]; National Institute for Biomedical Imaging and
   Bioengineering (NIBIB) [EB008047]
FX The authors acknowledge all our patients who participated in this study
   and the healthy volunteers who kindly donated their blood. Blood
   specimens for CTC isolation were obtained after informed patient consent
   according to institutional review board (IRB) protocol (05-300), at the
   Massachusetts General Hospital. This work was supported by grants from
   Stand Up to Cancer (D.A.H., M.T., S.M.), Howard Hughes Medical Institute
   (D.A.H.), NIH CA129933 (D.A.H.), National Institute for Biomedical
   Imaging and Bioengineering (NIBIB) EB008047 (M.T., D.A.H.), NIH P41
   EB002503-11 (M.T.). Thanks to Laura Libby and Octavio Hurtado for expert
   technical support. Thanks to Bavand Keshavarz for helping with microtip
   design, Matthew Phillips for the CTC enumeration scans, Thomas Carey for
   the atomic force microscopy analysis, and Charles P. Lai for the
   nanoparticle size characterization.
CR Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013
   Adams AA, 2008, J AM CHEM SOC, V130, P8633, DOI 10.1021/ja8015022
   Antonyak M. A., 2011, P NATL ACAD SCI US
   Chen L, 2011, ADV MATER, V23, P4376, DOI 10.1002/adma.201102435
   Cho EH, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016001
   Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766
   Cristofanilli M, 2006, P NATL ACAD SCI USA, V103, P17073, DOI 10.1073/pnas.0608651103
   Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223
   GLAVES D, 1988, BRIT J CANCER, V57, P32, DOI 10.1038/bjc.1988.4
   Hatch A, 2011, LANGMUIR, V27, P4257, DOI 10.1021/la105016a
   Hou S, 2013, ANGEW CHEM INT EDIT, V52, P3379, DOI 10.1002/anie.201208452
   Hou S, 2013, ADV MATER, V25, P1547, DOI 10.1002/adma.201203185
   Luo X, 2014, CELL REP, V7, P645, DOI 10.1016/j.celrep.2014.03.039
   Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668
   Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385
   Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616
   Pek YS, 2008, NAT NANOTECHNOL, V3, P671, DOI 10.1038/nnano.2008.270
   Powell A. A., 2012, PLOS ONE, V7, P33788
   Ran R, 2013, ANAL BIOANAL CHEM, V405, P7377, DOI 10.1007/s00216-013-7156-y
   Shah AM, 2012, ANAL CHEM, V84, P3682, DOI 10.1021/ac300190j
   Shen QL, 2013, ADV MATER, V25, P2368, DOI 10.1002/adma.201300082
   Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107
   Vizio D. D., 2012, AM J PATHOL, V181, P1573
   Wang ST, 2011, ANGEW CHEM INT EDIT, V50, P3084, DOI 10.1002/anie.201005853
   Westwood M, 2010, MACROMOLECULES, V43, P10582, DOI 10.1021/ma101466w
   Xie M, 2014, ANAL CHEM, V86, P4618, DOI 10.1021/ac500820p
   Yoon HJ, 2014, ACS NANO, V8, P1995, DOI 10.1021/nn5004277
   Yoon HJ, 2013, NAT NANOTECHNOL, V8, P735, DOI 10.1038/nnano.2013.194
   Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522
   Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217
   Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021
   Zhao LB, 2013, ADV MATER, V25, P2897, DOI 10.1002/adma.201205237
   Zhao WA, 2012, P NATL ACAD SCI USA, V109, P19626, DOI 10.1073/pnas.1211234109
NR 33
TC 64
Z9 65
U1 20
U2 247
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD MAR 4
PY 2015
VL 27
IS 9
BP 1593
EP +
DI 10.1002/adma.201404677
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CC7IO
UT WOS:000350541100015
PM 25640006
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Rutz, AL
   Hyland, KE
   Jakus, AE
   Burghardt, WR
   Shah, RN
AF Rutz, Alexandra L.
   Hyland, Kelly E.
   Jakus, Adam E.
   Burghardt, Wesley R.
   Shah, Ramille N.
TI A Multimaterial Bioink Method for 3D Printing Tunable, Cell-Compatible
   Hydrogels
SO ADVANCED MATERIALS
LA English
DT Article
ID CROSS-LINKING; POTENTIAL BIOMATERIALS; HYALURONIC-ACID; SCAFFOLDS;
   DELIVERY; BIOFABRICATION; FABRICATION; MATRICES; GROWTH; CARBODIIMIDE
AB A multimaterial bio-ink method using polyethylene glycol crosslinking is presented for expanding the biomaterial palette required for 3D bio printing of more mimetic and customizable tissue and organ constructs. Lightly crosslinked, soft hydrogels are produced from precursor solutions of various materials and 3D printed. Rheological and biological characterizations are presented, and the promise of this new bio-ink synthesis strategy is discussed.
C1 [Rutz, Alexandra L.; Hyland, Kelly E.; Jakus, Adam E.; Shah, Ramille N.] Simpson Querrey Inst BioNanotechnol, Chicago, IL 60611 USA.
   [Rutz, Alexandra L.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Hyland, Kelly E.; Jakus, Adam E.; Burghardt, Wesley R.; Shah, Ramille N.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
   [Burghardt, Wesley R.] Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Shah, Ramille N.] Northwestern Univ, Feinberg Sch Med, Dept Surg Organ Transplantat, Chicago, IL 60611 USA.
RP Shah, RN (reprint author), Simpson Querrey Inst BioNanotechnol, Chicago, IL 60611 USA.
EM ramille-shah@northwestern.edu
RI Burghardt, Wesley/B-7642-2009; Shah, Ramille/E-3737-2010
FU NCI CCSG [P30 CA060553]; NSF [DMR-0520513]; Engineering Center
   [EEC-0118025|003]; Peptide and Equipment Core Facilities at the Simpson
   Querrey Institute for BioNanotechnology at Northwestern University from
   U.S. Army Research Office; U.S. Army Medical Research and Materiel
   Command; Northwestern University; National Institutes of Health
   [1K01DK099454-01]; National Science Foundation
FX The authors thank Sumanas W. Jordan and Phillip L. Lewis for assistance
   with printing cell encapsulating bioinks. They would also like to thank
   the Woodruff Lab (PI: Teresa Woodruff, Ph.D.) at Northwestern University
   for gracious use of their Leica stereoscope as well as Peter Rios (PI:
   Lonnie Shea, Ph.D.) for use of their UV lamp. They also acknowledge use
   of the following facilities: Northwestern University Cell Imaging
   Facility generously supported by NCI CCSG P30 CA060553 awarded to the
   Robert H Lurie Comprehensive Cancer Center, EPIC facility (NUANCE
   Center-Northwestern University) which has received support from NSF
   DMR-0520513 and Engineering Center EEC-0118025|003, and the Peptide and
   Equipment Core Facilities at the Simpson Querrey Institute for
   BioNanotechnology at Northwestern University developed by support from
   the U.S. Army Research Office, the U.S. Army Medical Research and
   Materiel Command, and Northwestern University. This work was supported
   by the National Institutes of Health (1K01DK099454-01) and National
   Science Foundation (Graduate Research Fellowship for A.L.R.).
CR Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Capito RM, 2007, GENE THER, V14, P721, DOI 10.1038/sj.gt.3302918
   Censi R, 2011, ADV FUNCT MATER, V21, P1833, DOI 10.1002/adfm.201002428
   Chandler EM, 2011, BIOTECHNOL BIOENG, V108, P1683, DOI 10.1002/bit.23079
   Chang CC, 2011, J BIOMED MATER RES B, V98B, P160, DOI 10.1002/jbm.b.31831
   Cohen DL, 2006, TISSUE ENG, V12, P1325, DOI 10.1089/ten.2006.12.1325
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Derby B, 2012, SCIENCE, V338, P921, DOI 10.1126/science.1226340
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Fedorovich NE, 2012, TISSUE ENG PART C-ME, V18, P33, DOI [10.1089/ten.tec.2011.0060, 10.1089/ten.TEC.2011.0060]
   Fedorovich NE, 2009, BIOMACROMOLECULES, V10, P1689, DOI 10.1021/bm801463q
   Fu Y, 2012, BIOMATERIALS, V33, P48, DOI 10.1016/j.biomaterials.2011.09.031
   Gaetani R, 2012, BIOMATERIALS, V33, P1782, DOI 10.1016/j.biomaterials.2011.11.003
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Gorgieva S, 2012, J BIOMED MATER RES A, V100A, P1655, DOI 10.1002/jbm.a.34106
   HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2
   Jiang YJ, 2014, BIOMATERIALS, V35, P4969, DOI 10.1016/j.biomaterials.2014.03.001
   Khalil S., 2009, J BIOMECH ENG, V131, P1, DOI 10.1115/1.3129729
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   Loozen LD, 2013, J MATER CHEM B, V1, P6619, DOI 10.1039/c3tb21093f
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Malda J, 2013, ADV MATER, V25, P5011, DOI 10.1002/adma.201302042
   Matson JB, 2011, CURR OPIN SOLID ST M, V15, P225, DOI 10.1016/j.cossms.2011.08.001
   Mironov V, 2011, CURR OPIN BIOTECH, V22, P667, DOI 10.1016/j.copbio.2011.02.006
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Nimmo CM, 2011, BIOCONJUGATE CHEM, V22, P2199, DOI 10.1021/bc200281k
   Ozbolat IT, 2013, IEEE T BIO-MED ENG, V60, P691, DOI 10.1109/TBME.2013.2243912
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Pati F., 2014, NAT COMMUN, V5, P1
   Phelps EA, 2012, ADV MATER, V24, P64, DOI 10.1002/adma.201103574
   Rafat M, 2008, BIOMATERIALS, V29, P3960, DOI 10.1016/j.biomaterials.2008.06.017
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Ringeisen BR, 2013, MRS BULL, V38, P834, DOI 10.1557/mrs.2013.209
   Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4
   Schuurman W, 2013, MACROMOL BIOSCI, V13, P551, DOI 10.1002/mabi.201200471
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Shepherd JNH, 2011, ADV FUNCT MATER, V21, P47, DOI 10.1002/adfm.201001746
   Skardal A, 2010, TISSUE ENG PT A, V16, P2675, DOI 10.1089/ten.TEA.2009.0798
   Skardal A, 2012, BIOMATERIALS, V33, P4565, DOI 10.1016/j.biomaterials.2012.03.034
   Skardal A, 2010, BIOMATERIALS, V31, P6173, DOI 10.1016/j.biomaterials.2010.04.045
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   Wang XH, 2006, TISSUE ENG, V12, P83, DOI 10.1089/ten.2006.12.83
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 47
TC 132
Z9 134
U1 46
U2 466
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD MAR 4
PY 2015
VL 27
IS 9
BP 1607
EP +
DI 10.1002/adma.201405076
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CC7IO
UT WOS:000350541100017
PM 25641220
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Mehdizadeh, H
   Somo, SI
   Bayrak, ES
   Brey, EM
   Cinar, A
AF Mehdizadeh, Hamidreza
   Somo, Sami I.
   Bayrak, Elif S.
   Brey, Eric M.
   Cinar, Ali
TI Design of Polymer Scaffolds for Tissue Engineering Applications
SO INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH
LA English
DT Article
ID WOUND-HEALING ANGIOGENESIS; CAPILLARY FORMATION; TUMOR ANGIOGENESIS;
   MULTICELLULAR PATTERNS; SPROUTING ANGIOGENESIS; MATHEMATICAL-MODEL;
   VASCULARIZED BONE; CELL PHENOTYPES; SIMULATION; VEGF
AB Agent-based models (ABMs) provide a flexible multilayer platform for incorporating various modeling techniques into a single hybrid model for designing optimal biomaterial scaffolds for angiogenesis in tissue engineering applications. Scaffold geometrical variables are considered as design variables. The growth-factor concentration profile is the only process variable considered in this study. The product variables used to illustrate the combined effects of scaffold design variables and process variables on the outcome of angiogenesis include the density and depth of capillary invasion within the scaffold. The scaffold design process and the ABM developed to simulate angiogenesis are described in this article. The performance of the ABM and the vascularization of the polymer scaffolds are evaluated by simulation studies. The effects of pore size, pore size distribution, and interconnectivity on the total blood vessel length, invasion depth, and total number of sprouts formed during the vascularization process are reported. The integration of the simulation of angiogenesis with ABMs and scaffold design techniques provides an iterative process for designing optimal scaffold structures. Such an approach facilitates faster design of optimized scaffolds with significantly less cost and enables better understanding of the mechanisms of angiogenesis of polymer scaffolds for tissue engineering applications.
C1 [Mehdizadeh, Hamidreza; Somo, Sami I.; Bayrak, Elif S.; Brey, Eric M.; Cinar, Ali] IIT, Chicago, IL 60616 USA.
RP Cinar, A (reprint author), IIT, 3300 S Fed St, Chicago, IL 60616 USA.
EM cinar@iit.edu
OI Cinar, Ali/0000-0002-1607-9943
FU National Science Foundation [CBET-0731201, IIS-1125412]; Veterans
   Administration
FX This material is based on work supported in part by the National Science
   Foundation (CBET-0731201 and IIS-1125412) and the Veterans
   Administration.
CR Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183
   Annabi N, 2014, ADV MATER, V26, P85, DOI 10.1002/adma.201303233
   Artel A, 2011, TISSUE ENG PT A, V17, P2133, DOI [10.1089/ten.tea.2010.0571, 10.1089/ten.TEA.2010.0571]
   Athale C, 2005, J THEOR BIOL, V233, P469, DOI 10.1016/j.jtbi.2004.10.019
   Ausk BJ, 2006, J BIOMECH, V39, P2638, DOI 10.1016/j.jbiomech.2005.08.023
   Bae H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003688
   BALDING D, 1985, J THEOR BIOL, V114, P53, DOI 10.1016/S0022-5193(85)80255-1
   Behdani B, 2011, IND ENG CHEM RES, V50, P5086, DOI 10.1021/ie101554b
   Bentley K, 2008, J THEOR BIOL, V250, P25, DOI 10.1016/j.jtbi.2007.09.015
   Blinder YJ, 2014, CURR OPIN CHEM ENG, V3, P56, DOI 10.1016/j.coche.2013.11.003
   Breen EC, 2007, J CELL BIOCHEM, V102, P1358, DOI 10.1002/jcb.21579
   Brey EM, 2005, TISSUE ENG, V11, P567, DOI 10.1089/ten.2005.11.567
   BYRNE HM, 1995, B MATH BIOL, V57, P461, DOI 10.1016/S0092-8240(05)81778-1
   Chaplain MAJ, 2000, J NEURO-ONCOL, V50, P37, DOI 10.1023/A:1006446020377
   Checa S, 2010, J BIOMECH, V43, P961, DOI 10.1016/j.jbiomech.2009.10.044
   Chiu YC, 2010, TISSUE ENG PART C-ME, V16, P905, DOI [10.1089/ten.tec.2009.0646, 10.1089/ten.TEC.2009.0646]
   Dia H, 2002, TRANSPORT RES C-EMER, V10, P331, DOI 10.1016/S0968-090X(02)00025-6
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010
   Farmer JD, 2009, NATURE, V460, P685, DOI 10.1038/460685a
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Gauvin R, 2012, BIOMATERIALS, V33, P3824, DOI 10.1016/j.biomaterials.2012.01.048
   Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571
   Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hutton DL, 2014, CURR OPIN CHEM ENG, V3, P75, DOI 10.1016/j.coche.2013.12.002
   Jabbarzadeh E, 2007, TISSUE ENG, V13, P2073, DOI 10.1089/ten.2006.0057
   Jiang B, 2013, ACTA BIOMATER, V9, P4976, DOI 10.1016/j.actbio.2012.10.005
   Jones AC, 2009, BIOMATERIALS, V30, P1440, DOI 10.1016/j.biomaterials.2008.10.056
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khademhosseini A, 2014, CURR OPIN CHEM ENG, V3, pV, DOI 10.1016/j.coche.2014.01.003
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Kouvroukoglou S, 2000, BIOMATERIALS, V21, P1725, DOI 10.1016/S0142-9612(99)00205-7
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lemon G, 2011, BIOSYSTEMS, V103, P372, DOI 10.1016/j.biosystems.2010.11.009
   Levine HA, 2001, B MATH BIOL, V63, P801, DOI 10.1006/bulm.2001.0240
   Liu G, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-6
   Long BL, 2013, J THEOR BIOL, V326, P43, DOI 10.1016/j.jtbi.2012.11.030
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Lu TL, 2013, INT J NANOMED, V8, P337, DOI 10.2147/IJN.S38635
   Mansbridge J, 2006, J ANAT, V209, P527, DOI 10.1111/j.1469-7580.2006.00631.x
   MEHDIZADEH H, 2011, AGENTS PRINCIPLE AGE, V7047, P113
   Mehdizadeh H., 2014, VASCULARIZATION REGE
   Mehdizadeh H, 2013, BIOMATERIALS, V34, P2875, DOI 10.1016/j.biomaterials.2012.12.047
   Morreale P, 1998, IEEE SPECTRUM, V35, P34, DOI 10.1109/6.666958
   Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Olsen L, 1997, IMA J MATH APPL MED, V14, P261
   Orme ME, 1997, IMA J MATH APPL MED, V14, P189
   Peirce SM, 2012, CURR OPIN HEMATOL, V19, P184, DOI 10.1097/MOH.0b013e3283523ea6
   Peirce S, 2008, MICROCIRCULATION, V15, P739, DOI 10.1080/10739680802220331
   Peirce SM, 2004, FASEB J, V18, P731, DOI 10.1096/fj.03-0933fje
   Pettet GJ, 1996, MATH BIOSCI, V136, P35, DOI 10.1016/0025-5564(96)00044-2
   Post MJ, 2013, REGEN MED, V8, P759, DOI 10.2217/rme.13.74
   Qutub AA, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-13
   Ribatti D, 2012, DEV BIOL, V372, P157, DOI 10.1016/j.ydbio.2012.09.018
   Saltzman W. M., 2004, TISSUE ENG ENG PRINC
   Sandino C, 2010, BIOMATERIALS, V31, P2446, DOI 10.1016/j.biomaterials.2009.11.063
   Sicchieri LG, 2012, J TISSUE ENG REGEN M, V6, P155, DOI 10.1002/term.422
   Smith Q, 2014, CURR OPIN CHEM ENG, V3, P42, DOI 10.1016/j.coche.2013.11.001
   STOKES CL, 1991, J THEOR BIOL, V152, P377, DOI 10.1016/S0022-5193(05)80201-2
   Tesfatsion L, 2002, ARTIF LIFE, V8, P55, DOI 10.1162/106454602753694765
   Thorne Bryan C., 2007, Birth Defects Research, V81, P344, DOI 10.1002/bdrc.20106
   Tien J, 2014, CURR OPIN CHEM ENG, V3, P36, DOI 10.1016/j.coche.2013.10.006
   Vempati P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-59
   Walpole J, 2013, ANNU REV BIOMED ENG, V15, P137, DOI 10.1146/annurev-bioeng-071811-150104
   Wang MO, 2015, ADV MATER, V27, P138, DOI 10.1002/adma.201403943
   Wu FTH, 2010, AM J PHYSIOL-HEART C, V298, pH2174, DOI 10.1152/ajpheart.00365.2009
   ZAWICKI DF, 1981, MICROVASC RES, V21, P27, DOI 10.1016/0026-2862(81)90003-0
   Zhang L, 2007, J THEOR BIOL, V244, P96, DOI 10.1016/j.jtbi.2006.06.034
NR 71
TC 3
Z9 3
U1 1
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0888-5885
J9 IND ENG CHEM RES
JI Ind. Eng. Chem. Res.
PD MAR 4
PY 2015
VL 54
IS 8
BP 2317
EP 2328
DI 10.1021/ie503133e
PG 12
WC Engineering, Chemical
SC Engineering
GA CC8JT
UT WOS:000350615200007
DA 2018-10-19
ER

PT J
AU Dehoux, T
   Ghanem, MA
   Zouani, OF
   Rampnoux, JM
   Guillet, Y
   Dilhaire, S
   Durrieu, MC
   Audoin, B
AF Dehoux, T.
   Ghanem, M. Abi
   Zouani, O. F.
   Rampnoux, J. -M.
   Guillet, Y.
   Dilhaire, S.
   Durrieu, M. -C.
   Audoin, B.
TI All-optical broadband ultrasonography of single cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; ACOUSTIC MICROSCOPY; PICOSECOND ULTRASONICS;
   LIVING CELLS; LIVE CELLS; RESOLUTION; MECHANICS; MEMBRANE
AB Cell mechanics play a key role in several fundamental biological processes, such as migration, proliferation, differentiation and tissue morphogenesis. In addition, many diseased conditions of the cell are correlated with altered cell mechanics, as in the case of cancer progression. For this there is much interest in methods that can map mechanical properties with a sub-cell resolution. Here, we demonstrate an inverted pulsed opto-acoustic microscope (iPOM) that operates in the 10 to 100 GHz range. These frequencies allow mapping quantitatively cell structures as thin as 10 nm and resolving the fibrillar details of cells. Using this non-invasive all-optical system, we produce high-resolution images based on mechanical properties as the contrast mechanisms, and we can observe the stiffness and adhesion of single migrating stem cells. The technique should allow transferring the diagnostic and imaging abilities of ultrasonic imaging to the single-cell scale, thus opening new avenues for cell biology and biomaterial sciences.
C1 [Dehoux, T.; Ghanem, M. Abi; Guillet, Y.; Audoin, B.] Univ Bordeaux, I2M, UMR 5295, F-33400 Talence, France.
   [Dehoux, T.; Ghanem, M. Abi; Guillet, Y.; Audoin, B.] CNRS, I2M, UMR 5295, F-33400 Talence, France.
   [Zouani, O. F.; Durrieu, M. -C.] Univ Bordeaux, CBMN, UMR CNRS 5248, F-33607 Pessac, France.
   [Rampnoux, J. -M.; Dilhaire, S.] Univ Bordeaux, CNRS, LOMA, UMR 5798, F-33400 Talence, France.
RP Audoin, B (reprint author), Univ Bordeaux, I2M, UMR 5295, F-33400 Talence, France.
EM bertrand.audoin@u-bordeaux.fr
RI DURRIEU, Marie-Christine/I-4358-2016
OI DURRIEU, Marie-Christine/0000-0003-0583-9289; dehoux,
   thomas/0000-0003-0808-4037
FU Agence Nationale de la Recherche [ANR-13-BS09-0021-01]; Region
   Aquitaine; GIS Advanced Materials in Aquitaine
FX T.D., B.A. and M.C.D. acknowledge financial support from the Agence
   Nationale de la Recherche (grant no. ANR-13-BS09-0021-01), the Region
   Aquitaine and the GIS Advanced Materials in Aquitaine.
CR Abbas A, 2014, OPT EXPRESS, V22, P7831, DOI 10.1364/OE.22.007831
   Abi Ghanem M., 2014, J BIOPHOTONICS, V7, P453
   [Anonymous], 2008, [No title captured], Patent No. 12090893
   Audoin B, 2010, ULTRASONICS, V50, P202, DOI 10.1016/j.ultras.2009.09.019
   Bartels A, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2167812
   Bereiter-Hahn J., 1995, ADV ACOUST MICROS, V1, P79
   Brandao MM, 2003, EUR J HAEMATOL, V70, P207, DOI 10.1034/j.1600-0609.2003.00027.x
   Che S, 2015, ULTRASONICS, V56, P153, DOI 10.1016/j.ultras.2014.02.010
   Cheng ZA, 2013, NANO LETT, V13, P3923, DOI 10.1021/nl4020149
   Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388
   Dehoux T, 2012, J APPL PHYS, V112, DOI 10.1063/1.4769294
   Dehoux T, 2015, ULTRASONICS, V56, P160, DOI 10.1016/j.ultras.2014.07.010
   Gusev V. E., 1993, LASER OPTOACOUSTICS
   HILDEBRAND JA, 1981, P NATL ACAD SCI-BIOL, V78, P1656, DOI 10.1073/pnas.78.3.1656
   JOHNSTON RN, 1979, P NATL ACAD SCI USA, V76, P3325, DOI 10.1073/pnas.76.7.3325
   Lei Y., 2012, SMALL, V9, P1086, DOI DOI 10.1002/SMLL.201202410)
   Li Z, 2009, NANO LETT, V9, P3575, DOI 10.1021/nl901774m
   LUERS H, 1992, ACOUST IMAG, V19, P511
   Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9
   Maris H., 1998, Scientific American (International Edition), V278, P64
   Mechri C, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3220063
   MUHA MS, 1990, APPL PHYS LETT, V56, P1019, DOI 10.1063/1.102603
   Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102
   Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975
   Pernot G, 2010, NAT MATER, V9, P491, DOI [10.1038/NMAT2752, 10.1038/nmat2752]
   Raman A, 2011, NAT NANOTECHNOL, V6, P809, DOI [10.1038/NNANO.2011.186, 10.1038/nnano.2011.186]
   Rheinlaender J, 2013, SOFT MATTER, V9, P3230, DOI 10.1039/c2sm27412d
   Rossignol C, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2988470
   Scarcelli G, 2008, NAT PHOTONICS, V2, P39, DOI 10.1038/nphoton.2007.250
   Schaus SS, 1997, BIOPHYS J, V73, P1205, DOI 10.1016/S0006-3495(97)78153-0
   Schoen I, 2010, NANO LETT, V10, P1823, DOI 10.1021/nl100533c
   Sen S, 2005, BIOPHYS J, V89, P3203, DOI 10.1529/biophysj.105.063826
   Stricker J, 2010, J BIOMECH, V43, P9, DOI 10.1016/j.jbiomech.2009.09.003
   TATTERSALL HG, 1973, J PHYS D APPL PHYS, V6, P819, DOI 10.1088/0022-3727/6/7/305
   THOMSEN C, 1984, PHYS REV LETT, V53, P989, DOI 10.1103/PhysRevLett.53.989
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Weiss EC, 2007, ULTRASOUND MED BIOL, V33, P1320, DOI 10.1016/j.ultrasmedbio.2007.01-016
   Yang F, 2010, Journal of Applied Physics, V107, DOI 10.1063/1.3388283
   Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220
   Zhao Y, 2006, SENSOR ACTUAT B-CHEM, V114, P1108, DOI 10.1016/j.snb.2005.07.071
   Zouani OF, 2012, J CELL SCI, V125, P1217, DOI 10.1242/jcs.093229
NR 41
TC 19
Z9 19
U1 0
U2 41
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 3
PY 2015
VL 5
AR 8650
DI 10.1038/srep08650
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CC4UQ
UT WOS:000350349800003
PM 25731090
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Boraphech, P
   Thiravetyan, P
AF Boraphech, Phattara
   Thiravetyan, Paitip
TI Trimethylamine (fishy odor) adsorption by biomaterials: Effect of fatty
   acids, alkanes, and aromatic compounds in waxes
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE Adsorption; Leaf biomaterial; Sansevieria trifasciata; Trimethylamine;
   Wax component
ID WASTE-WATER; HEAVY-METALS; CHEMICAL-COMPOSITION; SORPTION KINETICS;
   CUTICULAR WAXES; COIR PITH; BIOFILTRATION; EMISSIONS; REMOVAL; PLANT
AB Thirteen plant leaf materials were selected to be applied as dried biomaterial adsorbents for polar gaseous trimethylamine (TMA) adsorption. Biomaterial adsorbents were efficient in adsorbing gaseous TMA up to 100% of total TMA (100 ppm) within 24 h. Sansevieria trifasciata is the most effective plant leaf material while Plerocatpus indicus was the least effective in TMA adsorption. Activated carbon (AC) was found to be lower potential adsorbent to adsorb TMA when compared to biomaterial adsorbents. As adsorption data, the Langmuir isotherm supported that the gaseous TMA adsorbed monolayer on the adsorbent surface and was followed pseudo-second order kinetic model. Wax extracted from plant leaf could also adsorb gaseous TMA up to 69% of total TMA within 24 h. Another 27-63% of TMA was adsorbed by cellulose and lignin that naturally occur in high amounts in plant leaf. Subsequently, the composition appearing in biomaterial wax showed a large quantity of short-chain fatty acids (<= C-18) especially octadecanoic acid (C-18), and short-chain alkanes (C-12-C-18) as well as total aromatic components dominated in the wax, which affected TMA adsorption. Hence, it has been demonstrated that plant biomaterial is a superior biosorbent for TMA removal. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Boraphech, Phattara; Thiravetyan, Paitip] King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Bangkok 10150, Thailand.
RP Thiravetyan, P (reprint author), King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Bangkok 10150, Thailand.
EM paitip.thi@kmutt.ac.th
FU Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program;
   King Mongkut's University of Technology Thonburi [PHD/0108/2553]
FX The authors would like to thank the Thailand Research Fund through the
   Royal Golden Jubilee Ph.D. Program and King Mongkut's University of
   Technology Thonburi for financially supporting Ms. Phattara Boraphech
   (Grant No. PHD/0108/2553).
CR *ACGIH, 1991, DOC THRESH LIM VAL B
   Amoore J E, 1983, J Appl Toxicol, V3, P272, DOI 10.1002/jat.2550030603
   Asikin Y, 2008, FOOD SCI TECHNOL RES, V14, P583, DOI 10.3136/fstr.14.583
   Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8
   Beck KR, 1997, TEXT CHEM COLOR, V29, P66
   Buschhaus C, 2007, ANN BOT-LONDON, V100, P1557, DOI 10.1093/aob/mcm255
   Buschhaus C, 2011, J EXP BOT, V62, P841, DOI 10.1093/jxb/erq366
   Cameron Carbon Incorporated, 2006, ACT CARB MAN STRUCT
   Cao NJ, 1997, APPL BIOCHEM BIOTECH, V63-5, P387, DOI 10.1007/BF02920440
   Cao W, 2011, CARBOHYD POLYM, V85, P571, DOI 10.1016/j.carbpol.2011.03.016
   Chakravarty S, 2010, J HAZARD MATER, V173, P502, DOI 10.1016/j.jhazmat.2009.08.113
   Chang CT, 2004, CHEMOSPHERE, V55, P751, DOI 10.1016/j.chemosphere.2003.11.037
   Chien YC, 2000, ANAL CHIM ACTA, V419, P73, DOI 10.1016/S0003-2670(00)00973-9
   Ding Y, 2007, J HAZARD MATER, V143, P341, DOI 10.1016/j.jhazmat.2006.09.031
   Dubey A, 2012, INT J ENVIRON SCI TE, V9, P15, DOI 10.1007/s13762-011-0012-8
   Dubis EN, 2001, J MOL STRUCT, V596, P83, DOI 10.1016/S0022-2860(01)00691-3
   Errasquin EL, 2003, CHEMOSPHERE, V50, P137
   Garnham G.W., 1997, USE ALGAE METAL BIOS, P11
   Gupta R, 2000, CURR SCI INDIA, V78, P967
   Han P., 2013, J HEBEI U SCI TECHNO
   Healy R.M., 2014, ANAL BIOANAL CHEM
   Ho KL, 2008, CHEMOSPHERE, V72, P250, DOI 10.1016/j.chemosphere.2008.01.044
   Ho YS, 2004, PROCESS BIOCHEM, V39, P759, DOI 10.1016/S0032-9592(03)00184-5
   Ho YS, 1999, J ENVIRON SCI HEAL A, V34, P1179, DOI 10.1080/10934529909376889
   Ho YS, 2006, J HAZARD MATER, V136, P681, DOI 10.1016/j.jhazmat.2005.12.043
   HODGE DS, 1994, ENVIRON PROG, V13, P167, DOI 10.1002/ep.670130311
   Hoerr CW, 1944, J ORG CHEM, V9, P329, DOI 10.1021/jo01186a005
   HSDB Hazardous Substances Data Bank, 2006, TRIM
   Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1
   Juniper B.E., 1983, PLANT SURFACES, P6
   Kapoor A., 1997, FUNGI BIOSORBENTS BI, P67
   Kumar KV, 2006, J HAZARD MATER, V137, P1538, DOI 10.1016/j.jhazmat.2006.04.036
   Kumar PS, 2009, J ENG SCI TECHNOL, V4, P351
   Lee SW, 2010, J IND ENG CHEM, V16, P973, DOI 10.1016/j.jiec.2010.04.002
   LEONARDOS G, 1969, Journal of the Air Pollution Control Association, V19, P91
   LESON G, 1991, J AIR WASTE MANAGE, V41, P1045, DOI 10.1080/10473289.1991.10466898
   Li Y, 2013, J APPL POLYM SCI, V128, P2746, DOI 10.1002/app.38437
   lyobe Tsutomu, 2004, Journal of Health Science, V50, P148
   Mackiewicz E, 2014, REACT KINET MECH CAT, V111, P763, DOI 10.1007/s11144-013-0666-y
   Martin J. T., 1970, CUTICLES PLANTS
   Melse RW, 2005, T ASAE, V48, P2303
   Nair V, 2014, CHEM ENG J, V254, P491, DOI 10.1016/j.cej.2014.05.045
   National Institute for Occupational Safety and Health (NIOSH)/Occupational Safety and Health Administration (OSHA), 1981, DHHS NIOSH PUBL
   NIST The National Institute of Standards and Technology, 2008, OCT CAN AC 57 11 4 N
   OSHA, 1994, OCC SAF HLTH GUID TR
   Overah L.C., 2011, J APPL SCI ENV MANAG, V15, P87, DOI DOI 10.4314/JASEM.V15I1.65681
   Pillai SM, 2012, CHEM ENGINEER TRANS, V30, P247, DOI 10.3303/CET1230042
   Plazinski W, 2013, ADSORPTION, V19, P1055, DOI 10.1007/s10450-013-9529-0
   Rafatullah M, 2010, J HAZARD MATER, V177, P70, DOI 10.1016/j.jhazmat.2009.12.047
   Rappert S, 2005, WASTE MANAGE, V25, P887, DOI 10.1016/j.wasman.2005.07.008
   RUTH JH, 1986, AM IND HYG ASSOC J, V47, pA142
   SANGSTER J, 1989, J PHYS CHEM REF DATA, V18, P1111, DOI 10.1063/1.555833
   Shieh W.K., 1986, BIOCH ENG J, V33, P132
   Sintermann J, 2014, BIOGEOSCIENCES, V11, P5073, DOI 10.5194/bg-11-5073-2014
   STEPHENS ER, 1971, CALIF AGR, V25, P10
   Suksabye P, 2007, J HAZARD MATER, V141, P637, DOI 10.1016/j.jhazmat.2006.07.018
   Suksabye P, 2012, J ENVIRON MANAGE, V102, P1, DOI 10.1016/j.jenvman.2011.10.020
   Szafranek B, 2008, ACTA BIOL CRACOV BOT, V50, P49
   Taghizadeh-Toosi A, 2012, PLANT SOIL, V350, P57, DOI 10.1007/s11104-011-0870-3
   Treesubsuntorn C, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1736-5
   Vieira B. Volesky, 2000, INT MICROBIOL, V3, P17
   Vijayaraghavan K, 2008, BIOTECHNOL ADV, V26, P266, DOI 10.1016/j.biotechadv.2008.02.002
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   Walton T.J., 1990, METHODS PLANT BIOCH, V4, P105
   Zhong QQ, 2014, CARBOHYD POLYM, V111, P788, DOI 10.1016/j.carbpol.2014.05.043
NR 65
TC 7
Z9 7
U1 3
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
EI 1873-3336
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD MAR 2
PY 2015
VL 284
BP 269
EP 277
DI 10.1016/j.jhazmat.2014.11.014
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA AY4YX
UT WOS:000347581900032
PM 25664363
DA 2018-10-19
ER

PT J
AU Zhang, Y
   Wang, CY
   Hu, RS
   Liu, ZH
   Xue, W
AF Zhang, Yi
   Wang, Changyong
   Hu, Rushan
   Liu, Zonghua
   Xue, Wei
TI Polyethylenimine-Induced Alterations of Red Blood Cells and Their
   Recognition by the Complement System and Macrophages
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE biosafety evaluation; polyethylenimine; red blood cells; macrophages
ID LOW-DENSITY-LIPOPROTEIN; IN-VITRO; BIOTINYLATED ERYTHROCYTES;
   ALTERNATIVE PATHWAYS; AVIDIN ATTACHMENT; AMINO-GROUPS;
   PHOSPHATIDYLSERINE; ACTIVATION; SURFACE; EXTERNALIZATION
AB In practical applications, biomedical materials introduced in vivo may interact with various host cells and/or biomacromolecules and alter their physiological characteristics. Biomaterial-altered cells and/or biomacromolecules may be recognized as "non-self" by the host immune system and may consequently cause further immune responses. In the present work, the gene carrier material branched polyethylenimine (1.8 lcDa) (BPEI-1.8k) induced a series of alterations of human red blood cells (RBCs), such as a morphological transition from biconcave disks to spheroechinocytes, vesiculation, a size decrease, a change in surface charge from negative to positive, a cell density reduction, membrane oxidation, and PS externalization. Furthermore, BPEI-1.8k-treated RBCs caused autologous complement activation and were recognized by autologous macrophages. This implies that the biomedical material BPEI-1.8k changed the identity of the RBCs, leading to their recognition by the autologous immune system. This study provides novel insights for the biocompatibility evaluation and clinical application of biomedical materials.
C1 [Zhang, Yi; Wang, Changyong; Hu, Rushan; Liu, Zonghua; Xue, Wei] Jinan Univ, Dept Biomed Engn, Guangdong Higher Educ Inst, Key Lab Biomat, Guangzhou 510632, Guangdong, Peoples R China.
RP Liu, ZH; Xue, W (reprint author), Jinan Univ, Dept Biomed Engn, Guangdong Higher Educ Inst, Key Lab Biomat, Guangzhou 510632, Guangdong, Peoples R China.
EM tliuzonghua@jnu.edu.cn; weixue_jnu@hotmail.com
FU National Natural Science Foundation of China [81101151, 31271019]
FX This work was financially supported by the National Natural Science
   Foundation of China (Grants 81101151 and 31271019).
CR Ahmed T, 2010, BIOMACROMOLECULES, V11, P2707, DOI 10.1021/bm1007579
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Balasubramanian K, 2007, J BIOL CHEM, V282, P18357, DOI 10.1074/jbc.M700202200
   Bratosin D, 1998, BIOCHIMIE, V80, P173, DOI 10.1016/S0300-9084(98)80024-2
   Chapanian R, 2012, BIOMATERIALS, V33, P3047, DOI 10.1016/j.biomaterials.2011.12.053
   Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223
   Fadeel B, 2006, CELL DEATH DIFFER, V13, P360, DOI 10.1038/sj.cdd.4401836
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   HAYASHI K, 1990, J BIOMED MATER RES, V24, P1385, DOI 10.1002/jbm.820241010
   Huang YX, 2011, J CELL MOL MED, V15, P2634, DOI 10.1111/j.1582-4934.2011.01310.x
   JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2
   Kainthan RK, 2007, BIOMATERIALS, V28, P4581, DOI 10.1016/j.biomaterials.2007.07.011
   Kainthan RK, 2006, BIOMACROMOLECULES, V7, P703, DOI 10.1021/bm0504882
   Kang YH, 2009, ADV EXP MED BIOL, V653, P117
   Koshkaryev A, 2003, AM J PHYSIOL-CELL PH, V285, pC720, DOI 10.1152/ajpcell.00542.2002
   Koshkaryev A, 2010, CELL BIOCHEM BIOPHYS, V56, P109, DOI 10.1007/s12013-009-9074-3
   Kriebardis AG, 2008, TRANSFUSION, V48, P1943, DOI 10.1111/j.1537-2995.2008.01794.x
   Li CH, 2013, J MATER CHEM B, V1, P1885, DOI 10.1039/c3tb00024a
   Liu ZH, 2012, J CONTROL RELEASE, V160, P14, DOI 10.1016/j.jconrel.2012.02.005
   Liu ZH, 2010, PROG POLYM SCI, V35, P1144, DOI 10.1016/j.progpolymsci.2010.04.007
   Liu ZH, 2010, BIOMATERIALS, V31, P3364, DOI 10.1016/j.biomaterials.2010.01.021
   Merkel OM, 2011, BIOMATERIALS, V32, P4936, DOI 10.1016/j.biomaterials.2011.03.035
   MOSCONE D, 1988, ANAL CHIM ACTA, V211, P195, DOI 10.1016/S0003-2670(00)83679-X
   Muzykantov VR, 1996, BBA-BIOMEMBRANES, V1279, P137, DOI 10.1016/0005-2736(95)00260-X
   MUZYKANTOV VR, 1991, BLOOD, V78, P2611
   Muzykantov VR, 1996, ANAL BIOCHEM, V241, P109, DOI 10.1006/abio.1996.0384
   MUZYKANTOV VR, 1993, FEBS LETT, V318, P108, DOI 10.1016/0014-5793(93)80002-C
   MUZYKANTOV VR, 1992, INT J ARTIF ORGANS, V15, P622
   Nam HY, 2009, J CONTROL RELEASE, V135, P259, DOI 10.1016/j.jconrel.2009.01.018
   Plank C, 1996, HUM GENE THER, V7, P1437, DOI 10.1089/hum.1996.7.12-1437
   Rihova B, 2002, ADV DRUG DELIVER REV, V54, P653
   Rossi NAA, 2010, BIOMATERIALS, V31, P4167, DOI 10.1016/j.biomaterials.2010.01.137
   SAMBRANO GR, 1995, P NATL ACAD SCI USA, V92, P1396, DOI 10.1073/pnas.92.5.1396
   SAMBRANO GR, 1994, P NATL ACAD SCI USA, V91, P3265, DOI 10.1073/pnas.91.8.3265
   SEEMAN P, 1972, PHARMACOL REV, V24, P583
   Toda M, 2008, BIOMATERIALS, V29, P407, DOI 10.1016/j.biomaterials.2007.10.005
   VANDERKAMP KWHJ, 1993, INT J ARTIF ORGANS, V16, P836
   Yao X, 2013, ADV MATER, V25, P5257, DOI 10.1002/adma.201301762
   Yedgar S, 2002, PATHOPHYSIOL HAEMO T, V32, P263, DOI 10.1159/000073578
   ZALTZMAN AB, 1995, BIOCHEM J, V307, P651, DOI 10.1042/bj3070651
   Zavodnik IB, 2002, BIOELECTROCHEMISTRY, V58, P127, DOI 10.1016/S1567-5394(01)00126-8
   Zavodnik IB, 1999, BBA-BIOMEMBRANES, V1421, P306, DOI 10.1016/S0005-2736(99)00136-4
   Zhong D, 2013, BIOMATERIALS, V34, P294, DOI 10.1016/j.biomaterials.2012.09.060
NR 43
TC 9
Z9 9
U1 1
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD MAR
PY 2015
VL 1
IS 3
BP 139
EP 147
DI 10.1021/ab500128q
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DC6RL
UT WOS:000369347200002
DA 2018-10-19
ER

PT J
AU Wang, D
   Bratlie, KM
AF Wang, Daniel
   Bratlie, Kaitlin M.
TI Influence of Polymer Chemistry on Cytokine Secretion from Polarized
   Macrophages
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE macrophage phenotypes; cytokines; TNF-alpha; IL-I0; polymer properties
ID TUMOR-ASSOCIATED MACROPHAGES; TNF-ALPHA; IN-VITRO; ALTERNATIVE
   ACTIVATION; IMMUNE-RESPONSES; NECROSIS-FACTOR; SURFACE; BIOMATERIAL;
   CANCER; VIVO
AB Of central importance to tissue engineering and drug delivery is identifying polymer parameters that increase or decrease specific cytokines in response to biomaterials. In this study, we have interrogated the effects of material descriptors and material.characteristics on pro-inflammatory, pro-angiogenic, and naive macrophages using polymeric particles (similar to 600 nm), functionalized with 13 different moieties. We characterized tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) secretion for the three macrophage populations and used the quantitative structure-activity relationship method (QSAR) to accurately predict cytokine secretion for the different macrophage phenotypes. The findings presented here demonstrate that altering cellular responses to polymers can be achieved through exploiting material parameters. For pro-inflammatory macrophages, polarity and the ability to hydrogen bond appear to significantly impact TNF-alpha secretion while charge impacted pro-angiogenic macrophages. Naive cells were impacted by charge in a similar manner as the proangiogenic cells; however, hydrophilicity also increased TNF-alpha secretion in these cells. For IL-10 secretion, hydrogen bonding was very negatively correlated with pro-inflammatory cells, whereas it was positively correlated with pro-angiogenic cells.
C1 [Wang, Daniel; Bratlie, Kaitlin M.] Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA.
   [Bratlie, Kaitlin M.] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA.
   [Bratlie, Kaitlin M.] Ames Natl Lab, Ames, IA 50011 USA.
RP Bratlie, KM (reprint author), Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA.
EM kbratlie@iastate.edu
FU National Science Foundation [CBET 1227867]; Roy J. Carver Charitable
   Trust [13-4265]; NSF ARI-R2 [CMMI-0963224]
FX This work was supported by the National Science Foundation under Grant
   CBET 1227867 and the Roy J. Carver Charitable Trust Grant 13-4265. The
   authors also acknowledge support from NSF ARI-R2 (CMMI-0963224) for
   funding the renovation of the research laboratories used for these
   studies.
CR Acharya AP, 2008, BIOMATERIALS, V29, P4736, DOI 10.1016/j.biomaterials.2008.08.040
   Akilbekova D, 2015, J BIOMED MATER RES A, V103, P262, DOI 10.1002/jbm.a.35169
   Alas S, 2001, CANCER RES, V61, P5137
   Ali MM, 2009, CHEM COMMUN, P6640, DOI 10.1039/b911559e
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Ariganello MB, 2011, BIOMATERIALS, V32, P439, DOI 10.1016/j.biomaterials.2010.09.004
   Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388
   Barth KA, 2013, J BIOMED MATER RES A, V101, P2679, DOI 10.1002/jbm.a.34562
   Bicerano J., 2002, PREDICTION POLYM PRO
   Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937
   Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009
   BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   Curnis F, 2000, NAT BIOTECHNOL, V18, P1185
   Das M, 2006, ADV MATER, V18, P80, DOI 10.1002/adma.200501043
   Dong L, 2009, J CONTROL RELEASE, V134, P214, DOI 10.1016/j.jconrel.2008.11.013
   Donnelly S, 2005, INFECT IMMUN, V73, P166, DOI 10.1128/IAI.73.1.166-173.2005
   Eriksson L, 2003, ENVIRON HEALTH PERSP, V111, P1361, DOI 10.1289/ehp.5758
   Hartley JW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-1
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Kikuchi A, 2002, ADV DRUG DELIVER REV, V54, P53, DOI 10.1016/S0169-409X(01)00243-5
   Kubinyi H, 1993, METHODS PRINCIPLES M
   Kufe D. W., 2003, HOLLAND FREI CANC ME
   Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933
   Lan Q, 2006, BLOOD, V107, P4101, DOI 10.1182/blood-2005-10-4160
   Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x
   Lejeune FJ, 1998, CURR OPIN IMMUNOL, V10, P573, DOI 10.1016/S0952-7915(98)80226-4
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Nair MG, 2003, IMMUNOL LETT, V85, P173, DOI 10.1016/S0165-2478(02)00225-0
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Petersen LK, 2011, BIOMATERIALS, V32, P6815, DOI 10.1016/j.biomaterials.2011.05.063
   Petersen LK, 2009, BIOMATERIALS, V30, P5131, DOI 10.1016/j.biomaterials.2009.05.069
   Porta C, 2007, ADV EXP MED BIOL, V604, P67, DOI 10.1007/978-0-387-69116-9_5
   Puzyn T, 2011, NAT NANOTECHNOL, V6, P175, DOI 10.1038/NNANO.2011.10
   Randow F, 1997, J IMMUNOL, V158, P2911
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Rodriguez A, 2009, J BIOMED MATER RES A, V89A, P152, DOI 10.1002/jbm.a.31939
   Rossato M, 2012, P NATL ACAD SCI USA, V109, pE3101, DOI 10.1073/pnas.1209100109
   Schmid MC, 2010, J ONCOL, V2010, DOI DOI 10.1155/2010/201026
   Schutte RJ, 2009, BIOMATERIALS, V30, P160, DOI 10.1016/j.biomaterials.2008.09.026
   Shnyra A, 1998, J IMMUNOL, V160, P3729
   Sierra JR, 2008, J EXP MED, V205, P1673, DOI 10.1084/jem.20072602
   Smallie T, 2010, J EXP MED, V207, P2081, DOI 10.1084/jem.20100414
   Tanaka M, 2005, NATURE, V437, P656, DOI 10.1038/nature04164
   Torroella-Kouri M, 2009, CANCER RES, V69, P4800, DOI 10.1158/0008-5472.CAN-08-3427
   Tweedie CA, 2005, ADV MATER, V17, P2599, DOI 10.1002/adma.200501142
   Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711
   Wang D, 2014, BIOMACROMOLECULES, V15, P4102, DOI 10.1021/bm5011382
   Wang J, 2003, AM J PHYSIOL-HEART C, V285, pH1871, DOI 10.1152/ajpheart.00387.2003
   Wang Y, 2007, KIDNEY INT, V72, P290, DOI 10.1038/sj.ki.5002275
   WANIDWORANUN C, 1993, J IMMUNOL, V151, P6853
   Watkins SK, 2007, J IMMUNOL, V178, P1357, DOI 10.4049/jimmunol.178.3.1357
   Zhang XZ, 2005, BIOMATERIALS, V26, P3299, DOI 10.1016/j.biomaterials.2004.08.024
NR 55
TC 7
Z9 7
U1 3
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD MAR
PY 2015
VL 1
IS 3
BP 166
EP 174
DI 10.1021/ab5001063
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DC6RL
UT WOS:000369347200005
DA 2018-10-19
ER

PT J
AU Brezestean, I
   Har, N
   Tantau, A
   Gorea, M
   Venter, MM
   Pinzaru, SC
AF Brezestean, Ioana
   Har, Nicolae
   Tantau, Alina
   Gorea, Maria
   Venter, Monica M.
   Pinzaru, Simona Cinta
TI ANALYTICAL STUDY OF GALLSTONES IN PATIENTS FROM TRANSYLVANIA, ROMANIA
SO STUDIA UNIVERSITATIS BABES-BOLYAI CHEMIA
LA English
DT Article
DE Human gallstones; Transylvania; FT-Raman spectroscopy; FT-IR;
   cholesterol
ID PIGMENT GALLSTONES; CHOLESTEROL; BILE; CRYSTALLIZATION; IDENTIFICATION;
   BILIRUBINATE; DISEASE; LIVER
AB Here we report the vibrational spectroscopy characterization on human gallstones from patients in Transylvania, Romania. A number of 93 gallstones resulted after surgical intervention were preliminary classified in 6 groups after provenance, shape and color aspect and investigated using optical microscopy and FT-(micro)-Raman spectroscopy in conjunction with the FT-IR. Optical microscopy of the gallstones cross sections revealed concentric layers growing depositions alternating with axial crystalline agglomerated biomaterial. Two distinct type of crystallinity on one hand and different spatial crystals distribution, on the other hand were optically observed. The studied specimens randomly showed very narrow amorphous zones. The microstructure, chemical composition, the nucleation and growing mechanism of gallstones were correlated with the vibrational spectroscopy data. Vibrational assignment allowed identifying cholesterol in all the samples. Other weak bands attributable to bilirubinate salts were randomly observed with different extent in all the groups. Brown, yellowish-brown and yellow gallstones showed higher content of bilirubinate as revealed by the relative intensity ratio of the bilirubinate band at 1620 cm(-1) versus cholesterol band at 1464 cm(-1) with values between 0.57 and 0.875. FT-vibrational techniques accurately provided the proof of the cholesterol specificity in the choletitiasis prevalence in the area and allowed getting additional insight into their growing mechanism.
C1 [Brezestean, Ioana; Pinzaru, Simona Cinta] Univ Babes Bolyai, Fac Phys, Biomol Phys Dept, Kogalniceanu 1, RO-400084 Cluj Napoca, Romania.
   [Har, Nicolae] Univ Babes Bolyai, Biol & Geol Fac, Dept Mineral, RO-400084 Cluj Napoca, Romania.
   [Tantau, Alina] Iuliu Hatieganu Univ Med & Pharm, RO-400012 Cluj Napoca, Romania.
   [Gorea, Maria; Venter, Monica M.] Univ Babes Bolyai, Fac Chem & Chem Engn, RO-400028 Cluj Napoca, Romania.
RP Pinzaru, SC (reprint author), Univ Babes Bolyai, Fac Phys, Biomol Phys Dept, Kogalniceanu 1, RO-400084 Cluj Napoca, Romania.
EM simona.cinta@phys.ubbcluj.ro
RI Cinta Pinzaru, Simona/A-4543-2011
OI Cinta Pinzaru, Simona/0000-0001-8016-4408
FU Babes-Bolyai Univesity
FX I. Brezestean would like to thank the financial support from the
   Babes-Bolyai Univesity for the 2013-2014 scientific performance
   scholarship.
CR ABEI M, 1994, GASTROENTEROLOGY, V106, P231, DOI 10.1016/S0016-5085(94)95643-X
   Acalovschi M, 2003, AM J GASTROENTEROL, V98, P1856, DOI 10.1016/S0002-9270(03)00509-4
   AHLBERG J, 1981, J LIPID RES, V22, P404
   Chen LY, 2012, WORLD J GASTROENTERO, V18, P4215, DOI 10.3748/wjg.v18.i31.4215
   CHIJIIWA K, 1991, BIOCHIM BIOPHYS ACTA, V1086, P44, DOI 10.1016/0005-2760(91)90152-8
   Donovan M., 1999, GASTROENTEROL CLIN N, V28, P75
   EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501
   ELEK G, 1982, KLIN WOCHENSCHR, V60, P33, DOI 10.1007/BF01721585
   Ferraro J.R., 1996, APPL SPECTROSC, V50, P7922
   Harding A.J., 1964, GALLSTONES CAUSES TR
   HARVEY PRC, 1991, J BIOL CHEM, V266, P13996
   Hrbasova H., 2000, INT J BIOCH CELLULAR, V32, P609
   Ko CW, 1999, GASTROENTEROL CLIN N, V28, P99, DOI 10.1016/S0889-8553(05)70045-5
   Kothai S., 2009, INT J CHEMTECH RES, V1, P430
   LI WH, 1995, BIOSPECTROSCOPY, V1, P149, DOI 10.1002/bspy.350010209
   Liu G, 2002, J MOL STRUCT, V616, P187, DOI 10.1016/S0022-2860(02)00330-7
   MAKI T, 1966, ANN SURG, V164, P90, DOI 10.1097/00000658-196607000-00010
   OFFNER GD, 1994, GASTROENTEROLOGY, V106, P755, DOI 10.1016/0016-5085(94)90712-9
   Paluszkiewicz C, 1998, CELL MOL BIOL, V44, P65
   Qiao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074887
   Roslyn J.J., 1994, PRINCIPLES SURG, P1376
   Sakorafas GH, 2007, DIGEST DIS SCI, V52, P1313, DOI 10.1007/s10620-006-9107-3
   SMITH BF, 1987, J LIPID RES, V28, P1088
   Tantau M, 2013, J GASTROINTEST LIVER, V22, P141
   TROTMAN BW, 1982, HEPATOLOGY, V2, P879, DOI 10.1002/hep.1840020624
   Wu J.G., 1979, CHINESE SCI BULL, V24, P1054
   YANG BJ, 1993, SPECTROCHIM ACTA A, V49, P1735, DOI 10.1016/0584-8539(93)80241-2
   Zhang Z., 2008, WORLD CHINESE J DIGE, V16, P1200
NR 28
TC 0
Z9 0
U1 1
U2 3
PU UNIV BABES-BOLYAI
PI CLUJ-NAPOCA
PA MIHAIL KOGALNICEANU NR. 1, CLUJ-NAPOCA RO-3400, ROMANIA
SN 1224-7154
J9 STUD U BABES-BOL CHE
JI Stud. Univ. Babes-Bolyai Chem.
PD MAR
PY 2015
VL 60
IS 1
BP 29
EP 43
PG 15
WC Chemistry, Multidisciplinary
SC Chemistry
GA DC4AI
UT WOS:000369161500003
DA 2018-10-19
ER

PT J
AU Chen, Y
   Shi, JL
AF Chen, Yu
   Shi, Jianlin
TI Mesoporous carbon biomaterials
SO SCIENCE CHINA-MATERIALS
LA English
DT Review
ID ULTRASOUND CANCER-SURGERY; REDUCED GRAPHENE OXIDE; BULKY DYE MOLECULES;
   SILICA NANOPARTICLES; IN-VIVO; BIOMEDICAL APPLICATIONS; PHOTOTHERMAL
   THERAPY; QUANTUM DOTS; FACILE SYNTHESIS; TEMPLATE ROUTE
AB Nano-biotechnology provides highly efficient and versatile strategies to improve the diagnostic precision and therapeutic efficiency of serious diseases. The development of new biomaterial systems provides great opportunities for the successful clinical translation of nano-biotechnology for personalized biomedicine to benefit patients. As a new inorganic material system, mesoporous carbon biomaterials (MCBs) combine the merits of a mesoporous nanostructure and carbonaceous composition, showing superior qualities compared with traditional mesoporous silica and other carbon-based nanosystems, such as graphene, carbon nanotubes, and fullerene. Thus, this review focuses on the rational design, chemical synthesis, and biomedical applications of MCBs. The synthetic strategies for MCBs, especially mesoporous carbon nanoparticles (MCNs), are summarized, and several representative biomedical applications of MCBs are discussed in detail. MCBs perform well for on-demand drug-release, photothermal therapy, synergistic therapy, fluorescent labeling of cancer cells, bio-adsorption of in vivo toxic pathogenic substances, peptide separation, and biosensing. The preliminary biosafety issue of MCBs is also briefly discussed. Finally, the critical issues and challenges facing the future development of MCBs for clinical translation are considered. There is great promise for MCBs to reach clinical translations for biomedical applications based on their unique nanostructure, composition, and biocompatibility once some critical issues are fully addressed.
C1 [Chen, Yu; Shi, Jianlin] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Chen, Y (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM chenyu@mail.sic.ac.cn; jlshi@mail.sic.ac.cn
FU National Natural Science Foundation of China [51302293, 51132009];
   Natural Science Foundation of Shanghai [13ZR1463500]; Shanghai
   Rising-Star Program [14QA1404100]; Youth Scholar of State Key Laboratory
   of High Performance Ceramics and Superfine Microstructures [SKL201203]
FX This research was supported by the National Natural Science Foundation
   of China (51302293 and 51132009), Natural Science Foundation of Shanghai
   (13ZR1463500), Shanghai Rising-Star Program (14QA1404100), and Youth
   Scholar of State Key Laboratory of High Performance Ceramics and
   Superfine Microstructures (SKL201203).
CR Allen MJ, 2010, CHEM REV, V110, P132, DOI 10.1021/cr900070d
   Ambrogio MW, 2011, ACCOUNTS CHEM RES, V44, P903, DOI 10.1021/ar200018x
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Beg S, 2011, J PHARM PHARMACOL, V63, P141, DOI 10.1111/j.2042-7158.2010.01167.x
   Cha CY, 2013, ACS NANO, V7, P2891, DOI 10.1021/nn401196a
   Chen BS, 2013, NANOSCALE, V5, P1967, DOI 10.1039/c2nr32675b
   Chen HM, 2014, ADV MATER, V26, P6761, DOI 10.1002/adma.201402964
   Chen Y, CHEM SOC REV, DOI 0.1039/C4CS00300D
   Chen Y, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400127
   Chen Y, 2014, J AM CHEM SOC, V136, P16326, DOI 10.1021/ja508721y
   Chen Y, 2014, ADV MATER, V26, P7019, DOI 10.1002/adma.201402572
   Chen Y, 2014, ADV FUNCT MATER, V24, P4386, DOI 10.1002/adfm.201400221
   Chen Y, 2014, ADV MATER, V26, P4294, DOI 10.1002/adma.201400303
   Chen Y, 2014, MOL PHARMACEUT, V11, P2495, DOI 10.1021/mp400596v
   Chen Y, 2014, EXPERT OPIN DRUG DEL, V11, P917, DOI 10.1517/17425247.2014.908181
   Chen Y, 2014, ACCOUNTS CHEM RES, V47, P125, DOI 10.1021/ar400091e
   Chen Y, 2013, ADV MATER, V25, P3144, DOI 10.1002/adma.201205292
   Chen Y, 2013, ADV MATER, V25, P3100, DOI 10.1002/adma.201204685
   Chen Y, 2012, BIOMATERIALS, V33, P7126, DOI 10.1016/j.biomaterials.2012.06.059
   Chen Y, 2011, ANGEW CHEM INT EDIT, V50, P12505, DOI 10.1002/anie.201106180
   Chen Y, 2011, SMALL, V7, P2935, DOI 10.1002/smll.201101055
   Chen Y, 2010, ACS NANO, V4, P529, DOI 10.1021/nn901398j
   Cheng G, 2014, ACS APPL MATER INTER, V6, P12719, DOI 10.1021/am502712a
   Chung C, 2013, ACCOUNTS CHEM RES, V46, P2211, DOI 10.1021/ar300159f
   Chung TH, 2007, BIOMATERIALS, V28, P2959, DOI 10.1016/j.biomaterials.2007.03.006
   Crayton SH, 2011, ACS NANO, V5, P9592, DOI 10.1021/nn202863x
   Cui YY, 2014, J MATER CHEM B, V2, P6947, DOI 10.1039/c4tb01085j
   Ding CQ, 2014, ACCOUNTS CHEM RES, V47, P20, DOI 10.1021/ar400023s
   Dong Y, 2013, J MATER CHEM A, V1, P7391, DOI 10.1039/c3ta10787f
   Dong Y, 2012, CHEM ENG J, V193, P169, DOI 10.1016/j.cej.2012.04.024
   Duffy P, 2012, J MATER CHEM, V22, P432, DOI 10.1039/c1jm14303d
   Fang Y, 2014, ANGEW CHEM INT EDIT, V53, P5366, DOI 10.1002/anie.201402002
   Fang Y, 2010, ANGEW CHEM INT EDIT, V49, P7987, DOI 10.1002/anie.201002849
   Feng LY, 2013, ADV MATER, V25, P168, DOI 10.1002/adma.201203229
   Gu JL, 2011, CHEM COMMUN, V47, P2101, DOI 10.1039/c0cc04598e
   Guo LM, 2010, CHEM COMMUN, V46, P7127, DOI 10.1039/c0cc02060e
   Guo LM, 2009, CHEM COMMUN, P6071, DOI 10.1039/b911083f
   Guo LM, 2009, CHEM-ASIAN J, V4, P1480, DOI 10.1002/asia.200900113
   Guo Y, 2008, ADV FUNCT MATER, V18, P2489, DOI 10.1002/adfm.200800406
   He QJ, 2012, BIOMATERIALS, V33, P4392, DOI 10.1016/j.biomaterials.2012.02.056
   He QJ, 2011, SMALL, V7, P271, DOI 10.1002/smll.201001459
   He QJ, 2010, MICROPOR MESOPOR MAT, V131, P314, DOI 10.1016/j.micromeso.2010.01.009
   Hu SH, 2012, ADV MATER, V24, P1748, DOI 10.1002/adma.201104070
   Huang XL, 2011, ACS NANO, V5, P5390, DOI 10.1021/nn200365a
   Hudson SP, 2008, BIOMATERIALS, V29, P4045, DOI 10.1016/j.biomaterials.2008.07.007
   Kamisako T, 2000, J GASTROENTEROL, V35, P659, DOI 10.1007/s005350070044
   Kim TW, 2008, NANO LETT, V8, P3724, DOI 10.1021/nl801976m
   Kong QL, 2014, CHEM COMMUN, V50, P15772, DOI 10.1039/c4cc07121b
   Ku SH, 2013, ADV HEALTHC MATER, V2, P244, DOI 10.1002/adhm.201200307
   Li HT, 2012, J MATER CHEM, V22, P24230, DOI 10.1039/c2jm34690g
   Li LL, 2013, NANOSCALE, V5, P4015, DOI 10.1039/c3nr33849e
   Li M, 2012, J COLLOID INTERF SCI, V377, P169, DOI 10.1016/j.jcis.2012.03.085
   Li RB, 2010, ACS NANO, V4, P1399, DOI 10.1021/nn9011225
   Li ZX, 2012, CHEM SOC REV, V41, P2590, DOI 10.1039/c1cs15246g
   Liang CD, 2004, ANGEW CHEM INT EDIT, V43, P5785, DOI 10.1002/anie.200461051
   Liang CD, 2008, ANGEW CHEM INT EDIT, V47, P3696, DOI 10.1002/anie.200702046
   Lim SY, 2015, CHEM SOC REV, V44, P362, DOI 10.1039/c4cs00269e
   Liu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3798
   Liu RL, 2014, CARBON, V76, P84, DOI 10.1016/j.carbon.2014.04.052
   Liu YZ, 2012, J MATER CHEM, V22, P11908, DOI 10.1039/c2jm31581e
   Liu Y, 2014, AUST J CHEM, V67, P151, DOI 10.1071/CH13401
   Liu Y, 2014, BIOMATERIALS, V35, P378, DOI 10.1016/j.biomaterials.2013.09.079
   Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x
   Liu Z, 2007, ACS NANO, V1, P50, DOI 10.1021/nn700040t
   Liu Z, 2011, MATER TODAY, V14, P316, DOI 10.1016/S1369-7021(11)70161-4
   Liu Z, 2009, ANGEW CHEM INT EDIT, V48, P7668, DOI 10.1002/anie.200902612
   Lu J, 2007, SMALL, V3, P1341, DOI 10.1002/smll.200700005
   Lu XB, 2009, J MATER CHEM, V19, P4707, DOI 10.1039/b903179k
   Luo PJG, 2013, J MATER CHEM B, V1, P2116, DOI 10.1039/c3tb00018d
   Mamaeva V, 2013, ADV DRUG DELIVER REV, V65, P689, DOI 10.1016/j.addr.2012.07.018
   Markovic ZM, 2011, BIOMATERIALS, V32, P1121, DOI 10.1016/j.biomaterials.2010.10.030
   Partha R, 2009, INT J NANOMED, V4, P261
   Qiao ZA, 2013, NANO LETT, V13, P207, DOI 10.1021/nl303889h
   Qin HQ, 2011, ANGEW CHEM INT EDIT, V50, P12218, DOI 10.1002/anie.201103666
   Qin HQ, 2011, ANAL CHEM, V83, P7721, DOI 10.1021/ac201198q
   Robinson JT, 2011, J AM CHEM SOC, V133, P6825, DOI 10.1021/ja2010175
   Ryoo R, 2001, ADV MATER, V13, P677, DOI 10.1002/1521-4095(200105)13:9<677::AID-ADMA677>3.3.CO;2-3
   Saha D, 2014, MICROPOR MESOPOR MAT, V196, P327, DOI 10.1016/j.micromeso.2014.05.024
   Schornack PA, 2003, NEOPLASIA, V5, P135, DOI 10.1016/S1476-5586(03)80005-2
   Shi JL, 2013, J INORG MATER, V28, P1, DOI 10.3724/SP.J.1077.2012.12082
   Sun W, 2009, ELECTROCHEM COMMUN, V11, P2105, DOI 10.1016/j.elecom.2009.09.005
   Sun ZK, 2013, ACS NANO, V7, P8706, DOI 10.1021/nn402994m
   Tang FQ, 2012, ADV MATER, V24, P1504, DOI 10.1002/adma.201104763
   Tang J, 2015, ANGEW CHEM INT EDIT, V54, P588, DOI 10.1002/anie.201407629
   Tao GJ, 2014, CARBON, V66, P547, DOI 10.1016/j.carbon.2013.09.037
   Tian B, 2011, ACS NANO, V5, P7000, DOI 10.1021/nn201560b
   Wang J, 2014, NPG ASIA MATER, V6, DOI 10.1038/am.2013.79
   Wang LM, 2015, J AM CHEM SOC, V137, P1947, DOI 10.1021/ja511560b
   Wang TY, 2011, EUR J PHARM SCI, V44, P653, DOI 10.1016/j.ejps.2011.10.012
   Wang X, 2012, ADV MATER, V24, P785, DOI 10.1002/adma.201104033
   Wang XF, 2013, MICROPOR MESOPOR MAT, V180, P257, DOI 10.1016/j.micromeso.2013.06.042
   Wang Y, 2014, ACS NANO, V8, P7870, DOI 10.1021/nn5027214
   Wang Y, 2014, ADV HEALTHC MATER, V3, P485, DOI 10.1002/adhm.201300324
   Wu SH, 2011, CHEM COMMUN, V47, P9972, DOI 10.1039/c1cc11760b
   Xiang D, 2015, ANALYST, V140, P644, DOI 10.1039/c4an01549e
   Xu GJ, 2014, RSC ADV, V4, P33986, DOI 10.1039/c4ra03993a
   Yang K, 2013, CHEM SOC REV, V42, P530, DOI 10.1039/c2cs35342c
   You CP, 2009, MICROCHIM ACTA, V167, P109, DOI 10.1007/s00604-009-0228-1
   Zhang FQ, 2007, J AM CHEM SOC, V129, P7746, DOI 10.1021/ja072316d
   Zheng M, 2014, ADV MATER, V26, P3554, DOI 10.1002/adma.201306192
   Zhou L, 2015, CARBON, V82, P479, DOI 10.1016/j.carbon.2014.10.091
   Zhu J, 2012, SMALL, V8, P2715, DOI 10.1002/smll.201200217
   Zhu SM, 2011, MATER CHEM PHYS, V126, P357, DOI 10.1016/j.matchemphys.2010.11.013
   Zhu SJ, 2013, ANGEW CHEM INT EDIT, V52, P3953, DOI 10.1002/anie.201300519
   Zhu WQ, 2014, ASIAN J PHARM SCI, V9, P82, DOI 10.1016/j.ajps.2014.02.001
   Zhuang X, 2009, CHEM MATER, V21, P706, DOI 10.1021/cm8028577
NR 106
TC 19
Z9 20
U1 9
U2 68
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 2095-8226
EI 2199-4501
J9 SCI CHINA MATER
JI Sci. China-Mater.
PD MAR
PY 2015
VL 58
IS 3
BP 241
EP 257
DI 10.1007/s40843-015-0037-2
PG 17
WC Materials Science, Multidisciplinary
SC Materials Science
GA CV7TF
UT WOS:000364477200008
OA Bronze
DA 2018-10-19
ER

PT J
AU Zhou, GQ
   He, W
   Pang, ZH
   Chen, XM
   Chen, ZQ
   Zhang, QW
   Fang, B
   Chen, D
AF Zhou, Guangquan
   He, Wei
   Pang, Zhihui
   Chen, Xiumin
   Chen, Zhenqiu
   Zhang, Qingwen
   Fang, Bin
   Chen, Da
TI Share Relationship Adjustment of Femoral Head Necrosis Through
   Biomaterial Allograft Bone
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Femoral Head Necrosis; Load Share Ratio; Allograft Bone; Anterolateral
   Column; Computational Biomechanics
ID TRANSTROCHANTERIC ROTATIONAL OSTEOTOMY; AVASCULAR NECROSIS; FOLLOW-UP;
   OSTEONECROSIS; STRESS; HIP; MODEL
AB Allogeneic bone grafting, as an alternative to autograft, is an effective hip preserving method that can be employed to delay or arrest the progression of the femoral head necrosis (FHN), and it can help to obtain the load balancing between subchondral cortical and cancellous bone, strengthen structural mechanics of the femoral head and provide biology repair materials for bone regeneration during bone healing. However, these conclusions have been drawn primarily from observational clinical experience and lack of biomechanical basis. The purpose of this study was to evaluate the efficacy of biomaterial allograft bone for the treatment of FHN using computational biomechanical models. The results showed that allogeneic bone grafting reduced the collapse risk of the necrotic femoral head and recovered the load share ratio between the cortical bone and trabeculae in weight-bearing areas. This study provided a considerable direction using computational biomechanical technology for orthopedic research and specific biomechanical evidence for the use of allogeneic bone grafting in clinics.
C1 [Zhou, Guangquan; He, Wei; Chen, Zhenqiu; Zhang, Qingwen; Fang, Bin; Chen, Da] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Guangzhou 510407, Guangdong, Peoples R China.
   [Zhou, Guangquan; Pang, Zhihui] Guangzhou Univ Chinese Med, Lab Natl Key Discipline Orthopaed & Traumatol Chi, Guangzhou 510405, Guangdong, Peoples R China.
   [Zhou, Guangquan] City Univ Hong Kong, Dept Informat Syst, Hong Kong 999077, Hong Kong, Peoples R China.
   [Chen, Xiumin] Guangdong Prov Hosp Chinese Med, Dept Rheumatol, Guangzhou, Guangdong, Peoples R China.
   [Chen, Xiumin] Guangzhou Univ Chinese Med, China & Postdoctoral Mobile Res Stn, Guangzhou 510000, Guangdong, Peoples R China.
RP He, W (reprint author), Guangzhou Univ Chinese Med, Affiliated Hosp 1, Guangzhou 510407, Guangdong, Peoples R China.
FU National Science Foundation of China [81173284, 81473697]; Science and
   Technology Project of Guangdong Province [2013A032500009]; Natural
   Science Foundation of Guangdong Province [S2013010011992,
   S2012010008123]
FX The authors would like to acknowledge funding support from National
   Science Foundation of China (81173284, 81473697), Science and Technology
   Project of Guangdong Province (2013A032500009) and Natural Science
   Foundation of Guangdong Province (S2013010011992, S2012010008123). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aldridge JM, 2007, ORTHOP CLIN N AM, V38, P13, DOI 10.1016/j.ocl.2006.10.012
   [Anonymous], 2012, CLIN J JOINT SURG EL, V6, P184
   Bonnie K. C., 2013, BIOMATERIALS, V34, P2455
   Bonnie K. C., 2013, BIOMATERIALS, V34, P1506
   Bose VC, 2010, J BONE JOINT SURG BR, V92B, P922, DOI 10.1302/0301-620X.92B7.23639
   Bostrom Mathias P G, 2005, HSS J, V1, P9, DOI 10.1007/s11420-005-0111-5
   BROWN TD, 1983, J BIOMECH ENG-T ASME, V105, P171, DOI 10.1115/1.3138402
   BROWN TD, 1981, CLIN ORTHOP RELAT R, P240
   BUCKLEY PD, 1991, J BONE JOINT SURG AM, V73A, P1357, DOI 10.2106/00004623-199173090-00011
   Chen ZhenQiu, 2010, Chinese Journal of Orthopaedics, V30, P42
   Fan W, 2010, BIOMATERIALS, V31, P3580, DOI 10.1016/j.biomaterials.2010.01.083
   GARDENIERS JW, 1993, BONE CIRCULATION VAS, V247, P375
   Gardeniers JWM, 1992, ARCO NEWS, V4, P41
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Grecu D, 2010, ROM J MORPHOL EMBRYO, V51, P151
   Guo Xiaozhong, 2005, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V19, P697
   HARRISON MHM, 1953, J BONE JOINT SURG BR, V35, P598
   Hasegawa Y, 1997, ARCH ORTHOP TRAUM SU, V116, P251
   Hasegawa Y, 2003, J BONE JOINT SURG BR, V85B, P191, DOI 10.1302/0301-620X.85B2.13190
   He Wei, 2009, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V23, P530
   Ito H., 2002, J BONE JT SURG BR, V94, P308
   Jerome M. G., 2014, J ORTHOP RES, V32, P39
   Keizer SB, 2006, J BONE JOINT SURG BR, V88B, P460, DOI 10.1302/0301-620x.88b4.16950
   Krackow K A, 1993, Orthop Rev, V22, P457
   Lee MS, 2006, CLIN BIOMECH, V21, P969, DOI 10.1016/j.clinbiomech.2006.05.005
   [李子荣 Li Zirong], 2012, [中华骨科杂志, Chinese Journal of Orthopedics], V32, P515
   LIN ZJ, 2009, CHINA J ORTHOP TRAUM, V22, P628
   MCCORMACK T, 1994, SPINE, V19, P1741, DOI 10.1097/00007632-199408000-00014
   [史风雷 Shi Fenglei], 2013, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V17, P7758
   Sverdlova NS, 2010, J BIOMECH, V43, P387, DOI 10.1016/j.jbiomech.2009.09.049
   Veillette CJH, 2006, J BONE JOINT SURG AM, V88A, P48, DOI 10.2106/JBJS.F.00538
   Xu Weihua, 2009, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V23, P527
   Yang SH, 2008, BIOTECHNOL BIOENG, V100, P560, DOI 10.1002/bit.21792
   [尧浩 Yao Hao], 2013, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V17, P3311
   Yu X., 2012, J BIOMATER TISS ENG, V2, P270
   Zhou GQ, 2014, COMPUT BIOL MED, V52, P96, DOI 10.1016/j.compbiomed.2014.04.002
NR 36
TC 0
Z9 0
U1 1
U2 6
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD MAR
PY 2015
VL 5
IS 3
BP 208
EP 212
DI 10.1166/jbt.2015.1277
PG 5
WC Cell & Tissue Engineering
SC Cell Biology
GA CN7OW
UT WOS:000358624900005
DA 2018-10-19
ER

PT J
AU de Oliveira, IR
   de Andrade, TL
   Parreira, RM
   Jacobovitz, M
   Pandolfelli, VC
AF de Oliveira, Ivone Regina
   de Andrade, Talita Luana
   Parreira, Renata Martins
   Jacobovitz, Marcos
   Pandolfelli, Victor Carlos
TI Characterization of Calcium Aluminate Cement Phases when in Contact with
   Simulated Body Fluid
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE dental cement; hydroxyapatite; simulated body fluid
ID MINERAL TRIOXIDE AGGREGATE; PORTLAND-CEMENT; IN-VITRO;
   MECHANICAL-PROPERTIES; ENDODONTIC CEMENT; BIOACTIVITY; VIVO; INHIBITION;
   PHOSPHATE
AB Recent studies involving the use of calcium aluminate cement (CAC) as a biomaterial are based on commercial products. Improvements can be attained by investigating the properties of their crystalline phases in order to better design the material's composition. Therefore, calcium aluminate phase samples immersed in simulated body fluid (SBF) solutions prepared according to Kokubo's (KSBF) and Rigo's (RSBF) methodology had their pH evaluated. The surfaces of these samples were analyzed by SEM, EDX and XRD techniques. The treatment with KSBF did not favor the precipitation of calcium phosphate phases on the surface of CAC phases. On the other hand, in RSBF solution, the pH value attained was higher than for the KSBF one and magnesium phosphate was identified on the surface of CA, C(3)A and C(12)A(7) samples. Only for CA(2), the optimal precipitation condition was attained in RSBF and a surface layer of the hydroxyapatite was detected. Based on its ability of stimulating hydroxyapatite deposition in SBF and other properties, CA(2) can be eligible as the most suitable composition for biomedical purposes.
C1 [de Oliveira, Ivone Regina; de Andrade, Talita Luana; Parreira, Renata Martins] Univ Vale Paraiba Univap, IP&D, Sao Jose Dos Campos, SP, Brazil.
   [Pandolfelli, Victor Carlos] Univ Fed Sao Carlos, Dept Engn Mat Dema, Sao Carlos, SP, Brazil.
RP de Oliveira, IR (reprint author), Univ Vale Paraiba Univap, IP&D, Av Shishima Hifumi 2911, Sao Jose Dos Campos, SP, Brazil.
EM ivoneregina.oliveira@gmail.com
FU Sao Paulo Research Foundation [2009/17451-0, 2013/22502-8]; National
   Council for Scientific and Technological Development - Brazil
FX The authors are grateful to grant #2009/17451-0 and #2013/22502-8, Sao
   Paulo Research Foundation and National Council for Scientific and
   Technological Development - Brazil for providing financial support for
   this research.
CR Aguilai FG, 2011, J ENDODONT, V37, P67, DOI 10.1016/j.joen.2010.10.001
   Aguilar FG, 2012, J ENDODONT, V38, P367, DOI 10.1016/j.joen.2011.11.002
   Andrade T. L., 2014, Cerâmica, V60, P88, DOI 10.1590/S0366-69132014000100013
   Barrere F, 1999, BONE, V25, p107S, DOI 10.1016/S8756-3282(99)00145-3
   Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008
   Camilleri J, 2008, INT ENDOD J, V41, P151
   Castro-Raucci LM, 2011, BRAZ DENT J, V22, P99
   Coleman NJ, 2007, CEMENT CONCRETE RES, V37, P1518, DOI 10.1016/j.cemconres.2007.08.008
   Engqvist H, 2004, BIOMATERIALS, V25, P2781, DOI 10.1016/j.biomaterials.2003.09.053
   Garcia JR, 2007, CERAMICA, V53, P42
   Jacobovitz M, 2009, ORAL SURG ORAL MED O, V108, P140, DOI 10.1016/j.tripleo.2009.03.013
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Loof J, 2003, J MATER SCI-MATER M, V14, P1033, DOI 10.1023/B:JMSM.0000003999.52349.0d
   Loof J., 2008, THESIS FS TECHNOLOGY
   MARTENS CS, 1970, GEOCHIM COSMOCHIM AC, V34, P621, DOI 10.1016/0016-7037(70)90020-7
   Oliveira IR, 2010, INT ENDOD J, V43, P1069, DOI 10.1111/j.1365-2591.2010.01770.x
   Oliveira IR, 2013, J ENDODONT, V39, P774, DOI 10.1016/j.joen.2013.01.013
   Orefice RL, 2006, BIOMATERIALS FUNDAME
   Pandolfelli V. C., 2009, Patent No, Patent No. [W02009067774, 2009067774]
   Pompeu L. L. M. F., 2013, Cerâmica, V59, P216, DOI 10.1590/S0366-69132013000200004
   Rigo ECS, 2004, MAT SCI ENG C-BIO S, V24, P647, DOI 10.1016/j.msec.2004.08.044
   Roberts HW, 2008, DENT MATER, V24, P149, DOI 10.1016/j.dental.2007.04.007
   Sarkar NK, 2005, J ENDODONT, V31, P97, DOI 10.1097/01.DON.0000133155.04468.41
   Silva EJNL, 2012, INT ENDOD J, V45, P815, DOI 10.1111/j.1365-2591.2012.02038.x
   Tay FR, 2007, J ENDODONT, V33, P1347, DOI 10.1016/j.joen.2007.07.008
   Wang XH, 2008, DENT MATER, V24, P74, DOI 10.1016/j.dental.2007.02.006
   Wu Chengtie, 2009, BONE TISSUE REGENERA, V2, P25
NR 27
TC 1
Z9 2
U1 0
U2 18
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
EI 1980-5373
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PD MAR-APR
PY 2015
VL 18
IS 2
BP 382
EP 389
DI 10.1590/1516-1439.336714
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA CJ2IY
UT WOS:000355308800023
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Boulila, S
   Elfeki, A
   Oudadesse, H
   Elfeki, H
AF Boulila, Salha
   Elfeki, Abdelfattah
   Oudadesse, Hassane
   Elfeki, Hafed
TI Substitution effects of a carbonated hydroxyapatite biomaterial against
   intoxication chloride nickel-exposed rats
SO TOXICOLOGY MECHANISMS AND METHODS
LA English
DT Article
DE Biomaterial; implantation; intoxication; metal; rats
ID AQUEOUS-SOLUTIONS; OXIDATIVE STRESS; TOXICITY; REMOVAL; APOPTOSIS;
   SULFATE; KIDNEY; CELLS; LIVER; BIOACCUMULATION
AB Aims: This study aimed to investigate the potential effects of a synthetic apatite (carbonated hydroxyapatite) on the detoxification of a group of male "Wistar'' rats exposed to nickel chloride.
   Methods: Toxicity was evaluated by rats' bioassay of nickel chloride. Wistar rats received this metal daily by gavage for seven days (4 mg/ml nickel chloride/200 g body weight, BW). To detoxify this organism, a subcutaneous implantation of the apatite is made.
   Results: The results revealed that exposure to nickel induced oxidative stress, disorders in the balances of ferric phosphocalcic, renal failures, liver toxicity and significant increase in nickel rates in the bones of intoxicated rats. The application of the carbonated hydroxyapatite presented in this study restored those disorders back to normal. The synthetic apatite protected the rats against the toxic effects of nickel by lowering the levels of lipid peroxidation markers and improving the activities of defense enzymes. It also amended ferric and phosphocalcic equilibriums, protected liver and kidney functions and reduced the nickel rate in the bones of the rats. Overall, the results provided strong support for the protective role of carbonated hydroxyapatite in the detoxification of rats exposed to nickel. Those beneficial effects were further confirmed by physico-chemical characterization (X-ray diffraction and infrared spectroscopy), which revealed its property of anionic and cationic substitution, thus supporting its promising candidacy for future biomedical application.
   Conclusion: The hydroxyapatite is an effective biomaterial to solve health problems, particularly detoxification against metals (nickel).
C1 [Boulila, Salha; Elfeki, Abdelfattah] Univ Sfax, Fac Sci Sfax, Lab Anim Ecophysiol, Sfax 3000, Tunisia.
   [Boulila, Salha; Oudadesse, Hassane] Univ Rennes 1, UMR CNRS 6226, Rennes, France.
   [Boulila, Salha; Elfeki, Hafed] Univ Sfax, Fac Sci Sfax, Lab Mat Sci & Environm, Sfax 3000, Tunisia.
RP Elfeki, H (reprint author), Univ Sfax, Fac Sci Sfax, Lab Mat Sci & Environm, BP 1171, Sfax 3000, Tunisia.
EM Hafedelfeki@yahoo.com
FU Tunisian Ministry of Higher Education and Scientific Research; Tunisian
   Ministry of Public Health
FX The authors declare no conflict of interest. This research was supported
   by the Tunisian Ministry of Higher Education and Scientific Research and
   the Tunisian Ministry of Public Health.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Al-Kattan A, 2012, INT J PHARMACEUT, V423, P26, DOI 10.1016/j.ijpharm.2011.07.005
   AMIARD JC, 1987, WATER RES, V21, P693, DOI 10.1016/0043-1354(87)90081-9
   Arts JJC, 2006, BIOMATERIALS, V27, P1110, DOI 10.1016/j.biomaterials.2005.07.024
   Bailliez S, 2004, PROCESS SAF ENVIRON, V82, P175, DOI 10.1205/095758204322972816
   BALTER P, 1976, Annals of Clinical and Laboratory Science, V6, P306
   Boubchir MA, 2002, BIOCH NEPHROLOGIE
   Boulila S, 2014, J ADV CHEM, V8, P1612
   Buege JA, 1984, J METH ENZYMOL, V105, P302
   Chai F, 2011, REV STOMATOL CHIR, V112, P212, DOI 10.1016/j.stomax.2011.06.003
   Chakraborty S, 2008, NUCL MED BIOL, V35, P589, DOI 10.1016/j.nucmedbio.2008.03.003
   Chen CY, 2010, J TOXICOL ENV HEAL A, V73, P529, DOI 10.1080/15287390903421250
   Chen CY, 1998, ARCH BIOCHEM BIOPHYS, V356, P127, DOI 10.1006/abbi.1998.0761
   Corami A, 2007, J HAZARD MATER, V146, P164, DOI 10.1016/j.jhazmat.2006.12.003
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   Dandevi K, 2003, REPROD TOXICOL, V17, P451, DOI 10.1016/S0890-6238(03)00040-6
   Das KK, 2000, BIOL TRACE ELEM RES, V73, P175, DOI 10.1385/BTER:73:2:175
   Denkhaus E, 2002, CRIT REV ONCOL HEMAT, V42, P35, DOI 10.1016/S1040-8428(01)00214-1
   Doreswamy C., 2004, Karnataka Journal of Agricultural Sciences, V17, P345
   DORMER RL, 1974, BIOCHEM J, V140, P135, DOI 10.1042/bj1400135
   Durand D, 2013, CAH NUTR DIET, V48, P218, DOI 10.1016/j.cnd.2013.04.005
   Eisler R, 1998, USGSBRDBSR19980001 P, P95
   El Feki H, 1999, J ALLOY COMPD, V287, P114, DOI 10.1016/S0925-8388(99)00070-5
   El Feki H, 2004, PHYS STATUS SOLIDI C, V1, P1985, DOI 10.1002/pssc.200304450
   El Feki H, 2000, J PHYS-CONDENS MAT, V12, P8331, DOI 10.1088/0953-8984/12/38/309
   Fary JR, 1993, J SCI, V222, P330
   Frank-Kamenetskaya O, 2011, J MOL STRUCT, V992, P9, DOI 10.1016/j.molstruc.2011.02.013
   Georgescu B, 2011, ANIM SCI BIOTECHNOL, V44, P89
   GERHARD I, 1992, GEBURTSH FRAUENHEILK, V52, P383, DOI 10.1055/s-2007-1023774
   GHAZALY KS, 1992, WATER AIR SOIL POLL, V64, P525, DOI 10.1007/BF00483362
   Gupta N, 2012, J TAIWAN INST CHEM E, V43, P125, DOI 10.1016/j.jtice.2011.07.009
   Hfaiedh N, 2005, CR BIOL, V328, P648, DOI 10.1016/j.crvi.2005.03.001
   Hfaiedh N, 2008, FOOD CHEM TOXICOL, V46, P3759, DOI 10.1016/j.fct.2008.09.059
   Jia J, 2008, ENVIRON TOXICOL, V23, P401, DOI 10.1002/tox.20346
   Kakela R, 1999, COMP BIOCHEM PHYS C, V123, P27, DOI 10.1016/S0742-8413(99)00006-7
   Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021
   Koedrith P, 2011, INT J MOL SCI, V12, P9576, DOI 10.3390/ijms12129576
   Krisanapiboon A, 2006, J Orthop Surg (Hong Kong), V14, P315
   Kubrak OI, 2012, AQUAT TOXICOL, V118, P88, DOI 10.1016/j.aquatox.2012.03.016
   Kurien BT, 2003, LIFE SCI, V73, P1655, DOI 10.1016/S0024-3205(03)00475-2
   Legeros RZ, 1980, FORMATION STABILITY, P89
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Mathur A. K., 1993, Biomedical and Environmental Sciences, V6, P231
   Mobasherpour I, 2011, J SAUDI CHEM SOC, V15, P105, DOI 10.1016/j.jscs.2010.06.003
   Nielsen PH, 2002, WATER SCI TECHNOL, V46, P73
   Obone E, 1999, J TOXICOL ENV HEAL A, V57, P379, DOI 10.1080/009841099157593
   Osmancik P, 2010, CARDIOLOGY, V116, P302, DOI 10.1159/000319619
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Pan JJ, 2010, CHEM RES TOXICOL, V23, P568, DOI 10.1021/tx9003193
   Pandey R, 1999, BIOMETALS, V12, P339, DOI 10.1023/A:1009291816033
   Ptashynski MD, 2002, AQUAT TOXICOL, V58, P249, DOI 10.1016/S0166-445X(01)00231-4
   RAY D, 1990, J INORG BIOCHEM, V38, P169, DOI 10.1016/0162-0134(90)84010-M
   Rosskopfova O, 2013, J RADIOANAL NUCL CH, V295, P459, DOI 10.1007/s10967-012-1799-6
   Sengupta P, 2013, DRUG CHEM TOXICOL, V36, P353, DOI 10.3109/01480545.2012.710631
   Simon FG, 2008, APPL GEOCHEM, V23, P2137, DOI 10.1016/j.apgeochem.2008.04.025
   Smiciklas I, 2006, WATER RES, V40, P2267, DOI 10.1016/j.watres.2006.04.031
   Stengel B, 1996, ENCY MED CHIRURG TOX
   STINSON TJ, 1992, TOXICOL APPL PHARM, V117, P98, DOI 10.1016/0041-008X(92)90222-E
   Sunderman FW, 1977, J ANN CLIN LAB SCI, V5, P377
   Thamaraiselvi T. V., 2004, TRENDS BIOMATER ARTI, V18, P9
   TJALVE H, 1988, WATER RES, V22, P1129, DOI 10.1016/0043-1354(88)90007-3
   Travlos GS, 1996, TOXICOLOGY, V107, P17, DOI 10.1016/0300-483X(95)03197-N
   Uthus EO, 1996, BIOL TRACE ELEM RES, V52, P23, DOI 10.1007/BF02784087
   Veiderma M, 2005, J ORGANOMET CHEM, V690, P2638, DOI 10.1016/j.jorganchem.2004.11.022
   Venugopal B., 1978, METAL TOXICITY MAMMA
   Wang YF, 2012, TOXICOL APPL PHARM, V259, P177, DOI 10.1016/j.taap.2011.12.022
   Yokoi K, 2003, BIOL TRACE ELEM RES, V93, P141, DOI 10.1385/BTER:93:1-3:141
   Young RA, 1975, C INT CNRS, V230, P21
   Zhu RH, 2008, CATAL TODAY, V139, P94, DOI 10.1016/j.cattod.2008.08.011
NR 70
TC 1
Z9 1
U1 2
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1537-6516
EI 1537-6524
J9 TOXICOL MECH METHOD
JI Toxicol. Mech. Methods
PD MAR
PY 2015
VL 25
IS 3
BP 155
EP 165
DI 10.3109/15376516.2014.1003358
PG 11
WC Toxicology
SC Toxicology
GA CK1ST
UT WOS:000355988300001
PM 25560666
DA 2018-10-19
ER

PT J
AU Tas, AC
AF Tas, A Cuneyt
TI Aragonite coating solutions (ACS) based on artificial seawater
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Aragonite; Coating; Biomimicry; Artificial; Seawater
ID AMORPHOUS CALCIUM-CARBONATE; SEA-WATER; SPHERULITIC GROWTH;
   SURFACE-STRUCTURE; SATURATION STATE; SULFATE-IONS; IN-VITRO;
   CRYSTALLIZATION; PRECIPITATION; MAGNESIUM
AB Aragonite (CaCO3, calcium carbonate) is an abundant biomaterial of marine life. It is the dominant inorganic phase of coral reefs, mollusc bivalve shells and the stalactites or stalagmites of geological sediments. Inorganic and initially precipitate-free aragonite coating solutions (ACS) of pH 7.4 were developed in this study to deposit monolayers of aragonite spherules or ooids on biomaterial (e.g., UHMWPE, ultrahigh molecular weight polyethylene) surfaces soaked in ACS at 30 degrees C. The ACS solutions of this study have been developed for the surface engineering of synthetic biomaterials. The abiotic ACS solutions, enriched with calcium and bicarbonate ions at different concentrations, essentially mimicked the artificial seawater composition and started to deposit aragonite after a long (4 h) incubation period at the tropical sea surface temperature of 30 degrees C. While numerous techniques for the solution deposition of calcium hydroxyapatite (Ca-10(PO4)(6)(OH)(2)), of low thermodynamic solubility, on synthetic biomaterials have been demonstrated, procedures related to the solution-based surface deposition of high solubility aragonite remained uncommon. Monolayers of aragonite ooids deposited at 30 degrees C on UHMWPE substrates soaked in organic-free ACS solutions were found to possess nano-structures similar to the mortar-and-bricktype botryoids observed in biogenic marine shells. Samples were characterized using SEM, XRD, FTIR, ICP-AES and contact angle goniometry. (C) 2015 Elsevier B.V. All rights reserved.
C1 Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA.
RP Tas, AC (reprint author), Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA.
EM c_tas@hotmail.com
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   Ahn JW, 2004, J AM CERAM SOC, V87, P286, DOI 10.1111/j.1551-2916.2004.00286.x
   Allison VC, 1923, J GEOL, V31, P106, DOI 10.1086/622988
   [Anonymous], 2013, D114198 ASTM
   Backstrom HLJ, 1925, J AM CHEM SOC, V47, P2432, DOI 10.1021/ja01687a002
   Barchiche C, 2009, ELECTROCHIM ACTA, V54, P3580, DOI 10.1016/j.electacta.2009.01.023
   Barchiche Ch, 2003, ELECTROCHIM ACTA, V48, P1645
   Bayraktar A.C. Tas, 1999, J EUR CERAM SOC, V19, P2573
   Beck R, 2010, J CRYST GROWTH, V312, P2226, DOI 10.1016/j.jcrysgro.2010.04.037
   Benedetti A, 2009, ELECTROCHIM ACTA, V54, P6472, DOI 10.1016/j.electacta.2009.06.022
   BERNER RA, 1965, GEOCHIM COSMOCHIM AC, V29, P947, DOI 10.1016/0016-7037(65)90087-6
   BERNER RA, 1972, AM J SCI, V272, P826, DOI 10.2475/ajs.272.9.826
   BERNER RA, 1975, GEOCHIM COSMOCHIM AC, V39, P489, DOI 10.1016/0016-7037(75)90102-7
   BILLS PM, 1985, CALCIFIED TISSUE INT, V37, P174, DOI 10.1007/BF02554837
   Bots P, 2011, GEOLOGY, V39, P331, DOI 10.1130/G31619.1
   Bragg WL, 1924, P R SOC LOND A-CONTA, V105, P16, DOI 10.1098/rspa.1924.0002
   BRAND U, 1991, GEOCHIM COSMOCHIM AC, V55, P505, DOI 10.1016/0016-7037(91)90008-S
   Brecevic L, 2007, CROAT CHEM ACTA, V80, P467
   Cubillas P, 2005, CHEM GEOL, V216, P59, DOI 10.1016/j.chemgeo.2004.11.009
   De Choudens-Sanchez V, 2009, J SEDIMENT RES, V79, P363, DOI 10.2110/jsr.2009.043
   de Leeuw NH, 1998, J PHYS CHEM B, V102, P2914, DOI 10.1021/jp973210f
   Debye P, 1923, PHYS Z, V24, P185
   Deng YL, 2013, MAT SCI ENG C-MATER, V33, P1339, DOI 10.1016/j.msec.2012.12.034
   Dill RF, 1998, CARBONATE EVAPORITE, V13, P189, DOI 10.1007/BF03176592
   Fabre S, 2013, PALAEOGEOGR PALAEOCL, V392, P524, DOI 10.1016/j.palaeo.2013.10.006
   FernandezDiaz L, 1996, J SEDIMENT RES, V66, P482
   Fransson A, 2013, J GEOPHYS RES-OCEANS, V118, P7001, DOI 10.1002/2013JC009164
   Gangsto R, 2008, BIOGEOSCIENCES, V5, P1057, DOI 10.5194/bg-5-1057-2008
   Gayathri S, 2007, CHEM-EUR J, V13, P3262, DOI 10.1002/chem.200600825
   Jiang JX, 2012, J AM CERAM SOC, V95, P3735, DOI 10.1111/jace.12077
   Jury CP, 2013, WATER-SUI, V5, P1303, DOI 10.3390/w5031303
   Karoui H, 2013, DESALINATION, V311, P234, DOI 10.1016/j.desal.2012.07.011
   KESTER DR, 1967, LIMNOL OCEANOGR, V12, P176, DOI 10.4319/lo.1967.12.1.0176
   Koga N, 2014, CRYST GROWTH DES, V14, P879, DOI 10.1021/cg4018689
   KOJIMA Y, 1993, NIPPON SERAM KYO GAK, V101, P1145
   Lee E, 2013, J ATMOS OCEAN TECH, V30, P2926, DOI 10.1175/JTECH-D-12-00238.1
   Lee JH, 2014, J AM CERAM SOC, V97, P3052, DOI 10.1111/jace.13124
   Lenders H.M., 2012, AM CHEM SOC, V134, P1367
   Lyman J, 1940, J MAR RES, V3, P134
   Mann S., 2001, BIOMINERALIZATION PR
   Matijevic E., 1999, COLLOID INTERFACE SC, V218, P545
   McClanahan TR, 2002, ENVIRON CONSERV, V29, P460, DOI 10.1017/S0376892902000334
   Monchau F, 2002, BIOMOL ENG, V19, P143, DOI 10.1016/S1389-0344(02)00023-0
   MORSE JW, 1980, GEOCHIM COSMOCHIM AC, V44, P85, DOI 10.1016/0016-7037(80)90178-7
   MUCCI A, 1983, GEOCHIM COSMOCHIM AC, V47, P217, DOI 10.1016/0016-7037(83)90135-7
   MUCCI A, 1987, GEOCHIM COSMOCHIM AC, V51, P1977, DOI 10.1016/0016-7037(87)90186-4
   MUCCI A, 1984, GEOCHIM COSMOCHIM AC, V48, P815, DOI 10.1016/0016-7037(84)90103-0
   MUCCI A, 1989, CHEM GEOL, V74, P309, DOI 10.1016/0009-2541(89)90040-5
   Njegic-Dzakula N., 2010, J COLLOID INTERF SCI, V343, P553
   OTA Y, 1995, J AM CERAM SOC, V78, P1983, DOI 10.1111/j.1151-2916.1995.tb08924.x
   Oyane A, 1999, J PHYS CHEM B, V103, P8230, DOI 10.1021/jp9910340
   Pan HB, 2010, ACTA BIOMATER, V6, P4181, DOI 10.1016/j.actbio.2010.05.013
   Papadimitriou S, 2004, GEOCHIM COSMOCHIM AC, V68, P1749, DOI 10.1016/j.gca.2003.07.004
   Park WK, 2008, J CRYST GROWTH, V310, P2593, DOI 10.1016/j.jcrysgro.2008.01.023
   Patey MD, 2008, TRAC-TREND ANAL CHEM, V27, P169, DOI 10.1016/j.trac.2007.12.006
   Pavlov M, 1998, J PHYS CHEM A, V102, P219, DOI 10.1021/jp972072r
   Plummer LN, 1982, GEOCHIM COSMOCHIM AC, P1011
   Raiteri P, 2010, J AM CHEM SOC, V132, P17623, DOI 10.1021/ja108508k
   Rau GH, 2011, ENVIRON SCI TECHNOL, V45, P1088, DOI 10.1021/es102671x
   REDDY MM, 1976, J CRYST GROWTH, V35, P33, DOI 10.1016/0022-0248(76)90240-2
   Riveiro A, 2014, APPL SURF SCI, V302, P236, DOI 10.1016/j.apsusc.2014.02.130
   rvloeller H., 2007, CORROS SCI, V49, P1992
   Sand KK, 2012, CRYST GROWTH DES, V12, P842, DOI 10.1021/cg2012342
   Segschneider J, 2013, GLOBAL BIOGEOCHEM CY, V27, P1214, DOI 10.1002/2013GB004684
   Sherwin CM, 2011, GEOCHIM COSMOCHIM AC, V75, P3915, DOI 10.1016/j.gca.2011.04.020
   SIMKISS K, 1964, NATURE, V201, P492, DOI 10.1038/201492a0
   Tas AC, 2014, J NON-CRYST SOLIDS, V400, P27, DOI 10.1016/j.jnoncrysol.2014.04.031
   Thachepan S, 2006, CHEM MATER, V18, P3557, DOI 10.1021/cm060847f
   Vater H., 1897, Z KRISTALLOGR MIN, V27, P477
   Villegas-Jimenez A, 2009, LANGMUIR, V25, P6813, DOI 10.1021/la803652x
   Vroman L, 2008, COLLOID SURFACE B, V62, P1, DOI 10.1016/j.colsurfb.2007.11.017
   WRAY JL, 1957, J AM CHEM SOC, V79, P2031, DOI 10.1021/ja01566a001
   Xu J, 2013, P NATL ACAD SCI USA, V110, P17750, DOI 10.1073/pnas.1307612110
   Zakaria FZ, 2008, J RAMAN SPECTROSC, V39, P1204, DOI 10.1002/jrs.1964
   ZHONG SJ, 1989, CHEM GEOL, V78, P283, DOI 10.1016/0009-2541(89)90064-8
   ZHONG SJ, 1995, GEOCHIM COSMOCHIM AC, V59, P443, DOI 10.1016/0016-7037(94)00381-U
   Zhou GT, 2010, EUR J MINERAL, V22, P259, DOI 10.1127/0935-1221/2009/0022-2008
   Zuddas P, 1998, GEOCHIM COSMOCHIM AC, V62, P757, DOI 10.1016/S0016-7037(98)00026-X
   ZUDDAS P, 1994, GEOCHIM COSMOCHIM AC, V58, P4353, DOI 10.1016/0016-7037(94)90339-5
NR 79
TC 3
Z9 3
U1 1
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 1
PY 2015
VL 330
BP 262
EP 269
DI 10.1016/j.apsusc.2014.12.195
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA CB4SE
UT WOS:000349617400033
DA 2018-10-19
ER

PT J
AU Van Ba, OL
   Aharony, S
   Loutochin, O
   Corcos, J
AF Van Ba, Ornella Lam
   Aharony, Shachar
   Loutochin, Oleg
   Corcos, Jacques
TI Bladder tissue engineering: A literature review
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Bladder; Tissue engineering; Scaffold; Biomaterial; Bladder
   reconstruction
ID SMALL-INTESTINAL SUBMUCOSA; MESENCHYMAL STEM-CELLS; ENDOTHELIAL
   GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; IN-VIVO DEGRADATION;
   URINARY-BLADDER; ACELLULAR MATRIX; RABBIT MODEL; AUGMENTATION
   CYSTOPLASTY; MAGNETIC-RESONANCE
AB Purpose of review: In bladder cancer and neuro-bladder, reconstruction of the bladder requires bowel segment grafting for augmentation cystoplasty or neo-bladder creation. However, even if currently considered as the gold standard, it is associated with potentially severe short- and long-term adverse effects. Thus, bladder tissue engineering is a promising approach to bladder reconstruction.
   Recent findings: In the last few years, progress has been made with the development of new biomaterials for bladder tissue replacement and in deciphering the role of stem cells as well as their contribution to bladder scaffold integration and tissue regeneration.
   Summary: This review of recently published articles allows us to forecast the characteristics of efficient and safe bladder biomaterials. However, several factors, such as native bladder traits, the specific involvement of urine, and bladder tissue replacement indications, have to be assessed with caution before including bladder tissue engineering in clinical trials. Many authors agree that these challenging techniques could deliver significant benefits with clinical application, reducing morbidity and global long-term costs. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Van Ba, Ornella Lam; Aharony, Shachar; Loutochin, Oleg; Corcos, Jacques] McGill Univ, Jewish Gen Hosp, Dept Urol, Montreal, PQ H3T 1E2, Canada.
RP Corcos, J (reprint author), McGill Univ, Jewish Gen Hosp, Dept Urol, 3755 Cote St Catherine Rd, Montreal, PQ H3T 1E2, Canada.
EM jcorcos@uro.jgh.mcgill.ca
CR Adamowicz J, 2012, TRANSPL P, V44, P1439, DOI 10.1016/j.transproceed.2012.01.128
   Altai C., 2006, J UROLOGY, V176, P1706
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anilkumar TV, 2014, J BIOMED MATER RES B, V102, P1506, DOI 10.1002/jbm.b.33131
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 2011, BRIT MED BULL, V97, P81, DOI 10.1093/bmb/ldr003
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Bharadwaj S, 2013, STEM CELLS, V31, P1840, DOI 10.1002/stem.1424
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Boruch AV, 2010, J SURG RES, V161, P217, DOI 10.1016/j.jss.2009.02.014
   Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940
   Caione P, 2012, PEDIATR SURG INT, V28, P421, DOI 10.1007/s00383-012-3063-0
   Chavan S, 2014, EUR UROL, V66, P59, DOI 10.1016/j.eururo.2013.10.001
   Chen BS, 2011, INT J ARTIF ORGANS, V34, P1137, DOI 10.5301/ijao.5000069
   Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]
   Cheng HLM, 2012, NMR BIOMED, V25, P418, DOI 10.1002/nbm.1617
   Cheng HLM, 2010, MAGN RESON MED, V64, P341, DOI 10.1002/mrm.22404
   Corcos J, 2011, NEUROUROL URODYNAM, V30, P447, DOI 10.1002/nau.20998
   Datum S. E., 1998, BR J UROL, V82, P411
   Drewa T, 2012, NAT REV UROL, V9, P561, DOI 10.1038/nrurol.2012.158
   Faulk DM, 2014, ACTA BIOMATER, V10, P183, DOI 10.1016/j.actbio.2013.09.006
   Feng JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096671
   GROVER PK, 1994, MINER ELECTROL METAB, V20, P361
   Hafner C, 2002, INT J CANCER, V101, P1, DOI 10.1002/ijc.10544
   Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003
   Herberts CA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-29
   Horst M, 2013, BIOMATERIALS, V34, P1537, DOI 10.1016/j.biomaterials.2012.10.075
   Jerman UD, 2014, TISSUE ENG PART C-ME, V20, P317, DOI [10.1089/ten.TEC.2013.0298, 10.1089/ten.tec.2013.0298]
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Joseph DB, 2014, J UROLOGY, V191, P1389, DOI 10.1016/j.juro.2013.10.103
   Juszczak K, 2012, CELL MOL BIOL LETT, V17, P196, DOI 10.2478/s11658-012-0002-y
   Kajbafzadeh AM, 2014, PEDIATR SURG INT, V30, P371, DOI 10.1007/s00383-014-3474-1
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kopparapu PK, 2013, ANTICANCER RES, V33, P2381
   Kropp BP, 1998, WORLD J UROL, V16, P262, DOI 10.1007/s003450050064
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lai JY, 2005, J PEDIATR SURG, V40, P1869, DOI 10.1016/j.jpedsurg.2005.08.028
   Lai JY, 2002, J UROLOGY, V168, P1853, DOI 10.1097/01.ju.0000030040.76258.5a
   Landman J, 2004, J UROLOGY, V171, P2450, DOI 10.1097/01.ju.0000127756.64619.27
   Lang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053980
   Lin HK, 2004, J UROLOGY, V171, P1348, DOI 10.1097/01.ju.0000108800.47594.8b
   Loai Y, 2010, J BIOMED MATER RES A, V94A, P1205, DOI 10.1002/jbm.a.32777
   Moad M, 2013, EUR UROL, V64, P753, DOI 10.1016/j.eururo.2013.03.054
   Nieuwenhuijzen JA, 2008, EUR UROL, V53, P834, DOI 10.1016/j.eururo.2007.09.008
   Nuininga JE, 2004, BIOMATERIALS, V25, P1657, DOI 10.1016/S0142-9612(03)00519-2
   Nuininga JE, 2010, TISSUE ENG PT A, V16, P3319, DOI 10.1089/ten.tea.2010.0053
   Oh SH, 2009, BIOMATERIALS, V30, P757, DOI 10.1016/j.biomaterials.2008.09.065
   Ohishi M, 2010, J CELL BIOCHEM, V109, P277, DOI 10.1002/jcb.22399
   Paterson RF, 2002, J UROLOGY, V168, P2253, DOI 10.1097/01.ju.0000024629.58795.43
   Petrovic V, 2011, THESCIENTIFICWORLDJO, V11, P1479, DOI 10.1100/tsw.2011.138
   Placzek MR, 2009, J R SOC INTERFACE, V6, P209, DOI 10.1098/rsif.2008.0442
   Pokrywczynska M, 2013, ARCH IMMUNOL THER EX, V61, P483, DOI 10.1007/s00005-013-0249-7
   Poluywczynska M., 2014, EXP BIOL MED, V239, P264
   Quek ML, 2003, J UROLOGY, V169, P195, DOI 10.1097/01.ju.0000039782.13395.0a
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   Rim NG, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014102
   Schaefer M, 2013, J PEDIATR UROL, V9, P878, DOI 10.1016/j.jpurol.2012.12.001
   Seth A, 2013, BIOMATERIALS, V34, P4758, DOI 10.1016/j.biomaterials.2013.03.038
   Sharma AK, 2013, P NATL ACAD SCI USA, V110, P4003, DOI 10.1073/pnas.1220764110
   Sharma AK, 2011, STEM CELLS, V29, P241, DOI 10.1002/stem.568
   Sloff M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098734
   Spencer R, 2012, NMR BIOMED, V25, P401, DOI 10.1002/nbm.1806
   Subramaniam R, 2011, J UROLOGY, V186, P2014, DOI 10.1016/j.juro.2011.07.031
   Sun Y., 2014, TISSUE ENG C, V24
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012
   Yang B, 2010, TISSUE ENG PART C-ME, V16, P1201, DOI [10.1089/ten.tec.2009.0311, 10.1089/ten.TEC.2009.0311]
   Yao C, 2013, INT J NANOMED, V8, P3285, DOI 10.2147/IJN.S44901
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Youssif M, 2005, UROLOGY, V66, P201, DOI 10.1016/j.urology.2005.01.054
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Yuan HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080959
   Zhang F, 2014, J UROLOGY, V192, P544, DOI 10.1016/j.juro.2014.01.116
   Zhang YY, 2008, J UROLOGY, V180, P2226, DOI 10.1016/j.juro.2008.07.023
   Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x
   Zhou LH, 2013, TISSUE ENG PT A, V19, P264, DOI [10.1089/ten.tea.2011.0609, 10.1089/ten.TEA.2011.0609]
   Zhu WD, 2010, WORLD J UROL, V28, P493, DOI 10.1007/s00345-010-0508-8
NR 79
TC 17
Z9 17
U1 0
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD MAR
PY 2015
VL 82-83
BP 31
EP 37
DI 10.1016/j.addr.2014.11.013
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CH0UF
UT WOS:000353737200005
PM 25446136
DA 2018-10-19
ER

PT J
AU Lin, HK
   Madihally, SV
   Palmer, B
   Frimberger, D
   Fung, KM
   Kropp, BP
AF Lin, Hsueh-Kung
   Madihally, Sundar V.
   Palmer, Blake
   Frimberger, Dominic
   Fung, Kar-Ming
   Kropp, Bradley P.
TI Biomatrices for bladder reconstruction
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Bioactive molecule; Biomaterials; Bladder augmentation; Nanotechnology;
   Stem cell; Tissue engineering
ID SMALL-INTESTINAL SUBMUCOSA; SMOOTH-MUSCLE-CELLS; ACELLULAR MATRIX GRAFT;
   ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; TISSUE ENGINEERING
   APPLICATIONS; NANO-STRUCTURED POLYMERS; HUMAN AMNIOTIC MEMBRANE;
   SILK-BASED BIOMATERIALS; IN-VIVO IMPLICATIONS
AB There is a demand for tissue engineering of the bladder needed by patients who experience a neurogenic bladder or idiopathic detrusor overactivity. To avoid complications from augmentation cystoplasty, the field of tissue engineering seeks optimal scaffolds for bladder reconstruction. Naturally derived biomaterials as well as synthetic and natural polymers have been explored as bladder substitutes. To improve regenerative properties, these biomaterials have been conjugated with functional molecules, combined with nanotechology, or seeded with exogenous cells. Although most studies reported complete and functional bladder regeneration in small-animal models, results from large-animal models and human clinical trials varied. For functional bladder regeneration, procedures for biomaterial fabrication, incorporation of biologically active agents, introduction of nanotechnology, and application of stem-cell technology need to be standardized. Advanced molecular and medical technologies such as next generation sequencing and magnetic resonance imaging can be introduced for mechanistic understanding and non-invasive monitoring of regeneration processes, respectively. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Lin, Hsueh-Kung; Palmer, Blake; Frimberger, Dominic; Fung, Kar-Ming; Kropp, Bradley P.] Univ Oklahoma, Hlth Sci Ctr, Dept Urol, Childrens Hosp Oklahoma, Oklahoma City, OK 73104 USA.
   [Madihally, Sundar V.] Oklahoma State Univ, Dept Chem Engn, Engn North 423, Stillwater, OK 74078 USA.
   [Fung, Kar-Ming] Univ Oklahoma, Hlth Sci Ctr, Dept Urol, Oklahoma City, OK 73104 USA.
RP Kropp, BP (reprint author), Univ Oklahoma, Hlth Sci Ctr, Dept Urol, 920 Stanton L Young Blvd,WP3150, Oklahoma City, OK 73104 USA.
EM Brad-Kropp@ouhsc.edu
RI Madihally, Sundararajan/D-9285-2012
OI Madihally, Sundararajan/0000-0001-7498-5760
CR Adamowicz J, 2012, TRANSPL P, V44, P1429, DOI 10.1016/j.transproceed.2012.01.144
   Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Ahvaz HH, 2013, J NANOSCI NANOTECHNO, V13, P4736, DOI 10.1166/jnn.2013.7193
   Aitken KJ, 2009, NAT REV UROL, V6, P596, DOI 10.1038/nrurol.2009.201
   Aitken KJ, 2009, NAT REV UROL, V6, P612, DOI 10.1038/nrurol.2009.202
   Akbal C, 2006, J UROLOGY, V176, P1706, DOI 10.1016/j.juro.2006.04.085
   Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Antoon R, 2012, J BIOMED MATER RES A, V100A, P72, DOI 10.1002/jbm.a.33230
   Ashley RA, 2010, BJU INT, V105, P1462, DOI 10.1111/j.1464-410X.2009.08965.x
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   BABU M, 1989, MOL CELL BIOL, V9, P1642, DOI 10.1128/MCB.9.4.1642
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Baker SC, 2009, BIOMATERIALS, V30, P1321, DOI 10.1016/j.biomaterials.2008.11.033
   Baumert H, 2007, EUR UROL, V52, P884, DOI 10.1016/j.eururo.2006.11.044
   Baumert H, 2007, EUR UROL, V52, P1492, DOI 10.1016/j.eururo.2007.04.098
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Biers SM, 2012, BJU INT, V109, P1280, DOI 10.1111/j.1464-410X.2011.10650.x
   Birder LA, 2012, NEUROUROL URODYNAM, V31, P293, DOI 10.1002/nau.22195
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Brown AL, 2006, BIOMATERIALS, V27, P3825, DOI 10.1016/j.biomaterials.2006.02.040
   Brown AL, 2002, BIOMATERIALS, V23, P2179, DOI 10.1016/S0142-9612(01)00350-7
   Caione P, 2006, PEDIATR SURG INT, V22, P593, DOI 10.1007/s00383-006-1705-9
   Caione P, 2012, PEDIATR SURG INT, V28, P421, DOI 10.1007/s00383-012-3063-0
   Campodonico F, 2004, EUR UROL, V46, P531, DOI 10.1016/j.eururo.2004.04.019
   Cao TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065654
   Cartwright L, 2006, J BIOMED MATER RES A, V77A, P390, DOI 10.1002/jbm.a.30648
   Cayan S, 2002, J UROLOGY, V168, P798, DOI 10.1016/S0022-5347(05)64746-5
   Chen BS, 2011, INT J ARTIF ORGANS, V34, P1137, DOI 10.5301/ijao.5000069
   Chen BSS, 2009, INT J ARTIF ORGANS, V32, P159
   CHEN NX, 1995, TRANSPLANTATION, V59, P933, DOI 10.1097/00007890-199504150-00002
   Chen W, 2014, TISSUE ENG PT A, V20, P2234, DOI [10.1089/ten.tea.2013.0730, 10.1089/ten.TEA.2013.0730]
   Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020
   Chung SY, 2005, J UROLOGY, V174, P353, DOI 10.1097/01.ju.0000161592.00434.c1
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Dantzer E, 2001, BRIT J PLAST SURG, V54, P659, DOI 10.1054/bjps.2001.3684
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Davis LM, 2014, J BIOMED MATER RES B, V102, P89, DOI 10.1002/jbm.b.32985
   Del Gaudio C, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/4/045013
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   Denuziere A., 2000, Annales Pharmaceutiques Francaises, V58, P47
   Dozmorov Mikhail G., 2007, Journal of Smooth Muscle Research, V43, P55, DOI 10.1540/jsmr.43.55
   Drewa T, 2006, TRANSPLANT P, V38, P133, DOI 10.1016/j.transproceed.2005.11.086
   Drewa T, 2009, TRANSPL P, V41, P4345, DOI 10.1016/j.transproceed.2009.08.059
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evren S, 2010, CELLS TISSUES ORGANS, V192, P250, DOI 10.1159/000317332
   Farhat W, 2003, J BIOMED MATER RES A, V67A, P970, DOI 10.1002/jbm.a.10171
   Franck D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056237
   Frimberger D, 2005, UROLOGY, V65, P827, DOI 10.1016/j.urology.2004.11.024
   Gabouev AI, 2003, INT J ARTIF ORGANS, V26, P935
   Galvin DJ, 2002, AM J PHYSIOL-RENAL, V283, pF1192, DOI 10.1152/ajprenal.00168.2002
   Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x
   Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   GARG HG, 1991, BURNS, V17, P452, DOI 10.1016/0305-4179(91)90070-W
   Gelain F, 2007, J NANOSCI NANOTECHNO, V7, P424, DOI 10.1166/jnn.2007.154
   Geng HQ, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-312
   Gomez P, 2011, BIOMATERIALS, V32, P7562, DOI 10.1016/j.biomaterials.2011.06.067
   Gratzer PF, 2006, TISSUE ENG, V12, P2975, DOI 10.1089/ten.2006.12.2975
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Harrington DA, 2006, J BIOMED MATER RES A, V78A, P157, DOI 10.1002/jbm.a.30718
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde JP, 2002, TISSUE ENG, V8, P225, DOI 10.1089/107632702753724996
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Horst M, 2014, J BIOMED MATER RES A, V102, P2116, DOI 10.1002/jbm.a.34889
   Horst M, 2013, J TISSUE ENG REGEN M, V7, P515, DOI 10.1002/term.547
   Horst M, 2013, BIOMATERIALS, V34, P1537, DOI 10.1016/j.biomaterials.2012.10.075
   Huang X, 2013, UROLOGY, V81, P468, DOI 10.1016/j.urology.2012.12.001
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Hurst RE, 2001, J BIOMAT SCI-POLYM E, V12, P1267, DOI 10.1163/156856201753395798
   Iijima K, 2007, TISSUE ENG, V13, P513, DOI 10.1089/ten.2006.0170
   Jayo MJ, 2008, REGEN MED, V3, P671, DOI 10.2217/17460751.3.5.671
   Jayo MJ, 2008, J UROLOGY, V180, P392, DOI 10.1016/j.juro.2008.02.039
   Jeong JH, 2000, COLLOID SURFACE B, V18, P371, DOI 10.1016/S0927-7765(99)00162-9
   Jerman UD, 2014, TISSUE ENG PART C-ME, V20, P317, DOI [10.1089/ten.TEC.2013.0298, 10.1089/ten.tec.2013.0298]
   Joseph DB, 2014, J UROLOGY, V191, P1389, DOI 10.1016/j.juro.2013.10.103
   Kajbafzadeh AM, 2007, J SURG RES, V139, P189, DOI 10.1016/j.jss.2006.11.003
   Kajbafzadeh AM, 2012, TISSUE ENG PT A, V18, P883, DOI [10.1089/ten.tea.2011.0202, 10.1089/ten.TEA.2011.0202]
   Kajbafzadeh AM, 2011, J PEDIATR UROL, V7, P317, DOI 10.1016/j.jpurol.2011.02.014
   KAMBIC H, 1992, J UROLOGY, V148, P539, DOI 10.1016/S0022-5347(17)36649-1
   Kanematsu A, 2005, AM J PATHOL, V166, P565, DOI 10.1016/S0002-9440(10)62278-X
   Kanematsu A, 2003, J UROLOGY, V170, P1633, DOI 10.1097/01.ju.0000084021.51099.8a
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]
   Kikuno N, 2009, BJU INT, V103, P1424, DOI 10.1111/j.1464-410X.2008.08129.x
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   Kranz H, 2000, J PHARM SCI-US, V89, P1558
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   Kropp BP, 1998, WORLD J UROL, V16, P262, DOI 10.1007/s003450050064
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Lai JY, 2005, J PEDIATR SURG, V40, P1869, DOI 10.1016/j.jpedsurg.2005.08.028
   Lamme EN, 1996, J HISTOCHEM CYTOCHEM, V44, P1311, DOI 10.1177/44.11.8918906
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   LANTZ GC, 1992, J SURG RES, V53, P175, DOI 10.1016/0022-4804(92)90031-T
   Lawrence BJ, 2009, J BIOMED MATER RES A, V88A, P634, DOI 10.1002/jbm.a.31903
   Liao W, 2013, TRANSPL P, V45, P730, DOI 10.1016/j.transproceed.2012.08.023
   Lin HK, 2004, J UROLOGY, V171, P1348, DOI 10.1097/01.ju.0000108800.47594.8b
   Lin HK, 2014, TISSUE ENG PART B-RE, V20, P73, DOI 10.1089/ten.TEB.2013.0126
   Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979
   Lindberg K, 2001, BURNS, V27, P254, DOI 10.1016/S0305-4179(00)00113-3
   LINDNER V, 1992, J CLIN INVEST, V90, P2044, DOI 10.1172/JCI116085
   Liu Y, 2009, BIOMATERIALS, V30, P3865, DOI 10.1016/j.biomaterials.2009.04.008
   Loai Y, 2010, J BIOMED MATER RES A, V94A, P1205, DOI 10.1002/jbm.a.32777
   Lorentz KM, 2012, BIOMATERIALS, V33, P494, DOI 10.1016/j.biomaterials.2011.09.088
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Madihally SV, 1999, STEM CELLS, V17, P295, DOI 10.1002/stem.170295
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5
   Marques AID, 2009, J SMALL ANIM PRACT, V50, P619, DOI 10.1111/j.1748-5827.2009.00819.x
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   Master VA, 2003, J UROLOGY, V170, P1628, DOI 10.1097/01.ju.0000084407.24615.f8
   Mauney JR, 2011, BIOMATERIALS, V32, P808, DOI 10.1016/j.biomaterials.2010.09.051
   Merguerian PA, 2000, BJU INT, V85, P894, DOI 10.1046/j.1464-410x.2000.00513.x
   Mi FL, 2002, BIOMATERIALS, V23, P3257, DOI 10.1016/S0142-9612(02)00084-4
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Miller Derick C, 2002, IEEE Trans Nanobioscience, V1, P61, DOI 10.1109/TNB.2002.806917
   Mondalek FG, 2008, BIOMATERIALS, V29, P1159, DOI 10.1016/j.biomaterials.2007.11.020
   Mondalek FG, 2010, J BIOMED MATER RES A, V94A, P712, DOI 10.1002/jbm.a.32748
   Moon SJ, 2011, KOREAN J UROL, V52, P150, DOI 10.4111/kju.2011.52.2.150
   Moshfeghian A, 2006, J BIOMED MATER RES A, V79A, P418, DOI 10.1002/jbm.a.30849
   Murphy F, 2007, PEDIATR SURG INT, V23, P353, DOI 10.1007/s00383-007-1882-1
   Nugent MA, 2000, P NATL ACAD SCI USA, V97, P6722, DOI 10.1073/pnas.97.12.6722
   Obara T, 2006, UROLOGY, V68, P892, DOI 10.1016/j.urology.2006.04.030
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Orgill DP, 1999, ANN NY ACAD SCI, V888, P233, DOI 10.1111/j.1749-6632.1999.tb07959.x
   Pariente JL, 2001, J BIOMED MATER RES, V55, P33, DOI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.0.CO;2-7
   Paterson RF, 2002, J UROLOGY, V168, P2253, DOI 10.1097/01.ju.0000024629.58795.43
   Pattison M, 2007, MACROMOL BIOSCI, V7, P690, DOI 10.1002/mabi.200600297
   Piechota HJ, 1998, J UROLOGY, V159, P1717, DOI 10.1097/00005392-199805000-00100
   PISTNER H, 1993, BIOMATERIALS, V14, P291, DOI 10.1016/0142-9612(93)90121-H
   Pokrywczynska M, 2013, ARCH IMMUNOL THER EX, V61, P483, DOI 10.1007/s00005-013-0249-7
   Pope JC, 1997, J UROLOGY, V158, P1105, DOI 10.1016/S0022-5347(01)64398-2
   Portis AJ, 2000, J UROLOGY, V164, P1405, DOI 10.1016/S0022-5347(05)67207-2
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   Probst M, 2000, BJU INT, V85, P362, DOI 10.1046/j.1464-410x.2000.00442.x
   Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268
   Reddy PP, 2000, J UROLOGY, V164, P936, DOI 10.1016/S0022-5347(05)67221-7
   Rosario DJ, 2008, REGEN MED, V3, P145, DOI 10.2217/17460751.3.2.145
   Roth CC, 2011, BJU INT, V108, P148, DOI 10.1111/j.1464-410X.2010.09757.x
   Saito N, 1999, J BIOMED MATER RES, V47, P104, DOI 10.1002/(SICI)1097-4636(199910)47:1<104::AID-JBM15>3.0.CO;2-7
   Salem SA, 2013, MALAYS J MED SCI, V20, P80
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Sarasam AR, 2008, J MATER SCI-MATER M, V19, P1083, DOI 10.1007/s10856-007-3072-z
   Sarasam AR, 2007, MACROMOL BIOSCI, V7, P1160, DOI 10.1002/mabi.200700001
   Sarasam AR, 2006, BIOMACROMOLECULES, V7, P1131, DOI 10.1021/bm050935d
   Sartoneva R, 2011, J R SOC INTERFACE, V8, P671, DOI 10.1098/rsif.2010.0520
   Sarwar Iram, 2010, J Ayub Med Coll Abbottabad, V22, P7
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Seth A, 2013, BIOMATERIALS, V34, P4758, DOI 10.1016/j.biomaterials.2013.03.038
   Shakhssalim N, 2013, INT J ARTIF ORGANS, V36, P113, DOI 10.5301/ijao.5000175
   Shalhav AL, 1999, J ENDOUROL, V13, P241, DOI 10.1089/end.1999.13.241
   Sharifiaghdas Farzaneh, 2007, Urol J, V4, P71
   Sharma AK, 2013, P NATL ACAD SCI USA, V110, P4003, DOI 10.1073/pnas.1220764110
   Sharma AK, 2011, STEM CELLS, V29, P241, DOI 10.1002/stem.568
   Sharma AK, 2010, BIOMATERIALS, V31, P6207, DOI 10.1016/j.biomaterials.2010.04.054
   SHIGEMASA Y, 1994, INT J BIOL MACROMOL, V16, P43, DOI 10.1016/0141-8130(94)90010-8
   Shoae-Hassani A., 2013, J TISSUE EN IN PRESS
   Shoae-Hassani A, 2013, BJU INT, V112, P854, DOI 10.1111/bju.12195
   Shukla D, 2008, WORLD J UROL, V26, P341, DOI 10.1007/s00345-008-0311-y
   Sievert KD, 2006, WORLD J UROL, V24, P101, DOI 10.1007/s00345-006-0052-8
   Sievert KD, 2000, WORLD J UROL, V18, P19, DOI 10.1007/s003450050004
   Song LJ, 2014, TISSUE ENG PART B-RE, V20, P163, DOI [10.1089/ten.teb.2013.0103, 10.1089/ten.TEB.2013.0103]
   Stehr M, 2003, J UROLOGY, V169, P1165, DOI 10.1097/01.ju.0000041501.01323.b9
   Su Y, 2007, BRAIN RES, V1145, P41, DOI 10.1016/j.brainres.2007.01.138
   Sun WL, 2012, TISSUE ENG PART C-ME, V18, P731, DOI 10.1089/ten.tec.2011.0593
   Sutherland RS, 1996, J UROLOGY, V156, P571, DOI 10.1016/S0022-5347(01)65755-0
   Taravel MN, 1996, BIOMATERIALS, V17, P451, DOI 10.1016/0142-9612(96)89663-3
   TARAVEL MN, 1995, BIOMATERIALS, V16, P865, DOI 10.1016/0142-9612(95)94149-F
   Thapa A, 2003, J BIOMED MATER RES A, V67A, P1374, DOI 10.1002/jbm.a.20037
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Towner RA, 2010, TISSUE ENG PT A, V16, P357, DOI [10.1089/ten.tea.2009.0233, 10.1089/ten.TEA.2009.0233]
   Towner RA, 2010, TISSUE ENG PT A, V16, P365, DOI [10.1089/ten.tea.2009.0234, 10.1089/ten.TEA.2009.0234]
   Tu DD, 2013, BIOMATERIALS, V34, P8681, DOI 10.1016/j.biomaterials.2013.08.001
   Urakami S, 2007, WORLD J UROL, V25, P207, DOI 10.1007/s00345-006-0142-7
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Vaught JD, 1996, J UROLOGY, V155, P374, DOI 10.1016/S0022-5347(01)66663-1
   Vila A, 2002, J CONTROL RELEASE, V78, P15, DOI 10.1016/S0168-3659(01)00486-2
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wallis MC, 2008, TISSUE ENG PT A, V14, P339, DOI 10.1089/tea.2006.0398
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   Wang YC, 2003, BIOMATERIALS, V24, P1047, DOI 10.1016/S0142-9612(02)00434-9
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117
   Witt C, 2000, BIOMATERIALS, V21, P931, DOI 10.1016/S0142-9612(99)00262-8
   Xiong Q, 2014, TISSUE EN A IN PRESS
   Xu CY, 2004, J BIOMED MATER RES A, V71A, P154, DOI 10.1002/jbm.a.30143
   YAMAMOTO M, 1993, EXP CELL RES, V204, P121, DOI 10.1006/excr.1993.1016
   Yang B, 2010, TISSUE ENG PART C-ME, V16, P1201, DOI [10.1089/ten.tec.2009.0311, 10.1089/ten.TEC.2009.0311]
   Yang B, 2010, J BIOMED MATER RES A, V93A, P1100, DOI 10.1002/jbm.a.32534
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   Yannas IV, 1997, ANN NY ACAD SCI, V831, P280
   Yao C, 2013, INT J NANOMED, V8, P3285, DOI 10.2147/IJN.S44901
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Yoon JJ, 2001, J BIOMED MATER RES, V55, P401, DOI 10.1002/1097-4636(20010605)55:3<401::AID-JBM1029>3.0.CO;2-H
   Youssif M, 2005, UROLOGY, V66, P201, DOI 10.1016/j.urology.2005.01.054
   Yu DS, 2007, INT J UROL, V14, P939, DOI 10.1111/j.1442-2042.2007.01871.x
   Yuan HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080959
   Zderic SA, 2012, J CELL MOL MED, V16, P203, DOI 10.1111/j.1582-4934.2011.01368.x
   Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x
   Zhang YY, 2005, BJU INT, V96, P1120, DOI 10.1111/j.1464-410X.2005.05741.x
   Zhang YY, 2004, TISSUE ENG, V10, P181, DOI 10.1089/107632704322791835
   Zhou LH, 2013, TISSUE ENG PT A, V19, P264, DOI [10.1089/ten.tea.2011.0609, 10.1089/ten.TEA.2011.0609]
   Zhu WD, 2011, UROLOGE, V50, P1420, DOI 10.1007/s00120-011-2627-2
   Zhu WD, 2010, WORLD J UROL, V28, P493, DOI 10.1007/s00345-010-0508-8
NR 209
TC 20
Z9 21
U1 5
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD MAR
PY 2015
VL 82-83
BP 47
EP 63
DI 10.1016/j.addr.2014.11.020
PG 17
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CH0UF
UT WOS:000353737200007
PM 25477305
DA 2018-10-19
ER

PT J
AU Wang, ZZ
   Fang, WZ
   Li, LJ
   Li, Y
   Yu, XT
   Gu, Q
   Zhou, FJ
AF Wang, Zhanzhong
   Fang, Wenzhi
   Li, Lijie
   Li, Yan
   Yu, Xiaoting
   Gu, Qing
   Zhou, Fengjuan
TI Effects of an ionic liquid as an additive on the thermal
   denaturation/degradation of lysozyme crystals
SO ASIA-PACIFIC JOURNAL OF CHEMICAL ENGINEERING
LA English
DT Article
DE thermal denaturation; degradation; kinetics; lysozyme; ionic liquid
ID EGG-WHITE LYSOZYME; DIFFERENTIAL SCANNING CALORIMETRY; PROTEIN
   CRYSTALLIZATION; NUCLEATION
AB Ionic liquids (ILs) have biomaterial applications and are used for protein crystallization. The present study explores the thermal denaturation and degradation kinetics of the lysozyme crystals induced by IL [C(4)mim]Cl using differential scanning calorimetry (DSC). Lysozyme crystals were scanned from 10 to 250 degrees C at different heating rates varying from 5 to 20 degrees Cmin(-1). Under the same heating rate, the addition of the IL makes lysozyme crystals confer more resistance to thermal denaturation and change values of conversion rate increase. The denaturation and degradation peak shifted towards higher temperature as heating rate increased and showed an activated denaturing kinetics of the lysozyme. It can be clearly noticed that the addition of the IL increases activation energy for denaturation and decreases it for degradation. The effect of the IL on thermal denaturation is attributed to the change of lysozyme-lysozyme molecular interaction. (c) 2014 Curtin University of Technology and John Wiley & Sons, Ltd.
C1 [Wang, Zhanzhong; Fang, Wenzhi; Li, Yan; Yu, Xiaoting; Gu, Qing; Zhou, Fengjuan] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.
   [Li, Lijie] Inner Mongolia Agr Univ, Coll Food Sci & Engn, Hohhot 010018, Peoples R China.
RP Zhou, FJ (reprint author), Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.
EM fengjuanzhou@126.com
FU National Natural Science Foundation of China [20806053]; Science and
   Technology Foundation of Tianjin Municipal Health Bureau [13KG138]
FX This work was funded by the National Natural Science Foundation of China
   (no. 20806053) and the Science and Technology Foundation of Tianjin
   Municipal Health Bureau (no. 13KG138).
CR ARNTFIELD SD, 1981, CAN I FOOD SC TECH J, V14, P289, DOI 10.1016/S0315-5463(81)72929-8
   Burke MW, 2001, J CRYST GROWTH, V232, P301, DOI 10.1016/S0022-0248(01)01060-0
   Chang HM, 2000, J AGR FOOD CHEM, V48, P161, DOI 10.1021/jf9902797
   Colombo A, 2010, J AGR FOOD CHEM, V58, P4434, DOI 10.1021/jf903426f
   Dang LP, 2013, APPL BIOCHEM BIOTECH, V169, P290, DOI 10.1007/s12010-012-9986-z
   Hekmat D, 2007, BIOTECHNOL LETT, V29, P1703, DOI 10.1007/s10529-007-9456-9
   Judge R. A., 2007, CRYST GROWTH DES, V9, P3463
   KISSINGER HE, 1957, ANAL CHEM, V29, P1702, DOI 10.1021/ac60131a045
   Lange C, 2005, PROTEIN SCI, V14, P2693, DOI 10.1110/ps.051596605
   Li-Chan ECY, 2002, FOOD CHEM, V77, P495, DOI 10.1016/S0308-8146(01)00365-X
   Liu YD, 2005, J CRYST GROWTH, V281, P616, DOI 10.1016/j.jcrysgro.2005.04.073
   McPherson A, 2004, METHODS, V34, P254, DOI 10.1016/j.ymeth.2004.03.019
   Myers C., 1990, THERMAL ANAL FOODS
   OZAWA T, 1992, THERMOCHIM ACTA, V203, P159, DOI 10.1016/0040-6031(92)85192-X
   Ozawa T., 1970, J THERM ANAL, V3, P301, DOI DOI 10.1007/BF01911411
   Paredi ME, 2002, J AGR FOOD CHEM, V50, P830, DOI 10.1021/jf010767q
   PUYOL P, 1994, J DAIRY SCI, V77, P1494, DOI 10.3168/jds.S0022-0302(94)77088-0
   UEDAIRA H, 1980, B CHEM SOC JPN, V53, P2451, DOI 10.1246/bcsj.53.2451
   Wang ZZ, 2012, BIOTECHNOL BIOPROC E, V17, P1025, DOI 10.1007/s12257-012-0096-0
   Wang ZZ, 2010, J AGR FOOD CHEM, V58, P5444, DOI 10.1021/jf1000343
   Zhao Y, 2009, CRYST GROWTH DES, V9, P4984, DOI 10.1021/cg900771c
NR 21
TC 1
Z9 1
U1 1
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-2135
EI 1932-2143
J9 ASIA-PAC J CHEM ENG
JI Asia-Pac. J. Chem. Eng.
PD MAR-APR
PY 2015
VL 10
IS 2
BP 163
EP 169
DI 10.1002/apj.1855
PG 7
WC Engineering, Chemical
SC Engineering
GA CH2XE
UT WOS:000353887600001
DA 2018-10-19
ER

PT J
AU Green, DW
   Kwon, HJ
   Jung, HS
AF Green, David W.
   Kwon, Hyuk-Jae
   Jung, Han-Sung
TI Osteogenic Potency of Nacre on Human Mesenchymal Stem Cells
SO MOLECULES AND CELLS
LA English
DT Article
DE bone morphogenetic protein; human bone marrow stromal cells; mesenchymal
   stem cells; nacre; nacre soluble matrix proteins; osteoinduction
ID OSTEOBLASTS MAINTAINED INVITRO; MOLECULAR-WEIGHT MOLECULES;
   WATER-SOLUBLE MATRIX; IN-VITRO; BONE-FORMATION; PINCTADA-FUCATA;
   MINERALIZATION; PEARL; BIOMINERALIZATION
AB Nacre seashell is a natural osteoinductive biomaterial with strong effects on osteoprogenitors, osteoblasts, and osteoclasts during bone tissue formation and morphogenesis. Although nacre has shown, in one study, to induce bridging of new bone across large non-union bone defects in 8 individual human patients, there have been no succeeding human surgical studies to confirm this outstanding potency. But the molecular mechanisms associated with nacre osteoinduction and the influence on bone marrow-derived mesenchymal stem cells (BMSC's), skeletal stem cells or bone marrow stromal cells remain elusive. In this study we highlight the phenotypic and biochemical effects of Pinctada maxima nacre chips and the global nacre soluble protein matrix (SPM) on primary human bone marrow-derived stromal cells (hBMSCs) in vitro. In static co-culture with nacre chips, the hBMSCs secreted Alkaline phosphatase (ALP) at levels that exceeded bone morphogenetic protein (rhBMP-2) treatment. Concentrated preparation of SPM applied to Stro-1 selected hBMSC's led to rapid ALP secretions, at concentrations exceeding the untreated controls even in osteogenic conditions. Within 21 days the same population of Stro-1 selected hBMSCs proliferated and secreted collagens I-IV, indicating the premature onset of an osteoblast phenotype. The same SPM was found to promote unselected hBMSC differentiation with osteocalcin detected at 7 days, and proliferation increased at 7 days in a dose-dependent manner. In conclusion, nacre particles and nacre SPM induced the early stages of human bone cell differentiation, indicating that they may be promising soluble factors with osteoinductive capacity in primary human bone cell progenitors such as, hBMSC's.
C1 [Green, David W.; Jung, Han-Sung] Univ Hong Kong, Fac Dent, Oral Biosci, Hong Kong, Hong Kong, Peoples R China.
   [Kwon, Hyuk-Jae] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.
   [Jung, Han-Sung] Yonsei Univ, Coll Dent, PLUS Project BK21, Oral Sci Res Ctr,Div Anat & Dev Biol,Dept Oral Bi, Seoul 120749, South Korea.
RP Jung, HS (reprint author), Univ Hong Kong, Fac Dent, Oral Biosci, Hong Kong, Hong Kong, Peoples R China.
EM hsjung@hku.hk
FU National Research Foundation of Korea [2013K2A2A4003305]
FX This work was supported under the framework of international cooperation
   program managed by National Research Foundation of Korea (No.
   2013K2A2A4003305).
CR Almeida MJ, 2001, J BIOMED MATER RES, V57, P306, DOI 10.1002/1097-4636(200111)57:2<306::AID-JBM1172>3.0.CO;2-H
   Atlan G, 1997, CR ACAD SCI III-VIE, V320, P253, DOI 10.1016/S0764-4469(97)86933-8
   Bedouet L, 2007, MAR BIOTECHNOL, V9, P638, DOI 10.1007/s10126-007-9017-1
   Bedouet L, 2006, COMP BIOCHEM PHYS B, V144, P532, DOI 10.1016/j.cbpb.2006.05.012
   Duplat D, 2007, BIOMATERIALS, V28, P4769, DOI 10.1016/j.biomaterials.2007.07.036
   Kim H, 2012, BIOMATERIALS, V33, P7489, DOI 10.1016/j.biomaterials.2012.06.098
   Lamghari M, 2001, BIOMATERIALS, V22, P555, DOI 10.1016/S0142-9612(00)00213-1
   Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6
   Lamghari M, 2001, J BONE MINER RES, V16, P2232, DOI 10.1359/jbmr.2001.16.12.2232
   Lao YX, 2007, COMP BIOCHEM PHYS B, V148, P201, DOI 10.1016/j.cbpb.2007.05.010
   Liao HH, 2002, BIOMATERIALS, V23, P2693, DOI 10.1016/S0142-9612(01)00421-5
   Lopez E, 2004, KEY ENG MAT, V254-2, P733, DOI 10.4028/www.scientific.net/KEM.254-256.733
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   Lopez E., 1995, French Patent, Patent No. [FR9515650,WO97/24133-10/07/97, 9724133100797]
   Lopez E., 2004, ARGOS SPINE NEWS, V8, P32
   Milet C, 2004, CR PALEVOL, V3, P493, DOI 10.1016/j.crpv.2004.07.010
   Oliveira DV, 2012, SCI WORLD J, DOI 10.1100/2012/765909
   Rousseau M, 2003, COMP BIOCHEM PHYS B, V135, P1, DOI 10.1016/S1096-4959(03)00032-0
   Rousseau M, 2008, J BIOMED MATER RES A, V85A, P487, DOI 10.1002/jbm.a.31553
   Shen YT, 2006, BIOMATERIALS, V27, P281, DOI 10.1016/j.biomaterials.2005.05.088
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
   Stewart K, 2003, CELL TISSUE RES, V313, P281, DOI 10.1007/s00441-003-0762-9
   Wang Jian-jun, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1838
   Yang XB, 2003, J BONE MINER RES, V18, P47, DOI 10.1359/jbmr.2003.18.1.47
   Zhang C, 2006, MAR BIOTECHNOL, V8, P624, DOI 10.1007/s10126-006-6037-1
NR 25
TC 11
Z9 14
U1 0
U2 17
PU KOREAN SOC MOLECULAR & CELLULAR  BIOLOGY
PI SEOUL
PA 635-4, YUCKSAM-DONG, GANGNAM-GU, SEOUL 135-703, SOUTH KOREA
SN 1016-8478
EI 0219-1032
J9 MOL CELLS
JI Mol. Cells
PD MAR
PY 2015
VL 38
IS 3
BP 267
EP 272
DI 10.14348/molcells.2015.2315
PG 6
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA CH8GY
UT WOS:000354275600010
PM 25666352
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Castilho, M
   Rodrigues, J
   Pires, I
   Gouveia, B
   Pereira, M
   Moseke, C
   Groll, J
   Ewald, A
   Vorndran, E
AF Castilho, Miguel
   Rodrigues, Jorge
   Pires, Ines
   Gouveia, Barbara
   Pereira, Manuel
   Moseke, Claus
   Groll, Juegen
   Ewald, Andrea
   Vorndran, Elke
TI Fabrication of individual alginate-TCP scaffolds for bone tissue
   engineering by means of powder printing
SO BIOFABRICATION
LA English
DT Article
DE 3D printing; biocomposite; mechanical properties; bioactivity; bone
   tissue engineering ceramics
ID CALCIUM-PHOSPHATE CEMENT; MECHANICAL CHARACTERIZATION; DRUG-DELIVERY;
   IN-VITRO; BIOMEDICAL APPLICATIONS; COMPOSITE SCAFFOLDS; FRACTURE;
   REGENERATION; BRUSHITE; BEHAVIOR
AB The development of polymer-calcium phosphate composite scaffolds with tailored architectures and properties has great potential for bone regeneration. Herein, we aimed to improve the functional performance of brittle ceramic scaffolds by developing a promising biopolymer-ceramic network. For this purpose, two strategies, namely, direct printing of a powder composition consisting of a 60: 40 mixture of alpha/beta-tricalcium phosphate (TCP) powder and alginate powder or vacuum infiltration of printed TCP scaffolds with an alginate solution, were tracked. Results of structural characterization revealed that the scaffolds printed with 2.5 wt% alginate-modified TCP powders presented a uniformly distributed and interfusing alginate TCP network. Mechanical results indicated a significant increase in strength, energy to failure and reliability of powder-modified scaffolds with an alginate content in the educts of 2.5 wt% when compared to pure TCP, as well as to TCP scaffolds containing 5 wt% or 7.5 wt% in the educts, in both dry and wet states. Culture of human osteoblast cells on these scaffolds also demonstrated a great improvement of cell proliferation and cell viability. While in the case of powder-mixed alginate TCP scaffolds, isolated alginate gels were formed between the calcium phosphate crystals, the vacuum-infiltration strategy resulted in the covering of the surface and internal pores of the TCP scaffold with a thin alginate film. Furthermore, the prediction of the scaffolds' critical fracture conditions under more complex stress states by the applied Mohr fracture criterion confirmed the potential of the powder-modified scaffolds with 2.5 wt% alginate in the educts as structural biomaterial for bone tissue engineering.
C1 [Castilho, Miguel; Rodrigues, Jorge; Pires, Ines; Gouveia, Barbara] Univ Lisbon, Inst Super Tecn, IDMEC, LAETA, P-1699 Lisbon, Portugal.
   [Pereira, Manuel] Univ Lisbon, Inst Super Tecn, CERENA, CEPGIST, P-1699 Lisbon, Portugal.
   [Moseke, Claus; Groll, Juegen; Ewald, Andrea; Vorndran, Elke] Univ Wurzburg, Dept Funct Mat Med & Dent, D-97070 Wurzburg, Germany.
   [Castilho, Miguel] Altakitin SA, Loures, Portugal.
RP Castilho, M (reprint author), Univ Lisbon, Inst Super Tecn, IDMEC, LAETA, P-1699 Lisbon, Portugal.
EM miguel.castilho@tecnico.ulisboa.pt
RI Moseke, Claus/G-5966-2012; Vorndran, Elke/G-6226-2012; Pereira,
   Manuel/H-7288-2012; Moseke, Claus/H-8982-2018; Groll,
   Jurgen/F-4202-2012; Gouveia, Barbara/E-7654-2012; Rodrigues,
   Jorge/I-7810-2015
OI Pereira, Manuel/0000-0002-7932-8062; Groll, Jurgen/0000-0003-3167-8466;
   Gouveia, Barbara/0000-0001-9930-8889; Rodrigues,
   Jorge/0000-0002-3387-2652; Castilho, Miguel/0000-0002-4269-5889
FU FCT within Altakitin SA [SFRH/BDE/51454/2011]
FX The authors would like to thank the PhD scholarship SFRH/BDE/51454/2011
   (Miguel Castilho), financed by FCT within Altakitin SA. They also want
   to acknowledge to the company FMC Biopolymer (Netherlands) for the
   generous gift of the Sodium alginate Protanal (R) LF10/60 used in these
   experiments; to Prof. Antonio Mauricio (Universidade de Lisboa) for his
   support and valuable discussions with mu-CT; and to Prof. Ana Paula Dias
   (Universidade de Lisboa) for her support with TG analysis.
CR [Anonymous], 2002, ASTME95194, DOI [10.1520/C0033-03, DOI 10.1520/C0033-03]
   Arafat MT, 2011, ACTA BIOMATER, V7, P809, DOI 10.1016/j.actbio.2010.09.010
   Bartolo P, 2012, CIRP ANN-MANUF TECHN, V61, P635, DOI 10.1016/j.cirp.2012.05.005
   Bharatham B H, 2014, BIOMED RES INT, V2014
   Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017
   Byrne RS, 2002, INT J PHARM, V246, P61, DOI 10.1016/S0378-5173(02)00357-5
   CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954, DOI 10.2106/00004623-197759070-00021
   Castilho M, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/025005
   Castilho M, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/1/015006
   Castilho M, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035012
   Charriere E, 2001, BIOMATERIALS, V22, P2937, DOI 10.1016/S0142-9612(01)00041-2
   Chen CHD, 2011, MAT SCI ENG C-MATER, V31, P334, DOI 10.1016/j.msec.2010.10.002
   Christensen R. M., 2013, THEORY MAT FAILURE
   Cordell JM, 2009, J MECH BEHAV BIOMED, V2, P560, DOI 10.1016/j.jmbbm.2009.01.009
   Cornelsen M, 2013, BIOMED TECH, V58, P4090
   Derby B, 2012, SCIENCE, V338, P921, DOI 10.1126/science.1226340
   Detsch R, 2011, J BIOMATER APPL, V26, P359, DOI 10.1177/0885328210373285
   Dimas LS, 2014, J MECH PHYS SOLIDS, V63, P481, DOI 10.1016/j.jmps.2013.07.006
   Ding SJ, 2005, CERAM INT, V31, P691, DOI 10.1016/j.ceramint.2004.08.007
   Doblare M, 2004, ENG FRACT MECH, V71, P1809, DOI 10.1016/j.engfracmech.2003.08.003
   Gbureck U, 2007, ADV FUNCT MATER, V17, P3940, DOI 10.1002/adfm.200700019
   Gisep A, 2004, J MATER SCI-MATER M, V15, P1065, DOI 10.1023/B:JMSM.0000046387.70323.41
   Grover LM, 2013, BIOMATERIALS, V34, P6631, DOI 10.1016/j.biomaterials.2013.05.001
   Habibovic P, 2008, J ORTHOP RES, V26, P1363, DOI 10.1002/jor.20648
   Henriksen SS, 2011, J MATER SCI-MATER M, V22, P1111, DOI 10.1007/s10856-011-4290-y
   Hondros G., 1959, Australian Journal of Applied Science, V10, P243
   Horga R, 2007, APPL CATAL A-GEN, V325, P251, DOI 10.1016/j.apcata.2007.02.042
   Inzana JA, 2014, BIOMATERIALS, V35, P4026, DOI 10.1016/j.biomaterials.2014.01.064
   Karande T S, 2014, TISSUE ENG NANOTECHN, P63
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   Kolednik O, 2014, ACTA MATER, V68, P279, DOI 10.1016/j.actamat.2014.01.034
   Lam CXF, 2002, MAT SCI ENG C-BIO S, V20, P49, DOI 10.1016/S0928-4931(02)00012-7
   LAMON J, 1983, J AM CERAM SOC, V66, P177, DOI 10.1111/j.1151-2916.1983.tb10012.x
   Lamon J, 1990, P 11 RISO INT S MET
   Lamon J, 1988, J AM CERAM SOC, V73, P2204
   Lee GS, 2011, ACTA BIOMATER, V7, P3178, DOI 10.1016/j.actbio.2011.04.008
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Lin HR, 2004, J BIOMED MATER RES B, V71B, P52, DOI 10.1002/b.30065
   Lorber B, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/1/015001
   Luo Yongxiang, 2014, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V28, P279
   Luo YX, 2013, J MATER CHEM B, V1, P4088, DOI 10.1039/c3tb20511h
   Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007
   Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084
   Palmer SH, 1999, J BONE JOINT SURG BR, V81B, P333, DOI 10.1302/0301-620X.81B2.9320
   Peroglio M, 2010, ACTA BIOMATER, V6, P4369, DOI 10.1016/j.actbio.2010.05.022
   Pfister A, 2004, J POLYM SCI POL CHEM, V42, P624, DOI 10.1002/pola.10807
   Pittet C, 2000, J BIOMED MATER RES, V53, P769, DOI 10.1002/1097-4636(2000)53:6<769::AID-JBM19>3.0.CO;2-P
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Shanjani Y, 2011, ACTA BIOMATER, V7, P1788, DOI 10.1016/j.actbio.2010.12.017
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Shie MY, 2008, ACTA BIOMATER, V4, P646, DOI 10.1016/j.actbio.2007.10.011
   Soares J.P., 2004, ECLET QUIM, V29, P53, DOI DOI 10.1590/S0100-46702004000200009
   Strand BL, 2003, BIOTECHNOL BIOENG, V82, P386, DOI 10.1002/bit.10577
   Suwanprateeb J, 2006, POLYM INT, V55, P57, DOI 10.1002/pi.1918
   Tamimi F, 2008, ACTA BIOMATER, V4, P1315, DOI 10.1016/j.actbio.2008.04.003
   Tampieri A, 2005, ACTA BIOMATER, V1, P343, DOI 10.1016/j.actbio.2005.01.001
   Torres AL, 2013, MAT SCI ENG C-MATER, V33, P4460, DOI 10.1016/j.msec.2013.07.003
   Turco G, 2009, BIOMACROMOLECULES, V10, P1575, DOI 10.1021/bm900154b
   Vorndran E, 2010, ADV FUNCT MATER, V20, P1585, DOI 10.1002/adfm.200901759
   Vorndran E, 2008, ADV ENG MATER, V10, pB67, DOI 10.1002/adem.200800179
   Wachtman J. B., 2009, MECH PROPERTIES CERA
   Wang L, 2003, BIOMATERIALS, V24, P3475, DOI 10.1016/S0142-9612(03)00167-4
   WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293
   Wohlers T.T., 2011, ADDITIVE MANUFACTURI
   Xu T, 2013, BIOMATERIALS, V34, P130, DOI 10.1016/j.biomaterials.2012.09.035
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Zhao J, 2009, COLLOID SURFACE B, V74, P159, DOI 10.1016/j.colsurfb.2009.07.012
   Zhou HZ, 2011, BIOMATERIALS, V32, P7503, DOI 10.1016/j.biomaterials.2011.06.045
NR 70
TC 19
Z9 20
U1 2
U2 83
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
EI 1758-5090
J9 BIOFABRICATION
JI Biofabrication
PD MAR
PY 2015
VL 7
IS 1
AR 015004
DI 10.1088/1758-5090/7/1/015004
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CG5OH
UT WOS:000353341000005
PM 25562119
DA 2018-10-19
ER

PT J
AU Ouyang, LL
   Yao, R
   Chen, X
   Na, J
   Sun, W
AF Ouyang, Liliang
   Yao, Rui
   Chen, Xi
   Na, Jie
   Sun, Wei
TI 3D printing of HEK 293FT cell-laden hydrogel into macroporous constructs
   with high cell viability and normal biological functions
SO BIOFABRICATION
LA English
DT Article
DE three dimensional printing; cell viability; signal transduction; Wnt;
   HEK293FT
ID HUMAN STEM-CELLS; IN-VITRO; LIVING CELLS; HEK-293 CELLS; TISSUE;
   BIOFABRICATION; TECHNOLOGY; CANCER; REGENERATION; DAMAGE
AB 3D printing has evolved into a versatile technology for fabricating tissue-engineered constructs with spatially controlled cells and biomaterial distribution to allow biomimicking of in vivo tissues. In this paper, we reported a novel study of 3D printing of cell lines derived from human embryonic kidney tissue into a macroporous tissue-like construct. Nozzle temperature, chamber temperature and the composition of the matrix material were studied to achieve high cell viability (>90%) after 3D printing and construct formation. Long-term construct stability with a clear grid structure up to 30 days was observed. Cells continued to grow as cellular spheroids with strong cell-cell interactions. Two transfected cell lines of HEK 293FT were also 3D printed and showed normal biological functions, i.e. protein synthesis and gene activation in responding to small molecule stimulus. With further refinement, this 3D cell printing technology may lead to a practical fabrication of functional embryonic tissues in vitro.
C1 [Ouyang, Liliang; Yao, Rui; Sun, Wei] Tsinghua Univ, Biomfg Ctr, Dept Mech Engn, Beijing 100084, Peoples R China.
   [Ouyang, Liliang; Yao, Rui; Sun, Wei] Biomfg & Rapid Forming Technol Key Lab Beijing, Beijing 100084, Peoples R China.
   [Chen, Xi; Na, Jie] Tsinghua Univ, Ctr Stem Cell Biol & Regenerat Med, Sch Med, Beijing 100084, Peoples R China.
   [Sun, Wei] Tsinghua Univ, Grad Sch Shenzhen, Biomfg Engn Res Lab, Shenzhen 518055, Peoples R China.
   [Sun, Wei] Drexel Univ, Dept Mech Engn, Philadelphia, PA 19104 USA.
RP Ouyang, LL (reprint author), Tsinghua Univ, Biomfg Ctr, Dept Mech Engn, Beijing 100084, Peoples R China.
EM jie.na@tsinghua.edu.cn; weisun@tsinghua.edu.cn
OI Na, Jie/0000-0003-1820-0548
FU National Natural Science Foundation of China [51235006, 31171381];
   National High Technology Research and Development Program of China (863
   Program) [2012AA020506]; Shenzhen Development and Reform Commission;
   National Basic Research Program of China, 973 program [2012CB966701];
   Tsinghua-Peking Center for Life Sciences
FX The authors acknowledge the funding supports from the National Natural
   Science Foundation of China through project No. 51235006, the National
   High Technology Research and Development Program of China (863 Program)
   through project No. 2012AA020506 and the Shenzhen Development and Reform
   Commission. This work was also supported by the National Natural Science
   Foundation of China Grant 31171381 and the National Basic Research
   Program of China, 973 program grant 2012CB966701 to (J.N.), and the
   funding of the Tsinghua-Peking Center for Life Sciences.
CR Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Barron JA, 2005, ANN BIOMED ENG, V33, P121, DOI 10.1007/s10439-005-8971-x
   Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009
   Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081
   Calvert P, 2007, SCIENCE, V318, P208, DOI 10.1126/science.1144212
   Chang R, 2008, TISSUE ENG PT C-METH, V14, P157, DOI 10.1089/ten.tec.2007.0392
   Chang R, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/4/045004
   Colina M, 2006, J APPL PHYS, V99, DOI 10.1063/1.2191569
   Cui XF, 2010, BIOTECHNOL BIOENG, V106, P963, DOI 10.1002/bit.22762
   Demirci U, 2007, LAB CHIP, V7, P1428, DOI 10.1039/b705809h
   Demirci U, 2007, LAB CHIP, V7, P1139, DOI 10.1039/b704965j
   Dickinson LE, 2012, LAB CHIP, V12, P4244, DOI 10.1039/c2lc40819h
   Faulkner-Jones A, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015013
   Fedorovich NE, 2011, TRENDS BIOTECHNOL, V29, P601, DOI 10.1016/j.tibtech.2011.07.001
   Ferris CJ, 2013, APPL MICROBIOL BIOT, V97, P4243, DOI 10.1007/s00253-013-4853-6
   Gaebel R, 2011, BIOMATERIALS, V32, P9218, DOI 10.1016/j.biomaterials.2011.08.071
   Gaetani R, 2012, CIRC RES, V111
   Gaetani R, 2012, BIOMATERIALS, V33, P1782, DOI 10.1016/j.biomaterials.2011.11.003
   Gruene M, 2011, TISSUE ENG PART C-ME, V17, P79, DOI [10.1089/ten.tec.2010.0359, 10.1089/ten.TEC.2010.0359]
   Gruene M, 2011, TISSUE ENG PART C-ME, V17, P973, DOI [10.1089/ten.tec.2011.0185, 10.1089/ten.TEC.2011.0185]
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Ilkhanizadeh S, 2007, BIOMATERIALS, V28, P3936, DOI 10.1016/j.biomaterials.2007.05.018
   Jakab K, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/022001
   Khatiwala C., 2012, GENE THER REGUL, V7, DOI DOI 10.1142/S1568558611000301
   Koch L, 2010, TISSUE ENG PART C-ME, V16, P847, DOI [10.1089/ten.tec.2009.0397, 10.1089/ten.TEC.2009.0397]
   Lee W, 2009, NEUROREPORT, V20, P798, DOI 10.1097/WNR.0b013e32832b8be4
   Liu HX, 2011, ADV MATER RES-SWITZ, V189-193, P2986, DOI 10.4028/www.scientific.net/AMR.189-193.2986
   Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Marucco A, 2013, J PHYS C SER, V429
   Matsusaki M, 2013, ADV HEALTHC MATER, V2, P534, DOI 10.1002/adhm.201200299
   McConnell MP, 2004, TISSUE ENG, V10, P1492, DOI 10.1089/1076327042500463
   Mironov V, 2011, CURR OPIN BIOTECH, V22, P667, DOI 10.1016/j.copbio.2011.02.006
   Nahmias Y, 2005, BIOTECHNOL BIOENG, V92, P129, DOI 10.1002/bit.20585
   Nair Kalyani, 2009, Biotechnology Journal, V4, P1168, DOI 10.1002/biot.200900004
   Nakamura M, 2005, TISSUE ENG, V11, P1658, DOI 10.1089/ten.2005.11.1658
   Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606
   Rodriguez-Devora JI, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/3/035001
   Shen CF, 2012, J BIOTECHNOL, V157, P228, DOI 10.1016/j.jbiotec.2011.11.016
   Tasoglu S, 2013, TRENDS BIOTECHNOL, V31, P10, DOI 10.1016/j.tibtech.2012.10.005
   Tirella A, 2011, J BIOSCI BIOENG, V112, P79, DOI 10.1016/j.jbiosc.2011.03.019
   Xu F, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034101
   Xu MG, 2010, BIOMATERIALS, V31, P3868, DOI 10.1016/j.biomaterials.2010.01.111
   Xu T, 2013, BIOMATERIALS, V34, P130, DOI 10.1016/j.biomaterials.2012.09.035
   Yan KC, 2010, J BIOMECH, V43, P1031, DOI 10.1016/j.jbiomech.2009.12.018
   Yan YN, 2005, BIOMATERIALS, V26, P5864, DOI 10.1016/j.biomaterials.2005.02.027
   Yao R, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/4/045005
   Yao R, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/025007
   Yao R, 2009, J BIOACT COMPAT POL, V24, P5, DOI 10.1177/0883911508099367
   Yu Y, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024575
   Yusof A, 2011, LAB CHIP, V11, P2447, DOI 10.1039/c1lc20176j
   Zhao Y, 2014, IN VITRO BIOFABRICAT, V6
NR 52
TC 31
Z9 32
U1 8
U2 93
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
EI 1758-5090
J9 BIOFABRICATION
JI Biofabrication
PD MAR
PY 2015
VL 7
IS 1
AR 015010
DI 10.1088/1758-5090/7/1/015010
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CG5OH
UT WOS:000353341000011
PM 25691496
DA 2018-10-19
ER

PT J
AU Anzai, R
   Murakami, Y
AF Anzai, Ryosuke
   Murakami, Yoshihiko
TI Poly(epsilon-caprolactone) (PCL)-polymeric micelle hybrid sheets for the
   incorporation and release of hydrophilic proteins
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Sheet; Polymeric micelle; Protein; Sustained release; Fractal analysis
ID ANHYDROUS ISOOCTANE; FRACTAL DIMENSION; POLYMERIC MICELLE;
   SUSTAINED-RELEASE; GROWTH-FACTOR; PLA RESEARCH; HYDROGEL; COMPLEX;
   SURFACE; PEG
AB Sheets have several advantages over conventional gel- or particle-type drug carriers. Sheets have several notable attributes: sheets' size and shape are easily adjustable, sheets are highly accessible in surgery, and sheets have a large contact area relative to drug-targeting sites. However, it is difficult to incorporate hydrophilic proteins into hydrophobic sheets and to release the proteins over the long term in a sustained manner. In the present study, we show that "poly(epsilon-caprolactone) (PCL)-polymeric micelle hybrid sheets" can be used for the incorporation and release of hydrophilic proteins. Polymeric micelles (i.e., spaces that can incorporate hydrophilic compounds) are, in this study, uniformly dispersed in hydrophobic and biocompatible biomaterial sheet. We have clarified that the composition of block copolymer, methoxy-terminated poly(ethylene glycol)-block-poly(epsilon-caprolactone) (CH3O-PEG-b-PCL), can affect two variables: the stability of w/o emulsion and the release properties of the resulting sheets, by means of visual qualitative observations, newly developed quantitative analyses (advanced fractal analysis, advanced FD) based on deviation of the fractal dimension (FD), and release experiments. We clarified that the release behavior of BSA was affected by the composition of the block copolymers and the resulting emulsion. The results obtained in this paper show that the hydrophobic sheets in which polymeric micelles providing hydrophilic spaces were dispersed could be an effective platform for incorporating and releasing hydrophilic proteins. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Anzai, Ryosuke; Murakami, Yoshihiko] Tokyo Univ Agr & Technol, Dept Organ & Polymer Mat Chem, Fac Engn, Koganei, Tokyo 1848588, Japan.
RP Murakami, Y (reprint author), Tokyo Univ Agr & Technol, Dept Organ & Polymer Mat Chem, Fac Engn, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.
EM muray@cc.tuat.ac.jp
RI Murakami, Yoshihiko/C-9485-2013
FU Ministry of Education, Culture, Sports, Science, and Technology of Japan
   (MEXT) [22700490]
FX This study was funded, in part, by Grants-in-Aid for Scientific Research
   from the Ministry of Education, Culture, Sports, Science, and Technology
   of Japan (MEXT) (grant number: 22700490).
CR Bisoi AK, 2001, PATTERN RECOGN LETT, V22, P631, DOI 10.1016/S0167-8655(00)00132-X
   BROWN GL, 1988, ANN SURG, V208, P788, DOI 10.1097/00000658-198812000-00019
   Cooper A, 2011, CARBOHYD POLYM, V85, P149, DOI 10.1016/j.carbpol.2011.02.008
   Domingos M, 2013, ACTA BIOMATER, V9, P5997, DOI 10.1016/j.actbio.2012.12.031
   Eck W, 2005, ADV MATER, V17, P2583, DOI 10.1002/adma.200500900
   Fujie T, 2009, ADV FUNCT MATER, V19, P2560, DOI 10.1002/adfm.200900103
   Gautam S, 2013, MAT SCI ENG C-MATER, V33, P1228, DOI 10.1016/j.msec.2012.12.015
   Ghasemi-Mobarakeh L, 2010, MAT SCI ENG C-MATER, V30, P1129, DOI 10.1016/j.msec.2010.06.004
   Griffin W.C., 1954, J SOC COSMET CHEM, V5, P249
   Ito T, 2013, MAT SCI ENG C-MATER, V33, P3697, DOI 10.1016/j.msec.2013.04.056
   Kanakubo Y, 2010, COLLOID SURFACE B, V78, P85, DOI 10.1016/j.colsurfb.2010.02.017
   Kopecek J, 2012, ANGEW CHEM INT EDIT, V51, P7396, DOI 10.1002/anie.201201040
   Lee F, 2009, J CONTROL RELEASE, V134, P186, DOI 10.1016/j.jconrel.2008.11.028
   Lee HJ, 2006, BIOMATERIALS, V27, P5268, DOI 10.1016/j.biomaterials.2006.06.001
   Lin NM, 2014, APPL SURF SCI, V311, P330, DOI 10.1016/j.apsusc.2014.05.062
   Maeda M, 2001, J CONTROL RELEASE, V77, P261, DOI 10.1016/S0168-3659(01)00512-0
   Mallwitz F, 2005, ADV MATER, V17, P1296, DOI 10.1002/adma.200401123
   McCarthy DW, 1996, J INVEST DERMATOL, V106, P49, DOI 10.1111/1523-1747.ep12327214
   Moroishi H, 2013, COLLOID SURFACE B, V102, P597, DOI 10.1016/j.colsurfb.2012.08.050
   Murakami Y, 2005, BIOMACROMOLECULES, V6, P2927, DOI 10.1021/bm0504330
   Murakami Y, 2005, MACROMOLECULES, V38, P1535, DOI 10.1021/ma047803h
   Murakami Y, 2003, J MOL CATAL B-ENZYM, V22, P79, DOI 10.1016/S1381-1177(03)00009-2
   Murakami Y, 1998, SEIBUTSU-KOGAKU KAIS, V76, P238
   Murakami Y, 1999, BIOTECHNOL TECH, V13, P545, DOI 10.1023/A:1008987431361
   Murakami Y, 2001, BIOTECHNOL LETT, V23, P125, DOI 10.1023/A:1010345318275
   Murakami Y, 1999, J BIOSCI BIOENG, V88, P441, DOI 10.1016/S1389-1723(99)80224-2
   Murakami Y., 2009, J BIOMED MAT RES B, V916, P102
   Murakami Y, 2008, COLLOID SURFACE B, V65, P186, DOI 10.1016/j.colsurfb.2008.04.005
   Murakami Y, 2007, J BIOMED MATER RES A, V80A, P421, DOI 10.1002/jbm.a.30911
   Nampoothiri KM, 2010, BIORESOURCE TECHNOL, V101, P8493, DOI 10.1016/j.biortech.2010.05.092
   Okamura Y, 2008, COLLOID SURFACE A, V318, P184, DOI 10.1016/j.colsurfa.2007.12.049
   Pang XA, 2010, BIOTECHNOL J, V5, P1125, DOI 10.1002/biot.201000135
   Park YJ, 1998, J CONTROL RELEASE, V51, P201, DOI 10.1016/S0168-3659(97)00169-7
   Singh S, 2007, J NANOSCI NANOTECHNO, V7, P2596, DOI 10.1166/jnn.2007.909
   Sutter M, 2007, J CONTROL RELEASE, V119, P301, DOI 10.1016/j.jconrel.2007.03.003
   Takami T, 2014, LANGMUIR, V30, P3329, DOI 10.1021/la500324j
   Takami T, 2011, COLLOID SURFACE B, V87, P433, DOI 10.1016/j.colsurfb.2011.06.004
   Tanaka M, 2008, POWDER TECHNOL, V186, P1, DOI 10.1016/j.powtec.2007.10.030
   Tang HP, 2012, POWDER TECHNOL, V217, P383, DOI 10.1016/j.powtec.2011.10.053
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Uchida Y, 2013, J POLYM SCI POL PHYS, V51, P124, DOI 10.1002/polb.23187
   Vinigradov S.V., 2002, ADV DRUG DELIV REV, V54, P135
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Williams DF, 2006, TRENDS BIOTECHNOL, V24, P4, DOI 10.1016/j.tibtech.2005.10.006
   Zhang JT, 2010, ACTA BIOMATER, V6, P3890, DOI 10.1016/j.actbio.2010.05.009
   Zhang Q, 2002, J BIOMED MATER RES, V60, P502, DOI 10.1002/jbm.1294
NR 46
TC 12
Z9 12
U1 2
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAR 1
PY 2015
VL 127
BP 292
EP 299
DI 10.1016/j.colsurfb.2015.01.028
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA CG0YY
UT WOS:000353001400037
PM 25723105
DA 2018-10-19
ER

PT J
AU Cheerarot, O
   Baimark, Y
AF Cheerarot, Onanong
   Baimark, Yodthong
TI Biodegradable silk fibroin/chitosan blend microparticles prepared by
   emulsification-diffusion method
SO E-POLYMERS
LA English
DT Article
DE blend microparticles; chitosan; conformational transition; morphology;
   silk fibroin
ID IN-VIVO EVALUATION; BOMBYX-MORI SILK; CHITOSAN MICROSPHERES;
   DRUG-DELIVERY; POLY(ETHYLENE OXIDE); FIBROIN; RELEASE; FILMS;
   CONFORMATION; BIOMATERIAL
AB In this study, biodegradable microparticles of silk fibroin (SF)/chitosan (CS) blends with SF/CS blend ratios of 1:0, 2:1, 1:1, 1:2 and 0:1 (w/w) were prepared using the water-in-oil emulsification-diffusion method without any surfactants. An aqueous SF/CS blend solution and ethyl acetate were used as the water and oil phases, respectively. The plain SF had an irregular shape, while the CS microparticles were spherical. The blend microparticles were spherical in shape with a rough surface. Average microparticle sizes were in the range of 73-80 mu m. The microparticle matrices had a sponge-like morphology. Conformational changes in the SF component, from random coil to the beta-sheet form, were observed in the FTIR data. The dissolution of the blend microparticles was lower than those of the plain SF and CS microparticles. Microparticle density steadily increased and porosity slightly decreased as the amount of CS in the blend increased.
C1 [Cheerarot, Onanong; Baimark, Yodthong] Mahasarakham Univ, Biodegradable Polymers Res Unit, Fac Sci, Dept Chem, Maha Sarakham 44150, Thailand.
   [Cheerarot, Onanong; Baimark, Yodthong] Mahasarakham Univ, Ctr Excellence Innovat Chem, Maha Sarakham 44150, Thailand.
RP Cheerarot, O (reprint author), Mahasarakham Univ, Biodegradable Polymers Res Unit, Fac Sci, Dept Chem, Maha Sarakham 44150, Thailand.
EM onanong.c@msu.ac.th
FU National Metal and Materials Technology Center (MTEC); National Science
   and Technology Development Agency (NSTDA); Ministry of Science and
   Technology, Thailand [MT-B-52-BMD-68-180-G]; Center of Excellence for
   Innovation in Chemistry (PERCH-CIC), Commission on Higher Education,
   Ministry of Education, Thailand
FX This work was supported by the National Metal and Materials Technology
   Center (MTEC), National Science and Technology Development Agency
   (NSTDA), Ministry of Science and Technology, Thailand
   (MT-B-52-BMD-68-180-G) and by the Center of Excellence for Innovation in
   Chemistry (PERCH-CIC), Commission on Higher Education, Ministry of
   Education, Thailand. The authors would like to thank Dr. Christopher M.
   Liauw, Manchester Metropolitan University, England, UK, for proofreading
   of the manuscript.
CR Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Baimark Y, 2013, POWDER TECHNOL, V249, P436, DOI 10.1016/j.powtec.2013.09.011
   Baimark Y, 2010, J APPL POLYM SCI, V118, P1127, DOI 10.1002/app.32506
   Chen X, 1997, J POLYM SCI POL PHYS, V35, P2293, DOI 10.1002/(SICI)1099-0488(199710)35:14<2293::AID-POLB9>3.0.CO;2-X
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   Guerrero S, 2010, CARBOHYD POLYM, V79, P1006, DOI 10.1016/j.carbpol.2009.10.034
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Imsombut T, 2013, E-POLYMERS, V11, P936
   Imsombut T, 2010, POWDER TECHNOL, V203, P603, DOI 10.1016/j.powtec.2010.06.027
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Klingler C, 2009, INT J PHARMACEUT, V377, P173, DOI 10.1016/j.ijpharm.2009.05.008
   Klose D, 2006, INT J PHARMACEUT, V314, P198, DOI 10.1016/j.ijpharm.2005.07.031
   Kosaraju SL, 2006, CARBOHYD POLYM, V64, P163, DOI 10.1016/j.carbpol.2005.11.027
   Kotsaeng N, 2010, PARTICUL SCI TECHNOL, V28, P369, DOI 10.1080/02726351003702574
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Lee KH, 2007, INT J BIOL MACROMOL, V41, P168, DOI 10.1016/j.ijbiomac.2007.01.011
   Li GY, 2011, J MACROMOL SCI A, V48, P904, DOI 10.1080/10601325.2011.614862
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Mucha M, 2011, E-POLYMERS
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V77, P1, DOI 10.1016/j.carbpol.2009.01.016
   Nakamatsu J, 2006, BIOMACROMOLECULES, V7, P3345, DOI 10.1021/bm0605311
   Niamsa N, 2009, CARBOHYD POLYM, V78, P60, DOI 10.1016/j.carbpol.2009.04.003
   Park SJ, 1999, J APPL POLYM SCI, V74, P2571, DOI 10.1002/(SICI)1097-4628(19991209)74:11<2571::AID-APP2>3.0.CO;2-A
   Park WH, 2004, POLYMER, V45, P7151, DOI 10.1016/j.polymer.2004.08.045
   Pritchard EM, 2010, J CONTROL RELEASE, V144, P159, DOI 10.1016/j.jconrel.2010.01.035
   Rawat A, 2008, J CONTROL RELEASE, V128, P224, DOI 10.1016/j.jconrel.2008.03.013
   Shanmuganathan S, 2008, CARBOHYD POLYM, V73, P201, DOI 10.1016/j.carbpol.2007.11.039
   Srisuwan Y, 2009, J MACROMOL SCI A, V46, P521, DOI 10.1080/10601320902797780
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Yang G, 2002, J MEMBRANE SCI, V210, P379, DOI 10.1016/S0376-7388(02)00419-2
   Yeo JH, 2003, EUR POLYM J, V39, P1195, DOI 10.1016/S0014-3057(02)00359-2
   Yuan Y, 2007, CARBOHYD POLYM, V68, P561, DOI 10.1016/j.carbpol.2006.10.023
NR 41
TC 6
Z9 6
U1 2
U2 34
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1618-7229
J9 E-POLYMERS
JI e-Polymers
PD MAR
PY 2015
VL 15
IS 2
BP 67
EP 74
DI 10.1515/epoly-2014-0134
PG 8
WC Polymer Science
SC Polymer Science
GA CF8MJ
UT WOS:000352814600002
OA Bronze
DA 2018-10-19
ER

PT J
AU Comaneanu, RM
   Hancu, V
   Barbu, HM
   Coman, C
   Cotrut, CM
   Tarcolea, M
   Holicov, AM
   Ormenisan, A
AF Comaneanu, Raluca Monica
   Hancu, Violeta
   Barbu, Horia Mihail
   Coman, Costin
   Cotrut, Cosmin Mihai
   Tarcolea, Mihail
   Holicov, Ana Maria
   Ormenisan, Alina
TI Comparative Assessment of Biocompatibility of NiCr and CoCr Alloys Used
   in Metal-fused-to-ceramic Technology
SO REVISTA DE CHIMIE
LA English
DT Article
DE NiCr and CoCr alloys; metal-fused-to-ceramic restoration; biomaterial;
   biocompatibility
AB A material is considered as biocompatible when it does not harm nor create toxic reactions or systemic side effects. Most of reactions caused by dental materials are of allergic type, with symptoms pointed out at the oral mucosa level or cutaneous tissue level. For saliva and dental tissues media, which a dental restoration comes into contact it is of extremely importance the proper knowledge of the changes which can occur in time at the materials level. The present study assays the biocompatibility of six samples of dental alloys used in metal-fused-to-ceramic technology, three based on NiCr and three based on CoCr. All biocompatibility assays were performed on an osteoblast-like cell line, phenotypically close to osteoblasts (MNNG-Human Osteosarcoma cell line - HOS).
C1 [Comaneanu, Raluca Monica; Hancu, Violeta; Barbu, Horia Mihail; Coman, Costin] Titu Maiorescu Univ Bucharest, Fac Med Dent, Bucharest 031593, Romania.
   [Cotrut, Cosmin Mihai; Tarcolea, Mihail] Univ Politehn Bucuresti, Fac Mat Sci & Engn, Bucharest 060042, Romania.
   [Holicov, Ana Maria] Gr T Popa Univ Med & Pharm, Fac Med, Dept Cell & Mol Biol, Iasi 700115, Romania.
   [Ormenisan, Alina] UMF Targu Mures, Fac Med Dent, Targu Mures 540142, Romania.
RP Hancu, V (reprint author), Titu Maiorescu Univ Bucharest, Fac Med Dent, 67A Gh Petrascu Str, Bucharest 031593, Romania.
EM dianateam@yahoo.com
RI Cotrut, Mihai Cosmin/G-4505-2011
OI Cotrut, Mihai Cosmin/0000-0002-8991-7485
FU ANCS, CNDI - UEFISCDI [175/02.07.2012]
FX All authors had equal contributions. This work was supported by
   Partnerships in priority areas program - PN developed with support from
   ANCS, CNDI - UEFISCDI, project no. 175/02.07.2012 (Coat4Dent).
CR Ardelean L, 2010, METAL INT, V15, P31
   Bortun CM, 2012, REV CHIM-BUCHAREST, V63, P906
   BRUCK SD, 1980, PROPERTIES BIOMATERI
   Craig RG, 2001, MAT DENTARE RESTAURA
   CUNNINGHAM DM, 1973, DENT CLIN N AM, V17, P719
   GHIBAN B., 2009, ALIAJE DENTARE COBAL
   GOLOMB G, 1991, BIOMATERIALS, V12, P397, DOI 10.1016/0142-9612(91)90008-X
   Hancu V, 2014, REV CHIM-BUCHAREST, V65, P706
   Kewal K., 2008, HDB NANOMEDICINE
   Minciuna MG, 2014, REV CHIM-BUCHAREST, V65, P335
   STELEA O., 1999, BIOMATERIALE
   STROSCIO M.A, 2004, BIOL NANOSTRUCTURES, V192
   SUCIU M, 2008, STUDIUL MAT
   VOICU G, LIANTI ANORGANICI SI
   Williams D. F., 1982, BIOCOMPATIBILITY CLI
   WILLIAMS DF, 1999, WILLIAMS DICT BIOMAT
NR 16
TC 7
Z9 7
U1 0
U2 8
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0034-7752
J9 REV CHIM-BUCHAREST
JI Rev. Chim.
PD MAR
PY 2015
VL 66
IS 3
BP 312
EP 315
PG 4
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA CF7SJ
UT WOS:000352756300004
DA 2018-10-19
ER

PT J
AU Gil, M
   Kawai, T
   Ishikawa-Nagai, S
   Da Silva, J
   Nagai, M
AF Gil, Mindy
   Kawai, Toshihisa
   Ishikawa-Nagai, Shigemi
   Da Silva, John
   Nagai, Masazumi
TI Identification of putative bone anabolic peptides targeting adherent
   plasma membrane
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Peptide display library; Adherent plasma membrane; Bone matrix;
   Biomaterial; Osteoblast; Differentiation
ID VIVO PHAGE DISPLAY; EXTRACELLULAR-MATRIX; DIFFERENTIATION; REPAIR
AB Bone matrix provides unknown essential cues for osteoblast lineage cells to develop, grow, repair and remodel bones via adherent plasma membrane. Because of its tight sealing with bone matrix in vivo and culture surface in vitro as well, the adherent plasma membrane has been unveiled target of investigation to date. Herein, we report a new approach to explore the adherence plasma membrane of osteoblasts with biofunctional peptide candidates in a bacterial peptide library. To accomplish this, human osteoblast like hFOB 1.19 cells were cultured on porous filter with 8 gm pore through which bacterial peptides were allowed to meet the membrane for affinity selection. The affinity-selected peptides were coated on culture plate to further evaluate their influence on osteoblastic cell adhesion, as well as expressions of osteoblast differentiation markers, alkaline phosphatase and osteocalcin. Finally, the serial screenings identified two prominent active peptides that enhanced the differentiation markers nearly to the same level as a control peptide of bone morphogenetic protein-2. Osteogenic activity is expected for the peptides when immobilized on bone implant surface. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Gil, Mindy; Kawai, Toshihisa] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA.
   [Kawai, Toshihisa; Nagai, Masazumi] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA 02142 USA.
   [Ishikawa-Nagai, Shigemi; Da Silva, John] Harvard Univ, Sch Dent Med, Restorat Dent & Biomat Sci, Boston, MA 02115 USA.
RP Nagai, M (reprint author), Forsyth Inst, Dept Immunol & Infect Dis, 245 First St, Cambridge, MA 02142 USA.
EM mnagai@forsyth.org
FU ITT Foundation, Basel, Switzerland [673_2009]; American Academy of
   Implant Dentistry Foundation (Student Research Grant)
FX This study was supported by the ITT Foundation, Basel, Switzerland
   (673_2009) and the American Academy of Implant Dentistry Foundation
   (Student Research Grant).
CR Aumailley M, 1998, J MOL MED-JMM, V76, P253, DOI 10.1007/s001090050215
   Barthes J., 2014, BIOMED RES INT, V2014, P1
   Hay ED, 1993, CURR OPIN CELL BIOL, V5, P1029, DOI 10.1016/0955-0674(93)90088-8
   Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Olmez E.O., 2012, BINGDING PROTEIN, P49
   Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0
   Rajotte D, 1998, J CLIN INVEST, V102, P430, DOI 10.1172/JCI3008
   Robert R, 2006, J BIOL CHEM, V281, P40135, DOI 10.1074/jbc.M609344200
   Saito A, 2006, J BIOMED MATER RES A, V77A, P700, DOI 10.1002/jbm.a.30662
   Saito A, 2005, J BIOMED MATER RES A, V72A, P77, DOI 10.1002/jbm.a.30208
   Shadidi Mohsen, 2003, FASEB Journal, V17, P256
   Streuli C, 1999, CURR OPIN CELL BIOL, V11, P634, DOI 10.1016/S0955-0674(99)00026-5
   Thayer AM, 2011, CHEM ENG NEWS, V89, P13
   Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620
   Zhang JB, 2001, CANCER LETT, V171, P153, DOI 10.1016/S0304-3835(01)00575-4
NR 16
TC 1
Z9 1
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAR
PY 2015
VL 459
IS 1
BP 71
EP 74
DI 10.1016/j.bbrc.2015.02.071
PG 4
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CE8UU
UT WOS:000352120400012
PM 25721672
DA 2018-10-19
ER

PT J
AU You, RC
   Li, XF
   Luo, ZW
   Qu, J
   Li, MZ
AF You, Renchuan
   Li, Xiufang
   Luo, Zuwei
   Qu, Jing
   Li, Mingzhong
TI Directional cell elongation through filopodia-steered lamellipodial
   extension on patterned silk fibroin films
SO BIOINTERPHASES
LA English
DT Article
ID CONTACT GUIDANCE; MOTILITY; SURFACE; BIOMATERIALS; SCAFFOLDS; SHAPE
AB Micropatterned biomaterials have been used to direct cell alignment for specific tissue engineering applications. However, the understanding of how cells respond to guidance cues remains limited. Plasticity in protrusion formation has been proposed to enable cells to adapt their motility mode to microenvironment. In this study, the authors investigated the key role of protrusion response in cell guidance on patterned silk fibroin films. The results revealed that the ability to transform between filopodia and small lamellipodia played important roles in directional cell guidance. Filopodia did not show directional extension on patterned substrates prior to spreading, but they transduced topographical cues to the cell to trigger the formation of small lamellipodia along the direction of a microgrooved or parallel nanofiber pattern. The polar lamellipodia formation provided not only a path with directionality, but a driving force for directional cell elongation. Moreover, aligned nanofibers coating provided better mechanical support for the traction of filopodia and lamellipodia, promoting cell attachment, spreading, and migration. This study provides new insight into how cells respond to guidance cues and how filopodia and lamellipodia control cell contact guidance on micropatterned biomaterial surfaces. (C) 2015 American Vacuum Society.
C1 [You, Renchuan; Li, Xiufang; Luo, Zuwei; Qu, Jing; Li, Mingzhong] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
RP Li, MZ (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, 199 Renai Rd,Ind Pk, Suzhou 215123, Peoples R China.
EM mzli@suda.edu.cn
FU National Nature Science Foundation of China [31370968]; Nature Science
   Foundation of Jiangsu Province [BK20131177]; College Natural Science
   Research Project of Jiangsu Province [12KJA430003]; Priority Academic
   Program Development of Jiangsu Higher Education Institutions; Jiangsu
   Province Ordinary Universities and Colleges Graduate Scientific and
   Innovation Plan [KYLX_1243]
FX This work was supported by the National Nature Science Foundation of
   China (31370968), Nature Science Foundation of Jiangsu Province
   (BK20131177), College Natural Science Research Project of Jiangsu
   Province (12KJA430003), Priority Academic Program Development of Jiangsu
   Higher Education Institutions and Jiangsu Province Ordinary Universities
   and Colleges Graduate Scientific and Innovation Plan (KYLX_1243).
CR Albuschies J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01658
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Bornschlogl T, 2013, CYTOSKELETON, V70, P590, DOI 10.1002/cm.21130
   Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002
   Franco D, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-34
   Gasiorowski JZ, 2010, BIOMATERIALS, V31, P8882, DOI 10.1016/j.biomaterials.2010.08.026
   Guex AG, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/021001
   Guillou H, 2008, EXP CELL RES, V314, P478, DOI 10.1016/j.yexcr.2007.10.026
   Heckman CA, 2013, CELL SIGNAL, V25, P2298, DOI 10.1016/j.cellsig.2013.07.006
   Heiman MG, 2010, CURR OPIN NEUROBIOL, V20, P86, DOI 10.1016/j.conb.2009.10.016
   Kanada M, 2008, MOL BIOL CELL, V19, P8, DOI 10.1091/mbc.E07-04-0370
   Kang K, 2012, ANGEW CHEM INT EDIT, V51, P2855, DOI 10.1002/anie.201106271
   Kim TG, 2012, ADV FUNCT MATER, V22, P2446, DOI 10.1002/adfm.201103083
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Kwon KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073960
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073
   Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406
   Menna E, 2011, EUR J NEUROSCI, V34, P1655, DOI 10.1111/j.1460-9568.2011.07897.x
   Moller J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02884
   Mongiu AK, 2007, J CELL SCI, V120, P1113, DOI 10.1242/jcs.03384
   Nathan AS, 2011, ACTA BIOMATER, V7, P57, DOI 10.1016/j.actbio.2010.08.007
   Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134
   Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079
   Pan Z, 2012, BIOMATERIALS, V33, P1730, DOI 10.1016/j.biomaterials.2011.11.023
   Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com
   Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Schafer C, 2009, EXP CELL RES, V315, P1212, DOI 10.1016/j.yexcr.2008.11.008
   Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1
   Song KH, 2014, INTEGR BIOL-UK, V6, P450, DOI 10.1039/c4ib00021h
   Tay CY, 2011, SMALL, V7, P1361, DOI 10.1002/smll.201100046
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   You RC, 2014, POLYM DEGRAD STABIL, V109, P226, DOI 10.1016/j.polymdegradstab.2014.07.029
   You RC, 2014, J BIOMED MATER RES A, V102, P4206, DOI 10.1002/jbm.a.35097
   Zhou F, 2009, CHINESE SCI BULL, V54, P3200, DOI [10.1007/s11434-009-0366-1, 10.1007/S11434-009-0366-1]
NR 39
TC 12
Z9 12
U1 1
U2 24
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD MAR
PY 2015
VL 10
IS 1
AR 011005
DI 10.1116/1.4914028
PG 8
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA CE8AL
UT WOS:000352063000005
PM 25743615
DA 2018-10-19
ER

PT J
AU Foster, NC
   Henstock, JR
   Reinwald, Y
   El Haj, AJ
AF Foster, Nicola C.
   Henstock, James R.
   Reinwald, Yvonne
   El Haj, Alicia J.
TI Dynamic 3D Culture: Models of Chondrogenesis and Endochondral
   Ossification
SO BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS
LA English
DT Review
DE chondrogenesis; mechanical load; 3D models; endochondral ossification
ID EMBRYONIC STEM-CELLS; CYCLIC HYDROSTATIC-PRESSURE; TISSUE-ENGINEERED
   CARTILAGE; MESENCHYMAL PROGENITOR CELLS; FACTOR-RELEASING HYDROGELS;
   FINITE-ELEMENT MODEL; MARROW STROMAL CELLS; FEMUR DEFECT MODEL;
   ARTICULAR-CARTILAGE; BONE-MARROW
AB The formation of cartilage from stem cells during development is a complex process which is regulated by both local growth factors and biomechanical cues, and results in the differentiation of chondrocytes into a range of subtypes in specific regions of the tissue. In fetal development cartilage also acts as a precursor scaffold for many bones, and mineralization of this cartilaginous bone precursor occurs through the process of endochondral ossification. In the endochondral formation of bones during fetal development the interplay between cell signalling, growth factors, and biomechanics regulates the formation of load bearing bone, in addition to the joint capsule containing articular cartilage and synovium, generating complex, functional joints from a single precursor anlagen. These joint tissues are subsequently prone to degeneration in adult life and have poor regenerative capabilities, and so understanding how they are created during development may provide useful insights into therapies for diseases, such as osteoarthritis, and restoring bone and cartilage lost in adulthood. Of particular interest is how these tissues regenerate in the mechanically dynamic environment of a living joint, and so experiments performed using 3D models of cartilage development and endochondral ossification are proving insightful. In this review, we discuss some of the interesting models of cartilage development, such as the chick femur which can be observed in ovo, or isolated at a specific developmental stage and cultured organotypically in vitro. Biomaterial and hydrogel-based strategies which have emerged from regenerative medicine are also covered, allowing researchers to make informed choices on the characteristics of the materials used for both original research and clinical translation. In all of these models, we illustrate the essential importance of mechanical forces and mechanotransduction as a regulator of cell behavior and ultimate structural function in cartilage. Birth Defects Research (Part C) 105:19-33, 2015. (c) 2015 Wiley Periodicals, Inc.
C1 [Foster, Nicola C.; Henstock, James R.; Reinwald, Yvonne; El Haj, Alicia J.] Keele Univ, Inst Sci & Technol Med, Guy Hilton Res Ctr, Keele ST4 7QB, Staffs, England.
RP El Haj, AJ (reprint author), Keele Univ, Inst Sci & Technol Med, Guy Hilton Res Ctr, Keele ST4 7QB, Staffs, England.
EM a.j.el.haj@keele.ac.uk
OI Reinwald, Yvonne/0000-0001-6733-605X
FU Medical Research Council [MR/K006312/1]; Engineering and Physical
   Sciences Research Council [EP/H028277/1]
CR Angele P, 2003, J ORTHOPAED RES, V21, P451, DOI 10.1016/S0736-0266(02)00230-9
   Bolgen N, 2008, TISSUE ENG PT A, V14, P1743, DOI 10.1089/ten.tea.2007.0277
   Bonassar LJ, 2000, ARCH BIOCHEM BIOPHYS, V379, P57, DOI 10.1006/abbi.2000.1820
   Boyd NL, 2009, TISSUE ENG PT A, V15, P1897, DOI 10.1089/ten.tea.2008.0351
   Cao L, 2006, J BIOMECH ENG-T ASME, V128, P766, DOI 10.1115/1.2246237
   Carroll SF, 2014, J BIOMECH, V47, P2115, DOI 10.1016/j.jbiomech.2013.12.006
   Carver SE, 1999, BIOTECHNOL BIOENG, V65, P274
   Chan SCW, 2011, EUR SPINE J, V20, P1796, DOI 10.1007/s00586-011-1827-1
   Cheng AX, 2014, TISSUE ENG PART B-RE, V20, P257, DOI [10.1089/ten.teb.2012.0757, 10.1089/ten.TEB.2012.0757]
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Correia C, 2012, TISSUE ENG PT A, V18, P1979, DOI [10.1089/ten.tea.2012.0083, 10.1089/ten.TEA.2012.0083]
   Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002
   Diederichs S, 2014, STEM CELLS DEV, V23, P1594, DOI 10.1089/scd.2013.0477
   Duke PJ, 1999, ADV SPACE RES-SERIES, V24, P821, DOI 10.1016/S0273-1177(99)00077-0
   DuRaine GD, 2015, BIOMECH MODEL MECHAN, V14, P73, DOI 10.1007/s10237-014-0589-1
   Elder BD, 2009, TISSUE ENG PART B-RE, V15, P43, DOI 10.1089/ten.teb.2008.0435
   Elder SH, 2006, J ORTHOP RES, V24, P740, DOI 10.1002/jor.20086
   Fecek C, 2008, TISSUE ENG PT A, V14, P1403, DOI 10.1089/tea.2007.0293
   Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012
   Freyria AM, 2005, TISSUE ENG, V11, P674, DOI 10.1089/ten.2005.11.674
   Gerber HP, 2000, TRENDS CARDIOVAS MED, V10, P223, DOI 10.1016/S1050-1738(00)00074-8
   Gong GC, 2010, J CELL PHYSIOL, V224, P664, DOI 10.1002/jcp.22166
   Grad S, 2011, CLIN ORTHOP RELAT R, V469, P2764, DOI 10.1007/s11999-011-1819-9
   Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691
   Guha U, 2002, DEV BIOL, V249, P108, DOI 10.1006/dbio.2002.0752
   Guilak F, 1999, OSTEOARTHR CARTILAGE, V7, P59, DOI 10.1053/joca.1998.0162
   GUILAK F, 1995, J ORTHOP RES, V13, P410, DOI 10.1002/jor.1100130315
   Guilak F, 2000, J BIOMECH, V33, P1663, DOI 10.1016/S0021-9290(00)00105-6
   HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104
   Handa T, 1997, SPINE, V22, P1085, DOI 10.1097/00007632-199705150-00006
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Henstock JR, 2013, BONE, V53, P468, DOI 10.1016/j.bone.2013.01.010
   Henstock JR, 2014, STEM CELLS TRANSLATI, V3, P1
   Hsu SH, 2006, ARTIF ORGANS, V30, P42, DOI 10.1111/j.1525-1594.2006.00179.x
   Hu JC, 2006, TISSUE ENG, V12, P1337, DOI 10.1089/ten.2006.12.1337
   Hwang NS, 2006, TISSUE ENG, V12, P2695, DOI 10.1089/ten.2006.12.2695
   Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024
   Hwang NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002498
   Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106
   Hwang Nathaniel S., 2007, V407, P351, DOI 10.1007/978-1-59745-536-7_24
   Irianto J, 2014, J BIOMECH, V47, P579, DOI 10.1016/j.jbiomech.2013.11.040
   Ishihara H, 1996, J APPL PHYSIOL, V80, P839
   Jukes JM, 2008, TISSUE ENG PT A, V14, P135, DOI 10.1089/ten.a.2006.0397
   Jukes JM, 2010, TISSUE ENG PT A, V16, P565, DOI [10.1089/ten.tea.2009.0173, 10.1089/ten.TEA.2009.0173]
   Kahn J, 2009, DEV CELL, V16, P734, DOI 10.1016/j.devcel.2009.04.013
   Kang Y, 2006, J BIOMED MATER RES A, V77A, P331, DOI 10.1002/jbm.a.30607
   Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073
   Koay EJ, 2007, STEM CELLS, V25, P2183, DOI 10.1634/stemcells.2007-0105
   Kopesky PW, 2010, MATRIX BIOL, V29, P427, DOI 10.1016/j.matbio.2010.02.003
   Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705
   Kunitomo T, 2009, J ORTHOP SCI, V14, P776, DOI 10.1007/s00776-009-1393-0
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Lomas AJ, 2013, TISSUE ENG PART C-ME, V19, P577, DOI [10.1089/ten.tec.2012.0457, 10.1089/ten.TEC.2012.0457]
   Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Mansour JM, 2003, KINESIOLOGY MECH PAT, P1992
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   McKay TR, 2011, STEM CELL RES, V7, P154, DOI 10.1016/j.scr.2011.04.005
   Meyer EG, 2011, J MECH BEHAV BIOMED, V4, P1257, DOI 10.1016/j.jmbbm.2011.04.012
   Mikic B, 2004, ANN BIOMED ENG, V32, P18, DOI 10.1023/B:ABME.0000007787.39262.a7
   MITROVIC D, 1982, ACTA ANAT, V113, P313
   Miyanishi K, 2006, TISSUE ENG, V12, P2253, DOI 10.1089/ten.2006.12.2253
   Miyanishi K, 2006, TISSUE ENG, V12, P1419, DOI 10.1089/ten.2006.12.1419
   Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023
   Muhammad H, 2012, CELL MOL LIFE SCI, V69, P2101, DOI 10.1007/s00018-011-0911-3
   Murray PDF, 1930, ROUX ARCH DEV BIOL, V122, P629, DOI 10.1007/BF00573594
   Nakagawa T, 2009, ARTHRITIS RHEUM-US, V60, P3686, DOI 10.1002/art.27229
   Natoli RM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2939368
   Nguyen LH, 2011, BIOMATERIALS, V32, P6946, DOI 10.1016/j.biomaterials.2011.06.014
   Nowlan NC, 2008, J BIOMECH, V41, P249, DOI 10.1016/j.jbiomech.2007.09.031
   Nowlan NC, 2012, BIOMECH MODEL MECHAN, V11, P207, DOI 10.1007/s10237-011-0304-4
   Nowlan NC, 2010, BIRTH DEFECTS RES C, V90, P203, DOI 10.1002/bdrc.20184
   Nowlan NC, 2010, BONE, V46, P1275, DOI 10.1016/j.bone.2009.11.026
   Ogawa R, 2009, TISSUE ENG PT A, V15, P2937, DOI [10.1089/ten.tea.2008.0672, 10.1089/ten.TEA.2008.0672]
   Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683
   Osborne A. C., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P448
   Oseni AO, 2011, TISSUE ENG TISSUE OR
   Pacifici Maurizio, 2005, Birth Defects Research, V75, P237, DOI 10.1002/bdrc.20050
   Park S, 2004, OSTEOARTHR CARTILAGE, V12, P65, DOI 10.1016/j.joca.2003.08.005
   PARKKINEN JJ, 1993, ARCH BIOCHEM BIOPHYS, V300, P458, DOI 10.1006/abbi.1993.1062
   Portner R, 2005, J BIOSCI BIOENG, V100, P235, DOI 10.1263/jbb.100.235
   Puetzer J, 2013, TISSUE ENG PT A, V19, P299, DOI [10.1089/ten.tea.2012.0015, 10.1089/ten.TEA.2012.0015]
   Responte DJ, 2012, FASEB J, V26, P3614, DOI 10.1096/fj.12-207241
   Reza AT, 2008, ANN BIOMED ENG, V36, P204, DOI 10.1007/s10439-007-9407-6
   RUANOGIL D, 1978, ACTA ANAT, V101, P36
   RUANOGIL D, 1985, ACTA ANAT, V123, P90
   Ruhlen R, 2014, OSTEOARTHR CARTILAGE, V22, P1071, DOI 10.1016/j.joca.2014.05.011
   Safshekan F, 2012, ARTIF ORGANS, V36, P1065, DOI 10.1111/j.1525-1594.2012.01507.x
   Sakao K, 2008, OSTEOARTHR CARTILAGE, V16, P805, DOI 10.1016/j.joca.2007.10.021
   Shao YY, 2012, BONE, V50, P79, DOI 10.1016/j.bone.2011.08.033
   Shepherd DET, 1999, RHEUMATOLOGY, V38, P124, DOI 10.1093/rheumatology/38.2.124
   Smith EL, 2014, ACTA BIOMATER, V10, P4186, DOI 10.1016/j.actbio.2014.06.011
   Smith EL, 2014, ACTA BIOMATER, V10, P4197, DOI 10.1016/j.actbio.2014.05.025
   Smith EL, 2013, EUR CELLS MATER, V26, P91, DOI 10.22203/eCM.v026a07
   Snyder TN, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-10
   Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.TEB.2011.0077, 10.1089/ten.teb.2011.0077]
   Takahashi K, 1998, ANN RHEUM DIS, V57, P231, DOI 10.1136/ard.57.4.231
   Thein-Han WW, 2007, J BIOMED MATER RES B, V80B, P92, DOI 10.1002/jbm.b.30573
   Tigli RS, 2011, J BIOMED MATER RES A, V96A, P21, DOI 10.1002/jbm.a.32949
   Toh WS, 2010, BIOMATERIALS, V31, P6968, DOI 10.1016/j.biomaterials.2010.05.064
   Vinardell T, 2012, EUR CELLS MATER, V23, P121, DOI 10.22203/eCM.v023a09
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   VunjakNovakovic G, 1996, AICHE J, V42, P850, DOI 10.1002/aic.690420323
   Wagner DR, 2008, ANN BIOMED ENG, V36, P813, DOI 10.1007/s10439-008-9448-5
   Wang QG, 2009, BIOCHEM BIOPH RES CO, V379, P738, DOI 10.1016/j.bbrc.2008.12.111
   Wann AKT, 2012, FASEB J, V26, P1663, DOI 10.1096/fj.11-193649
NR 107
TC 10
Z9 10
U1 0
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-975X
EI 1542-9768
J9 BIRTH DEFECTS RES C
JI Birth Defects Res. Part C-Embryo Today-Rev.
PD MAR
PY 2015
VL 105
IS 1
BP 19
EP 33
DI 10.1002/bdrc.21088
PG 15
WC Developmental Biology; Reproductive Biology
SC Developmental Biology; Reproductive Biology
GA CE8QT
UT WOS:000352109700003
PM 25777047
DA 2018-10-19
ER

PT J
AU Phansalkar, RS
   Nam, JW
   Chen, SN
   McAlpine, JB
   Napolitano, JG
   Leme, A
   Vidal, CMP
   Aguiar, T
   Bedran-Russo, AK
   Pauli, GF
AF Phansalkar, Rasika S.
   Nam, Joo-Won
   Chen, Shao-Nong
   McAlpine, James B.
   Napolitano, Jose G.
   Leme, Ariene
   Vidal, Cristina M. P.
   Aguiar, Thaiane
   Bedran-Russo, Ana K.
   Pauli, Guido F.
TI A galloylated dimeric proanthocyanidin from grape seed exhibits dentin
   biomodification potential
SO FITOTERAPIA
LA English
DT Article
DE Centrifugal partition and countercurrent chromatography (CPC/CCC);
   Countercurrent separation (CS); Oligomeric proanthocyanidins (OPACs);
   Dentin stiffness and biomodification; Galloylation; HiFSA
ID COLLAGEN CROSS-LINKERS; EQUIMOLAR CONDENSATION; NATURAL-PRODUCTS;
   VINIFERA L.; PROCYANIDINS; POLYMERIZATION; SEPARATION; APPLE;
   CHROMATOGRAPHY; BIOSYNTHESIS
AB Grape seeds are a rich source of polyphenols, especially proanthocyanidins (PACs), and are also known for the presence of galloylated oligomeric PACs (OPACs). The present study focuses on the phytochemical methodology for grape seed (O)PACs and their potential role as dentin biomodifiers to be used in restorative and reparative dentistry. A new method using centrifugal partition chromatography (CPC) was developed for the preparative separation of the grape seed (O)PACs. Orthogonal phytochemical profiling of the resulting CPC fractions was performed using C18 and diol HPLC, normal phase HPTLC, and IT-TOF MS analysis. A galloylated procyanidin dimer (1) was isolated from a CPC fraction in order to evaluate its potential to enhance dentin biomechanical properties. Moreover, it helped to evaluate the impact of the galloyl moiety on the observed bioactivity. Structure elucidation was performed using ESI-MS, 1D and 2D NMR analyses. For the first time, H-1 iterative full spin analysis (HiFSA) was performed on this type of molecule, enabling a detailed proton chemical shift and coupling constant assignment. The CPC fractions as well as 1 showed promising results in the dentin stiffness bioassay and indicate that they may be used as dental intervention biomaterial. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Phansalkar, Rasika S.; Nam, Joo-Won; Chen, Shao-Nong; McAlpine, James B.; Napolitano, Jose G.; Pauli, Guido F.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL USA.
   [Leme, Ariene; Vidal, Cristina M. P.; Aguiar, Thaiane; Bedran-Russo, Ana K.] Univ Illinois, Coll Dent, Dept Restorat Dent, Chicago, IL USA.
RP Pauli, GF (reprint author), UIC Coll Pharm, 833 S Wood St, Chicago, IL 60612 USA.
EM gfp@uic.edu
RI Bedran-Russo, Ana/B-6149-2017; Vidal, Cristina/H-4560-2014
OI Vidal, Cristina/0000-0003-4345-8487; Napolitano,
   Jose/0000-0003-1250-2262; Pauli, Guido/0000-0003-1022-4326; Chen,
   Shao-Nong/0000-0003-0748-0863
FU NIDCR/NIH [R01 DE021040]
FX The authors are particularly grateful to Dr. Benjamin Ramirez from the
   Center for Structural Biology at UIC for his general NMR support and his
   invaluable assistance in performing the low temperature NMR experiments.
   We also thank an anonymous reviewer for helpful suggestions regarding
   the nomenclature of oligomeric proanthocyanidins. This research was
   funded by grant R01 DE021040 from NIDCR/NIH.
CR Abe Y, 2008, TETRAHEDRON LETT, V49, P6413, DOI 10.1016/j.tetlet.2008.08.087
   Aguiar TR, 2014, J DENT RES, V93, P417, DOI 10.1177/0022034514523783
   BEART JE, 1985, J CHEM SOC PERK T 2, P1439, DOI 10.1039/p29850001439
   Bedran-Russo AK, 2014, DENT MATER, V30, P62, DOI 10.1016/j.dental.2013.10.012
   Bedran-Russo AKB, 2008, J BIOMED MATER RES B, V86B, P330, DOI 10.1002/jmb.b.31022
   Bedran-Russo AKB, 2007, J BIOMED MATER RES B, V80B, P268, DOI 10.1002/jbm.b.30593
   Bogacki RE, 2002, OPER DENT, V27, P488
   Castellan CS, 2011, J MECH BEHAV BIOMED, V4, P1343, DOI 10.1016/j.jmbbm.2011.05.003
   Castellan CS, 2010, DENT MATER, V26, P968, DOI 10.1016/j.dental.2010.06.001
   Castellan CS, 2010, J DENT, V38, P431, DOI 10.1016/j.jdent.2010.02.002
   D'Andrea G, 2010, FITOTERAPIA, V81, P724, DOI 10.1016/j.fitote.2010.06.011
   Esatbeyoglu T, 2010, J AGR FOOD CHEM, V59, P62
   Friesen BJ, 2005, J LIQ CHROMATOGR R T, V28, P2777
   Hayasaka Y, 2003, RAPID COMMUN MASS SP, V17, P9, DOI 10.1002/rcm.869
   Hayes CJ, 2006, J ORG CHEM, V71, P9701, DOI 10.1021/jo061740e
   He F, 2008, MOLECULES, V13, P2674, DOI 10.3390/molecules13102674
   Iglesias J, 2010, J AGR FOOD CHEM, V58, P7423, DOI 10.1021/jf100832z
   Karine F, 2013, LC GC N AM, V13, P132
   Kelm MA, 2006, J AGR FOOD CHEM, V54, P1571, DOI 10.1021/jf0525941
   Latif R, 2013, CURR OPIN CLIN NUTR, V16, P669, DOI 10.1097/MCO.0b013e328365a235
   Lizarraga D, 2007, FEBS J, V274, P4802, DOI 10.1111/j.1742-4658.2007.06010.x
   Mitjans M, 2011, J AGR FOOD CHEM, V59, P2113, DOI 10.1021/jf1025532
   Mohri Y, 2009, HETEROCYCLES, V79, P549, DOI 10.3987/COM-08-S(D)14
   Napolitano JG, 2014, J PHARMACEUT BIOMED, V93, P59, DOI 10.1016/j.jpba.2013.06.017
   Napolitano JG, 2013, J ORG CHEM, V78, P2827, DOI 10.1021/jo302720h
   Nonaka G-I, 1982, CHEM PHARM BULL, V31, P1906
   Nunez V, 2006, J SCI FOOD AGR, V86, P915, DOI 10.1002/jsfa.2438
   Ozdal T, 2013, FOOD RES INT, V51, P954, DOI 10.1016/j.foodres.2013.02.009
   Pauli GF, 2005, J NAT PROD, V68, P133, DOI 10.1021/np0497301
   Pauli GF, 2001, PHYTOCHEM ANALYSIS, V12, P28, DOI 10.1002/1099-1565(200101/02)12:1<28::AID-PCA549>3.0.CO;2-D
   Pauli GF, 2008, J NAT PROD, V71, P1489, DOI 10.1021/np800144q
   Pfeiffer J, 2006, PLANT PHYSIOL BIOCH, V44, P323, DOI 10.1016/j.plaphy.2006.06.001
   Robbins RJ, 2009, J CHROMATOGR A, V1216, P4831, DOI 10.1016/j.chroma.2009.04.006
   Saito A, 2005, BIOORGAN MED CHEM, V13, P2759, DOI 10.1016/j.bmc.2005.02.023
   Schroeter H, 2010, MOL ASPECTS MED, V31, P546, DOI 10.1016/j.mam.2010.09.008
   Shenoy Arvind, 2008, J Conserv Dent, V11, P99, DOI 10.4103/0972-0707.45247
   Shoji T, 2003, J AGR FOOD CHEM, V51, P3806, DOI 10.1021/jf0300184
   Suda M, 2013, BIOORG MED CHEM LETT, V23, P4935, DOI 10.1016/j.bmcl.2013.06.061
   Vidal CMP, 2014, LANGMUIR, V30, P14887, DOI 10.1021/la5034383
   Xi H, 2005, HUAXUE SHIJIE, V46, P759
   Yanagida A, 2003, J BIOCHEM BIOPH METH, V56, P311, DOI 10.1016/S0165-022X(03)00068-X
NR 41
TC 16
Z9 16
U1 4
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0367-326X
EI 1873-6971
J9 FITOTERAPIA
JI Fitoterapia
PD MAR
PY 2015
VL 101
BP 169
EP 178
DI 10.1016/j.fitote.2014.12.006
PG 10
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CF0RU
UT WOS:000352252700021
PM 25542682
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zhang, D
   Zhang, B
   Tang, XN
   Wang, Y
   Si, T
   Cui, S
AF Zhang, D.
   Zhang, B.
   Tang, X. N.
   Wang, Y.
   Si, T.
   Cui, S.
TI Optimised preparation of silver inorganic antibacterial material
   containing ytterbium using response surface methodology
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Antibacterial material; Silver; Ytterbium; Response surface methodology
ID COMPOSITE NANOPARTICLES; PHOTOCATALYTIC ACTIVITY; ANTIMICROBIAL
   ACTIVITY; BIOMATERIAL SYSTEM; NANOCOMPOSITES; LANTHANUM; SHELL; AG
AB In this work, a silver inorganic antibacterial containing ytterbium was synthesised using response surface methodology. Statistical analysis of the results showed that the bulk density of the Ag-Yb antibacterial white carbon black was characterised by the reaction time, reaction temperature and ytterbium ion concentration. The optimised reaction conditions were as follows: reaction time was 75 min, reaction temperature was 85uC and ytterbium ion concentration was 0.01 mol L-1. The structure and property of the inorganic antibacterial material were characterised by scanning electron microscopy, energy dispersive spectroscopy, X-ray diffraction, Fourier transform infrared spectroscopy and antibacterial experiments (Escherichia coli as experimental bacteria). Results showed that the bacteriostatic rate of Ag-Yb antibacterial white carbon black was >0%.
C1 [Zhang, D.; Tang, X. N.; Si, T.; Cui, S.] Kunming Univ Sci & Technol, Fac Chem Engn, Kunming 650500, Yunnan, Peoples R China.
   [Zhang, B.; Wang, Y.] Kunming Univ Sci & Technol, Fac Sci, Kunming 650500, Yunnan, Peoples R China.
RP Tang, XN (reprint author), Kunming Univ Sci & Technol, Fac Chem Engn, Kunming 650500, Yunnan, Peoples R China.
EM tangxn6666@sina.com
FU Yunnan Provincial Department of Education [2012Z102]; National High-tech
   RD Program [2014AA021801]
FX This work was supported by key projects of the Yunnan Provincial
   Department of Education (no. 2012Z102) and the National High-tech R&D
   Program (no. 2014AA021801).
CR Devesh R., 2012, ADV ENG MATER, V14, P93
   Girase B, 2011, MAT SCI ENG C-MATER, V31, P1759, DOI 10.1016/j.msec.2011.08.007
   Hu JQ, 2013, J DENT, V41, P927, DOI 10.1016/j.jdent.2013.07.014
   Jagdish R., 2007, MAT SCI ENG C, V27C, P540
   Kim JD, 2013, APPL SURF SCI, V283, P227, DOI 10.1016/j.apsusc.2013.06.086
   Konwarh R, 2013, CARBOHYD POLYM, V92, P1100, DOI 10.1016/j.carbpol.2012.10.055
   Li F, 2013, J DENT, V41, P881, DOI 10.1016/j.jdent.2013.07.006
   Li N., 2008, J MATER SCI-MATER M, V19, P3057
   Ma ZJ, 2011, COLLOID SURFACE A, V387, P57, DOI 10.1016/j.colsurfa.2011.07.025
   Olga Polydorou P., 2013, J ODONTOLOGY, V101, P170
   Pana a cek A., 2013, COLLOID SURFACE B, V110B, P191
   Park J, 2013, BIOMATERIALS, V34, P8766, DOI 10.1016/j.biomaterials.2013.07.064
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Ray S, 2011, CHEM ENG J, V169, P116, DOI 10.1016/j.cej.2011.02.061
   Sachsenmaier S, 2013, INJURY, V44, P1363, DOI 10.1016/j.injury.2013.07.014
   Tang XN, 2009, ADV MATER RES-SWITZ, V79-82, P1799, DOI 10.4028/www.scientific.net/AMR.79-82.1799
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Xu Y, 2005, J WUHAN UNIV TECHNOL, V20, P105
   Yao ZT, 2013, J MATER SCI, V48, P8580, DOI 10.1007/s10853-013-7683-0
   Zhang B., 2010, J RARE EARTH, P142
   Zhang B, 2012, LIGHT MET, P157
   Zhang B, 2010, J RARE EARTH, V28, P451, DOI 10.1016/S1002-0721(10)60346-8
   Zhu YJ, 2013, MATER LETT, V108, P103, DOI 10.1016/j.matlet.2013.06.073
NR 25
TC 0
Z9 1
U1 0
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD MAR
PY 2015
VL 30
IS 4
BP 241
EP 248
DI 10.1179/1753555714Y.0000000254
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA CE8OL
UT WOS:000352102600008
DA 2018-10-19
ER

PT J
AU Jeevithan, E
   Zhang, JY
   Wang, NP
   He, L
   Bao, B
   Wu, WH
AF Jeevithan, Elango
   Zhang Jingyi
   Wang, Nanping
   He, Lan
   Bao, Bin
   Wu, Wenhui
TI Physico-chemical, antioxidant and intestinal absorption properties of
   whale shark type-II collagen based on its solubility with acid and
   pepsin
SO PROCESS BIOCHEMISTRY
LA English
DT Article
DE Shark cartilage collagens; Glycoprotein content; Amino acid composition;
   Gut sac model; Antioxidant activity
ID STURGEON ACIPENSER-SCHRENCKII; CHICK STERNAL CARTILAGE; INDUCED
   ARTHRITIS; SOLUBLE COLLAGEN; SKIN; GELATIN; BONE; OPTIMIZATION;
   PURIFICATION; TOLERANCE
AB Type-II collagens (CIIs) were isolated from whale shark (WS) cartilage; and examined for their physico-functional and structural properties. The protein and ash content of WS cartilage were in the range of 8.02% and 23.39%, respectively. Pepsin soluble collagen (PSC) had high hydroxyproline content than acid soluble collagen (ASC). Fourier transform infrared (FTIR) spectra of ASC and PSC were similar and suggesting that pepsin hydrolysis did not affect the secondary structure of collagen, especially triple-helical structure. SEM microstructure depicted a homogenous, more compact, fibrillary and single-layered sheet like structure with coarse structural integrity. Low content of glycoprotein was observed in PSC than ASC due to the removal of some telopepdies by pepsin digestion. Denaturation temperature (T-d) of PSC (34.02 degrees C) was quite higher than ASC. The antioxidant activity against 1,1-dipheny1-2-picrylhydrazyl radicals and the reducing power of PSC was greater than that of ASC. Similar intestinal absorptive behavior was observed for PSC and ASC in an in vitro gut sac model. These results suggested that CI's isolated from WS cartilage could be the suitable biomaterial for commercial applications as alternative to mammalian collagen. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Jeevithan, Elango; Zhang Jingyi; Bao, Bin; Wu, Wenhui] Shanghai Ocean Univ, Coll Food Sci & Technol, Dept Marine Pharmacol, Shanghai 201306, Peoples R China.
   [Wang, Nanping; He, Lan] Shanghai Fisheries Res Inst, Shanghai 200433, Peoples R China.
   [Wu, Wenhui] Shanghai Ocean Univ, Inst Marine Sci, Shanghai 201306, Peoples R China.
RP Wu, WH (reprint author), Shanghai Ocean Univ, Coll Food Sci & Technol, Dept Marine Pharmacol, Shanghai 201306, Peoples R China.
EM srijeevithan@gmail.com; whwu@shou.edu.cn
OI Elango, Jeevithan/0000-0003-4115-9918; Wu, Wen Hui/0000-0002-1710-8582
FU National High Technology Research and Development Program of China
   [2011AA09070109]; National Natural Science Foundation of China
   [81341082]
FX This work received financial support from National High Technology
   Research and Development Program of China (No. 2011AA09070109) and
   National Natural Science Foundation of China (No. 81341082).
CR AOAC, 2000, OFFICIAL METHODS ANA
   Backlund J, 2002, EUR J IMMUNOL, V32, P3776, DOI 10.1002/1521-4141(200212)32:12<3776::AID-IMMU3776>3.0.CO;2-A
   BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053
   Cao H, 2013, EUR REV MED PHARMACO, V17, P1427
   Cao H, 2008, FOOD CHEM, V108, P439, DOI 10.1016/j.foodchem.2007.09.022
   Chang CY, 2007, FOOD CHEM, V100, P1537, DOI 10.1016/j.foodchem.2005.12.019
   Chen LJ, 2012, PHARMACEUTICALS, V5, P339, DOI 10.3390/ph5040339
   Cho SM, 2004, FOOD HYDROCOLLOID, V18, P573, DOI 10.1016/j.foodhyd.2003.10.001
   Duan R, 2009, FOOD CHEM, V112, P702, DOI 10.1016/j.foodchem.2008.06.020
   Edwards HGM, 1997, J MOL STRUCT, V435, P49, DOI 10.1016/S0022-2860(97)00122-1
   Garcia G, 1999, J AUTOIMMUN, V13, P315, DOI 10.1006/jaut.1999.0320
   HELEN E, 2005, J ORTHOP RES, V23, P142
   Jeevithan E, 2014, MAR DRUGS, V12, P3852, DOI 10.3390/md12073852
   Jonglareonrak A, 2005, FOOD CHEM, V93, P475, DOI 10.1016/j.foodchem.2004.10.026
   Joseph G, 2008, J BIOMED MATER RES A, V87, P1103
   Kittiphattanabawon P, 2005, FOOD CHEM, V89, P363, DOI 10.1016/j.foodchem.2004.02.042
   Kittiphattanabawon P, 2010, LWT-FOOD SCI TECHNOL, V43, P792, DOI 10.1016/j.lwt.2010.01.006
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Li ZR, 2013, FOOD HYDROCOLLOID, V31, P103, DOI 10.1016/j.foodhyd.2012.10.001
   Liang QF, 2014, PROCESS BIOCHEM, V49, P318, DOI 10.1016/j.procbio.2013.12.003
   Lima OC, 1999, BRAZ J MED BIOL RES, V32, P651, DOI 10.1590/S0100-879X1999000500020
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mendis E, 2005, LIFE SCI, V77, P2166, DOI 10.1016/j.lfs.2005.03.016
   Merly L, 2013, INT IMMUNOPHARMACOL, V15, P309, DOI [10.1016/j.intimp2012.12.001, 10.1016/j.intimp.2012.12.001]
   Muyonga JH, 2004, FOOD CHEM, V85, P81, DOI 10.1016/j.foodchem.2003.06.006
   Nagai T, 2008, FOOD CHEM, V111, P296, DOI 10.1016/j.foodchem.2008.03.087
   Oesser S., 1999, J NUTR, V1
   Ogawa M, 2003, J AGR FOOD CHEM, V51, P8088, DOI 10.1021/jf034350r
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Ota KG, 2009, J EXP ZOOL PART B, V312, P1
   Poole A.R., 2005, ARTHRITIS ALLIED CON, P223
   Potaros T., 2009, Kasetsart Journal, Natural Sciences, V43, P584
   Rochdi A, 2000, FOOD CHEM, V69, P295, DOI 10.1016/S0308-8146(99)00267-8
   Sadowska M, 2003, FOOD CHEM, V81, P257, DOI 10.1016/S0308-8146(02)00420-X
   SHIMADA K, 1992, J AGR FOOD CHEM, V40, P945, DOI 10.1021/jf00018a005
   Tang CH, 2009, FOOD CHEM, V115, P672, DOI 10.1016/j.foodchem.2008.12.068
   Usha R, 2005, COLLOID SURFACE B, V41, P21, DOI 10.1016/j.colsurfb.2004.11.001
   Veeruraj A, 2013, PROCESS BIOCHEM, V48, P1592, DOI 10.1016/j.procbio.2013.07.011
   Wang L, 2007, J FOOD SCI, V72, P450
   Wang L, 2014, FOOD HYDROCOLLOID, V38, P104, DOI 10.1016/j.foodhyd.2013.12.002
   Wong DWS, 1989, MECH THEORY FOOD CHE, P428
   Zhao W, 2011, INT IMMUNOPHARMACOL, V11, P12, DOI 10.1016/j.intimp.2010.09.018
   Zhu BW, 2012, FOOD HYDROCOLLOID, V28, P182, DOI 10.1016/j.foodhyd.2011.12.010
   Zhuang YL, 2009, J ZHEJIANG UNIV-SC B, V10, P572, DOI 10.1631/jzus.B0920081
NR 44
TC 16
Z9 18
U1 1
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-5113
EI 1873-3298
J9 PROCESS BIOCHEM
JI Process Biochem.
PD MAR
PY 2015
VL 50
IS 3
BP 463
EP 472
DI 10.1016/j.procbio.2014.11.015
PG 10
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering, Chemical
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering
GA CF7OD
UT WOS:000352745300017
DA 2018-10-19
ER

PT J
AU Johnson, CT
   Garcia, AJ
AF Johnson, Christopher T.
   Garcia, Andres J.
TI Scaffold-based Anti-infection Strategies in Bone Repair
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Biomaterial; Scaffold; Bone repair; Regeneration; Infection
ID RESISTANT STAPHYLOCOCCUS-AUREUS; STABILIZED SEGMENTAL DEFECT; HUMAN
   ANTIMICROBIAL PEPTIDES; BACTERIAL BIOFILM FORMATION;
   PSEUDOMONAS-AERUGINOSA; RAT FEMUR; MOUSE MODEL; SILVER NANOPARTICLES;
   CONTROLLED-RELEASE; ANTIBIOTIC-RESISTANCE
AB Bone fractures and non-union defects often require surgical intervention where biomaterials are used to correct the defect, and approximately 10% of these procedures are compromised by bacterial infection. Currently, treatment options are limited to sustained, high doses of antibiotics and surgical debridement of affected tissue, leaving a significant, unmet need for the development of therapies to combat device-associated biofilm and infections. Engineering implants to prevent infection is a desirable material characteristic. Tissue engineered scaffolds for bone repair provide a means to both regenerate bone and serve as a base for adding antimicrobial agents. Incorporating anti-infection properties into regenerative medicine therapies could improve clinical outcomes and reduce the morbidity and mortality associated with biomaterial implant-associated infections. This review focuses on current animal models and technologies available to assess bone repair in the context of infection, antimicrobial agents to fight infection, the current state of antimicrobial scaffolds, and future directions in the field.
C1 [Johnson, Christopher T.; Garcia, Andres J.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Johnson, Christopher T.] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Johnson, Christopher T.] Emory Univ, Atlanta, GA 30322 USA.
   [Johnson, Christopher T.] Emory Univ, Sch Med, Atlanta, GA USA.
   [Garcia, Andres J.] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
FU National Institutes of Health [R01 AR062920, R01 AR062368]
FX The authors gratefully acknowledge funding from the National Institutes
   of Health (R01 AR062920, R01 AR062368).
CR Adams CS, 2009, J ORTHOP RES, V27, P701, DOI 10.1002/jor.20815
   Afacan NJ, 2012, CURR PHARM DESIGN, V18, P807, DOI 10.2174/138161212799277617
   Alarcon EI, 2012, BIOMATERIALS, V33, P4947, DOI 10.1016/j.biomaterials.2012.03.033
   Alemayehu D, 2012, MBIO, V3, DOI 10.1128/mBio.00029-12
   AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w
   Beattie M, 2011, J CLIN NURS, V20, P2098, DOI 10.1111/j.1365-2702.2010.03561.x
   Bhattacharyya S, 2014, BIOMATERIALS, V35, P509, DOI 10.1016/j.biomaterials.2013.09.073
   Bi L, 2007, J BIOMED MATER RES B, V82B, P418, DOI 10.1002/jbm.b.30747
   Bjarnsholt T, 2013, NAT REV DRUG DISCOV, V12, P791, DOI 10.1038/nrd4000
   Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256
   Brogden NK, 2011, INT J ANTIMICROB AG, V38, P217, DOI 10.1016/j.ijantimicag.2011.05.004
   Brouwer CPJM, 2008, MINI-REV MED CHEM, V8, P1039, DOI 10.2174/138955708785740670
   Bruttin A, 2005, ANTIMICROB AGENTS CH, V49, P2874, DOI 10.1128/AAC.49.7.2874-2878.2005
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Chatzistavrou X, 2014, ACTA BIOMATER, V10, P3723, DOI 10.1016/j.actbio.2014.04.030
   Chen XQ, 2007, J ORTHOP TRAUMA, V21, P693, DOI 10.1097/BOT.0b013e31815a7e91
   Chen XQ, 2006, J BONE JOINT SURG AM, V88A, P1510, DOI 10.2106/JBJS.E.01136
   Chen XQ, 2005, J ORTHOP RES, V23, P816, DOI 10.1016/j.orthres.2005.01.009
   Chen XQ, 2002, J ORTHOPAED RES, V20, P142, DOI 10.1016/S0736-0266(01)00060-2
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Cui X, 2014, J MATER SCI-MATER M, V25, P733, DOI 10.1007/s10856-013-5122-z
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   Dinjaski N, 2014, ACTA BIOMATER, V10, P2935, DOI 10.1016/j.actbio.2014.03.005
   Doty HA, 2014, J MATER SCI-MATER M, V25, P1449, DOI 10.1007/s10856-014-5167-7
   Driffield K, 2008, J ANTIMICROB CHEMOTH, V61, P1053, DOI 10.1093/jac/dkn044
   Eggleston H, 2014, INFORMATICS-BASEL, V1, P72, DOI 10.3390/informatics1010072
   Engelsman AF, 2009, J BIOMED MATER RES B, V88B, P123, DOI 10.1002/jbm.b.31158
   Feng K, 2010, J CONTROL RELEASE, V146, P363, DOI 10.1016/j.jconrel.2010.05.035
   Fridkin SK, 2001, CRIT CARE MED, V29, pN64, DOI 10.1097/00003246-200104001-00002
   Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09
   Funao H, 2012, INFECT IMMUN, V80, P733, DOI 10.1128/IAI.06166-11
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Guelcher SA, 2011, J ORTHOP TRAUMA, V25, P477, DOI 10.1097/BOT.0b013e31821f624c
   Hanlon GW, 2007, INT J ANTIMICROB AG, V30, P118, DOI 10.1016/j.ijantimicag.2007.02.006
   Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]
   Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912
   Horst SA, 2012, AM J PATHOL, V181, P1206, DOI 10.1016/j.ajpath.2012.07.005
   Huang D, 2011, J BIOMAT SCI-POLYM E, V22, P931, DOI 10.1163/092050610X496576
   Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039
   Izadpanah A, 2005, J AM ACAD DERMATOL, V52, P381, DOI 10.1016/j.jaad.2004.08.026
   Jia WT, 2010, INT J PHARMACEUT, V387, P184, DOI 10.1016/j.ijpharm.2009.12.002
   Journeaux SF, 1999, J ARTHROPLASTY, V14, P677, DOI 10.1016/S0883-5403(99)90222-X
   Kadurugamuwa JL, 2003, ANTIMICROB AGENTS CH, V47, P3130, DOI 10.1128/AAC.47.10.3130-3137.2003
   Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003
   Kalghatgi S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006055
   Kanellakopoulou K, 2009, INT J ANTIMICROB AG, V33, P354, DOI 10.1016/j.ijantimicag.2008.09.008
   Kaur S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090411
   Kollef MH, 2008, JAMA-J AM MED ASSOC, V300, P805, DOI 10.1001/jama.300.7.805
   Kuijer R, 2007, BIOMATERIALS, V28, P5148, DOI 10.1016/j.biomaterials.2007.06.003
   Lazzarini L, 2004, J BONE JOINT SURG AM, V86A, P2305, DOI 10.2106/00004623-200410000-00028
   Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5
   Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001
   Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306
   Li B, 2010, J CONTROL RELEASE, V145, P221, DOI 10.1016/j.jconrel.2010.04.002
   LORD CF, 1988, J BONE JOINT SURG AM, V70A, P369, DOI 10.2106/00004623-198870030-00008
   Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104
   Lu TK, 2011, CURR OPIN MICROBIOL, V14, P524, DOI 10.1016/j.mib.2011.07.028
   Ma HY, 2013, J CONTROL RELEASE, V172, P1035, DOI 10.1016/j.jconrel.2013.10.005
   Macia MD, 2011, ANTIMICROB AGENTS CH, V55, P5230, DOI 10.1128/AAC.00617-11
   Mandal A, 2012, COLLOID SURFACE B, V90, P191, DOI 10.1016/j.colsurfb.2011.10.021
   Mankin HJ, 2005, CLIN ORTHOP RELAT R, P210, DOI 10.1097/01.blo.0000150371.77314.52
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   Meurice E, 2012, J MATER SCI-MATER M, V23, P2445, DOI 10.1007/s10856-012-4711-6
   Mills LA, 2012, J BONE JOINT SURG BR, V94B, P865, DOI 10.1302/0301-620X.94B7.27370
   Morello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016963
   Nijnik A, 2009, Emerg Health Threats J, V2, pe1, DOI 10.3134/ehtj.09.001
   O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110
   Penn-Barwell JG, 2014, BONE JOINT RES, V3, P187, DOI 10.1302/2046-3758.36.2000293
   Pierce GE, 2005, J IND MICROBIOL BIOT, V32, P309, DOI 10.1007/s10295-005-0225-2
   Rahaman MN, 2014, MAT SCI ENG C-MATER, V41, P224, DOI 10.1016/j.msec.2014.04.055
   Ramage G, 2003, BIOMATERIALS, V24, P3221, DOI 10.1016/S0142-9612(03)00173-X
   Reizner W, 2014, EUR CELLS MATER, V27, P196, DOI 10.22203/eCM.v027a15
   Rhoads D D, 2009, J Wound Care, V18, P237
   Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276
   Ruckh TT, 2012, J MATER SCI-MATER M, V23, P1411, DOI 10.1007/s10856-012-4609-3
   Ryan EM, 2012, FEMS IMMUNOL MED MIC, V65, P395, DOI 10.1111/j.1574-695X.2012.00977.x
   Sanchez CJ, 2013, BIOMATERIALS, V34, P7533, DOI 10.1016/j.biomaterials.2013.06.026
   Saravanan S, 2011, INT J BIOL MACROMOL, V49, P188, DOI 10.1016/j.ijbiomac.2011.04.010
   Schuch R, 2014, J INFECT DIS, V209, P1469, DOI 10.1093/infdis/jit637
   Shi XT, 2009, INT J PHARMACEUT, V373, P85, DOI 10.1016/j.ijpharm.2009.02.013
   Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0
   Sjollema J, 2010, BIOMATERIALS, V31, P1984, DOI 10.1016/j.biomaterials.2009.11.068
   Southwood LL, 2004, J ORTHOPAED RES, V22, P66, DOI 10.1016/S0736-0266(03)00129-3
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Storm-Versloot MN, 2010, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD006478.PUB.2
   Suri S., 2014, J BIOMED MAT RES A
   Thornes B, 2002, J BONE JOINT SURG BR, V84B, P758, DOI 10.1302/0301-620X.84B5.11907
   Trampuz A, 2006, INJURY, V37, P59, DOI 10.1016/j.injury.2006.04.010
   Trampuz A, 2006, CURR OPIN INFECT DIS, V19, P349, DOI 10.1097/01.qco.0000235161.85925.e8
   Trujillo NA, 2012, MAT SCI ENG C-MATER, V32, P2135, DOI 10.1016/j.msec.2012.05.012
   van Oosten M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3584
   Wang JP, 2011, ACS APPL MATER INTER, V3, P67, DOI 10.1021/am100862h
   Wang QC, 2013, ADV HEALTHC MATER, V2, P687, DOI 10.1002/adhm.201200306
   Wright A, 2009, CLIN OTOLARYNGOL, V34, P349, DOI 10.1111/j.1749-4486.2009.01973.x
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Xie ZP, 2009, J CONTROL RELEASE, V139, P118, DOI 10.1016/j.jconrel.2009.06.012
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Zheng Z, 2010, BIOMATERIALS, V31, P9293, DOI 10.1016/j.biomaterials.2010.08.041
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
NR 104
TC 9
Z9 9
U1 4
U2 35
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2015
VL 43
IS 3
BP 515
EP 528
DI 10.1007/s10439-014-1205-3
PG 14
WC Engineering, Biomedical
SC Engineering
GA CE3QF
UT WOS:000351742500004
PM 25476163
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Mauck, RL
   Burdick, JA
AF Mauck, Robert L.
   Burdick, Jason A.
TI From Repair to Regeneration: Biomaterials to Reprogram the Meniscus
   Wound Microenvironment
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Meniscus; Biomaterials; Wound healing; Regeneration; Scaffold;
   Extracellular matrix
ID STEM-CELL DIFFERENTIATION; NECROSIS-FACTOR-ALPHA; HUMAN KNEE-JOINT;
   IN-VITRO; NUCLEAR MECHANICS; HYALURONIC-ACID; SYNOVIAL-FLUID;
   3-DIMENSIONAL HYDROGELS; NANOFIBROUS SCAFFOLDS; PARTIAL MENISCECTOMY
AB When the field of tissue engineering first arose, scaffolds were conceived of as inert three-dimensional structures whose primary function was to support cellularity and tissue growth. Since then, advances in scaffold and biomaterial design have evolved to not only guide tissue formation, but also to interact dynamically with and manipulate the wound environment. At present, these efforts are being directed towards strategies that directly address limitations in endogenous wound repair, with the goal of reprogramming the local wound environment (and the cells within that locality) from a state that culminates in an inferior tissue repair into a state in which functional regeneration is achieved. This review will address this approach with a focus on recent advances in scaffold design towards the resolution of tears of the knee meniscus as a case example. The inherent limitations to endogenous repair will be discussed, as will specific examples of how biomaterials are being designed to overcome these limitations. Examples will include design of fibrous scaffolds that promote colonization by modulating local extracellular matrix density and delivering recruitment factors. Furthermore, we will discuss scaffolds that are themselves modulated by the wound environment to alter porosity and modulate therapeutic release through precise coordination of scaffold degradation. Finally, we will close with emerging concepts in local control of cell mechanics to improve interstitial cell migration and so advance repair. Overall, these examples will illustrate how emergent features within a biomaterial can be tuned to manipulate and harness the local tissue microenvironment in order to promote robust regeneration.
C1 [Mauck, Robert L.] Univ Penn, McKay Orthopaed Res Lab, Dept Orthopaed Surg, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Burdick, Jason A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
   [Mauck, Robert L.; Burdick, Jason A.] Philadelphia VA Med Ctr, Translat Musculoskeletal Res Ctr, Philadelphia, PA 19104 USA.
RP Mauck, RL (reprint author), Univ Penn, McKay Orthopaed Res Lab, Dept Orthopaed Surg, Perelman Sch Med, 424 Stemmler Hall,36th St & Hamilton Walk, Philadelphia, PA 19104 USA.
EM lemauck@mail.med.upenn.edu; burdick2@seas.upenn.edu
OI Mauck, Robert/0000-0002-9537-603X
FU National Institutes of Health [R01 EB008722, AR056624]; Department of
   Veterans Affairs [I01 RX000700, RX000174]
FX This work was supported with grants from the National Institutes of
   Health (R01 EB008722 and AR056624) and the Department of Veterans
   Affairs (I01 RX000700 and RX000174). The authors gratefully acknowledge
   Dr. Brendon Baker, Dr. Matt Fisher, Dr. Lara Ionescu, Dr. Iris Kim, Dr.
   Brendan Purcell, and Ms. Feini (Sylvia) Qu for their helpful input,
   graphical design, and in depth discussions on this topic.
CR Adams M. E., 1992, KNEE MENISCUS BASIC, P15
   AHMED AM, 1992, KNEE MENISCUS BASIC, P59
   Andrish J. T., 1996, J AM ACAD ORTHOP SUR, V4, P231
   ARNOCZKY SP, 1982, AM J SPORT MED, V10, P90, DOI 10.1177/036354658201000205
   Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032
   Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004
   Baker BM, 2011, TISSUE ENG PT A, V17, P1445, DOI [10.1089/ten.tea.2010.0535, 10.1089/ten.TEA.2010.0535]
   Baker BM, 2012, P NATL ACAD SCI USA, V109, P14176, DOI 10.1073/pnas.1206962109
   Baker BM, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3192140
   Barrett GR, 1998, ARTHROSCOPY, V14, P824, DOI 10.1016/S0749-8063(98)70018-0
   Bartova E, 2008, DIFFERENTIATION, V76, P24, DOI 10.1111/j.1432-0436.2007.00192.x
   Beredjiklian PK, 2003, ANN BIOMED ENG, V31, P1143, DOI 10.1114/1.1616931
   Bhattacharya D, 2009, BIOPHYS J, V96, P3832, DOI 10.1016/j.bpj.2008.11.075
   Booth-Gauthier EA, 2013, INTEGR BIOL-UK, V5, P569, DOI 10.1039/c3ib20231c
   Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046
   Bravenboer JV, 2004, ARTHRITIS RES THER, V6, pR469, DOI 10.1186/ar1216
   Burdick JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2271
   CLARK CR, 1983, J BONE JOINT SURG AM, V65, P538, DOI 10.2106/00004623-198365040-00018
   Connelly JT, 2008, J CELL PHYSIOL, V217, P145, DOI 10.1002/jcp.21484
   Dahl KN, 2005, BIOPHYS J, V89, P2855, DOI 10.1529/biophysj.105.062554
   Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989
   Dai M, 2010, AM J PATHOL, V177, P3089, DOI 10.2353/ajpath.2010.100340
   Day B, 1985, Arthroscopy, V1, P58, DOI 10.1016/S0749-8063(85)80080-3
   Dourte LM, 2008, J ORTHOP RES, V26, P1297, DOI 10.1002/jor.20646
   Doyle AD, 2013, CURR OPIN CELL BIOL, V25, P642, DOI 10.1016/j.ceb.2013.06.004
   Eckhouse SR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007244
   EGGLI S, 1995, AM J SPORT MED, V23, P715, DOI 10.1177/036354659502300614
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Favata M, 2006, J ORTHOP RES, V24, P2124, DOI 10.1002/jor.20271
   Fisher MB, 2013, ACTA BIOMATER, V9, P4496, DOI 10.1016/j.actbio.2012.10.018
   Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459
   Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015
   Fu Y, 2012, LAB CHIP, V12, P3774, DOI 10.1039/c2lc40477j
   Greiner AM, 2014, BIOMATERIALS, V35, P611, DOI 10.1016/j.biomaterials.2013.09.095
   Greis Patrick E, 2002, J Am Acad Orthop Surg, V10, P177
   Guilak F, 2000, BIOCHEM BIOPH RES CO, V269, P781, DOI 10.1006/bbrc.2000.2360
   Han WM, 2013, BIOPHYS J, V105, P807, DOI 10.1016/j.bpj.2013.06.023
   Harada T, 2014, J CELL BIOL, V204, P669, DOI 10.1083/jcb.201308029
   Hennerbichler A, 2007, OSTEOARTHR CARTILAGE, V15, P1053, DOI 10.1016/j.joca.2007.03.003
   Hennerbichler A., 2006, T ORS, V31, P1038
   Heo S. J., 2014, T ORTHOP RES SOC, V60, P457
   Heo S. J., 2014, T ORTHOP RES SOC, V60, P180
   Heo SJ, 2011, ANN BIOMED ENG, V39, P2780, DOI 10.1007/s10439-011-0365-7
   Ho CY, 2012, J CELL SCI, V125, P2087, DOI 10.1242/jcs.087288
   Ifkovits JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015717
   Imler SM, 2004, OSTEOARTHR CARTILAGE, V12, P736, DOI 10.1016/j.joca.2004.05.007
   Ionescu LC, 2011, TISSUE ENG PT A, V17, P193, DOI [10.1089/ten.tea.2010.0272, 10.1089/ten.TEA.2010.0272]
   Ionescu LC, 2013, TISSUE ENG PT A, V19, P538, DOI [10.1089/ten.tea.2012.0052, 10.1089/ten.TEA.2012.0052]
   Ionescu LC, 2010, BIOMATERIALS, V31, P4113, DOI 10.1016/j.biomaterials.2010.01.098
   Kambic HE, 2000, WOUND REPAIR REGEN, V8, P554, DOI 10.1046/j.1524-475x.2000.00554.x
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035
   Kim I. L., 2014, T SOC BIOM ANN M
   Kim IL, 2013, BIOMATERIALS, V34, P5571, DOI 10.1016/j.biomaterials.2013.04.004
   Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   Krause M, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/6/065002
   Krejci J, 2009, J CELL PHYSIOL, V219, P677, DOI 10.1002/jcp.21714
   Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670
   Lammerding Jan, 2005, V264, P264, DOI 10.1002/0470093765.ch18
   Lammerding J, 2011, COMPR PHYSIOL, V1, P783, DOI 10.1002/cphy.c100038
   Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200
   Lange JR, 2013, EXP CELL RES, V319, P2418, DOI 10.1016/j.yexcr.2013.04.023
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Li WJ, 2007, J BIOMECH, V40, P1686, DOI 10.1016/j.jbiomech.2006.09.004
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453
   Lohmander LS, 2005, ARTHRITIS RHEUM, V52, P3160, DOI 10.1002/art.21345
   Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037
   Martins RP, 2012, ANNU REV BIOMED ENG, V14, P431, DOI [10.1146/annurev-bioeng-071910-124638, 10.1146/annurev.bioeng-071910-124638]
   Masaeli M., 2013, MULTIPARAMETER HIGH, P383
   Mauck RL, 2009, TISSUE ENG PART B-RE, V15, P171, DOI [10.1089/ten.teb.2008.0652, 10.1089/ten.TEB.2008.0652]
   MCDEVITT CA, 1990, CLIN ORTHOP RELAT R, P8
   McNulty AL, 2010, OSTEOARTHR CARTILAGE, V18, P830, DOI 10.1016/j.joca.2010.02.009
   McNulty AL, 2008, BIORHEOLOGY, V45, P487, DOI 10.3233/BIR-2008-0489
   McNulty AL, 2007, ARTHRITIS RHEUM, V56, P3033, DOI 10.1002/art.22839
   Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017
   Mesiha M, 2007, AM J SPORT MED, V35, P103, DOI 10.1177/0363546506293700
   Metter RB, 2010, ACTA BIOMATER, V6, P1219, DOI 10.1016/j.actbio.2009.10.027
   Moretti M, 2005, J BIOMECH, V38, P1846, DOI 10.1016/j.jbiomech.2004.08.021
   Namba RS, 1998, J BONE JOINT SURG AM, V80A, P4, DOI 10.2106/00004623-199801000-00003
   Nathan AS, 2011, ACTA BIOMATER, V7, P57, DOI 10.1016/j.actbio.2010.08.007
   Natsu-Ume T, 2005, J ORTHOP SCI, V10, P396, DOI 10.1007/s00776-005-0912-x
   Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]
   Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104
   Petersen W, 1998, ANAT EMBRYOL, V197, P317, DOI 10.1007/s004290050141
   Petrosini AV, 1996, CLIN SPORT MED, V15, P445
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   PROCTOR CS, 1989, J ORTHOP RES, V7, P771, DOI 10.1002/jor.1100070602
   Provenzano PP, 2002, J ORTHOPAED RES, V20, P975, DOI 10.1016/S0736-0266(02)00036-0
   Purcell B. P., 2014, T 38 ANN M PION FUT, V38, P63
   Purcell BP, 2014, NAT MATER, V13, P653, DOI [10.1038/nmat3922, 10.1038/NMAT3922]
   Purcell BP, 2012, BIOMATERIALS, V33, P7849, DOI 10.1016/j.biomaterials.2012.07.005
   Qu F., 2014, MENISCAL SURGERY MAN, P89
   Qu FN, 2015, BIOMATERIALS, V39, P85, DOI 10.1016/j.biomaterials.2014.10.067
   Qu FN, 2013, ACTA BIOMATER, V9, P6393, DOI 10.1016/j.actbio.2013.01.016
   Rath E, 2000, BRIT J SPORT MED, V34, P252, DOI 10.1136/bjsm.34.4.252
   Rowat AC, 2008, BIOESSAYS, V30, P226, DOI 10.1002/bies.20720
   Rowat AC, 2013, J BIOL CHEM, V288, P8610, DOI 10.1074/jbc.M112.441535
   Scanzello CR, 2013, OSTEOARTHR CARTILAGE, V21, P1392, DOI 10.1016/j.joca.2013.05.011
   Scanzello CR, 2012, BONE, V51, P249, DOI 10.1016/j.bone.2012.02.012
   Scanzello CR, 2011, ARTHRITIS RHEUM-US, V63, P391, DOI 10.1002/art.30137
   Schmidt S, 2010, CELL TISSUE RES, V339, P83, DOI 10.1007/s00441-009-0892-9
   Shen WL, 2014, STEM CELL TRANSL MED, V3, P387, DOI 10.5966/sctm.2012-0170
   Shrive N G, 1978, Clin Orthop Relat Res, P279
   Sihvonen R, 2013, NEW ENGL J MED, V369, P2515, DOI 10.1056/NEJMoa1305189
   Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046
   Struglics A, 2006, OSTEOARTHR CARTILAGE, V14, P101, DOI 10.1016/j.joca.2005.07.018
   Struglics A, 2011, OSTEOARTHR CARTILAGE, V19, P1047, DOI 10.1016/j.joca.2011.05.006
   Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104
   Talwar S, 2013, BIOPHYS J, V104, P553, DOI 10.1016/j.bpj.2012.12.033
   Tchetverikov I, 2005, ANN RHEUM DIS, V64, P694, DOI 10.1136/ard.2004.022434
   TENUTA JJ, 1994, AM J SPORT MED, V22, P797, DOI 10.1177/036354659402200611
   Upton ML, 2006, CONNECT TISSUE RES, V47, P207, DOI 10.1080/03008200600846663
   Upton ML, 2003, J ORTHOPAED RES, V21, P963, DOI 10.1016/S0736-0266(03)00063-9
   Vanderhave KL, 2011, J PEDIATR ORTHOPED, V31, P496, DOI 10.1097/BPO.0b013e31821ffb8d
   Wade RJ, 2012, MATER TODAY, V15, P454, DOI 10.1016/S1369-7021(12)70197-9
   Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02
   Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152
   Wolf K, 2011, TRENDS CELL BIOL, V21, P736, DOI 10.1016/j.tcb.2011.09.006
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
   Zwerger M, 2013, HUM MOL GENET, V22, P2335, DOI 10.1093/hmg/ddt079
NR 122
TC 17
Z9 17
U1 1
U2 35
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2015
VL 43
IS 3
BP 529
EP 542
DI 10.1007/s10439-015-1249-z
PG 14
WC Engineering, Biomedical
SC Engineering
GA CE3QF
UT WOS:000351742500005
PM 25650096
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Allen, AB
   Priddy, LB
   Li, MTA
   Guldberg, RE
AF Allen, Ashley B.
   Priddy, Lauren B.
   Li, Mon-Tzu A.
   Guldberg, Robert E.
TI Functional Augmentation of Naturally-Derived Materials for Tissue
   Regeneration
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Naturally-derived; Natural polymer; Protein-based; Native extracellular
   matrix (ECM); Tissue regeneration; Augmentation; Structural;
   Biofunctional
ID MESENCHYMAL STEM-CELLS; GROWTH-FACTOR DELIVERY; DEMINERALIZED
   BONE-MATRIX; SMALL-INTESTINAL SUBMUCOSA; CONTROLLED SCAFFOLD
   DEGRADATION; MARROW STROMAL CELLS; EXTRACELLULAR-MATRIX; IN-VIVO;
   SUSTAINED DELIVERY; GENE DELIVERY
AB Tissue engineering strategies have utilized a wide spectrum of synthetic and naturally-derived scaffold materials. Synthetic scaffolds are better defined and offer the ability to precisely and reproducibly control their properties, while naturally-derived scaffolds typically have inherent biological and structural properties that may facilitate tissue growth and remodeling. More recently, efforts to design optimized biomaterial scaffolds have blurred the line between these two approaches. Naturally-derived scaffolds can be engineered through the manipulation of intrinsic properties of the pre-existing backbone (e.g., structural properties), as well as the addition of controllable functional components (e.g., biological properties). Chemical and physical processing techniques used to modify structural properties of synthetic scaffolds have been tailored and applied to naturally-derived materials. Such strategies include manipulation of mechanical properties, degradation, and porosity. Furthermore, biofunctional augmentation of natural scaffolds via incorporation of exogenous cells, proteins, peptides, or genes has been shown to enhance functional regeneration over endogenous response to the material itself. Moving forward, the regenerative mode of action of naturally-derived materials requires additional investigation. Elucidating such mechanisms will allow for the determination of critical design parameters to further enhance efficacy and capitalize on the full potential of naturally-derived scaffolds.
C1 [Allen, Ashley B.; Priddy, Lauren B.; Li, Mon-Tzu A.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Guldberg, Robert E.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
RP Guldberg, RE (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Parker H Petit Inst Bioengn & Biosci, 315 Ferst Dr NW, Atlanta, GA 30332 USA.
EM aallen37@gatech.edu; lbpriddy@gatech.edu; a.li@gatech.edu;
   robert.guldberg@me.gatech.edu
FU NIBIB NIH HHS [T32 EB006343]; NIGMS NIH HHS [T32 GM008433]
CR Adair-Kirk TL, 2003, J IMMUNOL, V171, P398, DOI 10.4049/jimmunol.171.1.398
   Allen AB, 2014, TISSUE ENG PART C-ME, V20, P806, DOI [10.1089/ten.TEC.2013.0587, 10.1089/ten.tec.2013.0587]
   Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   Andree B, 2013, TISSUE ENG PART B-RE, V19, P279, DOI [10.1089/ten.teb.2012.0583, 10.1089/ten.TEB.2012.0583]
   Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440
   Annabi N, 2010, BIOMATERIALS, V31, P1655, DOI 10.1016/j.biomaterials.2009.11.051
   Annabi N, 2009, BIOMATERIALS, V30, P1, DOI 10.1016/j.biomaterials.2008.09.031
   Bajaj P, 2014, ANNU REV BIOMED ENG, V16, P247, DOI 10.1146/annurev-bioeng-071813-105155
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Breitbart EA, 2010, J ORTHOP RES, V28, P942, DOI 10.1002/jor.21065
   Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Cai SS, 2005, BIOMATERIALS, V26, P6054, DOI 10.1016/j.biomaterials.2005.03.012
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Casettari L, 2012, BIOMATERIALS, V33, P7565, DOI 10.1016/j.biomaterials.2012.06.104
   Cavazzana-Calvo M, 2004, NATURE, V427, P779, DOI 10.1038/427779a
   Caves JM, 2011, BIOMATERIALS, V32, P5371, DOI 10.1016/j.biomaterials.2011.04.009
   Chan BK, 2012, MACROMOL BIOSCI, V12, P1490, DOI 10.1002/mabi.201200234
   Chen BS, 2011, INT J ARTIF ORGANS, V34, P1137, DOI 10.5301/ijao.5000069
   Chen LW, 2012, ORTHOPEDICS, V35, pE1402, DOI 10.3928/01477447-20120822-29
   Choi YJ, 2010, BIOMATERIALS, V31, P7226, DOI 10.1016/j.biomaterials.2010.05.022
   Chow LW, 2011, BIOMATERIALS, V32, P1574, DOI 10.1016/j.biomaterials.2010.10.048
   Collins C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4984
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   DePaoliLacerda S.H, 2005, BIOMATERIALS, V26, P7164
   Dewavrin JY, 2014, ACTA BIOMATER, V10, P4351, DOI 10.1016/j.actbio.2014.06.006
   El-Sharkawy H, 2007, J PERIODONTOL, V78, P661, DOI 10.1902/jop.2007.060302
   Elangovan S, 2014, BIOMATERIALS, V35, P737, DOI 10.1016/j.biomaterials.2013.10.021
   Engelhardt EM, 2011, BIOMATERIALS, V32, P3969, DOI 10.1016/j.biomaterials.2011.02.012
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erdbrugger W, 2006, TISSUE ENG, V12, P2059, DOI 10.1089/ten.2006.12.2059
   Evans CH, 2013, MAYO CLIN PROC, V88, P1323, DOI 10.1016/j.mayocp.2013.04.027
   Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Gao MY, 2013, BIOMATERIALS, V34, P1529, DOI 10.1016/j.biomaterials.2012.10.070
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Glover DJ, 2005, NAT REV GENET, V6, P299, DOI 10.1038/nrg1577
   Gu HJ, 2014, CELL TISSUE RES, V358, P453, DOI 10.1007/s00441-014-1952-3
   Guo HD, 2012, BIOCHEM BIOPH RES CO, V424, P105, DOI 10.1016/j.bbrc.2012.06.080
   Haghi AK, 2007, PHYS STATUS SOLIDI A, V204, P1830, DOI 10.1002/pssa.200675301
   Hahn SK, 2007, J BIOMED MATER RES A, V80A, P916, DOI 10.1002/jbm.a.30997
   Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035
   Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hettiaratchi MH, 2014, BIOMATERIALS, V35, P7228, DOI 10.1016/j.biomaterials.2014.05.011
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Hoffmann A, 2006, J CLIN INVEST, V116, P940, DOI 10.1172/JCI22689
   Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617
   Howes EL, 1929, NEW ENGL J MED, V200, P1285, DOI 10.1056/NEJM192906202002504
   Huang NF, 2009, REGEN MED, V4, P527, DOI [10.2217/rme.09.32, 10.2217/RME.09.32]
   Inzana JA, 2014, BIOMATERIALS, V35, P4026, DOI 10.1016/j.biomaterials.2014.01.064
   Ito H, 2005, NAT MED, V11, P291, DOI 10.1038/nm1190
   Jang YS, 2014, ACTA OTO-LARYNGOL, V134, P785, DOI 10.3109/00016489.2014.900702
   Jayasuriya AC, 2009, J MATER SCI-MATER M, V20, P1637, DOI 10.1007/s10856-009-3738-9
   Jeon O, 2014, ACTA BIOMATER, V10, P47, DOI 10.1016/j.actbio.2013.09.004
   Jeon O, 2011, J CONTROL RELEASE, V154, P258, DOI 10.1016/j.jconrel.2011.06.027
   Ji J, 2012, J MECH BEHAV BIOMED, V13, P185, DOI 10.1016/j.jmbbm.2012.04.016
   Jia HF, 2002, BIOTECHNOL PROGR, V18, P1027, DOI 10.1021/bp020042m
   Jiang T, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025012
   Johnson T. D., 2014, BIOMATER SCI, V2014
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kode JA, 2009, CYTOTHERAPY, V11, P377, DOI 10.1080/14653240903080367
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Koob TJ, 2013, INT WOUND J, V10, P493, DOI 10.1111/iwj.12140
   Krishna OD, 2010, BIOPOLYMERS, V94, P32, DOI 10.1002/bip.21333
   Kumar G, 2012, CYTOTHERAPY, V14, P494, DOI 10.3109/14653249.2011.651529
   Kurkalli BGS, 2010, CURR STEM CELL RES T, V5, P49, DOI 10.2174/157488810790442831
   Leach JB, 2005, ACTA BIOMATER, V1, P155, DOI 10.1016/j.actbio.2004.12.001
   Lee F, 2009, J CONTROL RELEASE, V134, P186, DOI 10.1016/j.jconrel.2008.11.028
   Lee HJ, 2014, ACS APPL MATER INTER, V6, P9338, DOI 10.1021/am501714k
   Li J, 2014, STEM CELL REV REP, V10, P79, DOI 10.1007/s12015-013-9478-8
   Lin KL, 2011, CERAM INT, V37, P2397, DOI 10.1016/j.ceramint.2011.03.079
   Liu ZN, 2014, INT J NANOMED, V9, P1275, DOI 10.2147/IJN.S58626
   Lu CH, 2013, BIOTECHNOL ADV, V31, P1695, DOI 10.1016/j.biotechadv.2013.08.015
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma FK, 2014, TISSUE ENG PT A, V20, P1253, DOI [10.1089/ten.TEA.2013.0158, 10.1089/ten.tea.2013.0158]
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Marelli B, 2011, BIOMATERIALS, V32, P8915, DOI 10.1016/j.biomaterials.2011.08.016
   Marshall AJ, 2005, AICHE J, V51, P1221, DOI 10.1002/aic.10390
   Martinez EC, 2013, STEM CELLS DEV, V22, P3087, DOI 10.1089/scd.2013.0119
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Mueller-Rath R, 2010, BIO-MED MATER ENG, V20, P317, DOI 10.3233/BME-2010-0645
   Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]
   Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   Park H, 2009, J BIOMED MATER RES A, V88A, P889, DOI 10.1002/jbm.a.31948
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   Pietrzak WS, 2006, J CRANIOFAC SURG, V17, P84, DOI 10.1097/01.scs.0000179745.91165.73
   Priddy LB, 2014, ACTA BIOMATER, V10, P4390, DOI 10.1016/j.actbio.2014.06.015
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h
   Renth AN, 2012, TISSUE ENG PART B-RE, V18, P341, DOI 10.1089/ten.teb.2012.0080
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Ruoslahti E, 2003, MATRIX BIOL, V22, P459, DOI 10.1016/S0945-053X(03)00083-0
   Schantz JT, 2003, TISSUE ENG, V9, pS127, DOI 10.1089/10763270360697030
   Schmidt C, 2014, J BIOMATER APPL, V28, P1408, DOI 10.1177/0885328213510331
   Schmoekel HG, 2005, BIOTECHNOL BIOENG, V89, P253, DOI 10.1002/bit.20168
   Schubert T, 2013, BIOMATERIALS, V34, P3279, DOI 10.1016/j.biomaterials.2013.01.057
   SENIOR RM, 1989, AM J RESP CELL MOL, V1, P479, DOI 10.1165/ajrcmb/1.6.479
   Sheyn D, 2010, TISSUE ENG PT A, V16, P3679, DOI [10.1089/ten.tea.2009.0786, 10.1089/ten.TEA.2009.0786]
   Shoichet MS, 1996, BIOTECHNOL BIOENG, V50, P374, DOI 10.1002/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I
   Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x
   Silva R, 2014, BIOMATERIALS, V35, P6727, DOI 10.1016/j.biomaterials.2014.04.078
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Stabenfeldt SE, 2012, BIOMATERIALS, V33, P535, DOI 10.1016/j.biomaterials.2011.09.079
   Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521
   Syedain ZH, 2008, P NATL ACAD SCI USA, V105, P6537, DOI 10.1073/pnas.0711217105
   Tejeda-Montes E, 2014, ACTA BIOMATER, V10, P134, DOI 10.1016/j.actbio.2013.09.001
   Thomas CB, 2011, J BIOMAT SCI-POLYM E, V22, P589, DOI 10.1163/092050610X488232
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   van Amerongen MJ, 2006, BIOMATERIALS, V27, P2247, DOI 10.1016/j.biomaterials.2005.11.002
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Wang L, 2014, ACTA CIR BRAS, V29, P252, DOI 10.1590/S0102-86502014000400006
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YF, 2013, J CONTROL RELEASE, V172, P1, DOI 10.1016/j.jconrel.2013.07.032
   Wegman F, 2013, BIOTECHNOL GENET ENG, V29, P206, DOI 10.1080/02648725.2013.801227
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012
   Wolf MT, 2012, BIOMATERIALS, V33, P2916, DOI 10.1016/j.biomaterials.2011.12.055
   Wust Silke, 2011, J Funct Biomater, V2, P119, DOI 10.3390/jfb2030119
   Yang HS, 2010, TISSUE ENG PT A, V16, P1225, DOI [10.1089/ten.tea.2009.0390, 10.1089/ten.TEA.2009.0390]
   Yang YM, 2007, J MATER SCI-MATER M, V18, P2117, DOI 10.1007/s10856-007-3013-x
   Yue TW, 2007, BIOMATERIALS, V28, P2350, DOI 10.1016/j.biomaterials.2007.01.035
   Yun YH, 2004, BIOMATERIALS, V25, P147, DOI 10.1016/S0142-9612(03)00467-8
   Zhang F, 2011, INT J BIOL MACROMOL, V48, P474, DOI 10.1016/j.ijbiomac.2011.01.012
   Zhong SP, 2005, BIOMACROMOLECULES, V6, P2998, DOI 10.1021/bm050318p
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zurita M, 2010, CYTOTHERAPY, V12, P522, DOI 10.3109/14653241003615164
NR 137
TC 9
Z9 9
U1 3
U2 17
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2015
VL 43
IS 3
BP 555
EP 567
DI 10.1007/s10439-014-1192-4
PG 13
WC Engineering, Biomedical
SC Engineering
GA CE3QF
UT WOS:000351742500007
PM 25422160
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Londono, R
   Badylak, SF
AF Londono, Ricardo
   Badylak, Stephen F.
TI Biologic Scaffolds for Regenerative Medicine: Mechanisms of In vivo
   Remodeling
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Extracellular matrix; Biomaterial; Tissue repair; Constructive
   remodeling; Macrophage response
ID SYSTEM EXTRACELLULAR-MATRIX; SMALL-INTESTINAL SUBMUCOSA; ESOPHAGEAL
   RECONSTRUCTION; HOST RESPONSE; MACROPHAGE ACTIVATION; CELL-MIGRATION;
   DERMAL MATRIX; GROWTH-FACTOR; DEGRADATION; COLLAGEN
AB Successful regenerative medicine strategies for functional tissue reconstruction include the in situ placement of acellular materials composed of the extracellular matrix (ECM) or individual components of the ECM. The composition and ultrastructure of these materials vary depending on multiple factors including the tissue source and species from which the materials are harvested, the methods of manufacture, the efficiency of decellularization, post-processing modifications such as chemical cross-linking or solubilization, and the methods of terminal sterilization. Appropriately configured materials have the ability to modulate different stages of the healing response by inducing a shift from a process of inflammation and scar tissue formation to one of constructive remodeling and functional tissue restoration. The events that facilitate such a dramatic change during the biomaterial-host interaction are complex and necessarily involve both the immune system and mechanisms of stem cell recruitment, growth, and differentiation. The present manuscript reviews the composition of biologic scaffolds, the methods and recommendations for manufacture, the mechanisms of the biomaterial-host interaction, and the clinical application of this regenerative medicine approach.
C1 [Londono, Ricardo; Badylak, Stephen F.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Londono, Ricardo] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15219 USA.
   [Badylak, Stephen F.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
RP Badylak, SF (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 450 Technol Dr,Suite 300, Pittsburgh, PA 15219 USA.
EM londonor@upmc.edu; badylaks@upmc.edu
OI Badylak, Stephen/0000-0003-3555-0689
CR Agrawal V, 2011, TISSUE ENG PT A, V17, P3033, DOI [10.1089/ten.tea.2011.0257, 10.1089/ten.TEA.2011.0257]
   Aller Maria-Angeles, 2014, World J Exp Med, V4, P16, DOI 10.5493/wjem.v4.i2.16
   Ambrosio F, 2010, PHYS THER, V90, P1807, DOI 10.2522/ptj.20100030
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Badylak SF, 2005, J SURG RES, V128, P87, DOI 10.1016/j.jss.2005.03.002
   Badylak SF, 2014, ANN BIOMED ENG, V42, P1517, DOI 10.1007/s10439-013-0963-7
   Badylak SF, 2011, TISSUE ENG PT A, V17, P1643, DOI 10.1089/ten.tea.2010.0739
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Baker SM, 2009, CALCIFIED TISSUE INT, V85, P66, DOI 10.1007/s00223-009-9248-4
   Birch Helen L, 2013, Muscles Ligaments Tendons J, V3, P12, DOI 10.11138/mltj/2013.3.1.012
   Bissell M J, 1987, Prog Clin Biol Res, V249, P251
   Brennan EP, 2006, TISSUE ENG, V12, P2949, DOI 10.1089/ten.2006.12.2949
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Butterfield JL, 2013, PLAST RECONSTR SURG, V131, P940, DOI 10.1097/PRS.0b013e3182865ab3
   Cao HST, 2010, AM SURGEON, V76, P1123
   Carey LE, 2014, BIOMATERIALS, V35, P8297, DOI 10.1016/j.biomaterials.2014.06.015
   Chattopadhyay S, 2014, BIOPOLYMERS, V101, P821, DOI 10.1002/bip.22486
   Chen M, 1997, J BIOL CHEM, V272, P14516, DOI 10.1074/jbc.272.23.14516
   CLARK RAF, 1988, J BIOL CHEM, V263, P12115
   Crapo PM, 2012, BIOMATERIALS, V33, P3539, DOI 10.1016/j.biomaterials.2012.01.044
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Daly KA, 2012, TISSUE ENG PT A, V18, P1293, DOI [10.1089/ten.tea.2011.0597, 10.1089/ten.TEA.2011.0597]
   Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1
   DiPietro LA, 2013, CURR OPIN RHEUMATOL, V25, P87, DOI 10.1097/BOR.0b013e32835b13b6
   Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225
   Gilbert TW, 2007, J BONE JOINT SURG AM, V89A, P621, DOI 10.2106/JBJS.F.00742
   Groulx JF, 2011, MATRIX BIOL, V30, P195, DOI 10.1016/j.matbio.2011.03.002
   Hodde J, 2002, BIOMATERIALS, V23, P1841, DOI 10.1016/S0142-9612(01)00310-6
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625
   Iozzo RV, 1996, FASEB J, V10, P598
   Johnson T. D., 2014, BIOMATER SCI, V2014
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Keane TJ, 2013, BIOMATERIALS, V34, P6729, DOI 10.1016/j.biomaterials.2013.05.052
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Kissane NA, 2012, PLAST RECONSTR SURG, V130, p194S, DOI 10.1097/PRS.0b013e318265a5ec
   Korpos E, 2010, CELL TISSUE RES, V339, P47, DOI 10.1007/s00441-009-0853-3
   Ladowski JM, 2011, ANN VASC SURG, V25, P646, DOI 10.1016/j.avsg.2010.11.008
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018
   Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062
   Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166
   Mills Stuart J, 2013, Cells, V2, P621, DOI 10.3390/cells2030621
   Mogford JE, 1996, CIRC RES, V79, P821, DOI 10.1161/01.RES.79.4.821
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921
   Nieponice A, 2014, ANN THORAC SURG, V97, P283, DOI 10.1016/j.athoracsur.2013.08.011
   Nieponice A, 2013, J SURG RES, V182, pE1, DOI 10.1016/j.jss.2012.09.029
   Ponce ML, 1999, CIRC RES, V84, P688, DOI 10.1161/01.RES.84.6.688
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   Reing JE, 2009, TISSUE ENG PT A, V15, P605, DOI 10.1089/ten.tea.2007.0425
   Ricard-Blum S, 2011, FRONT BIOSCI-LANDMRK, V16, P674, DOI 10.2741/3712
   Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048
   RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803
   Sarikaya A, 2002, TISSUE ENG, V8, P63, DOI 10.1089/107632702753503063
   Sawkins MJ, 2013, ACTA BIOMATER, V9, P7865, DOI 10.1016/j.actbio.2013.04.029
   Scholl FG, 2010, WORLD J PEDIATR CONG, V1, P132, DOI 10.1177/2150135110362092
   Schonherr E, 1998, ARCH BIOCHEM BIOPHYS, V355, P241, DOI 10.1006/abbi.1998.0720
   SCHONHERR E, 1995, J BIOL CHEM, V270, P8877, DOI 10.1074/jbc.270.15.8877
   Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Seiffert D, 1997, J BIOL CHEM, V272, P13705, DOI 10.1074/jbc.272.21.13705
   Sicari BM, 2012, BIOMATERIALS, V33, P5524, DOI 10.1016/j.biomaterials.2012.04.017
   SLACK SM, 1987, ANN NY ACAD SCI, V516, P223, DOI 10.1111/j.1749-6632.1987.tb33044.x
   Smaniotto S, 2010, BRAIN BEHAV IMMUN, V24, P451, DOI 10.1016/j.bbi.2009.11.014
   Soto-Gutierrez A, 2011, TISSUE ENG PART C-ME, V17, P677, DOI 10.1089/ten.tec.2010.0698
   Turner M. D., 2014, BIOCH BIOPHYS ACTA
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   VANDERREST M, 1991, FASEB J, V5, P2814
   Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007
   Wang J, 2014, ANN NY ACAD SCI, V1319, P66, DOI 10.1111/nyas.12445
   Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079
   Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051
   Wolf MT, 2012, BIOMATERIALS, V33, P2916, DOI 10.1016/j.biomaterials.2011.12.055
   YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0
   ZAMARRON C, 1990, THROMB HAEMOSTASIS, V64, P41
NR 79
TC 65
Z9 65
U1 8
U2 50
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2015
VL 43
IS 3
BP 577
EP 592
DI 10.1007/s10439-014-1103-8
PG 16
WC Engineering, Biomedical
SC Engineering
GA CE3QF
UT WOS:000351742500009
PM 25213186
DA 2018-10-19
ER

PT J
AU Walters, AA
   Krastev, C
   Hill, AVS
   Milicic, A
AF Walters, Adam A.
   Krastev, Christos
   Hill, Adrian V. S.
   Milicic, Anita
TI Next generation vaccines: single-dose encapsulated vaccines for improved
   global immunisation coverage and efficacy
SO JOURNAL OF PHARMACY AND PHARMACOLOGY
LA English
DT Review
DE Controlled release; microparticles
ID DOUBLE-WALLED MICROSPHERES; SHOT SUBUNIT VACCINE; CONTROLLED-RELEASE
   MICROPARTICLES; LOADED PLGA MICROSPHERES; DENDRITIC CELLS; BIODEGRADABLE
   MICROSPHERES; IN-VIVO; IMMUNE-RESPONSE; CROSS-PRESENTATION; DELIVERY
   SYSTEMS
AB ObjectivesVaccination is considered the most successful health intervention; yet incomplete immunisation coverage continues to risk outbreaks of vaccine preventable diseases worldwide. Vaccination coverage improvement through a single-dose prime-boost technology would revolutionise modern vaccinology, impacting on disease prevalence, significantly benefiting health care and lowering economic burden of disease.
   Key findingsOver the past 30 years, there have been efforts to develop a single-dose delayed release vaccine technology that could replace the repeated prime-boost immunisations required for many current vaccines. Biocompatible polymers have been employed to encapsulate model vaccines for delayed delivery in vivo, using either continuous or pulsed release. Biomaterial considerations, safety aspects, particle characteristics and immunological aspects of this approach are discussed in detail.
   SummaryDespite many studies showing the feasibility of vaccine encapsulation for single-dose prime-boost administration, none have been translated into convincing utility in animal models or human trials. Further development of the encapsulation technology, through optimising the particle composition, formulation, antigen loading efficacy and stability, could lead to the application of this important approach in vaccine deployment. If successful, this would provide a solution to better global vaccination coverage through a reduction in the number of immunisations needed to achieve protection against infectious diseases. This review provides an overview of single-dose vaccination in the context of today's vaccine needs and is derived from a body of literature that has not been reviewed for over a decade.
C1 [Walters, Adam A.; Krastev, Christos; Hill, Adrian V. S.; Milicic, Anita] Univ Oxford, Jenner Inst, ORCRB, Oxford OX3 7DQ, England.
RP Milicic, A (reprint author), Univ Oxford, Jenner Inst, ORCRB, Roosevelt Dr, Oxford OX3 7DQ, England.
EM anita.milicic@ndm.ox.ac.uk
FU Medical Research Council [MC_PC_13069]
CR AGUADO MT, 1992, IMMUNOBIOLOGY, V184, P113, DOI 10.1016/S0171-2985(11)80470-5
   AGUADO MT, 1993, VACCINE, V11, P596, DOI 10.1016/0264-410X(93)90241-O
   Allison SD, 2008, EXPERT OPIN DRUG DEL, V5, P615, DOI [10.1517/17425247.5.6.615 , 10.1517/17425240802157184]
   ALONSO MJ, 1994, VACCINE, V12, P299, DOI 10.1016/0264-410X(94)90092-2
   ALONSO MJ, 1993, PHARMACEUT RES, V10, P945, DOI 10.1023/A:1018942118148
   Arevshatian L, 2007, B WORLD HEALTH ORGAN, V85, P449, DOI 10.2471/BLT.06.031526
   ASANO M, 1993, BIOMATERIALS, V14, P797, DOI 10.1016/0142-9612(93)90047-6
   Bhatnagar A, 2009, ADV COLLOID INTERFAC, V152, P26, DOI 10.1016/j.cis.2009.09.003
   BLOOM BR, 1989, NATURE, V342, P115, DOI 10.1038/342115a0
   Boehm G, 2002, PHARMACEUT RES, V19, P1330, DOI 10.1023/A:1020354809581
   Cardamone M, 1997, J CONTROL RELEASE, V47, P205, DOI 10.1016/S0168-3659(97)01639-8
   Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y
   Chang CP, 2006, COLLOID SURFACE B, V50, P136, DOI 10.1016/j.colsurfb.2006.04.008
   Chang MW, 2010, LANGMUIR, V26, P5115, DOI 10.1021/la903592s
   Cleland JL, 1996, J PHARM SCI, V85, P1350, DOI 10.1021/js960329b
   Cleland JL, 1999, TRENDS BIOTECHNOL, V17, P25, DOI 10.1016/S0167-7799(98)01272-4
   Cleland JL, 1997, J CONTROL RELEASE, V47, P135, DOI 10.1016/S0168-3659(96)01625-2
   Cleland JL, 1998, J PHARM SCI, V87, P1489, DOI 10.1021/js980263f
   Cohen S, 1994, Int J Technol Assess Health Care, V10, P121
   Dang YB, 2011, CARBOHYD POLYM, V83, P1075, DOI 10.1016/j.carbpol.2010.08.071
   Demento SL, 2012, BIOMATERIALS, V33, P4957, DOI 10.1016/j.biomaterials.2012.03.041
   Dhiman N, 1998, FEMS IMMUNOL MED MIC, V21, P19
   Elamanchili P, 2004, VACCINE, V22, P2406, DOI 10.1016/j.vaccine.2003.12.032
   ELDRIDGE JH, 1991, INFECT IMMUN, V59, P2978
   Falagas ME, 2008, CURR MED RES OPIN, V24, P1719, DOI 10.1185/03007990802085692
   Favin M, 2012, INT HEALTH, V4, P229, DOI 10.1016/j.inhe.2012.07.004
   Feng L, 2006, J CONTROL RELEASE, V112, P35, DOI 10.1016/j.jconrel.2006.01.012
   Freeman P, 1994, Int J Technol Assess Health Care, V10, P1
   Gerelchuluun T, 2007, ARCH PHARM RES, V30, P1440, DOI 10.1007/BF02977369
   Guerin N, 1995, EUROSURVEILLANCE, P5
   Gupta RK, 1998, ADV DRUG DELIV REV, V32, P225
   Gust DA, 2008, PEDIATRICS, V122, P718, DOI 10.1542/peds.2007-0538
   Hirota K, 2007, J CONTROL RELEASE, V119, P69, DOI 10.1016/j.jconrel.2007.01.013
   Hu B, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40048
   Huntimer L, 2013, ADV HEALTHC MATER, V2, P369, DOI 10.1002/adhm.201200181
   Jain RA, 2000, J MICROENCAPSUL, V17, P343
   Jain S, 2011, EXPERT REV VACCINES, V10, P1731, DOI [10.1586/ERV.11.126, 10.1586/erv.11.126]
   Jiang WL, 2008, MOL PHARMACEUT, V5, P808, DOI 10.1021/mp800027f
   Johansen P, 2000, VACCINE, V19, P1047, DOI 10.1016/S0264-410X(00)00343-1
   Johansen P, 2000, TRENDS BIOTECHNOL, V18, P203, DOI 10.1016/S0167-7799(00)01437-2
   Kanchan V, 2009, BIOMATERIALS, V30, P4763, DOI 10.1016/j.biomaterials.2009.05.075
   Kang FR, 2003, INT J PHARM, V260, P149, DOI 10.1016/S0378-5173(03)00263-1
   Katare YK, 2003, DRUG DELIV, V10, P231, DOI 10.1080/10717540390235454
   Kersten GFA, 1996, VACCINE, V14, P1627, DOI 10.1016/S0264-410X(96)00145-4
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   Lee HJ, 1997, J PHARMACOL EXP THER, V281, P1431
   Lee TH, 2002, J CONTROL RELEASE, V83, P437, DOI 10.1016/S0168-3659(02)00235-3
   Lugade AA, 2013, NANOMED-NANOTECHNOL, V9, P923, DOI 10.1016/j.nano.2013.03.008
   Machluf M, 2000, WORLD J UROL, V18, P80, DOI 10.1007/s003450050014
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984
   Mao SR, 2007, INT J PHARM, V334, P137, DOI 10.1016/j.ijpharm.2006.10.036
   MEN Y, 1995, VACCINE, V13, P683
   Muscat M, 2014, CLIN MICROBIOL INFEC, V20, P12, DOI 10.1111/1469-0691.12584
   Mutua MK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-6
   O'Hagan Derek T, 2003, Expert Rev Vaccines, V2, P269, DOI 10.1586/14760584.2.2.269
   Obst R, 2007, P NATL ACAD SCI USA, V104, P15460, DOI 10.1073/pnas.0707331104
   OHAGAN DT, 1991, IMMUNOLOGY, V73, P239
   OKADA H, 1994, PHARMACEUT RES, V11, P1143, DOI 10.1023/A:1018936815654
   Okada H, 1997, ADV DRUG DELIVER REV, V28, P43, DOI 10.1016/S0169-409X(97)00050-1
   Okwo-Bele JM, 2011, VACCINE, V29, pD74, DOI 10.1016/j.vaccine.2012.01.080
   Oyewumi MO, 2010, EXPERT REV VACCINES, V9, P1095, DOI [10.1586/erv.10.89, 10.1586/ERV.10.89]
   Panos Ines, 2008, Curr Drug Discov Technol, V5, P333, DOI 10.2174/157016308786733528
   Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com
   Raghuvanshi RS, 2002, DRUG DELIV, V9, P113, DOI 10.1080/10426500290095557
   Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x
   Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155
   Sanchez A, 1996, J PHARM SCI, V85, P547, DOI 10.1021/js960069y
   Sanchez A, 1999, INT J PHARMACEUT, V185, P255, DOI 10.1016/S0378-5173(99)00178-7
   Sansdrap P, 1998, J MICROENCAPSUL, V15, P545, DOI 10.3109/02652049809008239
   Schliehe C, 2011, J IMMUNOL, V187, P2112, DOI 10.4049/jimmunol.1002084
   Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106
   Shen H, 2006, IMMUNOLOGY, V117, P78, DOI 10.1111/j.1365-2567.2005.02268.x
   Singh M, 1997, VACCINE, V15, P475, DOI 10.1016/S0264-410X(97)00225-9
   Singh M, 1998, VACCINE, V16, P346, DOI 10.1016/S0264-410X(97)80912-7
   Sinha VR, 2003, J CONTROL RELEASE, V90, P261, DOI 10.1016/S0168-3659(03)00194-9
   Slutter B, 2010, J CONTROL RELEASE, V148, P117, DOI 10.1016/j.jconrel.2010.06.009
   Smith J, 2004, PHARM RES, V21, P43, DOI 10.1023/B:PHAM.0000012150.60180.e3
   Sogias IA, 2008, BIOMACROMOLECULES, V9, P1837, DOI 10.1021/bm800276d
   Song XR, 2008, EUR J PHARM BIOPHARM, V69, P445, DOI 10.1016/j.ejpb.2008.01.013
   THAKKER Y, 1992, BRIT MED J, V304, P756, DOI 10.1136/bmj.304.6829.756
   Thomasin C, 1996, J CONTROL RELEASE, V41, P131, DOI 10.1016/0168-3659(96)01363-6
   Tran KK, 2009, BIOMATERIALS, V30, P1356, DOI 10.1016/j.biomaterials.2008.11.034
   van de Weert M, 2000, PHARMACEUT RES, V17, P1159, DOI 10.1023/A:1026498209874
   Visscher GE, 1987, BIOMATERIALS APPL, V2, P118
   Vogelhuber W, 2001, J CONTROL RELEASE, V73, P75, DOI 10.1016/S0168-3659(01)00282-6
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Xiang SD, 2006, METHODS, V40, P1, DOI 10.1016/j.ymeth.2006.05.016
   Xie SY, 2009, COLLOID SURFACE B, V74, P358, DOI 10.1016/j.colsurfb.2009.08.005
   Xu QX, 2012, J CONTROL RELEASE, V163, P130, DOI 10.1016/j.jconrel.2012.08.032
   Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107
   Zheng W, 2009, INT J PHARMACEUT, V374, P90, DOI 10.1016/j.ijpharm.2009.03.015
NR 92
TC 7
Z9 7
U1 1
U2 21
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3573
EI 2042-7158
J9 J PHARM PHARMACOL
JI J. Pharm. Pharmacol.
PD MAR
PY 2015
VL 67
IS 3
SI SI
BP 400
EP 408
DI 10.1111/jphp.12367
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CE4WZ
UT WOS:000351832300011
PM 25644530
OA Bronze
DA 2018-10-19
ER

PT J
AU Saqlain, F
   Popa, I
   Fernandez, JM
   Alegre-Cebollada, J
AF Saqlain, Farees
   Popa, Ionel
   Fernandez, Julio M.
   Alegre-Cebollada, Jorge
TI A Novel Strategy for Utilizing Voice Coil Servoactuators in Tensile
   Tests of Low Volume Protein Hydrogels
SO MACROMOLECULAR MATERIALS AND ENGINEERING
LA English
DT Article
DE hydrogels; muscle elasticity; protein biomaterial; tensile testing;
   tissue engineering; tissue mechanics; titin
ID MECHANICAL STABILITY; SINGLE PROTEIN; TITIN; BIOMATERIALS; DOMAINS;
   GIANT
AB We present a novel tensile testing system optimized for the mechanical, loading of microliter volume protein hydrogels. Our apparatus incorporates a voice coil servoactuator capable of carrying out fixed velocity extension-relaxation cycles as well as extension step protocols. The setup is equipped with a plastic cuvette permitting day-long incubations in solution. To demonstrate the functionality of the device, we photo-chemically crosslinked polyproteins of the 191 immunoglobulin domain from the muscle protein titin to create solid hydrogels that recapitulate elastic properties of muscle. We present data from tensile tests of these low volume biomaterials that support protein unfolding as a main determinant of the elasticity of protein hydrogels. Our results demonstrate the potential use of protein hydrogels as biomaterials whose elastic properties dynamically respond to their environment.
C1 [Saqlain, Farees; Popa, Ionel; Fernandez, Julio M.; Alegre-Cebollada, Jorge] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.
RP Alegre-Cebollada, J (reprint author), Ctr Nacl Invest Cardiovasc CNIC, Vasc Biol & Inflammat Dept, Madrid, Spain.
EM jfernandez@columbia.edu; jalegre@cnic.es
RI Popa, Ionel/P-4739-2016; Alegre-Cebollada, Jorge/I-4301-2014
OI Popa, Ionel/0000-0003-3111-4716; Alegre-Cebollada,
   Jorge/0000-0003-0542-0170
FU NIH [HL66030, HL61228]; NSF [1252857]; NIH K99 career development award
   [AI106072]; Columbia University Summer Undergraduate Research Fellowship
FX This work was supported by NIH grants HL66030, HL61228, and NSF grant
   1252857 to J.M.F. J.A.-C. was the recipient of an NIH K99 career
   development award (AI106072). F.S. acknowledges a Columbia University
   Summer Undergraduate Research Fellowship.
CR Ainavarapu RK, 2005, BIOPHYS J, V89, P3337, DOI 10.1529/biophysj.105.062034
   Alegre-Cebollada J, 2014, CELL, V156, P1235, DOI 10.1016/j.cell.2014.01.056
   Alegre-Cebollada J, 2011, NAT CHEM, V3, P882, DOI [10.1038/NCHEM.1155, 10.1038/nchem.1155]
   Cao Y, 2007, NAT MATER, V6, P109, DOI 10.1038/nmat1825
   Cao Y, 2011, BIOPHYS J, V100, P1794, DOI 10.1016/j.bpj.2011.02.030
   Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694
   Elvin CM, 2010, BIOMATERIALS, V31, P8323, DOI 10.1016/j.biomaterials.2010.07.032
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020
   Fang J, 2012, LANGMUIR, V28, P8260, DOI 10.1021/la301225w
   Helmes M, 1996, CIRC RES, V79, P619, DOI 10.1161/01.RES.79.3.619
   Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186
   LeWinter MM, 2010, CIRCULATION, V121, P2137, DOI 10.1161/CIRCULATIONAHA.109.860171
   Li HB, 2000, NAT STRUCT BIOL, V7, P1117
   Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00398
   Li HB, 2010, ACCOUNTS CHEM RES, V43, P1331, DOI 10.1021/ar100057a
   Linke WA, 2014, CIRC RES, V114, P1052, DOI 10.1161/CIRCRESAHA.114.301286
   Lv SS, 2013, ACTA BIOMATER, V9, P6481, DOI 10.1016/j.actbio.2013.01.002
   Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   WEISFOGH T, 1960, J EXP BIOL, V37, P889
   Xie YS, 1996, PROTEIN SCI, V5, P517
NR 22
TC 2
Z9 2
U1 4
U2 12
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1438-7492
EI 1439-2054
J9 MACROMOL MATER ENG
JI Macromol. Mater. Eng.
PD MAR
PY 2015
VL 300
IS 3
BP 369
EP 376
DI 10.1002/mame.201400271
PG 8
WC Materials Science, Multidisciplinary; Polymer Science
SC Materials Science; Polymer Science
GA CE2OD
UT WOS:000351654000012
PM 25960689
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Lee, H
   Hwang, YS
   Lee, HS
   Choi, S
   Kim, SY
   Moon, JH
   Kim, JH
   Kim, KC
   Han, DW
   Park, HJ
   Bae, H
AF Lee, Hanna
   Hwang, Yu-Shik
   Lee, Hyo-Seol
   Choi, Suji
   Kim, So Yeon
   Moon, Ji-Hoi
   Kim, Jae Hyung
   Kim, Kwang Chul
   Han, Dong-Wook
   Park, Hyun-Jin
   Bae, Hojae
TI Human hair keratin-based biofilm for potent application to periodontal
   tissue regeneration
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE human hair keratin; film; drug-eluting; periodontal tissue
ID CIRCULAR-DICHROISM; FEATHER KERATINS; BIOMATERIALS; EXTRACTION; RELEASE;
   SYSTEMS; FILMS
AB For the treatment of periodontitis, local delivery of antibiotics and their sustained release are preferable to enhance microbial susceptibility and to reduce possible side effects occurrence in systemic drug delivery. To address these issues, antibiotic loaded polymeric matrices implantable into periodontal pocket have been commercially used in dentistry and oral medicine. Recently, keratin has been drawing attention as a natural polymer for its ability to mediate cell behavior with minor or no immunogenicity enabling further process towards autologous implantation. In this study, human hair keratin was extracted with a cocktail of reducing agents, and antibiotic eluting keratin-based biofilms were fabricated. Physicochemical analysis and release test showed proper physical stability and sustained release of the loaded antibiotics. In addition, the released antibiotic suppressed the growth of various types of oral bacteria including porphyromonas gingivalis. Cellular interaction studies showed that human oral epithelial cell, human gingival fibroblast and periodontal ligament cells proliferated and guided well on biofilms. This study propose that antibiotic eluting keratin-based biofilms are provisional device for the treatment of chronic periodontitis offering advantages such as local controlled drug delivery and biocompatibility, and human hair keratin is able to be a good biomaterial for the potent applications to tissue engineering and regenerative medicine.
C1 [Lee, Hanna; Park, Hyun-Jin] Korea Univ, Dept Food Biochem & Engn, Seoul 136713, South Korea.
   [Hwang, Yu-Shik; Choi, Suji; Kim, So Yeon; Moon, Ji-Hoi; Kim, Kwang Chul] Kyung Hee Univ, Sch Dent, Dept Maxillofacial Biomed Engn, Seoul 130701, South Korea.
   [Hwang, Yu-Shik; Choi, Suji; Kim, So Yeon; Moon, Ji-Hoi; Kim, Kwang Chul] Kyung Hee Univ, Inst Oral Biol, Sch Dent, Seoul 130701, South Korea.
   [Lee, Hyo-Seol; Kim, Jae Hyung] Kyung Hee Univ, Sch Dent, Dept Pediat Dent, Seoul 130701, South Korea.
   [Han, Dong-Wook] Pusan Natl Univ, Dept Cognomechatron Engn, Pusan 609735, South Korea.
   [Bae, Hojae] Konkuk Univ, Dept Bioind Technol, Coll Anim Biosci & Technol, Seoul 143701, South Korea.
RP Bae, H (reprint author), Konkuk Univ, Dept Bioind Technol, Coll Anim Biosci & Technol, Seoul 143701, South Korea.
EM hojaebae@konkuk.ac.kr
RI Park, Hyun Jin/I-4942-2015
OI Han, Dong-Wook/0000-0001-8314-1981
FU Basic Research Program through the National Research Foundation of Korea
   (NRF) - Korea government (MEST) Republic of Korea [NRF-2013R1A1A2009706,
   2012R1A2A2A02010181, 2012R1A5A2051387]
FX This research was supported by grants NRF-2013R1A1A2009706,
   2012R1A2A2A02010181 and 2012R1A5A2051387 from the Basic Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Korea government (MEST) Republic of Korea.
CR Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202
   HEID HW, 1988, DIFFERENTIATION, V37, P137, DOI 10.1111/j.1432-0436.1988.tb00805.x
   HOLZWARTH G, 1965, J AM CHEM SOC, V87, P218, DOI 10.1021/ja01080a015
   Ikkai F, 2002, BIOMACROMOLECULES, V3, P482, DOI 10.1021/bm010160i
   Langbein L, 2010, J INVEST DERMATOL, V130, P55, DOI 10.1038/jid.2009.192
   Lee H, 2014, TISSUE ENG REGEN MED, V11, P255, DOI 10.1007/s13770-014-0029-4
   Lusiana, 2011, EUR J PHARM BIOPHARM, V78, P432, DOI 10.1016/j.ejpb.2011.01.022
   Nakamura A, 2002, BIOL PHARM BULL, V25, P569, DOI 10.1248/bpb.25.569
   *NAT COMM CLIN LAB, 2003, PERF STAND ANT DISK
   Paswan S., 2012, THESIS
   Reichl S, 2011, BIOMATERIALS, V32, P3375, DOI 10.1016/j.biomaterials.2011.01.052
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   Richter JR, 2011, BIOMATERIALS, V32, P7555, DOI 10.1016/j.biomaterials.2011.06.061
   Saul JM, 2011, J BIOMED MATER RES A, V98A, P544, DOI 10.1002/jbm.a.33147
   Schrooyen PMM, 2000, J AGR FOOD CHEM, V48, P4326, DOI 10.1021/jf9913155
   SIEGLE RJ, 1984, ARCH DERMATOL, V120, P183, DOI 10.1001/archderm.120.2.183
   Smith AW, 2005, ADV DRUG DELIVER REV, V57, P1539, DOI 10.1016/j.addr.2005.04.007
   Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Windoffer R, 2011, J CELL BIOL, V194, P669, DOI 10.1083/jcb.201008095
   Yamauchi C, 2008, BIOL PHARM BULL, V31, P994, DOI 10.1248/bpb.31.994
   Yin XC, 2013, BIOMATER SCI-UK, V1, P528, DOI 10.1039/c3bm00158j
NR 25
TC 4
Z9 4
U1 0
U2 42
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1598-5032
EI 2092-7673
J9 MACROMOL RES
JI Macromol. Res.
PD MAR
PY 2015
VL 23
IS 3
BP 300
EP 308
DI 10.1007/s13233-015-3036-y
PG 9
WC Polymer Science
SC Polymer Science
GA CE5KB
UT WOS:000351870800011
DA 2018-10-19
ER

PT J
AU Beltran-Partida, E
   Moreno-Ulloa, A
   Valdez-Salas, B
   Velasquillo, C
   Carrillo, M
   Escamilla, A
   Valdez, E
   Villarreal, F
AF Beltran-Partida, Ernesto
   Moreno-Ulloa, Aldo
   Valdez-Salas, Benjamin
   Velasquillo, Cristina
   Carrillo, Monica
   Escamilla, Alan
   Valdez, Ernesto
   Villarreal, Francisco
TI Improved Osteoblast and Chondrocyte Adhesion and Viability by
   Surface-Modified Ti6Al4V Alloy with Anodized TiO2 Nanotubes Using a
   Super-Oxidative Solution
SO MATERIALS
LA English
DT Article
ID OSTEOGENIC GENE-EXPRESSION; TITANIUM-ALLOY; HYDROXYAPATITE GROWTH; CELL
   RESPONSE; BIOACTIVITY; TI-6AL-4V; IMPLANTS; COATINGS; BIOCOMPATIBILITY;
   FABRICATION
AB Titanium (Ti) and its alloys are amongst the most commonly-used biomaterials in orthopedic and dental applications. The Ti-aluminum-vanadium alloy (Ti6Al4V) is widely used as a biomaterial for these applications by virtue of its favorable properties, such as high tensile strength, good biocompatibility and excellent corrosion resistance. TiO2 nanotube (NTs) layers formed by anodization on Ti6Al4V alloy have been shown to improve osteoblast adhesion and function when compared to non-anodized material. In his study, NTs were grown on a Ti6Al4V alloy by anodic oxidation for 5 min using a super-oxidative aqueous solution, and their in vitro biocompatibility was investigated in pig periosteal osteoblasts and cartilage chondrocytes. Scanning electron microscopy (SEM), energy dispersion X-ray analysis (EDX) and atomic force microscopy (AFM) were used to characterize the materials. Cell morphology was analyzed by SEM and AFM. Cell viability was examined by fluorescence microscopy. Cell adhesion was evaluated by nuclei staining and cell number quantification by fluorescence microscopy. The average diameter of the NTs was 80 nm. The results demonstrate improved cell adhesion and viability at Day 1 and Day 3 of cell growth on the nanostructured material as compared to the non-anodized alloy. In conclusion, this study evidences the suitability of NTs grown on Ti6Al4V alloy using a super-oxidative water and a short anodization process to enhance the adhesion and viability of osteoblasts and chondrocytes. The results warrant further investigation for its use as medical implant materials.
C1 [Beltran-Partida, Ernesto] Univ Autonoma Baja California, Fac Odontol Mexicali, Mexicali 21040, Baja California, Mexico.
   [Beltran-Partida, Ernesto; Valdez-Salas, Benjamin; Carrillo, Monica; Escamilla, Alan] Univ Autonoma Baja California, Inst Ingn, Mexicali 21280, Baja California, Mexico.
   [Beltran-Partida, Ernesto; Moreno-Ulloa, Aldo; Villarreal, Francisco] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.
   [Beltran-Partida, Ernesto; Velasquillo, Cristina] Inst Nacl Rehabil, Mexico City 14389, DF, Mexico.
   [Moreno-Ulloa, Aldo] Inst Politecn Nacl, Escuela Super Med, Secc Estudios Posgrad Invest, Mexico City 11340, DF, Mexico.
   [Valdez, Ernesto] Ctr Med Ixchel Bravo & Obregon, Mexicali 21000, Baja California, Mexico.
RP Valdez-Salas, B (reprint author), Univ Autonoma Baja California, Inst Ingn, Mexicali 21280, Baja California, Mexico.
EM beltrane@uabc.edu.mx; aldiux_1@yahoo.com.mx; benval@uabc.edu.mx;
   mvelasquillo@ciencias.unam.mx; monica@uabc.edu.mx;
   alan.escamilla@uabc.edu.mx; ixchelcentromedico@hotmail.com;
   fvillarr@ucsd.edu
RI Moreno Ulloa, Aldo/K-6128-2015
OI Moreno Ulloa, Aldo/0000-0001-7973-4215
FU Consejo Nacional de Ciencia y Tecnologia [CONACYT-CVU 348737, 114359]
FX This work was supported by Consejo Nacional de Ciencia y Tecnologia
   (CONACYT-CVU 348737, 114359) for a PhD scholarship. The authors would
   like to thank Julieta Garcia (Instituto Nacional de Rehabilitacion,
   Unidad de Ingenieria de Tejidos, Terapia Celular y Medicina
   Regenerativa) for her technical support.
CR Adams SL, 2007, J CELL PHYSIOL, V213, P635, DOI 10.1002/jcp.21262
   Advincula MC, 2007, J BIOMED MATER RES B, V80B, P107, DOI 10.1002/jbm.b.30575
   Altmann B, 2014, BIOMATERIALS, V35, P3208, DOI 10.1016/j.biomaterials.2013.12.088
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Balasundaram G, 2006, J MATER CHEM, V16, P3737, DOI 10.1039/b604966b
   Blau A, 2013, CURR OPIN COLLOID IN, V18, P481, DOI 10.1016/j.cocis.2013.07.005
   Brammer KS, 2012, TRENDS BIOTECHNOL, V30, P315, DOI 10.1016/j.tibtech.2012.02.005
   Brammer KS, 2010, MAT SCI ENG C-MATER, V30, P518, DOI 10.1016/j.msec.2010.01.013
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Burns K, 2009, J BIOMED MATER RES A, V88A, P561, DOI 10.1002/jbm.a.31899
   Cao X, 2012, J MATER SCI-MATER M, V23, P527, DOI 10.1007/s10856-011-4479-0
   Chen ZX, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/6/065003
   Chiapasco Matteo, 2003, Clin Implant Dent Relat Res, V5, P29, DOI 10.1111/j.1708-8208.2003.tb00179.x
   Christenson EM, 2007, J ORTHOP RES, V25, P11, DOI 10.1002/jor.20305
   Das K, 2009, J BIOMED MATER RES A, V90A, P225, DOI 10.1002/jbm.a.32088
   Faix J, 2009, INT J BIOCHEM CELL B, V41, P1656, DOI 10.1016/j.biocel.2009.02.012
   Frandsen CJ, 2014, MAT SCI ENG C-MATER, V37, P332, DOI 10.1016/j.msec.2014.01.014
   Gao Y, 2009, APPL SURF SCI, V255, P5009, DOI 10.1016/j.apsusc.2008.12.054
   Giordano C, 2011, COLLOID SURFACE B, V88, P648, DOI 10.1016/j.colsurfb.2011.07.054
   Gonzalez-Espinosa Diana, 2007, Int Wound J, V4, P241, DOI 10.1111/j.1742-481X.2007.00331.x
   Grenier S., 2014, J BIOMECH, V48, P122, DOI [10.1016/j.jbiomech.2014.10.02325468298, DOI 10.1016/J.JBIOMECH.2014.10.02325468298]
   Hao YQ, 2013, APPL SURF SCI, V268, P44, DOI 10.1016/j.apsusc.2012.11.142
   Hong Y, 2013, BIOMATERIALS, V34, P11, DOI 10.1016/j.biomaterials.2012.09.043
   Junker R, 2009, CLIN ORAL IMPLAN RES, V20, P185, DOI 10.1111/j.1600-0501.2009.01777.x
   Kim SY, 2014, APPL SURF SCI, V321, P412, DOI 10.1016/j.apsusc.2014.09.177
   Kim YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038242
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lee J. W., 2011, ANAL SCI, DOI [10.2116/analsci.27.36921233569, DOI 10.2116/ANALSCI.27.36921233569]
   Li BE, 2014, J MATER SCI-MATER M, V25, P199, DOI 10.1007/s10856-013-5064-5
   Liu HY, 2008, APPL SURF SCI, V254, P6305, DOI 10.1016/j.apsusc.2008.03.075
   Liu HN, 2010, INT J NANOMED, V5, P299
   Mellor H, 2010, BBA-MOL CELL RES, V1803, P191, DOI 10.1016/j.bbamcr.2008.12.018
   Mendez-Duran A., 2013, DIALISIS TRASPLANTE, V34, P160, DOI [10.1016/j.dialis.2013.05.006, DOI 10.1016/J.DIALIS.2013.05.006]
   Minagar S, 2013, J BIOMED MATER RES A, V101, P2726, DOI 10.1002/jbm.a.34575
   Mobasheri A, 2014, MATURITAS, V78, P188, DOI 10.1016/j.maturitas.2014.04.017
   Narayanan R, 2007, J MATER SCI-MATER M, V18, P779, DOI 10.1007/s10856-006-0007-z
   Narayanan R, 2011, MATER CHEM PHYS, V125, P510, DOI 10.1016/j.matchemphys.2010.10.024
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Qu D., 2014, ANN BIOMED ENG, DOI [10.1007/s10439-014-1190-6, DOI 10.1007/S10439-014-1190-6]
   Rosa AL, 2003, CLIN ORAL IMPLAN RES, V14, P43, DOI 10.1034/j.1600-0501.2003.140106.x
   Saharudin KA, 2013, J NANOSCI NANOTECHNO, V13, P1696, DOI 10.1166/jnn.2013.7115
   Sasagawa T, 2010, BIOMATERIALS, V31, P1646, DOI 10.1016/j.biomaterials.2009.11.036
   Smith BS, 2011, ACTA BIOMATER, V7, P2686, DOI 10.1016/j.actbio.2011.03.014
   Stan M. S., 2014, J BIOMED MATER RES A, V103, P48, DOI [10.1002/jbm.a.3514824639011, DOI 10.1002/JBM.A.3514824639011]
   Sun SJ, 2013, J MATER SCI-MATER M, V24, P1079, DOI 10.1007/s10856-013-4869-6
   Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902
   Swami N, 2011, J HEAT TRANS-T ASME, V133, DOI 10.1115/1.4002465
   Tan AW, 2014, APPL SURF SCI, V320, P161, DOI 10.1016/j.apsusc.2014.08.160
   Tan AW, 2014, CERAM INT, V40, P8301, DOI 10.1016/j.ceramint.2014.01.032
   Tan AW, 2012, CERAM INT, V38, P4421, DOI 10.1016/j.ceramint.2012.03.002
   Tavangar A, 2011, ACTA BIOMATER, V7, P2726, DOI 10.1016/j.actbio.2011.02.020
   Tsuchiya H, 2006, J BIOMED MATER RES A, V77A, P534, DOI 10.1002/jbm.a.30677
   Wang L, 2010, J NANOSCI NANOTECHNO, V10, P8312, DOI 10.1166/jnn.2010.3006
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   Yao C, 2008, J BIOMED MATER RES A, V85A, P157, DOI 10.1002/jbm.a.31551
   Zheng CY, 2011, APPL SURF SCI, V257, P9086, DOI 10.1016/j.apsusc.2011.05.105
NR 56
TC 11
Z9 11
U1 4
U2 38
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAR
PY 2015
VL 8
IS 3
BP 867
EP 883
DI 10.3390/ma8030867
PG 17
WC Materials Science, Multidisciplinary
SC Materials Science
GA CE6KN
UT WOS:000351945400003
PM 28787976
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Andorko, JI
   Hess, KL
   Jewell, CM
AF Andorko, James I.
   Hess, Krystina L.
   Jewell, Christopher M.
TI Harnessing Biomaterials to Engineer the Lymph Node Microenvironment for
   Immunity or Tolerance
SO AAPS JOURNAL
LA English
DT Review
DE autoimmunity and tolerance; biomaterials; immunology; nanoparticles and
   microparticles; vaccine
ID EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; REGULATORY T-CELLS;
   ANTIGEN-PRESENTING CELLS; GERMINAL CENTER B; DENDRITIC CELLS;
   INTRALYMPHATIC IMMUNOTHERAPY; MULTIPLE-SCLEROSIS; CONTROLLED-RELEASE;
   IN-VIVO; NANOPARTICLE VACCINES
AB Nanoparticles, microparticles, and other biomaterials are advantageous in vaccination because these materials provide opportunities to modulate specific characteristics of immune responses. This idea of "tuning" immune responses has recently been used to combat infectious diseases and cancer, and to induce tolerance during organ transplants or autoimmune disease. Lymph nodes and other secondary lymphoid organs such as the spleen play crucial roles in determining if and how these responses develop following vaccination or immunotherapy. Thus, by manipulating the local microenvironments within these immunological command centers, the nature of systemic immune response can be controlled. This review provides recent examples that harness the interactions between biomaterials and lymph nodes or other secondary lymphoid organs to generate immunity or promote tolerance. These strategies draw on mechanical properties, surface chemistry, stability, and targeting to alter the interactions of cells, signals, and vaccine components in lymph nodes. While there are still many unanswered questions surrounding how best to design biomaterial-based vaccines to promote specific structures or functions in lymph nodes, features such as controlled release and targeting will help pave the way for the next generation of vaccines and immunotherapies that generate immune responses tuned for specific applications.
C1 [Andorko, James I.; Hess, Krystina L.; Jewell, Christopher M.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Jewell, Christopher M.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.
   [Jewell, Christopher M.] Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD USA.
RP Jewell, CM (reprint author), Univ Maryland, Fischell Dept Bioengn, 2212 Jeong H Kim Engn Bldg, College Pk, MD 20742 USA.
EM cmjewell@umd.edu
FU NSF [1351688]; Pharmaceutics division of the PhRMA Foundation; Alex's
   Lemonade Stand "A" Award [27120]; Damon Runyon Foundation; Alliance for
   Cancer Gene Therapy; NIH [T32 AI089621]
FX This work was supported in part by NSF CAREER Award no. 1351688, the
   Pharmaceutics division of the PhRMA Foundation, and Alex's Lemonade
   Stand "A" Award no. 27120. CMJ is a Damon Runyon-Rachleff Innovator
   supported by the Damon Runyon Foundation, and is a Young Investigator
   supported by the Alliance for Cancer Gene Therapy. JIA is a trainee on
   NIH Grant no. T32 AI089621.
CR Abbas A, 2012, CELLULAR MOL IMMUNOL
   Adamina M, 2010, MOL THER, V18, P651, DOI 10.1038/mt.2009.275
   Akdis CA, 2012, NAT MED, V18, P736, DOI 10.1038/nm.2754
   Andorko JI, 2014, JOVE-J VIS EXP, DOI 10.3791/50984
   Azzi J, 2010, FASEB J, V24, P3927, DOI 10.1096/fj.10-154690
   Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868
   Berg CP, 2001, CELL DEATH DIFFER, V8, P1197, DOI 10.1038/sj.cdd.4400905
   Brito LA, 2014, J CONTROL RELEASE, V190, P563, DOI 10.1016/j.jconrel.2014.06.027
   Bryant J, 2014, BIOMATERIALS, V35, P8887, DOI 10.1016/j.biomaterials.2014.06.044
   Buyuktimkin B, 2012, MOL PHARMACEUT, V9, P979, DOI 10.1021/mp200614q
   Capini C, 2009, J IMMUNOL, V182, P3556, DOI 10.4049/jimmunol.0802972
   Card CM, 2014, J CLIN INVEST, V124, P943, DOI [10.1172/JC173316, 10.1172/JCI73316]
   Clemente-Casares X, 2014, IMMUNOL LETT, V158, P167, DOI 10.1016/j.imlet.2013.12.018
   Comabella M, 2012, CLIN IMMUNOL, V142, P2, DOI 10.1016/j.clim.2011.03.004
   Cubas R, 2009, J IMMUNOTHER, V32, P118, DOI 10.1097/CJI.0b013e31818f13c4
   Da Silva CA, 2009, J IMMUNOL, V182, P3573, DOI 10.4049/jimmunol.0802113
   de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154
   Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034
   Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330
   Foged C, 2005, INT J PHARM, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035
   Gallorini S, 2007, J IMMUNOL, V179, P8208, DOI 10.4049/jimmunol.179.12.8208
   Getts DR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007563
   Getts DR, 2012, NAT BIOTECHNOL, V30, P1217, DOI 10.1038/nbt.2434
   Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298
   Huang L, 2012, J IMMUNOL, V188, P4913, DOI 10.4049/jimmunol.1103668
   Hunter Z, 2014, ACS NANO, V8, P2148, DOI 10.1021/nn405033r
   Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]
   Irvine DJ, 2012, COMPREHENSIVE BIOMAT
   Jeanbart L, 2014, CANCER IMMUNOL RES, V2, P701
   Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108
   Jhunjhunwala S, 2012, ADV MATER, V24, P4735, DOI 10.1002/adma.201202513
   Jhunjhunwala S, 2012, J CONTROL RELEASE, V159, P78, DOI 10.1016/j.jconrel.2012.01.013
   Johansen P, 2005, EUR J IMMUNOL, V35, P568, DOI 10.1002/eji.200425599
   Johansen P, 2008, P NATL ACAD SCI USA, V105, P5189, DOI 10.1073/pnas.0706296105
   John ALS, 2012, NAT MATER, V11, P250, DOI 10.1038/NMAT3222
   Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737
   Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254
   Kaur R, 2012, J CONTROL RELEASE, V164, P331, DOI 10.1016/j.jconrel.2012.07.012
   Keijzer C, 2013, J CONTROL RELEASE, V168, P35, DOI 10.1016/j.jconrel.2013.02.027
   Keijzer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026684
   Kontos S, 2013, P NATL ACAD SCI USA, V110, pE60, DOI 10.1073/pnas.1216353110
   Kou PM, 2012, BIOMATERIALS, V33, P1699, DOI 10.1016/j.biomaterials.2011.10.066
   Kou PM, 2011, ACTA BIOMATER, V7, P1354, DOI 10.1016/j.actbio.2010.10.020
   Kwon YJ, 2005, P NATL ACAD SCI USA, V102, P18264, DOI 10.1073/pnas.0509541102
   Kwong B, 2011, BIOMATERIALS, V32, P5134, DOI 10.1016/j.biomaterials.2011.03.067
   Lewis JS, 2014, J MATER CHEM B, V2, P2562, DOI 10.1039/c3tb21460e
   Li AV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006516
   Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978
   Look M, 2013, J CLIN INVEST, V123, P1741, DOI 10.1172/JCI65907
   Lutterotti A, 2014, EXPERT OPIN INV DRUG, V23, P9, DOI 10.1517/13543784.2014.844788
   Mohanan D, 2010, J CONTROL RELEASE, V147, P342, DOI 10.1016/j.jconrel.2010.08.012
   Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109
   Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960
   Moyano DF, 2012, J AM CHEM SOC, V134, P3965, DOI 10.1021/ja2108905
   Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588
   Murphy K., 2012, JANEWAYS IMMUNOBIOLO
   Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019
   Nylander A, 2012, J CLIN INVEST, V122, P1180, DOI 10.1172/JCI58649
   Park J, 2011, MOL PHARMACEUT, V8, P143, DOI 10.1021/mp100203a
   Peine KJ, 2014, MOL PHARMACEUT, V11, P828, DOI 10.1021/mp4005172
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006
   Ribas A, 2011, CLIN CANCER RES, V17, P2987, DOI 10.1158/1078-0432.CCR-10-3272
   Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155
   Ruddle NH, 2009, J IMMUNOL, V183, P2205, DOI 10.4049/jimmunol.0804324
   Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272
   Senti G, 2012, J ALLERGY CLIN IMMUN, V129, P1290, DOI 10.1016/j.jaci.2012.02.026
   Senti G, 2009, CURR OPIN ALLERGY CL, V9, P537, DOI 10.1097/ACI.0b013e3283310ff7
   Senti G, 2008, P NATL ACAD SCI USA, V105, P17908, DOI 10.1073/pnas.0803725105
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106
   Shirali AC, 2011, AM J TRANSPLANT, V11, P2582, DOI 10.1111/j.1600-6143.2011.03725.x
   Smith KA, 2009, CLIN CANCER RES, V15, P6167, DOI 10.1158/1078-0432.CCR-09-0645
   Smith KA, 2009, VACCINE, V27, P2603, DOI 10.1016/j.vaccine.2009.02.038
   Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198
   Sunshine JC, 2014, BIOMATERIALS, V35, P269, DOI 10.1016/j.biomaterials.2013.09.050
   Swartz MA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003763
   Tang L., 2012, J TRANSPLANT, V2012, DOI DOI 10.1155/2012/896141
   Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858
   Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863
   Thomas SN, 2014, BIOMATERIALS, V35, P814, DOI 10.1016/j.biomaterials.2013.10.003
   Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015
   Turley SJ, 2010, NAT REV IMMUNOL, V10, P813, DOI 10.1038/nri2886
   van Broekhoven CL, 2004, CANCER RES, V64, P4357, DOI 10.1158/0008-5472.CAN-04-0138
   Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x
   Waeckerle-Men Y, 2013, VACCINE, V31, P1057, DOI 10.1016/j.vaccine.2012.12.034
   Warren KJ, 2014, J CLIN INVEST, V124, P2204, DOI 10.1172/JCI73683
   Witten M, 2013, J ALLERGY CLIN IMMUN, V132, P1248, DOI 10.1016/j.jaci.2013.07.033
   Yeste A, 2012, P NATL ACAD SCI USA, V109, P11270, DOI 10.1073/pnas.1120611109
   Zhang WF, 2014, PHARM RES-DORDR, V31, P1015, DOI 10.1007/s11095-013-1224-z
   Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586
NR 91
TC 30
Z9 32
U1 3
U2 39
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1550-7416
J9 AAPS J
JI AAPS J.
PD MAR
PY 2015
VL 17
IS 2
BP 323
EP 338
DI 10.1208/s12248-014-9708-2
PG 16
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CE0WM
UT WOS:000351530500007
PM 25533221
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Li, Y
   Wang, SW
   Huang, R
   Huang, Z
   Hu, BF
   Zheng, WF
   Yang, G
   Jiang, XY
AF Li, Ying
   Wang, Shiwen
   Huang, Rong
   Huang, Zhuo
   Hu, Binfeng
   Zheng, Wenfu
   Yang, Guang
   Jiang, Xingyu
TI Evaluation of the Effect of the Structure of Bacterial Cellulose on Full
   Thickness Skin Wound Repair on a Microfluidic Chip
SO BIOMACROMOLECULES
LA English
DT Article
ID MICROBIAL CELLULOSE; GOLD NANOPARTICLES; CELLS; BIOMATERIALS; SCAFFOLD;
   OXYGEN
AB Bacterial cellulose (BC) is a kind of nanobiomaterial for tissue engineering. How the nanoscale structure of BC affects skin wound repair is unexplored. Here, the hierarchical structure of BC films and their different effects on skin wound healing were studied both in vitro and in vivo. The bottom side of the BC film had a larger pore size, and a looser and rougher structure than that of the top side. By using a microfluidics-based in vitro wound healing model, we revealed that the bottom side of the BC film can better promote the migration of cells to facilitate wound healing. Furthermore, the full-thickness skin wounds on Wistar rats demonstrated that, compared with gauze and the top side of the BC film, the wound covered by the bottom side of the BC film showed faster recovery rate and less inflammatory response. The results indicate that the platform based on the microfluidic chip provide a rapid, reliable, and repeatable method for wound dressing screening. As an excellent biomaterial for wound healing, the BC film displays different properties on different sides, which not only provides a method to optimize the biocompatibility of wound dressings but also paves a new way to building heterogeneous BC-based biomaterials for complex tissue engineering.
C1 [Li, Ying; Yang, Guang] Huazhong Univ Sci & Technol, Dept Biomed Engn, Coll Life Sci & Technol, Natl Engn Res Ctr Nanomed, Wuhan 430074, Peoples R China.
   [Li, Ying; Wang, Shiwen; Huang, Rong; Huang, Zhuo; Hu, Binfeng; Zheng, Wenfu; Jiang, Xingyu] Natl Ctr NanoSci & Technol, Beijing Engn Res Ctr BioNanotechnol, CAS Key Lab Biol Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China.
   [Wang, Shiwen] Southwest Jiaotong Univ, Sch Mat Sci & Engn, Key Lab Adv Technol Mat, Minist Educ China, Chengdu 610031, Peoples R China.
RP Zheng, WF (reprint author), Natl Ctr NanoSci & Technol, Beijing Engn Res Ctr BioNanotechnol, CAS Key Lab Biol Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China.
EM zhengwf@nanoctr.cn; yang_sunny@yahoo.com; xingyujiang@nanoctr.cn
OI Jiang, Xingyu/0000-0002-5008-4703
FU Ministry of Science and Technology of China [2011CB933201,
   2012AA022703]; National Natural Science Foundation of China [21074041,
   31170905, 81361140345, 51373043]; Chinese Academy of Sciences
   [XDA09030305]; CAS/SAFEA International Partnership Program for Creative
   Research Teams
FX Financial support was provided by the Ministry of Science and Technology
   of China (2011CB933201, 2012AA022703), the National Natural Science
   Foundation of China (21074041, 31170905, 81361140345, 51373043), the
   Chinese Academy of Sciences (XDA09030305), and Research Supported by the
   CAS/SAFEA International Partnership Program for Creative Research Teams.
   The authors would like to acknowledge Professor Glyn. O. Phillips (the
   founder of the journal: Food Hydrocolloids, UK) for useful discussion.
CR Altmann B, 2013, TISSUE ENG PART C-ME, V19, P850, DOI [10.1089/ten.tec.2012.0695, 10.1089/ten.TEC.2012.0695]
   Atiyeh Bishara S., 2002, Current Pharmaceutical Biotechnology, V3, P179, DOI 10.2174/1389201023378283
   BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Bechtle M, 2010, CURR MED CHEM, V17, P42, DOI 10.2174/092986710789957814
   Chen ZL, 2009, ANGEW CHEM INT EDIT, V48, P8303, DOI 10.1002/anie.200902708
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Fu LN, 2012, J MATER CHEM, V22, P12349, DOI 10.1039/c2jm00134a
   Gao CA, 2011, J POROUS MAT, V18, P139, DOI 10.1007/s10934-010-9364-6
   Gil ES, 2013, ADV HEALTHC MATER, V2, P206, DOI 10.1002/adhm.201200192
   HERNDON DN, 1989, ANN SURG, V209, P547, DOI 10.1097/00000658-198905000-00006
   HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345
   HUNT TK, 1969, AM J SURG, V118, P521, DOI 10.1016/0002-9610(69)90174-3
   Jonas R, 1998, POLYM DEGRAD STABIL, V59, P101, DOI 10.1016/S0141-3910(97)00197-3
   Li Y., 2007, ANGEW CHEM, V119, P1112
   Li Y, 2014, CARBOHYD POLYM, V103, P496, DOI 10.1016/j.carbpol.2013.12.059
   Moreira S, 2009, TOXICOL LETT, V189, P235, DOI 10.1016/j.toxlet.2009.06.849
   Pertile RAN, 2012, J BIOMAT SCI-POLYM E, V23, P1339, DOI 10.1163/092050611X581516
   Sieminski AL, 2000, BIOMATERIALS, V21, P2233, DOI 10.1016/S0142-9612(00)00149-6
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Svensjo T, 2000, PLAST RECONSTR SURG, V106, P602, DOI 10.1097/00006534-200009030-00012
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   White RJ, 2006, OSTOMY WOUND MANAG, V52, P26
   Wu L, 2013, BIOMACROMOLECULES, V14, P1078, DOI 10.1021/bm3019664
   Xie YY, 2011, LAB CHIP, V11, P2819, DOI 10.1039/c0lc00562b
   Yang Y, 2011, BIOMATERIALS, V32, P4243, DOI 10.1016/j.biomaterials.2011.02.042
   Zahedi P, 2010, POLYM ADVAN TECHNOL, V21, P77, DOI 10.1002/pat.1625
   Zhao QL, 2012, ADV HEALTHC MATER, V1, P560, DOI 10.1002/adhm.201200008
   Zhao YY, 2014, ANGEW CHEM INT EDIT, V53, P8127, DOI 10.1002/anie.201401035
   Zhao YY, 2013, J AM CHEM SOC, V135, P12940, DOI 10.1021/ja4058635
   Zhao YY, 2010, J AM CHEM SOC, V132, P12349, DOI 10.1021/ja1028843
   Zheng WF, 2010, LAB CHIP, V10, P2906, DOI 10.1039/c005274d
NR 33
TC 35
Z9 37
U1 7
U2 108
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2015
VL 16
IS 3
BP 780
EP 789
DI 10.1021/bm501680s
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CD1NH
UT WOS:000350841100011
PM 25629225
DA 2018-10-19
ER

PT J
AU Kim, SE
   Harker, EC
   De Leon, AC
   Advincula, RC
   Pokorski, JK
AF Kim, Si-Eun
   Harker, Emily C.
   De Leon, Al C.
   Advincula, Rigoberto C.
   Pokorski, Jonathan K.
TI Coextruded, Aligned, and Gradient-Modified Poly(epsilon-caprolactone)
   Fibers as Platforms for Neural Growth
SO BIOMACROMOLECULES
LA English
DT Article
ID AZIDE-ALKYNE CYCLOADDITION; ELECTROSPUN NANOFIBERS; BIOMATERIAL
   SCAFFOLD; NERVE REGENERATION; PEPTIDE; LAMININ; PROTEIN; CELL; SURFACE;
   DIFFERENTIATION
AB Polymeric fibers are of increasing interest to regenerative medicine, as materials made from these fibers are porous, allowing for cell infiltration, influx of nutrients, and efflux of waste products. Recently, multilayered coextrusion has emerged as a scalable and rapid fabrication method to yield microscale to submicron fibers. In this report, we describe the multilayered coextrusion of aligned poly(epsilon-caprolactone) (PCL) fibers, followed by a simple photochemical patterning to create surface-immobilized gradients onto the polymer fibers. PCL fibers were photochemically decorated with a linear gradient of propargyl benzophenone using a gradient photomask to control light source intensity. The pendant alkynes were then able to undergo the copper-catalyzed azide-alkyne cycloaddition reaction with an azide-modified IKVAV peptide to further functionalize the surface. Gradient-modified IKVAV fibers were evaluated for neural cell adhesion and neural differentiation, using PC-12 cells cultured onto the fibers. The aligned gradient fibers provided directional cues for neurite outgrowth and alignment of neural cells, as observed by cellular elongation, neurite differentiation, and orientation. The work presented herein describes a scalable fiber system combined with simple chemical patterning to generate aligned fibers with controlled surface gradients as cell-seeding scaffolds.
C1 [Kim, Si-Eun; Harker, Emily C.; De Leon, Al C.; Advincula, Rigoberto C.; Pokorski, Jonathan K.] Case Western Reserve Univ, Dept Macromol Sci & Engn, Cleveland, OH 44106 USA.
RP Pokorski, JK (reprint author), Case Western Reserve Univ, Dept Macromol Sci & Engn, 2100 Adelbert Rd, Cleveland, OH 44106 USA.
EM jon.pokorski@case.edu
OI Pokorski, Jonathan/0000-0001-5869-6942
FU National Science Foundation (NSF) Center for Layered Polymeric Systems
   [DMR 0423914]; NIH Pathway to Independence Award [R00EB011530]
FX J.K.P. and R.C.A. acknowledge the National Science Foundation (NSF)
   Center for Layered Polymeric Systems for start-up funds (DMR 0423914)
   and generous use of the center's confocal microscope. J.K.P. also
   acknowledges a NIH Pathway to Independence Award for funding
   (R00EB011530).
CR Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075
   Callahan LAS, 2013, BIOMATERIALS, V34, P9089, DOI 10.1016/j.biomaterials.2013.08.028
   Canbolat MF, 2011, MACROMOL BIOSCI, V11, P1346, DOI 10.1002/mabi.201100108
   Chelli B, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0041
   Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   DHANDAYUTHAPANI B, 2011, INT J POLYM SCI
   Grodowska K, 2010, ACTA POL PHARM, V67, P3
   Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351
   Hong V, 2009, ANGEW CHEM INT EDIT, V48, P9879, DOI 10.1002/anie.200905087
   Hosseinkhani H, 2013, ACS CHEM NEUROSCI, V4, P1229, DOI 10.1021/cn400075h
   Khadka DB, 2012, NANOMED-NANOTECHNOL, V8, P1242, DOI 10.1016/j.nano.2012.02.013
   KIBBEY MC, 1993, P NATL ACAD SCI USA, V90, P10150, DOI 10.1073/pnas.90.21.10150
   Kim SE, 2014, ACS MACRO LETT, V3, P585, DOI 10.1021/mz500112d
   Lancaster JR, 2014, PHOTOCHEM PHOTOBIOL, V90, P394, DOI 10.1111/php.12214
   Lancuski A, 2012, ACS APPL MATER INTER, V4, P6499, DOI 10.1021/am301458y
   Li QQ, 2010, J BIOMED MATER RES A, V94A, P688, DOI 10.1002/jbm.a.32707
   Liu WY, 2012, ADV HEALTHC MATER, V1, P10, DOI 10.1002/adhm.201100021
   Luo CJ, 2012, CHEM SOC REV, V41, P4708, DOI 10.1039/c2cs35083a
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mai J, 2009, J NEUROSCI, V29, P7450, DOI 10.1523/JNEUROSCI.1121-09.2009
   Mammadov B, 2012, ACTA BIOMATER, V8, P2077, DOI 10.1016/j.actbio.2012.02.006
   Martins A, 2007, NANOMEDICINE-UK, V2, P929, DOI 10.2217/17435889.2.6.929
   Mattanavee W, 2009, ACS APPL MATER INTER, V1, P1076, DOI 10.1021/am900048t
   Persano L, 2013, MACROMOL MATER ENG, V298, P504, DOI 10.1002/mame.201200290
   Prucker O, 1999, J AM CHEM SOC, V121, P8766, DOI 10.1021/ja990962+
   Repka MA, 2012, EXPERT OPIN DRUG DEL, V9, P105, DOI 10.1517/17425247.2012.642365
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Schneider MH, 2011, LANGMUIR, V27, P1232, DOI 10.1021/la103345k
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Sivolella S, 2014, INT J MOL SCI, V15, P3088, DOI 10.3390/ijms15023088
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001
   Wang J, 2014, POLYMER, V55, P673, DOI 10.1016/j.polymer.2013.12.025
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Wrobel M. R., 2013, TISSUE ENG PART B-RE
   Wu JD, 2012, INTERFACE FOCUS, V2, P337, DOI 10.1098/rsfs.2011.0124
   Yamada M, 2002, FEBS LETT, V530, P48, DOI 10.1016/S0014-5793(02)03393-8
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Zheng JK, 2013, POLYM CHEM-UK, V4, P2215, DOI 10.1039/c3py00153a
   Zheng JK, 2012, J AM CHEM SOC, V134, P17274, DOI 10.1021/ja307647x
NR 41
TC 18
Z9 18
U1 1
U2 59
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2015
VL 16
IS 3
BP 860
EP 867
DI 10.1021/bm501767x
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CD1NH
UT WOS:000350841100020
PM 25715836
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Lin, MP
   Wang, HY
   Ruan, CS
   Xing, J
   Wang, JF
   Wang, YL
   Luo, YF
AF Lin, Manping
   Wang, Huaiyu
   Ruan, Changshun
   Xing, Juan
   Wang, Jinfeng
   Wang, Yuanliang
   Luo, Yanfeng
TI Adsorption Force of Fibronectin on Various Surface Chemistries and Its
   Vital Role in Osteoblast Adhesion
SO BIOMACROMOLECULES
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; CELL-MATRIX ADHESIONS; FLUID SHEAR-STRESS;
   PROTEIN ADSORPTION; PLASMA FIBRONECTIN; FUNCTIONAL-GROUPS; INTEGRIN
   BINDING; COATED SURFACES; MODEL SURFACES; IN-VITRO
AB The amount, type, and conformation of proteins adsorbed on an implanted biomaterial are believed to influence cell adhesion. Nevertheless, only a few research works have been dedicated to the contribution of protein adsorption force. To verify our hypothesis that the adsorption force of protein on biomaterial is another crucial mediator to cell adhesion, fibronectin (FN) adsorbed on self-assembled monolayers (SAMs) with terminal -OH, -CH3, and -NH2 was quantified for FN adsorption force (Fad) by utilizing a sphere/plane adsorption model and parallel plate flow chamber. As revealed, Fad on SAMs followed a chemistry-dependence of -NH2 > -CH3 >> -OH. It is further demonstrated that Fad together with FN conformation could regulate the late osteoblast adhesion and the consequent reorganization of the adsorbed FN and fibrillogenesis of the endogenous FN. Our study suggests that protein adsorption force plays a key role in cell adhesion and should be involved for better biomaterial design.
C1 [Lin, Manping; Xing, Juan; Wang, Jinfeng; Wang, Yuanliang; Luo, Yanfeng] Chongqing Univ, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 400030, Peoples R China.
   [Lin, Manping; Xing, Juan; Wang, Jinfeng; Wang, Yuanliang; Luo, Yanfeng] Chongqing Univ, Coll Bioengn, Res Ctr Bioinspired Mat Sci & Engn, Chongqing 400030, Peoples R China.
   [Wang, Huaiyu; Ruan, Changshun] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Ctr Human Tissue & Organs Degenerat, Shenzhen 518055, Peoples R China.
RP Luo, YF (reprint author), Chongqing Univ, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 400030, Peoples R China.
EM yfluo@cqu.edu.cn
FU National Natural Science Foundation of China [31370946]; Fundamental
   Research Funds for the Central Universities [CDJZR11235501]
FX This work was supported by grants from the National Natural Science
   Foundation of China (No. 31370946) and the Fundamental Research Funds
   for the Central Universities (No. CDJZR11235501).
CR Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026
   Beltran J. B., 2012, J MATER SCI, V23, P195
   Brooks SB, 1996, COMPUT FLUIDS, V25, P741, DOI 10.1016/S0045-7930(96)00024-2
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5
   Declercq H, 2004, BIOMATERIALS, V25, P757, DOI 10.1016/S0142-9612(03)00580-5
   ERICKSON HP, 1994, P NATL ACAD SCI USA, V91, P10114, DOI 10.1073/pnas.91.21.10114
   Faucheux N, 2006, BIOMATERIALS, V27, P234, DOI 10.1016/j.biomaterials.2005.05.076
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179
   Gonzalez-Garcia C, 2010, COLLOID SURFACE B, V77, P181, DOI 10.1016/j.colsurfb.2010.01.021
   Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473
   Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002
   Lee MH, 2005, BIOMATERIALS, V26, P1721, DOI 10.1016/j.biomaterials.2004.05.026
   Lemmon CA, 2011, J BIOL CHEM, V286, P26375, DOI 10.1074/jbc.M111.240028
   Li Y, 2013, COLLOID SURFACE B, V112, P51, DOI 10.1016/j.colsurfb.2013.07.001
   Llopis-Hernandez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019610
   Lorthois S, 2001, J COLLOID INTERF SCI, V241, P52, DOI 10.1006/jcis.2001.7679
   Luo YF, 2008, EUR POLYM J, V44, P1390, DOI 10.1016/j.eurpolymj.2008.01.043
   Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008
   Meadows PY, 2005, LANGMUIR, V21, P4096, DOI 10.1021/la047241v
   Mercier-Bonin M, 2009, J COLLOID INTERF SCI, V338, P73, DOI 10.1016/j.jcis.2009.06.019
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Ren YJ, 2009, BIOMATERIALS, V30, P1036, DOI 10.1016/j.biomaterials.2008.10.028
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Salmeron-Sanchez M, 2011, BIOMATERIALS, V32, P2099, DOI 10.1016/j.biomaterials.2010.11.057
   Schwierz N, 2012, J AM CHEM SOC, V134, P19628, DOI 10.1021/ja304462u
   SKORSTENGAARD K, 1986, EUR J BIOCHEM, V161, P441, DOI 10.1111/j.1432-1033.1986.tb10464.x
   Smith M.L., 2007, PLOS BIOL, V5, pe268
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Thoumine O, 2000, EUR BIOPHYS J BIOPHY, V29, P398, DOI 10.1007/s002490000087
   Vadillo-Rodriguez V, 2013, LANGMUIR, V29, P8554, DOI 10.1021/la401776e
   Vallieres K, 2007, LANGMUIR, V23, P9745, DOI 10.1021/la701323q
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang HY, 2009, ACTA BIOMATER, V5, P279, DOI 10.1016/j.actbio.2008.07.017
   Wang MS, 2004, LANGMUIR, V20, P7753, DOI 10.1021/la049849+
   Werthen M, 2001, BIOMATERIALS, V22, P827, DOI 10.1016/S0142-9612(00)00246-5
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Xing J, 2014, J BIOMED MATER RES A, V102, P4151, DOI 10.1002/jbm.a.35087
   Xu LC, 2006, COLLOID SURFACE B, V48, P84, DOI 10.1016/j.colsurfb.2006.01.012
   Yang DY, 2013, BIOMATERIALS, V34, P5747, DOI 10.1016/j.biomaterials.2013.04.028
   Zamir E, 2000, NAT CELL BIOL, V2, P191
NR 56
TC 22
Z9 24
U1 9
U2 58
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2015
VL 16
IS 3
BP 973
EP 984
DI 10.1021/bm501873g
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CD1NH
UT WOS:000350841100032
PM 25685886
DA 2018-10-19
ER

PT J
AU Verdonk, P
   Dhollander, A
   Almqvist, KF
   Verdonk, R
   Victor, J
AF Verdonk, P.
   Dhollander, A.
   Almqvist, K. F.
   Verdonk, R.
   Victor, J.
TI Treatment of osteochondral lesions in the knee using a cell-free
   scaffold
SO BONE & JOINT JOURNAL
LA English
DT Article
ID AUTOLOGOUS CHONDROCYTE TRANSPLANTATION; ARTICULAR-CARTILAGE DEFECTS;
   COMPOSITE MULTILAYERED BIOMATERIAL; REPAIR TISSUE; REGENERATION;
   MICROFRACTURE; MOSAICPLASTY; MANAGEMENT
AB The treatment of osteochondral lesions is of great interest to orthopaedic surgeons because most lesions do not heal spontaneously. We present the short-term clinical outcome and MRI findings of a cell-free scaffold used for the treatment of these lesions in the knee. A total of 38 patients were prospectively evaluated clinically for two years following treatment with an osteochondral nanostructured biomimetic scaffold. There were 23 men and 15 women; the mean age of the patients was 30.5 years (15 to 64). Clinical outcome was assessed using the Knee Injury and Osteoarthritis Outcome Score (KOOS), the Tegner activity scale and a Visual Analgue scale for pain. MRI data were analysed based on the Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) scoring system at three, 12 and 24 months post-operatively. There was a continuous significant clinical improvement after surgery. In two patients, the scaffold treatment failed (5.3%) There was a statistically significant improvement in the MOCART precentage scores. The repair tissue filled most of the defect sufficiently. We found subchondral laminar changes in all patients. Intralesional osteophytes were found in two patients (5.3%). We conclude that this one-step scaffold-based technique can be used for osteochondral repair. The surgical technique is straightforward, and the clinical results are promising. The MRI aspects of the repair tissue continue to evolve during the first two years after surgery. However, the subchondral laminar and bone changes are a concern.
C1 [Verdonk, P.; Dhollander, A.; Almqvist, K. F.; Verdonk, R.; Victor, J.] Ghent Univ Hosp, Ghent, Belgium.
RP Dhollander, A (reprint author), Monica Hosp, Antwerp Orthoped Ctr, Harmoniestr 68, B-2018 Antwerp, Belgium.
EM dhollander.aad@gmail.com
CR BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Cerynik DL, 2009, KNEE SURG SPORT TR A, V17, P1135, DOI 10.1007/s00167-009-0765-5
   Delcogliano M, 2014, KNEE SURG SPORT TR A, V22, P1260, DOI 10.1007/s00167-013-2717-3
   Dhollander AAM, 2011, KNEE SURG SPORT TR A, V19, P536, DOI 10.1007/s00167-010-1337-4
   Dhollander AAM, 2012, ARTHROSCOPY, V28, P225, DOI 10.1016/j.arthro.2011.07.017
   Dorotka R, 2005, BIOMATERIALS, V26, P3617, DOI 10.1016/j.biomaterials.2004.09.034
   Emmerson BC, 2007, AM J SPORT MED, V35, P907, DOI 10.1177/0363546507299932
   Filardo G, 2012, CARTILAGE, V3, P288, DOI 10.1177/1947603512436371
   FULKERSON JP, 1983, CLIN ORTHOP RELAT R, P176
   Gortz S, 2010, CLIN ORTHOP RELAT R, V468, P1269, DOI 10.1007/s11999-010-1250-7
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   Hangody L, 1998, ORTHOPEDICS, V21, P751
   Hindle P, 2014, KNEE SURG SPORT TR A, V22, P1235, DOI 10.1007/s00167-013-2493-0
   Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839
   KIM HKW, 1991, J BONE JOINT SURG AM, V73A, P1301, DOI 10.2106/00004623-199173090-00004
   Kon E, 2014, AM J SPORT MED, V42, P158, DOI 10.1177/0363546513505434
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2009, KNEE SURG SPORT TR A, V17, P1312, DOI 10.1007/s00167-009-0819-8
   Marlovits S, 2006, EUR J RADIOL, V57, P16, DOI 10.1016/j.ejrad.2005.08.007
   Marlovits S, 2004, EUR J RADIOL, V52, P310, DOI 10.1016/j.ejrad.2004.03.014
   Minas T, 1998, Am J Orthop (Belle Mead NJ), V27, P739
   Peterson L, 2000, Clin Orthop Relat Res, P212, DOI 10.1097/00003086-200005000-00020
   Peterson L, 2003, MASTER TECHNIQUES OR, P353
   Safran MR, 2008, J AM ACAD ORTHOP SUR, V16, P306, DOI 10.5435/00124635-200806000-00002
   Steadman JR, 1997, OPER TECH ORTHOP, V7, P300, DOI DOI 10.1016/S1048-6666(97)80033-X
   Vijayan S, 2014, BONE JOINT J, V96B, P54, DOI 10.1302/0301-620X.96B1.31979
NR 27
TC 14
Z9 15
U1 0
U2 24
PU BRITISH EDITORIAL SOC BONE JOINT SURGERY
PI LONDON
PA 22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND
SN 2049-4394
J9 BONE JOINT J
JI Bone Joint J.
PD MAR
PY 2015
VL 97B
IS 3
BP 318
EP 323
DI 10.1302/0301-620X.97B3.34555
PG 6
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA CD6HP
UT WOS:000351190500007
PM 25737514
DA 2018-10-19
ER

PT J
AU Ma, J
   Qin, JL
AF Ma, Jun
   Qin, Jinli
TI Graphene-like Zinc Substituted Hydroxyapatite
SO CRYSTAL GROWTH & DESIGN
LA English
DT Article
ID CALCIUM-PHOSPHATE; BONE; BIOMINERALIZATION; MINERALIZATION; ADSORPTION;
   SURFACES; CRYSTALLIZATION; BIOMATERIAL; COLLAGEN
AB The biological bone minerals form within a complex microenvironment that consists of various ions and template molecules. Silk fibroin provides an attractive template for biomimetic hydroxyapatite synthesis. In this study, graphene-like zinc substituted hydroxyapatite crystals were prepared using silk fibroin and sodium alginate as template molecules, and the resulting products were investigated. The alginate ions interacted with silk fibroin, and the additional zinc ions also influenced the crystal formation of hydroxyapatite. The graphene-like sheets with hydroxyapatite phase were approximately 3 nm in thickness, and the size was more than 100 nm. The structure of the zinc substituted hydroxyapatite was studied by transmission electron microscopy, and the results revealed that small crystallites of several nanometers were assembled into large size sheets. The synergy effect of zinc and alginate ions led to the preferred growth along (002) and (211) orientations. Accordingly, the mechanisms of crystal growth regulation have been demonstrated.
C1 [Ma, Jun; Qin, Jinli] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Adv Biomat & Tissue Engn Ctr, Wuhan 430074, Peoples R China.
   [Ma, Jun] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Dept Biomed Engn, Wuhan 430074, Peoples R China.
RP Ma, J (reprint author), Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Adv Biomat & Tissue Engn Ctr, Wuhan 430074, Peoples R China.
EM caltary@gmail.com
RI Ma, Jun/K-2084-2012
OI Ma, Jun/0000-0001-5167-1750
FU National Basic Research Program of China [2012CB933601]; National
   Natural Science Foundation of China [51202075]; Fundamental Research
   Funds for the Central Universities [2014QN121]
FX This work was supported by the National Basic Research Program of China
   (Grant No. 2012CB933601), the National Natural Science Foundation of
   China (Grant No. 51202075), and the Fundamental Research Funds for the
   Central Universities (Grant No. 2014QN121). We are also grateful to the
   Analytical and Testing Center (HUST).
CR Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Bonzani IC, 2006, CURR OPIN CHEM BIOL, V10, P568, DOI 10.1016/j.cbpa.2006.09.009
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Colfen H, 2010, NAT MATER, V9, P960, DOI 10.1038/nmat2911
   Cui FZ, 2007, MAT SCI ENG R, V57, P1, DOI 10.1016/j.mser.2007.04.001
   Dey A, 2010, NAT MATER, V9, P1010, DOI 10.1038/NMAT2900
   George A, 2010, NANO TODAY, V5, P254, DOI 10.1016/j.nantod.2010.05.005
   Gomez-Morales J, 2011, CRYST GROWTH DES, V11, P4802, DOI 10.1021/cg2004547
   Jimenez-Izal E, 2012, J PHYS CHEM C, V116, P14561, DOI 10.1021/jp304473p
   Junginger M, 2010, MACROMOL BIOSCI, V10, P1084, DOI 10.1002/mabi.201000093
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Kong XD, 2006, MAT SCI ENG C-BIO S, V26, P639, DOI 10.1016/j.msec.2005.09.097
   Koutsopoulos S, 2000, J CRYST GROWTH, V217, P410, DOI 10.1016/S0022-0248(00)00502-9
   Ma J, 2014, BIOTECHNOL ADV, V32, P744, DOI 10.1016/j.biotechadv.2013.10.014
   Marsi TCO, 2012, LANGMUIR, V28, P4413, DOI 10.1021/la300111k
   Ming JF, 2012, MATER CHEM PHYS, V137, P421, DOI 10.1016/j.matchemphys.2012.10.001
   Mostafa NY, 2011, J AM CERAM SOC, V94, P1584, DOI 10.1111/j.1551-2916.2010.04282.x
   Niu L, 2010, J NANOMATER, DOI 10.1155/2010/729457
   Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Ren FZ, 2009, ACTA BIOMATER, V5, P3141, DOI 10.1016/j.actbio.2009.04.014
   Rosseeva EV, 2008, CHEM MATER, V20, P6003, DOI 10.1021/cm8005748
   Samano EC, 2011, SOFT MATTER, V7, P3240, DOI 10.1039/c0sm01318h
   SANG S, 2004, BONE, V35, P108
   Shen JW, 2008, BIOMATERIALS, V29, P513, DOI 10.1016/j.biomaterials.2007.10.016
   Shen LM, 2011, J MATER CHEM, V21, P18868, DOI 10.1039/c1jm12238j
   Shepherd D, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/025003
   Tang YZ, 2009, BIOMATERIALS, V30, P2864, DOI 10.1016/j.biomaterials.2009.01.043
   Thian ES, 2013, J MATER SCI-MATER M, V24, P437, DOI 10.1007/s10856-012-4817-x
   Unuma H, 2011, J CERAM SOC JPN, V119, P623, DOI 10.2109/jcersj2.119.623
   Velard F, 2009, INT J ARTIF ORGANS, V32, P457
   Wang JL, 2011, J BIOMED MATER RES A, V99A, P327, DOI 10.1002/jbm.a.32602
   Wang J, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/041002
   Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001
   Wei X, 2012, CRYST GROWTH DES, V12, P3474, DOI 10.1021/cg201685x
   Zhao Y, 2009, J BIOMED MATER RES A, V91A, P1140, DOI 10.1002/jbm.a.32272
   Zhou H, 2007, BIOCHEM BIOPH RES CO, V361, P91, DOI 10.1016/j.bbrc.2007.06.169
NR 37
TC 10
Z9 10
U1 5
U2 59
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1528-7483
EI 1528-7505
J9 CRYST GROWTH DES
JI Cryst. Growth Des.
PD MAR
PY 2015
VL 15
IS 3
BP 1273
EP 1279
DI 10.1021/cg501659x
PG 7
WC Chemistry, Multidisciplinary; Crystallography; Materials Science,
   Multidisciplinary
SC Chemistry; Crystallography; Materials Science
GA CC8JL
UT WOS:000350614400034
DA 2018-10-19
ER

PT J
AU Sriram, M
   Sainitya, R
   Kalyanaraman, V
   Dhivya, S
   Selvamurugan, N
AF Sriram, M.
   Sainitya, R.
   Kalyanaraman, V.
   Dhivya, S.
   Selvamurugan, N.
TI Biomaterials mediated microRNA delivery for bone tissue engineering
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Review
DE Biomaterial; MicroRNA; Runx2; Osteoblast; Bone
ID MESENCHYMAL STEM-CELLS; OSTEOBLAST-LIKE CELLS; REGULATES OSTEOGENIC
   DIFFERENTIATION; IN-VIVO; MIRNA EXPRESSION; SCAFFOLDS; MOUSE;
   PROLIFERATION; BIOGENESIS; SUPPRESSES
AB Bone tissue engineering is an alternative strategy to overcome the problems associated with traditional treatments for bone defects. A number of bioactive materials along with new techniques like porous scaffold implantation, gene delivery, 3D organ printing are now-a-days emerging for traditional bone grafts and metal implants. Studying the molecular mechanisms through which these biomaterials induce osteogenesis is an equally hot field. Biomaterials could determine the fate of a cell via microRNAs (miRNAs). miRNAs are short non-coding RNAs that act as post-transcriptional regulators of gene expression and play an essential role for regulation of cell specific lineages including osteogenesis. Thus, this review focuses the recent trends on establishing a link of biomaterials with miRNAs and their delivery for bone tissue engineering applications. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Sriram, M.; Sainitya, R.; Kalyanaraman, V.; Dhivya, S.; Selvamurugan, N.] SRM Univ, Sch Bioengn, Dept Biotechnol, Kattankulathur 603203, Tamil Nadu, India.
RP Selvamurugan, N (reprint author), SRM Univ, Sch Bioengn, Dept Biotechnol, Kattankulathur 603203, Tamil Nadu, India.
EM selvamurugan.n@ktr.srmuniv.ac.in
FU Council for Scientific and Industrial Research, India
   [37(1574)/12/EMR-II, 60(0110)/13/EMR-II, N.S37(1574)/12/EMR-II]; Indian
   Council of Medical Research, India [80/11/2013-BMS]
FX We thank S. Saravanan and S. Vimalraj for their help in preparation of
   the article. This work was supported by the Council for Scientific and
   Industrial Research, India (No. 37(1574)/12/EMR-II; No.
   60(0110)/13/EMR-II to N.S37(1574)/12/EMR-II; 60(0110)/13/EMR-II to N.S.)
   and the Indian Council of Medical Research, India (No. 80/11/2013-BMS to
   N.S.).
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Alvarez K, 2009, MATERIALS, V2, P790, DOI 10.3390/ma2030790
   Beck GR, 2012, NANOMED-NANOTECHNOL, V8, P793, DOI 10.1016/j.nano.2011.11.003
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Chakravorty N, 2012, ACTA BIOMATER, V8, P3516, DOI 10.1016/j.actbio.2012.05.008
   Chen L, 2014, STEM CELLS, V32, P902, DOI 10.1002/stem.1615
   Chen S, 2014, MOL MED REP, V9, P1820, DOI 10.3892/mmr.2014.2024
   Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/eri.11.59, 10.1586/ERI.11.59]
   Deng Y, 2014, EUR CELLS MATER, V27, P13, DOI 10.22203/eCM.v027a02
   Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108
   Gerhardt LC, 2010, MATERIALS, V3, P3867, DOI 10.3390/ma3073867
   Guda T, 2008, CURR TOP MED CHEM, V8, P290, DOI 10.2174/156802608783790956
   Hupkes M, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-1
   Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106
   James EN, 2014, ACTA BIOMATER, V10, P3571, DOI 10.1016/j.actbio.2014.04.026
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Kapinas K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3325
   Kroeze RJ, 2009, MATERIALS, V2, P833, DOI 10.3390/ma2030833
   Lee Y, 2013, BONE, V56, P383, DOI 10.1016/j.bone.2013.07.007
   Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832
   Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234
   Liao YH, 2014, BIOMATERIALS, V35, P4901, DOI 10.1016/j.biomaterials.2014.02.055
   Lisse TS, 2013, J BONE MINER RES, V28, P1478, DOI 10.1002/jbmr.1882
   Liu H, 2014, J CELL PHYSIOL, V229, P1494, DOI 10.1002/jcp.24591
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Mahmood M, 2011, J CELL MOL MED, V15, P2297, DOI 10.1111/j.1582-4934.2010.01234.x
   Mai ZH, 2013, CHINESE MED J-PEKING, V126, P1544, DOI 10.3760/cma.j.issn.0366-6999.20123137
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Mizoguchi F, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4282
   Moorthi A, 2013, INT J BIOL MACROMOL, V56, P181, DOI 10.1016/j.ijbiomac.2013.02.017
   Moorthi A, 2012, J BIOMATER TISS ENG, V2, P197, DOI 10.1166/jbt.2012.1045
   Nejati E, 2009, MAT SCI ENG C-BIO S, V29, P942, DOI 10.1016/j.msec.2008.07.038
   Nguyen MK, 2014, BIOMATERIALS, V35, P6278, DOI 10.1016/j.biomaterials.2014.04.048
   Okamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043800
   Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028
   Palmieri A, 2008, J MATER SCI-MATER M, V19, P2471, DOI 10.1007/s10856-008-3386-5
   Palmieri A, 2008, BIO-MED MATER ENG, V18, P91, DOI 10.3233/BME-2008-0512
   Palmieri A, 2008, J CRANIOFAC SURG, V19, P328, DOI 10.1097/SCS.0b013e3181534ab3
   Palmieri A, 2008, IMPLANT DENT, V17, P100, DOI 10.1097/ID.0b013e318166d182
   Palmieri A, 2008, J BIOMED MATER RES B, V84B, P369, DOI 10.1002/jbm.b.30880
   Palmieri Annalisa, 2008, J Oral Implantol, V34, P190, DOI 10.1563/0.869.1
   Palmieri A, 2010, INT J PERIODONT REST, V30, P83
   Palmieri Annalisa, 2008, J Prosthodont, V17, P522, DOI 10.1111/j.1532-849X.2008.00331.x
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Qizhi C., 2012, PROG BIOMATER, V1, P1
   Qureshi AT, 2013, BIOMATERIALS, V34, P7799, DOI 10.1016/j.biomaterials.2013.07.004
   Rani V. V. Divya, 2009, NANOTECHNOLOGY, V19
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983
   Sahithi K, 2010, J BIOMED NANOTECHNOL, V6, P333, DOI 10.1166/jbn.2010.1138
   Sahithi K, 2010, INT J BIOL MACROMOL, V46, P281, DOI 10.1016/j.ijbiomac.2010.01.006
   Salgado AJ, 2004, TISSUE ENG, V10, P465, DOI 10.1089/107632704323061825
   Schade P., 2014, STEM CELLS INT, V2014
   Shi KK, 2013, BONE, V55, P487, DOI 10.1016/j.bone.2013.04.002
   Sowjanya JA, 2013, COLLOID SURFACE B, V109, P294, DOI 10.1016/j.colsurfb.2013.04.006
   Sugatani T, 2009, J BIOL CHEM, V284, P4667, DOI 10.1074/jbc.M805777200
   Suh JS, 2013, BIOMATERIALS, V34, P4347, DOI 10.1016/j.biomaterials.2013.02.039
   Sun K, 2011, EXPRESS POLYM LETT, V5, P342, DOI 10.3144/expresspolymlett.2011.34
   Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015
   Tripathi A, 2012, INT J BIOL MACROMOL, V50, P294, DOI 10.1016/j.ijbiomac.2011.11.013
   Trompeter HI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-111
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Vimalraj S, 2014, J CELL PHYSIOL, V229, P1236, DOI 10.1002/jcp.24557
   Vimalraj S, 2014, INT J BIOL MACROMOL, V66, P194, DOI 10.1016/j.ijbiomac.2014.02.030
   Vimalraj S, 2013, DIS MARKERS, DOI 10.1155/2013/451248
   Wang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072266
   Wei JW, 2012, J CELL BIOL, V197, P509, DOI 10.1083/jcb.201201057
   Wu KM, 2013, ACS APPL MATER INTER, V5, P2733, DOI 10.1021/am400374c
   Yan C, 2011, BIOMATERIALS, V32, P6435, DOI 10.1016/j.biomaterials.2011.05.031
   Yan J, 2014, BIOMATERIALS, V35, P7734, DOI 10.1016/j.biomaterials.2014.05.089
   Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024
   Zhang JF, 2011, RNA BIOL, V8, P829, DOI 10.4161/rna.8.5.16043
   Zhang Y, 2013, J CONTROL RELEASE, V172, P962, DOI 10.1016/j.jconrel.2013.09.015
   Zhou QA, 2011, BIOCHEM BIOPH RES CO, V404, P127, DOI 10.1016/j.bbrc.2010.11.079
NR 74
TC 22
Z9 25
U1 3
U2 53
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD MAR
PY 2015
VL 74
BP 404
EP 412
DI 10.1016/j.ijbiomac.2014.12.034
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CD7CO
UT WOS:000351248600053
PM 25543062
DA 2018-10-19
ER

PT J
AU Rey, R
   Nimmo, S
   Childs, GS
   Behar-Horenstein, LS
AF Rey, Rosalia
   Nimmo, Susan
   Childs, Gail S.
   Behar-Horenstein, Linda S.
TI Curriculum Time Compared to Clinical Procedures in Amalgam and Composite
   Posterior Restorations in US Dental Schools: A Preliminary Study
SO JOURNAL OF DENTAL EDUCATION
LA English
DT Article
DE dental education; clinical education; dental school clinics; general
   dentistry; operative dentistry; amalgam restorations; composite
   restorations
ID RESIN; PLACEMENT; LONGEVITY; DENTISTRY; FAILURE
AB Dental clinicians have an expanding range of biomaterial choices for restoring tooth structure. Scientific developments in cariology, advances in dental biomaterials, and patients' esthetic concerns have led to a reduction in amalgam restorations and an increase in composite restorations. The aim of this study was to compare teaching time with students' clinical procedures in amalgam and composite posterior restorations in dental schools across the United States. Academic deans in 60 schools were invited to complete a survey that asked for the amount of instructional time for amalgam and composite posterior restorations and the number of clinical restorations performed by their Classes of 2009, 2010, and 2011. Of these 60, 12 returned surveys with complete data, for a 20% response rate. Responses from these schools showed little change in lecture and preclinical laboratory instruction from 2009 to 2011. There was a slight increase in two-surface restorations for both amalgam and composites; however, the total number of reported composite and amalgam restorations remained the same. Of 204,864 restorations reported, 53% were composite, and 47% were amalgam. There were twice as many multisurface large or complex amalgam restorations as composites. One-surface composite restorations exceeded amalgams. Among the participating schools, there was little to no change between curriculum time and clinical procedures. Findings from this preliminary study reflect a modest increase in two-surface resin-based restorations placed by dental students from 2009 to 2011 and little change in curricular time devoted to teaching amalgam restorations. The total number of posterior composite restorations placed by students in these schools was slightly higher than amalgams.
C1 [Rey, Rosalia; Nimmo, Susan] Univ Florida, Coll Dent, Dept Restorat Dent Sci, Gainesville, FL 32610 USA.
   [Childs, Gail S.] Univ Florida, Coll Dent, Dept Community Dent & Behav Sci, Curriculum & Instruct, Gainesville, FL 32610 USA.
   [Behar-Horenstein, Linda S.] Univ Florida, Coll Dent, Dept Community Dent & Behav Sci, Gainesville, FL 32610 USA.
RP Rey, R (reprint author), Univ Florida, Coll Dent, Dept Restorat Dent Sci, 1395 Ctr Dr,Room D9-31, Gainesville, FL 32610 USA.
EM rrey@dental.ufl.edu
CR American Dental Association Council on Scientific Affairs, 2009, STAT DENT AM
   Ben-Gal G, 2011, J DENT EDUC, V75, P1590
   Commission on Dental Accreditation, 2013, ACCR STAND DENT ED P
   European Commission on Health and Consumer Protection, 2008, SCI OP SAF DENT AM A
   Gordan VV, 2011, J AM DENT ASSOC, V142, P842, DOI 10.14219/jada.archive.2011.0274
   Liew ZL, 2011, INT DENT J, V61, P12, DOI 10.1111/j.1875-595X.2011.00003.x
   Lynch CD, 2006, J AM DENT ASSOC, V137, P619, DOI 10.14219/jada.archive.2006.0257
   Lynch CD, 2006, J AM DENT ASSOC, V129, P1415
   Lynch CD, 2011, J AM DENT ASSOC, V142, P612, DOI 10.14219/jada.archive.2011.0243
   Mjor AM, 1998, J AM DENT ASSOC, V129, P1415
   Mjor IA, 2002, OPER DENT, V27, P528
   Murdoch-Kinch CA, 2003, J AM DENT ASSOC, V134, P87, DOI 10.14219/jada.archive.2003.0021
   Opdam NJM, 2010, J DENT RES, V89, P1063, DOI 10.1177/0022034510376071
   Ottenga ME, 2007, OPER DENT, V32, P524, DOI 10.2341/06-134
   Overton JD, 2012, J DENT EDUC, V76, P338
   Rosenstiel SF, 2004, J PROSTHET DENT, V91, P363, DOI 10.1016/j.prosdent.2004.02.004
   WILSON NHF, 1989, J DENT, V17, pS29, DOI 10.1016/0300-5712(89)90160-7
   Wilson NHF, 2004, J DENT, V32, P367, DOI 10.1016/j.jdent.2004.02.004
NR 18
TC 2
Z9 2
U1 0
U2 1
PU AMER DENTAL EDUCATION ASSOC-ADEA
PI WASHINGTON
PA 655 K STREET NW, SUITE 800, WASHINGTON, DC 20001 USA
SN 0022-0337
EI 1930-7837
J9 J DENT EDUC
JI J. Dent. Educ.
PD MAR
PY 2015
VL 79
IS 3
BP 331
EP 336
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CD7FA
UT WOS:000351255000012
PM 25729027
DA 2018-10-19
ER

PT J
AU Alhalawani, AMF
   Rodriguez, O
   Curran, DJ
   Co, R
   Kieran, S
   Arshad, S
   Keenan, TJ
   Wren, AW
   Crasto, G
   Peel, SAF
   Towler, MR
AF Alhalawani, Adel M. F.
   Rodriguez, Omar
   Curran, Declan J.
   Co, Russell
   Kieran, Sean
   Arshad, Saad
   Keenan, Timothy J.
   Wren, Anthony W.
   Crasto, Gazelle
   Peel, Sean A. F.
   Towler, Mark R.
TI A glass polyalkenoate cement carrier for bone morphogenetic proteins
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SUSTAINED-RELEASE; DELIVERY-SYSTEMS; SPINE FUSION; IN-VITRO; BMP-2;
   REGENERATION; BIOMATERIAL; ADSORPTION; INDUCTION; RHBMP-2
AB This work considers a glass polyalkenoate cement (GPC)-based carrier for the effective delivery of bone morphogenetic proteins (BMPs) at an implantation site. A 0.12 CaO-0.04 SrO-0.36 ZnO-0.48 SiO2 based glass and poly(acrylic acid) (PAA, Mw 213,000) were employed for the fabrication of the GPC. The media used for the water source in the GPC reaction was altered to produce a series of GPCs. The GPC liquid media was either 100 % distilled water with additions of albumin at 0, 2, 5 and 8 wt% of the glass content, 100 % formulation buffer (IFB), and 100 % BMP (150 mu g rhBMP-2/ml IFB). Rheological properties, compressive strength, ion release profiles and BMP release were evaluated. Working times (T-w) of the formulated GPCs significantly increased with the addition of 2 % albumin and remained constant with further increases in albumin content or IFB solutions. Setting time (T-s) experienced an increase with 2 and 5 % albumin content, but a decrease with 8 % albumin. Changing the liquid source to IFB containing 5 % albumin had no significant effect on T-s compared to the 8 % albumin-containing BT101. Replacing the albumin with IFB/BMP-2 did not significantly affect T-w. However, T-s increased for the BT101_BMP-2 containing GPCs, compared to all other samples. The compressive strength evaluated 1 day post cement mixing was not affected significantly by the incorporation of BMPs, but the ion release did increase from the cements, particularly for Zn and Sr. The GPCs released BMP after the first day, which decreased in content during the following 6 days. This study has proven that BMPs can be immobilized into GPCs and may result in novel materials for clinical applications.
C1 [Alhalawani, Adel M. F.; Rodriguez, Omar; Curran, Declan J.; Co, Russell; Kieran, Sean; Arshad, Saad; Towler, Mark R.] Ryerson Univ, Fac Engn & Architectural Sci, Dept Mech & Ind Engn, Toronto, ON M5B 2K3, Canada.
   [Keenan, Timothy J.; Wren, Anthony W.] Alfred Univ, Inamori Sch Engn, New York, NY USA.
   [Crasto, Gazelle; Peel, Sean A. F.] Univ Toronto, Fac Dent, Dent Res Inst, Toronto, ON, Canada.
   [Towler, Mark R.] Univ Malaya, Dept Biomed Engn, Kuala Lumpur, Malaysia.
RP Curran, DJ (reprint author), Ryerson Univ, Fac Engn & Architectural Sci, Dept Mech & Ind Engn, 350 Victoria St, Toronto, ON M5B 2K3, Canada.
EM curran@ryerson.ca
OI Alhalawani, Adel/0000-0002-3374-3172; Curran, Declan/0000-0002-8626-1003
FU Natural Sciences and Engineering Research Council of Canada (NSERC)
   Engage Program [449,981-13]
FX The authors thank the Natural Sciences and Engineering Research Council
   of Canada (NSERC) Engage Program (Grant # 449,981-13) for facilitating
   this research.
CR Alhalawani Adel M F, 2013, J Funct Biomater, V4, P329, DOI 10.3390/jfb4040329
   Autefage H, 2009, J BIOMED MATER RES B, V91B, P706, DOI 10.1002/jbm.b.31447
   Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P1, DOI 10.1002/term.63
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Bessho K, 2002, J BIOMED MATER RES, V61, P61, DOI 10.1002/jbm.10169
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   BOYAN BD, 1992, CLIN ORTHOP RELAT R, P286
   Boyd D, 2008, J MATER SCI-MATER M, V19, P1745, DOI 10.1007/s10856-007-3363-4
   Boyd D, 2008, J MATER SCI-MATER M, V19, P953, DOI 10.1007/s10856-006-0060-7
   Brown KV, 2011, TISSUE ENG PT A, V17, P1735, DOI 10.1089/ten.tea.2010.0446
   CARTER DR, 1976, SCIENCE, V194, P1174, DOI 10.1126/science.996549
   Chen S, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/1/015005
   CRISP S, 1974, J DENT RES, V53, P1414, DOI 10.1177/00220345740530062001
   Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006
   Furlan L, 1996, POLYMER, V37, P843, DOI 10.1016/0032-3861(96)87263-6
   Johnson MR, 2009, ACTA BIOMATER, V5, P23, DOI 10.1016/j.actbio.2008.09.001
   Khairoun I, 1998, J MATER SCI-MATER M, V9, P425, DOI 10.1023/A:1008811215655
   Kleeff J, 1999, GASTROENTEROLOGY, V116, P1202, DOI 10.1016/S0016-5085(99)70024-7
   Lane JM, 1999, CLIN ORTHOP RELAT R, P216
   LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0
   Lee KB, 2012, J ORTHOP RES, V30, P1985, DOI 10.1002/jor.22160
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   Mayer H, 1996, CALCIFIED TISSUE INT, V58, P249
   Mehta M, 2012, ADV DRUG DELIVER REV, V64, P1257, DOI 10.1016/j.addr.2012.05.006
   Mori M, 2000, J BIOMED MATER RES, V50, P191, DOI 10.1002/(SICI)1097-4636(200005)50:2<191::AID-JBM14>3.0.CO;2-0
   Niedhart C, 2003, J BIOMED MATER RES A, V65A, P17, DOI 10.1002/jbm.a.10362
   Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002
   Pneumaticos SG, 2010, J CELL MOL MED, V14, P2561, DOI 10.1111/j.1582-4934.2010.01062.x
   Rai B, 2005, BIOMATERIALS, V26, P3739, DOI 10.1016/j.biomaterials.2004.09.052
   Raida M, 2005, J CANCER RES CLIN, V131, P741, DOI 10.1007/s00432-005-0024-1
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   Reddi AH, 2005, CYTOKINE GROWTH F R, V16, P249, DOI 10.1016/j.cytogfr.2005.04.003
   Redweik S, 2013, ELECTROPHORESIS, V34, P1812, DOI 10.1002/elps.201300050
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Seiya J, 2002, J ORTHOP SCI, V7, P490
   Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72
   URIST MR, 1983, P SOC EXP BIOL MED, V173, P194
   van de Weert M, 2000, PHARM RES, V17, P1159, DOI DOI 10.1023/A:1026498209874
   WILSON AD, 1970, J DENT RES, V49, P7, DOI 10.1177/00220345700490013301
   Wilson AD, 2005, ACID BASE CEMENTS TH
   Wren AW, 2013, J MATER SCI-MATER M, V24, P1167, DOI 10.1007/s10856-013-4880-y
   Wren AW, 2010, J MATER SCI, V45, P3554, DOI 10.1007/s10853-010-4398-3
   Wren A, 2008, J MATER SCI-MATER M, V19, P1737, DOI 10.1007/s10856-007-3287-z
   Xie GP, 2010, J MATER SCI-MATER M, V21, P1875, DOI 10.1007/s10856-010-4038-0
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P761, DOI 10.1023/A:1013957431372
NR 46
TC 0
Z9 0
U1 1
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2015
VL 26
IS 3
AR 151
DI 10.1007/s10856-015-5494-3
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE1PA
UT WOS:000351582800005
PM 25773232
DA 2018-10-19
ER

PT J
AU Cai, MM
   Zhang, J
   Guan, LL
   Zhao, M
AF Cai, Mingming
   Zhang, Jie
   Guan, Lili
   Zhao, Min
TI Novel implantable composite biomaterial by fibrin glue and amniotic
   membrane for ocular surface reconstruction
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CORNEAL PERFORATION; TRANSPLANTATION; THERAPY; BURNS; MANAGEMENT;
   EPITHELIUM; INJURIES; FIXATION; ADHESIVE; CLOSURE
AB Amniotic membrane transplantation (AMT) is considered a substantial treatment option in the management of ocular surface disorders. However, several inherent drawbacks still remain. The present study devised a novel implantable composite biomaterial of fibrin glue-double layer Amniotic membrane (AM) and evaluated the biomechanical properties and effects on corneal surface reconstruction in alkali-burned rabbit model. Biomechanic parameters were calculated by an electronic universal testing machine. Corneal alkali burning was done in the right eyes of thirty rabbits, which were randomized into three groups of ten animals each. The eyes in group 1 underwent fibrin glue-double layer AMT, the eyes in group 2 underwent ordinary single layer AMT, and the eyes in group 3 (control group) did not undergo any surgical procedure. Healing of corneal epithelial defect, extent of corneal vascularization and corneal clarity were assessed and compared at two time points. One month after surgery, animals were killed and the eyes were processed for histopathology. The fibrin glue-double layer AM composites had more ideal biomechanical properties. In fibrin glue-double layer AM group, the rate of epithelial healing, vascularization inhibition and corneal clarity was significantly better than the other two groups. Novel fibrin glue-double layer AMT with corneal alkali burns is more effective and useful for ocular surface reconstruction and has great potential applications.
C1 [Cai, Mingming; Zhao, Min] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Eye Inst, Chongqing Key Lab Ophthalmol, Chongqing 400016, Peoples R China.
   [Cai, Mingming] Ninth Peoples Hosp Chongqing, Dept Ophthalmol, Chongqing 400700, Peoples R China.
   [Zhang, Jie] Ninth Peoples Hosp Chongqing, Dept Urol, Chongqing 400700, Peoples R China.
   [Guan, Lili] Chongqing Med Univ, Affiliated Hosp 1, Dept Nucl Med, Chongqing 400016, Peoples R China.
RP Zhao, M (reprint author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Eye Inst, Chongqing Key Lab Ophthalmol, Chongqing 400016, Peoples R China.
EM cqminzhao@126.com
FU Chongqing Science and Technology Committee (CSTC) [2008AC0086]; First
   Affiliated Hospital of Chongqing Medical University [YXJJ2009-09]
FX This study was supported by Grants from the Chongqing Science and
   Technology Committee (CSTC, 2008AC0086) and the First Affiliated
   Hospital of Chongqing Medical University (YXJJ2009-09). The authors
   thank Wenjun Zhou for providing technical assistance.
CR Baum J, 2002, CORNEA, V21, P339, DOI 10.1097/00003226-200205000-00001
   Dua HS, 1999, BRIT J OPHTHALMOL, V83, P748, DOI 10.1136/bjo.83.6.748
   Duchesne B, 2001, CORNEA, V20, P230, DOI 10.1097/00003226-200103000-00027
   Gatzioufas Z, 2012, AM J OPHTHALMOL, V153, P379, DOI 10.1016/j.ajo.2011.10.035
   Grau AE, 2012, CORNEA, V31, P98, DOI 10.1097/ICO.0b013e31821f28a2
   Ha HS, 2006, J KOREAN MED SCI, V21, P544, DOI 10.3346/jkms.2006.21.3.544
   Iakimenko SA, 2013, EUR J OPHTHALMOL, V23, P496, DOI 10.5301/ejo.5000243
   Kaufman HE, 2003, OPHTHALMOLOGY, V110, P2168, DOI 10.1016/S0161-6420(03)00832-7
   Kee C, 2002, AM J OPHTHALMOL, V133, P834, DOI 10.1016/S0002-9394(02)01415-0
   Kheirkhah A, 2008, ARCH OPHTHALMOL-CHIC, V126, P1059, DOI 10.1001/archopht.126.8.1059
   Kheirkhah A, 2008, AM J OPHTHALMOL, V145, P787, DOI 10.1016/j.ajo.2008.01.009
   Kheirkhah A, 2013, CORNEA, V32, P155, DOI 10.1097/ICO.0b013e318247983d
   KIM JC, 1995, CORNEA, V14, P473
   Kim JS, 2000, EXP EYE RES, V70, P329, DOI 10.1006/exer.1999.0794
   Kubo M, 2001, INVEST OPHTH VIS SCI, V42, P1539
   Le Nihouannen D, 2007, J MATER SCI-MATER M, V18, P225, DOI 10.1007/s10856-006-0684-7
   Liu T, 2012, MOL VIS, V18, P2137
   Mahdy RA, 2012, OPHTHALMIC RES, V47, P23, DOI 10.1159/000328629
   Martinez-de-la-Casa JM, 2013, ACTA OPHTHALMOL, V91, P425, DOI 10.1111/j.1755-3768.2012.02436.x
   MATSUDA H, 1973, ARCH OPHTHALMOL-CHIC, V89, P396
   Mohammadi AA, 2013, BURNS, V39, P1137, DOI 10.1016/j.burns.2013.01.017
   Nassiri N, 2011, ARCH OPHTHALMOL-CHIC, V129, P218, DOI 10.1001/archophthalmol.2010.370
   Nubile M, 2008, BRIT J OPHTHALMOL, V92, P54, DOI 10.1136/bjo.2007.123026
   ORMEROD LD, 1989, INVEST OPHTH VIS SCI, V30, P2148
   Pirouzian A, 2011, GRAEF ARCH CLIN EXP, V249, P261, DOI 10.1007/s00417-010-1499-2
   Shi WY, 2007, OPHTHALMOLOGY, V114, P1476, DOI 10.1016/j.ophtha.2006.11.027
   Sinha R, 2013, J CATARACT REFR SURG, V39, P1779, DOI 10.1016/j.jcrs.2013.08.037
   Solomon A, 2003, OPHTHALMOLOGY, V110, P93, DOI 10.1016/S0161-6420(02)01441-0
   Solomon A, 2002, OPHTHALMOLOGY, V109, P694, DOI 10.1016/S0161-6420(01)01032-6
   SONODA Y, 1992, TRANSPLANTATION, V54, P694, DOI 10.1097/00007890-199210000-00026
   Suri K, 2013, EYE CONTACT LENS, V39, P341, DOI 10.1097/ICL.0b013e3182a2f8fa
   Szurman P, 2006, CORNEA, V25, P460, DOI 10.1097/01.ico.0000183493.00884.8f
   Tamhane A, 2005, OPHTHALMOLOGY, V112, P1963, DOI 10.1016/j.ophtha.2005.05.022
   VANHERENDAEL BJ, 1978, AM J OBSTET GYNECOL, V131, P872, DOI 10.1016/S0002-9378(16)33135-0
   Wagoner MD, 1997, SURV OPHTHALMOL, V41, P275, DOI 10.1016/S0039-6257(96)00007-0
   Wolbank S, 2009, J TISSUE ENG REGEN M, V3, P651, DOI 10.1002/term.207
   Woo HM, 2001, BRIT J OPHTHALMOL, V85, P345, DOI 10.1136/bjo.85.3.345
   Yamada J, 2003, EXP EYE RES, V76, P161, DOI 10.1016/S0014-4835(02)00293-2
   Yang MB, 2013, OPHTHALMOLOGY, V120, P1935, DOI 10.1016/j.ophtha.2013.05.008
NR 39
TC 0
Z9 0
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2015
VL 26
IS 3
AR 149
DI 10.1007/s10856-015-5491-6
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE1PA
UT WOS:000351582800003
PM 25764084
DA 2018-10-19
ER

PT J
AU Xing, H
   Ma, H
   Fu, Y
   Xue, M
   Zhang, X
   Dong, X
   Zhang, X
AF Xing, H.
   Ma, H.
   Fu, Y.
   Xue, M.
   Zhang, X.
   Dong, X.
   Zhang, X.
TI Preparation of g-C3N4/ZnO composites and their enhanced photocatalytic
   activity
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Photocatalysis; g-C3N4; ZnO; Reactive brilliant blue
ID VISIBLE-LIGHT IRRADIATION; GRAPHITE-LIKE C3N4; SURFACE MODIFICATION;
   NICKEL FERRITE; MAGNETIC CORE; ANTIMICROBIAL ACTIVITY; HOLLOW
   MICROSPHERES; BIOMATERIAL SYSTEM; ZNO NANOCRYSTALS; METHYL-ORANGE
AB In this manuscript, g-C3N4/ZnO composite photocatalysts with various loadings of g-C3N4 were synthesised by a facile thermal decomposition method. The obtained g-C3N4/ZnO composites were characterised by X-ray diffraction, SEM, photoluminescence spectroscopy, UV-vis and Xray photoelectron spectroscopy. It is discovered that the introduction of g-C3N4 did not change the morphology and crystal structure of g-C3N4/ZnO composites but enhanced their light absorption in the visible region and promoted the charge separation of photoexcitated electron-hole pairs. As compared to ZnO, the Zn2p peak of the g-C3N4/ZnO composite showed an obvious shift to higher binding energy, implying the existence of a synergistic effect between g-C3N4 and ZnO. Furthermore, the introduction of g-C3N4 also increased the amount of hydroxyl groups where the surface hydroxyl groups can be trapped in the photogenerated holes to form hydroxyl radicals, and improved the photocatalytic efficiency. The photodegradation of reactive brilliant blue (KN-R) showed that the g-C3N4/ZnO composites possess better photocatalytic activity than that of g-C3N4 and ZnO under sunlight irradiation.
C1 [Xing, H.; Ma, H.; Fu, Y.; Xue, M.; Zhang, X.; Dong, X.; Zhang, X.] Dalian Polytech Univ, Sch Light Ind & Chem Engn, Dalian 116034, Liaoning, Peoples R China.
RP Ma, H (reprint author), Dalian Polytech Univ, Sch Light Ind & Chem Engn, 1 Qinggongyuan, Dalian 116034, Liaoning, Peoples R China.
EM m-h-c@sohu.com; dongxl@dlpu.edu.cn
FU National Natural Science Foundation of China [21243005, 21476033];
   Science and Technology Foundation of Liaoning of China [201102111];
   Program for Key Science and Technology Platform in Universities of
   Liaoning Province; Program for Liaoning Excellent Talents in University
   [LR2014013]; Science and Technology Public-Benefit Foundation of
   Liaoning of China [[2011] 49]
FX This study was supported by the National Natural Science Foundation of
   China (grant no. 21243005, 21476033), the Science and Technology
   Foundation of Liaoning of China (grant no. 201102111), the Program for
   Key Science and Technology Platform in Universities of Liaoning
   Province, the Program for Liaoning Excellent Talents in University
   (grant no. LR2014013), and the Science and Technology Public-Benefit
   Foundation of Liaoning of China (grant no. [2011] 49).
CR Ayoub K, 2010, J HAZARD MATER, V178, P10, DOI 10.1016/j.jhazmat.2010.02.042
   Bach U, 1998, NATURE, V395, P583, DOI 10.1038/26936
   Bai HW, 2011, PHYS CHEM CHEM PHYS, V13, P6205, DOI 10.1039/c0cp02546a
   Chen CQ, 2011, DALTON T, V40, P9566, DOI 10.1039/c1dt10799b
   Chen JS, 2011, NANOSCALE, V3, P2158, DOI 10.1039/c1nr10162e
   Chen SF, 2006, MATER CHEM PHYS, V98, P116, DOI 10.1016/j.matchemphys.2005.08.073
   Chong MN, 2010, WATER RES, V44, P2997, DOI 10.1016/j.watres.2010.02.039
   FRANK SN, 1977, J AM CHEM SOC, V99, P303, DOI 10.1021/ja00443a081
   Futsuhara M, 1998, THIN SOLID FILMS, V322, P274, DOI 10.1016/S0040-6090(97)00910-3
   Ge L, 2011, APPL CATAL B-ENVIRON, V108, P100, DOI 10.1016/j.apcatb.2011.08.014
   Ge L, 2011, MATER LETT, V65, P2652, DOI 10.1016/j.matlet.2011.05.069
   Gopinath CS, 2002, MATER RES BULL, V37, P1323, DOI 10.1016/S0025-5408(02)00763-8
   Gubbala S, 2006, MATER SCI TECH-LOND, V22, P845, DOI 10.1179/174328406X91096
   Hong RY, 2009, POWDER TECHNOL, V189, P426, DOI 10.1016/j.powtec.2008.07.004
   Huang LY, 2013, DALTON T, V42, P8606, DOI 10.1039/c3dt00115f
   Izaki M, 2007, J PHYS D APPL PHYS, V40, P3326, DOI 10.1088/0022-3727/40/11/010
   Jing LQ, 2004, J SOLID STATE CHEM, V177, P4221, DOI 10.1016/j.jssc.2004.08.016
   Kumar S, 2013, J MATER CHEM A, V1, P5333, DOI 10.1039/c3ta00186e
   Li XF, 2009, APPL PHYS A-MATER, V94, P387, DOI 10.1007/s00339-008-4816-4
   Liu W, 2012, CHEM ENG J, V209, P386, DOI 10.1016/j.cej.2012.08.033
   Lu WW, 2008, J PHYS CHEM C, V112, P16792, DOI 10.1021/jp803654k
   Mills A., 1997, J PHOTOCH PHOTOBIO A, V8A, P11
   Morales-Flores N, 2011, APPL CATAL A-GEN, V394, P269, DOI 10.1016/j.apcata.2011.01.011
   Norberg NS, 2005, J PHYS CHEM B, V109, P20810, DOI 10.1021/jp0535285
   Qin HC, 2011, ACS APPL MATER INTER, V3, P3152, DOI 10.1021/am200655h
   Qiu XQ, 2008, J PHYS CHEM C, V112, P12242, DOI 10.1021/jp803129e
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Ruankham P, 2011, J PHYS CHEM C, V115, P23809, DOI 10.1021/jp204325y
   Sun JX, 2012, DALTON T, V41, P6756, DOI 10.1039/c2dt12474b
   Takanabe K, 2010, PHYS CHEM CHEM PHYS, V12, P13020, DOI 10.1039/c0cp00611d
   Thomas A, 2008, J MATER CHEM, V18, P4893, DOI 10.1039/b800274f
   Udawatte N, 2011, ACS APPL MATER INTER, V3, P4531, DOI 10.1021/am201221x
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Wang XC, 2009, NAT MATER, V8, P76, DOI 10.1038/NMAT2317
   Wang YJ, 2012, J MATER CHEM, V22, P11568, DOI 10.1039/c2jm16873a
   Wang YJ, 2011, ENERG ENVIRON SCI, V4, P2922, DOI 10.1039/c0ee00825g
   Wu YL, 2007, APPL SURF SCI, V253, P5473, DOI 10.1016/j.apsusc.2006.12.091
   Xiang QJ, 2011, J PHYS CHEM C, V115, P7355, DOI 10.1021/jp200953k
   Xu HY, 2005, APPL PHYS B-LASERS O, V80, P871, DOI 10.1007/s00340-005-1790-9
   Xu XX, 2011, INT J HYDROGEN ENERG, V36, P13501, DOI 10.1016/j.ijhydene.2011.08.052
   Yan HJ, 2011, J ALLOY COMPD, V509, pL26, DOI 10.1016/j.jallcom.2010.09.201
   Yan SC, 2010, DALTON T, V39, P1488, DOI 10.1039/b914110c
   Yan SC, 2010, LANGMUIR, V26, P3894, DOI 10.1021/la904023j
   Yan SC, 2009, LANGMUIR, V25, P10397, DOI 10.1021/la900923z
   Ye LQ, 2013, APPL CATAL B-ENVIRON, V142, P1, DOI 10.1016/j.apcatb.2013.04.058
   Zhang J, 2007, ACTA BIOMATER, V3, P838, DOI 10.1016/j.actbio.2007.05.011
   Zhang JL, 2007, LANGMUIR, V23, P6342, DOI 10.1021/la0636199
   Zhang Y, 2007, SCRIPTA MATER, V57, P313, DOI 10.1016/j.scriptamat.2007.04.028
   Zhou XS, 2011, CHEM COMMUN, V47, P10323, DOI 10.1039/c1cc13862f
NR 54
TC 7
Z9 7
U1 8
U2 138
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD MAR
PY 2015
VL 30
IS 2
BP 122
EP 127
DI 10.1179/1753555714Y.0000000216
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA CD5KK
UT WOS:000351126300010
DA 2018-10-19
ER

PT J
AU Dou, Y
   Zhang, BN
   He, M
   Yin, GQ
   Cui, YD
   Savina, IN
AF Dou, Yao
   Zhang, Buning
   He, Ming
   Yin, Guoqiang
   Cui, Yingde
   Savina, Irina N.
TI Keratin/Polyvinyl Alcohol Blend Films Cross-Linked by Dialdehyde Starch
   and Their Potential Application for Drug Release
SO POLYMERS
LA English
DT Article
ID WATER-VAPOR PERMEABILITY; FEATHER KERATIN FILMS; POLY(VINYL ALCOHOL);
   PHYSICAL-PROPERTIES; BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES;
   TENSILE PROPERTIES; COMPOSITE FILMS; PROTEIN; GELATIN
AB Feather keratin (FK) extracted from feathers represents a valuable source of biodegradable and biocompatible polymer. The aim of this study was the development and characterization of blended films based on FK and polyvinyl alcohol (PVA) cross-linked by dialdehyde starch (DAS) for a potential drug release application. The compatibility of FK/PVA was improved when cross-linked by DAS: the relative crystallinity of the PVA/FK film slightly decreased, and the enthalpy value for the melting peak decreased by about 50% for the cross-linked films. The total soluble mass of all blend films in water was below 35% at 37 degrees C, indicating a good stability of the films in water. The results of the Rhodamine B dye (as a model drug) release tests showed that the release rates decreased with increasing DAS content. DAS-induced cross-linking improves several important properties of the FK/PVA films, such as the compactness, the compatibility, and the stability in water. These improvements offer the potential to expand the application of FK films in the biomaterial field.
C1 [Dou, Yao; He, Ming; Cui, Yingde] Northwestern Polytech Univ, Sch Mat Sci & Engn, Xian 710072, Shanxi, Peoples R China.
   [Zhang, Buning; Yin, Guoqiang] Zhongkai Univ Agr & Engn, Green Chem Engn Inst, Guangzhou 510225, Guangdong, Peoples R China.
   [Cui, Yingde] Guangzhou Vocat Coll Sci & Technol, Guangzhou 510550, Guangdong, Peoples R China.
   [Savina, Irina N.] Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
RP Yin, GQ (reprint author), Zhongkai Univ Agr & Engn, Green Chem Engn Inst, Guangzhou 510225, Guangdong, Peoples R China.
EM douyao1019@aliyun.com; eins001@163.com; heming1026@163.com;
   yingq007@163.com; 13602880087@139.com; I.N.Savina@brighton.ac.uk
FU National Natural Science Foundation of China [21176269]; EU
   FP7-PEOPLE-IRSES project ABREM [247599]; Higher School Science and
   Technology Innovation Project of Guangdong Province [2013KJCX0102];
   Science and Technology Plan Project of Guangdong Province
   [2013B010403029]
FX This work was supported by the National Natural Science Foundation of
   China (21176269) and the EU FP7-PEOPLE-2009-IRSES project ABREM
   (247599). Furthermore, the support from the Higher School Science and
   Technology Innovation Project of Guangdong Province (2013KJCX0102) and
   the Science and Technology Plan Project of Guangdong Province
   (2013B010403029) is also acknowledged.
CR Akhlaghi S, 2012, POLYM INT, V61, P646, DOI 10.1002/pi.3227
   Aluigi A, 2008, COMPOS PART A-APPL S, V39, P126, DOI 10.1016/j.compositesa.2007.08.022
   Alves PMA, 2011, FOOD HYDROCOLLOID, V25, P1751, DOI 10.1016/j.foodhyd.2011.03.018
   Barone JR, 2006, J CHEM EDUC, V83, P1003, DOI 10.1021/ed083p1003
   Bertini F, 2013, POLYM DEGRAD STABIL, V98, P980, DOI 10.1016/j.polymdegradstab.2013.02.011
   Costa ES, 2009, CARBOHYD POLYM, V76, P472, DOI 10.1016/j.carbpol.2008.11.015
   Dou Y, 2014, J MACROMOL SCI A, V51, P1009, DOI 10.1080/10601325.2014.967108
   Elizondo NJ, 2009, CARBOHYD POLYM, V75, P592, DOI 10.1016/j.carbpol.2008.08.020
   Figueiredo KCS, 2009, J APPL POLYM SCI, V111, P3074, DOI 10.1002/app.29263
   Flores-Hernandez CG, 2014, POLYMERS-BASEL, V6, P686, DOI 10.3390/polym6030686
   Hernandez-Munoz P, 2004, FOOD HYDROCOLLOID, V18, P403, DOI 10.1016/S0268-005X(03)00128-0
   Jin EQ, 2011, J AGR FOOD CHEM, V59, P1729, DOI 10.1021/jf1039519
   Kavitha A, 2005, J MACROMOL SCI PURE, VA42, P1703, DOI 10.1080/10601320500247154
   Kundu B, 2014, INT J BIOL MACROMOL, V70, P70, DOI 10.1016/j.ijbiomac.2014.06.022
   Langmaler F, 2008, WASTE MANAGE, V28, P549, DOI 10.1016/j.wasman.2007.02.003
   Lasekan A, 2013, WASTE MANAGE, V33, P552, DOI 10.1016/j.wasman.2012.08.001
   Limpan N, 2010, J FOOD ENG, V100, P85, DOI 10.1016/j.jfoodeng.2010.03.031
   Martelli SM, 2006, J POLYM ENVIRON, V14, P215, DOI 10.1007/s10924-006-0017-4
   Martucci JF, 2009, J APPL POLYM SCI, V112, P2166, DOI 10.1002/app.29695
   Mokrejs P, 2009, J THERM ANAL CALORIM, V98, P299, DOI 10.1007/s10973-009-0106-4
   Nakano Y, 2007, MACROMOL SYMP, V258, P63, DOI 10.1002/masy.200751208
   Park M, 2013, MAT SCI ENG C-MATER, V33, P5051, DOI 10.1016/j.msec.2013.08.032
   Parris N, 1997, J AGR FOOD CHEM, V45, P1596, DOI 10.1021/jf960809o
   Pereda M, 2010, J APPL POLYM SCI, V116, P18, DOI 10.1002/app.31425
   Moore GR, 2006, FOOD HYDROCOLLOID, V20, P975, DOI 10.1016/j.foodhyd.2005.11.001
   Prasong Srihanam, 2011, Pak J Biol Sci, V14, P351
   Ramos OL, 2013, FOOD HYDROCOLLOID, V30, P110, DOI 10.1016/j.foodhyd.2012.05.001
   Rhim JW, 2000, J AGR FOOD CHEM, V48, P4937, DOI 10.1021/jf0005418
   Rhim JW, 1998, IND CROP PROD, V8, P195, DOI 10.1016/S0926-6690(98)00003-X
   Song NB, 2013, FOOD HYDROCOLLOID, V31, P340, DOI 10.1016/j.foodhyd.2012.11.024
   Su JF, 2010, POLYM DEGRAD STABIL, V95, P1226, DOI 10.1016/j.polymdegradstab.2010.03.035
   Subramanian UM, 2014, INT J POLYM MATER PO, V63, P462, DOI 10.1080/00914037.2013.854216
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   Tian-Yu Ke, 2013, Advanced Materials Research, V647, P190, DOI 10.4028/www.scientific.net/AMR.647.190
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P243, DOI 10.1002/polb.1994.090320205
   Ustunol Z, 2004, J FOOD SCI, V69, pE129
   van den Berg LE, 2009, MAT SCI, V2, P171
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Ye M, 2014, MAT SCI ENG C-MATER, V44, P310, DOI 10.1016/j.msec.2014.08.044
NR 40
TC 11
Z9 12
U1 0
U2 57
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD MAR
PY 2015
VL 7
IS 3
BP 580
EP 591
DI 10.3390/polym7030580
PG 12
WC Polymer Science
SC Polymer Science
GA CE5JM
UT WOS:000351868600010
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Patra, C
   Boccaccini, AR
   Engel, FB
AF Patra, Chinmoy
   Boccaccini, Aldo R.
   Engel, Felix B.
TI Vascularisation for cardiac tissue engineering: the extracellular matrix
SO THROMBOSIS AND HAEMOSTASIS
LA English
DT Article
DE Heart; vascularisation; coronary vasculature; tissue engineering;
   extracellular matrix
ID SMOOTH-MUSCLE-CELLS; ZEBRAFISH HEART REGENERATION; PLURIPOTENT
   STEM-CELLS; BLOOD-VESSEL FORMATION; ACUTE MYOCARDIAL-INFARCTION;
   CORONARY-ARTERY-DISEASE; POROUS SILK SCAFFOLDS; ALPHA-GAL EPITOPE;
   IN-VITRO; ENDOTHELIAL-CELLS
AB Cardiovascular diseases present a major socio-economic burden. One major problem underlying most cardiovascular and congenital heart diseases is the irreversible loss of contractile heart muscle cells, the cardiomyocytes. To reverse damage incurred by myocardial infarction or by surgical correction of cardiac malformations, the loss of cardiac tissue with a thickness of a few millimetres needs to be compensated. A promising approach to this issue is cardiac tissue engineering. In this review we focus on the problem of in vitro vascularisation as implantation of cardiac patches consisting of more than three layers of cardiomyocytes (>100 mu m thick) already results in necrosis. We explain the need for vascularisation and elaborate on the importance to include non-myocytes in order to generate functional vascularised cardiac tissue. We discuss the potential of extracellular matrix molecules in promoting vascularisation and introduce nephronectin as an, example of a new promising candidate. Finally, we discuss current biomaterial-based approaches including micropatterning, electrospinning, 3D micro-manufacturing technology and porogens. Collectively, the current literature supports the notion that cardiac tissue engineering is a realistic option for future treatment of paediatric and adult patients with cardiac disease.
C1 [Patra, Chinmoy] Agharkar Res Inst, Dept Zool, Pune, Maharashtra, India.
   [Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Biomat, D-91054 Erlangen, Germany.
   [Engel, Felix B.] Univ Erlangen Nurnberg, Inst Pathol, Dept Nephropathol, Expt Renal & Cardiovasc Res, D-91054 Erlangen, Germany.
RP Engel, FB (reprint author), Univ Erlangen Nurnberg, Inst Pathol, Dept Nephropathol, Univ Str 22, D-91054 Erlangen, Germany.
EM felix.engel@uk-erlangen.de
RI Engel, Felix/A-1767-2008; Boccaccini, Aldo/C-7905-2013
OI Engel, Felix/0000-0003-2605-3429; 
FU ELAN Program of the Friedrich-Alexander-Universitat Erlangen-Nurnberg
FX This work was supported by the ELAN Program of the
   Friedrich-Alexander-Universitat Erlangen-Nurnberg (to F.B.E.).
CR Acarturk TO, 2004, ANN PLAS SURG, V53, P210, DOI 10.1097/01.sap.0000116285.98328.f7
   Adair-Kirk TL, 2008, INT J BIOCHEM CELL B, V40, P1101, DOI 10.1016/j.biocel.2007.12.005
   AMENTO EP, 1991, ARTERIOSCLER THROMB, V11, P1223, DOI 10.1161/01.ATV.11.5.1223
   Antman EM, 2006, NEW ENGL J MED, V354, P1477, DOI 10.1056/NEJMoa060898
   APPLEBY P, 1994, LANCET, V343, P311
   Arroyo AG, 2010, CARDIOVASC RES, V86, P226, DOI 10.1093/cvr/cvq049
   Aszodi A, 2006, ANNU REV CELL DEV BI, V22, P591, DOI 10.1146/annurev.cellbio.11.010305.104258
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atluri P, 2013, CIRCULATION, V128, pS95, DOI 10.1161/CIRCULATIONAHA.112.000368
   Aubin Hug, 2013, Methods Mol Biol, V1036, P163, DOI 10.1007/978-1-62703-511-8_14
   Aupecle B, 2002, ANN THORAC SURG, V74, P127, DOI 10.1016/S0003-4975(02)03639-1
   Aydin S, 2013, CARDIOVASCULAR SYSTE, V2, P612
   Babiarz JE, 2012, STEM CELLS DEV, V21, P1956, DOI 10.1089/scd.2011.0357
   Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007.
   Baranski JD, 2013, P NATL ACAD SCI USA, V110, P7586, DOI 10.1073/pnas.1217796110
   Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399
   Beier JP, 2009, MICROSURG, V29, P42, DOI 10.1002/micr.20564
   Bellon G, 2004, CRIT REV ONCOL HEMAT, V49, P203, DOI 10.1016/j.critrevonc.2003.10.004
   BELTRAMI CA, 1994, CIRCULATION, V89, P151, DOI 10.1161/01.CIR.89.1.151
   Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680
   Bian WN, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024109
   Boffito M, 2014, POLYM INT, V63, P2, DOI 10.1002/pi.4608
   Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   Boukens BJD, 2009, CIRC RES, V104, P19, DOI 10.1161/CIRCRESAHA.108.188698
   Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069
   Braunwald E, 2000, CIRCULATION, V102, P14
   Brautbar A, 2011, NAT REV CARDIOL, V8, P253, DOI 10.1038/nrcardio.2011.2
   Brizzio ME, 2011, REV CARDIOVASC MED, V12, pS40, DOI 10.3909/ricm12S1S0005
   Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003
   Buja LM, 2013, TEX HEART I J, V40, P221
   Busch R, 2014, ACTA BIOMATER, V10, P688, DOI 10.1016/j.actbio.2013.10.015
   Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004
   Byrne GW, 2012, CURR OPIN ORGAN TRAN, V17, P148, DOI 10.1097/MOT.0b013e3283509120
   Calve S, 2012, FASEB J, V26, P2538, DOI 10.1096/fj.11-200162
   Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007
   Cao JN, 2014, PROTEIN CELL, V5, P1, DOI 10.1007/s13238-013-0003-2
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4
   Chiu LLY, 2012, P NATL ACAD SCI USA, V109, pE3414, DOI 10.1073/pnas.1210580109
   Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627
   Ciubotaru A, 2013, BIOMED ENG-BIOMED TE, V58, P389, DOI 10.1515/bmt-2012-0148
   Ciucurel EC, 2014, TISSUE ENG PT A, V20, P1235, DOI [10.1089/ten.tea.2013.0242, 10.1089/ten.TEA.2013.0242]
   Coghlan H C, 2001, Semin Thorac Cardiovasc Surg, V13, P333
   Couzin-Frankel J, 2014, SCIENCE, V345, P252, DOI 10.1126/science.345.6194.252
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Daly KA, 2009, TISSUE ENG PT A, V15, P3877, DOI [10.1089/ten.tea.2009.0089, 10.1089/ten.TEA.2009.0089]
   Davies JE, 2007, NAT CLIN PRACT CARD, V4, P330, DOI 10.1038/ncpcardio0885
   de Valence S, 2012, BIOMATERIALS, V33, P38, DOI 10.1016/j.biomaterials.2011.09.024
   DeLeve LD, 2004, AM J PHYSIOL-GASTR L, V287, pG757, DOI 10.1152/ajpgi.00017.2004
   Didangelos A, 2010, MOL CELL PROTEOMICS, V9, P2048, DOI 10.1074/mcp.M110.001693
   Didie M, 2013, J CLIN INVEST, V123, P1285, DOI 10.1172/JCI66854
   DiNardo JA, 2013, SEMIN CARDIOTHORAC V, V17, P44, DOI 10.1177/1089253212469841
   Dolati F, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/14/145101
   Dvir T, 2007, TISSUE ENG, V13, P2185, DOI 10.1089/ten.2006.0364
   Dvorakova MC, 2008, NEUROSCIENCE, V151, P1016, DOI 10.1016/j.neuroscience.2007.07.069
   Echeverri D, 2013, J INVASIVE CARDIOL, V25, P98
   Edelman DA, 2006, J SURG RES, V135, P305, DOI 10.1016/j.jss.2006.06.010
   Ekser B, 2009, TRANSPL IMMUNOL, V21, P87, DOI 10.1016/j.trim.2008.10.005
   Eming SA, 2011, EXP DERMATOL, V20, P605, DOI 10.1111/j.1600-0625.2011.01309.x
   Engel FB, 2005, CELL CYCLE, V4, P1360, DOI 10.4161/cc.4.10.2081
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Eschenhagen T, 2012, AM J PHYSIOL-HEART C, V303, pH133, DOI 10.1152/ajpheart.00007.2012
   Fagiani E, 2013, CANCER LETT, V328, P18, DOI 10.1016/j.canlet.2012.08.018
   Faulk DM, 2014, J CELL PHYSIOL, V229, P984, DOI 10.1002/jcp.24532
   FEIGL EO, 1983, PHYSIOL REV, V63, P1
   Feinstein JA, 2012, J AM COLL CARDIOL, V59, pS1, DOI 10.1016/j.jacc.2011.09.022
   Ferrari R, 2014, EUR HEART J, V35, P2140, DOI 10.1093/eurheartj/ehu244
   Ferreira R, 2010, REV PORT CARDIOL, V29, P1037
   Fomovsky GM, 2010, J MOL CELL CARDIOL, V48, P490, DOI 10.1016/j.yjmcc.2009.08.003
   Frati C, 2011, CURR PHARM DESIGN, V17, P3252
   Fu XM, 2014, CELL MOL IMMUNOL, V11, P14, DOI 10.1038/cmi.2013.60
   Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086
   Gacche RN, 2014, BBA-REV CANCER, V1846, P161, DOI 10.1016/j.bbcan.2014.05.002
   Garkavenko O, 2008, J MED VIROL, V80, P2046, DOI 10.1002/jmv.21272
   GEORGE EL, 1993, DEVELOPMENT, V119, P1079
   Gerstel D, 2011, ONCOGENE, V30, P4275, DOI 10.1038/onc.2011.146
   Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323
   Ghista DN, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-129
   Gittenberger-de Groot AC, 1999, ARTERIOSCL THROM VAS, V19, P1589
   Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80
   Gonfiotti A, 2014, LANCET, V383, P238, DOI 10.1016/S0140-6736(13)62033-4
   Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5
   GRANT DS, 1992, J CELL PHYSIOL, V153, P614, DOI 10.1002/jcp.1041530324
   Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006
   Guo C, 2013, CURR GENE THER, V13, P133, DOI 10.2174/1566523211313020007
   Han LH, 2013, BIOMATERIALS, V34, P4251, DOI 10.1016/j.biomaterials.2013.02.051
   HARNARAYAN C, 1970, BRIT HEART J, V32, P728
   HASENFUSS G, 1991, CIRC RES, V68, P836, DOI 10.1161/01.RES.68.3.836
   Heusch G, 2014, LANCET, V383, P1933, DOI 10.1016/S0140-6736(14)60107-0
   Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057
   Higuchi K, 2000, ARCH HISTOL CYTOL, V63, P115, DOI 10.1679/aohc.63.115
   Hinek A, 1996, BIOL CHEM, V377, P471
   Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6
   Hirt MN, 2014, CIRC RES, V114, P354, DOI 10.1161/CIRCRESAHA.114.300522
   Hiura H, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-32
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Hoogaars WMH, 2007, CELL MOL LIFE SCI, V64, P646, DOI 10.1007/s00018-007-6518-z
   Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618
   Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002
   Ito S, 1997, Cardiovasc Surg, V5, P176, DOI 10.1016/S0967-2109(97)00004-5
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118
   Kalfa D, 2013, RAMBAM MAIMONIDES ME, V4, DOI 10.5041/RMMJ.10119
   Kaminsky SM, 2013, HUM GENE THER, V24, P948, DOI 10.1089/hum.2013.2516
   Kang TY, 2013, ACTA BIOMATER, V9, P4716, DOI 10.1016/j.actbio.2012.08.042
   Kawamura M, 2013, CIRCULATION, V128, pS87, DOI 10.1161/CIRCULATIONAHA.112.000366
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Keane TJ, 2014, J TISSUE ENG REGEN M, V14
   Kemeny SF, 2013, J CELL PHYSIOL, V228, P1727, DOI 10.1002/jcp.24313
   Kensah G, 2013, EUR HEART J, V34, P1134, DOI 10.1093/eurheartj/ehs349
   Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010
   Kim BR, 2014, BBA-MOL BASIS DIS, V1842, P1324, DOI 10.1016/j.bbadis.2014.05.004
   Kim J, 2010, P NATL ACAD SCI USA, V107, P17206, DOI 10.1073/pnas.0915016107
   Kim S, 2008, TISSUE ENG PART B-RE, V14, P133, DOI 10.1089/teb.2007.0304
   Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506
   Kolewe ME, 2013, ADV MATER, V25, P4459, DOI 10.1002/adma.201301016
   KORECKY B, 1982, CAN J PHYSIOL PHARM, V60, P23, DOI 10.1139/y82-003
   Krieger EV, 2014, HEART, V100, P1329, DOI 10.1136/heartjnl-2014-305667
   Lammert E, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006619
   Langone AJ, 2003, NEW ENGL J MED, V349, P704, DOI 10.1056/NEJMe038117
   Lavine KJ, 2007, TRENDS CARDIOVAS MED, V17, P77, DOI 10.1016/j.tcm.2007.01.002
   Lavine KJ, 2009, CIRC RES, V104, P159, DOI 10.1161/CIRCRESAHA.108.191239
   Le Gloan L, 2013, EXPERT REV CARDIOVAS, V11, P233, DOI [10.1586/erc.12.170, 10.1586/ERC.12.170]
   Lee B, 2011, J CLIN INVEST, V121, P3005, DOI 10.1172/JCI46358
   Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115
   Lesman A, 2010, TISSUE ENG PT A, V16, P115, DOI [10.1089/ten.tea.2009.0130, 10.1089/ten.TEA.2009.0130]
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   Lokmic Z, 2008, TISSUE ENG PART B-RE, V14, P87, DOI 10.1089/teb.2007.0299
   Longnus SL, 2014, NAT REV CARDIOL, V11, P354, DOI 10.1038/nrcardio.2014.45
   Lu TY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3307
   Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Mammadov R, 2011, BIOMACROMOLECULES, V12, P3508, DOI 10.1021/bm200957s
   Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765
   Martin-Puig S, 2012, ANN NY ACAD SCI, V1254, P71, DOI 10.1111/j.1749-6632.2012.06488.x
   Martins-Taylor K, 2012, STEM CELLS, V30, P22, DOI 10.1002/stem.705
   Matsa E, 2014, CIRC RES, V114, P21, DOI 10.1161/CIRCRESAHA.113.302895
   Matsuda K, 2013, TISSUE ENG PT A, V19, P1327, DOI [10.1089/ten.tea.2012.0391, 10.1089/ten.TEA.2012.0391]
   Matsuura K, 2014, INT HEART J, V55, P1
   Melchiorri AJ, 2013, TISSUE ENG PART B-RE, V19, P292, DOI [10.1089/ten.teb.2012.0577, 10.1089/ten.TEB.2012.0577]
   Mercer SE, 2013, DEV BIOL, V382, P457, DOI 10.1016/j.ydbio.2013.08.002
   Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51
   Mittal K, 2014, SEMIN ONCOL, V41, P235, DOI 10.1053/j.seminoncol.2014.02.007
   Moiseeva EP, 2001, CARDIOVASC RES, V52, P372, DOI 10.1016/S0008-6363(01)00399-6
   Montgomery M, 2014, J CARDIOVASC PHARM T, V19, P382, DOI 10.1177/1074248414528576
   Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003
   Moroni F, 2014, AM J STEM CELLS, V3, P1
   Morritt AN, 2007, CIRCULATION, V115, P353, DOI 10.1161/CIRCULATIONAHA.106.657379
   MULVANY MJ, 1990, PHYSIOL REV, V70, P921
   Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086
   Naito H, 2006, CIRCULATION, V114, P172, DOI DOI 10.1161/CIRCULATIONAHA.105.001560
   Nakayama M, 2013, NAT CELL BIOL, V15, P249, DOI 10.1038/ncb2679
   Naso F, 2012, XENOTRANSPLANTATION, V19, P215, DOI 10.1111/j.1399-3089.2012.00714.x
   Naugle JE, 2006, AM J PHYSIOL-HEART C, V290, pH323, DOI 10.1152/ajpheart.00321.2005
   Neethling WML, 2013, INTERACT CARDIOV TH, V17, P698, DOI 10.1093/icvts/ivt268
   Neumann A, 2014, TISSUE ENG PT A, V20, P1003, DOI [10.1089/ten.tea.2013.0316, 10.1089/ten.TEA.2013.0316]
   Neve A, 2014, BIOMED RES INT, DOI 10.1155/2014/756078
   Newman AC, 2011, MOL BIOL CELL, V22, P3791, DOI 10.1091/mbc.E11-05-0393
   Nikolic I, 2013, BLOOD, V121, P3041, DOI 10.1182/blood-2011-11-394882
   Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4
   Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047
   Olivey HE, 2010, CIRC RES, V106, P818, DOI 10.1161/CIRCRESAHA.109.209197
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420
   Pagliari S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00210
   Pan Y, 2008, DEVELOPMENT, V135, P301, DOI 10.1242/dev.014829
   Panaro F, 2014, J GASTROINTEST SURG, V18, P1518, DOI 10.1007/s11605-014-2484-6
   Panopoulos AD, 2011, CELL STEM CELL, V8, P347, DOI 10.1016/j.stem.2011.03.003
   Park H, 2014, STEM CELL TRANSL MED, V3, P599, DOI 10.5966/sctm.2013-0149
   Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F
   Pati F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4935
   Patra C, 2012, BIOMATERIALS, V33, P4327, DOI 10.1016/j.biomaterials.2012.03.021
   Patra C, 2011, DEVELOPMENT, V138, P4499, DOI 10.1242/dev.067454
   Pauziene N, 2000, J ANAT, V197, P437, DOI 10.1046/j.1469-7580.2000.19730437.x
   Pavo N, 2014, J MOL CELL CARDIOL, V75, P12, DOI 10.1016/j.yjmcc.2014.06.016
   Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a
   Picascia A, 2012, EXP CLIN TRANSPLANT, V10, P209, DOI 10.6002/ect.2011.0185
   Pincott ES, 2012, FUTUR CARDIOL, V8, P161, DOI [10.2217/fca.12.13, 10.2217/FCA.12.13]
   Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001
   Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708
   Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857
   Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039
   Pozzi Ambra, 1998, Journal of Cell Biology, V142, P587, DOI 10.1083/jcb.142.2.587
   Pries A. R., 2006, V176, P1
   Qian L, 2013, CIRC RES, V113, P915, DOI 10.1161/CIRCRESAHA.112.300625
   Radisic M, 2005, AM J PHYSIOL-HEART C, V288, pH1278, DOI 10.1152/ajpheart.00787.2004
   Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578
   Radisic M, 2008, NAT PROTOC, V3, P719, DOI 10.1038/nprot.2008.40
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   RAKUSAN K, 1992, CIRCULATION, V86, P38, DOI 10.1161/01.CIR.86.1.38
   Ramsauer M, 2007, J CELL SCI, V120, P1810, DOI 10.1242/jcs.003533
   Ratajska A, 2008, INT J DEV BIOL, V52, P229, DOI 10.1387/ijdb.072340ar
   Ravichandran R, 2011, TISSUE ENG PT A, V17, P1363, DOI [10.1089/ten.tea.2010.0441, 10.1089/ten.TEA.2010.0441]
   Ravichandran R, 2013, INT J CARDIOL, V167, P1461, DOI 10.1016/j.ijcard.2012.04.045
   Reffelmann T, 2003, HEART FAIL REV, V8, P201, DOI 10.1023/A:1024796912475
   Risau W, 1998, Kidney Int Suppl, V67, pS3
   Rizzoni D, 2009, BLOOD PRESSURE, V18, P242, DOI 10.1080/08037050903254923
   Robertson MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090406
   Rotenberg MY, 2012, LAB CHIP, V12, P2696, DOI [10.1039/c2lc40144d, 10.1039/c21c40144d]
   Sage H., 1982, PATHOBIOLOGY ENDOTHE, P215
   Samples J, 2013, SURG ONCOL CLIN N AM, V22, P629, DOI 10.1016/j.soc.2013.06.002
   Satchell S, 2013, NAT REV NEPHROL, V9, P717, DOI 10.1038/nrneph.2013.197
   Schoen FJ, 2011, CURR OPIN BIOTECH, V22, P698, DOI 10.1016/j.copbio.2011.01.004
   Schomig A, 2000, NEW ENGL J MED, V343, P385, DOI 10.1056/NEJM200008103430602
   Schwartz MA, 2001, TRENDS CELL BIOL, V11, P466, DOI 10.1016/S0962-8924(01)02152-3
   Segura I, 2009, TRENDS MOL MED, V15, P439, DOI 10.1016/j.molmed.2009.08.005
   Seifert AW, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-2
   Sekine H, 2008, CIRCULATION, V118, pS145, DOI 10.1161/CIRCULATIONAHA.107.757286
   Sekine H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2406
   Seol YJ, 2014, EUR J CARDIO-THORAC, V46, P342, DOI 10.1093/ejcts/ezu148
   Servick K, 2014, SCIENCE, V345, P254, DOI 10.1126/science.345.6194.254
   Shevach M, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024101
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje
   Simon-Assmann P, 2011, INT J DEV BIOL, V55, P455, DOI 10.1387/ijdb.103223ps
   Sluijter JPG, 2014, PHARMACOL THERAPEUT, V144, P60, DOI 10.1016/j.pharmthera.2014.05.005
   Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139
   Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106
   Sugaya N, 2008, J BIOL CHEM, V283, P10366, DOI 10.1074/jbc.M705948200
   Suzuki H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039562
   SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takebe T, 2012, TRANSPL P, V44, P1130, DOI 10.1016/j.transproceed.2012.03.039
   Taylor DO, 2008, J HEART LUNG TRANSPL, V27, P943, DOI 10.1016/j.healun.2008.06.017
   Tee R, 2012, TISSUE ENG PT A, V18, P1992, DOI [10.1089/ten.tea.2012.0151, 10.1089/ten.TEA.2012.0151]
   Tian T, 2014, ATHEROSCLEROSIS, V233, P485, DOI 10.1016/j.atherosclerosis.2014.01.027
   Tian XY, 2013, CELL RES, V23, P1075, DOI 10.1038/cr.2013.83
   Tiburcy M, 2011, CIRC RES, V109, P1105, DOI 10.1161/CIRCRESAHA.111.251843
   Tiruvannamalai-Annamalai R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084287
   Tonsho M, 2014, COLD SPRING HARB PER
   Torrent-Guasp F, 2001, Semin Thorac Cardiovasc Surg, V13, P301
   Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206
   van Amerongen MJ, 2008, J CELL MOL MED, V12, P2233, DOI 10.1111/j.1582-4934.2008.00439.x
   van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025
   VLIEGEN HW, 1991, EUR HEART J, V12, P488, DOI 10.1093/oxfordjournals.eurheartj.a059928
   Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9
   Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352
   Wainwright JM, 2010, TISSUE ENG PART C-ME, V16, P525, DOI [10.1089/ten.tec.2009.0392, 10.1089/ten.TEC.2009.0392]
   Wang JH, 2013, DEV BIOL, V382, P427, DOI 10.1016/j.ydbio.2013.08.012
   Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620
   Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231
   Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212
   Westerhof N, 2006, PHYSIOL REV, V86, P1263, DOI 10.1152/physrev.00029.2005
   Wray LS, 2013, ADV FUNCT MATER, V23, P3404, DOI 10.1002/adfm.201202926
   Xu J, 2014, BIOCH BIOPHYS ACTA
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
   Yang W, 2013, FEBS LETT, V587, P185, DOI 10.1016/j.febslet.2012.11.023
   Yang XL, 2014, CIRC RES, V114, P511, DOI 10.1161/CIRCRESAHA.114.300558
   Yang YK, 2002, J APPL PHYSIOL, V93, P1140, DOI 10.1152/japplphysiol.00307.2002
   Yasui H, 2014, BIOMATERIALS, V35, P7839, DOI 10.1016/j.biomaterials.2014.05.080
   Yoo S. Y, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/127170
   Zebrowski DC, 2013, REV PHYSIOL BIOCH P, V165, P67, DOI 10.1007/112_2013_12
   Zeng QC, 2013, INT HEART J, V54, P40, DOI 10.1536/ihj.54.40
   Zhang L, 2014, ARTERIOSCL THROM VAS, V34, P1114, DOI 10.1161/ATVBAHA.114.303809
   Zhao D, 2011, NAT REV CARDIOL, V8, P456, DOI 10.1038/nrcardio.2011.75
   Zhao L, 2014, P NATL ACAD SCI USA, V111, P1403, DOI 10.1073/pnas.1311705111
   Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135
   Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109
   Zieber L, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024102
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2009, PEDIATR CARDIOL, V30, P716, DOI 10.1007/s00246-009-9405-6
NR 269
TC 10
Z9 10
U1 1
U2 53
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0340-6245
J9 THROMB HAEMOSTASIS
JI Thromb. Haemost.
PD MAR
PY 2015
VL 113
IS 3
BP 532
EP 547
DI 10.1160/TH14-05-0480
PG 16
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA CD3ZZ
UT WOS:000351023700012
PM 25319066
DA 2018-10-19
ER

PT J
AU Wang, Q
   Zhang, H
   Li, QJ
   Ye, L
   Gan, HQ
   Liu, YJ
   Wang, H
   Wang, ZQ
AF Wang, Qian
   Zhang, Hui
   Li, Qijia
   Ye, Lei
   Gan, Hongquan
   Liu, Yingjie
   Wang, Hui
   Wang, Zhiqiang
TI Biocompatibility and osteogenic properties of porous tantalum
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article
DE porous tantalum; osteogenesis; biocompatibility; cell toxicity; bone
   tissue engineering
ID MECHANICAL-PROPERTIES; METAL IMPLANTS; TITANIUM; PROLIFERATION;
   BIOMATERIAL; SURFACES
AB Porous tantalum has been reported to be a promising material for use in bone tissue engineering. In the present study, the biocompatibility and osteogenic properties of porous tantalum were studied in vitro and in vivo. The morphology of porous tantalum was observed using scanning electron microscopy (SEM). Osteoblasts were cultured with porous tantalum, and cell morphology, adhesion and proliferation were investigated using optical microscopy and SEM. In addition, porous tantalum rods were implanted in rabbits, and osteogenesis was observed using laser scanning confocal microscopy and hard tissue slice examination. The osteoblasts were observed to proliferate over time and adhere to the tantalum surface and pore walls, exhibiting a variety of shapes and intercellular connections. The porous tantalum rod connected tightly with the host bone. At weeks 2 and 4 following implantation, new bone and small blood vessels were observed at the tantalum-host bone interface and pores. At week 10 after the porous tantalum implantation, new bone tissue was observed at the tantalum-host bone interface and pores. By week 12, the tantalum-host bone interface and pores were covered with new bone tissue and the bone trabeculae had matured and connected directly with the materials. Therefore, the results of the present study indicate that porous tantalum is non-toxic, biocompatible and a promising material for use in bone tissue engineering applications.
C1 [Wang, Qian; Zhang, Hui; Wang, Hui] Southern Med Univ, Grad Sch, Guangzhou 510515, Guangdong, Peoples R China.
   [Wang, Qian] Hebei United Univ, Basic Med Coll, Dept Anat, Tangshan 063000, Hebei, Peoples R China.
   [Zhang, Hui] Second Hosp Tangshan, Dept Joint Surg, Tangshan 063000, Hebei, Peoples R China.
   [Li, Qijia] Hebei United Univ, Expt Ctr, Tangshan 063000, Hebei, Peoples R China.
   [Ye, Lei] Chongqing Runze Pharmaceut Co Ltd, Chongqing 401120, Peoples R China.
   [Gan, Hongquan; Liu, Yingjie; Wang, Zhiqiang] Hebei United Univ, Dept Orthoped, Affiliated Hosp, Tangshan 063000, Hebei, Peoples R China.
   [Wang, Hui] Second Hosp Tangshan, Dept Hand Surg, Tangshan 063000, Hebei, Peoples R China.
RP Wang, ZQ (reprint author), Hebei United Univ, Dept Orthoped, Affiliated Hosp, 73 Jianshe Rd, Tangshan 063000, Hebei, Peoples R China.
EM wzhqde@126.com
CR [Anonymous], 2009, 109935 ISO
   Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046
   Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Cardaropoli F, 2012, ADV MATER RES-SWITZ, V535-537, P1222, DOI 10.4028/www.scientific.net/AMR.535-537.1222
   Christie Michael J, 2002, Am J Orthop (Belle Mead NJ), V31, P219
   Cohen Robert, 2002, Am J Orthop (Belle Mead NJ), V31, P216
   Hacking SA, 1999, CLIN ORTHOP RELAT R, P240
   Jonitz A, 2011, J MATER SCI-MATER M, V22, P2089, DOI 10.1007/s10856-011-4384-6
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Li Y, 2008, SURF COAT TECH, V202, P3017, DOI 10.1016/j.surfcoat.2007.11.003
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Mrosek EH, 2010, J ORTHOP RES, V28, P141, DOI 10.1002/jor.20983
   Pohler O. E., 2000, INJURY S4, V1, P7
   Sagomonyants KB, 2011, J ORTHOP RES, V29, P609, DOI 10.1002/jor.21251
   Shimko DA, 2005, J BIOMED MATER RES B, V73B, P315, DOI 10.1002/jbm.b.30229
   Stiehler M, 2008, J BIOMED MATER RES A, V86A, P448, DOI 10.1002/jbm.a.31602
   Tang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066263
   Wang JC, 1998, SPINE, V23, P1684, DOI 10.1097/00007632-199808010-00014
   Wang N, 2012, ACS APPL MATER INTER, V4, P4516, DOI 10.1021/am300727v
   Wigfield C, 2003, BRIT J NEUROSURG, V17, P418, DOI 10.1080/02688690310001611206
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   Zhang HY, 2013, J MECH BEHAV BIOMED, V20, P209, DOI 10.1016/j.jmbbm.2013.01.001
   Zhang HY, 2013, J TRIBOL-T ASME, V135, DOI 10.1115/1.4023802
NR 25
TC 14
Z9 17
U1 2
U2 23
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD MAR
PY 2015
VL 9
IS 3
BP 780
EP 786
DI 10.3892/etm.2015.2208
PG 7
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CD2OC
UT WOS:000350917900021
OA Green Published
DA 2018-10-19
ER

PT J
AU Notodihardjo, PV
   Morimoto, N
   Kakudo, N
   Matsui, M
   Sakamoto, M
   Liem, PH
   Suzuki, K
   Tabata, Y
   Kusumoto, K
AF Notodihardjo, Priscilla Valentin
   Morimoto, Naoki
   Kakudo, Natsuko
   Matsui, Makoto
   Sakamoto, Michiharu
   Liem, Pham Hieu
   Suzuki, Kenji
   Tabata, Yasuhiko
   Kusumoto, Kenji
TI Gelatin hydrogel impregnated with platelet-rich plasma releasate
   promotes angiogenesis and wound healing in murine model
SO JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Platelet-rich plasma; Biomaterial; Gelatin hydrogel; Growth factors;
   Wound healing
ID FIBROBLAST-GROWTH-FACTOR; BONE REGENERATION; SCAFFOLD; DEFECTS; CELLS
AB Platelet-rich plasma (PRP) contains numerous growth factors to promote wound healing and angiogenesis. The objective of this study was to explore the efficacy of biodegradable gelatin hydrogel impregnated with PRP releasate (PRPr) in the wound healing process compared with the single application of PRPr prepared from mouse PRP centrifuged by a double-spin method. Gelatin hydrogel disks with an isoelectric point of 5.0 were used in this study. A total of 180 mice (n = 45/group) were randomly assigned to the following 4 experimental groups: control group, biodegradable gelatin hydrogel group, PRPr group and gelatin hydrogel impregnated with PRPr (PRPrG) group. Wound area and epithelialization were compared on days 1, 5, 7, 14 and 21 post-wounding. After complete epithelialization, wound contraction was also evaluated. Neovascularization using immunohistochemical staining of von Willebrand factor was analyzed on day 14. The wound area of PRPrG on days 5, 7 and 14 was smaller than that in the other groups (p < 0.01). The epithelialization lengths of PRPrG on days 7 and 14 were significantly longer than the others (p < 0.01). The capillary formation of PRPrG was also superior to those in all other groups on day 14. On day 21, all wounds were completely epithelialized and PRPrG prevented wound contraction the most. It is concluded that the sustained-release system of gelatin impregnated with PRPr can stimulate angiogenesis and accelerate wound healing compared with the single application of PRP.
C1 [Notodihardjo, Priscilla Valentin; Morimoto, Naoki; Kakudo, Natsuko; Suzuki, Kenji; Kusumoto, Kenji] Kansai Med Univ, Dept Plast & Reconstruct Surg, Hirakata, Osaka 5731010, Japan.
   [Matsui, Makoto; Tabata, Yasuhiko] Kyoto Univ, Dept Biomat, Field Tissue Engn, Inst Frontier Med Sci, Kyoto, Japan.
   [Sakamoto, Michiharu; Liem, Pham Hieu] Kyoto Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Kyoto, Japan.
RP Notodihardjo, PV (reprint author), Kansai Med Univ, Dept Plast & Reconstruct Surg, 2-5-1 Shin Machi, Hirakata, Osaka 5731010, Japan.
EM priscilla.valentin@gmail.com; mnaoki22@kuhp.kyoto-u.ac.jp
OI Kakudo, Natsuko/0000-0001-9785-1490; Morimoto, Naoki/0000-0002-0712-3172
FU Kansai Medical University
FX This study was supported by a research Grant from Kansai Medical
   University.
CR Bir SC, 2009, J VASC SURG, V50, P870, DOI 10.1016/j.jvs.2009.06.016
   Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x
   Hokugo A, 2005, TISSUE ENG, V11, P1224, DOI 10.1089/ten.2005.11.1224
   Hong L, 2000, J NEUROSURG, V92, P315, DOI 10.3171/jns.2000.92.2.0315
   Iacopetti I, 2012, J EQUINE VET SCI, V32, P123, DOI 10.1016/j.jevs.2011.08.012
   Ishida K, 2007, TISSUE ENG, V13, P1103, DOI 10.1089/ten.2006.0193
   Ito R, 2013, TISSUE ENG PART A, V19, P140
   Kakudo N, 2008, PLAST RECONSTR SURG, V122, P1352, DOI 10.1097/PRS.0b013e3181882046
   Kanematsu A, 2004, BIOMATERIALS, V25, P4513, DOI 10.1016/j.biomaterials.2003.11.035
   Martinez-Zapata MJ, 2012, COCHRANE DB SYST REV, V10
   Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003
   Matsui M, 2012, ACTA BIOMATER, V8, P1792, DOI 10.1016/j.actbio.2012.01.016
   Miyoshi M, 2005, J BIOMAT SCI-POLYM E, V16, P893, DOI 10.1163/1568562054255709
   Morimoto N, 2013, TISSUE ENG PT A, V19, P1931, DOI [10.1089/ten.tea.2012.0634, 10.1089/ten.TEA.2012.0634]
   Nagae M, 2007, TISSUE ENG, V13, P147, DOI 10.1089/ten.2006.0042
   Ozeki M, 2002, TISSUE ENG, V8, P359, DOI 10.1089/107632702760184637
   Liem PH, 2013, J SURG RES, V182, P353, DOI 10.1016/j.jss.2012.10.018
   Sugimori E, 2006, DENT MATER J, V25, P591, DOI 10.4012/dmj.25.591
   Tabata Y, 1999, TISSUE ENG, V5, P127, DOI 10.1089/ten.1999.5.127
NR 19
TC 11
Z9 11
U1 3
U2 22
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 1434-7229
EI 1619-0904
J9 J ARTIF ORGANS
JI J. Artif. Organs
PD MAR
PY 2015
VL 18
IS 1
BP 64
EP 71
DI 10.1007/s10047-014-0795-8
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA CD2DQ
UT WOS:000350884800009
PM 25326193
DA 2018-10-19
ER

PT J
AU Anderson, JM
AF Anderson, James M.
TI Exploiting the inflammatory response on biomaterials research and
   development
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB Exploiting the inflammatory response on biomaterials research and development requires an in-depth understanding of the cellular and molecular mechanisms involved in the events comprising the tissue response continuum. Examples of how the biomaterial surface chemistry may modulate the foreign body reaction to biomaterials. The utilization of different surface chemistries on biomaterials may provide biological design criteria for the appropriate use and function of biomaterials when used in medical devices and prostheses.
C1 [Anderson, James M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [Anderson, James M.] Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
   [Anderson, James M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
EM jma6@case.edu
NR 0
TC 13
Z9 14
U1 3
U2 16
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2015
VL 26
IS 3
AR 121
DI 10.1007/s10856-015-5423-5
PG 2
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC9AI
UT WOS:000350659300001
PM 25690617
DA 2018-10-19
ER

PT J
AU de Mel, A
   Yap, T
   Cittadella, G
   Hale, LR
   Maghsoudlou, P
   de Coppi, P
   Birchall, MA
   Seifalian, AM
AF de Mel, Achala
   Yap, Trixie
   Cittadella, Giorgio
   Hale, Luke Richard
   Maghsoudlou, Panagiotis
   de Coppi, Paolo
   Birchall, Martin A.
   Seifalian, Alexander M.
TI A potential platform for developing 3D tubular scaffolds for paediatric
   organ development
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; SMOOTH-MUSCLE-CELLS; BYPASS GRAFTS;
   MECHANICAL-PROPERTIES; TISSUE; DIFFERENTIATION; NANOCOMPOSITE;
   REGENERATION; POROSITY; DESIGN
AB Children suffer from damaged or loss of hollow organs i.e. trachea, oesophagus or arteries from birth defects or diseases. Generally these organs possess an outer matrix consisting of collagen, elastin, and cells such as smooth muscle cells (SMC) and a luminal layer consisting of endothelial or epithelial cells, whilst presenting a barrier to luminal content. Tissue engineering research enables the construction of such organs and this study explores this possibility with a bioabsorbable nanocomposite biomaterial, polyhedral oligomeric silsesquioxane poly(e-caprolactone) urea urethane (POSS-PCL). Our established methods of tubular graft extrusion were modified using a porogen-in-corporated POSS-PCL and a new lamination method was explored. Porogen (40, 60 or 105 mu m) were introduced to POSS-PCL, which were fabricated into a bilayered, dual topography matching the exterior and luminal interior of tubular organs. POSS-PCL with different amounts of porogen were tested for their suitability as a SMC layer by measuring optimal interactions with human adipose derived stem cells. Angiogenesis potential was tested with the chorioallantoic membrane assay. Tensile strength and burst pressures of bilayared tubular grafts were determined. Scaffolds made with 40 mu m porogen demonstrated optimal adipose derived stem cell integration and the scaffolds were able to accommodate angiogenesis. Mechanical properties of the grafts confirmed their potential to match the relevant physiological and biophysical parameters. This study presents a platform for the development of hollow organs for transplantation based on POSS-PCL. These bilayered-tubular structures can be tailor-made for cellular integration and match physico-mechanical properties of physiological systems of interest. More specific luminal cell integration and sources of SMC for the external layer could be further explored.
C1 [de Mel, Achala; Yap, Trixie; Cittadella, Giorgio; Hale, Luke Richard; Seifalian, Alexander M.] UCL Div Surg & Intervent Sci, London NW3 2QG, England.
   [Maghsoudlou, Panagiotis; de Coppi, Paolo] UCL, Great Ormond St Hosp, Inst Child Hlth, London, England.
   [Birchall, Martin A.] UCL, UCL Ear Inst, Royal Natl Throat Nose & Ear Hosp, London, England.
   [Seifalian, Alexander M.] Royal Free London NHS Fdn Trust Hosp, London, England.
RP de Mel, A (reprint author), UCL Div Surg & Intervent Sci, Royal Free NHS Trust Hosp Campus,9th Floor,Rm 355, London NW3 2QG, England.
EM a.mel@ucl.ac.uk; a.seifalian@ucl.ac.uk
OI De Coppi, Paolo/0000-0002-1659-0207
FU Royal Free Charity; Medical Research Council [G1001539, MR/K026453/1];
   National Institute for Health Research [NF-SI-0513-10089,
   RP_2014-04-046]
FX Authors would like to thank Mr. Arnold Darbyshire for synthesising the
   nanocomposite materials and assistance with mechanical properties of the
   material. Philip Garner and Luke Hale for assistance with imaging during
   their work experience attachment with the authors. Royal Free Charity
   for their funding on development of hollow organs.
CR Ahmed M, 2014, BIOMATERIALS, V35, P9033, DOI 10.1016/j.biomaterials.2014.07.008
   Ahmed M, 2011, ACTA BIOMATER, V7, P3857, DOI 10.1016/j.actbio.2011.06.051
   Basu J, 2010, TRENDS BIOTECHNOL, V28, P526, DOI 10.1016/j.tibtech.2010.07.007
   Birchall MA, 2009, BRIT J SURG, V96, P565, DOI 10.1002/bjs.6666
   Chaloupka K, 2011, BIOTECHNOL APPL BIOC, V58, P363, DOI 10.1002/bab.53
   Cittadella G, 2013, ARTIF ORGANS, V37, P423, DOI 10.1111/aor.12022
   de Mel A, 2014, MACROMOL BIOSCI, V14, P307, DOI 10.1002/mabi.201300382
   de Mel A, 2012, MACROMOL BIOSCI, V12, P1010, DOI 10.1002/mabi.201200039
   Del GC, 2013, J BIOMED MATER RES A, V102, P2427
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Gong ZD, 2008, FASEB J, V22, P1635, DOI 10.1096/fj.07-087924
   Guasti L, 2013, NANOMEDICINE, V10, P279
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Huang JI, 2004, PLAST RECONSTR SURG, V113, P585, DOI 10.1097/01.PRS.0000101063.27008.E1
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Khalil AS, 2013, ACS CHEM BIOL, V9, P45
   Khani MM, 2014, ANN BIOMED ENG, V42, P1373, DOI 10.1007/s10439-013-0889-0
   Lanfranchi A, 2009, EARLY HUM DEV, V85, pS15, DOI 10.1016/j.earlhumdev.2009.08.005
   Lin CH, 2014, STEM CELLS DEV, V23, P2581, DOI 10.1089/scd.2014.0163
   Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.TEB.2012.0437, 10.1089/ten.teb.2012.0437]
   Mun CH, 2013, ARTIF ORGANS, V37, pE168, DOI 10.1111/aor.12108
   Nakamoto T, 2014, COLLOID SURFACE B, V122, P316, DOI 10.1016/j.colsurfb.2014.06.013
   Orbay H, 2012, STEM CELLS INT, V2012, DOI DOI 10.1155/2012/461718
   Partington L, 2013, ACTA BIOMATER, V9, P5251, DOI 10.1016/j.actbio.2012.10.004
   Post MJ, 2013, REGEN MED, V8, P759, DOI 10.2217/rme.13.74
   Sarkar S, 2006, J VASC SURG, V44, P846, DOI 10.1016/j.jvs.2006.07.023
   Sarkar S, 2009, J BIOMECH, V42, P722, DOI 10.1016/j.jbiomech.2009.01.003
   Seifalian AM, 2002, ARTIF ORGANS, V26, P307, DOI 10.1046/j.1525-1594.2002.06841.x
   Seifalian AM, 2001, J BIOMED MATER RES, V55, P637, DOI 10.1002/1097-4636(20010615)55:4<637::AID-JBM1058>3.0.CO;2-Z
   Seo CH, 2013, BIOMATERIALS, V34, P1764, DOI 10.1016/j.biomaterials.2012.11.031
   Seol YJ, 2014, EUR J CARDIO-THORAC, V46, P342, DOI 10.1093/ejcts/ezu148
   Totonelli G, 2012, BIOMATERIALS, V33, P3401, DOI 10.1016/j.biomaterials.2012.01.012
   Vacanti JP, 2012, BRIT J SURG, V99, P451, DOI 10.1002/bjs.7819
   Wang C, 2010, TISSUE ENG PT A, V16, P1201, DOI [10.1089/ten.tea.2009.0303, 10.1089/ten.TEA.2009.0303]
   Wilson A, 2011, CELL PROLIFERAT, V44, P86, DOI 10.1111/j.1365-2184.2010.00736.x
   Yannas IV, 2013, BIOMATERIALS, V34, P321, DOI 10.1016/j.biomaterials.2012.10.006
   Yildirimer L, 2014, TISSUE ENG C
   Yildirimer L, 2014, BIOTECHNOL ADV, V32, P984, DOI 10.1016/j.biotechadv.2014.04.014
   Zhao J, 2012, ARTIF ORGANS, V36, P93, DOI 10.1111/j.1525-1594.2011.01231.x
NR 39
TC 5
Z9 5
U1 0
U2 25
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2015
VL 26
IS 3
AR 141
DI 10.1007/s10856-015-5477-4
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC9AI
UT WOS:000350659300021
PM 25737129
DA 2018-10-19
ER

PT J
AU Kucharska, M
   Walenko, K
   Lewandowska-Szumiel, M
   Brynk, T
   Jaroszewicz, J
   Ciach, T
AF Kucharska, Martyna
   Walenko, Katarzyna
   Lewandowska-Szumiel, Malgorzata
   Brynk, Tomasz
   Jaroszewicz, Jakub
   Ciach, Tomasz
TI Chitosan and composite microsphere-based scaffold for bone tissue
   engineering: evaluation of tricalcium phosphate content influence on
   physical and biological properties
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FABRICATION; ROUGHNESS; MEMBRANE
AB In the hereby presented work the authors describe a technique of high-compression-resistant biodegradable bone scaffold preparation. The methodology is based on the agglomeration of chitosan (CH) and chitosan/beta-tricalcium phosphate (CH/TCP) microspheres and represents a novel approach to 3D matrices design for bone tissue engineering application. The materials were prepared from high deacetylation degree chitosan. The authors describe the method for scaffold fabrication, essential properties of the materials manufactured and the influence of various TCP concentrations on material morphology, mechanical properties (for dry and hydrated materials) and preliminary study on the interaction between CH or CH/TCP scaffolds and within cultured MG-63 osteoblast-like cells. The properties of the obtained materials were significantly affected by the calcium phosphate content, which had a particular influence on the granule microstructure, size distribution and inner biomaterial pore size. The water uptake ability was found to be lower for the materials enriched with the inorganic phase and tended to decrease with the increasing calcium phosphate concentration. The evaluation of mechanical properties has revealed that scaffolds produced with the usage of granule-based technology display a potential to be used as a load-bearing material since the Young's modulus values were limited to the range of 200-500 MPa for dry materials and 15-20 MPa for the hydrated state of the scaffolds. The cell number, identified in three time points (48 h, 7 and 14 days) by Pico Green assay, was lower for the materials enriched with inorganic phase (75 % of control), however cell distribution, when compared to CH only biomaterial, was acknowledged as steadier on the surface of the material containing the highest calcium phosphate concentration.
C1 [Kucharska, Martyna; Ciach, Tomasz] Warsaw Univ Technol, Fac Chem & Proc Engn, Biomed Engn Lab, PL-00645 Warsaw, Poland.
   [Kucharska, Martyna] Polish Acad Sci, Inst Fundamental Technol Res, Warsaw, Poland.
   [Walenko, Katarzyna; Lewandowska-Szumiel, Malgorzata] Med Univ Warsaw, Dept Biophys & Human Physiol, Warsaw, Poland.
   [Brynk, Tomasz; Jaroszewicz, Jakub] Warsaw Univ Technol, Fac Mat Sci & Engn, PL-00645 Warsaw, Poland.
RP Kucharska, M (reprint author), Warsaw Univ Technol, Fac Chem & Proc Engn, Biomed Engn Lab, Warynskiego 1, PL-00645 Warsaw, Poland.
EM martyna.kucharska@gmail.com
OI Jaroszewicz, Jakub/0000-0002-5037-8082; Ciach,
   Tomasz/0000-0002-8726-8944; Brynk, Tomasz/0000-0002-5825-4789;
   Lewandowska-Szumiel, Malgorzata/0000-0002-7140-0541
FU European Union through the Warsaw University of Technology Development
   Programme1#; National Centre for Research and Development [NR
   13-0008-10/2010]
FX This work has been supported by the European Union in the framework of
   European Social Fund through the Warsaw University of Technology
   Development Programme<SUP>1#</SUP> and Grant No. NR 13-0008-10/2010 from
   The National Centre for Research and Development.
CR Borchard G, 2001, ADV DRUG DELIVER REV, V52, P145, DOI 10.1016/S0169-409X(01)00198-3
   Champion E, 2013, ACTA BIOMATER, V9, P5855, DOI 10.1016/j.actbio.2012.11.029
   Chen JP, 2008, COLLOID SURFACE A, V313, P183, DOI 10.1016/j.colsurfa.2007.04.129
   Gasser B, 2000, INJURY, V31
   GIANNOUDIS PV, 2005, INJURY, V365, P520
   GOLDSTEIN SA, 1987, J BIOMECH, V20, P1055, DOI 10.1016/0021-9290(87)90023-6
   Hsieh CY, 2007, CARBOHYD POLYM, V67, P124, DOI 10.1016/j.carbpol.2006.05.002
   Hsu SH, 2004, J POLYM RES, V11, P141, DOI 10.1023/B:JPOL.0000031080.70010.0b
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kucharska M, 2010, MATER LETT, V64, P1059, DOI 10.1016/j.matlet.2010.02.012
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kumbar SG, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/6/065005
   Lichte P, 2011, INJURY, V42, P569, DOI 10.1016/j.injury.2011.03.033
   Lobo SE, 2010, MATERIALS, V3, P815, DOI 10.3390/ma3020815
   Lu SY, 2008, BURNS, V34, P623, DOI 10.1016/j.burns.2007.08.020
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Montanaro L, 2002, BIOMATERIALS, V23, P3651, DOI 10.1016/S0142-9612(02)00098-4
   Muzzarelli RAA, 2011, CARBOHYD POLYM, V83, P1433, DOI 10.1016/j.carbpol.2010.10.044
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   Peter M, 2010, CARBOHYD POLYM, V80, P687, DOI 10.1016/j.carbpol.2009.11.050
   Ren DW, 2005, CARBOHYD RES, V340, P2403, DOI 10.1016/j.carres.2005.07.022
   Seol YJ, 2004, BIOTECHNOL LETT, V26, P1037, DOI 10.1023/B:BILE.0000032962.79531.fd
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Tigli RS, 2007, J MATER SCI-MATER M, V18, P1665, DOI [10.1007/s10856-007-3066, 10.1007/s10856-007-3066-x]
   Yang B, 2010, CARBOHYD POLYM, V80, P860, DOI 10.1016/j.carbpol.2009.12.044
   Yang ZH, 2006, MOL THER, V13, pS76, DOI 10.1016/j.ymthe.2006.08.221
   Zan QF, 2008, APPL SURF SCI, V255, P401, DOI 10.1016/j.apsusc.2008.06.074
   Zhao L, 2004, J MATER SCI-MATER M, V15, P625, DOI 10.1023/B:JMSM.0000026103.44687.d0
NR 31
TC 7
Z9 8
U1 1
U2 40
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2015
VL 26
IS 3
AR 143
DI 10.1007/s10856-015-5464-9
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC9AI
UT WOS:000350659300023
PM 25737128
DA 2018-10-19
ER

PT J
AU Ospina, NM
   Alvarez, SPO
   Sierra, DME
   Vahos, DFR
   Ocampo, PAZ
   Orozco, CPO
AF Mesa Ospina, Natali
   Ospina Alvarez, Sandra Patricia
   Escobar Sierra, Diana Marcela
   Rojas Vahos, Diego Fernando
   Zapata Ocampo, Paola Andrea
   Ossa Orozco, Claudia Patricia
TI Isolation of chitosan from Ganoderma lucidum mushroom for biomedical
   applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CHITIN; DEACETYLATION; COATINGS; QUALITY; LIFE
AB Chitin biopolymer production and its by-product chitosan show great potential. These biomaterials have great applicability in various fields because they are non-toxic, biodegradable, biocompatible, and have antimicrobial effects. The most common source of chitin and chitosan is the crustaceous shell; however, mushrooms are an alternative source for isolating these biopolymers because their cellular wall has a high content of chitin, which may be transformed into chitosan through a deacetylation reaction. The main objective of this research was to obtain chitosan through the deacetylation of chitin isolated from the Ganoderma lucidum basidiomycetes mushroom, which is obtained through biotechnological culture. The material characterization was performed using X-ray diffraction, Fourier transform infrared spectroscopy, thermogravimetric analysis, and an evaluation of cytotoxicity comparing the results obtained with results for commercial chitosan. Protocol results showed that chitosan obtained from this mushroom had a significant similitude with commercial chitosan, yet the one obtained using P2 protocol was the one that rendered the best results: including diffractogram peaks, characteristic infrared analysis bands, and an 80.29 % degree of deacetylation. Cytotoxicity in vitro testing showed that the material was non-toxic; furthermore, it rendered very promising information regarding the evaluation of future applications of this biomaterial in the field of biomedicine.
C1 [Mesa Ospina, Natali; Escobar Sierra, Diana Marcela; Ossa Orozco, Claudia Patricia] Univ Antioquia UdeA, Fac Engn, Biomat Res Grp, Bioengn Program, Medellin, Colombia.
   [Ospina Alvarez, Sandra Patricia; Rojas Vahos, Diego Fernando; Zapata Ocampo, Paola Andrea] Univ Antioquia UdeA, Inst Biol, Biotechnol Res Grp, Medellin, Colombia.
RP Orozco, CPO (reprint author), Univ Antioquia UdeA, Fac Engn, Biomat Res Grp, Bioengn Program, Calle 70 52-21, Medellin, Colombia.
EM claudia.ossa@udea.edu.co
FU Universidad de Antioquia CODI
FX The authors of this study express their gratitude to both Universidad de
   Antioquia CODI for its funding of this research project and to the
   Biotechnology and Biomaterial Research Groups.
CR Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   [Anonymous], BIOL REACT TESTS IN
   BOUGH WA, 1978, BIOTECHNOL BIOENG, V20, P1931, DOI 10.1002/bit.260201208
   Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   Caprile MD, C MUND ISWA 2005 HAC
   Cervera MF, 2004, CARBOHYD POLYM, V58, P401, DOI 10.1016/j.carbpol.2004.08.017
   Chandumpai A, 2004, CARBOHYD POLYM, V58, P467, DOI 10.1016/j.carbpol.2004.08.015
   Crestini C, 1996, BIOTECHNOL BIOENG, V50, P207, DOI 10.1002/bit.260500202
   Di Mario F, 2008, INT J BIOL MACROMOL, V43, P8, DOI 10.1016/j.ijbiomac.2007.10.005
   Dutta PK, 2002, J MACROMOL SCI-POL R, VC42, P307, DOI 10.1081/MC-120006451
   Elsabee MZ, 2013, MAT SCI ENG C-MATER, V33, P1819, DOI 10.1016/j.msec.2013.01.010
   Galia CR, 2008, CLINICS, V63, P801, DOI 10.1590/S1807-59322008000600016
   Gol NB, 2013, POSTHARVEST BIOL TEC, V85, P185, DOI 10.1016/j.postharvbio.2013.06.008
   Hong KQ, 2012, SCI HORTIC-AMSTERDAM, V144, P172, DOI 10.1016/j.scienta.2012.07.002
   Ivshin VP, 2007, POLYM SCI, V49, P2215
   Kasaal MR, 2008, CARBOHYD POLYM, V71, P497, DOI 10.1016/j.carbpol.2007.07.009
   Kaya M, 2014, MAT SCI ENG C-MATER, V45, P72, DOI 10.1016/j.msec.2014.09.004
   Khor E., 2001, CHITIN FULFILLING BI
   Larez C, 2006, AVANCES QUIMICA, V1, P15
   Liao SK, 2004, MACROMOL RES, V12, P466, DOI 10.1007/BF03218428
   Methacanon P, 2003, CARBOHYD POLYM, V52, P119, DOI 10.1016/S0144-8617(02)00300-4
   Musarrat HM, 2013, FOOD HYDROCOLLOID, V31, P166
   MUZZARELLI RAA, 1976, CHITIN
   Olvera Acosta P., 2003, AISLAMIENTO LEVADURA, P79
   Ospina SP, 2014, BIOMED RES INT, V2014, P1
   Paulino AT, 2006, CARBOHYD POLYM, V64, P98, DOI 10.1016/j.carbpol.2005.10.032
   Peniche Covas C., 2006, THESIS U LA HABANA C
   Pochanavanich P, 2002, LETT APPL MICROBIOL, V35, P17, DOI 10.1046/j.1472-765X.2002.01118.x
   Prichystalova H, 2014, INT J BIOL MACROMOL, V65, P234, DOI 10.1016/j.ijbiomac.2014.01.050
   Quiriz FA, 2012, EVALUACION PROPIEDAD, P86
   Ramya R., 2012, INT J SCI RES PUBLIC, V2, P1
   Rojas D, 2013, OPEN C P J, V4, P93
   Wan ACA, 2013, BIOTECHNOL ADV, V31, P1776, DOI 10.1016/j.biotechadv.2013.09.007
   Wu T, 2005, J AGR FOOD CHEM, V53, P3888, DOI 10.1021/jf048202s
   Zakaria Z, 2012, BIORESOURCES, V7, P5568
   Zapata P, 2012, INT J MED MUSHROOMS, V14, P197, DOI 10.1615/IntJMedMushr.v14.i2.80
NR 36
TC 8
Z9 9
U1 0
U2 33
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2015
VL 26
IS 3
AR 135
DI 10.1007/s10856-015-5461-z
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC9AI
UT WOS:000350659300015
PM 25716022
DA 2018-10-19
ER

PT J
AU Salvage, J
   Thorpe, J
   Santin, M
AF Salvage, Jonathan
   Thorpe, Julian
   Santin, Matteo
TI Soybean-based biomaterial granules induce biomineralization in MG-63
   human osteosarcoma osteoblast-like cells through ultrastructural changes
   and phagocytic activity
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID INTRACELLULAR CALCIUM-PHOSPHATE; ANTIGENIC PHENOTYPE; T-LYMPHOCYTES;
   IFN-GAMMA; DIFFERENTIATION; EXPRESSION; PARTICLES; MOLECULES; CD54
C1 [Salvage, Jonathan; Santin, Matteo] Univ Brighton, Brighton Ctr Regenerat Med, Brighton Studies Tissue Mimicry & Aided Regenerat, Brighton BN2 4GJ, E Sussex, England.
   [Thorpe, Julian] Univ Sussex, Sch Life Sci, Sussex Ctr Adv Microscopy, Brighton BN1 9QG, E Sussex, England.
RP Santin, M (reprint author), Univ Brighton, Brighton Ctr Regenerat Med, Brighton Studies Tissue Mimicry & Aided Regenerat, Huxley Bldg Lewes Rd, Brighton BN2 4GJ, E Sussex, England.
EM M.Santin@brighton.ac.uk
OI Thorpe, Julian/0000-0002-0895-703X
CR Boonrungsiman S, 2012, P NATL ACAD SCI USA, V109, P14170, DOI 10.1073/pnas.1208916109
   Diaz-Rodriguez L, 2009, ANN NY ACAD SCI, V1173, pE46, DOI 10.1111/j.1749-6632.2009.04950.x
   Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1
   Garcia-Martinez O, 2006, BIOSCIENCE REP, V26, P39, DOI 10.1007/s10540-006-9006-z
   Giavaresi G, 2010, J MATER SCI-MATER M, V21, P615, DOI 10.1007/s10856-009-3870-6
   Heinemann DEH, 2000, J BONE JOINT SURG BR, V82B, P283, DOI 10.1302/0301-620X.82B2.9730
   Lisignoli G, 2004, J CELL PHYSIOL, V198, P388, DOI 10.1002/jcp.10427
   Mahamid J, 2011, J STRUCT BIOL, V174, P527, DOI 10.1016/j.jsb.2011.03.014
   Meikle ST, 2012, TISSUE ENG PT A, V18, P1932, DOI [10.1089/ten.tea.2011.0549, 10.1089/ten.TEA.2011.0549]
   Middleton E, 2000, PHARMACOL REV, V52, P673
   Morris C, 2006, J NUTR, V136, P1166
   Neve A, 2011, CELL TISSUE RES, V343, P289, DOI 10.1007/s00441-010-1086-1
   Reyes-Botella C, 2002, CELL PHYSIOL BIOCHEM, V12, P359, DOI 10.1159/000067906
   Reyes-Botella C, 2000, J PERIODONTOL, V71, P614, DOI 10.1902/jop.2000.71.4.614
   Rifas L, 2003, J CELL BIOCHEM, V88, P650, DOI 10.1002/jcb.10436
   Ruiz C, 2007, J BONE MINER METAB, V25, P286, DOI 10.1007/s00774-007-0767-7
   Ruiz C, 2003, CELL PHYSIOL BIOCHEM, V13, P309, DOI 10.1159/000074546
   Santin M, 2008, EXPERT REV MED DEVIC, V5, P349, DOI 10.1586/17434440.5.3.349
   Santin M, 2007, BIOMACROMOLECULES, V8, P2706, DOI 10.1021/bm0703362
   Stanley KT, 2006, J BONE MINER RES, V21, P29, DOI 10.1359/JBMR.051004
   Tomazic-Jezic VJ, 2001, J BIOMED MATER RES, V55, P523, DOI 10.1002/1097-4636(20010615)55:4<523::AID-JBM1045>3.0.CO;2-G
NR 21
TC 3
Z9 3
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2015
VL 26
IS 3
AR 122
DI 10.1007/s10856-015-5451-1
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC9AI
UT WOS:000350659300002
PM 25690618
DA 2018-10-19
ER

PT J
AU Daoush, WMRM
   Park, HS
   Inam, F
   Lim, BK
   Hong, SH
AF Daoush, Walid Mohamed Rashad Mohamed
   Park, Hee Sup
   Inam, Fawad
   Lim, Byung Kyu
   Hong, Soon Hyung
TI Microstructural and Mechanical Characterization of Ti-12Mo-6Zr
   Biomaterials Fabricated by Spark Plasma Sintering
SO METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND
   MATERIALS SCIENCE
LA English
DT Article
ID TOTAL HIP-REPLACEMENT; TI-TA ALLOYS; BIOMEDICAL APPLICATIONS; YOUNGS
   MODULUS; TITANIUM-ALLOYS; CORROSION; COATINGS; HYDROXYAPATITE;
   ARTHROPLASTY; COMBINATION
AB Ti-12Mo-6Zr/Al2O3 (titanium biomaterial) was prepared by a powder metallurgy route using Spark Plasma Sintering (SPS). Ti, Mo, and Zr powders were mixed by wet milling with different content of alumina nanoparticles (up to 5 wt pct) as an oxide dispersion strengthening phase. Composite powder mixtures were SPSed at 1273 K (1000 degrees C) followed by heat treatment and quenching. Composite powders, sintered materials, and heat-treated materials were examined using optical and high-resolution electronic microscopy (scanning and transmission) and X-ray diffraction to characterize particle size, surface morphology, and phase identifications for each composition. All sintered materials were evaluated by measuring density, Vickers hardness, and tensile properties. Fully dense sintered materials were produced by SPS and mechanical properties were found to be improved by subsequent heat treatment. The tensile properties as well as the hardness were increased by increasing the content of Al2O3 nanoparticles in the Ti-12Mo-6Zr matrix. (C) The Minerals, Metals & Materials Society and ASM International 2014
C1 [Daoush, Walid Mohamed Rashad Mohamed] Helwan Univ, Fac Ind Educ, Prod Technol Dept, Cairo 1151111668, Egypt.
   [Park, Hee Sup] ILJIN Diamond Co Ltd, Ind Technol Inst, Eumsung Kun 369824, Chungcheongbuk, South Korea.
   [Inam, Fawad] Northumbria Univ, Fac Engn & Environm, Dept Mech & Construct Engn, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.
   [Lim, Byung Kyu; Hong, Soon Hyung] Korea Adv Inst Sci & Technol, Dept Mat Sci & Engn, Composite Mat Lab, Taejon 305701, South Korea.
RP Daoush, WMRM (reprint author), Helwan Univ, Fac Ind Educ, Prod Technol Dept, 30 El Sawah St, Cairo 1151111668, Egypt.
EM waliddaoush@techedu.helwan.edu.eg
RI Hong, Soon Hyung/C-1943-2011; Inam, Fawad/Q-9531-2017
OI Inam, Fawad/0000-0002-3149-7991; daoush, walid/0000-0002-6430-5749;
   Hong, Soon Hyung/0000-0001-7358-3989
CR Akahori T., 2001, P PRICM, P209
   Bal SB, 2006, SEMIN ARTHROPLASTY, V17, P94
   Bierbaum BE, 2002, CLIN ORTHOP RELAT R, P158, DOI 10.1097/01.blo.0000038043.63743.9f
   Bigi A, 2007, J BIOMED MATER RES A, V82A, P213, DOI 10.1002/jbm.a.31132
   Black J., 1998, HDB BIOMATERIAL PROP
   BOUTIN P, 1988, J BIOMED MATER RES, V22, P1203, DOI 10.1002/jbm.820221210
   BOUTIN P, 1971, PRESSE MED, V79, P639
   Carbajal G, 2001, ANTI-CORROS METHOD M, V48, P241, DOI 10.1108/00035590110398899
   Chang J-D, 2007, STEINKOPFF, P123
   Cui Z., 2000, METALLOGRAPHY HEAT T
   Davidson J.A., 1987, P IMPL MAN MAT TECHN, P122
   DIETER DE, 1976, MECH METALLURGY
   Gibbesch B, 1989, Int J Oral Maxillofac Implants, V4, P131
   Hannouche D, 2005, CLIN ORTHOP RELAT R, P62, DOI 10.1097/01.blo.0000149996.91974.83
   Hao YL, 2002, METALL MATER TRANS A, V33, P3137, DOI 10.1007/s11661-002-0299-7
   HARMS J, 1979, J BIOMED MATER RES, V13, P67, DOI 10.1002/jbm.820130109
   Jackson HF, 2010, INT J APPL CERAM TEC, V7, P316, DOI 10.1111/j.1744-7402.2009.02434.x
   Kawahara H., 1963, J JPN SOC DENT APPAR, V4, P65
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Kuroda D, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P99
   Laskin RS, 2004, TECH KNEE SURG, V3, P187
   Lawrence K., 1980, NATURE, V283, P106, DOI DOI 10.1038/283106A07350519
   Lee HN, 2000, ACTA MATER, V48, P3221, DOI 10.1016/S1359-6454(00)00123-3
   LEE YT, 1991, METALL TRANS A, V22, P709, DOI 10.1007/BF02670293
   Li SJ, 2002, MATER TRANS, V43, P2964, DOI 10.2320/matertrans.43.2964
   MACK DJ, 1946, T AM I MIN MET ENG, V166, P68
   Majima T, 2008, KNEE SURG SPORT TR A, V16, P152, DOI 10.1007/s00167-007-0435-4
   McGregor DB, 2000, EUR J CANCER, V36, P307, DOI 10.1016/S0959-8049(99)00312-3
   Niinomi M., 2003, Science and Technology of Advanced Materials, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   NIINOMI M., 1998, MAT SCI ENG A-STRUCT, V243, P243
   Oonishi H, 2002, KEY ENG MAT, V218-2, P499, DOI 10.4028/www.scientific.net/KEM.218-220.499
   Oonishi H, 2000, J BIOMED MATER RES, V51, P37, DOI 10.1002/(SICI)1097-4636(200007)51:1<37::AID-JBM6>3.0.CO;2-T
   Oonishi H., 2006, BIOCERAMICS ALTERNAT, P101
   Pandorf T, 2007, CER ORTHO, P137, DOI 10.1007/978-3-7985-1783-7_18
   Sato M, 2008, J BIOMED MATER RES A, V84A, P265, DOI 10.1002/jbm.a.31469
   SEMLITSCH M, 1977, J BIOMED MATER RES, V11, P537, DOI 10.1002/jbm.820110409
   Shen GX, 2005, THIN SOLID FILMS, V489, P130, DOI 10.1016/j.tsf.2005.05.016
   Skinner HB, 1999, CLIN ORTHOP RELAT R, P83
   Song Y, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P273
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   Wang Y, 2006, WEAR, V260, P976, DOI 10.1016/j.wear.2005.06.013
   Wang YM, 2009, APPL SURF SCI, V255, P6875, DOI 10.1016/j.apsusc.2009.03.007
   WAPNER KL, 1991, CLIN ORTHOP RELAT R, P12
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, BIOMATERIALS, V20, P1222
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Xu JW, 2015, J ALLOY COMPD, V618, P343, DOI 10.1016/j.jallcom.2014.08.223
   Yoshimitsu O., 2004, BIOMATERIALS, V25, P5913
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V384, P92, DOI 10.1016/j.msea.2004.05.084
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
NR 53
TC 0
Z9 0
U1 1
U2 22
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1073-5623
EI 1543-1940
J9 METALL MATER TRANS A
JI Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.
PD MAR
PY 2015
VL 46A
IS 3
BP 1385
EP 1393
DI 10.1007/s11661-014-2693-3
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CC4DE
UT WOS:000350300200036
DA 2018-10-19
ER

PT J
AU Watts, MP
   Coker, VS
   Parry, SA
   Pattrick, RAD
   Thomas, RAP
   Kalin, R
   Lloyd, JR
AF Watts, Mathew P.
   Coker, Victoria S.
   Parry, Stephen A.
   Pattrick, Richard A. D.
   Thomas, Russell A. P.
   Kalin, Robert
   Lloyd, Jonathan R.
TI Biogenic nano-magnetite and nano-zero valent iron treatment of alkaline
   Cr(VI) leachate and chromite ore processing residue
SO APPLIED GEOCHEMISTRY
LA English
DT Article
ID PERMEABLE REACTIVE BARRIERS; X-RAY-ABSORPTION; MEDIATED CHROMATE
   REDUCTION; NANOSCALE ZEROVALENT IRON; CATION SITE OCCUPANCY; HEXAVALENT
   CHROMIUM; AQUEOUS CR(VI); PHOTOELECTRON-SPECTROSCOPY; ENVIRONMENTAL
   CHEMISTRY; MICROBIAL REDUCTION
AB Highly reactive nano-scale biogenic magnetite (BnM), synthesized by the Fe(III)-reducing bacterium Geobacter sulfurreducens, was tested for the potential to remediate alkaline Cr(VI) contaminated waters associated with chromite ore processing residue (COPR). The performance of this biomaterial, targeting aqueous Cr(VI) removal, was compared to a synthetic alternative, nano-scale zero valent iron (nZVI). Samples of highly contaminated alkaline groundwater and COPR solid waste were obtained from a contaminated site in Glasgow, UK. During batch reactivity tests, Cr(VI) removal from groundwater was inhibited by similar to 25% (BnM) and similar to 50% (nZVI) when compared to the treatment of less chemically complex model pH 12 Cr(VI) solutions. In both the model Cr(VI) solutions and contaminated groundwater experiments the surface of the nanoparticles became passivated, preventing complete coupling of their available electrons to Cr(VI) reduction. To investigate this process, the surfaces of the reacted samples were analyzed by TEM-EDX, XAS and XPS, confirming Cr(VI) reduction to the less soluble Cr(III) on the nanoparticle surface. In groundwater reacted samples the presence of Ca, Si and S was also noted on the surface of the nanoparticles, and is likely responsible for earlier onset of passivation. Treatment of the solid COPR material in contact with water, by addition of increasing weight % of the nanoparticles, resulted in a decrease in aqueous Cr(VI) concentrations to below detection limits, via the addition of >= 5% w/w BnM or >= 1% w/w nZVI. XANES analysis of the Cr K edge, showed that the % Cr(VI) in the COPR dropped from 26% to a minimum of 4-7% by the addition of 5% w/w BnM or 2% w/w nZVI, with higher additions unable to reduce the remaining Cr(VI). The treated materials exhibited minimal re-mobilization of soluble Cr(VI) by re-equilibration with atmospheric oxygen, with the bulk of the Cr remaining in the solid fraction. Both nanoparticles exhibited a considerable capacity for the remediation of COPR related Cr(VI) contamination, with the synthetic nZVI demonstrating greater reactivity than the BnM. However, the biosynthesized BnM was also capable of significant Cr(VI) reduction and demonstrated a greater efficiency for the coupling of its electrons towards Cr(VI) reduction than the nZVI. (C) 2014 The Authors. Published by Elsevier Ltd.
C1 [Watts, Mathew P.; Coker, Victoria S.; Pattrick, Richard A. D.; Lloyd, Jonathan R.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England.
   [Watts, Mathew P.; Coker, Victoria S.; Pattrick, Richard A. D.; Lloyd, Jonathan R.] Univ Manchester, Williamson Res Ctr Mol Environm Sci, Manchester M13 9PL, Lancs, England.
   [Parry, Stephen A.] Diamond Light Source, Didcot OX11 ODE, Oxon, England.
   [Thomas, Russell A. P.] Parsons Brinckerhoff, Bristol BS6 6US, Avon, England.
   [Kalin, Robert] Univ Strathclyde, Dept Civil & Environm Engn, Glasgow G1 1XJ, Lanark, Scotland.
RP Lloyd, JR (reprint author), Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England.
EM Jon.Lloyd@manchester.ac.uk
OI Lloyd, Jonathan/0000-0002-0719-0498; Coker,
   Victoria/0000-0002-1332-216X; Parry, Stephen/0000-0001-5205-4543
FU BBSRC; European Union [309517]; Office of Science, Office of Basic
   Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231];
   CASE support from Parsons Brinckerhoff
FX This work was supported by funding from BBSRC and CASE support from
   Parsons Brinckerhoff. In addition to support from the European Union
   Seventh Framework Programme (FP7/2007-2013) under Grant Agreement No.
   309517 (NANOREM). Thanks are due to Dr. A. Walton and Dr. M. Ward for
   their assistance with XPS and TEM analysis via the Leeds EPSRC
   Nanoscience and Nanotechnology Research Equipment Facility (LENNF). Dr.
   J. Waters, Mr. P. Lythgoe and Mr. A. Bewsher are thanked for their
   assistance with XRD, ICP-AES, XRF and IC analyses. Thanks also to Dr. P.
   Wincott for XPS analysis and data analysis. Special thanks to Mr. N.
   Johnson of ERS Land Regeneration and Dr. T. Henman of Parsons
   Brinckerhoff for help with obtaining COPR and groundwater samples
   respectively. We acknowledge Diamond Light Source for time on beam-line
   B18 under proposal SP8163. The Advanced Light Source is supported by the
   Director, Office of Science, Office of Basic Energy Sciences, of the
   U.S. Department of Energy under Contract No. DE-AC02-05CH11231.
CR Arenholz E, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2008027
   Aronniemi M, 2005, SURF SCI, V578, P108, DOI 10.1016/j.susc.2005.01.019
   ASAMI K, 1977, CORROS SCI, V17, P559, DOI 10.1016/S0010-938X(77)80002-4
   Ashwal LD, 1997, CONTRIB MINERAL PETR, V127, P75, DOI 10.1007/s004100050266
   BAJT S, 1993, ANAL CHEM, V65, P1800, DOI 10.1021/ac00061a026
   Biesinger MC, 2004, SURF INTERFACE ANAL, V36, P1550, DOI 10.1002/sia.1983
   Blowes DW, 1997, ENVIRON SCI TECHNOL, V31, P3348, DOI 10.1021/es960844b
   Blowes DW, 2000, J CONTAM HYDROL, V45, P123, DOI 10.1016/S0169-7722(00)00122-4
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Burke T., 1991, CHROMITE ORE PROCESS
   Byrne JM, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/45/455709
   Cao HS, 2006, J HAZARD MATER, V132, P213, DOI 10.1016/j.jhazmat.2005.09.008
   Chaplin BP, 2012, ENVIRON SCI TECHNOL, V46, P3655, DOI 10.1021/es204087q
   Chen JM, 1998, CRIT REV ENV SCI TEC, V28, P219, DOI 10.1080/10643389891254214
   Cheng YJ, 2012, ELEMENTS, V8, P107, DOI 10.2113/gselements.8.2.107
   Chrysochoou M, 2009, ENVIRON SCI TECHNOL, V43, P5461, DOI 10.1021/es9005338
   CLAIRE, 2007, CLAIRE TECHN B, VTB14
   Coker V.S., 2013, ENVIRON TECHNOL, V35, P1
   Coker VS, 2007, EUR J MINERAL, V19, P707, DOI 10.1127/0935-1221/2007/0019-1758
   Crane RA, 2012, J HAZARD MATER, V211, P112, DOI 10.1016/j.jhazmat.2011.11.073
   Crean DE, 2012, ENVIRON SCI TECHNOL, V46, P3352, DOI 10.1021/es2037146
   Cutting RS, 2009, GEOCHIM COSMOCHIM AC, V73, P4004, DOI 10.1016/j.gca.2009.04.009
   Cutting RS, 2010, ENVIRON SCI TECHNOL, V44, P2577, DOI 10.1021/es902119u
   Darrie G, 2001, ENVIRON GEOCHEM HLTH, V23, P187, DOI 10.1023/A:1012295927081
   Dayan AD, 2001, HUM EXP TOXICOL, V20, P439, DOI 10.1191/096032701682693062
   Dermatas D, 2006, ENVIRON SCI TECHNOL, V40, P5786, DOI 10.1021/es0604461
   Du J., 2012, J HAZARD MAT
   EARY LE, 1987, ENVIRON SCI TECHNOL, V21, P1187, DOI 10.1021/es00165a005
   EARY LE, 1988, ENVIRON SCI TECHNOL, V22, P972, DOI 10.1021/es00173a018
   EPA U., 1992, 3060A EPA
   Farmer JG, 2006, SCI TOTAL ENVIRON, V360, P90, DOI 10.1016/j.scitotenv.2005.08.027
   Farmer JG, 2002, J ENVIRON MONITOR, V4, P235, DOI 10.1039/b108681m
   Farmer JG, 1999, ENVIRON GEOCHEM HLTH, V21, P331, DOI 10.1023/A:1006788418483
   Fendorf S, 2000, INT GEOL REV, V42, P691, DOI 10.1080/00206810009465107
   Fendorf SE, 1996, ENVIRON SCI TECHNOL, V30, P1614, DOI 10.1021/es950618m
   FENDORF SE, 1995, GEODERMA, V67, P55, DOI 10.1016/0016-7061(94)00062-F
   FENDORF SE, 1992, ENVIRON SCI TECHNOL, V26, P79, DOI 10.1021/es00025a006
   Fordyce F.M., 2012, OR08002 BRIT GEOL SU, P1
   Fuller SJ, 2013, IND ENG CHEM RES, V52, P4704, DOI 10.1021/ie302914b
   Furukawa Y, 2002, ENVIRON SCI TECHNOL, V36, P5469, DOI 10.1021/es025533h
   Geelhoed JS, 2003, ENVIRON SCI TECHNOL, V37, P3206, DOI 10.1021/es0264798
   Geelhoed JS, 2002, GEOCHIM COSMOCHIM AC, V66, P3927, DOI 10.1016/S0016-7037(02)00977-8
   Giampaolo C, 2002, CEMENT CONCRETE RES, V32, P769, DOI 10.1016/S0008-8846(01)00760-8
   GIBB TC, 1992, J MATER CHEM, V2, P105, DOI 10.1039/jm9920200105
   Graham MC, 2006, SCI TOTAL ENVIRON, V364, P32, DOI 10.1016/j.scitotenv.2005.11.007
   Grosvenor AP, 2004, SURF INTERFACE ANAL, V36, P1564, DOI 10.1002/sia.1984
   GUPTA RP, 1975, PHYS REV B, V12, P15, DOI 10.1103/PhysRevB.12.15
   Hansel CM, 2003, GEOCHIM COSMOCHIM AC, V67, P401, DOI 10.1016/S0016-7037(02)01081-5
   He F, 2008, APPL CATAL B-ENVIRON, V84, P533, DOI 10.1016/j.apcatb.2008.05.008
   He YT, 2005, ENVIRON SCI TECHNOL, V39, P4499, DOI [10.1021/es0483692, 10.1021/eso0483692]
   He YT, 2004, ENVIRON SCI TECHNOL, V38, P5535, DOI 10.1021/es049809s
   Hillier S, 2007, ENVIRON SCI TECHNOL, V41, P1921, DOI 10.1021/es0621997
   Hillier S, 2003, SCI TOTAL ENVIRON, V308, P195, DOI 10.1016/S0048-9697(02)00680-0
   Hochella MF, 2008, SCIENCE, V319, P1631, DOI 10.1126/science.1141134
   Jimenez-Villacorta F, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.172404
   Jung Y, 2007, CHEMOSPHERE, V68, P1968, DOI 10.1016/j.chemosphere.2007.02.028
   Kamaludeen SPB, 2003, REV ENVIRON CONTAM T, V178, P93, DOI 10.1007/0-387-21728-2_4
   Kelly S.D., 2008, SOIL SCI SOC AM J
   Kendelewicz T, 2000, SURF SCI, V469, P144, DOI 10.1016/S0039-6028(00)00808-6
   Kendelewicz T, 1999, SURF SCI, V424, P219, DOI 10.1016/S0039-6028(98)00940-6
   Kim C, 2001, ENVIRON SCI TECHNOL, V35, P2219, DOI 10.1021/es0017007
   Kimbrough DE, 1999, CRIT REV ENV SCI TEC, V29, P1, DOI 10.1080/10643389991259164
   Kosmulski M, 2004, J COLLOID INTERF SCI, V275, P214, DOI 10.1016/j.jcis.2004.02.029
   Kotas J, 2000, ENVIRON POLLUT, V107, P263, DOI 10.1016/S0269-7491(99)00168-2
   Lai KCK, 2008, ENVIRON SCI TECHNOL, V42, P1238, DOI 10.1021/es071572n
   Li XQ, 2008, IND ENG CHEM RES, V47, P2131, DOI 10.1021/ie061655x
   Li XQ, 2006, CRIT REV SOLID STATE, V31, P111, DOI 10.1080/10408430601057611
   Lloyd JR, 2003, BIOCHEM J, V369, P153, DOI 10.1042/BJ20020597
   Lo IMC, 2006, WATER RES, V40, P595, DOI 10.1016/j.watres.2005.11.033
   LOVLEY DR, 1995, J IND MICROBIOL, V14, P85, DOI 10.1007/BF01569889
   LOVLEY DR, 1986, APPL ENVIRON MICROB, V52, P751
   Malherbe J, 2011, ENVIRON SCI TECHNOL, V45, P10492, DOI 10.1021/es201002g
   Manning BA, 2007, ENVIRON SCI TECHNOL, V41, P586, DOI 10.1021/es061721m
   MCCAFFERTY E, 1988, CORROS SCI, V28, P559, DOI 10.1016/0010-938X(88)90024-8
   MCINTYRE NS, 1977, ANAL CHEM, V49, P1521, DOI 10.1021/ac50019a016
   Moon DH, 2007, J HAZARD MATER, V143, P629, DOI [10.1016/j.jhazmat.2007.01.013, 10.1016/j.hazmat.2007.01.013]
   Moon DH, 2011, GEOSCI J, V15, P287, DOI 10.1007/s12303-011-0023-y
   Pattrick RAD, 2002, EUR J MINERAL, V14, P1095, DOI 10.1127/0935-1221/2002/0014-1095
   Peterson ML, 1997, ENVIRON SCI TECHNOL, V31, P1573, DOI 10.1021/es960868i
   Peterson ML, 1996, COLLOID SURFACE A, V107, P77, DOI 10.1016/0927-7757(95)03345-9
   Phillips DH, 2010, ENVIRON SCI TECHNOL, V44, P3861, DOI 10.1021/es902737t
   Pollock J, 2007, APPL MICROBIOL BIOT, V77, P927, DOI 10.1007/s00253-007-1220-5
   Ponder S.M., 2001, CHEM MAT, V13
   Ponder SM, 2000, ENVIRON SCI TECHNOL, V34, P2564, DOI 10.1021/es9911420
   Puls RW, 1999, APPL GEOCHEM, V14, P989, DOI 10.1016/S0883-2927(99)00010-4
   RAI D, 1989, SCI TOTAL ENVIRON, V86, P15, DOI 10.1016/0048-9697(89)90189-7
   Ravel B., 2009, ATHENA USERS GUIDE 1
   Rizoulis A, 2012, MINERAL MAG, V76, P3261, DOI 10.1180/minmag.2012.076.8.39
   Rowbotham AL, 2000, J TOXICOL ENV HEAL B, V3, P145, DOI 10.1080/10937400050045255
   SHIRLEY DA, 1972, PHYS REV B, V5, P4709, DOI 10.1103/PhysRevB.5.4709
   Skougstad M.W., 1979, 5 USGS, P5
   Stewart DI, 2007, GEOMICROBIOL J, V24, P655, DOI 10.1080/01490450701758221
   Stewart DI, 2010, ECOL ENG, V36, P211, DOI 10.1016/j.ecoleng.2008.12.028
   STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016
   Sun YP, 2006, ADV COLLOID INTERFAC, V120, P47, DOI 10.1016/j.cis.2006.03.001
   Telling ND, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3249578
   Tinjum JM, 2008, SCI TOTAL ENVIRON, V391, P13, DOI 10.1016/j.scitotenv.2007.10.041
   Tratnyek PG, 2006, NANO TODAY, V1, P44, DOI 10.1016/S1748-0132(06)70048-2
   Wang YT, 2000, ENVIRONMENTAL MICROBE-METAL INTERACTIONS, P225
   Wazne M, 2007, J HAZARD MATER, V143, P620, DOI 10.1016/j.jhazmat.2007.01.012
   Whalley C, 1999, WATER AIR SOIL POLL, V112, P389, DOI 10.1023/A:1005017506227
   Whittleston RA, 2011, GEOMICROBIOL J, V28, P68, DOI 10.1080/01490451.2010.498297
   Whittleston R.A., 2012, APPL GEOCHEM
   Whittleston RA, 2011, J HAZARD MATER, V194, P15, DOI 10.1016/j.jhazmat.2011.07.067
   WHO, 2008, GUID DRINK WAT QUAL
   Wielinga B, 2001, ENVIRON SCI TECHNOL, V35, P522, DOI 10.1021/es001457b
   Wilkin RT, 2005, ENVIRON SCI TECHNOL, V39, P4599, DOI 10.1021/es050157x
   Wilkin RT, 2003, GROUND WATER, V41, P493, DOI 10.1111/j.1745-6584.2003.tb02383.x
   Williamson AJ, 2013, APPL ENVIRON MICROB, V79, P3320, DOI 10.1128/AEM.03063-12
   Ye Q, 2004, APPL ENVIRON MICROB, V70, P5595, DOI 10.1128/AEM.70.9.5595-5602.2004
   Yuan P, 2009, J HAZARD MATER, V166, P821, DOI 10.1016/j.jhazmat.2008.11.083
   ZACHARA JM, 1987, ENVIRON SCI TECHNOL, V21, P589, DOI 10.1021/es00160a010
   Zhang WX, 2003, J NANOPART RES, V5, P323, DOI 10.1023/A:1025520116015
NR 113
TC 23
Z9 24
U1 7
U2 93
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0883-2927
J9 APPL GEOCHEM
JI Appl. Geochem.
PD MAR
PY 2015
VL 54
BP 27
EP 42
DI 10.1016/j.apgeochem.2014.12.001
PG 16
WC Geochemistry & Geophysics
SC Geochemistry & Geophysics
GA CC2JW
UT WOS:000350172300003
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Sonnenberg, SB
   Rane, AA
   Liu, CJ
   Rao, N
   Agmon, G
   Suarez, S
   Wang, R
   Munoz, A
   Bajaj, V
   Zhang, S
   Braden, R
   Schup-Magoffin, PJ
   Kwan, OL
   De Maria, AN
   Cochran, JR
   Christman, KL
AF Sonnenberg, Sonya B.
   Rane, Aboli A.
   Liu, Cassie J.
   Rao, Nikhil
   Agmon, Gillie
   Suarez, Sophia
   Wang, Raymond
   Munoz, Adam
   Bajaj, Vaibhav
   Zhang, Shirley
   Braden, Rebecca
   Schup-Magoffin, Pamela J.
   Kwan, Oi Ling
   De Maria, Anthony N.
   Cochran, Jennifer R.
   Christman, Karen L.
TI Delivery of an engineered HGF fragment in an extracellular
   matrix-derived hydrogel prevents negative LV remodeling post-myocardial
   infarction
SO BIOMATERIALS
LA English
DT Article
DE Myocardial infarction; Growth factor; Extracellular matrix;
   Decellularization; Hydrogel
ID HEPATOCYTE GROWTH-FACTOR; MYOCARDIAL-INFARCTION; HEART-FAILURE; ALGINATE
   BIOMATERIAL; CARDIAC-FUNCTION; FACTOR-BETA; FIBROSIS; LIVER;
   CARDIOMYOPATHY; DYSFUNCTION
AB Hepatocyte growth factor (HGF) has been shown to have anti-fibrotic, pro-angiogenic, and cardio-protective effects; however, it is highly unstable and expensive to manufacture, hindering its clinical translation. Recently, a HGF fragment (HGF-f), an alternative c-MET agonist, was engineered to possess increased stability and recombinant expression yields. In this study, we assessed the potential of HGF-f, delivered in an extracellular matrix (ECM)-derived hydrogel, as a potential treatment for myocardial infarction (MI). HGF-f protected cardiomyocytes from serum-starvation and induced down-regulation of fibrotic markers in whole cardiac cell isolate compared to the untreated control. The ECM hydrogel prolonged release of HGF-f compared to collagen gels, and in vivo delivery of HGF-f from ECM hydrogels mitigated negative left ventricular (LV) remodeling, improved fractional area change (FAC), and increased arteriole density in a rat myocardial infarction model. These results indicate that HGF-f may be a viable alternative to using recombinant HGF, and that an ECM hydrogel can be employed to increase growth factor retention and efficacy. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Sonnenberg, Sonya B.; Rane, Aboli A.; Rao, Nikhil; Agmon, Gillie; Suarez, Sophia; Wang, Raymond; Munoz, Adam; Bajaj, Vaibhav; Zhang, Shirley; Braden, Rebecca; Schup-Magoffin, Pamela J.; Christman, Karen L.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Sonnenberg, Sonya B.; Rane, Aboli A.; Rao, Nikhil; Agmon, Gillie; Suarez, Sophia; Wang, Raymond; Munoz, Adam; Bajaj, Vaibhav; Zhang, Shirley; Braden, Rebecca; Schup-Magoffin, Pamela J.; Christman, Karen L.] Univ Calif San Diego, Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA.
   [Liu, Cassie J.; Cochran, Jennifer R.] Stanford Univ, Dept Chem Engn, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.
   [Liu, Cassie J.; Cochran, Jennifer R.] Stanford Univ, Dept Bioengn, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.
   [Kwan, Oi Ling; De Maria, Anthony N.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
RP Christman, KL (reprint author), 2880 Torrey Pines Scen Dr, La Jolla, CA 92037 USA.
EM christman@eng.ucsd.edu
OI Zhang, Shirley/0000-0002-5882-5721; Agmon, Gillie/0000-0002-3451-3694
FU National Institutes of Health (NIH) [R01HL113468, R01CA151706,
   5UL1TR000100]
FX This research was supported in part by National Institutes of Health
   (NIH) through R01HL113468, R01CA151706, and 5UL1TR000100.
CR Beohar N, 2010, J AM COLL CARDIOL, V56, P1287, DOI 10.1016/j.jacc.2010.05.039
   Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6
   Burchfield JS, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-4
   Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105
   Cheng AS, 2008, SEMIN THORAC CARDIOV, V20, P94, DOI 10.1053/j.semtcvs.2008.04.003
   Chirgadze DY, 1999, NAT STRUCT BIOL, V6, P72
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3
   Esposito C, 2005, KIDNEY INT, V67, P2143, DOI 10.1111/j.1523-1755.2005.00319.x
   Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com
   Han YP, 2006, J GASTROEN HEPATOL, V21, pS88, DOI 10.1111/j.1440-1746.2006.04586.x
   Haruyama T, 2000, BIOCHEM BIOPH RES CO, V272, P681, DOI 10.1006/bbrc.2000.2837
   Jin HK, 2004, CURR PHARM DESIGN, V10, P2525, DOI 10.2174/1381612043383863
   Jin HK, 2003, J PHARMACOL EXP THER, V304, P654, DOI 10.1124/jpet.102.041772
   Jones DS, 2011, P NATL ACAD SCI USA, V108, P13035, DOI 10.1073/pnas.1102561108
   Kubo H, 2008, CIRCULATION, V118, P649, DOI 10.1161/CIRCULATIONAHA.107.761031
   LEE AA, 1995, J MOL CELL CARDIOL, V27, P2347, DOI 10.1016/S0022-2828(95)91983-X
   Li RK, 1997, CIRCULATION, V96, P874
   Li YW, 2003, CIRCULATION, V107, P2499, DOI 10.1161/01.CIR.0000065579.19126.B8
   Liehn EA, 2011, J AM COLL CARDIOL, V58, P2357, DOI 10.1016/j.jacc.2011.08.034
   Liu CJ, 2014, FEBS LETT, V588, P4831, DOI 10.1016/j.febslet.2014.11.018
   Messerli FH, 2004, EUR HEART J, V25, P1475, DOI 10.1016/j.ehj.2004.07.015
   MICHALOPOULOS GK, 1990, FASEB J, V4, P176
   Michieli P, 2002, NAT BIOTECHNOL, V20, P488, DOI 10.1038/nbt0502-488
   Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005
   Nakamura T, 2005, AM J PHYSIOL-HEART C, V288, pH2131, DOI 10.1152/ajpheart.01239.2003
   NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0
   Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226
   Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x
   Ono M, 2002, CIRCULATION, V106, pI264, DOI 10.1161/cir.0000032879.55215.f4
   Rajendran R, 2006, Indian J Dent Res, V17, P161
   Ross J, 2012, GASTROENTEROLOGY, V142, P897, DOI 10.1053/j.gastro.2011.12.006
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Seif-Naraghi SB, 2010, TISSUE ENG PT A, V16, P2017, DOI 10.1089/ten.TEA.2009.0768
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Seif-Naraghi SB, 2012, ACTA BIOMATER, V8, P3695, DOI 10.1016/j.actbio.2012.06.030
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Stewart N, 2013, AM J PHYSIOL-RENAL, V304, pF625, DOI 10.1152/ajprenal.00504.2012
   TAKAHASHI N, 1994, J CLIN INVEST, V94, P1470, DOI 10.1172/JCI117485
   Taniyama Y, 2002, HYPERTENSION, V40, P47, DOI 10.1161/01.HYP.0000020755.56955.BF
   Tomita H, 1998, HYPERTENSION, V32, P273, DOI 10.1161/01.HYP.32.2.273
   Ueda H, 2001, CARDIOVASC RES, V51, P41, DOI 10.1016/S0008-6363(01)00272-3
   Wang J, 2012, CELL RES, V22, P516, DOI 10.1038/cr.2011.132
   Yang ZJ, 2010, MOL BIOL REP, V37, P2075, DOI 10.1007/s11033-009-9665-5
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
NR 47
TC 31
Z9 33
U1 1
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2015
VL 45
BP 56
EP 63
DI 10.1016/j.biomaterials.2014.12.021
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC2RD
UT WOS:000350191400007
PM 25662495
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Laothumthut, T
   Jantarat, J
   Paemanee, A
   Roytrakul, S
   Chunhabundit, P
AF Laothumthut, Titikan
   Jantarat, Jeeraphat
   Paemanee, Atchara
   Roytrakul, Sittiruk
   Chunhabundit, Panjit
TI Shotgun proteomics analysis of proliferating STRO-1-positive human
   dental pulp cell after exposure to nacreous water-soluble matrix
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Article
DE Human dental pulp cell; Mineralization; Nacre; Pinctada maxima; Shotgun
   proteomics
ID HUMAN BONE-MARROW; PINCTADA-MAXIMA; ORGANIC MATRIX; STEM-CELLS;
   IN-VITRO; PROTEINS; REGENERATION; OSTEOBLASTS; EXPRESSION; INDUCTION
AB For dental treatment, dentin regeneration is required after a tooth injury with dental pulp exposure. The effects of the water-soluble matrix (WSM) extracted from the nacreous layer of the bivalve Pinctada maxima on human dental pulp cells in vitro were challenging and useful for clinical application.
   The biological activity of the STRO-1-positive human dental pulp cells in response to WSM compared to Dulbecco's modified Eagle medium (DMEM) as a normal control was monitored. The cell survival rate was analyzed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Proteomic profiles among inducers and noninducers with time dependency were compared by using sodium dodecyl sulfate-polyacrylamide gel electrophoresis combined with liquid chromatography-tandem mass spectrometry (GeLC-MS/MS).
   The human dental pulp cells cultured in nacreous WSM exhibited higher relative cell viability than those in DMEM with similar morphological appearance. Significant changes were found in the relative abundance of 44 proteins in cells after exposure to WSM for 2 weeks. They play a role in cell adhesion, cell proliferation, metabolic process, signal transduction, stress response, transcription, translation, and transport.
   These results indicate that WSM of P. maxima has the ability to induce proliferation of human dental pulp cells.
   This finding initiated the study to evaluate the suitability of nacre as biomaterial for dentistry.
C1 [Laothumthut, Titikan] Mahidol Univ, Fac Dent, Dept Oral Med & Periodontol, Bangkok 10700, Thailand.
   [Jantarat, Jeeraphat] Mahidol Univ, Fac Dent, Dept Operat Dent & Endodont, Bangkok 10700, Thailand.
   [Paemanee, Atchara; Roytrakul, Sittiruk] Natl Ctr Genet Engn & Biotechnol, Genome Inst, Klongluang, Pathumthani, Thailand.
   [Chunhabundit, Panjit] Mahidol Univ, Fac Dent, Dept Anat, Bangkok 10700, Thailand.
RP Laothumthut, T (reprint author), Mahidol Univ, Fac Dent, Dept Oral Med & Periodontol, Bangkok 10700, Thailand.
EM titikan.lao@mahidol.ac.th
OI Jantarat, Jeeraphat/0000-0001-8239-0716
CR Akkouch A, 2014, J BIOMATER APPL, V28, P922, DOI 10.1177/0885328213486705
   Asvanund P, 2012, IMPLANT DENT, V21, P248, DOI 10.1097/ID.0b013e3182563ae0
   Asvanund P, 2011, IMPLANT DENT, V20, P32, DOI 10.1097/ID.0b013e3182061be1
   Atlan G, 1997, CR ACAD SCI III-VIE, V320, P253, DOI 10.1016/S0764-4469(97)86933-8
   Bedouet L, 2001, COMP BIOCHEM PHYS B, V128, P389, DOI 10.1016/S1096-4959(00)00337-7
   Bedouet L, 2007, MAR BIOTECHNOL, V9, P638, DOI 10.1007/s10126-007-9017-1
   Burbelo PD, 1995, J BIOL CHEM, V270, P30919, DOI 10.1074/jbc.270.52.30919
   Fricain JC, 1998, J BIOMED MATER RES, V42, P96, DOI 10.1002/(SICI)1097-4636(199810)42:1<96::AID-JBM12>3.0.CO;2-M
   Helmut B, 1987, ELECTROPHORESIS, V8, P93
   Honda JY, 2008, HISTOL HISTOPATHOL, V23, P423, DOI 10.14670/HH-23.423
   Johansson C, 2006, PROTEOMICS, V6, P4475, DOI 10.1002/pmic.200500921
   Kuhn M, 2014, NUCLEIC ACIDS RES, V42, pD401, DOI 10.1093/nar/gkt1207
   Lee SK, 2010, J ENDODONT, V36, P1537, DOI 10.1016/j.joen.2010.04.027
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Melin M, 2000, J DENT RES, V79, P1689, DOI 10.1177/00220345000790090901
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mouries LP, 2002, COMP BIOCHEM PHYS B, V132, P217
   Murray PE, 2007, J ENDODONT, V33, P377, DOI 10.1016/j.joen.2006.09.013
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   Nakashima M, 2002, GENE THER, V9, P814, DOI 10.1038/sj/gt/3301692
   Nakashima M, 2005, J ENDODONT, V31, P711, DOI 10.1097/01.don.0000164138.49923.e5
   Nie X, 2006, CELL BIOL INT, V30, P295, DOI 10.1016/j.cellbi.2005.12.001
   Oaki K, 2005, ANGEW CHEM INT EDIT, V44, P6571, DOI 10.1002/anie.200500338
   Pereira-Mouries L, 2002, EUR J BIOCHEM, V269, P4994, DOI 10.1046/j.1432-1033.2002.03203.x
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Rousseau M, 2003, COMP BIOCHEM PHYS B, V135, P1, DOI 10.1016/S1096-4959(03)00032-0
   Saad FA, 2011, INT ORTHOP, V35, P447, DOI 10.1007/s00264-010-1076-7
   Benedete APS, 2008, PEDIATR DEVEL PATHOL, V11, P206, DOI 10.2350/07-09-0333.1
   Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696
   Shichijo S, 2004, CLIN CANCER RES, V10, P5828, DOI 10.1158/1078-0432.CCR-04-0350
   Terry DE, 2004, J AM SOC MASS SPECTR, V15, P784, DOI 10.1016/j.jasms.2004.02.005
   Thorsell A, 2007, RAPID COMMUN MASS SP, V21, P771, DOI 10.1002/rcm.2898
   Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1
   WEINER S, 1975, SCIENCE, V190, P987, DOI 10.1126/science.1188379
   Yang XC, 2007, J TISSUE ENG REGEN M, V1, P66, DOI 10.1002/term.16
   Zhu Q, 2000, Chin J Dent Res, V3, P21
NR 37
TC 2
Z9 2
U1 0
U2 8
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
EI 1436-3771
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD MAR
PY 2015
VL 19
IS 2
BP 261
EP 270
DI 10.1007/s00784-014-1256-8
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CC4VT
UT WOS:000350353300012
PM 24923583
DA 2018-10-19
ER

PT J
AU Karygianni, L
   Anderson, AC
   Tennert, C
   Kollmar, K
   Altenburger, MJ
   Hellwig, E
   Al-Ahmad, A
AF Karygianni, L.
   Anderson, A. C.
   Tennert, C.
   Kollmar, K.
   Altenburger, M. J.
   Hellwig, E.
   Al-Ahmad, A.
TI Supplementary sampling of obturation materials enhances microbial
   analysis of endodontic treatment failures: a proof of principle study
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Article
DE Posttreatment apical periodontitis; Obturation materials; Bacterial
   colonization; Culture method; 16S rDNA; Clone library analysis
ID ROOT-FILLED TEETH; CANAL-TREATED TEETH; GUTTA-PERCHA; PERIRADICULAR
   LESIONS; DENTIN INTERFACES; MICROORGANISMS; BACTERIAL; IDENTIFICATION;
   INFECTIONS; PERIODONTITIS
AB Root canal treatment failures often correlate with persistent biomaterial-associated endodontic infections. The aim of the present study was to assess the impact of endodontic obturation material sampling from root canals with posttreatment apical periodontitis on improving standard study protocols.
   Samples from previously filled root canals and their corresponding endodontic filling materials were obtained from five root-filled teeth with posttreatment periradicular lesions. After cultivation, the isolated microorganisms were quantified and biochemically identified. Moreover, clone libraries were constructed after the amplification of bacterial 16S ribosomal DNA (rDNA) from the same samples. DNA from selected clones was sequenced to identify microbial species. Transmission electron microscopy (TEM) aided visualization of the detected bacteria.
   Overall, 22 taxa of the phyla Firmicutes, Actinobacteria, and Bacteroidetes were detected in both obturation and root canal samples by culture-dependent and culture-independent methods. Root canal fillings sheltered 17 species (3.30-7.50 x 10(3) CFU/ml). Of these, nine were detected solely in the retrieved obturation materials. The reinfected root canals harbored 13 taxa (3.48-7.36 x 10(3) CFU/ml). Obligate and facultative anaerobic bacteria prevailed. The number of different species ranged from 1 to 5 within a single sample. Fungi were not detected.
   Bacteria can colonize both root canals and endodontic fillings in vivo.
   Integrating the sampling of obturation materials with standard root canal sample collection offers a clearer insight into the actual microbial flora of reinfected root canals and improves the study protocols of secondary/persistent endodontic infections.
C1 [Karygianni, L.; Anderson, A. C.; Tennert, C.; Kollmar, K.; Altenburger, M. J.; Hellwig, E.; Al-Ahmad, A.] Univ Freiburg, Dept Operat Dent & Periodontol, Ctr Dent Med, D-79106 Freiburg, Germany.
RP Al-Ahmad, A (reprint author), Univ Freiburg, Dept Operat Dent & Periodontol, Ctr Dent Med, Hugstetter Str 55, D-79106 Freiburg, Germany.
EM ali.al-ahmad@uniklinik-freiburg.de
FU German Research Foundation (DFG) [AL 1179/1-1]
FX The authors express their gratitude to Annette Wittmer, Bettina
   Spitzmuller, and Barbara Joch for their excellent technical help. This
   study was supported by the German Research Foundation (DFG, AL
   1179/1-1).
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Anderson AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049576
   Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005
   Borgo F, 2013, J BASIC MICROB, V53, P20, DOI 10.1002/jobm.201100464
   Chen TC, 2010, FLORA CHINA, V10, P6
   Cheung GSP, 2001, ORAL MICROBIOL IMMUN, V16, P332, DOI 10.1034/j.1399-302X.2001.160603.x
   Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879
   Farzaneh M, 2004, J ENDODONT, V30, P627, DOI 10.1097/01.DON.0000129958.12388.82
   Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07
   GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x
   George S, 2010, J ENDODONT, V36, P1241, DOI 10.1016/j.joen.2010.03.024
   Gomes BPFD, 2005, ORAL SURG ORAL MED O, V100, P512, DOI 10.1016/j.tripleo.2004.10.002
   Hirai VHG, 2010, ORAL SURG ORAL MED O, V109, pE131, DOI 10.1016/j.tripleo.2009.09.038
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hashimoto M, 2010, J BIOMED MATER RES B, V92B, P268, DOI 10.1002/jbm.b.31535
   Kermanshahi S, 2010, J DENT RES, V89, P996, DOI 10.1177/0022034510372885
   Linares DM, 2013, INT J FOOD MICROBIOL, V165, P43, DOI 10.1016/j.ijfoodmicro.2013.04.021
   Love RM, 2002, ORAL MICROBIOL IMMUN, V17, P32, DOI 10.1046/j.0902-0055.2001.00090.x
   Nagy E, 2013, ANAEROBE, V20, P20, DOI 10.1016/j.anaerobe.2013.01.007
   Nambu T, 2013, ARCH ORAL BIOL, V58, P681, DOI 10.1016/j.archoralbio.2012.10.017
   Nawal RR, 2011, ORAL SURG ORAL MED O, V111, P387, DOI 10.1016/j.tripleo.2010.09.070
   Noiri Y, 2002, J ENDODONT, V28, P679, DOI 10.1097/00004770-200210000-00001
   Paiva SSM, 2013, J ENDODONT, V39, P190, DOI 10.1016/j.joen.2012.09.014
   Pinheiro ET, 2003, INT ENDOD J, V36, P1, DOI 10.1046/j.1365-2591.2003.00603.x
   Pinheiro ET, 2003, ORAL MICROBIOL IMMUN, V18, P100, DOI 10.1034/j.1399-302X.2003.00058.x
   Richardson N, 2009, INT ENDOD J, V42, P908, DOI 10.1111/j.1365-2591.2009.01594.x
   Rocas IN, 2004, J ENDODONT, V30, P504, DOI 10.1097/00004770-200407000-00011
   Rocas IN, 2012, J CLIN MICROBIOL, V50, P1721, DOI 10.1128/JCM.00531-12
   Rolph HJ, 2001, J CLIN MICROBIOL, V39, P3282, DOI 10.1128/JCM.39.9.3282-3289.2001
   Roth KA, 2012, J ENDODONT, V38, P1253, DOI 10.1016/j.joen.2012.05.014
   Sakamoto SM, 2008, ORAL MICROBIOL IMMUN, V23, P275
   Schirrmeister JF, 2007, J ENDODONT, V33, P536, DOI 10.1016/j.joen.2007.01.012
   Schirrmeister JF, 2009, J ENDODONT, V35, P169, DOI 10.1016/j.joen.2008.10.024
   Senges C, 2011, J ENDODONT, V37, P1247, DOI 10.1016/j.joen.2011.05.034
   Shokati B, 2010, J BIOMED MATER RES B, V94B, P230, DOI 10.1002/jbm.b.31645
   Siqueira JF, 2007, ORAL MICROBIOL IMMUN, V22, P266, DOI 10.1111/j.1399-302X.2007.00355.x
   Siqueira JF, 2004, ORAL SURG ORAL MED O, V97, P85, DOI 10.1016/S1079-2104(03)00353-6
   Siqueira JF, 2005, J CLIN MICROBIOL, V43, P3314, DOI 10.1128/JCM.43.7.3314-3319.2005
   Subramanian K, 2009, J ENDODONT, V35, P950, DOI 10.1016/j.joen.2009.04.010
   Sundqvist G, 1998, ORAL SURG ORAL MED O, V85, P86, DOI 10.1016/S1079-2104(98)90404-8
   Takemura N, 2004, EUR J ORAL SCI, V112, P523, DOI 10.1111/j.1600-0722.2004.00165.x
   Teixeira CS, 2009, J APPL ORAL SCI, V17, P129, DOI 10.1590/S1678-77572009000200011
   Vianna ME, 2006, J CLIN MICROBIOL, V44, P1274, DOI 10.1128/JCM.44.4.1274-1282.2006
   Wahab R, 2010, APPL MICROBIOL BIOT, V87, P1917, DOI 10.1007/s00253-010-2692-2
   Young G, 2007, J ENDODONT, V33, P1417, DOI 10.1016/j.joen.2007.09.002
NR 45
TC 3
Z9 3
U1 0
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
EI 1436-3771
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD MAR
PY 2015
VL 19
IS 2
BP 319
EP 327
DI 10.1007/s00784-014-1231-4
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CC4VT
UT WOS:000350353300018
PM 24677170
DA 2018-10-19
ER

PT J
AU Barton, MJ
   Morley, JW
   Stoodley, MA
   Shaikh, S
   Mahns, DA
   Lauto, A
AF Barton, Matthew J.
   Morley, John W.
   Stoodley, Marcus A.
   Shaikh, Sumaiya
   Mahns, David A.
   Lauto, Antonio
TI Long term recovery of median nerve repair using laser-activated chitosan
   adhesive films
SO JOURNAL OF BIOPHOTONICS
LA English
DT Article
DE biomaterial; chitosan; laser; peripheral-nerve-repair;
   photochemical-tissue-bonding and rose-bengal
ID PROTEIN BAND TECHNIQUE; RAT SCIATIC-NERVE; IN-VITRO; PERIPHERAL-NERVES;
   SCHWANN-CELLS; FIBRIN GLUE; ROSE-BENGAL; TISSUE; REGENERATION; SUTURE
AB Sutures remain the standard peripheral nerve repair technique, whether applied directly or indirectly to nerve tissue. Unfortunately, significant postoperative complications can result, such as inflammation, neuroma formation and foreign body reactions. Photochemical-tissue-bonding (PTB) using rose Bengal (RB) integrated into a chitosan bioadhesive is an alternative nerve repair device that removes the need for sutures. Rats were arranged into three groups: RB-chitosan adhesives-repair, end-to-end epineural suture-repair (surgical standard) and sham laser-irradiated control. Groups were compared through histological assessment, electrophysiological recordings and grip motor strength. RB-chitosan adhesive repaired nerves displayed comparable results when compared to the standard suture-repair based on histological and electrophysiological findings. Functionally, RB-chitosan adhesive was associated with a quicker and more pronounced recovery of grip force when compared to the suture-repair.
   [GRAPHICS]
   Longitudinal sections of nerve anastomosis after 4 weeks (top) and 12 weeks (bottom); the nerves were repaired using the laser-adhesive technique (scale bar 50 mu m).
C1 [Barton, Matthew J.; Morley, John W.; Shaikh, Sumaiya; Mahns, David A.; Lauto, Antonio] Univ Western Sydney, Sch Med, Penrith, NSW 2751, Australia.
   [Morley, John W.; Mahns, David A.; Lauto, Antonio] Univ Western Sydney, MARCS Inst, Bioelect & Neurosci BENS Res Grp, Penrith, NSW 2751, Australia.
   [Stoodley, Marcus A.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia.
RP Lauto, A (reprint author), Univ Western Sydney, Sch Med, Locked Bag 1797, Penrith, NSW 2751, Australia.
EM a.lauto@uws.edu.au
OI Stoodley, Marcus/0000-0002-4207-8493; Mahns, David/0000-0003-2131-9638
FU University of Western Sydney
FX This study was supported by internal University of Western Sydney
   funding. We thank Dr Hong Duong for her assistance with the LFB
   histology preparation and Dr Richard Wuhrer for assistance with the SEM
   work.
CR Barton M, 2013, J BIOPHOTONICS, V6, P938, DOI 10.1002/jbio.201300054
   Barton M, 2012, LASER SURG MED, V44, P762, DOI 10.1002/lsm.22076
   Basbaum AI, 2009, SCI PAIN
   Bass LS, 1995, LASER SURG MED, V17, P315, DOI 10.1002/lsm.1900170402
   BENKE TA, 1989, LASER SURG MED, V9, P602, DOI 10.1002/lsm.1900090611
   CAMPION ER, 1990, J BONE JOINT SURG AM, V72A, P715, DOI 10.2106/00004623-199072050-00011
   CAREY DJ, 1983, J CELL BIOL, V97, P473, DOI 10.1083/jcb.97.2.473
   Chen MB, 2006, ANN PLAS SURG, V57, P462, DOI 10.1097/01.sap.0000237577.07219.b6
   Cheng J. W., 2013, BMC ANESTHESIOL, V13
   CHUDLER EH, 1983, PAIN, V17, P341, DOI 10.1016/0304-3959(83)90165-3
   Cronin L, 2014, J BIOPHOTONICS, V7, P410, DOI 10.1002/jbio.201200168
   Dagum A B, 1998, J Hand Ther, V11, P111
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   FITZGERALD M, 1979, J PHYSIOL-LONDON, V297, P207, DOI 10.1113/jphysiol.1979.sp013035
   HUANG TC, 1992, OTOLARYNG HEAD NECK, V107, P14, DOI 10.1177/019459989210700103
   Huang W, 2012, BIOMATERIALS, V33, P59, DOI 10.1016/j.biomaterials.2011.09.030
   Hwang K, 2005, J CRANIOFAC SURG, V16, P1102, DOI 10.1097/01.scs.0000179740.60671.e5
   Johnson EO, 2005, INJURY, V36, pS24, DOI 10.1016/j.injury.2005.10.012
   Johnson TS, 2007, J SURG RES, V143, P224, DOI 10.1016/j.jss.2007.01.028
   KAJANDER KC, 1992, NEUROSCI LETT, V138, P225, DOI 10.1016/0304-3940(92)90920-3
   Kamegaya Y, 2005, LASER SURG MED, V37, P264, DOI 10.1002/lsm.20221
   Lauto A, 1998, MICROSURG, V18, P60, DOI 10.1002/(SICI)1098-2752(1998)18:1<60::AID-MICR13>3.0.CO;2-Q
   Lauto A, 2007, LASER SURG MED, V39, P19, DOI 10.1002/lsm.20418
   Lauto A, 1998, MICROSURG, V18, P55, DOI 10.1002/(SICI)1098-2752(1998)18:1<55::AID-MICR12>3.0.CO;2-R
   Lauto A, 1997, LASER SURG MED, V21, P134, DOI 10.1002/(SICI)1096-9101(1997)21:2<134::AID-LSM4>3.0.CO;2-R
   Lauto A., 2012, J VIS EXP, V68
   Lauto A., 2010, BIOMED ENG, V9, P47
   Lauto A, 2008, PHOTOMED LASER SURG, V26, P227, DOI 10.1089/pho.2007.2131
   LUNDBORG G, 1987, ACTA ORTHOP SCAND, V58, P145, DOI 10.3109/17453678709146461
   Martins RS, 2011, NEUROSURGERY, V68, P765, DOI 10.1227/NEU.0b013e3182077332
   Matras H, 1973, J Maxillofac Surg, V1, P37, DOI 10.1016/S0301-0503(73)80010-4
   Menovsky T, 1995, NEUROSURG REV, V18, P225, DOI 10.1007/BF00383873
   Menovsky T, 2003, MICROSURG, V23, P109, DOI 10.1002/micr.10100
   Menovsky T, 2001, J NEUROSURG, V95, P694, DOI 10.3171/jns.2001.95.4.0694
   O'Neill AC, 2007, LASER SURG MED, V39, P716, DOI 10.1002/lsm.20548
   O'Neill AC, 2009, J SURG RES, V151, P33, DOI 10.1016/j.jss.2008.01.025
   Ornelas L, 2006, J RECONSTR MICROSURG, V22, P123, DOI 10.1055/s-2006-932507
   OZ MC, 1990, J VASC SURG, V11, P718, DOI 10.1067/mva.1990.18591
   Pabari A, 2010, J PLAST RECONSTR AES, V63, P1941, DOI 10.1016/j.bjps.2009.12.010
   Poppas DP, 1996, LASER SURG MED, V18, P335, DOI 10.1002/(SICI)1096-9101(1996)18:4<335::AID-LSM2>3.0.CO;2-T
   POPPAS DP, 1992, J UROLOGY, V148, P220, DOI 10.1016/S0022-5347(17)36557-6
   Rodriguez FJ, 2000, EXP NEUROL, V161, P571, DOI 10.1006/exnr.1999.7315
   Ronchi G, 2009, J NEUROSCI METH, V179, P51, DOI 10.1016/j.jneumeth.2009.01.011
   Santos AP, 2007, ANAT REC, V290, P477, DOI 10.1002/ar.20519
   SCHOBER R, 1986, SCIENCE, V232, P1421, DOI 10.1126/science.3715454
   Siemionow M, 2009, INT REV NEUROBIOL, V87, P141, DOI 10.1016/S0074-7742(09)87008-6
   Spector D, 2009, LASER SURG MED, V41, P504, DOI 10.1002/lsm.20799
   Talmor M, 2001, Arch Facial Plast Surg, V3, P207, DOI 10.1001/archfaci.3.3.207
   Temple CLF, 2004, J RECONSTR MICROSURG, V20, P645, DOI 10.1055/s-2004-861525
   Wachter E, 2003, LASER SURG MED, V32, P101, DOI 10.1002/lsm.10138
   Whitlock EL, 2009, MUSCLE NERVE, V39, P787, DOI 10.1002/mus.21220
   Xu J, 2009, PAIN, V144, P329, DOI 10.1016/j.pain.2009.05.019
   Yang PG, 2012, LASER SURG MED, V44, P163, DOI 10.1002/lsm.21137
   Yao M, 2010, LASER SURG MED, V42, P123, DOI 10.1002/lsm.20869
NR 54
TC 11
Z9 11
U1 0
U2 18
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1864-063X
EI 1864-0648
J9 J BIOPHOTONICS
JI J. Biophotonics
PD MAR
PY 2015
VL 8
IS 3
BP 196
EP 207
DI 10.1002/jbio.201300129
PG 12
WC Biochemical Research Methods; Biophysics; Optics
SC Biochemistry & Molecular Biology; Biophysics; Optics
GA CC6CQ
UT WOS:000350452700002
PM 24132983
DA 2018-10-19
ER

PT J
AU Jayakumar, GC
   Usharani, N
   Yasothai, A
   Kanth, SV
   Rao, JR
AF Jayakumar, Gladstone Christopher
   Usharani, Nagarajan
   Yasothai, Arjunan
   Kanth, Swarna Vinodh
   Rao, Jonnalagadda Raghava
TI KINETICS OF INHIBITION OF TYPE I COLLAGENASE BY DIALDEHYDE CELLULOSE IN
   STABILIZATION OF TYPE I COLLAGEN
SO JOURNAL OF THE AMERICAN LEATHER CHEMISTS ASSOCIATION
LA English
DT Article
ID CLOSTRIDIUM-HISTOLYTICUM COLLAGENASE; CIRCULAR-DICHROISM SPECTRA;
   ATOMIC-FORCE MICROSCOPY; MOLECULAR-STRUCTURE; TRIPLE-HELIX; PROTEINS;
   STABILITY; OXIDATION; PEPTIDE; SITES
AB Collagen is one of the widely studied biomaterial for various industrial applications. However, search of eco-friendly and biocompatible stabilizing agent is a thrust research domain. In this research work, application of dialdehyde cellulose (DAC) was studied to understand the effect on the enzymatic and conformational stability in collagen. The secondary structure of collagen is not significantly altered on interaction with DAC. But, it was found that DAC lead to changes in the amplitude of the circular dichroic (CD) spectrum but did not alter the triple helical conformation of collagen. DAC treated collagen exhibited 93% resistance to collagenolytic hydrolysis. Conversely, DAC treated collagenase exhibited 89% inhibition against collagen degradation and the inhibition was found to be concentration dependent. The kinetics of inhibition of collagenase by DAC was derived from the extent of hydrolysis of (2-furanacryloyl-L-leucyl-glycyl-L-prolyl-L-alanine), FALGPA. DAC exhibited non-competitive mode of inhibition against collagenase. CD data on DAC-modified collagenase substantiate the hypothesis that the inhibition of collagenase by DAC arises from secondary and quaternary structural changes in the enzyme. Gaining new insights in understanding the mechanism of stabilization of collagen by DAC through kinetics of inhibition of collagenase was presented.
C1 [Kanth, Swarna Vinodh] Cent Leather Res Inst, Council Sci & Ind Res, Madras 600020, Tamil Nadu, India.
RP Kanth, SV (reprint author), Cent Leather Res Inst, Council Sci & Ind Res, Madras 600020, Tamil Nadu, India.
EM chordclri@lycos.com
CR ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   BOND MD, 1984, BIOCHEMISTRY-US, V23, P3085, DOI 10.1021/bi00308a036
   Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7
   Calvini P, 2006, CELLULOSE, V13, P571, DOI 10.1007/s10570-005-9035-y
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   Espenson J.H., 1995, CHEM KINETICS REACTI, P113
   Fathima NN, 2004, INT J BIOL MACROMOL, V34, P241, DOI 10.1016/j.ijbiomac.2004.05.004
   FRENCH MF, 1992, J PROTEIN CHEM, V11, P83, DOI 10.1007/BF01025095
   GALARDY RE, 1983, BIOCHEMISTRY-US, V22, P4556, DOI 10.1021/bi00288a032
   Goodman M, 1996, J AM CHEM SOC, V118, P5156, DOI 10.1021/ja954132h
   HEINDL MC, 1980, BIOCHIM BIOPHYS ACTA, V624, P51, DOI 10.1016/0005-2795(80)90224-X
   JENNESS DD, 1976, BIOPOLYMERS, V15, P513, DOI 10.1002/bip.1976.360150308
   Kanth SV, 2006, J AM LEATHER CHEM AS, V101, P444
   KELLER S, 1963, ARCH BIOCHEM BIOPHYS, V101, P81, DOI 10.1016/0003-9861(63)90537-X
   Madhan B, 2007, INT J BIOL MACROMOL, V41, P16, DOI 10.1016/j.ijbiomac.2006.11.013
   Massova M., 1998, FASEB J, V12, P1075
   MILLER EJ, 1976, ARCH BIOCHEM BIOPHYS, V173, P631, DOI 10.1016/0003-9861(76)90300-3
   Ohtani K, 1997, FEMS MICROBIOL LETT, V146, P155, DOI 10.1016/S0378-1097(96)00472-7
   Paige MF, 2001, MICRON, V32, P341, DOI 10.1016/S0968-4328(00)00037-8
   PERCZEL A, 1992, ANAL BIOCHEM, V203, P83, DOI 10.1016/0003-2697(92)90046-A
   PERCZEL A, 1992, PROTEINS, V13, P57, DOI 10.1002/prot.340130106
   Persikov AV, 2002, J MOL BIOL, V316, P385, DOI 10.1006/jmbi.2001.5342
   RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0
   RYAN JN, 1971, BIOCHEM BIOPH RES CO, V44, P144, DOI 10.1016/S0006-291X(71)80170-5
   Sang QXA, 1996, J PROTEIN CHEM, V15, P137, DOI 10.1007/BF01887395
   Silvia V., 2004, THERMOCHIM ACTA, V418, P123
   STOCKER W, 1995, PROTEIN SCI, V4, P823
   VANWART HE, 1981, ANAL BIOCHEM, V113, P356, DOI 10.1016/0003-2697(81)90089-0
   Varma AJ, 2002, POLYM DEGRAD STABIL, V77, P25, DOI 10.1016/S0141-3910(02)00073-3
   VENCILL CF, 1985, BIOCHEMISTRY-US, V24, P3149, DOI 10.1021/bi00334a012
   Wang H, 2005, ANAL CHEM, V77, P6765, DOI 10.1021/ac051349d
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
NR 33
TC 0
Z9 0
U1 2
U2 13
PU AMER LEATHER CHEMISTS ASSOC
PI LUBBOCK
PA 1314 50 ST, STE 103, LUBBOCK, TX 79412 USA
SN 0002-9726
J9 J AM LEATHER CHEM AS
JI J. Am. Leather Chem. Assoc.
PD MAR
PY 2015
VL 110
IS 3
BP 72
EP 79
PG 8
WC Chemistry, Applied; Materials Science, Textiles
SC Chemistry; Materials Science
GA CC7AP
UT WOS:000350520400002
DA 2018-10-19
ER

PT J
AU Jones, CH
   Chen, CK
   Chen, MF
   Ravikrishnan, A
   Zhang, HG
   Gollakota, A
   Chung, TC
   Cheng, C
   Pfeifer, BA
AF Jones, Charles H.
   Chen, Chih-Kuang
   Chen, Mingfu
   Ravikrishnan, Anitha
   Zhang, Hanguang
   Gollakota, Akhila
   Chung, Taichun
   Cheng, Chong
   Pfeifer, Blaine A.
TI PEGylated Cationic Polylactides for Hybrid Biosynthetic Gene Delivery
SO MOLECULAR PHARMACEUTICS
LA English
DT Article
DE cationic polymer; polylactide; gene therapy; gene delivery; biosynthetic
   hybrid
ID MICROBIAL ADHESION; E. COLI; POLYMERS; RECOMBINANT; HYDROPHOBICITY;
   NANOPARTICLES; HYDROCARBONS; CHEMISTRY; CELLS; MATH
AB Genetic vaccination is predicated on the underlying principle that diseases can be prevented by the controlled introduction of genetic material encoding antigenic proteins from pathogenic organisms to elicit the formation of protective immune responses. Driving this process is the choice of carrier that is responsible for navigating the obstacles associated with gene delivery. In this work, we expand upon a novel class of hybrid biosynthetic gene delivery vectors that are composed of a biomaterial outer coating and a bacterial (Escherichia coli) inner core. Specifically, a series of newly developed biodegradable cationic polylactides (CPLAs) and their PEGylated variants were selected to investigate the role of low polydispersity index (PDI), charge density, and PEGylation upon hybrid vector assembly and gene delivery efficacy. Upon assembly, hybrid vectors mediated increased gene delivery beyond that of the individual bacterial vector in isolation, including assays with increasing medium protein content to highlight shielding properties afforded by the PEG-functionalized CPLA component. Furthermore, after extensive characterization of surface deposition of the polymer, results prompted a new model for describing hybrid vector assembly that includes cellular coating and penetration of the CPLA component. In summary, these results provide new options and insight toward the assembly and application of next-generation hybrid biosynthetic gene delivery vectors.
C1 [Jones, Charles H.; Chen, Chih-Kuang; Chen, Mingfu; Ravikrishnan, Anitha; Zhang, Hanguang; Gollakota, Akhila; Chung, Taichun; Cheng, Chong; Pfeifer, Blaine A.] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
   [Chen, Chih-Kuang] Feng Chia Univ, Dept Fiber & Composite Mat, Taichung 40724, Taiwan.
RP Pfeifer, BA (reprint author), SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
EM blainepf@buffalo.edu
RI Cheng, Chong/K-2050-2014
OI Chen, Mingfu/0000-0002-0169-613X
FU NSF [CBET-1019227, DMR-1133737]; NIH [AI088485]; SUNY-Buffalo Schomburg
   fellowship
FX The authors recognize support from NSF grants CBET-1019227 and
   DMR-1133737 (to C.C.), NIH award AI088485 (to B.A.P.), and a
   SUNY-Buffalo Schomburg fellowship (to C.H.J.).
CR Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Chen CK, 2013, BIOMATERIALS, V34, P9688, DOI 10.1016/j.biomaterials.2013.08.063
   Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8
   Chen HA, 2010, BIOMATERIALS, V31, P8172, DOI 10.1016/j.biomaterials.2010.07.056
   Critchley R, 2004, GENE THER, V11, P1224, DOI 10.1038/sj.gt.3302281
   GEERTSEMADOORNBUSCH GI, 1993, J MICROBIOL METH, V18, P61, DOI 10.1016/0167-7012(93)90072-P
   Grillot-Courvalin C, 2002, CELL MICROBIOL, V4, P177, DOI 10.1046/j.1462-5822.2002.00184.x
   HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0
   Higgins DE, 1999, MOL MICROBIOL, V31, P1631, DOI 10.1046/j.1365-2958.1999.01272.x
   Jones CH, 2014, P NATL ACAD SCI USA, V111, P12360, DOI 10.1073/pnas.1411355111
   Jones CH, 2013, MOL PHARMACEUT, V10, P4301, DOI 10.1021/mp4003927
   Jones CH, 2013, MOL PHARMACEUT, V10, P4082, DOI 10.1021/mp400467x
   Jones CH, 2013, MOL PHARMACEUT, V10, P1138, DOI 10.1021/mp300666s
   Kenawy ER, 2007, BIOMACROMOLECULES, V8, P1359, DOI 10.1021/bm061150q
   Lee J, 2011, P NATL ACAD SCI USA, V108, P14055, DOI 10.1073/pnas.1105777108
   Liu MA, 2011, IMMUNOL REV, V239, P62, DOI 10.1111/j.1600-065X.2010.00980.x
   Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Parsa S, 2008, J BIOTECHNOL, V137, P59, DOI 10.1016/j.jbiotec.2008.07.1815
   Parsa S, 2008, PHARM RES, V25, P1202, DOI 10.1007/s11095-008-9563-x
   Parsa S, 2007, MOL PHARMACEUT, V4, P4, DOI 10.1021/mp0600889
   Radford KJ, 2002, GENE THER, V9, P1455, DOI 10.1038/sj.gt.3301812
   Rosenberg M, 2006, FEMS MICROBIOL LETT, V262, P129, DOI 10.1111/j.1574-6968.2006.00291.x
   Salton M. R. J., 1996, MED MICROBIOLOGY
   Sunshine JC, 2012, MOL PHARMACEUT, V9, P3375, DOI 10.1021/mp3004176
   Sunshine JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037543
   Sunshine JC, 2011, BIOMACROMOLECULES, V12, P3592, DOI 10.1021/bm200807s
   Zou J, 2011, ADV MATER, V23, P4274, DOI 10.1002/adma.201101646
NR 28
TC 10
Z9 10
U1 0
U2 34
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1543-8384
J9 MOL PHARMACEUT
JI Mol. Pharm.
PD MAR
PY 2015
VL 12
IS 3
BP 846
EP 856
DI 10.1021/mp500683c
PG 11
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA CC5HY
UT WOS:000350390900018
PM 25625426
DA 2018-10-19
ER

PT J
AU Yasmin, C
   Otoi, T
   Setiadi, MA
   Karja, NWK
AF Yasmin, Cut
   Otoi, Takeshige
   Setiadi, Mohamad Agus
   Karja, Ni Wayan Kurniani
TI MATURATION AND FERTILISATION OF SHEEP OOCYTES CULTURED IN SERUM-FREE
   MEDIUM CONTAINING SILK PROTEIN SERICIN
SO ACTA VETERINARIA HUNGARICA
LA English
DT Article
DE Albumin; antioxidants; in vitro maturation; meiotic competence; ovine
   oocyte; silk protein; sericin
ID IN-VITRO MATURATION; EMBRYO DEVELOPMENT; BOVINE EMBRYOS; SILKWORMS
AB Sericin is a water-soluble component of silk and has been used as a biomaterial due to its antibacterial and ultraviolet radiation-resistant properties. This study was designed to evaluate the effect of sericin supplementation in a maturation medium on the meiotic competence and fertilisability of sheep oocytes. Cumulus-oocyte complexes (COCs) were cultured in TCM199 supplemented with sericin at various concentrations of 0 (control), 0.1, 0.25 and 0.5%, either with or without bovine serum albumin (BSA). When the COCs were matured without BSA, the supplementation of 0.1% sericin significantly increased the rates of maturation to metaphase II and the total fertilisation of oocytes compared with the other concentrations of sericin. When the COCs were matured with BSA, the beneficial effects of 0.1% sericin supplementation on the maturation and fertilisation of oocytes were not observed. Our findings indicate that supplementation with 0.1% sericin during maturation culture may improve the nuclear maturation and fertilisability of sheep oocytes. Moreover, it may be possible to replace BSA with sericin in chemically defined media without the risk of disease transmission.
C1 [Yasmin, Cut; Setiadi, Mohamad Agus; Karja, Ni Wayan Kurniani] Bogor Agr Univ, Dept Clin Reprod & Pathol, Div Reprod, Bogor, Jawa Barat, Indonesia.
   [Otoi, Takeshige] United Grad Sch Vet Sci, Lab Anim Reprod, Yamaguchi 7538515, Japan.
RP Otoi, T (reprint author), United Grad Sch Vet Sci, Lab Anim Reprod, Yamaguchi 7538515, Japan.
EM otoi@yamaguchi-u.ac.jp
OI Otoi, Takeshige/0000-0002-0382-959X
FU JSPS/DGHE
FX This work was partly supported by the JSPS/DGHE Joint Research Project
   2011-2013.
CR Dash R, 2008, BMB REP, V41, P236, DOI 10.5483/BMBRep.2008.41.3.236
   de Matos DG, 2002, THERIOGENOLOGY, V57, P1443, DOI 10.1016/S0093-691X(02)00643-X
   Do LTK, 2014, REPROD DOMEST ANIM, V49, pe17, DOI 10.1111/rda.12274
   George F, 2008, THERIOGENOLOGY, V69, P612, DOI 10.1016/j.theriogenology.2007.11.008
   Hosoe M, 2014, J REPROD DEVELOP, V60, P268, DOI 10.1262/jrd.2013-110
   Isobe T, 2012, THERIOGENOLOGY, V78, P747, DOI 10.1016/j.theriogenology.2012.03.021
   Kato N, 1998, BIOSCI BIOTECH BIOCH, V62, P145, DOI 10.1271/bbb.62.145
   Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002
   Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057
   Souza-Fabjan JMG, 2013, REPROD BIOL, V13, P325, DOI 10.1016/j.repbio.2013.09.005
   Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608
   Thibier M, 2006, REPROD DOMEST ANIM, V41, P260, DOI 10.1111/j.1439-0531.2006.00721.x
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
NR 13
TC 9
Z9 9
U1 0
U2 2
PU AKADEMIAI KIADO RT
PI BUDAPEST
PA PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY
SN 0236-6290
EI 1588-2705
J9 ACTA VET HUNG
JI Acta Vet. Hung.
PD MAR
PY 2015
VL 63
IS 1
BP 110
EP 117
DI 10.1556/AVet.2015.009
PG 8
WC Veterinary Sciences
SC Veterinary Sciences
GA CC0NT
UT WOS:000350033300011
PM 25655418
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Liu, X
   Pi, B
   Wang, H
   Wang, XM
AF Liu, Xi
   Pi, Bin
   Wang, Hui
   Wang, Xiu-Mei
TI Self-assembling peptide nanofiber hydrogels for central nervous system
   regeneration
SO FRONTIERS OF MATERIALS SCIENCE
LA English
DT Review
DE self-assembling peptide; hydrogel; central nervous system (CNS); nerve
   regeneration
ID SPINAL-CORD-INJURY; NEURAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; PROMOTES
   FUNCTIONAL RECOVERY; OLFACTORY ENSHEATHING CELLS; AXONAL GROWTH;
   AMPHIPHILE NANOFIBERS; ADULT-RAT; IN-VIVO; NEUROTROPHIC FACTOR
AB Central nervous system (CNS) presents a complex regeneration problem due to the inability of central neurons to regenerate correct axonal and dendritic connections. However, recent advances in developmental neurobiology, cell signaling, cell-matrix interaction, and biomaterials technologies have forced a reconsideration of CNS regeneration potentials from the viewpoint of tissue engineering and regenerative medicine. The applications of a novel tissue regeneration-inducing biomaterial and stem cells are thought to be critical for the mission. The use of peptide nanofiber hydrogels in cell therapy and tissue engineering offers promising perspectives for CNS regeneration. Self-assembling peptide undergo a rapid transformation from liquid to gel upon addition of counterions or pH adjustment, directly integrating with the host tissue. The peptide nanofiber hydrogels have mechanical properties that closely match the native central nervous extracellular matrix, which could enhance axonal growth. Such materials can provide an optimal three dimensional microenvironment for encapsulated cells. These materials can also be tailored with bioactive motifs to modulate the wound environment and enhance regeneration. This review intends to detail the recent status of self-assembling peptide nanofiber hydrogels for CNS regeneration.
C1 [Liu, Xi; Wang, Hui] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Liu, Xi; Wang, Xiu-Mei] Tsinghua Univ, Sch Mat Sci & Engn, Inst Regenerat Med & Biomimet Mat, Key Lab Adv Mat, Beijing 100084, Peoples R China.
   [Pi, Bin] Soochow Univ, Affiliated Hosp 1, Dept Orthoped, Suzhou 215006, Peoples R China.
RP Wang, XM (reprint author), Tsinghua Univ, Sch Mat Sci & Engn, Inst Regenerat Med & Biomimet Mat, Key Lab Adv Mat, Beijing 100084, Peoples R China.
EM wxm@mail.tsinghua.edu.cn
FU National Natural Science Foundation of China [51303119, 51203108];
   Natural Science Foundation of Jiangsu Province [BK20130309, BK201341421,
   BK2011355]; Natural Science Foundation of the Jiangsu Higher Education
   Institutions [13KJB430019]; National Science Foundation for
   Post-doctoral Scientists of China [2013M541724, 2014T70545]; Tsinghua
   University Initiative Scientific Research Program [20121087982]; 973
   Program [2011CB606205]
FX This work was supported by the National Natural Science Foundation of
   China (Grant Nos. 51303119 and 51203108), Natural Science Foundation of
   Jiangsu Province (BK20130309, BK201341421, BK2011355), Natural Science
   Foundation of the Jiangsu Higher Education Institutions (13KJB430019),
   National Science Foundation for Post-doctoral Scientists of China
   (2013M541724 and 2014T70545), Tsinghua University Initiative Scientific
   Research Program (20121087982), and 973 Program (2011CB606205).
CR Abidian MR, 2009, ADV MATER, V21, P3764, DOI 10.1002/adma.200900887
   Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962
   Alivisatos AP, 1998, ADV MATER, V10, P1297
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Angeloni N, 2013, J SEX MED, V10, P1240, DOI 10.1111/j.1743-6109.2012.02930.x
   Angeloni NL, 2011, BIOMATERIALS, V32, P1091, DOI 10.1016/j.biomaterials.2010.10.003
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Aulisa L, 2009, BIOMACROMOLECULES, V10, P2694, DOI 10.1021/bm900634x
   Bakota EL, 2013, BIOMACROMOLECULES, V14, P1370, DOI 10.1021/bm4000019
   Bakota EL, 2011, BIOMACROMOLECULES, V12, P1651, DOI 10.1021/bm200035r
   Bakota EL, 2009, BIOMACROMOLECULES, V10, P2201, DOI 10.1021/bm900382a
   Bartolomei JC, 2000, NEUROSURGERY, V47, P1057, DOI 10.1097/00006123-200011000-00006
   Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002
   Berns EJ, 2014, BIOMATERIALS, V35, P185, DOI 10.1016/j.biomaterials.2013.09.077
   BLAKEMORE WF, 1977, NATURE, V266, P68, DOI 10.1038/266068a0
   Bond CW, 2013, J SEX MED, V10, P730, DOI 10.1111/jsm.12030
   BOWES MP, 1993, EXP NEUROL, V119, P215, DOI 10.1006/exnr.1993.1023
   Boyd JG, 2005, FASEB J, V19, P694, DOI 10.1096/fj.04-2833rev
   Braun PV, 1999, J AM CHEM SOC, V121, P7302, DOI 10.1021/ja9833725
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536
   Cao Y, 2008, NEUROREHAB NEURAL RE, V22, P262, DOI 10.1177/1545968307308550
   Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586
   Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043
   Cigognini D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019782
   Cui HG, 2010, SCIENCE, V327, P555, DOI 10.1126/science.1182340
   Cunha C, 2011, INT J NANOMED, V6, P943, DOI 10.2147/IJN.S17292
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557
   Dong H, 2007, J AM CHEM SOC, V129, P12468, DOI 10.1021/ja072536r
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Ellis-Behnke RG, 2011, METHODS MOL BIOL, V726, P259, DOI 10.1007/978-1-61779-052-2_17
   French DD, 2007, J SPINAL CORD MED, V30, P477, DOI 10.1080/10790268.2007.11754581
   Galler KM, 2010, J AM CHEM SOC, V132, P3217, DOI 10.1021/ja910481t
   Garg T, 2012, CRIT REV THER DRUG, V29, P1
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1
   Grill R, 1997, J NEUROSCI, V17, P5560
   Guler MO, 2006, BIOMACROMOLECULES, V7, P1855, DOI 10.1021/bm060161g
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003
   Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001
   Hartgerink JD, 1996, J AM CHEM SOC, V118, P43, DOI 10.1021/ja953070s
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hong YS, 2003, BIOMACROMOLECULES, V4, P1433, DOI 10.1021/bm0341374
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559
   Hou TY, 2012, TISSUE ENG PT A, V18, P974, DOI [10.1089/ten.tea.2011.0151, 10.1089/ten.TEA.2011.0151]
   Hurlbert RJ, 2001, SPINE, V26, pS39, DOI 10.1097/00007632-200112151-00009
   Hurtado A, 2011, BIOMATERIALS, V32, P6068, DOI 10.1016/j.biomaterials.2011.05.006
   Hutchinson RW, 2011, NEUROSURGERY, V69, P921, DOI 10.1227/NEU.0b013e318222ad63
   Ikkala O, 2002, SCIENCE, V295, P2407, DOI 10.1126/science.1067794
   Jefferson SC, 2011, J NEUROSCI, V31, P5710, DOI 10.1523/JNEUROSCI.4459-10.2011
   Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9
   Kataoka K, 2004, TISSUE ENG, V10, P493, DOI 10.1089/107632704323061852
   Kato T, 2002, SCIENCE, V295, P2414, DOI 10.1126/science.1070967
   Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422
   KRAUSE TL, 1990, P NATL ACAD SCI USA, V87, P1471, DOI 10.1073/pnas.87.4.1471
   Kubinova S, 2010, NANOMEDICINE-UK, V5, P99, DOI [10.2217/nnm.09.93, 10.2217/NNM.09.93]
   Kuchner E F, 1976, Surg Neurol, V6, P371
   Kumada Y, 2010, SOFT MATTER, V6, P5073, DOI 10.1039/c0sm00333f
   Ladd MR, 2011, NANOFIBERS PRODUCTIO
   Langer R, 1998, NATURE, V392, P5
   Lehn JM, 2002, P NATL ACAD SCI USA, V99, P4763, DOI 10.1073/pnas.072065599
   Lehn JM, 2002, SCIENCE, V295, P2400, DOI 10.1126/science.1071063
   Liang YX, 2011, NANOMED-NANOTECHNOL, V7, P351, DOI 10.1016/j.nano.2010.12.001
   Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031
   Liu X, 2013, ACTA BIOMATER, V9, P6798, DOI 10.1016/j.actbio.2013.01.027
   Liu X, 2012, NANOSCALE, V4, P2720, DOI [10.1039/c2nr00001, 10.1039/c2nr00001f]
   Liu Y, 1999, J NEUROSCI, V19, P4370
   Liu Y, 2013, ACTA BIOMATER, V9, P8075, DOI 10.1016/j.actbio.2013.06.001
   Lord-Fontaine S, 2008, J NEUROTRAUM, V25, P1309, DOI 10.1089/neu.2008.0613
   Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2
   Luo ZL, 2012, CHEM SOC REV, V41, P4736, DOI 10.1039/c2cs15360b
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Mahoney MJ, 2006, TISSUE ENG, V12, P1915, DOI 10.1089/ten.2006.12.1915
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Mao HQ, 2010, STUD MECHANOBIOL TIS, V2, P89, DOI 10.1007/8415_2010_2
   Mershin A, 2005, NAT BIOTECHNOL, V23, P1379, DOI 10.1038/ndt1105-1379
   Moradi F, 2012, J NEUROSCI RES, V90, P2335, DOI 10.1002/jnr.23120
   Nesathurai S, 1998, J TRAUMA, V45, P1088, DOI 10.1097/00005373-199812000-00021
   Okada S, 2005, FASEB J, V19, P1839, DOI 10.1096/fj.05-4082fje
   Paramonov SE, 2006, J AM CHEM SOC, V128, P7291, DOI 10.1021/ja060573x
   Parr AM, 2007, J NEUROTRAUM, V24, P835, DOI 10.1089/neu.2006.3771
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765
   Pochan DJ, 2004, SCIENCE, V306, P94, DOI 10.1126/science.1102866
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084
   Russell LE, 2010, J AM CHEM SOC, V132, P3242, DOI 10.1021/ja909720g
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   Sheehan JJ, 2005, GLIA, V50, P340, DOI 10.1002/glia.20150
   Silva GA, 2005, SURG NEUROL, V63, P301, DOI 10.1016/j.surneu.2004.06.008
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844
   Stendahl JC, 2006, ADV FUNCT MATER, V16, P499, DOI 10.1002/adfm.200500161
   Stephanopoulos N, 2013, ACTA MATER, V61, P912, DOI 10.1016/j.actamat.2012.10.046
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   Stupp SI, 2005, CHEM REV, V105, P1023, DOI 10.1021/cr030060y
   Sur S, 2012, BIOMATERIALS, V33, P545, DOI 10.1016/j.biomaterials.2011.09.093
   Suzuki S, 2012, BIOMATERIALS SURG OP
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955
   Tosi G, 2010, J CONTROL RELEASE, V145, P49, DOI 10.1016/j.jconrel.2010.03.008
   Tysseling VM, 2010, J NEUROSCI RES, V88, P3161, DOI 10.1002/jnr.22472
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   Vroemen M, 2003, EUR J NEUROSCI, V18, P743, DOI 10.1046/j.1460-9568.2003.02804.x
   Walker PA, 2009, STEM CELL REV REP, V5, P283, DOI 10.1007/s12015-009-9081-1
   Wang XM, 2011, PROG NAT SCI, V21, P111, DOI 10.1016/S1002-0071(12)60043-4
   Wang XM, 2012, INTERFACE FOCUS, V2, P278, DOI 10.1098/rsfs.2012.0016
   Wang XM, 2008, SOFT MATTER, V4, P2388, DOI 10.1039/b807155a
   Weidner N, 1999, J COMP NEUROL, V413, P495, DOI 10.1002/(SICI)1096-9861(19991101)413:4<495::AID-CNE1>3.0.CO;2-Z
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Xu XY, 2010, BIOMATERIALS, V31, P3967, DOI 10.1016/j.biomaterials.2010.01.132
   Yang HN, 2013, NEUROSCI LETT, V556, P63, DOI 10.1016/j.neulet.2013.09.063
   Yang YL, 2009, NANO TODAY, V4, P193, DOI 10.1016/j.nantod.2009.02.009
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
   Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/nmat2778, 10.1038/NMAT2778]
   Zhang WW, 2012, J NANOMATER, DOI 10.1155/2012/724857
   Zhao X, 2013, J OTOLARYNGOL-HEAD N, V42, DOI 10.1186/1916-0216-42-60
   Zhou YF, 2009, CHEM COMMUN, P1172, DOI 10.1039/b814560c
   Zorner B, 2010, ANN NY ACAD SCI, V1198, pE22, DOI 10.1111/j.1749-6632.2010.05566.x
   Zubarev ER, 2002, J AM CHEM SOC, V124, P5762, DOI 10.1021/ja020071t
NR 138
TC 6
Z9 7
U1 3
U2 113
PU HIGHER EDUCATION PRESS
PI BEIJING
PA NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA
SN 2095-025X
EI 2095-0268
J9 FRONT MATER SCI
JI Front. Mater. Sci.
PD MAR
PY 2015
VL 9
IS 1
BP 1
EP 13
DI 10.1007/s11706-015-0274-z
PG 13
WC Materials Science, Multidisciplinary
SC Materials Science
GA CC0VZ
UT WOS:000350057700001
DA 2018-10-19
ER

PT J
AU Wang, P
   Pi, B
   Wang, JN
   Zhu, XS
   Yang, HL
AF Wang, Peng
   Pi, Bin
   Wang, Jin-Ning
   Zhu, Xue-Song
   Yang, Hui-Lin
TI Preparation and properties of calcium sulfate bone cement incorporated
   with silk fibroin and Sema3A-loaded chitosan microspheres
SO FRONTIERS OF MATERIALS SCIENCE
LA English
DT Article
DE Sema3A; chitosan microsphere; sustained release; silk fibroin (SF); bone
   cement
ID PHOSPHATE CEMENT; IN-VIVO; TRANSFORMING GROWTH-FACTOR-BETA-1;
   COMPRESSION FRACTURES; BIOMATERIAL SCAFFOLDS; VERTEBROPLASTY; SYSTEM;
   TISSUE; CELLS; PROLIFERATION
AB To search for new bioactive materials which can be used as the substitute of bone repairing and drug carriers, Sema3A-loaded chitosan microspheres (SLCM) and silk fibroin (SF) were mixed with calcium sulfate cement (CSC). SEM, particle size analysis and swelling rate determination were performed to study properties of the microspheres. The drug loading, encapsulation efficiency and drug release rate were determined by ELISA. Microspheres with different SLCM weight contents (0.5%, 1% and 5%) were prepared to determine which one has the strongest mechanical properties and the appropriate setting time. It was revealed that CSC/SF/0.5SLCM has satisfactory mechanical properties, and its in vitro biocompatibility was assessed by MTS. Chitosan microspheres (5-18 mu m) were globular, the surface was smooth, and the swelling rate is (77.02 +/- 5.57)%. With this formula, the setting time was increased with the addition of SLCM in CSC/SF, and the cumulative drug release rate is 44.62% in 28 d. XRD results demonstrate that the main component is calcium sulfate. Also it was found that CSC/SF/0.5SLCM supports the growth of MC3T3 cells. Thus the preparation of CSC/SF/0.5SLCM was reliable, and the products had good structures, physical properties and biocompatibility, appearing to be a promising bone substitute material.
C1 [Wang, Peng; Pi, Bin; Wang, Jin-Ning; Zhu, Xue-Song; Yang, Hui-Lin] Soochow Univ, Affiliated Hosp 1, Dept Orthoped Surg, Suzhou 215006, Peoples R China.
RP Zhu, XS (reprint author), Soochow Univ, Affiliated Hosp 1, Dept Orthoped Surg, Suzhou 215006, Peoples R China.
EM zhuxs@126.com; hlyang@suda.edu.cn
FU National Natural Science Foundation of China [81071454, 81171689,
   81301559]; Department of Orthopedics Clinical Medical Centers in Jiangsu
   Province [BL2012004]; Natural Science Foundation of Jiangsu Province
   [BK20130275]; Key Laboratory of Orthopedic Institute of Soochow
   University
FX This work was generously supported by the National Natural Science
   Foundation of China (Grant Nos. 81071454, 81171689 and 81301559),
   Department of Orthopedics Clinical Medical Centers in Jiangsu Province
   (BL2012004), the Natural Science Foundation of Jiangsu Province
   (BK20130275), and the Key Laboratory of Orthopedic Institute of Soochow
   University.
CR Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875
   Barralet JE, 2002, J BIOMED MATER RES, V63, P1, DOI 10.1002/jbm.1074
   Cai L, 2011, ACTA BIOMATER, V7, P2185, DOI 10.1016/j.actbio.2011.01.034
   Chen CC, 2014, J ALLOY COMPD, V585, P25, DOI 10.1016/j.jallcom.2013.09.138
   Cunin G, 2000, SPINE, V25, P1070, DOI 10.1097/00007632-200005010-00006
   Ding SJ, 2009, J MATER CHEM, V19, P1183, DOI 10.1039/b819033j
   Ginebra MP, 1997, J DENT RES, V76, P905, DOI 10.1177/00220345970760041201
   Grenha A, 2008, EUR J PHARM BIOPHARM, V69, P83, DOI 10.1016/j.ejpb.2007.10.017
   Gupta KC, 2006, CARBOHYD POLYM, V66, P43, DOI 10.1016/j.carbpol.2006.02.019
   Habraken WJEM, 2009, J BIOMED MATER RES B, V91B, P555, DOI 10.1002/jbm.b.31429
   Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000
   Hazra C, 2014, ULTRASON SONOCHEM, V21, P1117, DOI 10.1016/j.ultsonch.2013.12.020
   Heini PF, 2000, EUR SPINE J, V9, P445, DOI 10.1007/s005860000182
   Hesaraki S, 2009, J BIOMED MATER RES B, V91B, P651, DOI 10.1002/jbm.b.31441
   Hulme PA, 2006, SPINE, V31, P1983, DOI 10.1097/01.brs.0000229254.89952.6b
   Jensen ME, 2007, AM J NEURORADIOL, V28, P1439
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Kim SY, 2012, J IND ENG CHEM, V18, P128, DOI 10.1016/j.jiec.2011.11.001
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lazary A, 2007, BIOMATERIALS, V28, P393, DOI 10.1016/j.biomaterials.2006.09.002
   Li F, 2013, J CRYST GROWTH, V374, P31, DOI 10.1016/j.jcrysgro.2013.03.042
   Li YW, 2000, J BIOMED MATER RES, V52, P164, DOI 10.1002/1097-4636(200010)52:1<164::AID-JBM21>3.0.CO;2-R
   Lin Q, 2010, J MATER SCI-MATER M, V21, P3065, DOI 10.1007/s10856-010-4160-z
   Lu JX, 2002, J MATER SCI-MATER M, V13, P803, DOI 10.1023/A:1016135410934
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Potiron V, 2007, ADV EXP MED BIOL, V600, P132
   Puricelli E, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-10
   Roth L, 2009, CELL MOL LIFE SCI, V66, P649, DOI 10.1007/s00018-008-8518-z
   Ruediger T, 2012, DENT MATER, V28, pE239, DOI 10.1016/j.dental.2012.05.008
   Sadiasa A, 2014, J BIOMATER APPL, V28, P739, DOI 10.1177/0885328213478256
   Sariibrahimoglu K, 2014, J BIOMED MATER RES B, V102, P415, DOI 10.1002/jbm.b.33018
   Sugawara A, 2013, J MATER CHEM B, V1, P1081, DOI 10.1039/c2tb00061j
   Taylor RS, 2007, EUR SPINE J, V16, P1085, DOI 10.1007/s00586-007-0308-z
   Tian L, 2009, TRENDS IMMUNOL, V30, P91, DOI 10.1016/j.it.2008.11.002
   Wang AH, 2009, J MICROENCAPSUL, V26, P593, DOI 10.3109/02652040802586167
   Wang BA, 2011, ADV MATER RES-SWITZ, V332-334, P1655, DOI 10.4028/www.scientific.net/AMR.332-334.1655
   Wang BA, 2011, ADV MATER RES-SWITZ, V175-176, P100, DOI 10.4028/www.scientific.net/AMR.175-176.100
   Wang G, 2010, J BONE JOINT SURG BR, V92B, P320, DOI 10.1302/0301-620X.92B2.22602
   Wang HN, 2013, J CONTROL RELEASE, V166, P172, DOI 10.1016/j.jconrel.2012.12.015
   Wang QZ, 2008, J MATER SCI-MATER M, V19, P1371, DOI 10.1007/s10856-007-3243-y
   Zhang C, 2008, CARBOHYD POLYM, V72, P390, DOI 10.1016/j.carbpol.2007.09.004
   Zhang ML, 2012, J BIOMED MATER RES A, V100A, P2979, DOI 10.1002/jbm.a.34246
   Zhang YF, 2006, BIOCHEM BIOPH RES CO, V344, P362, DOI 10.1016/j.bbrc.2006.03.106
   Zhu C, 2011, J MATER SCI-MATER M, V22, P1965, DOI 10.1007/s10856-011-4376-6
NR 47
TC 7
Z9 9
U1 8
U2 51
PU HIGHER EDUCATION PRESS
PI BEIJING
PA NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA
SN 2095-025X
EI 2095-0268
J9 FRONT MATER SCI
JI Front. Mater. Sci.
PD MAR
PY 2015
VL 9
IS 1
BP 51
EP 65
DI 10.1007/s11706-015-0278-8
PG 15
WC Materials Science, Multidisciplinary
SC Materials Science
GA CC0VZ
UT WOS:000350057700004
DA 2018-10-19
ER

PT J
AU Kanitkar, A
   Chen, C
   Smoak, M
   Hogan, K
   Scherr, T
   Aita, G
   Hayes, D
AF Kanitkar, Akanksha
   Chen, Cong
   Smoak, Mollie
   Hogan, Katie
   Scherr, Thomas
   Aita, Giovanna
   Hayes, Daniel
TI In vitro characterization of polyesters of aconitic acid, glycerol, and
   cinnamic acid for bone tissue engineering
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Polyesters; aconitic acid; stem cells; bone scaffolds; mineralization
ID SUGARCANE BAGASSE; CANE MOLASSES; SCAFFOLDS; FABRICATION;
   HYDROXYAPATITE; OSTEOGENESIS; BIODEGRADATION; PROLIFERATION;
   FERMENTATION; BIOMATERIAL
AB In this study, a novel class of polyesters of glycerol, aconitic acid, and cinnamic acid were synthesized along with their hydroxyapatite (HA) composites, and studied for their potential application in bone defect repair. An osteogenic study was conducted with human adipose derived mesenchymal stem cells (hASCs) to determine the osteoinductive ability of aconitic acid-glycerol (AG) polyesters, AG:HA (80:20), aconitic acid-glycerol-cinnamic acid (AGC) polyesters, and AGC:HA (80:20) to serve as bone scaffolds. The results indicate that AGC scaffolds have the highest mechanical strength in comparison to AG, AG:HA (80:20), and AGC:HA (80:20) scaffolds due to its low porosity. It was determined by cytotoxicity and osteogenesis experiments that hASCs cultured for 21 days on AG:HA (80:20) scaffolds in stromal medium exhibited a greater number of live cells than control PCL:HA composites. Moreover, hASCs cultured on foamed AG:HA (80:20) scaffolds resulted in the highest levels of mineralization, increased alkaline phosphatase (ALP) expression, and the greatest osteocalcin (OCN) expression after 21 days. Overall, AG:HA (100:0 and 80:20) scaffolds had higher mechanical strength and cytocompatibility than the PCL:HA control. Invitro osteogenic study demonstrated that AG:HA (100:0 and 80:20) synthesized using sugarcane industry by-products hold potential as scaffolds for bone tissue engineering applications.
C1 [Kanitkar, Akanksha; Aita, Giovanna] Louisiana State Univ, Ctr Agr, Audubon Sugar Inst, St Gabriel, LA 70776 USA.
   [Kanitkar, Akanksha; Chen, Cong; Smoak, Mollie; Hogan, Katie; Hayes, Daniel] Louisiana State Univ & Agr Ctr, Dept Biol & Agr Engn, Baton Rouge, LA USA.
   [Scherr, Thomas] Louisiana State Univ, Cain Dept Chem Engn, Baton Rouge, LA 70803 USA.
RP Aita, G (reprint author), Louisiana State Univ, Ctr Agr, Audubon Sugar Inst, 3845 Hwy 75, St Gabriel, LA 70776 USA.
EM GAita@agcenter.lsu.edu
RI Chen, Cong/G-3137-2017
OI Scherr, Thomas/0000-0002-7077-535X; Hayes, Daniel/0000-0001-9499-4111
FU National Science Foundation [CMMI-963482, CBET-1254281]; LSU AgCenter
FX Financial support was provided from the National Science Foundation
   grants (Proposal numbers CMMI-963482 and CBET-1254281) and from LSU
   AgCenter.
CR Arsad M.S.M., 2011, 2 INT C BIOT FOOD SC, V7, P184
   ATTAWIA MA, 1995, BIOCHEM BIOPH RES CO, V213, P639, DOI 10.1006/bbrc.1995.2179
   Barrett DG, 2009, MOLECULES, V14, P4022, DOI 10.3390/molecules14104022
   BAUER TW, 2000, CLIN ORTHOP RELAT R, V371, P10, DOI DOI 10.1097/00003086-200002000-00003
   Bohner M, 2010, MATER TODAY, V13, P24, DOI 10.1016/S1369-7021(10)70014-6
   Cao HL, 2011, POLYM INT, V60, P630, DOI 10.1002/pi.2993
   Cardona CA, 2010, BIORESOURCE TECHNOL, V101, P4754, DOI 10.1016/j.biortech.2009.10.097
   Cazetta ML, 2007, BIORESOURCE TECHNOL, V98, P2824, DOI 10.1016/j.biortech.2006.08.026
   FitzPatrick M, 2010, BIORESOURCE TECHNOL, V101, P8915, DOI 10.1016/j.biortech.2010.06.125
   Garber L, 2013, J BIOMED MATER RES A, V101, P3531, DOI 10.1002/jbm.a.34651
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Ho ST, 2006, BIOMATERIALS, V27, P1362, DOI 10.1016/j.biomaterials.2005.08.035
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Jayabalan M, 2010, ACTA BIOMATER, V6, P763, DOI 10.1016/j.actbio.2009.09.015
   Jose MV, 2009, ACTA BIOMATER, V5, P305, DOI 10.1016/j.actbio.2008.07.019
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim M, 2011, J IND MICROBIOL BIOT, V38, P803, DOI 10.1007/s10295-010-0812-8
   Kurashina K, 2002, BIOMATERIALS, V23, P407, DOI 10.1016/S0142-9612(01)00119-3
   LAM KH, 1994, J MATER SCI-MATER M, V5, P181, DOI 10.1007/BF00121086
   Leong David Tai, 2008, Curr Drug Discov Technol, V5, P319, DOI 10.2174/157016308786733537
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   McMurray SH, 2002, J CHEM TECHNOL BIOT, V77, P1262, DOI 10.1002/jctb.703
   Moradi A, 2013, MATER DESIGN, V50, P446, DOI 10.1016/j.matdes.2013.03.026
   Navarro AR, 2000, WASTE MANAGE, V20, P581, DOI 10.1016/S0956-053X(00)00026-X
   Nelson C, 2013, J BIOMATER TISS ENG, V3, P426, DOI 10.1166/jbt.2013.1098
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Otsu N., 1975, AUTOMATICA, V11, P23, DOI DOI 10.1109/TSMC.1979.4310076
   Qureshi AT, 2013, BIOMATERIALS, V34, P7799, DOI 10.1016/j.biomaterials.2013.07.004
   Rahimi F, 1997, J Foot Ankle Surg, V36, P192
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Sabir MI, 2009, J MATER SCI, V44, P5713, DOI 10.1007/s10853-009-3770-7
   SCHIEKER M, 2006, EUR J TRAUMA, V32, P114, DOI DOI 10.1007/S00068-006-6047-8
   Serbetci K, 2004, POLYM TEST, V23, P145, DOI 10.1016/S0142-9418(03)00073-4
   Smoak M, 2014, J APPL POLYM SCI, V131, P1
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Thomas Lynda V, 2011, Biomatter, V1, P81, DOI 10.4161/biom.1.1.17301
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Xu F, 2005, ANAL CHIM ACTA, V552, P207, DOI 10.1016/j.aca.2005.07.037
   Zanetti AS, 2013, J BIOMATER APPL, P998
   Zebarjad S. M., 2011, ENGINEERING, V3, P795, DOI DOI 10.4236/ENG.2011.38096
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhang L, 2011, TISSUE ENGINEERING: FROM LAB TO CLINIC, P597, DOI 10.1007/978-3-642-02824-3_27
NR 45
TC 2
Z9 2
U1 2
U2 18
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAR
PY 2015
VL 29
IS 8
BP 1075
EP 1085
DI 10.1177/0885328214553961
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CB9UY
UT WOS:000349980100003
PM 25281649
DA 2018-10-19
ER

PT J
AU Ivashchenko, S
   Ivirico, JLE
   Cruz, DMG
   Campillo-Fernandez, A
   Ferrer, GG
   Pradas, MM
AF Ivashchenko, Sergiy
   Escobar Ivirico, Jorge L.
   Garcia Cruz, Dunia M.
   Campillo-Fernandez, Alberto
   Gallego Ferrer, Gloria
   Monleon Pradas, Manuel
TI Bioactive organic-inorganic poly(CLMA-co-HEA)/silica nanocomposites
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Nanocomposites; organic polymer; silica; bioactivity; biocompatibility
ID MODULATED WATER-UPTAKE; SOL-GEL SYNTHESIS;
   POLY(EPSILON-CAPROLACTONE)/SILICA HYBRID; POLYMER/SILICA NANOCOMPOSITES;
   BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES; SURFACE-CHEMISTRY; BONE
   REPAIR; HYDROPHILICITY; SCAFFOLDS
AB A series of novel poly(CLMA-co-HEA)/silica nanocomposites is synthesized from caprolactone 2-(methacryloyloxy)ethyl ester (CLMA) and 2-hydroxyethyl acrylate (HEA) as organic comonomers and the simultaneous sol-gel polymerization of tetraethyloxysilane (TEOS) as silica precursor, in different mass ratios up to a 30wt% of silica. The nanocomposites are characterized as to their mechanical and thermal properties, water sorption, bioactivity and biocompatibility, reflecting the effect on the organic matrix provided by the silica network formation. The nanocomposites nucleate the growth of hydroxyapatite (HAp) on their surfaces when immersed in the simulated body fluid of the composition used in this work. Proliferation of the MC3T3 osteoblast-like cells on the materials was assessed with the MTS assay showing their biocompatibility. Immunocytochemistry reveals osteocalcin and type I collagen production, indicating that osteoblast differentiation was promoted by the materials, and calcium deposition was confirmed by von Kossa staining. The results indicate that these poly(CLMA-co-HEA)/silica nanocomposites could be a promising biomaterial for bone tissue engineering.
C1 [Ivashchenko, Sergiy; Escobar Ivirico, Jorge L.; Garcia Cruz, Dunia M.; Gallego Ferrer, Gloria; Monleon Pradas, Manuel] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, E-46022 Valencia, Spain.
   [Campillo-Fernandez, Alberto] Univ Politecn Valencia, Appl Thermodynam Dept, E-46022 Valencia, Spain.
   [Gallego Ferrer, Gloria; Monleon Pradas, Manuel] CIBER BBN, Networking Res Ctr Bioengn Biomat & Nanomed, Valencia, Spain.
RP Ivashchenko, S (reprint author), Univ Politecn Valencia, Ctr Biomat & Tissue Engn, E-46022 Valencia, Spain.
EM seriv@posgrado.upv.es
RI Gallego-Ferrer, Gloria/H-6690-2015; Escobar ivirico, Jorge/J-1203-2016
OI Gallego-Ferrer, Gloria/0000-0002-2428-0903; Escobar ivirico,
   Jorge/0000-0002-1077-2333; MONLEON PRADAS, MANUEL/0000-0001-6457-0414;
   Ivashchenko, Sergiy/0000-0003-1633-4665
FU Spanish Ministry of Science and Innovation [DPI2010-20399-c04-03,
   MAT2011-28791-C03-02]; Torres Quevedo [PTQ08-02-06321]; CIBER-BBN
   initiative - Instituto de Salud Carlos III (Spain)
FX The authors acknowledge the financial support from the Spanish Ministry
   of Science and Innovation through projects DPI2010-20399-c04-03 and
   MAT2011-28791-C03-02. AJCF acknowledges support through Torres Quevedo
   grant PTQ08-02-06321. GGF and MMP acknowledge support of CIBER-BBN
   initiative, financed by Instituto de Salud Carlos III (Spain) with the
   assistance of the European Regional Development Fund.
CR Anselme K, 2010, P I MECH ENG H, V224, P1487, DOI 10.1243/09544119JEIM901
   Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   Barone DTJ, 2011, POLYM ADVAN TECHNOL, V22, P463, DOI 10.1002/pat.1845
   Bera O, 2011, THERMOCHIM ACTA, V515, P1, DOI 10.1016/j.tca.2010.12.006
   Boccaccini AR, 2010, COMPOS SCI TECHNOL, V70, P1764, DOI 10.1016/j.compscitech.2010.06.002
   Boxberg Y, 2006, J POLYM SCI POL PHYS, V44, P656, DOI 10.1002/polb.20723
   BRINKER CJ, 1982, J NON-CRYST SOLIDS, V48, P47, DOI 10.1016/0022-3093(82)90245-9
   Catauro M, 2004, J MATER SCI-MATER M, V15, P991, DOI 10.1023/B:JMSM.0000042684.13247.38
   Catauro M, 2003, J MATER SCI, V38, P3097, DOI 10.1023/A:1024773113001
   Ivirico JLE, 2007, J BIOMED MATER RES B, V83B, P266, DOI 10.1002/jbm.b.30792
   Ivirico JLE, 2009, J BIOMED MATER RES B, V91B, P277, DOI 10.1002/jbm.b.31400
   Ivirico JLE, 2006, MACROMOL CHEM PHYSIC, V207, P2195, DOI 10.1002/macp.200600399
   Hajji P, 1999, J POLYM SCI POL PHYS, V37, P3172, DOI 10.1002/(SICI)1099-0488(19991115)37:22<3172::AID-POLB2>3.3.CO;2-I
   Hanemann T, 2010, MATERIALS, V3, P3468, DOI 10.3390/ma3063468
   Izquierdo-Barba I, 2013, INT J APPL GLASS SCI, V4, P149, DOI 10.1111/ijag.12028
   Jones JR, 2009, J EUR CERAM SOC, V29, P1275, DOI 10.1016/j.jeurceramsoc.2008.08.003
   Kawai T, 2007, J MATER SCI-MATER M, V18, P1037, DOI 10.1007/s10856-006-0081-2
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kokubo T, 2005, MAT SCI ENG C-BIO S, V25, P97, DOI 10.1016/j.msec.2005.01.002
   Lee EJ, 2010, ACTA BIOMATER, V6, P3557, DOI 10.1016/j.actbio.2010.03.022
   Lluch AV, 2009, POLYMER, V50, P2874, DOI 10.1016/j.polymer.2009.04.022
   Nie KM, 2005, MATER LETT, V59, P1325, DOI 10.1016/j.matlet.2004.12.034
   Oliveira AL, 2003, BIOMATERIALS, V24, P2575, DOI 10.1016/S0142-9612(03)00060-7
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Palacio MLB, 2012, PHILOS T R SOC A, V370, P2321, DOI 10.1098/rsta.2011.0483
   Pantaleon R, 2010, POLYM COMPOSITE, V31, P1585, DOI 10.1002/pc.20946
   Olmedilla MPR, 2012, J BIOMATER APPL, V27, P299, DOI 10.1177/0885328211404263
   Poologasundarampillai G, 2010, J MATER CHEM, V20, P8952, DOI 10.1039/c0jm00930j
   Rhee SH, 2003, KEY ENG MAT, V240-2, P187, DOI 10.4028/www.scientific.net/KEM.240-242.187
   Rimer JD, 2007, CHEM MATER, V19, P4189, DOI 10.1021/cm070708d
   Hernandez JCR, 2008, J NON-CRYST SOLIDS, V354, P1900, DOI 10.1016/j.jnoncrysol.2007.10.016
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Salinas AJ, 2013, BIOMATER SCI-UK, V1, P40, DOI 10.1039/c2bm00071g
   Sprio S, 2010, J BIOTECHNOL, V156, P347
   Valles-Lluch A, 2010, COMPOS SCI TECHNOL, V70, P1789, DOI 10.1016/j.compscitech.2010.07.008
   Valles-Lluch A, 2010, EUR POLYM J, V46, P1446, DOI 10.1016/j.eurpolymj.2010.04.010
   Valles-Lluch A, 2010, EUR POLYM J, V46, P910, DOI 10.1016/j.eurpolymj.2010.02.004
   Yan SF, 2011, COLLOID SURFACE B, V86, P218, DOI 10.1016/j.colsurfb.2011.04.004
   Zhang ZG, 2011, CYTOTECHNOLOGY, V63, P437, DOI 10.1007/s10616-011-9367-4
   Zou H, 2008, CHEM REV, V108, P3893, DOI 10.1021/cr068035q
NR 42
TC 2
Z9 2
U1 6
U2 31
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAR
PY 2015
VL 29
IS 8
BP 1096
EP 1108
DI 10.1177/0885328214554816
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CB9UY
UT WOS:000349980100005
PM 25294191
DA 2018-10-19
ER

PT J
AU Cho, Y
   Hong, J
   Ryoo, H
   Kim, D
   Park, J
   Han, J
AF Cho, Y.
   Hong, J.
   Ryoo, H.
   Kim, D.
   Park, J.
   Han, J.
TI Osteogenic Responses to Zirconia with Hydroxyapatite Coating by Aerosol
   Deposition
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE implant dentistry; biomaterial(s); osteogenesis; surface chemistry;
   osseointegration; prosthetic dentistry
ID TITANIUM DENTAL IMPLANTS; ACID-ETCHED SURFACE; IN-VITRO; THICK-FILMS;
   BONE; OSSEOINTEGRATION; BIOCOMPATIBILITY; BIOMATERIAL; IMPROVEMENT;
   EXPRESSION
AB Previously, we found that osteogenic responses to zirconia co-doped with niobium oxide (Nb2O5) or tantalum oxide (Ta2O5) are comparable with responses to titanium, which is widely used as a dental implant material. The present study aimed to evaluate the in vitro osteogenic potential of hydroxyapatite (HA)-coated zirconia by an aerosol deposition method for improved osseointegration. Surface analysis by scanning electron microscopy and x-ray diffraction proved that a thin as-deposited HA film on zirconia showed a shallow, regular, crater-like surface. Deposition of dense and uniform HA films was measured by SEM, and the contact angle test demonstrated improved wettability of the HA-coated surface. Confocal laser scanning microscopy indicated that MC3T3-E1 pre-osteoblast attachment did not differ notably between the titanium and zirconia surfaces; however, cells on the HA-coated zirconia exhibited a lower proliferation than those on the uncoated zirconia late in the culture. Nevertheless, ALP, alizarin red S staining, and bone marker gene expression analysis indicated good osteogenic responses on HA-coated zirconia. Our results suggest that HA-coating by aerosol deposition improves the quality of surface modification and is favorable to osteogenesis.
C1 [Cho, Y.; Hong, J.; Han, J.] Seoul Natl Univ, Sch Dent, Dept Prosthodont, Seoul 110749, South Korea.
   [Cho, Y.; Hong, J.; Ryoo, H.; Han, J.] Seoul Natl Univ, Dent Res Inst, Program BK21, Seoul 110749, South Korea.
   [Cho, Y.] Seoul Natl Univ, Sch Dent, Dept Periodontol, Seoul 110749, South Korea.
   [Ryoo, H.] Seoul Natl Univ, Sch Dent, Dept Mol Genet, Seoul 110749, South Korea.
   [Kim, D.] Sejong Univ, Dept Adv Mat Engn, Seoul, South Korea.
   [Park, J.] IONES Co Ltd, Nano Business, R&D Ctr, Gyeonggi Do, South Korea.
RP Han, J (reprint author), Seoul Natl Univ, Sch Dent, Dept Prosthodont, 28 Yeongeon Dong, Seoul 110749, South Korea.
EM proshan@snu.ac.kr
FU Technology Innovation Program - Ministry of Trade, Industry & Energy
   (MI, Seoul, Korea) [10043164]; National Research Foundation - Ministry
   of Science, ICT & Future Planning [NRF-2014M3A9E3064466]
FX This research was supported by the Technology Innovation Program
   (10043164) funded by the Ministry of Trade, Industry & Energy (MI,
   Seoul, Korea) and the Bio & Medical Technology Development Program of
   the National Research Foundation (NRF-2014M3A9E3064466) funded by the
   Ministry of Science, ICT & Future Planning. The authors declare no
   potential conflicts of interest with respect to the authorship and/or
   publication of this article.
CR Akedo J, 2000, APPL PHYS LETT, V77, P1710, DOI 10.1063/1.1309029
   Akedo J, 2006, J AM CERAM SOC, V89, P1834, DOI 10.1111/j.1551-2916.2006.01030.x
   Aldini NN, 2002, J BIOMED MATER RES, V61, P282, DOI 10.1002/jbm.10162
   BURR DB, 1993, J BIOMED MATER RES, V27, P645, DOI 10.1002/jbm.820270512
   Buser D, 2012, CLIN IMPLANT DENT R, V14, P839, DOI 10.1111/j.1708-8208.2012.00456.x
   Chang YL, 1999, INT J ORAL MAX IMPL, V14, P239
   Cho YD, 2014, INT J MOL SCI, V15, P4442, DOI 10.3390/ijms15034442
   Cho YD, 2009, J BIOL CHEM, V284, P25230, DOI 10.1074/jbc.M109.008391
   De Maeztu MA, 2008, INT J ORAL MAX SURG, V37, P441, DOI 10.1016/j.ijom.2008.01.010
   FURLONG RJ, 1991, J BONE JOINT SURG BR, V73, P741
   Gahlert M, 2007, CLIN ORAL IMPLAN RES, V18, P662, DOI 10.1111/j.1600-0501.2007.01401.x
   Gremillard L, 2008, KEY ENG MAT, V361-363, P791, DOI 10.4028/www.scientific.net/KEM.361-363.791
   Han JY, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044109
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Hsu SH, 2007, BIO-MED MATER ENG, V17, P53
   Kaur G, 2014, J BIOMED MATER RES A, V102, P254, DOI 10.1002/jbm.a.34690
   Kim DJ, 2000, J BIOMED MATER RES, V53, P438, DOI 10.1002/1097-4636(2000)53:4<438::AID-JBM19>3.0.CO;2-3
   Knabe C, 2004, J BIOMED MATER RES A, V71A, P98, DOI 10.1002/jbm.a.30130
   Kuroda K, 2002, J BIOMED MATER RES, V59, P390, DOI 10.1002/jbm.10002
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   LEE J, 1995, BIO-MED MATER ENG, V5, P49
   Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006
   Mistry Surajit, 2011, J Indian Soc Periodontol, V15, P215, DOI 10.4103/0972-124X.85663
   OGISO M, 1992, J LONG-TERM EFF MED, V2, P235
   Ong J L, 2000, Crit Rev Biomed Eng, V28, P667
   Orsini G, 2000, INT J ORAL MAX IMPL, V15, P779
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pittayachawan P, 2009, J BIOMED MATER RES B, V88B, P366, DOI 10.1002/jbm.b.31064
   Rigo ECS, 2004, MAT SCI ENG C-BIO S, V24, P647, DOI 10.1016/j.msec.2004.08.044
   Roy M, 2011, SURF COAT TECH, V205, P2785, DOI 10.1016/j.surfcoat.2010.10.042
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Sailer I, 2007, INT J ESTHET DENT, V2, P296
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Tamura M, 2006, DENT MATER J, V25, P32, DOI 10.4012/dmj.25.32
   Wang HX, 2006, PEPTIDES, V27, P27, DOI 10.1016/j.peptides.2005.06.009
   Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63
   Yang GL, 2009, ORAL SURG ORAL MED O, V107, P782, DOI 10.1016/j.tripleo.2008.12.023
NR 38
TC 10
Z9 10
U1 1
U2 40
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD MAR
PY 2015
VL 94
IS 3
BP 491
EP 499
DI 10.1177/0022034514566432
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CC2CB
UT WOS:000350151400013
PM 25586588
OA Green Published
DA 2018-10-19
ER

PT J
AU Masood, R
   Miraftab, M
   Hussain, T
   Edward-Jones, V
AF Masood, Rashid
   Miraftab, Mohsen
   Hussain, Tanveer
   Edward-Jones, Valerie
TI Development of slow release silver-containing biomaterial for wound care
   applications
SO JOURNAL OF INDUSTRIAL TEXTILES
LA English
DT Article
DE Medical textiles; materials; polymer formation; fibrous materials;
   strength
ID MANAGEMENT; DRESSINGS; MODELS
AB Silver-containing wound dressings are now commonly available with much publicised claims of antimicrobial activities against all kinds of pathogens including methicillin-resistant Staphylococcus aureus (MRSA). However, there are little or no credible reports on the control release agents for the minimum potent quantities of silver needed in dressings for antimicrobial purposes over time. This paper introduces a new biomaterial fibre made from natural polymers with an inbuilt ability to gel and absorb large quantities of pseudo exudates. Furthermore, the new fibre carries up to six times less silver than it is conventionally used in silver dressings and displays a very slow rate of release whilst maintaining full potency over time against known microorganisms including methicillin-resistant S. aureus. The paper concludes that the developed fibre has long-lasting antimicrobial and gelling properties comparable, if not better, than Acticoat AA and Aquacel Ag, two commercially available silver dressings.
C1 [Masood, Rashid; Hussain, Tanveer] Natl Text Univ, Fac Engn & Technol, Faisalabad 37610, Pakistan.
   [Miraftab, Mohsen] Univ Bolton, Inst Mat Res & Innovat, Bolton, England.
   [Edward-Jones, Valerie] Manchester Metropolitan Univ, Sch Healthcare Sci, Manchester M15 6BH, Lancs, England.
RP Masood, R (reprint author), Natl Text Univ, Sheikhpura Rd, Faisalabad 37610, Pakistan.
EM rashidmasood78@gmail.com
CR Alloway B.J., 1995, HEAVY METALS SOILS, P324
   Bowler PG, 2004, J BURN CARE REHABIL, V25, P192, DOI 10.1097/01.BCR.0000112331.72232.1B
   Burd A, 2007, WOUND REPAIR REGEN, V15, P94, DOI 10.1111/j.1524-475X.2006.00190.x
   Burrell Robert E, 2003, Ostomy Wound Manage, V49, P19
   Cooper R, 2004, WORLDWIDE WOUNDS
   De SJ, 2003, J CONTROL RELEASE, V89, P101, DOI 10.1016/S0168-3659(03)00098-1
   Dunn K, 2004, BURNS, V30, pS1, DOI 10.1016/j.burns.2004.06.000
   Fan LH, 2006, CARBOHYD POLYM, V65, P447, DOI 10.1016/j.carbpol.2006.01.031
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Howe PD, 2002, SILVER SILVER COMPOU
   Jones-Edward V., 2002, J MED MICROBIOL, V51, P50
   Kalsen HJ, 2000, BURNS, V26, P117
   Keong LC, 2009, INT J MOL SCI, V10, P1300, DOI 10.3390/ijms10031300
   Kostenko V, 2010, ANTIMICROB AGENTS CH, V54, P5120, DOI 10.1128/AAC.00825-10
   Landis Stephan J, 2008, Adv Skin Wound Care, V21, P531, DOI 10.1097/01.ASW.0000323578.87700.a5
   Masood R, 2009, THESIS U BOLTON UK
   Patil BS, 2011, ORIENTAL PHARM EXP M, V11, P123, DOI 10.1007/s13596-011-0012-8
   Qin Y, 2004, TEXT MAG, V4, P23
   Ryan KJ, 2003, SHERRIS MED MICROBIL
   Samadra C., 1997, J CONTROL RELEASE, V44, P201
   Smith E. A., 1947, SAMPLING ASSAY PRECI, P71
   Stashak T. S., 2004, Clinical Techniques in Equine Practice, V3, P148, DOI 10.1053/j.ctep.2004.08.006
   Thomas S, 2004, ONLINE J WORLDWIDE W
   White WC, 2005, ANTIMICROBIAL TREATE
NR 24
TC 4
Z9 4
U1 2
U2 27
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1528-0837
EI 1530-8057
J9 J IND TEXT
JI J. Ind. Text.
PD MAR
PY 2015
VL 44
IS 5
BP 699
EP 708
DI 10.1177/1528083713510013
PG 10
WC Materials Science, Textiles
SC Materials Science
GA CB9XY
UT WOS:000349988900003
DA 2018-10-19
ER

PT J
AU Frohbergh, ME
   Katsman, A
   Mondrinos, MJ
   Stabler, CT
   Hankenson, KD
   Oristaglio, JT
   Lelkes, PI
AF Frohbergh, Michael E.
   Katsman, Anya
   Mondrinos, Mark J.
   Stabler, Collin T.
   Hankenson, Kurt D.
   Oristaglio, Jeffrey T.
   Lelkes, Peter I.
TI Osseointegrative Properties of Electrospun Hydroxyapatite-Containing
   Nanofibrous Chitosan Scaffolds
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; GUIDED BONE REGENERATION; IN-VIVO; PERIOSTEAL
   CELLS; STROMAL CELLS; CORTICAL BONE; ILIAC BONE; FIBERS; INFILTRATION;
   CARTILAGE
AB Our long-term goal is to develop smart biomaterials that can facilitate regeneration of critical-size craniofacial lesions. In this study, we tested the hypothesis that biomimetic scaffolds electrospun from chitosan (CTS) will promote tissue repair and regeneration in a critical size calvarial defect. To test this hypothesis, we first compared in vitro ability of electrospun CTS scaffolds crosslinked with genipin (CTS-GP) to those of mineralized CTS-GP scaffolds containing hydroxyapatite (CTS-HA-GP), by assessing proliferation/metabolic activity and alkaline phosphatase (ALP) levels of murine mesenchymal stem cells (mMSCs). The cells' metabolic activity exhibited a biphasic behavior, indicative of initial proliferation followed by subsequent differentiation for all scaffolds. ALP activity of mMSCs, a surrogate measure of osteogenic differentiation, increased over time in culture. After 3 weeks in maintenance medium, ALP activity of mMSCs seeded onto CTS-HA-GP scaffolds was approximately two times higher than that of cells cultured on CTS-GP scaffolds. The mineralized CTS-HA-GP scaffolds were also osseointegrative in vivo, as inferred from the enhanced bone regeneration in a murine model of critical size calvarial defects. Tissue regeneration was evaluated over a 3 month period by microCT and histology (Hematoxylin and Eosin and Masson's Trichrome). Treatment of the lesions with CTS-HA-GP scaffolds induced a 38% increase in the area of de novo generated mineralized tissue area after 3 months, whereas CTS-GP scaffolds only led to a 10% increase. Preseeding with mMSCs significantly enhanced the regenerative capacity of CTS-GP scaffolds (by similar to 3-fold), to 35% increase in mineralized tissue area after 3 months. CTS-HA-GP scaffolds preseeded with mMSCs yielded 45% new mineralized tissue formation in the defects. We conclude that the presence of HA in the CTS-GP scaffolds significantly enhances their osseointegrative capacity and that mineralized chitosan-based scaffolds crosslinked with genipin may represent a unique biomaterial with possible clinical relevance for the repair of critical calvarial bone defects.
C1 [Frohbergh, Michael E.; Lelkes, Peter I.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.
   [Frohbergh, Michael E.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.
   [Katsman, Anya] Drexel Univ, Coll Med, Dept Orthoped Surg, Philadelphia, PA 19104 USA.
   [Mondrinos, Mark J.] Temple Univ, Sch Med, Ctr Inflammat Translat & Clin Lung Res, Philadelphia, PA 19122 USA.
   [Stabler, Collin T.; Lelkes, Peter I.] Temple Univ, Coll Engn, Dept Bioengn, Philadelphia, PA 19122 USA.
   [Hankenson, Kurt D.] Michigan State Univ, Dept Nat Sci & Human Med, E Lansing, MI 48824 USA.
   [Oristaglio, Jeffrey T.] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA.
RP Lelkes, PI (reprint author), Temple Univ, Coll Engn, Dept Bioengn, Engn Bldg Room 811,1947 North 12th St, Philadelphia, PA 19122 USA.
EM pilelkes@temple.edu
OI Hankenson, Kurt/0000-0001-6361-143X
FU National Science Foundation [0434108]
FX This study was supported, in part, by a grant from the National Science
   Foundation [grant # 0434108]. The authors are grateful to Dr. Gozde
   Senel for her help with the SEM, Dr. Darwin Prokop from the Institute of
   Regenerative Medicine at Texas A&M University for his generous gift of
   the mMSCs used for this study, and Drs. Anant Chopra and Yasha Kresh for
   the use of the Z1 Observer Zeiss microscope for fluorescent imaging.
   P.I.L. is the Laura H. Carnell Professor of Bioengineering, College of
   Engineering, Temple University.
CR Acharya C, 2012, J CELL PHYSIOL, V227, P88, DOI 10.1002/jcp.22706
   Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032
   Bavariya AJ, 2014, J BIOMED MATER RES B, V102, P1084, DOI 10.1002/jbm.b.33090
   Bhumiratana S, 2012, STEM CELL TRANSL MED, V1, P64, DOI 10.5966/sctm.2011-0020
   Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272
   Cai YZ, 2010, J BIOMED MATER RES A, V95A, P49, DOI 10.1002/jbm.a.32816
   Casiraghi F, 2013, CURR OPIN ORGAN TRAN, V18, P51, DOI 10.1097/MOT.0b013e32835c5016
   Cooper GM, 2010, PLAST RECONSTR SURG, V125, P1685, DOI 10.1097/PRS.0b013e3181cb63a3
   Cooper LF, 1998, J PROSTHET DENT, V80, P439, DOI 10.1016/S0022-3913(98)70009-5
   De Bari C, 2006, ARTHRITIS RHEUM, V54, P1209, DOI 10.1002/art.21753
   Erickson IE, 2012, ACTA BIOMATER, V8, P3027, DOI 10.1016/j.actbio.2012.04.033
   Frohbergh ME, 2012, BIOMATERIALS, V33, P9167, DOI 10.1016/j.biomaterials.2012.09.009
   Ghasemi-Mobarakeh L, 2013, J NANOSCI NANOTECHNO, V13, P4656, DOI 10.1166/jnn.2013.7186
   Grassel Susanne, 2012, Methods Mol Biol, V879, P203, DOI 10.1007/978-1-61779-815-3_14
   Han JJ, 2011, BIOMACROMOLECULES, V12, P399, DOI 10.1021/bm101149r
   Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004
   Hoffman MD, 2013, CLIN ORTHOP RELAT R, V471, P721, DOI 10.1007/s11999-012-2695-7
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Hsieh CY, 2007, CARBOHYD POLYM, V67, P124, DOI 10.1016/j.carbpol.2006.05.002
   Hu ZM, 2011, J BIOMED MATER RES A, V98A, P473, DOI 10.1002/jbm.a.33119
   Hutmacher DW, 2003, TISSUE ENG, V9, pS45, DOI 10.1089/10763270360696978
   Im Jin-Young, 2013, Lab Anim Res, V29, P196, DOI 10.5625/lar.2013.29.4.196
   Kaji Hiroshi, 2007, Clin Calcium, V17, P1574
   Kang YM, 2010, INT J MOL SCI, V11, P4140, DOI 10.3390/ijms11104140
   Kim TG, 2008, ACTA BIOMATER, V4, P1611, DOI 10.1016/j.actbio.2008.06.008
   Kumaran S Thanga, 2010, Indian J Dent Res, V21, P3, DOI 10.4103/0970-9290.62796
   KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009
   LAURIE SWS, 1984, PLAST RECONSTR SURG, V73, P933, DOI 10.1097/00006534-198406000-00014
   Lee DW, 2010, J CRANIOFAC SURG, V21, P1084, DOI 10.1097/SCS.0b013e3181e1b64b
   Lee JH, 2014, TISSUE ENG PT A, V20, P2031, DOI 10.1089/ten.tea.2013.0282
   Lee YJ, 2013, BIOMATERIALS, V34, P5059, DOI 10.1016/j.biomaterials.2013.03.051
   LELKES PI, 1992, NATO ADV SCI I A-LIF, V227, P339
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Liu HH, 2013, BIOMATERIALS, V34, P4404, DOI 10.1016/j.biomaterials.2013.02.048
   Liu X, 2009, BIOMATERIALS, V30, P2252, DOI 10.1016/j.biomaterials.2008.12.068
   Lykins CL, 1998, ARCH OTOLARYNGOL, V124, P153, DOI 10.1001/archotol.124.2.153
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Martins A, 2010, TISSUE ENG PT A, V16, P3599, DOI 10.1089/ten.TEA.2009.0779
   Menard C, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt214
   Mohammadi Y, 2007, INT J ARTIF ORGANS, V30, P204
   Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542
   Nam J, 2007, TISSUE ENG, V13, P2249, DOI 10.1089/ten.2006.0306
   Norowski PA, 2015, J TISSUE ENG REGEN M, V9, P577, DOI 10.1002/term.1648
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   Ouyang HW, 2006, TRANSPLANTATION, V82, P170, DOI 10.1097/01.tp.0000226232.79106.72
   Peng HJ, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/48/485102
   Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080
   RIPAMONTI U, 1991, J ORAL MAXIL SURG, V49, P817, DOI 10.1016/0278-2391(91)90010-J
   Schofer MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025462
   Senagore A. J., 2004, GALE ENCY SURG GUIDE
   Shafiee A, 2011, BIOTECHNOL LETT, V33, P1257, DOI 10.1007/s10529-011-0541-8
   Skotak M, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055012
   Son SR, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/1/015009
   Stoddart MJ, 2011, METHODS MOL BIOL, V740, P1, DOI 10.1007/978-1-61779-108-6
   Tawonsawatruk Tulyapruek, 2012, J Med Assoc Thai, V95 Suppl 10, pS189
   Tchemtchoua VT, 2011, BIOMACROMOLECULES, V12, P3194, DOI 10.1021/bm200680q
   Wang GC, 2011, COLLOID SURFACE B, V86, P267, DOI 10.1016/j.colsurfb.2011.04.006
   Wolf-Brandstetter C., 2012, J BIOMED MATER RES B, V4, P599
   Xie C, 2007, TISSUE ENG, V13, P435, DOI 10.1089/ten.2006.0182
   Xie XH, 2015, J TISSUE ENG REGEN M, V9, P961, DOI 10.1002/term.1679
   Zhang W, 2013, BIOMATERIALS, V34, P713, DOI 10.1016/j.biomaterials.2012.10.027
   Zhang XP, 2008, CLIN ORTHOP RELAT R, V466, P1777, DOI 10.1007/s11999-008-0312-6
   Zhang XP, 2005, J BONE MINER RES, V20, P2124, DOI 10.1359/JBMR.050806
   Zhang YZ, 2010, TISSUE ENG PT A, V16, P1949, DOI [10.1089/ten.tea.2009.0221, 10.1089/ten.TEA.2009.0221]
   Zhu HY, 2013, J BIOMED MATER RES B, V101B, P541, DOI 10.1002/jbm.b.32854
   Zimmermann CE, 2011, TISSUE ENG PT A, V17, P1147, DOI [10.1089/ten.tea.2009.0577, 10.1089/ten.TEA.2009.0577]
NR 66
TC 12
Z9 12
U1 4
U2 28
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAR 1
PY 2015
VL 21
IS 5-6
BP 970
EP 981
DI 10.1089/ten.tea.2013.0789
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CC7LQ
UT WOS:000350549500011
PM 25336062
OA Green Published
DA 2018-10-19
ER

PT J
AU Peng, Y
   Xuan, M
   Zou, JP
   Liu, HW
   Zhuo, ZY
   Wan, Y
   Cheng, B
AF Peng, Yan
   Xuan, Min
   Zou, Jiping
   Liu, Hongwei
   Zhuo, Ziyuan
   Wan, Yu
   Cheng, Biao
TI Freeze-Dried Rat Bone Marrow Mesenchymal Stem Cell Paracrine Factors: A
   Simplified Novel Material for Skin Wound Therapy
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID PLATELET-RICH PLASMA; IMPROVES CARDIAC-FUNCTION; MYOCARDIAL-INFARCTION;
   STROMAL CELLS; GROWTH-FACTOR; INJURY; MODEL; TRANSPLANTATION;
   REGENERATION; MACROPHAGES
AB The mesenchymal stem cell (MSC) supernatant is well known as a rich source of autologous cytokines and universally used for tissue regeneration in current clinical medicine. However, the limitation of conditioned medium used in open-wound repair compels the need to find a more sophisticated way to take advantage of the trophic factors of MSCs. We have now fabricated a three-dimensional membrane from freeze-dried bone marrow mesenchymal stem cells-conditioned medium (FBMSC-CM) using a simple freeze-dried protocol. Scanning electron microscopy images showed the microstructure of the FBMSC-CM membrane (FBMSC-CMM) resembling a mesh containing growth factors. ELISA was used to test the paracrine factors retained in the FBMSC-CMM, and the results indicated that FBMSC-CMM withheld over 80% of the paracrine factors. Live/dead assays were adopted to test the toxicity of the FBMSC-CMM on cultured rat dermal fibroblasts, and the results confirmed its biological safety with low toxicity. Moreover, the FBMSC-CMM could significantly accelerate wound healing and enhance the neovascularization as well as epithelialization through strengthening the trophic factors in the wound bed as determined by immunohistochemical staining. Thus, the ability to maintain paracrine factors and enhance the effectiveness of these growth factors in the wound as well as the simple procedure and economical materials required for production qualifies the FBMSC-CMM to be a candidate biomaterial for open-wound regeneration.
C1 [Peng, Yan; Zou, Jiping; Zhuo, Ziyuan; Wan, Yu; Cheng, Biao] PLA, Key Lab Trauma Treatment & Tissue Repair Trop Are, Guangzhou Gen Hosp Guangzhou Command, Dept Plast Surg, Guangzhou 510010, Guangdong, Peoples R China.
   [Peng, Yan] Univ Hong Kong, LKS Fac Med, Dept Orthoped & Traumatol, Hong Kong, Hong Kong, Peoples R China.
   [Xuan, Min] Southern Med Univ, Guangzhou, Guangdong, Peoples R China.
   [Liu, Hongwei] Jinan Univ, Dept Plast Surg, Key Lab Regenerat Med, Affiliated Hosp 1,Minist Educ, Guangzhou, Guangdong, Peoples R China.
RP Cheng, B (reprint author), PLA, Key Lab Trauma Treatment & Tissue Repair Trop Are, Guangzhou Gen Hosp Guangzhou Command, Dept Plast Surg, Guangzhou 510010, Guangdong, Peoples R China.
EM chengbiaocheng@163.com
FU Science and Technology Project of Guangzhou, China [2012J4100044];
   National Natural Science Foundation of China [81171812]; National Basic
   Science and Development Program, China (973 Program) [2012CB518105]
FX This study was supported by grants from the Science and Technology
   Project of Guangzhou, China (2012J4100044), the National Natural Science
   Foundation of China (81171812), and the National Basic Science and
   Development Program, China (973 Program 2012CB518105).
CR Afzal MR, 2010, ANTIOXID REDOX SIGN, V12, P693, DOI 10.1089/ars.2009.2755
   Balogun WO, 2013, GERONTOLOGY, V59, P3, DOI 10.1159/000340062
   Buikema JW, 2013, STEM CELLS, V31, P2587, DOI 10.1002/stem.1467
   Burdon TJ, 2011, BONE MARROW RES, V2011, DOI DOI 10.1155/2011/207326
   Chan JKY, 2013, CANCER GENE THER, V20, P539, DOI 10.1038/cgt.2013.59
   Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886
   Du ZY, 2013, J SURG RES, V183, P907, DOI 10.1016/j.jss.2013.02.009
   Evsikov Alexei V, 2003, Science, V302, P393
   Kamota T, 2009, J AM COLL CARDIOL, V53, P1814, DOI 10.1016/j.jacc.2009.02.015
   Kawase T, 2011, J BIOMED MATER RES A, V98A, P100, DOI 10.1002/jbm.a.33074
   Kawase T, 2010, J PERIODONTOL, V81, P420, DOI 10.1902/jop.2009.090523
   Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC
   Kloss FR, 2008, BIOMATERIALS, V29, P2433, DOI 10.1016/j.biomaterials.2008.01.036
   Lange C, 2005, KIDNEY INT, V68, P1613, DOI 10.1111/j.1523-1755.2005.00573.x
   Mastri Michalis, 2014, World J Stem Cells, V6, P82, DOI 10.4252/wjsc.v6.i2.82
   Moghadasali R, 2013, EXP TOXICOL PATHOL, V65, P595, DOI 10.1016/j.etp.2012.06.002
   Nagaya N, 2004, AM J PHYSIOL-HEART C, V287, pH2670, DOI 10.1152/ajpheart.01071.2003
   Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447
   Nakajima Y, 2012, PLATELETS, V23, P594, DOI 10.3109/09537104.2011.645923
   Nie C., 2012, J TISSUE ENG REGEN M, DOI [10.1002/term.1622, DOI 10.1002/TERM.1622]
   Noale M, 2012, DIABETES METAB, V38, P135, DOI 10.1016/j.diabet.2011.09.005
   Patterson TE, 2008, J BONE JOINT SURG AM, V90A, P111, DOI 10.2106/JBJS.G.01572
   Pietramaggiori G, 2008, WOUND REPAIR REGEN, V16, P218, DOI 10.1111/j.1524-475X.2008.00362.x
   Pietramaggiori G, 2006, WOUND REPAIR REGEN, V14, P573, DOI 10.1111/j.1743-6109.2006.00164.x
   Pijpers E, 2012, AGE AGEING, V41, P358, DOI 10.1093/ageing/afr145
   Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530
   Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389
   Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1
   Samper E, 2013, STEM CELL REV REP, V9, P266, DOI 10.1007/s12015-012-9353-z
   Shen L, 2013, CELL TRANSPLANT, V22, P1011, DOI 10.3727/096368912X657495
   Shi RZ, 2009, EXP CELL RES, V315, P10, DOI 10.1016/j.yexcr.2008.09.024
   Song L, 2004, CYTOTHERAPY, V6, P596, DOI 10.1080/14653240410005276
   Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006
   Tam K, 2014, J CELL BIOCHEM, V115, P794, DOI 10.1002/jcb.24723
   Tang JM, 2010, MOL CELLS, V29, P9, DOI 10.1007/s10059-010-0001-7
   Titmarsh DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052405
   Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030
   Wilkins RG, 2013, ADV SKIN WOUND CARE, V26, P160, DOI 10.1097/01.ASW.0000428861.26671.41
   Xing YJ, 2012, MOL CELL BIOCHEM, V360, P279, DOI 10.1007/s11010-011-1067-z
   Yu B, 2014, INT J MOL SCI, V15, P4142, DOI 10.3390/ijms15034142
   Zhang QZ, 2010, STEM CELLS, V28, P1856, DOI 10.1002/stem.503
NR 41
TC 7
Z9 8
U1 1
U2 25
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAR 1
PY 2015
VL 21
IS 5-6
BP 1036
EP 1046
DI 10.1089/ten.tea.2014.0102
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CC7LQ
UT WOS:000350549500017
PM 25343727
OA Green Published
DA 2018-10-19
ER

PT J
AU White, JD
   Wang, SR
   Weiss, AS
   Kaplan, DL
AF White, James D.
   Wang, Siran
   Weiss, Anthony S.
   Kaplan, David L.
TI Silk-tropoelastin protein films for nerve guidance
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Nerve regeneration; Nerve guide; Silk; Elastin; Protein blends
ID ROOT GANGLION NEURONS; PERIPHERAL-NERVE; NEURITE EXTENSION;
   SCHWANN-CELLS; ELECTRICAL-STIMULATION; SUBSTRATE STIFFNESS; GEL
   STIFFNESS; COLLAGEN GEL; REGENERATION; BIOMATERIALS
AB Peripheral nerve regeneration may be enhanced through the use of biodegradable thin film biomaterials as highly tuned inner nerve conduit liners. Dorsal root ganglion neuron and Schwann cell responses were studied on protein films comprising silk fibroin blended with recombinant human tropoelastin protein. Tropoelastin significantly improved neurite extension and enhanced Schwann cell process length and cell area, while the silk provided a robust biomaterial template. Silk-tropoelastin blends afforded a 2.4-fold increase in neurite extension, when compared to silk films coated with poly-D-lysine. When patterned by drying on grooved polydimethylsiloxane (3.5 mu m groove width, 0.5 mu m groove depth), these protein blends induced both neurite and Schwann cell process alignment. Neurons were functional as assessed using patch-clamping, and displayed action potentials similar to those cultured on poly(lysine)-coated glass. Taken together, silk-tropoelastin films offer useful biomaterial interfacial platforms for nerve cell control, which can be considered for neurite guidance, disease models for neuropathies and surgical peripheral nerve repairs. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [White, James D.; Wang, Siran; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
   [Weiss, Anthony S.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia.
   [Weiss, Anthony S.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI WEISS, ANTHONY/0000-0002-8106-4836
FU Australian Research Council; National Health & Medical Research Council;
   NIH [EB014283]; NIH P41 Tissue Engineering Resource Cente [P41 EB002520]
FX The authors thank Dr Chuang Du for his expertise and assistance with
   electrophysiological experiments and Dr Min Tang-Schomer, Dr Lee W.
   Tien, Dr Amy Hopkins and Prof. Cristian Staii for insightful
   discussions. The authors also thank the NIH P41 Tissue Engineering
   Resource Center (P41 EB002520). A.S.W. is Scientific Founder of
   Elastagen Pty Ltd. A.S.W. acknowledges grant support from the Australian
   Research Council and the National Health & Medical Research Council.
   Part of this research was funded by NIH EB014283 (D.L.K. and A.S.W.).
CR Agnew SP, 2010, J HAND SURG-AM, V35A, P838, DOI 10.1016/j.jhsa.2010.02.025
   Akhtart K, 2011, J BIOL CHEM, V286, P13574, DOI 10.1074/jbc.M110.192088
   ARCHIBALD SJ, 1995, J NEUROSCI, V15, P4109
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Battiston B, 2009, INT REV NEUROBIOL, V87, P227, DOI 10.1016/S0074-7742(09)87011-6
   Bax DV, 2011, BIONANOSCIENCE, V1, P123, DOI 10.1007/s12668-011-0018-1
   Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525
   Bertleff MJOE, 2005, J HAND SURG-AM, V30A, P513, DOI 10.1016/j.jhsa.2004.12.009
   Blewitt MJ, 2007, ANN BIOMED ENG, V35, P2159, DOI 10.1007/s10439-007-9389-4
   Borschel GH, 2003, J SURG RES, V114, P133, DOI 10.1016/S0022-4804(03)00255-5
   Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200
   BUNGE RP, 1994, J NEUROL, V242, pS19, DOI 10.1007/BF00939235
   Cheng CM, 2011, J BIOMECH, V44, P856, DOI 10.1016/j.jbiomech.2010.12.006
   Chiono V, 2011, MACROMOL BIOSCI, V11, P245, DOI 10.1002/mabi.201000354
   Clements IP, 2009, BIOMATERIALS, V30, P3834, DOI 10.1016/j.biomaterials.2009.04.022
   Cunha C, 2011, NANOMED-NANOTECHNOL, V7, P50, DOI 10.1016/j.nano.2010.07.004
   Dadsetan M, 2009, BIOMATERIALS, V30, P3874, DOI 10.1016/j.biomaterials.2009.04.018
   de Boer R, 2011, MICROSURG, V31, P293, DOI 10.1002/micr.20869
   DICHTER MA, 1977, J PHYSIOL-LONDON, V267, P281, DOI 10.1113/jphysiol.1977.sp011813
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Gu Y, 2012, BIOMATERIALS, V33, P6672, DOI 10.1016/j.biomaterials.2012.06.006
   HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997
   Ho C, 2011, MOL CELL NEUROSCI, V46, P159, DOI 10.1016/j.mcn.2010.08.017
   Hopkins AM, 2013, ADV FUNCT MATER, V23, P5140, DOI 10.1002/adfm.201300435
   Hronik-Tupaj M, 2013, J BIOMED MATER RES A, V101, P2559, DOI 10.1002/jbm.a.34565
   Hu X, 2013, ADV FUNCT MATER, V23, P3875, DOI 10.1002/adfm.201202685
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Isaacs J, 2013, HAND CLIN, V29, P371, DOI 10.1016/j.hcl.2013.04.006
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Koppes AN, 2014, TISSUE ENG PT A, V20, P494, DOI 10.1089/ten.TEA.2013.0012
   Lee DY, 2006, J CRANIO MAXILL SURG, V34, P50, DOI 10.1016/jcm.2005.07.011
   Lin YC, 2011, ANN PLAS SURG, V67, P147, DOI 10.1097/SAP.0b013e3182240346
   Loverde JR, 2011, J NEUROTRAUM, V28, P2389, DOI 10.1089/neu.2010.1598
   Lu MC, 2009, J MATER SCI-MATER M, V20, P1175, DOI 10.1007/s10856-008-3646-4
   MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M
   Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022
   Mithieux SM, 2013, ADV DRUG DELIVER REV, V65, P421, DOI 10.1016/j.addr.2012.06.009
   Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614
   Nectow AR, 2012, TISSUE ENG PART B-RE, V18, P40, DOI [10.1089/ten.teb.2011.0240, 10.1089/ten.TEB.2011.0240]
   Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025
   Reid AJ, 2013, NEUROSCI LETT, V544, P125, DOI 10.1016/j.neulet.2013.04.001
   ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0
   Scholz T, 2009, J RECONSTR MICROSURG, V25, P339, DOI 10.1055/s-0029-1215529
   Shakhbazau A, 2012, MOL CELL NEUROSCI, V50, P103, DOI 10.1016/j.mcn.2012.04.004
   Spedden E, 2012, BIOPHYS J, V103, P868, DOI 10.1016/j.bpj.2012.08.005
   Suwantong O, 2007, INT J BIOL MACROMOL, V40, P217, DOI 10.1016/j.ijbiomac.2006.07.006
   Swindle-Reilly KE, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046007
   Taras JS, 2011, J HAND SURG-AM, V36A, P1441, DOI 10.1016/j.jhsa.2011.06.009
   Thaxton C, 2011, MOL CELL NEUROSCI, V47, P1, DOI 10.1016/j.mcn.2010.12.006
   Thompson DM, 2006, ANN BIOMED ENG, V34, P161, DOI 10.1007/s10439-005-9013-4
   Thorsen F, 2012, J PLAST SURG HAND SU, V46, P184, DOI 10.3109/2000656X.2012.676554
   Wang HK, 2012, BIOTECHNOL APPL BIOC, V59, P388, DOI 10.1002/bab.1031
   Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698
   Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   YANG J, 1990, J NEUROBIOL, V21, P661, DOI 10.1002/neu.480210413
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Zhou ZL, 2012, BIOMATERIALS, V33, P2473, DOI 10.1016/j.biomaterials.2011.12.005
   Zuidema JM, 2011, ACTA BIOMATER, V7, P1634, DOI 10.1016/j.actbio.2010.11.039
NR 60
TC 13
Z9 12
U1 4
U2 75
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2015
VL 14
BP 1
EP 10
DI 10.1016/j.actbio.2014.11.045
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CB6JR
UT WOS:000349733800001
PM 25481743
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Kutikov, AB
   Gurijala, A
   Song, J
AF Kutikov, Artem B.
   Gurijala, Anvesh
   Song, Jie
TI Rapid Prototyping Amphiphilic Polymer/Hydroxyapatite Composite Scaffolds
   with Hydration-Induced Self-Fixation Behavior
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID DYNAMIC-MECHANICAL PROPERTIES; TISSUE ENGINEERING SCAFFOLDS; GUIDED BONE
   REGENERATION; MARROW STROMAL CELLS; IN-VITRO; CONFORMATIONAL-CHANGES;
   FREEFORM FABRICATION; BLOCK-COPOLYMERS; POROUS SCAFFOLDS; DESIGN
AB Two major factors hampering the broad use of rapid prototyped biomaterials for tissue engineering applications are the requirement for custom-designed or expensive research-grade three-dimensional (3D) printers and the limited selection of suitable thermoplastic biomaterials exhibiting physical characteristics desired for facile surgical handling and biological properties encouraging tissue integration. Properly designed thermoplastic biodegradable amphiphilic polymers can exhibit hydration-dependent hydrophilicity changes and stiffening behavior, which may be exploited to facilitate the surgical delivery/self-fixation of the scaffold within a physiological tissue environment. Compared to conventional hydrophobic polyesters, they also present significant advantages in blending with hydrophilic osteoconductive minerals with improved interfacial adhesion for bone tissue engineering applications. Here, we demonstrated the excellent blending of biodegradable, amphiphilic poly(D,L-lactic acid)-poly(ethylene glycol)-poly(D,L-lactic acid) (PLA-PEG-PLA) (PELA) triblock co-polymer with hydroxyapatite (HA) and the fabrication of high-quality rapid prototyped 3D macroporous composite scaffolds using an unmodified consumer-grade 3D printer. The rapid prototyped HA-PELA composite scaffolds and the PELA control (without HA) swelled (66% and 44% volume increases, respectively) and stiffened (1.38-fold and 4-fold increases in compressive modulus, respectively) in water. To test the hypothesis that the hydration-induced physical changes can translate into self-fixation properties of the scaffolds within a confined defect, a straightforward in vitro pull-out test was designed to quantify the peak force required to dislodge these scaffolds from a simulated cylindrical defect at dry versus wet states. Consistent with our hypothesis, the peak fixation force measured for the PELA and HA-PELA scaffolds increased 6-fold and 15-fold upon hydration, respectively. Furthermore, we showed that the low-fouling 3D PELA inhibited the attachment of NIH3T3 fibroblasts or bone marrow stromal cells while the HA-PELA readily supported cellular attachment and osteogenic differentiation. Finally, we demonstrated the feasibility of rapid prototyping biphasic PELA/HA-PELA scaffolds for potential guided bone regeneration where an osteoconductive scaffold interior encouraging osteointegration and a nonadhesive surface discouraging fibrous tissue encapsulation is desired. This work demonstrated that by combining facile and readily translatable rapid prototyping approaches with unique biomaterial designs, biodegradable composite scaffolds with well-controlled macroporosities, spatially defined biological microenvironment, and useful handling characteristics can be developed.
C1 [Kutikov, Artem B.; Gurijala, Anvesh; Song, Jie] Univ Massachusetts, Sch Med, Dept Orthoped & Phys Rehabil, Worcester, MA 01655 USA.
   [Kutikov, Artem B.; Song, Jie] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01655 USA.
RP Song, J (reprint author), Univ Massachusetts, Sch Med, Dept Orthoped & Phys Rehabil, 55 Lake Ave North, Worcester, MA 01655 USA.
EM jie.song@umassmed.edu
OI Kutikov, Artem/0000-0001-9444-9156
FU National Institutes of Health [R01GM088678, R01AR055615]; University of
   Massachusetts Commercial Ventures and Intellectual Property Technology
   Award; National Center for Research Resources [S10RR021043]
FX This work was supported in part by the National Institutes of Health
   grants R01GM088678 and R01AR055615, and a University of Massachusetts
   Commercial Ventures and Intellectual Property Technology Award. Core
   resources supported by the National Center for Research Resources Grant
   S10RR021043 were used. We thank Evanthia Fylaktou and Prof. Stephen
   McCarthy at the University of Massachusetts Lowell for the generous help
   in extruding the amphiphilic polymer filaments and the kind permission
   for access of the extruder by Metabolix, Inc.
CR Bedoui F, 2012, SOFT MATTER, V8, P2230, DOI 10.1039/c1sm06619f
   Blakeney BA, 2011, BIOMATERIALS, V32, P1583, DOI 10.1016/j.biomaterials.2010.10.056
   Butscher A, 2011, ACTA BIOMATER, V7, P907, DOI 10.1016/j.actbio.2010.09.039
   COHN D, 1988, J BIOMED MATER RES, V22, P993, DOI 10.1002/jbm.820221104
   Cohn D, 2005, POLYMER, V46, P2068, DOI 10.1016/j.polymer.2005.01.012
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   Deschamps AA, 2004, BIOMATERIALS, V25, P247, DOI 10.1016/S0142-9612(03)00495-2
   Dimitriou R, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-81
   Faour O, 2011, INJURY, V42, pS87, DOI 10.1016/j.injury.2011.06.020
   Filion TM, 2011, TISSUE ENG PT A, V17, P503, DOI [10.1089/ten.tea.2010.0274, 10.1089/ten.TEA.2010.0274]
   Filion TM, 2011, BIOMEDICAL ENGINEERING - FRONTIERS AND CHALLENGES, P233
   Furukawa T, 2000, J BIOMED MATER RES, V50, P410, DOI 10.1002/(SICI)1097-4636(20000605)50:3<410::AID-JBM16>3.0.CO;2-Y
   Giordano RA, 1996, J BIOMAT SCI-POLYM E, V8, P63, DOI 10.1163/156856297X00588
   Gopferich A, 1999, J BIOMED MATER RES, V46, P390
   Heo SJ, 2009, TISSUE ENG PT A, V15, P977, DOI 10.1089/ten.tea.2008.0190
   Kapfer SC, 2011, BIOMATERIALS, V32, P6875, DOI 10.1016/j.biomaterials.2011.06.012
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim J, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/025003
   Kutikov AB, 2013, ACTA BIOMATER, V9, P8354, DOI 10.1016/j.actbio.2013.06.013
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee JH, 2005, BIOMATERIALS, V26, P671, DOI 10.1016/j.biomaterials.2004.03.009
   Leferink A., 2013, J TISSUE ENG REGEN M, DOI DOI 10.1002/TERM.1842
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Lieb E, 2003, TISSUE ENG, V9, P71, DOI 10.1089/107632703762687555
   LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A
   Melchels FPW, 2010, ACTA BIOMATER, V6, P4208, DOI 10.1016/j.actbio.2010.06.012
   Melchels FPW, 2010, BIOMATERIALS, V31, P6909, DOI 10.1016/j.biomaterials.2010.05.068
   Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023
   Moroni L, 2005, J BIOMED MATER RES A, V75A, P957, DOI 10.1002/jbm.a.30499
   Murthy NS, 2010, POLYMER, V51, P3978, DOI 10.1016/j.polymer.2010.06.024
   Neuendorf RE, 2008, ACTA BIOMATER, V4, P1288, DOI 10.1016/j.actbio.2008.04.006
   Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080
   Polini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026211
   Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P567, DOI 10.1111/j.1600-0501.2010.01922.x
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Schantz JT, 2005, J MATER SCI-MATER M, V16, P807, DOI 10.1007/s10856-005-3584-3
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Song J, 2003, J EUR CERAM SOC, V23, P2905, DOI 10.1016/S0955-2219(03)00302-9
   Song J, 2009, J BIOMED MATER RES A, V89A, P1098, DOI 10.1002/jbm.a.32110
   Sun Y, 2012, J BIOMED MATER RES A, V100A, P2739, DOI 10.1002/jbm.a.34210
   Supova M, 2009, J MATER SCI-MATER M, V20, P1201, DOI 10.1007/s10856-009-3696-2
   THOMAS KA, 1985, J BIOMED MATER RES, V19, P875, DOI 10.1002/jbm.820190802
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Wiria FE, 2007, ACTA BIOMATER, V3, P1, DOI 10.1016/j.actbio.2006.07.008
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Xu JQ, 2007, J AM CHEM SOC, V129, P506, DOI 10.1021/ja067986i
   Yang DJ, 2009, ACTA BIOMATER, V5, P2467, DOI 10.1016/j.actbio.2009.03.034
   Yang DJ, 2009, J BIOMAT SCI-POLYM E, V20, P1321, DOI 10.1163/156856209X453024
   Yoo D, 2013, MAT SCI ENG C-MATER, V33, P1759, DOI 10.1016/j.msec.2012.12.092
   Yoo D, 2012, MED ENG PHYS, V34, P762, DOI 10.1016/j.medengphy.2012.05.008
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
NR 52
TC 11
Z9 11
U1 1
U2 57
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD MAR 1
PY 2015
VL 21
IS 3
BP 229
EP 241
DI 10.1089/ten.tec.2014.0213
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CC0RL
UT WOS:000350043400001
PM 25025950
OA Green Published
DA 2018-10-19
ER

PT J
AU Custodio, CA
   Cerqueira, MT
   Marques, AP
   Reis, RL
   Mano, JF
AF Custodio, C. A.
   Cerqueira, M. T.
   Marques, A. P.
   Reis, R. L.
   Mano, J. F.
TI Cell selective chitosan microparticles as injectable cell carriers for
   tissue regeneration
SO BIOMATERIALS
LA English
DT Article
DE Cell separation; Antibody immobilization; Injectable materials;
   Functional materials; Chitosan microparticles
ID MESENCHYMAL STROMAL CELLS; CIRCULATING TUMOR-CELLS; STEM-CELLS;
   ENGINEERING APPLICATIONS; CANCER-PATIENTS; SEPARATION; DERIVATIVES;
   SCAFFOLDS; MEDICINE; ANTIBODY
AB The detection, isolation and sorting of cells holds an important role in cell therapy and regenerative medicine. Also, injectable systems have been explored for tissue regeneration in vivo, because it allows repairing complex shaped tissue defects through minimally invasive surgical procedures. Here we report the development of chitosan microparticles with a size of 115.8 mu m able to capture and expand a specific cell type that can also be regarded as an injectable biomaterial. Monoclonal antibodies against cell surface antigens specific to endothelial cells and stem cells were immobilized on the surface of the microparticles. Experimental results showed that particles bioconjugated with specific antibodies provide suitable surfaces to capture a target cell type and subsequent expansion of the captured cells. Primarily designed for an application in tissue engineering, three main challenges are accomplished with the herein presented microparticles: separation, scale-up expansion of specific cell type and successful use as an injectable system to form small tissue constructs in situ. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Custodio, C. A.; Cerqueira, M. T.; Marques, A. P.; Reis, R. L.; Mano, J. F.] Univ Minho, Res Grp 3Bs, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
   [Custodio, C. A.; Cerqueira, M. T.; Marques, A. P.; Reis, R. L.; Mano, J. F.] ICVS 3Bs, PT Govt Associated Lab, Braga, Guimaraes, Portugal.
RP Mano, JF (reprint author), Univ Minho, Res Grp 3Bs, AvePk, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM jmano@dep.uminho.pt
RI Custodio, Catarina/N-3290-2016; Reis, Rui L./A-8938-2008; Group,
   3Bs/E-4374-2012; Mano, Joao/A-4418-2009; Marques, Alexandra/B-1238-2012
OI Custodio, Catarina/0000-0003-2967-700X; Reis, Rui
   L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456; Mano,
   Joao/0000-0002-2342-3765; Marques, Alexandra/0000-0002-3222-0310;
   Cerqueira, Mariana/0000-0002-2430-7758
FU European Research Council [ERC-2012-ADG 20120216-321266]; European
   Union's Seventh Framework Programme (FP7)
   [REGPOT-CT2012-316331-POLARIS]; FCT [SFRH/BD/61390/2009]
FX This work was supported by European Research Council grant agreement
   ERC-2012-ADG 20120216-321266 for project CornplexiTE and by the European
   Union's Seventh Framework Programme (FP7/2007-2013) under grant
   agreement no REGPOT-CT2012-316331-POLARIS. The authors acknowledge the
   FCT for the fellowship SFRH/BD/61390/2009 (C.A.C.) for the financial
   support. We are grateful to Hospital da Prelada for the lipoaspirates
   donations.
CR ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059
   Alves NM, 2008, INT J BIOL MACROMOL, V43, P401, DOI 10.1016/j.ijbiomac.2008.09.007
   Astori G, 2007, J TRANSL MED, P5
   Balmayor ER, 2011, J R SOC INTERFACE, V8, P896, DOI 10.1098/rsif.2010.0531
   Borg DJ, 2009, J BIOMED MATER RES A, V88A, P184, DOI 10.1002/jbm.a.31864
   Cerqueira MT, 2013, BIOMACROMOLECULES, V14, P3997, DOI 10.1021/bm4011062
   Chen YC, 2014, LAB CHIP, V14, P626, DOI 10.1039/c3lc90136j
   Custodio CA, 2014, ADV FUNCT MATER, V24, P1391, DOI 10.1002/adfm.201301516
   Custodio CA, 2012, BIOINTERPHASES, P7
   Custodio CA, 2014, ADV HEALTHC MATER, V3, P797, DOI 10.1002/adhm.201300603
   Declercq HA, 2013, BIOMATERIALS, V34, P1004, DOI 10.1016/j.biomaterials.2012.10.051
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   DIAMANDIS EP, 1991, CLIN CHEM, V37, P625
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Cruz DMG, 2008, J TISSUE ENG REGEN M, V2, P378, DOI 10.1002/term.106
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Hervy M, 2014, PLOS ONE, P9
   Juopperi TA, 2007, EXP HEMATOL, V35, P335, DOI 10.1016/j.exphem.2006.09.014
   Kamihira M, 2007, ADV BIOCHEM ENG BIOT, V106, P173, DOI 10.1007/10_2006_043
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Mihaila SM, 2013, TISSUE ENG PT A, V19, P235, DOI [10.1089/ten.TEA.2012.0092, 10.1089/ten.tea.2012.0092]
   MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203
   Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385
   NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Oliveira MB, 2011, BIOTECHNOL PROGR, V27, P897, DOI 10.1002/btpr.618
   Say EAT, 2013, PLOS ONE, P8
   Schop D, 2010, J TISSUE ENG REGEN M, V4, P131, DOI 10.1002/term.224
   Sheng WA, 2014, LAB CHIP, V14, P89, DOI 10.1039/c3lc51017d
   Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720
   Valimaa L, 2003, BIOCONJUGATE CHEM, V14, P103, DOI 10.1021/bc020058y
   Vallee M, 2009, PATHOL BIOL, V57, P309, DOI 10.1016/j.patbio.2008.04.010
   Wadajkar AS, 2014, BIOMATERIALS, V35, P654, DOI 10.1016/j.biomaterials.2013.10.015
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/nmat3101, 10.1038/NMAT3101]
   Xu HY, 2011, BIOMATERIALS, V32, P9758, DOI 10.1016/j.biomaterials.2011.08.076
   Ye XF, 2009, TISSUE ENG PT A, V15, P1, DOI 10.1089/ten.tea.2008.0001
   Zborowski M, 2011, ANAL CHEM, V83, P8050, DOI 10.1021/ac200550d
NR 37
TC 24
Z9 24
U1 4
U2 92
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2015
VL 43
BP 23
EP 31
DI 10.1016/j.biomaterials.2014.11.047
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CB4GX
UT WOS:000349587300003
PM 25591958
DA 2018-10-19
ER

PT J
AU Appel, AA
   Larson, JC
   Garson, AB
   Guan, HF
   Zhong, Z
   Nguyen, BNB
   Fisher, JP
   Anastasio, MA
   Brey, EM
AF Appel, Alyssa A.
   Larson, Jeffery C.
   Garson, Alfred B., III
   Guan, Huifeng
   Zhong, Zhong
   Nguyen, Bao-Ngoc B.
   Fisher, John P.
   Anastasio, Mark A.
   Brey, Eric M.
TI X-ray Phase Contrast Imaging of Calcified Tissue and Biomaterial
   Structure in Bioreactor Engineered Tissues
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE X-ray phase contrast; micro-computed tomography; bioreactor; alginate
   microbeads; synchrotron; analyzer-based imaging
ID MARROW STROMAL CELLS; OPTICAL COHERENCE TOMOGRAPHY; TUBULAR PERFUSION
   SYSTEM; MICROCOMPUTED TOMOGRAPHY; DYNAMIC CULTURE; IN-VITRO; SCAFFOLDS;
   RADIOGRAPHY; EXPRESSION; CONSTRUCT
AB Tissues engineered in bioreactor systems have been used clinically to replace damaged tissues and organs. In addition, these systems are under continued development for many tissue engineering applications. The ability to quantitatively assess material structure and tissue formation is critical for evaluating bioreactor efficacy and for preimplantation assessment of tissue quality. Techniques that allow for the nondestructive and longitudinal monitoring of large engineered tissues within the bioreactor systems will be essential for the translation of these strategies to viable clinical therapies. X-ray Phase Contrast (XPC) imaging techniques have shown tremendous promise for a number of biomedical applications owing to their ability to provide image contrast based on multiple X-ray properties, including absorption, refraction, and scatter. In this research, mesenchymal stem cell-seeded alginate hydrogels were prepared and cultured under osteogenic conditions in a perfusion bioreactor. The constructs were imaged at various time points using XPC microcomputed tomography (mu CT). Imaging was performed with systems using both synchrotron- and tube-based X-ray sources. XPC mu CT allowed for simultaneous three-dimensional (3D) quantification of hydrogel size and mineralization, as well as spatial information on hydrogel structure and mineralization. Samples were processed for histological evaluation and XPC showed similar features to histology and quantitative analysis consistent with the histomorphometry. These results provide evidence of the significant potential of techniques based on XPC for noninvasive 3D imaging engineered tissues grown in bioreactors. Biotechnol. Bioeng. 2015;112: 612-620. (c) 2014 Wiley Periodicals, Inc.
C1 [Appel, Alyssa A.; Larson, Jeffery C.; Brey, Eric M.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
   [Appel, Alyssa A.; Larson, Jeffery C.; Brey, Eric M.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA.
   [Garson, Alfred B., III; Guan, Huifeng; Anastasio, Mark A.] Washington Univ, Dept Biomed Engn, St Louis, MO USA.
   [Zhong, Zhong] Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA.
   [Nguyen, Bao-Ngoc B.; Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
RP Brey, EM (reprint author), IIT, Dept Biomed Engn, 3255 South Dearborn St, Chicago, IL 60616 USA.
EM brey@iit.edu
FU Veterans Administration; National Science Foundation [CBET-1263994,
   IIS-1125412]; National Institute of Health [R01EB009715, R01AR061460]
FX Contract grant sponsor: Veterans Administration; Contract grant sponsor:
   National Science Foundation; Grant numbers: CBET-1263994; IIS-1125412;
   Contract grant sponsor: National Institute of Health; Grant numbers:
   R01EB009715; R01AR061460
CR Ahearne M, 2008, J TISSUE ENG REGEN M, V2, P521, DOI 10.1002/term.124
   Appel A, 2011, TISSUE ENG PART B-RE, V17, P321, DOI [10.1089/ten.teb.2011.0230, 10.1089/ten.TEB.2011.0230]
   Appel AA, 2012, TISSUE ENG PART C-ME, V18, P859, DOI [10.1089/ten.tec.2012.0123, 10.1089/ten.TEC.2012.0123]
   Appel AA, 2013, BIOMATERIALS, V34, P6615, DOI 10.1016/j.biomaterials.2013.05.033
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Bagnaninchi PO, 2007, TISSUE ENG, V13, P323, DOI 10.1089/ten.2006.0168
   Brankov JG, 2006, MED PHYS, V33, P278, DOI 10.1118/1.2150788
   Brey EM, 2010, TISSUE ENG PART C-ME, V16, P1597, DOI 10.1089/ten.tec.2010.0150
   Cartmell S, 2004, J BIOMED MATER RES A, V69A, P97, DOI 10.1002/jbm.a.20118
   Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024
   Chou CY, 2007, PHYS MED BIOL, V52, P1923, DOI 10.1088/0031-9155/52/7/011
   Gonfiotti A, 2014, LANCET, V383, P238, DOI 10.1016/S0140-6736(13)62033-4
   Guan H, 2014, P SPIE, V9033
   Hofmann M, 2012, INT J COMPUT VISION, V96, P103, DOI 10.1007/s11263-011-0451-1
   Hofmann MC, 2012, J BIOMED OPT, V17
   Izadifar Z, 2014, TISSUE ENG PART C-ME, V20, P140, DOI [10.1089/ten.tec.2013.0138, 10.1089/ten.TEC.2013.0138]
   Kak A. C., 1999, PRINCIPLES COMPUTERI
   Kotecha M, 2012, NMR BIOMED, V26, P709
   Kotecha M, 2013, TISSUE ENG PART B-RE, V19, P1
   Langer M, 2010, J MICROSC-OXFORD, V238, P230, DOI [10.1111/j.1365-2818.2009.03545.x, 10.1111/j.1365-2818.2009.03345.x]
   Lewis RA, 2004, PHYS MED BIOL, V49, P3573, DOI 10.1088/0031-9155/49/16/005
   Mason C, 2004, PHYS MED BIOL, V49, P1097, DOI 10.1088/0031-9155/49/7/002
   McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8
   Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11
   Moya ML, 2012, J MATER SCI-MATER M, V23, P903, DOI 10.1007/s10856-012-4575-9
   Othman SF, 2012, NMR BIOMED, V25, P452, DOI 10.1002/nbm.1663
   Parham C, 2009, ACAD RADIOL, V16, P911, DOI 10.1016/j.acra.2009.02.007
   Porter BD, 2007, BIOMATERIALS, V28, P2525, DOI 10.1016/j.biomaterials.2007.01.013
   Ramaswamy S, 2008, TISSUE ENG PART C-ME, V14, P243, DOI 10.1089/ten.tec.2007.0423
   Ramaswamy S, 2009, TISSUE ENG PT A, V15, P3899, DOI 10.1089/ten.tea.2008.0677
   Ravindran S, 2012, TISSUE ENG PT A, V18, P295, DOI [10.1089/ten.TEA.2011.0136, 10.1089/ten.tea.2011.0136]
   Reiter DA, 2012, NMR BIOMED, V25, P476, DOI 10.1002/nbm.1804
   Sikavitsas VI, 2005, ANN BIOMED ENG, V33, P63, DOI 10.1007/s10439-005-8963-x
   Smith S, 2010, ESSAY CAUSES VARIETY, P55
   Thompson AD, 2009, TISSUE ENG PT A, V15, P1181, DOI 10.1089/ten.tea.2007.0275
   Wenk PA, 2010, TECH POINTS, V39, P3
   Wernick MN, 2003, PHYS MED BIOL, V48, P3875, DOI 10.1088/0031-9155/48/23/006
   Wystrychowski W, 2013, J VASC SURG
   Yeatts AB, 2011, TISSUE ENG PART C-ME, V17, P337, DOI [10.1089/ten.tec.2010.0172, 10.1089/ten.TEC.2010.0172]
   Yeatts AB, 2012, BIOTECHNOL BIOENG, V109, P2381, DOI 10.1002/bit.24497
   Yeatts AB, 2011, TISSUE ENG PART C-ME, V17, P1171, DOI 10.1089/ten.tec.2011.0263
   Yoon DM, 2008, TISSUE ENG PT A, V14, P1263, DOI 10.1089/ten.tea.2007.0172
   Yoon DM, 2007, BIOMATERIALS, V28, P299, DOI 10.1016/j.biomaterials.2006.08.039
   Zhong Z, 2000, NUCL INSTRUM METH A, V450, P556, DOI 10.1016/S0168-9002(00)00308-9
   Zhou SA, 2008, PHYS MEDICA, V24, P129, DOI 10.1016/j.ejmp.2008.05.006
   Zhu N, 2011, TISSUE ENG PART C-ME, V17, P1071, DOI 10.1089/ten.tec.2011.0102
   Zysk AM, 2012, BIOMED OPT EXPRESS, V3, P1924, DOI 10.1364/BOE.3.001924
NR 47
TC 9
Z9 9
U1 2
U2 19
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD MAR
PY 2015
VL 112
IS 3
BP 612
EP 620
DI 10.1002/bit.25467
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CA8IJ
UT WOS:000349161400018
PM 25257802
DA 2018-10-19
ER

PT J
AU Banche, G
   Bracco, P
   Allizond, V
   Bistolfi, A
   Boffano, M
   Cimino, A
   del Prever, EMB
   Cuffini, AM
AF Banche, Giuliana
   Bracco, Pierangiola
   Allizond, Valeria
   Bistolfi, Alessandro
   Boffano, Michele
   Cimino, Andrea
   del Prever, Elena Maria Brach
   Cuffini, Anna Maria
TI Do Crosslinking and Vitamin E Stabilization Influence Microbial
   Adhesions on UHMWPE-based Biomaterials?
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID MOLECULAR-WEIGHT POLYETHYLENE; TOTAL JOINT REPLACEMENT; IN-VITRO;
   STAPHYLOCOCCUS-EPIDERMIDIS; MECHANICAL-PROPERTIES; LINKED POLYETHYLENE;
   SURFACE-PROPERTIES; BIOFILM FORMATION; CANDIDA-ALBICANS; OXIDATION
AB Microorganism adhesion on polyethylene for total joint arthroplasty is a concern. Many studies have focused on vitamin E-stabilized ultrahigh-molecular-weight polyethylene (UHMWPE), whereas first-generation, highly crosslinked UHMWPE, which is the most commonly used in clinical practice, has been scarcely evaluated.
   We aimed (1) to compare the adherence of Staphylococcus epidermidis, Staphylococcus aureus, Escherichia coli, and Candida albicans with virgin (untreated) UHMWPE (PE) and crosslinked UHMWPE (XLPE); (2) to correlate the results with the biomaterial surface properties; and (3) to determine whether the decreased adhesion on vitamin E-stabilized UHMWPE (VE-PE) previously recorded for bacteria can also be confirmed for C albicans.
   Microbial adhesion of biofilm-producing American Type Culture Collection (ATCC) and clinical strains on XLPE and VE-PE were compared with PE at 3, 7, 24, and 48 hours of incubation and quantified, as colony forming units (CFU)/mL, using a sonication protocol. Sample surfaces were characterized by scanning electron microscopy, roughness and contact angle measurements, attenuated total reflection-Fourier transform infrared spectroscopy, and x-ray photoelectron spectroscopy (XPS) to reveal qualitative differences in surface composition and topography that could influence the microbial adhesion. The results were analyzed by descriptive statistics and tested by unpaired t-tests.
   All microorganisms, both ATCC and clinical strains, showed lower adhesion (p < 0.05) on XLPE with adhesion percentages ranging from 18% to 25%, compared with PE with adhesion percentages ranging from 51% to 55%, after 48 hours. Only the ATCC S epidermidis showed a reduced adhesion profile even at 3 hours (adhesion ratio of 14% on XLPE versus 50% on PE) and 24 hours (19% on XLPE versus 55% on PE) of incubation. ATCC and clinical C albicans were less adherent to XLPE than to PE (p < 0.05) showing even at the earlier incubation time points adhesion values always of 10(3) CFU/mL and 10(4) CFU/mL, respectively. Roughness and contact angle were 0.8 +/- A 0.2 mu m and 92A degrees A A +/- A 3A degrees, respectively, with no differences among samples. Qualitative differences in the surface chemical composition were revealed by XPS only. A confirmation of the decreased adhesion on VE-PE respect to PE was also registered here for C albicans strains (p < 0.05).
   Vitamin E stabilization and crosslinking of UHMWPE are capable of reducing microbial adhesion. Further studies are needed to fully elucidate the mechanisms of modulation of microbial adhesion to medical-grade UHMWPE.
   Our results suggest that VE-PE and XLPE may have an added benefit of being more resistant to bacterial adhesion, even fungal strains.
C1 [Banche, Giuliana; Allizond, Valeria; del Prever, Elena Maria Brach; Cuffini, Anna Maria] Univ Turin, Dept Publ Hlth & Pediat, Turin, Italy.
   [Bracco, Pierangiola] Univ Turin, Dept Chem, Turin, Italy.
   [Bracco, Pierangiola] Univ Turin, NIS Nanostruct Interfaces & Surfaces Interdept Ct, Turin, Italy.
   [Bistolfi, Alessandro; Boffano, Michele; Cimino, Andrea] AO Citta Sci & Salute, Dept Orthoped, I-10126 Turin, Italy.
RP Bistolfi, A (reprint author), AO Citta Sci & Salute, Dept Orthoped, Via Zuretti 29, I-10126 Turin, Italy.
EM abistolfi@cittadellasalute.to.it
RI Bracco, Pierangiola/G-8522-2011
OI Bracco, Pierangiola/0000-0003-0477-2086; Banche,
   Giuliana/0000-0003-2219-0223; Allizond, Valeria/0000-0003-0585-9247;
   Cuffini, Anna Maria/0000-0002-2698-164X; bistolfi,
   alessandro/0000-0002-4396-6222
CR Banche G, 2014, BONE JOINT J, V96B, P497, DOI [10.1302/0301-620X.96B4/32895, 10.1302/0301-620X.96B4.32895]
   Banche G, 2011, J ORTHOP RES, V29, P1662, DOI 10.1002/jor.21432
   Banche G, 2010, INT J ANTIMICROB AG, V36, P319, DOI 10.1016/j.ijantimicag.2010.06.041
   Barton AJ, 1996, J BIOMED MATER RES, V32, P271, DOI 10.1002/(SICI)1097-4636(199610)32:2<271::AID-JBM17>3.0.CO;2-M
   Bistolfi A, 2011, ACTA BIOMATER, V7, P3398, DOI 10.1016/j.actbio.2011.05.018
   Bistolfi A, 2009, J BIOMED MATER RES B, V90B, P137, DOI 10.1002/jbm.b.31265
   Bladen CL, 2013, J BIOMED MATER RES B, V101B, P407, DOI 10.1002/jbm.b.32798
   Bracco P, 2006, POLYM DEGRAD STABIL, V91, P2030, DOI 10.1016/j.polymdegradstab.2006.02.003
   Bracco P, 2011, CLIN ORTHOP RELAT R, V469, P2286, DOI 10.1007/s11999-010-1717-6
   Costa L, 2006, J BIOMED MATER RES B, V78B, P20, DOI 10.1002/jbm.b.30454
   Costa L, 1998, BIOMATERIALS, V19, P659, DOI 10.1016/S0142-9612(97)00160-9
   Del Prado G, 2012, J BIOMED MATER RES A, V100A, P2813, DOI 10.1002/jbm.a.34220
   delPrever EB, 1996, BIOMATERIALS, V17, P873, DOI 10.1016/0142-9612(96)83282-0
   Esteban J, 2012, ACTA ORTHOP, V83, P299, DOI 10.3109/17453674.2012.693019
   Gomez-Barrena E, 2011, J MATER SCI-MATER M, V22, P1701, DOI 10.1007/s10856-011-4340-5
   Kurtz SM, 2009, UHMWPE BIOMATERIALS HANDBOOK: ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE IN TOTAL JOINT REPLACEMENT AND MEDICAL DEVICES, 2ND EDITION, P1
   Kurtz SM, 1999, BIOMATERIALS, V20, P1659, DOI 10.1016/S0142-9612(99)00053-8
   Kurtz SM, 2011, CLIN ORTHOP RELAT R, V469, P2262, DOI 10.1007/s11999-011-1872-4
   Liu HJ, 2011, SURF COAT TECH, V205, P2697, DOI 10.1016/j.surfcoat.2010.08.120
   MacKintosh EE, 2006, J BIOMED MATER RES A, V78A, P836, DOI 10.1002/jbm.a.30905
   Manning DW, 2005, J ARTHROPLASTY, V20, P880, DOI 10.1016/j.arth.2005.03.033
   Metso L, 2014, ACTA ORTHOP, V85, P165, DOI 10.3109/17453674.2014.889978
   Molina-Manso D, 2010, J PHYS C SER, V252, P1
   Monsen T, 2009, J CLIN MICROBIOL, V47, P2496, DOI 10.1128/JCM.02316-08
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   Muratoglu OK, 2001, J ARTHROPLASTY, V16, P149, DOI 10.1054/arth.2001.20540
   Olson ME, 2006, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000229320.45416.0c
   Poulsson AHC, 2009, LANGMUIR, V25, P3718, DOI 10.1021/la801820s
   Premnath V, 1996, BIOMATERIALS, V17, P1741, DOI 10.1016/0142-9612(95)00349-5
   Rohde H, 2010, EUR J CELL BIOL, V89, P103, DOI 10.1016/j.ejcb.2009.10.005
   Scalas D, 2012, INT J ANTIMICROB AG, V39, P73, DOI 10.1016/j.ijantimicag.2011.09.015
   Shinde RB, 2012, MYCOSCIENCE, V53, P220, DOI 10.1007/s10267-011-0155-y
   STREICHER RM, 1988, RADIAT PHYS CHEM, V31, P693
   Terada A, 2006, MICROBIOL-SGM, V152, P3575, DOI 10.1099/mic.0.28881-0
NR 34
TC 7
Z9 7
U1 2
U2 22
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0009-921X
EI 1528-1132
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD MAR
PY 2015
VL 473
IS 3
BP 974
EP 986
DI 10.1007/s11999-014-4024-9
PG 13
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA CA9KM
UT WOS:000349242200036
PM 25367109
OA Green Published
DA 2018-10-19
ER

PT J
AU Flores, C
   Diaz-Barrera, A
   Martinez, F
   Galindo, E
   Pena, C
AF Flores, Celia
   Diaz-Barrera, Alvaro
   Martinez, Fabiola
   Galindo, Enrique
   Pena, Carlos
TI Role of oxygen in the polymerization and de-polymerization of alginate
   produced by Azotobacter vinelandii
SO JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Review
DE Bioprocesses; Biotechnology; Fermentation; Bacteria; Bioreactors
ID PSEUDOMONAS-AERUGINOSA ALGX; MOLECULAR-WEIGHT; SHAKE FLASKS; CONTINUOUS
   CULTURES; LIMITED CONDITIONS; ESCHERICHIA-COLI; BIOSYNTHESIS;
   ACETYLATION; LYASE; GROWTH
AB Microbial polymers have diverse chemical structures, which determine their functional properties. Many microbial sources produce either intracellular or extracellular biopolymers. For example, Azotobacter vinelandii is a non-pathogenic soil bacterium that produces alginate, an extracellular polysaccharide. Alginates are used mainly in the food and pharmaceutical industries as stabilizing, thickening, gel- or film-forming agents. Due to its characteristics of biocompatibility, biodegradability and non-antigenicity, new applications for alginate are being discovered, such as biomaterial in the biomedical field and tissue engineering. It is well established that alginate is first synthesized as a polymannuronate from its cytosolic precursor. However, the mechanisms involved in the polymerization, modification (acetylation, epimerization and depolymerization) and translocation of alginate have been poorly elucidated. Two of the most important parameters in alginate production by A. vinelandii are dissolved oxygen tension (DOT) and the oxygen supply conditions, as these impact both the polymer concentration and its composition, particularly its molecular weight (MW). Several studies have revealed that increased alginate molecular weight occurs in oxygen limited conditions, specifically at oxygen concentrations near zero. This article reviews recent studies examining the influence of oxygen, under limitation (microaerophilic) and non-limitation conditions (measured as DOT and oxygen transfer rate, OTR), on the polymerization and degradation of alginate produced by A. vinelandii. This review also provides evidence for understanding these processes at the cellular level and the effect of oxygen on alginate biosynthesis. (c) 2014 Society of Chemical Industry
C1 [Flores, Celia; Galindo, Enrique; Pena, Carlos] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62250, Morelos, Mexico.
   [Diaz-Barrera, Alvaro; Martinez, Fabiola] Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Valparaiso, Chile.
RP Pena, C (reprint author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Apdo Post 510-3, Cuernavaca 62250, Morelos, Mexico.
EM carlosf@ibt.unam.mx
OI Alvaro, Diaz-Barrera/0000-0002-0922-8648
FU CONACyT (Mexico) [131851]; DGAPA-PAPIIT [IT100513]; Fondecyt from
   CONICYT (Chile) [11110311]
FX Financial support from CONACyT (Mexico) (grant 131851) and DGAPA-PAPIIT
   (IT100513) is gratefully acknowledged. Alvaro Diaz-Barrera thanks
   Fondecyt, Grant 11110311 from CONICYT (Chile).
CR AKIYAMA H, 1992, BIOSCI BIOTECH BIOCH, V56, P355, DOI 10.1271/bbb.56.355
   Anderlei T, 2004, BIOCHEM ENG J, V17, P187, DOI 10.1016/S1369-703X(03)00181-5
   ANDERSEN T, 2012, SPR CARB CH, V37, P227, DOI DOI 10.1039/9781849732765-00227
   Bakkevig K, 2005, J BACTERIOL, V187, P8375, DOI 10.1128/JB.187.24.8375-8384.2005
   Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236
   Clementi F, 1997, CRIT REV BIOTECHNOL, V17, P327, DOI 10.3109/07388559709146618
   Clementi F, 1999, J SCI FOOD AGR, V79, P602, DOI 10.1002/(SICI)1097-0010(19990315)79:4<602::AID-JSFA224>3.0.CO;2-N
   Diaz-Barrera A, 2007, APPL MICROBIOL BIOT, V76, P903, DOI 10.1007/s00253-007-1060-3
   Diaz-Barrera A, 2009, BIOTECHNOL LETT, V31, P825, DOI 10.1007/s10529-009-9949-9
   Diaz-Barrera A, 2014, BIOPROC BIOSYST ENG, V37, P1133, DOI 10.1007/s00449-013-1084-2
   Diaz-Barrera A, 2012, J IND MICROBIOL BIOT, V39, P613, DOI 10.1007/s10295-011-1055-z
   Diaz-Barrera A, 2011, PROCESS BIOCHEM, V46, P1879, DOI 10.1016/j.procbio.2011.06.022
   Diaz-Barrera A, 2010, BIORESOURCE TECHNOL, V101, P9405, DOI 10.1016/j.biortech.2010.07.038
   Draget KI, 2011, FOOD HYDROCOLLOID, V25, P251, DOI 10.1016/j.foodhyd.2009.10.007
   Ertesvag H., 2009, ALGINATES BIOL APPL
   Flores C, 2013, ENZYME MICROB TECH, V53, P85, DOI 10.1016/j.enzmictec.2013.04.010
   FRANKLIN MJ, 1994, J BACTERIOL, V176, P1821, DOI 10.1128/jb.176.7.1821-1830.1994
   Franklin MJ, 2002, J BACTERIOL, V184, P3000, DOI 10.1128/JB.184.11.3000-3007.2002
   Franklin MJ, 2011, FRONT MICROBIOL, V2, P1
   Galindo E, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-7
   Gimmestad M, 2009, J BACTERIOL, V191, P4845, DOI 10.1128/JB.00455-09
   Hay ID, 2014, ENVIRON MICROBIOL, V16, P2997, DOI 10.1111/1462-2920.12389
   Hay ID, 2013, MICROB BIOTECHNOL, V6, P637, DOI 10.1111/1751-7915.12076
   Hay ID, 2009, APPL ENVIRON MICROB, V75, P1110, DOI 10.1128/AEM.02416-08
   Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004
   Hu XK, 2005, J APPL PHYCOL, V17, P57, DOI 10.1007/s10811-005-5524-5
   Hu XK, 2004, J APPL PHYCOL, V16, P73, DOI 10.1023/B:JAPH.0000019139.35046.0c
   Huang Y-C, 2006, SCAFFOLDING TISSUE E
   Iwamoto M, 2005, FEBS LETT, V579, P4423, DOI 10.1016/j.febslet.2005.07.007
   Jain S, 2005, INFECT IMMUN, V73, P6429, DOI 10.1128/IAI.73.10.6429-6436.2005
   Jendrossek D, 2002, ANNU REV MICROBIOL, V56, P403, DOI 10.1146/annurev.micro.56.012302.160838
   Jimenez-Escrig A, 2000, NUTR RES, V20, P585, DOI 10.1016/S0271-5317(00)00149-4
   Kawada A, 1999, ARCH DERMATOL RES, V291, P542, DOI 10.1007/s004030050451
   Keiski CL, 2010, STRUCTURE, V18, P265, DOI 10.1016/j.str.2009.11.015
   Kim HS, 2011, BIOTECHNOL BIOPROC E, V16, P843, DOI 10.1007/s12257-011-0352-8
   Kurachi Maki, 2005, Journal of Infection and Chemotherapy, V11, P199, DOI 10.1007/s10156-005-0392-0
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   LEITAO JH, 1993, J APPL BACTERIOL, V74, P452, DOI 10.1111/j.1365-2672.1993.tb05153.x
   Lozano E, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-13
   Manzo J, 2011, J MOL MICROB BIOTECH, V21, P147, DOI 10.1159/000334244
   MejiaRuiz H, 1997, GENE, V199, P271, DOI 10.1016/S0378-1119(97)00380-6
   Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/i.1365-2958.2007.05817.x
   Oglesby LL, 2008, MICROBIOL-SGM, V154, P1605, DOI 10.1099/mic.0.2007/015305-0
   Parente E, 1998, J IND MICROBIOL BIOT, V20, P171, DOI 10.1038/sj.jim.2900510
   Pena C, 2006, LETT APPL MICROBIOL, V43, P200, DOI 10.1111/j.1472-765X.2006.01925.x
   Pena C, 2002, J BIOTECHNOL, V95, P1, DOI 10.1016/S0168-1656(01)00384-4
   Pena C, 2011, PROCESS BIOCHEM, V46, P290, DOI 10.1016/j.procbio.2010.08.025
   Pena C, 2002, J IND MICROBIOL BIOT, V29, P209, DOI 10.1038/sj.jim.7000310
   Pena C, 1997, APPL MICROBIOL BIOT, V48, P510, DOI 10.1007/s002530051088
   Pena C, 2000, ENZYME MICROB TECH, V27, P390, DOI 10.1016/S0141-0229(00)00221-0
   Pena C, 2007, BIOCHEM ENG J, V36, P73, DOI 10.1016/j.bej.2007.02.019
   POST E, 1983, ARCH MICROBIOL, V134, P68, DOI 10.1007/BF00429410
   Priego-Jimenez R, 2005, BIOCHEM ENG J, V25, P187, DOI 10.1016/j.bcj.2005.05.003
   Ramnani P, 2012, ANAEROBE, V18, P1, DOI 10.1016/j.anaerobe.2011.08.003
   Rediers H, 2004, MICROBIOL-SGM, V150, P1117, DOI 10.1099/mic.0.27096-0
   Rehm B. H. A, 2009, ALGINATES BIOL APPL
   REHM BHA, 1994, J BACTERIOL, V176, P5639
   Rehm BHA, 1997, APPL MICROBIOL BIOT, V48, P281, DOI 10.1007/s002530051051
   Remminghorst U, 2006, APPL ENVIRON MICROB, V72, P298, DOI 10.1128/AEM.72.1.298-305.2006
   Remminghorst U, 2006, BIOTECHNOL LETT, V28, P1701, DOI 10.1007/s10529-006-9156-x
   Remminghorst U, 2006, FEBS LETT, V580, P3883, DOI 10.1016/j.febslet.2006.05.077
   Remminghorst U, 2009, J BIOTECHNOL, V140, P176, DOI 10.1016/j.jbiotec.2009.02.006
   Reyes C, 2003, J BIOTECHNOL, V105, P189, DOI 10.1016/S0168-1656(03)00186-X
   Riley LM, 2013, J BIOL CHEM, V288, P22299, DOI 10.1074/jbc.M113.484931
   Robles-Price A, 2004, J BACTERIOL, V186, P7369, DOI 10.1128/JB.186.21.7369-7377.2004
   Sabra W, 1999, APPL MICROBIOL BIOT, V52, P773, DOI 10.1007/s002530051590
   Sabra W, 2000, APPL ENVIRON MICROB, V66, P4037, DOI 10.1128/AEM.66.9.4037-4044.2000
   SADOFF HL, 1975, BACTERIOL REV, V39, P516
   Salzig M, 2006, MICROBIAL NANOTECHNO
   SAXENA IM, 1995, J BACTERIOL, V177, P1419, DOI 10.1128/jb.177.6.1419-1424.1995
   Setubal JC, 2009, J BACTERIOL, V191, P4534, DOI 10.1128/JB.00504-09
   SKJAKBRAEK G, 1986, CARBOHYD RES, V154, P239
   Sun JC, 2013, MATERIALS, V6, P1285, DOI 10.3390/ma6041285
   Trujillo-Roldan MA, 2004, APPL MICROBIOL BIOT, V63, P742, DOI 10.1007/s00253-003-1419-z
   Trujillo-Roldan MA, 2001, BIOTECHNOL PROGR, V17, P1042, DOI 10.1021/bp010106d
   Vazquez A, 1999, GENE, V232, P217, DOI 10.1016/S0378-1119(99)00119-5
   Weadge JT, 2010, ACTA CRYSTALLOGR F, V66, P588, DOI 10.1107/S1744309110011851
   Whitney JC, 2011, P NATL ACAD SCI USA, V108, P13083, DOI 10.1073/pnas.1104984108
   Xu B, 1999, BIOTECHNOL PROGR, V15, P81, DOI 10.1021/bp9801087
NR 79
TC 10
Z9 10
U1 4
U2 43
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0268-2575
EI 1097-4660
J9 J CHEM TECHNOL BIOT
JI J. Chem. Technol. Biotechnol.
PD MAR
PY 2015
VL 90
IS 3
BP 356
EP 365
DI 10.1002/jctb.4548
PG 10
WC Biotechnology & Applied Microbiology; Chemistry, Multidisciplinary;
   Engineering, Environmental; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Chemistry; Engineering
GA CB2NY
UT WOS:000349465800002
DA 2018-10-19
ER

PT J
AU Li, XY
   Chen, RT
   Xu, SH
   Liu, HL
   Hu, Y
AF Li, Xiangye
   Chen, Ruting
   Xu, Shouhong
   Liu, Honglai
   Hu, Ying
TI Thermoresponsive behavior and rheology of SiO2-hyaluronic
   acid/poly(N-isopropylacrylamide) (NaHA/PNIPAm) core-shell structured
   microparticles
SO JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE biomaterial; inorganic; organic hybrid materials; core-shell structure;
   injectable gel; thermoresponsive polymer
ID ORGANIZED NANOSTRUCTURE FORMATION; N-ISOPROPYLACRYLAMIDE COPOLYMER;
   SERUM-ALBUMIN MONOLAYER; PHASE-TRANSITION; DRUG-RELEASE; HYDROGELS;
   POLY(N-ISOPROPYLACRYLAMIDE); GELS; HYALURONATE; KINETICS
AB BACKGROUNDInjectable polymer gels for tissue engineering offer specific advantages over preformed scaffolds. They can transform from a sol to a block gel as a response to an external stimulus. One effective strategy for improving the mechanical strength of a gel is to introduce an inorganic material.
   RESULTSMicroparticles composed of a hard SiO2 core covered with a thermoresponsive hybrid gel (sodium hyaluronate/poly(N-isopropylacrylamide); NaHA/PNIPAm) were synthesized. The microparticles were characterized by dynamic light-scattering and transmission electron microscopy; rheological measurements were also performed. The microparticles were perfectly spherical and had a core-shell structure. They can perform a sol-gel transformation, that is, they shrank and assembled to form a macroscopic hydrogel through physical cross-linking at the gelation temperature (T-gel), which was determined by rheological measurements. The T-gel was adjusted by changing the concentration of microparticles or Ca2+ ions.
   CONCLUSIONThe introduction of NaHA and SiO2 improved the mechanical properties of the macroscopic gels. The rigidity and stability of the macroscopic gel were controlled by the molecular weight of NaHA and the amount of PNIPAm. Such injectable hydrogels might have potential as scaffold biomaterials, and are expected to be the ink' for three-dimensional bioprinters. (c) 2014 Society of Chemical Industry
C1 [Xu, Shouhong] E China Univ Sci & Technol, Key Lab Adv Mat, Shanghai 200237, Peoples R China.
   [Xu, Shouhong] E China Univ Sci & Technol, Dept Chem, Shanghai 200237, Peoples R China.
RP Xu, SH (reprint author), E China Univ Sci & Technol, Key Lab Adv Mat, Shanghai 200237, Peoples R China.
EM xushouhong@ecust.edu.cn
FU National Natural Science Foundation of China [21076071, 21276074,
   91334203]; 111 Project of the Ministry of Education of China [B08021];
   Fundamental Research Funds for the Central Universities of China
FX Financial support for this work is provided by the National Natural
   Science Foundation of China (No. 21076071, No. 21276074, No. 91334203),
   the 111 Project of the Ministry of Education of China (No. B08021), and
   the Fundamental Research Funds for the Central Universities of China.
CR Amarnath LP, 2006, BIOMATERIALS, V27, P1416, DOI 10.1016/j.biomaterials.2005.08.008
   Arai K, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034113
   Bencherif SA, 2008, BIOMATERIALS, V29, P1739, DOI 10.1016/j.biomaterials.2007.11.047
   Chen SB, 2012, MAT SCI ENG C-MATER, V32, P2199, DOI 10.1016/j.msec.2012.05.052
   Dai YL, 2012, ACS NANO, V6, P3327, DOI 10.1021/nn300303q
   Duflo S, 2006, TISSUE ENG, V12, P2171, DOI 10.1089/ten.2006.12.2171
   FUJISHIGE S, 1989, J PHYS CHEM-US, V93, P3311, DOI 10.1021/j100345a085
   Gan DJ, 2001, J AM CHEM SOC, V123, P7511, DOI 10.1021/ja010609f
   Gan TT, 2010, J MATER CHEM, V20, P5937, DOI 10.1039/c0jm00338g
   Gan TT, 2009, BIOMACROMOLECULES, V10, P1410, DOI 10.1021/bm900022m
   Gariepy E. R., 2004, EUR J PHARM BIOPHARM, V58, P409
   Hijon N, 2005, CHEM MATER, V17, P1591, DOI 10.1021/cm048755i
   Hou QP, 2004, J MATER CHEM, V14, P1915, DOI 10.1039/b401791a
   Ibusuki S, 2003, TISSUE ENG, V9, P371, DOI 10.1089/107632703764664846
   Jha AK, 2011, BIOMATERIALS, V32, P2466, DOI 10.1016/j.biomaterials.2010.12.024
   Katta JK, 2004, I ELECT ELECT ENG, V4, P142
   Kawasaki H, 1998, LANGMUIR, V14, P773, DOI 10.1021/la970886t
   Kawasaki H, 2000, LANGMUIR, V16, P3195, DOI 10.1021/la991272m
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Kobayashi M, 2003, BIOMATERIALS, V24, P639, DOI 10.1016/S0142-9612(02)00378-2
   Kraan PM, 2002, OSTEOARTHR CARTILAGE, V8, P631
   Lin ZF, 2013, BIOMACROMOLECULES, V14, P2206, DOI 10.1021/bm4003442
   Mortisen D, 2010, BIOMACROMOLECULES, V11, P1261, DOI 10.1021/bm100046n
   Naik VV, 2011, LANGMUIR, V27, P13276, DOI 10.1021/la202876g
   Newbloom GM, 2012, SOFT MATTER, V8, P8854, DOI 10.1039/c2sm26114f
   Nonogaki T, 2000, LANGMUIR, V16, P4272, DOI 10.1021/la990444c
   Pan YZ, 2011, ADV FUNCT MATER, V21, P2754, DOI 10.1002/adfm.201100078
   Parsa S, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/025003
   Ravichandran R, 2012, MACROMOL BIOSCI, V12, P286, DOI 10.1002/mabi.201100325
   Recillas M, 2009, BIOMACROMOLECULES, V10, P1633, DOI 10.1021/bm9002317
   Schonhoff M, 2002, J PHYS CHEM B, V106, P7800, DOI 10.1021/jp0155381
   Sun BJ, 2008, MACROMOLECULES, V41, P1512, DOI 10.1021/ma702062h
   Tsai SW, 2006, BIOPOLYMERS, V83, P381, DOI 10.1002/bip.20568
   Vakifli A, 2010, J APPL POLYM SCI, V117, P817, DOI 10.1002/app.31188
   Vlierberghe S. V., 2011, BIOMACROMOLECULES, V12, P1387
   Wang DD, 2011, BIOMACROMOLECULES, V12, P578, DOI 10.1021/bm101187b
   Wang ZC, 2010, ACS APPL MATER INTER, V2, P1009, DOI 10.1021/am900712e
   Xu SH, 2003, MOL SIMULAT, V29, P711, DOI 10.1080/0892702031000103266
   Xu SH, 2013, J CHEM TECHNOL BIOT, V88, P1561, DOI 10.1002/jctb.4005
   Yang J, 2012, REACT FUNCT POLYM, V72, P438, DOI 10.1016/j.reactfunctpolym.2012.04.006
   You J, 2012, LANGMUIR, V28, P4965, DOI 10.1021/la2046417
NR 41
TC 1
Z9 1
U1 4
U2 76
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0268-2575
EI 1097-4660
J9 J CHEM TECHNOL BIOT
JI J. Chem. Technol. Biotechnol.
PD MAR
PY 2015
VL 90
IS 3
BP 407
EP 414
DI 10.1002/jctb.4308
PG 8
WC Biotechnology & Applied Microbiology; Chemistry, Multidisciplinary;
   Engineering, Environmental; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Chemistry; Engineering
GA CB2NY
UT WOS:000349465800007
DA 2018-10-19
ER

PT J
AU Sealy, C
AF Sealy, Cordelia
TI Conducting polymer makes promising biomaterial
SO MATERIALS TODAY
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1369-7021
EI 1873-4103
J9 MATER TODAY
JI Mater. Today
PD MAR
PY 2015
VL 18
IS 2
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA CB4UZ
UT WOS:000349625100004
DA 2018-10-19
ER

PT J
AU Trombino, S
   Poerio, T
   Ferrarelli, T
   Mauro, MV
   Giraldi, C
   Giorno, L
   Cassano, R
AF Trombino, Sonia
   Poerio, Teresa
   Ferrarelli, Teresa
   Mauro, Maria Vittoria
   Giraldi, Cristina
   Giorno, Lidietta
   Cassano, Roberta
TI Multifunctional membranes based on natural polymers: preparation,
   characterization and in vitro performance evaluation
SO POLYMER INTERNATIONAL
LA English
DT Article
DE hemp fibres; antioxidant; antibacterial; chelation; membranes
ID CELLULOSE; SYSTEM; COMBINATIONS; CADMIUM; LEAVES; ACID
AB The aim of this study was to synthesize new multifunctional biopolymers via esterification of hemp fibres with two reagents: meso-2,3-dimercaptosuccinic acid and ethylenediaminetetraacetic acid. The obtained biopolymers were characterized using infrared spectroscopy. The antibacterial activity of the derivative containing ethylenediaminetetraacetic acid moiety was evaluated by assessing the growth inhibition of Pseudomonas aeruginosa in Petri dishes. The results suggest that this biomaterial exhibits an excellent in vitro antibacterial activity. The antioxidant activity of the biopolymer from meso-2,3-dimercaptosuccinic acid was tested in rat liver microsomal membranes in the presence of tert-butylhydroperoxide as free radical source. Results suggest that this material inhibits lipid peroxidation induced by the free radical species. Both derivatives were used to prepare multifunctional membranes that were characterized and tested indicating the maintenance of biopolymer functionalized properties. Moreover, these functionalized biopolymers interact with metal ions due to their chelating functional groups. The absorption capacity for a selected metal ion, Cd(II), was investigated in aqueous solutions at pH = 0.65, 4.1 and 7.0 using optical emission spectroscopy. This study demonstrates that these new materials are very effective in chelating cadmium ions showing maximum efficiency at pH = 7.0. (c) 2014 Society of Chemical Industry
C1 [Trombino, Sonia; Ferrarelli, Teresa; Cassano, Roberta] Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87030 Arcavacata Di Rende, CS, Italy.
   [Poerio, Teresa; Giorno, Lidietta] Univ Calabria, Inst Membrane Technol ITM CNR, I-87030 Arcavacata Di Rende, CS, Italy.
   [Mauro, Maria Vittoria; Giraldi, Cristina] Annunziata Hosp, Virol & Microbiol Serv, I-87100 Cosenza, Italy.
RP Cassano, R (reprint author), Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87030 Arcavacata Di Rende, CS, Italy.
EM roberta.cassano@unical.it
OI Poerio, Teresa/0000-0001-8449-9344; Giorno, Lidietta/0000-0002-4408-5849
CR Alen R, 2000, PAPERMAKING SCI TECH, V3, P11
   APOSHIAN HV, 1990, ANNU REV PHARMACOL, V30, P279
   BARTOLI GM, 1988, BIOCHIM BIOPHYS ACTA, V966, P214, DOI 10.1016/0304-4165(88)90114-6
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brooks G. F., 2008, JAWETZ MELNICK ADELB
   Cadogan JIG, 1973, PRINCIPLES FREE RADI
   Cassano R, 2008, J AGR FOOD CHEM, V55, P9489
   Cassano R, 2013, CELLULOSE, V20, P547, DOI 10.1007/s10570-012-9804-3
   Cassano R, 2009, CARBOHYD POLYM, V78, P639, DOI 10.1016/j.carbpol.2009.05.030
   DAWSEY TR, 1990, J MACROMOL SCI R M C, VC30, P405, DOI 10.1080/07366579008050914
   Hagerman AE, 1998, J AGR FOOD CHEM, V46, P1887, DOI 10.1021/jf970975b
   HAHLBROCK K, 1989, ANNU REV PLANT PHYS, V40, P347, DOI 10.1146/annurev.pp.40.060189.002023
   HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x
   Hutmacher DW, 2000, BIOMATERIALS, V2, P2529
   Ioan S, 2011, J APPL POLYM SCI, V121, P127, DOI 10.1002/app.33380
   Jansen JC, 2011, CELLULOSE, V18, P359, DOI 10.1007/s10570-011-9492-4
   Montford S., 1999, Journal of the International Hemp Association, V6, P53
   Morgenstern B, 1996, TRENDS POLYM SCI, V4, P87
   MORGENSTERN B, 1993, ACTA POLYM, V44, P100, DOI 10.1002/actp.1993.010440208
   Mulder M., 1996, BASIC PRINCIPLES MEM
   Murray P, 2008, MICROBIOLOGIA MED
   Ohta T, 1997, BIOSCI BIOTECH BIOCH, V61, P1942, DOI 10.1271/bbb.61.1942
   Ray SS, 2003, PROG POLYM SCI, V28, P1539, DOI 10.1016/j.progpolymsci.2003.08.002
   Reddy SA, 2008, J HAZARD MATER, V152, P903, DOI 10.1016/j.jhazmat.2007.07.063
   Saka S, 2000, WOOD CELLULOSIC CHEM, P51
   Salim R, 2008, J ENVIRON MANAGE, V87, P521, DOI 10.1016/j.jenvman.2007.01.028
   Shogren R.L., 1999, ACS SYM SER, V723, P2
   Sjoholm E, 2000, CARBOHYD POLYM, V41, P153, DOI 10.1016/S0144-8617(99)00080-6
   Slater TF, 1984, BIOCHEMISTRY-US, V222, P1
   SPARKS TA, 1994, VET RES COMMUN, V18, P241, DOI 10.1007/BF01839190
   Steinbrecher UP, 1999, BIOCHIM BIOPHYS ACTA, V1496, P279
   Strathmann H., 2006, INTRO MEMBRANE SCI T
   Sun RC, 1999, J WOOD CHEM TECHNOL, V19, P287, DOI 10.1080/02773819909349613
   TATUM VL, 1990, LIPIDS, V25, P226, DOI 10.1007/BF02535752
   Trombino S, 2007, MACROMOL BIOSCI, V8, P86
   Trzcinka-Ochocka M, 2004, ENVIRON RES, V95, P143, DOI 10.1016/j.envres.2003.10.003
   Webb M., 1986, CADMIUM, V80, P281
   Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X
NR 38
TC 1
Z9 1
U1 1
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0959-8103
EI 1097-0126
J9 POLYM INT
JI Polym. Int.
PD MAR
PY 2015
VL 64
IS 3
BP 344
EP 351
DI 10.1002/pi.4844
PG 8
WC Polymer Science
SC Polymer Science
GA CB1PX
UT WOS:000349401200004
DA 2018-10-19
ER

PT J
AU Deng, BY
   Shen, L
   Wu, YZ
   Shen, YL
   Ding, XF
   Lu, SY
   Jia, JG
   Qian, JY
   Ge, JB
AF Deng, Biyong
   Shen, Li
   Wu, Yizhe
   Shen, Yunli
   Ding, Xuefeng
   Lu, Shuyang
   Jia, Jianguo
   Qian, Juying
   Ge, Junbo
TI Delivery of alginate-chitosan hydrogel promotes endogenous repair and
   preserves cardiac function in rats with myocardial infarction
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE infarction; cardiac; tissue engineering; biomaterial
ID STEM-CELLS; HEART; IMPROVEMENT; SCAFFOLDS; BIOMATERIALS; OPTIMIZATION;
   REGENERATION; GEOMETRY; SURVIVAL
AB The regenerative potential of alginate-chitosan composite in bone and cartilage tissue has been well documented, but its potential utility in cardiac tissue engineering has remained unknown. This study sought to determine whether early intramyocardial injection of alginate-chitosan could prevent left ventricular (LV) remodeling after myocardial infarction (MI), leading to a more favorable course of tissue restoration. In a rat model of acute MI, local injection of alginate-chitosan hydrogel into the peri-infarct zone preserved scar thickness, attenuated infarct expansion, and reduced scar fibrosis after 8 weeks, concomitantly with promoting increased angiogenesis and greater recruitment of endogenous repair at the infarct zone. Furthermore, this treatment prevented cell apoptosis, induced cardiomyocyte cell cycle re-entry. The cardiac function of the control-injected animals deteriorated over the 8-week course, while that of the hydrogel-injected animals did not.In addition, the hydrogel did not exacerbate inflammation in the heart. Intramyocardial injection of alginate-chitosan hydrogel represents a useful strategy to treat MI. It demonstrated marked therapeutic efficacies on various tissue levels after extensive MI, as well as potential to induce endogenous cardiomyocyte proliferation and recruit cardiac stem cells. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 907-918, 2015.
C1 [Deng, Biyong; Shen, Li; Wu, Yizhe; Ding, Xuefeng; Lu, Shuyang; Jia, Jianguo; Qian, Juying; Ge, Junbo] Fudan Univ, Shanghai Med Coll, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai 200032, Peoples R China.
   [Deng, Biyong; Shen, Li; Wu, Yizhe; Ding, Xuefeng; Qian, Juying; Ge, Junbo] Fudan Univ, Shanghai Med Coll, Zhongshan Hosp, Dept Cardiol, Shanghai 200032, Peoples R China.
   [Shen, Yunli] Tongji Univ, Shanghai East Hosp, Dept Cardiol, Shanghai 200120, Peoples R China.
   [Lu, Shuyang] Fudan Univ, Shanghai Med Coll, Zhongshan Hosp, Dept Cardiovasc Surg, Shanghai 200032, Peoples R China.
RP Qian, JY (reprint author), Fudan Univ, Shanghai Med Coll, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai 200032, Peoples R China.
EM qian.juying@zs-hospital.sh.cn
FU National Natural Science Foundation of China [81370323]; Science and
   Technology Commission of Shanghai Municipality, China [11nm0504900]
FX The authors extend appreciation to Dr. Ruiming Yao, Dr. Bingyu Li, and
   Prof. Xiangdong Yang for technical support and expertise. This work was
   supported by National Natural Science Foundation of China (No. 81370323)
   and Science and Technology Commission of Shanghai Municipality, China
   (No. 11nm0504900).
CR ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   BENZEEV A, 1988, P NATL ACAD SCI USA, V85, P2161, DOI 10.1073/pnas.85.7.2161
   Cabrales P, 2005, AM J PHYSIOL-HEART C, V288, pH1708, DOI 10.1152/ajpheart.00911.2004
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Jackson BM, 2003, AM J PHYSIOL-HEART C, V284, pH475, DOI 10.1152/ajpheart.00360.2002
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Leor J, 2000, CIRCULATION, V102, P56
   Lesman A, 2010, ANN NY ACAD SCI, V1188, P46, DOI 10.1111/j.1749-6632.2009.05082.x
   Li ZS, 2005, J BIOMED MATER RES A, V75A, P485, DOI 10.1002/jbm.a.30449
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044
   Lloyd-Jones D, 2009, CIRCULATION, V119, P480, DOI 10.1161/CIRCULATIONAHA.108.191259
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999
   Migrino RQ, 1997, CIRCULATION, V96, P116
   Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67
   Pawar SN, 2012, BIOMATERIALS, V33, P3279, DOI 10.1016/j.biomaterials.2012.01.007
   Plotkin M, 2014, BIOMATERIALS, V35, P1429, DOI 10.1016/j.biomaterials.2013.10.058
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Sankalia MG, 2007, EUR J PHARM BIOPHARM, V65, P215, DOI 10.1016/j.ejpb.2006.07.014
   Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809
   Sy JC, 2008, NAT MATER, V7, P863, DOI 10.1038/nmat2299
   Thu B, 1996, BIOMATERIALS, V17, P1069, DOI 10.1016/0142-9612(96)85907-2
   Wang HB, 2010, J HEART LUNG TRANSPL, V29, P881, DOI 10.1016/j.healun.2010.03.016
   Yu JH, 1999, J WUHAN U NAT SCI ED, V45, P440
   Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036
NR 36
TC 24
Z9 25
U1 2
U2 58
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2015
VL 103
IS 3
BP 907
EP 918
DI 10.1002/jbm.a.35232
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA7NG
UT WOS:000349103500006
PM 24827141
DA 2018-10-19
ER

PT J
AU Kroustalli, A
   Kotsikoris, V
   Karamitri, A
   Topouzis, S
   Deligianni, D
AF Kroustalli, A.
   Kotsikoris, V.
   Karamitri, A.
   Topouzis, S.
   Deligianni, D.
TI Mechanoresponses of human primary osteoblasts grown on carbon nanotubes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE carbon nanotubes; primary osteoblasts; bone; mechanotransduction;
   adhesion integrins
ID MESENCHYMAL STEM-CELLS; MECHANICAL STRAIN; MESSENGER-RNA; BONE REPAIR;
   DIFFERENTIATION; PROLIFERATION; EXPRESSION; MECHANOTRANSDUCTION;
   STIMULATION; PATHWAYS
AB Bone mechanotransduction is strongly influenced by the biomaterial properties. A good understanding of these mechanosensory mechanisms in bone has the potential to provide new strategies in the highly evolving field of bone tissue engineering. The aim of the present investigation was to study the interactive effects of local mechanical stimuli on multiwalled carbon nanotubes (MWCNTs)/osteoblast interface, using an in vitro model that allows the study of cell growth, attachment and differentiation. Strain was applied at physiological levels [strain magnitudes 500 microstrain (), at frequency of load application 0.5 Hz]. The effect of mechanical strain and substrate was thus studied by measuring the messenger RNA expression of alkaline phosphatase, vinculin, collagen 1A, and integrins 1, 3, 4, and v, using real-time quantitative polymerase chain reaction. The osteoblasts grown on MWCNTs displayed quick adaptation to the new environment by modulating the expression of key adhesion integrins. Furthermore, the addition of mechanical strain interplayed with the extracellular matrix and was efficiently transduced by cells grown on MWCNTs, providing stronger adhesion and survival. MWCNTs are therefore a material perfectly compatible with osteoblast differentiation, adhesion, and growth, and should be further evaluated, to derive new-generation biomaterial scaffolds for the treatment of skeletal defects which require bone reconstruction. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1038-1044, 2015.
C1 [Kroustalli, A.; Deligianni, D.] Univ Patras, Lab Biomechan & Biomed Engn, Dept Mech Engn & Aeronaut, Patras, Greece.
   [Kotsikoris, V.; Karamitri, A.; Topouzis, S.] Univ Patras, Mol Pharmacol Lab, Dept Pharm, Patras, Greece.
RP Deligianni, D (reprint author), Univ Patras, Lab Biomechan & Biomed Engn, Dept Mech Engn & Aeronaut, Patras, Greece.
EM deligian@mech.upatras.gr
OI Karamitri, Angeliki/0000-0002-8397-5529
FU EU [REGPOT-2011-1]; NSRF
FX Contract grant sponsor: EU grant: "Establishment of a Centre of
   Excellence for Structure-Based Drug Target Characterization:
   Strengthening the Research Capacity of South-Eastern Europe" ("SEE-DRUG"
   www.seedrug.upatras.gr; to Dr. Kotsikoris); contract grant number:
   FP7-REGPOT-2011-1; Contract grant sponsor: NSRF 2007-2013 National
   action: Cooperation sub-action II: Large Scale Cooperative Projects.
   DAMP (Development of novel Angiogenesis-Modulating Pharmaceuticals by
   screening of natural compounds and synthetic analogues; to Dr.
   Karamitri)
CR Ambikaipalan A, 2013, CURR STEM CELL RES T, V8, P210, DOI 10.2174/1574888X11308030005
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Boccafoschi F, 2013, CELL ADHES MIGR, V7, P165, DOI 10.4161/cam.23020
   BUCKLEY MJ, 1988, BONE MINER, V4, P225
   Carter DR, 1996, BONE, V18, p5S
   CARVALHO RS, 1995, ARCH ORAL BIOL, V40, P257, DOI 10.1016/0003-9969(95)98814-F
   Crowley C, 2013, CURR STEM CELL RES T, V8, P243, DOI 10.2174/1574888X11308030009
   Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095
   Hansen JC, 2007, J BIOMECH, V40, P2865, DOI 10.1016/j.jbiomech.2007.03.018
   Hastings NE, 2007, AM J PHYSIOL-CELL PH, V293, pC1824, DOI 10.1152/ajpcell.00385.2007
   Judex S, 2009, ORTHOD CRANIOFAC RES, V12, P94, DOI 10.1111/j.1601-6343.2009.01442.x
   Koike M, 2005, J BONE MINER METAB, V23, P219, DOI 10.1007/s00774-004-0587-y
   Kokkinos PA, 2009, J BIOMED MATER RES A, V90A, P387, DOI 10.1002/jbm.a.32105
   Kroustalli AA, 2013, ANN BIOMED ENG, V41, P2655, DOI 10.1007/s10439-013-0860-0
   Liedert A, 2006, BIOCHEM BIOPH RES CO, V349, P1, DOI 10.1016/j.bbrc.2006.07.214
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Matsuda N, 1998, BIOCHEM BIOPH RES CO, V249, P350, DOI 10.1006/bbrc.1998.9151
   Maul TM, 2011, BIOMECH MODEL MECHAN, V10, P939, DOI 10.1007/s10237-010-0285-8
   Nagatomi J, 2001, TISSUE ENG, V7, P717, DOI 10.1089/107632701753337672
   Nayak TR, 2010, ACS NANO, V4, P7717, DOI 10.1021/nn102738c
   NEIDLINGERWILKE C, 1994, J ORTHOP RES, V12, P70, DOI 10.1002/jor.1100120109
   Newman P, 2013, NANOMED-NANOTECHNOL, V9, P1139, DOI 10.1016/j.nano.2013.06.001
   PENDER N, 1991, J CELL SCI, V100, P187
   Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3
   STANFORD CM, 1995, J ORTHOPAED RES, V13, P664, DOI 10.1002/jor.1100130505
   Stegemann JP, 2005, J APPL PHYSIOL, V98, P2321, DOI 10.1152/japplphysiol.01114.2004
   Sumanasinghe RD, 2006, TISSUE ENG, V12, P3459, DOI 10.1089/ten.2006.12.3459
   Tanaka SM, 2003, J BIOMECH, V36, P73, DOI 10.1016/S0021-9290(02)00245-2
   Wang YK, 2013, J CELL MOL MED, V17, P823, DOI 10.1111/jcmm.12061
   Wijdicks FJG, 2013, CAN J SURG, V56, P58, DOI 10.1503/cjs.029511
   Zeng DH, 2010, BIOMECH MODEL MECHAN, V9, P19, DOI 10.1007/s10237-009-0156-3
NR 31
TC 1
Z9 1
U1 0
U2 23
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2015
VL 103
IS 3
BP 1038
EP 1044
DI 10.1002/jbm.a.35250
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA7NG
UT WOS:000349103500019
PM 24910375
DA 2018-10-19
ER

PT J
AU Garcia-Gareta, E
   Hua, J
   Blunn, GW
AF Garcia-Gareta, Elena
   Hua, Jia
   Blunn, Gordon W.
TI Osseointegration of acellular and cellularized osteoconductive
   scaffolds: Is tissue engineering using mesenchymal stem cells necessary
   for implant fixation?
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone tissue engineering; mesenchymal stem cells; in vivo;
   osseointegration; implant; bone fixation strength
ID TOTAL HIP-ARTHROPLASTY; DEBRIS-INDUCED OSTEOLYSIS; SYNTHETIC BONE-GRAFT;
   FUNCTIONAL ASSESSMENT; TITANIUM IMPLANTS; INGROWTH; MARROW;
   DIFFERENTIATION; REPLACEMENT; BIOMATERIAL
AB The main issue associated with revision total hip replacements (rTHRs) is how to generate new bone adjacent to implants and achieve fixation of the revision implant. In its simplest form, bone tissue engineering (BTE) combines cells and scaffolds in vitro to replace damaged or lost bone in vivo. Our aim was to develop BTE porous TiAl6V4 constructs with a calcium-phosphate coating without or with mesenchymal stem cells (MSCs) seeded throughout the entire porous structure to enhance new bone formation and which could be used for rTHRs. Porous titanium scaffolds made by selective laser sintering were seeded throughout with autologous bone marrow MSCs and cultured in a perfusion bioreactor. Constructs were implanted in the medial femoral condyle of 20 skeletally mature mule sheep with and without a gap of 2.5 mm between the construct and the host bone. After 6 weeks, the addition of MSCs to the scaffolds did not significantly increase osseointegration or implant-bone fixation strength. However, in the defects with a gap, the cellularized constructs showed higher implant-bone contact area and implant-bone fixation strength. BTE can be applied to develop acellular or cellularized constructs with clinical application in rTHRs where a lack of bone stock is problematic. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1067-1076, 2015.
C1 [Garcia-Gareta, Elena; Hua, Jia; Blunn, Gordon W.] Univ Coll, Royal Natl Orthopaed Hosp, Inst Orthopaed & Musculoskeletal Sci, John Scales Ctr Biomed Engn, Stanmore HA7 4LP, Middx, England.
RP Garcia-Gareta, E (reprint author), Mt Vernon Hosp, RAFT Inst Plast Surg, Northwood HA6 2RN, Middx, England.
EM garciae@raft.ac.uk
CR Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663
   AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, P7
   Babiker H, 2013, J TISSUE ENG REGEN M, DOI 10.1002/term.1685
   Babiker H, 2012, J BIOMED MATER RES B, V100B, P759, DOI 10.1002/jbm.b.32509
   Barckman Jeppe, 2013, Open Orthop J, V7, P18, DOI 10.2174/1874325001307010018
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bohner M., 2000, INJURY, V31, pSD37
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Cooper R A, 1992, J Arthroplasty, V7, P285, DOI 10.1016/0883-5403(92)90050-Z
   Delloye C, 2007, J BONE JOINT SURG BR, V89B, P574, DOI 10.1302/0301-620X.89B5.19039
   Disegi J. A., 2000, INJURY S4, V31, P14, DOI DOI 10.1016/S0020-1383(00)80017-0
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P531
   ENGH CA, 1987, J BONE JOINT SURG BR, V69, P45
   Eslaminejad MB, 2008, YAKHTEH, V10, P205
   Galois Laurent, 2004, Acta Orthop Belg, V70, P598
   Garcia-Gareta E, 2014, J MATER SCI-MATER M, V25, P1553, DOI 10.1007/s10856-014-5170-z
   Garcia-Gareta E, 2013, J MATER SCI-MATER M, V24, P199, DOI 10.1007/s10856-012-4789-x
   GIE GA, 1993, J BONE JOINT SURG BR, V75, P14
   Goldstein SA, 2002, ANN NY ACAD SCI, V961, P183, DOI 10.1111/j.1749-6632.2002.tb03079.x
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   HARRIS WH, 1995, CLIN ORTHOP RELAT R, P46
   Harris WH, 2001, CLIN ORTHOP RELAT R, P66
   Heisel C, 2003, J BONE JOINT SURG AM, V85A, P1366, DOI 10.2106/00004623-200307000-00026
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kruyt MC, 2004, J ORTHOPAED RES, V22, P544, DOI 10.1016/j.orthres.2003.10.010
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.2128.x
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   OHGUSHI H, 1993, J BIOMED MATER RES, V27, P1401, DOI 10.1002/jbm.820271107
   Pastoureau PME, 1989, J BONE MINER RES   S, V4, P237
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Redepenning J, 1996, J BIOMED MATER RES, V30, P287
   RIVERO DP, 1988, J BIOMED MATER RES, V22, P191, DOI 10.1002/jbm.820220304
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Sensebe L, 2010, VOX SANG, V98, P93, DOI 10.1111/j.1423-0410.2009.01227.x
   Unger AS, 2005, J ARTHROPLASTY, V20, P1002, DOI 10.1016/j.arth.2005.01.023
   Vaccaro AR, 2002, ORTHOPEDICS, V25, pS571
   WOLFF D, 1994, J ORTHOP RES, V12, P439, DOI 10.1002/jor.1100120317
NR 41
TC 8
Z9 8
U1 1
U2 15
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2015
VL 103
IS 3
BP 1067
EP 1076
DI 10.1002/jbm.a.35256
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA7NG
UT WOS:000349103500023
PM 24913035
DA 2018-10-19
ER

PT J
AU Ngwuluka, NC
   Choonara, YE
   Kumar, P
   du Toit, LC
   Khan, RA
   Pillay, V
AF Ngwuluka, Ndidi C.
   Choonara, Yahya E.
   Kumar, Pradeep
   du Toit, Lisa C.
   Khan, Riaz A.
   Pillay, Viness
TI A novel pH-responsive interpolyelectrolyte hydrogel complex for the oral
   delivery of levodopa. Part II: Characterization and formulation of an
   IPEC-based tablet matrix
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE interpolyelectrolyte complex; methacrylic acid copolymer;
   carboxymethylcellulose; hydrogel; controlled release; drug delivery;
   levodopa
ID MOISTURE-CONTENT; DRUG-DELIVERY; RELEASE; DSC
AB This study was undertaken in order to apply a synthesized interpolyelectrolyte complex (IPEC) of polymethacrylate and carboxymethylcellulose as a controlled release oral tablet matrix for the delivery of the model neuroactive drug levodopa. The IPEC (synthesized in Part I of this work) was characterized by techniques such as Fourier Transform Infra-Red (FTIR) spectroscopy, Differential Scanning Calorimetry (DSC), Advanced DSC (ADSC), and Scanning Electron Microscopy (SEM). The tablet matrices were formulated and characterized for their drug delivery properties and in vitro drug release. FTIR confirmed the interaction between the two polymers. The IPEC composite generated tablet matrices with a hardness ranging from 19.152-27.590 N/mm and a matrix resilience ranging between 42 and 46%. An IPEC of polymethacrylate and carboxymethylcellulose was indeed an improvement on the inherent properties of the native polymers providing a biomaterial with the ability to release poorly soluble drugs such as levodopa at a constant rate over a prolonged period of time. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1085-1094, 2015.
C1 [Ngwuluka, Ndidi C.; Choonara, Yahya E.; Kumar, Pradeep; du Toit, Lisa C.; Pillay, Viness] Univ Witwatersrand, Dept Pharm & Pharmacol, Wits Adv Drug Delivery Platform Res Unit, Sch Therapeut Sci,Fac Hlth Sci, ZA-2193 Parktown, South Africa.
   [Khan, Riaz A.] Manav Rachna Int Univ, Dept Chem, Faridabad, Haryana, India.
RP Pillay, V (reprint author), Univ Witwatersrand, Dept Pharm & Pharmacol, Wits Adv Drug Delivery Platform Res Unit, Sch Therapeut Sci,Fac Hlth Sci, 7 York Rd, ZA-2193 Parktown, South Africa.
EM viness.pillay@wits.ac.za
RI Pillay, Viness/C-1569-2010; Choonara, Yahya/B-2955-2013; Kumar,
   Pradeep/C-9424-2013
OI Pillay, Viness/0000-0002-8119-3347; Choonara, Yahya/0000-0002-3889-1529;
   Kumar, Pradeep/0000-0002-8640-4350; Khan, Riaz/0000-0003-0185-0149
FU National Research Foundation (NRF) of South Africa
FX Contract grant sponsor: National Research Foundation (NRF) of South
   Africa
CR Bravo-Osuna I, 2008, EUR J PHARM BIOPHARM, V69, P285, DOI 10.1016/j.ejpb.2007.09.020
   Bravo-Osuna I, 2007, EUR J PHARM BIOPHARM, V66, P63, DOI 10.1016/j.ejpb.2006.08.003
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Jivraj Mira, 2000, Pharmaceutical Science and Technology Today, V3, P58, DOI 10.1016/S1461-5347(99)00237-0
   KAMAT MS, 1989, PHARM RES-DORDR, V6, P961, DOI 10.1023/A:1015997530367
   KIM SW, 1992, PHARMACEUT RES, V9, P283, DOI 10.1023/A:1015887213431
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Nur AO, 2000, DRUG DEV IND PHARM, V26, P965, DOI 10.1081/DDC-100101323
   O'Brien S, 2009, CARBOHYD POLYM, V76, P557, DOI 10.1016/j.carbpol.2008.11.024
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Sauer BB, 2000, POLYMER, V41, P1099, DOI 10.1016/S0032-3861(99)00258-X
   Steendam R, 2000, INT J PHARM, V204, P23, DOI 10.1016/S0378-5173(00)00456-7
   Verdonck E, 1999, INT J PHARM, V192, P3, DOI 10.1016/S0378-5173(99)00267-7
   Zhao Q, 2009, J MEMBRANE SCI, V333, P68, DOI 10.1016/j.memsci.2009.02.001
NR 14
TC 2
Z9 2
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2015
VL 103
IS 3
BP 1085
EP 1094
DI 10.1002/jbm.a.35258
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA7NG
UT WOS:000349103500025
PM 24909309
DA 2018-10-19
ER

PT J
AU Wang, R
   Levi-Polyanchenko, N
   Morykwas, M
   Argenta, L
   Wagner, WD
AF Wang, Rui
   Levi-Polyanchenko, Nicole
   Morykwas, Michael
   Argenta, Louis
   Wagner, William D.
TI Novel nanofiber-based material for endovascular scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE heart valve; heart valve scaffold; nanocomposite scaffold; polyglycerol
   sebacate; fibroin; silk; collagen
ID IN-VITRO DEGRADATION; MORI SILK FIBROIN; HEART-VALVES; BOMBYX-MORI;
   POLY(GLYCEROL SEBACATE); MECHANICAL-PROPERTIES; TISSUE; COLLAGEN; ACID;
   MEMBRANE
AB Conventional collagen-based heart valves eventually fail because of insufficient replacement of graft material by host tissue. In this study, type I collagen was blended with silk fibroin and the synthetic elastic polymer poly (glycerol-sebacate) (PGS) in varying proportions to create multifunctional electrospun nanofibrous materials tailored for use as endovascular scaffolds such as heart valve replacement. Depending on the blended material the elastic moduli ranged from 2.3 to 5.0 Mpa; tensile stresses ranged from 0.8 to 1.5 Mpa; and strains ranged from 30% to 70%. Electrospun materials with a weight ratio of 4.5:4.5:1 (collagen, fibroin, and PGS) (termed PFC mats) were the most similar to native heart valves. In vitro degradation of PFC mats was 0.01% per week. Endothelial cells adhered to, proliferated, and formed cell-cell junctions on PFC mats. Compared with collagen hydrogels and electrospun collagen mats respectively 220-290% less platelet adhesion was observed for PFC mats. The study demonstrates that PFC material has superior mechanical properties, low degradation, and reduced thrombogenic potential and suggests that further investigation of this biomaterial for cardiovascular applications is warranted. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1150-1158, 2015.
C1 [Wang, Rui; Levi-Polyanchenko, Nicole; Morykwas, Michael; Argenta, Louis; Wagner, William D.] Wake Forest Univ, Sch Med, Dept Plast & Reconstruct Surg, Winston Salem, NC 27157 USA.
   [Wang, Rui; Levi-Polyanchenko, Nicole; Morykwas, Michael; Wagner, William D.] Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Winston Salem, NC 27157 USA.
RP Wagner, WD (reprint author), Wake Forest Univ, Sch Med, Dept Plast & Reconstruct Surg, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM wwagner@wakehealth.edu
FU Department of Plastic and Reconstructive Surgery Research Funds
FX Contract grant sponsor: Department of Plastic and Reconstructive Surgery
   Research Funds
CR Apte SS, 2011, FUTUR CARDIOL, V7, P77, DOI [10.2217/fca.10.120, 10.2217/FCA.10.120]
   Beun LH, 2011, ACS NANO, V6, P133
   Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P327, DOI 10.1115/1.1287158
   Breuer CK, 2004, TISSUE ENG, V10, P1725, DOI 10.1089/ten.2004.10.1725
   Butcher JT, 2011, ADV DRUG DELIVER REV, V63, P242, DOI 10.1016/j.addr.2011.01.008
   Cebotari S, 2011, CIRCULATION, V124, pS115, DOI 10.1161/CIRCULATIONAHA.110.012161
   Cilurzo F, 2011, INT J PHARMACEUT, V414, P218, DOI 10.1016/j.ijpharm.2011.05.023
   De Cupere VM, 2003, LANGMUIR, V19, P6957, DOI 10.1021/la030081n
   Dijkman PE, 2012, BIOMATERIALS, V33, P4545, DOI 10.1016/j.biomaterials.2012.03.015
   Edwards MB, 2005, J CARDIOV MAGN RESON, V7, P835, DOI 10.1080/10976640500288149
   Gu XX, 2010, J BIOMED MATER RES A, V93A, P1620, DOI 10.1002/jbm.a.32660
   Hayashi T, 2007, J PHYS CHEM B, V111, P11032, DOI 10.1021/jp070369b
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jordan JE, 2012, J THORAC CARDIOV SUR, V143, P201, DOI 10.1016/j.jtcvs.2011.10.005
   Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1
   Lee KW, 2011, P NATL ACAD SCI USA, V108, P2705, DOI 10.1073/pnas.1017834108
   Liu T, 2010, J BIOMED MATER RES A, V95A, P276, DOI 10.1002/jbm.a.32831
   LUCAS F, 1957, BIOCHEM J, V66, P468, DOI 10.1042/bj0660468
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Matsumoto A, 2008, MACROMOL BIOSCI, V8, P1006, DOI 10.1002/mabi.200800020
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   Mol A, 2004, J HEART VALVE DIS, V13, P272
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8
   Pomerantseva I, 2009, J BIOMED MATER RES A, V91A, P1038, DOI 10.1002/jbm.a.32327
   RENUGOPALAKRISHNAN V, 1989, MACROMOLECULES, V22, P4121, DOI 10.1021/ma00200a054
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Sacks MS, 2009, ANNU REV BIOMED ENG, V11, P289, DOI 10.1146/annurev-bioeng-061008-124903
   Sant S, 2010, ENG MED BIOL SOC EMB
   Schopka S, 2009, J BIOMED MATER RES B, V88B, P130, DOI 10.1002/jbm.b.31159
   SCHROEDER WA, 1955, J AM CHEM SOC, V77, P3908, DOI 10.1021/ja01619a066
   Sell SA, 2010, POLYMERS-BASEL, V2, P522, DOI 10.3390/polym2040522
   Shekaran A, BBA GEN SUBJECTS, V1810, P350
   Soliman S, 2011, J BIOMED MATER RES A, V96A, P566, DOI 10.1002/jbm.a.33010
   Sung HW, 2000, BIOMATERIALS, V21, P1353, DOI 10.1016/S0142-9612(00)00017-X
   Tedder ME, 2009, TISSUE ENG PT A, V15, P1257, DOI 10.1089/ten.tea.2008.0263
   TROWBRIDGE EA, 1989, J BIOMED ENG, V11, P311, DOI 10.1016/0141-5425(89)90065-4
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   VESELY I, 1992, J BIOMECH, V25, P101, DOI 10.1016/0021-9290(92)90249-Z
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Yi F, 2008, MACROMOL BIOSCI, V8, P803, DOI 10.1002/mabi.200800041
   Zhou JA, 2010, POLYM DEGRAD STABIL, V95, P1679, DOI 10.1016/j.polymdegradstab.2010.05.025
   Zoccola M, 2008, BIOMACROMOLECULES, V9, P2819, DOI 10.1021/bm800579a
   Zong XH, 2003, BIOMACROMOLECULES, V4, P416, DOI 10.1021/bm025717o
   Zou L, 2012, J BIOL CHEM, V287, P7190, DOI 10.1074/jbc.M111.304972
NR 46
TC 6
Z9 6
U1 5
U2 59
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2015
VL 103
IS 3
BP 1150
EP 1158
DI 10.1002/jbm.a.35267
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA7NG
UT WOS:000349103500031
PM 25044469
DA 2018-10-19
ER

PT J
AU Janson, IA
   Putnam, AJ
AF Janson, Isaac A.
   Putnam, Andrew J.
TI Extracellular matrix elasticity and topography: Material-based cues that
   affect cell function via conserved mechanisms
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE topography; matrix mechanics; cell fate; mechanotransduction;
   differentiation
ID MESENCHYMAL STEM-CELLS; SMOOTH-MUSCLE-CELLS; COPOLYMER MICELLE
   NANOLITHOGRAPHY; POLYMER-DEMIXED NANOTOPOGRAPHY; FOCAL ADHESION KINASE;
   NANOSCALE TOPOGRAPHY; OSTEOGENIC DIFFERENTIATION; COLLAGEN-I;
   OSTEOPROGENITOR RESPONSE; SUBSTRATE STIFFNESS
AB Chemical, mechanical, and topographic extracellular matrix (ECM) cues have been extensively studied for their influence on cell behavior. These ECM cues alter cell adhesion, cell shape, and cell migration and activate signal transduction pathways to influence gene expression, proliferation, and differentiation. ECM elasticity and topography, in particular, have emerged as material properties of intense focus based on strong evidence these physical cues can partially dictate stem cell differentiation. Cells generate forces to pull on their adhesive contacts, and these tractional forces appear to be a common element of cells' responses to both elasticity and topography. This review focuses on recently published work that links ECM topography and mechanics and their influence on differentiation and other cell behaviors. We also highlight signaling pathways typically implicated in mechanotransduction that are (or may be) shared by cells subjected to topographic cues. Finally, we conclude with a brief discussion of the potential implications of these commonalities for cell based therapies and biomaterial design. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1246-1258, 2015.
C1 [Janson, Isaac A.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   [Putnam, Andrew J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Putnam, AJ (reprint author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
EM putnam@umich.edu
OI Putnam, Andrew/0000-0002-1262-4377
FU National Heart, Lung, and Blood Institute of the National Institutes of
   Health [R01HL085339, R01HL118259]
FX Contract grant sponsor: National Heart, Lung, and Blood Institute of the
   National Institutes of Health; contract grant numbers: R01HL085339 and
   R01HL118259
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   Ahn EH, 2014, BIOMATERIALS, V35, P2401, DOI 10.1016/j.biomaterials.2013.11.037
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Ballet T, 2010, B POL ACAD SCI-TECH, V58, P303, DOI 10.2478/v10175-010-0028-0
   Barker TH, 2011, BIOMATERIALS, V32, P4211, DOI 10.1016/j.biomaterials.2011.02.027
   Bernard A, 1998, LANGMUIR, V14, P2225, DOI 10.1021/la980037l
   Biela SA, 2009, ACTA BIOMATER, V5, P2460, DOI 10.1016/j.actbio.2009.04.003
   Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049
   Brammer KS, 2008, NANO LETT, V8, P786, DOI 10.1021/nl072572o
   Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Charest JL, 2006, BIOMATERIALS, V27, P2487, DOI 10.1016/j.biomaterials.2005.11.022
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Choi SJ, 2011, J MATER CHEM, V21, P14325, DOI 10.1039/c1jm12201k
   Choi SJ, 2004, J AM CHEM SOC, V126, P7744, DOI 10.1021/ja048972k
   Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5
   Collier JH, 2011, BIOMATERIALS, V32, P4198, DOI 10.1016/j.biomaterials.2011.02.030
   Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076
   Coyer SR, 2012, J CELL SCI, V125, P5110, DOI 10.1242/jcs.108035
   Curtis ASG, 2001, BIOPHYS CHEM, V94, P275, DOI 10.1016/S0301-4622(01)00247-2
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Garcia AJ, 2002, CRIT REV EUKAR GENE, V12, P151, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774
   Glass R, 2003, NANOTECHNOLOGY, V14, P1153, DOI 10.1088/0957-4484/14/10/314
   Godek ML, 2009, J BIOMED MATER RES A, V88A, P503, DOI 10.1002/jbm.a.31886
   Gonzalez-Garcia C, 2010, COLLOID SURFACE B, V77, P181, DOI 10.1016/j.colsurfb.2010.01.021
   Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585
   Gu XX, 2010, J BIOMED MATER RES A, V93A, P1620, DOI 10.1002/jbm.a.32660
   Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   HORBETT TA, 1982, ADV CHEM SER, P233
   Huang XD, 2002, J VAC SCI TECHNOL B, V20, P2872, DOI 10.1116/1.1523404
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Jain R, 2003, J INVEST SURG, V16, P263, DOI 10.1080/08941930390230388
   Janson IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090719
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Khang D, 2012, BIOMATERIALS, V33, P5997, DOI 10.1016/j.biomaterials.2012.05.005
   Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005
   Khatiwala CB, 2007, J CELL PHYSIOL, V211, P661, DOI 10.1002/jcp.20974
   Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/JBMR.081240, 10.1359/jbmr.081240]
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Kim DH, 2009, ANNU REV BIOMED ENG, V11, P203, DOI 10.1146/annurev-bioeng-061008-124915
   Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042
   Kim J, 2013, BIOMATERIALS, V34, P7257, DOI 10.1016/j.biomaterials.2013.06.029
   Koh LB, 2010, PHYS CHEM CHEM PHYS, V12, P10301, DOI 10.1039/c001747g
   Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022
   Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102
   Kong YP, 2013, ACTA BIOMATER, V9, P6369, DOI 10.1016/j.actbio.2013.01.036
   Koo LY, 2002, J CELL SCI, V115, P1423
   Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110
   Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034
   LaPointe VLS, 2013, ADV HEALTHC MATER, V2, P1644, DOI 10.1002/adhm.201200382
   Li B., 2013, SCI REP, P3
   Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020
   Liu WF, 2007, ADV DRUG DELIVER REV, V59, P1319, DOI 10.1016/j.addr.2007.08.011
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lohmuller T, 2011, BIOINTERPHASES, V6, pMR1, DOI 10.1116/1.3536839
   Lu DY, 2014, BIOMATERIALS, V35, P3945, DOI 10.1016/j.biomaterials.2014.01.066
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Mello AP, 2003, ANN BIOMED ENG, V31, P1106, DOI 10.1114/1.1603261
   Mosqueira D, 2014, ACS NANO, V8, P2033, DOI 10.1021/nn4058984
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   Norde W, 2012, ACS SYM SER, V1120, P1
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peyton SR, 2008, BIOMATERIALS, V29, P2597, DOI 10.1016/j.biomaterials.2008.02.005
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   Pompe T, 2009, BIOPHYS J, V97, P2154, DOI 10.1016/j.bpj.2009.07.047
   Prodanov L, 2013, BIOMATERIALS, V34, P2920, DOI 10.1016/j.biomaterials.2013.01.027
   Prodanov L, 2010, BIOMATERIALS, V31, P7758, DOI 10.1016/j.biomaterials.2010.06.050
   Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O
   Ross AM, 2012, SMALL, V8, P336, DOI 10.1002/smll.201100934
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017
   Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716
   Sivaraman B, 2010, BIOMATERIALS, V31, P1036, DOI 10.1016/j.biomaterials.2009.10.017
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Suh KY, 2009, ADV FUNCT MATER, V19, P2699, DOI 10.1002/adfm.200900771
   Sun YB, 2014, NAT MATER, V13, P599, DOI [10.1038/NMAT3945, 10.1038/nmat3945]
   Szott LM, 2011, CURR OPIN CHEM BIOL, V15, P677, DOI 10.1016/j.cbpa.2011.04.021
   Tan J, 2002, BIOMATERIALS, V23, P3215, DOI 10.1016/S0142-9612(02)00074-1
   Tang Y, 2013, DEV CELL, V25, P402, DOI 10.1016/j.devcel.2013.04.011
   Taubenberger AV, 2010, BIOMATERIALS, V31, P2827, DOI 10.1016/j.biomaterials.2009.12.051
   Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z
   Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Wang PY, 2012, J MATER SCI-MATER M, V23, P3015, DOI 10.1007/s10856-012-4748-6
   Watari S, 2012, BIOMATERIALS, V33, P128, DOI 10.1016/j.biomaterials.2011.09.058
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Wheeldon I, 2011, NANOTECHNOLOGY, P22
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   Wood JA, 2012, EXP CELL RES, V318, P2438, DOI 10.1016/j.yexcr.2012.06.022
   Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/NMAT3889, 10.1038/nmat3889]
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   You MH, 2010, BIOMACROMOLECULES, V11, P1856, DOI 10.1021/bm100374n
   Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]
NR 134
TC 40
Z9 42
U1 9
U2 126
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2015
VL 103
IS 3
BP 1246
EP 1258
DI 10.1002/jbm.a.35254
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA7NG
UT WOS:000349103500041
PM 24910444
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Lee, WF
   Chen, CY
AF Lee, Wen-Fu
   Chen, Chien-Yu
TI Graft copolymerization of 3-(trimethoxysilyl) propyl methacrylate onto
   styrene-butadiene-styrene triblock copolymer
SO JOURNAL OF ELASTOMERS AND PLASTICS
LA English
DT Article
DE Styrene-butadiene-styrene triblock copolymer; graft copolymerization;
   silicone monomer
ID MALEIC-ANHYDRIDE; GLYCIDYL METHACRYLATE; SBS; RUBBER; POLYMERIZATION;
   BIOMATERIAL; ACID
AB Graft copolymerization of silicone monomer3-(trimethoxysilyl) propyl methacrylate (TMSPMA) grafted onto styrene-butadiene-styrene (SBS; SBS-g-TMSPMA) triblock copolymer was carried out by free radical polymerization, and the improvement of adhesive property of the grafted SBS for glass materials is the major purpose of this study. To gain the optimal reaction conditions and grafting effect, the effect of various factors, such as the monomer ratio and reaction time, on the grafting ratio and grafting efficiency (GE) of SBS-g-TMSPMA graft copolymers were investigated. In addition, various SBS-g-TMSPMA graft copolymers were coated on different substrates based on glass and their tensile strengths that were tested. The optimal graft condition for the SBS-g-TMSPMA was obtained when the molar ratio of TMSPMA to SBS was 1 and reaction time was 4 h. Their grafting ratio and GEreached to a maximum of 56.8% and 60.2%, respectively, and the tensile strength also reached maximum. In this article, we confirm that the higher the grafting ratio, the more the silicone-containing in the graft copolymer. Hence, the -Si-O-Si- bonding between SBS-g-TMSPMA and glass substrate was more intensive and tensile strength was stronger.
C1 [Lee, Wen-Fu; Chen, Chien-Yu] Tatung Univ, Dept Chem Engn, Taipei 104, Taiwan.
RP Lee, WF (reprint author), Tatung Univ, Dept Chem Engn, 40 Sec 3,Jhonhshan N Rd, Taipei 104, Taiwan.
EM wflee@ttu.edu.tw
FU Tatung University [B 101-C01-017]
FX The authors wish to thank the Tatung University for the financial
   support under Grant B 101-C01-017.
CR Brinkmann-Rengel S, 1999, KAUT GUMMI KUNSTST, V52, P806
   Coiai S, 2006, MACROMOL SYMP, V234, P193, DOI 10.1002/masy.200650225
   Cordella CD, 2003, J APPL POLYM SCI, V87, P2074, DOI 10.1002/app.11455
   HSIUE GH, 1988, J BIOMED MATER RES, V22, P405, DOI 10.1002/jbm.820220504
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Kennedy JE, 2011, MAT SCI ENG C-MATER, V31, P246, DOI 10.1016/j.msec.2010.09.004
   Kennedy JE, 2009, MAT SCI ENG C-BIO S, V29, P1655, DOI 10.1016/j.msec.2009.01.015
   Lasalle VL, 2003, J ADHES SCI TECHNOL, V17, P1713, DOI 10.1163/156856103322396758
   Lee WF, 2001, J APPL POLYM SCI, V82, P2641, DOI 10.1002/app.2117
   LEE WF, 1995, J APPL POLYM SCI, V55, P1197, DOI 10.1002/app.1995.070550807
   Lee WF, 2009, J ELASTOM PLAST, V42, P49
   Peng J, 2007, RADIAT PHYS CHEM, V76, P1741, DOI 10.1016/j.radphyschem.2007.02.086
   Wilhelm HM, 2002, J APPL POLYM SCI, V83, P2953, DOI 10.1002/app.10355
   Wu GL, 2010, MAT SCI ENG C-MATER, V30, P1030, DOI 10.1016/j.msec.2010.05.004
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yin CJ, 2011, J APPL POLYM SCI, V119, P2808, DOI 10.1002/app.33073
   Zhang A, 2003, EUR POLYM J, V39, P1291
   ZHAO Y, 1992, MACROMOLECULES, V25, P4705, DOI 10.1021/ma00044a035
   Zhou T, 2003, CHIN J COLLOID POLYM, V21, P15
NR 20
TC 1
Z9 1
U1 1
U2 31
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0095-2443
EI 1530-8006
J9 J ELASTOM PLAST
JI J. Elastomer Plast.
PD MAR
PY 2015
VL 47
IS 2
BP 103
EP 116
DI 10.1177/0095244313489911
PG 14
WC Materials Science, Multidisciplinary; Polymer Science
SC Materials Science; Polymer Science
GA CB0OV
UT WOS:000349326900001
DA 2018-10-19
ER

PT J
AU Ijaz, MF
   Kim, HY
   Hosoda, H
   Miyazaki, S
AF Ijaz, Muhammad Farzik
   Kim, Hee Young
   Hosoda, Hideki
   Miyazaki, Shuichi
TI Superelastic properties of biomedical (Ti-Zr)-Mo-Sn alloys
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Superelasticity; Reaystallization texture; Biomaterial; Ti alloy;
   Martensitic transformation
ID SHAPE-MEMORY ALLOY; TI-BASED ALLOYS; MECHANICAL-PROPERTIES;
   PHASE-STABILITY; NB ALLOYS; THERMOMECHANICAL TREATMENT; YOUNGS MODULUS;
   TITANIUM-ALLOY; HEAT-TREATMENT; SN CONTENT
AB A new class of Ti-50Zr base biomedical superelastic alloys was developed in this study. The (Ti-Zr)-Mo-Sn alloys exhibited a shape memory effect and superelastic property by adjusting Mo and Sn contents. The (Ti-Zr)-1.5Mo-3Sn alloy revealed the most stable superelasticity among (Ti-Zr)-(1-2)Mo-(2-4)Sn alloys. The superelastic recovery strain showed a strong dependence on heat treatment temperature after cold working in the (Ti-Zr)1.5Mo-3Sn alloy. The superelastic recovery strain increased as the heat treatment temperature increased although the critical stress for slip decreased. The (Ti-Zr)-1.5Mo-3Sn alloy heat treated at 1073 K exhibited excellent superelastic properties with a large recovery strain as large as 7% which is due to the strong {001}(beta)< 110 >(beta) recrystallizadon texture. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Ijaz, Muhammad Farzik; Kim, Hee Young; Miyazaki, Shuichi] Univ Tsukuba, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
   [Hosoda, Hideki] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.
RP Kim, HY (reprint author), Univ Tsukuba, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
EM heeykim@ims.tsukuba.ac.jp; miyazaki@ims.tsukuba.ac.jp
RI Kim, Hee Young/F-6065-2011; Miyazaki, Shuichi/A-3113-2012
OI Kim, Hee Young/0000-0003-1981-6678; Miyazaki,
   Shuichi/0000-0003-3849-4176
FU JSPS KAKENHI [26249104]; MEXT KAKENHI [25102704]
FX This work was partially supported by JSPS KAKENHI Grant Number 26249104
   and MEXT KAKENHI Grant Number 25102704.
CR Abdel-Hady M, 2008, MAT SCI ENG A-STRUCT, V480, P167, DOI 10.1016/j.msea.2007.06.083
   Abdel-Hady M, 2007, SCRIPTA MATER, V57, P1000, DOI 10.1016/j.scriptamat.2007.08.003
   Abdel-Hady M, 2006, SCRIPTA MATER, V55, P477, DOI 10.1016/j.scriptamat.2006.04.022
   Abriata J.P., 1983, B ALLOY PHASE DIAGRA, V4, P147, DOI DOI 10.1007/BF02884861
   Al-Zain Y, 2011, ACTA MATER, V59, P1464, DOI 10.1016/j.actamat.2010.11.008
   Al-Zain Y, 2010, ACTA MATER, V58, P4212, DOI 10.1016/j.actamat.2010.04.013
   Balazic Matej, 2007, International Journal of Nano and Biomaterials, V1, P3, DOI 10.1504/IJNBM.2007.016517
   Barras CDJ, 2000, EUR J VASC ENDOVASC, V19, P564, DOI 10.1053/ejvs.2000.1111
   BURSTONE CJ, 1980, AM J ORTHOD DENTOFAC, V77, P121, DOI 10.1016/0002-9416(80)90001-9
   Cai S, 2013, ACTA MATER, V61, P6830, DOI 10.1016/j.actamat.2013.07.062
   Cai S, 2013, MAT SCI ENG A-STRUCT, V562, P172, DOI 10.1016/j.msea.2012.11.005
   Cui Y, 2010, MAT SCI ENG A-STRUCT, V527, P652, DOI 10.1016/j.msea.2009.08.063
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   DUERIG TW, 1982, ACTA METALL MATER, V30, P2161, DOI 10.1016/0001-6160(82)90137-7
   DUWEZ P, 1951, J I MET, V80, P525
   El Feninat F, 2002, ADV ENG MATER, V4, P91, DOI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
   Fukui Y, 2004, MATER TRANS, V45, P1077, DOI 10.2320/matertrans.45.1077
   Gloriant T, 2006, ADV ENG MATER, V8, P961, DOI 10.1002/adem.200600106
   Hanawa T, 2009, J ARTIF ORGANS, V12, P73, DOI 10.1007/s10047-008-0456-x
   Hao YL, 2006, MAT SCI ENG A-STRUCT, V441, P112, DOI 10.1016/j.msea.2006.09.051
   Hao YL, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2037192
   HATT BA, 1959, ACTA METALL, V70, P682
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Hosoda H, 2006, MAT SCI ENG A-STRUCT, V438, P870, DOI 10.1016/j.msea.2006.02.151
   Ijaz MF, 2014, SCRIPTA MATER, V72-73, P29, DOI 10.1016/j.scriptamat.2013.10.007
   Inamura T, 2005, MAT SCI ENG C-BIO S, V25, P426, DOI 10.1016/j.msec.2005.01.025
   Kent D, 2010, MAT SCI ENG A-STRUCT, V527, P2246, DOI 10.1016/j.msea.2009.11.059
   Kim HY, 2006, ACTA MATER, V54, P2419, DOI 10.1016/j.actamat.2006.01.019
   Kim HY, 2006, MAT SCI ENG A-STRUCT, V417, P120, DOI 10.1016/j.msea.2005.10.065
   Kim HY, 2006, ACTA MATER, V54, P423, DOI 10.1016/j.actamat.2005.09.014
   Kim JI, 2006, MATER TRANS, V47, P505, DOI 10.2320/matertrans.47.505
   Kim JI, 2005, MAT SCI ENG A-STRUCT, V403, P334, DOI 10.1016/j.msea.2005.05.050
   KOBAYASHI S, 2004, MAT T, V42, P2398
   Li Q, 2012, MAT SCI ENG A-STRUCT, V536, P197, DOI 10.1016/j.msea.2011.12.103
   Li Y, 2011, SCRIPTA MATER, V64, P584, DOI 10.1016/j.scriptamat.2010.11.048
   Lin L, 1996, SCRIPTA MATER, V34, P1411, DOI 10.1016/1359-6462(96)00006-1
   Ma LW, 2013, INTERMETALLICS, V32, P44, DOI 10.1016/j.intermet.2012.07.024
   Miyazaki S, 2006, MAT SCI ENG A-STRUCT, V438, P18, DOI 10.1016/j.msea.2006.02.054
   Morgan NB, 2004, MAT SCI ENG A-STRUCT, V378, P16, DOI 10.1016/j.msea.2003.10.326
   MURRAY JI, 1987, BINARY ALLOY PHASE D, P294
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Obbard EG, 2011, ACTA MATER, V59, P112, DOI 10.1016/j.actamat.2010.09.015
   Otsuka K, 1998, SHAPE MEMORY MATERIA
   Ramarolahy A, 2012, J MECH BEHAV BIOMED, V9, P83, DOI 10.1016/j.jmbbm.2012.01.017
   Sakaguch N, 2004, MATER TRANS, V45, P1113, DOI 10.2320/matertrans.45.1113
   Saltykov VA, 2008, J ALLOY COMPD, V459, P348, DOI 10.1016/j.jallcom.2007.04.268
   Sun F, 2011, J MECH BEHAV BIOMED, V4, P1864, DOI 10.1016/j.jmbbm.2011.06.003
   Tada H, 2012, MATER TRANS, V53, P1981, DOI 10.2320/matertrans.M2012184
   Tahara M, 2010, MAT SCI ENG A-STRUCT, V527, P6844, DOI 10.1016/j.msea.2010.07.052
   Tahara M, 2009, MATER TRANS, V50, P2726, DOI 10.2320/matertrans.MA200907
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
   Wang BL, 2008, MAT SCI ENG A-STRUCT, V486, P146, DOI 10.1016/j.msea.2007.08.073
   Yang Y, 2014, J ALLOY COMPD, V591, P85, DOI 10.1016/j.jallcom.2013.12.207
   Yoneyama T, 2008, WOODHEAD PUBL MATER, P1
   Zhan YZ, 2009, J ALLOY COMPD, V485, P170, DOI 10.1016/j.jallcom.2009.05.110
   Zhang DC, 2013, MAT SCI ENG A-STRUCT, V559, P706, DOI 10.1016/j.msea.2012.09.012
   Zhang JY, 2013, MAT SCI ENG A-STRUCT, V563, P78, DOI 10.1016/j.msea.2012.11.045
   Zhao XL, 2011, MAT SCI ENG C-MATER, V31, P1436, DOI 10.1016/j.msec.2011.05.013
NR 58
TC 25
Z9 25
U1 5
U2 60
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2015
VL 48
BP 11
EP 20
DI 10.1016/j.msec.2014.11.010
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CA2PE
UT WOS:000348749200003
PM 25579891
DA 2018-10-19
ER

PT J
AU Dalmau, A
   Pina, VG
   Devesa, F
   Amigo, V
   Munoz, AI
AF Dalmau, A.
   Guinon Pina, V.
   Devesa, F.
   Amigo, V.
   Igual Munoz, A.
TI Electrochemical behavior of near-beta titanium biomedical alloys in
   phosphate buffer saline solution
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Near-beta titanium alloys; Passivation; Biomaterials; Corrosion;
   Electrochemical impedance spectroscopy (EIS)
ID NB-SN ALLOYS; AGING HEAT-TREATMENT; TI-NB; MECHANICAL-PROPERTIES;
   PHYSIOLOGICAL SOLUTION; POWDER-METALLURGY; PASSIVE FILM; CORROSION
   BEHAVIOR; MICROSTRUCTURE; IMPLANTS
AB The electrochemical behavior of three different near-beta titanium alloys (composed by Ti, Nb and Sn) obtained by powder metallurgy for biomedical applications has been investigated. Different electrochemical and microscopy techniques were used to study the influence of the chemical composition (Sn content) and the applied potential on the microstructure and the corrosion mechanisms of those titanium alloys. The addition of Sn below 4 wt% to the titanium powder improves the microstructural homogeneity and generates an alloy with high corrosion resistance with low elastic modulus, being more suitable as a biomaterial. When the Sn content is above 4%, the corrosion resistance considerably decreases by increasing the passive dissolution rate; this effect is enhanced with the applied potential. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Dalmau, A.; Guinon Pina, V.; Igual Munoz, A.] Univ Politecn Valencia, Inst Ind Radiophys & Environm Safety, E-46071 Valencia, Spain.
   [Devesa, F.; Amigo, V.] Univ Politecn Valencia, Inst Mat Technol, E-46071 Valencia, Spain.
RP Dalmau, A (reprint author), Univ Politecn Valencia, Inst Ind Radiophys & Environm Safety, POB 22012, E-46071 Valencia, Spain.
EM aldalbor@posgrado.upv.es
RI igual munoz, anna/K-7996-2014; Guinon Pina, Virginia/I-1845-2015; Amigo,
   Vicente/K-6893-2014
OI igual munoz, anna/0000-0002-1372-621X; Guinon Pina,
   Virginia/0000-0002-6630-6227; Amigo, Vicente/0000-0002-2107-0273;
   Dalmau, Alba/0000-0002-4224-4463
FU Ministerio de Ciencia e Innovacion of the Spanish Government
   [MAT2011-22481]
FX The authors would like to thank the Ministerio de Ciencia e Innovacion
   of the Spanish Government for the financial support under the project
   MAT2011-22481.
CR Aleixo GT, 2011, SOLID STATE PHENOMEN, V172-174, P190, DOI 10.4028/www.scientific.net/SSP.172-174.190
   Barranco V, 2011, ACTA BIOMATER, V7, P2716, DOI 10.1016/j.actbio.2011.02.040
   BRUG GJ, 1984, J ELECTROANAL CHEM, V176, P275, DOI 10.1016/S0022-0728(84)80324-1
   Dalmau A, 2013, ELECTROCHIM ACTA, V95, P102, DOI 10.1016/j.electacta.2013.01.155
   de Assis SL, 2006, ELECTROCHIM ACTA, V51, P1815, DOI 10.1016/j.electacta.2005.02.121
   Devesa F, 2012, MATER SCI FORUM, V727-728, P61, DOI 10.4028/www.scientific.net/MSF.727-728.61
   Dewidar MM, 2008, J ALLOY COMPD, V454, P442, DOI 10.1016/j.jallcom.2006.12.143
   Fan JK, 2014, MATER CHARACT, V96, P93, DOI 10.1016/j.matchar.2014.07.018
   Fan JK, 2014, RARE METAL MAT ENG, V43, P808, DOI 10.1016/S1875-5372(14)60089-8
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gepreel MAH, 2013, J MECH BEHAV BIOMED, V20, P407, DOI 10.1016/j.jmbbm.2012.11.014
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Guo S, 2013, PROG NAT SCI-MATER, V23, P1, DOI 10.1016/j.pnsc.2013.01.008
   Ivasishin OM, 2008, J ALLOY COMPD, V457, P296, DOI 10.1016/j.jallcom.2007.03.070
   Jo YJ, 2007, J MATER PROCESS TECH, V194, P121, DOI 10.1016/j.matprotec.2007.04.102
   Kolachev BA, 1997, RUSS METALL+, P118
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Liu B, 2011, ACTA BIOMATER, V7, P1407, DOI 10.1016/j.actbio.2010.11.001
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lopes ESN, 2011, MATER CHARACT, V62, P673, DOI 10.1016/j.matchar.2011.04.015
   Lopes ESN, 2011, ADV MATER RES-SWITZ, V324, P61, DOI 10.4028/www.scientific.net/AMR.324.61
   Martin E, 2010, TRIBOL INT, V43, P918, DOI 10.1016/j.triboint.2009.12.055
   Metikos-Hukovic M, 2003, BIOMATERIALS, V24, P3765, DOI 10.1016/S0142-9612(03)00252-7
   Milosev I, 2008, ELECTROCHIM ACTA, V53, P3547, DOI 10.1016/j.electacta.2007.12.041
   Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9
   Milosev I, 2013, ELECTROCHIM ACTA, V99, P176, DOI 10.1016/j.electacta.2013.03.086
   Miura K, 2011, ACTA BIOMATER, V7, P2320, DOI 10.1016/j.actbio.2011.02.008
   More NS, 2011, MAT SCI ENG C-MATER, V31, P400, DOI 10.1016/j.msec.2010.10.021
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Rehder D, 2003, INORG CHEM COMMUN, V6, P604, DOI 10.1016/S1387-7003(03)00050-9
   Taddei EB, 2004, MAT SCI ENG C-BIO S, V24, P683, DOI 10.1016/j.msec.2004.08.011
   Vidal CV, 2012, J ELECTROCHEM SOC, V159, pC233, DOI 10.1149/2.090205jes
   Wang BL, 2008, MAT SCI ENG A-STRUCT, V486, P146, DOI 10.1016/j.msea.2007.08.073
   Wang XP, 2013, MATER DESIGN, V49, P511, DOI 10.1016/j.matdes.2013.01.012
   Yang YL, 2009, MATER SCI FORUM, V618-619, P169, DOI 10.4028/www.scientific.net/MSF.618-619.169
   Yu S, 2011, COLLOID SURFACE B, V85, P103, DOI 10.1016/j.colsurfb.2011.02.025
   Zheng YF, 2006, MAT SCI ENG A-STRUCT, V438, P891, DOI 10.1016/j.msea.2006.01.131
NR 37
TC 11
Z9 12
U1 0
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2015
VL 48
BP 55
EP 62
DI 10.1016/j.msec.2014.11.036
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA CA2PE
UT WOS:000348749200008
PM 25579896
DA 2018-10-19
ER

PT J
AU Chatzinikolaidou, M
   Rekstyte, S
   Danilevicius, P
   Pontikoglou, C
   Papadaki, H
   Farsari, M
   Vamvakaki, M
AF Chatzinikolaidou, Maria
   Rekstyte, Sima
   Danilevicius, Paulius
   Pontikoglou, Charalampos
   Papadaki, Helen
   Farsari, Maria
   Vamvakaki, Maria
TI Adhesion and growth of human bone marrow mesenchymal stem cells on
   precise-geometry 3D organic-inorganic composite scaffolds for bone
   repair
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Human bone marrow mesenchymal stem cells; 3D scaffold fabrication;
   Hybrid material; Cell adhesion and proliferation; Cell variability
ID STROMAL CELLS; LASER; OSTEOGENESIS; FABRICATION; HYDROGELS; CULTURE;
   BIOLOGY
AB Engineering biomaterial scaffolds that promote attachment and growth of mesenchymal stem cells in three dimensions is a crucial parameter for successful bone tissue engineering. Towards this direction, a lot of research effort has focused recently into the development of three-dimensional porous scaffolds, aiming to elicit positive cellular behavior. However, the fabrication of three-dimensional tissue scaffolds with a precise geometry and complex micro- and nano-features, supporting cell in-growth remains a challenge. In this study we report on a positive cellular response of human bone marrow-derived (BM) mesenchymal stem cells (MSCs) onto hybrid material scaffolds consisting of methacryloxypropyl trimethoxysilane, zirconium propoxide, and 2-(dimethylamino)ethyl methacrylate (DMAEMA). First, we use Direct Is Laser Writing, a 3D scaffolding technology to fabricate the complex structures. Subsequently, we investigate the morphology, viability and proliferation of BM-MSCs onto the hybrid scaffolds and examine the cellular response from different donors. Finally, we explore the effect of the materials' chemical composition on cell proliferation, employing three different material surfaces: (i) a hybrid consisting of methacryloxypropyl trimethoxysilane, zirconium propoxide and 50 mol% DMAEMA, (ii) a hybrid material comprising methacryloxypropyl trimethoxysilane and zirconium propoxide, and (iii) a purely organic polyDMAEMA. Our results show a strong adhesion of BM-MSCs onto the hybrid material containing 50% DMAEMA from the first 2 h after seeding, and up to several days, and a proliferation increase after 14 and 21 days, similar to the polystyrene control, independent of cell donor. These findings support the potential use of our proposed cell material combination in bone tissue engineering. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Chatzinikolaidou, Maria; Vamvakaki, Maria] Univ Crete, Dept Mat Sci & Technol, GR-71003 Iraklion, Greece.
   [Pontikoglou, Charalampos; Papadaki, Helen] Univ Crete, Sch Med, Hematol Lab, GR-71003 Iraklion, Greece.
   [Chatzinikolaidou, Maria; Rekstyte, Sima; Danilevicius, Paulius; Farsari, Maria; Vamvakaki, Maria] Fdn Res & Technol Hellas FORTH, Inst Elect Struct & Laser, Iraklion, Greece.
RP Chatzinikolaidou, M (reprint author), Univ Crete, Dept Mat Sci & Technol, POB 2208, GR-71003 Iraklion, Greece.
EM mchatzin@materials.uoc.gr
RI Farsari, Maria/B-3767-2011
OI Farsari, Maria/0000-0003-2435-4156
FU Special Account for Research Fund of the University of Crete [3090];
   THALIS 3DSET Program of the Hellenic Ministry of Education [MIS380278];
   FP7 Marie Curie ITN program TopBio [PITN-GA-2010-264362]
FX This work was partly funded by the Special Account for Research Fund of
   the University of Crete (3090) and by the THALIS 3DSET Program
   (MIS380278) of the Hellenic Ministry of Education. PD and MF acknowledge
   financial support from the FP7 Marie Curie ITN program TopBio
   (PITN-GA-2010-264362). Konstantina Terzaki is acknowledged for the block
   structures, Maria Kissamitaki for the thin films preparation, and Prof.
   Pavlos Katonis is acknowledged for the donation of the bone marrow
   tissues. We would also like to thank Ms. Alexandra Siakouli for expert
   technical assistance with SEM.
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Christenson EM, 2007, J ORTHOP RES, V25, P11, DOI 10.1002/jor.20305
   Danilevicius P, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.081405
   Delorme Bruno, 2007, V140, P67
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Gomez-Barrena E, 2011, J CELL MOL MED, V15, P1266, DOI 10.1111/j.1582-4934.2011.01265.x
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   HULBERT SF, 1971, FED PROC, V30, pA705
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Isaksson H, 2010, J BIOMECH, V43, P2410, DOI 10.1016/j.jbiomech.2010.04.017
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kastrinaki MC, 2008, ANN RHEUM DIS, V67, P741, DOI 10.1136/ard.2007.076174
   Kim K, 2011, BIOMATERIALS, V32, P3750, DOI 10.1016/j.biomaterials.2011.01.016
   Klein F, 2011, ADV MATER, V23, P1341, DOI 10.1002/adma.201004060
   Koller MR, 1996, EXP HEMATOL, V24, P1484
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   Maruo S, 2008, LASER PHOTONICS REV, V2, P100, DOI 10.1002/lpor.200710039
   Melissinaki V, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/4/045005
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Oyen ML, 2009, J MECH BEHAV BIOMED, V2, P396, DOI 10.1016/j.jmbbm.2008.10.002
   Pontikoglou C, 2008, REGEN MED, V3, P731, DOI 10.2217/17460751.3.5.731
   Pontikoglou C, 2013, STEM CELLS DEV, V22, P1329, DOI 10.1089/scd.2012.0255
   Pountos I, 2005, INJURY, V36, P8, DOI 10.1016/j.injury.2005.07.028
   Raimondi MT, 2012, J APPL BIOMATER FUNC, V10, P56, DOI 10.5301/JABFM.2012.9278
   Ritschdorff ET, 2010, ANAL CHEM, V82, P8733, DOI 10.1021/ac101274u
   Sakellari I, 2010, APPL PHYS A-MATER, V100, P359, DOI 10.1007/s00339-010-5864-0
   Sakellari I, 2012, ACS NANO, V6, P2302, DOI 10.1021/nn204454c
   Seidlits SK, 2009, ADV FUNCT MATER, V19, P3543, DOI 10.1002/adfm.200901115
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Skarmoutsou A, 2013, J MECH BEHAV BIOMED, V25, P48, DOI 10.1016/j.jmbbm.2013.05.003
   Skoog SA, 2014, BIOINTERPHASES, V9, DOI 10.1116/1.4873688
   Story BJ, 1998, INT J ORAL MAX IMPL, V13, P749
   Sun W, 2004, BIOTECHNOL APPL BIOC, V39, P29, DOI 10.1042/BA20030108
   Terzaki K, 2013, J BIOMED MATER RES A, V101, P2283, DOI 10.1002/jbm.a.34516
   Terzaki K, 2011, OPT MATER EXPRESS, V1, P586, DOI 10.1364/OME.1.000586
   Torgersen J, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.105008
   Turunen S, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/4/045002
   Undale AH, 2009, MAYO CLIN PROC, V84, P893, DOI 10.1016/S0025-6196(11)60506-5
   Vasilantonakis N, 2012, ADV MATER, V24, P1101, DOI 10.1002/adma.201104778
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
NR 41
TC 18
Z9 18
U1 1
U2 64
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2015
VL 48
BP 301
EP 309
DI 10.1016/j.msec.2014.12.007
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CA2PE
UT WOS:000348749200039
PM 25579927
DA 2018-10-19
ER

PT J
AU Pardun, K
   Treccani, L
   Volkmann, E
   Streckbein, P
   Heiss, C
   Li Destri, G
   Marietta, G
   Rezwan, K
AF Pardun, Karoline
   Treccani, Laura
   Volkmann, Eike
   Streckbein, Philipp
   Heiss, Christian
   Li Destri, Giovanni
   Marietta, Giovanni
   Rezwan, Kurosch
TI Mixed zirconia calcium phosphate coatings for dental implants: Tailoring
   coating stability and bioactivity potential
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Calcium phosphate; Zirconia; Coating stability; Bioactivity;
   Dissolution; Cellular biocompatibility
ID OSTEOBLAST-LIKE CELLS; SIMULATED BODY-FLUID; MECHANICAL-PROPERTIES;
   TITANIUM-ALLOYS; HYDROXYAPATITE COATINGS; ADHESION; ROUGHNESS; CERAMICS;
   BIOCERAMICS; BIOMATERIAL
AB Enhanced coating stability and adhesion are essential for long-term success of orthopedic and dental implants. In this study, the effect of coating composition on mechanical, physico-chemical and biological properties of coated zirconia specimens is investigated. Zirconia discs and dental screw implants are coated using the wet powder spraying (WPS) technique. The coatings are obtained by mixing yttria-stabilized zirconia (TZ) and hydroxyapatite (HA) in various ratios while a pure HA coating served as reference material. Scanning electron microscopy (SEM) and optical profilometer analysis confirm a similar coating morphology and roughness for all studied coatings, whereas the coating stability can be tailored with composition and is probed by insertion and dissections experiments in bovine bone with coated zirconia screw implants. An increasing content of calcium phosphate (CP) resulted in a decrease of mechanical and chemical stability, while the bioactivity increased in simulated body fluid (SBF). In vitro experiments with human osteoblast cells (HOB) revealed that the cells grew well on all samples but are affected by dissolution behavior of the studied coatings. This work demonstrates the overall good mechanical strength, the excellent interfacial bonding and the bioactivity potential of coatings with higher TZ contents, which provide a highly interesting coating for dental implants. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Pardun, Karoline; Treccani, Laura; Volkmann, Eike; Rezwan, Kurosch] Univ Bremen, D-28359 Bremen, Germany.
   [Streckbein, Philipp] Univ Giessen, Univ Hosp, Dept Craniomaxillofacial Surg, D-35385 Giessen, Germany.
   [Heiss, Christian] Univ Hosp Giessen Marburg, Dept Trauma Surg, D-35385 Giessen, Germany.
   [Heiss, Christian] Expt Surg Lab, D-35392 Giessen, Germany.
   [Li Destri, Giovanni; Marietta, Giovanni] Univ Catania, Lab Mol Surfaces & Nanotechnol LAMSUN, Dept Chem, I-95125 Catania, Italy.
   [Li Destri, Giovanni; Marietta, Giovanni] CSGI, I-95125 Catania, Italy.
RP Treccani, L (reprint author), Biol Garten 2, D-28359 Bremen, Germany.
EM treccani@uni-bremen.de
RI Li Destri, Giovanni/C-8807-2012; Treccani, Laura/R-1725-2016; Rezwan,
   Kurosch/K-9451-2013; Marletta, Giovanni/F-3154-2012
OI Li Destri, Giovanni/0000-0001-6195-659X; Treccani,
   Laura/0000-0001-5365-9827; Rezwan, Kurosch/0000-0002-7318-1119;
   Marletta, Giovanni/0000-0002-6929-9499
FU Deutsche Forschungsgemeinschaft, DFG [RE 2735/7-1]
FX Authors would like to acknowledge financial support from the Deutsche
   Forschungsgemeinschaft, DFG (Grant No. RE 2735/7-1). We thank Petra
   Witte of Historical Geology-Palaeontology, University of Bremen for the
   performance of SEM and EDX analysis. We are also grateful to Martin
   Ellerhorst from BEGO Implant Systems for providing implant geometries
   and Andreas Reindl from Fraunhofer IFAM Bremen for preparation of
   zirconia implants, as well as Michael Teck for his help with
   experimental investigations.
CR Balasundaram G, 2007, J BIOMED MATER RES A, V80A, P602, DOI 10.1002/jbm.a.30954
   Barnes D, 2012, J MECH BEHAV BIOMED, V6, P128, DOI 10.1016/j.jmbbm.2011.10.010
   Borger A, 2002, J EUR CERAM SOC, V22, P1425, DOI 10.1016/S0955-2219(01)00458-7
   Borsari V, 2005, J BIOMED MATER RES B, V75B, P359, DOI 10.1002/jbm.b.30313
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Dorozhkin SV, 2013, J MATER SCI-MATER M, V24, P1335, DOI 10.1007/s10856-013-4898-1
   Fu L, 2002, J AM CERAM SOC, V85, P800
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Holthaus MG, 2012, ACTA BIOMATER, V8, P394, DOI 10.1016/j.actbio.2011.07.031
   Holthaus MG, 2013, J BIOMATER APPL, V27, P791, DOI 10.1177/0885328211426354
   IOKU K, 1990, BIOMATERIALS, V11, P57, DOI 10.1016/0142-9612(90)90053-S
   Izquierdo-Barba I, 2006, ACTA BIOMATER, V2, P445, DOI 10.1016/j.actbio.2006.02.002
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Kim HW, 2004, J BIOMED MATER RES A, V68A, P522, DOI 10.1002/jbm.a..20094
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   LHERMITTESEBIRE I, 1986, THIN SOLID FILMS, V138, P221, DOI 10.1016/0040-6090(86)90395-0
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Matsumoto TJ, 2011, DENT MATER, V27, pE205, DOI 10.1016/j.dental.2011.07.009
   Mohseni E, 2014, INT J ADHES ADHES, V48, P238, DOI 10.1016/j.ijadhadh.2013.09.030
   Montanaro L, 2002, BIOMATERIALS, V23, P3651, DOI 10.1016/S0142-9612(02)00098-4
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Pardun K, 2015, CLIN IMPLANT DENT R, V17, P186, DOI 10.1111/cid.12071
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Reinhardt B, 2014, ADVANCED CERAMICS FOR DENTISTRY, P51, DOI 10.1016/B978-0-12-394619-5.00004-3
   RUDER A, 1992, SURF COAT TECH, V53, P71, DOI 10.1016/0257-8972(92)90105-J
   Stefanic M, 2014, J MATER SCI-MATER M, V25, P2333, DOI 10.1007/s10856-014-5246-9
   Stefanic M, 2013, J EUR CERAM SOC, V33, P3455, DOI 10.1016/j.jeurceramsoc.2013.05.015
   Tang Q, 2010, J MATER SCI-MATER M, V21, P173, DOI 10.1007/s10856-009-3841-y
   Tschernitschek H, 2005, QUINTESSENCE INT, V36, P523
   Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7
   WHITE EM, 1983, AM ANTIQUITY, V48, P316, DOI 10.2307/280453
   Wu CT, 2008, ACTA BIOMATER, V4, P569, DOI 10.1016/j.actbio.2007.11.005
   Yang JZ, 2011, J EUR CERAM SOC, V31, P2065, DOI 10.1016/j.jeurceramsoc.2011.05.025
   Yugeswaran S, 2012, J MECH BEHAV BIOMED, V9, P22, DOI 10.1016/j.jmbbm.2011.11.002
   Zhang JX, 2006, J AM CERAM SOC, V89, P3348, DOI 10.1111/j.1551-2916.2006.01237.x
NR 36
TC 17
Z9 17
U1 3
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2015
VL 48
BP 337
EP 346
DI 10.1016/j.msec.2014.12.031
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CA2PE
UT WOS:000348749200043
PM 25579931
DA 2018-10-19
ER

PT J
AU Almeida, JC
   Lancastre, J
   Fernandes, MHV
   Margaca, FMA
   Ferreira, L
   Salvado, IMM
AF Carlos Almeida, J.
   Lancastre, Joana
   Helena Vaz Fernandes, M.
   Margaca, Fernanda M. A.
   Ferreira, Luis
   Miranda Salvado, Isabel M.
TI Evaluating structural and microstructural changes of PDMS-SiO2 hybrid
   materials after sterilization by gamma irradiation
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Sterilization; Gamma irradiation; Hybrid materials; Structure;
   Microstructure
ID MODIFIED CAO-SIO2-TIO2 HYBRIDS; NUCLEAR-MAGNETIC-RESONANCE; SI-29 NMR;
   IN-VITRO; FT-IR; SILOXANE; POLYDIMETHYLSILOXANE; NANOCOMPOSITES;
   HYDROLYSIS; TEOS
AB PDMS-SiO2 hybrid materials obtained by sol-gel process have been extensively studied over the past years due to its promising biomedical applications namely as bone substitutes, catheters, and drug delivery devices. Regardless of the intended biomedical application, all these materials should go through a sterilization process before interfacing with a living structure. However, it is unclear whether they undergo structural and microstructural changes when subjected to sterilization by gamma irradiation. This paper addresses this issue by showing that a sol-gel processed biomaterial based on the PDMS-CaO-SiO2 hybrid system suffers only small structural changes when submitted to a radiation dose of 25 kGy, the dose usually recommended to achieve a Sterility Assurance Level of 10(-6) when the natural contamination level and microorganism types cannot be calculated. The characterization was assessed by FT-IR, Si-29-{H-1} CP-MAS, thermal analysis (DTG), and SEM. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Carlos Almeida, J.; Helena Vaz Fernandes, M.; Miranda Salvado, Isabel M.] Univ Aveiro, Dept Mat & Ceram Engn, CICECO, P-3810193 Aveiro, Portugal.
   [Lancastre, Joana; Margaca, Fernanda M. A.; Ferreira, Luis] Univ Lisbon, IST, P-268695 Sacavem, Portugal.
RP Salvado, IMM (reprint author), Univ Aveiro, Dept Mat & Ceram Engn, CICECO, P-3810193 Aveiro, Portugal.
EM isabelmsalvado@ua.pt
RI Almeida, Jose/H-1629-2011; Margaca, Fernanda/J-6938-2013
OI Almeida, Jose/0000-0003-1552-9532; Margaca,
   Fernanda/0000-0002-3452-1870; V Fernandes, Maria
   Helena/0000-0002-1240-2512; Salvado, Isabel/0000-0003-0265-4553
FU FEDER funds (Program COMPETE); FCT [PTDC/CTM/101115/2008]; CICECO
   [Pest-C/CTM/LA0011/2013];  [SFRH/BD/72074/2010]; 
   [RECI/AAG-TEC/0400/2012]
FX This work is financed by FEDER funds (Program COMPETE) and by FCT funds,
   on the project PTDC/CTM/101115/2008 and by the grants SFRH/BD/72074/2010
   and RECI/AAG-TEC/0400/2012. We also acknowledge the program financing
   CICECO, Pest-C/CTM/LA0011/2013.
CR Aguiar H, 2009, J NON-CRYST SOLIDS, V355, P475, DOI 10.1016/j.jnoncrysol.2009.01.010
   Almeida JC, 2014, MATER CHEM PHYS, V143, P557, DOI 10.1016/j.matchemphys.2013.09.032
   Babonneau F, 2000, POLYHEDRON, V19, P315, DOI 10.1016/S0277-5387(99)00361-7
   BABONNEAU F, 1994, POLYHEDRON, V13, P1123, DOI 10.1016/S0277-5387(00)80249-1
   BABONNEAU F, 1993, MAT RES S C, V286, P289
   Babonneau F, 1989, CHEM MATER, V1, P554
   Babonneau F, 2010, CR CHIM, V13, P58, DOI 10.1016/j.crci.2009.08.001
   Camino G, 2002, POLYMER, V43, P2011, DOI 10.1016/S0032-3861(01)00785-6
   Almeida JC, 2014, MATER LETT, V128, P105, DOI 10.1016/j.matlet.2014.04.135
   Castro AGB, 2012, MATER LETT, V88, P12, DOI 10.1016/j.matlet.2012.08.022
   Chen Q, 2000, J SOL-GEL SCI TECHN, V19, P101, DOI 10.1023/A:1008774524468
   Chen Q, 1999, BIOMATERIALS, V20, P1127, DOI 10.1016/S0142-9612(99)00015-0
   Czarnobaj K, 2011, POLYM BULL, V66, P223, DOI 10.1007/s00289-010-0332-8
   de Monredon-Senani S, 2009, J SOL-GEL SCI TECHN, V50, P152, DOI 10.1007/s10971-009-1920-7
   Deng ZY, 2014, J MATER CHEM A, V2, P4178, DOI 10.1039/c3ta14942k
   Elvira MR, 2013, J CHEM CHEM ENG, V7, P120
   Fernandez MR, 2010, COLLOID SURFACE B, V81, P289, DOI 10.1016/j.colsurfb.2010.07.018
   GLASER RH, 1989, J NON-CRYST SOLIDS, V113, P73, DOI 10.1016/0022-3093(89)90320-7
   Gomes SR, 2006, NUCL INSTRUM METH B, V248, P291, DOI 10.1016/j.nimb.2006.04.070
   Hasegawa I, 1999, APPL ORGANOMET CHEM, V13, P273, DOI 10.1002/(SICI)1099-0739(199904)13:4<273::AID-AOC840>3.0.CO;2-D
   HASEGAWA I, 1994, MATER RES SOC SYMP P, V346, P163
   IAEA, 2008, TRENDS RAD STER HLTH
   Julian B, 2003, CHEM MATER, V15, P3026, DOI 10.1021/cm031054l
   Kataoka K, 2005, BIOMATERIALS, V26, P2509, DOI 10.1016/j.biomaterials.2004.07.012
   Lancastre JJH, 2012, RADIAT PHYS CHEM, V81, P1336, DOI 10.1016/j.radphyschem.2012.02.016
   Lin S, 2009, J MATER CHEM, V19, P1276, DOI 10.1039/b814292k
   Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984
   MILLER AA, 1960, J AM CHEM SOC, V82, P3519, DOI 10.1021/ja01499a011
   Nguyen Huynh, 2007, Cell and Tissue Banking, V8, P81, DOI 10.1007/s10561-006-9019-7
   Ortega J, 2000, FLUID PHASE EQUILIBR, V170, P87, DOI 10.1016/S0378-3812(00)00317-4
   Prokopowicz M, 2012, COLLOID SURFACE B, V93, P249, DOI 10.1016/j.colsurfb.2012.01.020
   Rubio F, 1998, SPECTROSC LETT, V31, P199, DOI 10.1080/00387019808006772
   Sanchez C, 2005, J MATER CHEM, V15, P3559, DOI 10.1039/b509097k
   Tellez L, 2004, SPECTROSC LETT, V37, P11, DOI 10.1081/SL-120028420
   Tsuru K, 1997, J MATER SCI-MATER M, V8, P157, DOI 10.1023/A:1018523203667
   Vallet-Regi M, 2011, CHEM SOC REV, V40, P596, DOI 10.1039/c0cs00025f
   vonRecum AF, 1999, HDB BIOMATERIALS EVA
   Williams IR, 1998, CLIN ORTHOP RELAT R, P170
   Yamashita T, 2011, CELL TRANSPLANT, V20, P95, DOI 10.3727/096368910X532800
   Zhang HZ, 2007, BRAIN RES, V1132, P29, DOI 10.1016/j.brainres.2006.09.117
   Zheludkevich ML, 2005, J MATER CHEM, V15, P5099, DOI 10.1039/b419153f
NR 41
TC 4
Z9 4
U1 3
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2015
VL 48
BP 354
EP 358
DI 10.1016/j.msec.2014.12.025
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA CA2PE
UT WOS:000348749200045
PM 25579933
OA Bronze
DA 2018-10-19
ER

PT J
AU Matsui, N
   Nozaki, K
   Ishihara, K
   Yamashita, K
   Nagai, A
AF Matsui, Natsuno
   Nozaki, Kosuke
   Ishihara, Kazuhiko
   Yamashita, Kimihiro
   Nagai, Akiko
TI Concentration-dependent effects of fibronectin adsorbed on
   hydroxyapatite surfaces on osteoblast adhesion
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Hydroxyapatite; Fibronectin; AFM; QCM-D; Concentration effect
ID HUMAN PLASMA FIBRONECTIN; ELECTRICALLY POLARIZED HYDROXYAPATITE;
   CELL-ADHESION; PROTEIN ADSORPTION; MULTILAYER FILMS; QCM-D; ATTACHMENT;
   DOMAIN; INTEGRINS; BINDING
AB Fibronectin (Fn) is an essential protein that is involved in cell attachment, migration, and differentiation. It is known that the conformation of Fn changes depending on its surrounding environment or on the surface properties of the substrate to which it is adsorbed. Here, we show that Fn adopts different conformations in physiological solutions and can play different roles in osteoblast adhesion on hydroxyapatite (HAp) depending on its concentration. The results of in situ observations showed that the adsorption configuration of Fn was an oblate ellipsoidal structure at low concentrations and a fibrillar structure at high concentrations, suggesting that individual Fn molecules attach to HAp with a side-on or end-on orientation, under low and high concentrations, respectively. Osteoblasts adhered more to the HAp surface under low concentrations of adsorbed Fn than under high concentrations. These observations suggest that the Fn concentration gradient is important for regulating biomaterial-cell interactions in regenerative medicine. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Matsui, Natsuno; Nozaki, Kosuke; Yamashita, Kimihiro; Nagai, Akiko] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
   [Ishihara, Kazuhiko] Univ Tokyo, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan.
RP Nagai, A (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM nag-bcr@tmd.ac.jp
FU JSPS [23500540]
FX We thank Dr. Yusuke Tsutsumi and Prof. Takao Hanawa for technical advice
   on the use of the AFM. This work was supported by Grants-in-Aid for
   Scientific Research (C) (23500540) from JSPS.
CR Ballet T, 2010, B POL ACAD SCI-TECH, V58, P303, DOI 10.2478/v10175-010-0028-0
   Benazeraf B, 2010, NATURE, V466, P248, DOI 10.1038/nature09151
   Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423
   Cairns ML, 2010, COLLOID SURFACE B, V78, P283, DOI 10.1016/j.colsurfb.2010.03.013
   Hemmersam AG, 2008, J COLLOID INTERF SCI, V320, P110, DOI 10.1016/j.jcis.2007.11.047
   Hook H., 2002, COLLOID SURFACE B, V24, P155
   Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473
   Kaselowsky B.G., 2003, J BIOMED MATER RES A, V66, P247
   Kobayashi T, 2001, J BIOMED MATER RES, V57, P477, DOI 10.1002/1097-4636(20011215)57:4<477::AID-JBM1193>3.0.CO;2-5
   Kowalczynska HM, 2005, J BIOMED MATER RES A, V72A, P228, DOI 10.1002/jbm.a.30238
   LAI CS, 1993, J MOL BIOL, V230, P625, DOI 10.1006/jmbi.1993.1174
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Liem KF, 2000, DEVELOPMENT, V127, P4855
   Llopis-Hernandez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019610
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   MCDONALD JA, 1987, J BIOL CHEM, V262, P2957
   Miyamoto S, 1998, ANN NY ACAD SCI, V857, P119, DOI 10.1111/j.1749-6632.1998.tb10112.x
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Ngankam AP, 2004, LANGMUIR, V20, P3362, DOI 10.1021/la035479y
   Ohba S, 2012, ACTA BIOMATER, V8, P2778, DOI 10.1016/j.actbio.2012.04.015
   PEARLSTEIN E, 1978, INT J CANCER, V22, P32, DOI 10.1002/ijc.2910220108
   Pellenc D, 2006, J COLLOID INTERF SCI, V298, P132, DOI 10.1016/j.jcis.2005.11.059
   Pirouz A.D., 2009, LANGMUIR, V25, P2971
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Sousa SR, 2007, LANGMUIR, V23, P7046, DOI 10.1021/la062956e
   Tagaya M, 2011, LANGMUIR, V27, P7635, DOI 10.1021/la200008z
   Talbot J, 2000, COLLOID SURFACE A, V165, P287, DOI 10.1016/S0927-7757(99)00409-4
   UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039
   Vadillo-Rodriguez V, 2013, LANGMUIR, V29, P8554, DOI 10.1021/la401776e
   Watarai E, 2012, SENSOR ACTUAT B-CHEM, V171, P1297, DOI 10.1016/j.snb.2012.05.010
   WILLIAMS EC, 1982, J BIOL CHEM, V257, P4973
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
NR 33
TC 8
Z9 8
U1 2
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2015
VL 48
BP 378
EP 383
DI 10.1016/j.msec.2014.12.042
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA CA2PE
UT WOS:000348749200049
PM 25579937
DA 2018-10-19
ER

PT J
AU Shah, DU
   Vollrath, F
   Stires, J
   Deheyn, DD
AF Shah, Darshil U.
   Vollrath, Fritz
   Stires, John
   Deheyn, Dimitri D.
TI The biocomposite tube of a chaetopterid marine worm constructed with
   highly-controlled orientation of nanofilaments
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biological composites; Parchment biomaterial; Ultrastructural
   organisation; Chaetopterus; Marine polychaete; Tube housing; Composite
   pipes and tanks
ID VARIOPEDATUS RENIER; WINDING ANGLE; POLYCHAETA; PIPES; BIOMECHANICS;
   BEHAVIOR
AB The ultrastructure of the self-constructed tube housing of the bioluminescent marine worm, Chaetopterus sp. reveals that the bio-nanocomposite tube comprises of multiple non-woven plies of multi-axially oriented organic nanofilaments (empty set 50-1100 nm) cemented together by an unstructured organic matrix binder. The thin-walled, impermeable tubes are bin-inspirational for conventional pipe technology. Orientation distribution analyses revealed that the dominant orientation angles of nanofilaments in the tube were 0 degrees, +/- 45 degrees and +/- 65 degrees, which correlate well with optimal winding angles for 'man-made' fibre reinforced composite pipes subjected to specific loading conditions. Such a use of high aspect ratio nanofilaments in multi-axial laminates would impart toughness and flexibility to the tube structure, and facilitate rapid tube growth. While the tube production mechanism is not entirely known at this stage, our time-lapse studies show that, contrary to generic assumptions in literature, the worm actively, rapidly and sporadically produces and expands the tube. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Shah, Darshil U.; Vollrath, Fritz] Univ Oxford, Dept Zool, Oxford Silk Grp, Oxford OX1 3PS, England.
   [Stires, John; Deheyn, Dimitri D.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.
RP Shah, DU (reprint author), Univ Oxford, Dept Zool, Oxford Silk Grp, South Pk Rd, Oxford OX1 3PS, England.
EM darshil.shah@zoo.ox.ac.uk; ddeheyn@ucsd.edu
OI Shah, Darshil/0000-0002-8078-6802
FU US Air Force Office for Scientific Research (AFOSR) [F49620-03-1-0111,
   FA9550-10-1-0112]; European Research Council [SP2-GA-2008-233409]
FX We are grateful to Phil Zerofski, marine collector at SIO, who kept a
   constant supply of the tube worms. We thank the US Air Force Office for
   Scientific Research (AFOSR Grant Number F49620-03-1-0111 to F.V. and
   FA9550-10-1-0112 to D.D.D.) and the European Research Council advanced
   Grant (SP2-GA-2008-233409) to F.V. for the generous funding.
CR BARNES RD, 1965, BIOL BULL, V129, P217, DOI 10.2307/1539840
   Bhaud MR, 1998, SARSIA, V83, P243, DOI 10.1080/00364827.1998.10413685
   BROWN SC, 1971, TISSUE CELL, V3, P65, DOI 10.1016/S0040-8166(71)80031-9
   BROWN SC, 1975, BIOL BULL-US, V149, P136, DOI 10.2307/1540485
   BROWN SC, 1978, ANIM BEHAV, V26, P160, DOI 10.1016/0003-3472(78)90015-5
   BROWN SC, 1977, BIOL BULL, V153, P121, DOI 10.2307/1540696
   Chen F, 2010, J MAT SCI ENG, V4, P28
   Chen FJ, 2012, MAT SCI ENG C-MATER, V32, P772, DOI 10.1016/j.msec.2012.01.023
   Costa Maria Angélica Martins, 2005, Mat. Res., V8, P177, DOI 10.1590/S1516-14392005000200016
   Dales R. P., 1969, CHEM ZOOLOGY, V4
   Deheyn DD, 2013, PHYSIOL BIOCHEM ZOOL, V86, P702, DOI 10.1086/673869
   Dill LM, 1997, BEHAV ECOL, V8, P186, DOI 10.1093/beheco/8.2.186
   DIXON DR, 1980, J MAR BIOL ASSOC UK, V60, P655, DOI 10.1017/S0025315400040340
   Ehrlich H, 2010, BIOL INSPIR SYST, V1, P465, DOI 10.1007/978-90-481-9130-7_34
   Enders H., 1907, P INDIANA ACAD SCI, P128
   FLOOD PR, 1982, MAR BIOL, V72, P27, DOI 10.1007/BF00393944
   Hickman C.J., 2001, INTEGRATED PRINCIPLE, P362
   Kiel S, 2009, ACTA PALAEONTOL POL, V54, P443, DOI 10.4202/app.2009.0022
   Liu DHF, 1997, ENV ENG HDB
   Macginitie GE, 1939, BIOL BULL-US, V77, P115, DOI 10.2307/1537850
   Majid MSA, 2013, ADV MATER RES-SWITZ, V795, P424, DOI 10.4028/www.scientific.net/AMR.795.424
   MISTRY J, 1992, COMPOS STRUCT, V20, P83, DOI 10.1016/0263-8223(92)90064-J
   Performance Composites Ltd, 2009, FIL WIND CARB FIBR A
   Reddy P., 2012, INT J ENG RES TECHNO, V1, P1
   Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z
   ROSENOW MWK, 1984, COMPOSITES, V15, P144, DOI 10.1016/0010-4361(84)90727-4
   Schnelle K. B., 2001, AIR POLLUTION CONTRO
   Shah DU, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0525
   Shillito Bruce, 1995, Geological Society Special Publication, V87, P295, DOI 10.1144/GSL.SP.1995.087.01.22
   SPENCER B, 1978, COMPOSITES, V9, P263, DOI 10.1016/0010-4361(78)90180-5
   Thompson ML, 2001, LIMNOL OCEANOGR, V46, P1899, DOI 10.4319/lo.2001.46.8.1899
   Vinn O, 2008, ZOOL J LINN SOC-LOND, V154, P633, DOI 10.1111/j.1096-3642.2008.00421.x
NR 32
TC 3
Z9 3
U1 2
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2015
VL 48
BP 408
EP 415
DI 10.1016/j.msec.2014.12.015
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA CA2PE
UT WOS:000348749200053
PM 25579941
DA 2018-10-19
ER

PT J
AU Basile, MA
   d'Ayala, GG
   Malinconico, M
   Laurienzo, P
   Coudane, J
   Nottelet, B
   Della Ragione, F
   Oliva, A
AF Basile, Maria Assunta
   d'Ayala, Giovanna Gomez
   Malinconico, Mario
   Laurienzo, Paola
   Coudane, Jean
   Nottelet, Benjamin
   Della Ragione, Fulvio
   Oliva, Adriana
TI Functionalized PCL/HA nanocomposites as microporous membranes for bone
   regeneration
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Poly(epsilon-caprolactone); Functionalization of polymers;
   Nanocomposites; Membranes; Biocompatibility; Guided tissue regeneration
ID SOL-GEL PROCESS; EPSILON-CAPROLACTONE; ALIPHATIC POLYESTERS; TISSUE
   REGENERATION; NANOPHASE CERAMICS; STEM-CELLS; IN-VITRO; DEGRADATION;
   POLY(EPSILON-CAPROLACTONE); COMPOSITES
AB In the present work, microporous membranes based on poly(epsilon-caprolactone) (PCL) and PCL functionalized with amine (PCL-DMAEA) or anhydride groups (PCL-MAGMA) were realized by solvent-non solvent phase inversion and proposed for use in Guided Tissue Regeneration (GTR). Nanowhiskers of hydroxyapatite (HA) were also incorporated in the polymer matrix to realize nanocomposite membranes. Scanning Electron Microscopy (SEM) showed improved interfacial adhesion with HA for functionalized polymers, and highlighted substantial differences in the porosity. A relationship between the developed porous structure of the membrane and the chemical nature of grafted groups was proposed. Compared to virgin PCL, hydrophilicity increases for functionalized PCL, while the addition of HA influences significantly the hydrophilic characteristics only in the case of virgin polymer. A significant increase of in vitro degradation rate was found for PCL-MAGMA based membranes, and at lower extent of PCL-DMAEA membranes. The novel materials were investigated regarding their potential as support for cell growth in bone repair using multipotent mesenchymal stromal cells (MSC) as a model. MSC plated onto the various membranes were analyzed in terms of adhesion, proliferation and osteogenic capacity that resulted to be related to chemical as well as porous structure. In particular, PCL-DMAEA and the relative nanocomposite membranes are the most promising in terms of cell-biomaterial interactions. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Basile, Maria Assunta; d'Ayala, Giovanna Gomez; Malinconico, Mario; Laurienzo, Paola] CNR, Inst Polymers Composites & Biomat, I-80125 Naples, Italy.
   [Coudane, Jean; Nottelet, Benjamin] Univ Montpellier I, Inst Biomol Max Mousseron, Artificial Biopolymers Grp, CNRS UMR 5247,Fac Pharm, F-34093 Montpellier, France.
   [Della Ragione, Fulvio; Oliva, Adriana] Univ Naples 2, Dept Biochem & Biophys, Naples, Italy.
RP Laurienzo, P (reprint author), CNR, Inst Polymers Composites & Biomat, Via Campi Flegrei 34, I-80125 Naples, Italy.
EM paola.laurienzo@ipcb.cnr.it; adriana.oliva@unina2.it
OI Della Ragione, Fulvio/0000-0002-0592-4283
CR Aslan S, 2000, J MATER SCI, V35, P1615, DOI 10.1023/A:1004787326273
   Barra GMO, 1999, J BRAZIL CHEM SOC, V10, P31, DOI 10.1590/S0103-50531999000100006
   Basile MA, 2012, J APPL BIOMATER FUNC, V10, P210, DOI 10.5301/JABFM.2012.10374
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   CABASSO I, 1979, J APPL POLYM SCI, V23, P2967, DOI 10.1002/app.1979.070231016
   Calandrelli L, 2004, J BIOACT COMPAT POL, V19, P301, DOI 10.1177/0883911504045234
   Chen BQ, 2005, POLYM TEST, V24, P978, DOI 10.1016/j.polymertesting.2005.07.013
   Coombes AGA, 2004, BIOMATERIALS, V25, P315, DOI 10.1016/S0142-9612(03)00535-0
   d'Ayala GG, 2009, EUR POLYM J, V45, P3215, DOI 10.1016/j.eurpolymj.2009.07.021
   Dorj B, 2013, J BIOMED MATER RES A, V101, P1670, DOI 10.1002/jbm.a.34470
   Fabbri P, 2010, J MATER SCI-MATER M, V21, P343, DOI 10.1007/s10856-009-3839-5
   Fu SZ, 2010, J NANOSCI NANOTECHNO, V10, P711, DOI 10.1166/jnn.2010.1888
   Garcia-Martinez JM, 1999, J APPL POLYM SCI, V73, P2837, DOI 10.1002/(SICI)1097-4628(19990929)73:14<2837::AID-APP6>3.0.CO;2-2
   Gentile P, 2011, BIOTECHNOL J, V6, P1187, DOI 10.1002/biot.201100294
   Hong H, 2007, COMPOS PART B-ENG, V38, P311, DOI 10.1016/j.compositesb.2006.05.005
   Huang MH, 2004, POLYMER, V45, P8675, DOI 10.1016/j.polymer.2004.10.054
   Huang MH, 2004, J BIOMED MATER RES A, V69A, P417, DOI 10.1002/jbm.a.30008
   Huang MH, 2006, J APPL POLYM SCI, V102, P1681, DOI 10.1002/app.24196
   Ikada Y., 2006, TISSUE ENG FUNDAMENT
   Lanzetta V, 2007, J MATER CHEM, V17, P4508, DOI 10.1039/b708153g
   Laurienzo P, 2006, MACROMOL CHEM PHYSIC, V207, P1861, DOI 10.1002/macp.200600262
   Lei LJ, 2009, POLYM DEGRAD STABIL, V94, P1494, DOI 10.1016/j.polymdegradstab.2009.04.034
   Mauney JR, 2005, TISSUE ENG, V11, P787, DOI 10.1089/ten.2005.11.787
   Mayer U., 1993, CELLS MAT, V3, P129
   Mota J, 2012, ACTA BIOMATER, V8, P4173, DOI 10.1016/j.actbio.2012.06.040
   Natu MV, 2013, POLYM DEGRAD STABIL, V98, P44, DOI 10.1016/j.polymdegradstab.2012.10.030
   Oliva A, 2005, Int J Immunopathol Pharmacol, V18, P47
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   Rezaei A, 2013, MAT SCI ENG C-MATER, V33, P390, DOI 10.1016/j.msec.2012.09.004
   Rezaei A, 2012, TISSUE ENG REGEN MED, V9, P295, DOI 10.1007/s13770-012-0002-z
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Saltzman W. M., 2000, PRINCIPLES TISSUE EN, P221
   Sclavons M, 1996, J APPL POLYM SCI, V62, P1205, DOI 10.1002/(SICI)1097-4628(19961121)62:8<1205::AID-APP10>3.0.CO;2-6
   Sculean A, 2008, J CLIN PERIODONTOL, V35, P106, DOI 10.1111/j.1600-051X.2008.01263.x
   Shalaby W.S., 1994, ACS S SERIES
   Suming L., 1996, J CONTROL RELEASE, V40, P41
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   Vert M, 2005, BIOMACROMOLECULES, V6, P538, DOI 10.1021/bm0494702
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   XIANMIAO C, 2009, MAT SCI ENG C, V29, P29, DOI DOI 10.1016/J.MSEC.2008.05.008
   Xie XM, 2000, POLYM INT, V49, P1677, DOI 10.1002/1097-0126(200012)49:12<1677::AID-PI590>3.0.CO;2-0
   Xu HHK, 2004, BIOMATERIALS, V25, P4615, DOI 10.1016/j.biomaterials.2003.12.058
   Yoshioka T, 2010, POLYM ENG SCI, V50, P1895, DOI 10.1002/pen.21714
   Yubao L, 1994, J MATER SCI-MATER M, V5, P326
   Zhang Y., 2013, ANN ORAL MAXILLOFAC, V1, P1, DOI DOI 10.1007/S11365-012-0246-Z
   Zhao ZT, 2012, J APPL POLYM SCI, V125, P2502, DOI 10.1002/app.36355
NR 47
TC 13
Z9 14
U1 3
U2 63
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2015
VL 48
BP 457
EP 468
DI 10.1016/j.msec.2014.12.019
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA CA2PE
UT WOS:000348749200059
PM 25579947
DA 2018-10-19
ER

PT J
AU Cheng, J
   Huang, T
   Zheng, YF
AF Cheng, J.
   Huang, T.
   Zheng, Y. F.
TI Relatively uniform and accelerated degradation of pure iron coated with
   micro-patterned Au disc arrays
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Micro-patterned Au coating; Pure iron; Biodegradation
ID IMMERSION ION-IMPLANTATION; CELL VIABILITY; IN-VITRO; STENTS;
   BIOMATERIAL; DEPOSITION; ALLOYS; BIOCOMPATIBILITY; NANOPARTICLES;
   SURFACES
AB Pure iron has been proven to be a potential biodegradable metal, but its degradation rate was too slow. To accelerate its biodegradation, micro-patterned Au disc films were deposited on the surface of pure iron by vacuum sputtering. The influence of Au disc films on the degradation of pure iron matrix in vitro was investigated in the present study. Electrochemical measurement results indicated that the corrosion current density of pure iron coated with micro-patterned Au disc films in Hank's solution was 4 times larger than that of the uncoated one, while the difference between the influences of micro-patterned Au discs with different diameters on the corrosion rate of pure iron was insignificant. Immersion test indicated that the corrosion depth for pure iron coated with Au disc films was about three times as that of bare pure iron. Both electrochemical test and immersion test revealed that the corrosion of pure iron matrix coated with Au disc array became more uniform. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Cheng, J.; Zheng, Y. F.] Peking Univ, Acad Adv Interdisciplinary Studies, Ctr Biomed Mat & Tissue Engn, Beijing 100871, Peoples R China.
   [Huang, T.; Zheng, Y. F.] Peking Univ, Coll Engn, Dept Mat Sci & Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
RP Zheng, YF (reprint author), Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing 100871, Peoples R China.
EM yfzheng@pku.edu.cn
RI Zheng, Yufeng/A-4146-2010
OI Zheng, Yufeng/0000-0002-7402-9979
FU National Basic Research Program of China (973 Program) [2012CB619102,
   2012CB619100]; National Science Fund for Distinguished Young Scholars
   [51225101]; National Natural Science Foundation of China [51431002,
   31170909]; NSFC/RGC Joint Research Scheme in Mainland China
   [51361165101]; NSFC/RGC Joint Research Scheme in Hong Kong
   [N_CUHK449/13]; Beijing Municipal Science and Technology Project
   [Z131100005213002]; Project for Supervisor of Excellent Doctoral
   Dissertation of Beijing [20121000101]
FX This work was supported by the National Basic Research Program of China
   (973 Program) (Grant Nos. 2012CB619102 and 2012CB619100), National
   Science Fund for Distinguished Young Scholars (Grant No. 51225101),
   National Natural Science Foundation of China (Grant Nos. 51431002 and
   31170909), NSFC/RGC Joint Research Scheme under Grant Nos. 51361165101
   in Mainland China and N_CUHK449/13 in Hong Kong, Beijing Municipal
   Science and Technology Project (Z131100005213002) and Project for
   Supervisor of Excellent Doctoral Dissertation of Beijing (20121000101).
CR ALLEN BT, 1986, ANN SURG, V203, P318, DOI 10.1097/00000658-198603000-00019
   [Anonymous], 2004, ASTM BOOK STAND
   Chang E, 2002, BIOMATERIALS, V23, P2917, DOI 10.1016/S0142-9612(01)00420-3
   Cheng J, 2013, J BIOMED MATER RES B, V101B, P485, DOI 10.1002/jbm.b.32783
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063
   Garg S, 2010, J AM COLL CARDIOL, V56, pS43, DOI 10.1016/j.jacc.2010.06.008
   Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029
   Hermawan H, 2007, ADV MATER RES-SWITZ, V15-17, P107, DOI 10.4028/www.scientific.net/AMR.15-17.107
   Hermawan H, 2010, ACTA BIOMATER, V6, P1852, DOI 10.1016/j.actbio.2009.11.025
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Jing FJ, 2007, SURF COAT TECH, V201, P6874, DOI 10.1016/j.surfcoat.2006.09.088
   Kong G, 2000, CANCER RES, V60, P4440
   Koo H, 2011, ACCOUNTS CHEM RES, V44, P1018, DOI 10.1021/ar2000138
   Liu B, 2011, ACTA BIOMATER, V7, P1407, DOI 10.1016/j.actbio.2010.11.001
   Longmire M, 2008, NANOMEDICINE-UK, V3, P703, DOI 10.2217/17435889.3.5.703
   Milazzo G., 1978, J ELECTROCHEM SOC, V125, p261C
   Moravej M, 2010, ACTA BIOMATER, V6, P1843, DOI 10.1016/j.actbio.2010.01.008
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Nie FL, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/065015
   O'Brien B, 2009, ACTA BIOMATER, V5, P945, DOI 10.1016/j.actbio.2008.11.012
   Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Ricci JL, 2008, J BIOMED MATER RES A, V85A, P313, DOI 10.1002/jbm.a.31379
   Schinhammer M, 2010, ACTA BIOMATER, V6, P1705, DOI 10.1016/j.actbio.2009.07.039
   Schneider GB, 2003, J DENT RES, V82, P372, DOI 10.1177/154405910308200509
   Vanysek P., 2005, CRC HDB CHEM PHYS, P20
   Waksman R, 2008, J INTERV CARDIOL, V21, P15, DOI 10.1111/j.1540-8183.2007.00319.x
   Waksman Ron, 2006, J Interv Cardiol, V19, P414, DOI 10.1111/j.1540-8183.2006.00187.x
   Wang B., 2012, ACCOUNTS CHEM RES, V46, P761
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Zhang LM, 2013, BIOMATERIALS, V34, P7117, DOI 10.1016/j.biomaterials.2013.05.043
   Zhu SF, 2009, APPL SURF SCI, V256, P99, DOI 10.1016/j.apsusc.2009.07.082
   Zhu SF, 2009, SURF COAT TECH, V203, P1523, DOI 10.1016/j.surfcoat.2008.11.033
NR 35
TC 8
Z9 8
U1 3
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2015
VL 48
BP 679
EP 687
DI 10.1016/j.msec.2014.12.053
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CA2PE
UT WOS:000348749200083
PM 25579971
DA 2018-10-19
ER

PT J
AU Montes, R
   Bartroli, J
   Baeza, M
   Cespedes, F
AF Montes, R.
   Bartroli, J.
   Baeza, M.
   Cespedes, F.
TI Improvement of the detection limit for biosensors: Advances on the
   optimization of biocomposite composition
SO MICROCHEMICAL JOURNAL
LA English
DT Article
DE Amperometric biosensor; EIS; CV; Graphite-epoxy; GOD; (Bio)composite
ID NANOTUBE-EPOXY COMPOSITES; AMPEROMETRIC BIOSENSOR; L-LACTATE;
   ELECTRODES; GLUCOSE; MICROELECTRODES; PERCOLATION; SENSOR
AB In this work the application of advanced characterization techniques in the development of amperometric biosensors based on biocomposites is described. The optimization of the conductive particle distribution and the amount of the biological material inside the biomaterial have allowed an improvement of the electrochemical properties, regarding the electroanalytical properties such as signal stability and limit of detection. The high signal-to-noise ratio obtained in the electrochemical transduction has allowed enhancing the limit of detection of the biosensor. In the present study, it has been demonstrated the feasibility of electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV) for the characterization and optimization of biosensors based On graphite-epoxy-enzyme, using an enzyme model. The optimum biocomposite proportion based on graphite-epoxy which incorporates the enzyme glucose oxidase (GOD) on the matrix ranges between 16% and 17% of graphite using 1% and 2% of enzyme. This range provides the optimal electroanalytical properties. Low limit of detection and good sensitivity have been achieved. Furthermore, confocal laser scanning microscopy was used to visualize the enzyme distribution onto the surface electrode. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Montes, R.; Bartroli, J.; Baeza, M.; Cespedes, F.] Univ Autonoma Barcelona, Fac Ciencias, Dept Quim, Grp Sensors Biosensors, Cerdanyola Del Valles Be 08193, Bellaterra, Spain.
RP Baeza, M (reprint author), Univ Autonoma Barcelona, Fac Ciencias, Dept Quim, Grp Sensors Biosensors, Edifici C Nord, Cerdanyola Del Valles Be 08193, Bellaterra, Spain.
EM mariadelmar.baeza@uab.cat
RI Cespedes, Francisco/L-7435-2014; Baeza Labat, Maria del Mar/C-1577-2010;
   Bartroli Molins, Jordi/L-6019-2017; Montes Martinez, Raquel/J-9405-2017
OI Cespedes, Francisco/0000-0002-0296-6314; Baeza Labat, Maria del
   Mar/0000-0002-2240-6410; Montes Martinez, Raquel/0000-0001-8805-9987
FU Universitat Autonoma de Barcelona (UAB)
FX R. Montes thanks Universitat Autonoma de Barcelona (UAB) for the award
   of PIF studentship.
CR BAEZA M, 2011, RESIN COMPOS PROP PR, P153
   Barsan MM, 2009, BIOELECTROCHEMISTRY, V76, P135, DOI 10.1016/j.bioelechem.2009.03.004
   Bellido-Milla D, 2013, ANAL BIOANAL CHEM, V405, P3525, DOI 10.1007/s00216-013-6816-2
   Bojorge N, 2011, METAL, CERAMIC AND POLYMERIC COMPOSITES FOR VARIOUS USES, P597
   Caro-Jara N, 2013, ELECTROANAL, V25, P308, DOI 10.1002/elan.201200391
   Cespedes F, 2000, TRAC-TREND ANAL CHEM, V19, P276, DOI 10.1016/S0165-9936(99)00179-X
   Cespedes F, 1996, TRAC-TREND ANAL CHEM, V15, P296, DOI 10.1016/0165-9936(96)00042-8
   CESPEDES F, 1993, ANAL CHIM ACTA, V273, P409, DOI 10.1016/0003-2670(93)80184-M
   Esplandiu MJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/35/355502
   ESPLANDIU MJ, 2010, DEV TUNABLE NANOCOMP, pCH5
   Haccoun J, 2004, BIOSENS BIOELECTRON, V19, P1325, DOI 10.1016/j.bios.2003.11.006
   Hare D. O., 2002, ELECTROCHEM COMMUN, V4, P245
   Ibanez AB, 2008, ANAL LETT, V41, P1419, DOI 10.1080/00032710802119483
   Marzouk SAM, 1997, ANAL CHEM, V69, P2646, DOI 10.1021/ac970020s
   McCreery RL, 2008, CHEM REV, V108, P2646, DOI 10.1021/cr068076m
   Morales A, 1996, ANAL CHIM ACTA, V332, P131, DOI 10.1016/0003-2670(96)82793-0
   Numnuam A, 2014, ANAL BIOANAL CHEM, V406, P3763, DOI 10.1007/s00216-014-7770-3
   Olive-Monllau R, 2010, TALANTA, V81, P1593, DOI 10.1016/j.talanta.2010.03.008
   Olive-Monllau R, 2010, SENSOR ACTUAT B-CHEM, V146, P353, DOI 10.1016/j.snb.2010.02.017
   Olive-Monllau R, 2009, ELECTROANAL, V21, P931, DOI 10.1002/elan.200804494
   Pacios M, 2008, J ELECTROANAL CHEM, V619, P117, DOI 10.1016/j.jelechem.2008.03.019
   Palmisano F, 2000, BIOSENS BIOELECTRON, V15, P531, DOI 10.1016/S0956-5663(00)00107-X
   Parra A, 2006, ANAL CHIM ACTA, V555, P308, DOI 10.1016/j.aca.2005.09.025
   Perez B, 2005, J NANOSCI NANOTECHNO, V5, P1694, DOI 10.1166/jnn.2005.400
   Perez S, 2012, ELECTROANAL, V24, P967, DOI 10.1002/elan.201100628
   Pumera M, 2006, SENSOR ACTUAT B-CHEM, V113, P617, DOI 10.1016/j.snb.2005.07.010
   Ramirez-Garcia S, 2004, ANAL CHEM, V76, P503, DOI 10.1021/ac034536p
   Ramirez- Garcia S, 2002, ANALYST, V127, P1512, DOI 10.1039/b206201a
   Ramirez-Garcia S, 2001, ELECTROANAL, V13, P529, DOI 10.1002/1521-4109(200105)13:7<529::AID-ELAN529>3.0.CO;2-I
   Rassaei L, 2007, ELECTROANAL, V19, P1461, DOI 10.1002/elan.200703887
   Rubianes MD, 2005, ELECTROANAL, V17, P73, DOI 10.1002/elan.200403121
   Sadana A, 2011, HANDBOOK OF BIOSENSORS AND BIOSENSOR KINETICS, P1, DOI 10.1016/B978-0-444-53262-6.00001-2
   Sanchez S, 2007, BIOSENS BIOELECTRON, V23, P332, DOI 10.1016/j.bios.2007.04.021
   Stulik K, 2000, PURE APPL CHEM, V72, P1483, DOI 10.1351/pac200072081483
   Trijueque J, 1999, ELECTROCHIM ACTA, V45, P789, DOI 10.1016/S0013-4686(99)00257-1
   WANG J, 1993, ANAL LETT, V26, P1819, DOI 10.1080/00032719308017433
   Wang J, 2003, ANALYST, V128, P1382, DOI 10.1039/b309928h
   Wang J, 2001, ELECTROANAL, V13, P983, DOI 10.1002/1521-4109(200108)13:12<983::AID-ELAN983>3.0.CO;2-#
   WANG J, 2000, PRACTICAL CONSIDERAT, P100
   Zacco E, 2004, J IMMUNOL METHODS, V286, P35, DOI 10.1016/j.jim.2003.11.014
   Zhao H, 2008, J PHYS CHEM C, V112, P9351, DOI 10.1021/jp711366u
NR 41
TC 7
Z9 7
U1 2
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0026-265X
EI 1095-9149
J9 MICROCHEM J
JI Microchem J.
PD MAR
PY 2015
VL 119
BP 66
EP 74
DI 10.1016/j.microc.2014.11.004
PG 9
WC Chemistry, Analytical
SC Chemistry
GA CA5ON
UT WOS:000348957800011
DA 2018-10-19
ER

PT J
AU He, SY
   Shen, L
   Wu, YX
   Li, L
   Chen, W
   Hou, CL
   Yang, MC
   Zeng, W
   Zhu, CH
AF He, Siyi
   Shen, Lei
   Wu, Yangxiao
   Li, Li
   Chen, Wen
   Hou, Chunli
   Yang, Mingcan
   Zeng, Wen
   Zhu, Chuhong
TI Effect of Brain-Derived Neurotrophic Factor on Mesenchymal Stem
   Cell-Seeded Electrospinning Biomaterial for Treating Ischemic Diabetic
   Ulcers via Milieu-Dependent Differentiation Mechanism
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID IN-VITRO; ENDOTHELIAL-CELLS; STROMAL CELLS; ANGIOGENESIS; PROMOTE;
   DISEASE; GLUCOSE; GENE; VEGF; MICE
AB Great challenges in transplantation of mesenchymal stem cells (MSCs) for treating ischemic diabetic ulcers (IDUs) are to find a suitable carrier and create a beneficial microenvironment. Brain-derived neurotrophic factor (BDNF), a member of neurotrophin family, is considered angiogenic and neuroprotective. Given that IDUs are caused by vascular disease and peripheral neuropathy, we used BDNF as a stimulant, and intended to explore the role of new biomaterials complex with MSCs in wound healing. BDNF promoted the proliferation and migration of MSCs using MTT, transwell, and cell scratch assays. The activity of human umbilical vein endothelial cells (HUVECs) was also enhanced by the MSC-conditioned medium in the presence of BDNF, via a vascular endothelial growth factor-independent pathway. Since proliferated HUVECs in the BDNF group made the microenvironment more conducive to endothelial differentiation of MSCs, by establishing co-culture systems with the two cell types, endothelial cells derived from MSCs increased significantly. A new biomaterial made of polylactic acid, silk and collagen was used as the carrier dressing. After transplantation of the BDNF-stimulated MSC/biomaterial complex, the ulcers in hindlimb ischemic mice healed prominently. More blood vessel formation was observed in the wound tissue, and more MSCs were co-stained with some endothelial-specific markers such as cluster of differentiation (CD)31 and von Willebrand Factor (vWF) in the treatment group than in the control group. These results demonstrated that BDNF could improve microenvironment in the new biomaterial, and induce MSCs to differentiate into endothelial cells indirectly, thus accelerating ischemic ulcer healing.
C1 [He, Siyi; Shen, Lei; Wu, Yangxiao; Li, Li; Chen, Wen; Hou, Chunli; Yang, Mingcan; Zeng, Wen; Zhu, Chuhong] Third Mil Med Univ, Key Lab Biomech Chongqing, Dept Anat, Natl & Reg Engn Lab Tissue Engn, Chongqing 400038, Peoples R China.
   [He, Siyi] Third Mil Med Univ, Xinqiao Hosp, Dept Cardiovasc Surg, Chongqing 400038, Peoples R China.
   [Shen, Lei] Qiqihar Med Univ, Dept Anat, Qiqihar, Peoples R China.
RP Zhu, CH (reprint author), Third Mil Med Univ, Key Lab Biomech Chongqing, Dept Anat, Natl & Reg Engn Lab Tissue Engn, Gao Tan Yan St, Chongqing 400038, Peoples R China.
EM zw0105@aliyun.com; zhuch99@yahoo.com
FU Training Program of the Major Research Plan of the National Natural
   Science Foundation of China [91439116]; National Science Foundation of
   China [31200731]; Natural Science Foundation Project of CQ CSTC
   [cstc2011jjjq0016]; Military Twelfth Five-year Key Project [BWS11C056];
   National High Technology Research and Development Program 863
   [2012AA020504]
FX This work was supported by the Training Program of the Major Research
   Plan of the National Natural Science Foundation of China (No.:
   91439116), the National Science Foundation of China (No.: 31200731),
   Natural Science Foundation Project of CQ CSTC (cstc2011jjjq0016), the
   Military Twelfth Five-year Key Project (BWS11C056), and National High
   Technology Research and Development Program 863 (2012AA020504).
CR Albayati MA, 2013, MED CLIN N AM, V97, P821, DOI 10.1016/j.mcna.2013.03.009
   Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138
   Bittira B, 2002, ANN THORAC SURG, V74, P1154, DOI 10.1016/S0003-4975(02)03857-2
   Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334
   Chin JA, 2014, CLIN PODIATR MED SUR, V31, P11, DOI 10.1016/j.cpm.2013.09.001
   Dinh T, 2005, CURR PHARM DESIGN, V11, P2301, DOI 10.2174/1381612054367328
   Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5
   Han YF, 2014, CYTOTHERAPY, V16, P160, DOI 10.1016/j.jcyt.2013.10.014
   Han YF, 2011, BIOCHEM BIOPH RES CO, V413, P561, DOI 10.1016/j.bbrc.2011.09.001
   He W, 2011, J ASIAN NAT PROD RES, V13, P1, DOI 10.1080/10286020.2010.535519
   Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009
   Hou CL, 2013, BIOMATERIALS, V34, P112, DOI 10.1016/j.biomaterials.2012.09.022
   Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893
   Kermani P, 2005, J CLIN INVEST, V115, P653, DOI 10.1172/JCI200522655
   Lim J. Y., 2011, CELL TRANSPLANT, V20, P11
   Lim JY, 2008, J NEUROSCI RES, V86, P2168, DOI 10.1002/jnr.21669
   Liu KM, 2008, MICROVASC RES, V75, P59, DOI 10.1016/j.mvr.2007.06.003
   Liu Y, 2009, DIABETES CARE, V32, P117, DOI [10.2337/dc08-0763, 10.2337/dc09-1394]
   Manna SK, 2005, J BIOL CHEM, V280, P7010, DOI 10.1074/jbc.M410994200
   Nakagawa T, 2002, DIABETES METAB RES, V18, P185, DOI 10.1002/dmrr.290
   Neufeld G, 1999, FASEB J, V13, P9
   Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403
   Shen L, 2013, CELL TRANSPLANT, V22, P1011, DOI 10.3727/096368912X657495
   Sun CY, 2006, CHINESE MED J-PEKING, V119, P589
   Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1
   Yamanaka M, 2007, DIABETES OBES METAB, V9, P59, DOI 10.1111/j.1463-1326.2006.00572.x
   Yu Q, 2000, GENE DEV, V14, P163
   Zeng W, 2010, BIOMATERIALS, V31, P1636, DOI 10.1016/j.biomaterials.2009.11.037
   Zhao LX, 2004, EXP NEUROL, V190, P396, DOI 10.1016/j.expneurol.2004.06.025
NR 29
TC 9
Z9 11
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAR 1
PY 2015
VL 21
IS 5-6
BP 928
EP 938
DI 10.1089/ten.tea.2014.0113
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CC7LQ
UT WOS:000350549500007
PM 25316594
DA 2018-10-19
ER

PT J
AU Gopi, D
   Bhuvaneshwari, N
   Kavitha, L
   Ramya, S
AF Gopi, D.
   Bhuvaneshwari, N.
   Kavitha, L.
   Ramya, S.
TI Novel malic acid mediated green route for the synthesis of
   hydroxyapatite particles and their spectral characterization
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Calcination; Spectroscopy; X-ray methods; Apatite; Biomedical
   applications
ID SOL-GEL TECHNIQUE; CALCIUM-PHOSPHATE; SILVER NANOPARTICLES;
   SPECTROSCOPIC CHARACTERIZATION; ELECTRODEPOSITION METHOD; ANTIBACTERIAL
   ACTIVITY; LEAF EXTRACT; IN-VITRO; NANOHYDROXYAPATITE; TEMPERATURE
AB Hydroxyapatite (Ca-10(PO4)(6)(OH)(2), HAP], a principal inorganic constituent of bone and teeth, is widely used in the biomedical field, due to its similarity, chemically and structurally to the bones. In this paper, We have reported the synthesis of HAP particles using the malic acid mediated green template method. The malic acid used in this method has been obtained from various sources, such as natural and commercially available one. The extract of the apple fruit is taken as the natural source of malic acid. The extracted malic acid and the as-synthesized HAP particles are characterized by various spectral techniques like Fourier transform infrared spectroscopy (FT-IR), proton-1 nuclear magnetic resonance spectroscopy (H-1-NMR), carbon-13 nuclear magnetic resonance spectroscopy (C-13-NMR) and X-ray diffraction (XRD) technique for the phase identification of the HAP particles. The morphology of the HAP particles were assessed thoroughly using a scanning electron microscope (SEM) equipped with energy dispersive X-ray analysis (EDAX). Moreover, the antibacterial activity of the as-synthesized HAP particles was evaluated against the two pathogen bacteria strains. The experimental results revealed that the HAP particles synthesized in the presence of an extracted malic acid are pure, low crystalline and spherical particles with reduced size. These HAP particles also showed an enhanced antibacterial activity than that of the HAP synthesized in the presence of commercially available malic acid. Hence, the HAP particles synthesized using the extracted malic acid as a green template can act as a good biomaterial for biomedical applications. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Gopi, D.; Bhuvaneshwari, N.; Ramya, S.] Periyar Univ, Dept Chem, Salem 636011, Tamil Nadu, India.
   [Gopi, D.] Periyar Univ, Ctr Nanosci & Nanotechnol, Salem 636011, Tamil Nadu, India.
   [Bhuvaneshwari, N.] Chikkaiah Naicker Coll, Dept Chem, Erode 638004, Tamil Nadu, India.
   [Kavitha, L.] Cent Univ Tamilnadu, Sch Basic & Appl Sci, Dept Phys, Thiruvarur 610101, Tamil Nadu, India.
RP Gopi, D (reprint author), Periyar Univ, Dept Chem, Salem 636011, Tamil Nadu, India.
EM dhanaraj_gopi@yahoo.com
RI Gopi, Dhanaraj/A-9163-2012; Louis, Kavitha/B-9313-2017
OI Gopi, Dhanaraj/0000-0001-6662-1238; Louis, Kavitha/0000-0002-8893-2050
FU Department of Science and Technology, New Delhi, India (DST-TSD)
   [DST/TSG/NTS/2011/73]; DST-EMEQ [SB/EMEQ-185/2013]; CSIR
   [01(2547)/11/EMR-II]; UGC [F. 30-1/2013
   (SA-II)/RA-2012-14-NEW-SC-TAM-3240, F. 30-1/2013
   (SA-II)/RA-2012-14-NEW-GT-TAM-3228]
FX One of the authors D. Gopi acknowledges the major functional support
   from the Department of Science and Technology, New Delhi, India
   (DST-TSD, Ref. no. DST/TSG/NTS/2011/73), DST-EMEQ, Ref. no.
   SB/EMEQ-185/2013 and CSIR, Ref. no. 01(2547)/11/EMR-II, Dated:
   12.12.2011). Also, D. Gopi and L. Kavitha acknowledge the UGC (Ref. no.
   F. 30-1/2013 (SA-II)/RA-2012-14-NEW-SC-TAM-3240 and Ref. no. F.
   30-1/2013 (SA-II)/RA-2012-14-NEW-GT-TAM-3228) for the Research Awards.
CR Arce H, 2004, POLYHEDRON, V23, P1897, DOI 10.1016/j.poly.2004.04.021
   Bankar A, 2010, COLLOID SURFACE A, V368, P58, DOI 10.1016/j.colsurfa.2010.07.024
   Bankar A, 2010, COLLOID SURFACE B, V80, P45, DOI 10.1016/j.colsurfb.2010.05.029
   Bezzi G, 2003, MATER CHEM PHYS, V78, P816, DOI 10.1016/S0254-0584(02)00392-9
   Bogdanoviciene I, 2006, MATER RES BULL, V41, P1754, DOI 10.1016/j.materresbull.2006.02.016
   Boyer J., 2003, NY FRUIT Q, V11, P11
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Chaturvedi D, 2012, POLYMER, V53, P2681, DOI 10.1016/j.polymer.2012.04.009
   Chaturvedi D, 2011, POLYMER, V52, P3118, DOI 10.1016/j.polymer.2011.05.011
   Cho JS, 2008, J ALLOY COMPD, V464, P282, DOI 10.1016/j.jallcom.2007.09.092
   Chu TMG, 2001, J MATER SCI-MATER M, V12, P471, DOI 10.1023/A:1011203226053
   Degirmenbasi N, 2006, COLLOID SURFACE B, V48, P42, DOI 10.1016/j.colsurfb.2006.01.002
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   Edison TJI, 2013, SPECTROCHIM ACTA A, V104, P262, DOI 10.1016/j.saa.2012.11.084
   GOMIS DB, 1988, CHROMATOGRAPHIA, V25, P1054, DOI 10.1007/BF02259384
   Gopi D, 2008, SPECTROCHIM ACTA A, V70, P1243, DOI 10.1016/j.saa.2008.02.015
   Gopi D, 2014, RSC ADV, V4, P34751, DOI 10.1039/c4ra04484c
   Gopi D, 2014, COLLOID SURFACE A, V451, P172, DOI 10.1016/j.colsurfa.2014.03.035
   Gopi D, 2014, SPECTROCHIM ACTA A, V118, P589, DOI 10.1016/j.saa.2013.09.034
   Gopi D, 2013, CORROS SCI, V73, P321, DOI 10.1016/j.corsci.2013.04.021
   Gopi D, 2012, B MATER SCI, V35, P1195, DOI 10.1007/s12034-012-0398-z
   Gopi D, 2012, SPECTROCHIM ACTA A, V93, P131, DOI 10.1016/j.saa.2012.02.033
   Gopi D, 2012, SPECTROCHIM ACTA A, V92, P194, DOI 10.1016/j.saa.2012.02.069
   Gopi D, 2010, SPECTROCHIM ACTA A, V77, P545, DOI 10.1016/j.saa.2010.06.013
   Gopi D, 2009, SPECTROCHIM ACTA A, V74, P282, DOI 10.1016/j.saa.2009.05.021
   Gopi D., 2010, CURR APPL PHYS, V11, P590
   Hattori H., 1990, J AM CERAM SOC, V73, P1803
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Huang Y, 2013, APPL SURF SCI, V282, P456, DOI 10.1016/j.apsusc.2013.05.152
   Huang Y, 2013, J MATER SCI-MATER M, V24, P1853, DOI 10.1007/s10856-013-4955-9
   Huang Y, 2013, APPL SURF SCI, V271, P299, DOI 10.1016/j.apsusc.2013.01.187
   Jiao FP, 2009, LAT AM APPL RES, V39, P127
   Karayil S, 1998, J Postgrad Med, V44, P93
   Kawata M, 2004, J MATER SCI-MATER M, V15, P817, DOI 10.1023/B:JMSM.0000032823.66093.aa
   Klinkaewnarong J, 2010, CURR APPL PHYS, V10, P521, DOI 10.1016/j.cap.2009.07.014
   Kuriakose TA, 2004, J CRYST GROWTH, V263, P517, DOI 10.1016/j.jcrysgro.2003.11.057
   Lata B., 2005, Folia Horticulturae, V17, P47
   LAVERNIA C, 1991, AM CERAM SOC BULL, V70, P95
   Legeros RZ, 1993, ADV SERIES CERAMICS, P139
   Lim GK, 1999, LANGMUIR, V15, P7472, DOI 10.1021/la981659+
   Lim GK, 1997, BIOMATERIALS, V18, P1433, DOI 10.1016/S0142-9612(97)00081-1
   Lopez-Macipe A, 1998, J MATER SYNTH PROCES, V6, P21, DOI 10.1023/A:1022603024806
   Manso-Silvan M, 2003, J EUR CERAM SOC, V23, P243, DOI 10.1016/S0955-2219(02)00187-5
   Matthes A, 2009, J APPL BOT FOOD QUAL, V82, P152
   Mavis B, 2000, J AM CERAM SOC, V83, P989
   Nadagouda MN, 2009, CRYST GROWTH DES, V9, P4979, DOI 10.1021/cg9007685
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Otsuka Makoto, 1994, Bio-Medical Materials and Engineering, V4, P357
   Pang YX, 2003, J EUR CERAM SOC, V23, P1697, DOI 10.1016/S0955-2219(02)00413-2
   Patil RS, 2012, SPECTROCHIM ACTA A, V91, P234, DOI 10.1016/j.saa.2012.02.009
   Prabakaran K, 2009, SPECTROCHIM ACTA A, V74, P1127, DOI 10.1016/j.saa.2009.09.021
   Prelot B, 2005, MAT SCI ENG C-BIO S, V25, P553, DOI 10.1016/j.msec.2005.07.008
   PUAJINDANETR S, 1994, BRIT CERAM T, V93, P96
   Ramanan SR, 2004, MATER LETT, V58, P3320, DOI 10.1016/j.matlet.2004.06.030
   Rao YS, 2013, SPECTROCHIM ACTA A, V103, P156, DOI 10.1016/j.saa.2012.11.028
   Rey C, 2007, MAT SCI ENG C-BIO S, V27, P198, DOI 10.1016/j.msec.2006.05.015
   RICHMOND ML, 1981, J AGR FOOD CHEM, V29, P4, DOI 10.1021/jf00103a002
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sun YX, 2006, J PHYS CHEM SOLIDS, V68, P373, DOI 10.1016/j.jpcs.2006.11.026
   van der Houwen JAM, 2003, J CRYST GROWTH, V249, P572, DOI 10.1016/S0022-0248(02)02227-3
   Varma HK, 2005, CERAM INT, V31, P109, DOI 10.1016/j.ceramint.2004.03.041
   Viswanath B, 2008, BIOMATERIALS, V29, P4855, DOI 10.1016/j.biomaterials.2008.09.001
   Wang YJ, 2006, MATER LETT, V60, P1484, DOI 10.1016/j.matlet.2005.11.053
   Weng W., 2002, MATER CHEM PHYS, P92
   Willmann G, 1996, BRIT CERAM T, V95, P212
NR 66
TC 2
Z9 3
U1 2
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD MAR
PY 2015
VL 41
IS 2
BP 3116
EP 3127
DI 10.1016/j.ceramint.2014.10.156
PN B
PG 12
WC Materials Science, Ceramics
SC Materials Science
GA AZ1MM
UT WOS:000348003100062
DA 2018-10-19
ER

PT J
AU Yang, S
   Umbrello, D
   Dillon, OW
   Puleo, DA
   Jawahir, IS
AF Yang, Shu
   Umbrello, Domenico
   Dillon, Oscar W., Jr.
   Puleo, David A.
   Jawahir, I. S.
TI Cryogenic cooling effect on surface and subsurface microstructural
   modifications in burnishing of Co-Cr-Mo biornaterial
SO JOURNAL OF MATERIALS PROCESSING TECHNOLOGY
LA English
DT Article
DE Cryogenic burnishing; Co-Cr-Mo biomaterial; Surface and subsurface
   microstructural modifications; Severe plastic deformation (SPD)
ID WEAR-RESISTANCE; MECHANICAL-PROPERTIES; PHASE-TRANSFORMATION; ALLOY;
   PARAMETERS; TOOL; DEFORMATION; COMPONENTS; INTEGRITY; STRENGTH
AB The aim of the present work is to investigate the effect of a severe plastic deformation (SPD) process, cryogenic burnishing, on the surface integrity modifications of a Co-Cr-Mo alloy due to the burnishing-induced surface integrity properties. A set of experiments was conducted to investigate the influence of different burnishing parameters on distribution of grain size, phase structure and hardness of the processed material. The results from this work show that the proper selection of burnishing conditions can significant improve the surface integrity of the Co-Cr-Mo alloy due to refined microstructure, high hardness, and favorable phase structure on the surface layer, which could potentially lead to advanced wear performance of such material. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Yang, Shu; Dillon, Oscar W., Jr.; Jawahir, I. S.] Univ Kentucky, Inst Sustainable Mfg, Lexington, KY 40506 USA.
   [Umbrello, Domenico] Univ Calabria, Dept Mech Energy & Management Engn, I-87036 Arcavacata Di Rende, CS, Italy.
   [Puleo, David A.] Univ Kentucky, Dept Biomed Engn, Lexington, KY 40506 USA.
RP Yang, S (reprint author), Univ Kentucky, Inst Sustainable Mfg, Lexington, KY 40506 USA.
EM shuyang1031@gmail.com
RI Umbrello, Domenico/C-5519-2012
OI Umbrello, Domenico/0000-0002-4211-6322
CR Ben Fredj N, 2006, CRYOGENICS, V46, P439, DOI 10.1016/j.cryogenics.2006.01.015
   Buckley H, 1968, COBALT, P20
   Buscher R, 2005, WEAR, V259, P887, DOI 10.1016/j.wear.2005.02.036
   Buscher R, 2003, MATERIALWISS WERKST, V34, P966, DOI 10.1002/mawe.200300680
   Chan CLH, 1996, J BONE JOINT SURG BR, V78B, P78
   CHAPELLIER P, 1990, ACTA METALL MATER, V38, P1475, DOI 10.1016/0956-7151(90)90116-X
   CROOK P, 1983, WEAR MAT, P272
   El-Axir MH, 2003, J MATER PROCESS TECH, V132, P82, DOI 10.1016/S0924-0136(02)00269-8
   GRAHAM AH, 1970, METALL TRANS, V1, P423, DOI 10.1007/BF02811551
   HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303
   Hassan AM, 1999, J MATER PROCESS TECH, V96, P73
   Hassan AM, 1996, J MATER PROCESS TECH, V59, P250, DOI 10.1016/0924-0136(95)02149-3
   HUANG JY, 1995, APPL PHYS LETT, V66, P308, DOI 10.1063/1.113527
   Khan AA, 2008, J MATER PROCESS TECH, V196, P149, DOI 10.1016/j.jmatprotec.2007.05.030
   Kohzu M, 2007, MATER TRANS, V48, P764, DOI 10.2320/matertrans.48.764
   Kumar KVBSK, 2008, J MATER PROCESS TECH, V203, P95, DOI 10.1016/j.jmatprotec.2007.10.036
   Kuroda M, 2005, AIP CONF PROC, V778, P445
   LOH NH, 1989, J MECH WORK TECHNOL, V18, P53, DOI 10.1016/0378-3804(89)90109-5
   Maximov JT, 2009, INT J MACH TOOL MANU, V49, P824, DOI 10.1016/j.ijmachtools.2009.05.011
   O'Sullivan D, 2002, P I MECH ENG B-J ENG, V216, P135, DOI 10.1243/0954405021519645
   OLSON GB, 1975, METALL TRANS, VA  6, P791, DOI 10.1007/BF02672301
   Park J.B., 2003, BIOMATERIALS PRINCIP, P1
   PETCH NJ, 1953, J IRON STEEL I, V174, P25
   Prevey P. S., 2000, EFFECT COLD WORK THE
   RAJAN K, 1982, J MATER SCI, V17, P769, DOI 10.1007/BF00540374
   Rao DS, 2008, MATER MANUF PROCESS, V23, P295, DOI 10.1080/10426910801937306
   Saldivar-Garcia AJ, 2005, J BIOMED MATER RES A, V74A, P269, DOI 10.1002/jbm.a.30392
   Salinas-Rodrfguez A., 1999, ASTM STP, V1365
   Seemikeri CY, 2008, TRIBOL INT, V41, P724, DOI 10.1016/j.triboint.2008.01.003
   Stoot F.H., 1977, MET TECHNOL, V4, P66
   Vandamme NS, 2005, J MATER SCI-MATER M, V16, P647, DOI 10.1007/s10856-005-2536-2
   Yamanaka K, 2009, METALL MATER TRANS A, V40A, P1980, DOI 10.1007/s11661-009-9879-0
   Yang S, 2013, J BIOMED MATER RES B, V101B, P139, DOI 10.1002/jbm.b.32827
   Zhang P, 2005, SCRIPTA MATER, V52, P1011, DOI 10.1016/j.scriptamat.2005.01.026
   Zurecki Z., 2003, P IMECE 03 WASH DC
NR 35
TC 5
Z9 5
U1 3
U2 13
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-0136
J9 J MATER PROCESS TECH
JI J. Mater. Process. Technol.
PD MAR
PY 2015
VL 217
BP 211
EP 221
DI 10.1016/j.jmatprotec.2014.11.004
PG 11
WC Engineering, Industrial; Engineering, Manufacturing; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA AY5AM
UT WOS:000347585900021
DA 2018-10-19
ER

PT J
AU Jaganathan, SK
   Balaji, A
   Vellayappan, MV
   Subramanian, AP
   John, AA
   Asokan, MK
   Supriyanto, E
AF Jaganathan, Saravana Kumar
   Balaji, Arunpandian
   Vellayappan, Muthu Vignesh
   Subramanian, Aruna Priyadarshni
   John, Agnes Aruna
   Asokan, Manjeesh Kumar
   Supriyanto, Eko
TI Review: Radiation-induced surface modification of polymers for
   biomaterial application
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Review
ID ANTIBACTERIAL LDPE SURFACE; PLASMA-TREATED POLYMERS; ADHESION; TISSUE;
   IMPROVEMENT; POLYDIMETHYLSILOXANE; BIOCOMPATIBILITY; ATTACHMENT;
   MORPHOLOGY; SCAFFOLDS
AB The field of biomaterials is one of the fast growing and continuously dominating in medical arena for the last five decades. Biomaterials utilize various kinds of materials ranging from metals, polymers, ceramics and biological substances as an alternative for replacing/assisting the functions of different parts of human system. Major issues associated with biomaterials are their properties and the biocompatibility which have to be addressed and resolved before promoting it to the market or clinical setting. In this scenario, polymers have emerged as a better candidate with versatile properties that make them ideal choice for biomedical applications. However, still the problem of biocompatibility limits the use of polymers in the human body. Several surface modification strategies are continuously evolving to improve the biocompatibility of polymers. This review initially outlines the polymers' biomedical applications and also elicits the immune aspects of biocompatibility. Further, a thorough attempt is made to summarize the radiation-induced surface modification of the polymers. This review will help us to keep abreast of the recent advances in the radiation-induced surface modification and also in promoting radiation as a probable candidate to enhance the biocompatibility of polymers.
C1 [Jaganathan, Saravana Kumar; Balaji, Arunpandian; Vellayappan, Muthu Vignesh; Subramanian, Aruna Priyadarshni; John, Agnes Aruna; Supriyanto, Eko] Univ Teknol Malaysia, Fac Biosci & Med Engn, IJN UTM Cardiovasc Engn Ctr, Johor Baharu 81310, Malaysia.
   [Asokan, Manjeesh Kumar] PSNA Coll Engn & Technol, Dept Res & Dev, Dindigul 624622, Tamil Nadu, India.
RP Jaganathan, SK (reprint author), Univ Teknol Malaysia, Fac Biosci & Med Engn, IJN UTM Cardiovasc Engn Ctr, Johor Baharu 81310, Malaysia.
EM jaganathaniitkgp@gmail.com
RI Jaganathan, Saravana Kumar/N-2385-2017
OI Balaji, Arunpandian/0000-0002-6745-9188
FU Ministry of Higher Education Malaysia [R.J130000.7809.4F444,
   PY/2014/03167]
FX This work was supported partly by the Ministry of Higher Education
   Malaysia with the Grant Vot No. R.J130000.7809.4F444 and the Ref No:
   PY/2014/03167.
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   AREFI F, 1992, PURE APPL CHEM, V64, P715, DOI 10.1351/pac199264050715
   BADEY JP, 1994, POLYMER, V35, P2472, DOI 10.1016/0032-3861(94)90365-4
   Bilek F, 2013, COLLOID SURFACE B, V102, P842, DOI 10.1016/j.colsurfb.2012.08.026
   Bilek F, 2011, COLLOID SURFACE B, V88, P440, DOI 10.1016/j.colsurfb.2011.07.027
   Boretos JW, 1984, CONT BIOMATERIALS MA, P232
   Chang HI, 2011, REGENERATIVE MED TIS, P1
   Costa CAS., 2001, METODOLOGIA CIENTIFI, P145
   Dadsetan M, 1999, RADIAT PHYS CHEM, V56, P597, DOI 10.1016/S0969-806X(99)00293-5
   Ginn BT, 2003, LANGMUIR, V19, P8117, DOI 10.1021/La034138h
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hamid Mirzadeh, 1996, IRAN PDYRM J, V5, P225
   Heidari S, 2011, INT J NANOMED, V6, P641, DOI DOI 10.1080/10426500902917644
   Heitz J, 2004, BIOTECHNOL APPL BIOC, V39, P59, DOI 10.1042/BA20030107
   Hoffman Allan S, 1995, CHIN J POLYM SCI, V13, P1
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Jaganathan SK, 2014, BIOMATERIALS CARDIOV
   Junkar I, 2011, MATER TEHNOL, V45, P221
   Kasalkova NS, 2012, NUCL INSTRUM METH B, V272, P391, DOI 10.1016/j.nimb.2011.01.108
   Khorasani MT, 2008, RADIAT PHYS CHEM, V77, P280, DOI 10.1016/j.radphyschem.2007.05.013
   Khorasani MT, 2005, APPL SURF SCI, V242, P339, DOI 10.1016/j.apsusc.2004.08.035
   Khorasani MT, 2004, J BIOMAT SCI-POLYM E, V15, P59, DOI 10.1163/156856204322752237
   Khorasani MT, 1996, RADIAT PHYS CHEM, V47, P881, DOI 10.1016/0969-806X(95)00166-U
   Kolska Z, 2012, VACUUM, V86, P643, DOI 10.1016/j.vacuum.2011.07.015
   Kwan-Hoong N., 2003, P INT C NON RAD UNIT
   Lahann J, 1999, J MATER SCI-MATER M, V10, P443, DOI 10.1023/A:1008939400812
   LEMONS J, 1986, DENT CLIN N AM, V30, P3
   Melnig V, 2005, J OPTOELECTRON ADV M, V7, P2521
   Michael Olbricha, 2007, J BIOMATER SCI, V18, P453
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Mohandas H, 2013, BIOMED RES INT, DOI 10.1155/2013/253473
   MUTEL B, 1988, REV PHYS APPL, V23, P1253, DOI 10.1051/rphysap:019880023070125300
   Nechifor CD, 2009, ROM J PHYS, V54, P349
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   O'Brien William J, DENT MAT THEIR SELEC
   Pallister CJ, 2010, HAEMATOLOGY, P334
   Rabiei A, 2013, J BIOMED MATER RES A, V101, P2621, DOI 10.1002/jbm.a.34557
   Rajajeyaganthan R, 2011, MACROMOL SYMP, V299-300, P175, DOI 10.1002/masy.200900128
   Reznickova A, 2011, NUCL INSTRUM METH B, V269, P83, DOI 10.1016/j.nimb.2010.11.018
   ROSSEN L, 1992, INT J FOOD MICROBIOL, V17, P37, DOI 10.1016/0168-1605(92)90017-W
   Ryou M, 2006, TECH GASTROINTEST EN, V8, P33, DOI 10.1016/j.tgie.2005.12.007
   SCHIEKER M, 2006, EUR J TRAUMA, V32, P114, DOI DOI 10.1007/S00068-006-6047-8
   Schmalz G, 2002, J DENT RES, V81, P660, DOI 10.1177/154405910208101001
   Sharma DS, 2004, IND APPL C, V4, P932
   Siegel J, 2008, RADIAT EFF DEFECT S, V163, P779, DOI 10.1080/10420150801969654
   Silvio LD, 2008, CELLULAR RESPONSE BI, P648
   Slepicka P, 2013, EXPRESS POLYM LETT, V7, P535, DOI 10.3144/expresspolymlett.2013.50
   Slepicka P, 2010, NUCL INSTRUM METH B, V268, P2111, DOI 10.1016/j.nimb.2010.02.012
   Stevens K. N. J., 2011, BLOOD CONTACTING BIO
   Su WY, 2010, SURF COAT TECH, V205, P465, DOI 10.1016/j.surfcoat.2010.07.013
   Subedi D.P., 2009, KATHMANDU U J SCI EN, V5, P37
   Suggs Allison, 2002, KR F LASER SURFACE T
   Toan Leaz Quoc, 2013, ECS J SOLID STATE SC, V5, pN93
   Valentin J., 2007, RECOMMENDATIONS INT
   Vo-Dinh T, 2000, FRESEN J ANAL CHEM, V366, P540, DOI 10.1007/s002160051549
   Wang ZK, 2010, SIMTECH TECHNICAL RE, V11
   Weibel DE, 2009, THIN SOLID FILMS, V517, P5489, DOI 10.1016/j.tsf.2009.03.204
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   Williams R, 2010, WOODHEAD PUBL MATER, P1
NR 63
TC 18
Z9 19
U1 3
U2 109
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD MAR
PY 2015
VL 50
IS 5
BP 2007
EP 2018
DI 10.1007/s10853-014-8718-x
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA AY6SS
UT WOS:000347696500001
DA 2018-10-19
ER

PT J
AU Gilca, IA
   Pupa, VI
   Crestini, C
AF Gilca, Iulian Andrei
   Pupa, Valentin I.
   Crestini, Claudia
TI Obtaining lignin nanoparticles by sonication
SO ULTRASONICS SONOCHEMISTRY
LA English
DT Article
DE Lignins; Ultrasound; Nanoparticles; Characterization
ID P-31 NMR; WOOD CHEMISTRY; ULTRASOUND; SPECTROSCOPY; ACCURATE; FTIR
AB Lignin, the main natural aromatic polymer was always aroused researchers interest. Currently around 90% of this biomaterial is burned for energy. It has a very complex and complicated structure which depends on the separation method and plant species, what determine difficulties to use as a raw material widely. This research presents a physical method to modify lignin by ultrasonic irradiation in order to obtain nanoparticles. The nanoparticles synthesized were dimensionally and morphologically characterized. At the same time the preoccupations were to determine the structural and compositional changes that occurred after sonication. To achieve this, two types of commercial lignins (wheat straw and Sarkanda grass) were used and the modifications were analyzed by FTIR-spectroscopy, GPC-chromatography, P-31-NMR-spectroscopy and HSQCO. The results confirm that the compositional and structural changes of nanoparticles obtained are not significantly modified at the intensity applied but depend on the nature of lignin. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Gilca, Iulian Andrei; Pupa, Valentin I.] Gheorghe Asachi Tech Univ, Fac Chem Engn & Environm Protect, Dept Nat & Synthet Polymers, Iasi 700050, Romania.
   [Crestini, Claudia] Univ Roma Tor Vergata, Dept Chem Sci & Technol, I-00133 Rome, Italy.
RP Gilca, IA (reprint author), Gheorghe Asachi Tech Univ, Fac Chem Engn & Environm Protect, Dept Nat & Synthet Polymers, Blvd Mangeron 73, Iasi 700050, Romania.
EM andreigilca@tuiasi.ro
RI Crestini, Claudia/O-6781-2015
OI Crestini, Claudia/0000-0001-9903-2675
FU POSDRU CUANTUMDOC [ID79407]; European Social Found and Romanian
   Government; University of Rome; Institute of Macromolecular Chemistry
FX This paper was realised with the support of POSDRU CUANTUMDOC "DOCTORAL
   STUDIES FOR EUROPEAN PERFORMANCES IN RESEARCH AND INOVATION" ID79407
   project funded by the European Social Found and Romanian Government.;
   Dr. Federica Me lone and Silvia Decina from University of Rome "Tor
   Vergata" for support in GPC acetylated and NMR analysis; Dr. Florica
   Doroftei from Institute of Macromolecular Chemistry "Petru Poni" Iasi
   for support in TEM analysis.
CR Alonso MV, 2001, J APPL POLYM SCI, V82, P2661, DOI 10.1002/app.2119
   ARGYROPOULOS DS, 1994, J WOOD CHEM TECHNOL, V14, P45, DOI 10.1080/02773819408003085
   ARGYROPOULOS DS, 1993, J WOOD CHEM TECHNOL, V13, P187, DOI 10.1080/02773819308020514
   ARGYROPOULOS DS, 1995, RES CHEM INTERMEDIAT, V21, P373, DOI 10.1007/BF03052265
   Asikkala J, 2012, J AGR FOOD CHEM, V60, P8968, DOI 10.1021/jf303003d
   Benar P, 1999, J WOOD CHEM TECHNOL, V19, P151, DOI 10.1080/02773819909349605
   Crestini C, 2011, BIOMACROMOLECULES, V12, P3928, DOI 10.1021/bm200948r
   Crestini C, 2011, BIOORGAN MED CHEM, V19, P5071, DOI 10.1016/j.bmc.2011.05.058
   Derkacheva O, 2008, MACROMOL SYMP, V265, P61, DOI 10.1002/masy.200850507
   Dimmel D., 2010, LIGNIN LIGNANS ADV C, P1
   Garcia A, 2012, CHEM ENG PROCESS, V62, P150, DOI 10.1016/j.cep.2012.07.011
   Garcia A, 2012, BIORESOURCE TECHNOL, V108, P155, DOI 10.1016/j.biortech.2012.01.010
   Gilca I.A., 2011, ITALIC 6 SCI TECHNOL
   Gilca IA, 2013, CELL CHEM TECHNOL, V47, P239
   Gilca IA, 2011, CELL CHEM TECHNOL, V45, P227
   GRANATA A, 1995, J AGR FOOD CHEM, V43, P1538, DOI 10.1021/jf00054a023
   Guerra A, 2007, PHYTOCHEMISTRY, V68, P2570, DOI 10.1016/j.phytochem.2007.05.026
   Hainal AR, 2012, CELL CHEM TECHNOL, V46, P87
   Huang Y, 2012, J WOOD CHEM TECHNOL, V32, P294, DOI 10.1080/02773813.2012.666316
   Iordache I., 2009, SONOCHIMIA EPURAREA
   Kim KH, 2008, ULTRASON SONOCHEM, V15, P1019, DOI 10.1016/j.ultsonch.2007.11.004
   Kuijpers MWA, 2002, ULTRASONICS, V40, P675, DOI 10.1016/S0041-624X(02)00197-X
   Lange H, 2013, EUR POLYM J, V49, P1151, DOI 10.1016/j.eurpolymj.2013.03.002
   Lu FC, 1998, J WOOD CHEM TECHNOL, V18, P219, DOI 10.1080/02773819809349578
   Mishra SP, 2011, BIORESOURCES, V6, P121
   Nada AAMA, 1998, POLYM DEGRAD STABIL, V60, P247, DOI 10.1016/S0141-3910(97)00072-4
   Patil MN, 2007, ULTRASON SONOCHEM, V14, P519, DOI 10.1016/j.ultsonch.2006.10.007
   Perazzini R, 2011, BIOORGAN MED CHEM, V19, P440, DOI 10.1016/j.bmc.2010.11.009
   Petrovici G., 1997, CHIMIA SI PRELUCRARE
   Popa VI, 2011, CELL CHEM TECHNOL, V45, P221
   Schilling P., 1993, US Patent, Patent No. [5,192,361, 5192361]
   Seino T, 2001, WOOD SCI TECHNOL, V35, P97, DOI 10.1007/s002260000080
   Sette M, 2011, CHEM-EUR J, V17, P9529, DOI 10.1002/chem.201003045
   SJOSTROM E, 1981, WOOD CHEM FUNDAMENTA
   Sun RC, 2002, ULTRASON SONOCHEM, V9, P85, DOI 10.1016/S1350-4177(01)00106-7
   Wells T, 2013, ULTRASON SONOCHEM, V20, P1463, DOI 10.1016/j.ultsonch.2013.05.001
   Wu CD, 2001, WATER RES, V35, P3927, DOI 10.1016/S0043-1354(01)00133-6
   Zimniewska M, 2008, MOL CRYST LIQ CRYST, V484, P409, DOI 10.1080/15421400801903395
NR 38
TC 35
Z9 36
U1 1
U2 86
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1350-4177
EI 1873-2828
J9 ULTRASON SONOCHEM
JI Ultrason. Sonochem.
PD MAR
PY 2015
VL 23
BP 369
EP 375
DI 10.1016/j.ultsonch.2014.08.021
PG 7
WC Acoustics; Chemistry, Multidisciplinary
SC Acoustics; Chemistry
GA AX6HH
UT WOS:000347023100048
PM 25218770
OA Green Published
DA 2018-10-19
ER

PT J
AU Yang, MY
   Zhou, GS
   Castano-Izquierdo, H
   Zhu, Y
   Mao, CB
AF Yang, Mingying
   Zhou, Guanshan
   Castano-Izquierdo, Harold
   Zhu, Ye
   Mao, Chuanbin
TI Biomineralization of Natural Collagenous Nanofibrous Membranes and Their
   Potential Use in Bone Tissue Engineering
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Biomineralization; Hydroxyapatite; Stem Cells; Tissue Engineering;
   Collagen
ID SMALL-INTESTINAL SUBMUCOSA; MESENCHYMAL STEM-CELLS; IN-VITRO;
   OSTEOBLASTIC DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; BIOLOGICAL
   NANOFIBERS; ORIENTED GROWTH; WALL REPAIR; MINERALIZATION; REGENERATION
AB Small intestinal submucosa (SIS) membranes as a decellularized tissue are known to be a natural nanofibrous biomaterial mainly made of type I collagen fibers and containing some growth factors (fibroblast growth factor 2 and transforming growth factor beta) desired in tissue engineering. Here we show that the SIS membranes can promote the formation of bone mineral hydroxylapatite (HAP) crystals along the collagen fibers constituting the membranes from a HAP-supersaturated solution. The resultant biomineralized HAP-SIS scaffolds were found to promote the attachment, growth and osteogenic differentiation of mesenchymal stem cells (MSCs) in both basal and osteogenic media by the evaluation of osteogenic marker formation. More importantly, the HAP-SIS scaffolds could induce the osteogenic differentiation in the basal media without osteogenic supplements due to the presence of HAP crystals in the scaffolds. Histological characterization of the MSC-seeded scaffolds showed that HAP-SIS scaffolds are biocompatible and promote the formation of new tissue in vitro. The biomineralized SIS membranes mimic some aspects of natural bone in terms of the composition and nanostructures and can find potential use in bone tissue engineering.
C1 [Yang, Mingying; Zhou, Guanshan] Zhejiang Univ, Coll Anim Sci, Inst Appl Bioresource Res, Hangzhou 310058, Zhejiang, Peoples R China.
   [Castano-Izquierdo, Harold; Zhu, Ye; Mao, Chuanbin] Univ Oklahoma, Stephenson Life Sci Res Ctr, Dept Chem & Biochem, Norman, OK 73019 USA.
RP Yang, MY (reprint author), Zhejiang Univ, Coll Anim Sci, Inst Appl Bioresource Res, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China.
EM yangm@zju.edu.cn; cbmao@ou.edu
OI Mao, Chuanbin/0000-0002-8142-3659
FU National Science Foundation [CBET-0854465, CMMI-1234957, CBET-0854414,
   DMR-0847758]; National Institutes of Health [HL0925264, EB015190,
   AR056848]; Department of Defense Peer Reviewed Medical Research Program
   [W81XWH-12-1-0384]; Oklahoma Center for the Advancement of Science and
   Technology [HR11-006]; Oklahoma Center for Adult Stem Cell Research
   [434003]; National High Technology Research and Development Program 863
   [2013AA102507]; Zhejiang Provincial Natural Science Foundation of China
   [LZ12C17001]; National Natural Science Foundation of China [20804037,
   21172194]; Silkworm Industry Science and Technology Innovation Team
   [2011R50028]
FX We would like to thank the financial support from National Science
   Foundation (CBET-0854465, CMMI-1234957, CBET-0854414, and DMR-0847758),
   National Institutes of Health (HL0925264, EB015190, AR056848),
   Department of Defense Peer Reviewed Medical Research Program
   (W81XWH-12-1-0384), Oklahoma Center for the Advancement of Science and
   Technology (HR11-006) and Oklahoma Center for Adult Stem Cell Research
   (434003). MY also thank the generous support from National High
   Technology Research and Development Program 863 (2013AA102507), Zhejiang
   Provincial Natural Science Foundation of China (LZ12C17001), National
   Natural Science Foundation of China (20804037 and 21172194) and Silkworm
   Industry Science and Technology Innovation Team (2011R50028).
CR Ayyildiz A, 2008, ANZ J SURG, V78, P82, DOI 10.1111/j.1445-2197.2007.04361.x
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   Bera S., 2005, BIOMATERIALS, V26, P1997
   Bourgeois B, 2003, J BIOMED MATER RES A, V65A, P402, DOI 10.1002/jbm.a.10518
   BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303
   Caione P, 2006, PEDIATR SURG INT, V22, P593, DOI 10.1007/s00383-006-1705-9
   Cao B, 2007, LANGMUIR, V23, P10701, DOI 10.1021/1a7014435
   Cao BR, 2014, METHODS MOL BIOL, V1108, P123, DOI 10.1007/978-1-62703-751-8_10
   Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082
   Chen MK, 2001, J SURG RES, V99, P352, DOI 10.1006/jsre.2001.6199
   Chou YF, 2005, J BIOMED MATER RES B, V75B, P81, DOI 10.1002/jbm.b.30261
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Datta N, 2005, BIOMATERIALS, V26, P971, DOI 10.1016/j.biomaterials.2004.04.001
   Declerq HA, 2005, BIOMATERIALS, V26, P4964, DOI 10.1016/j.biomaterials.2005.01.025
   Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675
   Gastel JA, 2001, ARTHROSCOPY, V17, P151, DOI 10.1053/jars.2001.20959
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Helton WS, 2005, ARCH SURG-CHICAGO, V140, P549, DOI 10.1001/archsurg.140.6.549
   Hing KA, 2004, PHILOS T R SOC A, V362, P2821, DOI 10.1098/rsta.2004.1466
   Kretlow JD, 2007, TISSUE ENG, V13, P927, DOI 10.1089/ten.2006.0394
   Kropp BP, 1998, UROLOGY, V52, P138, DOI 10.1016/S0090-4295(98)00114-9
   Lai JY, 2003, J PEDIATR SURG, V38, P1752, DOI 10.1016/S0022-3468(03)00617-1
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Ledet Eric H, 2002, Spine J, V2, P188, DOI 10.1016/S1529-9430(02)00182-1
   Li D, 2012, J MATER CHEM, V22, P15702, DOI 10.1039/c2jm31034a
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Lock J, 2012, J MATER SCI-MATER M, V23, P2543, DOI 10.1007/s10856-012-4709-0
   Mann S., 2001, BIOMINERALIZATION PR, P1
   Mao CB, 1999, J CRYST GROWTH, V206, P308, DOI 10.1016/S0022-0248(99)00315-2
   Mao CB, 1999, J MATER CHEM, V9, P2573, DOI 10.1039/a901309a
   Mao CB, 1998, J MATER CHEM, V8, P2795, DOI 10.1039/a801384e
   Murphy WL, 2002, NAT BIOTECHNOL, V20, P30, DOI 10.1038/nbt0102-30
   Musahl V, 2004, J ORTHOP RES, V22, P214, DOI 10.1016/S0736-0266(03)00163-3
   Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268
   Ramires PA, 2001, BIOMATERIALS, V22, P1467, DOI 10.1016/S0142-9612(00)00269-6
   Ravichandran R, 2012, BIOMATERIALS, V33, P846, DOI 10.1016/j.biomaterials.2011.10.030
   Rosa Adalberto Luiz, 2002, Pesqui Odontol Bras, V16, P209, DOI 10.1590/S1517-74912002000300005
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Sato M, 2004, EXPERT REV MED DEVIC, V1, P105, DOI 10.1586/17434440.1.1.105
   Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587
   SILVERSTONE LM, 1981, CARIES RES, V15, P138, DOI 10.1159/000260512
   Suganya S, 2014, J BIOMATER TISS ENG, V4, P9, DOI 10.1166/jbt.2014.1139
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Thorwarth M, 2005, BIOMATERIALS, V26, P5648, DOI 10.1016/j.biomaterials.2005.02.023
   Venugopal J, 2013, J BIOMAT SCI-POLYM E, V24, P170, DOI 10.1163/156856212X629845
   Venugopal JR, 2011, CELL BIOL INT, V35, P73, DOI 10.1042/CBI20090066
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wang JL, 2014, ADV MATER, V26, P4961, DOI 10.1002/adma.201400154
   Wang JL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01242
   Wang JL, 2012, J BIOMED MATER RES A, V100A, P2929, DOI 10.1002/jbm.a.34236
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Xu H, 2011, BIOMACROMOLECULES, V12, P2193, DOI 10.1021/bm200274r
   Yang MY, 2014, BIOMACROMOLECULES, V15, P1185, DOI 10.1021/bm401740x
   Zhang YZ, 2010, TISSUE ENG PT A, V16, P1949, DOI [10.1089/ten.tea.2009.0221, 10.1089/ten.TEA.2009.0221]
   Zhu HB, 2011, BIOMATERIALS, V32, P4744, DOI 10.1016/j.biomaterials.2011.03.030
NR 60
TC 20
Z9 20
U1 0
U2 110
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD MAR
PY 2015
VL 11
IS 3
BP 447
EP 456
DI 10.1166/jbn.2015.2038
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA AT5FL
UT WOS:000344969500008
PM 25883539
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Seo, SH
   Uhm, SH
   Kwon, JS
   Choi, EH
   Kim, KM
   Kim, KN
AF Seo, Sang-Hee
   Uhm, Soo-Hyuk
   Kwon, Jae-Sung
   Choi, Eun Ha
   Kim, Kwang-Mahn
   Kim, Kyoung-Nam
TI An Alternative to Annealing TiO2 Nanotubes for Morphology Preservation:
   Atmospheric Pressure Plasma Jet Treatment
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE Non-Thermal Atmospheric Pressure Plasma; Plasma Electrolytic Oxidation;
   TiO2 Nanotube Structure; Surface Characteristic; Osteoblast Behavior
ID HYDROTHERMAL TREATMENT; CHEMICAL-COMPOSITION; TITANIA NANOTUBES; CELL
   FATE; IN-VITRO; SURFACE; OSTEOBLAST; BONE; IMPLANTS; ADHESION
AB Titanium oxide nanotube layer formed by plasma electrolytic oxidation (PEO) is known to be excellent in biomaterial applications. However, the annealing process which is commonly performed on the TiO2 nanotubes cause defects in the nanotubular structure. The purpose of this work was to apply a non-thermal atmospheric pressure plasma jet on diameter-controlled TiO2 nanotubes to mimic the effects of annealing while maintaining the tubular structure for use as biomaterial. Diameter-controlled nanotube samples fabricated by plasma electrolytic oxidation were dried and prepared under three different conditions: untreated, annealed at 450 degrees C for 1 h in air with a heating rate of 10 degrees C/min, and treated with an air-based non-thermal atmospheric pressure plasma jet for 5 minutes. The contact angle measurement was investigated to confirm the enhanced hydrophilicity of the TiO2 nanotubes. The chemical composition of the surface was studied using X-ray photoelectron spectroscopy, and the morphology of TiO2 nanotubes was examined by field emission scanning electron microscopy. For the viability of the cell, the attachment of the osteoblastic cell line MC3T3-E1 was determined using the water-soluble tetrazolium salt assay. We found that there are no morphological changes in the TiO2 nanotubular structure after the plasma treatment. Also, we investigated a change in the chemical composition and enhanced hydrophilicity which result in improved cell behavior. The results of this study indicated that the non-thermal atmospheric pressure plasma jet results in osteoblast functionality that is comparable to annealed samples while maintaining the tubular structure of the TiO2 nanotubes. Therefore, this study concluded that the use of a non-thermal atmospheric pressure plasma jet on nanotube surfaces may replace the annealing process following plasma electrolytic oxidation.
C1 [Seo, Sang-Hee; Uhm, Soo-Hyuk; Kwon, Jae-Sung; Kim, Kwang-Mahn; Kim, Kyoung-Nam] Yonsei Univ, Dept & Res Inst Dent Biomat & Bioengn, Coll Dent, Seoul 120752, South Korea.
   [Seo, Sang-Hee; Kim, Kyoung-Nam] Yonsei Univ, Coll Dent, Brain Korea PLUS Project 21, Seoul 120752, South Korea.
   [Choi, Eun Ha] Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul 139701, South Korea.
RP Kim, KN (reprint author), Yonsei Univ, Dept & Res Inst Dent Biomat & Bioengn, Coll Dent, 50-1 Yonsei Ro, Seoul 120752, South Korea.
RI Kwon, Jae-Sung/M-5430-2018
OI Kwon, Jae-Sung/0000-0001-9803-7730
FU National Research Foundation of Korea (NRF) - Korea government (MSIP)
   [NRF-2010-0027963]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MSIP) (NRF-2010-0027963).
CR Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004
   Albu SP, 2010, EUR J INORG CHEM, P4351, DOI 10.1002/ejic.201000608
   Bai Y, 2011, SURF INTERFACE ANAL, V43, P998, DOI 10.1002/sia.3683
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Cooper LF, 2006, BIOMATERIALS, V27, P926, DOI 10.1016/j.biomaterials.2005.07.009
   De S, 2005, J BIOMAT SCI-POLYM E, V16, P973, DOI 10.1163/1568562054414612
   GONBEAU D, 1991, SURF SCI, V254, P81, DOI 10.1016/0039-6028(91)90640-E
   Guo J, 2007, BIOMATERIALS, V28, P5418, DOI 10.1016/j.biomaterials.2007.08.032
   Hong YC, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3272089
   Kieft IE, 2006, IEEE T PLASMA SCI, V34, P1331, DOI 10.1109/TPS.2006.876511
   Kim MC, 2003, SURF COAT TECH, V171, P312, DOI 10.1016/S0257-8972(03)00292-5
   Kwon JS, 2013, CURR APPL PHYS, V13, pS42, DOI 10.1016/j.cap.2012.12.022
   Lee EJ, 2013, CURR APPL PHYS, V13, pS36, DOI 10.1016/j.cap.2012.12.023
   LEGEROS RZ, 1993, J BONE MINER RES, V8, pS583
   Mazare A, 2012, BIOELECTROCHEMISTRY, V87, P124, DOI 10.1016/j.bioelechem.2012.01.002
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Ou HH, 2007, SEP PURIF TECHNOL, V58, P179, DOI 10.1016/j.seppur.2007.07.017
   Park G, 2012, J KOREAN PHYS SOC, V60, P916, DOI 10.3938/jkps.60.916
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Peng LL, 2009, NANO LETT, V9, P1932, DOI 10.1021/nl9001052
   Regonini D, 2010, SURF INTERFACE ANAL, V42, P139, DOI 10.1002/sia.3183
   Shibata Y, 2002, INT J ORAL MAX IMPL, V17, P771
   Sreekantan S, 2009, THIN SOLID FILMS, V518, P16, DOI 10.1016/j.tsf.2009.06.002
   Stoffels E, 2003, J PHYS D APPL PHYS, V36, P2908, DOI 10.1088/0022-3727/36/23/007
   Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4
   Uhm HS, 2012, J KOREAN PHYS SOC, V60, P897, DOI 10.3938/jkps.60.897
   Vlacic-Zischke J, 2011, BIOMATERIALS, V32, P665, DOI 10.1016/j.biomaterials.2010.09.025
   Wong CL, 2011, J ENVIRON MANAGE, V92, P1669, DOI 10.1016/j.jenvman.2011.03.006
   Yang B, 2011, MATER CHEM PHYS, V130, P1227, DOI 10.1016/j.matchemphys.2011.08.063
   Yu WQ, 2010, ORAL DIS, V16, P624, DOI 10.1111/j.1601-0825.2009.01643.x
NR 31
TC 4
Z9 4
U1 3
U2 50
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD MAR
PY 2015
VL 15
IS 3
BP 2501
EP 2507
DI 10.1166/jnn.2015.10244
PG 7
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA AT6NC
UT WOS:000345054200093
PM 26413696
DA 2018-10-19
ER

PT J
AU Rong, ZC
   Zeng, W
   Kuang, YS
   Zhang, JW
   Liu, XY
   Lu, Y
   Cheng, XR
AF Rong, Zhicheng
   Zeng, Wen
   Kuang, Yanshen
   Zhang, Jianwei
   Liu, Xingyun
   Lu, Yuan
   Cheng, Xiangrong
TI Enhanced Bioactivity of Osteoblast-like Cells on Poly(lactic
   acid)/Poly(methyl methacrylate)/Nano-hydroxyapatite Scaffolds for Bone
   Tissue Engineering
SO FIBERS AND POLYMERS
LA English
DT Article
DE Hydroxyapatite nanoparticles; Nanofibrous scaffolds; Bioactivity; Bone
   tissue engineering
ID INTERCALATED NANOFIBROUS MATS; BACTERIAL-INHIBITION ACTIVITY;
   MECHANICAL-PROPERTIES; DRUG-DELIVERY; IN-VITRO; CULTURE; FABRICATION;
   COLLAGEN; COMPOSITE; FIBERS
AB Bone tissue engineering has great potential but requires an appropriate substrate with good bioactivity. In this study, poly(lactic acid) (PLA)/poly(methyl methacrylate) (PMMA)/nano-hydroxyapatite (n-HA) hybrid nanofibrous scaffolds were fabricated via electrospinning. The morphologies of the scaffolds were observed by scanning electron microscopy, transmission electron microscopy and the structures of the scaffolds were measured by fourier transform infrared spectrum. After immersion in simulated body fluid, the more deposition of ball-like apatite can be observed on the surface of the hybrid PLA/PMMA/n-HA scaffold. In vitro degradation experiments showed that the less degradation occurred in the hybrid PLA/PMMA/n-HA scaffold. The studies of cell adhesion and growth capability were investigated by incubating the osteoblast-like cells (MG-63) in the scaffolds, which verified the addition of n-HA could promote the adhesion and proliferation of the Human osteoblast-like cells (MG-63). Hence, the electrospun hybrid PLA/PMMA/n-HA nanofibrous 'scaffold is a promising biomaterial, propitious to be a substrate for bone tissue engineering.
C1 [Rong, Zhicheng; Cheng, Xiangrong] Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed Engn, Minist Educ, Wuhan 430079, Peoples R China.
   [Zeng, Wen; Zhang, Jianwei] Wuhan Univ, Sch Resource & Environm Sci, Wuhan 430079, Peoples R China.
   [Kuang, Yanshen] Wuhan Univ, Zhongnan Hosp, Wuhan 430079, Peoples R China.
   [Liu, Xingyun; Lu, Yuan] Guangxi Univ, Sch Chem & Chem Engn, Nanning 530004, Peoples R China.
RP Cheng, XR (reprint author), Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed Engn, Minist Educ, Wuhan 430079, Peoples R China.
EM xiangrongcheng@hotmail.com
FU National Natural Science Foundation of China [30772445]
FX This project was funded by National Natural Science Foundation of China
   (No.30772445).
CR Antunes JC, 2010, J BIOMED MATER RES A, V94A, P856, DOI 10.1002/jbm.a.32753
   Cao H., 2012, J MATER SCI, V48, P150
   Chang BW, 2005, SENSOR ACTUAT B-CHEM, V105, P159, DOI 10.1016/j.snb.2004.05.048
   Chaplin RPS, 2006, J MATER SCI-MATER M, V17, P1433, DOI 10.1007/s10856-006-0619-3
   Deng HB, 2011, CARBOHYD POLYM, V83, P973, DOI 10.1016/j.carbpol.2010.09.008
   Deng HB, 2011, CARBOHYD POLYM, V83, P239, DOI 10.1016/j.carbpol.2010.07.042
   Deng HB, 2010, CARBOHYD POLYM, V80, P474, DOI 10.1016/j.carbpol.2009.12.004
   Dong H, 2004, J POLYM SCI POL PHYS, V42, P3934, DOI 10.1002/polb.20253
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   Du J, 2013, CURR NANOSCI, V9, P8
   Fischer RL, 2012, J MATER SCI-MATER M, V23, P1645, DOI 10.1007/s10856-012-4641-3
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   Frenot A, 2003, CURR OPIN COLLOID IN, V8, P64, DOI 10.1016/S1359-0294(03)00004-9
   Frohlich M, 2008, CURR STEM CELL RES T, V3, P254, DOI 10.2174/157488808786733962
   Goh YF, 2013, J MATER SCI, V48, P3027, DOI 10.1007/s10853-013-7145-8
   Hou XN, 2011, APPL SURF SCI, V257, P3417, DOI 10.1016/j.apsusc.2010.11.037
   Huang WJ, 2013, INT J BIOL MACROMOL, V53, P26, DOI 10.1016/j.ijbiomac.2012.10.024
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Jaiswal AK, 2013, APPL SURF SCI, V268, P477, DOI 10.1016/j.apsusc.2012.12.152
   Kai D, 2011, J BIOMED MATER RES A, V99A, P376, DOI 10.1002/jbm.a.33200
   Kane RJ, 2012, J MECH BEHAV BIOMED, V7, P41, DOI 10.1016/j.jmbbm.2011.09.010
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   Li W, 2012, EUR POLYM J, V48, P1846, DOI 10.1016/j.eurpolymj.2012.08.001
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Liao S, 2008, J MECH BEHAV BIOMED, V1, P252, DOI 10.1016/j.jmbbm.2008.01.007
   Liu HH, 2010, J BIOMED MATER RES B, V95B, P36, DOI 10.1002/jbm.b.31680
   Liu H, 2012, J APPL POLYM SCI, V125, pE468, DOI 10.1002/app.36757
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Mao L, 2013, NANOSCALE, V5, P9517, DOI 10.1039/c3nr02912c
   Mousa WF, 2000, BIOMATERIALS, V21, P2137, DOI 10.1016/S0142-9612(00)00097-1
   Nagarwal RC, 2011, COLLOID SURFACE B, V86, P28, DOI 10.1016/j.colsurfb.2011.03.023
   Nirmala R, 2010, SURF COAT TECH, V205, P174, DOI 10.1016/j.surfcoat.2010.06.027
   Pelipenko J., 2012, EUR J PHARM BIOPHARM, V84, P401
   Prabhakaran MP, 2009, ACTA BIOMATER, V5, P2884, DOI 10.1016/j.actbio.2009.05.007
   Rabadjieva D., 2011, NANOSCI NANOTECHNOL, V11, P182
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Tian LL, 2013, J BIOMAT SCI-POLYM E, V24, P1952, DOI 10.1080/09205063.2013.814096
   Wang XF, 2013, PROG MATER SCI, V58, P1173, DOI 10.1016/j.pmatsci.2013.05.001
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wu CT, 2006, J BIOMED MATER RES B, V78B, P47, DOI 10.1002/jbm.b.30456
   Wu C, 2009, BIOMATERIALS, V30, P2199, DOI 10.1016/j.biomaterials.2009.01.029
   Wu CT, 2006, J BIOMED MATER RES A, V76A, P73, DOI 10.1002/jbm.a.30496
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
   Yuan J, 2008, POLYM INT, V57, P1188, DOI 10.1002/pi.2463
   Zhang HL, 2011, J BIOACT COMPAT POL, V26, P590, DOI 10.1177/0883911511424015
NR 46
TC 7
Z9 7
U1 8
U2 63
PU KOREAN FIBER SOC
PI SEOUL
PA KOREA SCIENCE TECHNOLOGY CTR #501 635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA
SN 1229-9197
EI 1875-0052
J9 FIBER POLYM
JI Fiber. Polym.
PD FEB 28
PY 2015
VL 16
IS 2
BP 245
EP 253
DI 10.1007/s12221-015-0245-0
PG 9
WC Materials Science, Textiles; Polymer Science
SC Materials Science; Polymer Science
GA CC3TB
UT WOS:000350271200003
DA 2018-10-19
ER

PT J
AU Tverdokhlebov, SI
   Bolbasov, EN
   Shesterikov, EV
   Antonova, LV
   Golovkin, AS
   Matveeva, VG
   Petlin, DG
   Anissimov, YG
AF Tverdokhlebov, S. I.
   Bolbasov, E. N.
   Shesterikov, E. V.
   Antonova, L. V.
   Golovkin, A. S.
   Matveeva, V. G.
   Petlin, D. G.
   Anissimov, Y. G.
TI Modification of polylactic acid surface using RF plasma discharge with
   sputter deposition of a hydroxyapatite target for increased
   biocompatibility
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Polylactic acid; Biomaterial; Biocompatibility; Magnetron sputter
   deposition; Calcium-phosphate
ID CALCIUM-PHOSPHATE COATINGS; INFRARED CORRELATION SPECTROSCOPY; MULTIPLE
   MELTING BEHAVIOR; L-LACTIC ACID; POLY(L-LACTIC ACID); IMPLANT SURFACES;
   CRYSTALLIZATION; POLYMERS; POLYETHYLENE; CONFORMATION
AB Surface modification of polylactic acid (PLLA) by plasma of radio-frequency magnetron discharge with hydroxyapatite target sputtering was investigated. Increased biocompatibility was demonstrated using studies with bone marrow multipotent mesenchymal stromal cells. Atomic force microscopy demonstrates that the plasma treatment modifies the surface morphology of PLLA to produce rougher surface. Infrared spectroscopy and X-ray diffraction revealed that changes in the surface morphology are caused by the processes of PLLA crystallization. Fluorescent X-ray spectroscopy showed that the plasma treatment also changes the chemical composition of PLLA, enriching it with ions of the sputtered target: calcium, phosphorus and oxygen. It is hypothesized that these surface modifications increase biocompatibility of PLLA without increasing toxicity. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Tverdokhlebov, S. I.; Bolbasov, E. N.; Shesterikov, E. V.] Tomsk Polytech Univ, Tomsk 634050, Russia.
   [Antonova, L. V.; Golovkin, A. S.; Matveeva, V. G.] Fed State Budgetary Inst Res Inst Complex Issues, Kemerovo 650002, Russia.
   [Petlin, D. G.; Anissimov, Y. G.] Griffith Univ, Sch Nat Sci, Southport, Qld 4222, Australia.
RP Tverdokhlebov, SI (reprint author), Tomsk Polytech Univ, 30 Lenin Ave, Tomsk 634050, Russia.
EM tverd@tpu.ru
RI Griffith University, QMNC/I-5498-2013; Golovkin, Alexey/I-2583-2014;
   Anissimov, Yuri/H-4947-2013
OI Golovkin, Alexey/0000-0002-7577-628X; Anissimov,
   Yuri/0000-0002-1124-5826; Bolbasov, Evgeny/0000-0002-9789-2185;
   Tverdokhlebov, Sergei/0000-0002-2242-6358
FU Federal Target Program [14.578.21.0031, RFMEFI57714X0036]; Russian
   Foundation for Basic Research [13-08-98052 r_sibir_a]
FX The authors would like to thank V. Novikov (Tomsk State University) for
   conducting AFM studies. This work was financially supported by the
   Federal Target Program (agreement # 14.578.21.0031, unique identifier
   RFMEFI57714X0036); Russian Foundation for Basic Research (projects
   #13-08-98052 r_sibir_a).
CR Armentano I, 2010, POLYM DEGRAD STABIL, V95, P2126, DOI 10.1016/j.polymdegradstab.2010.06.007
   Bauer S, 2013, PROG MATER SCI, V58, P261, DOI 10.1016/j.pmatsci.2012.09.001
   Bolbasov EN, 2014, MATER LETT, V132, P281, DOI 10.1016/j.matlet.2014.06.115
   Boyd AR, 2013, SURF COAT TECH, V233, P131, DOI 10.1016/j.surfcoat.2013.04.017
   Boyd AR, 2013, J MATER SCI-MATER M, V24, P2845, DOI 10.1007/s10856-013-5021-3
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   DESANTIS P, 1968, BIOPOLYMERS, V6, P299, DOI 10.1002/bip.1968.360060305
   Djafer AZA, 2014, APPL SURF SCI, V312, P57, DOI 10.1016/j.apsusc.2014.05.084
   Feddes B, 2004, J ADHES SCI TECHNOL, V18, P655, DOI 10.1163/156856104839347
   Feddes B, 2004, SURF COAT TECH, V185, P346, DOI 10.1016/S0257-8972(03)01313-6
   Feddes B, 2004, BIOMATERIALS, V25, P633, DOI 10.1016/S0142-9612(03)00574-X
   Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742
   HULSHOFF JEG, 1995, J BIOMED MATER RES, V29, P967, DOI 10.1002/jbm.820290808
   Kister G, 1998, POLYMER, V39, P267, DOI 10.1016/S0032-3861(97)00229-2
   Konischev ME, 2014, RUSS PHYS J+, V56, P1144, DOI 10.1007/s11182-014-0154-5
   Lizundia E, 2013, J MECH BEHAV BIOMED, V17, P242, DOI 10.1016/j.jmbbm.2012.09.006
   Ma TY, 2013, APPL SURF SCI, V286, P131, DOI 10.1016/j.apsusc.2013.09.035
   Morent R, 2011, PLASMA PROCESS POLYM, V8, P171, DOI 10.1002/ppap.201000153
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Pan P, 2007, MACROMOLECULES, V40, P6898, DOI 10.1021/ma071258d
   Pan P, 2009, MACROMOLECULES, V42, P3374, DOI 10.1021/ma8024943
   Pichugin VF, 2008, SURF COAT TECH, V202, P3913, DOI 10.1016/j.surfcoat.2008.01.038
   Poncin-Epaillard F, 2013, MAT SCI ENG C-MATER, V33, P2526, DOI 10.1016/j.msec.2013.02.010
   Rasal RM, 2010, PROG POLYM SCI, V35, P338, DOI 10.1016/j.progpolymsci.2009.12.003
   Ribeiro C., 2011, SCI TECHNOL ADV MAT, V12, P1
   Ryu GH, 2005, SURF COAT TECH, V193, P60, DOI 10.1016/j.surfcoat.2004.07.062
   Saeidlou S, 2012, PROG POLYM SCI, V37, P1657, DOI 10.1016/j.progpolymsci.2012.07.005
   Shtansky DV, 2013, APPL SURF SCI, V285, P331, DOI 10.1016/j.apsusc.2013.07.169
   Shtansky DV, 2011, SURF COAT TECH, V206, P1188, DOI 10.1016/j.surfcoat.2011.08.029
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Tverdokhlebov SI, 2012, APPL SURF SCI, V263, P187, DOI 10.1016/j.apsusc.2012.09.025
   Vasanthan N, 2009, POLYM DEGRAD STABIL, V94, P1364, DOI 10.1016/j.polymdegradstab.2009.05.015
   von der Mark K, 2013, PROG MATER SCI, V58, P327, DOI 10.1016/j.pmatsci.2012.09.002
   Yasuniwa M, 2008, POLYMER, V49, P1943, DOI 10.1016/j.polymer.2008.02.034
   Yoshida S, 2013, SURF COAT TECH, V233, P99, DOI 10.1016/j.surfcoat.2013.02.042
   Zhang J, 2008, MACROMOLECULES, V41, P1352, DOI 10.1021/ma0706071
   Zhang JM, 2004, MACROMOLECULES, V37, P6433, DOI 10.1021/ma049288t
   Zhang JM, 2004, J PHYS CHEM B, V108, P11514, DOI 10.1021/jp048308q
   Zhang JM, 2005, MACROMOLECULES, V38, P8012, DOI 10.1021/ma051232r
NR 40
TC 17
Z9 18
U1 1
U2 49
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD FEB 28
PY 2015
VL 329
BP 32
EP 39
DI 10.1016/j.apsusc.2014.12.127
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA CB4RV
UT WOS:000349616500005
DA 2018-10-19
ER

PT J
AU Liu, Y
   Li, Y
   Yang, G
   Zheng, XT
   Zhou, SB
AF Liu, Ye
   Li, Ying
   Yang, Guang
   Zheng, Xiaotong
   Zhou, Shaobing
TI Multi-Stimulus-Responsive Shape-Memory Polymer Nanocomposite Network
   Cross-Linked by Cellulose Nanocrystals
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE shape memory; water-responsive; thermoresponsive; nonocomposite;
   cellulose nanocrystals
ID MICROCRYSTALLINE CELLULOSE; CRYSTAL-STRUCTURE; POLYURETHANE; COMPOSITES;
   COPOLYMER; DELIVERY; MOISTURE; BEHAVIOR; RELEASE; LIGHT
AB In this study, we developed a thermoresponsive and water-responsive shape-memory polymer nanocomposite network by chemically cross-linking cellulose nanocrystals (CNCs) with polycaprolactone (PCL) and polyethylene glycol (PEG). The nanocomposite network was fully characterized, including the microstructure, cross-link density, water contact angle, water uptake, crystallinity, thermal properties, and static and dynamic mechanical properties. We found that the PEG[60]-PCL[40]-CNC[10] nanocomposite exhibited excellent thermo-induced and water-induced shape-memory effects in water at 37 degrees C (close to body temperature), and the introduction of CNC clearly improved the mechanical properties of the mixture of both PEG and PCL polymers with low molecular weights. In addition, Alamar blue assays based on osteoblasts indicated that the nanocomposites possessed good cytocompatibility. Therefore, this thermoresponsive and water-responsive shape-memory nanocomposite could be potentially developed into a new smart biomaterial.
C1 [Liu, Ye; Li, Ying; Yang, Guang; Zheng, Xiaotong; Zhou, Shaobing] Southwest Jiaotong Univ, Key Lab Adv Technol Mat, Minist Educ, Sch Mat Sci & Engn, Chengdu 610031, Sichuan, Peoples R China.
RP Zhou, SB (reprint author), Southwest Jiaotong Univ, Key Lab Adv Technol Mat, Minist Educ, Sch Mat Sci & Engn, Chengdu 610031, Sichuan, Peoples R China.
EM shaobingzhou@swjtu.edu.cn
RI zhou, shaobing/B-3148-2010
FU National Basic Research Program of China (973 Program) [2012CB933600];
   National Natural Science Foundation of China [51173150, 51203130,
   51373138]; National Key Project of Scientific and Technical Supporting
   Programs - MSTC [2012BAI17B06]; Research Fund for the Doctoral Program
   of Higher Education of China [20120184110029]; Construction Program for
   Innovative Research Team of University in Sichuan Province [14TD0050]
FX This work was partially supported by the National Basic Research Program
   of China (973 Program, 2012CB933600), the National Natural Science
   Foundation of China (51173150, 51203130, and 51373138), the National Key
   Project of Scientific and Technical Supporting Programs Funded by MSTC
   (2012BAI17B06), the Research Fund for the Doctoral Program of Higher
   Education of China (20120184110029), and the Construction Program for
   Innovative Research Team of University in Sichuan Province (14TD0050).
CR Agarwal P, 2011, ANGEW CHEM INT EDIT, V50, P8670, DOI 10.1002/anie.201103908
   Auad ML, 2008, POLYM INT, V57, P651, DOI 10.1002/pi.2394
   Auad ML, 2012, POLYM INT, V61, P321, DOI 10.1002/pi.3193
   Azizi Samir M.A.S., 2005, BIOMACROMOLECULES, V6, P612, DOI DOI 10.1021/BM0493685
   Behl M, 2007, MATER TODAY, V10, P20, DOI 10.1016/S1369-7021(07)70047-0
   Bondeson D, 2006, CELLULOSE, V13, P171, DOI 10.1007/s10570-006-9061-4
   Cao XD, 2009, J MATER CHEM, V19, P7137, DOI 10.1039/b910517d
   Capadona JR, 2007, NAT NANOTECHNOL, V2, P765, DOI 10.1038/nnano.2007.379
   Chen SJ, 2011, J MATER SCI, V46, P6581, DOI 10.1007/s10853-011-5606-5
   Chen SJ, 2009, POLYMER, V50, P4424, DOI 10.1016/j.polymer.2009.07.031
   De Souza Lima M.M., 2004, MACROMOL RAPID COMM, V25, P771, DOI DOI 10.1002/MARC.200300268
   FAVIER V, 1995, POLYM ADVAN TECHNOL, V6, P351, DOI 10.1002/pat.1995.220060514
   Gong T, 2014, J MATER CHEM B, V2, P6855, DOI 10.1039/c4tb01155d
   Gu XZ, 2013, RSC ADV, V3, P15783, DOI 10.1039/c3ra41337c
   Gu XZ, 2012, POLYMER, V53, P5924, DOI 10.1016/j.polymer.2012.09.056
   Habibi Y, 2008, J MATER CHEM, V18, P5002, DOI 10.1039/b809212e
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   HU HL, 1990, MACROMOLECULES, V23, P4604, DOI 10.1021/ma00223a017
   Jiang HY, 2006, ADV MATER, V18, P1471, DOI 10.1002/adma.200502266
   Jonoobi M, 2010, COMPOS SCI TECHNOL, V70, P1742, DOI 10.1016/j.compscitech.2010.07.005
   Jung YC, 2006, J MACROMOL SCI B, V45, P453, DOI 10.1080/00222340600767513
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496
   Leng JS, 2011, PROG MATER SCI, V56, P1077, DOI 10.1016/j.pmatsci.2011.03.001
   Liu C, 2007, J MATER CHEM, V17, P1543, DOI 10.1039/b615954k
   Liu X, 2014, BIOMACROMOLECULES, V15, P1019, DOI 10.1021/bm401911p
   Liu YJ, 2009, COMPOS SCI TECHNOL, V69, P2064, DOI 10.1016/j.compscitech.2008.08.016
   Liu Y, 2014, CARBOHYD POLYM, V104, P101, DOI 10.1016/j.carbpol.2014.01.031
   Luo XF, 2010, SOFT MATTER, V6, P2146, DOI 10.1039/c001295e
   Marcovich NE, 2006, J MATER RES, V21, P870, DOI 10.1557/JMR.2006.0105
   Mendez J, 2011, MACROMOLECULES, V44, P6827, DOI 10.1021/ma201502k
   Mohr R, 2006, P NATL ACAD SCI USA, V103, P3540, DOI 10.1073/pnas.0600079103
   Mya KY, 2011, J MATER CHEM, V21, P4827, DOI 10.1039/c0jm04459h
   Pei AH, 2011, MACROMOLECULES, V44, P4422, DOI 10.1021/ma200318k
   Qi XD, 2014, J MATER CHEM A, V2, P2240, DOI 10.1039/c3ta14340f
   Ratna D, 2008, J MATER SCI, V43, P254, DOI 10.1007/s10853-007-2176-7
   Sahoo NG, 2007, COMPOS SCI TECHNOL, V67, P1920, DOI 10.1016/j.compscitech.2006.10.013
   Shao SJ, 2011, INT J PHARMACEUT, V421, P310, DOI 10.1016/j.ijpharm.2011.09.033
   TAKAHASHI Y, 1973, MACROMOLECULES, V6, P672, DOI 10.1021/ma60035a005
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   TSAGAROPOULOS G, 1995, MACROMOLECULES, V28, P6067, DOI 10.1021/ma00122a011
   Wischke C, 2009, J CONTROL RELEASE, V138, P243, DOI 10.1016/j.jconrel.2009.05.027
   Wu QJ, 2007, BIOMACROMOLECULES, V8, P3687, DOI 10.1021/bm701061t
   Xiao Y, 2010, ACS APPL MATER INTER, V2, P3506, DOI 10.1021/am100692n
   Yakacki CM, 2007, BIOMATERIALS, V28, P2255, DOI 10.1016/j.biomaterials.2007.01.030
   Yang B, 2006, POLYMER, V47, P1348, DOI 10.1016/j.polymer.2005.12.051
   Yang B, 2004, SMART MATER STRUCT, V13, P191, DOI 10.1088/0964-1726/13/1/022
   Yu XJ, 2012, J MATER SCI-MATER M, V23, P581, DOI 10.1007/s10856-011-4475-4
   Yu XJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/23/235702
   Zhang YM, 2011, J MATER CHEM, V21, P9073, DOI 10.1039/c1jm11022e
   Zhao Q, 2013, CARBOHYD POLYM, V91, P169, DOI 10.1016/j.carbpol.2012.08.020
   Zheng XT, 2009, COLLOID SURFACE B, V71, P67, DOI 10.1016/j.colsurfb.2009.01.009
   Zheng XT, 2006, BIOMATERIALS, V27, P4288, DOI 10.1016/j.biomaterials.2006.03.043
   Zhou SB, 2003, BIOMATERIALS, V24, P3563, DOI 10.1016/S0142-9612(03)00207-2
   Zhu Y, 2012, SOFT MATTER, V8, P2509, DOI 10.1039/c2sm07035a
NR 56
TC 56
Z9 56
U1 20
U2 215
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD FEB 25
PY 2015
VL 7
IS 7
BP 4118
EP 4126
DI 10.1021/am5081056
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CC2RT
UT WOS:000350193000030
PM 25647407
DA 2018-10-19
ER

PT J
AU Hauptmann, V
   Menzel, M
   Weichert, N
   Reimers, K
   Spohn, U
   Conrad, U
AF Hauptmann, Valeska
   Menzel, Matthias
   Weichert, Nicola
   Reimers, Kerstin
   Spohn, Uwe
   Conrad, Udo
TI In planta production of ELPylated spidroin-based proteins results in
   non-cytotoxic biopolymers
SO BMC BIOTECHNOLOGY
LA English
DT Article
DE Spider silk; Immunogenicity; Synthetic spidroin; Biomaterial;
   Biocompatibility; Atomic force microscopy
ID RECOMBINANT SPIDER SILK; DRAGLINE SILK; TRANSGENIC PLANTS;
   ESCHERICHIA-COLI; MECHANICAL-PROPERTIES; PURIFICATION; BIOMATERIALS;
   ELASTIN; FUSION; GENES
AB Background: Spider silk is a tear-resistant and elastic biopolymer that has outstanding mechanical properties. Additionally, exiguous immunogenicity is anticipated for spider silks. Therefore, spider silk represents a potential ideal biomaterial for medical applications. All known spider silk proteins, so-called spidroins, reveal a composite nature of silk-specific units, allowing the recombinant production of individual and combined segments.
   Results: In this report, a miniaturized spidroin gene, named VSO1 that contains repetitive motifs of MaSp1 has been synthesized and combined to form multimers of distinct lengths, which were heterologously expressed as elastin-like peptide (ELP) fusion proteins in tobacco. The elastic penetration moduli of layered proteins were analyzed for different spidroin-based biopolymers. Moreover, we present the first immunological analysis of synthetic spidroin-based biopolymers. Characterization of the binding behavior of the sera after immunization by competitive ELISA suggested that the humoral immune response is mainly directed against the fusion partner ELP. In addition, cytocompatibility studies with murine embryonic fibroblasts indicated that recombinant spidroin-based biopolymers, in solution or as coated proteins, are well tolerated.
   Conclusion: The results show that spidroin-based biopolymers can induce humoral immune responses that are dependent on the fusion partner and the overall protein structure. Furthermore, cytocompatibility assays gave no indication of spidroin-derived cytotoxicity, suggesting that recombinant produced biopolymers composed of spider silk-like repetitive elements are suitable for biomedical applications.
C1 [Hauptmann, Valeska; Weichert, Nicola; Conrad, Udo] Leibniz Inst Plant Genet & Crop Plant Res, D-06466 Stadt Seeland, Ot Gatersleben, Germany.
   [Menzel, Matthias; Spohn, Uwe] Fraunhofer Inst Mech Mat, D-06120 Halle, Germany.
   [Reimers, Kerstin] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-30659 Hannover, Germany.
RP Conrad, U (reprint author), Leibniz Inst Plant Genet & Crop Plant Res, Corrensstr 3, D-06466 Stadt Seeland, Ot Gatersleben, Germany.
EM conradu@ipk-gatersleben.de
FU Fachagentur Nachwachsende Rohstoffe e.V. [FKZ 22037511]; Federal
   Ministry of Food and Agriculture, Germany
FX We kindly acknowledge the skillful technical support of Isolde Tillack,
   Christine Helmold and Ulrike Gresch. The authors are also grateful to
   Christina Reufsteck (BioMedImplant) for her support in the
   hemocompatibility tests and to Frank Rabenstein (JKI Quedlinburg) for
   his support on the immunization experiments. Further, we acknowledge all
   members of the International Society for Plant Molecular Farming for
   inspiring us and the exciting discussions about the production of spider
   silks. AFM analysis was financed by grant FKZ 22037511 of the
   Fachagentur Nachwachsende Rohstoffe e.V., supported by the Federal
   Ministry of Food and Agriculture, Germany.
CR Agapov II, 2009, DOKL BIOCHEM BIOPHYS, V426, P127, DOI 10.1134/S1607672909030016
   Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x
   Annabi N, 2013, BIOCHEM ENG J, V77, P110, DOI 10.1016/j.bej.2013.05.006
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   BAUMLEIN H, 1986, NUCLEIC ACIDS RES, V14, P2707, DOI 10.1093/nar/14.6.2707
   Bogush VG, 2009, J NEUROIMMUNE PHARM, V4, P17, DOI 10.1007/s11481-008-9129-z
   Chung H, 2012, CURR OPIN BIOTECH, V23, P957, DOI 10.1016/j.copbio.2012.03.013
   Conrad U, 2011, PLANT BIOTECHNOL J, V9, P22, DOI 10.1111/j.1467-7652.2010.00523.x
   Dams-Kozlowska H, 2013, J BIOMED MATER RES A, V101, P456, DOI 10.1002/jbm.a.34353
   DEBLAERE R, 1985, NUCLEIC ACIDS RES, V13, P4777, DOI 10.1093/nar/13.13.4777
   EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fiedler U, 1997, IMMUNOTECHNOLOGY, V3, P205, DOI 10.1016/S1380-2933(97)00014-6
   Floss DM, 2013, FUSION PROTEIN TECHN, P211
   Floss DM, 2008, PLANT BIOTECHNOL J, V6, P379, DOI 10.1111/j.1467-7652.2008.00326.x
   Floss DM, 2010, TRENDS BIOTECHNOL, V28, P37, DOI 10.1016/j.tibtech.2009.10.004
   Floss DM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/274346
   FRANCK A, 1980, CELL, V21, P285, DOI 10.1016/0092-8674(80)90136-1
   Gahrtz Manfred, 2009, V483, P289, DOI 10.1007/978-1-59745-407-0_17
   Ge X, 2006, BIOTECHNOL BIOENG, V95, P424, DOI 10.1002/bit.21046
   Gerritsen VB, 2002, PROTEIN SPOTLIGHT
   Hauptmann V, 2013, TRANSGENIC RES, V22, P369, DOI 10.1007/s11248-012-9655-6
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   Phan HT, 2011, INT J MOL SCI, V12, P2808, DOI 10.3390/ijms12052808
   Hofer M, 2012, BIOMATERIALS, V33, P1554, DOI 10.1016/j.biomaterials.2011.10.053
   HORSCH RB, 1985, SCIENCE, V227, P1229
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Korayem AM, 2007, BIOCHEM BIOPH RES CO, V352, P317, DOI 10.1016/j.bbrc.2006.11.022
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Lin DC, 2007, J BIOMECH ENG-T ASME, V129, P430, DOI 10.1115/1.2720924
   Liu HF, 2011, BIOMACROMOLECULES, V12, P2914, DOI 10.1021/bm200479f
   Mackay JA, 2008, INT J HYPERTHER, V24, P483, DOI 10.1080/02656730802149570
   Menassa R, 2004, PLANT BIOTECHNOL J, V2, P431, DOI 10.1111/j.1467-7652.2004.00087.x
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9
   NOACK S, 1980, FRESEN Z ANAL CHEM, V304, P250, DOI 10.1007/BF00488792
   Radtke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016990
   Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   Spiess K, 2010, MACROMOL BIOSCI, V10, P998, DOI 10.1002/mabi.201000071
   Sponner A, 2005, BIOCHEMISTRY-US, V44, P4727, DOI 10.1021/bi047671k
   Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109
   Vollrath F, 2002, IN VIVO, V16, P229
   WANDELT CI, 1992, PLANT J, V2, P181
   Weichert N, 2014, PLANT BIOTECHNOL J, V12, P265, DOI 10.1111/pbi.12135
   Wen HX, 2010, MOL BIOL REP, V37, P1815, DOI 10.1007/s11033-009-9615-2
   Wendt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021833
   Widhe M, 2010, BIOMATERIALS, V31, P9575, DOI 10.1016/j.biomaterials.2010.08.061
   Winkler S, 1999, INT J BIOL MACROMOL, V24, P265, DOI 10.1016/S0141-8130(98)00088-9
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Zeplin PH, 2014, ADV FUNCT MATER, V24, P2658, DOI 10.1002/adfm.201302813
NR 55
TC 5
Z9 5
U1 1
U2 14
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6750
J9 BMC BIOTECHNOL
JI BMC Biotechnol.
PD FEB 19
PY 2015
VL 15
AR 9
DI 10.1186/s12896-015-0123-2
PG 14
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CC2JK
UT WOS:000350171100001
PM 25888206
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Bellas, E
   Lo, TJ
   Fournier, EP
   Brown, JE
   Abbott, RD
   Gil, ES
   Marra, KG
   Rubin, JP
   Leisk, GG
   Kaplan, DL
AF Bellas, Evangelia
   Lo, Tim J.
   Fournier, Eric P.
   Brown, Joseph E.
   Abbott, Rosalyn D.
   Gil, Eun S.
   Marra, Kacey G.
   Rubin, J. Peter
   Leisk, Gary G.
   Kaplan, David L.
TI Injectable Silk Foams for Soft Tissue Regeneration
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID ADIPOSE-TISSUE; IN-VITRO; STEM-CELLS; MACROPHAGE PHENOTYPE; SCAFFOLDS;
   VIVO; FIBROIN; MODEL; AUGMENTATION; BIOMATERIALS
AB Soft tissue fillers are needed for restoration of a defect or augmentation of existing tissues. Autografts and lipotransfer have been under study for soft tissue reconstruction but yield inconsistent results, often with considerable resorption of the grafted tissue. A minimally invasive procedure would reduce scarring and recovery time as well as allow the implant and/or grafted tissue to be placed closer to existing vasculature. Here, the feasibility of an injectable silk foam for soft tissue regeneration is demonstrated. Adipose-derived stem cells survive and migrate through the foam over a 10-d period in vitro. The silk foams are also successfully injected into the subcutaneous space in a rat and over a 3-month period integrating with the surrounding native tissue. The injected foams are palpable and soft to the touch through the skin and returning to their original dimensions after pressure is applied and then released. The foams readily absorb lipoaspirate making the foams useful as a scaffold or template for existing soft tissue filler technologies, useful either as a biomaterial alone or in combination with the lipoaspirate.
C1 [Bellas, Evangelia; Lo, Tim J.; Fournier, Eric P.; Brown, Joseph E.; Abbott, Rosalyn D.; Gil, Eun S.; Leisk, Gary G.; Kaplan, David L.] Tufts Univ, Medford, MA 02155 USA.
   [Marra, Kacey G.; Rubin, J. Peter] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
OI Marra, Kacey/0000-0002-8437-4864; Abbott, Rosalyn/0000-0003-3287-3175
FU Armed Forces Institute for Regenerative Medicine (AFIRM)
   [W81XWH-08-2-0032]; NIH [P41 EB002520]
FX The authors wish to thank Dr. Sonal Pandya for providing the surgical
   specimens and Jodie Moreau and Jonathan Kluge for insightful
   discussions. This work was funded by Armed Forces Institute for
   Regenerative Medicine (AFIRM) W81XWH-08-2-0032 and the NIH - P41
   EB002520.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   [Anonymous], 2010, AM SOC PLAST SURG RE
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Bellas E, 2013, TISSUE ENG PART C-ME, V19, P745, DOI [10.1089/ten.tec.2012.0620, 10.1089/ten.TEC.2012.0620]
   Bellas E, 2013, BIOMATERIALS, V34, P2960, DOI 10.1016/j.biomaterials.2013.01.058
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Choi JH, 2011, METHODS MOL BIOL, V702, P319, DOI 10.1007/978-1-61737-960-4_23
   Etienne O, 2009, J PERIODONTOL, V80, P1852, DOI 10.1902/jop.2009.090231
   Geerligs M, 2008, BIORHEOLOGY, V45, P677, DOI 10.3233/BIR-2008-0517
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Horan RL, 2009, HERNIA, V13, P189, DOI 10.1007/s10029-008-0459-9
   Kang JH, 2009, TISSUE ENG PT A, V15, P2227, DOI 10.1089/ten.tea.2008.0469
   Kim HJ, 2005, AUST J CHEM, V58, P716, DOI 10.1071/CH05170
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235
   Park JE, 2011, J MATER SCI-MATER M, V22, P1171, DOI 10.1007/s10856-011-4289-4
   Patrick C., 2001, ANAT REC, V366, P361
   Radisic M, 2003, BIOTECHNOL BIOENG, V82, P403, DOI 10.1002/bit.10594
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rohrich RJ, 2004, PLAST RECONSTR SURG, V113, P391, DOI 10.1097/01.PRS.0000097293.56504.00
   Samani A, 2003, PHYS MED BIOL, V48, P2183, DOI 10.1088/0031-9155/48/14/310
   Stosich MS, 2007, PLAST RECONSTR SURG, V119, P71, DOI 10.1097/01.prs.0000244840.80661.e7
   Stosich MS, 2009, METHODS, V47, P116, DOI 10.1016/j.ymeth.2008.10.013
   Suga H, 2008, PLAST RECONSTR SURG, V122, P103, DOI 10.1097/PRS.0b013e31817742ed
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Yoshimura K, 2008, AESTHET PLAST SURG, V32, P48, DOI 10.1007/s00266-007-9019-4
NR 27
TC 24
Z9 24
U1 4
U2 46
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD FEB 18
PY 2015
VL 4
IS 3
DI 10.1002/adhm.201400506
PG 8
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA CB9OQ
UT WOS:000349961600013
PM 25323438
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Maepa, CE
   Jayaramudu, J
   Okonkwo, JO
   Ray, SS
   Sadiku, ER
   Ramontja, J
AF Maepa, C. E.
   Jayaramudu, J.
   Okonkwo, J. O.
   Ray, S. S.
   Sadiku, E. R.
   Ramontja, J.
TI Extraction and Characterization of Natural Cellulose Fibers from Maize
   Tassel
SO INTERNATIONAL JOURNAL OF POLYMER ANALYSIS AND CHARACTERIZATION
LA English
DT Article
DE Infrared spectroscopy; Chemical composition; Maize tassel fiber; X-ray
   diffraction; Thermal properties
ID IONIC LIQUID PRETREATMENT; PHYSICOCHEMICAL CHARACTERIZATION;
   STERCULIA-URENS; BIOMASS; SWITCHGRASS; COMPOSITES; NANOFIBERS; FEATURES;
   BEHAVIOR; STRAW
AB This article reports on the extraction and characterization of novel natural cellulose fibers obtained from the maize (tassel) plant. Cellulose was extracted from the agricultural residue (waste biomaterial) of maize tassel. The maize tassel fibers were obtained after treatment with NaOH and were carefully characterized while the chemical composition was determined. The chemical composition of the maize tassel fibers showed that the cellulose content increased from 41% to 56%, following alkali treatment. FT-IR spectroscopic analysis of maize tassel fibers confirmed that this chemical treatment also shows the way to partial elimination of hemicelluloses and lignin from the structure of the maize tassel fibers. X-ray diffraction results indicated that this process resulted in enhanced crystallinity of the maize tassel fibers. The thermal properties of the maize tassel fibers were studied by the TGA technique and were found to have improved significantly. The degradation temperature of the alkali-treated maize tassel fiber is higher than that of the untreated maize tassel fibers. This value convincingly showed the potential of maize tassel fibers for use in reinforced biocomposites and waste water treatment.
C1 [Maepa, C. E.; Jayaramudu, J.; Ray, S. S.] CSIR, DST CSIR Natl Ctr Nanostruct Mat Mat Sci & Mfg, ZA-0001 Pretoria, South Africa.
   [Sadiku, E. R.] Tshwane Univ Technol, Dept Chem Met & Mat Engn, Pretoria, South Africa.
   [Maepa, C. E.; Okonkwo, J. O.] Tshwane Univ Technol, Dept Environm Water & Earth Sci, Pretoria, South Africa.
   [Ramontja, J.] Univ Johannesburg, Dept Appl Chem, Johannesburg, South Africa.
RP Ray, SS (reprint author), CSIR, DST CSIR Natl Ctr Nanostruct Mat Mat Sci & Mfg, ZA-0001 Pretoria, South Africa.
EM rsuprakas@csir.co.za
RI RAY, SUPRAKAS/E-7908-2011
OI RAY, SUPRAKAS/0000-0002-0007-2595
FU DST/CSIR National Centre for Nanostructured Materials; Tshwane
   University of Technology
FX The authors would like to thank the DST/CSIR National Centre for
   Nanostructured Materials, and the Tshwane University of Technology for
   their financial support.
CR Alemdar A, 2008, BIORESOURCE TECHNOL, V99, P1664, DOI 10.1016/j.biortech.2007.04.029
   Batra S.K., 1985, HDB FIBER SCI TECHNO, V4, P727
   Cheng G, 2011, BIOMACROMOLECULES, V12, P933, DOI 10.1021/bm101240z
   Ganjyal GM, 2004, J APPL POLYM SCI, V93, P2627, DOI 10.1002/app.20843
   Gastaldi G, 1998, IND CROP PROD, V8, P205, DOI 10.1016/S0926-6690(98)00004-1
   Gressel J, 2003, TRENDS BIOTECHNOL, V21, P525, DOI 10.1016/j.tibtech.2003.10.007
   Han J. S., 1998, P KOR SOC WOOD SCI T, P3
   He JX, 2007, IRAN POLYM J, V16, P807
   Jayaramudu J, 2013, ADV POLYM TECH, V32, DOI 10.1002/adv.21349
   Jayaramudu J, 2013, CARBOHYD POLYM, V93, P622, DOI 10.1016/j.carbpol.2013.01.032
   Jayaramudu J, 2011, CARBOHYD POLYM, V86, P1623, DOI 10.1016/j.carbpol.2011.06.071
   Jayaramudu J, 2010, CARBOHYD POLYM, V79, P847, DOI 10.1016/j.carbpol.2009.10.046
   Jayaramudu J, 2009, FIBER POLYM, V10, P338, DOI 10.1007/s12221-009-0338-8
   Jayaramudu J, 2009, INT J POLYM ANAL CH, V14, P115, DOI 10.1080/10236660802601415
   John MJ, 2008, CARBOHYD POLYM, V71, P343, DOI 10.1016/j.carbpol.2007.05.040
   Kadla JF, 2000, CELL CHEM TECHNOL, V34, P197
   Kim J, 2006, MACROMOLECULES, V39, P4202, DOI 10.1021/ma060261e
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Kumar R, 2009, BIORESOURCE TECHNOL, V100, P3948, DOI 10.1016/j.biortech.2009.01.075
   Le Troedec M, 2008, COMPOS PART A-APPL S, V39, P514, DOI 10.1016/j.compositesa.2007.12.001
   Li CL, 2010, BIORESOURCE TECHNOL, V101, P4900, DOI 10.1016/j.biortech.2009.10.066
   Li RJ, 2009, CARBOHYD POLYM, V76, P94, DOI 10.1016/j.carbpol.2008.09.034
   Lim LT, 2008, PROG POLYM SCI, V33, P820, DOI 10.1016/j.progpolymsci.2008.05.004
   Liu CF, 2006, CARBOHYD RES, V341, P2677, DOI 10.1016/j.carres.2006.07.008
   Liu XY, 2007, EXPRESS POLYM LETT, V1, P299, DOI 10.3144/expresspolymlett.2007.43
   Maya J. J., 2008, POLYM COMPOSITE, V29, P187
   Moran JI, 2008, CELLULOSE, V15, P149, DOI 10.1007/s10570-007-9145-9
   Park BD, 2003, BIOMASS BIOENERG, V25, P319, DOI 10.1016/S0961-9534(03)00014-X
   Park SM, 2010, BIOTECHNOL BIOFUELS, V3, P1, DOI DOI 10.1186/1754-6834-3-10
   Pasquini D, 2010, IND CROP PROD, V32, P486, DOI 10.1016/j.indcrop.2010.06.022
   Ramasamy S, 2013, BIORESOURCES, V8, P4258
   Reddy KO, 2014, INT J POLYM ANAL CH, V19, P48, DOI 10.1080/1023666X.2014.854520
   Reddy N, 2005, POLYMER, V46, P5494, DOI 10.1016/j.polymer.2005.04.073
   Reddy N, 2005, GREEN CHEM, V7, P190, DOI 10.1039/b415102j
   Reddy N., 2004, POLYM PREPRINTS, V45, P411
   Reddy N, 2007, BIOTECHNOL BIOENG, V97, P1021, DOI 10.1002/bit.21330
   Rosa MF, 2010, CARBOHYD POLYM, V81, P83, DOI 10.1016/j.carbpol.2010.01.059
   Rowell R. M., 1997, PAPER COMPOSITES AGR, P7
   Sun JX, 2004, CARBOHYD RES, V339, P291, DOI 10.1016/j.carres.2003.10.027
   Van de Velde K, 2002, J APPL POLYM SCI, V83, P2634, DOI 10.1002/app.10229
   Wang B, 2007, COMPOS SCI TECHNOL, V67, P2521, DOI 10.1016/j.compscitech.2006.12.015
   Zuluaga R, 2009, CARBOHYD POLYM, V76, P51, DOI 10.1016/j.carbpol.2008.09.024
NR 42
TC 15
Z9 15
U1 1
U2 31
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1023-666X
EI 1563-5341
J9 INT J POLYM ANAL CH
JI Int. J. Polym. Anal. Charact.
PD FEB 17
PY 2015
VL 20
IS 2
BP 99
EP 109
DI 10.1080/1023666X.2014.961118
PG 11
WC Polymer Science
SC Polymer Science
GA CA5EK
UT WOS:000348931000001
DA 2018-10-19
ER

PT J
AU Sirry, MS
   Davies, NH
   Kadner, K
   Dubuis, L
   Saleh, MG
   Meintjes, EM
   Spottiswoode, BS
   Zilla, P
   Franz, T
AF Sirry, Mazin S.
   Davies, Neil H.
   Kadner, Karen
   Dubuis, Laura
   Saleh, Muhammad G.
   Meintjes, Ernesta M.
   Spottiswoode, Bruce S.
   Zilla, Peter
   Franz, Thomas
TI Micro-structurally detailed model of a therapeutic hydrogel injectate in
   a rat biventricular cardiac geometry for computational simulations
SO COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING
LA English
DT Article
DE myocardial infarction; hydrogel; therapeutic injectate; image-based
   reconstruction; computational modelling
ID FINITE-ELEMENT MODEL; MYOCARDIAL-INFARCTION; HEART; CELLS;
   TRANSPLANTATION; BIOMATERIAL; EXPANSION; DELIVERY
AB Biomaterial injection-based therapies have showed cautious success in restoration of cardiac function and prevention of adverse remodelling into heart failure after myocardial infarction (MI). However, the underlying mechanisms are not well understood. Computational studies utilised simplified representations of the therapeutic myocardial injectates. Wistar rats underwent experimental infarction followed by immediate injection of polyethylene glycol hydrogel in the infarct region. Hearts were explanted, cryo-sectioned and the region with the injectate histologically analysed. Histological micrographs were used to reconstruct the dispersed hydrogel injectate. Cardiac magnetic resonance imaging data from a healthy rat were used to obtain an end-diastolic biventricular geometry which was subsequently adjusted and combined with the injectate model. The computational geometry of the injectate exhibited microscopic structural details found the in situ. The combination of injectate and cardiac geometry provides realistic geometries for multiscale computational studies of intra-myocardial injectate therapies for the rat model that has been widely used for MI research.
C1 [Sirry, Mazin S.; Davies, Neil H.; Kadner, Karen; Dubuis, Laura; Zilla, Peter; Franz, Thomas] Univ Cape Town, Chris Barnard Div Cardiothorac Surg, Cardiovasc Res Unit, Fac Hlth Sci, ZA-7935 Observatory, South Africa.
   [Saleh, Muhammad G.; Meintjes, Ernesta M.; Spottiswoode, Bruce S.] Univ Cape Town, Dept Human Biol, MRC UCT Med Imaging Res Unit, ZA-7935 Observatory, South Africa.
   [Spottiswoode, Bruce S.] Univ Stellenbosch, Dept Radiol, ZA-7505 Tygerberg, South Africa.
   [Franz, Thomas] Univ Cape Town, Programme Enhancement Res Capac, Res Off, Mowbray, South Africa.
   [Franz, Thomas] Univ Cape Town, Ctr Res Computat & Appl Mech, ZA-7700 Rondebosch, South Africa.
   [Franz, Thomas] Ctr High Performance Comp, Johannesburg, South Africa.
RP Franz, T (reprint author), Univ Cape Town, Chris Barnard Div Cardiothorac Surg, Cardiovasc Res Unit, Fac Hlth Sci, Private Bag X3, ZA-7935 Observatory, South Africa.
EM thomas.franz@uct.ac.za
OI Franz, Thomas/0000-0002-1504-3842
FU National Research Foundation (NRF) of South Africa; South African
   Research Chairs Initiative of the Department of Science and Technology
   and National Research Foundation of South Africa; Medical Research
   Council of South Africa; NIH [R21AA017410]
FX This study was supported financially, in part, by the National Research
   Foundation (NRF) of South Africa, the South African Research Chairs
   Initiative of the Department of Science and Technology and National
   Research Foundation of South Africa, the Medical Research Council of
   South Africa, and NIH Grant No. R21AA017410. Any opinion, findings and
   conclusions or recommendations expressed in this publication are those
   of the authors and therefore the NRF does not accept any liability in
   regard thereto. MSS acknowledges the International Society of
   Biomechanics Matching Dissertation Grant.
CR AHA, 2008, HEART DIS STROK STAT
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Guccione JM, 2003, ANN THORAC SURG, V76, P1171, DOI 10.1016/S0003-4975(03)00731-8
   Huang NF, 2006, NAT PROTOC, V1, P1596, DOI 10.1038/nprot.2006.188
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064
   Kadner K, 2012, BIOMATERIALS, V33, P2060, DOI 10.1016/j.biomaterials.2011.11.031
   Katz A.M., 2009, HEART FAILURE PATHOP
   Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50
   Klodell CT, 2008, J THORAC CARDIOV SUR, V135, P188, DOI 10.1016/j.jtcvs.2007.09.034
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Kortsmit J, 2013, COMPUT METHOD BIOMEC, V16, P1185, DOI 10.1080/10255842.2012.656611
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   OMENS JH, 1991, AM J PHYSIOL, V261, pH918
   Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Saleh MG, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/504037
   Tomita S, 2002, J THORAC CARDIOV SUR, V123, P1132, DOI 10.1067/mtc.2002.120716
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wenk JF, 2011, ANN THORAC SURG, V92, P935, DOI 10.1016/j.athoracsur.2011.04.089
   Wenk JF, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000165
   World Health Organization, 2008, ATLAS HEART DIS STRO
NR 26
TC 6
Z9 6
U1 1
U2 35
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1025-5842
EI 1476-8259
J9 COMPUT METHOD BIOMEC
JI Comput. Methods Biomech. Biomed. Eng.
PD FEB 17
PY 2015
VL 18
IS 3
BP 325
EP 331
DI 10.1080/10255842.2013.793765
PG 7
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical
SC Computer Science; Engineering
GA AR8GS
UT WOS:000343814400010
PM 23682845
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Mohajernia, S
   Hejazi, S
   Eslami, A
   Saremi, M
AF Mohajernia, Sh.
   Hejazi, S.
   Eslami, A.
   Saremi, M.
TI Modified nanostructured hydroxyapatite coating to control the
   degradation of magnesium alloy AZ31 in simulated body fluid
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Corrosion; Hydroxyapatite; Hydrogen evolution; Biomaterial
ID BONE-LIKE HYDROXYAPATITE; IN-VITRO DEGRADATION; PULSE ELECTRODEPOSITION;
   STAINLESS-STEEL; DEFICIENT HYDROXYAPATITE; VIVO CORROSION; BEHAVIOR;
   TITANIUM; BIOACTIVITY; PH
AB This research covers a different microstructural and electrochemical investigation on hydroxyapatite (HAP) coatings deposited on AZ31 magnesium alloy. Microstructure characterization and functional group identification were performed using X-ray diffraction (XRD), Fourier transform infrared and scanning electron microscopy (SEM) techniques. The prepared samples were immersed in simulated body fluid to study the degradation behavior of AZ31 and the amount of hydrogen produced. Electrochemical techniques were employed to evaluate and compare the corrosion behavior of the nano-HAP (n-HAP) coated and uncoated samples. The changes in pH value during the corrosion process were also measured. Results suggest the noticeable capability of n-HAP coatings to stabilize the alkalization behavior and to improve the corrosion resistance of AZ31 alloy. Consequently, the hydrogen evolution process beneath the n-HAP coating decreased significantly. It was concluded that an n-HAP coated AZ31 alloy could be a good candidate as a type of biodegradable implant material for biomedical applications. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Mohajernia, Sh.; Hejazi, S.; Eslami, A.; Saremi, M.] Univ Tehran, Fac Engn, Mat & Met Engn Dept, Tehran 14395515, Iran.
RP Hejazi, S (reprint author), Univ Tehran, Fac Engn, Mat & Met Engn Dept, North Kargar St, Tehran 14395515, Iran.
EM hejazi.sina@alumni.ut.ac.ir
OI Hejazi, Seyedsina/0000-0003-1526-5629
FU University of Tehran [810790067]
FX The authors would like to recognize financial support from the
   University of Tehran (Grant No. 810790067) and provision of laboratory
   facilities during the period that this research was conducted.
CR Altun H, 2004, MATER DESIGN, V25, P637, DOI 10.1016/j.matdes.2004.02.002
   Atrens A, 2013, J MAGNES ALLOY, V1, P177, DOI 10.1016/j.jma.2013.09.003
   Ayati NS, 2011, MATER CHEM PHYS, V126, P873, DOI 10.1016/j.matchemphys.2010.12.023
   Bakhsheshi-Rad HR, 2014, T NONFERR METAL SOC, V24, P2516, DOI 10.1016/S1003-6326(14)63378-1
   Batory D, 2012, SURF COAT TECH, V206, P2110, DOI 10.1016/j.surfcoat.2011.09.036
   Conz MB, 2011, J APPL ORAL SCI, V19, P337, DOI 10.1590/S1678-77572011005000007
   Demnati I, 2012, SURF COAT TECH, V206, P2346, DOI 10.1016/j.surfcoat.2011.10.025
   Drevet R, 2012, ADV ENG MATER, V14, P377, DOI 10.1002/adem.201100331
   Fathi MH, 2008, J MATER PROCESS TECH, V202, P536, DOI 10.1016/j.jmatprotec.2007.10.004
   Frankel GS, 2013, CORROS SCI, V70, P104, DOI 10.1016/j.corsci.2013.01.017
   Geng F, 2009, J MATER SCI-MATER M, V20, P1149, DOI 10.1007/s10856-008-3669-x
   Gopi D, 2012, SURF COAT TECH, V206, P2859, DOI 10.1016/j.surfcoat.2011.12.011
   Hu JL, 2014, SENSOR ACTUAT B-CHEM, V196, P194, DOI 10.1016/j.snb.2014.01.119
   Jamuna-Thevi K, 2011, VACUUM, V86, P235, DOI 10.1016/j.vacuum.2011.06.011
   Jin S, 2007, ADV ENG MATER, V9, P75, DOI 10.1002/adem.200600199
   King AD, 2014, ELECTROCHIM ACTA, V121, P394, DOI 10.1016/j.electacta.2013.12.124
   Kirkland NT, 2012, ACTA BIOMATER, V8, P925, DOI 10.1016/j.actbio.2011.11.014
   Kirkland NT, 2010, CORROS SCI, V52, P287, DOI 10.1016/j.corsci.2009.09.033
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kuo MC, 2002, MAT SCI ENG C-BIO S, V20, P153, DOI 10.1016/S0928-4931(02)00026-7
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   Leeflang MA, 2011, MATER SCI ENG B-ADV, V176, P1741, DOI 10.1016/j.mseb.2011.08.002
   Mansur MR, 2013, SURF COAT TECH, V232, P482, DOI 10.1016/j.surfcoat.2013.06.006
   Mohajernia S, 2013, J IRAN CHEM SOC, V10, P831, DOI 10.1007/s13738-012-0218-9
   Müller Wolf Dieter, 2007, Mat. Res., V10, P5, DOI 10.1590/S1516-14392007000100003
   NAGASE M, 1993, FEBS LETT, V325, P247, DOI 10.1016/0014-5793(93)81082-B
   Orazem ME, 2008, ELECTROCHEMICAL IMPE
   Pardo A., 2010, INT J CORROS, V2010
   Park JH, 2006, MATER LETT, V60, P2573, DOI 10.1016/j.matlet.2005.07.091
   PERRAULT GG, 1974, J ELECTROANAL CHEM, V51, P107, DOI 10.1016/S0022-0728(74)80298-6
   Prawel DA, 2013, MATER LETT, V97, P81, DOI 10.1016/j.matlet.2013.01.091
   Razavi M, 2010, MAT SCI ENG A-STRUCT, V527, P6938, DOI 10.1016/j.msea.2010.07.063
   Rojaee R, 2014, CERAM INT, V40, P15149, DOI 10.1016/j.ceramint.2014.06.129
   Rojaee R, 2013, MAT SCI ENG C-MATER, V33, P3817, DOI 10.1016/j.msec.2013.05.014
   Saremi M, 2014, MATER LETT, V129, P111, DOI 10.1016/j.matlet.2014.05.050
   Seydlova M, 2008, Prague Med Rep, V109, P142
   SHIRKHANZADEH M, 1995, J MATER SCI-MATER M, V6, P90, DOI 10.1007/BF00120414
   SHIRKHANZADEH M, 1991, J MATER SCI LETT, V10, P1415, DOI 10.1007/BF00735695
   Singh G, 2013, SURF COAT TECH, V228, P242, DOI 10.1016/j.surfcoat.2013.04.036
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song GL, 2011, WOODHEAD PUBL MATER, P1, DOI 10.1533/9780857091413
   Song L, 2012, SURF COAT TECH, V206, P2986, DOI 10.1016/j.surfcoat.2011.12.034
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Surmenev RA, 2012, SURF COAT TECH, V206, P2035, DOI 10.1016/j.surfcoat.2011.11.002
   Wang C, 2002, MATER LETT, V57, P99, DOI 10.1016/S0167-577X(02)00706-1
   Wang HX, 2010, ACTA BIOMATER, V6, P1743, DOI 10.1016/j.actbio.2009.12.009
   Wang J, 2009, ACTA BIOMATER, V5, P1798, DOI 10.1016/j.actbio.2009.01.005
   Wen CL, 2009, APPL SURF SCI, V255, P6433, DOI 10.1016/j.apsusc.2008.09.078
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Yamamoto A, 2004, MAT SCI ENG C-BIO S, V24, P737, DOI 10.1016/j.msec.2004.08.017
   Yang JX, 2010, SURF COAT TECH, V205, pS182, DOI 10.1016/j.surfcoat.2010.07.045
   Yang Y, 2013, SURF COAT TECH, V216, P282, DOI 10.1016/j.surfcoat.2012.11.059
NR 56
TC 11
Z9 11
U1 1
U2 41
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD FEB 15
PY 2015
VL 263
BP 54
EP 60
DI 10.1016/j.surfcoat.2014.12.059
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA CB3FC
UT WOS:000349512600008
DA 2018-10-19
ER

PT J
AU Naveen, SV
   Tan, IKP
   Goh, YS
   Raghavendran, HRB
   Murali, MR
   Kamarul, T
AF Naveen, Sangeetha Vasudevaraj
   Tan, Irene Kit Ping
   Goh, Yuh Shan
   Raghavendran, Hanumantha Rao Balaji
   Murali, Malliga Raman
   Kamarul, Tunku
TI Unmodified medium chain length polyhydroxyalkanoate (uMCL-PHA) as a thin
   film for tissue engineering application - characterization and in vitro
   biocompatibility
SO MATERIALS LETTERS
LA English
DT Article
DE Natural polymer; Polyhydroxyalkanoate; Low crystalline; Elastic
   properties; Thin films; Biomaterial
AB In the present study, we developed an unmodified/raw Medium chain length -PHA (MCL-PHA) polyhydroxyalkanoate (PHA), natural microbial polyester by using cost-effective saponified palm kernel oil (SPKO) technique. The functional groups, elemental composition, phase purity, water contact angle, and in vitro human-derived mesenchymal stromal cell attachment were examined. FTIR confirmed the presence of functional groups corresponding to alkyl halide, alkyne, hydroxyl group, and alkane groups, while XRD and EDX results revealed its phase purity and presence of elements such as carbon and oxygen respectively. SEM and confocal microscope analyses revealed that the bin-material supports cell attachment and this was further confirmed through cell viability assay. In conclusion, the characterization and compatibility studies revealed that this novel scaffold could be a potential candidate for possible tissue engineering applications. (C) 2014 Published by Elsevier B.V.
C1 [Naveen, Sangeetha Vasudevaraj; Raghavendran, Hanumantha Rao Balaji; Murali, Malliga Raman; Kamarul, Tunku] Univ Malaya, Tissue Engn Grp, Natl Orthopaed Ctr Excellence Res & Learning NOCE, Dept Orthopaed Surg,Fac Med, Kuala Lumpur 50603, Malaysia.
   [Tan, Irene Kit Ping; Goh, Yuh Shan] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia.
RP Kamarul, T (reprint author), Univ Malaya, Tissue Engn Grp, Natl Orthopaed Ctr Excellence Res & Learning NOCE, Dept Orthopaed Surg,Fac Med, Kuala Lumpur 50603, Malaysia.
EM sangeethanaveen@um.edu.my; tkzrea@um.edu.my
RI Tan, Irene/B-8661-2010; Malliga Raman, Murali/A-6987-2012; balaji
   raghavendran, hanumantha rao/B-8507-2012; Naveen, Sangeetha/F-4035-2011;
   Tunku Zainol Abidin, Tunku Kamarul Zaman/B-9633-2011
OI Tan, Irene/0000-0001-9601-5810; Malliga Raman,
   Murali/0000-0002-5696-4541; Naveen, Sangeetha/0000-0003-3180-6237; Tunku
   Zainol Abidin, Tunku Kamarul Zaman/0000-0002-6028-1313
FU HIR-MoE Grant [UM.C/625/1/HIR/ MOHE/MED/04, E000003-20001]; 
   [FP025/2010B]
FX This research was supported by HIR-MoE Grant (Reference number -
   UM.C/625/1/HIR/ MOHE/MED/04, Account number - E000003-20001) and
   FP025/2010B.
CR Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c
   DO YK, 2007, J MICROBIOL, V45, P87
   Dowling DP, 2011, J BIOMATER APPL, V26, P327, DOI 10.1177/0885328210372148
   Krishnamurithy G, 2011, J BIOMED MATER RES A, V99A, P500, DOI 10.1002/jbm.a.33184
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Sabine N, 2008, BIOMATERIALS, V29, P302
   Tan IKP, 1997, APPL MICROBIOL BIOT, V47, P207, DOI 10.1007/s002530050914
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Wang ZX, 2003, J BIOSCI BIOENG, V95, P541, DOI 10.1016/S1389-1723(03)80059-2
   Wenbin Guo, 2013, Microbiological Research, V168, P231
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
NR 13
TC 5
Z9 6
U1 1
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD FEB 15
PY 2015
VL 141
BP 55
EP 58
DI 10.1016/j.matlet.2014.10.144
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AZ5LU
UT WOS:000348263300013
DA 2018-10-19
ER

PT J
AU Reichel, CA
   Hessenauer, MET
   Pflieger, K
   Rehberg, M
   Kanse, SM
   Zahler, S
   Krombach, F
   Berghaus, A
   Strieth, S
AF Reichel, Christoph A.
   Hessenauer, Maximilian E. T.
   Pflieger, Kerstin
   Rehberg, Markus
   Kanse, Sandip M.
   Zahler, Stefan
   Krombach, Fritz
   Berghaus, Alexander
   Strieth, Sebastian
TI Components of the Plasminogen Activation System Promote Engraftment of
   Porous Polyethylene Biomaterial via Common and Distinct Effects
SO PLOS ONE
LA English
DT Article
ID ENDOTHELIAL-CELL PROLIFERATION; ISCHEMIA-REPERFUSION INJURY;
   INFLAMMATORY RESPONSES; INHIBITOR-1 PROMOTES; UROKINASE RECEPTOR;
   TURKISH DELIGHT; HOST TISSUE; IMPLANTS; ANGIOGENESIS; RECONSTRUCTION
AB Rapid fibrovascularization is a prerequisite for successful biomaterial engraftment. In addition to their well-known roles in fibrinolysis, urokinase-type plasminogen activator (uPA) and tissue plasminogen activator (tPA) or their inhibitor plasminogen activator inhibitor-1 (PAI-1) have recently been implicated as individual mediators in non-fibrinolytic processes, including cell adhesion, migration, and proliferation. Since these events are critical for fibrovascularization of biomaterial, we hypothesized that the components of the plasminogen activation system contribute to biomaterial engraftment. Employing in vivo and ex vivo microscopy techniques, vessel and collagen network formation within porous polyethylene (PPE) implants engrafted into dorsal skinfold chambers were found to be significantly impaired in uPA-, tPA-, or PAI-1-deficient mice. Consequently, the force required for mechanical disintegration of the implants out of the host tissue was significantly lower in the mutant mice than in wild-type controls. Conversely, surface coating with recombinant uPA, tPA, non-catalytic uPA, or PAI-1, but not with non-catalytic tPA, accelerated implant vascularization in wild-type mice. Thus, uPA, tPA, and PAI-1 contribute to the fibrovascularization of PPE implants through common and distinct effects. As clinical perspective, surface coating with recombinant uPA, tPA, or PAI-1 might provide a novel strategy for accelerating the vascularization of this biomaterial.
C1 [Reichel, Christoph A.; Hessenauer, Maximilian E. T.; Berghaus, Alexander] Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany.
   [Reichel, Christoph A.; Hessenauer, Maximilian E. T.; Rehberg, Markus; Krombach, Fritz] Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany.
   [Pflieger, Kerstin; Zahler, Stefan] Univ Munich, Dept Pharm, Munich, Germany.
   [Kanse, Sandip M.] Univ Oslo, Inst Basic Med Sci, Oslo, Norway.
   [Strieth, Sebastian] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, D-55122 Mainz, Germany.
RP Reichel, CA (reprint author), Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany.
EM christoph.reichel@med.uni-muenchen.de
OI Zahler, Stefan/0000-0002-5140-7287; Kanse, Sandip/0000-0003-0782-9957
FU Forderprogramm Forschung und Lehre (FoFoLe) der Medizinischen Fakultat
   der Ludwig-Maximilians-Universitat Manchen
FX This study was supported by Forderprogramm Forschung und Lehre (FoFoLe)
   der Medizinischen Fakultat der Ludwig-Maximilians-Universitat Manchen
   (to CAR and AB). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abraham E, 2003, J IMMUNOL, V170, P5644, DOI 10.4049/jimmunol.170.11.5644
   BERGHAUS A, 1985, ARCH OTOLARYNGOL, V111, P154
   Berghaus A, 2010, ADV OTO-RHINO-LARYNG, V68, P53, DOI 10.1159/000314562
   Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669
   Breuss JM, 2012, CELL ADHES MIGR, V6, P535, DOI 10.4161/cam.22243
   Brodsky S, 2001, AM J PHYSIOL-HEART C, V281, pH1784
   Busuttil SJ, 2004, J THROMB HAEMOST, V2, P1798, DOI 10.1111/j.1538-7836.2004.00916.x
   CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0
   CARMELIET P, 1993, J CLIN INVEST, V92, P2746, DOI 10.1172/JCI116892
   Czekay Ralf-Peter, 2011, Int J Cell Biol, V2011, P562481, DOI 10.1155/2011/562481
   Das R, 2010, TRENDS CARDIOVAS MED, V20, P120, DOI 10.1016/j.tcm.2010.10.002
   Deindl E, 2003, FASEB J, V17, P1174, DOI 10.1096/fj.02-0800fje
   Del Rosso M, 2011, CURR PHARM DESIGN, V17, P1924
   DIAMOND SL, 1989, SCIENCE, V243, P1483, DOI 10.1126/science.2467379
   Ehrmantraut S, 2012, TISSUE ENG PT A, V18, P1562, DOI [10.1089/ten.TEA.2011.0340, 10.1089/ten.tea.2011.0340]
   Erol OO, 2000, PLAST RECONSTR SURG, V105, P2229, DOI 10.1097/00006534-200005000-00051
   Gosau M, 2006, ORAL MAXILLOFAC SURG, V10, P178, DOI 10.1007/s10006-006-0688-y
   Hao S, 2010, AM J PATHOL, V177, P1164, DOI 10.2353/ajpath.2010.091269
   Isogai C, 2001, CANCER RES, V61, P5587
   Kim Nam Ju, 2006, Korean J Ophthalmol, V20, P143
   Kim SG, 2001, INT J ORAL MAX SURG, V30, P438, DOI 10.1054/ijom.2001.0104
   Laschke MW, 2012, EUR CELLS MATER, V24, P266, DOI 10.22203/eCM.v024a19
   Laschke MW, 2011, EUR CELLS MATER, V22, P147, DOI 10.22203/eCM.v022a12
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Lau CL, 2009, J THORAC CARDIOV SUR, V137, P1241, DOI 10.1016/j.jtcvs.2008.12.029
   LEHR HA, 1993, AM J PATHOL, V143, P1055
   McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156
   Menderes A, 2004, J CRANIOFAC SURG, V15, P719, DOI 10.1097/00001665-200409000-00004
   Monroy A, 2007, INT J PEDIATR OTORHI, V71, P547, DOI 10.1016/j.ijporl.2006.11.025
   Nicaeus TE, 1996, OPHTHALMIC PLAST REC, V12, P235, DOI 10.1097/00002341-199612000-00004
   Niechajev I, 2012, AESTHET PLAST SURG, V36, P917, DOI 10.1007/s00266-012-9911-4
   Park Won Chan, 2005, Korean J Ophthalmol, V19, P1
   PEPPER MS, 1987, J CELL BIOL, V105, P2535, DOI 10.1083/jcb.105.6.2535
   PEPPER MS, 1991, BIOCHEM BIOPH RES CO, V181, P902, DOI 10.1016/0006-291X(91)91276-I
   Potter JK, 2012, ORAL MAXIL SURG CLIN, V24, P609, DOI 10.1016/j.coms.2012.07.002
   Prager GW, 2009, BLOOD, V113, P1383, DOI 10.1182/blood-2008-06-164210
   Rehberg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028237
   Reichel CA, 2012, TRENDS CARDIOVAS MED, V22, P192, DOI 10.1016/j.tcm.2012.07.019
   Reichel CA, 2011, CIRCULATION, V124, P1849, DOI 10.1161/CIRCULATIONAHA.110.017012
   Richardson S, 2011, INT J ORAL MAX SURG, V40, P979, DOI 10.1016/j.ijom.2011.03.013
   Roelofs JJTH, 2006, J AM SOC NEPHROL, V17, P131, DOI 10.1681/ASN.2005010089
   Schumann P, 2013, J BIOMED MAT RES A
   Sheehan JJ, 2005, GLIA, V50, P340, DOI 10.1002/glia.20150
   Shetty S, 1996, AM J RESP CELL MOL, V15, P78, DOI 10.1165/ajrcmb.15.1.8679225
   Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821
   Soparkar CNS, 2000, OPHTHALMIC PLAST REC, V16, P337, DOI 10.1097/00002341-200009000-00006
   Stefansson Steingrimur, 2003, Sci STKE, V2003, ppe24, DOI 10.1126/stke.2003.189.pe24
   Stelter K, 2007, RHINOLOGY, V45, P325
   Strieth S, 2010, J BIOMED MATER RES A, V93A, P1566, DOI 10.1002/jbm.a.32670
   Syrovets T, 2012, J LEUKOCYTE BIOL, V92, P509, DOI 10.1189/jlb.0212056
   Thakker MM, 2004, OPHTHAL PLAST RECONS, V20, P368, DOI 10.1097/01.IOP.0000134247.29702.90
   Uhl B, 2014, ARTERIOSCL THROM VAS, V34, P1495, DOI 10.1161/ATVBAHA.114.303721
   van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17
   Welling TH, 1996, J SURG RES, V66, P36, DOI 10.1006/jsre.1996.0369
   Yaremchuk MJ, 2003, PLAST RECONSTR SURG, V111, P1818, DOI 10.1097/01.PRS.0000056866.80665.7A
   Yip HK, 2013, INT J CARDIOL, V168, P226, DOI 10.1016/j.ijcard.2012.09.090
   Zhang YP, 2013, THROMB RES, V131, P64, DOI 10.1016/j.thromres.2012.09.003
NR 57
TC 1
Z9 1
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 6
PY 2015
VL 10
IS 2
AR e0116883
DI 10.1371/journal.pone.0116883
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CB2GK
UT WOS:000349444900075
PM 25658820
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Trentin, DS
   Silva, DB
   Frasson, AP
   Rzhepishevska, O
   da Silva, MV
   Pulcini, ED
   James, G
   Soares, GV
   Tasca, T
   Ramstedt, M
   Giordani, RB
   Lopes, NP
   Macedo, AJ
AF Trentin, Danielle S.
   Silva, Denise B.
   Frasson, Amanda P.
   Rzhepishevska, Olena
   da Silva, Marcia V.
   Pulcini, Elinor de L.
   James, Garth
   Soares, Gabriel V.
   Tasca, Tiana
   Ramstedt, Madeleine
   Giordani, Raquel B.
   Lopes, Norberto P.
   Macedo, Alexandre J.
TI Natural Green Coating Inhibits Adhesion of Clinically Important Bacteria
SO Scientific Reports
LA English
DT Article
ID CRANBERRY PROANTHOCYANIDINS; TISSUE INTEGRATION; SURFACE-PROPERTIES;
   A-TYPE; BIOFILM; BIOMATERIALS; INFECTIONS; CELLS; STRATEGIES; SILICONE
AB Despite many advances, biomaterial-associated infections continue to be a major clinical problem. In order to minimize bacterial adhesion, material surface modifications are currently being investigated and natural products possess large potential for the design of innovative surface coatings. We report the bioguided phytochemical investigation of Pityrocarpa moniliformis and the characterization of tannins by mass spectrometry. It was demonstrated that B-type linked proanthocyanidins-coated surfaces, here termed Green coatings, reduced Gram-positive bacterial adhesion and supported mammalian cell spreading. The proposed mechanism of bacterial attachment inhibition is based on electrostatic repulsion, high hydrophilicity and the steric hindrance provided by the coating that blocks bacterium-substratum interactions. This work shows the applicability of a prototype Green-coated surface that aims to promote necessary mammalian tissue compatibility, while reducing bacterial colonization.
C1 [Trentin, Danielle S.; Frasson, Amanda P.; Tasca, Tiana; Macedo, Alexandre J.] Univ Fed Rio Grande do Sul, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil.
   [Trentin, Danielle S.; Macedo, Alexandre J.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
   [Silva, Denise B.; Lopes, Norberto P.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Nucleo Pesquisas Prod Nat & Sintet NPPNS, BR-14040903 Ribeirao Preto, SP, Brazil.
   [Rzhepishevska, Olena; Ramstedt, Madeleine] Umea Univ, Dept Chem, SE-90187 Umea, Sweden.
   [da Silva, Marcia V.] Univ Fed Pernambuco, Ctr Ciencias Biol, BR-50670901 Recife, PE, Brazil.
   [da Silva, Marcia V.] Univ Fed Pernambuco, Dept Bioquim, BR-50670901 Recife, PE, Brazil.
   [James, Garth] Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA.
   [Soares, Gabriel V.] Univ Fed Rio Grande do Sul, Inst Fis, BR-91509900 Porto Alegre, RS, Brazil.
   [Giordani, Raquel B.] Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Dept Farm, BR-59010180 Natal, RN, Brazil.
RP Lopes, NP (reprint author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Nucleo Pesquisas Prod Nat & Sintet NPPNS, BR-14040903 Ribeirao Preto, SP, Brazil.
EM npelopes@fcfrp.usp.br; alexandre.macedo@ufrgs.br
RI Vieira Soares, Gabriel/E-5065-2010; Lopes, Norberto/C-7148-2012
OI Vieira Soares, Gabriel/0000-0002-6875-0145; Lopes,
   Norberto/0000-0002-8159-3658; Trentin, Danielle/0000-0002-8622-1052; da
   Silva, Denise/0000-0003-0872-2756; Ramstedt,
   Madeleine/0000-0003-2646-8501
FU FAPERGS [1008844]; FAPESP [2009/54098-6, 2012/18031-7, 2014/50265-3];
   MCTI/CNPq [576774/2008-1]; INCT-if, NANOBIOTEC-Brazil from CAPES
   [703/2009]; STINT [IG2011-2048]
FX We acknowledge to FAPERGS (1008844), FAPESP (2009/54098-6; 2012/18031-7,
   2014/50265-3), MCTI/CNPq (576774/2008-1), INCT-if, NANOBIOTEC-Brazil
   from CAPES (703/2009) and STINT (IG2011-2048) for financial support. We
   thankfully acknowledge the CME/UFRGS for assistance in confocal and
   electron microscopies and Steve Fisher for support on LIVE/DEAD confocal
   microscopy.
CR Bazaka K, 2012, APPL MICROBIOL BIOT, V95, P299, DOI 10.1007/s00253-012-4144-7
   Bazaka K, 2011, ACTA BIOMATER, V7, P2015, DOI 10.1016/j.actbio.2010.12.024
   Bjarnsholt T, 2013, NAT REV DRUG DISCOV, V12, P791, DOI 10.1038/nrd4000
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Chan M, 2013, COLLOID SURFACE B, V110, P275, DOI 10.1016/j.colsurfb.2013.03.047
   Charlton AJ, 2002, J AGR FOOD CHEM, V50, P1593, DOI 10.1021/jf010897z
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   desla Fuente-Nunez C., 2013, CURR OPIN MICROBIOL, V16, P580
   Diaz JF, 2000, J BIOL CHEM, V275, P26265, DOI 10.1074/jbc.M003120200
   Douthwaite S, 2010, P NATL ACAD SCI USA, V107, P17065, DOI 10.1073/pnas.1012547107
   Eydelnant IA, 2008, LANGMUIR, V24, P10273, DOI 10.1021/la801525d
   Feliciano RP, 2012, FOOD CHEM, V135, P1485, DOI 10.1016/j.foodchem.2012.05.102
   Foo LY, 2000, PHYTOCHEMISTRY, V54, P173, DOI 10.1016/S0031-9422(99)00573-7
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Gu H, 2014, FRONT CHEM SCI ENG, V8, P20, DOI 10.1007/s11705-014-1412-3
   Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hickok NJ, 2012, ADV DRUG DELIVER REV, V64, P1165, DOI 10.1016/j.addr.2012.03.015
   Hidalgo G, 2011, APPL ENVIRON MICROB, V77, P1532, DOI 10.1128/AEM.02201-10
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   Howell AB, 2005, PHYTOCHEMISTRY, V66, P2281, DOI 10.1016/j.phytochem.2005.05.022
   Howell AB, 2007, MOL NUTR FOOD RES, V51, P732, DOI 10.1002/mnfr.200700038
   Jacobs A, 2007, COLLOID SURFACE B, V59, P35, DOI 10.1016/j.colsurfb.2007.04.008
   Khanbabaee K, 2001, NAT PROD REP, V18, P641, DOI 10.1039/b101061l
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lewis K, 2008, CURR TOP MICROBIOL, V322, P107
   Li M, 2012, LANGMUIR, V28, P16408, DOI 10.1021/la303438t
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044
   Roosjen A, 2006, MICROBIOL-SGM, V152, P2673, DOI 10.1099/mic.0.29005-0
   Salwiczek M, 2014, TRENDS BIOTECHNOL, V32, P82, DOI 10.1016/j.tibtech.2013.09.008
   Shah SR, 2013, MATER TODAY, V16, P177, DOI 10.1016/j.mattod.2013.05.003
   Shlaes DM, 2003, CURR OPIN PHARMACOL, V3, P470, DOI 10.1016/j.coph.2003.04.003
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Trentin D. S., 2013, PLOS ONE, V8, P1
   Trentin DD, 2011, J ETHNOPHARMACOL, V137, P327, DOI 10.1016/j.jep.2011.05.030
   Trentin DS, 2014, SURF COAT TECH, V245, P84, DOI 10.1016/j.surfcoat.2014.02.046
   Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F
   Wang, 2012, ARCH INTERN MED, V172, P988
   Wang Y, 2011, ADV FUNCT MATER, V21, P3916, DOI 10.1002/adfm.201100659
   Zaat SAJ, 2010, FUTURE MICROBIOL, V5, P1149, DOI [10.2217/fmb.10.89, 10.2217/FMB.10.89]
NR 42
TC 19
Z9 19
U1 0
U2 44
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 6
PY 2015
VL 5
AR 8287
DI 10.1038/srep08287
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CA4VK
UT WOS:000348903900002
PM 25655943
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Jin, L
   Guo, W
   Xue, PH
   Gao, HN
   Zhao, M
   Zheng, C
   Zhang, YL
   Han, D
AF Jin, Lin
   Guo, Wen
   Xue, Peihong
   Gao, Hainan
   Zhao, Ming
   Zheng, Chen
   Zhang, Yali
   Han, Dong
TI Quantitative assay for the colonization ability of heterogeneous
   bacteria on controlled nanopillar structures
SO NANOTECHNOLOGY
LA English
DT Article
DE nanotopography; bacterial colonization; roughness; morphology
ID BIOFILM FORMATION; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA;
   STAPHYLOCOCCUS-AUREUS; COLLOIDAL LITHOGRAPHY; SURFACE-ROUGHNESS; POLYMER
   SURFACES; GLASS SURFACES; SOLID-SURFACES; CELL-SHAPE
AB The colonization ability of bacteria on biomaterial surfaces is influenced by the morphology of the bacteria and the nanotopography of the biomaterial. However, interactions between the bacterial morphology and nanotopography of biomaterials have not yet been completely elucidated. In this article, we quantitatively characterized the bacterial morphology to illuminate the integrated effects of polyethylene terephthalate (PET) nanopillar arrays on the colonization of bacteria cells with different shapes. Our results demonstrated that the interaction between interpillar spacing and the diameter of the bacterial cells impacted the number of bacterial cells that adhered to different PET substrates. The interpillar spacing of nanopillar arrays promotes bacterial adhesion in a definite range (<50 nm). However, further increasing the interpillar spacing inhibited the adhesion of bacteria to the nanopillar arrays. Moreover, the interpillar spacing also influenced the morphologies of adherent bacterial cells on the PET nanopillar arrays, which consequently facilitated bacterial adhesion to the nanopillar arrays. Our findings enhance the understanding of interactions between controlled nanotopography and bacterial colonization and provide an appropriate parameter for the design of antibacterial materials with nanotopography.
C1 [Jin, Lin; Guo, Wen; Zhang, Yali] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China.
   [Jin, Lin; Zheng, Chen; Han, Dong] Natl Ctr Nanosci & Technol, Beijing, Peoples R China.
   [Xue, Peihong; Gao, Hainan] Jilin Univ, Coll Chem, State Key Lab Supramol Struct & Mat, Changchun 130023, Peoples R China.
   [Zhao, Ming] Southern Med Univ, Coll Basic Med Sci, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China.
RP Jin, L (reprint author), Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China.
EM zyl41531@163.com; dhan@nanoctr.cn
FU National Basic Research Program of China [2012CB933800]
FX This work was support by National Basic Research Program of China
   (2012CB933800).
CR Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Bakker DP, 2004, MICROBIOL-SGM, V150, P1779, DOI 10.1099/mic.0.26983-0
   Bonis M, 2010, MOL MICROBIOL, V78, P809, DOI 10.1111/j.1365-2958.2010.07383.x
   Braga PC, 1997, J ANTIMICROB CHEMOTH, V39, P79, DOI 10.1093/jac/39.1.79
   Callow M. E., 2002, BIOFOULING, V18, P229, DOI DOI 10.1080/08927010290014908
   Chan C.-M., 1996, Surface Science Reports, V24, P1, DOI 10.1016/0167-5729(96)80003-3
   Chen R, 2012, COLLOID SURFACE B, V96, P62, DOI 10.1016/j.colsurfb.2012.03.019
   Crawford RJ, 2012, ADV COLLOID INTERFAC, V179, P142, DOI 10.1016/j.cis.2012.06.015
   Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   Diaz C, 2011, COLLOID SURFACE B, V82, P536, DOI 10.1016/j.colsurfb.2010.10.013
   Diaz C, 2007, MAT RES, V10, P11
   Diaz C, 2009, ACS APPL MATER INTER, V1, P136, DOI 10.1021/am8000677
   Epstein AK, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494007
   Ercan B, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295102
   Friedlander RS, 2013, P NATL ACAD SCI USA, V110, P5624, DOI 10.1073/pnas.1219662110
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hochbaum AI, 2010, NANO LETT, V10, P3717, DOI 10.1021/nl102290k
   Hou SY, 2011, LANGMUIR, V27, P2686, DOI 10.1021/la1046194
   Hsu LC, 2013, APPL ENVIRON MICROB, V79, P2703, DOI 10.1128/AEM.03436-12
   Ivanova EP, 2011, SCI REP-UK, V1, DOI 10.1038/srep00165
   Jiantao F, 2014, NANO RES, V7, P432
   Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233
   Lai JN, 2006, APPL SURF SCI, V252, P3375, DOI 10.1016/j.apsusc.2005.05.038
   Li YF, 2010, LANGMUIR, V26, P9842, DOI 10.1021/la100183y
   Loo CY, 2012, ACTA BIOMATER, V8, P1881, DOI 10.1016/j.actbio.2012.01.015
   Ma ZW, 2005, BIOMATERIALS, V26, P2527, DOI 10.1016/j.biomaterials.2004.07.026
   Madara J L, 2011, PHYSIOL
   Mitik-Dineva N, 2010, BIOFOULING, V26, P461, DOI 10.1080/08927011003753399
   Mitik-Dineva N, 2009, BIOFOULING, V25, P621, DOI 10.1080/08927010903012773
   Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8
   MURPHY JG, 1992, CIRCULATION, V86, P1596, DOI 10.1161/01.CIR.86.5.1596
   Muto A, 2009, J VASC SURG, V50, P206, DOI 10.1016/j.jvs.2009.01.062
   Neufeld KA, 2009, J PSYCHIATR NEUROSCI, V34, P230
   Nie M, 2009, 2009 4TH IEEE INTERNATIONAL CONFERENCE ON NANO/MICRO ENGINEERED AND MOLECULAR SYSTEMS, VOLS 1 AND 2, P1017, DOI 10.1109/NEMS.2009.5068746
   Paynter RW, 2000, SURF INTERFACE ANAL, V29, P56, DOI 10.1002/(SICI)1096-9918(200001)29:1<56::AID-SIA693>3.0.CO;2-2
   Pincus Z, 2007, J MICROSC-OXFORD, V227, P140, DOI 10.1111/j.1365-2818.2007.01799.x
   Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x
   Prigent-Combaret C, 2000, ENVIRON MICROBIOL, V2, P450, DOI 10.1046/j.1462-2920.2000.00128.x
   Renner LD, 2011, MRS BULL, V36, P347, DOI 10.1557/mrs.2011.65
   Rizzello L, 2013, NANOMEDICINE-UK, V8, P807, DOI [10.2217/NNM.13.63, 10.2217/nnm.13.63]
   Rizzello L, 2011, ACS NANO, V5, P1865, DOI 10.1021/nn102692m
   Saito N, 2002, HELICOBACTER, V7, P112, DOI 10.1046/j.1083-4389.2002.00070.x
   Scardino AJ, 2006, BIOFOULING, V22, P55, DOI 10.1080/08927010500506094
   Singh AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025029
   Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046
   Tang HY, 2009, J BIOMED MATER RES A, V88A, P454, DOI 10.1002/jbm.a.31788
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Verran J, 2001, BIOFOULING, V17, P59, DOI 10.1080/08927010109378465
   Weiser JN, 2013, CURR OPIN MICROBIOL, V16, P59, DOI 10.1016/j.mib.2013.01.001
   Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.10.010
   Yang SM, 2006, SMALL, V2, P458, DOI 10.1002/smll.200500390
   Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06
NR 53
TC 5
Z9 5
U1 3
U2 35
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
EI 1361-6528
J9 NANOTECHNOLOGY
JI Nanotechnology
PD FEB 6
PY 2015
VL 26
IS 5
AR 055702
DI 10.1088/0957-4484/26/5/055702
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA AZ0RJ
UT WOS:000347952000023
PM 25581320
DA 2018-10-19
ER

PT J
AU Toumia, Y
   Orlanducci, S
   Basoli, F
   Licoccia, S
   Paradossi, G
AF Toumia, Yosra
   Orlanducci, Silvia
   Basoli, Francesco
   Licoccia, Silvia
   Paradossi, Gaio
TI "Soft" Confinement of Graphene in Hydrogel Matrixes
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID VOLUME PHASE-TRANSITION; EXFOLIATED GRAPHITE OXIDE; DRUG-DELIVERY;
   FUNDAMENTAL PROPERTIES; AQUEOUS DISPERSIONS; CONTROLLED-RELEASE;
   BLOCK-COPOLYMERS; TEMPERATURE; REDUCTION; SHEETS
AB Graphene plays as protagonist among the newly discovered carbon nanomaterials on the laboratory bench. Confinement of graphene, combined with enhanced exchange properties within aqueous environment, is key for the development of biosensors, biomedicine devices, and water remediation applications. Such confinement is possible using hydrogels as soft matrixes. Many entrapment methods focused on the modification of the graphene structure. In this paper, however, we address a confinement method that leaves unchanged the graphene structure, although intimately participating in the buildup of a network of polyvinyl alcohol (PVA) chains. PVA is a polymer known as biomaterial for its hydrophilicity, biocompatibility, and chemical versatility. A robust hybrid PVA - graphene construct was obtained starting from a surfactant-assisted sonication of an aqueous dispersion of graphite. Stable graphene sheets suspension was photopolymerized in a methacryloyl-grafted PVA, using the vinyl moiety present on the surfactant scaffold. This method can allow the incorporation in the polymer network of oligomers of N-(isopropylacrylammide), p(NiPAAm). These chains display in aqueous solution a low critical solution temperature, LCST, around 33 degrees C and trigger a volume phase transition when incorporated in a hydrophilic network around the physiological temperature. Raman analysis was used to characterize the state of hydrogel embedded graphene single sheets. Evidence for an intimate interaction of graphene sheets and polymer matrix was collected. Release of the anticancer drug doxorubicin showed the active role of the graphene/PVA/p(NiPAAm) construct in the drug delivery.
C1 [Toumia, Yosra; Orlanducci, Silvia; Basoli, Francesco; Licoccia, Silvia; Paradossi, Gaio] Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, I-00133 Rome, Italy.
RP Paradossi, G (reprint author), Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, Via Ric Sci, I-00133 Rome, Italy.
EM paradossi@stc.uniroma2.it
RI Paradossi, Gaio/B-8330-2014
OI Paradossi, Gaio/0000-0003-3051-3811; Basoli,
   Francesco/0000-0003-0549-0048
CR Calvert P, 2009, ADV MATER, V21, P743, DOI 10.1002/adma.200800534
   Cavalieri F, 2004, BIOMACROMOLECULES, V5, P2439, DOI 10.1021/bm049654g
   Constantin M, 2011, EXPRESS POLYM LETT, V5, P839, DOI 10.3144/expresspolymlett.2011.83
   Cui X, 2011, NANOSCALE, V3, P2118, DOI 10.1039/c1nr10127g
   Das TK, 2012, J RES NANOBIOTECHNOL, V1
   Delbecq F, 2013, POLYMER, V54, P1064, DOI 10.1016/j.polymer.2012.11.052
   Depan D, 2011, MAT SCI ENG C-MATER, V31, P1305, DOI 10.1016/j.msec.2011.04.010
   Dreyer DR, 2010, ANGEW CHEM INT EDIT, V49, P9336, DOI 10.1002/anie.201003024
   El-Toony M. M, 2011, NAT SCI, V9, P160
   Feng LZ, 2011, NANOMEDICINE-UK, V6, P317, DOI 10.2217/NNM.10.158
   Fernandez-Merino MJ, 2010, J PHYS CHEM C, V114, P6426, DOI 10.1021/jp100603h
   Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401
   Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052
   Frank O, 2011, ACS NANO, V5, P2231, DOI 10.1021/nn103493g
   Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849
   Ghugare SV, 2011, MACROMOLECULES, V44, P4470, DOI 10.1021/ma200979h
   Ghugare SV, 2010, J PHYS CHEM B, V114, P10285, DOI 10.1021/jp100962p
   Ghugare SV, 2009, BIOMACROMOLECULES, V10, P1589, DOI 10.1021/bm900185u
   Gomez-Navarro C, 2007, NANO LETT, V7, P3499, DOI 10.1021/nl072090c
   Green AA, 2009, NANO LETT, V9, P4031, DOI 10.1021/nl902200b
   Grigorenko AN, 2012, NAT PHOTONICS, V6, P749, DOI [10.1038/nphoton.2012.262, 10.1038/NPHOTON.2012.262]
   Guardia L, 2011, CARBON, V49, P1653, DOI 10.1016/j.carbon.2010.12.049
   Guo J, 2011, COMPOS PART B-ENG, V42, P2130, DOI 10.1016/j.compositesb.2011.05.008
   Hernandez Y, 2008, NAT NANOTECHNOL, V3, P563, DOI 10.1038/nnano.2008.215
   Jablan M, 2013, P IEEE, V101, P1689, DOI 10.1109/JPROC.2013.2260115
   Jastrzebska AM, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1320-8
   Koshino M, 2013, NEW J PHYS, V15
   Layek RK, 2010, POLYMER, V51, P5846, DOI 10.1016/j.polymer.2010.09.067
   Lee DW, 2011, CHEM COMMUN, V47, P8259, DOI 10.1039/c1cc12868j
   Li XL, 2008, NAT NANOTECHNOL, V3, P538, DOI 10.1038/nnano.2008.210
   Li YF, 2013, P NATL ACAD SCI USA, V110, P12295, DOI 10.1073/pnas.1222276110
   Liu JH, 2011, MACROMOLECULES, V44, P7682, DOI 10.1021/ma201620w
   Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x
   Lotya M, 2009, J AM CHEM SOC, V131, P3611, DOI 10.1021/ja807449u
   Matassa R, 2014, J APPL CRYSTALLOGR, V47, P222, DOI 10.1107/S1600576713029488
   Notley SM, 2012, LANGMUIR, V28, P14110, DOI 10.1021/la302750e
   Novoselov KS, 2007, SCIENCE, V315, P1379, DOI 10.1126/science.1137201
   Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Papageorgiou G, 2010, POLYM INT, V59, P1630, DOI 10.1002/pi.2896
   Park MH, 2012, SURF INTERFACE ANAL, V44, P1538, DOI 10.1002/sia.4995
   Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/NNANO.2009.58, 10.1038/nnano.2009.58]
   Potts JR, 2011, POLYMER, V52, P5, DOI 10.1016/j.polymer.2010.11.042
   Pu NW, 2012, J TAIWAN INST CHEM E, V43, P140, DOI 10.1016/j.jtice.2011.06.012
   Rao R, 2011, ACS NANO, V5, P1594, DOI 10.1021/nn1031017
   Ritter KA, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/01/015704
   Salavagione HJ, 2009, MACROMOLECULES, V42, P6331, DOI 10.1021/ma900845w
   Seo JWT, 2011, J PHYS CHEM LETT, V2, P1004, DOI 10.1021/jz2003556
   Sham AYW, 2013, SOFT MATTER, V9, P6645, DOI 10.1039/c3sm00092c
   Shen JF, 2012, COMPOS PART A-APPL S, V43, P1476, DOI 10.1016/j.compositesa.2012.04.006
   SHIBAYAMA M, 1993, ADV POLYM SCI, V109, P1
   Smith RJ, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125008
   Stankovich S, 2006, J MATER CHEM, V16, P155, DOI 10.1039/b512799h
   Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034
   Tang ZH, 2012, POLYMER, V53, P673, DOI 10.1016/j.polymer.2011.11.056
   Topel O, 2013, J MOL LIQ, V177, P40, DOI 10.1016/j.molliq.2012.10.013
   Tyagi M.G., 2013, WORLD J PHARM PHARM, V3, P339
   USUKI A, 1993, J MATER RES, V8, P1179, DOI 10.1557/JMR.1993.1179
   VANDIJKWOLTHUIS WNE, 1995, MACROMOLECULES, V28, P6317, DOI 10.1021/ma00122a044
   Wang CY, 2013, NANOMED-NANOTECHNOL, V9, P903, DOI 10.1016/j.nano.2013.01.003
   Wang PJ, 2013, CHEM PHYS LETT, V556, P146, DOI 10.1016/j.cplett.2012.11.018
   Wenceslau AC, 2012, MAT SCI ENG C-MATER, V32, P1259, DOI 10.1016/j.msec.2012.04.001
   Yang XY, 2008, J PHYS CHEM C, V112, P17554, DOI 10.1021/jp806751k
   Zhang M, 2010, SMALL, V6, P1100, DOI 10.1002/smll.200901978
   Zheng W., 2013, NEW PROGR GRAPHENE R, P207
NR 65
TC 12
Z9 12
U1 3
U2 79
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD FEB 5
PY 2015
VL 119
IS 5
BP 2051
EP 2061
DI 10.1021/jp510654h
PG 11
WC Chemistry, Physical
SC Chemistry
GA CA7ZT
UT WOS:000349137000028
PM 25574863
DA 2018-10-19
ER

PT J
AU Kamath, AF
   Lewallen, DG
   Hanssen, AD
AF Kamath, Atul F.
   Lewallen, David G.
   Hanssen, Arlen D.
TI Porous Tantalum Metaphyseal Cones for Severe Tibial Bone Loss in
   Revision Knee Arthroplasty A Five to Nine-Year Follow-up
SO JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
LA English
DT Article
ID TRABECULAR METAL CONES; STRUCTURAL ALLOGRAFT; UNCONTAINED DEFECTS; HUMAN
   OSTEOBLASTS; HINGE PROSTHESIS; REPLACEMENT; RECONSTRUCTION; BIOMATERIAL;
   DEFICIENCY; OSTEOLYSIS
AB Background: Severe metaphyseal and meta-diaphyseal bone loss poses important challenges in revision total knee arthroplasty. The best strategy for addressing massive tibial bone loss has not been determined. The purpose of this study was to assess the intermediate-term clinical and radiographic results of porous tibial cone implantation.
   Methods: Sixty-six porous tantalum tibial cones (sixty-three patients) were reviewed at a mean follow-up time of seventy months (range, sixty to 106 months). According to the Anderson Orthopaedic Research Institute bone defect classification, twenty-four knees had a Type-3 defect, twenty-five knees had a Type-2B defect, and seventeen knees had a Type-2A defect.
   Results: The mean age at the time of the index revision was sixty-seven years (range, forty-one to eighty-three years), and 57% of patients were female. The mean American Society of Anesthesiologists Physical Status was 2.4 (range, 2 to 3), and the mean body mass index was 33 kg/m(2) (range, 25 to 53 kg/m(2)). Fifteen patients (24%) were on immunosuppressant medications, and eight patients (13%) were current smokers. The patients underwent a mean number of 3.4 prior knee surgical procedures (range, one to twenty procedures), and 49% of patients (thirty-one patients) had a history of periprosthetic infection. The mean Knee Society Scores improved significantly from 55 points preoperatively (range, 4 to 97 points) to 80 points (range, 28 to 100 points) at the time of the latest follow-up (p < 0.0001). One patient had progressive radiolucencies about the tibial stem and cone on radiographs. One patient had complete radiolucencies about the tibial cone, concerning for fibrous ingrowth. Three other cones were revised: one for infection, one for aseptic loosening, and one for periprosthetic fracture. Revision-free survival of the tibial cone component was >95% at the time of the latest follow-up.
   Conclusions: Porous tantalum tibial cones offer a promising management option for severe tibial bone loss. At the intermediate-term follow-up (five to nine years), porous tantalum tibial cones had durable clinical results and radiographic fixation. The biologic ingrowth of these implants offers the potential for successful long-term structural support in complex knee reconstruction.
C1 [Kamath, Atul F.; Lewallen, David G.; Hanssen, Arlen D.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA.
RP Kamath, AF (reprint author), Mayo Clin, Dept Orthoped Surg, 200 First St SW,Gonda 14, Rochester, MN 55905 USA.
EM hanssen.arlen@mayo.edu
CR Alexander GE, 2013, J ARTHROPLASTY, V28, P604, DOI 10.1016/j.arth.2012.08.006
   ASA, 2014, ASA PHYS STAT CLASS
   Backstein D, 2006, CLIN ORTHOP RELAT R, P104, DOI 10.1097/01.blo.0000214426.52206.2c
   Bauman RD, 2009, CLIN ORTHOP RELAT R, V467, P818, DOI 10.1007/s11999-008-0679-4
   Benjamin J, 2001, CLIN ORTHOP RELAT R, P62
   Berend KR, 2010, ORTHOPEDICS, V33, P8, DOI [10.3928/01477447-20100722-37, 10.3928/01477447-20100722-61, 10.3928/01477447-20100722-38]
   Berry Daniel J, 2004, Instr Course Lect, V53, P261
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P45, DOI 10.1007/s11999-009-0945-0
   Breer S, 2012, INT ORTHOP, V36, P2269, DOI 10.1007/s00264-012-1640-4
   Bush JL, 2006, CLIN ORTHOP RELAT R, P186, DOI 10.1097/01.blo.0000229360.04620.93
   Clatworthy MG, 2001, J BONE JOINT SURG AM, V83A, P404, DOI 10.2106/00004623-200103000-00013
   Cohen Robert, 2002, Am J Orthop (Belle Mead NJ), V31, P216
   Dennis DA, 2002, J ARTHROPLASTY, V17, P90, DOI 10.1054/arth.2002.32456
   Derome P, 2014, J ARTHROPLASTY, V29, P122, DOI 10.1016/j.arth.2013.04.033
   Engh G A, 1997, Instr Course Lect, V46, P227
   Engh GA, 2004, ORTHOPEDICS, V27, P999
   Engh GA, 1997, REVISION TOTAL KNEE, P63
   Engh GA, 1999, INSTR COURSE LECT, V48, P167
   Engh GA, 2007, J BONE JOINT SURG AM, V89A, P2640, DOI 10.2106/JBJS.F00865
   EWALD FC, 1989, CLIN ORTHOP RELAT R, P9
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   Ghazavi MT, 1997, J BONE JOINT SURG AM, V79A, P17, DOI 10.2106/00004623-199701000-00002
   Hanzlik JA, 2013, J ARTHROPLASTY, V28, P922, DOI 10.1016/j.arth.2013.01.035
   HARRIS AI, 1995, J BONE JOINT SURG AM, V77A, P373, DOI 10.2106/00004623-199503000-00007
   Harrysson OLA, 2004, CLIN ORTHOP RELAT R, P162, DOI 10.1097/01.blo.0000127115.05754.ce
   Hockman DE, 2005, J ARTHROPLASTY, V20, P35, DOI 10.1016/j.arth.2004.09.059
   Howard JL, 2011, J BONE JOINT SURG AM, V93A, P478, DOI 10.2106/JBJS.l.01322
   INSALL JN, 1989, CLIN ORTHOP RELAT R, P13
   Jensen CL, 2012, J ARTHROPLASTY, V27, P1820, DOI 10.1016/j.arth.2012.04.036
   Jensen CL, 2012, INT ORTHOP, V36, P1857, DOI 10.1007/s00264-012-1601-y
   Joglekar SB, 2012, CLIN ORTHOP RELAT R, V470, P3041, DOI 10.1007/s11999-012-2382-8
   Jones RE, 2001, J ARTHROPLASTY, V16, P279, DOI 10.1054/arth.2001.21498
   Kuchinad RA, 2011, ADV ORTHOP, V2011
   Lachiewicz PF, 2012, CLIN ORTHOP RELAT R, V470, P199, DOI 10.1007/s11999-011-1888-9
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Long WJ, 2009, J ARTHROPLASTY, V24, P1086, DOI 10.1016/j.arth.2008.08.011
   Lonner JH, 2002, CLIN ORTHOP RELAT R, P145, DOI 10.1097/01.blo.0000036534.46246.4b
   Meneghini RM, 2008, J BONE JOINT SURG AM, V90A, P78, DOI 10.2106/JBJS.F.01495
   Meneghini RM, 2010, J ARTHROPLASTY, V25, P741, DOI 10.1016/j.arth.2009.04.025
   Meneghini RM, 2009, J BONE JOINT SURG AM, V91A, P131, DOI 10.2106/JBJS.H.01061
   MNAYMNEH W, 1990, CLIN ORTHOP RELAT R, P144
   Mow CS, 1996, J ARTHROPLASTY, V11, P235, DOI 10.1016/S0883-5403(96)80072-6
   MURRAY PB, 1994, CLIN ORTHOP RELAT R, P116
   Nadaud MC, 2004, J ARTHROPLASTY, V19, P110, DOI 10.1016/j.arth.2003.08.005
   Nasser S, 2004, J ARTHROPLASTY, V19, P562, DOI 10.1016/j.arth.2004.02.025
   Nehme A, 2004, CLIN ORTHOP RELAT R, P201, DOI 10.1097/01.blo.0000150133.88271
   Parks NL, 1997, CLIN ORTHOP RELAT R, P17
   Peersman G, 2001, CLIN ORTHOP RELAT R, P15
   Peters CL, 2005, J ARTHROPLASTY, V20, P302, DOI 10.1016/j.arth.2004.08.010
   Rao BM, 2013, BONE JOINT J, V95B, P1069, DOI 10.1302/0301-620X.95B8.29194
   Richards CJ, 2011, J ARTHROPLASTY, V26, P1299, DOI 10.1016/j.arth.2010.12.003
   Ries M D, 1996, Am J Knee Surg, V9, P51
   Ritter MA, 2004, J ARTHROPLASTY, V19, P587, DOI 10.1016/j.arth.2003.11.009
   Rorabeck CH, 1998, ORTHOP CLIN N AM, V29, P361, DOI 10.1016/S0030-5898(05)70335-7
   Schildhauer TA, 2009, J BIOMED MATER RES A, V88A, P332, DOI 10.1002/jbm.a.31850
   Schmitz HCR, 2013, J ARTHROPLASTY, V28, P1556, DOI 10.1016/j.arth.2013.01.028
   Shen C, 2014, J ARTHROPLASTY, V29, P127, DOI [10.1016/j.arth.2013.09.048, 10.1016/j.arth.2013.04.042]
   Springer BD, 2001, CLIN ORTHOP RELAT R, P283
   STOCKLEY I, 1992, J BONE JOINT SURG BR, V74, P393
   Suarez-Suarez M A, 2002, Acta Orthop Belg, V68, P163
   Toms AD, 2004, J BONE JOINT SURG AM, V86A, P2050, DOI 10.2106/00004623-200409000-00028
   TSAHAKIS PJ, 1994, CLIN ORTHOP RELAT R, P86
   Villanueva-Martinez M, 2013, J ARTHROPLASTY, V28, P988, DOI 10.1016/j.arth.2012.09.003
   Wang JW, 2013, BONE JOINT J, V95B, P643, DOI 10.1302/0301-620X.95B5.29915
   Welldon KJ, 2008, J BIOMED MATER RES A, V84A, P691, DOI 10.1002/jbm.a.31336
   Whaley AL, 2003, J ARTHROPLASTY, V18, P592, DOI 10.1016/S0883-5403(03)00200-6
   Whiteside LA, 1998, ORTHOPEDICS, V21, P1041
   WILDE AH, 1990, J BONE JOINT SURG AM, V72A, P815, DOI 10.2106/00004623-199072060-00004
NR 70
TC 29
Z9 30
U1 2
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0021-9355
EI 1535-1386
J9 J BONE JOINT SURG AM
JI J. Bone Joint Surg.-Am. Vol.
PD FEB 4
PY 2015
VL 97A
IS 3
BP 216
EP 223
DI 10.2106/JBJS.N.00540
PG 8
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA CB1NQ
UT WOS:000349395000015
PM 25653322
DA 2018-10-19
ER

PT J
AU Rodrguez-Fuentes, N
   Reynoso-Ducoing, O
   Rodriguez-Hernandez, A
   Ambrosio-Hernandez, JR
   Pina-Barba, MC
   Zepeda-Rodriguez, A
   Cerbon-Cervantes, MA
   Tapia-Ramirez, J
   Alcantara-Quintana, LE
AF Rodrguez-Fuentes, Nayeli
   Reynoso-Ducoing, Olivia
   Rodriguez-Hernandez, Ana
   Ambrosio-Hernandez, Javier R.
   Pina-Barba, Maria C.
   Zepeda-Rodriguez, Armando
   Cerbon-Cervantes, Marco A.
   Tapia-Ramirez, Jose
   Alcantara-Quintana, Luz E.
TI Isolation of Human Mesenchymal Stem Cells and their Cultivation on the
   Porous Bone Matrix
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Developmental Biology; Issue 96; Human mesenchymal stem cells; porous
   biomaterials; Nukbone; bone; bone tissue engineering; amnion
ID HUMAN AMNIOTIC MEMBRANE; DIFFERENTIATION; PROLIFERATION; OSTEOBLASTS;
   CULTURE
AB Mesenchymal stem cells (MSCs) have a differentiation potential towards osteoblastic lineage when they are stimulated with soluble factors or specific biomaterials. This work presents a novel option for the delivery of MSCs from human amniotic membrane (AM-hMSCs) that employs bovine bone matrix Nukbone (NKB) as a scaffold. Thus, the application of MSCs in repair and tissue regeneration processes depends principally on the efficient implementation of the techniques for placing these cells in a host tissue. For this reason, the design of biomaterials and cellular scaffolds has gained importance in recent years because the topographical characteristics of the selected scaffold must ensure adhesion, proliferation and differentiation into the desired cell lineage in the microenvironment of the injured tissue. This option for the delivery of MSCs from human amniotic membrane (AM-hMSCs) employs bovine bone matrix as a cellular scaffold and is an efficient culture technique because the cells respond to the topographic characteristics of the bovine bone matrix Nukbone (NKB), i.e., spreading on the surface, macroporous covering and colonizing the depth of the biomaterial, after the cell isolation process. We present the procedure for isolating and culturing MSCs on a bovine matrix.
C1 [Rodrguez-Fuentes, Nayeli; Pina-Barba, Maria C.] Univ Nacl Autonoma Mexico, Inst Invest Mat, Dept Mat Met & Ceram, Mexico City 04510, DF, Mexico.
   [Reynoso-Ducoing, Olivia; Rodriguez-Hernandez, Ana; Ambrosio-Hernandez, Javier R.] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico.
   [Zepeda-Rodriguez, Armando] Univ Nacl Autonoma Mexico, Fac Med, Dept Biol Celular & Tisular, Mexico City 04510, DF, Mexico.
   [Cerbon-Cervantes, Marco A.] Univ Nacl Autonoma Mexico, Fac Quim, Dept Biol Celular, Mexico City 04510, DF, Mexico.
   [Tapia-Ramirez, Jose] CINVESTAV, IPN, Dept Genet & Mol Biol, Ciudad De Mexico, DF, Mexico.
   [Alcantara-Quintana, Luz E.] Secretaria Salud, Ctr Nacl Transfus Sanguinea, Subd Invest, Madrid, Spain.
RP Alcantara-Quintana, LE (reprint author), Secretaria Salud, Ctr Nacl Transfus Sanguinea, Subd Invest, Madrid, Spain.
EM luzalcantara@gmail.com
RI Rodriguez-Hernandez, Ana/E-8729-2011
OI Rodriguez-Hernandez, Ana/0000-0001-7094-1912; Ambrosio,
   Javier/0000-0001-7441-0609
FU Consejo Nacional de Ciencia y Tecnologia (CONACyT) [49887]; Facultad de
   Medicina-UNAM [DGAPA IN201510, DGAPA IN216213]
FX We acknowledge the scholarship and financial support provided by the
   Consejo Nacional de Ciencia y Tecnologia (CONACyT No. 49887), Facultad
   de Medicina-UNAM DGAPA IN201510 and DGAPA IN216213; Salvador Correa of
   Instituto Nacional de Perinatologia for help with the biological
   material; and Biocriss, S. A. de C. V for donating Nukbone. Also thank
   to Ing. Hector Martinez of IIM, UNAM and M en C Fabiola Gonzalez of
   CINVESTAV for technical assistance.
CR Alviano F, 2007, BMC DEV BIOL, V7, P1
   Anker P. S., STEM CELLS, V22, P1338
   Fassina L, 2010, BIOINORG CHEM APPL, DOI 10.1155/2010/456240
   Fassina L, 2009, TISSUE ENG PART C-ME, V15, P233, DOI 10.1089/ten.tec.2008.0398
   Gomes ME, 2006, TISSUE ENG, V12, P801, DOI 10.1089/ten.2006.12.801
   Leyva-Leyva M, 2013, STEM CELLS DEV, V22, P1275, DOI 10.1089/scd.2012.0359
   Pochsmpally R., 2008, MESENCHYMAL STEM CEL
   Rivera N, 2013, PARASITOL RES, V112, P1021, DOI 10.1007/s00436-012-3224-z
   Rodriguez-Fuentes N, 2013, BIOCHEM BIOPH RES CO, V434, P676, DOI 10.1016/j.bbrc.2013.04.007
   Seebach C, 2010, INJURY, V41, P731, DOI 10.1016/j.injury.2010.02.017
   Villajosa C.L.M.-O.d., 2006, REV ORTOP TRAUMATOL, V50, P224
NR 11
TC 3
Z9 3
U1 1
U2 8
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD FEB
PY 2015
IS 96
AR e51999
DI 10.3791/51999
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CR7MH
UT WOS:000361533700009
PM 25742362
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Deng, J
   Sun, MC
   Wang, SS
   Han, LL
   Mao, ZW
   Li, D
   Chen, H
   Gao, CY
AF Deng, Jun
   Sun, Mingcong
   Wang, Shasha
   Han, Lulu
   Mao, Zhengwei
   Li, Dan
   Chen, Hong
   Gao, Changyou
TI Adsorption of Fibronectin on Salt-Etched Polyelectrolyte Multilayers and
   its Roles in Mediating the Adhesion and Migration of Vascular Smooth
   Muscle Cells
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterial surfaces; cell adhesion and migration; fibronectin;
   multilayers; protein adsorption
ID PROTEIN ADSORPTION; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELL; MODEL
   SURFACES; NMR ANALYSIS; FILMS; SUBSTRATE; DENSITY; GRADIENTS;
   POLYURETHANE
AB Protein adsorption on biomaterials strongly mediates the subsequent cell responses. Here adsorption of fibronectin (Fn) on salt-treated PEI(PSS/PDDA)(7) multilayers was characterized. The amounts of adsorbed Fn increased linearly along with the increase of thickness of multilayers pretreated with 1 M and 5 M NaCl solutions (Multilayer-1M and 5M), but was independent on the thickness of Multilayer-3M. The normalized relative RGD activity of Fn were significantly higher on the Multilayer-3M than on others. By comparison of cellular behaviors of VSMCs being cultured in the normal and Fn-depleted serum-containing medium, the significant role of Fn on modulating the behaviors of VSMCs was verified. The Fn adsorption model and its role on linking the biomaterials surface to the VSMCs behaviors are proposed.
C1 [Deng, Jun; Sun, Mingcong; Han, Lulu; Mao, Zhengwei; Gao, Changyou] Zhejiang Univ, MOE Key Lab Macromol Synth & Functionalizat, Dept Polymer Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China.
   [Wang, Shasha; Li, Dan; Chen, Hong] Soochow Univ, Jiangsu Key Lab Adv Funct Polymer Design & Applic, Dept Polymer Sci & Engn, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China.
RP Gao, CY (reprint author), Zhejiang Univ, MOE Key Lab Macromol Synth & Functionalizat, Dept Polymer Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China.
EM cygao@mail.hz.zj.cn
RI mao, zhengwei/I-5785-2012; Li, Dan/R-8422-2016
OI Li, Dan/0000-0002-1141-8838; Deng, Jun/0000-0002-9951-2393
FU National Basic Research Programme of China [2011CB606203]; Natural
   Science Foundation of China [21434006, 21374097]
FX This study was financially supported by the National Basic Research
   Programme of China (2011CB606203), and the Natural Science Foundation of
   China (21434006 and 21374097).
CR Asakura T, 2011, BIOMACROMOLECULES, V12, P3910, DOI 10.1021/bm2011196
   Barbucci R, 2005, BIOMACROMOLECULES, V6, P638, DOI 10.1021/bm049642v
   Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI [10.1016/j.colsurfb.2007.11.015, 10.1016/j.coisurfb.2007.11.015]
   Boura C, 2005, BIOMATERIALS, V26, P4568, DOI 10.1016/j.biomaterials.2004.11.036
   Brown RA, 2007, INT REV CYTOL, V262, P75, DOI 10.1016/S0074-7696(07)62002-6
   Chen H, 2009, J BIOMED MATER RES A, V90A, P940, DOI 10.1002/jbm.a.32152
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199
   Dubas ST, 2001, LANGMUIR, V17, P7725, DOI 10.1021/la0112099
   Dubas ST, 2001, MACROMOLECULES, V34, P3736, DOI 10.1021/ma001720t
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Han LL, 2013, BIOMATERIALS, V34, P975, DOI 10.1016/j.biomaterials.2012.10.041
   Han LL, 2012, J R SOC INTERFACE, V9, P3455, DOI 10.1098/rsif.2012.0546
   Han LL, 2012, LANGMUIR, V28, P193, DOI 10.1021/la2040533
   Hashizume R, 2010, BIOMATERIALS, V31, P3253, DOI 10.1016/j.biomaterials.2010.01.051
   Heuvingh J, 2005, LANGMUIR, V21, P3165, DOI 10.1021/la047388m
   Hillberg AL, 2009, BIOMATERIALS, V30, P4463, DOI 10.1016/j.biomaterials.2009.05.026
   Hong Y, 2009, BIOMATERIALS, V30, P2457, DOI 10.1016/j.biomaterials.2009.01.013
   Idiris A, 2005, BIOMACROMOLECULES, V6, P2776, DOI 10.1021/bm0502617
   Inoue Y, 2011, REACT FUNCT POLYM, V71, P350, DOI 10.1016/j.reactfunctpolym.2010.11.017
   Ramos JJI, 2010, MACROMOLECULES, V43, P9063, DOI 10.1021/ma1015984
   Jeon H, 2010, BIOMATERIALS, V31, P4286, DOI 10.1016/j.biomaterials.2010.01.103
   Kaiser JP, 2006, BIOMATERIALS, V27, P5230, DOI 10.1016/j.biomaterials.2006.06.002
   Kim DH, 2009, ADV FUNCT MATER, V19, P1579, DOI 10.1002/adfm.200801174
   Li D, 2009, ACTA BIOMATER, V5, P1864, DOI 10.1016/j.actbio.2009.03.001
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lucassen-Reynders EH, 2004, J PHYS CHEM B, V108, P9173, DOI 10.1021/jp049682t
   MAZZUCOTELLI JP, 1991, INT J ARTIF ORGANS, V14, P482
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Miyamoto S., 1981, ANN NY ACAD SCI, V91, P673
   Murata H, 2007, BIOMATERIALS, V28, P4870, DOI 10.1016/j.biomaterials.2007.06.012
   Ngankam AP, 2004, LANGMUIR, V20, P3362, DOI 10.1021/la035479y
   OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6
   Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003
   Pei J, 2011, BIOMATERIALS, V32, P8968, DOI 10.1016/j.biomaterials.2011.08.034
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Penkett CJ, 1997, J MOL BIOL, V274, P152, DOI 10.1006/jmbi.1997.1369
   Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Salloum DS, 2004, BIOMACROMOLECULES, V5, P1089, DOI 10.1021/bm034522t
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   Sell S, 2007, POLYM INT, V56, P1349, DOI 10.1002/pi.2344
   Sivaraman B, 2011, BIOMATERIALS, V32, P5365, DOI 10.1016/j.biomaterials.2011.04.011
   Tan JL, 2004, TISSUE ENG, V10, P865, DOI 10.1089/1076327041348365
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Thompson MT, 2005, BIOMATERIALS, V26, P6836, DOI 10.1016/j.biomaterials.2005.05.003
   Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wu JD, 2012, BIOMATERIALS, V33, P810, DOI 10.1016/j.biomaterials.2011.10.022
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Zhang C, 2014, J BIOMED MATER RES A, V102, P170, DOI 10.1002/jbm.a.34687
NR 55
TC 8
Z9 8
U1 3
U2 43
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD FEB
PY 2015
VL 15
IS 2
BP 241
EP 252
DI 10.1002/mabi.201400344
PG 12
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA CE2VJ
UT WOS:000351677900006
PM 25283882
DA 2018-10-19
ER

PT J
AU Wu, CC
   Wei, CK
   Ho, CC
   Ding, SJ
AF Wu, Ching-Chou
   Wei, Chung-Kai
   Ho, Chia-Che
   Ding, Shinn-Jyh
TI Enhanced Hydrophilicity and Biocompatibility of Dental Zirconia Ceramics
   by Oxygen Plasma Treatment
SO MATERIALS
LA English
DT Article
ID OSTEOBLAST-LIKE CELLS; VITRO PHYSICOCHEMICAL PROPERTIES; OSTEOGENIC
   ACTIVITY; SURFACE MODIFICATION; COMPOSITE COATINGS; DICALCIUM SILICATE;
   ADHESION; WETTABILITY; TOPOGRAPHY; BONE
AB Surface properties play a critical role in influencing cell responses to a biomaterial. The objectives of this study were (1) to characterize changes in surface properties of zirconia (ZrO2) ceramic after oxygen plasma treatment; and (2) to determine the effect of such changes on biological responses of human osteoblast-like cells (MG63). The results indicated that the surface morphology was not changed by oxygen plasma treatment. In contrast, oxygen plasma treatment to ZrO2 not only resulted in an increase in hydrophilicity, but also it retained surface hydrophilicity after 5-min treatment time. More importantly, surface properties of ZrO2 modified by oxygen plasma treatment were beneficial for cell growth, whereas the surface roughness of the materials did not have a significant efficacy. It is concluded that oxygen plasma treatment was certified to be effective in modifying the surface state of ZrO2 and has the potential in the creation and maintenance of hydrophilic surfaces and the enhancement of cell proliferation and differentiation.
C1 [Wu, Ching-Chou] Natl Chung Hsing Univ, Dept Bioind Mechatron Engn, Taichung 402, Taiwan.
   [Wei, Chung-Kai; Ho, Chia-Che; Ding, Shinn-Jyh] Chung Shan Med Univ, Inst Oral Sci, Taichung 402, Taiwan.
   [Ding, Shinn-Jyh] Chung Shan Med Univ Hosp, Dept Dent, Taichung 402, Taiwan.
RP Ding, SJ (reprint author), Chung Shan Med Univ, Inst Oral Sci, Taichung 402, Taiwan.
EM ccwu@dragon.nchu.edu.tw; tiyeg2@gmail.com; sfox1223@gmail.com;
   sjding@csmu.edu.tw
OI Wu, Ching-Chou/0000-0002-8683-3796
CR Chen CC, 2014, J ALLOY COMPD, V585, P25, DOI 10.1016/j.jallcom.2013.09.138
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chiang TY, 2014, J MED BIOL ENG, V34, P30, DOI 10.5405/jmbe.1386
   Ding SJ, 2011, ACS APPL MATER INTER, V3, P4142, DOI 10.1021/am201017v
   Dulgar-Tulloch AJ, 2009, J BIOMED MATER RES A, V90A, P586, DOI 10.1002/jbm.a.32116
   Duske K, 2012, J CLIN PERIODONTOL, V39, P400, DOI 10.1111/j.1600-051X.2012.01853.x
   Eriksson C, 2004, BIOMATERIALS, V25, P4759, DOI 10.1016/j.biomaterials.2003.12.006
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   Giljean S, 2011, APPL SURF SCI, V257, P9631, DOI 10.1016/j.apsusc.2011.06.088
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Han Y, 2009, J BIOMED MATER RES A, V88A, P117, DOI 10.1002/jbm.a.31859
   Hao L, 2004, J BIOMED MATER RES A, V69A, P748, DOI 10.1002/jbm.a.30055
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Huang SC, 2015, J MATER CHEM B, V3, P570, DOI 10.1039/c4tb01617c
   Ito H, 2013, DENT MATER J, V32, P122, DOI 10.4012/dmj.2012-208
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Kim HW, 2004, BIOMATERIALS, V25, P4203, DOI 10.1016/j.biomaterials.2003.10.094
   Kim MC, 2003, SURF COAT TECH, V171, P312, DOI 10.1016/S0257-8972(03)00292-5
   Lee PJ, 2014, SURF COAT TECH, V258, P374, DOI 10.1016/j.surfcoat.2014.08.066
   Nakamura M, 2014, J MED BIOL ENG, V34, P44, DOI 10.5405/jmbe.1450
   Noro A, 2013, J BIOMED MATER RES B, V101B, P355, DOI 10.1002/jbm.b.32846
   Novotna K, 2013, MATERIALS, V6, P1632, DOI 10.3390/ma6051632
   Pelaez-Vargas A, 2011, DENT MATER, V27, P581, DOI 10.1016/j.dental.2011.02.014
   Sandhyarani M, 2013, J ALLOY COMPD, V553, P324, DOI 10.1016/j.jallcom.2012.11.147
   Shie MY, 2014, J BIOMED MATER RES A, V102, P769, DOI 10.1002/jbm.a.34737
   Shon WJ, 2014, CLIN ORAL IMPLAN RES, V25, P573, DOI 10.1111/clr.12115
   Smeacetto F, 2010, MATER LETT, V64, P2450, DOI 10.1016/j.matlet.2010.08.016
   Vesel A, 2006, PLASMA CHEM PLASMA P, V26, P577, DOI 10.1007/s11090-006-9025-3
   Wang CW, 2014, J MATER SCI-MATER M, V25, P2193, DOI 10.1007/s10856-014-5258-5
   Watanabe H, 2012, DENT MATER J, V31, P806, DOI 10.4012/dmj.2012-069
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
   Wu BC, 2013, MATERIALS, V6, P5675, DOI 10.3390/ma6125675
   Wu CC, 2011, SURF COAT TECH, V205, P3182, DOI 10.1016/j.surfcoat.2010.11.036
   Xu XX, 2009, NANO RES, V2, P891, DOI 10.1007/s12274-009-9092-x
   Yamashita D, 2009, DENT MATER J, V28, P461, DOI 10.4012/dmj.28.461
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
NR 36
TC 23
Z9 23
U1 3
U2 19
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD FEB
PY 2015
VL 8
IS 2
BP 684
EP 699
DI 10.3390/ma8020684
PG 16
WC Materials Science, Multidisciplinary
SC Materials Science
GA CE7WM
UT WOS:000352052600022
PM 28787965
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Augustine, R
   Kalarikkal, N
   Thomas, S
AF Augustine, Robin
   Kalarikkal, Nandakumar
   Thomas, Sabu
TI An In vitro Method for the Determination of Microbial Barrier Property
   (MBP) of Porous Polymeric Membranes for Skin Substitute and Wound
   Dressing Applications
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE skin substitutes; wound dressings; microbial barrier; in vitro method
ID GAMMA-IRRADIATION; SCAFFOLDS; NANOFIBERS
AB Barrier property of materials to microbes is an important aspect in many applications like wound dressings and skin substitutes. Lack of a standard method for the evaluation of microbial barrier property limits the consideration of this important aspect by many bioengineers and biomaterial scientists. Thus, in this study we are intended to develop a standard method for the quantitative assessment of Microbial Barrier Property (MBP) and express this in terms of percentage in comparison with a control which resembles a bare wound or a standard existing wound coverage material. In this study, we have evaluated the microbial barrier property of electrospun materials with different pore spaces and our study showed that this method can be successfully used for the assessment of bacterial barrier property of materials intended for wound dressing and skin substitute applications. Further, the results showed that the MBP will vary with the test conditions. This methodology can be used to measure the microbial barrier property of wide range of materials like skin substitute materials, wound dressings, medical textiles and many other materials where microbial prevention is important. This methodology can also be extended to the specific determination of bacterial, fungal or viral barrier property with minor modifications.
C1 [Augustine, Robin; Kalarikkal, Nandakumar; Thomas, Sabu] Mahatma Gandhi Univ, Int & Inter Univ Ctr Nanosci & Nanotech, Kottayam 686560, Kerala, India.
   [Kalarikkal, Nandakumar] Mahatma Gandhi Univ, Sch Pure & Appl Phys, Kottayam 686560, Kerala, India.
   [Thomas, Sabu] Mahatma Gandhi Univ, Sch Chem Sci, Kottayam 686560, Kerala, India.
RP Thomas, S (reprint author), Mahatma Gandhi Univ, Int & Inter Univ Ctr Nanosci & Nanotech, Priyadarshini Hills, Kottayam 686560, Kerala, India.
EM nkkalarikkal@mgu.ac.in; sabuchathukulam@yahoo.co.uk
RI Thomas, Prof. Sabu/G-7310-2016
OI Thomas, Prof. Sabu/0000-0003-4726-5746; KALARIKKAL,
   NANDAKUMAR/0000-0002-4595-6466; Augustine, Robin/0000-0001-9724-8392
FU Department of Science and Technology (DST); Department of Biotechnology
   (DBT), Government of India, New Delhi; UGC SAP; DST-FIST; SAARD-KSCSTE
FX The authors acknowledge Department of Science and Technology (DST) and
   Department of Biotechnology (DBT), Government of India, New Delhi for
   the financial support through Nanomission and MSUB IPLSARE programs
   respectively. Funding from UGC SAP, DST-FIST, SAARD-KSCSTE are also
   gratefully acknowledged.
CR Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Ali AA, 2012, APPL NANOSCI, V2, P55, DOI 10.1007/s13204-011-0042-z
   Augustine R, 2012, INT J NANO DIMENS, V2, P205, DOI 10.7508/ijnd.2011.03.009
   Augustine R., 2014, RSC ADV, V4, P93
   Augustine R, 2014, DIABETES MELLITUS HU, P273
   Augustine R., 2013, HDB BIOPOLYMER BASED, P801
   Augustine R., 2014, RSC ADV, V4, P48
   Augustine R, 2014, PROG BIOMATER, V3, P103, DOI 10.1007/s40204-014-0030-y
   Augustine R, 2015, INT J POLYM MATER PO, V64, P526, DOI 10.1080/00914037.2014.977900
   Augustine R, 2014, J POLYM RES, V21, DOI 10.1007/s10965-013-0347-6
   Bhende Shubhangi, 2002, Surg Infect (Larchmt), V3, P251, DOI 10.1089/109629602761624216
   Biazar E, 2010, INT J NANO DIMENS, V1, P1, DOI 10.7508/ijnd.2010.0x.001
   Blocher J, 2009, EFFECT RELATIVE HUMI
   Garcia-Vargas M, 2014, INT J PHARMACEUT, V461, P286, DOI 10.1016/j.ijpharm.2013.11.060
   Jeong SI, 2014, TISSUE ENG REGEN MED, V11, P64, DOI 10.1007/s13770-014-0423-y
   Jeong SI, 2014, TISSUE ENG REGEN MED, V11, P56, DOI 10.1007/s13770-014-0424-x
   Jiang LY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-65
   Jin GR, 2013, EUR J PHARM BIOPHARM, V85, P689, DOI 10.1016/j.ejpb.2013.06.002
   Jin GR, 2013, BIOMATERIALS, V34, P724, DOI 10.1016/j.biomaterials.2012.10.026
   Jo AR, 2014, TISSUE ENG REGEN MED, V11, P16, DOI 10.1007/s13770-013-1105-x
   Joo YH, 2013, TISSUE ENG REGEN MED, V10, P65, DOI 10.1007/s13770-013-0358-8
   Kim HS, 2013, ACTA BIOMATER, V9, P7371, DOI 10.1016/j.actbio.2013.03.018
   Kobsa S, 2013, BIOMATERIALS, V34, P3891, DOI 10.1016/j.biomaterials.2013.02.016
   Kumar PTS, 2012, ACS APPL MATER INTER, V4, P2618, DOI 10.1021/am300292v
   Lakshman LR, 2010, J MACROMOL SCI A, V47, P1012, DOI 10.1080/10601325.2010.508001
   Osathanon T, 2014, TISSUE ENG REGEN MED, V11, P239, DOI 10.1007/s13770-014-0015-x
   Ovington L, 2010, WOUND HEALING EVIDEN, V180
   Rezaei A, 2012, TISSUE ENG REGEN MED, V9, P295, DOI 10.1007/s13770-012-0002-z
   Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032
   Yanez F, 2010, J MEMBRANE SCI, V365, P248, DOI 10.1016/j.memsci.2010.09.012
NR 30
TC 15
Z9 15
U1 0
U2 10
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JONGRO-GU
PA 199-1, DONGSUNG-DONG,, JONGRO-GU, SEOUL 110-810, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD FEB
PY 2015
VL 12
IS 1
BP 12
EP 19
DI 10.1007/s13770-014-0032-9
PG 8
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA CE5JG
UT WOS:000351867900002
DA 2018-10-19
ER

PT J
AU Wach, RA
   Adamus, A
   Kowalska-Ludwicka, K
   Grobelski, B
   Cala, J
   Rosiak, JM
   Pasieka, Z
AF Wach, Radoslaw A.
   Adamus, Agnieszka
   Kowalska-Ludwicka, Karolina
   Grobelski, Bartlomiej
   Cala, Jaroslaw
   Rosiak, Janusz M.
   Pasieka, Zbigniew
TI In vivo evaluation of nerve guidance channels of PTMC/PLLA porous
   biomaterial
SO ARCHIVES OF MEDICAL SCIENCE
LA English
DT Article
DE peripheral nerve regeneration; poly(L-lactic acid); poly(trimethylene
   carbonate); tubulisation
ID PERIPHERAL-NERVE; POLY(TRIMETHYLENE CARBONATE); 1,3-TRIMETHYLENE
   CARBONATE; POLY(L-LACTIC ACID); VITRO DEGRADATION; REPAIR; REGENERATION;
   COPOLYMERS; SCAFFOLDS; CONDUITS
AB Introduction: Peripheral nerve disruptions, frequently occurring during limb injuries, give rise to serious complications of patients recovery resulting from limitations in neural tissue regeneration capabilities. To overcome this problem bridging techniques utilizing guidance channels gain their importance. Biodegradable polymeric tubes seem to be more prospective then non-degradable materials - no necessity of implant removal and possibilities of release of incorporated drugs or biologically active agents that may support nerve regeneration process are the main advantages.
   Material and methods: Polymer blend of commercial poly(L-lactic acid) (PLLA) and in-house synthesized poly(trimethylene carbonate) (PTMC) were processed in an organic solvent - phase inversion process on a supporting rod - to form a guidance porous tube of 1.1 mm inner diameter. In vivo experiments on rat's cut femoral nerve by using either the tubes or end-to-end suturing (control group) involved 22 and 19 rats, respectively. Motor recovery of operated limbs, neuroma occurrence and histopathology of explanted nerves were evaluated after 30, 60 and 90 days of implantation.
   Results: Motor recovery of the limbs was of similar rate for the two animal groups. The neuroma formation was evident in over 90% control specimens, while for the bridging group it was less than 40% of all evaluable samples (p = 0.0022). Biocompatibility of applied materials was affirmed by moderate tissue response.
   Conclusions: Application of the biodegradable PLLA/PTMC polymeric tubes effectively supports regeneration of discontinued nerves. The applied material prevents neuroma formation, by reducing the scar tissue formation time and, thus, accelerating the process of neural tissue restoration.
C1 [Wach, Radoslaw A.; Adamus, Agnieszka; Rosiak, Janusz M.] Tech Univ Lodz, Fac Chem, Inst Appl Radiat Chem, PL-90924 Lodz, Poland.
   [Kowalska-Ludwicka, Karolina] Lodz Univ Technol, Inst Tech Biochem, Lodz, Poland.
   [Grobelski, Bartlomiej] Med Univ Lodz, Fac Pharm, Lodz, Poland.
   [Cala, Jaroslaw; Pasieka, Zbigniew] Med Univ Lodz, Dept Expt Surg, Lodz, Poland.
RP Wach, RA (reprint author), Tech Univ Lodz, Fac Chem, Inst Appl Radiat Chem, 15 Wroblewskiego St, PL-90924 Lodz, Poland.
EM wach@mitr.p.lodz.pl
FU European Commission project 'NerveRegeneration' [MIGR-CT-2007-206269];
   Ministry of Science and Higher Education, Poland [1953/B/P01/2008/35];
   Ministry of Science and Higher Education, Poland SPB grant [843/7 PR
   UE/2008/7]
FX This work has been partially financed by the European Commission project
   'NerveRegeneration' MIGR-CT-2007-206269 within 7FP and by the Ministry
   of Science and Higher Education, Poland: 1953/B/P01/2008/35 and SPB
   grant 843/7 PR UE/2008/7.
CR Adamus A, 2012, POLYM DEGRAD STABIL, V97, P532, DOI 10.1016/j.polymdegradstab.2012.01.021
   AMECKE B, 1992, Clinical Materials, V10, P47, DOI 10.1016/0267-6605(92)90084-7
   Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127
   Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151
   Dahlin LB, 2008, SCAND J SURG, V97, P310, DOI 10.1177/145749690809700407
   Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002
   Diao E, 2000, HAND CLIN, V16, P53
   Doolabh VB, 1996, REV NEUROSCIENCE, V7, P47
   DUDA A, 1994, MACROMOL RAPID COMM, V15, P559, DOI 10.1002/marc.1994.030150617
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Evans GRD, 2001, ANAT RECORD, V263, P396, DOI 10.1002/ar.1120
   Fu K, 2000, PHARMACEUT RES, V17, P100, DOI 10.1023/A:1007582911958
   Geuna S, 2009, INT REV NEUROBIOL, V87, P27, DOI 10.1016/S0074-7742(09)87003-7
   Ichihara S, 2008, INJURY, V39, pS29, DOI 10.1016/j.injury.2008.08.029
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Jozwiakowska J, 2011, POLYM DEGRAD STABIL, V96, P1430, DOI 10.1016/j.polymdegradstab.2011.05.010
   Kowalska-Ludwicka K, ARCH MED SC IN PRESS
   Kryger GS, 2001, J HAND SURG-AM, V26A, P635, DOI 10.1053/jhsu.2001.26035
   Liu GB, 2011, ARCH MED SCI, V7, P592, DOI 10.5114/aoms.2011.24127
   Medical Research Council Nerve Injuries Committee, 1943, 7 MRC NERV INJ COMM, V7
   Nugroho P, 2001, POLYM DEGRAD STABIL, V72, P337, DOI 10.1016/S0141-3910(01)00030-1
   Pego AP, 2003, J CONTROL RELEASE, V87, P69, DOI 10.1016/S0168-3659(02)00351-6
   Pego AP, 2003, J MATER SCI-MATER M, V14, P767, DOI 10.1023/A:1025084304766
   Pego AP, 2002, MACROMOL BIOSCI, V2, P411, DOI 10.1002/mabi.200290000
   Plikk P, 2009, BIOMACROMOLECULES, V10, P1259, DOI 10.1021/bm900093r
   Qin YY, 2006, J BIOMED MATER RES B, V79B, P312, DOI 10.1002/jbm.b.30544
   Ro LS, 1999, PAIN, V79, P265, DOI 10.1016/S0304-3959(98)00164-X
   ROWSHAN K, 2004, OPER TECH ORTHOP, V14, P163
   Sun HZ, 2012, ARCH MED SCI, V8, P924, DOI 10.5114/aoms.2012.31623
   Tyson T, 2009, BIOMACROMOLECULES, V10, P149, DOI 10.1021/bm801052m
   Wach RA, 2013, J APPL POLYM SCI, V127, P2259, DOI 10.1002/app.37932
   Wolford Larry M, 2003, Proc (Bayl Univ Med Cent), V16, P152
   Yuksel F, 1999, PLAST RECONSTR SURG, V104, P2092
   Zhang Z, 2006, BIOMATERIALS, V27, P1741, DOI 10.1016/j.biomaterials.2005.09.017
   Zhang Z, 2004, MACROMOL CHEM PHYSIC, V205, P867, DOI 10.1002/macp.200300184
NR 35
TC 1
Z9 1
U1 6
U2 39
PU TERMEDIA PUBLISHING HOUSE LTD
PI POZNAN
PA WENEDOW ST 9-1, POZNAN, 61-614, POLAND
SN 1734-1922
EI 1896-9151
J9 ARCH MED SCI
JI Arch. Med. Sci.
PD FEB
PY 2015
VL 11
IS 1
BP 210
EP 219
DI 10.5114/aoms.2013.34732
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA CE1BX
UT WOS:000351547900024
PM 25861309
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Bean, AC
   Tuan, RS
AF Bean, Allison C.
   Tuan, Rocky S.
TI Fiber diameter and seeding density influence chondrogenic
   differentiation of mesenchymal stem cells seeded on electrospun
   poly(epsilon-caprolactone) scaffolds
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE mesenchymal stem cells; chondrogenesis; electrospinning; fibrous
   scaffolds; biomaterials
ID ARTICULAR-CARTILAGE; PROGENITOR CELLS; PROLIFERATION; GROWTH;
   CHONDROCYTES; PREVALENCE; MIGRATION; ARTHRITIS; MATRICES; MESHES
AB Chondrogenic differentiation of mesenchymal stem cells is strongly influenced by the surrounding chemical and structural milieu. Since the majority of the native cartilage extracellular matrix is composed of nanofibrous collagen fibrils, much of recent cartilage tissue engineering research has focused on developing and utilizing scaffolds with similar nanoscale architecture. However, current literature lacks consensus regarding the ideal fiber diameter, with differences in culture conditions making it difficult to compare between studies. Here, we aimed to develop a more thorough understanding of how cell-cell and cell-biomaterial interactions drive in vitro chondrogenic differentiation of bone-marrow-derived mesenchymal stem cells (MSCs). Electrospun poly(epsilon-caprolactone) microfibers (4.3 +/- 0.8 mu m diameter, 90 mu m(2) pore size) and nanofibers (440 +/- 20 nm diameter, 1.2 mu m(2) pore size) were seeded with MSCs at initial densities ranging from 1 x 10(5) to 4 x 10(6) cells cm(-3)-scaffold and cultured under transforming growth factor-beta (TGF-beta) induced chondrogenic conditions for 3 or 6 weeks. Chondrogenic gene expression, cellular proliferation, as well as sulfated glycosaminoglycan and collagen production were enhanced on microfiber in comparison to nanofiber scaffolds, with high initial seeding densities being required for significant chondrogenic differentiation and extracellular matrix deposition. Both cell-cell and cell-material interactions appear to play important roles in chondrogenic differentiation of MSCs in vitro and consideration of several variables simultaneously is essential for understanding cell behavior in order to develop an optimal tissue engineering strategy.
C1 [Bean, Allison C.; Tuan, Rocky S.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Ctr Cellular & Mol Engn, Pittsburgh, PA 15219 USA.
RP Bean, AC (reprint author), Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Ctr Cellular & Mol Engn, 450 Technol Dr,Room 221, Pittsburgh, PA 15219 USA.
EM rst13@pitt.edu
FU Commonwealth of Pennsylvania; Cardiovascular Bioengineering Training
   Program at the University of Pittsburgh [NIH T32HL076124]
FX Funding for this work was provided by the Commonwealth of Pennsylvania
   and the Cardiovascular Bioengineering Training Program at the University
   of Pittsburgh (NIH T32HL076124). We would also like to acknowledge the
   Center for Biologic Imaging at the University of Pittsburgh for the use
   of their confocal microscopes and the staff for their technical
   assistance.
CR Badami AS, 2006, BIOMATERIALS, V27, P596, DOI 10.1016/j.biomaterials.2005.05.084
   Bade MJ, 2010, J ORTHOP SPORT PHYS, V40, P559, DOI 10.2519/jospt.2010.3317
   Bashur CA, 2006, BIOMATERIALS, V27, P5681, DOI 10.1016/j.biomaterials.2006.07.005
   Bashur CA, 2009, TISSUE ENG PT A, V15, P2435, DOI 10.1089/ten.tea.2008.0295
   Buckwalter Joseph A, 2005, Instr Course Lect, V54, P465
   Buxton A, 2010, TISSUE ENG PART A, V17, P371
   Caron MMJ, 2012, OSTEOARTHR CARTILAGE, V20, P1170, DOI 10.1016/j.joca.2012.06.016
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   CLARKE I C, 1971, Journal of Bone and Joint Surgery British Volume, V53, P732
   Darling EM, 2004, J ORTHOP RES, V22, P1182, DOI 10.1016/j.orthres.2004.03.001
   DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306
   DESSAU W, 1980, J EMBRYOL EXP MORPH, V57, P51
   He LM, 2010, ACTA BIOMATER, V6, P2960, DOI 10.1016/j.actbio.2010.02.039
   Health N I, 2003, NIH CONSENS STATE SC, V20, P1
   Hootman JM, 2006, ARTHRITIS RHEUM, V54, P226, DOI 10.1002/art.21562
   Hsu YM, 2009, J BIOMED MATER RES B, V91B, P737, DOI 10.1002/jbm.b.31450
   Huang AH, 2009, TISSUE ENG PT A, V15, P3461, DOI [10.1089/ten.tea.2009.0198, 10.1089/ten.TEA.2009.0198]
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Ju YM, 2010, BIOMATERIALS, V31, P4313, DOI 10.1016/j.biomaterials.2010.02.002
   Kavalkovich KW, 2002, IN VITRO CELL DEV-AN, V38, P457
   Kobayashi S, 2008, J ORTHOP RES, V26, P493, DOI 10.1002/jor.20507
   Kumbar SG, 2008, BIOMATERIALS, V29, P4100, DOI 10.1016/j.biomaterials.2008.06.028
   Labek G, 2011, J BONE JOINT SURG BR, V93B, P293, DOI 10.1302/0301-620X.93B3.25467
   Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176
   Lee WC, 2011, LAB CHIP, V11, P1359, DOI 10.1039/c0lc00579g
   Li WJ, 2006, TISSUE ENG, V12, P1775, DOI 10.1089/ten.2006.12.1775
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Lin Z, 2006, TISSUE ENG, V12, P1971, DOI 10.1089/ten.2006.12.1971
   Mariconda M, 2011, BMC MUSCULOSKEL DIS, V12, P29, DOI DOI 10.1186/1471-2474-12-222
   Noriega SE, 2012, CELLS TISSUES ORGANS, V195, P207, DOI 10.1159/000325144
   Shanmugasundaram S, 2011, TISSUE ENG PT A, V17, P831, DOI [10.1089/ten.tea.2010.0409, 10.1089/ten.TEA.2010.0409]
   Sisson K, 2010, J BIOMED MATER RES A, V94A, P1312, DOI 10.1002/jbm.a.32756
   STOCKWELL RA, 1967, J ANAT, V101, P753
   Takahashi Y, 2004, J BIOMAT SCI-POLYM E, V15, P41, DOI 10.1163/156856204322752228
   Talukdar S, 2011, BIOMATERIALS, V32, P8927, DOI 10.1016/j.biomaterials.2011.08.027
   Tan F, 2011, BIOTECHNOL ADV, V30, P352
   Tian F, 2008, J BIOMED MATER RES A, V84A, P291, DOI 10.1002/jbm.a.31304
   Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200
   Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020
   Wang LM, 2009, TISSUE ENG PT A, V15, P1009, DOI 10.1089/ten.tea.2008.0012
   Wise JK, 2009, TISSUE ENG PT A, V15, P913, DOI 10.1089/ten.tea.2008.0109
   Yao L, 2009, J BIOMED MATER RES B, V90B, P483, DOI 10.1002/jbm.b.31308
   Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134
NR 43
TC 23
Z9 24
U1 3
U2 46
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2015
VL 10
IS 1
AR 015018
DI 10.1088/1748-6041/10/1/015018
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CD3JU
UT WOS:000350975400019
PM 25634427
OA Green Accepted
DA 2018-10-19
ER

PT J
AU He, T
   Zhang, Y
   Lai, ACK
   Chan, V
AF He, Tao
   Zhang, Ying
   Lai, Alvin C. K.
   Chan, Vincent
TI Engineering bio-adhesive functions in an antimicrobial polymer
   multilayer
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE adhesive ligands; bacteria/cell adhesion; detachment force;
   antibacterial; S. aureus; E. coli
ID STAPHYLOCOCCUS-AUREUS; STAINLESS-STEEL; POLYELECTROLYTE MULTILAYER;
   BACTERIAL ADHESION; ESCHERICHIA-COLI; CELL-ADHESION; SURFACE;
   ANTIBACTERIAL; TITANIUM; COLLAGEN
AB Functionalization of a biomaterial surface with adhesive ligands is an effective way to promote specific cell adhesion. Ideally, biomaterial for applications in biomedical implants should simultaneously promote host cell adhesion and inhibit bacterial adhesion. Currently, little attention has been paid to the design of antimicrobial biomaterial with selective adhesiveness towards only targeted cells or tissues. In this study, the role of two typical adhesive ligands on the bioadhesion functions of a model antimicrobial film was elucidated. First, an adhesive ligand including an RGD peptide or collagen (CL) was chemically coupled to an antimicrobial polymeric multilayer composed of dextran sulfate (DS) and chitosan (CS). It was demonstrated that the density of RGD and CL immobilized on the DS/CS multilayer ranges between 4 to 137 ng cm(-2) and 100 to 1000 ng cm(-2), respectively. Then the effect of immobilized RGD or CL on both bacterial and fibroblast adhesion was investigated. By determining the density and morphology of adherent fibroblast on a DS/CS multilayer with or without an adhesive ligand, it was shown that RGD or CL effectively promoted fibroblast adhesion and proliferation in a concentration-dependent manner. Interestingly, the type of adhesive ligands imposed distinct effects in bacterial adhesion. Immobilized RGD did not enhance Staphylococcus aureus and Escherichia coli adhesion on DS/CS multilayers under all concentrations. In contrast, CL triggered significant S. aureus adhesion on DS/CS multilayers even at low surface concentration and when fibroblast adhesion was absent. Moreover, the detachment forces of individual S. aureus on CL coated DS/CS multilayers probed by atomic force microscopy (AFM) was 3 times and 20 times higher than that on the control substrate and on unmodified DS/CS multilayers, respectively. Interestingly, the lowest detachment force of E. coli was found on the CL coated DS/CS multilayers. This study demonstrated the possibility of engineering an antimicrobial multilayer coating with tailored adhesive properties towards specific cell types for potential applications in biomedical implants.
C1 [He, Tao] ASTAR, Inst Mat Res & Engn, Singapore 117602, Singapore.
   [Zhang, Ying; Chan, Vincent] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore.
   [Lai, Alvin C. K.] City Univ Hong Kong, Dept Civil & Architectural Engn, Kowloon, Hong Kong, Peoples R China.
RP He, T (reprint author), ASTAR, Inst Mat Res & Engn, 3 Res Link, Singapore 117602, Singapore.
EM het@imre.a-star.edu.sg; mvchan@ntu.edu.sg
RI Chan, Vincent/G-6197-2010
OI Chan, Vincent/0000-0003-2149-4479; LAI, Chi Keung
   Alvin/0000-0002-6202-1988
CR Adams Katherine T, 2014, Manag Care, V23, P54
   Agarwal A, 2010, BIOMATERIALS, V31, P680, DOI 10.1016/j.biomaterials.2009.09.092
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   Baier R E, 1984, J BIOMED MATER RES, V18, P327
   Beloin C, 2014, CURR OPIN PHARMACOL, V18, P61, DOI 10.1016/j.coph.2014.09.005
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Cue DR, 1997, INFECT IMMUN, V65, P2759
   Fowler T, 2000, EUR J CELL BIOL, V79, P672, DOI 10.1078/0171-9335-00104
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   GLOWACKI J, 1983, P SOC EXP BIOL MED, V172, P93
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Harding JL, 2014, TRENDS BIOTECHNOL, V32, P140, DOI 10.1016/j.tibtech.2013.12.004
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   He T, 2009, BIOMATERIALS, V30, P317, DOI 10.1016/j.biomaterials.2008.09.049
   Ho Cht S C, 2004, ADV MATER, P16957
   Hogan S, 2014, CURR PHARM DESIGN, V21, P100
   Holgers KM, 1999, BIOMATERIALS, V20, P1319, DOI 10.1016/S0142-9612(99)00033-2
   Ignatova M, 2006, LANGMUIR, V22, P255, DOI 10.1021/la051954b
   Jo YK, 2014, ACS APPL MATER INTER, V6, P20242, DOI 10.1021/am505784k
   Khalil F, 2014, COLLOID SURFACE B, V117, P185, DOI 10.1016/j.colsurfb.2014.02.022
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lichter JA, 2008, BIOMACROMOLECULES, V9, P1571, DOI 10.1021/bm701430y
   Lim K, 2013, ACS APPL MATER INTER, V5, P6412, DOI 10.1021/am401629p
   LJUNGH A, 1990, ZBL BAKT-INT J MED M, V274, P126, DOI 10.1016/S0934-8840(11)80982-5
   LUDWICKA A, 1984, ZBL BAKT-INT J MED M, V256, P479, DOI 10.1016/S0174-3031(84)80024-4
   Maddikeri RR, 2008, J BIOMED MATER RES A, V84A, P425, DOI 10.1002/jbm.a.31323
   McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110
   Medina MB, 2001, INT J FOOD MICROBIOL, V69, P199, DOI 10.1016/S0168-1605(01)00497-4
   Mohamed N, 1999, INFECT IMMUN, V67, P589
   Orgovan N, 2014, SCI REP-UK, V4, DOI 10.1038/srep04034
   Patel S, 2006, BIOMATERIALS, V27, P2890, DOI 10.1016/j.biomaterials.2005.12.009
   PATTI JM, 1993, BIOCHEMISTRY-US, V32, P11428, DOI 10.1021/bi00093a021
   PELLETIER LL, 1977, MEDICINE, V56, P287, DOI 10.1097/00005792-197707000-00002
   Ramstedt M, 2009, BIOMATERIALS, V30, P1524, DOI 10.1016/j.biomaterials.2008.12.008
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Senechal A, 2004, LANGMUIR, V20, P4172, DOI 10.1021/la035847y
   Serizawa T, 2002, BIOMACROMOLECULES, V3, P724, DOI 10.1021/bm0200027
   Shinji H, 2003, INFECT IMMUN, V71, P140, DOI 10.1128/IAI.71.1.140-146.2003
   Sin MC, 2014, ACS APPL MATER INTER, V6, P861, DOI 10.1021/am4041256
   Taschner S, 2002, BIOCHEM J, V367, P393, DOI 10.1042/BJ20020164
   Tedjo C, 2007, J BIOMED MATER RES A, V82A, P479, DOI 10.1002/jbm.a.31172
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   Vasilev K, 2010, NANO LETT, V10, P202, DOI 10.1021/nl903274q
   Veerachamy S, 2014, P I MECH ENG H, V228, P1083, DOI 10.1177/0954411914556137
   Wagner VE, 2004, J BIOMED MATER RES A, V69A, P79, DOI 10.1002/jbm.a.20115
   WALDVOGEL FA, 1980, NEW ENGL J MED, V303, P360, DOI 10.1056/NEJM198008143030703
   Wong SY, 2010, J AM CHEM SOC, V132, P17840, DOI 10.1021/ja106288c
   Wu J, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035005
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   Yu DG, 2007, J BIOMED MATER RES B, V83B, P105, DOI 10.1002/jbm.b.30772
NR 52
TC 5
Z9 5
U1 2
U2 45
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2015
VL 10
IS 1
AR 015015
DI 10.1088/1748-6041/10/1/015015
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CD3JU
UT WOS:000350975400016
PM 25634058
DA 2018-10-19
ER

PT J
AU Yu, J
   Zhang, WY
   Li, Y
   Wang, G
   Yang, LD
   Jin, JF
   Chen, QH
   Huang, MH
AF Yu, Jian
   Zhang, Wenyun
   Li, Yang
   Wang, Gang
   Yang, Lidou
   Jin, Jianfeng
   Chen, Qinghua
   Huang, Minghua
TI Synthesis, characterization, antimicrobial activity and mechanism of a
   novel hydroxyapatite whisker/nano zinc oxide biomaterial
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE hydroxyapatite whisker; zinc oxide; antibacterial mechanism; biomaterial
ID ANTIBACTERIAL ACTIVITY; ZNO NANOPARTICLES; BROAD-SPECTRUM; BONE-CEMENT;
   BIOCOMPATIBILITY; PHOTOCATALYSIS; SUSCEPTIBILITY; INFECTIONS; BACTERIA;
   RELEASE
AB Postoperative infections remain a risk factor that leads to failures in oral and maxillofacial artificial bone transplantation. This study aimed to synthesize and evaluate a novel hydroxyapatite whisker (HAPw) / nano zinc oxide (n-ZnO) antimicrobial bone restorative biomaterial. A scanning electron microscope (SEM), energy dispersive spectroscopy (EDS) and x-ray diffraction (XRD) were employed to characterize and analyze the material. Antibacterial capabilities against Staphylococcus aureus, Escherichia coli, Candida albicans and Streptococcus mutans were determined by minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC), and kinetic growth inhibition assays were performed under darkness and simulated solar irradiation. The mode of antibiotic action was observed by transmission electron microscopy (TEM) and confocal laser scanning microscopy (CLSM). The MIC and MBC were 0.078-1.250 mg ml(-1) and 0.156-2.500 mg ml(-1), respectively. The inhibitory function on the growth of the microorganisms was achieved even under darkness, with gram-positive bacteria found to be more sensitive than gram-negative, and enhanced antimicrobial activity was exhibited under simulated solar excitation compared to darkness. TEM and CLSM images revealed a certain level of bacterial cell membrane destruction after treatment with 1 mg ml(-1) of the material for 12 h, causing the leakage of intracellular contents and bacteria death. These results suggest favorable antibiotic properties and a probable mechanism of the biomaterial for the first time, and further studies are needed to determine its potential application as a postoperative anti-inflammation method in bone transplantation.
C1 [Yu, Jian; Zhang, Wenyun; Li, Yang; Wang, Gang; Yang, Lidou] Kunming Gen Hosp Chengdu Mil Reg, Dept Stomatol, Kunming, Yunnan Province, Peoples R China.
   [Yu, Jian; Li, Yang] Kunming Med Univ, Clin Coll, Kunming, Peoples R China.
   [Jin, Jianfeng] Kunming Municipal Stomatol Hosp, Kunming, Peoples R China.
   [Chen, Qinghua; Huang, Minghua] Kunming Univ Sci & Technol, Fac Mat Sci & Engn, Kunming, Peoples R China.
RP Zhang, WY (reprint author), Kunming Gen Hosp Chengdu Mil Reg, Dept Stomatol, 212 Daguan Rd, Kunming, Yunnan Province, Peoples R China.
EM wenyunzh88@126.com
FU Natural Science Foundation of China (NSFC) [81260272]
FX The research was funded by the Natural Science Foundation of China
   (NSFC) No. 81260272. We are grateful to Professor Fukai Bao (Kunming
   Medical University, China) for providing the bacterial strains and
   Professor Qinghua Chen (Kunming University of Science and Technology,
   China) for providing the hydroxyapatite whisker in this experiment.
CR Applerot G, 2012, RSC ADV, V2, P2314, DOI 10.1039/c2ra00602b
   Applerot G, 2009, ADV FUNCT MATER, V19, P842, DOI 10.1002/adfm.200801081
   Astala R, 2005, CHEM MATER, V17, P4125, DOI 10.1021/cm050523b
   Bagherifard S, 2014, ACS APPL MATER INTER, V6, P7963, DOI 10.1021/am501119k
   Bamba H, 1997, AM J GASTROENTEROL, V92, P659
   Betz RR, 2002, ORTHOPEDICS, V25, pS561
   Castellano Joseph J, 2007, Int Wound J, V4, P114, DOI 10.1111/j.1742-481X.2007.00316.x
   Chwalibog A, 2010, INT J NANOMED, V5, P1085, DOI 10.2147/IJN.S13532
   Converse GL, 2010, ACTA BIOMATER, V6, P856, DOI 10.1016/j.actbio.2009.08.004
   Esberg A, 2012, INFECT IMMUN, V80, P3869, DOI 10.1128/IAI.00435-12
   Ewald A, 2011, ACTA BIOMATER, V7, P4064, DOI 10.1016/j.actbio.2011.06.049
   Fang M, 2006, INT J ANTIMICROB AG, V27, P513, DOI 10.1016/j.ijantimicag.2006.01.008
   Foldbjerg R, 2011, ARCH TOXICOL, V85, P743, DOI 10.1007/s00204-010-0545-5
   FOX MA, 1993, CHEM REV, V93, P341, DOI 10.1021/cr00017a016
   Fukui H, 2012, CHEM-BIOL INTERACT, V198, P29, DOI 10.1016/j.cbi.2012.04.007
   Ghosh S, 2012, RSC ADV, V2, P930, DOI 10.1039/c1ra00815c
   Gogniat G, 2006, FEMS MICROBIOL LETT, V258, P18, DOI 10.1111/j.1574-6968.2006.00190.x
   Gong HY, 2013, ASIAN PAC J CANCER P, V14, P3351, DOI 10.7314/APJCP.2013.14.5.3351
   Gopikrishnan R, 2010, NANO-MICRO LETT, V2, P31, DOI 10.5101/nml.v2i1.p31-36
   Hickok NJ, 2012, ADV DRUG DELIVER REV, V64, P1165, DOI 10.1016/j.addr.2012.03.015
   Hirota K, 2010, CERAM INT, V36, P497, DOI 10.1016/j.ceramint.2009.09.026
   HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004
   Jalal R, 2010, MATER CHEM PHYS, V121, P198, DOI 10.1016/j.matchemphys.2010.01.020
   Jan J. I. Tariq, 2013, INT J NANOMED, V8, P3679, DOI DOI 10.2147/IJN.S45439
   Jin J F, 2013, APPL MECH MAT, V364, P655
   Jones N, 2008, FEMS MICROBIOL LETT, V279, P71, DOI 10.1111/j.1574-6968.2007.01012.x
   Zhou J, 2006, ADV MATER, V18, P2432, DOI 10.1002/adma.200600200
   Kim SG, 2010, IMPLANT DENT, V19, P115, DOI 10.1097/ID.0b013e3181d43a76
   Li F, 2009, J DENT, V37, P289, DOI 10.1016/j.jdent.2008.12.004
   Li F, 2011, J AM DENT ASSOC, V142, P184, DOI 10.14219/jada.archive.2011.0062
   Li M., 2010, ENVIRON SCI TECHNOL, V45, P755, DOI DOI 10.1021/ES102266G
   Li Y, 2012, ACS NANO, V6, P5164, DOI 10.1021/nn300934k
   Li Z, 2008, J PHYS CHEM C, V112, P20114, DOI 10.1021/jp808878p
   Liu Y, 2009, J APPL MICROBIOL, V107, P1193, DOI 10.1111/j.1365-2672.2009.04303.x
   Lu WW, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/44/445711
   Lusvardi G, 2002, J MATER SCI-MATER M, V13, P91, DOI 10.1023/A:1013655123340
   Mori R, 2011, CLIN ORTHOP RELAT R, V469, P600, DOI 10.1007/s11999-010-1626-8
   Ohira T, 2008, J MATER SCI-MATER M, V19, P1407, DOI 10.1007/s10856-007-3246-8
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Raqhupathi K R, 2011, LANGMUIR, V27, P4020
   Rodriguez-Tudela JL, 2001, J CLIN MICROBIOL, V39, P2513, DOI 10.1128/JCM.39.7.2513-2517.2001
   Sawai J, 1996, J CHEM ENG JPN, V29, P627, DOI 10.1252/jcej.29.627
   Sawai J, 2003, J MICROBIOL METH, V54, P177, DOI 10.1016/S0167-7012(03)00037-X
   Seil JT, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/49/495101
   Sevinc BA, 2010, J BIOMED MATER RES B, V94B, P22, DOI 10.1002/jbm.b.31620
   Shrestha A, 2010, J ENDODONT, V36, P1030, DOI 10.1016/j.joen.2010.02.008
   Siamani S, 2013, J BIOMED MATER RES A, V101, P222
   Siddique S, 2013, ACTA CHIM SLOV, V60, P660
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   Singh AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025029
   Smith AJ, 2001, J MED MICROBIOL, V50, P940, DOI 10.1099/0022-1317-50-11-940
   Tan JW, 2013, CHINESE MED J-PEKING, V126, P2495, DOI 10.3760/cma.j.issn.0366-6999.20120323
   Thian ES, 2008, J BIOMED MATER RES A, V85A, P188, DOI 10.1002/jbm.a.31564
   Torroni A, 2009, J ORAL MAXIL SURG, V67, P1121, DOI 10.1016/j.joms.2008.11.020
   Venugopal J, 2010, PHILOS T R SOC A, V368, P2065, DOI 10.1098/rsta.2010.0012
   Vidic J., 2013, J NANOPART RES, V15, P1
   Wilson APR, 2012, J ANTIMICROB CHEMOTH, V67, pI23, DOI 10.1093/jac/dks198
   Xie YP, 2011, APPL ENVIRON MICROB, V77, P2325, DOI 10.1128/AEM.02149-10
   Xu XL, 2013, LANGMUIR, V29, P5573, DOI 10.1021/la400378t
   Yamamoto O, 2004, J MATER SCI-MATER M, V15, P847, DOI 10.1023/B:JMSM.0000036271.35440.36
   Yamamoto O, 2001, CARBON, V39, P1643, DOI 10.1016/S0008-6223(00)00289-X
   Yang L, 2006, BIOTECHNOL PROGR, V22, P387, DOI 10.1021/bp050282c
   Yang ZH, 2006, COLLOID SURFACE B, V47, P140, DOI 10.1016/j.colsurfb.2005.12.007
   Zaragoza O, 2011, ANTIMICROB AGENTS CH, V55, P1563, DOI 10.1128/AAC.01631-10
   Zhang HQ, 2011, ACTA BIOMATER, V7, P2960, DOI 10.1016/j.actbio.2011.03.020
   Zhang LL, 2010, J NANOPART RES, V12, P1625, DOI 10.1007/s11051-009-9711-1
   Zhu WD, 2012, P NATL ACAD SCI USA, V109, P14194, DOI 10.1073/pnas.1117676109
NR 67
TC 15
Z9 15
U1 3
U2 91
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2015
VL 10
IS 1
AR 015001
DI 10.1088/1748-6041/10/1/015001
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CD3JU
UT WOS:000350975400002
PM 25534679
DA 2018-10-19
ER

PT J
AU Sadaf, S
   Bhatti, HN
   Nausheen, S
   Amin, M
AF Sadaf, Sana
   Bhatti, Haq Nawaz
   Nausheen, Sana
   Amin, Misbah
TI Application of a novel lignocellulosic biomaterial for the removal of
   Direct Yellow 50 dye from aqueous solution: Batch and column study
SO JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS
LA English
DT Article
DE Biosorption; Polyethyleneimine; Kinetic studies; Thermodynamic study;
   Bed depth service time (BDST) model
ID DE-OILED SOYA; SUGARCANE BAGASSE; ADSORPTIVE REMOVAL; CRYSTAL VIOLET;
   HAZARDOUS DYE; BED COLUMN; BASIC DYE; WASTE; BIOSORPTION; EQUILIBRIUM
AB This study focused on the utilization of sugarcane bagasse for the removal of Direct Yellow 50 dye from aqueous solution. Sugarcane bagasse was used in native, modified and immobilized forms. Polyethyleneimine (PEI) was used as the modifying agent and modified biomass depicted the enhanced biosorption capacity as compare to native and immobilized forms. Batch mode experiments were conducted to explore the biosorption potential of sugarcane bagasse at different operating conditions. The best conditions for the maximum dye removal were found to be lower pH (2.0), low biosorbent dose (0.05 g) and low temperature (30 degrees C). Maximum dye removal with native, PEI treated and immobilized biomass was 43.17, 65.8 and 15.7 mg/g, respectively. Kinetic studies were carried out and results showed the best fitness of pseudo-second-order kinetic model on the experimental results. Experimental results were also interpreted by different equilibrium isotherms. Thermodynamic study was carried out to evaluate Gibbs free energy (Delta G degrees), enthalpy (Delta H degrees) and entropy (Delta S degrees). Continuous mode experiments were conducted to check the optimized conditions of bed height, flow rate and initial dye concentration for maximum dye removal. Maximum dye removal in continuous study was 10.4 mg/g at 4 cm bed height and 50 mg/L initial dye concentration. Thomas and bed depth service time (BDST) models were applied on the experimental results of column study. The results prove that sugarcane bagasse can be used as a potential biosorbent for the removal of Direct Yellow 50 dye from aqueous solutions. (C) 2014 Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Sadaf, Sana] Govt Coll Women Univ, Dept Chem, Faisalabad, Pakistan.
   [Bhatti, Haq Nawaz; Nausheen, Sana; Amin, Misbah] Univ Agr Faisalabad, Dept Chem, Faisalabad 38040, Pakistan.
RP Sadaf, S (reprint author), Govt Coll Women Univ, Dept Chem, Faisalabad, Pakistan.
EM sanasadaf@gmail.com; hnbhatti2005@yahoo.com
OI Bhatti, Haq Nawaz/0000-0002-5445-8338
CR Ahmad AA, 2010, J HAZARD MATER, V175, P298, DOI 10.1016/j.jhazmat.2009.10.003
   Akar T, 2009, J HAZARD MATER, V168, P1302, DOI 10.1016/j.jhazmat.2009.03.011
   Aksu Z, 2010, J ENVIRON MANAGE, V91, P1546, DOI 10.1016/j.jenvman.2010.02.026
   Asgher M, 2011, CAN J CHEM ENG, V9999, P1
   Asgher M, 2012, ECOL ENG, V38, P79, DOI 10.1016/j.ecoleng.2011.10.004
   Bayramoglu G, 2002, MICROCHEM J, V72, P63, DOI 10.1016/S0026-265X(01)00151-5
   Bhatti HN, 2009, CHEM ENG J, V148, P434, DOI 10.1016/j.cej.2008.09.028
   Chakraborty S, 2012, SEP SCI TECHNOL, V47, P1898, DOI 10.1080/01496395.2012.663047
   Chakraborty S, 2012, J WATER REUSE DESAL, V2, P55, DOI 10.2166/wrd.2012.008
   Charumathi D, 2012, DESALINATION, V285, P22, DOI 10.1016/j.desal.2011.09.023
   Chowdhury S, 2012, ENVIRON PROG SUSTAIN, V31, P415, DOI 10.1002/ep.10564
   Chowdhury S, 2011, CLEAN-SOIL AIR WATER, V39, P274, DOI 10.1002/clen.201000170
   Das Saha P, 2012, SEP SCI TECHNOL, V47, P112, DOI 10.1080/01496395.2011.610397
   Doubinin M., 1947, PHYS CHEM, V55, P327
   Freundlich H M F, 1906, J PHYS CHEM, V57, P385
   Gupta VK, 2006, J COLLOID INTERF SCI, V293, P16, DOI 10.1016/j.cis.2005.06.021
   HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011
   Haq IU, 2011, CAN J CHEM ENG, V89, P593, DOI 10.1002/cjce.20436
   Harkins WD, 1944, J AM CHEM SOC, V66, P1366, DOI 10.1021/ja01236a048
   Helfferich F.G., 1962, ION EXCHANGE
   Ho YS, 2000, ADSORPT SCI TECHNOL, V18, P639, DOI 10.1260/0263617001493693
   Ho YS, 2005, PROCESS BIOCHEM, V40, P119, DOI 10.1016/j.procbio.2003.11.035
   Kara I, 2012, CHEM ENG J, V211, P442, DOI 10.1016/j.cej.2012.09.086
   Khaled A, 2009, J HAZARD MATER, V165, P100, DOI 10.1016/j.jhazmat.2008.09.122
   Kundu S, 2006, SEP PURIF TECHNOL, V51, P165, DOI 10.1016/j.seppur.2006.01.007
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Mall ID, 2006, COLLOID SURFACE A, V278, P175, DOI 10.1016/j.colsurfa.2005.12.017
   Mao J, 2009, BIORESOURCE TECHNOL, V100, P1463, DOI 10.1016/j.biortech.2008.07.053
   Mittal A, 2013, J MOL LIQ, V179, P133, DOI 10.1016/j.molliq.2012.11.032
   Mittal A, 2010, J COLLOID INTERF SCI, V342, P518, DOI 10.1016/j.jcis.2009.10.046
   Onyango MS, 2004, J COLLOID INTERF SCI, V279, P341, DOI 10.1016/j.jcis.2004.06.038
   Pehlivan E, 2013, FOOD CHEM, V138, P133, DOI 10.1016/j.foodchem.2012.09.110
   Sadaf S, 2014, ARCH ENVIRON CON TOX, V66, P557, DOI 10.1007/s00244-013-9992-3
   Sadaf S, 2014, DESALIN WATER TREAT, V52, P184, DOI 10.1080/19443994.2013.780985
   Sadaf S, 2011, AFR J BIOTECHNOL, V10, P13548
   Safa Y, 2011, AFR J BIOTECHNOL, V10, P3128
   Safa Y, 2011, DESALINATION, V272, P313, DOI 10.1016/j.desal.2011.01.040
   Salleh MAM, 2011, DESALINATION, V280, P1, DOI 10.1016/j.desal.2011.07.019
   Savova D, 2003, CARBON, V41, P1897, DOI 10.1016/S0008-6223(03)00179-9
   Sene L, 2002, BIORESOURCE TECHNOL, V83, P153, DOI 10.1016/S0960-8524(01)00192-4
   Tahir SS, 2006, CHEMOSPHERE, V63, P1842, DOI 10.1016/j.chemosphere.2005.10.033
   Temkin MJ, 1940, ACTA PHYSIOCHIM USSR
   Teng MY, 2006, DESALINATION, V194, P156, DOI 10.1016/j.desal.2005.11.008
   Thomas HC, 1944, J AM CHEM SOC, V66, P1664, DOI 10.1021/ja01238a017
   Uddin MT, 2009, J ENVIRON MANAGE, V90, P3443, DOI 10.1016/j.jenvman.2009.05.030
   Vijayaraghavan K, 2005, SEP PURIF TECHNOL, V44, P53, DOI 10.1016/j.seppur.2004.12.003
   Weber W, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
NR 48
TC 47
Z9 48
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-1070
EI 1876-1089
J9 J TAIWAN INST CHEM E
JI J. Taiwan Inst. Chem. Eng.
PD FEB
PY 2015
VL 47
BP 160
EP 170
DI 10.1016/j.jtice.2014.10.001
PG 11
WC Engineering, Chemical
SC Engineering
GA CD8BU
UT WOS:000351321000017
DA 2018-10-19
ER

PT J
AU Gangadoo, S
   Taylor-Robinson, A
   Chapman, J
AF Gangadoo, S.
   Taylor-Robinson, A.
   Chapman, J.
TI Nanoparticle and biomaterial characterisation techniques
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Nanoparticle; Biomaterials; Microscopy; Characterisation
ID SULFATE-REDUCING BACTERIA; ATOMIC-FORCE MICROSCOPY;
   DEPOSITION-PRECIPITATION; SILVER NANOPARTICLES; INHIBITION; GROWTH;
   STAPHYLOCOCCUS; QUANTITATION; ABSORPTION; PHTHALATE
AB The physicochemical properties of nanoparticles and biomaterials exert influences over their interactions with cells and consequently play an important role when introduced into any given system. Characterisation of these said materials is a detailed and, above all, a cross-disciplinary relationship of physical, chemical, mechanical, surface, in vitro and in vivo multi-integrated research topics. The biocompatibility of a functional structure with desired properties is affected by the biomaterials' structural characteristics and building block pathways. Moreover, the sensitivity, depth of field, resolution and dimension of a given material also make structural analysis of a nano-biomaterial particularly challenging to characterise. In this paper, we discuss the use of biomaterial characterisation techniques (fluorescent and optical) to characterise structural aspects of biomaterials, with the aim of improving both the understanding and relationship between a biomaterials' structure and its functionality.
C1 [Gangadoo, S.; Taylor-Robinson, A.; Chapman, J.] Cent Queensland Univ, Sch Med & Appl Sci, Rockhampton, Qld 4702, Australia.
RP Chapman, J (reprint author), Cent Queensland Univ, Sch Med & Appl Sci, Rockhampton, Qld 4702, Australia.
EM j.chapman@cqu.edu.au
RI Chapman, James/J-7883-2018
OI Chapman, James/0000-0002-9850-0403; Taylor-Robinson,
   Andrew/0000-0001-7342-8348
FU CQUniversity HEALTH CRN; Australian Government's Collaborative Research
   Networks Program
FX This manuscript and project has been supported by the CQUniversity
   HEALTH CRN www.cqu.edu.au/crn and the Australian Government's
   Collaborative Research Networks Program.
CR ABDOLLAHI H, 1990, J GEN MICROBIOL, V136, P1025, DOI 10.1099/00221287-136-6-1025
   Amos WB, 2003, BIOL CELL, V95, P335, DOI 10.1016/S0248-4900(03)00078-9
   Beech IB, 2005, INT MICROBIOL, V8, P157
   Braeckmans K, 2003, BIOPHYS J, V85, P2240, DOI 10.1016/S0006-3495(03)74649-9
   Briggs D., 1983, PRACTICAL SURFACE AN, p[500, 605]
   Callow ME, 2002, BIOLOGIST, V49, P1
   Chapman J, 2012, RSC NANOSCI NANOTECH, P1, DOI 10.1039/9781849735261
   Chapman J., 2011, DEV NOVEL ANTIFOULIN
   CHAPMAN J, 2014, INT J MATER ENG TECH, V12, P1
   Chapman J, 2014, HIST J FILM RADIO TV, V34, P1, DOI 10.1080/01439685.2014.879010
   Chapman J, 2013, J MATER CHEM B, V1, P6194, DOI 10.1039/c3tb21285h
   Chapman J, 2012, ADV ENG MATER, V14, pB175, DOI 10.1002/adem.201180037
   Chapman J, 2011, J APPL BIOMATER BIOM, V9, P176, DOI 10.5301/JABB.2011.8787
   Chapman J, 2010, J MEMBRANE SCI, V365, P180, DOI 10.1016/j.memsci.2010.09.003
   Chapman J, 2010, COLLOID SURFACE B, V78, P208, DOI 10.1016/j.colsurfb.2010.03.002
   CLAUSE O, 1991, J CATAL, V130, P21, DOI 10.1016/0021-9517(91)90088-L
   COSTERTON JW, 1978, SCI AM, V238, P86, DOI 10.1038/scientificamerican0178-86
   DEALMEIDA JLG, 1994, J AM OIL CHEM SOC, V71, P675, DOI 10.1007/BF02541423
   DILLING W, 1990, FEMS MICROBIOL LETT, V71, P123
   Dulon S, 2007, J APPL ELECTROCHEM, V37, P173, DOI 10.1007/s10800-006-9250-8
   Dunn RC, 1999, CHEM REV, V99, P2891, DOI 10.1021/cr980130e
   Eby GA, 2008, MED HYPOTHESES, V71, P584, DOI 10.1016/j.mehy.2008.04.025
   FELIU S, 1990, ACI MATER J, V87, P457
   FREUNDLICH M, 1963, SCIENCE, V142, P185, DOI 10.1126/science.142.3589.185
   Goda T., 2006, SOFT CONTACT LENS BI
   Grunenwald A, 2014, J ARCHAEOL SCI, V49, P134, DOI 10.1016/j.jas.2014.05.004
   Gu J. D., 2002, MICROBES ENVIRON, V17, P105
   HARDY JA, 1981, CURR MICROBIOL, V6, P259, DOI 10.1007/BF01566873
   Holm ER, 2004, BIOFOULING, V20, P219, DOI 10.1080/08927010400011245
   Horn O, 2004, WATER RES, V38, P3693, DOI 10.1016/j.watres.2004.06.012
   Iverson F., 1959, ADV APPL MICROBIOL, V1
   Jain PK, 2006, J PHYS CHEM B, V110, P7238, DOI 10.1021/jp057170o
   Janagama D. G., NANOBIOELECTRONIC PH, P613
   Jeong L, 2014, INT J MOL SCI, V15, P6857, DOI 10.3390/ijms15046857
   Kaneko Y, 2007, J CLIN INVEST, V117, P877, DOI 10.1172/JCI30783
   Knipe E., 1985, CONF850606
   Kodama Y, 2003, APPL ENVIRON MICROB, V69, P107, DOI 10.1128/AEM.69.1.107-112.2003
   Koh IO, 2001, J PHOTOCH PHOTOBIO A, V139, P205, DOI 10.1016/S1010-6030(00)00427-5
   Kumar VG, 2006, ULTRASON SONOCHEM, V13, P549, DOI 10.1016/j.ultsonch.2005.09.010
   Landau MV, 2001, J CATAL, V201, P22, DOI 10.1006/jcat.2001.3227
   Lemire M, 1996, MAR ECOL PROG SER, V135, P77, DOI 10.3354/meps135077
   Li H, 2007, SCI TOTAL ENVIRON, V380, P181, DOI 10.1016/j.scitotenv.2006.12.033
   Li X, 2007, MICROPOR MESOPOR MAT, V102, P151, DOI 10.1016/j.micromeso.2006.12.048
   LOVLEY DR, 1993, ANNU REV MICROBIOL, V47, P263, DOI 10.1146/annurev.mi.47.100193.001403
   Lytle FW, 1999, J SYNCHROTRON RADIAT, V6, P123, DOI 10.1107/S0909049599001260
   Magot M, 1997, INT J SYST BACTERIOL, V47, P818, DOI 10.1099/00207713-47-3-818
   Margui E, 2014, TRAC-TREND ANAL CHEM, V53, P73, DOI 10.1016/j.trac.2013.09.009
   Marmur A, 2006, SOFT MATTER, V2, P12, DOI 10.1039/b514811c
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Menzel M, 2014, ANAL CHEM, V86, P3053, DOI 10.1021/ac404017u
   Minz D, 1999, APPL ENVIRON MICROB, V65, P4666
   Nagao E, 1998, J MICROSC-OXFORD, V191, P8
   Nakamiya K, 2005, J BIOSCI BIOENG, V99, P115, DOI 10.1263/jbb.99.115
   Papoulis D, 2014, APPL CATAL B-ENVIRON, V147, P526, DOI 10.1016/j.apcatb.2013.09.025
   Porter A. L., 1990, SCI PUBL POLICY, V17, P229
   Pumera M, 2011, ENERG ENVIRON SCI, V4, P668, DOI 10.1039/c0ee00295j
   Qiao YQ, 2014, BIOMATERIALS, V35, P6882, DOI 10.1016/j.biomaterials.2014.04.101
   Rajadhyaksha M, 1999, J INVEST DERMATOL, V113, P293, DOI 10.1046/j.1523-1747.1999.00690.x
   Regan F., 2011, INSTRUMENT VIEWPOINT, P11
   Seto J, 1996, THIN SOLID FILMS, V273, P97, DOI 10.1016/0040-6090(95)06800-7
   Shapiro L, 2007, THIN SOLID FILMS, V515, P4624, DOI 10.1016/j.tsf.2006.11.117
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   Tatsumisago M, 2005, SOLID STATE IONICS, V176, P2909, DOI 10.1016/j.ssi.2005.09.022
   Thiyagarajan V, 2003, J EXP MAR BIOL ECOL, V287, P223, DOI 10.1016/S0022-0981(02)00570-1
   TSAI CL, 1988, J ORTHOPAED RES, V6, P666, DOI 10.1002/jor.1100060507
   Vallet-Regi M, 2004, SOLID STATE IONICS, V172, P435, DOI 10.1016/j.ssi.2004.04.036
   VANPETT K, 1990, J ORTHOPAED RES, V8, P321, DOI 10.1002/jor.1100080303
   Whelan A, 2006, J ENVIRON MONITOR, V8, P880, DOI 10.1039/b603289c
   Whitehead K, 2001, MAR BIOL, V139, P1013
   Wu J, 2014, BIOMATERIALS, V35, P3744, DOI 10.1016/j.biomaterials.2013.12.078
   Yonehara Y, 2001, PROG ORG COAT, V42, P150, DOI 10.1016/S0300-9440(01)00157-6
   Zhang ML, 2013, MATER LETT, V93, P282, DOI 10.1016/j.matlet.2012.11.103
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 73
TC 2
Z9 2
U1 1
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD FEB
PY 2015
VL 30
IS B1
SI SI
BP B44
EP B56
DI 10.1179/1753555714Y.0000000201
PG 13
WC Materials Science, Multidisciplinary
SC Materials Science
GA CD5KE
UT WOS:000351125700009
DA 2018-10-19
ER

PT J
AU Oguchi, Y
   Akahori, T
   Hattori, T
   Fukui, H
   Niinomi, M
AF Oguchi, Yurie
   Akahori, Toshikazu
   Hattori, Tomokazu
   Fukui, Hisao
   Niinomi, Mitsuo
TI Change in Mechanical Strength and Bone Contactability of Biomedical
   Titanium Alloy with Low Young's Modulus Subjected to Fine Particle
   Bombarding Process
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE metallic biomaterial; microstructure; tensile and fatigue properties;
   Young's modulus; biocompatibility
ID BIOCOMPATIBILITY; IMPROVEMENT; STABILITY
AB Beta-type Ti-29Nb-13Ta-4.6Zr (TNTZ), which is a recently developed biomedical titanium alloys, shows a relatively low Young's modulus of around 60 GPa when subjected to a solution treatment.
   However, our focus in this study was on the practical applications of TNTZ in vivo because its mechanical strength decreases with solution treatment progress. Therefore, we investigated the effect of fine particle bombarding (FPB) on the mechanical properties of TNTZ subjected to a cold-swaging treatment in order to maintain its relatively low Young's modulus and to improve its mechanical properties. The relative bone contact ratios between the cancellous bones of Japanese white rabbits and column-shaped TNTZ samples subjected to FPB were also evaluated.
   The microstructure of cold-swaged TNTZ showed a single beta-phase with a marble-like structure. Moreover, its Vickers hardness did not increase remarkably with changes in its diameter, although the average diameter of the beta-grains of solutionized TNTZ ranged from 5.0 to 20 mu m, depending on the increase in the holding time of the solution treatment. The Vickers hardness and Young's modulus of TNTZ subjected to FPB increased at the edge of the specimen surface to be around 70% and 15%, respectively, more than those of cold-swaged TNTZ. Further, the fatigue strength of TNTZ subjected to FPB became significantly higher than that of cold-swaged TNTZ in the high-cycle fatigue life region. Lastly, TNTZ with a rough surface texture (Ra: 0.65 mu m) showed a relative bone contact ratio of more than 80% after undergoing FPB; this value was significantly higher than that of cold-swaged TNTZ with a very smooth surface texture (Ra: 0.07 mu m).
C1 [Oguchi, Yurie] Meijo Univ, Grad Sch Sci & Technol, Nagoya, Aichi 4688502, Japan.
   [Akahori, Toshikazu; Hattori, Tomokazu] Meijo Univ, Fac Sci & Technol, Nagoya, Aichi 4688502, Japan.
   [Fukui, Hisao] Aichi Gakuin Univ, Sch Dent, Nagoya, Aichi 4648650, Japan.
   [Niinomi, Mitsuo] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Oguchi, Y (reprint author), Meijo Univ, Nagoya, Aichi 4688502, Japan.
RI Niinomi, Mitsuo/B-5965-2011
FU Light Metal Educational Foundation; Amada Foundation; Tatematsu
   Foundation; Japan Titanium Society
FX This work was supported in part by The Light Metal Educational
   Foundation, The Amada Foundation, The Tatematsu Foundation and The Japan
   Titanium Society.
CR Abe T., 1994, T JSS, V39, P17
   Akahori T, 2005, MAT SCI ENG C-BIO S, V25, P248, DOI 10.1016/j.msec.2004.12.007
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   Chehroudi B., 1990, J BIOMED MATER RES, V24, P1067
   Egami N., 2006, Journal of the Japan Society of Precision Engineering, V72, P1071
   Fujimori S., 1995, J JPN DENT MAT, V17, P155
   Furuta T, 2006, J JPN I MET, V70, P579, DOI 10.2320/jinstmet.70.579
   Hattori H., 2002, JPN CLIN BIOMECHANIC, V23, P299
   Ishikura K, 2013, J JPN I MET, V77, P253, DOI 10.2320/jinstmet.J2013003
   Itakura R., 1987, ANN JPN PROSTHODONTI, V31, P21
   John R, 2010, PROCEDIA ENGINEER, V2, P1887, DOI 10.1016/j.proeng.2010.03.203
   Kagaya C., 2006, Journal of the Japan Society of Precision Engineering, V72, P1067
   Ko H., 2002, T JPN SOC MECH ENG A, V68, P484
   Maeda H., 2001, T JPN SOC MECH ENG, V67, P306
   Mitsubayashi M., 1995, T JPN SOC MECH ENG A, V61, P1172
   Miyahara T, 2006, SOLID STATE PHENOMEN, V118, P215, DOI 10.4028/www.scientific.net/SSP.118.215
   MURAKAMI Y, 1993, EFFECT SMALL DEFECTS
   Nakazawa H., 1982, FATIGUE STRENGTH MET, V51
   Nambu K., 2010, T JPN SOC MECH ENG, V76, P88
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Niinomi M, 2010, EXPERT REV MED DEVIC, V7, P481, DOI [10.1586/erd.10.16, 10.1586/ERD.10.16]
   Oshida Y., 2007, BIOSCIENCE BIOENGINE, P179
   Takagi M., 2006, J IRON STEEL I JPN, V92, P24
   Todaka Y, 2003, J JPN I MET, V67, P690, DOI 10.2320/jinstmet1952.67.12_690
   Ushida K, 2012, J JPN I MET, V76, P397, DOI 10.2320/jinstmet.76.397
NR 28
TC 0
Z9 0
U1 0
U2 14
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD FEB
PY 2015
VL 56
IS 2
BP 218
EP 223
DI 10.2320/matertrans.M2014349
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CE2MQ
UT WOS:000351650100008
OA Bronze
DA 2018-10-19
ER

PT J
AU Hac-Wydro, K
   Wydro, P
   Cetnar, A
   Wlodarczyk, G
AF Hac-Wydro, Katarzyna
   Wydro, Pawel
   Cetnar, Andrzej
   Wlodarczyk, Grzegorz
TI Phospatidylserine or ganglioside - Which of anionic lipids determines
   the effect of cationic dextran on lipid membrane?
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Cationic dextran; Lipid-polymer interactions; Model membrane; BAM images
ID CARRIER; CELLS; PHOSPHATIDYLSERINE; ACCUMULATION; PERMEABILITY;
   DERIVATIVES; POLYMERS; AGENTS; LIVER; RAT
AB In this work the influence of cationic polymer, namely diethylaminoethyl DEAE-dextran on model lipid membranes was investigated. This polymer is of a wide application as a biomaterial and a drug carrier and its cytotoxicity toward various cancer cells was also confirmed. It was suggested that anticancer effect of cationic dextran is connected with the binding of the polymer to the negatively charged sialic acid residues overexpressed in cancer membrane. This fact encouraged us to perform the studies aimed at verifying whether the effect of cationic DEAE-dextran on membrane is determined only by the presence of the negatively charged lipid in the system or the kind of anionic lipid is also important. To reach this goal systematic investigations on the effect of dextran on various one-component lipid monolayers and multicomponent hepatoma cell model membranes differing in the level and the kind of anionic lipids (phosphatidylserine, sialic acid-containing ganglioside GM3 or their mixture) were done. As evidenced the results the effect of DEAE-dextran on the model system is determined by anionic lipid-polymer electrostatic interactions. However, the magnitude of the effect of cationic polymer is strongly dependent on the kind of anionic lipid in the model system. Namely, the packing and ordering of the mixtures containing ganglioside GM3 were more affected by DEAE-dextran than phosphatidylserine-containing monolayers. Although the experiments were done on model systems and therefore further studies are highly needed, the collected data may indicate that ganglioside may be important in the differentiation of the effect of cationic dextran on membranes. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Hac-Wydro, Katarzyna; Cetnar, Andrzej; Wlodarczyk, Grzegorz] Jagiellonian Univ, Fac Chem, Dept Environm Chem, PL-30387 Krakow, Poland.
   [Wydro, Pawel] Jagiellonian Univ, Fac Chem, Dept Phys Chem & Electrochem, PL-30060 Krakow, Poland.
RP Hac-Wydro, K (reprint author), Jagiellonian Univ, Fac Chem, Dept Environm Chem, Gronostajowa 3, PL-30387 Krakow, Poland.
EM hac@chemia.uj.edu.pl
CR Baldwin AD, 2010, BIOPOLYMERS, V94, P128, DOI 10.1002/bip.21334
   Davies J.T., 1963, INTERFACIAL PHENOMEN
   Dhaneshwar Suneela S., 2006, Indian Journal of Pharmaceutical Sciences, V68, P705
   Dreher MR, 2006, J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070
   Dyatlovitskaya E.V., 1997, EUR J BIOCHEM, V63, P357
   Eshita Y., 2012, J NANOMED NANOTECHNO, VS5, P2, DOI [10.4172/2157-7439.S5-002, DOI 10.4172/2157-7439.S5-002]
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Hong SP, 2006, BIOCONJUGATE CHEM, V17, P728, DOI 10.1021/bc060077y
   Karp G., 2004, CELL MOL BIOL CONCEP
   Kay JG, 2011, SENSORS-BASEL, V11, P1744, DOI 10.3390/s110201744
   Kolter T., 2012, GANGLIOZIDE BIOCH
   MAEDA H, 1992, BIOCONJUGATE CHEM, V3, P351, DOI 10.1021/bc00017a001
   Marquez M, 2004, ANTICANCER RES, V24, P1347
   Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3
   Mehvar R, 2000, J CONTROL RELEASE, V69, P1, DOI 10.1016/S0168-3659(00)00302-3
   Naessens M, 2005, J CHEM TECHNOL BIOT, V80, P845, DOI 10.1002/jctb.1322
   Nevozhay D, 2006, ANTICANCER RES, V26, P1135
   Onishi Y, 2007, NANOMED-NANOTECHNOL, V3, P184, DOI 10.1016/j.nano.2007.07.002
   Riedl S, 2011, BBA-BIOMEMBRANES, V1808, P2638, DOI 10.1016/j.bbamem.2011.07.026
   Tabata Y, 1997, DRUG DELIV, V4, P213, DOI 10.3109/10717549709051895
   Tanaka T, 2004, INT J PHARM, V286, P9, DOI 10.1016/j.ijpharm.2004.07.031
   VANHOEVEN RP, 1972, J MEMBRANE BIOL, V9, P105, DOI 10.1007/BF01868047
   YAMAOKA T, 1995, INT J PHARM, V113, P149, DOI 10.1016/0378-5173(94)00189-C
NR 23
TC 1
Z9 1
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD FEB 1
PY 2015
VL 126
BP 204
EP 209
DI 10.1016/j.colsurfb.2014.12.031
PG 6
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA CD2OM
UT WOS:000350918900025
PM 25576813
DA 2018-10-19
ER

PT J
AU Morra, M
   Cassinelli, C
   Bollati, D
   Cascardo, G
   Bellanda, M
AF Morra, Marco
   Cassinelli, Clara
   Bollati, Daniele
   Cascardo, Giovanna
   Bellanda, Marco
TI Adherent Endotoxin on Dental Implant Surfaces: A Reappraisal
SO JOURNAL OF ORAL IMPLANTOLOGY
LA English
DT Article
DE Dental implants; implant surface; endotoxin; osteoimmunology;
   inflammatory response
ID BONE MORPHOGENETIC PROTEIN-2; MACROPHAGE CELL-LINE; BIOMATERIAL;
   OSTEOIMMUNOLOGY; CYTOKINES; TOPOGRAPHY; EXPRESSION; J774A.1
AB Osteoimmunology is the crosstalk between cells from the immune and skeletal systems, suggesting a role of pro-inflammatory cytokines in the stimulation of osteoclast activity. Endotoxin or bacterial challenges to inflammatory cells are directly relevant to dental implant pathologies involving bone resorption, such as osseointegration failure and peri-implantitis. While the endotoxin amount on implant devices is regulated by standards, it is unknown whether commercially available dental implants elicit different levels of adherent-endotoxin stimulated cytokines. The objective of this work is to develop a model system and evaluate endotoxin-induced expression of pro-inflammatory cytokine genes relevant to osteoclast activation on commercially available dental implants. Murine J774-A1 macrophages were cultured on Ti disks with different level of lipopolysaccharide (LPS) contamination to define the time-course of the inflammatory response to endotoxin, as evaluated by reverse transcription polymerase chain reaction analysis. The developed protocol was then used to measure adherent endotoxin on commercially available packaged and sterile dental implants in the "as-implanted" condition. Results show that tested dental implants induce variable expression of endotoxin-stimulated genes, sometimes above the level expected to promote bone resorption in vivo. Results are unaffected by the specific surface treatment; rather, they likely reflect care in cleaning and packaging protocols. In conclusion, expression of genes that enhance osteoclast activity through endotoxin stimulation of inflammatory cells is widely different on commercially available dental implants. A reappraisal of the clinical impact of adherent endotoxins on dental (and bone) implant devices is required in light of increasing knowledge on crosstalk between cells from the immune and skeletal systems.
C1 [Morra, Marco; Cassinelli, Clara; Bollati, Daniele; Cascardo, Giovanna; Bellanda, Marco] Nobil Bio Ric, Portacomaro, Italy.
RP Morra, M (reprint author), Nobil Bio Ric, Portacomaro, Italy.
EM mmorra@nobilbio.it
CR Albrektsson T, 2008, PERIODONTOL 2000, V47, P15, DOI 10.1111/j.1600-0757.2007.00247.x
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bi YM, 2001, J BONE MINER RES, V16, P2082, DOI 10.1359/jbmr.2001.16.11.2082
   Bryans Trabue D., 2004, Biomedical Instrumentation & Technology, V38, P73, DOI 10.2345/0899-8205(2004)38[73:BETARO]2.0.CO;2
   Chamberlain LM, 2009, J BIOMED MATER RES A, V88A, P858, DOI 10.1002/jbm.a.31930
   Chang DT, 2009, J BIOMED MATER RES A, V91A, P1210, DOI 10.1002/jbm.a.32218
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233
   Dean David D, 2008, J Oral Implantol, V34, P303, DOI 10.1563/1548-1336-34.6.303
   Ehrenfest DMD, 2011, J ORAL IMPLANTOL, V37, P525, DOI 10.1563/AAID-JOI-D-11-00080
   Ehrenfest DMD, 2011, J ORAL IMPLANTOL, V37, P506, DOI 10.1563/AAID-JOI-D-11-00081
   Gorbet B, 2005, BIOMATERIALS, V26, P6811
   Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183
   Greenfield EM, 2005, J BIOMED MATER RES B, V72B, P179, DOI 10.1002/jbm.b.30150
   Henderson B, 1996, MICROBIOL REV, V60, P316
   Irinakis T, 2009, J ORAL IMPLANTOL, V35, P277, DOI 10.1563/AAID-JOI-D-09-00020.1
   Juodzbalys Gintaras, 2007, J Oral Implantol, V33, P177, DOI 10.1563/1548-1336(2007)33[177:TDISMO]2.0.CO;2
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Lee SH, 2008, BMB REP, V41, P495, DOI 10.5483/BMBRep.2008.41.7.495
   Lorenzo J, 2005, IMMUNOL REV, V208, P5, DOI 10.1111/j.0105-2896.2005.00340.x
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   Nakashima T, 2009, J BONE MINER METAB, V27, P519, DOI 10.1007/s00774-009-0089-z
   Omar MO, 2001, BIOMATERIALS, V32, P8190
   Ota-Tsuzuki C, 2011, J ORAL IMPLANTOL, V37, P641, DOI 10.1563/AAID-JOI-D-09-00125.1
   Ratner B D, 2001, J Dent Educ, V65, P1340
   Rauner M, 2007, INT ARCH ALLERGY IMM, V143, P31, DOI 10.1159/000098223
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1069, DOI 10.1002/jbm.820250903
   Sugiyama T, 2011, J ORAL IMPLANTOL, V37, P273, DOI 10.1563/AAID-JOI-D-09-00113.1
   Takebe J, 2007, J BIOMED MATER RES A, V80A, P711, DOI 10.1002/jbm.a.30988
   Takebe J, 2003, J BIOMED MATER RES A, V64A, P207, DOI 10.1002/jbm.a.10275
   Wataha JC, 2001, J ORAL IMPLANTOL, V27, P174
   Wieland M, 2000, BONE ENG, P163
NR 33
TC 5
Z9 5
U1 0
U2 5
PU ALLEN PRESS INC
PI LAWRENCE
PA 810 E 10TH ST, LAWRENCE, KS 66044 USA
SN 0160-6972
EI 1548-1336
J9 J ORAL IMPLANTOL
JI J. Oral Implant.
PD FEB
PY 2015
VL 41
IS 1
BP 10
EP 16
DI 10.1563/AAID-JOI-D-12-00137
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CC7BM
UT WOS:000350522700003
PM 25699642
DA 2018-10-19
ER

PT J
AU Babbush, CA
   Kanawati, A
AF Babbush, Charles A.
   Kanawati, Ali
TI Clinical Evaluation of 262 Osseointegrated Implants Placed in Sites
   Grafted With Calcium Phosphosilicate Putty: A Retrospective Study
SO JOURNAL OF ORAL IMPLANTOLOGY
LA English
DT Article
DE bone grafting; implant dentistry; maxillofacial surgery; oral surgery;
   prosthodontics
ID RIDGE PRESERVATION; SUCCESS; RECONSTRUCTION; ALLOGRAFT
AB Along with the widespread use of dental implants, regenerative procedures have become an indispensable tool for implant surgeons in managing residual ridges and the surrounding bone. Putty bone grafts have significantly superior handling characteristics in comparison to particulates. These include ease of placement, enhanced particle containment, and a viscous consistency that has allowed for unique delivery systems to be developed. The aim of this study was to report the clinical efficacy of calcium phosphosilicate (CPS) putty in a wide variety of indications related to implant reconstruction and to report the survival rate of implants placed in these grafted sites. The CPS putty was used as the graft material of choice. Treatments were categorized into following groups: extraction graft, extraction with immediate implant placement, all-on-four concept, peri-implantitis treatment, bone augmentation before implant placement, implant replacement graft, and grafting around implant placed in resorbed ridges. Included in the analysis were 65 patients (36 men, 29 women) with a mean age of 63 +/- 12 years. In total, 262 implants were placed. Four implants were diagnosed with peri-implantitis and were treated as described in category 4, for a total of 266 grafted sites. Two implants from the extraction graft category and 3 implants from the all-on-four group were lost and replaced with successfully osseointegrated implants during a mean study follow-up period of 12.24 +/- 2.32 months. The implant success rate at 1 year was 98.1% (257/262). Based on results of this large-scale, retrospective study we conclude that (1) the use of putty bone grafts can simplify bone-grafting procedures and reduce intraoperative time in various grafting indications, (2) this study verified the efficacy of a CPS putty bone graft biomaterial in a large array of implant-related surgical indications, and (3) implants placed in sites grafted with CPS putty yield very high survival rates.
C1 [Babbush, Charles A.; Kanawati, Ali] ClearChoice Dent Implant Ctr, Cleveland, OH 44124 USA.
   [Babbush, Charles A.; Kanawati, Ali] Case Western Reserve Univ, Case Sch Dent Med, Cleveland, OH 44106 USA.
   [Kanawati, Ali] W Virginia Univ, Sch Dent, Dept Prosthodont, Morgantown, WV 26506 USA.
RP Babbush, CA (reprint author), ClearChoice Dent Implant Ctr, Cleveland, OH 44124 USA.
EM cbabbush@bellsouth.net
FU Novabone Products, LLC, Alachua, Fla
FX This project/study was supported by a grant from Novabone Products, LLC,
   Alachua, Fla.
CR Aichelmann-Reidy ME, 2004, J PERIODONTOL, V75, P340, DOI 10.1902/jop.2004.75.3.340
   Babbush C A, 1998, Implant Dent, V7, P205, DOI 10.1097/00008505-199807030-00008
   BABBUSH CA, 1986, J ORAL MAXIL SURG, V44, P274, DOI 10.1016/0278-2391(86)90078-9
   Babbush CA., 2011, DENTAL IMPLANTS THE
   Babbush Charles A, 2003, Implant Dent, V12, P325, DOI 10.1097/01.ID.0000095466.18042.31
   Babbush CA, 2011, J ORAL IMPLANTOL, V37, P431, DOI 10.1563/AAID-JOI-D-10-00133
   Cho YR, 2004, CLIN PLAST SURG, V31, P377, DOI 10.1016/j.cps.2004.03.001
   Clementini M, 2012, INT J ORAL MAX SURG, V41, P847, DOI 10.1016/j.ijom.2012.03.016
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hu YC, 2009, CHINESE MED J-PEKING, V122, P2386, DOI 10.3760/cma.j.issn.0366-6999.2009.19.035
   Karoussis IK, 2004, CLIN ORAL IMPLAN RES, V15, P8, DOI 10.1111/j.1600-0501.2004.00983.x
   Kotsakis G, 2014, J ORAL IMPLANTOL, V40, P690, DOI 10.1563/AAID-JOI-D-12-00028
   Kotsakis GA, 2014, INT J PERIODONT REST, V34, P233, DOI 10.11607/prd.1855
   Kotsakis GA, 2014, INT J ORAL MAX IMPL, V29, P141, DOI 10.11607/jomi.3230
   Mahesh L, J ORAL IMPLANTOL IN
   Mahesh Lanka, 2012, Compend Contin Educ Dent, V33, pe109
   Mazor Z, 2013, INT J ORAL IMPLANTOL, V4, P78
   Misch CE, 2008, CONT IMPLANT DENT, P645
   Simion M, 1998, Int J Periodontics Restorative Dent, V18, P8
   Soltan M, 2012, IMPLANT DENT, V21, P295, DOI 10.1097/ID.0b013e31825e5425
   Vance GS, 2004, INT J ORAL MAX IMPL, V19, P491
NR 21
TC 1
Z9 1
U1 0
U2 7
PU ALLEN PRESS INC
PI LAWRENCE
PA 810 E 10TH ST, LAWRENCE, KS 66044 USA
SN 0160-6972
EI 1548-1336
J9 J ORAL IMPLANTOL
JI J. Oral Implant.
PD FEB
PY 2015
VL 41
IS 1
BP 63
EP 69
DI 10.1563/AAID-JOI-D-13-00336
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CC7BM
UT WOS:000350522700011
PM 25072734
DA 2018-10-19
ER

PT J
AU Byun, J
AF Byun, Jonghoe
TI Emerging Frontiers of Graphene in Biomedicine
SO JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Review
DE Graphene; graphene oxide; nanosheet; functionalization; biomedicine;
   nanobiotechnology
ID STEM-CELLS; DRUG-DELIVERY; LABEL-FREE; OXIDE; DNA; CHALLENGES; TOXICITY;
   ACID; FUNCTIONALIZATION; DIFFERENTIATION
AB Graphene is a next-generation biomaterial with increasing biomedical applicability. As a new class of one-atom-thick nanosheets, it is a true two-dimensional honeycomb network nanomaterial that attracts interest in various scientific fields and is rapidly becoming the most widely studied carbon-based material. Since its discovery in 2004, its unique optical, mechanical, electronic, thermal, and magnetic properties are the basis of exploration of the potential applicability of graphene. Graphene materials, such as graphene oxide and its reduced form, are studied extensively in the biotechnology arena owing to their multivalent functionalization and efficient surface loading with various biomolecules. This review provides a brief summary of the recent progress in graphene and graphene oxide biological research together with current findings to spark novel applications in biomedicine. Graphene-based applications are progressively developing; hence, the opportunities and challenges of this rapidly growing field are discussed together with the versatility of these multifaceted materials.
C1 [Byun, Jonghoe] Dankook Univ, Dept Mol Biol, Yongin 448701, South Korea.
   [Byun, Jonghoe] Dankook Univ, Inst Nanosensor & Biotechnol, Yongin 448701, South Korea.
RP Byun, J (reprint author), Dankook Univ, Dept Mol Biol, Yongin 448701, South Korea.
EM jonghoe@dankook.ac.kr
FU Dankook University
FX The present research was conducted by the research fund of Dankook
   University in 2013.
CR Bitounis D, 2013, ADV MATER, V25, P2258, DOI 10.1002/adma.201203700
   Bressan E, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0296-9
   Carpio IEM, 2012, NANOSCALE, V4, P4746, DOI 10.1039/c2nr30774j
   Chang YL, 2011, TOXICOL LETT, V200, P201, DOI 10.1016/j.toxlet.2010.11.016
   Chen GY, 2012, BIOMATERIALS, V33, P418, DOI 10.1016/j.biomaterials.2011.09.071
   Chung C, 2012, ACCOUNTS CHEM RES, V46, P2211
   Dong HF, 2010, ANAL CHEM, V82, P5511, DOI 10.1021/ac100852z
   Feng LZ, 2011, NANOMEDICINE-UK, V6, P317, DOI 10.2217/NNM.10.158
   Feng LZ, 2011, NANOSCALE, V3, P1252, DOI 10.1039/c0nr00680g
   Garaj S, 2010, NATURE, V467, P190, DOI 10.1038/nature09379
   Georgakilas V, 2012, CHEM REV, V112, P6156, DOI 10.1021/cr3000412
   Goenka S, 2014, J CONTROL RELEASE, V173, P75, DOI 10.1016/j.jconrel.2013.10.017
   Gurunathan S, 2012, INT J NANOMED, V7, P5901, DOI 10.2147/IJN.S37397
   He SJ, 2010, ADV FUNCT MATER, V20, P453, DOI 10.1002/adfm.200901639
   Kanakia S, 2014, BIOMATERIALS, V35, P7022, DOI 10.1016/j.biomaterials.2014.04.066
   Kim H, 2014, SMALL, V10, P117, DOI 10.1002/smll.201202636
   Kong HY, 2013, BIOMOL THER, V21, P423, DOI 10.4062/biomolther.2013.085
   Kong HY, 2012, B KOREAN CHEM SOC, V33, P657, DOI 10.5012/bkcs.2012.33.2.657
   Kong HY, 2011, B KOREAN CHEM SOC, V32, P53, DOI 10.5012/bkcs.2011.32.1.53
   Kong HY, 2015, MOL CELLS
   Kostarelos K, 2009, NAT NANOTECHNOL, V4, P627, DOI 10.1038/nnano.2009.241
   Krishna KV, 2013, NANOMEDICINE-UK, V8, P1669, DOI [10.2217/NNM.13.140, 10.2217/nnm.13.140]
   Kuzum D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6259
   Elias AL, 2010, NANO LETT, V10, P366, DOI 10.1021/nl901631z
   Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c
   Li F, 2013, ADV FUNCT MATER, V23, P4140, DOI 10.1002/adfm.201203816
   Li JL, 2014, J BIOMED MATER RES A, V102, P2181, DOI 10.1002/jbm.a.34871
   Li N, 2011, BIOMATERIALS, V32, P9374, DOI 10.1016/j.biomaterials.2011.08.065
   Liu JQ, 2013, ACTA BIOMATER, V9, P9243, DOI 10.1016/j.actbio.2013.08.016
   Liu SB, 2011, ACS NANO, V5, P6971, DOI 10.1021/nn202451x
   Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x
   Lu BG, 2012, NANOSCALE, V4, P2978, DOI 10.1039/c2nr11958g
   Mahmoudi M, 2012, NANOSCALE, V4, P7322, DOI 10.1039/c2nr31657a
   Mir M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04434
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   Nezakati T, 2014, ARCH TOXICOL, V88, P1987, DOI 10.1007/s00204-014-1361-0
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Park DW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6258
   Pinto AM, 2013, COLLOID SURFACE B, V111, P188, DOI 10.1016/j.colsurfb.2013.05.022
   Quick J, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-22
   Santos CM, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/39/395101
   Shan CS, 2009, ANAL CHEM, V81, P2378, DOI 10.1021/ac802193c
   Shen H, 2012, ACS APPL MATER INTER, V4, P6317, DOI 10.1021/am3019367
   Shen H, 2012, THERANOSTICS, V2, P283, DOI 10.7150/thno.3642
   Tang ZW, 2010, SMALL, V6, P1205, DOI 10.1002/smll.201000024
   Tao Y, 2012, ANALYST, V137, P2588, DOI 10.1039/c2an35373c
   Tatavarty R, 2014, CHEM COMMUN, V50, P8484, DOI 10.1039/c4cc02442g
   Wells DB, 2012, NANO LETT, V12, P4117, DOI 10.1021/nl301655d
   Xu ZY, 2014, ACS APPL MATER INTER, V6, P17268, DOI 10.1021/am505308f
   Yang M, 2013, ANALYST, V138, P72, DOI 10.1039/c2an35744e
   Yang YQ, 2013, MATER TODAY, V16, P365, DOI 10.1016/j.mattod.2013.09.004
   Zhang LM, 2010, SMALL, V6, P537, DOI 10.1002/smll.200901680
   Zhang M, 2011, BIOSENS BIOELECTRON, V26, P3260, DOI 10.1016/j.bios.2010.12.037
   Zhou XF, 2014, CURR MED CHEM, V21, P855, DOI 10.2174/0929867320666131119124325
NR 54
TC 22
Z9 22
U1 6
U2 105
PU KOREAN SOC MICROBIOLOGY & BIOTECHNOLOGY
PI SEOUL
PA KOREA SCI TECHNOL CENTER #507,  635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA
SN 1017-7825
EI 1738-8872
J9 J MICROBIOL BIOTECHN
JI J. Microbiol. Biotechnol.
PD FEB
PY 2015
VL 25
IS 2
BP 145
EP 151
DI 10.4014/jmb.1412.12045
PG 7
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA CC3RN
UT WOS:000350267100001
PM 25563423
DA 2018-10-19
ER

PT J
AU Vano-Herrera, K
   Misiun, A
   Vogt, C
AF Vano-Herrera, Kelim
   Misiun, Anna
   Vogt, Carla
TI Preparation and characterization of poly( lactic acid)/poly(methyl
   methacrylate) blend tablets for application in quantitative analysis by
   micro Raman spectroscopy
SO JOURNAL OF RAMAN SPECTROSCOPY
LA English
DT Article
DE poly(lactic acid); poly(methyl methacrylate) blend; polymer blend;
   quantification; implant; micro Raman spectroscopy
ID GLASS-TRANSITION TEMPERATURES; POLY(METHYL METHACRYLATE); DETECTION
   LIMITS; BINARY BLENDS; POLYLACTIDE; COPOLYMERS; MISCIBILITY; DEFINITION;
   MORPHOLOGY; MIXTURES
AB Poly(lactic acid) (PLA) is a biodegradable polymer that has a variety of applications, one of which is as biomaterial in surgery or as functional layers on implants, due to its compatibility with living tissue. This paper reports the possibilities of quantification of poly(lactic acid) (PLA) in a polymer matrix such as poly(methyl methacrylate) (PMMA) by micro Raman spectroscopy (MRS). Blends of amorphous poly(DL-lactic acid) with poly(methyl methacrylate) were prepared by the procedure of dissolution/precipitation. Thermal properties of the blends such as the glass transition temperature (Tg) were characterized by differential scanning calorimetry (DSC). The PLA/PMMA blends exhibited only a single glass transition region, indicating that this system is miscible. The PLA/PMMA system obeys the Gordon-Taylor equation (Tg versus PLA content). Various concentration ratios of PLA blends were prepared to use as a basis for quantitative analysis by MRS. Intensities of the characteristic bands at 813cm(-1) (COC of PMMA) and 873cm(-1) (C?COO of PLA) were used for the calculation. The calibration graph showed a good linear correlation with an R-2 value of 0.9985. On the basis of the calibration curve obtained, the determined content of several PLA/PMMA blends was in good agreement when compared with nominal contents. The limit of detection (LOD) and quantification (LOQ) were calculated by the calibration data set as signal-to-noise method. The relative standard deviation of this method was lower than 10% and the accuracy better than 4%. This study demonstrated that Raman spectroscopy provides an alternative non destructive method for quantitative analysis of PLA in a PMMA matrix. Copyright (c) 2015 John Wiley & Sons, Ltd.
C1 [Vano-Herrera, Kelim; Vogt, Carla] Leibniz Univ Hannover, Dept Analyt Chem, Inst Inorgan Chem, D-30167 Hannover, Germany.
   [Misiun, Anna] German Inst Rubber Technol, Dept Mat Dev & Testing, D-30511 Hannover, Germany.
RP Vogt, C (reprint author), Leibniz Univ Hannover, Dept Analyt Chem, Callinstr 9, D-30167 Hannover, Germany.
EM vogt@acc.uni-hannover.de
OI Vano Herrera, Kelim/0000-0001-8553-5060
CR [Anonymous], 2013, 113572 DIN EN ISO
   [Anonymous], 2008, 32645 DIN
   Auras R, 2004, MACROMOL BIOSCI, V4, P835, DOI 10.1002/mabi.200400043
   Auras R, 2010, POLYLACTIC ACID SYNT
   Babu RJ, 2009, MATER LETT, V63, P2666, DOI 10.1016/j.matlet.2009.09.033
   Brostow W, 2008, MATER LETT, V62, P3152, DOI 10.1016/j.matlet.2008.02.008
   Craver C., 2000, APPL POLYM SCI 21 CE
   Eguiburu JL, 1998, POLYMER, V39, P6891, DOI 10.1016/S0032-3861(98)00182-7
   EURACHEM / CITAT, 2012, QUANT UNC AN MEAS
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   Gupta AP, 2007, EUR POLYM J, V43, P4053, DOI 10.1016/j.eurpolymj.2007.06.045
   Kalogeras IM, 2010, THERMOCHIM ACTA, V509, P135, DOI 10.1016/j.tca.2010.06.016
   KISTER G, 1995, J RAMAN SPECTROSC, V26, P307, DOI 10.1002/jrs.1250260409
   Kister G, 1998, POLYMER, V39, P3335, DOI 10.1016/S0032-3861(97)10057-X
   Kister G, 1998, POLYMER, V39, P267, DOI 10.1016/S0032-3861(97)00229-2
   Kister G, 2000, POLYMER, V41, P925, DOI 10.1016/S0032-3861(99)00223-2
   Koenig J. L., 1999, SPECTROSCOPY POLYM
   Kromidas S., 2011, HDB VALIDIERUNG ANAL
   Kucharczyk P., 2011, 5 INT C EN DEV ENV B, V11, P341
   Kucharczyk P., 2011, 5 INT C EN DEV ENG B
   Larkin PJ, 2011, INFRARED AND RAMAN SPECTROSCOPY: PRINCIPLES AND SPECTRAL INTERPRETATION, P1
   Li SH, 2008, POLYM INT, V57, P1242, DOI 10.1002/pi.2469
   Miller J. N., 2005, STAT CHEMOMETRICS AN
   Nampoothiri KM, 2010, BIORESOURCE TECHNOL, V101, P8493, DOI 10.1016/j.biortech.2010.05.092
   NEPPEL A, 1984, J RAMAN SPECTROSC, V15, P257, DOI 10.1002/jrs.1250150410
   Nielsen AS, 2002, POLYMER, V43, P2671, DOI 10.1016/S0032-3861(02)00053-8
   Pinal R, 2008, ENTROPY, V10, P207, DOI 10.3390/entropy-e10030207
   Rasal RM, 2010, PROG POLYM SCI, V35, P338, DOI 10.1016/j.progpolymsci.2009.12.003
   Reichenbacher M, 2011, CHALLENGES IN ANALYTICAL QUALITY ASSURANCE, P1
   Ren J, 2010, BIODEGRADABLE POLY(LACTIC ACID): SYNTHESIS, MODIFICATION, PROCESSING AND APPLICATIONS, P1
   Shemouratov YV, 2009, LASER PHYS, V19, P2179, DOI 10.1134/S1054660X09220010
   Sin L. T, 2012, POLYLACTIC ACID PLA
   Taddei P, 2001, J RAMAN SPECTROSC, V32, P619, DOI 10.1002/jrs.723
   Vandenabeele P, 2012, PLANET SPACE SCI, V62, P48, DOI 10.1016/j.pss.2011.12.006
   Vandenabeele P, 2012, J RAMAN SPECTROSC, V43, P1545, DOI 10.1002/jrs.4055
   Zavgorodnev Y. V., P INT C ADV LAS TECH
   Zhang GB, 2003, J POLYM SCI POL PHYS, V41, P23, DOI 10.1002/polb.10353
   Zou YA, 2010, J BIOMED MATER RES A, V94A, P288, DOI 10.1002/jbm.a.32692
NR 38
TC 12
Z9 12
U1 3
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0377-0486
EI 1097-4555
J9 J RAMAN SPECTROSC
JI J. Raman Spectrosc.
PD FEB
PY 2015
VL 46
IS 2
BP 273
EP 279
DI 10.1002/jrs.4603
PG 7
WC Spectroscopy
SC Spectroscopy
GA CB8PC
UT WOS:000349891900011
DA 2018-10-19
ER

PT J
AU Teoh, GZ
   Klanrit, P
   Kasimatis, M
   Seifalian, AM
AF Teoh, G. Z.
   Klanrit, P.
   Kasimatis, M.
   Seifalian, A. M.
TI Role of nanotechnology in development of artificial organs
SO MINERVA MEDICA
LA English
DT Article
DE Artificial organs; Tissue engineering; Nanomedicine; Regenerative
   medicine; Chemistry
ID POLYHEDRAL OLIGOMERIC SILSESQUIOXANE; MESENCHYMAL STEM-CELLS; QUANTUM
   DOTS; NANOCOMPOSITE POLYMER; IN-VITRO; SILVER NANOPARTICLES; SURFACE
   MODIFICATION; POSS-NANOCOMPOSITE; NANOPHASE CERAMICS; CARBON NANOTUBE
AB Improvements in our understanding of the interactions between implants and cells have directed attention towards nanoscale technologies. To date, nanotechnology has played a helping hand in the development of synthetic artificial organs and regenerative medicine. This includes the production of smart nanocomposite materials; fluorescent nanoparticles like Quantum Dots (QD) and magnetic nano particles (MNP) for stem cell tracking; and carbon nano tubes (CNT) and graphene for enhancement of material properties. The scope of this paper includes the role of nanoparticles in the development of nanomaterials; the chemical surface modifications possible to improve implant function and an overview of the performance of nano-engineered organs thus far. This includes implants developed for aesthetic purposes like nasal and auricular scaffolds, plastic and reconstructive surgical constructs (i.e. dermal grafts), hollow organs for cardiothoracic applications; and last but not least, orthopedic implants. The five-year outlook for nanoenhanced artificial organs is also discussed, highlighting the key research and development areas, available funds and the hurdles we face in accomplishing progression from prototypes on the laboratory bench to offthe-shelf products for the consumer market. Ultimately, this review aims to delineate the advantages of incorporating nanotechnology, as an individual entity or as a part of a construct for the development of tissue engineering scaffolds and/or artificial organs, and unravel the mechanisms of tissue cell-biomaterial interactions at the nanoscale, allowing for better progress in the development and optimization of unique nanoscale surface features for a wide range of applications.
C1 [Teoh, G. Z.; Klanrit, P.; Kasimatis, M.; Seifalian, A. M.] UCL, Ctr Nanotechnol & Regenerat Med, Div Surg & Intervent Sci, London, England.
   [Seifalian, A. M.] Royal Free London NHS Fdn Trust Hosp, London, England.
RP Seifalian, AM (reprint author), UCL, London, England.
EM a.seifalian@ucl.ac.uk
CR Ahmed M, 2011, ACTA BIOMATER, V7, P3857, DOI 10.1016/j.actbio.2011.06.051
   Alves P, 2014, J MATER SCI-MATER M, V25, P2017, DOI 10.1007/s10856-014-5233-1
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Ballou B, 2007, BIOCONJUGATE CHEM, V18, P389, DOI 10.1021/bc060261j
   Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340
   BREUERS W, 1991, J MATER SCI-MATER M, V2, P106, DOI 10.1007/BF00703468
   Cardoso VS, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/s12951-014-0036-6
   Chaloupka K, 2011, BIOTECHNOL APPL BIOC, V58, P363, DOI 10.1002/bab.53
   Chang JC, 2008, BIOMATERIALS, V29, P925, DOI 10.1016/j.biomaterials.2007.10.046
   Chawla R, 2014, J SURG RES, V188, P361, DOI 10.1016/j.jss.2014.01.006
   Chen Y, 2013, J NANOSCI NANOTECHNO, V13, P2136, DOI 10.1166/jnn.2013.6903
   Chen Y, 2014, BIOINTERPHASES, V9, DOI 10.1116/1.4878461
   Cheng K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5880
   Choi HS, 2009, NIH PUBLIC ACCESS, V25, P1165
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Chung TW, 2006, ARTIF ORGANS, V30, P35, DOI 10.1111/j.1525-1594.2006.00178.x
   Collier TO, 2002, J BIOMED MATER RES, V60, P487, DOI 10.1002/jbm.10043
   Cordes DB, 2010, CHEM REV, V110, P2081, DOI 10.1021/cr900201r
   Crombez M, 2005, BIOMATERIALS, V26, P7402, DOI 10.1016/j.biomaterials.2005.05.051
   Devine C, 2004, J VASC SURG, V40, P924, DOI 10.1016/j.jvs.2004.08.033
   Dinklage A., 2005, PLASMA PHYS
   Eaglstein WH, 1997, CLIN THER, V19, P894, DOI 10.1016/S0149-2918(97)80043-4
   Gong FR, 2010, INT J POLYM SCI, DOI 10.1155/2010/807935
   Gu XZ, 2011, BIOMACROMOLECULES, V12, P3066, DOI 10.1021/bm2006938
   Guo YL, 2010, J TISSUE ENG REGEN M, V4, P553, DOI 10.1002/term.272
   Gupta A, 2009, BIOTECHNOL APPL BIOC, V54, P221, DOI 10.1042/BA20090214
   HERGENROTHER RW, 1992, J MATER SCI-MATER M, V3, P313, DOI 10.1007/BF00705361
   Hervault A, 2014, NANOSCALE, V21, P11553
   Holbrook RD, 2014, J MATER SCI-MATER M, V25, P2481, DOI 10.1007/s10856-014-5265-6
   Hoshi RA, 2013, BIOMATERIALS, V34, P30, DOI 10.1016/j.biomaterials.2012.09.046
   Hsieh SC, 2006, J BIOMED MATER RES B, V79B, P95, DOI 10.1002/jbm.30517
   IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt.767
   Jaiswal JK, 2004, TRENDS CELL BIOL, V14, P497, DOI 10.1016/j.tcb.2004.07.012
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920
   Kong LR, 2014, ADV MATER, V26, P1025, DOI 10.1002/adma.201303432
   Korematsu A, 2002, BIOMATERIALS, V23, P263, DOI 10.1016/S0142-9612(01)00104-1
   Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780
   Li GZ, 2001, J INORG ORGANOMET P, V11, P123, DOI 10.1023/A:1015287910502
   Lim Yong Taik, 2003, Mol Imaging, V2, P50, DOI 10.1162/153535003765276282
   Liu QS, 2014, J APPL POLYM SCI, V131, DOI [10.1002/APP.40789, 10.1002/app.40789]
   Lu LH, 2012, ADV MATER, V24, P4317, DOI 10.1002/adma.201201320
   Mattheakis LC, 2004, ANAL BIOCHEM, V327, P200, DOI 10.1016/j.ab.2004.01.031
   McNally AK, 2008, EXP MOL PATHOL, V84, P37, DOI 10.1016/j.yexmp.2007.10.005
   Meyer U., 2009, FUNDAMENTALS TISSUE
   Motwani MS, 2011, BIOTECHNOL APPL BIOC, V58, P2, DOI 10.1002/bab.10
   Nayyer L, 2014, NANOMED-NANOTECHNOL, V10, P235, DOI 10.1016/j.nano.2013.06.006
   Nezakati T, 2014, ARCH TOXICOL, V88, P1987, DOI 10.1007/s00204-014-1361-0
   Nezakati T, 2014, J COLLOID INTERF SCI, V435, P145, DOI 10.1016/j.jcis.2014.08.020
   Oseni AO, 2011, BRIT J SURG, V98, P6
   Pacak CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108695
   Pankajakshan D, 2010, CAN J PHYSIOL PHARM, V88, P855, DOI [10.1139/y10-073, 10.1139/Y10-073]
   Petryk AA, 2013, INT J HYPERTHER, V29, P819, DOI 10.3109/02656736.2013.845801
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Rahimi M, 2010, NANOMED-NANOTECHNOL, V6, P672, DOI 10.1016/j.nano.2010.01.012
   Rahmani B, 2012, J BIOMECH, V45, P1205, DOI 10.1016/j.jbiomech.2012.01.046
   Rashid ST, 2008, FASEB J, V22, P2084, DOI 10.1096/fj.07-096586
   Recek N, 2013, MOLECULES, V18, P12441, DOI 10.3390/molecules181012441
   Schroeder JE, 2007, J CONTROL RELEASE, V124, P28, DOI 10.1016/j.jconrel.2007.08.028
   Seleverstov O, 2006, NANO LETT, V6, P2826, DOI 10.1021/nl0619711
   Shah BS, 2011, METHODS MOL BIOL, V680, P61, DOI 10.1007/978-1-60761-901-7_4
   Shameli K, 2011, INT J NANOMED, V6, P331, DOI 10.2147/IJN.S16964
   STORM G, 1995, ADV DRUG DELIVER REV, V17, P31, DOI 10.1016/0169-409X(95)00039-A
   Sun T, 2005, TISSUE ENG, V11, P1023, DOI 10.1089/ten.2005.11.1023
   Tan A, 2013, BIOINTERPHASES, V8, P1
   Tao ZW, 2014, J TISSUE ENG REGEN M
   Thomas S, 2003, J Wound Care, V12, P101
   Verma S, 2011, NANOMEDICINE-UK, V6, P157, DOI [10.2217/nnm.10.157, 10.2217/NNM.10.146]
   Voura EB, 2004, NAT MED, V10, P993, DOI 10.1038/nm1096
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wu XR, 2010, DENT MATER, V26, P456, DOI 10.1016/j.dental.2009.11.161
   Xin L, 2014, HUM EXP TOXICOL
   Yoshioka T, 2011, J TISSUE ENG REGEN M, V5, P437, DOI 10.1002/term.329
   Yue WW, 2013, J MEMBRANE SCI, V446, P79, DOI 10.1016/j.memsci.2013.06.029
NR 80
TC 3
Z9 3
U1 4
U2 45
PU EDIZIONI MINERVA MEDICA
PI TURIN
PA CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY
SN 0026-4806
EI 1827-1669
J9 MINERVA MED
JI Minerva Med.
PD FEB
PY 2015
VL 106
IS 1
BP 17
EP 33
PG 17
WC Medicine, General & Internal
SC General & Internal Medicine
GA CC0DP
UT WOS:000350006300003
PM 25300897
DA 2018-10-19
ER

PT J
AU Molino, PJ
   Innis, PC
   Higgins, MJ
   Kapsa, RMI
   Wallace, GG
AF Molino, Paul J.
   Innis, Peter C.
   Higgins, Michael J.
   Kapsa, Robert M. I.
   Wallace, Gordon G.
TI Influence of biopolymer loading on the physiochemical and
   electrochemical properties of inherently conducting polymer biomaterials
SO SYNTHETIC METALS
LA English
DT Article
DE Conducting polymer; Polypyrrole; Biopolymer; QCM; Biomaterial
ID POLYPYRROLE FILMS; SURFACE-MORPHOLOGY; NEURITE OUTGROWTH; STIMULATION;
   GROWTH
AB The physicochemical and electrochemical properties of polypyrrole (PPy) doped with the biological dopant dextran sulphate (DS) were shown to be significantly altered as a function of varying the salt concentration (0.2, 2 or 20 mg/ml) in the polymerisation electrolyte. Films grown in the presence of 0.2 mg/ml DS generated the highest potential during galvanostatic growth, with the potential decreasing with each subsequent increase in DS concentration. The electroactivity of the polymers was similar for all three DS concentrations, with the 20 mg/ml film drawing slightly more current upon reduction in PBS. Increasing the DS concentration reduced film interfacial roughness and increased polymer hydrophilicity. Polymer mass and thickness was larger for DS films grown from 0.2 mg/ml and 2 mg/ml DS electrolyte solutions, compared to the 20 mg/ml films. The latter also demonstrated a much higher shear modulus than the 2 mg/ml and 0.2 mg/ml films, respectively. The changes in the polymer physicochemical properties were associated with an increase in polymer densification with increasing DS loading, correlating with a likely higher conjugation generated during polymerisation at a potential closer to the ideal oxidation potential of pyrrole. Herein we describe a facile approach through which polymer properties may be varied significantly by varying the dopant concentration in the electrolyte, providing the ability to tune polymer properties for enhanced functionality while preserving fundamental polymer chemistry. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Molino, Paul J.; Innis, Peter C.; Higgins, Michael J.; Kapsa, Robert M. I.; Wallace, Gordon G.] Univ Wollongong, ARC Ctr Excellence Electromat Sci, Intelligent Polymer Res Inst, Wollongong, NSW 2522, Australia.
RP Molino, PJ (reprint author), Univ Wollongong, ARC Ctr Excellence Electromat Sci, Intelligent Polymer Res Inst, Wollongong, NSW 2522, Australia.
EM pmolino@uow.edu.au; gordon_wallace@uow.edu.au
RI Wallace, Gordon/H-1123-2011; Innis, Peter/D-6715-2012
OI Wallace, Gordon/0000-0002-0381-7273; Innis, Peter/0000-0003-4445-3899;
   Molino, Paul/0000-0002-8868-2733
FU National Health and Medical Research Council [573430]; Australian
   Research Council
FX The authors gratefully acknowledge the Australian Research Council and
   the National Health and Medical Research Council (Grant No. 573430). We
   also acknowledge the Australian National Nanofabrication Facility (ANFF)
   for access to equipment. The authors acknowledge the use of the
   facilities and the assistance of Mr Tony Romeo at the UOW Electron
   Microscopy Centre.
CR Almario AAA, 2009, J CHIL CHEM SOC, V54, P14, DOI 10.4067/S0717-97072009000100004
   Breukers RD, 2010, J BIOMED MATER RES A, V95A, P256, DOI 10.1002/jbm.a.32822
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Fonner J.M., 2008, BIOMED MAT, V3
   Fonner JM, 2010, POLYMER, V51, P4985, DOI 10.1016/j.polymer.2010.08.024
   Gelmi A, 2010, BIOMATERIALS, V31, P1974, DOI 10.1016/j.biomaterials.2009.11.040
   Gilmore KJ, 2009, BIOMATERIALS, V30, P5292, DOI 10.1016/j.biomaterials.2009.06.059
   Gomez N, 2007, ADV FUNCT MATER, V17, P1645, DOI 10.1002/adfm.200600669
   Green RA, 2009, BIOMATERIALS, V30, P3637, DOI 10.1016/j.biomaterials.2009.03.043
   HALL M, 1952, J CLIN PATHOL, V5, P366, DOI 10.1136/jcp.5.4.366
   Irie H., 2005, ELECTROCHEM SOLID ST, V8
   Kaynak A, 2000, MATER RES BULL, V35, P813, DOI 10.1016/S0025-5408(00)00280-4
   Kaynak A, 1997, MATER RES BULL, V32, P271, DOI 10.1016/S0025-5408(96)00200-0
   Liu YC, 2004, J ELECTROANAL CHEM, V571, P255, DOI 10.1016/j.jelechem.2004.05.015
   Molino PJ, 2012, LANGMUIR, V28, P8433, DOI 10.1021/la300692y
   Quigley AF, 2009, ADV MATER, V21, P4393, DOI 10.1002/adma.200901165
   Richardson RT, 2007, BIOMATERIALS, V28, P513, DOI 10.1016/j.biomaterials.2006.09.008
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Silk T, 1998, SYNTHETIC MET, V93, P59, DOI 10.1016/S0379-6779(98)80131-8
   Thompson BC, 2011, BIOMATERIALS, V32, P3822, DOI 10.1016/j.biomaterials.2011.01.053
   Wallace G. G, 2009, CONDUCTIVE ELECTROAC
   Wang SF, 2011, INT J POLYM SCI, DOI 10.1155/2011/184623
NR 23
TC 4
Z9 4
U1 2
U2 26
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0379-6779
J9 SYNTHETIC MET
JI Synth. Met.
PD FEB
PY 2015
VL 200
BP 40
EP 47
DI 10.1016/j.synthmet.2014.12.018
PG 8
WC Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer
   Science
SC Materials Science; Physics; Polymer Science
GA CC2PI
UT WOS:000350186700005
DA 2018-10-19
ER

PT J
AU Verissimo, DM
   Leitao, RF
   Figueiro, SD
   Goes, JC
   Lima, V
   Silveira, CO
   Brito, GAC
AF Verissimo, Denusa M.
   Leitao, Renata F. C.
   Figueiro, Sonia D.
   Goes, Julio C.
   Lima, Vilma
   Silveira, Charles O.
   Brito, Gerly A. C.
TI Guided bone regeneration produced by new mineralized and reticulated
   collagen membranes in critical-sized rat calvarial defects
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Biomaterial(s); bone regeneration; collagen(s); guided bone
   regeneration; tissue engineering
ID TISSUE REGENERATION; EXPERIMENTAL-MODEL; DENTAL IMPLANTS; CROSS-LINKING;
   IN-VITRO; GLUTARALDEHYDE; MATRIX; DEGRADATION; MECHANISM
AB The aim of this study was to evaluate the bone regenerative effect of glutaraldehyde (GA) cross-linking on mineralized polyanionic collagen membranes in critical-sized defects on rat calvarias. Bone calvarial defects were induced in Wistar rats, which were then divided into five groups: a sham group; a control group, which received a commercial membrane; and GA, 25GA, and 75GA groups, which received one of three different polyanionic collagen membranes mineralized by 0, 25, or 75 hydroxyapatite cycles and then cross-linked by GA. Bone formation was evaluated based on digital radiography and computerized tomography. Histological analyses were performed 4 and 12 weeks after the surgical procedure to observe bone formation, membrane resorption, and fibrous tissue surrounding the membranes. Measurement of myeloperoxidase activity, tumor necrosis factor alpha, and interleukin 1beta production was performed 24h after surgery. The percentage of new bone formation in the GA, 25GA, and 75GA groups was higher compared with the control and sham groups. In the GA and 25 GA groups, the membranes were still in place and were contained in a thick fibrous capsule after 12 weeks. No significant difference was found among the groups regarding myeloperoxidase activity and interleukin 1beta levels, although the GA, 25GA, and 75GA groups presented decreased levels of tumor necrosis factor alpha compared with the control group. These new GA cross-linked membranes accelerated bone healing of the calvarium defects and did not induce inflammation. In addition, unlike the control membrane, the experimental membranes were not absorbed during the analyzed period, so they may offer advantages in large bone defects where prolonged membrane barrier functions are desirable.
C1 [Verissimo, Denusa M.; Lima, Vilma] Univ Fed Ceara, Dept Physiol & Pharmacol, BR-60430270 Fortaleza, Ceara, Brazil.
   [Leitao, Renata F. C.; Brito, Gerly A. C.] Univ Fed Ceara, Sch Med, Dept Morphol, BR-60430270 Fortaleza, Ceara, Brazil.
   [Figueiro, Sonia D.; Goes, Julio C.] Univ Fed Ceara, Dept Phys, BR-60430270 Fortaleza, Ceara, Brazil.
   [Silveira, Charles O.] Univ Fed Ceara, Sch Med, BR-60430270 Fortaleza, Ceara, Brazil.
RP Verissimo, DM (reprint author), Univ Fed Ceara, Dept Physiol & Pharmacol, BR-60430270 Fortaleza, Ceara, Brazil.
EM denusa.verissimo@terra.com.br
RI Universidade Federal do Ceara, Physics Department/J-4630-2016; UFC,
   DF/E-1564-2017; Brito, Gerly/C-8597-2013
OI Universidade Federal do Ceara, Physics Department/0000-0002-9247-6780;
   Brito, Gerly/0000-0002-8214-4379; Lima, Vilma/0000-0002-8652-4133; Goes,
   Julio Cesar/0000-0002-6324-7647
FU Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico
   (FUNCAP);  [INCT 573928/2008-8]
FX The authors thank Conceicao da Silva Martins and Maria do Socorro Franca
   Monte, Department of Morphology, Faculty of Medicine, Federal University
   of Ceara, Brazil, for providing technical assistance and Perboyre
   Castelo in Dentistry Radiology for radiological assistance. This work
   was supported by Grant INCT 573928/2008-8 and Fundacao Cearense de Apoio
   ao Desenvolvimento Cientifico e Tecnologico (FUNCAP).
CR Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004
   BRADLEY PP, 1982, BLOOD, V60, P618
   Bunyaratavej P, 2001, J PERIODONTOL, V72, P215, DOI 10.1902/jop.2001.72.2.215
   Chang MC, 2001, J MATER SCI LETT, V20, P1199, DOI 10.1023/A:1010914621089
   Chen GP, 2005, BIOMATERIALS, V26, P2559, DOI 10.1016/j.biomaterials.2004.07.034
   CUNHA FQ, 1993, EUR J PHARMACOL, V238, P47, DOI 10.1016/0014-2999(93)90503-A
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   Dupoirieux L, 2001, INT J ORAL MAX SURG, V30, P58, DOI 10.1054/ijom.2000.0011
   Furlaneto FAC, 2007, CLIN ORAL IMPLAN RES, V18, P311, DOI 10.1111/j.1600-0501.2006.01331.x
   Goes JC, 2007, ACTA BIOMATER, V3, P773, DOI 10.1016/j.actbio.2007.02.008
   Goissis G, 2009, MATER RES-IBERO-AM J, V12, P113, DOI 10.1590/S1516-14392009000100015
   Greenstein G, 2000, PERIODONTOL, V1, P36
   Hammerle CHF, 1998, CLIN ORAL IMPLAN RES, V9, P151, DOI 10.1034/j.1600-0501.1998.090302.x
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   Hollinger JO, 1999, APPL MAXILLOFACIAL S, P17
   Kawashita M, 2003, BIOMATERIALS, V24, P2477, DOI 10.1016/S0142-9612(03)00050-4
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275
   Kozlovsky A, 2009, CLIN ORAL IMPLAN RES, V20, P1116, DOI 10.1111/j.1600-0501.2009.01740.x
   Liao S, 2005, BIOMATERIALS, V26, P7564, DOI 10.1016/j.biomaterials.2005.05.050
   Mardas N, 2002, J CRANIOFAC SURG, V13, P453, DOI 10.1097/00001665-200205000-00017
   Moses O, 2005, CLIN ORAL IMPLAN RES, V16, P210, DOI 10.1111/j.1600-0501.2004.01100.x
   Moses O, 2008, J PERIODONTOL, V79, P905, DOI [10.1902/jop.2008.070361, 10.1902/jop.2008.070361 ]
   Nowzari H, 1995, Int J Oral Maxillofac Implants, V10, P67
   Nowzari J, 1998, J PERIODONTOL, V69, P528
   NYMAN S, 1987, J PERIODONTAL RES, V22, P252, DOI 10.1111/j.1600-0765.1987.tb01581.x
   Patino Maria G, 2002, J Oral Implantol, V28, P220, DOI 10.1563/1548-1336(2002)028<0220:CAAIMI>2.3.CO;2
   Potijanyakul P, 2010, J ORAL IMPLANTOL, V36, P195, DOI 10.1563/AAID-JOI-D-09-00042
   Pryor ME, 2006, J CLIN PERIODONTOL, V33, P455, DOI 10.1111/j.1600-051X.2006.00921.x
   SaWeh-Garabedian B, 1995, BRIT J PHARMACOL, V115, P1265
   Schlegel AK, 1997, BIOMATERIALS, V18, P535, DOI 10.1016/S0142-9612(96)00175-5
   Schliephake H, 2004, CLIN ORAL IMPLAN RES, V15, P112, DOI 10.1111/j.1600-0501.2004.00992.x
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Simion M, 1997, INT J ORAL MAX IMPL, V12, P159
   SIMION M, 1994, J PERIODONTOL, V65, P755, DOI 10.1902/jop.1994.65.8.755
   Verissimo DM, 2010, ACTA BIOMATER, V6, P4011, DOI 10.1016/j.actbio.2010.04.012
   Verna C, 2002, J CLIN PERIODONTOL, V29, P865, DOI 10.1034/j.1600-051X.2002.290912.x
   Yang F, 2009, ACTA BIOMATER, V5, P3295, DOI 10.1016/j.actbio.2009.05.023
   Yeom H, 2008, J CRANIOFAC SURG, V19, P446, DOI 10.1097/SCS.0b013e318052fe05
   Yoshioka SA, 2008, J MATER SCI-MATER M, V19, P1215, DOI 10.1007/s10856-007-0151-0
   Zhu XL, 2006, J BIOMED MATER RES A, V79A, P114, DOI 10.1002/jbm.a.30706
NR 41
TC 4
Z9 4
U1 0
U2 13
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD FEB
PY 2015
VL 240
IS 2
BP 175
EP 184
DI 10.1177/1535370214549518
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CB4VT
UT WOS:000349627100006
PM 25245073
OA Green Published
DA 2018-10-19
ER

PT J
AU Bawazer, L
AF Bawazer, Lukmaan
TI Bio Focus Biomaterial NanoART combats HIV
SO MRS BULLETIN
LA English
DT News Item
CR BIOMATERIALS, P141, DOI DOI 10.1016/J.BIOMATERIALS.2014.11.012
NR 1
TC 0
Z9 0
U1 0
U2 1
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0883-7694
EI 1938-1425
J9 MRS BULL
JI MRS Bull.
PD FEB
PY 2015
VL 40
IS 2
BP 105
EP 105
DI 10.1557/mrs.2015.16
PG 1
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA CB5SB
UT WOS:000349686700006
DA 2018-10-19
ER

PT J
AU Zhou, Y
   Snead, ML
   Tamerler, C
AF Zhou, Yan
   Snead, Malcolm L.
   Tamerler, Candan
TI Bio-inspired hard-to-soft interface for implant integration to bone
SO NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
LA English
DT Article
DE Biomaterial interface; Chimeric peptide; Wnt signaling; Osteogenesis;
   Bone regeneration
ID RICH AMELOGENIN PEPTIDE; OSTEOBLASTOGENESIS; NANOTECHNOLOGY;
   BIOMATERIALS; WNT10B
AB Accomplishing full, functional integration at the host-to-biomaterial interface has been a critical roadblock in engineering implants with performance similar to biological materials. Molecular recognition-based self-assembly, coupled with biochemical signaling, may lead to controllable and predictable cellular differentiation at the implant interface. Here, we engineer a bio-inspired interface built upon a chimeric peptide. Binding to the biomaterial interface is achieved using a molecular recognition domain specific for the titanium/titanium alloy implant surface and a biochemical signal guiding stem cells to differentiate by activating the Wnt signaling pathway for bone formation. During a critical period of host cell growth and determination, the bioactive implant interface signals mouse, as well as human, stem cells to differentiate along osteogenic lineages. The Wnt-induced cells show enhanced mineral deposition in an extracellular matrix of their creation and an enhanced gene expression profile consistent with osteogenesis, thereby providing a bone-to-implant interface that promotes bone regeneration. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Zhou, Yan; Snead, Malcolm L.] Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent USC, Los Angeles, CA USA.
   [Tamerler, Candan] Univ Kansas, Sch Engn, Dept Mech Engn, Res Ctr, Lawrence, KS 66045 USA.
RP Snead, ML (reprint author), Univ So Calif, Ctr Craniofacial Mol Biol, Los Angeles, CA 90089 USA.
EM yzhou@usc.edu; mlsnead@usc.edu; ctamerler@ku.edu
OI Tamerler, Candan/0000-0002-1960-2218
FU USPHS; National Institutes of Health, the National Institute of Dental
   and Craniofacial Research [DE13045]; National Institute of Arthritis and
   Musculoskeletal and Skin Disease [AR062249]; University of Kansas,
   School of Engineering
FX Supported by USPHS, National Institutes of Health, the National
   Institute of Dental and Craniofacial Research, DE13045 (YZ, MLS), the
   National Institute of Arthritis and Musculoskeletal and Skin Disease,
   AR062249 (CT), and the University of Kansas, School of Engineering. We
   thank Bridget Samuel for excellent assistance with manuscript
   preparation.
CR Anand Rajan, 2011, J Bone Joint Surg Am, V93 Suppl 3, P51, DOI 10.2106/JBJS.K.00867
   [Anonymous], 2012, BIOM IMP AR FUT INV
   Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102
   Bhatia Dinesh, 2013, J Pharm Bioallied Sci, V5, P30, DOI 10.4103/0975-7406.106561
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Cranford SW, 2013, ADV MATER, V25, P802, DOI 10.1002/adma.201202553
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Evans JS, 2008, MRS BULL, V33, P514, DOI 10.1557/mrs2008.103
   Huang Y, 2005, NANO LETT, V5, P1429, DOI 10.1021/nl050795d
   Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200
   Levy Y, 2006, ACCOUNTS CHEM RES, V39, P135, DOI 10.1021/ar040204a
   Maia FR, 2013, ACTA BIOMATER, V9, P8773, DOI 10.1016/j.actbio.2013.08.004
   Saiz E, 2013, DENT MATER, V29, P103, DOI 10.1016/j.dental.2012.08.001
   Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5
   Tomsia AP, 2011, INT J ORAL MAX IMPL, V26, P25
   Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X
   Warotayanont R, 2009, BIOCHEM BIOPH RES CO, V387, P558, DOI 10.1016/j.bbrc.2009.07.058
   Wen X, 2011, BIOMATERIALS, V32, P6478, DOI 10.1016/j.biomaterials.2011.05.045
   Yazici H, 2013, ACTA BIOMATER, V9, P5341, DOI 10.1016/j.actbio.2012.11.004
NR 20
TC 11
Z9 11
U1 1
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1549-9634
EI 1549-9642
J9 NANOMED-NANOTECHNOL
JI Nanomed.-Nanotechnol. Biol. Med.
PD FEB
PY 2015
VL 11
IS 2
BP 431
EP 434
DI 10.1016/j.nano.2014.10.003
PG 4
WC Nanoscience & Nanotechnology; Medicine, Research & Experimental
SC Science & Technology - Other Topics; Research & Experimental Medicine
GA CB6NW
UT WOS:000349744700020
PM 25461292
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Hozumi, K
   Kumai, J
   Yamada, Y
   Nomizu, M
AF Hozumi, Kentaro
   Kumai, Jun
   Yamada, Yuji
   Nomizu, Motoyoshi
TI Active Peptide-Conjugated Chitosan Matrices as an Artificial Basement
   Membrane
SO POLYMERS
LA English
DT Review
ID LAMININ ALPHA-1 CHAIN; CELL-BINDING SEQUENCES; BIOLOGICAL-ACTIVITIES;
   EXTRACELLULAR-MATRIX; TARGETED DISRUPTION; SYNTHETIC PEPTIDES; SCAFFOLD
   MATERIAL; GLOBULAR DOMAIN; LG4 MODULE; STEM-CELLS
AB The basement membrane, a thin extracellular matrix, plays a critical role in tissue development and repair. Laminins are the major component of basement membrane and have diverse biological activities. We have identified various cell-adhesive peptides from laminins and their specific cell surface receptors. Polysaccharides, including chitosan, have been used as scaffolds, which regulate cellular functions for tissue engineering. We have developed laminin-derived active peptide-chitosan matrices as functional scaffolds. The biological activity of the peptides was enhanced when the peptides were conjugated to a chitosan matrix, suggesting that the peptide-chitosan matrix approach has an advantage for an active biomaterial. Further, the laminin peptide-chitosan matrices have the potential to mimic the basement membrane and are useful for tissue engineering as an artificial basement membrane.
C1 [Hozumi, Kentaro; Kumai, Jun; Yamada, Yuji; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Dept Clin Biochem, Sch Pharm, Hachioji, Tokyo 1920392, Japan.
RP Hozumi, K (reprint author), Tokyo Univ Pharm & Life Sci, Dept Clin Biochem, Sch Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.
EM hozumi@toyaku.ac.jp; y071096@toyaku.ac.jp; y041219@toyaku.ac.jp;
   nomizu@toyaku.ac.jp
FU Ministry of Education, Cultures, Sports, Science and Technology of Japan
   [24500530, 25560228]
FX We are grateful to Yamato Kikkawa, Fumihiko Katagiri and Yuichi Kadoya
   for invaluable comments and suggestions. This work was supported by
   Grants-in-Aid for Scientific Research from the Ministry of Education,
   Cultures, Sports, Science and Technology of Japan (24500530 and
   25560228).
CR Araki E, 2009, MOL BIOL CELL, V20, P3012, DOI 10.1091/mbc.E08-09-0977
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003
   Charonis A, 2005, CURR MED CHEM, V12, P1495, DOI 10.2174/0929867054039071
   Chen HP, 2014, EXP CELL RES, V323, P346, DOI 10.1016/j.yexcr.2014.02.028
   Chen YH, 2012, BIOMATERIALS, V33, P1336, DOI 10.1016/j.biomaterials.2011.10.048
   Couchman JR, 2001, INT REV CYTOL, V207, P113
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   Dieckmann C, 2010, EXP DERMATOL, V19, P697, DOI 10.1111/j.1600-0625.2010.01087.x
   Durbeej M, 1998, CURR OPIN CELL BIOL, V10, P594, DOI 10.1016/S0955-0674(98)80034-3
   Fox IJ, 2014, SCIENCE, V345, P889, DOI 10.1126/science.1247391
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Hansson A, 2012, CARBOHYD POLYM, V90, P1494, DOI 10.1016/j.carbpol.2012.07.020
   Hibino S, 2005, CANCER RES, V65, P10494, DOI 10.1158/0008-5472.CAN-05-0314
   Hibino S, 2004, CANCER RES, V64, P4810, DOI 10.1158/0008-5472.CAN-04-0129
   Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633
   Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727
   Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200
   Hozumi K, 2012, BIOMATERIALS, V33, P4241, DOI 10.1016/j.biomaterials.2012.02.055
   Hozumi K, 2010, ARCH BIOCHEM BIOPHYS, V503, P213, DOI 10.1016/j.abb.2010.08.012
   Hozumi K, 2010, BIOMATERIALS, V31, P3237, DOI 10.1016/j.biomaterials.2010.01.043
   Hozumi K, 2009, BIOMATERIALS, V30, P1596, DOI 10.1016/j.biomaterials.2008.12.011
   Ikemoto S, 2006, J BIOMED MATER RES A, V79A, P716, DOI 10.1002/jbm.a.30804
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Kasai S, 2007, BIOCHEMISTRY-US, V46, P3966, DOI 10.1021/bi062097t
   Kikkawa Y, 2005, CONNECT TISSUE RES, V46, P193, DOI 10.1080/03008200500344074
   Kikkawa Y, 2013, CELL ADHES MIGR, V7, P150, DOI 10.4161/cam.22827
   Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x
   Kuang W, 1998, EXP CELL RES, V241, P117, DOI 10.1006/excr.1998.4025
   Liu X, 2011, ADV POLYM SCI, V244, P81, DOI 10.1007/12_2011_118
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Martin-Lopez E, 2012, J BIOMAT SCI-POLYM E, V23, P207, DOI 10.1163/092050610X546426
   Masuda R, 2009, WOUND REPAIR REGEN, V17, P127, DOI 10.1111/j.1524-475X.2008.00450.x
   Masuko T, 2005, BIOMATERIALS, V26, P5339, DOI 10.1016/j.biomaterials.2005.01.062
   Matsuda A, 2005, BIOMATERIALS, V26, P2273, DOI 10.1016/j.biomaterials.2004.07.032
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713
   Miner JH, 2004, DEVELOPMENT, V131, P2247, DOI 10.1242/dev.01112
   Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7
   Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje
   Mochizuki M, 2007, BIOPOLYMERS, V88, P122, DOI 10.1002/bip.20684
   Mochizuki M, 2007, ARCH BIOCHEM BIOPHYS, V459, P249, DOI 10.1016/j.abb.2006.12.026
   NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O
   Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198
   Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583
   Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828
   Otagiri D, 2013, BIOPOLYMERS, V100, P751, DOI 10.1002/bip.22303
   Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8
   Renner L, 2004, J MATER SCI-MATER M, V15, P387, DOI 10.1023/B:JMSM.0000021107.12809.8d
   Ryan MC, 1999, J CELL BIOL, V145, P1309, DOI 10.1083/jcb.145.6.1309
   Scheele S, 2007, J MOL MED-JMM, V85, P825, DOI 10.1007/s00109-007-0182-5
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   Shigemasa Y, 1996, BIOTECHNOL GENET ENG, V13, P383, DOI 10.1080/02648725.1996.10647935
   Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527
   Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200
   Suzuki N, 2010, MATRIX BIOL, V29, P143, DOI 10.1016/j.matbio.2009.09.006
   Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002
   Tuan RS, 2013, NAT REV RHEUMATOL, V9, P74, DOI 10.1038/nrrheum.2012.235
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   Urushibata S, 2010, ARCH BIOCHEM BIOPHYS, V497, P43, DOI 10.1016/j.abb.2010.03.006
   Wang JM, 2006, J BIOL CHEM, V281, P213, DOI 10.1074/jbc.M505061200
   Wiradjaja F, 2010, BIRTH DEFECTS RES C, V90, P8, DOI 10.1002/bdrc.20172
   Woods A, 1998, TRENDS CELL BIOL, V8, P189, DOI 10.1016/S0962-8924(98)01244-6
   Yamada Y, 2013, BIOMATERIALS, V34, P6539, DOI 10.1016/j.biomaterials.2013.05.044
   Yamada Y, 2011, CHEM-EUR J, V17, P10500, DOI 10.1002/chem.201101064
   Yamada Y, 2010, BIOPOLYMERS, V94, P711, DOI 10.1002/bip.21429
   Yang DY, 2013, BIOMATERIALS, V34, P5747, DOI 10.1016/j.biomaterials.2013.04.028
   Zhu N, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/4/045002
NR 71
TC 2
Z9 2
U1 4
U2 32
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD FEB
PY 2015
VL 7
IS 2
BP 281
EP 297
DI 10.3390/polym7020281
PG 17
WC Polymer Science
SC Polymer Science
GA CC3AP
UT WOS:000350216800006
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Lee, HS
   Dastgheyb, SS
   Hickok, NJ
   Eckmann, DM
   Composto, RJ
AF Lee, Hyun-Su
   Dastgheyb, Sana S.
   Hickok, Noreen J.
   Eckmann, David M.
   Composto, Russell J.
TI Targeted Release of Tobramycin from a pH-Responsive Grafted Bilayer
   Challenged with S. aureus
SO BIOMACROMOLECULES
LA English
DT Article
ID POLYELECTROLYTE MULTILAYER FILMS; POLYMER BRUSHES; BACTERIAL BIOFILMS;
   IN-SITU; STAPHYLOCOCCUS-AUREUS; TITANIUM-ALLOY; DRUG-RELEASE;
   THIN-FILMS; SURFACES; INFECTION
AB A stimuli-responsive, controlled release bilayer for the prevention of bacterial infection on biomaterials is presented. Drug release is locally controlled by the pH-responsiveness of the bilayer, comprised of an inner poly(acrylic acid) (PAA) monolayer grafted to a biomaterial and cross-linked with an outer chitosan (CH) brush. Tobramycin (TOB) is loaded in the inner PAA in part to minimize bacteria resistance. Because biofilm formation causes a decrease in local pH, TOB is released from PAA and permeates through the CH, which is in contact with the biofilm. Antibiotic capacity is controlled by the PAA thickness, which depends on PAA brush length and the extent of cross-linking between CH and PAA at the bilayer interface. This TOB-loaded, pH-responsive bilayer exhibits significantly enhanced antibacterial activity relative to controls.
C1 [Lee, Hyun-Su; Composto, Russell J.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
   [Lee, Hyun-Su; Eckmann, David M.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.
   [Dastgheyb, Sana S.; Hickok, Noreen J.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Orthopaed Surg, Philadelphia, PA 19107 USA.
RP Composto, RJ (reprint author), Univ Penn, Dept Mat Sci & Engn, 3231 Walnut St, Philadelphia, PA 19104 USA.
EM composto@seas.upenn.edu
OI Dastgheyb, Sana/0000-0001-8275-1614; Lee, Hyun-Su/0000-0002-5245-8430
FU Pennsylvania Nanomaterials Commercialization Center [NANO-2013-0065];
   Benjamin Franklin Technology Partners of Southeastern PA [NTI
   1011-05-10]; National Institutes of Health [NIH R01 HL60230]; NIH
   [HD-061053, DE-019901]; NIH (National Institute of Arthritis and
   Musculoskeletal and Skin Diseases) training grant [T32-AR-05227];
   NSF/NBIC [DMR08-32802]; Colgate-Palmolive
FX R.J.C., D.M.E., and H.L. acknowledge funding from the Pennsylvania
   Nanomaterials Commercialization Center (NANO-2013-0065) and Benjamin
   Franklin Technology Partners of Southeastern PA (NTI 1011-05-10). This
   work was supported by the National Institutes of Health (NIH R01
   HL60230). N.J.H. and S.S.D thank the NIH (HD-061053 and DE-019901) and
   the NIH (National Institute of Arthritis and Musculoskeletal and Skin
   Diseases) training grant (T32-AR-05227) for support. R.J.C. and H.L.
   also thank NSF/NBIC (DMR08-32802) and Colgate-Palmolive for support. We
   also thank Dr. Daeyeon Lee for permission to use SE and thank Dr.
   Alexander Horswill for permission to use his AH1710 strain.
CR Abu-Lail NI, 2006, SENSOR ACTUAT B-CHEM, V114, P371, DOI 10.1016/j.snb.2005.06.003
   Allison DG, 1998, FEMS MICROBIOL LETT, V167, P179, DOI 10.1016/S0378-1097(98)00386-3
   Antoci V, 2007, J ORTHOP RES, V25, P858, DOI 10.1002/jor.20348
   Antoci V, 2008, BIOMATERIALS, V29, P4684, DOI 10.1016/j.biomaterials.2008.08.016
   Ayres N, 2007, LANGMUIR, V23, P182, DOI 10.1021/la0615261
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Berg MC, 2006, BIOMACROMOLECULES, V7, P357, DOI 10.1021/bm050174e
   BOYLE VJ, 1973, ANTIMICROB AGENTS CH, V3, P418, DOI 10.1128/AAC.3.3.418
   Bromberg L, 2007, POLYMER, V48, P7490, DOI 10.1016/j.polymer.2007.10.040
   Brunner H, 1999, J COLLOID INTERF SCI, V212, P545, DOI 10.1006/jcis.1998.6062
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Caruso F, 2000, LANGMUIR, V16, P8932, DOI 10.1021/la000401s
   COLTON MB, 1953, J AM DENT ASSOC, V47, P524, DOI 10.14219/jada.archive.1953.0206
   COSTERTON JW, 1994, ANTIMICROB AGENTS CH, V38, P2803, DOI 10.1128/AAC.38.12.2803
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295
   Deiss F, 2014, LAB CHIP, V14, P167, DOI 10.1039/c3lc50887k
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Draper J, 2004, LANGMUIR, V20, P4064, DOI 10.1021/la0361316
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   Garcia-Fernandez L, 2013, ADV MATER, V25, P529, DOI 10.1002/adma.201203362
   Genzer J, 2006, BIOFOULING, V22, P339, DOI 10.1080/08927010600980223
   Grunlan JC, 2005, BIOMACROMOLECULES, V6, P1149, DOI 10.1021/bm049528c
   Guegan C, 2014, COLLOID SURFACE B, V114, P193, DOI 10.1016/j.colsurfb.2013.10.010
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hannig M, 2010, NAT NANOTECHNOL, V5, P565, DOI [10.1038/NNANO.2010.83, 10.1038/nnano.2010.83]
   Hidalgo G, 2009, APPL ENVIRON MICROB, V75, P7426, DOI 10.1128/AEM.01220-09
   Hiller J, 2002, NAT MATER, V1, P59, DOI 10.1038/nmat719
   Hiller J, 2003, MACROMOLECULES, V36, P4078, DOI 10.1021/ma025837o
   HUANG CT, 1995, APPL ENVIRON MICROB, V61, P2252
   Itano K, 2005, MACROMOLECULES, V38, P3450, DOI 10.1021/ma047667g
   Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002
   Jakubovics NS, 2013, LETT APPL MICROBIOL, V57, P467, DOI 10.1111/lam.12134
   Jhon YK, 2006, MACROMOL RAPID COMM, V27, P697, DOI 10.1002/marc.200600031
   Kandel J, 2014, BIOSENS BIOELECTRON, V58, P249, DOI 10.1016/j.bios.2014.02.053
   Kearney CJ, 2013, NAT MATER, V12, P1004, DOI [10.1038/NMAT3758, 10.1038/nmat3758]
   Kenawy ER, 2007, BIOMACROMOLECULES, V8, P1359, DOI 10.1021/bm061150q
   Kharlampieva E, 2004, LANGMUIR, V20, P9677, DOI 10.1021/la048763d
   Kim J, 2008, ANTIMICROB AGENTS CH, V52, P1446, DOI 10.1128/AAC.00054-07
   Krishnamoorthy M, 2014, CHEM REV, V114, P10976, DOI 10.1021/cr500252u
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Laloyaux X, 2010, ADV MATER, V22, P5024, DOI 10.1002/adma.201002538
   Lee H., 2013, POLYM MAT SCI ENG, V109, P76
   Lee HS, 2008, MACROMOLECULES, V41, P8124, DOI 10.1021/ma8009307
   Lee HS, 2013, J MATER CHEM B, V1, P6382, DOI [10.1039/C3TB21218A, 10.1039/c3tb21218a]
   Lee HS, 2013, J BIOMED MATER RES A, V101, P203, DOI 10.1002/jbm.a.34309
   Lee HS, 2012, J MATER CHEM, V22, P19605, DOI 10.1039/c2jm34316a
   Lee HS, 2011, LANGMUIR, V27, P12458, DOI 10.1021/la202616u
   Lee JS, 2013, ADV MATER, V25, P1173, DOI 10.1002/adma.201203370
   Lego B, 2008, LANGMUIR, V24, P379, DOI 10.1021/la703051b
   Lego B, 2009, LANGMUIR, V25, P5313, DOI 10.1021/la804060s
   Lewis K, 2005, TRENDS BIOTECHNOL, V23, P343, DOI 10.1016/j.tibtech.2005.05.004
   Li Z, 2006, LANGMUIR, V22, P9820, DOI 10.1021/la0622166
   Lichter JA, 2009, MACROMOLECULES, V42, P8573, DOI 10.1021/ma901356s
   Liu JY, 2010, ACS NANO, V4, P6903, DOI 10.1021/nn102272n
   Maillard JY, 2013, CRIT REV MICROBIOL, V39, P373, DOI 10.3109/1040841X.2012.713323
   Malone CL, 2009, J MICROBIOL METH, V77, P251, DOI 10.1016/j.mimet.2009.02.011
   McLeod BR, 1999, METHOD ENZYMOL, V310, P656
   Moskowitz JS, 2010, BIOMATERIALS, V31, P6019, DOI 10.1016/j.biomaterials.2010.04.011
   Moya S, 2005, ANGEW CHEM INT EDIT, V44, P4578, DOI 10.1002/anie.200500228
   Mura S, 2013, NAT MATER, V12, P991, DOI [10.1038/NMAT3776, 10.1038/nmat3776]
   Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   PASSERINI L, 1992, CRIT CARE MED, V20, P665, DOI 10.1097/00003246-199205000-00020
   POPLE IK, 1992, J NEUROSURG, V77, P29, DOI 10.3171/jns.1992.77.1.0029
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Sanjuan S, 2007, LANGMUIR, V23, P5769, DOI 10.1021/la063450z
   Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002
   SAUERBREY G, 1959, Z PHYS, V155, P155
   Stickler DJ, 2008, NAT CLIN PRACT UROL, V5, P598, DOI 10.1038/ncpuro1231
   Stoodley P, 1997, ANTIMICROB AGENTS CH, V41, P1876, DOI 10.1128/AAC.41.9.1876
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Vats N, 2000, ARCH ORAL BIOL, V45, P305, DOI 10.1016/S0003-9969(99)00139-9
   Vazquez E, 2002, J AM CHEM SOC, V124, P13992, DOI 10.1021/ja026405w
   Vogt BD, 2004, J PHYS CHEM B, V108, P12685, DOI 10.1021/jp0481005
   Vroom JM, 1999, APPL ENVIRON MICROB, V65, P3502
   Walter F, 1999, CURR OPIN CHEM BIOL, V3, P694, DOI 10.1016/S1367-5931(99)00028-9
   Wood KC, 2005, LANGMUIR, V21, P1603, DOI 10.1021/la0476480
   Wu T, 2007, MACROMOLECULES, V40, P8756, DOI 10.1021/ma0710176
   YU FP, 1994, J MICROBIOL METH, V20, P1, DOI 10.1016/0167-7012(94)90058-2
   Yuan Y, 2013, ADV MATER, V25, P6619, DOI 10.1002/adma.201301955
   Zhuk I, 2014, ACS NANO, V8, P7733, DOI 10.1021/nn500674g
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
NR 86
TC 23
Z9 23
U1 3
U2 81
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FEB
PY 2015
VL 16
IS 2
BP 650
EP 659
DI 10.1021/bm501751v
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CA9VN
UT WOS:000349273000024
PM 25585173
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Jiang, X
   Jeffries, RE
   Acosta, MA
   Tikunov, AP
   Macdonald, JM
   Walker, GM
   Gamcsik, MP
AF Jiang, Xiao
   Jeffries, Rex E.
   Acosta, Miguel A.
   Tikunov, Andrey P.
   Macdonald, Jeffrey M.
   Walker, Glenn M.
   Gamcsik, Michael P.
TI Biocompatibility of Tygon (R) tubing in microfluidic cell culture
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE Biomaterial; Cancer cell; Biocompatibility; Toxicity; Polyvinylchloride;
   Spectroscopy
ID SMALL MOLECULES
AB Growth of the MDA-MB-231 breast cancer cell line in microfluidic channels was inhibited when culture media was delivered to the channels via microbore Tygon (R) tubing. Culture media incubated within this tubing also inhibited growth of these cells in conventional 96-well plates. These detrimental effects were not due to depletion of critical nutrients due to adsorption of media components onto the tubing surface. A pH change was also ruled out as a cause. Nuclear magnetic resonance spectroscopy of the cell growth media before and after incubation in the tubing confirmed no detectable loss of media components but did detect the presence of additional unidentified signals in the aliphatic region of the spectrum. These results indicate leaching of a chemical species from microbore Tygon (R) tubing that can affect cell growth in microfluidic devices.
C1 [Jiang, Xiao; Jeffries, Rex E.; Acosta, Miguel A.; Tikunov, Andrey P.; Macdonald, Jeffrey M.; Walker, Glenn M.; Gamcsik, Michael P.] UNC NCSU Joint Dept Biomed Engn, Raleigh, NC 27695 USA.
RP Gamcsik, MP (reprint author), UNC NCSU Joint Dept Biomed Engn, 4206D Engn Bldg 3,911 Oval Dr, Raleigh, NC 27695 USA.
EM mgamcsi@ncsu.edu
OI Jiang, Xiao/0000-0001-8307-2170
FU National Institutes of Health [CA167471]
FX This work was supported by National Institutes of Health grant CA167471.
   NMR data was collected at the Hamner-UNC Metabolomics Facility of the
   Hamner Institutes for Health Sciences, Research Triangle Park, NC.
CR Berthier E, 2012, LAB CHIP, V12, P1224, DOI 10.1039/c2lc20982a
   Cimetta E, 2010, LAB CHIP, V10, P3277, DOI 10.1039/c0lc00033g
   Cooksey GA, 2011, ANAL CHEM, V83, P3890, DOI 10.1021/ac200273f
   Hung PJ, 2005, LAB CHIP, V5, P44, DOI 10.1039/b410743h
   Kim L, 2006, LAB CHIP, V6, P394, DOI 10.1039/b511718f
   Kim L, 2007, LAB CHIP, V7, P681, DOI 10.1039/b704602b
   Kim T, 2009, BIOMED MICRODEVICES, V11, P65, DOI 10.1007/s10544-008-9210-7
   Kolnik M, 2012, LAB CHIP, V12, P4732, DOI 10.1039/c2lc40569e
   Leclerc E, 2003, BIOMED MICRODEVICES, V5, P109, DOI 10.1023/A:1024583026925
   Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712
   PRICE NM, 1986, MAR ECOL PROG SER, V34, P41, DOI 10.3354/meps034041
   Toepke MW, 2006, LAB CHIP, V6, P1484, DOI 10.1039/b612140c
   Walker GM, 2007, LAB CHIP, V7, P226, DOI 10.1039/b608990a
   Zhou JH, 2011, LAB CHIP, V11, P2288, DOI 10.1039/c0lc00466a
NR 14
TC 1
Z9 1
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
EI 1572-8781
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD FEB
PY 2015
VL 17
IS 1
AR 20
DI 10.1007/s10544-015-9938-9
PG 7
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA CB3SH
UT WOS:000349548200020
PM 25653072
DA 2018-10-19
ER

PT J
AU Pieretti, EF
   Pessine, EJ
   Correa, OV
   de Rossi, W
   das Neves, MDM
AF Pieretti, Eurico Felix
   Pessine, Elisabete Jorge
   Correa, Olandir Vercino
   de Rossi, Wagner
   Martins das Neves, Maurcio David
TI Effect of Laser Parameters on the Corrosion Resistance of the ASTM F139
   Stainless Steel
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE Biomaterials; stainless steel; corrosion; laser marks
ID SEMICONDUCTING PROPERTIES; SURFACE-ROUGHNESS; IMPLANT MATERIALS;
   OXIDE-FILMS; MARKING; SPECTROSCOPY; IMPEDANCE; HARDNESS; ALBUMIN
AB The investigation on the corrosion resistance of biomaterials and the effects of manufacturing processes, including marking for traceability, is extremely important to evaluate whether the surface modification caused by marking affects the properties of the biomaterial. The engraving process by laser beam has been used to ensure the identification and traceability of orthopedic implants. This study evaluates the influence of the laser marking parameters, specifically the pulse energy and engraving rate, on the corrosion resistance of the ASTM F139 austenitic stainless steel, after engraving with Nd: YAG laser beam by means of electrochemical methods. The electrolyte used was a phosphate buffered solution, with pH 7.4, and 37 degrees C. The results showed that the laser marking parameters affect the protective properties of the passive film and influence the susceptibility to corrosion of this biomaterial.
C1 [Pieretti, Eurico Felix; Pessine, Elisabete Jorge; Correa, Olandir Vercino; de Rossi, Wagner; Martins das Neves, Maurcio David] Inst Pesquisas Energet & Nucl IPEN CNEN, BR-05508000 Sao Paulo, Brazil.
RP Pieretti, EF (reprint author), Inst Pesquisas Energet & Nucl IPEN CNEN, Ave Prof Lineu Prestes 2242, BR-05508000 Sao Paulo, Brazil.
EM efpieretti@usp.br
RI de Rossi, Wagner/J-8344-2013; Neves, Mauricio/D-7588-2012
OI Neves, Mauricio/0000-0002-1304-2117; de Rossi,
   Wagner/0000-0003-1371-7521
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   [Anonymous], 129322010 ABNT NBR
   AZUMI K, 1986, T JPN I MET, V27, P382, DOI 10.2320/matertrans1960.27.382
   Belo MD, 1998, CORROS SCI, V40, P447, DOI 10.1016/S0010-938X(97)00158-3
   Bizi-Bandoki P, 2011, APPL SURF SCI, V257, P5213, DOI 10.1016/j.apsusc.2010.12.089
   Bonora PL, 1996, ELECTROCHIM ACTA, V41, P1073, DOI 10.1016/0013-4686(95)00440-8
   BORRUTO A, 1995, WEAR, V184, P119, DOI 10.1016/0043-1648(94)06554-3
   Diaci J, 2011, OPT LASER ENG, V49, P195, DOI 10.1016/j.optlaseng.2010.09.003
   Feng ZC, 2010, CORROS SCI, V52, P3646, DOI 10.1016/j.corsci.2010.07.013
   Ge HH, 2003, APPL SURF SCI, V211, P321, DOI 10.1016/S0169-4332(03)00355-6
   Hakiki NE, 2000, CORROS SCI, V42, P687, DOI 10.1016/S0010-938X(99)00082-7
   HAKIKI NE, 1995, CORROS SCI, V37, P1809, DOI 10.1016/0010-938X(95)00084-W
   Hakiki NE, 1998, J ELECTROCHEM SOC, V145, P3821, DOI 10.1149/1.1838880
   HENCH LL, 1975, ANNU REV MATER SCI, V5, P279, DOI 10.1146/annurev.ms.05.080175.001431
   Hong T, 1997, CORROS SCI, V39, P1665, DOI 10.1016/S0010-938X(97)00072-3
   Leone C., 2010, J MAT PROC TEC, V210, P1293
   Okasaki Y., 2002, BIOMATERIALS, V23, P2071
   Patrikar RA, 2004, APPL SURF SCI, V228, P213, DOI 10.1016/j.apsusc.2004.01.010
   Pieretti EF, 2014, INT J ELECTROCHEM SC, V9, P3828
   Pieretti EF, 2014, ELECTROCHIM ACTA, V124, P150, DOI 10.1016/j.electacta.2013.10.137
   Pieretti EF, 2014, INT J ELECTROCHEM SC, V9, P2435
   Pieretti EF, 2013, ELECTROCHIM ACTA, V114, P838, DOI 10.1016/j.electacta.2013.05.101
   Pourbaix M., 1963, CORROS SCI, V3, P239
   Qi J, 2003, J MATER PROCESS TECH, V139, P273, DOI 10.1016/S0924-0136(03)00234-6
   Qian M, 2010, CORROS SCI, V52, P3548, DOI 10.1016/j.corsci.2010.07.007
   Soriano C, 2011, APPL SURF SCI, V257, P7101, DOI 10.1016/j.apsusc.2011.03.059
   Valette S, 2006, APPL SURF SCI, V252, P4696, DOI 10.1016/j.apsusc.2005.07.161
   WILLIAMS DF, 1976, ANNU REV MATER SCI, V6, P237, DOI 10.1146/annurev.ms.06.080176.001321
   Zhang GA, 2009, ELECTROCHIM ACTA, V55, P316, DOI 10.1016/j.electacta.2009.09.001
NR 29
TC 3
Z9 3
U1 1
U2 14
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD FEB
PY 2015
VL 10
IS 2
BP 1221
EP 1232
PG 12
WC Electrochemistry
SC Electrochemistry
GA AZ6YS
UT WOS:000348365800015
DA 2018-10-19
ER

PT J
AU Manchon, A
   Alkhraisat, M
   Rueda-Rodriguez, C
   Torres, J
   Prados-Frutos, JC
   Ewald, A
   Gbureck, U
   Azama, JC
   Rodriguez-Gonzalez, A
   Lopez-Cabarcos, E
AF Manchon, A.
   Alkhraisat, M.
   Rueda-Rodriguez, C.
   Torres, J.
   Prados-Frutos, J. C.
   Ewald, A.
   Gbureck, U.
   Cabrejos Azama, J.
   Rodriguez-Gonzalez, A.
   Lopez-Cabarcos, E.
TI Silicon calcium phosphate ceramic as novel biomaterial to simulate the
   bone regenerative properties of autologous bone
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biphasic calcium phosphate; silicon doped ceramic; bone substitution;
   tricalcium phosphate; bone graft
ID SUBSTITUTED HYDROXYAPATITE GRANULES; STABILIZED TRICALCIUM PHOSPHATE;
   IN-VIVO BEHAVIOR; MECHANICAL-PROPERTIES; GENE-EXPRESSION; IONIC
   PRODUCTS; DIFFERENTIATION; PROLIFERATION; DISSOLUTION; RELEASE
AB This study was conducted to develop novel ceramic bone substitute that resembles the autologous bone behavior when used as graft material. Solid-state reaction at 1100 degrees C was performed to synthesize beta-tricalcium phosphate (beta-TCP) and biphasic calcium phosphate (BCP). The ceramics were further analyzed to characterize phase composition, microstructural properties, cytocompatability and then challenged to regenerate critical bone defects in the parietal bone of rabbits. X-ray diffraction analysis confirmed the production of beta-TCP and indicated the synthesis of novel BCP composed of beta-TCP and silicocarnotite (calcium phosphate silicate mineral). The cytocompatibility test with human osteoblast cell line revealed enhanced cell proliferation on the BCP ceramic. The novel BCP induced the filling of about 73% of the bone defect with a newly formed bone tissue and an almost complete degradation after 12 weeks of healing. This novel ceramic resembles the autologous bone properties of complete degradation and efficient enhancement of bone formation, making it promising as bone graft material. (C) 2014 Wiley Periodicals, Inc.
C1 [Manchon, A.; Torres, J.; Prados-Frutos, J. C.; Rodriguez-Gonzalez, A.] Univ Complutense Madrid, Fac Pharm, Dept Phys Chem 2, E-28040 Madrid, Spain.
   [Alkhraisat, M.; Rueda-Rodriguez, C.; Cabrejos Azama, J.; Lopez-Cabarcos, E.] URJC, Fac Hlth Sci, Dept Stomatol, Alcorcon Madrid 28922, Spain.
   [Ewald, A.; Gbureck, U.] Univ Wurzburg, D-97070 Wurzburg, Germany.
RP Manchon, A (reprint author), Univ Complutense Madrid, Fac Pharm, Dept Phys Chem 2, E-28040 Madrid, Spain.
EM angel.manchon@urjc.es
RI Gbureck, Uwe/G-1430-2012
OI Alkhraisat, Mohammad/0000-0003-4422-4527; TORRES GARCIA DENCHE,
   JESUS/0000-0002-8310-9209; Prados Frutos, Juan
   Carlos/0000-0003-1464-0968
FU Spanish Science and Innovation Ministry [MAT2010-15349]
FX Contract grant sponsor: Spanish Science and Innovation Ministry;
   contract grant number: MAT2010-15349
CR Alkhraisat MH, 2008, BIOMATERIALS, V29, P4691, DOI 10.1016/j.biomaterials.2008.08.026
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Camire CL, 2006, J BIOMED MATER RES B, V76B, P424, DOI 10.1002/jbm.b.30385
   CARLISLE EM, 1982, NUTR REV, V40, P193
   CARLISLE EM, 1988, SCI TOTAL ENVIRON, V73, P95, DOI 10.1016/0048-9697(88)90190-8
   CARLISLE EM, 1970, SCIENCE, V167, P179
   De la Riva B, 2010, J CONTROL RELEASE, V143, P45, DOI 10.1016/j.jconrel.2009.11.026
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Gao TJ, 2001, BIOMATERIALS, V22, P1475, DOI 10.1016/S0142-9612(00)00288-X
   Ghanaati SM, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/2/025004
   Alkhraisat MH, 2010, ACTA BIOMATER, V6, P1522, DOI 10.1016/j.actbio.2009.10.043
   Alkhraisat MH, 2013, MAT SCI ENG C-MATER, V33, P475, DOI 10.1016/j.msec.2012.09.017
   Heinemann S, 2009, ACTA BIOMATER, V5, P1979, DOI 10.1016/j.actbio.2009.02.029
   Hing KA, 2006, BIOMATERIALS, V27, P5014, DOI 10.1016/j.biomaterials.2006.05.039
   Kannan S, 2011, ACTA BIOMATER, V7, P1835, DOI 10.1016/j.actbio.2010.12.009
   KEETING PE, 1992, J BONE MINER RES, V7, P1281, DOI 10.1002/jbmr.5650071107
   Kruse A, 2011, CLIN ORAL IMPLAN RES, V22, P506, DOI 10.1111/j.1600-0501.2010.02039.x
   Mastrogiacomo M, 2006, TISSUE ENG, V12, P1261, DOI 10.1089/ten.2006.12.1261
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   Patel N, 2005, J MATER SCI-MATER M, V16, P429, DOI 10.1007/s10856-005-6983-6
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   Porter AE, 2006, MICRON, V37, P681, DOI 10.1016/j.micron.2006.03.006
   Rawal A, 2008, CHEM MATER, V20, P2583, DOI 10.1021/cm702928h
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Sayer M, 2003, BIOMATERIALS, V24, P369, DOI 10.1016/S0142-9612(02)00327-7
   SCHWARZ K, 1973, P NATL ACAD SCI USA, V70, P1608, DOI 10.1073/pnas.70.5.1608
   Sun JY, 2009, ACTA BIOMATER, V5, P1284, DOI 10.1016/j.actbio.2008.10.011
   Tamimi F, 2010, BIOMATERIALS, V31, P2762, DOI 10.1016/j.biomaterials.2009.12.039
   Tamimi F, 2009, BIOMATERIALS, V30, P6318, DOI 10.1016/j.biomaterials.2009.07.049
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Van den Vreken NMF, 2010, ACTA BIOMATER, V6, P617, DOI 10.1016/j.actbio.2009.07.038
   Vandiver J, 2006, J BIOMED MATER RES A, V78A, P352, DOI 10.1002/jbm.a.30737
   VANLANDUYT P, 1995, J MATER SCI-MATER M, V6, P8, DOI 10.1007/BF00121239
   Xu HHK, 2004, BIOMATERIALS, V25, P4615, DOI 10.1016/j.biomaterials.2003.12.058
   Xu S, 2008, BIOMATERIALS, V29, P2588, DOI 10.1016/j.biomaterials.2008.03.013
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yamada M, 2003, BIOL TRACE ELEM RES, V95, P113, DOI 10.1385/BTER:95:2:113
   Zerbo IR, 2004, CLIN ORAL IMPLAN RES, V15, P724, DOI 10.1111/j.1600-0501.2004.01055.x
NR 40
TC 14
Z9 14
U1 3
U2 40
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2015
VL 103
IS 2
BP 479
EP 488
DI 10.1002/jbm.a.35196
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA7MP
UT WOS:000349101700006
PM 24737706
DA 2018-10-19
ER

PT J
AU Kumar, A
   Biswas, K
   Basu, B
AF Kumar, Alok
   Biswas, Krishanu
   Basu, Bikramjit
TI Hydroxyapatite-titanium bulk composites for bone tissue engineering
   applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE hydroxyapatite; titanium; composite; fracture toughness;
   biocompatibility
ID FUNCTIONALLY GRADED BIOMATERIAL; CRACK DEFLECTION PROCESSES; TOTAL JOINT
   REPLACEMENT; IN-VITRO BIOACTIVITY; MECHANICAL-PROPERTIES; CELLULAR
   PROLIFERATION; THERMAL-EXPANSION; MICROSTRUCTURE; BIOCOMPATIBILITY;
   SCAFFOLDS
AB The research work on bulk hydroxyapatite (HA)-based composites are driven by the need to develop biomaterials with better mechanical properties without compromising its bioactivity and biocompatibility properties. Despite several years of research, the mechanical properties of the HA-based composites still need to be enhanced to match the properties of natural cortical bone. In this regard, the scope of this review on the HA-based bulk biomaterials is limited to the processing and the mechanical as well as biocompatibility properties for bone tissue engineering applications of a model system that is hydroxyapatite-titanium (HA-Ti) bulk composites. It will be discussed in this review how HA-Ti based bulk composites can be processed to have better fracture toughness and strength without compromising biocompatibility. The advantages of the functionally gradient materials to integrate the mechanical and biocompatibility properties is a promising approach in hard tissue engineering and has been emphasized here in reference to the limited literature reports. On the biomaterials fabrication aspect, the recent results are discussed to demonstrate that advanced manufacturing techniques, like spark plasma sintering can be adopted as a processing route to restrict the sintering reactions, while enhancing the mechanical properties. Various toughening mechanisms related to careful tailoring of microstructure are discussed. The in vitro cytocompatibilty, cell fate processes as well as in vivo biocompatibility results are also reviewed and the use of flow cytometry to quantify in vitro cell fate processes is being emphasized. (C) 2014 Wiley Periodicals, Inc.
C1 [Kumar, Alok; Basu, Bikramjit] Indian Inst Sci, Mat Res Ctr, Lab Biomat, Bangalore 560012, Karnataka, India.
   [Biswas, Krishanu] Indian Inst Technol, Dept Mat Sci & Engn, Kanpur 208016, Uttar Pradesh, India.
RP Basu, B (reprint author), Indian Inst Sci, Mat Res Ctr, Lab Biomat, Bangalore 560012, Karnataka, India.
EM bikram@mrc.iisc.ernet.in
RI Kumar, Alok/O-1876-2016
OI Kumar, Alok/0000-0002-8363-2286
FU Department of Science and Technology, Government of India; Department of
   Biotechnology, Government of India; CARE Grant, IIT Kanpur
FX Contract grant sponsors: CARE Grant, IIT Kanpur, Department of Science
   and Technology, Government of India and Department of Biotechnology,
   Government of India
CR ALLIOTLICHT B, 1991, BIOMATERIALS, V12, P752, DOI 10.1016/0142-9612(91)90025-6
   ASHBY MF, 1989, ACTA METALL MATER, V37, P1847, DOI 10.1016/0001-6160(89)90069-2
   Audekercke RV, 1984, MECH PROPERTIES CANC
   AZIMOV SY, 1981, INORG MATER+, V17, P1384
   BABUSHKIN O, 1994, J MATER CHEM, V4, P413, DOI 10.1039/jm9940400413
   Bajpai I, 2013, J AM CERAM SOC, V96, P2100, DOI 10.1111/jace.12386
   BAO G, 1990, INT J SOLIDS STRUCT, V26, P631, DOI 10.1016/0020-7683(90)90034-S
   Basu B., 2011, ADV STRUCTURAL CERAM
   Basu B, 2013, RSC ADV, V3, P14622, DOI 10.1039/c3ra42369g
   BEGLEY CT, 1995, BIOMATERIALS, V16, P1181, DOI 10.1016/0142-9612(95)93584-Z
   Billi F, 2010, J APPL BIOMATER BIOM, V8, P1
   Biring G, 2007, FRICTION LUBRICATION
   Black J, 1988, ORTHOPEDIC BIOMATERI
   Blitterswijk CAv, 1991, BIOMATERIALS, V12, P187
   BONEL G, 1964, CR HEBD ACAD SCI, V258, P923
   Bonfield W, 1984, ELASTICITY VISCOELAS
   BONFIGLIO M, 1972, CLIN ORTHOP RELAT R, P19
   CARPINTERI A, 1994, MECH MATER, V18, P89, DOI 10.1016/0167-6636(94)00008-5
   Charkaluk E, 1998, ENG FRACT MECH, V61, P119, DOI 10.1016/S0013-7944(98)00035-6
   Chenglin C., 1999, MAT SCI ENG A-STRUCT, V271, P95
   Christoffersen J, 1997, BONE, V20, P47, DOI 10.1016/S8756-3282(96)00316-X
   Chu C, 2002, J MATER SCI-MATER M, V13, P985, DOI 10.1023/A:1019873015772
   Chu CL, 2006, MAT SCI ENG A-STRUCT, V429, P18, DOI 10.1016/j.msea.2006.03.099
   Chu CL, 2003, MAT SCI ENG A-STRUCT, V348, P244, DOI 10.1016/S0921-5093(02)00738-4
   Chun Y., 2010, T NONFERR METAL SOC, V20, P254
   Dabrowski B, 2010, J BIOMED MATER RES B, V95B, P53, DOI 10.1002/jbm.b.31682
   Davies John E, 2003, J Dent Educ, V67, P932
   Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Dowson D., 1992, BIOTRIBOLOGY NATURAL
   Dubey AK, 2013, J AM CERAM SOC, V96, P3753, DOI 10.1111/jace.12566
   Dujovne A R, 1993, J Arthroplasty, V8, P7, DOI 10.1016/S0883-5403(06)80102-6
   ENGH CA, 1988, CLIN ORTHOP RELAT R, P7
   Ergun C, 2002, J BIOMED MATER RES, V59, P305, DOI 10.1002/jbm.1246
   EVANS AG, 1986, ACTA METALL MATER, V34, P2435, DOI 10.1016/0001-6160(86)90146-X
   Evans FG, 1961, BIOMEDICAL STUDIES M
   FABER KT, 1983, ACTA METALL MATER, V31, P565, DOI 10.1016/0001-6160(83)90046-9
   FABER KT, 1983, ACTA METALL MATER, V31, P577, DOI 10.1016/0001-6160(83)90047-0
   Fahami A, 2011, SOLID STATE SCI, V13, P135, DOI 10.1016/j.solidstatesciences.2010.10.026
   Faiz MA, 2012, MAT SCI ENG C, V32, P1164
   GDB GD, 1983, J BONE JOINT SURG AM, V65-A, P239
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Ghaith ES, 2006, J MATER SCI, V41, P2521, DOI 10.1007/s10853-006-5241-8
   Groot K., 1983, BIOCERAMICS CALCIUM
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Huang SP, 2008, J MATER SCI-MATER M, V19, P437, DOI 10.1007/s10856-006-0104-z
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   Jee WSS, 1983, HISTOLOGY CELL TISSU
   Katti KS, 2004, COLLOID SURFACE B, V39, P133, DOI 10.1016/j.colsurfb.2003.12.002
   Kaw AK, 2006, MACHANICS COMPOSITE
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kong YM, 1999, J AM CERAM SOC, V82, P2963
   Kreidler ER, 1970, AM MINERAL, V55, P170
   Kumar A, 2013, MICROSTRUCTURE DEV B
   Kumar A, 2013, J BIOMED MATER RES A, V101, P2925, DOI 10.1002/jbm.a.34603
   Kumar A, 2013, ACTA MATER, V61, P5198, DOI 10.1016/j.actamat.2013.05.013
   Kumar A, 2013, J BIOMED MATER RES B, V101B, P223, DOI 10.1002/jbm.b.32829
   Kwon SH, 2003, J EUR CERAM SOC, V23, P1039, DOI 10.1016/S0955-2219(02)00263-7
   Lawn B., 1998, FRACTURE BRITTLE SOL
   LEGEROS RZ, 1993, J BONE MINER RES, V8, pS583
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   LeGeros RZ, 1982, EFFECT FLUORIDE STAB
   LeGeros RZ, 2008, BIOACTIVE BIOCERAMIC
   Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099
   Li YF, 2013, P NATL ACAD SCI USA, V110, P12295, DOI 10.1073/pnas.1222276110
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lutjering G., 2007, TITANIUM
   MacDonald DE, 2001, J BIOMED MATER RES, V54, P480
   Mallik PK, 2014, J BIOMED MATER RES A, V102, P842, DOI 10.1002/jbm.a.34752
   Mandal S, 2013, MAT TECHNOL ADV PERF, V29, pB21
   MANDELBROT BB, 1984, NATURE, V308, P721, DOI 10.1038/308721a0
   MIYAKE M, 1986, J SOLID STATE CHEM, V61, P230, DOI 10.1016/0022-4596(86)90026-5
   Mondal D, 2013, J BIOMED MATER RES A, V101, P1489, DOI 10.1002/jbm.a.34455
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Muller RT, 1997, ARCH ORTHOP TRAUM SU, V116, P334
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Murugan R, 2004, NANOSTRUCTURED BIOMA
   Nakahira A, 2001, J CERAM PROCESS RES, V2, P108
   Nath S, 2009, MAT SCI ENG C-BIO S, V29, P97, DOI 10.1016/j.msec.2008.05.019
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Ning CQ, 2002, BIOMATERIALS, V23, P2909, DOI 10.1016/S0142-9612(01)00419-7
   Oonishi H, 2000, J BIOMED MATER RES, V51, P37, DOI 10.1002/(SICI)1097-4636(200007)51:1<37::AID-JBM6>3.0.CO;2-T
   Palsson BO, 2009, TISSUE ENG
   Park Joon, 2008, BIOCERAMICS PROPERTI
   PRENDERGAST PJ, 1995, IRISH J MED SCI, V164, P152, DOI 10.1007/BF02973285
   Putlyaev VI, 2006, GLASS CERAM+, V63, P99, DOI 10.1007/s10717-006-0049-1
   Rapacz-Kmita A, 2006, J EUR CERAM SOC, V26, P1481, DOI 10.1016/j.jeurceramsoc.2005.01.059
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Reddy KM, 2010, SCRIPTA MATER, V62, P435, DOI 10.1016/j.scriptamat.2009.11.030
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Ribeiro CC, 2006, BIOMATERIALS, V27, P1749, DOI 10.1016/j.biomaterials.2005.09.043
   Rishabh A, 2010, J APPL PHYS, V107, DOI 10.1063/1.3445869
   Rivera EM, 1999, MATER LETT, V41, P128, DOI 10.1016/S0167-577X(99)00118-4
   Rivera-Munoz E, 2001, J MATER SCI-MATER M, V12, P305, DOI 10.1023/A:1011290919642
   Rudnik E, 1997, J THERM ANAL, V49, P471, DOI 10.1007/BF01987473
   Saenz A, 1999, J MATER EDUC, V21, P297
   Saha N, 2012, J BIOMED MATER RES B, V100B, P256, DOI 10.1002/jbm.b.31948
   Sanosh KP, 2009, CURR APPL PHYS, V9, P1459, DOI 10.1016/j.cap.2009.03.024
   Sansone V, 2013, CLIN CASES MINER BON, V10, P34, DOI 10.11138/ccmbm/2013.10.1.034
   Silva RV, 2004, INT J ORAL MAXILLOF, V10, P1
   Steinemann S. G., 1980, CORROSION SURG IMPLA
   Steinemann SG., 1985, CORROSION TITANIUM T, P1373
   Suchanek W, 1997, J AM CERAM SOC, V80, P2805, DOI 10.1111/j.1151-2916.1997.tb03197.x
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   SUZUKI T, 1981, J CHEM SOC FARAD T 1, V77, P1059, DOI 10.1039/f19817701059
   Swanson PL, 1988, CRACK INTERFACE TRAC
   Tagai H, 1980, PREPARATION SYNTHETI
   Tancred DC, 1998, BIOMATERIALS, V19, P1735, DOI 10.1016/S0142-9612(98)00082-9
   TUMMALA RR, 1970, J APPL PHYS, V41, P5104, DOI 10.1063/1.1658618
   URIST MARSHALL R., 1967, CLIN ORTHOP RELATED RESIN COMPLICATIONS OF ORTHOPAEDIC SURGERY, V53, P243
   Vaccaro AR, 2002, ORTHOPEDICS, V25, pS571
   Valiathan MS, 1999, NATL MED J INDIA, V12, P270
   WANG BC, 1993, SURF COAT TECH, V58, P107, DOI 10.1016/0257-8972(93)90181-M
   Wang YY, 2002, J IMMUNOL METHODS, V268, P179, DOI 10.1016/S0022-1759(02)00190-4
   Weertman J., 1996, DISLOCATION BASED FR
   WENG J, 1994, J MATER SCI LETT, V13, P159, DOI 10.1007/BF00278148
   Whang Peter G, 2003, Spine J, V3, P155, DOI 10.1016/S1529-9430(02)00539-9
   WILES P, 1958, BRIT J SURG, V45, P488, DOI 10.1002/bjs.18004519315
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Wolff J., 1986, LAW BONE REMODELLING
   Xu LH, 2005, CERAM INT, V31, P953, DOI 10.1016/j.ceramint.2004.10.008
   Yang YZ, 2004, BIOMATERIALS, V25, P2927, DOI 10.1016/j.biomaterials.2003.09.072
   ZHANG SZ, 1989, J PHYS D APPL PHYS, V22, P790, DOI 10.1088/0022-3727/22/6/012
   Zhang X, 1997, J MATER SCI, V32, P235, DOI 10.1023/A:1018568308926
NR 129
TC 20
Z9 22
U1 0
U2 73
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2015
VL 103
IS 2
BP 791
EP 806
DI 10.1002/jbm.a.35198
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA7MP
UT WOS:000349101700036
PM 24737723
OA Bronze
DA 2018-10-19
ER

PT J
AU Frick, CP
   DiRienzo, AL
   Hoyt, AJ
   Safranski, DL
   Saed, M
   Losty, EJ
   Yakacki, CM
AF Frick, Carl P.
   DiRienzo, Amy L.
   Hoyt, Anthony J.
   Safranski, David L.
   Saed, Mohand
   Losty, Eric J.
   Yakacki, Christopher M.
TI High-strength poly(para-phenylene) as an orthopedic biomaterial (vol
   102, pg 3122, 2014)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Correction
C1 [Frick, Carl P.; DiRienzo, Amy L.; Hoyt, Anthony J.] Univ Wyoming, Dept Mech Engn, Laramie, WY 82071 USA.
   [Safranski, David L.] MedShape Inc, Res & Dev, Atlanta, GA 30318 USA.
   [Saed, Mohand; Losty, Eric J.; Yakacki, Christopher M.] Univ Colorado, Dept Mech Engn, Denver, CO 80217 USA.
RP Frick, CP (reprint author), Univ Wyoming, Dept Mech Engn, Laramie, WY 82071 USA.
CR Frick CP, 2014, J BIOMED MATER RES A, V102, P3122, DOI 10.1002/jbm.a.34982
NR 1
TC 0
Z9 0
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2015
VL 103
IS 2
BP 860
EP 860
DI 10.1002/jbm.a.35350
PG 1
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA7MP
UT WOS:000349101700041
OA Bronze
DA 2018-10-19
ER

PT J
AU Hench, LL
AF Hench, Larry L.
TI The future of bioactive ceramics
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID EMBRYONIC STEM-CELLS; IN-VITRO; IMPLANT INTERFACE; HUMAN OSTEOBLASTS;
   IONIC PRODUCTS; BONE-FORMATION; GLASS; BIOGLASS; DIFFERENTIATION;
   ANGIOGENESIS
AB Two important worldwide needs must be satisfied in the future; (1) treatment of the deteriorating health of an aging population and, (2) decreasing healthcare costs to meet the needs of an increased population. The ethical and economic dilemma is how to achieve equality in quality of care while at the same time decreasing cost of care for an ever-expanding number of people. The limited lifetime of prosthetic devices made from first-generation nearly inert biomaterials requires new approaches to meet these two large needs. This paper advises an expanded emphasis on: (1) regeneration of tissues and (2) prevention of tissue deterioration to meet this growing need. Innovative use of bioactive ceramics with genetic control of in situ tissue responses offers the potential to achieve both tissue regeneration and prevention. Clinical success of use of bioactive glass for bone regeneration is evidence that this concept works. Likewise the use of micron sized bioactive glass powders in a dentifrice for re-mineralization of teeth provides evidence that prevention of tissue deterioration is also possible. This opinion paper outlines clinical needs that could be met by innovative use of bioactive glasses and ceramics in the near future; including: regeneration of skeletal tissues that is patient specific and genetic based, load-bearing bioactive glass-ceramics for skeletal and ligament and tendon repair, repair and regeneration of soft tissues, and rapid low-cost analysis of human cell-biomaterial interactions leading to patient specific diagnoses and treatments using molecularly tailored bioceramics.
C1 Florida Inst Technol, Dept Biomed Engn, Melbourne, FL 32901 USA.
RP Hench, LL (reprint author), Florida Inst Technol, Dept Biomed Engn, 150 W Univ Blvd, Melbourne, FL 32901 USA.
EM larryhench@embarqmail.com
CR BECKHAM CA, 1971, CALC TISS RES, V8, P165, DOI 10.1007/BF02010133
   CLARK AE, 1976, J BIOMED MATER RES, V10, P161, DOI 10.1002/jbm.820100202
   Day RM, 2005, TISSUE ENG, V11, P768, DOI 10.1089/ten.2005.11.768
   Gentleman E, 2009, NAT MATER, V8, P763, DOI [10.1038/nmat2505, 10.1038/NMAT2505]
   Gillette RL, 2001, AM J VET RES, V62, P1149, DOI 10.2460/ajvr.2001.62.1149
   Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]
   Hench L., 2004, J AUST CERAM SOC, V40, P1
   Hench L. L., 2013, INTRO BIOCERAMICS
   Hench LL, 2013, J AUST CERAM SOC, V49, P1
   Hench LL, 2000, MATER RES INNOV, V3, P313, DOI 10.1007/s100190000055
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hench LL, 2002, J INORG MATER, V17, P897
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hu GF, 2012, INT J NANOMED, V7, P2613, DOI 10.2147/IJN.S31081
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Jung S. B., 2012, BIOGLASSES INTRO, P75
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   Leu A, 2008, PHARM RES, V25, P1222, DOI 10.1007/s11095-007-9508-9
   Mahony O, 2010, ADV FUNCT MATER, V20, P3835, DOI 10.1002/adfm.201000838
   Miguez-Pacheco V, 2015, ACTA BIOMATER, V13, P1, DOI 10.1016/j.actbio.2014.11.004
   Notingher I, 2004, ANAL CHEM, V76, P3185, DOI 10.1021/ac0498720
   Notingher L, 2005, J MOL STRUCT, V744, P179, DOI 10.1016/j.molstruc.2004.12.046
   Notingher L, 2004, VIB SPECTROSC, V35, P199, DOI 10.1016/j.vibspec.2004.01.014
   Peitl O, 2012, ACTA BIOMATER, V8, P321, DOI 10.1016/j.actbio.2011.10.014
   PIOTROWSKI G, 1975, J BIOMED MATER RES, V9, P47, DOI 10.1002/jbm.820090408
   Tsigkou O, 2010, P NATL ACAD SCI USA, V107, P3311, DOI 10.1073/pnas.0905445107
   WILSON J, 1992, J APPL BIOMATER, V3, P123, DOI 10.1002/jab.770030208
   WILSON J, 1981, J BIOMED MATER RES, V15, P805, DOI 10.1002/jbm.820150605
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
NR 35
TC 13
Z9 15
U1 8
U2 92
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2015
VL 26
IS 2
AR 86
DI 10.1007/s10856-015-5425-3
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CB1QI
UT WOS:000349402400025
PM 25644100
DA 2018-10-19
ER

PT J
AU Kido, HW
   Tim, CR
   Bossini, PS
   Parizotto, NA
   de Castro, CA
   Crovace, MC
   Rodrigues, ACM
   Zanotto, ED
   Peitl, O
   Anibal, FD
   Renno, ACM
AF Kido, Hueliton Wilian
   Tim, Carla Roberta
   Bossini, Paulo Sergio
   Parizotto, Nivaldo Antonio
   de Castro, Cynthia Aparecida
   Crovace, Murilo Camuri
   Martins Rodrigues, Ana Candida
   Zanotto, Edgar Dutra
   Peitl Filho, Oscar
   Anibal, Fernanda de Freitas
   Muniz Renno, Ana Claudia
TI Porous bioactive scaffolds: characterization and biological performance
   in a model of tibial bone defect in rats
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID OF-THE-ART; GRAFT SUBSTITUTES; ORTHOPEDIC TRAUMA; BIOSILICATE(R);
   MICROSPHERES; BIOMATERIALS; REGENERATION; OSTEOGENESIS; ENHANCEMENT;
   PERSPECTIVE
AB The aim of this study was to evaluate the effects of highly porous Biosilicate (R) scaffolds on bone healing in a tibial bone defect model in rats by means of histological evaluation (histopathological and immunohistochemistry analysis) of the bone callus and the systemic inflammatory response (immunoenzymatic assay). Eighty Wistar rats (12 weeks-old, weighing +/-300 g) were randomly divided into 2 groups (n = 10 per experimental group, per time point): control group and Biosilicate (R) group (BG). Each group was euthanized 3, 7, 14 and 21 days post-surgery. Histological findings revealed a similar inflammatory response in both experimental groups, 3 and 7 days post-surgery. During the experimental periods (3-21 days post-surgery), it was observed that the biomaterial degradation, mainly in the periphery region, provided the development of the newly formed bone into the scaffolds. Immunohistochemistry analysis demonstrated that the Biosilicate (R) scaffolds stimulated cyclooxygenase-2, vascular endothelial growth factor and runtrelated transcription factor 2 expression. Furthermore, in the immunoenzymatic assay, BG presented no difference in the level of tumor necrosis factor alpha in all experimental periods. Still, BG showed a higher level of interleukin 4 after 14 days post-implantation and a lower level of interleukin 10 in 21 days post-surgery. Our results demonstrated that Biosilicate (R) scaffolds can contribute for bone formation through a suitable architecture and by stimulating the synthesis of markers related to the bone repair.
C1 [Kido, Hueliton Wilian; Tim, Carla Roberta; Parizotto, Nivaldo Antonio] Fed Univ Sao Carlos UFSCar, Dept Physiotherapy, Postgrad Program Biotechnol, Sao Carlos, SP, Brazil.
   [Bossini, Paulo Sergio; Muniz Renno, Ana Claudia] Fed Univ Sao Paulo UNIFESP, Dept Biosci, Santos, SP, Brazil.
   [de Castro, Cynthia Aparecida] Fed Univ Sao Carlos UFSCar, Dept Physiol Sci, Sao Carlos, SP, Brazil.
   [Crovace, Murilo Camuri; Martins Rodrigues, Ana Candida; Zanotto, Edgar Dutra; Peitl Filho, Oscar] Fed Univ Sao Carlos UFSCar, Dept Mat Engn, Vitreous Mat Lab LaMaV, Sao Carlos, SP, Brazil.
   [Anibal, Fernanda de Freitas] Fed Univ Sao Carlos UFSCar, Dept Morphol & Pathol, Sao Carlos, SP, Brazil.
RP Renno, ACM (reprint author), Fed Univ Sao Paulo UNIFESP, Dept Biosci, Ana Costa 95, Santos, SP, Brazil.
EM hueliton_kido@yahoo.com.br; a.renno@unifesp.br
RI Bossini, Paulo/G-2333-2014; Parizotto, Nivaldo/D-5347-2014; Kido,
   Hueliton/O-9970-2015; CerTEV, CeRTEV/J-6817-2015; Castro,
   Cynthia/I-7368-2016
OI Parizotto, Nivaldo/0000-0003-1774-9053; Kido,
   Hueliton/0000-0001-8554-432X; Castro, Cynthia/0000-0002-2675-8069; Tim,
   Carla/0000-0002-4745-9375
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)
FX The authors thank FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo) for their financial support.
CR Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Axelrad TW, 2007, INJURY, V38, pS49, DOI 10.1016/j.injury.2007.02.010
   Bhatt RA, 2012, HAND CLIN, V28, P457, DOI 10.1016/j.hcl.2012.08.001
   Bossini PS, 2011, J TISSUE ENG REGEN M, V5, P229, DOI 10.1002/term.309
   Crovace MC, 2009, THESIS FEDERAL U SAO
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   Dorozhkin SV, 2009, J MATER SCI, V44, P2343, DOI 10.1007/s10853-008-3124-x
   Drosse I, 2008, TISSUE ENG PART C-ME, V14, P79, DOI 10.1089/tec.2007.0234
   Filho OP, 1996, J BIOMED MATER RES, V30, P509
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   Granito RN, 2011, J BIOMED MATER RES B, V97B, P139, DOI 10.1002/jbm.b.31795
   Granito RN, 2009, J MATER SCI-MATER M, V20, P2521, DOI 10.1007/s10856-009-3824-z
   Hak DJ, 2007, J AM ACAD ORTHOP SUR, V15, P525, DOI 10.5435/00124635-200709000-00003
   Hallab NJ, 2009, BULL HOSP JT DIS, V67, P182
   Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hu YC, 2009, CHINESE MED J-PEKING, V122, P2386, DOI 10.3760/cma.j.issn.0366-6999.2009.19.035
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Keramaris NC, 2008, INJURY, V39, pS45, DOI 10.1016/S0020-1383(08)70015-9
   Kido HW, 2013, J BIOMED MATER RES A, V101, P667, DOI 10.1002/jbm.a.34360
   Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420
   Link DP, 2008, J BIOMED MATER RES A, V87A, P760, DOI 10.1002/jbm.a.31831
   Matsumoto MA, 2012, J MATER SCI-MATER M, V23, P1447, DOI 10.1007/s10856-012-4612-8
   Moura J, 2007, J BIOMED MATER RES A, V82A, P545, DOI 10.1002/jbm.a.31165
   Nandi SK, 2010, INDIAN J MED RES, V132, P15
   Ohtsuki C, 2009, J R SOC INTERFACE, V6, pS349, DOI 10.1098/rsif.2008.0419.focus
   Oliveira P, 2010, J MATER SCI-MATER M, V21, P1379, DOI 10.1007/s10856-009-3945-4
   Pape HC, 2010, J ORTHOP TRAUMA, V24, P522, DOI 10.1097/BOT.0b013e3181ed1361
   Pascu EI, 2013, MAT SCI ENG C-MATER, V33, P4905, DOI 10.1016/j.msec.2013.08.012
   Phieffer LS, 2006, J BONE JOINT SURG AM, V88A, P206, DOI 10.2106/00004623-200601000-00026
   Renno ACM, 2013, BIOMED RES INT, DOI 10.1155/2013/141427
   Sachot N, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0684
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   SCHIEKER M, 2006, EUR J TRAUMA, V32, P114, DOI DOI 10.1007/S00068-006-6047-8
   SHIOI A, 1991, J CELL BIOCHEM, V47, P272, DOI 10.1002/jcb.240470313
   Valimaki VV, 2005, J BIOMED MATER RES A, V75A, P501, DOI 10.1002/jbm.a.30236
   Wu CT, 2010, J BIOMED MATER RES B, V94B, P32, DOI 10.1002/jbm.b.31621
   Xin RL, 2010, J NON-CRYST SOLIDS, V356, P1180, DOI 10.1016/j.jnoncrysol.2010.03.010
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Pinto KNZ, 2013, PHOTOMED LASER SURG, V31, P252, DOI 10.1089/pho.2012.3435
   ZANOTTO ED, 2004, Patent No. 2004074199
   Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681
NR 43
TC 4
Z9 4
U1 1
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2015
VL 26
IS 2
AR 74
DI 10.1007/s10856-015-5411-9
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CB1QI
UT WOS:000349402400014
PM 25631271
DA 2018-10-19
ER

PT J
AU Mas-Moruno, C
   Garrido, B
   Rodriguez, D
   Ruperez, E
   Gil, FJ
AF Mas-Moruno, Carlos
   Garrido, Beatriz
   Rodriguez, Daniel
   Ruperez, Elisa
   Javier Gil, F.
TI Biofunctionalization strategies on tantalum-based materials for
   osseointegrative applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID POROUS-TANTALUM; IN-VITRO; TITANIUM SURFACES; HUMAN OSTEOBLASTS;
   TRABECULAR METAL; CELL-ADHESION; COLLAGEN IMMOBILIZATION; IMPLANT
   MATERIALS; RGD PEPTIDES; BONE
AB The use of tantalum as biomaterial for orthopedic applications is gaining considerable attention in the clinical practice because it presents an excellent chemical stability, body fluid resistance, biocompatibility, and it is more osteoconductive than titanium or cobalt-chromium alloys. Nonetheless, metallic biomaterials are commonly bioinert and may not provide fast and long-lasting interactions with surrounding tissues. The use of short cell adhesive peptides derived from the extracellular matrix has shown to improve cell adhesion and accelerate the implant's biointegration in vivo. However, this strategy has been rarely applied to tantalum materials. In this work, we have studied two immobilization strategies (physical adsorption and covalent binding via silanization) to functionalize tantalum surfaces with a cell adhesive RGD peptide. Surfaces were used untreated or activated with either HNO3 or UV/ozone treatments. The process of biofunctionalization was characterized by means of physicochemical and biological methods. Physisorption of the RGD peptide on control and HNO3-treated tantalum surfaces significantly enhanced the attachment and spreading of osteoblast-like cells; however, no effect on cell adhesion was observed in ozone-treated samples. This effect was attributed to the inefficient binding of the peptide on these highly hydrophilic surfaces, as evidenced by contact angle measurements and X-ray photoelectron spectroscopy. In contrast, activation of tantalum with UV/ozone proved to be the most efficient method to support silanization and subsequent peptide attachment, displaying the highest values of cell adhesion. This study demonstrates that both physical adsorption and silanization are feasible methods to immobilize peptides onto tantalum-based materials, providing them with superior bioactivity.
C1 [Mas-Moruno, Carlos; Garrido, Beatriz; Rodriguez, Daniel; Ruperez, Elisa; Javier Gil, F.] Tech Univ Catalonia UPC, ETSEIB, Dept Mat Sci & Met Engn, Biomat Biomech & Tissue Engn Grp, Barcelona 08028, Spain.
   [Mas-Moruno, Carlos; Rodriguez, Daniel; Javier Gil, F.] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona 08028, Spain.
   [Mas-Moruno, Carlos; Rodriguez, Daniel; Ruperez, Elisa] Ctr Res NanoEngn CRNE UPC, Barcelona 08028, Spain.
RP Mas-Moruno, C (reprint author), Tech Univ Catalonia UPC, ETSEIB, Dept Mat Sci & Met Engn, Biomat Biomech & Tissue Engn Grp, Ave Diagonal 647, Barcelona 08028, Spain.
EM carles.mas.moruno@upc.edu
RI Mas-Moruno, Carlos/H-7511-2015; Ruperez, Elisa/J-8792-2017
OI Mas-Moruno, Carlos/0000-0001-8337-0872; Ruperez,
   Elisa/0000-0001-8845-512X
FU Spanish Government [MAT2012-30706]; European Union through European
   Regional Development Funds; Government of Catalonia [SGR2009 1039];
   Ministry of Economy and Knowledge of the Government of Catalonia
   [2011-BP-B-00042]; European Union [321985]
FX The authors acknowledge the Spanish Government for financial support
   through Project MAT2012-30706, co-funded by the European Union through
   European Regional Development Funds, and the Government of Catalonia
   (SGR2009 1039). Carlos Mas-Moruno thanks the support of the Secretary
   for Universities and Research of the Ministry of Economy and Knowledge
   of the Government of Catalonia (2011-BP-B-00042) and the People
   Programme (Marie Curie Actions) of the European Union's Seventh
   Framework Programme (FP7-PEOPLE-2012-CIG, REA Grant Agreement 321985).
   The authors thank Mrs. Montse Dominguez and Mr. Trifon Trifonov (CRNE)
   for their excellent technical support with the XPS and SEM measurements,
   respectively.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Aubry D, 2009, APPL SURF SCI, V255, P4765, DOI 10.1016/j.apsusc.2008.11.022
   Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046
   Balla VK, 2010, ACTA BIOMATER, V6, P2234
   Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057
   Bauer S, 2013, PROG MATER SCI, V58, P261, DOI 10.1016/j.pmatsci.2012.09.001
   Bellis SL, 2011, BIOMATERIALS, V32, P4205, DOI 10.1016/j.biomaterials.2011.02.029
   Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   Budge MD, 2013, J SHOULDER ELB SURG, V22, P709, DOI 10.1016/j.jse.2012.07.001
   Chen X., 2013, THIN FILMS COATINGS, P105
   Chen X, 2013, COLLOID SURFACE B, V107, P189, DOI 10.1016/j.colsurfb.2013.02.005
   Dahmen C, 2004, ANGEW CHEM INT EDIT, V43, P6649, DOI 10.1002/anie.200460770
   Deglurkar M, 2007, J BIOMED MATER RES B, V80B, P528, DOI 10.1002/jbm.b.30627
   Dolatshahi-Pirouz A, 2010, ACS NANO, V4, P2874, DOI 10.1021/nn9017872
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   Frandsen CJ, 2014, MAT SCI ENG C-MATER, V37, P332, DOI 10.1016/j.msec.2014.01.014
   Hanawa T, 2011, J PERIODONTAL IMPLAN, V41, P263, DOI 10.5051/jpis.2011.41.6.263
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Jafari SM, 2010, CLIN ORTHOP RELAT R, V468, P459, DOI 10.1007/s11999-009-1090-5
   Kaivosoja E, 2013, J BIOMATER APPL, V27, P862, DOI 10.1177/0885328211428094
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044
   Lachiewicz PF, 2012, CLIN ORTHOP RELAT R, V470, P199, DOI 10.1007/s11999-011-1888-9
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Liu PS, 2011, ACTA BIOMATER, V7, P3488, DOI 10.1016/j.actbio.2011.05.025
   Maccauro Giulio, 2009, Recent Pat Biotechnol, V3, P157, DOI 10.2174/187220809789389153
   Mantripragada VP, 2013, J BIOMED MATER RES A, V101, P3349, DOI 10.1002/jbm.a.34605
   Mas-Moruno C, 2013, BIOMATERIALS SURFACE SCIENCE, P337
   Mas-Moruno C, 2014, ACS APPL MATER INTER, V6, P6525, DOI 10.1021/am5001213
   Mas-Moruno C, 2013, J BIOMED MATER RES A, V101, P87, DOI 10.1002/jbm.a.34303
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   McNichols C, 2014, J BIOMED MATER RES A, V102, P532, DOI 10.1002/jbm.a.34700
   Miyazaki T, 2002, BIOMATERIALS, V23, P827, DOI 10.1016/S0142-9612(01)00188-0
   Morra M, 2003, BIOMATERIALS, V24, P4639, DOI 10.1016/S0142-9612(03)00360-0
   Muller R, 2005, BIOMATERIALS, V26, P6962, DOI 10.1016/j.biomaterials.2005.05.013
   Nakashima Y, 2013, MOD RHEUMATOL, V23, P112, DOI 10.1007/s10165-012-0618-9
   Petrie TA, 2009, J CELL MOL MED, V13, P2602, DOI 10.1111/j.1582-4934.2008.00476.x
   PetrieTA Raynor JE, 2008, BIOMATERIALS, V29, P2849
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Rechenmacher F, 2013, CHEM-EUR J, V19, P9218, DOI 10.1002/chem.201301478
   Rechenmacher F, 2013, ANGEW CHEM INT EDIT, V52, P1572, DOI 10.1002/anie.201206370
   Schliephake H, 2008, J MATER CHEM, V18, P2404, DOI 10.1039/015355b
   Schuler M, 2009, J BIOMED MATER RES B, V91B, P517, DOI 10.1002/jbm.b.31425
   Sevilla P, 2007, J ALLOY COMPD, V439, P67, DOI [10.1016/j.jallcom.2006.08.069, 10.1016/j.jallcom.2006.008.069]
   Shekaran A, 2011, J BIOMED MATER RES A, V96A, P261, DOI 10.1002/jbm.a.32979
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Song YY, 2010, SURF SCI, V604, P346, DOI 10.1016/j.susc.2009.11.027
   Stiehl JB, 2005, ORTHOPEDICS, V28, P662
   Stiehler C, 2013, CELL MOL BIOENG, V6, P199, DOI 10.1007/s12195-012-0255-6
   Stilling M, 2011, ACTA ORTHOP, V82, P177, DOI 10.3109/17453674.2011.566139
   Sun YS, 2013, THIN SOLID FILMS, V528, P130, DOI 10.1016/j.tsf.2012.06.088
   Tang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066263
   Villanueva-Martinez M, 2013, J ARTHROPLASTY, V28, P988, DOI 10.1016/j.arth.2012.09.003
   Pham VH, 2013, THIN SOLID FILMS, V536, P269, DOI 10.1016/j.tsf.2013.03.042
   Welander M, 2007, J CLIN PERIODONTOL, V34, P452, DOI 10.1111/j.1600-051X.2007.01073.x
   WILLIAMS DF, 2001, ENG MAT SER, P13
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   Zhu MJ, 2012, LANGMUIR, V28, P416, DOI 10.1021/la203638g
NR 61
TC 11
Z9 13
U1 2
U2 38
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2015
VL 26
IS 2
AR 109
DI 10.1007/s10856-015-5445-z
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CB1QI
UT WOS:000349402400048
PM 25665847
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Vamze, J
   Pilmane, M
   Skagers, A
AF Vamze, Jolanta
   Pilmane, Mara
   Skagers, Andrejs
TI Biocompatibility of pure and mixed hydroxyapatite and alpha-tricalcium
   phosphate implanted in rabbit bone
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IN-VITRO; BETA-DEFENSINS; OSTEOPROTEGERIN; BIOMATERIALS; OSTEOCALCIN;
   EXPRESSION; CYTOKINES; DISEASE
AB Calcium phosphates and hydroxyapatite, in particular, are used as substitute materials in experimental implantology. These materials are primarily used in hard tissue replacement because their chemical and crystallographic characteristics are considered to be similar to the mineral content, osteoconductivity and bioactivity of normal bone. Cytokines, such as interleukin (IL)-1, IL-6, IL-8, IL-10 and antimicrobial protein beta-defensin-2 (beta Def-2), are used as biomarkers of non-specific reactogenicity. Other biomarkers, including bone morphogenetic protein-2/4 (BMP-2/4), bone regeneration protein osteoprotegerin (OPG), bone matrix protein osteopontin (OP) and osteocalcin (OC), are regarded as specific factors of reactogenicity in bone substitution. The aim of our study was to assess the changes in the distribution and expression of the aforementioned proteins in the lower jaws of rabbits following implantation with pure hydroxyapatite (HAP), alpha-tricalcium phosphate (alpha-TCP) or a mix of the two (HAP/alpha-TCP) manufactured under different temperatures. Our results reveal osteoblast proliferation and regions of granulation tissue formation between biomaterial granules close to the original implantation site, but in the control tissue these changes were less noticeable. Our study showed low variability in the distribution of bDef-2, OPG and all of the tested interleukins and these proteins were less expressed than BMP2/4, OP and OC. But across all experiments, no statistically significant difference in mean bDef-2, IL-1, IL-6, IL-8, IL-10, OP, OC, BMP-2/4 and OPG expression in osteocytes was detected between experimental and control groups. We concluded that pure and mixed HAP and alpha-TCP sintered at different temperatures do not affect the production of cytokines and bone-specific proteins; regions with osteoblast proliferation and low levels of anti-inflammatory cytokines IL-6 and IL-10 indicates better biocompatibility for HAP/alpha-TCP and alpha TCP-2 biomaterials and the moderate number of BMP-2/4 and a prevalence of OC- and OP-positive osteocytes in experimental tissues implanted with HAP at 3 months after implantation indicates potential bone regeneration stimulated by pure HAP.
C1 [Vamze, Jolanta] Riga Stradins Univ, LV-1007 Riga, Latvia.
   [Pilmane, Mara] Riga Stradins Univ, Inst Anat & Anthropol, LV-1007 Riga, Latvia.
   [Skagers, Andrejs] Riga Stradins Univ, Dept Oral & Maxillofacial Surg, LV-1007 Riga, Latvia.
RP Vamze, J (reprint author), Riga Stradins Univ, Dzirciema Str 16, LV-1007 Riga, Latvia.
EM jolantavmz@gmail.com
CR Bissell J, 2004, J ORAL PATHOL MED, V33, P278, DOI 10.1111/j.0904-2512.2004.00143.x
   Bohner M, 2010, EUR CELLS MATER, V20, P1
   Crovella S, 2005, CURR PROTEIN PEPT SC, V6, P7, DOI 10.2174/1389203053027593
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Eskdale J, 1997, IMMUNOGENETICS, V46, P120, DOI 10.1007/s002510050250
   Haake SK, 2002, MOL BIOL HOST MICROB
   Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079
   Holt G, 2007, CLIN ORTHOP RELAT R, P240, DOI 10.1097/BLO.0b013e31804b4147
   HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661
   Kamitakahara M, 2008, J BIOMATER APPL, V23, P197, DOI 10.1177/0885328208096798
   Kiernan JA, 2008, HISTOLOGICAL HISTOCH, P141
   Lange T, 2011, BIOMATERIALS, V32, P4067, DOI 10.1016/j.biomaterials.2011.02.039
   Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200
   Lee AJ, 2000, ANN CLIN BIOCHEM, V37, P432, DOI 10.1258/0004563001899573
   Madhwani T, 2012, FEMS IMMUNOL MED MIC, V64, P374, DOI 10.1111/j.1574-695X.2011.00922.x
   Ninomiya JT, 2001, J ORTHOPAED RES, V19, P621, DOI 10.1016/S0736-0266(00)00061-9
   Pearce G, 2008, PEPTIDES, V29, P2083, DOI 10.1016/j.peptides.2008.08.019
   PILMANE M, 1995, THORAX, V50, P551, DOI 10.1136/thx.50.5.551
   Reinis A, 2011, MED LITH, V47, P560
   Salma Ilze, 2009, Stomatologija, V11, P113
   Sarfati J, 2004, J CREAT, V18, P11
   Shepherd JH, 2011, JOM-US, V63, P83, DOI 10.1007/s11837-011-0063-9
   Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3
   Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101
   Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6
   Yun TJ, 2001, J IMMUNOL, V166, P1482, DOI 10.4049/jimmunol.166.3.1482
NR 26
TC 2
Z9 2
U1 1
U2 17
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2015
VL 26
IS 2
AR 73
DI 10.1007/s10856-015-5406-6
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CB1QI
UT WOS:000349402400013
PM 25631269
DA 2018-10-19
ER

PT J
AU Deng, YH
   Li, LH
   He, J
   Li, M
   Zhang, Y
   Wang, XM
   Cui, FZ
   Xia, H
AF Deng, Ying-Hu
   Li, Li-Hua
   He, Jin
   Li, Mei
   Zhang, Yu
   Wang, Xiu-Mei
   Cui, Fu-Zhai
   Xia, Hong
TI Self-assembled monolayers of alkanethiolates on surface chemistry groups
   in osteosarcoma cells
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article
DE osteosarcoma; functional groups; self-assembled monolayers
ID FIBRONECTIN CONFORMATION; INTEGRIN BINDING; IN-VITRO; ADHESION;
   PROLIFERATION; APOPTOSIS; DIFFERENTIATION; BIOMATERIALS; SPECIFICITY;
   SARCOMA
AB Cell biomedical behavior is influenced by a number of factors, and the extracellular matrix (ECM) of the cellular microenvironment affects certain cancer cells. In the current study, U-2OS cells were cultured on gold surfaces 'modified with different terminal chemical groups [methyl (-CH3), amino (-NH2), hydroxyl (-OH) and carboxyl (-COOH)]. The results revealed that different chemical surfaces convey different behaviors. The density of the different functional surfaces was confirmed by atomic force microscopy. Cell morphology, proliferation rate and cell cycle were investigated using scanning electron microscopy, cell counting and flow cytometry. In conclusion, the type of chemical group on a biomaterial is an important property for the growth of osteosarcoma cells; -NH2 and -COOH surfaces sustained visible cell adhesion and promoted cell growth.
C1 [Deng, Ying-Hu] Southern Med Univ, Clin Med Coll 1, Dept Orthopaed Surg, Guangzhou 510515, Guangdong, Peoples R China.
   [Deng, Ying-Hu] Tongling Peoples Hosp, Dept Orthopaed, Tongling 244000, Anhui, Peoples R China.
   [Li, Li-Hua; Li, Mei; Zhang, Yu; Cui, Fu-Zhai; Xia, Hong] Guangzhou Mil Command, Guangzhou Gen Hosp, Orthoped Hosp, Dept Spinal Surg, Guangzhou 510010, Guangdong, Peoples R China.
   [He, Jin; Wang, Xiu-Mei] Tsinghua Univ, Inst Regenerat & Biomimet Mat, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
RP Xia, H (reprint author), Guangzhou Mil Command, Guangzhou Gen Hosp, Orthoped Hosp, Dept Spinal Surg, 111 Liuhua Rd, Guangzhou 510010, Guangdong, Peoples R China.
EM gzxiahong2@126.com
FU National Natural Science Foundation of China [81272057]; Military
   Medical Science and Technology Research of China during the '12th
   five-year plan' [81271957]
FX The authors thank Professor Zhang of the Herbarium at Guangdong
   Institute of Microbiology (HMIGD) for the use of the scanning electron
   microscope. This study was supported by grants from the National Natural
   Science Foundation of China General program (no. 81272057) and The
   Military Medical Science and Technology Research of China during the
   '12th five-year plan' (no. 81271957).
CR Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   Curran JM, 2005, BIOMATERIALS, V26, P7057, DOI 10.1016/j.biomaterials.2005.05.008
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Heare T, 2009, CURR OPIN PEDIATR, V21, P365, DOI 10.1097/MOP.0b013e32832b1111
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030
   LAPPALAINEN K, 1994, PHARMACEUT RES, V11, P1127, DOI 10.1023/A:1018932714745
   Li LH, 2013, J BIOMATER TISS ENG, V3, P554, DOI 10.1166/jbt.2013.1114
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Picci P, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-6
   Ryan D, 2004, LANGMUIR, V20, P9080, DOI 10.1021/la048443u
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Shin Y, 1997, ARTIF ORGANS, V21, P995
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   WIDRIG CA, 1991, J AM CHEM SOC, V113, P2805, DOI 10.1021/ja00008a001
   Wu JX, 1996, ANTICANCER RES, V16, P2233
   Yan HJ, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/3/035008
   Yu XL, 2013, SURF COAT TECH, V228, pS48, DOI 10.1016/j.surfcoat.2012.08.054
   ZAMBONIN G, 1995, BIOMATERIALS, V16, P397, DOI 10.1016/0142-9612(95)98857-A
NR 24
TC 1
Z9 1
U1 0
U2 14
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD FEB
PY 2015
VL 11
IS 2
BP 975
EP 981
DI 10.3892/mmr.2014.2876
PG 7
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA CB3CS
UT WOS:000349506400030
PM 25373556
OA Green Published
DA 2018-10-19
ER

PT J
AU Gawlitta, D
   Benders, KEM
   Visser, J
   van der Sar, AS
   Kempen, DHR
   Theyse, LFH
   Malda, J
   Dhert, WJA
AF Gawlitta, Debby
   Benders, Kim E. M.
   Visser, Jetze
   van der Sar, Anja S.
   Kempen, Diederik H. R.
   Theyse, Lars F. H.
   Malda, Jos
   Dhert, Wouter J. A.
TI Decellularized Cartilage-Derived Matrix as Substrate for Endochondral
   Bone Regeneration
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; MULTIPOTENT STROMAL CELLS; EQUINE
   ARTICULAR-CARTILAGE; TISSUE; OSSIFICATION; CHONDROGENESIS; CONSTRUCTS;
   SCAFFOLDS; REPAIR
AB Following an endochondral approach to bone regeneration, multipotent stromal cells (MSCs) can be cultured on a scaffold to create a cartilaginous callus that is subsequently remodeled into bone. An attractive scaffold material for cartilage regeneration that has recently regained attention is decellularized cartilage-derived matrix (CDM). Since this material has shown potential for cartilage regeneration, we hypothesized that CDM could be a potent material for endochondral bone regeneration. In addition, since decellularized matrices are known to harbor bioactive cues for tissue formation, we evaluated the need for seeded MSCs in CDM scaffolds. In this study, ectopic bone formation in rats was evaluated for CDM scaffolds seeded with human MSCs and compared with unseeded controls. The MSC-seeded samples were preconditioned in chondrogenic medium for 37 days. After 8 weeks of subcutaneous implantation, the extent of mineralization was significantly higher in the MSC-seeded constructs versus unseeded controls. The mineralized areas corresponded to bone formation with bone marrow cavities. In addition, rat-specific bone formation was confirmed by collagen type I immunohistochemistry. Finally, fluorochrome incorporation at 3 and 6 weeks revealed that the bone formation had an inwardly directed progression. Taken together, our results show that decellularized CDM is a promising biomaterial for endochondral bone regeneration when combined with MSCs at ectopic locations. Modification of current decellularization protocols may lead to enhanced functionality of CDM scaffolds, potentially offering the prospect of generation of cell-free off-the-shelf bone regenerative substitutes.
C1 [Gawlitta, Debby; Benders, Kim E. M.; Visser, Jetze; Kempen, Diederik H. R.; Malda, Jos; Dhert, Wouter J. A.] Univ Med Ctr Utrecht, Dept Orthoped, NL-3508 GA Utrecht, Netherlands.
   [van der Sar, Anja S.] Cent Lab Anim Inst, Utrecht, Netherlands.
   [Theyse, Lars F. H.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.
   [Malda, Jos] Univ Utrecht, Fac Vet Med, Dept Equine Sci, Utrecht, Netherlands.
   [Dhert, Wouter J. A.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands.
RP Gawlitta, D (reprint author), Univ Med Ctr Utrecht, Dept Orthopaed, G05-228,POB 85500, NL-3508 GA Utrecht, Netherlands.
EM d.gawlitta@umcutrecht.nl
OI Kempen, Diederik/0000-0002-4504-7756; Malda, Jos/0000-0002-9241-7676
FU Dutch Technology Foundation, STW [Veni 11208]; Alexandre Suerman
   Fellowship of the UMC Utrecht; Dutch Arthritis Foundation; Netherlands
   Institute for Regenerative Medicine (NIRM); NICHD
FX The authors would like to acknowledge Rick van der Spek, Jason
   Doppenberg, and Selynda Toma for their input and technical assistance.
   D.G. was supported by the Dutch Technology Foundation, STW (Veni 11208).
   K.B. was funded by an Alexandre Suerman Fellowship of the UMC Utrecht.
   J.M. was supported by the Dutch Arthritis Foundation, and J.V. was
   supported by the Netherlands Institute for Regenerative Medicine
   (NIRM).; The antibody against collagen type II (II-II6B3), developed by
   T.F. Linsenmayer, was obtained from the DSHB developed under the
   auspices of the NICHD and maintained by The University of Iowa,
   Department of Biology, Iowa City, IA 52242. The authors are grateful to
   Dr. E. Muinos Pury Ripalda for providing the protocol for the anti-human
   mitochondria staining.
CR ASCH L, 1989, Archives d'Anatomie d'Histologie et d'Embryologie Normales et Experimentales, V72, P81
   Barradas A. M. C., 2010, TERMIS
   Benders KEM, 2014, CARTILAGE, V5, P221, DOI 10.1177/1947603514535245
   Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004
   Brama PAJ, 1999, AM J VET RES, V60, P341
   Chen HC, 2006, BIOTECHNOL LETT, V28, P1415, DOI 10.1007/s10529-006-9111-x
   Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050
   Farrell E, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-31
   Farrell E, 2009, TISSUE ENG PART C-ME, V15, P285, DOI 10.1089/ten.tec.2008.0297
   GABRIELLI M F, 1986, Journal of Nihon University School of Dentistry, V28, P87
   Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x
   Gawlitta D, 2010, TISSUE ENG PART B-RE, V16, P385, DOI 10.1089/ten.TEB.2009.0712
   Gawlitta D, 2012, TISSUE ENG PT A, V18, P1957, DOI [10.1089/ten.TEA.2011.0657, 10.1089/ten.tea.2011.0657]
   Janicki P, 2010, ACTA BIOMATER, V6, P3292, DOI 10.1016/j.actbio.2010.01.037
   Jukes JM, 2008, P NATL ACAD SCI USA, V105, P6840, DOI 10.1073/pnas.0711662105
   Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171
   Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009
   Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038
   Malda J, 2012, OSTEOARTHR CARTILAGE, V20, P1147, DOI 10.1016/j.joca.2012.06.005
   Pautke C, 2005, BONE, V37, P441, DOI 10.1016/j.bone.2005.05.008
   Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136
   Platt D, 1998, EQUINE VET J, V30, P43, DOI 10.1111/j.2042-3306.1998.tb04087.x
   Schwarz S, 2015, J TISSUE ENG REGEN M, V9, pE239, DOI 10.1002/term.1650
   Schwarz S, 2012, TISSUE ENG PT A, V18, P2195, DOI [10.1089/ten.tea.2011.0705, 10.1089/ten.TEA.2011.0705]
   Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107
   Tortelli F, 2010, BIOMATERIALS, V31, P242, DOI 10.1016/j.biomaterials.2009.09.038
   URIST M R, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P198
   URIST MR, 1952, J BONE JOINT SURG AM, V34-A, P443, DOI 10.2106/00004623-195234020-00015
   van Gaalen S. M., 2009, TISSUE ENG PART B-RE, V16, P209
   Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037
   Yang ZQ, 2010, TISSUE ENG PART C-ME, V16, P865, DOI [10.1089/ten.tec.2009.0444, 10.1089/ten.TEC.2009.0444]
   Ye K, 2013, REGEN MED, V8, P333, DOI [10.2217/RME.13.28, 10.2217/rme.13.28]
NR 32
TC 29
Z9 29
U1 3
U2 17
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB 1
PY 2015
VL 21
IS 3-4
BP 694
EP 703
DI 10.1089/ten.tea.2014.0117
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CB4PZ
UT WOS:000349611600027
PM 25316202
DA 2018-10-19
ER

PT J
AU Sosio, C
   Di Giancamillo, A
   Deponti, D
   Gervaso, F
   Scalera, F
   Melato, M
   Campagnol, M
   Boschetti, F
   Nonis, A
   Domeneghini, C
   Sannino, A
   Peretti, GM
AF Sosio, Corrado
   Di Giancamillo, Alessia
   Deponti, Daniela
   Gervaso, Francesca
   Scalera, Francesca
   Melato, Marco
   Campagnol, Marino
   Boschetti, Federica
   Nonis, Alessandro
   Domeneghini, Cinzia
   Sannino, Alessandro
   Peretti, Giuseppe Michele
TI Osteochondral Repair by a Novel Interconnecting Collagen-Hydroxyapatite
   Substitute: A Large-Animal Study
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID TISSUE-ENGINEERING APPLICATIONS; MESENCHYMAL STEM-CELLS; FIBRIN GLUE;
   ARTICULAR-CARTILAGE; BILAYERED SCAFFOLD; KNEE LESIONS; FOLLOW-UP;
   IN-VIVO; DEFECTS; REGENERATION
AB A novel three-dimensional bicomponent substitute made of collagen type I and hydroxyapatite was tested for the repair of osteochondral lesions in a swine model. This scaffold was assembled by a newly developed method that guarantees the strict integration between the organic and the inorganic parts, mimicking the biological tissue between the chondral and the osseous phase. Thirty-six osteochondral lesions were created in the trochlea of six pigs; in each pig, two lesions were treated with scaffolds seeded with autologous chondrocytes (cell+group), two lesions were treated with unseeded scaffolds (cell- group), and the two remaining lesions were left untreated (untreated group). After 3 months, the animals were sacrificed and the newly formed tissue was analyzed to evaluate the degree of maturation. The International Cartilage Repair Society (ICRS) macroscopic assessment showed significantly higher scores in the cell- and untreated groups when compared with the cell+ group. Histological evaluation showed the presence of repaired tissue, with fibroblast-like and hyaline-like areas in all groups; however, with respect to the other groups, the cell- group showed significantly higher values in the ICRS II histological scores for "cell morphology" and for the "surface/superficial assessment." While the scaffold seeded with autologous chondrocytes promoted the formation of a reparative tissue with high cellularity but low glycosaminoglycans (GAG) production, on the contrary, the reparative tissue observed with the unseeded scaffold presented lower cellularity but higher and uniform GAG distribution. Finally, in the lesions treated with scaffolds, the immunohistochemical analysis showed the presence of collagen type II in the peripheral part of the defect, indicating tissue maturation due to the migration of local cells from the surroundings. This study showed that the novel osteochondral scaffold was easy to handle for surgical implantation and was stable within the site of lesion; at the end of the experimental time, all implants were well integrated with the surrounding tissue and no signs of synovitis were observed. The quality of the reparative tissue seemed to be superior for the lesions treated with the unseeded scaffolds, indicating the promising potential of this novel biomaterial for use in a one-stage procedure for osteochondral repair.
C1 [Sosio, Corrado; Di Giancamillo, Alessia; Deponti, Daniela; Boschetti, Federica; Peretti, Giuseppe Michele] IRCCS Ist Ortoped Galeazzi, Milan, Italy.
   [Gervaso, Francesca; Scalera, Francesca; Sannino, Alessandro] Univ Salento, Dept Engn Innovat, Lecce, Italy.
   [Melato, Marco] Univ Milan, Residency Program Orthopaed & Traumatol, Milan, Italy.
   [Campagnol, Marino] Univ Milan, CRABCC, Rivolta Adda CR, Milan, Italy.
   [Boschetti, Federica] Politecn Milan, Lab Biol Struct Mech, Dept Struct Engn, I-20133 Milan, Italy.
   [Nonis, Alessandro] Univ Vita Salute San Raffaele, Univ Ctr Stat Biomed Sci CUSSB, Milan, Italy.
   [Domeneghini, Cinzia] Univ Milan, Dept Hlth Anim Sci & Food Safety, Milan, Italy.
   [Peretti, Giuseppe Michele] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.
RP Peretti, GM (reprint author), Univ Milan, Dept Biomed Sci Hlth, IRCCS Ist Ortoped Galeazzi, Via R Galeazzi 4, I-20161 Milan, Italy.
EM gperetti@iol.it
RI Boschetti, Federica/I-8623-2018; Gervaso, Francesca/G-8874-2013;
   Peretti, Giuseppe/K-6358-2016; scalera, francesca/D-8595-2014
OI Boschetti, Federica/0000-0002-1932-7535; Gervaso,
   Francesca/0000-0002-8644-1653; Peretti, Giuseppe/0000-0001-9341-7187;
   scalera, francesca/0000-0002-1686-6736; Sannino,
   Alessandro/0000-0001-8959-4412; DI GIANCAMILLO,
   ALESSIA/0000-0003-1674-3020; Domeneghini, Cinzia/0000-0002-2040-6783
FU Fondazione CARIPLO [5682]
FX This work was funded by the Fondazione CARIPLO (project No. 5682). The
   authors acknowledge Dr. Alessandro Addis, Dr. Alessandro Pozzi, and Dr.
   Rosa Ballis for the animal care and management and for their precious
   help in the sample preparation and shipping. The authors thank Dr.
   Fraschini for his support in the present study. The authors also
   acknowledge Rahmat Cholas for revising the English language of this
   manuscript. Special thanks is given to Prof. Clelia Di Serio for the
   supervision of the statistical analysis and to Dr. Sanosh Kunjalukkal
   Padmanabhan and Dr. Antonio Licciulli for the synthesis of the HA
   component.
CR Betsch M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071602
   Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2
   Chou CH, 2007, J BIOMED MATER RES A, V82A, P757, DOI 10.1002/bjm.a.31186
   Deponti D., 2013, J TISSUE ENG REGEN M, DOI 10.1002/term.1760
   Deponti D, 2014, TISSUE ENG PT A, V20, P1113, DOI [10.1089/ten.tea.2013.0171, 10.1089/ten.TEA.2013.0171]
   Deponti D, 2012, TISSUE ENG PT A, V18, P1109, DOI [10.1089/ten.tea.2011.0272, 10.1089/ten.TEA.2011.0272]
   Ding M, 2010, ACTA ORTHOP, V81, P5, DOI 10.3109/17453671003619037
   Emmerson BC, 2007, AM J SPORT MED, V35, P907, DOI 10.1177/0363546507299932
   Filardo G, 2014, OSTEOARTHR CARTILAGE, V22, P557, DOI 10.1016/j.joca.2014.01.004
   Filardo G, 2013, KNEE, V20, P570, DOI 10.1016/j.knee.2013.05.007
   Filardo G, 2014, INT ORTHOP, V38, P1905, DOI 10.1007/s00264-014-2322-1
   Filova E, 2013, INT J PHARMACEUT, V447, P139, DOI 10.1016/j.ijpharm.2013.02.056
   Gervaso Francesca, 2012, Key Engineering Materials, V493-494, P890, DOI 10.4028/www.scientific.net/KEM.493-494.890
   Gervaso F, 2012, INT J APPL CERAM TEC, V9, P507, DOI 10.1111/j.1744-7402.2011.02662.x
   Gross AE, 2008, CLIN ORTHOP RELAT R, V466, P1863, DOI 10.1007/s11999-008-0282-8
   Gun I., 2010, TISSUE ENG, V16, P1189
   Hangody L, 2003, J BONE JOINT SURG AM, V85A, P25, DOI 10.2106/00004623-200300002-00004
   HAYES WC, 1972, J BIOMECH, V5, P541, DOI 10.1016/0021-9290(72)90010-3
   Hunzinker E. B., 2001, OSTEOARTHR CARTILAGE, V10, P432
   Intema F, 2010, OSTEOARTHR CARTILAGE, V18, P691, DOI 10.1016/j.joca.2010.01.004
   Jakob RP, 2002, CLIN ORTHOP RELAT R, P170
   Kon E, 2010, J TISSUE ENG REGEN M, V4, P300, DOI 10.1002/term.243
   Kon E., 2010, BMC MUSCULOSKEL DIS, V27, P11
   Kon E, 2014, AM J SPORT MED, V42, P158, DOI 10.1177/0363546513505434
   Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197
   Lu HX, 2010, BIOMATERIALS, V31, P5825, DOI 10.1016/j.biomaterials.2010.04.019
   Madry H, 2010, KNEE SURG SPORT TR A, V18, P419, DOI 10.1007/s00167-010-1054-z
   Maehara H, 2010, J ORTHOP RES, V28, P677, DOI 10.1002/jor.21032
   Mainil-Varlet P, 2010, AM J SPORT MED, V38, P880, DOI 10.1177/0363546509359068
   Malicev E, 2007, BIOTECHNOL BIOENG, V96, P364, DOI 10.1002/bit.21038
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Mizuno S, 2001, J BIOMED MATER RES, V56, P368, DOI 10.1002/1097-4636(20010905)56:3<368::AID-JBM1105>3.0.CO;2-V
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Oliveira SM, 2010, J BIOMED MATER RES A, V94A, P371, DOI 10.1002/jbm.a.32694
   Pan J, 2009, J ORTHOP RES, V27, P1347, DOI 10.1002/jor.20883
   Pape D, 2010, KNEE SURG SPORT TR A, V18, P448, DOI 10.1007/s00167-010-1052-1
   Perdisa F, 2014, HISTOL HISTOPATHOL, V29, P805, DOI 10.14670/HH-29.805
   Peretti GM, 2000, TISSUE ENG, V6, P567, DOI 10.1089/107632700750022206
   Peretti GM, 2006, TISSUE ENG, V12, P1151, DOI 10.1089/ten.2006.12.1151
   Peretti GM, 2001, ANN PLAS SURG, V46, P533, DOI 10.1097/00000637-200105000-00013
   Proffen BL, 2012, KNEE, V19, P493, DOI 10.1016/j.knee.2011.07.005
   Qu D, 2011, J BIOMED MATER RES B, V96B, P9, DOI 10.1002/jbm.b.31697
   Roche S, 2001, BIOMATERIALS, V22, P9, DOI 10.1016/S0142-9612(00)00084-3
   ROFFI A, 2013, BMC MUSCULOSKEL DIS, V21, P330
   Scalera F, 2013, CERAM INT, V39, P4839, DOI 10.1016/j.ceramint.2012.11.076
   Schaefer D, 2002, ARTHRITIS RHEUM, V46, P2524, DOI 10.1002/art.10493
   Scotti C, 2012, TISSUE ENG PT A, V18, P362, DOI [10.1089/ten.tea.2011.0234, 10.1089/ten.TEA.2011.0234]
   Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159
   Siebelt M, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4461
   Silverman RP, 1999, PLAST RECONSTR SURG, V103, P1809, DOI 10.1097/00006534-199906000-00001
   Sosio C, 2007, KNEE SURG SPORT TR A, V15, P1251, DOI 10.1007/s00167-007-0339-3
   Sosio C, 2011, KNEE SURG SPORT TR A, V19, P1035, DOI 10.1007/s00167-010-1296-9
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Wang W, 2010, BIOMATERIALS, V31, P5953, DOI 10.1016/j.biomaterials.2010.04.029
   Xu JW, 2004, PLAST RECONSTR SURG, V113, P1361, DOI 10.1097/01.PRS.000011594.52661.29
   Xue DT, 2010, J BIOMED MATER RES A, V94A, P259, DOI 10.1002/jbm.a.32691
NR 56
TC 7
Z9 7
U1 3
U2 29
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB 1
PY 2015
VL 21
IS 3-4
BP 704
EP 715
DI 10.1089/ten.tea.2014.0129
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CB4PZ
UT WOS:000349611600028
PM 25316498
DA 2018-10-19
ER

PT J
AU Magalhaes, J
   Lebourg, M
   Deplaine, H
   Ribelles, JLG
   Blanco, FJ
AF Magalhaes, Joana
   Lebourg, Myriam
   Deplaine, Harmony
   Gomez Ribelles, Jose Luis
   Blanco, Francisco J.
TI Effect of the Physicochemical Properties of Pure or Chitosan-Coated
   Poly(L-Lactic Acid)Scaffolds on the Chondrogenic Differentiation of
   Mesenchymal Stem Cells from Osteoarthritic Patients
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID ARTICULAR-CARTILAGE REPAIR; IN-VITRO; COMPOSITE SCAFFOLDS; POROUS
   SCAFFOLDS; ACID) SCAFFOLDS; HYALURONIC-ACID; FABRICATION; HYDROGELS;
   BIOMATERIAL; RELEASE
AB Due to the attractive properties of poly(L-lactic acid) (PLLA) and chitosan (CHT) for tissue engineering applications, this study is aimed at analyzing the chondrogenic potential of human bone marrow-derived mesenchymal stem cells (BM-MSCs) derived from osteoarthritic (OA) patients, in pure or CHT-coated PLLA, using different coating methodologies. Although PLLA scaffolds coated in one-step (PLLA-CHT1) yielded CHT smooth pellicles filling the PLLA macropores, a two-step strategy resulted in a CHT fiber-like thin coating covering PLLA pore walls (PLLA-CHT2). Both strategies led to the incorporation of similar content of CHT and a two-fold increase in the scaffold's water uptake capacity, providing elastic moduli values comparable to the ones found for human articular cartilage. After confirming OA-derived BM-MSCs, metabolic activity in the scaffolds, the chondrogenic potential was tested at 30 and 60 days, in a chondrogenic differentiation medium. PLLA scaffolds improved the chondrogenic differentiation of BM-MSCs, regarding cell pellet conventional culture and presented a typical cartilage zonal distribution, although was not able to revert a terminal differentiation. In PLLA-CHT1, on a short term, a rather heterogeneous tissue was formed, with confined areas of either slower cell infiltration or a faster maturation, with enhanced chondrogenic phenotype. In PLLA-CHT2, a similar tissue to PLLA was obtained, albeit on the long term, these scaffolds helped to maintain a hyaline-like phenotype and prevented the advance of the hypertrophic process. These results demonstrate the importance of the scaffolds microenvironment on the cellular events of chondrogenesis.
C1 [Magalhaes, Joana; Lebourg, Myriam; Gomez Ribelles, Jose Luis] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona, Spain.
   [Magalhaes, Joana; Blanco, Francisco J.] Univ Coruna UDC, Grp Bioingn Tisular & Terapia Celular GBTTC CHUAC, Serv Reumatol, Inst Invest Biomed A Coruna INIBIC,Complexo Hosp, La Coruna, Spain.
   [Lebourg, Myriam; Deplaine, Harmony; Gomez Ribelles, Jose Luis] Univ Politecn Valencia, Ctr Biomat & Ingn Tisular, E-46022 Valencia, Spain.
RP Magalhaes, J (reprint author), Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona, Spain.
EM joana.cristina.silva.magalhaes@sergas.es; fblagar@sergas.es
RI Blanco, Francisco J/C-3192-2014; Gomez Ribelles, Jose Luis/L-5629-2014
OI Blanco, Francisco J/0000-0001-9821-7635; Gomez Ribelles, Jose
   Luis/0000-0001-9099-0885
FU Program ACI-PRO-MOCIONA [ACI2010-1095, MAT2010-21611-CO3-01]; Iniciativa
   Ingenio; Consolider Program
FX The authors are thankful to the microscopy service of UPV for useful
   help and service; the Department of Orthopedic Surgery-CHUAC for
   providing human samples; T.H. Gomez and M.J. Sanchez for cell isolation
   and SCH of INIBIC for histological processing. The Biomedical Research
   Networking Center in Bioengineering, Biomaterials, and Nanomedicine
   (CIBER-BBN) is a national initiative of ISCIII. This study was supported
   by Program ACI-PRO-MOCIONA (ACI2010-1095), MAT2010-21611-CO3-01,
   Iniciativa Ingenio 2010, and Consolider Program.
CR Abrahamsson CK, 2010, TISSUE ENG PT A, V16, P3709, DOI [10.1089/ten.tea.2010.0190, 10.1089/ten.TEA.2010.0190]
   da Silva MLA, 2011, J TISSUE ENG REGEN M, V5, P722, DOI 10.1002/term.372
   Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2
   Blanco FJ, 2013, ANN RHEUM DIS, V72, P631, DOI [10.1136/annrheumdis-2012-202652, 10.1136/annrheumdis-2012-201745]
   Bopp Stephanie K., 2008, BMC Pharmacology, V8, P8, DOI 10.1186/1471-2210-8-8
   BRANDRUP J, 1975, POLYM HDB
   Casper ME, 2010, OSTEOARTHR CARTILAGE, V18, P981, DOI 10.1016/j.joca.2010.04.009
   Cicione C, 2010, DIFFERENTIATION, V80, P155, DOI 10.1016/j.diff.2010.06.001
   Correia CR, 2011, TISSUE ENG PART C-ME, V17, P717, DOI 10.1089/ten.tec.2010.0467
   Custodio CA, 2010, J TISSUE ENG REGEN M, V4, P316, DOI 10.1002/term.248
   Deplaine H, 2013, J BIOMED MATER RES B, V101B, P173, DOI 10.1002/jbm.b.32831
   Deplaine H, 2010, COMPOS SCI TECHNOL, V70, P1805, DOI 10.1016/j.compscitech.2010.06.009
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Diekman BO, 2013, CURR OPIN RHEUMATOL, V25, P119, DOI 10.1097/BOR.0b013e32835aa28d
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Fujihara Y, 2009, TISSUE ENG PT A, V15, P1565, DOI 10.1089/ten.tea.2008.0154
   Gibson L. J, 1999, CELLULAR SOLIDS STRU
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   Grad S, 2003, J BIOMED MATER RES A, V66A, P571, DOI 10.1002/jbm.a.10007
   Griffon DJ, 2011, J TISSUE ENG REGEN M, V5, P169, DOI 10.1002/term.302
   He LM, 2009, POLYMER, V50, P4128, DOI 10.1016/j.polymer.2009.06.025
   Hellingman CA, 2012, J TISSUE ENG REGEN M, V6, pe1, DOI 10.1002/term.502
   Hermida-Gomez T, 2011, TISSUE ENG PT A, V17, P1169, DOI [10.1089/ten.tea.2010.0346, 10.1089/ten.TEA.2010.0346]
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Hu J, 2009, BIOMATERIALS, V30, P5061, DOI 10.1016/j.biomaterials.2009.06.013
   Huang Q, 2002, TISSUE ENG, V8, P469, DOI 10.1089/107632702760184727
   Izal I, 2013, KNEE SURG SPORT TR A, V21, P1737, DOI 10.1007/s00167-012-2148-6
   Jiao YP, 2007, J BIOMED MATER RES A, V80A, P820, DOI 10.1002/jbm.a.31061
   Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18
   Kafienah W, 2007, ARTHRITIS RHEUM, V56, P177, DOI 10.1002/art.22285
   Kretlow JD, 2008, AICHE J, V54, P3048, DOI 10.1002/aic.11610
   Lebourg M, 2010, J MATER SCI-MATER M, V21, P33, DOI 10.1007/s10856-009-3838-6
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Ma K, 2012, ACTA BIOMATER, V8, P3754, DOI 10.1016/j.actbio.2012.06.028
   Magalhaes J, 2013, J BIOMED MATER RES A, V101, P157, DOI 10.1002/jbm.a.34312
   Ni PY, 2011, INT J NANOMED, V6, P3065, DOI 10.2147/IJN.S25297
   Niu XF, 2012, J BIOMAT SCI-POLYM E, V23, P391, DOI 10.1163/092050610X551961
   Noth U, 2008, NAT CLIN PRACT RHEUM, V4, P371, DOI 10.1038/ncprheum0816
   Painter PC, 1997, FUNDAMENTALS POLYM S
   Payne KA, 2010, OSTEOARTHR CARTILAGE, V18, P705, DOI 10.1016/j.joca.2010.01.011
   Ragetly GR, 2010, ACTA BIOMATER, V6, P1430, DOI 10.1016/j.actbio.2009.10.040
   Ragetly GR, 2010, J BIOMED MATER RES A, V93A, P46, DOI 10.1002/jbm.a.32514
   Ringe J, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2572
   Scharstuhl A, 2007, STEM CELLS, V25, P3244, DOI 10.1634/stemcells.2007.0300
   Shen Y, 2014, CURR STEM CELL RES T, V9, P254, DOI 10.2174/1574888X09666140213202700
   Silva JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055451
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   Tanaka T, 2009, J BIOMED MATER RES A, V91A, P428, DOI 10.1002/jbm.a.32253
   Vaghani SS, 2011, DRUG DEV IND PHARM, V37, P1160, DOI 10.3109/03639045.2011.563422
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   VONRECUM HA, 1995, BIOMATERIALS, V16, P441, DOI 10.1016/0142-9612(95)98816-W
   Wu SC, 2010, BIOMATERIALS, V31, P631, DOI 10.1016/j.biomaterials.2009.09.089
   Yang WX, 2013, ACTA BIOMATER, V9, P4505, DOI 10.1016/j.actbio.2012.10.003
   Yang WD, 2006, TISSUE ENG, V12, P2009, DOI 10.1089/ten.2006.12.2009
   Yang Z, 2012, TISSUE ENG PT A, V18, P242, DOI [10.1089/ten.tea.2011.0315, 10.1089/ten.TEA.2011.0315]
   Zhang JJ, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035011
   Zhang LM, 2010, BIOTECHNOL LETT, V32, P1339, DOI 10.1007/s10529-010-0293-x
   Zhang Lijie, 2009, Critical Reviews in Biomedical Engineering, V37, P1
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
NR 59
TC 5
Z9 5
U1 4
U2 26
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB 1
PY 2015
VL 21
IS 3-4
BP 716
EP 728
DI 10.1089/ten.tea.2014.0133
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CB4PZ
UT WOS:000349611600029
PM 25297938
DA 2018-10-19
ER

PT J
AU Bassi, G
   Guilloton, F
   Menard, C
   Di Trapani, M
   Deschaseaux, F
   Sensebe, L
   Schrezenmeier, H
   Giordano, R
   Bourin, P
   Dominici, M
   Tarte, K
   Krampera, M
AF Bassi, Giulio
   Guilloton, Fabien
   Menard, Cedric
   Di Trapani, Mariano
   Deschaseaux, Frederic
   Sensebe, Luc
   Schrezenmeier, Hubert
   Giordano, Rosaria
   Bourin, Philippe
   Dominici, Massimo
   Tarte, Karin
   Krampera, Mauro
TI Effects of a Ceramic Biomaterial on Immune Modulatory Properties and
   Differentiation Potential of Human Mesenchymal Stromal Cells of
   Different Origin
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID BIPHASIC CALCIUM-PHOSPHATE; TISSUE-ENGINEERED BONE; STEM-CELLS;
   OSTEOGENIC DIFFERENTIATION; IMMUNOLOGICAL-PROPERTIES; MOUSE MODEL;
   TNF-ALPHA; T-CELLS; MARROW; GRAFT
AB The aim of this study was to assess the immune modulatory properties of human mesenchymal stromal cells obtained from bone marrow (BM-MSCs), fat (ASCs), and cord blood (CB-MSCs) in the presence of a hydroxyapatite and tricalcium-phosphate (HA/TCP) biomaterial as a scaffold for MSC delivery. In resting conditions, a short-term culture with HA/TCP did not modulate the anti-apoptotic and suppressive features of the various MSC types toward T, B, and NK cells; in addition, when primed with inflammatory cytokines, MSCs similarly increased their suppressive capacities in the presence or absence of HA/TCP. The long-term culture of BM-MSCs with HA/TCP induced an osteoblast-like phenotype with upregulation of OSTERIX and OSTEOCALCIN, similar to what was obtained with dexamethasone and, to a higher extent, with bone morphogenetic protein 4 (BMP-4) treatment. MSC-derived osteoblasts did not trigger immune cell activation, but were less efficient than undifferentiated MSCs in inhibiting stimulated T and NK cells. Interestingly, their suppressive machinery included not only the activation of indoleamine-2,3 dioxygenase (IDO), which plays a central role in T-cell inhibition, but also cyclooxygenase-2 (COX-2) that was not significantly involved in the immune modulatory effect of human undifferentiated MSCs. Since COX-2 is significantly involved in bone healing, its induction by HA/TCP could also contribute to the therapeutic activity of MSCs for bone tissue engineering.
C1 [Bassi, Giulio; Di Trapani, Mariano; Krampera, Mauro] Univ Verona, Sect Hematol, Dept Med, Stem Cell Res Lab, I-37134 Verona, Italy.
   [Guilloton, Fabien; Deschaseaux, Frederic; Sensebe, Luc; Bourin, Philippe] Univ Toulouse 3, EFS Pyrenees Mediterrane, UMR5273, INSERM U1031, F-31062 Toulouse, France.
   [Menard, Cedric; Tarte, Karin] Univ Rennes 1, Fac Med, INSERM U917, EFS Bretagne, F-35043 Rennes, France.
   [Schrezenmeier, Hubert] Univ Ulm, Inst Transfus Med, D-89069 Ulm, Germany.
   [Schrezenmeier, Hubert] German Red Cross Blood Donor Serv Baden Wurttembe, Ulm, Germany.
   [Giordano, Rosaria] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Cell Factory, Milan, Italy.
   [Bourin, Philippe] CSA21, Toulouse, France.
   [Dominici, Massimo] Univ Hosp Modena & Reggio Emilia, Lab Cell Biol & Adv Canc Therapies, Dept Med & Surg Sci Children & Adults, Modena, Italy.
RP Tarte, K (reprint author), Univ Rennes 1, Fac Med, INSERM U917, EFS Bretagne, 2 Ave Pr Leon Bernard, F-35043 Rennes, France.
EM karin.tarte@univ-rennes1.fr; mauro.krampera@univr.it
RI Di Trapani, Mariano/J-9877-2016; Giordano, Rosaria/N-6565-2015
OI Di Trapani, Mariano/0000-0002-3077-8038; Giordano,
   Rosaria/0000-0002-7263-0752; Dominici, Massimo/0000-0002-4007-1503;
   Bourin, Philippe/0000-0002-9652-4380
FU seventh Framework Program of the European Commission: CASCADE
   [FP7-HEALTH-233236]; seventh Framework Program of the European
   Commission: REBORNE "Regenerating bone defects using new biomedical
   approaches" [FP7-HEALTH-241879]; Italian Ministry of University and
   Scientific Research-PRIN; Ricerca Sanitaria Finalizzata; Cariverona
   Foundation, Verona, Italy (Bando); European Center for Transplantation
   Sciences and Immunotherapy (IHU CESTI) [ANR-10-IBHU-0005];
   Infrastructure Program ECELL-FRANCE [ANR-11-INSB-005]; CPER
FX This work was supported by grants from the seventh Framework Program of
   the European Commission: CASCADE (FP7-HEALTH-233236) and REBORNE
   "Regenerating bone defects using new biomedical approaches"
   (FP7-HEALTH-241879) and by grants from the Italian Ministry of
   University and Scientific Research-PRIN 2009; Ricerca Sanitaria
   Finalizzata 2008; Cariverona Foundation, Verona, Italy (Bando 2008 e
   2012); the European Center for Transplantation Sciences and
   Immunotherapy (IHU CESTI, ANR-10-IBHU-0005), the Infrastructure Program
   ECELL-FRANCE (ANR-11-INSB-005), and the CPER 2007-2013 (axe
   Biotherapie). The authors thank Biomatlante for providing customized
   HA/TCP discs. The funders had no role in the study design, data
   collection and analysis, decision to publish, or preparation of this
   article.
CR Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007
   Al-Nbaheen M, 2013, STEM CELL REV REP, V9, P32, DOI 10.1007/s12015-012-9365-8
   Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Atkins GJ, 2009, BIOMATERIALS, V30, P3672, DOI 10.1016/j.biomaterials.2009.03.035
   Audige L, 2005, CLIN ORTHOP RELAT R, P221, DOI 10.1097/01.blo.0000163836.66906.74
   Benvenuto F, 2007, STEM CELLS, V25, P1753, DOI 10.1634/stemcells.2007-0068
   Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228
   Chai YC, 2012, BIOMATERIALS, V33, P3127, DOI 10.1016/j.biomaterials.2012.01.015
   Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1
   Connick P, 2012, LANCET NEUROL, V11, P150, DOI 10.1016/S1474-4422(11)70305-2
   Cordonnier T, 2010, J MATER SCI-MATER M, V21, P981, DOI 10.1007/s10856-009-3916-9
   Cordonnier T., 2010, TISSUE ENG PART C-ME, V17, P249
   Pinheiro CHD, 2012, STEM CELL REV REP, V8, P363, DOI 10.1007/s12015-011-9304-0
   Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   Ding SJ, 2010, TISSUE ENG PT A, V16, P2343, DOI [10.1089/ten.tea.2009.0749, 10.1089/ten.TEA.2009.0749]
   Dupont KM, 2012, CELL TISSUE RES, V347, P575, DOI 10.1007/s00441-011-1197-3
   Dupont KM, 2010, P NATL ACAD SCI USA, V107, P3305, DOI 10.1073/pnas.0905444107
   Eyckmans J, 2013, BIOMATERIALS, V34, P4612, DOI 10.1016/j.biomaterials.2013.03.011
   Fekete N, 2012, CYTOTHERAPY, V14, P540, DOI 10.3109/14653249.2012.655420
   Fellah BH, 2010, J BIOMED MATER RES A, V93A, P1588, DOI 10.1002/jbm.a.32663
   Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584
   Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367
   Gotherstrom C, 2004, AM J OBSTET GYNECOL, V190, P239, DOI 10.1016/j.ajog.2003.07.022
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Huang H, 2011, CELL PROLIFERAT, V44, P420, DOI 10.1111/j.1365-2184.2011.00769.x
   Jegoux F, 2010, ARCH OTOLARYNGOL, V136, P971, DOI 10.1001/archoto.2010.173
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Khan Y, 2008, J BONE JOINT SURG AM, V90A, P36, DOI 10.2106/JBJS.G.01260
   Krampera M, 2013, CYTOTHERAPY, V15, P1054, DOI 10.1016/j.jcyt.2013.02.010
   KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009
   Lang JL, 2013, J IMMUNOL, V190, P2090, DOI 10.4049/jimmunol.1202810
   Lau KHW, 2013, BONE, V53, P369, DOI 10.1016/j.bone.2013.01.003
   Lavenus S, 2011, ACTA BIOMATER, V7, P1525, DOI 10.1016/j.actbio.2010.12.033
   Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3
   LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X
   Lee JS, 2011, BIOMATERIALS, V32, P760, DOI 10.1016/j.biomaterials.2010.09.042
   Lin CL, 2009, J TRAUMA, V67, P1393, DOI 10.1097/TA.0b013e31818c1595
   Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542
   Marini JC, 2012, NEW ENGL J MED, V366, P2522, DOI 10.1056/NEJMcibr1204283
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   Menard C, 2013, STEM CELLS DEV, V22, P1789, DOI 10.1089/scd.2012.0594
   Myeroff C, 2011, J BONE JOINT SURG AM, V93A, P2227, DOI 10.2106/JBJS.J.01513
   Okamoto K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3323
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118
   Roch T, 2012, CLIN HEMORHEOL MICRO, V52, P375, DOI 10.3233/CH-2012-1612
   Schmidt-Bleek K, 2012, CELL TISSUE RES, V347, P567, DOI 10.1007/s00441-011-1205-7
   SKJODT H, 1989, IMMUNOLOGY, V68, P416
   Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062
   Tan JM, 2012, JAMA-J AM MED ASSOC, V307, P1169, DOI 10.1001/jama.2012.316
   Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395
   Vacanti CA, 2001, NEW ENGL J MED, V344, P1511, DOI 10.1056/NEJM200105173442004
   Wang L, 2006, TRANSPLANT P, V38, P2267, DOI 10.1016/j.transproceed.2006.06.048
   Ward WG, 2008, CLIN ORTHOP RELAT R, V466, P1837, DOI 10.1007/s11999-008-0294-4
   Xu JP, 2008, TISSUE ENG PT A, V14, P667, DOI 10.1089/tea.2007.0272
   Zhang ZY, 2012, BIOMATERIALS, V33, P2656, DOI 10.1016/j.biomaterials.2011.12.025
NR 57
TC 9
Z9 9
U1 2
U2 23
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB 1
PY 2015
VL 21
IS 3-4
BP 767
EP 781
DI 10.1089/ten.tea.2014.0269
PG 15
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CB4PZ
UT WOS:000349611600033
PM 25322665
OA Green Published
DA 2018-10-19
ER

PT J
AU Evans, NT
   Torstrick, FB
   Lee, CSD
   Dupont, KM
   Safranski, DL
   Chang, WA
   Macedo, AE
   Lin, ASP
   Boothby, JM
   Whittingslow, DC
   Carson, RA
   Guldberg, RE
   Gall, K
AF Evans, Nathan T.
   Torstrick, F. Brennan
   Lee, Christopher S. D.
   Dupont, Kenneth M.
   Safranski, David L.
   Chang, W. Allen
   Macedo, Annie E.
   Lin, Angela S. P.
   Boothby, Jennifer M.
   Whittingslow, Daniel C.
   Carson, Robert A.
   Guldberg, Robert E.
   Gall, Ken
TI High-strength, surface-porous polyether-ether-ketone for load-bearing
   orthopedic implants
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Polyether-ether-ketone (PEEK); Fatigue; Surface porous; Orthopedic
   implant
ID TREATED POLYETHERETHERKETONE PEEK; FIBER-REINFORCED PEEK; BONE DEFECT
   REPAIR; MECHANICAL-PROPERTIES; BIOMATERIAL SCAFFOLDS; BIOLOGICAL
   RESPONSE; PLASMA; TITANIUM; OSSEOINTEGRATION; ARTHROPLASTY
AB Despite its widespread clinical use in load-bearing orthopedic implants, polyether-ether-ketone (PEEK) is often associated with poor osseointegration. In this study, a surface-porous PEEK material (PEEK-SP) was created using a melt extrusion technique. The porous layer was 399.6 +/- 63.3 lam thick and possessed a mean pore size of 279.9 +/- 31.6 mu m. strut spacing of 186.8 +/- 55.5 mu m, porosity of 67.3 +/- 3.1% and interconnectivity of 99.9 +/- 0.1%. Monotonic tensile tests showed that PEEK-SP preserved 73.9% of the strength (71.06 +/- 2.17 MPa) and 73.4% of the elastic modulus (2.45 +/- 0.31 GPa) of as-received, injection-molded PEEK. PEEK-SP further demonstrated a fatigue strength of 60.0 MPa at one million cycles, preserving 73.4% of the fatigue resistance of injection-molded PEEK. Interfacial shear testing showed the pore layer shear strength to be 23.96 +/- 2.26 MPa. An osseointegration model in the rat revealed substantial bone formation within the pore layer at 6 and 12 weeks via microcomputed tomography and histological evaluation. Ingrown bone was more closely apposed to the pore wall and fibrous tissue growth was reduced in PEEK-SP when compared to non-porous PEEK controls. These results indicate that PEEK-SP could provide improved osseointegration while maintaining the structural integrity necessary for load-bearing orthopedic applications. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Evans, Nathan T.; Gall, Ken] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
   [Torstrick, F. Brennan; Lin, Angela S. P.; Carson, Robert A.; Guldberg, Robert E.; Gall, Ken] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Torstrick, F. Brennan; Lin, Angela S. P.; Guldberg, Robert E.; Gall, Ken] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Lee, Christopher S. D.; Chang, W. Allen] Vertera Inc, Atlanta, GA 30332 USA.
   [Dupont, Kenneth M.; Safranski, David L.] MedShape Inc, Atlanta, GA 30318 USA.
   [Macedo, Annie E.; Boothby, Jennifer M.; Whittingslow, Daniel C.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Macedo, Annie E.; Boothby, Jennifer M.; Whittingslow, Daniel C.] Emory Univ, Atlanta, GA 30332 USA.
RP Evans, NT (reprint author), Georgia Inst Technol, Sch Mat Sci & Engn, 771 Ferst Dr,J Erskine Love Bldg, Atlanta, GA 30332 USA.
EM nevans3@gatech.edu
OI Boothby, Jennifer/0000-0003-3095-0640
FU Solvay Specialty Polymers; National Science Foundation [2013162284];
   National Center for Advancing Translational Sciences of the National
   Institutes of Health [UL1TR000454]
FX This work was supported by Solvay Specialty Polymers. The authors would
   like to thank Katie Poynter and Haley Harris for their assistance in the
   mechanical characterization and Laura Gartner for her assistance
   regarding SEM imaging. N.T.E., D.C.W., D.L.S. and K.G. are inventors of
   the technology disclosed in this manuscript. The technology disclosed in
   this manuscript has been licensed from Georgia Tech Research
   Corporation. N.T.E is supported by the National Science Foundation
   Graduate Research Fellowship under Grant No. 2013162284. F.B.T. is
   supported by the National Center for Advancing Translational Sciences of
   the National Institutes of Health under Award No. UL1TR000454. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health.
CR Abu Bakar MS, 2003, BIOMATERIALS, V24, P2245, DOI 10.1016/S0142-9612(03)00028-0
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   ASPENBERG P, 1992, ACTA ORTHOP SCAND, V63, P141, DOI 10.3109/17453679209154809
   Bakar A, 2003, BIOMATERIALS, V24, P2245
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P291
   Briem D, 2005, J MATER SCI-MATER M, V16, P671, DOI 10.1007/s10856-005-2539-z
   CHEAL EJ, 1992, J ORTHOPAED RES, V10, P405, DOI 10.1002/jor.1100100314
   Converse GL, 2009, J MECH BEHAV BIOMED, V2, P627, DOI 10.1016/j.jmbbm.2009.07.002
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   DiRienzo AL, 2014, J MECH BEHAV BIOMED, V30, P347, DOI 10.1016/j.jmbbm.2013.10.012
   Dupont KM, 2010, P NATL ACAD SCI USA, V107, P3305, DOI 10.1073/pnas.0905444107
   Eshraghi S, 2010, ACTA BIOMATER, V6, P2467, DOI 10.1016/j.actbio.2010.02.002
   Gittens RA, 2014, ACTA BIOMATER
   GOLDSTEIN SA, 1987, J BIOMECH, V20, P1055, DOI 10.1016/0021-9290(87)90023-6
   Gotz HE, 2004, BIOMATERIALS, V25, P4057, DOI 10.1016/j.biomaterials.2003.11.002
   Guldberg RE, 1997, J BIOMECH, V30, P147, DOI 10.1016/S0021-9290(96)00106-6
   Ha SW, 1997, J MATER SCI-MATER M, V8, P683, DOI 10.1023/A:1018535923173
   Ha SW, 1997, SURF COAT TECH, V96, P293, DOI 10.1016/S0257-8972(97)00179-5
   He Q, 2012, PLOS ONE, P7
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   Jarman-Smith M, 2012, PDL HANDB SER, P181, DOI 10.1016/B978-1-4377-4463-7.10012-0
   JOCKISCH KA, 1992, J BIOMED MATER RES, V26, P133, DOI 10.1002/jbm.820260202
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Kurtz SM, 2012, PDL HANDB SER, P1, DOI 10.1016/B978-1-4377-4463-7.10001-6
   Kurtz SM, 2016, PDL HANDB SER, P1, DOI 10.1016/B978-0-12-374721-1.00001-8
   Landy BC, 2013, J APPL BIOMATER FUNC, V11, P35, DOI 10.5301/JABFM.2012.9771
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Meyer U, 2005, Eur Cell Mater, V9, P39
   Muller U, 2006, EUR CELLS MATER, V11, P8, DOI 10.22203/eCM.v011a02
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Nieminen T, 2008, J BIOMED MATER RES A, V84A, P377, DOI 10.1002/jbm.a.31310
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   Pereira HD, 2013, KNEE SURG SPORT TR A, P1
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Poulsson AHC, 2014, BIOMATERIALS, V35, P3717, DOI 10.1016/j.biomaterials.2013.12.056
   Poulsson AHC, 2012, PDL HANDB SER, P145, DOI 10.1016/B978-1-4377-4463-7.10010-7
   Rai B, 2007, J BIOMED MATER RES A, V81A, P888, DOI 10.1002/jbm.a.31142
   Robotti P, 2012, PDL HANDB SER, P119, DOI 10.1016/B978-1-4377-4463-7.10009-0
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   Shenton MJ, 2001, J PHYS D APPL PHYS, V34, P2761, DOI 10.1088/0022-3727/34/18/308
   Shimko DA, 2005, J BIOMED MATER RES B, V73B, P315, DOI 10.1002/jbm.b.30229
   Sinclair SK, 2012, SPINE, V37, pE571, DOI 10.1097/BRS.0b013e318240f981
   Suwanprateeb J, 2006, J BIOMED MATER RES B, V78B, P138, DOI 10.1002/jbm.b.30469
   Van der Stok J, 2013, J ORTHOP RES, V31, P792, DOI 10.1002/jor.22293
   Wang LM, 2013, J BIOMED MATER RES B, V101B, P813, DOI 10.1002/jbm.b.32885
   WILLIAMS DF, 1987, J MATER SCI LETT, V6, P188, DOI 10.1007/BF01728981
   Wojtowicz AM, 2010, BIOMATERIALS, V31, P2574, DOI 10.1016/j.biomaterials.2009.12.008
   Yao C, 2007, INT J NANOMED, V2, P487
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   Zhao Y, 2013, BIOMATERIALS, V34, P9264, DOI 10.1016/j.biomaterials.2013.08.071
   Zhou J, 2010, BIOMATERIALS, V31, P1171, DOI 10.1016/j.biomaterials.2009.10.043
NR 52
TC 30
Z9 31
U1 9
U2 67
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2015
VL 13
BP 159
EP 167
DI 10.1016/j.actbio.2014.11.030
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA2QZ
UT WOS:000348753700016
PM 25463499
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Berdichevski, A
   Shachaf, Y
   Wechsler, R
   Seliktar, D
AF Berdichevski, Alexandra
   Shachaf, Yonatan
   Wechsler, Roni
   Seliktar, Dror
TI Protein composition alters in vivo resorption of PEG-based hydrogels as
   monitored by contrast-enhanced MRI
SO BIOMATERIALS
LA English
DT Article
DE MRI; Contrast agents; Biomaterial scaffold; PEG hydrogel;
   Biodegradation; Implant biocompatibility
ID POLY(ETHYLENE GLYCOL)-BASED HYDROGELS; MACROPHAGE RESPONSE;
   TISSUE-REPAIR; HOST RESPONSE; CELL-CULTURE; GELATIN; DEGRADATION;
   FIBRINOGEN; MATRIX; NANOPARTICLES
AB We report on the use of magnetic resonance imaging (MRI)-based non-invasive monitoring to document the role of protein adjuvants in hydrogel implant integration in vivo. Polyethylene glycol (PEG) hydrogels were formed with different protein constituents, including albumin, fibrinogen and gelatin. The hydrogels were designed to exhibit similar material properties, including modulus, swelling and hydrolytic degradation kinetics. The in vivo resorption properties of these PEG-based hydrogels, which contained a tethered gadolinium contrast agent, were characterized by MRI and histology, and compared to their in vitro characteristics. MRI data revealed that PEG-Albumin implants remained completely intact throughout the experiments, PEG-Fibrinogen implants lost about 10% of their volume and PEG-Gelatin implants underwent prominent swelling and returned to their initial volume by day 25. Fully synthetic PEG-diacrylate (PEG DA) control hydrogels lost about half of their volume after 25 days in vivo. Transverse MRI cross-sections of the implants revealed distinct mechanisms of the hydrogel's biodegradation: PEG-Fibrinogen and PEG-Albumin underwent surface erosion, whereas PEG-Gelatin and PEG-DA hydrogels mainly underwent bulk degradation. Histological findings substantiated the MRI data and demonstrated significant cellular response towards PEG-DA and PEG-Gelatin scaffolds with relatively low reaction towards PEG-Fibrinogen and PEG-Albumin hydrogels. These findings demonstrate that PEG-protein hydrogels can degrade via a different mechanism than PEG-hydrogels, and that this difference can be linked to a reduced foreign body response. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Berdichevski, Alexandra; Seliktar, Dror] Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
   [Shachaf, Yonatan; Wechsler, Roni] Regentis Biomat Ltd, IL-30600 Or Akiva, Israel.
RP Seliktar, D (reprint author), Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
EM dror@bm.technion.ac.il
OI Seliktar, Dror/0000-0001-6964-8567
FU Singapore National Research Foundation (NRF)-Technion-NUS Grant for
   Regenerative Medicine Initiative in Cardiac Restoration Therapy; Lorry
   I. Lokey Interdisciplinary Center for Life Sciences and Engineering;
   Russell Berrie Nanotechnology Institute; EC-IP FP7 [262948-2]
FX This work was supported by the Singapore National Research Foundation
   (NRF)-Technion-NUS Grant for Regenerative Medicine Initiative in Cardiac
   Restoration Therapy, the Lorry I. Lokey Interdisciplinary Center for
   Life Sciences and Engineering, Russell Berrie Nanotechnology Institute,
   as well as by EC-IP FP7 grant Biodesign (262948-2). We thank the
   Preclinical Research Authority and the Imaging & Microscopy Center at
   the Bruce Rappaport Faculty of Medicine, Technion, Israel for their help
   and technical support. The authors thank Shlomit Cohen and Dr. Offra
   Sang-Nadir for their help with establishing the IHC staining of
   PEG-based implants.
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   AMIJI M, 1992, J BIOMAT SCI-POLYM E, V3, P375, DOI 10.1163/156856292X00196
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x
   Censi R, 2012, J CONTROL RELEASE, V161, P680, DOI 10.1016/j.jconrel.2012.03.002
   Chen JS, 2002, J MATER SCI-MATER M, V13, P1029, DOI 10.1023/A:1020380203499
   Cheng TL, 2005, BIOCONJUGATE CHEM, V16, P1225, DOI 10.1021/bc050133f
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Dumin JA, 2001, PROCOLLAGENASE 1 MAT
   Frisman I, 2010, J MATER SCI-MATER M, V21, P73, DOI 10.1007/s10856-009-3848-4
   Fu Y, 2012, BIOMATERIALS, V33, P48, DOI 10.1016/j.biomaterials.2011.09.031
   Ge YB, 2011, YAKUGAKU ZASSHI, V131, P1807, DOI 10.1248/yakushi.131.1807
   Gonen-Wadmany M, 2011, BIOMATERIALS, V32, P6025, DOI 10.1016/j.biomaterials.2011.04.055
   Gornall JL, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.031908
   Graves KL, 1996, AM J PHYSIOL-LUNG C, V271, pL61
   Hillel AT, 2011, SCI TRANSL MED, V3, P93
   JANUSZ MJ, 1993, J IMMUNOL, V150, P1922
   Johnstone SA, 2001, BBA-BIOMEMBRANES, V1513, P25, DOI 10.1016/S0005-2736(01)00292-9
   Killer M, 2011, NEURORADIOLOGY, V53, P449, DOI 10.1007/s00234-010-0744-z
   KimberleePotter BJB, 1994, CARBOHYD RES, V257, P117
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kopecek J, 1974, Polim Med, V4, P109
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Labow RS, 2005, BIOMATERIALS, V26, P7357, DOI 10.1016/j.biomaterials.2005.05.048
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Liu L, MACROMOLECULAR RAPID, V25, P1197
   Ludwig T, 2005, BIOESSAYS, V27, P1181, DOI 10.1002/bies.20306
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Lynn AD, 2011, J BIOMED MATER RES A, V96A, P621, DOI 10.1002/jbm.a.33015
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110
   Miyawaki O, 2003, BIOPOLYMERS, V70, P482, DOI 10.1002/bip.10473
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Nicodemus GD, 2009, BIOTECHNOL BIOENG, V102, P948, DOI 10.1002/bit.22105
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Reid B, 2013, J TISSUE ENG REGEN M
   Richardson JC, 2005, ADV DRUG DELIVER REV, V57, P1191, DOI 10.1016/j.addr.2005.01.024
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shachaf Y, 2014, J TISSUE ENG REGEN M, V8, P113
   Shapira-Schweitzer K, 2009, J MOL CELL CARDIOL, V46, P213, DOI 10.1016/j.yjmcc.2008.10.018
   Shen F, 2003, BIOTECHNOL BIOENG, V83, P282, DOI 10.1002/bit.10674
   Shuhendler AJ, 2012, J CONTROL RELEASE, V157, P478, DOI 10.1016/j.jconrel.2011.09.061
   Simms HH, 1997, ANN SURG, V225, P757, DOI 10.1097/00000658-199706000-00013
   Simms HH, 1997, ANN SURG, V225, P63
   Skarja GA, 1998, BIOMATERIALS, V19, P2129, DOI 10.1016/S0142-9612(98)00045-3
   Stevens KR, 2002, J BIOMAT SCI-POLYM E, V13, P1353, DOI 10.1163/15685620260449741
   Swartzlander MD, 2013, BIOMATERIALS, V34, P952, DOI 10.1016/j.biomaterials.2012.10.037
   Sweryda-Krawiec B, 2004, LANGMUIR, V20, P2054, DOI 10.1021/la034870g
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d
   Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546
   van Putten SM, 2011, J BIOMED MATER RES A, V98A, P527, DOI 10.1002/jbm.a.33144
   Xu KD, 2013, ACTA BIOMATER, V9, P8802, DOI 10.1016/j.actbio.2013.06.021
   Xu KD, 2012, ACTA BIOMATER, V8, P2504, DOI 10.1016/j.actbio.2012.03.049
   Yallapu MM, 2010, PHARM RES-DORDR, V27, P2283, DOI 10.1007/s11095-010-0260-1
NR 56
TC 13
Z9 13
U1 3
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2015
VL 42
BP 1
EP 10
DI 10.1016/j.biomaterials.2014.11.015
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA4OH
UT WOS:000348883700001
PM 25542788
DA 2018-10-19
ER

PT J
AU Pirvu, T
   Blanquer, SBG
   Benneker, LM
   Grijpma, DW
   Richards, RG
   Alini, M
   Eglin, D
   Grad, S
   Li, Z
AF Pirvu, Tatiana
   Blanquer, Sebastien B. G.
   Benneker, Lorin M.
   Grijpma, Dirk W.
   Richards, Robert G.
   Alini, Mauro
   Eglin, David
   Grad, Sibylle
   Li, Zhen
TI A combined biomaterial and cellular approach for annulus fibrosus
   rupture repair
SO BIOMATERIALS
LA English
DT Article
DE Annulus fibrosus rupture repair; Poly(trimethylene carbonate) scaffold;
   Poly(esterurethane) membrane; Mesenchymal stromal cells; Implantation
ID INTERVERTEBRAL DISC CELLS; MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX;
   LUMBAR DISKECTOMY; ANULAR REPAIR; SCAFFOLDS; REGENERATION;
   DIFFERENTIATION; DEGENERATION; HERNIATION
AB Recurrent intervertebral disc (IVD) herniation and degenerative disc disease have been identified as the most important factors contributing to persistent pain and disability after surgical discectomy. An annulus fibrosus (AF) closure device that provides immediate closure of the AF rupture, restores disc height, reduces further disc degeneration and enhances self-repair capacities is an unmet clinical need. In this study, a poly(trimethylene carbonate) (PTMC) scaffold seeded with human bone marrow derived mesenchymal stromal cells (MSCs) and covered with a poly(ester-urethane) (PU) membrane was assessed for AF rupture repair in a bovine organ culture annulotomy model under dynamic load for 14 days. PTMC scaffolds combined with the sutured PU membrane restored disc height of annulotomized discs and prevented herniation of nucleus pulposus (NP) tissue. Implanted MSCs showed an up-regulated gene expression of type V collagen, a potential AF marker, indicating in situ differentiation capability. Furthermore, MSCs delivered within PTMC scaffolds induced an up-regulation of anabolic gene expression and down-regulation of catabolic gene expression in adjacent native disc tissue. In conclusion, the combined biomaterial and cellular approach has the potential to hinder herniation of NP tissue, stabilize disc height, and positively modulate cell phenotype of native disc tissue. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Pirvu, Tatiana; Richards, Robert G.; Alini, Mauro; Eglin, David; Grad, Sibylle; Li, Zhen] AO Res Inst Davos, CH-7270 Davos, Switzerland.
   [Blanquer, Sebastien B. G.; Grijpma, Dirk W.] Univ Twente, Dept Biomat Sci & Technol, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands.
   [Benneker, Lorin M.] Univ Bern, Dept Orthopaed Surg, CH-3010 Bern, Switzerland.
   [Grijpma, Dirk W.] Univ Groningen, Univ Med Ctr Groningen, WJ Kolff Inst, Dept Biomed Engn, NL-9700 AD Groningen, Netherlands.
   [Pirvu, Tatiana; Blanquer, Sebastien B. G.; Benneker, Lorin M.; Grijpma, Dirk W.; Richards, Robert G.; Alini, Mauro; Eglin, David; Grad, Sibylle; Li, Zhen] AO Fdn, Collaborat Res Partner Annulus Fibrosus Repair Pr, CH-7270 Davos, Switzerland.
RP Li, Z (reprint author), AO Res Inst Davos, Clavadelerstr 8, CH-7270 Davos, Switzerland.
EM zhen.li@aofoundation.org
RI Richards, Robert/I-8235-2015
OI Richards, Robert/0000-0002-7778-2480; Li, Zhen/0000-0002-9754-6389
FU Annulus Fibrosus Repair Collaborative Research Programme from AO
   Foundation
FX This study is funded by the Annulus Fibrosus Repair Collaborative
   Research Programme from AO Foundation. We thank Markus Glarner for his
   help with the poly(ester-urethane) synthesis, and Xu Chen for his help
   with the OHP assay. Fibrin components were kindly provided by Baxter
   Biosurgery, Vienna.
CR Ahlgren BD, 2000, SPINE, V25, P2165, DOI 10.1097/00007632-200009010-00004
   Asch HL, 2002, J NEUROSURG, V96, P34, DOI 10.3171/spi.2002.96.1.0034
   Bailey A, 2013, SPINE, V38, P1161, DOI 10.1097/BRS.0b013e31828b2e2f
   Blanquer SBG, 2013, MACROMOL SYMP, V334, P75, DOI 10.1002/masy.201300102
   Bron J, 2009, EUR SPINE J, V18, P301, DOI 10.1007/s00586-008-0856-x
   Carragee EJ, 2003, J BONE JOINT SURG AM, V85A, P102, DOI 10.2106/00004623-200301000-00016
   Chang G, 2010, J BIOMED MATER RES A, V92A, P43, DOI 10.1002/jbm.a.32326
   Chiang CJ, 2011, SPINE, V36, P761, DOI 10.1097/BRS.0b013e3181e08f01
   Clouet J, 2009, RHEUMATOLOGY, V48, P1447, DOI 10.1093/rheumatology/kep262
   Driscoll TP, 2013, J ORTHOP RES, V31, P864, DOI 10.1002/jor.22312
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Gilbert HTJ, 2010, ARTHRITIS RHEUM-US, V62, P3385, DOI 10.1002/art.27643
   Gorna K, 2006, J BIOMED MATER RES A, V79A, P128, DOI 10.1002/jbm.a.30708
   Gruber HE, 2009, SPINE, V34, P4, DOI 10.1097/BRS.0b013e31818f8c02
   Grunert P, 2014, SPINE, V39, P198, DOI 10.1097/BRS.0000000000000103
   Guterl CC, 2014, TISSUE ENG A
   Guterl CC, 2013, EUR CELLS MATER, V25, P1
   Heuer F, 2008, J NEUROSURG-SPINE, V9, P307, DOI 10.3171/SPI/2008/9/9/307
   Illien-Junger S, 2010, SPINE, V35, P1744, DOI 10.1097/BRS.0b013e3181c48019
   Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   Le Visage C, 2006, SPINE, V31, P2036, DOI 10.1097/01.brs.0000231442.05245.87
   Lee CR, 2005, TISSUE ENG, V11, P1562, DOI 10.1089/ten.2005.11.1562
   Lee CR, 2007, EUR SPINE J, V16, P2174, DOI 10.1007/s00586-007-0475-y
   Li Z, 2014, REGEN MED, V9, P309, DOI [10.2217/RME.14.5, 10.2217/rme.14.5]
   Li Z, 2010, J CELL MOL MED, V14, P1338, DOI 10.1111/j.1582-4934.2009.00780.x
   Liebscher T, 2011, SPINE, V36, P153, DOI 10.1097/BRS.0b013e3181cd588c
   McGirt MJ, 2009, SPINE, V34, P2044, DOI 10.1097/BRS.0b013e3181b34a9a
   Nerurkar NL, 2011, BIOMATERIALS, V32, P461, DOI 10.1016/j.biomaterials.2010.09.015
   Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]
   Nesti LJ, 2008, TISSUE ENG PT A, V14, P1527, DOI 10.1089/ten.tea.2008.0215
   Pattappa G, 2012, J ANAT, V221, P480, DOI 10.1111/j.1469-7580.2012.01521.x
   Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147
   Richardson SM, 2006, STEM CELLS, V24, P707, DOI 10.1634/stemcells.2005-0205
   Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1
   See EYS, 2011, SPINE, V36, P1744, DOI 10.1097/BRS.0b013e31821986b3
   Sharifi S, 2014, J TISSUE ENG REGEN M
   Strassburg S, 2010, REGEN MED, V5, P701, DOI 10.2217/RME.10.59
   Weber H, 1994, SPINE, V19, P2233
   Wilke HJ, 2013, SPINE, V38, pE587, DOI 10.1097/BRS.0b013e31828ca4bc
   Wismer N, 2014, TISSUE ENG PT A, V20, P672, DOI 10.1089/ten.TEA.2012.0679
NR 41
TC 26
Z9 27
U1 5
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2015
VL 42
BP 11
EP 19
DI 10.1016/j.biomaterials.2014.11.049
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA4OH
UT WOS:000348883700002
PM 25542789
DA 2018-10-19
ER

PT J
AU Svensson, S
   Trobos, M
   Hoffman, M
   Norlindh, B
   Petronis, S
   Lausmaa, J
   Suska, F
   Thomsen, P
AF Svensson, Sara
   Trobos, Margarita
   Hoffman, Maria
   Norlindh, Birgitta
   Petronis, Sarunas
   Lausmaa, Jukka
   Suska, Felicia
   Thomsen, Peter
TI A novel soft tissue model for biomaterial-associated infection and
   inflammation - Bacteriological, morphological and molecular observations
SO BIOMATERIALS
LA English
DT Article
DE Animal model; Bacteria; Infection; Inflammation; Nanotopography
ID VIVO CELLULAR INTERACTIONS; PERI-IMPLANT TISSUE; KAPPA-B ACTIVATION;
   STAPHYLOCOCCUS-EPIDERMIDIS; NEUTROPHIL ELASTASE; ANODIZED TITANIUM;
   BIOFILM FORMATION; OPERATING-ROOM; COPPER; SURFACES
AB Infection constitutes a major risk for implant failure, but the reasons why biomaterial sites are more vulnerable than normal tissue are not fully elucidated. In this study, a soft tissue infection model was developed, allowing the analysis of cellular and molecular responses in each of the sub-compartments of the implant-tissue interface (on the implant surface, in the surrounding exudate and in the tissue). Smooth and nanostructured titanium disks with or without noble metal chemistry (silver, gold, palladium), and sham sites, were inoculated with Staphylococcus epidermidis and analysed with respect to number of viable bacteria, number, viability and gene expression of host cells, and using different morphological techniques after 4 h, 24 h and 72 h. Non-infected rats were controls. Results showed a transient inflammatory response at control sites, whereas bacterial administration resulted in higher recruitment of inflammatory cells (mainly polymorphonuclear), higher, continuous cell death and higher gene expression of tumour necrosis factor-alpha, interleukin-6, interleukin-8, Toll-like receptor 2 and elastase. At all time points, S. epidermidis was predominantly located in the interface zone, extra- and intracellularly, and lower levels were detected on the implants compared with surrounding exudate. This model allows detailed analysis of early events in inflammation and infection associated to biomaterials in vivo leading to insights into host defence mechanisms in biomaterial-associated infections. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Svensson, Sara; Trobos, Margarita; Hoffman, Maria; Norlindh, Birgitta; Petronis, Sarunas; Lausmaa, Jukka; Suska, Felicia; Thomsen, Peter] BIOMATCELL VINN Excellence Ctr Biomat & Cell Ther, S-40530 Gothenburg, Sweden.
   [Svensson, Sara; Trobos, Margarita; Hoffman, Maria; Norlindh, Birgitta; Suska, Felicia; Thomsen, Peter] Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, S-40530 Gothenburg, Sweden.
   [Petronis, Sarunas; Lausmaa, Jukka] SP Tech Res Inst Sweden, S-50115 Boras, Sweden.
RP Thomsen, P (reprint author), Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, Box 412, S-40530 Gothenburg, Sweden.
EM peter.thomsen@biomaterials.gu.se
OI Thomsen, Peter/0000-0003-3910-6665
FU BIOMATCELL Vinn Excellence Center of Biomaterials and Cell Therapy;
   VINNOVA; Vastra Gotaland Region; Swedish Research Council
   [K2012-52X-09495-25-3]; Hjalmar Svensson Foundation; IngaBritt and Arne
   Lundberg Foundation; Felix Neubergh Foundation
FX The authors would like to acknowledge Dr Hossein Agheli for help with
   AFM measurements and Billy Sodervall and Bactiguard AB for performing
   the noble metal coating of the surfaces and scientific discussion.
   Financial support was obtained from the BIOMATCELL Vinn Excellence
   Center of Biomaterials and Cell Therapy, supported by VINNOVA and the
   Vastra Gotaland Region, the Swedish Research Council (grant
   K2012-52X-09495-25-3), the Hjalmar Svensson Foundation, the IngaBritt
   and Arne Lundberg Foundation and the Felix Neubergh Foundation.
CR Ainslie KM, 2009, J BIOMED MATER RES A, V91A, P647, DOI 10.1002/jbm.a.32262
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185
   Broekhuizen CAN, 2010, INFECT IMMUN, V78, P954, DOI 10.1128/IAI.00849-09
   Broekhuizen CAN, 2007, INFECT IMMUN, V75, P1129, DOI 10.1128/IAI.01262-06
   Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2
   Busscher HJ, 2012, SCI TRANSL MED, V4, P1
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Cheung GYC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001133
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   ERIKSSON AS, 1994, J MATER SCI-MATER M, V5, P269, DOI 10.1007/BF00122396
   FITZGERALD RH, 1979, ARCH SURG-CHICAGO, V114, P772
   Garcia-Garcia E, 2001, J LEUKOCYTE BIOL, V70, P649
   Grainger DW, 2013, BIOMATERIALS, V34, P9237, DOI 10.1016/j.biomaterials.2013.08.043
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   Hughes SPF, 1999, J BONE JOINT SURG BR, V81B, P754, DOI 10.1302/0301-620X.81B5.10370
   Lausmaa J, 2001, TITANIUM MED MAT SCI
   Lederer JW, 2014, J WOUND OSTOMY CONT, V41, P473, DOI 10.1097/WON.0000000000000056
   Lee S, 2011, ACTA BIOMATER, V7, P2337, DOI 10.1016/j.actbio.2011.01.006
   Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08
   Otto M, 2012, SEMIN IMMUNOPATHOL, V34, P201, DOI 10.1007/s00281-011-0296-2
   Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182
   Ozturan KE, 2010, J ORTHOP RES, V28, P1368, DOI 10.1002/jor.21159
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Rajyalakshmi A, 2011, INT J NANOMED, V6, P1765, DOI 10.2147/IJN.S22763
   Riool M, 2014, ACTA BIOMATER, V10, P5202, DOI 10.1016/j.actbio.2014.08.012
   ROSENGREN A, 1994, BIOMATERIALS, V15, P17, DOI 10.1016/0142-9612(94)90190-2
   Russo TA, 2008, INFECT IMMUN, V76, P3577, DOI 10.1128/IAI.00269-08
   SCHAAD HJ, 1994, J ANTIMICROB CHEMOTH, V33, P1191, DOI 10.1093/jac/33.6.1191
   Schumm K, 2009, COCHRANE SYST REV, V1
   Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406
   Shi ZL, 2008, J BIOMED MATER RES A, V86A, P865, DOI 10.1002/jbm.a.31648
   Subbiahdoss G, 2010, MICROBIOL-SGM, V156, P3073, DOI 10.1099/mic.0.040378-0
   Subbiandoss G, 2011, PLOS ONE, V6
   Suska F, 2003, BIOMATERIALS, V24, P461, DOI 10.1016/S0142-9612(02)00359-9
   Suska F, 2001, J MATER SCI-MATER M, V12, P939, DOI 10.1023/A:1012844612753
   Suska F, 2005, BIOMATERIALS, V26, P519, DOI 10.1016/j.biomaterials.2004.02.066
   Suska F, 2008, J BIOMED MATER RES A, V85A, P888, DOI 10.1002/jbm.a.31575
   Suska F, 2010, J BIOMED MATER RES B, V92B, P86, DOI 10.1002/jbm.b.31492
   Svensson S, 2014, INT J NANOMED, V9, P775, DOI 10.2147/IJN.S51465
   Svensson S, 2013, NANOMED-NANOTECHNOL, V9, P1048, DOI 10.1016/j.nano.2013.04.009
   TAKAHASHI H, 1988, J BIOL CHEM, V263, P14739
   Tillander J, 2010, CLIN ORTHOP RELAT R, V468, P2781, DOI 10.1007/s11999-010-1370-0
   Verdrengh M, 1997, INFECT IMMUN, V65, P2517
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Yao C, 2008, J BIOMED MATER RES A, V85A, P157, DOI 10.1002/jbm.a.31551
   Yilmaz C, 2013, J BONE JOINT SURG AM, V95A, P117, DOI 10.2106/JBJS.K.01135
NR 49
TC 10
Z9 10
U1 2
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2015
VL 41
BP 106
EP 121
DI 10.1016/j.biomaterials.2014.11.032
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA6XY
UT WOS:000349062100011
PM 25522970
DA 2018-10-19
ER

PT J
AU Choi, JS
   Lee, S
   Kim, DY
   Kim, YM
   Kim, MS
   Lim, JY
AF Choi, Jeong-Seok
   Lee, Songyi
   Kim, Da Yeon
   Kim, Young-Mo
   Kim, Moon Suk
   Lim, Jae-Yol
TI Functional remodeling after vocal fold injury by small intestinal
   submucosa gel containing hepatocyte growth factor
SO BIOMATERIALS
LA English
DT Article
DE Hepatocyte growth factor; Vocal folds; Wound healing; Extracellular
   matrix; Biomimetic materials
ID BOVINE ACELLULAR SCAFFOLD; MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX;
   DELIVERY-SYSTEM; LARYNGEAL INJECTION; BIOLOGIC SCAFFOLD; CANINE MODEL;
   RELEASE; FIBROBLASTS; RECONSTRUCTION
AB A biomaterial derived from porcine small intestinal submucosa (SIS) was used in smart drug delivery and tissue remodeling. SIS suspensions were easily formulated by simple mixing with the drug of choice and formed an in situ gel upon injection into tissues, enabling them to act as protein drug depots. This study was conducted to determine whether functional remodeling of an injured vocal fold (VF) could be achieved by hepatocyte growth factor (HGF)-containing SIS in situ-forming gel after VF injury in a rabbit model. To accomplish this, we loaded HGF in SIS suspensions and observed a gradual, sustained release of HGF for at least 21 days in vitro. Evaluation of the in vivo efficacy demonstrated that the HGF and HGF-loaded SIS treated VFs showed improved mucosal healing when compared with the PBS-injected VFs. Histopathological evaluations revealed that treatment with the HGF/SIS group alone successfully ameliorated the deposition of type I collagen and increased synthesis of hyaluronic acids relative to the PBS group at three months post-injury. Functional analyses showed that the HGF/SIS group prevented deterioration of mucosal vibration and induced significant improvement in the mean viscoelastic modulus, but that other groups failed to achieve functional rescue of VF biomechanics. Additionally, the VF oscillation in the HGF/SIS group was superior to that in the HGF group. The results of this study suggest that SIS in situ gel has the potential for use as an HGF delivery carrier for enhancement of wound (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Choi, Jeong-Seok; Lee, Songyi; Kim, Young-Mo; Lim, Jae-Yol] Dept Otorhinolaryngol Head & Neck Surg, Songnam, South Korea.
   [Choi, Jeong-Seok; Lee, Songyi; Kim, Young-Mo; Lim, Jae-Yol] Inha Univ, Sch Med, Translat Res Ctr, Inchon 400711, South Korea.
   [Kim, Da Yeon; Kim, Moon Suk] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.
RP Lim, JY (reprint author), Inha Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, 27 Inhang Ro, Inchon 400711, South Korea.
EM jylim@inha.ac.kr
FU Basic Science Research Program of the National Research Foundation -
   Korean Ministry of Education, Science and Technology
   [NRF-2013R1A2A2A04014200]; Inha University Research Grant
FX This research was supported by the Basic Science Research Program of the
   National Research Foundation (NRF-2013R1A2A2A04014200) funded by the
   Korean Ministry of Education, Science and Technology and an Inha
   University Research Grant.
CR Andree B, 2013, TISSUE ENG PART B-RE, V19, P279, DOI [10.1089/ten.teb.2012.0583, 10.1089/ten.TEB.2012.0583]
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Benninger MS, 1996, OTOLARYNG HEAD NECK, V115, P474, DOI 10.1016/S0194-5998(96)70087-6
   Choi JW, 2014, BIOMATERIALS, V35, P4911, DOI 10.1016/j.biomaterials.2014.03.008
   Choi JS, 2012, OTOLARYNG HEAD NECK, V147, P515, DOI 10.1177/0194599812446913
   Gilbert TW, 2009, LARYNGOSCOPE, V119, P1856, DOI 10.1002/lary.20575
   Hirano S, 2004, LARYNGOSCOPE, V114, P548, DOI 10.1097/00005537-200403000-00030
   Hirano S, 2003, LARYNGOSCOPE, V113, P144, DOI 10.1097/00005537-200301000-00027
   Hirano S, 2002, ANN OTO RHINOL LARYN, V111, P661, DOI 10.1177/000348940211100801
   Kang KN, 2011, INT J PHARMACEUT, V420, P266, DOI 10.1016/j.ijpharm.2011.08.047
   Kim YM, 2014, LARYNGOSCOPE, V124, pE64, DOI 10.1002/lary.24405
   Kim YM, 2013, ANN OTO RHINOL LARYN, V122, P121, DOI 10.1177/000348941312200208
   Kishimoto Y, 2010, LARYNGOSCOPE, V120, P108, DOI 10.1002/lary.20642
   Kishimoto Y, 2009, ANN OTO RHINOL LARYN, V118, P606, DOI 10.1177/000348940911800813
   Kolachala VL, 2011, LARYNGOSCOPE, V121, P1237, DOI 10.1002/lary.21796
   Kolachala VL, 2010, LARYNGOSCOPE, V120, P988, DOI 10.1002/lary.20856
   Kutty JK, 2009, TISSUE ENG PART B-RE, V15, P249, DOI 10.1089/ten.TEB.2008.0588
   Lim JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054256
   Long JL, 2010, CURR OPIN OTOLARYNGO, V18, P521, DOI 10.1097/MOO.0b013e32833febf2
   Luo Y, 2006, TISSUE ENG, V12, P3365, DOI 10.1089/ten.2006.12.3365
   Maytag AL, 2013, J VOICE, V27, P24, DOI 10.1016/j.jvoice.2012.08.004
   Mizuno S, 1998, J CLIN INVEST, V101, P1827, DOI 10.1172/JCI1709
   Mizuta M, 2014, LARYNGOSCOPE, V124, P2131, DOI 10.1002/lary.24690
   Moreno E, 2005, TRANSPLANT P, V37, P3943, DOI 10.1016/j.transproceed.2005.10.089
   Ohno T, 2007, ANN OTO RHINOL LARYN, V116, P762, DOI 10.1177/000348940711601008
   Ueki T, 1999, NAT MED, V5, P226
   Xu CC, 2010, J BIOMED MATER RES A, V93A, P1335, DOI 10.1002/jbm.a.32632
   Xu CC, 2010, J BIOMED MATER RES A, V92A, P18, DOI 10.1002/jbm.a.32279
NR 28
TC 15
Z9 16
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2015
VL 40
BP 98
EP 106
DI 10.1016/j.biomaterials.2014.11.028
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA5QW
UT WOS:000348963900011
PM 25433606
DA 2018-10-19
ER

PT J
AU Zhang, LH
   Wu, XJ
   Hu, Y
   Wang, XH
   He, ZH
   Xie, YT
   Pan, KF
   Wang, N
   Dong, ZH
   Zhang, L
   Ji, JF
AF Zhang, Lianhai
   Wu, Xiaojiang
   Hu, Ying
   Wang, Xiaohong
   He, Zhonghu
   Xie, Yuntao
   Pan, Kaifeng
   Wang, Ning
   Dong, Zhihua
   Zhang, Lei
   Ji, Jiafu
TI Establishment of a Network-Based Intra-Hospital Virtual Cancer Biobank
SO BIOPRESERVATION AND BIOBANKING
LA English
DT Article
ID SAMPLE PREANALYTICAL CODE; STANDARD; CHINA
AB There is a growing interest in integrating biomaterial repositories into larger infrastructures in order to meet research demands. However, even for a single hospital or institute, where both population-based and multiple disease-based biobanks have existed for a long time, the integration of existing separate biobanks into a virtual cancer biobank is still challenging. The guidelines and procedures for biobanking are varied and not universally enforced or followed in separate biobanks. Within the last 2 years, we initiated a project to establish a centralized biobank facility in a common storage environment. Analyzing the challenges and interests of stakeholders for the biobanks, a working group comprised of representatives from the central and separate banks, ethic committees, and research administration offices reached an agreement to implement a central facility by following the ISBER best practices for biobanking, and including regular project reviews by the ethical and scientific boards. Furthermore, by implementing a modified minimum information system with biobank data sharing, a network based intra-hospital virtual cancer bank was established to facilitate sharing information of samples held by separate banks. Meanwhile, this virtual biobank network, which has integrated patient information from hospital health care systems, will gradually integrate follow-up information from the cancer registry office and data from epidemiology studies, providing controlled access for sample providers and resource users. In the future, this infrastructure designed for a single hospital may be helpful for building a broader virtual network for data and specimen exchanges.
C1 [Zhang, Lianhai; Hu, Ying; Wang, Xiaohong; Ji, Jiafu] Peking Univ, Canc Biobank, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China.
   [Zhang, Lianhai; Wu, Xiaojiang; Ji, Jiafu] Peking Univ, Dept Surg, Canc Hosp & Inst, Beijing 100142, Peoples R China.
   [He, Zhonghu] Peking Univ, Dept Genet, Canc Hosp & Inst, Beijing 100142, Peoples R China.
   [Xie, Yuntao] Peking Univ, Dept Breast Canc, Canc Hosp & Inst, Beijing 100142, Peoples R China.
   [Pan, Kaifeng] Peking Univ, Dept Epidemiol, Canc Hosp & Inst, Beijing 100142, Peoples R China.
   [Zhang, Lianhai] Peking Univ, Res Adm Off, Canc Hosp & Inst, Beijing 100142, Peoples R China.
   [Wu, Xiaojiang] Peking Univ, Eth Comm, Canc Hosp & Inst, Beijing 100142, Peoples R China.
   [Wang, Ning] Peking Univ, Beijing Off Canc Prevent & Control, Canc Hosp & Inst, Beijing 100142, Peoples R China.
   [Dong, Zhihua; Zhang, Lei] Goodwill Informat Technol Co Ltd, Beijing, Peoples R China.
RP Ji, JF (reprint author), Peking Univ, Dept Surg, Canc Hosp & Inst, 52 Fucheng Rd, Beijing 100142, Peoples R China.
EM jiafuj@gmail.com
OI JI, JIAFU/0000-0001-6878-5543
FU National Key Technology RD Program [2012AA02A203-B01, 2012AA02A504-B01,
   2012AA020101, 2015ZX09307-001]; Beijing Municipal Science & Technology
   Commission [Z121100007512010, D131100005313010]
FX The authors declare the following competing financial interests: LZ and
   ZD are employees of Goodwill Information Technology Co. Ltd. This study
   is partially supported by National Key Technology R&D Program
   (2012AA02A203-B01, 2012AA02A504-B01, 2012AA020101, 2015ZX09307-001) and
   Beijing Municipal Science & Technology Commission (Z121100007512010,
   D131100005313010).
CR [Anonymous], 2012, BIOPRESERV BIOBANK, V10, P79
   Betsou F, 2010, CANCER EPIDEM BIOMAR, V19, P1004, DOI 10.1158/1055-9965.EPI-09-1268
   Bjugn R, 2012, BIOPRESERV BIOBANK, V10, P239, DOI 10.1089/bio.2011.0047
   Chen HD, 2013, BIOPRESERV BIOBANK, V11, P267, DOI 10.1089/bio.2013.0016
   De Souza YG, 2013, AIDS, V27, P303, DOI 10.1097/QAD.0b013e32835c1244
   Gottweis H, 2012, J COMMUN GENET, V3, P61, DOI 10.1007/s12687-011-0070-0
   Harris JR, 2012, EUR J HUM GENET, V20, P1105, DOI 10.1038/ejhg.2012.96
   Ji X, 2014, BIOMED ENVIRON SCI, V27, P481, DOI 10.3967/bes2014.079
   Lehmann S, 2012, BIOPRESERV BIOBANK, V10, P366, DOI 10.1089/bio.2012.0012
   Liu M, 2014, BIOETHICS, V28, P181, DOI 10.1111/j.1467-8519.2012.01985.x
   Mitchell R, 2010, SCI TECHNOL HUM VAL, V35, P330, DOI 10.1177/0162243909340267
   Myles Renate, 2011, Journal of the National Cancer Institute Monographs, P16, DOI 10.1093/jncimonographs/lgr008
   Norlin L, 2012, BIOPRESERV BIOBANK, V10, P343, DOI 10.1089/bio.2012.0003
   Nussbeck SY, 2014, BIOPRESERV BIOBANK, V12, P199, DOI 10.1089/bio.2013.0085
   Quinlan PR, 2014, BIOPRESERV BIOBANK, V12, P184, DOI 10.1089/bio.2013.0089
NR 15
TC 0
Z9 1
U1 1
U2 9
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1947-5535
EI 1947-5543
J9 BIOPRESERV BIOBANK
JI Biopreserv. Biobank.
PD FEB 1
PY 2015
VL 13
IS 1
SI SI
BP 43
EP 48
DI 10.1089/bio.2014.0086
PG 6
WC Cell Biology; Chemistry, Applied; Medical Laboratory Technology
SC Cell Biology; Chemistry; Medical Laboratory Technology
GA CB1PF
UT WOS:000349399300010
PM 25686047
DA 2018-10-19
ER

PT J
AU Felden, A
   Vaz, G
   Kreps, S
   Anract, P
   Hamadouche, M
   Biau, DJ
AF Felden, A.
   Vaz, G.
   Kreps, S.
   Anract, P.
   Hamadouche, M.
   Biau, D. J.
TI A cemented acetabular component with a reinforcement cross provides
   excellent medium-term fixation in total hip arthroplasty after pelvic
   irradiation
SO BONE & JOINT JOURNAL
LA English
DT Article
ID POROUS TANTALUM BIOMATERIAL; URINARY-TRACT INFECTION; RADIATION-THERAPY;
   COMPETING RISKS; BONE; FAILURE; RADIOTHERAPY; COMPLICATIONS;
   MALIGNANCIES; REPLACEMENT
AB Conventional cemented acetabular components are reported to have a high rate of failure when implanted into previously irradiated bone. We recommend the use of a cemented reconstruction with the addition of an acetabular reinforcement cross to improve fixation.
   We reviewed a cohort of 45 patients (49 hips) who had undergone irradiation of the pelvis and a cemented total hip arthroplasty (THA) with an acetabular reinforcement cross. All hips had received a minimum dose of 30 Gray (Gy) to treat a primary nearby tumour or metastasis. The median dose of radiation was 50 Gy (Q1 to Q3: 45 to 60; mean: 49.57, 32 to 72).
   The mean follow-up after THA was 51 months (17 to 137). The cumulative probability of revision of the acetabular component for a mechanical reason was 0% (0 to 0%) at 24 months, 2.9% (0.2 to 13.3%) at 60 months and 2.9% (0.2% to 13.3%) at 120 months, respectively. One hip was revised for mechanical failure and three for infection.
   Cemented acetabular components with a reinforcement cross provide good medium-term fixation after pelvic irradiation. These patients are at a higher risk of developing infection of their THA.
C1 [Felden, A.; Vaz, G.; Kreps, S.; Anract, P.; Hamadouche, M.; Biau, D. J.] Hop Cochin, F-75014 Paris, France.
RP Felden, A (reprint author), Hop Cochin, 27 Rue Faubourg St Jacques, F-75014 Paris, France.
EM tere_arno@hotmail.fr
CR Abolghasemian M, 2013, BONE JOINT J, V95B, P166, DOI 10.1302/0301-620X.95B2.30608
   [Anonymous], 1963, ANESTHESIOL, V24, P111
   Barth HD, 2011, BIOMATERIALS, V32, P8892, DOI 10.1016/j.biomaterials.2011.08.013
   Bessell E M, 1994, Clin Oncol (R Coll Radiol), V6, P116, DOI 10.1016/S0936-6555(05)80114-1
   BIALAS I, 1989, RADIOTHER ONCOL, V16, P305, DOI 10.1016/0167-8140(89)90043-1
   Biau DJ, 2011, CLIN ORTHOP RELAT R, V469, P2661, DOI 10.1007/s11999-011-1908-9
   Biau DJ, 2011, INT ORTHOP, V35, P151, DOI 10.1007/s00264-010-1097-2
   Biau DJ, 2008, CLIN ORTHOP RELAT R, V466, P2282, DOI 10.1007/s11999-008-0346-9
   Biau DJ, 2007, CLIN ORTHOP RELAT R, P229, DOI 10.1097/BLO.0b013e3180986753
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   BRAGG DG, 1970, RADIOLOGY, V97, P103, DOI 10.1148/97.1.103
   Cho MR, 2005, CLIN ORTHOP RELAT R, P165, DOI 10.1097/01.blo.0000167671.10820.29
   DALINKA MK, 1974, SEMIN ROENTGENOL, V9, P29, DOI 10.1016/0037-198X(74)90007-8
   DAUBIGNE RM, 1990, REV CHIR ORTHOP, V76, P371
   Dean CB, 2007, LIFETIME DATA ANAL, V13, P497, DOI 10.1007/s10985-007-9065-x
   DELEE JG, 1976, CLIN ORTHOP RELAT R, P20
   Gruen TA, 1979, CLIN ORTHOP RELAT R, V141, P17, DOI DOI 10.1097/00003086-197906000-00002
   Hailer NP, 2010, ACTA ORTHOP, V81, P34, DOI 10.3109/17453671003685400
   Jacobs JJ, 1995, J BONE JOINT SURG AM, V77A, P1829, DOI 10.2106/00004623-199512000-00006
   Joglekar SB, 2012, CLIN ORTHOP RELAT R, V470, P3041, DOI 10.1007/s11999-012-2382-8
   JOHNSON JT, 1989, HEAD NECK-J SCI SPEC, V11, P132, DOI 10.1002/hed.2880110206
   Kawanabe K, 2011, J ARTHROPLASTY, V26, P1061, DOI 10.1016/j.arth.2011.04.019
   Kerboull M, 2000, CLIN ORTHOP RELAT R, P155
   Kim KI, 2007, J BONE JOINT SURG AM, V89A, P798, DOI 10.2106/JBJS.F.00183
   Kwon JW, 2008, AM J ROENTGENOL, V191, P987, DOI 10.2214/AJR.07.3634
   MARKOLF KL, 1976, CLIN ORTHOP RELAT R, P99
   MASSIN P, 1995, J BONE JOINT SURG BR, V77B, P847
   Mitchell MJ, 1998, RADIOGRAPHICS, V18, P1125, DOI 10.1148/radiographics.18.5.9747611
   NOBLE PC, 1983, ACTA ORTHOP SCAND, V54, P566, DOI 10.3109/17453678308992890
   Passick J, 1989, J Arthroplasty, V4, P87, DOI 10.1016/S0883-5403(89)80057-9
   Pelker RR, 1997, CLIN ORTHOP RELAT R, P267
   PHILLIPS TW, 1989, CAN J SURG, V32, P353
   PRASAD KN, 1995, GYNECOL ONCOL, V57, P380, DOI 10.1006/gyno.1995.1158
   PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374
   SMITHERS D W, 1946, Postgrad Med J, V22, P127
   Wisplinghoff H, 2003, CLIN INFECT DIS, V36, P1103, DOI 10.1086/374339
   Yang Shu-Hua, 2001, J Orthop Surg (Hong Kong), V9, P41
NR 38
TC 5
Z9 5
U1 0
U2 1
PU BRITISH EDITORIAL SOC BONE JOINT SURGERY
PI LONDON
PA 22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND
SN 2049-4394
J9 BONE JOINT J
JI Bone Joint J.
PD FEB
PY 2015
VL 97B
IS 2
BP 177
EP 184
DI 10.1302/0301-620X.97B2.34545
PG 8
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA CA0NG
UT WOS:000348613700008
PM 25628279
DA 2018-10-19
ER

PT J
AU Ilin, Y
   Kraft, ML
AF Ilin, Yelena
   Kraft, Mary L.
TI Secondary ion mass spectrometry and Raman spectroscopy for tissue
   engineering applications
SO CURRENT OPINION IN BIOTECHNOLOGY
LA English
DT Review
ID EMBRYONIC STEM-CELLS; ADSORBED PROTEIN FILMS; PLASMA-DEPOSITED FILMS;
   IN-VITRO; MULTIVARIATE-ANALYSIS; TOF-SIMS; EXTRACELLULAR-MATRIX;
   MESODERMAL PROGENITORS; SCATTERING MICROSCOPY; NONINVASIVE ANALYSIS
AB Identifying the matrix properties that permit directing stem cell fate is crucial for expanding desired cell lineages ex vivo for disease treatment. Such efforts require knowledge of matrix surface chemistry and the cell responses they elicit. Recent progress in analyzing biomaterial composition and identifying cell phenotype with two label-free chemical imaging techniques, TOF-SIMS and Raman spectroscopy are presented. TOF-SIMS is becoming indispensable for the surface characterization of biomaterial scaffolds. Developments in TOF-SIMS data analysis enable correlating surface chemistry with biological response. Advances in the interpretation of Raman spectra permit identifying the fate decisions of individual, living cells with location specificity. Here we highlight this progress and discuss further improvements that would facilitate efforts to develop artificial scaffolds for tissue regeneration.
EM mlkraft@illinois.edu
FU NIH Training Program in the Chemistry-Biology Interface [T32 GM070421];
   U.S. National Science Foundation [CHE-1058809]
FX This work was partially supported by the NIH Training Program in the
   Chemistry-Biology Interface T32 GM070421, and a grant from the U.S.
   National Science Foundation (CHE-1058809).
CR Anderton CR, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-2
   Anderton CR, 2012, SURF INTERFACE ANAL, V44, P322, DOI 10.1002/sia.3806
   Antonio KA, 2014, ANAL CHEM, V86, P30, DOI 10.1021/ac403640f
   Baker MJ, 2008, ANALYST, V133, P175, DOI 10.1039/b712853c
   Barnes CA, 2012, ANAL CHEM, V84, P893, DOI 10.1021/ac201179t
   Barnes CA, 2011, BIOMATERIALS, V32, P137, DOI 10.1016/j.biomaterials.2010.09.007
   Bigdeli N, 2010, TISSUE ENG PT A, V16, P3427, DOI 10.1089/ten.tea.2010.0112
   Bonnier F, 2012, VIB SPECTROSC, V61, P124, DOI 10.1016/j.vibspec.2012.03.009
   Boyd AR, 2010, J MATER SCI-MATER M, V21, P2317, DOI 10.1007/s10856-009-3965-0
   Brackmann C, 2012, TISSUE ENG PART C-ME, V18, P227, DOI [10.1089/ten.tec.2011.0211, 10.1089/ten.TEC.2011.0211]
   Brackmann C, 2012, J BIOPHOTONICS, V5, P404, DOI 10.1002/jbio.201100141
   Brackmann C, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3534782
   Brauchle E, 2013, BIOTECHNOL J, V8, P288, DOI 10.1002/biot.201200163
   Brown BN, 2010, BIOMATERIALS, V31, P428, DOI 10.1016/j.biomaterials.2009.09.061
   Canavan HE, 2007, LANGMUIR, V23, P50, DOI 10.1021/la062330o
   Chan JW, 2009, ANAL CHEM, V81, P1324, DOI 10.1021/ac801665m
   Chiang HK, 2009, J RAMAN SPECTROSC, V40, P546, DOI 10.1002/jrs.2161
   CHILKOTI A, 1993, ANAL CHEM, V65, P1736, DOI 10.1021/ac00061a017
   CHILKOTI A, 1995, ANAL CHEM, V67, P2883, DOI 10.1021/ac00113a024
   Conovaloff A, 2009, ORGANOGENESIS, V5, P231, DOI 10.4161/org.5.4.10404
   de Peppo GM, 2010, TISSUE ENG PT A, V16, P3413, DOI [10.1089/ten.tea.2010.0052, 10.1089/ten.TEA.2010.0052]
   de Peppo GM, 2013, TISSUE ENG PT A, V19, P175, DOI [10.1089/ten.tea.2011.0412, 10.1089/ten.TEA.2011.0412]
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   Downes A, 2011, J RAMAN SPECTROSC, V42, P1864, DOI 10.1002/jrs.2975
   Fletcher JS, 2011, CURR OPIN CHEM BIOL, V15, P733, DOI 10.1016/j.cbpa.2011.05.016
   Frisz JF, 2012, ANAL CHEM, V84, P4307, DOI 10.1021/ac203329j
   Gentleman E, 2009, NAT MATER, V8, P763, DOI [10.1038/nmat2505, 10.1038/NMAT2505]
   Ghita A, 2012, ANAL CHEM, V84, P3155, DOI 10.1021/ac202994e
   Gonzalez M, 2013, J BIOMED MATER RES A, V101, P819, DOI 10.1002/jbm.a.34388
   Harkness L, 2012, STEM CELLS DEV, V21, P2152, DOI 10.1089/scd.2011.0600
   Hung PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065438
   Ilin Y, 2014, ANALYST, V139, P2177, DOI 10.1039/c3an02156d
   Jell G, 2008, J BIOMED MATER RES A, V86A, P31, DOI 10.1002/jbm.a.31542
   Kim BS, 2008, STEM CELLS DEV, V17, P185, DOI 10.1089/scd.2007.0076
   Kingshott P, 2011, CURR OPIN CHEM BIOL, V15, P667, DOI 10.1016/j.cbpa.2011.07.012
   Klerk LA, 2010, ANAL CHEM, V82, P4337, DOI 10.1021/ac100837n
   Konorov SO, 2007, ANAL CHEM, V79, P7221, DOI 10.1021/ac070544k
   Konorov SO, 2013, ANAL CHEM, V85, P8996, DOI 10.1021/ac400310b
   Krafft C, 2009, ANALYST, V134, P1046, DOI 10.1039/b822354h
   Kraft ML, 2014, BBA-MOL CELL BIOL L, V1841, P1108, DOI 10.1016/j.bbalip.2014.03.003
   Kulp KS, 2006, ANAL CHEM, V78, P3651, DOI 10.1021/ac060054c
   Kunstar A, 2011, TISSUE ENG PART C-ME, V17, P737, DOI [10.1089/ten.tec.2010.0574, 10.1089/ten.TEC.2010.0574]
   Kunstar A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0464
   Lee YJ, 2014, TISSUE ENG PART C-ME, V20, P562, DOI [10.1089/ten.tec.2013.0472, 10.1089/ten.TEC.2013.0472]
   Lhoest JB, 1998, J BIOMED MATER RES, V41, P95, DOI 10.1002/(SICI)1097-4636(199807)41:1<95::AID-JBM12>3.0.CO;2-G
   Lo WL, 2011, J RAMAN SPECTROSC, V42, P174, DOI 10.1002/jrs.2688
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   McManus LL, 2011, ANALYST, V136, P2471, DOI 10.1039/c1an15167c
   Meade AD, 2007, ANAL BIOANAL CHEM, V387, P1717, DOI 10.1007/s00216-006-0876-5
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Michel R, 2006, SURF INTERFACE ANAL, V38, P1386, DOI 10.1002/sia.2382
   Monroe EB, 2005, J AM CHEM SOC, V127, P12152, DOI 10.1021/ja051223y
   Mortati L, 2012, J RAMAN SPECTROSC, V43, P675, DOI 10.1002/jrs.3171
   Mouras R, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.116011
   Notingher I, 2004, ANAL CHEM, V76, P3185, DOI 10.1021/ac0498720
   Notingher L, 2005, J MOL STRUCT, V744, P179, DOI 10.1016/j.molstruc.2004.12.046
   Notingher L, 2004, VIB SPECTROSC, V35, P199, DOI 10.1016/j.vibspec.2004.01.014
   Park J, 2012, SMALL, V8, P98, DOI 10.1002/smll.201100790
   Pascut FC, 2013, BBA-GEN SUBJECTS, V1830, P3517, DOI 10.1016/j.bbagen.2013.01.030
   Pascut FC, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3570302
   Pasqui D, 2014, J BIOMED MATER RES A, V102, P1568, DOI 10.1002/jbm.a.34810
   Pliss A, 2013, ANAL CHEM, V85, P3545, DOI 10.1021/ac303806j
   Rangarajan S, 2006, J VAC SCI TECHNOL A, V24, P1730, DOI 10.1116/1.2217980
   Saha K, 2011, P NATL ACAD SCI USA, V108, P18714, DOI 10.1073/pnas.1114854108
   Schulze HG, 2010, ANAL CHEM, V82, P5020, DOI 10.1021/ac902697q
   Swain RJ, 2008, J CELL BIOCHEM, V104, P1427, DOI 10.1002/jcb.21720
   Swain RJ, 2008, BIOPHYS J, V95, P5978, DOI 10.1529/biophysj.108.136168
   Tejero R, 2013, LANGMUIR, V29, P902, DOI 10.1021/la303360f
   Tidwell CD, 2001, SURF INTERFACE ANAL, V31, P724, DOI 10.1002/sia.1101
   Tsai TH, 2014, ANALYST, V139, P2799, DOI 10.1039/c4an00155a
   Tyler B, 2003, APPL SURF SCI, V203, P825, DOI 10.1016/S0169-4332(02)00835-8
   Ulrich TA, 2011, BIOMATERIALS, V32, P5633, DOI 10.1016/j.biomaterials.2011.04.045
   Wagner MS, 2004, APPL SURF SCI, V231, P366, DOI 10.1016/j.apsusc.2004.03.100
   Wagner MS, 2003, APPL SURF SCI, V203, P704, DOI 10.1016/S0169-4332(02)00795-X
   Wagner MS, 2003, J BIOMED MATER RES A, V64A, P1, DOI 10.1002/jbm.a.10263
   Xia N, 2003, J BIOMED MATER RES A, V67A, P179, DOI 10.1002/jbm.a.10063
   Yang L, 2011, J VAC SCI TECHNOL A, V29, DOI 10.1116/1.3654147
   Yang L, 2011, LAB CHIP, V11, P2481, DOI 10.1039/c0lc00676a
   YU ML, 1982, PHYS REV B, V26, P4731, DOI 10.1103/PhysRevB.26.4731
NR 79
TC 13
Z9 12
U1 2
U2 55
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0958-1669
EI 1879-0429
J9 CURR OPIN BIOTECH
JI Curr. Opin. Biotechnol.
PD FEB
PY 2015
VL 31
BP 108
EP 116
DI 10.1016/j.copbio.2014.10.011
PG 9
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA CA5PL
UT WOS:000348960200016
PM 25462628
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Batista, L
   Rodrigues, SSFR
   Dullius, J
   David, AC
AF Batista, L.
   Rodrigues, S. S. F. R.
   Dullius, J.
   David, A. C.
TI BIOMATERIAL USED AS A WAY TO PREVENTION THE DIABETIC FOOT CONSEQUENCES
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Meeting Abstract
C1 [Batista, L.; Rodrigues, S. S. F. R.; Dullius, J.; David, A. C.] Univ Brasilia, Brasilia, DF, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD FEB 1
PY 2015
VL 17
SU 1
MA 239
BP A106
EP A106
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CB0LL
UT WOS:000349317500240
DA 2018-10-19
ER

PT J
AU Lan, GB
   Li, M
   Tan, Y
   Li, LH
   Yang, XM
   Ma, LM
   Yin, QS
   Xia, H
   Zhang, Y
   Tan, GX
   Ning, CY
AF Lan, Guobo
   Li, Mei
   Tan, Ying
   Li, Lihua
   Yang, Xiaoming
   Ma, Limin
   Yin, Qingshui
   Xia, Hong
   Zhang, Yu
   Tan, Guoxin
   Ning, Chengyun
TI Promoting Bone Mesenchymal Stem Cells and Inhibiting Bacterial Adhesion
   of Acid-Etched Nanostructured Titanium by Ultraviolet Functionalization
SO JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY
LA English
DT Article
DE UV treatment; Nanostructures; Bone mesenchymal stem cells; Antibacterial
   activity; Titanium
ID DIOXIDE PHOTOCATALYTIC OXIDATION; ESCHERICHIA-COLI; OSTEOGENIC
   DIFFERENTIATION; UV PHOTOFUNCTIONALIZATION; HIP-ARTHROPLASTY;
   NANOTOPOGRAPHY; ANTIBACTERIAL; INACTIVATION; SURFACES; DISINFECTION
AB Titanium (Ti) and its alloys are used extensively in orthopedic implants because of their excellent biocompatibility, mechanical properties and corrosion resistance. However, titanium-based implant materials face many severe complications, such as implant loosening due to poor osseointegration and bacterial infections, which may lead to implant failure. Hence, preparing a biomaterial surface, which enhances the interactions with host cells and inhibits bacterial adhesion, may be an optimal strategy to reduce the incidence of implant failure. This study aims to improve osseointegration and confer antibacterial properties on Ti through a combination of two surface modifications including nanostructuring generated by acid etching and ultraviolet (UV) light treatment. Our results showed that without UV treatment, the acid etching treatment of Ti surface was effective at both improving the adhesion of bone mesenchymal stem cells (BMSCs) and increasing bacterial adhesion. A further UV treatment of the acid-etched surface however, not only significantly improved the cell adhesion but also inhibited bacterial adhesion. The acid-etched nanostructured titanium with UV treatment also showed a significant enhancement on cell proliferation, alkaline phosphatase (ALP) activity and mineralization. These results suggest that such nanostructured materials with UV treatment can be expected to have a good potential in orthopedic applications.
C1 [Lan, Guobo; Yang, Xiaoming] Southern Med Univ, Guangzhou 510515, Guangdong, Peoples R China.
   [Lan, Guobo; Li, Mei; Li, Lihua; Ma, Limin; Yin, Qingshui; Xia, Hong; Zhang, Yu] Gen Hosp Guangzhou Mil Command, Orthoped Hosp, Guangzhou 510010, Guangdong, Peoples R China.
   [Tan, Ying; Tan, Guoxin] Guangdong Univ Technol, Fac Light & Chem, Guangzhou 510006, Guangdong, Peoples R China.
   [Ning, Chengyun] S China Univ Technol, Coll Mat Sci & Technol, Guangzhou 510641, Guangdong, Peoples R China.
RP Zhang, Y (reprint author), Gen Hosp Guangzhou Mil Command, Orthoped Hosp, Guangzhou 510010, Guangdong, Peoples R China.
EM luck_2001@126.com; tanguoxin@126.com; imcyning@scut.edu.cn
FU National Key Basic Research Program of China [2012CB619106]; National
   Natural Science Foundation of China [81271957]; Military Medical
   Research "12th Five-Year Plan" General Program of China [cws11c268];
   Guangdong Provincial Science and Technology Project, China
   [2012A030400064]
FX This work was supported by the National Key Basic Research Program of
   China (Grant No. 2012CB619106), the National Natural Science Foundation
   of China (Grant No. 81271957), the Military Medical Research "12th
   Five-Year Plan" General Program of China (Grant No. cws11c268) and
   Guangdong Provincial Science and Technology Project, China (Grant No.
   2012A030400064).
CR Aita H, 2009, ACTA BIOMATER, V5, P3247, DOI 10.1016/j.actbio.2009.04.022
   Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004
   Aninwene GE, 2008, INT J NANOMED, V3, P257
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Chen W, 2007, J BIOMED MATER RES A, V82A, P899, DOI 10.1002/jbm.a.31197
   Cho M, 2005, APPL ENVIRON MICROB, V71, P270, DOI 10.1128/AEM.71.1.270-275.2005
   Dixon T, 2004, ANN RHEUM DIS, V63, P825, DOI 10.1136/ard.2003.012724
   Foster HA, 2011, APPL MICROBIOL BIOT, V90, P1847, DOI 10.1007/s00253-011-3213-7
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Havelin LI, 2009, ACTA ORTHOP, V80, P393, DOI 10.3109/17453670903039544
   Hori N, 2011, ACTA BIOMATER, V7, P3679, DOI 10.1016/j.actbio.2011.06.022
   IRELAND JC, 1993, APPL ENVIRON MICROB, V59, P1668
   Kaur G, 2010, BIOMATERIALS, V31, P5813, DOI 10.1016/j.biomaterials.2010.04.017
   Kubo K, 2009, BIOMATERIALS, V30, P5319, DOI 10.1016/j.biomaterials.2009.06.021
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094
   MATSUNAGA T, 1988, APPL ENVIRON MICROB, V54, P1330
   Mendonca G, 2010, J BIOMED MATER RES A, V94A, P169, DOI 10.1002/jbm.a.32701
   Miyauchi T, 2010, BIOMATERIALS, V31, P3827, DOI 10.1016/j.biomaterials.2010.01.133
   National Center for Health Statistics, 2012, NAT HOSP DISCH SURV
   Ogawa T, 2008, J DENT RES, V87, P751, DOI 10.1177/154405910808700809
   Park MR, 2008, INT J NANOMED, V3, P497
   Pedersen AB, 2005, ACTA ORTHOP, V76, P182, DOI 10.1080/00016470510030553
   Pohler OEM, 2000, INJURY, V31, pS7
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Salih FM, 2002, J APPL MICROBIOL, V92, P920, DOI 10.1046/j.1365-2672.2002.01601.x
   Schwartz Z, 2001, J BIOMED MATER RES, V56, P417, DOI 10.1002/1097-4636(20010905)56:3<417::AID-JBM1111>3.0.CO;2-K
   Takeuchi K, 2005, J BIOMED MATER RES A, V72A, P296, DOI 10.1002/jbm.a.30227
   Tsukimura N, 2011, BIOMATERIALS, V32, P4358, DOI 10.1016/j.biomaterials.2011.03.001
   Vetrone F, 2009, NANO LETT, V9, P659, DOI 10.1021/nl803051f
   Visai L, 2011, INT J ARTIF ORGANS, V34, P929, DOI 10.5301/ijao.5000050
   Wang XX, 2002, BIOMATERIALS, V23, P1353, DOI 10.1016/S0142-9612(01)00254-X
   Wang XX, 2001, J BIOMED MATER RES, V54, P172, DOI 10.1002/1097-4636(200102)54:2<172::AID-JBM3>3.0.CO;2-#
   Webster TJ, 2005, NANOTECHNOLOGY, V16, pS449, DOI 10.1088/0957-4484/16/7/021
   Webster TJ, 2005, BIOMATERIALS, V26, P953, DOI 10.1016/j.biomaterials.0204.03.040
   Zhao LZ, 2012, BIOMATERIALS, V33, P2629, DOI 10.1016/j.biomaterials.2011.12.024
   Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040
   Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014
NR 39
TC 8
Z9 8
U1 1
U2 47
PU JOURNAL MATER SCI TECHNOL
PI SHENYANG
PA 72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA
SN 1005-0302
J9 J MATER SCI TECHNOL
JI J. Mater. Sci. Technol.
PD FEB
PY 2015
VL 31
IS 2
BP 182
EP 190
DI 10.1016/j.jmst.2014.08.007
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CA8ZG
UT WOS:000349209100010
DA 2018-10-19
ER

PT J
AU Sun, Y
   Jallerat, Q
   Szymanski, JM
   Feinberg, AW
AF Sun, Yan
   Jallerat, Quentin
   Szymanski, John M.
   Feinberg, Adam W.
TI Conformal nanopatterning of extracellular matrix proteins onto
   topographically complex surfaces
SO NATURE METHODS
LA English
DT Article
AB Our Patterning on Topography (PoT) printing technique enables fibronectin, laminin and other proteins to be applied to biomaterial surfaces in complex geometries that are inaccessible using traditional soft lithography techniques. Engineering combinatorial surfaces that integrate topographical and biochemical micropatterns enhances control of the biotic-abiotic interface. Here, we used this method to understand cardiomyocyte response to competing physical and chemical cues in the microenvironment.
C1 [Sun, Yan; Jallerat, Quentin; Szymanski, John M.; Feinberg, Adam W.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.
   [Sun, Yan] Beihang Univ, Sch Biol Sci & Med Engn, Beijing 100191, Peoples R China.
   [Feinberg, Adam W.] Carnegie Mellon Univ, Dept Mat Sci & Engn, Pittsburgh, PA 15213 USA.
RP Feinberg, AW (reprint author), Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.
EM feinberg@andrew.cmu.edu
RI Feinberg, Adam/A-7103-2009
OI Feinberg, Adam/0000-0003-3338-5456; Jallerat,
   Quentin/0000-0001-9717-0505
FU China Scholarship Council (CSC) [[2008]3027]; Carnegie Mellon University
   Dowd-ICES Fellowship; NIH Biomechanics in Regenerative Medicine T32
   training grant [T32EB003392]; Bertucci Graduate Fellowship; NIH
   Director's New Innovator Award [DP2HL117750]
FX We acknowledge financial support from China Scholarship Council (CSC)
   for State Scholarship Fund No. [2008]3027 (Y.S.), the Carnegie Mellon
   University Dowd-ICES Fellowship (Q.J.), the NIH Biomechanics in
   Regenerative Medicine T32 training grant (T32EB003392) and the Bertucci
   Graduate Fellowship (J.M.S.) and the NIH Director's New Innovator Award
   (DP2HL117750) (A.W.F.).
CR Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bray MAP, 2010, BIOMATERIALS, V31, P5143, DOI 10.1016/j.biomaterials.2010.03.028
   Chung CY, 2011, FASEB J, V25, P851, DOI 10.1096/fj.10-168625
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Feinberg A.W., 2007, J BIOMED MATER RES A, V86A, P522
   Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885
   Feinberg AW, 2012, BIOMATERIALS, V33, P5732, DOI 10.1016/j.biomaterials.2012.04.043
   Feinberg AW, 2010, NANO LETT, V10, P2184, DOI 10.1021/nl100998p
   Greene AC, 2011, BIOMATERIALS, V32, P8860, DOI 10.1016/j.biomaterials.2011.08.003
   Klotzsch E, 2009, P NATL ACAD SCI USA, V106, P18267, DOI 10.1073/pnas.0907518106
   Palchesko R N, 2012, PLOS ONE, V7, P1
   Szymanski J. M., 2014, JOVE-J VIS EXP, V86
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
NR 13
TC 24
Z9 24
U1 1
U2 34
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1548-7091
EI 1548-7105
J9 NAT METHODS
JI Nat. Methods
PD FEB
PY 2015
VL 12
IS 2
BP 134
EP U168
DI 10.1038/nmeth.3210
PG 5
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA CA4GL
UT WOS:000348862500015
PM 25506720
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Wang, YY
   Deng, H
   Huangfu, CX
   Lu, ZW
   Wang, XX
   Zeng, XY
   He, HB
   Rao, H
AF Wang, Yanying
   Deng, Hao
   Huangfu, Changxin
   Lu, Zhiwei
   Wang, Xianxiang
   Zeng, Xianyin
   He, Hua
   Rao, Hanbing
TI Research of protein adsorption on the different surface topography of
   the zinc oxide
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE zinc oxide (ZnO); surface topography; mono-protein adsorption;
   multi-protein adsorption; adsorption kinetics
ID BOVINE SERUM-ALBUMIN; CONFORMATIONAL-CHANGES; KINETIC-MODEL;
   NANOPARTICLES; FIBRONECTIN; FIBRINOGEN; PARTICLES; TITANIUM; TIO2;
   BIOCOMPATIBILITY
AB The effect of the surface topography on the protein adsorption process is of great significance for designing biomaterial surfaces and the biocompatibility for specific biomedical applications. In this work, we have systematically investigated the mono-protein adsorption kinetics of bovine serum albumin (BSA) and fibrinogen (Fg) adsorbed on the four different surface topographies (nanoparticles (NPs), nanorods (NRs), nanosheets (NSs) and nanobeams (NBs) of Zinc oxide (ZnO), respectively. The competition of multi-protein adsorbed on them has been studied as well. Results showed that each protein had a singular process of adsorption that fitted well by Spreading Particle Model (SPM). It confirmed that ZnO NRs compared with other samples had more adsorption sites, which could provide more opportunities for the interaction between material and protein molecules. In addition, the Fg compared to the BSA could be more tightly adsorbed to the surface, both of which existed slight conformational changes by Fourier transform infrared (FTIR) and circular dichroism spectra (CD). Taken together, all these consequences well demonstrated that NRs may have wider applications in designing biomaterial surfaces and the biocompatibility for implanted biomaterials. Copyright (c) 2014 John Wiley & Sons, Ltd.
C1 [Wang, Yanying; Huangfu, Changxin; Lu, Zhiwei; Wang, Xianxiang; Rao, Hanbing] Sichuan Agr Univ, Coll Sci, Yaan 625014, Peoples R China.
   [Deng, Hao] Southwest Univ Sci & Technol, State Key Lab Cultivat Base Nonmet Composites & F, Mianyang 621010, Peoples R China.
   [Zeng, Xianyin] Sichuan Agr Univ, Coll Life Sci, Yaan 625014, Peoples R China.
   [He, Hua] Sichuan Agr Univ, Anim Genet & Breeding Inst, Yaan 625014, Sichuan, Peoples R China.
RP Rao, H (reprint author), Sichuan Agr Univ, Coll Sci, Yaan 625014, Peoples R China.
EM rhbsau@gmail.com
FU Sichuan Agricultural University [03570113, 121062639]; Education
   Department of Sichuan Provincial, PR China [12ZA268, 13ZA0255]
FX This work was supported by a grant from the Two-Way Support Programs of
   Sichuan Agricultural University (Project No. 03570113), Students
   Innovative projects of Sichuan Agricultural University (No. 121062639)
   and the Education Department of Sichuan Provincial, PR China (Grant Nos.
   12ZA268, 13ZA0255). We thank Professor Feng Zhu from Chongqing
   University and Xinyuan Zhang from Sichuan University for the use of
   equipment. We thank the anonymous reviewers for their valuable
   suggestions.
CR Bai ZJ, 2009, SURF SCI, V603, P839, DOI 10.1016/j.susc.2009.01.040
   Blanco EM, 2008, LANGMUIR, V24, P2284, DOI 10.1021/la702957f
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brusatori MA, 2003, LANGMUIR, V19, P5089, DOI 10.1021/la0269558
   Brusatori MA, 1999, J COLLOID INTERF SCI, V219, P333, DOI 10.1006/jcis.1999.6496
   Chakraborti S, 2010, LANGMUIR, V26, P3506, DOI 10.1021/la903118c
   Damodaran S, 2003, ANAL BIOANAL CHEM, V376, P182, DOI 10.1007/s00216-003-1873-6
   Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o
   Farmer V. C., 1974, INFRARED SPECTRA MIN
   Galli C, 2002, COLLOID SURFACE B, V26, P255, DOI 10.1016/S0927-7765(02)00015-2
   Galli C, 2001, SURF SCI, V474, pL180, DOI 10.1016/S0039-6028(00)01054-2
   Gentile F, 2010, BIOMATERIALS, V31, P7205, DOI 10.1016/j.biomaterials.2010.06.016
   Goyal K. D., 2010, THIN SOLID FILMS, V518, P2186
   HINRICHSEN EL, 1986, J STAT PHYS, V44, P793, DOI 10.1007/BF01011908
   Zhou J, 2006, ADV MATER, V18, P2432, DOI 10.1002/adma.200600200
   Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o
   Kruger NJ, 2009, SPRINGER PROTOC HAND, P17, DOI 10.1007/978-1-59745-198-7_4
   Lefaix H, 2013, COLLOID SURFACE A, V439, P207, DOI 10.1016/j.colsurfa.2013.04.009
   Li Z, 2008, J PHYS CHEM C, V112, P20114, DOI 10.1021/jp808878p
   Lousinian S, 2013, J COLLOID INTERF SCI, V395, P294, DOI 10.1016/j.jcis.2013.01.007
   Lu T. S., 2010, AM J MED SCI, V2, P325, DOI DOI 10.4297/NAJMS.2010.2325
   Lundqvist M, 2004, LANGMUIR, V20, P10639, DOI 10.1021/la0484725
   LUNDSTROM I, 1985, PROG COLL POL SCI S, V70, P76
   MacDonald DE, 2002, BIOMATERIALS, V23, P1269, DOI 10.1016/S0142-9612(01)00317-9
   Niu LN, 2010, J DENT RES, V89, P746, DOI 10.1177/0022034510366682
   Oliva FY, 2003, J COLLOID INTERF SCI, V261, P299, DOI 10.1016/S0021-9797(03)00029-8
   Ozacar M, 2006, J HAZARD MATER, V137, P218, DOI 10.1016/j.jhazmat.2006.01.058
   Pegueroles M, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0048-4
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Renner L, 2005, LANGMUIR, V21, P4571, DOI 10.1021/la046801n
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Sasidharan NP, 2013, COLLOID SURFACE B, V102, P195, DOI 10.1016/j.colsurfb.2012.07.034
   Satriano C, 2012, J COLLOID INTERF SCI, V365, P90, DOI 10.1016/j.jcis.2011.09.014
   Schmidt DR, 2009, BIOLOGICAL INTERACTIONS ON MATERIALS SURFACES: UNDERSTANDING AND CONTROLLING PROTEIN, CELL, AND TISSUE RESPONSES, P1, DOI 10.1007/978-0-387-98161-1_1
   Sevinc BA, 2010, J BIOMED MATER RES B, V94B, P22, DOI 10.1002/jbm.b.31620
   Silva-Bermudez P, 2013, SURF COAT TECH, V233, P147, DOI 10.1016/j.surfcoat.2013.04.028
   Simsikova M, 2013, COLLOID SURFACE B, V103, P630, DOI 10.1016/j.colsurfb.2012.10.058
   Sousa SR, 2004, LANGMUIR, V20, P9745, DOI 10.1021/la049158d
   Talebian N, 2011, APPL SURF SCI, V258, P547, DOI 10.1016/j.apsusc.2011.08.070
   Tzoneva R, 2002, J MATER SCI-MATER M, V13, P1235, DOI 10.1023/A:1021131113711
   Walker J. M., 2002, PROTEOMICS PROTOCOLS
   WEBER K, 1969, J BIOL CHEM, V244, P4406
   Yang YZ, 2003, J BIOMED MATER RES A, V67A, P344, DOI 10.1002/jbm.a.10578
   Zhang YZ, 2008, J FLUORESC, V18, P109, DOI 10.1007/s10895-007-0247-4
NR 45
TC 5
Z9 5
U1 3
U2 49
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2421
EI 1096-9918
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD FEB
PY 2015
VL 47
IS 2
BP 245
EP 252
DI 10.1002/sia.5698
PG 8
WC Chemistry, Physical
SC Chemistry
GA AZ9GY
UT WOS:000348523000011
DA 2018-10-19
ER

PT J
AU Andreaus, U
   Giorgio, I
   Madeo, A
AF Andreaus, Ugo
   Giorgio, Ivan
   Madeo, Angela
TI Modeling of the interaction between bone tissue and resorbable
   biomaterial as linear elastic materials with voids
SO ZEITSCHRIFT FUR ANGEWANDTE MATHEMATIK UND PHYSIK
LA English
DT Article
DE Mechanical-biological coupling; Mechanical loading; Growth/resorption
   processes; Continuum mixture model; Poro-elasticity
ID PHASE-TRANSITIONS; VARIATIONAL APPROACH; PERTURBATION-METHODS;
   GRANULAR-MATERIALS; HOPF BIFURCATIONS; HUMAN OSTEOCLASTS; CONTINUUM
   MODEL; MIXTURE MODEL; POROUS-MEDIA; TRUSS BEAMS
AB In this paper, a continuum mixture model with evolving mass densities and porosity is proposed to describe the process of bone remodeling in the presence of bio-resorbable materials as driven by externally applied loads. From a mechanical point of view, both bone tissue and biomaterial are modeled as linear elastic media with voids in the sense of Cowin and Nunziato (J Elast 13:125-147, 1983). In the proposed continuum model, the change of volume fraction related to the void volume is directly accounted for by considering porosity as an independent kinematical field. The bio-mechanical coupling is ensured by the introduction of a suitable stimulus which allows for discriminating between resorption (of both bone and biomaterial) and synthesis (of the sole natural bone) depending on the level of externally applied loads. The presence of a 'lazy zone' associated with intermediate deformation levels is also considered in which neither resorption nor synthesis occur. Some numerical solutions of the integro-differential equations associated with the proposed model are provided for the two-dimensional case. Ranges of values of the parameters for which different percentages of biomaterial substitution occur are proposed, namely parameters characterizing initial and maximum values of mass densities of bone tissue and of the bio-resorbable material.
C1 [Andreaus, Ugo; Giorgio, Ivan] Univ Roma La Sapienza, Dipartimento Ingn Strutturale & Geotecn, Fac Ingn Civile & Ind, I-00184 Rome, Italy.
   [Giorgio, Ivan; Madeo, Angela] Univ Aquila, Int Res Ctr Math & Mech Complex Syst M& MoCS, I-67100 Laquila, Italy.
   [Madeo, Angela] Univ Lyon, INSA, F-69621 Villeurbanne, France.
RP Andreaus, U (reprint author), Univ Roma La Sapienza, Dipartimento Ingn Strutturale & Geotecn, Fac Ingn Civile & Ind, Via Eudossiana 18, I-00184 Rome, Italy.
EM ugo.andreaus@uniroma1.it; ivan.giorgio@uniroma1.it;
   angela.madeo@insa-lyon.fr
RI madeo, angela/L-5066-2015; Giorgio, Ivan/E-9341-2010
OI madeo, angela/0000-0003-1940-9853; Giorgio, Ivan/0000-0002-0044-9188
CR Andreaus U, 2004, J VIB CONTROL, V10, P625, DOI 10.1177/1077546304038224
   Andreaus U, 2009, P I MECH ENG H, V223, P589, DOI 10.1243/09544119JEIM559
   Andreaus U., 2012, BIOMEDICAL IMAGING C, P19
   Andreaus U., 2013, J APPL MATH MECH ZAM, P1, DOI http://dx.doi.org/10.1063/1A808446
   Andreaus U., 2008, BIOPHYSICS BIOENGINE, V10, P1
   Andreaus U, 2014, COMPUT METH PROG BIO, V113, P80, DOI 10.1016/j.cmpb.2013.09.002
   Andreaus U, 2012, CONTROL ENG PRACT, V20, P575, DOI 10.1016/j.conengprac.2012.02.002
   Andreaus U, 2011, STRUCT MULTIDISCIP O, V43, P43, DOI 10.1007/s00158-010-0531-9
   Armentano I, 2010, POLYM DEGRAD STABIL, V95, P2126, DOI 10.1016/j.polymdegradstab.2010.06.007
   BEAUPRE GS, 1990, J ORTHOPAED RES, V8, P662, DOI 10.1002/jor.1100080507
   BEAUPRE GS, 1990, J ORTHOP RES, V8, P651, DOI 10.1002/jor.1100080506
   Carcaterra A, 2004, J ACOUST SOC AM, V115, P683, DOI 10.1121/1.1642619
   Carcaterra A, 2002, MECH SYST SIGNAL PR, V16, P905, DOI 10.1006/mssp.2002.1486
   Carcaterra A., 2011, P 7 EUR NONL OSC C J
   CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954, DOI 10.2106/00004623-197759070-00021
   Casanova R, 2010, MED BIOL ENG COMPUT, V48, P811, DOI 10.1007/s11517-010-0637-7
   Cazzani A, 1997, COMPUT MECH, V20, P560, DOI 10.1007/s004660050276
   Cazzani A, 2012, SOIL DYN EARTHQ ENG, V37, P56, DOI 10.1016/j.soildyn.2012.01.011
   Contrafatto L, 2005, INT J NUMER METH ENG, V63, P1089, DOI 10.1002/nme.1235
   Contro R., 1988, ENG COMPUTATION, V5, P53
   COWIN SC, 1976, Z ANGEW MATH MECH, V56, P281, DOI 10.1002/zamm.19760560702
   COWIN SC, 1983, J ELASTICITY, V13, P125, DOI 10.1007/BF00041230
   Culla A, 2003, MECH SYST SIGNAL PR, V17, P635, DOI 10.1006/mssp.2002.1487
   Cuomo M, 2006, Computational Modelling of Concrete Structures, P533
   Cuomo M, 2000, INT J SOLIDS STRUCT, V37, P3935, DOI 10.1016/S0020-7683(99)00163-8
   Cuomo M, 1998, MATH COMPUT MODEL, V28, P185, DOI 10.1016/S0895-7177(98)00117-4
   CURREY JD, 1988, J BIOMECH, V21, P131, DOI 10.1016/0021-9290(88)90006-1
   DELL'ISOLA F, 1987, INT J ENG SCI, V25, P1469, DOI 10.1016/0020-7225(87)90024-3
   dell'Isola F, 1998, ARCH APPL MECH, V68, P1, DOI 10.1007/s004190050142
   dell'Isola F, 2009, INT J SOLIDS STRUCT, V46, P3150, DOI 10.1016/j.ijsolstr.2009.04.008
   DELL'ISOLA F, 1987, INT J ENG SCI, V25, P1459, DOI 10.1016/0020-7225(87)90023-1
   Dell'Isola F, 1998, ARCH APPL MECH, V68, P626, DOI 10.1007/s004190050192
   dell'Isola F, 1998, ACTA MECH, V127, P165, DOI 10.1007/BF01170371
   Dell'Isola F, 1997, Z ANGEW MATH MECH, V77, P519, DOI 10.1002/zamm.19970770711
   Dell'Isola F, 1997, INT J FRACTURE, V83, P175, DOI 10.1023/A:1007331628395
   dell'Isola F, 1997, ARCH APPL MECH, V67, P215
   Dell'Isola F, 1997, J ELASTICITY, V47, P73, DOI 10.1023/A:1007478322647
   Dell'Isola F, 1998, P ROY SOC A-MATH PHY, V454, P1169, DOI 10.1098/rspa.1998.0201
   dell'Isola F, 2000, ARCH APPL MECH, V70, P323, DOI 10.1007/s004199900020
   dell'Isola F, 2012, ZAMM-Z ANGEW MATH ME, V92, P52, DOI 10.1002/zamm.201100022
   DiCarlo A, 2002, MECH RES COMMUN, V29, P449, DOI 10.1016/S0093-6413(02)00297-5
   Epstein M, 2000, INT J PLASTICITY, V16, P951, DOI 10.1016/S0749-6419(99)00081-9
   Eremeev VA, 2003, DOKL PHYS, V48, P359, DOI 10.1134/1.1598247
   Eremeyev VA, 2011, J MECH PHYS SOLIDS, V59, P1395, DOI 10.1016/j.jmps.2011.04.005
   Eremeyev VA, 2009, ARCH MECH, V61, P41
   Eremeyev VA, 2004, J ELASTICITY, V74, P67, DOI 10.1023/B:ELAS.0000026106.09385.8c
   ESHELBY JD, 1957, PROC R SOC LON SER-A, V241, P376, DOI 10.1098/rspa.1957.0133
   Federico S, 2010, INT J MECH SCI, V52, P175, DOI 10.1016/j.ijmecsci.2009.09.006
   Garusi E., 2004, INT J COMPUTATIONAL, V5, P589
   Ghiba I.D., MATH MECH SOLI UNPUB
   Giorgio I, 2009, ARCH APPL MECH, V79, P859, DOI 10.1007/s00419-008-0258-x
   GOODMAN MA, 1972, ARCH RATION MECH AN, V44, P249
   Grillo A, 2012, INT J NONLIN MECH, V47, P388, DOI 10.1016/j.ijnonlinmec.2011.09.026
   HILLSLEY MV, 1994, BIOTECHNOL BIOENG, V43, P573, DOI 10.1002/bit.260430706
   HUISKES R, 1987, J BIOMECH, V20, P1135, DOI 10.1016/0021-9290(87)90030-3
   Klein-Nulend J., 2003, CURR OSTEOPOROS REP, V1, P5
   Koc IM, 2005, J ACOUST SOC AM, V118, P3031, DOI 10.1121/1.2074807
   Lekszycki T, 2002, MECCANICA, V37, P343, DOI 10.1023/A:1020831519496
   Lekszycki T, 2012, ZAMM-Z ANGEW MATH ME, V92, P426, DOI 10.1002/zamm.201100082
   Luongo A, 2004, COMPUT STRUCT, V82, P2705, DOI 10.1016/j.compstruc.2004.04.022
   Luongo A, 2003, NONLINEAR DYNAM, V34, P269, DOI 10.1023/B:NODY.0000013508.50435.39
   Luongo A, 1996, NONLINEAR DYNAM, V10, P317, DOI 10.1007/BF00045480
   Luongo A, 1999, NONLINEAR DYNAM, V19, P133
   Luongo A, 1997, NONLINEAR DYNAM, V14, P193, DOI 10.1023/A:1008201828000
   Madeo A, 2013, J MECH PHYS SOLIDS, V61, P2196, DOI 10.1016/j.jmps.2013.06.009
   Madeo A, 2013, CONTINUUM MECH THERM, V25, P173, DOI 10.1007/s00161-012-0236-y
   Madeo A., 2013, CONTINUUM MECH THERM, DOI [10.1007/s00161-013-0329-2:1-20, DOI 10.1007/S00161-013-0329-2:1-20]
   Madeo A, 2008, J MECH MATER STRUCT, V3, P607, DOI 10.2140/jomms.2008.3.607
   Madeo A, 2012, CR MECANIQUE, V340, P575, DOI 10.1016/j.crme.2012.05.003
   Madeo A, 2011, CR MECANIQUE, V339, P625, DOI 10.1016/j.crme.2011.07.004
   Martin R.B., 1984, POROSITY SPECIFIC SU, P179
   Maurini C, 2004, INT J SOLIDS STRUCT, V41, P4473, DOI 10.1016/j.ijsolstr.2004.03.002
   Maurini C, 2004, MECH SYST SIGNAL PR, V18, P1243, DOI 10.1016/S0888-3270(03)00082-7
   Maurini C, 2006, COMPUT STRUCT, V84, P1438, DOI 10.1016/j.compstruc.2006.01.016
   Neff P., 2013, CONTIN MECH THERMODY, P1, DOI [10.1007/s00161-013-0322-9, DOI 10.1007/S00161-013-0322-9]
   Neff P, 2007, J ELASTICITY, V87, P239, DOI 10.1007/s10659-007-9106-4
   Neff P, 2006, ZAMM-Z ANGEW MATH ME, V86, P892, DOI 10.1002/zamm.200510281
   OLIVETO G, 1988, ENG STRUCT, V10, P2, DOI 10.1016/0141-0296(88)90011-9
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Pietraszkiewicz W, 2007, ZAMM-Z ANGEW MATH ME, V87, P150, DOI 10.1002/zamm.200610309
   Placidi L, 2008, EUR J MECH A-SOLID, V27, P582, DOI 10.1016/j.euromechsol.2007.10.003
   Quiligotti S, 2003, ACTA MECH, V160, P45, DOI 10.1007/s00707-002-0968-z
   Ramaswamy Y, 2005, J MATER SCI-MATER M, V16, P1199, DOI 10.1007/s10856-005-4729-0
   Reccia E., 2012, OPEN CIVIL ENG J, V6, P231
   Rinaldi A, 2007, INT J PLASTICITY, V23, P1796, DOI 10.1016/j.ijplas.2007.03.005
   Rinaldi A., 2013, MICROSCALE 2 GRADIEN, DOI [10.1002/zamm.201300028, DOI 10.1002/ZAMM.201300028]
   Rinaldi A, 2009, INT J DAMAGE MECH, V18, P233, DOI 10.1177/1056789508097544
   Rosi G, 2013, J VIB CONTROL, V19, P658, DOI 10.1177/1077546312437236
   Rosi G, 2010, EUR J MECH A-SOLID, V29, P859, DOI 10.1016/j.euromechsol.2010.02.014
   RUBIN CT, 1987, J ORTHOPAED RES, V5, P300, DOI 10.1002/jor.1100050217
   Sanz-Herrera JA, 2008, COMPUT METHOD APPL M, V197, P3092, DOI 10.1016/j.cma.2008.02.010
   Sanz-Herrera JA, 2011, INT J SOLIDS STRUCT, V48, P257, DOI 10.1016/j.ijsolstr.2010.09.025
   Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079
   Sciarra G, 2001, CONTINUUM MECH THERM, V13, P287, DOI 10.1007/s001610100053
   Sethuraman S, 2010, ACTA BIOMATER, V6, P1931, DOI 10.1016/j.actbio.2009.12.012
   Tricoteaux A, 2011, J EUR CERAM SOC, V31, P1361, DOI 10.1016/j.jeurceramsoc.2011.02.005
   Yeremeyev VA, 2007, PMM-J APPL MATH MEC+, V71, P61, DOI 10.1016/j.jappmathmech.2007.03.007
   Yusop AH, 2012, INT J BIOMATER, DOI [10.1155/2012/641430, DOI 10.1155/2012/641430]
   Zanetta M, 2009, ACTA BIOMATER, V5, P1126, DOI 10.1016/j.actbio.2008.12.003
   Zhou H, 2012, ACTA BIOMATER, V8, P1999, DOI 10.1016/j.actbio.2012.01.031
NR 100
TC 43
Z9 43
U1 2
U2 18
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 0044-2275
EI 1420-9039
J9 Z ANGEW MATH PHYS
JI Z. Angew. Math. Phys.
PD FEB
PY 2015
VL 66
IS 1
BP 209
EP 237
DI 10.1007/s00033-014-0403-z
PG 29
WC Mathematics, Applied
SC Mathematics
GA CA6NE
UT WOS:000349030200013
DA 2018-10-19
ER

PT J
AU Gugerell, A
   Neumann, A
   Kober, J
   Tammaro, L
   Hoch, E
   Schnabelrauch, M
   Kamolz, L
   Kasper, C
   Keck, M
AF Gugerell, Alfred
   Neumann, Anne
   Kober, Johanna
   Tammaro, Loredana
   Hoch, Eva
   Schnabelrauch, Matthias
   Kamolz, Lars
   Kasper, Cornelia
   Keck, Maike
TI Adipose-derived stem cells cultivated on electrospun L-lactide/glycolide
   copolymer fleece and gelatin hydrogels under flow conditions - aiming
   physiological reality in hypodermis tissue engineering
SO BURNS
LA English
DT Article
DE Adipose-derived stem cells; Skin tissue engineering; Scaffold;
   Bioreactor; Hydrogel; Electrospinning
ID SHEAR-STRESS; PERFUSION; MATRIX; VASCULARIZATION; RECONSTRUCTION;
   KERATINOCYTES; BIOREACTORS; SUBSTITUTE; THICKNESS; SURVIVAL
AB Introduction: Generation of adipose tissue for bum patients that suffer from an irreversible loss of the hypodermis is still one of the most complex challenges in tissue engineering. Electrospun materials with their micro- and nanostructures are already well established for their use as extracellular matrix substitutes. Gelatin is widely used in tissue engineering to gain thickness and volume. Under conventional static cultivation methods the supply of nutrients and transport of toxic metabolites is controlled by diffusion and therefore highly dependent on size and porosity of the biomaterial. A widely used method in order to overcome these limitations is the medium perfusion of 3D biomaterial-cell-constructs.
   In this study we combined perfusion bioreactor cultivation techniques with electrospun poly((L)-lactide-co-glycolide) (P(LLG)) and gelatin hydrogels together with adipose-derived stem cells (ASCs) for a new approach in soft tissue engineering.
C1 [Gugerell, Alfred; Kober, Johanna; Keck, Maike] Med Univ Vienna, Div Plast & Reconstruct Surg, Dept Surg, A-1090 Vienna, Austria.
   [Neumann, Anne; Kasper, Cornelia] Univ Nat Resources & Life Sci, Dept Biotechnol, A-1190 Vienna, Austria.
   [Tammaro, Loredana] Univ Salerno, Dept Ind Engn, I-84084 Fisciano, SA, Italy.
   [Hoch, Eva] Univ Stuttgart, Inst Interfacial Proc Engn & Plasma Technol, D-70669 Stuttgart, Germany.
   [Schnabelrauch, Matthias] INNOVENT eV, Biomat Dept, D-07745 Jena, Germany.
   [Kamolz, Lars] Med Univ Graz, Div Plast Aesthet & Reconstruct Surg, Dept Surg, A-8036 Graz, Austria.
RP Gugerell, A (reprint author), Med Univ Vienna, Div Plast & Reconstruct Surg, Dept Surg, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
EM Alfred.Gugerell@meduniwien.ac.at; Anne.Neumann@boku.ac.at;
   Johanna.Kober@meduniwien.ac.at; Itammaro@unisa.it;
   Eva.Hoch@igvp.uni-stuttgart.de; MS@innovent-jena.de;
   Lars.Kamolz@medunigraz.at; Cornelia.Kasper@boku.ac.at;
   Maike.Keck@meduniwien.ac.at
OI Kamolz, Lars-Peter/0000-0002-5975-876X; Gugerell,
   Alfred/0000-0002-5178-9967
FU European Union Seventh Framework Programme (FP7) through the ArtiVasc 3D
   project [263416]
FX The research leading to these results has received funding from the
   European Union Seventh Framework Programme (FP7) through the ArtiVasc 3D
   project under grant agreement no. 263416. The funding source had no
   involvement in study design, in the collection, analysis and
   interpretation of data, in the writing of the report and in the decision
   to submit the article for publication.
CR Auger FA, 2013, ANNU REV BIOMED ENG, V15, P177, DOI 10.1146/annurev-bioeng-071812-152428
   Carriel V, 2012, CELLS TISSUES ORGANS, V196, P1, DOI 10.1159/000330682
   Carrier RL, 2002, TISSUE ENG, V8, P175, DOI 10.1089/107632702753724950
   Fan WW, 2013, STEM CELLS, V31, P203, DOI 10.1002/stem.1265
   Haj AJ, 2009, ADV BIOCHEM ENG BIOT, V112, P81
   Hanson SE, 2010, PLAST RECONSTR SURG, V125, P510, DOI 10.1097/PRS.0b013e3181c722bb
   Hendrickx B, 2011, TISSUE ENG PART B-RE, V17, P13, DOI [10.1089/ten.teb.2010.0315, 10.1089/ten.TEB.2010.0315]
   Hoch E, 2013, J MATER CHEM B, V1, P5675, DOI 10.1039/c3tb20745e
   Hoch E, 2012, J MATER SCI-MATER M, V23, P2607, DOI 10.1007/s10856-012-4731-2
   Horch R, 2009, TISSUE ENG, P123
   Kalyanaraman B, 2008, TISSUE ENG PT A, V14, P583, DOI 10.1089/tea.2007.0237
   Keck M, 2013, EUR SURG, V45, P263, DOI 10.1007/s10353-013-0211-2
   Keck M, 2012, BURNS, V38, P388, DOI 10.1016/j.burns.2011.09.026
   Keck M, 2011, BURNS, V37, P626, DOI 10.1016/j.burns.2010.07.016
   Khil MS, 2005, J BIOMED MATER RES B, V72B, P117, DOI 10.1002/jbm.b.30122
   Kluger PJ, 2010, J MATER SCI-MATER M, V21, P2665, DOI 10.1007/s10856-010-4128-z
   Knippenberg M, 2005, TISSUE ENG, V11, P1780, DOI 10.1089/ten.2005.11.1780
   Liao JH, 2010, BIOMATERIALS, V31, P8911, DOI 10.1016/j.biomaterials.2010.07.110
   Marino D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006894
   Mikos AG, 1998, ADV DRUG DELIV REV, V33, P111
   Navarro FA, 2001, WOUND REPAIR REGEN, V9, P507, DOI 10.1046/j.1524-475x.2001.00507.x
   Palumbo FS, 2013, MAT SCI ENG C-MATER, V33, P2541, DOI 10.1016/j.msec.2013.02.015
   Priya SG, 2008, TISSUE ENG PART B-RE, V14, P105, DOI 10.1089/teb.2007.0318
   Santoro R, 2010, BIOMATERIALS, V31, P8946, DOI 10.1016/j.biomaterials.2010.08.009
   Shenaq SM, 2002, CLIN PLAST SURG, V29, P111, DOI 10.1016/S0094-1298(03)00089-0
   Shenaq SM, 2002, CLIN PLAST SURG, V29, pvi
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Sodian R, 2002, TISSUE ENG, V8, P863, DOI 10.1089/10763270260424222
   van den Broek LJ, 2014, TISSUE ENG PT A, V20, P197, DOI [10.1089/ten.TEA.2013.0123, 10.1089/ten.tea.2013.0123]
   van der Veen VC, 2011, WOUND REPAIR REGEN, V19, pS59, DOI 10.1111/j.1524-475X.2011.00713.x
   von Heimburg D, 2005, RESP PHYSIOL NEUROBI, V146, P107, DOI 10.1016/j.resp.2004.12.013
   Walles T, 2003, BIOMATERIALS, V24, P1233, DOI 10.1016/S0142-9612(02)00490-8
   Williams C, 2005, ANN BIOMED ENG, V33, P920, DOI 10.1007/s10439-005-3238-0
   Yeatts AB, 2011, BONE, V48, P171, DOI 10.1016/j.bone.2010.09.138
NR 34
TC 10
Z9 11
U1 2
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0305-4179
EI 1879-1409
J9 BURNS
JI Burns
PD FEB
PY 2015
VL 41
IS 1
BP 163
EP 171
DI 10.1016/j.burns.2014.06.010
PG 9
WC Critical Care Medicine; Dermatology; Surgery
SC General & Internal Medicine; Dermatology; Surgery
GA AZ5JL
UT WOS:000348257400022
PM 25440846
DA 2018-10-19
ER

PT J
AU Wang, YC
   Li, PW
   Chen, LJ
   Gao, WM
   Zeng, FB
   Kong, LX
AF Wang, Yichao
   Li, Puwang
   Chen, Lijue
   Gao, Weimin
   Zeng, Fanbo
   Kong, Ling Xue
TI Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient
   folic acid-conjugated nanoparticles
SO DRUG DELIVERY
LA English
DT Article
DE HT-29; nanoparticles; PLGA-1, 3-diaminopropane-folic acid; targeting
ID DRUG-DELIVERY; IN-VITRO; PLGA NANOPARTICLES; CELLULAR UPTAKE; COATED
   SPHERE; SLOW-RELEASE; TUMOR-CELLS; CHITOSAN; CANCER; DOCETAXEL
AB The incorporation of a high percentage of targeting molecules into drug delivery system is one of the important methods for improving efficacy of targeting therapeutic drugs to cancer cells. PLGA-based drug delivery carriers with folic acid (FA) as targeting molecule have a low targeting efficiency due to a low FA conjugation ratio. In this work, we fabricated a FA-conjugated PLGA system using a crosslinker 1, 3-diaminopropane and have achieved a high conjugation ratio of 46.7% (mol/mol). The as-prepared PLGA-based biomaterial was used to encapsulate therapeutic drug 5-fluorouracil (5-FU) into nanoparticles. In the in vitro experiments, an IC50 of 5.69 mg/mL has been achieved for 5-FU loaded PLGA-1, 3-diaminopropane-folic acid nanoparticles on HT-29 cancer cells and is significantly lower than that of 5-FU and 5-FU loaded PLGA nanoparticles which only have an IC50 of 22.9 and 14.17 mg/mL, respectively. The fluorescent microscopy images showed that nanoparticles with FA are largely taken up by HT-29 cancer cells and the targeting nanoparticles have more affinity to cancer cells than the pure drugs and untreated nanoparticles. Therefore, the 1, 3-diaminopropane can facilitate the conjugation of FA to PLGA to form a novel polymer and 5-FU loaded PLGA-1, 3-diaminopropane-folic acid nanoparticles can be a highly efficient system for specific delivery of drugs to cancer cells.
C1 [Wang, Yichao; Li, Puwang; Chen, Lijue; Gao, Weimin; Kong, Ling Xue] Deakin Univ, Inst Frontier Mat, Waurn Ponds, Vic 3216, Australia.
   [Li, Puwang] Chinese Acad Trop Agr Sci, Agr Prod Proc Res Inst, Zhanjiang, Peoples R China.
   [Zeng, Fanbo] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 430074, Peoples R China.
RP Kong, LX (reprint author), Deakin Univ, Inst Frontier Mat, 75 Pigdons Rd, Waurn Ponds, Vic 3216, Australia.
EM lingxue.kong@deakin.edu.au
RI Kong, Lingxue/D-8216-2011
OI Kong, Lingxue/0000-0001-6219-3897; Gao, Weimin/0000-0002-7390-169X;
   Wang, Yichao/0000-0002-6295-6492
CR Banfi L, 1999, TETRAHEDRON-ASYMMETR, V10, P3571, DOI 10.1016/S0957-4166(99)00371-7
   Chen YS, 2011, DRUG DELIV, V18, P493, DOI 10.3109/10717544.2011.589088
   Choi SW, 2007, J CONTROL RELEASE, V122, P24, DOI 10.1016/j.jconrel.2007.06.003
   Ebrahimnejad P, 2010, NANOMED-NANOTECHNOL, V6, P478, DOI 10.1016/j.nano.2009.10.003
   Elnakat H, 2004, ADV DRUG DELIVER REV, V56, P1067, DOI 10.1016/j.addr.2004.01.001
   Esmaeili F, 2008, J DRUG TARGET, V16, P415, DOI [10.1080/10611860802088630, 10.1080/10611860802088630 ]
   Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103
   Gupta Y, 2007, J DRUG TARGET, V15, P231, DOI 10.1080/10611860701289719
   Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074
   Kasuya Y, 2001, BIOORG MED CHEM LETT, V11, P2089, DOI 10.1016/S0960-894X(01)00374-2
   LEE DJ, 1995, J PHARM SCI, V84, P1366, DOI 10.1002/jps.2600841119
   Li PW, 2011, CARBOHYD RES, V346, P801, DOI 10.1016/j.carres.2011.01.027
   Liao YC, 1997, J PHARM SCI, V86, P92, DOI 10.1021/js960143c
   Lu YJ, 2002, CANCER IMMUNOL IMMUN, V51, P153, DOI 10.1007/s00262-002-0266-6
   Musumeci T, 2006, INT J PHARM, V325, P172, DOI 10.1016/j.ijpharm.2006.06.023
   Nie Y, 2009, J MATER SCI-MATER M, V20, P1849, DOI 10.1007/s10856-009-3750-0
   Park EK, 2005, BIOMATERIALS, V26, P1053, DOI 10.1016/j.biomaterials.2004.04.008
   Sahana DK, 2008, J PHARM SCI-US, V97, P1530, DOI 10.1002/jps.21158
   Townsend SA, 2007, BIOMATERIALS, V28, P5176, DOI 10.1016/j.biomaterials.2007.08.011
   Wang YC, 2013, AAPS PHARMSCITECH, V14, P585, DOI 10.1208/s12249-013-9943-3
   Wang YC, 2013, J APPL POLYM SCI, V129, P714, DOI 10.1002/app.38582
   Yoo HS, 2004, J CONTROL RELEASE, V96, P273, DOI 10.1016/j.jconrel.2004.02.003
   Zaki NM, 2014, DRUG DELIV, V21, P265, DOI 10.3109/10717544.2013.838808
   Zhang ZP, 2007, BIOMATERIALS, V28, P1889, DOI 10.1016/j.biomaterials.2006.12.018
   Zhang ZP, 2006, BIOMATERIALS, V27, P4025, DOI 10.1016/j.biomaterials.2006.03.006
   Zhao HZ, 2008, INT J PHARMACEUT, V349, P256, DOI 10.1016/j.ijpharm.2007.07.040
   Zheng YL, 2007, EUR J PHARM BIOPHARM, V67, P621, DOI 10.1016/j.ejpb.2007.04.007
NR 27
TC 24
Z9 24
U1 0
U2 40
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1071-7544
EI 1521-0464
J9 DRUG DELIV
JI Drug Deliv.
PD FEB
PY 2015
VL 22
IS 2
BP 191
EP 198
DI 10.3109/10717544.2013.875603
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AZ6UG
UT WOS:000348355200005
PM 24437926
OA Bronze
DA 2018-10-19
ER

PT J
AU Zhang, XW
   Zhang, C
   Zhang, W
   Meng, S
   Liu, DH
   Wang, P
   Guo, J
   Li, JX
   Guan, YM
   Yang, D
AF Zhang, Xiaowei
   Zhang, Chong
   Zhang, Wei
   Meng, Shu
   Liu, Danhua
   Wang, Ping
   Guo, Jing
   Li, Jianxin
   Guan, Yanmin
   Yang, Dan
TI Feasibility of poly (epsilon-caprolactone-co-DL-lactide) as a
   biodegradable material for in situ forming implants: evaluation of drug
   release and in vivo degradation
SO DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
LA English
DT Article
DE Biocompatibility; biodegradable polymers; controlled delivery; in situ
   forming implants; poly (epsilon-caprolactone-co-DL-lactide);
   testosterone undecanoate
ID PHASE INVERSION DYNAMICS; DELIVERY SYSTEMS; MOLECULAR-WEIGHT;
   TESTOSTERONE UNDECANOATE; MALE CONTRACEPTION; SUSTAINED-RELEASE; VITRO
   RELEASE; COPOLYMERS; BLENDS; POLY(EPSILON-CAPROLACTONE)
AB The purpose of this study was to evaluate the technical feasibility of poly (epsilon-caprolactone-coDL-lactide), P (CL/DL-LA), for injectable in situ forming implants (ISFI). The ISFI was prepared by dissolving P (CL/DL-LA) in N-methyl-2-pyrrolidone (NMP), and Testosterone undecanoate (TU) was used as model drug. The effect of various polymer concentrations, molecular weights (Mws) and drug loads on the drug release from the TU-loaded ISFI systems was investigated in vitro. The release of TU-loaded ISFI was also evaluated in rats. In addition, a subcutaneous rabbit model was used to evaluate the degradation and foreign-body reaction of P (CL/DL-LA) ISFI. The use of higher concentration of P (CL/DL-LA) with higher molecule weight and larger CL:DL-LA monomer ratio for the TU-loaded ISFI gave a slower drug release. The ISFI of 80/20 P (CL/DL-LA) (Mw 61 753):NMP 20: 80 with 16% TU formulation increased serum testosterone levels in rats over a period of three months. The in vivo degradation and biocompatibility study of ISFI shows that P (CL/DL-LA) degrades by a process of bulk degradation and that the foreignbody reaction of this biomaterial is relatively mild. In summary, our investigations demonstrate that in situ parenteral drug delivery systems can be obtained from P (CL/DL-LA) solutions.
C1 [Zhang, Xiaowei; Zhang, Chong; Zhang, Wei; Meng, Shu; Liu, Danhua; Wang, Ping; Guo, Jing; Li, Jianxin; Guan, Yanmin; Yang, Dan] Liaoning Res Inst Family Planning, Shenyang 110031, Peoples R China.
RP Yang, D (reprint author), Liaoning Res Inst Family Planning, PuHe Rd 10, Shenyang 110031, Peoples R China.
EM yangdan999@hotmail.com
CR Ahola M., 1999, International Journal of Pharmaceutics (Amsterdam), V181, P181, DOI 10.1016/S0378-5173(99)00022-8
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Barakat NS, 2013, DRUG DEV IND PHARM, V39, P352, DOI 10.3109/03639045.2012.681383
   Bertram U, 2012, DRUG DEV IND PHARM, V38, P659, DOI 10.3109/03639045.2011.598536
   Brodbeck KJ, 1999, J CONTROL RELEASE, V62, P333, DOI 10.1016/S0168-3659(99)00159-5
   Brodbeck KJ, 1999, PHARMACEUT RES, V16, P1825, DOI 10.1023/A:1018943107688
   Camargo JA, 2013, DRUG DEV IND PHARM, V39, P146, DOI 10.3109/03639045.2012.660952
   Cheung HY, 2007, COMPOS PART B-ENG, V38, P291, DOI 10.1016/j.compositesb.2006.06.014
   Cohn D, 2005, BIOMACROMOLECULES, V6, P1168, DOI 10.1021/bm0495250
   denDunnen WFA, 1997, J BIOMED MATER RES, V36, P337, DOI 10.1002/(SICI)1097-4636(19970905)36:3<337::AID-JBM9>3.3.CO;2-8
   Deschamps AA, 2004, BIOMATERIALS, V25, P247, DOI 10.1016/S0142-9612(03)00495-2
   DesNoyer JR, 2001, J CONTROL RELEASE, V70, P285, DOI 10.1016/S0168-3659(00)00354-0
   Einmahl S, 2001, ADV DRUG DELIVER REV, V53, P45, DOI 10.1016/S0169-409X(01)00220-4
   Gan ZH, 1999, POLYMER, V40, P2859, DOI 10.1016/S0032-3861(98)00549-7
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Graham PD, 1999, J CONTROL RELEASE, V58, P233, DOI 10.1016/S0168-3659(98)00158-8
   Gu YQ, 2009, J CLIN ENDOCR METAB, V94, P1910, DOI 10.1210/jc.2008-1846
   Hakkarainen M, 2000, POLYMER, V41, P2331, DOI 10.1016/S0032-3861(99)00393-6
   Hatefi A, 2002, J CONTROL RELEASE, V80, P9, DOI 10.1016/S0168-3659(02)00008-1
   Hutmacher D, 1996, Int J Oral Maxillofac Implants, V11, P667
   JALIL RU, 1990, DRUG DEV IND PHARM, V16, P2353, DOI 10.3109/03639049009058535
   Kang FR, 2005, INT J PHARM, V304, P83, DOI 10.1016/j.ijpharm.2005.07.024
   Lemmouchi Y, 1998, J CONTROL RELEASE, V55, P79, DOI 10.1016/S0168-3659(98)00021-2
   Liu PY, 2010, CONTRACEPTION, V82, P471, DOI 10.1016/j.contraception.2010.03.010
   Liu QF, 2010, INT J PHARMACEUT, V397, P122, DOI 10.1016/j.ijpharm.2010.07.015
   LIU Y, 2010, EUR J PHARM BIOPHARM, V76, P222
   Malin M, 1996, J APPL POLYM SCI, V59, P1289, DOI 10.1002/(SICI)1097-4628(19960222)59:8<1289::AID-APP12>3.0.CO;2-1
   Meriggiola MC, 2005, J CLIN ENDOCR METAB, V90, P2005, DOI 10.1210/jc.2004-1852
   Packhaeuser CB, 2004, EUR J PHARM BIOPHARM, V58, P445, DOI 10.1016/uj.ejpb.2004.03.003
   Patel RB, 2010, J CONTROL RELEASE, V147, P350, DOI 10.1016/j.jconrel.2010.08.020
   PEREGO G, 1993, MAKROMOL CHEM, V194, P2463
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   Qian Y, 2010, DRUG DEV IND PHARM, V36, P1340, DOI 10.3109/03639041003801893
   Ravivarapu HB, 2000, INT J PHARM, V194, P181, DOI 10.1016/S0378-5173(99)00371-3
   Rich J, 2001, INT J PHARM, V212, P121, DOI 10.1016/S0378-5173(00)00601-3
   Royals MA, 1999, J BIOMED MATER RES, V45, P231, DOI 10.1002/(SICI)1097-4636(19990605)45:3<231::AID-JBM11>3.0.CO;2-H
   Shive M. S., 1997, ADV DRUG DELIV REV, V28, P5
   Siparsky GL, 1998, J ENVIRON POLYM DEGR, V6, P31, DOI 10.1023/A:1022826528673
   Vieira AC, 2011, J MECH BEHAV BIOMED, V4, P451, DOI 10.1016/j.jmbbm.2010.12.006
   VION JM, 1986, MACROMOLECULES, V19, P1828, DOI 10.1021/ma00161a009
   Wang C, 2010, CURR OPIN UROL, V20, P520, DOI 10.1097/MOU.0b013e32833f1b4a
   Wang LW, 2004, J CONTROL RELEASE, V99, P207, DOI 10.1016/j.jconrel.2004.06.021
   Wang SH, 2007, INT J PHARM, V337, P102, DOI 10.1016/j.ijpharm.2006.12.031
   Williams DF, 1981, ENG MED, V10, P5, DOI DOI 10.1243/EMED_JOUR_1981_010_004_02
   Yang Y, 2012, DRUG DEV IND PHARM, V38, P550, DOI 10.3109/03639045.2012.665928
   Ye W P, 1996, Pharm Dev Technol, V1, P1
   Zhang C, 2013, J APPL POLYM SCI, V130, P3800, DOI 10.1002/app.39646
NR 47
TC 1
Z9 1
U1 2
U2 14
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0363-9045
EI 1520-5762
J9 DRUG DEV IND PHARM
JI Drug Dev. Ind. Pharm.
PD FEB
PY 2015
VL 41
IS 2
BP 342
EP 352
DI 10.3109/03639045.2013.866140
PG 11
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CA5BT
UT WOS:000348923200022
PM 24320881
DA 2018-10-19
ER

PT J
AU Villa, MM
   Wang, LP
   Huang, JP
   Rowe, DW
   Wei, M
AF Villa, Max M.
   Wang, Liping
   Huang, Jianping
   Rowe, David W.
   Wei, Mei
TI Bone tissue engineering with a collagen-hydroxyapatite scaffold and
   culture expanded bone marrow stromal cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE tissue engineering; stem cells; bone; collagen; bone marrow
ID MESENCHYMAL STEM-CELLS; I COLLAGEN; EXTRACELLULAR-MATRIX; PROGENITOR
   CELLS; IMAGE-ANALYSIS; DEFECTS; REPAIR; SITES; MICROSCOPY; PROTEIN
AB Osteoprogenitor cells combined with supportive biomaterials represent a promising approach to advance the standard of care for bone grafting procedures. However, this approach faces challenges, including inconsistent bone formation, cell survival in the implant, and appropriate biomaterial degradation. We have developed a collagen-hydroxyapatite (HA) scaffold that supports consistent osteogenesis by donor-derived osteoprogenitors, and is more easily degraded than a pure ceramic scaffold. Herein, the material properties are characterized as well as cell attachment, viability, and progenitor distribution in vitro. Furthermore, we examined the biological performance in vivo in a critical-size mouse calvarial defect. To aid in the evaluation of the in-house collagen-HA scaffold, the in vivo performance was compared with a commercial collagen-HA scaffold (Healos((R)), Depuy). The in-house collagen-HA scaffold supported consistent bone formation by predominantly donor-derived osteoblasts, nearly completely filling a 3.5 mm calvarial defect with bone in all samples (n=5) after 3 weeks of implantation. In terms of bone formation and donor cell retention at 3 weeks postimplantation, no statistical difference was found between the in-house and commercial scaffold following quantitative histomorphometry. The collagen-HA scaffold presented here is an open and well-defined platform that supports robust bone formation and should facilitate the further development of collagen-hydroxyapatite biomaterials for bone tissue engineering. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 243-253, 2015.
C1 [Villa, Max M.; Wei, Mei] Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT 06269 USA.
   [Wang, Liping; Huang, Jianping; Rowe, David W.] Univ Connecticut, Ctr Hlth, Sch Dent Med, Dept Reconstruct Sci,Ctr Regenerat Med & Skeletal, Farmington, CT 06030 USA.
RP Wei, M (reprint author), Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT 06269 USA.
EM meiwei@engr.uconn.edu
FU GAANN pre-doctoral fellowship from the Department of Education
   [P200A09315]; NIH [1R21AR059962-01A1, 3 R01 AR064381-01S1]; NSF
   [CBET-1133883]
FX Contract grant sponsor: GAANN pre-doctoral fellowship from the
   Department of Education; contract grant number: P200A09315; Contract
   grant sponsor: NIH; contract grant number: 1R21AR059962-01A1, 3 R01
   AR064381-01S1; Contract grant sponsor: NSF; contract grant number:
   CBET-1133883
CR Auletta JJ, 2012, BLOOD, V119, P1801, DOI 10.1182/blood-2011-10-384354
   Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x
   Boskey A. L., 2013, PRIMER METABOLIC BON
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1
   DAVIS GE, 1992, BIOCHEM BIOPH RES CO, V182, P1025, DOI 10.1016/0006-291X(92)91834-D
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023
   English K, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015560
   Fields GB, 1995, CONNECT TISSUE RES, V31, P235, DOI 10.3109/03008209509010815
   Grcevic D, 2012, STEM CELLS, V30, P187, DOI 10.1002/stem.780
   Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215
   Holy CE, 2001, BIOMATERIALS, V22, P25, DOI 10.1016/S0142-9612(00)00136-8
   Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15
   Kemppainen JM, 2010, BIOMATERIALS, V31, P279, DOI 10.1016/j.biomaterials.2009.09.041
   Krebsbach PH, 1998, TRANSPLANTATION, V66, P1272, DOI 10.1097/00007890-199811270-00002
   Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Parks WC, 1999, WOUND REPAIR REGEN, V7, P423, DOI 10.1046/j.1524-475X.1999.00423.x
   PATE FD, 1994, J ARCHAEOL METHOD TH, V1, P161, DOI DOI 10.1007/BF02231415
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qu HB, 2008, J AM CERAM SOC, V91, P3211, DOI 10.1111/j.1551-2916.2008.02634.x
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P246, DOI [10.1089/ten.TEB.2011.0427, 10.1089/ten.teb.2011.0427]
   VansAmerongen MJ, 2006, BIOMATERIALS, V27, P2247
   Villa MM, 2013, TISSUE ENG PART C-ME, V19, P839, DOI [10.1089/ten.tec.2012.0490, 10.1089/ten.TEC.2012.0490]
   WERB Z, 1975, J EXP MED, V142, P346, DOI 10.1084/jem.142.2.346
   Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308
   Yu XH, 2013, J TISSUE ENG REGEN M, V7, P974, DOI 10.1002/term.1490
   Yu XH, 2012, J MATER CHEM, V22, P9721, DOI 10.1039/c2jm30332a
   Zeitouni S, 2012, SCI TRANSL MED, V4
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
NR 41
TC 29
Z9 30
U1 1
U2 33
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2015
VL 103
IS 2
BP 243
EP 253
DI 10.1002/jbm.b.33225
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AZ7TD
UT WOS:000348419700001
PM 24909953
OA Green Accepted, Bronze
DA 2018-10-19
ER

PT J
AU Atayde, LM
   Cortez, PP
   Afonso, A
   Santos, M
   Mauricio, AC
   Santos, JD
AF Atayde, L. M.
   Cortez, P. P.
   Afonso, A.
   Santos, M.
   Mauricio, A. C.
   Santos, J. D.
TI Morphology effect of bioglass-reinforced hydroxyapatite (Bonelike (R))
   on osteoregeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bone ingrowth; porous; calcium phosphate(s); in vivo; bone graft
ID BONE-GRAFT SUBSTITUTES; CALCIUM-PHOSPHATE CERAMICS; SPHERICAL
   TETRACALCIUM PHOSPHATE; ANIMAL-MODEL; ORTHOPEDIC TRAUMA; BASIC
   PROPERTIES; FRACTURE REPAIR; SHEEP MODEL; COMPOSITES; SCAFFOLDS
AB In the last decades, the well-known disadvantages of autografts and allografts have driven to the development of synthetic bone grafts for bone regeneration. Bonelike((R)), a glass-reinforced hydroxyapatite (HA) composite was developed and registered for bone grafting. This biomaterial is composed by a modified HA matrix, with - and -tricalcium phosphate secondary phases. Aiming to improve the biological characteristics of Bonelike((R)), new spherical pelleted granules, of different shape and size, were developed with controlled micro and macrostructure. In the present study, it was compared the physicochemical properties and in vivo performance of different Bonelike((R)) granule presentationsBonelike((R)) polygonal (500-1000 mu m size) and Bonelike spherical (250-500 mu m; 500-1000 mu m size). For the in vivo study, Bonelike((R)) was implanted on sheep femurs, with various implantation times (30 days, 60 days, 120 days, and 180 days). X-ray diffraction analysis revealed that the phase composition of different granules presentations was similar. Bonelike((R)) spherical 500-1000 mu m was the most porous material (global porosity and intraporosity) and Bonelike((R)) polygonal 500-1000 mu m the less porous. Considering the in vivo study, both polygonal and spherical granules presented osteoconductive proprieties. The spherical granules showed several advantages, including easier medical application through syringe and improved osteointegration, osteoconduction, and degradation, by the presence of larger pores, controlled micro- and macrosctructure and suitable particle format that adapts to bone growth. Bonelike((R)) spherical 500-1000 mu m showed improved new bone invasion throughout the material's structure and Bonelike((R)) spherical 250-500 mu m appeared to induce faster bone regeneration, presenting less unfilled areas and less lacunae in the histological analysis. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 292-304, 2015.
C1 [Atayde, L. M.; Cortez, P. P.; Mauricio, A. C.] Univ Porto, ICBAS, Dept Clin Vet, P-4050313 Oporto, Portugal.
   [Atayde, L. M.; Cortez, P. P.; Mauricio, A. C.] CECA, ICETA, P-4051401 Oporto, Portugal.
   [Afonso, A.] Univ Porto FMDUP, Fac Med Dent, P-4200393 Oporto, Portugal.
   [Santos, M.] Biosckin Mol & Cell Therapies SA, P-4470605 Maia, Portugal.
   [Santos, J. D.] Univ Porto, Dept Engn Met & Mat, CEMUC, Fac Engn, P-4200465 Oporto, Portugal.
RP Atayde, LM (reprint author), Univ Porto, ICBAS, Dept Clin Vet, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal.
EM ataydelm@gmail.com
OI Santos, Jose Domingos/0000-0002-6871-9850; Mauricio, Ana
   Colette/0000-0002-0018-9363; Cortez, Paulo/0000-0001-7132-6786
FU QREN I&DT Cluster in Development of Products for Regenerative Medicine
   and Cell Therapies - Projects Biomat Cell QREN [2008/1372]; Project
   TRIBONE [11458]; European Community FEDER fund through ON2 - O Novo
   Norte - North Portugal Regional Operational Program; project FCT from
   Fundacao para a Ciencia e Tecnologia (FCT) [ENMED/0002/2010]; Ministerio
   da Educacao e da Ciencia; EuroNanoMed JTC Program; program COMPETE -
   Programa Operacional Factores de Competitividade
   [Pest-OE/AGR/UI0211/2011]
FX This research was supported by QREN I&DT Cluster in Development of
   Products for Regenerative Medicine and Cell Therapies - Projects Biomat
   & Cell QREN 2008/1372 and Project TRIBONE, No 11458, co-financed by the
   European Community FEDER fund through ON2 - O Novo Norte - North
   Portugal Regional Operational Program 2007-2013, by project FCT -
   ENMED/0002/2010 from Fundacao para a Ciencia e Tecnologia (FCT),
   Ministerio da Educacao e da Ciencia and EuroNanoMed JTC 2010 Program,
   and by the program COMPETE - Programa Operacional Factores de
   Competitividade, Project Pest-OE/AGR/UI0211/2011. The authors are
   grateful to Mrs. Ana Mota (FMD-UP) for her technical assistance with the
   histological studies. The authors are grateful to Mrs. Ana Mota (FMD-UP)
   for her technical assistance with the histological studies.
CR ASSELMEIER MA, 1993, AM J SPORT MED, V21, P170, DOI 10.1177/036354659302100202
   Atayde LM, 2014, J MATER SCI-MATER M, V25, P1885, DOI 10.1007/s10856-014-5216-2
   Baino F, 2011, J BIOMED MATER RES A, V97A, P514, DOI 10.1002/jbm.a.33072
   Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Bohner M, 2013, BIOMATTER, V3, P1
   Bohner M, 2012, J EUR CERAM SOC, V32, P2663, DOI 10.1016/j.jeurceramsoc.2012.02.028
   Bohner M, 2010, MATER TODAY, V13, P24, DOI 10.1016/S1369-7021(10)70014-6
   Boyan BD, 2003, BONE GRAFT SUBSTITUT, P231
   Bucholz R, 2000, BONE GRAFTS DERIVATI, V1994, P260
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Reis ECC, 2010, BRAZ ARCH BIOL TECHN, V53, P817, DOI 10.1590/S1516-89132010000400010
   Carson JS, 2007, INJURY, V38, pS33, DOI 10.1016/j.injury.2007.02.008
   Chen LW, 2012, FOOT ANKLE INT, V33, P424, DOI 10.3113/FAI.2012.0424
   Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, P131
   Cortez PP, 2011, J BIOMED MATER RES B, V99B, P170, DOI 10.1002/jbm.b.31884
   Cortez PP, 2011, J BIOMATER APPL, P201
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   Damien E, 2004, J Appl Biomater Biomech, V2, P65
   DAVIDSON MK, 1987, ISRAEL J MED SCI, V23, P551
   Doblare M, 2004, ENG FRACT MECH, V71, P1809, DOI 10.1016/j.engfracmech.2003.08.003
   Dorozhkin SV, 2013, MATERIALS, V6, P3840, DOI 10.3390/ma6093840
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Fleming JE, 2000, ORTHOP CLIN N AM, V31, P357, DOI 10.1016/S0030-5898(05)70156-5
   Fujishiro Y, 2001, J BIOMED MATER RES, V54, P525, DOI 10.1002/1097-4636(20010315)54:4<525::AID-JBM80>3.0.CO;2-#
   Galois Laurent, 2004, Acta Orthop Belg, V70, P598
   Gentile JV, 2013, J PEDIATR ORTHOPED, V33, P254, DOI 10.1097/BPO.0b013e318285c56c
   Giannoudis R V., 2005, INJURY S3, V3, pS20
   Goller G, 2003, CERAM INT, V29, P721, DOI 10.1016/S0272-8842(02)00223-7
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Griffon DJ, 2005, AO PRINCIPLES FRACTU, P72
   Hak DJ, 2007, J AM ACAD ORTHOP SUR, V15, P525, DOI 10.5435/00124635-200709000-00003
   Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Ishikawa K, 2004, J MATER SCI-MATER M, V15, P13, DOI 10.1023/B:JMSM.0000010092.01661.a8
   Ishikawa K, 2003, KEY ENG MAT, V240-2, P369, DOI 10.4028/www.scientific.net/KEM.240-242.369
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jha LJ, 1996, J BIOMED MATER RES, V31, P481, DOI 10.1002/(SICI)1097-4636(199608)31:4<481::AID-JBM7>3.0.CO;2-H
   Jha LJ, 1997, J MATER SCI-MATER M, V8, P185, DOI 10.1023/A:1018531505484
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Keating JF, 2001, J BONE JOINT SURG BR, V83B, P3, DOI 10.1302/0301-620X.83B1.11952
   KOHRI M, 1993, BIOMATERIALS, V14, P299, DOI 10.1016/0142-9612(93)90122-I
   LeGeros R Z, 1988, Ann N Y Acad Sci, V523, P268, DOI 10.1111/j.1749-6632.1988.tb38519.x
   Lobato JV, 2006, THIN SOLID FILMS, V515, P362, DOI 10.1016/j.tsf.2005.12.153
   Lobato JV, 2005, KEY ENG MAT, V284-286, P877, DOI 10.4028/www.scientific.net/KEM.284-286.877
   Lopes MA, 2001, J BIOMED MATER RES, V54, P463, DOI 10.1002/1097-4636(20010315)54:4<463::AID-JBM10>3.0.CO;2-Y
   Lopes MA, 2000, BIOMATERIALS, V21, P1165, DOI 10.1016/S0142-9612(00)00007-7
   Lopes MA, 1998, J BIOMED MATER RES, V41, P649, DOI 10.1002/(SICI)1097-4636(19980915)41:4<649::AID-JBM17>3.0.CO;2-9
   Martini L, 2001, COMPARATIVE MED, V51, P292
   McAuliffe John A, 2003, J Hand Ther, V16, P180
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   MISIEK DJ, 1984, J ORAL MAXIL SURG, V42, P150, DOI 10.1016/S0278-2391(84)80025-7
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.2128.x
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Oliveira SM, 2008, J BIOMED MATER RES B, V87B, P49, DOI 10.1002/jbm.b.31066
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Piattelli A, 1996, BIOMATERIALS, V17, P1767, DOI 10.1016/0142-9612(95)00342-8
   Pioletti DP, 2000, BIOMATERIALS, V21, P1103, DOI 10.1016/S0142-9612(99)00250-1
   Ravarian R, 2010, CERAM INT, V36, P291, DOI 10.1016/j.ceramint.2009.09.016
   REJDA BV, 1977, J BIOENG, V1, P93
   Ribeiro CC, 2006, J MATER SCI-MATER M, V17, P455, DOI 10.1007/s10856-006-8473-x
   Sa MJC, 2007, J BIOMATER APPL, V22, P5, DOI 10.1177/0885328206065860
   Salgado P. C., 2011, J BIOMATER NANOBIOTE, V2, P318, DOI 10.4236/jbnb.2011.23039
   Santos JD, 1996, J MATER SCI-MATER M, V7, P181, DOI 10.1007/BF00121258
   SANTOS JD, 1994, BIOMATERIALS, V15, P5, DOI 10.1016/0142-9612(94)90188-0
   SANTOS JD, 2010, Patent No. 2010021559
   SANTOS JD, 2000, Patent No. 2000068164
   Sanzana ES, 2014, J BIOMED MATER RES A, V102, P1767, DOI 10.1002/jbm.a.34845
   SHAPIRO F, 1988, J BONE JOINT SURG AM, V70A, P1067, DOI 10.2106/00004623-198870070-00016
   Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05
   Stevenson S, 1999, ORTHOP CLIN N AM, V30, P543, DOI 10.1016/S0030-5898(05)70107-3
   Trombelli L, 2012, CLIN ORAL IMPLAN RES, V23, P424, DOI 10.1111/j.1600-0501.2011.02318.x
   Uchino T, 2010, J MATER SCI-MATER M, V21, P1921, DOI 10.1007/s10856-010-4042-4
   Vaccaro AR, 2002, ORTHOPEDICS, V25, pS571
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Zyman Z, 2004, J MATER SCI-MATER M, V15, P551, DOI 10.1023/B:JMSM.0000026099.74563.db
NR 79
TC 5
Z9 5
U1 0
U2 31
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2015
VL 103
IS 2
BP 292
EP 304
DI 10.1002/jbm.b.33195
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AZ7TD
UT WOS:000348419700006
PM 24819340
DA 2018-10-19
ER

PT J
AU Brochu, ABW
   Matthys, OB
   Craig, SL
   Reichert, WM
AF Brochu, Alice B. W.
   Matthys, Oriane B.
   Craig, Stephen L.
   Reichert, William M.
TI Extended fatigue life of a catalyst free self-healing acrylic bone
   cement using microencapsulated 2-octyl cyanoacrylate
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bone cement; PMMA; acrylic; mechanical properties; fatigue;
   cyanoacrylate; self-healing
ID TOUGHENED EPOXY COMPOSITE; MECHANICAL-PROPERTIES; POLYMER COMPOSITES;
   REPAIR; RETARDATION; PERFORMANCE; CRACKS
AB The tissue adhesive 2-octyl cyanoacrylate (OCA) was encapsulated in polyurethane microshells and incorporated into bone cement to form a catalyst free, self-healing bone cement comprised of all clinically approved components. The bending strength, modulus, and fatigue lifetime were investigated in accordance with ASTM and ISO standards for the testing of PMMA bone cement. The bending strength of bone cement specimens decreased with increasing wt % capsules content for capsules without or with OCA, with specimens of <5 wt % capsule content showing minimal effect. In contrast, bone cement bending modulus was insensitive to capsule content. Load controlled fatigue testing was performed in air at room temperature on capsule free bone cement (0 wt %), bone cement with 5 wt % OCA-free capsules (5 wt % No OCA), and 5 wt % OCA-containing capsules (5 wt % OCA). Specimens were tested at a frequency of 5 Hz at maximum stresses of 90%, 80%, 70%, and 50% of each specimen's bending strength until failure. The 5 wt % OCA exhibited significant self-healing at 70% and 50% of its reference strength (p<0.05). Fatigue testing of all three specimen types in air at 22 MPa (50% of reference strength of the 5 wt % OCA specimens) showed that the cycles to failure of OCA-containing specimens was increased by two-fold compared with the OCA-free and capsule-free specimens. This study represents the first demonstration of dynamic, catalyst free self-healing in a biomaterial formulation. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 305-312, 2015.
C1 [Brochu, Alice B. W.; Matthys, Oriane B.; Reichert, William M.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
   [Craig, Stephen L.] Duke Univ, Dept Chem, Durham, NC 27708 USA.
RP Reichert, WM (reprint author), Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
EM reichert@duke.edu
RI Craig, Stephen/D-3484-2011
OI Craig, Stephen/0000-0002-8810-0369
FU NIH [EB 013874]
FX Contract grant sponsor: NIH; contract grant number: EB 013874 (to
   W.M.R.)
CR Andersson HM, 2007, SPRINGER SER MATER S, V100, P19, DOI 10.1007/978-1-4020-6250-6_2
   Bergman SD, 2007, SPRINGER SER MATER S, V100, P45, DOI 10.1007/978-1-4020-6250-6_3
   Brochu ABW, 2014, J BIOMED MATER RES B, V102, P181, DOI 10.1002/jbm.b.32994
   Brochu ABW, 2012, J BIOMED MATER RES B, V100B, P1764, DOI 10.1002/jbm.b.32743
   Brochu ABW, 2011, J BIOMED MATER RES A, V96A, P492, DOI 10.1002/jbm.a.32987
   Brown EN, 2005, COMPOS SCI TECHNOL, V65, P2474, DOI 10.1016/j.compscitech.2005.04.053
   Brown EN, 2005, COMPOS SCI TECHNOL, V65, P2466, DOI 10.1016/j.compscitech.2005.04.020
   Dailey MMC, 2013, J BIOMED MAT RES A
   Dry C, 1996, COMPOS STRUCT, V35, P263, DOI 10.1016/0263-8223(96)00033-5
   Fu SY, 2008, COMPOS PART B-ENG, V39, P933, DOI 10.1016/j.compositesb.2008.01.002
   Garcia SJ, 2011, PROG ORG COAT, V70, P142, DOI 10.1016/j.porgcoat.2010.11.021
   Jeffers JRT, 2007, J BIOMECH, V40, P1525, DOI 10.1016/j.jbiomech.2006.07.029
   Kessler MR, 2007, P I MECH ENG G-J AER, V221, P479, DOI 10.1243/09544100JAERO172
   Kessler MR, 2003, COMPOS PART A-APPL S, V34, P743, DOI 10.1016/S1359-835X(03)00138-6
   Kessler MR, 2001, COMPOS PART A-APPL S, V32, P683, DOI 10.1016/S1359-835X(00)00149-4
   Kuehn K-D, 2000, BONE CEMENTS UP TO D
   Kuehn KD, 2005, ORTHOP CLIN N AM, V36, P29, DOI 10.1016/j.ocl.2004.06.011
   LEWIS G, 1994, J APPL BIOMATER, V5, P307, DOI 10.1002/jab.770050405
   Lewis G, 2003, J BIOMED MATER RES B, V66B, P457, DOI 10.1002/jbm.b.10018
   Lewis G, 2005, BIOMATERIALS, V26, P4317, DOI 10.1016/j.biomaterials.2004.11.003
   Lewis G, 2004, BIOMATERIALS, V25, P1415, DOI 10.1016/S0142-9612(03)00631-8
   Lewis G, 2009, J APPL BIOMATER BIOM, V7, P90
   Palacos R, 2012, INSTRUCTIONS FOR USE
   PEREK J, 1992, J MATER SCI-MATER M, V3, P333, DOI 10.1007/BF00705365
   SOLTESZ U, 1994, J MATER SCI-MATER M, V5, P654, DOI 10.1007/BF00120350
   Soltesz UR, 2005, J ASTM INT, V2, P2
   Toohey KS, 2007, NAT MATER, V6, P581, DOI 10.1038/nmat1934
   White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232
   White SR, 2013, 4 INT C SELF HEAL MA
   Yang JL, 2008, MACROMOLECULES, V41, P9650, DOI 10.1021/ma801718v
   Yang YZ, 2009, CEMENT CONCRETE RES, V39, P382, DOI 10.1016/j.cemconres.2009.01.013
NR 31
TC 6
Z9 6
U1 3
U2 54
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2015
VL 103
IS 2
BP 305
EP 312
DI 10.1002/jbm.b.33199
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AZ7TD
UT WOS:000348419700007
PM 24825796
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Matuska, AM
   McFetridge, PS
AF Matuska, Andrea M.
   McFetridge, Peter S.
TI The effect of terminal sterilization on structural and biophysical
   properties of a decellularized collagen-based scaffold; implications for
   stem cell adhesion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cell adhesion; sterilization; surface modification; tissue engineering;
   collagen
ID TEMPOROMANDIBULAR-JOINT DISC; SELF-ASSEMBLED MONOLAYERS; TENDON-BONE
   ALLOGRAFTS; GAMMA-IRRADIATION; PERACETIC-ACID; BIOMECHANICAL PROPERTIES;
   MECHANICAL-PROPERTIES; VASCULAR TISSUES; RAMAN MICROSCOPY; FOCAL
   ADHESION
AB Terminal sterilization induces physical and chemical changes in the extracellular matrix (ECM) of ex vivo-derived biomaterials due to their aggressive mechanism of action. Prior studies have focused on how sterilization affects the mechanical integrity of tissue-based biomaterials but have rarely characterized effects on early cellular interaction, which is indicative of the biological response. Using a model fibrocartilage disc scaffold, these investigations compare the effect of three common sterilization methods [peracetic acid (PAA), gamma irradiation (GI), and ethylene oxide (EtO)] on a range of material properties and characterized early cellular interactions. GI and EtO produced unfavorable structural damage that contributed to inferior cell adhesion. Conversely, exposure to PAA resulted in limited structural alterations while inducing chemical modifications that favored cell attachment. Results suggest that the sterilization approach can be selected to modulate biomaterial properties to favor cellular adhesion and has relevance in tissue engineering and regenerative medicine applications. Furthermore, the study of cellular interactions with modified biomaterials in vitro provides information of how materials may react in subsequent clinical applications. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 397-406, 2015.
C1 [Matuska, Andrea M.; McFetridge, Peter S.] Univ Florida, Dept Biomed Engn, Gainesville, FL 32611 USA.
RP McFetridge, PS (reprint author), Univ Florida, Dept Biomed Engn, Gainesville, FL 32611 USA.
EM pmcfetridge@bme.ufl.edu
FU NIH [1R21DE022449]; National Science Foundation Graduate Research
   Fellowship [DGE-1315138]
FX Contract grant sponsor: NIH; contract grant number: 1R21DE022449;
   Contract grant sponsor: National Science Foundation Graduate Research
   Fellowship; contract grant number: DGE-1315138
CR Ali SM, 2013, ANAL METHODS-UK, V5, P2281, DOI 10.1039/c3ay40185e
   Amensag S, 2012, TISSUE ENG PART C-ME, V18, P903, DOI [10.1089/ten.tec.2012.0119, 10.1089/ten.TEC.2012.0119]
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   BAILEY AJ, 1964, RADIAT RES, V23, P145, DOI 10.2307/3571687
   Bailey MM, 2007, TISSUE ENG, V13, P2003, DOI 10.1089/ten.2006.0150
   Balsly CR, 2008, CELL TISSUE BANK, V9, P289, DOI 10.1007/s10561-008-9069-0
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   Borges AMG, 2013, MAT SCI ENG C-MATER, V33, P1315, DOI 10.1016/j.msec.2012.12.031
   Chassot Ana Lúcia Campani, 2006, Braz. Dent. J., V17, P117, DOI 10.1590/S0103-64402006000200006
   CHEUNG DT, 1990, J BIOMED MATER RES, V24, P581, DOI 10.1002/jbm.820240505
   Conway K, 1999, BIOTECH HISTOCHEM, V74, P20, DOI 10.3109/10520299909066473
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   Cwikel D, 2010, LANGMUIR, V26, P15289, DOI 10.1021/la1020252
   DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P149, DOI 10.1002/jbm.820290203
   Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002
   Dziedzic-Goclawska Anna, 2005, Cell and Tissue Banking, V6, P201, DOI 10.1007/s10561-005-0338-x
   FIDELER BM, 1995, AM J SPORT MED, V23, P643, DOI 10.1177/036354659502300521
   Finnegan M, 2010, J ANTIMICROB CHEMOTH, V65, P2108, DOI 10.1093/jac/dkq308
   FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Goktas S, 2014, J BIOMED MATER RES A, V102, P8, DOI 10.1002/jbm.a.34692
   Grabenwoger M, 1996, ANN THORAC SURG, V62, P772
   Grinnell F, 1978, Int Rev Cytol, V53, P65
   Haimi S, 2008, BIOLOGICALS, V36, P99, DOI 10.1016/j.biologicals.2007.06.001
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hirota N, 1998, J MOL BIOL, V275, P365, DOI 10.1006/jmbi.1997.1468
   Hoemann CD, 2007, OSTEOARTHR CARTILAGE, V15, P78, DOI 10.1016/j.joca.2006.06.015
   Holy CE, 2001, BIOMATERIALS, V22, P25, DOI 10.1016/S0142-9612(00)00136-8
   Huang QH, 2004, WOUND REPAIR REGEN, V12, P276, DOI 10.1111/j.1067-1927.2004.012312.x
   Johns DE, 2007, P I MECH ENG H, V221, P509, DOI 10.1243/09544119JEIM158
   Juran CM, 2013, J DENT RES, V92, P193, DOI 10.1177/0022034512468749
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kim KW, 2003, ANN BIOMED ENG, V31, P924, DOI 10.1114/1.1591190
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   Lindford AJ, 2012, BURNS, V38, P274, DOI 10.1016/j.burns.2011.08.009
   Lomas R. J., 2004, Cell and Tissue Banking, V5, P149, DOI 10.1023/B:CATB.0000046071.11459.bd
   Lumpkins SB, 2008, ACTA BIOMATER, V4, P808, DOI 10.1016/j.actbio.2008.01.016
   Mendes GCC, 2007, AM J INFECT CONTROL, V35, P574, DOI 10.1016/j.ajic.2006.10.014
   Moore M, 2013, TISSUE ENG PT A, V19, P2005, DOI [10.1089/ten.tea.2012.0592, 10.1089/ten.TEA.2012.0592]
   Nguyen Huynh, 2007, Cell and Tissue Banking, V8, P81, DOI 10.1007/s10561-006-9019-7
   Ogawa M, 2009, BIOCHEM BIOPH RES CO, V382, P370, DOI 10.1016/j.bbrc.2009.03.028
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Salehpour A, 1995, J ORTHOP RES, V13, P898, DOI 10.1002/jor.1100130614
   Scheffler S. U., 2005, Cell and Tissue Banking, V6, P109, DOI 10.1007/s10561-004-6403-z
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Uzarski JS, 2013, J BIOMED MATER RES A, V101, P123, DOI 10.1002/jbm.a.34308
   Vangsness CT, 2003, AM J SPORT MED, V31, P474, DOI 10.1177/03635465030310032701
   Wang YN, 2000, J BIOMECH, V33, P483, DOI 10.1016/S0021-9290(99)00194-3
   Widgerow AD, 2012, ANN PLAS SURG, V68, P574, DOI 10.1097/SAP.0b013e31824b3d1c
   Woon CYL, 2011, PLAST RECONSTR SURG, V127, P1107, DOI 10.1097/PRS.0b013e318205f298
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
NR 56
TC 30
Z9 31
U1 2
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2015
VL 103
IS 2
BP 397
EP 406
DI 10.1002/jbm.b.33213
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AZ7TD
UT WOS:000348419700017
PM 24895116
OA Green Accepted, Bronze
DA 2018-10-19
ER

PT J
AU Kirsten, A
   Hausmann, A
   Weber, M
   Fischer, J
   Fischer, H
AF Kirsten, A.
   Hausmann, A.
   Weber, M.
   Fischer, J.
   Fischer, H.
TI Bioactive and Thermally Compatible Glass Coating on Zirconia Dental
   Implants
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE biomaterial(s); materials science(s); ceramics; surface coated
   materials; endosseous dental implantation; cell culture techniques
ID SURFACE-MORPHOLOGY; APATITE-FORMATION; TITANIUM IMPLANT; BONE;
   OSSEOINTEGRATION; CERAMICS; DOG
AB The healing time of zirconia implants may be reduced by the use of bioactive glass coatings. Unfortunately, existing glasses are either bioactive like Bioglass 45S5 but thermally incompatible with the zirconia substrate, or they are thermally compatible but exhibit only a very low level of bioactivity. In this study, we hypothesized that a tailored substitution of alkaline earth metals and alkaline metals in 45S5 can lead to a glass composition that is both bioactive and thermally compatible with zirconia implants. A novel glass composition was analyzed using x-ray fluorescence spectroscopy, dilatometry, differential scanning calorimetry, and heating microscopy to investigate its chemical, physical, and thermal properties. Bioactivity was tested in vitro using simulated body fluid (SBF). Smooth and microstructured glass coatings were applied using a tailored spray technique with subsequent thermal treatment. Coating adhesion was tested on implants that were inserted in bovine ribs. The cytocompatibility of the coating was analyzed using L929 mouse fibroblasts. The coefficient of thermal expansion of the novel glass was shown to be slightly lower (11.5810(-6) K-1) than that of the zirconia (11.6710(-6) K-1). After storage in SBF, the glass showed reaction layers almost identical to the bioactive glass gold standard, 45S5. A process window between 800 degrees C and 910 degrees C was found to result in densely sintered and amorphous coatings. Microstructured glass coatings on zirconia implants survived a minimum insertion torque of 60 Ncm in the in vitro experiment on bovine ribs. Proliferation and cytotoxicity of the glass coatings was comparable with the controls. The novel glass composition showed a strong adhesion to the zirconia substrate and a significant bioactive behavior in the SBF in vitro experiments. Therefore, it holds great potential to significantly reduce the healing time of zirconia dental implants.
C1 [Kirsten, A.; Hausmann, A.; Weber, M.; Fischer, H.] RWTH Aachen Univ Hosp, D-52074 Aachen, Germany.
   [Fischer, J.] Univ Basel, Inst Dent Mat & Engn, Univ Hosp Dent Med, Basel, Switzerland.
RP Fischer, H (reprint author), RWTH Aachen Univ Hosp, Pauwelsstr 30, D-52074 Aachen, Germany.
EM hfischer@ukaachen.de
FU VITA Zahnfabrik, Bad Sackingen, Germany
FX The authors thank Wolfgang Wilsmann and Tanja Mund from the Department
   of Glass and Ceramic Composites, Institute of Mineral Engineering, RWTH
   Aachen for their help concerning the thermal analysis of the novel
   glass. They also thank Peter Konig, Margit Kehren, and Petra Schott from
   the Department of Ceramics and Refractory Materials, Institute of
   Mineral Engineering, RWTH Aachen for their help concerning laser
   granulometry, x-ray fluorescence spectroscopy, and x-ray diffraction
   analysis. Stefan Rutten from the Electron Microscopy Facility, RWTH
   Aachen University Hospital is thanked for his help concerning SEM and
   EDS analysis. Dr. Hendrik Meyer Luckel and Dr. Marcella Esteves Oliveira
   from the Department of Operative Dentistry, Periodontology and
   Preventive Dentistry are thanked for their help concerning laser
   scanning microscopy. The authors are grateful to VITA Zahnfabrik, Bad
   Sackingen, Germany, for financial support and for providing zirconia
   dental implants for the experiments. The authors declare no potential
   conflicts of interest with respect to the authorship and/or publication
   of this article.
CR Abrahamsson I, 2004, CLIN ORAL IMPLAN RES, V15, P381, DOI 10.1111/j.1600-0501.2004.01082.x
   Al-Noaman A, 2012, J NON-CRYST SOLIDS, V358, P3019, DOI 10.1016/j.jnoncrysol.2012.07.039
   Arstila H, 2005, KEY ENG MAT, V284-286, P925, DOI 10.4028/www.scientific.net/KEM.284-286.925
   Bloyer DR, 2007, BIOMATERIALS, V28, P4901, DOI 10.1016/j.biomaterials.2007.08.005
   Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008
   Bredbenner TL, 2000, ORAL SURG ORAL MED O, V90, P574, DOI 10.1067/moe.2000.111025
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Depprich Rita, 2008, Head Face Med, V4, P30, DOI 10.1186/1746-160X-4-30
   Elias CN, 2012, J MECH BEHAV BIOMED, V16, P169, DOI 10.1016/j.jmbbm.2012.10.010
   EVANS AG, 1983, OXID MET, V20, P193, DOI 10.1007/BF00656841
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   Fischer J, 2007, DENT MATER J, V26, P766, DOI 10.4012/dmj.26.766
   Gahlert M, 2009, CLIN ORAL IMPLAN RES, V20, P1247, DOI 10.1111/j.1600-0501.2009.01734.x
   Gomez-Vega JM, 1999, J BIOMED MATER RES, V46, P549, DOI 10.1002/(SICI)1097-4636(19990915)46:4<549::AID-JBM13>3.0.CO;2-M
   Granito RN, 2011, J BIOMED MATER RES B, V97B, P139, DOI 10.1002/jbm.b.31795
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   International Organization for Standardization (ISO), 2014, 233172014 ISO
   International Organization for Standardization (ISO), 2009, 1099320095 ISO
   International Organization for Standardization (ISO), 1997, 42871997 ISO
   Katranji A, 2007, J PERIODONTOL, V78, P874, DOI 10.1902/jop.2007.060342
   Koch FP, 2010, CLIN ORAL IMPLAN RES, V21, P350, DOI 10.1111/j.1600-0501.2009.01832.x
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Krajewski A, 1996, BIOMATERIALS, V17, P53, DOI 10.1016/0142-9612(96)80755-1
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   Lopez-Esteban S, 2003, J EUR CERAM SOC, V23, P2921, DOI 10.1016/S0955-2219(03)00303-0
   O'Donnell MD, 2012, BIOGLASSES, P13
   Pan HB, 2010, ACTA BIOMATER, V6, P4181, DOI 10.1016/j.actbio.2010.05.013
   Plewinski M, 2013, DENT MATER, V29, P1256, DOI 10.1016/j.dental.2013.09.016
   Priven AI, 2004, GLASS TECHNOL, V45, P244
   Salmang H., 2007, KERAMIK
   Suzuki T, 1999, J BIOSCI BIOENG, V87, P320, DOI 10.1016/S1389-1723(99)80039-5
   Szmukler-Moncler S, 1998, J BIOMED MATER RES, V43, P192, DOI 10.1002/(SICI)1097-4636(199822)43:2<192::AID-JBM14>3.0.CO;2-K
   Wenz HJ, 2008, INT J PROSTHODONT, V21, P27
   Zechner W, 2003, CLIN ORAL IMPLAN RES, V14, P150, DOI 10.1034/j.1600-0501.2003.140203.x
NR 34
TC 7
Z9 7
U1 9
U2 48
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD FEB
PY 2015
VL 94
IS 2
BP 297
EP 303
DI 10.1177/0022034514559250
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CA1BO
UT WOS:000348647900008
PM 25421839
OA Green Published
DA 2018-10-19
ER

PT J
AU Zhao, XB
   Liu, GP
   Zheng, H
   Cao, HL
   Liu, XY
AF Zhao, Xiaobing
   Liu, Gaopeng
   Zheng, Hai
   Cao, Huiliang
   Liu, Xuanyong
TI Dose-Dependent Effects of CeO2 on Microstructure and Antibacterial
   Property of Plasma-Sprayed TiO2 Coatings for Orthopedic Application
SO JOURNAL OF THERMAL SPRAY TECHNOLOGY
LA English
DT Article
DE antibacterial property; ceria; osteoblast; plasma spray; titania
ID TITANIUM SURFACES; BIOACTIVITY; SUBSTRATE; ALLOYS; TOPOGRAPHY;
   RESPONSES; ADHESION; APATITE; ENERGY; LAYER
AB Titanium and its alloys have been used extensively for orthopedic and dental implants. Although these devices have achieved high rates of success, two major complications may be encountered: the lack of osseointegration and the biomaterial-related infection. Accordingly, cerium oxide (CeO2)-doped titanium oxide (TiO2) materials were coated on titanium by an atmospheric plasma spraying (APS) technique. The phase structures, morphologies, and surface chemical states of the obtained coatings were characterized by x-ray diffraction, scanning electron microscopy, and x-ray photoelectron spectroscopy techniques. The in vitro antibacterial and cytocompatibility of the materials were studied with Staphylococcus aureus (S. aureus, ATCC25923) and osteoblast precursor cell line MC3T3-E1. The results indicated that the addition of CeO2 shifts slightly the diffraction peaks of TiO2 matrix to low angles but does not change its rutile phase structure. In addition, the CeO2/TiO2 composite coatings possess dose-dependent corrosion resistance and antimicrobial properties. And doping of 10 wt.% CeO2 exhibits the highest activity against S. aureus, improved corrosion resistance, and competitive cytocompatibility, which argues a promising option for balancing the osteogenetic and antibacterial properties of titanium implants.
C1 [Zhao, Xiaobing; Liu, Gaopeng; Zheng, Hai] Changzhou Univ, Sch Mat Sci & Engn, Changzhou 213164, Peoples R China.
   [Zheng, Hai; Cao, Huiliang; Liu, Xuanyong] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Zhao, XB (reprint author), Changzhou Univ, Sch Mat Sci & Engn, Changzhou 213164, Peoples R China.
EM zhaoxiaobing00@163.com
RI Cao, Huiliang/V-1999-2017; Liu, Xuanyong/J-2609-2018
OI Cao, Huiliang/0000-0002-5209-4497; 
FU National Basic Research Program of China (973 Program) [2012CB933600];
   National Natural Science Foundation of China [81271704, 31370962];
   Shanghai Science and Technology RD Fund [11JC1413700, 13441902400]
FX The authors acknowledge the joint financial support form the National
   Basic Research Program of China (973 Program, 2012CB933600), the
   National Natural Science Foundation of China (81271704 and 31370962),
   and Shanghai Science and Technology R&D Fund (11JC1413700 and
   13441902400).
CR BOND GC, 1989, FARADAY DISCUSS, V87, P65, DOI 10.1039/dc9898700065
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Dabala M, 2001, APPL SURF SCI, V172, P312, DOI 10.1016/S0169-4332(00)00873-4
   Goh YF, 2014, CERAM INT, V40, P729, DOI 10.1016/j.ceramint.2013.06.062
   Han Y, 2008, ACTA BIOMATER, V4, P1518, DOI 10.1016/j.actbio.2008.03.005
   Hassan MS, 2012, COLLOID SURFACE A, V415, P268, DOI 10.1016/j.colsurfa.2012.08.058
   Hu XL, 2010, LANGMUIR, V26, P3031, DOI 10.1021/la902142b
   Huo KF, 2013, BIOMATERIALS, V34, P3467, DOI 10.1016/j.biomaterials.2013.01.071
   Kang CW, 2006, SURF COAT TECH, V200, P5462, DOI 10.1016/j.surfcoat.2005.07.067
   Koutcheiko S, 2005, CERAM INT, V31, P965, DOI 10.1016/j.ceramint.2004.10.010
   Li BE, 2009, MATER CHEM PHYS, V118, P99, DOI 10.1016/j.matchemphys.2009.07.011
   Li CL, 2001, MAT SCI ENG A-STRUCT, V308, P268, DOI 10.1016/S0921-5093(00)01976-6
   Liu XY, 2008, ACTA BIOMATER, V4, P544, DOI 10.1016/j.actbio.2008.01.011
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Liu XY, 2005, BIOMATERIALS, V26, P6143, DOI 10.1016/j.biomaterials.2005.04.035
   Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018
   Puchett S. D., 2010, BIOMATERIALS, V31, P706
   Singh SP, 2010, B MATER SCI, V33, P33, DOI 10.1007/s12034-010-0005-0
   Taheri S, 2014, BIOMATERIALS, V35, P4601, DOI 10.1016/j.biomaterials.2014.02.033
   Tenover FC, 2006, AM J MED, V119, pS3, DOI 10.1016/j.amjmed.2006.03.011
   Teterin YA, 1998, J ELECTRON SPECTROSC, V88, P275, DOI 10.1016/S0368-2048(97)00139-4
   Wang GC, 2012, J MATER CHEM, V22, P19081, DOI 10.1039/c2jm34367c
   Wang GC, 2011, COLLOID SURFACE B, V86, P267, DOI 10.1016/j.colsurfb.2011.04.006
   Wang HY, 2014, COLLOID SURFACE B, V117, P89, DOI 10.1016/j.colsurfb.2014.02.019
   Wang HF, 2010, MATER CHEM PHYS, V124, P791, DOI 10.1016/j.matchemphys.2010.07.063
   Wang XY, 2004, THIN SOLID FILMS, V451, P37, DOI 10.1016/j.tsf.2003.10.151
   Yan WQ, 1997, BIOMATERIALS, V18, P1185, DOI 10.1016/S0142-9612(97)00057-4
   Yang YC, 2007, MATER CHEM PHYS, V104, P312, DOI 10.1016/j.matchemphys.2007.03.021
   Yao XH, 2014, APPL SURF SCI, V292, P944, DOI 10.1016/j.apsusc.2013.12.083
   Yun JH, 2012, RSC ADV, V2, P8164, DOI 10.1039/c2ra20827j
   Zhao BX, 2011, DESALINATION, V268, P55, DOI 10.1016/j.desal.2010.09.050
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
   Zhao XB, 2005, J BIOMED MATER RES A, V75A, P888, DOI 10.1002/jbm.a.30485
   Zhao XB, 2013, J SOL-GEL SCI TECHN, V66, P22, DOI 10.1007/s10971-013-2961-5
   Zhou XW, 2013, SURF COAT TECH, V235, P433, DOI 10.1016/j.surfcoat.2013.07.070
   Zinelis S, 2003, J PROSTHET DENT, V90, P332, DOI 10.1016/S0022-3913(03)00493-1
NR 36
TC 5
Z9 5
U1 4
U2 42
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9630
EI 1544-1016
J9 J THERM SPRAY TECHN
JI J. Therm. Spray Technol.
PD FEB
PY 2015
VL 24
IS 3
BP 401
EP 409
DI 10.1007/s11666-014-0179-x
PG 9
WC Materials Science, Coatings & Films
SC Materials Science
GA AZ7CR
UT WOS:000348376500013
DA 2018-10-19
ER

PT J
AU O'Brien, CM
   Holmes, B
   Faucett, S
   Zhang, LG
AF O'Brien, Christopher M.
   Holmes, Benjamin
   Faucett, Scott
   Zhang, Lijie Grace
TI Three-Dimensional Printing of Nanomaterial Scaffolds for Complex Tissue
   Regeneration
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; SMOOTH-MUSCLE-CELLS; CARTILAGE REPAIR;
   OSTEOGENIC DIFFERENTIATION; BACTERIAL NANOCELLULOSE; PHOSPHATE
   SCAFFOLDS; RECENT PROGRESS; AIRWAY SPLINT; IN-VIVO; BONE
AB Three-dimensional (3D) printing has recently expanded in popularity, and become the cutting edge of tissue engineering research. A growing emphasis from clinicians on patient-specific care, coupled with an increasing knowledge of cellular and biomaterial interaction, has led researchers to explore new methods that enable the greatest possible control over the arrangement of cells and bioactive nanomaterials in defined scaffold geometries. In this light, the cutting edge technology of 3D printing also enables researchers to more effectively compose multi-material and cell-laden scaffolds with less effort. In this review, we explore the current state of 3D printing with a focus on printing of nanomaterials and their effect on various complex tissue regeneration applications.
C1 [O'Brien, Christopher M.; Holmes, Benjamin; Zhang, Lijie Grace] George Washington Univ, Sch Engn & Appl Sci, Dept Mech & Aerosp Engn, Washington, DC 20052 USA.
   [Faucett, Scott] George Washington Univ, Dept Orthoped Surg, Sch Med & Hlth Sci, Washington, DC 20052 USA.
   [Zhang, Lijie Grace] George Washington Univ, Dept Med, Sch Med & Hlth Sci, Washington, DC 20052 USA.
RP Zhang, LG (reprint author), George Washington Univ, Sch Engn & Appl Sci, Dept Mech & Aerosp Engn, 801 22n St NW, Washington, DC 20052 USA.
EM lgzhang@gwu.edu
FU NIH from the NIH National Center for Advancing Translational Sciences
   [UL1TR000075]; George Washington Institute for Biomedical Engineering
   (GWIBE); GW Institute for Nanotechnology (GWIN)
FX This work was supported by NIH Award Number UL1TR000075 from the NIH
   National Center for Advancing Translational Sciences, by the George
   Washington Institute for Biomedical Engineering (GWIBE), and by GW
   Institute for Nanotechnology (GWIN).
CR Ahn SH, 2011, BIOMACROMOLECULES, V12, P4256, DOI 10.1021/bm201126j
   Akhavan O, 2013, J MATER CHEM B, V1, P6291, DOI 10.1039/c3tb21085e
   Alajati A, 2008, NAT METHODS, V5, P439, DOI 10.1038/NMETH.1198
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 2011, BRIT MED BULL, V97, P81, DOI 10.1093/bmb/ldr003
   Atala A, 2011, J UROLOGY, V185, P354, DOI 10.1016/S0022-5347(11)60070-0
   Bellucci D, 2013, MAT SCI ENG C-MATER, V33, P1091, DOI 10.1016/j.msec.2012.11.038
   Berthiaume F, 2011, ANNU REV CHEM BIOMOL, V2, P403, DOI 10.1146/annurev-chembioeng-061010-114257
   Castilho M, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/1/015006
   Castro NJ, 2014, AICHE J, V60, P432, DOI 10.1002/aic.14296
   Castro NJ, 2012, ANN BIOMED ENG, V40, P1628, DOI 10.1007/s10439-012-0605-5
   Chen Jiang, 2007, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V21, P523
   Childs A, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/6/065003
   Cohen DL, 2006, TISSUE ENG, V12, P1325, DOI 10.1089/ten.2006.12.1325
   Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.TEA.2011.0543, 10.1089/ten.tea.2011.0543]
   Cui Xiaofeng, 2012, Recent Pat Drug Deliv Formul, V6, P149
   Curley J. L., 2011, JOVE-J VIS EXP, V48, pe2636
   de Valence S, 2012, BIOMATERIALS, V33, P38, DOI 10.1016/j.biomaterials.2011.09.024
   Duan B, 2014, ACTA BIOMATER, V10, P1836, DOI 10.1016/j.actbio.2013.12.005
   Fedorovich NE, 2012, TISSUE ENG PART C-ME, V18, P33, DOI [10.1089/ten.tec.2011.0060, 10.1089/ten.TEC.2011.0060]
   Fedorovich NE, 2012, J BIOMED MATER RES A, V100A, P2412, DOI 10.1002/jbm.a.34171
   Ferris CJ, 2013, BIOMATER SCI-UK, V1, P224, DOI 10.1039/c2bm00114d
   Fu LN, 2013, MAT SCI ENG C-MATER, V33, P2995, DOI 10.1016/j.msec.2013.03.026
   Fullhase C, 2009, J UROLOGY, V181, P282, DOI 10.1016/S0022-5347(09)60805-3
   Ganey T, 2011, CELL PROLIFERATION V
   Godino N, 2012, LAB CHIP, V12, P3281, DOI 10.1039/c2lc40223h
   Gupta PK, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt116
   Halberstadt Craig, 2013, Methods Mol Biol, V1001, P279, DOI 10.1007/978-1-62703-363-3_23
   Holmes B, 2015, TISSUE ENG PT A, V21, P403, DOI [10.1089/ten.tea.2014.0138, 10.1089/ten.TEA.2014.0138]
   Holmes B, 2012, TISSUE ENG PART B-RE, V18, P478, DOI [10.1089/ten.TEB.2012.0096, 10.1089/ten.teb.2012.0096]
   Holmes B, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/36/365102
   Horst M, 2013, J TISSUE ENG REGEN M, V7, P515, DOI 10.1002/term.547
   Huang YJ, 2012, SMALL, V8, P2869, DOI 10.1002/smll.201200715
   Im O, 2012, INT J NANOMED, V7, P2087, DOI 10.2147/IJN.S29743
   Jolly SW, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4731782
   Jones AC, 2007, BIOMATERIALS, V28, P2491, DOI 10.1016/j.biomaterials.2007.01.046
   Kane R, 2013, MATER TODAY, V16, P418, DOI 10.1016/j.mattod.2013.11.001
   Kang H, 2012, J BIOMECH, V45, P2241, DOI 10.1016/j.jbiomech.2012.06.011
   Kaplan FS, 1994, AM ACAD ORTHOPAEDIC, V1, P127
   Kettner M, 2011, J FORENSIC SCI, V56, P1015, DOI 10.1111/j.1556-4029.2011.01764.x
   Kolan KCR, 2012, J MECH BEHAV BIOMED, V13, P14, DOI 10.1016/j.jmbbm.2012.04.001
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laurent Torvard C., 1996, Immunology and Cell Biology, V74, pA1, DOI 10.1038/icb.1996.32
   Lu Y, 2012, METHODS MOL BIOL, V868, P289, DOI 10.1007/978-1-61779-764-4_17
   Marga F, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/022001
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Mironov V, 2011, CURR OPIN BIOTECH, V22, P667, DOI 10.1016/j.copbio.2011.02.006
   Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084
   Moon S, 2010, TISSUE ENG PART C-ME, V16, P157, DOI [10.1089/ten.tec.2009.0179, 10.1089/ten.TEC.2009.0179]
   Nimeskern L, 2013, J MECH BEHAV BIOMED, V22, P12, DOI 10.1016/j.jmbbm.2013.03.005
   Owens CM, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/4/045007
   Park SY, 2013, NANOMEDICINE-UK, V8, P715, DOI [10.2217/NNM.12.143, 10.2217/nnm.12.143]
   Pepper ME, 2009, IEEE ENG MED BIO, P6001, DOI 10.1109/IEMBS.2009.5332513
   Pham DT, 1998, INT J MACH TOOL MANU, V38, P1257, DOI 10.1016/S0890-6955(97)00137-5
   Pilliar RM, 2013, J BIOMED MATER RES B, V101B, P1, DOI 10.1002/jbm.b.32832
   Preston Marnie, 2011, Front Biosci (Schol Ed), V3, P1165
   Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609
   Ryu S, 2013, TISSUE ENG REGEN MED, V10, P39, DOI 10.1007/s13770-013-0384-6
   Schantz JT, 2005, J MATER SCI-MATER M, V16, P807, DOI 10.1007/s10856-005-3584-3
   Skardal A, 2010, TISSUE ENG PT A, V16, P2675, DOI 10.1089/ten.TEA.2009.0798
   Skardal A, 2010, BIOMATERIALS, V31, P6173, DOI 10.1016/j.biomaterials.2010.04.045
   Srouji S, 2011, TISSUE ENG PT A, V17, P269, DOI [10.1089/ten.tea.2010.0250, 10.1089/ten.TEA.2010.0250]
   Sun LL, 2012, TISSUE ENG PT A, V18, P1741, DOI [10.1089/ten.tea.2011.0456, 10.1089/ten.TEA.2011.0456]
   Suri S, 2011, BIOMED MICRODEVICES, V13, P983, DOI 10.1007/s10544-011-9568-9
   Tarafder S, 2013, J TISSUE ENG REGEN M, V7, P631, DOI 10.1002/term.555
   Tel-Vered R, 2012, ADV EXP MED BIOL, V733, P1, DOI 10.1007/978-94-007-2555-3_1
   Temple JP, 2014, J BIOMED MATER RES A, V102, P4317, DOI 10.1002/jbm.a.35107
   Todo M, 2013, IEEE ENG MED BIO, P409, DOI 10.1109/EMBC.2013.6609523
   Tran PA, 2009, ADV DRUG DELIVER REV, V61, P1097, DOI 10.1016/j.addr.2009.07.010
   Tran RT, 2011, BIOTECHNOL APPL BIOC, V58, P335, DOI 10.1002/bab.44
   Vacanti JP, 1999, LANCET, V354, pSI32
   Vatankhah E, 2014, ACS APPL MATER INTER, V6, P4089, DOI 10.1021/am405673h
   Wagner DE, 2013, MAT SCI ENG C-MATER, V33, P1710, DOI 10.1016/j.msec.2012.12.084
   Wang MA, 2014, TISSUE ENG PT A, V20, P1060, DOI [10.1089/ten.tea.2013.0235, 10.1089/ten.TEA.2013.0235]
   Wang M, 2012, J NANOSCI NANOTECHNO, V12, P7692, DOI 10.1166/jnn.2012.6624
   Wang Q, 2010, J BIOMED MATER RES A, V93A, P442, DOI 10.1002/jbm.a.32562
   Williams SK, 2013, BIORESEARCH OPEN ACC, V2, P448, DOI 10.1089/biores.2013.0046
   Wu W, 2011, ADV MATER, V23, pH178, DOI 10.1002/adma.201004625
   Xu F, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014105
   Xu F, 2011, BIOTECHNOL J, V6, P204, DOI 10.1002/biot.201000340
   Xu T, 2006, BIOMATERIALS, V27, P3580, DOI 10.1016/j.biomaterials.2006.01.048
   Xu T, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015001
   Xu T, 2013, BIOMATERIALS, V34, P130, DOI 10.1016/j.biomaterials.2012.09.035
   Yeo M, 2011, BIOMACROMOLECULES, V12, P502, DOI 10.1021/bm1013052
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang AP, 2012, ADV MATER, V24, P4266, DOI 10.1002/adma.201202024
   Zhang L, 2009, ADV BIOMATERIALS FUN, P205
   Zhang L, 2012, VASC PHARMACOL, V56, P280, DOI 10.1016/j.vph.2012.02.014
   Zhang Lijie, 2009, Critical Reviews in Biomedical Engineering, V37, P1
   Zhang LJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/17/175101
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhang QW, 2011, BIOMATERIALS, V32, P87, DOI 10.1016/j.biomaterials.2010.08.090
   Zhang T, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/4/045010
   Zhao CY, 2013, BIOTECHNOL ADV, V31, P654, DOI 10.1016/j.biotechadv.2012.08.001
   Zhao JH, 2012, J MATER SCI-MATER M, V23, P517, DOI 10.1007/s10856-011-4468-3
   Zhu W, 2014, NANOMEDICINE-UK, V9, P859, DOI [10.2217/nnm.14.36, 10.2217/NNM.14.36]
   Zopf DA, 2014, JAMA OTOLARYNGOL, V140, P66, DOI 10.1001/jamaoto.2013.5644
   Zopf DA, 2013, NEW ENGL J MED, V368, P2043, DOI 10.1056/NEJMc1206319
NR 98
TC 37
Z9 43
U1 4
U2 117
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD FEB 1
PY 2015
VL 21
IS 1
BP 103
EP 114
DI 10.1089/ten.teb.2014.0168
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CA6HG
UT WOS:000349011200009
PM 25084122
OA Green Published
DA 2018-10-19
ER

PT J
AU Bernhardt, A
   Schumacher, M
   Gelinsky, M
AF Bernhardt, Anne
   Schumacher, Matthias
   Gelinsky, Michael
TI Formation of Osteoclasts on Calcium Phosphate Bone Cements and
   Polystyrene Depends on Monocyte Isolation Conditions
SO Tissue Engineering Part C-Methods
LA English
DT Article
ID BLOOD MONONUCLEAR-CELLS; DIFFERENTIATION IN-VITRO; T-LYMPHOCYTES;
   RESORPTION; COCULTURE; BIOMATERIALS; PRECURSORS; OSTEOBLAST; BEHAVIOR;
   CULTURE
AB Objectives: Peripheral blood mononuclear cells (PBMC) are an attractive source for the generation of osteoclasts in vitro, which is an important prerequisite for the examination of resorption and remodeling of biomaterials. In this study, different preparation methods are used to obtain cell populations with a rising content of CD14(+) monocytes. We wanted to address the question whether there is a correlation between content of CD14(+) cells in the preparation and functionality of formed osteoclasts.
   Materials and Methods: PBMC obtained by density gradient centrifugation with and without further purification by plastic adherence or immunomagnetic separation of CD14(+) cells were seeded on both cell culture polystyrene and a calcium phosphate bone cement (CPC) and cultivated under stimulation with macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor-kappa B ligand (RANKL). Cell cultures were characterized by histological and fluorescent staining of multinucleated cells that were positive for tartrate-resistant acid phosphatase (TRAP) activity and the presence of actin rings, respectively. Furthermore, activities of osteoclast marker enzymes TRAP and carbonic anhydrase II (CA II) were quantified. For osteoclasts cultured on CPC, resorption pits were visualized using scanning electron microscopy (SEM).
   Results: Monocytes of all preparations were successfully differentiated into multinucleated osteoclasts showing TRAP and CA II activity on both cell culture plastic and CPC. Preparations involving an additional plastic adherence step exhibited only a minor increase of TRAP and CA II activity in the second week of cultivation. Furthermore, the number of resorption pits on CPC was reduced in these cultures compared with immunomagnetically enriched monocytes and preparations without additional plastic adherence steps. Optimal results with regard to yield, number of multinucleated osteoclasts, activity of TRAP and CA II, and resorption of CPC were obtained by simple density gradient centrifugation.
   Conclusion: All examined monocyte preparation protocols were suitable for the generation of osteoclasts on both polystyrene and CPC. Highly purified monocytes are not mandatory to obtain functional osteoclasts for investigation of biomaterial resorption.
C1 [Bernhardt, Anne; Schumacher, Matthias; Gelinsky, Michael] Tech Univ Dresden, Univ Hosp, Ctr Translat Bone Joint & Soft Tissue Res, Med Fac Carl Gustav Carus, D-01307 Dresden, Germany.
RP Bernhardt, A (reprint author), Tech Univ Dresden, Univ Hosp, Ctr Translat Bone Joint & Soft Tissue Res, Med Fac Carl Gustav Carus, Fetscher Str 74, D-01307 Dresden, Germany.
EM anne.bernhardt@tu-dresden.de
RI Bernhardt, Anne/O-1242-2015; Schumacher, Matthias/I-1530-2013
OI Bernhardt, Anne/0000-0002-1903-1929; Schumacher,
   Matthias/0000-0001-7207-7355; Gelinsky, Michael/0000-0001-9075-5121
FU DFG [SFB/TR79]
FX The authors wish to thank Hella Luksch (Pediatric Clinic of the
   University Hospital Dresden) and Angela Jacobi for FACS measurements.
   They are grateful to InnoTERE GmbH (Radebeul, Germany) for providing CPC
   precursor powder and acknowledge the technical assistance of Sophie
   Brueggemeier, Anna Rumiantseva, and Kristin Faulwasser and the financial
   support rendered by DFG (SFB/TR79).
CR Alatalo SL, 2000, CLIN CHEM, V46, P1751
   BENNETT S, 1994, J LEUKOCYTE BIOL, V56, P236
   Bernhardt A, 2010, J BIOMED MATER RES A, V95A, P848, DOI 10.1002/jbm.a.32856
   Botelho C. M., 2006, J BIOMED MATER RES, V78, P708
   Costa-Rodrigues J, 2011, CELL PROLIFERAT, V44, P410, DOI 10.1111/j.1365-2184.2011.00768.x
   Costa-Rodrigues J, 2012, ACTA BIOMATER, V8, P1137, DOI 10.1016/j.actbio.2011.11.032
   de Almeida MC, 2000, MEM I OSWALDO CRUZ, V95, P221, DOI 10.1590/S0074-02762000000200014
   Detsch R, 2010, ACTA BIOMATER, V6, P3223, DOI 10.1016/j.actbio.2010.03.003
   Detsch R, 2014, J TISSUE ENG REGEN M, V2014, DOI [10.1002/term.1851, DOI 10.1002/TERM.1851]
   Driessens F. C. M, 1996, BIOCERAMICS, V9, P231
   Gillespie MT, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2141
   Hayden RS, 2014, BIOMATERIALS, V35, P3794, DOI 10.1016/j.biomaterials.2014.01.034
   Heinemann C, 2011, EUR CELLS MATER, V21, P80, DOI 10.22203/eCM.v021a07
   Janckila AJ, 2001, J BONE MINER RES, V16, P788, DOI 10.1359/jbmr.2001.16.4.788
   Jones G. L., 2011, CELL MAT, V21, P80
   Keller J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046757
   Komano Y, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2046
   Lehenkari P, 1998, EXP CELL RES, V242, P128, DOI 10.1006/excr.1998.4071
   Matsuzaki K, 1998, BIOCHEM BIOPH RES CO, V246, P199, DOI 10.1006/bbrc.1998.8586
   Nakagawa K, 2004, TISSUE ENG, V10, P93, DOI 10.1089/107632704322791736
   Nicholson GC, 2000, CLIN SCI, V99, P133, DOI 10.1042/CS19990355
   Panzavolta S, 2010, J INORG BIOCHEM, V104, P1099, DOI 10.1016/j.jinorgbio.2010.06.008
   Perrotti V, 2009, J BIOMED MATER RES A, V90A, P238, DOI 10.1002/jbm.a.32079
   Pirraco RP, 2013, J TISSUE ENG REGEN M, V7, P392, DOI 10.1002/term.535
   Repnik U, 2003, J IMMUNOL METHODS, V278, P283, DOI 10.1016/S0022-1759(03)00231-X
   Rochet N, 2009, BIOMATERIALS, V30, P4260, DOI 10.1016/j.biomaterials.2009.04.044
   Rousselle AV, 2002, BONE, V30, P533, DOI 10.1016/S8756-3282(02)00672-5
   Rumpler M, 2013, CALCIFIED TISSUE INT, V93, P526, DOI 10.1007/s00223-013-9786-7
   Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522
   Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079
   Schumacher M, 2013, ACTA BIOMATER, V9, P9547, DOI 10.1016/j.actbio.2013.07.027
   Seager DJ, 2004, J IMMUNOL METHODS, V288, P123
   Shalhoub V, 2000, BRIT J HAEMATOL, V111, P501, DOI 10.1046/j.1365-2141.2000.02379.x
   Sinclair SSK, 2011, J BIOMAT SCI-POLYM E, V22, P789, DOI 10.1163/092050610X496260
   Vandooren B, 2009, ARTHRITIS RHEUM-US, V60, P1020, DOI 10.1002/art.24413
   Zhang ZY, 2012, ACTA BIOMATER, V8, P13, DOI 10.1016/j.actbio.2011.09.020
   Zhou L, 2012, CLIN VACCINE IMMUNOL, V19, P1065, DOI 10.1128/CVI.05715-11
NR 37
TC 9
Z9 9
U1 0
U2 21
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD FEB 1
PY 2015
VL 21
IS 2
BP 160
EP 170
DI 10.1089/ten.tec.2014.0187
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CA6HR
UT WOS:000349012400006
PM 24919531
DA 2018-10-19
ER

PT J
AU Neo, PY
   Tan, DJA
   Shi, PJ
   Toh, SL
   Goh, JCH
AF Neo, Puay Yong
   Tan, Daryl Jian-An
   Shi, Pujiang
   Toh, Siew Lok
   Goh, James Cho-Hong
TI Enhancing Analysis of Cells and Proteins by Fluorescence Imaging on
   Silk-Based Biomaterials: Modulating the Autofluorescence of Silk
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID SUDAN BLACK-B; DRUG-DELIVERY; FIBROIN; TISSUE; HISTOCHEMISTRY;
   REDUCTION; ADHESION; SERICIN; IMMUNOFLUORESCENCE; FIBRONECTIN
AB Silk is a versatile and established biomaterial for various tissue engineering purposes. However, it also exhibits strong autofluorescence signals-thereby hindering fluorescence imaging analysis of cells and proteins on silk-derived biomaterials. Sudan Black B (SB) is a lysochrome dye commonly used to stain lipids in histology. It has also been reported to be able to quench autofluorescence of tissues in histology and has been tested on artificial biomedical polymers in recent years. It was hypothesized that SB would exert similar quenching effects on silk, modulating the autofluorescence signals, and thereby enabling improved imaging analysis of cells and molecules of interests. The quenching effect of SB on the intrinsic fluorescence properties of silk and on commercial fluorescent dyes were first investigated in this study. SB was then incorporated into typical fluorescence-based staining protocols to study its effectiveness in improving fluorescence-based imaging of the cells and proteins residing with the silk-based biomaterials. Silk processed into various forms of biomaterials (e.g., films, sponges, fibers, and electrospun mats) was seeded with cells and cultured in vitro. At sacrificial time points, specimens were harvested, fixed, and prepared for fluorescence staining. SB, available commercially as a powder, was dissolved in 70% ethanol (0.3% [w/v]) to form staining solutions. SB treatment was introduced at the last step of typical immunofluorescence staining protocols for 15-120 min. For actin staining protocols by phalloidin toxin, SB staining solutions were added before and after permeabilization with Triton-X for 15-30 min. Results showed that ideal SB treatment duration is about 15 min. Apart from being able to suppress the autofluorescence of silk, this treatment duration was also not too long to adversely affect the fluorescent labeling probes used. The relative improvement brought about by SB treatment was most evident in the blue and green emission wavelengths compared with the red emission wavelength. This study has showed that the use of SB is a cost and time effective approach to enhance fluorescence-based imaging analyses of cell-seeded silk biomaterials, which otherwise would have been hindered by the unmodulated autofluorescence signals.
C1 [Neo, Puay Yong; Tan, Daryl Jian-An; Shi, Pujiang; Toh, Siew Lok; Goh, James Cho-Hong] Natl Univ Singapore, Dept Biomed Engn, Fac Engn, Singapore 117575, Singapore.
   [Shi, Pujiang] ASTAR, Inst Mat Res & Engn, Singapore, Singapore.
   [Toh, Siew Lok] Natl Univ Singapore, Dept Mech Engn, Fac Engn, Singapore 117575, Singapore.
   [Goh, James Cho-Hong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Orthopaed Surg, Singapore 117575, Singapore.
RP Goh, JCH (reprint author), Natl Univ Singapore, Dept Biomed Engn, Fac Engn, Block EA,03-12 9 Engn Dr 1, Singapore 117575, Singapore.
EM biehead@nus.edu.sg
RI Shi, Pujiang/P-7482-2017
OI Shi, Pujiang/0000-0002-8051-6773
FU Biomedical Research Council; Singapore National Research Foundation
FX This research was supported, in part, by the Biomedical Research Council
   and the Singapore National Research Foundation under its Cooperative
   Basic Research Grant and administered by the Singapore Ministry of
   Health's National Medical Research Council.
CR Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Acharya C, 2009, ACTA BIOMATER, V5, P429, DOI 10.1016/j.actbio.2008.07.003
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Aramwit P, 2007, BIOSCI BIOTECH BIOCH, V71, P2473, DOI 10.1271/bbb.70243
   Baschong W, 2001, J HISTOCHEM CYTOCHEM, V49, P1565, DOI 10.1177/002215540104901210
   Chiu YC, 2012, J FLUORESC, V22, P907, DOI 10.1007/s10895-011-1029-6
   Clarke RJ, 2004, J CHEM EDUC, V81, P705, DOI 10.1021/ed081p705
   Coleman R, 2000, ACTA HISTOCHEM, V102, P5, DOI 10.1078/0065-1281-00542
   COWEN T, 1985, HISTOCHEMISTRY, V82, P205, DOI 10.1007/BF00501396
   FREDERIKS W M, 1977, Histochemistry, V54, P27
   Ganta SR, 2003, J BIOMED MATER RES A, V64A, P242, DOI 10.1002/jbm.a.10402
   Georgakoudi I, 2007, OPT EXPRESS, V15, P1043, DOI 10.1364/OE.15.001043
   HATA RI, 1989, J CELL PHYSIOL, V138, P8, DOI 10.1002/jcp.1041380103
   HIGH OBB, 1981, ACTA HISTOCHEM, P247
   Jaafar IH, 2011, ACTA BIOMATER, V7, P1588, DOI 10.1016/j.actbio.2010.12.007
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/nmat2745, 10.1038/NMAT2745]
   Kundu SC, 2012, BIOPOLYMERS, V97, P455, DOI 10.1002/bip.22024
   Lakowicz J. R, 2007, PRINCIPLES FLUORESCE
   Lu B, 2010, LAB CHIP, V10, P1826, DOI 10.1039/b924855b
   Miyamoto S, 1998, ANN NY ACAD SCI, V857, P119, DOI 10.1111/j.1749-6632.1998.tb10112.x
   Mosiman VL, 1997, CYTOMETRY, V30, P151
   Nagai N, 2009, BIOL PHARM BULL, V32, P933, DOI 10.1248/bpb.32.933
   Neo PY, 2016, J TISSUE ENG REGEN M, V10, P564, DOI 10.1002/term.1776
   Neumann M, 2002, J HISTOCHEM CYTOCHEM, V50, P437, DOI 10.1177/002215540205000315
   Oliveira VC, 2010, HISTOL HISTOPATHOL, V25, P1017, DOI 10.14670/HH-25.1017
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   RUOSLAHTI E, 1984, CANCER METAST REV, V3, P43, DOI 10.1007/BF00047692
   Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601
   Shadpour H, 2006, J CHROMATOGR A, V1111, P238, DOI 10.1016/j.chroma.2005.08.083
   Teh TKH, 2011, TISSUE ENG PART C-ME, V17, P687, DOI 10.1089/ten.tec.2010.0513
   Teuschl AH, 2014, TISSUE ENG PART C-ME, V20, P431, DOI [10.1089/ten.tec.2013.0278, 10.1089/ten.TEC.2013.0278]
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Viegas MS, 2007, EUR J HISTOCHEM, V51, P59
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007
   WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498
   Yang YH, 2004, BIOMACROMOLECULES, V5, P773, DOI 10.1021/bm0343848
   Zaoming W., 1995, J INVEST ALLERG CLIN, V6, P237
NR 40
TC 2
Z9 2
U1 3
U2 31
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD FEB 1
PY 2015
VL 21
IS 2
BP 218
EP 228
DI 10.1089/ten.tec.2014.0209
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CA6HR
UT WOS:000349012400011
PM 25050876
DA 2018-10-19
ER

PT J
AU Zahn, G
   Schulze, HA
   Lippke, J
   Konig, S
   Sazama, U
   Froba, M
   Behrens, P
AF Zahn, Gesa
   Schulze, Hendrik Albert
   Lippke, Jann
   Koenig, Sandra
   Sazama, Uta
   Froeba, Michael
   Behrens, Peter
TI A water-born Zr-based porous coordination polymer: Modulated synthesis
   of Zr-fumarate MOF
SO MICROPOROUS AND MESOPOROUS MATERIALS
LA English
DT Article
DE Metal-organic frameworks; Water-based synthesis; Microporous materials;
   Modulation approach; Zr-fumarate MOF
ID METAL-ORGANIC FRAMEWORKS; DETERMINING SURFACE-AREAS; NEUTRON-SCATTERING;
   BET METHOD; DIFFRACTION; ADSORPTION; STABILITY; HYDROGEN; SORPTION;
   SITES
AB In this work, we present the water-based synthesis of the Zr-fumarate MOF (Zr-film MOF) by applying a monocarboxylic acid as modulator. The original synthesis of Zr-fum MOF was performed in a DMF-based batch at 120 degrees C. The product showed exceptional stability against aqueous solutions. Thus, a water-based synthesis seemed to be promising. Indeed, by adding various amounts of formic acid, acetic acid or propionic acid as modulator, respectively, highly crystalline Zr-film MOF can be obtained from water at 120 degrees C. The investigation of the influence of modulating molecules with different alkyl chain lengths showed that the particle size decreases when monocarboxylic acids with longer alkyl chains are used, e.g. acetic acid and propionic acid in comparison to formic acid. For the formation of the Zr-fum MOF synthesised with formic acid as modulator, the thermogravimetric and sorption behaviour as well as the stability against various solvents and pH values is discussed in detail. Furthermore, the Zr-turn MOF can also be obtained under very benign reaction conditions at room temperature from water, making this material interesting for various applications, for example as a biomaterial. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Zahn, Gesa; Schulze, Hendrik Albert; Lippke, Jann; Behrens, Peter] Leibniz Univ Hannover, Inst Anorgan Chem, D-30167 Hannover, Germany.
   [Zahn, Gesa; Schulze, Hendrik Albert; Lippke, Jann; Behrens, Peter] ZFM Ctr Solid State Chem & New Mat, Hannover, Germany.
   [Koenig, Sandra; Sazama, Uta; Froeba, Michael] Univ Hamburg, Inst Anorgan & Angew Chem, D-20146 Hamburg, Germany.
RP Behrens, P (reprint author), Leibniz Univ Hannover, Inst Anorgan Chem, Callinstr 9, D-30167 Hannover, Germany.
EM Peter.Behrens@acb.uni-hannover.de
FU DFG priority program [1362]
FX This work was performed within the DFG priority program 1362 (Porous
   Metal organic Frameworks). The authors like to thank Georg Platz and
   Natalja Wendt for performing the argon sorption measurements.
CR Bae YS, 2010, LANGMUIR, V26, P5475, DOI 10.1021/la100449z
   Bauer S, 2008, INORG CHEM, V47, P7568, DOI 10.1021/ic800538r
   Cavka JH, 2008, J AM CHEM SOC, V130, P13850, DOI 10.1021/ja8057953
   Cravillon J, 2012, CRYSTENGCOMM, V14, P492, DOI 10.1039/c1ce06002c
   DeCoste JB, 2013, J MATER CHEM A, V1, P5642, DOI 10.1039/c3ta10662d
   Diring S, 2010, CHEM MATER, V22, P4531, DOI 10.1021/cm101778g
   Furukawa H, 2014, J AM CHEM SOC, V136, P4369, DOI 10.1021/ja500330a
   Gaab M, 2012, MICROPOR MESOPOR MAT, V157, P131, DOI 10.1016/j.micromeso.2011.08.016
   Horcajada P, 2010, NAT MATER, V9, P172, DOI [10.1038/NMAT2608, 10.1038/nmat2608, 10.1038/NMAT260B]
   Jhung SH, 2007, ADV MATER, V19, P121, DOI 10.1002/adma.200601604
   Kandiah M, 2010, CHEM MATER, V22, P6632, DOI 10.1021/cm102601v
   Loiseau T, 2005, CR CHIM, V8, P765, DOI 10.1016/j.crci.2004.10.011
   Peterson VK, 2006, J AM CHEM SOC, V128, P15578, DOI 10.1021/ja0660857
   Rowsell JLC, 2005, J AM CHEM SOC, V127, P14904, DOI 10.1021/ja0542690
   Schaate A, 2012, EUR J INORG CHEM, P790, DOI 10.1002/ejic.201101151
   Schaate A, 2011, CHEM-EUR J, V17, P9320, DOI 10.1002/chem.201101015
   Schaate A, 2011, CHEM-EUR J, V17, P6643, DOI 10.1002/chem.201003211
   Schmitz B, 2008, CHEMPHYSCHEM, V9, P2181, DOI 10.1002/cphc.200800463
   Senkovska I, 2009, MICROPOR MESOPOR MAT, V122, P93, DOI 10.1016/j.micromeso.2009.02.020
   Southon PD, 2002, CHEM MATER, V14, P4313, DOI 10.1021/cm0211913
   Sumida K, 2011, J PHYS CHEM C, V115, P8414, DOI 10.1021/jp200638n
   Tsuruoka T, 2009, ANGEW CHEM INT EDIT, V48, P4739, DOI 10.1002/anie.200901177
   Valenzano L, 2011, CHEM MATER, V23, P1700, DOI 10.1021/cm1022882
   Walton KS, 2007, J AM CHEM SOC, V129, P8552, DOI 10.1021/ja071174k
   Wilssmann G., 2012, MICROPOR MESOPOR MAT, V152, P64
   Zahn G, 2014, CRYSTENGCOMM, V16, P9198, DOI 10.1039/c4ce01095g
NR 26
TC 31
Z9 32
U1 12
U2 103
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1387-1811
EI 1873-3093
J9 MICROPOR MESOPOR MAT
JI Microporous Mesoporous Mat.
PD FEB
PY 2015
VL 203
BP 186
EP 194
DI 10.1016/j.micromeso.2014.10.034
PG 9
WC Chemistry, Applied; Chemistry, Physical; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA AY5DI
UT WOS:000347593000022
DA 2018-10-19
ER

PT J
AU Ho, YH
   Vora, HD
   Dahotre, NB
AF Ho, Yee-Hsien
   Vora, Hitesh D.
   Dahotre, Narendra B.
TI Laser surface modification of AZ31B Mg alloy for bio-wettability
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Laser surface modification; bio-implant; bio-wettability; grain
   refinement; contact-angle measurement; surface energy
ID IN-VITRO DEGRADATION; MAGNESIUM ALLOYS; CORROSION-RESISTANCE; TITANIUM
   SURFACES; BODY-FLUID; AZ91D; MICROSTRUCTURE; BIOMATERIAL; BEHAVIOR;
   ALUMINA
AB Magnesium alloys are the potential degradable materials for load-bearing implant application due to their comparable mechanical properties to human bone, excellent bioactivity, and invivo non-toxicity. However, for a successful load-bearing implant, the surface of bio-implant must allow protein absorption and layer formation under physiological environment that can assist the cell/osteoblast growth. In this regard, surface wettability of bio-implant plays a key role to dictate the quantity of protein absorption. In light of this, the main objective of the present study was to produce favorable bio-wettability condition of AZ31B Mg alloy bio-implant surface via laser surface modification technique under various laser processing conditions. In the present efforts, the influence of laser surface modification on AZ31B Mg alloy surface on resultant bio-wettability was investigated via contact-angle measurements and the co-relationships among microstructure (grain size), surface roughness, surface energy, and surface chemical composition were established. In addition, the laser surface modification technique was simulated by computational (thermal) model to facilitate the prediction of temperature and its resultant cooling/solidification rates under various laser processing conditions for correlating with their corresponding composition and phase evolution. These predicted thermal properties were later used to correlate with the corresponding microstructure, chemical composition, and phase evolution via experimental analyses (X-ray diffractometer, scanning electron microscope, energy-dispersive spectroscopy).
C1 [Ho, Yee-Hsien; Vora, Hitesh D.; Dahotre, Narendra B.] Univ N Texas, Dept Mat Sci & Engn, Lab Laser Aided Addit & Subtract Mfg, Denton, TX 76203 USA.
RP Dahotre, NB (reprint author), Univ N Texas, Dept Mat Sci & Engn, Lab Laser Aided Addit & Subtract Mfg, 1155 Union Circle 305310, Denton, TX 76203 USA.
EM Narendra.Dahotre@unt.edu
CR Abbas G, 2006, WEAR, V260, P175, DOI 10.1016/j.wear.2005.01.036
   [Anonymous], 1999, ASM INT HDB COMMITTE, P27
   Au AG, 2007, J BIOMECH, V40, P1410, DOI 10.1016/j.jbiomech.2006.05.020
   Bargir S, 2009, APPL SURF SCI, V255, P4873, DOI 10.1016/j.apsusc.2008.12.017
   Calin M, 2013, MAT SCI ENG C-MATER, V33, P875, DOI 10.1016/j.msec.2012.11.015
   Cheng YL, 2009, T NONFERR METAL SOC, V19, P517, DOI 10.1016/S1003-6326(08)60305-2
   Dahotre SN, 2014, ANN BIOMED ENG, V42, P50, DOI 10.1007/s10439-013-0898-z
   Dahotre SN, 2013, APPL SURF SCI, V271, P141, DOI 10.1016/j.apsusc.2013.01.151
   Erdmann N, 2011, ACTA BIOMATER, V7, P1421, DOI 10.1016/j.actbio.2010.10.031
   Gross S, 2001, J BIOMECH, V34, P995, DOI 10.1016/S0021-9290(01)00072-0
   Guan YC, 2009, SURF REV LETT, V16, P801, DOI 10.1142/S0218625X09013347
   Guan YC, 2009, APPL SURF SCI, V255, P8235, DOI 10.1016/j.apsusc.2009.05.055
   Guan YC, 2009, J APPL ELECTROCHEM, V39, P1457, DOI 10.1007/s10800-009-9825-2
   Guangling Song SS, 2007, ADV ENG MATER, V9, P298
   Guo YB, 2012, CIRP ANN-MANUF TECHN, V61, P583, DOI 10.1016/j.cirp.2012.03.125
   Haase K, 2013, COMPUT BIOL MED, V43, P1748, DOI 10.1016/j.compbiomed.2013.07.032
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kannatey-Asibu E., 2009, PRINCIPLES LASER MAT
   Kurella A, 2005, J BIOMATER APPL, V20, P5, DOI 10.1177/0885328205052974
   Kurella AK, 2008, MAT SCI ENG C-BIO S, V28, P1560, DOI 10.1016/j.msec.2008.04.015
   Lin Z, 2013, SURF COAT TECH, V228, pS131, DOI 10.1016/j.surfcoat.2012.07.007
   Luckey TD, 1977, METAL TOXICITY MAMMA
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Moncayo MA, 2013, CERAM INT, V39, P6207, DOI 10.1016/j.ceramint.2013.01.040
   Moncayo MA, 2013, OPT LASER TECHNOL, V48, P570, DOI 10.1016/j.optlastec.2012.11.019
   Mueller WD, 2009, J BIOMED MATER RES A, V90A, P487, DOI 10.1002/jbm.a.32106
   Ng CC, 2011, APPL SURF SCI, V257, P7447, DOI 10.1016/j.apsusc.2011.03.004
   Paital SR, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/025001
   Paital SR, 2009, ACTA BIOMATER, V5, P2763, DOI 10.1016/j.actbio.2009.03.004
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Park JW, 2009, ACTA BIOMATER, V5, P2311, DOI 10.1016/j.actbio.2009.02.026
   Park JH, 2012, BIOMATERIALS, V33, P7386, DOI 10.1016/j.biomaterials.2012.06.066
   Ren L, 2013, J MATER SCI TECHNOL, V29, P1005, DOI 10.1016/j.jmst.2013.09.008
   Rosales-Leal JI, 2010, COLLOID SURFACE A, V365, P222, DOI 10.1016/j.colsurfa.2009.12.017
   Sagari ARA, 2008, NUCL INSTRUM METH B, V266, P2515, DOI 10.1016/j.nimb.2008.03.069
   Santhanakrishnan S, 2012, MATER TECHNOL, V27, P273, DOI 10.1179/1753555712Y.0000000022
   Sealy MP, 2010, J MECH BEHAV BIOMED, V3, P488, DOI 10.1016/j.jmbbm.2010.05.003
   Sealy MP, 2011, J MED DEVICES T ASME, V5
   Shtansky DV, 2012, SURF COAT TECH, V208, P14, DOI 10.1016/j.surfcoat.2012.07.008
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Sunil BR, 2014, MAT SCI ENG C-MATER, V39, P315, DOI 10.1016/j.msec.2014.03.004
   Sunil BR, 2013, MAT SCI ENG C-MATER, V33, P1607, DOI 10.1016/j.msec.2012.12.095
   Taltavull C, 2014, MATER DESIGN, V57, P40, DOI 10.1016/j.matdes.2013.12.069
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   Vora HD, 2013, MAT SCI TECHNOL, P1
   Vora HD, 2014, J MECH BEHAV BIOMED, V37, P153, DOI 10.1016/j.jmbbm.2014.05.017
   Vora HD, 2013, ADV MATER PROCESS, V171, P45
   Vora HD, 2013, INT J PRECIS ENG MAN, V14, P1421, DOI 10.1007/s12541-013-0192-x
   Vora HD, 2013, J ALLOY COMPD, V570, P133, DOI 10.1016/j.jallcom.2013.03.115
   Vora HD, 2012, J EUR CERAM SOC, V32, P4205, DOI 10.1016/j.jeurceramsoc.2012.06.015
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Xiao DM, 2012, T NONFERR METAL SOC, V22, P2554, DOI 10.1016/S1003-6326(11)61500-8
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Xue-Nan Gu, 2010, Frontiers of Materials Science in China, V4, P111, DOI 10.1007/s11706-010-0024-1
   Zhou DW, 2007, MATER SCI-POLAND, V25, P145
   Zhou W, 2010, CORROS SCI, V52, P1035, DOI 10.1016/j.corsci.2009.11.030
NR 57
TC 12
Z9 13
U1 5
U2 56
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD FEB
PY 2015
VL 29
IS 7
BP 915
EP 928
DI 10.1177/0885328214551156
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AZ0YH
UT WOS:000347967300001
PM 25201909
OA Green Published
DA 2018-10-19
ER

PT J
AU Ferreira, LB
   Bradaschia-Correa, V
   Moreira, MM
   Marques, NDM
   Arana-Chavez, VE
AF Ferreira, Lorraine B.
   Bradaschia-Correa, Vivian
   Moreira, Mariana M.
   Marques, Natasha D. M.
   Arana-Chavez, Victor E.
TI Evaluation of bone repair of critical size defects treated with
   simvastatin-loaded poly(lactic-co-glycolic acid) microspheres in rat
   calvaria
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Bone regeneration; osteoconduction; osteoinduction; PLGA; simvastatin
ID IN-VITRO DEGRADATION; FRACTURE; STATINS; DELIVERY; BIOCOMPATIBILITY;
   OSTEOADHERIN; REGENERATION; OSTEOBLASTS; SCAFFOLD; GROWTH
AB Purpose Statins are hypolipemiant drugs with osteoinductive effect. We evaluated the potential of simvastatin loaded into poly(lactic-co-glycolic acid) (PLGA) microspheres to heal critical size defects in rat calvaria.
   Methods PLGA scaffolds (50:50 ratio) were synthesized as pure membranes or as microspheres loaded with 2.5% simvastatin. Critical size defects (5-mm diameter) were created in the parietal bone of 3-month-old male Wistar rats; they were either left filled with blood clot (C group), covered with a PLGA membrane (M group) or with PLGA microspheres loaded with simvastatin (MSI group) or not (MM group), and then covered with the PLGA membrane. The defects were evaluated after 30 or 60 days by light and electron microscopy, immunohistochemistry for osteopontin (OPN), bone sialoprotein (BSP) and osteoadherin (OSAD), and immunocytochemistry for OPN.
   Results Scanning electron microscopy showed that the calvarial defects treated with MSI were almost completely healed after 60 days, while groups M and C presented less bone formation, whereas the bone matrix formed into the defects of MSI group was more organized and mature. The immunolabeling for OPN and BSP on the matrix in groups C and M showed typical areas of primary bone unlike the MSI that presented weak labeling at the formed area. In the MSI group, there was an intense immunostaining for OSAD in osteoid, as well as in osteocyte cytoplasm. The immunocytochemistry showed intense labeling for OPN with homogeneous distribution in the interfibrillar spaces in all groups after 30 days and after 60 days; however, while C and M groups exhibited similar aspect, the MSI specimens showed weak labeling. The ultrastructural evaluation showed the interaction between the biomaterial and the surrounding tissue where some cells established intimate contact with microspheres.
   Conclusions The repair of critical size bone defects was accelerated and enhanced by the implantation of simvastatin-loaded PLGA microspheres.
C1 [Ferreira, Lorraine B.; Bradaschia-Correa, Vivian; Moreira, Mariana M.; Marques, Natasha D. M.; Arana-Chavez, Victor E.] Univ Sao Paulo, Sch Dent, Dept Biomat & Oral Biol, BR-05508900 Sao Paulo, Brazil.
RP Arana-Chavez, VE (reprint author), Univ Sao Paulo, Sch Dent, Dept Biomat & Oral Biol, Ave Prof Lineu Prestes 2227, BR-05508900 Sao Paulo, Brazil.
EM vearana@usp.br
FU CAPES/Brazil; CNPq; FAPESP, Brazil
FX This study was supported by CAPES/Brazil and partially supported by CNPq
   and FAPESP, Brazil.
CR Adeeb N, 2012, CHILD NERV SYST, V28, P827, DOI 10.1007/s00381-012-1744-6
   Arana-Chavez VE, 2001, J HISTOCHEM CYTOCHEM, V49, P1099, DOI 10.1177/002215540104900904
   ARANACHAVEZ VE, 1995, ARCH HISTOL CYTOL, V58, P285, DOI 10.1679/aohc.58.285
   Barbanti SH, 2004, J MATER SCI-MATER M, V15, P1315, DOI 10.1007/s10856-004-5740-6
   Berkland C, 2002, J CONTROL RELEASE, V82, P137, DOI 10.1016/S0168-3659(02)00136-0
   Brinkkoetter PT, 2013, NAT REV NEPHROL, V9, P328, DOI 10.1038/nrneph.2013.78
   Brown J. L., 2013, BIOMATERIALS SCI INT, P1194
   Cameron JA, 2013, CURR TOP MICROBIOL, V367, P113, DOI 10.1007/82_2012_291
   Chang PC, 2012, J BIOMED MATER RES A, V100A, P2970, DOI 10.1002/jbm.a.34244
   Couble ML, 2004, HISTOCHEM CELL BIOL, V121, P47, DOI 10.1007/s00418-003-0608-2
   Davignon J, 1999, CURR OPIN LIPIDOL, V10, P543, DOI 10.1097/00041433-199912000-00010
   Garrett IR, 2007, J ORTHOP RES, V25, P1351, DOI 10.1002/jor.20391
   Garrett IR, 2001, CURR PHARM DESIGN, V7, P715, DOI 10.2174/1381612013397762
   He FP, 2012, J BIOMED MATER RES A, V100A, P3239, DOI 10.1002/jbm.a.34265
   Imbronito AV, 2005, J BIOMED MATER RES A, V74A, P215, DOI 10.1002/jbm.a.30350
   Jadhav SB, 2006, J PHARM PHARMACOL, V58, P3, DOI 10.1211/jpp.58.1.0002
   Jeon JH, 2008, J PERIODONTOL, V79, P1457, DOI [10.1902/jop.2008.080004, 10.1902/jop.2008.080004 ]
   Maciel-Oliveira N, 2011, ORAL SURG ORAL MED O, V112, P170, DOI 10.1016/j.tripleo.2010.08.027
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Massa LF, 2000, EUR J ORAL SCI, V108, P74, DOI 10.1034/j.1600-0722.2000.00753.x
   Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946
   Nath SD, 2014, J BIOMATER APPL, V28, P1151, DOI 10.1177/0885328213499272
   Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F
   Oxlund H, 2004, BONE, V34, P609, DOI 10.1016/j.bone.2003.12.014
   Pietro L, 2008, J MATER SCI-MATER M, V19, P1069, DOI 10.1007/s10856-007-3017-6
   Ramstad VE, 2003, CALCIFIED TISSUE INT, V72, P57, DOI 10.1007/s00223-002-2047-6
   Rey C, 2009, OSTEOPOROSIS INT, V20, P1013, DOI 10.1007/s00198-009-0860-y
   Scaglione S, 2010, J TISSUE ENG REGEN M, V4, P505, DOI 10.1002/term.265
   Sinha VR, 2004, INT J PHARMACEUT, V278, P1, DOI 10.1016/j.ijpharm.2004.01.044
   Skoglund B, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-98
   Song CL, 2003, BIOCHEM BIOPH RES CO, V308, P458, DOI 10.1016/S0006-291X(03)01408-6
   Stein D, 2005, J PERIODONTOL, V76, P1861, DOI 10.1902/jop.2005.76.11.1861
   Tai IC, 2013, INT J NANOMED, V8, P3895, DOI 10.2147/IJN.S48694
NR 33
TC 7
Z9 7
U1 0
U2 14
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD FEB
PY 2015
VL 29
IS 7
BP 965
EP 976
DI 10.1177/0885328214550897
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AZ0YH
UT WOS:000347967300005
PM 25209881
DA 2018-10-19
ER

PT J
AU Son, SR
   Sarkar, SK
   Linh, NTB
   Padalhin, AR
   Kim, BR
   Jung, HI
   Lee, BT
AF Son, So-Ra
   Sarkar, Swapan Kumar
   Linh, Nguyen-Thuy Ba
   Padalhin, Andrew R.
   Kim, Bo Ram
   Jung, Hae Il
   Lee, Byong-Taek
TI Platelet-rich plasma encapsulation in hyaluronic acid/gelatin-BCP
   hydrogel for growth factor delivery in BCP sponge scaffold for bone
   regeneration
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Hyaluronic acid; gelatin; biphasic calcium phosphate; platelet-rich
   plasma; bone substitutes
ID CALCIUM-PHOSPHATE CERAMICS; RAT ECTOPIC MODEL; IN-VITRO; BIOMATERIAL
   CARRIERS; SUSTAINED DELIVERY; FACTOR-BB; COMBINATION; SURGERY; RELEASE;
   REPAIR
AB Microporous calcium phosphate based synthetic bone substitutes are used for bone defect healing. Different growth factor loading has been investigated for enhanced bone regeneration. The platelet is a cellular component of blood which naturally contains a pool of necessary growth factors that mediate initiation, continuation, and completion of cellular mechanism of healing. In this work, we have investigated the encapsulation and immobilization of platelet-rich plasma (PRP) with natural polymers like hyaluronic acid (HA) and gelatin (Gel) and loading them in a biphasic calcium phosphate (BCP) scaffold, for a synthetic-allologous hybrid scaffold. Effect of PRP addition in small doses was evaluated for osteogenic potential invitro and invivo. BCP (10%) mixed HA-Gel hydrogel with or without PRP, was loaded into a BCP sponge scaffold. We investigated the hydrogel-induced improvement in mechanical property and PRP-mediated enhancement in biocompatibility. Invitro studies for cytotoxicity, cell attachment, and proliferation were carried out using MC3T3-E1 pre-osteoblast cells. In invitro studies, the cell count, cell proliferation, and cell survival were higher in the scaffold with PRP loading than without PRP. However, in the invivo studies using a rat model, the PRP scaffold was not superior to the scaffold without PRP. This discrepancy was investigated in terms of the interaction of PRP in the invivo environment.
C1 [Son, So-Ra; Padalhin, Andrew R.; Kim, Bo Ram; Lee, Byong-Taek] Dept Regenerat Med, Ssangyong Dong, Chungnam, South Korea.
   [Sarkar, Swapan Kumar; Linh, Nguyen-Thuy Ba; Lee, Byong-Taek] Soonchunhyang Univ, Coll Med, Inst Tissue Regenerat, Ssangyong Dong, Chungnam, South Korea.
   [Jung, Hae Il] Soonchunhyang Univ, Cheonan Hosp, Dept Surg, Cheonan, South Korea.
RP Lee, BT (reprint author), Dept Regenerat Med, Cheonan 330090, Chungnam, South Korea.
EM lbt@sch.ac.kr
FU Korea Health Technology R & D project, Ministry of Health & Welfare,
   Republic of Korea [A111084]; Soonchunhyang University research fund
FX This work was supported by a grant of the Korea Health Technology R & D
   project, Ministry of Health & Welfare, Republic of Korea (A111084). The
   work was partially supported by the Soonchunhyang University research
   fund.
CR [Anonymous], 2010, Hydrogel and biomedical applications thereof US 20100021544, A1 Xavier Bourges, Serge Baroth, Patent No. 20100021544
   Aspenberg P, 2011, ACTA ORTHOP, V82, P511, DOI 10.3109/17453674.2011.623576
   Axelrad TW, 2009, CYTOKINE GROWTH F R, V20, P481, DOI 10.1016/j.cytogfr.2009.10.003
   Blumenfeld I, 2002, EXP GERONTOL, V37, P553, DOI 10.1016/S0531-5565(01)00215-7
   Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x
   Castellani C, 2009, CLIN ORAL IMPLAN RES, V20, P1367, DOI 10.1111/j.1600-0501.2009.01760.x
   Choi BH, 2005, INT J ORAL MAX SURG, V34, P420, DOI 10.1016/j.ijom.2004.10.018
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   Daculsi G, 2004, KEY ENG MAT, V254-2, P1005, DOI 10.4028/www.scientific.net/KEM.254-256.1005
   Daculsi G, 2013, IRBM, V34, P346, DOI 10.1016/j.irbm.2013.07.001
   De Biase P, 2005, INJURY, V36, P43, DOI 10.1016/j.injury.2005.07.034
   Devescovi Valentina, 2008, Chir Organi Mov, V92, P161, DOI 10.1007/s12306-008-0064-1
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Dorhozin S, 2012, ACTA BIOMATER, V8, P963
   Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7
   Frechette JP, 2005, J DENT RES, V84, P434, DOI 10.1177/154405910508400507
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Guehennec LL, 2004, EUR CELLS MATER, V8, P1
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977
   Howell TH, 1997, J PERIODONTOL, V68, P1186, DOI 10.1902/jop.1997.68.12.1186
   Huang ZN, 2007, TISSUE ENG, V13, P2311, DOI 10.1089/ten.2006.0423
   Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   Kim M, 2011, J EUR CERAM SOC, V31, P1541, DOI 10.1016/j.jeurceramsoc.2011.03.019
   King WJ, 2012, ADV DRUG DELIVER REV, V64, P1239, DOI 10.1016/j.addr.2012.03.004
   KIURU J, 1991, LIFE SCI, V49, P1997, DOI 10.1016/0024-3205(91)90642-O
   Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z
   Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017
   Lu HH, 2008, J BIOMED MATER RES A, V86A, P1128, DOI 10.1002/jbm.a.31740
   Gimeno FL, 2006, THROMB J, V4, DOI 10.1186/1477-9560-4-18
   Malizos KN, 2005, INJURY, V36, P13, DOI 10.1016/j.injury.2005.07.030
   Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003
   Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745
   Matsui M, 2012, ACTA BIOMATER, V8, P1792, DOI 10.1016/j.actbio.2012.01.016
   Nevins M, 2003, J PERIODONTOL, V74, P1282, DOI 10.1902/jop.2003.74.9.1282
   Nguyen LTB, TISSUE ENG PART A, DOI [10.1089/ten.tea.2013.0352, DOI 10.1089/TEN.TEA.2013.0352.]
   NIHOUANNEN DL, 2006, BIOMATERIALS, V27, P2716
   Park MS, 2006, J BIOMED MATER RES B, V79B, P353, DOI 10.1002/jbm.b.30549
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Phillips AM, 2005, INJURY, V36, P5, DOI 10.1016/j.injury.2005.07.027
   Plachokova AS, 2007, CLIN ORAL IMPLAN RES, V18, P244, DOI 10.1111/j.1600-0501.2006.01327.x
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   Ramay HR, 2003, BIOMATERIALS, V24, P3293, DOI 10.1016/S0142-9612(03)00171-6
   Ranly DM, 2005, J BONE JOINT SURG AM, V87A, P2052, DOI 10.2106/JBJS.D.02752
   Ratanavaraporn J, 2011, BIOMATERIALS, V32, P2797, DOI 10.1016/j.biomaterials.2010.12.052
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Ripamonti U, 2009, J CRANIOFAC SURG, V20, P1544, DOI 10.1097/SCS.0b013e3181b09ca6
   Saffarzadeh A, 2009, CLIN ORAL IMPLAN RES, V20, P1133, DOI 10.1111/j.1600-0501.2009.01738.x
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Yuan HP, 2006, TISSUE ENG, V12, P1607, DOI 10.1089/ten.2006.12.1607
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
NR 57
TC 13
Z9 14
U1 4
U2 29
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD FEB
PY 2015
VL 29
IS 7
BP 988
EP 1002
DI 10.1177/0885328214551373
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AZ0YH
UT WOS:000347967300007
PM 25234121
DA 2018-10-19
ER

PT J
AU Zhang, QB
   Shan, GH
   Cao, P
   He, J
   Lin, ZS
   Huang, YX
   Ao, NJ
AF Zhang, Quanbin
   Shan, Guanghua
   Cao, Ping
   He, Jia
   Lin, Zhongshi
   Huang, Yaoxiong
   Ao, Ningjian
TI Mechanical and biological properties of oxidized horn keratin
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Horn keratin; Protein oxidation; Mechanical properties;
   Biocompatibility; Biomaterial
ID TRANSFORM INFRARED-SPECTROSCOPY; HYDROGEN-PEROXIDE TREATMENT;
   FOREIGN-BODY REACTION; BLOOD COMPATIBILITY; SECONDARY STRUCTURE; SILK
   FIBROIN; FORMIC-ACID; WOOL FIBERS; HEMOCOMPATIBILITY; HEPARIN
AB The goal of this study was to investigate the mechanical and biological properties of oxidized keratin materials, which were obtained by using buffalo horns to oxidize. It could provide a way to evaluate their potential for clinical translatability. The characterization on their composition, mechanical properties, and biological responses was performed. It is found that the oxidation process could lead the disulfide bond to break down and then to form sulfonic acid, or even make partial peptide chain to be fragment for the new modification of amino acid. Hence the oxidized horn keratins have lower thermal stability and hydrolytic stability in comparison with horn keratin, but the degradation products of oxidized horn keratins have no significant difference. In addition, the mechanical properties of oxidized horn keratins are poorer than that of horn keratin, but the oxidized horn keratins still have disulfide bonds to form a three-dimensional structure, which benefits for their mechanical properties. The fracture toughness of oxidized horn keratins increases with the increase in the degree of oxidation. After oxidation, the oxidized horn keratins have lower cytotoxicity and lower hemolysis ratio. Moreover, when the oxidized horn keratins, as well as different concentration of degradation products of oxidized horn keratins, are directly in contact with platelet-rich plasma, platelets are not activated. It suggests that the oxidized horn keratins have good hemocompatibility, without triggering blood thrombosis. The implantation experiment in vivo also demonstrates that the oxidized horn keratins are compatible with the tissue, because there are minimal fibrous capsule and less of infiltration of host cells, without causing serious inflammation. In summary, the oxidized horn keratins can act as implanted biomaterigdevices that are directly in contact with blood and tissue. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Zhang, Quanbin; Huang, Yaoxiong; Ao, Ningjian] Jinan Univ, Dept Biomed Engn, Guangzhou 510632, Guangdong, Peoples R China.
   [Shan, Guanghua] Jinan Univ, Affiliated Hosp 1, Guangzhou 510632, Guangdong, Peoples R China.
   [Cao, Ping; He, Jia; Lin, Zhongshi] Shenzhen Testing Ctr Med Devices, Shenzhen 518057, Peoples R China.
RP Ao, NJ (reprint author), Jinan Univ, Dept Biomed Engn, Guangzhou 510632, Guangdong, Peoples R China.
EM taonj@jnu.edu.cn
FU National Natural Science Foundation of China [20976068/B060805]; Science
   and Technology Program of Guangdong Province [268017]
FX This work has been financially supported by the National Natural Science
   Foundation of China (Grant No. 20976068/B060805) and the Science and
   Technology Program of Guangdong Province (No. 268017). In addition, the
   authors would like to thank Shenzhen Testing Center of Medical Devices,
   China. They would also like to thank Yuan Tian, coming from Biomedical
   Engineering of Jinan University.
CR Aluigi A, 2007, INT J BIOL MACROMOL, V41, P266, DOI 10.1016/j.ijbiomac.2007.03.002
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Barone JR, 2005, J APPL POLYM SCI, V97, P1644, DOI 10.1002/app.21901
   Brady P.R, 1997, FINISHING WOOL FABRI
   BUCHANAN JH, 1977, BIOCHEM J, V167, P489, DOI 10.1042/bj1670489
   Callister WD, 2007, MAT SCI ENG INTRO
   Chen PY, 2012, PROG MATER SCI, V57, P1492, DOI 10.1016/j.pmatsci.2012.03.001
   COHEN J, 1959, J BONE JOINT SURG AM, V41, P152, DOI 10.2106/00004623-195941010-00018
   Douglas JE, 1996, J EXP BIOL, V199, P1829
   EARLAND C, 1956, BIOCHIM BIOPHYS ACTA, V22, P405, DOI 10.1016/0006-3002(56)90048-8
   Edwards HGM, 1998, SPECTROCHIM ACTA A, V54, P745, DOI 10.1016/S1386-1425(98)00013-4
   Erra P, 1997, TEXT RES J, V67, P397, DOI 10.1177/004051759706700602
   FEUGHELMAN M, 1971, TEXT RES J, V41, P469, DOI 10.1177/004051757104100601
   Franck A, 2006, BIOSYST ENG, V93, P459, DOI 10.1016/j.biosystemseng.2006.01.007
   FU FN, 1994, APPL SPECTROSC, V48, P1432, DOI 10.1366/0003702944028065
   Gama RM, 2011, J THERM ANAL CALORIM, V106, P399
   GIROUD A, 1951, ANN NY ACAD SCI, V53, P613, DOI 10.1111/j.1749-6632.1951.tb31963.x
   Guzman R. C. D., 2011, BIOMATERIALS, V32, P8205
   Hashemi S, 2000, J MATER SCI, V35, P5851, DOI 10.1023/A:1026704323702
   KAMINSKL EDWARD J., 1968, J BIOMED MAT RES, V2, P81, DOI 10.1002/jbm.820020106
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Li GC, 2011, BIOMATERIALS, V32, P4691, DOI 10.1016/j.biomaterials.2011.03.025
   Li JS, 2013, FOOD CHEM TOXICOL, V57, P338, DOI 10.1016/j.fct.2013.03.047
   Li LH, 2001, BIOMATERIALS, V22, P2595, DOI 10.1016/S0142-9612(00)00222-2
   Li Q, 2011, TEXT RES J, V82, P195
   Li Q, 2012, J TEXT I, V103, P662, DOI 10.1080/00405000.2011.597569
   Lin SY, 1996, METHOD FIND EXP CLIN, V18, P175
   Lin WC, 2004, BIOMATERIALS, V25, P1947, DOI 10.1016/j.biomaterials.2003.08.027
   Liu X., 2012, J THERM ANAL CALORIM, V111, P259
   MACLAREN JA, 1962, AUST J CHEM, V15, P824, DOI 10.1071/CH9620824
   Mao C, 2004, ADV COLLOID INTERFAC, V110, P5, DOI 10.1016/j.cis.2004.02.001
   MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030
   Marti M, 2007, J APPL POLYM SCI, V104, P545, DOI 10.1002/app.25586
   Merouani S, 2010, J HAZARD MATER, V178, P1007, DOI 10.1016/j.jhazmat.2010.02.039
   Miale J.B., 1962, ACAD MED, V37, P1147
   MOEN O, 1995, ANN THORAC SURG, V60, P1317, DOI 10.1016/0003-4975(95)00777-I
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Nagarajan M, 2013, FOOD CHEM, V138, P1101, DOI 10.1016/j.foodchem.2012.11.069
   NOISHIKI Y, 1982, KOBUNSHI RONBUNSHU, V39, P221, DOI 10.1295/koron.39.221
   ODONNELL IJ, 1964, AUST J BIOL SCI, V17, P973, DOI 10.1071/BI9640973
   Plowman JE, 2003, J CHROMATOGR B, V787, P63, DOI 10.1016/S1570-0232(02)00211-8
   Rahmany MB, 2013, BIOMATERIALS, V34, P2492, DOI 10.1016/j.biomaterials.2012.12.008
   Rizvi TZ, 2008, INT J BIOL MACROMOL, V42, P292, DOI 10.1016/j.ijbiomac.2008.01.001
   Sasidharan A, 2012, SMALL, V8, P1251, DOI 10.1002/smll.201102393
   Singhal JP, 2002, BIOMATERIALS, V23, P1139, DOI 10.1016/S0142-9612(01)00228-9
   SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001
   Tombolato L, 2010, ACTA BIOMATER, V6, P319, DOI 10.1016/j.actbio.2009.06.033
   Tonin C, 2004, J THERM ANAL CALORIM, V77, P987, DOI 10.1023/B:JTAN.0000041674.04961.b4
   Trim MW, 2011, ACTA BIOMATER, V7, P1228, DOI 10.1016/j.actbio.2010.11.024
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vasconcelos A, 2013, CURR DRUG TARGETS, V14, P612, DOI 10.2174/1389450111314050010
   Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531
   Vincent J. F. V., 1980, MECH PROPERTIES BIOL
   Wang X, 2012, APPL SURF SCI, V258, P10012, DOI 10.1016/j.apsusc.2012.06.065
   Wang X, 2009, J APPL POLYM SCI, V112, P1959, DOI 10.1002/app.29573
   Yang SL, 2008, POLYM TEST, V27, P957, DOI 10.1016/j.polymertesting.2008.08.009
   ZAHN H, 1980, IND ENG CHEM PROD RD, V19, P496, DOI 10.1021/i360076a005
   Zhang J, 2013, POWDER TECHNOL, V246, P356, DOI 10.1016/j.powtec.2013.05.037
   Zhang QB, 2013, MAT SCI ENG C-MATER, V33, P5036, DOI 10.1016/j.msec.2013.08.034
   Zoccola M, 2009, J MOL STRUCT, V938, P35, DOI 10.1016/j.molstruc.2009.08.036
NR 63
TC 9
Z9 9
U1 1
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2015
VL 47
BP 123
EP 134
DI 10.1016/j.msec.2014.11.051
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA AY4YT
UT WOS:000347581600015
PM 25492180
DA 2018-10-19
ER

PT J
AU Sakthivel, N
   Socrates, R
   Shanthini, GM
   Rajaram, A
   Kalkura, SN
AF Sakthivel, N.
   Socrates, R.
   Shanthini, G. M.
   Rajaram, A.
   Kalkura, S. Narayana
TI Silver ion impregnated composite biomaterial optimally prepared using
   zeta potential measurements
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Zeta potential; Isoelectric point; Silver ion release; Composites
ID HYDROXYAPATITE-GELATIN NANOCOMPOSITE; SUBSTITUTED HYDROXYAPATITE;
   ANTIMICROBIAL ACTIVITY; DOPED HYDROXYAPATITE; PROTEIN ADSORPTION;
   ANTIBACTERIAL; NANOPARTICLES; SPECTROSCOPY; STRENGTH; MATRICES
AB Biodegradable, antimicrobial composite of various silver ion concentrations was synthesized using zeta potential and isoelectric point measurements, for a controlled release of silver ions, and in addition to assess the effect of protein adsorption with the increase of the silver ion concentration. The interaction between hydroxyapatite (HAp) and silver incorporated hydroxyapatite (AgHAp) with gelatin was increased by optimally adjusting the zeta potential and isoelectric point of the ceramic (HAp and AgHAp), and bio-polymer individually. The electrostatic interactions between the ceramic and biopolymer were confirmed, through shifts in N-H stretching, decrease in the swelling ratio, and increase in the degradation temperature observed by the derivative thermo-gravimetric analysis (DTG). These results substantiate that, the zeta potential is a novel tool to increase the ceramic-biopolymer interaction. Increasing electrostatic interaction between the biopolymer and ceramic, decreases the release of silver ions in the simulated body fluid, due to the controlled degradation of the biopolymer. The isoelectric point decreases with the increase of the silver ion concentration, which evidenced the change in the net surface charge. With the increase of the silver ion concentration, the protein adsorption decreases due to an increase in hydrophilic character of the composite. This study examines the minimum concentration of silver ion essential for maximum protein adsorption, antimicrobial and hemocompatibility. This study provides a novel route to control the release of silver ions by enhancing the ceramic-polymer interaction and estimate the silver ion concentration suitable for protein adsorption. The prepared composite is nontoxic, degradable, and antimicrobial, with the controlled release of silver ions in the simulated body fluid. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Sakthivel, N.; Shanthini, G. M.; Kalkura, S. Narayana] Anna Univ, Ctr Crystal Growth, Madras 600025, Tamil Nadu, India.
   [Socrates, R.; Rajaram, A.] Cent Leather Res Inst, Biophys Lab, Madras 600025, Tamil Nadu, India.
RP Kalkura, SN (reprint author), Anna Univ, Ctr Crystal Growth, Madras 600025, Tamil Nadu, India.
EM kalkura@yahoo.com
OI , G.M. Shanthini/0000-0002-2381-5996
FU Department of Biotechnology, New Delhi (DBT)
   [BT/PR11799/MED/32/103/2009]
FX This work was supported by Department of Biotechnology, New Delhi (DBT)
   through the project BT/PR11799/MED/32/103/2009. The authors thank Dr.
   Rama Rajaram, Central Leather Research Institute, Chennai for valuable
   discussion.
CR Bajpai AK, 2006, J MATER SCI-MATER M, V17, P49, DOI 10.1007/s10856-006-6329-z
   Barbani N, 2012, J MATER SCI-MATER M, V23, P51, DOI 10.1007/s10856-011-4505-2
   Bera T, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025001
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Chang MC, 2008, J MATER SCI-MATER M, V19, P3411, DOI 10.1007/s10856-008-3488-0
   Dhandayuthapani B., 2011, INT J POLYM SCI, V2011, P19, DOI DOI 10.1155/2011/290602
   Diaz M, 2009, J NANOMATER, DOI 10.1155/2009/498505
   Dibrov P., 2002, ANTIMICROB AGENTS CH, V46, P8
   Dorozhkin S.V., 2011, BIOMATTER, V1, P1, DOI DOI 10.5618/BI0.2011.V1.N1.1
   DOYLE BB, 1975, BIOPOLYMERS, V14, P937, DOI 10.1002/bip.1975.360140505
   Einerson NJ, 2003, BIOMATERIALS, V24, P509, DOI 10.1016/S0142-9612(02)00369-1
   Ewald A, 2011, ACTA BIOMATER, V7, P4064, DOI 10.1016/j.actbio.2011.06.049
   Haider S, 2008, SOFT MATTER, V4, P485, DOI 10.1039/b713944f
   ISIKLI B, 1998, TURK J MED SCI, V28, P655
   Ivashchenko OA, 2011, MATERIALWISS WERKST, V42, P98, DOI 10.1002/mawe.201100739
   Joshy MIA, 2013, MAT SCI ENG C-MATER, V33, P466, DOI 10.1016/j.msec.2012.09.016
   Kim J.H., 2002, ENCY SURFACE COLLOID, V1, P4373
   Kokubo T, 1996, THERMOCHIM ACTA, V280, P479, DOI 10.1016/0040-6031(95)02784-X
   Kuboki Y, 1995, CONNECT TISSUE RES, V32, P219, DOI 10.3109/03008209509013726
   Kusmanto F, 2008, CHEM ENG J, V139, P398, DOI 10.1016/j.cej.2007.11.041
   Lim PN, 2013, J BIOMED MATER RES A, V101, P2456, DOI 10.1002/jbm.a.34544
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   Mucksch C, 2011, LANGMUIR, V27, P12938, DOI 10.1021/la201972f
   Pauksch L, 2014, ACTA BIOMATER, V10, P439, DOI 10.1016/j.actbio.2013.09.037
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   Percival SL, 2005, J HOSP INFECT, V60, P1, DOI 10.1016/j.jhin.2004.11.014
   Rameshbabu N, 2007, J BIOMED MATER RES A, V80A, P581, DOI 10.1002/jbm.a.30958
   RAMSDEN JJ, 1994, J PHYS CHEM-US, V98, P5376, DOI 10.1021/j100071a031
   Rattanaruengsrikul V, 2009, MACROMOL BIOSCI, V9, P1004, DOI 10.1002/mabi.200900131
   Rodenas LG, 2005, J COLLOID INTERF SCI, V290, P145, DOI 10.1016/j.jcis.2005.04.041
   Singhal JP, 2002, BIOMATERIALS, V23, P1139, DOI 10.1016/S0142-9612(01)00228-9
   Smeets Ralf, 2009, Head Face Med, V5, P13, DOI 10.1186/1746-160X-5-13
   Smith IO, 2004, J BIOMED MATER RES A, V70A, P436, DOI 10.1002/jbm.a.30098
   Stanic V, 2011, APPL SURF SCI, V257, P4510, DOI 10.1016/j.apsusc.2010.12.113
   SVENSSON H, 1961, ACTA CHEM SCAND, V15, P325, DOI 10.3891/acta.chem.scand.15-0325
   TRIPPEL SB, 1986, J BONE JOINT SURG AM, V68A, P1297, DOI 10.2106/00004623-198668080-00026
   Wu X, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/044105
   Xu XY, 2006, EUR POLYM J, V42, P2081, DOI 10.1016/j.eurpolymj.2006.03.032
   Yang JM, 1996, J BIOMED MATER RES, V33, P83, DOI 10.1002/(SICI)1097-4636(199622)33:2<83::AID-JBM4>3.0.CO;2-H
   Yang ZW, 2005, J MATER CHEM, V15, P1807, DOI 10.1039/b418015c
   Yu LL, 2013, J CHROMATOGR A, V1305, P85, DOI 10.1016/j.chroma.2013.07.016
NR 41
TC 1
Z9 1
U1 3
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2015
VL 47
BP 222
EP 229
DI 10.1016/j.msec.2014.11.018
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA AY4YT
UT WOS:000347581600027
PM 25492192
DA 2018-10-19
ER

PT J
AU Zhang, SC
   Liu, P
   Chen, L
   Wang, YJ
   Wang, ZG
   Zhang, B
AF Zhang, Shichang
   Liu, Ping
   Chen, Li
   Wang, Yingjie
   Wang, Zhengguo
   Zhang, Bo
TI The effects of spheroid formation of adipose-derived stem cells in a
   microgravity bioreactor on sternness properties and therapeutic
   potential
SO BIOMATERIALS
LA English
DT Article
DE Adipose-derived stem cells; Microgravity bioreactor; Sternness property;
   Therapeutic potential
ID ACUTE LIVER-FAILURE; PROGENITOR CELLS; DROSOPHILA-OVARY; TISSUE;
   DIFFERENTIATION; MAINTENANCE; SCAFFOLD; CHITOSAN; NICHES; REGENERATION
AB Adipose-derived stem cells (ADSCs) represent a valuable source of stem cells for regenerative medicine, but the loss of their sternness during in vitro expansion remains a major roadblock. We employed a microgravity bioreactor (MB) to develop a method for biomaterial-free-mediated spheroid formation to maintain the sternness properties of ADSCs. ADSCs spontaneously formed three-dimensional spheroids in the MB. Compared with monolayer culture, the expression levels of E-cadherin and pluripotent markers were significantly upregulated in ADSC spheroids. Spheroid-derived ADSCs exhibited increased proliferative ability and colony-forming efficiency. By culturing the spheroid-derived ADSCs in an appropriate induction medium, we found that the multipotency differentiation capacities of ADSCs were significantly improved by spheroid culture in the MB. Furthermore, when ADSCs were administered to mice with carbon tetrachloride-induced acute liver failure, spheroid-derived ADSCs showed more effective potentials to rescue liver failure than ADSCs derived from constant monolayer culture. Our results suggest that spheroid formation of ADSCs in an MB enhances their sternness properties and increases their therapeutic potential. Therefore, spheroid culture in an MB can be an efficient method to maintain stemness properties, without the involvement of any biomaterials for clinical applications of in vitro cultured ADSCs. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Zhang, Shichang; Liu, Ping; Wang, Zhengguo; Zhang, Bo] Third Mil Med Univ, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Dept 4,Inst Surg Res, Chongqing 400042, Peoples R China.
   [Chen, Li] Nanjing Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Nanjing 210017, Jiangsu, Peoples R China.
   [Wang, Yingjie] Third Mil Med Univ, Southwest Hosp, Inst Infect Dis, Chongqing 400038, Peoples R China.
RP Zhang, B (reprint author), Third Mil Med Univ, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Dept 4,Inst Surg Res, Chongqing 400042, Peoples R China.
EM zhangbo67184@l63.com
FU National Program on Key Basic Research Project of China [2011CB964701];
   National Natural Science Foundation of China [30800237]; Foundation for
   Science and Technology Research Project of Chongqing [CSTC2012GGB1003]
FX This research was supported by funds from the National Program on Key
   Basic Research Project of China (2011CB964701), the National Natural
   Science Foundation of China (30800237) and the Foundation for Science
   and Technology Research Project of Chongqing (CSTC2012GGB1003). We
   gratefully acknowledge all of the members of the laboratory for sharing
   reagents and advice.
CR Baer PC, 2010, CYTOTHERAPY, V12, P96, DOI 10.3109/14653240903377045
   Baraniak PR, 2012, CELL TISSUE RES, V347, P701, DOI 10.1007/s00441-011-1215-5
   Bongso A, 2013, STEM CELL REV REP, V9, P226, DOI 10.1007/s12015-012-9418-z
   Cawthorn WP, 2012, TRENDS ENDOCRIN MET, V23, P270, DOI 10.1016/j.tem.2012.01.003
   Cheng NC, 2013, STEM CELL TRANSL MED, V2, P584, DOI 10.5966/sctm.2013-0007
   Cheng NC, 2012, BIOMATERIALS, V33, P1748, DOI 10.1016/j.biomaterials.2011.11.049
   Cho HJ, 2012, MOL THER, V20, P1750, DOI 10.1038/mt.2012.109
   Emmert MY, 2013, BIOMATERIALS, V34, P6339, DOI 10.1016/j.biomaterials.2013.04.034
   Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214
   Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010
   Fridley KM, 2010, TISSUE ENG PT A, V16, P3285, DOI [10.1089/ten.tea.2010.0166, 10.1089/ten.TEA.2010.0166]
   Frith JE, 2010, TISSUE ENG PART C-ME, V16, P735, DOI [10.1089/ten.tec.2009.0432, 10.1089/ten.TEC.2009.0432]
   Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202
   Gimble JM, 2012, REGEN MED, V7, P225, DOI [10.2217/RME.11.119, 10.2217/rme.11.119]
   Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010
   Hsu SH, 2014, BIOMATERIALS, V35, P7295, DOI 10.1016/j.biomaterials.2014.05.033
   Huang GS, 2011, BIOMATERIALS, V32, P6929, DOI 10.1016/j.biomaterials.2011.05.092
   Huang JY, 2009, CELL RES, V19, P1127, DOI 10.1038/cr.2009.106
   Kapur SK, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/025004
   Keung AJ, 2010, ANNU REV CELL DEV BI, V26, P533, DOI 10.1146/annurev-cellbio-100109-104042
   Laschke MW, 2013, ACTA BIOMATER, V9, P6876, DOI 10.1016/j.actbio.2013.02.013
   Lee EJ, 2012, MOL THER, V20, P1424, DOI 10.1038/mt.2012.58
   Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014
   Li S, 2009, STEM CELLS DEV, V18, P1273, DOI 10.1089/scd.2008.0371
   Liu TM, 2009, STEM CELLS DEV, V18, P1013, DOI 10.1089/scd.2008.0335
   Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013
   Lu DY, 2014, BIOMATERIALS, V35, P3945, DOI 10.1016/j.biomaterials.2014.01.066
   Ma JL, 2014, STEM CELL TRANSL MED, V3, P98, DOI 10.5966/sctm.2013-0126
   Marx V, 2013, NATURE, V496, P253, DOI 10.1038/496253a
   Meier RPH, 2013, STEM CELL RES, V11, P1348, DOI 10.1016/j.scr.2013.08.011
   Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542
   Park E, 2010, CELL BIOL INT, V34, P979, DOI 10.1042/CBI20100124
   Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530
   Riekstina U, 2009, STEM CELL REV REP, V5, P378, DOI 10.1007/s12015-009-9094-9
   Russo FP, 2011, CYTOTHERAPY, V13, P135, DOI 10.3109/14653249.2010.545386
   Rustad KC, 2012, BIOMATERIALS, V33, P80, DOI 10.1016/j.biomaterials.2011.09.041
   Saleh Fatima A, 2012, Methods Mol Biol, V916, P31, DOI 10.1007/978-1-61779-980-8_4
   Saraswati S, 2012, WOUND REPAIR REGEN, V20, P185, DOI 10.1111/j.1524-475X.2012.00767.x
   Shah FS, 2013, CYTOTHERAPY, V15, P979, DOI 10.1016/j.jcyt.2013.04.001
   Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399
   Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871
   Spelke DP, 2011, METHODS MOL BIOL, V690, P151, DOI 10.1007/978-1-60761-962-8_10
   Spencer HL, 2007, MOL BIOL CELL, V18, P2838, DOI 10.1091/mbc.E06-09-0875
   Su GN, 2013, BIOMATERIALS, V34, P3215, DOI 10.1016/j.biomaterials.2013.01.044
   Trohatou O, 2014, STEM CELL TRANSL MED, V3, P54, DOI 10.5966/sctm.2013-0081
   Volarevic V, 2014, STEM CELLS, V32, P2818, DOI 10.1002/stem.1818
   Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427
   Wei JS, 2014, BIOMATERIALS, V35, P7724, DOI 10.1016/j.biomaterials.2014.05.060
   Yan XZ, 2014, TISSUE ENG PART B-RE, V20, P340, DOI [10.1089/ten.TEB.2013.0349, 10.1089/ten.teb.2013.0349]
   Yeh HY, 2012, BIOMATERIALS, V33, P8943, DOI 10.1016/j.biomaterials.2012.08.069
   Yu JS, 2014, BIOMATERIALS, V35, P3516, DOI 10.1016/j.biomaterials.2014.01.015
   Zamperone A, 2013, STEM CELLS DEV, V22, P2873, DOI 10.1089/scd.2012.0718
   Zhang D, 2013, BIOMATERIALS, V34, P3962, DOI 10.1016/j.biomaterials.2013.02.029
   Zhang SC, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt356
   Zhang SC, 2012, TISSUE ENG PT A, V18, P1352, DOI [10.1089/ten.TEA.2011.0516, 10.1089/ten.tea.2011.0516]
NR 55
TC 32
Z9 33
U1 4
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2015
VL 41
BP 15
EP 25
DI 10.1016/j.biomaterials.2014.11.019
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA6XY
UT WOS:000349062100002
PM 25522961
DA 2018-10-19
ER

PT J
AU Tallawi, M
   Rai, R
   Boccaccini, AR
   Aifantis, KE
AF Tallawi, Marwa
   Rai, Ranjana
   Boccaccini, Aldo. R.
   Aifantis, Katerina E.
TI Effect of Substrate Mechanics on Cardiomyocyte Maturation and Growth
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Article
ID EMBRYONIC STEM-CELLS; ATOMIC-FORCE MICROSCOPY; CARDIAC MYOCYTES;
   NEONATAL CARDIOMYOCYTES; HEART-DISEASE; SARCOPLASMIC-RETICULUM;
   INTRACELLULAR CALCIUM; VENTRICULAR MYOCYTES; CYCLIC STRAIN; STIFFNESS
AB Cardiac tissue engineering constructs are a promising therapeutic treatment for myocardial infarction, which is one of the leading causes of death. In order to further advance the development and regeneration of engineered cardiac tissues using biomaterial platforms, it is important to have a complete overview of the effects that substrates have on cardiomyocyte (CM) morphology and function. This article summarizes recent studies that investigate the effect of mechanical cues on the CM differentiation, maturation, and growth. In these studies, CMs derived from embryos, neonates, and mesenchymal stem cells were seeded on different substrates of various elastic modulus. Measuring the contractile function by force production, work output, and calcium handling, it was seen that cell behavior on substrates was optimized when the substrate stiffness mimicked that of the native tissue. The contractile function reflected changes in the sarcomeric protein confirmation and organization that promoted the contractile ability. The analysis of the literature also revealed that, in addition to matrix stiffness, mechanical stimulation, such as stretching the substrate during cell seeding, also played an important role during cell maturation and tissue development.
C1 [Tallawi, Marwa; Rai, Ranjana; Boccaccini, Aldo. R.] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Biomat, D-91054 Erlangen, Germany.
   [Aifantis, Katerina E.] Aristotle Univ Thessaloniki, Lab Mech & Mat, Sch Engn, GR-54006 Thessaloniki, Greece.
   [Aifantis, Katerina E.] Univ Arizona, Tucson, AZ USA.
RP Aifantis, KE (reprint author), Dept Civil Engn Engn Mech, 1209 E Second St, Tucson, AZ 85721 USA.
EM aifantis@email.arizona.edu
RI Boccaccini, Aldo/C-7905-2013
FU European Research Council [MINATRAN 211166]
FX The authors would like to acknowledge the financial support received
   from the European Research Council Starting Grant MINATRAN 211166 to
   initiate this study.
CR Asahi M, 2004, P NATL ACAD SCI USA, V101, P9199, DOI 10.1073/pnas.0402596101
   Azeloglu EU, 2010, AM J PHYSIOL-HEART C, V298, pH853, DOI 10.1152/ajpheart.00427.2009
   Bajaj P, 2010, J BIOMED MATER RES A, V95A, P1261, DOI 10.1002/jbm.a.32951
   Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005
   Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32
   BORG TK, 1981, FED PROC, V40, P2037
   BRADY AJ, 1991, PHYSIOL REV, V71, P413
   De R, 2008, BIOPHYS J, V94, pL29, DOI 10.1529/biophysj.107.126060
   Dowell JD, 2003, CARDIOVASC RES, V58, P336, DOI 10.1016/S0008-6363(03)00254-2
   Du AP, 2003, DEV BIOL, V257, P382, DOI 10.1016/S0012-1606(03)00104-0
   Ehler E, 1999, J CELL SCI, V112, P1529
   Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FISHER DJ, 1992, PEDIATR RES, V32, P664, DOI 10.1203/00006450-199212000-00007
   Forte G, 2012, TISSUE ENG PT A, V18, P1837, DOI [10.1089/ten.tea.2011.0707, 10.1089/ten.TEA.2011.0707]
   Fukuda K, 2006, CIRC RES, V98, P1002, DOI 10.1161/01.RES.0000218272.18669.6e
   GOMEZ JP, 1994, CELL CALCIUM, V15, P265, DOI 10.1016/0143-4160(94)90066-3
   Gopalan SM, 2003, BIOTECHNOL BIOENG, V81, P578, DOI 10.1002/bit.10506
   Gwak SJ, 2008, BIOMATERIALS, V29, P844, DOI 10.1016/j.biomaterials.2007.10.050
   Hazeltine LB, 2014, ACTA BIOMATER, V10, P604, DOI 10.1016/j.actbio.2013.10.033
   Husse B, 1996, MOL CELL BIOCHEM, V164, P13
   Illi B, 2005, CIRC RES, V96, P501, DOI 10.1161/01.RES.0000159181.06379.63
   Jacot JG, 2008, BIOPHYS J, V95, P3479, DOI 10.1529/biophysj.107.124545
   Jawad H, 2008, BRIT MED BULL, V87, P31, DOI 10.1093/bmb/ldn026
   Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506
   Lieber SC, 2004, AM J PHYSIOL-HEART C, V287, pH645, DOI 10.1152/ajpheart.00564.2003
   Liu JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037559
   Lodish H., 2000, MOL CELL BIOL, P154
   McCain ML, 2011, PFLUG ARCH EUR J PHY, V462, P89, DOI 10.1007/s00424-011-0951-4
   Menasche P, 2005, CURR OPIN MOL THER, V7, P293
   Miller CE, 2000, IN VITRO CELL DEV-AN, V36, P633
   MOORMAN AFM, 1995, CIRC RES, V76, P616, DOI 10.1161/01.RES.76.4.616
   Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218
   Noma K, 2006, AM J PHYSIOL-CELL PH, V290, pC661, DOI 10.1152/ajpcell.00459.2005
   Patel AA, 2010, BIOMED MICRODEVICES, V12, P287, DOI 10.1007/s10544-009-9384-7
   Patel JK, 2011, CIRCULATION, V124, pE132, DOI 10.1161/CIRCULATIONAHA.110.017319
   Rodriguez AG, 2011, BIOPHYS J, V101, P2455, DOI 10.1016/j.bpj.2011.09.057
   Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046
   Saha S, 2006, J CELL PHYSIOL, V206, P126, DOI 10.1002/jcp.20441
   Schmelter M, 2006, FASEB J, V20, P1182, DOI 10.1096/fj.05-4723fje
   Shimko VF, 2008, TISSUE ENG PT A, V14, P49, DOI 10.1089/ten.a.2007.0092
   Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15
   Srivastava D, 2006, NATURE, V441, P1097, DOI 10.1038/nature04961
   Tobita K, 2006, AM J PHYSIOL-HEART C, V291, pH1829, DOI 10.1152/ajpheart.00205.2006
   Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001
   Wang PY, 2011, ACTA BIOMATER, V7, P3285, DOI 10.1016/j.actbio.2011.05.021
   WIBO M, 1991, CIRC RES, V68, P662, DOI 10.1161/01.RES.68.3.662
NR 47
TC 17
Z9 18
U1 1
U2 6
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD FEB 1
PY 2015
VL 21
IS 1
BP 157
EP 165
DI 10.1089/ten.teb.2014.0383
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CA6HG
UT WOS:000349011200012
PM 25148904
OA Green Published
DA 2018-10-19
ER

PT J
AU Wolf, MT
   Vodovotz, Y
   Tottey, S
   Brown, BN
   Badylak, SF
AF Wolf, Matthew T.
   Vodovotz, Yoram
   Tottey, Stephen
   Brown, Bryan N.
   Badylak, Stephen F.
TI Predicting In Vivo Responses to Biomaterials via Combined In Vitro and
   In Silico Analysis
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID FOREIGN-BODY REACTION; INCISIONAL HERNIA REPAIR; DECELLULARIZED
   PERICARDIAL BIOMATERIAL; CLASSICALLY ACTIVATED MACROPHAGES;
   EXTRACELLULAR-MATRIX; INFLAMMATORY RESPONSE; POLYPROPYLENE MESHES;
   SKELETAL-MUSCLE; GENE-EXPRESSION; BIOLOGIC MESHES
AB The host response to both synthetic and biologically derived biomaterials is a temporally regulated, complex process that involves multiple interacting cell types. This complexity has classically limited the efficacy of in vitro assays for predicting the in vivo outcome, necessitating the use of costly animal models for biomaterial development. The present study addressed these challenges by developing an in vitro assay that characterized the dynamic inflammatory response of human monocyte-derived-macrophages to biomaterials, coupled with quasi-mechanistic analysis in silico analysis: principal component analysis (PCA) and dynamic network analysis (DyNA). Synthetic and extracellular matrix (ECM)-derived materials were evaluated using this method, and were then associated with the in vivo remodeling and macrophage polarization response in a rodent skeletal muscle injury model. PCA and DyNA revealed a distinct in vitro macrophage response to ECM materials that corresponded to constructive remodeling and an increased M2 macrophage presence in vivo. In contrast, PCA and DyNA suggested a response to crosslinked ECM and synthetic materials characteristic of a foreign body reaction and dominant M1 macrophage response. These results suggest that in silico analysis of an in vitro macrophage assay may be useful as a predictor for determining the in vivo host response to implanted biomaterials.
C1 [Wolf, Matthew T.; Brown, Bryan N.; Badylak, Stephen F.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Wolf, Matthew T.; Vodovotz, Yoram; Tottey, Stephen; Brown, Bryan N.; Badylak, Stephen F.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Vodovotz, Yoram; Tottey, Stephen; Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
RP Badylak, SF (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 450 Technol Dr Suite 300, Pittsburgh, PA 15219 USA.
EM badylaks@upmc.edu
OI Badylak, Stephen/0000-0003-3555-0689
FU NIH-NHLBI [T32-HL76124-6]; NIH K12 Award [HD043441]
FX M.T.W. was partially supported by the NIH-NHLBI training grant
   (T32-HL76124-6) entitled "Cardiovascular Bioengineering Training
   Program," and B.N.B. was partially supported by the NIH K12 Award
   "Interdisciplinary Research Careers in Women's Health" (HD043441). The
   authors would like to thank Deanna Rhoads and the McGowan Histology
   Center for histologic section preparation, and Hongbin Jiang for
   assistance with animal care.
CR Akhyari P, 2011, TISSUE ENG PART C-ME, V17, P915, DOI [10.1089/ten.tec.2011.0210, 10.1089/ten.TEC.2011.0210]
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Ariganello MB, 2011, BIOMATERIALS, V32, P439, DOI 10.1016/j.biomaterials.2010.09.004
   Ariganello MB, 2010, J BIOMED MATER RES A, V93A, P280, DOI 10.1002/jbm.a.32554
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Brunelli S, 2008, PHARMACOL RES, V58, P117, DOI 10.1016/j.phrs.2008.06.008
   Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009
   Deeken CR, 2011, J AM COLL SURGEONS, V212, P880, DOI 10.1016/j.jamcollsurg.2011.01.006
   Di Vita G, 2006, AM J SURG, V191, P785, DOI 10.1016/j.amjsurg.2005.11.008
   Di Vita G, 2005, LANGENBECK ARCH SURG, V390, P306, DOI 10.1007/s00423-004-0534-3
   Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com
   Hanania R, 2012, J BIOL CHEM, V287, P8468, DOI 10.1074/jbc.M111.290676
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde J, 2007, J MATER SCI-MATER M, V18, P537, DOI 10.1007/s10856-007-2300-x
   Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010
   Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041
   Jansen PL, 2007, FASEB J, V21, P1047, DOI 10.1096/fj.06-6755com
   Klinge U, 1999, EUR J SURG, V165, P665
   Kobara M, 2010, CARDIOVASC RES, V87, P424, DOI 10.1093/cvr/cvq078
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   Liao IC, 2008, CELL MOL BIOENG, V1, P133, DOI 10.1007/s12195-008-0021-y
   Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588
   Mi Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019424
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Namas RA, 2012, MOL MED, V18, P1366, DOI 10.2119/molmed.2012.00106
   Nelson DM, 2011, PHARM RES-DORDR, V28, P1282, DOI 10.1007/s11095-011-0391-z
   Nieman G, 2012, CRIT CARE MED, V40, P1052, DOI 10.1097/CCM.0b013e31823e986a
   Orenstein SB, 2010, HERNIA, V14, P401, DOI 10.1007/s10029-010-0634-7
   Ozawa T, 2002, J THORAC CARDIOV SUR, V124, P1157, DOI 10.1067/mtc.2002.127449
   Pierce RA, 2009, SURG INNOV, V16, P46, DOI 10.1177/1553350608330479
   Rashid ST, 2004, BIOMATERIALS, V25, P1627, DOI 10.1016/S0142-9612(03)00522-2
   Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889
   Reing JE, 2009, TISSUE ENG PT A, V15, P605, DOI 10.1089/ten.tea.2007.0425
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   Rhee JW, 2007, J BIOCHEM MOL BIOL, V40, P88
   Schachtrupp A, 2003, BRIT J SURG, V90, P114, DOI 10.1002/bjs.4023
   Sussman EM, 2014, ANN BIOMED ENG, V42, P1508, DOI 10.1007/s10439-013-0933-0
   USHER FC, 1963, SURG GYNECOL OBSTET, V117, P239
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   Webster NL, 2006, J LEUKOCYTE BIOL, V80, P1052, DOI 10.1189/jlb0306152
   Weyhe D, 2008, ANZ J SURG, V78, P55, DOI 10.1111/j.1445-2197.2007.04362.x
   Weyhe D, 2007, REGUL PEPTIDES, V138, P10, DOI 10.1016/j.regpep.2006.07.010
   Weyhe D, 2006, WORLD J SURG, V30, P1586, DOI 10.1007/s00268-005-0601-0
   Wolf MT, 2014, J BIOMED MATER RES A, V102, P234, DOI 10.1002/jbm.a.34671
   Wolf MT, 2012, BIOMATERIALS, V33, P2916, DOI 10.1016/j.biomaterials.2011.12.055
   Zaaqoq AM, 2014, CRIT CARE MED, V42, P1487, DOI 10.1097/CCM.0000000000000248
   Ziraldo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079804
NR 52
TC 25
Z9 25
U1 2
U2 7
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD FEB 1
PY 2015
VL 21
IS 2
BP 148
EP 159
DI 10.1089/ten.tec.2014.0167
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CA6HR
UT WOS:000349012400005
PM 24980950
OA Green Published
DA 2018-10-19
ER

PT J
AU Djordjevic, A
   Ignjatovic, N
   Seke, M
   Jovic, D
   Uskokovic, D
   Rakocevic, Z
AF Djordjevic, Aleksandar
   Ignjatovic, Nenad
   Seke, Mariana
   Jovic, Danica
   Uskokovic, Dragan
   Rakocevic, Zlatko
TI Synthesis and Characterization of Hydroxyapatite/Fullerenol
   Nanocomposites
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE Hydroxyapatite; Fullerenol; Nanocomposite; Surface Analysis
ID DRUG-DELIVERY; BIOMEDICAL APPLICATIONS; COMPOSITE BIOMATERIALS; CALCIUM
   PHOSPHATES; NANO-RODS; FULLERENE; BONE; NANOPARTICLES; CHEMISTRY; TISSUE
AB Fullerenols are polyhydroxylated, water soluble derivatives of fullerene C-60, with potential application in medicine as diagnostic agents, antioxidants or nano drug carriers. This paper describes synthesis and physical characterization of a new nanocomposite hydroxyapatite/fullerenol. Surface of the nanocomposite hydroxyapatite/fullerenol is inhomogeneous with the diameter of the particles in the range from 100 nm to 350 nm. The zeta potential of this nanocomposite is ten times lower when compared to hydroxyapatite. Surface phosphate groups of hydroxyapatite are prone to forming hydrogen bonds, when in close contact with hydroxyl groups, which could lead to formation of hydrogen bonds between hydroxyapatite and hydroxyl groups of fullerenol. The surface of hydroxyapatite particles (-2.5 mV) was modified by fullerenol particles, as confirmed by the obtained zeta potential value of the nanocomposite biomaterial hydroxyapatite/fullerenol (-25.0 mV).
C1 [Djordjevic, Aleksandar; Jovic, Danica] Univ Novi Sad, Fac Sci, Dept Chem Biochem & Environm Protect, Novi Sad 21000, Serbia.
   [Ignjatovic, Nenad; Uskokovic, Dragan] Serbian Acad Arts & Sci, Inst Tech Sci, Ctr Fine Particles Proc & Nanotechnol, Belgrade 11000, Serbia.
   [Seke, Mariana; Rakocevic, Zlatko] Univ Belgrade, Vinca Inst Nucl Sci, Belgrade 11001, Serbia.
RP Djordjevic, A (reprint author), Univ Novi Sad, Fac Sci, Dept Chem Biochem & Environm Protect, Trg Dositeja Obradovica 3, Novi Sad 21000, Serbia.
RI Ignjatovic, Nenad/C-4489-2008; Uskokovic, Dragan/B-4129-2008
OI Ignjatovic, Nenad/0000-0002-5749-094X; Uskokovic,
   Dragan/0000-0002-0421-4968; , Aleksandar/0000-0003-4120-7318
FU Ministry of Science, Republic of Serbia [III45005, III45004]
FX This work is supported by the Ministry of Science, Republic of Serbia
   (No. III45005, No. III45004). The authors acknowledge Milos Bokorov and
   Ph.D. Danijela Petrovic for the special contribution in carrying out
   this paper.
CR Borum-Nicholas L, 2003, BIOMATERIALS, V24, P3671, DOI 10.1016/S0142-9612(03)00239-4
   Chao TC, 2011, ANAL CHEM, V83, P1777, DOI 10.1021/ac1031379
   Chen Y, 2001, J PHYS CHEM SOLIDS, V62, P999, DOI 10.1016/S0022-3697(00)00242-0
   CHIANG LY, 1993, J AM CHEM SOC, V115, P5453, DOI 10.1021/ja00066a014
   Dhanalakshmi CP, 2012, J BIOMATER TISS ENG, V2, P314, DOI 10.1166/jbt.2012.1052
   Djordjevic A, 2006, J BUON, V11, P391
   Djordjevic A, 1998, FULLERENE SCI TECHN, V6, P689, DOI 10.1080/10641229809350229
   Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m
   Fileti E., 2008, NANOTECHNOLOGY, V19, P365
   Gonzalez KA, 2002, BIOORGAN MED CHEM, V10, P1991, DOI 10.1016/S0968-0896(02)00049-4
   Hinokuma K, 2001, CHEM PHYS LETT, V341, P442, DOI 10.1016/S0009-2614(01)00549-8
   Husebo LO, 2004, J AM CHEM SOC, V126, P12055, DOI 10.1021/ja047593o
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2004, SPECTROSC-INT J, V18, P553, DOI 10.1155/2004/917656
   Ignjatovic NL, 2007, ACTA BIOMATER, V3, P927, DOI 10.1016/j.actbio.2007.04.001
   Ignjatovic NL, 2010, J MATER SCI-MATER M, V21, P231, DOI 10.1007/s10856-009-3854-6
   Injac R., 2008, AFR J BIOTECHNOL, V7, P4940
   Ishikawa T., 1989, LANGMUIR, V5, P144
   Jevtic M, 2008, CRYST GROWTH DES, V8, P2217, DOI 10.1021/cg7007304
   Joshy MIA, 2011, CURR APPL PHYS, V11, P1100, DOI 10.1016/j.cap.2011.02.003
   Kalambettu A. B., 2012, J BIOMATER TISS ENG, V2, P244
   Kumta PN, 2005, ACTA BIOMATER, V1, P65, DOI 10.1016/j.actbio.2004.09.008
   Liu TY, 2005, J CONTROL RELEASE, V107, P112, DOI 10.1016/j.jconrel.2005.05.025
   Mrdanovic JZ, 2012, DIG J NANOMATER BIOS, V7, P673
   Nikcevic I, 2006, MATER TRANS, V47, P2980, DOI 10.2320/matertrans.47.2980
   Oviedo MJ, 2012, SCI ADV MATER, V4, P558, DOI 10.1166/sam.2012.1318
   Partha R, 2009, INT J NANOMED, V4, P261
   Uskokovic V, 2011, J BIOMED MATER RES B, V96B, P152, DOI 10.1002/jbm.b.31746
   Vallet-Regi M, 2011, ADV MATER, V23, P5177, DOI 10.1002/adma.201101586
   Victoria E. Caroline, 2002, TRENDS BIOMATER ARTI, V16, P12
   Vileno B, 2006, ADV FUNCT MATER, V16, P120, DOI 10.1002/adfm.200500425
   Vukomanovic M, 2011, COLLOID SURFACE B, V87, P226, DOI 10.1016/j.colsurfb.2011.05.023
   Wiglusz RJ, 2012, J BIOMED NANOTECHNOL, V8, P605, DOI 10.1166/jbn.2012.1424
NR 33
TC 1
Z9 1
U1 4
U2 76
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD FEB
PY 2015
VL 15
IS 2
BP 1538
EP 1542
DI 10.1166/jnn.2015.8671
PG 5
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA AT6NB
UT WOS:000345054100091
PM 26353688
DA 2018-10-19
ER

PT J
AU Zhang, F
   Vanmeensel, K
   Inokoshi, M
   Batuk, M
   Hadermann, J
   Van Meerbeek, B
   Naert, I
   Vleugels, J
AF Zhang, F.
   Vanmeensel, K.
   Inokoshi, M.
   Batuk, M.
   Hadermann, J.
   Van Meerbeek, B.
   Naert, I.
   Vleugels, J.
TI Critical influence of alumina content on the low temperature degradation
   of 2-3 mol% yttria-stabilized TZP for dental restorations
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE Y-TZP; Degradation; Amount of alumina
ID MONOCLINIC PHASE-TRANSFORMATION; ZIRCONIA CERAMICS; TETRAGONAL ZRO2;
   Y-TZP; HYDROTHERMAL DEGRADATION; FRACTURE-TOUGHNESS; BIOMATERIAL;
   SYSTEM; FUTURE; 3Y-TZP
AB The influence of 0.25, 2 and 5 wt.% alumina addition on the mechanical properties and low temperature degradation (LTD) of 3, 2.5 and 2 mol% yttria-stabilized TZP ceramics was investigated. The amount of alumina addition was observed to have a crucial impact on the degradation of Y-TZP ceramics.
   Independent on the yttria stabilizer content, 0.25 wt.% alumina had a higher degradation retarding effect to Y-TZP ceramics than 2 and 5 wt.% of alumina addition, which had a comparable effect. The apparent activation energy for the degradation process was increased by adding alumina, but it was the same for 0.25-5 wt.% alumina doped 3Y-TZP ceramics. For Y-TZPs containing a small amount of alumina addition, only the segregated Al3+ at the grain boundaries of the zirconia grains was effective to retard the degradation of Y-TZPs. The secondary phase Al2O3 grains increased the degradation kinetics, which might be attributed to the residual stresses. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Zhang, F.; Vanmeensel, K.; Vleugels, J.] Katholieke Univ Leuven, Dept Mat Engn, B-3001 Heverlee, Belgium.
   [Inokoshi, M.; Van Meerbeek, B.; Naert, I.] KU Leuven & Dent, Univ Hosp Leuven, Dept Oral Hlth Sci, KU Leuven BIOMAT, B-3000 Leuven, Belgium.
   [Batuk, M.; Hadermann, J.] Univ Antwerp, B-2020 Antwerp, Belgium.
RP Zhang, F (reprint author), Katholieke Univ Leuven, Dept Mat Engn, Kasteelpk Arenberg 44, B-3001 Heverlee, Belgium.
EM fei.zhang@mtm.kuleuven.be
RI Vanmeensel, Kim/B-7792-2018; Hadermann, Joke/F-4644-2011; Vleugels,
   Jozef/C-8262-2017
OI Vanmeensel, Kim/0000-0001-5189-7055; Hadermann,
   Joke/0000-0002-1756-2566; Vleugels, Jozef/0000-0003-4432-4675
FU Research Fund of KU Leuven [0T/10/052]; Fund for Scientific Research
   Flanders [G.0431.10N]; Fund for Scientific Research Flanders (FWO)
FX This work was performed within the framework of the Research Fund of KU
   Leuven under project 0T/10/052 and the Fund for Scientific Research
   Flanders under grant G.0431.10N. K. Vanmeensel thanks the Fund for
   Scientific Research Flanders (FWO) for his post-doctoral fellowship.
CR ANSTIS GR, 1981, J AM CERAM SOC, V64, P533, DOI 10.1111/j.1151-2916.1981.tb10320.x
   Ban S, 2008, JPN DENT SCI REV, V44, P3, DOI 10.1016/j.jdsr.2008.04.001
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x
   CLARKE DR, 1982, J AM CERAM SOC, V65, P284, DOI 10.1111/j.1151-2916.1982.tb10445.x
   Deville S, 2006, BIOMATERIALS, V27, P2186, DOI 10.1016/j.biomaterials.2005.11.021
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Gutknecht D, 2007, J EUR CERAM SOC, V27, P1547, DOI 10.1016/j.jeurceramsoc.2006.04.123
   Jiang L, 2011, J WUHAN UNIV TECHNOL, V26, P690, DOI 10.1007/s11595-011-0294-1
   Kohorst P, 2012, ACTA BIOMATER, V8, P1213, DOI 10.1016/j.actbio.2011.11.016
   Kosmac T, 2012, J EUR CERAM SOC, V32, P2613, DOI 10.1016/j.jeurceramsoc.2012.02.024
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   LEE RR, 1988, J AM CERAM SOC, V71, P694, DOI 10.1111/j.1151-2916.1988.tb06390.x
   Li JF, 1997, J MATER SCI, V32, P1149, DOI 10.1023/A:1018567414745
   Lorente MC, 2011, ACTA BIOMATER, V7, P858
   MECARTNEY ML, 1989, ACTA METALL MATER, V37, P1859, DOI 10.1016/0001-6160(89)90070-9
   Nogiwa-Valdez AA, 2013, ACTA BIOMATER, V9, P6226, DOI 10.1016/j.actbio.2012.11.027
   Norton MR, 2002, J BONE JOINT SURG BR, V84B, P631, DOI 10.1302/0301-620X.84B5.12679
   Olga F, 2004, Z METALLK MAT RES AD, V95, P27
   Ozkurt Z, 2010, J PROSTHODONT, V19, P64, DOI 10.1111/j.1532-849X.2009.00513.x
   Pecharroman C, 2003, ADV MATER, V15, P507, DOI 10.1002/adma.200390117
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Ross IM, 2004, J EUR CERAM SOC, V24, P2023, DOI 10.1016/S0955-2219(03)00375-3
   Ross IM, 2001, SCRIPTA MATER, V45, P653, DOI 10.1016/S1359-6462(01)01076-4
   SATO T, 1985, J MATER SCI, V20, P3988, DOI 10.1007/BF00552389
   Schechner G, 2013, Patent, Patent No. [US20130341812 A1, 20130341812]
   Stough MA, 2002, J AM CERAM SOC, V85, P2895
   Suzuki T, 2013, J JPN SOC DENT MAT D, V32, P92
   Takaki M, 1986, INT J HIGH TECH CERA, V2, P85
   TORAYA H, 1984, J AM CERAM SOC, V67, pC119
   TSUBAKINO H, 1993, J MATER SCI LETT, V12, P196, DOI 10.1007/BF00819957
   TSUBAKINO H, 1991, J AM CERAM SOC, V74, P440, DOI 10.1111/j.1151-2916.1991.tb06905.x
   Vleugels J, 2002, J EUR CERAM SOC, V22, P873, DOI 10.1016/S0955-2219(01)00389-2
   Wang F, 2013, J PROSTHET DENT, V110, P14, DOI 10.1016/S0022-3913(13)60333-9
   Zhang F, 2014, J EUR CERAM SOC, V34, P2453, DOI 10.1016/j.jeurceramsoc.2014.02.026
NR 37
TC 22
Z9 23
U1 0
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
EI 1873-619X
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PD FEB
PY 2015
VL 35
IS 2
BP 741
EP 750
DI 10.1016/j.jeurceramsoc.2014.09.018
PG 10
WC Materials Science, Ceramics
SC Materials Science
GA AT8SG
UT WOS:000345201700032
DA 2018-10-19
ER

PT J
AU Sukumar, N
   Ramachandran, T
   Kalaiarasi, H
   Sengottuvelu, S
AF Sukumar, Nachiappan
   Ramachandran, T.
   Kalaiarasi, H.
   Sengottuvelu, S.
TI Characterization and in vivo evaluation of silk hydrogel with
   enhancement of dextrin, rhEGF, and alginate beads for diabetic Wistar
   Albino wounded rats
SO JOURNAL OF THE TEXTILE INSTITUTE
LA English
DT Article
DE chitosan; medical textile; dextrin; rhEGF; diabetic wound; silk fibroin
ID DRUG-DELIVERY SYSTEMS; GROWTH-FACTOR; CHITOSAN; FIBROIN; VITRO;
   BIOMATERIAL; RELEASE; ACCELERATION; FORMULATION; SCAFFOLDS
AB Silk is a natural bio material that is used as a wound-healing material for a long period. Favorable properties like natural slow biodegradation, superior mechanical properties, and biocompatibility make it an ideal material for the wound-healing process. It was observed that diabetic wounds require increased protection and treatment than the normal wounds. Therefore, current research is focused on preparation of silk-based hydrogels for diabetic wound healing with the combination of chitosan-alginate beads, dextrin, and recombinant human epidermal growth factor. The prepared hydrogel was tested and established for its morphology, water uptake ability, and porosity that are the special properties required for an ideal wound-dressing material. In extrapolating these findings, the prepared silk-based hydrogel was applied and tested for its wound-healing effect on diabetic-induced rats that is a widely used in vivo method of wound healing. Full-thickness wounds were created in the dorsal of rat's skin. Wounded rats were treated topically with silk fibroin hydrogel immediately after the injury. The wound-healing rate was observed through tissue deposition and wound closure for over a 21-days period. The results established that integrated silk-based hydrogel promotes the healing process through controlled release of drug and recovery of the deep wounds of diabetic-induced male Wistar Albino rats was commendable. Therefore, the use of silk fibroin-based hydrogel may be extended to the clinical setting and act as an effective promoter for wound healing in human beings with diabetics.
C1 [Sukumar, Nachiappan] KSR Coll Technol, Dept Text Technol, Tiruchengode, India.
   [Ramachandran, T.] Karpagam Inst Technol, Dept Text Technol, Coimbatore, India.
   [Kalaiarasi, H.] PSG Coll Technol, PSG Inst Management, Coimbatore, Tamil Nadu, India.
   [Sengottuvelu, S.] Nandha Coll Pharm, Dept Pharmacol, Erode, India.
RP Sukumar, N (reprint author), KSR Coll Technol, Dept Text Technol, Tiruchengode, India.
EM sugumaraan@yahoo.com
CR Alemdaroglu C, 2006, BURNS, V32, P319, DOI 10.1016/j.burns.2005.10.015
   [Anonymous], 2012, IDF DIABETES ATLAS
   Babaei S, 2013, EUR J PHARMACOL, V700, P165, DOI 10.1016/j.ejphar.2012.11.024
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   DANCKWERTS M, 1991, DRUG DEV IND PHARM, V17, P1465, DOI 10.3109/03639049109026629
   Daugherty AL, 2006, ADV DRUG DELIVER REV, V58, P686, DOI 10.1016/j.addr.2006.03.011
   Gil ES, 2013, ADV HEALTHC MATER, V2, P206, DOI 10.1002/adhm.201200192
   Hansson A, 2012, CARBOHYD POLYM, V90, P1494, DOI 10.1016/j.carbpol.2012.07.020
   Hardwicke J, 2008, J CONTROL RELEASE, V130, P275, DOI 10.1016/j.jconrel.2008.07.023
   Hardwicke JT, 2011, J CONTROL RELEASE, V152, P411, DOI 10.1016/j.jconrel.2011.03.016
   Holliday EG, 2013, DIABETES, V62, P1369, DOI 10.2337/db12-1836
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Kwon AH, 2009, AM J SURG, V197, P503, DOI 10.1016/j.amjsurg.2007.11.021
   LANGER R, 1980, CHEM ENG COMMUN, V6, P1, DOI 10.1080/00986448008912519
   Lee YH, 2012, CARBOHYD POLYM, V88, P809, DOI 10.1016/j.carbpol.2011.12.045
   Liu TL, 2010, J ZHEJIANG UNIV-SC B, V11, P10, DOI 10.1631/jzus.B0900163
   Ma YF, 2013, MAT SCI ENG C-MATER, V33, P2413, DOI 10.1016/j.msec.2013.02.006
   Mhuka V, 2013, INT J BIOL MACROMOL, V52, P305, DOI 10.1016/j.ijbiomac.2012.09.010
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Murakami K, 2010, BIOMATERIALS, V31, P83, DOI 10.1016/j.biomaterials.2009.09.031
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Musson DS, 2013, PROCEDIA ENGINEER, V59, P138, DOI 10.1016/j.proeng.2013.05.103
   Ngah WSW, 2008, CHEM ENG J, V143, P62, DOI 10.1016/j.cej.2007.12.006
   Pattanayak SR, 2008, J ETHNOPHARMACOL, V120, P241, DOI 10.1016/j.jep.2008.08.019
   PRITCHARD EM, 2011, SILK BIOMATERIALS FO
   Ribeiro MP, 2013, MAT SCI ENG C-MATER, V33, P2958, DOI 10.1016/j.msec.2013.03.025
   Ribeiro MP, 2009, WOUND REPAIR REGEN, V17, P817, DOI 10.1111/j.1524-475X.2009.00538.x
   Seol YJ, 2004, BIOTECHNOL LETT, V26, P1037, DOI 10.1023/B:BILE.0000032962.79531.fd
   She ZD, 2008, POLYM DEGRAD STABIL, V93, P1316, DOI 10.1016/j.polymdegradstab.2008.04.001
   Simsek-Ege FA, 2003, J APPL POLYM SCI, V88, P346, DOI 10.1002/app.11989
   Sionkowska A, 2013, J MOL LIQ, V178, P5, DOI 10.1016/j.molliq.2012.10.042
   Smitha B, 2005, EUR POLYM J, V41, P1859, DOI 10.1016/j.eurpolymj.2005.02.018
   Sukumar N, 2014, J IND TEXT, V43, P565, DOI 10.1177/1528083712470159
   Thu HE, 2012, INT J PHARMACEUT, V434, P375, DOI 10.1016/j.ijpharm.2012.05.044
   Wang W, 2008, LIFE SCI, V82, P190, DOI 10.1016/j.lfs.2007.11.009
NR 35
TC 1
Z9 1
U1 3
U2 58
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0040-5000
EI 1754-2340
J9 J TEXT I
JI J. Text. Inst.
PD FEB 1
PY 2015
VL 106
IS 2
BP 133
EP 140
DI 10.1080/00405000.2014.906100
PG 8
WC Materials Science, Textiles
SC Materials Science
GA AU4HH
UT WOS:000345570900003
DA 2018-10-19
ER

PT J
AU Oliva, N
   Carcole, M
   Beckerman, M
   Seliktar, S
   Hayward, A
   Stanley, J
   Parry, NMA
   Edelman, ER
   Artzi, N
AF Oliva, Nuria
   Carcole, Maria
   Beckerman, Margarita
   Seliktar, Sivan
   Hayward, Alison
   Stanley, James
   Parry, Nicola Maria Anne
   Edelman, Elazer R.
   Artzi, Natalie
TI Regulation of dendrimer/dextran material performance by altered tissue
   microenvironment in inflammation and neoplasia
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID COLITIS
AB A "one material fits all" mindset ignores profound differences in target tissues that affect their responses and reactivity. Yet little attention has been paid to the role of diseased tissue on material performance, biocompatibility, and healing capacity. We assessed material-tissue interactions with a prototypical adhesive material based on dendrimer/dextran and colon as a model tissue platform. Adhesive materials have high sensitivity to changes in their environment and can be exploited to probe and quantify the influence of even subtle modifications in tissue architecture and biology. We studied inflammatory colitis and colon cancer and found not only a difference in adhesion related to surface chemical interactions but also the existence of a complex interplay that determined the overall dendrimer/dextran biomaterial compatibility. Compatibility was contextual, not simply a constitutive property of the material, and was related to the extent and nature of immune cells in the diseased environment present before material implantation. We then showed how to use information about local alterations of the tissue microenvironment to assess disease severity. This in turn guided us to an optimal dendrimer/dextran formulation choice using a predictive model based on clinically relevant conditions.
C1 [Oliva, Nuria; Carcole, Maria; Beckerman, Margarita; Seliktar, Sivan; Edelman, Elazer R.; Artzi, Natalie] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA.
   [Carcole, Maria] Univ Ramon Llull, Inst Quim Sarria, Dept Ind Engn, Barcelona 08017, Spain.
   [Beckerman, Margarita; Seliktar, Sivan] Ort Braude Coll, IL-21982 Karmiel, Israel.
   [Hayward, Alison; Stanley, James] Concord Biomed Sci & Emerging Technol, Lexington, MA 02421 USA.
   [Parry, Nicola Maria Anne] MIT, Div Comparat Med, Cambridge, MA 02139 USA.
   [Edelman, Elazer R.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc,Dept Med, Boston, MA 02115 USA.
   [Artzi, Natalie] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Anesthesiol, Boston, MA 02115 USA.
RP Artzi, N (reprint author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM nartzi@mit.edu
RI Oliva, Nuria/P-7825-2016
OI Oliva, Nuria/0000-0002-6305-0801
FU RO1 grant [GM49039]; MIT Deshpande Center for Technological Innovation;
   Fundacio d'Investigacio de l'Hospital Sant Pau (FISP)
FX Supported by RO1 grant (GM49039), MIT Deshpande Center for Technological
   Innovation, and the Fundacio d'Investigacio de l'Hospital Sant Pau
   (FISP).
CR Armentano Ilaria, 2013, Recent Pat Drug Deliv Formul, V7, P9
   Artzi N., ADV MAT, V21, P3399
   Artzi N, 2009, MACROMOL BIOSCI, V9, P754, DOI 10.1002/mabi.200800355
   Brown BN, 2013, ACTA BIOMATER, V9, P4948, DOI 10.1016/j.actbio.2012.10.025
   Cam C, 2013, CURR OPIN BIOTECH, V24, P855, DOI 10.1016/j.copbio.2013.04.007
   Cury DB, 2013, CELL IMMUNOL, V282, P66, DOI 10.1016/j.cellimm.2013.04.004
   Lenglet S, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/659282
   Morimoto Y, 2011, J GASTROINTEST SURG, V15, P1842, DOI 10.1007/s11605-011-1632-5
   Mowat AM, 2011, J INNATE IMMUN, V3, P550, DOI 10.1159/000329099
   Oliva N, 2012, LANGMUIR, V28, P15402, DOI 10.1021/la303155p
   Orive G., 2013, ADV DRUG DELIV REV, V67-68, P3
   Orlando G, 2013, GUT, V62, P774, DOI 10.1136/gutjnl-2011-301111
   Saiz E, 2013, DENT MATER, V29, P103, DOI 10.1016/j.dental.2012.08.001
NR 13
TC 24
Z9 25
U1 2
U2 18
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD JAN 28
PY 2015
VL 7
IS 272
AR 272ra11
DI 10.1126/scitranslmed.aaa1616
PG 8
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA CB1YA
UT WOS:000349422700004
PM 25632035
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Kanungo, I
   Fathima, NN
   Rao, JR
   Nair, BU
AF Kanungo, Ivy
   Fathima, Nishter Nishad
   Rao, Jonnalagadda Raghava
   Nair, Balachandran Unni
TI Go natural and smarter: fenugreek as a hydration designer of collagen
   based biomaterials
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID DIELECTRIC-PROPERTIES; CIRCULAR-DICHROISM; RELEASE; TISSUE;
   POLYSACCHARIDES; COMPOSITES; PROTEINS; DYNAMICS; WATER; GUM
AB Collagen-based biomaterials have received considerable attention for smarter biomedical applications due to their inherent superior mechano-biological properties. However, accumulating evidence suggests that water, as a probe liquid bound in collagen, might be investigated to explore the influence of additives on the static and dynamic solvation behavior of collagen. The structure and dynamics of water near the surface/interface of collagen-fenugreek composites were demonstrated via circular dichroic spectroscopy, thermoporometry and impedimetric measurements to enlighten about the configuration-function relationship of collagen. Thermodynamic parameters of the composites signify the fenugreek concentration dependent structural robustness of collagen. Thermodynamic parameters such as free energies for unfolding, enthalpies, entropies and activation energies indicate that the residual structure modulates the stability of the denatured state up to 22 kcal mol(-1) and the parameters correlate with structural data for collagen complexed with fenugreek. The association constant of fenugreek is found to be 0.5807 M-1. The binding of fenugreek influences rearrangement of the collagen-water network, resulting in the transition from a disordered (high entropy) unbound state to a structured (lower entropy) bound state. Fenugreek concentration plays a crucial role in shaping up the free energy that governs the folding, structure and stability of collagen. Dielectric data emphasize the effect of hydrophobic and hydrophilic clusters on the side chain motion constraints. The thermoporometry technique probes the pore size distributions of the composites. These methods provide insights into the role of excluded volume, chain stiffness and stability of a new collagen-galactomannan based composite, expanding its utility in "smart biomaterial applications''.
C1 [Kanungo, Ivy; Fathima, Nishter Nishad; Rao, Jonnalagadda Raghava; Nair, Balachandran Unni] CSIR, Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
RP Rao, JR (reprint author), CSIR, Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
EM jrrao@clri.res.in
FU CSIR; CSIR under the Suprainstitutional Project-S&T Revolution in
   Leather with a Green Touch [CSC0201]
FX One of the authors (I. Kanungo) would like to acknowledge CSIR for
   providing senior research fellowship. The authors thank CSIR for funding
   under the Suprainstitutional Project-S&T Revolution in Leather with a
   Green Touch (CSC0201). CSIR communication code: 1077.
CR Antipova AS, 1999, COLLOID SURFACE B, V12, P261, DOI 10.1016/S0927-7765(98)00081-2
   Barnes FS, 2006, HDB BIOL EFFECTS ELE
   Cametti C, 2011, J PHYS CHEM B, V115, P7144, DOI 10.1021/jp2019389
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   Fenimore PW, 2004, P NATL ACAD SCI USA, V101, P14408, DOI 10.1073/pnas.0405573101
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Garti N, 1997, FOOD SCI TECHNOL-LEB, V30, P305
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Gratton SEA, 2008, ACCOUNTS CHEM RES, V41, P1685, DOI 10.1021/ar8000348
   Greenfield NJ, 2006, NAT PROTOC, V1, P2733, DOI 10.1038/nprot.2006.229
   Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204
   Jafarpour G, 2009, J NON-CRYST SOLIDS, V355, P1669, DOI 10.1016/j.jnoncrysol.2009.06.026
   Jezek J, 2011, ADV DRUG DELIVER REV, V63, P1107, DOI 10.1016/j.addr.2011.09.008
   Kaminski K, 2009, J PHYS CHEM B, V113, P10088, DOI 10.1021/jp809760t
   Kanungo I, 2014, CARBOHYD POLYM, V103, P250, DOI 10.1016/j.carbpol.2013.12.051
   Kanungo I, 2013, MAT SCI ENG C-MATER, V33, P4651, DOI 10.1016/j.msec.2013.07.020
   Kanungo I, 2013, MATER CHEM PHYS, V140, P357, DOI 10.1016/j.matchemphys.2013.03.049
   Khodadadi S, 2011, J PHYS CHEM B, V115, P6222, DOI 10.1021/jp1122213
   Lakowicz J. R., 1983, PRINCIPLES FLUORESCE, V278, P113
   Li K, 2013, BIOMATERIALS, V34, P2834, DOI 10.1016/j.biomaterials.2013.01.013
   Lima CGA, 2006, MATER CHEM PHYS, V99, P284, DOI 10.1016/j.matchemphys.2005.10.027
   Manikoth R, 2012, CARBOHYD POLYM, V88, P628, DOI 10.1016/j.carbpol.2012.01.031
   Marion M., 2008, ADV ENG MATER, V10, P33
   Marzec E, 2005, BIOELECTROCHEMISTRY, V65, P89, DOI 10.1016/j.bioelechem.2004.10.001
   Mathur V, 2005, J SCI IND RES INDIA, V64, P475
   Mi FL, 2005, BIOMACROMOLECULES, V6, P975, DOI 10.1021/bm049335p
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Myshakina NS, 2008, J PHYS CHEM B, V112, P11873, DOI 10.1021/jp8057355
   Orzechowski K, 2008, PHYSIOL MEAS, V29, pS321, DOI 10.1088/0967-3334/29/6/S27
   Pietrucha K, 2005, BIOPHYS CHEM, V118, P51, DOI 10.1016/j.bpc.2005.07.006
   Prado BA, 2005, J AGR FOOD CHEM, V53, P2823, DOI 10.1021/jf0485537
   Ray N, 2013, ZAMM-Z ANGEW MATH ME, V93, P811, DOI 10.1002/zamm.201200196
   REID JSG, 1973, PLANTA, V112, P301
   Shah N, 2011, EXPERT OPIN DRUG DEL, V8, P779, DOI 10.1517/17425247.2011.574121
   Shayegan M., 2013, PLOS ONE, V8, P1
   Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003
   Smiechowski MF, 2006, BIOSENS BIOELECTRON, V22, P670, DOI 10.1016/j.bios.2006.02.008
   Srinivasan R, 2008, CHINESE J POLYM SCI, V26, P679, DOI 10.1142/S0256767908003424
   Sulea D, 2010, REV ROUM CHIM, V55, P543
   Tabata Y, 2005, DRUG DISCOV TODAY, V10, P1639, DOI 10.1016/S1359-6446(05)03639-1
   Turquois T, 1996, CARBOHYD POLYM, V31, P269, DOI 10.1016/S0144-8617(96)00031-8
   Wang ZD, 2013, CARBOHYD POLYM, V94, P505, DOI 10.1016/j.carbpol.2013.01.090
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Xiao FJ, 2014, SPECTROCHIM ACTA A, V118, P1106, DOI 10.1016/j.saa.2013.09.074
   Xu X, 2007, CARBOHYD POLYM, V70, P192, DOI 10.1016/j.carbpol.2007.03.017
   Yalcin O, 2013, J PHYS CHEM B, V117, P8931, DOI 10.1021/jp402219t
NR 46
TC 6
Z9 6
U1 1
U2 18
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
EI 1463-9084
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PD JAN 28
PY 2015
VL 17
IS 4
BP 2778
EP 2793
DI 10.1039/c4cp04363d
PG 16
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA AX4MN
UT WOS:000346906700055
PM 25502597
DA 2018-10-19
ER

PT J
AU Griffin, MF
   Butler, PE
   Seifalian, AM
   Kalaskar, DM
AF Griffin, Michelle F.
   Butler, Peter E.
   Seifalian, Alexander M.
   Kalaskar, Deepak M.
TI Control of stem cell fate by engineering their micro and nanoenvironment
SO WORLD JOURNAL OF STEM CELLS
LA English
DT Review
DE Biomaterials; Scaffold; Stem cells; Surface topography; Tissue
   engineering
AB Stem cells are capable of long-term self-renewal and differentiation into specialised cell types, making them an ideal candidate for a cell source for regenerative medicine. The control of stem cell fate has become a major area of interest in the field of regenerative medicine and therapeutic intervention. Conventional methods of chemically inducing stem cells into specific lineages is being challenged by the advances in biomaterial technology, with evidence highlighting that material properties are capable of driving stem cell fate. Materials are being designed to mimic the clues stem cells receive in their in vivo stem cell niche including topographical and chemical instructions. Nanotopographical clues that mimic the extracellular matrix (ECM) in vivo have shown to regulate stem cell differentiation. The delivery of ECM components on biomaterials in the form of short peptides sequences has also proved successful in directing stem cell lineage. Growth factors responsible for controlling stem cell fate in vivo have also been delivered via biomaterials to provide clues to determine stem cell differentiation. An alternative approach to guide stem cells fate is to provide genetic clues including delivering DNA plasmids and small interfering RNAs via scaffolds. This review, aims to provide an overview of the topographical, chemical and molecular clues that biomaterials can provide to guide stem cell fate. The promising features and challenges of such approaches will be highlighted, to provide directions for future advancements in this exciting area of stem cell translation for regenerative medicine.
C1 [Griffin, Michelle F.; Butler, Peter E.; Seifalian, Alexander M.; Kalaskar, Deepak M.] UCL, Ctr Nanotechnol & Regenerat Med, UCL Div Surg & Intervent Sci, 9th Floor,Royal Free Campus,Rowland Hill St, London NW3 2PF, England.
   [Butler, Peter E.] Royal Free Hampstead NHS Trust Hosp, Dept Plast & Reconstruct Surg, London NW3 2PF, England.
RP Kalaskar, DM (reprint author), UCL, Ctr Nanotechnol & Regenerat Med, UCL Div Surg & Intervent Sci, 9th Floor,Royal Free Campus,Rowland Hill St, London NW3 2PF, England.
EM d.kalaskar@ucl.ac.uk
OI Butler, Peter/0000-0001-7419-1493
CR Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004419900074
   Aizawa Y, 2008, BIOMATERIALS, V29, P4676, DOI 10.1016/j.biomaterials.2008.08.018
   Andersen MO, 2010, MOL THER, V18, P2018, DOI 10.1038/mt.2010.166
   Bagasra O, 2004, J MOL HISTOL, V35, P545
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Basnar B, 2009, SMALL, V5, P28, DOI 10.1002/smll.200800583
   Beazley KE, 2014, BIOTECHNOL LETT, V36, P1901, DOI 10.1007/s10529-014-1551-0
   Beduer A, 2012, BIOMATERIALS, V33, P504, DOI 10.1016/j.biomaterials.2011.09.073
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   BIANCO P, 1993, J HISTOCHEM CYTOCHEM, V41, P183, DOI 10.1177/41.2.8419458
   Biehl JK, 2009, DEV DYNAM, V238, P1964, DOI 10.1002/dvdy.22030
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Chiang CK, 2010, ACTA BIOMATER, V6, P1904, DOI 10.1016/j.actbio.2009.12.005
   Chien CY, 2013, ACS APPL MATER INTER, V5, P6975, DOI 10.1021/am401071f
   Chuang CK, 2007, GENE THER, V14, P1417, DOI 10.1038/sj.gt.3302996
   Connelly JT, 2011, EUR CELLS MATER, V22, P168, DOI 10.22203/eCM.v022a13
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   D'Angelo F, 2010, EUR CELLS MATER, V20, P231
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028
   Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987
   EMERMAN JT, 1979, TISSUE CELL, V11, P109, DOI 10.1016/0040-8166(79)90011-9
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Even-Ram S, 2006, CELL, V126, P645, DOI 10.1016/j.cell.2006.08.008
   Ferrand A, 2014, MACROMOL BIOSCI, V14, P45, DOI 10.1002/mabi.201300283
   Frith JE, 2012, J CELL SCI, V125, P317, DOI 10.1242/jcs.087916
   Gandavarapu NR, 2013, ACTA BIOMATER, V9, P4525, DOI 10.1016/j.actbio.2012.09.007
   Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308
   Harrison RG, 1911, SCIENCE, V34, P279, DOI 10.1126/science.34.870.279
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107
   Hsiong SX, 2008, BIOMACROMOLECULES, V9, P1843, DOI 10.1021/bm8000606
   Hudalla GA, 2009, LANGMUIR, V25, P5737, DOI 10.1021/la804077t
   Il Cho Y, 2010, ACTA BIOMATER, V6, P4725, DOI 10.1016/j.actbio.2010.06.019
   Im GI, 2011, BIOMATERIALS, V32, P4385, DOI 10.1016/j.biomaterials.2011.02.054
   Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927
   Kantawong Fahsai, 2011, J Tissue Eng, V2011, P534603, DOI 10.4061/2011/534603
   Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m
   Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37
   Ko E, 2013, BIOMACROMOLECULES, V14, P3202, DOI 10.1021/bm4008343
   Krebs MD, 2011, CHEM-EUR J, V17, P3054, DOI 10.1002/chem.201003144
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103
   Lafrenie RM, 1996, J CELL BIOCHEM, V61, P543, DOI 10.1002/(SICI)1097-4644(19960616)61:4<543::AID-JCB7>3.0.CO;2-O
   Lai GJ, 2014, CARBOHYD POLYM, V111, P288, DOI 10.1016/j.carbpol.2014.04.094
   Lee JS, 2010, ACTA BIOMATER, V6, P21, DOI 10.1016/j.actbio.2009.08.003
   Lee JY, 2007, BIOCHEM BIOPH RES CO, V357, P68, DOI 10.1016/j.bbrc.2007.03.106
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Lee SJ, 2010, BIOMATERIALS, V31, P5652, DOI 10.1016/j.biomaterials.2010.03.019
   Li JH, 2010, J BIOMED MATER RES A, V95A, P973, DOI 10.1002/jbm.a.32926
   Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200
   Lin ZY, 2010, J CONTROL RELEASE, V144, P190, DOI 10.1016/j.jconrel.2010.02.016
   Liu XJ, 2014, ACS APPL MATER INTER, V6, P9733, DOI 10.1021/am502170s
   Low WC, 2013, BIOMATERIALS, V34, P3581, DOI 10.1016/j.biomaterials.2013.01.093
   Lu David, 2016, Methods Mol Biol, V1307, P281, DOI 10.1007/7651_2014_81
   Lu HX, 2012, BIOMATERIALS, V33, P6140, DOI 10.1016/j.biomaterials.2012.05.038
   Luo W, 2008, LANGMUIR, V24, P12129, DOI 10.1021/la802836g
   Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359
   Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McBride SH, 2008, TISSUE ENG PT A, V14, P1561, DOI 10.1089/ten.tea.2008.0112
   McNamara LE, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/120623
   MERRY K, 1993, J CELL SCI, V104, P1013
   Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542
   Morito A, 2009, ARCH HISTOL CYTOL, V72, P51, DOI 10.1679/aohc.72.51
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Murphy CM, 2012, J MECH BEHAV BIOMED, V11, P53, DOI 10.1016/j.jmbbm.2011.11.009
   Nguyen MK, 2014, BIOMATERIALS, V35, P6278, DOI 10.1016/j.biomaterials.2014.04.048
   Nieponice A, 2008, BIOMATERIALS, V29, P825, DOI 10.1016/j.biomaterials.2007.10.044
   Nimesh S, 2011, NANOMEDICINE-UK, V6, P729, DOI [10.2217/NNM.11.15, 10.2217/nnm.11.15]
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   Nuttelman CR, 2006, BIOMATERIALS, V27, P1377, DOI 10.1016/j.biomaterials.2005.08.014
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Pan HT, 2013, MAT SCI ENG C-MATER, V33, P3336, DOI 10.1016/j.msec.2013.04.019
   Park JS, 2011, BIOMATERIALS, V32, P3679, DOI 10.1016/j.biomaterials.2011.01.063
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Peng LH, 2011, DRUG DISCOV TODAY, V16, P957, DOI 10.1016/j.drudis.2011.07.009
   Phillips JE, 2010, ACTA BIOMATER, V6, P12, DOI 10.1016/j.actbio.2009.07.023
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Platt MO, 2009, J CELL PHYSIOL, V221, P306, DOI 10.1002/jcp.21854
   Poh CK, 2010, BIOMATERIALS, V31, P1578, DOI 10.1016/j.biomaterials.2009.11.042
   Puetzer JL, 2010, TISSUE ENG PART B-RE, V16, P435, DOI [10.1089/ten.teb.2009.0705, 10.1089/ten.TEB.2009.0705]
   Rahman N, 2010, BIOMATERIALS, V31, P8262, DOI 10.1016/j.biomaterials.2010.07.040
   Rao BM, 2005, CURR OPIN BIOTECH, V16, P568, DOI 10.1016/j.copbio.2005.08.001
   Rao Meenakshi, 2005, Birth Defects Res C Embryo Today, V75, P28, DOI 10.1002/bdrc.20030
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Ren YJ, 2009, BIOMATERIALS, V30, P1036, DOI 10.1016/j.biomaterials.2008.10.028
   Seidlits SK, 2008, NANOMEDICINE-UK, V3, P183, DOI 10.2217/17435889.3.2.183
   Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1
   Shin YM, 2014, MACROMOL BIOSCI, V14, P1190, DOI 10.1002/mabi.201400023
   Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434
   Smith LA, 2009, TISSUE ENG PT A, V15, P1855, DOI 10.1089/ten.tea.2008.0227
   Sonawane ND, 2003, J BIOL CHEM, V278, P44826, DOI 10.1074/jbc.M308643200
   STAATZ WD, 1990, J BIOL CHEM, V265, P4778
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Strauss S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051264
   Valamehr B, 2008, P NATL ACAD SCI USA, V105, P14459, DOI 10.1073/pnas.0807235105
   van Dorp WF, 2012, ACS NANO, V6, P10076, DOI 10.1021/nn303793w
   Wang GC, 2011, TISSUE ENG PT A, V17, P1341, DOI [10.1089/ten.tea.2010.0497, 10.1089/ten.TEA.2010.0497]
   Wang PY, 2012, J MATER SCI-MATER M, V23, P3015, DOI 10.1007/s10856-012-4748-6
   Wilkinson AE, 2014, J BIOMED MATER RES A, V102, P3419, DOI 10.1002/jbm.a.35001
   Wingate K, 2012, ACTA BIOMATER, V8, P1440, DOI 10.1016/j.actbio.2011.12.032
   Wu YN, 2014, NANOMED-NANOTECHNOL, V10, P1507, DOI 10.1016/j.nano.2014.04.002
   Xu T, 2013, BIOMATERIALS, V34, P130, DOI 10.1016/j.biomaterials.2012.09.035
   Yang K, 2013, ACS APPL MATER INTER, V5, P10529, DOI 10.1021/am402156f
   Yang X, 2012, J BIOMED MATER RES A, DOI [10.1002/jbm.a.34064, DOI 10.1002/JBM.A.34064]
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   You ML, 2011, BIOMATERIALS, V32, P2305, DOI 10.1016/j.biomaterials.2010.12.009
   ZANETTI NC, 1984, J CELL BIOL, V99, P115, DOI 10.1083/jcb.99.1.115
   Zhang G, 2010, ACTA BIOMATER, V6, P3395, DOI 10.1016/j.actbio.2010.03.019
   Zouani OF, 2013, BIOMATERIALS, V34, P2157, DOI 10.1016/j.biomaterials.2012.12.007
   Zouani OF, 2012, J CELL SCI, V125, P1217, DOI 10.1242/jcs.093229
NR 115
TC 33
Z9 33
U1 2
U2 15
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 1948-0210
J9 WORLD J STEM CELLS
JI World J. Stem Cells
PD JAN 26
PY 2015
VL 7
IS 1
BP 37
EP 50
DI 10.4252/wjsc.v7.i1.37
PG 14
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA V64OT
UT WOS:000211111000004
PM 25621104
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Lo, TY
   Wang, YJ
   Liu, DM
   Whang, WT
AF Lo, Teng-Yuan
   Wang, Yen-Jen
   Liu, Dean-Mo
   Whang, Wha-Tzong
TI Surface characteristics and biofunctionality of a novel
   high-performance, hydrophilic Jeffamine-added fluoro-containing
   polyimide for biomedical applications
SO JOURNAL OF POLYMER RESEARCH
LA English
DT Article
DE Fluoro-containing PI; Jeffamine; 6FPI-J(x) series; Biocompatibility;
   Surface biofunctionality
ID NANOSCALE ROUGHNESS; BLOCK-COPOLYMERS; FLUORINATED POLYIMIDE;
   POLY(ETHYLENE GLYCOL); BIOCOMPATIBILITY; ATTACHMENT; MEMBRANES;
   DELIVERY; FILMS
AB A brand-new class of Jeffamine-modified fluorocontaining polyimide (6FPI-J(x) series, where x ranges from 10, 20, and 30 % by weight) was developed in this study. The existing pristine fluoro-containing polyimide (6FPI) is a flexible and high-performance polymer with low surface energy for advanced engineering applications. Although it has been considered a promising biomaterial for its good blood compatibility, it has known to be toxic to normal cells. Here, we modified 6FPI [with -C (CF3)(2)-group on backbone] with a hydrophilic diamine monomer, Jeffamine, denoted as 6FPI-J(x), where x is the molar percentage of the total diamines. The newly synthesized 6FPI-J(x) series was systematically characterized in terms of surface properties included surface texture, chemistry, potential, and charging. Besides, the 6FPI-J(x) copolymer exhibited good mechanical and stability as pristine 6FPI. With the addition of Jeffamine (x=10 %), 6FPI-J(10) displayed considerably improved blood and cell compatibility compared to 6FPI, which was explainable as a combined effect of morphological texture and chemical environment of resulting surface. The new class of 6FPI-J(x) exhibited excellent solubility toward a number of organic solvents, which rendered the 6FPI-J(10) a great potential candidate as a biocompatible coating for implantable medical devices and also for potential therapeutic applications.
C1 [Lo, Teng-Yuan; Wang, Yen-Jen; Liu, Dean-Mo; Whang, Wha-Tzong] Natl Chiao Tung Univ, Dept Mat Sci & Engn, Hsinchu 30049, Taiwan.
RP Whang, WT (reprint author), Natl Chiao Tung Univ, Dept Mat Sci & Engn, Hsinchu 30049, Taiwan.
EM wtwhang@mail.nctu.edu.tw
FU Ministry of Science and Technology, Taiwan [NSC 100-2221-E-009-023-MY3,
   MOST 103-2221-E-009-216]
FX This project is supported by the Ministry of Science and Technology,
   Taiwan, under Contract No. NSC 100-2221-E-009-023-MY3 and MOST
   103-2221-E-009-216.
CR ANANTHAPADMANABHAN KP, 1987, LANGMUIR, V3, P25, DOI 10.1021/la00073a005
   Bruck R, 2011, BIOSENS BIOELECTRON, V26, P3832, DOI 10.1016/j.bios.2011.02.042
   Brunetti V, 2010, P NATL ACAD SCI USA, V107, P6264, DOI 10.1073/pnas.0914456107
   Chen J, 2005, GREEN CHEM, V7, P64, DOI 10.1039/b413546f
   Childress AE, 1996, J MEMBRANE SCI, V119, P253, DOI 10.1016/0376-7388(96)00127-5
   Choi JK, 2010, SYNTHETIC MET, V160, P1938, DOI 10.1016/j.synthmet.2010.07.013
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   FENTON DE, 1973, POLYMER, V14, P589, DOI 10.1016/0032-3861(73)90146-8
   Froimowicz P, 2012, MACROMOL RES, V20, P800, DOI 10.1007/s13233-012-0120-4
   HOUGHAM G, 1994, MACROMOLECULES, V27, P3642, DOI 10.1021/ma00091a028
   Hsiao YS, 2008, THIN SOLID FILMS, V516, P4258, DOI 10.1016/j.tsf.2007.12.166
   Ivanova EP, 2010, LANGMUIR, V26, P1973, DOI 10.1021/la902623c
   Julien S, 2011, BIOMATERIALS, V32, P3890, DOI 10.1016/j.biomaterials.2011.02.016
   Kanno M, 2002, J BIOMED MATER RES, V60, P53, DOI 10.1002/jbm.1280
   Kawakami H, 2003, J BIOMED MATER RES A, V67A, P1393, DOI 10.1002/jbm.a.20052
   Kawakami H, 2008, J ARTIF ORGANS, V11, P177, DOI 10.1007/s10047-008-0427-2
   Khan SP, 2005, NANOMED-NANOTECHNOL, V1, P125, DOI 10.1016/j.nano.2005.03.007
   Kim SH, 2011, BIOMATERIALS, V32, P5505, DOI 10.1016/j.biomaterials.2011.04.017
   Melnik E, 2011, ANAL CHIM ACTA, V699, P206, DOI 10.1016/j.aca.2011.05.017
   Metz S, 2004, BIOSENS BIOELECTRON, V19, P1309, DOI 10.1016/j.bios.2003.11.021
   Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8
   Myllymaa S, 2010, COLLOID SURFACE B, V76, P505, DOI 10.1016/j.colsurfb.2009.12.011
   Nagaoka S, 2001, INT J ARTIF ORGANS, V4, P107
   Nagarajan S, 1998, PURE APPL CHEM, V70, P1245, DOI 10.1351/pac199870061245
   Nakayama Y, 1999, BIOMATERIALS, V20, P963, DOI 10.1016/S0142-9612(98)00252-X
   Park D, 2011, BIOMATERIALS, V32, P777, DOI 10.1016/j.biomaterials.2010.09.044
   Postiglione L, 2003, J DENT RES, V82, P692, DOI 10.1177/154405910308200907
   Prichard HL, 2007, BIOMATERIALS, V28, P936, DOI 10.1016/j.biomaterials.2006.09.012
   Qiu ZM, 2006, POLYMER, V47, P8444, DOI 10.1016/j.polymer.2006.10.031
   Quesnel R, 2005, MOLECULES, V10, P98, DOI 10.3390/10010098
   Rubehn B, 2010, BIOMATERIALS, V31, P3449, DOI 10.1016/j.biomaterials.2010.01.053
   Saeed MB, 2007, INT J ADHES ADHES, V27, P9, DOI 10.1016/j.ijadhadh.2005.12.001
   Saito T, 2010, MAT SCI ENG C-MATER, V30, P1, DOI 10.1016/j.msec.2009.06.010
   Sen SK, 2009, J APPL POLYM SCI, V113, P1550, DOI 10.1002/app.30032
   Severcan F, 2000, TALANTA, V53, P55, DOI 10.1016/S0039-9140(00)00379-9
   Tian WW, 2003, EUR POLYM J, V39, P1935, DOI 10.1016/S0014-3057(03)00091-0
   Tsai MH, 2013, THIN SOLID FILMS, V544, P324, DOI 10.1016/j.tsf.2013.02.105
   Tsai MH, 2011, THIN SOLID FILMS, V519, P5238, DOI 10.1016/j.tsf.2011.01.167
   Wang CY, 2009, POLYM DEGRAD STABIL, V94, P1526, DOI 10.1016/j.polymdegradstab.2009.04.032
   Xiao S, 2007, MACROMOL CHEM PHYSIC, V208, P2665, DOI 10.1002/macp.200700328
   Yang CY, 2005, J VAC SCI TECHNOL A, V23, P862, DOI 10.1116/1.1868632
   Yang CY, 2006, J ELECTROCHEM SOC, V153, P120
   Yuan J, 2004, POLYM INT, V53, P1722, DOI 10.1002/pi.1545
   Zimmermann J, 2002, BIOMATERIALS, V23, P2121
   Zivanovic S, 2007, BIOMACROMOLECULES, V8, P1505, DOI 10.1021/bm061140p
NR 45
TC 6
Z9 6
U1 3
U2 24
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1022-9760
EI 1572-8935
J9 J POLYM RES
JI J. Polym. Res.
PD JAN 24
PY 2015
VL 22
IS 2
AR 4
DI 10.1007/s10965-014-0628-8
PG 12
WC Polymer Science
SC Polymer Science
GA CD7WF
UT WOS:000351305100002
DA 2018-10-19
ER

PT J
AU Khajuria, DK
   Razdan, R
   Mahapatra, DR
AF Khajuria, Deepak Kumar
   Razdan, Rema
   Mahapatra, Debiprosad Roy
TI Development, in vitro and in vivo characterization of zoledronic acid
   functionalized hydroxyapatite nanoparticle based formulation for
   treatment of osteoporosis in animal model
SO EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE Rat model; Postmenopausal osteoporosis; Zoledronic acid; Hydroxyapatite
   nanoparticles
ID MESENCHYMAL STEM-CELLS; OVARIECTOMIZED RATS; DRUG-DELIVERY; BONE
   TURNOVER; BISPHOSPHONATE; OSTEOINDUCTIVITY; ALFACALCIDOL; PROPRANOLOL;
   BIOMATERIAL; ALENDRONATE
AB We investigated the potential of using novel zoledronic acid (ZOL)-hydroxyapatite (HA) nanoparticle based drug formulation in a rat model of postmenopausal osteoporosis. By a classical adsorption method, nanoparticles of HA loaded with ZOL (HNLZ) drug formulation with a size range of 100-130 nm were prepared. 56 female Wistar rats were ovariectomized (OVX) or sham-operated at 3 months of age. Twelve weeks post surgery, rats were randomized into seven groups and treated with various doses of HNLZ (100, 50 and 25 mu g/kg, intravenous single dose), ZOL (100 mu g/kg, intravenous single dose) and HA nanoparticle (100 mu g/kg, intravenous single dose). Untreated OVX and sham OVX served as controls. After three months treatment period, we evaluated the mechanical properties of the lumbar vertebra and femoral mid-shaft. Femurs were also tested for trabecular microarchitecture. Sensitive biochemical markers of bone formation and bone resorption in serum were also determined. With respect to improvement in the mechanical strength of the lumbar spine and the femoral mid-shaft, the therapy with HNLZ drug formulation was more effective than ZOL therapy in OVX rats. Moreover, HNLZ drug therapy preserved the trabecular microarchitecture better than ZOL therapy in OVX rats. Furthermore, the HNLZ drug formulation corrected increase in serum levels of bone-specific alkaline phosphatase, procollagen type I N-terminal propeptide, osteocalcin, tartrate-resistant acid phosphatase 5b and C-telopeptide of type 1 collagen better than ZOL therapy in OVX rats. The results strongly suggest that HNLZ novel drug formulation appears to be more effective approach for treating severe osteoporosis in humans. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Khajuria, Deepak Kumar; Razdan, Rema] Al Ameen Coll Pharm, Dept Pharmacol, Bangalore 560027, Karnataka, India.
   [Khajuria, Deepak Kumar; Mahapatra, Debiprosad Roy] Indian Inst Sci, Dept Aerosp Engn, Lab Integrat Multiscale Engn Mat & Syst, Bangalore 560012, Karnataka, India.
RP Khajuria, DK (reprint author), Al Ameen Coll Pharm, Dept Pharmacol, Bangalore 560027, Karnataka, India.
EM deepak_kumarkhajuria@yahoo.co.in
OI /0000-0002-3737-8504
FU Indian Council of Medical Research (ICMR), Govt. of India, New Delhi
   [45/35/2010-PHA/BMS]
FX Authors would wholeheartedly thank Prof. B.G. Shivananda, Principal,
   Al-Ameen College of Pharmacy for his kind support and encouragement to
   carry out this project. Authors gratefully acknowledge financial support
   and granting research fellowship (File No: 45/35/2010-PHA/BMS) from
   Indian Council of Medical Research (ICMR), Govt. of India, New Delhi.
   Authors are thankful to Mr. B.K. Jain, Naprod Life Sciences,
   Maharashtra, India for providing gift sample of Zoledronic acid. Authors
   also gratefully acknowledge the contribution of Mr. Shashishekarayya
   Hiremath, Mr. Vijay Kumar, Mr. Anil Krishna Konduri, Mr. Aman Chandra,
   and Mr. Manish Kumar Priydarshi from Department of Aerospace
   Engineering, Indian Institute of Science, in carrying out the X-ray
   imaging, three point-bending and compression tests.
CR Aoki H, 2000, J Mater Sci Mater Med, V11, P67, DOI 10.1023/A:1008993814033
   Apelt D, 2004, BIOMATERIALS, V25, P1439, DOI 10.1016/j.biomaterials.2003.08.073
   Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312
   Boanini E, 2008, BIOMATERIALS, V29, P790, DOI 10.1016/j.biomaterials.2007.10.040
   Fathi MH, 2008, J MATER PROCESS TECH, V202, P536, DOI 10.1016/j.jmatprotec.2007.10.004
   Fernandez-Pareja A, 2007, CLIN DRUG INVEST, V27, P227, DOI 10.2165/00044011-200727040-00001
   Fox K, 2012, CHEMPHYSCHEM, V13, P2495, DOI 10.1002/cphc.201200080
   Gomes AJ, 2007, INT J PHARM, V332, P153, DOI 10.1016/j.ijpharm.2006.09.035
   Hengst V, 2007, INT J PHARM, V331, P224, DOI 10.1016/j.ijpharm.2006.11.024
   Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4
   Kalu DK, 1991, BONE MINER, V1991, P175
   Khajuria D.K., 2014, J ORTHOP SC IN PRESS, V10
   Khajuria D.K., 2013, SCI PHARM IN PRESS, V10
   Khajuria D.K., 2014, J OSTEOPOROS, V2014
   Khajuria DK, 2013, LAT AM J PHARM, V32, P968
   Khajuria DK, 2013, J ORTHOP SCI, V18, P832, DOI 10.1007/s00776-013-0433-y
   Khajuria DK, 2012, REV BRAS REUMATOL, V52, P462
   Khajuria DK, 2011, REV BRAS REUMATOL, V51, P365
   Leppanen OV, 2008, J BIOMECH, V41, P1623, DOI 10.1016/j.jbiomech.2008.03.017
   Lin LW, 2009, J BIOMED MATER RES A, V89A, P326, DOI 10.1002/jbm.a.31994
   Liu Li-Ping, 2005, Wei Sheng Yan Jiu, V34, P474
   Liu TY, 2005, J CONTROL RELEASE, V107, P112, DOI 10.1016/j.jconrel.2005.05.025
   McLeod K, 2006, J BIOMED MATER RES A, V79A, P271, DOI 10.1002/jbm.a.30792
   Ong HT, 2008, J NANOPART RES, V10, P141, DOI 10.1007/s11051-007-9239-1
   Ooms EM, 2003, BIOMATERIALS, V24, P989, DOI 10.1016/S0142-9612(02)00438-6
   Papapoulos SE, 2008, BEST PRACT RES CL EN, V22, P831, DOI 10.1016/j.beem.2008.07.001
   Pignatello R, 2009, NANOMEDICINE-UK, V4, P161, DOI 10.2217/17435889.4.2.161
   Power RA, 2004, OSTEOPOROSIS INT, V15, P716, DOI 10.1007/s00198-004-1595-4
   Rao BM, 2005, J PHARMACEUT BIOMED, V39, P781, DOI 10.1016/j.jpba.2005.04.012
   Roelofs AJ, 2006, CLIN CANCER RES, V12, p6222S, DOI 10.1158/1078-0432.CCR-06-0843
   Saleh A, 2013, ORTHOP CLIN N AM, V44, P137, DOI 10.1016/j.ocl.2013.01.001
   Shirke SS, 2008, EXP BIOL MED, V233, P1403, DOI 10.3181/0803-RM-93
   Singer FR, 2008, CLEV CLIN J MED, V75, P739, DOI 10.3949/ccjm.75.10.739
   Sorensen TC, 2013, J BIOMATER APPL, V27, P727, DOI 10.1177/0885328211424623
   Sun H, 2008, TRANSPL P, V40, P2645, DOI 10.1016/j.transproceed.2008.07.096
   Vallet-Regi Maria, 2007, Drug Metab Lett, V1, P37, DOI 10.2174/187231207779814382
   Becerril NV, 2013, J AUST CERAM SOC, V49, P112
   Ye F, 2010, ACTA BIOMATER, V6, P2212, DOI 10.1016/j.actbio.2009.12.014
   Zhang Y, 2007, BIOL PHARM BULL, V30, P898, DOI 10.1248/bpb.30.898
NR 39
TC 19
Z9 19
U1 1
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-0987
EI 1879-0720
J9 EUR J PHARM SCI
JI Eur. J. Pharm. Sci.
PD JAN 23
PY 2015
VL 66
BP 173
EP 183
DI 10.1016/j.ejps.2014.10.015
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AX7ZP
UT WOS:000347130500022
PM 25444840
DA 2018-10-19
ER

PT J
AU Han, KS
   Song, JE
   Kang, SJ
   Lee, D
   Khang, G
AF Han, Kap-Soo
   Song, Jeong Eun
   Kang, Su Ji
   Lee, Dongwon
   Khang, Gilson
TI Effect of demineralized bone particle/poly(lactic-co-glycolic acid)
   scaffolds on the attachment and proliferation of mesenchymal stem cells
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE mesenchymal stem cells; proliferation; demineralized bone particle;
   intervertebral disc; poly(lactide-co-glycolide)
ID INTERVERTEBRAL DISC DEGENERATION; PLGA/DBP HYBRID SCAFFOLD; IN-VITRO;
   OSTEOGENIC DIFFERENTIATION; MATRIX; MODEL; RAT; THERAPY; REGENERATION;
   VIVO
AB The aim of this study was to investigate the effect of demineralized bone particle/ poly(lactic-co-glycolic acid) (DBP/PLGA) scaffolds on the proliferation of mesenchymal stem cells (MSCs). DBP/PLGA hybrid scaffolds were fabricated by solvent casting/salt-leaching with DBP contents of 0, 20, 40, and 80 wt%. MSCs were seeded on the DBP/PLGA scaffolds and then evaluated by a series of analytical process: SEM, MTT, RT-PCR, and in vivo histological assay. As the DBP contents increased, the cell attachment behavior and cell viability also increased. A DBP content of 80 wt% marked the best water absorption performance and the highest cell viability. Gene expression of aggrecan on DBP/PLGA scaffolds tended to increase, whereas that on PLGA scaffolds was decreased at 1week. However, strong expression of aggrecan was observed at 2weeks regardless of the contents of DBP. Scaffolds showed a trend of increasing type II and I collagen at 2weeks. The results showed that MSCs on DBP/PLGA scaffolds showed more efficient cell proliferation and tissue formation in the presence of tissue-inductive stimuli. Suitable biomaterials could be more conducive to proliferation of MSCs. These results suggest that the DBP/PLGA scaffolds are a feasible biomaterial for intervertebral disc regeneration.
C1 [Han, Kap-Soo] Chonbuk Natl Univ, Sch Med, Jeonju 561180, South Korea.
   [Song, Jeong Eun; Kang, Su Ji; Lee, Dongwon; Khang, Gilson] Chonbuk Natl Univ, Dept BIN Fus Technol, Jeonju 561756, South Korea.
   [Song, Jeong Eun; Kang, Su Ji; Lee, Dongwon; Khang, Gilson] Chonbuk Natl Univ, Dept Polymer Nano Sci & Technol, Jeonju 561756, South Korea.
   [Song, Jeong Eun; Kang, Su Ji; Lee, Dongwon; Khang, Gilson] Chonbuk Natl Univ, Polymer BIN Res Ctr, Jeonju 561756, South Korea.
RP Khang, G (reprint author), Chonbuk Natl Univ, Dept BIN Fus Technol, Jeonju 561756, South Korea.
EM gskhang@jbnu.ac.kr
RI song, jeong eun/P-9106-2015; Khang, Gilson/B-2109-2013
OI song, jeong eun/0000-0001-6879-7616; 
FU Bio & Medical Technology Development Program of the National Research
   Foundation (NRF) - Korean government (MEST) [2012M3A9C6050204];
   Industry, University and Research Institute Core Technology development
   & Industrialized Supporting Business
FX This research was supported by the Bio & Medical Technology Development
   Program of the National Research Foundation (NRF) funded by Korean
   government (MEST) (2012M3A9C6050204), and Industry, University and
   Research Institute Core Technology development & Industrialized
   Supporting Business conducted by Jeonbuk province in 2013.
CR BOKORI J, 1980, MAGY ALLATORVOSOK, V35, P44
   Boxberger JI, 2006, J ORTHOP RES, V24, P1906, DOI 10.1002/jor.20221
   Boyd L, 2006, EUR SPINE J, V15, P414
   BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022
   Cartmell SH, 2014, J BIOMED MATER RES A, V102, P1047, DOI 10.1002/jbm.a.34790
   CATSBARIL WL, 1991, SPINE, V16, P605, DOI 10.1097/00007632-199106000-00001
   Chan SCW, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13598
   Chen D, 2004, FRONT BIOSCI, V9, P349, DOI 10.2741/1090
   Chesmel KD, 1998, J ORAL MAXIL SURG, V56, P857, DOI 10.1016/S0278-2391(98)90015-5
   Diefenderfer DL, 2003, CONNECT TISSUE RES, V44, P305, DOI 10.1080/03008200390181825
   Freemont AJ, 2002, J PATHOL, V196, P374, DOI 10.1002/path.1050
   Gruber HE, 2002, SPINE, V27, P1626, DOI 10.1097/01.BRS.0000018788.88555.21
   Hammond JS, 2011, J HEPATOL, V54, P279, DOI 10.1016/j.jhep.2010.06.040
   HANAMURA H, 1980, CLIN ORTHOP RELAT R, P281
   Huang SS, 2011, CURR STEM CELL RES T, V6, P317, DOI 10.2174/157488811797904335
   Huang WB, 2004, EXP CELL RES, V299, P325, DOI 10.1016/j.yexcr.2004.04.051
   HUMZAH MD, 1988, ANAT RECORD, V220, P337, DOI 10.1002/ar.1092200402
   Kim CH, 2006, J BIOMED MATER RES B, V78B, P283, DOI 10.1002/jbm.b.30484
   Kim HE, 2012, MACROMOL RES, V20, P1044, DOI 10.1007/s13233-012-0148-5
   Kim SH, 2011, J BIOMATER SCI POLYM, V29, P31
   Kim SH, 2006, ADV EXP MED BIOL, V585, P167
   Ko EK, 2008, TISSUE ENG PT A, V14, P2105, DOI 10.1089/ten.tea.2008.0057
   Ko YK, 2007, POLYM-KOREA, V31, P14
   Lam MT, 2013, TISSUE ENG PT A, V19, P738, DOI [10.1089/ten.tea.2012.0480, 10.1089/ten.TEA.2012.0480]
   Lee JH, 2010, INT J TISSUE REGEN, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0015394
   Munirah S, 2008, J BIOMAT SCI-POLYM E, V19, P1219
   Murphy JM, 2003, ARTHRITIS RHEUM, V48, P3464, DOI 10.1002/art.11365
   Nomura T, 2001, CLIN ORTHOP RELAT R, P94
   Omlor GW, 2012, EUR SPINE J, V21, P1700, DOI 10.1007/s00586-012-2291-2
   Pei M, 2011, TISSUE ENG PT A, V17, P3067, DOI [10.1089/ten.TEA.2011.0158, 10.1089/ten.tea.2011.0158]
   Preradovic A, 2005, CELL TISSUE RES, V321, P459, DOI 10.1007/s00441-005-1116-6
   Richardson SM, 2007, HISTOL HISTOPATHOL, V22, P1033, DOI 10.14670/HH-22.1033
   Richardson SM, 2006, STEM CELLS, V24, P707, DOI 10.1634/stemcells.2005-0205
   Richardson SM, 2006, BIOMATERIALS, V27, P4069, DOI 10.1016/j.biomaterials.2006.03.017
   Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018
   Risbud MV, 2004, SPINE, V29, P2627, DOI 10.1097/01.brs.0000146462.92171.7f
   Rui YF, 2012, INT ORTHOP, V36, P1099, DOI 10.1007/s00264-011-1417-1
   Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9
   Sato M, 2003, SPINE, V28, P548, DOI 10.1097/00007632-200303150-00007
   Shoukry M, 2013, STEM CELLS DEV, V22, P1162, DOI 10.1089/scd.2012.0597
   Sobajima S, 2008, SPINE J, V8, P888, DOI 10.1016/j.spinee.2007.09.011
   Vadala G, 2013, J TISSUE ENG REGEN M
   Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007
   Williamson AK, 2001, J ORTHOPAED RES, V19, P1113, DOI 10.1016/S0736-0266(01)00052-3
   Woo Y., 2012, INT J TISSUE REGEN, V3, P63
   Yang D. H., 2011, INT J TISSUE REGEN, V2, P119
   Yerramalli CS, 2007, BIOMECH MODEL MECHAN, V6, P13, DOI 10.1007/s10237-006-0043-0
   Yoon ST, 2003, SPINE, V28, P1773, DOI 10.1097/01.BRS.0000083204.44190.34
NR 48
TC 7
Z9 7
U1 0
U2 20
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD JAN 22
PY 2015
VL 26
IS 2
BP 92
EP 110
DI 10.1080/09205063.2014.982930
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA AU8ID
UT WOS:000345838900002
PM 25431827
DA 2018-10-19
ER

PT J
AU Saini, M
   Singh, Y
   Arora, P
   Arora, V
   Jain, K
AF Saini, Monika
   Singh, Yashpal
   Arora, Pooja
   Arora, Vipin
   Jain, Krati
TI Implant biomaterials: A comprehensive review
SO WORLD JOURNAL OF CLINICAL CASES
LA English
DT Review
DE Biomaterials; Zirconium; Surface roughness; Ceramic; Corrosion
AB Appropriate selection of the implant biomaterial is a key factor for long term success of implants. The biologic environment does not accept completely any material so to optimize biologic performance, implants should be selected to reduce the negative biologic response while maintaining adequate function. Every clinician should always gain a thorough knowledge about the different biomaterials used for the dental implants. This article makes an effort to summarize various dental biomaterials which were used in the past and as well as the latest material used now.
C1 [Saini, Monika; Singh, Yashpal] Al Qaseem Pvt Coll, Dept Oral & Maxillofacial Rehabil, POB 156, Buraydah 51431, Qassim, Saudi Arabia.
   [Arora, Pooja; Jain, Krati] Subharati Dent Coll, Dept Prosthodont, Meerut 250003, Uttar Pradesh, India.
   [Arora, Vipin] Subharati Dent Coll, Dept Operat Dent & Endodont, Meerut 250003, Uttar Pradesh, India.
RP Singh, Y (reprint author), Al Qaseem Pvt Coll, Dept Oral & Maxillofacial Rehabil, POB 156, Buraydah 51431, Qassim, Saudi Arabia.
EM dryashpal.singh@gmail.com
CR Adatia ND, 2009, J PROSTHODONT, V18, P17, DOI 10.1111/j.1532-849X.2008.00378.x
   Adya N., 2005, J INDIAN PROSTHODONT, V5, P126, DOI DOI 10.4103/0972-4052.17104
   ARVIDSON K, 1987, SCAND J DENT RES, V95, P356
   ASHMAN A, 1971, J PROSTHET DENT, V25, P342, DOI 10.1016/0022-3913(71)90197-1
   Block MS, 1997, IMPLANTS DENT, P4
   Carvalho TLL, 1997, INT J ORAL MAX SURG, V26, P149, DOI 10.1016/S0901-5027(05)80838-0
   Chaturvedi T P, 2009, Indian J Dent Res, V20, P91
   Chiapasco M, 2012, CLIN ORAL IMPLAN RES, V23, P1136, DOI 10.1111/j.1600-0501.2011.02296.x
   Cranin AN, 1982, BIOCOMPATIBILITY DEN, V4, P92
   Depprich Rita, 2008, Head Face Med, V4, P30, DOI 10.1186/1746-160X-4-30
   GETTLEMAN L, 1977, J PROSTHET DENT, V37, P74, DOI 10.1016/0022-3913(77)90195-0
   HODOSH M, 1969, J PROSTHET DENT, V22, P371, DOI 10.1016/0022-3913(69)90200-5
   Hoffmann O, 2008, INT J ORAL MAX IMPL, V23, P691
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   HULBERT SF, 1975, J DENT RES, V54, pB153, DOI 10.1177/00220345750540021001
   KAWAHARA H, 1983, INT DENT J, V33, P350
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   LEMONS JE, 1990, J AM DENT ASSOC, V121, P716, DOI 10.14219/jada.archive.1990.0268
   Manivasagam G., 2010, RECENT PAT CORROS SC, V2, P40, DOI DOI 10.2174/1877610801002010040
   MEFFERT RM, 1992, J PERIODONTOL, V63, P859, DOI 10.1902/jop.1992.63.11.859
   Misch CE, 1999, IMPLANT DENT, V8, P90, DOI DOI 10.1097/00008505-199901000-00013
   Muddugangadhar B., 2011, INT J ORAL IMPLANTOL, V2, P13, DOI DOI 10.5005/JP-JOURNALS-10012-1030
   Ozkurt Z, 2011, J ORAL IMPLANTOL, V37, P367, DOI 10.1563/AAID-JOI-D-09-00079
   Phillips R. W., 1982, SKINNERS SCI DENT MA
   Prithviraj D R, 2012, Indian J Dent Res, V23, P643, DOI 10.4103/0970-9290.107383
   RAVNHOLT G, 1988, SCAND J DENT RES, V96, P466
   SHKLAR G, 1970, J PROSTHET DENT, V24, P636, DOI 10.1016/0022-3913(70)90100-9
   Smith D C, 1993, Int J Prosthodont, V6, P106
   Sykaras N, 2000, INT J ORAL MAX IMPL, V15, P675
   Tschernitschek H, 2005, QUINTESSENCE INT, V36, P523
   WAERHAUG J., 1956, ORAL SURG ORAL MED AND ORAL PATHOL, V9, P46, DOI 10.1016/0030-4220(56)90173-6
   Wennerberg A, 1996, Int J Oral Maxillofac Implants, V11, P38
   Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63
   WILLIAMS DF, 1981, BIOMATERIALS, V2, P133, DOI 10.1016/0142-9612(81)90039-9
NR 34
TC 61
Z9 63
U1 5
U2 32
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 2307-8960
J9 WORLD J CLIN CASES
JI World J. Clin. Cases
PD JAN 16
PY 2015
VL 3
IS 1
BP 52
EP 57
DI 10.12998/wjcc.v3.i1.52
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA VB7SD
UT WOS:000417235100006
PM 25610850
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Yan, LP
   Silva-Correia, J
   Oliveira, MB
   Vilela, C
   Pereira, H
   Sousa, RA
   Mano, JF
   Oliveira, AL
   Oliveira, JM
   Reis, RL
AF Yan, Le-Ping
   Silva-Correia, Joana
   Oliveira, Mariana B.
   Vilela, Carlos
   Pereira, Helder
   Sousa, Rui A.
   Mano, Joao F.
   Oliveira, Ana L.
   Oliveira, Joaquim M.
   Reis, Rui L.
TI Bilayered silk/silk-nanoCaP scaffolds for osteochondral tissue
   engineering: In vitro and in vivo assessment of biological performance
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Bilayered scaffold; Silk fibroin; Calcium phosphate; Osteochondral
   regeneration; Nanocomposite
ID CALCIUM-PHOSPHATE SCAFFOLDS; MESENCHYMAL STEM-CELLS; MARROW STROMAL
   CELLS; SILK-BASED SCAFFOLDS; ARTICULAR-CARTILAGE; MACRO/MICROPOROUS
   SILK; BIOMATERIAL SCAFFOLDS; COMPOSITE SCAFFOLD; SUBCHONDRAL BONE;
   REPAIR
AB Novel porous bilayered scaffolds, fully integrating a silk fibroin (SF) layer and a silk-nano calcium phosphate (silk-nanoCaP) layer for osteochondral defect (OCD) regeneration, were developed. Homogeneous porosity distribution was achieved in the scaffolds, with calcium phosphate phase only retained in the silk-nanoCaP layer. The scaffold presented compressive moduli of 0.4 MPa in the wet state. Rabbit bone marrow mesenchymal stromal cells (RBMSCs) were cultured on the scaffolds, and good adhesion and proliferation were observed. The silk-nanoCaP layer showed a higher alkaline phosphatase level than the silk layer in osteogenic conditions. Subcutaneous implantation in rabbits demonstrated weak inflammation. In a rabbit knee critical size OCD model, the scaffolds firmly integrated into the host tissue. Histological and immunohistochemical analysis showed that collagen II positive cartilage and glycosaminoglycan regeneration presented in the silk layer, and de novo bone ingrowths and vessel formation were observed in the silk-nanoCaP layer. These bilayered scaffolds can therefore be promising candidates for OCD regeneration. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Yan, Le-Ping; Silva-Correia, Joana; Oliveira, Mariana B.; Vilela, Carlos; Pereira, Helder; Sousa, Rui A.; Mano, Joao F.; Oliveira, Ana L.; Oliveira, Joaquim M.; Reis, Rui L.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-4806909 Taipas, Guimaraes, Portugal.
   [Yan, Le-Ping; Silva-Correia, Joana; Oliveira, Mariana B.; Vilela, Carlos; Pereira, Helder; Sousa, Rui A.; Mano, Joao F.; Oliveira, Ana L.; Oliveira, Joaquim M.; Reis, Rui L.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
   [Vilela, Carlos] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, P-4719 Braga, Portugal.
   [Vilela, Carlos] Ctr Hosp Alto Ave, Dept Orthoped, Guimaraes, Portugal.
   [Pereira, Helder] Univ Minho, Saude Atlantica Sports Ctr, FC Porto Stadium, Oporto, Portugal.
   [Pereira, Helder] Univ Porto, Res Ctr, P-4100 Oporto, Portugal.
   [Pereira, Helder] Ctr Hosp Povoa Varzim, Dept Orthoped, Vila Do Conde, Portugal.
   [Oliveira, Ana L.] Portuguese Catholic Univ, Sch Biotechnol, CBQF Ctr Biotechnol & Fine Chem, P-4200072 Oporto, Portugal.
RP Oliveira, JM (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, AvePk, P-4806909 Taipas, Guimaraes, Portugal.
EM miguel.oliveira@dep.uminho.pt
RI Oliveira, Ana/J-3404-2013; Oliveira, Mariana/A-1440-2014; Silva-Correia,
   Joana/D-4980-2012; Group, 3Bs/E-4374-2012; Oliveira, Joaquim
   Miguel/H-8636-2012; Oliveira, Mariana/H-6933-2017; Reis, Rui
   L./A-8938-2008; Mano, Joao/A-4418-2009
OI Oliveira, Ana/0000-0001-8012-4203; Oliveira,
   Mariana/0000-0002-6104-6075; Silva-Correia, Joana/0000-0003-1312-3109;
   Group, 3Bs/0000-0002-5195-3456; Oliveira, Joaquim
   Miguel/0000-0001-7052-8837; Oliveira, Mariana/0000-0002-6104-6075; Reis,
   Rui L./0000-0002-4295-6129; Mano, Joao/0000-0002-2342-3765; Sousa,
   Rui/0000-0003-0362-7418; Yan, Leping/0000-0002-4806-5052
FU Portuguese Foundation for Science and Technology (FCT)
   [PTDC/CTM/105703/2008, PTDC/CTM-BPC/115977/2009]; European Union
   [REGPOT-CT2012-316331-POLARIS]; FCT PhD scholarship
   [SFRH/BD/64717/2009]; FCT program [IF/00423/2012]
FX This study was funded by the Portuguese Foundation for Science and
   Technology (FCT) projects Tissue2Tissue (PTDC/CTM/105703/2008) and
   OsteoCart (PTDC/CTM-BPC/115977/2009), as well as the European Union's
   FP7 Programme under grant agreement no REGPOT-CT2012-316331-POLARIS. The
   authors are grateful to Viviana P. Ribeiro and Teresa Oliveira for the
   assistance with the immunohistochemical staining. L-P.Y. was awarded a
   FCT PhD scholarship (SFRH/BD/64717/2009). The FCT distinction attributed
   to J.M.O. under the Investigator FCT program (IF/00423/2012) is also
   greatly acknowledged.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bedi A, 2010, CARTILAGE, V1, P20, DOI 10.1177/1947603509355970
   Bhardwaj N, 2011, CARBOHYD POLYM, V85, P325, DOI 10.1016/j.carbpol.2011.02.027
   Bitton Ryan, 2009, Am J Manag Care, V15, pS230
   Chen JN, 2011, BIOMATERIALS, V32, P4793, DOI 10.1016/j.biomaterials.2011.03.041
   Collins AM, 2009, ADV MATER, V21, P75, DOI 10.1002/adma.200802239
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Fuchs S, 2009, BIOMATERIALS, V30, P1329, DOI 10.1016/j.biomaterials.2008.11.028
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   Grayson WL, 2008, TRENDS BIOTECHNOL, V26, P181, DOI 10.1016/j.tibtech.2007.12.009
   Guo X, 2009, BIOMATERIALS, V30, P2741, DOI 10.1016/j.biomaterials.2009.01.048
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Joshi N, 2012, AM J SPORT MED, V40, P1289, DOI 10.1177/0363546512441585
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Khanarian NT, 2012, TISSUE ENG PT A, V18, P533, DOI [10.1089/ten.tea.2011.0279, 10.1089/ten.TEA.2011.0279]
   Kim K, 2013, J CONTROL RELEASE, V168, P166, DOI 10.1016/j.jconrel.2013.03.013
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kon E, 2012, J BONE JOINT SURG AM
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kundu B, 2010, PROG POLYM SCI, V35, P1116, DOI 10.1016/j.progpolymsci.2010.04.004
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liu X, 2009, BIOMATERIALS, V30, P2252, DOI 10.1016/j.biomaterials.2008.12.068
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Marolt D, 2006, BIOMATERIALS, V27, P6138, DOI 10.1016/j.biomaterials.2006.07.015
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   McMahon LA, 2008, REGEN MED, V3, P743, DOI 10.2217/17460751.3.5.743
   Minas T, 2009, AM J SPORT MED, V37, P902, DOI 10.1177/0363546508330137
   Mohan N, 2011, TISSUE ENG PT A, V17, P2845, DOI 10.1089/ten.tea.2011.0135
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   O'Shea TM, 2008, TISSUE ENG PART B-RE, V14, P447, DOI 10.1089/ten.teb.2008.0327
   Oliveira AL, 2012, ACTA BIOMATER, V8, P1530, DOI 10.1016/j.actbio.2011.12.015
   Oliveira AL, 2006, 20 EUR C BIOM NANT 2
   Oliveira JM, 2010, BONE, V46, P1424, DOI 10.1016/j.bone.2010.02.007
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Oliveira JM, 2009, J BIOMED MATER RES A, V91A, P175, DOI 10.1002/jbm.a.32213
   Panseri S, 2012, KNEE SURG SPORT TR A, V20, P1182, DOI 10.1007/s00167-011-1655-1
   Reyes R, 2014, J TISSUE ENG REGEN M, V8, P521, DOI 10.1002/term.1549
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Shao XX, 2006, BIOMATERIALS, V27, P1071, DOI 10.1016/j.biomaterials.2005.07.040
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang TW, 2009, ACTA BIOMATER, V5, P2371, DOI 10.1016/j.actbio.2009.03.033
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Weil Lowell Jr, 2011, Foot Ankle Spec, V4, P249, DOI 10.1177/1938640011415373
   Xue DT, 2010, J BIOMED MATER RES A, V94A, P259, DOI 10.1002/jbm.a.32691
   Yan LP, 2014, KEY ENG MATER, V587, P245, DOI 10.4028/www.scientific.net/KEM.587.245
   Yan LP, 2013, J BIOACT COMPAT POL, V28, P439, DOI 10.1177/0883911513503538
   Yan LP, 2013, NANOMEDICINE-UK, V8, P359, DOI [10.2217/NNM.12.118, 10.2217/nnm.12.118]
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Yang PJ, 2009, TISSUE ENG PART B-RE, V15, P127, DOI 10.1089/ten.teb.2008.0371
   Zengerink M, 2010, KNEE SURG SPORT TR A, V18, P238, DOI 10.1007/s00167-009-0942-6
   Zhang W, 2013, BIOMATERIALS, V34, P6046, DOI 10.1016/j.biomaterials.2013.04.055
   Zhang YF, 2010, BIOMATERIALS, V31, P2848, DOI 10.1016/j.biomaterials.2009.12.049
NR 57
TC 42
Z9 43
U1 6
U2 79
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 15
PY 2015
VL 12
BP 227
EP 241
DI 10.1016/j.actbio.2014.10.021
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA1QF
UT WOS:000348686100024
PM 25449920
DA 2018-10-19
ER

PT J
AU Minagar, S
   Li, YC
   Berndt, CC
   Wen, C
AF Minagar, Sepideh
   Li, Yuncang
   Berndt, Christopher C.
   Wen, Cuie
TI The influence of titania-zirconia-zirconium titanate nanotube
   characteristics on osteoblast cell adhesion
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Nanotube; Titania (TiO2); Zirconia (ZrO2); Zirconium titanate (ZrTiO4);
   Osteoblast cell response
ID SURFACE-TOPOGRAPHY; TIO2 NANOTUBES; TERM ADHESION; ANODIZATION;
   CHEMISTRY; ROUGHNESS; ALLOY; TIZR; FABRICATION; BEHAVIOR
AB Studies of biomaterial surfaces and their influence on cell behavior provide insights concerning the design of surface physicochemical and topography properties of implant materials. Fabrication of biocompatible metal oxide nanotubes on metallic biomaterials, especially titanium alloys such as Ti50Zr via anodization, alters the surface chemistry as well as surface topography of the alloy. In this study, four groups of TiO2-ZrO2-ZrTiO4 nanotubes that exhibit diverse nanoscale dimensional characteristics (i.e. inner diameter D-i, outer diameter Do and wall thicknesses W-t) were fabricated via anodization. The nanotubes were annealed and characterized using scanning electron microscopy and 3-D profilometry. The potential applied during anodization influenced the oxidation rate of titanium and zirconium, thereby resulting in different nanoscale characteristics for the nanotubes. The different oxidation and dissolution rates both led to changes in the surface roughness parameters. The in vitro cell response to the nanotubes with different nanoscale dimensional characteristics was assessed using osteoblast cells (SaOS2). The results of the MTS assay indicated that the nanotubes with inner diameter (D-i) approximate to 40 nm exhibited the highest percentage of cell adhesion of 41.0%. This result can be compared to (i) 25.9% cell adhesion at D-i approximate to 59 nm, (ii) 33.1% at D-i approximate to 64 nm, and (iii) 33.5% at D-i approximate to 82 nm. The nanotubes with D-i approximate to 59 nm exhibited the greatest roughness parameter of Sa (mean roughness), leading to the lowest ability to interlock with SaOS2 cells. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Minagar, Sepideh; Berndt, Christopher C.; Wen, Cuie] Swinburne Univ Technol, Fac Sci Engn & Technol, Hawthorn, Vic 3122, Australia.
   [Li, Yuncang] Deakin Univ, Inst Frontier Mat, Geelong, Vic 3217, Australia.
   [Berndt, Christopher C.] SUNY Stony Brook, Dept Mat Sci & Engn, Stony Brook, NY 11794 USA.
RP Wen, C (reprint author), Swinburne Univ Technol, Fac Sci Engn & Technol, Hawthorn, Vic 3122, Australia.
EM cwen@swin.edu.au
RI Li, Yuncang/I-5832-2012
OI Li, Yuncang/0000-0003-4290-4772; Minagar, Sepideh/0000-0002-0822-3239
FU Australian Research Council (ARC) through the ARC Discovery Project
   [DP110101974]; State Government of Victoria, Australia through a
   Victorian International Research Scholarship
FX This research is supported by the Australian Research Council (ARC)
   through the ARC Discovery Project DP110101974. S.M. would like to
   acknowledge the State Government of Victoria, Australia, for supporting
   and funding this research project through a Victorian International
   Research Scholarship.
CR Alexander J. F. S. a. W., 2000, CRC MAT SCI ENG HDB
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2006, J MATER SCI-MATER M, V17, P471, DOI 10.1007/s10856-006-8475-8
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Anselme K, 2011, OSTEOPOROSIS INT, V22, P2037, DOI 10.1007/s00198-011-1618-x
   Anselme K, 2010, P I MECH ENG H, V224, P1487, DOI 10.1243/09544119JEIM901
   Anselme K, 2010, J ADHES SCI TECHNOL, V24, P831, DOI 10.1163/016942409X12598231568186
   Balaur E, 2005, J MATER CHEM, V15, P4488, DOI 10.1039/b509672c
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Capellato P, 2012, MAT SCI ENG C-MATER, V32, P2060, DOI 10.1016/j.msec.2012.05.013
   Chen XB, 2008, BIOTECHNOL BIOENG, V101, P378, DOI 10.1002/bit.21900
   Choe HC, 2011, THIN SOLID FILMS, V519, P4652, DOI 10.1016/j.tsf.2011.01.011
   DANN JR, 1970, J COLLOID INTERF SCI, V32, P302, DOI 10.1016/0021-9797(70)90054-8
   Gadelmawla ES, 2002, J MATER PROCESS TECH, V123, P133, DOI 10.1016/S0924-0136(02)00060-2
   Grigorescu S, 2014, BIOELECTROCHEMISTRY, V98, P39, DOI 10.1016/j.bioelechem.2014.03.002
   Jha H, 2010, ELECTROCHIM ACTA, V55, P8883, DOI 10.1016/j.electacta.2010.07.098
   Kim SE, 2008, ELECTROCHIM ACTA, V53, P4846, DOI 10.1016/j.electacta.2008.02.005
   Kim WG, 2009, T NONFERR METAL SOC, V19, P1005, DOI 10.1016/S1003-6326(08)60396-9
   Macak JM, 2007, CURR OPIN SOLID ST M, V11, P3, DOI 10.1016/j.cossms.2007.08.004
   Minagar S, 2014, J MATER CHEM B, V2, P71, DOI 10.1039/c3tb21204a
   Minagar S, 2012, ACTA BIOMATER, V8, P2875, DOI 10.1016/j.actbio.2012.04.005
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476
   Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374
   Shin D.H., 2011, NANOTECHNOLOGY, V22
   Sista S, 2011, J BIOMED MATER RES A, V97A, P27, DOI 10.1002/jbm.a.33013
   Veeco Instruments Inc, 2009, VIS FOR PROF
   Yasuda K, 2007, J ELECTROCHEM SOC, V154, pC472, DOI 10.1149/1.2749091
   Yu WQ, 2010, ORAL DIS, V16, P624, DOI 10.1111/j.1601-0825.2009.01643.x
   Zhang WY, 2009, SMALL, V5, P1742, DOI 10.1002/smll.200900148
NR 32
TC 21
Z9 21
U1 2
U2 63
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 15
PY 2015
VL 12
BP 281
EP 289
DI 10.1016/j.actbio.2014.10.037
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA1QF
UT WOS:000348686100029
PM 25448349
DA 2018-10-19
ER

PT J
AU Kumar, D
   Akhtar, SN
   Patel, AK
   Ramkumar, J
   Balani, K
AF Kumar, Dharmesh
   Akhtar, Syed Nadeem
   Patel, Anup Kumar
   Ramkumar, J.
   Balani, Kantesh
TI Tribological performance of laser peened Ti-6Al-4V
SO WEAR
LA English
DT Article
DE Fretting; Other materials (Ti-6Al-4V); Laser processing; Profilometry;
   Residual stress; Stick-slip
ID ALLOYS; ABLATION
AB Ti-6Al-4V is a well-known metallic biomaterial used for implants, but its use is limited by its inferior hardness and tribological resistance in vivo. Laser peening (LP) is one potential means to enhance its tribological properties. LP induces surface residual compressive stresses due to plastic deformation caused by the propagation of a shock wave. Further, performing laser peening under water can enhance a material's hardness and wear resistance because it confines shock waves to the surface of the material. In the current research, the influence of an excimer laser (Kr-F, 248 nm) with varying fluence on the fretting behavior of Ti-6Al-4V was carried out. An optimized laser fluence of 100 J/cm(2) resulted in an increase in hardness by 28% in air and 35% in water confining media, respectively, when compared to that of an untreated Ti-6Al-4V substrate. It was observed that the residual compressive stresses from LP increased from 540 MPa in air to 604 MPa in water. Fretting wear against bearing steel type AISI E52100 shows a major wear reduction on LP Ti-6Al-4V samples as wear volume decreased from 1.211 x 10(-3) mm(3) to either 0.139 x 10(-3) mm(3) or to 0.106 x 10(-3) mm(3) in samples peened in air and water, respectively. Frictional hysteresis data show that the dissipation energy loss for Ti-6Al-4V substrate from 11.412 x 10(-4) J is decreased to 3.284 x 10(-4) J for LP sample at 20 N load. Moreover, a considerable fall in contact diameter is observed from the non-processed surface (0.29 x 10(-3) mu m) to the LP sample (0.176 x 10(-3) mu m). Friction log plots indicate that wear mechanisms are mostly adhesion, abrasion and delamination. Enhanced tribological performance of LP Ti-6Al-4V was observed using LP in a water medium, and indicates potential improvements when the alloy is used in joint replacements. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Kumar, Dharmesh] Indian Inst Technol, Mat Sci Programme, Kanpur 208016, Uttar Pradesh, India.
   [Akhtar, Syed Nadeem; Ramkumar, J.] Indian Inst Technol, Kanpur 208016, Uttar Pradesh, India.
   [Patel, Anup Kumar; Balani, Kantesh] Indian Inst Technol, Kanpur 208016, Uttar Pradesh, India.
RP Balani, K (reprint author), Indian Inst Technol, Kanpur 208016, Uttar Pradesh, India.
EM kbalani@iitk.ac.in
OI Balani, Kantesh/0000-0003-0619-9164
CR Ageev V.A., 1997, J APPL SPECTROSC, P64
   BALLARD P, 1991, J PHYS IV, V1, P487, DOI 10.1051/jp4:1991369
   Ballard P, 1991, THESIS ECOLE POLYTEC
   Bhushan B., 1991, HDB TRIBOLOGY MAT CO, P155
   Boyer R, 1994, MAT PROPERTIES HDB T, V42, P1339
   Buckley D.H., 1981, SURFACE EFFECTS ADHE, P220
   BUDINSKI KG, 1991, WEAR, V151, P203, DOI 10.1016/0043-1648(91)90249-T
   Holt John M., 1996, STRUCTURAL ALLOYS HD
   IHLEMANN J, 1992, APPL PHYS A-MATER, V54, P363, DOI 10.1007/BF00324203
   Kolsky H., 1963, STRESS WAVES SOLIDS, P177
   Mallozi P. I., 1974, US Patent, Patent No. [3 850 698, 3850698]
   Menezes PL, 2008, SADHANA-ACAD P ENG S, V33, P181, DOI 10.1007/s12046-008-0011-8
   MEYERS M. A., 1994, DYNAMIC BEHAV MAT
   Montross CS, 2002, INT J FATIGUE, V24, P1021, DOI 10.1016/S0142-1123(02)00022-1
   Moore A.J.W., P ROYAL SOC LONDON M, V212, P452
   Moroz E.M., 1963, SOVIET PHYS JETP USS, V17, P1463
   Payre P., 1995, OPT QUANT ELECTRON, V27, P1213
   Qu J., 2004, WEAR, V126, P1348
   See D., 2003, P 8 NAT TURB ENG HIG
   Sikdar K, 2014, WEAR, V318, P177, DOI 10.1016/j.wear.2014.06.012
   Stachowiak G., 2013, ENG TRIBOLOGY, P525
   Swaminathan V, 2012, BIOMATERIALS, V33, P5487, DOI 10.1016/j.biomaterials.2012.04.015
   Trdan U, 2012, SURF COAT TECH, V208, P109, DOI 10.1016/j.surfcoat.2012.08.048
   VINCENT L, 1994, MAT FRETTING, P323
   Waterhouse R.B, RESIDUAL STRESSES FR, VIV
   Welsch Gerhard, MAT PROPERTIES HDB T, P101
   Ye C., 2010, ADV ENG MAT, V12
   Zhu S, 2001, J APPL PHYS, V89, P2400, DOI 10.1063/1.1342200
NR 28
TC 19
Z9 19
U1 1
U2 37
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
EI 1873-2577
J9 WEAR
JI Wear
PD JAN 15
PY 2015
VL 322
BP 203
EP 217
DI 10.1016/j.wear.2014.11.016
PG 15
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA CA4PD
UT WOS:000348886000020
DA 2018-10-19
ER

PT J
AU Ye, XX
   Tse, ZTH
   Tang, GY
   Song, GL
AF Ye, Xiaoxin
   Tse, Zion T. H.
   Tang, Guoyi
   Song, Guolin
TI The effect of electropulsing induced gradient topographic oxide coating
   of Ti-Al-V alloy strips on the fibroblast adhesion and growth
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Electropulsing effect; Gradient topographic coating; Titanium alloy;
   Biocompatibility; Biomedical application
ID TI-6AL-4V ALLOY; TITANIUM-ALLOY; IN-VITRO; MECHANICAL-PROPERTIES; CARBON
   NANOTUBES; PART II; MICROSTRUCTURE; BIOCOMPATIBILITY; PHASE; CELLS
AB The effects of electropulsing induced gradient topographic oxide coating of Ti-Al-V alloy matrix strips on the fibroblast adhesion and growth were investigated. The goal in biomaterial surface modification was to possess desired recognition and specificity through modifying its surface condition like topological structure. Here we developed a unique strategy of high-energy electropulsing treatment (EPT) for manipulating surface gradient bio-functionalization of basal textured Ti-6Al-4V alloy strips with the surface gradient topographic oxide coating, which brings in the gradient distribution of surface conditions including matrix alloy, ordinary TiO2 film and TiO2 microwaves on a single strip. High-energy electropulse is frequently used as an electrically-treated method in improving the material microstructure and mechanical property. This paper reports firstly the surface modification under EPT aiming to improve the biocompatibility, which will meet the demand of biomaterials in different parts of human beings.
   Novel TiO2 microwave topological structure on the material surface resulted in better biocompatibility with more active fibroblast bio-reaction including higher cell viability, better physiological morphology and stronger adhesion binding, which is ascribed to surface chemical components, surface energy and specific surface area under EPT manipulation. The key role of forming TiO2 microwave structure solely under EPT is the selective effect of the electropulses going through the textured specimen, which thus builds a selective growth of the oxide and forms the microwave topological structure on the material surface. The positive contributions of EPT in the thermodynamics and kinetics of oxide coating growth are attributed to the reduction of nucleation energy barrier and acceleration of atomic diffusion. Thus, the gradient functionalization of biomaterials can be tuned over several second EPT in the titanium alloys, opening an energy-saving and high-efficiency door to diverse biomedical applications including the tissue engineering and biological interfaces. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Ye, Xiaoxin; Tang, Guoyi; Song, Guolin] Tsinghua Univ, Adv Mat Inst, Grad Sch Shenzhen, Shenzhen 518055, Peoples R China.
   [Ye, Xiaoxin; Tang, Guoyi] Tsinghua Univ, Key Lab Adv Mat, Minist Educ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
   [Tse, Zion T. H.] Univ Georgia, Coll Engn, Athens, GA 30602 USA.
RP Tang, GY (reprint author), Tsinghua Univ, Adv Mat Inst, Grad Sch Shenzhen, Shenzhen 518055, Peoples R China.
EM xiaoxinye905@gmail.com; tanggy@mails.tsinghua.edu.cn
FU National Natural Science Foundation of China [50571048]; Shenzhen
   Science and Technology Research funding project of China
   [SGLH20121008144756946]
FX The work is supported by National Natural Science Foundation of China
   (No. 50571048) and Shenzhen Science and Technology Research funding
   project of China (No. SGLH20121008144756946).
CR Auden EC, 2013, IEEE T NUCL SCI, V60, P4094, DOI 10.1109/TNS.2013.2289737
   Bogdanski D, 2002, BIOMATERIALS, V23, P4549, DOI 10.1016/S0142-9612(02)00200-4
   Chen HY, 2006, ADV MATER, V18, P3089, DOI 10.1002/adma.200600615
   Deville S, 2004, ACTA MATER, V52, P5709, DOI 10.1016/j.actamat.2004.08.036
   Docampo P, 2014, ADV MATER, V26, P4013, DOI 10.1002/adma.201400486
   Garay JE, 2003, ACTA MATER, V51, P4487, DOI 10.1016/S1359-6454(03)00284-2
   Hofmann D. C., 2008, NATURE, V451, P1083
   Jeon TY, 2014, ADV MATER, V26, P1422, DOI 10.1002/adma.201304317
   Jiang YB, 2009, ACTA MATER, V57, P4797, DOI 10.1016/j.actamat.2009.06.044
   Kotanen CN, 2013, BIOMATERIALS, V34, P6318, DOI 10.1016/j.biomaterials.2013.05.022
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Levitas VI, 2013, ACTA MATER, V61, P4305, DOI 10.1016/j.actamat.2013.03.034
   Li JT, 2014, BIOMATERIALS, V35, P642, DOI 10.1016/j.biomaterials.2013.09.099
   Li XM, 2012, BIOMATERIALS, V33, P4818, DOI 10.1016/j.biomaterials.2012.03.045
   Liu H, 2011, ADV MATER, V23, P3832, DOI 10.1002/adma.201101783
   Miola M, 2009, J MATER SCI-MATER M, V20, P741, DOI 10.1007/s10856-008-3618-8
   Mush J., 2011, SURF COAT TECH, V2052, pS84
   Park J, 2012, SMALL, V8, P98, DOI 10.1002/smll.201100790
   Seh ZW, 2012, ADV MATER, V24, P2310, DOI 10.1002/adma.201104241
   Sun YS, 2013, THIN SOLID FILMS, V528, P130, DOI 10.1016/j.tsf.2012.06.088
   Duong TT, 2011, ADV MATER, V23, P5557, DOI 10.1002/adma.201103030
   Twite AA, 2012, ADV MATER, V24, P2380, DOI 10.1002/adma.201104336
   Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113
   Vergassola M, 2007, NATURE, V445, P406, DOI 10.1038/nature05464
   Wang H, 2013, INT J PLASTICITY, V47, P49, DOI 10.1016/j.ijplas.2013.01.007
   Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046
   Xiaoxin Y., 2014, MAT SCI ENG A
   Xiaoxin Y., J MAT SCI MAT MED
   Yang XM, 2013, SURF COAT TECH, V233, P65, DOI 10.1016/j.surfcoat.2013.01.052
   Ye X., APPL PHYS A
   Ye X., ADV ENG MAT
   Ye XX, 2014, MATER CHARACT, V98, P147, DOI 10.1016/j.matchar.2014.10.026
   Ye XX, 2014, SURF COAT TECH, V258, P467, DOI 10.1016/j.surfcoat.2014.08.052
   Ye XX, 2015, J ALLOY COMPD, V621, P66, DOI 10.1016/j.jallcom.2014.09.192
   Ye XX, 2014, J MECH BEHAV BIOMED, V40, P287, DOI 10.1016/j.jmbbm.2014.08.022
   Ye XX, 2014, J ALLOY COMPD, V616, P173, DOI 10.1016/j.jallcom.2014.07.143
   Ye XX, 2014, J MATER RES, V29, P1500, DOI 10.1557/jmr.2014.171
   Ye XX, 2014, J ALLOY COMPD, V599, P1, DOI 10.1016/j.jallcom.2014.02.055
   Zhang PC, 2013, ADV MATER, V25, P3566, DOI 10.1002/adma.201300888
   Zhao Y, 2013, SURF COAT TECH, V229, P130, DOI 10.1016/j.surfcoat.2012.08.053
   Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622
   Zhu RF, 2013, APPL PHYS A-MATER, V111, P1195, DOI 10.1007/s00339-012-7342-3
NR 42
TC 9
Z9 10
U1 3
U2 50
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JAN 15
PY 2015
VL 261
BP 213
EP 218
DI 10.1016/j.surfcoat.2014.11.028
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA AZ5IR
UT WOS:000348255500029
DA 2018-10-19
ER

PT J
AU Zivkovic, LTI
   Zivkovic, LS
   Babic, BM
   Kokunesoski, MJ
   Jokic, BM
   Karadzic, IM
AF Zivkovic, Lidija T. Izrael
   Zivkovic, Ljiljana S.
   Babic, Biljana M.
   Kokunesoski, Maja J.
   Jokic, Bojan M.
   Karadzic, Ivanka M.
TI Immobilization of Candida rugosa lipase by adsorption onto biosafe
   meso/macroporous silica and zirconia
SO BIOCHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Immobilization; Adsorption; Lipase; SBA-15; Zirconia; Kinetic parameters
ID OLIVE OIL HYDROLYSIS; BOVINE SERUM-ALBUMIN; ENZYME IMMOBILIZATION;
   MESOPOROUS SILICA; MICROBIAL LIPASES; SOLID-SURFACES; NANOPARTICLES;
   STABILIZATION; BIOMATERIAL; PARTICLES
AB Lipase from Candida rugosa was immobilized by adsorption onto laboratory prepared supports, silica SBA-15 and zirconia. The adsorption process was studied as a function of pH in terms of percent of adsorbed lipase, enzyme activity and zeta potential of support and enzyme. Several analytical approaches such as laser Doppler electrophoresis, Fourier transform infrared spectroscopy (FTIR) and field emission scanning electron microscopy (FESEM) showed that the lipase was successfully immobilized onto both supports. The zeta-potential data suggest that the adsorption efficiency does not depends on the sign but on the magnitude of the surface charge of adsorption partners, and therefore underline the importance of their dispersion stability. Adsorption to material surface altered enzyme characteristics. nu(max), for the lipase immobilized onto silica and zirconia were 4.8-fold and 3.6-fold lower than that of the free lipase, respectively. The Km showed no alteration of enzyme-substrate affinity on zirconia support, whereas the enzyme immobilized on silica had 3.6 times lower affinity. Thermostability at 60 degrees C of the lipase was improved 12-fold on zirconia and 4-fold on silica. Finally, in examining reusability, the immobilized lipase retained more than 90% of initial activity after eight reuses on both supports. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Zivkovic, Lidija T. Izrael; Karadzic, Ivanka M.] Univ Belgrade, Sch Med, Inst Med Chem, Belgrade 11000, Serbia.
   [Zivkovic, Ljiljana S.; Babic, Biljana M.; Kokunesoski, Maja J.] Univ Belgrade, Vinca Inst Nucl Sci, Belgrade 11000, Serbia.
   [Jokic, Bojan M.] Univ Belgrade, Fac Technol & Met, Belgrade 11000, Serbia.
RP Zivkovic, LTI (reprint author), Univ Belgrade, Sch Med, Inst Med Chem, Visegradska 26, Belgrade 11000, Serbia.
EM lidija.izrael-zivkovic@mfub.bg.ac.rs
RI Kokunesoski, Maja/N-8046-2017
OI Kokunesoski, Maja/0000-0003-1732-002X; Izrael Zivkovic,
   Lidija/0000-0002-0385-4373
FU Ministry of Education, Science and Technological Development, Republic
   of Serbia [III 43004, III 45012]
FX The zirconia powder was supplied by courtesy of Prof. E.A. Levashov,
   Moscow State Institute of Steel and Alloys, Technological Institute, in
   the framework of Russian-Serbian project 2003-2005. This research was
   financed by the Ministry of Education, Science and Technological
   Development, Republic of Serbia (Projects Nos. III 43004 and III 45012).
CR Adlercreutz P, 2013, CHEM SOC REV, V42, P6406, DOI 10.1039/c3cs35446f
   Andrew H.L., 2005, PROTEINS, V61, P704
   Andualema B., 2012, Biotechnology, V11, P100
   Aubin-Tam ME, 2005, LANGMUIR, V21, P12080, DOI 10.1021/la052102e
   Blagoveschenskii Y.Y., 1999, ELECTROMETALLURGIYA, V3, P28
   Boncel S, 2013, ENZYME MICROB TECH, V53, P263, DOI 10.1016/j.enzmictec.2013.05.003
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chen GC, 2011, BIOTECHNOL LETT, V33, P525, DOI 10.1007/s10529-010-0451-1
   Chen YZ, 2008, LANGMUIR, V24, P8877, DOI 10.1021/la801384c
   Dandavate V, 2009, PROCESS BIOCHEM, V44, P349, DOI 10.1016/j.procbio.2008.11.001
   Datta S., 2013, BIO-TECHNOL, V3, P1, DOI DOI 10.1007/S13205-012-0071-7
   Ehlert N, 2013, CHEM SOC REV, V42, P3847, DOI 10.1039/c3cs35359a
   Fadiloglu S, 1998, J AGR FOOD CHEM, V46, P3411, DOI 10.1021/jf9709865
   Fariha H., 2006, ENZYME MICROB TECHNO, V39, P235
   Gardimalla HMR, 2005, CHEM COMMUN, P4432, DOI 10.1039/b504128g
   GOPALAN R, 1995, J MATER SCI, V30, P3075, DOI 10.1007/BF01209219
   Hanefeld U, 2013, CHEM SOC REV, V42, P6211, DOI 10.1039/c3cs90042h
   Hartmann M, 2013, CHEM SOC REV, V42, P6277, DOI 10.1039/c3cs60021a
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Huang L, 2008, CHEM ENG J, V144, P103, DOI 10.1016/j.cej.2008.05.015
   Huang SH, 2003, BIOTECHNOL PROGR, V19, P1095, DOI 10.1021/bp025587v
   Hudson S, 2005, J PHYS CHEM B, V109, P19496, DOI 10.1021/jp052102n
   Karadzic I., 2006, J BIOSCI BIOENG, V102, P309
   Kim MI, 2006, J MOL CATAL B-ENZYM, V39, P62, DOI 10.1016/j.molcatb.2006.01.028
   Kim MI, 2007, BIOTECHNOL BIOENG, V96, P210, DOI 10.1002/bit.21107
   Klein MP, 2011, PROCESS BIOCHEM, V46, P1375, DOI 10.1016/j.procbio.2011.02.021
   Knezevic Z, 2006, BIOCHEM ENG J, V30, P269, DOI 10.1016/j.bej.2006.05.009
   Kokunesoski M, 2010, MATER CHEM PHYS, V124, P1248, DOI 10.1016/j.matchemphys.2010.08.066
   Krajewska B, 2005, BIOCATAL BIOTRANSFOR, V23, P225, DOI 10.1080/10242420500208852
   Lee DH, 2006, J IND ENG CHEM, V12, P777
   Lins L, 2003, PROTEIN SCI, V12, P1406, DOI 10.1110/ps.0304803
   Magner E, 2013, CHEM SOC REV, V42, P6213, DOI 10.1039/c2cs35450k
   Mak K. H., 2009, SCI TECHNOL VISION, V5, P19
   Mendes A.A., 2009, BIOCATAL BIOTRANSFOR, V25, P393
   Metin AU, 2013, MACROMOL RES, V21, P176, DOI 10.1007/s13233-013-1026-5
   Michele M., 2011, ENZYME RES, V2011, P10
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   Oh JM, 2007, J IND ENG CHEM, V13, P429
   Pandey A, 1999, BIOTECHNOL APPL BIOC, V29, P119
   Pedretti A, 2002, J MOL GRAPH MODEL, V21, P47, DOI 10.1016/S1093-3263(02)00123-7
   Pereira EB, 2001, APPL BIOCHEM BIOTECH, V91-3, P739, DOI 10.1385/ABAB:91-93:1-9:739
   Pimentel MCB, 2007, ARTIF CELL BLOOD SUB, V35, P221, DOI 10.1080/10731190601188380
   Pugh R.J., 1994, DISPERSION COLLOIDAL
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Rajendran A, 2009, BRAZ ARCH BIOL TECHN, V52, P207, DOI 10.1590/S1516-89132009000100026
   Ratledge C., 2006, BASIC BIOTECHNOLOGY, P605
   Ren YH, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-63
   Rezwan K, 2005, J PHYS CHEM B, V109, P14469, DOI 10.1021/jp050528w
   Rezwan K, 2004, LANGMUIR, V20, P10055, DOI 10.1021/la048459k
   Santos JC, 2007, CHEM ENG TECHNOL, V30, P1255, DOI 10.1002/ceat.200700153
   Schultz N, 2008, COLLOID SURFACE B, V66, P39, DOI 10.1016/j.colsurfb.2008.05.004
   Sheldon RA, 2013, CHEM SOC REV, V42, P6223, DOI 10.1039/c3cs60075k
   Sheldon RA, 2011, APPL MICROBIOL BIOT, V92, P467, DOI 10.1007/s00253-011-3554-2
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Walker J.M., 2005, PROTEOMICS PROTOCOLS, P571
   Wu SC, 2008, J MOL CATAL B-ENZYM, V54, P103, DOI 10.1016/j.molcatb.2007.12.021
   Xia HS, 2010, J POROUS MAT, V17, P225, DOI 10.1007/s10934-009-9284-5
NR 57
TC 28
Z9 29
U1 1
U2 58
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1369-703X
EI 1873-295X
J9 BIOCHEM ENG J
JI Biochem. Eng. J.
PD JAN 15
PY 2015
VL 93
BP 73
EP 83
DI 10.1016/j.bej.2014.09.012
PG 11
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA AY1OL
UT WOS:000347362100010
DA 2018-10-19
ER

PT J
AU Periyathambi, P
   Vedakumari, WS
   Baskar, SK
   Bojja, S
   Sastry, TP
AF Periyathambi, Prabu
   Vedakumari, Weslen S.
   Baskar, Santhosh Kumar
   Bojja, Sreedhar
   Sastry, Thotapalli P.
TI Osteogenic potency of magnetic fibrin nanoparticles-A novel perspective
   in bone tissue engineering
SO MATERIALS LETTERS
LA English
DT Article
DE Nanoparticles; Magnetic materials; Electron microscopy; Saos-2; Cell
   viability
AB In the present study, goat blood has been used as the starting material for the preparation of novel magnetic fibrin nanoparticles (MAG-FNPs) in tissue engineering. The synthesised nanoparticles were characterized by X-ray diffractometer (XRD), transmittance electron microscope (TEM), scanning electron microscope (SEM), Fourier Transform Infrared spectroscopy (FTIR), energy dispersive X-ray spectroscopy (EDX) and vibrating sample magnetometer (VSM) analysis. The osteogenic potential of MAG-FNPs was evaluated by performing cell viability assay and quantifying alkaline phosphatase (ALP) levels using Saos-2 cells. The results obtained suggested that MAG-FNPs could serve as promising biomaterial for bone tissue engineering. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Periyathambi, Prabu; Vedakumari, Weslen S.; Baskar, Santhosh Kumar; Sastry, Thotapalli P.] Cent Leather Res Inst, Bioprod Lab, Madras 600020, Tamil Nadu, India.
   [Bojja, Sreedhar] Indian Inst Chem Technol, Inorgan & Phys Chem Div, Hyderabad 500607, Andhra Pradesh, India.
RP Sastry, TP (reprint author), Cent Leather Res Inst, Bioprod Lab, Madras 600020, Tamil Nadu, India.
EM sastrytp@hotmail.com
FU Council of Scientific and Industrial Research (CSIR) Network project-ADD
   [CSCO302]
FX The authors greatly acknowledge the financial support from Council of
   Scientific and Industrial Research (CSIR) Network project-ADD (CSCO302)
   under XII Plan.
CR Chamundeeswari M, 2011, MATER RES BULL, V46, P901, DOI 10.1016/j.materresbull.2011.02.021
   Niketica AS, 2014, MATER LETT, V120, P86
   Vedakumari WS, 2014, COLLOID SURFACE B, V120, P208, DOI 10.1016/j.colsurfb.2014.04.021
   Vittlakumari WS, 2013, BIECHRO BIOOHYS ACTA, V1830, P4244
NR 4
TC 6
Z9 6
U1 2
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD JAN 15
PY 2015
VL 139
BP 108
EP 111
DI 10.1016/j.matlet.2014.045
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AU5IN
UT WOS:000345640300029
DA 2018-10-19
ER

PT J
AU Deepthi, S
   Jeevitha, K
   Sundaram, MN
   Chennazhi, KP
   Jayakumar, R
AF Deepthi, S.
   Jeevitha, K.
   Sundaram, M. Nivedhitha
   Chennazhi, K. P.
   Jayakumar, R.
TI Chitosan-hyaluronic acid hydrogel coated poly(caprolactone) multiscale
   bilayer scaffold for ligament regeneration
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Electrospinning; Hydrogel coating; Poly(caprolactone); Multiscale
   fibers; Layered scaffold; Ligament tissue engineering
ID TISSUE ENGINEERING SCAFFOLDS; IN-VITRO; FIBROUS SCAFFOLDS; DESIGN;
   ADHESION; CHITIN; CELLS; NANO
AB Ligament tears, seen in young athletes to elderly people, pose a very challenging problem to achieve complete healing, due to its hypocellularity that decelerate regeneration of ligament after injury. Tissue engineering is an approach for the ligament regeneration that optimizes the response of cell biomaterial interaction to fasten regeneration using engineered scaffolds that mimic the native environment. Electrospinning techniques and hydrogels are useful to engineer the structure of ligament. In this study, electrospun multiscale fibrous scaffold of PCL aligned microfibers/random nanofibers (PCL aligned multiscale fibers) and PCL random microfibers/nanofibers (PCL random multiscale fibers) were developed. Chitosan hyaluronic acid hydrogel coating was done on these fibrous scaffolds and this was layered to form a bilayered construct. The developed scaffold was characterized by SEM, FTIR, and tensile testing. Protein adsorption studies show better protein adsorption on coated scaffolds compared to uncoated scaffolds which further improved the cell viability as determined by Alamar blue assay and DNA quantification by Pico green assay. Rabbit ligament fibroblast cell attachment and infiltration study conducted on the scaffolds showed cell elongation along the aligned fibers, which would be advantageous in the need to align cells along the direction of force in native ligament environment. Hydrogel coating on PCL random multiscale fibers show better cell infiltration. This study implies the use of hydrogel coated systems to provide a reservoir for cells and nutrients and further modifications of these systems would make it promising for ligament regeneration. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Deepthi, S.; Jeevitha, K.; Sundaram, M. Nivedhitha; Chennazhi, K. P.; Jayakumar, R.] Amrita Vishwa Vidyapeetham Univ, Amrita Ctr Nanosci & Mol Med, Amrita Inst Med Sci & Res Ctr, Kochi 682041, Kerala, India.
RP Jayakumar, R (reprint author), Amrita Vishwa Vidyapeetham Univ, Amrita Ctr Nanosci & Mol Med, Amrita Inst Med Sci & Res Ctr, Kochi 682041, Kerala, India.
EM rjayakumar@aims.amrita.edu
FU Department of Biotechnology (DBT), India [BT/PR 13585/NNT/28/474/2010];
   Council of Scientific and Industrial Research, India
   [9/963(0034)2K13-EMR-I]
FX One of the authors R. jayakumar is grateful to the Department of
   Biotechnology (DBT), India, for providing fund under the scheme of
   Nanoscience and Nanotechnology Program (Ref. No. BT/PR
   13585/NNT/28/474/2010). The author Deepthi Sankar is grateful to the
   Council of Scientific and Industrial Research, India for supporting
   financially under the CSIR-SRF Award No: 9/963(0034)2K13-EMR-I. The
   authors are thankful to Mr. Sajin. P. Ravi for his help in SEM studies
   and Mr. Sarath for confocal microscopic imaging.
CR Anisha BS, 2013, CARBOHYD POLYM, V92, P1470, DOI 10.1016/j.carbpol.2012.10.058
   Anitha A, 2014, PROG POLYM SCI, V39, P1644, DOI 10.1016/j.progpolymsci.2014.02.008
   Bell E, 1995, Tissue Eng, V1, P163, DOI 10.1089/ten.1995.1.163
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Fan HB, 2009, BIOMATERIALS, V30, P4967, DOI 10.1016/j.biomaterials.2009.05.048
   Freeman JW, 2007, J BIOMECH, V40, P2029, DOI 10.1016/j.jbiomech.2006.09.025
   Freeman JW, 2011, J BIOMECH, V44, P694, DOI 10.1016/j.jbiomech.2010.10.043
   Harrison SL, 2011, J ORTHOP RES, V29, P1361, DOI 10.1002/jor.21321
   Hayami JWS, 2010, J BIOMED MATER RES A, V92A, P1407, DOI 10.1002/jbm.a.32472
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Jayaraman K, 2004, J NANOSCI NANOTECHNO, V4, P52, DOI 10.1166/jnn.2004.078
   Kim HW, 2005, BIOMATERIALS, V26, P5221, DOI 10.1016/j.biomaterials.2005.01.047
   Kumbar Sangamesh Q., 2008, Recent Patents on Biomedical Engineering, V1, P68
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   Laurencin CT, 2005, BIOMATERIALS, V26, P7530, DOI 10.1016/j.biomaterials.2005.05.073
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee JHW, 2011, J HYDRO-ENVIRON RES, V5, P143, DOI 10.1016/j.jher.2011.07.001
   Liljensten E, 2002, J MATER SCI-MATER M, V13, P351, DOI 10.1023/A:1014380332762
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   Lu HH, 2005, BIOMATERIALS, V26, P4805, DOI 10.1016/j.biomaterials.2004.11.050
   Rathbone S, 2010, J BIOMED MATER RES A, V93A, P1391, DOI 10.1002/jbm.a.32641
   Sabir Muhammad Iqbal, 2009, J MATER SCI, V44, P5713
   Sankar D, 2014, TISSUE ENG PT A, V20, P1689, DOI [10.1089/ten.tea.2013.0569, 10.1089/ten.TEA.2013.0569]
   Shalumon KT, 2011, J MACROMOL SCI A, V48, P21, DOI 10.1080/10601325.2011.528288
   Snook G.A., 1983, CLIN ORTHOP RELAT R, V172, P3
   Srinivasan S, 2012, ADV POLYM SCI, V246, P1, DOI 10.1007/12_2011_163
   Teo WE, 2006, NANOTECHNOLOGY, V17, pR89, DOI 10.1088/0957-4484/17/14/R01
   Thayer PS, 2014, BIOMACROMOLECULES, V15, P75, DOI 10.1021/bm4013056
   Voytik Harbin S.L., 1997, J CELL BIOCHEM, V67, P478
   Wang PY, 2013, BIOTECHNOL BIOENG, V110, P327, DOI 10.1002/bit.24615
   WIIG ME, 1990, J ORTHOP RES, V8, P425, DOI 10.1002/jor.1100080314
   Xia X., 1994, J INNER MONGOLIA I A, V15, P15
NR 33
TC 23
Z9 23
U1 14
U2 180
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
EI 1873-3212
J9 CHEM ENG J
JI Chem. Eng. J.
PD JAN 15
PY 2015
VL 260
BP 478
EP 485
DI 10.1016/j.cej.2014.08.106
PG 8
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA AU2XE
UT WOS:000345477100051
DA 2018-10-19
ER

PT J
AU Zhang, Y
   Ying, GM
   Ren, CH
   Jizhang, YN
   Brogan, D
   Liu, ZJ
   Li, SJ
   Ding, YC
   Borlongan, CV
   Zhang, J
   Ji, XM
AF Zhang, Ying
   Ying, Guomin
   Ren, Changhong
   Jizhang, Yunneng
   Brogan, David
   Liu, Zongjian
   Li, Sijie
   Ding, Yuchuan
   Borlongan, Cesar V.
   Zhang, Jian
   Ji, Xunming
TI Administration of human platelet-rich plasma reduces infarction volume
   and improves motor function in adult rats with focal ischemic stroke
SO BRAIN RESEARCH
LA English
DT Article
DE Biomaterials; Neuroprotection; Stroke; Therapeutics; Platelets; Albumin
ID FIBROBLAST-GROWTH-FACTOR; CEREBRAL-ISCHEMIA; INFUSION; INJURY; BRAIN;
   NEUROPROTECTION; ANGIOGENESIS; DAMAGE; MODEL; BETA
AB Platelet-rich plasma (PRP) is a milieu of bioactive factors, including platelet derived growth factor, transforming growth factor beta, among many others. Despite accumulating evidence on PRP's safety and efficacy for treating musculoskeletal injuries, limited studies have been performed using PRP in brain disorders. This study aimed to explore the potential benefits of administration of human PRP lysate after ischemic stroke in rats. An ischemic stroke model was generated by occlusion of the right middle cerebral artery, then 90 min later, stroke rats were randomly assigned to receive local infusion to the ischemic area of human PRP lysate, human albumin solution (HSA), saline or no treatment at all. An additional group of stroke rats received systemic infusion of human PRP lysate to further assess the therapeutic effects of this treatment. Results showed that while local infusion of HSA or saline, and systemic administration of human PRP lysate, compared to no treatment significantly reduced infarct volume (37.4%, 40.1%, and 39.9% vs 49.7%) and neurological deficit score (2.2, 2.6, and 2.8 vs 3.7), the greatest neuroprotection (31.0% infarct volume and 1.6 neurological deficit score) was found in stroke animals that received local intra-arterial infusion of human PRP lysate (p's <0.05). In conclusion, administration of human PRP attenuates brain injury after focal ischemia. Our results suggest PRP should be investigated further as a potential point-of-care biomaterial following stroke. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Zhang, Ying; Ying, Guomin; Ren, Changhong; Liu, Zongjian; Li, Sijie; Ji, Xunming] Capital Med Univ, Xuanwu Hosp, Inst Hypoxia Med, Beijing 100053, Peoples R China.
   [Zhang, Ying; Ying, Guomin; Ren, Changhong; Liu, Zongjian; Li, Sijie; Ji, Xunming] Capital Med Univ, Beijing Inst Brain Disorders, Beijing 100069, Peoples R China.
   [Jizhang, Yunneng] Brownell Talbot Sch, Omaha, NE USA.
   [Brogan, David; Ding, Yuchuan] Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI USA.
   [Borlongan, Cesar V.] Univ S Florida, Dept Neurosurg & Brain Repair, Tampa, FL USA.
   [Zhang, Jian] Capital Med Univ, Xuanwu Hosp, Dept Vasc Surg, Beijing 100053, Peoples R China.
   [Ji, Xunming] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing 100053, Peoples R China.
RP Zhang, J (reprint author), Capital Med Univ, Xuanwu Hosp, 45 Changchun St, Beijing 100053, Peoples R China.
EM zhangyzh@public3.bta.net.cn; jixm@ccmu.edu.cn
FU National Basic Research Program of China [2011CB707804]; National
   Science Fund for Distinguished Young Scholars of China [81325007]
FX This work was supported by the National Basic Research Program of China
   (2011CB707804), and National Science Fund for Distinguished Young
   Scholars of China (81325007). We thank Jinhuan Gao and Ning Li
   (Institute of Hypoxia Medicine, Xuanwu Hospital) for technical
   assistance.
CR Arboix A, 2004, CEREBROVASC DIS, V18, P304, DOI 10.1159/000080356
   Ay H, 1999, CEREBROVASC DIS, V9, P131, DOI 10.1159/000015941
   Boswell SG, 2012, ARTHROSCOPY, V28, P429, DOI 10.1016/j.arthro.2011.10.018
   Centeno CJ, 2010, CURR STEM CELL RES T, V5, P81, DOI 10.2174/157488810790442796
   Chen J, 2013, STROKE, V44, P260, DOI 10.1161/STROKEAHA.112.675462
   Cheng K, 2012, J AM COLL CARDIOL, V59, P256, DOI 10.1016/j.jacc.2011.10.858
   Clark WM, 2000, NEUROLOGY, V54, pA88
   Davalos A, 2012, LANCET, V380, P349, DOI 10.1016/S0140-6736(12)60813-7
   Ding YC, 2002, STROKE, V33, P2492, DOI 10.1161/01.STR.0000028237.15541.CC
   FISHER M, 1995, J CEREBR BLOOD F MET, V15, P953, DOI 10.1038/jcbfm.1995.121
   Font MA, 2010, CURR CARDIOL REV, V6, P238, DOI 10.2174/157340310791658802
   Foster TE, 2009, AM J SPORT MED, V37, P2259, DOI 10.1177/0363546509349921
   Gonshor A, 2002, INT J PERIODONT REST, V22, P547
   GROSS CE, 1993, STROKE, V24, P558, DOI 10.1161/01.STR.24.4.558
   Guo HL, 2006, NEUROSCI LETT, V393, P56, DOI 10.1016/j.neulet.2005.09.043
   Harrigan MR, 2003, ACTA NEUROCHIR, V145, P49, DOI 10.1007/s00701-002-1035-1
   Hayashi T, 1998, J CEREBR BLOOD F MET, V18, P887, DOI 10.1097/00004647-199808000-00009
   Intini G, 2009, BIOMATERIALS, V30, P4956, DOI 10.1016/j.biomaterials.2009.05.055
   Issa Razao, 2005, Angiogenesis, V8, P53, DOI 10.1007/s10456-005-5613-8
   Krupinski J, 1997, STROKE, V28, P564, DOI 10.1161/01.STR.28.3.564
   Lee SC, 2010, EUR J NEUROL, V17, P45, DOI 10.1111/j.1468-1331.2009.02731.x
   Li Q, 2002, EXP NEUROL, V177, P531, DOI 10.1006/exnr.2002.7994
   Moraes VY, 2013, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD010071.PUB2
   Osterhout DJ, 1997, J NEUROSCI, V17, P9122
   PREHN JHM, 1993, J CEREBR BLOOD F MET, V13, P521, DOI 10.1038/jcbfm.1993.67
   Ren CH, 2011, NEUROL RES, V33, P514, DOI 10.1179/016164111X13007856084241
   Ren Jing Mei, 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P121, DOI 10.2174/1568007053544101
   Renner O, 2003, MOL BRAIN RES, V113, P44, DOI 10.1016/S0169-328X(03)00085-8
   Ruocco A, 1999, J CEREBR BLOOD F MET, V19, P1345, DOI 10.1097/00004647-199912000-00008
   Shen J, 2012, J CEREBR BLOOD F MET, V32, P353, DOI 10.1038/jcbfm.2011.136
   Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977
   Willemsen JCN, 2013, EUR J PLAST SURG, V36, P777, DOI 10.1007/s00238-013-0887-3
   Woitzik J, 2007, J NEUROSURG, V106, P872, DOI 10.3171/jns.2007.106.5.872
   Won SJ, 2006, BRAIN RES, V1123, P237, DOI 10.1016/j.brainres.2006.09.055
   Yu WJ, 2011, INT J NEUROSCI, V121, P176, DOI 10.3109/00207454.2010.544432
   Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369
   Zhu Y, 2002, J NEUROSCI, V22, P3898, DOI 10.1523/JNEUROSCI.22-10-03898.2002
NR 37
TC 3
Z9 6
U1 1
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-8993
EI 1872-6240
J9 BRAIN RES
JI Brain Res.
PD JAN 12
PY 2015
VL 1594
BP 267
EP 273
DI 10.1016/j.brainres.2014.10.035
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA AY5CE
UT WOS:000347590100026
PM 25452023
DA 2018-10-19
ER

PT J
AU Sharma, BB
   Verma, AK
   Thomas, S
   Murli, C
   Sharma, SM
AF Sharma, Bharat Bhooshan
   Verma, Ashok K.
   Thomas, Susy
   Murli, Chitra
   Sharma, Surinder M.
TI Hydrogen Bonds and Ionic Forms versus Polymerization of Imidazole at
   High Pressures
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID SOLID-STATE; CRYSTAL; NH
AB Imidazole (C3H4N2) is an important biomaterial for material research and applications. Our high-pressure Raman spectroscopic investigations combined with ab initio calculations on crystalline imidazole suggest that C-H---X (X = N, pi) and N-H---N intermolecular hydrogen bonding interactions largely influence the nature of its structural and polymeric transformations under pressure. At pressures around similar to 10 GPa, the reduction in the N---N distances close to the symmetrization limit and the emergence of the spectral features of the cationic form indicate the onset of proton disorder. The pressure-induced strengthening of the "blue-shifting hydrogen bonds" C-H---X (X = N, pi) in this compound is revealed by the Raman spectra and the ab initio calculations. No polymer phase was retrieved on release from the highest pressure of 20 GPa in this study.
C1 [Sharma, Bharat Bhooshan; Verma, Ashok K.; Thomas, Susy; Murli, Chitra; Sharma, Surinder M.] Bhabha Atom Res Ctr, High Pressure & Synchrotron Radiat Phys Div, Bombay 400085, Maharashtra, India.
RP Murli, C (reprint author), Bhabha Atom Res Ctr, High Pressure & Synchrotron Radiat Phys Div, Bombay 400085, Maharashtra, India.
EM cmurli@barc.gov.in
CR AFTERGUT S, 1961, NATURE, V191, P379, DOI 10.1038/191379a0
   Benoit M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.145501
   Bernasconi M, 1997, PHYS REV LETT, V78, P2008, DOI 10.1103/PhysRevLett.78.2008
   Carven B. M., 1977, ACTA CRYSTALLOGR B, VB33, P2585
   Ceppatelli M., 2010, PHASE TRANSITION, V80, P1085
   DAYCOCK JT, 1968, NATURE, V218, P672, DOI 10.1038/218672a0
   De L. L., 2006, CURR MED CHEM, V13, P1
   Dziubek K, 2007, J AM CHEM SOC, V129, P12620, DOI 10.1021/ja074885r
   Fischbach I, 2004, J PHYS CHEM B, V108, P18500, DOI 10.1021/jp046848h
   Goncharov AF, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.065505
   Hermansson K, 2002, J PHYS CHEM A, V106, P4695, DOI 10.1021/jp0143948
   Hobza P, 2000, CHEM REV, V100, P4253, DOI 10.1021/cr990050q
   Horiuchi S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2322
   Inagaki S, 2012, PHYS CHEM CHEM PHYS, V14, P2008, DOI 10.1039/c2cp23047j
   Ji CM, 2013, CRYSTENGCOMM, V15, P2157, DOI 10.1039/c3ce26942f
   Jiong R., 2006, THEORETICAL STUDY CH
   KAWADA A, 1970, J CHEM PHYS, V52, P3121, DOI 10.1063/1.1673447
   Lankau T, 2011, PHYS CHEM CHEM PHYS, V13, P12758, DOI 10.1039/c0cp02172e
   MAJOUBE M, 1982, J CHEM PHYS, V76, P2838, DOI 10.1063/1.443385
   Murli C, 2012, J PHYS CHEM B, V116, P4671, DOI 10.1021/jp300248b
   Murli C, 2010, J PHYS CHEM B, V114, P9744, DOI 10.1021/jp1034757
   NAKAMOTO K, 1955, J AM CHEM SOC, V77, P6480, DOI 10.1021/ja01629a013
   Nishio M., 1998, CH PI INTERACTION EV
   Palasyuk T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4460
   Paliwoda D, 2012, CRYST GROWTH DES, V12, P4302, DOI 10.1021/cg300852t
   Perrin CL, 1997, ANNU REV PHYS CHEM, V48, P511, DOI 10.1146/annurev.physchem.48.1.511
   SADLEJ J, 1992, J MOL STRUCT, V274, P247, DOI 10.1016/0022-2860(92)80161-A
   Serpell CJ, 2013, CRYST GROWTH DES, V13, P2866, DOI 10.1021/cg400273p
   Sharma BB, 2013, J RAMAN SPECTROSC, V44, P785, DOI 10.1002/jrs.4264
   Sharma SM, 1996, PROG MATER SCI, V40, P1, DOI 10.1016/0079-6425(95)00006-2
   Sikora M, 2013, J PHYS CHEM C, V117, P10661, DOI 10.1021/jp401389v
   Su CC, 2003, J CHEM PHYS, V119, P10753, DOI 10.1063/1.1620500
   Wang G, 2002, J RAMAN SPECTROSC, V33, P125, DOI 10.1002/jrs.825
   Xu WM, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.175501
   Zhou M, 2012, SPECTROCHIM ACTA A, V97, P526, DOI 10.1016/j.saa.2012.07.001
   Zielinski W, 2013, CRYST GROWTH DES, V13, P696, DOI 10.1021/cg301374z
NR 36
TC 4
Z9 4
U1 1
U2 22
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD JAN 8
PY 2015
VL 119
IS 1
BP 372
EP 378
DI 10.1021/jp510688c
PG 7
WC Chemistry, Physical
SC Chemistry
GA AY7QJ
UT WOS:000347753900038
PM 25494241
DA 2018-10-19
ER

PT J
AU de Vera, P
   Garcia-Molina, R
   Abril, I
AF de Vera, Pablo
   Garcia-Molina, Rafael
   Abril, Isabel
TI Angular and Energy Distributions of Electrons Produced in Arbitrary
   Biomaterials by Proton Impact
SO PHYSICAL REVIEW LETTERS
LA English
DT Article
ID TRACK STRUCTURE; WATER-VAPOR; CHARGED-PARTICLES; CROSS-SECTIONS; LIQUID
   WATER; ION IMPACT; IONIZATION; EMISSION; COLLISIONS; MOLECULES
AB We present a simple method for obtaining reliable angular and energy distributions of electrons ejected from arbitrary condensed biomaterials by proton impact. Relying on a suitable description of the electronic excitation spectrum and a physically motivated relation between the ion and electron scattering angles, it yields cross sections in rather good agreement with experimental data in a broad range of ejection angles and energies, by only using as input the target composition and density. The versatility and simplicity of the method, which can be also extended to other charged particles, make it especially suited for obtaining ionization data for any complex biomaterial present in realistic cellular environments.
C1 [de Vera, Pablo; Abril, Isabel] Univ Alacant, Dept Fis Aplicada, E-03080 Alacant, Spain.
   [Garcia-Molina, Rafael] Univ Murcia, Dept Fis, Ctr Invest Opt & Nanofis, E-30100 Murcia, Spain.
RP de Vera, P (reprint author), Univ Alacant, Dept Fis Aplicada, E-03080 Alacant, Spain.
EM pablo.vera@ua.es
RI Abril, Isabel/L-6938-2014; de Vera, Pablo/L-6674-2014; Garcia-Molina,
   Rafael/L-5679-2014
OI Abril, Isabel/0000-0001-9366-3484; de Vera, Pablo/0000-0002-5645-412X;
   Garcia-Molina, Rafael/0000-0001-8755-8709
FU Spanish Ministerio de Economia y Competitividad; European Regional
   Development Fund [FIS2010-17225]; European Union's FP7-People Program
   (Marie Curie Actions) within the Initial Training Network [608163];
   European COST Action [MP1002 NanoIBCT]
FX The authors recognize the financial support from the Spanish Ministerio
   de Economia y Competitividad and the European Regional Development Fund
   (Project No. FIS2010-17225). PdV acknowledges financial support from the
   European Union's FP7-People Program (Marie Curie Actions) within the
   Initial Training Network No. 608163 "ARGENT". Support from the European
   COST Action MP1002 NanoIBCT is gratefully acknowledged.
CR Abdoul-Carime H, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.168103
   Abril I, 2010, NUCL INSTRUM METH B, V268, P1763, DOI 10.1016/j.nimb.2010.02.069
   Agnihotri AN, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.032716
   Belkic D, 2013, ADV QUANTUM CHEM, V65, P1
   BELKIC D, 1978, J PHYS B-AT MOL OPT, V11, P3529, DOI 10.1088/0022-3700/11/20/015
   Belkic D., 2012, FAST ION ATOM ION MO
   Belkic D, 2010, J MATH CHEM, V47, P1366, DOI 10.1007/s10910-010-9662-x
   Boudaiffa B, 2000, SCIENCE, V287, P1658, DOI 10.1126/science.287.5458.1658
   Champion C, 2009, NUCL INSTRUM METH B, V267, P881, DOI 10.1016/j.nimb.2009.02.040
   CROTHERS DSF, 1983, J PHYS B-AT MOL OPT, V16, P3229, DOI 10.1088/0022-3700/16/17/015
   Cucinotta FA, 1996, ADV SPACE RES-SERIES, V18, P183, DOI 10.1016/0273-1177(96)00039-7
   Dal Cappello C, 2009, NUCL INSTRUM METH B, V267, P781, DOI 10.1016/j.nimb.2008.12.010
   de Vera P, 2013, J PHYS CONF SER, V438, DOI 10.1088/1742-6596/438/1/012015
   de Vera P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.148104
   Dingfelder M, 2002, RADIAT PROT DOSIM, V99, P23, DOI 10.1093/oxfordjournals.rpd.a006770
   Egerton R. F., 1989, ELECT ENERGY LOSS SP
   EMERSON LC, 1975, RADIAT RES, V63, P235, DOI 10.2307/3574149
   Galassi ME, 2012, PHYS MED BIOL, V57, P2081, DOI 10.1088/0031-9155/57/7/2081
   Garcia-Molina R, 2012, RAD DAMAGE BIOMOLECU
   Gobet F, 2001, PHYS REV LETT, V86, P3751, DOI 10.1103/PhysRevLett.86.3751
   Hayashi H, 2000, P NATL ACAD SCI USA, V97, P6264, DOI 10.1073/pnas.110572097
   Heredia-Avalos S, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.052902
   Iriki Y, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.032704
   Konig C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.018105
   Lindhard J., 1954, VIDENSK SELSK MAT FY, V28, P8
   Loeffler JS, 2013, NAT REV CLIN ONCOL, V10, P411, DOI 10.1038/nrclinonc.2013.79
   LONG KA, 1991, J CHEM PHYS, V95, P1049, DOI 10.1063/1.461132
   MERMIN ND, 1970, PHYS REV B-SOLID ST, V1, P2362, DOI 10.1103/PhysRevB.1.2362
   Nandi S, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.052710
   Nikjoo H, 1998, INT J RADIAT BIOL, V73, P355, DOI 10.1080/095530098142176
   Nikjoo H., 2012, INTERACTION RAD MATT
   Olivera GH, 1996, PHYS MED BIOL, V41, P1633, DOI 10.1088/0031-9155/41/9/005
   RITCHIE RH, 1957, PHYS REV, V106, P874, DOI 10.1103/PhysRev.106.874
   RITCHIE RH, 1977, PHILOS MAG, V36, P463, DOI 10.1080/14786437708244948
   Rudd M.E., 1996, SECONDARY ELECT SPEC
   RUDD ME, 1992, REV MOD PHYS, V64, P441, DOI 10.1103/RevModPhys.64.441
   SALIN A, 1969, J PHYS PT B ATOM M P, V2, P631, DOI 10.1088/0022-3700/2/6/301
   Salvat F., 2011, PENELOPE 2011 CODE S
   Schardt D, 2010, REV MOD PHYS, V82, P383, DOI 10.1103/RevModPhys.82.383
   SCHOLZ M, 1996, ADV SPACE RES-SERIES, V18, P5, DOI 10.1016/0273-1177(95)00784-C
   SENGER B, 1984, NUCL INSTRUM METH B, V2, P204, DOI 10.1016/0168-583X(84)90190-3
   Solov'yov AV, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.011909
   Surdutovich E, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051918
   Tan ZY, 2004, NUCL INSTRUM METH B, V222, P27, DOI 10.1016/j.nimb.2004.02.017
   VRIENS L, 1967, P PHYS SOC LOND, V90, P935, DOI 10.1088/0370-1328/90/4/307
NR 45
TC 17
Z9 17
U1 2
U2 13
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 0031-9007
EI 1079-7114
J9 PHYS REV LETT
JI Phys. Rev. Lett.
PD JAN 5
PY 2015
VL 114
IS 1
AR 018101
DI 10.1103/PhysRevLett.114.018101
PG 5
WC Physics, Multidisciplinary
SC Physics
GA AZ0HI
UT WOS:000347926300003
PM 25615504
OA Green Published
DA 2018-10-19
ER

PT J
AU Sugiura, Y
   Onuma, K
   Yamazaki, A
AF Sugiura, Yuki
   Onuma, Kazuo
   Yamazaki, Atsushi
TI Solution Chemical Synthesis of Hollow Vaterite Particles for Advanced
   Biomaterial Applications
SO CHEMISTRY LETTERS
LA English
DT Article
ID AMORPHOUS CALCIUM-CARBONATE; PHOSPHATE IONS; BIOMINERALIZATION;
   TRANSFORMATION; ARAGONITE; GROWTH
AB In this work, we develop a new simple synthesis method of hollow polycrystalline monophase vaterite particles without impurities such as calcite and toxic buffer (tris(hydroxylmethyl)-aminomethane: Tris). Starting materials consist of CaCl2, NaHCO3, NaCl, and a flavin mononucleotide, a vitamin B-2 derivative. The resulting vaterite particles showed a spherical shell of 2-5 mu m surrounding a 50-500 nm diameter cavity. The shells comprised 10-100 nm wide elongated fibrous crystals, which were tightly packed and radially elongated from the center of a vaterite sphere.
C1 [Sugiura, Yuki; Yamazaki, Atsushi] Waseda Univ, Sch Creat Sci & Engn, Shinjuku Ku, Tokyo 1860049, Japan.
   [Sugiura, Yuki; Onuma, Kazuo] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan.
RP Sugiura, Y (reprint author), Waseda Univ, Sch Creat Sci & Engn, Shinjuku Ku, 3-1-4 Okubo, Tokyo 1860049, Japan.
EM ya81349@waseda.jp
RI Sugiura, Yuki/L-6895-2018
OI Sugiura, Yuki/0000-0003-1472-5435
FU material characterization central laboratory (MCCL), Waseda University;
   Japan Society for the Promotion of Science; Ministry of Education,
   Culture, Sports, Science and Technology of Japan [25-2283]
FX We thank Dr. A. Oyane and Dr. K. Yoshinaka for their helpful advice. Dr.
   A. Ito helped us for XRD measurement; Mr. N. Sugimura helped us for
   FT-LR measurement. This study was supported by material characterization
   central laboratory (MCCL), Waseda University and a Grant-in-Aid of
   Research for Doctoral Course Students (DC2) from the Japan Society for
   the Promotion of Science, Ministry of Education, Culture, Sports,
   Science and Technology of Japan (Grant number 25-2283).
CR ANDERSEN FA, 1991, ACTA CHEM SCAND, V45, P1018, DOI 10.3891/acta.chem.scand.45-1018
   Beck R, 2012, CRYST RES TECHNOL, V47, P404, DOI 10.1002/crat.201100599
   Bentov S, 2010, J STRUCT BIOL, V171, P207, DOI 10.1016/j.jsb.2010.04.007
   BRECEVIC L, 1989, J CRYST GROWTH, V98, P504, DOI 10.1016/0022-0248(89)90168-1
   Colfen H., 2008, MESOCRYSTALS NONCLAS, DOI [10.1002/9780470994603., DOI 10.1002/9780470994603]
   Deer W. A., 1992, INTRO ROCK FORMING M
   Gago-Duport L, 2008, J STRUCT BIOL, V162, P422, DOI 10.1016/j.jsb.2008.02.007
   Karampas IA, 2013, VIB SPECTROSC, V64, P126, DOI 10.1016/j.vibspec.2012.11.003
   Kasuga T, 2003, BIOMATERIALS, V24, P3247, DOI 10.1016/S0142-9612(03)00190-X
   Katsifaras A, 1999, J CRYST GROWTH, V204, P183, DOI 10.1016/S0022-0248(99)00174-8
   Kuther J, 1998, J MATER CHEM, V8, P641, DOI 10.1039/a705859d
   Mann S., 2001, BIOMINERALIZATION PR
   Nakamura J, 2014, J MATER CHEM B, V2, P1250, DOI 10.1039/c3tb21571g
   PLUMMER LN, 1982, GEOCHIM COSMOCHIM AC, V46, P1011, DOI 10.1016/0016-7037(82)90056-4
   Rodriguez-Blanco JD, 2011, NANOSCALE, V3, P265, DOI 10.1039/c0nr00589d
   Sato A, 2011, NAT CHEM BIOL, V7, P197, DOI 10.1038/NCHEMBIO.532
   Sugiura Y, 2014, J CERAM SOC JPN, V122, P679, DOI 10.2109/jcersj2.122.679
   Sugiura Y, 2013, AM MINERAL, V98, P262, DOI 10.2138/am.2013.4212
   Sunagawa I., 2005, CRYSTALS GROWTH MORP
   Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001
   Xu AW, 2006, ADV FUNCT MATER, V16, P903, DOI 10.1002/adfm.200500716
NR 21
TC 3
Z9 3
U1 3
U2 40
PU CHEMICAL SOC JAPAN
PI TOKYO
PA 1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN
SN 0366-7022
EI 1348-0715
J9 CHEM LETT
JI Chem. Lett.
PD JAN 5
PY 2015
VL 44
IS 1
BP 20
EP 22
DI 10.1246/cl.140823
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA AY2SC
UT WOS:000347438400004
DA 2018-10-19
ER

PT J
AU Schwitalla, AD
   Abou-Emara, M
   Spintig, T
   Lackmann, J
   Muller, WD
AF Schwitalla, A. D.
   Abou-Emara, M.
   Spintig, T.
   Lackmann, J.
   Mueller, W. D.
TI Finite element analysis of the biomechanical effects of PEEK dental
   implants on the peri-implant bone
SO JOURNAL OF BIOMECHANICS
LA English
DT Article
DE Finite element analysis; Platform-switched dental implant; PEEK;
   Titanium; Endolign
ID STRESS-DISTRIBUTION; LOADING CONDITIONS; REPLACEMENT; PARAMETERS;
   DENTISTRY; DESIGN; FORCE; MODEL
AB Dental implants are mostly fabricated of titanium. Potential problems associated with these implants are discussed in the literature, for example, overloading of the jawbone during mastication due to the significant difference in the elastic moduli of titanium (110 GPa) and bone (approximate to 1-30 GPa). Therefore polyether-ether-ketone (PEEK) could represent an alternative biomaterial (elastic modulus 3-4 GPa). Endolign (R) represents an implantable carbon fiber reinforced (CFR)-PEEK including parallel oriented endless carbon fibers. According to the manufacturer it has an elastic modulus of 150 GPa. PEEK compounds filled with powders show an elastic modulus around 4 GPa.
   The aim of the present finite element analysis was to point out the differences in the biomechanical behavior of a dental implant of Endoligne (R) and a commercial powder-filled PEEK. Titanium served as control.
   These three materials were used for a platform-switched dental implant-abutment assembly, whereas Type 1 completely consisted of titanium, Type 2 of a powder-filled PEEK and Type 3 of Endolign (R). A force of 100 N was applied vertically and of 30 degrees to the implant axis.
   All types showed a minimum safety factor regarding the yield strength of cortical bone. However, within the limits of this study the Type 2 implant showed higher stresses within the adjacent cortical bone than Type 1 and Type 3. These implant assemblies showed similar stress distributions. Endless carbon fibers give PEEK a high stability.
   Further investigations are necessary to evaluate whether there is a distinct amount of endless carbon fibers causing an optimal stress distribution behavior of CFR-PEEK. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Schwitalla, A. D.; Spintig, T.; Mueller, W. D.] Charite, Sch Dent, Dept Dent Mat & Biomat Res, D-14197 Berlin, Germany.
   [Abou-Emara, M.; Lackmann, J.] Beuth Univ Appl Sci, Berlin, Germany.
RP Muller, WD (reprint author), Charite, Sch Dent, Dept Dent Mat & Biomat Res, Assmannshauser Str 4-6, D-14197 Berlin, Germany.
EM wolf-dieter.mueller@charite.de
FU Central Innovation Programme for SMEs (ZIM) of the German Federal
   Ministry for Economic Affairs and Energy; AiF Projekt GmbH, Berlin
   [ZIM-2863301KJ1]
FX This work was supported by the Central Innovation Programme for SMEs
   (ZIM) of the German Federal Ministry for Economic Affairs and Energy
   (Project management agency: AiF Projekt GmbH, Berlin; grant number
   ZIM-2863301KJ1).
CR Barbero E.J, 2008, FINITE ELEMENT ANAL
   BORCHERS L, 1983, J DENT RES, V62, P155, DOI 10.1177/00220345830620021401
   Colling EW, 1984, PHYS METALLURGY TITA
   Cook S D, 1995, J Oral Implantol, V21, P176
   COOK SD, 1982, J DENT RES, V61, P1006, DOI 10.1177/00220345820610080201
   Corvelli AA, 1997, J ADV MATER, V28, P2
   Cowin SC, 1989, BONE MECH, P97
   Demenko V, 2011, J DENT RES, V90, P1211, DOI 10.1177/0022034511417442
   Gomes SGF, 2011, BRAZ ORAL RES, V25, P446, DOI 10.1590/S1806-83242011000500012
   Geng JP, 2001, J PROSTHET DENT, V85, P585, DOI 10.1067/mpr.2001.115251
   Guan H, 2010, INT J ORAL MAX IMPL, V25, P461
   Helgason B, 2008, CLIN BIOMECH, V23, P135, DOI 10.1016/j.clinbiomech.2007.08.024
   Kelsey DJ, 1997, J COMPOS MATER, V31, P1593, DOI 10.1177/002199839703101603
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Lewinstein I, 1995, Int J Oral Maxillofac Implants, V10, P355
   LIAO K, 1994, EXP TECHNIQUES, V18, P33
   MAHARAJ GR, 1993, AM SOC TEST MATER, V1178, P98, DOI 10.1520/STP15546S
   Mehrali M, 2013, J BIOMED MATER RES A, V101, P3046, DOI 10.1002/jbm.a.34588
   Meijer HJA, 1996, J ORAL REHABIL, V23, P757, DOI 10.1046/j.1365-2842.1996.d01-185.x
   Payne E.V., 1961, NEW TECHNOL B, V1, P36
   Rieg F., 2006, HDB MACHINE DESIGN
   Sarot JR, 2010, J MATER SCI-MATER M, V21, P2079, DOI 10.1007/s10856-010-4084-7
   Schwartz-Dabney CL, 2003, AM J PHYS ANTHROPOL, V120, P252, DOI 10.1002/ajpa.10121
   Van Staden R. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P257, DOI 10.1080/10255840600837074
   WEINSTEIN AM, 1979, BIOMATER ARTIF CELL, V7, P169, DOI 10.3109/10731197909119384
   WIDERA GEO, 1976, J BIOMED MATER RES, V10, P613, DOI 10.1002/jbm.820100418
   Winter W, 2013, J ORAL IMPLANTOL, V39, P23, DOI 10.1563/AAID-JOI-D-11-00221
NR 27
TC 11
Z9 11
U1 4
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
EI 1873-2380
J9 J BIOMECH
JI J. Biomech.
PD JAN 2
PY 2015
VL 48
IS 1
BP 1
EP 7
DI 10.1016/j.jbiomech.2014.11.017
PG 7
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA AZ6NL
UT WOS:000348336200001
PM 25435385
DA 2018-10-19
ER

PT J
AU Leigh, DR
   Kim, MS
   Kovacevic, D
   Baker, AR
   Tan, CD
   Calabro, A
   Derwin, KA
AF Leigh, Diane R.
   Kim, Myung-Sun
   Kovacevic, David
   Baker, Andrew R.
   Tan, Carmela D.
   Calabro, Anthony
   Derwin, Kathleen A.
TI Human fascia lata ECM scaffold augmented with immobilized hyaluronan:
   inflammatory response and remodeling in the canine body wall and
   shoulder implantation sites
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE polarized light microscopy; animal model; graft remodeling; biologic
   graft; tyramine-substituted hyaluronan
ID ROTATOR CUFF REPAIR; EXTRACELLULAR-MATRIX; COMPOSITIONAL PROPERTIES;
   MACROPHAGE PHENOTYPE; ARTICULAR-CARTILAGE; TENDON
AB We postulate that immobilization of tyramine-substituted hyaluronan (THA) into an extracellular matrix (ECM) scaffold may be a strategy to promote an anti-inflammatory response to the ECM. Further, we posit that the implantation site could influence the inflammatory response and remodeling of an ECM scaffold. Eight beagles underwent implantation of fascia ECM grafts, treated with either immobilized low molecular weight (57kDa) THA or water only, in both the shoulder injury and body wall sites. Dogs were euthanized at 12weeks and fascia grafts harvested en bloc for histology. Grafts implanted at the body wall had significantly higher inflammatory cell infiltrate and vascularity, and significantly lower retardance (collagen density), than grafts at the shoulder, suggestive of a more intense, persistent, and perhaps degradative inflammatory and remodeling response at the body wall than shoulder injury site in the canine model. However, the presence of immobilized low MW THA had no effect on the inflammation response or remodeling of fascia ECM compared to water-treated controls. Importantly, these results suggest that the inflammatory response and remodeling of biomaterial implants depends on the location of implantation and therefore our animal models need to be carefully chosen. Further, the potential anti-inflammatory advantages of hyaluronan (HA) in wound healing do not appear to be realized when presenting it to the host as non-degradable hydrogel even if its capacity for binding HA binding protein is maintained. Further study treating ECM with uncross-linked (free) HA or immobilized low MW THA as a means to deliver free HA or other biomolecules to a surgical repair site is warranted.
C1 [Leigh, Diane R.; Baker, Andrew R.; Calabro, Anthony; Derwin, Kathleen A.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA.
   [Leigh, Diane R.; Baker, Andrew R.; Calabro, Anthony; Derwin, Kathleen A.] Cleveland Clin, Orthopaed Res Ctr, Cleveland, OH 44195 USA.
   [Kim, Myung-Sun] Chonnam Natl Univ, Coll Med, Dept Orthopaed Surg, Kwangju, South Korea.
   [Kovacevic, David] Cleveland Clin, Dept Orthopaed Surg, Cleveland, OH 44195 USA.
   [Tan, Carmela D.] Cleveland Clin, Dept Anat Pathol, Cleveland, OH 44195 USA.
RP Derwin, KA (reprint author), Cleveland Clin, Dept Biomed Engn, ND 20,9500 Euclid Ave, Cleveland, OH 44195 USA.
EM derwink@ccf.org
OI Kovacevic, David/0000-0002-1900-5181
FU National Institutes of Health [AR056633]
FX This work was supported by The National Institutes of Health [AR056633].
CR Alhadlaq HA, 2007, CONNECT TISSUE RES, V48, P76, DOI 10.1080/03008200601130950
   Allemann M, 2001, J BIOMED MATER RES, V55, P13
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Bedi Asheesh, 2009, HSS J, V5, P51, DOI 10.1007/s11420-008-9096-1
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Chin LK, 2011, J MATER SCI-MATER M, V22, P1465, DOI 10.1007/s10856-011-4325-4
   Cook JL, 2008, AM J VET RES, V69, P148, DOI 10.2460/ajvr.69.1.148
   Darr A, 2009, J MATER SCI-MATER M, V20, P33, DOI 10.1007/s10856-008-3540-0
   Derwin KA, 2008, J BIOMED MATER RES A, V84A, P500, DOI 10.1002/jbm.a.31455
   Derwin KA, 2009, J BONE JOINT SURG AM, V91A, P1159, DOI 10.2106/JBJS.H.00775
   Hodde J, 2006, ANZ J SURG, V76, P1096, DOI 10.1111/j.1445-2197.2006.03948.x
   Hu M, 2003, J BIOMED MATER RES B, V67B, P586, DOI 10.1002/jbm.b.20001
   Malcarney HL, 2005, AM J SPORT MED, V33, P907, DOI 10.1177/0363546504271500
   Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6
   Raub CB, 2013, OSTEOARTHR CARTILAGE, V21, P860, DOI 10.1016/j.joca.2013.03.014
   Ricchetti ET, 2012, J SHOULDER ELB SURG, V21, P251, DOI 10.1016/j.jse.2011.10.003
   Schimizzi Aimee L, 2006, Spine J, V6, P550, DOI 10.1016/j.spinee.2005.12.005
   Shu XZ, 2006, J BIOMED MATER RES A, V79A, P902, DOI 10.1002/jbm.a.30831
   Snyder SJ, 2009, ARTHROSCOPY, V25, P329, DOI 10.1016/j.arthro.2008.05.023
   Thomopoulos S, 2003, J BIOMECH ENG-T ASME, V125, P106, DOI 10.1115/1.1536660
   Thomopoulos S, 2003, J ORTHOPAED RES, V21, P413, DOI 10.1016/S0736-0266(03)00057-3
   Thomopoulos S, 2011, TISSUE ENG PT A, V17, P1039, DOI [10.1089/ten.tea.2009.0499, 10.1089/ten.TEA.2009.0499]
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Van Kampen Craig, 2013, Muscles Ligaments Tendons J, V3, P229
   Whitlock PW, 2007, BIOMATERIALS, V28, P4321, DOI 10.1016/j.biomaterials.2007.05.029
   Yagi M, 2010, J HAND SURG-AM, V35A, P791, DOI 10.1016/j.jhsa.2010.02.010
   Yasuda T, 2010, TOHOKU J EXP MED, V220, P229, DOI 10.1620/tjem.220.229
NR 27
TC 0
Z9 0
U1 1
U2 27
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD JAN 2
PY 2015
VL 26
IS 1
BP 1
EP 15
DI 10.1080/09205063.2014.975394
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA AU1KM
UT WOS:000345379600001
PM 25400204
DA 2018-10-19
ER

PT J
AU Lim, JI
   Im, H
   Lee, WK
AF Lim, Jin Ik
   Im, Heejung
   Lee, Woo-Kul
TI Fabrication of porous chitosan-polyvinyl pyrrolidone scaffolds from a
   quaternary system via phase separation
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE minute pore; chitosan-PVP; quaternary system; tissue engineering; porous
   scaffold
ID POLY(VINYLPYRROLIDONE)/POLY(ACRYLIC ACID) FILM; TISSUE ENGINEERING
   APPLICATIONS; BIOMATERIAL SCAFFOLDS; DESIGN; POLYMERS; GROWTH;
   REGENERATION; FIBROBLAST; CELLS
AB Three-dimensional porous chitosan-polyvinyl pyrrolidone (PVP) scaffolds were fabricated for tissue engineering applications via liquid-liquid or liquid-solid phase separation. A mixture of an acidic aqueous solution with butanol as a non-solvent and a chitosan-PVP quaternary system were freeze-dried. We then studied the homogenous open pore structure and the minute pore distribution in order to improve the mass transfer and cell seeding efficiency while also obtaining the optimal ratio of PVP to provide high interconnectivity and to improve the open-pore structure. The properties of the porous chitosan-PVP scaffolds - including the microstructure, chemical release, water absorption properties, and cell proliferation tests were studied - and the results were compared against those obtained from conventional scaffolds. chitosan-PVP scaffolds with a porosity of over 70% were obtained, and the pore morphology on the surface and within the porous scaffolds showed the presence of homogenous open pores with excellent interconnectivity. As the PVP content increased, main pores (50-100 mu m) and minute pores (4-10 mu m) could be clearly observed. Also, the porous scaffold showed an improved efficiency for cell adhesion after the cells were cultured for 4h. After 72h, the cultured cells presented an increase in the cell proliferation and on the porous scaffolds. These results strongly suggest that the porous chitosan-PVP scaffolds can be widely used in tissue engineering, including for biopatches and artificial skin applications.
C1 [Lim, Jin Ik; Im, Heejung; Lee, Woo-Kul] Dankook Univ, Inst Tissue Regenerat Engn, Dept Chem Engn, Lab Biointerfaces Tissue Engn,Coll Engn, Yongin, Gyeonggi Do, South Korea.
RP Lee, WK (reprint author), Dankook Univ, Inst Tissue Regenerat Engn, Dept Chem Engn, Lab Biointerfaces Tissue Engn,Coll Engn, Yongin, Gyeonggi Do, South Korea.
EM leewo@dankook.ac.kr
CR Baldino L, 2014, J SUPERCRIT FLUID, V90, P27, DOI 10.1016/j.supflu.2014.03.002
   Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031
   Cao YG, 2011, COLLOID SURFACE A, V392, P83, DOI 10.1016/j.colsurfa.2011.09.037
   Choong C, 2009, REACT FUNCT POLYM, V69, P77, DOI 10.1016/j.reactfunctpolym.2008.11.003
   COHEN S, 1993, CLIN MATER, V13, P3, DOI 10.1016/0267-6605(93)90082-I
   Domingos M, 2013, ACTA BIOMATER, V9, P5997, DOI 10.1016/j.actbio.2012.12.031
   Dorati R, 2014, MAT SCI ENG C-MATER, V34, P130, DOI 10.1016/j.msec.2013.08.037
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Jana S, 2014, ACTA BIOMATER, V10, P2877, DOI 10.1016/j.actbio.2014.03.014
   Ji CD, 2013, MAT SCI ENG C-MATER, V33, P3780, DOI 10.1016/j.msec.2013.05.010
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kellomaki M, 2000, BIOMATERIALS, V21, P2495, DOI 10.1016/S0142-9612(00)00117-4
   Kim MS, 2012, CARBOHYD POLYM, V87, P2683, DOI 10.1016/j.carbpol.2011.11.060
   Lee LY, 2009, EUR POLYM J, V45, P3247, DOI 10.1016/j.eurpolymj.2009.07.016
   Li J, 2010, CARBOHYD POLYM, V79, P786, DOI 10.1016/j.carbpol.2009.09.028
   Lim JI, 2013, COLLOID SURFACE B, V103, P463, DOI 10.1016/j.colsurfb.2012.11.016
   Lim JI, 2007, KEY ENG MATER, V342-343, P65, DOI 10.4028/www.scientific.net/KEM.342-343.65
   Lu Q, 2009, MAT SCI ENG C-MATER, V29, P2239, DOI 10.1016/j.msec.2009.05.014
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Ma ZW, 2002, EUR POLYM J, V38, P2279, DOI 10.1016/S0014-3057(02)00119-2
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mehdizadeh H, 2013, BIOMATERIALS, V34, P2875, DOI 10.1016/j.biomaterials.2012.12.047
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mou ZL, 2011, J SUPERCRIT FLUID, V58, P398, DOI 10.1016/j.supflu.2011.07.003
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Serrano MC, 2014, PROG POLYM SCI, V39, P1448, DOI 10.1016/j.progpolymsci.2014.02.004
   Shirosaki Y, 2008, CHEM ENG J, V137, P122, DOI 10.1016/j.cej.2007.10.012
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Wu SL, 2014, MAT SCI ENG R, V80, P1, DOI 10.1016/j.mser.2014.04.001
   Yao CK, 2012, APPL SURF SCI, V262, P218, DOI 10.1016/j.apsusc.2012.05.128
   Yuan Q, 2014, COLLOID SURFACE A, V456, P153, DOI 10.1016/j.colsurfa.2014.05.030
NR 31
TC 6
Z9 6
U1 1
U2 37
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD JAN 2
PY 2015
VL 26
IS 1
BP 32
EP 41
DI 10.1080/09205063.2014.979386
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA AU1KM
UT WOS:000345379600003
PM 25410721
DA 2018-10-19
ER

PT B
AU Djordjevic, N
AF Djordjevic, Nina
BE Ristic, G
TI ANTIBIOTIC-LOADED HYDROXIAPATITE AND CALCIUM SULPHATE COMPOSITE IS A
   POTENT BIOMATERIAL FOR ONE STAGE TREATMENT OF THE EXTENSIVE INFECTED
   BONE DEFECT
SO RAD 2015: THE THIRD INTERNATIONAL CONFERENCE ON RADIATION AND
   APPLICATIONS IN VARIOUS FIELDS OF RESEARCH
LA English
DT Proceedings Paper
CT 3rd International Conference on Radiation and Applications in Various
   Fields of Research (RAD)
CY JUN 08-12, 2015
CL Budva, MONTENEGRO
DE Chronic osteomyelitis; Septic bone defect; PerOssal; One stage surgery
ID GENTAMICIN-PMMA-BEADS; CHRONIC OSTEOMYELITIS; SUBSTITUTES
AB Antibiotic-loaded hydroxyapatite and calcium sulphate (PerOssal, aap Bioniaterials GmbH, Dieburg, Germany) compound is completely absorbable biomaterial able to deliver high concentration of an active antimicrobial agent directly to the site of infection.
   Paper is presenting one stage surgery of the extensive infected bone defect. During the operation segestrectomy left a large bone defect which was filled with the PerOssal pellets soaked in the high concetrated antibiotic of choice. This patient is a good example of the efficient way to treat extensive septic bone defect with local administration of very high concentration of specific antibiotic. High concentration is achieved due to the technological characteristics of PerOssal pellets. This and the fact that the PerOssal is completely absorbable made this biomaterial a very potent weapon against the most resistant infections and even in one stage surgery. The osteoinductive and osteoconductive effects of PerOssal are additional contribution when the extensive bone defect is in case.
C1 [Djordjevic, Nina] Univ Nis, Sch Med, Nish, Serbia.
   [Djordjevic, Nina] Clin Ctr Nis, Univ Clin Orthopaed Surg & Traumatol, Nish, Serbia.
RP Djordjevic, N (reprint author), Univ Nis, Sch Med, Nish, Serbia.
CR Anagnostakos K, 2008, ACTA ORTHOP, V79, P302, DOI 10.1080/17453670710015120
   DACQUET V, 1992, CLIN ORTHOP RELAT R, P241
   Drakou A, 2011, J BONE JOINT SURG BR, V93, P323
   Geurts J, 2011, INJURY, V42, pS82, DOI 10.1016/j.injury.2011.06.189
   KLEMM K, 1979, ZBL CHIR, V104, P934
   Kraus R, 2010, SEPTIC BONE JOINT SU, P126
   Lee Gregory H, 2002, Iowa Orthop J, V22, P35
   MAJID SA, 1985, ACTA ORTHOP SCAND, V56, P265, DOI 10.3109/17453678508993010
   McKee MD, 2002, J ORTHOP TRAUMA, V16, P622, DOI 10.1097/01.BOT.0000031145.58425.82
   PELTIER LF, 1959, AM J SURG, V97, P311, DOI 10.1016/0002-9610(59)90305-8
   Rauschmann MA, 2005, BIOMATERIALS, V26, P2677, DOI 10.1016/j.biomaterials.2004.06.045
   Robinson D, 1999, Ann Transplant, V4, P91
   Romano CL, 2014, BONE JOINT J, V96B, P845, DOI 10.1302/0301-620X.96B6.33014
   VECSEI V, 1981, CLIN ORTHOP RELAT R, P201
   Zalavras CG, 2004, CLIN ORTHOP RELAT R, P86, DOI 10.1097/01.blo.0000143571.18892.8d
NR 15
TC 0
Z9 0
U1 0
U2 1
PU RAD ASSOC
PI `
PA BULEVAR NIKOLE TESLE 17-12, `, 18000, SERBIA
BN 978-86-80300-01-6
PY 2015
BP 483
EP 486
PG 4
WC Nuclear Science & Technology; Physics, Applied; Radiology, Nuclear
   Medicine & Medical Imaging
SC Nuclear Science & Technology; Physics; Radiology, Nuclear Medicine &
   Medical Imaging
GA BG3KU
UT WOS:000387979700101
DA 2018-10-19
ER

PT S
AU Park, S
   Kim, S
   Choi, J
AF Park, Sanghoon
   Kim, Seongjun
   Choi, Jaesoon
GP IEEE
TI Development of a Multi-nozzle Bioprinting System for 3D Tissue Structure
   Fabrication
SO 2015 15TH INTERNATIONAL CONFERENCE ON CONTROL, AUTOMATION AND SYSTEMS
   (ICCAS)
SE International Conference on Control Automation and Systems
LA English
DT Proceedings Paper
CT 15th International Conference on Control, Automation and Systems (ICCAS)
CY OCT 13-16, 2015
CL Busan, SOUTH KOREA
SP Busan Tourism Org, Korea Tourism Org, Koh Young Technol Inc, Chonnam Natl Univ, Robot Res Initiat, SNU, Bio Mimet Robot Res Ctr, Samsung Heavy Ind Co Ltd, LS Ind Syst Co Ltd, RS Automat, Dongil SHIMADZI Corp
DE Bioprinting; Multi-nozzle; 3D structure
ID CELL-LADEN; HYDROGEL
AB The aim of this study was to develop a multi-nozzle based bioprinting system for fabrication of three-dimensional (3D) biological structure. In this study, a thermoplastic biomaterial that has relatively high mechanical stability, polycaprolactone (PCL), was used to make the 3D structure. A multi-nozzle bioprinting system was designed to dispense thermoplastic biomaterial and hydrogel simultaneously. The system consists of three axes of x-y-z motion control stage and I-axis actuator for change of nozzle. The controllability of the printed line width was tested as a representative performance index.
C1 [Park, Sanghoon; Kim, Seongjun; Choi, Jaesoon] Asan Med Ctr, Asan Inst Life Sci, Biomed Engn Res Ctr, Seoul 138736, South Korea.
   Univ Ulsan, Coll Med, Ulsan 680749, South Korea.
RP Choi, J (reprint author), Asan Med Ctr, Asan Inst Life Sci, Biomed Engn Res Ctr, Seoul 138736, South Korea.
EM dieuaimer@gmail.com; jaesoon@gmail.com
CR Censi R, 2011, ADV FUNCT MATER, V21, P1833, DOI 10.1002/adfm.201002428
   Fedorovich NE, 2008, TISSUE ENG PT A, V14, P127, DOI 10.1089/ten.a.2007.0158
   Fedorovich NE, 2012, TISSUE ENG PART C-ME, V18, P33, DOI [10.1089/ten.tec.2011.0060, 10.1089/ten.TEC.2011.0060]
   Fedorovich NE, 2009, BIOMACROMOLECULES, V10, P1689, DOI 10.1021/bm801463q
   Shim J. H., 2012, J MICROMECH MICROENG, V22, P1
   Song SJ, 2011, ARTIF ORGANS, V35, P1132, DOI 10.1111/j.1525-1594.2011.01377.x
NR 6
TC 2
Z9 2
U1 1
U2 7
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2093-7121
BN 978-8-9932-1509-0
J9 INT C CONTR AUTOMAT
PY 2015
BP 1874
EP 1877
PG 4
WC Automation & Control Systems; Engineering, Electrical & Electronic
SC Automation & Control Systems; Engineering
GA BF5MU
UT WOS:000382295200391
DA 2018-10-19
ER

PT B
AU Muller, R
   Zhou, M
   Liebert, T
   Dellith, A
   Dutz, S
   Borin, D
   Heinze, T
AF Mueller, R.
   Zhou, M.
   Liebert, T.
   Dellith, A.
   Dutz, S.
   Borin, D.
   Heinze, T.
GP IEEE
TI Bio-nano composite for remote melting
SO 2015 IEEE 15TH INTERNATIONAL CONFERENCE ON NANOTECHNOLOGY (IEEE-NANO)
LA English
DT Proceedings Paper
CT IEEE NANO 2015 15th INTERNATIONAL CONFERENCE ON NANOTECHNOLOGY
CY JUL 27-30, 2015
CL ROME, ITALY
SP Univ di Roma, SAPIENZA UNIV DI ROMA, IEEE, IEEE NANO, USN DEPT OF THE NAVY SCI & TECHNOL, ISTITUTO ITALIANO DI TECNOLOGIA, CAMBRIDGE UNIV PRESS, Centro Studi e Documentazione sulla Sensoristica, FEI, Nanoscale Horizons, UNIV NOTRE DAME
DE bio-nano composite; remote melting; magnetic field
ID PARTICLES
AB The fabrication of biocompatible composites, consisting of magnetite nanoparticles embedded into a matrix of meltable dextran ester is presented which can be softened under an induced alternating magnetic field and may allow in that way a magnetically controlled release application. This could be a suitable alternative for swellable hydrogel composites embedded with magnetic particles as remote controlled biomaterial. Furthermore a texturing of particles in the polymer matrix by a static magnetic field was investigated.
C1 [Mueller, R.; Dellith, A.] Leibniz Inst Photon Technol IPHT, D-07743 Jena, Germany.
   [Zhou, M.; Liebert, T.; Heinze, T.] Univ Jena, Inst Organ Chem & Macromol Chem, D-07743 Jena, Germany.
   [Dutz, S.] Tech Univ Ilmenau, Inst Biomed Engn & Informat, D-98693 Ilmenau, Germany.
   [Borin, D.] Tech Univ Dresden, Inst Fluid Mech, D-01062 Dresden, Germany.
RP Muller, R (reprint author), Leibniz Inst Photon Technol IPHT, D-07743 Jena, Germany.
RI Dutz, Silvio/E-3865-2010
CR Campbell SB, 2013, BIOMACROMOLECULES, V14, P644, DOI 10.1021/bm301703x
   Dutz S, 2012, J NANO ELECTRON PHYS, V4
   HENKEL O, 1964, PHYS STATUS SOLIDI, V7, P919, DOI 10.1002/pssb.19640070320
   Liebert T, 2011, BIOMACROMOLECULES, V12, P3107, DOI 10.1021/bm200841b
   Muller R, 2011, J MAGN MAGN MATER, V323, P1223, DOI 10.1016/j.jmmm.2010.11.010
   Mura S, 2013, NAT MATER, V12, P991, DOI [10.1038/NMAT3776, 10.1038/nmat3776]
   WOHLFARTH EP, 1958, J APPL PHYS, V29, P595, DOI 10.1063/1.1723232
NR 7
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4673-8155-0
PY 2015
BP 1
EP 4
PG 4
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BF3AF
UT WOS:000380515200111
DA 2018-10-19
ER

PT J
AU Agbay, A
   Edgar, JM
   Robinson, M
   Styan, T
   Wilson, K
   Schroll, J
   Ko, J
   Mohtaram, NK
   Jun, MBG
   Willerth, SM
AF Agbay, Andrew
   Edgar, John M.
   Robinson, Meghan
   Styan, Tara
   Wilson, Krista
   Schroll, Julian
   Ko, Junghyuk
   Mohtaram, Nima Khadem
   Jun, Martin Byung-Guk
   Willerth, Stephanie M.
TI Biomaterial Strategies for Delivering Stem Cells as a Treatment for
   Spinal Cord Injury
SO CELLS TISSUES ORGANS
LA English
DT Review
DE Hydrogels; Electrospinning; Neuroscience; Stem cells; Controlled release
ID PROMOTES FUNCTIONAL RECOVERY; ANTI-INHIBITORY MOLECULES; NEURAL
   PROGENITOR CELLS; FIBRIN SCAFFOLDS; NEURONAL DIFFERENTIATION;
   DRUG-DELIVERY; GROWTH-FACTOR; TISSUE; SURVIVAL; RELEASE
AB Ongoing clinical trials are evaluating the use of stem cells as a way to treat traumatic spinal cord injury (SCI). However, the inhibitory environment present in the injured spinal cord makes it challenging to achieve the survival of these cells along with desired differentiation into the appropriate phenotypes necessary to regain function. Transplanting stem cells along with an instructive biomaterial scaffold can increase cell survival and improve differentiation efficiency. This study reviews the literature discussing different types of instructive biomaterial scaffolds developed for transplanting stem cells into the injured spinal cord. We have chosen to focus specifically on biomaterial scaffolds that direct the differentiation of neural stem cells and pluripotent stem cells since they offer the most promise for producing the cell phenotypes that could restore function after SCI. In terms of biomaterial scaffolds, this article reviews the literature associated with using hydrogels made from natural biomaterials and electrospun scaffolds for differentiating stem cells into neural phenotypes. It then presents new data showing how these different types of scaffolds can be combined for neural tissue engineering applications and provides directions for future studies. (C) 2016 S. Karger AG, Basel
C1 [Agbay, Andrew; Willerth, Stephanie M.] Univ Victoria, Div Med Sci, Dept Neurosci, Victoria, BC, Canada.
   [Edgar, John M.; Robinson, Meghan; Styan, Tara; Wilson, Krista; Schroll, Julian; Willerth, Stephanie M.] Univ Victoria, Dept Biomed Engn, Victoria, BC, Canada.
   [Ko, Junghyuk; Jun, Martin Byung-Guk; Willerth, Stephanie M.] Univ Victoria, Dept Mech Engn, Victoria, BC, Canada.
   [Mohtaram, Nima Khadem] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada.
   [Willerth, Stephanie M.] Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada.
RP Willerth, SM (reprint author), Univ Victoria, Div Med Sci, Dept Mech Engn, POB 1700 STN CSC, Victoria, BC V8W 2Y2, Canada.
EM willerth@uvic.ca
CR Abbasi N, 2016, J BIOMED MATER RES A, V104, P155, DOI 10.1002/jbm.a.35551
   Assuncao-Silva R.C., 2015, STEM CELLS INT, V2015
   Ballios BG, 2015, STEM CELL REP, V4, P1031, DOI 10.1016/j.stemcr.2015.04.008
   Brown AC, 2014, ACTA BIOMATER, V10, P1502, DOI 10.1016/j.actbio.2013.09.008
   Bunge MB, 2001, NEUROSCIENTIST, V7, P325, DOI 10.1177/107385840100700409
   Cheung Vincent, 2015, Surg Neurol Int, V6, P142, DOI 10.4103/2152-7806.163452
   Chew SY, 2005, BIOMACROMOLECULES, V6, P2017, DOI 10.1021/bm0501149
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Fukushima Kazuyuki, 2008, J Med Dent Sci, V55, P71
   Greitz D, 2006, NEUROSURG REV, V29, P251, DOI 10.1007/s10143-006-0029-5
   Han SF, 2015, BIOMATERIALS, V41, P89, DOI 10.1016/j.biomaterials.2014.11.031
   Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127
   Hutmacher DW, 2011, CHEM-ASIAN J, V6, P44, DOI 10.1002/asia.201000436
   Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Kandel ER, 2013, PRINCIPLES NEURAL SC
   Kaneko A, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/1/015008
   Khaing ZZ, 2012, NEUROSCI LETT, V519, P103, DOI 10.1016/j.neulet.2012.02.027
   Ko J, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/6/065009
   Ko J, 2014, J BIOMAT SCI-POLYM E, V25, P1, DOI 10.1080/09205063.2013.830913
   Kolehmainen K, 2012, JOVE-J VIS EXP, V2012, pe3641
   Li XR, 2015, ADV HEALTHC MATER, V4, P1869, DOI 10.1002/adhm.201500271
   Liu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117709
   Low WC, 2015, DRUG DELIV TRANSL RE, V5, P89, DOI 10.1007/s13346-013-0131-5
   Lu P, 2014, JOVE-J VIS EXP, V89
   Lu P, 2014, NEURON, V83, P789, DOI 10.1016/j.neuron.2014.07.014
   Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020
   Mahairaki V, 2011, TISSUE ENG PT A, V17, P855, DOI [10.1089/ten.tea.2010.0377, 10.1089/ten.TEA.2010.0377]
   MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634
   McCreedy DA, 2014, BIOMATER SCI-UK, V2, P1672, DOI 10.1039/c4bm00106k
   Mohtaram NK, 2015, J MATER CHEM B, V3, P7974, DOI 10.1039/c5tb00871a
   Mohtaram NK, 2015, J BIOMED MATER RES A, V103, P2591, DOI 10.1002/jbm.a.35392
   Mohtaram NK, 2014, J BIOMATER TISS ENG, V4, P906, DOI 10.1166/jbt.2014.1223
   Mohtaram NK, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/022001
   Montgomery A, 2015, BIOMATER SCI-UK, V3, P401, DOI 10.1039/c4bm00299g
   Rajangam T, 2013, INT J NANOMED, V8, P3641, DOI 10.2147/IJN.S43945
   Raspa A, 2016, BIOTECHNOL BIOENG, V113, P253, DOI 10.1002/bit.25689
   Robinson M, 2015, BIOMARK INSIGHTS, V10, P61, DOI 10.4137/BMIMI.S20064
   Schaub NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136780
   Scott CT, 2014, STEM CELL TRANSL MED, V3, P1398, DOI 10.5966/sctm.2014-0147
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Silver J., 2014, COLD SPRING HARB PER, V7, DOI DOI 10.1101/CSHPERSPECT.A020602
   Sugai K, 2015, J NEUROSCI RES, V93, P1826, DOI 10.1002/jnr.23636
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tsukamoto A, 2013, STEM CELL RES THER, V4, DOI [10.1186/1757-6512-4-102, 10.1186/scrt313]
   Wang J, 2015, NEUROCHEM RES, V40, P98, DOI 10.1007/s11064-014-1470-4
   Wilems TS, 2015, ACTA BIOMATER, V28, P23, DOI 10.1016/j.actbio.2015.09.018
   Wilems TS, 2015, J CONTROL RELEASE, V213, P103, DOI 10.1016/j.jconrel.2015.06.031
   Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Willerth SM, 2008, STEM CELL RES, V1, P205, DOI 10.1016/j.scr.2008.05.006
   Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0
   Xie JW, 2009, ADV FUNCT MATER, V19, P2312, DOI 10.1002/adfm.200801904
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Yang F, 2004, J BIOMAT SCI-POLYM E, V15, P1483, DOI 10.1163/1568562042459733
   Yuan N, 2014, NEURAL REGEN RES, V9, P1014, DOI 10.4103/1673-5374.133160
   Zhang N, 2012, INDIAN J MED RES, V135, P287
   Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017
NR 64
TC 6
Z9 7
U1 2
U2 15
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
EI 1422-6421
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2015
VL 202
IS 1-2
BP 42
EP 51
DI 10.1159/000446474
PG 10
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA DX9OU
UT WOS:000384725800004
PM 27701166
DA 2018-10-19
ER

PT J
AU Russell, LN
   Lampe, KJ
AF Russell, Lauren N.
   Lampe, Kyle J.
TI Engineering Biomaterials to Influence Oligodendroglial Growth,
   Maturation, and Myelin Production
SO CELLS TISSUES ORGANS
LA English
DT Review
DE Oligodendrocytes; Neural stem cells; Differentiation; Biomaterials;
   Nerve regeneration
ID SPINAL-CORD-INJURY; NEURAL STEM-CELLS; TRAUMATIC BRAIN-INJURY;
   CENTRAL-NERVOUS-SYSTEM; PROMOTES FUNCTIONAL RECOVERY; PROGENITOR CELLS;
   MULTIPLE-SCLEROSIS; POLY(ETHYLENE GLYCOL); HYDROGEL SCAFFOLDS; NEURITE
   EXTENSION
AB Millions of people suffer from damage or disease to the nervous system that results in a loss of myelin, such as through a spinal cord injury or multiple sclerosis. Diminished myelin levels lead to further cell death in which unmyelinated neurons die. In the central nervous system, a loss of myelin is especially detrimental because of its poor ability to regenerate. Cell therapies such as stem or precursor cell injection have been investigated as stem cells are able to grow and differentiate into the damaged cells; however, stem cell injection alone has been unsuccessful in many areas of neural regeneration. Therefore, researchers have begun exploring combined therapies with biomaterials that promote cell growth and differentiation while localizing cells in the injured area. The regrowth of myelinating oligodendrocytes from neural stem cells through a biomaterials approach may prove to be a beneficial strategy following the onset of demyelination. This article reviews recent advancements in biomaterial strategies for the differentiation of neural stem cells into oligodendrocytes, and presents new data indicating appropriate properties for oligodendrocyte precursor cell growth. In some cases, an increase in oligodendrocyte differentiation alongside neurons is further highlighted for functional improvements where the biomaterial was then tested for increased myelination both in vitro and in vivo. (C) 2016 S. Karger AG, Basel
C1 [Russell, Lauren N.; Lampe, Kyle J.] Univ Virginia, Chem Engn, 102 Engineers Way, Charlottesville, VA 22904 USA.
RP Lampe, KJ (reprint author), Univ Virginia, Chem Engn, 102 Engineers Way, Charlottesville, VA 22904 USA.
EM lampe@virginia.edu
FU UVA Biotechnology Training Program; University of Virginia
FX This work was supported by the UVA Biotechnology Training Program
   (L.N.R.) and the University of Virginia. The authors thank the Gaultier
   lab at UVA for the generous gift of OPC lines.
CR Aboody K, 2011, NEURON, V70, P597, DOI 10.1016/j.neuron.2011.05.007
   Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]
   Aizawa Y, 2008, BIOMATERIALS, V29, P4676, DOI 10.1016/j.biomaterials.2008.08.018
   Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8
   Asmani MN, 2013, CELL BIOL INT, V37, P1340, DOI 10.1002/cbin.10171
   Aurand ER, 2012, NEUROSCI RES, V72, P199, DOI 10.1016/j.neures.2011.12.005
   Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059
   Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012
   Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106
   Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a
   Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Burns AJ, 2014, NAT REV GASTRO HEPAT, V11, P317, DOI 10.1038/nrgastro.2013.226
   Cao QL, 2002, J NEUROSCI RES, V68, P501, DOI 10.1002/jnr.10240
   Carenini S, 1998, GLIA, V22, P213, DOI 10.1002/(SICI)1098-1136(199803)22:3<213::AID-GLIA1>3.0.CO;2-6
   Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025
   Cholas RH, 2012, BIOMATERIALS, V33, P2050, DOI 10.1016/j.biomaterials.2011.11.028
   Cooke MJ, 2010, SOFT MATTER, V6, P4988, DOI 10.1039/c0sm00448k
   Diao HJ, 2015, J CONTROL RELEASE, V208, P85, DOI 10.1016/j.jconrel.2015.03.005
   Elias PZ, 2012, J NEUROSCI METH, V209, P199, DOI 10.1016/j.jneumeth.2012.06.003
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Gelain F, 2007, J NANOSCI NANOTECHNO, V7, P424, DOI 10.1166/jnn.2007.154
   Gingras M, 2008, GLIA, V56, P354, DOI 10.1002/glia.20617
   Goddard DR, 1999, J NEUROSCI RES, V57, P74, DOI 10.1002/(SICI)1097-4547(19990701)57:1<74::AID-JNR8>3.0.CO;2-O
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Hammang JP, 1997, EXP NEUROL, V147, P84, DOI 10.1006/exnr.1997.6592
   Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158
   Hsieh A, 2010, SOFT MATTER, V6, P2227, DOI 10.1039/b924349f
   Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Kandel E., 2000, PRINCIPLES NEURAL SC
   Karandikar NJ, 2002, J CLIN INVEST, V109, P641, DOI 10.1172/JCI200214380
   Ke Y, 2006, STEM CELLS, V24, P1011, DOI 10.1634/stemcells.2005-0249
   Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803
   Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096
   Lampe KJ, 2010, TISSUE ENG PT A, V16, P1857, DOI [10.1089/ten.tea.2009.0509, 10.1089/ten.TEA.2009.0509]
   Lampe KJ, 2013, ACTA BIOMATER, V9, P5590, DOI 10.1016/j.actbio.2012.10.033
   Lampe KJ, 2012, NEUROSCI LETT, V519, P138, DOI 10.1016/j.neulet.2012.01.042
   Lampe KJ, 2010, J BIOMED MATER RES A, V94A, P1162, DOI 10.1002/jbm.a.32787
   Lampe KJ, 2009, BIOTECHNOL BIOENG, V103, P1214, DOI 10.1002/bit.22352
   Lee S, 2013, NAT PROTOC, V8, P771, DOI 10.1038/nprot.2013.039
   Lee S, 2012, NAT METHODS, V9, P917, DOI 10.1038/nmeth.2105
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Li H, 2014, BIOMATERIALS, V35, P9049, DOI 10.1016/j.biomaterials.2014.07.038
   Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048824
   Li XW, 2013, FASEB J, V27, P1127, DOI 10.1096/fj.12-211151
   Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014
   Lodish H., 2000, MOL CELL BIOL, P154
   Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v
   Martin BC, 2008, J NEURAL ENG, V5, P221, DOI 10.1088/1741-2560/5/2/013
   McDonald JW, 2002, PROG BRAIN RES, V137, P299
   Mekhail M, 2012, PROG NEUROBIOL, V96, P322, DOI 10.1016/j.pneurobio.2012.01.008
   Morell P., 1999, BASIC NEUROCHEMISTRY
   Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]
   Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561
   Nakamura M, 2013, CELL RES, V23, P70, DOI 10.1038/cr.2012.171
   Nisbet DR, 2008, J BIOMED MATER RES B, V87B, P251, DOI 10.1002/jbm.b.31000
   Noble M, 2013, CELL STEM CELL, V12, P503, DOI 10.1016/j.stem.2013.04.021
   Paintlia AS, 2008, MOL PHARMACOL, V73, P1381, DOI 10.1124/mol.107.044230
   Pathan Shadab A, 2009, Recent Pat Drug Deliv Formul, V3, P71
   Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K
   Pittier R, 2005, J NEUROBIOL, V63, P1, DOI 10.1002/neu.20116
   Pohl HBF, 2011, J NEUROSCI, V31, P1069, DOI 10.1523/JNEUROSCI.5035-10.2011
   Rafalski VA, 2013, NAT CELL BIOL, V15, P614, DOI 10.1038/ncb2735
   Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1227/01.NEU.0000027826.68845.CF
   Sack I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023451
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501
   Shreiber DI, 2009, BIOMECH MODEL MECHAN, V8, P311, DOI 10.1007/s10237-008-0137-y
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Silva NA, 2010, TISSUE ENG PT A, V16, P45, DOI [10.1089/ten.tea.2008.0559, 10.1089/ten.TEA.2008.0559]
   Sindou MP, 2001, NEUROSURG QUART, V11, P45, DOI 10.1097/00013414-200103000-00006
   Soderquist RG, 2010, PHARM RES-DORDR, V27, P841, DOI 10.1007/s11095-010-0077-y
   Stabenfeldt SE, 2010, TISSUE ENG PT A, V16, P3747, DOI [10.1089/ten.tea.2009.0837, 10.1089/ten.TEA.2009.0837]
   Stabenfeldt SE, 2011, ACTA BIOMATER, V7, P4102, DOI 10.1016/j.actbio.2011.07.026
   Stabenfeldt SE, 2011, CURR STEM CELL RES T, V6, P208
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Syed YA, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E4
   Tam RY, 2012, J MATER CHEM, V22, P19402, DOI 10.1039/c2jm33680d
   Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027
   Thomas AM, 2014, INTEGR BIOL-UK, V6, P694, DOI 10.1039/c4ib00009a
   Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313
   van Lith R, 2014, BIOMATERIALS, V35, P8113, DOI 10.1016/j.biomaterials.2014.06.004
   Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001
   Wilkinson AE, 2014, J BIOMED MATER RES A, V102, P3419, DOI 10.1002/jbm.a.35001
   Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111
   Willerth SM, 2008, STEM CELL RES, V1, P205, DOI 10.1016/j.scr.2008.05.006
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   Woerly S, 2004, J NEUROSCI RES, V75, P262, DOI 10.1002/jnr.10774
   Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091
   Xiong Y, 2012, INT J NANOMED, V7, P1977, DOI 10.2147/IJN.S30706
   Yang N, 2013, NAT BIOTECHNOL, V31, P434, DOI 10.1038/nbt.2564
   Yla-Outinen L, 2014, J TISSUE ENG REGEN M, V8, P186, DOI 10.1002/term.1512
   Yu D, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E10
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071
   Zuchero JB, 2015, DEVELOPMENT, V142, P3805, DOI 10.1242/dev.129304
   Zustiak SP, 2013, BIOTECHNOL PROGR, V29, P1255, DOI 10.1002/btpr.1761
NR 102
TC 4
Z9 4
U1 3
U2 6
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
EI 1422-6421
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2015
VL 202
IS 1-2
BP 85
EP 101
DI 10.1159/000446645
PG 17
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA DX9OU
UT WOS:000384725800007
PM 27701172
DA 2018-10-19
ER

PT J
AU Johnson, CDL
   D'Amato, AR
   Gilbert, RJ
AF Johnson, Christopher D. L.
   D'Amato, Anthony R.
   Gilbert, Ryan J.
TI Electrospun Fibers for Drug Delivery after Spinal Cord Injury and the
   Effects of Drug Incorporation on Fiber Properties
SO CELLS TISSUES ORGANS
LA English
DT Article
DE Electrospun fibers; Drug incorporation; Riluzole; Neurotrophin-3; Spinal
   cord injury; Fiber characteristics; Alignment; Diameter
ID TEMPLATED AGAROSE SCAFFOLDS; ADULT SENSORY NEURONS; AXONAL REGENERATION;
   NERVOUS-SYSTEM; NANOFIBER SCAFFOLDS; NEUROTROPHIC FACTOR;
   CONTROLLED-RELEASE; NEURITE OUTGROWTH; POLYMER-SOLUTIONS; SHELL
   NANOFIBERS
AB There is currently no cure for individuals with spinal cord injury (SCI). While many promising approaches are being tested in clinical trials, the complexity of SCI limits several of these approaches from aiding complete functional recovery. Several different categories of biomaterials are investigated for their ability to guide axonal regeneration, to deliver proteins or small molecules locally, or to improve the viability of transplanted stem cells. The purpose of this study is to provide a brief overview of SCI, present the different categories of biomaterial scaffolds that direct and guide axonal regeneration, and then focus specifically on electrospun fiber guidance scaffolds. Much like other polymer guidance approaches, electrospun fibers can retain and deliver therapeutic drugs. The experimental section presents new data showing the incorporation of two therapeutic drugs into electrospun poly- L- lactic acid fibers. Two different concentrations of either riluzole or neurotrophin- 3 were loaded into the electrospun fibers to examine the effect of drug concentration on the physical characteristics of the fibers (fiber alignment and fiber diameter). Overall, the drugs were successfully incorporated into the fibers and the release was related to the loading concentration. The fiber diameter decreased with the inclusion of the drug, and the decreased diameter was correlated with a decrease in fiber alignment. Subsequently, the study includes considerations for successful incorporation of a therapeutic drug without changing the physical properties of the fibers. (C) 2016 S. Karger AG, Basel
C1 Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
   Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA.
RP Gilbert, RJ (reprint author), Dept Biomed Engn, 110 8th St, Troy, NY 12180 USA.
EM gilber2@rpi.edu
FU National Science Foundation [11050125]; National Institutes of Health
   [R01 NS092754]; New York Spinal Cord Injury Research Trust [C030239];
   New York Spinal Cord Injury Research Trust (RFA) [1412220226]
FX The authors gratefully acknowledge grant support provided by the
   National Science Foundation (CAREER grant 11050125), National Institutes
   of Health (R01 NS092754), and the New York Spinal Cord Injury Research
   Trust (contract No. C030239) awarded to Ryan J. Gilbert, and the
   Predoctoral Fellowship awarded to Christopher Johnson by the New York
   Spinal Cord Injury Research Trust (RFA No. 1412220226).
CR ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0
   Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623
   Bao J, 2013, J MATER SCI, V48, P4223, DOI 10.1007/s10853-013-7235-7
   Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x
   BRESNAHAN JC, 1978, J NEUROL SCI, V37, P59, DOI 10.1016/0022-510X(78)90228-9
   Chew SY, 2005, BIOMACROMOLECULES, V6, P2017, DOI 10.1021/bm0501149
   Choi JS, 2004, INT J BIOL MACROMOL, V34, P249, DOI 10.1016/j.ijbiomac.2004.06.001
   Corey JM, 2008, ACTA BIOMATER, V4, P863, DOI 10.1016/j.actbio.2008.02.020
   Cox A, 2015, J NEUROTRAUM, V32, P1413, DOI 10.1089/neu.2014.3730
   Dlubek G, 2003, POLYMER, V44, P1921, DOI 10.1016/S0032-3861(03)00056-9
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Drumright RE, 2000, ADV MATER, V12, P1841, DOI 10.1002/1521-4095(200012)12:23<1841::AID-ADMA1841>3.0.CO;2-E
   Elliott Donaghue I, 2015, BIOMATER SCI-UK, V3, P65, DOI 10.1039/c4bm00311j
   Fan JA, 2011, J BIOMED MATER RES B, V97B, P271, DOI 10.1002/jbm.b.31810
   Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004
   Fon D, 2014, BIOMATERIALS, V35, P2692, DOI 10.1016/j.biomaterials.2013.12.016
   Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   Fridrikh SV, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.144502
   Frizzo MED, 2004, CELL MOL NEUROBIOL, V24, P123, DOI 10.1023/B:CEMN.0000012717.37839.07
   Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w
   Ghitescu RE, 2015, INT J PHARMACEUT, V494, P278, DOI 10.1016/j.ijpharm.2015.08.020
   Griffin J, 2011, J BIOMED MATER RES A, V97A, P230, DOI 10.1002/jbm.a.33049
   Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035
   Gupta D, 2009, ACTA BIOMATER, V5, P2560, DOI 10.1016/j.actbio.2009.01.039
   Haggerty AE, 2013, NEUROSCI BULL, V29, P445, DOI 10.1007/s12264-013-1362-7
   He LM, 2009, TISSUE ENG PART C-ME, V15, P243, DOI 10.1089/ten.tec.2008.0255
   Hou SP, 2012, J NEUROSCI, V32, P13206, DOI 10.1523/JNEUROSCI.5041-11.2012
   Hurtado A, 2011, BIOMATERIALS, V32, P6068, DOI 10.1016/j.biomaterials.2011.05.006
   Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008
   Jeffries EM, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035015
   Ji W, 2011, PHARM RES-DORDR, V28, P1259, DOI 10.1007/s11095-010-0320-6
   Koppes AN, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046002
   Krishna V, 2013, J SPINAL CORD MED, V36, P174, DOI 10.1179/2045772313Y.0000000095
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Lee S, 2012, NAT METHODS, V9, P917, DOI 10.1038/nmeth.2105
   Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445
   Lin K, 2007, POLYMER, V48, P6384, DOI 10.1016/j.polymer.2007.08.056
   LINDSAY RM, 1988, J NEUROSCI, V8, P2394
   Liu T, 2012, TISSUE ENG PT A, V18, P1057, DOI [10.1089/ten.tea.2011.0430, 10.1089/ten.TEA.2011.0430]
   Liu XZ, 1997, J NEUROSCI, V17, P5395
   LOO JA, 1991, RAPID COMMUN MASS SP, V5, P101, DOI 10.1002/rcm.1290050303
   Luong-Van E, 2006, BIOMATERIALS, V27, P2042, DOI 10.1016/j.biomaterials.2005.10.028
   Macaya D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012001
   MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006
   McKee MG, 2004, MACROMOLECULES, V37, P1760, DOI 10.1021/ma035689h
   Meinel AJ, 2012, EUR J PHARM BIOPHARM, V81, P1, DOI 10.1016/j.ejpb.2012.01.016
   Mit-uppatham C, 2004, MACROMOL SYMP, V216, P293, DOI 10.1002/masy.200451227
   Mizuta I, 2001, NEUROSCI LETT, V310, P117, DOI 10.1016/S0304-3940(01)02098-5
   MOCCHETTI I, 1995, J NEUROTRAUM, V12, P853, DOI 10.1089/neu.1995.12.853
   Mohtaram NK, 2015, J MATER CHEM B, V3, P7974, DOI 10.1039/c5tb00871a
   Morcuende S, 2013, NEUROSCIENCE, V250, P31, DOI 10.1016/j.neuroscience.2013.06.050
   Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575
   NSCISC, 2014, SPIN CORD INJ SCI FA
   Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281
   Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101
   Palm MD, 2009, J DRUGS DERMATOL, V8, pS15
   Peluffo H, 1997, NEUROSCI LETT, V228, P207, DOI 10.1016/S0304-3940(97)00384-4
   Perale G, 2011, ACS CHEM NEUROSCI, V2, P336, DOI 10.1021/cn200030w
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Qian W, 2014, INT J MOL SCI, V15, P774, DOI 10.3390/ijms15010774
   Reneker DH, 2008, POLYMER, V49, P2387, DOI 10.1016/j.polymer.2008.02.002
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Schaub N.J., 2015, J NEUROTRAUM, DOI [10.1089/neu.2015.4165, DOI 10.1089/NEU.2015.4165]
   Schaub NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136780
   Schaub NJ, 2013, ACS APPL MATER INTER, V5, P10173, DOI 10.1021/am402827g
   Schaub NJ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046026
   SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0
   Shah BL, 2003, J APPL POLYM SCI, V90, P3278, DOI 10.1002/app.13049
   Sheng XY, 2013, INT J BIOL MACROMOL, V56, P49, DOI 10.1016/j.ijbiomac.2013.01.029
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Skaper SD, 2008, CNS NEUROL DISORD-DR, V7, P46, DOI 10.2174/187152708783885174
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Su Y, 2012, J BIOMAT SCI-POLYM E, V23, P861, DOI 10.1163/092050611X564137
   TAYLOR G, 1964, PROC R SOC LON SER-A, V280, P383, DOI 10.1098/rspa.1964.0151
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Theron SA, 2004, POLYMER, V45, P2017, DOI 10.1016/j.polymer.2004.01.024
   Tsintou M, 2015, NEURAL REGEN RES, V10, P726, DOI 10.4103/1673-5374.156966
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020
   Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001
   Wen XJ, 2006, J BIOMED MATER RES A, V76A, P626, DOI 10.1002/jbm.a.30520
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Yao L, 2013, GENE THER, V20, P1149, DOI 10.1038/gt.2013.42
   Yarin AL, 2001, J APPL PHYS, V90, P4836, DOI 10.1063/1.1408260
   Zamani M, 2010, EUR J PHARM BIOPHARM, V75, P179, DOI 10.1016/j.ejpb.2010.02.002
   Zeng J., 2013, E-POLYMERS, V3, P102
   Zeng Jing, 2003, Journal of Controlled Release, V92, P227, DOI 10.1016/S0168-3659(03)00372-9
   Zhang CX, 2005, EUR POLYM J, V41, P423, DOI 10.1016/j.europolymj.2004.10.027
   Zhu YQ, 2010, ADV FUNCT MATER, V20, P1433, DOI 10.1002/adfm.200901889
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
   Zuidema JM, 2014, BIOMATERIALS, V35, P1439, DOI 10.1016/j.biomaterials.2013.10.079
   Zuo WW, 2005, POLYM ENG SCI, V45, P704, DOI 10.1002/pen.20304
NR 100
TC 9
Z9 9
U1 1
U2 4
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
EI 1422-6421
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2015
VL 202
IS 1-2
BP 116
EP 135
DI 10.1159/000446621
PG 20
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA DX9OU
UT WOS:000384725800009
PM 27701153
OA Green Accepted, Bronze
DA 2018-10-19
ER

PT B
AU Kutbay, I
   Akfirat, FS
AF Kutbay, Isil
   Akfirat, Funda Senturk
BE Sener, S
   Saridogan, E
   Staub, S
TI Mapping of Biochemical Constituents in Platanus acerifolia Leaves By
   Analytical Techniques
SO WORLD CONFERENCE ON TECHNOLOGY, INNOVATION AND ENTREPRENEURSHIP
LA English
DT Proceedings Paper
CT World Conference on Technology, Innovation and Entrepreneurship
CY MAY 28-30, 2015
CL Istanbul, TURKEY
DE ATR-FTIR; leaf; Platanus acerifolia; SEM EDX; XRD
ID ORIENTALIS LEAF POWDER; MEDICINAL-PLANTS; BIOSORPTION; GLYCOSIDE
AB Platanus acerifolia (Plataceae) is woody perennial tree, a native of Asia, Europe, and Eastern Mediterranean regions of the world. It is commonly cultivated and highly valued as an ornamental and medicinal tree. Its leaves as a natural waste is available in abudance, easy to obtain and cheap. In the present study, P. acerifolia leaves were obtained from Kocaeli region of Turkey at the autumn period. All of the specimens were dried in air before using analytical techniques. The leaves were analyzed by using X-ray diffraction (XRD), Attenuated Total internal Reflectance-Fourier Transform Infrared Spectroscopy (ATR-FTIR), Scanning Electro Microscopy-Enegy-Dispersive X-ray Spectroscopy (SEM-EDX). All analysis were performed for providing an accurate detection of the leaf molecular structure, crystalline phase, chemical compositions (organic or inorganic constituent), elemental index, morphology and microstructure. From X-ray diffraction pattern, crystaline phase and chemical compositions of the leaf specimens were identified as whewellite (C2CaO4 center dot H2O), schertelite (Mg(NH4)(2)H-2(PO4)(2)4H(2)O), silicon oxide (SiO2), amide (C13H17N7O3), ester (C37H68O8), benzene (C28H40O10). According to ATR-FTIR analysis results, characteristic peak values of the leaf specimens were detected functional groups as (P-O), (C=O), (Cl=O), (C-O), (P-O-H), (C-H), (N-H), (O-C=O), (K-N=O), (Ca-C equivalent to O), (N equivalent to H), (C=H), (N=O), (O-H), (C equivalent to H), (N equivalent to N), (Si-O-Si). SEM-EDX analysis showed the present of carbon, nitrogen, oxygen, magnesium, silicon, phosphor, chloride, potassium, and calcium in the leaf specimens. Morphology and microstructure of opened or closed stomas, fiber of leaf specimens were monitored. The chemical compositions, the functional groups and the elements are responsible for various medicinal properties of P. acerifolia leaves. Nanoparticles obtained from the leaves by using developed plant extract process can be used as biomaterial, biosorbent and nanomedicine against various plant, human, and animal diseases or pathogens. (C) 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.
C1 [Kutbay, Isil] Gebze Tech Univ, Dept Mat Sci & Engn, Fac Engn, Kocaeli, Turkey.
   [Akfirat, Funda Senturk] Gebze Tech Univ, Dept Mol Biol & Genet, Fac Basic Sci, Kocaeli, Turkey.
RP Kutbay, I (reprint author), Gebze Tech Univ, Dept Mat Sci & Engn, Fac Engn, Kocaeli, Turkey.
EM kutbay@gtu.edu.tr
CR Bachheti R. K, 2012, INT J PHARM PHARM SC, V4, P359
   Baily LH, 1953, STANDARD CYCLOPEDIA, P2706
   Baseri M. K., 2011, Romanian Journal of Biophysics, V21, P277
   Bibi Samra, 2006, PAK J PL SCI, V12, P141
   Chopra RN, 1956, GLOSSARY INDIAN MED, P196
   Dimas K, 2000, PHARMACOL RES, V41, P85
   Ekinci N, 2004, J RADIOANAL NUCL CH, V260, P127, DOI 10.1023/B:JRNC.0000027071.72742.ee
   El-Alfy TS, 2008, NAT PROD COMMUN, V3, P1899
   Erdik E., 2007, ORGANIK KIMYADA SPEK, P82
   Gunther TR, 1959, GREEK HERBAL DIOSCOR, P58
   Hameed I, 2008, PAK J BOT, V40, P2493
   Ibrahim MA, 2009, J NAT PROD, V72, P2141, DOI 10.1021/np900499q
   Kirmani M. Z., 2011, Journal of Basic & Applied Sciences, V7, P89
   Mahvi A. H., 2007, World Applied Sciences Journal, V2, P40
   Mamikoglu N. G., 2007, TREES SHRUBS TURKEY, P266
   Mitali Konwar, 2011, Archives of Applied Science Research, V3, P214
   Mitrocotsa D, 1999, ANTICANCER RES, V19, P2085
   MITROKOTSA D, 1993, PLANTA MED, V59, P517, DOI 10.1055/s-2006-959751
   Monji AB, 2008, GREEN CHEM LETT REV, V1, P107, DOI 10.1080/17518250802101907
   Nie XQ, 2013, SPECTROSC SPECT ANAL, V33, P1290, DOI 10.3964/j.issn.1000-0593(2013)05-1290-05
   Parekh Jigna, 2007, Turkish Journal of Biology, V31, P53
   Peydayesh M, 2015, J IND ENG CHEM, V21, P1014, DOI 10.1016/j.jiec.2014.05.010
   Rao K.S., 2010, INT J ENG SCI TECHNO, V2, P81
   Sahaya S.S., 2012, INT J PHARM SCI DRUG, V4, P56
   Saxena Mamta, 2012, IJPBR, V3, P498
   Sert S, 2008, HYDROMETALLURGY, V90, P13, DOI 10.1016/j.hydromet.2007.09.006
   Song JY, 2009, BIOPROC BIOSYST ENG, V32, P79, DOI 10.1007/s00449-008-0224-6
   Starlin T., 2012, INT RES J PHARM, V3, P180
   Stuart H. B., 2004, INFRARED SPECTROSCOP, P71
   Tantry MA, 2012, FITOTERAPIA, V83, P281, DOI 10.1016/j.fitote.2011.11.004
   Thangarajan S., 2012, INT J PHARM PHARM S5, V4, P343
   Wang X, 2015, RSC ADV, V5, P15969, DOI 10.1039/c4ra14357d
   Zhang DQ, 2011, KEY ENG MATER, V480-481, P502, DOI 10.4028/www.scientific.net/KEM.480-481.502
NR 33
TC 1
Z9 1
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
PY 2015
BP 1719
EP 1727
DI 10.1016/j.sbspro.2015.06.287
PG 9
WC Business
SC Business & Economics
GA BF2YI
UT WOS:000380509900204
OA Other Gold
DA 2018-10-19
ER

PT B
AU Shreepad, S
   Ravi, W
AF Shreepad, Sarange
   Ravi, Warkhedkar
BE Sener, S
   Saridogan, E
   Staub, S
TI New Revolutionary Ideas of Material Processing - A Path to Biomaterial
   Fabrication by Rapid Prototyping
SO WORLD CONFERENCE ON TECHNOLOGY, INNOVATION AND ENTREPRENEURSHIP
LA English
DT Proceedings Paper
CT World Conference on Technology, Innovation and Entrepreneurship
CY MAY 28-30, 2015
CL Istanbul, TURKEY
DE Rapid prototyping (RP); Biomaterial; Hydroxyapatite
ID CALCIUM-PHOSPHATE CERAMICS; SCAFFOLDS; POWDERS
AB The fundamentally different features of Rapid prototyping (RP) from that of conventional sintering offerus some new approaches to develop materials with excellent properties. Applying this method, porous Hydroxyapatite (Hap) ceramics, as well as the HAp-zirconia composites have been fabricated successfully. Porous hydroxyapatite (Hap) is expected to have desired mechanical and biological properties for biomedical applications. However, due to material processing problems, to date, this material can only be prepared by conventional techniques. Fuse deposition Machine is modified to fabricate Hap conventional support structure is not required three nozzle system is utilized for fabrication. Main nozzle is provided with heating arrangement. Two nozzles provided for transient Hap and solvent. Three stages heating with two lasers arrangement for gradual temperature change so transformation is faster. Primary result shows mechanical properties and porosity is as per bone structure. The micro structural characterizations such as phase purity and composition of porous BCP granules were performed and verified by X-ray diffraction (XRD) and Fourier transform infrared spectroscopy (FT-IR) analysis. The chemical and the microstructure information of the Fabricated Hap were investigated by FT-IR (Fourier Transform Infra-Red), SEM (Scanning Electron Microscopy), X-ray Diffraction (XRD). Result shows interconnected regular pores and uniformly distribution of Hap. There is covalent boding makes stronger adhesion to prosthetic. Using this technique, it is possible to produce scaffolds with mechanical and structural properties close to those of the natural bone and teeth. The prepared scaffold has an open, regular pattern and uniformly interconnected porous structure. Some extent problem of small Nano particle aggregate together is called Balling and product of different temperature solidify on the layer is called recasting is dominates the process. By optimizing the operating parameter these problem can be minimized. (C) 2015 The Authors. Published by Elsevier Ltd.
C1 [Shreepad, Sarange; Ravi, Warkhedkar] Govt Coll Engn, Aurangabad 431001, Maharashtra, India.
RP Shreepad, S (reprint author), Govt Coll Engn, Aurangabad 431001, Maharashtra, India.
EM sarangeshreepad@gmail.com
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Ang TH, 2002, MAT SCI ENG C-BIO S, V20, P35, DOI 10.1016/S0928-4931(02)00010-3
   Archer R, 2005, NAT BIOTECHNOL, V23, P1353, DOI 10.1038/ndt1105-1353
   BLENDELL JE, 1986, J CRYST GROWTH, V75, P138, DOI 10.1016/0022-0248(86)90235-6
   Byrne Damien P., BIOMATERIALS
   Casavola C, 2008, P 11 INT C EXP JUN 2
   Chen TB, 2006, J MANUF SCI E-T ASME, V128, P299, DOI 10.1115/1.2122947
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   Frijns A. J. H., NUMERICAL MODELLING
   Gauthier O, 1999, J MATER SCI-MATER M, V10, P199, DOI 10.1023/A:1008949910440
   Hing KA, 2007, SPINE J, V7, P475, DOI 10.1016/j.spinee.2006.07.017
   HOLLISTER SJ, 2002, ELSEVIER BIOMATERIAL, V23, P4095
   Jafari A., 2008, IUST INT J ENG SCI, V19, P187
   Lobo SE, 2010, MATERIALS, V3, P815, DOI 10.3390/ma3020815
   Rao RR, 1997, J MATER SCI-MATER M, V8, P511, DOI 10.1023/A:1018586412270
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Schroeder Craig, REPRESENTATION POROU
   Simchi A, 2006, MAT SCI ENG A-STRUCT, V428, P148, DOI 10.1016/j.msea.2006.04.117
   SVOBODA J, 1994, ACTA METALL MATER, V42, P435, DOI 10.1016/0956-7151(94)90498-7
   YEH TS, 1990, CERAM TRANS, V7, P309
   ZHENG JM, 1989, J AM CERAM SOC, V72, P810, DOI 10.1111/j.1151-2916.1989.tb06222.x
NR 23
TC 1
Z9 1
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
PY 2015
BP 2761
EP 2768
DI 10.1016/j.sbspro.2015.06.390
PG 8
WC Business
SC Business & Economics
GA BF2YI
UT WOS:000380509900334
OA Other Gold
DA 2018-10-19
ER

PT B
AU Ribeiro, AC
   Fonseca, LP
   Soares, RMD
   da Silveira, NP
   Peres, GL
AF Ribeiro, C. Andresa
   Fonseca, P. Luis
   Soares, M. D. Rosane
   da Silveira, P. Nadya
   Peres, L. Gisele
BE Jorge, RN
   Belinha, J
   Martins, P
   Parente, M
   LeiteMoreira, A
   Tavares, JMRS
TI PREPARATION AND CHARACTERIZATION OF AMYLOSE-PYRAZINAMIDE INCLUSION
   COMPLEXES
SO 2015 IEEE 4TH PORTUGUESE MEETING ON BIOENGINEERING (ENBENG)
LA English
DT Proceedings Paper
CT IEEE 4th Portuguese meeting on bioengineering (enbeg)
CY FEB 26-28, 2015
CL porto, PORTUGAL
SP emb, ieee, fac engenharia univ porto, univ combra, univ minho, tecnico, ift
DE Amylose; Inclusion complexes; Drug delivery system; Pyrazinamide
AB Amylose is a linear polymer composed almost entirely of alpha-1,4-linked units. This biopolymer tends to form single helical inclusion complexes with suitable agents. The study of these complexes presents a great interest since the guest molecules that have been trapped at some stage can be release later, thus leading to many applications, especially in the pharmaceutical and food industry. Amylose is considered as a promising carrier biomaterial of prodrugs [1]. Pyrazinamide (PZA) has long been recognized as an active drug against Mycobacterium tuberculosis, however the administration of PZA in high dosage can cause bacterial resistance. Therefore there is a need for new methodologies which would reduce the administration time and improve therapeutic effect of PZA [2]. The aim of our study was to characterize the amylose-PZA complex. The inclusion complex was prepared by acidification of an alkali solution. Formation and characterization (particle size) of the inclusion complexes in solution were characterized by dynamic light scattering and UV spectroscopy. As the complexation causes changes in the absorption spectrum of a guest molecule, change in the colour of the solution from yellow to colourless was noticed. Furthermore, differences in intensity of the bands, and a slight shift of the absorption spectrum of inclusion complexes, in comparison with the pure amylose solution were observed. The UV analyses confirmed the formation of the amylose-PZA inclusion complexes. DLS analysis has been made for: complexes with pure amylose (without PZA), with PZA (without amylose) and amylose-PZA complexes. The amylose particle size, without the guest molecule, was (101,16 +/- 2,60) nm and its relative average polydispersity index was 0,41 +/- 0,04. For the PZA particle the size was (223,70 +/- 13,76) nm and its relative average polydispersity index was 0,27 +/- 0,10. On the other hand for the amylose-PZA inclusion complexes the size (81,11 +/- 1,43) nm was observed and its relative average polydispersity index was 0,26 +/- 0,02. As can be seen the size of the complex is smaller than of the pure amylose or PZA particle in solution. This can be attributed to the presence of PZA that induces hydrophobic interactions resulting in the contraction of the complexes and providing a relatively hydrophilic surface. Furthermore, PDI results also indicated that sizes generated from inclusion complexes have a narrow size distribution. Thus, new analysis tests will be conducted to provide more information about structure and morphology of inclusion complexes.
C1 [Ribeiro, C. Andresa; Fonseca, P. Luis] Univ Lisbon, Inst Super Tecn, Dept Bioengn, Inst Biotechnol & Biosci, P-1699 Lisbon, Portugal.
   [Ribeiro, C. Andresa; Soares, M. D. Rosane; da Silveira, P. Nadya; Peres, L. Gisele] Univ Fed Rio Grande do Sul, Inst Quim, Porto Alegre, RS, Brazil.
RP Ribeiro, AC (reprint author), Univ Lisbon, Inst Super Tecn, Dept Bioengn, Inst Biotechnol & Biosci, P-1699 Lisbon, Portugal.
EM desa.ribeiro@hotmail.com
RI P. Fonseca, Luis/A-4228-2013; Soares, Rosane/H-2156-2018; silveira,
   nadya/G-9970-2016
OI P. Fonseca, Luis/0000-0001-8429-6977; Soares,
   Rosane/0000-0002-5225-7559; silveira, nadya/0000-0002-1556-7304
CR Rachmawati R, 2013, BIOMACROMOLECULES, V14, P575, DOI 10.1021/bm301994u
   Saikia N, 2013, J COMPUT AID MOL DES, V27, P257, DOI 10.1007/s10822-013-9638-6
NR 2
TC 0
Z9 0
U1 1
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4799-8269-1
PY 2015
PG 1
WC Engineering, Biomedical
SC Engineering
GA BF1QB
UT WOS:000380427000008
DA 2018-10-19
ER

PT S
AU Lideskog, H
   Karlberg, M
   Bergsten, U
AF Lideskog, Hakan
   Karlberg, Magnus
   Bergsten, Urban
BE Roy, R
   Tiwari, A
   Tracht, K
   Shehab, E
   Mehnen, J
   Erkoyuncu, JA
   Tapoglou, N
   Tomiyama, T
TI Development of a research vehicle platform to improve productivity and
   value-extraction in forestry
SO PROCEEDINGS OF THE 4TH INTERNATIONAL CONFERENCE ON THROUGH-LIFE
   ENGINEERING SERVICES
SE Procedia CIRP
LA English
DT Proceedings Paper
CT 4th International Conference on Through-Life Engineering Services
   (TESConf)
CY NOV 03-04, 2015
CL Cranfield Univ, Cranfield, ENGLAND
HO Cranfield Univ
DE autonomy; automation; forestry; performance-based contract; Functional
   Products
ID INDUCED SUBSOIL COMPACTION; PREVENTION STRATEGIES; DESIGN
AB In spite of the high level of mechanization in most forestry operations there is a continued need for improvements in productivity and cost effectiveness. Automation of mechanised operations is one possible solution to achieve such improvements but new techniques that can acquire information from the surroundings and make proper analyses rendering in streamlined or new work procedures are prerequisites. Furthermore, product producers buying forest biomaterials often have certain quality wishes. As an addition to automatic work procedures, new technology can further be used to retrieve information for identification and selection of certain tree assortments with different biomaterial properties. In this way, performance-based delivery of tree biomaterial extracted with highly automated work procedures has the possibility to be an enabler to continue the productivity development progress in the forest sector. The objective for this paper is therefore to summarize possible technical needs for and to design an experimental terrain vehicle platform for researchers and machine developers to test and validate new solutions that could improve cost effectiveness in forestry. The platform is designed specifically to test and validate various control systems for autonomy and robotics and also to enable tests and validation of attachments, e.g. to enable better planting procedures or identification of trees with certain properties. Sensors are embedded in the platform to register angles, rotation speed, etc., thus actualising machine automation as an enabler for performance-based delivery of planting or of tree biomaterial assortments. (C) 2015 The Authors. Published by Elsevier B.V.
C1 [Lideskog, Hakan; Karlberg, Magnus] Lulea Univ Technol, Faste Lab, Div Prod & Prod Dev, SE-97187 Lulea, Sweden.
   [Bergsten, Urban] Swedish Univ Agr Sci, Dept Forest Biomat & Technol, SE-90183 Umea, Sweden.
RP Lideskog, H (reprint author), Lulea Univ Technol, Faste Lab, Div Prod & Prod Dev, SE-97187 Lulea, Sweden.
EM hakan.lideskog@ltu.se
CR Alakukku L, 2003, SOIL TILL RES, V73, P145, DOI 10.1016/S0167-1987(03)00107-7
   Backlund I., 2013, THESIS
   Berg S., 2014, THESIS
   Bucur V, 2003, NONDESTRUCTIVE CHARA
   Chamen T, 2003, SOIL TILL RES, V73, P161, DOI 10.1016/S0167-1987(03)00108-9
   Edlund J, 2013, J TERRAMECHANICS, V50, P73, DOI 10.1016/j.jterra.2013.02.001
   Hallongren H, 2014, SCAND J FOREST RES, V29, P144, DOI 10.1080/02827581.2014.881542
   Hellstrom T, 2006, SPRINGER TRAC ADV RO, V25, P603
   Jonoobi M, 2012, IND CROP PROD, V40, P232, DOI 10.1016/j.indcrop.2012.03.018
   Karlsson L., 2013, THESIS
   Kemppainen T, 2013, IEEE INT CONF ROBOT, P739, DOI 10.1109/ICRA.2013.6630655
   Lideskog H., 2012, P 1 INT C THROUGH LI, P139
   Lideskog H, 2014, P 5 FOR ENG C 47 INT
   Lindstrom J, 2013, FUNCTIONAL PRODUCTS, P251
   Lundgren C., 2003, THESIS
   Prahalad CK, 2004, J INTERACT MARK, V18, P5, DOI 10.1002/dir.20015
   Rantala J, 2010, SCAND J FOREST RES, V25, P507, DOI 10.1080/02827581.2010.522591
   Rantala J, 2009, SILVA FENN, V43, P659, DOI 10.14214/sf.186
   Reed Sean, 2013, International Journal of Product Development, V18, P48
   Sutton R. F., 1993, New Forests, V7, P151, DOI 10.1007/BF00034198
   Ulrich K. T., 2012, PRODUCT DESIGN DEV
   Vestlund K, 2006, J TERRAMECHANICS, V43, P505, DOI 10.1016/j.jterra.2005.07.001
NR 22
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2212-8271
J9 PROC CIRP
PY 2015
VL 38
BP 68
EP 73
DI 10.1016/j.procir.2015.07.014
PG 6
WC Engineering, Industrial
SC Engineering
GA BF4JZ
UT WOS:000381110000012
OA Other Gold
DA 2018-10-19
ER

PT S
AU Carnio, M
   Massimiani, C
   Piperni, SG
   Zambuzzii, W
   Cappelletti, C
   Graziani, F
AF Carnio, Martina
   Massimiani, Chiara
   Piperni, Sara Gemini
   Zambuzzii, Willian
   Cappelletti, Chantal
   Graziani, Filippo
BE Sandau, R
TI Space systems design for research on the interaction of osteoblast-like
   cells and biomaterials (hydroxyapatite particles and titanium) in
   microgravity environment
SO SCIENTIFIC AND TECHNOLOGICAL EXPERIMENTS ON AUTOMATIC SPACE VEHICLES AND
   SMALL SATELLITES
SE Procedia Engineering
LA English
DT Proceedings Paper
CT 3rd IAA-RACTs Conference on Scientific and Technological Experiments on
   Automatic Space Vehicles and Small Satellites (SPEXP)
CY SEP 09-11, 2014
CL Samara State Aerosp Univ, Samara, RUSSIA
SP Int Acad Astronaut, Russian Acad Cosmonaut Tsiolkovsky, Joint Stock Co Rocket & Space Ctr Progress
HO Samara State Aerosp Univ
DE microgravity; hydroxyapatite; titanium discs; bone; biomaterials;
   ionizing radiation
AB Microgravity and ionizing radiations are some of the special condition that characterize the space environment. These conditions cause major changes in human bodies, or in biomedical samples; in particular, the bone tissue in microgravity conditions, lack of mechanical loading which is one of the main stimulus to bone remodelling needed, loose elasticity and toughness.
   In 2014 a cooperation between GAUSS srl. (Group of Astrodynamic for the Use of Space System, Rome, Italy), the University of Brasilia (UnB, Brasilia, Brazil) and the State University of Sao Paulo (UNESP, Botucatu, Sao Paulo, Brazil) has been started to study in orbit the effects of the exposure of osteoblast-like cells, responsible to forming-up a new bone, to gold standard biomaterials (hydroxyapatite particles and titanium).
   Biomaterials are artificial materials, with potential biocompatibility. They are more used in regenerative medicine to support cells behaviour to repair the damage. Nowadays, this field of medicine requires collaboration among engineers, biologists, chemists to create and test new biomaterials and to investigate what might be the best to use to enhance the performance during the repair of the damage. By now, in a field so critical to human health and biomaterial development, it is very important to explore and exploit new research pathways and hence, it is clear that the exposition of osteoblast-like cells to biomaterials under reduced gravity conditions certainly will induce changes in cell adhesion, growth and differentiation of those cells. Each experiment will use the microgravity environment to conduct experimentation that could produce tremendous health benefits for humankind such as advancements in biomaterial screening, tissue engineering/regeneration, cell replacement therapy. Therefor the main goal of this project is to investigate potential effects of the space environment exposure on osteoblast-like cells and biomaterials through an autonomous space system, designed and manufactured specifically for this goal. Specifically, this paper describes the engineering solutions to design and manufacturing autonomous space system that can allow to keep alive and to study these kinds of cells. (C) 2015 The Authors. Published by Elsevier Ltd.
C1 [Carnio, Martina; Massimiani, Chiara; Piperni, Sara Gemini; Graziani, Filippo] GAUSS Srl, St Via S Scaroni 27, I-25131 Brescia, Italy.
   [Zambuzzii, Willian] Univ Estadual Paulista UNESP, Sao Jose Do Rio Preto, SP, Brazil.
   [Cappelletti, Chantal] Univ Brasilia, BR-70910900 Brasilia, DF, Brazil.
RP Graziani, F (reprint author), GAUSS Srl, St Via S Scaroni 27, I-25131 Brescia, Italy.
EM marti.carnio@gmail.com
OI Cappelletti, Chantal/0000-0003-1995-3728
CR Mettam G. R., 1999, INTRO ELECT AGE, P281
   van der Geer J., 2000, J SCI COMMUN, V163, P51
NR 3
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-7058
J9 PROCEDIA ENGINEER
PY 2015
VL 104
BP 23
EP 28
DI 10.1016/j.proeng.2015.04.092
PG 6
WC Engineering, Aerospace; Engineering, Multidisciplinary
SC Engineering
GA BF4JS
UT WOS:000381101900004
OA Other Gold
DA 2018-10-19
ER

PT B
AU Basim, GB
   Ozdemir, Z
AF Basim, G. Bahar
   Ozdemir, Zeynep
GP IEEE
TI Chemical Mechanical Polishing Implementation on Dental Implants
SO 2015 INTERNATIONAL CONFERENCE ON PLANARIZATION/CMP TECHNOLOGY (ICPT)
LA English
DT Proceedings Paper
CT International Conference on Planarization/CMP Technology (ICPT)
CY SEP 30-OCT 02, 2015
CL Chandler, AZ
AB In this study, chemical mechanical polishing (CMP) technique is introduced as a new alternative to generate controlled nano/micro scale roughness on the titanium implant surfaces. It is known that micro scale patterns induced on biomaterial surfaces promote bio-compatibility by increasing the capability of cell attachment. However, current developments on biomaterials highlight the impact of nano-scale roughness in promoting the biocompatibility on the metallic implant surfaces. CMP process brings the advantage of inducing smoothness or controlled nano-structures on the bio-implant material surfaces. Here, we focus particularly on the dental implant applications to change the surface roughness and the resulting bioactivity in a controlled manner.
C1 [Basim, G. Bahar; Ozdemir, Zeynep] Ozyegin Univ, Dept Mech Engn, Istanbul, Turkey.
RP Basim, GB (reprint author), Ozyegin Univ, Dept Mech Engn, Istanbul, Turkey.
EM Bahar.Basim@ozyegin.edu.tr; Zeynep.Ozdemir@ozyegin.edu.tr
CR Basim G. B., 2012, P ICPT, P385
   Chathapuram VS, 2003, MICROELECTRON ENG, V65, P478, DOI 10.1016/S0167-9317(03)00177-1
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   Jouanny I, 2010, THIN SOLID FILMS, V518, P3212, DOI 10.1016/j.tsf.2009.09.046
   KAUFMAN FB, 1991, J ELECTROCHEM SOC, V138, P3460, DOI 10.1149/1.2085434
   Kurella A, 2005, J BIOMATER APPL, V20, P5, DOI 10.1177/0885328205052974
   Ozdemir Z, 2014, ECS TRANSACTIONS, V61, P21, DOI 10.1149/06117.0021ecst
   Ozdemir Z., 2015, MRS P
NR 8
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
PY 2015
PG 4
WC Engineering, Chemical; Engineering, Mechanical
SC Engineering
GA BF1MR
UT WOS:000380410600037
DA 2018-10-19
ER

PT S
AU Rachid, D
   Mohand, OO
AF Rachid, Djeridi
   Mohand, Ould Ouali
BE Papuga, J
   Ruzicka, M
TI On the numerical simulation of damage for the visco-hyperelastic
   anisotropic behavior of the biomaterials in cyclic loading: relationship
   of the Mullins effect and fibers reinforcement
SO 3RD INTERNATIONAL CONFERENCE ON MATERIAL AND COMPONENT PERFORMANCE UNDER
   VARIABLE AMPLITUDE LOADING, VAL 2015
SE Procedia Engineering
LA English
DT Proceedings Paper
CT 3rd International Conference on Material and Component Performance under
   Variable Amplitude Loading, VAL
CY MAR 23-26, 2015
CL Prague, CZECH REPUBLIC
DE visco-hyperelasticty; Mullins effect; biomaterial; fiber reinforcement;
   anisotropic; elastomer
ID FILLER-LOADED RUBBERS; CONSTITUTIVE MODEL; ELASTIC-MATERIALS;
   LARGE-STRAIN; IMPLEMENTATION; POLYMERS; LAWS
AB This work is focused on the homogeneous macroscopic material level in order to provide a suitable formulation for structural finite element simulation. A reduction of the stiffness depending on loading, summarized as ` damage phenomena', is considered. We present the modeling of visco-hyperelastic damage with the Mullins effect of fiberreinforced biomaterials. We show that the Ogden-Roxburgh model is more realistic for a reproduction of the damage of hyperelastic materials. Analyzing the parameters set, compressibility and reinforcement (reinforcement contribution, fibers directions and their dispersion in the material) on the hysteresis phenomenon in the tensile cyclic deformation of these biomaterials is achieved (C) 2015 The Authors. Published by Elsevier Ltd.
C1 [Rachid, Djeridi; Mohand, Ould Ouali] Univ Tizi Ouzou, Lab Elaborat & Characterizat Mat & Modeling LEC2M, Tizi Ouzou 15100, Algeria.
RP Rachid, D (reprint author), Univ Tizi Ouzou, Lab Elaborat & Characterizat Mat & Modeling LEC2M, Tizi Ouzou 15100, Algeria.
EM djeridi_rachid@yahoo.fr
OI OULD OUALI, Mohand/0000-0001-7958-4974
CR ARRUDA EM, 1993, J MECH PHYS SOLIDS, V41, P389, DOI 10.1016/0022-5096(93)90013-6
   Beatty MF, 2000, J MECH PHYS SOLIDS, V48, P1931, DOI 10.1016/S0022-5096(99)00085-X
   Boyce MC, 2000, RUBBER CHEM TECHNOL, V73, P504, DOI 10.5254/1.3547602
   Dannenberg E. M., 1975, RUBBER CHEM TECHNOL, V48, P410, DOI DOI 10.5254/1.3547460
   Diani J, 2004, MECH MATER, V36, P313, DOI 10.1016/S0167-6636(03)00025-5
   Djeridi R, 2013, KEY ENG MATER, V554-557, P2414, DOI 10.4028/www.scientific.net/KEM.554-557.2414
   Donnet J.B., 1986, J POLYM SCI, V24, P103
   Dorfmann A, 2004, INT J SOLIDS STRUCT, V41, P1855, DOI 10.1016/j.ijsolstr.2003.11.014
   Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073
   GOVINDJEE S, 1992, INT J SOLIDS STRUCT, V29, P1737, DOI 10.1016/0020-7683(92)90167-R
   GOVINDJEE S, 1991, J MECH PHYS SOLIDS, V39, P87, DOI 10.1016/0022-5096(91)90032-J
   Hardwood J.A.C., 1966, J APPL POLYM SCI, V10, P1203
   HARTSMITH LJ, 1966, Z ANGEW MATH PHYS, V17, P608, DOI 10.1007/BF01597242
   HARWOOD JAC, 1966, J APPL POLYM SCI, V10, P315, DOI 10.1002/app.1966.070100212
   HARWOOD JAC, 1965, J APPL POLYM SCI, V9, P3011, DOI 10.1002/app.1965.070090907
   Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564
   Huber N, 2000, MECH MATER, V32, P1, DOI 10.1016/S0167-6636(99)00045-9
   Kaliske M, 2001, COMPUT STRUCT, V79, P2133, DOI 10.1016/S0045-7949(01)00061-X
   KILIAN HG, 1994, RUBBER CHEM TECHNOL, V67, P1, DOI 10.5254/1.3538664
   Lambert-Diani J, 1999, EUR J MECH A-SOLID, V18, P1027, DOI 10.1016/S0997-7538(99)00147-3
   Marckmann G, 2002, J MECH PHYS SOLIDS, V50, P2011, DOI 10.1016/S0022-5096(01)00136-3
   MIEHE C, 1995, EUR J MECH A-SOLID, V14, P697
   Miehe C, 2000, J MECH PHYS SOLIDS, V48, P323, DOI 10.1016/S0022-5096(99)00017-4
   Mullins L., 1969, RUBBER CHEM TECHNOL, V42, P339, DOI DOI 10.5254/1.3539210
   Mullins L., 1957, RUBBER CHEM TECHNOL, V30, P551
   MULLINS L, 1947, J RUBBER RES, V16, P275, DOI DOI 10.5254/1.3546914
   OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026
   Ogden RW, 1999, P ROY SOC A-MATH PHY, V455, P2861, DOI 10.1098/rspa.1999.0431
   Pawelski H, 2001, CONSTITUTIVE MODELS FOR RUBBER II, P27
   Reese S, 2003, INT J PLASTICITY, V19, P909, DOI 10.1016/S0749-6419(02)00086-4
   Rigbi Z., 1981, ADV POLYM SCI, V35
   Rivelin R.S, 1983, ENG FRACT MECAN, P389
   Schmidt J., 2004, 22 CAD FEM US M INT
   Weiss JA, 1996, COMPUT METHOD APPL M, V135, P107, DOI 10.1016/0045-7825(96)01035-3
NR 34
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-7058
J9 PROCEDIA ENGINEER
PY 2015
VL 101
BP 126
EP 134
DI 10.1016/j.proeng.2015.02.017
PG 9
WC Engineering, Multidisciplinary; Engineering, Mechanical
SC Engineering
GA BF2RF
UT WOS:000380492500016
OA Other Gold
DA 2018-10-19
ER

PT S
AU Sun, DW
   Sealy, MP
   Liu, ZY
   Fu, CH
   Guo, YB
   Fang, FZ
   Zhang, B
AF Sun, D. W.
   Sealy, M. P.
   Liu, Z. Y.
   Fu, C. H.
   Guo, Y. B.
   Fang, F. Z.
   Zhang, B.
BE Shih, AJ
   Wang, LH
TI Finite Element Analysis of Machining Damage in Single-Grit Grinding of
   Ceramic Knee Implants
SO 43RD NORTH AMERICAN MANUFACTURING RESEARCH CONFERENCE, NAMRC 43
SE Procedia Manufacturing
LA English
DT Proceedings Paper
CT 43rd North American Manufacturing Research Conference, NAMRC 43
CY JUN 08-12, 2015
CL Charlotte, NC
DE Bioceramics; machining damage; surface integrity; grinding; finite
   element analysis
ID BRITTLE MATERIALS; SURFACE; MECHANISMS; SIMULATION; DUCTILE; CRACKS
AB Alumina is a common biomaterial used for knee implants due to its excellent biomechanical properties. However, the complex geometry and required surface integrity make precision machining of knee implants very difficult. Machining mechanics and damage mechanism is not well understood. In order to better understand the mechanism of alumina grinding, this work presents a numerical simulation of single point grinding of alumina at a shallow depth-of-cut. A 3D finite element model of single-grit ceramic grinding has been developed using the pressure dependent Johnson-Holmquist constitutive model. Failure strain (FS) was adopted as a user-defined element removal criterion to reveal damage mechanism during the grinding process. The predicted machining groove topography correlated well with the experimental observations. Surface and subsurface microcracks were characterized at different FS. The thrust, frictional, and grinding force histories were also investigated. Furthermore, material behaviors at different locations below the machined groove were analyzed to shed light on subsurface microcrack initiation and propagation.
C1 [Sun, D. W.; Sealy, M. P.; Liu, Z. Y.; Fu, C. H.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
   [Fang, F. Z.] Tianjin Univ, Ctr MicroNano Mfg Technol, Tianjin 300072, Peoples R China.
   [Zhang, B.] Univ Connecticut, Dept Mech Engn, Storrs, CT 06269 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
RI Sealy, Michael/K-5248-2017
OI Sealy, Michael/0000-0002-9236-5458; Fang, Fengzhou/0000-0002-8716-5988
CR Agarwal S, 2008, INT J MACH TOOL MANU, V48, P698, DOI 10.1016/j.ijmachtools.2007.10.013
   Axinte D, 2013, INT J MACH TOOL MANU, V74, P12, DOI 10.1016/j.ijmachtools.2013.06.002
   Bergschmidt P, 2011, COMPOSITE CERAMICS T, V22, P264
   BIFANO TG, 1991, J ENG IND-T ASME, V113, P184, DOI 10.1115/1.2899676
   Bombac D, 2007, RMZ MAT GEOENVIRON, V54, P471
   Carter C. B., 2013, CERAMIC MAT SCI ENG
   Chuang TJ, 2003, J EUR CERAM SOC, V23, P1723, DOI 10.1016/S0955-2219(02)00409-0
   Cronin DS, 2003, IMPLEMENTATION VALID, P47
   Holmquist T, 1995, BALLISTIC EXPT COMPU, P265
   Howes T.D., 1994, CIRP ANN-MANUF TECHN, V43, P305
   Isaacson E, 1983, FRACTURE MECH CERAMI, P557
   JOHNSON GR, 1994, AIP C P, V309, P981, DOI DOI 10.1063/1.46199
   Krause R.F., 1995, J AM CERAM SOC, V78, P260
   Li B, 2014, COMP MATER SCI, P9213
   Liu XB, 2002, J MANUF SCI E-T ASME, V124, P553, DOI 10.1115/1.1463034
   Ma LJ, 2014, INT J MACH TOOL MANU, V77, P82, DOI 10.1016/j.ijmachtools.2013.11.001
   Maccauro G, 2011, ALUMINA ZIRCONIA CER, P299
   Maksoud TMA, 1999, J MATER PROCESS TECH, V88, P222, DOI 10.1016/S0924-0136(98)00403-8
   MALKIN S, 1989, J ENG IND-T ASME, V111, P167, DOI 10.1115/1.3188746
   Marsh E.R, 2007, SEMICONDUCTOR MACHIN
   Marti A, 2000, INJURY, V31, pD33
   Patten JA, 2008, J MANUF PROCESS, V10, P28, DOI DOI 10.1016/J.JMAPR0.2008.08.001
   Rahaman MN, 2007, J AM CERAM SOC, V90, P1965, DOI 10.1111/j.1551-2916.2007.01725.x
   Tan YQ, 2008, INT J MACH TOOL MANU, V48, P975, DOI 10.1016/j.ijmachtools.2008.01.010
   Van Manen MD, 2012, J AM OSTEOPATH ASSOC, V112, P709
   Walter W.L., 2010, SEMINARS ARTHROPLAST, V21, P27
   Zarudi I, 1996, J MATER SCI, V31, P905, DOI 10.1007/BF00352889
   ZHANG BI, 1988, J MATER SCI, V23, P3214
NR 28
TC 5
Z9 5
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2351-9789
J9 PROCEDIA MANUF
PY 2015
VL 1
BP 644
EP 654
DI 10.1016/j.promfg.2015.09.058
PG 11
WC Engineering, Manufacturing
SC Engineering
GA BF2ZE
UT WOS:000380512300057
OA Other Gold
DA 2018-10-19
ER

PT S
AU Caseiro, AR
   Pereira, T
   Bartolo, PJ
   Santos, JD
   Luis, AL
   Mauricio, AC
AF Caseiro, A. R.
   Pereira, T.
   Bartolo, P. J.
   Santos, J. D.
   Luis, A. L.
   Mauricio, A. C.
BE Fernandes, PR
   Bartolo, P
TI Mesenchymal Stem Cells and Biomaterials Systems - Perspectives for
   Skeletal Muscle Tissue Repair and Regeneration
SO 4TH INTERNATIONAL CONFERENCE ON TISSUE ENGINEERING, ICTE2015, AN ECCOMAS
   THEMATIC CONFERENCE
SE Procedia Engineering
LA English
DT Proceedings Paper
CT 4th International Conference on Tissue Engineering, ICTE2015
CY JUN 25-27, 2015
CL Lisbon, PORTUGAL
SP ECCOMAS, the European Community Association on Computational Methods in Applied Sciences
DE skeletal muscle; mesenchymal stem cells; Wharton's jelly; umbilical
   cord; dental pulp; biomaterials; secretome
ID IN-VIVO; EXTRACELLULAR-MATRIX; STROMAL CELLS; MYOGENIC DIFFERENTIATION;
   SATELLITE CELL; MURINE MODEL; INJURY; VITRO; TRANSPLANTATION;
   PROGENITORS
AB Skeletal muscle is essential in voluntary movement and other major vital functions. Muscle injuries are important in clinical practice and, despite skeletal muscle's good regenerative ability, severe tissue loss impairs complete myofibre regeneration, limiting structural and functional recovery of the affected muscle, eventually leading to the development of non-contractile fibrous scar. The intrinsic healing mechanisms rely in great extent on the residing progenitor population but significant drawbacks to their practical application in regenerative strategies boosted the search for alternative cell sources, such as extra-fetal mesenchymal stem cells (MSCs). MSCs have demonstrated to positively influence the regeneration of different disease models. When severe volumetric muscle tissue loss occurs, the body is seldom capable of replacing the lost portions with fully functional tissue. A rational strategy to aid the healing of such situations is the application of biomaterial implants that provide a structural matrix for the ingrowth of regenerating muscle fibres. Both synthetic and natural biomaterials have been hypothesized for this purpose and some have reached as far clinical cases applications. Obvious improvements are observed in most cases, but reaction to some biomaterials and functional recovery are still a challenge. The addition of MSCs to the biomaterials seems to improve the systems' performance in the overall regenerative milieu. This strategies promote scaffold's vascularization and integration, as well as accelerated tissue ingrowth and reduces scar formation, resulting in improved recovery rates at both structural and functional levels. (C) 2015 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/) Peer-review under responsibility of IDMEC-IST.
C1 [Caseiro, A. R.; Pereira, T.; Luis, A. L.; Mauricio, A. C.] Univ Porto UP, Dept Clin Vet, Inst Ciencias Biomed Abel Salazar ICBAS, Oporto, Portugal.
   [Caseiro, A. R.; Pereira, T.; Luis, A. L.; Mauricio, A. C.] Inst Ciencias & Tecnol Agr & Agroalimentares ICET, Ctr Estudos Ciencia Anim CECA, Oporto, Portugal.
   [Caseiro, A. R.] Inst Politecn Leiria, CDRsp Ctr Desenvolvimento Rapido & Sustentado Pro, Marinha Grande, Portugal.
   [Bartolo, P. J.] Univ Manchester, Sch Mech Aerosp & Civil Engn, Manchester, Lancs, England.
   [Bartolo, P. J.] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.
   [Caseiro, A. R.; Santos, J. D.] Univ Porto, Fac Engn, Dept Engn Met & Mat, CEMUC, Oporto, Portugal.
RP Caseiro, AR (reprint author), Univ Porto UP, Dept Clin Vet, Inst Ciencias Biomed Abel Salazar ICBAS, Oporto, Portugal.
EM rita.caseiro.santos@gmail.com
OI Mauricio, Ana Colette/0000-0002-0018-9363; Santos, Jose
   Domingos/0000-0002-6871-9850; Caseiro Santos, Ana
   Rita/0000-0002-1143-2461
CR Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74
   Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469
   Caseiro AR, 2015, PROGR STEM CELL TRAN
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Chen Liwen, 2008, PLoS One, V3, pe1886, DOI 10.1371/journal.pone.0001886
   Conconi MT, 2006, INT J MOL MED, V18, P1089
   Corona BT, 2012, TISSUE ENG PT A, V18, P1213, DOI [10.1089/ten.tea.2011.0614, 10.1089/ten.TEA.2011.0614]
   Do MKQ, 2012, ANIM SCI J, V83, P712, DOI 10.1111/j.1740-0929.2012.01057.x
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Doorn J, 2012, TISSUE ENG PART B-RE, V18, P101, DOI [10.1089/ten.teb.2011.0488, 10.1089/ten.TEB.2011.0488]
   Fossett E, 2012, STEM CELLS INT, V2012, DOI DOI 10.1155/2012/46525922448172
   Gates C, 2005, OPER TECHN SPORT MED, V13, P247, DOI 10.1053/j.otsm.2006.01.012
   Gentile NE, 2014, AM J PHYS MED REHAB, V93, pS79, DOI 10.1097/PHM.0000000000000145
   Giordani L, 2013, FEBS J, V280, P4014, DOI 10.1111/febs.12383
   Grogan BF, 2011, J AM ACAD ORTHOP SUR, V19, pS35, DOI 10.5435/00124635-201102001-00007
   Hayashi S, 2004, HISTOCHEM CELL BIOL, V122, P427, DOI 10.1007/s00418-004-0704-y
   Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053
   Husmann Irene, 1996, Cytokine and Growth Factor Reviews, V7, P249, DOI 10.1016/S1359-6101(96)00029-9
   Hwang JH, 2013, BIOMATERIALS, V34, P6037, DOI 10.1016/j.biomaterials.2013.04.049
   Jarvinen TAHJ, 2005, AM J SPORT MED, V33, P745, DOI 10.1177/0363546505274714
   Jarvinen TAH, 2007, BEST PRACT RES CL RH, V21, P317, DOI 10.1016/j.berh.2006.12.004
   Kawashima N, 2012, ARCH ORAL BIOL, V57, P1439, DOI 10.1016/j.archoralbio.2012.08.010
   Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068
   Kim DW, 2013, INT J MOL SCI, V14, P11692, DOI 10.3390/ijms140611692
   Koning M, 2009, J TISSUE ENG REGEN M, V3, P407, DOI 10.1002/term.190
   Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044
   Lavoie JR, 2013, BIOCHIMIE, V95, P2212, DOI 10.1016/j.biochi.2013.06.017
   Le Blanc K, 2005, BIOL BLOOD MARROW TR, V11, P321, DOI 10.1016/j.bbmt.2005.01.005
   Lee MJ, 2010, J PROTEOME RES, V9, P1754, DOI 10.1021/pr900898n
   Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4
   Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899
   Machingal MA, 2011, TISSUE ENG PT A, V17, P2291, DOI [10.1089/ten.TEA.2010.0682, 10.1089/ten.tea.2010.0682]
   Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24
   MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493
   Mccoy MK, 2008, EXP NEUROL, V210, P14, DOI 10.1016/j.expneurol.2007.10.011
   Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002
   Merritt EK, 2010, TISSUE ENG PT A, V16, P1395, DOI [10.1089/ten.tea.2009.0226, 10.1089/ten.TEA.2009.0226]
   Merritt EK, 2010, TISSUE ENG PT A, V16, P2871, DOI [10.1089/ten.tea.2009.0826, 10.1089/ten.TEA.2009.0826]
   Mirabella T, 2011, BIOMATERIALS, V32, P4218, DOI [10.1016/j.biomaterials.2011.01.071, 10.1016/j.biomaterials.2010.12.028]
   Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025
   Mizuno H, 2002, PLAST RECONSTR SURG, V109, P199, DOI 10.1097/00006534-200201000-00030
   Muguruma Y, 2003, EXP HEMATOL, V31, P1323, DOI 10.1016/j.exphem.2003.09.003
   Page RL, 2011, TISSUE ENG PT A, V17, P2629, DOI [10.1089/ten.tea.2011.0024, 10.1089/ten.TEA.2011.0024]
   Pannerec A, 2013, DEVELOPMENT, V140, P2879, DOI 10.1242/dev.089326
   Pannerec A, 2012, TRENDS MOL MED, V18, P599, DOI 10.1016/j.molmed.2012.07.004
   Pannerec A, 2010, M S-MED SCI, V26, P797, DOI 10.1051/medsci/20102610797
   Pecanha R, 2012, J BONE JOINT SURG AM, V94A, P609, DOI 10.2106/JBJS.K.00351
   Pereira T, 2012, J TISSUE ENG REGEN M, V6, P396
   Pereira T., 2014, STEM CELLS INT, V2014
   Pereira T., 2012, 17 ANN C EUR COLL SP
   Pereira T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113769
   Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637
   Qazi TH, 2015, BIOMATERIALS, V53, P502, DOI 10.1016/j.biomaterials.2015.02.110
   Rossi CA, 2011, FASEB J, V25, P2296, DOI 10.1096/fj.10-174755
   Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103
   Santa Maria L, 2004, EXP CELL RES, V300, P418, DOI 10.1016/j.yexcr.2004.07.017
   Sato K, 2003, MUSCLE NERVE, V28, P365, DOI 10.1002/mus.10436
   Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035
   Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085
   Sicari BM, 2014, ANAT REC, V297, P51, DOI 10.1002/ar.22794
   Skalnikova H, 2011, PROTEOMICS, V11, P691, DOI 10.1002/pmic.201000402
   Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127
   Tidball JG, 2014, DEVELOPMENT, V141, P1184, DOI 10.1242/dev.098285
   Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004
   Turner NJ, 2010, TISSUE ENG PT A, V16, P3309, DOI [10.1089/ten.tea.2010.0169, 10.1089/ten.TEA.2010.0169]
   Vigodarzere GC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00362
   Walter MNM, 2010, EXP CELL RES, V316, P1271, DOI 10.1016/j.yexcr.2010.02.026
   Wolf M.T., 2014, ADV DRUG DELIVERY RE
NR 69
TC 2
Z9 2
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-7058
J9 PROCEDIA ENGINEER
PY 2015
VL 110
BP 90
EP 97
DI 10.1016/j.proeng.2015.07.014
PG 8
WC Cell & Tissue Engineering; Engineering, Multidisciplinary
SC Cell Biology; Engineering
GA BF2SQ
UT WOS:000380496300013
OA Other Gold
DA 2018-10-19
ER

PT S
AU Heris, HK
   Latifi, N
   Vali, H
   Li, N
   Mongeau, L
AF Heris, Hossein K.
   Latifi, Neda
   Vali, Hojattolah
   Li, Nicole
   Mongeau, Luc
BE Fernandes, PR
   Bartolo, P
TI Investigation of chitosan-glycol/glyoxal as an injectable biomaterial
   for vocal fold tissue engineering
SO 4TH INTERNATIONAL CONFERENCE ON TISSUE ENGINEERING, ICTE2015, AN ECCOMAS
   THEMATIC CONFERENCE
SE Procedia Engineering
LA English
DT Proceedings Paper
CT 4th International Conference on Tissue Engineering, ICTE2015
CY JUN 25-27, 2015
CL Lisbon, PORTUGAL
SP ECCOMAS, the European Community Association on Computational Methods in Applied Sciences
DE Chitosan; Human fibroblasts; Viability; Migration; Degradation; Vocal
   fold; In vitro
ID BIOMEDICAL APPLICATIONS; IN-VIVO; HYDROGELS; GELATIN; GLYOXAL
AB Injectable hydrogels offer promising tissue engineering approaches for vocal fold (VF) tissue repair. Research on VF tissue engineering scaffolds has largely been focused on derivatives of hyaluronan and collagen. Although chitosan hydrogels have been extensively investigated for various soft tissues, their potential use for VF tissue engineering has been overlooked. The aim of the present study was to investigate cross-linked Chitosan-glycol (GCs)/ glyoxal (Gy) hydrogels for VFLP tissue engineering. The effects of Gy concentration on cell viability, viscoelastic properties, enzymatic degradation, and cell migration were studied. Six different groups of cell-seeded hydrogels, consisting of immortalized human vocal fold fibroblasts encapsulated in GCs/Gy hydrogels, were prepared to obtain target concentrations of 2X106 cells/ml, GCs 2% and Gy 0.02% (Group# 1), 0.015% (Group# 2), 0.01% (Group# 3), 0.0075% (Group# 4), 0.005% (Group# 5), or 0.0025% (Group# 6). The storage and loss moduli were 629 +/- 35Pa and 9 +/- 1 Pa, 560 +/- 28 Pa and 9 +/- 1Pa, 489 +/- 41 Pa and 8 +/- 1 Pa, 307 +/- 25 Pa and 4 +/- 1 Pa, 149 +/- 31 Pa and 3 +/- 1 Pa, 55 +/- 17 Pa and 3 +/- 1 Pa for groups 1, 2, 3, 4, 5, and 6, respectively. The viability rates were above 90% for all groups, 3 hours after encapsulation. The viability rates were 60.0 +/- 2.2%, 80.3 +/- 2.2%, 83.5 +/- 0.5%, 83.1 +/- 1.3%, 88.2 +/- 0.1%, and 88.0 +/- 1.1% for groups 1,2,3,4,5, and 6, respectively, one week after encapsulation inside GCs/Gy hydrogels. The average cell motility speed was 0.09 +/- 0.03 mu m/minute, 0.07 +/- 0.043 +/- m/minute, and 0.09 +/- 0.02 +/- m/minute for groups 4, 5, and 6, respectively. Following four weeks enzymatic degradation study, the mass loss was 10%, 21%, and 100% for groups 4, 5, and 6, respectively. Our results indicated that GCs/Gy hydrogels could be potential candidates for use in human VF tissue repair and regeneration. (C) 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/) Peer-review under responsibility of IDMEC-IST.
C1 [Heris, Hossein K.; Latifi, Neda; Mongeau, Luc] McGill Univ, Dept Mech Engn, 817 Rue Sherbrooke Ouest, Montreal, PQ H3A 0C3, Canada.
   [Vali, Hojattolah] McGill Univ, Sch Commun Sci & Disorders, Montreal, PQ H3A 1G1, Canada.
   [Li, Nicole] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada.
RP Heris, HK (reprint author), McGill Univ, Dept Mech Engn, 817 Rue Sherbrooke Ouest, Montreal, PQ H3A 0C3, Canada.
EM hossein.khadiviheris@mail.mcgill.ca
OI Latifi, Neda/0000-0002-8099-8354; Mongeau, Luc/0000-0003-0344-227X
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Benninger MS, 1996, OTOLARYNG HEAD NECK, V115, P474, DOI 10.1016/S0194-5998(96)70087-6
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Chan RW, 1999, J ACOUST SOC AM, V106, P2008, DOI 10.1121/1.427947
   Chen XG, 2002, BIOMATERIALS, V23, P4609, DOI 10.1016/S0142-9612(02)00207-7
   Coppoolse JMS, 2014, J SPEECH LANG HEAR R, V57, pS658, DOI 10.1044/2014_JSLHR-S-12-0292
   Costa-Pinto AR, 2014, J BIOACT COMPAT POL, V29, P137, DOI 10.1177/0883911514521919
   Heris HK, 2015, J BIOMECHANICS
   Heris HK, 2013, J MECH BEHAV BIOMED, V28, P383, DOI 10.1016/j.jmbbm.2013.05.026
   Heris HK, 2012, MACROMOL BIOSCI, V12, P202, DOI 10.1002/mabi.201100335
   Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112
   HIRANO M, 1974, FOLIA PHONIATR, V26, P89, DOI 10.1159/000263771
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Jin R, 2009, BIOMATERIALS, V30, P2544, DOI 10.1016/j.biomaterials.2009.01.020
   Kazemirad S, 2015, J BIOMEDICAL MAT R B
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Lapolla A, 2003, CLIN CHEM LAB MED, V41, P1166, DOI 10.1515/CCLM.2003.180
   Latifi N, 2014, ASME 2014 INT MECH E
   Latifi N, 2014, J MECH BEHAV BIOMED, V39, P366, DOI 10.1016/j.jmbbm.2014.07.031
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Li Nicole Y K, 2013, J Cytol Mol Biol, V1, P001
   Li YL, 2012, CHEM SOC REV, V41, P2193, DOI 10.1039/c1cs15203c
   Mason B., 2012, ENG BIOMATERIALS REG, P19, DOI DOI 10.1007/978-1-4614-1080-5_2
   Mourya VK, 2008, REACT FUNCT POLYM, V68, P1013, DOI 10.1016/j.reactfunctpolym.2008.03.002
   Prestwich GD, 2007, TISSUE ENG, P125
   Shanyari N, 2006, BIOCHEM PHARMACOL, V71, P1610, DOI 10.1016/j.bcp.2006.02.016
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Thibeault SL, 2002, J VOICE, V16, P96, DOI 10.1016/S0892-1997(02)00078-4
   Yu LMY, 2007, J BIOMED MATER RES A, V82A, P243, DOI 10.1002/jbm.a.31069
   Zhang L, 2006, J BIOMED MATER RES A, V77A, P277, DOI 10.1002/jbm.a.30614
NR 30
TC 2
Z9 2
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-7058
J9 PROCEDIA ENGINEER
PY 2015
VL 110
BP 143
EP 150
DI 10.1016/j.proeng.2015.07.022
PG 8
WC Cell & Tissue Engineering; Engineering, Multidisciplinary
SC Cell Biology; Engineering
GA BF2SQ
UT WOS:000380496300021
OA Other Gold
DA 2018-10-19
ER

PT B
AU Violano, A
   Ciravoglu, A
   Erkenez, S
   Montaniero, V
   Verde, F
AF Violano, Antonella
   Ciravoglu, Aysen
   Erkenez, Semin
   Montaniero, Veronica
   Verde, Francesca
BA Piscitelli, M
BF Piscitelli, M
TI BIOMATERIALS: the synthetic biology applied to architecture
SO Heritage and Technology: Mind Knowledge Experience
SE Fabbrica della Conoscenza
LA English
DT Proceedings Paper
CT Heritage and Technology Mind Knowledge Experienc e
CY JUN 11-13, 2015
CL Aversa, ITALY
SP Progetto CAMPUS Pompei, REPVBBLICA ITALIANA, REGIONE CAMPANIA
DE Biomaterial; LCA; technological design; sustainable architecture
AB Currently, our planet is suffering for problems related to overpopulation, accumulation of waste, depletion of raw materials, extreme exploitation of the productive soil and reckless issuance of pollutants in air, soil and water to such an extent as to make the habitat less and less suitable for the survival of living organisms. Thus, project interventions are necessary in order to safeguard first the natural environment so that an adequate social and economic development is possible. In this context, the role of architecture can be significant.
   It is believed that 'making architecture' today means to search for harmony between man, environment and built through cradle-to-cradle sustainable projects that cleverly use natural resources in order to restore the ecological cycles compromised by the destructive impact of the human species. Scientific knowledge acquired in biotechnology and engineering allow us to achieve this goal by working with natural systems and benefiting from them, without destroying the integrity and the capacity for renewal. A new branch of biological sciences, named synthetic biology, will be able to imagine and build new living systems for useful purposes, according the approach: "House like a tree".
   The paper illustrates the contribution of this new discipline to the construction sector and analyses the performances of some kind of biomaterials that offer a paradigm shift in the perception of buildings from mechanical entities to living or like-living organisms. This study discussed how transformation could be achieved with the help of the sustainable design approach and environmental philosophy. The environmentalist discourse has an ideological influence on architectural approaches, as well as shaping these. Thus, we urgently have to change our conceptions about nature, such as human-centrism and the control-over-nature approach. We have to talk about new ways of collaborating with nature.
C1 [Violano, Antonella; Montaniero, Veronica; Verde, Francesca] Univ Naples 2, Dept Architecture & Ind Design L Vanvitelli, Aversa, Italy.
   [Ciravoglu, Aysen; Erkenez, Semin] Yildiz Tech Univ, Istanbul, Turkey.
RP Violano, A (reprint author), Univ Naples 2, Dept Architecture & Ind Design L Vanvitelli, Aversa, Italy.
EM antonella.violano@unina2.it; aysenc@gmail.com; seminerkenez@gmail.com;
   veronica.montaniero1@studenti.unina2.it; francesca.verde7@gmail.com
RI Violano, Antonella/G-5544-2013
OI Violano, Antonella/0000-0002-5313-3988
CR [7 Group Reed B 7 Group . 2009], 2009, INTEGRATIVE DESIGN G
   Armstrong R., 2012, LIVING ARCHITECTURE
   BENJAMIN D., 2011, BIOFEVER RECENT DEV
   Birkeland J., 2002, DESIGN SUSTAINABILIT
   Bookchin M., 1986, THE MODERN CRISIS
   CIRAVOGLU A., 2009, MIMARIST, V2, P38
   CIRAVOGLU A., 2008, MIMARLIK, V340, P13
   ERKENEZ S., 2014, WORLD SUST BUILD C B
   European Commission,, 2005, SYNTH BIOL APPL ENG, P5
   FERRARI M., 2012, NEMETON HIGH GREEN T, P7
   FIELSON R., 2004, ARCHITECTURE ENV, V6, P20
   FONTANA J., 2014, COME BIOL PUO DARE N
   Girard L. Fusco, 1997, VALUTAZIONI SVILUPPO
   GOLEMAN D, 2009, INTELLIGENZA ECOLOGI, P55
   GOULD K., 2007, WOMEN GREEN VOICE SU
   Guy S, 2001, J ARCHIT EDUC, V54, P140, DOI 10.1162/10464880152632451
   Hopwood B, 2005, SUSTAIN DEV, V13, P38, DOI 10.1002/sd.244
   Lovelock J. E., 1988, AGES GAIA BIOGRAPHY
   Madge Pauline, 1993, J DESIGN HIST, V6, P149, DOI DOI 10.1093/JDH/6.3.149
   MYERS W., 2012, BIODESIGN NATURE SCI, P8
   NAESS A., 1988, ECOLOGIST, V18
   ORiordan T., 1989, NEW MODELS GEOGRAPHY, P77
   PALLASMAA J., 1996, ACAD SERIES POLEMICS
   PLUMWOOD V., 2004, FEMINIZM DOGAYA HUKM
   Rees W. E., 1995, J PLAN LIT, V9, P343, DOI [DOI 10.1177/088541229500900402), DOI 10.1177/088541229500900402]
   VIOLANO A., 2013, ARCHITECTURAL ED REA, P365
   Zimmerman M. J, 2001, NATURE INTRINSIC VAL
NR 27
TC 0
Z9 0
U1 1
U2 6
PU SCUOLA PITAGORA EDITRICE
PI NAPOLI
PA PIAZZA SANTA MARIA DEGLI ANGELI, 1, NAPOLI, 80132, ITALY
BN 978-88-6542-416-2
J9 FABBR CONOSCENZA
PY 2015
VL 56
BP 1930
EP 1939
PG 10
WC Architecture; Art
SC Architecture; Art
GA BF3JE
UT WOS:000380548200219
DA 2018-10-19
ER

PT B
AU Balogova, A
   Harvanova, D
   Hudak, R
   Rosocha, J
   Zivcak, J
AF Balogova, Alena
   Harvanova, Denisa
   Hudak, Radovan
   Rosocha, Jan
   Zivcak, Jozef
GP IEEE
TI 3D cultivation of mesenchymal stromal cells from adipose tissue in
   alginate beads
SO 2015 IEEE 13TH INTERNATIONAL SYMPOSIUM ON APPLIED MACHINE INTELLIGENCE
   AND INFORMATICS (SAMI)
LA English
DT Proceedings Paper
CT IEEE 13th International Symposium on Applied Machine Intelligence and
   Informatics (SAMI)
CY JAN 22-24, 2015
CL Herl'any, SLOVAKIA
AB New trends of 3D printing of biological structures are still expanding and witnessing rapid rise of new knowledge. The basis for proper and successful 3D printed structures of biological materials is to create adequate biomaterial which would serve as ink for a 3D printer. Alginate is one of the materials that can be used. Alginate is a hydrogel, which is used mainly in the field of tissue engineering for its useful properties as a biomaterial. The main aim of this study was to create a biomaterial for the purposes of 3D printing and encapsulate selected type of cells to alginate beads, along with studying cell survival and stability of the biomaterial for three weeks. In this study mesenchymal stem cells (MSCs), isolated from rabbit adipose tissue, were used.
C1 [Harvanova, Denisa; Rosocha, Jan; Zivcak, Jozef] Safarik Univ, Fac Med, Associated Tissue Bank, Kosice 04166, Slovakia.
   [Harvanova, Denisa; Rosocha, Jan; Zivcak, Jozef] L Pasteur Univ Hosp, Kosice 04166, Slovakia.
   [Balogova, Alena; Hudak, Radovan] Tech Univ Kosice, Fac Mech Engn, Dept Biomed Engn & Measurements, Kosice 04200, Slovakia.
RP Balogova, A (reprint author), Tech Univ Kosice, Fac Mech Engn, Dept Biomed Engn & Measurements, Kosice 04200, Slovakia.
EM alena.balogova@tuke.sk; denisa.harvanova@upjs.sk; radovan.hudak@tuke.sk;
   jan.rosocha@upjs.sk; jozef.zivcak@tuke.sk
OI Harvanova, Denisa/0000-0002-3038-7520
CR Cigankova V., 2007, VET HISTOLOGY EMBRAO
   Coatney S., 2013, 3D BIOPRINTING
   Excell J., 2013, ENGINEER
   Fedorovich NE, 2007, TISSUE ENG, V13, P1905, DOI 10.1089/ten.2006.0175
   Hajduk Maros, 2013, THESIS
   Huaping Tan, INJECTABLE BIODEGRAD
   Lin Hong-Ru, 2003, POROUS ALGINATE HYDR
   Organovo, 2014, BIOPR PROC
   Sargus-Patino Catherine, 2013, ALGINATE HYDROGEL 3
NR 9
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4799-8221-9
PY 2015
BP 67
EP 70
PG 4
WC Computer Science, Artificial Intelligence; Computer Science,
   Interdisciplinary Applications
SC Computer Science
GA BF3CD
UT WOS:000380524900004
DA 2018-10-19
ER

PT B
AU Mozayan, C
   Chabra, R
   Wu, P
   Narayan, R
   Li, C
AF Mozayan, C.
   Chabra, R.
   Wu, P.
   Narayan, R.
   Li, C.
GP IEEE
TI A NOVEL BIOCOMPATIBLE BIOMATERIAL FOR ON-DEMAND GENERATION OF
   THREE-DIMENSIONAL OXYGEN GRADIENTS IN VITRO
SO 2015 TRANSDUCERS - 2015 18TH INTERNATIONAL CONFERENCE ON SOLID-STATE
   SENSORS, ACTUATORS AND MICROSYSTEMS (TRANSDUCERS)
LA English
DT Proceedings Paper
CT 18th International Conference on Solid-State Sensors, Actuators and
   Microsystems (TRANSDUCERS)
CY JUN 21-25, 2015
CL Anchorage, AK
SP TRF, IEEE, Elect Devices Soc
DE Oxygen gradient; oxygen tension; hypoxia; macrophage; cell culture
   device
ID CELL-CULTURE; MICROFLUIDIC DEVICE; ISCHEMIC-STROKE
AB Oxygen gradients play essential roles in many in vitro cell, tissue and organ experimental models. This paper reports a novel biocompatible biomaterial for on-demand generation of three-dimensional oxygen gradients in vitro. By exposing the oxygen-consuming biomaterial consisting of glucose oxidase and catalase enzymes to the cell culture media or gel, precisely-controlled oxygen gradients (2.5 mmHg per 100 mu m distance) that closely mimic in vivo hypoxia can be generated. This biomaterial will serve as the basis for a new generation of experimental models previously impossible or very difficult to implement by simplifying and refining the control of in vitro microenvironments.
C1 [Mozayan, C.; Narayan, R.; Li, C.] Hofstra North Shore LIJ Sch Med, Hempstead, NY 11549 USA.
   [Chabra, R.] Rensselaer Polytech Inst, Troy, NY USA.
   [Wu, P.; Narayan, R.; Li, C.] Feinstein Inst Med Res, Manhasset, NY USA.
RP Li, C (reprint author), Hofstra North Shore LIJ Sch Med, Hempstead, NY 11549 USA.
EM cli11@nshs.edu
CR Chang CW, 2014, LAB CHIP, V14, P3762, DOI 10.1039/c4lc00732h
   Chen YA, 2011, LAB CHIP, V11, P3626, DOI 10.1039/c1lc20325h
   Funamoto K, 2012, LAB CHIP, V12, P4855, DOI 10.1039/c2lc40306d
   Lo JF, 2010, LAB CHIP, V10, P2394, DOI 10.1039/c004660d
   Lovatt D, 2014, NAT METHODS, V11, P190, DOI [10.1038/NMETH.2804, 10.1038/nmeth.2804]
   Mehta G, 2007, BIOMED MICRODEVICES, V9, P123, DOI 10.1007/s10544-006-9005-7
   Moore M., 2013, TISSUE ENG PART A, P17
   Rajan N., 2013, TRANSD 2013 C BARC S, P412
   Ravo M, 2008, LAB INVEST, V88, P430, DOI 10.1038/labinvest.2008.11
   TONI D, 1995, ARCH NEUROL-CHICAGO, V52, P670, DOI 10.1001/archneur.1995.00540310040014
   Vila N, 2000, STROKE, V31, P2325, DOI 10.1161/01.STR.31.10.2325
   Wang L, 2013, LAB CHIP, V13, P695, DOI [10.1039/c2lc40661f, 10.1039/C2LC40661F]
NR 12
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4799-8955-3
PY 2015
BP 1593
EP 1596
PG 4
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BF2EU
UT WOS:000380461400397
DA 2018-10-19
ER

PT B
AU Lausecker, R
   Badilita, V
   Wallrabe, U
AF Lausecker, R.
   Badilita, V.
   Wallrabe, U.
GP IEEE
TI NATURAL SHELLAC FOR GREEN MICROFLUIDIC APPLICATIONS
SO 2015 TRANSDUCERS - 2015 18TH INTERNATIONAL CONFERENCE ON SOLID-STATE
   SENSORS, ACTUATORS AND MICROSYSTEMS (TRANSDUCERS)
LA English
DT Proceedings Paper
CT 18th International Conference on Solid-State Sensors, Actuators and
   Microsystems (TRANSDUCERS)
CY JUN 21-25, 2015
CL Anchorage, AK
SP TRF, IEEE, Elect Devices Soc
DE Microfluidics; shellac; biomaterial; sustainable
AB We hereby introduce the biomaterial shellac as a new player in the field of sustainable microfluidics.
   We demonstrate a fully "green" technological process for wafer-level fabrication of microstructures by means of shellac hot embossing. The process is labeled as "green" because it can be carried out completely outside the cleanroom, it is fast, cheap, energy saving, and uses natural and exclusively non-toxic materials. Moreover, the end products are biodegradable, opening new perspectives for disposable point-of-care (POC) devices.
   The implementation capability is demonstrated through successful fabrication of basic building blocks such as pillars, channels, mixers and reservoirs. Process parameters, limitations and challenges are clearly defined.
C1 [Lausecker, R.; Badilita, V.; Wallrabe, U.] Univ Freiburg, Dept Microsyst Engn, Lab Microactuators, Freiburg, Germany.
RP Lausecker, R (reprint author), Univ Freiburg, Dept Microsyst Engn, Lab Microactuators, Freiburg, Germany.
EM roland.lausecker@imtek.uni-freiburg.de
RI Wallrabe, Ulrike/F-5217-2013
CR Branham MS, 2010, ENVIRON SCI TECHNOL, V44, P4295, DOI 10.1021/es902388b
   Irimia-Vladu M, 2013, GREEN CHEM, V15, P1473, DOI 10.1039/c3gc40388b
   Li X, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3687398
   Williams ED, 2002, ENVIRON SCI TECHNOL, V36, P5504, DOI 10.1021/es025643o
NR 4
TC 2
Z9 2
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4799-8955-3
PY 2015
BP 1680
EP 1683
PG 4
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BF2EU
UT WOS:000380461400419
DA 2018-10-19
ER

PT S
AU Hughes, G
   Ochsner, A
AF Hughes, Gideon
   Ochsner, Andreas
BE Ochsner, A
   Altenbach, H
TI Design, Manufacture and Testing of Three-Dimensional Scaffolds
SO APPLICATIONS OF COMPUTATIONAL TOOLS IN BIOSCIENCES AND MEDICAL
   ENGINEERING
SE Advanced Structured Materials
LA English
DT Proceedings Paper
CT 8th International Conference on Advanced Computational Engineering and
   Experimenting (ACEX)
CY JUN 30-JUL 03, 2014
CL Paris, FRANCE
DE Additive manufacturing; 3D printing; Unit cells; Periodic structure;
   Biomaterial
AB The presented work involved the design, manufacture and testing of three-dimensional scaffolds with the aim of advancing the field of bio-scaffolds from a mechanical prospective. Three different scaffold structure configurations were tested in regards to stiffness, ultimate stress and their fracture behavior. The configurations were named after the unit-cell geometry which they are based on, 0 degrees-90 degrees cylinder structure, 0 degrees-90 degrees holes in cube structure and negative body centered cubic structure (negative BCC). It could be shown that the negative BCC configuration shows the best performance with respect to the mechanical behavior under compression force.
C1 [Hughes, Gideon; Ochsner, Andreas] Griffith Univ, Sch Engn, Gold Coast, Australia.
RP Hughes, G (reprint author), Griffith Univ, Sch Engn, Gold Coast, Australia.
EM gideon.hughes@griffithuni.edu.au; a.oechsner@griffith.edu.au
CR Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017
   Dao D., 2014, LECT NOTES
   Greaves GN, 2011, NAT MATER, V10, P823, DOI [10.1038/NMAT3134, 10.1038/nmat3134]
   GRENDA E, 2007, MED APPL RAPID PROTO
   Hajar S., 2011, ACTA BIOMATER, V7
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Olson Jennifer L, 2011, Chonnam Med J, V47, P1, DOI 10.4068/cmj.2011.47.1.1
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Yen HJ, 2009, BIOMED MICRODEVICES, V11, P615, DOI 10.1007/s10544-008-9271-7
NR 9
TC 3
Z9 3
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1869-8433
BN 978-3-319-19470-7; 978-3-319-19469-1
J9 ADV STRUCT MAT
PY 2015
VL 71
BP 133
EP 179
DI 10.1007/978-3-319-19470-7_9
PG 47
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Theory & Methods
SC Computer Science
GA BF3JJ
UT WOS:000380548700009
DA 2018-10-19
ER

PT S
AU Gutierrez, TJ
   Morales, NJ
   Tapia, MS
   Perez, E
   Fama, L
AF Gutierrez, Tomy J.
   Morales, Noe J.
   Soledad Tapia, Maria
   Perez, Elevina
   Fama, Lucia
BA Schvezov, CE
BF Schvezov, CE
TI Corn Starch 80:20 "Waxy":Regular, "Native" and Phosphated, as
   Bio-Matrixes for Edible Films
SO INTERNATIONAL CONGRESS OF SCIENCE AND TECHNOLOGY OF METALLURGY AND
   MATERIALS, SAM - CONAMET 2013
SE Procedia Materials Science
LA English
DT Proceedings Paper
CT International Congress of Science and Technology of Metallurgy and
   Materials (SAM CONAMET)
CY AUG 20-23, 2013
CL Puerto Iguazu, ARGENTINA
DE Starch; Chemical modification; Corn; Edible films; Biomaterial
ID WATER-VAPOR PERMEABILITY; MECHANICAL-PROPERTIES; BARRIER PROPERTIES;
   COATINGS; GLYCEROL; GELATIN; GELLAN; WHEAT
AB Films made from starches are colorless, tasteless, non-toxic, biodegradable, and economical, besides having a low permeability to oxygen. Moreover, the cross-linking modification (phosphatation) could improve its physicochemical properties by reinforcing the hydrogen links inside the granules. The goals of this study were to elaborate and characterize starch corn films 80:20 "waxy":regular, from native and modified (cross-linked), to define their potential application. Results showed, that films with modified starch had highest hydrophilic properties which increased its thickness, permeability and solubility, and with mayor stability in acidic and alkaline medium. Finally, physicochemical properties and water vapor barrier data of the films denote the strong interaction phosphated starch-plasticizer. (C) 2015 The Authors. Published by Elsevier Ltd.
C1 [Gutierrez, Tomy J.; Soledad Tapia, Maria; Perez, Elevina] Cent Univ Venezuela, Fac Ciencias, Inst Ciencia & Tecnol Alimentos, Apartado 47097, Caracas 1041A, Venezuela.
   [Morales, Noe J.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET UBA, INQUIMAE, RA-1428 Buenos Aires, DF, Argentina.
   [Fama, Lucia] Univ Buenos Aires, LP&MC, Dept Fis, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina.
   [Fama, Lucia] Univ Buenos Aires, IFIBA CONICET, Buenos Aires, DF, Argentina.
RP Gutierrez, TJ (reprint author), Cent Univ Venezuela, Fac Ciencias, Inst Ciencia & Tecnol Alimentos, Apartado 47097, Caracas 1041A, Venezuela.
EM tomy.gutierrez@ciens.ucv.ve
OI Gutierrez, Tomy/0000-0001-9968-7778
CR Alejandra Rojas-Graue Maria, 2007, Alimentaria, P105
   Bello-Perez L. A., 2002, Agrociencia (Montecillo), V36, P169
   Chillo S, 2008, J FOOD ENG, V88, P159, DOI 10.1016/j.jfoodeng.2008.02.002
   Fama L, 2013, TECHNOLOGICAL ADVANC
   Fama L, 2005, J LEBENSM WISS TECHN, V38, P631
   Garcia MA, 1998, J SCI FOOD AGR, V76, P411, DOI 10.1002/(SICI)1097-0010(199803)76:3<411::AID-JSFA965>3.0.CO;2-I
   GENNADIOS A, 1994, J FOOD ENG, V21, P395, DOI 10.1016/0260-8774(94)90062-0
   Ghanbarzadeh B, 2010, INNOV FOOD SCI EMERG, V11, P697, DOI 10.1016/j.ifset.2010.06.001
   GONTARD N, 1993, J FOOD SCI, V58, P206, DOI 10.1111/j.1365-2621.1993.tb03246.x
   Gutierrez T. J., 2013, PROPIEDADES FISICAS
   Hu GF, 2009, CARBOHYD POLYM, V76, P291, DOI 10.1016/j.carbpol.2008.10.032
   Jongjareonrak A, 2006, FOOD HYDROCOLLOID, V20, P492, DOI 10.1016/j.foodhyd.2005.04.007
   Kaur L, 2004, CARBOHYD POLYM, V55, P211, DOI 10.1016/j.carbpol.2003.09.011
   Krotchta JM, 1997, J FOOD TECHNOL CHICA, V51, P2
   Lawton JW, 1996, CARBOHYD POLYM, V29, P203, DOI 10.1016/0144-8617(96)00028-8
   Lee KY, 2004, CARBOHYD POLYM, V56, P251, DOI 10.1016/j.carbpol.2003.04.001
   LIGHT JM, 1990, CEREAL FOOD WORLD, V35, P1081
   LIM S, 1993, CEREAL CHEM, V70, P137
   Lu YS, 2005, CARBOHYD POLYM, V61, P174, DOI 10.1016/j.carbpol.2005.04.013
   Mali S, 2004, CARBOHYD POLYM, V56, P129, DOI 10.1016/j.carbpol.2004.01.004
   Matos M. E., 2003, J CEREAL FOOD WORLD, V48, P78
   McHugh T.H., 1994, EDIBLE COATINGS FILM, P139
   MCHUGH TH, 1993, J FOOD SCI, V58, P899, DOI 10.1111/j.1365-2621.1993.tb09387.x
   Melian D., 2006, DESARROLLO PELICULA
   Moorthy S. N., 1994, TECH B SERIES CENTRA, V18, P40
   Perez E, 2012, J CELL PLAST, V48, P545, DOI 10.1177/0021955X12445603
   ROMEROBASTIDAS CA, 2005, J CARBOHYDR POLYM, V60, P235, DOI DOI 10.1016/J.CARBPOL.2005.01.004
   Sivoli L., 2009, THESIS
   Sothornvit R, 2001, J FOOD ENG, V50, P149, DOI 10.1016/S0260-8774(00)00237-5
   Swinkels JJ, 1985, HANBOOK FOOD ADDITIV, VI
   Tapia M., 2007, THESIS
   Tharanathan RN, 2003, TRENDS FOOD SCI TECH, V14, P71, DOI 10.1016/S0924-2244(02)00280-7
   Wurzburg O.B, 1986, MODIFIED STARCHES PR
   WURZBURG OB, 1970, J AGR FOOD CHEM, V18, P997, DOI 10.1021/jf60172a030
   Yang L, 2000, FOOD RES INT, V33, P563, DOI 10.1016/S0963-9969(00)00092-2
NR 35
TC 15
Z9 15
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2211-8128
J9 PROC MAT SCI
PY 2015
VL 8
BP 304
EP 310
DI 10.1016/j.mspro.2015.04.077
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BF2WT
UT WOS:000380505600036
OA Other Gold
DA 2018-10-19
ER

PT B
AU Lara, H
   Rodriguez, C
   Mendoza-Buenrostro, C
AF Lara, Hernan
   Rodriguez, Ciro
   Mendoza-Buenrostro, Christian
BE Monsalve, C
   Sanchez, A
   Chaczko, Z
TI Fuzzy inference system applied to mechanical design of bone tissue
   engineering scaffolds
SO 2015 ASIA-PACIFIC CONFERENCE ON COMPUTER-AIDED SYSTEM ENGINEERING -
   APCASE 2015
LA English
DT Proceedings Paper
CT 2015 Asia-Pacific Conference on Computer Aided System Engineering
CY JUL 14-16, 2015
CL Quito, ECUADOR
SP Univ San Francisco, IEEE, IEEE Comp Soc, Escuela Super Politecn Litoral, Univ Politecn SALESIANA Ecuador, UTS Engn & Informat Technol, Univ Technol Sydney, Oberosterreich, BINUS Univ People Innovat Excellence, ULPGC, Wroclaw Univ Technol, BCDS Solutions
DE scaffold; bone tissue; fuzzy system; biomaterial properties
AB Solid free form fabrication are now being developed to fabricate scaffolds with controlled architecture for bone tissue engineering. These techniques use computer-aided design (CAD) to aid the design of optimized three-dimensional structures in a large number of materials. The development of mechanical models to simulate the scaffolds behavior for bone tissue engineering represents a relevant area in regenerative medicine. This paper presents a computer tool to design tailored scaffolds as a function of mechanical properties considering a specific kind of bone tissue. The kernel of this tool is formed from a fuzzy inference system (FIS) and a parametric design algorithm. The models obtained from this methodology were evaluated using finite element analysis (FEA) and they exhibit suitable features and characteristics to be used in experimental case studies.
C1 [Lara, Hernan; Rodriguez, Ciro; Mendoza-Buenrostro, Christian] Tecnol Monterrey, Ctr Innovac Diseno & Tecnol, E Garza Sada 2501, Monterrey, Mexico.
   [Lara, Hernan] Univ Fuerzas Armadas ESPE, DECEM, Sangolqui, Ecuador.
RP Lara, H (reprint author), Tecnol Monterrey, Ctr Innovac Diseno & Tecnol, E Garza Sada 2501, Monterrey, Mexico.
OI Mendoza-Buenrostro, Christian/0000-0003-2509-0025
CR Almeida HA, 2014, MED ENG PHYS, V36, P1033, DOI 10.1016/j.medengphy.2014.05.006
   Bayraktar H., 2004, J BIOMECH, V37, P27
   Doppalapudi S, 2015, ADV POLYM MED, P33
   Guldberg R., 2010, FDN REGENERATIVE MED, P260
   Heise R. L., 2015, ADV POLYM MED, P177
   Hollister S., 2005, BONE TISSUE ENG, P168
   Hudson D. L., 2000, NEURAL NETWORKS ARTI
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kovalovs M., 2013, 17 INT C BIOM ENG KA
   Liu YC, 2013, BIOTECHNOL ADV, V31, P688, DOI 10.1016/j.biotechadv.2012.10.003
   Malo MKH, 2013, BONE, V53, P451, DOI 10.1016/j.bone.2013.01.015
   Reichert JC, 2011, TISSUE ENGINEERING: FROM LAB TO CLINIC, P431, DOI 10.1007/978-3-642-02824-3_21
   Ross T.J., 2010, FUZZY LOGIC ENG APPL
   Thavornyutikarn B., 2014, PROG BIOMATER, V3, P61
   TURNER CH, 2001, BONE MECH HDB
   Wolfe PS, 2011, TISSUE ENGINEERING: FROM LAB TO CLINIC, P41, DOI 10.1007/978-3-642-02824-3_3
NR 16
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4799-7588-4
PY 2015
BP 409
EP 413
DI 10.1109/APCASE.2015.79
PG 5
WC Engineering, Electrical & Electronic
SC Engineering
GA BF1JY
UT WOS:000380403600064
DA 2018-10-19
ER

PT S
AU Farcasiu, AT
   Farcasiu, C
   Tanasescu, LA
   Andrei, OC
   Stefanescu, DM
   Munteanu, A
AF Farcasiu, Alexandru-Titus
   Farcasiu, Catalina
   Tanasescu, Livia-Alice.
   Andrei, Oana Cella
   Stefanescu, Dan Mihai
   Munteanu, Aneta
GP IEEE
TI In-vitro and in-vivo evaluation of two surface treatments on a
   commercial denture base biomaterial
SO 2015 E-HEALTH AND BIOENGINEERING CONFERENCE (EHB)
SE E-Health and Bioengineering Conference
LA English
DT Proceedings Paper
CT E-Health And Bioengineering Conference (EHB)
CY NOV 19-21, 2015
CL Iasi, ROMANIA
SP IEEE, IEEE-EMB Romania Chapter, Inst Comp Sci Roamanian Acad Iasi Branch, Romanian Soc Med Bioengineering, IEEE Romania Sect, EHB
DE denture base; plasma deposition; sandblasting; wettability; digital
   measurement
ID ACRYLIC RESIN SURFACES; PLASMA TREATMENT; GLOW-DISCHARGE; WETTABILITY;
   SALIVA; RETENTION
AB Denture base materials are involved in the edentulous patient's therapy as part of a three component system: underlying tissue, saliva and denture. Saliva's properties are influenced by a wide range of factors therefore xerostomic signs and symptoms can be seen increasingly often, especially in geriatric patients. Extensive use of available saliva is possible only respecting clinical design principles and is enhanced by surface treatments. Plasma deposition and sandblasting effect on a commercial denture base material were analyzed in a comparative approach. Wettability with natural saliva represented the in-vitro evaluation of the biological process, while measurement of retention force of palatal plates defined the in-vivo section. Both techniques increased wettability and retention force, plasma deposition proving to be more effective than sandblasting. The difference between in vitro and in vivo experiments may due to variation of quantity and quality of saliva, emphasizing its role in complete denture retention.
C1 [Farcasiu, Alexandru-Titus; Farcasiu, Catalina; Tanasescu, Livia-Alice.; Andrei, Oana Cella; Munteanu, Aneta] Carol Davila Univ Med & Pharm Bucharest, Bucharest, Romania.
   [Stefanescu, Dan Mihai] Romanian Measurement Soc, Bucharest, Romania.
RP Farcasiu, AT (reprint author), Carol Davila Univ Med & Pharm Bucharest, Bucharest, Romania.
RI ANDREI, OANA CELLA/P-6128-2014
OI ANDREI, OANA CELLA/0000-0001-7960-4488
CR Anil S., 2014, HONG KONG DENT J, DOI 10.1111/jicd.12120
   Cha S, 2014, CHINESE J PROSTHODON, P4
   Cha S, 2014, CLIN PLASMA MED, V2, P4, DOI 10.1016/j.cpme.2014.04.002
   Chai JN, 2004, LANGMUIR, V20, P10919, DOI 10.1021/la048947s
   Chitre V., 2008, J INDIAN PROSTHODONT, V8, P30
   Etienne O, 2006, J DENT RES, V85, P44, DOI 10.1177/154405910608500107
   Farcasiu AT, 2011, ROM J ORAL REHABIL, V3, P95
   Hahnel S, 2014, J DENT, V42, P664, DOI 10.1016/j.jdent.2014.03.003
   Han P, 2015, J PROSTHODONT RES, V59, P6, DOI 10.1016/j.jpor.2014.11.001
   Hidetoshi O., 2004, OHU U DENT J, V31, P201
   Husham AM, 2006, AM J DENT, V19, P115
   Kaluzny Jaroslaw, 2014, Otolaryngol Pol, V68, P1, DOI 10.1016/j.otpol.2013.09.002
   Kikuchi M, 1999, J PROSTHET DENT, V81, P399, DOI 10.1016/S0022-3913(99)80005-5
   Kuhar M, 2005, J PROSTHET DENT, V93, P76, DOI 10.1016/j.prosdent.2004.10.002
   Lee J. H., 2001, J KOREAN ACAD PROSTH, V39, P58
   Leun K. C. M, 2005, HONGKONG DENT J, V2, P132
   Murray M D, 1989, Int J Prosthodont, V2, P234
   Murray M.D., 1989, BIOMED RES INT, V2, P234
   Murray MD, 1989, THESIS
   NAVAZESH M, 1992, J DENT RES, V71, P1275, DOI 10.1177/00220345920710060201
   Nobuko K., 2001, J KANAGAWA ODONTOLOG, V36, P63
   Ozden N, 1999, J PROSTHET DENT, V82, P680, DOI 10.1016/S0022-3913(99)70009-0
   Park MS, 2007, ORAL DIS, V13, P181, DOI 10.1111/j.1601-0825.2006.01263.x
   Schipper RG, 2007, ARCH ORAL BIOL, V52, P1114, DOI 10.1016/j.archoralbio.2007.06.009
   Shetty SR, 2012, CONTEMP CLIN DENT, V3, P173, DOI 10.4103/0976-237X.96821
   Stefanescu DM, 2011, HANDBOOK OF FORCE TRANSDUCERS: PRINCIPLES AND COMPONENTS, P1
   Tokita Takuya, 2007, Journal of Medical and Dental Sciences, V54, P177
   Xu H, 2003, MATER CHEM PHYS, V80, P278, DOI 10.1016/S0254-0584(02)00490-X
   Yildirim MS, 2006, J ORAL REHABIL, V33, P775, DOI 10.1111/j.1365-2842.2006.01646.x
   Yodmongkol S, 2014, J PROSTHET DENT, V112, P1530, DOI 10.1016/j.prosdent.2014.06.019
   Zamperini CA, 2010, ARCH ORAL BIOL, V55, P763, DOI 10.1016/j.archoralbio.2010.06.015
   Zhang HQ, 2010, DENT MATER J, V29, P398, DOI 10.4012/dmj.2009-124
   Zissis A, 2001, QUINTESSENCE INT, V32, P457
NR 33
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2575-5137
EI 2575-5145
BN 978-1-4673-7545-0
J9 E-HEALTH BIOENG CONF
PY 2015
PG 4
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BF1HQ
UT WOS:000380397900149
DA 2018-10-19
ER

PT S
AU RossemaryApetroaei, M
   Manea, AM
   Tihan, GT
   Zgarian, RG
   Schroder, V
   Lilios, G
   Apetroaei, MG
   Rau, I
AF RossemaryApetroaei, Manuela
   Manea, Ana-Maria
   Tihan, Gratiela Teodora
   Zgarian, Roxana Gabriela
   Schroder, Verginica
   Lilios, Gabriela
   Apetroaei, Marius Gabriel
   Rau, Ileana
GP IEEE
TI Chitosan an eco-friendly biomaterial from marine invertebrates
SO 2015 E-HEALTH AND BIOENGINEERING CONFERENCE (EHB)
SE E-Health and Bioengineering Conference
LA English
DT Proceedings Paper
CT E-Health And Bioengineering Conference (EHB)
CY NOV 19-21, 2015
CL Iasi, ROMANIA
SP IEEE, IEEE-EMB Romania Chapter, Inst Comp Sci Roamanian Acad Iasi Branch, Romanian Soc Med Bioengineering, IEEE Romania Sect, EHB
DE marine organisms; chitosan; spawning; crustaceans
ID PHYSICOCHEMICAL CHARACTERISTICS; CHITIN; EXTRACTION; PRODUCTS
AB Marine organisms are formed by bio compounds with a lot of properties and characteristics that may justify their potential applications within the biomedical field. Assuring the exploitation of natural marine resources and the valorization of residues from marine origin, like those obtained from food processing, represent a highly interesting platform for development of novel eco-friendly biomaterials, with higher benefits due to the fact that the source is practically inexhaustible.
   This study involves the extraction and identification of chitosan from samples of invertebrates organisms by chemical extraction method. The samples of aquatic organisms consist of exoskeleton of crab and spawning of gastropoda.
   This paper presents the possible raw materials for production of chitosan extracted from marine organisms and the characterization of the chitosan extract.
C1 [RossemaryApetroaei, Manuela; Manea, Ana-Maria; Tihan, Gratiela Teodora; Rau, Ileana] Univ Politehn Bucuresti, Dept Gen Chem, Bucharest, Romania.
   [Schroder, Verginica; Lilios, Gabriela] Ovidius Univ, Dept Farmaceut Sci, Constanta, Romania.
   [Apetroaei, Marius Gabriel] Mircea Cel Batran Naval Acad, Navigat Dept, Constanta, Romania.
RP Rau, I (reprint author), Univ Politehn Bucuresti, Dept Gen Chem, Bucharest, Romania.
EM ileana_brandusa@yahoo.com
CR Abdou ES, 2008, BIORESOURCE TECHNOL, V99, P1359, DOI 10.1016/j.biortech.2007.01.051
   Al Sagheer FA, 2009, CARBOHYD POLYM, V77, P410, DOI 10.1016/j.carbpol.2009.01.032
   Bacescu M., 1967, DECAPODA FAUNA R S R, P20
   Bigatti G, 2010, J MOLLUS STUD, V76, P279, DOI 10.1093/mollus/eyq006
   Chen PY, 2008, ACTA BIOMATER, V4, P587, DOI 10.1016/j.actbio.2007.12.010
   Cho YI, 1998, J AGR FOOD CHEM, V46, P3839, DOI 10.1021/jf971047f
   Galed G, 2008, NAT PROD COMMUN, V3, P543
   KNORR D, 1984, FOOD TECHNOL-CHICAGO, V38, P85
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Lertsutthiwong P., 2002, J METALS MAT MINERAL, V12, P11
   Mitra T, 2013, MATER RES-IBERO-AM J, V16, P755, DOI [10.1590/S1516-14392013000400009, 10.1590/S1516-14392013005000059]
   No H. K., 1995, Journal of Aquatic Food Product Technology, V4, P27, DOI 10.1300/J030v04n02_03
   No HK, 2000, J FOOD SCI, V65, P1134, DOI 10.1111/j.1365-2621.2000.tb10252.x
   Peniche C, 2008, MONOMERS, POLYMERS AND COMPOSITES FROM RENEWABLE RESOURCES, P517, DOI 10.1016/B978-0-08-045316-3.00025-9
   Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001
   Rawlings TA, 1999, AM ZOOL, V39, P230
NR 16
TC 0
Z9 0
U1 1
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2575-5137
EI 2575-5145
BN 978-1-4673-7545-0
J9 E-HEALTH BIOENG CONF
PY 2015
PG 4
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BF1HQ
UT WOS:000380397900260
DA 2018-10-19
ER

PT B
AU Fanous, M
   Ozhikandathil, J
   Badilescu, S
   Packirisamy, M
AF Fanous, Michael
   Ozhikandathil, Jayan
   Badilescu, Simona
   Packirisamy, Muthukumaran
GP IEEE
TI Evaluation Of Optical Properties And Biocompatibility Of Polymer
   Materials For Microfluidic Applications
SO 2015 PHOTONICS NORTH
LA English
DT Proceedings Paper
CT Photonics North 2015
CY JUN 09-11, 2015
CL Ottawa, CANADA
ID PROTEIN
AB Microfluidic technologies have become increasingly effective for diagnostic, physiological, and biochemical applications. The biocompatibility of MEMS devices, which are evolving rapidly in their practicality, has become the paramount property to investigate and optimize through biological and optical testing. Potential applications comprise cell culture, biosensing, immunoisolation, bioparticle sorting, and biomaterial synthesis. In this work we undertake the study of various polymer and nanocomposite materials, such as cyclic olefin copolymer (COC), polymethylmethacrylate (PMMA), polydimethylsiloxane (PDMS), SU-8, polycarbonate (PC) and polystyrene (PS). After the polymer is adequately functionalized, tagged antibodies are attached to the polymer films and, then, the corresponding antigens are brought in contact with the antibodies. The work is novel and complements the contemporary research involving other methods to evaluate the biocompatibility, such as for example, cell culture. The affinity of antibodies toward the polymer is evaluated by the amount of attached antibodies measured by fluorescence spectroscopy.
C1 [Fanous, Michael; Ozhikandathil, Jayan; Badilescu, Simona; Packirisamy, Muthukumaran] Concordia Univ, Mech & Ind Engn Dept, Opt Bio Microsyst Lab, Montreal, PQ, Canada.
RP Fanous, M (reprint author), Concordia Univ, Mech & Ind Engn Dept, Opt Bio Microsyst Lab, Montreal, PQ, Canada.
CR Becker H, 2002, TALANTA, V56, P267, DOI 10.1016/S0039-9140(01)00594-X
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Christie R. J, BIOCOMPATIBLE UNPUB
   Cristina I., 2012, INTECH, P47
   Mann K. G., 1978, BIOCHEMSTRY, V78, P0417
   Masson JF, 2005, TALANTA, V67, P918, DOI 10.1016/j.talanta.2005.04.023
   Masson JF, 2004, TALANTA, V64, P716, DOI 10.1016/j.talanta.2004.03.051
   Midwoud P. M., 2010, BIOCOMPATIBILITY ADS, P137
   Ozhikandathil J., 2010, GOLD NANOISLAND STRU
   Ozhikandathil J, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.017006
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P61, DOI 10.1007/BF00839070
   Swatowski B. W, 2013, FLEXIBLE STABLE EASI
   Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509
   Young EWK, 2011, ANAL CHEM, V83, P1408, DOI 10.1021/ac102897h
NR 14
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4673-6806-3
PY 2015
PG 4
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BF2ID
UT WOS:000380469700008
DA 2018-10-19
ER

PT B
AU Vaz, P
   Fernandes, MS
   Gois, F
   Braga, A
   Fernandes, JCS
   Felino, A
AF Vaz, Paula
   Fernandes, Margarida Sampaio
   Gois, Francisco
   Braga, Ana
   Sampaio Fernandes, J. C.
   Felino, Antonio
BE Gomes, JFS
   Meguid, SA
TI GTR WITH DENTAL IMPLANTS REHABILITATION OUTCOME AND IL1 GENE
   POLYMORPHISMS
SO M2D2015: PROCEEDINGS OF THE 6TH INTERNATIONAL CONFERENCE ON MECHANICS
   AND MATERIALS IN DESIGN
LA English
DT Proceedings Paper
CT 6th International Conference on Mechanics and Materials in Design (M2D)
CY JUL 26-30, 2015
CL P Delgada, PORTUGAL
SP Univ Porto, Unit Toronto, Univ Azores, Univ Porto, Faculdade Engn, Univ Toronto, Mech & Aerosp Design Lab, Univ Azores, DCDT, Governo Reg Acores, Portuguese Assoc Experimental Mech, European Soc Experimental Mech, Amer Soc Experimental Mech, British Soc Strain Measurement, Japanese Soc Mech Engn, Int Measurement Confederat, Assoc Francaise Mecanique, European Assoc Dynam Mat, Inst Engn Mecanica Gestao Ind, Laboratorio Biomecanica Porto, Fundacao Ciencia Tecnologia, Profess Congress Org
DE biomaterials; IL-1 gene polymorphisms; dental implants rehabilitation;
   GTR
ID GUIDED TISSUE REGENERATION; INTRABONY DEFECTS; PERIODONTAL REGENERATION
AB This study aims to present the relation between dental implants rehabilitations outcome (result success and no success) performed with guided tissue regeneration (GTR) and the IL1 gene polymorphisms (positions IL1A-889, IL1B+3953) in a Portuguese Caucasian population.
   In a sample composed by seventy unrelated patients rehabilitated together with GTR [resorbable membrane Bio-Gide (R) (Geistlich Pharma, Switzerland) and bone reconstruction biomaterial Bio-Oss (R) (Geistlich, Switzerland)-and dental implants, a oral evaluation and a genetic test (TGP (R), CGC genetics) for combined detection of IL1 polymorphisms were performed. The statistical analysis revealed that successful results of dental implant rehabilitations with GTR procedures were more related to the presence of allele1 of IL1A and IL1B genes.
C1 [Vaz, Paula] Univ Porto, Fac Med Dent, Med & Orofacial Genet, Oporto, Portugal.
   [Fernandes, Margarida Sampaio; Gois, Francisco] Univ Porto, Fac Med Dent, Oporto, Portugal.
   [Braga, Ana] U Minho, Div Stat, Dept Prod & Syst Engn, Braga, Portugal.
   [Sampaio Fernandes, J. C.] Univ Porto, Fac Med Dent, Dept Fixed Prosthesis, Oporto, Portugal.
   [Felino, Antonio] Univ Porto, Fac Med Dent, Dept Oral Surg, Oporto, Portugal.
RP Vaz, P (reprint author), Univ Porto, Fac Med Dent, Med & Orofacial Genet, Oporto, Portugal.
EM pvaz@fmd.up.pt
RI Braga, Ana Cristina/O-6628-2014
OI Braga, Ana Cristina/0000-0002-1991-9418
CR Christgau M, 2003, J PERIODONTAL RES, V38, P20, DOI 10.1034/j.1600-0765.2003.01373.x
   Cortellini P, 2000, PERIODONTOL 2000, V22, P104, DOI 10.1034/j.1600-0757.2000.2220108.x
   Galindo-Moreno P, 2005, CLIN ORAL IMPLAN RES, V16, P579, DOI 10.1111/j.1600-0501.2005.01148.x
   Kornman KS, 2000, PERIODONTOL 2000, V22, P22, DOI 10.1034/j.1600-0757.2000.2220103.x
   Slots J, 1999, PERIODONTOL 2000, V19, P164, DOI 10.1111/j.1600-0757.1999.tb00154.x
   Tonetti MS, 1996, J CLIN PERIODONTOL, V23, P548, DOI 10.1111/j.1600-051X.1996.tb01823.x
   TONETTI MS, 1995, J CLIN PERIODONTOL, V22, P229
   Vaz P, 2012, CLIN ORAL IMPLAN RES, V23, P1404, DOI 10.1111/j.1600-0501.2011.02322.x
NR 8
TC 0
Z9 0
U1 0
U2 1
PU INEGI-FEUP
PI PORTO
PA RUA DR ROBERTO FRIAS, PORTO, 4200-465, PORTUGAL
BN 978-989-98832-3-9
PY 2015
BP 1505
EP 1508
PG 4
WC Engineering, Biomedical; Engineering, Mechanical; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BF0DR
UT WOS:000378595500265
DA 2018-10-19
ER

PT B
AU Frattolin, J
   Gottellini, L
   Roy, R
   Bertrand, OF
   Mongrain, R
AF Frattolin, Jennifer
   Gottellini, Luca
   Roy, Ranjan
   Bertrand, Olivier F.
   Mongrain, Rosaire
BE Gomes, JFS
   Meguid, SA
TI EFFECT OF ANNEALING ON THE CORROSION RATE OF A NOVEL METALLIC AMALGAMATE
   FOR BIODEGRADABLE STENTS
SO M2D2015: PROCEEDINGS OF THE 6TH INTERNATIONAL CONFERENCE ON MECHANICS
   AND MATERIALS IN DESIGN
LA English
DT Proceedings Paper
CT 6th International Conference on Mechanics and Materials in Design (M2D)
CY JUL 26-30, 2015
CL P Delgada, PORTUGAL
SP Univ Porto, Unit Toronto, Univ Azores, Univ Porto, Faculdade Engn, Univ Toronto, Mech & Aerosp Design Lab, Univ Azores, DCDT, Governo Reg Acores, Portuguese Assoc Experimental Mech, European Soc Experimental Mech, Amer Soc Experimental Mech, British Soc Strain Measurement, Japanese Soc Mech Engn, Int Measurement Confederat, Assoc Francaise Mecanique, European Assoc Dynam Mat, Inst Engn Mecanica Gestao Ind, Laboratorio Biomecanica Porto, Fundacao Ciencia Tecnologia, Profess Congress Org
DE biomaterials; corrosion; biodegradable stent; cold spray
AB Achieving a controlled corrosion rate is a challenging prospect in the design process of a biodegradable stent. Investigations were conducted to determine the effect of annealing temperature and duration on the corrosion rate. A novel nanostructured biomaterial for stent application was utilized, fabricated using cold gas-dynamic spray technology with iron and stainless steel 316L powders. The results from the static immersion tests indicated that increasing the annealing parameters decreased the overall corrosion rate of the material.
C1 [Frattolin, Jennifer; Gottellini, Luca; Roy, Ranjan; Bertrand, Olivier F.; Mongrain, Rosaire] McGill Univ, Dept Mech Chem Engn, Montreal, PQ, Canada.
   [Frattolin, Jennifer; Mongrain, Rosaire] Montreal Heart Inst, Montreal, PQ, Canada.
   [Gottellini, Luca] Politecn Milan, Dept Chem Mat & Chem Engn, Milan, Italy.
   [Bertrand, Olivier F.] Univ Laval, Dept Intervent Cardiol, Quebec City, PQ, Canada.
RP Frattolin, J (reprint author), McGill Univ, Dept Mech Chem Engn, Montreal, PQ, Canada.
EM jennifer.frattolin@mail.mcgill.ca
CR Serruys PW, 2006, NEW ENGL J MED, V354, P483, DOI 10.1056/NEJMra051091
NR 1
TC 0
Z9 0
U1 0
U2 1
PU INEGI-FEUP
PI PORTO
PA RUA DR ROBERTO FRIAS, PORTO, 4200-465, PORTUGAL
BN 978-989-98832-3-9
PY 2015
BP 1583
EP 1584
PG 2
WC Engineering, Biomedical; Engineering, Mechanical; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BF0DR
UT WOS:000378595500281
DA 2018-10-19
ER

PT B
AU Sun, G
   Fang, Y
AF Sun, Gang
   Fang, Yan
BE Liu, HC
   Sung, WP
   WenliYao
TI Anisotropic property of the multiple-dimensional rough surface on moth
   wing
SO COMPUTING, CONTROL, INFORMATION AND EDUCATION ENGINEERING
LA English
DT Proceedings Paper
CT 2nd International Conference on Computer, Intelligent Computing and
   Education Technology (CICET)
CY APR 11-12, 2015
CL Guilin, PEOPLES R CHINA
DE Superhydrophobicity; Adhesion; Self-cleaning; Biomaterial; Moth wing
ID MECHANISM
AB The micro-morphology, superhydrophobicity, self-cleaning property and chemical composition of the moth wing surface were investigated by a Scanning Electron Microscope (SEM), a contact angle meter and a Fourier transform infrared spectrometer (FT-IR). The wetting mechanism of the moth wing was discussed from the perspective of biological coupling. The moth wing displays multiple-dimensional structural anisotropism. The micrometric scales constitute the primary structure, the submicrometric vertical ribs and horizontal bridges on the scales constitute the secondary structure, and the nano stripes on the vertical ribs and horizontal bridges constitute the tertiary structure. The moth wing surface is of superhydrophobicity (contact angle 150.5 similar to 158.4 degrees) and low adhesion (sliding angle 1 similar to 3 degrees). In addition, the water droplet exhibits anisotropic sliding behavior on the wing surface. The scale plays a crucial role in determining the self-cleaning property of the moth wing. The coupling effect of material element and structural element contributes to the special wettability of the wing surface. The moth wing can be potentially used as a template for biomimetic design of functional surface with complex wettability. This work may offer insights into the preparation of smart interfacial material and directional self-cleaning coatings.
C1 [Sun, Gang; Fang, Yan] Changchun Normal Univ, Sch Life Sci, Changchun, Peoples R China.
RP Sun, G (reprint author), Changchun Normal Univ, Sch Life Sci, Changchun, Peoples R China.
CR Fang Y, 2007, CHINESE SCI BULL, V52, P711, DOI 10.1007/s11434-007-0120-5
   Gleiche M, 2000, NATURE, V403, P173, DOI 10.1038/35003149
   Higgins AM, 2000, NATURE, V404, P476, DOI 10.1038/35006597
   Liu H, 2006, SOFT MATTER, V2, P811, DOI 10.1039/b606654b
   Sun TL, 2005, ACCOUNTS CHEM RES, V38, P644, DOI 10.1021/ar040224c
   Wang XJ, 2009, CHINESE SCI BULL, V54, P569, DOI 10.1007/s11434-009-0071-0
NR 6
TC 0
Z9 0
U1 0
U2 0
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-315-68589-2; 978-1-138-02800-5
PY 2015
BP 241
EP 243
PG 3
WC Automation & Control Systems; Computer Science, Theory & Methods;
   Engineering, Electrical & Electronic
SC Automation & Control Systems; Computer Science; Engineering
GA BE9JH
UT WOS:000377652000055
DA 2018-10-19
ER

PT B
AU Krupskaya, LT
   Rastanina, NK
   Gul, LP
   Zvereva, VP
   Volobueva, NG
AF Krupskaya, L. T.
   Rastanina, N. K.
   Gul, L. P.
   Zvereva, V. P.
   Volobueva, N. G.
BE Sung, WP
   Chen, R
TI Heavy Metal Content in Biomaterial as an Integrating Indicator of
   Technogenic Pollution Assessment of the Environment and Human Health
   Impact
SO MANUFACTURING, DESIGN SCIENCE AND INFORMATION ENGINEERING, VOLS I AND II
LA English
DT Proceedings Paper
CT International Conference on Frontiers of Manufacturing and Design
   Science (ICFMD)
CY DEC 18-19, 2015
CL Hong Kong, PEOPLES R CHINA
SP Control Engn & Informat Sci Res Assoc, Int Frontiers Sci & Technol Res Assoc, Natl Chin Yi Univ Technol, Integrated Res Ctr Green Living Tech, Trans Tech Publicat
DE technogenic pollution; environment; processing waste; tin raw materials;
   health
AB The article describes the results of long-term researches of heavy metals environment technogenic pollution with mineral processing waste, contributing to environmentally caused diseases of mining settlement population (Solnechny settlement in Khabarovskiy Krai). It was found that the heavy metals content in biomaterial is an integral indicator of the assessment of their impact on human health. The measures are proposed to decrease the negative waste impact on human morbidity.
C1 [Krupskaya, L. T.; Rastanina, N. K.] Pacific Natl Univ, Khabarovsk, Russia.
   [Krupskaya, L. T.; Gul, L. P.] Far East Sci Res Inst Forestry, Khabarovsk, Russia.
   [Zvereva, V. P.] Far East Fed Univ, Vladivostok, Russia.
   [Zvereva, V. P.] Far East Geol Inst FEB RAS, Vladivostok, Russia.
   [Volobueva, N. G.] Northeastern State Univ, Magadan, Russia.
RP Krupskaya, LT (reprint author), Pacific Natl Univ, Khabarovsk, Russia.
CR Gorgoshidze B.E., 2006, EXPT CLIN MED, V6, P60
   Gorovaya A. I., 2007, MINING NEWS B, V12, P123
   Gudkov A.V., 2004, INFECT PATHOLOGY PRI, P90
   Kharischarishvili I. Z., 2006, EXP CLIN MED, V7, P65
   Kolesnikov B.P., 1978, METHODS STUDY BIOGEO
   Krupskaya L.T., 2010, MINING NEWS B MAGAZI, V4, P349
   Krupskaya LT, 2012, ENVIRON MONIT ASSESS, V184, P2775, DOI 10.1007/s10661-011-2150-3
   Rastanina N.K., 2013, 3 INT REC C DNEPR, P312
   Rastanina N.K., 2007, FAR E, V15, P318
   Rastanina N.K., 2012, MINING INFORM ANAL B, V1, P207
   Sukachev C.O., 1961, METHODICAL RECOMMEND, P9
   Vernadsky V. I., 1967, BIOSPHERE
   Zonn S. V., 1974, PROGRAM MET BIOGEOCE, P215
NR 13
TC 0
Z9 0
U1 0
U2 0
PU DESTECH PUBLICATIONS, INC
PI LANCASTER
PA 439 DUKE STREET, LANCASTER, PA 17602-4967 USA
BN 978-1-60595-300-7
PY 2015
BP 1138
EP 1144
PG 7
WC Engineering, Industrial; Engineering, Manufacturing; Operations Research
   & Management Science
SC Engineering; Operations Research & Management Science
GA BE9IK
UT WOS:000377606200180
DA 2018-10-19
ER

PT S
AU Bragazzi, NL
   Gasparini, R
   Amicizia, D
   Panatto, D
   Larosa, C
AF Bragazzi, Nicola Luigi
   Gasparini, Roberto
   Amicizia, Daniela
   Panatto, Donatella
   Larosa, Claudio
BE Donev, R
TI Porous Alumina as a Promising Biomaterial for Public Health
SO ADVANCES IN PROTEIN CHEMISTRY AND STRUCTURAL BIOLOGY, VOL 101
SE Advances in Protein Chemistry and Structural Biology
LA English
DT Review; Book Chapter
ID ATOMIC LAYER DEPOSITION; BACILLUS-CEREUS SPORES; CROSS-FLOW FILTRATION;
   POPULATION HETEROGENEITY; NANOPOROUS MEMBRANE; OUTGROWTH HETEROGENEITY;
   BACTERIAL DETECTION; CERAMIC MEMBRANES; WASTE-WATER; CULTURE
AB Porous aluminum is a nanostructured material characterized by unique properties, such as chemical stability, regular uniformity, dense hexagonal porous lattice with high aspect ratio nanopores, excellent mechanical strength, and biocompatibility. This overview examines how the structure and properties of porous alumina can be exploited in the field of public health. Porous alumina can be employed for fabricating membranes and filters for bioremediation, water ultrafiltration, and microfiltration/nanofiltration, being a promising technique for having clean and fresh water, which is essential for human health. Porous alumina-based nanobiosensor coated with specific antibodies or peptides seem to be a useful tool to detect and remove pathogens both in food and in water, as well as for environmental monitoring. Further, these applications, being low-energy demanding and cost-effective, are particularly valuable in resource-limited settings and contexts, and can be employed as point of use devices in developing countries, where there is an urgent need of hygiene and safety assurance.
C1 [Bragazzi, Nicola Luigi; Gasparini, Roberto; Amicizia, Daniela; Panatto, Donatella] Univ Genoa, Dept Hlth Sci DISSAL, Via Antonio Pastore 1, Genoa, Italy.
   [Larosa, Claudio] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy.
RP Gasparini, R (reprint author), Univ Genoa, Dept Hlth Sci DISSAL, Via Antonio Pastore 1, Genoa, Italy.
EM robertobragazzi@gmail.com
OI Bragazzi, Nicola/0000-0001-8409-868X
CR Ashraf A., 2012, AICHE 2012 2012 AICH
   Basu M, 2004, GLYCOCONJUGATE J, V21, P487, DOI 10.1007/s10719-004-5539-1
   Binh TTN, 2012, BIOELECTROCHEMISTRY, V88, P15, DOI 10.1016/j.bioelechem.2012.04.006
   Chai C, 2010, SENSORS-BASEL, V10, P11414, DOI 10.3390/s101211414
   Chai C, 2010, SENSORS-BASEL, V10, P655, DOI 10.3390/s100100655
   Chan KY, 2013, BIOSENS BIOELECTRON, V41, P532, DOI 10.1016/j.bios.2012.09.016
   Chen DD, 2002, ANAL BIOANAL CHEM, V372, P737, DOI 10.1007/s00216-001-1214-6
   Chua YT, 2013, CHEM COMMUN, V49, P4534, DOI 10.1039/c3cc40434j
   den Besten HMW, 2007, APPL ENVIRON MICROB, V73, P4797, DOI 10.1128/AEM.00404-07
   den Besten HMW, 2010, APPL ENVIRON MICROB, V76, P927, DOI 10.1128/AEM.01372-09
   den Hertog AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011008
   Durtschi JD, 2005, J MED MICROBIOL, V54, P843, DOI 10.1099/j.mm.0.46092-0
   Fang H, 2012, J MEMBRANE SCI, V403, P41, DOI 10.1016/j.memsci.2012.02.011
   Ferrari BC, 2005, APPL ENVIRON MICROB, V71, P8714, DOI 10.1128/AEM.71.12.8714-8720.2005
   Gefen O, 2008, TRENDS BIOTECHNOL, V26, P345, DOI 10.1016/j.tibtech.2008.03.007
   Hong SU, 2007, LANGMUIR, V23, P1716, DOI 10.1021/la061701y
   Hong YC, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3272089
   Hua M, 2012, J HAZARD MATER, V211, P317, DOI 10.1016/j.jhazmat.2011.10.016
   Ingham CJ, 2008, INT J TUBERC LUNG D, V12, P645
   Ingham CJ, 2005, APPL ENVIRON MICROB, V71, P8978, DOI 10.1128/AEM.71.12.8978-8981.2005
   Ingham C, 2010, LAB CHIP, V10, P1410, DOI 10.1039/b925796a
   Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104
   Ingham CJ, 2006, J MED MICROBIOL, V55, P1511, DOI 10.1099/jmm.0.46585-0
   Ingham CJ, 2012, BIOTECHNOL ADV, V30, P1089, DOI 10.1016/j.biotechadv.2011.08.005
   Ingham CJ, 2008, APPL ENVIRON MICROB, V74, P7750, DOI 10.1128/AEM.00982-08
   IWASAKI K, 1993, PROCESS BIOCHEM, V28, P39, DOI 10.1016/0032-9592(94)80034-0
   IWASAKI KI, 1992, J FERMENT BIOENG, V73, P375, DOI 10.1016/0922-338X(92)90282-Y
   Izuhara S, 2001, CERAM T, V112, P553
   Jagminas A, 2015, DALTON T, V44, P4512, DOI 10.1039/c4dt03644a
   Javaid A, 2006, J MEMBRANE SCI, V275, P255, DOI 10.1016/j.memsci.2005.09.038
   Kang WS, 2010, SURF COAT TECH, V205, pS418, DOI 10.1016/j.surfcoat.2010.08.138
   Lee KP, 2013, J MEMBRANE SCI, V435, P52, DOI 10.1016/j.memsci.2013.01.051
   Lee W, 2014, CHEM REV, V114, P7487, DOI 10.1021/cr500002z
   Lei L, 1997, WATER SCI TECHNOL, V35, P311, DOI 10.1016/S0273-1223(97)00040-1
   Li LX, 2004, J COLLOID INTERF SCI, V273, P540, DOI 10.1016/j.jcis.2003.09.008
   Liew MKH, 1997, BIOTECHNOL BIOENG, V56, P89, DOI 10.1002/(SICI)1097-0290(19971005)56:1<89::AID-BIT10>3.0.CO;2-5
   Ling ZY, 2015, SPRINGER SER MATER S, V219, P1, DOI 10.1007/978-3-319-20334-8_1
   Liu TY, 2012, J NANOSCI NANOTECHNO, V12, P5004, DOI 10.1166/jnn.2012.4941
   MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466
   Mishra NN, 2008, NSTI NANOTECH 2008, VOL 3, TECHNICAL PROCEEDINGS, P343
   Mizuno T., 1999, 12 FALL M CER SOC JA
   Moon JM, 2009, BIOMED MICRODEVICES, V11, P135, DOI 10.1007/s10544-008-9217-0
   Moueddeb H, 1996, J MEMBRANE SCI, V114, P59, DOI 10.1016/0376-7388(95)00307-X
   Narayan RJ, 2010, MATER TODAY, V13, P60, DOI 10.1016/S1369-7021(10)70035-3
   Narayan RJ, 2010, PHILOS T R SOC A, V368, P2033, DOI 10.1098/rsta.2010.0011
   Neubacher H, 2014, LANGMUIR, V30, P4767, DOI 10.1021/la500358h
   Nguyen BTT, 2009, ANAL CHEM, V81, P7226, DOI 10.1021/ac900761a
   Nishinaga O, 2013, SCI REP-UK, V3, DOI 10.1038/srep02748
   Nishiyama N, 2003, J MEMBRANE SCI, V218, P165, DOI 10.1016/S0376-7388(03)00169-8
   Oliveira F. R., 2015, DESALINATIO IN PRESS
   OSULLIVAN JP, 1970, PROC R SOC LON SER-A, V317, P511, DOI 10.1098/rspa.1970.0129
   Pinheiro AFM, 2014, J MEMBRANE SCI, V463, P24, DOI 10.1016/j.memsci.2014.03.050
   Qi Hong, 2011, Journal of the Chinese Ceramic Society, V39, P239
   Ray M, 2015, J POROUS MAT, V22, P1043, DOI 10.1007/s10934-015-9978-9
   Rosa D. S., 2006, Cerâmica, V52, P167, DOI 10.1590/S0366-69132006000200008
   Sabbani S, 2010, MICROPOR MESOPOR MAT, V135, P131, DOI 10.1016/j.micromeso.2010.06.020
   Sabbatini P, 2010, WATER RES, V44, P5702, DOI 10.1016/j.watres.2010.05.059
   Schiza MV, 2005, APPL SPECTROSC, V59, P1068, DOI 10.1366/0003702054615188
   Silva K. K. O. S., 2015, DESALINATIO IN PRESS
   Skoog SA, 2012, MATER SCI ENG B-ADV, V177, P992, DOI 10.1016/j.mseb.2012.04.024
   Sondhi R, 2000, ENVIRON TECHNOL, V21, P699, DOI 10.1080/09593332108618086
   Sondhi R, 2000, J MEMBRANE SCI, V174, P111, DOI 10.1016/S0376-7388(00)00384-7
   Tan F, 2011, SENSOR ACTUAT B-CHEM, V159, P328, DOI 10.1016/j.snb.2011.06.074
   Tsou PH, 2010, BIOSENS BIOELECTRON, V26, P289, DOI 10.1016/j.bios.2010.06.034
   Tuaprakone T., 2011, IOP C SERIES MAT SCI, V18
   Van der Bruggen B, 2003, ENVIRON POLLUT, V122, P435, DOI 10.1016/S0269-7491(02)00308-1
   van Melis CCJ, 2014, INT J FOOD MICROBIOL, V177, P57, DOI 10.1016/j.ijfoodmicro.2014.02.015
   Wang ML, 2011, ANALYST, V136, P278, DOI 10.1039/c0an00510j
   Warda AK, 2015, INT J FOOD MICROBIOL, V201, P27, DOI 10.1016/j.ijfoodmicro.2015.02.010
   Wei HR, 2013, WATER RES, V47, P4139, DOI 10.1016/j.watres.2012.11.062
   Yagur-Kroll S, 2015, BIOSENS BIOELECTRON, V64, P625, DOI 10.1016/j.bios.2014.09.076
NR 71
TC 1
Z9 1
U1 0
U2 21
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1876-1623
BN 978-0-12-803368-5; 978-0-12-803367-8
J9 ADV PROTEIN CHEM STR
JI Adv. Protein Chem. Struct. Biol.
PY 2015
VL 101
BP 213
EP 229
DI 10.1016/bs.apcsb.2015.08.003
PG 17
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BE7PE
UT WOS:000375652700007
PM 26572980
DA 2018-10-19
ER

PT S
AU Racheva, M
   Romero, O
   Julich-Gruner, KK
   Ulrich, AS
   Wischke, C
   Lendlein, A
AF Racheva, M.
   Romero, O.
   Julich-Gruner, K-K
   Ulrich, A. S.
   Wischke, C.
   Lendlein, A.
BE Lendlein, A
   Tirelli, N
   Weiss, RA
   Xie, T
TI Purity of mushroom tyrosinase as a biocatalyst for biomaterial synthesis
   affects the stability of therapeutic peptides
SO MULTIFUNCTIONAL POLYMERIC AND HYBRID MATERIALS
SE Materials Research Society Symposium Proceedings
LA English
DT Proceedings Paper
CT Symposium on Multifunctional Polymeric and Hybrid Materials / MRS Fall
   Meeting
CY NOV 30-DEC 05, 2014
CL Boston, MA
SP FEI Deutschland GmbH, Royal Soc Chem, RSC Mat Horizons
ID GRAMICIDIN-S; HYDROGELS; CHITOSAN; PROTEIN; SURFACE
AB The formation of injectable implants in the presence of cells or solutes has previously been conceptualized to be based on the selectivity of bioorthogonal chemical reactions. As an alternative approach, hydrogel network synthesis by enzymatic reactions with a typically high inherent substrate specificity and low toxicity have been repeatedly proposed, e.g. using commercial mushroom tyrosinase (MTyr), which specifically catalyzes phenol oxidation. In this study, it should be explored whether MTyr is compatible with therapeutic peptides that may be delivered from such hydrogels in the future. Based on the specificity of MTyr to phenol residues, no modification of peptides lacking the amino acid tyrosine would be expected. One example of such peptides is gramicidin S (GS), a potent antimicrobial peptide. However, when GS was incubated with commercial MTyr, peptide degradation occurred as observed by HPLC analysis. Several fragments of the peptide were detected by MALDI-TOF. Contamination of MTyr with peptidases was proven as the source of undesired peptide cleavage, which needs to be considered when preparing enzymatically crosslinked hydrogels for biomedical applications.
C1 [Racheva, M.; Romero, O.; Julich-Gruner, K-K; Wischke, C.; Lendlein, A.] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
   [Racheva, M.; Romero, O.; Julich-Gruner, K-K; Wischke, C.; Lendlein, A.] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, D-14513 Teltow, Germany.
   [Ulrich, A. S.] Karlsruhe Inst Technol, Inst Biol Interfaces IBG 2, D-76131 Karlsruhe, Germany.
   [Ulrich, A. S.] Inst Organ Chem, D-76131 Karlsruhe, Germany.
RP Racheva, M (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
RI Wischke, Christian/K-9651-2013; Romero, Oscar/K-4864-2016; Lendlein,
   Andreas/K-9553-2013
OI Wischke, Christian/0000-0001-5531-9033; Romero,
   Oscar/0000-0002-0223-5167; Lendlein, Andreas/0000-0003-4126-4670;
   Ulrich, Anne S./0000-0001-5571-9483
CR Berditsch M, 2007, APPL ENVIRON MICROB, V73, P6620, DOI 10.1128/AEM.00881-07
   Chen TH, 2003, BIOMATERIALS, V24, P2831, DOI 10.1016/S0142-9612(03)00096-6
   Chen TH, 2003, LANGMUIR, V19, P9382, DOI 10.1021/la0347098
   Hartmann M, 2010, ANTIMICROB AGENTS CH, V54, P3132, DOI 10.1128/AAC.00124-10
   Ismaya WT, 2011, BIOCHEMISTRY-US, V50, P5477, DOI 10.1021/bi200395t
   Jin R, 2014, POLYM CHEM-UK, V5, P391, DOI 10.1039/c3py00864a
   Jin R, 2013, POLYM INT, V62, P353, DOI 10.1002/pi.4306
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee SH, 2011, ACTA BIOMATER, V7, P1468, DOI 10.1016/j.actbio.2010.11.029
   Nimmo CM, 2011, BIOCONJUGATE CHEM, V22, P2199, DOI 10.1021/bc200281k
   Selinheimo E, 2008, J AGR FOOD CHEM, V56, P3118, DOI 10.1021/jf0730791
   Seo SY, 2003, J AGR FOOD CHEM, V51, P2837, DOI 10.1021/jf020826f
   Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942
   Teixeira LSM, 2012, BIOMATERIALS, V33, P1281, DOI 10.1016/j.biomaterials.2011.10.067
   Xu DY, 2012, BIOCHEM ENG J, V63, P88, DOI 10.1016/j.bej.2011.11.009
NR 15
TC 0
Z9 0
U1 1
U2 3
PU MATERIALS RESEARCH SOC
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 978-1-60511-695-2
J9 MATER RES SOC SYMP P
PY 2015
VL 1718
BP 85
EP 90
DI 10.1557/opl.2015.260
PG 6
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA BE8FP
UT WOS:000376420800013
DA 2018-10-19
ER

PT S
AU Roch, T
   Julich-Gruner, KK
   Neffe, AT
   Ma, N
   Lendlein, A
AF Roch, Toralf
   Julich-Gruner, Konstanze K.
   Neffe, Axel T.
   Ma, Nan
   Lendlein, Andreas
BE Lendlein, A
   Tirelli, N
   Weiss, RA
   Xie, T
TI Immuno-compatibility of desaminotyrosine and desaminotyrosyl tyrosine
   functionalized star-shaped oligo(ethylene glycol)s with different
   molecular weights
SO MULTIFUNCTIONAL POLYMERIC AND HYBRID MATERIALS
SE Materials Research Society Symposium Proceedings
LA English
DT Proceedings Paper
CT Symposium on Multifunctional Polymeric and Hybrid Materials / MRS Fall
   Meeting
CY NOV 30-DEC 05, 2014
CL Boston, MA
SP FEI Deutschland GmbH, Royal Soc Chem, RSC Mat Horizons
ID MECHANISMS
AB Polymer-based therapeutic strategies require biomaterials with properties and functions tailored to the demands of specific applications leading to an increasing number of newly designed polymers. For the evaluation of those new materials, comprehensive biocompatibility studies including cyto-, tissue-, and immunocompatibility are essential. Recently, it could be demonstrated that star-shaped amino oligo(ethylene glycol)s (sOEG) with a number average molecular weight of 5 kDa and functionalized with the phenol-derived moieties desaminotyrosine (DAT) or desaminotyrosyl tyrosine (DATT) behave in aqueous solution like surfactants without inducing a substantial cytotoxicity, which may qualify them as solubilizer for hydrophobic drugs in aqueous solution. However, for biomedical applications the polymer solutions need to be free of immunogenic contaminations, which could result from inadequate laboratory environment or contaminated starting material. Furthermore, the materials should not induce uncontrolled or undesired immunological effects arising from material intrinsic properties. Therefore, a comprehensive immunological evaluation as perquisite for application of each biomaterial batch is required. This study investigated the immunological properties of sOEG-DAT(T) solutions, which were prepared using sOEG with number average molecular weights of 5 kDa, 10 kDa, and 20 kDa allowing analyzing the influence of the sOEG chain lengths on innate immune mechanisms. A macrophage-based assay was used to first demonstrate that all DAT(T)-sOEG solutions are free of endotoxins and other microbial contaminations such as fungal products. In the next step, the capacity of the different DAT(T)-functionalized sOEG solutions to induce cytokine secretion and generation of reactive oxygen species (ROS) was investigated using whole human blood. It was observed that low levels of the pro-inflammatory cytokines interleukin(IL)-1 beta and IL-6 were detected for all sOEG solutions but only when used at concentrations above 250 mu g-mL(-1). Furthermore, only the 20 kDa sOEG-DAT induced low amounts of ROS-producing monocytes. Conclusively, the data indicate that the materials were not contaminated with microbial products and do not induce substantial immunological adverse effects in vitro, which is a prerequisite for future biological applications.
C1 [Roch, Toralf; Julich-Gruner, Konstanze K.; Neffe, Axel T.; Ma, Nan; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
   [Roch, Toralf; Julich-Gruner, Konstanze K.; Neffe, Axel T.; Ma, Nan; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-14513 Teltow, Germany.
   [Roch, Toralf; Neffe, Axel T.; Ma, Nan; Lendlein, Andreas] Hehnholtz Virtual Inst, Multifunct Biomat Med, Teltow, Germany.
   [Roch, Toralf; Neffe, Axel T.; Ma, Nan; Lendlein, Andreas] Hehnholtz Virtual Inst, Multifunct Biomat Med, Berlin, Germany.
   [Ma, Nan; Lendlein, Andreas] Free Univ Berlin, Dept Biol Chem & Pharm, Inst Chem & Biochem, Takustr 3, D-14195 Berlin, Germany.
RP Roch, T (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
RI Neffe, Axel/H-6997-2013; Lendlein, Andreas/K-9553-2013
OI Neffe, Axel/0000-0002-5056-3990; Lendlein, Andreas/0000-0003-4126-4670
CR Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942
   BERG B, 1981, REFERENCE VALUES LAB, P55
   Julich-Gruner K.K., 2013, MATER RES SOC S P, V1569, P9
   Julich-Gruner KK, 2012, J APPL BIOMATER FUNC, V10, P170, DOI 10.5301/JABFM.2012.10342
   Kader KN, 2007, J BIOMED MATER RES B, V83B, P138, DOI 10.1002/jbm.b.30777
   Lu Y, 2013, INT J PHARMACEUT, V453, P198, DOI 10.1016/j.ijpharm.2012.08.042
   Roch T, 2014, CLIN HEMORHEOL MICRO, V57, P203, DOI 10.3233/CH-141831
   Tan Chalet, 2013, Pharmaceutics, V5, P201, DOI 10.3390/pharmaceutics5010201
   Ulbricht J, 2014, BIOMATERIALS, V35, P4848, DOI 10.1016/j.biomaterials.2014.02.029
NR 9
TC 1
Z9 1
U1 0
U2 1
PU MATERIALS RESEARCH SOC
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 978-1-60511-695-2
J9 MATER RES SOC SYMP P
PY 2015
VL 1718
BP 97
EP 102
DI 10.1557/opl.2015.327
PG 6
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA BE8FP
UT WOS:000376420800015
DA 2018-10-19
ER

PT S
AU Pal, RK
   Kurland, NE
   Kundu, SC
   Yadavalli, VK
AF Pal, Ramendra K.
   Kurland, Nicholas E.
   Kundu, Subhas C.
   Yadavalli, Vamsi K.
BE Lendlein, A
   Tirelli, N
   Weiss, RA
   Xie, T
TI Fabrication of Silk Microstructures Using Photolithography
SO MULTIFUNCTIONAL POLYMERIC AND HYBRID MATERIALS
SE Materials Research Society Symposium Proceedings
LA English
DT Proceedings Paper
CT Symposium on Multifunctional Polymeric and Hybrid Materials / MRS Fall
   Meeting
CY NOV 30-DEC 05, 2014
CL Boston, MA
SP FEI Deutschland GmbH, Royal Soc Chem, RSC Mat Horizons
ID FIBROIN FILMS; BIOMATERIALS; LITHOGRAPHY; PROTEINS
AB Precise spatial patterns and micro and nanostructures of peptides and proteins have widespread applications in tissue engineering, bioelectronics, photonics, and therapeutics. Optical lithography using proteins provides a route to directly fabricate intricate, bio-friendly architectures rapidly and across a range of length scales. The unique mechanical strength, optical properties, biocompatibility and controllable degradation of biomaterials from silkworms offer several advantages in this paradigm. Here, we present the biochemical synthesis and applications of a "protein photoresist" synthesized from the silk proteins, fibroin and sericin. Using light activated direct-write processes such as photolithography, we show how silk proteins can form high resolution, high fidelity structures in two and three dimensions. Protein features can be precisely patterned at sub-microscale resolution (gm) at the bench-top over macroscale areas (cm), easily and repeatedly with high-throughput. For instance, periodic, microstructured arrays can be patterned over large areas to form structurally induced iridescent patterns and functional opto-electronic structures. We further demonstrate how photocrosslinked protein micro architectures can function for the spatial guidance of cells without use of cell-adhesive ligands as biocompatible and biodegradable scaffolds. The ease of biochemical functionalization, biocompatibility, as well as favorable mechanical properties and biodegradation of this silk biomaterial provide opportunities for otherwise inaccessible applications as sustainable, bioresorbable protein microdevices.
C1 [Pal, Ramendra K.; Kurland, Nicholas E.; Yadavalli, Vamsi K.] Virginia Commonwealth Univ, Richmond, VA USA.
   [Kundu, Subhas C.] Indian Inst Technol, Kharagpur 721302, W Bengal, India.
RP Pal, RK (reprint author), Virginia Commonwealth Univ, Richmond, VA USA.
OI Kundu, Subhas C./0000-0002-7170-2291; Yadavalli,
   Vamsi/0000-0002-8879-1948
CR Boretius T, 2011, ARTIF ORGANS, V35, P245, DOI 10.1111/j.1525-1594.2011.01210.x
   Borkner CB, 2014, ACS APPL MATER INTER, V6, P15611, DOI 10.1021/am5008479
   Brenckle MA, 2013, ADV MATER, V25, P2409, DOI 10.1002/adma.201204678
   Coma V, 2013, POLIMEROS, V23, P287, DOI 10.4322/polimeros020ov002
   Fattahi P, 2014, ADV MATER, V26, P1846, DOI 10.1002/adma.201304496
   Galeotti F, 2012, SOFT MATTER, V8, P4815, DOI 10.1039/c2sm25089f
   Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Jagur-Grodzinski J, 2010, POLYM ADVAN TECHNOL, V21, P27, DOI 10.1002/pat.1504
   Kim S, 2014, NAT NANOTECHNOL, V9, P306, DOI [10.1038/nnano.2014.47, 10.1038/NNANO.2014.47]
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Kurland NE, 2014, ADV MATER, V26, P4431, DOI 10.1002/adma.201400777
   Kurland NE, 2013, ADV MATER, V25, P6207, DOI 10.1002/adma.201302823
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   Li ZX, 2011, J ARTIF ORGANS, V14, P163, DOI 10.1007/s10047-011-0585-5
   Malliaras GG, 2013, BBA-GEN SUBJECTS, V1830, P4286, DOI 10.1016/j.bbagen.2012.10.007
   Narayan RJ, 2010, PHILOS T R SOC A, V368, P1831, DOI 10.1098/rsta.2010.0001
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Seago AE, 2009, J R SOC INTERFACE, V6, pS165, DOI 10.1098/rsif.2008.0354.focus
   Stegemann JP, 2007, TISSUE ENG, V13, P2601, DOI 10.1089/ten.2007.0196
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
NR 25
TC 1
Z9 1
U1 0
U2 7
PU MATERIALS RESEARCH SOC
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 978-1-60511-695-2
J9 MATER RES SOC SYMP P
PY 2015
VL 1718
BP 163
EP 170
DI 10.1557/opl.2015.437
PG 8
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA BE8FP
UT WOS:000376420800024
DA 2018-10-19
ER

PT B
AU Slovakova, M
   Srbova, J
   Munzarova, M
   Dvorakova, P
   Bilkova, Z
AF Slovakova, Marcela
   Srbova, Jana
   Munzarova, Marcela
   Dvorakova, Petra
   Bilkova, Zuzana
GP TANGER Ltd
TI TESTING OF COLLAGENASE COVALENTLY LINKED TO CHITOSAN NANOFIBERS FOR
   BIOMEDICAL APPLICATIONS
SO NANOCON 2015: 7TH INTERNATIONAL CONFERENCE ON NANOMATERIALS - RESEARCH &
   APPLICATION
LA English
DT Proceedings Paper
CT 7th International Conference on Nanomaterials - Research and Application
CY OCT 14-16, 2015
CL Brno, CZECH REPUBLIC
SP Tanger Ltd, Czech Soc New Mat & Technologies, Reg Ctr Adv Technologies & Mat, Mat Res Soc Serbia, Norsk Materialteknisk Selskap
DE Chitosan nanofibers; collagenase; enzyme immobilization;
   Michaelis-Menten constant
ID DEBRIDEMENT
AB Nanofibers biofunctionalized with enzymes are materials of interest in the biomedical field due to their potential application in wound healing. This work describes the production and characterisation of electrospun chitosan nanofibers biofunctionalized with a microbial collagenase. The morphology and microstructure of the chitosan nanofibers prepared with Nanospider technology were examined using a scanning electron microscope (SEM). Amino groups of a chitosan nanofiber were connected with the carboxylic acid groups of the collagenase using EDAC and sulfo-NHS methodology. Collagenase enzymatic activity was evaluated with a peptidic substrate (Pz-peptide, 4-phenylazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-D-Arg) in order to estimate the ability of this biomaterial to be used as an enzymatic debriding wound dressing. The characterisation of collagenase chitosan nanofibers in terms of measuring apparent Michaelis-Menten constants (K-M(app) and v(max)) revealed a higher enzyme to substrate affinity than with the soluble form of the collagenase. The resulting novel collagenase chitosan nanofibers exhibited excellent operational stability and long shelf life for at least 6 weeks. Therefore, the novel collagenase chitosan nanofibers are expected to be a potential scaffold for wound healing applications, such as e. g. enzymatic debridement.
C1 [Slovakova, Marcela; Srbova, Jana; Dvorakova, Petra; Bilkova, Zuzana] Univ Pardubice, Fac Chem Technol, Dept Biol & Biochem Sci, Pardubice, Czech Republic.
   [Munzarova, Marcela] Nanovia Ltd, Litvinov Chuderin, Czech Republic.
RP Slovakova, M (reprint author), Univ Pardubice, Fac Chem Technol, Dept Biol & Biochem Sci, Pardubice, Czech Republic.
RI Slovakova, Marcela/M-6650-2015
OI Slovakova, Marcela/0000-0002-4975-0983
CR Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Dubsky M, 2012, J MATER SCI-MATER M, V23, P931, DOI 10.1007/s10856-012-4577-7
   Eckhard U, 2009, BIOL CHEM, V390, P11, DOI 10.1515/BC.2009.004
   Korecka L, 2005, J MAGN MAGN MATER, V293, P349, DOI 10.1016/j.jmmm.2005.02.030
   MOZHAEV VV, 1990, BIOCATALYSIS, V3, P179, DOI DOI 10.3109/10242429008992060
   PAYNE W. G., 2008, EPLASTY, V8, P151
   Qu FN, 2013, ACTA BIOMATER, V9, P6393, DOI 10.1016/j.actbio.2013.01.016
   Ramundo J, 2008, J WOUND OSTOMY CONT, V35, P273, DOI 10.1097/01.WON.0000319125.21854.78
   Ramundo J, 2009, J WOUND OSTOMY CONT, V36, pS4, DOI 10.1097/WON.0b013e3181bfdf83
   SLOVAKOVA M, 2015, PROCESS BIO IN PRESS
   SORU E, 1972, ENZYMOLOGIA, V43, P45
   SRBOVA J., 2015, J BIOMEDICAL B UNPUB
   STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4
   Tallis A, 2013, CLIN THER, V35, P1805, DOI 10.1016/j.clinthera.2013.09.013
   Treethammathurot B, 2008, INT J PHARMACEUT, V357, P252, DOI 10.1016/j.ijpharm.2008.01.016
   WUNSCH E, 1963, H-S Z PHYSIOL CHEM, V333, P149, DOI 10.1515/bchm2.1963.333.1.149
NR 16
TC 0
Z9 0
U1 2
U2 4
PU TANGER LTD
PI SLEZSKA
PA KELTICKOVA 62, SLEZSKA, OSTRAVA 710 00, CZECH REPUBLIC
BN 978-80-87294-63-5
PY 2015
BP 435
EP 441
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA BE6SM
UT WOS:000374708800077
DA 2018-10-19
ER

PT B
AU Han, C
   Park, S
   Kim, H
AF Han, Changwan
   Park, Seonghun
   Kim, Hanjong
GP ASME
TI DYNAMIC RESPONSE OF POLYVINYL ALCOHOL(PVA)-HYDROGEL WITH DIFFERENT PVA
   CONCENTRATIONS
SO PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS
   AND EXPOSITION, 2014, VOL 14
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
   (IMECE2014)
CY NOV 14-20, 2014
CL Montreal, CANADA
SP ASME
ID H ARTIFICIAL MENISCUS; BOVINE ARTICULAR-CARTILAGE; UNCONFINED
   COMPRESSION; IN-VIVO; HYDROGEL; COMPOSITES
AB Polyvinyl Alcohol-Hydrogel (PVA-H) is a biomaterial used for manufacturing contact lenses as well as for the medium of drug delivery. Previous studies have also showed that PVA-H exhibits superior biocompatibility with hydrophilic elastic nature. The aim of this study is to examine the possible usage of the PVA-H as cartilage replacement material by determining the static and dynamic mechanical properties of PVA-H with different ratios of polyvinyl alcohol (PVA) and phosphate buffered saline (PBS) compositions.
   Three different types of PVA-H specimens were made by changing the ratio of PVA (Sigma-Aldrich) and PBS (Sigma-Aldrich) compositions (PVA-H1: 10 wt% PVA and 90 wt% PBS; PVA-H2: 20 wt% PVA and 80 wt% PBS; PVA-H3: 25 wt% PVA, 45 wt% PBS and DMSO 30 wt%). Static and dynamic tensile tests under the loading frequencies of 0.001, 0.01, 0:1, and 1 Hz were carried out to measure the biomechanical properties of PVA-H1,-H2 within PBS solution and-H3 within PBS/ DMSO solution.
   The equilibrium Young's moduli (EY) of PVA-H1, -H2 and-H3 evaluated from the static displacement control were 84.2 +/- 35.1 kPa (n=10), 254 +/- 32.2 kPa (n=10) and 588 +/- 38.9 kPa (n=5), respectively. The amplitudes of dynamic tensile moduli were varied from 86.3 +/- 33.4 kPa (n=10) at 0.001 Hz to 96.9 +/- 42.0 kPa (n=10) at 1 Hz for PVA-H1, from 282.7 +/- 26.4 kPa (n=10) at 0.001 Hz to 309.1 +/- 32.2 kPa (n=10) at 1 Hz for PVA-H2 and from 643.8 +/- 49.8 kPa (n=10) at 0.001 Hz to 747.7 +/- 67.7 kPa (n=5) at 1 Hz for PVA-H3. According to the current results, the frequency dependence of the magnitude of the dynamic modulus confirms the viscoelastic nature of PVA-H material. However, it can be noted that the dynamic modulus increases by up to a factor of 1.15 for PVA-H1, 1.22 for PVA-H2 and 1.27 for PVA-H3, showing insignificant viscoelasticity compared with that for cartilage. The result that static and dynamic moduli of PVA-H3 are larger than those of PVA-H1 and PVA-H2 also suggests that the amount of PVA composition in PVA-H plays an important role in improving both static and dynamic mechanical strengths of PVA-H material. The phase angle decreased from 5.2 +/- 2.1 degrees at 0.001 Hz to 0.3 +/- 1.7 degrees at 1 Hz for PVA-H1, from 5.6 +/- 0.6 degrees at 0.001 Hz to 0.3 +/- 0.7 degrees at 1 Hz for PVA-H2 and from 8.2 +/- 1.1 degrees at 0.001 Hz to 0.7 +/- 0.7 degrees at 1 Hz for PVA-H3.
C1 [Han, Changwan; Park, Seonghun; Kim, Hanjong] Pusan Natl Univ, Busan, South Korea.
RP Han, C (reprint author), Pusan Natl Univ, Busan, South Korea.
CR Chu KC, 1997, MAGNET RESON MED, V37, P314, DOI 10.1002/mrm.1910370230
   CIFKOVA I, 1990, BIOMATERIALS, V11, P393, DOI 10.1016/0142-9612(90)90093-6
   Gu Zheng-Qiu, 1998, Bio-Medical Materials and Engineering, V8, P75
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   Jiang S, 2011, J MECH BEHAV BIOMED, V4, P1228, DOI 10.1016/j.jmbbm.2011.04.005
   Jo SY, 2009, POLYM-KOREA, V33, P551
   Kobayashi M, 2004, BIO-MED MATER ENG, V14, P505
   Kobayashi M, 2003, BIOMATERIALS, V24, P639, DOI 10.1016/S0142-9612(02)00378-2
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Kobayashi M, 2010, MATERIALS, V3, P2753, DOI 10.3390/ma3042753
   Kroschwitz J I, 1989, POLYM BIOMATERIALS M
   Li F, 2010, ADV MAT RES, V87-88, P188, DOI 10.4028/www.scientific.net/AMR.87-88.188
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Nakashima K, 2005, JSME INT J C-MECH SY, V48, P555, DOI 10.1299/jsmec.48.555
   Paradossi G, 2003, J MATER SCI-MATER M, V14, P687, DOI 10.1023/A:1024907615244
   Park S, 2004, OSTEOARTHR CARTILAGE, V12, P65, DOI 10.1016/j.joca.2003.08.005
   Park S, 2006, J BIOMECH ENG-T ASME, V128, P623, DOI 10.1115/1.2206201
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Silver F., 1989, BIOCOMPATIBILITY INT
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Vijayasekaran S, 1998, BIOMATERIALS, V19, P2255, DOI 10.1016/S0142-9612(98)00128-8
   Vrana N. E., P MACCR S WIL ONL LI, P106
   Wu G, 2007, J WUHAN UNIV TECHNOL, V22, P490, DOI 10.1007/s11595-006-3490-7
NR 23
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4963-7
PY 2015
AR V014T11A044
PG 5
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BE6KR
UT WOS:000374279300080
DA 2018-10-19
ER

PT B
AU Kotoka, R
   Fialkova, S
   Yarmolenko, S
   Pai, D
   Sankar, J
AF Kotoka, Ruben
   Fialkova, Svitlana
   Yarmolenko, Sergey
   Pai, Devdas
   Sankar, Jag
GP ASME
TI Physical and structural properties of pulsed-DC sputtered Al2O3, MgO and
   ZrO2 coating for Mg corrosion control
SO PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS
   AND EXPOSITION, 2014, VOL 14
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
   (IMECE2014)
CY NOV 14-20, 2014
CL Montreal, CANADA
SP ASME
DE magnetron sputtering; aluminum oxide; magnesium oxide; simulated body
   fluid (SBF); electrochemical impedance spectroscopy (EIS)
ID THIN-FILMS; OXIDE COATINGS; STEEL; MICROSTRUCTURE; PROTECTION; ALLOYS
AB Magnesium has attracted a lot of attention over the last few decades, due to its light weight and potential use as biomaterial. However, the poor corrosion resistance of magnesium restricts its practical use for application where exposure to aggressive aqueous media is unavoidable. This paper describes the growth, characterization and corrosion analyses of Al2O3, MgO and ZrO2 coatings for slowing down the degradation of Mg. Different thicknesses of Al2O3, MgO and ZrO2 were deposited on pure magnesium (99.95%) substrates using pulsed-DC magnetron sputtering process. The phase composition and microstructure analyses were performed using X-ray diffraction (XRD) and scanning electron microscopy (SEM) respectively. The corrosion protection behavior of the Al2O3, MgO and ZrO2 coated samples were evaluated using electrochemical measurements as such open-circuit potential, potentiodynamics and EIS. The corrosion test were performed in 0.9 wt% saline solution. The results showed that the Al2O3-coated Mg alloy exhibit a much superior stability and lower corrosion rate. The surface analyses of the corroded samples showed that the coating improved the corrosion resistance, whereas the bare Mg suffered severe localized corrosion. Adhesion assay was performed on the Al2O3, MgO and ZrO2 coatings to determine their biocompatibility. The results showed significant cell attachment to the coating compare to the control (bare glass).
C1 [Kotoka, Ruben; Fialkova, Svitlana; Yarmolenko, Sergey; Pai, Devdas; Sankar, Jag] North Carolina A&T State Univ, NSF Engn Res Ctr Revolutionizing Metall Biomat, Greensboro, NC 27411 USA.
RP Kotoka, R (reprint author), North Carolina A&T State Univ, NSF Engn Res Ctr Revolutionizing Metall Biomat, Greensboro, NC 27411 USA.
CR Arrabal R, 2008, CORROS SCI, V50, P1744, DOI 10.1016/j.corsci.2008.03.002
   Ben Amor S, 1998, MAT SCI ENG B-SOLID, V57, P28, DOI 10.1016/S0921-5107(98)00205-0
   Cano E, 2010, J SOLID STATE ELECTR, V14, P381, DOI 10.1007/s10008-009-0902-6
   CHINDAUDOM P, 1994, APPL OPTICS, V33, P2664, DOI 10.1364/AO.33.002664
   Creus J, 2000, SURF COAT TECH, V130, P224, DOI 10.1016/S0257-8972(99)00659-3
   Diaz B, 2011, ELECTROCHIM ACTA, V56, P9609, DOI 10.1016/j.electacta.2011.07.104
   Jia JX, 2006, CORROS SCI, V48, P2133, DOI 10.1016/j.corsci.2005.08.013
   Kelly PJ, 1999, J VAC SCI TECHNOL A, V17, P945, DOI 10.1116/1.581669
   Kotoka R., 2012, ASME 2012 INT MECH C
   Kotoka R., P ASME2013 INT MECH
   Lei T, 2010, CORROS SCI, V52, P3504, DOI 10.1016/j.corsci.2010.06.028
   Mueller WD, 2010, ACTA BIOMATER, V6, P1749, DOI 10.1016/j.actbio.2009.12.048
   Musil J, 2005, THIN SOLID FILMS, V475, P208, DOI 10.1016/j.tsf.2004.07.041
   Poinern G. E. J., 2012, AM J BIOMEDICAL ENG, P218
   Sarikaya O, 2005, SURF COAT TECH, V190, P388, DOI 10.1016/j.surfcoat.2004.02.007
   Segda BG, 2001, VACUUM, V62, P27, DOI 10.1016/S0042-207X(01)00114-2
   Sollazzo V, 2008, DENT MATER, V24, P357, DOI 10.1016/j.dental.2007.06.003
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Stippich F, 1998, SURF COAT TECH, V104, P29, DOI 10.1016/S0257-8972(98)00365-X
   Yun Y, 2009, MAT SCI ENG C-MATER, V29, P1814, DOI 10.1016/j.msec.2009.02.008
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
   Zhang E., ACTA BIOMAT IN PRESS
   Zhang EL, 2008, MAT SCI ENG A-STRUCT, V497, P111, DOI 10.1016/j.msea.2008.06.019
   Zhang WJ, 2004, SURF COAT TECH, V182, P192, DOI 10.1016/j.surfcoat.2003.08.050
NR 24
TC 0
Z9 0
U1 0
U2 5
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4963-7
PY 2015
AR V014T11A017
PG 10
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BE6KR
UT WOS:000374279300053
DA 2018-10-19
ER

PT J
AU Kim, J
   Wilson, DR
   Zamboni, CG
   Green, JJ
AF Kim, Jayoung
   Wilson, David R.
   Zamboni, Camila G.
   Green, Jordan J.
TI Targeted polymeric nanoparticles for cancer gene therapy
SO JOURNAL OF DRUG TARGETING
LA English
DT Review
DE Cancer therapy; cell-specificity; gene delivery; nanoparticles;
   polymeric biomaterial; promoter; targeting ligands; tissue-specificity
ID NUCLEIC-ACID DELIVERY; HEPATOCELLULAR-CARCINOMA CELLS; MESENCHYMAL
   STEM-CELLS; SMALL INTERFERING RNAS; PLASMID DNA DELIVERY; IN-VIVO;
   BREAST-CANCER; SUICIDE GENE; TRANSGENE EXPRESSION; PROSTATE-CANCER
AB In this article, advances in designing polymeric nanoparticles for targeted cancer gene therapy are reviewed. Characterization and evaluation of biomaterials, targeting ligands, and transcriptional elements are each discussed. Advances in biomaterials have driven improvements to nanoparticle stability and tissue targeting, conjugation of ligands to the surface of polymeric nanoparticles enable binding to specific cancer cells, and the design of transcriptional elements has enabled selective DNA expression specific to the cancer cells. Together, these features have improved the performance of polymeric nanoparticles as targeted non-viral gene delivery vectors to treat cancer. As polymeric nanoparticles can be designed to be biodegradable, non-toxic, and to have reduced immunogenicity and tumorigenicity compared to viral platforms, they have significant potential for clinical use. Results of polymeric gene therapy in clinical trials and future directions for the engineering of nanoparticle systems for targeted cancer gene therapy are also presented.
C1 [Kim, Jayoung; Wilson, David R.; Zamboni, Camila G.; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.
   [Kim, Jayoung; Wilson, David R.; Zamboni, Camila G.; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Translat Tissue Engn Ctr, Baltimore, MD USA.
   [Zamboni, Camila G.] Johns Hopkins Med Inst, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21205 USA.
   [Zamboni, Camila G.] Univ Sao Paulo, Fac Med, Hosp Clin, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil.
   [Green, Jordan J.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.
   [Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.
   [Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA.
RP Green, JJ (reprint author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21231 USA.
EM green@jhu.edu
FU NIH [1R01EB016721]; Samsung; National Science Foundation; CAPES-Brazil
FX This work was supported in part by the NIH (1R01EB016721). For graduate
   fellowship/scholarship support, JK thanks Samsung, DRW thanks the
   National Science Foundation, and CGZ thanks CAPES-Brazil.
CR Abdallah B, 1996, HUM GENE THER, V7, P1947, DOI 10.1089/hum.1996.7.16-1947
   Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846
   Adryan B, 2007, FLY, V1, P142, DOI 10.4161/fly.4571
   Akar U, 2008, AUTOPHAGY, V4, P669, DOI 10.4161/auto.6083
   Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85
   Alberts B, 2002, MOL BIOL CELL
   Alvarez RD, 2014, GYNECOL ONCOL, V133, P433, DOI 10.1016/j.ygyno.2014.03.571
   Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917
   Ambrosini G, 1998, J BIOL CHEM, V273, P11177, DOI 10.1074/jbc.273.18.11177
   Ando S, 1999, J PHARM SCI, V88, P126, DOI 10.1021/js9801687
   Anton M, 2005, CANCER GENE THER, V12, P640, DOI 10.1038/sj.cgt.7700829
   Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637
   Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010
   Barh D, 2010, CURR ONCOL, V17, P70
   Bateman BT, 2001, INFECT IMMUN, V69, P7851, DOI 10.1128/IAI.69.12.7851-7857.2001
   Bayele HK, 2005, J PHARM SCI-US, V94, P446, DOI 10.1002/jps.20230
   Bazzoni F, 2001, CANCER RES, V61, P1050
   Bellocq NC, 2003, BIOCONJUGATE CHEM, V14, P1122, DOI 10.1021/bc034125f
   Benoit MA, 2001, J DRUG TARGET, V9, P253, DOI 10.3109/10611860108997934
   Bhang HEC, 2011, NAT MED, V17, P123, DOI 10.1038/nm.2269
   Bhatia S, 2013, DISCOV MED, V15, P309
   Bhatnagar A, 2014, CANCER RES, V74, P5772, DOI 10.1158/0008-5472.CAN-14-0018
   Bhise NS, 2010, BIOMATERIALS, V31, P8088, DOI 10.1016/j.biomaterials.2010.07.023
   Bishop CJ, 2013, J AM CHEM SOC, V135, P6951, DOI 10.1021/ja4002376
   Bivas-Benita M, 2004, EUR J PHARM BIOPHARM, V58, P1, DOI 10.1016/j.ejpb.2004.03.008
   Blessing T, 2001, BIOCONJUGATE CHEM, V12, P529, DOI 10.1021/bc0001488
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Boylan NJ, 2012, J CONTROL RELEASE, V157, P72, DOI 10.1016/j.jconrel.2011.08.031
   Buchholz Daniel R, 2012, Methods Mol Biol, V917, P265, DOI 10.1007/978-1-61779-992-1_16
   BURATOWSKI S, 1994, CELL, V77, P1, DOI 10.1016/0092-8674(94)90226-7
   Buscail L, 2015, MOL THER, V23, P779, DOI 10.1038/mt.2015.1
   Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894
   Carlberg C, 2014, TRANSCRIPTION FACTOR, P55
   Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010
   Chen JQ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-15
   Chen J, 2009, BIOMACROMOLECULES, V10, P2921, DOI 10.1021/bm900724c
   Chen YC, 2010, MOL THER, V18, P1650, DOI 10.1038/mt.2010.136
   Cheng ZL, 2012, SCIENCE, V338, P903, DOI 10.1126/science.1226338
   Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o
   Chiu SH, 2004, J CONTROL RELEASE, V97, P357, DOI 10.1016/j.jconrel.2004.03.019
   Choi KY, 2012, BIOMATERIALS, V33, P6186, DOI 10.1016/j.biomaterials.2012.05.029
   Cohen H, 2000, GENE THER, V7, P1896, DOI 10.1038/sj.gt.3301318
   Cohen JL, 2011, BIOCONJUGATE CHEM, V22, P1056, DOI 10.1021/bc100542r
   Cohen JA, 2010, ADV MATER, V22, P3593, DOI 10.1002/adma.201000307
   Cooper TA, 1997, AM J HUM GENET, V61, P259, DOI 10.1086/514856
   Crew JP, 2000, BRIT J CANCER, V82, P161
   Danhier F, 2010, J CONTROL RELEASE, V148, P135, DOI 10.1016/j.jconrel.2010.08.027
   DARVEAU A, 1985, P NATL ACAD SCI USA, V82, P2315, DOI 10.1073/pnas.82.8.2315
   Das B, 2004, P NATL ACAD SCI USA, V101, P4839, DOI 10.1073/pnas.0401011101
   DATTA R, 1992, P NATL ACAD SCI USA, V89, P10149, DOI 10.1073/pnas.89.21.10149
   Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956
   Davis ME, 2009, MOL PHARMACEUT, V6, P659, DOI 10.1021/mp900015y
   Davis ME, 2004, CURR MED CHEM, V11, P179, DOI 10.2174/0929867043456179
   DeFatta RJ, 2002, CANCER GENE THER, V9, P573, DOI 10.1038/sj.cgt.7700468
   Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107
   Devi GR, 2006, CANCER GENE THER, V13, P819, DOI 10.1038/sj.cgt.7700931
   Dutta D, 2007, TOXICOL SCI, V100, P303, DOI 10.1093/toxsci/kfm217
   Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636
   Fields RJ, 2012, J CONTROL RELEASE, V164, P41, DOI 10.1016/j.jconrel.2012.09.020
   Forrest ML, 2003, BIOCONJUGATE CHEM, V14, P934, DOI 10.1021/bc034014g
   Francis SM, 2014, MOL THER, V22, P1643, DOI 10.1038/mt.2014.24
   Gallagher SJ, 2013, ONCOGENE, V32, P2230, DOI 10.1038/onc.2012.229
   Gao P, 2008, CANCER SCI, V99, P2209, DOI 10.1111/j.1349-7006.2008.00941.x
   Goverdhana S, 2005, MOL THER, V12, P189, DOI 10.1016/j.ymthe.2005.03.022
   Green JJ, 2007, NANO LETT, V7, P874, DOI 10.1021/nl062395b
   Grzmil M, 2003, AM J PATHOL, V163, P543, DOI 10.1016/S0002-9440(10)63682-6
   Gu JJ, 2012, BIOMATERIALS, V33, P644, DOI 10.1016/j.biomaterials.2011.09.076
   Guerrero-Cazares H, 2014, ACS NANO, V8, P5141, DOI 10.1021/nn501197v
   GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L
   Han SE, 2009, J DRUG TARGET, V17, P123, DOI [10.1080/10611860802472461, 10.1080/10611860802472461 ]
   Hanna N, 2012, CANCER GENE THER, V19, P374, DOI 10.1038/cgt.2012.10
   Harrington KJ, 2000, ADV DRUG DELIVER REV, V44, P167, DOI 10.1016/S0169-409X(00)00093-4
   HARRIS JD, 1994, GENE THER, V1, P170
   Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005
   Harris TJ, 2010, BIOMATERIALS, V31, P998, DOI 10.1016/j.biomaterials.2009.10.012
   Hayes GM, 2002, CANCER GENE THER, V9, P133, DOI 10.1038/sj.cgt.7700427
   Hedley ML, 1998, NAT MED, V4, P365, DOI 10.1038/nm0398-365
   Hildebrandt IJ, 2003, GENE THER, V10, P758, DOI 10.1038/sj.gt.3301939
   Hsu YY, 1999, J DRUG TARGET, V7, P313, DOI 10.3109/10611869909085514
   Hu BG, 2014, EXP CELL RES, V324, P183, DOI 10.1016/j.yexcr.2014.04.005
   Huang RQ, 2007, FASEB J, V21, P1117, DOI 10.1096/fj.06-7380com
   Huang YH, 2009, CANCER RES, V69, P6184, DOI 10.1158/0008-5472.CAN-09-0061
   Ito T, 2010, BIOMATERIALS, V31, P2912, DOI 10.1016/j.biomaterials.2009.12.032
   Jafari M, 2012, CURR MED CHEM, V19, P197, DOI 10.2174/092986712803414141
   Jaggar RT, 1997, HUM GENE THER, V8, P2239, DOI 10.1089/hum.1997.8.18-2239
   Jeong GJ, 2007, J CONTROL RELEASE, V118, P118, DOI 10.1016/j.jconrel.2006.12.009
   Jones HE, 2006, ENDOCR-RELAT CANCER, V13, pS45, DOI 10.1677/erc.1.01275
   Kawashita Y, 1999, HUM GENE THER, V10, P1509, DOI 10.1089/10430349950017842
   KEREKATTE V, 1995, INT J CANCER, V64, P27, DOI 10.1002/ijc.2910640107
   Kevil C, 1995, ONCOGENE, V11, P2339
   Khan JA, 2007, CHEMBIOCHEM, V8, P1237, DOI 10.1002/cbic.200700165
   Kim J, 2014, BIOCONJUGATE CHEM, V25, P43, DOI 10.1021/bc4002322
   Kircheis R, 1997, GENE THER, V4, P409, DOI 10.1038/sj.gt.3300418
   Klutz K, 2011, MOL THER, V19, P676, DOI 10.1038/mt.2010.296
   Knapinska AM, 2005, CURR GENOMICS, V6, P471, DOI 10.2174/138920205774482954
   Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672
   Komarova S, 2006, MOL CANCER THER, V5, P755, DOI 10.1158/1535-7163.MCT-05-0334
   KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x
   Kunath K, 2003, J CONTROL RELEASE, V89, P113, DOI 10.1016/S0168-3659(03)00076-2
   Kurosaki T, 2009, BIOMATERIALS, V30, P2846, DOI 10.1016/j.biomaterials.2009.01.055
   Labhasetwar V, 1998, J PHARM SCI, V87, P1347, DOI 10.1021/js980077+
   Lee H, 2012, NAT NANOTECHNOL, V7, P389, DOI [10.1038/nnano.2012.73, 10.1038/NNANO.2012.73]
   Lee SG, 2006, P NATL ACAD SCI USA, V103, P17390, DOI 10.1073/pnas.0608386103
   Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77
   Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81
   Li JJ, 2013, CHEM COMMUN, V49, P6974, DOI 10.1039/c3cc43576h
   Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035
   Li Q, 2014, CLIN CANCER RES, V20, P2375, DOI 10.1158/1078-0432.CCR-13-1415
   Lombardo Y, 2011, GASTROENTEROLOGY, V140, P297, DOI 10.1053/j.gastro.2010.10.005
   Lunsford L, 2000, J DRUG TARGET, V8, P39, DOI 10.3109/10611860009009208
   MAKAROV SS, 2000, PROG INFLAM RES, P13
   Manome Y, 1998, HUM GENE THER, V9, P1409, DOI 10.1089/hum.1998.9.10-1409
   Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
   Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623
   Mastorakos P, 2015, NANOSCALE, V7, P3845, DOI 10.1039/c4nr04284k
   Menard S, 2001, ANN ONCOL, V12, P15, DOI 10.1023/A:1011151505425
   Meric F, 2002, MOL CANCER THER, V1, P971
   Meyer M, 2009, MOL PHARMACEUT, V6, P752, DOI 10.1021/mp9000124
   Minn I, 2014, ADV CANCER RES, V124, P131, DOI 10.1016/B978-0-12-411638-2.00004-5
   MOCHIZUKI H, 1992, MOL CARCINOGEN, V6, P83, DOI 10.1002/mc.2940060203
   Moffatt S, 2006, GENE THER, V13, P761, DOI 10.1038/sj.gt.3302721
   Needham CJ, 2012, BIOMACROMOLECULES, V13, P1429, DOI 10.1021/bm300145q
   Nettelbeck DM, 2000, TRENDS GENET, V16, P174, DOI 10.1016/S0168-9525(99)01950-2
   O'Keefe DS, 2000, PROSTATE, V45, P149
   Ogris M, 2003, J CONTROL RELEASE, V91, P173, DOI 10.1016/S0168-3659(03)00230-X
   Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900
   Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Pan CX, 1999, MED HYPOTHESES, V53, P130, DOI 10.1054/mehy.1998.0731
   PANG S, 1995, HUM GENE THER, V6, P1417, DOI 10.1089/hum.1995.6.11-1417
   Papadakis ED, 2004, CURR GENE THER, V4, P89, DOI 10.2174/1566523044578077
   Parr MJ, 1997, NAT MED, V3, P1145, DOI 10.1038/nm1097-1145
   Patel PC, 2010, BIOCONJUGATE CHEM, V21, P2250, DOI 10.1021/bc1002423
   Pecot CV, 2014, MOL CANCER THER, V13, P2876, DOI 10.1158/1535-7163.MCT-14-0074
   Peng SF, 2009, BIOMATERIALS, V30, P1797, DOI 10.1016/j.biomaterials.2008.12.019
   Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591
   Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349
   Poon Z, 2011, NANO LETT, V11, P2096, DOI 10.1021/nl200636r
   Prabha S, 2004, MOL PHARMACEUT, V1, P211, DOI 10.1021/mp049970+
   Rice J, 2008, NAT REV CANCER, V8, P108, DOI 10.1038/nrc2326
   Robson T, 2003, J BIOMED BIOTECHNOL, P110, DOI 10.1155/S1110724303209074
   Rojanarata T, 2008, PHARM RES-DORDR, V25, P2807, DOI 10.1007/s11095-008-9648-6
   ROSS JF, 1994, CANCER-AM CANCER SOC, V73, P2432, DOI 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S
   Roth JA, 2006, EXPERT OPIN BIOL TH, V6, P55, DOI 10.1517/14712598.6.1.55
   Sakae M, 2008, BIOMED PHARMACOTHER, V62, P448, DOI 10.1016/j.biopha.2007.12.009
   Schaffer DV, 2000, BIOTECHNOL BIOENG, V67, P598, DOI 10.1002/(SICI)1097-0290(20000305)67:5<598::AID-BIT10>3.0.CO;2-G
   Sestakova B, 2006, FOLIA BIOL-PRAGUE, V52, P161
   Shmueli RB, 2012, NANOMED-NANOTECHNOL, V8, P1200, DOI 10.1016/j.nano.2012.01.006
   SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152
   Smith-Arica JR, 2000, MOL THER, V2, P579, DOI 10.1006/mthe.2000.0215
   Song J, 2004, CANCER RES, V64, P7661, DOI 10.1158/0008-5472.CAN-04-1751
   Struhl K, 1995, ANNU REV GENET, V29, P651, DOI 10.1146/annurev.ge.29.120195.003251
   Studeny M, 2002, CANCER RES, V62, P3603
   Su ZZ, 1997, P NATL ACAD SCI USA, V94, P9125, DOI 10.1073/pnas.94.17.9125
   Su ZZ, 2005, P NATL ACAD SCI USA, V102, P1059, DOI 10.1073/pnas.0409141102
   Tinsley-Bown AM, 2000, J CONTROL RELEASE, V66, P229, DOI 10.1016/S0168-3659(99)00275-8
   Torchilin V, 2011, ADV DRUG DELIVER REV, V63, P131, DOI 10.1016/j.addr.2010.03.011
   Tuschl T, 2001, CHEMBIOCHEM, V2, P239, DOI 10.1002/1439-7633(20010401)2:4<239::AID-CBIC239>3.0.CO;2-R
   Tzeng SY, 2013, J BIOMED MATER RES A, V101, P1837, DOI 10.1002/jbm.a.34616
   Urban-Klein B, 2005, GENE THER, V12, P461, DOI 10.1038/sj.gt.3302425
   van Vlerken LE, 2007, PHARM RES, V24, P1405, DOI 10.1007/s11095-007-9284-6
   Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158
   Vilaboa N, 2011, J GENET SYNDR GENE T, V2, P107
   VILE RG, 1993, CANCER RES, V53, P962
   Viola JR, 2010, EXPERT OPIN DRUG DEL, V7, P721, DOI 10.1517/17425241003716810
   WAGNER E, 1991, P NATL ACAD SCI USA, V88, P4255, DOI 10.1073/pnas.88.10.4255
   WAGNER E, 1992, P NATL ACAD SCI USA, V89, P7934, DOI 10.1073/pnas.89.17.7934
   WAGNER E, 1990, P NATL ACAD SCI USA, V87, P3410, DOI 10.1073/pnas.87.9.3410
   Walczak H, 1999, NAT MED, V5, P157
   Walter E, 2001, J CONTROL RELEASE, V76, P149, DOI 10.1016/S0168-3659(01)00413-8
   Wang DQ, 1999, J CONTROL RELEASE, V57, P9, DOI 10.1016/S0168-3659(98)00099-6
   Wang R, 2009, LUNG CANCER, V66, P237, DOI 10.1016/j.lungcan.2009.02.001
   Wang Z, 2011, PHARM RES-DORDR, V28, P2983, DOI 10.1007/s11095-011-0604-5
   Wang Z, 2010, TRANSL ONCOL, V3, P1, DOI 10.1593/tlo.09250
   Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293
   Xiong J, 2012, CANCER-AM CANCER SOC, V118, P536, DOI 10.1002/cncr.26289
   Yadav S, 2009, CANCER CHEMOTH PHARM, V63, P711, DOI 10.1007/s00280-008-0790-y
   Yao YD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003601
   Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763
   YOKOTA J, 1988, ONCOGENE, V2, P283
   Zarogoulidis P, 2013, J GENET SYNDR GENE T, V4, P1
   Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100
   Zhang C, 2010, BIOMATERIALS, V31, P6075, DOI 10.1016/j.biomaterials.2010.04.042
   Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698
   Zhang LX, 2012, CANCER RES, V72, P4276, DOI 10.1158/0008-5472.CAN-12-1013
   Zhao XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056395
   Zheng ZM, 2004, J BIOMED SCI, V11, P278, DOI 10.1159/000077096
   Zhou JB, 2012, NAT MATER, V11, P82, DOI [10.1038/NMAT3187, 10.1038/nmat3187]
NR 188
TC 16
Z9 18
U1 3
U2 24
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1061-186X
EI 1029-2330
J9 J DRUG TARGET
JI J. Drug Target.
PY 2015
VL 23
IS 7-8
BP 627
EP 641
DI 10.3109/1061186X.2015.1048519
PG 15
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DK2UF
UT WOS:000374769200007
PM 26061296
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Marycz, K
   Smieszek, A
   Grzesiak, J
   Siudzinska, A
   Maredziak, M
   Donesz-Sikorska, A
   Krzak, J
AF Marycz, Krzysztof
   Smieszek, Agnieszka
   Grzesiak, Jakub
   Siudzinska, Anna
   Maredziak, Monika
   Donesz-Sikorska, Anna
   Krzak, Justyna
TI The Osteogenic Properties of Multipotent Mesenchymal Stromal Cells in
   Cultures on TiO2 Sol-Gel-Derived Biomaterial
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID 316L STAINLESS-STEEL; IN-VITRO; BONE-MARROW; ADIPOSE-TISSUE;
   CORROSION-RESISTANCE; BIOCOMPATIBILITY; PROLIFERATION; EXPRESSION;
   COATINGS; METALS
AB The biocompatibility of the bone implants is a crucial factor determining the successful tissue regeneration. The aim of this work was to compare cellular behavior and osteogenic properties of rat adipose-derived multipotent stromal cells (ASCs) and bone marrow multipotent stromal cells (BMSCs) cultured on metallic substrate covered with TiO2 sol-gel-derived nanolayer. The morphology, proliferation rate, and osteogenic differentiation potential of both ASCs and BMSCs propagated on the biomaterials were examined. The potential for osteogenic differentiation of ASCs and BMSCs was determined based on the presence of specific markers of osteogenesis, that is, alkaline phosphatase (ALP), osteopontin (OPN), and osteocalcin (OCL). Additionally, the concentration of calcium and phosphorus in extracellular matrix was determined using energy-dispersive X-ray spectroscopy (SEM-EDX). Obtained results showed that TiO2 layer influenced proliferation activity of ASCs, which manifested by shortening of population doubling time and increase of OPN secretion. However, characteristic features of cells morphology and growth pattern of cultures prompted us to conclude that ultrathin TiO2 layer might also enhance osteodifferentiation of BMSCs. Therefore in our opinion, both populations of MSCs should be used for biological evaluation of biomaterials compatibility, such results may enhance the area of investigations related to regenerative medicine.
C1 [Marycz, Krzysztof; Smieszek, Agnieszka; Grzesiak, Jakub; Siudzinska, Anna; Maredziak, Monika] Univ Environm & Life Sci, Electron Microscopy Lab, PL-50631 Wroclaw, Poland.
   [Marycz, Krzysztof; Smieszek, Agnieszka; Grzesiak, Jakub; Donesz-Sikorska, Anna] Wroclaw Res Ctr EIT, PL-54066 Wroclaw, Poland.
   [Donesz-Sikorska, Anna; Krzak, Justyna] Wroclaw Univ Technol, Inst Mat Sci & Appl Mech, PL-50370 Wroclaw, Poland.
RP Smieszek, A (reprint author), Univ Environm & Life Sci, Electron Microscopy Lab, Kozuchowska 5b, PL-50631 Wroclaw, Poland.
EM smieszek.agnieszka@gmail.com
RI KRZAK, JUSTYNA/G-4511-2015; Smieszek, Agnieszka/A-4887-2017; Marycz,
   Krzysztof/A-2249-2017
OI KRZAK, JUSTYNA/0000-0002-1525-5589; Smieszek,
   Agnieszka/0000-0002-7314-9821; 
FU Wroclaw Research Centre EIT+ under the project "Biotechnologies and
   advanced medical technologies"-BioMed - European Regional Development
   Fund (Operational Programme Innovative Economy)
   [POIG.01.01.02-02-003/08, 1.1.2]; Leading National Research Centre
   "KNOW" (Krajowy Naukowy Osrodek Wiodacy)
FX The research was supported by Wroclaw Research Centre EIT+ under the
   project "Biotechnologies and advanced medical technologies"-BioMed
   (POIG.01.01.02-02-003/08) financed from the European Regional
   Development Fund (Operational Programme Innovative Economy, 1.1.2).
   Additionally, the authors acknowledge the Leading National Research
   Centre "KNOW" (Krajowy Naukowy Osrodek Wiodacy) for covering the
   publication fees.
CR [Anonymous], 2009, TITANIUM MED, V8, P171
   Antunes RA, 2010, SURF COAT TECH, V205, P2074, DOI 10.1016/j.surfcoat.2010.08.101
   Arenas MA, 2011, J MATER SCI-MATER M, V22, P1005, DOI 10.1007/s10856-011-4284-9
   Bamoulid L, 2008, SURF COAT TECH, V202, P5020, DOI 10.1016/j.surfcoat.2008.05.011
   Bordji K, 1996, BIOMATERIALS, V17, P491, DOI 10.1016/0142-9612(96)82723-2
   Buhagiar J, 2011, J MATER SCI-MATER M, V22, P1269, DOI 10.1007/s10856-011-4298-3
   Fink T, 2011, STEM CELL RES, V7, P89, DOI 10.1016/j.scr.2011.03.003
   Gallardo J, 2001, J SOL-GEL SCI TECHN, V21, P65, DOI 10.1023/A:1011257516468
   Habazaki H, 2014, J ELECTROCHEM SOC, V161, pC57, DOI 10.1149/2.060401jes
   Hildebrandt C, 2011, TISSUE CELL, V43, P91, DOI 10.1016/j.tice.2010.12.004
   Hilfiker A, 2011, LANGENBECK ARCH SURG, V396, P489, DOI 10.1007/s00423-011-0762-2
   Keegan GM, 2007, J BONE JOINT SURG BR, V89B, P567, DOI 10.1302/0301-620X.89B5.18903
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kisiel AH, 2012, AM J VET RES, V73, P1305, DOI 10.2460/ajvr.73.8.1305
   Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341
   Lim YW, 2011, CLIN ORTHOP RELAT R, V469, P330, DOI 10.1007/s11999-010-1613-0
   Maredziak M, 2014, IN VITRO CELL DEV-AN, V50, P562, DOI 10.1007/s11626-013-9730-1
   Marycz K., 2014, J NANOMATER, V2014
   Marycz K, 2014, KAFKAS UNIV VET FAK, V20, P201, DOI 10.9775/kvfd.2013.9799
   Marycz K, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/6/065004
   Neuhuber B, 2008, EXP HEMATOL, V36, P1176, DOI 10.1016/j.exphem.2008.03.019
   Orimo Hideo, 2010, Journal of Nippon Medical School, V77, P4
   Saino E, 2010, TISSUE ENG PT A, V16, P995, DOI [10.1089/ten.tea.2009.0051, 10.1089/ten.TEA.2009.0051]
   Sansone V, 2013, CLIN CASES MINER BON, V10, P34, DOI 10.11138/ccmbm/2013.10.1.034
   Shih CC, 2004, CORROS SCI, V46, P427, DOI 10.1016/S0010-938X(03)00148-3
   Smieszek A, 2014, J BIOMATER APPL, V29, P699, DOI 10.1177/0885328214545095
   Sun H, 2008, TRANSPL P, V40, P2645, DOI 10.1016/j.transproceed.2008.07.096
   Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030
   Wongkhantee S, 2007, J PERIODONTOL, V78, P1113, DOI 10.1902/jop.2007.060433
   Zhou Yi-li, 2011, Hua Xi Kou Qiang Yi Xue Za Zhi, V29, P13
   Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488
NR 31
TC 7
Z9 9
U1 2
U2 9
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 651097
DI 10.1155/2015/651097
PG 11
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CB6CP
UT WOS:000349714800001
PM 25710015
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT B
AU Yuruker, SU
   Arik, M
   Tamdogan, E
   Melikov, R
   Nizamoglu, S
   Press, DA
   Durak, I
AF Yuruker, Sevket Umut
   Arik, Mehmet
   Tamdogan, Enes
   Melikov, Rustamjon
   Nizamoglu, Sedat
   Press, Daniel Aaron
   Durak, Ilkem
GP ASME
TI THERMAL AND OPTICAL PERFORMANCE OF ECO-FRIENDLY SILK FIBROIN PROTEINS AS
   A CAVITY ENCAPSULATION OVER LED SYSTEMS
SO INTERNATIONAL TECHNICAL CONFERENCE AND EXHIBITION ON PACKAGING AND
   INTEGRATION OF ELECTRONIC AND PHOTONIC MICROSYSTEMS, 2015, VOL 3
LA English
DT Proceedings Paper
CT ASME International Technical Conference and Exhibition on Packaging and
   Integration of Electronic and Photonic Microsystems (InterPACK)
CY JUL 06-09, 2015
CL San Francisco, CA
SP ASME
DE LED efficiency; thermal conductivity; LED encapsulation; silk fibroin;
   optical performance; CFD
AB The demand for high power LEDs for illumination applications is increasing. LED package encapsulation is one of most critical materials that affect the optical path of the generated light by LEDs, and may result in lumen degradation. A typical encapsulation material is a mixture of phosphor and a polymer based binder such as silicone. After LED chips are placed at the base of a cavity, phosphor particles are mixed with silicone and carefully placed into the cavity. One of the important technical challenges is to ensure a better thermal conductivity than 0.2 W/m-K of current materials for most of the traditional polymers in SSL applications.
   In this study, we investigated an unconventional material of the silk fibroin proteins for LED applications, and showed that this biomaterial provides thermal advantages leading to an order of magnitude higher thermal performance than conventional silicones. Silk fibroin is a natural protein and directly extracted from silk cocoons produced by Bombyx mori silkworm. Therefore, it presents a "green" material for photonic applications with its superior properties of biocompatibility and high optical transparency with a minimal absorption. Combining these properties with high thermal performance makes this biomaterial promising for future LED applications.
   An experimental and computational study to understand the optical and thermal performance is performed. A computational fluid dynamics study with a commercial CFD software was performed and an experimental set-up was developed to validate the computational findings to determine the thermal conductivity of the proposed material.
C1 [Yuruker, Sevket Umut; Arik, Mehmet; Tamdogan, Enes; Durak, Ilkem] Ozyegin Univ, Sch Engn, Istanbul, Turkey.
   [Melikov, Rustamjon; Nizamoglu, Sedat; Press, Daniel Aaron] Koc Univ, Sch Engn, Istanbul, Turkey.
RP Yuruker, SU (reprint author), Ozyegin Univ, Sch Engn, Istanbul, Turkey.
RI Nizamoglu, Sedat/H-5845-2018
OI Nizamoglu, Sedat/0000-0003-0394-5790
CR [Anonymous], 2009, THEOR GUID
   Arik M., 2010, ITHERM 2010
   ARIK M, 2006, J ELECTRON PACKAGING, P328
   Arik M., 2014, THERM THERM PHEN EL
   Arik M., 2004, ADV PACKAGING IEEE T
   Garg J., 2004, 9 INT C THERM THERM
   Philips News Center, TECHN LEDS
   Royce C., 2008, ASME JSME THERM ENG
   Tamdogan E., 2013, ASME INTERPACK 2013
NR 9
TC 0
Z9 0
U1 1
U2 3
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5690-1
PY 2015
AR V003T04A015
PG 7
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA BE5WD
UT WOS:000373517400021
DA 2018-10-19
ER

PT J
AU Kostic, MM
   Slipper, IJ
   Antonijevic, MD
   Mitrovic, JZ
   Radovic, MD
   Bojic, DV
   Bojic, AL
AF Kostic, M. M.
   Slipper, I. J.
   Antonijevic, M. D.
   Mitrovic, J. Z.
   Radovic, M. D.
   Bojic, D. V.
   Bojic, A. L.
TI PREPARATION AND CHARACTERISATION OF XANTHATED Lagenaria vulgaris SHELL
   BIOSORBENT
SO OXIDATION COMMUNICATIONS
LA English
DT Article
DE copper(II); kinetics; sorption; thermodynamics; xanthated biomaterial
ID HEAVY-METAL IONS; AQUEOUS-SOLUTIONS; EQUILIBRIUM SORPTION; BIOSORPTION;
   ADSORPTION; REMOVAL; WATER; ULTRAFILTRATION; PARAMETERS; INDUSTRIAL
AB Preparation and characterisation of chemically modified, improved biosorbent, xanthated Lagenaria vulgaris shell (xLVB), and its application for Cu(II) ions removal from aqueous solutions, were investigated in the present study. The chemically modified material was characterised by using FTIR, SEM and EDX analysis. Equilibrium isotherms and kinetics were obtained and the effect of various parameters including contact time, initial pH, biosorbent dosage, particle size, temperature, initial Cu(II) concentration was studied under batch conditions. xLVB was applied to test the sorption of Cu(II) ions in batch column system with recirculation of aqueous phase. The experimental data were best fitted by using pseudo-second order kinetics and the Langmuir isotherm model; equilibrium within less than 40 min and sorption capacity of 25.2 mg g(-1) for Cu(II) ions, at 20 degrees C were achieved. With increasing temperature from 10 to 40 degrees C the free energy change was negative, suggesting that the biosorption was exothermic and spontaneous.
C1 [Kostic, M. M.; Antonijevic, M. D.; Mitrovic, J. Z.; Radovic, M. D.; Bojic, D. V.; Bojic, A. L.] Univ Nis, Fac Sci & Math, Dept Chem, 33 Visegradska St, Nish 18000, Serbia.
   [Slipper, I. J.] Univ Greenwich, Fac Sci & Engn, Sch Sci, Chatham ME4 4TB, Kent, England.
RP Kostic, MM (reprint author), Univ Nis, Fac Sci & Math, Dept Chem, 33 Visegradska St, Nish 18000, Serbia.
EM mk484475@gmail.com
FU Ministry of Education, Science and Technological Development of the
   Republic of Serbia [TR34008]
FX The authors would like to acknowledge the Ministry of Education, Science
   and Technological Development of the Republic of Serbia (Grant No
   TR34008) for financial support.
CR Al-Rub FAA, 2006, PROCESS BIOCHEM, V41, P457, DOI 10.1016/j.procbio.2005.07.018
   Alok A, 2010, OXID COMMUN, V33, P583
   BASHYAL D., 2010, J NEPAL CHEM SOC, V26, P53
   Bjelajac Z, 2012, OXID COMMUN, V35, P1056
   Brady JM, 1999, J CHEM TECHNOL BIOT, V74, P71, DOI 10.1002/(SICI)1097-4660(199901)74:1<71::AID-JCTB985>3.0.CO;2-8
   Canizares P, 2005, J MEMBRANE SCI, V253, P149, DOI 10.1016/j.memsci.2004.12.042
   Dash Surya Narayan, 2010, International Journal of Environmental Sciences, V1, P296
   Decker-Walters DS, 2004, ECON BOT, V58, P501, DOI 10.1663/0013-0001(2004)058[0501:DAGAOW]2.0.CO;2
   Feng D, 2000, MINER ENG, V13, P623, DOI 10.1016/S0892-6875(00)00045-5
   Freundlich H M F, 1906, J PHYS CHEM, V57, P385
   Ho YS, 2002, PROCESS BIOCHEM, V37, P1421, DOI 10.1016/S0032-9592(02)00036-5
   Horsfall M, 2005, ACTA CHIM SLOV, V52, P174
   HOSSAIN M.A., 2012, J WATER SUSTAINABILI, V2, P87
   Huang YH, 2007, J HAZARD MATER, V144, P406, DOI 10.1016/j.jhazmat.2006.10.061
   Khan MN, 2007, J HAZARD MATER, V141, P237, DOI 10.1016/j.jhazmat.2006.06.119
   Kumar KV, 2007, J HAZARD MATER, V146, P214, DOI 10.1016/j.jhazmat.2006.12.010
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Li FT, 2007, CHINESE CHEM LETT, V18, P325, DOI 10.1016/j.cclet.2007.01.034
   Marder L, 2003, J BRAZIL CHEM SOC, V14, P610, DOI 10.1590/S0103-50532003000400018
   Nadeem R, 2008, J HAZARD MATER, V150, P335, DOI 10.1016/j.jhazmat.2007.04.110
   NORHAFIZAH BINTI A., 2011, ASIAN T ENG, V1, P49
   Ofomaja AE, 2010, BIORESOURCE TECHNOL, V101, P5868, DOI 10.1016/j.biortech.2010.03.033
   Ozaki H, 2002, DESALINATION, V144, P287, DOI 10.1016/S0011-9164(02)00329-6
   Ozer A, 2004, PROCESS BIOCHEM, V39, P2183, DOI 10.1016/j.procbio.2003.11.008
   Pavasant P, 2006, BIORESOURCE TECHNOL, V97, P2321, DOI 10.1016/j.biortech.2005.10.032
   Rehman R, 2011, J CHEM SOC PAKISTAN, V33, P515
   Stancheva KA, 2011, OXID COMMUN, V34, P792
   STANKOVIC M., 2012, AUST J CHEM, V66, P227
   Sud D, 2008, BIORESOURCE TECHNOL, V99, P6017, DOI 10.1016/j.biortech.2007.11.064
   Trivunac K, 2006, CHEMOSPHERE, V64, P486, DOI 10.1016/j.chemosphere.2005.11.073
   Weber W, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Yao ZY, 2010, J HAZARD MATER, V174, P137, DOI 10.1016/j.jhazmat.2009.09.027
NR 32
TC 0
Z9 0
U1 0
U2 0
PU SCIBULCOM LTD
PI SOFIA
PA PO BOX 249, 1113 SOFIA, BULGARIA
SN 0209-4541
J9 OXID COMMUN
JI Oxid. Commun.
PY 2015
VL 38
IS 4A
SI SI
BP 2173
EP 2188
PG 16
WC Chemistry, Multidisciplinary
SC Chemistry
GA DI1IR
UT WOS:000373250300021
DA 2018-10-19
ER

PT S
AU Barrias, CC
AF Barrias, Cristina C.
GP IEEE
TI Bioengineered cell-instructive 3D matrices as vehicles for cellular
   therapies
SO 2015 37TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN
   MEDICINE AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 37th Annual International Conference of the IEEE Engineering in Medicine
   and Biology Society (EMBC)
CY AUG 25-29, 2015
CL Milan, ITALY
ID SYNTHETIC EXTRACELLULAR-MATRIX; SENSITIVE ALGINATE HYDROGELS;
   MESENCHYMAL STEM-CELLS; BIOMEDICAL APPLICATIONS; DELIVERY;
   IMMOBILIZATION; FATE
AB The delivery of cells, namely of stem cells, from biomaterial-based vehicles has been used to promote and accelerate functional tissue regeneration. Carrier materials can transport and localize cells into target sites, increase their survival and engraftment, and provide a supportive matrix to assist cellular assembly into a newly formed tissue. Hydrogels are amongst the most widely used carrier materials, as they can entrap and protect cells within a real three-dimensional (3D) microenvironment, and intrinsically present many structural properties of the natural extracellular matrix (ECM). To recreate important features of the native ECM, hydrogels may be bio-functionalized with specific cell-instructive moieties for improved biomimetic properties. The biophysical properties of hydrogels can also be tuned, increasing their versatility, as it is currently recognized that stem cells respond to their biomechanical environment. Here, an overview of some strategies commonly employed in the preparation of biomimetic matrices is presented, using alginate as a model hydrogel.
C1 [Barrias, Cristina C.] Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
RP Barrias, CC (reprint author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM ccbarrias@ineb.up.pt
OI Barrias, Cristina/0000-0002-8178-6134
CR Bidarra SJ, 2014, ACTA BIOMATER, V10, P1646, DOI 10.1016/j.actbio.2013.12.006
   Bidarra SJ, 2011, BIOMATERIALS, V32, P7897, DOI 10.1016/j.biomaterials.2011.07.013
   Bidarra SJ, 2010, BIOMACROMOLECULES, V11, P1956, DOI 10.1021/bm100264a
   DeForest CA, 2012, ANNU REV CHEM BIOMOL, V3, P421, DOI 10.1146/annurev-chembioeng-062011-080945
   Evangelista MB, 2007, BIOMATERIALS, V28, P3644, DOI 10.1016/j.biomaterials.2007.04.028
   Fonseca KB, 2014, PROG POLYM SCI, V39, P2010, DOI 10.1016/j.progpolymsci.2014.07.003
   Fonseca KB, 2014, BIOMACROMOLECULES, V15, P380, DOI 10.1021/bm4016495
   Fonseca KB, 2013, SOFT MATTER, V9, P3283, DOI 10.1039/c3sm27560d
   Fonseca KB, 2011, ACTA BIOMATER, V7, P1674, DOI 10.1016/j.actbio.2010.12.029
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Maia FR, 2014, J CONTROL RELEASE, V189, P158, DOI 10.1016/j.jconrel.2014.06.030
   Maia FR, 2014, ACTA BIOMATER, V10, P3197, DOI 10.1016/j.actbio.2014.02.049
   Martin I, 2015, TISSUE ENG PT A, V21, P1, DOI [10.1089/ten.tea.2014.0515, 10.1089/ten.TEA.2014.0515]
   Neves SC, 2015, J MATER CHEM B, V3, P2096, DOI 10.1039/c4tb00885e
   Maia FR, 2013, ACTA BIOMATER, V9, P8773, DOI 10.1016/j.actbio.2013.08.004
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
NR 21
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4244-9270-1
J9 IEEE ENG MED BIO
PY 2015
BP 1737
EP 1740
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BE4HD
UT WOS:000371717202007
PM 26736613
DA 2018-10-19
ER

PT S
AU Neuta, PA
   Rojas, DM
   Agredo, W
   Gutierrez, JO
AF Neuta, P. A.
   Rojas, D. M.
   Agredo, W.
   Gutierrez, J. O.
GP IEEE
TI Evaluation of the Repairing Effect of Collagen Type I and MaxGel on the
   Infarcted Myocardium in an Animal Model
SO 2015 37TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN
   MEDICINE AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 37th Annual International Conference of the IEEE Engineering in Medicine
   and Biology Society (EMBC)
CY AUG 25-29, 2015
CL Milan, ITALY
AB Nowadays and in spite of all the preventive effort made, cardiovascular diseases remain as one of the leading causes of death worldwide. Current treatments decrease the progression of the disease but fail to offer a solution where the contractile function lost due to the injury can be recovered. In response to this, regenerative medicine proposes new approaches and one of this is the use of biomaterials that can mimic the role of the extracellular matrix and provide support for new cells in the affected heart. This study evaluated the repairing effect of collagen type I and MaxGel when injected, alone or combined, into the infarcted heart of Wistar rats. Cardiac function was quantified using the ejection fraction as the main parameter and it was measured in three time points during the study: pre-infarction, post-infarction, and post-treatment. Additionally, histological samples of the hearts were taken for evaluation. The data obtained showed a marked recovery of the cardiac function in the animals were collagen type I was injected with an increase of 8.2% on the mean ejection fraction, suggesting that this biomaterial has the capacity to stop the progressive decline of the cardiac function in an infarcted heart.
C1 [Neuta, P. A.; Rojas, D. M.; Agredo, W.] Univ Autonoma Occidente, G Bio Res Grp, Cali, Colombia.
   [Gutierrez, J. O.] Univ Valle, Pharmacol Res Grp, Cali, Colombia.
RP Neuta, PA (reprint author), Univ Autonoma Occidente, G Bio Res Grp, Cali, Colombia.
EM paneuta@uao.edu.co; dianamarcela.rojasgonzalez@ugent.be
CR Booloki M., 2010, ACUTE MYOCARDIAL INF
   Collins SD, 2007, CARDIOVASC REVASCULA, V8, P43, DOI 10.1016/j.carrev.2006.11.005
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dimarakis I., 2006, J CARDIOTHORACIC REN, V1, P108
   George J., 2010, J LAB CLIN MED, V155, P10
   Ivernici G., EXPT CELL RES, V314, P366
   Jackson K., 2004, STEM CELLS HDB, P259
   Martin-Rendon E., 2009, STEM CELL TREATMENT, P1
   Pan-American Health Organization, 2010, HLTH AM, P10
   Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003
   World Health Organization, 2014, 10 LEAD CAUS DEATH W
   World Health Organization, 2015, CARD DIS CVDS
NR 12
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4244-9270-1
J9 IEEE ENG MED BIO
PY 2015
BP 3529
EP 3532
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BE4HD
UT WOS:000371717203201
PM 26737054
DA 2018-10-19
ER

PT S
AU Anindyajati, A
   Boughton, P
   Ruys, A
AF Anindyajati, Adhi
   Boughton, Philip
   Ruys, Andrew
BE Guojian, C
   Muhammad, Y
TI The Effect of Rotating Collector Design on Tensile Properties and
   Morphology of Electrospun Polycaprolactone Fibres
SO 2015 4TH INTERNATIONAL CONFERENCE ON ENGINEERING AND INNOVATIVE
   MATERIALS (ICEIM 2015)
SE MATEC Web of Conferences
LA English
DT Proceedings Paper
CT 4th International Conference on Engineering and Innovative Materials
   (ICEIM)
CY SEP 03-04, 2015
CL Penang, MALAYSIA
SP Int Acad Comp Technol, UKM Malaysia
ID HUMAN ACETABULAR LABRUM; INDUCED ORIENTATION; POLYMER NANOFIBERS;
   SCAFFOLDS; FIBROCARTILAGE; ALIGNMENT
AB Electrospinning is a technique that can produce fibres in the nanoscale range. This process is useful for many applications, including fabrication of fibrous scaffolds for fibrocartilage tissue engineering. For this application, cell attachment and tissue development is influenced by fibre morphology and mechanical properties. This electrospinning study investigated the influence of rotating collector design on morphology and mechanical properties of electrospun polycaprolactone fibre. The experiment employed 4 mandrel designs: 1) full surface of aluminium; 2) with gap feature; 3) with gap feature and teflon support; 4) with gap feature and tape support. The highest elastic modulus was obtained from mandrel with gap and tape support, which was 24.6 MPa and significantly higher compared to fibres acquired from other collector designs. Fibre diameter attained was identical across the different collectors, ranging from 0.5 - 2 mu m. Gap introduction showed enhanced alignment in the resultant fibre. It can be concluded that fibre alignment and tensile properties can be improved by simply modifying the collector design. This improved fibre mat can be developed as a biomaterial for fibrocartilage tissue engineering scaffolds.
C1 [Anindyajati, Adhi; Boughton, Philip; Ruys, Andrew] Univ Sydney, Sydney, NSW 2006, Australia.
RP Anindyajati, A (reprint author), Univ Sydney, Sydney, NSW 2006, Australia.
EM aani2456@uni.sydney.edu.au; philip.boughton@sydney.edu.au;
   andrew.ruys@sydney.edu.au
RI Boughton, Philip/N-8359-2016
OI Boughton, Philip/0000-0003-4318-8966
CR Badrossamay MR, 2010, NANO LETT, V10, P2257, DOI 10.1021/nl101355x
   Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004
   Benjamin M, 1998, J ANAT, V193, P481, DOI 10.1046/j.1469-7580.1998.19340481.x
   BENJAMIN M, 1990, J ANAT, V171, P1
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Cipitria A, 2011, J MATER CHEM, V21, P9419, DOI 10.1039/c0jm04502k
   Dalton PD, 2005, POLYMER, V46, P611, DOI 10.1016/j.polymer.2004.11.075
   Dersch R, 2003, J POLYM SCI POL CHEM, V41, P545, DOI 10.1002/pola.10609
   Hutmacher D, 1996, Int J Oral Maxillofac Implants, V11, P667
   Ishiko T, 2005, J ORTHOP RES, V23, P1448, DOI 10.1016/j.orthres.2004.08.025
   Kakade MV, 2007, J AM CHEM SOC, V129, P2777, DOI 10.1021/ja065043f
   Katta P, 2004, NANO LETT, V4, P2215, DOI 10.1021/nl0486158
   Kim HW, 2006, ADV FUNCT MATER, V16, P1529, DOI 10.1002/adfm.200500750
   Koepsell L, 2011, J BIOMED MATER RES A, V99A, P564, DOI 10.1002/jbm.a.33216
   Kongkhlang T, 2008, J AM CHEM SOC, V130, P15460, DOI 10.1021/ja804185s
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li D, 2003, NANO LETT, V3, P1167, DOI 10.1021/nl0344256
   Li WJ, 2007, J BIOMECH, V40, P1686, DOI 10.1016/j.jbiomech.2006.09.004
   Liao C.-C., 2011, POLYMER, V52, P4303
   Liao CC, 2011, POLYMER, V52, P2263, DOI 10.1016/j.polymer.2011.03.018
   Liao CC, 2011, EUR POLYM J, V47, P911, DOI 10.1016/j.eurpolymj.2011.01.006
   Nerurkar N. L., 2011, BIOMATERIALS, V32, P461
   Nerurkar NL, 2010, SPINE, V35, P867, DOI 10.1097/BRS.0b013e3181d74414
   Petersen W, 2003, ARCH ORTHOP TRAUM SU, V123, P283, DOI 10.1007/s00402-003-0527-7
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Seldes RM, 2001, CLIN ORTHOP RELAT R, P232
   Smith CD, 2009, BRIT J SPORT MED, V43, P574, DOI 10.1136/bjsm.2008.053645
   Sundaray B, 2004, APPL PHYS LETT, V84, P1222, DOI 10.1063/1.1647685
   Theron A, 2001, NANOTECHNOLOGY, V12, P384, DOI 10.1088/0957-4484/12/3/329
   Thorvaldsson A, 2008, BIOMACROMOLECULES, V9, P1044, DOI 10.1021/bm701225a
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
NR 32
TC 1
Z9 1
U1 1
U2 7
PU E D P SCIENCES
PI CEDEX A
PA 17 AVE DU HOGGAR PARC D ACTIVITES COUTABOEUF BP 112, F-91944 CEDEX A,
   FRANCE
SN 2261-236X
J9 MATEC WEB CONF
PY 2015
VL 27
AR 02002
DI 10.1051/matecconf/20152702002
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BE5BH
UT WOS:000372507600013
OA DOAJ Gold
DA 2018-10-19
ER

PT S
AU Kaur, K
   Singh, KJ
   Anand, V
   Kaur, H
   Arora, DS
AF Kaur, Kulwinder
   Singh, K. J.
   Anand, Vikas
   Kaur, Harpreet
   Arora, Daljit Singh
BE Sinha, MM
   Verma, SS
TI In-Vitro Study of Copper Doped SiO2-CaO-P2O5 System for Bioactivity and
   Antimicrobial Properties
SO ADVANCED MATERIALS AND RADIATION PHYSICS (AMRP-2015)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 4th National Conference on Advanced Materials and Radiation Physics
   (AMRP)
CY MAR 13-14, 2015
CL S L I E T, Dept Phys, Longowal, INDIA
SP S L I E T, TEQIP II Project, Dept Sci & Technol
HO S L I E T, Dept Phys
DE Biomaterials; Hydroxylapatite; Antimicrobial Properties
ID GLASS-CERAMIC NANOPARTICLES; SOL-GEL; SCAFFOLDS
AB Samples of the xCuO-(45-x) CaO-10P(2)O(5)-45SiO(2) system (x varies from 0 to 4 mole%) have been synthesized for application as biomaterials to slow or inhibit the growth of living organisms (fungi and other pathogenic microorganisms) by the combination of sol-gel and co-precipitation processes. Prepared samples have been characterized by X-Ray Diffraction, Fourier Transform Infra-Red and Field Emission Scanning Electron Microscopy techniques before and after immersion in simulated body fluid. Antimicrobial activity of samples has been investigated against Staphylococcus aureus. Releasing of Cu2+ and other ions in the simulated body fluid has been determined by Atomic Absorption Spectroscopy to ensure the use of prepared material as biomaterial with good antibacterial properties.
C1 [Kaur, Kulwinder; Singh, K. J.; Anand, Vikas] Guru Nanak Dev Univ, Dept Phys, Amritsar 143005, Punjab, India.
   [Kaur, Harpreet; Arora, Daljit Singh] Guru Nanak Dev Univ, Dept Microbiol, Amritsar 143005, Punjab, India.
RP Singh, KJ (reprint author), Guru Nanak Dev Univ, Dept Phys, Amritsar 143005, Punjab, India.
EM kanwarjitsingh@yahoo.com
CR Anand V, 2014, J NON-CRYST SOLIDS, V406, P88, DOI 10.1016/j.jnoncrysol.2014.09.050
   Hong ZK, 2008, ACTA BIOMATER, V4, P1297, DOI 10.1016/j.actbio.2008.03.007
   Hong ZK, 2009, J NON-CRYST SOLIDS, V355, P368, DOI 10.1016/j.jnoncrysol.2008.12.003
   Hong Z, 2009, J BIOMED MATER RES A, V88A, P304, DOI 10.1002/jbm.a.31848
   Hoppe A, 2013, J MATER CHEM B, V1, P5659, DOI 10.1039/c3tb21007c
   Hoppe A, 2013, BIOMATER SCI-UK, V1, P254, DOI 10.1039/c2bm00116k
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Stahli C, 2014, ACTA BIOMATER, V10, P3317, DOI 10.1016/j.actbio.2014.03.015
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Xia W, 2007, MATER LETT, V61, P3251, DOI 10.1016/j.matlet.2006.11.048
   Zhao S., 2015, ACTA BIOMATERIALIA
NR 12
TC 1
Z9 1
U1 1
U2 2
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1322-1
J9 AIP CONF PROC
PY 2015
VL 1675
AR 020020
DI 10.1063/1.4929178
PG 4
WC Physics, Applied; Physics, Nuclear; Physics, Particles & Fields
SC Physics
GA BE4GI
UT WOS:000371686800020
DA 2018-10-19
ER

PT S
AU Guarino, V
   Altobelli, R
   Cirillo, V
   Ambrosio, L
AF Guarino, Vincenzo
   Altobelli, Rosaria
   Cirillo, Valentina
   Ambrosio, Luigi
BE Pantani, R
   DeSantis, F
   Speranza, V
TI Electro Fluido Dynamic Techniques To Design Instructive Biomaterials For
   Tissue Engineering and Drug Delivery
SO POLYMER PROCESSING WITH RESULTING MORPHOLOGY AND PROPERTIES: FEET IN THE
   PRESENT AND EYES AT THE FUTURE
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT GT70 International Conference
CY OCT 15-17, 2015
CL Salerno, ITALY
ID ALGINATE MICROSPHERES; REGENERATION; FIBERS; MINERALIZATION;
   NANOTECHNOLOGY; NANOPARTICLES; ENCAPSULATION; NANOFIBERS; STRATEGIES;
   PLATFORMS
AB A large variety of processes and tools is continuously investigated to discover new solutions to design instructive materials with controlled chemical, physical and biological properties for tissue engineering and drug delivery. Among them, electro fluido dynamic techniques (EFDTs) are emerging as an interesting strategy, based on highly flexible and low-cost processes, to revisit old biomaterial's manufacturing approach by utilizing electrostatic forces as the driving force for the fabrication of 3D architectures with controlled physical and chemical functionalities to guide in vitro and in vivo cell activities. By a rational selection of polymer solution properties and process conditions, EFDTs allow to produce fibres and/or particles at micro and/or nanometric size scale which may be variously assembled by tailored experimental setups, thus giving the chance to generate a plethora of different 3D devices able to incorporate biopolymers (i.e., proteins, polysaccharides) or active molecules (e.g., drugs) for different applications. Here, we focus on the optimization of basic EFDTs-namely electrospinning, electrospraying and electrodynamic atomization - to develop active platforms (i.e., monocomponent, protein and drug loaded scaffolds and mu-scaffolds) made of synthetic (PCL, PLGA) or natural (chitosan, alginate) polymers. In particular, we investigate how to set materials and process parameters to impart specific morphological, biochemical or physical cues to trigger all the fundamental cell-biomaterial and cell-cell cross-talking elicited during regenerative processes, in order to reproduce the complex microenvironment of native or pathological tissues.
C1 [Guarino, Vincenzo; Altobelli, Rosaria; Cirillo, Valentina; Ambrosio, Luigi] Natl Res Council Italy, Dept Chem Sci & Mat Technol, Inst Polymers Composites & Biomat, Vle Kennedy 54, Naples, Italy.
RP Guarino, V (reprint author), Natl Res Council Italy, Dept Chem Sci & Mat Technol, Inst Polymers Composites & Biomat, Vle Kennedy 54, Naples, Italy.
EM vguarino@unina.it
OI AMBROSIO, LUIGI/0000-0002-8367-2405; Guarino,
   Vincenzo/0000-0003-1546-3721
CR Alvarez-Perez MA, 2010, BIOMACROMOLECULES, V11, P2238, DOI 10.1021/bm100221h
   Aviss KJ, 2010, EUR CELLS MATER, V19, P193, DOI 10.22203/eCM.v019a19
   Bock N, 2012, PROG POLYM SCI, V37, P1510, DOI 10.1016/j.progpolymsci.2012.03.002
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   Cirillo V, 2014, J MATER SCI-MATER M, V25, P2323, DOI 10.1007/s10856-014-5214-4
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   Dong B, 2009, SMALL, V5, P1508, DOI 10.1002/smll.200801750
   Grellier M, 2009, BIOMATERIALS, V30, P3271, DOI 10.1016/j.biomaterials.2009.02.033
   Gu Z, 2013, ACS NANO, V7, P6758, DOI 10.1021/nn401617u
   Guaccio A, 2011, BIOTECHNOL BIOENG, V108, P1965, DOI 10.1002/bit.23113
   Guarino V, 2012, INT MATER REV, V57, P256, DOI 10.1179/0950660812Z.00000000021
   Guarino V., 2009, Patent No. [WO 2009143947, 2009143947]
   Guarino V., MAT BIOCOMPATIBILI M
   Guarino V, 2015, EXPERT REV MED DEVIC, V12, P113, DOI 10.1586/17434440.2014.953058
   Guarino V, 2013, MACROMOL SYMP, V331, P65, DOI 10.1002/masy.201300074
   Guarino V, 2012, J APPL BIOMATER FUNC, V10, P191, DOI 10.5301/JABFM.2012.10369
   Guarino V, 2011, MACROMOL BIOSCI, V11, P1694, DOI 10.1002/mabi.201100204
   Huang I.Y., 2012, J MATER SCI, V47, P1372
   Jaworek A, 2008, J ELECTROSTAT, V66, P197, DOI 10.1016/j.elstat.2007.10.001
   Kenawy ER, 2009, MATER CHEM PHYS, V113, P296, DOI 10.1016/j.matchemphys.2008.07.081
   Khodir WKWA, 2013, J BIOACT COMPAT POL, V28, P258, DOI 10.1177/0883911513481133
   Mayol L, 2014, J MATER SCI-MATER M, V25, P383, DOI 10.1007/s10856-013-5080-5
   Midhun BT, 2011, J BIOMAT SCI-POLYM E, V22, P2431, DOI 10.1163/092050610X540486
   Nie HM, 2010, J BIOMED MATER RES A, V95A, P709, DOI 10.1002/jbm.a.32867
   Perez MAA, 2012, J BIOMED MATER RES A, V100A, P3008, DOI 10.1002/jbm.a.34233
   Sailaja G, 2002, GENE THER, V9, P1722, DOI 10.1038/sj.gt.3301858
   Salata OV, 2005, CURR NANOSCI, V1, P25, DOI 10.2174/1573413052953192
   Xie JW, 2007, J COLLOID INTERF SCI, V312, P247, DOI 10.1016/j.jcis.2007.04.023
   Zamani M., 2013, INT J NANOMED, V13, P4656
NR 29
TC 2
Z9 2
U1 1
U2 6
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1342-9
J9 AIP CONF PROC
PY 2015
VL 1695
AR 020004
DI 10.1063/1.4937282
PG 5
WC Physics, Applied; Polymer Science
SC Physics; Polymer Science
GA BE4DP
UT WOS:000371592000004
DA 2018-10-19
ER

PT J
AU Peter, I
   Rosso, M
AF Peter, Ildiko
   Rosso, Mario
TI Study of Ti-Enriched CoCrMo Alloy for Dental Application
SO IEEE ACCESS
LA English
DT Article
DE Metallic materials; CoCrMo alloy; microstructure; residual stress;
   biomedical application
ID METAL-ION RELEASE; POROUS TANTALUM BIOMATERIAL; AUSTENITIC
   STAINLESS-STEELS; ZR-NB ALLOYS; MECHANICAL-PROPERTIES; CORROSION
   BEHAVIOR; IN-VITRO; MAGNESIUM ALLOYS; BONE INGROWTH; IMPLANTS
AB Metallic materials can be considered to be in a peculiar position for production of medical devices, because of their attractive properties. In this paper, a new enriched Co-based composition is proposed for dental application, starting from a conventional CoCrMo alloy. Macrostructural and microstructural investigations, mechanical and corrosion resistance evaluation, and metal ions release are carried out. The best composition, among the studied alloys, is identified for dental purpose.
C1 [Peter, Ildiko; Rosso, Mario] Politecn Torino, Dept Appl Sci & Technol, Inst Sci & Engn Mat Innovat Technol, I-10129 Turin, Italy.
RP Peter, I (reprint author), Politecn Torino, Dept Appl Sci & Technol, Inst Sci & Engn Mat Innovat Technol, I-10129 Turin, Italy.
EM ildiko.peter@polito.it
CR [Anonymous], 2001, F7507 ASTM
   [Anonymous], 1999, IARC MON EV CARC RIS, V74, P65
   Aparicio C, 2003, BIOMATERIALS, V24, P263, DOI 10.1016/S0142-9612(02)00314-9
   Ashby M F, 1980, ENG MAT
   Bal W, 2000, J INORG BIOCHEM, V79, P213, DOI 10.1016/S0162-0134(99)00169-5
   Bannon B. P., 1981, TITANIUM ALLOYS SURG, P7
   Bertrand OF, 1998, J AM COLL CARDIOL, V32, P562, DOI 10.1016/S0735-1097(98)00289-7
   Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   Blackburn M. J., 1967, PHASE TRANSFORMATION, V239, P1200
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   BROWNE M, 1994, BIOMATERIALS, V15, P894, DOI 10.1016/0142-9612(94)90113-9
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   Cobb AG, 2006, P I MECH ENG H, V220, P385, DOI 10.1243/09544119JEIM78
   Collings E. W., 1984, PHYS METALLURGY TITA, P321
   Czerwinski F, 2011, MAGNESIUM ALLOYS - CORROSION AND SURFACE TREATMENTS, pIX
   Davis J. R., 2003, HDB MAT MED DEVICES
   DEPALMA VA, 1972, J BIOMED MATER RES, V6, P37, DOI 10.1002/jbm.820060406
   Eftekhari A, 2003, APPL SURF SCI, V220, P343, DOI 10.1016/S0169-4332(03)00842-0
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   Fischer A, 2012, J MECH BEHAV BIOMED, V9, P50, DOI 10.1016/j.jmbbm.2012.01.007
   Gil FJ, 2001, J ALLOY COMPD, V329, P142, DOI 10.1016/S0925-8388(01)01571-7
   Gomez M, 1997, J BIOMED MATER RES, V34, P157, DOI 10.1002/(SICI)1097-4636(199702)34:2<157::AID-JBM3>3.0.CO;2-P
   Hanawa T, 2004, MAT SCI ENG C-BIO S, V24, P745, DOI 10.1016/j.msec.2004.08.018
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   Kajzer W., 2008, J ACHIEVEMENTS MAT M, V26, P131
   Karaali A, 2005, MAT SCI ENG A-STRUCT, V390, P255, DOI 10.1016/j.msea.2004.08.001
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   KOBAYASHI E, 1995, J J DENT MAT, V14, P321
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kondo R, 2011, ACTA BIOMATER, V7, P4278, DOI 10.1016/j.actbio.2011.07.020
   Kraus T, 2012, ACTA BIOMATER, V8, P1230, DOI 10.1016/j.actbio.2011.11.008
   Kuroda D, 2002, MATER TRANS, V43, P3100, DOI 10.2320/matertrans.43.3100
   Lei MK, 2001, BIOMATERIALS, V22, P641, DOI 10.1016/S0142-9612(00)00226-X
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Li JN, 2010, BIOMATERIALS, V31, P5782, DOI 10.1016/j.biomaterials.2010.04.023
   Lin HY, 2008, DENT MATER, V24, P378, DOI 10.1016/j.dental.2007.06.010
   Lin JH, 2007, J MATER PROCESS TECH, V192, P97, DOI 10.1016/j.jmatprotec.2007.04.068
   Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]
   Mahendra G, 2009, ACTA ORTHOP, V80, P653, DOI 10.3109/17453670903473016
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Matkovic T, 2006, J ALLOY COMPD, V407, P294, DOI 10.1016/j.jallcom.2005.06.025
   Morais LS, 2007, ACTA BIOMATER, V3, P331, DOI 10.1016/j.actbio.2006.10.010
   Nomura N, 2009, MATER TRANS, V50, P2466, DOI 10.2320/matertrans.M2009187
   Park J. B., 2000, BIOMEDICAL ENG HDB, V1
   Peter Ildiko, 2014, Materials Science Forum, V790-791, P235, DOI 10.4028/www.scientific.net/MSF.790-791.235
   PETER I., 2013, ARCH MAT SCI ENG, V61, P62
   Pilliar R., 1999, COBALT BASE ALLOYS B, V432
   Pilliar RM, 2009, BIOMEDICAL MATERIALS, P41, DOI 10.1007/978-0-387-84872-3_2
   Podrez-Radziszewska M., 2010, ARCH FOUNDRY ENG, V10, P51
   Polmear I. J., 1981, LIGHT METALS METALLU, P239
   POURBAIX M, 1984, BIOMATERIALS, V5, P122, DOI 10.1016/0142-9612(84)90046-2
   Sedriks AJ., 1996, CORROSION STAINLESS
   Semlitsch M. F., 1981, TITANIUM ALLOYS SURG, P120
   Sevilla P, 2007, J ALLOY COMPD, V439, P67, DOI [10.1016/j.jallcom.2006.08.069, 10.1016/j.jallcom.2006.008.069]
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Takazawa Kenji, 2003, J Artif Organs, V6, P71, DOI 10.1007/s100470300011
   Talha M, 2014, B MATER SCI, V37, P1321, DOI 10.1007/s12034-014-0078-2
   Tandon R, 1999, AM SOC TEST MATER, V1365, P3, DOI 10.1520/STP14259S
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   Thomann UI, 2000, WEAR, V239, P48, DOI 10.1016/S0043-1648(99)00372-5
   Tulinski M, 2012, APPL SURF SCI, V260, P80, DOI 10.1016/j.apsusc.2012.07.071
   Vahter M, 2002, ENVIRON RES, V88, P145, DOI 10.1006/enrs.2002.4338
   Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9
   Virtanen S, 2011, MATER SCI ENG B-ADV, V176, P1600, DOI 10.1016/j.mseb.2011.05.028
   Vormann Juergen, 2003, Molecular Aspects of Medicine, V24, P27, DOI 10.1016/S0098-2997(02)00089-4
   Withers PJ, 2001, MATER SCI TECH-LOND, V17, P355, DOI 10.1179/026708301101509980
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Yamanaka K, 2011, MAT SCI ENG A-STRUCT, V528, P5961, DOI 10.1016/j.msea.2011.04.027
   Yamanaka K, 2009, METALL MATER TRANS A, V40A, P1980, DOI 10.1007/s11661-009-9879-0
   Zangeneh S, 2010, MAT SCI ENG A-STRUCT, V527, P6494, DOI 10.1016/j.msea.2010.06.081
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
NR 75
TC 5
Z9 5
U1 0
U2 7
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 2169-3536
J9 IEEE ACCESS
JI IEEE Access
PY 2015
VL 3
BP 73
EP 80
DI 10.1109/ACCESS.2015.2398312
PG 8
WC Computer Science, Information Systems; Engineering, Electrical &
   Electronic; Telecommunications
SC Computer Science; Engineering; Telecommunications
GA DF5JP
UT WOS:000371388200005
OA DOAJ Gold
DA 2018-10-19
ER

PT S
AU Bertucci, CP
   Ramamoorthy, S
   Karande, PJ
   Thompson, DM
AF Bertucci, C. P.
   Ramamoorthy, S.
   Karande, P. J.
   Thompson, D. M.
GP IEEE
TI 3D High Throughput Assays for Combinatorial Screening of Biomaterials
   for Tissue Regeneration
SO 2015 41ST ANNUAL NORTHEAST BIOMEDICAL ENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 41st Annual Northeast Biomedical Engineering Conference (NEBEC)
CY APR 17-19, 2015
CL Troy, NY
DE high throughput; 3D cell culture; combinatorial screening; neural tissue
   engineering; extracellular matrix; biomaterials
AB Tissue engineered strategies suffer from a lack of complexity, which manifests itself as unsatisfactory functional recovery in clinical applications. Better understanding of cell response to complex combinations of matrix proteins and growth factors mediating regeneration is necessary for increased biomaterial performance. A high throughput 3D multiplex assay has been designed for evaluating cell behavior in response to differential composite biomaterials. Specifically, Schwann cell (SC) and neuronal viability, death, and morphology were measured in response to varying collagen (COL) hydrogel concentration (1-3 mg/mL) and Matrigel T (MAT) concentration (0-100% v/v). SCs were sensitive to differences in MAT and relatively insensitive to COL differences within this range, whereas neurons were sensitive to changes in both MAT and COL concentration. This strategy is capable of rapidly identifying large differences in cell behavior within combinatorial biomaterials, demonstrating its utility for narrowing large experimental libraries to optimal multifunctional composite materials.
C1 [Bertucci, C. P.; Thompson, D. M.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
   [Ramamoorthy, S.; Karande, P. J.] Rensselaer Polytech Inst, Dept Chem Engn, Troy, NY 12180 USA.
RP Bertucci, CP (reprint author), Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
EM Thompd4@rpi.edu
CR Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002
   Dumont CM, 2014, TISSUE ENG PART C-ME, V20, P620, DOI [10.1089/ten.tec.2013.0362, 10.1089/ten.TEC.2013.0362]
   Ide C, 1996, NEUROSCI RES, V25, P101
NR 3
TC 0
Z9 0
U1 0
U2 4
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4799-8360-5
J9 NORTHEAST BIOENGIN C
PY 2015
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BE3MX
UT WOS:000370977700022
DA 2018-10-19
ER

PT S
AU Ersumo, NT
   Spitler, KL
AF Ersumo, Nathan Tessema
   Spitler, Kara L.
GP IEEE
TI Effects of hydrogel properties and extrusion parameters on 3D
   bioprinting
SO 2015 41ST ANNUAL NORTHEAST BIOMEDICAL ENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 41st Annual Northeast Biomedical Engineering Conference (NEBEC)
CY APR 17-19, 2015
CL Troy, NY
AB In recent years, advances in tissue engineering have brought about the development of 3D bioprinting. By encapsulating cells within a biomaterial for three-dimensional extrusion, this efficient and integrated biofabrication method overcomes the limitations of two-dimensional cell culture, allows for the study of complex cell interactions in a physiologically relevant microenvironment and is a promising stepping stone to the functional replacement of lost or damaged tissue. Despite efforts to improve the cytocompatibility of the extruded biomaterial and to induce specific tissue formation upon extrusion, the effects of hydrogel properties on the extruded construct have been poorly characterized. Here, we assess the impact of various parameters, including biomaterial composition, computer-designed structure and printing speed, on the structural integrity, stress distribution and resolution of the extruded construct.
C1 [Ersumo, Nathan Tessema; Spitler, Kara L.] Drexel Univ, 3141 Chestnut St, Philadelphia, PA 19104 USA.
RP Ersumo, NT (reprint author), Drexel Univ, 3141 Chestnut St, Philadelphia, PA 19104 USA.
CR Bertassoni LE, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024105
   Butscher A, 2012, ACTA BIOMATER, V8, P373, DOI 10.1016/j.actbio.2011.08.027
   Cohen D L, 2010, TISSUE ENG PART C-ME, V17, P239
   Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055
   Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506
   Malda J, 2013, ADV MATER, V25, P5011, DOI 10.1002/adma.201302042
   Murphy SV, 2013, J BIOMED MATER RES A, V101, P272, DOI 10.1002/jbm.a.34326
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Tirella A, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/4/045002
   Wang M. O., 2014, ADV MAT
NR 10
TC 0
Z9 0
U1 0
U2 8
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4799-8360-5
J9 NORTHEAST BIOENGIN C
PY 2015
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BE3MX
UT WOS:000370977700051
DA 2018-10-19
ER

PT S
AU Ramamoorthy, S
   Bertucci, CP
   Thompson, DM
   Karande, P
AF Ramamoorthy, S.
   Bertucci, C. P.
   Thompson, D. M.
   Karande, P.
GP IEEE
TI High Throughput Screening of Endothelial Cell Response to Combinatorial
   Collagen - Matrigel Biomaterials
SO 2015 41ST ANNUAL NORTHEAST BIOMEDICAL ENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 41st Annual Northeast Biomedical Engineering Conference (NEBEC)
CY APR 17-19, 2015
CL Troy, NY
DE tissue engineering; extracellular matrix; biomaterials; high throughput
   screening; endothelial cells
ID NERVE REGENERATION
AB Peripheral nerve regeneration is limited by lack of growth permissive microenvironment and glial scarring. An ideal biomaterial for regeneration should support neurons and non-neural cells of Schwann cells and endothelial cells. Numerous tissue engineered strategies have been proposed for PNS regeneration but only a few approaches look at the role of support cells and microenvironment. It is therefore necessary to study the effect of scaffold, ECM proteins and growth factors and optimize the microenvironment for supporting all cell types. In this work, we evaluated the endothelial cell response to combinatorial collagen - matrigel library. Composite biomaterial library was fabricated in a microwell array and collagen and matrigel were varied at 1 - 3 mg/mL and 0 - 100% respectively. A flatbed fluorescent scanner was used for high throughput acquisition of images. Cell response analysis of cell number, morphology and metabolic activity was quantified. Endothelial cell responses is modulated by both collagen and matrigel concentration. An optimum matrigel content of 20% supported cell proliferation, spreading and increased metabolic activity.
C1 [Ramamoorthy, S.; Karande, P.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY USA.
   [Bertucci, C. P.; Thompson, D. M.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
   [Ramamoorthy, S.; Bertucci, C. P.; Thompson, D. M.; Karande, P.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA.
RP Ramamoorthy, S (reprint author), Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY USA.
CR Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   Hobson MI, 1997, BRIT J PLAST SURG, V50, P125, DOI 10.1016/S0007-1226(97)91325-4
   Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009
NR 3
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4799-8360-5
J9 NORTHEAST BIOENGIN C
PY 2015
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BE3MX
UT WOS:000370977700081
DA 2018-10-19
ER

PT S
AU Liviu, S
   Ion, S
AF Liviu, Serbanescu
   Ion, Sima
GP IEEE
TI A Software Architecture for the Control of Biomaterials Maintenance
SO PROCEEDINGS OF THE 2015 7TH INTERNATIONAL CONFERENCE ON ELECTRONICS,
   COMPUTERS AND ARTIFICIAL INTELLIGENCE (ECAI)
SE International Conference on Electronics Computers and Artificial
   Intelligence
LA English
DT Proceedings Paper
CT 7th International Conference on Electronics, Computers and Artificial
   Intelligence (ECAI)
CY JUN 25-27, 2015
CL Bucharest, ROMANIA
SP IEEE Romania section, IEEE Industry Applications Society, Univ Pitesti, Univ Europei Sud Est Lumina, Ministerul Educatiei Cercetarii Stiintifice
DE biomaterial; maintenance; software arhitecture
AB Most biomaterials are undergoing a process degradation faster than other materials. The biomaterials are often combined with other materials by various methods of treatment in order to ensure certain performance and functionality. Maintenance biomaterials must take into account both their particular as well as the evolution of experience accumulated. Treatment of the biomaterial, in many cases does not have an immediate effect and the treatment effect can be retrieve through out the entire life cycle of the biomaterial. This paper aims to outline a software architecture that implements an expert system in order to elaborate decision on choosing optimal maintenance solution.
C1 [Liviu, Serbanescu] Hyper Univ Bucharest, Bucharest, Romania.
   [Ion, Sima] Lumina Univ South East Europe, Bucharest, Romania.
RP Liviu, S (reprint author), Hyper Univ Bucharest, Bucharest, Romania.
EM livius969@gmail.com; ion.sima@lumina.org
CR Baura G.D., 2004, IEMBS 04 26 ANN INT
   Cristian M., 2014, SYST THEOR CONTR COM
   Gasparyan O.N., 2006, COMP AID CONTR SYST, P1958
   Hendler J. A., 1988, EXPERT SYSTEMS USER
   Li-qing Xing, 2007, MAN SCI ENG 2007 ICM
   Noth G., 1999, CONTR C ECC 1999 EUR, P4813
   Rusnak I., 2006, EL EL ENG ISR 2006 I, P320
   Shinskey F. G., 1996, PROCESS CONTROL SYST
   Sturrock C. P., 2005, 7255 NISTIR
   WANG H, 1991, IEE PROC-D, V138, P500, DOI 10.1049/ip-d.1991.0069
   Xu Xiangzhong, 2008, SYST SIM SCI COMP 20
NR 11
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2378-7147
BN 978-1-4673-6647-2
J9 INT C ELECT COMPUT
PY 2015
BP BB5
EP BB8
PG 4
WC Computer Science, Artificial Intelligence; Computer Science, Theory &
   Methods; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BE3MO
UT WOS:000370971100103
DA 2018-10-19
ER

PT S
AU Mihaela-Adina, M
   Gheorghisa, P
AF Mihaela-Adina, Mateescu
   Gheorghisa, Pescaru
GP IEEE
TI An Expert System Architecture for Managing the Biomaterials Used in
   Medical Devices
SO PROCEEDINGS OF THE 2015 7TH INTERNATIONAL CONFERENCE ON ELECTRONICS,
   COMPUTERS AND ARTIFICIAL INTELLIGENCE (ECAI)
SE International Conference on Electronics Computers and Artificial
   Intelligence
LA English
DT Proceedings Paper
CT 7th International Conference on Electronics, Computers and Artificial
   Intelligence (ECAI)
CY JUN 25-27, 2015
CL Bucharest, ROMANIA
SP IEEE Romania section, IEEE Industry Applications Society, Univ Pitesti, Univ Europei Sud Est Lumina, Ministerul Educatiei Cercetarii Stiintifice
DE component; biomaterials; expert system; xml database field type
AB Data describing biomaterials have a complex structure because they describe the so static characteristics and dynamic characteristics. These data also include time interaction with other organic or inorganic materials. Due to their large variety looking for a particular biomaterial it is difficult due to the complexity of their representation. A representation of biomaterials by using the techniques of expert systems can help identify a particular biomaterial. By developing methods and analysis techniques for biomaterials increases measurement accuracy. Following their reconsideration they can not meet their purpose intitial medical device. This paper aims to outline the architecture of an expert system that manages a database of biomaterials.
C1 [Mihaela-Adina, Mateescu] Romanian Acad, Econ Ctr Ind & Serv, Bucharest, Romania.
   [Gheorghisa, Pescaru] Lumina Univ South East Europe, Bucharest, Romania.
RP Mihaela-Adina, M (reprint author), Romanian Acad, Econ Ctr Ind & Serv, Bucharest, Romania.
EM mateescuadina@yahoo.com; ghcorghita.pescaru@lumina.org
CR Avouris N. M., 1993, USER INTERFACE DESIG
   Bray Tim, 2006, CONVERSATION T BRAY
   Bria M., 2004, INTRO MAT ENG SCI CH
   Carroll J. M., 1987, INTERFACE DESIGN ISS
   Darlington K., 2000, ESSENCE EXPERT SYSTE
   Jennings N.R., 1993, TRANSFORMING STANDAL
   Khetan S., 2013, 331 BNG BUTT HALL UN
   Liebowitz J, 1997, HDB APPL EXPERT SYST
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Sturrock C. P., 2005, DATA INFORM NEEDS BI
NR 10
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2378-7147
BN 978-1-4673-6647-2
J9 INT C ELECT COMPUT
PY 2015
BP P67
EP P70
PG 4
WC Computer Science, Artificial Intelligence; Computer Science, Theory &
   Methods; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BE3MO
UT WOS:000370971100119
DA 2018-10-19
ER

PT S
AU Pearson, C
   Martin, K
AF Pearson, Craig
   Martin, Keith
BE Bagetta, G
   Nucci, C
TI Stem cell approaches to glaucoma: from aqueous outflow modulation to
   retinal neuroprotection
SO NEW TRENDS IN BASIC AND CLINICAL RESEARCH OF GLAUCOMA: A
   NEURODEGENERATIVE DISEASE OF THE VISUAL SYSTEM, PT A
SE Progress in Brain Research
LA English
DT Review; Book Chapter
DE Glaucoma; Stem cells; Retina; Optic nerve; Neuroprotection; Replacement
ID NEURAL PROGENITOR CELLS; NECROSIS-FACTOR-ALPHA; CHONDROITIN SULFATE
   PROTEOGLYCANS; LOADED BIODEGRADABLE MICROSPHERES; HUMAN TRABECULAR
   MESHWORK; CENTRAL-NERVOUS-SYSTEM; GANGLION-LIKE CELLS;
   SPINAL-CORD-INJURY; HUMAN MULLER GLIA; OPTIC-NERVE
AB Long-term pharmacological management of glaucoma currently relies on self-administered drugs to regulate intraocular pressure (IOP). A number of approaches using stem cells have recently shown promise as potential future treatment strategies complementary to IOP lowering. Several sources of endogenous stem cells have been identified in the eye, some of which may be able to repair the damaged trabecular meshwork and restore functional regulation of aqueous outflow. Neural and mesenchymal stem cells secrete growth factors which provide neuroprotective effects, reducing loss of retinal ganglion cells (RGCs) in animal models. In the future, stem cells may even replace RGCs to reform functional connections between the eye and the brain, although the complexity of such a repair task is formidable. With advances in biomaterial cell scaffolds and concurrent efforts in other neural systems, stem cell therapies are becoming a realistic option for treating multiple eye diseases, and despite ongoing challenges, there are reasons for optimism that stem cells may play a role in the treatment of human glaucoma in the future.
C1 [Pearson, Craig; Martin, Keith] Univ Cambridge, John van Geest Ctr Brain Repair, Cambridge, England.
   [Pearson, Craig; Martin, Keith] Cambridge NIHR Biomed Res Ctr, Cambridge, England.
   [Pearson, Craig] NHLBI, NIH, Bethesda, MD 20892 USA.
   [Martin, Keith] Wellcome Trust Res Labs, MRC, Cambridge Stem Cell Inst, Cambridge, England.
RP Martin, K (reprint author), Univ Cambridge, John van Geest Ctr Brain Repair, Cambridge, England.
EM krgm2@cam.ac.uk
CR Abu-Hassan DW, 2015, STEM CELLS, V33, P751, DOI 10.1002/stem.1885
   Acott T. S., 2014, J OCUL PHARMACOL TH, V30, P1
   Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013
   ALVARADO J, 1981, INVEST OPHTH VIS SCI, V21, P714
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Assawachananont J, 2014, STEM CELL REP, V2, P662, DOI 10.1016/j.stemcr.2014.03.011
   Baldwin KT, 2015, P NATL ACAD SCI USA, V112, P2581, DOI 10.1073/pnas.1423221112
   Banin E, 2006, STEM CELLS, V24, P246, DOI 10.1634/stemcells.2005-0009
   Barber AC, 2013, P NATL ACAD SCI USA, V110, P354, DOI 10.1073/pnas.1212677110
   Becker S, 2013, MOL VIS, V19, P1925
   Berry M, 1996, J NEUROCYTOL, V25, P147, DOI 10.1007/BF02284793
   Bonner JF, 2015, BRAIN RES, V1619, P115, DOI 10.1016/j.brainres.2015.01.006
   Braunger BM, 2014, INVEST OPHTH VIS SCI, V55, P7499, DOI 10.1167/iovs.14-14872
   Bull ND, 2008, PROG BRAIN RES, V173, P511, DOI 10.1016/S0079-6123(08)01135-7
   Bull ND, 2008, INVEST OPHTH VIS SCI, V49, P3449, DOI 10.1167/iovs.08-1770
   Bull ND, 2011, STEM CELLS, V29, P1170, DOI 10.1002/stem.676
   Bull ND, 2009, INVEST OPHTH VIS SCI, V50, P4244, DOI 10.1167/iovs.08-3239
   BULLER C, 1990, INVEST OPHTH VIS SCI, V31, P2156
   Carr AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008152
   Carr AJ, 2009, MOL VIS, V15, P283
   Cartarozzi LP, 2015, BRAIN RES BULL, V112, P14, DOI 10.1016/j.brainresbull.2015.01.005
   Chen MF, 2010, INVEST OPHTH VIS SCI, V51, P5970, DOI 10.1167/iovs.09-4504
   Cheung HK, 2014, BIOMATERIALS, V35, P1914, DOI 10.1016/j.biomaterials.2013.11.067
   Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029
   de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109
   Ding QJ, 2014, INVEST OPHTH VIS SCI, V55, P7065, DOI 10.1167/iovs.14-14800
   Du YQ, 2013, INVEST OPHTH VIS SCI, V54, P1450, DOI 10.1167/iovs.12-11056
   Du YQ, 2012, INVEST OPHTH VIS SCI, V53, P1566, DOI 10.1167/iovs.11-9134
   Eiraku M, 2012, CURR OPIN NEUROBIOL, V22, P768, DOI 10.1016/j.conb.2012.02.005
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Emre E, 2015, CYTOTHERAPY, V17, P543, DOI 10.1016/j.jcyt.2014.12.005
   Englund-Johansson U, 2010, EXP EYE RES, V90, P292, DOI 10.1016/j.exer.2009.11.005
   Flachsbarth K, 2014, INVEST OPHTH VIS SCI, V55, P7029, DOI 10.1167/iovs.14-15266
   Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006
   Gamm DM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000338
   Gill KP, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.4.2
   Goel M, 2010, OPEN OPHTHALMOL J, V4, P52, DOI 10.2174/1874364101004010052
   Goldman D, 2014, NAT REV NEUROSCI, V15, P431, DOI 10.1038/nrn3723
   GRIERSON I, 1987, EYE, V1, P204, DOI 10.1038/eye.1987.38
   Guo Y, 2003, INVEST OPHTH VIS SCI, V44, P3194, DOI 10.1167/iovs.02-0875
   Gupta N, 2009, BRIT J OPHTHALMOL, V93, P56, DOI 10.1136/bjo.2008.138172
   Gust J, 2011, INVEST OPHTH VIS SCI, V52, P5266, DOI 10.1167/iovs.10-6329
   Harper MM, 2011, INVEST OPHTH VIS SCI, V52, P4506, DOI 10.1167/iovs.11-7346
   Higuchi A, 2014, PROG POLYM SCI, V39, P1585, DOI 10.1016/j.progpolymsci.2014.05.001
   Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035
   Hu Y, 2013, CLIN INTERV AGING, V8, P1467, DOI 10.2147/CIA.S47350
   Ito Y, 2009, EXP EYE RES, V89, P246, DOI 10.1016/j.exer.2009.03.013
   Iwabe S, 2007, VET OPHTHALMOL, V10, P12, DOI 10.1111/j.1463-5224.2007.00504.x
   Jiang C, 2007, MOL VIS, V13, P1783
   Jiao Y, 2014, BIOMED RES INT, DOI 10.1155/2014/356415
   Johnson TV, 2011, EXPERT REV OPHTHALMO, V6, P165, DOI 10.1586/EOP.11.3
   Johnson TV, 2013, CURR OPIN PHARMACOL, V13, P78, DOI 10.1016/j.coph.2012.08.003
   Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P2051, DOI 10.1167/iovs.09-4509
   Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P960, DOI 10.1167/iovs.09-3884
   Keller KE, 2009, EXP EYE RES, V88, P676, DOI 10.1016/j.exer.2008.11.023
   Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010
   Kwok JCF, 2008, RESTOR NEUROL NEUROS, V26, P131
   Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103
   Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763
   Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015
   Levkovitch-Verbin H, 2010, INVEST OPHTH VIS SCI, V51, P6394, DOI 10.1167/iovs.09-4310
   Li TQ, 2013, CELL RES, V23, P788, DOI 10.1038/cr.2013.48
   Liton PB, 2005, EXP GERONTOL, V40, P745, DOI 10.1016/j.exger.2005.06.005
   MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161
   MacLaren RE, 2014, LANCET, V383, P1129, DOI 10.1016/S0140-6736(13)62117-0
   Manuguerra-Gagne R, 2013, STEM CELLS, V31, P1136, DOI 10.1002/stem.1364
   Martin KRG, 2006, EXP EYE RES, V83, P255, DOI 10.1016/j.exer.2005.11.025
   Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332
   Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908
   Mellough CB, 2007, RESTOR NEUROL NEUROS, V25, P177
   Mellough CB, 2004, EXP NEUROL, V186, P6, DOI 10.1016/j.expneurol.2003.10.021
   Nadri S, 2013, NEUROSCI LETT, V541, P43, DOI 10.1016/j.neulet.2012.12.055
   Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009
   Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006
   Nishida A, 2000, INVEST OPHTH VIS SCI, V41, P4268
   Nork TM, 2000, ARCH OPHTHALMOL-CHIC, V118, P235
   Parent JM, 2015, NAT NEUROSCI, V18, P360, DOI 10.1038/nn.3944
   Park HYL, 2012, BRAIN RES, V1469, P10, DOI 10.1016/j.brainres.2012.06.006
   Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997
   Pearson RA, 2014, VISUAL NEUROSCI, V31, P333, DOI 10.1017/S0952523814000200
   Pease ME, 2009, INVEST OPHTH VIS SCI, V50, P2194, DOI 10.1167/iovs.08-3013
   Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764
   Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889
   Quittet MS, 2015, ACTA BIOMATER, V15, P77, DOI 10.1016/j.actbio.2014.12.017
   Ramer LM, 2014, LANCET NEUROL, V13, P1241, DOI 10.1016/S1474-4422(14)70144-9
   Riazifar H, 2014, STEM CELL TRANSL MED, V3, P424, DOI 10.5966/sctm.2013-0147
   Roozafzoon R, 2015, BIOCHEM BIOPH RES CO, V457, P154, DOI 10.1016/j.bbrc.2014.12.069
   Sadan O, 2008, STEM CELLS, V26, P2542, DOI 10.1634/stemcells.2008-0240
   Sadan O, 2009, STEM CELLS DEV, V18, P1179, DOI 10.1089/scd.2008.0411
   Sadan O, 2009, ISR MED ASSOC J, V11, P201
   Schroeder J, 2015, WORLD J STEM CELLS, V7, P186, DOI 10.4252/wjsc.v7.i1.186
   Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2
   Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103
   Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230
   Singhal S, 2008, STEM CELLS, V26, P1074, DOI 10.1634/stemcells.2007-0898
   Singhal S, 2012, STEM CELL TRANSL MED, V1, P188, DOI 10.5966/sctm.2011-0005
   Song W. T., 2014, CYTOTECHNOLOGY
   Stamer WD, 2012, CURR OPIN OPHTHALMOL, V23, P135, DOI 10.1097/ICU.0b013e32834ff23e
   STREILEIN JW, 1990, SURV OPHTHALMOL, V35, P67, DOI 10.1016/0039-6257(90)90048-Z
   Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594
   Sun GW, 2006, DEV BIOL, V289, P243, DOI 10.1016/j.ydbio.2005.10.035
   Sun Y., 2014, SURV OPHTHALMOL, V60, P93
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721
   Tanaka T., 2015, SCI REP, V5, P1
   Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787
   Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013
   Vugler A, 2008, EXP NEUROL, V214, P347, DOI 10.1016/j.expneurol.2008.09.007
   Wang SM, 2008, INVEST OPHTH VIS SCI, V49, P3201, DOI 10.1167/iovs.08-1831
   Wang X, 2002, HISTOL HISTOPATHOL, V17, P1043, DOI 10.14670/HH-17.1043
   Ward MS, 2007, J PHARM SCI-US, V96, P558, DOI 10.1002/jps.20629
   Wei ZZ, 2015, CELL TRANSPLANT, V24, P391, DOI 10.3727/096368915X686887
   Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192
   Wohl SG, 2012, PROG RETIN EYE RES, V31, P213, DOI 10.1016/j.preteyeres.2012.02.001
   Yan XM, 2000, ARCH OPHTHALMOL-CHIC, V118, P666
   Yasukawa T, 2005, ADV DRUG DELIVER REV, V57, P2033, DOI 10.1016/j.addr.2005.09.005
   Yin YQ, 2009, P NATL ACAD SCI USA, V106, P19587, DOI 10.1073/pnas.0907085106
   Yu S, 2006, BIOCHEM BIOPH RES CO, V344, P1071, DOI 10.1016/j.bbrc.2006.03.231
   Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.0.CO;2-3
   Zhang XY, 2007, EXP EYE RES, V84, P275, DOI 10.1016/j.exer.2006.09.022
   Zhong X., 2014, NAT COMMUN, V5, P1
NR 121
TC 4
Z9 4
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0079-6123
BN 978-0-444-63566-2
J9 PROG BRAIN RES
JI Prog. Brain Res.
PY 2015
VL 220
BP 241
EP 256
DI 10.1016/bs.pbr.2015.04.005
PG 16
WC Medicine, Research & Experimental; Neurosciences; Ophthalmology
SC Research & Experimental Medicine; Neurosciences & Neurology;
   Ophthalmology
GA BE3CT
UT WOS:000370523000013
PM 26497794
DA 2018-10-19
ER

PT J
AU Szklarska, M
   Dercz, G
   Rak, J
   Simka, W
   Losiewicz, B
AF Szklarska, M.
   Dercz, G.
   Rak, J.
   Simka, W.
   Losiewicz, B.
TI THE INFLUENCE OF PASSIVATION TYPE ON CORROSION RESISTANCE OF Ti15Mo
   ALLOY IN SIMULATED BODY FLUIDS
SO ARCHIVES OF METALLURGY AND MATERIALS
LA English
DT Article
DE biomaterial; electrochemical impedance spectroscopy; corrosion
   resistance; passivation; titanium alloys
ID TI-MO ALLOYS; TI-13NB-13ZR ALLOY; BEHAVIOR; TITANIUM
AB This work reports on determination of the influence of passivation type of Ti15wt.% Mo implant alloy surface on its corrosion resistance in simulated body fluids. The alloy under investigation was subjected to natural self-passivation in air, and forced passivation by autoclaving in steam, boiling in 30 % solution of H2O2, and electrochemical passivation in 0.9 % NaCl solution. Resistance of the passivated Ti15Mo alloy to pitting corrosion was studied at 37 degrees C in 0.9 % NaCl solution using open circuit potential method, anodic polarization curves, and electrochemical impedance spectroscopy (EIS). Comparative estimation of the determined parameters of corrosion resistance revealed that the obtained passive layers improve anticorrosive properties of the tested alloy. Surface of the alloy subjected to passivation in steam autoclave reveals the highest protection against pitting corrosion. Anodic potentiodynamic curves showed that the Ti15Mo alloy after different passivation types of the surface is characterized by a lack of susceptibility to pitting corrosion up to potential of 9 V. Based on the EIS investigations, the thickness of the formed oxide layers (TiO2, anatase) was determined to be in the range from 2.0 to 7.8 nm in dependence on the applied type of passivation. It was ascertained that electrochemical properties of the Ti15Mo alloy and possibility of its surface passivation using simple methods, make it an attractive material for use in biomedicine for long-term implants.
C1 [Szklarska, M.; Dercz, G.; Rak, J.; Losiewicz, B.] Univ Silesia, Inst Mat Sci, Silesian Interdisciplinary Ctr Educ & Res, 75 Pulku Piechoty 1A, PL-41500 Chorzow, Poland.
   [Simka, W.] Silesian Tech Univ, Fac Chem, PL-44100 Gliwice, Poland.
RP Szklarska, M (reprint author), Univ Silesia, Inst Mat Sci, Silesian Interdisciplinary Ctr Educ & Res, 75 Pulku Piechoty 1A, PL-41500 Chorzow, Poland.
EM mszklarska@us.edu.pl
OI Simka, Wojciech/0000-0002-2648-5523; Dercz,
   Grzegorz/0000-0003-3682-7184; Szklarska, Magdalena/0000-0001-8716-630X
FU European Social Fund
FX Research under the FORSZT project financed by the European Social Fund.
CR [Anonymous], G10289 ASTM
   Birch JR, 2000, CORROSION, V56, P1233, DOI 10.5006/1.3280511
   Blaszczyk T., 2010, ENG BIOMAT, V96-98, P10
   Disegi J, 2009, IMPLANT MAT WROUGHT
   Freitag M, 2012, SOLID STATE PHENOMEN, V183, P57, DOI 10.4028/www.scientific.net/SSP.183.57
   Geetha M, 2004, CORROS SCI, V46, P877, DOI 10.1016/S0010-938X(03)00186-0
   Habazaki H, 2003, SURF COAT TECH, V169, P151, DOI 10.1016/S0257-8972(03)00216-0
   Lasia A., 2002, MODERN ASPECTS ELECT, V35
   Lekston Z., 2010, ENG BIOMAT, V96-98, P29
   Metikos-Hukovic M, 2003, BIOMATERIALS, V24, P3765, DOI 10.1016/S0142-9612(03)00252-7
   Morawiec H., 2004, ENG BIOMATERIALS, V37, P32
   Oliveira NTC, 2009, ACTA BIOMATER, V5, P399, DOI 10.1016/j.actbio.2008.07.010
   Papakyriacou M, 2000, INT J FATIGUE, V22, P873, DOI 10.1016/S0142-1123(00)00057-8
   Pardo A, 2008, CORROS SCI, V50, P1796, DOI 10.1016/j.corsci.2008.04.005
   Shabalovskaya S, 2008, ACTA BIOMATER, V4, P447, DOI 10.1016/j.actbio.2008.01.013
   Simka W, 2011, ELECTROCHIM ACTA, V56, P9831, DOI 10.1016/j.electacta.2011.08.049
   Szewczenko J., 2011, ENG BIOMAT, V106-108, P21
   Takeno N., 2005, 419 NAT I ADV IND SC
   Wang K, 1998, ELECTROCHIM ACTA, V43, P2459, DOI 10.1016/S0013-4686(97)00317-4
   Zhou YL, 2011, J ALLOY COMPD, V509, P6267, DOI 10.1016/j.jallcom.2011.03.045
NR 20
TC 3
Z9 3
U1 2
U2 11
PU POLSKA AKAD NAUK, POLISH ACAD SCIENCES, INST METALL & MATER SCI PAS
PI WARSZAWA
PA PL, 00-901 WARSZAWA, POLAND
SN 1733-3490
EI 2300-1909
J9 ARCH METALL MATER
JI Arch. Metall. Mater.
PY 2015
VL 60
IS 4
BP 2687
EP 2693
DI 10.1515/amm-2015-0433
PG 7
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA DC8XB
UT WOS:000369502200035
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Gadjanski, I
   Vunjak-Novakovic, G
AF Gadjanski, Ivana
   Vunjak-Novakovic, Gordana
TI Challenges in engineering osteochondral tissue grafts with hierarchical
   structures
SO EXPERT OPINION ON BIOLOGICAL THERAPY
LA English
DT Review
DE anatomical shape; biomimetics; osteochondral grafts; tissue engineering
ID EMBRYONIC STEM-CELLS; AUTOLOGOUS CHONDROCYTE IMPLANTATION; COMPOSITE
   MULTILAYERED BIOMATERIAL; HUMAN BONE-GRAFTS; CHONDROGENIC
   DIFFERENTIATION; SCAFFOLD DESIGN; IN-VITRO; ELECTROSPUN NANOFIBERS;
   CARTILAGE REGENERATION; BIOMIMETIC SCAFFOLDS
AB Introduction: A major hurdle in treating osteochondral (OC) defects is the different healing abilities of two types of tissues involved - articular cartilage and subchondral bone. Biomimetic approaches to OC-construct engineering, based on recapitulation of biological principles of tissue development and regeneration, have potential for providing new treatments and advancing fundamental studies of OC tissue repair.
   Areas covered: This review on state of the art in hierarchical OC tissue graft engineering is focused on tissue engineering approaches designed to recapitulate the native milieu of cartilage and bone development. These biomimetic systems are discussed with relevance to bioreactor cultivation of clinically sized, anatomically shaped human cartilage/bone constructs with physiologic stratification and mechanical properties. The utility of engineered OC tissue constructs is evaluated for their use as grafts in regenerative medicine, and as high-fidelity models in biological research.
   Expert opinion: A major challenge in engineering OC tissues is to generate a functionally integrated stratified cartilage-bone structure starting from one single population of mesenchymal cells, while incorporating perfusable vasculature into the bone, and in bone-cartilage interface. To this end, new generations of advanced scaffolds and bioreactors, implementation of mechanical loading regimens and harnessing of inflammatory responses of the host will likely drive the further progress.
C1 Columbia Univ, Lab Stem Cells & Tissue Engn, New York, NY USA.
   [Gadjanski, Ivana] Belgrade Metropolitan Univ, Ctr Bioengn BioIRC, Kragujevac 34000, Serbia.
   [Vunjak-Novakovic, Gordana] Columbia Univ, Lab Stem Cells & Tissue Engn, Biomed Engn & Med Sci, New York, NY USA.
RP Vunjak-Novakovic, G (reprint author), Columbia Univ, Lab Stem Cells & Tissue Engn, New York, NY USA.
EM gv2131@columbia.edu
RI Gadjanski, Ivana/I-2162-2016
OI Gadjanski, Ivana/0000-0003-0713-7897; Vunjak-Novakovic,
   Gordana/0000-0002-9382-1574
FU Ministry of Education and Science of Serbia [ON174028, III41007];
   National Institutes of Health [DE016525, EB002520, AR061988]
FX I Gadjanski has received research funding from The Ministry of Education
   and Science of Serbia (grants ON174028 and III41007) and G
   Vunjak-Novakovic has received research funding from the National
   Institutes of Health (grants DE016525, EB002520, and AR061988). In
   addition, G Vunjak-Novakovic is a co-founder of epiBone, a Columbia
   University spin out focused on growing human bones for craniofacial
   repair. The authors have no other relevant affiliations or financial
   involvement with any organization or entity with a financial interest in
   or financial conflict with the subject matter or materials discussed in
   the manuscript. This includes employment, consultancies, honoraria,
   stock ownership or options, expert testimony, grants or patents received
   or pending, or royalties.
CR Alexander PG, 2014, EXP BIOL MED, V239, P1080, DOI 10.1177/1535370214539232
   Amler E, 2014, NANOMEDICINE-UK, V9, P1083, DOI [10.2217/NNM.14.57, 10.2217/nnm.14.57]
   Athanasiou K. A., 2009, SYNTHESIS LEC TISSUE, V1, P1
   Athanasiou KA, 2013, ANNU REV BIOMED ENG, V15, P115, DOI [10.1146/annurev-bioeng-071812-152423, 10.1146/annurev-bioeng-071812-15242]
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Bhumiratana S, 2015, METHODS
   Bhumiratana S, 2014, P NATL ACAD SCI USA, V111, P6940, DOI 10.1073/pnas.1324050111
   Bigdeli N, 2009, STEM CELLS, V27, P1812, DOI 10.1002/stem.114
   Bitton Ryan, 2009, Am J Manag Care, V15, pS230
   Boccaccio A, 2011, INT J BIOL SCI, V7, P112, DOI 10.7150/ijbs.7.112
   Bornes TD, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0432-1
   Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017
   Buda R, 2015, INT ORTHOP, V39, P893, DOI 10.1007/s00264-015-2685-y
   Chang NJ, 2013, OSTEOARTHR CARTILAGE, V21, P1613, DOI 10.1016/j.joca.2013.07.016
   Chen GB, 2015, CURR PHARM DESIGN, V21, P1967, DOI 10.2174/1381612821666150302152704
   Cheng AX, 2014, TISSUE ENG PART B-RE, V20, P257, DOI [10.1089/ten.teb.2012.0757, 10.1089/ten.TEB.2012.0757]
   Cheng HW, 2011, BIOMATERIALS, V32, P1526, DOI 10.1016/j.biomaterials.2010.10.021
   Christensen BB, 2015, KNEE SURG SPORTS TRA
   Correia C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028352
   Cosson S, 2015, STEM CELL TRANSL MED, V4, P156, DOI 10.5966/sctm.2014-0203
   Cui X., 2014, J VIS EXP, V88
   Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.TEA.2011.0543, 10.1089/ten.tea.2011.0543]
   De Caro F, 2015, ARTHROSCOPY, V31, P757, DOI 10.1016/j.arthro.2014.11.025
   de Peppo GM, 2014, METHODS MOL BIOL, V1202, P173, DOI 10.1007/7651_2013_52
   Di Luca A, 2015, BIRTH DEFECTS RES C, V105, P34, DOI 10.1002/bdrc.21092
   Dormer NH, 2010, ANN BIOMED ENG, V38, P2167, DOI 10.1007/s10439-010-0028-0
   Dunkin BS, 2013, OPER TECHN SPORT MED, V21, P100, DOI 10.1053/j.otsm.2013.03.003
   Falah M, 2010, INT ORTHOP, V34, P621, DOI 10.1007/s00264-010-0959-y
   Feinberg SE, 2001, CELLS TISSUES ORGANS, V169, P309, DOI 10.1159/000047896
   Foster NC, 2015, BIRTH DEFECTS RES C, V105, P19, DOI 10.1002/bdrc.21088
   Frohlich M, 2010, TISSUE ENG PT A, V16, P179, DOI 10.1089/ten.TEA.2009.0164
   Gadjanski I, 2012, STEM CELL REV REP, V8, P863, DOI 10.1007/s12015-011-9328-5
   Garg T, 2014, EXPERT OPIN DRUG DEL, V11, P767, DOI 10.1517/17425247.2014.891014
   GLYN-JONES S, 2015, LANCET
   GOULET RW, 1994, J BIOMECH, V27, P375, DOI 10.1016/0021-9290(94)90014-0
   Grayson WL, 2010, OSTEOARTHR CARTILAGE, V18, P714, DOI 10.1016/j.joca.2010.01.008
   Grayson WL, 2008, TRENDS BIOTECHNOL, V26, P181, DOI 10.1016/j.tibtech.2007.12.009
   Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106
   Grigolo B, 2015, J MATER SCI-MATER M, V26, P5500
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1066, DOI 10.1002/jbm.a.32361
   Hoemann CD, 2012, J KNEE SURG, V25, P85, DOI 10.1055/s-0032-1319782
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hutmacher DW, 2008, TRENDS BIOTECHNOL, V26, P166, DOI 10.1016/j.tibtech.2007.11.012
   Jacobs JC, 2015, ORTHOP CLIN N AM, V46, P133, DOI 10.1016/j.ocl.2014.09.009
   Jeon JE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0184
   Jeon JE, 2014, ANAT REC, V297, P26, DOI 10.1002/ar.22795
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim YS, 2015, AM J SPORT MED, V43, P399, DOI 10.1177/0363546514559822
   Ko JY, 2014, BIOMATERIALS, V35, P3571, DOI 10.1016/j.biomaterials.2014.01.009
   Kon E, 2015, ARTHROSCOPY, V31, P767, DOI 10.1016/j.arthro.2014.11.017
   Kon E, 2014, AM J SPORT MED, V42, P158, DOI 10.1177/0363546513505434
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Lacroix D, 2009, PHILOS T R SOC A, V367, P1993, DOI 10.1098/rsta.2009.0024
   Lee JY, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/4/045003
   Lee TJ, 2014, TISSUE ENG PT A, V20, P1306, DOI [10.1089/ten.tea.2013.0265, 10.1089/ten.TEA.2013.0265]
   Lee WD, 2015, OSTEOARTHRITIS CARTI
   Lima EG, 2004, BIORHEOLOGY, V41, P577
   Lin H, 2014, MOL PHARMACEUT, V11, P2203, DOI 10.1021/mp500136b
   Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.TEB.2012.0437, 10.1089/ten.teb.2012.0437]
   Lopa S, 2014, TISSUE ENG PT A, V20, P2052, DOI 10.1089/ten.tea.2013.0356
   Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197
   Lozito TP, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt367
   Lynch TS, 2015, ARTHROSCOPY, V31, P746, DOI 10.1016/j.arthro.2014.11.018
   Madry H, 2015, TISSUE REGENERATION, P219
   Makris EA, 2015, NAT REV RHEUMATOL, V11, P21, DOI 10.1038/nrrheum.2014.157
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mallick Kajal K, 2013, Front Biosci (Elite Ed), V5, P341
   Marolt D, 2012, P NATL ACAD SCI USA, V109, P8705, DOI 10.1073/pnas.1201830109
   Matta Csaba, 2013, Front Biosci (Schol Ed), V5, P305
   Melton JTK, 2010, EXPERT REV MED DEVIC, V7, P333, DOI 10.1586/ERD.10.15
   Mikos A G, 2000, ELECTRON J BIOTECHN, V3, P23
   Millikan PD, 2015, CURR REV MUSCULOSKEL
   Mohan N, 2008, J BIOMED MATER RES B, V84B, P584, DOI 10.1002/jbm.b.30906
   Mohan N, 2014, BIOTECHNOL BIOENG, V111, P829, DOI 10.1002/bit.25145
   Mosher TJ, 2009, ARTHRITIS COLOR ADV, P23
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Nejadnik H, 2015, STEM CELL REV REP, V11, P242, DOI 10.1007/s12015-014-9581-5
   Nukavarapu SP, 2013, BIOTECHNOL ADV, V31, P706, DOI 10.1016/j.biotechadv.2012.11.004
   Obradovic B, 1999, J ORTHOP RES, V17, P130
   Oh SH, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014101
   Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Perez RA, 2013, ADV DRUG DELIVER REV, V65, P471, DOI 10.1016/j.addr.2012.03.009
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Preitschopf A, 2012, STEM CELL REV REP, V8, P1267, DOI 10.1007/s12015-012-9405-4
   Qu D, 2015, ANN BIOMED ENG, V43, P697, DOI 10.1007/s10439-014-1190-6
   Ren KX, 2015, BIOMATERIALS, V51, P238, DOI 10.1016/j.biomaterials.2015.02.026
   Roach BL, 2015, METHODS
   Roberts SJ, 2015, BONE, V70, P10, DOI 10.1016/j.bone.2014.08.007
   Saw KY, 2013, ARTHROSCOPY, V29, P684, DOI 10.1016/j.arthro.2012.12.008
   Schaefer D, 2000, BIOMATERIALS, V21, P2599, DOI 10.1016/S0142-9612(00)00127-7
   Seo S.-J., 2014, J TISSUE ENG, V5, DOI DOI 10.1177/2041731414541850
   Shafiee A, 2011, BIOMED MAT RES A, V99, P467
   Sherman SL, 2014, J AM ACAD ORTHOP SUR, V22, P121, DOI 10.5435/JAAOS-22-02-121
   Shi J, 2010, ACS APPL MATER INTER, V2, P1025, DOI 10.1021/am9007962
   Singh M, 2008, TISSUE ENG PART B-RE, V14, P341, DOI 10.1089/ten.teb.2008.0304
   Solchaga LA, 2010, TISSUE ENG PT A, V16, P1009, DOI [10.1089/ten.tea.2009.0100, 10.1089/ten.TEA.2009.0100]
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   St-Pierre JP, 2012, ACTA BIOMATER, V8, P1603, DOI 10.1016/j.actbio.2011.12.022
   Suzuki S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3869
   Tampieri A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/1/015104
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Temple JP, 2014, METHODS MOL BIOL, V1202, P57, DOI 10.1007/7651_2013_33
   Vaquette C, 2013, ACTA BIOMATER, V9, P4599, DOI 10.1016/j.actbio.2012.08.015
   Verhaegen J, 2015, CARTILAGE, V6, P12, DOI 10.1177/1947603514548890
   Veronesi F, 2014, J BIOMED MATER RES A, V102, P2448, DOI 10.1002/jbm.a.34896
   Vunjak-Novakovic Gordana, 2012, HSS J, V8, P57, DOI 10.1007/s11420-011-9245-9
   Vunjak-Novakovic G, 2011, CELL STEM CELL, V8, P252, DOI 10.1016/j.stem.2011.02.014
   Wang XF, 2013, MATER TODAY, V16, P229, DOI 10.1016/j.mattod.2013.06.005
   Weng L, 2015, CURR PHARM DESIGN, V21, P1944, DOI 10.2174/1381612821666150302151959
   Xia Z, 2014, J MATER CHEM B, V2, P1998, DOI 10.1039/c3tb21595d
   Xu T, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015001
   Yan L, 2015, ACS BIOMATER SCI ENG
   Yang PJ, 2009, TISSUE ENG PART B-RE, V15, P127, DOI 10.1089/ten.teb.2008.0371
   Yang WX, 2013, ACTA BIOMATER, V9, P4505, DOI 10.1016/j.actbio.2012.10.003
   Yodmuang S, 2015, STEM CELL REV REP, V11, P228, DOI 10.1007/s12015-015-9584-x
   Yodmuang S, 2015, ACTA BIOMATER, V11, P27, DOI 10.1016/j.actbio.2014.09.032
   Yousefi AM, 2015, J BIOMED MATER RES A, V103, P2460, DOI 10.1002/jbm.a.35356
   Yu LL, 2015, J ARTHROPLASTY, V30, P1273, DOI 10.1016/j.arth.2015.01.037
   Zhang X, 2015, CELL BIOCH BIOPHY
NR 120
TC 11
Z9 11
U1 2
U2 37
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1471-2598
EI 1744-7682
J9 EXPERT OPIN BIOL TH
JI Expert Opin. Biol. Ther.
PY 2015
VL 15
IS 11
BP 1583
EP 1599
DI 10.1517/14712598.2015.1070825
PG 17
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA DD4SH
UT WOS:000369912400004
PM 26195329
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Kabra, H
   Hwang, YS
   Lim, HL
   Kar, M
   Arya, G
   Varghese, S
AF Kabra, Harsha
   Hwang, Yongsung
   Lim, Han Liang
   Kar, Mrityunjoy
   Arya, Gaurav
   Varghese, Shyni
TI Biomimetic Material-Assisted Delivery of Human Embryonic Stem Cell
   Derivatives for Enhanced In Vivo Survival and Engraftment
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE human embryonic stem cells; myogenesis; biomaterials; hyaluronic acid;
   stem cell transplantation
ID FUNCTIONAL SKELETAL-MUSCLE; FIBROBLAST-GROWTH-FACTOR; HYALURONIC-ACID;
   EXTRACELLULAR-MATRIX; MYOGENIC-DIFFERENTIATION; ANTITUMOR BIOCONJUGATE;
   SATELLITE CELLS; BONE-MARROW; PROGENITORS; HYDROGELS
AB The ability of human embryonic stem cells (hESCs) and their derivatives to differentiate and contribute to tissue repair has enormous potential to treat various debilitating diseases. However, improving the in vivo viability and function of the transplanted cells, a key determinant of translating cell-based therapies to the clinic, remains a daunting task. Here, we develop a hybrid biomaterial consisting of hyaluronic acid (HA) grafted with 6-aminocaproic acid moieties (HA-6ACA) to improve cell delivery and their subsequent in vivo function using skeletal muscle as a model system. Our findings show that the biomimetic material-assisted delivery of hESC-derived myogenic progenitor cells into cardiotoxin-injured skeletal muscles of NOD/SCID mice significantly promotes survival and engraftment of transplanted cells in a dose-dependent manner. The donor cells were found to contribute to the regeneration of damaged muscle fibers and to the satellite cell (muscle specific stem cells) compartment. Such biomimetic cell delivery vehicles that are cost-effective and easy-to-synthesize could play a key role in improving the outcomes of other stem cell-based therapies.
C1 [Kabra, Harsha; Hwang, Yongsung; Lim, Han Liang; Kar, Mrityunjoy; Varghese, Shyni] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Arya, Gaurav] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA.
RP Varghese, S (reprint author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
EM svarghese@ucsd.edu
OI Kar, Mrityunjoy/0000-0002-7910-9580
FU California Institute of Regenerative Medicine [RN2-00945]
FX This work was funded by the California Institute of Regenerative
   Medicine (RN2-00945).
CR Ahrens T, 2001, J INVEST DERMATOL, V116, P93, DOI 10.1046/j.1523-1747.2001.00236.x
   ALLEN RE, 1990, P SOC EXP BIOL MED, V194, P81
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533
   BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047
   Bentzinger CF, 2013, BIOESSAYS, V35, P231, DOI 10.1002/bies.201200063
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Calve S, 2012, AM J PHYSIOL-CELL PH, V303, pC577, DOI 10.1152/ajpcell.00057.2012
   Cheung WF, 1999, BIOCHEM SOC T, V27, P135, DOI 10.1042/bst0270135
   Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067
   CLEGG CH, 1987, J CELL BIOL, V105, P949, DOI 10.1083/jcb.105.2.949
   Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705
   Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015
   de Peppo GM, 2010, TISSUE ENG PT A, V16, P2161, DOI [10.1089/ten.tea.2009.0629, 10.1089/ten.TEA.2009.0629]
   Ekblad T, 2008, BIOMACROMOLECULES, V9, P2775, DOI 10.1021/bm800547m
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Goudenege S, 2012, MOL THER, V20, P2153, DOI 10.1038/mt.2012.188
   Hunt LC, 2013, J BIOL CHEM, V288, P13006, DOI 10.1074/jbc.M113.453209
   Hwang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05916
   Hwang YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072023
   Lian QZ, 2007, STEM CELLS, V25, P425, DOI 10.1634/stemcells.2006-0420
   Luo Y, 2002, PHARMACEUT RES, V19, P396, DOI 10.1023/A:1015170907274
   Luo Y, 1999, BIOCONJUGATE CHEM, V10, P755, DOI 10.1021/bc9900338
   Luo Y, 2000, BIOMACROMOLECULES, V1, P208, DOI 10.1021/bm000283n
   Mahmood A, 2010, J BONE MINER RES, V25, P1216, DOI 10.1002/jbmr.34
   Malkowski A, 2007, ACTA BIOCHIM POL, V54, P357
   Meng JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017454
   PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257
   Phadke A, 2012, MACROMOL BIOSCI, V12, P1022, DOI 10.1002/mabi.201100289
   Phadke A, 2012, P NATL ACAD SCI USA, V109, P4383, DOI 10.1073/pnas.1201122109
   Prestwich GD, 2011, J CONTROL RELEASE, V155, P193, DOI 10.1016/j.jconrel.2011.04.007
   Purcell BP, 2012, BIOMATERIALS, V33, P7849, DOI 10.1016/j.biomaterials.2012.07.005
   Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257
   Rossi CA, 2011, FASEB J, V25, P2296, DOI 10.1096/fj.10-174755
   Sahoo S, 2008, BIOMACROMOLECULES, V9, P1088, DOI 10.1021/bm800051m
   Sangaj N, 2010, BIOMACROMOLECULES, V11, P3294, DOI 10.1021/bm101041f
   Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021
   Shu XZ, 2006, J BIOMED MATER RES A, V79A, P902, DOI 10.1002/jbm.a.30831
   Solchaga LA, 2002, TISSUE ENG, V8, P333, DOI 10.1089/107632702753725085
   Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Yang DR, 2011, PHYS CHEM CHEM PHYS, V13, P2911, DOI 10.1039/c0cp01487g
   Zhu H, 2006, STEM CELLS, V24, P928, DOI 10.1634/stemcells.2005-0186
   Zieris A, 2010, J MATER SCI-MATER M, V21, P915, DOI 10.1007/s10856-009-3913-z
NR 44
TC 7
Z9 7
U1 3
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD JAN
PY 2015
VL 1
IS 1
BP 7
EP 12
DI 10.1021/ab500021a
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA DC4KP
UT WOS:000369189900003
PM 26280019
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Eddhahak, A
   Zidi, M
AF Eddhahak, Anissa
   Zidi, Mustapha
TI Influence of viscoelastic properties of an hyaluronic acid-based
   hydrogel on viability of mesenchymal stem cells
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Mesenchymal stem cells (MSCs); hydrogel based on hyaluronic acid;
   rheology; cellular viability
ID ANEURYSMS; THERAPY; MODEL
AB BACKGROUND: The present research is involved in the framework of the biotherapy using mesenchymal stem cells (MSCs). Here, MSC encapsulation in a hydrogel based on hyaluronic acid (HA) is investigated to optimize the composition of the biomaterial.
   METHODS: Several formulations candidates of the hydrogel (9 in total) are postulated as a scaffold for the 3D MSC culture in order to investigate their potential to mimic the in vivo cellular environment. Rheological measurements in oscillation mode of complex modulus and complex viscosity are performed on the different hydrogels. Biological tests are carried out for the measurement of the cell viability of MSC encapsulated in the hydrogels.
   RESULTS: Rheological and biological findings are correlated together in order to establish relationships between the viscoelastic properties of the hydrogel and the cellular viability of MSC.
   CONCLUSIONS: In the light of the viability results, the composition of the hydrogel was related to the MSC proliferation. Thus, such relations are useful tools for scientists offering them more flexibility in the design of their hydrogels while ensuring an acceptable level of MSC viability.
C1 [Eddhahak, Anissa] Arts & Metiers ParisTech, CNRS UMR 8006, Lab PIMM, 151 Blvd Hop, F-75013 Paris, France.
   [Zidi, Mustapha] Univ Paris Est Creteil, Fac Med, Lab BIOTN, Ctr Rech Chirurg, 8 Rue Gen Sarrail, F-94010 Creteil, France.
RP Zidi, M (reprint author), Univ Paris Est Creteil, Fac Med, Lab BIOTN, Ctr Rech Chirurg, 8 Rue Gen Sarrail, F-94010 Creteil, France.
EM zidi@u-pec.fr
FU University Paris-Est Creteil; European Union [FP7-Health-200647]; CNRS
FX This work is supported by CNRS, University Paris-Est Creteil and the
   European Union Grant (FP7-Health-200647, Fighting Aneurysmal Diseases).
   The authors acknowledge gratefully Dr. Faiza Mohand-Kaci and Professor
   Eric Allaire (University Paris-Est Creteil, France) for their help in
   the experimental protocols and their useful discussions.
CR Allaire E, 2004, ANN SURG, V239, P417, DOI 10.1097/01.sla.0000114131.79899.82
   ALLAIRE E, 1994, J VASC SURG, V19, P446, DOI 10.1016/S0741-5214(94)70071-0
   Clark A.H., 1987, ADV POLYM SCI, V83, P157, DOI DOI 10.1007/BFB0023330
   CLARK AH, 1992, IFT BAS SYM, V7, P263
   Deligkaris K., 2010, SENSOR ACTUAT B-CHEM, V47, P765
   DJABOUROV M, 1988, J PHYS-PARIS, V49, P333, DOI 10.1051/jphys:01988004902033300
   Gloria A, 2012, J BIOMATER APPL, V26, P745, DOI 10.1177/0885328210387174
   Haraguchi Y, 2012, STEM CELL TRANSL MED, V1, P136, DOI [10.5966/sctm.2011-0030, 10.5966/sctm.2012-0030]
   Haycock JW, 2011, METHODS MOL BIOL, V695, P1, DOI 10.1007/978-1-60761-984-0_1
   Lam J, 2014, ACTA BIOMATER, V10, P1571, DOI 10.1016/j.actbio.2013.07.025
   Mohand-Kaci F., 2012, THESIS U PARIS EST C
   Mohand-Kaci F., 2012, TISSUE ENG PART C-ME, V19, P288
   Mohand-Kaci F, 2012, COMPUT METHOD BIOMEC, V15, P435, DOI 10.1080/10255842.2010.540759
   Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070
   Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057
   Rammal H, 2014, STEM CELLS DEV, V23, P2931, DOI 10.1089/scd.2014.0132
   Schneider F, 2013, EUR J VASC ENDOVASC, V45, P666, DOI 10.1016/j.ejvs.2013.03.007
   Willerth S. M., 2008, STEMBOOK, DOI [10.3824/stembook.1.1.1, DOI 10.3824/STEMBOOK.1.1.1]
NR 18
TC 3
Z9 3
U1 1
U2 9
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2015
VL 26
IS 3-4
BP 103
EP 114
DI 10.3233/BME-151557
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DD2QO
UT WOS:000369767500002
PM 26684883
DA 2018-10-19
ER

PT J
AU Bedouin, Y
   Mussi, PP
   Tricot-Doleux, S
   Chauvel-Lebret, D
   Auroy, P
   Ravalec, X
   Oudadesse, H
   Perez, F
AF Bedouin, Y.
   Mussi, P. Pellen
   Tricot-Doleux, S.
   Chauvel-Lebret, D.
   Auroy, P.
   Ravalec, X.
   Oudadesse, H.
   Perez, F.
TI 3D cell culture to determine in vitro biocompatibility of bioactive
   glass in association with chitosan
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Spheroids; biocompatibility; bioactive glass; chitosan
ID HUMAN OSTEOBLASTS; IONIC PRODUCTS; DISSOLUTION PRODUCTS; COLLAGEN
   PRODUCTION; 45S5 BIOGLASS(R); PROLIFERATION; DIFFERENTIATION;
   EXPRESSION; COMPOSITE; GROWTH
AB This study reports the in vitro biocompatibility of a composite biomaterial composed of 46S6 bioactive glass in association with chitosan (CH) by using 3D osteoblast culture of SaOS(2). The 46S6 and CH composite (46S6-CH) forms small hydroxyapatite crystals on its surface after only three days immersion in the simulated body fluid. For 2D osteoblast culture, a significant increase in cell proliferation was observed after three days of contact with 46S6 or 46S6-CH-immersed media. After six days, 46S6-CH led to a significant increase in cell proliferation (128%) compared with pure 46S6 (113%) and pure CH (122%). For 3D osteoblast culture, after six days of culture, there was an increase in gene expression of markers of the early osteoblastic differentiation (RUNX2, ALP, COL1A1). Geometric structures corresponding to small apatite clusters were observed by SEM on the surface of the spheroids cultivated with 46S6 or 46S6-CH-immersed media.
   We showed different cellular responses depending on the 2D and 3D cell culture model. The induction of osteoblast differentiation in the 3D cell culture explained the differences of cell proliferation in contact with 46S6, CH or 46S6-CH-immersed media. This study confirmed that the 3D cell culture model is a very promising tool for in vitro biological evaluation of bone substitutes' properties.
C1 [Bedouin, Y.; Mussi, P. Pellen; Tricot-Doleux, S.; Chauvel-Lebret, D.; Oudadesse, H.; Perez, F.] Univ Europeenne Bretagne, Univ Rennes 1, UMR CNRS 6226, Equipe Chim Solide & Mat,Sci Chim Rennes, Campus Beaulieu,263 Ave Gen Leclerc,2 Ave Prof Le, F-35042 Rennes, France.
   [Bedouin, Y.; Chauvel-Lebret, D.; Ravalec, X.] CHU Rennes, Pole Odontol & Chirurg Buccale, 2 Pl Pasteur, F-35000 Rennes, France.
   [Auroy, P.] Univ Auvergne, Fac Chirurg Dent, 11 Blvd Charles de Gaulle, F-63000 Clermont Ferrand, France.
   [Auroy, P.] CHU Clermont Ferrand, Serv Odontol, 11 Rue Leon Malfreyt, F-63000 Clermont Ferrand, France.
   [Perez, F.] CHU Nantes, Serv Odontol, 1 Pl Alexis Ricordeau, F-44000 Nantes, France.
RP Bedouin, Y (reprint author), Univ Europeenne Bretagne, Univ Rennes 1, UMR CNRS 6226, Equipe Chim Solide & Mat,Sci Chim Rennes, Campus Beaulieu,263 Ave Gen Leclerc,2 Ave Prof Le, F-35042 Rennes, France.
EM yvan.bedouin@univ-rennes1.fr
FU Fondation Langlois
FX The authors would like to thank Jean Lecerf, Joseph Le Lannic, Helene
   Solhi and Celine Allaire for their valuable assistance. This work was
   supported by the Fondation Langlois.
CR Alno N, 2010, J BIOMED MATER RES A, V95A, P137, DOI 10.1002/jbm.a.32818
   Anderson SI, 1998, J MATER SCI-MATER M, V9, P731, DOI 10.1023/A:1008955002955
   Benien P, 2014, FUTURE ONCOL, V10, P1311, DOI 10.2217/fon.13.274
   Bielby RC, 2004, TISSUE ENG, V10, P1018, DOI 10.1089/1076327041887664
   Bombonato-Prado KF, 2009, J BIOMED MATER RES A, V88A, P401, DOI 10.1002/jbm.a.31701
   Bosetti M, 2003, J BIOMED MATER RES A, V64A, P189, DOI 10.1002/jbm.a.10415
   Chesnutt B.M., 2008, J BIOMED MATER RES A, V88A, P491, DOI [10.1002/jbm.a.31878, DOI 10.1002/JBM.A.31878]
   Couto DS, 2009, ACTA BIOMATER, V5, P115, DOI 10.1016/j.actbio.2008.08.006
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Dietrich E, 2009, J BIOMED MATER RES A, V88A, P1087, DOI 10.1002/jbm.a.31901
   Friedrich J, 2007, J BIOMOL SCREEN, V12, P925, DOI 10.1177/1087057107306839
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Howes AL, 2007, MOL CANCER THER, V6, P2505, DOI 10.1158/1535-7163.MCT-06-0698
   Jell G, 2008, J BIOMED MATER RES A, V86A, P31, DOI 10.1002/jbm.a.31542
   Jones JR, 2007, BIOMATERIALS, V28, P1653, DOI 10.1016/j.biomaterials.2006.11.022
   Jun SH, 2010, ACTA BIOMATER, V6, P302, DOI 10.1016/j.actbio.2009.06.024
   Kang YM, 2009, ACTA BIOMATER, V5, P462, DOI 10.1016/j.actbio.2008.07.004
   Kaufmann EABE, 2000, TISSUE ENG, V6, P19, DOI 10.1089/107632700320856
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Lee EJ, 2009, BIOMATERIALS, V30, P743, DOI 10.1016/j.biomaterials.2008.10.025
   Luz GM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/5/054104
   Luz GM, 2012, LANGMUIR, V28, P6970, DOI 10.1021/la300667g
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mota J, 2012, ACTA BIOMATER, V8, P4173, DOI 10.1016/j.actbio.2012.06.040
   Oudadesse H, 2011, APPL SURF SCI, V257, P8587, DOI 10.1016/j.apsusc.2011.05.022
   Oudadesse H, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/3/035006
   Oudadesse H, 2013, KOREAN J CHEM ENG, V30, P1775, DOI 10.1007/s11814-013-0104-x
   Qiu Z, 2009, J INT MED RES, V37, P737, DOI 10.1177/147323000903700317
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Silver IA, 2001, BIOMATERIALS, V22, P175, DOI 10.1016/S0142-9612(00)00173-3
   Sitarz M, 1999, J MOL STRUCT, V511, P281, DOI 10.1016/S0022-2860(99)00169-6
   Tsigkou O, 2009, BIOMATERIALS, V30, P3542, DOI 10.1016/j.biomaterials.2009.03.019
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Varanasi VG, 2009, ACTA BIOMATER, V5, P3536, DOI 10.1016/j.actbio.2009.05.035
   Wang J, 2007, BIOMED MATER, V2, P32, DOI 10.1088/1748-6041/2/1/006
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Zong Z, 2000, POLYMER, V41, P899, DOI 10.1016/S0032-3861(99)00270-0
NR 41
TC 0
Z9 0
U1 2
U2 9
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2015
VL 26
IS 3-4
BP 169
EP 181
DI 10.3233/BME-151555
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DD2QO
UT WOS:000369767500008
PM 26684889
DA 2018-10-19
ER

PT J
AU Daskalopoulos, EP
   Vilaeti, AD
   Barka, E
   Mantzouratou, P
   Kouroupis, D
   Kontonika, M
   Tourmousoglou, C
   Papalois, A
   Pantos, C
   Blankesteijn, WM
   Agathopoulos, S
   Kolettis, TM
AF Daskalopoulos, Evangelos P.
   Vilaeti, Agapi D.
   Barka, Eleonora
   Mantzouratou, Polixeni
   Kouroupis, Dimitrios
   Kontonika, Marianthi
   Tourmousoglou, Christos
   Papalois, Apostolos
   Pantos, Constantinos
   Blankesteijn, W. Matthijs
   Agathopoulos, Simeon
   Kolettis, Theofilos M.
TI Attenuation of post-infarction remodeling in rats by sustained
   myocardial growth hormone administration
SO GROWTH FACTORS
LA English
DT Article
DE Alginate; angiogenesis; growth hormone; myofibroblasts; myocardial
   infarction; ventricular remodeling
ID REDUCES INFARCT EXPANSION; IMPROVES CARDIAC-FUNCTION; MESENCHYMAL
   STEM-CELLS; POSTMYOCARDIAL INFARCTION; FACTOR-I; ALGINATE HYDROGELS;
   HEART-FAILURE; INFLAMMATORY RESPONSE; GENE-EXPRESSION; PORCINE MODEL
AB Prevention of left ventricular remodeling is an important therapeutic target post-myocardial infarction. Experimentally, treatment with growth hormone (GH) is beneficial, but sustained local administration has not been thoroughly investigated. We studied 58 rats (322 +/- 4 g). GH was administered via a biomaterial-scaffold, following in vitro and in vivo evaluation of degradation and drug-release curves. Treatment consisted of intra-myocardial injection of saline or alginate-hydrogel, with or without GH, 10 min after permanent coronary artery ligation. Echocardiographic and histologic remodeling-indices were examined 3 weeks post-ligation, followed by immunohistochemical evaluation of angiogenesis, collagen, macrophages and myofibroblasts. GH-release completed at 3 days and alginate-degradation at similar to 7 days. Alginate + GH consistently improved left ventricular end-diastolic and end-systolic diameters, ventricular sphericity, wall tension index and infarct-thickness. Microvascular-density and myofibroblast-count in the infarct and peri-infarct areas were higher after alginate + GH. Macrophage-count and collagen-content did not differ between groups. Early, sustained GH-administration enhances angiogenesis and myofibroblast-activation and ameliorates post-infarction remodeling.
C1 [Daskalopoulos, Evangelos P.; Blankesteijn, W. Matthijs] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Pharmacol, NL-6200 MD Maastricht, Netherlands.
   [Daskalopoulos, Evangelos P.; Vilaeti, Agapi D.; Barka, Eleonora; Kontonika, Marianthi; Tourmousoglou, Christos; Papalois, Apostolos; Kolettis, Theofilos M.] Cardiovasc Res Inst, Athens, Greece.
   [Barka, Eleonora; Agathopoulos, Simeon] Univ Ioannina, Dept Mat Sci & Engn, Ceram & Composites Lab, GR-45110 Ioannina, Greece.
   [Mantzouratou, Polixeni; Pantos, Constantinos] Univ Athens, Sch Med, Dept Pharmacol, GR-11527 Athens, Greece.
   [Kouroupis, Dimitrios] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Dept Biomed Res, Ioannina, Greece.
   [Papalois, Apostolos] Expt Res Ctr ELPEN, Athens, Greece.
RP Kolettis, TM (reprint author), Univ Ioannina, Cardiol, 1 Stavrou Niarxou Ave, GR-45110 Ioannina, Greece.
EM theofilos.m.kolettis@gmail.com
CR Agathopoulos S, 2014, CURR PHARM DESIGN, V20, P1925, DOI 10.2174/138161282012140401153832
   Aikawa Y, 2001, AM HEART J, V141, P234, DOI 10.1067/mhj.2001.112237
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Baltogiannis GG, 2005, CARDIOVASC RES, V67, P647, DOI 10.1016/j.cardiores.2005.04.020
   Banquet S, 2011, CIRCULATION, V124, P1059, DOI 10.1161/CIRCULATIONAHA.110.010264
   Bruel A, 1999, GROWTH HORM IGF RES, V9, P123, DOI 10.1054/ghir.1999.0097
   Chintalgattu V, 2003, J MOL CELL CARDIOL, V35, P277, DOI 10.1016/S0022-2828(03)00006-3
   Cittadini A, 1996, CIRCULATION, V93, P800
   Cittadini A, 1997, J AM COLL CARDIOL, V29, P1109, DOI 10.1016/S0735-1097(97)00010-7
   Cittadini A, 2003, J AM COLL CARDIOL, V41, P2154, DOI 10.1016/S0735-1097(03)00483-2
   Cochain C, 2013, ANTIOXID REDOX SIGN, V18, P1100, DOI 10.1089/ars.2012.4849
   COOK JJ, 1988, J CLIN INVEST, V81, P206, DOI 10.1172/JCI113296
   Daskalopoulos EP, 2014, CURR PHARM DESIGN, V20, P1987, DOI 10.2174/13816128113199990452
   de Jong R, 2014, CIRC-CARDIOVASC INTE, V7, P673, DOI 10.1161/CIRCINTERVENTIONS.114.001580
   Elaiopoulos DA, 2007, CLIN SCI, V112, P385, DOI 10.1042/CS20060193
   Ertl G, 2005, CARDIOVASC RES, V66, P22, DOI 10.1016/j.cardiores.2005.01.011
   Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28
   Friberg L, 2000, EUR HEART J, V21, P1547, DOI 10.1053/euhj.2000.2125
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hatzistergos KE, 2008, GROWTH HORM IGF RES, V18, P157, DOI 10.1016/j.ghir.2007.08.002
   Jayasankar V, 2004, J MOL CELL CARDIOL, V36, P531, DOI 10.1016/j.yjmcc.2004.01.010
   Jin HK, 2002, GROWTH HORM IGF RES, V12, P208, DOI 10.1016/S1096-6374(02)00042-4
   Khan AS, 2001, J GERONTOL A-BIOL, V56, pB364, DOI 10.1093/gerona/56.8.B364
   Kolettis TM, 2011, MINI-REV MED CHEM, V11, P263
   Kolettis TM, 2007, EUROPACE, V9, P1099, DOI 10.1093/europace/eum196
   Kolettis TM, 2006, CARDIOVASC RES, V69, P299, DOI 10.1016/j.cardiores.2005.12.007
   Kontonika M, 2014, TRENDS BIOMATER ARTI, V28, P79
   Laeremans H, 2011, CIRCULATION, V124, P1626, DOI 10.1161/CIRCULATIONAHA.110.976969
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee SW, 2010, J PLAST RECONSTR AES, V63, pE364, DOI 10.1016/j.bjps.2009.10.027
   Mitsi AC, 2006, GROWTH HORM IGF RES, V16, P93, DOI 10.1016/j.ghir.2006.02.001
   Mitsi AC, 2005, MED HYPOTHESES, V64, P582, DOI 10.1016/j.mehy.2004.07.028
   Mukherjee R, 2008, ANN THORAC SURG, V86, P1268, DOI 10.1016/j.athoracsur.2008.04.107
   Nagasawa N, 2000, POLYM DEGRAD STABIL, V69, P279, DOI 10.1016/S0141-3910(00)00070-7
   O'Sullivan JF, 2011, CIRC-CARDIOVASC INTE, V4, P327, DOI 10.1161/CIRCINTERVENTIONS.110.960765
   Omerovic E, 2000, ENDOCRINOLOGY, V141, P4592, DOI 10.1210/en.141.12.4592
   Pantos C, 2008, BASIC RES CARDIOL, V103, P308, DOI 10.1007/s00395-008-0697-0
   Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002
   Robitaille R, 2005, BIOMATERIALS, V26, P4119, DOI 10.1016/j.biomaterials.2004.10.028
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Struman I, 1999, P NATL ACAD SCI USA, V96, P1246, DOI 10.1073/pnas.96.4.1246
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   Tanaka N, 1998, AM J PHYSIOL-HEART C, V275, pH393, DOI 10.1152/ajpheart.1998.275.2.H393
   van den Borne SWM, 2009, CARDIOVASC RES, V84, P273, DOI 10.1093/cvr/cvp207
   Vilaeti AD, 2013, INT J CARDIOL, V165, P278, DOI 10.1016/j.ijcard.2011.08.036
   Wright EJ, 2012, STEM CELL TRANSL MED, V1, P759, DOI 10.5966/sctm.2012-0064
   Yang D, 2009, J BIOMED MATER RES A, V90A, P411, DOI 10.1002/jbm.a.32096
NR 49
TC 3
Z9 3
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0897-7194
EI 1029-2292
J9 GROWTH FACTORS
JI Growth Factors
PY 2015
VL 33
IS 4
BP 250
EP 258
DI 10.3109/08977194.2015.1072527
PG 9
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA DD3IN
UT WOS:000369815600002
PM 26290214
DA 2018-10-19
ER

PT J
AU Liu, GL
   Xu, GQ
   Gao, ZH
   Liu, ZH
   Xu, JJ
   Wang, JS
   Zhang, CM
   Wang, SL
AF Liu, Guolin
   Xu, Guoquan
   Gao, Zhenhua
   Liu, Zhenhai
   Xu, Junji
   Wang, Jinsong
   Zhang, Chunmei
   Wang, Songlin
TI Demineralized Dentin Matrix Induces Odontoblastic Differentiation of
   Dental Pulp Stem Cells
SO CELLS TISSUES ORGANS
LA English
DT Article
DE Demineralized dentin matrix; Dental pulp stem cell; Biomaterial;
   Osteogenesis; Dentinogenesis
ID GROWTH-FACTORS; IN-VITRO; SCAFFOLD MATERIAL; MESSENGER-RNA; TGF-BETA;
   REGENERATION; TISSUE; EXPRESSION; PROPERTY; MODEL
AB The aim of this study was to investigate the effect of demineralized dentin matrix (DDM) on dental pulp stem cells (DPSCs) and the potential of complexes with DPSCs and DDM for mineralized tissue formation. Stem cells derived from the dental pulp of healthy pigs aged 18 months were isolated and cultured. DPSCs were incubated with alpha minimum essential medium treated with DDM extract at 1 mg/ml (DDM1) or 10 mg/ml (DDM10). The concentrations of 3 growth factors in DDM extract was measured by enzyme-linked immunosorbent assay. Adhesion of DPSCs on DDM and hydroxyapatite-tricalcium phosphate (HA-TCP) surfaces was observed using scanning electron microscopy. Cell proliferation was evaluated with cell counting kit-8 and migration by Transwell migration assays. Odontoblastic differentiation was assessed by alkaline phosphatase (ALP) and alizarin red staining, ALP activity and real-time polymerase chain reaction analysis of markers of ALP, runt-related transcription factor 2, type I collagen, dentin matrix acidic phosphoprotein-1, osteonectin and dentin sialophosphoprotein (DSPP). Finally, DPSCs were combined with DDM and placed subcutaneously in nude mice for 12 weeks; DPSCs combined with HA-TCP and DDM alone served as controls. DDM could promote DPSC adhesion, migration and odontoblastic differentiation. Mineralized tissue formation was observed with the DPSC and DDM combination and the DPSC and HATCP combination. The mineralized tissue of the DPSC + DDM combination stained positive for DSPP, similar to the dentin tissue. These results indicate that DDM induces DPSC odontoblastic differentiation, suggesting applications for dentin regeneration. (C) 2015 S. Karger AG, Basel
C1 [Liu, Guolin; Xu, Guoquan; Gao, Zhenhua; Liu, Zhenhai; Xu, Junji; Wang, Jinsong; Zhang, Chunmei; Wang, Songlin] Capital Med Univ, Sch Stomatol, Beijing Key Lab Tooth Regenerat & Funct Reconstru, Mol Lab Gene Therapy & Tooth Regenerat, Tian Tan Xi Li 4, Beijing 100050, Peoples R China.
   [Wang, Songlin] Capital Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Tian Tan Xi Li 4, Beijing 100050, Peoples R China.
   [Liu, Guolin] Cangzhou Cent Hosp, Cangzhou, Peoples R China.
   [Xu, Guoquan] North China Univ Sci & Technol, Affiliated Hosp, Tangshan, Peoples R China.
RP Wang, SL (reprint author), Capital Med Univ, Sch Stomatol, Beijing Key Lab Tooth Regenerat & Funct Reconstru, Mol Lab Gene Therapy & Tooth Regenerat, Tian Tan Xi Li 4, Beijing 100050, Peoples R China.
EM slwang@ccmu.edu.cn
FU Beijing Municipality Government grants (Beijing Scholar Program)
   [PXM2014_014226_000180, PXM2014_014226_000048, PXM2014_014226_000013,
   PXM2014_014226_000053, Z121100005212004, PXM2013_014226_000021,
   PXM2013_014226_07_000080, TJSHG201310025005]; National Basic Research
   Program of China [2010CB944801]
FX This work was supported by Beijing Municipality Government grants
   (Beijing Scholar Program: PXM2014_014226_000180, PXM2014_014226_000048,
   PXM2014_014226_000013, PXM2014_014226_000053, Z121100005212004,
   PXM2013_014226_000021, PXM2013_014226_07_000080, and TJSHG201310025005
   to S.W.) and the National Basic Research Program of China (2010CB944801
   to S.W.).
CR Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bakhshalian N, 2013, INT J ORAL MAX IMPL, V28, P1655, DOI 10.11607/jomi .2833
   Cassidy N, 1997, ARCH ORAL BIOL, V42, P219, DOI 10.1016/S0003-9969(96)00115-X
   Chun SY, 2011, TISSUE ENG PT A, V17, P181, DOI [10.1089/ten.tea.2010.0121, 10.1089/ten.TEA.2010.0121]
   de Oliveira GS, 2013, AUST DENT J, V58, P326, DOI 10.1111/adj.12088
   Dechichi P, 2007, MICRON, V38, P486, DOI 10.1016/j.micron.2006.08.001
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   FINKELMAN RD, 1990, J BONE MINER RES, V5, P717
   Gomes MF, 2002, INT J ORAL MAX IMPL, V17, P488
   Gomes MF, 2001, INT J ORAL MAX IMPL, V16, P563
   Gomes MF, 2007, INT J ORAL MAX IMPL, V22, P939
   Gomes Mônica Fernandes, 2006, Braz. oral res., V20, P324, DOI 10.1590/S1806-83242006000400008
   Gomes Mônica Fernandes, 2008, Braz. oral res., V22, P275, DOI 10.1590/S1806-83242008000300015
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Guo WH, 2009, BIOMATERIALS, V30, P6708, DOI 10.1016/j.biomaterials.2009.08.034
   HOLLAND PWH, 1987, J CELL BIOL, V105, P473, DOI 10.1083/jcb.105.1.473
   Huang GTJ, 2010, TISSUE ENG PT A, V16, P605, DOI [10.1089/ten.tea.2009.0518, 10.1089/ten.TEA.2009.0518]
   Jensen J, 2015, TISSUE ENG PT A, V21, P729, DOI [10.1089/ten.tea.2014.0177, 10.1089/ten.TEA.2014.0177]
   Jiao L, 2014, BIOMATERIALS, V35, P4929, DOI 10.1016/j.biomaterials.2014.03.016
   Khorsand A, 2013, J ORAL IMPLANTOL, V39, P433, DOI 10.1563/AAID-JOI-D-12-00027
   Kim D, 2014, ARCH ORAL BIOL, V59, P765, DOI 10.1016/j.archoralbio.2014.04.014
   Kim KS, 2010, BIOMATERIALS, V31, P1104, DOI 10.1016/j.biomaterials.2009.10.020
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Martens W, 2014, FASEB J, V28, P1634, DOI 10.1096/fj.13-243980
   Mathieu S, 2013, J ENDODONT, V39, P228, DOI 10.1016/j.joen.2012.11.007
   Mead B, 2014, NEURAL REGEN RES, V9, P577, DOI 10.4103/1673-5374.130089
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Nemeth CL, 2014, TISSUE ENG PT A, V20, P2817, DOI [10.1089/ten.tea.2013.0614, 10.1089/ten.TEA.2013.0614]
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Press T, 2015, INT ENDOD J, V48, P185, DOI 10.1111/iej.12299
   Qu TJ, 2014, TISSUE ENG PT A, V20, P2422, DOI [10.1089/ten.TEA.2013.0741, 10.1089/ten.tea.2013.0741]
   Roberts-Clark DJ, 2000, ARCH ORAL BIOL, V45, P1013, DOI 10.1016/S0003-9969(00)00075-3
   Roozafzoon R, 2015, BIOCHEM BIOPH RES CO, V457, P154, DOI 10.1016/j.bbrc.2014.12.069
   Saghiri MA, 2015, J ENDODONT, V41, P797, DOI 10.1016/j.joen.2014.12.019
   Schaffer E.M., 1957, J PERIODONTOL, V28, P125
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Silvent J, 2013, J MOL EVOL, V76, P59, DOI 10.1007/s00239-013-9539-2
   Sonoyama W, 2008, J ENDODONT, V34, P166, DOI 10.1016/j.joen.2007.11.021
   Tran H.L., 2015, CELL TISSUE BANK
   URIST MARSHALL R., 1967, CLIN ORTHOP RELATED RESIN COMPLICATIONS OF ORTHOPAEDIC SURGERY, V53, P243
   Woloszyk A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111010
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Yamamoto A, 2014, NEUROSCI RES, V78, P16, DOI 10.1016/j.neures.2013.10.010
   Yao S, 2008, J DENT RES, V87, P767, DOI 10.1177/154405910808700801
   Zhao S, 2000, HISTOCHEM J, V32, P489, DOI 10.1023/A:1004100518245
   Zheng Y, 2012, J DENT RES, V91, P676, DOI 10.1177/0022034512449834
NR 46
TC 7
Z9 7
U1 0
U2 9
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
EI 1422-6421
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2015
VL 201
IS 1
BP 65
EP 76
DI 10.1159/000440952
PG 12
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA DC1JR
UT WOS:000368973100006
PM 26569105
DA 2018-10-19
ER

PT J
AU Saxena, AK
   Misra, RK
   Dixit, A
AF Saxena, Arjit Kumar
   Misra, Raghvendra Kumar
   Dixit, Anurag
TI Numerical Analysis of Hip Joint Implant
SO MATERIALS TODAY-PROCEEDINGS
LA English
DT Proceedings Paper
CT 4th International Conference on Materials Processing and Characterzation
   (ICMPC)
CY MAR 14, 2015
CL Gokaraju Rangaraju Inst Engin & Technol, Hyderabad, INDIA
HO Gokaraju Rangaraju Inst Engin & Technol
DE Biomaterial; Hip Implant; Femur; Prosthesis; ANSYS
ID BONE
AB Bones form the rigid skeletal framework of the body which deftly protect the internal vital organs along with allowing various movements and tasks at the different kinds of joints formed by these bones. It is a well - known fact that there are 206 bones in the adult body. However, this skeleton over which our entire body is structured is highly prone to get affected by trauma. Any trauma to any bone in the body can be mighty painful for the patient. These situations are dealt with by Orthopaedic surgeons. When trauma is suffered by Femur, the longest and strongest bone of the body, forming the length of the thigh, it becomes an emergency as often the patient is an elderly with weak bones and, if not attended to on time, this fracture can lead to massive blood loss. In elderly patients, a mere repair of the fracture of femur doesn't work. It is required to make their bone strong enough to bear the weight of the body again. For this, surgeons often use implants made of biomaterials like Titanium. A comparative study has been performed between Titanium, Stainless Steel and Aluminium made implant. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Saxena, Arjit Kumar; Misra, Raghvendra Kumar; Dixit, Anurag] Gautam Buddha Univ, Sch Engn, Dept Mech Engn, Greater Noida 201312, India.
RP Saxena, AK (reprint author), Gautam Buddha Univ, Sch Engn, Dept Mech Engn, Greater Noida 201312, India.
EM author@institute.xxx
CR Abdullah Abdul H., 2010, P INT MULTICONFERENC, VIII
   Chen TH, 2009, J MED BIOL ENG, V29, P108
   Das Sandeep, 2014, INT J BASIC APPL BIO, V1, P1
   Grecu D, 2010, ROM J MORPHOL EMBRYO, V51, P151
   Huang BW, 2012, LIFE SCI J, V9, P723
   Jade Sameer, 1896, THESIS
   Keaveny Tony M., STANDARD HDB BIOMEDI
   LI CD, 2003, FAILURE ANAL COMPOSI, V40, P131
   Monostori R., 2011, HUNGARIAN J IND CHEM, V39, P225
   O'Neill MC, 2004, J HUM EVOL, V47, P221, DOI 10.1016/j.jhevol.2004.07.002
   Pierre MA, 2010, J BIOMECH, V43, P2228, DOI 10.1016/j.jbiomech.2010.02.032
   RoyiFedida Zohar Yosibash, 2005, 2 INT C COMP BIOENG
   Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253
   Shinge AR, 2011, INT J ADV BIOTECHNOL, V2, P278
   Vahdat SeyedEbrahim, 2013, ADV MAT MANUFACTURIN, V3
   Voo Liming, 2004, J HOPKINS APL TECHNI, V25
   Weaver Timothy D., 2003, SHAPE NEANDERTAL FEM, V100
   Yousif A. E., 2012, IOSR J ENG IOSRJEN, V2, P13
   Ziylan T, 2002, TURK J MED SCI, V32, p231 
NR 19
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2214-7853
J9 MATER TODAY-PROC
JI Mater. Today-Proc.
PY 2015
VL 2
IS 4-5
BP 1649
EP 1656
DI 10.1016/j.matpr.2015.07.092
PG 8
GA CU4AF
UT WOS:000363467600075
DA 2018-10-19
ER

PT J
AU Banoriya, D
   Purohit, R
   Dwivedi, RK
AF Banoriya, Deepen
   Purohit, Rajesh
   Dwivedi, R. K.
TI Modern Trends in Rapid Prototyping for Biomedical Applications
SO MATERIALS TODAY-PROCEEDINGS
LA English
DT Proceedings Paper
CT 4th International Conference on Materials Processing and Characterzation
   (ICMPC)
CY MAR 14, 2015
CL Gokaraju Rangaraju Inst Engin & Technol, Hyderabad, INDIA
HO Gokaraju Rangaraju Inst Engin & Technol
DE Rapidprototyping; Stereo lithography; Biomaterials; Surgery; Dentresty;
   Orthopaedics
ID SCAFFOLDS; TECHNOLOGY; STEREOLITHOGRAPHY; FABRICATION; DENTISTRY
AB Rapid prototyping is known by many terms as per the technologies involved, like SFF or solid freeform fabrication, FF or freeform fabrication, digital fabrication, AFF or automated freeform fabrication, 3D printing, solid imaging, layer based manufacturing, laser prototyping and additive manufacturing. Rapid prototyping is a revolutionary and powerful technology with wide range of applications. The importance of rapid prototyping is to quickly fabricate complex-shaped, 3D parts directly from computer aided design models, which is based upon decomposition of 3D computer models data into thin cross-sectional layers, followed by physically forming the layers and stacking them up; "layer by layer technique". The process of prototyping involves quick building up of a prototype or working models for the purpose of testing the various design features, ideas, concepts, functionality, output and performance. This paper covers possibilities of using RP technologies based on biomaterial. Using RP in biomedical is a quite complex task which implies a multidisciplinary approach and very good knowledge of engineering as well as medicine. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Banoriya, Deepen; Purohit, Rajesh; Dwivedi, R. K.] MANIT, Dept Mech Engn, Bhopal 462003, India.
RP Purohit, R (reprint author), MANIT, Dept Mech Engn, Bhopal 462003, India.
EM deepenbanoriya007@gmail.com; rpurohit73@gmail.com; nitb.ravi@gmail.com
OI Purohit, Rajesh/0000-0001-6702-4662
CR Azari A, 2009, RAPID PROTOTYPING J, V15, P216, DOI 10.1108/13552540910961946
   Chan Daniel C N, 2004, J Dent Educ, V68, P64
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Clair JJ, 1996, J MATER PROCESS TECH, V57, P393, DOI 10.1016/0924-0136(95)02072-1
   Garrett R, 2006, BIOMATERIALS, V27, P2651
   Greiner C, 2005, ACTA BIOMATER, V1, P705, DOI 10.1016/j.actbio.2005.07.005
   Hammel EC, 2014, CERAM INT, V40, P15351, DOI 10.1016/j.ceramint.2014.06.095
   Jelena M, 2007, MECH ENG, V5, P79
   Karthicka R., 2014, PROCEDIA MAT SCI, V6, P1989
   Landers R, 2002, J MATER SCI, V37, P3107, DOI 10.1023/A:1016189724389
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Li JP, 2006, BIOMATERIALS, V27, P1223, DOI 10.1016/j.biomaterials.2005.08.033
   Liu QB, 2006, INT J ADV MANUF TECH, V29, P317, DOI 10.1007/s00170-005-2523-2
   Lopez-Heredia MA, 2008, BIOMATERIALS, V29, P2608, DOI 10.1016/j.biomaterials.2008.02.021
   Madhav VNV, 2013, J DENT ALLIED SCI, V2, P57
   Melchels FPW, 2010, BIOMATERIALS, V31, P6909, DOI 10.1016/j.biomaterials.2010.05.068
   Melchels Ferry PW, 2010, BIOMATERIALS, V31, p6 121, DOI DOI 10.1016/J.BIOMATERIALS.2010.04.050
   Mota Carlos, 2014, J TISSUE ENG REGEN M, V1, P245
   Nizam A, 2006, ARCH OROFAC SCI, V1, P60
   Ovsianikov A, 2007, APPL SURF SCI, V253, P6603, DOI 10.1016/j.apsusc.2007.01.062
   Petzold R, 1999, COMPUT MED IMAG GRAP, V23, P277, DOI 10.1016/S0895-6111(99)00025-7
   Purohit Rajesh, 2007, FUTURE TRENDS COMPOS, V1, P12
   Ryan GE, 2008, BIOMATERIALS, V29, P3625, DOI 10.1016/j.biomaterials.2008.05.032
   Seol YJ, 2014, EUR J CARDIO-THORAC, V46, P342, DOI 10.1093/ejcts/ezu148
   van Noort R, 2012, DENT MATER, V28, P3, DOI 10.1016/j.dental.2011.10.014
   Webb PA, 2000, J MED ENG TECHNOL, V24, P149, DOI 10.1080/03091900050163427
   Wu M, 2001, DENT MATER, V17, P102, DOI 10.1016/S0109-5641(00)00037-3
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
NR 28
TC 4
Z9 4
U1 5
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2214-7853
J9 MATER TODAY-PROC
JI Mater. Today-Proc.
PY 2015
VL 2
IS 4-5
BP 3409
EP 3418
DI 10.1016/j.matpr.2015.07.316
PG 10
GA CU4AF
UT WOS:000363467600284
DA 2018-10-19
ER

PT S
AU Hotaling, NA
   Tang, L
   Irvine, DJ
   Babensee, JE
AF Hotaling, Nathan A.
   Tang, Li
   Irvine, Darrell J.
   Babensee, Julia E.
BE Yarmush, ML
TI Biomaterial Strategies for Immunomodulation
SO ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 17
SE Annual Review of Biomedical Engineering
LA English
DT Review; Book Chapter
DE immunoengineering; vaccination; immunotherapy
ID EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SECONDARY LYMPHOID ORGANS;
   ADAPTIVE IMMUNE-RESPONSES; DENDRITIC CELL MATURATION; ANTIGEN-PRESENTING
   CELL; REGULATORY T-CELLS; DRUG-DELIVERY; IN-VITRO; POLYMERIC
   NANOPARTICLES; CONTROLLED-RELEASE
AB Strategies to enhance, suppress, or qualitatively shape the immune response are of importance for diverse biomedical applications, such as the development of new vaccines, treatments for autoimmune diseases and allergies, strategies for regenerative medicine, and immunotherapies for cancer. However, the intricate cellular and molecular signals regulating the immune system are major hurdles to predictably manipulating the immune response and developing safe and effective therapies. To meet this challenge, biomaterials are being developed that control how, where, and when immune cells are stimulated in vivo, and that can finely control their differentiation in vitro. We review recent advances in the field of biomaterials for immunomodulation, focusing particularly on designing biomaterials to provide controlled immunostimulation, targeting drugs and vaccines to lymphoid organs, and serving as scaffolds to organize immune cells and emulate lymphoid tissues. These ongoing efforts highlight the many ways in which biomaterials can be brought to bear to engineer the immune system.
C1 [Hotaling, Nathan A.; Babensee, Julia E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Hotaling, Nathan A.; Babensee, Julia E.] Emory Univ, Sch Med, Atlanta, GA 30332 USA.
   [Hotaling, Nathan A.; Babensee, Julia E.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Babensee, Julia E.] Georgia Inst Technol, Ctr Immunoengn, Atlanta, GA 30332 USA.
   [Tang, Li; Irvine, Darrell J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
   [Tang, Li; Irvine, Darrell J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
   [Tang, Li; Irvine, Darrell J.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
   [Tang, Li; Irvine, Darrell J.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
   [Irvine, Darrell J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
RP Hotaling, NA (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
EM djirvine@mit.edu; julia.babensee@bme.gatech.edu
OI Hotaling, Nathan/0000-0001-8423-6464; Tang, Li/0000-0002-6393-982X
FU NCI NIH HHS [R01 CA174795, CA172164, R01 CA172164, CA174795]; NCATS NIH
   HHS [UL1 TR000454, UL1TR000454]; NIAID NIH HHS [R01 AI095109, AI104715,
   AI095109, P01 AI104715]; NIBIB NIH HHS [1R21EB012339-01A1, R21 EB012339,
   R01 EB004633, 1R01EB004633-01A1]; Howard Hughes Medical Institute
CR Abensee JEB, 2008, SEMIN IMMUNOL, V20, P101, DOI 10.1016/j.smim.2007.10.013
   Acharya AP, 2008, BIOMATERIALS, V29, P4736, DOI 10.1016/j.biomaterials.2008.08.040
   Al Kobiasi M, 2012, J BIOMED MATER RES A, V100A, P1859, DOI 10.1002/jbm.a.34153
   Aldinucci A, 2013, NANO LETT, V13, P6098, DOI 10.1021/nl403396e
   Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m
   Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Andersen PS, 2001, J BIOL CHEM, V276, P49125, DOI 10.1074/jbc.M109396200
   Anderson AO, 2005, IMMUNITY, V22, P3, DOI 10.1016/j.immuni.2005.01.003
   Arvizo RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024374
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Ballester M, 2011, VACCINE, V29, P6959, DOI 10.1016/j.vaccine.2011.07.039
   BAUMGARTNER HR, 1973, MICROVASC RES, V5, P167, DOI 10.1016/0026-2862(73)90069-1
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   Berger C, 2009, BLOOD, V114, P2417, DOI 10.1182/blood-2008-12-189266
   Bielekova B, 2000, NAT MED, V6, P1167
   Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y
   Champion JA, 2007, J CONTROL RELEASE, V121, P3, DOI 10.1016/j.jconrel.2007.03.022
   Champion JA, 2009, PHARM RES-DORD, V26, P244, DOI 10.1007/s11095-008-9626-z
   Chen JJ, 2013, BIOMATERIALS, V34, P8776, DOI 10.1016/j.biomaterials.2013.07.063
   Chen L, 1997, J CONTROL RELEASE, V43, P261, DOI 10.1016/S0168-3659(96)01496-4
   Chueh FY, 2012, BIOCHEM BIOPH RES CO, V426, P242, DOI 10.1016/j.bbrc.2012.08.074
   Cupedo T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00343
   Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628
   Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614
   Decuzzi P, 2005, ANN BIOMED ENG, V33, P179, DOI 10.1007/s10439-005-8976-5
   Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x
   Demento S, 2009, IEEE ENG MED BIO, P1161, DOI 10.1109/IEMBS.2009.5332625
   Demento SL, 2011, TRENDS BIOTECHNOL, V29, P294, DOI 10.1016/j.tibtech.2011.02.004
   Demento SL, 2010, J IMMUNOL, V185, P2989, DOI 10.4049/jimmunol.1000768
   Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034
   Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330
   Duan XP, 2013, SMALL, V9, P1521, DOI 10.1002/smll.201201390
   Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514
   Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x
   Fadel TR, 2008, NANO LETT, V8, P2070, DOI 10.1021/nl080332i
   Fadel TR, 2013, SMALL, V9, P666, DOI 10.1002/smll.201201684
   Fahmy TM, 2007, NANOMED-NANOTECHNOL, V3, P75, DOI 10.1016/j.nano.2006.11.010
   Fernandez I, 2014, STEM CELLS, V32, P93, DOI 10.1002/stem.1512
   Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148
   Flach TL, 2011, NAT MED, V17, P479, DOI 10.1038/nm.2306
   Foged C, 2005, INT J PHARM, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035
   Forte G, 2012, TISSUE ENG PT A, V18, P1837, DOI [10.1089/ten.tea.2011.0707, 10.1089/ten.TEA.2011.0707]
   Franco LM, 2013, ELIFE, V2, DOI 10.7554/eLife.00299
   Freedman MS, 2011, NEUROLOGY, V77, P1551, DOI 10.1212/WNL.0b013e318233b240
   Garcia-Cordero JL, 2013, INTEGR BIOL-UK, V5, P650, DOI 10.1039/c3ib20263a
   Garcia-Vallejo JJ, 2013, MOL IMMUNOL, V53, P387, DOI 10.1016/j.molimm.2012.09.012
   Garrigues GE, 2005, BIOMATERIALS, V26, P2933, DOI 10.1016/j.biomaterials.2004.06.034
   Getts DR, 2012, NAT BIOTECHNOL, V30, P1217, DOI 10.1038/nbt.2434
   Giese C, 2006, ARTIF ORGANS, V30, P803, DOI 10.1111/j.1525-1594.2006.00303.x
   GOLUMBEK PT, 1993, CANCER RES, V53, P5841
   Gonzalez PA, 2005, P NATL ACAD SCI USA, V102, P4824, DOI 10.1073/pnas.0500922102
   GREF R, 1995, ADV DRUG DELIVER REV, V16, P215, DOI 10.1016/0169-409X(95)00026-4
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065
   Higbee RG, 2009, ATLA-ALTERN LAB ANIM, V37, P19
   Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748
   Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466
   Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213
   Holzapfel V, 2005, MACROMOL CHEM PHYSIC, V206, P2440, DOI 10.1002/macp.200500372
   Hor Y, 2009, BIOMATERIALS, V30, P6757, DOI 10.1016/j.biomaterials.2009.08.037
   HORA MS, 1990, BIO-TECHNOL, V8, P755, DOI 10.1038/nbt0890-755
   Hori Y, 2008, BIOMATERIALS, V29, P3671, DOI 10.1016/j.biomaterials.2008.05.033
   Hori Y, 2009, ACTA BIOMATER, V5, P969, DOI 10.1016/j.actbio.2008.11.019
   Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631
   Hotaling NA, 2014, BIOMATER SCI-UK, V2, P1426, DOI 10.1039/c4bm00138a
   Hotaling NA, 2014, BIOMATERIALS, V35, P5862, DOI 10.1016/j.biomaterials.2014.03.048
   Hudalla GA, 2013, ADV HEALTHC MATER, V2, P1114, DOI 10.1002/adhm.201200435
   Hume PS, 2012, BIOMATERIALS, V33, P3615, DOI 10.1016/j.biomaterials.2012.02.009
   Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251
   ILLUM L, 1982, INT J PHARM, V12, P135
   Irvine DJ, 2008, SEMIN IMMUNOL, V20, P137, DOI 10.1016/j.smim.2007.10.010
   Ishii KJ, 2005, J CLIN IMMUNOL, V25, P511, DOI 10.1007/s10875-005-7829-1
   Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108
   Jhunjhunwala S, 2013, J LEUKOCYTE BIOL, V94, P981, DOI 10.1189/jlb.0312167
   Jhunjhunwala S, 2012, J CONTROL RELEASE, V159, P78, DOI 10.1016/j.jconrel.2012.01.013
   John ALS, 2012, NAT MATER, V11, P250, DOI 10.1038/NMAT3222
   Joshi VB, 2013, AAPS J, V15, P85, DOI 10.1208/s12248-012-9418-6
   JULIANO RL, 1975, BIOCHEM BIOPH RES CO, V63, P651, DOI 10.1016/S0006-291X(75)80433-5
   Jung JP, 2011, INTEGR BIOL-UK, V3, P185, DOI 10.1039/c0ib00112k
   Kaminskas LM, 2011, FUND BIOMED TECHNOL, V5, P155, DOI 10.1007/978-94-007-1248-5_6
   Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006
   Kim J, 2015, NAT BIOTECHNOL, V33, P64, DOI 10.1038/nbt.3071
   Kodali VK, 2007, SOFT MATTER, V3, P337, DOI 10.1039/b611022n
   Kou PM, 2012, BIOMATERIALS, V33, P1699, DOI 10.1016/j.biomaterials.2011.10.066
   Kou PM, 2011, ACTA BIOMATER, V7, P1354, DOI 10.1016/j.actbio.2010.10.020
   Kou PM, 2010, ACTA BIOMATER, V6, P2621, DOI 10.1016/j.actbio.2010.01.023
   Kuo-Haller P, 2010, MOL PHARMACEUT, V7, P1585, DOI 10.1021/mp100009e
   Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x
   Lai SK, 2010, P NATL ACAD SCI USA, V107, P598, DOI 10.1073/pnas.0911748107
   Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002
   Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004
   Li AV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006516
   Li HY, 2011, NAT NANOTECHNOL, V6, P645, DOI [10.1038/nnano.2011.153, 10.1038/NNANO.2011.153]
   Li YP, 2001, J CONTROL RELEASE, V71, P287, DOI 10.1016/S0168-3659(01)00235-8
   Link A, 2012, J IMMUNOL, V188, P3724, DOI 10.4049/jimmunol.1103312
   Look M, 2013, J CLIN INVEST, V123, P1741, DOI 10.1172/JCI65907
   Lu L, 2000, J BIOMED MATER RES, V50, P440, DOI 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G
   Luo XR, 2008, P NATL ACAD SCI USA, V105, P14527, DOI 10.1073/pnas.0805204105
   Mackinnon S, 2008, BLOOD CELL MOL DIS, V40, P63, DOI 10.1016/j.bcmd.2007.07.003
   Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984
   Matzelle MM, 2004, BIOMATERIALS, V25, P295, DOI 10.1016/S0142-9612(03)00531-3
   Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054
   Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673
   Mesure L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012949
   Metcalfe SM, 2005, TRANSPLANTATION, V79, P726, DOI 10.1097/01.TP.0000149324.42994.38
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   Moon JJ, 2012, ADV MATER, V24, P3724, DOI 10.1002/adma.201200446
   Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109
   Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960
   Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003
   Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817
   Muro S, 2008, MOL THER, V16, P1450, DOI 10.1038/mt.2008.127
   Musyanovych A, 2011, ACTA BIOMATER, V7, P4160, DOI 10.1016/j.actbio.2011.07.033
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Nembrini C, 2011, P NATL ACAD SCI USA, V108, pE989, DOI 10.1073/pnas.1104264108
   Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777
   Ng THS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00129
   Okamoto N, 2007, J CLIN INVEST, V117, P997, DOI 10.1172/JCI30379
   Owens DE, 2006, INT J PHARM, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010
   Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011
   Park J, 2015, J BIOMED MATER RES A, V103, P170, DOI 10.1002/jbm.a.35150
   Park J, 2012, ACTA BIOMATER, V8, P3606, DOI 10.1016/j.actbio.2012.06.006
   Park J, 2012, NAT MATER, V11, P895, DOI [10.1038/NMAT3355, 10.1038/nmat3355]
   Park J, 2011, MOL PHARMACEUT, V8, P143, DOI 10.1021/mp100203a
   Pescatori M, 2013, BIOMATERIALS, V34, P4395, DOI 10.1016/j.biomaterials.2013.02.052
   Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591
   Pisani MJ, 2009, J INORG BIOCHEM, V103, P373, DOI 10.1016/j.jinorgbio.2008.11.014
   Poznansky MC, 2000, NAT BIOTECHNOL, V18, P729
   Puffer EB, 2007, ACS CHEM BIOL, V2, P252, DOI 10.1021/cb600489g
   Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Reddy ST, 2006, TRENDS IMMUNOL, V27, P573, DOI 10.1016/j.it.2006.10.005
   Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006
   Rehor A, 2005, LANGMUIR, V21, P411, DOI 10.1021/la0478043
   Rogers TH, 2011, BIOMATERIALS, V32, P1270, DOI 10.1016/j.biomaterials.2010.10.014
   Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100
   Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116
   Roser M, 1998, EUR J PHARM BIOPHARM, V46, P255, DOI 10.1016/S0939-6411(98)00038-1
   Rudra JS, 2012, BIOMATERIALS, V33, P6476, DOI 10.1016/j.biomaterials.2012.05.041
   Rudra JS, 2012, ACS NANO, V6, P1557, DOI 10.1021/nn204530r
   Rudra JS, 2010, P NATL ACAD SCI USA, V107, P622, DOI 10.1073/pnas.0912124107
   Sanchez A, 2003, EUR J PHARM SCI, V18, P221, DOI 10.1016/S0928-0987(03)00019-8
   Schroeder U, 2009, J MOL BIOL, V386, P1368, DOI 10.1016/j.jmb.2008.11.023
   Schweingruber N, 2011, J IMMUNOL, V187, P4310, DOI 10.4049/jimmunol.1101604
   Sheng Y, 2009, BIOMATERIALS, V30, P2340, DOI 10.1016/j.biomaterials.2008.12.070
   Shibata Y, 2012, J IMMUNOL, V188
   Shokouhi B, 2010, BIOMATERIALS, V31, P5759, DOI 10.1016/j.biomaterials.2010.04.015
   Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311
   Sieving A, 2003, J BIOMED MATER RES A, V64A, P457, DOI 10.1002/jbm.a.10368
   Singh A, 2011, J CONTROL RELEASE, V155, P184, DOI 10.1016/j.jconrel.2011.06.008
   Singh A, 2009, BIOMATERIALS, V30, P5187, DOI 10.1016/j.biomaterials.2009.06.001
   Singh A, 2008, MOL THER, V16, P2011, DOI 10.1038/mt.2008.206
   Smith CE, 2005, P NATL ACAD SCI USA, V102, P9595, DOI 10.1073/pnas.0504131102
   Stachowiak AN, 2008, J BIOMED MATER RES A, V85A, P815, DOI 10.1002/jbm.a.31661
   Stachowiak AN, 2005, ADV MATER, V17, P399, DOI 10.1002/adma.200400507
   Steenblock ER, 2011, J BIOL CHEM, V286, P34883, DOI 10.1074/jbc.M111.276329
   Stephan MT, 2012, BIOMATERIALS, V33, P5776, DOI 10.1016/j.biomaterials.2012.04.029
   Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198
   STORM G, 1995, ADV DRUG DELIVER REV, V17, P31, DOI 10.1016/0169-409X(95)00039-A
   Suematsu S, 2004, NAT BIOTECHNOL, V22, P1539, DOI 10.1038/nbt1039
   Tan JKH, 2010, ADV IMMUNOL, V105, P131, DOI 10.1016/S0065-2776(10)05005-4
   Taqvi S, 2006, J BIOMED MATER RES A, V79A, P689, DOI 10.1002/jbm.a.30916
   Thiele L, 2001, J CONTROL RELEASE, V76, P59, DOI 10.1016/S0168-3659(01)00412-6
   Thomas TP, 2011, ARTHRITIS RHEUM-US, V63, P2671, DOI 10.1002/art.30459
   THOMPSON JA, 1987, CANCER RES, V47, P4202
   Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667
   Tomei AA, 2009, J IMMUNOL, V183, P4273, DOI 10.4049/jimmunol.0900835
   Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690
   Tran KK, 2009, BIOMATERIALS, V30, P1356, DOI 10.1016/j.biomaterials.2008.11.034
   Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015
   Vaine CA, 2013, J IMMUNOL, V190, P3525, DOI 10.4049/jimmunol.1200492
   Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004
   Vonarbourg A, 2006, BIOMATERIALS, V27, P4356, DOI 10.1016/j.biomaterials.2006.03.039
   Wang L, 2014, MOL MED REP, V10, P473, DOI 10.3892/mmr.2014.2178
   Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499
   Xiao K, 2011, BIOMATERIALS, V32, P3435, DOI 10.1016/j.biomaterials.2011.01.021
   Xu F, 2009, INT J PHARMACEUT, V377, P199, DOI 10.1016/j.ijpharm.2009.05.015
   Yang J, 2010, BIOMATERIALS, V31, P8827, DOI 10.1016/j.biomaterials.2010.08.028
   Yang ZP, 2004, J CHROMATOGR A, V1053, P79, DOI 10.1016/j.chroma.2004.08.150
   Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107
   Yeste A, 2012, P NATL ACAD SCI USA, V109, P11270, DOI 10.1073/pnas.1120611109
   Yin YD, 2001, ADV MATER, V13, P267, DOI 10.1002/1521-4095(200102)13:4<267::AID-ADMA267>3.0.CO;2-9
   Yoo JW, 2011, ADV DRUG DELIVER REV, V63, P1247, DOI 10.1016/j.addr.2011.05.004
   Yoo JW, 2010, CURR PHARM DESIGN, V16, P2298, DOI 10.2174/138161210791920496
   Yoo JW, 2010, MACROMOL RAPID COMM, V31, P142, DOI 10.1002/marc.200900592
   Yuan F, 1998, SEMIN RADIAT ONCOL, V8, P164, DOI 10.1016/S1053-4296(98)80042-8
   Zahr AS, 2006, LANGMUIR, V22, P8178, DOI 10.1021/la060951b
   Zhang K, 2008, BIOCONJUGATE CHEM, V19, P1880, DOI 10.1021/bc800160b
   Zhao H, 2010, J CONTROL RELEASE, V141, P145, DOI 10.1016/j.jconrel.2009.09.002
   Zheng Y, 2013, J CONTROL RELEASE, V172, P426, DOI 10.1016/j.jconrel.2013.05.037
   Zhou JH, 2011, MOL THER, V19, P2228, DOI 10.1038/mt.2011.207
NR 193
TC 37
Z9 38
U1 8
U2 74
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 1523-9829
BN 978-0-8243-3517-5
J9 ANNU REV BIOMED ENG
JI Annu. Rev. Biomed. Eng.
PY 2015
VL 17
BP 317
EP 349
DI 10.1146/annurev-bioeng-071813-104814
PG 33
WC Engineering, Biomedical
SC Engineering
GA BE0XE
UT WOS:000367291800013
PM 26421896
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Konakov, VG
   Kurapova, OY
   Novik, NN
   Pivovarov, MM
   Archakov, IY
AF Konakov, V. G.
   Kurapova, O. Yu
   Novik, N. N.
   Pivovarov, M. M.
   Archakov, I. Yu
TI NANOSTRUCTURED YSZ COATINGS ON TITANIUM
SO REVIEWS ON ADVANCED MATERIALS SCIENCE
LA English
DT Article
ID ZIRCONIA COATINGS; HPT TITANIUM; IMPLANTS; BIOMATERIAL; CERAMICS; ALLOY
AB An approach providing yttrium-stabilized zirconia coatings deposition on titanium is suggested. High-quality YSZ coatings with 5-6 mu m thickness were studied using SEM and XRD, the mechanical properties (Brenell and Moos hardness) of covered samples were compared with pure titanium characteristics. The regimes of titanium wafer pretreatment were optimized. It was shown that both 8Y(2)O(3)-92ZrO(2) and 9Y(2)O(3)-10TiO(2)-92ZrO(2) coatings increase the material hardness.
C1 [Konakov, V. G.; Kurapova, O. Yu; Novik, N. N.; Archakov, I. Yu] Peter Great St Petersburg Polytech Univ, Res Lab Mech New Nanomat, St Petersburg 195251, Russia.
   [Konakov, V. G.; Kurapova, O. Yu; Novik, N. N.] St Petersburg State Univ, Inst Chem, St Petersburg 198504, Russia.
   [Konakov, V. G.; Kurapova, O. Yu; Novik, N. N.; Pivovarov, M. M.] Glass & Ceram Ltd, St Petersburg 199004, Russia.
   [Archakov, I. Yu] St Petersburg State Univ, Dept Mech & Math, St Petersburg 198504, Russia.
   [Archakov, I. Yu] Inst Problems Mech Engn, St Petersburg 199178, Russia.
RP Kurapova, OY (reprint author), Peter Great St Petersburg Polytech Univ, Res Lab Mech New Nanomat, Polytech Skaya 29, St Petersburg 195251, Russia.
EM glasscer@yandex.ru
OI Kurapova, Olga/0000-0002-7148-7755
FU Russian Science Foundation [14-29-00199]
FX This work was supported by the Russian Science Foundation (Project
   14-29-00199).
CR Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Clarke IC, 2003, J BONE JOINT SURG AM, V85A, P73, DOI 10.2106/00004623-200300004-00009
   de Groot K., 1998, P I MECH ENG, V2, P212
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Huang HL, 2013, THIN SOLID FILMS, V528, P151, DOI 10.1016/j.tsf.2012.07.143
   Ivanov-Pavlov D. A., 2010, B ST PETERSBURG STAT, V4, P139
   Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041
   KLEIN CPAT, 1991, J BIOMED MATER RES, V25, P53, DOI 10.1002/jbm.820250105
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   Konakov VG, 2014, MATER PHYS MECH, V21, P305
   Konakov VG, 2015, REV ADV MATER SCI, V41, P99
   Kurapova OY, 2012, REV ADV MATER SCI, V32, P112
   Lamolle S. F., 2008, J BIOMEDICAL MAT R A, V88, P581
   Langhoff JD, 2008, INT J ORAL MAX SURG, V37, P1125, DOI 10.1016/j.ijom.2008.09.008
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Schwarz M. L., 2008, J BIOMEDICAL MAT R A, V89, P667
   Wenz H. J., 2007, INT J PROSTHODONT, V21, P27
   Zhilyaev AP, 2014, REV ADV MATER SCI, V39, P15
   Zhou H, 2007, SURF COAT TECH, V201, P7360, DOI 10.1016/j.surfcoat.2007.02.010
NR 20
TC 1
Z9 1
U1 0
U2 2
PU INST PROBLEMS MECHANICAL ENGINEERING-RUSSIAN ACAD SCIENCES
PI ST PTERSBURG
PA BOLSHOJ 61, VAS OSTROV, ST PTERSBURG, 199178, RUSSIA
SN 1606-5131
J9 REV ADV MATER SCI
JI Rev. Adv. Mater. Sci.
PY 2015
VL 43
IS 1-2
BP 94
EP 101
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CZ7KF
UT WOS:000367277600015
DA 2018-10-19
ER

PT J
AU Ventura, MG
   Paninho, AI
   Nunes, AVM
   Fonseca, IM
   Branco, LC
AF Ventura, Marcia G.
   Paninho, Ana I.
   Nunes, Ana V. M.
   Fonseca, Isabel M.
   Branco, Luis C.
TI Biocompatible locust bean gum mesoporous matrices prepared by ionic
   liquids and a scCO(2) sustainable system
SO RSC ADVANCES
LA English
DT Article
ID DRUG-DELIVERY SYSTEMS; CONTROLLED-RELEASE; SODIUM ALGINATE; AEROGELS;
   IBUPROFEN; POLYSACCHARIDES; CELLULOSE; SILICA; GALACTOMANNAN; SOLVENTS
AB Locust bean gum (LBG) is a natural polymer that belongs to the increasingly attractive biodegradable polymers derived from natural sources. This polymer possesses a number of appealing features such as non-toxicity that confer it a high potential for the use in fields such as pharmacy and food industries. In this work, three methylimidazolium-based ionic liquids (ILs) were used as alternative media in the preparation of biocompatible LBG gel matrices. The process consists of dissolving the biomaterial in a selected IL followed by a multi-step solvent exchange using a mixture of water and ethanol. The final gel (internal surface areas ranging from 60 to 180 m(2) g(-1)) is then dried using a semi-continuous high pressure CO2 extraction process. To the best of our knowledge this is the first time that LBG mesoporous gel matrices are reported using this efficient sustainable method.
C1 [Ventura, Marcia G.; Paninho, Ana I.; Nunes, Ana V. M.; Fonseca, Isabel M.; Branco, Luis C.] Univ Nova Lisboa, Dept Quim, LAQV REQUIMTE, Fac Ciencias & Tecnol, P-2829516 Monte De Caparica, Portugal.
RP Ventura, MG (reprint author), Univ Nova Lisboa, Dept Quim, LAQV REQUIMTE, Fac Ciencias & Tecnol, P-2829516 Monte De Caparica, Portugal.
EM mm.ventura@fct.unl.pt; l.branco@fct.unl.pt
RI Branco, Luis/C-6426-2013; Nunes, Ana/D-2045-2013; Ventura,
   Marcia/C-6702-2013; Fonseca, Isabel/D-2513-2013
OI Branco, Luis/0000-0003-2520-1151; Nunes, Ana/0000-0001-9928-1903;
   Fonseca, Isabel/0000-0001-7007-9525; Ventura, Marcia/0000-0003-2493-4900
FU FCT-MCTES (Portugal) [PTDC/CTM/103664/2008, PTDC/CTM-NAN/120658/2010,
   PTDC/EQU-EQU/104552/2008, SFRH/BPD/40008/2007, SFRH/BPD/74994/2010]
FX FCT-MCTES (Portugal) is acknowledged for financial support through the
   projects PTDC/CTM/103664/2008, PTDC/CTM-NAN/120658/2010,
   PTDC/EQU-EQU/104552/2008, and post-doc grants SFRH/BPD/40008/2007 (MGV)
   and SFRH/BPD/74994/2010 (AVMN). The authors would like to thanks to Dr
   Nuno Costa for the technical support on the porosimetry analysis.
CR Aaltonen O, 2009, CARBOHYD POLYM, V75, P125, DOI 10.1016/j.carbpol.2008.07.008
   Andersson J, 2004, CHEM MATER, V16, P4160, DOI 10.1021/cm0401490
   Avachat AM, 2011, INDIAN J PHARM EDUC, V45, P86
   Babu VR, 2006, J APPL POLYM SCI, V99, P2671, DOI 10.1002/app.22760
   Biswas A, 2006, CARBOHYD POLYM, V66, P546, DOI 10.1016/j.carbpol.2006.04.005
   Dionisio M, 2012, J PHARM BIOALLIED SC, V4, P175, DOI 10.4103/0975-7406.99013
   Escudero RR, 2009, CARBOHYD POLYM, V75, P52, DOI 10.1016/j.carbpol.2008.06.008
   FRICKE J, 1988, SCI AM, V258, P92, DOI 10.1038/scientificamerican0588-92
   Garcia-Gonzalez CA, 2011, CARBOHYD POLYM, V86, P1425, DOI 10.1016/j.carbpol.2011.06.066
   Hirsch S, 1999, EUR J PHARM BIOPHARM, V47, P61, DOI 10.1016/S0939-6411(98)00089-7
   Innerlohinger J, 2006, MACROMOL SYMP, V244, P126, DOI 10.1002/masy.200651212
   Kadokawa JI, 2013, J BIOBASED MATER BIO, V7, P3, DOI 10.1166/jbmb.2013.1275
   Kilpelainen I, 2007, J AGR FOOD CHEM, V55, P9142, DOI 10.1021/jf071692e
   Kulkarni VS, 2012, INT J PHARM BIOMED S, V3, P1597
   Liebert T, 2008, BIORESOURCES, V3, P576
   Martins JT, 2012, FOOD HYDROCOLLOID, V29, P280, DOI 10.1016/j.foodhyd.2012.03.004
   Paninho AB, 2013, J SUPERCRIT FLUID, V83, P35, DOI 10.1016/j.supflu.2013.08.002
   Pinkert A, 2009, CHEM REV, V109, P6712, DOI 10.1021/cr9001947
   Prajapati VD, 2013, CARBOHYD POLYM, V94, P814, DOI 10.1016/j.carbpol.2013.01.086
   Quignard F, 2008, NEW J CHEM, V32, P1300, DOI 10.1039/b808218a
   Rao KSVK, 2006, J APPL POLYM SCI, V102, P5708, DOI 10.1002/app.25087
   Robitzer M, 2011, MICROPOR MESOPOR MAT, V140, P9, DOI 10.1016/j.micromeso.2010.10.006
   Santamaria E, 2014, J SOLID STATE CHEM, V210, P242, DOI 10.1016/j.jssc.2013.11.031
   Smirnova I, 2003, LANGMUIR, V19, P8521, DOI 10.1021/la0345587
   Sujja-areevath J, 1998, EUR J PHARM SCI, V6, P207, DOI 10.1016/S0928-0987(97)00072-9
   Takada A, 2015, BIOMOLECULES, V5, P244, DOI 10.3390/biom5010244
   Vendruscolo CW, 2005, INT J PHARMACEUT, V296, P1, DOI 10.1016/j.ijpharm.2005.02.007
   Vijayaraghavan C., 2008, PHARMAZIE, V5, P342
   White RJ, 2008, CHEMSUSCHEM, V1, P408, DOI 10.1002/cssc.200800012
   Williams P. A., 2000, HDB HYDROCOLLOIDS, P137
   Yamagar M., 2004, INT J RES PHARM BIOM, V2, P453
   Zohuriaan MJ, 2004, POLYM TEST, V23, P575, DOI 10.1016/j.polymertesting.2003.11.001
NR 32
TC 4
Z9 4
U1 1
U2 23
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 130
BP 107700
EP 107706
DI 10.1039/c5ra17314k
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA CZ7HY
UT WOS:000367271700060
DA 2018-10-19
ER

PT J
AU Ma, GF
   Zhang, ZG
   Sun, KJ
   Peng, H
   Yang, Q
   Ran, FT
   Lei, ZQ
AF Ma, Guofu
   Zhang, Zhiguo
   Sun, Kanjun
   Peng, Hui
   Yang, Qian
   Ran, Feitian
   Lei, Ziqiang
TI White clover based nitrogen-doped porous carbon for a high energy
   density supercapacitor electrode
SO RSC ADVANCES
LA English
DT Article
ID HIGH-PERFORMANCE SUPERCAPACITORS; STORAGE; GRAPHENE; PYROLYSIS; FLOWER
AB We have employed the biomaterial white clover as a carbon precursor and ZnCl2 as an activating agent to prepare white clover carbons (WCCs). The WCC-2 (mass ratios of white clover and ZnCl2 is 1 : 2) possesses as high as 6.9 wt% nitrogen content and 857 m(2) g(-1) BET surface area. Furthermore, it exhibits 233.1 F g(-1) specific capacitance at a current density of 1.0 A g(-1), even 82.9% capacitance retention at 20 A g(-1) in 2 mol L-1 KOH electrolyte. The specific capacitance could remain at almost about 100.0% when the cycle number is between the 200-5000 cycles. Because of the wide potential window (0-2.0 V) and high specific capacitance, the WCC-2//WCC-2 symmetric capacitor shows an energy density of 30-13.1 W h kg(-1) under the power outputs of 503.5-9991.5 W kg(-1) in 0.5 mol L-1 Na2SO4 electrolyte. The results demonstrate WCC-2 can be a promising candidate for the electrode material of high performance supercapacitors.
C1 [Ma, Guofu; Zhang, Zhiguo; Peng, Hui; Yang, Qian; Ran, Feitian; Lei, Ziqiang] Northwest Normal Univ, Key Lab Polymer Mat Gansu Prov, Key Lab Ecoenvironm Related Polymer Mat, Minist Educ,Coll Chem & Chem Engn, Lanzhou 730070, Peoples R China.
   [Sun, Kanjun] Lanzhou City Univ, Coll Chem & Environm Sci, Lanzhou 730070, Peoples R China.
RP Ma, GF (reprint author), Northwest Normal Univ, Key Lab Polymer Mat Gansu Prov, Key Lab Ecoenvironm Related Polymer Mat, Minist Educ,Coll Chem & Chem Engn, Lanzhou 730070, Peoples R China.
EM magf@nwnu.edu.cn; leizq@nwnu.edu.cn
FU National Science Foundation of China [21164009, 21174114]; program for
   Changjiang Scholars and Innovative Research Team in University
   [IRT1177]; Science and Technology Program of Gansu Province
   [1308RJZA295, 1308RJZA265]; Key Laboratory of Eco-Environment-Related
   Polymer Materials (Northwest Normal University) of Ministry of
   Education; Key Laboratory of Polymer Materials of Gansu Province
FX This research was financially supported by the National Science
   Foundation of China (No. 21164009, 21174114), the program for Changjiang
   Scholars and Innovative Research Team in University (IRT1177), the
   Science and Technology Program of Gansu Province (No. 1308RJZA295,
   1308RJZA265), Key Laboratory of Eco-Environment-Related Polymer
   Materials (Northwest Normal University) of Ministry of Education, and
   Key Laboratory of Polymer Materials of Gansu Province.
CR Casey NM, 2010, THEOR APPL GENET, V121, P567, DOI 10.1007/s00122-010-1330-9
   Chang JL, 2015, ELECTROCHIM ACTA, V157, P290, DOI 10.1016/j.electacta.2014.12.169
   Chen HC, 2013, J PHYS CHEM C, V117, P8318, DOI 10.1021/jp4017773
   Chen LF, 2012, ACS NANO, V6, P7092, DOI 10.1021/nn302147s
   Dai LM, 2012, SMALL, V8, P1130, DOI 10.1002/smll.201101594
   Denisa H. J., 2009, ADV FUNCT MATER, V19, P438
   Ding J, 2015, ENERG ENVIRON SCI, V8, P941, DOI 10.1039/c4ee02986k
   Dutta S, 2014, ENERG ENVIRON SCI, V7, P3574, DOI 10.1039/c4ee01075b
   Frackowiak E, 2001, CARBON, V39, P937, DOI 10.1016/S0008-6223(00)00183-4
   Gao SY, 2015, ENERG ENVIRON SCI, V8, P221, DOI 10.1039/c4ee02087a
   Hu CX, 2015, RSC ADV, V5, P14441, DOI 10.1039/c4ra12220h
   Li Z, 2013, ENERG ENVIRON SCI, V6, P871, DOI 10.1039/c2ee23599d
   Lillo-Rodenas MA, 2001, CARBON, V39, P751, DOI 10.1016/S0008-6223(00)00186-X
   Liu MX, 2015, J MATER CHEM A, V3, P11517, DOI 10.1039/c5ta02224j
   Luo W, 2014, NANO LETT, V14, P2225, DOI 10.1021/nl500859p
   Ma XM, 2013, J SOLID STATE ELECTR, V17, P2293, DOI 10.1007/s10008-013-2110-7
   Mascotto S, 2015, CARBON, V82, P425, DOI 10.1016/j.carbon.2014.10.086
   Paraknowitsch JP, 2010, ADV MATER, V22, P87, DOI 10.1002/adma.200900965
   PELS JR, 1995, CARBON, V33, P1641, DOI 10.1016/0008-6223(95)00154-6
   Pensado AS, 2014, RSC ADV, V4, P18017, DOI 10.1039/c4ra02059f
   Puthusseri D, 2014, ENERG ENVIRON SCI, V7, P728, DOI 10.1039/c3ee42551g
   Qu WH, 2015, BIORESOURCE TECHNOL, V189, P285, DOI 10.1016/j.biortech.2015.04.005
   Ramanathan R, 2015, RSC ADV, V5, P1424, DOI 10.1039/c4ra14510k
   Sadezky A, 2005, CARBON, V43, P1731, DOI 10.1016/j.carbon.2005.02.018
   Sun L, 2014, CHEM-EUR J, V20, P564, DOI 10.1002/chem.201303345
   Tang J, 2015, ANGEW CHEM INT EDIT, V54, P588, DOI 10.1002/anie.201407629
   Tripathi PK, 2014, J MATER CHEM A, V2, P8534, DOI 10.1039/c4ta00578c
   Vaseva I, 2011, SCI HORTIC-AMSTERDAM, V130, P653, DOI 10.1016/j.scienta.2011.08.021
   Wang H, 2013, ACS NANO, V7, P5131, DOI 10.1021/nn400731g
   Wang Q, 2014, CARBON, V67, P119, DOI 10.1016/j.carbon.2013.09.070
   Wang Q, 2013, J POWER SOURCES, V225, P101, DOI 10.1016/j.jpowsour.2012.10.022
   Wu H, 2013, J POWER SOURCES, V226, P202, DOI 10.1016/j.jpowsour.2012.11.014
   Wu XL, 2013, ACS NANO, V7, P3589, DOI 10.1021/nn400566d
   Wu XZ, 2012, J MATER CHEM, V22, P23186, DOI 10.1039/c2jm35278h
   Yan J, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201400500
   Yang XW, 2013, SCIENCE, V341, P534, DOI 10.1126/science.1239089
   Zhai YP, 2011, ADV MATER, V23, P4828, DOI 10.1002/adma.201100984
   Zhang YZ, 2015, CHEM SOC REV, V44, P5181, DOI 10.1039/c5cs00174a
   Zhao QL, 2015, ELECTROCHIM ACTA, V173, P566, DOI 10.1016/j.electacta.2015.05.096
   Zhao YH, 2015, ELECTROCHIM ACTA, V153, P448, DOI 10.1016/j.electacta.2014.11.173
   Zhong HX, 2014, J MATER CHEM A, V2, P17047, DOI 10.1039/c4ta03778b
   Zhu DZ, 2015, ELECTROCHIM ACTA, V158, P166, DOI 10.1016/j.electacta.2015.01.155
NR 42
TC 1
Z9 2
U1 2
U2 25
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 130
BP 107707
EP 107715
DI 10.1039/c5ra20327a
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA CZ7HY
UT WOS:000367271700061
DA 2018-10-19
ER

PT J
AU Boehm, MW
   Shewan, HM
   Steen, JA
   Stokes, JR
AF Boehm, Michael W.
   Shewan, Heather M.
   Steen, Jennifer A.
   Stokes, Jason R.
TI ILLUSTRATING ULTRA-LOW-VOLUME RHEOLOGY ON A CONVENTIONAL RHEOMETER:
   CHARTING THE DEVELOPMENT OF HYALURONAN DURING FERMENTATION
SO APPLIED RHEOLOGY
LA English
DT Article
DE Ultra-low-volume rheology; narrow gap; hyaluronan; intrinsic viscosity;
   molecular weight
ID ATOMIC-FORCE MICROSCOPY; PARALLEL-PLATE RHEOMETRY; MOLECULAR-WEIGHT;
   STREPTOCOCCUS-ZOOEPIDEMICUS; BIOMATERIAL HYDROGELATORS; VISCOELASTIC
   BEHAVIOR; KNEE OSTEOARTHRITIS; ACID PRODUCTION; SHEAR-RATE; THIN-FILM
AB We provide methodologiesto characterise the rheology of ultra-low volumes of polymer solutions and biological fluids (10-100 mu L) on a rotational rheometer. The technique utilises a parallel plate geometry with narrow gaps of 20-100 micrometers, which is an order of magnitude less than conventional methods. Despite the complications these gaps present, the use of appropriate protocols ensures reliable and accurate rheological characterisation offluids, including shear-dependent viscosity, normal stresses and linear viscoelasticity. This rheological technique's usefulness is further demonstrated by showing how the rheology of hyaluronan solutions evolve during fermentation. The intrinsic viscosity of the hyaluronan macromolecule is determined using less than loo mu L of solution extracted directly from the bioreactor, and this is used to provide a reasonable indicator of its molecular weight as it develops during the fermentation process. The ability to measure rheology of ultra-low volumes has applications in the characterisation of biological fluids and high value macromolecules, as well as generally in biotechnology and nanotechnology research fields.
C1 [Boehm, Michael W.; Shewan, Heather M.; Stokes, Jason R.] Univ Queensland, Sch Chem Engn, Rheol & Biolubricat Lab, Brisbane, Qld 4072, Australia.
   [Steen, Jennifer A.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
   [Stokes, Jason R.] Univ Queensland, ARC Ctr Excellence Plant Cell Walls, Brisbane, Qld 4072, Australia.
RP Stokes, JR (reprint author), Univ Queensland, Sch Chem Engn, Rheol & Biolubricat Lab, Brisbane, Qld 4072, Australia.
EM jason.stokes@uq.edu.au
RI Shewan, Heather/F-7488-2011; Stokes, Jason/A-1608-2009; Boehm,
   Michael/N-4770-2017
OI Shewan, Heather/0000-0002-4405-679X; Stokes, Jason/0000-0001-7784-9297;
   Boehm, Michael/0000-0002-5022-4999; Steen, Jennifer/0000-0002-4760-9492
FU Australian Postgraduate Award
FX HMS acknowledges Ph.D. funding by an Australian Postgraduate Award.
CR Allison DD, 2006, TISSUE ENG, V12, P2131, DOI 10.1089/ten.2006.12.2131
   ARMSTRONG DC, 1995, BIOTECHNOL TECH, V9, P491, DOI 10.1007/BF00159564
   Baik SJ, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3571297
   Bajaj I, 2011, BIORESOURCE TECHNOL, V102, P5551, DOI 10.1016/j.biortech.2011.02.047
   Balazs EA, 1974, PHYS PROPERTIES SYNO, P63
   Balazs Endre A, 2004, Surg Technol Int, V12, P278
   Barnes HA, 1989, INTRO RHEOLOGY
   Bird R. B., 1977, DYNAMICS POLYM LIQUI
   BOHDANECKY M, 1983, MACROMOLECULES, V16, P1483, DOI 10.1021/ma00243a014
   Bongaerts JHH, 2009, BIOMACROMOLECULES, V10, P1287, DOI 10.1021/bm801079a
   Bureau L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218302
   Chau L, 2009, LAB CHIP, V9, P1897, DOI 10.1039/b823180j
   Chen WY, 2009, J BIOL CHEM, V284, P18007, DOI 10.1074/jbc.M109.011999
   Chong BF, 2003, BIOCHEM ENG J, V16, P153, DOI 10.1016/S1369-703X(03)00031-7
   Clasen C, 2006, J RHEOL, V50, P883, DOI 10.1122/1.2357190
   Clasen C, 2010, APPL RHEOL, V20, DOI 10.3933/ApplRheol-20-45049
   CLELAND RL, 1970, BIOPOLYMERS, V9, P799, DOI 10.1002/bip.1970.360090706
   CONNELLY RW, 1985, J RHEOL, V29, P209, DOI 10.1122/1.549828
   Cubukcu D, 2005, CLIN RHEUMATOL, V24, P336, DOI 10.1007/s10067-004-1043-z
   Davies GA, 2008, J NON-NEWTON FLUID, V148, P73, DOI 10.1016/j.jnnfm.2007.04.013
   Davies GA, 2005, J RHEOL, V49, P919, DOI 10.1122/1.1942501
   Dealy J. M., 2006, STRUCTURE RHEOLOGY M
   DIFERRANTE N, 1956, J BIOL CHEM, V220, P303
   Fam H, 2007, BIORHEOLOGY, V44, P59
   Fam H, 2009, BIORHEOLOGY, V46, P31, DOI 10.3233/BIR-2009-0521
   FOUISSAC E, 1993, MACROMOLECULES, V26, P6945, DOI 10.1021/ma00077a036
   Fujii K, 1996, BIOPOLYMERS, V38, P583, DOI 10.1002/(SICI)1097-0282(199605)38:5<583::AID-BIP4>3.3.CO;2-T
   Fusco S, 2007, BIORHEOLOGY, V44, P403
   Gaffney J, 2010, MOL BIOSYST, V6, P437, DOI 10.1039/b910552m
   Garcia-Abuin A, 2011, CARBOHYD POLYM, V85, P500, DOI 10.1016/j.carbpol.2011.02.028
   HANSMA HG, 1995, BIOPHYS J, V68, P1672, DOI 10.1016/S0006-3495(95)80343-7
   Haward SJ, 2011, SOFT MATTER, V7, P9908, DOI 10.1039/c1sm05493g
   Haward SJ, 2011, RHEOL ACTA, V50, P869, DOI 10.1007/s00397-010-0494-1
   Huggins ML, 1942, J AM CHEM SOC, V64, P2716, DOI 10.1021/ja01263a056
   Hwang DS, 2010, SOFT MATTER, V6, P3232, DOI 10.1039/c002632h
   Khair AS, 2005, J RHEOL, V49, P1449, DOI 10.1122/1.2085173
   Kraemer EO, 1938, IND ENG CHEM, V30, P1200, DOI 10.1021/ie50346a023
   Kravchuk O, 2013, J RHEOL, V57, P365, DOI 10.1122/1.4774323
   Lapcik L, 1998, CHEM REV, V98, P2663, DOI 10.1021/cr941199z
   LAURENT TC, 1960, BIOCHIM BIOPHYS ACTA, V42, P476, DOI 10.1016/0006-3002(60)90826-X
   LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003
   Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6
   Liu L, 2008, LETT APPL MICROBIOL, V46, P383, DOI 10.1111/j.1472-765X.2008.02325.x
   Lyubchenko YL, 1997, P NATL ACAD SCI USA, V94, P496, DOI 10.1073/pnas.94.2.496
   Maisonneuve BGC, 2013, BIOMACROMOLECULES
   Marcellin E, 2014, APPL MICROBIOL BIOT, V98, P6947, DOI 10.1007/s00253-014-5853-x
   Meyer A, 2006, J RHEOL, V50, P77, DOI 10.1122/1.2139098
   Mo YQ, 2001, BIORHEOLOGY, V38, P379
   Morris E. R., 1981, Carbohydrate Polymers, V1, P5, DOI 10.1016/0144-8617(81)90011-4
   MORRIS ER, 1980, J MOL BIOL, V138, P383, DOI 10.1016/0022-2836(80)90294-6
   Mukhopadhyay A, 2001, CURR OPIN COLLOID IN, V6, P423, DOI 10.1016/S1359-0294(01)00119-4
   Ozturk C, 2006, RHEUMATOL INT, V26, P314, DOI 10.1007/s00296-005-0584-z
   PEACHEY J, 1991, REV SCI INSTRUM, V62, P463, DOI 10.1063/1.1142089
   Pipe CJ, 2008, RHEOL ACTA, V47, P621, DOI 10.1007/s00397-008-0268-1
   Remminghorst Uwe, 2009, P13
   Rief M, 1999, NAT STRUCT BIOL, V6, P346
   Schultz KM, 2012, SOFT MATTER, V8, P6198, DOI 10.1039/c2sm25187f
   Schultz KM, 2011, BIOMACROMOLECULES, V12, P4178, DOI 10.1021/bm201214r
   Schultz KM, 2011, LAB CHIP, V11, P3802, DOI 10.1039/c1lc20376b
   SHIPMAN RWG, 1991, IND ENG CHEM RES, V30, P918, DOI 10.1021/ie00053a014
   Smith BA, 2005, BIOPHYS J, V88, P2994, DOI 10.1529/biophysj.104.046649
   Stokes JR, 2007, BIORHEOLOGY, V44, P141
   Stokes JR, 2011, LANGMUIR, V27, P3474, DOI 10.1021/la104040d
   Stokes JR, 2012, ORAL RHEOLOGY FOOD O, P227
   Tadmor R, 2003, MACROMOLECULES, V36, P9519, DOI 10.1021/ma030379k
   Tadmor R, 2002, J BIOMED MATER RES, V61, P514, DOI 10.1002/jbm.10215
   Vleminckx G, 2014, CURR OPIN COLLOID IN, V19, P503, DOI 10.1016/j.cocis.2014.11.002
   Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200
   Weigel PH, 2012, GLYCOBIOLOGY, V22, P1302, DOI 10.1093/glycob/cws102
   Widner B, 2005, APPL ENVIRON MICROB, V71, P3747, DOI 10.1128/AEM.71.7.3747-3752.2005
   Yakubov GE, 2007, BIOMACROMOLECULES, V8, P3467, DOI 10.1021/bm700607w
   Yamaguchi N, 2005, BIOMACROMOLECULES, V6, P1931, DOI 10.1021/bm0500042
   Yuan CB, 2000, BIOCHEMISTRY-US, V39, P10219, DOI 10.1021/bi992715o
NR 73
TC 3
Z9 3
U1 1
U2 5
PU KERSCHENSTEINER VERLAG GMBH
PI LAPPERSDORF
PA MORIKESTR 4, LAPPERSDORF, 93138, GERMANY
SN 1430-6395
EI 1617-8106
J9 APPL RHEOL
JI Appl. Rheol.
PY 2015
VL 25
IS 5
AR 55609
DI 10.3933/APPLRHEOL-25-55609
PG 8
WC Mechanics
SC Mechanics
GA CZ7KQ
UT WOS:000367278700007
DA 2018-10-19
ER

PT J
AU Lee, JW
   Wen, HB
   Battula, S
   Akella, R
   Collins, M
   Romanos, GE
AF Lee, Jin Whan
   Wen, Hai Bo
   Battula, Suneel
   Akella, Rama
   Collins, Michael
   Romanos, Georgios E.
TI Outcome After Placement of Tantalum Porous Engineered Dental Implants in
   Fresh Extraction Sockets: A Canine Study
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE bone ingrowth; osseoincorporation; porous tantalum; trabecular metal
   dental implant
ID RESONANCE FREQUENCY-ANALYSIS; TOTAL HIP-ARTHROPLASTY; IMMEDIATE
   IMPLANTS; BONE INGROWTH; STABILITY; INTERFACE; TITANIUM; DOG;
   BIOMATERIAL; MORPHOLOGY
AB Purpose: This study evaluated the stability and histologic proof of osseoincorporation of Trabecular Metal (TM) dental implants, which feature a tantalum-based porous midsection. Materials and Methods: A total of 48 TM implants (test group) and Tapered Screw-Vent implants (control group) were immediately placed bilaterally into mandibular extraction sockets in dogs. Resonance frequency analysis was performed at weeks 0, 2, 4, and 12 after implant placement. Histologic and histomorphometric evaluations of the implant interface were performed. Results: Changes in mean implant stability quotients (ISQ) revealed no statistical differences between the test and control groups. Histologic analysis showed bone ingrowth into the porous tantalum structure of all test group implants. Histomorphometric analysis revealed an increased percentage of bone-to-implant contact between 4 and 8 weeks in both test and control groups. The porous sections of the test group exhibited significantly more new bone inside the pores at week 12 in comparison to weeks 2 and 4. No correlation was observed between ISQ and histomorphometric parameters. Conclusion: In a canine immediate extraction socket model, both test and control implants demonstrated comparable implant stability and bone-to-implant contact. Bone ingrowth was evident within the tantalum porous section of the test implants during the early healing.
C1 [Lee, Jin Whan; Wen, Hai Bo] Zimmer Dent, Res, Carlsbad, CA USA.
   [Battula, Suneel] Zimmer Dent, Carlsbad, CA USA.
   [Akella, Rama] Zimmer Orthobiol, Austin, TX USA.
   [Collins, Michael] Zimmer Dent, Res & Dev, Carlsbad, CA USA.
   [Collins, Michael] Zimmer Dent, Zfx, Carlsbad, CA USA.
   [Romanos, Georgios E.] SUNY Stony Brook, Sch Dent Med, Stony Brook, NY 11794 USA.
RP Romanos, GE (reprint author), SUNY Stony Brook, Sch Dent Med, 106 Rockland Hall, Stony Brook, NY 11794 USA.
EM georgios.romanos@stonybrook.edu
CR Abed Ahmad Moghareh, 2011, Dent Res J (Isfahan), V8, P132
   Abrahamsson I, 2009, CLIN ORAL IMPLAN RES, V20, P313, DOI 10.1111/j.1600-0501.2008.01646.x
   Al-Hezaimi K, 2013, J ORAL IMPLANTOL
   Araujo MG, 2011, CLIN ORAL IMPLAN RES, V22, P1, DOI 10.1111/j.1600-0501.2010.01920.x
   Becker W, 1995, Int J Oral Maxillofac Implants, V10, P143
   Bencharit S, 2013, CLIN IMPLANT DENT RE
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   CAMERON HU, 1976, J BIOMED MATER RES, V10, P295
   Caneva M, 2012, CLIN ORAL IMPLAN RES, V23, P789, DOI 10.1111/j.1600-0501.2011.02332.x
   Chen ST, 2007, CLIN ORAL IMPLAN RES, V18, P552, DOI 10.1111/j.1600-0501.2007.01388.x
   Covani U, 2011, CLIN ORAL IMPLAN RES, V22, P820, DOI 10.1111/j.1600-0501.2010.02060.x
   de Sanctis M, 2009, J CLIN PERIODONTOL, V36, P705, DOI 10.1111/j.1600-051X.2009.01427.x
   DEPORTER DA, 1986, J DENT RES, V65, P1064, DOI 10.1177/00220345860650080501
   Elias CN, 2012, J MECH BEHAV BIOMED, V16, P169, DOI 10.1016/j.jmbbm.2012.10.010
   Ito Y, 2008, CLIN ORAL IMPLAN RES, V19, P9, DOI 10.1111/j.1600-0501.2007.01419.x
   Kim DG, 2013, IMPLANT DENT, V22, P399, DOI 10.1097/ID.0b013e31829b17b5
   Levine Brett, 2007, J Knee Surg, V20, P185
   Levine B, 2006, J AM ACAD ORTHOP SUR, V14, P646, DOI 10.5435/00124635-200611000-00008
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Li JP, 2005, J BIOMED MATER RES A, V73A, P223, DOI 10.1002/jbm.a.30278
   Mazor Z, 2003, INT J ORAL MAX IMPL, V18, P729
   Meneghini RM, 2010, J ARTHROPLASTY, V25, P741, DOI 10.1016/j.arth.2009.04.025
   Meredith N, 1996, CLIN ORAL IMPLAN RES, V7, P261, DOI 10.1034/j.1600-0501.1996.070308.x
   Schliephake H, 2006, INT J ORAL MAX SURG, V35, P941, DOI 10.1016/j.ijom.2006.05.002
   Shimko DA, 2005, J BIOMED MATER RES B, V73B, P315, DOI 10.1002/jbm.b.30229
   Stiehler M, 2008, J BIOMED MATER RES A, V86A, P448, DOI 10.1002/jbm.a.31602
   Szmukler-Moncler S, 1998, J BIOMED MATER RES, V43, P192, DOI 10.1002/(SICI)1097-4636(199822)43:2<192::AID-JBM14>3.0.CO;2-K
   Tsao AK, 2005, J BONE JOINT SURG AM, V87A, P22, DOI 10.2106/JBJS.E.00490
   Unger AS, 2005, J ARTHROPLASTY, V20, P1002, DOI 10.1016/j.arth.2005.01.023
   Wigfield C, 2003, BRIT J NEUROSURG, V17, P418, DOI 10.1080/02688690310001611206
NR 32
TC 4
Z9 4
U1 0
U2 2
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD JAN-FEB
PY 2015
VL 30
IS 1
BP 134
EP 142
DI 10.11607/jomi.3692
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CZ6VV
UT WOS:000367240000017
PM 25615921
OA Bronze
DA 2018-10-19
ER

PT J
AU Scarano, A
   Piattelli, A
   Murmura, G
   Iezzi, G
   Assenza, B
   Mancino, C
AF Scarano, Antonio
   Piattelli, Adriano
   Murmura, Giovanna
   Iezzi, Giovanna
   Assenza, Bartolomeo
   Mancino, Carlo
TI Delayed Expansion of the Atrophic Mandible by Ultrasonic Surgery: A
   Clinical and Histologic Case Series
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE alveolar bone loss; alveolar ridge augmentation; bone regeneration; bone
   resorption; piezosurgery
ID LIFE-TABLE ANALYSIS; IMPLANT PLACEMENT; DENTAL IMPLANTS; SPLIT-CREST;
   RIDGE
AB Purpose: Ridge expansion is used to widen narrow ridges with adequate height for implant placement. This human case series presents the clinical and histologic results of delayed expansion of mandibles by ultrasonic surgery. Materials and Methods: Patients with residual alveolar ridge width between 2.3 and 4.1 mm in the coronal area of the posterior mandible were included in the study. First, four linear corticotomies were carried out by ultrasonic surgical device. Four weeks later, adequate bone expansion with a combination of scalpels, thin chisels, and threaded osteotomes that did not compromise cortical vascularization was performed, and two implants per ridge were inserted. Any gaps were filled with corticospongious porcine biomaterial. Three months after implant placement, healing caps were inserted, and bone cores were harvested from the regenerated areas for histologic analysis. Crestal width was recorded at each surgery. Results: The postoperative course was uneventful in all 32 patients (64 implants) who took part in the study, and the implant success rate was 96.88% at 3 months. The mean increase in ridge width was 5.17 +/- 0.86 mm. The histologic specimens showed a mixture of new bone and particles of biomaterial, as well as newly formed bone. Histomorphometry demonstrated that 64% +/- 3.1% of the specimen was composed of newly formed bone, 8% +/- 0.8% was made up of marrow spaces, and 27% +/- 2.6% comprised the residual grafted biomaterial. Conclusion: This study showed that mandibular ridge expansion using a delayed splitcrest technique by means of ultrasonic surgery and association with biomaterial led to good horizontal bone gain, with no fractures of the buccal plate, and a high implant success rate. The histologic specimens showed newly formed bone and good integration of the biomaterial.
C1 [Scarano, Antonio; Murmura, Giovanna; Iezzi, Giovanna] Univ G dAnnunzio, Sch Dent, Chieti, Italy.
   [Piattelli, Adriano] Univ G dAnnunzio, Sch Dent, Oral Pathol & Med, Chieti, Italy.
   [Mancino, Carlo] Univ G dAnnunzio, Chieti, Italy.
RP Scarano, A (reprint author), Via Frentani 98-B, I-66100 Chieti, Italy.
EM ascarano@unich.it
RI Scarano, Antonio/F-6961-2017
OI Scarano, Antonio/0000-0003-1374-6146
FU Ministry of Education, University and Research (M.I.U.R.), Rome, Italy
FX This study was supported by the Ministry of Education, University and
   Research (M.I.U.R.), Rome, Italy. The authors reported no conflicts of
   interest related to this study.
CR Basa S, 2004, INT J ORAL MAX IMPL, V19, P554
   Blus C, 2006, CLIN ORAL IMPLAN RES, V17, P700, DOI 10.1111/j.1600-0501.2006.01206.x
   Buser D, 1990, CLIN ORAL IMPLAN RES, V1, P22, DOI 10.1034/j.1600-0501.1990.010104.x
   Chiapasco M, 2006, CLIN ORAL IMPLAN RES, V17, P265, DOI 10.1111/j.1600-0501.2005.01196.x
   Demarosi F, 2009, BRIT J ORAL MAX SURG, V47, P535, DOI 10.1016/j.bjoms.2008.11.012
   Ferrigno N, 2005, CLIN ORAL IMPLAN RES, V16, P147, DOI 10.1111/j.1600-0501.2005.01125.x
   Jensen OT, 2009, J ORAL MAXIL SURG, V67, P1921, DOI 10.1016/j.joms.2009.04.017
   Nedir R, 2004, CLIN ORAL IMPLAN RES, V15, P150, DOI 10.1111/j.1600-0501.2004.00978.x
   Piattelli A, 1997, BIOMATERIALS, V18, P577, DOI 10.1016/S0142-9612(96)00177-9
   Pikos M A, 2000, Implant Dent, V9, P67, DOI 10.1097/00008505-200009010-00012
   Scarano A, 2011, J IMMUNOPATHOL PHARM, V24, P71
   Scarano A, 2011, CLIN ORAL IMPLAN RES, V22, P1125, DOI 10.1111/j.1600-0501.2010.02083.x
   Scipioni A, 1997, CLIN ORAL IMPLAN RES, V8, P39, DOI 10.1111/j.1600-0501.1997.tb00006.x
   Scipioni A, 1994, Int J Periodontics Restorative Dent, V14, P451
   Selcuk B, 2004, INT J ORAL MAXILLOF, V19, P554
   Sethi A, 2000, INT J ORAL MAX IMPL, V15, P491
   Takahashi T, 2004, INT J ORAL MAX IMPL, V19, P291
NR 17
TC 5
Z9 5
U1 0
U2 2
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD JAN-FEB
PY 2015
VL 30
IS 1
BP 144
EP 149
DI 10.11607/jomi.2753
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CZ6VV
UT WOS:000367240000018
PM 25615922
OA Bronze
DA 2018-10-19
ER

PT J
AU Michida, SMD
   Kimpara, ET
   dos Santos, C
   Souza, ROA
   Bottino, MA
   Ozcan, M
AF de Araujo Michida, Silvia Masae
   Kimpara, Estevao Tomomitsu
   dos Santos, Claudinei
   Assuncao Souza, Rodrigo Othavio
   Bottino, Marco Antonio
   Oezcan, Mutlu
TI Effect of air-abrasion regimens and fine diamond bur grinding on
   flexural strength, Weibull modulus and phase transformation of zirconium
   dioxide
SO JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS
LA English
DT Article
DE Air abrasion; Polishing; Flexural strength; Weibull modulus; Phase
   transformation; Yttria-stabilized tetragonal zirconia
ID PARTICLE ABRASION; DENTAL CERAMICS; TETRAGONAL ZIRCONIA;
   SURFACE-TOPOGRAPHY; BOND STRENGTH; PROTOCOLS; RESTORATIONS; BIOMATERIAL;
   RELIABILITY; CEMENTS
AB Purpose: This study evaluated the effect of air abrasion and polishing regimens on the flexural strength of yttrium stabilized polycrystalline tetragonal zirconia (Y-TZP).
   Methods: From Y-TZP blocks (InCeram 2000 YZ Cubes; Vita Zahnfabrik, Bad Sackingen, Germany) 120 bars (25 mm x 4 mm x 1.2 mm) were obtained according to ISO 6872: 2008 and randomly divided into 4 groups: Group C: (control) without surface treatment (n = 30); Group APA: Air abrasion with aluminum oxide (44 mu m) (n = 30); Group SC: Silica-coating (CoJet, 30 mu m) (n = 30); Group FD: Fine diamond bur (n = 30). Subsequently, all specimens were subjected to 4-point bending test (in distilled water at 37 degrees C) in a universal testing machine (EMIC DL 1000; Sao Jose dos Pinhais, Parana, Brazil); cross-head speed: 0.5 mm/min). The characteristic strength (sigma(0)) of each specimen was obtained from the flexural strength test and evaluated using Weibull analysis. X-ray diffraction analysis was utilized to quantity the monoclinic phase. The surface topography of specimens was analyzed using 3D optical profilometer and scanning electron microscopy (SEM) after surface conditioning methods. The flexural strength data (sigma(4p)) were statistically analyzed by 1-way ANOVA, Tukey test (alpha = 0.05) and Weibull (m = modulus, sigma(0) = characteristic strength) were calculated.
   Results: The mean +/- standard deviations (MPa) of the groups were as follows: C: 1196.2 +/- 284.2(a); APA: 1369.7 +/- 272.3(a); SC: 1207.1 +/- 229.7(a) and FD: 874.4 +/- 365.4(b). The values (m) and (sigma(0)) were as follows: C: 4.5 and 1308.12; APA: 5.9 and 1477.88; SC: 6.0 and 1300.28; and FD: 2.6 and 985.901, respectively.
   Conclusions: Air particle abrasion with neither silica nor alumina showed significant difference compared to the control group but grinding with fine diamond bur impaired the flexural strength of the zirconia tested.
C1 [de Araujo Michida, Silvia Masae] Inga Univ, Sch Dent, Post Grad Program, Maringa, Parana, Brazil.
   [Kimpara, Estevao Tomomitsu; Bottino, Marco Antonio] Sao Paulo State Univ, Sao Jose dos Campos Dent Sch, Dept Dent Mat & Prosthodont, Sao Jose Dos Campos, Brazil.
   [dos Santos, Claudinei] Univ Estado Rio De Janeiro, Dept Mech & Energy, Fac Technol, Resende, Brazil.
   [Assuncao Souza, Rodrigo Othavio] Univ Fed Rio Grande do Norte, Dept Restorat Dent, Div Prosthodont, BR-59072970 Natal, RN, Brazil.
   [Oezcan, Mutlu] Univ Zurich, Ctr Dent & Oral Med, Clin Fixed & Removable Prosthodont & Dent Mat Sci, Dent Mat Unit, CH-8032 Zurich, Switzerland.
RP Ozcan, M (reprint author), Univ Zurich, Ctr Dent & Oral Med, Clin Fixed & Removable Prosthodont & Dent Mat Sci, Dent Mat Unit, Plattenstr 11, CH-8032 Zurich, Switzerland.
EM mutluozcan@hotmail.com
OI Bottino, Marco Antonio/0000-0003-0077-3161
FU Sao Paolo State University
FX The study was supported entirely by Sao Paolo State University.
CR Aboushelib MN, 2005, DENT MATER, V21, P984, DOI 10.1016/j.dental.2005.03.013
   Aboushellib MN, 2007, J PROSTHET DENT, V98, P379, DOI 10.1016/S0022-3913(07)60123-1
   Albert FE, 2004, INT J PROSTHODONT, V17, P529
   [Anonymous], 1999, 69 ANSIADA
   Blatz MB, 2002, QUINTESSENCE INT, V33, P415
   Borges GA, 2003, J PROSTHET DENT, V89, P479, DOI 10.1016/S0022-3913(03)52704-9
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   EVANS AG, 1990, J AM CERAM SOC, V73, P187, DOI 10.1111/j.1151-2916.1990.tb06493.x
   GREEN DJ, 1983, J AM CERAM SOC, V66, pC178, DOI 10.1111/j.1151-2916.1983.tb10543.x
   Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001
   GUPTA TK, 1980, J AM CERAM SOC, V63, P117, DOI 10.1111/j.1151-2916.1980.tb10671.x
   KERN M, 1994, J PROSTHET DENT, V71, P453, DOI 10.1016/0022-3913(94)90182-1
   Kosmac T, 1999, DENT MATER, V15, P426, DOI 10.1016/S0109-5641(99)00070-6
   Kosmac T, 2000, J BIOMED MATER RES, V53, P304, DOI 10.1002/1097-4636(2000)53:4<304::AID-JBM4>3.0.CO;2-S
   KOSMAC T, 1981, J AM CERAM SOC, V64, pC72
   Ozcan M, 2013, J MECH BEHAV BIOMED, V20, P19, DOI 10.1016/j.jmbbm.2013.01.005
   Ozcan M, 2003, DENT MATER, V19, P725, DOI 10.1016/S0109-5641(03)00019-8
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Raigrodski AJ., 2004, DENT CLIN N AM, V48, P531, DOI DOI 10.1016/J.CDEN.2003.12.008
   RITTER JE, 1981, AM CERAM SOC BULL, V60, P798
   Sarmento HR, 2014, ACTA ODONTOL SCAND, V72, P346, DOI 10.3109/00016357.2013.837958
   Scherrer SS, 1996, INT J PROSTHODONT, V9, P580
   Souza ROA, 2013, J MECH BEHAV BIOMED, V26, P155, DOI 10.1016/j.jmbbm.2013.04.018
   SWAIN MV, 1989, J AM CERAM SOC, V72, P1358, DOI 10.1111/j.1151-2916.1989.tb07652.x
   Toraya H., 1984, J AM CERAM SOC, V67, P119
   Xible AA, 2006, J PROSTHET DENT, V95, P224, DOI 10.1016/j.prosdent.2005.12.010
   Xu HHK, 1997, MACH SCI TECHNOL, V1, P49, DOI 10.1080/10940349708945637
   Zhang Y, 2004, J BIOMED MATER RES B, V71B, P381, DOI 10.1002/jbm.b.30097
   Zhang Y, 2006, INT J PROSTHODONT, V19, P442
NR 29
TC 5
Z9 5
U1 1
U2 8
PU WICHTIG PUBL
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PY 2015
VL 13
IS 3
BP E266
EP E273
DI 10.5301/jabfm.5000232
PG 8
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA CZ5QV
UT WOS:000367158000011
PM 26391866
DA 2018-10-19
ER

PT S
AU Li, TT
   Gong, ZQ
   Dong, HY
   Li, XY
AF Li, Tingting
   Gong, Ziqiang
   Dong, Haiying
   Li, Xiaoyun
BE Yarlagadda, P
TI Synthesis and properties of faceted hexagonal hydroxyapatite nanotubes
SO PROCEEDINGS OF THE 3RD INTERNATIONAL CONFERENCE ON MATERIAL, MECHANICAL
   AND MANUFACTURING ENGINEERING
SE AER-Advances in Engineering Research
LA English
DT Proceedings Paper
CT 3rd International Conference on Material, Mechanical and Manufacturing
   Engineering (IC3ME)
CY JUN 27-28, 2015
CL Guangzhou, PEOPLES R CHINA
DE hydroxyapatite; nanorod; nanotube; one-step hydrothermal
ID TEMPLATE
AB Nanoscale hydroxyapatite (HA) is an optimal candidate biomaterial for bone tissue engineering because of its excellent bioactive and osteoconductive properties. Here we have been successfully synthesized the faceted hexagonal hydroxyapatite nanotubes by one-step hydrothermal method. The obtained product microstructure is nanotube with faceted hexagonal. The results of cell culture shows that those novel HA nanatubes are nontoxic for the proliferation of the cell, which gives a great potential for bone repairation.
C1 [Li, Tingting; Gong, Ziqiang; Li, Xiaoyun] Zhejiang Sci Tech Univ, Ctr Nanosci & Nanotechnol, Hangzhou 310018, Peoples R China.
   [Dong, Haiying] Fujian Med Univ, Ningde Hosp, Ningde 352000, Peoples R China.
RP Li, TT (reprint author), Zhejiang Sci Tech Univ, Ctr Nanosci & Nanotechnol, Hangzhou 310018, Peoples R China.
EM 15700198481@163.com; 870013447@qq.com; 359298598@qq.com;
   506598308@qq.com
CR Costa DO, 2012, ACS APPL MATER INTER, V4, P1490, DOI 10.1021/am201735k
   Guo XK, 2014, J MATER CHEM B, V2, P1760, DOI 10.1039/c3tb21652g
   Liu G, 2009, J AM CHEM SOC, V131, P9937, DOI 10.1021/ja903817z
   Yang Z, 2005, J MATER SCI, V40, P1121, DOI 10.1007/s10853-005-6927-z
   Yuan Y, 2008, MATER CHEM PHYS, V112, P275, DOI 10.1016/j.matchemphys.2008.05.068
   Zhao HX, 2011, BIOMATERIALS, V32, P5837, DOI 10.1016/j.biomaterials.2011.04.083
NR 6
TC 0
Z9 0
U1 0
U2 3
PU ATLANTIS PRESS
PI PARIS
PA 29 AVENUE LAVMIERE, PARIS, 75019, FRANCE
SN 2352-5401
BN 978-94-6252-100-1
J9 AER ADV ENG RES
PY 2015
VL 27
BP 399
EP 402
PG 4
WC Engineering, Multidisciplinary; Engineering, Manufacturing; Engineering,
   Mechanical
SC Engineering
GA BE0UT
UT WOS:000367097600078
DA 2018-10-19
ER

PT J
AU Vasilescu, VG
   Stan, MS
   Patrascu, I
   Dinischiotu, A
   Vasilescu, E
AF Vasilescu, Vlad Gabriel
   Stan, Miruna Silvia
   Patrascu, Ion
   Dinischiotu, Anca
   Vasilescu, Elisabeta
TI IN VITRO TESTING OF MATERIALS BIOCOMPATIBILITY WITH CONTROLED CHEMICAL
   COMPOSITION
SO REVISTA ROMANA DE MATERIALE-ROMANIAN JOURNAL OF MATERIALS
LA English
DT Article
DE biomaterial; biocompatibility; cell adhesion; osteoblasts
ID SURFACE-ROUGHNESS; TITANIUM SURFACE; TI ALLOYS; BIOMATERIALS;
   CYTOCOMPATIBILITY; TI-6AL-4V; CORROSION; IMPLANTS; BEHAVIOR; CELLS
AB In vitro testing of materials biocompatibility provides information on cell behavior in relation to chemical composition and surface topography of materials. The studied biomaterial Is a new one proposed to be used in oral implantology and therefore requires studying its biocompatibility compared to conventional materials commonly used in oral implantology.
   The in vitro response Induced by this bioalloy with surface characteristics conferred by casting, corrosion and anodizing was evaluated on G292 human osteoblasts. The experimental obtained surface after anodizing presented a stable and consistent oxide "gel-looking" layer well highlighted in scanning electron microscopy Images. The results demonstrated the ability of the biomaterial to support attachment, growth and proliferation of human osteoblasts. As compared to the other materials tested and demonstrates the improved properties that facilitated rapid cellular adaptation to these surfaces.
C1 [Vasilescu, Vlad Gabriel; Patrascu, Ion] Carol Davila Med & Pharm Univ, Fac Dent, Bucharest 010221, Romania.
   [Stan, Miruna Silvia; Dinischiotu, Anca] Univ Bucharest, Fac Biol, Bucharest 050095, Romania.
   [Vasilescu, Elisabeta] Univ Galatzi, Fac Engn Galati, Galati 800201, Romania.
RP Vasilescu, E (reprint author), Univ Galatzi, Fac Engn Galati, Str Domneasca 111, Galati 800201, Romania.
EM elisabeta.vasilescu@yahoo.com
FU European Social Fund [POSDRU/159/1.5/S/133391]
FX M.S. Stan gratefully acknowledges the support of the European Social
   Fund through the contract POSDRU/159/1.5/S/133391.
CR Anderson J., 2004, BIOMATERIALS SCI INT
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   [Anonymous], 2001, ENG MAT SER, P485
   [Anonymous], 134852012 EN ISO
   Bordji K, 1996, BIOMATERIALS, V17, P929, DOI 10.1016/0142-9612(96)83289-3
   Boyan BD, 2002, CALCIFIED TISSUE INT, V71, P519, DOI 10.1002/s00223-001-1114-y
   CAREW E.O., 2004, BIOMATERIALS SCI INT, P23
   Cremasco A, 2011, MAT SCI ENG C-MATER, V31, P833, DOI 10.1016/j.msec.2010.12.013
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Dima O., 2014, ANN DUNAREA JOS U GA, V1, P8
   Dragan-Raileanu L.A., 2013, ANN ROMANIAN SOC CEL, VXVIII
   Gittens RA, 2012, BIOMATERIALS, V33, P8986, DOI 10.1016/j.biomaterials.2012.08.059
   Gotman I, 1997, J ENDOUROL, V11, P383, DOI 10.1089/end.1997.11.383
   Hadi SA, 2011, BIOL MED, V3, P164
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   Kumar V, 2009, ARCH TOXICOL, V83, P965, DOI 10.1007/s00204-009-0455-6
   Leyensand C., 2004, TITANIUM TITANIUM AL
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Meng WY, 2011, J BIONIC ENG, V8, P234, DOI 10.1016/S1672-6529(11)60031-0
   Morant C, 2003, APPL SURF SCI, V220, P79, DOI 10.1016/S0169-4332(03)00746-3
   Nonami T, 1998, MAT SCI ENG C-BIO S, V6, P281, DOI 10.1016/S0928-4931(98)00063-0
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   Park J. B., 2003, BIOMATERIALS PRINCIP
   Park J. B., 1995, BIOMEDICAL ENG HDB, P537
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Stan MS, 2015, J BIOMED MATER RES A, V103, P48, DOI 10.1002/jbm.a.35148
   VASILESCU V. G., 2014, ANN DUNAREA JOS U GA, P32
   Zareidoost A, 2012, J MATER SCI-MATER M, V23, P1479, DOI 10.1007/s10856-012-4611-9
NR 30
TC 2
Z9 2
U1 0
U2 4
PU SERBAN SOLACOLU FOUNDATION
PI BUCUREST
PA STR GHEORGHE POLIZU NR 1, COD 011061 SECTOR 1, BUCUREST, 00000, ROMANIA
SN 1583-3186
J9 REV ROM MATER
JI Rev. Rom. Mat.
PY 2015
VL 45
IS 4
BP 315
EP 323
PG 9
WC Construction & Building Technology; Materials Science, Multidisciplinary
SC Construction & Building Technology; Materials Science
GA CZ3UP
UT WOS:000367029800002
DA 2018-10-19
ER

PT S
AU Sharipova, A
   Psakhie, SG
   Swain, SK
   Gutmanas, EY
   Gotman, I
AF Sharipova, Aliya
   Psakhie, Sergey G.
   Swain, Sanjaya K.
   Gutmanas, Elazar Y.
   Gotman, Irena
BE Panin, VE
   Psakhie, SG
   Fomin, VM
TI High-Strength Bioresorbable Fe-Ag Nanocomposite Scaffolds: Processing
   and Properties
SO INTERNATIONAL CONFERENCE ON ADVANCED MATERIALS WITH HIERARCHICAL
   STRUCTURE FOR NEW TECHNOLOGIES AND RELIABLE STRUCTURES 2015
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT International Conference on Advanced Materials with Hierarchical
   Structure for New Technologies and Reliable Structures
CY SEP 21-25, 2015
CL Tomsk, RUSSIA
SP Inst Strength Phys & Mat Sci SB RAS, Inst Theorit & Appl Mech SB RAS, Lavrentyev Inst Hydrodynam SB RAS, Inst Metal Superspecial Problems RAS, Fed Agcy Sci Org, Siberian Branch RAS, Tomsk Polytechn Russia, Tomsk State Univ, Inst Continuous Media Mech UrB RAS, Inst Mech Engn Sci UrB RAS, Inst Phys Tech Problems N SB RAS, Inst Problems Chem & Energy Technol SB RAS, Inst Petr Chem SB RAS, Tech Univ Berlin, Univ Stuttgart, Techn Inst Technol, Josef Stefan Inst, Technol Platform Med Future, Technol Platform Light & Reliable Structures, Technol Platform Natl Informat Satelite Syst, Technol Platform Hydrocarbon Extract & Proc Technol, Natl Res Tomsk Polytechn Univ, Natl Res Tomsk State Univ
ID MECHANICAL-PROPERTIES; HIGH-PRESSURE; BONE; HYDROXYAPATITE; IMPLANTS;
   BIOMATERIAL; DEGRADATION; MAGNESIUM; ALLOYS
AB High strength ductile iron-silver nanocomposite scaffolds were fabricated employing high energy attrition milling of micron-submicron powders, followed by cold sintering/high pressure consolidation. Particulate leaching method with soluble Na2SO4 and K2CO3 salts as porogens was used to create scaffolds with 50, 55, 60 and 73% volume fraction of pores. Part of specimens was annealed at 600, 800 and 900 degrees C. Specimens were characterized employing X-ray diffraction, scanning electron microscopy (SEM) with electron probe microanalysis (EDS) and high resolution SEM. Mechanical properties were measured in compression and permeability was measured in permeameter based on Darcy's law. Scaffolds with 50% and 55% porosity exhibited high compressive strength (18-22 MPa), compressive strength of 8-12 MPa was observed for scaffolds with 73% porosity. Treatments at 800 and 900 degrees C result in increase of strength and ductility with some coarsening of microstructure. Best combination of compressive strength (15 MPa) and permeability (0.6(-6) cm(2)) is close to the range of trabecular bone.
C1 [Gutmanas, Elazar Y.] Technion Israel Inst Technol, Dept Mat Sci & Technol, IL-32000 Haifa, Israel.
   [Sharipova, Aliya; Swain, Sanjaya K.; Gutmanas, Elazar Y.; Gotman, Irena] Technion Israel Inst Technol, Dept Mat Sci & Technol, IL-32000 Haifa, Israel.
   [Sharipova, Aliya; Psakhie, Sergey G.] Skolkovo Inst Sci & Technol, Skolkovo 143025, Russia.
   [Psakhie, Sergey G.; Gutmanas, Elazar Y.; Gotman, Irena] Natl Res Tomsk Polytech Univ, Tomsk 634050, Russia.
   [Psakhie, Sergey G.] Inst Strength Phys & Mat Sci SB RAS, Tomsk 634055, Russia.
RP Gutmanas, EY (reprint author), Technion Israel Inst Technol, Dept Mat Sci & Technol, IL-32000 Haifa, Israel.
EM gutmanas@technion.ac.il
RI Psakhie, Sergey/F-1469-2014
CR Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Bohner M, 2000, INJURY, V31, pS37
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   GIBSON LJ, 1985, J BIOMECH, V18, P317, DOI 10.1016/0021-9290(85)90287-8
   Gotman I, 1997, J ENDOUROL, V11, P383, DOI 10.1089/end.1997.11.383
   Gotman I, 2013, ACTA BIOMATER, V9, P8440, DOI 10.1016/j.actbio.2013.05.030
   Gotman I, 2010, ADV ENG MATER, V12, pB320, DOI 10.1002/adem.201080006
   Gutmanas E. Y., 1994, Nanostructured Materials, V4, P893, DOI 10.1016/0965-9773(94)90095-7
   GUTMANAS EY, 1983, POWDER METALL INT, V15, P129
   GUTMANAS EY, 1979, SCRIPTA METALL MATER, V13, P11, DOI 10.1016/0036-9748(79)90380-6
   Haddock SM, 1999, J BIOMED MATER RES, V47, P71, DOI 10.1002/(SICI)1097-4636(199910)47:1<71::AID-JBM10>3.0.CO;2-U
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Ladd A.I, 2003, OPER TECH PLAST RECO, V9, P151, DOI DOI 10.1053/J.OTPR.2003.09.003
   Liao JA, 2010, INT J NANOMED, V5, P261
   Metsger DS, 1999, J MATER SCI-MATER M, V10, P9, DOI 10.1023/A:1008883809160
   Moravej M, 2010, ACTA BIOMATER, V6, P1843, DOI 10.1016/j.actbio.2010.01.008
   Nair LS, 2008, J BONE JOINT SURG AM, V90A, P128, DOI 10.2106/JBJS.G.01520
   Nirmala R., 2010, J NANOPART RES
   Rakovsky A, 2013, J MECH BEHAV BIOMED, V18, P37, DOI 10.1016/j.jmbbm.2012.11.004
   Schinhammer M, 2010, ACTA BIOMATER, V6, P1705, DOI 10.1016/j.actbio.2009.07.039
   Sepulveda P, 2000, J AM CERAM SOC, V83, P3021, DOI 10.1111/j.1151-2916.2000.tb01677.x
   St John Thomas A, 2003, Am J Orthop (Belle Mead NJ), V32, P18
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Vaccaro AR, 2002, CLIN ORTHOP RELAT R, P19
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
NR 28
TC 4
Z9 4
U1 0
U2 3
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1330-6
J9 AIP CONF PROC
PY 2015
VL 1683
AR UNSP 020244
DI 10.1063/1.4932934
PG 7
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA BE0NI
UT WOS:000366393300244
DA 2018-10-19
ER

PT S
AU Nikityuk, DB
   Urakov, AL
   Reshetnikov, AP
   Kopylov, MV
   Baimurzin, DY
AF Nikityuk, D. B.
   Urakov, A. L.
   Reshetnikov, A. P.
   Kopylov, M. V.
   Baimurzin, D. Yu
BE Sadovoy, MA
   Orlov, SN
   Kistenev, YV
   Sharkeev, YP
TI New Operational Techniques of Implantation of Biomaterials and Titanium
   Implants in the Jaw with the Atrophy of the Bone and Soft Tissues
SO NEW OPERATIONAL TECHNOLOGIES (NEWOT'2015)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 5th International Scientific Conference on New Operational Technologies
   (NEWOT)
CY SEP 29-30, 2015
CL Tomsk, RUSSIA
SP Natl Res Tomsk State Univ, Peoples Friendship Univ Russia, Dept Hlth Adm Tomsk Region, Sci Res Inst Microsurgery, Med Future, Russian Acad Sci, Siberian Branch, Inst Strength Phys & Mat Sci, Res Inst Traumatol & Orthoped n a Ya L Tsivyan, Tomsk Canc Res Inst, Tomsk Cardiol Res Inst
AB The research into dynamics of quality of clinical use in 2003 2012 of autologous and xenogeneic biomaterials at dental transplantation and implantation among 1,100 of adult patients was made. The analysis results show that at autologous bone transplantation implant survival is observed only in 72% of cases, and the "necessary" result of bone repair occurred only in 6 9 months. Transplantation of biomaterials of OsteoBiol (R) (materials "mp3", "Genus" and "Evolution") provided engratIment and bone regeneration in 100 % of cases and allowed the use of dental implantation immediately after transplantation even in case of reduction in the patient's alveolar crest down to 2.0 ram Replace Select implants of Nobel Biocare (R) were used at plantation. In order to exclude Schneiderian membrane's perforation lighting of Highmore's sinus with the cold blue-violet light from inside at sinus elevation is recommended as well as deepening of dental instruments into the bone only until the blue-violet light appears under them. To exclude deficiency of soft tissue under the cervical part of the ceramic crown application of special anti-tissure technology involving biomaterial flap dissection and its laying around the implant is suggested.
C1 [Nikityuk, D. B.; Urakov, A. L.; Reshetnikov, A. P.; Kopylov, M. V.; Baimurzin, D. Yu] Izhevsk State Med Acad, Dept Gen & Clin Pharmacol, Russian Minist Hlth, Izhevsk, Russia.
RP Urakov, AL (reprint author), Izhevsk State Med Acad, Dept Gen & Clin Pharmacol, Russian Minist Hlth, Izhevsk, Russia.
EM urakoval@live.ru; areshetnikov@list.ru
RI Urakov, Aleksandr/F-7037-2013; Nikitjuk, Dmitry/G-2079-2017
OI Urakov, Aleksandr/0000-0002-9829-9463; Nikitjuk,
   Dmitry/0000-0002-4968-4517
CR [Anonymous], 2013, OSTEOBIOL TECNOSS BO, P111
   Fabbro M. D., 2004, INT J PERIODONT REST, V24, P565
   Martegani P., 2014, MAXILLARY SINUS AUGM, P71
   Nikityuk D. B., 2015, MODERN PROBLEMS SCI, V4, P1
   Rcshctmkov A. P., 2014, Application for invention RUS No, Patent No. 2563090
   Reshetnikov A.P., 2009, Russian Federation patent, Patent No. [RU 2360640, 2360640]
   Reshetnikov A.P., 2015, Russian Federation patent RU, Patent No. 2558996
   Schold J., 2014, AM J TRANSPLANT, V14, P1251
   Soiher M. G., 2014, THERMOLOGY INT, V2, P60
   Urakov A L, 2014, Invention RU Patent, Patent No. [2533840 C2, 2533840]
   Urakov A.L., 2012, Russian Federation patent, Patent No. [RU 2469640, 2469640]
   Urakov A. L., 2014, INT J APPL FUNDAMENT, V10, P22
   Urban IA, 2010, INT J ORAL MAX IMPL, V25, P1203
NR 13
TC 0
Z9 0
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1335-1
J9 AIP CONF PROC
PY 2015
VL 1688
AR UNSP 080001
DI 10.1063/1.4936064
PG 6
WC Physics, Applied
SC Physics
GA BE0PQ
UT WOS:000366562700073
DA 2018-10-19
ER

PT S
AU Fara, ANKA
   Abdullah, HZ
AF Fara, A. N. K. A.
   Abdullah, H. Z.
BE BinHussain, P
   Bhat, AH
   Chowdhury, S
   Mohamed, NMB
   Othman, F
   BinMamat, O
TI Characterization of Derived Natural Hydroxyapatite (HAp) Obtained From
   Different Types of Tilapia Fish Bones and Scales
SO PROCEEDINGS OF THE 23RD SCIENTIFIC CONFERENCE OF MICROSCOPY SOCIETY
   MALAYSIA (SCMSM 2014)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 23rd Scientific Conference of Microscopy-Society-Malaysia (SCMSM)
CY DEC 10-12, 2014
CL Univ Teknologi Petronas, Tronoh, MALAYSIA
SP Microscopy Soc Malaysia
HO Univ Teknologi Petronas
ID HEAT-TREATMENT; PHOSPHATE; APATITES
AB Hydroxyapatite, (HAp), Ca-10(PO4)(6)(OH)(2), is recognised as a biomaterial that is widely used for bone implant due to its chemical and structural similarity to the mineral components in human bone and enamel. The elements of HAp are primarily composed of calcium and phosphorus molar ratio of calcium to phosphorous is 1.67 capable to promote bone in-growth into prosthetic implant. Enormous amounts of by-product waste produced from fish factories generated an undesirable environmental impact. Thus, this study was conducted to obtain natural biological HAp from different types of tilapia fish bones and scales from fishery waste. Therefore, fish bones and scales can be as cheap source to produce biological HAp for medical applications. For this purpose, fish bones and scales of tilapia fish were boiled at 100 degrees C to remove adhering meat and other impurities. Later, fish bones and scales were separated into several groups and subjected to different calcination temperatures of 800 degrees C and 900 degrees C for 3h respectively. Afterward, all calcined samples were crushed to form a fine powder. The XRD result revealed the presence of derived HAp from the samples powder and were identical with standard HAp. Thermo Gravimetric Analysis was carried out to show the thermal stability of the HAp powder from different types of fish bones and scales. SEM results show porous structure appeared in calcined samples compared to raw samples. The findings are the promising alternative to produce calcium and phosphorus from fishery wastes that beneficial to medical applications.
C1 [Fara, A. N. K. A.; Abdullah, H. Z.] Univ Tun Hussein Onn Malaysia, Fac Mech & Mfg Engn, Batupahat 86400, Johor, Malaysia.
RP Fara, ANKA (reprint author), Univ Tun Hussein Onn Malaysia, Fac Mech & Mfg Engn, Batupahat 86400, Johor, Malaysia.
EM normankhaleez@gmail.com; hasan@uthm.edu.my
CR Akram M, 2014, J MATER SCI, V49, P1461, DOI 10.1007/s10853-013-7864-x
   [Anonymous], 2010, ANN FISHERIES STAT
   Antonakos A, 2007, BIOMATERIALS, V28, P3043, DOI 10.1016/j.biomaterials.2007.02.028
   Boutinguiza M, 2012, MAT SCI ENG C-MATER, V32, P478, DOI 10.1016/j.msec.2011.11.021
   Fang Z, 2014, MAT SCI ENG C-MATER, V43, P145, DOI 10.1016/j.msec.2014.07.015
   Figueiredo M, 2010, CERAM INT, V36, P2383, DOI 10.1016/j.ceramint.2010.07.016
   Haberko K, 2006, J EUR CERAM SOC, V26, P537, DOI 10.1016/j.jeurceramsoc.2005.07.033
   Herliansyah M. K., 2012, P AS PAC INDUSTENG M, P1137
   Huang YC, 2011, CERAM INT, V37, P1825, DOI 10.1016/j.ceramint.2011.01.018
   Lopatin CM, 1998, THIN SOLID FILMS, V326, P227, DOI 10.1016/S0040-6090(98)00531-8
   Mondal S., 2012, J MINERALS MAT CHARA, V11, P55
   MORTIER A, 1989, THERMOCHIM ACTA, V143, P265, DOI 10.1016/0040-6031(89)85065-8
   Nagai T, 2004, INT J FOOD SCI TECH, V39, P239, DOI 10.1111/j.1365-2621.2004.00777.x
   Orlovskii VP, 2002, INORG MATER+, V38, P973, DOI 10.1023/A:1020585800572
   Ozawa M, 2002, J AM CERAM SOC, V85, P1315, DOI 10.1111/j.1151-2916.2002.tb00268.x
   Pena J, 2003, J EUR CERAM SOC, V23, P1687, DOI 10.1016/S0955-2219(02)00369-2
   Rustad T., 2003, J ENV AGR FOOD CHEM, V2, P458
NR 17
TC 0
Z9 0
U1 4
U2 11
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1316-0
J9 AIP CONF PROC
PY 2015
VL 1669
AR 020077
DI 10.1063/1.4919215
PG 6
WC Microscopy; Physics, Applied
SC Microscopy; Physics
GA BE0NN
UT WOS:000366404900077
DA 2018-10-19
ER

PT S
AU Te Chuan, L
   Rathi, MFM
   Abidin, MYZ
   Abdullah, HZ
   Idris, MI
AF Te Chuan, Lee
   Rathi, Muhammad Fareez Mohamad
   Abidin, Muhamad Yusuf Zainal
   Abdullah, Hasan Zuhudi
   Idris, Maizlinda Izwana
BE BinHussain, P
   Bhat, AH
   Chowdhury, S
   Mohamed, NMB
   Othman, F
   BinMamat, O
TI Effect of Applied Voltage on Surface Properties of Anodised Titanium in
   Mixture of beta-Glycerophosphate (beta-GP) and Calcium Acetate (CA)
SO PROCEEDINGS OF THE 23RD SCIENTIFIC CONFERENCE OF MICROSCOPY SOCIETY
   MALAYSIA (SCMSM 2014)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 23rd Scientific Conference of Microscopy-Society-Malaysia (SCMSM)
CY DEC 10-12, 2014
CL Univ Teknologi Petronas, Tronoh, MALAYSIA
SP Microscopy Soc Malaysia
HO Univ Teknologi Petronas
ID OXIDATION; FILMS
AB Anodic oxidation is a surface modification method which combines electric field driven metal and oxygen ion diffusion for formation of oxide layer on the anode surface. This method has been widely used to modify the surface morphology of biomaterial especially titanium. This study aimed to investigate the effect of applied voltage on titanium. Specifically, the titanium foil was anodised in mixture of beta-glycerophosphate disodium salt pentahydrate (beta-GP) and calcium acetate monohydrate (CA) with different applied voltage (50-350 V), electrolyte concentration (0.04 M beta-GP + 0.4 M CA), anodising time (10minutes) and current density (50 and 70 mA.cm(-2)) at room temperature. Surface oxide properties of anodised titanium were characterised by digital single-lens reflex camera (DSLR camera), field emission scanning electron microscope (FESEM) and atomic force microscopy (AFM). At lower applied voltage (<= 150 V), surface of titanium foils were relatively smooth. With increasing applied voltage (>= 250 V), the oxide layer became more porous and donut-shaped pores were formed on the surface of titanium foils. The AFM results indicated that the surface roughness of anodised titanium increases with increasing of applied voltage. The porous and rough surface is able to promote the osseointegration and reduce the suffering time of patient.
C1 [Te Chuan, Lee; Rathi, Muhammad Fareez Mohamad; Abidin, Muhamad Yusuf Zainal; Abdullah, Hasan Zuhudi; Idris, Maizlinda Izwana] Univ Tun Hussein Onn Malaysia, Fac Mech & Mfg Engn, Batu Pahat 86400, Johor, Malaysia.
RP Te Chuan, L (reprint author), Univ Tun Hussein Onn Malaysia, Fac Mech & Mfg Engn, Batu Pahat 86400, Johor, Malaysia.
EM gd130079@siswa.uthm.edu.my; cd110238@siswa.uthm.edu.my;
   cd110221@siswa.uthm.edu.my; hasan@uthm.edu.my; izwana@uthm.edu.my
CR Abdullah HZ, 2007, MATER SCI FORUM, V561-565, P2159, DOI 10.4028/www.scientific.net/MSF.561-565.2159
   Abdullah HZ, 2014, KEY ENG MATER, V594-595, P275, DOI 10.4028/www.scientific.net/KEM.594-595.275
   Abdullah H. Z., 2015, ADV MAT RES, V212-217, P1087
   Abdullah H. Z., 2010, THESIS
   Abdullah H. Z., 2012, ADV MAT RES, V223-228, P545
   Abdullah H. Z., 2007, J AUST CERAM SOC, V125-130, P43
   Cui X, 2009, DENT MATER, V25, P80, DOI 10.1016/j.dental.2008.04.012
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Han Y, 2003, SURF COAT TECH, V168, P249, DOI 10.1016/S0257-8972(03)00016-1
   Kim KH, 2009, DENT MATER J, V28, P20, DOI 10.4012/dmj.28.20
   Kuromoto NK, 2007, MATER CHARACT, V58, P114, DOI [10.1016/j.matchar.2006.03.020, 10.1016/j.matchar.2006.06.020]
   Lane W. A., 1895, BRIT MED J, V861, P1
   Lee T. C., 2015, J ADV MAT RES, V116-120, P1087
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Patel N. R., 2012, INT J EMERG TECH ADV, V91-101, P4
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Yao C., 2006, J NANOSCI NANOTECHNO, V2682-2692, P9
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
NR 18
TC 0
Z9 0
U1 0
U2 0
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1316-0
J9 AIP CONF PROC
PY 2015
VL 1669
AR 020054
DI 10.1063/1.4919192
PG 7
WC Microscopy; Physics, Applied
SC Microscopy; Physics
GA BE0NN
UT WOS:000366404900054
DA 2018-10-19
ER

PT J
AU Steffens, D
   Mathor, MB
   Santi, BTS
   Luco, DP
   Pranke, P
AF Steffens, Daniela
   Mathor, Monica B.
   Santi, Bruna T. S.
   Luco, Dayane P.
   Pranke, Patricia
TI Development of a biomaterial associated with mesenchymal stem cells and
   keratinocytes for use as a skin substitute
SO REGENERATIVE MEDICINE
LA English
DT Article
DE electrospinning; keratinocytes; laminin; scaffolds; skin substitute;
   stem cells; tissue engineering
ID TISSUE ENGINEERING SCAFFOLDS; EXFOLIATED DECIDUOUS TEETH; IN-VITRO
   CHARACTERIZATION; BIOTIC DEGRADATION; POLYLACTIDE FOAMS; NANOFIBERS;
   DIFFERENTIATION; REGENERATION; BIOGLASS(R); COLLAGEN
AB Aim: The present study has aimed to produce a cutaneous substitute, bringing together stem cells (mesenchymal stem cells) and keratinocytes, and an electrospun biomaterial. Materials & methods: Three groups of scaffolds were studied: group 1,poly-DL-lactic acid (PDLLA); group 2, hydrolyzed PDLLA (PDLLA/NaOH) and group 3, PDLLA/Lam - a PDLLA/NaOH scaffold linked to laminin protein. They were characterized by physicochemical and biological parameters. Results: As a result, the scaffolds presented well-formed and randomly distributed fibers. Group 3 showed the greatest hydrophilic characteristics. Group 1 showed a greater degradation rate after 14 days. Groups 2 and 3 presented molecular weight of about 40-50 Da. In general, group 3 showed the best results concerning cell adhesion and viability. Conclusion: This study associated two revolutionary fields, stem cells and nanotechnology, for use in regenerative medicine.
C1 [Steffens, Daniela; Pranke, Patricia] Univ Fed Rio Grande do Sul, Fac Pharm, Hematol & Stem Cell Lab, BR-91501970 Porto Alegre, RS, Brazil.
   [Steffens, Daniela; Santi, Bruna T. S.; Pranke, Patricia] Univ Fed Rio Grande do Sul, Postgrad Program Physiol, BR-90050170 Porto Alegre, RS, Brazil.
   [Mathor, Monica B.] Inst Pesquisas Energet & Nucl, BR-05508000 Sao Paulo, Brazil.
   [Luco, Dayane P.; Pranke, Patricia] Inst Pesquisa Celulas Tronco, Stem Cell Res Inst, BR-90020010 Porto Alegre, RS, Brazil.
RP Steffens, D (reprint author), Univ Fed Rio Grande do Sul, Fac Pharm, Hematol & Stem Cell Lab, BR-91501970 Porto Alegre, RS, Brazil.
EM dani_ste@hotmail.com
RI Mathor, Monica/C-3975-2012
OI Mathor, Monica/0000-0002-7294-9106
FU National Council of Technological and Scientific Development (CNPq);
   CAPES; FAPERGS; Stem Cell Research Institute; International Atomic
   Energy Agency
FX This work was supported by the National Council of Technological and
   Scientific Development (CNPq), CAPES, FAPERGS, Stem Cell Research
   Institute and International Atomic Energy Agency. The authors have no
   other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Bernardi L, 2011, J ENDODONT, V37, P973, DOI 10.1016/j.joen.2011.04.010
   Blaker JJ, 2003, J BIOMED MATER RES A, V67A, P1401, DOI 10.1002/jbm.a.20055
   Boccafoschi F, 2012, J BIOMED MATER RES A, V100A, P2373, DOI 10.1002/jbm.a.34180
   Braghirolli DI, 2014, DRUG DISCOV TODAY, V19, P743, DOI 10.1016/j.drudis.2014.03.024
   Domogatskaya A, 2012, ANNU REV CELL DEV BI, V28, P523, DOI 10.1146/annurev-cellbio-101011-155750
   Fujimori Y, 2006, ANN PLAS SURG, V57, P408, DOI 10.1097/01.sap.0000237057.49772.4f
   Fukushima K, 2013, EUR POLYM J, V49, P706, DOI 10.1016/j.eurpolymj.2012.12.011
   Herson MR, 2001, ARTIF ORGANS, V25, P901, DOI 10.1046/j.1525-1594.2001.06896.x
   Hilmi ABM, 2015, WORLD J STEM CELLS, V7, P428, DOI 10.4252/wjsc.v7.i2.428
   Hussain D, 2010, POLYMER, V51, P3989, DOI 10.1016/j.polymer.2010.06.036
   Jin GR, 2011, ACTA BIOMATER, V7, P3113, DOI 10.1016/j.actbio.2011.04.017
   Junka R, 2013, J BIOMATER TISS ENG, V3, P494, DOI 10.1166/jbt.2013.1110
   Karlsson S, 1998, MACROMOL SYMP, V127, P219, DOI 10.1002/masy.19981270129
   Kim J-E, 2010, ADV ENG MATER, V12, P94
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Lu W, 2012, CELLS TISSUES ORGANS, V195, P197, DOI 10.1159/000324921
   Maquet V, 2004, BIOMATERIALS, V25, P4185, DOI 10.1016/j.biomaterials.2003.10.082
   Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179
   Middelkoop E, 2004, BIOMATERIALS, V25, P1559, DOI 10.1016/S0142-9612(03)00502-7
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Nakagawa H, 2005, BRIT J DERMATOL, V153, P29, DOI 10.1111/j.1365-2133.2005.06554.x
   Nourbakhsh N, 2011, INT J DEV BIOL, V55, P189, DOI 10.1387/ijdb.103090nn
   Powell HM, 2008, BIOMATERIALS, V29, P834, DOI 10.1016/j.biomaterials.2007.10.036
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Tanikawa DYS, 2010, ACTA CIR BRAS, V25, P541, DOI 10.1590/S0102-86502010000600015
   Silva FD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098050
   Steffens D, 2013, J BIOMED NANOTECHNOL, V9, P710, DOI 10.1166/jbn.2013.1571
   Steffens D, 2014, BURNS, V40, P1650, DOI 10.1016/j.burns.2014.03.008
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Sun BK, 2014, SCIENCE, V346, P941, DOI 10.1126/science.1253836
   Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Tsuji H, 2001, BIOMACROMOLECULES, V2, P597, DOI 10.1021/bm010048k
   Acasigua GAX, 2014, CURR STEM CELL RES T, V9, P330, DOI 10.2174/1574888X09666140228123911
   Yamaguchi R, 2007, WOUND REPAIR REGEN, V15, P87, DOI 10.1111/j.1524-475X..2006.00189.x
   Zanatta G, 2012, J BIOMED NANOTECHNOL, V8, P211, DOI 10.1166/jbn.2012.1382
   Zander NE, 2012, ACS APPL MATER INTER, V4, P2074, DOI 10.1021/am300045y
NR 39
TC 4
Z9 5
U1 0
U2 11
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
EI 1746-076X
J9 REGEN MED
JI Regen. Med.
PY 2015
VL 10
IS 8
BP 975
EP 987
DI 10.2217/rme.15.58
PG 13
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA CY7TN
UT WOS:000366612100008
PM 26542841
DA 2018-10-19
ER

PT J
AU Chen, XH
   Zhang, Y
   Yuan, L
   Zhang, H
   Dai, WB
   He, B
   Wang, XQ
   Zhang, Q
AF Chen, Xianhui
   Zhang, Yang
   Yuan, Lan
   Zhang, Hua
   Dai, Wenbing
   He, Bing
   Wang, Xueqing
   Zhang, Qiang
TI The P-glycoprotein inhibitory effect and related mechanisms of thiolated
   chitosan and its S-protected derivative
SO RSC ADVANCES
LA English
DT Article
ID CACO-2 CELL MONOLAYERS; EFFLUX PUMP INHIBITION; IN-VIVO EVALUATION;
   DRUG-DELIVERY; ORAL DELIVERY; MEDIATED EFFLUX; ATPASE ACTIVITY;
   MOLECULAR-MASS; GP; TRANSPORTERS
AB Thiolated polymers have attracted more and more attention for their prominent efflux pump inhibitory properties. The aim of this study was to unravel the P-glycoprotein (P-gp) inhibitory mechanisms mediated by new synthetic thiolated chitosan, chitosan-thioglycolic acid (CS-TGA) and its S-protected derivative (CS-TGA-6MNA). P-gp inhibitory activity was first assessed by determining rhodamine-123 (Rho-123) accumulation in Caco-2 cells, transportation across Caco-2 cell monolayers and across freshly excised rat intestine after exposure to CS-TGA or CS-TGA-6MNA. The results showed that after incubation with CS-TGA or CS-TGA-6MNA, a significant increase in intracellular Rho-123 level was observed in Caco-2 cells, more transportation in the absorptive (AP -> BL) direction and less transportation in the secretory (BL -> AP) direction of Rho-123 was observed in Caco-2 cell monolayers compared with DMEM solution control. In freshly excised rat intestine transportation, more Rho-123 was transported in a concentration-dependent manner. Then the P-gp inhibitory mechanisms were evaluated from four aspects: P-gp expression level, P-gp ATPase activity, intracellular ATP level and plasma membrane fluidity. No obvious changes in P-gp expression or intracellular ATP level were detected after exposure. However, the plasma membrane fluidization decreased and the P-gp ATPase activity reduced, which might contribute to the P-gp inhibitory effect. These features suggested this novel biomaterial might contribute to enhance the oral bioavailability of P-gp substrate drugs, such as cyclosporine A and paclitaxel.
C1 [Chen, Xianhui; Zhang, Yang; Zhang, Hua; Dai, Wenbing; He, Bing; Wang, Xueqing; Zhang, Qiang] Peking Univ, Beijing Key Lab Mol Pharmaceut & New Drug Deliver, Sch Pharmaceut Sci, Beijing 100191, Peoples R China.
   [Yuan, Lan] Peking Univ, Med & Hlth Analyt Ctr, Beijing 100191, Peoples R China.
   [Zhang, Qiang] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China.
RP Wang, XQ (reprint author), Peking Univ, Beijing Key Lab Mol Pharmaceut & New Drug Deliver, Sch Pharmaceut Sci, Beijing 100191, Peoples R China.
EM wangxq@bjmu.edu.cn
FU National Natural Science Foundation of China [81273456, 81473159];
   National Basic Research Program of China [2015CB932100]
FX Andreas Bernkop-Schnurch (Institute of Pharmacy, University of
   Innsbruck) is acknowledged for his leading me to the research field of
   thiomers. This study was supported by the National Natural Science
   Foundation of China (No. 81273456, 81473159) and the National Basic
   Research Program of China (No. 2015CB932100).
CR Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750
   Anderle P, 1998, J PHARM SCI, V87, P757, DOI 10.1021/js970372e
   Barthelmes J, 2013, NANOMEDICINE-UK, V8, P65, DOI [10.2217/NNM.12.76, 10.2217/nnm.12.76]
   Batrakova EV, 2004, PHARM RES, V21, P2226, DOI 10.1007/s11095-004-7675-5
   Batrakova EV, 2001, J PHARMACOL EXP THER, V299, P483
   Baumert C, 2009, ANTI-CANCER AGENT ME, V9, P415, DOI 10.2174/1871520610909040415
   Bernkop-Schnurch A., 2006, AM J DRUG DELIV, V4, P263
   Chuan XX, 2014, MOL PHARMACEUT, V11, P3656, DOI 10.1021/mp500399j
   Colabufo NA, 2010, J MED CHEM, V53, P1883, DOI 10.1021/jm900743c
   Collnot EM, 2007, MOL PHARM, V4, P465, DOI 10.1021/mp060121r
   Constantinides PP, 2007, J PHARM SCI-US, V96, P235, DOI 10.1002/jps.20780
   Dunnhaupt S, 2012, CARBOHYD POLYM, V90, P765, DOI 10.1016/j.carbpol.2012.05.028
   Dunnhaupt S, 2012, MOL PHARMACEUT, V9, P1331, DOI 10.1021/mp200598j
   Foger F, 2006, BIOMATERIALS, V27, P5855, DOI 10.1016/j.biomaterials.2006.08.004
   Foger F, 2006, BIOMATERIALS, V27, P4250, DOI 10.1016/j.biomaterials.2006.03.033
   Grabovac V, 2015, INT J PHARMACEUT, V493, P374, DOI 10.1016/j.ijpharm.2015.05.079
   Greindl M, 2009, EUR J PHARM BIOPHARM, V72, P561, DOI 10.1016/j.ejpb.2009.03.008
   HILGERS AR, 1990, PHARMACEUT RES, V7, P902, DOI 10.1023/A:1015937605100
   Hugger ED, 2002, J PHARM SCI, V91, P1980, DOI 10.1002/jps.10175
   Ijaz M, 2015, EXPERT OPIN DRUG DEL, V12, P1269, DOI 10.1517/17425247.2015.1005598
   Krishna R, 2000, EUR J PHARM SCI, V11, P265, DOI 10.1016/S0928-0987(00)00114-7
   Lin D. J. H., 2003, CLIN PHARMACOKINET, V42, P59
   Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012
   Palmberger TF, 2015, INT J PHARMACEUT, V491, P318, DOI 10.1016/j.ijpharm.2015.06.023
   Rege BD, 2002, EUR J PHARM SCI, V16, P237, DOI 10.1016/S0928-0987(02)00055-6
   Risovic V, 2004, DRUG DEV IND PHARM, V30, P767, DOI 10.1081/DDC-120039793
   Sakloetsakun D, 2011, DRUG DEV IND PHARM, V37, P648, DOI 10.3109/03639045.2010.534484
   Schmitz T, 2008, DRUG DELIV, V15, P245, DOI 10.1080/10717540802006708 
   Shaik N, 2008, J PHARM SCI-US, V97, P5421, DOI 10.1002/jps.21372
   Shukla S, 2009, DRUG METAB DISPOS, V37, P359, DOI 10.1124/dmd.108.024612
   Summers MA, 2004, ANN PHARMACOTHER, V38, P1631, DOI 10.1345/aph.1E068
   Trapani A, 2014, BIOMACROMOLECULES, V15, P882, DOI 10.1021/bm401733p
   Werle M, 2006, J CONTROL RELEASE, V111, P41, DOI 10.1016/j.cornel.2005.11.011
   Werle M, 2008, PHARM RES, V25, P500, DOI 10.1007/s11095-007-9347-8
   Werle M, 2009, J PHARM SCI-US, V98, P1643, DOI 10.1002/jps.21550
   Yang Jian-sheng, 2014, Yaoxue Xuebao, V49, P942
   Zhao B, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-47
   Zhu X, 2012, MOL VIS, V18, P1973
NR 38
TC 0
Z9 0
U1 3
U2 15
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 126
BP 104228
EP 104238
DI 10.1039/c5ra19418k
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA CY5FO
UT WOS:000366433700057
DA 2018-10-19
ER

PT J
AU Parazzi, V
   Lavazza, C
   Boldrin, V
   Montelatici, E
   Pallotti, F
   Marconi, M
   Lazzari, L
AF Parazzi, Valentina
   Lavazza, Cristiana
   Boldrin, Valentina
   Montelatici, Elisa
   Pallotti, Francesco
   Marconi, Maurizio
   Lazzari, Lorenza
TI Extensive Characterization of Platelet Gel Releasate From Cord Blood in
   Regenerative Medicine
SO CELL TRANSPLANTATION
LA English
DT Article
DE Adipose mesenchymal stem cells; Human cord blood; Human peripheral
   blood; Platelet gel; Proteome array
ID MESENCHYMAL STEM-CELLS; RICH PLASMA PRP; IN-VITRO; CHEMOKINE RECEPTORS;
   ANGIOGENESIS; DIFFERENTIATION; GROWTH; ERYTHROPOIETIN; PROLIFERATION;
   INFLAMMATION
AB Platelet gel derived from peripheral blood is widely applied in many clinical fields of surgery as biomaterial containing growth factors with high proliferative properties. In 2010, we studied and patented a platelet gel derived from cord blood. In this study, due to the crucial role of the factors released by the platelet gel, we first extended the characterization of its releasate. Using a wide proteomic array and splitting the two components of the releasate, that is, platelets and plasma, we have been able to study their growth factor content. Interestingly, we discovered high levels of hormones and molecules able to support tissue growth in the cord blood platelet gel releasate and, in addition, higher concentrations of several angiogenic factors if compared with the peripheral blood counterpart. On the contrary, the latter was much richer in inflammatory factors. The second aim of our work was to study the effects on cell culture, immunophenotype, and function of mesenchymal stem cells exposed to these two platelet gel releasates as substitute for the animal serum. Since our findings nicely show that the use of the peripheral versus the cord blood platelet gel releasate can differently influence the mesenchymal stem cell commitment, we can suggest that in addition to its peculiar angiogenic properties cord blood platelet gel releasate shows excellent proliferative properties as cell culture supplement.
C1 [Parazzi, Valentina; Lavazza, Cristiana; Boldrin, Valentina; Montelatici, Elisa; Lazzari, Lorenza] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Unit Cellular Therapy & Cryobiol, Cell Factory, I-20122 Milan, Italy.
   [Pallotti, Francesco] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Anat Pathol Unit, I-20122 Milan, Italy.
   [Marconi, Maurizio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Ctr Blood Transfus, I-20122 Milan, Italy.
RP Lazzari, L (reprint author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Unit Cellular Therapy & Cryobiol, Cell Factory, Via F Sforza 35, I-20122 Milan, Italy.
EM lorenza.lazzari@policlinico.mi.it
RI Lazzari, Lorenza/J-4279-2015; Montelatici, Elisa/O-1404-2015
OI Lazzari, Lorenza/0000-0002-9434-4538; Montelatici,
   Elisa/0000-0002-0717-2695; Lavazza, Cristiana/0000-0002-1167-6167;
   BOLDRIN, VALENTINA/0000-0003-1802-1603
FU Regione Lombardia [PB 0098]; Ministero della Salute Italiano [R.F.G.R.
   2010-2318448, R.F.G.R. 2010-2312573]; European Union [241879]
FX The authors would like to thank Paolo Rebulla for his scientific support
   in developing the Cord Blood Platelet Gel project. We are also grateful
   to the Milano Cord Blood group for their help in providing cord blood
   units. This work was partially supported by funds from Regione Lombardia
   (PB 0098), from Ministero della Salute Italiano ("Young Researchers"
   grants: R.F.G.R. 2010-2318448, R.F.G.R. 2010-2312573), and from European
   Union's Seventh Programme (Grant Agreement No. 241879). All these funds
   cooperated to support this study mainly covering the salaries of the
   authors involved in this research. Valentina Parazzi and Lorenza Lazzari
   declare their role as inventors in patent No. PCT WO/2010/007502
   "Platelet fraction deriving from placental blood." The other authors
   declare no conflicts of interest.
CR Albanese A, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-23
   Bernuzzi G, 2013, BLOOD TRANSFUS, V3, P1
   Boswell SG, 2012, ARTHROSCOPY, V28, P429, DOI 10.1016/j.arthro.2011.10.018
   Brand A, 2008, VOX SANG, V95, P335, DOI 10.1111/j.1423-0410.2008.01106.x
   Burnouf T, 2009, ISBT SCI SER, V4, P136, DOI 10.1111/j.1751-2824.2009.01222.x
   Caimi PF, 2010, CURR OPIN HEMATOL, V17, P505, DOI 10.1097/MOH.0b013e32833e5b18
   Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200
   Corbacho AM, 2002, J ENDOCRINOL, V173, P219, DOI 10.1677/joe.0.1730219
   Creeper F, 2009, J PERIODONTAL RES, V44, P258, DOI 10.1111/j.1600-0765.2008.01125.x
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Di Renzo GC, 2005, CURR OPIN OBSTET GYN, V17, P598, DOI 10.1097/01.gco.0000191899.84567.4d
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Folman CC, 2000, THROMB HAEMOSTASIS, V83, P923
   Frith JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082931
   Gear ARL, 2003, MICROCIRCULATION, V10, P335, DOI 10.1038/sj.mn.7800198
   GEORGE JN, 1988, BLOOD, V72, P362
   Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3
   Iudicone P, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-28
   Jo CH, 2011, ACTA ORTHOP BELG, V77, P676
   Kertesz N, 2004, DEV BIOL, V276, P101, DOI 10.1016/j.ydbio.2004.08.025
   Kilan K. A., 2010, P NATL ACAD SCI USA, V107, P4872
   Langer HF, 2008, BASIC RES CARDIOL, V103, P299, DOI 10.1007/s00395-008-0721-4
   Li Yon-hong, 2008, Zhonghua Xinxueguanbing Zazhi, V36, P266
   Liurba E., 2013, EUR HEART J, V35, P701
   Lo Cicero V, 2008, CELL PROLIFERAT, V41, P460, DOI 10.1111/j.1365-2184.2008.00533.x
   Lohmann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037839
   Madla W, 2012, VOX SANG, V102, P116, DOI 10.1111/j.1423-0410.2011.01518.x
   Mark P, 2013, STEM CELLS INT, V2013, DOI DOI 10.1155/2013.698076
   Mazzucco L, 2008, VOX SANG, V94, P202, DOI 10.1111/j.1423-0410.2007.01027.x
   Middleton Kellie K, 2012, Iowa Orthop J, V32, P150
   Morigi M, 2010, STEM CELLS, V28, P513, DOI 10.1002/stem.293
   Moroz A, 2013, CYTOTHERAPY, V15, P1436, DOI 10.1016/j.jcyt.2013.05.019
   Mu H, 2006, CARDIOVASC RES, V70, P146, DOI 10.1016/j.cardiores.2006.01.015
   Murphy MB, 2012, BIOMATERIALS, V33, P5308, DOI 10.1016/j.biomaterials.2012.04.007
   Nagaishi VS, 2014, NEUROSCIENCE, V259, P71, DOI 10.1016/j.neuroscience.2013.11.050
   Ojala M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048659
   Parazzi V, 2010, PLATELETS, V21, P549, DOI 10.3109/09537104.2010.514626
   Ragni E, 2013, J CELL MOL MED, V17, P168, DOI 10.1111/j.1582-4934.2012.01660.x
   Rodrigues S, 2003, FASEB J, V17, P7, DOI 10.1096/fj.02-0201com
   Rosso L., 2013, BLOOD TRANSFUS, V14, P1
   Santos-Martinez MJ, 2008, THROMB RES, V121, P535, DOI 10.1016/j.thromres.2007.06.002
   Schieving JH, 2014, EUR J PAEDIATR NEURO, V18, P243, DOI 10.1016/j.ejpn.2013.09.003
   Sirchia G, 1998, BONE MARROW TRANSPL, V21, P843
   Smalley DM, 2007, THROMB HAEMOSTASIS, V97, P67, DOI 10.1160/TH06-02-0066
   Stockmann C, 2006, CLIN EXP PHARMACOL P, V33, P968, DOI 10.1111/j.1440-1681.2006.04474.x
   Tamama K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795385
   Ullah M., 2013, STEM CELL RES THER, V4, P99
   van der Valk J, 2010, TOXICOL IN VITRO, V24, P1053, DOI 10.1016/j.tiv.2010.03.016
   White GE, 2013, PHARMACOL REV, V65, P47, DOI 10.1124/pr.111.005074
   Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba
   Zhang D, 2013, BIOMATERIALS, V34, P3962, DOI 10.1016/j.biomaterials.2013.02.029
   Zhang YZ, 2014, METHODS MOL BIOL, V1105, P43, DOI 10.1007/978-1-62703-739-6_4
NR 52
TC 6
Z9 7
U1 0
U2 4
PU COGNIZANT COMMUNICATION CORP
PI PUTNAM VALLEY
PA 18 PEEKSKILL HOLLOW RD, PO BOX 37, PUTNAM VALLEY, NY 10579 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2015
VL 24
IS 12
BP 2573
EP 2584
DI 10.3727/096368915X687471
PG 12
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA CY1UR
UT WOS:000366193900012
PM 25695232
OA Bronze
DA 2018-10-19
ER

PT J
AU Fernandez-Lacruz, R
   Di Fulvio, F
   Athanassiadis, D
   Bergstrom, D
   Nordfjell, T
AF Fernandez-Lacruz, Raul
   Di Fulvio, Fulvio
   Athanassiadis, Dimitris
   Bergstrom, Dan
   Nordfjell, Tomas
TI Distribution, characteristics and potential of biomass-dense thinning
   forests in Sweden
SO SILVA FENNICA
LA English
DT Article
DE early thinning; small-tree harvesting; unthinned stand; GIS; wood fuel;
   bioenergy; biomaterial
ID LAND ABANDONMENT; YOUNG FORESTS; BIRCH STANDS; ENERGY-WOOD; SYSTEMS;
   COST; FINLAND; SIMULATION; CHIPS; FUEL
AB Understanding the characteristics of unutilized biomass resources, such as small-diameter trees from biomass-dense thinning forests (BDTF) (non-commercially-thinned forests), can provide important information for developing a bio-based economy. The aim of this study was to describe the areal distribution, characteristics (biomass of growing stock, tree height, etc.) and harvesting potential of BDTF in Sweden. A national forest inventory plot dataset was imported into a geographical information system and plots containing BDTF were selected by applying increasingly stringent constraints. Results show that, depending on the constraints applied, BDTF covers 9-44% (2.1-9.8 M ha) of the productive forest land area, and contains 7-34% of the total growing stock (119-564 M OD t), with an average biomass density of 57 OD t ha-1. Of the total BDTF area, 65% is located in northern Sweden and 2% corresponds to set-aside farmlands. Comparisons with a study from 2008 indicate that BDTF area has increased by at least 4% (about 102 000 ha), in line with general trends for Sweden and Europe. Analyses revealed that the technical harvesting potential of delimbed stemwood (over bark, including tops) from BDTF ranges from 3.0 to 6.1 M OD t yr(-1) (7.5 to 15.1 M m(3) yr(-1)), while the potential of whole-tree harvesting ranges from 4.3 to 8.7 M OD t yr(-1) (10.2 to 20.6 M m(3) yr(-1)) depending on the scenario considered. However, further technological developments of the harvest and supply systems are needed to utilize the full potential of BDTF.
C1 [Fernandez-Lacruz, Raul; Di Fulvio, Fulvio; Athanassiadis, Dimitris; Bergstrom, Dan; Nordfjell, Tomas] Swedish Univ Agr Sci SLU, Dept Forest Biomat & Technol SBT, SE-90183 Umea, Sweden.
   [Di Fulvio, Fulvio] Int Inst Appl Syst Anal, Ecosyst Serv & Management Program ESM, A-2361 Laxenburg, Austria.
RP Fernandez-Lacruz, R (reprint author), Swedish Univ Agr Sci SLU, Dept Forest Biomat & Technol SBT, SE-90183 Umea, Sweden.
EM raul.fernandez@slu.se
RI Fernandez-Lacruz, Raul/E-4472-2015
OI Fernandez-Lacruz, Raul/0000-0001-9284-8911
FU Swedish national research programme Efficient Forest Fuel Systems (ESS);
   European Union Seventh Framework Programme (FP7) [311881]; project
   INFRES (Innovative and Effective Technology and Logistics for Forest
   Residual Biomass Supply in the EU); project Forest Refine (part of the
   Botnia-Atlantica Programme)
FX We gratefully acknowledge the financial support from the Swedish
   national research programme Efficient Forest Fuel Systems (ESS), the
   European Union Seventh Framework Programme (FP7/2012-2015) under grant
   agreement no 311881 financing the research project INFRES (Innovative
   and Effective Technology and Logistics for Forest Residual Biomass
   Supply in the EU) and the project Forest Refine (part of the
   Botnia-Atlantica Programme).
CR Anttila P, 2013, WORK PAP FINN FOR RE, V267, P24
   Axelsson AL, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P541, DOI 10.1007/978-90-481-3233-1_35
   Belbo H, 2014, FORESTS, V5, P2084, DOI 10.3390/f5092084
   Berg S, 1992, TERRAIN CLASSIFICATI
   Bergstrom D., 2009, ACTA U AGR SUECIAE, V87
   Bergstrom D., 2015, SKOG KLIMAT MILJO PR
   Bergstrom D., 2014, INT J FOREST ENG, V25, P156, DOI [http://dx.doi.org/10.1080/14942119.2014.945697, DOI 10.1080/14942119.2014.945697]
   Bergstrom D, 2007, SILVA FENN, V41, P137, DOI 10.14214/sf.311
   Bergstrom D, 2014, SCAND J FOREST RES, V29, P793, DOI 10.1080/02827581.2014.976590
   Claesson S., 1999, FOREST RES B, V210
   Di Fulvio F., 2013, INT J FOREST ENG, V24, P2, DOI DOI 10.1080/14942119.2013.798935
   Di Fulvio F., 2011, 3432011 SWED U AGR S
   Di Fulvio F, 2011, SCAND J FOREST RES, V26, P339, DOI 10.1080/02827581.2011.568951
   Direct Knowledge (Kunskap Direkt), 2012, ROJ NAR BOR ROJN GOR
   Emanuelsson U., 2014, FOR CLIM ENV SKM FIN
   Enstrom J., 2013, 8132013 FOR RES I SW
   Fernandez-Lacruz R, 2013, SILVA FENN, V47, DOI 10.14214/sf.904
   Food and Agriculture Organization (FAO), 2014, GLOB FOR RES ASS FRA
   Fridman J., 2011, MORKNAR BYGDERNA SKO, P4
   Gellrich M, 2007, AGR ECOSYST ENVIRON, V118, P93, DOI 10.1016/j.agee.2006.05.001
   Heikkila J, 2009, SILVA FENN, V43, P129, DOI 10.14214/sf.220
   Junden L., 2013, INT J FOREST ENG, V24, P16, DOI DOI 10.1080/14942119.2013.798131
   Jylha P., 2011, THESIS, V133, DOI [http://dx.doi.org/10.14214/df.133, DOI 10.14214/DF.133]
   Jylha P, 2015, BIOMASS BIOENERG, V75, P272, DOI 10.1016/j.biombioe.2015.02.027
   Karha K., 2005, International Journal of Forest Engineering, V16, P15
   Karlsson L., 2013, THESIS
   Karttunen K., 2015, THESIS, DOI [http://dx.doi.org/10.14214/df.186, DOI 10.14214/DF.186]
   Kons K., 2014, INT J FOREST ENG, V25, P238, DOI [http://dx.doi.org/10.1080/14942119.2014.980494, DOI 10.1080/14942119.2014.980494]
   Laitila J, 2008, SILVA FENN, V42, P267, DOI 10.14214/sf.256
   Laitila J, 2010, SILVA FENN, V44, P465, DOI 10.14214/sf.143
   Larsson F., 2013, WECALC WOOD ENERGY C
   Lundstrom A., 2009, DEFINITIONER TILLGAN
   MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335
   Marklund L. G., 1988, 45 SWED U AGR SCI DE
   Matisons M., 2014, 182014 SWED U AGR SC
   Melin Y., 2014, THESIS
   Nilsson P., 2011, SKOGSDATA AKTUELLA U
   Nordfjell T., 2008, Proceedings of the World Bioenergy Conference and Exhibition on Biomass for Energy, Jonkoping, Sweden, 27-29 May 2008, P323
   Oikari M, 2010, SILVA FENN, V44, P481, DOI 10.14214/sf.144
   Pasanen K., 2014, INT J FOREST ENG, V25, P51, DOI DOI 10.1080/14942119.2014.903614
   Petty A., 2014, DISSERTATIONES FORES, V173, DOI [http://dx.doi.org/10.14214/df.175, DOI 10.14214/DF.175]
   Raisanen T., 2013, POTENTIAL DISTRIBUTI
   Ranta T, 2005, BIOMASS BIOENERG, V28, P171, DOI 10.1016/j.biombioe.2004.08.010
   Ranta T, 2011, BIOMASS BIOENERG, V35, P1841, DOI 10.1016/j.biombioe.2011.01.029
   Ringman M., 1996, 250 SWED U AGR SCI D
   Romero-Calcerrada R, 2004, LANDSCAPE URBAN PLAN, V66, P217, DOI 10.1016/S0169-2046(03)00112-9
   Roser D., 2012, DISSERTATIONES FORES, V146, DOI [http://dx.doi.org/10.14214/df.146, DOI 10.14214/DF.146]
   Routa J., 2013, ENERGY ENV, V2, P602, DOI DOI 10.1002/WENE.24
   Sangstuvall L, 2012, SCAND J FOREST RES, V27, P56, DOI 10.1080/02827581.2011.628335
   Statistics Sweden (Statistika Centralbyran SCB), 2014, 201409 SCB ES
   Swedish Bioenergy Association (Svebio), 2013, SWED EN SUPPL NOW 50
   Swedish Bioenergy Association (Svebio), 2014, BIOEN SWED COUNTR RE
   Swedish Board of Agriculture (Jordbruksverket), 2015, US AGR LAND 2014 FIN
   Swedish Energy Agency, 2015, EN SIFFR 2015
   Swedish Energy Agency (Energymyndigheten), 2012, ER201209 SWED EN AG
   Swedish Energy Agency (Energymyndigheten), 2013, ET201316 SWED EN AG
   Swedish Forest Agency (Skogsstyrelsen), 2014, DEF LAND US
   Swedish Forest Agency (Skogsstyrelsen), 2014, SWED STAT YB FISH SI
   Thornqvist T., 1986, 180 SWED U AGR SCI D
   Tomppo E, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P185, DOI 10.1007/978-90-481-3233-1_11
   Tucker G., 2010, FARMLAND ABANDONMENT
   Ulvcrona K.A., 2011, THESIS
   Varmola M, 2004, SCAND J FOREST RES, V19, P142, DOI 10.1080/02827580310019545
   VMF Qbera, 2012, MATNING AV MASSAVED
   Windisch J., 2015, DISSERTATIONES FORES, V189, DOI [http://dx.doi.org/10.14214/df.189, DOI 10.14214/DF.189]
NR 65
TC 5
Z9 6
U1 1
U2 13
PU FINNISH SOC FOREST SCIENCE-NATURAL RESOURCES INST FINLAND
PI VANTAA
PA PO BOX 18, FI-01301 VANTAA, FINLAND
SN 0037-5330
EI 2242-4075
J9 SILVA FENN
JI Silva. Fenn.
PY 2015
VL 49
IS 5
AR 1377
DI 10.14214/sf.1377
PG 17
WC Forestry
SC Forestry
GA CX5YQ
UT WOS:000365778800009
DA 2018-10-19
ER

PT J
AU Gonsior, M
   Kustosz, R
   Koscielniak-Ziemniak, M
   Wierzchon, T
AF Gonsior, M.
   Kustosz, R.
   Koscielniak-Ziemniak, M.
   Wierzchon, T.
TI BIOCOMPATIBLE EVALUATION OF BIOMATERIALS USED IN THE NEW POLISH
   EXTRACORPOREAL PULSATILE HEART ASSIST DEVICE RELIGAHEART EXT
SO ARCHIVES OF METALLURGY AND MATERIALS
LA English
DT Article
DE biomaterial biocompatybility evaluation; ventricular assist device;
   polyurethanes; diffusive layers; titanium nitride
AB The innovative extracorporeal heart support device ReligaHeart (RH EXT) has been developed, based on POLVAD ventricular assist device clinical experience, collected in more than 300 patient applications. The innovative surface engineering technologies are applied in ReligaHeart EXT device. The pump is manufactured of new generation, modified surface structure, biocompatible polyurethanes, and equipped with original tilting disc valves, Moll type. The valve ring is made of titanium alloy, TiN+Ti2N+alpha Ti(N) diffusive layer modified, produced with glow discharge at plasma potential, in order to obtain the lowest thrombogenicity. The valve disc is made of polyether ether ketone. The complex in vitro and in vivo biological evaluations were performed, confirming both biomaterials biocompatible properties and device biocompatibility, proved in 30 days animal heart support.
C1 [Gonsior, M.; Kustosz, R.; Koscielniak-Ziemniak, M.] Prof Zbigniew Religa Fdn Cardiac Surg Dev, Artificial Heart Lab, PL-41800 Zabrze, Poland.
   [Wierzchon, T.] Warsaw Univ Technol, Fac Mat Sci & Engn, PL-02507 Warsaw, Poland.
RP Gonsior, M (reprint author), Prof Zbigniew Religa Fdn Cardiac Surg Dev, Artificial Heart Lab, 345A Wolnosci Str, PL-41800 Zabrze, Poland.
EM gosiag@frk.pl
CR Gawlikowski M., 2013, POSTEPY INZYNIERII B
   Gonsior M., 2009, INZYNIERIA BIOMATERI, VXII
   Gonsior M., 2011, INZYNIERIA BIOMATERI, V14, P102
   Gonsior M., 2013, POLSKIE PROTEZY SERC
   Gonsior M., 2010, KOMPOZYTY, V3, P175
   Gonsior M., 2009, P BIOM AFR PRET S AF
   Kapis A., 2013, POLSKIE PROTEZY SERC
   Religa G., 2013, POLSKIE PROTEZY SERC
   Szuber A., 2013, POSTEPY INZYNIERII B
   Szuber A., 2013, POLSKIE PROTEZY SERC
NR 10
TC 1
Z9 1
U1 1
U2 6
PU POLSKA AKAD NAUK, POLISH ACAD SCIENCES, INST METALL & MATER SCI PAS
PI WARSZAWA
PA PL, 00-901 WARSZAWA, POLAND
SN 1733-3490
EI 2300-1909
J9 ARCH METALL MATER
JI Arch. Metall. Mater.
PY 2015
VL 60
IS 3
BP 2271
EP 2278
DI 10.1515/amm-2015-0374
PG 8
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA CW9YL
UT WOS:000365354000101
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Major, R
AF Major, R.
TI BIO-INSPIERED BLOOD-CONTACTING MATERIALS ELABORATED FOR THE HEART ASSIST
   SYSTEM
SO ARCHIVES OF METALLURGY AND MATERIALS
LA English
DT Article
DE Surface modification; cell-material interaction; tissue precursors;
   materials for regenerative medicine
ID POLYELECTROLYTE MULTILAYER FILMS; SURFACE-ROUGHNESS; TITANIUM IMPLANT;
   NANOMETER-SCALE; CELL-ADHESION; THIN-FILMS; COATINGS; DEPOSITION;
   GROWTH; DISCHARGES
AB The paper presents the main achievements of the author on the development of blood contacting materials. The main objective of the work is to elaborate materials dedicated for the heart support systems. Appropriately designed biomaterial surfaces enable fully controlled cellular differentiation, proliferation, and even restoration of the tissue structure on solids. The paper presents two approaches to modify the surface, which can control the life processes of tissue. The first solution considers the topography in the form of cell niches. The main objective of the study is a modified surface of thin films deposited on the polymer substrate constituting the microenvironment for the cells caused by residual stress and optimized stiffness of the surface using the plasma methods. The research hypothesis was the plasma surface modification method generating a controlled contribution of residual stress in the coating affect the surface topography in the form of nano- wrinkles similar to the niches in the tissue environment. Topography and stiffness of the surface coating allows the targeted cellular differentiation. The properly formed surface topography effectively inhibits blood clotting processes. The second solution considers implementation of self-organizing feature of extracellular matrix like coatings and selective cell mobilization. The multiscale analysis and phenomenologic description were performed to experimental research. For this purpose, the deposition method was based on electrostatic interactions in polyelectrolytes. This type of cell-polymer structure imitate the native structures.
C1 [Major, R.] Polish Acad Sci, Inst Met & Mat Sci, PL-30059 Krakow, Poland.
RP Major, R (reprint author), Polish Acad Sci, Inst Met & Mat Sci, 25 Reymonta Str, PL-30059 Krakow, Poland.
EM r.major@imim.pl
FU project CardioBioMat MNT Era-Net under the National Centre of Research
   and Development [MNT/15/2009]; Polish National Center of Science
   [2011/03/D/ST8/04103]; Polish-Austrian exchange project [PL 023/2012]
FX The research associated with inner surface modification of tubes was
   supported financially by the project CardioBioMat MNT Era-Net
   MNT/15/2009 "Nonstructural materials for implants and cardiovascular
   biomedical devices" under the National Centre of Research and
   Development. The research work connected with porous coatings was
   financially supported by the project 2011/03/D/ST8/04103
   "Self-assembling, biomimetic porous scaffolds in terms of inhibiting the
   activation of the coagulation system" of the Polish National Center of
   Science and Polish-Austrian exchange project PL 023/2012. The coatings
   were deposited in JOANNEUM RESEARCH Forschungs-GmbH,
   MATERIALS-Functional Surfaces, Leoben, Austria. The experiments were
   executed with the cooperation of Jagiellonian University Medical College
   and Department of Medicine Cracow, Poland, Grenoble Institute National
   Polytechnique Minatec Phelma LMGP
CR Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Chehroudi B, 2002, BIOMATERIALS, V23, P229, DOI 10.1016/S0142-9612(01)00100-4
   Chung TW, 2003, BIOMATERIALS, V24, P4655, DOI 10.1016/S0142-9612(03)00361-1
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Kapis A., 2013, POLISH ARTIFICIAL HE, P2013
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Lackner J. M., 2005, IND SCALED HYBRID PU
   Lackner JM, 2005, VACUUM, V78, P73, DOI [10.1016/j.vacuum.2004.12.017, 10.1016/j/vacuum.2004.12.017]
   Lackner JM, 2014, PLASMA CHEM PLASMA P, V34, P259, DOI 10.1007/s11090-013-9519-8
   Lackner JM, 2011, VACUUM, V86, P144, DOI 10.1016/j.vacuum.2011.05.005
   Lackner JM, 2010, BIOMED TECH, V55, P57, DOI 10.1515/BMT.2010.001
   Laha A, 2004, MAT SCI ENG B-SOLID, V106, P111, DOI 10.1016/j.mseb.2003.08.001
   Lange M., 2012, ANATOMY PHYSL UNITY
   Major R., J MAT SCI M IN PRESS
   Major R, 2014, RSC ADV, V4, P9491, DOI 10.1039/c3ra43794a
   Major R, 2013, J MATER SCI-MATER M, V24, P725, DOI 10.1007/s10856-012-4824-y
   Mirhosseini N, 2007, APPL SURF SCI, V253, P7738, DOI 10.1016/j.apsusc.2007.02.168
   Mylvaganam K, 2003, THIN SOLID FILMS, V425, P145, DOI 10.1016/S0040-6090(02)01287-7
   Mzyk A, 2015, RSC ADV, V5, P13906, DOI 10.1039/c4ra14474k
   Mzyk A, 2014, RSC ADV, V4, P31948, DOI 10.1039/c4ra03914a
   Mzyk A, 2014, ARCH CIV MECH ENG, V14, P262, DOI 10.1016/j.acme.2013.09.006
   Naduvinamania NB, 2005, TRIBOL INT, V38, P451, DOI 10.1016/j.triboint.2004.09.001
   Ohta Yuji, 2003, J Artif Organs, V6, P101
   Picart C, 2007, COLLOID SURFACE A, V303, P30, DOI 10.1016/j.colsurfa.2007.02.015
   Richert L, 2004, SURF SCI, V570, P13, DOI 10.1016/j.susc.2004.06.178
   Rupp F, 2004, BIOMATERIALS, V25, P1429, DOI 10.1016/j.biomaterials.2003.08.015
   Sanak M, 2010, B POL ACAD SCI-TECH, V58, P317, DOI 10.2478/v10175-010-0029-z
   Sefton M.V., 2004, NONTHROMBOGENIC TREA
   THORNTON JA, 1977, ANNU REV MATER SCI, V7, P239, DOI 10.1146/annurev.ms.07.080177.001323
   Trembecka-Wojciga K, 2015, ARCH CIV MECH ENG, V15, P621, DOI 10.1016/j.acme.2014.12.005
   Trtica M, 2006, APPL SURF SCI, V253, P2551, DOI 10.1016/j.apsusc.2006.05.024
   Tsyganov T.I., 2005, SURF COAT TECH, V200, P1041
   Wagner W.R., 2004, BIOMATERIALS SCI
   Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328
NR 37
TC 0
Z9 0
U1 0
U2 8
PU POLSKA AKAD NAUK, POLISH ACAD SCIENCES, INST METALL & MATER SCI PAS
PI WARSZAWA
PA PL, 00-901 WARSZAWA, POLAND
SN 1733-3490
EI 2300-1909
J9 ARCH METALL MATER
JI Arch. Metall. Mater.
PY 2015
VL 60
IS 3
BP 2279
EP 2287
DI 10.1515/amm-2015-0375
PG 9
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA CW9YL
UT WOS:000365354000102
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Wu, H
   Liu, GH
   Wu, Q
   Yu, B
AF Wu, H.
   Liu, G. H.
   Wu, Q.
   Yu, B.
TI Repairing rabbit radial defects by combining bone marrow stroma stem
   cells with bone scaffold material comprising a core-cladding structure
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE Core-cladding structure; Osteogenic capability; Bone defect; Bone tissue
   engineering
ID TISSUE; BIOMATERIAL; VASCULARIZATION
AB We prepared a bone scaffold material comprising a PLGA/beta-TCP core and a Type I collagen cladding, and recombined it with bone marrow stroma stem cells (BMSCs) to evaluate its potential for use in bone tissue engineering by in vivo and in vitro experiments. PLGA/beta-TCP without a cladding was used for comparison. The adherence rate of the BMSCs to the scaffold was determined by cell counting. Cell proliferation rate was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide method. The osteogenic capability was evaluated by alkaline phosphatase activity. The scaffold materials were recombined with the BMSCs and implanted into a large segmental rabbit radial defect model to evaluate defect repair. Osteogenesis was assessed in the scaffold materials by histological and double immunofluorescence labeling, etc. The adherence number, proliferation number, and alkaline phosphatase expression of the cells on the bone scaffold material with core-cladding structure were significantly higher than the corresponding values in the PLGA/beta-TCP composite scaffold material (P < 0.05). An in vivo test indicated that the bone scaffold material with core-cladding structure completely degraded at the bone defect site and bone formation was completed. The rabbit large sentimental radial defect was successfully repaired. The degradation and osteogenesis rates matched well. The bone scaffold with core-cladding structure exhibited better osteogenic activity and capacity to repair a large segmental bone defect compared to the PLGA/beta-TCP composite scaffold. The bone scaffold with core-cladding structure has excellent physical properties and biocompatibility. It is an ideal scaffold material for bone tissue engineering.
C1 [Wu, H.; Wu, Q.; Yu, B.] Southern Med Univ, Guangzhou, Guangdong, Peoples R China.
   [Wu, H.; Liu, G. H.] Inner Mongolia Med Univ, Affiliated Hosp 2, Hohhot, Peoples R China.
RP Yu, B (reprint author), Southern Med Univ, Guangzhou, Guangdong, Peoples R China.
EM yubinsmu@163.com
CR Amini AR, 2012, J ORTHOP RES, V30, P1507, DOI 10.1002/jor.22097
   Asaoka T, 2013, J BIOMED MATER RES A, V101, P3295, DOI 10.1002/jbm.a.34517
   Bellucci D, 2012, J MATER SCI-MATER M, V23, P1397, DOI 10.1007/s10856-012-4622-6
   Cai YZ, 2012, J BIOMED MATER RES A, V100A, P1187, DOI 10.1002/jbm.a.34063
   Delabarde C, 2012, J MATER SCI-MATER M, V23, P1371, DOI 10.1007/s10856-012-4619-1
   Dias MR, 2012, J BIOMECH, V45, P938, DOI 10.1016/j.jbiomech.2012.01.019
   Fassina L, 2010, IEEE ENG MED BIO, P247, DOI 10.1109/IEMBS.2010.5627475
   Feng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082945
   He NY, 2012, J NANOSCI NANOTECHNO, V12, P2858, DOI 10.1166/jnn.2012.5756
   Jakob M, 2012, EUR SURG RES, V49, P1, DOI 10.1159/000338362
   Kang HW, 2012, TISSUE ENG PART C-ME, V18, P719, DOI [10.1089/ten.tec.2011.0621, 10.1089/ten.TEC.2011.0621]
   Liu M, 2013, ORTHOPEDICS, V36, P868, DOI 10.3928/01477447-20131021-10
   Liundup A V, 2013, Vestn Ross Akad Med Nauk, P10
   Lu CH, 2013, BIOTECHNOL ADV, V31, P1695, DOI 10.1016/j.biotechadv.2013.08.015
   Moshaverinia A, 2013, J BIOMED MATER RES A, V101, P3285, DOI 10.1002/jbm.a.34546
   Murphy CM, 2013, EUR CELLS MATER, V26, P120, DOI 10.22203/eCM.v026a09
   Nguyen LH, 2012, TISSUE ENG PART B-RE, V18, P363, DOI 10.1089/ten.teb.2012.0012
   Pascu EI, 2013, MAT SCI ENG C-MATER, V33, P4905, DOI 10.1016/j.msec.2013.08.012
   Rao RR, 2013, CYTOTHERAPY, V15, P1309, DOI 10.1016/j.jcyt.2013.06.005
   Sadiasa A, 2014, J BIOMAT SCI-POLYM E, V25, P150, DOI 10.1080/09205063.2013.846633
   Sajesh KM, 2013, INT J BIOL MACROMOL, V62, P465, DOI 10.1016/j.ijbiomac.2013.09.028
   Shahini A, 2014, INT J NANOMED, V9, P167, DOI 10.2147/IJN.S54668
   Sreejit P, 2013, STEM CELL REV REP, V9, P158, DOI 10.1007/s12015-013-9427-6
   Tarafder S, 2013, J TISSUE ENG REGEN M, V7, P631, DOI 10.1002/term.555
   Tsai WB, 2014, J BIOMATER APPL, V28, P837, DOI 10.1177/0885328213483842
   Varoni E, 2012, CONNECT TISSUE RES, V53, P548, DOI 10.3109/03008207.2012.712583
   Vishnoi T, 2013, J MATER SCI-MATER M, V24, P447, DOI 10.1007/s10856-012-4795-z
   Walser R, 2013, EUR CELLS MATER, V26, P222, DOI 10.22203/eCM.v026a16
   Wen Y, 2013, OR SURG OR MED OR PA, V116, pE324, DOI 10.1016/j.oooo.2012.02.024
   Zou J, 2014, MOL MED REP, V9, P185, DOI 10.3892/mmr.2013.1758
NR 30
TC 2
Z9 3
U1 0
U2 5
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000,
   BRAZIL
SN 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2015
VL 14
IS 4
BP 11933
EP 11943
DI 10.4238/2015.October.5.7
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA CX7ZZ
UT WOS:000365922800027
PM 26505341
OA Bronze
DA 2018-10-19
ER

PT J
AU Gregoric, M
   Blackledge, TA
   Agnarsson, I
   Kuntner, M
AF Gregoric, Matjaz
   Blackledge, Todd A.
   Agnarsson, Ingi
   Kuntner, Matjaz
TI A molecular phylogeny of bark spiders reveals new species from Africa
   and Madagascar (Araneae: Araneidae: Caerostris)
SO JOURNAL OF ARACHNOLOGY
LA English
DT Article
DE Biomaterial; spider silk; web gigantism; sexual size dimorphism;
   emasculation
ID DNA BARCODES; ORB WEBS; ADAPTIVE RADIATION; SEXUAL SELECTION; MALE
   ADAPTATION; THERAPHOSIDAE; EVOLUTION; SIZE; MYGALOMORPHAE; APHONOPELMA
AB Bark spiders (genus Caerostris Thorell 1868) are important models in biomaterial research due to the remarkable biomechanical properties of the silk of C. darwini Kuntner & Agnarsson 2010 and its gigantic web. They also exhibit female gigantism and are promising candidates for coevolutionary research on sexual dimorphism. However, Caerostris spiders are taxonomically understudied and the lack of a phylogeny impedes evolutionary research. Using a combination of one mitochondrial and one nuclear marker, we provide the first species-level phylogeny of Caerostris including half of its species diversity but dense terminal sampling focusing on new lineages. Our phylogenetic and morphological results provide the evidence for six previously undescribed species: C. almae n. sp., C. bojani n. sp., C. pero n. sp. and C. wallacei n. sp., all from Madagascar, C. linnaeus n. sp. from Mozambique and C. tinamaze n. sp. from the Republic of South Africa.
C1 [Gregoric, Matjaz; Kuntner, Matjaz] Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, SI-1001 Ljubljana, Slovenia.
   [Gregoric, Matjaz; Blackledge, Todd A.] Univ Akron, Dept Biol, Integrated Biosci Program, Akron, OH 44325 USA.
   [Agnarsson, Ingi] Univ Vermont, Dept Biol, Burlington, VT USA.
   [Agnarsson, Ingi; Kuntner, Matjaz] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA.
   [Kuntner, Matjaz] Hubei Univ, Coll Life Sci, Ctr Behav Ecol & Evolut, Wuhan, Hubei, Peoples R China.
RP Gregoric, M (reprint author), Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Novi Trg 2,POB 306, SI-1001 Ljubljana, Slovenia.
EM matjaz.gregoric@gmail.com
FU Slovenian Research Agency [P1-0236, J1-2063]; United States National
   Science Foundation [IOS-0745379]; National Geographic Society [8655-09]
FX We thank Ren-Chung Cheng, Shakira G. Qinones Lebron, Heine C. Kiesbuy,
   Tjasa Lokovsek, Laura May-Collado, Yadira Ortiz and Joel Duff for their
   laboratory and logistic help. We thank Jonathan Coddington (USNM), Jason
   Dunlop (ZMB), Charles Griswold (CAS), Peter Jager, Rudy Jocque, Daiqin
   Li, Wenjin Gan, Liu Shengjie, Honore Rabarison, Sahondra Lalao
   Rahanitriniaina, and MICET and ICTE crews for museum loans, fresh
   material and help in the field. We thank Jason Bond and an anonymous
   reviewer for useful comments. This contribution was funded by the
   Slovenian Research Agency (grants P1-0236, J1-2063), the United States
   National Science Foundation (IOS-0745379) and the National Geographic
   Society (grant 8655-09).
CR Agnarsson I., 2013, SPIDER RES 21 CENTUR, P58
   Agnarsson I, 2015, ZOOKEYS, P13, DOI 10.3897/zookeys.509.8897
   Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234
   Andrade MCB, 1996, SCIENCE, V271, P70, DOI 10.1126/science.271.5245.70
   Arnedo MA, 2007, CONSERV GENET, V8, P1147, DOI 10.1007/s10592-006-9270-2
   Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024
   BARTH F.G., 2002, SPIDERS WORLD SENSES
   Blackledge TA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00833
   Blackledge TA, 2011, ADV INSECT PHYSIOL, V41, P175, DOI 10.1016/B978-0-12-415919-8.00004-5
   Blagoev G, 2009, ZOOKEYS, V16, P27, DOI DOI 10.3897/ZOOKEYS.16.239
   Bond JE, 1998, EVOLUTION, V52, P403, DOI 10.1111/j.1558-5646.1998.tb01641.x
   Candek K, 2015, MOL ECOL RESOUR, V15, P268, DOI 10.1111/1755-0998.12304
   Cheng RC, 2015, EVOL BIOL, V42, P223, DOI 10.1007/s11692-015-9313-z
   Cheng RC, 2014, EVOLUTION, V68, P2861, DOI 10.1111/evo.12504
   CODDINGTON JA, 1994, PHYLOGENETICS ECOLOG, P53
   Danielson-Francois A, 2012, ANIM BEHAV, V84, P937, DOI 10.1016/j.anbehav.2012.07.018
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Foelix RF, 2011, BIOL SPIDERS
   Foellmer MW, 2008, EVOL ECOL RES, V10, P449
   Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294
   Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875
   GRASSHOFF M, 1984, Revue de Zoologie Africaine, V98, P725
   Gregoric M., 2015, ZOOLOGICAL J LINNEAN, DOI [10.1111/zoj.1.12281, DOI 10.1111/Z0J.1.12281]
   Gregoric M, 2011, J ARACHNOL, V39, P287, DOI 10.1636/CB10-95.1
   Gregoric M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026847
   Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103
   Hamilton CA, 2014, MOL PHYLOGENET EVOL, V71, P79, DOI 10.1016/j.ympev.2013.11.007
   Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101
   Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218
   Hedin MC, 2001, MOL PHYLOGENET EVOL, V18, P386, DOI 10.1006/mpev.2000.0883
   Hendrixson BE, 2013, MOL PHYLOGENET EVOL, V66, P327, DOI 10.1016/j.ympev.2012.10.004
   Herberstein Marie E., 2011, P1
   Jaeger Peter, 2007, Acta Arachnologica, V56, P29, DOI 10.2476/asjaa.56.29
   Kasumovic MM, 2009, J EVOLUTION BIOL, V22, P324, DOI 10.1111/j.1420-9101.2008.01648.x
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Kralj-Fiser S, 2011, ANIM BEHAV, V81, P933, DOI 10.1016/j.anbehav.2011.02.010
   Kuntner M., 2014, FRONT ECOL EVOL, V2, P26, DOI [10.3389/fevo.2014.00026, DOI 10.3389/FEVO.2014.00026]
   Kuntner M, 2008, CLADISTICS, V24, P147, DOI 10.1111/j.1096-0031.2007.00176.x
   Kuntner M, 2015, BIOL REV, V90, P279, DOI 10.1111/brv.12109
   Kuntner M, 2013, MOL PHYLOGENET EVOL, V69, P961, DOI 10.1016/j.ympev.2013.06.008
   Kuntner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040939
   Kuntner M, 2011, MOL PHYLOGENET EVOL, V59, P477, DOI 10.1016/j.ympev.2011.02.002
   Kuntner M, 2010, J ARACHNOL, V38, P346, DOI 10.1636/B09-113.1
   Li DQ, 2012, BIOL LETTERS, V8, P512, DOI 10.1098/rsbl.2011.1202
   Longhorn SJ, 2007, J ARACHNOL, V35, P278, DOI 10.1636/S05-62.1
   Maddison W. P., 2013, MESQUITE MODULAR SYS
   Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129
   Modanu M, 2013, EVOL DEV, V15, P205, DOI 10.1111/ede.12034
   Nessler SH, 2007, BEHAV ECOL, V18, P174, DOI 10.1093/beheco/arl074
   Scharff N, 1997, ZOOL J LINN SOC-LOND, V120, P355, DOI 10.1111/j.1096-3642.1997.tb01281.x
   Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x
   Smit J, 2013, ZOOKEYS, P279, DOI 10.3897/zookeys.365.5819
   Talavera G, 2007, SYSTEMATIC BIOL, V56, P564, DOI 10.1080/10635150701472164
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Taylor HR, 2012, MOL ECOL RESOUR, V12, P377, DOI 10.1111/j.1755-0998.2012.03119.x
   Vidergar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113030
   Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1
   World Spider Catalog, 2015, NAT HIST MUS BERN
   Yin CM, 1997, FAUNA SINICA ARACHNI
   Zhang SC, 2011, ANIM BEHAV, V82, P1299, DOI 10.1016/j.anbehav.2011.09.010
NR 61
TC 3
Z9 3
U1 0
U2 15
PU AMER ARACHNOLOGICAL SOC
PI COLLEGE PARK
PA UNIV MARYLAND, DEPT ENTOMOLOGY, 4112 PLANT SCIENCES BLDG, COLLEGE PARK,
   MD 20742-4454 USA
SN 0161-8202
EI 1937-2396
J9 J ARACHNOL
JI J. Arachnol.
PY 2015
VL 43
IS 3
BP 293
EP 312
DI 10.1636/0161-8202-43.3.293
PG 20
WC Entomology
SC Entomology
GA CX2WS
UT WOS:000365558100002
OA Bronze
DA 2018-10-19
ER

PT J
AU Sun, BB
   Shen, H
AF Sun, Bingbing
   Shen, Hong
TI Controlling Surface-Induced Nanocomposites by Lipoplexes for Enhanced
   Gene Transfer
SO JOURNAL OF NANOMATERIALS
LA English
DT Article
ID DNA DELIVERY; IN-VITRO; PLASMID DNA; LIPOFECTION EFFICIENCY;
   ELECTRON-MICROSCOPY; MAMMALIAN-CELLS; COMPLEXES; CALCIUM; SCAFFOLDS;
   SERUM
AB Surface-induced biomineralization represents a flexible approach to immobilizing DNA onto biomaterial surfaces for surface-mediated DNA delivery. Immobilized naked DNA is uniformly embedded in thin films of nanocomposites, which limits the internalization of DNA to some cell types, such as neuronal cells. In this study, DNA molecules were initially complexed with liposomes to form lipoplexes. Subsequently, these lipoplexes were immobilized onto a cell culture compatible surface through surface-induced biomineralization. Under all the conditions we examined, lipoplexes were efficiently immobilized onto the surface and formed lipoplex-nanocomposites. We have shown that the size of liposomes and the composition of mineralizing solutions have significant effects on the morphology and topology of nanocomposites and thus the organization and the intracellular levels of DNA. The transgene expression mediated by lipoplex-nanocomposites was greatly enhanced in neuronal cells compared to the immobilized naked DNA.
C1 [Sun, Bingbing] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
   [Shen, Hong] Elsa Biol LLC, Seattle, WA 98165 USA.
RP Shen, H (reprint author), Elsa Biol LLC, POB 25725, Seattle, WA 98165 USA.
EM hong.shen@elsa-biologics.com
RI Sun, Bingbing/I-8197-2012
OI Sun, Bingbing/0000-0002-5444-5078
FU National Institutes of Health [EB007494]; National Science Foundation
   CAREER Award
FX This work was supported by the Grant EB007494 from the National
   Institutes of Health and by the National Science Foundation CAREER Award
   given to H. Shen. AFM was provided by NanoTech User Facility at
   University of Washington.
CR Almofti MR, 2003, MOL MEMBR BIOL, V20, P35, DOI 10.1080/0968768021000035104
   ARCHIBALD DD, 1993, NATURE, V364, P430, DOI 10.1038/364430a0
   Bengali Z, 2005, BIOTECHNOL BIOENG, V90, P290, DOI 10.1002/bit.20393
   Bengali Z, 2007, J GENE MED, V9, P668, DOI 10.1002/jgm.1058
   Bielinska AU, 2000, BIOMATERIALS, V21, P877, DOI 10.1016/S0142-9612(99)00229-X
   Chatzinikolaidou M, 2014, J TISSUE ENG REGEN M, V8, P417
   De Bartolo L, 2002, BIOMATERIALS, V23, P2485, DOI 10.1016/S0142-9612(01)00383-0
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051
   Ewe A, 2014, ACTA BIOMATER, V10, P2663, DOI 10.1016/j.actbio.2014.02.037
   Garcia-Castellano J M, 2000, Iowa Orthop J, V20, P49
   Jang JH, 2006, J BIOMED MATER RES A, V77A, P50, DOI 10.1002/jbm.a.30643
   Kofron MD, 2004, BIOMATERIALS, V25, P2637, DOI 10.1016/j.biomaterials.2003.09.042
   Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78
   Lakshminarayanan A, 2013, BIOCONJUGATE CHEM, V24, P1612, DOI 10.1021/bc400247w
   Lee ER, 1996, HUM GENE THER, V7, P1701, DOI 10.1089/hum.1996.7.14-1701
   Letellier SR, 1998, BBA-GEN SUBJECTS, V1380, P31, DOI 10.1016/S0304-4165(97)00121-9
   Levine RM, 2013, LANGMUIR, V29, P9208, DOI 10.1021/la400859e
   Liu Y, 1997, NAT BIOTECHNOL, V15, P167, DOI 10.1038/nbt0297-167
   Luong LN, 2009, BIOMATERIALS, V30, P6996, DOI 10.1016/j.biomaterials.2009.09.001
   Masotti A, 2009, COLLOID SURFACE B, V68, P136, DOI 10.1016/j.colsurfb.2008.09.017
   MORIN LG, 1974, AM J CLIN PATHOL, V61, P114
   Oyane A, 2007, GENE THER, V14, P1750, DOI 10.1038/sj.gt.3303041
   Pereira-Rodrigues N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009667
   Radler JO, 1997, SCIENCE, V275, P810, DOI 10.1126/science.275.5301.810
   Reimer DL, 1997, J BIOL CHEM, V272, P19480, DOI 10.1074/jbc.272.31.19480
   Ross PC, 1999, GENE THER, V6, P651, DOI 10.1038/sj.gt.3300863
   Segura T, 2005, BIOMATERIALS, V26, P1575, DOI 10.1016/j.biomaterials.2004.05.007
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   Shen H, 2004, NAT MATER, V3, P569, DOI 10.1038/nmat1179
   Slamenova D, 1996, CELL BIOL TOXICOL, V12, P11, DOI 10.1007/BF00143390
   STERNBERG B, 1994, FEBS LETT, V356, P361, DOI 10.1016/0014-5793(94)01315-2
   Sun B, 2012, ACTA BIOMATER, V8, P1109, DOI 10.1016/j.actbio.2011.12.005
   Sun BB, 2009, BIOMATERIALS, V30, P6386, DOI 10.1016/j.biomaterials.2009.08.006
   Tabatt K, 2004, J CONTROL RELEASE, V97, P321, DOI 10.1016/j.jconrel.2004.02.029
   Traikia M, 2000, EUR BIOPHYS J BIOPHY, V29, P184, DOI 10.1007/s002490000077
   Wang L, 2007, MOL PHARM, V4, P615, DOI 10.1021/mp0601291
   Wong PT, 2014, BIOMACROMOLECULES, V15, P4134, DOI 10.1021/bm501169s
   Xu YH, 1999, BIOPHYS J, V77, P341, DOI 10.1016/S0006-3495(99)76894-3
   Zhang Y, 2008, J PHARM SCI-US, V97, P237, DOI 10.1002/jps.21076
NR 40
TC 0
Z9 0
U1 0
U2 8
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-4110
EI 1687-4129
J9 J NANOMATER
JI J. Nanomater.
PY 2015
AR 784836
DI 10.1155/2015/784836
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CX7YV
UT WOS:000365919800001
OA DOAJ Gold
DA 2018-10-19
ER

PT B
AU Tourlomousis, F
   Babakhanov, A
   Ding, HZ
   Chang, RC
AF Tourlomousis, Filippos
   Babakhanov, Azizbek
   Ding, Houzhu
   Chang, Robert C.
GP ASME
TI A NOVEL MELT ELECTROSPINNING SYSTEM FOR STUDYING CELL SUBSTRATE
   INTERACTIONS
SO PROCEEDINGS OF THE ASME 10TH INTERNATIONAL MANUFACTURING SCIENCE AND
   ENGINEERING CONFERENCE, 2015, VOL 2
LA English
DT Proceedings Paper
CT 10th ASME International Manufacturing Science and Engineering Conference
   (MSEC2015)
CY JUN 08-12, 2015
CL Charlotte, NC
SP ASME, Mfg Engn Div
ID PHENOMENOLOGICAL OBSERVATIONS; SCAFFOLDS; CUES
AB Controlling cell behavior has generated immense attention in the fields of tissue engineering and regenerative medicine. Particular emphasis has been given to the creation of 3D biomimetic cellular microenvironments that replicate the complex nature of the extracellular matrix (ECM). A key factor that has not been rigorously deconstructed using scalable, layered manufacturing approaches is the structural dimension or scale aspect of in vitro culture models. Melt electrospinning represents a bio-additive manufacturing process that has been relatively under-reported. Although complex in nature, the melt electrospinning process can furnish a 3D cell delivery format with physiologically relevant 3D structural cues. In the present work, poly-epsilon-caprolactone (PCL) has been chosen as the biomaterial substrate. Rheological studies that guide the design phase of the reported system have been performed for the entire PCL melt processing range, implicating the governing effect of the experimental melt temperature on the scale and the topography in the final processed material. Notable challenges that arise from the nature of the process with respect to the electrospun fiber stability and resolution have been overcome through the design of a novel heating element configuration. In this paper, a reliable biofabrication process with tunable processing of the fiber diameter and alignment is reported. Fundamental parametric studies utilizing the Major processing parameters demonstrate the potential for the system to precisely fabricate 3D PCL scaffolds with microstructural features.
C1 [Tourlomousis, Filippos; Babakhanov, Azizbek; Ding, Houzhu; Chang, Robert C.] Stevens Inst Technol, Dept Mech Engn, Hoboken, NJ 07030 USA.
RP Tourlomousis, F (reprint author), Stevens Inst Technol, Dept Mech Engn, Hoboken, NJ 07030 USA.
CR Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Bird R. B., 1987, DYNAMICS POLYM LIQUI
   Brown T., 2011, ADV MAT
   Brown TD, 2014, MAT SCI ENG C-MATER, V45, P698, DOI 10.1016/j.msec.2014.07.034
   Brown TD, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0013-7
   Brown TD, 2011, ADV MATER, V23, P5651, DOI 10.1002/adma.201103482
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Cipitria A, 2011, J MATER CHEM, V21, P9419, DOI 10.1039/c0jm04502k
   Dalton P., MELT ELECTROSPINNING
   Dalton PD, 2007, POLYMER, V48, P6823, DOI 10.1016/j.polymer.2007.09.037
   Dalton PD, 2013, BIOMATER SCI-UK, V1, P171, DOI 10.1039/c2bm00039c
   Dalton PD, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034109
   Detta N, 2010, POLYM INT, V59, P1558, DOI 10.1002/pi.2954
   Farooque TM, 2014, BIOMATERIALS, V35, P2558, DOI 10.1016/j.biomaterials.2013.12.092
   Farrugia BL, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/2/025001
   Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062
   Hogue M. E., 2011, BIOPOLYMERS, V97, P83
   Hutmacher DW, 2011, CHEM-ASIAN J, V6, P44, DOI 10.1002/asia.201000436
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kumar G, 2011, BIOMATERIALS, V32, P9188, DOI 10.1016/j.biomaterials.2011.08.054
   Ladoux B, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/11/116601
   Luo CJ, 2012, CHEM SOC REV, V41, P4708, DOI 10.1039/c2cs35083a
   Muerza-Cascante M. L., 2014, TISSUE ENG PART B-RE, P1
   Park JU, 2007, NAT MATER, V6, P782, DOI 10.1038/nmat1974
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Zhang ZG, 2014, J BIOMED MATER RES B, V102, P12, DOI 10.1002/jbm.b.32947
   Zhou HJ, 2006, POLYMER, V47, P7497, DOI 10.1016/j.polymer.2006.08.042
   Zhrnayev E, 2008, J NON-NEWTON FLUID, V153, P95, DOI 10.1016/j.jnnfm.2007.11.011
NR 29
TC 0
Z9 0
U1 1
U2 7
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5683-3
PY 2015
AR V002T03A006
PG 11
WC Engineering, Manufacturing; Engineering, Mechanical; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BD9RJ
UT WOS:000365147200019
DA 2018-10-19
ER

PT J
AU Wu, SY
   An, SSA
   Hulme, J
AF Wu, Si-Ying
   An, Seong Soo A.
   Hulme, John
TI Current applications of graphene oxide in nanomedicine
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Review
DE imaging; green; cancer; therapy; diagnostics; antibacterial;
   cytotoxicity; contrast agent; biofunctionalization
ID PEGYLATED NANOGRAPHENE OXIDE; BONE MORPHOGENETIC PROTEIN-2;
   CHEMO-PHOTOTHERMAL THERAPY; ENHANCED RAMAN-SCATTERING; DRUG-DELIVERY;
   FUNCTIONALIZED GRAPHENE; BIOMEDICAL APPLICATIONS; IN-VIVO;
   NANO-GRAPHENE; TARGETED DELIVERY
AB Graphene has attracted the attention of the entire scientific community due to its unique mechanical and electrochemical, electronic, biomaterial, and chemical properties. The water-soluble derivative of graphene, graphene oxide, is highly prized and continues to be intensely investigated by scientists around the world. This review seeks to provide an overview of the currents applications of graphene oxide in nanomedicine, focusing on delivery systems, tissue engineering, cancer therapies, imaging, and cytotoxicity, together with a short discussion on the difficulties and the trends for future research regarding this amazing material.
C1 [Wu, Si-Ying; An, Seong Soo A.; Hulme, John] Gachon Univ, Gachon Med Res Inst, Dept Bionanotechnol, Sungnamsi, South Korea.
RP An, SSA (reprint author), Gachon Univ, Gachon Med Res Inst, Dept Bionanotechnol, San 65, Songnam 461701, South Korea.
EM seongaan@gachon.ac.kr; flp15@gachon.ac.kr
FU National Research Foundation Korea [2012014335]
FX This research was supported by the National Research Foundation Korea
   project number 2012014335.
CR Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114
   Ahluwalia A., 2013, BIONANOMATERIALS, V14, P195, DOI [10.1515/bnm-2013-0011, DOI 10.1515/BNM-2013-0011]
   Ali-Boucetta H, 2013, ADV HEALTHC MATER, V2, P433, DOI 10.1002/adhm.201200248
   Ananta JS, 2010, NAT NANOTECHNOL, V5, P815, DOI [10.1038/nnano.2010.203, 10.1038/NNANO.2010.203]
   Bai H, 2014, J PHYS CHEM C, V118, P10519, DOI 10.1021/jp503413s
   Bai H, 2010, CHEM COMMUN, V46, P2376, DOI 10.1039/c000051e
   Balcioglu M, 2015, ACS BIOMATER SCI ENG, V1, P27, DOI 10.1021/ab500029h
   Bao HQ, 2011, SMALL, V7, P1569, DOI 10.1002/smll.201100191
   Bressan E, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0296-9
   Bussy C, 2013, ACCOUNTS CHEM RES, V46, P692, DOI 10.1021/ar300199e
   Campbell S, 2015, ACS MACRO LETT, V4, P312, DOI 10.1021/acsmacrolett.5b00057
   Carpio IEM, 2012, NANOSCALE, V4, P4746, DOI 10.1039/c2nr30774j
   Chang YL, 2011, TOXICOL LETT, V200, P201, DOI 10.1016/j.toxlet.2010.11.016
   Chaudhuri B, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015009
   Chen BA, 2011, J MATER CHEM, V21, P7736, DOI 10.1039/c1jm10341e
   Chen DQ, 2015, J CONTROL RELEASE, V210, P230, DOI 10.1016/j.jconrel.2015.04.021
   Chen HQ, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/16/165101
   Chen H, 2013, J THER ULTRASOUND, V1, DOI 10.1186/2050-5736-1-10
   Chen Y, 2015, CHEM SOC REV, V44, P2681, DOI 10.1039/c4cs00300d
   Chowdhury SM, 2015, J NANOMED NANOTECHNO, V11, P109
   Cianfrocca M, 2010, CANCER-AM CANCER SOC, V116, P3969, DOI 10.1002/cncr.25362
   Dallavalle M, 2015, ACS APPL MATER INTER, V7, P4406, DOI 10.1021/am508938u
   Daniels TR, 2006, CLIN IMMUNOL, V121, P159, DOI 10.1016/j.clim.2006.06.006
   Deepachitra R, 2015, MATER MANUF PROCESS, V30, P804, DOI 10.1080/10426914.2014.994758
   Depan D, 2011, MAT SCI ENG C-MATER, V31, P1305, DOI 10.1016/j.msec.2011.04.010
   Dinauer N, 2005, BIOMATERIALS, V26, P5898, DOI 10.1016/j.biomaterials.2005.02.038
   Ding ZJ, 2014, ACS APPL MATER INTER, V6, P19797, DOI 10.1021/am505084s
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Dubey P, 2015, ADV COLLOID INTERFAC, V221, P4, DOI 10.1016/j.cis.2015.02.007
   El-Aneed A, 2004, J CONTROL RELEASE, V94, P1, DOI 10.1016/j.jconrel.2003.09.013
   Ethirajan M, 2011, CHEM SOC REV, V40, P340, DOI 10.1039/b915149b
   Fan HL, 2010, BIOMACROMOLECULES, V11, P2345, DOI 10.1021/bm100470q
   Feng LZ, 2011, NANOMEDICINE-UK, V6, P317, DOI 10.2217/NNM.10.158
   Feng LZ, 2011, NANOSCALE, V3, P1252, DOI 10.1039/c0nr00680g
   Feng LY, 2013, ADV MATER, V25, P168, DOI 10.1002/adma.201203229
   Gao L, 2014, BIOSENS BIOELECTRON, V60, P22, DOI 10.1016/j.bios.2014.03.039
   Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x
   Ge SG, 2014, SENSOR ACTUAT B-CHEM, V192, P317, DOI 10.1016/j.snb.2013.10.127
   Georgantzopoulou A., 2015, EFFECTS SILVER NANOP
   Goenka S, 2014, J CONTROL RELEASE, V173, P75, DOI 10.1016/j.jconrel.2013.10.017
   Gollavelli G, 2012, BIOMATERIALS, V33, P2532, DOI 10.1016/j.biomaterials.2011.12.010
   Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001
   Gu YJ, 2015, BIOSENS BIOELECTRON, V66, P24, DOI 10.1016/j.bios.2014.10.070
   Gurunathan S, 2013, INT J NANOMED, V8, P2719, DOI 10.2147/IJN.S45174
   Gurunathan S, 2013, J IND ENG CHEM, V19, P1280, DOI 10.1016/j.jiec.2012.12.029
   Gurunathan S, 2013, INT J NANOMED, V8, P1015, DOI 10.2147/IJN.S42047
   Gurunathan S, 2012, INT J NANOMED, V7, P5901, DOI 10.2147/IJN.S37397
   Hinzmann M, 2014, INT J NANOMED, V9, P2409, DOI 10.2147/IJN.S62497
   Hong H, 2012, BIOMATERIALS, V33, P4147, DOI 10.1016/j.biomaterials.2012.02.031
   Hong SW, 2014, BIOMED RES INT, DOI 10.1155/2014/212149
   Hou WC, 2015, ENVIRON SCI TECHNOL, V49, P3435, DOI 10.1021/es5047155
   Hu WB, 2010, ACS NANO, V4, P4317, DOI 10.1021/nn101097v
   Huang J, 2012, SMALL, V8, P2577, DOI 10.1002/smll.201102743
   Huang J, 2010, NANOSCALE, V2, P2733, DOI 10.1039/c0nr00473a
   Huang N, 2015, ANAL CHIM ACTA, V853, P249, DOI 10.1016/j.aca.2014.10.016
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Huschka R, 2011, J AM CHEM SOC, V133, P12247, DOI 10.1021/ja204578e
   Jaque D, 2014, NANOSCALE, V6, P9494, DOI 10.1039/c4nr00708e
   Johannsen M, 2005, INT J HYPERTHER, V21, P637, DOI 10.1080/02656730500158360
   Josefsen LB, 2012, THERANOSTICS, V2, P916, DOI 10.7150/thno.4571
   Justin R, 2014, MAT SCI ENG C-MATER, V34, P50, DOI 10.1016/j.msec.2013.10.010
   Kakran M, 2011, CURR MED CHEM, V18, P4503, DOI 10.2174/092986711797287548
   Kanakia S, 2013, INT J NANOMED, V8, P2821, DOI 10.2147/IJN.S47062
   Karakoti A, 2010, CHEM SOC REV, V39, P4422, DOI 10.1039/b919677n
   Kim H, 2014, SMALL, V10, P117, DOI 10.1002/smll.201202636
   Kim H, 2013, ACS NANO, V7, P6735, DOI 10.1021/nn403096s
   Kim MG, 2015, BIOMATERIALS, V48, P129, DOI 10.1016/j.biomaterials.2015.01.009
   Kim SJ, 2015, ACS NANO, V9, P2677, DOI 10.1021/nn5064634
   Kim TH, 2015, ACS NANO, V9, P3780, DOI 10.1021/nn5066028
   Kim TH, 2014, BIOMED RES INT, V2014, DOI [10.1155/2014/193401, DOI 10.1155/2014/193401]
   Kurantowicz N, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-0749-y
   La WG, 2014, INT J NANOMED, V9, P107, DOI 10.2147/IJN.S50742
   Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996
   Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c
   Li JL, 2014, J BIOMED MATER RES A, V102, P2181, DOI 10.1002/jbm.a.34871
   Li KY, 2014, ACS APPL MATER INTER, V6, P5900, DOI 10.1021/am5008134
   Liao KH, 2011, ACS APPL MATER INTER, V3, P2607, DOI 10.1021/am200428v
   Lim DK, 2013, NANO LETT, V13, P4075, DOI 10.1021/nl4014315
   Lim HN, 2011, INT J NANOMED, V6, P1817, DOI 10.2147/IJN.S23392
   Liu HW, 2012, J MATER CHEM, V22, P17311, DOI 10.1039/c2jm32772d
   Liu JQ, 2013, ACTA BIOMATER, V9, P9243, DOI 10.1016/j.actbio.2013.08.016
   Liu KP, 2011, J MATER CHEM, V21, P12034, DOI 10.1039/c1jm10749f
   Liu QH, 2012, NANOSCALE, V4, P7084, DOI 10.1039/c2nr32525j
   Liu SB, 2011, ACS NANO, V5, P6971, DOI 10.1021/nn202451x
   Liu XH, 2014, ACS APPL MATER INTER, V6, P8173, DOI 10.1021/am500812h
   Liu YY, 2013, SCI REP-UK, V3, DOI 10.1038/srep03469
   Liu ZM, 2013, PHYS CHEM CHEM PHYS, V15, P2961, DOI 10.1039/c2cp43715e
   Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x
   Liu Z, 2011, MATER TODAY, V14, P316, DOI 10.1016/S1369-7021(11)70161-4
   Lu YJ, 2012, INT J NANOMED, V7, P1737, DOI 10.2147/IJN.S29376
   Ma J, 2012, J APPL POLYM SCI, V123, P2933, DOI 10.1002/app.34901
   Madeira C, 2015, TRENDS BIOTECHNOL, V33, P35, DOI 10.1016/j.tibtech.2014.11.003
   Mangadlao JD, 2015, CHEM COMMUN, V51, P2886, DOI 10.1039/c4cc07836e
   Mao L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03126
   Marcano DC, 2010, ACS NANO, V4, P4806, DOI 10.1021/nn1006368
   Matsusaki M, 2012, ADV MATER, V24, P454, DOI 10.1002/adma.201103698
   Mendes RG, 2013, J MATER CHEM B, V1, P401, DOI 10.1039/c2tb00085g
   Mogharabi M, 2014, J PHARM SCI, V22, DOI [10.1186/2008-2231-22-23, DOI 10.1186/2008-2231-22-23]
   Mu QX, 2012, ACS APPL MATER INTER, V4, P2259, DOI 10.1021/am300253c
   Mudavath SL, 2014, DRUG DES DEV THER, V8, P1235, DOI 10.2147/DDDT.S63994
   Nanda SS, 2015, INT J NANOMED, V10, P549, DOI 10.2147/IJN.S75768
   Nasongkla N., 2004, ANGEW CHEM, V116, P6483
   Nezakati T, 2014, ARCH TOXICOL, V88, P1987, DOI 10.1007/s00204-014-1361-0
   Nilsson EE, 2015, TRANSL RES, V165, P12, DOI 10.1016/j.trsl.2014.02.003
   Nishiguchi A, 2011, ADV MATER, V23, P3506, DOI 10.1002/adma.201101787
   Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233
   Pan YZ, 2012, EXPERT OPIN DRUG DEL, V9, P1365, DOI 10.1517/17425247.2012.729575
   Parveen S, 2012, NANOMED-NANOTECHNOL, V8, P147, DOI 10.1016/j.nano.2011.05.016
   Peng L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6716
   Nguyen P, 2012, J PHYS CHEM LETT, V3, P1024, DOI 10.1021/jz300033g
   Prajapati VK, 2012, J INFECT DIS, V205, P333, DOI 10.1093/infdis/jir735
   Qi W, 2014, J MATER CHEM B, V2, P325, DOI 10.1039/c3tb21387k
   Qin XC, 2013, J PHOTOCH PHOTOBIO B, V120, P156, DOI 10.1016/j.jphotobiol.2012.12.005
   Rana VK, 2011, MACROMOL MATER ENG, V296, P131, DOI 10.1002/mame.201000307
   Rao CNR, 2009, ANGEW CHEM INT EDIT, V48, P7752, DOI 10.1002/anie.200901678
   Ren HL, 2010, ACS NANO, V4, P7169, DOI 10.1021/nn101696r
   Ren TB, 2012, POLYM CHEM-UK, V3, P2561, DOI 10.1039/c2py20343j
   Robinson JT, 2011, J AM CHEM SOC, V133, P6825, DOI 10.1021/ja2010175
   Rong PF, 2014, THERANOSTICS, V4, P229, DOI 10.7150/thno.8070
   Ryu S, 2013, TISSUE ENG REGEN MED, V10, P39, DOI 10.1007/s13770-013-0384-6
   Sasidharan A, 2012, SMALL, V8, P1251, DOI 10.1002/smll.201102393
   Seabra AB, 2014, CHEM RES TOXICOL, V27, P159, DOI 10.1021/tx400385x
   Servant A, 2014, BIOORG MED CHEM LETT, V24, P1638, DOI 10.1016/j.bmcl.2014.01.051
   Servant A, 2014, ADV HEALTHC MATER, V3, P1334, DOI 10.1002/adhm.201400016
   Shen H, 2012, THERANOSTICS, V2, P283, DOI 10.7150/thno.3642
   Shi SX, 2014, BIOCONJUGATE CHEM, V25, P1609, DOI 10.1021/bc500332c
   Shi SX, 2013, BIOMATERIALS, V34, P3002, DOI 10.1016/j.biomaterials.2013.01.047
   Shi XZ, 2013, BIOMATERIALS, V34, P4786, DOI 10.1016/j.biomaterials.2013.03.023
   Shin SR, 2014, ADV FUNCT MATER, V24, P6136, DOI 10.1002/adfm.201401300
   Smolkova B, 2015, FOOD CHEM TOXICOL, V77, P64, DOI 10.1016/j.fct.2014.12.015
   Soenen SJ, 2015, CHEM REV, V115, P2109, DOI 10.1021/cr400714j
   Sreejith S, 2012, J AM CHEM SOC, V134, P17346, DOI 10.1021/ja305352d
   Sreeprasad TS, 2011, ACS APPL MATER INTER, V3, P2643, DOI 10.1021/am200447p
   Srivastava S, 2012, SMALL, V8, P1099, DOI 10.1002/smll.201101863
   Srivatsan A, 2011, MOL PHARMACEUT, V8, P1186, DOI 10.1021/mp200018y
   Sun XM, 2008, NANO RES, V1, P203, DOI 10.1007/s12274-008-8021-8
   Tang LAL, 2012, SMALL, V8, P423, DOI 10.1002/smll.201101690
   Termaat MF, 2005, J BONE JOINT SURG AM, V87A, P1367, DOI 10.2106/JBJS.D.02585
   Tian B, 2011, ACS NANO, V5, P7000, DOI 10.1021/nn201560b
   Tripathi SK, 2013, CARBON, V51, P224, DOI 10.1016/j.carbon.2012.08.047
   Wan CY, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055010
   Wang H, 2014, INT J NANOMED, V9, P1433, DOI 10.2147/IJN.S58783
   Wang HS, 2011, THERMOCHIM ACTA, V526, P229, DOI 10.1016/j.tca.2011.10.006
   Wang L, 2014, RSC ADV, V4, P40312, DOI 10.1039/c4ra04529g
   Wang Y, 2011, TRENDS BIOTECHNOL, V29, P205, DOI 10.1016/j.tibtech.2011.01.008
   Wang YH, 2013, BIOMATERIALS, V34, P7715, DOI 10.1016/j.biomaterials.2013.06.045
   WEITMAN SD, 1992, CANCER RES, V52, P3396
   Wen HY, 2012, SMALL, V8, P760, DOI 10.1002/smll.201101613
   Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742
   Wojtoniszak M, 2012, COLLOID SURFACE B, V89, P79, DOI 10.1016/j.colsurfb.2011.08.026
   Xiong HL, 2014, J PHOTOCH PHOTOBIO B, V138, P191, DOI 10.1016/j.jphotobiol.2014.05.023
   Yang K, 2015, EXPERT OPIN DRUG DEL, V12, P601, DOI 10.1517/17425247.2015.978760
   Yang K, 2012, BIOMATERIALS, V33, P2206, DOI 10.1016/j.biomaterials.2011.11.064
   Yang K, 2011, ACS NANO, V5, P516, DOI 10.1021/nn1024303
   Yang K, 2010, NANO LETT, V10, P3318, DOI 10.1021/nl100996u
   Yang XY, 2008, J PHYS CHEM C, V112, P17554, DOI 10.1021/jp806751k
   Yao Y., 2013, J MOL GENET MED, V7, P86, DOI [10.4172/1747-0862.1000086., DOI 10.4172/1747-0862.1000086]
   Yao Y, 2015, SENSOR ACTUAT B-CHEM, V211, P52, DOI 10.1016/j.snb.2014.12.134
   Yin PT, 2015, CHEM REV, V115, P2483, DOI 10.1021/cr500537t
   Yue H, 2012, BIOMATERIALS, V33, P4013, DOI 10.1016/j.biomaterials.2012.02.021
   Zhan SH, 2015, ACS APPL MATER INTER, V7, P4290, DOI 10.1021/am508682s
   Zhang B, 2012, BIOSENS BIOELECTRON, V31, P105, DOI 10.1016/j.bios.2011.09.046
   Zhang H, 2015, BIOMATERIALS, V42, P66, DOI 10.1016/j.biomaterials.2014.11.055
   Zhang HC, 2013, J MATER CHEM B, V1, P2542, DOI 10.1039/c3tb20405g
   Zhang JB, 2011, IND ENG CHEM RES, V50, P13885, DOI 10.1021/ie202132m
   Zhang LM, 2013, J MATER CHEM B, V1, P749, DOI 10.1039/c2tb00096b
   Zhang LM, 2011, SMALL, V7, P460, DOI 10.1002/smll.201001522
   Zhang LM, 2010, SMALL, V6, P537, DOI 10.1002/smll.200901680
   Zhang YB, 2010, ACS NANO, V4, P3181, DOI 10.1021/nn1007176
   Zhao XB, 2015, BIOCONJUGATE CHEM, V26, P128, DOI 10.1021/bc5005137
   Zheng X, 2009, J MED CHEM, V52, P4306, DOI 10.1021/jm9001617
   Zhi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060034
   Zhou HJ, 2014, POLYM CHEM-UK, V5, P3563, DOI 10.1039/c4py00136b
   Zhou KF, 2010, NEW J CHEM, V34, P2950, DOI 10.1039/c0nj00283f
   Zhu L, 2007, NANO LETT, V7, P3592, DOI 10.1021/nl071303v
   Zwicke G.L., 2012, NANO REV, V3
NR 176
TC 42
Z9 42
U1 1
U2 104
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2015
VL 10
SI SI
BP 9
EP 24
DI 10.2147/IJN.S88285
PG 16
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA CW6QL
UT WOS:000365122300003
PM 26345988
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Deiana, M
   Mettra, B
   Matczyszyn, K
   Piela, K
   Pitrat, D
   Olesiak-Banska, J
   Monnereau, C
   Andraud, C
   Samoc, M
AF Deiana, Marco
   Mettra, Bastien
   Matczyszyn, Katarzyna
   Piela, Katarzyna
   Pitrat, Delphine
   Olesiak-Banska, Joanna
   Monnereau, Cyrille
   Andraud, Chantal
   Samoc, Marek
TI Interactions of a biocompatible water-soluble anthracenyl polymer
   derivative with double-stranded DNA
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID CALF THYMUS DNA; MINOR-GROOVE; 2-PHOTON ABSORPTION; ETHIDIUM-BROMIDE;
   ANTICANCER DRUG; SMALL MOLECULES; B-DNA; DOUBLE HELIX; BINDING;
   FLUORESCENCE
AB We have studied the interaction of a polymeric water soluble anthracenyl derivative (Ant-PHEA) with salmon testes DNA. The results from UV-Vis, fluorescence, Fourier transform infrared (FT-IR) and circular dichroism spectroscopies indicate that the groove binding process regulates the interaction between Ant-PHEA and DNA. The binding constants, calculated by absorption spectroscopy at 298, 304 and 310 K, were equal to 3.2 x 10(5) M-1, 4.7 x 10(5) M-1, and 6.6 x 10(5) M-1 respectively, proving a relatively high affinity of Ant-PHEA for salmon testes DNA. Results of Hoechst 33258 displacement assays strongly support the groove binding mode of Ant-PHEA to DNA. The association stoichiometry of the Ant-PHEA:DNA adduct was found to be 1 for every 5 base pairs. FT-IR spectra, recorded at different Ant-PHEA/DNA molar ratios, indicate the involvement of the phosphate groups and adenine and thymine DNA bases in the association process. Thermodynamic results suggest that hydrophobic forces regulate the binding of Ant-PHEA with DNA without excluding some extent of involvement of van der Waals forces and hydrogen bonding arising due to surface binding between the hydrophilic polymeric arms of the ligand and the functional groups positioned on the edge of the groove. The resulting composite biomaterial could constitute a valuable candidate for future biological and/or photonic applications.
C1 [Deiana, Marco; Matczyszyn, Katarzyna; Olesiak-Banska, Joanna; Samoc, Marek] Wroclaw Univ Technol, Fac Chem, Adv Mat Engn & Modelling Grp, PL-50370 Wroclaw, Poland.
   [Mettra, Bastien; Pitrat, Delphine; Monnereau, Cyrille; Andraud, Chantal] Univ Lyon 1, Ecole Normale Super Lyon, CNRS UMR 5182, Chim Lab, F-69365 Lyon, France.
   [Piela, Katarzyna] Wroclaw Univ Technol, Fac Chem, Dept Phys & Quantum Chem, PL-50370 Wroclaw, Poland.
RP Matczyszyn, K (reprint author), Wroclaw Univ Technol, Fac Chem, Adv Mat Engn & Modelling Grp, Wyb Wyspianskiego 27, PL-50370 Wroclaw, Poland.
EM katarzyna.matczyszyn@pwr.edu.pl
OI Olesiak-Banska, Joanna/0000-0002-7226-0077; Monnereau,
   Cyrille/0000-0002-8928-2416; Matczyszyn, Katarzyna/0000-0001-8578-8340;
   Samoc, Marek/0000-0002-5404-2455
FU NCN OPUS project [DEC-2013/09/B/ST5/03417]
FX The financial support from NCN OPUS project DEC-2013/09/B/ST5/03417 and
   a statutory activity subsidy from the Polish Ministry of Science and
   Higher Education for the Faculty of Chemistry of WUT are acknowledged.
CR ALEXEEV DG, 1987, NATURE, V325, P821, DOI 10.1038/325821a0
   BAGULEY BC, 1991, ANTI-CANCER DRUG DES, V6, P1
   Bailly C, 1998, BIOCONJUGATE CHEM, V9, P513, DOI 10.1021/bc980008m
   Banerjee D, 2007, J PHYS CHEM B, V111, P10833, DOI 10.1021/jp074697n
   BENESI HA, 1949, J AM CHEM SOC, V71, P2703, DOI 10.1021/ja01176a030
   Bhadra K, 2011, BBA-GEN SUBJECTS, V1810, P485, DOI 10.1016/j.bbagen.2011.01.011
   Bi SY, 2008, SPECTROCHIM ACTA A, V69, P123, DOI 10.1016/j.saa.2007.03.017
   Ciardelli F, 2013, POLYM INT, V62, P22, DOI 10.1002/pi.4395
   Deiana M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129817
   Demeunynck M, 2002, DNA RNA BINDERS SMAL, DOI [10.1002/, DOI 10.1002/]
   DERVAN PB, 1986, SCIENCE, V232, P464, DOI 10.1126/science.2421408
   Dervan PB, 2001, BIOORGAN MED CHEM, V9, P2215, DOI 10.1016/S0968-0896(01)00262-0
   Dewey T. G., 1991, BIOPHYSICAL BIOCH AS, DOI 10.1007/978-1-4757-9513-4
   Dey S, 2010, POLYHEDRON, V29, P1583, DOI 10.1016/j.poly.2010.01.022
   DICKERSON RE, 1981, J MOL BIOL, V149, P761, DOI 10.1016/0022-2836(81)90357-0
   Dorraji P. S., 2012, J BRAZIL CHEM SOC, V24, P939
   Dragan AI, 2012, J FLUORESC, V22, P1189, DOI 10.1007/s10895-012-1059-8
   Ellestad G. A., 2012, NATURAL PROD BIOMOL, V2, P635
   Ellestad G. A., 2012, COMPREHENSIVE CHIROP, V2
   FREDERICK CA, 1990, BIOCHEMISTRY-US, V29, P2538, DOI 10.1021/bi00462a016
   Froehlich E, 2011, J PHYS CHEM B, V115, P9873, DOI 10.1021/jp205079u
   Froehlich E, 2011, BIOMACROMOLECULES, V12, P511, DOI 10.1021/bm1013102
   Garbett NC, 2007, NAT PROTOC, V2, P3166, DOI 10.1038/nprot.2007.475
   Gonzalez M. V., 1996, J INORG BIOCHEM, V63, P57
   Grote JG, 2004, J PHYS CHEM B, V108, P8584, DOI 10.1021/jp038056d
   Guan Y, 2006, ANAL CHIM ACTA, V570, P21, DOI 10.1016/j.aca.2006.03.106
   Guo YJ, 2007, SPECTROCHIM ACTA A, V68, P231, DOI 10.1016/j.saa.2006.11.019
   Hackl EV, 1997, J MOL STRUCT, V408, P229, DOI 10.1016/S0022-2860(96)09534-8
   He GS, 2008, CHEM REV, V108, P1245, DOI 10.1021/cr050054x
   Heckman EM, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2378400
   Huang Y, 2009, ORG BIOMOL CHEM, V7, P2278, DOI 10.1039/b823416g
   Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749
   Ihmels H, 2005, TOP CURR CHEM, V258, P161, DOI 10.1007/b135804
   Jalali F, 2017, ARAB J CHEM, V10, pS3947, DOI 10.1016/j.arabjc.2014.06.001
   James M.B., 1991, BIOCHEMISTRY-US, V30, P8918
   Jaumot J, 2012, CURR PHARM DESIGN, V18, P1900, DOI 10.2174/138161212799958486
   Kalanur SS, 2009, J ELECTROANAL CHEM, V636, P93, DOI 10.1016/j.jelechem.2009.09.018
   Kumar CV, 2000, TETRAHEDRON, V56, P7027, DOI 10.1016/S0040-4020(00)00526-3
   Kumar KA, 2009, APPL ORGANOMET CHEM, V23, P409, DOI 10.1002/aoc.1534
   Kumar S, 2012, J BIOSCIENCES, V37, P553, DOI 10.1007/s12038-012-9212-8
   Kwon YW, 2012, POLYM J, V44, P1191, DOI 10.1038/pj.2012.165
   Lakowicz J.R., 1999, PRINCIPLES FLUORESCE
   Laughton CA, 1996, BIOCHEMISTRY-US, V35, P5655, DOI 10.1021/bi952162r
   LAVERY R, 1981, NUCLEIC ACIDS RES, V9, P3765, DOI 10.1093/nar/9.15.3765
   Li XL, 2012, BIOMACROMOLECULES, V13, P873, DOI 10.1021/bm2017959
   Liu J, 2002, J INORG BIOCHEM, V91, P269, DOI 10.1016/S0162-0134(02)00441-5
   Liu YJ, 2008, SPECTROCHIM ACTA A, V70, P171, DOI 10.1016/j.saa.2007.07.029
   Mansouri M, 2013, MOLECULES, V18, P789, DOI 10.3390/molecules18010789
   MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8
   Massin J, 2013, OPT MATER, V35, P1810, DOI 10.1016/j.optmat.2013.04.021
   Massin J, 2013, CHEM SCI, V4, P2833, DOI 10.1039/c3sc22325f
   Matczyszyn K, 2012, J NANOPHOTONICS, V6, DOI 10.1117/1.JNP.6.064505
   MEYERALMES FJ, 1993, BIOCHEMISTRY-US, V32, P4246, DOI 10.1021/bi00067a012
   Mojzisova H, 2009, BIOPHYS J, V97, P2348, DOI 10.1016/j.bpj.2009.07.053
   Monnereau C, 2012, NEW J CHEM, V36, P2328, DOI 10.1039/c2nj40407a
   MORJANI H, 1993, CANCER RES, V53, P4784
   Nafisi S, 2005, DNA CELL BIOL, V24, P634, DOI 10.1089/dna.2005.24.634
   Nafisi S, 2007, J MOL STRUCT, V827, P35, DOI 10.1016/j.molstruc.2006.05.004
   Nakamoto N., 2008, METHOD BIOCHEM ANAL, V51, P1
   Navarro JRG, 2013, BIOMATERIALS, V34, P8344, DOI 10.1016/j.biomaterials.2013.07.032
   Neault JF, 1998, J PHYS CHEM B, V102, P1610, DOI 10.1021/jp972082s
   Neault JF, 1996, J BIOL CHEM, V271, P8140, DOI 10.1074/jbc.271.14.8140
   Neidle S, 2001, NAT PROD REP, V18, P291, DOI 10.1039/a705982e
   NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0
   Olesiak-Banska J, 2013, J PHYS CHEM B, V117, P12013, DOI 10.1021/jp407144k
   Olesiak-Banska J, 2012, CHEM PHYS, V404, P33, DOI 10.1016/j.chemphys.2012.02.001
   Olesiak-Banska J, 2011, BIOPOLYMERS, V95, P365, DOI 10.1002/bip.21583
   Ortiz M, 2011, J PHOTOCH PHOTOBIO A, V218, P26, DOI 10.1016/j.jphotochem.2010.11.020
   Paul A, 2012, CURR SCI INDIA, V102, P212
   Pawlicki M, 2009, ANGEW CHEM INT EDIT, V48, P3244, DOI 10.1002/anie.200805257
   PJURA PE, 1987, J MOL BIOL, V197, P257, DOI 10.1016/0022-2836(87)90123-9
   Pratviel G, 1998, ADV INORG CHEM, V45, P251, DOI 10.1016/S0898-8838(08)60027-6
   Qiao CY, 2008, SPECTROCHIM ACTA A, V70, P136, DOI 10.1016/j.saa.2007.07.038
   Rafique B, 2013, BIOSENS BIOELECTRON, V44, P21, DOI 10.1016/j.bios.2012.12.028
   Raman N, 2012, MONATSH CHEM, V143, P1487, DOI 10.1007/s00706-012-0718-4
   ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017
   Sarkar R, 2007, BIOMACROMOLECULES, V8, P3332, DOI 10.1021/bm700690p
   Sarwar T, 2015, MOL BIOSYST, V11, P522, DOI 10.1039/c4mb00636d
   Senthil K., 2009, INT J BIOTECHNOLOGY, V5, P251
   Shahabadi N, 2014, MOL BIOSYST, V10, P338, DOI 10.1039/c3mb70340a
   Shahabadi N, 2010, TRANSIT METAL CHEM, V35, P699, DOI 10.1007/s11243-010-9382-x
   Shakir M, 2009, SPECTROCHIM ACTA A, V71, P1851, DOI 10.1016/j.saa.2008.07.002
   Shi Y, 2011, BIOMACROMOLECULES, V12, P797, DOI 10.1021/bm101414w
   Sirajuddin M, 2013, J PHOTOCH PHOTOBIO B, V124, P1, DOI 10.1016/j.jphotobiol.2013.03.013
   Slobodyansky E., 1998, BIOPOLYMERS, V27, P1107
   Srour H, 2015, MACROMOL RAPID COMM, V36, P55, DOI 10.1002/marc.201400478
   Sun HX, 2011, BIOCHIMIE, V93, P1351, DOI 10.1016/j.biochi.2011.06.007
   Tan WB, 2006, PHOTOCHEM PHOTOBIOL, V82, P20, DOI 10.1562/2005-05-24-RA-539
   WALKER GT, 1985, BIOCHEMISTRY-US, V24, P7471, DOI 10.1021/bi00346a066
   Zhao N, 2010, SPECTROCHIM ACTA A, V75, P1435, DOI 10.1016/j.saa.2010.01.013
NR 90
TC 12
Z9 12
U1 1
U2 20
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
EI 1463-9084
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PY 2015
VL 17
IS 45
BP 30318
EP 30327
DI 10.1039/c5cp05381a
PG 10
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA CW2ZP
UT WOS:000364862000012
PM 26506886
DA 2018-10-19
ER

PT J
AU Plonska-Brzezinska, ME
   Bobrowska, DM
   Sharma, A
   Rodziewicz, P
   Tomczyk, M
   Czyrko, J
   Brzezinski, K
AF Plonska-Brzezinska, M. E.
   Bobrowska, D. M.
   Sharma, A.
   Rodziewicz, P.
   Tomczyk, M.
   Czyrko, J.
   Brzezinski, K.
TI Triple helical collagen-like peptide interactions with selected
   polyphenolic compounds
SO RSC ADVANCES
LA English
DT Article
ID SURFACE-PLASMON RESONANCE; SELF-ASSEMBLED MONOLAYERS; ATOMIC-FORCE
   MICROSCOPY; ALUMINUM-CHLORIDE PRETREATMENT; IMAGING ELLIPSOMETRY; TEA
   POLYPHENOLS; CROSS-LINKING; HYDROPHOBIC INTERACTIONS;
   MOLECULAR-STRUCTURE; MASS-SPECTROMETRY
AB Because collagen is the most abundant component of connective tissue, it is an excellent biomaterial in numerous medical applications. However, the utility of collagen is limited by its low mechanical strength in aqueous solutions and its susceptibility to proteolytic degradation in vivo. To improve the physical properties of collagen and to enhance its chemical resistance, it is necessary to stabilize its structure through chemical or physical modifications. In this study, we analyzed the interactions of a model molecule, a synthetic triple helical collagen-like peptide, with polyphenols such as curcumin, rutin, quercetin, naringin, and hypericin. Interactions between the peptide and polyphenolic compounds were analyzed using various techniques. The layer-by-layer assembly processes of a gold surface using the peptide and polyphenols was performed via surface plasmon resonance (SPR), atomic force microscopy (AFM), and ellipsometry. SPR screening of polyphenols was conducted in real time to select compounds that bind to the collagen-like peptide and could thus be applied to the stabilization of collagen. Selected polyphenols, especially naringin and hypericin, demonstrated notable binding to the peptide. To determine the nature of these interactions, experiments were supplemented with crystallographic studies and molecular docking of plant metabolites and collagen-like peptides.
C1 [Plonska-Brzezinska, M. E.; Bobrowska, D. M.; Rodziewicz, P.; Czyrko, J.; Brzezinski, K.] Univ Bialystok, Fac Chem & Biol, Inst Chem, PL-15399 Bialystok, Poland.
   [Sharma, A.] Ecole Polytech, CNRS, Lab Chim Mol, F-91128 Palaiseau, France.
   [Tomczyk, M.] Med Univ Bialystok, Fac Pharm, Dept Pharmacognosy, PL-15230 Bialystok, Poland.
RP Plonska-Brzezinska, ME (reprint author), Univ Bialystok, Fac Chem & Biol, Inst Chem, Hurtowa 1, PL-15399 Bialystok, Poland.
EM mplonska@uwb.edu.pl; k.brzezinski@uwb.edu.pl
RI Tomczyk, Michal/G-2161-2016
OI Tomczyk, Michal/0000-0002-4063-1048; Brzezinski,
   Krzysztof/0000-0001-9339-7745
FU National Science Centre, Poland [2011/01/B/ST5/06051,
   2012/05/E/ST5/03800]; European Funds for Regional Development as part of
   the Operational Programme Development of Eastern Poland
   [POPW.01.03.00-20-034/09]; European Community's Seventh Framework
   Programme (FP7) under BioStruct-X [283570]
FX We gratefully acknowledge the financial support of the National Science
   Centre, Poland (grants #2011/01/B/ST5/06051 and 2012/05/E/ST5/03800) to
   M.E.P.-B. AFM and FTIR were funded by the European Funds for Regional
   Development as part of the Operational Programme Development of Eastern
   Poland 2007-2013 (project: POPW.01.03.00-20-034/09). We thank HZB for
   the allocation of synchrotron radiation beamtime. Crystallographic study
   leading to these results has received funding from the European
   Community's Seventh Framework Programme (FP7/2007-2013) under
   BioStruct-X (grant agreement: 283570).
CR Aicart-Ramos C, 2012, BIOCHEMISTRY-US, V51, P7403, DOI 10.1021/bi300848x
   Allison DP, 2002, CURR OPIN BIOTECH, V13, P47, DOI 10.1016/S0958-1669(02)00283-5
   AVNIR D, 1994, CHEM MATER, V6, P1605, DOI 10.1021/cm00046a008
   BABU PS, 1995, MOL CELL BIOCHEM, V152, P13
   Bae YM, 2004, ANAL CHEM, V76, P1799, DOI 10.1021/ac034748m
   Bailey M, 2001, AM J PATHOL, V159, P1981, DOI 10.1016/S0002-9440(10)63048-9
   Bakhtiar R, 2013, J CHEM EDUC, V90, P203, DOI 10.1021/ed200549g
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Bella J, 2006, J MOL BIOL, V362, P298, DOI 10.1016/j.jmb.2006.07.014
   Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980
   Borch J, 2004, ANAL CHEM, V76, P5243, DOI 10.1021/ac049335f
   Hernandez JCR, 2007, BIOPHYS J, V93, P202, DOI 10.1529/biophysj.106.102491
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Choi S, 2010, JALA-J LAB AUTOM, V15, P172, DOI 10.1016/j.jala.2009.09.002
   D'Armiento J, 2003, J CLIN INVEST, V112, P1308, DOI 10.1172/JCI200320226
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   Damodaran G, 2009, J BIOMED MATER RES A, V89A, P1001, DOI 10.1002/jbm.a.32045
   Davila J, 2013, LANGMUIR, V29, P7488, DOI 10.1021/la3045779
   Ellis DL, 1996, BIOMATERIALS, V17, P291, DOI 10.1016/0142-9612(96)85567-0
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Erdmann RS, 2011, ANGEW CHEM INT EDIT, V50, P6835, DOI 10.1002/anie.201008118
   Faury G, 2003, J CLIN INVEST, V112, P1419, DOI 10.1172/JCI200319028
   FRASER RDB, 1979, J MOL BIOL, V129, P463, DOI 10.1016/0022-2836(79)90507-2
   Garcia-Marin A, 2014, ANAL CHEM, V86, P4969, DOI 10.1021/ac5005212
   Georgiadis R, 2000, J AM CHEM SOC, V122, P3166, DOI 10.1021/ja9930824
   Gough JE, 2002, J BIOMED MATER RES, V61, P121, DOI 10.1002/jbm.10145
   Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210
   Hafemann B, 2001, J MATER SCI-MATER M, V12, P437, DOI 10.1023/A:1011205221972
   HOFMANN H, 1978, J MOL BIOL, V125, P137, DOI 10.1016/0022-2836(78)90342-X
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Isenburg JC, 2006, BIOMATERIALS, V27, P3645, DOI 10.1016/j.biomaterials.2006.02.016
   Isenburg JC, 2005, BIOMATERIALS, V26, P1237, DOI 10.1016/j.biomaterials.2004.04.034
   Jarman-Smith ML, 2004, J MATER SCI-MATER M, V15, P925, DOI 10.1023/B:JMSM.0000036281.47596.cc
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kpegba K, 2007, ANAL CHEM, V79, P5479, DOI 10.1021/ac062276g
   Kramer RZ, 1998, J MOL BIOL, V280, P623, DOI 10.1006/jmbi.1998.1881
   Kumar VA, 2014, BIOMACROMOLECULES, V15, P1484, DOI 10.1021/bm500091e
   Kuroda Y, 1999, MUTAT RES-REV MUTAT, V436, P69, DOI 10.1016/S1383-5742(98)00019-2
   Li YJ, 2008, ANAL CHEM, V80, P891, DOI 10.1021/ac701873v
   LONG CG, 1992, J MOL BIOL, V225, P1, DOI 10.1016/0022-2836(92)91020-P
   LONG CG, 1993, BIOCHEMISTRY-US, V32, P11688, DOI 10.1021/bi00094a027
   Luther JM, 2011, NAT MATER, V10, P361, DOI [10.1038/nmat3004, 10.1038/NMAT3004]
   Madhan B, 2005, INT J BIOL MACROMOL, V37, P47, DOI 10.1016/j.ijbiomac.2005.08.005
   Madhan B, 2002, BIOMATERIALS, V23, P2841, DOI 10.1016/S0142-9612(01)00410-0
   Mandal A., 2010, BIOL ENG, V2, P63
   MARCHAND R, 1993, BRAIN RES BULL, V30, P415, DOI 10.1016/0361-9230(93)90273-E
   MLCZOCH J, 1975, RESPIRATION, V32, P424
   Munoz MG, 2000, LANGMUIR, V16, P1083, DOI 10.1021/la990142a
   Newton L, 2013, J MATER CHEM C, V1, P376, DOI 10.1039/c2tc00146b
   Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498
   PELI E, 1990, J OPT SOC AM A, V7, P2032, DOI 10.1364/JOSAA.7.002032
   Quinones M, 2013, PHARMACOL RES, V68, P125, DOI 10.1016/j.phrs.2012.10.018
   Rathi Badal, 2013, Sci Pharm, V81, P567, DOI 10.3797/scipharm.1301-16
   Saravanan S, 2014, IND CROP PROD, V54, P272, DOI 10.1016/j.indcrop.2014.01.038
   Shalev M, 2011, MATERIALS, V4, P469, DOI 10.3390/ma4030469
   Sigal GB, 1996, ANAL CHEM, V68, P490, DOI 10.1021/ac9504023
   SPEER DP, 1975, J SURG RES, V19, P169, DOI 10.1016/0022-4804(75)90077-3
   Sundararaghavan HG, 2008, J BIOMED MATER RES A, V87A, P308, DOI 10.1002/jbm.a.31715
   Swamy Radhakrishnan Narayana, 2011, BMC Res Notes, V4, P399, DOI 10.1186/1756-0500-4-399
   Taatjes DJ, 2013, J CELL PHYSIOL, V228, P1949, DOI 10.1002/jcp.24363
   Tang HR, 2003, BIOPOLYMERS, V70, P403, DOI 10.1002/bip.10499
   Tang HR, 2003, J AGR FOOD CHEM, V51, P6652, DOI 10.1021/jf034380u
   Tiong WHC, 2008, LANGMUIR, V24, P11752, DOI 10.1021/la801913c
   Tomczyk M, 2006, BIOCHEM SYST ECOL, V34, P770, DOI 10.1016/j.bse.2006.06.002
   Tsao R, 2010, NUTRIENTS, V2, P1231, DOI 10.3390/nu2121231
   Venkatesan N, 2000, BRIT J PHARMACOL, V129, P231, DOI 10.1038/sj.bjp.0703067
   Vita J. A., 2005, AM J CLIN NUTR, V81, p292S
   VONDERMARK K, 1981, INT REV CONNECT TISS, V9, P265
   Vutukuru S, 2006, LANGMUIR, V22, P10152, DOI 10.1021/la062093p
   Vyavahare N, 1999, AM J PATHOL, V155, P973, DOI 10.1016/S0002-9440(10)65197-8
   Wang W, 2013, ANAL CHEM, V85, P4446, DOI 10.1021/ac303783j
   Ward J, 2010, BIOMACROMOLECULES, V11, P3093, DOI 10.1021/bm100898p
   Wark AW, 2005, ANAL CHEM, V77, P3904, DOI 10.1021/ac050402v
   WASSER SK, 1991, J REPROD FERTIL, V92, P415
   Yamada H, 2007, CARDIOVASC RES, V73, P439, DOI 10.1016/j.cardiores.2006.11.008
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Yanase Y, 2010, BIOSENS BIOELECTRON, V26, P674, DOI 10.1016/j.bios.2010.06.065
   Yang CS, 2009, ARCH TOXICOL, V83, P11, DOI 10.1007/s00204-008-0372-0
   Zeugois DI, 2010, J BIOMED MATER RES A, V92A, P1310, DOI 10.1002/jbm.a.32383
NR 79
TC 3
Z9 4
U1 0
U2 16
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 116
BP 95443
EP 95453
DI 10.1039/c5ra15469c
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA CW3QR
UT WOS:000364907300006
DA 2018-10-19
ER

PT J
AU Poorvisha, R
   Suriyaraj, SP
   Thavamani, P
   Naidu, R
   Megharaj, M
   Bhattacharyya, A
   Selvakumar, R
AF Poorvisha, R.
   Suriyaraj, S. P.
   Thavamani, P.
   Naidu, Ravi
   Megharaj, Mallavarapu
   Bhattacharyya, Amitava
   Selvakumar, R.
TI Synthesis and characterisation of 3-dimensional hydroxyapatite
   nanostructures using a thermoplastic polyurethane nanofiber sacrificial
   template
SO RSC ADVANCES
LA English
DT Article
ID CALCIUM PHOSPHATES; AQUEOUS-SOLUTIONS; IN-VIVO; NANOPARTICLES; CERAMICS;
   SURFACE; SIZE; BIOMATERIAL; COMPOSITE; MEMBRANE
AB In this study, we report a facile synthesis of shape controlled three dimensional hydroxyapatite nanostructures (HAp) using a sacrificial thermoplastic polyurethane (TPU) nanofiber template. The TPU nanofibers synthesised using an electrospinning process were used as a template during the HAp synthesis through a precipitation process. Various HAp morphologies including distinctly placed cylindrically porous HAp architecture, coral reef like, tightly packed fibrous sheet like and nanofiber like were synthesised using the TPU nanofiber template. All the synthesised HAp were characterized using appropriate techniques like Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), field emission scanning electron microscopy (FESEM) attached with selected area electron diffraction (SAED), energy dispersive X-ray spectroscopy (EDS) and X-ray photoelectron spectroscopy (XPS). The morphology, pore arrangement and the particle size of the HAp varied significantly with varying dimensions of the template and the template available per unit area of HAp. Hence, we have achieved four different 3D HAp morphologies using a single type of TPU nanofiber template. The TPU templated HAp nanostructures were more biodegradable than the control HAp.
C1 [Poorvisha, R.; Suriyaraj, S. P.; Selvakumar, R.] PSG Inst Adv Studies, Nanobiotechnol Lab, Coimbatore 641004, Tamil Nadu, India.
   [Thavamani, P.; Naidu, Ravi; Megharaj, Mallavarapu; Selvakumar, R.] Univ Newcastle, GCER, Callaghan, NSW 2308, Australia.
   [Bhattacharyya, Amitava] PSG Inst Adv Studies, Adv Text & Polymer Res Lab, Coimbatore 641004, Tamil Nadu, India.
RP Selvakumar, R (reprint author), PSG Inst Adv Studies, Nanobiotechnol Lab, Coimbatore 641004, Tamil Nadu, India.
EM rsk@psgias.ac.in
RI Bhattacharyya, Amitava/O-3382-2017; Mallavarapu, Megharaj/D-3408-2011
OI Bhattacharyya, Amitava/0000-0001-6644-4294; Mallavarapu,
   Megharaj/0000-0002-6230-518X
FU Water Technology Initiatives (WTI), Department of Science and
   Technology, Government of India [DST/TM/WTI/2K13/137]
FX The authors are thankful to Water Technology Initiatives (WTI),
   Department of Science and Technology, Government of India for funding
   this study (Sanction no: DST/TM/WTI/2K13/137). Support and help rendered
   by PSG Management and PSG Institute of Advanced Studies is acknowledged.
   COE medical textiles, South India textile research association (SITRA)
   is acknowledged for helping us through FE-SEM imaging. The authors are
   thankful to Bayer Material Science for providing polymers.
CR Bailliez S, 2004, CHEM ENG J, V98, P141, DOI 10.1016/j.cej.2003.07.001
   Bajsic Emi Govorcin, 2014, Journal of Polymers, DOI 10.1155/2014/289283
   Chen F, 2002, MATER LETT, V57, P858, DOI 10.1016/S0167-577X(02)00885-6
   Cyster LA, 2005, BIOMATERIALS, V26, P697, DOI 10.1016/j.biomaterials.2004.03.017
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Erzsebet S. B., 2009, CHEM PAP, V63, P568
   Eslami H, 2010, MATER SCI-POLAND, V28, P5
   Ferraz M P, 2004, J Appl Biomater Biomech, V2, P74
   Gao S, 2009, J FLUORINE CHEM, V130, P550, DOI 10.1016/j.jfluchem.2009.03.007
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Ji LJ, 2011, CHEM COMMUN, V47, P9048, DOI 10.1039/c1cc11819f
   Junior J. H. S. A., 2013, MAT RES, V16, P860
   Lee JH, 2012, J MATER CHEM, V22, P11556, DOI 10.1039/c2jm31224g
   Li Z., 2007, J MATER SCI-MATER M, V16, P213
   Liang C, 2011, NANOTECHNOLOGY, V22
   Lu HB, 2000, ANAL CHEM, V72, P2886, DOI 10.1021/ac990812h
   Mahabole MP, 2005, B MATER SCI, V28, P535, DOI 10.1007/BF02706339
   Maries G. R. E., 2005, ANALELE U DIN ORADEA, V2, P125
   Mi HY, 2014, J BIOMED MATER RES B, V102, P1434, DOI 10.1002/jbm.b.33122
   Neumann M., 2006, EUR J TRAUMA, V2, P125
   Nguyen N., 2012, J MICRONANOMECHATRON, P1
   Paul W, 1999, J MATER SCI-MATER M, V10, P383, DOI 10.1023/A:1008918412198
   Pedicini A., 2003, J POLYM, V44, P6857
   Petrovic Z., 1991, J PROG POLYM SCI, V16, P695
   Raikar G. N., 1997, SURF SCI SPECTRA, V4, P9
   Rigo ECS, 2004, MAT SCI ENG C-BIO S, V24, P647, DOI 10.1016/j.msec.2004.08.044
   Rusu VM, 2005, BIOMATERIALS, V26, P5414, DOI 10.1016/j.biomaterials.2005.01.051
   SAGGIOWOYANSKY J, 1992, AM CERAM SOC BULL, V71, P1674
   Salimi E., 2012, ISRN CERAM, V2012
   Schachschal S, 2007, COLLOID POLYM SCI, V285, P1175, DOI 10.1007/s00396-007-1685-x
   Sheikh FA, 2012, EXPRESS POLYM LETT, V6, P41, DOI 10.3144/expresspolymlett.2012.5
   Singh A, 2012, B MATER SCI, V35, P1031, DOI 10.1007/s12034-012-0384-5
   Suriyaraj SP, 2015, RSC ADV, V5, P68420, DOI 10.1039/c5ra09469k
   Suriyaraj SP, 2015, RSC ADV, V5, P26905, DOI 10.1039/c5ra02523k
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   Temenoff J. S., 2008, BIOMATERIAL DEGRADAT, P178
   Tjandra W, 2006, NANOTECHNOLOGY, V17, P5988, DOI 10.1088/0957-4484/17/24/014
   Wen T, 2014, DALTON T, V43, P7464, DOI 10.1039/c3dt53591f
   Xia ZG, 2009, MATER RES BULL, V44, P1626, DOI 10.1016/j.materresbull.2009.04.014
   Yao C, 2013, POLYM COMPOSITE, V34, P1163, DOI 10.1002/pc.22525
   Yoshida Y, 2000, J DENT RES, V79, P709, DOI 10.1177/00220345000790020301
   Zhang Y, 2011, CHEM COMMUN, V47, P4126, DOI 10.1039/c1cc10489f
   Zhang YJ, 2003, CHEM PHYS LETT, V376, P493, DOI 10.1016/S0009-2614(03)01038-8
NR 43
TC 2
Z9 2
U1 4
U2 29
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 118
BP 97773
EP 97780
DI 10.1039/c5ra18593a
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CW8AF
UT WOS:000365220100083
DA 2018-10-19
ER

PT J
AU Sugimoto, H
   Imakita, K
   Fujii, M
AF Sugimoto, H.
   Imakita, K.
   Fujii, M.
TI Growth of novel boron-rich nanocrystals from oxygen-deficient
   borophosphosilicate glasses for boron neutron capture therapy
SO RSC ADVANCES
LA English
DT Article
ID SILICON NANOCRYSTALS; NANOPARTICLES; BNCT; SIZE; PHOTOLUMINESCENCE;
   LUMINESCENCE; PHOSPHORUS; SPECTRA; ALLOYS; RANGE
AB We develop a new type of boron (B)-rich nanocrystals (NCs) for applications in Boron Neutron Capture Therapy (BNCT). Phase separation of oxygen (O) deficient borophosphosilicate glasses (BPSG) by annealing in inert ambient gas results in the growth of different types of B-rich NCs. When the silicon (Si) concentration is much higher than the others, B and phosphorus (P) co-doped Si-NCs are grown. In the opposite case, cubic boron phosphide (BP) NCs are grown. In between two extremes, we demonstrate the growth of a new type of cubic NCs consisting of B, Si and P with an average B concentration up to 36 at%. The B-rich NCs are dispersible in water and exhibit photoluminescence in the biological window. These properties in combination with the capability of the bio-functionalization via the surface Si-hydrogen (H) and Si-O bonds suggest that the B-rich NCs can be a multifunctional biomaterial used for imaging, diagnosis and BNCT.
C1 [Sugimoto, H.; Imakita, K.; Fujii, M.] Kobe Univ, Grad Sch Engn, Dept Elect & Elect Engn, Nada Ku, Kobe, Hyogo 6578501, Japan.
RP Fujii, M (reprint author), Kobe Univ, Grad Sch Engn, Dept Elect & Elect Engn, Nada Ku, Kobe, Hyogo 6578501, Japan.
EM fujii@eedept.Kobe-u.ac.jp
RI Kobe Univ, Engineering/D-2028-2017; Sugimoto, Hiroshi/G-3034-2013;
   Fujii, Minoru/G-3777-2011
OI Fujii, Minoru/0000-0003-4869-7399
FU JSPS Bilateral Joint Research Projects (Japan-Czech Republic); 
   [26-3120]
FX HS acknowledges Grant-in-Aid for JSPS Fellows (# 26-3120). This work is
   supported by 2014 JSPS Bilateral Joint Research Projects (Japan-Czech
   Republic).
CR Achilli C, 2014, NANOMED-NANOTECHNOL, V10, P589, DOI 10.1016/j.nano.2013.10.003
   Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162
   Barth R. F., 1999, NEUROSURGERY, V44, P146
   Barth R. F., 2009, APPL RADIAT ISOTOPES, V67, P67
   Barth RF, 2003, J NEURO-ONCOL, V62, P1
   Barth RF, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-146
   Chen GJ, 2014, MOL PHARMACEUT, V11, P3291, DOI 10.1021/mp400641u
   Dasog M, 2014, ACS NANO, V8, P9636, DOI 10.1021/nn504109a
   Grandi S, 2012, J SOL-GEL SCI TECHN, V64, P358, DOI 10.1007/s10971-012-2865-9
   Hannah DC, 2012, NANO LETT, V12, P4200, DOI 10.1021/nl301787g
   Hessel C. M., 2011, CHEM MATER, V24, P393
   Hyam RS, 2008, COLLOID SURFACE A, V315, P61, DOI 10.1016/j.colsurfa.2007.07.010
   Irvine DJ, 2011, NAT MATER, V10, P342, DOI 10.1038/nmat3014
   Kabalka GW, 1997, J NUCL MED, V38, P1762
   Lee JE, 2010, J AM CHEM SOC, V132, P552, DOI 10.1021/ja905793q
   Lu ZH, 1997, APPL PHYS LETT, V71, P2764, DOI 10.1063/1.120438
   LUCOVSKY G, 1979, PHYS REV B, V19, P2064, DOI 10.1103/PhysRevB.19.2064
   Maruyama K, 2004, J CONTROL RELEASE, V98, P195, DOI 10.1016/j.jconrel.2004.04.018
   Montalti M, 2015, CHEM SOC REV, V44, P4853, DOI 10.1039/c4cs00486h
   Mortensen MW, 2006, APPL RADIAT ISOTOPES, V64, P315, DOI 10.1016/j.apradiso.2005.08.003
   PEARSON GL, 1949, PHYS REV, V75, P865, DOI 10.1103/PhysRev.75.865
   Shubina ES, 2002, J ORGANOMET CHEM, V657, P155, DOI 10.1016/S0022-328X(02)01380-3
   Smith AM, 2009, NAT NANOTECHNOL, V4, P710, DOI 10.1038/nnano.2009.326
   Soloway AH, 1998, CHEM REV, V98, P1515, DOI 10.1021/cr941195u
   Soraru GD, 1999, CHEM MATER, V11, P910, DOI 10.1021/cm980353l
   Soraru GD, 2000, J SOL-GEL SCI TECHN, V18, P11, DOI 10.1023/A:1008733511697
   Sugimoto H, 2015, RSC ADV, V5, P8427, DOI 10.1039/c4ra13530j
   Sugimoto H, 2014, NANOSCALE, V6, P122, DOI 10.1039/c3nr03863g
   Sugimoto H, 2013, J PHYS CHEM C, V117, P11850, DOI 10.1021/jp4027767
   Sugimoto H, 2012, J PHYS CHEM C, V116, P17969, DOI 10.1021/jp305832x
   TAGUE TJ, 1994, J AM CHEM SOC, V116, P4970, DOI 10.1021/ja00090a048
   Tsutsui K, 2008, J APPL PHYS, V104, DOI 10.1063/1.3014033
NR 32
TC 5
Z9 5
U1 0
U2 7
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 119
BP 98248
EP 98253
DI 10.1039/c5ra18500a
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA CX0QZ
UT WOS:000365403000044
DA 2018-10-19
ER

PT J
AU Mitra, T
   Manna, PJ
   Raja, STK
   Gnanamani, A
   Kundu, PP
AF Mitra, Tapas
   Manna, Piyali Jana
   Raja, S. T. K.
   Gnanamani, A.
   Kundu, P. P.
TI Curcumin loaded nano graphene oxide reinforced fish scale collagen - a
   3D scaffold biomaterial for wound healing applications
SO RSC ADVANCES
LA English
DT Article
ID GRAPHITE OXIDE; STEM-CELLS; SKIN; FILMS; DELIVERY; SHEETS; BONE;
   DIFFERENTIATION; ADSORPTION; REDUCTION
AB In recent years, graphene oxide (GO) has been functionalized to make GO a potential useful material in the biomedical field. GO is a one-atom thick planar sheet of sp(2)-bonded carbon atoms with functional groups containing oxygen attached to both the sides and surface area of the flake. Functionalized GO has attracted significant research interest based on its potential application in different fields including biomedicine. In the present work we prepare highly stabilized nano graphene oxide (NGO) in aqueous media. NGO is functionalized with type I collagen (2 : 1, NGO : collagen) to make a 3D scaffold as a novel platform for better tissue engineering research. The functionalization of NGO is achieved by a grafting process, an innovative method to modify the properties of NGO. The size of the prepared NGO is measured by dynamic light scattering, and the collagen functionalized NGO (CFNGO) is characterized by X-ray diffraction, attenuated total reflectance (ATR)-FTIR, ultraviolet visible (UV-vis), atomic force microscopy (AFM) and Raman spectroscopy. The surface property of the CFNGO is characterized by employing transmission electron microscopy (TEM) and scanning electron microscopy (SEM). The mechanical stability of the CFNGO is three times greater than that of native collagen. An in vitro cell line study reveals no toxicity of CFNGO against NIH 3T3 fibroblast cell line. The antimicrobial study of curcumin loaded CFNGO shows Gram +ve and Gram -ve organism growth is reduced by a considerable amount, and in vivo wound healing studies showed faster wound healing efficiency of curcumin loaded CFNGO scaffold than that of collagen alone. These findings suggest that curcumin loaded CFNGO could serve as a better platform for wound healing applications.
C1 [Mitra, Tapas; Manna, Piyali Jana; Kundu, P. P.] Univ Calcutta, Univ Coll Sci & Technol, Dept Polymer Sci & Technol, Kolkata 700009, W Bengal, India.
   [Raja, S. T. K.; Gnanamani, A.] CSIR, Div Microbiol, Cent Leather Res Inst, Madras 600020, Tamil Nadu, India.
RP Kundu, PP (reprint author), Univ Calcutta, Univ Coll Sci & Technol, Dept Polymer Sci & Technol, 92 APC Rd, Kolkata 700009, W Bengal, India.
EM ppk923@yahoo.com
RI Selvaraj, ThirupathiKumaraRaja/P-1646-2014
OI Selvaraj, ThirupathiKumaraRaja/0000-0002-0502-1172; Mitra,
   Tapas/0000-0003-0813-7389
FU UGC, New Delhi
FX One of he authors Dr Tapas Mitra acknowledges UGC, New Delhi, for
   financial assistance provided in the form of Dr D. S. Kothari
   Post-Doctoral Fellowship. All authors thank Dr Achintya Singha,
   Department of Physics, Bose Institute, 93/1, Acharya Prafulla Chandra
   Road, Kolkata 700009, India, for his assistance with Raman spectroscopy.
   Authors also acknowledge Mr Sourav Chakraborty, Calcutta University -
   DBT Interdisciplinary Program in Life Science (DBT-IPLS), 35 Ballygunge
   Circular Road Kolkata-700019, for AFM analysis. Authors also acknowledge
   Miss Urmila Goswami, CRNN, University of Calcutta, JD-2, Salt Lake City,
   Kolkata 700098, West Bengal, India for her help with the TEM images of
   the samples.
CR Aggarwal BB, 2003, ANTICANCER RES, V23, P363
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Balakrishnan B, 2005, BIOMATERIALS, V26, P6335, DOI 10.1016/j.biomaterials.2005.04.012
   Bama P., 2010, INT J PHARM PHARM SC, V2, P133
   Bao HQ, 2011, SMALL, V7, P1569, DOI 10.1002/smll.201100191
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Bilgen G, 1999, TURK J VET ANIM SCI, V23, P483
   Bisht Savita, 2009, Curr Drug Discov Technol, V6, P192
   Cha CY, 2013, ACS NANO, V7, P2891, DOI 10.1021/nn401196a
   Chen GY, 2012, BIOMATERIALS, V33, P418, DOI 10.1016/j.biomaterials.2011.09.071
   Chng ELK, 2013, CHEM-EUR J, V19, P8227, DOI 10.1002/chem.201300824
   Cuong TV, 2010, MATER LETT, V64, P399, DOI 10.1016/j.matlet.2009.11.029
   Desimone MF, 2010, J MATER CHEM, V20, P666, DOI 10.1039/b921572g
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Gopinath D, 2004, BIOMATERIALS, V25, P1911, DOI 10.1016/S0142-9612(03)00625-2
   Han SY, 2005, DYES PIGMENTS, V64, P157, DOI 10.1016/j.dyepig.2004.05.008
   Hong J, 2012, ACS NANO, V6, P81, DOI 10.1021/nn202607r
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Jonglareonrak A, 2005, FOOD CHEM, V93, P475, DOI 10.1016/j.foodchem.2004.10.026
   Kudin KN, 2008, NANO LETT, V8, P36, DOI 10.1021/nl071822y
   La WG, 2013, SMALL, V9, DOI 10.1002/smll.201300571
   Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c
   Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30
   Liao KH, 2011, ACS APPL MATER INTER, V3, P2607, DOI 10.1021/am200428v
   Liu L, 2012, TALANTA, V93, P350, DOI 10.1016/j.talanta.2012.02.051
   Loh KP, 2010, NAT CHEM, V2, P1015, DOI 10.1038/NCHEM.907
   Malesu V. K., 2011, INT J APPL BIOL PHAR, V3, P402
   Manna PJ, 2015, INT J BIOL MACROMOL, V75, P437, DOI 10.1016/j.ijbiomac.2015.01.047
   Mitra T, 2014, J CHEM SCI, V126, P127, DOI 10.1007/s12039-013-0543-2
   Nagai T, 2004, INT J FOOD SCI TECH, V39, P239, DOI 10.1111/j.1365-2621.2004.00777.x
   Nagai T, 2002, FOOD CHEM, V78, P173, DOI 10.1016/S0308-8146(01)00396-X
   Nagai T, 2000, FOOD CHEM, V68, P277, DOI 10.1016/S0308-8146(99)00188-0
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   Nguyen V. C., 2013, INT J POLYM SCI, V2013
   Ogawa M, 2003, J AGR FOOD CHEM, V51, P8088, DOI 10.1021/jf034350r
   Panchatcharam M, 2006, MOL CELL BIOCHEM, V290, P87, DOI 10.1007/s11010-006-9170-2
   Paredes JI, 2008, LANGMUIR, V24, P10560, DOI 10.1021/la801744a
   Park SY, 2008, FOOD CHEM TOXICOL, V46, P2881, DOI 10.1016/j.fct.2008.05.030
   Park S, 2008, CHEM MATER, V20, P6592, DOI 10.1021/cm801932u
   Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/NNANO.2009.58, 10.1038/nnano.2009.58]
   Pati F, 2010, BIORESOURCE TECHNOL, V101, P3737, DOI 10.1016/j.biortech.2009.12.133
   Schniepp HC, 2006, J PHYS CHEM B, V110, P8535, DOI 10.1021/jp060936f
   Shi XT, 2012, ADV FUNCT MATER, V22, P751, DOI 10.1002/adfm.201102305
   Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034
   Strasser EM, 2005, BIOCHEM PHARMACOL, V70, P552, DOI 10.1016/j.bcp.2005.05.030
   Sun XM, 2008, NANO RES, V1, P203, DOI 10.1007/s12274-008-8021-8
   Swatschek D, 2002, EUR J PHARM BIOPHARM, V53, P107, DOI 10.1016/S0939-6411(01)00192-8
   Tang ML, 2013, BIOMATERIALS, V34, P6402, DOI 10.1016/j.biomaterials.2013.05.024
   Vajragupta O, 2005, BIOORG MED CHEM LETT, V15, P3364, DOI 10.1016/j.bmcl.2005.05.032
   Wakeland S, 2010, CARBON, V48, P3463, DOI 10.1016/j.carbon.2010.05.043
   Wang JC, 2011, POLYM INT, V60, P816, DOI 10.1002/pi.3025
   Wang K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9751-6
   Xia ZM, 2013, ACTA BIOMATER, V9, P7308, DOI 10.1016/j.actbio.2013.03.038
   Yang D, 2009, CARBON, V47, P145, DOI 10.1016/j.carbon.2008.09.045
   Yang K, 2011, ACS NANO, V5, P516, DOI 10.1021/nn1024303
   Yunoki S, 2003, J BIOSCI BIOENG, V96, P575, DOI 10.1016/S1389-1723(04)70152-8
   Zhang LM, 2010, SMALL, V6, P537, DOI 10.1002/smll.200901680
   Zhu YW, 2010, ADV MATER, V22, P3906, DOI 10.1002/adma.201001068
NR 58
TC 12
Z9 12
U1 1
U2 49
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 119
BP 98653
EP 98665
DI 10.1039/c5ra15726a
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA CX0QZ
UT WOS:000365403000093
DA 2018-10-19
ER

PT J
AU Wang, XC
   Shi, MC
   Zhai, D
   Wu, CT
AF Wang, Xiaocheng
   Shi, Mengchao
   Zhai, Dong
   Wu, Chengtie
TI Preparation, physicochemical properties and in vitro bioactivity of
   hierarchically porous bioactive glass scaffolds
SO RSC ADVANCES
LA English
DT Article
ID GENE-EXPRESSION; IMMOBILIZATION; BIOMATERIALS; REGENERATION; EFFICIENCY;
   STIFFNESS; STRENGTH; BEHAVIOR; LIPASE; SBA-15
AB Exploring bioactive scaffolds with the desired architecture and high osteogenic capacity has been a challenging issue for biomaterials and bone tissue engineering. Herein, a hierarchically porous bioactive glass scaffold (noted as YMBG) has been prepared by using P123, yeast cells and polyurethane sponges as templates. This synthesis strategy created high porosity scaffolds with interconnected macropores (300-500 mm), well-ordered mesopores (similar to 5 nm) and mid-level pores (20 nm to 2 mm). The utilization of yeast cells as a midpore biotemplate in the scaffolds significantly promoted the crystallization and improved their mechanical strengths. In addition, the prepared scaffolds could support attachment and proliferation of BMSCs, and more importantly, significantly improved the expression of bone-related genes (Runx2, OCN, Col I and BMP2). The results suggest that the novel bioactive glass scaffolds with widely-distributed porous structures, which can be employed as an effective carrier for a variety of therapeutic molecules and tissue cells, are expected to be a promising biomaterial for bone regeneration and tissue engineering.
C1 [Wang, Xiaocheng; Shi, Mengchao; Zhai, Dong; Wu, Chengtie] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Wu, CT (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM chengtiewu@mail.sic.ac.cn
FU Recruitment Program of Global Young Talent, China; National High
   Technology Research and Development Program of China (863 Program)
   [SS2015AA020302]; Program of Shanghai Outstanding Academic Leaders
   [15XD1503900]
FX Funding for this study was provided by the Recruitment Program of Global
   Young Talent, China (Dr Wu), the National High Technology Research and
   Development Program of China (863 Program, SS2015AA020302) and Program
   of Shanghai Outstanding Academic Leaders (15XD1503900).
CR Alcaide M, 2010, ACTA BIOMATER, V6, P892, DOI 10.1016/j.actbio.2009.09.008
   Arcos D, 2009, J MATER SCI-MATER M, V20, P447, DOI 10.1007/s10856-008-3616-x
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Chatzistavrou X, 2004, PHYS STATUS SOLIDI A, V201, P944, DOI 10.1002/pssa.200306776
   Cui JJ, 2009, COLLOID SURFACE B, V74, P274, DOI 10.1016/j.colsurfb.2009.07.030
   Deng Y, 2015, INT J NANOMED, V10, P1425, DOI 10.2147/IJN.S75557
   Douglas T, 2007, BIOMACROMOLECULES, V8, P1085, DOI 10.1021/bm0609644
   Fan J, 2003, ANGEW CHEM INT EDIT, V42, P3146, DOI 10.1002/anie.200351027
   Gao SL, 2010, BIORESOURCE TECHNOL, V101, P3830, DOI 10.1016/j.biortech.2010.01.023
   Gibson M. F. A. L. J., 1999, CELLULAR SOLIDS STRU, P429
   He W, 2014, ADV FUNCT MATER, V24, P2206, DOI 10.1002/adfm.201303278
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   Her GJ, 2013, ACTA BIOMATER, V9, P5170, DOI 10.1016/j.actbio.2012.10.012
   Hong YL, 2010, ADV MATER, V22, P754, DOI 10.1002/adma.200901656
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Huang MJ, 2012, J MATER CHEM, V22, P626, DOI 10.1039/c1jm13905c
   Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Kang Y, 2007, IND ENG CHEM RES, V46, P4474, DOI 10.1021/ie061440n
   Kim HW, 2006, ADV FUNCT MATER, V16, P1529, DOI 10.1002/adfm.200500750
   Kobayashi M, 1998, J BIOMED MATER RES, V42, P223, DOI 10.1002/(SICI)1097-4636(199811)42:2<223::AID-JBM7>3.0.CO;2-R
   Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000
   Li X, 2008, J MATER CHEM, V18, P4103, DOI 10.1039/b805114c
   Li X, 2007, CHEM MATER, V19, P4322, DOI 10.1021/cm0708564
   Li Z, 2013, BIOMATERIALS, V34, P7616, DOI 10.1016/j.biomaterials.2013.06.059
   Luo C, 2012, J MATER CHEM, V22, P15654, DOI 10.1039/c2jm32007j
   Selvakumar R, 2014, RSC ADV, V4, P52156, DOI 10.1039/c4ra07903e
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Wu CT, 2012, INTERFACE FOCUS, V2, P292, DOI 10.1098/rsfs.2011.0121
   Wu CT, 2011, ACTA BIOMATER, V7, P2644, DOI 10.1016/j.actbio.2011.03.009
   Wu CT, 2010, BIOMATERIALS, V31, P3429, DOI 10.1016/j.biomaterials.2010.01.061
   Wu Y, 2014, ADV FUNCT MATER, V24, P4473, DOI 10.1002/adfm.201304304
   Xia W, 2008, MICROPOR MESOPOR MAT, V108, P345, DOI 10.1016/j.micromeso.2007.04.013
   Xu MC, 2013, BIOMATER SCI-UK, V1, P933, DOI 10.1039/c3bm60028a
   Yan XX, 2005, J NON-CRYST SOLIDS, V351, P3209, DOI 10.1016/j.jnoncrysol.2005.08.024
   Yan XX, 2004, ANGEW CHEM INT EDIT, V43, P5980, DOI 10.1002/anie.200460598
   Yun HS, 2007, CHEM COMMUN, P2139, DOI 10.1039/b702103h
   Zhang B, 2015, COLLOID SURFACE B, V131, P129, DOI 10.1016/j.colsurfb.2015.04.060
   Zhang XD, 2013, COLLOID SURFACE B, V103, P114, DOI 10.1016/j.colsurfb.2012.10.002
   Zhu YF, 2008, MICROPOR MESOPOR MAT, V112, P494, DOI 10.1016/j.micromeso.2007.10.029
   Zhu YF, 2011, MICROPOR MESOPOR MAT, V143, P311, DOI 10.1016/j.micromeso.2011.03.007
NR 41
TC 0
Z9 0
U1 2
U2 33
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 120
BP 98796
EP 98804
DI 10.1039/c5ra19125d
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA CW9OL
UT WOS:000365328000009
DA 2018-10-19
ER

PT J
AU Hu, ZM
   Li, C
   Nie, RM
   Li, YQ
   Tang, JX
   Deng, XY
AF Hu, Zhimei
   Li, Chi
   Nie, Riming
   Li, Yan-Qing
   Tang, Jian-Xin
   Deng, Xianyu
TI Biomaterial functionalized graphene oxides with tunable work function
   for high sensitive organic photodetectors
SO RSC ADVANCES
LA English
DT Article
ID HIGH-DETECTIVITY; TRANSPARENT; FILMS; IMMOBILIZATION; COMPOSITES;
   ELECTRODES; MOLECULES; CATALYSIS
AB Graphene acts as an ideal material for transparent conductive electrodes in optoelectronic devices attributed to its excellent electrical conductivity, optical transparency, and mechanical properties. Graphene oxide (GO) in the form of a colloidal suspension is considered to be more commonly useful because of its low cost and high volume production. However, controlling the work function of graphene and GO as transparent electrodes in optoelectronic devices is still a challenging task, since it is important to match the energy level of the active materials. In this study, GO sheets functionalized with amino acids were fabricated via a mild and environmentally friendly approach. The work functions of the novel amino acid functionalized graphenes and their compounds with poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS) were tuned over a wide range, which matched well with the energy of various semiconductors. Organic photodetectors with the functionalized GO exhibited the highest normalized detectivity of 5.7 x 10(12) jones at -0.1 V. The results indicated that the synthesized solution-processable GO exhibits promising potential as transparent electrodes for various photoelectric devices.
C1 [Hu, Zhimei; Nie, Riming; Deng, Xianyu] Harbin Inst Technol, Res Ctr Adv Funct Mat & Devices, Shenzhen Key Lab Adv Mat, Shenzhen Grad Sch,Sch Mat Sci & Engn, Shenzhen 518055, Peoples R China.
   [Li, Chi; Li, Yan-Qing; Tang, Jian-Xin] Soochow Univ, Inst Funct Nano & Soft Mat FUNSOM, Jiangsu Key Lab Carbon Based Funct Mat & Devices, Suzhou 215123, Peoples R China.
RP Deng, XY (reprint author), Harbin Inst Technol, Res Ctr Adv Funct Mat & Devices, Shenzhen Key Lab Adv Mat, Shenzhen Grad Sch,Sch Mat Sci & Engn, Shenzhen 518055, Peoples R China.
EM jxtang@suda.edu.cn; xydeng@hitsz.edu.cn
RI Tang, Jianxin/A-1452-2013; Li, Yanqing/C-7262-2013
OI Deng, Xianyu/0000-0003-0653-6765
FU Shenzhen Research Foundation Project [JCYJ20140417161,
   KQCX20140521144147315]
FX This work is supported by the Shenzhen Research Foundation Project
   (Grants JCYJ20140417161, and KQCX20140521144147315).
CR Bao HQ, 2011, SMALL, V7, P1569, DOI 10.1002/smll.201100191
   Deng XY, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201400215
   Depan D, 2014, BIOMATER SCI-UK, V2, P264, DOI 10.1039/c3bm60192g
   Devi R, 2014, J CHEM SCI, V126, P75, DOI 10.1007/s12039-013-0536-1
   Eda G, 2008, NAT NANOTECHNOL, V3, P270, DOI 10.1038/nnano.2008.83
   Eda G, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2937846
   Gong X, 2009, SCIENCE, V325, P1665, DOI 10.1126/science.1176706
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Kapitanova OO, 2012, J KOREAN PHYS SOC, V60, P1789, DOI 10.3938/jkps.60.1789
   Li AY, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4870096
   Li QZ, 2013, IND ENG CHEM RES, V52, P6343, DOI 10.1021/ie400558u
   Liu YF, 2015, ORG ELECTRON, V26, P81, DOI 10.1016/j.orgel.2015.06.031
   Lu F, 2012, ACS APPL MATER INTER, V4, P3278, DOI 10.1021/am300634n
   Lu Q., 2010, SCI CHINA TECHNOL SC, V9, P2311
   Nie RM, 2014, ACS APPL MATER INTER, V6, P7032, DOI 10.1021/am501977w
   Nie RM, 2014, J MATER CHEM A, V2, P6734, DOI 10.1039/c4ta00152d
   Si Y, 2008, NANO LETT, V8, P1679, DOI 10.1021/nl080604h
   Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034
   Su Q, 2009, ADV MATER, V21, P3191, DOI 10.1002/adma.200803808
   Sun ST, 2010, J MATER CHEM, V20, P5605, DOI 10.1039/c0jm01269f
   Wan L, 2015, J MATER SCI, V50, P2148, DOI 10.1007/s10853-014-8777-z
   Wang X, 2008, NANO LETT, V8, P323, DOI 10.1021/nl072838r
   Wang Y, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3204698
   Wu JB, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2924771
   Wu JB, 2010, ACS NANO, V4, P43, DOI 10.1021/nn900728d
   Xu T., 2011, ENERG ENVIRON SCI, V8, P2700
   Xu YF, 2010, CARBON, V48, P3308, DOI 10.1016/j.carbon.2010.05.017
   Yan H, 2009, POLYM J, V41, P1028, DOI 10.1295/polymj.PJ2009143
   Yin ZY, 2010, ACS NANO, V4, P5263, DOI 10.1021/nn1015874
   Yoo D, 2014, NANO RES, V7, P717, DOI 10.1007/s12274-014-0433-z
   Zhang LM, 2010, SMALL, V6, P537, DOI 10.1002/smll.200901680
   Zhang WF, 2013, NANOSCALE, V5, P6030, DOI 10.1039/c3nr01323e
   Zhang Y., 2010, ACS NANO, V4, P2865
   Zhu JH, 2011, CARBON, V49, P1900, DOI 10.1016/j.carbon.2011.01.014
NR 34
TC 9
Z9 9
U1 5
U2 33
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 120
BP 99431
EP 99438
DI 10.1039/c5ra19476h
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CW9OL
UT WOS:000365328000083
DA 2018-10-19
ER

PT J
AU Bhaskar, TBV
   Ma, N
   Lendlein, A
   Roch, T
AF Bhaskar, Thanga Bhuvanesh Vijaya
   Ma, Nan
   Lendlein, Andreas
   Roch, Toralf
TI The interaction of human macrophage subsets with silicone as a
   biomaterial
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Biomaterials; silicone; macrophage subsets; cytokines/chemokines
ID POLY(N-BUTYL ACRYLATE) NETWORKS; BREAST IMPLANTS; ANTIINFLAMMATORY
   CYTOKINES; INNATE IMMUNITY; ACTIVATION; POLARIZATION; CELLS;
   POLYDIMETHYLSILOXANE; ATTACHMENT; ELASTOMERS
AB Silicones are widely used as biomaterials for medical devices such as extracorporeal equipments. However, there is often conflicting evidence about their supposed cell-and histocompatibility. Macrophages could mediate silicone-induced adverse responses such as foreign body reaction and fibrous encapsulation. The polarization behaviour of macrophages could determine the clinical outcome after implantation of biomaterials. Induction of classically activated macrophages (CAM) may induce and support uncontrolled inflammatory responses and undesired material degradation. In contrast, polarization into alternatively activated macrophages (AAM) is assumed to support healing processes and implant integration.
   This study compared the interaction of non-polarized macrophages (M0), CAM, and AAM with commercially available tissue culture polystyrene (TCP) and a medical grade silicone-based biomaterial, regarding the secretion of inflammatory mediators such as cytokines and chemokines. Firstly, by using the Limulus amoebocyte lysate (LAL) test the silicone films were shown to be free of soluble endotoxins, which is the prerequisite to investigate their interaction with primary immune cells. Primary human monocyte-derived macrophages (M0) were polarized into CAM and AAM by addition of suitable differentiation factors. These macrophage subsets were incubated on the materials for 24 hours and their viability and cytokine secretion was assessed. In comparison to TCP, cell adhesion was lower on silicone after 24 hours for all three macrophage subsets. However, compared to TCP, silicone induced higher levels of certain inflammatory and chemotactic cytokines in M0, CAM, and AAM macrophage subsets.
   Conclusively, it was shown that silicone has the ability to induce a pro-inflammatory state to different magnitudes dependent on the macrophage subsets. This priming of the macrophage phenotype by silicone could explain the incidence of severe foreign body complications observed in vivo.
C1 [Bhaskar, Thanga Bhuvanesh Vijaya; Ma, Nan; Lendlein, Andreas; Roch, Toralf] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, D-14513 Teltow, Germany.
   [Bhaskar, Thanga Bhuvanesh Vijaya; Ma, Nan; Lendlein, Andreas; Roch, Toralf] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, D-14513 Teltow, Germany.
   [Bhaskar, Thanga Bhuvanesh Vijaya; Lendlein, Andreas] Univ Potsdam, Inst Chem, Potsdam, Germany.
   [Ma, Nan; Lendlein, Andreas] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany.
   [Bhaskar, Thanga Bhuvanesh Vijaya; Ma, Nan; Lendlein, Andreas; Roch, Toralf] Helmholtz Virtual Inst Multifunct Biomat Med, Teltow, Germany.
   [Bhaskar, Thanga Bhuvanesh Vijaya; Ma, Nan; Lendlein, Andreas; Roch, Toralf] Helmholtz Virtual Inst Multifunct Biomat Med, Berlin, Germany.
RP Roch, T (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
EM toralf.roch@hzg.de
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Roch, Toralf/0000-0003-2948-8700
FU Helmholtz Virtual Institute, Multifunctional Biomaterials for Medicine
   [VH-VI-423]; Helmholtz-Association, Impuls- und Vernetzungsfond [SO-036]
FX The authors acknowledge Ruth Hesse and Anja Muller-Heyn for their
   technical assistance. This work was funded by the Helmholtz Virtual
   Institute, Multifunctional Biomaterials for Medicine (grant no.
   VH-VI-423) and partially supported by the Helmholtz-Association, Impuls-
   und Vernetzungsfond (grant no. SO-036).
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   [Anonymous], 2012, GUIDANCE IND PYROGEN
   Backovic A, 2007, J IMMUNOL METHODS, V328, P118, DOI 10.1016/j.jim.2007.08.016
   Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406
   BERG B, 1981, REFERENCE VALUES LAB, P55
   BONFIELD TL, 1991, J BIOMED MATER RES, V25, P165, DOI 10.1002/jbm.820250204
   Braune S, 2011, CLIN HEMORHEOL MICRO, V49, P375, DOI 10.3233/CH-2011-1487
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Franca DCC, 2011, J CRANIOFAC SURG, V22, P837, DOI 10.1097/SCS.0b013e31820f367b
   Classen Andrea, 2009, V531, P29, DOI 10.1007/978-1-59745-396-7_3
   Colas A., 2013, BIOMATERIAL SCI, P82
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   Dinarello CA, 2007, EUR J IMMUNOL, V37, pS34, DOI 10.1002/eji.200737772
   Duffield S., 2003, CLIN SCI, V104, P27
   Franca Diurianne Caroline Campos, 2013, Acta Inform Med, V21, P93, DOI 10.5455/aim.2013.21.93-97
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   GARRIDO L, 1993, MAGNET RESON MED, V29, P839, DOI 10.1002/mrm.1910290620
   Grutz G, 2005, J LEUKOCYTE BIOL, V77, P3, DOI 10.1189/jlb.0904484
   Hiebl B, 2012, J BIOMAT SCI-POLYM E, V23, P901, DOI 10.1163/092050611X566144
   Iribarren Pablo, 2002, BMC Immunol, V3, P6, DOI 10.1186/1471-2172-3-6
   Isailovic N, 2015, J AUTOIMMUN, V60, P1, DOI 10.1016/j.jaut.2015.04.006
   Ishida Y, 2006, J IMMUNOL, V176, P5598, DOI 10.4049/jimmunol.176.9.5598
   Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010
   Jung DH, 2007, PLAST RECONSTR SURG, V120, P1997, DOI 10.1097/01.prs.0000287323.71630.e6
   Koster M, 2013, CLIN HEMORHEOL MICRO, V54, P325, DOI 10.3233/CH-131737
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Lampert FM, 2012, GEBURTSH FRAUENHEILK, V72, P243, DOI 10.1055/s-0031-1298323
   Legrand AP, 2005, J MATER SCI-MATER M, V16, P477, DOI 10.1007/s10856-005-6989-0
   Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   McFarland CD, 2000, J BIOMED MATER RES, V49, P200, DOI 10.1002/(SICI)1097-4636(200002)49:2<200::AID-JBM7>3.3.CO;2-C
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Naim JO, 1998, COLLOID SURFACE B, V11, P79, DOI 10.1016/S0927-7765(98)00023-X
   Naim JO, 2000, CLIN DIAGN LAB IMMUN, V7, P366, DOI 10.1128/CDLI.7.3.366-370.2000
   Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162
   OWEN MJ, 1981, CHEMTECH, V11, P288
   Prantl L, 2014, CLIN HEMORHEOL MICRO, V58, P521, DOI 10.3233/CH-141812
   Roch T, 2014, CLIN HEMORHEOL MICRO, V58, P147, DOI 10.3233/CH-141885
   Roch T, 2011, MACROMOL SYMP, V309-310, P182, DOI 10.1002/masy.201100048
   Rohrich RJ, 1999, PLAST RECONSTR SURG, V104, P1786, DOI 10.1097/00006534-199911000-00026
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   van Diest PJ, 1998, J CLIN PATHOL, V51, P493, DOI 10.1136/jcp.51.7.493
   Vazquez G, 2007, AESTHET PLAST SURG, V31, P330, DOI 10.1007/s00266-006-0207-4
   Wick G, 2013, ANNU REV IMMUNOL, V31, P107, DOI 10.1146/annurev-immunol-032712-095937
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wolfram D, 2012, PLAST RECONSTR SURG, V129, P327
NR 51
TC 5
Z9 5
U1 0
U2 9
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2015
VL 61
IS 2
BP 119
EP 133
DI 10.3233/CH-151991
PG 15
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA CV9GP
UT WOS:000364596000002
PM 26444613
DA 2018-10-19
ER

PT J
AU Braune, S
   Zhou, S
   Groth, B
   Jung, F
AF Braune, S.
   Zhou, S.
   Groth, B.
   Jung, F.
TI Quantification of adherent platelets on polymer-based biomaterials.
   Comparison of colorimetric and microscopic assessment
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Platelet; biomaterial; thrombogenicity; lactate dehydrogenase; acid
   phosphatase; colorimetric assay; microscopy
ID IN-VITRO; BLOOD-PLATELETS; ADHESION; SURFACE; HEMOCOMPATIBILITY;
   COAGULATION; ADSORPTION; THROMBOSIS; STANDARDS; ARTERIES
AB BACKGROUND: Platelet adhesion to artificial surfaces is one of the most important indicators for the thrombogenicity of implant materials. Currently, a variety of enzyme activity-based colorimetric assays or microscopy-based techniques are commonly in use to assess this characteristic. Studies about how data of colorimetric assays correlate with the image-based quantification of adherent platelets are scarce. To address this question, the present study compared two colorimetric assays (lactate dehydrogenase (LDH) and acid phosphatase (ACP)) with an image-based quantification of the density of platelets adhering on polymer-based biomaterial surfaces.
   MATERIALS AND METHODS: Tri-sodium citrated whole blood was collected from apparently healthy subjects and platelet rich plasma (PRP) was prepared according to a standardized protocol. An in vitro static thrombogenicity test was applied to study platelet adhesion from PRP adjusted to 50,000 platelets per mu L on three different polymers: medical grade polytetrafluoroethylene (PTFE), silicone and polyethylene terephthalate (PET). For the direct image-based approach, surface adherent platelets were fixed, fluorescently labelled and microscopically visualized. The image-based determination of platelet densities provided reference values for the comparison with data of the colorimetric assays. Correlation between standard platelet concentrations and ACP/LDH absorbance measurements were analysed to estimate accuracy and association of both parameters. ACP and LDH release from resting and ADP-stimulated platelets was studied to estimate how platelet activation influences colorimetric assay results.
   RESULTS: The density of adherent platelets ranged from 15,693 +/- 2,487 platelets.mm(-2) (PTFE) to 423 +/- 99 platelets.mm(-2) (silicone) and 4,621 +/- 1,427 platelets.mm(-2) (PET) and differed significantly between the three polymers (ANOVA: p < 0.05). Correlation coefficients between microscopic and colorimetric determination of platelet densities ranged between r = 0.93 (LDH, p < 0.001) and r = 0.94 (ACP, p < 0.001). ACP absorbance measurements of platelet standards with different concentrations corresponded well to an ideal linear regression, while LDH data either deceeded or exceeded the expected values. The LDH release during ADP-induced platelet activation was significantly higher compared to the release of ACP.
   CONCLUSION: For an adjusted platelet concentration of 50,000 platelets.mu L-1, both colorimetric assays (ACP and LDH) allowed a similar accurate quantification of the mean platelet density compared to the microscopic evaluation. Better linearity of the assay standards, less variability of the results and a lower influence of platelet activation on the measurements mark the ACP assay as more suitable for the assessment of material surface adherent platelets compared to the LDH assay, particularly, if near physiological platelet concentrations are applied.
C1 [Braune, S.; Zhou, S.; Groth, B.; Jung, F.] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, D-14531 Teltow, Germany.
   [Braune, S.; Zhou, S.; Groth, B.; Jung, F.] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, D-14531 Teltow, Germany.
   [Zhou, S.] Tianjin Univ, Helmholtz Zentrum Geesthacht, Joint Lab Biomat & Regenerat Med, Teltow, Germany.
RP Jung, F (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14531 Teltow, Germany.
EM friedrich.jung@hzg.de
RI Braune, Steffen/D-2315-2015; Jung, Friedrich/L-1301-2013; Lendlein,
   Andreas/K-9553-2013
OI Jung, Friedrich/0000-0001-8098-7180; Lendlein,
   Andreas/0000-0003-4126-4670
FU Helmholtz-Association; Impuls- und Vernetzungsfond [SO-036]; German
   Federal Ministry of Education and Research (BMBF) [0315496]
FX This work was financially supported by the Helmholtz-Association,
   Impuls- und Vernetzungsfond (grant no. SO-036) and the German Federal
   Ministry of Education and Research (BMBF, grant no. 0315496).
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   BAK IJ, 1969, Z ZELLFORSCH MIK ANA, V96, P641, DOI 10.1007/BF00973339
   BELLAVITE P, 1994, ANAL BIOCHEM, V216, P444, DOI 10.1006/abio.1994.1066
   BERG B, 1981, REFERENCE VALUES LAB, P55
   Bertino AM, 2003, TRANSFUSION, V43, P857, DOI 10.1046/j.1537-2995.2003.t01-4-00431.x
   Braune S, 2012, CLIN HEMORHEOL MICRO, V52, P349, DOI 10.3233/CH-2012-1610
   Braune S, 2011, CLIN HEMORHEOL MICRO, V49, P375, DOI 10.3233/CH-2011-1487
   Braune S, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-33
   Cattaneo M, 2013, J THROMB HAEMOST, V11, P1183, DOI 10.1111/jth.12231
   Collins TJ, 2007, BIOTECHNIQUES, V43, P25
   CONDREA E, 1987, CLIN CHIM ACTA, V169, P309, DOI 10.1016/0009-8981(87)90330-5
   Eriksson Andreas C., 2005, Journal of Pharmacological and Toxicological Methods, V52, P356, DOI 10.1016/j.vascn.2005.06.002
   Erlandsen SL, 2001, J HISTOCHEM CYTOCHEM, V49, P809, DOI 10.1177/002215540104900702
   Favaloro EJ, 2010, CLIN CHEM LAB MED, V48, P579, DOI 10.1515/CCLM.2010.121
   Favaloro EJ, 2008, SEMIN THROMB HEMOST, V34, P709, DOI 10.1055/s-0029-1145254
   Frank RD, 2000, J BIOMED MATER RES, V52, P374, DOI 10.1002/1097-4636(200011)52:2<374::AID-JBM18>3.3.CO;2-Q
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Harrison P, 2005, BLOOD REV, V19, P111, DOI 10.1016/j.blre.2004.05.002
   Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186
   Hylton DM, 2005, J BIOMED MATER RES A, V73A, P349, DOI 10.1002/jbm.a.30295
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022
   Lima-Oliveira G., 2014, J MED BIOCHEM, P1
   Lippi G, 2012, SEMIN THROMB HEMOST, V38, P565, DOI 10.1055/s-0032-1315961
   Liu T, 2014, J BIOMED MATER RES A, V102, P3754, DOI 10.1002/jbm.a.35025
   Lutter C, 2015, CLIN HEMORHEOL MICRO, V59, P219, DOI 10.3233/CH-141839
   Mackie I, 2013, INT J LAB HEMATOL, V35, P1, DOI 10.1111/ijlh.12004
   Massa TM, 2007, J BIOMED MATER RES A, V81A, P178, DOI 10.1002/jbm.a.30936
   Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528
   Neffe AT, 2013, MACROMOL BIOSCI, V13, P1720, DOI 10.1002/mabi.201300309
   Okroj W, 2009, ACTA BIOENG BIOMECH, V11, P45
   Papp J, 2014, CLIN HEMORHEOL MICRO, V56, P1, DOI 10.3233/CH-2012-1636
   Papp J, 2013, CLIN HEMORHEOL MICRO, V53, P81, DOI 10.3233/CH-2012-1578
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Paternotte E, 2013, CLIN HEMORHEOL MICRO, V54, P223, DOI 10.3233/CH-131728
   Pierce BF, 2012, MACROMOL BIOSCI, V12, P312, DOI 10.1002/mabi.201100237
   Polasek J, 2004, PLATELETS, V15, P403, DOI 10.1080/09537100410001721315
   Reinhart WH, 2013, CLIN HEMORHEOL MICRO, V53, P71, DOI 10.3233/CH-2012-1577
   Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227
   Seyfert UT, 2002, BIOMOL ENG, V19, P91, DOI 10.1016/S1389-0344(02)00015-1
   SHATTIL SJ, 1994, CURR OPIN CELL BIOL, V6, P695, DOI 10.1016/0955-0674(94)90096-5
   Sheriff J, 2010, ANN BIOMED ENG, V38, P1442, DOI 10.1007/s10439-010-9936-2
   Sivaraman B, 2010, BIOMATERIALS, V31, P1036, DOI 10.1016/j.biomaterials.2009.10.017
   Ullm S, 2014, BIOMATERIALS, V35, P9755, DOI 10.1016/j.biomaterials.2014.08.023
   Vanickova M, 2006, PLATELETS, V17, P470, DOI 10.1080/09537100600758875
NR 45
TC 5
Z9 5
U1 1
U2 13
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2015
VL 61
IS 2
BP 225
EP 236
DI 10.3233/CH-151995
PG 12
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA CV9GP
UT WOS:000364596000012
PM 26410874
DA 2018-10-19
ER

PT J
AU Giovagnoli, S
   Luca, G
   Blasi, P
   Mancuso, F
   Schoubben, A
   Arato, I
   Calvitti, M
   Falabella, G
   Basta, G
   Bodo, M
   Calafiore, R
   Ricci, M
AF Giovagnoli, Stefano
   Luca, Giovanni
   Blasi, Paolo
   Mancuso, Francesca
   Schoubben, Aurelie
   Arato, Iva
   Calvitti, Mario
   Falabella, Giulia
   Basta, Giuseppe
   Bodo, Maria
   Calafiore, Riccardo
   Ricci, Maurizio
TI Alginates in Pharmaceutics and Biomedicine: Is the Future so Bright?
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE Alginate; microencapsulation; alginate drug delivery systems; cell
   microencapsulation; clinical studies; cell transplantation
ID IN-VITRO CHARACTERIZATION; PANCREATIC-CELL CLUSTERS; TYPE-1
   DIABETIC-PATIENT; DRUG-DELIVERY SYSTEMS; ORAL INSULIN DELIVERY; PORCINE
   SERTOLI-CELLS; HUMAN-FACTOR-IX; POLYELECTROLYTE COMPLEXES; SODIUM
   ALGINATE; MATRIX TABLETS
AB Alginate represents one of the most appealing biopolymers for pharmaceutical and biomedical applications. Alginate as a biomaterial for clinical use has been established, although not free from issues. Here we provide a critical review on some of the main recent advances in alginate research in drug delivery and its prominent role in cell microencapsulation for the treatment of diseases, such as type 1 diabetes mellitus. A brief description of the basic properties of the polymer will be provided as well. Based on our experience and contributions, as well as wide research in the field, the correlation between physicochemical and biological properties of alginate systems and clinical outcomes will be investigated and discussed to address the actual future clinical impact of alginate-based delivery strategies.
C1 [Giovagnoli, Stefano; Schoubben, Aurelie; Ricci, Maurizio] Univ Perugia, Dept Pharmaceut Sci, I-06123 Perugia, Italy.
   [Luca, Giovanni; Mancuso, Francesca; Arato, Iva; Calvitti, Mario; Falabella, Giulia; Bodo, Maria] Univ Perugia, Dept Expt Med, I-06123 Perugia, Italy.
   [Blasi, Paolo] Univ Camerino, Sch Pharm, I-62032 Camerino, Italy.
   [Basta, Giuseppe; Calafiore, Riccardo] Univ Perugia, Dept Med, I-06123 Perugia, Italy.
RP Giovagnoli, S (reprint author), Univ Perugia, Dept Pharmaceut Sci, Via Liceo 1, I-06123 Perugia, Italy.
EM stefano.giovagnoli@unipg.it
RI Giovagnoli, Stefano/N-1064-2018
OI Giovagnoli, Stefano/0000-0001-5043-7233; Blasi,
   Paolo/0000-0002-8543-4275
FU Altucell Inc., Dix Hills, New York, NY
FX This work has been supported by a grant from Mr. Gary Harlem (Altucell
   Inc. 3 Astor Court, Dix Hills, New York, NY).
CR Abdelbary GA, 2008, EUR J PHARM BIOPHARM, V69, P1019, DOI 10.1016/j.ejpb.2008.01.011
   AEBISCHER P, 1994, EXP NEUROL, V126, P151, DOI 10.1006/exnr.1994.1053
   Agulhon P, 2014, CARBOHYD POLYM, V112, P525, DOI 10.1016/j.carbpol.2014.05.097
   Agulhon P, 2012, BIOMACROMOLECULES, V13, P1899, DOI 10.1021/bm300420z
   Almond A, 2005, CARBOHYD RES, V340, P907, DOI 10.1016/j.carres.2005.01.014
   ANDERSEN T, 2012, SPR CARB CH, V37, P227, DOI DOI 10.1039/9781849732765-00227
   [Anonymous], 2003, F231503 ASTM INT
   [Anonymous], 2011, F231511 ASTM INT
   [Anonymous], 2010, F231510 ASTM INT
   [Anonymous], 2006, F2064002006E1 ASTM I
   Aquino RP, 2012, CARBOHYD POLYM, V89, P740, DOI 10.1016/j.carbpol.2012.04.003
   Araujo V, 2013, J PHARM SCI-US, V102, P2748, DOI 10.1002/jps.23656
   ASTM International, 2000, F2064 ASTM INT
   Auriemma G, 2013, CARBOHYD POLYM, V92, P367, DOI 10.1016/j.carbpol.2012.09.056
   Basta G, 2010, Process for the ultrapurification of alginates, Patent No. [US2010/0298262A1, 20100298262]
   Basta G, 2011, DIABETES CARE, V34, P2406, DOI 10.2337/dc11-0731
   Becheran-Maron L, 2004, INT J BIOL MACROMOL, V34, P127, DOI 10.1016/j.ijbiomac.2004.03.010
   Bhandari B, 2009, Australian Patent, Patent No. [WO2009062254, 2009062254]
   Bidarra SJ, 2014, ACTA BIOMATER, V10, P1646, DOI 10.1016/j.actbio.2013.12.006
   Bistoni G, 2012, BIOMATERIALS, V33, P5333, DOI 10.1016/j.biomaterials.2012.04.020
   Bjornmalm M, 2014, J CONTROL RELEASE, V190, P139, DOI 10.1016/j.jconrel.2014.04.030
   Breger JC, 2015, J BIOMED MATER RES B, V103, P1120, DOI 10.1002/jbm.b.33282
   Buthe A, 2004, J MICROENCAPSUL, V21, P865, DOI 10.1080/02652040400015478
   Calafiore R, 2006, DIABETES CARE, V29, P137, DOI 10.2337/diacare.29.01.06.dc05-1270
   Calafiore R, 2004, BIOTECHNOL APPL BIOC, V39, P159, DOI 10.1042/BA20030151
   Calafiore R, 2014, ADV DRUG DELIVER REV, V67-68, P84, DOI 10.1016/j.addr.2013.09.020
   Calafiore Riccardo, 2007, V140, P197
   Calija B, 2013, COLLOID SURFACE B, V110, P395, DOI 10.1016/j.colsurfb.2013.05.016
   Cascone S, 2012, DRUG DEV IND PHARM, V38, P1486, DOI 10.3109/03639045.2011.653814
   Cefalu WT, 2013, DIABETES CARE, V36, P1, DOI 10.2337/dc12-2182
   Cesaro A, 2012, EUR BIOPHYS J BIOPHY, V41, P379, DOI 10.1007/s00249-011-0753-9
   Chan AW, 2009, BIOMACROMOLECULES, V10, P609, DOI 10.1021/bm801316z
   Chan LW, 2007, DRUG DEV IND PHARM, V33, P667, DOI 10.1080/03639040600943814
   CHANG PL, 1993, HUM GENE THER, V4, P433, DOI 10.1089/hum.1993.4.4-433
   Chiu CT, 2013, ALIMENT PHARM THER, V38, P1054, DOI 10.1111/apt.12482
   Choi HG, 2000, J CONTROL RELEASE, V68, P397, DOI 10.1016/S0168-3659(00)00276-5
   CID E, 1986, BIOPHARM DRUG DISPOS, V7, P559, DOI 10.1002/bdd.2510070605
   Cocchietto Moreno, 2013, J Funct Biomater, V4, P312, DOI 10.3390/jfb4040312
   Dang TD, 2013, COLLOID SURFACE B, V102, P766, DOI 10.1016/j.colsurfb.2012.09.016
   de Oliveira EF, 2014, COLLOID SURFACE B, V113, P146, DOI 10.1016/j.colsurfb.2013.08.038
   de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010
   de Vos P, 2012, BIOMATERIALS, V33, P5552, DOI 10.1016/j.biomaterials.2012.04.039
   Deat-Laine E, 2012, INT J PHARMACEUT, V439, P136, DOI 10.1016/j.ijpharm.2012.10.003
   Del Gaudio P, 2005, INT J PHARM, V302, P1, DOI 10.1016/j.ijpharm.2005.05.041
   Del Gaudio P, 2014, EUR J PHARM BIOPHARM, V87, P541, DOI 10.1016/j.ejpb.2014.02.010
   Dentini M, 2007, CARBOHYD POLYM, V67, P465, DOI 10.1016/j.carbpol.2006.06.020
   Donati I, 2005, BIOMACROMOLECULES, V6, P1031, DOI 10.1021/bm049306e
   Dorati R, 2013, J MICROENCAPSUL, V30, P559, DOI 10.3109/02652048.2013.764938
   Douglas KL, 2005, J BIOMAT SCI-POLYM E, V16, P43, DOI 10.1163/1568562052843339
   Draget KI, 2003, BIOMACROMOLECULES, V4, P1661, DOI 10.1021/bm034105g
   DRAGET KI, 2002, BIOPOLYMERS, V6, P215
   Draget KI, 2011, FOOD HYDROCOLLOID, V25, P251, DOI 10.1016/j.foodhyd.2009.10.007
   Du J, 2014, AAPS PHARMSCITECH, V15, P1535, DOI 10.1208/s12249-014-0176-x
   Duarte ARC, 2014, LANGMUIR, V30, P12391, DOI 10.1021/la502822v
   Dumitriu RP, 2009, CELL CHEM TECHNOL, V43, P251
   Dumitriu S., 2002, POLYM BIOMATERIALS
   Dusseault J, 2006, J BIOMED MATER RES A, V76A, P243, DOI 10.1002/jbm.a.30541
   Ebara M., 2014, NIMS MONOGRAPHS, P9
   Elliott RB, 2011, 23 WORLD C IPITA PRA
   Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x
   Elmowafy E, 2014, INT J NANOMED, V9, P4449, DOI 10.2147/IJN.S66876
   Emerich DF, 2014, ADV DRUG DELIVER REV, V67-68, P131, DOI 10.1016/j.addr.2013.07.008
   Engl W, 2008, CURR OPIN COLLOID IN, V13, P206, DOI 10.1016/j.cocis.2007.09.003
   ERTESVAG H, 1995, MOL MICROBIOL, V16, P719, DOI 10.1111/j.1365-2958.1995.tb02433.x
   Espevik T., 2009, BIOARTIFICIAL PANCRE, P279
   Fallarino F, 2009, J EXP MED, V206, P2511, DOI 10.1084/jem.20090134
   Fang YP, 2007, J PHYS CHEM B, V111, P2456, DOI 10.1021/jp0689870
   Flo TH, 2002, J BIOL CHEM, V277, P35489, DOI 10.1074/jbc.M201366200
   FRANKLIN MJ, 1994, J BACTERIOL, V176, P1821, DOI 10.1128/jb.176.7.1821-1830.1994
   Fu S, 2011, AAPS PHARMSCITECH, V12, P453, DOI 10.1208/s12249-011-9587-0
   Gannon PM, CMBO PERSPECTIVE BIO
   Gattas-Asfura KM, 2014, J MATER CHEM B, V2, P8208, DOI 10.1039/c4tb01241k
   George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017
   Giovagnoli S, 2005, J CONTROL RELEASE, V107, P65, DOI 10.1016/j.jconrel.2005.05.021
   Giovagnoli S, 2010, PHARM RES-DORD, V27, P285, DOI 10.1007/s11095-009-0017-x
   Goh CH, 2012, CARBOHYD POLYM, V88, P1, DOI 10.1016/j.carbpol.2011.11.012
   Gryshkov O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107911
   Hadi MA, 2015, PAK J PHARM SCI, V28, P185
   Hansson SF, 2013, J PATHOL, V229, P719, DOI 10.1002/path.4166
   Hariyadi DM, 2010, J DRUG TARGET, V18, P831, DOI 10.3109/1061186X.2010.525651
   Hassan N, 2010, PHARM DEV TECHNOL, V15, P124, DOI 10.3109/10837450903055494
   HASSAN RM, 1992, COLLOID POLYM SCI, V270, P1237, DOI 10.1007/BF01095065
   Hassan RM, 2013, J LIFE MED, V1, P41
   Hasse C, 1997, LANCET, V350, P1296, DOI 10.1016/S0140-6736(05)62473-7
   HAUG A, 1965, ACTA CHEM SCAND, V19, P341, DOI 10.3891/acta.chem.scand.19-0341
   HAUG A, 1967, ACTA CHEM SCAND, V21, P768, DOI 10.3891/acta.chem.scand.21-0768
   HAUG A, 1966, ACTA CHEM SCAND, V20, P183, DOI 10.3891/acta.chem.scand.20-0183
   HAUG A, 1967, ACTA CHEM SCAND, V21, P691, DOI 10.3891/acta.chem.scand.21-0691
   HODSDON AC, 1995, J CONTROL RELEASE, V33, P143, DOI 10.1016/0168-3659(94)00076-7
   Hortelano G, 1996, BLOOD, V87, P5095
   Hosseini SM, 2014, CARBOHYD POLYM, V103, P573, DOI 10.1016/j.carbpol.2013.12.078
   Hosseini SM, 2013, INT J BIOL MACROMOL, V62, P582, DOI 10.1016/j.ijbiomac.2013.09.054
   Huanbutta K, 2013, CARBOHYD POLYM, V97, P26, DOI 10.1016/j.carbpol.2013.04.073
   Huang KS, 2014, ELECTROPHORESIS, V35, P330, DOI 10.1002/elps.201300194
   Ige O. O., 2012, ISRN MAT SCI, V2012
   Ikinci G, 2004, INT J PHARM, V277, P173, DOI 10.1016/j.ijpharm.2003.10.040
   Itoh K, 2010, DRUG DEV IND PHARM, V36, P449, DOI 10.3109/03639040903244480
   Iwanaga S, 2013, COLLOID SURFACE B, V109, P301, DOI 10.1016/j.colsurfb.2013.04.007
   Jacobs-Tulleneers-Thevissen D, 2013, DIABETOLOGIA, V56, P1605, DOI 10.1007/s00125-013-2906-0
   Jayant RD, 2011, INT J PHARMACEUT, V403, P268, DOI 10.1016/j.ijpharm.2010.10.035
   Jelvehgari M, 2014, JUNDISHAPUR J NAT PH, V9, P39
   Jitraruch S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113609
   Kanjickal DG, 2004, CRIT REV THER DRUG, V21, P345
   Kashima K, 2011, DESALIN WATER TREAT, V34, P257, DOI 10.5004/dwt.2011.2892
   Khotimchenko YS, 2001, RUSS J MAR BIOL, V27, pS53, DOI DOI 10.1023/A:1013851022276
   Kim T, 2012, J MINIM INVAS GYN, V19, P731, DOI 10.1016/j.jmig.2012.08.003
   King A. H., 1983, FOOD HYDROCOLLOIDS, V2, P115
   Ko JA, 2012, BIOTECHNOL LETT, V34, P515, DOI 10.1007/s10529-011-0791-5
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   Korbutt GS, 2000, DIABETOLOGIA, V43, P474, DOI 10.1007/s001250051331
   Korbutt GS, 1996, J CLIN INVEST, V97, P2119, DOI 10.1172/JCI118649
   Lacerda L, 2014, MAT SCI ENG C-MATER, V39, P161, DOI 10.1016/j.msec.2014.01.054
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Li DH, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/981321
   Li L, 2014, INT J PHARMACEUT, V476, P253, DOI 10.1016/j.ijpharm.2014.09.057
   Li XY, 2009, J MICROENCAPSUL, V26, P315, DOI 10.1080/02652040802328685
   Li XX, 2009, POLYM DEGRAD STABIL, V94, P1, DOI 10.1016/j.polymdegradstab.2008.10.017
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Lin YH, 2005, BIOMATERIALS, V26, P2105, DOI 10.1016/j.biomaterials.2004.06.011
   Lin YS, 2013, ELECTROPHORESIS, V34, P425, DOI 10.1002/elps.201200282
   LIU HW, 1993, HUM GENE THER, V4, P291, DOI 10.1089/hum.1993.4.3-291
   Liu L, 2013, J COLLOID INTERF SCI, V404, P85, DOI 10.1016/j.jcis.2013.04.044
   Liu XD, 2002, J MICROENCAPSUL, V19, P775, DOI 10.1080/0265204021000022743
   Liu XD, 2003, J APPL POLYM SCI, V87, P848, DOI 10.1002/app.11537
   Lotfipour F, 2012, ADV PHARM BULL, V2, P71, DOI 10.5681/apb.2012.010
   Luca G, 2005, CELL TRANSPLANT, V14, P249, DOI 10.3727/000000005783983034
   Luca G, 2003, BIOMATERIALS, V24, P3101, DOI 10.1016/S0142-9612(03)00118-2
   Luca G, 2013, J CONTROL RELEASE, V165, P75, DOI 10.1016/j.jconrel.2012.08.028
   Lucinda-Silva RM, 2003, J MICROENCAPSUL, V20, P145, DOI 10.1080/02652040210162621
   Luo YC, 2014, INT J BIOL MACROMOL, V64, P353, DOI 10.1016/j.ijbiomac.2013.12.017
   Maderuelo C, 2011, J CONTROL RELEASE, V154, P2, DOI 10.1016/j.jconrel.2011.04.002
   Mansourpour M., 2015, AAPS PHARMSCITECH
   Martins S, 2007, CARBOHYD POLYM, V69, P725, DOI 10.1016/j.carbpol.2007.02.012
   Matricardi P, 2008, EXPERT OPIN DRUG DEL, V5, P417, DOI [10.1517/17425247.5.4.417, 10.1517/17425247.5.4.417 ]
   Maurstad G, 2003, J PHYS CHEM B, V107, P8172, DOI 10.1021/jp0271965
   MELIA CD, 1991, CRIT REV THER DRUG, V8, P395
   MICHAELS AS, 1961, J PHYS CHEM-US, V65, P1765, DOI 10.1021/j100827a020
   Mithun U, 2014, INT J CHEM TECH RES, V6, P3579
   Mladenovska K, 2007, INT J PHARM, V345, P59, DOI 10.1016/j.ijpharm.2007.05.059
   Mobus K, 2009, EUR J PHARM BIOPHARM, V72, P42
   Mobus K., 2012, EUR J PHARM SCI, V45, P358
   Moe Storker T., 1995, V67, P245
   Mobus K, 2012, EUR J PHARM BIOPHARM, V81, P121, DOI 10.1016/j.ejpb.2012.01.018
   MONSHIPOURI M, 1995, J MICROENCAPSUL, V12, P255, DOI 10.3109/02652049509010294
   Montanucci P, 2014, BIOMED RES INT
   Morch YA, 2006, BIOMACROMOLECULES, V7, P1471, DOI 10.1021/bm060010d
   Moroni A, 2011, DRUG DEV IND PHARM, V37, P216, DOI 10.3109/03639045.2010.504726
   Moyer HR, 2010, ANN PLAS SURG, V65, P497, DOI 10.1097/SAP.0b013e3181d37713
   Muniswamy P, 2012, J BIOMED PHARM RES, V1, P101
   Omer A, 2003, DIABETES, V52, P69, DOI 10.2337/diabetes.52.1.69
   Orive G, 2014, ADV DRUG DELIVER REV, V67-68, P3, DOI 10.1016/j.addr.2013.07.009
   OTTERLEI M, 1991, J IMMUNOTHER, V10, P286, DOI 10.1097/00002371-199108000-00007
   Ouwerx C, 1998, POLYM GELS NETW, V6, P393, DOI 10.1016/S0966-7822(98)00035-5
   Paques JP, 2014, ADV COLLOID INTERFAC, V209, P163, DOI 10.1016/j.cis.2014.03.009
   Paredes Juarez Genaro Alberto, 2014, Front Bioeng Biotechnol, V2, P26, DOI 10.3389/fbioe.2014.00026
   Patel VM, 2007, AAPS PHARMSCITECH, V8
   Pawar SN, 2012, BIOMATERIALS, V33, P3279, DOI 10.1016/j.biomaterials.2012.01.007
   PHILIPP B, 1989, PROG POLYM SCI, V14, P91, DOI 10.1016/0079-6700(89)90018-X
   Ponce S, 2006, BIOMATERIALS, V27, P4831, DOI 10.1016/j.biomaterials.2006.05.014
   Poojari R, 2013, EXPERT OPIN DRUG DEL, V10, P1061, DOI 10.1517/17425247.2013.796361
   Prakash A, 1999, DRUGS, V57, P383, DOI 10.2165/00003495-199957030-00013
   Prokop A, 1997, ANN NY ACAD SCI, V831, P223
   Qi M., 2014, ADV MED, V2014, P1
   Reis CP, 2006, J MICROENCAPSUL, V23, P245, DOI 10.1080/02652040500286086
   Reis CP, 2007, BIOTECHNOL BIOENG, V96, P977, DOI 10.1002/bit.21164
   RENDLEMAN JA, 1978, FOOD CHEM, V3, P127, DOI 10.1016/0308-8146(78)90031-6
   Ribeiro CC, 2004, BIOMATERIALS, V25, P4363, DOI 10.1016/j.biomaterials.2003.11.028
   Ricci M, 2005, J CONTROL RELEASE, V107, P395, DOI 10.1016/j.jconrel.2005.06.023
   RINAUDO M, 1993, INT J BIOL MACROMOL, V15, P281, DOI 10.1016/0141-8130(93)90027-J
   Rokstad AMA, 2014, ADV DRUG DELIVER REV, V67-68, P111, DOI 10.1016/j.addr.2013.07.010
   Rondeau E, 2008, LANGMUIR, V24, P6937, DOI 10.1021/la703339u
   Roy DS, 2002, EUR J PHARM SCI, V16, P193
   Roy Harekrishna, 2014, Int J Appl Basic Med Res, V4, pS31, DOI 10.4103/2229-516X.140728
   Rraju K.N, 2011, INT J PHARM PHARM SC, V3, P239
   Saether HV, 2008, CARBOHYD POLYM, V74, P813, DOI 10.1016/j.carbpol.2008.04.048
   Sagiri SS, 2014, AAPS PHARMSCITECH, V15, P1197, DOI 10.1208/s12249-014-0147-2
   Sankar R, 2013, DRUG DES DEV THER, V7, P1455, DOI 10.2147/DDDT.S52890
   Santos E, 2013, J CONTROL RELEASE, V170, P1, DOI 10.1016/j.jconrel.2013.04.015
   Sarmento B, 2007, PHARM RES, V24, P2198, DOI 10.1007/s11095-007-9367-4
   Schatz C, 2004, BIOMACROMOLECULES, V5, P1882, DOI 10.1021/bm049786
   Schoubben A, 2010, CHEM ENG J, V160, P363, DOI 10.1016/j.cej.2010.02.062
   Schoubben A, 2009, EUR J PHARM SCI, V36, P226, DOI 10.1016/j.ejps.2008.09.008
   Scocca Sarah, 2007, Current Drug Delivery, V4, P103, DOI 10.2174/156720107780362311
   SELAWRY HP, 1993, CELL TRANSPLANT, V2, P123, DOI 10.1177/096368979300200206
   Siepmann J, 2012, J CONTROL RELEASE, V161, P351, DOI 10.1016/j.jconrel.2011.10.006
   Simsek-Ege FA, 2003, J APPL POLYM SCI, V88, P346, DOI 10.1002/app.11989
   Skaugrud O, 1999, BIOTECHNOL GENET ENG, V16, P23, DOI 10.1080/02648725.1999.10647970
   SOONSHIONG P, 1994, LANCET, V343, P950, DOI 10.1016/S0140-6736(94)90067-1
   Sosnik Alejandro, 2014, ISRN Pharm, V2014, P926157, DOI 10.1155/2014/926157
   Spasojevic M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109837
   Sriamornsak P, 2007, EUR J PHARM BIOPHARM, V66, P435, DOI 10.1016/j.ejpb.2006.12.003
   Stewart MB, 2014, CARBOHYD POLYM, V112, P486, DOI 10.1016/j.carbpol.2014.06.001
   Stewart MB, 2014, CARBOHYD POLYM, V102, P246, DOI 10.1016/j.carbpol.2013.11.034
   Strand BL, 2001, CELL TRANSPLANT, V10, P263, DOI 10.3727/000000001783986800
   Strugala V, 2012, ISRN OBSTET GYNECOL, V2012
   Su R, 2011, INT J BIOL MACROMOL, V49, P979, DOI 10.1016/j.ijbiomac.2011.08.018
   Suarez-Pinzon W, 2000, DIABETES, V49, P1810, DOI 10.2337/diabetes.49.11.1810
   Suksamran T, 2009, J MICROENCAPSUL, V26, P563, DOI 10.3109/02652040802500622
   Sun JC, 2013, MATERIALS, V6, P1285, DOI 10.3390/ma6041285
   Swain Suryakanta, 2012, Recent Pat Drug Deliv Formul, V6, P259
   Syed IA, 2014, INT J PHARM INVESTIG, V4, P38, DOI 10.4103/2230-973X.127739
   Tapia C, 2004, EUR J PHARM BIOPHARM, V57, P65, DOI 10.1016/S0939-641(03)00153-X
   Tenenbaum DJ, POLYM AND PEOPLE
   Tharavanij T, 2008, TRANSPLANTATION, V86, P1161, DOI 10.1097/TP.0b013e31818a7f45
   Thompson RC, 2009, PHILOS T R SOC B, V364, P2153, DOI 10.1098/rstb.2009.0053
   Thu B, 1996, BIOMATERIALS, V17, P1031, DOI 10.1016/0142-9612(96)84680-1
   Tiwari SB, 2011, DRUG POLYM MATRICES, P131
   Trouche E, 2010, CELL TRANSPLANT, V19, P1623, DOI 10.3727/096368910X514297
   Tuch BE, 2009, DIABETES CARE, V32, P1887, DOI 10.2337/dc09-0744
   U. S. Department of Health and Human Services FDA, 2009, GUID IND CONS ALL PA
   U.S. Pharmacopeia/National Formulary, 2011, 85 BACT END TEST
   Valla S, 1996, CARBOHYDR EUR, V14, P14
   VELINGS NM, 1995, POLYM GELS NETW, V3, P311, DOI 10.1016/0966-7822(94)00043-7
   Vold IMN, 2006, BIOMACROMOLECULES, V7, P2136, DOI 10.1021/bm060099n
   von Schmeling HHKB, 2011, COLLOID POLYM SCI, V289, P1407, DOI 10.1007/s00396-011-2464-2
   Wen JP, 2007, J GENE MED, V9, P1002, DOI 10.1002/jgm.1098
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   Wittaya-areekul S, 2006, INT J PHARM, V312, P113, DOI 10.1016/j.ijpharm.2006.01.003
   Woitiski CB, 2009, ACTA BIOMATER, V5, P2475, DOI 10.1016/j.actbio.2009.03.007
   WONG H, 1986, INT J ARTIF ORGANS, V9, P335
   Zhang H, 2006, J AM CHEM SOC, V128, P12205, DOI 10.1021/ja0635682
   Zhang TT, 2010, J PHARM SCI-US, V99, P4678, DOI 10.1002/jps.22163
   Zhang YL, 2011, EUR J PHARM BIOPHARM, V77, P11, DOI 10.1016/j.ejpb.2010.09.016
   Zhao XH, 2010, J APPL PHYS, V107, DOI 10.1063/1.3343265
NR 224
TC 7
Z9 7
U1 5
U2 40
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2015
VL 21
IS 33
BP 4917
EP 4935
DI 10.2174/1381612821666150820105639
PG 19
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CV8FO
UT WOS:000364516500010
PM 26290204
DA 2018-10-19
ER

PT J
AU Rodoplu, D
   Boyaci, IH
   Bozkurt, AG
   Eksi, H
   Zengin, A
   Tamer, U
   Aydogan, N
   Ozcan, S
   Tugcu-Demiroz, F
AF Rodoplu, Didem
   Boyaci, Ismail H.
   Bozkurt, Akif G.
   Eksi, Haslet
   Zengin, Adem
   Tamer, Ugur
   Aydogan, Nihal
   Ozcan, Sadan
   Tugcu-Demiroz, Fatmanur
TI Quantitative Characterization of Magnetic Mobility of Nanoparticle in
   Solution-Based Condition
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE Magnetophoretic mobility; Saturation magnetism; Initial Mobility;
   Superparamagnetic iron oxide nanoparticles
ID IRON-OXIDE NANOPARTICLES; SURFACE-PLASMON RESONANCE; ESCHERICHIA-COLI
   O157-H7; DOT-LABELED ANTIBODIES; MAGNETOPHORETIC MOBILITY; BIOLOGICAL
   APPLICATIONS; IMMUNOMAGNETIC SEPARATION; SALMONELLA-ENTERITIDIS;
   LISTERIA-MONOCYTOGENES; NANOSTRUCTURED FILMS
AB Magnetic nanoparticles are considered as the ideal substrate to selectively isolate target molecules or organisms from sample solutions in a wide variety of applications including bioassays, bioimaging and environmental chemistry. The broad array of these applications in fields requires the accurate magnetic characterization of nanoparticles for a variety of solution based-conditions. Because the freshly synthesized magnetic nanoparticles demonstrated a perfect magnetization value in solid form, they exhibited a different magnetic behavior in solution. Here, we present simple quantitative method for the measurement of magnetic mobility of nanoparticles in solution-based condition. Magnetic mobility of the nanoparticles was quantified with initial mobility of the particles using UV-vis absorbance spectroscopy in water, ethanol and MES buffer. We demonstrated the efficacy of this method through a systematic characterization of four different core-shell structures magnetic nanoparticles over three different surface modifications. The solid nanoparticles were characterized using transmission electron microscopy (TEM), X-ray diffraction (XRD) and saturation magnetization (Ms). The surfaces of the nanoparticles were functionalized with 11-mercaptoundecanoic acid and bovine serum albumin BSA was selected as biomaterial. The effect of the surface modification and solution media on the stability of the nanoparticles was monitored by zeta potentials and hydrodynamic diameters of the nanoparticles. Results obtained from the mobility experiments indicate that the initial mobility was altered with solution media, surface functionalization, size and shape of the magnetic nanoparticle. The proposed method easily determines the interactions between the magnetic nanoparticles and their surrounding biological media, the magnetophoretic responsiveness of nanoparticles and the initial mobilities of the nanoparticles.
C1 [Rodoplu, Didem; Boyaci, Ismail H.] Hacettepe Univ, Inst Sci, Nanotechnol & Nanomed Div, TR-06800 Ankara, Turkey.
   [Boyaci, Ismail H.; Bozkurt, Akif G.; Eksi, Haslet] Hacettepe Univ, Dept Food Engn, Fac Engn, TR-06800 Ankara, Turkey.
   [Zengin, Adem] Yuzuncu Yil Univ, Dept Chem Engn, Fac Engn & Architecture, TR-65080 Van, Turkey.
   [Tamer, Ugur] Gazi Univ, Dept Analyt Chem, Fac Pharm, TR-06330 Ankara, Turkey.
   [Aydogan, Nihal] Hacettepe Univ, Dept Chem Engn, Fac Engn, TR-06800 Ankara, Turkey.
   [Ozcan, Sadan] Hacettepe Univ, Dept Engn Phys, Fac Engn, TR-06800 Ankara, Turkey.
   [Tugcu-Demiroz, Fatmanur] Gazi Univ, Dept Pharmaceut Technol, Fac Pharm, TR-06330 Ankara, Turkey.
RP Boyaci, IH (reprint author), Hacettepe Univ, Dept Food Engn, TR-06800 Ankara, Turkey.
EM ihb@hacettepe.edu.tr; utamer@gazi.edu.tr
RI Bayram, Cem/D-7403-2013
OI Bayram, Cem/0000-0001-8717-4668
CR Agarwal R, 2008, SMALL, V4, P1872, DOI 10.1002/smll.200800556
   Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927
   Amagliani G, 2006, J APPL MICROBIOL, V100, P375, DOI 10.1111/j.1365-2672.2005.02761.x
   Andreu JS, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021402
   Arai T, 2007, J OPT A-PURE APPL OP, V9, P699, DOI 10.1088/1464-4258/9/7/022
   Arai T, 2006, MATER RES SOC SYMP P, V915, P41
   Aravamudhan S, 2008, SENSOR ACTUAT B-CHEM, V132, P623, DOI 10.1016/j.snb.2008.01.046
   Arbos P, 2002, INT J PHARM, V242, P129, DOI 10.1016/S0378-5173(02)00182-5
   Arias JL, 2001, J CONTROL RELEASE, V77, P309, DOI 10.1016/S0168-3659(01)00519-3
   Asthana R, 2006, MATERIALS PROCESSING AND MANUFACTURING SCIENCE, pXVIII, DOI 10.1016/B978-075067716-5/50001-7
   Augustin MA, 2009, ADV FOOD NUTR RES, V58, P183, DOI 10.1016/S1043-4526(09)58005-9
   Bagwe RP, 2003, J DISPER SCI TECHNOL, V24, P453, DOI 10.1081/DIS-120021801
   Bakumov V, 2007, J EUR CERAM SOC, V27, P3287, DOI 10.1016/j.jeurceramsoc.2007.01.004
   Bally M, 2009, NANOMEDICINE-UK, V4, P447, DOI [10.2217/nnm.09.16, 10.2217/NNM.09.16]
   Baniukevic J, 2013, BIOSENS BIOELECTRON, V43, P281, DOI 10.1016/j.bios.2012.12.014
   Bao N, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2937088
   Benelmekki M, 2011, J MAGN MAGN MATER, V323, P1945, DOI 10.1016/j.jmmm.2011.02.027
   Benelmekki M, 2011, J NANOPART RES, V13, P3199, DOI 10.1007/s11051-010-0218-6
   Beyaz S., 2009, J OPTOELECTRON ADV S, V1, P447
   Boyaci IH, 2005, ANAL BIOANAL CHEM, V382, P1234, DOI 10.1007/s00216-005-3263-8
   Chalmers JJ, 1999, J MAGN MAGN MATER, V194, P231, DOI 10.1016/S0304-8853(98)00557-5
   Cheng YX, 2009, TALANTA, V77, P1332, DOI 10.1016/j.talanta.2008.09.014
   Chertok B, 2008, BIOMATERIALS, V29, P487, DOI 10.1016/j.biomaterials.2007.08.050
   Chu HY, 2008, APPL SPECTROSC, V62, P922, DOI 10.1366/000370208785284330
   Crespo P, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/48/484006
   Crystallization Reserach Tools, 2014, CRYST RES TOOLS, V18, P51
   Davar F, 2009, J ALLOY COMPD, V476, P797, DOI 10.1016/j.jallcom.2008.09.121
   DAVIS RS, 1993, MEAS SCI TECHNOL, V4, P141, DOI 10.1088/0957-0233/4/2/001
   De Las Cuevas G, 2008, J PHYS CHEM C, V112, P945, DOI 10.1021/jp0755286
   Digigow RG, 2014, J MAGN MAGN MATER, V362, P72, DOI 10.1016/j.jmmm.2014.03.026
   Ding HL, 2012, CHEM MATER, V24, P4572, DOI 10.1021/cm302828d
   Dobson J, 2006, DRUG DEVELOP RES, V67, P55, DOI 10.1002/ddr.20067
   Dorozhkin SV, 2010, ACTA BIOMATER, V6, P715, DOI 10.1016/j.actbio.2009.10.031
   Dudak FC, 2008, J RAPID METH AUT MIC, V16, P122, DOI 10.1111/j.1745-4581.2008.00120.x
   Dudak Fahriye Ceyda, 2011, Front Biosci (Elite Ed), V3, P1109
   Dudak FC, 2009, J RAPID METH AUT MIC, V17, P315, DOI 10.1111/j.1745-4581.2009.00155.x
   El-Boubbou K, 2007, J AM CHEM SOC, V129, P13392, DOI 10.1021/ja076086e
   Faraudo J, 2010, COLLOID POLYM SCI, V288, P207, DOI 10.1007/s00396-009-2107-z
   Farimani MHR, 2013, PHYSICA E, V53, P207, DOI 10.1016/j.physe.2013.04.032
   Friedman G, 2005, CURR OPIN COLLOID IN, V10, P158, DOI 10.1016/j.cocis.2005.08.002
   Gao JH, 2006, ADV MATER, V18, P3145, DOI 10.1002/adma.200601058
   GERBER R, 1983, IEEE T MAGN, V19, P2115, DOI 10.1109/TMAG.1983.1062795
   GILL SJ, 1960, REV SCI INSTRUM, V31, P1299, DOI 10.1063/1.1716878
   Gu HW, 2006, CHEM COMMUN, P941, DOI 10.1039/b514130c
   Gu HW, 2003, CHEM COMMUN, P1966, DOI 10.1039/b305421g
   Gubin SP, 2005, RUSS CHEM REV, V74, P489, DOI DOI 10.1070/RC2005V074N06ABEH000897
   Hafeli UO, 2005, J MAGN MAGN MATER, V293, P224, DOI 10.1016/j.jmmm.2005.02.001
   Hatch DM, 2008, CHEMBIOCHEM, V9, P2433, DOI 10.1002/cbic.200800188
   Hecht E, 2001, OPTICS, P680
   Hofmann-Amtenbrink M, 2009, NANOSTRUCTURED MAT B, P119
   Jin T, 2009, J FOOD SCI, V74, pM46, DOI 10.1111/j.1750-3841.2008.01013.x
   Jing Y, 2008, FASEB J, V22, P4239, DOI 10.1096/fj.07-105544
   Jun YW, 2008, ACCOUNTS CHEM RES, V41, P179, DOI 10.1021/ar700121f
   Jung JS, 2007, J MAGN MAGN MATER, V310, P2361, DOI 10.1016/j.jmmm.2006.11.180
   Kang WS, 2008, FABRICATION NANOPART
   Kim D, 2009, J AM CHEM SOC, V131, P454, DOI 10.1021/ja8086906
   Kolhatkar AG, 2013, INT J MOL SCI, V14, P15977, DOI 10.3390/ijms140815977
   Larumbe S, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/26/266007
   Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e
   Lee KB, 2004, ANGEW CHEM INT EDIT, V43, P3048, DOI 10.1002/anie.200454088
   Lim J, 2011, ACS NANO, V5, P217, DOI 10.1021/nn102383s
   Lin J, 2001, J SOLID STATE CHEM, V159, P26, DOI 10.1006/jssc.2001.9117
   Lin YS, 2005, ANAL CHEM, V77, P1753, DOI 10.1021/ac048990k
   Liu JC, 2009, ANALYST, V134, P2087, DOI 10.1039/b908069d
   Liu WT, 2006, J BIOSCI BIOENG, V102, P1, DOI 10.1263/jbb.102.1
   Liu YC, 2002, J MICROBIOL METH, V51, P369, DOI 10.1016/S0167-7012(02)00107-0
   Mayer DP, 2012, PRZ ELEKTROTECHNICZN, P229
   McCloskey KE, 2000, CYTOMETRY, V40, P307, DOI 10.1002/1097-0320(20000801)40:4<307::AID-CYTO6>3.0.CO;2-H
   Moghal J, 2012, ACS APPL MATER INTER, V4, P854, DOI 10.1021/am201494m
   Murphy D, 2004, HELV CHIM ACTA, V87, P2727, DOI 10.1002/hlca.200490245
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   Nishida K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001269
   Olbrich C, 2004, J CONTROL RELEASE, V96, P425, DOI 10.1016/j.jconrel.2004.02.024
   Pal S, 2009, J APPL PHYS, V105, DOI 10.1063/1.3059607
   Pamme N, 2004, ANAL CHEM, V76, P7250, DOI 10.1021/ac049183c
   Parak WJ, 2003, NANOTECHNOLOGY, V14, pR15, DOI 10.1088/0957-4484/14/7/201
   Pei ZC, 2010, ANAL BIOCHEM, V398, P161, DOI 10.1016/j.ab.2009.11.038
   Polyanskiy M, 2013, REFRACTIVE INDEX DAT
   Ranjbakhsh E, 2012, CHEM ENG J, V179, P272, DOI 10.1016/j.cej.2011.10.097
   Ravindranath SP, 2009, ANAL CHEM, V81, P2840, DOI 10.1021/ac802158y
   Ray TR, 2015, LANGMUIR, V31, P3577, DOI 10.1021/la504511j
   Rong H., 2007, NANOTECHNOLOGY, V18
   Rotariu O, 2002, J MAGN MAGN MATER, V252, P390, DOI 10.1016/S0304-8853(02)00707-2
   Sajja VSK, 2011, BIOTECHNOL BIOENG, V108, P2107, DOI 10.1002/bit.23157
   Salado J, 2011, CHEM MATER, V23, P2879, DOI 10.1021/cm200253k
   Salazar-Alvarez G, 2008, J AM CHEM SOC, V130, P13234, DOI 10.1021/ja0768744
   Simsek T, 2014, J MAGN MAGN MATER, V351, P47, DOI 10.1016/j.jmmm.2013.09.051
   Smolensky ED, 2013, J MATER CHEM B, V1, P2818, DOI 10.1039/c3tb00369h
   Su XL, 2004, ANAL CHEM, V76, P4806, DOI 10.1021/ac049442+
   Sulatha Dwarakanath, 2006, Journal of Clinical Ligand Assay, V29, P136
   Suttiponparnit K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9772-1
   Tamer U, 2010, J NANOPART RES, V12, P1187, DOI 10.1007/s11051-009-9749-0
   Temur E, 2010, ANAL BIOANAL CHEM, V397, P1595, DOI 10.1007/s00216-010-3676-x
   Thapa D, 2004, MATER LETT, V58, P2692, DOI 10.1016/j.matlet.2004.03.045
   Varshney M, 2005, J FOOD PROTECT, V68, P1804, DOI 10.4315/0362-028X-68.9.1804
   Varshney M, 2007, BIOSENS BIOELECTRON, V22, P2408, DOI 10.1016/j.bios.2006.08.030
   Wang J, 2005, PERSP BIOANAL, V1, P369, DOI 10.1016/S1871-0069(05)01011-6
   Ware MW, 2003, J MICROBIOL METH, V55, P575, DOI 10.1016/j.mimet.2003.06.001
   Watarai H, 2004, ANAL BIOANAL CHEM, V378, P1693, DOI 10.1007/s00216-003-2354-7
   Wei Y., 2012, PROCEDIA ENG, V27, P632, DOI DOI 10.1016/J.PROENG.2011.12.498
   West JL, 2000, CURR OPIN BIOTECH, V11, P215, DOI 10.1016/S0958-1669(00)00082-3
   West JL, 2003, ANNU REV BIOMED ENG, V5, P285, DOI 10.1146/annurev.bioeng.5.011303.120723
   Yang H, 2008, MICROFLUID NANOFLUID, V5, P571, DOI 10.1007/s10404-008-0302-8
   Yang LJ, 2006, ANALYST, V131, P394, DOI 10.1039/b510888h
   Yavuz CT, 2009, CHEM ENG SCI, V64, P2510, DOI 10.1016/j.ces.2008.11.018
   Yu FQ, 2010, BIOMATERIALS, V31, P5842, DOI 10.1016/j.biomaterials.2010.03.072
   Yu LSL, 2002, J MICROBIOL METH, V49, P63, DOI 10.1016/S0167-7012(01)00352-9
NR 108
TC 4
Z9 4
U1 2
U2 17
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2015
VL 21
IS 37
BP 5389
EP 5400
DI 10.2174/1381612821666150917092327
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CV8GC
UT WOS:000364518200008
PM 26377661
DA 2018-10-19
ER

PT J
AU Cui, HX
   Guo, J
   Han, Z
   Guo, YX
   Guo, ML
AF Cui, H. X.
   Guo, J.
   Han, Z.
   Guo, Y. X.
   Guo, M. L.
TI Biocompatibility of differently proportioned HA/PLGA/BMP-2 composite
   biomaterials in rabbits
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE HA/PLGA/BMP-2 composite material; Histocompatibility; Bone tissue
   engineering
ID BONE REGENERATION; MECHANICAL-PROPERTIES; IN-VITRO; BMP-2; SCAFFOLDS;
   COMPATIBILITY; MICROSPHERES; DELIVERY; VIVO
AB The aim of this study was to assess the histocompatibility of hydroxyapatite (HA)/poly(lactic-co-glycolic acid) (PLGA)/bone morphogenetic protein-2 (BMP-2) composite materials in rabbits. Thirty healthy New Zealand white rabbits were randomly divided into 3 groups (N = 10). HA/PLGA/BMP-2 composite materials with the HA/PLGA proportions of 1: 1, 1: 2, and 1: 3 were implanted in the animals, which were subsequently sacrificed on the 30th and 60th days post-implantation to allow for differences in routine blood and biochemical indices to be assessed between the animal groups. The degree of biomaterial degradation was also assessed in the three groups. Thirty and 60 days after the implantation of titanium plates and composite materials, no rabbits succumbed to inflammatory reactions, adverse reactions, abnormal blood routine and biochemical indices, or unstable liver functions. The presence of newborn tissues was identified within the 60 days post-implantation. No significant differences were observed between the three groups (P < 0.05). The wide clinical application of HA/PLGA/BMP-2 composite biomaterial, which is highly compatible with rabbits with no apparent effects on the animals, is highly feasible.
C1 [Cui, H. X.; Guo, J.; Han, Z.; Guo, Y. X.; Guo, M. L.] Luoyang Orthoped Hosp Henan Prov, Luoyang, Henan Province, Peoples R China.
RP Guo, ML (reprint author), Luoyang Orthoped Hosp Henan Prov, Luoyang, Henan Province, Peoples R China.
EM guomalongloth@126.com
CR Bhattarai SR, 2008, J BIOMED MATER RES A, V86A, P289, DOI 10.1002/jbm.a.31490
   Fu YC, 2008, BIOTECHNOL BIOENG, V99, P996, DOI 10.1002/bit.21648
   Hannink G, 2013, J MATER SCI-MATER M, V24, P325, DOI 10.1007/s10856-012-4802-4
   Ji Y, 2010, ANN BIOMED ENG, V38, P632, DOI 10.1007/s10439-009-9888-6
   Jose MV, 2009, ACTA BIOMATER, V5, P305, DOI 10.1016/j.actbio.2008.07.019
   Kharaziha M, 2010, J MECH BEHAV BIOMED, V3, P530, DOI 10.1016/j.jmbbm.2010.06.003
   Kleinschmidt K, 2013, BIOMATERIALS, V34, P5926, DOI 10.1016/j.biomaterials.2013.04.029
   Kobayashi S, 2009, J MATER SCI-MATER M, V20, P379, DOI 10.1007/s10856-008-3583-2
   Lee JW, 2011, BIOMATERIALS, V32, P744, DOI 10.1016/j.biomaterials.2010.09.035
   Lin YT, 2012, J MATER SCI-MATER M, V23, P2453, DOI 10.1007/s10856-012-4723-2
   Lin ZY, 2010, J CONTROL RELEASE, V144, P190, DOI 10.1016/j.jconrel.2010.02.016
   Nguyen DT, 2013, J BIOMAT SCI-POLYM E, V24, P1071, DOI 10.1080/09205063.2012.735099
   Niu XF, 2009, J CONTROL RELEASE, V134, P111, DOI 10.1016/j.jconrel.2008.11.020
   Sagar N, 2012, J BIOMED MATER RES B, V100B, P624, DOI 10.1002/jbm.b.31983
   Schopper C, 2008, J BIOMED MATER RES A, V85A, P954, DOI 10.1002/jbm.a.31525
   Testori T, 2012, INT J PERIODONT REST, V32, P295
   Thorey F, 2011, J APPL BIOMATER BIOM, V9, P26, DOI 10.5301/JABB.2011.7731
   Wu ZM, 2010, J PHARM PHARMACOL, V62, P873, DOI [10.1211/jpp.62.05.0008, 10.1211/jpp.62.07.0008]
   Xia Y, 2012, J BIOMED MATER RES A, V100A, P1044, DOI 10.1002/jbm.a.33232
   Zheng Z, 2010, BIOMATERIALS, V31, P9293, DOI 10.1016/j.biomaterials.2010.08.041
NR 20
TC 3
Z9 4
U1 1
U2 12
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000,
   BRAZIL
SN 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2015
VL 14
IS 4
BP 13511
EP 13518
DI 10.4238/2015.October.28.12
PG 8
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA CV9BJ
UT WOS:000364582000048
PM 26535665
OA Bronze
DA 2018-10-19
ER

PT S
AU Michaels, SC
   Moses, KC
   Bachmann, RJ
   Hamilton, R
   Pena-Francesch, A
   Lanba, A
   Demirel, MC
   Quinn, RD
AF Michaels, Simone C.
   Moses, Kenneth C.
   Bachmann, Richard J.
   Hamilton, Reginald
   Pena-Francesch, Abdon
   Lanba, Asheesh
   Demirel, Melik C.
   Quinn, Roger D.
BE Wilson, SP
   Verschure, PFMJ
   Mura, A
   Prescott, TJ
TI Biomimicry of the Manduca Sexta Forewing Using SRT Protein Complex for
   FWMAV Development
SO BIOMIMETIC AND BIOHYBRID SYSTEMS, LIVING MACHINES 2015
SE Lecture Notes in Artificial Intelligence
LA English
DT Proceedings Paper
CT 4th International Conference on Biomimetic and Biohybrid Systems (Living
   Machines)
CY JUL 28-31, 2015
CL Barcelona, SPAIN
SP Convergence Sci Network Biomimet & Neurotechnol, Univ Sheffield, Univ Pompeu Fabra Barcelona, Inst Catalana Recerca Estudis Avancats
DE Protein; Wing; FWMAV; Biomaterial; Manduca sexta; Hawkmoth; Biomimicry
ID FLIGHT
AB A new thermoplastic protein complex, Squid Ring Teeth (SRT), has been adapted for use in the artificial reconstruction of a Manduca sexta wing. The SRT protein complex exhibits consistent material properties over a wide range of temperatures (25 degrees C to 196 degrees C) and retains it mechanical integrity across a large frequency spectrum (0.1 Hz to 150 Hz). Insect-inspired wings comprised of SRT can therefore be reliable and robust, which are essential characteristics for flapping wing MAVs (FWMAV). The preliminary results in this paper suggest that a thorough analysis of an SRT-based wing be conducted using load cell, optical digitization, and PIV techniques. With these results, we believe it will be possible to accurately mimic the M. sexta wing in order to pave the way for next generation FWMAV development.
C1 [Michaels, Simone C.; Moses, Kenneth C.; Bachmann, Richard J.; Quinn, Roger D.] Case Western Reserve Univ, Biol Inspired Robot Lab, Cleveland, OH 44106 USA.
   [Hamilton, Reginald; Pena-Francesch, Abdon; Lanba, Asheesh; Demirel, Melik C.] Penn State Univ, State Coll, PA USA.
RP Michaels, SC (reprint author), Case Western Reserve Univ, Biol Inspired Robot Lab, Cleveland, OH 44106 USA.
EM scm61@case.edu; kcm7@case.edu; rjb3@case.edu; MDemirel@engr.psu.edu;
   rdq@case.edu
RI Demirel, Melik/E-3775-2016
OI Demirel, Melik/0000-0003-0466-7649; Pena-Francesch,
   Abdon/0000-0002-7779-1651
CR Ansari SA, 2006, PROG AEROSP SCI, V42, P129, DOI 10.1016/j.paerosci.2006.07.001
   Chirarattananon P, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/2/025004
   Combes SA, 2010, ENCY AEROSPACE ENG, P1
   DeLeon N.E., 2011, MANUFACTURING EVALUA
   ENNOS AR, 1989, J EXP BIOL, V142, P87
   O'Hara RP, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/4/046011
   OHara R.P., 2011, MAT PROPERTY STRUCTU
   Pena Francesch A., 2014, ADV FUNCTIONAL MAT, V24, P6227
   Pena Francesch A., 2014, ADV FUNCTIONAL MAT, V24, P7401
NR 9
TC 1
Z9 1
U1 1
U2 2
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0302-9743
BN 978-3-319-22979-9; 978-3-319-22978-2
J9 LECT NOTES ARTIF INT
PY 2015
VL 9222
BP 86
EP 91
DI 10.1007/978-3-319-22979-9_8
PG 6
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems; Computer Science, Theory & Methods; Robotics
SC Computer Science; Robotics
GA BD8QF
UT WOS:000364183200008
DA 2018-10-19
ER

PT J
AU Wang, L
   Xu, C
   Zhu, YJ
   Yu, Y
   Sun, N
   Zhang, XQ
   Feng, K
   Qin, JH
AF Wang, Li
   Xu, Cong
   Zhu, Yujuan
   Yu, Yue
   Sun, Ning
   Zhang, Xiaoqing
   Feng, Ke
   Qin, Jianhua
TI Human induced pluripotent stem cell-derived beating cardiac tissues on
   paper
SO LAB ON A CHIP
LA English
DT Article
ID CARDIOMYOCYTE DIFFERENTIATION; CULTURE; NEURONS
AB There is a growing interest in using paper as a biomaterial scaffold for cell-based applications. In this study, we made the first attempt to fabricate a paper-based array for the culture, proliferation, and direct differentiation of human induced pluripotent stem cells (hiPSCs) into functional beating cardiac tissues and create "a beating heart on paper." This array was simply constructed by binding a cured multi-well polydimethylsiloxane (PDMS) mold with common, commercially available paper substrates. Three types of paper material (print paper, chromatography paper and nitrocellulose membrane) were tested for adhesion, proliferation and differentiation of human-derived iPSCs. We found that hiPSCs grew well on these paper substrates, presenting a three-dimensional (3D)-like morphology with a pluripotent property. The direct differentiation of human iPSCs into functional cardiac tissues on paper was also achieved using our modified differentiation approach. The cardiac tissue retained its functional activities on the coated print paper and chromatography paper with a beating frequency of 40-70 beats per min for up to three months. Interestingly, human iPSCs could be differentiated into retinal pigment epithelium on nitrocellulose membrane under the conditions of cardiac-specific induction, indicating the potential roles of material properties and mechanical cues that are involved in regulating stem cell differentiation. Taken together, these results suggest that different grades of paper could offer great opportunities as bioactive, low-cost, and 3D in vitro platforms for stem cell-based high-throughput drug testing at the tissue/organ level and for tissue engineering applications.
C1 [Wang, Li; Xu, Cong; Zhu, Yujuan; Yu, Yue; Zhang, Xiaoqing; Feng, Ke; Qin, Jianhua] Chinese Acad Sci, Dalian Inst Chem Phys, Dept Biotechnol, Dalian, Peoples R China.
   [Sun, Ning] Fudan Univ, Coll Basic Med Sci, Dept Physiol & Pathophysiol, Shanghai 200032, Peoples R China.
RP Qin, JH (reprint author), Chinese Acad Sci, Dalian Inst Chem Phys, Dept Biotechnol, Dalian, Peoples R China.
EM jhqin@dicp.ac.cn
OI Sun, Ning/0000-0002-7861-3646; Yu, Yue/0000-0003-0633-9577; xu,
   cong/0000-0001-8714-1890
FU International Science & Technology Cooperation Program of China
   [2015DFA00740]; Key Laboratory of Separation Science for Analytical
   Chemistry (Dalian Institute of Chemical Physics, Chinese Academy of
   Sciences); National Nature Science Foundation of China [81273483,
   81201689]; Special Fund for Agro-scientific Research in the Public
   Interest [201303045]
FX This research was supported by the International Science & Technology
   Cooperation Program of China (2015DFA00740), Key Laboratory of
   Separation Science for Analytical Chemistry (Dalian Institute of
   Chemical Physics, Chinese Academy of Sciences), National Nature Science
   Foundation of China (No. 81273483, 81201689), and Special Fund for
   Agro-scientific Research in the Public Interest (No. 201303045).
CR Bilousova G., 2011, STEM CELLS, V20, P233
   Brandl C, 2014, NEUROMOL MED, V16, P551, DOI 10.1007/s12017-014-8308-8
   Cimetta E, 2013, LAB CHIP, V13, P355, DOI 10.1039/c2lc40836h
   Cordey M, 2008, STEM CELLS, V26, P2586, DOI 10.1634/stemcells.2008-0498
   Csobonyeiova M, 2015, CELL TISSUE BANK, V16, P171, DOI 10.1007/s10561-014-9462-9
   Derda R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018940
   Derda R, 2009, P NATL ACAD SCI USA, V106, P18457, DOI 10.1073/pnas.0910666106
   Giri S, 2015, DRUG DISCOV TODAY, V20, P37, DOI 10.1016/j.drudis.2014.10.011
   Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127
   Ikonen L, 2013, BIOMED RES INT, DOI 10.1155/2013/285678
   Kawada J, 2012, LAB CHIP, V12, P4508, DOI 10.1039/c2lc40268h
   Khademhosseini A, 2007, BIOMED MICRODEVICES, V9, P149, DOI 10.1007/s10544-006-9013-7
   Kitagawa Y, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035011
   Lee J, 2013, BIOMATERIALS, V34, P8140, DOI 10.1016/j.biomaterials.2013.07.074
   Lian X., 2012, P NATL ACAD SCI USA, V27, P1848
   Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109
   Mosadegh B, 2015, BIOMATERIALS, V52, P262, DOI 10.1016/j.biomaterials.2015.02.012
   Mosadegh B, 2014, ADV HEALTHC MATER, V3, P1036, DOI 10.1002/adhm.201300575
   Myers FB, 2013, INTEGR BIOL-UK, V5, P1495, DOI 10.1039/c2ib20191g
   Park HJ, 2014, BIOMATERIALS, V35, P9811, DOI 10.1016/j.biomaterials.2014.09.002
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Sapp MC, 2015, ACTA BIOMATER, V13, P199, DOI 10.1016/j.actbio.2014.11.039
   Stout DA, 2012, INT J NANOMED, V7, P5653, DOI 10.2147/IJN.S34574
   Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
NR 26
TC 17
Z9 17
U1 7
U2 49
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
EI 1473-0189
J9 LAB CHIP
JI Lab Chip
PY 2015
VL 15
IS 22
BP 4283
EP 4290
DI 10.1039/c5lc00919g
PG 8
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA CV2FL
UT WOS:000364072300005
PM 26430714
DA 2018-10-19
ER

PT J
AU Newman, P
   Lu, Z
   Roohani-Esfahani, SI
   Church, TL
   Biro, M
   Davies, B
   King, A
   Mackenzie, K
   Minett, AI
   Zreiqat, H
AF Newman, P.
   Lu, Z.
   Roohani-Esfahani, S. I.
   Church, T. L.
   Biro, M.
   Davies, B.
   King, A.
   Mackenzie, K.
   Minett, A. I.
   Zreiqat, H.
TI Porous and strong three-dimensional carbon nanotube coated ceramic
   scaffolds for tissue engineering
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; CHEMICAL-VAPOR-DEPOSITION; BONE-FORMATION;
   CELLULAR BEHAVIOR; PROLIFERATION; GROWTH; DIFFERENTIATION;
   BIOCOMPATIBILITY; REGENERATION; COMPOSITES
AB Biomaterials research is investigating increasingly complex materials capable of mirroring the highly organized biochemical and architectural environments of the body. Accordingly, tissue scaffolds with nanoscale properties that mirror the fibrous proteins present in tissue are being developed. Such materials can benefit from the inherent dimensional similarities and nanocomposite nature of the cellular environment, altering nanoscale dimensional and biochemical properties to mimic the regulatory characteristics of natural cellular environments. One nanomaterial which demonstrates potential across a diverse range of biomaterial applications is carbon nanotubes (CNTs). Building on previous reports, a method to coat CNTs throughout 3D porous structures is developed. Through modifications to typical chemical vapour deposition (CVD), a high-quality uniform coating of carbon nanotubes (CNTs) is demonstrated over beta-tricalcium phosphate/hydroxyapatite (or TCP/HA), which is in clinical use; and the high-mechanical-strength multicomponent ceramic Ca2ZnSi2O7-ZnAl2O4, (or Sr-HT-Gah). The resulting materials address deficiencies of previously reported CNT biomaterials by simultaneously presenting properties of high porosity, biocompatibility and a mechanical stability. Together, this unique combination of properties makes these scaffolds versatile materials for tissue engineering in load bearing applications.
C1 [Newman, P.; Lu, Z.; Roohani-Esfahani, S. I.; Davies, B.; Zreiqat, H.] Univ Sydney, Sch Aeronaut Mech & Mechatron Engn, Biomat & Tissue Engn Res Unit, Sydney, NSW 2006, Australia.
   [Newman, P.; Church, T. L.; Davies, B.; King, A.; Mackenzie, K.; Minett, A. I.] Univ Sydney, Sch Chem & Biomol Engn, Lab Sustainable Technol, Sydney, NSW 2006, Australia.
   [Church, T. L.] Stockholm Univ, Dept Mat & Environm Chem, S-10691 Stockholm, Sweden.
   [Biro, M.] Centenary Inst Canc Med & Cell Biol, Sydney, NSW 2042, Australia.
   [Biro, M.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
RP Newman, P (reprint author), Univ Sydney, Sch Aeronaut Mech & Mechatron Engn, Biomat & Tissue Engn Res Unit, Sydney, NSW 2006, Australia.
EM p.newman@sydney.edu.au; hala.zreiqat@sydney.edu.au
OI Roohani, Iman/0000-0001-6618-8577; Lu, ZuFu/0000-0003-4843-4441; King,
   Alice/0000-0002-1637-757X
FU Australian National Health and Medical Research Council; Rebecca Copper
   Foundation; Australian Research Council
FX The authors gratefully acknowledge the financial support of the
   Commonwealth Government for providing an Australian Postgraduate Award
   Scholarship to P.N. The Australian National Health and Medical Research
   Council, the Rebecca Copper Foundation and the Australian Research
   Council are also acknowledged for financial support. The authors
   acknowledge the facilities of the Australian Microscopy and
   Microanalysis Research Facility at the Australian Centre for Microscopy
   and Microanalysis, The University of Sydney, and the scientific and
   technical assistance with SEM, TEM and CT analysis that was provided by
   Mr Victor Lo and Dr Matthew Foley.
CR Abarrategi A, 2008, BIOMATERIALS, V29, P94, DOI 10.1016/j.biomaterials.2007.09.021
   Ali-Boucetta H, 2011, METHODS MOL BIOL, V726, P299, DOI 10.1007/978-1-61779-052-2_19
   Baik KY, 2011, SMALL, V7, P741, DOI 10.1002/smll.201001930
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bhattacharya M, 2011, J BIOMED MATER RES A, V96A, P75, DOI 10.1002/jbm.a.32958
   Boccaccini AR, 2007, ADV FUNCT MATER, V17, P2815, DOI 10.1002/adfm.200600887
   BOTHWELL TH, 1995, NUTR REV, V53, P237
   Breuer O, 2004, POLYM COMPOSITE, V25, P630, DOI 10.1002/pc.20058
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Casey A, 2007, CARBON, V45, P1425, DOI 10.1016/j.carbon.2007.03.033
   Chahine NO, 2014, TISSUE ENG PT A, V20, P2305, DOI [10.1089/ten.tea.2013.0328, 10.1089/ten.TEA.2013.0328]
   Chen WQ, 2014, NANO TODAY, V9, P759, DOI 10.1016/j.nantod.2014.12.002
   Coleman JN, 2006, CARBON, V44, P1624, DOI 10.1016/j.carbon.2006.02.038
   Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]
   Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006
   Ducati C, 2002, J APPL PHYS, V92, P3299, DOI 10.1063/1.1499746
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Endo M, 2008, TOP APPL PHYS, V111, P13, DOI 10.1007/978-3-540-72865-8_2
   Fan L, 2012, NANO LETT, V12, P3668, DOI 10.1021/nl301428w
   Firme CP, 2010, NANOMED-NANOTECHNOL, V6, P245, DOI 10.1016/j.nano.2009.07.003
   Goh KL, 2005, BBA-GEN SUBJECTS, V1722, P183, DOI 10.1016/j.bbagen.2004.12.004
   Habelitz S, 2002, J STRUCT BIOL, V138, P227, DOI 10.1016/S1047-8477(02)00029-1
   Hata K, 2004, SCIENCE, V306, P1362, DOI 10.1126/science.1104962
   Hirata E, 2011, CARBON, V49, P3284, DOI 10.1016/j.carbon.2011.04.002
   Hirata E, 2009, J BIOMED MATER RES B, V90B, P629, DOI 10.1002/jbm.b.31327
   Holy J, 2011, IET NANOBIOTECHNOL, V5, P41, DOI 10.1049/iet-nbt.2010.0014
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Huang FM, 1998, J APPL PHYS, V84, P4022, DOI 10.1063/1.368585
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jan E, 2007, NANO LETT, V7, P1123, DOI 10.1021/nl0620132
   Jones LJ, 2001, J IMMUNOL METHODS, V254, P85, DOI 10.1016/S0022-1759(01)00404-5
   Kaiser JP, 2009, NANOMEDICINE-UK, V4, P57, DOI 10.2217/17435889.4.1.57
   Kalbacova M, 2007, CARBON, V45, P2266, DOI 10.1016/j.carbon.2007.06.025
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kirschner CM, 2013, SMALL, V9, P578, DOI 10.1002/smll.201201841
   Kostarelos K, 2009, NAT NANOTECHNOL, V4, P627, DOI 10.1038/nnano.2009.241
   Lakhkar NJ, 2013, ADV DRUG DELIVER REV, V65, P405, DOI 10.1016/j.addr.2012.05.015
   Lewitus DY, 2011, ADV FUNCT MATER, V21, P2624, DOI 10.1002/adfm.201002429
   Li C, 2008, COMPOS SCI TECHNOL, V68, P1227, DOI 10.1016/j.compscitech.2008.01.006
   Liu Z, 2009, NAT PROTOC, V4, P1372, DOI 10.1038/nprot.2009.146
   Lobo AO, 2010, CARBON, V48, P245, DOI 10.1016/j.carbon.2009.09.012
   Lu CG, 2006, J PHYS CHEM B, V110, P20254, DOI 10.1021/jp0632283
   Lynch I, 2008, NANO TODAY, V3, P40, DOI 10.1016/S1748-0132(08)70014-8
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   MacKenzie KJ, 2013, CARBON, V59, P344, DOI 10.1016/j.carbon.2013.03.029
   MacKenzie KJ, 2010, IND ENG CHEM RES, V49, P5323, DOI 10.1021/ie9019787
   Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055
   Mei F, 2007, BIOMACROMOLECULES, V8, P3729, DOI 10.1021/bm7006295
   Miralles P, 2012, ENVIRON SCI TECHNOL, V46, P9224, DOI 10.1021/es202995d
   Mooney E, 2008, NANO LETT, V8, P2137, DOI 10.1021/nl073300o
   Mwenifumbo S, 2007, J MATER CHEM, V17, P1894, DOI 10.1039/b617708e
   Namgung S, 2011, ACS NANO, V5, P7383, DOI 10.1021/nn2023057
   Namgung S, 2011, SMALL, V7, P56, DOI 10.1002/smll.201001513
   Nayak TR, 2010, ACS NANO, V4, P7717, DOI 10.1021/nn102738c
   Newman P, 2013, NANOMED-NANOTECHNOL, V9, P1139, DOI 10.1016/j.nano.2013.06.001
   Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339
   Ogihara N, 2012, NANOMEDICINE-UK, V7, P981, DOI [10.2217/NNM.12.1, 10.2217/nnm.12.1]
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Park SY, 2007, ADV MATER, V19, P2530, DOI 10.1002/adma.200600875
   Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111
   Porter AE, 2007, NAT NANOTECHNOL, V2, P713, DOI 10.1038/nnano.2007.347
   Pulskamp K, 2007, TOXICOL LETT, V168, P58, DOI 10.1016/j.toxlet.2006.11.001
   Quigley AF, 2012, ADV HEALTHC MATER, V1, P801, DOI 10.1002/adhm.201200102
   Roduner E, 2006, CHEM SOC REV, V35, P583, DOI 10.1039/b502142c
   Roohani-Esfahani SI, 2013, ACTA BIOMATER, V9, P7014, DOI 10.1016/j.actbio.2013.02.039
   Roohani-Esfahani SI, 2013, MATER LETT, V107, P378, DOI 10.1016/j.matlet.2013.06.046
   Ryman-Rasmussen JP, 2009, NAT NANOTECHNOL, V4, P747, DOI [10.1038/NNANO.2009.305, 10.1038/nnano.2009.305]
   Saito N, 2014, CHEM REV, V114, P6040, DOI 10.1021/cr400341h
   Schipper ML, 2008, NAT NANOTECHNOL, V3, P216, DOI 10.1038/nnano.2008.68
   Shimizu M, 2012, ADV MATER, V24, P2176, DOI 10.1002/adma.201103832
   Sitharaman B, 2008, BONE, V43, P362, DOI 10.1016/j.bone.2008.04.013
   Soenen SJ, 2012, METHOD ENZYMOL, V509, P195, DOI 10.1016/B978-0-12-391858-1.00011-3
   Tay CY, 2010, CARBON, V48, P1095, DOI 10.1016/j.carbon.2009.11.031
   Touri R, 2013, BIOMED RES INT, DOI 10.1155/2013/465086
   Usui Y, 2008, SMALL, V4, P240, DOI 10.1002/smll.200700670
   Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c
   Yang XS, 2011, J PHYS CHEM C, V115, P14093, DOI 10.1021/jp203469y
   Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e
   Zhang M, 2005, SCIENCE, V309, P1215, DOI 10.1126/science.1115311
NR 81
TC 3
Z9 5
U1 1
U2 27
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 42
BP 8337
EP 8347
DI 10.1039/c5tb01052g
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA CU9MG
UT WOS:000363868000010
DA 2018-10-19
ER

PT J
AU Tang, JY
   Bao, LH
   Li, X
   Chen, L
   Hong, FF
AF Tang, Jingyu
   Bao, Luhan
   Li, Xue
   Chen, Lin
   Hong, Feng F.
TI Potential of PVA-doped bacterial nano-cellulose tubular composites for
   artificial blood vessels
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID POLYVINYL-ALCOHOL HYDROGEL; BIOMEDICAL APPLICATIONS;
   MECHANICAL-PROPERTIES; VASCULAR GRAFTS; POLY(VINYL ALCOHOL);
   NANOCOMPOSITE; PROSTHESIS; RELEASE; SYSTEM; BYPASS
AB Bacterial nano-cellulose (BNC) hydrogel has been suggested as a promising biomaterial for artificial blood vessels. However, some properties of BNC do not achieve all of the requirements of a native blood vessel - compliance, for instance. In order to improve the properties of BNC tubes, poly(vinyl alcohol) (PVA) was introduced in the BNC tubes to make composites. Two types of pristine BNC tubes with different inner structures were produced in two bioreactors. A PVA tube and PVA-BNC tubular composites were made for comparison by using a thermally-induced phase separation method. The morphology, water permeability, cytotoxicity, and mechanical properties, including the axial stretch strength, suture retention, burst pressure, and compliance of all the tubes, were evaluated and compared. The results indicated that PVA impregnated into BNC tubes and then significantly improved the properties of BNC, especially the mechanical properties and water permeability. The BNC tube itself played a great role in the performances of the composites as the skeleton base material. The PVA-BNC composite tubes could constitute new biomaterial candidates for vascular grafts.
C1 [Tang, Jingyu; Bao, Luhan; Li, Xue; Chen, Lin; Hong, Feng F.] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Grp Microbiol Engn & Ind Biotechnol, Shanghai 201620, Peoples R China.
   [Hong, Feng F.] Donghua Univ, Minist Educ, Key Lab High Performance Fibers & Prod, Shanghai 201620, Peoples R China.
RP Hong, FF (reprint author), Donghua Univ, Coll Chem Chem Engn & Biotechnol, Grp Microbiol Engn & Ind Biotechnol, North Ren Min Rd 2999, Shanghai 201620, Peoples R China.
EM fhong@dhu.edu.cn
RI Hong, Feng/D-3878-2017
OI Hong, Feng/0000-0001-5120-3519
FU Program for New Century Excellent Talents in University [NCET-12-0828];
   National Natural Science Foundation of China [51373031]; Science and
   Technology Commission of Shanghai Municipality [12nm0500600]; 111
   Project [B07024]; Fundamental Research Funds for Central Universities
   [2232014A3-04]
FX Sponsoring funds: financial support provided by Program for New Century
   Excellent Talents in University (NCET-12-0828), by the National Natural
   Science Foundation of China (No. 51373031), the Science and Technology
   Commission of Shanghai Municipality (12nm0500600), the 111 Project
   B07024, and the Fundamental Research Funds for the Central Universities
   (2232014A3-04) is gratefully acknowledged.
CR [Anonymous], 2010, [No title captured], Patent No. 101921700
   [Anonymous], 2010, [No title captured], Patent No. 20101270524
   [Anonymous], 2010, [No title captured], Patent No. 20102511755
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Bodin A., 2008, MODERN MULTIDISCIPLI, P619
   Bodin A, 2007, BIOTECHNOL BIOENG, V97, P425, DOI 10.1002/bit.21314
   Fink H, 2011, J BIOMED MATER RES A, V97A, P52, DOI 10.1002/jbm.a.33031
   Gatenholm P, 2010, MRS BULL, V35, P208, DOI 10.1557/mrs2010.653
   Gea S, 2010, MATER LETT, V64, P901, DOI 10.1016/j.matlet.2010.01.042
   Gelin K, 2007, POLYMER, V48, P7623, DOI 10.1016/j.polymer.2007.10.039
   Hong F., 2010, China Patent, Patent No. [CN201809341, 201809341]
   Hong F, 2015, BIOMED RES INT, DOI 10.1155/2015/560365
   Indriyatia R., 2012, PRO CHEM, V4, P73
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Kong XY, 2012, J BIOMED MATER RES A, V100A, P1938, DOI 10.1002/jbm.a.34136
   Konig G, 2009, BIOMATERIALS, V30, P1542, DOI 10.1016/j.biomaterials.2008.11.011
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   Leitao AF, 2013, COLLOID SURFACE B, V111, P493, DOI 10.1016/j.colsurfb.2013.06.031
   Leitao AF, 2013, MATERIALS, V6, P1956, DOI 10.3390/ma6051956
   Lozinsky VI, 1998, ENZYME MICROB TECH, V23, P227, DOI 10.1016/S0141-0229(98)00036-2
   MARTZ H, 1987, J BIOMED MATER RES, V21, P399, DOI 10.1002/jbm.820210311
   McClure MJ, 2012, J MECH BEHAV BIOMED, V10, P48, DOI 10.1016/j.jmbbm.2012.02.026
   Million LE, 2008, J BIOMED MATER RES B, V86B, P444, DOI 10.1002/jbm.b.31040
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P305, DOI 10.1002/jbm.b.30543
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P245, DOI 10.1002/jbm.b.30535
   Millon LE, 2009, J BIOMED MATER RES B, V90B, P922, DOI 10.1002/jbm.b.31364
   Mori Y, 1997, J MATER SCI, V32, P491, DOI 10.1023/A:1018586307534
   Pavaloiu RD, 2014, INT J BIOL MACROMOL, V68, P117, DOI 10.1016/j.ijbiomac.2014.04.040
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   Prichard HL, 2011, J CARDIOVASC TRANSL, V4, P674, DOI 10.1007/s12265-011-9306-y
   Putra A, 2008, POLYMER, V49, P1885, DOI 10.1016/j.polymer.2008.02.022
   Qiu KY, 2012, J MATER SCI, V47, P6066, DOI 10.1007/s10853-012-6517-9
   Quint C, 2012, J VASC SURG, V55, P790, DOI 10.1016/j.jvs.2011.07.098
   Rouabhia M, 2014, ACS APPL MATER INTER, V6, P1439, DOI 10.1021/am4027983
   Sayers RD, 1998, BRIT J SURG, V85, P934
   Scherner M, 2014, J SURG RES, V189, P340, DOI 10.1016/j.jss.2014.02.011
   Schumann DA, 2009, CELLULOSE, V16, P877, DOI 10.1007/s10570-008-9264-y
   Seifalian AM, 2003, BIOMATERIALS, V24, P2549, DOI 10.1016/S0142-9612(02)00608-7
   Seifu DG, 2013, NAT REV CARDIOL, V10, P410, DOI 10.1038/nrcardio.2013.77
   Sonoda H, 2002, J BIOMED MATER RES, V60, P191, DOI 10.1002/jbm.10055
   Stoica-Guzun A, 2013, RADIAT PHYS CHEM, V84, P200, DOI 10.1016/j.radphyschem.2012.06.017
   Stroescu M, 2013, J FOOD ENG, V114, P153, DOI 10.1016/j.jfoodeng.2012.08.023
   Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1006/ejvs.2002.1654
   Valenta J., 1993, BIOMECHANICS, P142
   van Det RJ, 2009, EUR J VASC ENDOVASC, V37, P457, DOI 10.1016/j.ejvs.2008.11.041
   Wan WK, 2002, J BIOMED MATER RES, V63, P854, DOI 10.1002/jbm.10333
   Wang JH, 2010, MAT SCI ENG C-MATER, V30, P214, DOI 10.1016/j.msec.2009.10.006
   Wang SD, 2009, J APPL POLYM SCI, V113, P2675, DOI 10.1002/app.30346
   Wang WZ, 2015, J BIOMED MATER RES A, V103, P1784, DOI 10.1002/jbm.a.35315
   Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007
   Yaguchi T, 2002, J ARTIF ORGANS, V5, P117
   Zidi M, 2003, COMPUT BIOL MED, V33, P65, DOI 10.1016/S0010-4825(02)00059-8
NR 52
TC 18
Z9 20
U1 10
U2 88
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 43
BP 8537
EP 8547
DI 10.1039/c5tb01144b
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA CV2RC
UT WOS:000364103100013
DA 2018-10-19
ER

PT J
AU Kim, YJ
   Takahashi, Y
   Kato, N
   Matsunaga, YT
AF Kim, Young-Jin
   Takahashi, Yuta
   Kato, Norihiro
   Matsunaga, Yukiko T.
TI Fabrication of biomimetic bundled gel fibres using dynamic microfluidic
   gelation of phase-separated polymer solutions
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID NANOFIBROUS SCAFFOLDS; AQUEOUS-SOLUTIONS; HYDROGELS; SUPERCAPACITORS;
   GLYCOL); TISSUES; STORAGE
AB Here, we discuss the fabrication of biomimetic bundle-structured gel fibres using a microfluidic device and the rapid cross-linking of a phase-separated polymer blend solution. The products are potential candidates for cell culture scaffolds that mimic artificial tissues. Two naturally derived, biocompatible polysaccharide polymers are the raw materials for the bundled gel fibres, which are approximately 200-400 mu m in diameter and consist of 10(2)-10(3) aligned continuous microfibres of 1-3 mu m in diameter. They create a composite fibrous material with enhanced toughness and tensile strength because of the unique three-dimensional, cross-linked hierarchic structure. Because the main component of the gel fibre is temperature responsive, the mechanical properties improve at higher temperatures, yet are reversible without collapsing in response to temperature changes. Cell cultures form a cylinder-like shape along the fibre orientation. These unique features would be advantageous for tissue scaffolds as well as other biomaterial applications such as tissue engineering, actuators, drug carriers, and biosensors with the remotely controllable "on-off'' properties.
C1 [Kim, Young-Jin; Takahashi, Yuta; Matsunaga, Yukiko T.] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan.
   [Kim, Young-Jin] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1028472, Japan.
   [Takahashi, Yuta; Kato, Norihiro] Utsunomiya Univ, Grad Sch Engn, Utsunomiya, Tochigi 3218585, Japan.
   [Matsunaga, Yukiko T.] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan.
RP Matsunaga, YT (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.
EM mat@iis.u-tokyo.ac.jp
OI Matsunaga, Yukiko/0000-0002-0483-9423
FU PRESTO, Japan Science and Technology (JST), Japan; JSPS [25706010]
FX This work was partly supported by PRESTO, Japan Science and Technology
   (JST), Japan. This work was also supported by a JSPS Grant-in-Aid for
   Young Scientists (A) (No. 25706010 to Y.T.M.).
CR Ali U, 2012, J TEXT I, V103, P80, DOI 10.1080/00405000.2011.552254
   Barber J, 2011, TISSUE ENG PART A, V19, P1265
   Boustany K., 1976, J ELASTOPLAST, V8, P160, DOI DOI 10.1177/009524437600800202
   Caner C, 1998, J FOOD SCI, V63, P1049, DOI 10.1111/j.1365-2621.1998.tb15852.x
   Chae SK, 2013, ADV MATER, V25, P3071, DOI 10.1002/adma.201300837
   Chang CY, 2011, CARBOHYD POLYM, V84, P40, DOI 10.1016/j.carbpol.2010.12.023
   Chung BG, 2012, LAB CHIP, V12, P45, DOI 10.1039/c1lc20859d
   Du HB, 2010, J PHYS CHEM B, V114, P16594, DOI 10.1021/jp105652c
   Fang M, 2012, ACS NANO, V6, P9503, DOI 10.1021/nn302483x
   Fu YP, 2012, ADV MATER, V24, P5713, DOI 10.1002/adma.201202930
   Gillies AR, 2011, MUSCLE NERVE, V44, P318, DOI 10.1002/mus.22094
   Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907
   Gonzalez-Rodriguez D, 2012, SCIENCE, V338, P910, DOI 10.1126/science.1226418
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   HASHIMOTO T, 1995, PHYS REV LETT, V74, P126, DOI 10.1103/PhysRevLett.74.126
   Hey MJ, 2005, POLYMER, V46, P2567, DOI 10.1016/j.polymer.2005.02.019
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Holzwarth JM, 2011, J MATER CHEM, V21, P10243, DOI 10.1039/c1jm10522a
   Kang E, 2012, ADV MATER, V24, P4271, DOI 10.1002/adma.201201232
   Kim Y.- J., 2012, ANGEW CHEM INT EDIT, V124, P10689
   Kim YJ, 2013, ADV FUNCT MATER, V23, P5753, DOI 10.1002/adfm.201300746
   Kim YJ, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/6/064203
   Kiriya D, 2012, ANGEW CHEM INT EDIT, V51, P7942, DOI 10.1002/anie.201202078
   Koster S, 2007, LANGMUIR, V23, P357, DOI 10.1021/la062473a
   LEDBETTER MC, 1963, J CELL BIOL, V19, P239, DOI 10.1083/jcb.19.1.239
   Lee WY, 2011, TISSUE ENG PART C-ME, V17, P651, DOI 10.1089/ten.tec.2010.0621
   Liedl T, 2010, NAT NANOTECHNOL, V5, P520, DOI [10.1038/NNANO.2010.107, 10.1038/nnano.2010.107]
   Liu F, 2014, J AM CHEM SOC, V136, P6846, DOI 10.1021/ja502410e
   Matsunaga YT, 2011, ADV MATER, V23, pH90, DOI 10.1002/adma.201004375
   Onoe H, 2013, NAT MATER, V12, P584, DOI [10.1038/NMAT3606, 10.1038/nmat3606]
   Sadeghi R, 2009, FLUID PHASE EQUILIBR, V280, P68, DOI 10.1016/j.fluid.2009.03.005
   Schafmeister CE, 1997, NAT STRUCT BIOL, V4, P1039, DOI 10.1038/nsb1297-1039
   Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409
   Tanaka H, 2000, J PHYS-CONDENS MAT, V12, pR207, DOI 10.1088/0953-8984/12/15/201
   Teo WE, 2005, NANOTECHNOLOGY, V16, P1878, DOI 10.1088/0957-4484/16/9/077
   Tsougeni K, 2010, LAB CHIP, V10, P462, DOI 10.1039/b916566e
   vandeWitte P, 1996, J MEMBRANE SCI, V117, P1, DOI 10.1016/0376-7388(96)00088-9
   Xu JH, 2006, LAB CHIP, V6, P131, DOI 10.1039/b509939k
   Yue ZL, 2010, BIOMATERIALS, V31, P8141, DOI 10.1016/j.biomaterials.2010.07.059
   Zhai SC, 2012, J MATER SCI, V47, P949, DOI 10.1007/s10853-011-5874-0
   Zhang DH, 2014, ACS NANO, V8, P4571, DOI 10.1021/nn5001386
NR 41
TC 6
Z9 6
U1 4
U2 33
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 41
BP 8154
EP 8161
DI 10.1039/c5tb01395j
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA CT9QY
UT WOS:000363152900012
DA 2018-10-19
ER

PT J
AU Turdean-Ionescu, C
   Stevensson, B
   Grins, J
   Izquierdo-Barba, I
   Garcia, A
   Arcos, D
   Vallet-Regi, M
   Eden, M
AF Turdean-Ionescu, Claudia
   Stevensson, Baltzar
   Grins, Jekabs
   Izquierdo-Barba, Isabel
   Garcia, Ana
   Arcos, Daniel
   Vallet-Regi, Maria
   Eden, Mattias
TI Composition-dependent in vitro apatite formation at mesoporous bioactive
   glass-surfaces quantified by solid-state NMR and powder XRD
SO RSC ADVANCES
LA English
DT Article
ID SIMULATED BODY-FLUID; PHOSPHOSILICATE GLASSES; SILICATE-GLASSES; GEL
   GLASSES; REACTIVITY; P-31; MINERALIZATION; DISSOLUTION; SPECTROSCOPY;
   SCAFFOLDS
AB Silicate-based bioactive glasses exhibit bone-bonding properties due to the formation of a hydroxycarbonate apatite (HCA) layer at the glass surface on its contact with living tissues. This bone-healing process is triggered by ionic exchange between the glass and the surrounding fluids and thereby depends on the glass composition. In this work, the HCA formation from three mesoporous bioactive glasses (MBGs) of different compositions immersed in a simulated body fluid (SBF) was monitored for variable time intervals between 15 minutes to 30 days. By utilizing two independent assessment techniques, solid-state P-31 NMR spectroscopy and powder X-ray diffraction (PXRD), we report the first quantitative assessment of the HCA growth (i.e., "in vitro bioactivity") from a bioactive glass: both techniques allow for monitoring the crystallization of the amorphous calcium phosphate (ACP) precursor into HCA, i.e., a profile of the relative ACP/HCA fractions of the biomimetic phosphate layer formed at each MBG surface and SBF-exposure period. The amount of HCA present in each solid specimen after the SBF treatment, as well as the composition of the remaining cation-depleted MBG phase, was determined from PXRD data in conjunction with measured concentrations of Ca, Si, and P in the solution. In contrast with previous findings from in vitro bioactivity assessments of the same MBG compositions, the HCA formation is herein observed to increase concurrently with the Ca and P contents of the MBG; these apparently different composition-bioactivity observations stem from a significantly lower MBG-loading in the SBF solution utilized herein. The results are discussed in relation to the general task of performing bioactivity testing in SBF, where we highlight the importance of adapting the concentration of the biomaterial to its composition to avoid perturbing the HCA crystallization and thereby altering the outcome of the test.
C1 [Turdean-Ionescu, Claudia; Stevensson, Baltzar; Grins, Jekabs; Eden, Mattias] Stockholm Univ, Arrhenius Lab, Dept Mat & Environm Chem, SE-10691 Stockholm, Sweden.
   [Izquierdo-Barba, Isabel; Garcia, Ana; Arcos, Daniel; Vallet-Regi, Maria] Univ Complutense Madrid, Inst Invest Sanitaria Hosp 12 Octubre I 12, Fac Farm, Dept Quim Inorgan & Bioinorgan, Madrid 28040, Spain.
   [Izquierdo-Barba, Isabel; Garcia, Ana; Arcos, Daniel; Vallet-Regi, Maria] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain.
RP Eden, M (reprint author), Stockholm Univ, Arrhenius Lab, Dept Mat & Environm Chem, SE-10691 Stockholm, Sweden.
EM mattias.eden@mmk.su.se
RI IZQUIERDO-BARBA, ISABEL/M-9921-2014; Vallet-Regi, Maria/M-3378-2014;
   Garcia Fontecha, Ana/B-1301-2015
OI IZQUIERDO-BARBA, ISABEL/0000-0002-4139-4646; Vallet-Regi,
   Maria/0000-0002-6104-4889; Garcia Fontecha, Ana/0000-0002-8792-872X
FU Swedish Research Council [VR-NT 2010-4943, 2014-4667]; Ministerio de
   Ciencia e Innovacion [MAT2012-35556]; Ministerio de Economia y
   Competitividad [MAT2013-43299-R]; Agening Network of Excellence
   [CSO2010-11384-E]; Carl Trygger Foundation; Swedish Research Council;
   Knut and Alice Wallenberg Foundation; Faculty of Natural Sciences at
   Stockholm University
FX This work was supported by the Swedish Research Council (projects VR-NT
   2010-4943; 2014-4667), the Faculty of Natural Sciences at Stockholm
   University, Ministerio de Ciencia e Innovacion (project MAT2012-35556),
   Ministerio de Economia y Competitividad (project MAT2013-43299-R) and
   Agening Network of Excellence (CSO2010-11384-E). C. T.-I. was supported
   by a postdoctoral grant from the Carl Trygger Foundation. We gratefully
   acknowledge NMR equipment Grants from the Swedish Research Council, and
   the Knut and Alice Wallenberg Foundation. We thank Renny Mathew for
   experimental help.
CR [Anonymous], 23317 ISO
   Arcos D, 2003, J BIOMED MATER RES A, V65A, P344, DOI 10.1002/jbm.a.10503
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Brinker CJ, 1999, ADV MATER, V11, P579, DOI 10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.0.CO;2-R
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Cerruti M, 2005, BIOMATERIALS, V26, P1665, DOI 10.1016/j.biomaterials.2004.07.009
   Dietrich E, 2009, ADV ENG MATER, V11, pB98, DOI 10.1002/adem.200800400
   Eden M, 2011, J NON-CRYST SOLIDS, V357, P1595, DOI 10.1016/j.jnoncrysol.2010.11.098
   Garcia A, 2009, CHEM MATER, V21, P5474, DOI 10.1021/cm9022776
   Gregg S. L., 1982, ADSORPTION SURFACE A
   Gunawidjaja PN, 2012, J MATER CHEM, V22, P7214, DOI 10.1039/c2jm15066b
   Gunawidjaja PN, 2012, PHILOS T R SOC A, V370, P1376, DOI 10.1098/rsta.2011.0257
   Gunawidjaja PN, 2010, J PHYS CHEM C, V114, P19345, DOI 10.1021/jp105408c
   Hayakawa S, 1999, J AM CERAM SOC, V82, P2155
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Izquierdo-Barba I, 2000, J BIOMED MATER RES, V51, P191, DOI 10.1002/(SICI)1097-4636(200008)51:2<191::AID-JBM7>3.0.CO;2-T
   Izquierdo-Barba I, 2008, CHEM MATER, V20, P3191, DOI DOI 10.1021/CM800172X
   Jones JR, 2001, J BIOMED MATER RES, V58, P720, DOI 10.1002/jbm.10053
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lebecq I, 2007, J BIOMED MATER RES A, V83A, P156, DOI 10.1002/jbm.a.31228
   Leonova E, 2008, J PHYS CHEM C, V112, P5552, DOI 10.1021/jp7107973
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Li X, 2007, CHEM MATER, V19, P4322, DOI 10.1021/cm0708564
   Lin KSK, 2005, CHEM MATER, V17, P4493, DOI 10.1021/cm0505654c
   Lopez-Noriega A, 2006, CHEM MATER, V18, P3137, DOI 10.1021/cm060488o
   Macon ALB, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5403-9
   Mathew R, 2013, CHEM MATER, V25, P1877, DOI 10.1021/cm400487a
   Mathew R, 2011, J PHYS CHEM C, V115, P20572, DOI 10.1021/jp206237n
   O'Donnell MD, 2009, J MATER SCI-MATER M, V20, P1611, DOI 10.1007/s10856-009-3732-2
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   Pecharsky V. K., 2009, FUNDAMENTALS POWDER
   RODRIGUEZCARVAJ.J, 1998, NEWSLETTER, V20, P35
   Rohanova D., 2015, J NONCRYST SOLIDS, DOI [10.1016/j.jnoncrysol.2015.03.016, DOI 10.1016/J.JN0NCRYS0L.2015.03.016]
   Sepulveda P, 2002, J BIOMED MATER RES, V61, P301, DOI 10.1002/jbm.10207
   Skipper LJ, 2005, PHYS CHEM GLASSES, V46, P372
   Souza MT, 2013, J NON-CRYST SOLIDS, V382, P57, DOI 10.1016/j.jnoncrysol.2013.10.001
   Stevensson B, 2014, J PHYS CHEM B, V118, P8863, DOI 10.1021/jp504601c
   Vallet-Regi M, 2003, EUR J INORG CHEM, P1029
   Wilson A. J. C., 1995, INT TABLES CRYSTALLO
   Yan HW, 2001, CHEM MATER, V13, P1374, DOI 10.1021/cm000895e
   Yan XX, 2010, MICROPOR MESOPOR MAT, V132, P282, DOI 10.1016/j.micromeso.2010.03.009
   Yan XX, 2006, BIOMATERIALS, V27, P3396, DOI 10.1016/j.biomaterials.2006.01.043
   Yan XX, 2004, ANGEW CHEM INT EDIT, V43, P5980, DOI 10.1002/anie.200460598
   Yun HS, 2008, SOLID STATE SCI, V10, P1083, DOI 10.1016/j.solidstatesciences.2007.11.037
   Yun HS, 2007, CHEM COMMUN, P2139, DOI 10.1039/b702103h
   Zhang D, 2008, MATER CHEM PHYS, V111, P497, DOI 10.1016/j.matchemphys.2008.04.055
   Zhang K, 2003, J BIOMED MATER RES A, V66A, P860, DOI 10.1002/jbm.a.10093
   Zhu YF, 2008, MICROPOR MESOPOR MAT, V112, P494, DOI 10.1016/j.micromeso.2007.10.029
NR 49
TC 13
Z9 13
U1 3
U2 22
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 105
BP 86061
EP 86071
DI 10.1039/c5ra13410b
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA CU0BD
UT WOS:000363179500011
OA Bronze
DA 2018-10-19
ER

PT J
AU Balaji, A
   Vellayappan, MV
   John, AA
   Subramanian, AP
   Jaganathan, SK
   SelvaKumar, M
   Faudzi, AAB
   Supriyanto, E
   Yusof, M
AF Balaji, Arunpandian
   Vellayappan, Muthu Vignesh
   John, Agnes Aruna
   Subramanian, Aruna Priyadarshini
   Jaganathan, Saravana Kumar
   SelvaKumar, M.
   Faudzi, Ahmad Athif bin Mohd
   Supriyanto, Eko
   Yusof, Mustafa
TI Biomaterials based nano-applications of Aloe vera and its perspective: a
   review
SO RSC ADVANCES
LA English
DT Review
ID TISSUE ENGINEERING APPLICATIONS; BIOMEDICAL APPLICATIONS; DRUG-DELIVERY;
   REGENERATIVE MEDICINE; NANOFIBROUS SCAFFOLDS; DERMAL WOUNDS; LEAF GEL;
   PEG-PLA; NANOPARTICLES; EXTRACT
AB Aloe vera is noted for its meritable medicinal as well as commercial usages. From the past until now, it has been used as a promising remedy for several ailments. Recently, the concept of nanotechnology has astonishingly changed its outlook for biomedical applications. Nanotechnology has revolutionized several fields with its admirable capabilities and ground-breaking innovations. In the field of medicine, nanostructured materials have introduced a great range of flexibility by refashioning traditional practices and also by exploring new effective approaches. Accordingly, the usage of Aloe vera in the form of hydrogels, nanoparticles, nanocomposites, nanofibers and bio-inspired sponges has extended its well established application spectrum in the fields of wound healing, tissue engineering and drug delivery. In addition, the growing interest in consuming and synthesizing materials based on green or eco-friendly methods also highly encourages the use of numerous plant-based natural products including Aloe vera. Hence, an effort has been made to discuss the works related to recent advancements made in the use of Aloe vera, especially in the form of biomaterial-based nanostructures. This will encourage scientists to explore the unplumbed abilities of Aloe vera. Moreover, it will also help the industry players to recognise its immense potential and bring significant Aloe products to the market.
C1 [Balaji, Arunpandian; Vellayappan, Muthu Vignesh; John, Agnes Aruna; Subramanian, Aruna Priyadarshini; Jaganathan, Saravana Kumar; Supriyanto, Eko; Yusof, Mustafa] Univ Teknol Malaysia, IJN UTM Cardiovasc Engn Ctr, Fac Biosci & Med Engn, Johor Baharu 81310, Malaysia.
   [SelvaKumar, M.] Indian Inst Technol, Rubber Technol Ctr, Kharagpur 721302, W Bengal, India.
   [Faudzi, Ahmad Athif bin Mohd] Univ Teknol Malaysia, Fac Elect Engn, Dept Control & Mechatron Engn, Johor Baharu 81310, Malaysia.
RP Jaganathan, SK (reprint author), Univ Teknol Malaysia, IJN UTM Cardiovasc Engn Ctr, Fac Biosci & Med Engn, Johor Baharu 81310, Malaysia.
EM jaganathaniitkgp@gmail.com
RI Jaganathan, Saravana Kumar/N-2385-2017
OI Balaji, Arunpandian/0000-0002-6745-9188
FU Ministry of Higher Education Malaysia [R.J130000.7809.4F444,
   Q.J130000.2509.10H13]
FX This work was supported partly by the Ministry of Higher Education
   Malaysia with the Grant Vot numbers: R.J130000.7809.4F444 and
   Q.J130000.2509.10H13.
CR Ahmad M. R., 2014, P INT C TEXT ENG FAS, DOI [10.1007/978-981-287-011-7_2, DOI 10.1007/978-981-287-011-7_2]
   Ahmed F, 2004, J CONTROL RELEASE, V96, P37, DOI 10.1016/j.jconrel.2003.12.021
   Almeida JF, 2011, INT J BIOL MACROMOL, V49, P948, DOI 10.1016/j.ijbiomac.2011.08.010
   Amar S, 2008, INDIAN J DERMATOL, V53, P163
   Antherton P., 1998, NURS STAND, V12, P49
   Ayeshamariam A, 2014, J OPTOELECTRON BIOME, V6, P85
   Balaji A, 2015, INT J NANOMED, V10, P5909, DOI 10.2147/IJN.S84307
   Bhaarathy V, 2014, MAT SCI ENG C-MATER, V44, P268, DOI 10.1016/j.msec.2014.08.018
   Boudreau MD, 2006, J ENVIRON SCI HEAL C, V24, P103, DOI 10.1080/10590500600614303
   BRADLEY PR, 1992, BRIT HERBAL COMPENDI
   Castleman M., 1991, THE HEALING HERBS, P42
   Chandran SP, 2006, BIOTECHNOL PROGR, V22, P577, DOI 10.1021/bp0501423
   Chang HI, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P569
   Chauhan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032049
   Chithra P, 1998, J ETHNOPHARMACOL, V59, P179, DOI 10.1016/S0378-8741(97)00112-8
   Chithra P, 1998, J ETHNOPHARMACOL, V59, P195, DOI 10.1016/S0378-8741(97)00124-4
   Coats B. C., 1979, SILENT HEALER A MODE
   Collins CE, 1935, AM J ROENTGENOL RADI, V33, P396
   Dagne E, 2000, CURR ORG CHEM, V4, P1055, DOI 10.2174/1385272003375932
   Das N, 2004, NATURAL PRODUCT RADI, V3, P85
   Davis R. H., 1997, SCI APPROACH
   DAVIS RH, 1994, J AM PODIAT MED ASSN, V84, P77, DOI 10.7547/87507315-84-2-77
   DAVIS RH, 1989, J AM PODIAT MED ASSN, V79, P559, DOI 10.7547/87507315-79-11-559
   Eshun K, 2004, CRIT REV FOOD SCI, V44, P91, DOI 10.1080/10408690490424694
   Esmaeili A, 2015, SYNTH REACT INORG M, V45, P40, DOI 10.1080/15533174.2013.818027
   Fenig E, 2004, ONCOL REP, V11, P213
   Fisher MB, 2013, TISSUE ENG PART B-RE, V19, P1, DOI [10.1089/ten.teb.2012.0723, 10.1089/ten.TEB.2012.0723]
   Furukawa F., 1991, ANTIMICROB AGENTS CH, V35, P2463
   Gabriela G. P., 2014, BIOMED RES INT, V2014, P9
   Gaur A., 2008, ASIAN J PHARM, P80
   GRINDLAY D, 1986, J ETHNOPHARMACOL, V16, P117, DOI 10.1016/0378-8741(86)90085-1
   Gupta RB, 2006, NANOPARTICLE TECHNOL, P1
   Hamman JH, 2008, MOLECULES, V13, P1599, DOI 10.3390/molecules13081599
   Harrison RH, 2014, TISSUE ENG PART B-RE, V20, P1, DOI 10.1089/ten.TEB.2013.0668
   Hayes Steven M., 1999, General Dentistry, V47, P268
   Heggers J P, 1996, J Altern Complement Med, V2, P271, DOI 10.1089/acm.1996.2.271
   Hilt JZ, 2004, ADV DRUG DELIVER REV, V56, P1533, DOI 10.1016/j.addr.2004.07.002
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Ibrahim U., 2010, J BIOL CHEM, V38, P19
   Ibrahim U, 2013, CURR NANOSCI, V9, P489
   Inoue T, 2011, JACC-CARDIOVASC INTE, V4, P1057, DOI 10.1016/j.jcin.2011.05.025
   Inpanya P, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/3/035008
   Jettanacheawchankit S, 2009, J PHARMACOL SCI, V109, P525, DOI 10.1254/jphs.08204FP
   Jitin P. M., 2014, AM J PHYTOMED CLIN T, V2, P61
   Jittapiromsak N, 2010, TISSUE ENG PT A, V16, P1997, DOI [10.1089/ten.tea.2009.0593, 10.1089/ten.TEA.2009.0593]
   Josias H., 2008, MOLECULES, V13, P1599, DOI DOI 10.3390/M0LECULES13081599
   KAEHLER T, 1994, CLIN CHEM, V40, P1797
   Karuppuswamy P, 2014, APPL SURF SCI, V322, P162, DOI 10.1016/j.apsusc.2014.10.074
   Klaus T, 1999, P NATL ACAD SCI USA, V96, P13611, DOI 10.1073/pnas.96.24.13611
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Lissoni P, 1998, NAT IMMUN, V16, P27, DOI 10.1159/000069427
   Lya P., 2014, BMC P, V8, pP61
   Mandeville FB, 1939, RADIOLOGY, V32, P598
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   Mary SA, 2015, J TEXT I, V106, P886, DOI 10.1080/00405000.2014.951247
   Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007
   Moon S. K., 2011, POLYM REV, V5, P23
   Mora-Huertas CE, 2010, INT J PHARMACEUT, V385, P113, DOI 10.1016/j.ijpharm.2009.10.018
   Myung H. C., 2003, SEMIN INTEGR MED, V1, P53
   Nadagouda MN, 2008, GREEN CHEM, V10, P859, DOI 10.1039/b804703k
   Ni Y, 2004, INT IMMUNOPHARMACOL, V4, P1745, DOI 10.1016/j.intimp.2004.07.006
   Nithya K., 2013, INT C ADV NAN EM ENG
   Pal K, 2009, DES MONOMERS POLYM, V12, P197, DOI 10.1163/156855509X436030
   Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06
   Pankaj K. S., 2013, PHARM PHARM, V4, P599
   Panneerselvam J., 2013, ACS APPL MATER INTER, V5, P7291
   Parish LC, 1991, INT J DERMATOL, V30, P679
   Park YI, 2006, NEW PERSPECTIVES ALO
   Pecere T, 2000, CANCER RES, V60, P2800
   Pim-on R., 2008, POLYMER, V49, P4723
   Prabaharan M, 2009, MACROMOL BIOSCI, V9, P515, DOI 10.1002/mabi.200800269
   Prabjone R, 2006, CLIN HEMORHEOL MICRO, V35, P359
   Ratner B. D., 2004, BIOMATERIALS SCI INT, P1
   Reynolds T, 1999, J ETHNOPHARMACOL, V68, P3, DOI 10.1016/S0378-8741(99)00085-9
   Rigogliuso S, 2012, CHEM ENGINEER TRANS, V27, P415, DOI 10.3303/CET1227070
   Roco MC, 2003, CURR OPIN BIOTECH, V14, P337, DOI 10.1016/S0958-1669(03)00068-5
   Ruben P., 2011, INT J POLYM ANAL CH, V16, P449
   Ruben P., 2013, INT J BIOL MACROMOL, V52, P221
   Saccu D, 2001, J AGR FOOD CHEM, V49, P4526, DOI 10.1021/jf010179c
   Saji Viswanathan S., 2010, International Journal of Nano and Biomaterials, V3, P119, DOI 10.1504/IJNBM.2010.037801
   Sani B., 2013, ODONTOLOGY, V102, P310
   Sarah I. H., 2014, J AL NAHRAIN U, V17, P165
   Saritha V, 2010, INT J PHARM BIOL ARC, V1, P376
   Savio M. G., 2013, ELECTRON J BIOTECHN, V16, P3458
   SHELTON RM, 1991, INT J DERMATOL, V30, P679, DOI 10.1111/j.1365-4362.1991.tb02607.x
   Shreya M, 2015, APPL NANOSCI, V106, P886
   Shuna C., 2014, J APPL POLYM SCI, V131, P40592
   Silva SS, 2014, CARBOHYD POLYM, V112, P264, DOI 10.1016/j.carbpol.2014.05.042
   Silva SS, 2013, CARBOHYD POLYM, V98, P581, DOI 10.1016/j.carbpol.2013.06.022
   Silva SS, 2013, ACTA BIOMATER, V9, P6790, DOI 10.1016/j.actbio.2013.02.027
   Singh B, 2012, POLYM-PLAST TECHNOL, V51, P1303, DOI 10.1080/03602559.2012.698684
   Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003
   Sridhar R, 2014, J BIOMAT SCI-POLYM E, V25, P985, DOI 10.1080/09205063.2014.917039
   Suganya S, 2014, INT J BIOL MACROMOL, V68, P135, DOI 10.1016/j.ijbiomac.2014.04.031
   Suganya S, 2014, IRAN POLYM J, V23, P237, DOI 10.1007/s13726-013-0219-2
   Suganyaa S., 2014, J BIOMATER APPL, V29, P46
   Thomas J. B., 2005, NANOTECHNOLOGY BIOMA, P605
   Thomson R.H., 1971, NATURALLY OCCURRING
   Townsend J., 1998, ALOE VERA UK REFEREN
   TYLER VE, 1993, HONEST HERBAL SENSIB
   Versari D, 2007, CURR PHARM DESIGN, V13, P1811, DOI 10.2174/138161207780831239
   Vogler BK, 1999, BRIT J GEN PRACT, V49, P823
   Weiss RB, 2003, J CLIN ONCOL, V21, P1825, DOI 10.1200/JCO.2003.09.006
   *WHO, 1999, WHO MON SEL MED PLAN, V1
   Xiao RZ, 2010, INT J NANOMED, V5, P1057, DOI [10.2147/IJN.S14912, 10.2147/ijn.S14912]
   Xie JP, 2007, ACS NANO, V1, P429, DOI 10.1021/nn7000883
   Yagi A, 2003, PLANTA MED, V69, P269, DOI 10.1055/s-2003-38481
   Yildirimer L, 2012, TRENDS BIOTECHNOL, V30, P638, DOI 10.1016/j.tibtech.2012.08.004
   Young C. N., 2004, J APPL POLYM SCI, V91, P1612
   Zhang Y, 2010, NANO BIOMED ENG, V2, P252
   Zhang YZ, 2007, INT J NANOMED, V2, P623
   Zoli W, 2005, BREAST CANCER RES, V7, pR681, DOI 10.1186/bcr1274
NR 112
TC 7
Z9 7
U1 1
U2 15
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 105
BP 86199
EP 86213
DI 10.1039/c5ra13282g
PG 15
WC Chemistry, Multidisciplinary
SC Chemistry
GA CU0BD
UT WOS:000363179500026
DA 2018-10-19
ER

PT J
AU Bernardeschi, D
   Nguyen, Y
   Russo, FY
   Mosnier, I
   Ferrary, E
   Sterkers, O
AF Bernardeschi, Daniele
   Nguyen, Yann
   Russo, Francesca Yoshie
   Mosnier, Isabelle
   Ferrary, Evelyne
   Sterkers, Olivier
TI Cutaneous and Labyrinthine Tolerance of Bioactive Glass S53P4 in Mastoid
   and Epitympanic Obliteration Surgery: Prospective Clinical Study
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID CHRONIC OTITIS-MEDIA; BONE-GRAFT SUBSTITUTES; CANAL WALL; IN-VITRO;
   AUTOGENOUS BONE; CHRONIC OSTEOMYELITIS; CAVITY OBLITERATION;
   GENE-TRANSFER; GRANULES; REHABILITATION
AB Objective. To evaluate the cutaneous and the inner ear tolerance of bioactive glass S53P4 when used in the mastoid and epitympanic obliteration for chronic otitis surgery. Material and Methods. Forty-one cases have been included in this prospective study. Cutaneous tolerance was clinically evaluated 1 week, 1 month, and 3 months after surgery with a physical examination of the retroauricular and external auditory canal (EAC) skin and the presence of otalgia; the inner ear tolerance was assessed by bone-conduction hearing threshold 1 day after surgery and by the presence of vertigo or imbalance. Results. All surgeries but 1 were uneventful: all patients maintained the preoperative bone-conduction hearing threshold except for one case in which the round window membrane was opened during the dissection of the cholesteatoma in the hypotympanum and this led to a dead ear. No dizziness or vertigo was reported. Three months after surgery, healing was achieved in all cases with a healthy painless skin. No cases of revision surgery for removal of the granules occurred in this study. Conclusion. The bioactive glass S53P4 is a well-tolerated biomaterial for primary or revision chronic otitis surgery, as shown by the local skin reaction which lasted less than 3 months and by the absence of labyrinthine complications.
C1 [Bernardeschi, Daniele; Nguyen, Yann; Russo, Francesca Yoshie; Mosnier, Isabelle; Ferrary, Evelyne; Sterkers, Olivier] Grp Hosp Pitie Salpetriere, AP HP, Serv Otorhinolaryngol, Dept Otol Implants Auditifs & Chirurg Base Crane, F-75013 Paris, France.
   [Bernardeschi, Daniele; Nguyen, Yann; Russo, Francesca Yoshie; Mosnier, Isabelle; Ferrary, Evelyne; Sterkers, Olivier] Univ Paris 06, Sorbonne Univ, F-75005 Paris, France.
   [Bernardeschi, Daniele; Nguyen, Yann; Russo, Francesca Yoshie; Mosnier, Isabelle; Ferrary, Evelyne; Sterkers, Olivier] INSERM, UMR S Rehabil Chirurg Miniinvas & Robotisee Audit, F-75018 Paris, France.
RP Bernardeschi, D (reprint author), Grp Hosp Pitie Salpetriere, AP HP, Serv Otorhinolaryngol, Dept Otol Implants Auditifs & Chirurg Base Crane, F-75013 Paris, France.
EM daniele.bernardeschi@psl.aphp.fr
OI Russo, Francesca Yoshie/0000-0001-5244-2423
CR ANDERSSON OH, 1992, J MATER SCI-MATER M, V3, P145, DOI 10.1007/BF00705283
   Bernardeschi D, 2015, OTOL NEUROTOL, V36, P604, DOI 10.1097/MAO.0000000000000702
   Bernardeschi D, 2014, EUR ARCH OTO-RHINO-L, V271, P59, DOI 10.1007/s00405-013-2393-4
   Bosetti M, 2005, BIOMATERIALS, V26, P3873, DOI 10.1016/j.biomaterials.2004.09.059
   Chelikh L, 2003, ACTA OTO-LARYNGOL, V123, P199, DOI 10.1080/00016480310001042
   Cho SW, 2012, CLIN EXP OTORHINOLAR, V5, P23, DOI 10.3342/ceo.2012.5.1.23
   Coraca-Huber DC, 2014, J ORTHOP RES, V32, P175, DOI 10.1002/jor.22463
   Couloigner V, 2002, NEPHROLOGIE, V23, P245
   Couloigner V, 2006, PFLUG ARCH EUR J PHY, V453, P11, DOI 10.1007/s00424-006-0103-4
   D'Arc MB, 2004, ANN OTO RHINOL LARYN, V113, P711, DOI 10.1177/000348940411300907
   D'Arc MB, 2003, J MATER SCI-MATER M, V14, P229, DOI 10.1023/A:1022828606312
   DACULSI G, 1992, ANN OTO RHINOL LARYN, V101, P669, DOI 10.1177/000348949210100808
   DECHER H, 1985, LARYNG RHINOL OTOL V, V64, P423, DOI 10.1055/s-2007-1008172
   Deveze A, 2010, OTOL NEUROTOL, V31, P220, DOI 10.1097/MAO.0b013e3181c9960d
   Dornhoffer JL, 1999, OTOLARYNG HEAD NECK, V120, P361, DOI 10.1016/S0194-5998(99)70276-7
   Drago L, 2014, FUTURE MICROBIOL, V9, P593, DOI 10.2217/fmb.14.20
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1993, INTRO BIOCERAMICS
   IRVING RM, 1994, CLIN OTOLARYNGOL, V19, P158, DOI 10.1111/j.1365-2273.1994.tb01202.x
   Keating JF, 2001, J BONE JOINT SURG BR, V83B, P3, DOI 10.1302/0301-620X.83B1.11952
   Lepparanta O, 2008, J MATER SCI-MATER M, V19, P547, DOI 10.1007/s10856-007-3018-5
   Lindfors NC, 2009, J BIOMED MATER RES B, V90B, P131, DOI 10.1002/jbm.b.31263
   McAndrew J, 2013, IRISH J MED SCI, V182, P509, DOI 10.1007/s11845-012-0895-5
   MONTANDON P, 1995, ORL J OTO-RHINO-LARY, V57, P198, DOI 10.1159/000276739
   Munukka E, 2008, J MATER SCI-MATER M, V19, P27, DOI 10.1007/s10856-007-3143-1
   PALVA T, 1973, ACTA OTO-LARYNGOL, V75, P289, DOI 10.3109/00016487309139718
   Peltola M, 1998, HEAD NECK-J SCI SPEC, V20, P315, DOI 10.1002/(SICI)1097-0347(199807)20:4<315::AID-HED6>3.0.CO;2-1
   Peltola M, 2006, HEAD NECK-J SCI SPEC, V28, P834, DOI 10.1002/hed.20436
   Pernaa K, 2011, J Long Term Eff Med Implants, V21, P139
   Rantakokko J, 2012, SCAND J SURG, V101, P66, DOI 10.1177/145749691210100113
   Romano CL, 2014, BONE JOINT J, V96B, P845, DOI 10.1302/0301-620X.96B6.33014
   Sarin J, 2012, ANN OTO RHINOL LARYN, V121, P563, DOI 10.1177/000348941212100901
   Shea M C Jr, 1972, Otolaryngol Clin North Am, V5, P161
   Silvola JT, 2012, OTOLARYNG HEAD NECK, V147, P119, DOI 10.1177/0194599812438168
   Stoor P, 2010, ANN OTO RHINOL LARYN, V119, P377, DOI 10.1177/000348941011900603
   Turunen T, 2004, CLIN ORAL IMPLAN RES, V15, P135, DOI 10.1111/j.1600-0501.2004.00989.x
   Valimaki VV, 2006, SCAND J SURG, V95, P95
   Valimaki VV, 2005, J BIOMED MATER RES A, V75A, P501, DOI 10.1002/jbm.a.30236
   Valimaki VV, 2005, TISSUE ENG, V11, P387, DOI 10.1089/ten.2005.11.387
   Virolainen P, 1997, J BIOMED MATER RES, V35, P9, DOI 10.1002/(SICI)1097-4636(199704)35:1<9::AID-JBM2>3.3.CO;2-H
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
NR 43
TC 5
Z9 5
U1 2
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 242319
DI 10.1155/2015/242319
PG 6
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CT9DS
UT WOS:000363117200001
PM 26504792
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Romagnoli, C
   Zonefrati, R
   Galli, G
   Puppi, D
   Pirosa, A
   Chiellini, F
   Martelli, FS
   Tanini, A
   Brandi, ML
AF Romagnoli, Cecilia
   Zonefrati, Roberto
   Galli, Gianna
   Puppi, Dario
   Pirosa, Alessandro
   Chiellini, Federica
   Martelli, Francesco Saverio
   Tanini, Annalisa
   Brandi, Maria Luisa
TI In Vitro Behavior of Human Adipose Tissue-Derived Stem Cells on
   Poly(epsilon-caprolactone) Film for Bone Tissue Engineering Applications
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID MARROW STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; REGENERATIVE MEDICINE;
   PERIODONTAL-LIGAMENT; SURFACE MODIFICATION; SCAFFOLDS; POLYCAPROLACTONE;
   ADHESION; REPAIR; PROLIFERATION
AB Bone tissue engineering is an emerging field, representing one of the most exciting challenges for scientists and clinicians. The possibility of combining mesenchymal stem cells and scaffolds to create engineered tissues has brought attention to a large variety of biomaterials in combination with osteoprogenitor cells able to promote and regenerate bone tissue. Human adipose tissue is officially recognized as an easily accessible source of mesenchymal stem cells (AMSCs), a significant factor for use in tissue regenerative medicine. In this study, we analyze the behavior of a clonal finite cell line derived from human adipose tissue seeded on poly(epsilon-caprolactone) (PCL) film, prepared by solvent casting. PCL polymer is chosen for its good biocompatibility, biodegradability, and mechanical properties. We observe that AMSCs are able to adhere to the biomaterial and remain viable for the entire experimental period. Moreover, we show that the proliferation process and osteogenic activity of AMSCs are maintained on the biofilm, demonstrating that the selected biomaterial ensures cell colonization and the development of an extracellular mineralized matrix. The results of this study highlight that AMSCs and PCL film can be used as a suitable model to support regeneration of new bone for future tissue engineering strategies.
C1 [Romagnoli, Cecilia; Zonefrati, Roberto; Galli, Gianna; Tanini, Annalisa; Brandi, Maria Luisa] Univ Florence, Dept Surg & Translat Med, I-50139 Florence, Italy.
   [Puppi, Dario; Pirosa, Alessandro; Chiellini, Federica] Univ Pisa, UdR INSTMPisa, Dept Chem & Ind Chem, BIOLab Res Grp, I-56124 Pisa, Italy.
   [Martelli, Francesco Saverio] Microdent Inst, I-50123 Florence, Italy.
RP Brandi, ML (reprint author), Univ Florence, Dept Surg & Translat Med, I-50139 Florence, Italy.
EM marialuisa.brandi@unifi.it
RI Chiellini, Federica/F-3233-2010; Pirosa, Alessandro/B-9179-2018; Puppi,
   Dario/I-4008-2012
OI Chiellini, Federica/0000-0003-4680-9975; Pirosa,
   Alessandro/0000-0002-3795-3193; Puppi, Dario/0000-0002-9251-4388
FU Tuscan Region (Italy)
FX This study was founded and supported by the Tuscan Region (Italy) as
   part of the program POR CReO FESR 2007-2013, "Le ali alle tue idee."
CR Asatrian G, 2015, STEM CELLS CLONING, V8, P39, DOI 10.2147/SCCAA.S48423
   Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709
   Boquest AC, 2006, METH MOL B, V325, P35
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Choong C, 2012, J BIOMED MATER RES A, V100A, P353, DOI 10.1002/jbm.a.33278
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x
   Gastaldi G, 2010, J BIOMED MATER RES A, V94A, P790, DOI 10.1002/jbm.a.32721
   Ghorbani FM, 2015, CARBOHYD POLYM, V118, P133, DOI 10.1016/j.carbpol.2014.10.071
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463
   Hidalgo-Bastida LA, 2010, TISSUE ENG PART B-RE, V16, P405, DOI [10.1089/ten.teb.2009.0714, 10.1089/ten.TEB.2009.0714]
   Hu JZ, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-246
   Kellomaki M, 2000, BIOMATERIALS, V21, P2495, DOI 10.1016/S0142-9612(00)00117-4
   Kim SE, 2014, CARBOHYD POLYM, V99, P700, DOI 10.1016/j.carbpol.2013.08.053
   Kishimoto S, 2012, BIORESEARCH OPEN ACC, V1, P314, DOI 10.1089/biores.2012.0251
   Lee KH, 2003, POLYMER, V44, P1287, DOI 10.1016/S0032-3861(02)00820-0
   Li XM, 2011, J BIOMED MATER RES B, V97B, P10, DOI 10.1002/jbm.b.31773
   Lu ZF, 2015, NANOMED-NANOTECHNOL, V11, P219, DOI 10.1016/j.nano.2014.09.008
   Lu ZF, 2011, TISSUE ENG PT A, V17, P1651, DOI 10.1089/ten.tea.2010.0567
   Lu ZF, 2012, NANOMED-NANOTECHNOL, V8, P507, DOI 10.1016/j.nano.2011.07.012
   Marino G, 2012, J BIOMED MATER RES A, V100A, P543, DOI 10.1002/jbm.a.33296
   Marolt D, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt10
   Marrazzo C, 2008, POLYM ENG SCI, V48, P336, DOI 10.1002/pen.20937
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Nardone V, 2012, INT J BIOMATER, V2012
   Oyane A, 2005, J BIOMED MATER RES A, V75A, P138, DOI 10.1002/jbm.a.30397
   Panetta NJ, 2010, CURR STEM CELL RES T, V5, P122
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Puppi D., 2011, BIODEGRADABLE POLYM, P545
   Puppi D, 2012, BIOMED MICRODEVICES, V14, P1115, DOI 10.1007/s10544-012-9677-0
   Rai B, 2007, J BIOMED MATER RES A, V81A, P888, DOI 10.1002/jbm.a.31142
   Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Song L, 2005, STEM CELLS DEV, V14, P712, DOI 10.1089/scd.2005.14.712
   Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132
   Sudo K, 2007, STEM CELLS, V25, P1610, DOI 10.1634/stemcells.2006-0504
   Sun JJ, 2007, J MATER SCI-MATER M, V18, P1017, DOI 10.1007/s10856-007-0155-9
   Tognarini I, 2008, BIOMATERIALS, V29, P809, DOI 10.1016/j.biomaterials.2007.10.043
   Velasco MA, 2015, BIOMED RES INT, V2015, P21, DOI DOI 10.1155/2015/729076
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Zhang HN, 2009, J BIOMAT SCI-POLYM E, V20, P1975, DOI 10.1163/156856208X396074
   Zhang HN, 2009, BIOMATERIALS, V30, P4063, DOI 10.1016/j.biomaterials.2009.04.015
   Zhang Y, 2010, BIOMATERIALS, V31, P3231, DOI 10.1016/j.biomaterials.2010.01.029
   Zhou CJ, 2013, ACS APPL MATER INTER, V5, P3847, DOI 10.1021/am4005072
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 49
TC 1
Z9 1
U1 1
U2 5
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 323571
DI 10.1155/2015/323571
PG 12
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CT9GH
UT WOS:000363124400001
PM 26558266
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Wahl, EA
   Fierro, FA
   Peavy, TR
   Hopfner, U
   Dye, JF
   Machens, HG
   Egana, JT
   Schenck, TL
AF Wahl, Elizabeth A.
   Fierro, Fernando A.
   Peavy, Thomas R.
   Hopfner, Ursula
   Dye, Julian F.
   Machens, Hans-Guenther
   Egana, Jose T.
   Schenck, Thilo L.
TI In Vitro Evaluation of Scaffolds for the Delivery of Mesenchymal Stem
   Cells to Wounds
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; STROMAL CELLS; REGENERATIVE MEDICINE; DERMAL
   REGENERATION; PARACRINE FACTORS; TISSUE; MIGRATION; EXPRESSION;
   DIFFERENTIATION; COLLAGEN
AB Mesenchymal stemcells (MSCs) have been shown to improve tissue regeneration in several preclinical and clinical trials. These cells have been used in combination with three-dimensional scaffolds as a promising approach in the field of regenerative medicine. We compare the behavior of human adipose-derived MSCs (AdMSCs) on four different biomaterials that are awaiting or have already received FDA approval to determine a suitable regenerative scaffold for delivering these cells to dermal wounds and increasing healing potential. AdMSCs were isolated, characterized, and seeded onto scaffolds based on chitosan, fibrin, bovine collagen, and decellularized porcine dermis. In vitro results demonstrated that the scaffolds strongly influence key parameters, such as seeding efficiency, cellular distribution, attachment, survival, metabolic activity, and paracrine release. Chick chorioallantoic membrane assays revealed that the scaffold composition similarly influences the angiogenic potential of AdMSCs in vivo. The wound healing potential of scaffolds increases by means of a synergistic relationship between AdMSCs and biomaterial resulting in the release of proangiogenic and cytokine factors, which is currently lacking when a scaffold alone is utilized. Furthermore, the methods used herein can be utilized to test other scaffold materials to increase their wound healing potential with AdMSCs.
C1 [Wahl, Elizabeth A.; Hopfner, Ursula; Machens, Hans-Guenther; Egana, Jose T.; Schenck, Thilo L.] Tech Univ Munich, Univ Hosp Klinikum Rechts Isar, Dept Plast Surg & Hand Surg, D-81675 Munich, Germany.
   [Fierro, Fernando A.] Univ Calif Davis, Inst Regenerat Cures, Sacramento, CA 95817 USA.
   [Peavy, Thomas R.] Calif State Univ Sacramento, Dept Biol Sci, Sacramento, CA 95819 USA.
   [Dye, Julian F.] Royal Inst Great Britain, UCL, Inst Biomed Engn, London W1S 4BS, England.
   [Egana, Jose T.] Univ Chile, Fac Sci, FONDAP Ctr Genome Regulat, Santiago 7800024, Chile.
RP Egana, JT (reprint author), Tech Univ Munich, Univ Hosp Klinikum Rechts Isar, Dept Plast Surg & Hand Surg, D-81675 Munich, Germany.
EM tomasega@gmail.com
FU CIRM-BMBF Early Translational II Award; FONDAP Center for Genome
   regulation [15090007]
FX This project was supported by a grant from the CIRM-BMBF Early
   Translational II Award to Jose T. Egana and Fernando A. Fierro and the
   FONDAP Center for Genome regulation (no. 15090007) to Jose T. Egana. The
   authors acknowledge the efforts by Ravneet S. Kang from the Department
   of Biological Sciences, California State University, Sacramento, in
   analyzing confocal images for seeding efficiencies of the matrices.
CR Akpinar G, 2014, STEM CELLS INT, V2014
   Amos PJ, 2008, ANN PLAS SURG, V60, P437, DOI 10.1097/SAP.0b013e318095a771
   Anthony DF, 2013, TRANSPLANT RES, V2, DOI 10.1186/2047-1440-2-10
   Asare Y, 2013, THROMB HAEMOSTASIS, V109, P391, DOI 10.1160/TH12-11-0831
   Atala A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004890
   Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539
   Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74
   Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A
   Baron F, 2012, BIOL BLOOD MARROW TR, V18, P822, DOI 10.1016/j.bbmt.2011.09.003
   Bieback K, 2012, J MOL MED, V90, P773, DOI 10.1007/s00109-012-0915-y
   Bishop CJ, 2014, ANN BIOMED ENG, V42, P1557, DOI 10.1007/s10439-013-0932-1
   Blaber SP, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-172
   Branch MJ, 2012, INVEST OPHTH VIS SCI, V53, P5109, DOI 10.1167/iovs.11-8673
   Brem H, 2010, AM J SURG, V200, P473, DOI 10.1016/j.amjsurg.2009.12.021
   Broughton 2nd G., 2006, PLASTIC RECONSTRUCTI, V117, p1e
   Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904
   Chen GC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098565
   Chen HT, 2012, J CELL MOL MED, V16, DOI 10.1111/j.1582-4934.2011.01335.x
   Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886
   Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736
   Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786
   Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/eri.11.59, 10.1586/ERI.11.59]
   Danner S, 2012, J INVEST DERMATOL, V132, P1707, DOI 10.1038/jid.2012.31
   Dash SN, 2014, REJUV RES, V17, P40, DOI 10.1089/rej.2013.1467
   Dohle D. S., 2009, J VISUALIZED EXPT
   DUNCAN MR, 1991, J INVEST DERMATOL, V97, P686, DOI 10.1111/1523-1747.ep12483971
   Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278
   Garcia-Gareta E, 2013, BIORESEARCH OPEN ACC, V2, P412, DOI 10.1089/biores.2013.0043
   Glasberg SB, 2012, PLAST RECONSTR SURG, V129, P1223, DOI 10.1097/PRS.0b013e31824ec429
   Gould Lisa, 2015, Wound Repair Regen, V23, P1, DOI 10.1111/wrr.12245
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Harris LJ, 2010, J SURG RES, V163, pE105, DOI 10.1016/j.jss.2010.04.025
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hou CL, 2013, BIOMATERIALS, V34, P112, DOI 10.1016/j.biomaterials.2012.09.022
   Hou Y, 2014, CELL BIOL INT, V38, P1050, DOI 10.1002/cbin.10294
   Jackson WM, 2012, STEM CELL TRANSL MED, V1, P44, DOI 10.5966/sctm.2011-0024
   Kang S. K., 2012, STEM CELLS INT, V2012, DOI DOI 10.1155/2012/342968
   Kim EJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.2
   King Jonathan, 2013, J Med Case Rep, V7, P258, DOI 10.1186/1752-1947-7-258
   Lin CS, 2012, STEM CELLS DEV, V21, P2770, DOI 10.1089/scd.2012.0176
   Lin CS, 2010, HISTOL HISTOPATHOL, V25, P807, DOI 10.14670/HH-25.807
   Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158
   Ma T, 2009, BIOTECHNOL PROGR, V25, P32, DOI [10.1021/bp.128, 10.1002/btpr.128]
   Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200
   Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018
   McClelland RE, 2000, J BIOMECH ENG-T ASME, V122, P268, DOI 10.1115/1.429657
   Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932
   Mirastschijski U, 2013, PLAST RECONSTR SURG, V132, P861, DOI 10.1097/PRS.0b013e31829fe461
   Mirsaidi A, 2012, J TISSUE ENG REGEN M, V6, P378, DOI 10.1002/term.440
   Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076
   Monteiro G. A., 2013, J TISSUE ENG, V4, P1
   Newman Robert E., 2009, Inflammation & Allergy Drug Targets, V8, P110
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pozner JN, 2013, AESTHET SURG J, V33, P681, DOI 10.1177/1090820X13491279
   Providence KM, 2008, ARCH DERMATOL RES, V300, P303, DOI 10.1007/s00403-008-0845-2
   Qi JF, 1997, BLOOD, V90, P3595
   Reagan MR, 2011, STEM CELLS, V29, P920, DOI 10.1002/stem.645
   Ribatti D, 2006, NAT PROTOC, V1, P85, DOI 10.1038/nprot.2006.13
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Shin L, 2013, STEM CELL TRANSL MED, V2, P33, DOI 10.5966/sctm.2012-0041
   Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230
   Steigman Shaun A, 2007, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01e02s1
   Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132
   Thomson T., 2000, DESIGN APPL HYDROPHI
   Tjwa M, 2003, CELL TISSUE RES, V314, P5, DOI 10.1007/s00441-003-0776-3
   Egana JT, 2009, TISSUE ENG PT A, V15, P1191, DOI 10.1089/ten.tea.2008.0097
   Tully-Dartez S, 2010, TISSUE ENG PART C-ME, V16, P339, DOI [10.1089/ten.tec.2009.0132, 10.1089/ten.TEC.2009.0132]
   Volkmer E, 2012, J MATER SCI-MATER M, V23, P2793, DOI 10.1007/s10856-012-4725-0
   Xie MW, 2013, J INVEST DERMATOL, V133, P553, DOI 10.1038/jid.2012.326
   Xing YJ, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-6
   Yasuda H, 2010, J NEUROSURG, V112, P336, DOI 10.3171/2009.2.JNS08495
   Yew TL, 2011, CELL TRANSPLANT, V20, P693, DOI 10.3727/096368910X550198
   Zippel Nina, 2010, Recent Pat Biotechnol, V4, P1, DOI 10.2174/187220810790069497
   Zomorodian E., 2012, STEM CELLS INT, V2012
NR 74
TC 5
Z9 5
U1 0
U2 7
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 108571
DI 10.1155/2015/108571
PG 14
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CT9AW
UT WOS:000363109100001
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Satish, A
   Korrapati, PS
AF Satish, Aishwarya
   Korrapati, Purna Sai
TI Fabrication of a triiodothyronine incorporated nanofibrous biomaterial:
   its implications on wound healing
SO RSC ADVANCES
LA English
DT Article
ID POLYCAPROLACTONE NANOFIBERS; PROLIFERATION; DELIVERY; SKIN; MIGRATION;
   INSULIN; GROWTH; MICE
AB With rising incidents of non-healing chronic wounds, functional restoration of the organs after a major wound insult is an essential requisite. The delivery of endogenous molecules through nanomaterials for supporting healing of such wounds has gained impetus in the past decade. Triiodothyronine (T-3) is a hormone that exerts its activity at various target organs and is reported to play a critical role in repair and regeneration of tissues after injury. The encapsulation of T-3 in nanofibers and its sustained release to enable wound healing has been attempted for the first time in this work. The physico-chemical characterization confirmed the encapsulation and uniform distribution of the hormone in the nanofiber. Functional characterization of the composite nanofibers revealed the significant positive influence of the T-3-entrapped nanofibers on the proliferation and migration of skin cells. Consistent with the in vitro results, application of the composite nanofibers on full thickness excisional wounds in rat model (in vivo) confirmed the potential of the hormone in accelerating the rate of wound closure. Thus this work reveals the effect of prolonged sustained delivery of T-3 from nanofibers which might promote the healing of chronic wounds.
C1 [Satish, Aishwarya; Korrapati, Purna Sai] CSIR Cent Leather Res Inst, Biomat Dept, Madras 600020, Tamil Nadu, India.
RP Korrapati, PS (reprint author), CSIR Cent Leather Res Inst, Biomat Dept, Madras 600020, Tamil Nadu, India.
EM purnasaik.clri@gmail.com
FU DST-INSPIRE programme, New Delhi [IF130876]
FX The authors are grateful to the Director, CSIR - CLRI for his constant
   support. The first author would like to acknowledge the DST-INSPIRE
   programme, New Delhi for the research fellowship (IF130876).
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Antonini Dario, 2013, Front Endocrinol (Lausanne), V4, P104, DOI 10.3389/fendo.2013.00104
   Azarbayjani AF, 2010, J PHARM PHARM SCI, V13, P400
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   BRAJKOVICH IE, 1983, METABOLISM, V32, P745, DOI 10.1016/0026-0495(83)90101-4
   Bui HT, 2014, MACROMOL RES, V22, P1288, DOI 10.1007/s13233-014-2179-6
   da Silva MA, 2009, TISSUE ENG PT A, V15, P377, DOI 10.1089/ten.tea.2007.0327
   Fuquan D., 1999, SCI CHINA CHEM, V42, P663
   Haase I, 2003, J CELL SCI, V116, P3227, DOI 10.1242/jcs.00610
   Hulbert AJ, 2000, BIOL REV, V75, P519, DOI 10.1017/S146479310000556X
   Karuppuswamy P, 2015, MATER LETT, V141, P180, DOI 10.1016/j.matlet.2014.11.044
   Kassem R, 2012, CLIN EXP DERMATOL, V37, P850, DOI 10.1111/j.1365-2230.2012.04456.x
   Kenawy ER, 2009, MATER CHEM PHYS, V113, P296, DOI 10.1016/j.matchemphys.2008.07.081
   Krishnaswamy VR, 2014, SCI REP-UK, V4, DOI 10.1038/srep07385
   Lin Y, 2011, BRIT J PHARMACOL, V162, P597, DOI 10.1111/j.1476-5381.2010.01056.x
   Liu Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-1
   Madhaiyan K, 2013, INT J PHARMACEUT, V444, P70, DOI 10.1016/j.ijpharm.2013.01.040
   Mdzinarishvili A, 2013, DRUG DELIV TRANSL RE, V3, P309, DOI 10.1007/s13346-012-0117-8
   MEHREGAN AH, 1974, J CUTAN PATHOL, V1, P113, DOI 10.1111/j.1600-0560.1974.tb00201.x
   Merrell JG, 2009, CLIN EXP PHARMACOL P, V36, P1149, DOI 10.1111/j.1440-1681.2009.05216.x
   Montero G. A., 2005, INT SOC ADVANCEMENT
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mourouzis I., 2013, J THYROID RES, V2013, P1
   Paneva D, 2008, EUR POLYM J, V44, P566, DOI 10.1016/j.eurpolymj.2008.01.010
   Safer J. D., 2008, THYROID DISORDERS CU, V14, P181
   Safer J. D., 2013, J THYROID RES, V2013, P1
   Safer JD, 2005, ENDOCRINOLOGY, V146, P4425, DOI 10.1210/en.2005-0192
   Safer JD, 2003, THYROID, V13, P159, DOI 10.1089/105072503321319468
   Safer JD, 2001, THYROID, V11, P717, DOI 10.1089/10507250152484547
   Shoba E, 2014, RSC ADV, V4, P60209, DOI 10.1039/c4ra10239h
   Tarameshloo Mahsa, 2012, Anat Cell Biol, V45, P170, DOI 10.5115/acb.2012.45.3.170
   Zhang G.-Y., 2013, THESIS U LUBECK
NR 33
TC 11
Z9 11
U1 1
U2 4
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 102
BP 83773
EP 83780
DI 10.1039/c5ra14142g
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CT4CB
UT WOS:000362752400028
DA 2018-10-19
ER

PT J
AU Wang, J
   Qiu, WT
   Wang, N
   Li, L
AF Wang, Jia
   Qiu, Wenting
   Wang, Ning
   Li, Li
TI Influence of hydroxyapatite on thermoplastic foaming performance of
   water-plasticized poly(vinyl alcohol)
SO RSC ADVANCES
LA English
DT Article
ID MECHANICAL-PROPERTIES; INTERMOLECULAR INTERACTIONS; BILAYERED SCAFFOLD;
   POLY(ACRYLIC ACID); BIOMATERIAL; BLENDS; FTIR; CARTILAGE; SURFACE;
   STATES
AB Poly(vinyl alcohol) (PVA)/hydroxyapatite (HA) composite foams suitable for bone tissue restoration were prepared through thermoplastic molding foaming using water as both a plasticizer and physical blowing agent. The effects of HA content on the foaming properties of the composites including the water states, water evaporation behaviors, interactions among the components as well as the cell structure and mechanical properties of the composite foams were studied. The results showed that HA nano-particles could form different hydrogen bonding or coordination interactions with water and PVA, thus making the bounded water in the system increase to a larger extent and the phase transition temperature of free water shift from 0.24 degrees C to -1.26 degrees C, consequently changing the relative content of different water. In this way, more nonfreezing water was formed, which was beneficial to the controllable foaming of water. HA particles could also act as a heterogeneous nucleating agent, thus effectively increasing the number of heterogeneous nucleating points in the system. With an increase in the HA content, foams with a more dense and uniform cell structure were obtained, and the mean size of the cell decreased from 760 mu m (HA 0 wt%) to 270 mu m (HA 20 wt%). The addition of HA improved the compression yield strength and compression modulus of the composite foams.
C1 [Wang, Jia; Qiu, Wenting; Wang, Ning; Li, Li] Sichuan Univ, Polymer Res Inst, State Key Lab Polymer Mat Engn, Chengdu 610065, Peoples R China.
RP Li, L (reprint author), Sichuan Univ, Polymer Res Inst, State Key Lab Polymer Mat Engn, Chengdu 610065, Peoples R China.
EM powerlily@scu.edu.cn
FU International Science & Technology Cooperation Program of China
   [2013DFG52300]; National Natural Science Foundation of China [51121001]
FX The authors greatly acknowledge the financial support of the
   International Science & Technology Cooperation Program of China
   (2013DFG52300) and the National Natural Science Foundation of China
   (51121001).
CR Aronin CEP, 2009, J BIOMED MATER RES A, V89A, P632, DOI 10.1002/jbm.a.32015
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chen N, 2007, PLAST RUBBER COMPOS, V36, P283, DOI 10.1179/174328907X237575
   [陈晓 Chen Xiao], 2013, [高分子通报, Polymer Bulletin], P26
   Covert RJ, 2003, WEAR, V255, P1064, DOI 10.1016/S0043-1648(03)00113-3
   Daniliuc L, 1996, POLYMER, V37, P5219, DOI 10.1016/0032-3861(96)00328-X
   DANILIUC L, 1992, EUR POLYM J, V28, P1365, DOI 10.1016/0014-3057(92)90277-9
   Eaves D., 2004, HDB POLYM FOAMS
   Georgiou G, 2007, J BIOMED MATER RES B, V80B, P322, DOI 10.1002/jbm.b.30600
   Gonzalez JS, 2014, J MECH BEHAV BIOMED, V34, P47, DOI 10.1016/j.jmbbm.2014.01.019
   Guo YW, 2014, ARTIF ORGANS, V38, P580, DOI 10.1111/aor.12257
   Ibrahim NS, 2013, MATER LETT, V113, P25, DOI 10.1016/j.matlet.2013.09.026
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Leong KF, 2008, J MECH BEHAV BIOMED, V1, P140, DOI 10.1016/j.jmbbm.2007.11.002
   Li L, 2005, J APPL POLYM SCI, V98, P774, DOI 10.1002/app.22158
   Li WB, 2005, POLYMER, V46, P12026, DOI 10.1016/j.polymer.2005.09.016
   Li Y M, 2011, SYST SCI HICSS 2011, P1
   Mansur HS, 2004, POLYMER, V45, P7193, DOI 10.1016/j.polymer.2004.08.036
   Miyata S, 2004, MAT SCI ENG C-BIO S, V24, P425, DOI 10.1016/j.msec.2003.11.007
   Pan YS, 2013, MECH TIME-DEPEND MAT, V17, P195, DOI 10.1007/s11043-012-9186-9
   Pan YS, 2010, J WUHAN UNIV TECHNOL, V25, P474, DOI 10.1007/s11595-010-0026-y
   Ping ZH, 2001, POLYMER, V42, P8461, DOI 10.1016/S0032-3861(01)00358-5
   Qu D, 2011, J BIOMED MATER RES B, V96B, P9, DOI 10.1002/jbm.b.31697
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Maiolo AS, 2012, MAT SCI ENG C-MATER, V32, P1490, DOI 10.1016/j.msec.2012.04.030
   Tanigami T, 1999, EUR POLYM J, V35, P1165, DOI 10.1016/S0014-3057(98)00087-1
   Wang Q, 2011, ACTA POLYM SIN, P932, DOI 10.3724/SP.J.1105.2011.11135
   Wang R, 2003, POLYM INT, V52, P1820, DOI 10.1002/pi.1385
   Wang R., 2001, POLYM MAT SCI ENG, P111
   Wang X, 2012, CHEM J CHINESE U, V33, P813, DOI 10.3969/j.issn.0251-0790.2012.04.029
   White LJ, 2012, ACTA BIOMATER, V8, P61, DOI 10.1016/j.actbio.2011.07.032
   Xiong X. H., 2007, CHINA PLAST IND, P10
   Zhao N, 2014, IND ENG CHEM RES, V53, P11962, DOI 10.1021/ie502018v
NR 33
TC 9
Z9 10
U1 6
U2 28
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 103
BP 84578
EP 84586
DI 10.1039/c5ra11993f
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA CT5LF
UT WOS:000362851000030
DA 2018-10-19
ER

PT S
AU Cetiner, BN
   Erkmen, ZE
AF Cetiner, B. N.
   Erkmen, Z. E.
BE Oral, AY
   Bahsi, ZB
   Ozer, M
   Sezer, M
   Akoz, ME
TI Production and Characterization of Alumina-Titania Biocomposite
SO 4TH INTERNATIONAL CONGRESS IN ADVANCES IN APPLIED PHYSICS AND MATERIALS
   SCIENCE (APMAS 2014)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 4th International Congress in Advances in Applied Physics and Materials
   Science (APMAS)
CY APR 24-27, 2014
CL Fethiye, TURKEY
DE Tialite; Seydisehir Alumina; bioceramic composites and structural
   properties
ID SOL-GEL SYNTHESIS; CERAMICS; COMPOSITES
AB Alumina is a biomaterial of choice for more than 20 years due to its high hardness accompanied by low friction, wear and inertness to in vivo environment. It has been reported that titanium oxidized to the rutile phase is bioactive. This is a property discovered for certain ceramics such as Bioglass and sintered hydroxylapatite (HA). But the combination of alumina and titania forming tialite (Aluminium titanate-50 mol % Al2O3 and 50 mol % TiO2) is a new challenge. In this work we made firstly the beneficiation of the Seydisehir alumina by leaching it in the acidic solution "the Aqua Regia" followed by preparation of batches containing 2,5 wt %, 3,5 wt % and 4,5 wt % of MgO as the sintering aid, 1 wt % of SiO2 and the balance; the alumina and titania powder mixture (1:1 mole). After sintering these batches at 1600 degrees C for about 12 h, their mechanical properties (the compression and hardness testings) and phase ratios (the XRD analysis) were analyzed and compared with the control group containing the laboratory scale alumina instead of the Seydisehir alumina. Following the characterization (the SEM and the EDS analysis) of the substrate material, the comparison of two different materials was carried out.
C1 [Cetiner, B. N.; Erkmen, Z. E.] Univ Marmara, Fac Engn, Dept Met & Mat Engn, TR-34722 Istanbul, Turkey.
RP Cetiner, BN (reprint author), Univ Marmara, Fac Engn, Dept Met & Mat Engn, Goztepe Campus, TR-34722 Istanbul, Turkey.
EM nilgun.cetiner@marmara.edu.tr; cerkmen@marmara.edu.tr
CR Ananthakumar S, 2006, ACTA MATER, V54, P2965, DOI 10.1016/j.actamat.2006.02.032
   Beherei HH, 2009, CERAM INT, V35, P1991, DOI 10.1016/j.ceramint.2008.10.014
   Bueno S, 2008, J EUR CERAM SOC, V28, P1961, DOI 10.1016/j.jeurceramsoc.2008.01.017
   Celik E., COMMUNICATION
   Chen CH, 2007, J EUR CERAM SOC, V27, P13, DOI 10.1016/j.jeurceramsoc.2006.04.182
   Forsgren J, 2007, ACTA BIOMATER, V3, P980, DOI 10.1016/j.actbio.2007.03.006
   Jayasankar M, 2008, J SOLID STATE CHEM, V181, P2748, DOI 10.1016/j.jssc.2008.06.057
   Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0
   Lee SW, 2003, WEAR, V255, P1040, DOI 10.1016/S0043-1648(03)00099-1
   Low IM, 2008, MATER CHEM PHYS, V111, P9, DOI 10.1016/j.matchemphys.2008.03.017
   Naghizadeh R, 2009, MATER SCI ENG B-ADV, V157, P20, DOI 10.1016/j.mseb.2008.12.002
   Otterstein E, 2008, THERMOCHIM ACTA, V468, P10, DOI 10.1016/j.tca.2007.11.023
   Park JB, 2013, BIOMATERIALS: PRINCIPLES AND PRACTICES
   Park SY, 2003, CERAM INT, V29, P707, DOI 10.1016/S0272-8842(02)00221-3
   Shi CG, 1998, MATER RES BULL, V33, P817, DOI 10.1016/S0025-5408(98)00061-0
   Sobhani M, 2008, J MATER PROCESS TECH, V206, P282, DOI 10.1016/j.jmatprotec.2007.12.023
   Verne E, 2002, BIOMATERIALS, V23, P3395, DOI 10.1016/S0142-9612(02)00040-6
NR 17
TC 0
Z9 0
U1 0
U2 4
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1295-8
J9 AIP CONF PROC
PY 2015
VL 1653
AR 020028
DI 10.1063/1.4914219
PG 7
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA BD6KC
UT WOS:000362294100028
OA Bronze
DA 2018-10-19
ER

PT S
AU Oboh, I
   Aluyor, E
   Audu, T
AF Oboh, I.
   Aluyor, E.
   Audu, T.
BE Oral, AY
   Bahsi, ZB
   Ozer, M
   Sezer, M
   Akoz, ME
TI Kinetic Modelling for Zinc (II) Ions Biosorption Onto Luffa Cylindrica
SO 4TH INTERNATIONAL CONGRESS IN ADVANCES IN APPLIED PHYSICS AND MATERIALS
   SCIENCE (APMAS 2014)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 4th International Congress in Advances in Applied Physics and Materials
   Science (APMAS)
CY APR 24-27, 2014
CL Fethiye, TURKEY
DE Coefficient of non-determination; biomaterial; Luffa cylindrica;
   non-linear regression; Kinetic models
ID AQUEOUS-SOLUTION; WASTE-WATER; REMOVAL; ADSORPTION; CU(II);
   10-AMINE-4-AZADECYLSILICA; EQUILIBRIUM; ADSORBENT; CAPACITY; FE(III)
AB The biosorption of Zinc (II) ions onto a biomaterial - Luffa cylindrica has been studied. This biomaterial was characterized by elemental analysis, surface area, pore size distribution, scanning electron microscopy, and the biomaterial before and after sorption, was characterized by Fourier Transform Infra Red (FTIR) spectrometer. The kinetic nonlinear models fitted were Pseudo-first order, Pseudo-second order and Intra-particle diffusion. A comparison of non-linear regression method in selecting the kinetic model was made. Four error functions, namely coefficient of determination (R-2), hybrid fractional error function (HYBRID), average relative error (ARE), and sum of the errors squared (ERRSQ), were used to predict the parameters of the kinetic models. The strength of this study is that a biomaterial with wide distribution particularly in the tropical world and which occurs as waste material could be put into effective utilization as a biosorbent to address a crucial environmental problem.
C1 [Oboh, I.] Univ Uyo, Dept Chem & Petr Engn, Uyo, Nigeria.
   [Aluyor, E.; Audu, T.] Univ Uyo, Dept Chem Engn, Benin, Nigeria.
RP Oboh, I (reprint author), Univ Uyo, Dept Chem & Petr Engn, Uyo, Nigeria.
EM innocentoboh@uniuyo.edu.ng
CR Abdelwahab O, 2013, CHEM ENG RES DES, V91, P165, DOI 10.1016/j.cherd.2012.07.005
   Arenas LT, 2004, MATER LETT, V58, P895, DOI 10.1016/j.matlet.2003.07.031
   Bal K. J., 2004, NARC LIBIRD IPGRI
   Basil JL, 2006, J HAZARD MATER, V133, P143
   Goyal P, 2008, INT J ENVIRON SCI TE, V5, P27, DOI 10.1007/BF03325994
   Hamoudi S, 2003, MICROPOR MESOPOR MAT, V59, P195, DOI 10.1016/S1387-1811(03)00311-1
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Jacques RA, 2007, SEPAR SCI TECHNOL, V42, P591, DOI 10.1080/01496390601069952
   Kuyucak N., 1990, BIOSORPTION HEAVY ME, P173
   Largegren S., 1898, KUNGLIGA SUENSK VETE, V241, P1
   Lima EC, 2007, J HAZARD MATER, V140, P211, DOI 10.1016/j.jhazmat.2006.06.073
   MARSHALL WE, 1995, J ENVIRON SCI HEAL A, V30, P241, DOI 10.1080/10934529509376198
   Mazali IO, 2005, AN ACAD BRAS CIENC, V77, P25, DOI 10.1590/S0001-37652005000100003
   Mishra V., 2014, APPL WATER SCI, V44, P218
   Passos CG, 2008, COLLOID SURFACE A, V316, P297, DOI 10.1016/j.colsurfa.2007.09.025
   Passos CG, 2006, J COLLOID INTERF SCI, V302, P396, DOI 10.1016/j.jcis.2006.06.052
   Pavia D.L., 1996, INTRO SPECTROSCOPY
   Rodrigues MS, 2012, J HAZARD MATER, V217, P246, DOI 10.1016/j.jhazmat.2012.03.022
   Sahmoune MN, 2009, INT J ENVIRON RES, V3, P229
   Vaghetti JCP, 2003, J ANAL ATOM SPECTROM, V18, P376, DOI 10.1039/b209133j
   Vimala R, 2011, DESALINATION, V275, P291, DOI 10.1016/j.desal.2011.03.014
   Volesky B., 2003, SORPTION BIOSORPTION, P316
   Weber W, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
NR 23
TC 0
Z9 0
U1 0
U2 2
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1295-8
J9 AIP CONF PROC
PY 2015
VL 1653
AR 020079
DI 10.1063/1.4914270
PG 8
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA BD6KC
UT WOS:000362294100079
OA Bronze
DA 2018-10-19
ER

PT J
AU Siebert, JR
   Eade, A
   Osterhout, DJ
AF Siebert, Justin R.
   Eade, AmberM.
   Osterhout, Donna J.
TI Biomaterial Approaches to Enhancing Neurorestoration after Spinal Cord
   Injury: Strategies for Overcoming Inherent Biological Obstacles
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID CHONDROITIN SULFATE PROTEOGLYCANS; CENTRAL-NERVOUS-SYSTEM; OLFACTORY
   ENSHEATHING CELLS; LEUKEMIA INHIBITORY FACTOR; LONG-TERM SURVIVAL;
   OLIGODENDROCYTE PROGENITOR CELLS; CUPRIZONE-INDUCED DEMYELINATION;
   CELLULAR INFLAMMATORY RESPONSE; MYELIN-ASSOCIATED GLYCOPROTEIN; PROMOTES
   FUNCTIONAL RECOVERY
AB While advances in technology and medicine have improved both longevity and quality of life in patients living with a spinal cord injury, restoration of full motor function is not often achieved. This is due to the failure of repair and regeneration of neuronal connections in the spinal cord after injury. In this review, the complicated nature of spinal cord injury is described, noting the numerous cellular and molecular events that occur in the central nervous system following a traumatic lesion. In short, postinjury tissue changes create a complex and dynamic environment that is highly inhibitory to the process of neural regeneration. Strategies for repair are outlined with a particular focus on the important role of biomaterials in designing a therapeutic treatment that can overcome this inhibitory environment. The importance of considering the inherent biological response of the central nervous system to both injury and subsequent therapeutic interventions is highlighted as a key consideration for all attempts at improving functional recovery.
C1 [Siebert, Justin R.; Eade, AmberM.] Seton Hill, Lake Erie Coll Osteopath Med, Greensburg, PA 15601 USA.
   [Osterhout, Donna J.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA.
RP Osterhout, DJ (reprint author), SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA.
EM osterhod@upstate.edu
CR Adamo AM, 2006, EXP NEUROL, V198, P519, DOI 10.1016/j.expneurol.2005.12.027
   Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812
   Akiyama Y, 2002, GLIA, V39, P229, DOI 10.1002/glia.10102
   Akiyama Y, 2002, J NEUROSCI, V22, P6623
   Akiyama Y, 2004, NEURON GLIA BIOL, V1, P47, DOI 10.1017/s1740925x04000079
   Andrews EM, 2012, EXP NEUROL, V235, P174, DOI 10.1016/j.expneurol.2011.09.008
   Andrews MR, 2007, J NEUROTRAUM, V24, P1773, DOI 10.1089/neu.2007.0353
   Andrews MR, 2004, EXP NEUROL, V190, P311, DOI 10.1016/j.expneurol.2004.08.011
   Apara A, 2014, NEURAL REGEN RES, V9, P1418, DOI 10.4103/1673-5374.139454
   Armstrong RC, 2002, J NEUROSCI, V22, P8574
   Asher RA, 2002, J NEUROSCI, V22, P2225, DOI 10.1523/JNEUROSCI.22-06-02225.2002
   Assuncao-Silva RC, 2015, STEM CELLS INT, DOI 10.1155/2015/948040
   Bambakidis Nicholas C, 2004, Spine J, V4, P16, DOI 10.1016/j.spinee.2003.07.004
   BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499
   Barres BA, 1999, J CELL BIOL, V147, P1123, DOI 10.1083/jcb.147.6.1123
   Barritt AW, 2006, J NEUROSCI, V26, P10856, DOI 10.1523/JNEUROSCI.2980-06.2006
   Bartus K, 2014, J NEUROSCI, V34, P4822, DOI 10.1523/JNEUROSCI.4369-13.2014
   Baumann N, 2001, PHYSIOL REV, V81, P871
   Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X
   Beller JA, 2014, NEURAL REGEN RES, V9, P343, DOI 10.4103/1673-5374.128235
   BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0
   Blakemore W. F., 1973, NAT NEUROSCI, V4, P1116
   Blesch A, 1999, J NEUROSCI, V19, P3556
   Blesch A, 2004, MOL CELL NEUROSCI, V27, P190, DOI 10.1016/j.mcn.2004.06.007
   Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a
   Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964
   Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015
   BRAUNEWELL KH, 1995, EUR J NEUROSCI, V7, P805, DOI 10.1111/j.1460-9568.1995.tb00683.x
   Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705
   Bugiani M, 2013, BRAIN, V136, P209, DOI 10.1093/brain/aws320
   BUNGE RP, 1993, ADV NEUROL, V59, P75
   Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004
   Cadavid D., 2014, NEUROLOGY SP3, V82, P154
   Cafferty WBJ, 2001, J NEUROSCI, V21, P7161, DOI 10.1523/JNEUROSCI.21-18-07161.2001
   Caggiano AO, 2005, J NEUROTRAUM, V22, P226, DOI 10.1089/neu.2005.22.226
   Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8
   Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000
   Chau CH, 2004, FASEB J, V18, P194, DOI 10.1096/fj.03-0196fje
   Chockalingam K, 2007, PROTEIN ENG DES SEL, V20, P155, DOI 10.1093/protein/gzm008
   CHUNG KS, 1983, J COMP NEUROL, V217, P47, DOI 10.1002/cne.902170105
   Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001
   Cox A. A., 2015, J NEUROTRAUMA
   Crespo D, 2007, EXP NEUROL, V206, P159, DOI 10.1016/j.expneurol.2007.05.001
   Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73
   Dahlin LB, 2004, J AM SOC SURG HAND, V4, P143, DOI DOI 10.1016/J.JASSH.2004.06.006
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043
   Dasari VR, 2007, J NEUROTRAUM, V24, P391, DOI 10.1089/neu.2006.0142
   DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034
   Deal DN, 2012, J AM ACAD ORTHOP SUR, V20, P63, DOI 10.5435/JAAOS-20-02-063
   DeBellard ME, 1996, MOL CELL NEUROSCI, V7, P89, DOI 10.1006/mcne.1996.0007
   Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070
   Dow KE, 1998, CELL MOL LIFE SCI, V54, P567, DOI 10.1007/s000180050185
   Dowling P, 1999, NEUROLOGY, V53, P1676, DOI 10.1212/WNL.53.8.1676
   Elatorai I. M., 2003, SPINAL CORD MED PRIN, P3
   Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004
   Fawcett James W, 2008, J Biol, V7, P25, DOI 10.1186/jbiol89
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Fidler PS, 1999, J NEUROSCI, V19, P8778, DOI 10.1523/JNEUROSCI.19-20-08778.1999
   Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195
   FILBIN MT, 1995, CURR OPIN NEUROBIOL, V5, P588, DOI 10.1016/0959-4388(95)80063-8
   Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011
   Fisher J. D., 2015, CLIN IMMUNOLOGY
   Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014
   Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296
   FOKSEANG J, 1995, DEV BIOL, V171, P1, DOI 10.1006/dbio.1995.1255
   Fouad K, 2004, EUR J NEUROSCI, V20, P2479, DOI 10.1111/j.1460-9568.2004.03716.x
   Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072
   Franklin RJM, 1997, J NEUROSCI RES, V50, P337, DOI 10.1002/(SICI)1097-4547(19971015)50:2<337::AID-JNR21>3.0.CO;2-3
   Franklin RJM, 2002, BRAIN RES BULL, V57, P827, DOI 10.1016/S0361-9230(01)00765-1
   Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436
   Freund P, 2007, J COMP NEUROL, V502, P644, DOI 10.1002/cne.21321
   FRIEDLANDER DR, 1994, J CELL BIOL, V125, P669, DOI 10.1083/jcb.125.3.669
   Friedman W, 2012, BASIC NEUROCHEMISTRY: PRINCIPLES OF MOLECULAR, CELLULAR, AND MEDICAL NEUROBIOLOGY, 8THEDITION, P546
   Fujita Y, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00338
   Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006
   Geddis MS, 2003, J NEUROBIOL, V54, P555, DOI 10.1002/neu.10183
   Giehl KM, 1997, EUR J NEUROSCI, V9, P2479, DOI 10.1111/j.1460-9568.1997.tb01665.x
   Giehl KM, 1998, J NEUROSCI, V18, P7351
   Goetz L. L., 2014, MEDSCAPE
   Goldberg JL, 2003, GENE DEV, V17, P941, DOI 10.1101/gad.1062303
   Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5
   Gregg C, 2005, DEVELOPMENT, V132, P565, DOI 10.1242/dev.01592
   Grill R, 1997, J NEUROSCI, V17, P5560
   Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628
   Gu Haigang, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P11
   Haggerty AE, 2013, NEUROSCI BULL, V29, P445, DOI 10.1007/s12264-013-1362-7
   Hains BC, 2003, J COMP NEUROL, V462, P328, DOI 10.1002/cne.10733
   Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818
   Hammond ENL, 1999, NEUROREPORT, V10, P2671, DOI 10.1097/00001756-199908200-00043
   Harlow DE, 2014, EXP NEUROL, V251, P39, DOI 10.1016/j.expneurol.2013.10.017
   Henke-Fahle S, 2001, MOL CELL NEUROSCI, V18, P541, DOI 10.1006/mcne.2001.1034
   Hiebert GW, 2002, J NEUROSCI RES, V69, P160, DOI 10.1002/jnr.10275
   Houweling DA, 1998, EXP NEUROL, V153, P49, DOI 10.1006/exnr.1998.6867
   HUGHES JT, 1988, PARAPLEGIA, V26, P71, DOI 10.1038/sc.1988.15
   Iwashita Y, 2000, EXP NEUROL, V164, P292, DOI 10.1006/exnr.2000.7440
   Jiang YJ, 2014, BIOMATERIALS, V35, P4969, DOI 10.1016/j.biomaterials.2014.03.001
   Jin Y, 2011, J NEUROSCI METH, V199, P208, DOI 10.1016/j.jneumeth.2011.05.007
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Jones LL, 2001, MICROSC RES TECHNIQ, V54, P317, DOI 10.1002/jemt.1144
   Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6
   Kamber D, 2009, EXP NEUROL, V219, P112, DOI 10.1016/j.expneurol.2009.05.004
   Kandel E. R., 1991, PRINCIPLES NEUROSCIE
   Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005
   Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009
   Kim David H, 2003, Spine J, V3, P510, DOI 10.1016/S1529-9430(03)00117-7
   KLEIN R, 1990, DEVELOPMENT, V109, P845
   Kobayashi NR, 1997, J NEUROSCI, V17, P9583
   Krenz NR, 2000, J NEUROCHEM, V74, P730, DOI 10.1046/j.1471-4159.2000.740730.x
   Kubo Takekazu, 2008, Ther Clin Risk Manag, V4, P605
   Kwon BK, 2004, EXP NEUROL, V189, P45, DOI 10.1016/j.expneurol.2004.05.034
   Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899
   Laabs T, 2005, CURR OPIN NEUROBIOL, V15, P116, DOI 10.1016/j.conb.2005.01.014
   Lakatos A, 2000, GLIA, V32, P214, DOI 10.1002/1098-1136(200012)32:3<214::AID-GLIA20>3.0.CO;2-7
   Lang BT, 2015, NATURE, V518, P404, DOI 10.1038/nature13974
   Lau LW, 2012, ANN NEUROL, V72, P419, DOI 10.1002/ana.23599
   Leibinger M, 2009, J NEUROSCI, V29, P14334, DOI 10.1523/JNEUROSCI.2770-09.2009
   Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X
   Li GL, 1999, ACTA NEUROPATHOL, V98, P473, DOI 10.1007/s004010051112
   Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003
   Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627
   LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6
   Lingor P, 2007, J NEUROCHEM, V103, P181, DOI 10.1111/j.1471-4159.2007.04756.x
   Liu Y, 1999, J NEUROSCI, V19, P4370
   Liu Y, 2002, EXP NEUROL, V178, P150, DOI 10.1006/exnr.2002.7977
   Logan A, 2006, BRAIN, V129, P490, DOI 10.1093/brain/awh706
   Loh NK, 2001, EXP NEUROL, V170, P72, DOI 10.1006/exnr.2001.7692
   Lu P, 2001, J COMP NEUROL, V436, P456, DOI 10.1002/cne.1080
   Ma J, 2007, BIOMED MATER, V2, P233, DOI 10.1088/1748-6041/2/4/005
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   Maier IC, 2009, BRAIN, V132, P1426, DOI 10.1093/brain/awp085
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Matsushima GK, 2001, BRAIN PATHOL, V11, P107
   Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L
   McKenzie IA, 2006, J NEUROSCI, V26, P6651, DOI 10.1523/JNEUROSCI.1007-06.2006
   McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x
   McTigue DM, 2006, J NEUROPATH EXP NEUR, V65, P406, DOI 10.1097/01.jnen.0000218447.32320.52
   McTigue DM, 1998, J NEUROSCI, V18, P5354
   Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460
   Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664
   Mi S, 2013, CNS DRUGS, V27, P493, DOI 10.1007/s40263-013-0068-8
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/NMAT2344, 10.1038/nmat2344]
   Mohtaram NK, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/022001
   Monnier PP, 2003, MOL CELL NEUROSCI, V22, P319, DOI 10.1016/S1044-7431(02)00035-0
   Moon LDF, 2001, NAT NEUROSCI, V4, P465
   Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737
   Munzel EJ, 2013, DRUGS, V73, P2017, DOI 10.1007/s40265-013-0146-8
   Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165
   Nazari-Robati M, 2013, BBA-PROTEINS PROTEOM, V1834, P479, DOI 10.1016/j.bbapap.2012.11.002
   Nisbet DR, 2008, J BIOMED MATER RES B, V87B, P251, DOI 10.1002/jbm.b.31000
   Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575
   Oberoi HS, 2013, ADV DRUG DELIVER REV, V65, P1667, DOI 10.1016/j.addr.2013.09.014
   Osterhout D. J., NANOSPHERE DEL UNPUB
   Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281
   Pabari A, 2014, PLAST RECONSTR SURG, V133, P1420, DOI 10.1097/PRS.0000000000000226
   Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566
   Pendleton JC, 2013, EXP NEUROL, V247, P113, DOI 10.1016/j.expneurol.2013.04.003
   Pepinsky RB, 2014, J PHARMACOL EXP THER, V350, P110, DOI 10.1124/jpet.113.211771
   Perale G, 2011, ACS CHEM NEUROSCI, V2, P336, DOI 10.1021/cn200030w
   Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6
   PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Pilakka-Kanthikeel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062241
   Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S
   Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015
   Radtke C, 2003, FASEB J, V17, P335, DOI 10.1096/fj.03-0214fje
   Ramer MS, 2002, MOL CELL NEUROSCI, V19, P239, DOI 10.1006/mcne.2001.1067
   Raposo C, 2014, GLIA, V62, P1895, DOI 10.1002/glia.22676
   REMAHL S, 1990, J NEUROCYTOL, V19, P883, DOI 10.1007/BF01186817
   Reynolds AJ, 2000, BRAIN RES REV, V33, P169, DOI 10.1016/S0165-0173(00)00028-X
   RICHARDSON PM, 1984, J NEUROCYTOL, V13, P165, DOI 10.1007/BF01148324
   Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591
   Romero MI, 2001, J NEUROSCI, V21, P8408
   Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3
   Ruschel J, 2015, SCIENCE, V348, P347, DOI 10.1126/science.aaa2958
   Sakiyama-Elbert S., 2012, HDB CLIN NEUROLOGY S, P109
   Saxena T, 2015, ACS NANO, V9, P1492, DOI 10.1021/nn505980z
   SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0
   Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004
   Sengottuvel Vetrivel, 2011, Commun Integr Biol, V4, P391, DOI 10.4161/cib.4.4.15552
   Sengottuvel V, 2011, J NEUROSCI, V31, P2688, DOI 10.1523/JNEUROSCI.4885-10.2011
   Setzu A, 2004, GLIA, V45, P307, DOI 10.1002/glia.10321
   Seymour AB, 2005, J CEREBR BLOOD F MET, V25, P1366, DOI 10.1038/sj.jcbfm.9600134
   Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310
   Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y
   Siebert J. R., 2014, BIOMED RES INT, V2014
   Siebert J. R., STRATEGIES IN PRESS
   Siebert JR, 2011, J NEUROCHEM, V119, P176, DOI 10.1111/j.1471-4159.2011.07370.x
   Siebert JR, 2011, EXP NEUROL, V231, P19, DOI 10.1016/j.expneurol.2011.05.002
   Siebert JR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-69
   Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002
   Steencken ACC, 2010, NEUROSCIENCE, V170, P971, DOI 10.1016/j.neuroscience.2010.06.064
   STENSAAS SS, 1978, ACTA NEUROPATHOL, V41, P145, DOI 10.1007/BF00689766
   Stidworthy MF, 2003, BRAIN PATHOL, V13, P329
   STOLL G, 1989, J NEUROSCI, V9, P2327
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594
   Surey S, 2014, NEUROSCIENCE, V275, P62, DOI 10.1016/j.neuroscience.2014.06.003
   Tan AM, 2005, J ANAT, V207, P717, DOI 10.1111/j.1469-7580.2005.00452.x
   Taylor L, 2006, J NEUROSCI, V26, P9713, DOI 10.1523/JNEUROSCI.0734-06.2006
   Taylor SJ, 2006, J CONTROL RELEASE, V116, P204, DOI 10.1016/j.jconrel.2006.07.005
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Tester NJ, 2008, EXP NEUROL, V209, P483, DOI 10.1016/j.expneurol.2007.07.019
   Tester NJ, 2007, J NEUROSCI RES, V85, P1110, DOI 10.1002/jnr.21199
   Tobias CA, 2001, J NEUROTRAUM, V18, P287, DOI 10.1089/08977150151070937
   Tobias CA, 2005, J NEUROTRAUM, V22, P138, DOI 10.1089/neu.2005.22.138
   Tom VJ, 2009, J NEUROTRAUM, V26, P2323, DOI 10.1089/neu.2009.1047
   Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Tsai SY, 2007, EXP BRAIN RES, V182, P261, DOI 10.1007/s00221-007-1067-0
   Tsai SY, 2011, STROKE, V42, P186, DOI 10.1161/STROKEAHA.110.590083
   Twiss JL, 2006, BRAIN PATHOL, V16, P320, DOI 10.1111/j.1750-3639.2006.00039.x
   Tyor WR, 2002, J NEUROL SCI, V200, P33, DOI 10.1016/S0022-510X(02)00113-2
   Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354
   Vavrek R, 2006, BRAIN, V129, P1534, DOI 10.1093/brain/awl087
   VAZQUEZ ME, 1991, NEUROREPORT, V2, P593, DOI 10.1097/00001756-199110000-00010
   Viapiano MS, 2006, TRENDS MOL MED, V12, P488, DOI 10.1016/j.molmed.2006.08.007
   Walthers CM, 2015, BIOMARK INSIGHTS, V10, P11, DOI [10.4137/BMIMI.S20063, 10.4137/BMI.S20063]
   Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867
   Wang MD, 2011, TISSUE ENG PART B-RE, V17, P177, DOI 10.1089/ten.teb.2010.0648
   Wang T, 2012, BRAIN RES BULL, V87, P499, DOI 10.1016/j.brainresbull.2012.02.011
   Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P1
   Wong DY, 2008, J NEUROTRAUM, V25, P1027, DOI 10.1089/neu.2007.0473
   Woodhoo A, 2007, BRAIN, V130, P2175, DOI 10.1093/brain/awm125
   Wu B, 2009, J NEUROTRAUM, V26, P1847, DOI 10.1089/neu.2008.0551
   Xie F, 2008, EXP NEUROL, V209, P302, DOI 10.1016/j.expneurol.2007.07.005
   Xie YM, 2006, J BIOL CHEM, V281, P16482, DOI 10.1074/jbc.M603131200
   Xu GY, 2004, EXP NEUROL, V187, P329, DOI 10.1016/j.expneurol.2004.01.029
   XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113
   YAWO H, 1985, J NEUROSCI, V5, P1626
   Yick LW, 2003, EXP NEUROL, V182, P160, DOI 10.1016/S0014-4886(02)00052-3
   Yick LW, 2000, NEUROREPORT, V11, P1063, DOI 10.1097/00001756-200004070-00032
   Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956
   Young W, 2002, PROG BRAIN RES, V137, P231
   Zhang YJ, 2015, EXP NEUROL, V266, P68, DOI 10.1016/j.expneurol.2015.02.006
   Zhao RR, 2011, J NEUROSCI METH, V201, P228, DOI 10.1016/j.jneumeth.2011.08.003
   Zhou LJ, 2003, J NEUROSCI RES, V74, P221, DOI 10.1002/jnr.10718
   Zhou XF, 2007, J NEUROSCI RES, V85, P1601, DOI 10.1002/jnr.21220
   Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013
   Zuo J, 1998, EXP NEUROL, V154, P654, DOI 10.1006/exnr.1998.6951
   Zuo J, 2002, EXP NEUROL, V176, P221, DOI 10.1006/exnr.2002.7922
NR 245
TC 8
Z9 9
U1 0
U2 6
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 752572
DI 10.1155/2015/752572
PG 20
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CT4AC
UT WOS:000362747100001
PM 26491685
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Neacsu, P
   Mazare, A
   Schmuki, P
   Cimpean, A
AF Neacsu, Patricia
   Mazare, Anca
   Schmuki, Patrik
   Cimpean, Anisoara
TI Attenuation of the macrophage inflammatory activity by TiO2 nanotubes
   via inhibition of MAPK and NF-kappa B pathways
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE titania nanotubes; macrophage; mitogen-activated protein kinases;
   NF-kappa B; inflammatory mediators
ID NITRIC-OXIDE SYNTHASE; ACTIVATED PROTEIN-KINASE; RAW 264.7 CELLS;
   PROINFLAMMATORY CYTOKINE PRODUCTION; SIGNAL-REGULATED KINASE;
   GENE-EXPRESSION; IN-VITRO; RAW-264.7 MACROPHAGES; MURINE MACROPHAGES;
   SURFACE-TOPOGRAPHY
AB Biomaterial implantation in a living tissue triggers the activation of macrophages in inflammatory events, promoting the transcription of pro-inflammatory mediator genes. The initiation of macrophage inflammatory processes is mainly regulated by signaling proteins of mitogen-activated protein kinase (MAPK) and by nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) pathways. We have previously shown that titania nanotubes modified Ti surfaces (Ti/TiO2) mitigate the immune response, compared with flat Ti surfaces; however, little is known regarding the underlying mechanism. Therefore, the aim of this study is to investigate the mechanism(s) by which this nanotopography attenuates the inflammatory activity of macrophages. Thus, we analyzed the effects of TiO2 nanotubes on the activation of MAPK and NF-kappa B signaling pathways in standard and lipopolysaccharide-evoked conditions. Results showed that the Ti/TiO2 significantly reduce the expression levels of the phosphorylated forms of p38, ERK1/2, c-Jun NH2-terminal kinase (JNK), IKK beta, and IkB-alpha. Furthermore, a significant reduction in the p65 nuclear accumulation on the nanotubular surface was remarked. Following, by using specific MAPK inhibitors, we observed that lipopolysaccharide-induced production of monocyte chemotactic protein-1 and nitric oxide was significantly inhibited on the Ti/TiO2 surface via p38 and ERK1/2, but not via JNK. However, the selective inhibitor for JNK signaling pathway (SP600125) was effective in reducing tumor necrosis factor alpha release as well as monocyte chemotactic protein-1 and nitric oxide production. Altogether, these data suggest that titania nanotubes can attenuate the macrophage inflammatory response via suppression of MAPK and NF-kappa B pathways providing a potential mechanism for their anti-inflammatory activity.
C1 [Neacsu, Patricia; Cimpean, Anisoara] Univ Bucharest, Dept Biochem & Mol Biol, Bucharest 050095, Romania.
   [Mazare, Anca; Schmuki, Patrik] Univ Erlangen Nurnberg, Dept Mat Sci, D-91054 Erlangen, Germany.
RP Cimpean, A (reprint author), Univ Bucharest, Dept Biochem & Mol Biol, 91-95 Splaiul Independentei, Bucharest 050095, Romania.
EM anisoara.cimpean@bio.unibuc.ro
OI Mazare, Anca/0000-0002-4836-946X
FU Romanian Ministry of National Education, CNCS-UEFISCDI [PNII-ID-PCE
   188/2011]
FX This work was supported by the Romanian Ministry of National Education,
   CNCS-UEFISCDI through project PNII-ID-PCE 188/2011.
CR Abarikwu SO, 2014, BBA-GEN SUBJECTS, V1840, P2373, DOI 10.1016/j.bbagen.2014.03.006
   Achoui M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015105
   Ainslie KM, 2009, J BIOMED MATER RES A, V91A, P647, DOI 10.1002/jbm.a.32262
   Ajizian SJ, 1999, J INFECT DIS, V179, P939, DOI 10.1086/314659
   Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391
   Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649
   Bergqvist S, 2008, PROTEIN SCI, V17, P2051, DOI 10.1110/ps.037481.108
   Bhat NR, 1998, J NEUROSCI, V18, P1633
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Budai MM, 2013, MOL IMMUNOL, V56, P471, DOI 10.1016/j.molimm.2013.05.005
   Carter AB, 1999, J BIOL CHEM, V274, P30858, DOI 10.1074/jbc.274.43.30858
   Chamberlain ML, 2011, J BIOMATER NANOBIOTE, V2, P293
   Chan ED, 1998, BIOCHEM BIOPH RES CO, V253, P790, DOI 10.1006/bbrc.1998.9857
   Chan ED, 2001, AM J PHYSIOL-CELL PH, V280, pC441
   Chen BC, 2001, BRIT J PHARMACOL, V134, P1055, DOI 10.1038/sj.bjp.0704334
   Chen BC, 1999, IMMUNOLOGY, V97, P124
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Choi HJ, 2008, EUR J PHARMACOL, V601, P171, DOI 10.1016/j.ejphar.2008.09.032
   Dai XH, 2015, J NANOMATER, DOI 10.1155/2015/712810
   Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5
   Feng GJ, 1999, J IMMUNOL, V163, P6403
   Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225
   Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1
   Ghrebi S, 2013, J BIOMED MATER RES A, V101, P2118, DOI 10.1002/jbm.a.34509
   Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2
   Hommes DW, 2003, GUT, V52, P144, DOI 10.1136/gut.52.1.144
   Ion R, 2015, ACTA BIOMATER, V24, P370, DOI 10.1016/j.actbio.2015.06.016
   Jang KJ, 2013, INT J MOL MED, V31, P1357, DOI 10.3892/ijmm.2013.1330
   Jang SI, 2006, EUR J PHARMACOL, V542, P1, DOI 10.1016/j.ejphar.2006.04.044
   Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017
   Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621
   Kim DH, 2013, FOOD CHEM TOXICOL, V58, P273, DOI 10.1016/j.fct.2013.04.051
   Kim KN, 2013, FOOD CHEM TOXICOL, V57, P126, DOI 10.1016/j.fct.2013.03.017
   Kim SH, 2004, PHARMACOL RES, V49, P433, DOI 10.1016/j.phrs.2003.11.004
   Kim YH, 2004, EUR J PHARMACOL, V494, P1, DOI 10.1016/j.ejphar.2004.04.040
   Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651
   Lee JC, 1996, J LEUKOCYTE BIOL, V59, P152
   Lee KH, 2012, INT J MOL SCI, V13, P2985, DOI 10.3390/ijms13032985
   Lee K, 2014, CHEM REV, V114, P9385, DOI 10.1021/cr500061m
   Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910
   Neacsu P, 2014, INT J BIOCHEM CELL B, V55, P187, DOI 10.1016/j.biocel.2014.09.006
   Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049
   RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420
   Rajapakse N, 2008, IMMUNOLOGY, V123, P348, DOI 10.1111/j.1365-2567.2007.02683.x
   Rajyalakshmi A, 2011, INT J NANOMED, V6, P1765, DOI 10.2147/IJN.S22763
   Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X
   Smith BS, 2013, BIOMATER SCI-UK, V1, P322, DOI 10.1039/c2bm00079b
   Soromou LW, 2012, MOLECULES, V17, P3574, DOI 10.3390/molecules17033574
   Sung MJ, 2009, INT IMMUNOPHARMACOL, V9, P319, DOI 10.1016/j.intimp.2008.12.005
   Tsao LT, 2005, BIOCHEM PHARMACOL, V70, P618, DOI 10.1016/j.bcp.2005.05.032
   Uto T, 2005, BIOCHEM PHARMACOL, V70, P1211, DOI 10.1016/j.bcp.2005.07.011
   Wang N, 2011, BIOMATERIALS, V32, P6900, DOI 10.1016/j.biomaterials.2011.06.023
   Waterfield JD, 2010, J BIOMED MATER RES A, V95A, P837, DOI 10.1002/jbm.a.32857
   WEINSTEIN SL, 1992, J BIOL CHEM, V267, P14955
   Xagorari A, 2002, BRIT J PHARMACOL, V136, P1058, DOI 10.1038/sj.bjp.0704803
   Xagorari A, 2001, J PHARMACOL EXP THER, V296, P181
   Yang Y, 2014, MEDIAT INFLAMM, V2014, P352
   Yoon WJ, 2012, ARCH PHARM RES, V35, P1421, DOI 10.1007/s12272-012-0812-5
   Yuan F, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-84
   Zhou HY, 2008, EUR J PHARMACOL, V586, P340, DOI 10.1016/j.ejphar.2008.02.044
NR 60
TC 11
Z9 11
U1 1
U2 17
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2015
VL 10
BP 6455
EP 6467
DI 10.2147/IJN.S92019
PG 13
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA CT3AN
UT WOS:000362678300002
PM 26491301
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Cecen, B
   Kozaci, D
   Yuksel, M
   Erdemli, D
   Bagriyanik, A
   Havitcioglu, H
AF Cecen, Berivan
   Kozaci, Didem
   Yuksel, Mithat
   Erdemli, Diler
   Bagriyanik, Alper
   Havitcioglu, Hasan
TI Biocompatibility of MG-63 cells on collagen, poly-L-lactic acid,
   hydroxyapatite scaffolds with different parameters
SO JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS
LA English
DT Article
DE Collagen; Hydroxyapatite; MG-63; Poly-L-lactic acid; Scaffold
ID COMPOSITE SCAFFOLDS; CHITIN FIBERS; IN-VITRO
AB Purpose: In this study, osteoblast-like MG-63 cells were cultured on 3 different scaffold types composed of (a) collagen + poly-L-lactic acid (PLLA), (b) collagen + hydroxyapatite (HA; 30 degrees C) or (c) collagen + hydroxyapatite (HA; 37 degrees C) and produced with different porosities.
   Methods: Biomechanical properties of the scaffolds were characterized by tensile strength measurements. Properties of the cell-seeded scaffolds were evaluated with scanning electron microscopy (SEM). Cell adhesion and proliferation capacities were evaluated. Alkaline phosphatase (ALP) levels in media were measured. Transmission electron microscopy (TEM) and histological analyses were used to assess morphological characteristics.
   Results: Our results showed that collagen-based PLLA and HA scaffolds have good cell biocompatibility. MTT test showed that the scaffolds exhibited no cytotoxicity. According to the force and displacement data, collagen + HA at 37 degrees C showed the highest mechanical strength and displacement.
   Conclusion: The results suggest that collagen-based PLLA and HA scaffolds might improve osteoblastic growth in vitro and have biomaterial integration potential in possible therapeutic approaches for future clinical studies.
C1 [Cecen, Berivan; Erdemli, Diler; Havitcioglu, Hasan] Dokuz Eylul Univ, Inst Hlth Sci, Dept Biomech, TR-35340 Izmir, Turkey.
   [Kozaci, Didem] Adnan Menderes Univ, Fac Med, Dept Med Biochem, Aydin, Turkey.
   [Yuksel, Mithat] Ege Univ, Fac Engn, Dept Chem Engn, Izmir, Turkey.
   [Bagriyanik, Alper] Dokuz Eylul Univ, Fac Med, Dept Histol, TR-35340 Izmir, Turkey.
   [Havitcioglu, Hasan] Dokuz Eylul Univ, Fac Med, Dept Orthopaed & Traumatol, TR-35340 Izmir, Turkey.
RP Cecen, B (reprint author), Dokuz Eylul Univ, Biyomekan Anabilim Dali, TR-35340 Izmir, Turkey.
EM berivan.erik@deu.edu.tr
OI Bagriyanik, Husnu Alper/0000-0003-4064-7637
CR Bacakova L, 2004, PHYSIOL RES, V53, pS35
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kim HW, 2005, BIOMATERIALS, V26, P5221, DOI 10.1016/j.biomaterials.2005.01.047
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Li XM, 2006, MAT SCI ENG C-BIO S, V26, P716, DOI 10.1016/j.msec.2005.06.062
   Li XM, 2006, J BIOMED MATER RES B, V77B, P219, DOI 10.1002/jbm.b.30425
   Liuyun Jiang, 2009, J Biomed Sci, V16, P65, DOI 10.1186/1423-0127-16-65
   Panzavolta S, 2012, J MATER SCI-MATER M, V23, P1363, DOI 10.1007/s10856-012-4618-2
   Paul W, 2007, J MATER SCI-MATER M, V18, P699, DOI 10.1007/s10856-006-0005-1
   Prabhakaran MP, 2009, ACTA BIOMATER, V5, P2884, DOI 10.1016/j.actbio.2009.05.007
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   WEI J, 2004, EUR POLYM J, V40, P509, DOI DOI 10.1016/J.EURP0LYMJ.2003.10.028
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 15
TC 6
Z9 6
U1 1
U2 17
PU WICHTIG PUBLISHING
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PY 2015
VL 13
IS 1
BP 10
EP 16
DI 10.5301/jabfm.5000182
PG 7
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA CS8WM
UT WOS:000362370500002
PM 24744232
DA 2018-10-19
ER

PT J
AU Bryan, N
   Ashwin, H
   Smart, NJ
   Wohlert, S
   Bayon, Y
   Hunt, JA
AF Bryan, Nicholas
   Ashwin, Helen
   Smart, Neil J.
   Wohlert, Stephen
   Bayon, Yves
   Hunt, John A.
TI Characterisation and comparison of the host response of 6 tissue-based
   surgical implants in a subcutaneous in vivo rat model
SO JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS
LA English
DT Article
DE Animal model; Biomaterial; Hernia; Inflammation; In vivo
ID VENTRAL HERNIA REPAIR; BIOLOGIC PROSTHESES; CROSS-LINKING; COLLAGEN;
   CELLS; DECELLULARIZATION; BIOMATERIALS; INFLAMMATION; LYMPHOCYTES;
   MACROPHAGES
AB Background: Hernia repair often involves fascial augmentation using biologic prostheses. Small processing changes during preparation modulate host tissue response, which influence material efficacy and longevity. In this pilot study, a rat model was used to determine the specific influence of tissue origin, decellularisation treatment and 1,6-hexamethylene diisocyanate (HMDI) cross-linking.
   Methods: Materials (1 cm(2)) were implanted subcutaneously into 6-week-old Wistar rats (4 materials per animal, n=6/material per time point) for 2, 5, 7, 14 and 28 days. Histologic processing was carried out after resin infiltration, observing classical histopathology and pathologic indexing. Materials comprised 6 tissue-based grafts covering both experimental and commercial porcine decellularised dermal and small intestinal submucosal materials.
   Results: Subcutaneous delivery of biologics demonstrated material-specific inflammatory/host responses. Controlled variations of the Permacol (TM) manufacturing process showed sodium dodecyl sulfate (SDS) was the most proinflammatory decellularisation reagent, and HMDI cross-linking had no effect on host response. All materials remained recoverable after 28 days, although Surgisis (TM) had partially resorbed.
   Conclusion: Differences in host responses exist between biologic implants for hernia repair in this rat model. It is postulated that these modifications are induced during processing and may have an effect on the clinical outcome of hernia repair.
C1 [Bryan, Nicholas; Hunt, John A.] Univ Liverpool, Inst Ageing & Chron Dis, Clin Engn UKCTE, Liverpool L69 3GA, Merseyside, England.
   [Ashwin, Helen; Wohlert, Stephen; Bayon, Yves] Covidien Sofradim Prod, Trevoux, France.
   [Smart, Neil J.] Royal Devon & Exeter Hosp, Exeter Hlth Sci Res Unit, Exeter EX2 5DW, Devon, England.
RP Bryan, N (reprint author), Univ Liverpool, Inst Ageing & Chron Dis, Clin Engn UKCTE, Duncan Bldg,Daulby St, Liverpool L69 3GA, Merseyside, England.
EM n.bryan@liv.ac.uk
OI Ashwin, Helen/0000-0003-1029-0032; Hunt, John/0000-0002-5168-4778
FU Covidien
FX The authors would like to thank Covidien for funding this research.
CR Bellows CF, 2006, EXPERT REV MED DEVIC, V3, P657, DOI 10.1586/17434440.3.5.657
   Bras LED, 2012, HERNIA, V16, P77, DOI 10.1007/s10029-011-0859-0
   Bras LED, 2010, J BIOMED MATER RES B, V95B, P239, DOI 10.1002/jbm.b.31704
   Bryan D, 2005, CYTOKINE, V31, P429, DOI 10.1016/j.cyto.2005.06.015
   Bryan N, 2009, BIOMATERIALS, V30, P180, DOI 10.1016/j.biomaterials.2008.09.003
   Butler CE, 2010, J AM COLL SURGEONS, V211, P368, DOI 10.1016/j.jamcollsurg.2010.04.024
   Butterfield TA, 2006, J ATHL TRAINING, V41, P457
   Catena F, 2007, SURG ENDOSC, V21, P690, DOI 10.1007/s00464-006-9110-y
   Deeken CR, 2011, J AM COLL SURGEONS, V212, P880, DOI 10.1016/j.jamcollsurg.2011.01.006
   Dubay DA, 2003, SURG CLIN N AM, V83, P463, DOI 10.1016/S0039-6109(02)00196-2
   EFRON JE, 1990, J SURG RES, V48, P460, DOI 10.1016/0022-4804(90)90013-R
   FOSTER SJ, 1986, BIOCHEM PHARMACOL, V35, P1709, DOI 10.1016/0006-2952(86)90328-X
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gaertner WB, 2007, J GASTROINTEST SURG, V11, P1275, DOI 10.1007/s11605-007-0242-8
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Goldberg SR, 2010, SURG CLIN N AM, V90, P1133, DOI 10.1016/j.suc.2010.08.003
   Haney AF, 2000, FERTIL STERIL, V73, P988, DOI 10.1016/S0015-0282(00)00490-8
   Hiles M, 2009, SURG INNOV, V16, P26, DOI 10.1177/1553350609331397
   Hsu PW, 2009, J PLAST RECONSTR AES, V62, P1484, DOI 10.1016/j.bjps.2008.04.060
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   KIKLY K, 2001, DENDRITIC CELLS, P539
   Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P1325, DOI 10.1016/j.intimp.2010.08.012
   MARTIN CW, 1990, BRIT J PLAST SURG, V43, P655, DOI 10.1016/0007-1226(90)90185-3
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003
   Miserez M, 2010, BRIT J SURG, V97, P1598, DOI 10.1002/bjs.7282
   Mulier KE, 2011, HERNIA, V15, P315, DOI 10.1007/s10029-010-0777-6
   Nienhuijs S W, 2008, Int J Surg, V6, P351, DOI 10.1016/j.ijsu.2008.02.005
   Oliveira HC, 2010, IMMUNOBIOLOGY, V215, P215, DOI 10.1016/j.imbio.2009.03.009
   Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4
   Pham CTN, 2008, INT J BIOCHEM CELL B, V40, P1317, DOI 10.1016/j.biocel.2007.11.008
   REISER K, 1992, FASEB J, V6, P2439
   Sandor M, 2008, TISSUE ENG PT A, V14, P2021, DOI 10.1089/ten.tea.2007.0317
   Smart NJ, 2012, SURG-J R COLL SURG E, V10, P159, DOI 10.1016/j.surge.2012.02.006
   Smart NJ, 2011, SURG INNOV, P221
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Tsirogianni AK, 2006, INJURY, V37, pS5, DOI 10.1016/j.injury.2006.02.035
   van't Riet M, 2007, Hernia, V11, P409
   VATER CA, 1979, BIOCHEM J, V181, P639, DOI 10.1042/bj1810639
   Wilgus TA, 2008, PHARMACOL RES, V58, P112, DOI 10.1016/j.phrs.2008.07.009
   Williams DF, 2006, TRENDS BIOTECHNOL, V24, P4, DOI 10.1016/j.tibtech.2005.10.006
   Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067
NR 43
TC 2
Z9 2
U1 0
U2 4
PU WICHTIG PUBLISHING
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PY 2015
VL 13
IS 1
BP 35
EP 42
DI 10.5301/jabfm.5000172
PG 8
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA CS8WM
UT WOS:000362370500005
PM 24700265
DA 2018-10-19
ER

PT J
AU Loh, XJ
   Karim, AA
   Owh, C
AF Loh, Xian Jun
   Karim, Anis Abdul
   Owh, Cally
TI Poly(glycerol sebacate) biomaterial: synthesis and biomedical
   applications
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Review
ID TAILORED MECHANICAL-PROPERTIES; BIODEGRADABLE ELASTOMERS; NANOFIBROUS
   SCAFFOLDS; TISSUE; REGENERATION; BIOCOMPATIBILITY; CULTURE; ACID;
   COMPOSITES; COPOLYMERS
AB The recently developed poly(glycerol sebacate) (PGS) has been gaining attraction as a biomaterial for tissue engineering applications. Reported in 2002, a simple polycondensation method was developed to synthesize PGS for soft tissue engineering applications. It has since become a highly sought after biomaterial due to its soft, robust and flexible characteristics and it is relatively low cost compared to other biodegradable elastomers currently available in the market. We summarise in this review, the various synthetic approaches of PGS and highlight selected applications in nerve guidance, soft tissue regeneration, vascular and myocardial tissue regeneration, blood vessel reconstruction, drug delivery, and the replacement of photoreceptor cells. A critical assessment of the material is provided as a scope for future improvement. The future outlook of this material is also provided at the end of this review.
C1 [Loh, Xian Jun; Karim, Anis Abdul; Owh, Cally] ASTAR, IMRE, Singapore 117602, Singapore.
   [Loh, Xian Jun] Natl Univ Singapore, Dept Mat Sci & Engn, Singapore 117576, Singapore.
   [Loh, Xian Jun] Singapore Eye Res Inst, Singapore 168751, Singapore.
RP Loh, XJ (reprint author), ASTAR, IMRE, 3 Res Link, Singapore 117602, Singapore.
EM lohxj@imre.a-star.edu.sg
OI Loh, Xian Jun/0000-0001-8118-6502
CR Allen RA, 2014, BIOMATERIALS, V35, P165, DOI 10.1016/j.biomaterials.2013.09.081
   Appel EA, 2012, CHEM SOC REV, V41, P6195, DOI 10.1039/c2cs35264h
   Aydin HM, 2013, BIOMATER SCI-UK, V1, P503, DOI 10.1039/c3bm00157a
   Bodakhe S, 2013, NANOMEDICINE-UK, V8, P1777, DOI 10.2217/nnm.12.192
   Bruggeman JP, 2008, BIOMATERIALS, V29, P4726, DOI 10.1016/j.biomaterials.2008.08.037
   Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chen QZ, 2011, J MECH BEHAV BIOMED, V4, P1805, DOI 10.1016/j.jmbbm.2011.05.038
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   Chen QZ, 2011, SOFT MATTER, V7, P6484, DOI 10.1039/c1sm05350g
   Dong WF, 2013, POLYMERS-BASEL, V5, P1339, DOI 10.3390/polym5041339
   Dou QQ, 2014, ADV HEALTHC MATER, V3, P977, DOI 10.1002/adhm.201300627
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FDA: U.S. Food and Drug Administration, SEL COMM GRAS SUBST
   Frydrych M, 2013, J MATER CHEM B, V1, P6650, DOI 10.1039/c3tb20842g
   Gaharwar AK, 2015, BIOMATER SCI-UK, V3, P46, DOI 10.1039/c4bm00222a
   Gao J, 2006, TISSUE ENG, V12, P917, DOI 10.1089/ten.2006.12.917
   Gerecht S, 2007, BIOMATERIALS, V28, P4826, DOI 10.1016/j.biomaterials.2007.07.039
   Guillemette MD, 2010, MACROMOL BIOSCI, V10, P1330, DOI 10.1002/mabi.201000165
   Guo XL, 2014, J BIOMED MATER RES A, V102, P3903, DOI 10.1002/jbm.a.35066
   Ifkovits JL, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034104
   Jeffries EM, 2015, ACTA BIOMATER, V18, P30, DOI 10.1016/j.actbio.2015.02.005
   Kai D, 2014, ACS SUSTAIN CHEM ENG, V2, P106, DOI 10.1021/sc400340p
   Karim AA, 2015, SOFT MATTER, V11, P5425, DOI 10.1039/c5sm00665a
   Kemppainen JM, 2010, J BIOMED MATER RES A, V94A, P9, DOI 10.1002/jbm.a.32653
   Kharaziha M, 2013, BIOMATERIALS, V34, P6355, DOI 10.1016/j.biomaterials.2013.04.045
   Labet M, 2009, CHEM SOC REV, V38, P3484, DOI 10.1039/b820162p
   Lang N., 2014, SCI TRANSL MED, V6
   Li XD, 2015, BIOMACROMOLECULES, V16, P1525, DOI 10.1021/acs.biomac.5b00018
   Li ZB, 2015, CHEM SOC REV, V44, P2865, DOI 10.1039/c5cs00089k
   Liang SL, 2010, BIOMATERIALS, V31, P8516, DOI 10.1016/j.biomaterials.2010.07.105
   Liang SL, 2012, POLYM INT, V61, P17, DOI 10.1002/pi.3165
   Liu QY, 2009, POLYM DEGRAD STABIL, V94, P1427, DOI 10.1016/j.polymdegradstab.2009.05.023
   Loh XJ, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39924
   Loh XJ, 2011, J MATER CHEM, V21, P2246, DOI 10.1039/c0jm03051a
   Loh XJ, 2009, MACROMOL BIOSCI, V9, P1069, DOI 10.1002/mabi.200900081
   Loh XJ, 2009, SOFT MATTER, V5, P2937, DOI 10.1039/b904171k
   Loh XJ, 2009, MACROMOLECULES, V42, P194, DOI 10.1021/ma8019865
   Low ZW, 2015, RSC ADV, V5, P57678, DOI 10.1039/c5ra09926a
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Nguyen VPN, 2011, SOFT MATTER, V7, P2150, DOI 10.1039/c0sm00764a
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Park H, 2011, BIOMATERIALS, V32, P1856, DOI 10.1016/j.biomaterials.2010.11.032
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Pomerantseva I, 2009, J BIOMED MATER RES A, V91A, P1038, DOI 10.1002/jbm.a.32327
   Pritchard CD, 2010, BIOMATERIALS, V31, P2153, DOI 10.1016/j.biomaterials.2009.11.074
   Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578
   Rai R, 2013, MAT SCI ENG C-MATER, V33, P3677, DOI 10.1016/j.msec.2013.04.058
   Ravichandran R, 2011, TISSUE ENG PT A, V17, P1363, DOI [10.1089/ten.tea.2010.0441, 10.1089/ten.TEA.2010.0441]
   Ravichandran R, 2013, INT J CARDIOL, V167, P1461, DOI 10.1016/j.ijcard.2012.04.045
   Redenti S, 2009, BIOMATERIALS, V30, P3405, DOI 10.1016/j.biomaterials.2009.02.046
   Roether JA, 2014, MATER SCI TECH-LOND, V30, P574, DOI 10.1179/1743284713Y.0000000499
   Salehi S, 2014, KLIN MONATSBL AUGENH, V231, P626, DOI 10.1055/s-0034-1368533
   Salehi S, 2014, RSC ADV, V4, P16951, DOI 10.1039/c4ra01237b
   Salehi S, 2014, MACROMOL MATER ENG, V299, P455, DOI 10.1002/mame.201300187
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Toh WS, 2014, MAT SCI ENG C-MATER, V45, P690, DOI 10.1016/j.msec.2014.04.026
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wu Y, 2012, J APPL POLYM SCI, V123, P1612, DOI 10.1002/app.34556
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yang J, 2006, BIOMATERIALS, V27, P1889, DOI 10.1016/j.biomaterials.2005.05.106
   Ye EY, 2014, MATER TODAY, V17, P194, DOI 10.1016/j.mattod.2014.04.004
   Ye HY, 2015, RSC ADV, V5, P48720, DOI 10.1039/c5ra08222f
   Zhao X, 2015, J MATER CHEM B, V3, P3222, DOI 10.1039/c4tb01693a
   Zhou L, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.42196
NR 67
TC 35
Z9 34
U1 4
U2 63
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 39
BP 7641
EP 7652
DI 10.1039/c5tb01048a
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA CS8PP
UT WOS:000362350600001
DA 2018-10-19
ER

PT J
AU Khaing, ZZ
   Seidlits, SK
AF Khaing, Zin Z.
   Seidlits, Stephanie K.
TI Hyaluronic acid and neural stem cells: implications for biomaterial
   design
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Review
ID SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; OLIGODENDROCYTE PROGENITOR
   CELLS; MOLECULAR-WEIGHT HYALURONAN; EXTRACELLULAR-MATRIX PROTEOGLYCANS;
   CHONDROITIN SULFATE PROTEOGLYCAN; RESTRICTED PRECURSOR CELLS; NOGO-66
   RECEPTOR ANTIBODY; MEDIATED MOTILITY RHAMM; TRAUMATIC BRAIN-INJURY
AB While in the past hyaluronic acid (HA) was considered a passive component with a primarily structural role in tissues, research over the past few decades has revealed its diverse and complex biological functions, resulting in a major ideological shift. HA is abundant during normal central nervous system (CNS) development and, although down-regulated, remains ubiquitous in adult extracellular matrix (ECM). Significant changes in HA content are associated with pathological conditions, including stroke, traumatic injury and multiple sclerosis, and these changes likely disrupt repair by endogenous neural stem cells (NSCs). In this review, we describe recent findings in HA biology relevant to NSCs-focusing on the potential of HA-NSC interactions to mediate CNS regeneration. Currently, HA biomaterials are being developed to counteract matrix changes associated with CNS injury and disease, thereby promoting NSC survival and directing differentiation. In parallel, HA-based biomaterials engineered to mimic the native CNS microenvironment are being used to investigate the relationship between NSCs and their HA-rich surroundings within a controlled experimental space. As our understanding of HA-NSC interactions improves, so will the therapeutic potential of HA-based biomaterials. Efforts to better understand the relationship between HA bioactivities and biomaterial design parameters are already underway. Although significant progress has been made improving techniques for controlled fabrication of HA-based hydrogels with precisely defined features, there is still much work to be done. Ideally, future designs will incorporate multiple types of microenvironmental cues - orthogonally tuned in time and space - to direct differentiation of NSCs into various specialized lineages within a single biomaterial platform.
C1 [Khaing, Zin Z.] Univ Washington, Inst Stem Cell & Regenerat Med, Dept Neurol Surg, Seattle, WA 98195 USA.
   [Seidlits, Stephanie K.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Brain Res Inst, Dept Bioengn, Los Angeles, CA 90024 USA.
RP Khaing, ZZ (reprint author), Univ Washington, Inst Stem Cell & Regenerat Med, Dept Neurol Surg, Seattle, WA 98195 USA.
EM zink@uw.edu
CR Abaskharoun M, 2010, BRAIN RES, V1327, P6, DOI 10.1016/j.brainres.2010.02.048
   Addington CP, 2014, BIOMATERIALS, V35, P3263, DOI 10.1016/j.biomaterials.2013.12.102
   Al'Qteishat A, 2006, BRAIN, V129, P2158, DOI 10.1093/brain/awl139
   Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038
   Ananthanarayanan B, 2011, BIOMATERIALS, V32, P7913, DOI 10.1016/j.biomaterials.2011.07.005
   Arulmoli J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08499
   Aurand ER, 2014, STEM CELL RES, V12, P11, DOI 10.1016/j.scr.2013.09.013
   Aurand Emily R, 2012, J Funct Biomater, V3, P839, DOI 10.3390/jfb3040839
   Austin JW, 2012, J NEUROCHEM, V122, P344, DOI 10.1111/j.1471-4159.2012.07789.x
   Austin JW, 2012, BIOMATERIALS, V33, P4555, DOI 10.1016/j.biomaterials.2012.03.022
   Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611
   Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279
   Back SA, 2011, ANN NEUROL, V70, P465, DOI 10.1002/ana.22484
   Baier C, 2007, MATRIX BIOL, V26, P348, DOI 10.1016/j.matbio.2007.02.002
   Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322
   Bambakidis NC, 2003, J NEUROSURG, V99, P70, DOI 10.3171/spi.2003.99.1.0070
   Bambakidis NC, 2009, J NEUROSURG-SPINE, V10, P171, DOI 10.3171/2008.10.SPI08231
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201
   Barbucci R, 2000, J BIOMAT SCI-POLYM E, V11, P383, DOI 10.1163/156856200743779
   Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014
   Bergstrom T, 2014, BBA-GEN SUBJECTS, V1840, P2526, DOI 10.1016/j.bbagen.2014.01.021
   BIGNAMI A, 1992, BRAIN RES, V579, P173, DOI 10.1016/0006-8993(92)90759-3
   BIGNAMI A, 1992, INT J DEV NEUROSCI, V10, P45, DOI 10.1016/0736-5748(92)90006-L
   BIGNAMI A, 1992, INT J DEV NEUROSCI, V10, P291, DOI 10.1016/0736-5748(92)90018-U
   BIGNAMI A, 1992, EXP NEUROL, V117, P90, DOI 10.1016/0014-4886(92)90115-7
   Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x
   Boregowda Rajeev K, 2006, J Carcinog, V5, P2, DOI 10.1186/1477-3163-5-2
   Bouvier-Labit C, 2002, J NEURO-ONCOL, V60, P127, DOI 10.1023/A:1020630732625
   Brannvall K, 2007, J NEUROSCI RES, V85, P2138, DOI 10.1002/jnr.21358
   Bruckner G, 2003, J CHEM NEUROANAT, V26, P37, DOI 10.1016/S0891-0618(03)00036-X
   Bruckner G, 2008, NEUROSCIENCE, V151, P489, DOI 10.1016/j.neuroscience.2007.10.033
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Cam C, 2014, ACTA BIOMATER, V10, P205, DOI 10.1016/j.actbio.2013.10.002
   CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0
   Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exner.2002.7981
   Cargill R, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.006
   Carletti B, 2011, CURR NEUROPHARMACOL, V9, P313, DOI 10.2174/157015911795596603
   Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822
   Carulli D, 2007, J COMP NEUROL, V501, P83, DOI 10.1002/cne.21231
   Cassiani-Ingoni R, 2007, J NEUROPATH EXP NEUR, V66, P637, DOI 10.1097/nen.0b013e318093f3ef
   Celio MR, 1998, TRENDS NEUROSCI, V21, P510, DOI 10.1016/S0166-2236(98)01298-3
   CELIO MR, 1994, BRAIN RES REV, V19, P128, DOI 10.1016/0165-0173(94)90006-X
   Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Chopra A, 2014, BIOMATERIALS, V35, P71, DOI 10.1016/j.biomaterials.2013.09.066
   Cizkova D, 2009, CELL MOL NEUROBIOL, V29, P999, DOI 10.1007/s10571-009-9387-1
   Colognato H, 2011, DEV NEUROBIOL, V71, P924, DOI 10.1002/dneu.20966
   Csoka T., 1996, INVAS METAST, V17, P297
   Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7
   Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200
   DeForest CA, 2012, ANGEW CHEM, V124, P1852, DOI DOI 10.1002/ANGE.201106463
   DeForest CA, 2010, CHEM MATER, V22, P4783, DOI 10.1021/cm101391y
   Delpech B, 2002, ANTICANCER RES, V22, P2423
   DELPECH B, 1993, EUR J CANCER, V29A, P1012, DOI 10.1016/S0959-8049(05)80214-X
   Dicker KT, 2014, ACTA BIOMATER, V10, P1558, DOI 10.1016/j.actbio.2013.12.019
   Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898
   Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036
   Dzwonek J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00175
   Edelman DB, 2005, EXP NEUROL, V192, P1, DOI 10.1016/j.expneurol.2004.10
   Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927
   Eng D, 2010, ACTA BIOMATER, V6, P2407, DOI 10.1016/j.actbio.2009.12.049
   Fancy SPJ, 2004, MOL CELL NEUROSCI, V27, P247, DOI 10.1016/j.mcn.2004.06.015
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Florczyk SJ, 2013, BIOMATERIALS, V34, P10143, DOI 10.1016/j.biomaterials.2013.09.034
   Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   Frenkel JS, 2014, INT WOUND J, V11, P159, DOI 10.1111/j.1742-481X.2012.01057.x
   Frischknecht R, 2012, ADV EXP MED BIOL, V970, P153, DOI 10.1007/978-3-7091-0932-8_7
   Fujiwara T, 2008, GENES CELLS, V13, P759, DOI 10.1111/j.1365-2443.2008.01203.x
   FUXE K, 1994, NEUROSCI LETT, V169, P25, DOI 10.1016/0304-3940(94)90348-4
   Galtrey CM, 2008, EUR J NEUROSCI, V27, P1373, DOI 10.1111/j.1460-9568.2008.06108.x
   Gao F, 2008, CLIN INVEST MED, V31, pE106, DOI 10.25011/cim.v31i3.3467
   Giamanco KA, 2010, NEUROSCIENCE, V170, P1314, DOI 10.1016/j.neuroscience.2010.08.032
   Gilg AG, 2008, CLIN CANCER RES, V14, P1804, DOI 10.1158/1078-0432.CCR-07-1228
   Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8
   Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263
   Griffin DR, 2015, NAT MATER, V14, P737, DOI [10.1038/NMAT4294, 10.1038/nmat4294]
   Griffin DR, 2013, BIOMACROMOLECULES, V14, P1199, DOI 10.1021/bm400169d
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Hachet E, 2012, BIOMACROMOLECULES, V13, P1818, DOI 10.1021/bm300324m
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Han LH, 2013, BIOMATERIALS, V34, P4251, DOI 10.1016/j.biomaterials.2013.02.051
   Happel MFK, 2014, P NATL ACAD SCI USA, V111, P2800, DOI 10.1073/pnas.1310272111
   He H, 2013, J BIOL CHEM, V288, P25792, DOI 10.1074/jbc.M113.479584
   Heris HK, 2012, MACROMOL BIOSCI, V12, P202, DOI 10.1002/mabi.201100335
   Hernot S, 2008, ADV DRUG DELIVER REV, V60, P1153, DOI 10.1016/j.addr.2008.03.005
   Hoffmann JC, 2010, SOFT MATTER, V6, P5056, DOI 10.1039/c0sm00140f
   Horn EM, 2007, J NEUROSURG-SPINE, V6, P133, DOI 10.3171/spi.2007.6.2.133
   Horowitz MP, 2011, ANTIOXID REDOX SIGN, V15, P855, DOI 10.1089/ars.2010.3629
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Hugnot JP, 2011, FRONT BIOSCI-LANDMRK, V16, P1044, DOI 10.2741/3734
   Ishii K, 2001, J NEUROSCI RES, V65, P500, DOI 10.1002/jnr.1180
   Jackson J. A., 2004, STEM CELL THERAPY AU, P11
   Jager C, 2013, NEUROSCIENCE, V238, P168, DOI 10.1016/j.neuroscience.2013.02.014
   Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315
   Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337
   Johnson P, 2000, BIOCHEM PHARMACOL, V59, P455, DOI 10.1016/S0006-2952(99)00266-X
   Kasko AM, 2010, FUTURE MED CHEM, V2, P1669, DOI 10.4155/FMC.10.253
   Ke Y, 2006, STEM CELLS, V24, P1011, DOI 10.1634/stemcells.2005-0249
   Keung AJ, 2011, STEM CELLS, V29, P1886, DOI 10.1002/stem.746
   Khaing ZZ, 2014, MATER TODAY, V17, P332, DOI 10.1016/j.mattod.2014.05.011
   Khaing ZZ, 2012, NEUROSCI LETT, V519, P103, DOI 10.1016/j.neulet.2012.02.027
   Khaing ZZ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046033
   Khetan S, 2011, SOFT MATTER, V7, P830, DOI 10.1039/c0sm00852d
   Kim J, 2008, BIOPOLYMERS, V89, P1144, DOI 10.1002/bip.21066
   KOOCHEKPOUR S, 1995, INT J CANCER, V63, P450, DOI 10.1002/ijc.2910630325
   Koppe G, 1997, HISTOCHEM J, V29, P11, DOI 10.1023/A:1026408716522
   Kouvidi K, 2011, J BIOL CHEM, V286, P38509, DOI 10.1074/jbc.M111.275875
   Kurkowska-Jastrzebska I, 1999, EXP NEUROL, V156, P50, DOI 10.1006/exnr.1998.6993
   Kwok JCF, 2011, DEV NEUROBIOL, V71, P1073, DOI 10.1002/dneu.20974
   Kwok JCF, 2010, J NEUROCHEM, V114, P1447, DOI 10.1111/j.1471-4159.2010.06878.x
   Lam J, 2014, ADV FUNCT MATER, V24, P7053, DOI 10.1002/adfm.201401483
   Lavik E, 2011, THERAPEUTIC ANGIOGENESIS FOR VASCULAR DISEASES, P145, DOI 10.1007/978-90-481-9495-7_7
   Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003
   Lei YG, 2011, J CONTROL RELEASE, V153, P255, DOI 10.1016/j.jconrel.2011.01.028
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Lewis ND, 2014, J NEUROIMMUNOL, V277, P26, DOI 10.1016/j.jneuroim.2014.09.014
   Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048824
   Li XW, 2014, J NEUROTRAUM, V31, P1431, DOI 10.1089/neu.2013.3215
   Li XW, 2013, FASEB J, V27, P1127, DOI 10.1096/fj.12-211151
   Liang JR, 2007, J IMMUNOL, V178, P2469, DOI 10.4049/jimmunol.178.4.2469
   Liang Y, 2013, BIOMATERIALS, V34, P5521, DOI 10.1016/j.biomaterials.2013.03.095
   Lim TC, 2013, FASEB J, V27, P1023, DOI 10.1096/fj.12-221515
   Lin CM, 2009, SURG NEUROL, V72, P50, DOI 10.1016/j.wneu.2009.09.004
   Lindwall C, 2013, BRAIN RES, V1503, P62, DOI 10.1016/j.brainres.2013.01.045
   Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018
   Liu Y, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-135
   Loulier K, 2006, J NEUROCHEM, V98, P530, DOI 10.1111/j.1471-4159.2006.03896.x
   Lowry N, 2012, BIOMATERIALS, V33, P2892, DOI 10.1016/j.biomaterials.2011.12.048
   Ma J, 2007, BIOMED MATER, V2, P233, DOI 10.1088/1748-6041/2/4/005
   Mabry KM, 2015, BIOMATERIALS, V49, P47, DOI 10.1016/j.biomaterials.2015.01.047
   MARGOLIS RU, 1975, BIOCHEMISTRY-US, V14, P85, DOI 10.1021/bi00672a014
   Matou-Nasri S, 2009, INT J ONCOL, V35, P761, DOI 10.3892/ijo_00000389
   Matsumoto T, 2012, NEUROSCI LETT, V520, P115, DOI 10.1016/j.neulet.2012.05.048
   McKinnon DD, 2014, ADV MATER, V26, P865, DOI 10.1002/adma.201303680
   McPherson CA, 2014, NEUROTOX RES, V25, P45, DOI 10.1007/s12640-013-9422-3
   McRae PA, 2012, NEUROCHEM INT, V61, P963, DOI 10.1016/j.neuint.2012.08.007
   Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182
   MERZAK A, 1994, CANCER RES, V54, P3988
   Meszar Z, 2008, BRAIN RES BULL, V75, P414, DOI 10.1016/j.brainresbull.2007.10.052
   Miron VE, 2011, BBA-MOL BASIS DIS, V1812, P184, DOI 10.1016/j.bbadis.2010.09.010
   Moon C, 2004, NEUROSCI LETT, V367, P133, DOI 10.1016/j.neulet.2004.05.101
   Moon C, 2006, J VET MED SCI, V68, P761, DOI 10.1292/jvms.68.761
   Moon LDF, 2003, J NEUROSCI RES, V71, P23, DOI 10.1002/jnr.10449
   Moshayedi Pouria, 2013, Biomatter, V3, DOI 10.4161/biom.23863
   Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002
   Naruse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053109
   Nguyen HX, 2014, J COMP NEUROL, V522, P2767, DOI 10.1002/cne.23604
   Nielsen HM, 2012, CURR ALZHEIMER RES, V9, P257
   Nimmo CM, 2011, BIOMACROMOLECULES, V12, P824, DOI 10.1021/bm101446k
   NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469
   Novak T, 2015, ACTA BIOMATER, V11, P274, DOI 10.1016/j.actbio.2014.09.031
   Okun E, 2010, J NEUROCHEM, V114, P462, DOI 10.1111/j.1471-4159.2010.06778.x
   Olofsson B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090921
   Owen SC, 2013, LANGMUIR, V29, P7393, DOI 10.1021/la305000w
   Oz Buge, 2000, Pathology and Oncolgy Research, V6, P118
   Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101
   Pan LJ, 2009, J NEUROSCI RES, V87, P3207, DOI 10.1002/jnr.22142
   Park JB, 2008, CELL ADHES MIGR, V2, P202, DOI 10.4161/cam.2.3.6320
   Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519
   Perosa SR, 2002, BRAIN RES BULL, V58, P509, DOI 10.1016/S0361-9230(02)00822-5
   Piao JH, 2013, GLIA, V61, P361, DOI 10.1002/glia.22438
   Piaton G, 2010, J NEUROCHEM, V114, P1243, DOI 10.1111/j.1471-4159.2010.06831.x
   Pollard SM, 2008, MOL CELL NEUROSCI, V38, P393, DOI 10.1016/j.mcn.2008.03.012
   Preston M, 2013, ANN NEUROL, V73, P266, DOI 10.1002/ana.23788
   Preston Marnie, 2011, Front Biosci (Schol Ed), V3, P1165
   Purcell BP, 2012, BIOMATERIALS, V33, P7849, DOI 10.1016/j.biomaterials.2012.07.005
   Radotra B, 1997, ANTICANCER RES, V17, P945
   RADOTRA B, 1994, NEUROPATH APPL NEURO, V20, P399, DOI 10.1111/j.1365-2990.1994.tb00986.x
   Ramanan VV, 2010, J MATER CHEM, V20, P8920, DOI 10.1039/c0jm00734j
   Rampon C, 2008, STEM CELLS, V26, P1673, DOI 10.1634/stemcells.2008-0122
   Rauch U, 2004, CELL MOL LIFE SCI, V61, P2031, DOI 10.1007/s00018-004-4043-x
   Riquelme PA, 2008, PHILOS T R SOC B, V363, P123, DOI 10.1098/rstb.2006.2016
   Roberts JJ, 2014, BIOMACROMOLECULES, V15, P1132, DOI 10.1021/bm401524h
   Rosines E, 2007, BIOMATERIALS, V28, P4806, DOI 10.1016/j.biomaterials.2007.07.034
   Ruff CA, 2012, EXP NEUROL, V235, P78, DOI 10.1016/j.expneurol.2011.02.010
   Ruffini F, 2004, AM J PATHOL, V164, P1519, DOI 10.1016/S0002-9440(10)63709-1
   Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489
   Ruppert SM, 2014, IMMUNOL RES, V58, P186, DOI 10.1007/s12026-014-8495-2
   Schizas N, 2014, J BIOMATER APPL, V28, P825, DOI 10.1177/0885328213483636
   Scott JE, 2002, BIOMACROMOLECULES, V3, P547, DOI 10.1021/bm010170j
   Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359
   Segura T, 2005, BIOMATERIALS, V26, P1575, DOI 10.1016/j.biomaterials.2004.05.007
   Seidlits SK, 2013, EXPERT OPIN DRUG DEL, V10, P499, DOI 10.1517/17425247.2013.764864
   Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125
   Seidlits SK, 2009, ADV FUNCT MATER, V19, P3543, DOI 10.1002/adfm.200901115
   Senkov O, 2014, PROG BRAIN RES, V214, P53, DOI 10.1016/B978-0-444-63486-3.00003-7
   Setzu A, 2006, GLIA, V54, P297, DOI 10.1002/glia.20371
   Shepard JA, 2012, BIOMATERIALS, V33, P7412, DOI 10.1016/j.biomaterials.2012.06.081
   Sherman LS, 2008, TRENDS NEUROSCI, V31, P44, DOI 10.1016/i.tins.2007.11.001
   Shin T, 2005, BRAIN RES, V1041, P95, DOI 10.1016/j.brainres.2005.02.019
   Shu XZ, 2006, J BIOMED MATER RES A, V79A, P902, DOI 10.1002/jbm.a.30831
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128
   Slevin M, 1998, LAB INVEST, V78, P987
   Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261
   Sloane JA, 2010, P NATL ACAD SCI USA, V107, P11555, DOI 10.1073/pnas.1006496107
   Sontag CJ, 2014, STEM CELL REP, V2, P620, DOI 10.1016/j.stemcr.2014.03.005
   Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009
   Stowers RS, 2015, P NATL ACAD SCI USA, V112, P1953, DOI 10.1073/pnas.1421897112
   Struve J, 2005, GLIA, V52, P16, DOI 10.1002/glia.20215
   Suttkus A, 2016, MOL NEUROBIOL, V53, P73, DOI 10.1007/s12035-014-8990-4
   Takahashi Y, 2005, J BIOL CHEM, V280, P24195, DOI 10.1074/jbc.M411913200
   Talbott JF, 2005, EXP NEUROL, V192, P11, DOI 10.1016/j.expneurol.2004.05.038
   Tang SQ, 2007, J BIOMED MATER RES A, V82A, P323, DOI 10.1002/jbm.a.30974
   Teixeira AI, 2007, CELL RES, V17, P56, DOI 10.1038/sj.cr.7310414
   Teixeira AI, 2009, BIOMATERIALS, V30, P4567, DOI 10.1016/j.biomaterials.2009.05.013
   Thomas AM, 2013, BIOMATERIALS, V34, P2213, DOI 10.1016/j.biomaterials.2012.12.002
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Tian WM, 2005, J CONTROL RELEASE, V102, P13, DOI 10.1016/j.jconrel.2004.09.025
   Tibbitt MW, 2013, MACROMOLECULES, V46, P2785, DOI 10.1021/ma302522x
   Tokatlian T, 2015, ADV HEALTHC MATER, V4, P1084, DOI 10.1002/adhm.201400783
   Tokatlian T, 2014, BIOMATERIALS, V35, P825, DOI 10.1016/j.biomaterials.2013.10.014
   Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Toole BP, 2008, DRUG RESIST UPDATE, V11, P110, DOI 10.1016/j.drup.2008.04.002
   Toole BP, 2008, SEMIN CANCER BIOL, V18, P244, DOI 10.1016/j.semcancer.2008.03.009
   Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002
   Valenzuela JC, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0606
   Vedunova M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00149
   Vulic K, 2012, J AM CHEM SOC, V134, P882, DOI 10.1021/ja210638x
   Wakao N, 2011, NEUROSCI LETT, V488, P299, DOI 10.1016/j.neulet.2010.11.051
   Wallace M, 2014, CHEM-EUR J, V20, P16484, DOI 10.1002/chem.201405500
   Wang AM, 2014, J BIOL CHEM, V289, P9418, DOI 10.1074/jbc.M113.541441
   Wang DF, 2012, CELL TISSUE RES, V349, P147, DOI 10.1007/s00441-012-1375-y
   Wang J, 2012, NEUROSCIENCE, V210, P467, DOI 10.1016/j.neuroscience.2012.03.016
   Wang X., 2012, INTERFACE FOCUS
   Wang Y, 2011, PHARM RES-DORDR, V28, P1406, DOI 10.1007/s11095-011-0452-3
   Ward JA, 2003, AM J PATHOL, V162, P1403, DOI 10.1016/S0002-9440(10)64273-3
   Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11
   Wei YT, 2010, J BIOMED MATER RES B, V95B, P110, DOI 10.1002/jbm.b.31689
   WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340
   Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/nmat3101, 10.1038/NMAT3101]
   Xu KM, 2015, ACTA BIOMATER, V24, P159, DOI 10.1016/j.actbio.2015.06.026
   Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209
   Yang Y, 2011, DEV BIOL, V350, P127, DOI 10.1016/j.ydbio.2010.11.028
   Yao SL, 2013, PROG NAT SCI-MATER, V23, P103, DOI 10.1016/j.pnsc.2013.02.009
   YASUHARA O, 1994, BRAIN RES, V635, P269, DOI 10.1016/0006-8993(94)91448-6
   Zawko SA, 2010, ACTA BIOMATER, V6, P2415, DOI 10.1016/j.actbio.2010.02.021
   Zhang T, 2007, J BIOACT COMPAT POL, V22, P19, DOI 10.1177/0883911506074025
   Zhao C, 2009, J NEUROSCI RES, V87, P3447, DOI 10.1002/jnr.22231
   Zhong J, 2010, NEUROREHAB NEURAL RE, V24, P636, DOI 10.1177/1545968310361958
   ZHONG SP, 1994, BIOMATERIALS, V15, P359, DOI 10.1016/0142-9612(94)90248-8
   Zhu H, 2006, STEM CELLS, V24, P928, DOI 10.1634/stemcells.2005-0186
   Zimmermann DR, 2008, HISTOCHEM CELL BIOL, V130, P635, DOI 10.1007/s00418-008-0485-9
NR 248
TC 6
Z9 6
U1 3
U2 44
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 40
BP 7850
EP 7866
DI 10.1039/c5tb00974j
PG 17
WC Materials Science, Biomaterials
SC Materials Science
GA CT2VO
UT WOS:000362663000004
DA 2018-10-19
ER

PT J
AU Fan, CJ
   Wang, DA
AF Fan, Changjiang
   Wang, Dong-An
TI Potential use of alginate beads as a chondrocyte delivery vehicle and
   stepwise dissolving porogen in a hydrogel scaffold for cartilage tissue
   engineering
SO RSC ADVANCES
LA English
DT Article
ID DEGRADABLE PEG HYDROGELS; ARTICULAR-CARTILAGE; HYALURONIC-ACID;
   STEM-CELLS; IN-VITRO; SYSTEM; ENCAPSULATION; BIOMATERIAL; CULTURE
AB The submicron- or nano-sized pores and uncontrollable degradation of conventional hydrogels have severely constrained cell growth and neo-tissue formation. In this study, alginate beads are explored as both delivery vehicles of chondrocytes and stimuli-responsive porogens within hydrogel scaffolds for cartilage tissue engineering. A typical chondroitin sulfate (CS)-alginate beads composite gel (CS-ABG) is fabricated by photo-encapsulating alginate beads into the CS gel, and subsequently batch-wise dissolution and leaching out of the alginate beads is achieved by twice exposing CS-ABG to chelating agents. The combining and gradual removal of alginate beads effectively modulate the gel's physical properties (e.g. swelling ratio, crosslink density) as well as create macro-scale cavities within CS-ABG. The efficacy of CS-ABG as a scaffold for cartilage tissue engineering is compared with a conventional photocrosslinked CS gel (CS-G). The CS-ABG constructs are developed by co-encapsulating chondrocytes and cell-laden alginate beads within the CS gel body and undergo EDTA treatment on day 7 and 14 of culture, respectively, for stepwise removal of the alginate beads. The chondrocytes cultured in CS-ABG constructs exhibit higher cell viability and proliferation, enhanced cartilage-specific gene expressions as well as ECM production compared with those in CS-G constructs. This study demonstrates the potential of alginate beads as cell delivery vehicles and gradually dissolving porogens within gel scaffolds for cartilage tissue engineering.
C1 [Fan, Changjiang; Wang, Dong-An] Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, Singapore 637457, Singapore.
   [Fan, Changjiang] Qingdao Univ, Inst Translat Med, Coll Med, Qingdao 266071, Peoples R China.
RP Wang, DA (reprint author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, 70 Nanyang Dr, Singapore 637457, Singapore.
EM DAWang@ntu.edu.sg
RI Wang, Dong-an/G-6195-2010
FU NSFC, China [51328301]; AcRF Tier 2, Ministry of Education, Singapore
   [ARC 1/13]
FX The work is financially supported by AcRF Tier 2 ARC 1/13, Ministry of
   Education, Singapore, and NSFC (51328301), China.
CR Atzet S, 2008, BIOMACROMOLECULES, V9, P3370, DOI 10.1021/bm800686h
   Bryant SJ, 2004, MACROMOLECULES, V37, P6726, DOI 10.1021/ma0499324
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Collins MN, 2013, CARBOHYD POLYM, V92, P1262, DOI 10.1016/j.carbpol.2012.10.028
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Fan CJ, 2015, EUR POLYM J, V72, P651, DOI 10.1016/j.eurpolymj.2015.02.038
   Fan CJ, 2015, MACROMOL BIOSCI, V15, P535, DOI 10.1002/mabi.201400453
   Fan CJ, 2013, J MATER CHEM B, V1, P4251, DOI 10.1039/c3tb20600a
   Gong YH, 2010, TISSUE ENG PT A, V16, P3611, DOI [10.1089/ten.tea.2010.0219, 10.1089/ten.TEA.2010.0219]
   Han LH, 2013, BIOMATERIALS, V34, P4251, DOI 10.1016/j.biomaterials.2013.02.051
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   Hwang CM, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035003
   Hwang YS, 2009, BIOMATERIALS, V30, P499, DOI 10.1016/j.biomaterials.2008.07.028
   Jin R, 2010, BIOMATERIALS, V31, P3103, DOI 10.1016/j.biomaterials.2010.01.013
   Khalil M, 2001, J HEPATOL, V34, P68, DOI 10.1016/S0168-8278(00)00080-5
   Kim J, 2014, MACROMOL RAPID COMM, V35, P1578, DOI 10.1002/marc.201400278
   Lau TT, 2013, BIOMATERIALS, V34, P6659, DOI 10.1016/j.biomaterials.2013.05.034
   Lee DA, 2003, ACTA ORTHOP SCAND, V74, P6, DOI 10.1080/00016470310013581
   Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050
   Leong W, 2013, ACTA BIOMATER, V9, P6459, DOI 10.1016/j.actbio.2012.10.047
   Loening AM, 2000, ARCH BIOCHEM BIOPHYS, V381, P205, DOI 10.1006/abbi.2000.1988
   Ma HL, 2003, J BIOMED MATER RES A, V64A, P273, DOI 10.1002/jbm.a.10370
   Metters A, 2005, BIOMACROMOLECULES, V6, P290, DOI 10.1021/bm049607o
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nuttelman CR, 2008, PROG POLYM SCI, V33, P167, DOI 10.1016/j.progpolymsci.2007.09.006
   Ochi M, 2004, ARTIF ORGANS, V28, P28, DOI 10.1111/j.1525-1594.2004.07317.x
   Oliveira JT, 2010, J BIOMED MATER RES A, V93A, P852, DOI 10.1002/jbm.a.32574
   Rayment P, 2009, FOOD HYDROCOLLOID, V23, P816, DOI 10.1016/j.foodhyd.2008.04.011
   Rocher V, 2008, WATER RES, V42, P1290, DOI 10.1016/j.watres.2007.09.024
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Simon TM, 2006, SPORTS MED ARTHROSC, V14, P146, DOI 10.1097/00132585-200609000-00006
   Skaalure SC, 2014, ACTA BIOMATER, V10, P3409, DOI 10.1016/j.actbio.2014.04.013
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   Strehin I, 2010, BIOMATERIALS, V31, P2788, DOI 10.1016/j.biomaterials.2009.12.033
   Su K, 2012, ADV FUNCT MATER, V22, P972, DOI 10.1002/adfm.201102884
   Temenoff JS, 2004, BIOMACROMOLECULES, V5, P5, DOI 10.1021/bm030067p
   Wang CC, 2011, BIOMATERIALS, V32, P7118, DOI 10.1016/j.biomaterials.2011.06.018
   Wang DA, 2003, BIOMATERIALS, V24, P3969, DOI 10.1016/S0142-9612(03)00280-1
   Zhang C, 2011, ACTA BIOMATER, V7, P3362, DOI 10.1016/j.actbio.2011.05.024
   Zhang C, 2009, SOFT MATTER, V5, P3831, DOI 10.1039/b912102a
   Zhu HG, 2005, BIOMACROMOLECULES, V6, P2221, DOI 10.1021/bm0501656
NR 43
TC 2
Z9 2
U1 7
U2 34
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 98
BP 80688
EP 80697
DI 10.1039/c5ra15376j
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA CS9KK
UT WOS:000362409800078
DA 2018-10-19
ER

PT J
AU Silveira, CP
   Apolinario, LM
   Favaro, WJ
   Paula, AJ
   Duran, N
AF Silveira, C. P.
   Apolinario, L. M.
   Favaro, W. J.
   Paula, A. J.
   Duran, N.
TI Hybrid biomaterial based on porous silica nanoparticles and Pluronic
   F-127 for sustained release of sildenafil: in vivo study on prostate
   cancer
SO RSC ADVANCES
LA English
DT Article
ID DRUG-DELIVERY; PROTEIN CORONA; SIZE; EFFICACY; SYSTEM; BIOCOMPATIBILITY;
   BIODISTRIBUTION; CLASSIFICATION; STABILIZATION; NANOCARRIERS
AB We describe here a drug depot hydrogel system comprising sildenafil (SIL; commercially available as Viagra (R)) incorporated in mesoporous silica nanoparticles (MSNs; around 60 nm of diameter) and conjugated with a thermosensitive poloxamer (Pluronic F-127 or PF127; possessing a liquid-gel transition over a determined temperature). The conjugation of these components results in an anticancer biomaterial with optimized physico-chemical properties: (i) MSNs are colloidally stabilized mainly through repulsive depletion forces manifested in PF127 concentrations above 5 wt%; (ii) the gelation temperature of the systems is set to about 20 degrees C (attained with 18 wt% of PF127) in order to result in prompt gelation when they are intraperitoneally administered (in rats) as liquids; (iii) and the hydrogel is able to induce a prolonged release of MSNs + SIL. After testing these new formulations against chemically induced prostate cancer in rats, the histopathological analyses of the prostate showed that the hybrid systems were able to largely reduce the prostate tumor level, and also highlighted the role of the MSNs in this process, since the improvement of the tumor condition was proportional to the nanoparticles concentration.
C1 [Silveira, C. P.; Duran, N.] Univ Estadual Campinas UNICAMP, Inst Chem, Campinas, SP, Brazil.
   [Apolinario, L. M.; Favaro, W. J.] Univ Estadual Campinas UNICAMP, Dept Struct Funct Biol, Campinas, SP, Brazil.
   [Favaro, W. J.; Duran, N.] Farmabrasilis R&D Div, Campinas, SP, Brazil.
   [Paula, A. J.] Univ Fed Ceara, Dept Fis, Solid Biol Interface Grp SolBIN, Fortaleza, Ceara, Brazil.
   [Favaro, W. J.; Duran, N.] Univ Estadual Campinas UNICAMP, Inst Chem, NanoBioss, Campinas, SP, Brazil.
RP Paula, AJ (reprint author), Univ Fed Ceara, Dept Fis, Solid Biol Interface Grp SolBIN, Fortaleza, Ceara, Brazil.
EM amaurijp@gmail.com; duran@iqm.unicamp.br
RI UFC, DF/E-1564-2017; Paula, Amauri/D-9254-2011; Universidade Federal do
   Ceara, Physics Department/J-4630-2016
OI Paula, Amauri/0000-0002-3113-2597; Universidade Federal do Ceara,
   Physics Department/0000-0002-9247-6780; Apolinario, Leticia
   Montanholi/0000-0003-1627-4973; Duran, Nelson/0000-0001-8372-5143;
   Favaro, Wagner/0000-0001-5830-8938
FU FAPESP; CNPq; INOMAT (MCTI/CNPq); FUNCAP; NanoBioss (MCTI); Brazilian
   Network of Nanotoxicology (MCTI/CNPq)
FX Support from FAPESP, CNPq, INOMAT (MCTI/CNPq), FUNCAP, NanoBioss (MCTI)
   and the Brazilian Network of Nanotoxicology (MCTI/CNPq) are
   acknowledged.
CR ALEXANDRIDIS P, 1995, COLLOID SURFACE A, V96, P1, DOI 10.1016/0927-7757(94)03028-X
   Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Boorjian SA, 2008, J UROLOGY, V179, P1354, DOI 10.1016/j.juro.2007.11.061
   Cauda V, 2009, J AM CHEM SOC, V131, P11361, DOI 10.1021/ja809346n
   Chen F, 2014, MOL PHARMACEUT, V11, P4007, DOI 10.1021/mp500306k
   Chen F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05080
   Crocker JC, 1999, PHYS REV LETT, V82, P4352, DOI 10.1103/PhysRevLett.82.4352
   Das A, 2010, P NATL ACAD SCI USA, V107, P18202, DOI 10.1073/pnas.1006965107
   Djavan B, 2001, J UROLOGY, V166, P1679, DOI 10.1016/S0022-5347(05)65652-2
   Dumortier G, 2006, PHARM RES, V23, P2709, DOI 10.1007/s11095-006-9104-4
   Favaro W. J., 2014, Br. Pat., Patent No. [10 2014 023118 8, 1020140231188]
   Fu CH, 2013, BIOMATERIALS, V34, P2565, DOI 10.1016/j.biomaterials.2012.12.043
   Heilmann S, 2013, INT J PHARMACEUT, V444, P96, DOI 10.1016/j.ijpharm.2013.01.027
   Hudson SP, 2008, BIOMATERIALS, V29, P4045, DOI 10.1016/j.biomaterials.2008.07.007
   Ibrahim EA, 2012, ACTA PHARMACEUT, V62, P59, DOI 10.2478/v10007-012-0009-y
   Kecht J, 2008, CHEM MATER, V20, P7207, DOI 10.1021/cm801484r
   Li SH, 2013, LANGMUIR, V29, P5742, DOI 10.1021/la401056t
   Liong M, 2008, ACS NANO, V2, P889, DOI 10.1021/nn800072t
   Lu J., 2010, NANOMEDICINE, V8, P212
   Lu J, 2007, SMALL, V3, P1341, DOI 10.1002/smll.200700005
   Lu J, 2010, SMALL, V6, P1794, DOI 10.1002/smll.201000538
   Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105
   Maeda H, 2002, BIOMEDICAL ASPECTS OF DRUG TARGETING, P211
   Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5
   Mai WX, 2013, INTEGR BIOL-UK, V5, P19, DOI 10.1039/c2ib20137b
   Meng H, 2011, ACS NANO, V5, P4131, DOI 10.1021/nn200809t
   Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6
   MIYAZAKI S, 1986, CHEM PHARM BULL, V34, P1801
   Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/NNANO.2012.207, 10.1038/nnano.2012.207]
   Monopoli MP, 2011, NAT NANOTECHNOL, V6, P11, DOI 10.1038/nnano.2011.267
   MORIKAWA K, 1987, CANCER RES, V47, P37
   Nakanishi K, 2005, HANDBOOK OF SOL-GEL SCIENCE AND TECHNOLOGY: PROCESSING CHARACTERIZATION AND APPLICATIONS, VOL. II: CHARACTERIZATION AND PROPERTIES OF SOL-GEL MATERIALS AND PRODUCTS, P191
   Padilla M, 2000, J AM DENT ASSOC, V131, P184, DOI 10.14219/jada.archive.2000.0146
   Padovani GC, 2015, J PHYS CHEM C, V119, P18741, DOI 10.1021/acs.occ.5b04274
   Paula AJ, 2014, ACS APPL MATER INTER, V6, P3437, DOI 10.1021/am405594q
   Paula AJ, 2013, ACS APPL MATER INTER, V5, P8387, DOI 10.1021/am4014693
   Paula AJ, 2012, J BRAZIL CHEM SOC, V23, P1807, DOI 10.1590/S0103-50532012005000048
   Paula AJ, 2012, CHEM COMMUN, V48, P591, DOI 10.1039/c1cc16535f
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   Pragatheeswaran AM, 2013, LANGMUIR, V29, P9694, DOI 10.1021/la401639g
   Sarfati M, 2003, BLOOD, V101, P265, DOI 10.1182/blood-2002-01-0075
   Serafini P, 2006, J EXP MED, V203, P2691, DOI 10.1084/jem.20061104
   Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946
   Shi Z, 2011, CANCER RES, V71, P3735, DOI 10.1158/0008-5472.CAN-11-0375
   STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5
   Tang L, 2013, MOL PHARMACEUT, V10, P883, DOI 10.1021/mp300684a
   Tao ZM, 2010, ACS NANO, V4, P789, DOI 10.1021/nn9015345
   Xie M, 2014, INT J PHARMACEUT, V474, P223, DOI 10.1016/j.ijpharm.2014.08.027
   Yuan L, 2011, J PHYS CHEM C, V115, P9926, DOI 10.1021/jp201053d
   Zhang Q, 2014, ADV FUNCT MATER, V24, P2450, DOI 10.1002/adfm.201302988
   Zhang X, 2012, J AM CHEM SOC, V134, P9910, DOI 10.1021/ja303787e
NR 51
TC 3
Z9 3
U1 3
U2 27
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 99
BP 81348
EP 81355
DI 10.1039/c5ra15006j
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CS9UB
UT WOS:000362436800055
DA 2018-10-19
ER

PT J
AU Ma, T
   Ge, XY
   Jia, SN
   Jiang, X
   Zhang, Y
   Lin, Y
AF Ma, Ting
   Ge, Xi-Yuan
   Jia, Sheng-Nan
   Jiang, Xi
   Zhang, Yu
   Lin, Ye
TI The influence of titanium surfaces treated by alkalis on macrophage and
   osteoblast-like cell adhesion and gene expression in vitro
SO RSC ADVANCES
LA English
DT Article
ID BONE-FORMATION; BIOMATERIAL SURFACES; IMPLANT SURFACES; DENTAL IMPLANTS;
   WEAR PARTICLES; TNF-ALPHA; DIFFERENTIATION; OSSEOINTEGRATION;
   HYDROPHILICITY; MICROROUGHNESS
AB Achieving fast and long-term osseointegration is one of the major goals in dental implant design. Physic-chemical surface modification is a key to osseointegration improvement. Two types of alkaline modifications, 1 M sodium bicarbonate and 0.05 M sodium hydroxide, were applied on the sand-blasting and acid etching (SLA) titanium surface. After the alkaline treatments, superhydrophilic SLA surfaces were produced. The mRNA expression level of IL-1 beta of Raw264.7 cells cultured on the sodium bicarbonate treated SLA surface was inhibited compared with SLA and sodium hydroxide treated surfaces, while MMP-9 expression on the sodium hydroxide treated SLA surface was increased with comparison to SLA and sodium bicarbonate treated surfaces. Cell adhesion of osteoblast-like MG63 cells on surfaces with alkaline treatments were moderately more pronounced than that on the SLA surface. With comparison to SLA surface, the proliferation of MG63 cells was decreased, while the alkaline phosphatase (ALP) activity was enhanced on the sodium bicarbonate treated SLA surface after 3 days. An increased mRNA expression level of integrin alpha(v) of MG63 cells were observed on the alkali treated surfaces compared with the SLA surface. Integrin beta 1, osteocalcin (OCN) and bone morphogenetic protein-2 (BMP-2) were enhanced on the sodium bicarbonate treated SLA surface when compared to the SLA surface. The results imply that the inflammation-related gene expression of macrophage cells is changed on sodium hydroxide and sodium bicarbonate treated SLA surfaces; the early adhesion of osteoblast-like cells is enhanced by both alkaline treatments, while the osteogenic differentiation is improved on sodium bicarbonate treated surface.
C1 [Ma, Ting; Jia, Sheng-Nan; Jiang, Xi; Zhang, Yu; Lin, Ye] Peking Univ, Sch Stomatol, Dept Oral Implantol, Beijing 100081, Peoples R China.
   [Ge, Xi-Yuan] Peking Univ, Sch & Hosp Stomatol, Cent Lab, Beijing 100081, Peoples R China.
RP Zhang, Y (reprint author), Peking Univ, Sch Stomatol, Dept Oral Implantol, Beijing 100081, Peoples R China.
EM zhang76yu@163.com; yorcklin@263.net
OI Jia, Shengnan/0000-0002-5673-7744
FU National Basic Research Program of China (973 Program) [2012CB933900]
FX This study was supported by a Grant from the National Basic Research
   Program of China (973 Program-2012CB933900) and the authors gratefully
   thank for the Central Laboratory of Peking University School of
   Stomatology. Titanium substrates were generously provided by Wego (Wego
   Jericom Biomaterials Co., Weihai, China). Technical assistance of
   engineer Jishu Yin (Wego Jericom Biomaterials Co., Weihai, China) is
   gratefully acknowledged.
CR Al Mustafa M, 2015, CLIN ORAL IMPLAN RES, V26, P15, DOI 10.1111/clr.12294
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Borras T, 2009, EXP EYE RES, V88, P738, DOI 10.1016/j.exer.2008.11.027
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Calvo-Guirado JL, 2010, CLIN ORAL IMPLAN RES, V21, P308, DOI 10.1111/j.1600-0501.2009.01841.x
   Chiapasco M, 2004, INT J ORAL MAX IMPL, V19, P76
   Chug A, 2013, J ORAL MAX SURG MED, V25, P1, DOI 10.1016/j.ajoms.2012.01.008
   Cochran DL, 1999, J PERIODONTOL, V70, P139, DOI 10.1902/jop.1999.70.2.139
   Colnot C, 2007, J DENT RES, V86, P862, DOI 10.1177/154405910708600911
   Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049
   De Jong PT, 2011, ACTA HISTOCHEM, V113, P556, DOI 10.1016/j.acthis.2010.06.001
   Feller L., 2015, BIOMED RES INT, V2015, P1
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Gardner AB, 2013, BIOMED RES INT, DOI 10.1155/2013/732182
   Gittens RA, 2014, ACTA BIOMATER, V10, P3363, DOI 10.1016/j.actbio.2014.03.037
   Gittens RA, 2014, ACTA BIOMATER, V10, P2907, DOI 10.1016/j.actbio.2014.03.032
   Goodman SB, 2007, BIOMATERIALS, V28, P5044, DOI 10.1016/j.biomaterials.2007.06.035
   Goodman SB, 2013, BIOMATERIALS, V34, P3174, DOI 10.1016/j.biomaterials.2013.01.074
   Gu Y, 2010, FEMS IMMUNOL MED MIC, V58, P218, DOI 10.1111/j.1574-695X.2009.00625.x
   Hamlet S., COMMUNICATION
   Hamlet S, 2011, ACTA BIOMATER, V7, P2345, DOI 10.1016/j.actbio.2011.01.032
   Huynh-Ba G, 2008, CLIN ORAL IMPLAN RES, V19, P1154, DOI 10.1111/j.1600-0501.2008.01596.x
   Jiang ZL, 2013, DIS MARKERS, V34, P295, DOI 10.3233/DMA-130974
   Keselowsky BG, 2007, J BIOMED MATER RES A, V80A, P700, DOI 10.1002/jbm.a.30898
   Klein MO, 2013, CLIN IMPLANT DENT R, V15, P166, DOI 10.1111/j.1708-8208.2011.00339.x
   Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI 10.1089/ten.TEB.2009.0687
   Lee JS, 2014, J PERIODONTAL IMPLAN, V44, P242, DOI 10.5051/jpis.2014.44.5.242
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004
   Milleret V, 2011, EUR CELLS MATER, V21, P430, DOI 10.22203/eCM.v021a32
   Moussa FM, 2014, J CELL BIOCHEM, V115, P1243, DOI 10.1002/jcb.24760
   Omar O, 2010, J MATER SCI-MATER M, V21, P969, DOI 10.1007/s10856-009-3915-x
   Osta B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00048
   Ram V. S., 2015, J CLIN DIAGN RES, V9
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Schwarz F, 2009, J BIOMED MATER RES B, V88B, P544, DOI 10.1002/jbm.b.31233
   SMITH DE, 1989, J PROSTHET DENT, V62, P567, DOI 10.1016/0022-3913(89)90081-4
   Song WL, 2013, SOFT MATTER, V9, P2985, DOI 10.1039/c3sm27739a
   Song WL, 2009, ADV MATER, V21, P1830, DOI 10.1002/adma.200803680
   Stadlinger B, 2012, BRIT J ORAL MAX SURG, V50, P74, DOI 10.1016/j.bjoms.2010.11.013
   Tan KS, 2006, BIOMATERIALS, V27, P5170, DOI 10.1016/j.biomaterials.2006.05.002
   Tugulu S, 2010, J MATER SCI-MATER M, V21, P2751, DOI 10.1007/s10856-010-4138-x
   Vlacic-Zischke J, 2011, BIOMATERIALS, V32, P665, DOI 10.1016/j.biomaterials.2010.09.025
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wall I, 2009, BONE, V45, P17, DOI 10.1016/j.bone.2009.03.662
   Wang XK, 2015, J BIOMED MATER RES A, V103, P1907, DOI 10.1002/jbm.a.35323
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
NR 49
TC 2
Z9 2
U1 2
U2 16
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 99
BP 81378
EP 81387
DI 10.1039/c5ra10701f
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA CS9UB
UT WOS:000362436800059
DA 2018-10-19
ER

PT J
AU Duan, HB
   Ma, YJ
   Liu, X
   Hao, LJ
   Zhao, NR
AF Duan, Haibo
   Ma, Yijuan
   Liu, Xiao
   Hao, Lijing
   Zhao, Naru
TI Hierarchically nanostructured hydroxyapatite microspheres as drug
   delivery carriers and their effects on cell viability
SO RSC ADVANCES
LA English
DT Article
ID MESOPOROUS BIOACTIVE GLASSES; IN-VITRO RELEASE; HYDROTHERMAL SYNTHESIS;
   GROWTH-PROCESS; GENTAMICIN; CARBONATE; BONE; FABRICATION; PHOSPHATE;
   PROPERTY
AB Hydroxyapatite microspheres (HAMSs) were fabricated via hydrothermal synthesis using propionamide (PA) as a pH-adjusting agent and trisodium citrate (TSC) as a regulating agent. Scanning electron microscopy (SEM) images indicated that the microspheres possessed well-defined 3D nanostructures constructed by nanoplates as building blocks. In vitro cell tests demonstrated that the HAMSs with or without heat treatment were able to promote the proliferation of mouse bone mesenchymal stem cells (mBMSCs). Gentamicin sulphate (GS), an anti-inflammatory, was successfully loaded in the HAMS particles at a distinctively high loading efficiency of approximately 87%. The resultant HAMS-GS delivery systems displayed a sustained release property, and the release of GS from the HAMS-B-GS500 system could significantly inhibit S. epidermidis growth. Moreover, the biocompatibility tests indicated that the HAMS-B-GS500 system exhibited excellent biocompatibility and had no toxic effects on the mBMSCs. These outstanding characteristics may make HAMSs a good candidate as an injectable and drug-loading biomaterial for in vivo tissue regeneration and drug control release.
C1 [Duan, Haibo; Ma, Yijuan; Liu, Xiao; Hao, Lijing; Zhao, Naru] S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
   [Duan, Haibo; Ma, Yijuan; Liu, Xiao; Hao, Lijing; Zhao, Naru] Nation Engn Res Ctr Tissue Restorat & Reconstruct, Guangzhou 510006, Guangdong, Peoples R China.
RP Zhao, NR (reprint author), S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
EM nrzhao@scut.edu.cn
FU National Basic Research Programme of China [2012CB619100]; National
   Natural Science Foundation of China [51232002]; Science and Technology
   Programme of Guangdong Province [2012A061100002]; Fundamental Research
   Funds for the Central Universities [2015ZZ009]
FX The authors sincerely thank Professor Xuetao Shi, South China University
   of Technology, Guangzhou, China, for his kind help on the preparation of
   this manuscript. This work was financially supported by the National
   Basic Research Programme of China (Grant No. 2012CB619100), the National
   Natural Science Foundation of China (Grant No. 51232002), the Science
   and Technology Programme of Guangdong Province (Grant No.
   2012A061100002) and the Fundamental Research Funds for the Central
   Universities (Grant No. 2015ZZ009).
CR ANABEL LM, 1998, ADV MATER, V10, P49
   Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5
   Aviv M, 2007, J BIOMED MATER RES A, V83A, P10, DOI 10.1002/jbm.a.31184
   Cai YR, 2008, J MATER CHEM, V18, P3775, DOI 10.1039/b805407j
   Chen JD, 2015, COLLOID SURFACE B, V127, P47, DOI 10.1016/j.colsurfb.2014.12.055
   Cho JS, 2008, J ALLOY COMPD, V464, P282, DOI 10.1016/j.jallcom.2007.09.092
   Culpepper BK, 2013, BIOMATERIALS, V34, P2455, DOI 10.1016/j.biomaterials.2012.12.026
   Dallari D, 2012, BIOMATERIALS, V33, P72, DOI 10.1016/j.biomaterials.2011.09.029
   Eimar H, 2012, ACTA BIOMATER, V8, P3400, DOI 10.1016/j.actbio.2012.06.002
   Fleet ME, 2003, J SOLID STATE CHEM, V174, P412, DOI 10.1016/S0022-4596(03)00281-0
   Govindan R, 2014, J MATER CHEM B, V2, P5468, DOI 10.1039/c4tb00549j
   GRANT RL, 1992, TOXICOLOGY, V76, P153, DOI 10.1016/0300-483X(92)90162-8
   Guo YJ, 2013, MAT SCI ENG C-MATER, V33, P3166, DOI 10.1016/j.msec.2013.03.040
   Guo YP, 2014, J MATER CHEM B, V2, P2899, DOI 10.1039/c3tb21829e
   Guo YP, 2012, MICROPOR MESOPOR MAT, V155, P245, DOI 10.1016/j.micromeso.2012.01.037
   Guo YP, 2011, CHEM COMMUN, V47, P12215, DOI [10.1039/c1c15190h, 10.1039/c1cc15190h]
   Hao LJ, 2014, MATER LETT, V131, P252, DOI 10.1016/j.matlet.2014.05.193
   Hao LJ, 2014, POWDER TECHNOL, V253, P172, DOI 10.1016/j.powtec.2013.11.020
   Hong MH, 2011, J MATER SCI-MATER M, V22, P349, DOI 10.1007/s10856-010-4197-z
   Hutchens SA, 2006, BIOMATERIALS, V27, P4661, DOI 10.1016/j.biomaterials.2006.04.032
   Iafisco M, 2014, MAT SCI ENG C-MATER, V35, P212, DOI 10.1016/j.msec.2013.11.009
   Kniep R, 1996, ANGEW CHEM INT EDIT, V35, P2624, DOI 10.1002/anie.199626241
   Lacy MK, 1998, CLIN INFECT DIS, V27, P23, DOI 10.1086/514620
   Liu Y, 2012, BIOMATERIALS, V33, P8745, DOI 10.1016/j.biomaterials.2012.08.010
   Long T, 2013, RSC ADV, V3, P24169, DOI 10.1039/c3ra44497j
   Ma YJ, 2014, J INORG MATER, V29, P284, DOI 10.3724/SP.J.1077.2014.13271
   Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006
   Mizushima Y, 2006, J CONTROL RELEASE, V110, P260, DOI 10.1016/j.jconrel.2005.09.051
   OGINO T, 1987, GEOCHIM COSMOCHIM AC, V51, P2757, DOI 10.1016/0016-7037(87)90155-4
   Oyane A, 2012, ACTA BIOMATER, V8, P2034, DOI 10.1016/j.actbio.2012.02.003
   Qi C, 2013, CHEM-EUR J, V19, P5332, DOI 10.1002/chem.201203886
   REY C, 1991, CALCIFIED TISSUE INT, V49, P251, DOI 10.1007/BF02556214
   Ristic BZ, 2014, BIOMATERIALS, V35, P4428, DOI 10.1016/j.biomaterials.2014.02.014
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Sivakumar M, 2002, CARBOHYD POLYM, V49, P281, DOI 10.1016/S0144-8617(01)00331-9
   Sousa A, 2008, ACTA BIOMATER, V4, P671, DOI 10.1016/j.actbio.2007.11.003
   Sun RX, 2009, MAT SCI ENG C-BIO S, V29, P1088, DOI 10.1016/j.msec.2008.08.010
   Takai C, 2009, CHEM COMMUN, V37, P5533
   Virto MR, 2007, BIOMATERIALS, V28, P877, DOI 10.1016/j.biomaterials.2006.09.045
   Virto MR, 2003, BIOMATERIALS, V24, P79, DOI 10.1016/S0142-9612(02)00254-5
   Wu J, 2010, ADV MATER, V22, P749, DOI 10.1002/adma.200903020
   Wu TJ, 2004, BIOMATERIALS, V25, P651, DOI 10.1016/S0142-9612(03)00576-3
   Wu YJ, 2010, CRYST GROWTH DES, V10, P4240, DOI 10.1021/cg100859m
   Xia W, 2006, J CONTROL RELEASE, V110, P522, DOI 10.1016/j.jconrel.2005.11.002
   Xia W, 2008, EUR J PHARM BIOPHARM, V69, P546, DOI 10.1016/j.ejpb.2007.11.018
   Yang H, 2013, RSC ADV, V3, P23184, DOI 10.1039/c3ra44839h
   Yang H, 2013, MATER CHEM PHYS, V141, P488, DOI 10.1016/j.matchemphys.2013.05.048
   Yang H, 2013, CRYSTENGCOMM, V15, P5760, DOI 10.1039/c3ce40710a
   Yang LX, 2012, CERAM INT, V38, P495, DOI 10.1016/j.ceramint.2011.07.033
   Yang PP, 2009, BIOMATERIALS, V30, P4786, DOI [10.1016/j.biomaterials.2009.05.038, 10.1016/j.biomatetials.2009.05.038]
   Yu M, 2014, CERAM INT, V40, P12617, DOI 10.1016/j.ceramint.2014.04.100
   Zhang HB, 2009, J PHYS CHEM SOLIDS, V70, P243, DOI 10.1016/j.jpcs.2008.10.011
   Zhang WD, 2014, APPL SURF SCI, V322, P71, DOI 10.1016/j.apsusc.2014.10.064
   Zhao LZ, 2008, MICROPOR MESOPOR MAT, V109, P210, DOI 10.1016/j.micromeso.2007.04.041
NR 54
TC 11
Z9 11
U1 4
U2 36
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 101
BP 83522
EP 83529
DI 10.1039/c5ra11956a
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CS9UQ
UT WOS:000362438300099
DA 2018-10-19
ER

PT J
AU Gentile, P
   Ghione, C
   Tonda-Turo, C
   Kalaskar, DM
AF Gentile, P.
   Ghione, C.
   Tonda-Turo, C.
   Kalaskar, D. M.
TI Peptide functionalisation of nanocomposite polymer for bone tissue
   engineering using plasma surface polymerisation
SO RSC ADVANCES
LA English
DT Article
ID ACRYLIC-ACID; ORTHOPEDIC IMPLANTS; FIBROBLAST-GROWTH; ADHESION; CELLS;
   BIOMATERIALS; COATINGS; COLLAGEN; IMMOBILIZATION; MINERALIZATION
AB In this work, we explored the modification of a new nanocomposite polymer called POSS-PCU for its functionalisation with bone inducing peptides using a plasma surface polymerisation method for bone tissue engineering applications. KRSR and FHRRIKA peptides, which are heparin binding domains, have been shown before to induce cell adhesion and bone mineralisation. In this work a plasma surface polymerisation process was developed to graft biomimetic peptides on polymeric biomaterial. Plasma polymerisation and peptide coupling was confirmed using various techniques such as toluidine blue O assay, IR-spectroscopy and X-ray photon spectroscopy (XPS). Surface chemical analysis confirmed that 10 W power and 20 min of plasma treatment was optimum in order to obtain the highest grafting density of carboxyl groups, which were later used to attach bone biomimetic peptides via carbodiimide chemistry. IR-spectroscopy and XPS confirmed functionalisation with carboxyl and peptide grafting. Finally, preliminarily in vitro study with bone marrow mesenchymal stem cells was performed in order to assess the efficacy of peptide functionalised surfaces to promote differentiation into osteogenic lineage. Cell tests showed increased cell adhesion and osteoblastic differentiation on KRSR and FHRRIKA peptide modified samples. This study has implications for the design and development of a new generation of orthopedic implants using the plasma modification technique.
C1 [Gentile, P.] Newcastle Univ, Sch Mech & Syst Engn, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Ghione, C.; Tonda-Turo, C.] Politecn Torino, Dept Mech & Aerosp Engn, I-10129 Turin, Italy.
   [Kalaskar, D. M.] UCL, Ctr Nanotechnol & Tissue Engn, UCL Div Surg & Intervent Sci, London NW3 2PF, England.
RP Gentile, P (reprint author), Newcastle Univ, Sch Mech & Syst Engn, Stephenson Bldg,Claremont Rd, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM piergiorgio.gentile@ncl.ac.uk; d.kalaskar@ucl.ac.uk
OI Gentile, Piergiorgio/0000-0002-3036-6594
FU Marie Curie programme [FP7-PEOPLE-2011-IEF-302315-NBC-ReGen4]; UK EPSRC
   Centre for Innovative Manufacturing of Medical Devices (MeDe Innovation,
   EPSRC) [EP/K029592/1]; Engineering and Physical Sciences Research
   Council [EP/K029592/1]
FX The authors acknowledge the Marie Curie programme
   (FP7-PEOPLE-2011-IEF-302315-NBC-ReGen4 Grant) and the UK EPSRC Centre
   for Innovative Manufacturing of Medical Devices (MeDe Innovation, EPSRC
   grant EP/K029592/1) for financial support. Finally, thanks are also due
   to Prof Steven Armes and Dr Lee Fielding for access to ATR-FTIR. X-ray
   photoelectron spectra were obtained at the National EPSRC XPS User's
   Service (NEXUS) at Newcastle University, a UK EPSRC Mid-Range Facility.
CR Choi HS, 2004, SURF COAT TECH, V182, P55, DOI 10.1016/S0257-8972(02)00880-6
   Ciardelli G, 2010, J BIOMED MATER RES A, V92A, P137, DOI 10.1002/jbm.a.32344
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   Dupont KM, 2012, CELL TISSUE RES, V347, P575, DOI 10.1007/s00441-011-1197-3
   Elahi MF, 2014, MATERIALS, V7, P2956, DOI 10.3390/ma7042956
   Fortunati E, 2013, BIOMACROMOLECULES, V14, P626, DOI 10.1021/bm301524e
   Goodman SB, 2013, BIOMATERIALS, V34, P3174, DOI 10.1016/j.biomaterials.2013.01.074
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Hancock S., 2005, JOURNAL
   Harbers GM, 2005, J BIOMED MATER RES A, V75A, P855, DOI 10.1002/jbm.a.30482
   Hasenbein ME, 2002, BIOMATERIALS, V23, P3937, DOI 10.1016/S0142-9612(02)00129-1
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P467
   LIEBERMAN MA, 2005, PRINC PLASM DISCH, P1
   Liu Y, 2005, BONE, V36, P745, DOI 10.1016/j.bone.2005.02.005
   Mathews S, 2011, BIOCHEM BIOPH RES CO, V414, P270, DOI 10.1016/j.bbrc.2011.09.071
   Olbrich M, 2007, J BIOMAT SCI-POLYM E, V18, P453, DOI 10.1163/156856207780425059
   Punshon G, 2005, BIOMATERIALS, V26, P6271, DOI 10.1016/j.biomaterials.2005.03.034
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Santocildes-Romero ME, 2015, J TISSUE ENG REGEN M, V9, P619, DOI 10.1002/term.2003
   Schuler M, 2009, J BIOMED MATER RES B, V91B, P517, DOI 10.1002/jbm.b.31425
   Shen H, 2008, BIOMATERIALS, V29, P2388, DOI 10.1016/j.biomaterials.2008.02.008
   Solouk A, 2011, IRAN POLYM J, V20, P91
   Talreja Prakash S, 2013, J Indian Soc Periodontol, V17, P131, DOI 10.4103/0972-124X.107490
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Tan Aaron, 2013, Critical Reviews in Biomedical Engineering, V41, P495
   Tan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077112
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Wojtowicz AM, 2010, BIOMATERIALS, V31, P2574, DOI 10.1016/j.biomaterials.2009.12.008
   Wu J, 2009, POLYM REV, V49, P25, DOI 10.1080/15583720802656237
   Zaldivar RJ, 2010, J COMPOS MATER, V44, P1435, DOI 10.1177/0021998309355846
   Zhang BGX, 2014, INT J MOL SCI, V15, P11878, DOI 10.3390/ijms150711878
   Zitzmann NU, 2008, J CLIN PERIODONTOL, V35, P286, DOI 10.1111/j.1600-051X.2008.01274.x
NR 33
TC 13
Z9 13
U1 2
U2 39
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 97
BP 80039
EP 80047
DI 10.1039/c5ra15579g
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA CS1OC
UT WOS:000361834900093
DA 2018-10-19
ER

PT S
AU Ekdahl, KN
   Teramura, Y
   Asif, S
   Jonsson, N
   Magnusson, PU
   Nilsson, B
AF Ekdahl, Kristina N.
   Teramura, Yuji
   Asif, Sana
   Jonsson, Nina
   Magnusson, Peetra U.
   Nilsson, Bo
BE Lambris, JD
   Ekdahl, KN
   Ricklin, D
   Nilsson, B
TI Thromboinflammation in Therapeutic Medicine
SO IMMUNE RESPONSES TO BIOSURFACES: MECHANISMS AND THERAPEUTIC
   INTERVENTIONS
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 1st International Conference on Immune Response to Biosurfaces
CY SEP 27-OCT 02, 2014
CL Chania, GREECE
DE Coagulation; Complement; Extracorporeal treatment; Platelets;
   Therapeutic medicine; Thromboinflammation
ID CLINICAL ISLET TRANSPLANTATION; MEDIATED INFLAMMATORY REACTION;
   LEUKOCYTE INTEGRIN MAC-1; GLYCOPROTEIN IB-ALPHA; COMPLEMENT ACTIVATION;
   CONTACT ACTIVATION; WHOLE-BLOOD; VASCULAR INJURY; INHIBITS COMPLEMENT;
   BIOMATERIAL SURFACE
AB Thromboinflammation is primarily triggered by the humoral innate immune system, which mainly consists of the cascade systems of the blood, i.e., the complement, contact/coagulation and fibrinolytic systems. Activation of these systems subsequently induces activation of endothelial cells, leukocytes and platelets, finally resulting in thrombotic and inflammatory reactions. Such reactions are triggered by a number of medical procedures, e.g., treatment with biomaterials or drug delivery devices as well as in transplantation with cells, cell clusters or whole vascularized organs. Here, we (1) describe basic mechanisms for thromboinflammation; (2) review thromboinflammatory reactions in therapeutic medicine; and (3) discuss emerging strategies to dampen thromboinflammation.
C1 [Ekdahl, Kristina N.; Nilsson, Bo] Uppsala Univ, Immunol Genet & Pathol, Uppsala, Sweden.
   [Teramura, Yuji] Univ Tokyo, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan.
   [Asif, Sana; Jonsson, Nina; Magnusson, Peetra U.] Uppsala Univ, Dept Immunol Genet & Pathol IGP, Rudbeck Lab C5 3, S-75185 Uppsala, Sweden.
   [Jonsson, Nina] Linnaeus Univ, Linnaeus Ctr Biomat Chem, S-39182 Kalmar, Sweden.
RP Ekdahl, KN (reprint author), Uppsala Univ, Immunol Genet & Pathol, Uppsala, Sweden.
EM Kristina.Nilsson_Ekdahl@igp.uu.se
RI Nilsson Ekdahl, Kristina/B-5301-2012; Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730
FU Swedish Research Council (VR) [2013-65X-05647-34-4]; European Community
   [602699]; Carl Tryggers Foundation; Swedish Foundation for International
   Cooperation in Research and Higher Education (STINT); Bilateral Joint
   Research Projects (Japan-Sweden) of the Japan Society for the Promotion
   of Science (JSPS); AFA Insurance; Linnaeus University
FX We thank Dr. Deborah McClellan for excellent editorial assistance. This
   work was supported by grant 2013-65X-05647-34-4 from the Swedish
   Research Council (VR), the European Community's Seventh Framework
   Programme under the grant agreement no. 602699 (DIREKT), the Carl
   Tryggers Foundation, the Swedish Foundation for International
   Cooperation in Research and Higher Education (STINT), the Bilateral
   Joint Research Projects (Japan-Sweden) of the Japan Society for the
   Promotion of Science (JSPS), and from the AFA Insurance. AFA is a
   nonprofit insurance company that is jointly owned by the Swedish Labor
   Organization and the Swedish Employers Organization, and faculty grants
   from the Linnaeus University.
CR Andersson J, 2006, J BIOMED MATER RES A, V76A, P25, DOI 10.1002/jbm.a.30377
   Andersson J, 2001, BIOMATERIALS, V22, P2435, DOI 10.1016/S0142-9612(00)00431-2
   Back J, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4399
   Back J, 2010, BIOCHEM BIOPH RES CO, V391, P11, DOI 10.1016/j.bbrc.2009.10.123
   Back J, 2009, BIOMATERIALS, V30, P6573, DOI 10.1016/j.biomaterials.2009.07.052
   Buergler JM, 2005, J THROMB THROMBOLYS, V19, P115, DOI 10.1007/s11239-005-1381-y
   Cai M, 2011, J MOL CELL CARDIOL, V51, P927, DOI 10.1016/j.yjmcc.2011.09.003
   Cavalli A, 2010, MINERVA UROL NEFROL, V62, P1
   Chavakis T, 2003, J BIOL CHEM, V278, P45375, DOI 10.1074/jbc.M304344200
   Chien HW, 2012, BIOMATERIALS, V33, P5706, DOI 10.1016/j.biomaterials.2012.04.031
   Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218
   Crikis S, 2010, AM J TRANSPLANT, V10, P2586, DOI 10.1111/j.1600-6143.2010.03257.x
   Croix DA, 1996, J EXP MED, V183, P1857, DOI 10.1084/jem.183.4.1857
   Dwyer KM, 2004, J CLIN INVEST, V113, P1440, DOI 10.1172/JCI200419560
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066
   Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891
   Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507
   Engberg AE, 2015, BIOMATERIALS, V36, P55, DOI 10.1016/j.biomaterials.2014.09.011
   Engberg AE, 2011, J BIOMED MATER RES A, V97A, P74, DOI 10.1002/jbm.a.33030
   Engberg AE, 2009, BIOMATERIALS, V30, P2653, DOI 10.1016/j.biomaterials.2009.01.001
   Goto M, 2008, XENOTRANSPLANTATION, V15, P225, DOI 10.1111/j.1399-3089.2008.00482.x
   Gustafson EK, 2011, TRANSPLANTATION, V91, P632, DOI 10.1097/TP.0b013e31820ae459
   Hajishengallis G, 2013, TRENDS IMMUNOL, V34, P1, DOI 10.1016/j.it.2012.08.003
   Hamad OA, 2008, J THROMB HAEMOST, V6, P1413, DOI 10.1111/j.1538-7836.2008.03034.x
   Hamad OA, 2010, PLOS ONE, V5, P12889
   Hamad OA, 2012, ADV EXP MED BIOL, V946, P185, DOI 10.1007/978-1-4614-0106-3_11
   Hamad OA, 2010, J IMMUNOL, V184, P2686, DOI 10.4049/jimmunol.0902810
   Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810
   Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667
   Jin RC, 2005, MICROCIRCULATION, V12, P247, DOI 10.1080/10739680590925493
   Johansson H, 2005, DIABETES, V54, P1755, DOI 10.2337/diabetes.54.6.1755
   Kolafova H., 2014, MEDIAT INFLAMM, V2014, DOI DOI 10.1155/2014/694312
   Kourtzelis I, 2010, BLOOD, V116, P631, DOI 10.1182/blood-2010-01-264051
   Langer HF, 2012, CIRC RES, V110, P1202, DOI 10.1161/CIRCRESAHA.111.256370
   Langer HF, 2009, J CELL MOL MED, V13, P1211, DOI 10.1111/j.1582-4934.2009.00811.x
   Lappegard KT, 2008, J BIOMED MATER RES A, V87A, P129, DOI 10.1002/jbm.a.31750
   Leijon J, 2013, TISSUE ENG PT A, V19, P1336, DOI [10.1089/ten.tea.2011.0712, 10.1089/ten.TEA.2011.0712]
   Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006
   Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4
   Moll G, 2012, STEM CELLS, V30, P1565, DOI 10.1002/stem.1111
   Moll G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021703
   Nilsson B, 1998, BLOOD, V92, P1661
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nilsson B, 2014, MOL IMMUNOL, V61, P185, DOI 10.1016/j.molimm.2014.06.009
   Nilsson B, 2011, CURR OPIN ORGAN TRAN, V16, P620, DOI 10.1097/MOT.0b013e32834c2393
   Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005
   Nilsson PH, 2010, BIOMATERIALS, V31, P4484, DOI 10.1016/j.biomaterials.2010.02.036
   Nilsson PH, 2012, BIOMATERIALS, V34, P985
   Qu HC, 2011, MOL IMMUNOL, V48, P481, DOI 10.1016/j.molimm.2010.10.004
   Reutershan J, 2007, J IMMUNOL, V179, P1254, DOI 10.4049/jimmunol.179.2.1254
   RICHTER AW, 1984, INT ARCH ALLER A IMM, V74, P36, DOI 10.1159/000233512
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Roberts V, 2013, PURINERG SIGNAL, V9, P135, DOI 10.1007/s11302-012-9342-3
   Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267
   Simon DI, 2012, CIRC J, V76, P1811, DOI 10.1253/circj.CJ-12-0801
   Simon DI, 2000, J EXP MED, V192, P193, DOI 10.1084/jem.192.2.193
   Singh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055852
   Teramura Y, 2013, BIOMATERIALS, V34, P2683, DOI 10.1016/j.biomaterials.2013.01.015
   Teramura Y, 2011, TRANSPLANTATION, V91, P271, DOI 10.1097/TP.0b013e3182034fa4
   Teramura Y, 2010, BIOCONJUGATE CHEM, V21, P792, DOI 10.1021/bc900494x
   Teramura Y, 2009, TRANSPLANTATION, V88, P624, DOI 10.1097/TP.0b013e3181b230ac
   van der Windt DJ, 2007, XENOTRANSPLANTATION, V14, P288, DOI 10.1111/j.1399-3089.2007.00419.x
   van Golen RF, 2012, FREE RADICAL BIO MED, V52, P1382, DOI 10.1016/j.freeradbiomed.2012.01.013
   Vazquez MA, 2009, CURR OPIN NEPHROL HY, V18, P116, DOI 10.1097/MNH.0b013e328325d635
   Wang YM, 2005, CIRCULATION, V112, P2993, DOI 10.1161/CIRCULATIONHA.105.571315
   Watkins NJ, 1997, IMMUNOPHARMACOLOGY, V38, P111, DOI 10.1016/S0162-3109(97)00068-4
   Wu YQ, 2011, J IMMUNOL, V186, P4269, DOI 10.4049/jimmunol.1003802
   Yang Guang, 2010, J Cardiovasc Dis Res, V1, P59, DOI 10.4103/0975-3583.64432
   Yang W, 2012, BIOMATERIALS, V33, P7945, DOI 10.1016/j.biomaterials.2012.07.035
NR 70
TC 9
Z9 9
U1 1
U2 5
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
BN 978-3-319-18603-0; 978-3-319-18602-3
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2015
VL 865
BP 3
EP 17
DI 10.1007/978-3-319-18603-0_1
PG 15
WC Biology; Immunology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Immunology; Research &
   Experimental Medicine
GA BD5WF
UT WOS:000361838300002
PM 26306440
DA 2018-10-19
ER

PT S
AU Moore, LB
   Kyriakides, TR
AF Moore, Laura Beth
   Kyriakides, Themis R.
BE Lambris, JD
   Ekdahl, KN
   Ricklin, D
   Nilsson, B
TI Molecular Characterization of Macrophage-Biomaterial Interactions
SO IMMUNE RESPONSES TO BIOSURFACES: MECHANISMS AND THERAPEUTIC
   INTERVENTIONS
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 1st International Conference on Immune Response to Biosurfaces
CY SEP 27-OCT 02, 2014
CL Chania, GREECE
DE Biomaterials; Foreign body response; Foreign body giant cells;
   Inflammation; Inflammasome; Macrophage
ID FOREIGN-BODY RESPONSE; GIANT-CELL FORMATION; KAPPA-B ACTIVATION;
   IN-VIVO; OSTEOCLAST DIFFERENTIATION; MATRICELLULAR PROTEINS;
   RHEUMATOID-ARTHRITIS; E-CADHERIN; DC-STAMP; FUSION
AB Implantation of biomaterials in vascularized tissues elicits the sequential engagement of molecular and cellular elements that constitute the foreign body response. Initial events include the non-specific adsorption of proteins to the biomaterial surface that render it adhesive for cells such as neutrophils and macrophages. The latter undergo unique activation and in some cases undergo cell-cell fusion to form foreign body giant cells that contribute to implant damage and fibrotic encapsulation. In this review, we discuss the molecular events that contribute to macrophage activation and fusion with a focus on the role of the inflammasome, signaling pathways such as JAK/STAT and NF-kappa B, and the putative involvement of micro RNAs in the regulation of these processes.
C1 [Moore, Laura Beth] Yale Univ, Dept Genet, New Haven, CT USA.
   [Moore, Laura Beth; Kyriakides, Themis R.] Yale Univ, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA.
   [Kyriakides, Themis R.] Yale Univ, Biomed Engn, New Haven, CT USA.
   [Kyriakides, Themis R.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06519 USA.
RP Kyriakides, TR (reprint author), Yale Univ, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA.
EM themis.kyriakides@yale.edu
FU NIGMS NIH HHS [T32 GM007223, R01 GM072194]
CR Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Anglicheau D, 2010, TRANSPLANTATION, V90, P105, DOI 10.1097/TP.0b013e3181e913c2
   Barker TH, 2005, AM J PATHOL, V166, P923, DOI 10.1016/S0002-9440(10)62312-7
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104
   Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002
   Bueter CL, 2014, J IMMUNOL, V192, P5943, DOI 10.4049/jimmunol.1301695
   Busuttil SJ, 2004, J THROMB HAEMOST, V2, P1798, DOI 10.1111/j.1538-7836.2004.00916.x
   Cekaite Lina, 2010, Front Biosci (Elite Ed), V2, P818
   Chang DT, 2009, J BIOMED MATER RES A, V89A, P490, DOI 10.1002/jbm.a.31981
   Chen SY, 2014, RHEUMATOL INT, V34, P285, DOI 10.1007/s00296-013-2720-5
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Cheng HS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00422
   Chuang-Tsai S, 2003, AM J PATHOL, V163, P445, DOI 10.1016/S0002-9440(10)63674-7
   Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902
   Dadsetan M, 2003, J CONTROL RELEASE, V93, P259, DOI 10.1016/j.jconrel.2003.08.010
   Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236
   Dormoy-Raclet V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3388
   Dou C, 2014, BBA-GENE REGUL MECH, V1839, P1084, DOI 10.1016/j.bbagrm.2014.08.002
   Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024
   Fet N, 2014, LANGENBECK ARCH SURG, V399, P579, DOI 10.1007/s00423-014-1192-8
   Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613
   Gonzalo P, 2010, DEV CELL, V18, P77, DOI 10.1016/j.devcel.2009.11.012
   Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020
   Helming L, 2007, IMMUNOBIOLOGY, V212, P785, DOI 10.1016/j.imbio.2007.09.012
   Helming L, 2007, EUR J IMMUNOL, V37, P33, DOI 10.1002/eji.200636788
   Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005
   Helming L, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159665
   Helming L, 2009, J CELL SCI, V122, P453, DOI 10.1242/jcs.037200
   Henao-Mejia J, 2012, NAT IMMUNOL, V13, P321, DOI 10.1038/ni.2257
   Jay SM, 2007, AM J PATHOL, V171, P632, DOI 10.2353/ajpath.2007.061213
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Klueh U, 2005, BIOMATERIALS, V26, P1155, DOI 10.1016/j.biomaterials.2004.04.017
   Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Kyriakides TR, 1999, P NATL ACAD SCI USA, V96, P4449, DOI 10.1073/pnas.96.8.4449
   Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399
   Laskin DL, 2009, CHEM RES TOXICOL, V22, P1376, DOI 10.1021/tx900086v
   Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452
   Lemaire Irma, 2012, Front Biosci (Elite Ed), V4, P41
   Li YT, 2012, ARTHRITIS RHEUM-US, V64, P3240, DOI 10.1002/art.34550
   MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588
   Maitra R, 2009, MOL IMMUNOL, V47, P175, DOI 10.1016/j.molimm.2009.09.023
   Malik AF, 2011, P NATL ACAD SCI USA, V108, P20095, DOI 10.1073/pnas.1105152108
   Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   McNally AK, 2011, ADV EXP MED BIOL, V713, P97, DOI 10.1007/978-94-007-0763-4_7
   Miyamoto H, 2012, J BIOL CHEM, V287, P32479, DOI 10.1074/jbc.M112.358226
   Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575
   Montagner S, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-14
   Mooney JE, 2014, IMMUNOL CELL BIOL, V92, P518, DOI 10.1038/icb.2014.19
   Moore LB, 2015, ACTA BIOMATER, V11, P37, DOI 10.1016/j.actbio.2014.09.022
   Moreno JL, 2007, J LEUKOCYTE BIOL, V82, P1542, DOI 10.1189/jlb.0107058
   Morris AH, 2014, MATRIX BIOL, V37, P183, DOI 10.1016/j.matbio.2014.03.002
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Nothnick WB, 2008, SEMIN REPROD MED, V26, P494, DOI 10.1055/s-0028-1096129
   Park KM, 2014, DEVELOPMENT, V141, P2760, DOI 10.1242/dev.102194
   Pellegrino L, 2013, NUCLEIC ACIDS RES, V41, P5400, DOI 10.1093/nar/gkt245
   Perera RF, 2007, BIODRUGS, V21, P97, DOI 10.2165/00063030-200721020-00004
   Puolakkainen P, 2003, AM J PATHOL, V162, P627, DOI 10.1016/S0002-9440(10)63856-4
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Rhee I, 2013, MOL CELL BIOL, V33, P2458, DOI 10.1128/MCB.00197-13
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Shibuya H, 2013, MOD RHEUMATOL, V23, P674, DOI 10.1007/s10165-012-0710-1
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Sissons JR, 2012, J IMMUNOL, V189, P23, DOI 10.4049/jimmunol.1102477
   Skokos EA, 2011, AM J PATHOL, V178, P2311, DOI 10.1016/j.ajpath.2011.01.045
   St Pierre CA, 2010, J ORTHOP RES, V28, P1418, DOI 10.1002/jor.21149
   Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759
   Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270
   Sugatani T, 2007, J CELL BIOCHEM, V101, P996, DOI 10.1002/jcb.21335
   Sugatani T, 2011, BLOOD, V117, P3648, DOI 10.1182/blood-2010-10-311415
   Suska F, 2005, BIOMATERIALS, V26, P519, DOI 10.1016/j.biomaterials.2004.02.066
   Sussman EM, 2014, ANN BIOMED ENG, V42, P1508, DOI 10.1007/s10439-013-0933-0
   Tang LP, 2002, J BIOMED MATER RES, V62, P471, DOI 10.1002/jbm.10271
   Tsai AT, 2005, BIOMATERIALS, V26, P5835, DOI 10.1016/j.biomaterials.2005.03.003
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wolf MT, 2014, TISSUE ENG PART C-ME, V21, P148
   Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409
   Yagi M, 2006, J BONE MINER METAB, V24, P355, DOI 10.1007/s00774-006-0697-9
   Yang J, 2014, J BIOMED MATER RES A, V102, P2017, DOI 10.1002/jbm.a.35152
   Yu MJ, 2011, J IMMUNOL, V187, P1797, DOI 10.4049/jimmunol.1002628
   Zaveri TD, 2014, BIOMATERIALS, V35, P3504, DOI 10.1016/j.biomaterials.2014.01.007
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 90
TC 13
Z9 13
U1 2
U2 11
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
BN 978-3-319-18603-0; 978-3-319-18602-3
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2015
VL 865
BP 109
EP 122
DI 10.1007/978-3-319-18603-0_7
PG 14
WC Biology; Immunology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Immunology; Research &
   Experimental Medicine
GA BD5WF
UT WOS:000361838300008
PM 26306446
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Li, XG
   Tao, L
   Cao, C
   Shi, HS
   Li, L
   Chen, L
   Li, SR
AF Li, Xiaoge
   Tao, Ling
   Cao, Chuan
   Shi, Haishan
   Li, Le
   Chen, Liang
   Li, Shirong
TI A new surgical method for penile girth enhancement
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article
DE Penis; penile girth enhancement; model; biomaterial; ultrasound
ID AUGMENTATION; SILICONE; FAT
AB Objective: We developed a new surgical model of penile girth enhancement in dog, with minimal damage, fewer complications, and high success rate, to enable the experimental investigation of penile implants. Methods: We obtained materials for penile girth enhancement by processing the pericardium and blood vessel wall collected from pigs. Incisions were made at the penile bulb for the implantation of the materials, and facilitate observation and data collection, based on the anatomical features of dog's penis. We measured the girth of the flaccid penis before and after the operation, and erectile function at 1-month postoperation. In addition to evaluation of recovery from the incision and local pathological changes, ultrasonic examination was performed to monitor the long-term changes associated with implantation. Results: The mean girth of the flaccid penis significantly increased from 7.37 +/- 0.40 cm before the operation, to 8.70 +/- 0.56 cm postoperation. Dogs resumed normal mating at 1 month after the operation, without any significant change in the mating time. Ultrasonic examination clearly illustrated the implants, and helped in the measurement of the distance between the materials and the baculum. Conclusion: Chinese Rural dog is a promising animal model for penile girth enhancement surgery. The findings demonstrated that surgical implantation into penile bulb was associated with less damage, faster postoperative recovery, and higher success. For the first time, ultrasonic examination provided objective data on the surgical outcomes of penile girth enhancement.
C1 [Li, Xiaoge; Tao, Ling; Cao, Chuan; Shi, Haishan; Li, Le; Chen, Liang; Li, Shirong] Third Mil Med Univ, Southwest Hosp, Dept Plast & Reconstruct Surg, Chongqing, Peoples R China.
RP Li, SR (reprint author), Third Mil Med Univ, Southwest Hosp, Dept Plast & Reconstruct Surg, Chongqing, Peoples R China.
EM zhengxing@vip.163.com
CR Bjurlin Marc A, 2010, J Clin Aesthet Dermatol, V3, P41
   CHRIST JE, 1982, PLAST RECONSTR SURG, V69, P337, DOI 10.1097/00006534-198202000-00028
   ERSEK RA, 1991, PLAST RECONSTR SURG, V87, P219, DOI 10.1097/00006534-199102000-00001
   Foxton G, 2011, AUSTRALAS J DERMATOL, V52, pE12, DOI 10.1111/j.1440-0960.2010.00665.x
   Il Kwak T, 2011, J SEX MED, V8, P3407, DOI 10.1111/j.1743-6109.2010.01748.x
   Karakan T, 2012, CASE REP UROL, V2012
   Lee SW, 2007, YONSEI MED J, V48, P723, DOI 10.3349/ymj.2007.48.4.723
   Manny T, 2011, J SEX MED, V8, P3505, DOI 10.1111/j.1743-6109.2010.01980.x
   Perovic SV, 2006, EUR UROL, V49, P139, DOI 10.1016/j.eururo.2005.08.016
   Shamsodini A, 2012, J SEX MED, V9, P3279, DOI 10.1111/j.1743-6109.2011.02563.x
   Silberstein J, 2008, J SEX MED, V5, P2231, DOI 10.1111/j.1743-6109.2008.00911.x
   Spyriounis PK, 2012, J PLAST RECONSTR AES, V65, pE15, DOI 10.1016/j.bjps.2011.07.025
   Yang B, 2009, J PLAST RECONSTR AES, V62, P357, DOI 10.1016/j.bjps.2008.11.033
   Yang Zhe, 2012, Zhonghua Zheng Xing Wai Ke Za Zhi, V28, P172
NR 14
TC 0
Z9 0
U1 0
U2 2
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1940-5901
J9 INT J CLIN EXP MED
JI Int. J. Clin. Exp. Med.
PY 2015
VL 8
IS 7
BP 10753
EP 10759
PG 7
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CR7UR
UT WOS:000361557500055
PM 26379868
DA 2018-10-19
ER

PT J
AU Plenderleith, RA
   Pateman, CJ
   Rodenburg, C
   Haycock, JW
   Claeyssens, F
   Sammond, C
   Rimmer, S
AF Plenderleith, Richard A.
   Pateman, Christopher J.
   Rodenburg, Cornelia
   Haycock, John W.
   Claeyssens, Frederik
   Sammond, Chris
   Rimmer, Stephen
TI Arginine-glycine-aspartic acid functional branched semi-interpenetrating
   hydrogels
SO SOFT MATTER
LA English
DT Article
ID METHACRYLATE-BLOCK-(2,3 PROPANDIOL-1-METHACRYLATE-STAT-ETHANDIOL
   DIMETHACRYLATE)); INTERPENETRATING NETWORK HYDROGELS; MESENCHYMAL
   STEM-CELLS; MATRIX STIFFNESS; RGD PEPTIDES; REGENERATIVE MEDICINE;
   DERMAL FIBROBLASTS; FTIR SPECTROSCOPY; BLOCK CONETWORKS; DRUG-DELIVERY
AB For the first time a series of functional hydrogels based on semi-interpenetrating networks with both branched and crosslinked polymer components have been prepared and we show the successful use of these materials as substrates for cell culture. The materials consist of highly branched poly(N-isopropyl acrylamide)s with peptide functionalised end groups in a continuous phase of crosslinked poly(vinyl pyrrolidone). Functionalisation of the end groups of the branched polymer component with the GRGDS peptide produces a hydrogel that supports cell adhesion and proliferation. The materials provide a new synthetic functional biomaterial that has many of the features of extracellular matrix, and as such can be used to support tissue regeneration and cell culture. This class of high water content hydrogel material has important advantages over other functional hydrogels in its synthesis and does not require post-processing modifications nor are functional-monomers, which change the polymerisation process, required. Thus, the systems are amenable to large scale and bespoke manufacturing using conventional moulding or additive manufacturing techniques. Processing using additive manufacturing is exemplified by producing tubes using microstereolithography.
C1 [Plenderleith, Richard A.; Rimmer, Stephen] Univ Sheffield, Dept Chem, Polymer & Biomat Chem Labs, Sheffield S3 7HF, S Yorkshire, England.
   [Pateman, Christopher J.; Haycock, John W.; Claeyssens, Frederik] Univ Sheffield, Kroto Res Inst, Dept Mat & Engn, Sheffield S3 7HQ, S Yorkshire, England.
   [Rodenburg, Cornelia] Univ Sheffield, Dept Mat Sci & Engn, Sheffield S1 3JD, S Yorkshire, England.
   [Sammond, Chris] Sheffield Hallam Univ, Mat & Engn Res Inst, Sheffield South S1 1WN, Yorks, England.
RP Rimmer, S (reprint author), Univ Sheffield, Dept Chem, Polymer & Biomat Chem Labs, Sheffield S3 7HF, S Yorkshire, England.
EM s.rimmer@bradford.ac.uk
RI Rodenburg, Cornelia/O-4363-2017
OI Rodenburg, Cornelia/0000-0002-9590-375X; Haycock,
   John/0000-0002-3950-3583; Sammon, Chris/0000-0003-1714-1726
FU EPSRC; Biotechnology and Biological Sciences Research Council
   [BB/E012981/1, BB/D524983/1]; Engineering and Physical Sciences Research
   Council [1520640]
FX The authors acknowledge funding from EPSRC for a studentship for Richard
   Penderleith.
CR Billiet T, 2012, BIOMATERIALS, V33, P6020, DOI 10.1016/j.biomaterials.2012.04.050
   Chaudhuri O, 2014, NAT MATER, V13, P970, DOI [10.1038/NMAT4009, 10.1038/nmat4009]
   Chien HW, 2014, BIOTECHNOL J, V9, P1613, DOI 10.1002/biot.201300433
   Collett J, 2007, J R SOC INTERFACE, V4, P117, DOI 10.1098/rsif.2006.0158
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dragan ES, 2014, CHEM ENG J, V243, P572, DOI 10.1016/j.cej.2014.01.065
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Grundfest-Broniatowski SF, 2009, ASAIO J, V55, P400, DOI 10.1097/MAT.0b013e3181a8deba
   Guan Y, 2011, SOFT MATTER, V7, P6375, DOI 10.1039/c0sm01541e
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   Hansen TD, 2014, BIOMATER SCI-UK, V2, P745, DOI [10.1039/C3BM60278H, 10.1039/c3bm60278h]
   Hopkins S, 2009, SOFT MATTER, V5, P4928, DOI 10.1039/b909656f
   Hopp I, 2013, BIOMATERIALS, V34, P5070, DOI 10.1016/j.biomaterials.2013.03.075
   Ingavle GC, 2014, BIOMATERIALS, V35, P3558, DOI 10.1016/j.biomaterials.2014.01.002
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Jiang YJ, 2014, BIOMATERIALS, V35, P4969, DOI 10.1016/j.biomaterials.2014.03.001
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Kilian KA, 2012, ANGEW CHEM INT EDIT, V51, P4891, DOI 10.1002/anie.201108746
   Koo LY, 2002, J CELL SCI, V115, P1423
   Kostanski LK, 2009, J BIOMAT SCI-POLYM E, V20, P271, DOI 10.1163/156856208X3999107
   Kumar V, 2014, ORG ELECTRON, V15, P2059, DOI 10.1016/j.orgel.2014.06.001
   Lee SH, 2008, BIOMATERIALS, V29, P2962, DOI 10.1016/j.biomaterials.2008.04.004
   Li X, 2014, BIOMATERIALS, V35, P5679, DOI 10.1016/j.biomaterials.2014.03.067
   Maeda Y, 2001, MACROMOLECULES, V34, P1391, DOI 10.1021/ma001306t
   Malik S, 2004, J PHYS CHEM B, V108, P597, DOI 10.1021/jp036590f
   Martinez E, 2009, NANOMEDICINE-UK, V4, P65, DOI 10.2217/17435889.4.1.65
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   McHugh KJ, 2013, J BIOMED MATER RES B, V101, P1571, DOI 10.1002/jbm.b.32968
   MORITA Y, 1992, RADIAT PHYS CHEM, V39, P473
   Owaki T, 2014, BIOTECHNOL J, V9, P904, DOI 10.1002/biot.201300432
   Ozbolat IT, 2013, IEEE T BIO-MED ENG, V60, P691, DOI 10.1109/TBME.2013.2243912
   Perlin L, 2008, SOFT MATTER, V4, P2331, DOI 10.1039/b801646a
   Postek MT, 2008, SCANNING, V30, P457, DOI 10.1002/sca.20129
   Ralston DR, 1999, BRIT J DERMATOL, V140, P605
   Maia FR, 2014, MACROMOL BIOSCI, V14, P759, DOI 10.1002/mabi.201300567
   Rimmer S, 2005, BIOMATERIALS, V26, P2219, DOI 10.1016/j.biomaterials.2004.07.013
   Rimmer S, 2007, SOFT MATTER, V3, P971, DOI 10.1039/b705188c
   Ross AM, 2012, SMALL, V8, P336, DOI 10.1002/smll.201100934
   Rzaev ZMO, 2007, PROG POLYM SCI, V32, P534, DOI 10.1016/j.progpolymsci.2007.01.006
   Sammon C, 2006, POLYMER, V47, P6123, DOI 10.1016/j.polymer.2006.06.013
   Saunders BR, 2009, ADV COLLOID INTERFAC, V147-48, P251, DOI 10.1016/j.cis.2008.08.008
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   Seelbach RJ, 2014, ACTA BIOMATER, V10, P4340, DOI 10.1016/j.actbio.2014.06.028
   Shivashanka M., 2012, INT J PHRAM PHRAM SC, V4, P1
   Smith LE, 2006, BIOMATERIALS, V27, P2806, DOI 10.1016/j.biomaterials.2005.12.018
   Su YL, 2003, MOL SIMULAT, V29, P803, DOI 10.1080/0892702031000121888
   Su YL, 2002, MACROMOLECULES, V35, P6426, DOI 10.1021/ma0105284
   Sun Y, 2007, BIOMATERIALS, V28, P661, DOI 10.1016/j.biomaterials.2006.09.024
   Tong XM, 2014, BIOMATERIALS, V35, P1807, DOI 10.1016/j.biomaterials.2013.11.064
   Wang LS, 2006, ADV FUNCT MATER, V16, P1171, DOI 10.1002/adfm.200500408
   Yamato M, 2007, PROG POLYM SCI, V32, P1123, DOI 10.1016/j.progpolymsci.2007.06.002
   Ye K, 2015, NANO LETT, V15, P4720, DOI 10.1021/acs.nanolett.5b01619
   Yu CH, 2013, CELL REP, V5, P1456, DOI 10.1016/j.celrep.2013.10.040
   Yu Q, 2014, ADV FUNCT MATER, V24, P3751, DOI 10.1002/adfm.201304274
   Zhang R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2341
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 56
TC 2
Z9 2
U1 1
U2 31
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2015
VL 11
IS 38
BP 7567
EP 7578
DI 10.1039/c5sm00695c
PG 12
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA CS1NQ
UT WOS:000361833500014
PM 26280624
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Soto-Rios, PC
   Nakano, K
   Leon-Romero, M
   Aikawa, Y
   Arai, S
   Nishimura, O
AF Soto-Rios, Paula Cecilia
   Nakano, Kazunori
   Leon-Romero, Marco
   Aikawa, Yoshio
   Arai, Shigeyuki
   Nishimura, Osamu
TI Differences in the removal mechanisms of Undaria pinnatifida and
   Phragmites australis as biomaterials for lead removal
SO WATER SCIENCE AND TECHNOLOGY
LA English
DT Article
DE biomaterials; heavy metals; permeable reactive barriers
ID PERMEABLE REACTIVE BARRIERS; HEAVY-METAL; GROUNDWATER REMEDIATION;
   BIOSORPTION; ADSORPTION; BROWN; ALGAE
AB This study offers the opportunity to utilize Undaria pinnatifida and Phragmites australis to remove lead from water in permeable reactive barrier (PRB) technology. Its efficacy was tested using batch experiments and PRB column systems. From the batch experiment results, a higher adsorption capacity was observed for Undaria pinnatifida. Nevertheless, Phragmites australis in the column system efficiently removed lead and the breakthrough occurred at the same time for both biomaterials. To dissipate this difference, a sequential extraction for metal speciation analysis was used for both columns. The results have shown that each biomaterial has a dominant mechanism. Phragmites australis removed lead by physical adsorption, whereas Undaria pinnatifida showed a higher tendency to bind lead due to organic matter, primary and secondary minerals.
C1 [Soto-Rios, Paula Cecilia; Leon-Romero, Marco; Aikawa, Yoshio; Nishimura, Osamu] Tohoku Univ, Ecol Engn Lab, Grad Sch Engn, Tohoku 9808579, Japan.
   [Nakano, Kazunori] Nihon Univ, Ecol Engn Lab, Fac Engn, Nihon 9638642, Japan.
   [Arai, Shigeyuki] Mitsubishi Mat Corp, Environm Technol Res Ctr, Kurihara, Miyagi 9895402, Japan.
RP Soto-Rios, PC (reprint author), Tohoku Univ, Ecol Engn Lab, Grad Sch Engn, Tohoku 9808579, Japan.
EM cecisoto@eco.civil.tohoku.ac.jp
CR Babel S, 2004, CHEMOSPHERE, V54, P951, DOI 10.1016/j.chemosphere.2003.10.001
   Cardwell AJ, 2002, CHEMOSPHERE, V48, P653, DOI 10.1016/S0045-6535(02)00164-9
   Choong J., 2002, WATER RES, V36, P1814
   Dabrowski A, 2001, ADV COLLOID INTERFAC, V93, P135, DOI 10.1016/S0001-8686(00)00082-8
   Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8
   Duruibe JO, 2007, INT J PHYS SCI, V2, P112
   Fu W, 2011, J ENVIRON MANAGE, V92, P407
   Gavaskar AR, 1999, J HAZARD MATER, V68, P41, DOI 10.1016/S0304-3894(99)00031-X
   Hashim MA, 2004, CHEM ENG J, V97, P249, DOI 10.1016/S1385-8947(03)00216-X
   KIM YH, 1995, BIOTECHNOL LETT, V17, P345, DOI 10.1007/BF01190651
   Kurniawan TA, 2006, SCI TOTAL ENVIRON, V366, P409, DOI 10.1016/j.scitotenv.2005.10.001
   Obiri-Nyarko F, 2014, CHEMOSPHERE, V111, P243, DOI 10.1016/j.chemosphere.2014.03.112
   Park D, 2010, BIOTECHNOL BIOPROC E, V15, P86, DOI 10.1007/s12257-009-0199-4
   PEREBAR, 2002, EVK1CT199900035 PERE
   Rocca C. della, 2007, Desalination, V210, P194, DOI 10.1016/j.desal.2006.05.044
   Roehl KE, 2005, LONG TERM PERFORMANC
   Romera E, 2007, BIORESOURCE TECHNOL, V98, P3344, DOI 10.1016/j.biotech.2006.09.026
   Schiewer S., 2000, REMEDIATION, P139
   SCOTT CD, 1992, BIOTECHNOL BIOENG, V39, P1064, DOI 10.1002/bit.260391011
   Soto Rios P. C., 2014, WATER SCI TECHNOL, V70, P307
   Southichak B, 2009, WATER SCI TECHNOL, V59, P339, DOI 10.2166/wst.2009.867
   Southichak B., 2002, THESIS TOHOKU U SEND
   TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017
   Thiruverikatachari R, 2008, J IND ENG CHEM, V14, P145, DOI 10.1016/j.jiec.2007.10.001
   VOLESKY B, 1994, FEMS MICROBIOL REV, V14, P291, DOI 10.1111/j.1574-6976.1994.tb00102.x
   Volesky B., 1990, BIOSORPTION HEAVY ME, P3
   Walter J., 1974, PURE APPL CHEM J, P375, DOI [10.1016/B978-0-408-70636-0.50006-5, DOI 10.1016/B978-0-408-70636-0.50006-5]
   Wang JL, 2009, BIOTECHNOL ADV, V27, P195, DOI 10.1016/j.biotechadv.2008.11.002
   Yong H. K., 1995, BIOTECHNOL LETT, V17, P345
NR 29
TC 1
Z9 2
U1 0
U2 16
PU IWA PUBLISHING
PI LONDON
PA ALLIANCE HOUSE, 12 CAXTON ST, LONDON SW1H0QS, ENGLAND
SN 0273-1223
EI 1996-9732
J9 WATER SCI TECHNOL
JI Water Sci. Technol.
PY 2015
VL 72
IS 7
BP 1226
EP 1233
DI 10.2166/wst.2015.334
PG 8
WC Engineering, Environmental; Environmental Sciences; Water Resources
SC Engineering; Environmental Sciences & Ecology; Water Resources
GA CS1PL
UT WOS:000361839200022
PM 26398039
DA 2018-10-19
ER

PT J
AU McCanna, DJ
   Barthod-Malat, AV
   Gorbet, MB
AF McCanna, David Joseph
   Barthod-Malat, Aurore V.
   Gorbet, Maud B.
TI In vitro methods of assessing ocular biocompatibility using
   THP-1-derived macrophages
SO CUTANEOUS AND OCULAR TOXICOLOGY
LA English
DT Article
DE AlamarBlue; annexin V; benzalkonium chloride; biocompatibility; CD54;
   confocal microscopy; macrophage
ID STANDARD REFERENCE MATERIALS; RUBBER LATEX MATERIALS; INTRAOCULAR
   LENSES; BENZALKONIUM CHLORIDE; CELL-DEATH; CAPSULAR BIOCOMPATIBILITY;
   SIGNAL-TRANSDUCTION; CYTOTOXICITY TESTS; ALAMAR BLUE; SURFACE
AB Macrophages play an important role in the elimination of infections, the removal of debris and in tissue repair after infection and trauma. In vitro models that assess ocular biomaterials for toxicity typically focus on the effects of these materials on epithelial or fibroblast cells. This investigation evaluated known ocular toxins deposited on model materials for their effects on the viability and activation of macrophages. THP-1-derived macrophages were cultured onto silicone films (used as a base biomaterial) deposited with chemical toxins (benzalkonium chloride (BAK), zinc diethyldithiocarbamate (ZDEC) and lipopolysaccharide (LPS)). Utilizing three fluorescent dyes calcein, ethidium homodimer-1 (EthD-1) and annexin V, the viability of macrophages attached to the biomaterial was determined using confocal microscopy. Propidium iodide (PI) staining and alamarBlue (R) (resazurin) reduction were used to assess cell death and metabolic activity. CD14, CD16, CD33, CD45, and CD54 expression of adherent macrophages, were also evaluated to detect LPS activation of macrophages using flow cytometry. The sensitivity of this test battery was demonstrated as significant toxicity from treated surfaces with ZDEC (0.001-0.01%), and BAK (0.001%-0.1%) was detected. Also, macrophage activation could be detected by measuring CD54 expression after exposure to adsorbed LPS. These in vitro methods will be helpful in determining the toxicity potential of new ocular biomaterials.
C1 [McCanna, David Joseph; Gorbet, Maud B.] Univ Waterloo, Ctr Contact Lens Res, Sch Optometry & Vis Sci, Waterloo, ON N2L 3G1, Canada.
   [Barthod-Malat, Aurore V.; Gorbet, Maud B.] Univ Waterloo, Dept Syst Design Engn, Waterloo, ON N2L 3G1, Canada.
RP McCanna, DJ (reprint author), Univ Waterloo, Ctr Contact Lens Res, Sch Optometry & Vis Sci, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.
EM djmccann@uwaterloo.ca
FU 20:20 NSERC Opthalmic Materials Network
FX Authors do not have any financial/conflicting interests to disclose.
   This project was funded by 20:20 NSERC Opthalmic Materials Network.
CR Abela-Formanek C, 2002, J CATARACT REFR SURG, V28, P1141, DOI 10.1016/S0886-3350(02)01425-6
   Alexander DR, 2000, SEMIN IMMUNOL, V12, P349, DOI 10.1006/smim.2000.0218
   Ammar DA, 2011, BRIT J OPHTHALMOL, V95, P1466, DOI 10.1136/bjophthalmol-2011-300012
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   ANDREESEN R, 1990, J LEUKOCYTE BIOL, V47, P490
   Anwar Z, 2013, CURR OPIN OPHTHALMOL, V24, P136, DOI 10.1097/ICU.0b013e32835c8aba
   AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244
   AUWERX J, 1992, LEUKEMIA RES, V16, P317, DOI 10.1016/0145-2126(92)90070-N
   Baudouin Christophe, 2012, Trans Am Ophthalmol Soc, V110, P40
   Beasley AM, 1996, J INVEST SURG, V9, P399, DOI 10.3109/08941939609025857
   Buchen SY, 2012, OPHTHALMOLOGY, V119, pE4, DOI 10.1016/j.ophtha.2012.04.006
   Crocker PR, 2012, ANN NY ACAD SCI, V1253, P102, DOI 10.1111/j.1749-6632.2011.06449.x
   Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668
   Devitt A, 2003, CELL DEATH DIFFER, V10, P371, DOI 10.1038/sj.cdd.4401168
   DEVOS AF, 1995, EXP EYE RES, V60, P199, DOI 10.1016/S0014-4835(95)80011-5
   DURANDCAVAGNA G, 1989, FUND APPL TOXICOL, V13, P500, DOI 10.1016/0272-0590(89)90286-8
   Eckhardt A, 2009, BIOMATERIALS, V30, P1665, DOI 10.1016/j.biomaterials.2008.09.024
   Goto Y, 2003, ARCH OPHTHALMOL-CHIC, V121, P835, DOI 10.1001/archopht.121.6.835
   Hamid R, 2004, TOXICOL IN VITRO, V18, P703, DOI 10.1016/j.tiv.2004.03.012
   Hao XJ, 2012, BIOMATERIALS, V33, P5659, DOI 10.1016/j.biomaterials.2012.04.052
   Hexig B, 2008, J ARTIF ORGANS, V11, P204, DOI 10.1007/s10047-008-0429-0
   Hopkins HA, 1995, AM J PHYSIOL-LUNG C, V269, pL849
   Hoyer JD, 2008, AM J CLIN PATHOL, V129, P316, DOI 10.1309/E36008Y2H08Q1AYY
   Huang XD, 2010, J CATARACT REFR SURG, V36, P290, DOI 10.1016/j.jcrs.2009.09.027
   Hyde GK, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025001
   IKARASHI Y, 1992, J BIOMED MATER RES, V26, P339, DOI 10.1002/jbm.820260306
   Imayasu Masaki, 1994, CLAO Journal, V20, P183
   Iribarren Pablo, 2002, BMC Immunol, V3, P6, DOI 10.1186/1471-2172-3-6
   Irwin EF, 2008, J BIOMAT SCI-POLYM E, V19, P1363, DOI 10.1163/156856208786052407
   Ishikawa N, 2011, J CATARACT REFR SURG, V37, P1333, DOI 10.1016/j.jcrs.2011.04.001
   Jager MJ, 2011, PROG RETIN EYE RES, V30, P129, DOI 10.1016/j.preteyeres.2010.11.004
   Jha P, 2007, INVEST OPHTH VIS SCI, V48, P5091, DOI 10.1167/iovs.07-0651
   Lee HS, 2013, J BIOMED MATER RES A, V101, P203, DOI 10.1002/jbm.a.34309
   Lucas AD, 2001, IN VITRO MOL TOXICOL, V14, P169
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Matylevitch NP, 1998, AM J PATHOL, V153, P567, DOI 10.1016/S0002-9440(10)65599-X
   Melino M, 2012, WORLD J GASTROENTERO, V18, P1732, DOI 10.3748/wjg.v18.i15.1732
   Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661
   Michee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072459
   Miyake K, 2001, ARCH OPHTHALMOL-CHIC, V119, P387, DOI 10.1001/archopht.119.3.387
   Munoz LE, 2007, J LEUKOCYTE BIOL, V81, P6, DOI 10.1189/jlb.0306166
   NAKAMURA A, 1990, BIOMATERIALS, V11, P92
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x
   Park H, 1996, PHARMACEUT RES, V13, P1770, DOI 10.1023/A:1016012520276
   Park JC, 2002, YONSEI MED J, V43, P518, DOI 10.3349/ymj.2002.43.4.518
   Perez VL, 2013, J AUTOIMMUN, V45, P7, DOI 10.1016/j.jaut.2013.06.011
   Pick N., 2004, BIOL PROCED ONLINE, V6, P220, DOI DOI 10.1251/BP092
   Roesel M, 2008, GRAEF ARCH CLIN EXP, V246, P1609, DOI 10.1007/s00417-008-0886-4
   ROTHLEIN R, 1986, J IMMUNOL, V137, P1270
   Saika S, 1998, GRAEF ARCH CLIN EXP, V236, P758, DOI 10.1007/s004170050155
   Sakaguchi H, 2007, ARCH DERMATOL RES, V298, P427, DOI 10.1007/s00403-006-0714-9
   Song L, 2010, J PHYS CHEM B, V114, P7172, DOI 10.1021/jp100876c
   Stevens AM, 2012, ACTA OPHTHALMOL, V90, pe221, DOI 10.1111/j.1755-3768.2011.02338.x
   Thomas L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070691
   TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208
   Tsuchiya T, 1994, J Biomater Appl, V9, P138
   TSUCHIYA T, 1993, J BIOMED MATER RES, V27, P885, DOI 10.1002/jbm.820270707
   TSUCHIYA T, 1993, J APPL BIOMATER, V4, P153, DOI 10.1002/jab.770040206
   Tsuchiya Toshie, 1994, Clinical Materials, V16, P1, DOI 10.1016/0267-6605(94)90085-X
   Uusitalo M, 1997, GRAEF ARCH CLIN EXP, V235, P506, DOI 10.1007/BF00947008
   Vermonden T, 2008, BIOMACROMOLECULES, V9, P919, DOI 10.1021/bm7013075
   Wang ZQ, 2001, IMMUNOLOGY, V102, P331, DOI 10.1046/j.1365-2567.2001.01171.x
   Wiegand C, 2008, GMS HYG INFECT CONTR, V3
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
   Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Youn HY, 2004, TOXICOL IN VITRO, V18, P841, DOI 10.1016/j.tiv.2004.04.007
   Zhao H, 2010, CYTOM PART A, V77A, P399, DOI 10.1002/cyto.a.20867
NR 69
TC 1
Z9 1
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1556-9527
EI 1556-9535
J9 CUTAN OCUL TOXICOL
JI Cutan. Ocul. Toxicol.
PY 2015
VL 34
IS 2
BP 89
EP 100
DI 10.3109/15569527.2014.908205
PG 12
WC Ophthalmology; Toxicology
SC Ophthalmology; Toxicology
GA CR4SM
UT WOS:000361328600001
PM 24738714
DA 2018-10-19
ER

PT J
AU Feng, SB
   Nie, L
   Zou, P
   Suo, JP
AF Feng, Shuibin
   Nie, Lei
   Zou, Peng
   Suo, Jinping
TI Drug-loaded PLGA-mPEG microparticles as treatment for atopic
   dermatitis-like skin lesions in BALB/c mice model
SO JOURNAL OF MICROENCAPSULATION
LA English
DT Article
DE Biomaterial; controlled release; dermatitis; microspheres
ID IN-VIVO EVALUATION; ALLERGIC RHINITIS; BIODEGRADABLE MICROPARTICLES;
   CHITOSAN NANOPARTICLES; POLYMER DEGRADATION; VITRO RELEASE; NC/NGA MICE;
   NASAL SPRAY; MOUSE MODEL; DELIVERY
AB This study evaluated the feasibility of mizolastine-loaded microparticles as therapy for atopic dermatitis. Microparticles have been researched for decades as a controlled-release drug delivery system, but seldom been used as treatment for skin disease. In this research, we induced dermatitis in BALB/c mice model by repeated topical application of dinitrofluorobenzene and compared the mizolastine microparticles injection and daily mizolastine injection treatment. The results showed that the mizolastine microparticles treatments significantly inhibited ear thickness and dermatitis index in dermatitis model compared with the dermatitis mice without treatment, showing a similar curative effect compared with daily mizolastine injection treatment, and the improvement continued for several days. Inflammatory cells infiltration into the ears and the plasma level of immunoglobulin E were also suppressed by mizolastine microparticles according to the histopathology analysis. In conclusion, the results suggested that drug-loaded microparticles could be a proper candidate for the treatment of skin diseases.
C1 [Feng, Shuibin; Nie, Lei; Zou, Peng; Suo, Jinping] Huazhong Univ Sci & Technol, Coll Mat Sci & Engn, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Peoples R China.
RP Suo, JP (reprint author), 1034 Luoyu Rd, Wuhan, Peoples R China.
EM jinpingsuo@hust.edu.cn
OI nie, lei/0000-0002-6175-5883
CR Al-Qadi S, 2012, J CONTROL RELEASE, V157, P383, DOI 10.1016/j.jconrel.2011.08.008
   Avgoustakis K, 2002, J CONTROL RELEASE, V79, P123, DOI 10.1016/S0168-3659(01)00530-2
   Bachert C, 2001, ALLERGY, V56, P653, DOI 10.1034/j.1398-9995.2001.00756.x
   Bachert C, 2011, J ASTHMA, V48, P965, DOI 10.3109/02770903.2011.616616
   Barzegar C, 2002, REV FR ALLERGOL, V42, P410, DOI 10.1016/S0335-7457(02)00169-7
   Belloni B, 2007, J ALLERGY CLIN IMMUN, V120, P1223, DOI 10.1016/j.jaci.2007.08.060
   Bjorses K, 2011, ACTA BIOMATER, V7, P2558, DOI 10.1016/j.actbio.2011.03.003
   Boguniewicz M, 2006, J ALLERGY CLIN IMMUN, V117, pS475, DOI 10.1016/j.jaci.2005.10.018
   Boguniewicz Mark, 2003, Journal of Allergy and Clinical Immunology, V112, pS140, DOI 10.1016/j.jaci.2003.09.031
   Dibildox J, 2001, J ALLERGY CLIN IMMUN, V108, pS54, DOI 10.1067/mai.2001.115567
   Fujii Y, 2009, SKIN PHARMACOL PHYS, V22, P240, DOI 10.1159/000235551
   Fujimoto M, 2009, EUR J PHARMACOL, V602, P432, DOI 10.1016/j.ejphar.2008.11.040
   Hazekawa M, 2012, J MICROENCAPSUL, V29, P211, DOI 10.3109/02652048.2011.622054
   Hochhaus G, 2008, CLIN THER, V30, P1, DOI 10.1016/j.clinthera.2008.01.005
   Inagaki N, 2006, EUR J PHARMACOL, V546, P189, DOI 10.1016/j.ejphar.2006.07.019
   Jay SM, 2009, J CONTROL RELEASE, V134, P26, DOI 10.1016/j.jconrel.2008.10.019
   Jhunjhunwala S, 2012, J CONTROL RELEASE, V159, P78, DOI 10.1016/j.jconrel.2012.01.013
   Kang JS, 2008, INT IMMUNOPHARMACOL, V8, P1475, DOI 10.1016/j.intimp.2008.06.004
   Karal-Yilmaz O, 2011, J MICROENCAPSUL, V28, P46, DOI 10.3109/02652048.2010.523795
   Kim CH, 2012, SCAND J IMMUNOL, V75, P471, DOI 10.1111/j.1365-3083.2011.02659.x
   Koo J, 1998, CLIN THER, V20, P283, DOI 10.1016/S0149-2918(98)80091-X
   Lecaroz C, 2006, J MICROENCAPSUL, V23, P782, DOI 10.1080/02652040600946886
   Lee JS, 2012, J CONTROL RELEASE, V158, P312, DOI 10.1016/j.jconrel.2011.10.025
   Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060
   Leynadier F, 1996, ANN ALLERG ASTHMA IM, V76, P163, DOI 10.1016/S1081-1206(10)63417-5
   Li J, 2008, J APPL POLYM SCI, V109, P475, DOI 10.1002/app.28122
   Li J, 2008, J APPL POLYM SCI, V108, P2458, DOI 10.1002/app.27823
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Matsuoka H, 2003, ALLERGY, V58, P139, DOI 10.1034/j.1398-9995.2003.23790.x
   Na JH, 2012, J CONTROL RELEASE, V163, P2, DOI 10.1016/j.jconrel.2012.07.028
   Nagai H, 1997, J PHARMACOL EXP THER, V283, P321
   Park J, 2009, NANOMED-NANOTECHNOL, V5, P410, DOI 10.1016/j.nano.2009.02.002
   Patel B, 2012, J CONTROL RELEASE, V162, P310, DOI 10.1016/j.jconrel.2012.07.003
   de la Ossa DHP, 2012, J CONTROL RELEASE, V161, P927, DOI 10.1016/j.jconrel.2012.05.003
   Pople PV, 2012, INT J PHARMACEUT, V434, P70, DOI 10.1016/j.ijpharm.2012.04.051
   Reis CP, 2014, DRUG DEV IND PHARM, V40, P409, DOI 10.3109/03639045.2013.767826
   Rosado C, 2013, PHARM DEV TECHNOL, V18, P710, DOI 10.3109/10837450.2012.712537
   Rosca ID, 2004, J CONTROL RELEASE, V99, P271, DOI 10.1016/j.jconrel.2004.07.007
   Samukawa K, 2012, J PHARMACOL SCI, V118, P391, DOI 10.1254/jphs.11182FP
   Terakawa M, 2008, EUR J PHARMACOL, V601, P186, DOI 10.1016/j.ejphar.2008.10.040
   Yang XZ, 2011, J CONTROL RELEASE, V156, P203, DOI 10.1016/j.jconrel.2011.07.035
   Yang YY, 2001, BIOMATERIALS, V22, P231, DOI 10.1016/S0142-9612(00)00178-2
   Yeh MK, 2004, J MICROENCAPSUL, V21, P91, DOI 10.1080/02652040310001619794
   Yuan XY, 2011, EUR J PHARMACOL, V658, P263, DOI 10.1016/j.ejphar.2011.02.013
   Zou P, 2012, POLYMER, V53, P1245, DOI 10.1016/j.polymer.2012.01.044
NR 45
TC 1
Z9 2
U1 0
U2 11
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0265-2048
EI 1464-5246
J9 J MICROENCAPSUL
JI J. Microencapsul.
PY 2015
VL 32
IS 2
BP 201
EP 209
DI 10.3109/02652048.2014.995727
PG 9
WC Chemistry, Applied; Engineering, Chemical; Pharmacology & Pharmacy
SC Chemistry; Engineering; Pharmacology & Pharmacy
GA CR4UM
UT WOS:000361335100012
PM 25539424
DA 2018-10-19
ER

PT J
AU Ge, HL
   Kong, Y
   Pan, Y
   Deng, LH
   Shou, D
   Lu, QY
AF Ge, Hanli
   Kong, Yong
   Pan, Yan
   Deng, Linhong
   Shou, Dan
   Lu, Qingyun
TI Polydopamine Core Half-Polyamidoamine Dendrimers Based Drug-Delivery
   Platform and Characterization by Electrochemical Impedance Spectroscopy
SO JOURNAL OF THE ELECTROCHEMICAL SOCIETY
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYER; SOLUBILITY ENHANCEMENT; SURFACE-CHEMISTRY;
   PAMAM DENDRIMERS; ASCORBIC-ACID; DOPAMINE; NANOPARTICLES;
   FUNCTIONALIZATION; IMMOBILIZATION; MEMBRANE
AB Dopamine was self-polymerized onto the surface of a glassy carbon electrode (GCE), and the obtained polydopamine (PDOA) functioned as a scaffold for the grafting of half-polyamidoamine (H-PAMAM) dendrimers, which is a new class of polymeric biomaterial as drug carriers. Aspirin was chosen as the model drug and loaded into the H-PAMAM dendrimers via ion pairing, hydrogen bonding and hydrophobic interaction. The synthesis of H-PAMAM dendrimers grafted PDOA was characterized by electrochemical impedance spectroscopy (EIS), attenuated total reflection infrared spectroscopy (ATR-TR), atomic force microscopy (AFM), transmission electron microscopy (TEM), UV-visible spectroscopy and water contact measurement. The process of aspirin loading and delivery was also monitored by EIS. The results demonstrate that PDOA films can be used as an excellent platform for grafting of H-PAMAM dendrimers, which is an ideal carrier for drug loading and delivery. (C) 2015 The Electrochemical Society. All rights reserved.
C1 [Ge, Hanli; Kong, Yong; Pan, Yan; Deng, Linhong] Changzhou Univ, Jiangsu Key Lab Adv Catalyt Mat & Technol, Changzhou 213164, Peoples R China.
   [Shou, Dan] Zhejiang Acad Tradit Chinese Med, Dept Med, Hangzhou 310007, Zhejiang, Peoples R China.
   [Lu, Qingyun] Changzhou Univ, Hua Lookeng Honors Coll, Changzhou 213164, Peoples R China.
RP Ge, HL (reprint author), Changzhou Univ, Jiangsu Key Lab Adv Catalyt Mat & Technol, Changzhou 213164, Peoples R China.
EM yzkongyong@126.com; shoudanok@163.com
CR Amoozgar Z, 2014, BIOMACROMOLECULES, V15, P4187, DOI 10.1021/bm5011933
   Arteta MY, 2014, J PHYS CHEM B, V118, P12892, DOI 10.1021/jp506510s
   Bagherzadeh M, 2014, ELECTROCHIM ACTA, V115, P573, DOI 10.1016/j.electacta.2013.11.012
   Barreto WJ, 1999, SPECTROCHIM ACTA A, V55, P65
   Cao CY, 2014, J POWER SOURCES, V248, P224, DOI 10.1016/j.jpowsour.2013.09.027
   Chegeni BK, 2014, COLLOID POLYM SCI, V292, P3337, DOI 10.1007/s00396-014-3398-2
   Chen W, 2000, MACROMOLECULES, V33, P9169, DOI 10.1021/ma000791p
   Cui JW, 2012, BIOMACROMOLECULES, V13, P2225, DOI 10.1021/bm300835r
   Devarakonda B, 2004, INT J PHARM, V284, P133, DOI 10.1016/j.ijpharm.2004.07.006
   Duncan R, 2005, ADV DRUG DELIVER REV, V57, P2215, DOI 10.1016/j.addr.2005.09.019
   Fei B, 2008, CARBON, V46, P1795, DOI 10.1016/j.carbon.2008.06.049
   Feng JJ, 2012, NEW J CHEM, V36, P148, DOI 10.1039/c1nj20850k
   Gupta U, 2006, BIOMACROMOLECULES, V7, P649, DOI 10.1021/bm050802s
   He H, 2005, J COLLOID INTERF SCI, V289, P446, DOI 10.1016/j.jcis.2005.03.085
   He YK, 2014, J MATER CHEM A, V2, P9548, DOI 10.1039/c3ta15301k
   Jo S, 2013, MACROMOL BIOSCI, V13, P1389, DOI 10.1002/mabi.201300203
   Kolhe P, 2006, BIOMATERIALS, V27, P660, DOI 10.1016/j.biomaterials.2005.06.007
   Kong Y, 2014, ANAL CHIM ACTA, V809, P54, DOI 10.1016/j.aca.2013.12.003
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Leng ZH, 2013, CARBOHYD POLYM, V98, P1173, DOI 10.1016/j.carbpol.2013.07.021
   Li XJ, 2014, BIOMATERIALS, V35, P6576, DOI 10.1016/j.biomaterials.2014.04.043
   Li YL, 2006, THIN SOLID FILMS, V497, P270, DOI 10.1016/j.tsf.2005.10.048
   Liao YA, 2010, MATER CHEM PHYS, V121, P534, DOI 10.1016/j.matchemphys.2010.02.019
   Liao Y, 2009, APPL SURF SCI, V255, P8207, DOI 10.1016/j.apsusc.2009.05.038
   Lin Q, 2013, J NANOPART RES, V15, P1
   Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c
   Mondin G, 2013, J COLLOID INTERF SCI, V411, P187, DOI 10.1016/j.jcis.2013.08.028
   Pop-Georgievski O, 2013, THIN SOLID FILMS, V543, P180, DOI 10.1016/j.tsf.2012.11.128
   Shervedani RK, 2008, ELECTROCHIM ACTA, V53, P6293, DOI 10.1016/j.electacta.2008.04.051
   Shervedani RK, 2008, ELECTROANAL, V20, P550, DOI 10.1002/elan.200704096
   Shervedani RK, 2007, ANAL CHIM ACTA, V587, P254, DOI 10.1016/j.aca.2007.01.053
   Shervedani RK, 2010, ELECTROANAL, V22, P969, DOI 10.1002/elan.200900327
   Shervedani RK, 2009, J ELECTROANAL CHEM, V633, P259, DOI 10.1016/j.jelechem.2009.05.012
   Shervedani RK, 2009, SENSOR ACTUAT B-CHEM, V139, P657, DOI 10.1016/j.snb.2009.03.060
   Shervedani RK, 2006, SENSOR ACTUAT B-CHEM, V115, P614, DOI 10.1016/j.snb.2005.10.027
   Waite JH, 2008, NAT MATER, V7, P8, DOI 10.1038/nmat2087
   Wang JT, 2009, J POWER SOURCES, V192, P336, DOI 10.1016/j.jpowsour.2009.03.014
   Wang L, 2013, COMMUN COMPUT PHYS, V13, P13, DOI 10.4208/cicp.300611.120911s
   Zhao DM, 2009, COLLOID SURFACE B, V74, P317, DOI 10.1016/j.colsurfb.2009.07.044
   Zhou ZY, 2013, INT J PHARMACEUT, V452, P173, DOI 10.1016/j.ijpharm.2013.04.075
NR 40
TC 7
Z9 7
U1 1
U2 18
PU ELECTROCHEMICAL SOC INC
PI PENNINGTON
PA 65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA
SN 0013-4651
EI 1945-7111
J9 J ELECTROCHEM SOC
JI J. Electrochem. Soc.
PY 2015
VL 162
IS 10
BP G87
EP G93
DI 10.1149/2.0221510jes
PG 7
WC Electrochemistry; Materials Science, Coatings & Films
SC Electrochemistry; Materials Science
GA CR7BB
UT WOS:000361501800101
DA 2018-10-19
ER

PT J
AU Jia, XJ
   Chen, MW
   Wan, JB
   Su, HX
   He, CW
AF Jia, Xuejing
   Chen, Meiwan
   Wan, Jian-Bo
   Su, Huanxing
   He, Chengwei
TI Review on the extraction, characterization and application of soybean
   polysaccharide
SO RSC ADVANCES
LA English
DT Review
ID STEPWISE ENZYMATIC DEGRADATION; CELL-WALL POLYSACCHARIDES; BY-PRODUCT
   OKARA; SOLUBLE POLYSACCHARIDES; EMULSIFYING PROPERTIES; ACIDIC
   CONDITIONS; BEET PECTIN; PHYSICOCHEMICAL STABILITY; MOLECULAR
   CONSTRUCTION; RHEOLOGICAL PROPERTIES
AB Soybean polysaccharide (SPS) is a class of soluble polysaccharide derived from soybean cotyledon, soybean meal or okara, and has broadly been used in the food industry. In recent decades, due to its attractive physicochemical properties, SPS has been developed into various emulsifiers or stabilizers for beverages. Additionally, studies have emerged to reveal its potential in biomaterial and biological applications. In this review, we critically appraise the latest literature on the extraction and the structural features of SPS, and provide a perspective on the biological applications of SPS. We focus on the current strategies for the extraction of this unique polysaccharide, specific structural features, and functional utilization of SPS. Notably, SPS-based food additives have been demonstrated to add value in biological applications due to their anticancer and immunoregulatory effects, encouraging us to use SPS directly in the area of biomedicine. Lastly, we suggest some potential directions for the development of SPS for extensive utilization in biomedicine.
C1 [Jia, Xuejing; Chen, Meiwan; Wan, Jian-Bo; Su, Huanxing; He, Chengwei] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa 999078, Peoples R China.
RP He, CW (reprint author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, N22-7038 Ave Univ, Taipa 999078, Peoples R China.
EM chengweihe@umac.mo
OI Wan, Jian-Bo/0000-0002-6750-2617
FU Macao Science and Technology Development Fund [074/2013/A]; Research
   Fund of the University of Macau [MYRG107(Y1-L3)-ICMS13-HCW,
   MYRG2015-00081-ICMS-QRCM]
FX This study was supported by the Macao Science and Technology Development
   Fund (074/2013/A) and the Research Fund of the University of Macau
   (MYRG107(Y1-L3)-ICMS13-HCW, MYRG2015-00081-ICMS-QRCM).
CR Aspinall G. O., 1967, J CHEM SOC C, P1065
   ASPINALL GO, 1971, CAN J CHEMISTRY, V49, P1019, DOI 10.1139/v71-169
   Chen H., 2011, FOOD SCI TECHNOL, V36, P211
   [陈红 CHEN Hong], 2011, [食品科学, Food Science], V32, P139
   [陈红 CHEN Hong], 2011, [吉林农业大学学报, Journal of Jilin Agricultural University], V33, P581
   Chen WP, 2010, J FOOD SCI, V75, pC478, DOI 10.1111/j.1750-3841.2010.01688.x
   [陈姿含 Chen Zihan], 2012, [食品与发酵工业, Food and Fermentation Industries], V38, P194
   [丁冬梅 Ding Dongmei], 2014, [中草药, Chinese Traditional and Herbal Drugs], V45, P46
   Fang X, 2003, BIOSCI BIOTECH BIOCH, V67, P1864, DOI 10.1271/bbb.67.1864
   Funami T, 2008, FOOD HYDROCOLLOID, V22, P1528, DOI 10.1016/j.foodhyd.2007.10.008
   Furuta H, 2003, BIOSCI BIOTECH BIOCH, V67, P677, DOI 10.1271/bbb.67.677
   Furuta H, 1998, BIOSCI BIOTECH BIOCH, V62, P2300, DOI 10.1271/bbb.62.2300
   Furuta H, 1999, FOOD HYDROCOLLOID, V13, P267, DOI 10.1016/S0268-005X(99)00009-0
   HIGASHIRA K, 1988, NAGOYA KEIZAI DAIGAK, V22, P9
   Hisashi K., 1997, JPN J CROP SCI, V66, P62
   Hou ZQ, 2010, J AGR FOOD CHEM, V58, P8604, DOI 10.1021/jf1015686
   Huisman MMH, 1999, CARBOHYD POLYM, V38, P299, DOI 10.1016/S0144-8617(98)00127-1
   Huisman MMH, 1998, CARBOHYD POLYM, V37, P87, DOI 10.1016/S0144-8617(97)00111-2
   Inada N., 2014, BIOSCI BIOTECH BIOCH, V79, P97
   KAWAMURA S, 1961, AGR BIOL CHEM TOKYO, V25, P527, DOI 10.1080/00021369.1961.10857841
   Khare SK, 1995, BIORESOURCE TECHNOL, V54, P323, DOI 10.1016/0960-8524(95)00155-7
   KIOSSEOGLOU V, 1988, LEBENSM WISS TECHNOL, V21, P33
   Lai Fu-rao, 2010, Journal of South China University of Technology, V38, P50, DOI 10.3969/j.issn.1000-565X.2010.04.010
   Li J, 2009, BIOSCI BIOTECH BIOCH, V73, P2568, DOI 10.1271/bbb.70799
   Li SH, 2014, J TAIWAN INST CHEM E, V45, P6, DOI 10.1016/j.jtice.2013.05.019
   Li Y., 2006, BEVERAGE FAST FROZEN, V12, P33
   Liao HF, 2005, LIFE SCI, V77, P400, DOI 10.1016/j.lfs.2004.10.080
   Liu J, 2015, J AGR FOOD CHEM, V63, P225, DOI 10.1021/jf505172m
   Liu J, 2015, INT J BIOL MACROMOL, V72, P1182, DOI 10.1016/j.ijbiomac.2014.08.058
   [娄冠群 Lou Guanqun], 2010, [中国油脂, China Oils and Fats], V35, P61
   Mateos-Aparicio I, 2010, CARBOHYD POLYM, V82, P245, DOI 10.1016/j.carbpol.2010.04.020
   Meng Y. C., 2009, FOOD RES DEV, V30, P83
   MORITA M, 1965, AGR BIOL CHEM TOKYO, V29, P564
   Nakamura A, 2006, INT DAIRY J, V16, P361, DOI 10.1016/j.idairyj.2005.01.014
   Nakamura A, 2004, FOOD HYDROCOLLOID, V18, P795, DOI 10.1016/j.foodhyd.2003.12.005
   Nakamura A, 2003, FOOD HYDROCOLLOID, V17, P333, DOI 10.1016/S0268-005X(02)00095-4
   Nakamura A, 2002, BIOSCI BIOTECH BIOCH, V66, P1155, DOI 10.1271/bbb.66.1155
   Nakamura A, 2002, BIOSCI BIOTECH BIOCH, V66, P1301, DOI 10.1271/bbb.66.1301
   Nakamura A, 2001, BIOSCI BIOTECH BIOCH, V65, P2249, DOI 10.1271/bbb.65.2249
   Nakamura A, 2007, J AGR FOOD CHEM, V55, P502, DOI 10.1021/jf062634g
   Nakamura A, 2006, FOOD HYDROCOLLOID, V20, P1029, DOI 10.1016/j.foodhyd.2005.12.002
   Nakamura A, 2012, FOOD HYDROCOLLOID, V29, P75, DOI 10.1016/j.foodhyd.2012.01.018
   Nakauma M, 2008, FOOD HYDROCOLLOID, V22, P1254, DOI 10.1016/j.foodhyd.2007.09.004
   Nobuhara T, 2014, FOOD HYDROCOLLOID, V34, P39, DOI 10.1016/j.foodhyd.2013.01.022
   Ntazinda A, 2014, DAIRY SCI TECHNOL, V94, P283, DOI 10.1007/s13594-014-0162-9
   Ray M, 2013, FOOD RES INT, V52, P298, DOI 10.1016/j.foodres.2013.03.008
   Redondo-Cuenca A, 2008, FOOD CHEM, V108, P1099, DOI 10.1016/j.foodchem.2007.11.061
   Salarbashi D, 2014, FOOD CHEM, V146, P614, DOI 10.1016/j.foodchem.2013.09.014
   Salarbashi D, 2013, CARBOHYD POLYM, V98, P1127, DOI 10.1016/j.carbpol.2013.07.031
   Shi XQ, 2015, LWT-FOOD SCI TECHNOL, V62, P89, DOI 10.1016/j.lwt.2015.01.024
   SHOREY RL, 1985, J AM DIET ASSOC, V85, P1461
   Song H., 2011, CHINA FOOD ADDIT, P89
   Surel O, 2005, J SCI FOOD AGR, V85, P1343, DOI 10.1002/jsfa.2097
   Tajik S, 2013, CARBOHYD POLYM, V97, P817, DOI 10.1016/j.carbpol.2013.05.037
   Tian H. J., 2014, FOOD RES DEV, V35, P66
   [田龙 TIAN Long], 2008, [中国油脂, China Oils and Fats], V33, P64
   TODD JJ, 1993, PLANT PHYSIOL, V102, P663, DOI 10.1104/pp.102.2.663
   [涂宗财 TU Zongcai], 2011, [食品工业科技, Science & Technology of Food Industry], V32, P118
   Wang Q, 2005, CARBOHYD RES, V340, P2637, DOI 10.1016/j.carres.2005.08.012
   [王思远 Wang Siyuan], 2013, [中国粮油学报, Journal of the Chinese Cereals and Oils Association], V28, P33
   Wu JE, 2014, FOOD HYDROCOLLOID, V39, P144, DOI 10.1016/j.foodhyd.2013.12.029
   Wu MH, 2011, IMMUNOL INVEST, V40, P39, DOI 10.3109/08820139.2010.513021
   [熊杰 XIONG Jie], 2009, [大豆科学, Soybean Science], V28, P1119
   Xiong X. H., 2014, FOOD BIOPROD PROCESS, V94, P1
   [熊小辉 Xiong Xiaohui], 2013, [中国油脂, China Oils and Fats], V38, P64
   Yamaguchi F, 1996, CARBOHYD POLYM, V30, P265, DOI 10.1016/S0144-8617(96)00046-X
   Yao L, 2011, INT J MOL SCI, V12, P8096, DOI 10.3390/ijms12118096
   Yao XQ, 2012, CARBOHYD POLYM, V90, P392, DOI 10.1016/j.carbpol.2012.05.056
   [易阳 Yi Yang], 2013, [中国粮油学报, Journal of the Chinese Cereals and Oils Association], V28, P50
   Yin Y., 2009, SCI TECHNOL FOOD IND, V30, P83
   [张树和 ZHANG Shuhe], 2008, [中国微生态学杂志, Chinese Journal of Microecology], V20, P135
   Zhang X. J., 2012, DRUG EVAL RES, V35, P420
   [张秀娟 Zhang Xiujuan], 2014, [食品工业科技, Science & Technology of Food Industry], V35, P359
   [张秀娟 Zhang Xiujuan], 2013, [中国微生态学杂志, Chinese Journal of Microecology], V25, P521
   [张秀娟 Zhang Xiujuan], 2012, [食品工业科技, Science & Technology of Food Industry], V33, P389
   Zhao JJ, 2014, FOOD RES INT, V66, P216, DOI 10.1016/j.foodres.2014.09.019
   Zhao JJ, 2015, FOOD HYDROCOLLOID, V44, P443, DOI 10.1016/j.foodhyd.2014.10.025
   Zhao X., 2013, FOOD FERMENT IND, V39, P44
   许晨, 2002, [中国海洋药物, Chinese Journal of Marine Drugs], V21, P26
NR 79
TC 6
Z9 6
U1 13
U2 65
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 90
BP 73525
EP 73534
DI 10.1039/c5ra12421b
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA CQ8LY
UT WOS:000360860500024
DA 2018-10-19
ER

PT J
AU Chen, SS
   Lu, XM
   Zhu, DD
   Lu, QH
AF Chen, Shuangshuang
   Lu, Xuemin
   Zhu, Dandan
   Lu, Qinghua
TI Targeted grafting of thermoresponsive polymers from a penetrative
   honeycomb structure for cell sheet engineering
SO SOFT MATTER
LA English
DT Article
ID PROTEIN ADSORPTION; HIERARCHICAL STRUCTURES; BREATH FIGURES; SURFACE;
   ADHESION; BRUSHES; FILMS; ROUGHNESS; CHEMISTRY; BIOMATERIALS
AB Responsive membranes have been used to construct smart biomaterial interfaces. We report a novel approach to fabricate honeycomb films with a pattern of thermoresponsive polymer, namely poly( N-isopropylacrylamide). The approach was based on a combination of the breath figure method and reversible addition-fragmentation chain transfer. The hybrid film had morphological and chemical patterns resulting in varied wettability and morphology at various stages, as well as high thermo-responsiveness. Enhanced cell adhesion was observed at an incubation temperature of 37 degrees C, which is above its lower critical solution temperature (LCST). Furthermore, cells could be harvested at temperatures below the LCST without trypsin treatment. The non-invasive characteristics give this membrane potential as a substrate for cell sheet engineering.
C1 [Chen, Shuangshuang; Lu, Xuemin; Zhu, Dandan; Lu, Qinghua] Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Sch Chem & Chem Engn, Shanghai 200240, Peoples R China.
RP Lu, XM (reprint author), Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Sch Chem & Chem Engn, Shanghai 200240, Peoples R China.
EM xueminlu@sjtu.edu.cn; qhlu@sjtu.edu.cn
RI shuangshuang, chen/R-4029-2017
OI shuangshuang, chen/0000-0002-8478-5030
FU Chinese National Programs for Fundamental Research and Development (973
   Project) [2012CB933803]; National Science Foundation of China [21374060,
   51173103]; Excellent Academic Leaders of Shanghai [11XD1403000]
FX This work was supported by the Major Program of Chinese National
   Programs for Fundamental Research and Development (973 Project:
   2012CB933803), the National Science Foundation of China (21374060,
   51173103), and the Excellent Academic Leaders of Shanghai (11XD1403000).
CR Ahuja R.T., 2009, SENSOR ACTUAT B-CHEM, V136, P275
   Arisaka Y, 2013, BIOMATERIALS, V34, P4214, DOI 10.1016/j.biomaterials.2013.02.056
   Baharloo B, 2005, J BIOMED MATER RES A, V74A, P12, DOI 10.1002/jbm.a.30321
   Bai H, 2013, ANGEW CHEM INT EDIT, V52, P12240, DOI 10.1002/anie.201303594
   Baussard JF, 2004, POLYMER, V45, P3615, DOI 10.1016/j.polymer.2004.03.081
   Bhushan B, 2009, PHILOS T R SOC A, V367, P1631, DOI 10.1098/rsta.2009.0014
   Bryksin AV, 2014, ACTA BIOMATER, V10, P1761, DOI 10.1016/j.actbio.2014.01.019
   Chen DQ, 2011, INT J NANOMED, V6, P2053, DOI 10.2147/IJN.S24344
   Chen SS, 2015, CHEM COMMUN, V51, P5698, DOI 10.1039/c4cc10379c
   Chen SS, 2015, BIOMATER SCI-UK, V3, P85, DOI 10.1039/c4bm00233d
   Chu E, 2015, ACS APPL MATER INTER, V7, P12505, DOI 10.1021/am5080248
   Cooperstein MA, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4894530
   Cui JX, 2013, MACROMOL RAPID COMM, V34, P310, DOI 10.1002/marc.201200634
   de Leon AS, 2013, POLYM CHEM-UK, V4, P4024, DOI 10.1039/c3py00394a
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   Ercole F, 2010, POLYM CHEM-UK, V1, P37, DOI 10.1039/b9py00300b
   Escale P, 2012, EUR POLYM J, V48, P1001, DOI 10.1016/j.eurpolymj.2012.03.001
   Fang N, 2005, COLLOID SURFACE B, V42, P245, DOI 10.1016/j.colsurfb.2004.11.002
   George J, 2008, J BIOMED MATER RES A, V87A, P1103, DOI 10.1002/jbm.a.32277
   Heng LP, 2013, LANGMUIR, V29, P9491, DOI 10.1021/la401991n
   Hernandez-Guerrero M, 2008, J MATER CHEM, V18, P4718, DOI 10.1039/b807495j
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Isenberg BC, 2008, BIOMATERIALS, V29, P2565, DOI 10.1016/j.biomaterials.2008.02.023
   Jones JR, 2006, MATER TODAY, V9, P34, DOI 10.1016/S1369-7021(06)71741-2
   Kohen A., 1999, CHEM BIOL, V6, P191
   Kroning A, 2015, ACS APPL MATER INTER, V7, P12430, DOI 10.1021/am5075997
   Li LH, 2011, COLLOID SURFACE B, V85, P12, DOI 10.1016/j.colsurfb.2010.09.028
   Masuda S, 2008, ADV DRUG DELIVER REV, V60, P277, DOI 10.1016/j.addr.2007.08.031
   Mrksich M, 2002, CURR OPIN CHEM BIOL, V6, P794, DOI 10.1016/S1367-5931(02)00362-9
   Nagase K, 2011, MACROMOL BIOSCI, V11, P400, DOI 10.1002/mabi.201000312
   Natalia B, 2015, J BIOMED MATER RES A, V103, P145, DOI 10.1002/jbm.a.35163
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Okano T, 1996, P SOC PHOTO-OPT INS, V2779, P34, DOI 10.1117/12.237120
   Psarra E, 2015, ACS APPL MATER INTER, V7, P12516, DOI 10.1021/am508161q
   Ranella A, 2010, ACTA BIOMATER, V6, P2711, DOI 10.1016/j.actbio.2010.01.016
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Romeis D, 2015, ACS APPL MATER INTER, V7, P12496, DOI 10.1021/am507959k
   Shimauchi H., 2013, JPN DENT SCI REV, V49, P118
   Talab SS, 2014, BJU INT, V114, P937, DOI 10.1111/bju.12685
   Wan LS, 2012, J AM CHEM SOC, V134, P95, DOI 10.1021/ja2092745
   Wan PB, 2012, PROG CHEM, V24, P1
   Yamazaki H, 2014, J BIOSCI BIOENG, V118, P455, DOI 10.1016/j.jbiosc.2014.03.006
   Yin RX, 2010, COLLOID SURFACE B, V76, P483, DOI 10.1016/j.colsurfb.2009.12.008
   Zhang Y, 2007, ADV MATER, V19, P913, DOI 10.1002/adma.200601169
   Zhao C, 2013, BIOMATERIALS, V34, P4714, DOI 10.1016/j.biomaterials.2013.03.028
NR 45
TC 6
Z9 6
U1 3
U2 44
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2015
VL 11
IS 37
BP 7420
EP 7427
DI 10.1039/c5sm01769f
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA CR7SC
UT WOS:000361550000023
PM 26268946
DA 2018-10-19
ER

PT J
AU Yu, ML
   Yu, MF
   Zhu, LQ
   Wang, TT
   Zhou, Y
   Wang, HM
AF Yu, Meng-Liu
   Yu, Meng-Fei
   Zhu, Li-Qin
   Wang, Tian-Tian
   Zhou, Yi
   Wang, Hui-Ming
TI The Effects of TiO2 Nanodot Films with RGD Immobilization on
   Light-Induced Cell Sheet Technology
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; ARG-GLY-ASP; GENE-EXPRESSION; PEPTIDE; ADHESION;
   TITANIUM; GROWTH; DIFFERENTIATION; ATTACHMENT; DETACHMENT
AB Cell sheet technology is a new strategy in tissue engineering which could be possible to implant into the body without a scaffold. In order to get an integrated cell sheet, a light-induced method via UV365 is used for cell sheet detachment from culture dishes. In this study, we investigated the possibility of cell detachment and growth efficiency on TiO2 nanodot films with RGD immobilization on light-induced cell sheet technology. Mouse calvaria-derived, preosteoblastic (MC3T3-E1) cells were cultured on TiO2 nanodot films with (TR) or without (TN) RGD immobilization. After cells were cultured with or without 5.5mW/cm(2) UV365 illumination, cell morphology, cell viability, osteogenesis related RNA and protein expression, and cell detachment ability were compared, respectively. Light-induced cell detachment was possible when cells were cultured on TR samples. Also, cells cultured on TR samples showed better cell viability, alongside higher protein and RNA expression than on TN samples. This study provides a new biomaterial for light-induced cell/cell sheet harvesting.
C1 [Yu, Meng-Liu; Yu, Meng-Fei; Zhou, Yi; Wang, Hui-Ming] Zhejiang Univ, Coll Med, Affiliated Hosp Stomatol, Hangzhou 310006, Zhejiang, Peoples R China.
   [Zhu, Li-Qin; Wang, Hui-Ming] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou 310006, Zhejiang, Peoples R China.
   [Wang, Tian-Tian] Zhejiang Univ, State Key Lab Silicon Mat, Dept Mat Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China.
RP Wang, HM (reprint author), Zhejiang Univ, Coll Med, Affiliated Hosp Stomatol, Hangzhou 310006, Zhejiang, Peoples R China.
EM hmwang1960@hotmail.com
FU National Natural Science Foundation of China [81171003, 81371120];
   Medical Technology and Education of Zhejiang Province of China
   [wkj-zj-11]
FX This work is financially supported by National Natural Science
   Foundation of China (81171003 and 81371120) and Medical Technology and
   Education of Zhejiang Province of China (wkj-zj-11).
CR Andiappan M., 2013, PROG BIOMATER, V2, P1
   BHALERAO J, 1995, TISSUE CELL, V27, P369, DOI 10.1016/S0040-8166(95)80058-1
   Bidarra SJ, 2010, BIOMACROMOLECULES, V11, P1956, DOI 10.1021/bm100264a
   Cao FY, 2015, ACS APPL MATER INTER, V7, P6698, DOI 10.1021/acsami.5b00064
   Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033
   Csucs G, 2003, BIOMATERIALS, V24, P1713, DOI 10.1016/S0142-9612(02)00568-9
   deLaat A, 1997, CARCINOGENESIS, V18, P1013, DOI 10.1093/carcin/18.5.1013
   Fukumori K, 2009, ACTA BIOMATER, V5, P470, DOI 10.1016/j.actbio.2008.06.018
   Guillaume-Gentil O, 2011, BIOMATERIALS, V32, P4376, DOI 10.1016/j.biomaterials.2011.02.058
   Han YL, 2013, COLLOID SURFACE B, V111, P479, DOI 10.1016/j.colsurfb.2013.06.042
   Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402
   Hazrin-Chong NH, 2012, J MICROBIOL METH, V90, P96, DOI 10.1016/j.mimet.2012.04.014
   Hong Y, 2013, BIOMATERIALS, V34, P11, DOI 10.1016/j.biomaterials.2012.09.043
   Huang HL, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-36
   Huang YC, 2013, SPINE J, V13, P352, DOI 10.1016/j.spinee.2012.12.005
   Inaba R, 2009, BIOMATERIALS, V30, P3573, DOI 10.1016/j.biomaterials.2009.03.045
   Ito A, 2005, BIOMATERIALS, V26, P6185, DOI 10.1016/j.biomaterials.2005.03.039
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KM, 2013, ACTA BIOMATER, V9, P5600, DOI 10.1016/j.actbio.2012.10.036
   Little MW, 2007, J PHYS CHEM C, V111, P1412, DOI 10.1021/jp063154v
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Marie PJ, 2014, CALCIFIED TISSUE INT, V94, P46, DOI 10.1007/s00223-013-9733-7
   Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406
   MCAUSLAN BR, 1987, J BIOMED MATER RES, V21, P921, DOI 10.1002/jbm.820210708
   Michel JB, 2003, ARTERIOSCL THROM VAS, V23, P2146, DOI 10.1161/01.ATV.0000099882.52647.E4
   Oya K, 2009, BIOMATERIALS, V30, P1281, DOI 10.1016/j.biomaterials.2008.11.030
   Papadopoulou EL, 2009, J PHYS CHEM C, V113, P2891, DOI 10.1021/jp8085057
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   QUAITE FE, 1994, PLANT MOL BIOL, V24, P475, DOI 10.1007/BF00024115
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   Schliephake H, 2002, CLIN ORAL IMPLAN RES, V13, P312, DOI 10.1034/j.1600-0501.2002.130312.x
   Schliephake H, 2008, J MATER CHEM, V18, P2404, DOI 10.1039/015355b
   Schroeder Tania M., 2005, Birth Defects Research, V75, P213, DOI 10.1002/bdrc.20043
   Shachar M, 2011, ACTA BIOMATER, V7, P152, DOI 10.1016/j.actbio.2010.07.034
   STEIN GS, 1990, FASEB J, V4, P3111
   Tang ZL, 2010, BIOMATERIALS, V31, P7435, DOI 10.1016/j.biomaterials.2010.06.040
   Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806
   Von Recum HA, 1999, EXP EYE RES, V69, P97, DOI 10.1006/exer.1999.0682
   Wang F, 2013, INT J MOL SCI, V14, P13447, DOI 10.3390/ijms140713447
   Wu YS, 2015, INT J ONCOL, V46, P2586, DOI 10.3892/ijo.2015.2976
   Yamato M, 2004, MATER TODAY, V7, P42, DOI 10.1016/S1369-7021(04)00234-2
   Zhu K, 2007, NANO LETT, V7, P69, DOI 10.1021/nl062000o
NR 43
TC 1
Z9 1
U1 1
U2 11
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 582359
DI 10.1155/2015/582359
PG 10
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CR3CN
UT WOS:000361208200001
PM 26417596
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Lu, DS
   Zheng, ZZ
   Guo, SZ
   Wang, C
   Kaplan, DL
   Wang, XQ
AF Lu, Disi
   Zheng, Zhaozhu
   Guo, Shaozhe
   Wang, Cheng
   Kaplan, David L.
   Wang, Xiaoqin
TI Binding Quantum Dots to Silk Biomaterials for Optical Sensing
SO JOURNAL OF SENSORS
LA English
DT Article
ID COMPOSITES; GLUCOSE; NANOCRYSTALS; PROTEINS; SENSORS; CHARGE; SIZE; FILM
AB Quantum dots (QDs), have great potential for fabricating optical sensing devices and imaging biomaterial degradation in vivo. In the present study, 2-mercaptoethylamine- (MEA-) and mercaptopropionic acid-(MPA-) capped CdTe-QDs were physically incorporated in silk films that contained a high content (>30%) of crystalline beta-sheet structure. The beta-sheets were induced by the addition of glycerol, water annealing, glycerol/annealing, or treatment with methanol. Incorporation of QDs did not influence the formation of beta-sheets. When the films were extracted with water, most QDs remained associated with the silk, based on the retention of photoluminescence in the silk films and negligible photoluminescence in the extracts. Compared to the solution state, photoluminescence intensity significantly decreased for MEA-QDs but not for MPA-QDs in the silk films, while the emission maximum blue shifted (approximate to 4 nm) slightly for both. Further film digestion using protease XIV, alpha-chymotrypsin, and the combination of the two proteases suggested that QDs may be bound to the silk beta-sheet regions but not the amorphous regions. QDs photoluminescence in silk films was quenched when the concentration of hydrogen peroxide (H2O2) was above 0.2-0.3 mM, indicating the QDs-incorporated silk films can be used to report oxidation potential in solution.
C1 [Lu, Disi; Wang, Cheng] Heilongjiang Univ, Coll Chem Engn & Mat Chem, Harbin 150086, Peoples R China.
   [Zheng, Zhaozhu; Guo, Shaozhe; Wang, Xiaoqin] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Wang, XQ (reprint author), Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM xiaoqin.wang@tufts.edu
FU Natural Science Foundation of China Grant [51273138]; Start-Up Fund of
   Soochow University [14317432]; Natural Science Foundation of Suzhou City
   Jiangsu Province China [SYN201403]; Postdoctoral Science Foundation of
   Jiangsu Province China
FX This work was supported by Natural Science Foundation of China Grant
   (Project no. 51273138), Start-Up Fund of Soochow University (Project no.
   14317432), Natural Science Foundation of Suzhou City Jiangsu Province
   China (Grant no. SYN201403), and Postdoctoral Science Foundation of
   Jiangsu Province China.
CR Bakker E, 2004, ANAL CHEM, V76, P3285, DOI 10.1021/ac049580z
   Brown J., 2015, ACTA BIOMATER, V11, P212
   Broza YY, 2013, NANOMEDICINE-UK, V8, P785, DOI [10.2217/NNM.13.64, 10.2217/nnm.13.64]
   Cho S, 2013, CHEM MATER, V25, P1071, DOI 10.1021/cm3040505
   Chong Y, 2014, BIOMATERIALS, V35, P5041, DOI 10.1016/j.biomaterials.2014.03.021
   Dong ZM, 2013, J PROTEOME RES, V12, P5213, DOI 10.1021/pr4005772
   Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194
   Gaponik N, 2002, J PHYS CHEM B, V106, P7177, DOI 10.1021/jp025541k
   Gill R, 2008, ANGEW CHEM INT EDIT, V47, P1676, DOI 10.1002/anie.200704794
   Hardy JG, 2013, MACROMOL BIOSCI, V13, P1431, DOI 10.1002/mabi.201300233
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Ismaili H, 2011, CHEM MATER, V23, P1519, DOI 10.1021/cm103284g
   Kaniyankandy S, 2010, PHYS CHEM CHEM PHYS, V12, P4210, DOI 10.1039/b921130f
   Kuang H, 2011, TRAC-TREND ANAL CHEM, V30, P1620, DOI 10.1016/j.trac.2011.04.022
   Li YP, 2013, LUMINESCENCE, V28, P667, DOI 10.1002/bio.2413
   Lu SZ, 2010, BIOMACROMOLECULES, V11, P143, DOI 10.1021/bm900993n
   Luccardini C, 2006, LANGMUIR, V22, P2304, DOI 10.1021/la052704y
   Ludwigs S, 2003, NAT MATER, V2, P744, DOI 10.1038/nmat997
   Ma Q, 2011, ANALYST, V136, P4883, DOI 10.1039/c1an15741h
   Murphy CJ, 2002, ANAL CHEM, V74, p520A, DOI 10.1021/ac022124v
   Osaki F, 2004, J AM CHEM SOC, V126, P6520, DOI 10.1021/ja048792a
   Pellegrino T, 2004, NANO LETT, V4, P703, DOI 10.1021/nl035172j
   Pritchard EM, 2012, BIOPOLYMERS, V97, P479, DOI 10.1002/bip.22026
   Reece TJ, 2003, APPL PHYS LETT, V82, P142, DOI 10.1063/1.1533844
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Saran AD, 2011, COLLOID SURFACE A, V384, P393, DOI 10.1016/j.colsurfa.2011.04.022
   Stolarek R, 2010, CLIN CHIM ACTA, V411, P1849, DOI 10.1016/j.cca.2010.08.031
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109
   Venugopal BR, 2006, J PHYS CHEM B, V110, P772, DOI 10.1021/jp054774j
   Yao HB, 2012, ACS NANO, V6, P8250, DOI 10.1021/nn3029315
   Zimnitsky D, 2007, LANGMUIR, V23, P4509, DOI 10.1021/la0636917
NR 32
TC 3
Z9 3
U1 2
U2 26
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 315 MADISON AVE 3RD FLR, STE 3070, NEW YORK, NY 10017 USA
SN 1687-725X
EI 1687-7268
J9 J SENSORS
JI J. Sens.
PY 2015
AR 819373
DI 10.1155/2015/819373
PG 10
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA CR3GG
UT WOS:000361218700001
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Sund, JB
   Wolter, SD
   Parker, CB
   Natishan, PM
   Glass, JT
AF Sund, James B.
   Wolter, Scott D.
   Parker, Charles B.
   Natishan, Paul M.
   Glass, Jeffrey T.
TI Diamond for Biosensing: Electrochemical Detection of NOx Species with
   Thiol-Amine Functionalized Diamond
SO JOURNAL OF THE ELECTROCHEMICAL SOCIETY
LA English
DT Article
ID NITRIC-OXIDE MICROSENSOR; MODIFIED CARBON-FIBER; ELECTROCATALYTIC
   OXIDATION; ELECTRODE; FILMS; POLYMER; SENSORS; BRAIN
AB Diamond has long been of interest as a biomaterial due to its expected biocompatibility and chemical stability. Progress in surface functionalization of diamond and diamond electrochemistry has extended this interest to use as a biosensor platform. The sensitivity and selectivity of the diamond surface can be enhanced by covalently attaching carbon-based biochemicals. In this communication, an amine-thiol molecule was attached to a boron-doped diamond (BDD) surface to produce an enhanced ability to detect NO species. In the case of hydrogen terminated BDD, it was found that NO (aqueous) oxidation was insufficiently distinct to electrochemically detect NO. However, the amine-thiol functionalized BDD surface provided a distinct oxidation peak from 65 nanomolar to 236 nanomolar concentrations. Multiple cyclic voltammagrams with amine-thiol functionalized BDD electrode in (HPLC-quality) purified water indicated that the covalently attached surface molecules resisted decomposition during both anodic and cathodic polarization. (C) The Author(s) 2015. Published by ECS. All rights reserved.
C1 [Sund, James B.; Parker, Charles B.; Glass, Jeffrey T.] Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA.
   [Wolter, Scott D.] Elon Univ, Dept Phys, Elon, NC 27244 USA.
   [Natishan, Paul M.] Naval Res Lab, Washington, DC 20375 USA.
RP Sund, JB (reprint author), Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA.
EM cbparker@duke.edu
FU NASA [NNL05AA14A]
FX A significant amount of this work was funded in part by Dr. Seun Kahng,
   NASA grant No. NNL05AA14A; Boron doped diamond samples were provided by
   Taka Tachibana, Kobe Steel, Ltd., Electronics Research Laboratory. 1-5-5
   Takatsukadai, Nishi-ku, Kobe 651-2271 Japan. We also thank Corey P.
   Causey and his doctoral advisor Professor Eric J. Toone in the
   Departments of Chemistry and Biochemistry, Duke University, Durham, NC
   USA for their direct involvement in extending the amine surface tether
   to a terminal Thiol. We are grateful to Dr. Michael Garcia, Nicki
   Thompson, and Prof. Joseph Bonaventura for help in developing the NO
   calibration protocol. Finally, we thank Edmond F. Bowden of North
   Carolina State University for use of the electrochemical cell.
CR Allen BW, 2000, NITRIC OXIDE-BIOL CH, V4, P75, DOI 10.1006/niox.2000.0273
   Beckman Joseph S., 1995, Methods (Orlando), V7, P35, DOI 10.1006/meth.1995.1005
   BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030
   Casero E, 2003, TALANTA, V61, P61, DOI 10.1016/S0039-9140(03)00360-6
   Casero E, 2003, ANAL BIOANAL CHEM, V375, P294, DOI 10.1007/s00216-002-1650-y
   Ciszewski A, 1996, ELECTROANAL, V8, P293, DOI 10.1002/elan.1140080316
   Davies IR, 2008, METHOD ENZYMOL, V436, P63, DOI 10.1016/S0076-6879(08)36005-4
   Derjaguin D. L. H., 1973, CARBON, V11, P299
   Fabre B, 1997, J ELECTROANAL CHEM, V426, P75, DOI 10.1016/S0022-0728(96)04985-6
   Fan CH, 2000, ANAL CHIM ACTA, V423, P95, DOI 10.1016/S0003-2670(00)01093-X
   Fan CH, 2002, ANAL SCI, V18, P129, DOI 10.2116/analsci.18.129
   Feelisch M, 1996, METHODS NITRIC OXIDE
   Ferreira NR, 2005, ANAL CHIM ACTA, V535, P1, DOI 10.1016/j.aca.2004.12.017
   Friedemann MN, 1996, ANAL CHEM, V68, P2621, DOI 10.1021/ac960093w
   GE Analytical Instruments, 2009, SEIVERS NITRIC OXIDE
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   Haruyama T, 1998, BIOSENS BIOELECTRON, V13, P763, DOI 10.1016/S0956-5663(98)00040-2
   He XC, 2000, ANALYST, V125, P793, DOI 10.1039/a909837b
   ICHIMORI K, 1994, REV SCI INSTRUM, V65, P2714, DOI 10.1063/1.1144674
   Ji YB, 1999, ARCH BIOCHEM BIOPHYS, V362, P67, DOI 10.1006/abbi.1998.1013
   Kato D, 2005, SENSOR ACTUAT B-CHEM, V108, P384, DOI 10.1016/j.snb.2004.12.095
   Katrlik J, 2002, BIOELECTROCHEMISTRY, V56, P73, DOI 10.1016/S1567-5394(02)00024-5
   Kitajima A, 2001, ELECTROCHEMISTRY, V69, P16
   Kitamura Y, 2000, ANAL CHEM, V72, P2957, DOI 10.1021/ac000165q
   LANTOINE F, 1995, J ELECTROANAL CHEM, V392, P85, DOI 10.1016/0022-0728(95)04042-M
   Lee Y, 2004, ANAL CHEM, V76, P536, DOI 10.1021/ac035064h
   Mizutani F, 2001, SENSOR ACTUAT B-CHEM, V76, P489, DOI 10.1016/S0925-4005(01)00596-2
   Park JK, 1998, BIOSENS BIOELECTRON, V13, P1187, DOI 10.1016/S0956-5663(98)00078-5
   Pontie M, 1999, ELECTROANAL, V11, P845, DOI 10.1002/(SICI)1521-4109(199908)11:12<845::AID-ELAN845>3.3.CO;2-4
   Shin JH, 2005, ANAL CHEM, V77, P3494, DOI 10.1021/ac048153i
   Smith SR, 1998, INORG CHIM ACTA, V273, P316, DOI 10.1016/S0020-1693(97)06062-3
   Steffen K., 2004, ELECTROANAL, V16, P253
   Strother T, 2002, LANGMUIR, V18, P968, DOI 10.1021/la0112561
   Sund JB, 2014, APPL SURF SCI, V301, P293, DOI 10.1016/j.apsusc.2014.02.067
   Wallace John L., 1995, Methods (Orlando), V7, P55, DOI 10.1006/meth.1995.1008
   WENNMALM A, 1990, ANAL BIOCHEM, V187, P359, DOI 10.1016/0003-2697(90)90470-T
   Williams D. L. H., 2004, NITROSATION REACTION
   Xian YZ, 1999, ANAL CHIM ACTA, V381, P191, DOI 10.1016/S0003-2670(98)00765-X
NR 38
TC 2
Z9 2
U1 4
U2 23
PU ELECTROCHEMICAL SOC INC
PI PENNINGTON
PA 65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA
SN 0013-4651
EI 1945-7111
J9 J ELECTROCHEM SOC
JI J. Electrochem. Soc.
PY 2015
VL 162
IS 8
BP B225
EP B229
DI 10.1149/2.0691508jes
PG 5
WC Electrochemistry; Materials Science, Coatings & Films
SC Electrochemistry; Materials Science
GA CR2WS
UT WOS:000361192200038
OA Other Gold
DA 2018-10-19
ER

PT J
AU Miki, M
   Morita, M
AF Miki, Masahito
   Morita, Masafumi
TI Evaluation of the Biocompatibility of a Ti-Ta-Sn Alloy Using Cell
   Cultures
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE titanium alloy; cell adhesion rate; cell proliferation rate;
   cytotoxicity analysis; metallic biomaterial
AB The purpose of this study was to determine the suitability of a newly developed Ti-Ta-Sn alloy for use as a metallic biomaterial. The in vitro cell toxicity was determined by testing the corroding metal solutions using cell culture. Besides the cell adhesion rate, cell proliferation and colony formation were tested on the metal plates. Results of the cytotoxicity tests for higher concentrations of the corroding metal solutions (32 ppm and 64 ppm) revealed that the toxicity for U937 macrophages was lowest for the Ti-Ta-Sn alloy, followed by SUS316L and Co-Cr-Mo, with Ni-Ti being the most toxic. The Ti-Ta-Sn solution showed no cytotoxicity, even at a concentration of 64 ppm. The Co-Cr-Mo and Ni-Ti solutions showed high cytotoxicity for L929 cells. The cytotoxicity that was measured from the lactate dehydrogenase (LDH) release was highest for the Co-Cr-Mo alloy, followed by Ni-Ti, SUS316L, and Ti-Ta-Sn that showed the lowest value. Besides, the success rate of cell adhesion was highest for the Ti-Ta-Sn alloy after culturing for 6, 12, and 24 h. The cell proliferation tests showed that the cell proliferation speed and the relative cell proliferation rate after 3 days were both highest on Ti-Ta-Sn plates. Colony formation was highest on the Ti-Ta-Sn plates, and it was lowest on Co-Cr-Mo and SUS316L plates. These results demonstrated the suitability of the Ti-Ta-Sn alloy for use as a metallic biomaterial at the cellular level.
C1 [Miki, Masahito] Saitama Univ, Res & Dev Bur, Tech Support Ctr, Saitama 3388570, Japan.
   [Morita, Masafumi] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan.
RP Miki, M (reprint author), Saitama Univ, Res & Dev Bur, Tech Support Ctr, Saitama 3388570, Japan.
EM miki@mech.saitama-u.ac.jp
FU Japan Science and Technology Agency Revitalization Promotion Program
   (A-STEP) [241FS0064]
FX Part of this study was conducted under the auspices of the Japan Science
   and Technology Agency Revitalization Promotion Program (A-STEP), seeds
   validation type (241FS0064).
CR Hanawa T., 2007, METALS BIOMATERIALS, P85
   Ishihara K., 2010, FOUNDAMETALS BIOMATE, P30
   Ishikawa Y., 2014, MAT SCI TECHN JAPAN, V51, P217
   Kawanishi S, 2001, FREE RADICAL BIO MED, V31, P108, DOI 10.1016/S0891-5849(01)00558-5
   Kobayashi E., 2002, MAT JAPAN, V41, P553
   Miki M., 2014, MAT SCI TECHN JAPAN, V51, P117
   Oshida Y, 1991, ZAIRYO TO KANKYO, V40, P834
   Pourbaix M., 1974, ATLAS ELECTROCHEMICA, P80
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
NR 9
TC 1
Z9 1
U1 0
U2 4
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PY 2015
VL 56
IS 7
BP 1087
EP 1091
DI 10.2320/matertrans.M2015062
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CR2JZ
UT WOS:000361156900038
OA Bronze
DA 2018-10-19
ER

PT J
AU Kowalski, SJ
   Szadzinska, J
   Pawlowski, A
AF Kowalski, S. J.
   Szadzinska, J.
   Pawlowski, A.
TI Ultrasonic-Assisted Osmotic Dehydration of Carrot Followed by Convective
   Drying with Continuous and Intermittent Heating
SO DRYING TECHNOLOGY
LA English
DT Article
DE Carrot; Intermittent drying; Osmotic pretreatment; Quality; Ultrasound
ID POWER ULTRASOUND; PRODUCT QUALITY; BETA-CAROTENE; COLOR CHANGES;
   KINETICS; PRETREATMENT; SLICES; VEGETABLES; PINEAPPLE; FRUITS
AB The aim of the studies was to analyze the effect of ultrasound action on osmotic pretreatment and then on drying kinetics in continuous and intermittent drying conditions, and on the final product quality. This article presents the results of intermittent-convective drying of carrot preceded by ultrasonic assisted osmotic dehydration in fructose aqueous solutions. The theoretical drying kinetics developed from the numerical solution of mathematical model is validated using the experimental data. It has been shown that combination of ultrasonic assisted osmosis with intermittent-convective drying accelerates the drying process and improves the quality of dried biomaterial. A good adherence of the numerically determined kinetic curves confirms the usefulness of the presented model and its possible application to construction of controlled and optimized drying processes.
C1 [Kowalski, S. J.; Szadzinska, J.; Pawlowski, A.] Poznan Univ Tech, Inst Technol & Chem Engn, Dept Proc Engn, PL-60965 Poznan, Poland.
RP Kowalski, SJ (reprint author), Poznan Univ Tech, Inst Technol & Chem Engn, Dept Proc Engn, Berdychowo 4, PL-60965 Poznan, Poland.
EM Stefan.J.Kowalski@put.poznan.pl
RI Pawlowski, Andrzej/P-3989-2015; Szadzinska, Justyna/R-5862-2016
FU National Science Center Poland [2012/05/B/ST8/01773]
FX This work was carried out as a part of the research project No
   2012/05/B/ST8/01773 sponsored by the National Science Center Poland.
CR Adams M., 1999, BASIC FOOD SAFETY HL, P29
   Burri BJ, 1997, NUTR RES, V17, P547, DOI 10.1016/S0271-5317(97)00011-0
   Chua KJ, 2003, BIORESOURCE TECHNOL, V90, P285, DOI 10.1016/S0960-8524(03)00133-0
   Chua KJ, 2001, DRY TECHNOL, V19, P1949, DOI 10.1081/DRT-100107282
   Fernandes FAN, 2009, J FOOD ENG, V90, P186, DOI 10.1016/j.jfoodeng.2008.06.021
   Frias J, 2010, J AGR FOOD CHEM, V58, P10539, DOI 10.1021/jf102797y
   Gajewska I., 1974, PHYS CHEM HDB
   Jayaraman KS, 2006, HDB IND DRYING, P606
   Kek SP, 2013, FOOD BIOPROD PROCESS, V91, P495, DOI 10.1016/j.fbp.2013.05.003
   Koca N, 2007, J FOOD ENG, V78, P449, DOI 10.1016/j.jfoodeng.2005.10.014
   Kowalski SJ, 2014, DRY TECHNOL, V32, P1310, DOI 10.1080/07373937.2014.915555
   Kowalski SJ, 2013, DRY TECHNOL, V31, P1849, DOI 10.1080/07373937.2013.833518
   Kowalski SJ, 2010, DRY TECHNOL, V28, P1023, DOI 10.1080/07373937.2010.497095
   Kowalski SJ, 2013, J FOOD ENG, V118, P393, DOI 10.1016/j.jfoodeng.2013.04.028
   Krokida MK, 2000, DRY TECHNOL, V18, P1251, DOI 10.1080/07373930008917775
   Kudra T, 2004, DRY TECHNOL, V22, P917, DOI [10.1081/DRT-120038572, 10.1081/drt-120038572]
   Lewicki PP, 2006, HDB IND DRYING, P665
   Pan YK, 1999, DRY TECHNOL, V17, P2323, DOI 10.1080/07373939908917686
   Pan YK, 2003, DRY TECHNOL, V21, P1101, DOI 10.1081/DRT-120021877
   Sabarez HT, 2012, DRY TECHNOL, V30, P989, DOI 10.1080/07373937.2012.677083
   Sagar VR, 2010, J FOOD SCI TECH MYS, V47, P15, DOI 10.1007/s13197-010-0010-8
   Saltmarch M., 1982, Diabetes, V31, P29
   Sikorski Z.E., 2007, FOOD CHEM FOOD INGRE
   Tan M, 2001, DRY TECHNOL, V19, P2193, DOI 10.1081/DRT-100107494
   Zheng J, 2014, INT J FOOD SCI TECH, V49, P531, DOI 10.1111/ijfs.12334
NR 25
TC 13
Z9 14
U1 1
U2 19
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0737-3937
EI 1532-2300
J9 DRY TECHNOL
JI Dry. Technol.
PY 2015
VL 33
IS 13
SI SI
BP 1570
EP 1580
DI 10.1080/07373937.2015.1012265
PN 1
PG 11
WC Engineering, Chemical; Engineering, Mechanical
SC Engineering
GA CQ5RS
UT WOS:000360663900007
DA 2018-10-19
ER

PT J
AU Lim, JI
   Kim, SH
AF Lim, Jin Ik
   Kim, Soo Hyun
TI Blood-compatible Bio-inspired Surface of
   Poly(L-lactide-co-epsilon-caprolactone) Films Prepared Using Poor
   Co-solvent Casting
SO POLYMER-KOREA
LA English
DT Article
DE antithrombotic material; lotus-leaf-like structure; co-solvent system;
   blood vessel; surface modification
ID ENDOTHELIAL GROWTH-FACTOR; SUPERHYDROPHOBIC SURFACES; LOTUS-LEAF;
   MICROSPHERES; FABRICATION; BEHAVIOR; RELEASE; ACID)
AB Simple poor-cosolvent casting was used to surface treat biodegradable elastic poly(L-lactide-co-epsilon-caprolactone) (PLCL; 50:50) copolymer films that presented lotus-leaf-like structures. We evaluated whether the lotus-leaflike-structured PLCL (L-PLCL) films could be used as a biomaterial for artificial vascular grafts. The surface morphology, hydrophobicity, and antithrombotic efficiency of the films were examined while immersed in platelet-rich plasma (PRP) using scanning electron microscopy (SEM) and a contact angle meter. The recovery and crystallinity of the films were measured using a tensile-strength testing machine and an X-ray diffractometer, respectively. The solvent containing acetic acid, as a poor co-solvent, and methylene chloride mixed in a 1:2 ratio produced an optimal PLCL film with a water contact angle of approximately 124 degrees. Furthermore, the surface of the L-PLCL films immersed in PRP showed a lower rate of platelet adhesion (<10%) than that of the surface of an untreated PLCL film immersed in PRP.
C1 [Lim, Jin Ik] Dancook Univ, Coll Engn, Lab Biointetfaces Tissue Engn, Dept Chem Engn,Inst Tissue Regenerat Engn,Coll En, Yongin 448701, Gyeonggi Do, South Korea.
   [Kim, Soo Hyun] Korea Inst Sci & Technol, Biomat Res Ctr, Div Life & Hlth Sci, Seoul 136791, South Korea.
   [Kim, Soo Hyun] Korea Univ, KU KIST Grad Sch Converging Sci & Technol, Seoul 136701, South Korea.
RP Kim, SH (reprint author), Korea Inst Sci & Technol, Biomat Res Ctr, Div Life & Hlth Sci, Seoul 136791, South Korea.
EM soohkim@kist.re.kr
OI Kim, Soo Hyun/0000-0002-8391-3686
FU National Research Foundation of Korea Grant - Korean Government (MEST)
   [NRF-2010-C1AAA001-2010-0028939]; Fundamental Research Program of KIST
FX This work was supported by the National Research Foundation of Korea
   Grant funded by the Korean Government (MEST)
   NRF-2010-C1AAA001-2010-0028939 and the Fundamental Research Program of
   KIST.
CR AGRAWAL CM, 1992, BIOMATERIALS, V13, P176, DOI 10.1016/0142-9612(92)90068-Y
   Brash J.L., 1995, PROTEINS INTERFACE 2, V5, P1
   Chen G., 2001, MAT SCI ENG C, V17, P36
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   COURTNEY JM, 1994, BRIT MED BULL, V50, P966, DOI 10.1093/oxfordjournals.bmb.a072937
   Crick CR, 2010, CHEM-EUR J, V16, P3568, DOI 10.1002/chem.200903335
   Ensikat HJ, 2011, BEILSTEIN J NANOTECH, V2, P152, DOI 10.3762/bjnano.2.19
   FORBES CD, 1995, SCOT MED J, V40, P99, DOI 10.1177/003693309504000401
   Gao L., 2009, LANGMUIR, V25, P1410
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   Jeong SI, 2004, BIOMATERIALS, V25, P5939, DOI 10.1016/j.biomaterials.2004.01.057
   Kim HI, 2011, BIOMATERIALS, V32, P2241, DOI 10.1016/j.biomaterials.2010.11.067
   Kim SI, 2014, COLLOID SURFACE B, V114, P28, DOI 10.1016/j.colsurfb.2013.09.038
   Kim Y. H., 1996, POLYM MAT ENCY, P825
   Lim JI, 2013, POLYM-KOREA, V37, P411, DOI 10.7317/pk.2013.37.4.411
   Ma ML, 2006, CURR OPIN COLLOID IN, V11, P193, DOI 10.1016/j.cocis.2006.06.002
   Olsson P, 2000, J BIOMAT SCI-POLYM E, V11, P1261, DOI 10.1163/156856200744192
   Schwarzer HC, 2005, CHEM ENG SCI, V60, P11, DOI 10.1016/j.ces.2004.06.050
   Shen H, 2007, BIOMATERIALS, V28, P4219, DOI 10.1016/j.biomaterials.2007.06.004
   Shen H, 2010, ACTA BIOMATER, V6, P455, DOI 10.1016/j.actbio.2009.07.016
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Song WL, 2009, ADV MATER, V21, P1830, DOI 10.1002/adma.200803680
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Wu H, 2012, REACT FUNCT POLYM, V72, P427, DOI 10.1016/j.reactfunctpolym.2012.04.007
   Yan YY, 2011, ADV COLLOID INTERFAC, V169, P80, DOI 10.1016/j.cis.2011.08.005
   Yianni YP, 1992, STRUCTURAL DYNAMIC P, P187
   Zhou M, 2008, J NANO RES-SW, V2, P129, DOI 10.4028/www.scientific.net/JNanoR.2.129
   Zolnik BS, 2008, J CONTROL RELEASE, V127, P137, DOI 10.1016/j.jconrel.2008.01.004
NR 28
TC 0
Z9 0
U1 0
U2 25
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 0379-153X
J9 POLYM-KOREA
JI Polym.-Korea
PD JAN
PY 2015
VL 39
IS 1
BP 40
EP 45
DI 10.7317/pk.2015.39.1.40
PG 6
WC Polymer Science
SC Polymer Science
GA CQ3QF
UT WOS:000360516900006
DA 2018-10-19
ER

PT J
AU Priya, BA
   Senthilguru, K
   Agarwal, T
   Narayana, SNGH
   Giri, S
   Pramanik, K
   Pal, K
   Banerjee, I
AF Priya, B. Anu
   Senthilguru, K.
   Agarwal, T.
   Narayana, S. N. Gautham Hari
   Giri, S.
   Pramanik, K.
   Pal, K.
   Banerjee, I.
TI Nickel doped nanohydroxyapatite: vascular endothelial growth factor
   inducing biomaterial for bone tissue engineering
SO RSC ADVANCES
LA English
DT Article
ID BIOACTIVE GLASS SCAFFOLDS; OSTEOBLAST-LIKE CELLS; IN-VITRO;
   HYDROXYAPATITE NANOPARTICLES; FACTOR-1-ALPHA EXPRESSION; HYPOXIA;
   ANGIOGENESIS; BEHAVIOR; PROTEIN; COBALT
AB Biomaterial induced activation of vascular endothelial growth factor (VEGF) pathway for angiogenesis is now gaining recognition as an effective option for tissue engineering. In this context, bivalent nickel (Ni2+) ion doped nano-hydroxyapatites (nHAp) were synthesized by wet chemical method, characterized and evaluated for their osteoconductive and proangiogenic properties. Electron microscopy (FESEM and TEM) along with ICP-OES analysis ensured formation of Ni2+ doped nanoparticles (average ferret diameter 15-17 nm). The 'apatite identity' of the nanoparticles was confirmed by XRD and FT-IR. Analysis revealed that Ni2+ doping caused no significant distortion in the crystal structure but decreased the crystallinity of nHAp considerably. Similarly, no major variation in the surface area (BET analysis), the zeta potential and the protein adsorption was observed among the samples. Biological characterization showed that Ni2+ doping influenced the cell viability, proliferation and differentiation of bone cells (MG-63) in a concentration dependent way. ELISA and RT-PCR study revealed that Ni2+ doped nHAp induced cellular VEGF expression many fold in comparison to control. Profiling of hypoxia inducible factor 1 alpha (HIF-1 alpha) expression by immuno-cytochemistry and RT-PCR implied its involvement in cellular VEGF production. In conclusion, Ni2+ doped nHAp may serve as proangiogenic-osteogenic biomaterial for bone tissue engineering.
C1 [Priya, B. Anu; Senthilguru, K.; Agarwal, T.; Narayana, S. N. Gautham Hari; Pramanik, K.; Pal, K.; Banerjee, I.] Natl Inst Technol, Dept Biotechnol & Med Engn, Rourkela 769008, Odisha, India.
   [Giri, S.] Natl Inst Technol, Dept Chem, Rourkela 769008, Odisha, India.
RP Banerjee, I (reprint author), Natl Inst Technol, Dept Biotechnol & Med Engn, Rourkela 769008, Odisha, India.
EM banerjeei@nitrkl.ac.in
RI Pramanik, Krishna/M-3729-2018
OI Pramanik, Krishna/0000-0002-5676-7740; Banerjee,
   Indranil/0000-0003-3634-8765; Pal, Kunal/0000-0002-4618-8809; Giri,
   Supratim/0000-0002-1658-1968; Agarwal, Tarun/0000-0002-3300-7781
FU DBT, Govt of India (RGYI scheme project) [BT/PR6230/GBD/27/391/2012,
   BT/PR6227/GBD/27/390/2012]
FX 1. PSG Institute of Advanced Studies for HR-TEM analysis. 2. SAIF, IIT
   Madras for ICP-OES analysis. 3. DBT, Govt of India (RGYI scheme project
   no. BT/PR6230/GBD/27/391/2012). 4. DBT, Govt of India (RGYI scheme
   project no. BT/PR6227/GBD/27/390/2012). 5. Prof. T. K. Maiti for
   providing the molecular biology laboratory facility. 6. Centre of
   Excellence, orthopaedic Tissue engineering and Rehabilitation
   (TEQIP-II).
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Armstrong D, 1998, OPHTHALMOLOGICA, V212, P410, DOI 10.1159/000027378
   Baiguera S, 2013, ANGIOGENESIS, V16, P1, DOI 10.1007/s10456-012-9307-8
   Bose S, 2013, TRENDS BIOTECHNOL, V31, P594, DOI 10.1016/j.tibtech.2013.06.005
   CARROLL M, 1995, P NATL ACAD SCI USA, V92, P2869, DOI 10.1073/pnas.92.7.2869
   Chachami G, 2004, AM J RESP CELL MOL, V31, P544, DOI 10.1165/rcmb.2003-0426OC
   Chen LA, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/10/105708
   Cheng K, 2005, BIOMATERIALS, V26, P6288, DOI 10.1016/j.biomaterials.2005.03.041
   Chun YS, 2002, J KOREAN MED SCI, V17, P581, DOI 10.3346/jkms.2002.17.5.581
   CIVJAN S, 1975, J DENT RES, V54, P89, DOI 10.1177/00220345750540014301
   Das KK, 2008, INDIAN J MED RES, V128, P412
   Feng WK, 2009, MOL PHARMACOL, V75, P174, DOI 10.1124/mol.108.051516
   Ferraz M P, 2004, J Appl Biomater Biomech, V2, P74
   Fields RC, 2003, TISSUE ENG, V9, P1281, DOI 10.1089/10763270360728198
   Fini M, 2003, BIOMATERIALS, V24, P4929, DOI 10.1016/S0142-9612(03)00416-2
   Frohlich M, 2008, CURR STEM CELL RES T, V3, P254, DOI 10.2174/157488808786733962
   Gergely G, 2010, CENT EUR J CHEM, V8, P375, DOI 10.2478/s11532-010-0004-4
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Guerra-Lopez J, 2000, J SOLID STATE CHEM, V151, P163, DOI 10.1006/jssc.1999.8615
   Guerra-Lopez J, 2001, J RAMAN SPECTROSC, V32, P255, DOI 10.1002/jrs.689
   Han YC, 2009, J NANOPART RES, V11, P1235, DOI 10.1007/s11051-008-9507-8
   Hasan A, 2014, BIOMATERIALS, V35, P7308, DOI 10.1016/j.biomaterials.2014.04.091
   Holder WD, 1997, TISSUE ENG, V3, P149, DOI 10.1089/ten.1997.3.149
   Hwang JT, 2004, CARCINOGENESIS, V25, P2497, DOI 10.1093/carcin/bgh253
   Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673
   Kaczmarek M, 2007, FREE RADICAL BIO MED, V42, P1246, DOI 10.1016/j.freeradbiomed.2007.01.026
   Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029
   Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730
   Kulanthaivel S, 2015, CERAM INT, V41, P11323, DOI 10.1016/j.ceramint.2015.05.090
   Lee SH, 2012, J BIOL CHEM, V287, P14760, DOI 10.1074/jbc.M112.340232
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Li Y, 2010, MAT SCI ENG C-MATER, V30, P1137, DOI 10.1016/j.msec.2010.06.011
   Lukman H., 2010, KEY ENG MATER, V447, P770
   Mabilleau G, 2010, ACTA BIOMATER, V6, P1555, DOI 10.1016/j.actbio.2009.10.035
   Malda J, 2007, TISSUE ENG, V13, P2153, DOI 10.1089/ten.2006.0417
   Monmaturapoj N, 2008, J MET MAT MINER, V18, P15
   Mravic M., 2014, BIOMED RES INT, V2014, P1
   Neelakandeswari N, 2012, TETRAHEDRON LETT, V53, P2980, DOI 10.1016/j.tetlet.2012.03.086
   Nemec A. A., 2008, FASEB J, V22, P764
   Panseri S, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-32
   Pautke C, 2004, ANTICANCER RES, V24, P3743
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Perez AL, 2003, INT ENDOD J, V36, P564, DOI 10.1046/j.1365-2591.2003.00691.x
   Puvvada N, 2010, NANOSCALE, V2, P2631, DOI 10.1039/c0nr00611d
   Rajendran A, 2014, CERAM INT, V40, P10831, DOI 10.1016/j.ceramint.2014.03.075
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Sadat-Shojai M, 2013, ACTA BIOMATER, V9, P7591, DOI 10.1016/j.actbio.2013.04.012
   Saeri MR, 2003, MATER LETT, V57, P4064, DOI 10.1016/S0167-577X(03)00266-0
   Salarian M, 2009, MATER SCI-POLAND, V27, P961
   Sallam S.M., 2012, BIOPHYS CHEM, V3, P278
   Salnikow K, 1999, CARCINOGENESIS, V20, P1819, DOI 10.1093/carcin/20.9.1819
   Sanosh KP, 2009, B MATER SCI, V32, P465, DOI 10.1007/s12034-009-0069-x
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Shi ZL, 2009, ACTA BIOMATER, V5, P338, DOI 10.1016/j.actbio.2008.07.023
   Shibuya M, 2001, CELL STRUCT FUNCT, V26, P25, DOI 10.1247/csf.26.25
   SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0
   Shyong YJ, 2015, J MATER CHEM B, V3, P2331, DOI 10.1039/c4tb01639d
   Tank K. P., 2013, J NANOPART RES, V15, P1
   Tay SL, 2013, INTERMETALLICS, V33, P8, DOI 10.1016/j.intermet.2012.09.016
   Vandamme K., 2010, TISSUE ENG PART C-ME, V17, P311
   Wadekar MP, 2006, J PHARMACEUT BIOMED, V41, P1473, DOI 10.1016/j.jpba.2006.03.032
   Wakamura M, 1998, COLLOID SURFACE A, V142, P107, DOI 10.1016/S0927-7757(98)00486-5
   Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JC131581
   Wang YF, 2008, J WUHAN UNIV TECHNOL, V23, P395, DOI 10.1007/s11595-007-3395-0
   WASSELL DTH, 1995, BIOMATERIALS, V16, P697, DOI 10.1016/0142-9612(95)99697-K
   Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001
   Williams RL, 2013, J MATER CHEM B, V1, P4370, DOI 10.1039/c3tb20775g
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042
   Yan-Zhong Z., 2011, NANOSCALE RES LETT, V6, P1
   Zerbo I. R., 2005, BIOMATERIALS, V26, P1445
   Zhuang Z, 2013, ACTA BIOMATER, V9, P6732, DOI 10.1016/j.actbio.2013.02.001
NR 72
TC 4
Z9 4
U1 5
U2 19
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 89
BP 72515
EP 72528
DI 10.1039/c5ra09560c
PG 14
WC Chemistry, Multidisciplinary
SC Chemistry
GA CQ4CO
UT WOS:000360552000012
DA 2018-10-19
ER

PT J
AU Xu, JK
   Zhu, WY
   Jiang, LJ
   Xu, J
   Zhang, YC
   Cui, YZ
AF Xu, Jinku
   Zhu, Weiyue
   Jiang, Lijuan
   Xu, Jing
   Zhang, Yongchun
   Cui, Yuezhi
TI Carbazole-grafted silicone hydrogel with a high refractive index for
   intraocular lens
SO RSC ADVANCES
LA English
DT Article
ID POLYSILOXANES; ADHESION
AB The refractive index (RI) is an important parameter for intraocular lens biomaterials. In this paper, a novel carbazole-grafted methacrylic polysiloxane macromonomer (MA-CZ-PDMS) with a high RI value was synthesized and its structure was confirmed by proton nuclear magnetic resonance (H-1 NMR). The polysiloxane macromonomer can copolymerize with monomers of 3-methacryloxypropyl tris(trimethylsiloxy) silane (TRIS) and N, N-dimethylacrylamide (DMA) to prepare transparent high RI silicone hydrogel. Increasing MA-CZ-PDMS macromonomer content in the silicone hydrogels improved its water content, RI value, and mechanical properties, however decreased slightly glass transition temperature (T-g) and transmittance of blue light. The carbazole-grafted silicone hydrogel possessed good cytocompatibility and in vivo biocompatibility in rabbit eyes. The results demonstrate that the carbazole-grafted silicone hydrogel has a potential application as high RI ocular refractive correction biomaterial.
C1 [Xu, Jinku; Zhu, Weiyue; Xu, Jing; Zhang, Yongchun; Cui, Yuezhi] Qilu Univ Technol, Sch Chem & Pharmaceut Engn, Shandong Prov Key Lab Fine Chem, Jinan 250353, Peoples R China.
   [Xu, Jinku] Jiangxi Agr Univ, Sch Biosci & Bioengn, Key Lab Bioresources Protect & Utilizat Nanchang, Nanchang 330045, Peoples R China.
   [Jiang, Lijuan] Shandong Success Pharmaceut Technol Co Ltd, Jinan 250353, Peoples R China.
RP Xu, JK (reprint author), Qilu Univ Technol, Sch Chem & Pharmaceut Engn, Shandong Prov Key Lab Fine Chem, Jinan 250353, Peoples R China.
EM xujk@qlu.edu.cn
FU National Nature Science Foundation of China [51163007, 21276149]; Nature
   Science Foundation of Jiangxi Province [20114BAB206025]; Nature Science
   Foundation of Shandong Province [ZR2013BQ014]; Science and Technology
   Development Program of Shandong Province [2014GSF118009]; Nature Science
   Foundation of Jiangxi Agricultural University [09003332]; Program for
   Scientific Research Innovation Team in Colleges and Universities of
   Shandong Province
FX The projects were supported by National Nature Science Foundation of
   China (No. 51163007 and 21276149); Nature Science Foundation of Jiangxi
   Province (No. 20114BAB206025), Nature Science Foundation of Shandong
   Province (No. ZR2013BQ014), Science and Technology Development Program
   of Shandong Province (No. 2014GSF118009), Nature Science Foundation of
   Jiangxi Agricultural University (No. 09003332), and Program for
   Scientific Research Innovation Team in Colleges and Universities of
   Shandong Province.
CR Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Beiko G, 2007, CURR OPIN OPHTHALMOL, V18, P74, DOI 10.1097/ICU.0b013e328011fbab
   Belfield KD, 1998, MACROMOLECULES, V31, P2918, DOI 10.1021/ma970910+
   Foster A., 2000, COMMUNITY EYE HLTH, V13, P17
   Glasser A, 2006, CURR OPIN OPHTHALMOL, V17, P12, DOI 10.1097/01.icu.0000193069.32369.e1
   Hao XJ, 2012, BIOMATERIALS, V33, P5659, DOI 10.1016/j.biomaterials.2012.04.052
   Hao XJ, 2010, BIOMATERIALS, V31, P8153, DOI 10.1016/j.biomaterials.2010.07.065
   Hua YJ, 2001, MACROMOLECULES, V34, P2488, DOI 10.1021/ma0018502
   Hume EBH, 2004, INVEST OPHTH VIS SCI, V45, P3161, DOI 10.1167/iovs.03-1242
   Koopmans SA, 2006, INVEST OPHTH VIS SCI, V47, P2976, DOI 10.1167/iovs.05-1346
   Koopmans SA, 2003, INVEST OPHTH VIS SCI, V44, P250, DOI 10.1167/iovs.02-0256
   LAI YC, 1995, J APPL POLYM SCI, V56, P317, DOI 10.1002/app.1995.070560303
   Lan XK, 2010, EUR POLYM J, V46, P1545, DOI 10.1016/j.eurpolymj.2010.04.011
   Liu YY, 2005, BIOMATERIALS, V26, P6367, DOI 10.1016/j.biomaterials.2005.04.011
   Menapace R, 2007, GRAEF ARCH CLIN EXP, V245, P473, DOI 10.1007/s00417-006-0391-6
   NISHI H, 1981, B CHEM SOC JPN, V54, P1897, DOI 10.1246/bcsj.54.1897
   Nishi O, 1998, J CATARACT REFR SURG, V24, P975, DOI 10.1016/S0886-3350(98)80054-0
   Nishi O, 2008, J CATARACT REFR SURG, V34, P302, DOI 10.1016/j.jcrs.2007.09.042
   PEPPAS NA, 1990, J MEMBRANE SCI, V48, P281, DOI 10.1016/0376-7388(90)85009-A
   Senchyna M, 2004, CURR EYE RES, V28, P25, DOI 10.1076/ceyr.28.1.25.23496
   Sparrow JM, 2007, BRIT J OPHTHALMOL, V91, P852, DOI 10.1136/bjo.2006.111211
   Tanito M, 2010, J CATARACT REFR SURG, V36, P299, DOI 10.1016/j.jcrs.2009.08.036
   Tranoudis Ioannis, 2004, Cont Lens Anterior Eye, V27, P193, DOI 10.1016/j.clae.2004.08.003
   Wang T, 2012, IND ENG CHEM RES, V51, P15832, DOI 10.1021/ie302638g
   Zhang Shangtong, 2005, Cont Lens Anterior Eye, V28, P113, DOI 10.1016/j.clae.2005.06.003
NR 25
TC 5
Z9 5
U1 2
U2 21
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 89
BP 72736
EP 72744
DI 10.1039/c5ra10614a
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA CQ4CO
UT WOS:000360552000035
DA 2018-10-19
ER

PT J
AU Oak, JJ
   Bang, JI
   Bae, KC
   Kim, YH
   Lee, YC
   Chun, HH
   Park, YH
AF Oak, J-J.
   Bang, J. I.
   Bae, K-C
   Kim, Y. H.
   Lee, Y-C.
   Chun, H. H.
   Park, Y. H.
TI CHARACTERIZATION OF THE GRADED MICROSTRUCTURE IN POWDER SINTERED POROUS
   TITANIUM
SO ARCHIVES OF METALLURGY AND MATERIALS
LA English
DT Article
DE titanium; powder metallurgy; porous structure; sintering; biomaterial
ID MECHANICAL-PROPERTIES; BIOMATERIALS; BEHAVIOR; ALLOYS
AB The proposed sintering process produce porosity and functional graded microstructure in the sinterd titanium powders. Titanium powders with different micro sizes were sintered at the proposed temperature region at 1200 and 1300 degrees C for 2h. The apatite-forming on the graded microstructure is observed by immersion test in Hanks balanced salt soluion at 37 degrees C. Sintering condition of titanium powders is estimated by thermogravitmetry-differential thermal analysis (TG-DTA). The synthersied surface structures and apatite-forming ability were characterized by a field emission scanning electron microscopy (FE-SEM) observation and energy dispersive X-ray spectroscopy (EDS) analysis. As results, these graded microstructure of sintered porous titanium powders reveals apatite-forming ability as osseointegration by calcification in Hanks balanced salt soluion(HBSS) at 37 degrees C.
C1 [Oak, J-J.] Pusan Natl Univ, GCRC SOP, Busan, South Korea.
   [Bang, J. I.; Bae, K-C; Kim, Y. H.; Park, Y. H.] Pusan Natl Univ, Dept Mat Sci & Engn, Busan, South Korea.
   [Lee, Y-C.] Korea Inst Ind Technol, Busan, South Korea.
   [Chun, H. H.] Pusan Natl Univ, Dept Naval Architechture & Ocean Engn, Busan, South Korea.
RP Park, YH (reprint author), Pusan Natl Univ, Dept Mat Sci & Engn, Busan, South Korea.
EM yhpark@pusan.ac.kr
FU National Research Foundation of Korea (NRF) grant - Korea government
   (MEST) through GCRC-SOP [2011-0030658]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MEST) through GCRC-SOP
   (2011-0030658).
CR Akahori T, 2013, J JPN I MET, V77, P543, DOI 10.2320/jinstmet.J2013052
   German RM, 2013, MATERIALS, V6, P3641, DOI 10.3390/ma6083641
   Guden M, 2005, MATER CHARACT, V54, P399, DOI 10.1016/j.matchar.2005.01.006
   Gwak J.-N., 2013, J KOREAN POWDER META, V20, P467
   Jones JR, 2006, PHILOS T ROY SOC A, V364, P263, DOI 10.1098/rsta.2005.1689
   Kim H.M., 2000, BIOCERAMICS, V192-1, P227
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Miura Hideshi, 2013, [JOURAL OF KOREAN POWER METALLURGY INSTIT, 한국분말야금학회지], V20, P323
   Niinomi M, 2007, BIOMED MATER, V2, pS167, DOI 10.1088/1748-6041/2/3/S15
   Oak JJ, 2007, MAT SCI ENG A-STRUCT, V449, P220, DOI 10.1016/j.msea.2006.02.307
   Oak JJ, 2007, J MATER RES, V22, P1346, DOI 10.1557/JMR.2007.0154
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   Paital SR, 2007, BIOMED MATER, V2, P274, DOI 10.1088/1748-6041/2/4/011
   Ramesh K.T., 2002, SCIENCE, V33, P927
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Wang H, 2013, J NON-CRYST SOLIDS, V379, P155, DOI 10.1016/j.jnoncrysol.2013.08.001
   Yavari SA, 2014, J MECH BEHAV BIOMED, V36, P109, DOI 10.1016/j.jmbbm.2014.04.010
NR 17
TC 0
Z9 0
U1 0
U2 5
PU POLSKA AKAD NAUK, POLISH ACAD SCIENCES, INST METALL & MATER SCI PAS
PI WARSZAWA
PA PL, 00-901 WARSZAWA, POLAND
SN 1733-3490
EI 2300-1909
J9 ARCH METALL MATER
JI Arch. Metall. Mater.
PY 2015
VL 60
IS 2
BP 1265
EP 1269
DI 10.1515/amm-2015-0111
PG 5
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA CP5WE
UT WOS:000359955000127
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Gao, JL
   Chu, JK
   Shang, HX
   Guan, L
AF Gao, Jiali
   Chu, Jinkui
   Shang, Haixin
   Guan, Le
TI Vibration attenuation performance of long-eared owl plumage
SO BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS
LA English
DT Article
DE biomaterial; material properties; multi-scale structure
ID AERODYNAMIC NOISE; TRAILING-EDGE; SILENT FLIGHT
AB A comparative study of vibration attenuation behaviour of primary remex with lateral branches from the long-eared owl (a silent flying bird), golden eagle and pigeon (two noisy flying birds) was conducted in order to investigate the damping ability of owl's primary remex. Amplitude variation of the measurement points on the rachis with vane structures was measured by a laser displacement sensor, and vibration process of the observation point on the barb with lateral barbules was recorded by a high-speed camera. Amplitude-time analysis results indicate that loss factors of long-eared owl's complete primary feathers and barbs are higher than those of the golden eagle and pigeon feathers. Thus, vibration amplitudes of the long-eared owl feathers and their barbs decay much faster, showing a superior vibration-damping characteristic. Consequently, mechanical noise caused by the relative motion of the owl primary feather structures during flight may be effectively suppressed. Vibration reduction principle of the long-eared owl primary feather was briefly discussed based on the damping-by-branching mechanism at last.
C1 [Gao, Jiali; Chu, Jinkui; Shang, Haixin; Guan, Le] Dalian Univ Technol, Minist Educ, Key Lab Precis & Nontradit Machining, Dalian, Peoples R China.
RP Chu, JK (reprint author), Dalian Univ Technol, Minist Educ, Key Lab Precis & Nontradit Machining, Dalian, Peoples R China.
EM chujk@dlut.edu.cn
RI Guan, Le/C-6634-2009
FU National Basic Research Program of China [2011CB302101, 2011CB302105]
FX The authors would like to thank Dalian Forest Zoo for providing the
   feather samples of long-eared owl, golden eagle and pigeon. Financial
   support for this research was provided by the National Basic Research
   Program of China (grants: 2011CB302101 and 2011CB302105).
CR Bachmann T, 2012, J ANAT, V221, P1, DOI 10.1111/j.1469-7580.2012.01504.x
   Bachmann T, 2012, INTEGR COMP BIOL, V52, pE9
   Bachmann T, 2011, J ANAT, V219, P192, DOI 10.1111/j.1469-7580.2011.01384.x
   Borelli G. A., 1680, DE MOTU ANIMALIUM, P182
   Chen K, 2012, J BIONIC ENG, V9, P192, DOI 10.1016/S1672-6529(11)60109-1
   Gao J., 2014, SHOCK VIB, V2014
   Geyer T, 2010, EXP FLUIDS, V48, P291, DOI 10.1007/s00348-009-0739-x
   Graham R.R., 1934, J ROYAL AERONAUTICAL, V286, P837
   GRUSCHKA HD, 1971, NATURE, V233, P409, DOI 10.1038/233409a0
   Hansson KM, 2002, BIOSENS BIOELECTRON, V17, P747, DOI 10.1016/S0956-5663(02)00048-9
   Herr M, 3470 AIAA, P3470
   HOWE MS, 1991, J ACOUST SOC AM, V90, P482, DOI 10.1121/1.401273
   Jaworski JW, 2013, J FLUID MECH, V723, P456, DOI 10.1017/jfm.2013.139
   Klan S, 2009, EXP FLUIDS, V46, P975, DOI 10.1007/s00348-008-0600-7
   Kroeger R. A., 1972, 96117 DTIC, P96
   Lilley GM, 2001, J SOUND VIB, V239, P849, DOI 10.1006/jsvi.2000.3219
   Lilley GM, 1998, AIAA PAPER, V4, P1
   Mascha E, 1903, Z WISSENSCHAFTLICHE, V77, P606
   Punyamurtula VK, 2007, ADV ENG MATER, V9, P209, DOI 10.1002/adem.200600177
   Rao MD, 2003, J SOUND VIB, V262, P457, DOI 10.1016/S0022-460X(03)00106-8
   Sharma JN, 2014, ACTA MECH, V225, P1581, DOI 10.1007/s00707-013-1010-3
   Sick H, 1937, J ORNITHOL, V85, P206, DOI DOI 10.1007/BF01905702
   Sun S., 2008, NOISE VIBRAT CONT, V3, P119
   Theckes B, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/4/046010
   Videler JJ, 2005, AVIAN FLIGHT
   Viswanathan KK, 2011, ACTA MECH, V221, P309, DOI 10.1007/s00707-011-0505-z
NR 26
TC 1
Z9 1
U1 2
U2 15
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2045-9858
EI 2045-9866
J9 BIOINSPIR BIOMIM NAN
JI Bioinspired Biomim. Nanobiomat.
PY 2015
VL 4
IS 3
BP 187
EP 198
DI 10.1680/bbn.15.00003
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CP9HP
UT WOS:000360205000004
DA 2018-10-19
ER

PT S
AU Gasymov, OK
   Aydemirova, A
   Alekperov, O
   Aslanov, RB
   Khalilova, K
   Gasimov, N
   Mamedov, N
   Mamedova, I
   Babayev, S
   Gasanov, N
AF Gasymov, Oktay K.
   Aydemirova, Arzu
   Alekperov, Oktay
   Aslanov, Rasim B.
   Khalilova, Khuraman
   Gasimov, Nagi
   Mamedov, Nazim
   Mamedova, Irada
   Babayev, Sardar
   Gasanov, Namig
BE Tsuboi, N
   Wakita, K
   Yamada, A
   Shirakata, S
   Wada, T
   Niki, S
   Imaizumi, M
   Hara, K
   Uchitomi, N
TI IR ellipsometry of silk fibroin films on Al nanoislands
SO PHYSICA STATUS SOLIDI C: CURRENT TOPICS IN SOLID STATE PHYSICS, VOL 12,
   NO 6
SE Physica Status Solidi C-Current Topics in Solid State Physics
LA English
DT Proceedings Paper
CT 19th International Conference on Ternary and Multinary Compounds (ICTMC)
CY SEP 01-05, 2014
CL Niigata, JAPAN
SP Japan Soc Appl Physics, Murata Sci Fdn, Niigata Prefecture, Nakaya Corporat, NAMICS Corporat, Tokyo Instruments Inc, Bunkoukeiki Co Ltd, Fdn Promot Mat Sci & Technol Japan, Int Servo Data Corporat, Osaka Asahi Metal Mfg Co Ltd, TOYO Corporat, ULVAC TECHNO Ltd, Japan Soc Appl Physics, Japanese Profess Grp Multinary Compounds & Solar Cells
DE surface enhanced ellipsometry; protein films; plasmon; metallic
   nanoislands
ID BIOMATERIAL
AB Infrared spectroscopic ellipsometry (IRSE) is a powerful tool for the characterization of various types of organic and inorganic films. In application to protein films, IRSE can be utilized to detect structural changes, orientation of specific group, etc. Because of sensitivity, enhanced IRSE will be very useful to study protein thin films. Here we show that fibroin films on Al mirror display surface-enhanced infrared spectroscopic ellipsometry (SEIRSE). AFM data indicate that nanoislands on the Al mirror are responsible for the plasmon-enhanced mechanism. SEIRSE for fibroin films shows non-uniform enhancement across the spectrum. Possible mechanisms of such enhancement are provided. Evidently, as proposed previously, at least two mechanisms, the electromagnetic (EM) and chemical, are expected to contribute to the enhancement.
C1 [Gasymov, Oktay K.; Aydemirova, Arzu; Alekperov, Oktay; Aslanov, Rasim B.; Khalilova, Khuraman; Gasimov, Nagi; Mamedov, Nazim; Mamedova, Irada; Babayev, Sardar] Azerbaijan Natl Acad Sci, Inst Phys, Baku 1143, Azerbaijan.
   [Gasanov, Namig] Minist Agr, Inst Silk Farming, Genje 2012, Azerbaijan.
RP Gasymov, OK (reprint author), Azerbaijan Natl Acad Sci, Inst Phys, 131 H Javid, Baku 1143, Azerbaijan.
EM oktay.qasimov@physics.science.az; ozalekperov@physics.science.az
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bradford DC, 2005, J PHYS CHEM B, V109, P20914, DOI 10.1021/jp052764c
   Guan L, 2013, CELLS TISSUES ORGANS, V198, P190, DOI 10.1159/000355944
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Hinrichs K, 2005, APPL SPECTROSC, V59, p272A, DOI 10.1366/000370205774783106
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Monti P., 1998, J RAMAN SPECTROSC, V29
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
NR 9
TC 1
Z9 1
U1 0
U2 4
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PAPPELALLEE 3, W-69469 WEINHEIM, GERMANY
SN 1862-6351
J9 PHYS STATUS SOLIDI C
PY 2015
VL 12
IS 6
BP 628
EP 630
DI 10.1002/pssc.201500005
PG 3
WC Physics, Condensed Matter
SC Physics
GA BD3UN
UT WOS:000360198000033
DA 2018-10-19
ER

PT J
AU Carvalho, I
   Polcar, T
   Henriques, M
   Carvalho, S
AF Carvalho, Isabel
   Polcar, Tomas
   Henriques, Mariana
   Carvalho, Sandra
TI MATERIALS INCOMPATIBILITY AS A MAJOR CAUSE OF HIP PROSTHESES REJECTION
SO REVIEWS ON ADVANCED MATERIALS SCIENCE
LA English
DT Article
ID DIAMOND-LIKE CARBON; METAL-ON-METAL; EPIDERMIDIS BIOFILM FORMATION;
   PULSED-LASER DEPOSITION; TOTAL JOINT REPLACEMENT; SILVER ION RELEASE;
   SI-C-ON; STAPHYLOCOCCUS-EPIDERMIDIS; BIOMEDICAL APPLICATIONS;
   SYNOVIAL-FLUID
AB The development of new multifunctional coatings to apply on medical biomaterials continues to be required, since materials commonly used in hip prostheses still presenting failures. Multifunctionality is the result of a synergy, on the nanoscale level, of good corrosion, mechanical and tribological properties. Additionally, a biomaterial must always be biocompatible. Besides these properties, the major challenge would be to get a material that also has antimicrobial activity. In this context, the development of advanced materials with the ability to present these properties is being regarded as a strategy to prevent the colonization of implant and biofilm formation by bacteria. So, in this review, the attention is focused on the description of the fundamental points of the natural synovial joint, since, its mechanical and tribological characteristics are the main causes that lead to the necessity of its replacement by an implant. Moreover, a contextualization was also performed on the hip replacement surgery and the biomaterials used, with a focus on their mechanical and tribological properties. Finally, it is explained the need of surface modification and the potential of TiCN coatings doped with silver.
C1 [Carvalho, Isabel; Polcar, Tomas] Czech Tech Univ, Fac Elect Engn, Dept Control Engn, Tech 2, CR-16635 Prague 6, Czech Republic.
   [Polcar, Tomas] Univ Southampton, Engn Mat, Southampton SO17 1BJ, Hants, England.
   [Henriques, Mariana] Univ Minho, Ctr Biol Engn, CEB, LIBRO, P-4700057 Braga, Portugal.
   [Carvalho, Sandra] Univ Minho, GRF CFUM, P-4800058 Guimaraes, Portugal.
   [Carvalho, Sandra] Univ Coimbra, SEG CEMUC Mech Engn Dept, P-3030788 Coimbra, Portugal.
RP Carvalho, I (reprint author), Czech Tech Univ, Fac Elect Engn, Dept Control Engn, Tech 2, CR-16635 Prague 6, Czech Republic.
EM isascarvalho@hotmail.com
RI Henriques, Mariana/A-2117-2013; Carvalho, Sandra/F-3530-2013; Polcar,
   Tomas/G-5742-2013
OI Henriques, Mariana/0000-0003-0317-4877; Carvalho,
   Sandra/0000-0002-3643-4973; Polcar, Tomas/0000-0002-0863-6287; Carvalho,
   Isabel/0000-0002-7569-2019
FU FEDER funds through the program COMPETE - Programa Operacional Factores
   de Competitividade; national funds through FCT - Fundacao para a Ciencia
   e a Tecnologia [PEST-C/FIS/UI607/2011, PEST-C/EME/UI0285/2011,
   PTDC/CTM/102853/2008]; FCT - Fundacao para a Ciencia e a Tecnologia
   [SFRH / BD / 67022 / 2009]; FCT [UID/BIO/04469/2013,
   RECI/BBB-EBI/0179/2012 (FCOMP-01-0124-FEDER-027462)]; project "BioInd -
   Biotechnology and Bioengineering for improved Industrial and Agro-Food
   processes" - Programa Operacional Regional do Norte (ON.2 - O Novo
   Norte), QREN, FEDER [NORTE-07-0124-FEDER-000028]
FX This research is sponsored by FEDER funds through the program COMPETE -
   Programa Operacional Factores de Competitividade - and by national funds
   through FCT - Fundacao para a Ciencia e a Tecnologia - in the framework
   of the Strategic Projects PEST-C/FIS/UI607/2011, PEST-C/EME/UI0285/2011,
   PTDC/CTM/102853/2008, and FCT - Fundacao para a Ciencia e a Tecnologia
   through the grant SFRH / BD / 67022 / 2009.; The authors thank the FCT
   Strategic Project of UID/BIO/04469/2013 unit, the project
   RECI/BBB-EBI/0179/2012 (FCOMP-01-0124-FEDER-027462) and the project
   "BioInd - Biotechnology and Bioengineering for improved Industrial and
   Agro-Food processes", REF. NORTE-07-0124-FEDER-000028 Co-funded by the
   Programa Operacional Regional do Norte (ON.2 - O Novo Norte), QREN,
   FEDER.
CR Allcock BW, 2003, SURF COAT TECH, V163, P62, DOI 10.1016/S0257-8972(02)00586-8
   Amstutz HC, 1996, CLIN ORTHOP RELAT R, pS11
   An YH, 1996, J HOSP INFECT, V33, P93, DOI 10.1016/S0195-6701(96)90094-8
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Anderson AE, 2010, J BIOMECH, V43, P1351, DOI 10.1016/j.jbiomech.2010.01.010
   [Anonymous], 2013, NJR 10 ANN REP
   Archibald LK, 1997, INFECT DIS CLIN N AM, V11, P245, DOI 10.1016/S0891-5520(05)70354-8
   Ateshian GA, 2009, J BIOMECH, V42, P1163, DOI 10.1016/j.jbiomech.2009.04.040
   Babonneau D, 1998, SURF SCI, V409, P358, DOI 10.1016/S0039-6028(98)00280-5
   Bahl R, 1999, APPL PHYS A-MATER, V69, pS643, DOI 10.1007/s003390051495
   Bellantone M, 2002, ANTIMICROB AGENTS CH, V46, P1940, DOI 10.1128/AAC.46.6.1940-1945.2002
   Betts AJ, 2005, MATER DESIGN, V26, P217, DOI 10.1016/j.matdes.2004.02.006
   Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155
   Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P570, DOI 10.2106/JBJS.D.02121
   Bull SJ, 2003, SURF COAT TECH, V163, P499, DOI 10.1016/S0257-8972(02)00650-3
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Carvalho I, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/3/035009
   Cereatti A, 2010, J BONE JOINT SURG BR, V92B, P311, DOI 10.1302/0301-620X.92B2.22625
   Chekan NM, 2009, DIAM RELAT MATER, V18, P1006, DOI 10.1016/j.diamond.2009.02.024
   Chen W, 2007, J BIOMED MATER RES A, V82A, P899, DOI 10.1002/jbm.a.31197
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Corbett KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013520
   Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000
   DAVIDSON JA, 1993, CLIN ORTHOP RELAT R, P361
   De Scheerder I, 2000, J INVASIVE CARDIOL, V12, P389
   Delaunay C, 2010, ORTHOP TRAUMATOL-SUR, V96, P894, DOI 10.1016/j.otsr.2010.05.008
   Donaruma L. G., 1987, J POLYM SCI POL LETT, V26, P414
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Doorn PF, 1998, J BIOMED MATER RES, V42, P103, DOI 10.1002/(SICI)1097-4636(199810)42:1<103::AID-JBM13>3.0.CO;2-M
   Ehab Kheir DS, 2009, ORTHOPAEDICS TRAUMA, V23, P450
   Endrino JL, 2008, SURF COAT TECH, V202, P3675, DOI 10.1016/j.surfcoat.2008.01.011
   Endrino JL, 2002, SURF COAT TECH, V157, P95, DOI 10.1016/S0257-8972(02)00138-X
   Ewald A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-22
   Fang TH, 2004, APPL SURF SCI, V228, P365, DOI 10.1016/j.apsusc.2004.01.053
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Feng WR, 2007, APPL SURF SCI, V253, P4923, DOI 10.1016/j.apsusc.2006.10.069
   Firkins PJ, 2001, J BIOMECH, V34, P1291, DOI 10.1016/S0021-9290(01)00096-3
   Fitzpatrick F, 2002, J HOSP INFECT, V52, P212, DOI 10.1053/jhin.2002.1309
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Genda E, 2001, J BIOMECH, V34, P895, DOI 10.1016/S0021-9290(01)00041-0
   Gispert MP, 2008, J BIOMED MATER RES B, V84B, P98, DOI 10.1002/jbm.b.30849
   Gispert MP, 2007, WEAR, V263, P1060, DOI 10.1016/j.wear.2006.11.036
   Gispert MP, 2006, WEAR, V260, P149, DOI 10.1016/j.wear.2004.12.040
   GRILL A, 1993, WEAR, V168, P143, DOI 10.1016/0043-1648(93)90210-D
   Guimaraes F, 2008, SURF COAT TECH, V202, P2403, DOI 10.1016/j.surfcoat.2007.08.056
   Hall RM, 1997, BIOMATERIALS, V18, P1017, DOI 10.1016/S0142-9612(97)00034-3
   Hallab NJ, 2005, J ORTHOP RES, V23, P384, DOI 10.1016/j.orthres.2004.09.001
   Harman MK, 1997, J ARTHROPLASTY, V12, P938, DOI 10.1016/S0883-5403(97)90164-9
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hlidek P, 2008, THIN SOLID FILMS, V516, P4581, DOI 10.1016/j.tsf.2007.05.085
   Hsieh JH, 2008, SURF COAT TECH, V202, P5586, DOI 10.1016/j.surfcoat.2008.06.107
   Huang HL, 2010, SURF COAT TECH, V205, P1636, DOI 10.1016/j.surfcoat.2010.07.096
   Munoz AI, 2011, J MATER SCI-MATER M, V22, P437, DOI 10.1007/s10856-010-4224-0
   Jafari SM, 2010, CLIN ORTHOP RELAT R, V468, P2046, DOI 10.1007/s11999-010-1251-6
   Jaiswal S, 2012, COLLOID SURFACE B, V94, P170, DOI 10.1016/j.colsurfb.2012.01.035
   Jamuna-Thevi K, 2011, VACUUM, V86, P235, DOI 10.1016/j.vacuum.2011.06.011
   Jassim SS, 2012, SEMIN ARTHROPLASTY, V23, P197
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Katti KS, 2004, COLLOID SURFACE B, V39, P133, DOI 10.1016/j.colsurfb.2003.12.002
   Kelly PJ, 2010, SURF COAT TECH, V205, P1606, DOI 10.1016/j.surfcoat.2010.07.029
   Kelly PJ, 2009, SURF COAT TECH, V204, P1137, DOI 10.1016/j.surfcoat.2009.05.012
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   Kim TN, 1998, J MATER SCI-MATER M, V9, P129, DOI 10.1023/A:1008811501734
   KNOX P, 1988, Q J EXP PHYSIOL CMS, V73, P33, DOI 10.1113/expphysiol.1988.sp003121
   Kumar R, 2005, BIOMATERIALS, V26, P2081, DOI 10.1016/j.biomaterials.2004.05.030
   KURRAT HJ, 1978, J ANAT, V126, P145
   Lackner JM, 2004, SURF COAT TECH, V188, P519, DOI 10.1016/j.surfcoat.2004.07.009
   Lan WC, 2013, CERAM INT, V39, P4099, DOI 10.1016/j.ceramint.2012.10.264
   Lee SH, 2013, THIN SOLID FILMS, V529, P374, DOI 10.1016/j.tsf.2012.09.027
   Liu CL, 2005, MATER LETT, V59, P3813, DOI 10.1016/j.matlet.2005.06.058
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Lo KH, 2009, MAT SCI ENG R, V65, P39, DOI 10.1016/j.mser.2009.03.001
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Love CA, 2013, TRIBOL INT, V63, P141, DOI 10.1016/j.triboint.2012.09.006
   Mack D, 1999, J HOSP INFECT, V43, pS113, DOI 10.1016/S0195-6701(99)90074-9
   Martinez-Martinez D, 2005, THIN SOLID FILMS, V472, P64, DOI 10.1016/j.tsf.2004.06.140
   Mattei L, 2011, TRIBOL INT, V44, P532, DOI 10.1016/j.triboint.2010.06.010
   McKellop H, 1996, CLIN ORTHOP RELAT R, pS128
   Mellon SJ, 2013, MATURITAS, V75, P221, DOI 10.1016/j.maturitas.2013.04.011
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   Monteiro DR, 2009, INT J ANTIMICROB AG, V34, P103, DOI 10.1016/j.ijantimicag.2009.01.017
   Morrison ML, 2006, DIAM RELAT MATER, V15, P138, DOI 10.1016/j.diamond.2005.08.031
   Moura M., 2013, METHODS, V18, P19
   Mulligan CP, 2005, SURF COAT TECH, V200, P1495, DOI 10.1016/j.surfcoat.2005.08.063
   Myant C, 2014, J MECH BEHAV BIOMED, V34, P338, DOI 10.1016/j.jmbbm.2013.12.016
   Nevelos JE, 1999, BIOMATERIALS, V20, P1833, DOI 10.1016/S0142-9612(99)00081-2
   Nishii T, 2004, OSTEOARTHR CARTILAGE, V12, P650, DOI 10.1016/j.joca.2004.04.009
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Oliveira C, 2008, SURF COAT TECH, V203, P490, DOI 10.1016/j.surfcoat.2008.06.121
   Ollivere B, 2012, J BONE JOINT SURG BR, V94B, P10, DOI 10.1302/0301-620X.94B1.28047
   Park J., 2007, BIOMATERIALS
   Pawaskar SS, 2011, MED ENG PHYS, V33, P96, DOI 10.1016/j.medengphy.2010.09.009
   Piscanec S, 2004, ACTA MATER, V52, P1237, DOI 10.1016/j.actamat.2003.11.020
   Pishbin F, 2013, ACTA BIOMATER, V9, P7469, DOI 10.1016/j.actbio.2013.03.006
   Pivec R, 2012, LANCET, V380, P1768, DOI 10.1016/S0140-6736(12)60607-2
   Pramanik S, 2005, TRENDS BIOMATER ARTI, V19, P15
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Ratner B.D., 1996, BIOMATER SCI
   RATNER BD, 1983, ANN BIOMED ENG, V11, P313, DOI 10.1007/BF02363290
   Ribeiro Marta, 2012, Biomatter, V2, P176, DOI 10.4161/biom.22905
   Roba M, 2009, BIOMATERIALS, V30, P2072, DOI 10.1016/j.biomaterials.2008.12.062
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.04515.x
   Saikko V, 1997, WEAR, V207, P86, DOI 10.1016/S0043-1648(96)07482-0
   Sanchez-Lopez JC, 2012, SURF COAT TECH, V206, P2192, DOI 10.1016/j.surfcoat.2011.09.059
   Sant SB, 2007, ACTA BIOMATER, V3, P341, DOI 10.1016/j.actbio.2006.10.008
   Sargeant A, 2006, MATER DESIGN, V27, P287, DOI 10.1016/j.matdes.2004.10.028
   Schmidt TA, 2007, OSTEOARTHR CARTILAGE, V15, P35, DOI 10.1016/j.joca.2006.06.005
   Schrand AM, 2010, WIRES NANOMED NANOBI, V2, P544, DOI 10.1002/wnan.103
   Serro AP, 2009, SURF COAT TECH, V203, P3701, DOI 10.1016/j.surfcoat.2009.06.010
   Sharkey PF, 2002, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000036002.13841.32
   Silva E, 2010, SURF COAT TECH, V205, P2134, DOI 10.1016/j.surfcoat.2010.08.126
   Slonaker M, 2004, MATER DESIGN, V25, P395, DOI 10.1016/j.matdes.2003.11.011
   Stobie N, 2009, COLLOID SURFACE B, V72, P62, DOI 10.1016/j.colsurfb.2009.03.014
   Suh J, 1995, OPERATIVE TECH SPORT, V3, P78
   SUH JK, 1995, J BIOMECH, V28, P357, DOI 10.1016/0021-9290(94)00103-B
   Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1
   Takadoum J, 1997, SURF COAT TECH, V88, P232, DOI 10.1016/S0257-8972(96)02905-2
   TANDON PN, 1990, APPL MATH MODEL, V14, P312, DOI 10.1016/0307-904X(90)90083-H
   Tipper JL, 2001, WEAR, V250, P120, DOI 10.1016/S0043-1648(01)00653-6
   Trujillo NA, 2012, MAT SCI ENG C-MATER, V32, P2135, DOI 10.1016/j.msec.2012.05.012
   Tseng CC, 2009, THIN SOLID FILMS, V517, P4970, DOI 10.1016/j.tsf.2009.03.136
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Wang FC, 2008, PHYS MED BIOL, V53, P1277, DOI 10.1088/0031-9155/53/5/008
   Wang XQ, 2009, J ORTHOP RES, V27, P1487, DOI 10.1002/jor.20917
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   WILLIAMS DF, 1987, MATER SCI TECH SER, V3, P797, DOI 10.1179/mst.1987.3.10.797
   Wong M, 2003, BONE, V33, P1, DOI 10.1016/S8756-3282(03)00083-8
   Yao SH, 2006, SURF COAT TECH, V201, P2520, DOI 10.1016/j.surfcoat.2006.04.066
   Yen SK, 2001, BIOMATERIALS, V22, P125, DOI 10.1016/S0142-9612(00)00133-2
   Yoshida H, 2006, J BIOMECH, V39, P1996, DOI 10.1016/j.jbiomech.2005.06.026
   Zhang GJ, 2009, APPL SURF SCI, V255, P8788, DOI 10.1016/j.apsusc.2009.06.090
   Zhao J, 2009, J MATER SCI-MATER M, V20, P101, DOI 10.1007/s10856-008-3491-5
NR 134
TC 0
Z9 0
U1 1
U2 17
PU INST PROBLEMS MECHANICAL ENGINEERING-RUSSIAN ACAD SCIENCES
PI ST PTERSBURG
PA BOLSHOJ 61, VAS OSTROV, ST PTERSBURG, 199178, RUSSIA
SN 1606-5131
J9 REV ADV MATER SCI
JI Rev. Adv. Mater. Sci.
PY 2015
VL 42
IS 1
BP 36
EP 49
PG 14
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CP8AC
UT WOS:000360110800005
DA 2018-10-19
ER

PT J
AU Aunkor, MTH
   Mahbubul, IM
   Saidur, R
   Metselaar, HSC
AF Aunkor, M. T. H.
   Mahbubul, I. M.
   Saidur, R.
   Metselaar, H. S. C.
TI Deoxygenation of graphene oxide using household baking soda as a
   reducing agent: a green approach
SO RSC ADVANCES
LA English
DT Article
ID EXFOLIATED GRAPHITE OXIDE; LITHIUM ION BATTERIES; CHEMICAL-REDUCTION;
   ROOM-TEMPERATURE; FUNCTIONALIZED GRAPHENE; PHOTOVOLTAIC DEVICES;
   SOLVOTHERMAL METHOD; PRODUCE GRAPHENE; AG NANOPARTICLES; FACILE
   SYNTHESIS
AB A one-step, novel, easy, fast, facile, economic, and environmental friendly route to reduce graphene oxide (GO) is studied and explained in this study. The household baking soda (sodium bicarbonate/NaHCO3) was applied here as a reducing agent. In aqueous solution, NaHCO3 hydrolyses into hydroxide ion and leads to deoxygenate GO sheets. The confirmation of oxygen reduction was checked with UV-visible spectroscopy, X-ray diffraction, Fourier transform infrared spectrometry and Raman spectroscopy. Thermal behavior of graphene was analyzed by thermogravimetry analysis and differential scanning calorimetry. Again, atomic force microscopy, scanning electron microscopy, field emission scanning electron microscopy and transmission electron microscopy were used for morphological study. Energy dispersive X-ray spectrometer was applied to analyze the elemental composition. The results of the above experiments demonstrate that the house-hold baking soda is able to produce functional graphene, which can be a suitable replacement of hydrazine, sodium borohydrate or other toxic reducing agents. This method is high yielding and safe to use in biomaterial applications.
C1 [Aunkor, M. T. H.; Mahbubul, I. M.; Metselaar, H. S. C.] Univ Malaya, Fac Engn, Dept Mech Engn, Kuala Lumpur 50603, Malaysia.
   [Saidur, R.] King Fahd Univ Petr & Minerals KFUPM, Ctr Res Excellence Renewable Energy CoRE RE, Dhahran 31261, Saudi Arabia.
RP Mahbubul, IM (reprint author), Univ Malaya, Fac Engn, Dept Mech Engn, Kuala Lumpur 50603, Malaysia.
EM immahbubul@gmail.com; h.metselaar@um.edu.my
RI Islam, Mohammed Mahbubul/A-6303-2013; Engineering, Faculty/I-7935-2015;
   Metselaar, Hendrik/B-5324-2010
OI Islam, Mohammed Mahbubul/0000-0002-2101-3471; Engineering,
   Faculty/0000-0002-4848-7052; Metselaar, Hendrik/0000-0003-1047-654X
FU University of Malaya under the High Impact Research MoE from the
   Ministry of Education Malaysia [UM.C/625/1/HIR/MoE/ENG/40
   (D000040-16001)]
FX "The authors would like to thank the University of Malaya for financial
   support under the High Impact Research MoE Grant:
   UM.C/625/1/HIR/MoE/ENG/40 (D000040-16001) from the Ministry of Education
   Malaysia".
CR Acik M, 2010, NAT MATER, V9, P840, DOI [10.1038/nmat2858, 10.1038/NMAT2858]
   Ahmed MS, 2013, CARBON, V61, P164, DOI 10.1016/j.carbon.2013.04.080
   Akhavan O, 2012, CARBON, V50, P1853, DOI 10.1016/j.carbon.2011.12.035
   Amarnath CA, 2011, CARBON, V49, P3497, DOI 10.1016/j.carbon.2011.04.048
   Balandin AA, 2008, NANO LETT, V8, P902, DOI 10.1021/nl0731872
   Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925
   Bo Z, 2014, SCI REP-UK, V4, DOI 10.1038/srep04684
   Bosch-Navarro C, 2012, NANOSCALE, V4, P3977, DOI 10.1039/c2nr30605k
   Bose S, 2012, J MATER CHEM, V22, P9696, DOI 10.1039/c2jm00011c
   Cai WW, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3220807
   Cambaz ZG, 2008, CARBON, V46, P841, DOI 10.1016/j.carbon.2008.02.013
   Cheianov VV, 2007, SCIENCE, V315, P1252, DOI 10.1126/science.1138020
   Chen DZ, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/32/325601
   De Silva KSB, 2012, J MATER CHEM, V22, P13941, DOI 10.1039/c2jm30323j
   Dickinson JW, 2013, SENSORS-BASEL, V13, P3635, DOI 10.3390/s130303635
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Du FP, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/47/475704
   Fan XB, 2008, ADV MATER, V20, P4490, DOI 10.1002/adma.200801306
   Fan ZJ, 2011, ACS NANO, V5, P191, DOI 10.1021/nn102339t
   Fan ZJ, 2010, CARBON, V48, P1686, DOI 10.1016/j.carbon.2009.12.063
   Fernandez-Merino MJ, 2010, J PHYS CHEM C, V114, P6426, DOI 10.1021/jp100603h
   Gao J, 2010, CHEM MATER, V22, P2213, DOI 10.1021/cm902635j
   Guo CX, 2011, ADV ENERGY MATER, V1, P736, DOI 10.1002/aenm.201100223
   Guo CX, 2010, ANGEW CHEM INT EDIT, V49, P3014, DOI 10.1002/anie.200906291
   Gurunathan S, 2013, COLLOID SURFACE B, V111, P376, DOI 10.1016/j.colsurfb.2013.06.018
   Heo Y, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1196-7
   Hernandez Y, 2008, NAT NANOTECHNOL, V3, P563, DOI 10.1038/nnano.2008.215
   Janowska I, 2009, APPL CATAL A-GEN, V371, P22, DOI 10.1016/j.apcata.2009.09.013
   Jayasena B, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-95
   Jeong HK, 2008, J AM CHEM SOC, V130, P1362, DOI 10.1021/ja076473o
   Ji ZY, 2012, NEW J CHEM, V36, P1774, DOI 10.1039/c2nj40133a
   Jin M, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/27/275402
   Jin YH, 2013, APPL SURF SCI, V268, P541, DOI 10.1016/j.apsusc.2013.01.004
   Katsnelson MI, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195426
   Khanra P, 2012, CHEM ENG J, V183, P526, DOI 10.1016/j.cej.2011.12.075
   Kim HJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05176
   Kudin KN, 2008, NANO LETT, V8, P36, DOI 10.1021/nl071822y
   Kuila T, 2012, CARBON, V50, P914, DOI 10.1016/j.carbon.2011.09.053
   Lei YD, 2011, GREEN CHEM, V13, P1655, DOI 10.1039/c1gc15081b
   Li CB, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0875-8
   Li J, 2013, J MATER CHEM A, V1, P1481, DOI 10.1039/c2ta00638c
   Li YG, 2011, J AM CHEM SOC, V133, P7296, DOI 10.1021/ja201269b
   Liu CG, 2010, NANO LETT, V10, P4863, DOI 10.1021/nl102661q
   Liu S, 2011, CARBON, V49, P3158, DOI 10.1016/j.carbon.2011.03.036
   Liu ZF, 2008, ADV MATER, V20, P3924, DOI 10.1002/adma.200800366
   Lotya M, 2009, J AM CHEM SOC, V131, P3611, DOI 10.1021/ja807449u
   Malesevic A, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/30/305604
   McAllister MJ, 2007, CHEM MATER, V19, P4396, DOI 10.1021/cm0630800
   Mehrali M, 2014, ACS APPL MATER INTER, V6, P3947, DOI 10.1021/am500845x
   Mei XG, 2011, CARBON, V49, P5389, DOI 10.1016/j.carbon.2011.08.019
   Metin O, 2013, NANO RES, V6, P10, DOI 10.1007/s12274-012-0276-4
   Meyer JC, 2007, NATURE, V446, P60, DOI 10.1038/nature05545
   Naeimi H, 2015, NEW J CHEM, V39, P2697, DOI 10.1039/c4nj02340d
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/NNANO.2009.58, 10.1038/nnano.2009.58]
   Peng HD, 2012, J PHYS CHEM C, V116, P16294, DOI 10.1021/jp3043889
   Qian Y, 2011, MATER LETT, V65, P56, DOI 10.1016/j.matlet.2010.09.042
   Ren PG, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/5/055705
   Shao YY, 2010, ELECTROANAL, V22, P1027, DOI 10.1002/elan.200900571
   Shin HJ, 2009, ADV FUNCT MATER, V19, P1987, DOI 10.1002/adfm.200900167
   Song P, 2012, RSC ADV, V2, P1168, DOI 10.1039/c1ra00934f
   Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034
   Sun GL, 2008, MATER LETT, V62, P703, DOI 10.1016/j.matlet.2007.06.035
   Thakur S, 2012, CARBON, V50, P5331, DOI 10.1016/j.carbon.2012.07.023
   Tran D. N., 2014, CARBON
   Khai TV, 2013, CHEM ENG J, V232, P346, DOI 10.1016/j.cej.2013.07.123
   Tung VC, 2009, NAT NANOTECHNOL, V4, P25, DOI [10.1038/nnano.2008.329, 10.1038/NNANO.2008.329]
   Ulbricht H, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.075404
   Pham VH, 2012, J MATER CHEM, V22, P10530, DOI 10.1039/c2jm30562c
   Wang DW, 2012, CARBON, V50, P3333, DOI 10.1016/j.carbon.2011.12.054
   Wang GM, 2011, NANO RES, V4, P563, DOI 10.1007/s12274-011-0112-2
   Wang GX, 2008, J PHYS CHEM C, V112, P8192, DOI 10.1021/jp710931h
   Wang GX, 2009, CARBON, V47, P2049, DOI 10.1016/j.carbon.2009.03.053
   Wang GX, 2009, CARBON, V47, P1359, DOI 10.1016/j.carbon.2009.01.027
   Wang GX, 2009, CARBON, V47, P68, DOI 10.1016/j.carbon.2008.09.002
   Wang Y, 2011, ACS APPL MATER INTER, V3, P1127, DOI 10.1021/am1012613
   Williams JR, 2007, SCIENCE, V317, P638, DOI 10.1126/science.1144657
   XianaGuo C., 2011, ENERG ENVIRON SCI, V4, P4504
   Xu LQ, 2010, MACROMOLECULES, V43, P8336, DOI 10.1021/ma101526k
   Yan J, 2010, CARBON, V48, P3825, DOI 10.1016/j.carbon.2010.06.047
   Yang HB, 2011, J PHYS CHEM C, V115, P12209, DOI 10.1021/jp201178a
   Yang S, 2012, RSC ADV, V2, P8827, DOI 10.1039/c2ra20746j
   Yoo E, 2008, NANO LETT, V8, P2277, DOI 10.1021/nl800957b
   Zhang JL, 2010, CHEM COMMUN, V46, P1112, DOI 10.1039/b917705a
   Zhang YW, 2012, RSC ADV, V2, P538, DOI 10.1039/c1ra00641j
   Zhao JG, 2012, CARBON, V50, P4939, DOI 10.1016/j.carbon.2012.06.024
   Zhu CZ, 2010, ACS NANO, V4, P2429, DOI 10.1021/nn1002387
   Zhu JX, 2011, NANOSCALE, V3, P1084, DOI 10.1039/c0nr00744g
   Zhu YW, 2010, ADV MATER, V22, P3906, DOI 10.1002/adma.201001068
   Zhuo QQ, 2013, CARBON, V52, P559, DOI 10.1016/j.carbon.2012.10.014
   Zickler GA, 2006, CARBON, V44, P3239, DOI 10.1016/j.carbon.2006.06.029
NR 91
TC 10
Z9 10
U1 0
U2 17
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 86
BP 70461
EP 70472
DI 10.1039/c5ra10520j
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA CQ2BN
UT WOS:000360404400071
DA 2018-10-19
ER

PT J
AU Zhan, YX
   Niu, XR
AF Zhan, Yuexing
   Niu, Xinrui
TI Tuning methods and mechanical modelling of hydrogels
SO BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS
LA English
DT Article
DE biomaterial; material properties; modelling
ID DOUBLE-NETWORK HYDROGELS; POLY(ETHYLENE GLYCOL) HYDROGELS; BIOMEDICAL
   APPLICATIONS; LARGE-DEFORMATION; DRUG-DELIVERY; POLYACRYLAMIDE
   HYDROGELS; NANOCOMPOSITE HYDROGELS; VISCOELASTIC PROPERTIES; SPHERICAL
   INDENTATION; COMPOSITE-MATERIALS
AB Hydrogels are cross-linked polymeric networks filled with high water content. They are used as tissue/cell culture scaffolds, biomedical devices and healthcare products. As the performance of hydrogels is significantly affected by their mechanical properties, it is required to tune hydrogels into desired mechanical systems. To provide guidance to the tuning process, it is important to evaluate and model the mechanical properties of hydrogels. However, due to the structural complexity of hydrogels, both tuning and modelling face challenges and uncertainties. This article briefly reviews the tuning methods and summarises key mechanical models that address linear elastic, hyperelastic, viscoelastic, poroelastic and hybrid mechanical behaviours of hydrogels.
C1 [Zhan, Yuexing; Niu, Xinrui] City Univ Hong Kong, Dept Mech & Biomed Engn, Kowloon, Hong Kong, Peoples R China.
   [Zhan, Yuexing; Niu, Xinrui] City Univ Hong Kong, CASM, Kowloon, Hong Kong, Peoples R China.
RP Zhan, YX (reprint author), City Univ Hong Kong, Dept Mech & Biomed Engn, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM yxzhan4-c@my.cityu.edu.hk
OI NIU, Xinrui/0000-0001-9965-4423
FU City University of Hong Kong [7200274, 2011SRG067, 9610217]
FX The authors acknowledge the financial support from the City University
   of Hong Kong for Start-up Grant for New Faculty 7200274, Strategic
   Research Grant 2011SRG067 and Equipment Fund 9610217.
CR Andrade A.L., 2012, J NANOMATER, V2012, P15
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   ARRUDA EM, 1993, J MECH PHYS SOLIDS, V41, P389, DOI 10.1016/0022-5096(93)90013-6
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Bignon A, 2003, J MATER SCI-MATER M, V14, P1089, DOI 10.1023/B:JMSM.0000004006.90399.b4
   Billiet T, 2012, BIOMATERIALS, V33, P6020, DOI 10.1016/j.biomaterials.2012.04.050
   Biot MA, 1941, J APPL PHYS, V12, P155, DOI 10.1063/1.1712886
   Cai SQ, 2010, J APPL PHYS, V108, DOI 10.1063/1.3517146
   Calvert P, 2009, ADV MATER, V21, P743, DOI 10.1002/adma.200800534
   Chan BK, 2012, MACROMOL BIOSCI, V12, P1490, DOI 10.1002/mabi.201200234
   Chan EP, 2012, SOFT MATTER, V8, P1492, DOI 10.1039/c1sm06514a
   Choi YJ, 2006, J NANOSCI NANOTECHNO, V6, P633, DOI 10.1166/jnn.2006.132
   Chyasnavichyus M, 2014, LANGMUIR, V30, P10566, DOI 10.1021/la404925h
   Cordell JM, 2009, J MECH BEHAV BIOMED, V2, P560, DOI 10.1016/j.jmbbm.2009.01.009
   Counto U. J., 1964, MAGAZINE CONCRETE RE, V16, P129
   Crichton ML, 2011, BIOMATERIALS, V32, P4670, DOI 10.1016/j.biomaterials.2011.03.012
   Cui J, 2012, MACROMOLECULES, V45, P6104, DOI 10.1021/ma300593g
   Cui J, 2012, BIOMACROMOLECULES, V13, P584, DOI 10.1021/bm300015s
   Delaney JT, 2010, SOFT MATTER, V6, P866, DOI 10.1039/b922888h
   DERJAGUIN BV, 1975, J COLLOID INTERF SCI, V53, P314, DOI 10.1016/0021-9797(75)90018-1
   Di Giacomo R, 2013, IEEE T NANOTECHNOL, V12, P1026, DOI 10.1109/TNANO.2013.2285438
   Djonlagic J, 2004, J POLYM SCI POL PHYS, V42, P3987, DOI 10.1002/polb.20247
   Douce J, 2004, THIN SOLID FILMS, V466, P114, DOI 10.1016/j.tsf.2004.03.024
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Einstein A, 1905, ANN PHYS-BERLIN, V17, P549
   Einstein A., 1956, INVESTIGATIONS THEOR
   El-Mohdy H.L.A., 2013, J POLYM RES, V20, P1
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erickson IE, 2009, OSTEOARTHR CARTILAGE, V17, P1639, DOI 10.1016/j.joca.2009.07.003
   Faghihi S, 2014, MAT SCI ENG C-MATER, V38, P299, DOI 10.1016/j.msec.2014.02.015
   Friedrich K., 2005, POLYM COMPOSITES NAN
   Fu SY, 2002, COMPOS PART B-ENG, V33, P291, DOI 10.1016/S1359-8368(02)00013-6
   FUNG YCB, 1967, AM J PHYSIOL, V213, P1532
   Gaharwar AK, 2013, MAT SCI ENG C-MATER, V33, P1800, DOI 10.1016/j.msec.2012.12.099
   Gaharwar AK, 2011, ACTA BIOMATER, V7, P4139, DOI 10.1016/j.actbio.2011.07.023
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Gong JP, 2010, SOFT MATTER, V6, P2583, DOI 10.1039/b924290b
   Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   GUTH E, 1945, J APPL PHYS, V16, P20, DOI 10.1063/1.1707495
   Guvendiren M, 2013, CURR OPIN BIOTECH, V24, P841, DOI 10.1016/j.copbio.2013.03.009
   Haque MA, 2012, POLYMER, V53, P1805, DOI 10.1016/j.polymer.2012.03.013
   Henderson KJ, 2010, MACROMOLECULES, V43, P6193, DOI 10.1021/ma100963m
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hong W, 2008, J MECH PHYS SOLIDS, V56, P1779, DOI 10.1016/j.jmps.2007.11.010
   Hu YH, 2012, ACTA MECH SOLIDA SIN, V25, P441, DOI 10.1016/S0894-9166(12)60039-1
   Hu YH, 2011, J APPL PHYS, V110, DOI 10.1063/1.3647758
   Hu YH, 2011, J MATER RES, V26, P785, DOI 10.1557/jmr.2010.35
   Hu YH, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3370354
   Huang GY, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/1/012001
   Huang WC, 2014, ACTA BIOMATER, V10, P3546, DOI 10.1016/j.actbio.2014.04.025
   Huang WC, 2012, SOFT MATTER, V8, P10868, DOI 10.1039/c2sm26361k
   HYON SH, 1994, J BIOMAT SCI-POLYM E, V5, P397, DOI 10.1163/156856294X00103
   Ji XL, 2002, POLYM ENG SCI, V42, P983, DOI 10.1002/pen.11007
   Johnson JA, 2010, PROG POLYM SCI, V35, P332, DOI 10.1016/j.progpolymsci.2009.12.002
   JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141
   Kalcioglu ZI, 2012, SOFT MATTER, V8, P3393, DOI 10.1039/c2sm06825g
   Karimi A, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40257
   Karimi A, 2014, TISSUE CELL, V46, P97, DOI 10.1016/j.tice.2013.12.004
   Kim B, 2013, J APPL POLYM SCI, V130, P3574, DOI 10.1002/app.39544
   KINLOCH AJ, 1985, J MATER SCI, V20, P4169, DOI 10.1007/BF00552413
   Kirschner CM, 2013, ACTA MATER, V61, P931, DOI 10.1016/j.actamat.2012.10.037
   Kurokawa T, 2010, ACTA BIOMATER, V6, P1353, DOI 10.1016/j.actbio.2009.10.046
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Levesque SG, 2005, BIOMATERIALS, V26, P7436, DOI 10.1016/j.biomaterials.2005.05.054
   LEWIS TB, 1970, J APPL POLYM SCI, V14, P1449, DOI 10.1002/app.1970.070140604
   Lin DC, 2007, J BIOMECH ENG-T ASME, V129, P430, DOI 10.1115/1.2720924
   Lin DC, 2009, BIOMECH MODEL MECHAN, V8, P345, DOI 10.1007/s10237-008-0139-9
   Lin WC, 2011, SOFT MATTER, V7, P6578, DOI 10.1039/c1sm05420a
   Lin WC, 2010, MACROMOLECULES, V43, P2554, DOI 10.1021/ma901937r
   Liu JQ, 2014, EUR POLYM J, V50, P9, DOI 10.1016/j.eurpolymj.2013.10.015
   Liu TY, 2006, LANGMUIR, V22, P9740, DOI 10.1021/la061471n
   Lu GD, 2007, POLYM INT, V56, P1016, DOI [10.1002/pi.2235, 10.1002/pi]
   Lucas SR, 2008, ACTA BIOMATER, V4, P117, DOI 10.1016/j.actbio.2007.08.003
   Lucas SR, 2009, BIOMECH MODEL MECHAN, V8, P487, DOI 10.1007/s10237-009-0152-7
   Mandal SK, 2013, CHEM-EUR J, V19, P12486, DOI 10.1002/chem.201300302
   Mattice JM, 2006, J MATER RES, V21, P2003, DOI 10.1557/JMR.2006.0243
   MAXWELL D, 1984, J MATER SCI LETT, V3, P9, DOI 10.1007/BF00720061
   Mishra S, 2005, J POLYM SCI POL PHYS, V43, P107, DOI 10.1002/polb.20296
   Mooney M, 1940, J APPL PHYS, V11, P582, DOI 10.1063/1.1712836
   MOONEY M, 1951, J COLL SCI IMP U TOK, V6, P162, DOI 10.1016/0095-8522(51)90036-0
   Nemir S, 2010, BIOTECHNOL BIOENG, V105, P636, DOI 10.1002/bit.22574
   NIELSEN LE, 1979, J POLYM SCI POL PHYS, V17, P1897, DOI 10.1002/pol.1979.180171106
   NIELSEN LE, 1970, J APPL PHYS, V41, P4626, DOI 10.1063/1.1658506
   OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026
   Omidian H, 2010, BIOMEDICAL APPLICATIONS OF HYDROGELS HANDBOOK, P1, DOI 10.1007/978-1-4419-5919-5_1
   Ou YC, 1998, J POLYM SCI POL PHYS, V36, P789
   Oyen ML, 2006, PHILOS MAG, V86, P5625, DOI 10.1080/14786430600740666
   Oyen ML, 2014, INT MATER REV, V59, P44, DOI 10.1179/1743280413Y.0000000022
   Parlato M, 2014, MACROMOL BIOSCI, V14, P687, DOI 10.1002/mabi.201300418
   Pasqui D, 2011, MATER LETT, V65, P392, DOI 10.1016/j.matlet.2010.10.053
   Peak CW, 2013, COLLOID POLYM SCI, V291, P2031, DOI 10.1007/s00396-013-3021-y
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   RADFORD KC, 1971, J MATER SCI, V6, P1286, DOI 10.1007/BF00552042
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   RIVLIN RS, 1948, PHILOS TR R SOC S-A, V241, P379, DOI 10.1098/rsta.1948.0024
   Roberts JJ, 2011, J BIOMED MATER RES B, V99B, P158, DOI 10.1002/jbm.b.31883
   Sakai M, 2002, PHILOS MAG A, V82, P1841, DOI 10.1080/01418610210134738
   Sannino A, 2009, MATERIALS, V2, P353, DOI 10.3390/ma2020353
   Santin M, 1996, BIOMATERIALS, V17, P1459, DOI 10.1016/0142-9612(96)89769-9
   Sasson A, 2012, J MECH BEHAV BIOMED, V8, P143, DOI 10.1016/j.jmbbm.2011.12.008
   Schapery R. A., 1997, Mechanics of Time-Dependent Materials, V1, P209, DOI 10.1023/A:1009767812821
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shapiro JM, 2014, ACTA MECH SINICA-PRC, V30, P7, DOI 10.1007/s10409-014-0025-x
   Shin SR, 2012, ACS NANO, V6, P362, DOI 10.1021/nn203711s
   Sneddon IN, 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4
   Sopyan I, 2007, SCI TECHNOL ADV MAT, V8, P116, DOI 10.1016/j.stam.2006.11.017
   Stachowiak AN, 2005, ADV MATER, V17, P399, DOI 10.1002/adma.200400507
   Strange DGT, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4789368
   Sudheesh Kumar PT, 2012, ACS APPL MATER INTER, V4, P2618, DOI DOI 10.1021/AM300292V
   Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409
   TABOR D, 1948, PROC R SOC LON SER-A, V192, P247, DOI 10.1098/rspa.1948.0008
   Tabor D., 1951, HARDNESS METALS
   Tighe BJ, 2013, EYE CONTACT LENS, V39, P4, DOI 10.1097/ICL.0b013e318275452b
   Tokuyama H, 2007, LANGMUIR, V23, P11246, DOI 10.1021/la701492u
   Tuncaboylu DC, 2011, MACROMOLECULES, V44, P4997, DOI 10.1021/ma200579v
   Verbeek CJR, 2003, MATER LETT, V57, P1919, DOI 10.1016/S0167-577X(02)01105-9
   Wang QM, 2014, ACTA MECH SINICA-PRC, V30, P20, DOI 10.1007/s10409-014-0015-z
   Wang Q, 2012, SOFT MATTER, V8, P6048, DOI 10.1039/c2sm07233e
   Wang X, 2012, P ROY SOC A-MATH PHY, V468, P3824, DOI 10.1098/rspa.2012.0385
   WEI Qingbo, 2014, J POLYM RES, V21, P1
   Weng LH, 2008, BIOMATERIALS, V29, P2153, DOI 10.1016/j.biomaterials.2008.01.012
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Wu CJ, 2013, MACROMOL BIOSCI, V13, P59, DOI 10.1002/mabi.201200362
   Wu CJ, 2011, MACROMOLECULES, V44, P8215, DOI 10.1021/ma200562k
   Xu YX, 2013, ACS NANO, V7, P4042, DOI 10.1021/nn4000836
   YEOH OH, 1993, RUBBER CHEM TECHNOL, V66, P754, DOI 10.5254/1.3538343
   Yun J, 2011, MATER SCI ENG B-ADV, V176, P276, DOI 10.1016/j.mseb.2010.11.011
   Zhang MG, 2014, BIOMECH MODEL MECHAN, V13, P1, DOI 10.1007/s10237-013-0481-4
   Zhao XH, 2012, J MECH PHYS SOLIDS, V60, P319, DOI 10.1016/j.jmps.2011.10.005
NR 133
TC 2
Z9 2
U1 1
U2 21
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2045-9858
EI 2045-9866
J9 BIOINSPIR BIOMIM NAN
JI Bioinspired Biomim. Nanobiomat.
PY 2015
VL 4
IS 2
BP 140
EP 154
DI 10.1680/bbn.14.00029
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CP8OT
UT WOS:000360154200005
DA 2018-10-19
ER

PT J
AU Utku, FS
   Yuca, E
   Seckin, E
   Goller, G
   Karatas, AY
   Urgen, M
   Tamerler, C
AF Utku, Feride Sermin
   Yuca, Esra
   Seckin, Eren
   Goller, Gultekin
   Karatas, Ayten Yazgan
   Urgen, Mustafa
   Tamerler, Candan
TI Protein-mediated hydroxyapatite composite layer formation on nanotubular
   titania
SO BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS
LA English
DT Article
DE biocompatible; biointerface; biomaterial
ID CALCIUM-PHOSPHATE COATINGS; IN-VITRO; ELECTROCHEMICAL DEPOSITION;
   SURFACE MODIFICATION; MATERIALS SCIENCE; DENTAL IMPLANTS; OXIDE
   NANOTUBES; SUBSTRATE; PEPTIDES; CELL
AB Realising controllable interactions at the bio-nanomaterial interfaces are vital in developing next-generation engineered implant materials. Titanium-based implants are key materials in biomedical engineering due to excellent bulk mechanical properties and biocompatibilities. Advanced bio-interfaces resolving nanostructured modulated surfaces that allow manipulation with the biological molecules is one of the keys to enhance favourable interactions with the surrounding biological species. Here, we developed a protein-mediated hydroxyapatite composite layer on nanotubular titania surface. Green fluorescence protein, engineered to contain hydroxyapatite binding peptides (GFPuv-HABP), was co-deposited with the hydroxyapatite precursors onto the titania nanotubes that are formed by anodisation. Ordered titanium dioxide nanotubular surfaces were coated with hydroxyapatite at physiological pH and temperature using simulated body fluid and pulsed electrochemical cathodisation. The hydroxyapatite deposit interdigitated into the nanotubes, producing a metal oxide-mineral composite. The engineered GFPuv-HABP protein was then self-assembled on the hydroxyapatite, forming a bio-modulated interface. Additionally, the engineered proteins were co-deposited with the precursor ions of hydroxyapatite mineral on the nanotubular titania plate. Bio-mediated assembly resulted in formation of a hybrid composite as an integrated interface on the nanotubular surface. Biomolecular assisted fabrication of hybrid composite interface on metal oxide substrate offers wide range of opportunities to design novel interfaces.
C1 [Utku, Feride Sermin] Yeditepe Univ, Dept Biomed Engn, Istanbul, Turkey.
   [Yuca, Esra; Tamerler, Candan] Univ Kansas, Bioengn Res Ctr, Lawrence, KS 66045 USA.
   [Yuca, Esra] Yildiz Tech Univ, Dept Mol Biol & Genet, Istanbul, Turkey.
   [Seckin, Eren; Goller, Gultekin; Urgen, Mustafa] Istanbul Tech Univ, Dept Met Engn, TR-80626 Istanbul, Turkey.
   [Karatas, Ayten Yazgan] Istanbul Tech Univ, Dept Mol Biol & Genet, TR-80626 Istanbul, Turkey.
   [Tamerler, Candan] Univ Kansas, Dept Mech Engn, Lawrence, KS 66045 USA.
RP Tamerler, C (reprint author), Univ Kansas, Bioengn Res Ctr, Lawrence, KS 66045 USA.
EM ctamerler@ku.edu
RI Urgen, Mustafa/D-5422-2014
OI Urgen, Mustafa/0000-0003-3549-0049; UTKU, FERIDE
   SERMIN/0000-0002-5143-3602; Tamerler, Candan/0000-0002-1960-2218
FU TUBITAK BIDEB [2218, 2219]; TR-SPO; University of Kansas NFRF funds
FX This study has been supported by TUBITAK BIDEB 2218 and 2219
   Post-Doctoral Research Project, TR-SPO and University of Kansas NFRF
   funds. We thank Huseyin Sezer, Talat Apak, Berk Alkan, SevginTurkeli and
   Mizrap Canibeyaz for the characterisation of CHA coatings.
CR ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531
   Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255
   ALBREKTSSON T, 1983, ANN BIOMED ENG, V11, P1, DOI 10.1007/BF02363944
   Alves C, 2005, SURF COAT TECH, V194, P196, DOI 10.1016/j.surfcoat.2004.10.009
   Angelescu N, 2011, METAL INT, V16, P125
   Ban S, 1998, J BIOMED MATER RES, V42, P387, DOI 10.1002/(SICI)1097-4636(19981205)42:3<387::AID-JBM6>3.3.CO;2-Q
   BAN SJ, 1995, BIOMATERIALS, V16, P977, DOI 10.1016/0142-9612(95)94904-Y
   Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001
   Bavykin DV, 2006, ADV MATER, V18, P2807, DOI 10.1002/adma.200502696
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Boyan BD, 2001, ANN REV MATER RES, V31, P357, DOI 10.1146/annurev.matsci.31.1.357
   Boyan BD, 1999, BIOMATERIALS, V20, P2305, DOI 10.1016/S0142-9612(99)00159-3
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   CHEHROUDI B, 1992, CELL MATER, V2, P89
   COOK SD, 1991, CLIN ORTHOP RELAT R, P280
   Deporter D, 2009, INT J PERIODONT REST, V29, P625
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Dietz H, 2006, P NATL ACAD SCI USA, V103, P12724, DOI 10.1073/pnas.0602995103
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Evans JS, 2008, MRS BULL, V33, P514, DOI 10.1557/mrs2008.103
   Faghihi S, 2007, ADV MATER, V19, P1069, DOI 10.1002/adma.200602276
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Frenkel SR, 2002, J BIOMED MATER RES, V63, P706, DOI 10.1002/jbm.10408
   Fukumoto S, 1999, MAT SCI ENG A-STRUCT, V263, P205, DOI 10.1016/S0921-5093(98)01166-6
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gungormus M, 2008, BIOMACROMOLECULES, V9, P966, DOI 10.1021/bm701037x
   Gungormus M, 2012, INT J ORAL SCI, V4, P69, DOI 10.1038/ijos.2012.40
   Hnilova M, 2012, J COLLOID INTERF SCI, V365, P97, DOI 10.1016/j.jcis.2011.09.006
   Ho WF, 2009, SURF COAT TECH, V203, P3142, DOI 10.1016/j.surfcoat.2009.03.042
   HULBERT SF, 1973, J BIOMED MATER RES, V7, P1, DOI 10.1002/jbm.820070303
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   Jiang PL, 2013, ELECTROCHIM ACTA, V107, P16, DOI 10.1016/j.electacta.2013.05.120
   Kannan S, 2008, J AM CERAM SOC, V91, P1, DOI 10.1111/j.1551-2916.2007.02117.x
   Kar A, 2006, SURF COAT TECH, V201, P3723, DOI 10.1016/j.surfcoat.2006.09.008
   Khatayevich D, 2010, ACTA BIOMATER, V6, P4634, DOI 10.1016/j.actbio.2010.06.004
   Kokubo T, 2004, J MATER SCI-MATER M, V15, P99, DOI 10.1023/B:JMSM.0000011809.36275.0c
   Kunze J, 2008, ELECTROCHIM ACTA, V53, P6995, DOI 10.1016/j.electacta.2008.01.027
   Kuo MC, 2002, MAT SCI ENG C-BIO S, V20, P153, DOI 10.1016/S0928-4931(02)00026-7
   Leeuwenburgh SCG, 2006, BIOMATERIALS, V27, P3368, DOI 10.1016/j.biomaterials.2006.01.052
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198
   Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865
   Narayanan R, 2007, SCRIPTA MATER, V56, P229, DOI 10.1016/j.scriptamat.2006.10.004
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Redepenning J, 1996, J BIOMED MATER RES, V30, P287
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   Rossler S, 2003, J BIOMED MATER RES A, V64A, P655, DOI 10.1002/jbm.a.10330
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Seker UOS, 2009, BIOMACROMOLECULES, V10, P250, DOI 10.1021/bm8009895
   Shirkhanzadeh M, 1998, J MATER SCI-MATER M, V9, P67, DOI 10.1023/A:1008838813120
   Slosarczyk A, 2005, J MOL STRUCT, V744, P657, DOI 10.1016/j.molstruc.2004.11.078
   Stojanovic D, 2007, J EUR CERAM SOC, V27, P1595, DOI 10.1016/j.jeurceramsoc.2006.04.111
   Tamerler C, 2006, LANGMUIR, V22, P7712, DOI 10.1021/la0606897
   Tamerler C, 2009, ACS NANO, V3, P1606, DOI 10.1021/nn900720g
   Tomsia AP, 2011, INT J ORAL MAX IMPL, V26, P25
   Utku FS, 2014, CERAM INT, V40, P15479, DOI 10.1016/j.ceramint.2014.07.004
   Utku FS, 2008, J STRUCT BIOL, V162, P361, DOI 10.1016/j.jsb.2008.01.004
   Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e
   Wang H, 2009, APPL SURF SCI, V255, P4074, DOI 10.1016/j.apsusc.2008.10.111
   Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/nmat4089, 10.1038/NMAT4089]
   Woesz A, 2006, J MATER RES, V21, P2068, DOI 10.1557/JMR.2006.0251
   Yazici H, 2013, ACTA BIOMATER, V9, P5341, DOI 10.1016/j.actbio.2012.11.004
   Yen SK, 2003, MATER CHEM PHYS, V77, P70, DOI 10.1016/S0254-0584(01)00562-4
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yuca E, 2011, BIOTECHNOL BIOENG, V108, P1021, DOI 10.1002/bit.23041
   Yucesoy DT, 2015, JOM-US, V67, P754, DOI 10.1007/s11837-015-1350-7
   Zhang QY, 2009, J BIOMED MATER RES A, V88A, P481, DOI 10.1002/jbm.a.31820
   Zhou Y, 2015, NANOMED-NANOTECHNOL, V11, P431, DOI 10.1016/j.nano.2014.10.003
NR 72
TC 3
Z9 3
U1 1
U2 30
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2045-9858
EI 2045-9866
J9 BIOINSPIR BIOMIM NAN
JI Bioinspired Biomim. Nanobiomat.
PY 2015
VL 4
IS 2
BP 155
EP 165
DI 10.1680/bbn.15.00001
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CP8OT
UT WOS:000360154200006
DA 2018-10-19
ER

PT J
AU Yao, HB
   Fan, MH
   Wang, YJ
   Luo, GS
   Fei, WY
AF Yao, Hongbao
   Fan, Maohong
   Wang, Yujun
   Luo, Guangsheng
   Fei, Weiyang
TI Magnetic titanium dioxide based nanomaterials: synthesis,
   characteristics, and photocatalytic application in pollutant degradation
SO JOURNAL OF MATERIALS CHEMISTRY A
LA English
DT Review
ID FERRITE COMPOSITE NANOPARTICLES; VISIBLE-LIGHT; NICKEL FERRITE; TIO2
   PHOTOCATALYST; ACTIVATED CARBON; BIOMATERIAL SYSTEM; ENVIRONMENTAL
   APPLICATIONS; SEPARATED PHOTOCATALYST; SHELL NANOCOMPOSITES; ORGANIC
   POLLUTANTS
AB Magnetic titanium dioxide based nanocomposites have been gaining increasingly high attention in sustainable environmental protection fields; these materials can integrate the advantages of magnetic recovery and the superior photocatalysis performance of titanium dioxide. However, direct contact between crystalline photoactive titanium dioxide and magnetic iron oxide gives rise to lower photoreactivity than pure titanium dioxide for the pollutant degradation. To overcome the challenge, a number of researches have been done and significant process has been made in this area in recent years. This review primarily focuses on the properties of magnetic particles, structural models, preparation methods and techniques to improve photocatalytic performance of magnetic titanium dioxide based photocatalysts, and aims to provide a systematic overview of the current knowledge of these subjects. Notably, the recently discovered technique coupling graphene into magnetic iron oxide-titanium dioxide system is discussed, which opens a promising future for preparation of magnetic semiconductors with excellent properties. Current challenges and prospects are also proposed at the end of this article. In particular, the examination of corresponding deactivation or regeneration mechanisms should be investigated further, from the point of view of practical applications.
C1 [Yao, Hongbao; Fan, Maohong] Univ Wyoming, Dept Chem & Petr Engn, Laramie, WY 82071 USA.
   [Yao, Hongbao; Wang, Yujun; Luo, Guangsheng; Fei, Weiyang] Tsinghua Univ, Dept Chem Engn, State Key Lab Chem Engn, Beijing 100084, Peoples R China.
   [Fan, Maohong] Univ Wyoming, Sch Energy Resources, Laramie, WY 82071 USA.
   [Fan, Maohong] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA.
RP Fan, MH (reprint author), Univ Wyoming, Dept Chem & Petr Engn, Laramie, WY 82071 USA.
EM mfan@uwyo.edu; wangyujun@mail.tsinghua.edu.cn
RI Fan, Maohong/H-3624-2015
OI Fan, Maohong/0000-0003-1334-7292
FU Department of Energy; State of Wyoming
FX The authors gratefully acknowledge the great support from the Department
   of Energy and State of Wyoming.
CR Abd Aziz A, 2014, CHEM ENG J, V235, P264, DOI 10.1016/j.cej.2013.09.043
   Alvarez PM, 2010, APPL CATAL B-ENVIRON, V100, P338, DOI 10.1016/j.apcatb.2010.08.010
   Ao YH, 2009, J PHYS CHEM SOLIDS, V70, P1042, DOI 10.1016/j.jpcs.2009.05.019
   Ao YH, 2008, J HAZARD MATER, V160, P295, DOI 10.1016/j.jhazmat.2008.02.114
   Arabatzis IM, 2002, J PHOTOCH PHOTOBIO A, V149, P237, DOI 10.1016/S1010-6030(01)00645-1
   Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051
   Aziz AA, 2013, J EXP NANOSCI, V8, P295, DOI 10.1080/17458080.2012.675087
   Belessi V, 2009, APPL CATAL B-ENVIRON, V87, P181, DOI 10.1016/j.apcatb.2008.09.012
   Belova V, 2011, ULTRASON SONOCHEM, V18, P310, DOI 10.1016/j.ultsonch.2010.06.012
   Beydoun D, 2002, J MOL CATAL A-CHEM, V180, P193, DOI 10.1016/S1381-1169(01)00429-0
   Beydoun D, 2002, MAT SCI ENG B-SOLID, V94, P71, DOI 10.1016/S0921-5107(02)00085-5
   Beydoun D, 2001, CHEM ENG TECHNOL, V24, P745, DOI 10.1002/1521-4125(200107)24:7<745::AID-CEAT745>3.0.CO;2-D
   Beydoun D, 2000, J PHYS CHEM B, V104, P4387, DOI 10.1021/jp992088c
   Chen F, 1999, CATAL LETT, V58, P245, DOI 10.1023/A:1019071126825
   Chen F, 2001, CHEMOSPHERE, V44, P1159, DOI 10.1016/S0045-6535(00)00277-0
   Chen JY, 2010, J MATER SCI, V45, P6018, DOI 10.1007/s10853-010-4685-z
   Chen XB, 2005, ADV FUNCT MATER, V15, P41, DOI 10.1002/adfm.200400184
   Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535
   Chen YH, 2009, J HAZARD MATER, V172, P20, DOI 10.1016/j.jhazmat.2009.06.122
   Chen YH, 2009, IND ENG CHEM RES, V48, P7616, DOI 10.1021/ie900509t
   Chen YH, 2009, J HAZARD MATER, V163, P973, DOI 10.1016/j.jhazmat.2008.07.097
   CHOI WY, 1994, J PHYS CHEM-US, V98, P13669, DOI 10.1021/j100102a038
   Chung YS, 2004, MATER CHEM PHYS, V86, P375, DOI 10.1016/j.matchemphys.2004.03.027
   Cornell R.M., 2006, IRON OXIDES STRUCTUR
   Costa AL, 2012, J COLLOID INTERF SCI, V388, P31, DOI 10.1016/j.jcis.2012.07.077
   Cushing SK, 2012, J AM CHEM SOC, V134, P15033, DOI 10.1021/ja305603t
   Dabrowski A, 2005, CHEMOSPHERE, V58, P1049, DOI 10.1016/j.chemosphere.2004.09.067
   Fu WY, 2006, COLLOID SURFACE A, V289, P47, DOI 10.1016/j.colsurfa.2006.04.013
   Fu WY, 2006, MATER LETT, V60, P2723, DOI 10.1016/j.matlet.2006.01.078
   Fu WY, 2005, MATER LETT, V59, P3530, DOI 10.1016/j.matlet.2005.06.071
   Fu YP, 2010, J MATER RES, V25, P134, DOI 10.1557/JMR.2010.0015
   Fu YS, 2012, IND ENG CHEM RES, V51, P725, DOI 10.1021/ie2026212
   Fu YS, 2012, AICHE J, V58, P3298, DOI 10.1002/aic.13716
   Gao Y, 2003, MATER CHEM PHYS, V80, P348, DOI 10.1016/S0254-0584(02)00515-1
   Gawande MB, 2013, CHEM SOC REV, V42, P3371, DOI 10.1039/c3cs35480f
   Ghavami M, 2014, MAT SCI SEMICON PROC, V26, P69, DOI 10.1016/j.mssp.2014.04.007
   Gondal MA, 2012, J ENVIRON SCI HEAL A, V47, P570, DOI 10.1080/10934529.2012.650566
   Gopal M, 1997, J MATER SCI, V32, P6001, DOI 10.1023/A:1018671212890
   Gul IH, 2008, J MAGN MAGN MATER, V320, P270, DOI 10.1016/j.jmmm.2007.05.032
   Gupta VK, 2009, J ENVIRON MANAGE, V90, P2313, DOI 10.1016/j.jenvman.2008.11.017
   HAGUE DC, 1994, J AM CERAM SOC, V77, P1957, DOI 10.1111/j.1151-2916.1994.tb07078.x
   Hankare PP, 2011, APPL CATAL B-ENVIRON, V107, P333, DOI 10.1016/j.apcatb.2011.07.033
   Harra J, 2013, POWDER TECHNOL, V243, P46, DOI 10.1016/j.powtec.2013.03.027
   He YM, 2015, APPL CATAL B-ENVIRON, V168, P1, DOI 10.1016/j.apcatb.2014.12.017
   He YM, 2015, ENVIRON SCI TECHNOL, V49, P649, DOI 10.1021/es5046309
   He ZQ, 2012, SEP PURIF TECHNOL, V96, P50, DOI 10.1016/j.seppur.2012.05.005
   Hou WB, 2013, ADV FUNCT MATER, V23, P1612, DOI 10.1002/adfm.201202148
   Huang HC, 2006, THIN SOLID FILMS, V515, P1033, DOI 10.1016/j.tsf.2006.07.071
   Hussain ST, 2011, INT J ENVIRON SCI TE, V8, P351, DOI 10.1007/BF03326222
   Jiang Y, 2014, ACS APPL MATER INTER, V6, P11766, DOI 10.1021/am5025275
   Kostedt WL, 2010, ENVIRON PROG SUSTAIN, V29, P10, DOI 10.1002/ep.10364
   Kwon S, 2008, CRIT REV ENV SCI TEC, V38, P197, DOI 10.1080/10643380701628933
   Lee SW, 2006, MATER CHEM PHYS, V96, P483, DOI 10.1016/j.matchemphys.2005.07.039
   Lee SW, 2004, CHEM MATER, V16, P1160, DOI 10.1021/cm0351902
   Li HX, 2007, ENVIRON SCI TECHNOL, V41, P4410, DOI 10.1021/es062680x
   Li W, 2011, J AM CHEM SOC, V133, P15830, DOI 10.1021/ja2055287
   Li XY, 2012, J MATER SCI, V47, P465, DOI 10.1007/s10853-011-5821-0
   Li Y, 2011, PARTICUOLOGY, V9, P475, DOI 10.1016/j.partic.2011.04.005
   Liang YT, 2011, NANO LETT, V11, P2865, DOI 10.1021/nl2012906
   Liang YL, 2014, RSC ADV, V4, P56883, DOI 10.1039/c4ra08258c
   Lin Y, 2012, EUR J INORG CHEM, P4439, DOI 10.1002/ejic.201200454
   Linley S, 2014, ACS APPL MATER INTER, V6, P4658, DOI 10.1021/am4039272
   Liu SQ, 2012, ENVIRON CHEM LETT, V10, P209, DOI 10.1007/s10311-011-0348-9
   Ljubas D, 2014, SEP PURIF TECHNOL, V136, P274, DOI 10.1016/j.seppur.2014.09.018
   Luo JY, 2011, ACS NANO, V5, P8943, DOI 10.1021/nn203115u
   Luo L, 2009, J HAZARD MATER, V161, P175, DOI 10.1016/j.jhazmat.2008.03.105
   Luo ML, 2009, APPL CATAL B-ENVIRON, V87, P1, DOI 10.1016/j.apcatb.2008.09.002
   Ma Y, 2001, CHEMOSPHERE, V44, P1087, DOI 10.1016/S0045-6535(00)00360-X
   Mathew DS, 2007, CHEM ENG J, V129, P51, DOI 10.1016/j.cej.2006.11.001
   Matos J, 1998, APPL CATAL B-ENVIRON, V18, P281, DOI 10.1016/S0926-3373(98)00051-4
   Nakaruk A, 2012, J SOL-GEL SCI TECHN, V61, P175, DOI 10.1007/s10971-011-2607-4
   Nakata K, 2012, J PHOTOCH PHOTOBIO C, V13, P169, DOI 10.1016/j.jphotochemrev.2012.06.001
   Nam HD, 1998, JPN J APPL PHYS 1, V37, P4603, DOI 10.1143/JJAP.37.4603
   Narayani H, 2013, CATAL LETT, V143, P807, DOI 10.1007/s10562-013-1024-4
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Pang HA, 2011, CATAL COMMUN, V12, P611, DOI 10.1016/j.catcom.2010.12.015
   Pelaez M, 2012, APPL CATAL B-ENVIRON, V125, P331, DOI 10.1016/j.apcatb.2012.05.036
   Pongsorrarith V, 2012, MATER LETT, V67, P1, DOI 10.1016/j.matlet.2011.09.018
   Primo A, 2011, PHYS CHEM CHEM PHYS, V13, P886, DOI 10.1039/c0cp00917b
   Rafatullah M, 2010, J HAZARD MATER, V177, P70, DOI 10.1016/j.jhazmat.2009.12.047
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Reyes-Garcia EA, 2007, J PHYS CHEM C, V111, P17146, DOI 10.1021/jp070941z
   Reyes-Garcia EA, 2009, SOLID STATE NUCL MAG, V35, P74, DOI 10.1016/j.ssnmr.2009.02.004
   Shan AY, 2010, APPL CATAL A-GEN, V389, P1, DOI 10.1016/j.apcata.2010.08.053
   Shchukin DG, 2002, PHOTOCH PHOTOBIO SCI, V1, P742, DOI 10.1039/b207477j
   Shen JH, 2012, J MATER CHEM, V22, P13341, DOI 10.1039/c2jm31998e
   Shi ZL, 2011, J TAIWAN INST CHEM E, V42, P652, DOI 10.1016/j.jtice.2010.10.001
   Shi ZL, 2012, RUSS J PHYS CHEM A+, V86, P1326, DOI 10.1134/S0036024412060337
   Shi ZL, 2011, PHOTOCHEM PHOTOBIOL, V87, P626, DOI 10.1111/j.1751-1097.2011.00893.x
   Su JW, 2014, NANOSCALE, V6, P5181, DOI 10.1039/c4nr00534a
   Sun JW, 2013, RSC ADV, V3, P22490, DOI 10.1039/c3ra43416h
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Tang HQ, 2012, SEP PURIF TECHNOL, V95, P165, DOI 10.1016/j.seppur.2012.05.004
   Tang SCN, 2013, WATER RES, V47, P2613, DOI 10.1016/j.watres.2013.02.039
   Tang YH, 2013, J HAZARD MATER, V252, P115, DOI 10.1016/j.jhazmat.2013.02.053
   Tawkaew S, 2008, MATER CHEM PHYS, V108, P147, DOI 10.1016/j.matchemphys.2007.09.026
   TERABE K, 1994, J MATER SCI, V29, P1617, DOI 10.1007/BF00368935
   Tojo S, 2008, J PHYS CHEM C, V112, P14948, DOI 10.1021/jp804985f
   Tong H, 2012, ADV MATER, V24, P229, DOI 10.1002/adma.201102752
   Tryba B, 2003, APPL CATAL B-ENVIRON, V41, P427, DOI 10.1016/S0926-3373(02)00173-X
   Vereb G, 2012, APPL CATAL A-GEN, V417, P26, DOI 10.1016/j.apcata.2011.12.018
   Wang CX, 2009, J PHYS CHEM C, V113, P4008, DOI 10.1021/jp809835a
   Wang Y, 2014, RSC ADV, V4, P44442, DOI 10.1039/c4ra07457b
   Wang ZH, 2012, INT J PHOTOENERGY, DOI 10.1155/2012/202519
   Watson S, 2005, J NANOPART RES, V7, P691, DOI 10.1007/s11051-005-7520-8
   Watson S, 2002, J PHOTOCH PHOTOBIO A, V148, P303, DOI 10.1016/S1010-6030(02)00057-6
   Wu W., 2014, NANOSCALE, V7, P38
   Xiang QJ, 2010, APPL CATAL B-ENVIRON, V96, P557, DOI 10.1016/j.apcatb.2010.03.020
   Xu H, 2008, J SOLID STATE CHEM, V181, P2516, DOI 10.1016/j.jssc.2008.06.019
   Xu MW, 2005, MATER LETT, V59, P2194, DOI 10.1016/j.matlet.2005.02.065
   Xu SH, 2007, SCI TECHNOL ADV MAT, V8, P40, DOI 10.1016/j.stam.2006.09.009
   Xu SH, 2007, APPL CATAL B-ENVIRON, V71, P177, DOI 10.1016/j.apcatb.2006.09.004
   Xu SH, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/9/095606
   Xuan SH, 2009, J PHYS CHEM C, V113, P553, DOI 10.1021/jp8073859
   Yamazaki S, 2001, WATER RES, V35, P1022, DOI 10.1016/S0043-1354(00)00347-X
   Yao SH, 2012, ENVIRON TECHNOL, V33, P983, DOI 10.1080/09593330.2011.604857
   Yao SH, 2010, PHOTOCHEM PHOTOBIOL, V86, P1215, DOI 10.1111/j.1751-1097.2010.00813.x
   Ye MM, 2010, CHEM-EUR J, V16, P6243, DOI 10.1002/chem.200903516
   Zhang N, 2012, NANOSCALE, V4, P5792, DOI 10.1039/c2nr31480k
   Zhang N, 2012, NANOSCALE, V4, P2227, DOI 10.1039/c2nr00009a
   Zhang YH, 2011, ACS NANO, V5, P7426, DOI 10.1021/nn202519j
   Zhang ZY, 2014, NANOSCALE, V6, P5217, DOI 10.1039/c3nr06562f
   Zhao D, 2008, ENVIRON SCI TECHNOL, V42, P308, DOI 10.1021/es071770e
   Zheng ZK, 2011, J MATER CHEM, V21, P9079, DOI 10.1039/c1jm10983a
   Zi ZF, 2008, J MAGN MAGN MATER, V320, P2746, DOI 10.1016/j.jmmm.2008.06.009
NR 127
TC 24
Z9 25
U1 14
U2 186
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-7488
EI 2050-7496
J9 J MATER CHEM A
JI J. Mater. Chem. A
PY 2015
VL 3
IS 34
BP 17511
EP 17524
DI 10.1039/c5ta03215f
PG 14
WC Chemistry, Physical; Energy & Fuels; Materials Science,
   Multidisciplinary
SC Chemistry; Energy & Fuels; Materials Science
GA CP7EL
UT WOS:000360049900002
DA 2018-10-19
ER

PT S
AU Sun, G
   Fang, Y
AF Sun, Gang
   Fang, Yan
BE Wu, Y
   Deng, W
TI Micro-morphological Models for Hydrophobicity on the Surface of Moth
   Wing
SO PROCEEDINGS OF THE AASRI INTERNATIONAL CONFERENCE ON INDUSTRIAL
   ELECTRONICS AND APPLICATIONS (IEA 2015)
SE AER-Advances in Engineering Research
LA English
DT Proceedings Paper
CT AASRI International Conference on Industrial Electronics and
   Applications (IEA)
CY JUN 27-28, 2015
CL London, ENGLAND
SP Amer Appl Sci Res Inst, Huazhong Normal Univ
DE micro-morphology; contact angle; hydrophobicity model; biomaterial; moth
ID MECHANISM
AB The micro-morphology, wettability and chemical composition of the moth wing surfaces were investigated by a scanning electron microscope (SEM), a contact angle (CA) meter and a Fourier transform infrared spectrometer (FT-IR). The micro-morphological models for hydrophobicity on the wing surface were established on the basis of the Cassie-Baxter equation. The wetting mechanism was discussed from the perspective of biological coupling. The moth wing surfaces are composed of naturally hydrophobic material and display micro/nano hierarchical structures, including primary structure (micrometric scales), secondary structure (submicro longitudinal ridges and lateral bridges) and tertiary structure (nano stripes). The wing surfaces exhibit high hydrophobicity (CA 150 similar to 158 degrees) and low adhesion (sliding angle 1 similar to 3 degrees). The cooperative effect of material element and structural element contributes to the special wettability of the wing surface. In micro-dimension, the smaller the width and the bigger the spacing of the scale, the stronger the hydrophobicity of the wing surfaces. In nano-dimension, the smaller the height and the smaller the width and the bigger the spacing of the longitudinal ridge, the stronger the hydrophobicity of the wing surfaces. The micro/nano structural model provides CA predictions in good accord with the data measured. The result may bring inspiration for biomimetic design and preparation of smart interfacial materials and novel self-cleaning coatings.
C1 [Sun, Gang; Fang, Yan] Changchun Normal Univ, Sch Life Sci, Changchun 130032, Peoples R China.
RP Fang, Y (reprint author), Changchun Normal Univ, Sch Life Sci, Changchun 130032, Peoples R China.
EM sungang@nenu.edu.cn; fangyan124@aliyun.com
CR Fang Y, 2007, CHINESE SCI BULL, V52, P711, DOI 10.1007/s11434-007-0120-5
   Gleiche M, 2000, NATURE, V403, P173, DOI 10.1038/35003149
   Higgins AM, 2000, NATURE, V404, P476, DOI 10.1038/35006597
   Liu H, 2006, SOFT MATTER, V2, P811, DOI 10.1039/b606654b
   Sun TL, 2005, ACCOUNTS CHEM RES, V38, P644, DOI 10.1021/ar040224c
   Wang XJ, 2009, CHINESE SCI BULL, V54, P569, DOI 10.1007/s11434-009-0071-0
NR 6
TC 0
Z9 0
U1 0
U2 0
PU ATLANTIS PRESS
PI PARIS
PA 29 AVENUE LAVMIERE, PARIS, 75019, FRANCE
SN 2352-5401
BN 978-94-62520-65-3
J9 AER ADV ENG RES
PY 2015
VL 2
BP 707
EP 711
PG 5
WC Engineering, Multidisciplinary; Engineering, Mechanical; Materials
   Science, Multidisciplinary
SC Engineering; Materials Science
GA BD3KW
UT WOS:000359815600175
DA 2018-10-19
ER

PT J
AU Xu, F
   Bao, MM
   Rui, LF
   Liu, JJ
   Li, JL
   Dou, YJ
   Yang, K
   Yuan, B
   Ma, YQ
AF Xu, Fan
   Bao, Meimei
   Rui, Longfei
   Liu, Jiaojiao
   Li, Jingliang
   Dou, Yujiang
   Yang, Kai
   Yuan, Bing
   Ma, Yuqiang
TI Self-assembly of monolayered lipid membranes for surface-coating of a
   nanoconfined Bombyx mori silk fibroin film
SO RSC ADVANCES
LA English
DT Article
ID DRUG-DELIVERY; BIOMATERIAL; SCAFFOLDS; BILAYERS; BEHAVIOR; METHANOL
AB Regenerated Bombyx mori (B. mori) silk fibroin is a type of widely used biomaterial. The beta-sheet structure of it after methanol treatment provides water-insolubility and mechanical stability while on the other side leads to a hydrophobic surface which is less preferred by biological systems. In this work we prepare a novel type of nanoconfined silk fibroin film with a thickness below 100 nm. The film has a flat while hydrophobic surface because of its beta-sheet structure due to the z-direction confinement during formation. Different types of lipid monolayers, DOPC, DPPC and MO, are assembled on the silk film surface. The lipid coating, especially the DPPC membrane, provides a much smoother and more hydrophilic surface due to the gel phase tails of the lipids, in comparison with the DOPC and MO ones which are in a liquid phase and have a much stronger interfacial association between silk film surface and lipid tails. Such a lipid coating preserves the biocompatibility and cellular affinity of the silk film which promises potential applications as surface coatings for materials for biological use.
C1 [Xu, Fan; Ma, Yuqiang] Nanjing Univ, Natl Lab Solid State Microstruct, Nanjing 210093, Jiangsu, Peoples R China.
   [Xu, Fan; Ma, Yuqiang] Nanjing Univ, Dept Phys, Nanjing 210093, Jiangsu, Peoples R China.
   [Bao, Meimei; Rui, Longfei; Liu, Jiaojiao; Yang, Kai; Yuan, Bing; Ma, Yuqiang] Soochow Univ, Ctr Soft Condensed Matter Phys & Interdisciplinar, Suzhou 215006, Peoples R China.
   [Bao, Meimei; Rui, Longfei; Liu, Jiaojiao; Yang, Kai; Yuan, Bing; Ma, Yuqiang] Soochow Univ, Coll Phys Optoelect & Energy, Suzhou 215006, Peoples R China.
   [Dou, Yujiang] Soochow Univ, Sch Elect & Informat Engn, Suzhou 215006, Peoples R China.
   [Li, Jingliang] Deakin Univ, Inst Frontier Mat, Waurn Ponds, Vic 3216, Australia.
RP Xu, F (reprint author), Nanjing Univ, Natl Lab Solid State Microstruct, Nanjing 210093, Jiangsu, Peoples R China.
EM xfjjhd@126.com; yuanbing@suda.edu.cn; myqiang@nju.edu.cn
RI li, jingliang/E-5075-2010
OI li, jingliang/0000-0003-0709-2246
FU National Science Foundation of China [91027040, 31061160496, 21374074,
   21422404]; National Basic Research Program of China [2012CB821500];
   Natural Science Foundation of Jiangsu Province of China [BK2012177,
   BK20131194]
FX This work was financially supported by the National Science Foundation
   of China (No. 91027040, 31061160496, 21374074, and 21422404), and the
   National Basic Research Program of China (No. 2012CB821500). B.Y. and
   K.Y. thank the support of the Natural Science Foundation of Jiangsu
   Province of China (No. BK2012177 and BK20131194). The authors also thank
   the Small Angle X-ray Scattering Station (BL16B) and X-ray Diffraction
   Station (BL14B) at Shanghai Synchrotron Radiation Facility (SSRF) for
   sample characterizations.
CR Ahmed S, 2011, SOFT MATTER, V7, P1936, DOI 10.1039/c0sm01045f
   Bai LQ, 2008, APPL SURF SCI, V254, P2988, DOI 10.1016/j.apsusc.2007.10.049
   Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI [10.1089/ten.tea.2007.0224, 10.1089/tea.2007.0224]
   Dou YJ, 2014, APPL SURF SCI, V296, P95, DOI 10.1016/j.apsusc.2014.01.050
   FRASER RDB, 1973, CONFORMATION FIBROUS, P95
   Freddi G, 1999, J APPL POLYM SCI, V71, P1563, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1563::AID-APP4>3.0.CO;2-E
   Goksu EI, 2009, BBA-BIOMEMBRANES, V1788, P254, DOI 10.1016/j.bbamem.2008.08.021
   Howland MC, 2005, J AM CHEM SOC, V127, P6752, DOI 10.1021/ja043439q
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kawahara Y, 2006, MACROMOL MATER ENG, V291, P458, DOI 10.1002/mame.200500350
   KELLER D, 2005, PHYS REV LETT, V94, P1
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kweon HY, 1999, J APPL POLYM SCI, V73, P2887, DOI 10.1002/(SICI)1097-4628(19990929)73:14<2887::AID-APP12>3.0.CO;2-I
   Kweon HY, 2000, POLYMER, V41, P7361, DOI 10.1016/S0032-3861(00)00100-2
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Lee D.W., 2014, P NATL ACAD SCI USA, V111, P768
   Li MZ, 2003, POLYM ADVAN TECHNOL, V14, P694, DOI 10.1002/pat.409
   Liu JJ, 2013, LANGMUIR, V29, P8039, DOI 10.1021/la4015652
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Plaza GR, 2008, J APPL POLYM SCI, V109, P1793, DOI 10.1002/app.28288
   Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rui LF, 2015, BBA-BIOMEMBRANES, V1848, P1203, DOI 10.1016/j.bbamem.2015.02.018
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Shi YF, 2014, MACROMOLECULES, V47, P7987, DOI 10.1021/ma501864g
   Shreve AP, 2008, LANGMUIR, V24, P13250, DOI 10.1021/la802909c
   Sublimi Saponetti Matilde, 2014, PLoS One, V9, pe115780, DOI 10.1371/journal.pone.0115780
   Sugihara K, 2010, ACS NANO, V4, P5047, DOI 10.1021/nn100773q
   Tang FQ, 2012, ADV MATER, V24, P1504, DOI 10.1002/adma.201104763
   Tero R, 2012, MATERIALS, V5, P2658, DOI 10.3390/ma5122658
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Zhang H, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-117
NR 33
TC 0
Z9 0
U1 3
U2 20
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 81
BP 65684
EP 65689
DI 10.1039/c5ra09683a
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA CO6BU
UT WOS:000359243000005
DA 2018-10-19
ER

PT J
AU Kobielarz, M
   Chwilkowska, A
   Turek, A
   Maksymowicz, K
   Marciniak, M
AF Kobielarz, Magdalena
   Chwilkowska, Agnieszka
   Turek, Artur
   Maksymowicz, Krzysztof
   Marciniak, Monika
TI Influence of selective digestion of elastin and collagen on mechanical
   properties of human aortas
SO ACTA OF BIOENGINEERING AND BIOMECHANICS
LA English
DT Article
DE collagen; elastin; selective digestion; mechanical properties; human
   aorta
ID ARTERIAL STIFFNESS; UNIAXIAL TENSION; ABDOMINAL AORTAS; TISSUE; WALL;
   PURIFICATION; BIOMATERIAL; SCAFFOLDS; DISEASE; STRESS
AB Purpose: There are two families of fibres taking part in the process of mechanical loads transfer, i.e. elastin and collagen fibres. Their number, spatial arrangement and specific properties determine the capacity of a blood vessels to resist mechanical loads resulting from the impact of blood on vessel walls. The purpose of the present paper is to define the load-bearing capacities of elastin and collagen scaffolds equivalent to natural fibre arrangements of human aorta and produced by selective digestion. Methods: Samples of thoracic human aortas were digested by using phosphate buffer of trypsin at pH 8.0 for 22 hours in order to degrade elastin and by autoclaving followed by incubation in 90% formic acid for 22 hours. The efficacy of digestion was assessed immunohistochemically. Mechanical properties of pre-stretched native and digested samples were determined by uniaxial tensile test. Results: Samples subjected to autoclaving have been successfully deprived of both types of collagen and elastin has been intact. Treatment with trypsin caused a removal of elastin and the presence of type I and IV collagen was demonstrated. Digestion of aortic samples either by formic acid or trypsin has resulted significantly decreasing mechanical properties in comparison with native samples. Conclusions: Collagen and elastin scaffold-like stuctures have been effectively produced by selective digestion of thoracic human aorta and their contribution to the load-bearing process was evaluated. Isolated collagen network are more durable and stiffer and less deformable than elastin network, hence are responsible for load-bearing process at higher strain since the range of working of elastin is at lower strain values.
C1 [Kobielarz, Magdalena] Wroclaw Univ Technol, Dept Biomed Engn Mechatron & Theory Mech, PL-50371 Wroclaw, Poland.
   [Kobielarz, Magdalena] Reg Specialist Hosp Wroclaw, Ctr Res & Dev, Wroclaw, Poland.
   [Chwilkowska, Agnieszka] Med Univ, Dept Med Biochem, Wroclaw, Poland.
   [Turek, Artur] Med Univ Silesia, Sch Pharm, Div Lab Med Sosnowiec, Katowice, Poland.
   [Turek, Artur] Chair & Dept Biopharm, Sosnowiec, Poland.
   [Turek, Artur] Polish Acad Sci, Ctr Polymer & Carbon Mat, Zabrze, Poland.
   [Maksymowicz, Krzysztof] Wroclaw Med Univ, Dept Forens Med, Fac Med, Wroclaw, Poland.
   [Marciniak, Monika] Wroclaw Univ Technol, Dept Plast Forming & Metrol, PL-50370 Wroclaw, Poland.
RP Kobielarz, M (reprint author), Wroclaw Univ Technol, Dept Biomed Engn Mechatron & Theory Mech, Ul Lukasiewicza 7-9, PL-50371 Wroclaw, Poland.
EM magdalena.kobielarz@pwr.edu.pl
FU European Regional Development Fund, within Innovative Economy
   Operational Program
FX This publication is part of the project "Wrovasc - Integrated
   Cardiovascular Centre", co-financed by the European Regional Development
   Fund, within Innovative Economy Operational Program, 2007-2013.
CR ARMENTANO RL, 1991, AM J PHYSIOL, V260, pH1870
   Assoul N, 2008, J BIOMECH, V41, P2227, DOI 10.1016/j.jbiomech.2008.04.017
   Carmo M, 2002, EUR J VASC ENDOVASC, V23, P543, DOI 10.1054/ejvs.2002.1620
   Chow MJ, 2011, J SURG RES, V171, P434, DOI 10.1016/j.jss.2010.04.007
   Claridge MW, 2009, ATHEROSCLEROSIS, V205, P477, DOI 10.1016/j.atherosclerosis.2008.12.030
   Cwalina B, 2005, INT J ARTIF ORGANS, V28, P648
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Daamen WF, 2001, BIOMATERIALS, V22, P1997, DOI 10.1016/S0142-9612(00)00383-5
   Faury G, 2001, PATHOL BIOL, V49, P310, DOI 10.1016/S0369-8114(01)00147-X
   Gasior-Glogowska M., 2010, ACTA BIOENG BIOMECH, V12, P53
   Gundiah N, 2007, J BIOMECH, V40, P586, DOI 10.1016/j.jbiomech.2006.02.004
   Hanuza J, 2010, J RAMAN SPECTROSC, V41, P1163, DOI 10.1002/jrs.2554
   Holzapfel GA, 2006, J THEOR BIOL, V238, P290, DOI 10.1016/j.jtbi.2005.05.006
   KATSUDA S, 1992, ARTERIOSCLER THROMB, V12, P494, DOI 10.1161/01.ATV.12.4.494
   Kobielarz M, 2013, J THEOR APP MECH-POL, V51, P949
   Kot M, 2011, T FAMENA, V35, P49
   LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72
   Lu QJ, 2004, BIOMATERIALS, V25, P5227, DOI 10.1016/j.biomaterials.2003.12.019
   Maksymowicz K, 2011, ADV CLIN EXP MED, V20, P221
   Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235
   Mecham RP, 2008, METHODS, V45, P32, DOI 10.1016/j.ymeth.2008.01.007
   Pezowicz C, 2010, J THEOR APP MECH-POL, V48, P917
   ROACH MR, 1957, CAN J BIOCH PHYSL, V35, P181
   Sakuragi S, 2010, INT J CARDIOL, V138, P112, DOI 10.1016/j.ijcard.2009.04.027
   Schriefl AJ, 2015, ACTA BIOMATER, V17, P125, DOI 10.1016/j.actbio.2015.01.003
   Simionescua DT, 2006, BIOMATERIALS, V27, P702, DOI 10.1016/j.biomaterials.2005.06.013
   Sokolis DP, 2006, J BIOMECH, V39, P1651, DOI 10.1016/j.jbiomech.2005.05.003
   Turek A, 2013, NUKLEONIKA, V58, P511
   WALKERCAPRIOGLIO HM, 1992, CELL TISSUE RES, V269, P141, DOI 10.1007/BF00384734
   Watton PN, 2009, J BIOMECH, V42, P1320, DOI 10.1016/j.jbiomech.2009.03.012
   Zou Y, 2009, ANN BIOMED ENG, V37, P1572, DOI 10.1007/s10439-009-9724-z
NR 31
TC 1
Z9 1
U1 1
U2 13
PU WROCLAW UNIV TECHNOLOGY
PI WROCLAW
PA WROCLAW UNIV TECHNOLOGY, MECHANICAL DEPT, WYBRZEZE WYSPIANSKIEGO 27,
   WROCLAW, 50-370, POLAND
SN 1509-409X
J9 ACTA BIOENG BIOMECH
JI Acta Bioeng. Biomech.
PY 2015
VL 17
IS 2
BP 55
EP 62
DI 10.5277/ABB-00184-2014-02
PG 8
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA CP2TR
UT WOS:000359730600006
PM 26415712
DA 2018-10-19
ER

PT J
AU Wu, JT
   Sun, TP
   Huang, CW
   Su, CT
   Wu, CY
   Yeh, SY
   Yang, DK
   Chen, LC
   Ding, ST
   Chen, HY
AF Wu, Jyun-Ting
   Sun, Ting-Pi
   Huang, Chao-Wei
   Su, Chiao-Tzu
   Wu, Chih-Yu
   Yeh, Shu-Yun
   Yang, Deng-Kai
   Chen, Lin-Chi
   Ding, Shih-Torng
   Chen, Hsien-Yeh
TI Tunable coverage of immobilized biomolecules for biofunctional interface
   design
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID COATINGS; ADHESION; POLYMERS
AB The controlled coverage of immobilized biomolecules is introduced, illustrating a concept for designing biomaterial surfaces such that the extent of manipulation employed to elicit biological responses is controlled according to density changes in the underlying chemical motifs and the density of immobilized biomolecules.
C1 [Wu, Jyun-Ting; Sun, Ting-Pi; Su, Chiao-Tzu; Wu, Chih-Yu; Yeh, Shu-Yun; Chen, Hsien-Yeh] Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan.
   [Huang, Chao-Wei; Ding, Shih-Torng] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10617, Taiwan.
   [Su, Chiao-Tzu] Aeon Biotherapeut Corp, Taipei 11494, Taiwan.
   [Yang, Deng-Kai; Chen, Lin-Chi] Natl Taiwan Univ, Dept Bioind Mechatron Engn, Taipei 10617, Taiwan.
RP Wu, JT (reprint author), Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan.
EM hsychen@ntu.edu.tw
OI Yang, Deng-Kai/0000-0001-5161-8052; Chen, Lin-Chi/0000-0001-5947-2019;
   Ding, Shih-Torng/0000-0002-9866-1776
FU Ministry of Science and Technology of Taiwan [101-2628-E-002-034-MY3,
   102-2911-I-002-507]; National Taiwan University [102R7745, 103R7745]
FX H.-Y. Chen gratefully acknowledges support from the Ministry of Science
   and Technology of Taiwan (101-2628-E-002-034-MY3 and 102-2911-I-002-507)
   and the National Taiwan University (102R7745 and 103R7745).
CR Alves D, 2014, BIOFOULING, V30, P483, DOI 10.1080/08927014.2014.889120
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chen HY, 2013, CHEM COMMUN, V49, P4531, DOI 10.1039/c3cc41491d
   Elkasabi YM, 2011, BIOMATERIALS, V32, P1809, DOI 10.1016/j.biomaterials.2010.10.046
   Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Kerwin SM, 2010, J AM CHEM SOC, V132, P2466, DOI 10.1021/ja1005306
   Lee D, 2009, SENSOR ACTUAT B-CHEM, V135, P444, DOI 10.1016/j.snb.2008.10.026
   Luo Y, 2004, BIOMACROMOLECULES, V5, P2315, DOI 10.1021/bm0495811
   Rusu GB, 2014, BIOSENS BIOELECTRON, V53, P154, DOI 10.1016/j.bios.2013.09.035
   Su CT, 2014, COLLOID SURFACE B, V116, P727, DOI 10.1016/j.colsurfb.2013.11.044
   Sun TL, 2011, CHEM SOC REV, V40, P2909, DOI 10.1039/c0cs00124d
   Tsai MY, 2014, ADV FUNCT MATER, V24, P2281, DOI 10.1002/adfm.201303050
   Yang R, 2012, LANGMUIR, V28, P12266, DOI 10.1021/la302059s
   Yoshioka K, 1997, J AM CERAM SOC, V80, P2667
   Zhao XB, 2011, LANGMUIR, V27, P7654, DOI 10.1021/la201245q
NR 16
TC 12
Z9 12
U1 4
U2 12
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2015
VL 3
IS 9
BP 1266
EP 1269
DI 10.1039/c5bm00127g
PG 4
WC Materials Science, Biomaterials
SC Materials Science
GA CO8XE
UT WOS:000359454700002
PM 26261855
DA 2018-10-19
ER

PT J
AU Ruso, JM
   Sartuqui, J
   Messina, PV
AF Ruso, Juan M.
   Sartuqui, Javier
   Messina, Paula V.
TI Multiscale Inorganic Hierarchically Materials: Towards an Improved
   Orthopaedic Regenerative Medicine
SO CURRENT TOPICS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE Bio-glass; Bioactive scaffolds; Bone; Hydroxyapatite; Templates; Tissue
   engineering
ID BIOACTIVE GLASS SCAFFOLDS; NANOCRYSTALLINE HYDROXYAPATITE PASTE;
   DRUG-DELIVERY-SYSTEMS; FULLERENE-LIKE STRUCTURES; BONE TISSUE
   REGENERATION; MECHANICAL-PROPERTIES; PROTEIN ADSORPTION; OSTEOBLAST
   ADHESION; APATITE FORMATION; LAMELLAR BONE
AB Bone is a biologically and structurally sophisticated multifunctional tissue. It dynamically responds to biochemical, mechanical and electrical clues by remodelling itself and accordingly the maximum strength and toughness are along the lines of the greatest applied stress. The challenge is to develop an orthopaedic biomaterial that imitates the micro- and nano-structural elements and compositions of bone to locally match the properties of the host tissue resulting in a biologically fixed implant. Looking for the ideal implant, the convergence of life and materials sciences occurs. Researchers in many different fields apply their expertise to improve implantable devices and regenerative medicine. Materials of all kinds, but especially hierarchical nano-materials, are being exploited. The application of nano-materials with hierarchical design to calcified tissue reconstructive medicine involve intricate systems including scaffolds with multifaceted shapes that provides temporary mechanical function; materials with nano-topography modifications that guarantee their integration to tissues and that possesses functionalized surfaces to transport biologic factors to stimulate tissue growth in a controlled, safe, and rapid manner. Furthermore materials that should degrade on a timeline coordinated to the time that takes the tissues regrow, are prepared. These implantable devices are multifunctional and for its construction they involve the use of precise strategically techniques together with specific material manufacturing processes that can be integrated to achieve in the design, the required multifunctionality. For such reasons, even though the idea of displacement from synthetic implants and tissue grafts to regenerative-medicine-based tissue reconstruction has been guaranteed for well over a decade, the reality has yet to emerge. In this paper, we examine the recent approaches to create enhanced bioactive materials. Their design and manufacturing procedures as well as the experiments to integrate them into engineer hierarchical inorganic materials for their practical application in calcified tissue reparation are evaluated.
C1 [Ruso, Juan M.] Univ Santiago de Compostela, Dept Appl Phys, Soft Matter & Mol Biophys Grp, Santiago De Compostela 15782, Spain.
   [Sartuqui, Javier; Messina, Paula V.] Univ Nacl Sur, Dept Chem, RA-8000 Bahia Blanca, Buenos Aires, Argentina.
   [Sartuqui, Javier; Messina, Paula V.] INQUISUR CONICET, Buenos Aires, DF, Argentina.
RP Messina, PV (reprint author), Univ Nacl Sur, Dept Chem, RA-8000 Bahia Blanca, Buenos Aires, Argentina.
EM pmessina@uns.edu.ar
OI Ruso, Juan/0000-0001-5909-6754
FU CONICET
FX The authors acknowledge Universidad Nacional del Sur (PGI 24/Q064),
   Concejo Nacional de Investigaciones Cientificas y Tecnicas de la
   Republica Argentina (CONICET, PIP - 11220130100100CO) and Fundacion
   Ramon Areces. JS have doctoral fellowships of CONICET. PVM is an
   independent researcher of CONICET.
CR Ackerman L.V., 1976, MONOGRAPHS PATHOLOGY
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Aparicio C, 2007, J BIOMED MATER RES A, V82A, P521, DOI 10.1002/jbm.a.31164
   Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   Arts JJC, 2006, BIOMATERIALS, V27, P1110, DOI 10.1016/j.biomaterials.2005.07.024
   Autumn K, 2000, NATURE, V405, P681
   Avnir D, 2006, J MATER CHEM, V16, P1013, DOI 10.1039/5512706h
   Avnir D., 1998, CHEM ORGANOSILICON C, P2317
   Avnir D., 1996, BIOCH ASPECTS SOL GE
   Barthelat F, 2007, PHILOS T R SOC A, V365, P2907, DOI 10.1098/rsta.2007.0006
   Bass JD, 2007, CHEM MATER, V19, P4349, DOI 10.1021/cm071305g
   Behrens P., 2009, HDB BIOMINERALIZATIO
   Bhushan B, 2009, PHILOS T R SOC A, V367, P1445, DOI 10.1098/rsta.2009.0011
   BOBBIO A, 1970, B HIST DENT, V20, P1
   Brambilla G, 2009, ADV OPT PHOTONICS, V1, P107, DOI 10.1364/AOP.1.000107
   Brinker C.J., 1990, SOL GEL SCI PHYS CHE, P1
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Cai YR, 2008, J MATER CHEM, V18, P3775, DOI 10.1039/b805407j
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Chen B, 2008, P R SOC A, V464, P1639, DOI 10.1098/rspa.2007.0350
   Chen B, 2012, LANGMUIR, V28, P2937, DOI 10.1021/la204154h
   Chen IH, 2011, J MECH BEHAV BIOMED, V4, P713, DOI 10.1016/j.jmbbm.2010.12.013
   Chen PY, 2008, J MECH BEHAV BIOMED, V1, P208, DOI 10.1016/j.jmbbm.2008.02.003
   Chen PY, 2008, ACTA BIOMATER, V4, P587, DOI 10.1016/j.actbio.2007.12.010
   Chen Q, 2013, J MECH BEHAV BIOMED, V19, P3, DOI 10.1016/j.jmbbm.2012.10.012
   Chen XB, 2009, ACTA BIOMATER, V5, P2290, DOI 10.1016/j.actbio.2009.02.027
   Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025
   Choi SY, 2012, J MATER CHEM, V22, P25288, DOI 10.1039/c2jm33354f
   Choi Y., 2007, J MATER SCI, V17, P3780
   CHOPRA NG, 1995, SCIENCE, V269, P966, DOI 10.1126/science.269.5226.966
   Chu CL, 2013, SURF COAT TECH, V232, P68, DOI 10.1016/j.surfcoat.2013.04.054
   Chung WJ, 2011, NATURE, V478, P364, DOI 10.1038/nature10513
   Clyne T. W., 1996, INTRO COMPOSITE MAT
   Colilla M, 2008, EXPERT OPIN THER PAT, V18, P639, DOI 10.1517/13543770802106746
   Colilla M, 2008, INT J NANOMED, V3, P403
   Collins M.W., 2004, OPTIMIZATION MECH NA
   Coradin T, 2006, CURR MED CHEM, V13, P99, DOI 10.2174/092986706775197999
   COWIN SC, 2001, BONE MECH HDB
   Currey JD, 2010, J MECH BEHAV BIOMED, V3, P357, DOI 10.1016/j.jmbbm.2010.03.002
   Currey J. D., 2002, BONES STRUCTURE MECH
   CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050
   D'Elia N.L., 2013, BIOCH BIOPHYS ACTA G, V1830, P5014
   Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   Dan N, 2000, TRENDS BIOTECHNOL, V18, P370, DOI 10.1016/S0167-7799(00)01482-7
   Das M, 2007, BIOMATERIALS, V28, P1918, DOI 10.1016/j.biomaterials.2006.11.036
   Deliormanli AM, 2012, J EUR CERAM SOC, V32, P3637, DOI 10.1016/j.jeurceramsoc.2012.05.005
   Diaz A, 2006, ACTA BIOMATER, V2, P173, DOI 10.1016/j.actbio.2005.12.006
   Doiphode ND, 2011, J MATER SCI-MATER M, V22, P515, DOI 10.1007/s10856-011-4236-4
   Dolatshahi-Pirouz A, 2008, COLLOID SURFACE B, V66, P53, DOI 10.1016/j.colsurfb.2008.05.010
   Dorozhkin SV, 2010, ACTA BIOMATER, V6, P715, DOI 10.1016/j.actbio.2009.10.031
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Dreesmann H, 1892, BEITR KLIN CHIR, V9, P804
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Engel E, 2008, TRENDS BIOTECHNOL, V26, P39, DOI 10.1016/j.tibtech.2007.10.005
   FELDMAN Y, 1995, SCIENCE, V267, P222, DOI 10.1126/science.267.5195.222
   Fernandez-Leyes M, 2012, J MATER SCI, V47, P2837, DOI 10.1007/s10853-011-6113-4
   Ferrer ML, 2006, CHEM MATER, V18, P554, DOI 10.1021/cm052087z
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Fratzl P, 2007, J R SOC INTERFACE, V4, P637, DOI 10.1098/rsif.2007.0218
   Fu Q, 2011, MAT SCI ENG C-MATER, V31, P1245, DOI 10.1016/j.msec.2011.04.022
   Fu Q, 2011, ACTA BIOMATER, V7, P3547, DOI 10.1016/j.actbio.2011.06.030
   Fu QA, 2011, ADV FUNCT MATER, V21, P1058, DOI 10.1002/adfm.201002030
   Fu QS, 2011, BIOMATERIALS, V32, P7333, DOI 10.1016/j.biomaterials.2011.06.051
   Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100
   Gao HJ, 2005, J APPL MECH-T ASME, V72, P732, DOI 10.1115/1.1988348
   Gibson L. J, 1999, CELLULAR SOLIDS STRU
   Gravina N., 2014, J MATER CHEM B, V2, P834
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Gutierrez MC, 2008, CHEM MATER, V20, P634, DOI 10.1021/cm702028z
   Hacohen YR, 1998, NATURE, V395, P336, DOI 10.1038/26380
   Han M, 2003, LANGMUIR, V19, P9868, DOI 10.1021/la030132g
   Hassan N, 2012, SOFT MATTER, V8, P9553, DOI 10.1039/c2sm26263k
   Hassan N, 2012, SOFT MATTER, V8, P6582, DOI 10.1039/c2sm25489a
   Hassan N, 2011, LANGMUIR, V27, P8905, DOI 10.1021/la201555f
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hodge A. J., 1963, ASPECTS PROTEIN STRU, P289
   Huang TS, 2011, MAT SCI ENG C-MATER, V31, P1482, DOI 10.1016/j.msec.2011.06.004
   Huber FX, 2008, J MATER SCI-MATER M, V19, P33, DOI 10.1007/s10856-007-3039-0
   Huber FX, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-50
   Huber FX, 2006, ARCH ORTHOP TRAUM SU, V126, P533, DOI 10.1007/s00402-006-0170-1
   Hulander M, 2011, INT J NANOMED, V6, P2653, DOI 10.2147/IJN.S24578
   Hulmes DJS, 2002, J STRUCT BIOL, V137, P2, DOI 10.1006/jsbi.2002.4450
   IMAE T, 1986, J PHYS CHEM-US, V90, P5216, DOI 10.1021/j100412a065
   Innocenzi P, 2011, CHEM MATER, V23, P2501, DOI 10.1021/cm200050r
   ISRAELACHVILI JN, 1985, INTERMOLECULAR SURFA
   Jiang PL, 2013, ELECTROCHIM ACTA, V107, P16, DOI 10.1016/j.electacta.2013.05.120
   Johnson F. E., 2006, BIONIC HUMAN HLTH PR
   Jones JR, 2010, P I MECH ENG H, V224, P1373, DOI 10.1243/09544119JEIM836
   Jones JR, 2006, PHILOS T ROY SOC A, V364, P263, DOI 10.1098/rsta.2005.1689
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kasuga T, 2002, J CRYST GROWTH, V235, P235, DOI 10.1016/S0022-0248(01)01782-1
   Katz A, 2006, TRIBOL LETT, V21, P135, DOI 10.1007/s11249-006-9029-4
   Keshmiri M, 2003, J NON-CRYST SOLIDS, V324, P289, DOI 10.1016/S0022-3093(03)00363-6
   Koegler P, 2012, ADV DRUG DELIVER REV, V64, P1820, DOI 10.1016/j.addr.2012.06.001
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Lim JY, 2005, J ROY SOC INTERFACE, V2, P97, DOI 10.1098/rsif.2004.0019
   Lipowsky Reinhard, 2006, Biophysical Reviews and Letters, V1, P223, DOI 10.1142/S1793048006000100
   Lord MS, 2006, BIOMATERIALS, V27, P4856, DOI 10.1016/j.biomaterials.2006.05.037
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Ma ZJ, 2013, APPL SURF SCI, V284, P738, DOI 10.1016/j.apsusc.2013.08.003
   Manzano M., 2009, EXPERT OPIN DRUG DEL, V6, P1
   Manzano M, 2012, PROG SOLID STATE CH, V40, P17, DOI 10.1016/j.progsolidstchem.2012.05.001
   MARGULIS L, 1993, NATURE, V365, P113, DOI 10.1038/365113b0
   Mattheck C, 1998, DESIGN NATURE LEARNI
   McConnell GA, 1996, PHYS REV E, V54, P5447, DOI 10.1103/PhysRevE.54.5447
   Messina PV, 2013, RSC ADV, V3, P24256, DOI 10.1039/c3ra42204f
   Messina PV, 2013, COLLOID POLYM SCI, V291, P835, DOI 10.1007/s00396-012-2798-4
   Meyers MA, 2008, J MECH BEHAV BIOMED, V1, P76, DOI 10.1016/j.jmbbm.2007.03.001
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Midha S., 2013, ACTA BIOMATER
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Nieto A, 2009, ACTA BIOMATER, V5, P3478, DOI 10.1016/j.actbio.2009.05.033
   Niklas K.J., 1992, PLANT BIOMECHANICS E
   Niklas KJ, 2006, AM J BOT, V93, P1369, DOI 10.3732/ajb.93.10.1369
   Nishiguchi S, 2001, J BIOMED MATER RES, V54, P198, DOI 10.1002/1097-4636(200102)54:2<198::AID-JBM6>3.0.CO;2-7
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Orlando G, 2010, TRANSPL P, V42, P1011, DOI 10.1016/j.transproceed.2010.03.066
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Paul W, 2006, AM J BIOCH BIOTECHNO, V2, P41, DOI DOI 10.3844/AJBBSP.2006.41.48
   Pompe W, 2013, BIO-NANOMATERIALS: DESIGNING MATERIALS INSPIRED BY NATURE, P1, DOI 10.1002/9783527655267
   Puckett S, 2008, INT J NANOMED, V3, P229
   Rahmany MB, 2013, ACTA BIOMATER, V9, P5431, DOI 10.1016/j.actbio.2012.11.019
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Redlich M, 2008, J MATER RES, V23, P2909, DOI 10.1557/JMR.2008.0350
   Ren TZ, 2006, LANGMUIR, V22, P3886, DOI 10.1021/la0533011
   Reznikov N, 2014, BONE, V59, P93, DOI 10.1016/j.bone.2013.10.023
   Rhee H, 2009, MAT SCI ENG C-MATER, V29, P2333, DOI 10.1016/j.msec.2009.06.002
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   RIEGER W, 2001, WORLD TRIBOLOGY FORU
   Rock M, 1933, German Patent, Patent No. [583589, DRP 583.589]
   Ruso JM, 2013, DALTON T, V42, P7991, DOI 10.1039/c3dt32936d
   Ruso JM, 2013, LANGMUIR, V29, P2350, DOI 10.1021/la305080x
   Sachot N, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0684
   Sadat-Shojai M, 2013, ACTA BIOMATER, V9, P7591, DOI 10.1016/j.actbio.2013.04.012
   Samorodnitzky-Naveh GR, 2009, NANOMEDICINE-UK, V4, P943, DOI [10.2217/nnm.09.68, 10.2217/NNM.09.68]
   Sanchez C., 2001, BIOMIMETISME MAT
   Sanchez C, 2008, CHEM MATER, V20, P682, DOI 10.1021/cm702100t
   Schubert D, 2006, BIOCHEM BIOPH RES CO, V342, P86, DOI 10.1016/j.bbrc.2006.01.129
   Schwarz F, 2006, J CLIN PERIODONTOL, V33, P491, DOI 10.1111/j.1600-051X.2006.00936.x
   Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862
   Shirtliff VJ, 2003, J MATER SCI, V38, P4697, DOI 10.1023/A:1027414700111
   Shruti S, 2013, ACTA BIOMATER, V9, P4836, DOI 10.1016/j.actbio.2012.09.024
   Sikavitsas VI, 2003, J BIOMED MATER RES A, V67A, P944, DOI 10.1002/jbm.a.10126
   Silva-Bermudez P, 2013, SURF COAT TECH, V233, P147, DOI 10.1016/j.surfcoat.2013.04.028
   Smeets Ralf, 2008, Schweiz Monatsschr Zahnmed, V118, P203
   Stephanopoulos N., 2008, CHEM REV, V108, P4935
   Stephanopoulos N, 2013, ACTA MATER, V61, P912, DOI 10.1016/j.actamat.2012.10.046
   Stupp SI, 2010, NANO LETT, V10, P4783, DOI 10.1021/nl103567y
   Sun RX, 2013, MATER RES BULL, V48, P1143, DOI 10.1016/j.materresbull.2012.12.013
   Tahir MN, 2010, PHYS STATUS SOLIDI B, V247, P2338, DOI 10.1002/pssb.201046076
   Tan AW, 2012, CERAM INT, V38, P4421, DOI 10.1016/j.ceramint.2012.03.002
   TENNE R, 1992, NATURE, V360, P444, DOI 10.1038/360444a0
   Tenne R, 2009, ANNU REV MATER RES, V39, P387, DOI 10.1146/annurev-matsci-082908-145429
   Termine John D., 1996, P24
   Thian ES, 2008, J BIOMED MATER RES A, V85A, P188, DOI 10.1002/jbm.a.31564
   Tirrell D. A., 1994, HIERARCHICAL STRUCTU
   Torquato S., 2002, RANDOM HETEROGENEOUS
   Vagaska B, 2010, PHYSIOL RES, V59, P309
   Vallet-Regi M, 2008, J BIOMED NANOTECHNOL, V4, P1, DOI 10.1166/jbn.2008.002
   Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488
   Vallet-Regi M, 2006, CHEM-EUR J, V12, P5934, DOI 10.1002/chem.200600226
   van den Dolder J, 2003, BIOMATERIALS, V24, P1745, DOI 10.1016/S0142-9612(02)00537-9
   Vanzillotta PS, 2006, DENT MATER, V22, P275, DOI 10.1016/j.dental.2005.03.012
   Vincent JFV., 1990, STRUCTURAL BIOMATERI
   Vincent JFV, 2006, J R SOC INTERFACE, V3, P471, DOI 10.1098/rsif.2006.0127
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Wainwright S. A., 1982, MECH DESIGN ORGANISM
   Wang GC, 2012, J MATER CHEM, V22, P19081, DOI 10.1039/c2jm34367c
   Wang HS, 2012, MATER LETT, V76, P237, DOI 10.1016/j.matlet.2012.02.099
   Wang XX, 2002, BIOMATERIALS, V23, P1353, DOI 10.1016/S0142-9612(01)00254-X
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 2006, ADV BIOCHEM ENG BIOT, V103, P275
   Wei J, 2010, BIOMATERIALS, V31, P1260, DOI 10.1016/j.biomaterials.2009.11.005
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107
   Weiner S, 1997, BONE, V20, P509, DOI 10.1016/S8756-3282(97)00053-7
   Wen CE, 2002, J MATER RES, V17, P2633, DOI 10.1557/JMR.2002.0382
   WHITE SW, 1977, NATURE, V266, P421, DOI 10.1038/266421a0
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042
   Wu CT, 2011, ACTA BIOMATER, V7, P3563, DOI 10.1016/j.actbio.2011.06.028
   Wu CT, 2011, BIOMATERIALS, V32, P7068, DOI 10.1016/j.biomaterials.2011.06.009
   Wu SL, 2008, NANO LETT, V8, P3803, DOI 10.1021/nl802145n
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Yang DY, 2013, BIOMATERIALS, V34, P5747, DOI 10.1016/j.biomaterials.2013.04.028
   Yao C, 2005, J BIOMED NANOTECHNOL, V1, P68, DOI 10.1166/jbn.2005.008
   Yao HB, 2011, CHEM SOC REV, V40, P3764, DOI 10.1039/c0cs00121j
   Zarzycki J., 1997, J SOL-GEL SCI TECHN, V8, P1
   Zhang L., 2009, SCI TECHNOL ADV MAT, V10
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhang WJ, 2013, BIOMATERIALS, V34, P3184, DOI 10.1016/j.biomaterials.2013.01.008
   Zhao LZ, 2013, NANOBIOMATERIALS IN CLINICAL DENTISTRY, P337
   Zhao LZ, 2012, BIOMATERIALS, V33, P2629, DOI 10.1016/j.biomaterials.2011.12.024
   Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014
NR 205
TC 1
Z9 1
U1 0
U2 29
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1568-0266
EI 1873-5294
J9 CURR TOP MED CHEM
JI Curr. Top. Med. Chem.
PY 2015
VL 15
IS 22
BP 2290
EP 2305
DI 10.2174/1568026615666150605115610
PG 16
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA CO7ZT
UT WOS:000359384400005
PM 26043736
DA 2018-10-19
ER

PT J
AU Liang, KN
   Xiao, SM
   Shi, WY
   Li, JS
   Yang, X
   Gao, Y
   Gou, YP
   Hao, LY
   He, LB
   Cheng, L
   Xu, X
   Zhouab, XD
   Li, JY
AF Liang, Kunneng
   Xiao, Shimeng
   Shi, Wenyuan
   Li, Jianshu
   Yang, Xiao
   Gao, Yuan
   Gou, Yaping
   Hao, Liying
   He, Libang
   Cheng, Lei
   Xu, Xin
   Zhouab, Xuedong
   Li, Jiyao
TI 8DSS-promoted remineralization of demineralized dentin in vitro
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID TERMINATED PAMAM DENDRIMER; BIOMIMETIC MINERALIZATION; CPP-ACP; ENAMEL;
   COLLAGEN; BIOMINERALIZATION; INHIBITION; NUCLEATION; PROTEINS;
   PHOSPHOPHORYN
AB Dentin phosphoprotein (DPP) plays an extremely important role in the biomineralization of human tooth. The repetitive nucleotide sequence of aspartate-serine-serine (DSS) is the fundamental unit within DPP, and peptides containing 8 repeats of DSS (8DSS) have been shown to possess the ability to induce remineralization of the demineralized enamel. In this work, we coated the 8DSS peptide on the completely demineralized dentin to evaluate the effect of 8DSS peptide coating on dentin remineralization. Human dentin samples were demineralized with 37% phosphoric acid for 2 min, and then the 8DSS peptide (1 mg mL(-1)) was coated and the binding strength of the 8DSS peptide to demineralized dentin was examined using attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR). Then the coated dentin samples were immersed in artificial saliva for 3 weeks. After that, the remineralized dentin samples were characterized by scanning electron microscopy (SEM), energy dispersive spectroscopy (EDS), X-ray diffraction (XRD) analysis and ATR-FTIR. The mechanical properties of the remineralized surfaces were determined by nano-indentation and atomic force microscopy (AFM). The results showed that the 8DSS peptide had good binding strength to demineralized dentin and could induce nanocrystals precipitation both on the surfaces and within the dentinal tubules. The mechanical properties of the 8DSS-coated samples were significantly improved. In contrast, there were hardly any newly generated minerals deposited on the samples without 8DSS peptide coating. In conclusion, the 8DSS peptide may be a promising biomaterial for restoring the demineralized human dentin.
C1 [Liang, Kunneng; Xiao, Shimeng; Gao, Yuan; Gou, Yaping; Hao, Liying; He, Libang; Cheng, Lei; Xu, Xin; Zhouab, Xuedong; Li, Jiyao] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China.
   [Liang, Kunneng; Gao, Yuan; Gou, Yaping; He, Libang; Cheng, Lei; Xu, Xin; Zhouab, Xuedong; Li, Jiyao] Sichuan Univ, West China Hosp Stomatol, Dept Operat Dent & Endodont, Chengdu 610041, Sichuan Provinc, Peoples R China.
   [Shi, Wenyuan] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90095 USA.
   [Li, Jianshu; Yang, Xiao] Sichuan Univ, Coll Polymer Sci & Engn, Dept Biomed Polymers & Artificial Organs, Chengdu 610065, Peoples R China.
RP Li, JY (reprint author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China.
EM jiyaoliscu@163.com
OI Yang, Xiao/0000-0002-0036-1872; Li, Jianshu/0000-0002-1522-7326
FU National Natural Science Foundation of China [81170958, 51073102,
   81400508]; Specialized Research Fund for the Doctoral Program of Higher
   Education of China [20100181110056, 20130181120125]; Sichuan Province
   Science and Technology support program [2011SZ0130]
FX Financial support from National Natural Science Foundation of China
   (Grant No. 81170958, 51073102 and 81400508, L. He), Specialized Research
   Fund for the Doctoral Program of Higher Education of China (Grant No.
   20100181110056 and 20130181120125, L. He) and Sichuan Province Science
   and Technology support program (Grant No. 2011SZ0130) is gratefully
   acknowledged. The authors thank the New Century Excellent Talents
   University Support Program and Professor Wenyuan Shi, School of
   Dentistry, University of California, Los Angeles for guiding us to
   synthesize 8DSS peptides. The authors also thank Chengdu Sennuowei
   Biotechnology Co., Ltd for providing us the equipment for the
   experiment.
CR Boanini E, 2006, EUR J INORG CHEM, P4821, DOI 10.1002/ejic.200600423
   Cao Y, 2014, CLIN ORAL INVEST, V18, P873, DOI 10.1007/s00784-013-1035-y
   Cao Y, 2014, ACS APPL MATER INTER, V6, P410, DOI 10.1021/am4044823
   Cao Y, 2013, J DENT, V41, P818, DOI 10.1016/j.jdent.2013.06.008
   Colfen H, 2010, NAT MATER, V9, P960, DOI 10.1038/nmat2911
   Deng M, 2013, INT J ORAL SCI, V5, P103, DOI 10.1038/ijos.2013.31
   Duijsters PPE, 1982, CARIES RES, V16, P201, DOI [10.1159/000260599, DOI 10.1159/000260599]
   Featherstone J D B, 2009, Adv Dent Res, V21, P4, DOI 10.1177/0895937409335590
   George A, 1996, J BIOL CHEM, V271, P32869, DOI 10.1074/jbc.271.51.32869
   George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729
   Guo B, 2012, INT J ORAL SCI, V4, P152, DOI 10.1038/ijos.2012.45
   Hao JJ, 2004, BONE, V34, P921, DOI 10.1016/j.bone.2004.01.020
   He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945
   Hsu CC, 2011, J DENT RES, V90, P88, DOI 10.1177/0022034510381904
   Hsu CC, 2011, J MECH BEHAV BIOMED, V4, P1982, DOI 10.1016/j.jmbbm.2011.06.017
   LEE SL, 1980, INT J PEPT PROT RES, V16, P231
   Li JH, 2013, BIOMATERIALS, V34, P6738, DOI 10.1016/j.biomaterials.2013.05.046
   Liang KN, 2015, MACROMOL MATER ENG, V300, P107, DOI 10.1002/mame.201400207
   Liang KN, 2014, RSC ADV, V4, P43496, DOI 10.1039/c4ra07100j
   Liu Y, 2011, ADV MATER, V23, P975, DOI 10.1002/adma.201003882
   LUSSI A, 1988, ARCH ORAL BIOL, V33, P685, DOI 10.1016/0003-9969(88)90124-0
   Marshall GW, 1997, J DENT, V25, P441, DOI 10.1016/S0300-5712(96)00065-6
   Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875
   Rahiotis C, 2007, J DENT, V35, P695, DOI 10.1016/j.jdent.2007.05.008
   Ruan Q, 2015, J MATER CHEM B, V3, P3112, DOI 10.1039/c5tb00163c
   Sun J, 2014, J MATER CHEM B, V2, P4544, DOI 10.1039/c4tb00451e
   Toroian D, 2007, J BIOL CHEM, V282, P22437, DOI 10.1074/jbc.M700591200
   Veis A, 1998, EUR J ORAL SCI, V106, P234, DOI 10.1111/j.1600-0722.1998.tb02181.x
   Vollenweider M, 2007, ACTA BIOMATER, V3, P936, DOI 10.1016/j.actbio.2007.04.003
   Wang Q, 2011, SOFT MATTER, V7, P9673, DOI 10.1039/c1sm05018d
   Xu HHK, 2011, DENT MATER, V27, P762, DOI 10.1016/j.dental.2011.03.016
   Yang Y, 2014, J DENT RES, V93, P520, DOI 10.1177/0022034514522815
   Yarbrough DK, 2010, CALCIFIED TISSUE INT, V86, P58, DOI 10.1007/s00223-009-9312-0
   Zhang H, 2015, COLLOID SURFACE B, V128, P304, DOI 10.1016/j.colsurfb.2015.01.058
   Zhang W, 2003, CHEM MATER, V15, P3221, DOI 10.1021/cm030080g
   Zhou YZ, 2012, ACS APPL MATER INTER, V4, P6900, DOI 10.1021/am302041b
NR 36
TC 14
Z9 14
U1 4
U2 40
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 33
BP 6763
EP 6772
DI 10.1039/c5tb00764j
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CO8ZD
UT WOS:000359460100006
DA 2018-10-19
ER

PT J
AU Horiuchi, N
   Endo, J
   Wada, N
   Nozaki, K
   Nakamura, M
   Nagai, A
   Katayama, K
   Yamashita, K
AF Horiuchi, N.
   Endo, J.
   Wada, N.
   Nozaki, K.
   Nakamura, M.
   Nagai, A.
   Katayama, K.
   Yamashita, K.
TI Dielectric properties of fluorine substituted hydroxyapatite: the effect
   of the substitution on configuration of hydroxide ion chains
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID SINTERED HYDROXYFLUORAPATITES; MONOCLINIC HYDROXYAPATITE;
   MECHANICAL-PROPERTIES; SHARK TEETH; REORIENTABILITY; CONDUCTIVITY;
   SPECTROSCOPY; FLUORAPATITE; DISSOLUTION; TRANSITION
AB Hydroxyapatite (HAp) [Ca-5(PO4)(3)OH] is an extremely popular biomaterial. Moreover, HAp durability is well-known to be enhanced by fluoridation. We prepared fluoridated HAp (F-HAp; Ca-5(PO4)(3)(OH)(1-x)F-x) ceramics by substituting F- ions for OH- ions of HAp. F-substitution dependence of dielectric properties in F-HAp was measured to detect the configuration change of OH- ion chains. Dielectric relaxation of two kinds was observed. Each kind had a different relaxation time. Faster relaxation, which is associated with the reorientation motion of OH- ions, was only observed at the low F-substitution range (0 <= x <= 0.35). The relaxation strength decreased as the F-substitution increased. It became zero at x = 0.35, suggesting that F-substitution induces hydrogen bonds. One F- ion substituted for an OH- ion forms two hydrogen bonds with the two neighboring OH- ions and inhibits the motion of OH- ions, which results in some kind of ordered configuration in F-HAp. The configuration might be an origin that enhances the durability of the F-HAp.
C1 [Horiuchi, N.; Wada, N.; Nozaki, K.; Nakamura, M.; Nagai, A.; Yamashita, K.] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Inorgan Mat, Chiyoda Ku, Tokyo 1010062, Japan.
   [Endo, J.; Katayama, K.] Tokai Univ, Dept Appl Chem, Hiratsuka, Kanagawa 2591292, Japan.
RP Horiuchi, N (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Inorgan Mat, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM nhori.bcr@tmd.ac.jp
RI Nakamura, Miho/T-3166-2017
FU JSPS KAKENHI Grant [23300178]; Kazuchika Okura Memorial Foundation
FX This work was partially supported by JSPS KAKENHI Grant No. 23300178.
   One of the authors (N.H.) appreciates a grant from the Kazuchika Okura
   Memorial Foundation (2012).
CR ARENDS J, 1968, PHYS LETT A, VA 27, P720, DOI 10.1016/0375-9601(68)91025-6
   BAUMER A, 1985, B MINERAL, V108, P145
   Chen CL, 2014, ANGEW CHEM INT EDIT, V53, P1543, DOI 10.1002/anie.201307689
   Chen YM, 2005, BIOMATERIALS, V26, P1205, DOI 10.1016/j.biomaterials.2004.04.027
   Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906
   Dorozhkin SV, 1997, J CRYST GROWTH, V182, P133, DOI 10.1016/S0022-0248(97)00331-X
   Dorozhkin SV, 1997, J COLLOID INTERF SCI, V191, P489, DOI 10.1006/jcis.1997.4942
   ELLIOTT JC, 1973, SCIENCE, V180, P1055, DOI 10.1126/science.180.4090.1055
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Enax J, 2012, J STRUCT BIOL, V178, P290, DOI 10.1016/j.jsb.2012.03.012
   FREUND F, 1977, J CHEM SOC DALTON, P1136, DOI 10.1039/dt9770001136
   Gittings JP, 2009, ACTA BIOMATER, V5, P743, DOI 10.1016/j.actbio.2008.08.012
   Gross KA, 2004, BIOMATERIALS, V25, P1375, DOI 10.1016/S0142-9612(03)00565-9
   Gross KA, 2004, BIOMATERIALS, V25, P1385, DOI 10.1016/S0142-9612(03)00636-7
   Heling I, 1981, J Oral Implantol, V9, P548
   HITMI N, 1988, J PHYS CHEM SOLIDS, V49, P541, DOI 10.1016/0022-3697(88)90065-0
   HITMI N, 1986, J PHYS CHEM SOLIDS, V47, P533, DOI 10.1016/0022-3697(86)90155-1
   Hochrein O, 2005, CHEM MATER, V17, P1978, DOI 10.1021/cm0401903
   Horiuchi N, 2013, J APPL PHYS, V113, DOI 10.1063/1.4799130
   Horiuchi N, 2013, J CERAM SOC JPN, V121, P770, DOI 10.2109/jcersj2.121.770
   Ikoma T, 1999, J MATER SCI LETT, V18, P1225, DOI 10.1023/A:1006610521173
   Kim HW, 2004, BIOMATERIALS, V25, P3351, DOI 10.1016/j.biomaterials.2003.09.104
   MORENO EC, 1974, NATURE, V247, P64, DOI 10.1038/247064a0
   Orlovskii VP, 1996, INORG MATER+, V32, P654
   Rodriguez-Lorenzo LM, 2003, J PHYS CHEM B, V107, P8316, DOI [10.1021/jp027556o, 10.1021/jp0275560o]
   Shellis R P, 1994, Int Dent J, V44, P263
   Suzuki S, 2004, CERAM INT, V30, P625, DOI 10.1016/j.ceramint.2003.07.006
   TAKAHASHI T, 1978, ELECTROCHIM ACTA, V23, P369, DOI 10.1016/0013-4686(78)80076-0
   Tofail SAM, 2005, FERROELECTRICS, V319, P117, DOI 10.1080/00150190590965523
   Uskokovic V, 2015, RSC ADV, V5, P36614, DOI 10.1039/c4ra17180b
   Van Rees H. B., 1973, MAT RES B, V8, P1307
   YAMASHITA K, 1995, J AM CERAM SOC, V78, P1191, DOI 10.1111/j.1151-2916.1995.tb08468.x
   YAMASHITA K, 1990, SOLID STATE IONICS, V40-1, P918, DOI 10.1016/0167-2738(90)90153-I
   Yashima M, 2014, J PHYS CHEM C, V118, P5180, DOI 10.1021/jp412771f
   Yashima M, 2011, J PHYS CHEM C, V115, P25077, DOI 10.1021/jp208746y
NR 35
TC 4
Z9 4
U1 1
U2 15
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 33
BP 6790
EP 6797
DI 10.1039/c5tb00944h
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA CO8ZD
UT WOS:000359460100009
DA 2018-10-19
ER

PT J
AU Castro, NJ
   O'Brien, J
   Zhang, LG
AF Castro, Nathan J.
   O'Brien, Joseph
   Zhang, Lijie Grace
TI Integrating biologically inspired nanomaterials and table-top
   stereolithography for 3D printed biomimetic osteochondral scaffolds
SO NANOSCALE
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; ARTICULAR-CARTILAGE; NANOCRYSTALLINE
   HYDROXYAPATITE; ACID HYDROGELS; BONE; REGENERATION; BIOMATERIAL;
   OSTEOBLAST; CELLS; POLYCAPROLACTONE
AB The osteochondral interface of an arthritic joint is notoriously difficult to regenerate due to its extremely poor regenerative capacity and complex stratified architecture. Native osteochondral tissue extracellular matrix is composed of numerous nanoscale organic and inorganic constituents. Although various tissue engineering strategies exist in addressing osteochondral defects, limitations persist with regards to tissue scaffolding which exhibit biomimetic cues at the nano to micro scale. In an effort to address this, the current work focused on 3D printing biomimetic nanocomposite scaffolds for improved osteochondral tissue regeneration. For this purpose, two biologically-inspired nanomaterials have been synthesized consisting of (1) osteoconductive nanocrystalline hydroxyapatite (nHA) (primary inorganic component of bone) and (2) core-shell poly(lactic-co-glycolic) acid (PLGA) nanospheres encapsulated with chondrogenic transforming growth-factor beta 1 (TGF-beta 1) for sustained delivery. Then, a novel table-top stereolithography 3D printer and the nano-ink (i.e., nHA + nanosphere + hydrogel) were employed to fabricate a porous and highly interconnected osteochondral scaffold with hierarchical nano-to-micro structure and spatiotemporal bioactive factor gradients. Our results showed that human bone marrow-derived mesenchymal stem cell adhesion, proliferation, and osteochondral differentiation were greatly improved in the biomimetic graded 3D printed osteochondral construct in vitro. The current work served to illustrate the efficacy of the nano-ink and current 3D printing technology for efficient fabrication of a novel nanocomposite hydrogel scaffold. In addition, tissue-specific growth factors illustrated a synergistic effect leading to increased cell adhesion and directed stem cell differentiation.
C1 [Castro, Nathan J.; Zhang, Lijie Grace] George Washington Univ, Dept Mech & Aerosp Engn, Washington, DC 20052 USA.
   [O'Brien, Joseph] George Washington Univ, Dept Orthoped Surg, Washington, DC 20052 USA.
   [O'Brien, Joseph] George Washington Univ, Dept Neurol Surg, Washington, DC 20052 USA.
   [Zhang, Lijie Grace] George Washington Univ, Dept Biomed Engn, Washington, DC 20052 USA.
   [Zhang, Lijie Grace] George Washington Univ, Dept Med, Washington, DC 20052 USA.
RP Zhang, LG (reprint author), George Washington Univ, Dept Mech & Aerosp Engn, Washington, DC 20052 USA.
EM lgzhang@gwu.edu
OI Castro, Nathan/0000-0002-2526-3849
FU NIH [DP2EB020549]; GW Institute for Biomedical Engineering
FX The authors would like to thank NIH Director's New Innovator Award
   (DP2EB020549) and GW Institute for Biomedical Engineering for financial
   support.
CR Baji A, 2006, MATER MANUF PROCESS, V21, P211, DOI 10.1081/AMP-200068681
   Bian WG, 2012, RAPID PROTOTYPING J, V18, P68, DOI 10.1108/13552541211193511
   Castro N. J., 2015, CELL MOL BIOENG, P1
   Castro NJ, 2014, AICHE J, V60, P432, DOI 10.1002/aic.14296
   Chim H, 2012, CELL TISSUE RES, V350, P89, DOI 10.1007/s00441-012-1449-x
   Dawson JI, 2008, BIOMATERIALS, V29, P3105, DOI 10.1016/j.biomaterials.2008.03.040
   Ergun A, 2012, TISSUE ENG PT A, V18, P2426, DOI [10.1089/ten.tea.2011.0625, 10.1089/ten.TEA.2011.0625]
   Ergun A, 2011, J BIOMED MATER RES A, V99A, P354, DOI 10.1002/jbm.a.33190
   Erisken C, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/16/165302
   Erisken C, 2008, BIOMATERIALS, V29, P4065, DOI 10.1016/j.biomaterials.2008.06.022
   Ertan A. B., 2011, J TISSUE ENG REGEN M, V7, P149
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Holmes B, 2015, TISSUE ENG PT A, V21, P403, DOI [10.1089/ten.tea.2014.0138, 10.1089/ten.TEA.2014.0138]
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Hwang YK, 2008, LANGMUIR, V24, P2446, DOI 10.1021/la703546f
   Ichinose S, 2005, CLIN EXP PHARMACOL P, V32, P561, DOI 10.1111/j.1440-1681.2005.04231.x
   Im O, 2012, INT J NANOMED, V7, P2087, DOI 10.2147/IJN.S29743
   Iwatsubo T, 2006, BIOMACROMOLECULES, V7, P95, DOI 10.1021/bm0504476
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Kim M, 2012, J MECH BEHAV BIOMED, V11, P92, DOI 10.1016/j.jmbbm.2012.03.006
   Li J., 2011, INT J SMART NANO MAT, V3, P2
   Lin-Gibson S, 2007, BIOMACROMOLECULES, V8, P1511, DOI 10.1021/bm061139q
   Madhumathi K, 2009, INT J BIOL MACROMOL, V45, P12, DOI 10.1016/j.ijbiomac.2009.03.011
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Marchesi DG, 2000, EUR SPINE J, V9, P372, DOI 10.1007/s005860000203
   Matsumura K, 2010, J BIOMED MATER RES A, V92A, P1225, DOI 10.1002/jbm.a.32448
   Moreau David, 2014, Biomatter, V4, pe28764, DOI 10.4161/biom.28764
   Murphy SV, 2013, J BIOMED MATER RES A, V101, P272, DOI 10.1002/jbm.a.34326
   O'Brien CM, 2015, TISSUE ENG PART B-RE, V21, P103, DOI [10.1089/ten.TEB.2014.0168, 10.1089/ten.teb.2014.0168]
   Ozkan S, 2010, J BIOMED MATER RES A, V92A, P1007, DOI 10.1002/jbm.a.32425
   Ozkan S, 2009, BIOMATERIALS, V30, P4336, DOI 10.1016/j.biomaterials.2009.04.050
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Sibilla P, 2006, J DENT RES, V85, P354, DOI 10.1177/154405910608500414
   Smith IO, 2009, WIRES NANOMED NANOBI, V1, P226, DOI 10.1002/wnan.026
   Sopyan I, 2007, SCI TECHNOL ADV MAT, V8, P116, DOI 10.1016/j.stam.2006.11.017
   Sugino A, 2008, J MATER SCI-MATER M, V19, P2269, DOI 10.1007/s10856-007-3327-8
   Sun LL, 2012, TISSUE ENG PT A, V18, P1741, DOI [10.1089/ten.tea.2011.0456, 10.1089/ten.TEA.2011.0456]
   Tang GW, 2012, J BIOMAT SCI-POLYM E, V23, P2241, DOI 10.1163/156856211X614185
   Tarafder S, 2010, LANGMUIR, V26, P16625, DOI 10.1021/la101851f
   Tezcan B, 2010, J MOL HISTOL, V41, P247, DOI 10.1007/s10735-010-9284-4
   Vats A, 2003, CLIN OTOLARYNGOL, V28, P165, DOI 10.1046/j.1365-2273.2003.00686.x
   Wang M, 2012, J NANOSCI NANOTECHNO, V12, P7692, DOI 10.1166/jnn.2012.6624
   Weigel T, 2006, EXPERT REV MED DEVIC, V3, P835, DOI 10.1586/17434440.3.6.835
   Wu LC, 2011, BIOMATERIALS, V32, P5341, DOI 10.1016/j.biomaterials.2011.04.014
   Zhang L, 2009, ADV BIOMATERIALS FUN, P205
   Zhang LJ, 2008, INT J NANOMED, V3, P323
   Zhang Lijie, 2009, Critical Reviews in Biomedical Engineering, V37, P1
   Zhang LJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/17/175101
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhou XZ, 2008, INT J ARTIF ORGANS, V31, P480
   Zustiak SP, 2010, BIOMACROMOLECULES, V11, P1348, DOI 10.1021/bm100137q
NR 53
TC 44
Z9 44
U1 11
U2 159
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-3364
EI 2040-3372
J9 NANOSCALE
JI Nanoscale
PY 2015
VL 7
IS 33
BP 14010
EP 14022
DI 10.1039/c5nr03425f
PG 13
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CP0DV
UT WOS:000359546900025
PM 26234364
OA Green Accepted
DA 2018-10-19
ER

PT S
AU Lang, XY
   Lyubovitsky, J
AF Lang, Xuye
   Lyubovitsky, Julia
BE Amelink, A
   Vitkin, IA
TI Second harmonic generation (SHG) and two-photon fluorescence (TPF)
   contrast imaging in biomaterial analysis
SO NOVEL BIOPHOTONICS TECHNIQUES AND APPLICATIONS III
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Novel Biophotonics Techniques and Applications III
CY JUN 24-25, 2015
CL Munich, GERMANY
SP SPIE, Opt Soc
DE Second Harmonic Generation (SHG) microscopy; two-photon fluorescence
   (TPF) microscopy; collagen imaging; polarization; cross-linking;
   genipin; biomaterial; hydrogel
ID COLLAGEN
AB Collagen hydrogels are natural biomaterials that comprise 3D networks of high water content and have viscoelastic properties and biocompatibility similar to native tissues. Consequently, these materials play an important role in tissue engineering and regenerative medicine for quite some time. Second harmonic generation (SHG) and two-photon fluorescence (TPF) contrasts transpire as valuable label-free spectroscopic probes for analysis of these biomaterials and this presentation will report the structural, mechanical and physicochemical parameters leading to the observed optical SHG and TPF effects in synthesized 3D collagen hydrogels. We will present results regarding understanding the dependency of collagen fiber formation on ion types, new results regarding strengthening of these biomaterials with a nontoxic chemical cross-linker genipin and polarization selection of collagen fibers' orientations.
C1 [Lang, Xuye; Lyubovitsky, Julia] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.
   [Lyubovitsky, Julia] Univ Calif Riverside, Dept Bioengn, Mat Sci & Engn 239, Riverside, CA 92521 USA.
RP Lyubovitsky, J (reprint author), Univ Calif Riverside, Dept Biochem, A110 Bourns Hall, Riverside, CA 92521 USA.
EM julial@ucr.edu
CR Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009
   Gusachenko I, 2012, BIOPHYS J, V102, P2220, DOI 10.1016/j.bpj.2012.03.068
   Hwang Y., 2011, ACS APPL MATER INTER, V4, P261
   Hwang YJ, 2011, ANAL METHODS-UK, V3, P529, DOI 10.1039/c0ay00381f
   Lang XY, 2015, ANAL METHODS-UK, V7, P1680, DOI 10.1039/c4ay02242d
   Stoller P, 2002, BIOPHYS J, V82, P3330, DOI 10.1016/S0006-3495(02)75673-7
   Xu P, 2004, P SOC PHOTO-OPT INS, V5323, P343, DOI 10.1117/12.528740
NR 7
TC 0
Z9 0
U1 0
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-1-62841-705-0
J9 PROC SPIE
PY 2015
VL 9540
AR 95400Y
DI 10.1117/12.2197636
PG 6
WC Engineering, Biomedical; Optics; Radiology, Nuclear Medicine & Medical
   Imaging
SC Engineering; Optics; Radiology, Nuclear Medicine & Medical Imaging
GA BD3FP
UT WOS:000359602700024
DA 2018-10-19
ER

PT S
AU Ma, YH
   Shang, WB
   Fan, XY
   Gao, ZH
   Wang, HB
   Luy, XM
AF Ma, Yunhai
   Shang, Wenbo
   Fan, Xueying
   Gao, Zhihui
   Wang, Hubiao
   Luy, Xueman
BE Carl, J
TI Microstructure and Performance of Mg-substituted alpha-TCP Porous
   Ceramics
SO PROCEEDINGS OF THE 2015 ASIA-PACIFIC ENERGY EQUIPMENT ENGINEERING
   RESEARCH CONFERENCE (AP3ER 2015)
SE AER-Advances in Engineering Research
LA English
DT Proceedings Paper
CT Asia-Pacific Energy Equipment Engineering Research Conference (AP3ER)
CY JUN 13-14, 2015
CL Zhuhai, PEOPLES R CHINA
DE beta-TCP; Mg-substituted; porosity; Microstructure; Immersion
ID TRICALCIUM PHOSPHATE; BIOCERAMICS; MAGNESIUM
AB beta-tricalcium phosphate(beta-TCP) is an important biomaterial with good biocompatibility. The study was concentrated on the microstructure and performance of Mg-substituted beta-TCP porous ceramics. The 6mol.% Mg-doped powders were fabricated by the method of gel-sol combustion with raw materials of Ca(NO3)2, PBTC and Mg(NO3)2. Mg-substituted beta-TCP porous ceramics were obtained by molded-pressing with the foaming agent and the binder before calcined at 1000 degrees C. The mechanical properties, microstructure, immersion performance had been evaluated by means of mechanical testing machine, X-ray diffraction, scanning electron microscopy with EDS and immersion test. The compressive test showed that the compressive strength of Mg-doped porous ceramics increased 10.5% from 5.92MPa to 6.54MPa compared with the pure porous scaffolds. The SEM Images demonstrated that the porosity of ceramic was about 65%, the size of interconnect holes were ranging from 50 to 200 mu m. Immersion test indicated that the Mg-substituted improved the performance of degradation apparently.
C1 [Ma, Yunhai; Shang, Wenbo; Fan, Xueying; Gao, Zhihui; Wang, Hubiao; Luy, Xueman] Jilin Univ, Coll Biol & Agr Engn, Changchun, Peoples R China.
   [Ma, Yunhai; Shang, Wenbo; Fan, Xueying; Gao, Zhihui; Wang, Hubiao; Luy, Xueman] Jilin Univ, Minist Educ, Key Lab Bion Engn, Changchun 130021, Peoples R China.
   [Luy, Xueman] Jilin Univ, China Japan Union Hosp, Changchun 130033, Peoples R China.
RP Luy, XM (reprint author), Jilin Univ, Coll Biol & Agr Engn, Nanling Campus, Changchun, Peoples R China.
EM myh@jlu.edu.cn; shangwenbo123@163.com; 390916495@qq.com;
   570814141@qq.com; 616598148@qq.com; lv_xueman@sina.com
CR Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Engin NO, 1999, J EUR CERAM SOC, V19, P2569
   HENCH LL, 1993, INTRO BIOCERAMICS
   Ilaria C., 2011, CERAM INT, V37, P127
   Itatani K, 2002, J MATER SCI-MATER M, V13, P707, DOI 10.1023/A:1015754229181
   Lin FH, 2001, BIOMATERIALS, V22, P2981, DOI 10.1016/S0142-9612(01)00044-8
   Lin KL, 2006, J INORG MATER, V21, P1429
   Okuma T, 2001, NUTRITION, V17, P679, DOI 10.1016/S0899-9007(01)00551-2
   Rude RK, 2004, J NUTR BIOCHEM, V15, P710, DOI 10.1016/j.jnutbio.2004.08.001
   Toriyama M., 1987, J CERAM SOC JPN YOGY, V95, P822
   Wang X, 2013, MAT SCI ENG C-MATER, V33, P618, DOI 10.1016/j.msec.2012.10.006
   YONEZAKI H, 1998, J MATER SCI-MATER M, V9, P381
   Yoshida K, 2005, J AM CERAM SOC, V88, P2315, DOI 10.1111/j.1551-2916.2005.00399.x
   [张士华 Zhang Shihua], 2005, [南京理工大学学报. 自然科学版, Journal of nanjing university of science and technology], V29, P231
NR 14
TC 0
Z9 0
U1 0
U2 3
PU ATLANTIS PRESS
PI PARIS
PA 29 AVENUE LAVMIERE, PARIS, 75019, FRANCE
SN 2352-5401
BN 978-94-62520-63-9
J9 AER ADV ENG RES
PY 2015
VL 9
BP 156
EP 161
PG 6
WC Engineering, Multidisciplinary; Engineering, Mechanical; Materials
   Science, Multidisciplinary
SC Engineering; Materials Science
GA BD3KU
UT WOS:000359813100038
DA 2018-10-19
ER

PT S
AU Lu, G
   Yu, HP
   Wang, YZ
   Luo, YY
   Zeng, ZQ
AF Lu, Guang
   Yu, Heping
   Wang, Yongzhou
   Luo, Yongyue
   Zeng, Zongqiang
BE Carl, J
TI Preparation and Mechanical Properties of Prevulcanized Natural Rubber
   Latex/Chitosan/Poly (3-hydroxybutyrate) Blends
SO PROCEEDINGS OF THE 2015 ASIA-PACIFIC ENERGY EQUIPMENT ENGINEERING
   RESEARCH CONFERENCE (AP3ER 2015)
SE AER-Advances in Engineering Research
LA English
DT Proceedings Paper
CT Asia-Pacific Energy Equipment Engineering Research Conference (AP3ER)
CY JUN 13-14, 2015
CL Zhuhai, PEOPLES R CHINA
DE natural rubber latex; chitosan; poly(3-hydroxybutyrate); blend;
   mechanical properties
ID BEHAVIOR; LATEX
AB In order to obtain natural rubber (NR) latex-based biomaterial, the NR latex concentrate was prepared into prevulcanized natural rubber latex (SNRL) and then blended with a water dispersion of chitosan (CS) and poly(3-hydroxybutyrate) (PHB) together, with the total amount of CS and PHB is of 1, 3, 5, 10 parts per hundred rubber (phr), and CS and PHB is of a ratio of 1:1; the SNRL was also blended with a water dispersion of CS or PHB only in the same amount for properties comparison. The mechanical properties including the tensile strength, elongation at break, 300% modulus, tear strength and hardness of the 24h water-leached SNRL/CS/PHB, SNRL/CS or SNRL/PHB films were tested. The results indicated that, the tensile strength first increased with increase in CS/PHB, CS or PHB content up to 1.0 phr then decreased, the elongation at break decreased, the 300% modulus, tear strength and Shore A hardness increased, with increase in CS/PHB, CS or PHB content, whereas most of the tensile strength and elasticity of the films can be retained when the content of CS/PHB, CS or PHB was less than 5.0 phr.
C1 [Lu, Guang; Yu, Heping; Wang, Yongzhou; Luo, Yongyue; Zeng, Zongqiang] Chinese Acad Trop Agr Sci, Agr Prod Proc Res Inst, Zhanjiang, Peoples R China.
RP Lu, G (reprint author), Chinese Acad Trop Agr Sci, Agr Prod Proc Res Inst, Zhanjiang, Peoples R China.
EM lug_sc8@163.com; yheping@yahoo.com; wyz011120@163.com;
   lyy6226@hotmail.com; zengzongqiang08@163.com
CR Johns J, 2009, INT J POLYM ANAL CH, V14, P508, DOI 10.1080/10236660903072797
   Johns J, 2009, J MATER SCI, V44, P4087, DOI 10.1007/s10853-009-3589-2
   Klamklang S., 2002, SCI ASIA, V28, P135
   Lu G., 2012, China Patent, Patent No. [ZL 201010225247.5, 2010102252475]
   Lu G, 2012, ADV MATER RES-SWITZ, V396-398, P400, DOI 10.4028/www.scientific.net/AMR.396-398.400
   Meng X., 2009, FUNCTIONAL MAT, V40, P436
   [孟晓荣 MENG Xiaorong], 2007, [功能高分子学报, Journal of Functional Polymer], V19/20, P364
   Rao V, 2008, J THERM ANAL CALORIM, V92, P801, DOI 10.1007/s10973-007-8854-5
   Rao V, 2008, J APPL POLYM SCI, V107, P2217, DOI 10.1002/app.27265
   Zhang LN, 2006, MODIFIED MAT NATURAL
NR 10
TC 0
Z9 0
U1 0
U2 1
PU ATLANTIS PRESS
PI PARIS
PA 29 AVENUE LAVMIERE, PARIS, 75019, FRANCE
SN 2352-5401
BN 978-94-62520-63-9
J9 AER ADV ENG RES
PY 2015
VL 9
BP 269
EP 272
PG 4
WC Engineering, Multidisciplinary; Engineering, Mechanical; Materials
   Science, Multidisciplinary
SC Engineering; Materials Science
GA BD3KU
UT WOS:000359813100063
DA 2018-10-19
ER

PT S
AU Triwahyuni, E
   Muryanto
   Sudiyani, Y
   Abimanyu, H
AF Triwahyuni, Eka
   Muryanto
   Sudiyani, Yanni
   Abimanyu, Haznan
BE Bakar, RBA
   Froome, C
TI The effect of substrate loading on simultaneous saccharification and
   fermentation process for bioethanol production from oil palm empty fruit
   bunches
SO 2ND INTERNATIONAL CONFERENCE ON SUSTAINABLE ENERGY ENGINEERING AND
   APPLICATION (ICSEEA) 2014 SUSTAINABLE ENERGY FOR GREEN MOBILITY
SE Energy Procedia
LA English
DT Proceedings Paper
CT 2nd International Conference on Sustainable Energy Engineering and
   Application (ICSEEA)
CY OCT 14-16, 2014
CL Indonesian Inst Sci, Res Ctr Elect Power & Mechatron, Bandung, INDONESIA
HO Indonesian Inst Sci, Res Ctr Elect Power & Mechatron
DE simultaneous saccharification and fermentation (SSF); substrate loading;
   high-concentration ethanol; high-concentration substrate
ID DIFFERENT PROCESS CONFIGURATIONS; LIGNOCELLULOSIC MATERIALS;
   ENZYMATIC-HYDROLYSIS; ETHANOL-PRODUCTION; PRETREATMENT; STRAW; BIOMASS;
   ALKALI
AB Increasing energy demand and concern about increased greenhouse gas emissions make lignocellulosic biomass increasingly to be recognized as having great potential for biofuel and biomaterial production based on the biorefinery concept. Oil Palm Empty Fruit Bunches (EFBs) is one of the major solid wastes in the palm oil industries as a source of lignocellulosic biomass. Cellulose is the highest component of EFBs that can be converted to ethanol. The aim of this research was to investigate the different strategies for high substrate loading on SSF process of bioethanol production from EFBs. Increasing substrate loading is one of the most important challenges to make bioethanol production more economical. This research used two methods to increase the substrate concentration loading on Simultaneous Saccharification and Fermentation (SSF) i.e: direct variation of substrate concentration loading and substrate loading gradually to obtain a high-concentration substrate. A range of substrate loading was from 15% to 25% (g.mL(-1)). The SSF process was carried out at 32 degrees C, pH 4.8, and 150 rpm for 72 hours. The result shows that the highest concentration of ethanol can be produced by a high concentration of substrate loading gradually. The highest ethanol concentration was 83.40 g.L-1 (80.21% ethanol yield) by using 25% (g.mL(-1)) substrate loading gradually, 18 FPU/g substrate enzyme Cellic (R) Ctec2 and 20% Cellic (R) Htec2 (based on volume of Cellic (R) Ctec2), and 1% (g.mL(-1)) yeast Saccharomyces cereviceae in SSF process. Whereas, 20% (g.mL(-1)) concentration substrate loading by directly or gradually produce almost same ethanol concentration. (C) 2015 The Authors. Published by Elsevier Ltd.
C1 [Triwahyuni, Eka; Muryanto; Sudiyani, Yanni; Abimanyu, Haznan] Indonesian Inst Sci, Res Ctr Chem, Tangerang Selatan 15314, Indonesia.
RP Triwahyuni, E (reprint author), Indonesian Inst Sci, Res Ctr Chem, Tangerang Selatan 15314, Indonesia.
EM ekatriwahyuni@gmail.com
OI Abimanyu, Haznan/0000-0003-1532-2232; , muryanto/0000-0002-9478-6037
CR Adney B., 2008, NRELTP51042628
   Alfani F, 2000, J IND MICROBIOL BIOT, V25, P184, DOI 10.1038/sj.jim.7000054
   Andric P, 2010, BIOTECHNOL ADV, V28, P308, DOI 10.1016/j.biotechadv.2010.01.003
   Badger P.C., 2002, TRENDS NEW CROPS NEW
   Lopez-Linares JC, 2014, FUEL, V122, P112, DOI 10.1016/j.fuel.2014.01.024
   Carolina CM., 2011, PROCESS SAF ENVIRON, V90, P189
   Chen HZ, 2007, APPL BIOCHEM MICRO+, V43, P57, DOI 10.1134/S0003683807010103
   Collins K., 2007, EN INF ADM EIA EN OU
   CONVERSE AO, 1990, APPL BIOCHEM BIOTECH, V24-5, P67, DOI 10.1007/BF02920234
   Coyle WT, 2010, REPORT EC RES SERVIC
   Duangwang Sairudee, 2013, Advanced Materials Research, V622-623, P117, DOI 10.4028/www.scientific.net/AMR.622-623.117
   Han M, 2014, BIOPROCESS BIOSYST E
   Han M, 2013, PROCESS BIOCHEM, V48, P488, DOI 10.1016/j.procbio.2013.01.007
   Hodge DB, 2008, BIORESOURCE TECHNOL, V99, P8940, DOI 10.1016/j.biortech.2008.05.015
   Jorgensen H, 2007, BIOTECHNOL BIOENG, V96, P862, DOI 10.1002/bit.21115
   Kang KE, 2013, FUEL, V109, P520, DOI 10.1016/j.fuel.2013.03.026
   Koppram R., 2013, TRENDS BIOTECHNOL
   Madson P. W., 2009, ALCOHOL TXB, P292
   Manzanares P, 2011, J CHEM TECHNOL BIOT, V86, P881, DOI 10.1002/jctb.2604
   Minister of Agriculture, 2012, AGR STAT 2012
   Modenbach AA, 2013, BIOMASS BIOENERG, V56, P526, DOI 10.1016/j.biombioe.2013.05.031
   National Renewable Energy Laboratory, STAND BIOM AN PROC
   Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736
   Sheil D, 2009, IMPACTS OPPORTUNITIE
   Sluiter B., 2011, NRELTP51042618
   Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7
   TARKOW H, 1969, ADV CHEM SER, P197
   Triwahyuni E., 2013, P INT C BIOT 2012, P129
   Wang W, 2011, APPL BIOCHEM BIOTECH, V164, P1139, DOI 10.1007/s12010-011-9200-8
   Wyman CE, 2005, BIORESOURCE TECHNOL, V96, P2026, DOI 10.1016/j.biortech.2005.01.018
   Yano S., 2009, J JPN I ENERGY, V88, P923
   Zhang YHP, 2009, ENERG ENVIRON SCI, V2, P272, DOI 10.1039/b818694d
NR 32
TC 14
Z9 14
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2015
VL 68
BP 138
EP 146
DI 10.1016/j.egypro.2015.03.242
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BD2EH
UT WOS:000358692000017
OA Other Gold
DA 2018-10-19
ER

PT J
AU Nguyen, KV
   Minteer, SD
AF Khiem Van Nguyen
   Minteer, Shelley D.
TI Investigating DNA hydrogels as a new biomaterial for enzyme
   immobilization in biobatteries
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID GLUCOSE-OXIDASE; BIOFUEL CELLS; OXIDATION; DEVICES
AB We report the usage of DNA hydrogels for enzyme entrapment in an enzymatic biobattery. With the recent advancements in DNA nanotechnology, the incorporation of DNA materials to bioelectrocatalytic electrodes holds great promise to improve the performance of bioelectrocatalysis-based devices.
C1 [Minteer, Shelley D.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA.
   Univ Utah, Dept Mat Sci & Engn, Salt Lake City, UT 84112 USA.
RP Minteer, SD (reprint author), Univ Utah, Dept Chem, 315 S 1400 E Room 2020, Salt Lake City, UT 84112 USA.
EM minteer@chem.utah.edu
OI Minteer, Shelley/0000-0002-5788-2249
FU Air Force Office of Scientific Research
FX The authors would like to acknowledge the Air Force Office of Scientific
   Research for funding.
CR Bardea A, 1997, J AM CHEM SOC, V119, P9114, DOI 10.1021/ja971192+
   Bhatnagar D, 2011, PHYS CHEM CHEM PHYS, V13, P86, DOI 10.1039/c0cp01362e
   Calabrese-Barton S., 2004, CHEM REV, V104, P4867
   Cooney MJ, 2008, ENERG ENVIRON SCI, V1, P320, DOI 10.1039/b809009b
   GREGG BA, 1990, ANAL CHEM, V62, P258, DOI 10.1021/ac00202a007
   Heller A, 2006, CURR OPIN CHEM BIOL, V10, P664, DOI 10.1016/j.cbpa.2006.09.018
   Kim YH, 2013, ANGEW CHEM INT EDIT, V52, P1437, DOI 10.1002/anie.201207423
   Leech D, 2012, ELECTROCHIM ACTA, V84, P223, DOI 10.1016/j.electacta.2012.02.087
   Lilienthal S, 2015, ACS APPL MATER INTER, V7, P8923, DOI 10.1021/acsami.5b02156
   Liu DS, 2011, NPG ASIA MATER, V3, P109, DOI 10.1038/asiamat.2011.147
   Merchant SA, 2009, LANGMUIR, V25, P7736, DOI 10.1021/la9004938
   Meredith MT, 2012, ANNU REV ANAL CHEM, V5, P157, DOI 10.1146/annurev-anchem-062011-143049
   Moore CM, 2004, BIOMACROMOLECULES, V5, P1241, DOI 10.1021/bm0345256
   Neto SA, 2015, J POWER SOURCES, V285, P493, DOI 10.1016/j.jpowsour.2015.03.121
   Park N, 2009, NAT MATER, V8, P432, DOI [10.1038/nmat2419, 10.1038/NMAT2419]
   Um SH, 2006, NAT MATER, V5, P797, DOI 10.1038/nmat1741
   Wheeldon IR, 2008, P NATL ACAD SCI USA, V105, P15275, DOI 10.1073/pnas.0805249105
   Xing YZ, 2011, ADV MATER, V23, P1117, DOI 10.1002/adma.201003343
   Yang DY, 2014, ACCOUNTS CHEM RES, V47, P1902, DOI 10.1021/ar5001082
   Zhu Z., 2009, ANGEW CHEM INT EDIT, V49, P1052
NR 20
TC 8
Z9 8
U1 5
U2 34
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PY 2015
VL 51
IS 66
BP 13071
EP 13073
DI 10.1039/c5cc04810a
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA CO4SO
UT WOS:000359151100002
PM 26165384
DA 2018-10-19
ER

PT J
AU Ouyang, ZZ
   Bai, S
AF Ouyang, Zhenzhong
   Bai, Shan
TI Preparation and In-Vitro Biocompatibility of Gelatin/SA/HYA Composite
   Scaffold for Tissue Engineering
SO POLYMERS & POLYMER COMPOSITES
LA English
DT Article
DE Gelatin; Hyaluronic acid; Sodium alginate; Composite hydrogel;
   Biocompatibility; in-vitro
ID CHEMICAL CROSS-LINKING; HYALURONIC-ACID; GELATIN/CHITOSAN MICROSPHERES;
   BIOLOGICAL-PROPERTIES; FABRICATION; BIOMATERIAL; SPONGE; SIZE
AB Novel gelatin/sodium alginate (SA) porous scaffolds containing hyaluronic acid (HYA) were fabricated via freeze-drying technique and their in-vitro biocompatibility was investigated. It was demonstrated that the gelatin/SA/HYA composite scaffolds had highly homogeneous and interconnected pores with average pore size ranging from 50 to 400 mu m. The extracts of gelatin/SA/HYA with various contents of 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide (EDC) showed no toxicity due to easy removal of excess EDC. Fibroblastic cells attached to the culture plate and showed normal morphology when cultured in the extract of gelatin/SA/HYA hydrogel. The introduction of HYA into the gelatin/SA matrix facilitated the adhesion of fibroblasts in the gelatin/SA/HYA scaffolds. The haemolytic test indicated that the gelatin/SA/HYA composite hydrogel showed no haemolysis. Therefore, the gelatin/SA/HYA composite scaffolds would be suitable for cell adhesion and growth and could offer new and important options for tissue engineering applications.
C1 [Ouyang, Zhenzhong; Bai, Shan] Changsha Environm Protect Coll, Changsha, Hunan, Peoples R China.
RP Ouyang, ZZ (reprint author), Changsha Environm Protect Coll, Changsha, Hunan, Peoples R China.
EM zhenzhongouyang@163.com
CR [Anonymous], 1992, 109934 ISO
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Choi SM, 2013, INT J POLYM MATER PO, V62, P384, DOI 10.1080/00914037.2012.710862
   Jha AK, 2011, BIOMATERIALS, V32, P2466, DOI 10.1016/j.biomaterials.2010.12.024
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kuo C. K., 2007, J BIOMED MATER RES A, V90, P899
   Li JX, 2006, BIOMACROMOLECULES, V7, P2243, DOI 10.1021/bm0603342
   Liu HF, 2004, J BIOMAT SCI-POLYM E, V15, P25, DOI 10.1163/156856204322752219
   Liu Y, 2013, POLYM-PLAST TECHNOL, V52, P1154, DOI 10.1080/03602559.2013.798818
   Mao J. S., 2003, BIOMATERIALS, V24, P1621
   Peng ZY, 2012, J MACROMOL SCI B, V51, P12, DOI 10.1080/00222348.2011.562807
   Peng ZY, 2012, POLYM-PLAST TECHNOL, V51, P739, DOI 10.1080/03602559.2012.663037
   Peng ZY, 2012, POLYM-PLAST TECHNOL, V51, P381, DOI 10.1080/03602559.2011.639830
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   Price RD, 2005, AM J CLIN DERMATOL, V6, P393, DOI 10.2165/00128071-200506060-00006
   Rosellini E, 2008, J BIOMED MATER RES A, V91, P447
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Srivastava S, 2012, INT J POLYM MATER, V61, P679, DOI 10.1080/00914037.2011.610070
   Sun L. P., 2009, BIOMED MATER, V4, P1
   Tang SQ, 2007, J BIOMED MATER RES A, V82A, P323, DOI 10.1002/jbm.a.30974
   Wu L, 2013, J MACROMOL SCI A, V50, P1121, DOI 10.1080/10601325.2013.829360
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Yamane S, 2007, J BIOMED MATER RES A, V81A, P586, DOI 10.1002/jbm.a.31095
   Zhou ZH, 2013, MATER RES INNOV, V17, P420, DOI 10.1179/1433075X13Y.0000000084
   Zhou ZH, 2013, INT J POLYM MATER PO, V62, P81, DOI 10.1080/00914037.2012.664213
   Zhou ZH, 2013, POLYM-PLAST TECHNOL, V52, P45, DOI 10.1080/03602559.2012.718400
   Zhou ZH, 2012, POLYM POLYM COMPOS, V20, P791, DOI 10.1177/096739111202000904
NR 27
TC 1
Z9 1
U1 1
U2 13
PU ISMITHERS
PI SHROPSHIRE
PA SHAWBURY, SHREWSBURY, SHROPSHIRE, SY4 4NR, ENGLAND
SN 0967-3911
J9 POLYM POLYM COMPOS
JI Polym. Polym. Compos.
PY 2015
VL 23
IS 7
BP 503
EP 508
DI 10.1177/096739111502300709
PG 6
WC Materials Science, Characterization & Testing; Materials Science,
   Composites; Polymer Science
SC Materials Science; Polymer Science
GA CO1AM
UT WOS:000358885300009
DA 2018-10-19
ER

PT J
AU Christo, SN
   Diener, KR
   Bachhuka, A
   Vasilev, K
   Hayball, JD
AF Christo, Susan N.
   Diener, Kerrilyn R.
   Bachhuka, Akash
   Vasilev, Krasimir
   Hayball, John D.
TI Innate Immunity and Biomaterials at the Nexus: Friends or Foes
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID TOLL-LIKE RECEPTORS; SELF-ASSEMBLED MONOLAYERS; FOREIGN-BODY RESPONSE;
   GIANT-CELL FORMATION; GROUP BOX 1; NLRP3 INFLAMMASOME ACTIVATION;
   MOBILITY GROUP BOX-1; NF-KAPPA-B; POLY(ETHYLENE GLYCOL)-BASED HYDROGELS;
   TITANIUM SURFACE-TOPOGRAPHY
AB Biomaterial implants are an established part of medical practice, encompassing a broad range of devices that widely differ in function and structural composition. However, one common property amongst biomaterials is the induction of the foreign body response: an acute sterile inflammatory reaction which overlaps with tissue vascularisation and remodelling and ultimately fibrotic encapsulation of the biomaterial to prevent further interaction with host tissue. Severity and clinical manifestation of the biomaterial-induced foreign body response are different for each biomaterial, with cases of incompatibility often associated with loss of function. However, unravelling the mechanisms that progress to the formation of the fibrotic capsule highlights the tightly intertwined nature of immunological responses to a seemingly noncanonical "antigen." In this review, we detail the pathways associated with the foreign body response and describe possible mechanisms of immune involvement that can be targeted. We also discuss methods of modulating the immune response by altering the physiochemical surface properties of the biomaterial prior to implantation. Developments in these areas are reliant on reproducible and effective animal models and may allow a "combined" immunomodulatory approach of adapting surface properties of biomaterials, as well as treating key immune pathways to ultimately reduce the negative consequences of biomaterial implantation.
C1 [Christo, Susan N.; Diener, Kerrilyn R.; Hayball, John D.] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst & Hanson Inst, Expt Therapeut Lab, Adelaide, SA 5000, Australia.
   [Diener, Kerrilyn R.] Univ Adelaide, Sch Paediat & Reprod Hlth, Robarts Res Inst, Adelaide, SA 5005, Australia.
   [Bachhuka, Akash; Vasilev, Krasimir] Univ S Australia, Mawson Inst, Adelaide, SA 5095, Australia.
   [Hayball, John D.] Univ Adelaide, Sch Med, Adelaide, SA 5005, Australia.
RP Hayball, JD (reprint author), Univ S Australia, Sch Pharm & Med Sci, Sansom Inst & Hanson Inst, Expt Therapeut Lab, Adelaide, SA 5000, Australia.
EM john.hayball@unisa.edu.au
RI Hayball, John/F-4137-2013
OI Hayball, John/0000-0002-3089-4506
CR Abe A, 2014, PATHOL INT, V64, P267, DOI 10.1111/pin.12167
   Abensee JEB, 2008, SEMIN IMMUNOL, V20, P101, DOI 10.1016/j.smim.2007.10.013
   Agrawal P, 2014, INT J LOW EXTR WOUND, V13, P180, DOI 10.1177/1534734614544523
   Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Akita K, 1997, J BIOL CHEM, V272, P26595, DOI 10.1074/jbc.272.42.26595
   Al-Okla S, 1999, CELL MICROBIOL, V1, P157, DOI 10.1046/j.1462-5822.1999.00016.x
   ALTIERI DC, 1986, J CLIN INVEST, V78, P968, DOI 10.1172/JCI112687
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121
   Artel A, 2011, TISSUE ENG PT A, V17, P2133, DOI [10.1089/ten.tea.2010.0571, 10.1089/ten.TEA.2010.0571]
   AYER LM, 1994, J RHEUMATOL, V21, P2071
   Babiak I, 2014, INT WOUND J, V11, P476, DOI 10.1111/j.1742-481X.2012.01112.x
   Bai B, 2013, BIOMED RES INT, DOI 10.1155/2013/361906
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   Baker DW, 2011, BIOMACROMOLECULES, V12, P997, DOI 10.1021/bm1013487
   Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023
   Bar-On E, 2009, J CHILD ORTHOP, V3, P137, DOI 10.1007/s11832-009-0165-x
   Barbe F., 2014, CYTOKINE GROWTH F R, V25, P681
   Barbosa JN, 2006, J BIOMED MATER RES A, V76A, P737, DOI 10.1002/jbm.a.30602
   Barbosa JN, 2004, BIOMATERIALS, V25, P2557, DOI [10.1016/j.biomaterials.2003.09.047, 10.1016/j .biomaterials.2003.09.047]
   Barbosa JN, 2003, J BIOMED MATER RES A, V65A, P429, DOI 10.1002/jbm.a.10488
   Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613
   Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363
   Bedoya F, 2007, J IMMUNOL, V178, P3837, DOI 10.4049/jimmunol.178.6.3837
   Behera AK, 2006, J IMMUNOL, V177, P657, DOI 10.4049/jimmunol.177.1.657
   Benesch J, 2001, J BIOMAT SCI-POLYM E, V12, P581, DOI 10.1163/156856201316883421
   Betancourt T, 2006, INT J NANOMED, V1, P483, DOI 10.2147/nano.2006.1.4.483
   Bhagwat SS, 2009, PURINERG SIGNAL, V5, P107, DOI 10.1007/s11302-008-9117-z
   Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164
   Bianchi ME, 1998, AM J HUM GENET, V63, P1573, DOI 10.1086/302170
   BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595
   Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104
   Boccafoschi F, 2014, J TISSUE ENG REGEN M, V8, P253, DOI 10.1002/term.1526
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brown BN, 2013, ACTA BIOMATER, V9, P4948, DOI 10.1016/j.actbio.2012.10.025
   Brunette RL, 2012, J EXP MED, V209, P1969, DOI 10.1084/jem.20121960
   BURD PR, 1995, J EXP MED, V181, P1373, DOI 10.1084/jem.181.4.1373
   Burton L, 2013, J ORTHOP RES, V31, P73, DOI 10.1002/jor.22190
   Cachinho S. C. P., 2012, INT J BIOMATERIALS, V2012
   Caicedo MS, 2013, J ORTHOP RES, V31, P1633, DOI 10.1002/jor.22411
   Campana L, 2009, J LEUKOCYTE BIOL, V86, P609, DOI 10.1189/jlb.0908576
   Carver W, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/101979
   Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105
   Castro PR, 2012, MICROVASC RES, V84, P9, DOI 10.1016/j.mvr.2012.04.003
   Chang DT, 2008, J BIOMED MATER RES A, V87A, P676, DOI 10.1002/jbm.a.31630
   Chang DT, 2009, J BIOMED MATER RES A, V89A, P490, DOI 10.1002/jbm.a.31981
   CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Chitanuwat A, 2013, J ORAL SCI, V55, P45, DOI 10.2334/josnusd.55.45
   Chiumiento A, 2007, BIOMACROMOLECULES, V8, P523, DOI 10.1021/bm060664m
   Chrcanovic BR, 2014, J ORAL REHABIL, V41, P443, DOI 10.1111/joor.12157
   Chrcanovic BR, 2014, J DENT, V42, P1509, DOI 10.1016/j.jdent.2014.09.013
   CHRISTENSON L, 1991, J BIOMED MATER RES, V25, P1119, DOI 10.1002/jbm.820250906
   Chuang SK, 2002, J DENT RES, V81, P572, DOI 10.1177/154405910208100814
   Cobelli N, 2011, NAT REV RHEUMATOL, V7, P600, DOI 10.1038/nrrheum.2011.128
   Collie AMB, 2011, J BIOMED MATER RES A, V96A, P162, DOI 10.1002/jbm.a.32963
   Communi D, 2000, CELL SIGNAL, V12, P351, DOI 10.1016/S0898-6568(00)00083-8
   Crane DD, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00438
   Curtsinger JM, 1999, J IMMUNOL, V162, P3256
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   DAYTON ET, 1988, P NATL ACAD SCI USA, V85, P569, DOI 10.1073/pnas.85.2.569
   de Fougerolles AR, 2002, IMMUNOL REV, V186, P208, DOI 10.1034/j.1600-065X.2002.18617.x
   de Zoete MR, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016287
   DEUEL TF, 1981, P NATL ACAD SCI-BIOL, V78, P4584, DOI 10.1073/pnas.78.7.4584
   Diacovo TG, 1996, BLOOD, V88, P146
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Diener KR, 2013, IMMUNOL CELL BIOL, V91, P443, DOI 10.1038/icb.2013.25
   Dolatshahi-Pirouz A, 2010, ACS NANO, V4, P2874, DOI 10.1021/nn9017872
   Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995
   Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506
   Ebina Masahito, 2011, Pulm Med, V2011, P916486, DOI 10.1155/2011/916486
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345
   Entezari M, 2012, MOL MED, V18, P477, DOI 10.2119/molmed.2012.00024
   FABRIZIUSHOMAN DJ, 1991, J BIOMED MATER RES, V25, P953, DOI 10.1002/jbm.820250804
   FABRIZIUSHOMAN DJ, 1991, J BIOMAT SCI-POLYM E, V3, P27, DOI 10.1163/156856292X00060
   Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710
   Fink J, 2008, CLIN HEMORHEOL MICRO, V39, P205, DOI 10.3233/CH-2008-1090
   Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741
   Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200
   Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gamboa JR, 2013, COLLOID SURFACE B, V104, P318, DOI 10.1016/j.colsurfb.2012.11.035
   Gao Q., 2015, J LEUKOCYTE BIOL
   Garg K, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/031001
   Garg K, 2013, BIOMATERIALS, V34, P4439, DOI 10.1016/j.biomaterials.2013.02.065
   Ge WS, 2011, WORLD J GASTROENTERO, V17, P4090, DOI 10.3748/wjg.v17.i36.4090
   Ghasemzadeh M, 2013, BLOOD, V121, P4555, DOI 10.1182/blood-2012-09-459636
   Gifford R, 2005, J BIOMED MATER RES A, V75A, P755, DOI 10.1002/jbm.a.30359
   Gilchrist CL, 2014, BIOMATERIALS, V35, P10015, DOI 10.1016/j.biomaterials.2014.08.047
   Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011
   Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029
   GOODMAN S, 1994, ACTA ORTHOP SCAND, V65, P157, DOI 10.3109/17453679408995425
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gowen BB, 2000, MATRIX BIOL, V19, P61, DOI 10.1016/S0945-053X(99)00052-9
   Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313
   Grainger DW, 2013, NAT BIOTECHNOL, V31, P507, DOI 10.1038/nbt.2600
   GRIERSON JP, 1995, J BIOL CHEM, V270, P4451, DOI 10.1074/jbc.270.9.4451
   Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965
   GROTH T, 1994, J BIOMAT SCI-POLYM E, V6, P729
   Guo TL, 2014, MOLECULES, V19, P149, DOI 10.3390/molecules19010149
   Hamada N, 2008, AM J RESP CELL MOL, V39, P440, DOI 10.1165/rcmb.2007-0330OC
   Hamilton RF, 2008, FREE RADICAL BIO MED, V44, P1246, DOI 10.1016/j.freeradbiomed.2007.12.027
   Han SH, 2014, CLIN ENDOSC, V47, P415, DOI 10.5946/ce.2014.47.5.415
   Harvey AG, 2013, EXPERT REV MED DEVIC, V10, P257, DOI [10.1586/ERD.12.82, 10.1586/erd.12.82]
   Hassan H, 2011, THESCIENTIFICWORLDJO, V11, P2418, DOI 10.1100/2011/429192
   Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939
   Hirata I, 2003, J BIOMED MATER RES A, V66A, P669, DOI 10.1002/jbm.a.10067
   Hodgkinson CR, 2008, THROMB HAEMOSTASIS, V100, P301, DOI 10.1160/TH08-03-0179
   Holand W, 2008, EXPERT REV MED DEVIC, V5, P729, DOI 10.1586/17434440.5.6.729
   Hoesli CA, 2014, BIOMATERIALS, V35, P879, DOI 10.1016/j.biomaterials.2013.09.076
   HOFFMAN AS, 1974, J BIOMED MATER RES, V8, P77, DOI 10.1002/jbm.820080309
   Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631
   Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725
   Hou C., 2014, CELLULAR MOL IMMUNOL
   Hovgaard MB, 2008, J PHYS CHEM B, V112, P8241, DOI 10.1021/jp801103n
   Hulander M, 2013, COLLOID SURFACE B, V110, P261, DOI 10.1016/j.colsurfb.2013.04.010
   Hulander M, 2011, INT J NANOMED, V6, P2653, DOI 10.2147/IJN.S24578
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110
   Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861
   Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095
   Ireland LD, 2014, CONTRACEPTION, V90, P253, DOI 10.1016/j.contraception.2014.05.010
   Itala A, 2003, J BIOMED MATER RES B, V65B, P163, DOI 10.1002/jbm.b.10529
   Jacobs SR, 2012, J LEUKOCYTE BIOL, V92, P469, DOI 10.1189/jlb.0312132
   Jahed Z, 2014, BIOMATERIALS, V35, P9363, DOI 10.1016/j.biomaterials.2014.07.022
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jensen SS, 2005, INT J ORAL MAX IMPL, V20, P703
   Jin TC, 2013, J BIOL CHEM, V288, P13225, DOI 10.1074/jbc.M113.468033
   Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Kalltorp M, 1999, BIOMATERIALS, V20, P2123, DOI 10.1016/S0142-9612(99)00115-5
   Kam KR, 2014, TISSUE ENG PT A, V20, P130, DOI [10.1089/ten.tea.2012.0772, 10.1089/ten.TEA.2012.0772]
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   Kanbe N, 1999, CLIN EXP ALLERGY, V29, P105
   Kanbe N, 1999, INT ARCH ALLERGY IMM, V119, P138, DOI 10.1159/000024189
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558
   Kelsh Rhiannon M, 2013, Trends Cancer Res, V9, P1
   Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Khan MM, 2012, STROKE, V43, P1376, DOI 10.1161/STROKEAHA.111.635516
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim J, 2003, J AM CHEM SOC, V125, P3150, DOI 10.1021/ja028987n
   Kim MH, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-13
   Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399
   Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547
   Kopnin PB, 2004, ONCOGENE, V23, P8834, DOI 10.1038/sj.onc.1208108
   Kosyfaki P, 2014, ACTA BIOMATER, V10, P4861, DOI 10.1016/j.actbio.2014.07.028
   Kovarova M, 2012, J IMMUNOL, V189, P2006, DOI 10.4049/jimmunol.1201065
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Kukkonen MK, 2014, OCCUP ENVIRON MED, V71, P48, DOI 10.1136/oemed-2013-101555
   Kulka A, 2006, MOL IMMUNOL, V43, P1579, DOI 10.1016/j.molimm.2005.09.019
   Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Labrousse AM, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00051
   Lachke MW, 2014, ACTA BIOMATER, V10, P4661, DOI 10.1016/j.actbio.2014.07.004
   Lahdeoja T, 2010, J ORTHOP RES, V28, P184, DOI 10.1002/jor.20979
   Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007
   Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Le Nga N, 2011, J Diabetes Sci Technol, V5, P605
   Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   Lee SA, 2014, YONSEI MED J, V55, P1165, DOI 10.3349/ymj.2014.55.5.1165
   Lefrancais E, 2012, EUR CYTOKINE NETW, V23, P120, DOI 10.1684/ecn.2012.0320
   Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109
   Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9
   LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485
   Li D, 2014, J ALLERGY CLIN IMMUN, V134, P1422, DOI 10.1016/j.jaci.2014.05.011
   Li LC, 2014, J CELL MOL MED, V18, P2331, DOI 10.1111/jcmm.12419
   Liu L, 1997, CLIN EXP IMMUNOL, V109, P204, DOI 10.1046/j.1365-2249.1997.4311329.x
   Liu LY, 2014, BIOCHEM BIOPH RES CO, V450, P851, DOI 10.1016/j.bbrc.2014.06.074
   Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.TEB.2012.0437, 10.1089/ten.teb.2012.0437]
   Lopacinska JM, 2012, NANOSCALE, V4, P3739, DOI 10.1039/c2nr11455k
   Lopetuso LR, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-18
   Lorenzoni G, 2014, J EVAL CLIN PRACT, V20, P570, DOI 10.1111/jep.12132
   Lu A, 2015, FEBS J, V282, P435, DOI 10.1111/febs.13133
   Lukens JR, 2014, P NATL ACAD SCI USA, V111, P1066, DOI 10.1073/pnas.1318688111
   Lunov O, 2011, ACS NANO, V5, P9648, DOI 10.1021/nn203596e
   Luzina IG, 2013, AM J RESP CELL MOL, V49, P999, DOI 10.1165/rcmb.2013-0093OC
   Lynn AD, 2011, ACTA BIOMATER, V7, P123, DOI 10.1016/j.actbio.2010.07.033
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Ma QL, 2014, BIOMATERIALS, V35, P9853, DOI 10.1016/j.biomaterials.2014.08.025
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Maitra R, 2009, MOL IMMUNOL, V47, P175, DOI 10.1016/j.molimm.2009.09.023
   Maitra R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002438
   Malik AF, 2011, P NATL ACAD SCI USA, V108, P20095, DOI 10.1073/pnas.1105152108
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   Marcolongo M, 1998, J BIOMED MATER RES, V39, P161, DOI 10.1002/(SICI)1097-4636(199801)39:1<161::AID-JBM18>3.0.CO;2-I
   Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516
   Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3
   Marvie P, 2010, J CELL MOL MED, V14, P1726, DOI 10.1111/j.1582-4934.2009.00801.x
   Matena J, 2015, INT J MOL SCI, V16, P7478, DOI 10.3390/ijms16047478
   Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406
   Maugeri N, 2014, ANTIOXID REDOX SIGN, V20, P1060, DOI 10.1089/ars.2013.5298
   Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018
   McIvor ME, 1998, PACE, V21, P1847, DOI 10.1111/j.1540-8159.1998.tb00002.x
   McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   McNamara LE, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414536177
   Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529
   Mesure L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012949
   Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x
   Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342
   MILNER P, 1992, J VASC RES, V29, P420, DOI 10.1159/000158960
   Mohiuddin M, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-394
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Morris AH, 2014, MATRIX BIOL, V37, P183, DOI 10.1016/j.matbio.2014.03.002
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Muller D., 2011, STEM CELLS INT, V2011
   Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016
   Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109
   Mustafa K, 2003, CLIN ORAL IMPLAN RES, V14, P50, DOI 10.1034/j.1600-0501.2003.140107.x
   Nair A, 2008, LANGMUIR, V24, P2015, DOI 10.1021/la7025973
   Nakayama T, 2004, J CLIN INVEST, V114, P1317, DOI 10.1172/JCI200422089
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661
   Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nimeri G, 2003, J BIOMED MATER RES A, V67A, P439, DOI 10.1002/jbm.a.10081
   Nimeri G, 2002, BIOMATERIALS, V23, P1785, DOI 10.1016/S0142-9612(01)00305-2
   NIMERI G, 1994, J BIOMAT SCI-POLYM E, V6, P573, DOI 10.1163/156856294X00527
   Nonckreman CJ, 2010, COLLOID SURFACE B, V77, P139, DOI 10.1016/j.colsurfb.2010.01.014
   Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200
   Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363
   Oosting M, 2014, P NATL ACAD SCI USA, V111, pE4478, DOI 10.1073/pnas.1410293111
   Oppenheim JJ, 2007, ADV EXP MED BIOL, V601, P185
   Oviedo-Socarras T, 2014, MICROVASC RES, V93, P23, DOI 10.1016/j.mvr.2014.02.011
   PALABRICA T, 1992, NATURE, V359, P848, DOI 10.1038/359848a0
   Palod PA, 2014, APPL BIOCHEM BIOTECH, V174, P1059, DOI 10.1007/s12010-014-0988-x
   Papenburg BJ, 2010, SOFT MATTER, V6, P4377, DOI 10.1039/b927207k
   Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005
   Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200
   Park TH, 2012, AESTHET PLAST SURG, V36, P421, DOI 10.1007/s00266-011-9803-z
   Pazyar N, 2012, CURR CLIN PHARMACOL, V7, P271, DOI 10.2174/157488412803305821
   PERALTA O, 1995, J STEROID BIOCHEM, V53, P223, DOI 10.1016/0960-0760(95)00051-Z
   Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195
   Piccinini AM, 2010, MEDIAT INFLAMM, DOI 10.1155/2010/672395
   Pietrella D, 2013, EUR J IMMUNOL, V43, P679, DOI 10.1002/eji.201242691
   Pitsch RJ, 1997, J VASC SURG, V26, P70, DOI 10.1016/S0741-5214(97)70149-6
   Provoost S, 2011, J IMMUNOL, V187, P3331, DOI 10.4049/jimmunol.1004062
   Py BF, 2014, CELL REP, V6, P1122, DOI 10.1016/j.celrep.2014.02.015
   Qiao Y, 2012, FEBS LETT, V586, P1022, DOI 10.1016/j.febslet.2012.02.045
   Rahmany MB, 2013, ACTA BIOMATER, V9, P5431, DOI 10.1016/j.actbio.2012.11.019
   Rankin AL, 2010, J IMMUNOL, V184, P1526, DOI 10.4049/jimmunol.0903306
   Ranzato E, 2010, CELL BIOCHEM BIOPHYS, V57, P9, DOI 10.1007/s12013-010-9077-0
   Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ratner BD, 2011, J CARDIOVASC TRANSL, V4, P523, DOI 10.1007/s12265-011-9287-x
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Reisetter AC, 2011, J BIOL CHEM, V286, P21844, DOI 10.1074/jbc.M111.238519
   Rezzani R, 2004, ARCH HISTOL CYTOL, V67, P211, DOI 10.1679/aohc.67.211
   Ribatti D, 2012, BBA-MOL BASIS DIS, V1822, P2, DOI 10.1016/j.bbadis.2010.11.010
   Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153
   ROCHE WR, 1985, INT J CANCER, V36, P721, DOI 10.1002/ijc.2910360617
   Rodriguez A, 2008, J BIOMED MATER RES A, V85A, P556, DOI 10.1002/jbm.a.31562
   Rodriguez A, 2010, J BIOMED MATER RES A, V92A, P214, DOI 10.1002/jbm.a.32362
   Rodriguez A, 2009, J BIOMED MATER RES A, V90A, P106, DOI 10.1002/jbm.a.32050
   Rodriguez A, 2009, J BIOMED MATER RES A, V89A, P152, DOI 10.1002/jbm.a.31939
   Rogers TH, 2010, BIOMATERIALS, V31, P594, DOI 10.1016/j.biomaterials.2009.09.077
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Rouhiainen A, 2004, BLOOD, V104, P1174, DOI 10.1182/blood-2003-10-3536
   Rowe SM, 2008, AM J RESP CRIT CARE, V178, P822, DOI 10.1164/rccm.200712-1894OC
   Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37
   Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043
   Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004
   Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858
   Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015
   Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862
   Secott TE, 2004, INFECT IMMUN, V72, P3724, DOI 10.1128/IAI.72.7.3724-3732.2004
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   Shen EC, 2006, CLIN ORAL IMPLAN RES, V17, P572, DOI 10.1111/j.1600-0501.2005.01241.X
   Shen MC, 2004, J BIOMED MATER RES A, V70A, P533, DOI 10.1002/jbm.a.30069
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Shokouhi B, 2010, BIOMATERIALS, V31, P5759, DOI 10.1016/j.biomaterials.2010.04.015
   Sivaraman B, 2009, LANGMUIR, V25, P3050, DOI 10.1021/la8036814
   Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887
   Smith Kevin Christopher, 2008, Dermatol Online J, V14, P3
   Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706
   Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060
   Soskolne WA, 2002, CLIN ORAL IMPLAN RES, V13, P86, DOI 10.1034/j.1600-0501.2002.130111.x
   Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042
   Stehlik C, 2007, J IMMUNOL, V179, P7993, DOI 10.4049/jimmunol.179.12.7993
   Suehiro K, 2000, J BIOCHEM-TOKYO, V128, P705, DOI 10.1093/oxfordjournals.jbchem.a022804
   Szaba FM, 2002, BLOOD, V99, P1053, DOI 10.1182/blood.V99.3.1053
   Szott LM, 2011, CURR OPIN CHEM BIOL, V15, P677, DOI 10.1016/j.cbpa.2011.04.021
   Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126
   Tamaki Y, 2009, J RHEUMATOL, V36, P598, DOI 10.3899/jrheum.080390
   Tan KS, 2006, BIOMATERIALS, V27, P5170, DOI 10.1016/j.biomaterials.2006.05.002
   Tang LP, 1998, J BIOMAT SCI-POLYM E, V9, P1257
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   Teunissen AM, 2014, EUR J CONTRACEP REPR, V19, P15, DOI 10.3109/13625187.2013.862231
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Thompson JK, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-24
   TREZZINI C, 1988, BIOCHEM BIOPH RES CO, V156, P477, DOI 10.1016/S0006-291X(88)80866-0
   Tsuchiya K, 2014, EUR J IMMUNOL, V44, P3696, DOI 10.1002/eji.201444673
   Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244
   Valladares RD, 2014, J BIOMED MATER RES A, V102, P3004, DOI 10.1002/jbm.a.34972
   Vanni S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5916
   Venkayya R, 2002, AM J RESP CELL MOL, V26, P202, DOI 10.1165/ajrcmb.26.2.4600
   Vieira EP, 2009, LANGMUIR, V25, P9879, DOI 10.1021/la9009948
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Vorup-Jensen T, 2005, P NATL ACAD SCI USA, V102, P1614, DOI 10.1073/pnas.0409057102
   VROMAN L, 1980, BLOOD, V55, P156
   Wahamaa H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3450
   Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248
   Wegiel B, 2014, J CLIN INVEST, V124, P4926, DOI 10.1172/JCI72853
   Wettero J, 2000, J BIOMED MATER RES, V51, P742, DOI 10.1002/1097-4636(20000915)51:4<742::AID-JBM24>3.0.CO;2-D
   Wiegering Verena, 2014, BMC Hematol, V14, P18, DOI 10.1186/2052-1839-14-18
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Winter M, 2011, NANOTOXICOLOGY, V5, P326, DOI 10.3109/17435390.2010.506957
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Yang D, 2013, EUR J IMMUNOL, V43, P1412, DOI 10.1002/eji.201243138
   Yang EJ, 2012, BIOMATERIALS, V33, P6858, DOI 10.1016/j.biomaterials.2012.06.016
   Yang J, 2014, J BIOMED MATER RES A, V102, P2017, DOI 10.1002/jbm.a.35152
   Yaseen M, 2010, BIOMATERIALS, V31, P3781, DOI 10.1016/j.biomaterials.2010.01.107
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   YOKOYAMA M, 1986, J BIOMED MATER RES, V20, P867, DOI 10.1002/jbm.820200702
   Zafiropoulos GG, 2014, J ORAL IMPLANTOL, V40, P271, DOI 10.1563/AAID-JOI-D-11-00048
   ZANETTI A, 1994, BLOOD, V84, P1116
   Zarbock A, 2007, BLOOD REV, V21, P99, DOI 10.1016/j.blre.2006.06.001
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
   Zhang Q, 2012, J SURG RES, V176, P343, DOI 10.1016/j.jss.2011.06.069
   Zhang WJ, 2013, J CLIN IMMUNOL, V33, P925, DOI 10.1007/s10875-013-9881-6
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831
NR 345
TC 15
Z9 16
U1 3
U2 31
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 342304
DI 10.1155/2015/342304
PG 23
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CN5VE
UT WOS:000358498700001
PM 26247017
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Ren, B
   Zhai, ZB
   Guo, K
   Liu, YP
   Hou, WH
   Zhu, QS
   Zhu, JY
AF Ren, Bo
   Zhai, Zhenbo
   Guo, Kai
   Liu, Yanpu
   Hou, Weihuan
   Zhu, Qingsheng
   Zhu, Jinyu
TI The application of porous tantalum cylinder to the repair of comminuted
   bone defects: a study of rabbit firearm injuries
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article
DE Firearm injury; tibial defect; porous tantalum
ID SCAFFOLDS; INGROWTH; IMPLANT; MODEL; GRAFT; MANAGEMENT; INFECTION;
   SURGERY
AB The aim of this study is to investigate the effect of porous tantalum material in repair tibial defects caused by firearm injuries in a rabbit model. A multifunctional biological impact machine was used to establish a rabbit tibial defect model of firearm injury. Porous tantalum rods were processed into a hollow cylinder. Kirschner wires were used for intramedullary fixation. We compared the differences of the bone ingrowth of the porous tantalum material by gross observations, X-rays and histological evaluations. The radiographic observations revealed that fibrous tissue covered the material surface after 4 weeks, and periosteal reactions and new bone callus extending materials appeared after 8 weeks. After 16 weeks, the calluses of the firearm injury group were completely wrapped around a porous tantalum material. The group with the highest Lane-Sandhu X-rays cores was the firearm injury and tantalum implant group, and the blank control group exhibited the lowest scores. The histological evaluations revealed that the presence of new bone around the biomaterial had grown into the porous tantalum. By the 16th week, the areas of bone tissue of the firearm injury group was significant higher than that of non-firearm injury group (P<0.05). The comminuted fractures treated with tantalum cylinders exhibited greater bone ingrowth in the firearm injury group. In conditions of firearm injuries, the porous tantalum biomaterial exhibited bone ingrowth that was beneficial to the treatment of bone defects.
C1 [Ren, Bo; Guo, Kai; Zhu, Qingsheng; Zhu, Jinyu] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Shaanxi, Peoples R China.
   [Ren, Bo] Xian Honghui Hosp, Dept Orthopaed, Xian, Shaanxi, Peoples R China.
   [Zhai, Zhenbo] Shanxi Prov Canc Hosp, Dept Gynecol Oncol, Xian, Shaanxi, Peoples R China.
   [Liu, Yanpu] Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Shaanxi, Peoples R China.
   [Hou, Weihuan] Fourth Mil Med Univ, Xijing Hosp, Dept Radiol, Xian 710032, Shaanxi, Peoples R China.
RP Zhu, JY (reprint author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, 127 Changle Western Rd, Xian 710032, Shaanxi, Peoples R China.
EM zhuqsh@fmmu.edu.cn; zhujinyu@fmmu.edu.cn
CR Adams JE, 2005, J HAND SURG-AM, V30A, P1128, DOI 10.1016/j.jhsa.2005.08.008
   Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bullens PHJ, 2010, INJURY, V41, P1284, DOI 10.1016/j.injury.2010.07.247
   Bullens PHJ, 2010, J BIOMED MATER RES B, V92B, P24, DOI 10.1002/jbm.b.31485
   Bullens PHJ, 2009, CLIN ORTHOP RELAT R, V467, P783, DOI 10.1007/s11999-008-0686-5
   Chou TGR, 2010, J BIOMED MATER RES A, V92A, P942, DOI 10.1002/jbm.a.32413
   Frank M, 2013, ACTA CHIR ORTHOP TR, V80, P197
   Frigg A, 2010, CLIN ORTHOP RELAT R, V468, P209, DOI 10.1007/s11999-009-0948-x
   Jansen EJP, 2005, BIOMATERIALS, V26, P4423, DOI 10.1016/j.biomaterials.2004.11.001
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Li BC, 2009, J TRAUMA, V66, P450, DOI 10.1097/TA.0b013e3181848cd6
   [刘彦普 Liu Yanpu], 2003, [实用口腔医学杂志, Journal of Practical Stomatology], V19, P269
   LIU YQ, 1988, J TRAUMA, V28, pS95, DOI 10.1097/00005373-198801001-00021
   Maiden N, 2009, FORENSIC SCI MED PAT, V5, P204, DOI 10.1007/s12024-009-9096-6
   Mattila VM, 2006, J TRAUMA, V61, P1222, DOI 10.1097/01.ta.0000197179.50226.1d
   Mrosek EH, 2010, J ORTHOP RES, V28, P141, DOI 10.1002/jor.20983
   Patil N, 2009, J BIOMED MATER RES B, V89B, P242, DOI 10.1002/jbm.b.31198
   Poultsides LA, 2008, J ORTHOP RES, V26, P1355, DOI 10.1002/jor.20608
   Ramrattan NN, 2005, TISSUE ENG, V11, P1212, DOI 10.1089/ten.2005.11.1212
   Tian L, 2009, J TRAUMATIC SURG, V11, P438
   Tosti R, 2013, ORTHOP CLIN N AM, V44, P529, DOI 10.1016/j.ocl.2013.06.006
   van der Stok J, 2013, TISSUE ENG PT A, V19, P2605, DOI [10.1089/ten.tea.2013.0181, 10.1089/ten.TEA.2013.0181]
   Van der Stok J, 2013, J ORTHOP RES, V31, P792, DOI 10.1002/jor.22293
   Yavari SA, 2013, MAT SCI ENG C-MATER, V33, P4849, DOI 10.1016/j.msec.2013.08.006
   Zou Xuenong, 2004, Spine J, V4, P99, DOI 10.1016/S1529-9430(03)00407-8
NR 27
TC 2
Z9 4
U1 0
U2 6
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1940-5901
J9 INT J CLIN EXP MED
JI Int. J. Clin. Exp. Med.
PY 2015
VL 8
IS 4
BP 5055
EP 5064
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CN4CV
UT WOS:000358377700030
PM 26131078
DA 2018-10-19
ER

PT J
AU Zhang, L
   Qian, JS
   Fan, YJ
   Feng, W
   Tao, Z
   Yang, HY
AF Zhang, Lei
   Qian, Jiasheng
   Fan, Yujiao
   Feng, Wei
   Tao, Zhen
   Yang, Haiyang
TI A facile CO2 switchable nanocomposite with reversible transition from
   sol to self-healable hydrogel
SO RSC ADVANCES
LA English
DT Article
ID SURFACTANTS; CHEMISTRY; LAPONITE; CLAY
AB In this paper, we report a CO2/N-2-switchable sol to gel transition system based on a triblock copolymer of dimethylaminoethyl methacrylate (DMAEMA) and ethylene oxide (EO), with a measured composition DMAEMA(6)-EO109-DMAEMA(6), in aqueous nanoclay dispersions. LAPONITE (R) is exfoliated and stabilized by Pluronic F127. The aqueous mixture exhibits a strong response to CO2, changing from a low viscous sol to a self-healable gel. In the presence of CO2, the PDMAEMA blocks are protonated and the positive charged triblock copolymer bridge the negative charged nanoclays, formation of a physical network. As a consequence, a sol to gel transition is observed at the macro level. Upon removal of CO2 through bubbling with N-2, a corresponding gel to sol transition occurs due to the deconstruction of the physical network, which is a result of the departure of the deprotonated PDMAEMA blocks from the nanoclays. This sol to gel transition is fully reversible. Furthermore, the formed gel possesses excellent self-healing ability, meaning that this hydrogel is capable of autonomous healing upon damage. Thus, we believe the fundamentals of the present CO2-responsive smart hydrogel may hold promise for a wide range of areas, such as intelligent delivery systems and smart biomaterial fields, or a potential CO2 plugging agent for enhanced oil recovery (EOR) performed by CO2 flooding.
C1 [Zhang, Lei; Fan, Yujiao; Feng, Wei; Tao, Zhen; Yang, Haiyang] Univ Sci & Technol China, Dept Polymer Sci & Engn, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China.
   [Zhang, Lei; Qian, Jiasheng] Anhui Univ, Dept Chem & Chem Engn, Hefei 230000, Peoples R China.
RP Yang, HY (reprint author), Univ Sci & Technol China, Dept Polymer Sci & Engn, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China.
EM yhy@ustc.edu.cn
RI Feng, Wei/L-8814-2014
OI Feng, Wei/0000-0001-8715-0113; TAO, ZHEN/0000-0002-6298-2877
FU National Natural Science Foundation of China [51273189]; National
   Science and Technology Major Project of the Ministry of Science and
   Technology of China [2011ZX05010-003]; Petro China Innovation Foundation
   [2012D-5006-0202]; China Postdoctoral Science Foundation [2013M531513]
FX This work was supported by the National Natural Science Foundation of
   China (Grant no. 51273189), the National Science and Technology Major
   Project of the Ministry of Science and Technology of China
   (2011ZX05010-003), Petro China Innovation Foundation (2012D-5006-0202),
   and China Postdoctoral Science Foundation funded project (no.
   2013M531513).
CR Bonino CA, 2011, SOFT MATTER, V7, P11510, DOI 10.1039/c1sm06109g
   Dawson JI, 2013, ADV MATER, V25, P4069, DOI 10.1002/adma.201301034
   Han D, 2011, ACS MACRO LETT, V1, P57
   Hao X, 2013, J MATER CHEM A, V1, P6920, DOI 10.1039/c3ta10285h
   Haraguchi K, 2002, ADV MATER, V14, P1120, DOI 10.1002/1521-4095(20020816)14:16<1120::AID-ADMA1120>3.0.CO;2-9
   Herrera NN, 2004, LANGMUIR, V20, P1564, DOI 10.1021/la0349267
   Hu ZQ, 2013, RSC ADV, V3, P12021, DOI 10.1039/c3ra42425a
   Jessop PG, 2005, NATURE, V436, P1102, DOI 10.1038/4361102a
   Jessop PG, 2012, ENERG ENVIRON SCI, V5, P7240, DOI 10.1039/c2ee02912j
   Jessop PG, 2010, GREEN CHEM, V12, P809, DOI 10.1039/b926885e
   Lamont RE, 1998, J AM CHEM SOC, V120, P7602, DOI 10.1021/ja9742895
   Lin SJ, 2013, MACROMOL RAPID COMM, V34, P1118, DOI 10.1002/marc.201300288
   Liu MJ, 2015, NATURE, V517, P68, DOI 10.1038/nature14060
   Liu YX, 2006, SCIENCE, V313, P958, DOI 10.1126/science.1128142
   Nagai D, 2011, CHEM COMMUN, V47, P8856, DOI 10.1039/c1cc12084k
   Nelson A, 2005, LANGMUIR, V21, P9176, DOI 10.1021/la050680p
   Ning JY, 2013, MACROMOLECULES, V46, P5317, DOI 10.1021/ma4009059
   Qian Y, 2014, GREEN CHEM, V16, P4963, DOI 10.1039/c4gc01242a
   Rudkevich DM, 2004, ANGEW CHEM INT EDIT, V43, P558, DOI 10.1002/anie.200300606
   Sun YL, 2010, COLLOID POLYM SCI, V288, P997, DOI 10.1007/s00396-010-2225-7
   van Olphen H., 1977, INTRO CLAY COLLOID C
   Wu YT, 2009, J MATER CHEM, V19, P7340, DOI 10.1039/b909125d
   Yan B, 2013, SOFT MATTER, V9, P2011, DOI 10.1039/c2sm27469h
   Yan Q., 2011, ANGEW CHEM, V123, P5025, DOI DOI 10.1002/ANGE.201100708
NR 24
TC 5
Z9 5
U1 7
U2 83
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 76
BP 62229
EP 62234
DI 10.1039/c5ra10597h
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA CN3UO
UT WOS:000358353100088
DA 2018-10-19
ER

PT J
AU Leiviska, T
   Keranen, A
   Vainionpaa, N
   Al Amir, J
   Hormi, O
   Tanskanen, J
AF Leiviska, T.
   Keranen, A.
   Vainionpaa, N.
   Al Amir, J.
   Hormi, O.
   Tanskanen, J.
TI Vanadium(V) removal from aqueous solution and real wastewater using
   quaternized pine sawdust
SO WATER SCIENCE AND TECHNOLOGY
LA English
DT Article
DE biomaterial; chemical modification; strong anion exchanger; vanadate
ID METAL SPECIATION; RECOVERY; CHITOSAN; SORPTION; IONS
AB Cross-linked and quaternized pine sawdust was tested for vanadium removal from a synthetic aqueous solution as well as from real industrial wastewater which had a considerable amount of vanadium and other ions such as sulphate, ammonium and nickel. The maximum vanadium sorption capacity of the modified pine sawdust was found to be 130 mg/g in synthetic solution and 103 mg/g in real wastewater. Modified pine sawdust worked well over a wide range of pH. Column studies with real wastewater proved that vanadium was efficiently desorbed from the material with 2 M NaOH and that the material could be reused.
C1 [Leiviska, T.; Keranen, A.; Vainionpaa, N.; Al Amir, J.; Tanskanen, J.] Univ Oulu, Chem Proc Engn, FIN-90014 Oulu, Finland.
   [Hormi, O.] Univ Oulu, Dept Chem, FIN-90014 Oulu, Finland.
RP Leiviska, T (reprint author), Univ Oulu, Chem Proc Engn, POB 4300, FIN-90014 Oulu, Finland.
EM tiina.leiviska@oulu.fi
FU Maj and Tor Nessling Foundation; Maa- ja vesitekniikan tuki ry
FX This work was financially supported by the Maj and Tor Nessling
   Foundation and Maa- ja vesitekniikan tuki ry.
CR [Anonymous], 1980, 3047 SFS
   [Anonymous], 2009, 103041 SFSEN
   [Anonymous], 1990, 5047 SFS
   [Anonymous], 1997, 13395 SFSEN ISO
   [Anonymous], 2005, 11732 SFSEN ISO
   ATSDR-Agency for Toxic Substances and Disease Registry, 2012, TOX PROF VAN
   Dowex, 2014, ION EXCH RES WAT CON
   Guzman J, 2002, LANGMUIR, V18, P1567, DOI 10.1021/la010802n
   Keranen A., 2015, DESALIN WATER TREAT, V53, P2645
   Keranen A, 2013, CHEM ENG SCI, V98, P59, DOI 10.1016/j.ces.2013.05.007
   Lazaridis NK, 2003, SEPAR SCI TECHNOL, V38, P2201, DOI 10.1081/SS-120021620
   Min XB, 2009, T NONFERR METAL SOC, V19, P1360, DOI 10.1016/S1003-6326(08)60450-1
   Naeem A, 2007, WATER RES, V41, P1596, DOI 10.1016/j.watres.2007.01.002
   Namasivayam C, 2006, ADSORPTION, V12, P103, DOI 10.1007/s10450-006-0373-3
   Navarro R, 2003, MACROMOL BIOSCI, V3, P552, DOI 10.1002/mabi.200300013
   Ro CU, 1999, ANAL CHEM, V71, P1521, DOI 10.1021/ac981070f
   Roccaro P., 2008, QUAL WAT RES EXP PER
   Wang WY, 2010, CHEM ENG J, V157, P161, DOI 10.1016/j.cej.2009.11.024
   Xu X, 2013, CARBOHYD POLYM, V98, P132, DOI 10.1016/j.carbpol.2013.05.058
   Xu X, 2010, CARBOHYD POLYM, V82, P1212, DOI 10.1016/j.carbpol.2010.06.053
   Yeom BY, 2009, J HAZARD MATER, V166, P415, DOI 10.1016/j.jhazmat.2008.11.032
NR 21
TC 6
Z9 7
U1 1
U2 8
PU IWA PUBLISHING
PI LONDON
PA ALLIANCE HOUSE, 12 CAXTON ST, LONDON SW1H0QS, ENGLAND
SN 0273-1223
EI 1996-9732
J9 WATER SCI TECHNOL
JI Water Sci. Technol.
PY 2015
VL 72
IS 3
BP 437
EP 442
DI 10.2166/wst.2015.227
PG 6
WC Engineering, Environmental; Environmental Sciences; Water Resources
SC Engineering; Environmental Sciences & Ecology; Water Resources
GA CN7GX
UT WOS:000358603500013
PM 26204076
DA 2018-10-19
ER

PT S
AU Kien, PT
   Kanji, T
   Ishikawa, K
AF Pham Trung Kien
   Kanji, Tsuru
   Ishikawa, Kunio
BE VanToi, V
   Phuong, THL
TI Development and Characterization of Porous Calcium Phosphate Cement
   Using alpha-Tricalcium Phosphate Bead
SO 5TH INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING IN VIETNAM
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 5th International Conference on the Development of Biomedical
   Engineering in Vietnam
CY JUN 16-18, 2014
CL Ho Chi Minh City, VIETNAM
SP Vietnam Natl Univ, Int Univ Vietnam Natl Univ, Arizona State Univ, ViKOmed, Trung Son Sci Equipment, SAIGON SCIENTISTS, USN Global, Off Naval Res, Sci & Technol, Natl Instruments, U S ARMY RDECOM, Univ Alberta, ITS Vietnam, SAIGON ISG, SPIE
DE alpha-TCP; brushite; apatite; porous cement; setting reaction
AB Interconnected set porous-calcium phosphate cement (set porous-CPC), which has fully interconnected pores could be an ideal bone substitute. In this study, set porous-CPC consisting of alpha-tricalcium phosphate (alpha-TCP) beads and acidic calcium phosphate solution was developed and its basic setting reaction was studied. When alpha-TCP beads were exposed to the acidic calcium phosphate solution, brushite (CaHPO4 center dot 2H(2)O) was formed on the surface of the alpha-TCP beads. The formed brushite crystals interlocked with each other, resulting in a setting reaction of alpha-TCP microspheres within 10 min at 37 degrees C. As a result of this setting reaction, a fully-interconnected calcium phosphate macroporous structure was obtained. The set porous-CPC were immersed into simulated body fluid (SBF) at 37oC for different immersion time, The result clearly showed that brushite surface layer transformed to apatite layer after 3 days immersion into SBF solution by dissolution-precipitation reaction. Since apatite layer show excellent tissue response, the set porous-CPC would be a promising biomaterial used as artificial bone substitutes, and as the scaffold for tissue engineering.
C1 [Pham Trung Kien] Ho Chi Minh Univ Technol, Dept Ceram Mat, Ho Chi Minh City, Vietnam.
   [Kanji, Tsuru; Ishikawa, Kunio] Kyushu Univ, Dept Biomat, Fukuoka 812, Japan.
RP Kien, PT (reprint author), Ho Chi Minh Univ Technol, Dept Ceram Mat, Ho Chi Minh City, Vietnam.
CR Brown WE, 1986, J AM CERAM SOC, P352
   Burguera EF, 2006, J BIOMED MATER RES B, V77B, P126, DOI 10.1002/jbm.b.30403
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kunio I, 2012, KEY ENG MATER, V493-494, P832
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P475, DOI 10.1016/0142-9612(89)90089-6
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P634, DOI 10.1016/0142-9612(89)90120-8
   Monma H., 1976, J CERAM SOC JPN, V84, P209
   Pham TK, 2010, J AUSTR CERAMIC SOC, V46, P63
   Real RP, 2002, BIOMATERIALS, V23, P3673
NR 9
TC 0
Z9 0
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-319-11776-8; 978-3-319-11775-1
J9 IFMBE PROC
PY 2015
VL 46
BP 507
EP 510
DI 10.1007/978-3-319-11776-8_125
PG 4
WC Engineering, Biomedical
SC Engineering
GA BD0WM
UT WOS:000357778100125
DA 2018-10-19
ER

PT J
AU Lozano-Perez, AA
   Gil, AL
   Perez, SA
   Cutillas, N
   Meyer, H
   Pedreno, M
   Aznar-Cervantes, SD
   Janiak, C
   Cenis, JL
   Ruiz, J
AF Abel Lozano-Perez, A.
   Gil, Ana L.
   Perez, Sergio A.
   Cutillas, Natalia
   Meyer, Hajo
   Pedreno, Monica
   Aznar-Cervantes, Salvador D.
   Janiak, Christoph
   Cenis, Jose Luis
   Ruiz, Jose
TI Antitumor properties of platinum(IV) prodrug-loaded silk fibroin
   nanoparticles
SO DALTON TRANSACTIONS
LA English
DT Article
ID PLGA-PEG NANOPARTICLES; DRUG-DELIVERY; BIOMEDICAL APPLICATIONS; TARGETED
   DELIVERY; ANTICANCER DRUGS; CANCER-THERAPY; PT(IV) PRODRUG;
   SERUM-ALBUMIN; CISPLATIN; RESISTANCE
AB Platinum(IV) complexes take advantage of the exclusive conditions that occur within the tumor to carry out their cytotoxic activity. On the other hand, silk fibroin has natural properties which make it very interesting as a biomaterial: high biocompatibility, biodegradability, low immunogenicity, high cellular penetration capacity and high reactive surface. Herein we report the preparation of silk fibroin nanoparticles (SFNs) loaded with the hydrophobic Pt(IV) complex cis,cis,trans-[Pt(NH3)(2)Cl-2(O2CC6H5)(2)] (PtBz). Only a small fraction of the loaded PtBz is released (less than 10% after 48 h). PtBz-SFNs trigger strong cytotoxic effects against human ovarian carcinoma A2780 cells and their cisplatin-resistant variant A2780cisR cells. Interestingly, PtBz-SFNs are very cytotoxic (nanomolar IC50 values) toward the triple negative breast tumor cell line MDA-MB-231, and also toward SK-BR-3 and MCF-7, while maintaining an excellent selectivity index.
C1 [Abel Lozano-Perez, A.; Aznar-Cervantes, Salvador D.; Cenis, Jose Luis] Inst Murciano Invest & Desarrollo Agr & Alimentar, E-30150 Murcia, Spain.
   [Gil, Ana L.; Perez, Sergio A.; Cutillas, Natalia; Pedreno, Monica; Ruiz, Jose] Univ Murcia, Dept Quim Inorgan, E-30071 Murcia, Spain.
   [Gil, Ana L.; Perez, Sergio A.; Cutillas, Natalia; Pedreno, Monica; Ruiz, Jose] IMIB Arrixaca, E-30071 Murcia, Spain.
   [Meyer, Hajo; Janiak, Christoph] Univ Dusseldorf, Inst Anorgan Chem & Strukturchem, D-40204 Dusseldorf, Germany.
RP Ruiz, J (reprint author), Univ Murcia, Dept Quim Inorgan, E-30071 Murcia, Spain.
EM jrui@um.es
RI Ruiz, Jose/B-8271-2008; Janiak, Christoph/A-6021-2013; Cutillas,
   Natalia/L-6501-2014; Lozano Perez, Antonio Abel/B-4373-2013
OI Ruiz, Jose/0000-0002-0834-337X; Janiak, Christoph/0000-0002-6288-9605;
   Cutillas, Natalia/0000-0002-1158-9303; Lozano Perez, Antonio
   Abel/0000-0002-5749-3737; AZNAR CERVANTES, SALVADOR/0000-0001-9809-7215
FU Spanish Ministerio de Economia y Competitividad; FEDER/ERDF
   [SAF2011-26611]; Fundacion Seneca-CARM [15354/PI/10]; FEDER/ERDF of the
   Region of Murcia
FX This work was supported by the Spanish Ministerio de Economia y
   Competitividad and FEDER/ERDF (Project SAF2011-26611) and by Fundacion
   Seneca-CARM (Project 15354/PI/10). COST CM1105 for providing
   opportunities of discussion and Dr Ignacio Lopez for AAS assistance are
   also acknowledged. Dr A. Abel Lozano-Perez's research contract was
   partially supported (80%) by the FEDER/ERDF of the Region of Murcia
   2007-2013.
CR Ang WH, 2005, J AM CHEM SOC, V127, P1382, DOI 10.1021/ja0432618
   BRANDON RJ, 1984, J MED CHEM, V27, P861, DOI 10.1021/jm00373a009
   Cabral H, 2011, ACCOUNTS CHEM RES, V44, P999, DOI 10.1021/ar200094a
   Chen MJ, 2012, J BIOMED MATER RES A, V100A, P203, DOI 10.1002/jbm.a.33265
   Chen T. R., 1975, TCA MANUAL, V1, P229
   Della Rocca J, 2011, ACCOUNTS CHEM RES, V44, P957, DOI 10.1021/ar200028a
   Dhar S, 2008, P NATL ACAD SCI USA, V105, P17356, DOI 10.1073/pnas.0809154105
   Dhar S, 2011, P NATL ACAD SCI USA, V108, P1850, DOI 10.1073/pnas.1011379108
   Dhar S, 2009, P NATL ACAD SCI USA, V106, P22199, DOI 10.1073/pnas.0912276106
   Fuertes MA, 2003, CHEM REV, V103, P645, DOI 10.1021/cr020010d
   Graf N, 2012, ADV DRUG DELIVER REV, V64, P993, DOI 10.1016/j.addr.2012.01.007
   Graf N, 2012, ACS NANO, V6, P4530, DOI 10.1021/nn301148e
   Gu Y, 2014, BIOMATERIALS, V35, P2253, DOI 10.1016/j.biomaterials.2013.11.087
   Hall MD, 2007, J MED CHEM, V50, P3403, DOI 10.1021/jm070280u
   Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139
   Kamaly N, 2012, CHEM SOC REV, V41, P2971, DOI 10.1039/c2cs15344k
   Kasoju N, 2012, ADV HEALTHC MATER, V1, P393, DOI 10.1002/adhm.201200097
   Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004
   Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167
   Kelland LR, 2000, DRUGS, V59, P1, DOI 10.2165/00003495-200059004-00001
   Kolishetti N, 2010, P NATL ACAD SCI USA, V107, P17939, DOI 10.1073/pnas.1011368107
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Li J, 2012, CHEM SCI, V3, P2083, DOI 10.1039/c2sc01086k
   Lu Q, 2011, ACTA BIOMATER, V7, P2782, DOI 10.1016/j.actbio.2011.03.001
   Maldonado CR, 2013, COORDIN CHEM REV, V257, P2668, DOI 10.1016/j.ccr.2013.04.014
   Mathur AB, 2010, NANOMEDICINE-UK, V5, P807, DOI 10.2217/NNM.10.51
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Min YZ, 2014, ANGEW CHEM INT EDIT, V53, P1012, DOI 10.1002/anie.201308834
   Min YZ, 2012, ANGEW CHEM INT EDIT, V51, P6742, DOI 10.1002/anie.201201562
   Moreno D, 2010, EUR J PHARM BIOPHARM, V74, P265, DOI 10.1016/j.ejpb.2009.10.005
   Oberoi HS, 2013, ADV DRUG DELIVER REV, V65, P1667, DOI 10.1016/j.addr.2013.09.014
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Ozgur A, 2012, INT J PHARMACEUT, V422, P472, DOI 10.1016/j.ijpharm.2011.11.013
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   Prabhakar U., 2013, CANCER RES, V73, P2417
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Qu J, 2014, MAT SCI ENG C-MATER, V44, P166, DOI 10.1016/j.msec.2014.08.034
   Seib FP, 2013, ADV HEALTHC MATER, V2, P1606, DOI 10.1002/adhm.201300034
   Shi PJ, 2013, BIOMATERIALS, V34, P5947, DOI 10.1016/j.biomaterials.2013.04.046
   SIAMWIZA MN, 1975, BIOCHEMISTRY-US, V14, P4870, DOI 10.1021/bi00693a014
   Subia B, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/3/035103
   Subia B, 2014, INTEGR BIOL-UK, V6, P203, DOI 10.1039/c3ib40184g
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang CY, 2011, ACTA BIOMATER, V7, P634, DOI 10.1016/j.actbio.2010.09.011
   Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691
   Zhang W, 2013, BIOMATERIALS, V34, P6046, DOI 10.1016/j.biomaterials.2013.04.055
   Zhang YQ, 2007, J NANOPART RES, V9, P885, DOI 10.1007/s11051-006-9162-x
   Zheng YR, 2014, J AM CHEM SOC, V136, P8790, DOI 10.1021/ja5038269
NR 48
TC 10
Z9 10
U1 11
U2 42
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1477-9226
EI 1477-9234
J9 DALTON T
JI Dalton Trans.
PY 2015
VL 44
IS 30
BP 13513
EP 13521
DI 10.1039/c5dt00378d
PG 9
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA CN1VM
UT WOS:000358208400016
PM 25799077
DA 2018-10-19
ER

PT J
AU Wen, XX
   Zheng, YD
   Wu, J
   Wang, LN
   Yuan, ZY
   Peng, J
   Meng, HY
AF Wen, Xiaoxiao
   Zheng, Yudong
   Wu, Jian
   Wang, Lu-Ning
   Yuan, Zhenya
   Peng, Jiang
   Meng, Haoye
TI Immobilization of collagen peptide on dialdehyde bacterial cellulose
   nanofibers via covalent bonds for tissue engineering and regeneration
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE bacterial cellulose; dialdehyde cellulose; collagen peptide; composite
   materials; cytoactivity
ID DRUG-DELIVERY-SYSTEMS; CROSS-LINKING; IN-VITRO; DISSOLUTION PROFILES;
   AMINO-ACID; PART 1; SCAFFOLDS; POLYSACCHARIDES; ADSORPTION; STABILITY
AB Bacterial cellulose (BC) is an alternative nanostructured biomaterial to be utilized for a wide range of biomedical applications. Because of its low bioactivity, which restricted its practical application, collagen and collagen hydrolysate were usually composited into BC. It is necessary to develop a new method to generate covalent bonds between collagen and cellulose to improve the immobilization of collagen on BC. This study describes a facile dialdehyde BC/collagen peptide nanocomposite. BC was oxidized into dialdehyde bacterial cellulose (DBC) by regioselective oxidation, and then composited with collagen peptide (Col-p) via covalent bonds to form Schiff's base type compounds, which was demonstrated by the results of microstructures, contact angle, Col-p content, and peptide-binding ratio. The peptide-binding ratio was further affected by the degree of oxidation, pH value, and zeta potential. In vitro desorption measurement of Col-p suggested a controlled release mechanism of the nanocomposite. Cell tests indicated that the prepared DBC/Col-p composite was bioactive and suitable for cell adhesion and attachment. This work demonstrates that the DBC/Col-p composite is a promising material for tissue engineering and regeneration.
C1 [Wen, Xiaoxiao; Zheng, Yudong; Wang, Lu-Ning; Yuan, Zhenya] Univ Sci & Technol Beijing, Sch Mat Sci & Engn, Beijing 100083, Peoples R China.
   [Wu, Jian] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Suzhou, Peoples R China.
   [Peng, Jiang; Meng, Haoye] Chinese Peoples Liberat Army Gen Hosp, Inst Orthoped, Beijing, Peoples R China.
RP Zheng, YD (reprint author), Univ Sci & Technol Beijing, Sch Mat Sci & Engn, 30 Xueyuan Rd, Beijing 100083, Peoples R China.
EM zhengyudong@mater.ustb.edu.cn
FU National Natural Science Foundation of China [51473019, 51273021];
   National Science and Technology Support Project of China [2011BAK15B04];
   National Basic Research Program of China [2014CB542201]
FX This study is financially supported by the National Natural Science
   Foundation of China Project (Grant number 51473019 and Grant number
   51273021), the National Science and Technology Support Project of China
   (Grant number 2011BAK15B04), and the National Basic Research Program of
   China (Grant number 2014CB542201).
CR Acevedo-Jake AM, 2015, BIOMACROMOLECULES, V16, P145, DOI 10.1021/bm501281a
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   BOWES JH, 1968, BIOCHIM BIOPHYS ACTA, V168, P341, DOI 10.1016/0005-2795(68)90156-6
   BUBNIS WA, 1992, ANAL BIOCHEM, V207, P129, DOI 10.1016/0003-2697(92)90513-7
   Cai ZJ, 2011, J APPL POLYM SCI, V120, P2938, DOI 10.1002/app.33318
   CASSEL JM, 1949, J RES NAT BUR STAND, V42, P557, DOI 10.6028/jres.042.047
   Changez M, 2003, BIOMATERIALS, V24, P527, DOI 10.1016/S0142-9612(02)00364-2
   Cordova A, 2002, J AM CHEM SOC, V124, P1866, DOI 10.1021/ja017833p
   Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1
   d'Ayala GG, 2008, MOLECULES, V13, P2069, DOI 10.3390/molecules13092069
   Draye JP, 1998, BIOMATERIALS, V19, P1677, DOI 10.1016/S0142-9612(98)00049-0
   Dugan JM, 2013, NANOMEDICINE-UK, V8, P287, DOI [10.2217/NNM.12.211, 10.2217/nnm.12.211]
   EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441
   Fathima NN, 2004, INT J BIOL MACROMOL, V34, P241, DOI 10.1016/j.ijbiomac.2004.05.004
   Fernandes R, 2006, BIOCHEM MOL BIOL EDU, V34, P294, DOI 10.1002/bmb.2006.494034042636
   Fuchs D, 2006, IND ENG CHEM RES, V45, P6578, DOI 10.1021/ie0602097
   Honary S, 2013, TROP J PHARM RES, V12, P255, DOI 10.4314/tjpr.v12i2.19
   JACKSON DS, 1957, BIOCHIM BIOPHYS ACTA, V26, P638, DOI 10.1016/0006-3002(57)90112-9
   Jung Y, 2012, J TISSUE ENG REGEN M, V6, P227
   Kanth SV, 2009, PROCESS BIOCHEM, V44, P869, DOI 10.1016/j.procbio.2009.04.008
   Kim UJ, 2000, BIOMACROMOLECULES, V1, P488, DOI 10.1021/bm0000337
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Larraneta E, 2014, J PHARM SCI-US, V103, P197, DOI 10.1002/jps.23774
   Lin N, 2014, EUR POLYM J, V59, P302, DOI 10.1016/j.eurpolymj.2014.07.025
   Liu Y, 2011, J BIOMED MATER RES A, V99A, P485, DOI 10.1002/jbm.a.33209
   Luan JB, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/6/065006
   Luo HL, 2008, MATER CHEM PHYS, V110, P193, DOI 10.1016/j.matchemphys.2008.01.040
   Martinez H, 2012, J BIOMED MATER RES A, V100A, P948, DOI 10.1002/jbm.a.34035
   Mitsumori S, 2006, J AM CHEM SOC, V128, P1040, DOI 10.1021/ja056984f
   OLIVER RF, 1980, BRIT J EXP PATHOL, V61, P544
   Patil S, 2007, BIOMATERIALS, V28, P4600, DOI 10.1016/j.biomaterials.2007.07.029
   Paul DR, 2011, INT J PHARMACEUT, V418, P13, DOI 10.1016/j.ijpharm.2010.10.037
   Pretsch E., 2009, STRUCTURE DETERMINAT
   Rezwan K, 2004, LANGMUIR, V20, P10055, DOI 10.1021/la048459k
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Salgin S, 2012, INT J ELECTROCHEM SC, V7, P12404
   Saska S, 2012, J MATER CHEM, V22, P22102, DOI 10.1039/c2jm33762b
   Shebani AN, 2008, THERMOCHIM ACTA, V471, P43, DOI 10.1016/j.tca.2008.02.020
   Siepmann J, 2011, INT J PHARMACEUT, V418, P6, DOI 10.1016/j.ijpharm.2011.03.051
   SINGH M, 1982, BIOMATERIALS, V3, P16, DOI 10.1016/0142-9612(82)90055-2
   SUH J, 1994, BIOORG CHEM, V22, P318, DOI 10.1006/bioo.1994.1025
   Tan X, 2012, EXPERT OPIN DRUG DEL, V9, P1263, DOI 10.1517/17425247.2012.711756
   Wu J, 2014, RSC ADV, V4, P3998, DOI 10.1039/c3ra45407j
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yu SM, 2011, SOFT MATTER, V7, P7927, DOI 10.1039/c1sm05329a
NR 46
TC 10
Z9 12
U1 4
U2 56
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2015
VL 10
BP 4623
EP 4637
DI 10.2147/IJN.S84452
PG 15
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA CN2XC
UT WOS:000358284900001
PM 26229466
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Wang, HY
   Jia, HR
   Lu, XL
   Chen, B
   Zhou, GX
   He, NY
   Chen, Z
   Wu, FG
AF Wang, Hong-Yin
   Jia, Hao-Ran
   Lu, Xiaolin
   Chen, Bo
   Zhou, Gaoxin
   He, Nongyue
   Chen, Zhan
   Wu, Fu-Gen
TI Imaging plasma membranes without cellular internalization: multisite
   membrane anchoring reagents based on glycol chitosan derivatives
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID IN-VIVO; POLYMERIC NANOPARTICLES; DNA HYBRIDIZATION; FLUORESCENT-PROBE;
   SERUM-ALBUMIN; LIVING CELLS; SURFACE; OLIGONUCLEOTIDES; ASSEMBLIES;
   ADHESION
AB Plasma membrane imaging has received substantial attention due to its capability for dynamically tracing significant biological processes including cell trafficking, vesicle transportation, apoptosis, etc. However, cellular internalization of staining molecules poses challenges to the development of fluorescent dyes to specifically label plasma membranes rather than intracellular organelles. In this work, glycol chitosan, a multifunctional biomaterial derived from natural polymers, was used for the first time to image the plasma membranes based on a strategy of multisite membrane anchoring. A glycol chitosan derivative, glycol chitosan-cholesterol-FITC (Chito-Chol-FITC), was synthesized by using glycol chitosan as the backbone, and PEG-cholesterols and FITC molecules as side chains. The cholesterol groups and FITC molecules serve as hydrophobic anchoring units and fluorescent units, respectively. Benefitting from the strategy, this molecular probe could rapidly stain the cell membrane within 5 min as well as effectively restrain the cellular uptake process-it could tolerate an incubation time of 6 h without substantial cellular internalization. Its imaging performance far exceeds that of the current commercial plasma membrane imaging reagents based on small molecules (such as DiD and FM families), which will be easily internalized by the cells within 10-15 min. The present work shows the biomacromolecular assembly of the glycol chitosan derivative on the cell surface, which may shed new light on the interactions of biomaterials with biological systems. Besides, the multisite membrane anchoring strategy developed herein also provides a novel platform for future cell surface engineering studies.
C1 [Wang, Hong-Yin; Jia, Hao-Ran; Lu, Xiaolin; Chen, Bo; Zhou, Gaoxin; He, Nongyue; Wu, Fu-Gen] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
   [Chen, Zhan] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
RP Wu, FG (reprint author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
EM wufg@seu.edu.cn
RI Wu, Fu-Gen/B-1444-2009; Chen, Zhan/G-8312-2016; Wang,
   Hong-Yin/C-1423-2014
OI Wu, Fu-Gen/0000-0003-1773-2868; Chen, Zhan/0000-0001-8687-8348; 
FU National Key Basic Research Program of China (973 Program)
   [2010CB933903]; National Natural Science Foundation of China [21303017];
   Fundamental Research Funds for the Central Universities [2242014K10010];
   Scientific Research Foundation of Graduate School of Southeast
   University [YBJJ1412]; Graduate Students' Scientific Research Innovation
   Project of Jiangsu Province Ordinary University [CXZZ13 0122];
   University of Michigan
FX This work was supported by grants from the National Key Basic Research
   Program of China (973 Program) (No. 2010CB933903), the National Natural
   Science Foundation of China (21303017), the Fundamental Research Funds
   for the Central Universities (2242014K10010), the Scientific Research
   Foundation of Graduate School of Southeast University (YBJJ1412), and
   Graduate Students' Scientific Research Innovation Project of Jiangsu
   Province Ordinary University (No. CXZZ13 0122). ZC thanks the University
   of Michigan for supporting his sabbatical.
CR Altman MO, 2013, SCI REP-UK, V3, DOI [10.1038/srep03343, 10.1038/srep03343(2013)]
   Benkoski JJ, 2005, J PHYS CHEM B, V109, P9773, DOI 10.1021/jp044947p
   Borisenko G. G., 2008, NUCLEIC ACIDS RES, V37, pe28
   Bunge A, 2007, LANGMUIR, V23, P4455, DOI 10.1021/la063188u
   Chanana M, 2005, NANO LETT, V5, P2605, DOI 10.1021/nl0521219
   Chandra RA, 2006, ANGEW CHEM INT EDIT, V45, P896, DOI 10.1002/ANIE.200502421
   Chen MM, 2011, CARBOHYD POLYM, V84, P1244, DOI 10.1016/j.carbpol.2011.01.012
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Fakhrullin RF, 2012, CHEM SOC REV, V41, P4189, DOI 10.1039/c2cs15264a
   Gartner ZJ, 2009, P NATL ACAD SCI USA, V106, P4606, DOI 10.1073/pnas.0900717106
   Gauthier NC, 2011, P NATL ACAD SCI USA, V108, P14467, DOI 10.1073/pnas.1105845108
   Germain M, 2006, BIOSENS BIOELECTRON, V21, P1566, DOI 10.1016/j.bios.2005.07.011
   Heek T, 2013, BIOCONJUGATE CHEM, V24, P153, DOI 10.1021/bc3005655
   Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050
   Hsiao SC, 2009, LANGMUIR, V25, P6985, DOI 10.1021/la900150n
   Inui O, 2010, ACS APPL MATER INTER, V2, P1514, DOI 10.1021/am100134v
   Jakobsen U, 2008, J AM CHEM SOC, V130, P10462, DOI 10.1021/ja8030054
   Jeong JH, 2013, J AM CHEM SOC, V135, P8770, DOI 10.1021/ja400636d
   Kamitani R, 2009, CHEMBIOCHEM, V10, P230, DOI 10.1002/cbic.200800621
   Kawamura R, 2013, LANGMUIR, V29, P6429, DOI 10.1021/la4012229
   Ke GL, 2014, ACS APPL MATER INTER, V6, P15329, DOI 10.1021/am503818n
   Kitamura N, 2013, BIOORGAN MED CHEM, V21, P7175, DOI 10.1016/j.bmc.2013.08.063
   Koo CK, 2009, INORG CHEM, V48, P7501, DOI 10.1021/ic9007679
   Kreder R, 2015, RSC ADV, V5, P22899, DOI 10.1039/c4ra16225k
   Krol S, 2006, NANO LETT, V6, P1933, DOI 10.1021/nl061049r
   Li M, 2014, CHEM-ASIAN J, V9, P3121, DOI 10.1002/asia.201402711
   Li N, 2008, BRAIN RES, V1215, P11, DOI 10.1016/j.brainres.2007.09.095
   Li XM, 2012, COLLOID SURFACE B, V92, P136, DOI 10.1016/j.colsurfb.2011.11.030
   Liu HP, 2011, ANGEW CHEM INT EDIT, V50, P7052, DOI 10.1002/anie.201101266
   Liu HP, 2010, CHEM-EUR J, V16, P3791, DOI 10.1002/chem.200901546
   Liu JS, 2012, CELL REP, V2, P1461, DOI 10.1016/j.celrep.2012.08.037
   Liu JS, 2012, TRENDS CELL BIOL, V22, P683, DOI 10.1016/j.tcb.2012.09.004
   Ma XC, 2014, J AM CHEM SOC, V136, P17734, DOI 10.1021/ja511656q
   Matsuda M, 2014, BIOCONJUGATE CHEM, V25, P2134, DOI 10.1021/bc500465j
   Mercier R, 2013, CELL, V152, P997, DOI 10.1016/j.cell.2013.01.043
   Luan NM, 2013, BIOMATERIALS, V34, P5019, DOI 10.1016/j.biomaterials.2013.03.041
   Palte MJ, 2012, J AM CHEM SOC, V134, P6218, DOI 10.1021/ja2106477
   Parveen S, 2008, J DRUG TARGET, V16, P108, DOI [10.1080/10611860701794353, 10.1080/10611860701794353 ]
   Patwa A, 2011, CHEM SOC REV, V40, P5844, DOI 10.1039/c1cs15038c
   Pereira P, 2013, MACROMOL BIOSCI, V13, P1369, DOI 10.1002/mabi.201300123
   Pfeiffer I, 2004, J AM CHEM SOC, V126, P10224, DOI 10.1021/ja048514b
   Qiu LP, 2014, J AM CHEM SOC, V136, P13090, DOI 10.1021/ja5047389
   Rabuka D, 2008, J AM CHEM SOC, V130, P5947, DOI 10.1021/ja710644g
   RAGNARSON B, 1992, HISTOCHEMISTRY, V97, P329, DOI 10.1007/BF00270034
   Ralston KS, 2014, NATURE, V508, P526, DOI 10.1038/nature13242
   Sakurai K, 2013, BIOMATERIALS, V34, P361, DOI 10.1016/j.biomaterials.2012.09.080
   Selden NS, 2012, J AM CHEM SOC, V134, P765, DOI 10.1021/ja2080949
   Shi GX, 2014, ADV HEALTHC MATER, V3, P142, DOI 10.1002/adhm.201300084
   Shim SH, 2012, P NATL ACAD SCI USA, V109, P13978, DOI 10.1073/pnas.1201882109
   Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682
   Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053
   Teramura Y, 2010, SOFT MATTER, V6, P1081, DOI 10.1039/b913621e
   Tomita U, 2013, BIOTECHNOL BIOENG, V110, P2785, DOI 10.1002/bit.24933
   Veerabadran NG, 2007, MACROMOL BIOSCI, V7, P877, DOI 10.1002/mabi.200700061
   Wang B, 2014, ADV MATER, V26, P2371, DOI 10.1002/adma.201304593
   Wang B, 2013, POLYM CHEM-UK, V4, P5212, DOI 10.1039/c3py00097d
   Wang YS, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/14/145101
   Weber RJ, 2014, BIOMACROMOLECULES, V15, P4621, DOI 10.1021/bm501467h
   Wong Tin W, 2009, Recent Pat Drug Deliv Formul, V3, P8
   Xiong XL, 2013, ANGEW CHEM INT EDIT, V52, P1472, DOI 10.1002/anie.201207063
   Yhee JY, 2014, J CONTROL RELEASE, V193, P202, DOI 10.1016/j.jconrel.2014.05.009
   Yu JM, 2008, EUR POLYM J, V44, P555, DOI 10.1016/j.eurpolymj.2008.01.013
   Yu JM, 2009, J PHARM PHARMACOL, V61, P713, DOI [10.1211/jpp/61.06.0003, 10.1211/jpp.61.06.0003]
   Zhang CQ, 2014, ACS APPL MATER INTER, V6, P8971, DOI 10.1021/am5025897
   Zhang WD, 2013, BIOMATERIALS, V34, P6495, DOI 10.1016/j.biomaterials.2013.04.030
   Zhang XD, 2012, BIOMATERIALS, V33, P6408, DOI 10.1016/j.biomaterials.2012.05.047
   Zhang XF, 2014, ACS APPL MATER INTER, V6, P12372, DOI 10.1021/am503849c
   Zhang ZD, 2014, MOL CELL BIOCHEM, V385, P79, DOI 10.1007/s11010-013-1816-2
   Zhu CL, 2011, CHEM COMMUN, V47, P5524, DOI 10.1039/c0cc05158f
NR 69
TC 15
Z9 15
U1 4
U2 52
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 30
BP 6165
EP 6173
DI 10.1039/c5tb00930h
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CN3UC
UT WOS:000358351400004
DA 2018-10-19
ER

PT J
AU Kai, D
   Jiang, S
   Low, ZW
   Loh, XJ
AF Kai, Dan
   Jiang, Shan
   Low, Zhi Wei
   Loh, Xian Jun
TI Engineering highly stretchable lignin-based electrospun nanofibers for
   potential biomedical applications
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID THERMAL-PROPERTIES; MECHANICAL-PROPERTIES; PHYSICAL-PROPERTIES;
   POLYPROPYLENE COMPOSITES; POLYMER COMPOSITES; GRAFT-COPOLYMERS;
   STEM-CELLS; POLYETHYLENE; DELIVERY; POLY(DMAEMA-CO-PPGMA)
AB Lignin, one of the most abundant biopolymers on Earth, has been recognized as a renewable alternative to traditional petroleum-based plastics. The integration of lignin with synthetic and engineering plastics is an important approach to develop sustainable polymers. However, it is challenging to blend lignin with other polymers due to its brittle nature and poor dispersion in many composites. In order to improve the miscibility and compatibility of lignin with other plastics, a series of poly(methyl methacrylate) (PMMA) grafted lignin copolymers were prepared from atom transfer radical polymerization. The chain length of PMMA oligomers and glass transition temperature of the lignin copolymers was controlled by varying the lignin: methyl methacrylate ratio. The lignin mass fractions in the copolymers varied from 5.6% to 46.1%. These lignin-PMMA copolymers were further blended with poly(e-caprolactone) (PCL) and engineered into nanofibrous composites by electrospinning. Tensile test and dynamical mechanical analysis showed that the incorporation of lignin-PMMA copolymers significantly improved the tensile strength, Young's modulus, and storage modulus of the resulting nanofibrous composites. The length of the PMMA chain played a crucial role in the miscibility of lignin in PCL, and therefore enhanced the stiffness and ultimate elongation of the resulting nanofibers. Cell culture studies suggested that these PCL/lignin-PMMA nanofibers were biocompatible and promoted the proliferation, attachment and interactions of human dermal fibroblasts. With reinforced mechanical properties and good biocompatibility, these green and stretchable electrospun nanofibers are potentially useful as biomaterial substrates for biomedical applications.
C1 [Kai, Dan; Jiang, Shan; Loh, Xian Jun] ASTAR, IMRE, Singapore 117602, Singapore.
   [Low, Zhi Wei; Loh, Xian Jun] Natl Univ Singapore, Dept Mat Sci & Engn, Singapore 117576, Singapore.
   [Loh, Xian Jun] Singapore Eye Res Inst, Singapore 168751, Singapore.
RP Kai, D (reprint author), ASTAR, IMRE, 3 Res Link, Singapore 117602, Singapore.
EM kaid@imre.a-star.edu.sg; lohxj@imre.a-star.edu.sg
OI Loh, Xian Jun/0000-0001-8118-6502
FU Institute of Materials Research and Engineering (IMRE); A*STAR (Agency
   for Science, Technology and Research), Singapore; Science and
   Engineering Research Council (SERC) Personal Care Program
FX This work was supported by the Institute of Materials Research and
   Engineering (IMRE), A*STAR (Agency for Science, Technology and
   Research), Singapore, and funded by the Science and Engineering Research
   Council (SERC) Personal Care Program.
CR Ago M, 2012, BIOMACROMOLECULES, V13, P918, DOI 10.1021/bm201828g
   Alexy P, 2000, POLYMER, V41, P4901, DOI 10.1016/S0032-3861(99)00714-4
   Ashammakhi N, 2007, J NANOSCI NANOTECHNO, V7, P862, DOI 10.1166/jnn.2007.485
   Aussawasathien D, 2005, SYNTHETIC MET, V154, P37, DOI 10.1016/j.synthmet.2005.07.018
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Chen F, 2011, POLYM COMPOSITE, V32, P1019, DOI 10.1002/pc.21087
   Chen XY, 2015, CHEM COMMUN, V51, P487, DOI 10.1039/c4cc08681c
   Chung YL, 2013, ACS SUSTAIN CHEM ENG, V1, P1231, DOI 10.1021/sc4000835
   Cui CZ, 2013, BIORESOURCES, V8, P864
   Gregorova A, 2005, WOOD RES-SLOVAKIA, V50, P41
   Hilburg SL, 2014, POLYMER, V55, P995, DOI 10.1016/j.polymer.2013.12.070
   HUANG YF, 1992, J APPL POLYM SCI, V45, P71, DOI 10.1002/app.1992.070450108
   Jankovic A, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5333-y
   Kai D., 2012, NANOTECHNOLOGY, V23, P10
   Kai D, 2014, ACTA BIOMATER, V10, P2727, DOI 10.1016/j.actbio.2014.02.030
   Kai D, 2013, BIOTECHNOL J, V8, P59, DOI 10.1002/biot.201200249
   Kai D, 2011, J BIOMED MATER RES A, V99A, P376, DOI 10.1002/jbm.a.33200
   Kai D, 2011, J BIOMED MATER RES B, V98B, P379, DOI 10.1002/jbm.b.31862
   Kanani AG, 2011, J NANOMATER, DOI 10.1155/2011/724153
   Kim YS, 2010, BIOMACROMOLECULES, V11, P981, DOI 10.1021/bm901455p
   Kriegel C, 2008, CRIT REV FOOD SCI, V48, P775, DOI 10.1080/10408390802241325
   Laurichesse S, 2014, PROG POLYM SCI, V39, P1266, DOI 10.1016/j.progpolymsci.2013.11.004
   Li ZB, 2015, CHEM SOC REV, V44, P2865, DOI 10.1039/c5cs00089k
   Lin ZF, 2013, BIOMACROMOLECULES, V14, P2206, DOI 10.1021/bm4003442
   Loh XJ, 2015, CHEM COMMUN, V51, P10815, DOI 10.1039/c5cc03686k
   Loh XJ, 2013, MAT SCI ENG C-MATER, V33, P4545, DOI 10.1016/j.msec.2013.07.011
   Loh XJ, 2013, J APPL POLYM SCI, V127, P992, DOI 10.1002/app.37530
   Loh XJ, 2009, MACROMOL BIOSCI, V9, P1069, DOI 10.1002/mabi.200900081
   Loh XJ, 2009, SOFT MATTER, V5, P2937, DOI 10.1039/b904171k
   Lora JH, 2002, J POLYM ENVIRON, V10, P39, DOI 10.1023/A:1021070006895
   Mai C, 1999, APPL MICROBIOL BIOT, V51, P527, DOI 10.1007/s002530051428
   Mai C, 2000, ENZYME MICROB TECH, V27, P167, DOI 10.1016/S0141-0229(00)00214-3
   MEISTER JJ, 1992, MACROMOLECULES, V25, P611, DOI 10.1021/ma00028a020
   Mohanty S, 2006, COMPOS SCI TECHNOL, V66, P538, DOI 10.1016/j.compscitech.2005.06.014
   Ouyang WZ, 2012, J POLYM ENVIRON, V20, P1, DOI 10.1007/s10924-011-0359-4
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Poursorkhabi V., 2015, J APPL POLYM SCI, V132, P9
   Pucciariello R, 2004, POLYMER, V45, P4159, DOI 10.1016/j.polymer.2004.03.098
   Qin XH, 2012, J THERM ANAL CALORIM, V107, P1007, DOI 10.1007/s10973-011-1640-4
   Sailaja RRN, 2010, MATER DESIGN, V31, P4369, DOI 10.1016/j.matdes.2010.03.046
   Sailaja RRN, 2005, POLYM INT, V54, P1589, DOI 10.1002/pi.1864
   Saito T, 2013, RSC ADV, V3, P21832, DOI 10.1039/c3ra44794d
   Saito T, 2012, GREEN CHEM, V14, P3295, DOI 10.1039/c2gc35933b
   Subbiah T, 2005, J APPL POLYM SCI, V96, P557, DOI 10.1002/app.21481
   Tajvidi M, 2006, J APPL POLYM SCI, V101, P4341, DOI 10.1002/app.24289
   Thakur VK, 2014, ACS SUSTAIN CHEM ENG, V2, P1072, DOI 10.1021/sc500087z
   Tortora M, 2014, BIOMACROMOLECULES, V15, P1634, DOI 10.1021/bm500015j
   Ugartondo V, 2008, BIORESOURCE TECHNOL, V99, P6683, DOI 10.1016/j.biortech.2007.11.038
   Van der Schueren L, 2011, EUR POLYM J, V47, P1256, DOI 10.1016/j.eurpolymj.2011.02.025
   Viswanathan P, 2015, BIOMACROMOLECULES, V16, P66, DOI 10.1021/bm500671j
   Wang JF, 2011, J POLYM SCI POL CHEM, V49, P3728, DOI 10.1002/pola.24809
   Wang SX, 2013, ACS APPL MATER INTER, V5, P12275, DOI 10.1021/am4043867
   Xu X, 2014, MACROMOL RES, V22, P1084, DOI 10.1007/s13233-014-2161-3
   Ye HY, 2015, RSC ADV, V5, P48720, DOI 10.1039/c5ra08222f
NR 54
TC 60
Z9 60
U1 5
U2 57
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 30
BP 6194
EP 6204
DI 10.1039/c5tb00765h
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA CN3UC
UT WOS:000358351400007
DA 2018-10-19
ER

PT J
AU Gorka, AP
   Nani, RR
   Schnermann, MJ
AF Gorka, Alexander P.
   Nani, Roger R.
   Schnermann, Martin J.
TI Cyanine polyene reactivity: scope and biomedical applications
SO ORGANIC & BIOMOLECULAR CHEMISTRY
LA English
DT Review
ID INFRARED FLUORESCENT-PROBES; BIOMATERIAL-ASSOCIATED INFLAMMATION; DYE
   LABELING REAGENTS; IN-VIVO; LIVING CELLS; HYDROGEN-SULFIDE; ORGANIC
   FLUOROPHORES; PHOTOACTIVATABLE FLUOROPHORES; IMPROVED PHOTOSTABILITY;
   NIR FLUORESCENCE
AB Cyanines are indispensable fluorophores that form the chemical basis of many fluorescence-based applications. A feature that distinguishes cyanines from other common fluorophores is an exposed polyene linker that is both crucial to absorption and emission and subject to covalent reactions that dramatically alter these optical properties. Over the past decade, reactions involving the cyanine polyene have been used as foundational elements for a range of biomedical techniques. These include the optical sensing of biological analytes, super-resolution imaging, and near-IR light-initiated uncaging. This review surveys the chemical reactivity of the cyanine polyene and the biomedical methods enabled by these reactions. The overarching goal is to highlight the multifaceted nature of cyanine chemistry and biology, as well as to point out the key role of reactivity-based insights in this promising area.
C1 [Gorka, Alexander P.; Nani, Roger R.; Schnermann, Martin J.] NCI, Biol Chem Lab, Ctr Canc Res, Frederick, MD 21702 USA.
RP Schnermann, MJ (reprint author), NCI, Biol Chem Lab, Ctr Canc Res, Frederick, MD 21702 USA.
EM martin.schnermann@nih.gov
OI Schnermann, Martin/0000-0002-0503-0116
FU Intramural Research Program of the National Institutes of Health; Center
   for Cancer Research; National Cancer Institute, National Institutes of
   Health
FX We thank Rolf Swenson (NIH, NHLBI) and members of the Chemical Biology
   Laboratory for helpful suggestions. This work was supported by the
   Intramural Research Program of the National Institutes of Health, Center
   for Cancer Research, and the National Cancer Institute, National
   Institutes of Health.
CR Alford R, 2009, MOL IMAGING, V8, P341, DOI 10.2310/7290.2009.00031
   Altman RB, 2012, NAT METHODS, V9, P626, DOI 10.1038/nmeth0612-626b
   Bak DW, 2015, MOL BIOSYST, V11, P678, DOI 10.1039/c4mb00571f
   Bates M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108101
   Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598
   Berbasova T, 2013, J AM CHEM SOC, V135, P16111, DOI 10.1021/ja404900k
   Brieke C, 2012, ANGEW CHEM INT EDIT, V51, P8446, DOI 10.1002/anie.201202134
   Busch D. R., 2010, MOL IMAGING PRINCIPL, P214
   BYERS GW, 1976, PHOTOCHEM PHOTOBIOL, V23, P37, DOI 10.1111/j.1751-1097.1976.tb06768.x
   Chen GW, 2012, CHEM COMMUN, V48, P2949, DOI 10.1039/c2cc17617c
   Chen P, 1998, DYES PIGMENTS, V37, P213, DOI 10.1016/S0143-7208(97)00059-4
   Chen XQ, 2011, CHEM SOC REV, V40, P4783, DOI 10.1039/c1cs15037e
   Chen Y, 2013, INT J BIOL MACROMOL, V52, P52, DOI 10.1016/j.ijbiomac.2012.09.005
   Chozinski TJ, 2014, FEBS LETT, V588, P3603, DOI 10.1016/j.febslet.2014.06.043
   Crivat G, 2012, TRENDS BIOTECHNOL, V30, P8, DOI 10.1016/j.tibtech.2011.08.002
   Davies SS, 2014, CHEM PHYS LIPIDS, V181, P1, DOI 10.1016/j.chemphyslip.2014.03.002
   Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]
   Dempsey GT, 2009, J AM CHEM SOC, V131, P18192, DOI 10.1021/ja904588g
   Deniz E, 2012, J PHYS CHEM C, V116, P6058, DOI 10.1021/jp211796p
   Dore TM, 2011, NEUROMETHODS, V55, P57, DOI 10.1007/978-1-61779-031-7_4
   Engel E, 2008, INVEST OPHTH VIS SCI, V49, P1777, DOI 10.1167/iovs.07-0911
   ERNST LA, 1989, CYTOMETRY, V10, P3, DOI 10.1002/cyto.990100103
   FABIAN J, 1992, CHEM REV, V92, P1197, DOI 10.1021/cr00014a003
   Fan JL, 2013, CHEM SOC REV, V42, P29, DOI 10.1039/c2cs35273g
   Farina M, 2011, LIFE SCI, V89, P555, DOI 10.1016/j.lfs.2011.05.019
   Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007
   Gerdes MJ, 2013, P NATL ACAD SCI USA, V110, P11982, DOI 10.1073/pnas.1300136110
   Goodson P, 2012, AM J PHYSIOL-LUNG C, V302, pL410, DOI 10.1152/ajplung.00260.2011
   Gorka AP, 2014, J AM CHEM SOC, V136, P14153, DOI 10.1021/ja5065203
   Grimm JB, 2013, PROG MOL BIOL TRANSL, V113, P1, DOI 10.1016/B978-0-12-386932-6.00001-6
   Guo ZQ, 2014, CHEM SOC REV, V43, P16, DOI 10.1039/c3cs60271k
   Guo ZQ, 2012, CHEM SCI, V3, P2760, DOI 10.1039/c2sc20540h
   Guo Z, 2010, CHEM-EUR J, V16, P14424, DOI 10.1002/chem.201001769
   Han JY, 2010, CHEM REV, V110, P2709, DOI 10.1021/cr900249z
   Heilemann M, 2005, J AM CHEM SOC, V127, P3801, DOI 10.1021/ja044686x
   Henary M, 2008, TOP HETEROCYCL CHEM, V14, P221, DOI 10.1007/7081_2008_111
   Hilderbrand SA, 2008, BIOCONJUGATE CHEM, V19, P1635, DOI 10.1021/bc800188p
   Hossion AML, 2013, ACS MED CHEM LETT, V4, P124, DOI 10.1021/ml3003617
   Hu C, 2013, ORG LETT, V15, P4022, DOI 10.1021/ol401838p
   Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014
   Jiang MY, 2008, J AM CHEM SOC, V130, P4236, DOI 10.1021/ja800140g
   Jing CR, 2011, ACCOUNTS CHEM RES, V44, P784, DOI 10.1021/ar200099f
   Kanofsky JR, 2000, PHOTOCHEM PHOTOBIOL, V71, P361, DOI 10.1562/0031-8655(2000)071<0361:SAERFQ>2.0.CO;2
   Karton-Lifshin N, 2013, ORG BIOMOL CHEM, V11, P2903, DOI 10.1039/c3ob27385g
   Karton-Lifshin N, 2012, J AM CHEM SOC, V134, P20412, DOI 10.1021/ja308124q
   Karton-Lifshin N, 2011, J AM CHEM SOC, V133, P10960, DOI 10.1021/ja203145v
   Kim HN, 2012, CHEM SOC REV, V41, P3210, DOI 10.1039/c1cs15245a
   Kim JY, 2011, J CONTROL RELEASE, V156, P398, DOI 10.1016/j.jconrel.2011.07.017
   Kim YM, 2007, BIOORG MED CHEM LETT, V17, P5054, DOI 10.1016/j.bmcl.2007.07.026
   Kisin-Finfer E, 2014, BIOORG MED CHEM LETT, V24, P2453, DOI 10.1016/j.bmcl.2014.04.022
   Kundu K, 2010, ANGEW CHEM INT EDIT, V49, P6134, DOI 10.1002/anie.201002228
   Kundu K, 2009, ANGEW CHEM INT EDIT, V48, P299, DOI 10.1002/anie.200804851
   Lee H, 2013, PHOTOCHEM PHOTOBIOL, V89, P326, DOI 10.1111/php.12009
   Lee H, 2011, BIOCONJUGATE CHEM, V22, P777, DOI 10.1021/bc100584d
   Lee YJ, 2001, J CELL SCI, V114, P677
   LENHARD JR, 1993, J PHYS CHEM-US, V97, P8269, DOI 10.1021/j100133a025
   LEPAJA S, 1983, Z NATURFORSCH A, V38, P56
   Levitus M, 2011, Q REV BIOPHYS, V44, P123, DOI 10.1017/S0033583510000247
   Li P, 2008, ANALYST, V133, P1409, DOI 10.1039/b802836b
   Li YH, 2015, J AM CHEM SOC, V137, P6407, DOI 10.1021/jacs.5b04097
   Lim SY, 2014, J AM CHEM SOC, V136, P7018, DOI 10.1021/ja500962u
   Lin VS, 2015, CHEM SOC REV, V44, P4596, DOI 10.1039/c4cs00298a
   Lippert AR, 2014, J INORG BIOCHEM, V133, P136, DOI 10.1016/j.jinorgbio.2013.10.010
   Lou ZR, 2013, ANALYST, V138, P6291, DOI 10.1039/c3an00198a
   Luo SL, 2011, BIOMATERIALS, V32, P7127, DOI 10.1016/j.biomaterials.2011.06.024
   Magalotti S, 2013, MOL IMAGING BIOL, V15, P423, DOI 10.1007/s11307-013-0614-2
   Maity D, 2013, ORG BIOMOL CHEM, V11, P2098, DOI 10.1039/c2ob27138a
   Marshall Milton V, 2010, Open Surg Oncol J, V2, P12
   Marshall MV, 2010, MOL IMAGING BIOL, V12, P583, DOI 10.1007/s11307-010-0317-x
   Mishra A, 2000, CHEM REV, V100, P1973, DOI 10.1021/cr990402t
   Montserrat M., 2013, BIOCHIM BIOPHYS ACTA, V1830, P3317
   Moysan E, 2013, MOL PHARMACEUT, V10, P430, DOI 10.1021/mp300370t
   MUJUMDAR RB, 1993, BIOCONJUGATE CHEM, V4, P105, DOI 10.1021/bc00020a001
   Mustroph H, 2006, ANGEW CHEM INT EDIT, V45, P2016, DOI 10.1002/anie.200502820
   Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335
   Myochin T, 2011, J AM CHEM SOC, V133, P3401, DOI 10.1021/ja1063058
   Nani RR, 2015, ORG LETT, V17, P302, DOI 10.1021/ol503398f
   Nguyen QT, 2013, NAT REV CANCER, V13, P653, DOI 10.1038/nrc3566
   Oushiki D, 2010, J AM CHEM SOC, V132, P2795, DOI 10.1021/ja910090v
   Panigrahi M, 2012, TETRAHEDRON, V68, P781, DOI 10.1016/j.tet.2011.10.069
   Pansare VJ, 2012, CHEM MATER, V24, P812, DOI 10.1021/cm2028367
   Patonay G, 2005, APPL SPECTROSC, V59, P682, DOI 10.1366/0003702053945976
   Pu KY, 2013, ANGEW CHEM INT EDIT, V52, P10325, DOI 10.1002/anie.201303420
   Que EL, 2008, CHEM REV, V108, P1517, DOI 10.1021/cr078203u
   Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028
   Redy-Keisar O, 2014, NAT PROTOC, V9, P27, DOI 10.1038/nprot.2013.166
   Renikuntla BR, 2004, ORG LETT, V6, P909, DOI 10.1021/ol036081w
   Rotaru A, 2007, ANGEW CHEM INT EDIT, V46, P6180, DOI 10.1002/anie.200700641
   Ruebner A, 1999, P NATL ACAD SCI USA, V96, P14692, DOI 10.1073/pnas.96.26.14692
   Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929
   Samanta A, 2010, CHEM COMMUN, V46, P7406, DOI 10.1039/c0cc02366c
   Sasaki E, 2005, J AM CHEM SOC, V127, P3684, DOI 10.1021/ja042967z
   Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018
   Selvam S, 2011, BIOMATERIALS, V32, P7785, DOI 10.1016/j.biomaterials.2011.07.020
   Sengupta P, 2014, CHEM REV, V114, P3189, DOI 10.1021/cr400614m
   Sengupta P, 2012, DEV CELL, V23, P1092, DOI 10.1016/j.devcel.2012.09.022
   Shell TA, 2014, ANGEW CHEM INT EDIT, V53, P875, DOI 10.1002/anie.201308816
   Shi YM, 2013, ANALYST, V138, P1952, DOI 10.1039/c3an36807f
   Shim SH, 2012, P NATL ACAD SCI USA, V109, P13978, DOI 10.1073/pnas.1201882109
   Shiraishi Y, 2014, CHEM COMMUN, V50, P11583, DOI 10.1039/c4cc05412a
   Shuhendler AJ, 2014, NAT BIOTECHNOL, V32, P373, DOI 10.1038/nbt.2838
   Singha S, 2015, CHEM SOC REV, V44, P4367, DOI 10.1039/c4cs00328d
   Singha S, 2015, ANAL CHEM, V87, P1188, DOI 10.1021/ac503806w
   Stennett EMS, 2014, CHEM SOC REV, V43, P1057, DOI 10.1039/c3cs60211g
   STREKOWSKI L, 1992, J ORG CHEM, V57, P4578, DOI 10.1021/jo00043a009
   Strekowski L, 2004, J HETEROCYCLIC CHEM, V41, P227, DOI 10.1002/jhet.5570410213
   Strekowski L, 1996, J HETEROCYCLIC CHEM, V33, P1685, DOI 10.1002/jhet.5570330622
   Suri S, 2015, J BIOMED MATER RES A, V103, P76, DOI 10.1002/jbm.a.35162
   Swanson PA, 2011, P NATL ACAD SCI USA, V108, P8803, DOI 10.1073/pnas.1010042108
   Tang B, 2007, CHEM COMMUN, P3726, DOI 10.1039/b707173f
   Tarazi L, 1998, TALANTA, V46, P1413, DOI 10.1016/S0039-9140(98)00012-5
   Tian JW, 2011, CHEM-EUR J, V17, P6626, DOI 10.1002/chem.201100148
   Toutchkine A, 2003, J AM CHEM SOC, V125, P4132, DOI 10.1021/ja0290882
   Toutchkine A, 2007, ORG LETT, V9, P2775, DOI 10.1021/ol070780h
   Uno SN, 2014, NAT CHEM, V6, P681, DOI [10.1038/NCHEM.2002, 10.1038/nchem.2002]
   van de Linde S, 2014, CHEM SOC REV, V43, P1076, DOI 10.1039/c3cs60195a
   van der Velde JHM, 2014, J PHYS CHEM LETT, V5, P3792, DOI 10.1021/jz501874f
   van der Velde JHM, 2013, CHEMPHYSCHEM, V14, P4084, DOI 10.1002/cphc.201300785
   Vaughan JC, 2013, J AM CHEM SOC, V135, P1197, DOI 10.1021/ja3105279
   Vaughan JC, 2012, NAT METHODS, V9, P1181, DOI [10.1038/NMETH.2214, 10.1038/nmeth.2214]
   Viger ML, 2014, ACS NANO, V8, P4815, DOI 10.1021/nn500702g
   Wang BS, 2013, CHEM COMMUN, V49, P5790, DOI 10.1039/c3cc42313a
   Wang WJ, 2012, SCIENCE, V338, P1340, DOI 10.1126/science.1226135
   Wang X, 2013, CHEM SCI, V4, P2551, DOI 10.1039/c3sc50369k
   Warther D, 2010, BIOORGAN MED CHEM, V18, P7753, DOI 10.1016/j.bmc.2010.04.084
   Widengren J, 2007, J PHYS CHEM A, V111, P429, DOI 10.1021/jp0646325
   WILLIAMS CHG, 1856, T R SOC EDINBURGH, V21, P377
   Wu XJ, 2014, BIOORG MED CHEM LETT, V24, P314, DOI 10.1016/j.bmcl.2013.11.016
   Wu XM, 2015, CHEM SOC REV, V44, P4179, DOI 10.1039/c4cs00152d
   Yang YM, 2012, ANGEW CHEM INT EDIT, V51, P3125, DOI 10.1002/anie.201107919
   Yang ZH, 2012, ORG BIOMOL CHEM, V10, P5073, DOI 10.1039/c2ob25516b
   Yang Z, 2013, J AM CHEM SOC, V135, P11657, DOI 10.1021/ja405372k
   Yapici I, 2015, J AM CHEM SOC, V137, P1073, DOI 10.1021/ja506376j
   Ye YP, 2003, J AM CHEM SOC, V125, P7766, DOI 10.1021/ja034186o
   Yin J, 2015, CHEM SOC REV, V44, P4619, DOI 10.1039/c4cs00275j
   You Y, 2014, CHEM SCI, V5, P4123, DOI 10.1039/c4sc01637h
   Yuan L, 2013, CHEM SOC REV, V42, P622, DOI 10.1039/c2cs35313j
   Yuan L, 2010, CHEM COMMUN, V46, P7930, DOI 10.1039/c0cc02390f
   Zheng QS, 2014, PHOTOCHEM PHOTOBIOL, V90, P448, DOI 10.1111/php.12204
   Zheng QS, 2014, CHEM SOC REV, V43, P1044, DOI 10.1039/c3cs60237k
   Zhu DJ, 2013, ORG BIOMOL CHEM, V11, P4577, DOI 10.1039/c3ob40932e
NR 141
TC 35
Z9 35
U1 5
U2 71
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1477-0520
EI 1477-0539
J9 ORG BIOMOL CHEM
JI Org. Biomol. Chem.
PY 2015
VL 13
IS 28
BP 7584
EP 7598
DI 10.1039/c5ob00788g
PG 15
WC Chemistry, Organic
SC Chemistry
GA CN2IC
UT WOS:000358243200001
PM 26052876
DA 2018-10-19
ER

PT J
AU Rosengren-Holmberg, JP
   Andersson, J
   Smith, JR
   Alexander, C
   Alexander, MR
   Tovar, G
   Ekdahl, KN
   Nicholls, IA
AF Rosengren-Holmberg, Jenny P.
   Andersson, Jonas
   Smith, James R.
   Alexander, Cameron
   Alexander, Morgan R.
   Tovar, Guenter
   Ekdahl, Kristina N.
   Nicholls, Ian A.
TI Heparin molecularly imprinted surfaces for the attenuation of complement
   activation in blood
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID IN-VITRO MODEL; CARDIOPULMONARY BYPASS; BIOMATERIAL; COAGULATION;
   BINDING; PROTEOGLYCANS; INFLAMMATION; RECOGNITION; INHIBITION;
   STRATEGIES
AB Heparin-imprinted synthetic polymer surfaces with the ability to attenuate activation of both the complement and the coagulation system in whole blood were successfully produced. Imprinting was achieved using a template coated with heparin, a highly sulfated glycosaminoglycan known for its anticoagulant properties. The N,N'-diacryloylpiperazine-methacrylic acid copolymers were characterized using goniometry, AFM and XPS. The influence of the molecular imprinting process on morphology and template rebinding was demonstrated by radioligand binding assays. Surface hemocompatibility was evaluated using human whole blood without anticoagulants followed by measurement of complement activation markers C3a and sC5b-9 and platelet consumption as a surrogate coagulation activation marker. The observed low thrombogenicity of this copolymer combined with the attenuation of complement activation induced by the molecular imprint offer potential for the development of self-regulating surfaces with important potential clinical applications. We propose a mechanism for the observed phenomena based upon the recruitment of endogenous sulfated glycosaminoglycans with heparin-like activities.
C1 [Rosengren-Holmberg, Jenny P.; Ekdahl, Kristina N.; Nicholls, Ian A.] Linnaeus Univ, Dept Chem & Biomed Sci, Ctr Biomat Chem, SE-39182 Kalmar, Sweden.
   [Rosengren-Holmberg, Jenny P.] Swedish Natl Forens Ctr, Drugs Unit, SE-58194 Linkoping, Sweden.
   [Andersson, Jonas; Ekdahl, Kristina N.] Univ Uppsala Hosp, Clin Immunol Sect, Rudbeck Lab C5, Dept Oncol Radiol & Clin Immunol, SE-75185 Uppsala, Sweden.
   [Smith, James R.] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England.
   [Alexander, Cameron; Alexander, Morgan R.] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.
   [Tovar, Guenter] Univ Stuttgart, Inst Interfacial Engn, D-70569 Stuttgart, Germany.
   [Tovar, Guenter] Fraunhofer Inst Interfacial Engn & Biotechnol, D-70569 Stuttgart, Germany.
   [Nicholls, Ian A.] Uppsala Univ, Biomed Ctr, Dept Chem, SE-75123 Uppsala, Sweden.
RP Rosengren-Holmberg, JP (reprint author), Linnaeus Univ, Dept Chem & Biomed Sci, Ctr Biomat Chem, SE-39182 Kalmar, Sweden.
EM ian.nicholls@lnu.se
RI Nilsson Ekdahl, Kristina/B-5301-2012; Alexander, Morgan/C-2506-2009;
   Smith, James/D-2350-2011; Alexander, Cameron/N-7729-2014; Smith,
   James/F-1108-2014
OI Alexander, Morgan/0000-0001-5182-493X; Smith, James/0000-0001-8805-3788;
   Alexander, Cameron/0000-0001-8337-1875; Smith,
   James/0000-0001-8805-3788; Rosengren Holmberg, Jenny/0000-0003-2417-9175
FU Swedish Research Council (VR); Carl Tryggers Foundation; Linnaeus
   University; European Community's Seventh Framework Programme [602699];
   Engineering and Physical Sciences Research Council [EP/H005625/1]
FX This work was supported by grants from the Swedish Research Council
   (VR), Carl Tryggers Foundation, Linnaeus University and the European
   Community's Seventh Framework Programme in the projects Biodesign and
   DIREKT (no 602699). The authors thank Professors Bo Nilsson and Rolf
   Larsson (both Uppsala University, Sweden), Dr Michael J. Whitcombe
   (University of Leicester, UK) and Dr Jesper G. Wiklander (Linnaeus
   University) for helpful discussions and Ms. Kerstin Sandholm for
   technical assistance.
CR Alexander C, 2006, J MOL RECOGNIT, V19, P106, DOI 10.1002/jmr.760
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson J, 2003, J BIOMED MATER RES A, V67A, P458, DOI 10.1002/jbm.a.10104
   Baydemir G., 2014, ARTIF CELL NANOMED B, P1
   BJORK I, 1982, MOL CELL BIOCHEM, V48, P161, DOI 10.1007/BF00421226
   Cunliffe D, 2003, LANGMUIR, V19, P2888, DOI 10.1021/la026358l
   D'Souza SM, 1999, NATURE, V398, P312, DOI 10.1038/18636
   Drelich J, 1996, J COLLOID INTERF SCI, V179, P37, DOI 10.1006/jcis.1996.0186
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hamad OA, 2008, J THROMB HAEMOST, V6, P1413, DOI 10.1111/j.1538-7836.2008.03034.x
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Hoshino Y, 2008, J AM CHEM SOC, V130, P15242, DOI 10.1021/ja8062875
   Karlsson BCG, 2009, J AM CHEM SOC, V131, P13297, DOI 10.1021/ja902087t
   KODAMA K, 1987, THROMB HAEMOSTASIS, V58, P1064
   Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230
   Lappegard KT, 2004, ANN THORAC SURG, V78, P38, DOI 10.1016/j.athorascur.2004.02.005
   Larsson R., 2004, ENCY BIOMATER BIOMED, V2, P753
   Li LF, 2013, ANAL BIOCHEM, V434, P242, DOI 10.1016/j.ab.2012.12.007
   Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006
   MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P197, DOI 10.1111/j.1365-3083.1985.tb01871.x
   MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849
   Nicholls IA, 2001, BIOSEPARATION, V10, P301, DOI 10.1023/A:1021541631063
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005
   Piletsky SA, 1999, MACROMOLECULES, V32, P633, DOI 10.1021/ma9812736
   Reber D, 2008, HEART SURG FORUM, V11, pE276, DOI 10.1532/HSF98.20081024
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Sellergren B., 2001, TECHNIQUES INSTRUMEN
   Shi HQ, 1999, NATURE, V398, P593
   Svenson J, 2001, ANAL CHIM ACTA, V435, P19, DOI 10.1016/S0003-2670(00)01396-9
   Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev
   van Der Giessen W. J., 1999, CURR INTERV CARDIOL, V1, P234
   VLATAKIS G, 1993, NATURE, V361, P645, DOI 10.1038/361645a0
   Wan S, 1997, CHEST, V112, P676, DOI 10.1378/chest.112.3.676
   Yoshimi Y, 2013, ANALYST, V138, P5121, DOI 10.1039/c3an00909b
NR 39
TC 8
Z9 8
U1 0
U2 35
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2015
VL 3
IS 8
BP 1208
EP 1217
DI 10.1039/c5bm00047e
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CM8GR
UT WOS:000357937400004
PM 26222036
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Bishop, CJ
   Abubaker-Sharif, B
   Guiriba, T
   Tzeng, SY
   Green, JJ
AF Bishop, C. J.
   Abubaker-Sharif, B.
   Guiriba, T.
   Tzeng, S. Y.
   Green, J. J.
TI Gene delivery polymer structure-function relationships elucidated via
   principal component analysis
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID DNA; NANOPARTICLES; CANCER; SIRNA
AB Principal component analysis was applied to a biomaterial library of poly(beta-amino ester)s, useful for non-viral gene delivery, to elucidate chemical parameters that drive biological function. Correlative relationships and principal components were analyzed between 24 physico-chemical polymer properties and 3 cell-based functional variables in human glioblastoma cells (transfection, uptake, and viability).
C1 [Bishop, C. J.; Abubaker-Sharif, B.; Tzeng, S. Y.; Green, J. J.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Translat Tissue Engn Ctr, Baltimore, MD 21205 USA.
   [Guiriba, T.; Green, J. J.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21205 USA.
   [Green, J. J.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.
   [Green, J. J.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA.
RP Green, JJ (reprint author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Translat Tissue Engn Ctr, 400 North Broadway, Baltimore, MD 21205 USA.
EM green@jhu.edu
OI Abubaker-Sharif, Bedri/0000-0001-5003-7934
FU NIH [1R01EB016721]; NSF Research Fellowship [DGE-0707427]
FX We would like to acknowledge our funding sources: the NIH (1R01EB016721)
   and the NSF Research Fellowship awarded to CJB (DGE-0707427).
CR Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Bishop CJ, 2015, ACTA BIOMATER, V11, P393, DOI 10.1016/j.actbio.2014.09.020
   Bishop CJ, 2013, J AM CHEM SOC, V135, P6951, DOI 10.1021/ja4002376
   Bishop CJ, 2010, J HEART LUNG TRANSPL, V29, P27, DOI 10.1016/j.healun.2009.08.027
   Kamat CD, 2013, MOL CANCER THER, V12, P405, DOI 10.1158/1535-7163.MCT-12-0956
   Martinerie J, 1998, NAT MED, V4, P1173, DOI 10.1038/2667
   Sunshine JC, 2011, BIOMACROMOLECULES, V12, P3592, DOI 10.1021/bm200807s
   Tzeng SY, 2013, ADV HEALTHC MATER, V2, P468, DOI 10.1002/adhm.201200257
   Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763
NR 9
TC 11
Z9 11
U1 0
U2 14
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PY 2015
VL 51
IS 60
BP 12134
EP 12137
DI 10.1039/c5cc04417k
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA CM8LC
UT WOS:000357951400048
PM 26126593
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zhang, Y
   Cui, LL
   Chen, Y
   Zhang, H
   Zhong, J
   Sun, Y
   Shi, NQ
   Li, CL
   Kong, W
AF Zhang, Yong
   Cui, Lili
   Chen, Yan
   Zhang, Heng
   Zhong, Jian
   Sun, Yanan
   Shi, Nianqiu
   Li, Chunlei
   Kong, Wei
TI Zein-Based Nanofibres for Drug Delivery: Classes and Current
   Applications
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE Biocompatibility; biomedical application; biopolymer; immunogenicity;
   zein
ID COAXIAL ELECTROSPINNING PROCESS; FIBROUS MEMBRANES; RELEASE PROFILES;
   CROSS-LINKING; ACETIC-ACID; FIBERS; COMPOSITE; FABRICATION; DEGRADATION;
   TEMPERATURE
AB Plant proteins have been drawing increasing attention owing to their safety, abundance and relatively low cost in comparison with animal proteins. The development of plant protein-based delivery vehicles may lead to the provision of novel pharmaceutical products to patients. Zein is a class of alcohol-soluble prolamine proteins present in maize endosperm that was approved as a generally recognised as safe excipient in 1985 by the US FDA for use in pharmaceutical film coatings. Over the past few decades, numerous studies have been carried out to illustrate zein's potential for novel applications in the biomedical field. This paper reviews the present status of zein-based nanofibres, with emphasis on their fabrication and biomedical applications, particularly for drug delivery. Their benefits and limitations are also discussed to provide further insight into zein's potential as a promising biomaterial.
C1 [Zhang, Yong; Chen, Yan; Sun, Yanan; Kong, Wei] Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130012, Peoples R China.
   [Zhang, Yong; Chen, Yan; Shi, Nianqiu; Kong, Wei] Jilin Univ, Sch Life Sci, Key Lab Mol Enzymol & Engn, Minist Educ, Changchun 130012, Peoples R China.
   [Zhang, Yong; Li, Chunlei] China Shijiazhuang Pharmaceut Grp Co Ltd, State Key Lab New Pharmaceut Preparat & Excipient, Shijiazhuang 050051, Peoples R China.
   [Cui, Lili] Kings Coll London, Inst Pharmaceut Sci, Pharmaceut Biophys Grp, London SE1 9NH, England.
   [Zhang, Heng] Jilin Univ, Coll Mat Sci & Engn, Changchun 130025, Peoples R China.
   [Zhong, Jian] Natl Engn Res Ctr Nanotechnol, Shanghai 200241, Peoples R China.
   [Shi, Nianqiu] Jilin Med Coll, Sch Pharm, Dept Pharmaceut, Fengman 132013, Jilin, Peoples R China.
RP Zhang, Y (reprint author), Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Qianjin St 2699, Changchun 130012, Peoples R China.
EM zhangyongking1@gmail.com; weikong@jlu.edu.cn
RI Zhong, Jian/B-3743-2015; zhang, yong/H-2552-2013
OI Zhong, Jian/0000-0002-2475-3221; zhang, yong/0000-0001-6577-5235
FU China Postdoctoral Science Foundation [20110491321]; Hebei Provincial
   Natural Science Foundation of China-Shijiazhuang Pharmaceutical Group
   (CSPC) Foundation [C2011319001]; Fundamental Research Funds for the
   Central Universities [101832013]; Jilin Province Science and Technology
   Development Plan [20140309007YY]
FX This work was supported by the China Postdoctoral Science Foundation
   (Grant No 20110491321), Hebei Provincial Natural Science Foundation of
   China-Shijiazhuang Pharmaceutical Group (CSPC) Foundation (Grant No.
   C2011319001), Fundamental Research Funds for the Central Universities
   (Grant No. 101832013) and Jilin Province Science and Technology
   Development Plan (Grant No 20140309007YY).
CR [Anonymous], 1985, FED REGISTER, V50, P8997
   [Anonymous], 1939, Oil Paint Drug Rep, V137, P32, Patent No. [1, 316, 854, 1316854]
   [Anonymous], 1944, OIL PAINT DRUG REP, V54, P670
   Asher GN, 2013, ALTERN THER HEALTH M, V19, P20
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Brahatheeswaran D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045001
   Chakraborty S, 2009, ADV DRUG DELIVER REV, V61, P1043, DOI 10.1016/j.addr.2009.07.013
   Dhandayuthapani B., 2012, INT J BIOMATER, V2012
   Dhandayuthapani B, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/025008
   ESEN A, 1987, J CEREAL SCI, V5, P117, DOI 10.1016/S0733-5210(87)80015-2
   Formhals A., 1934, U. S. Patent, Patent No. [1,975,504, 1975504]
   Gorham J., 1821, Q J SCI LIT ART, V11, P206
   Huang WD, 2013, AAPS PHARMSCITECH, V14, P675, DOI 10.1208/s12249-013-9953-1
   Hurtado-Lopez P, 2006, J PHARM PHARMACOL, V58, P769, DOI 10.1211/jpp.58.6.0007
   Jiang HL, 2007, MACROMOL BIOSCI, V7, P517, DOI 10.1002/mabi.200600277
   Jiang QR, 2011, J BIOMAT SCI-POLYM E, V22, P1393, DOI 10.1163/092050610X508437
   Jiang QR, 2010, ACTA BIOMATER, V6, P4042, DOI 10.1016/j.actbio.2010.04.024
   Jiang YN, 2012, INT J PHARMACEUT, V438, P232, DOI 10.1016/j.ijpharm.2012.08.053
   John W.L., 2002, CEREAL CHEM, V79, P1
   Karthikeyan K, 2012, INT J PHARMACEUT, V438, P117, DOI 10.1016/j.ijpharm.2012.07.075
   Krishnan HB, 2011, J AGR FOOD CHEM, V59, P1223, DOI 10.1021/jf103613s
   Krishnan HB, 2010, J AGR FOOD CHEM, V58, P7323, DOI 10.1021/jf100927u
   Li JJ, 2013, J BIOMAT SCI-POLYM E, V24, P1923, DOI 10.1080/09205063.2013.808960
   Lin JT, 2012, ACS APPL MATER INTER, V4, P1050, DOI 10.1021/am201669z
   Lin LK, 2013, J TISSUE ENG REGEN M, V7, P994, DOI 10.1002/term.1493
   McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004
   Mellan I, 1961, BEHAV PLASTICISERS
   Miyoshi T, 2005, POLYM INT, V54, P1187, DOI 10.1002/pi.1829
   Neo YP, 2013, FOOD CHEM, V136, P1013, DOI 10.1016/j.foodchem.2012.09.010
   Nie W, 2012, MATER RES INNOV, V16, P14, DOI 10.1179/1433075X11Y.0000000013
   Nour A, 2013, DRUG DELIV TRANSL RE, V3, P542
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Rishi S, 2001, IND CROP PROD, V13, P171
   Selling GW, 2008, MACROMOL CHEM PHYSIC, V209, P1003, DOI 10.1002/macp.200700606
   Selling GW, 2007, MACROMOL CHEM PHYS, V208, P1002, DOI 10.1002/macp.200700056
   Song TY, 2010, CHINESE J POLYM SCI, V28, P171, DOI 10.1007/s10118-010-8239-2
   Sun G, 2013, NANOMED-NANOTECHNOL, V9, P829, DOI 10.1016/j.nano.2012.12.003
   THOMPSON GA, 1989, BIOESSAYS, V10, P108, DOI 10.1002/bies.950100404
   Torres-Giner S, 2008, FOOD HYDROCOLLOID, V22, P601, DOI 10.1016/j.foodhyd.2007.02.005
   Torres-Giner S, 2009, CARBOHYD POLYM, V77, P261, DOI 10.1016/j.carbpol.2008.12.035
   Unnithan AR, 2014, CARBOHYD POLYM, V102, P884, DOI 10.1016/j.carbpol.2013.10.070
   Wang YX, 2014, ACS APPL MATER INTER, V6, P1709, DOI 10.1021/am404624z
   Wang YX, 2012, J MATER CHEM, V22, P21592, DOI 10.1039/c2jm34611g
   Wang YX, 2012, MACROMOL MATER ENG, V297, P902, DOI 10.1002/mame.201100410
   WILSON CM, 1991, PLANT PHYSIOL, V95, P777, DOI 10.1104/pp.95.3.777
   Wongsasulak S, 2014, J FOOD ENG, V120, P110, DOI 10.1016/j.jfoodeng.2013.07.028
   Wongsasulak S, 2013, J FOOD SCI, V78, pN926, DOI 10.1111/1750-3841.12126
   Wongsasulak S, 2010, J APPL POLYM SCI, V118, P910, DOI 10.1002/app.32433
   Xu WJ, 2008, POLYM INT, V57, P1110, DOI 10.1002/pi.2450
   Yang JM, 2013, COLLOID SURFACE B, V102, P737, DOI 10.1016/j.colsurfb.2012.09.039
   Yao C, 2007, J BIOMAT SCI-POLYM E, V18, P731, DOI 10.1163/156856207781034070
   Yao C, 2007, J APPL POLYM SCI, V103, P380, DOI 10.1002/app.24619
   Yu DG, 2013, J MEMBRANE SCI, V428, P150, DOI 10.1016/j.memsci.2012.09.062
   Zamani M, 2013, INT J NANOMED, V8, P2997, DOI 10.2147/IJN.S43575
   1944, CHEM IND, V54, P670
NR 55
TC 9
Z9 9
U1 4
U2 34
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2015
VL 21
IS 22
BP 3199
EP 3207
DI 10.2174/1381612821666150531170448
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CM8GS
UT WOS:000357937500015
PM 26027566
DA 2018-10-19
ER

PT J
AU Nagaoka, H
AF Nagaoka, Hiroyuki
TI An HASApf-redoxin complex causing asymmetric catalytic oxidation via the
   regenerative formation of a reactive oxygen species
SO DALTON TRANSACTIONS
LA English
DT Article
ID IRON(III) PORPHYRIN COMPLEXES; OPTICALLY-ACTIVE ALCOHOLS; HEME-BINDING
   PROTEIN; ALPHA-HYDROXYLATION; HYDROGEN-PEROXIDE; BIO-CATALYSTS; PEA
   PROTEIN; RESOLUTION; CYTOCHROME-P450; BIOCATALYSIS
AB A PP (pea)-HASApf-redoxin complex eluted from encapsulated PP gel with aeration displays asymmetric oxidation activity over 200 times greater than that of a similar protein expressed by E. coli cells. The intermediate spin, identified in the ESR spectrum, appears at g = 4.3 and g = 2.0, suggesting that an iron electron-transfer system for the asymmetric oxidation of secondary alcohols may be successfully created by the PP-HASApf-redoxin complex (39 kDa). FTIR experiments provided values nu(s)(SO2) approximate to 950-1050 cm(-1) and nu(as)(SO2) approximate to 1100-1200 cm(-1) for metal-bound sulfinate S-O and Fe-O vibrations. The sulfur and iron detected by physicochemical inspection (IC/ICP-AES) may facilitate the electron transport of a sulfateiron complex (e.g., rubredoxin (6 kDa) or ferredoxin (9 kDa)) to the HASApf (21 kDa). The observations are consistently acceptable; i.e., the oxygen-driven PP-HASApf-redoxin complex functions regenerate via the successive asymmetric catalytic event - Fe(II) + O-2 -> Fe(III)-O-O- -> Fe(IV) = O (oxidizing rac-1 or rac-2) -> Fe(II) + H2O. Therefore, the use of a raw biomaterial as a PP-HASApf-redoxin complex-catalytic system for asymmetric oxidation is an important novelty, despite the apparent difficulties in working with pure dehydrogenase enzymatic/redox-cofactor systems for biotransformation.
C1 Sanyo Shokuhin Co Ltd R&D, Maebashi, Gunma 3710811, Japan.
RP Nagaoka, H (reprint author), Sanyo Shokuhin Co Ltd R&D, 555-4 Asakura, Maebashi, Gunma 3710811, Japan.
EM hnagaoka@sanyofoods.co.jp
FU Sanyo Shokuhin Co., Ltd
FX The author would like to thank Associate Prof. Osami Shoji from Nagoya
   University and Prof. Shinichi Ozaki from Yamaguchi University for
   providing the HASApf sample. Thanks to General Manager Koh Ueda from
   Wako Pure Chemical Industries Ltd, for placing SanCat-R on the market
   (PEG precipitate 2: Code No. 351-34213 (5 g)). This study was fully
   funded by Sanyo Shokuhin Co., Ltd.
CR Adam W, 1998, J AM CHEM SOC, V120, P11044, DOI 10.1021/ja981252r
   Auld DS, 2008, CELL MOL LIFE SCI, V65, P3961, DOI 10.1007/s00018-008-8593-1
   Egami H, 2007, J AM CHEM SOC, V129, P8940, DOI 10.1021/ja071916+
   Garcia-Rubio I, 2007, BIOPHYS J, V92, P1361, DOI 10.1529/biophysj.106.098277
   Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1
   Giles NM, 2003, BIOCHEM BIOPH RES CO, V300, P1, DOI 10.1016/S0006-291X(02)02770-5
   Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583
   Hirakawa H, 2010, CHEMBIOCHEM, V11, P1517, DOI 10.1002/cbic.201000226
   Ikeue T, 2001, ANGEW CHEM INT EDIT, V40, P2617, DOI 10.1002/1521-3773(20010716)40:14<2617::AID-ANIE2617>3.0.CO;2-B
   Izadi-Pruneyre N, 1999, EUR J BIOCHEM, V261, P562, DOI 10.1046/j.1432-1327.1999.00305.x
   Jepkorir G, 2010, J AM CHEM SOC, V132, P9857, DOI 10.1021/ja103498z
   Johansson AL, 2013, BIOCHEMISTRY-US, V52, P827, DOI 10.1021/bi301597a
   Kamezawa M., 1996, LIEBIGS ANN, V1996, P167
   Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106
   Lam MK, 2010, BIOTECHNOL ADV, V28, P500, DOI 10.1016/j.biotechadv.2010.03.002
   Landwehr M, 2006, J AM CHEM SOC, V128, P6058, DOI 10.1021/ja061261x
   Liou YF, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S16-S4
   McDonald AR, 2010, J AM CHEM SOC, V132, P17118, DOI 10.1021/ja1045428
   Nagaoka H., 2003, Current Topics in Nutraceutical Research, V1, P281
   Nagaoka H, 2005, BIOTECHNOL PROGR, V21, P405, DOI 10.1021/bp0496777
   Nagaoka H, 1999, BIOSCI BIOTECH BIOCH, V63, P1991, DOI 10.1271/bbb.63.1991
   Nagaoka H, 2000, BIOSCI BIOTECH BIOCH, V64, P781, DOI 10.1271/bbb.64.781
   Nagaoka H, 2004, BIOTECHNOL PROGR, V20, P128, DOI 10.1021/bp0342046
   Nagaoka H, 2003, BIOTECHNOL PROGR, V19, P1149, DOI 10.1021/bp034059w
   Nagaoka H, 2001, BIOSCI BIOTECH BIOCH, V65, P634, DOI 10.1271/bbb.65.634
   Nagaoka H., 2014, RSC ADV, V4, P16333, DOI [10.1039/C3RA45936E, DOI 10.1039/C3RA45936E]
   Nagaoka H, 2014, ACS CATAL, V4, P553, DOI 10.1021/cs400768x
   Nagaoka H, 2012, BIOTECHNOL PROGR, V28, P953, DOI 10.1002/btpr.1580
   Ohgo Y, 2006, CHEM COMMUN, P1935, DOI 10.1039/b601412g
   Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264
   Ortiz de Montellano P.R., 2004, CYTOCHROME P450 STRU
   Ozaki S, 2014, J INORG BIOCHEM, V138, P31, DOI 10.1016/j.jinorgbio.2014.04.013
   Ozaki S, 2011, CHEM LETT, V40, P362, DOI 10.1246/cl.2011.362
   Paulsen I. T., 2005, NAT BIOTECHNOL, V23, P873
   Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039
   SAKAI M, 1995, SOIL SCI PLANT NUTR, V41, P605, DOI 10.1080/00380768.1995.10419622
   SANO S, 1986, P NATL ACAD SCI USA, V83, P531, DOI 10.1073/pnas.83.3.531
   Schoemaker HE, 2003, SCIENCE, V299, P1694, DOI 10.1126/science.1079237
   Shoji O, 2007, ANGEW CHEM INT EDIT, V46, P3656, DOI 10.1002/anie.200700068
   Sobolov B. S., 1996, J ORG CHEM, V61, P2125, DOI 10.1021/jo951408v
   Thakur VV, 2005, INDIAN J CHEM B, V44, P557
   Yosca TH, 2013, SCIENCE, V342, P825, DOI 10.1126/science.1244373
   Zhao ZY, 2013, RSC ADV, V3, P22008, DOI 10.1039/c3ra43382j
NR 43
TC 2
Z9 2
U1 0
U2 11
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1477-9226
EI 1477-9234
J9 DALTON T
JI Dalton Trans.
PY 2015
VL 44
IS 29
BP 13384
EP 13393
DI 10.1039/c5dt01768h
PG 10
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA CM9IO
UT WOS:000358022300050
PM 26135291
DA 2018-10-19
ER

PT J
AU Qiu, JH
   Dong, SH
   Wang, HB
   Cheng, X
   Du, ZL
AF Qiu, Jinghong
   Dong, Shihua
   Wang, Haibo
   Cheng, Xu
   Du, Zongliang
TI Adsorption performance of low-cost gelatin-montmorillonite nanocomposite
   for Cr(III) ions
SO RSC ADVANCES
LA English
DT Article
ID TRIVALENT CHROMIUM REMOVAL; AQUEOUS-SOLUTION; ACTIVATED CARBON;
   WASTE-WATER; CR(VI) IONS; SORPTION; BINDING; BIOMASS; CLAY; CR
AB A gelatin-montmorillonite (G-MMT) nanocomposite was prepared by Na-montmorillonite (Na-MMT) and a biomaterial gelatin through an intercalation method. Samples were studied by XRD and FTIR and the results indicated that gelatin has been successfully intercalated into the interlayers of MMT. The effect of G-MMT nanocomposite adsorbed Cr(III) from aqueous solution was investigated in terms of the initial concentration of Cr(III), adsorption temperature and solution pH. The maximum adsorption capacity was 52.91 mg g(-1) for an initial Cr(III) concentration of 300 mg L-1, temperature of 343 K and pH value of 5.5. Furthermore, kinetic and isotherm models were used for the description of the adsorption process. The results demonstrated that the adsorption process was fitted to a pseudo-second-order kinetic model and the equilibrium data gave good fits with both Freundlich and Langmuir equations. The thermodynamic study revealed the endothermic and non-spontaneous nature of the adsorption process, and the increased randomness at the solid-solution interface.
C1 [Qiu, Jinghong; Dong, Shihua; Wang, Haibo; Cheng, Xu; Du, Zongliang] Sichuan Univ, Coll Light Ind Text & Food Sci Engn, Text Inst, Chengdu 610065, Peoples R China.
RP Cheng, X (reprint author), Sichuan Univ, Coll Light Ind Text & Food Sci Engn, Text Inst, Chengdu 610065, Peoples R China.
EM scuchx@163.com; dzl407@163.com
FU National Natural Science Foundation of China [51073101]; support plan of
   Science and Technology Department of Sichuan Province, China
   [2010GZ0177]
FX This work was funded by the National Natural Science Foundation of China
   (no. 51073101) and support plan of Science and Technology Department of
   Sichuan Province, China (no. 2010GZ0177).
CR Almeida MAF, 1997, WASTE MANAGE, V17, P201
   APHA, 1998, STANDARD METHODS EXA
   Aravindhan R, 2012, CLEAN TECHNOL ENVIR, V14, P727, DOI 10.1007/s10098-011-0440-7
   Bakhti A, 2001, EUR J SOIL SCI, V52, P683, DOI 10.1046/j.1365-2389.2001.00413.x
   Bhattacharyya KG, 2008, ADV COLLOID INTERFAC, V140, P114, DOI 10.1016/j.cis.2007.12.008
   Chen JH, 2013, J HAZARD MATER, V248, P285, DOI 10.1016/j.jhazmat.2013.01.042
   Chen J, 2013, J MATER SCI, V48, P7708, DOI 10.1007/s10853-013-7591-3
   Das DD, 2000, J COLLOID INTERF SCI, V232, P235, DOI 10.1006/jcis.2000.7141
   Donmez G, 2002, PROCESS BIOCHEM, V38, P751, DOI 10.1016/S0032-9592(02)00204-2
   Esfandian H, 2012, J VINYL ADDIT TECHN, V18, P250, DOI 10.1002/vnl.20310
   Fonseca-Correa R, 2013, J ANAL APPL PYROL, V101, P132, DOI 10.1016/j.jaap.2013.01.019
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Gode F, 2003, J HAZARD MATER, V100, P231, DOI 10.1016/S0304-3894(03)00110-9
   Gomez-Guillen MC, 2011, FOOD HYDROCOLLOID, V25, P1813, DOI 10.1016/j.foodhyd.2011.02.007
   HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011
   Ho YS, 1999, WATER RES, V33, P578, DOI 10.1016/S0043-1354(98)00207-3
   Ho YS, 1998, PROCESS SAF ENVIRON, V76, P183, DOI 10.1205/095758298529326
   Khezami L, 2005, J HAZARD MATER, V123, P223, DOI 10.1016/j.jhazmat.2005.04.012
   Konczyk J, 2010, DESALINATION, V263, P211, DOI 10.1016/j.desal.2010.06.061
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   LEYVARAMOS R, 1995, J CHEM TECHNOL BIOT, V62, P64, DOI 10.1002/jctb.280620110
   Li JH, 2012, J HAZARD MATER, V221, P56, DOI 10.1016/j.jhazmat.2012.04.004
   Li Q, 2007, J HAZARD MATER, V141, P163, DOI 10.1016/j.jhazmat.2006.06.109
   Li W, 2012, CHEM ENG J, V193, P88, DOI 10.1016/j.cej.2012.03.084
   Lodeiro P, 2008, ENVIRON CHEM, V5, P355, DOI 10.1071/EN08035
   Mohan D, 2006, J HAZARD MATER, V135, P280, DOI 10.1016/j.jhazmat.2005.11.075
   Oliveira DQL, 2008, J HAZARD MATER, V151, P280, DOI 10.1016/j.jhazmat.2007.11.001
   Park SJ, 2001, J COLLOID INTERF SCI, V243, P316, DOI 10.1006/jcis.2001.7910
   Romero-Gonzalez J, 2006, BIORESOURCE TECHNOL, V97, P178, DOI 10.1016/j.biortech.2005.01.037
   Sarin V, 2006, BIORESOURCE TECHNOL, V97, P15, DOI 10.1016/j.biortech.2005.02.010
   Tahir SS, 2007, SEP PURIF TECHNOL, V53, P312, DOI 10.1016/j.seppur.2006.08.008
   Tkaczyk C, 2010, J BIOMED MATER RES A, V94A, P214, DOI 10.1002/jbm.a.32700
   Vinichenko IG, 2005, RUSS J INORG CHEM+, V50, P187
   Webber W.J., 1963, J SANIT ENG DIV AM S, V89, P31
   Wu Y, 2008, BIORESOURCE TECHNOL, V99, P7709, DOI 10.1016/j.biortech.2008.01.069
   Yang ZH, 2013, J CENT SOUTH UNIV, V20, P1319, DOI 10.1007/s11771-013-1618-4
   Zhou Q, 2013, ADSORPTION, V19, P709, DOI 10.1007/s10450-013-9496-5
   Zhu J, 2011, CHEMOSPHERE, V84, P484, DOI 10.1016/j.chemosphere.2011.03.020
NR 38
TC 7
Z9 8
U1 6
U2 43
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 72
BP 58284
EP 58291
DI 10.1039/c5ra08781c
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CM6KW
UT WOS:000357798400021
DA 2018-10-19
ER

PT J
AU Peng, HS
   Chiu, DT
AF Peng, Hong-Shang
   Chiu, Daniel T.
TI Soft fluorescent nanomaterials for biological and biomedical imaging
SO CHEMICAL SOCIETY REVIEWS
LA English
DT Review
ID SEMICONDUCTING POLYMER DOTS; AGGREGATION-INDUCED EMISSION; IN-VIVO;
   DRUG-DELIVERY; ORGANIC NANOPARTICLES; SILICA NANOPARTICLES; CLICK
   CHEMISTRY; CELLULAR UPTAKE; CONJUGATED POLYMERS; OXYGEN NANOSENSORS
AB Soft fluorescent nanomaterials have attracted recent attention as imaging agents for biological applications, because they provide the advantages of good biocompatibility, high brightness, and easy biofunctionalization. Here, we provide a survey of recent developments in fluorescent soft nano-sized biological imaging agents. Various soft fluorescent nanoparticles (NPs) (including dye-doped polymer NPs, semiconducting polymer NPs, small-molecule organic NPs, nanogels, micelles, vesicles, and biomaterial-based NPs) are summarized from the perspectives of preparation methods, structure, optical properties, and surface functionalization. Based on both optical and functional properties of the nano-sized imaging agents, their applications are then reviewed in terms of in vitro imaging, in vivo imaging, and cellular-process imaging, by means of specific or nonspecific targeting.
C1 [Peng, Hong-Shang; Chiu, Daniel T.] Univ Washington, Dept Chem, Seattle, WA 98195 USA.
   [Peng, Hong-Shang] Beijing Jiaotong Univ, Key Lab Luminescence & Opt Informat, Minist Educ, Inst Optoelect Technol, Beijing 100044, Peoples R China.
RP Chiu, DT (reprint author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.
EM chiu@chem.washington.edu
FU National Institutes of Health [R21CA186798, R01CA175215]
FX We are grateful to the National Institutes of Health (R21CA186798 and
   R01CA175215) for support of this work.
CR Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]
   Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m
   Amici J, 2012, J MATER SCI, V47, P412, DOI 10.1007/s10853-011-5814-z
   An FF, 2013, J MATER CHEM B, V1, P3144, DOI 10.1039/c3tb20271b
   Averick SE, 2011, POLYM CHEM-UK, V2, P1476, DOI 10.1039/c1py00050k
   Behnke T, 2013, BIOMATERIALS, V34, P160, DOI 10.1016/j.biomaterials.2012.09.028
   Behnke T, 2012, DYES PIGMENTS, V94, P247, DOI 10.1016/j.dyepig.2012.01.021
   BENYA R, 1989, CATHETER CARDIO DIAG, V17, P231, DOI 10.1002/ccd.1810170410
   Birks J. B., 1970, PHOTOPHYSICS AROMATI
   Brunstein M, 2013, OPT EXPRESS, V21, P26162, DOI 10.1364/OE.21.026162
   Buckle T, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/35/355101
   Bunschoten A, 2012, BIOMATERIALS, V33, P867, DOI 10.1016/j.biomaterials.2011.10.005
   Chan YH, 2012, ANAL CHEM, V84, P9431, DOI 10.1021/ac302245t
   Chan YH, 2011, ANAL CHEM, V83, P1448, DOI 10.1021/ac103140x
   Chen CY, 2011, CHEM COMMUN, V47, P994, DOI 10.1039/c0cc04450d
   Chen JI, 2013, MACROMOL BIOSCI, V13, P623, DOI 10.1002/mabi.201200396
   Chen Y, 2013, CHEM COMMUN, V49, P297, DOI 10.1039/c2cc37386f
   Cho EC, 2010, TRENDS MOL MED, V16, P561, DOI 10.1016/j.molmed.2010.09.004
   Cova L, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/24/245603
   Cu Y, 2009, NAT MATER, V8, P11, DOI 10.1038/nmat2347
   Davis CM, 2011, J PHYS CHEM C, V115, P19065, DOI 10.1021/jp206438p
   Demay-Drouhard P, 2013, CHEM-EUR J, V19, P8388, DOI 10.1002/chem.201300903
   Ding D, 2013, ADV MATER, V25, P6083, DOI 10.1002/adma.201301938
   Ding D, 2013, SMALL, V9, P3093, DOI 10.1002/smll.201300171
   Dmitriev RI, 2012, ANAL CHEM, V84, P2930, DOI 10.1021/ac3000144
   Feng LH, 2013, CHEM SOC REV, V42, P6620, DOI 10.1039/c3cs60036j
   Feng XL, 2012, ADV MATER, V24, P637, DOI 10.1002/adma.201102026
   Feng XL, 2010, ACS APPL MATER INTER, V2, P2429, DOI 10.1021/am100435k
   Fercher A, 2011, ACS NANO, V5, P5499, DOI 10.1021/nn200807g
   Fernando LP, 2010, BIOMACROMOLECULES, V11, P2675, DOI 10.1021/bm1007103
   Ferrari R, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/4/045102
   Fischer I, 2013, CHEM-EUR J, V19, P16646, DOI 10.1002/chem.201302647
   Fryd MM, 2012, ANNU REV PHYS CHEM, V63, P493, DOI 10.1146/annurev-physchem-032210-103436
   Fu GD, 2012, MACROMOL RAPID COMM, V33, P1523, DOI 10.1002/marc.201200337
   GARNETT MC, 2006, J OCCUP MED, V56, P307, DOI DOI 10.1093/OCCMED/KQL052
   Gluz E, 2013, J POLYM SCI POL CHEM, V51, P4282, DOI 10.1002/pola.26858
   Goncalves M, 2014, BIOMACROMOLECULES, V15, P492, DOI 10.1021/bm401400r
   Gong J, 2013, PROG CHEM, V25, P1928
   Goutayer M, 2010, EUR J PHARM BIOPHARM, V75, P137, DOI 10.1016/j.ejpb.2010.02.007
   Hayashi K, 2010, CHEM MATER, V22, P3768, DOI 10.1021/cm100810g
   He XX, 2012, ANAL CHEM, V84, P9056, DOI 10.1021/ac301461s
   Heintzmann R, 2009, NAT PHOTONICS, V3, P362, DOI 10.1038/nphoton.2009.102
   Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395
   Hemmer E, 2013, NANOSCALE, V5, P11339, DOI 10.1039/c3nr02286b
   Hoffmann K, 2013, ACS NANO, V7, P6674, DOI 10.1021/nn4029458
   Hong GS, 2012, NAT MED, V18, P1841, DOI 10.1038/nm.2995
   Hong YN, 2011, CHEM SOC REV, V40, P5361, DOI 10.1039/c1cs15113d
   Howes P, 2010, J AM CHEM SOC, V132, P3989, DOI 10.1021/ja1002179
   Howes P, 2009, CHEM COMMUN, P2490, DOI 10.1039/b903405f
   Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014
   Huang JG, 2011, NANO TODAY, V6, P478, DOI 10.1016/j.nantod.2011.08.002
   Jahn A, 2010, ACS NANO, V4, P2077, DOI 10.1021/nn901676x
   Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139
   Jin YH, 2011, ACS NANO, V5, P1468, DOI 10.1021/nn103304m
   Karnik R, 2008, NANO LETT, V8, P2906, DOI 10.1021/nl801736q
   Kietzke T, 2003, NAT MATER, V2, P408, DOI 10.1038/nmat889
   Kievit FM, 2011, ADV MATER, V23, pH217, DOI 10.1002/adma.201102313
   Kilin VN, 2014, BIOMATERIALS, V35, P4950, DOI 10.1016/j.biomaterials.2014.02.053
   Kim S, 2010, CHEM COMMUN, V46, P1617, DOI 10.1039/b923309a
   Kim Y, 2013, ACS NANO, V7, P9975, DOI 10.1021/nn4039063
   Kim YT, 2012, NANO LETT, V12, P3587, DOI 10.1021/nl301253v
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X
   Kolishetti N, 2010, P NATL ACAD SCI USA, V107, P17939, DOI 10.1073/pnas.1011368107
   Kondrashina AV, 2012, ADV FUNCT MATER, V22, P4931, DOI 10.1002/adfm.201201387
   Kurokawa N, 2004, CHEMPHYSCHEM, V5, P1609, DOI 10.1002/cphc.200400117
   Landfester K, 2002, ADV MATER, V14, P651, DOI 10.1002/1521-4095(20020503)14:9<651::AID-ADMA651>3.0.CO;2-V
   Laux EM, 2012, ANAL METHODS-UK, V4, P1759, DOI 10.1039/c2ay05822g
   Lee KJ, 2010, CHEM COMMUN, V46, P5229, DOI 10.1039/c002533j
   Lee YD, 2012, ACS NANO, V6, P6759, DOI 10.1021/nn3014905
   Lee YEK, 2010, ANAL CHEM, V82, P8446, DOI 10.1021/ac1015358
   Li JL, 2013, BIOMATERIALS, V34, P9519, DOI 10.1016/j.biomaterials.2013.08.066
   Li JT, 2013, LANGMUIR, V29, P11547, DOI 10.1021/la401990d
   Li K, 2014, CHEM SOC REV, V43, P6570, DOI 10.1039/c4cs00014e
   Li K, 2011, ADV FUNCT MATER, V21, P287, DOI 10.1002/adfm.201001435
   Li ZH, 2012, NANOSCALE, V4, P7097, DOI 10.1039/c2nr32047a
   Liechty WB, 2010, ANNU REV CHEM BIOMOL, V1, P149, DOI 10.1146/annurev-chembioeng-073009-100847
   Liu Q, 2013, NANO LETT, V13, P2436, DOI 10.1021/nl400368v
   Louie AY, 2010, CHEM REV, V110, P3146, DOI 10.1021/cr9003538
   Ma CP, 2014, MACROMOL BIOSCI, V14, P235, DOI 10.1002/mabi.201300259
   Mackiewicz N, 2014, CHEM MATER, V26, P1834, DOI 10.1021/cm403822w
   Madsen J, 2013, J AM CHEM SOC, V135, P14863, DOI 10.1021/ja407380t
   Mahmoudi M, 2011, CHEM REV, V111, P253, DOI 10.1021/cr1001832
   Mahtab F, 2011, SMALL, V7, P1448, DOI 10.1002/smll.201002195
   Maldonado CR, 2013, COORDIN CHEM REV, V257, P2668, DOI 10.1016/j.ccr.2013.04.014
   Miki K, 2010, BIOMATERIALS, V31, P934, DOI 10.1016/j.biomaterials.2009.10.005
   Miyata K, 2011, REACT FUNCT POLYM, V71, P227, DOI 10.1016/j.reactfunctpolym.2010.10.009
   Montalti M, 2014, CHEM COMMUN, V50, P5326, DOI 10.1039/c3cc48464e
   Nalwa H. S., 2009, SOFT NANOMATERIALS
   Okabe K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1714
   Ong BS, 2005, ADV MATER, V17, P1141, DOI 10.1002/adma.200401660
   Ozcan I, 2011, J PHARM SCI-US, V100, P4877, DOI 10.1002/jps.22678
   Pansare VJ, 2012, CHEM MATER, V24, P812, DOI 10.1021/cm2028367
   Papkovsky DB, 2013, CHEM SOC REV, V42, P8700, DOI 10.1039/c3cs60131e
   Park HS, 2012, MACROMOL RAPID COMM, V33, P1549, DOI 10.1002/marc.201200246
   Pecher J, 2010, CHEM REV, V110, P6260, DOI 10.1021/cr100132y
   Pecher J, 2010, BIOMACROMOLECULES, V11, P2776, DOI 10.1021/bm100854a
   Peng HS, 2010, ANGEW CHEM INT EDIT, V49, P4246, DOI 10.1002/anie.200906926
   Peng HS, 2010, ADV MATER, V22, P716, DOI 10.1002/adma.200901614
   Petkau K, 2011, J AM CHEM SOC, V133, P17063, DOI 10.1021/ja2075345
   Qiao J, 2012, J MATER CHEM, V22, P11543, DOI 10.1039/c2jm31093g
   Qin W, 2012, ADV FUNCT MATER, V22, P771, DOI 10.1002/adfm.201102191
   Reul R, 2012, POLYM CHEM-UK, V3, P694, DOI 10.1039/c2py00520d
   Rong Y, 2013, ACS NANO, V7, P376, DOI 10.1021/nn304376z
   Roy M, 2012, SMALL, V8, P1780, DOI 10.1002/smll.201102105
   Schadlich A, 2011, ACS NANO, V5, P8710, DOI 10.1021/nn2026353
   Sharma J, 2011, CHEM COMMUN, V47, P2294, DOI 10.1039/c0cc03711g
   So MK, 2006, NAT BIOTECHNOL, V24, P339, DOI 10.1038/nbt1188
   Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034
   Sun GR, 2010, NANOSCALE, V2, P548, DOI 10.1039/b9nr00304e
   Sun W, 2013, ANGEW CHEM INT EDIT, V52, P11294, DOI 10.1002/anie.201304822
   Swierczewska M, 2011, MOL IMAGING, V10, P3, DOI 10.2310/7290.2011.00001
   Szymanski C, 2005, J PHYS CHEM B, V109, P8543, DOI 10.1021/jp051062k
   Tang L, 2013, NANO TODAY, V8, P290, DOI 10.1016/j.nantod.2013.04.007
   Tantra R, 2011, NANOTOXICOLOGY, V5, P381, DOI 10.3109/17435390.2010.512987
   Tao ZM, 2013, ANGEW CHEM INT EDIT, V52, P13002, DOI 10.1002/anie.201307346
   Thielbeer F, 2011, BIOMACROMOLECULES, V12, P4386, DOI 10.1021/bm201394k
   Tosi G, 2011, J NEURAL TRANSM, V118, P145, DOI 10.1007/s00702-010-0497-1
   Tuncel D, 2010, NANOSCALE, V2, P484, DOI 10.1039/b9nr00374f
   Vollrath A, 2013, J MATER CHEM B, V1, P1994, DOI 10.1039/c3tb20089b
   Wang F, 2005, J AM CHEM SOC, V127, P10350, DOI 10.1021/ja0521730
   Wang G, 2011, CHEM MATER, V23, P4428, DOI 10.1021/cm201377u
   Wang M, 2010, PHARMACOL RES, V62, P90, DOI 10.1016/j.phrs.2010.03.005
   Wang SY, 2012, ACS NANO, V6, P6843, DOI 10.1021/nn301633m
   Wang XH, 2014, ANGEW CHEM INT EDIT, V53, P12471, DOI 10.1002/anie.201405048
   Wang XH, 2013, J MATER CHEM B, V1, P5143, DOI 10.1039/c3tb20884b
   Wang XH, 2012, J MATER CHEM, V22, P16066, DOI 10.1039/c2jm32122j
   Wang XD, 2013, SENSOR ACTUAT B-CHEM, V188, P257, DOI 10.1016/j.snb.2013.06.087
   Wang XD, 2012, J AM CHEM SOC, V134, P17011, DOI 10.1021/ja308830e
   Wang XD, 2011, CHEM SCI, V2, P901, DOI 10.1039/c0sc00610f
   Wang Y, 2012, BIOMACROMOLECULES, V13, P2585, DOI 10.1021/bm3008346
   Wang Z, 2013, BIOMATERIALS, V34, P6194, DOI 10.1016/j.biomaterials.2013.05.004
   Warnement MR, 2007, CURR NANOSCI, V3, P273, DOI 10.2174/157341307782418595
   Welsher K, 2011, P NATL ACAD SCI USA, V108, P8943, DOI 10.1073/pnas.1014501108
   Wu CF, 2006, LANGMUIR, V22, P2956, DOI 10.1021/la060188l
   Wu CF, 2011, ANGEW CHEM INT EDIT, V50, P3430, DOI 10.1002/anie.201007461
   Wu CF, 2013, ANGEW CHEM INT EDIT, V52, P3086, DOI 10.1002/anie.201205133
   Wu CF, 2010, ANGEW CHEM INT EDIT, V49, P9436, DOI 10.1002/anie.201004260
   Wu CF, 2010, J AM CHEM SOC, V132, P15410, DOI 10.1021/ja107196s
   Wu C, 2008, ACS NANO, V2, P2415, DOI 10.1021/nn800590n
   Wu CF, 2009, ANGEW CHEM INT EDIT, V48, P2741, DOI 10.1002/anie.200805894
   Wu CC, 2013, ACS NANO, V7, P5724, DOI 10.1021/nn402517v
   Wu PJ, 2014, ANAL CHEM, V86, P4831, DOI 10.1021/ac404237q
   Wu XM, 2013, CHEM SCI, V4, P1221, DOI 10.1039/c2sc22035k
   Ye DJ, 2014, NAT CHEM, V6, P519, DOI [10.1038/NCHEM.1920, 10.1038/nchem.1920]
   Ye FM, 2012, CHEM COMMUN, V48, P1778, DOI 10.1039/c2cc16486h
   Ye FM, 2011, J AM CHEM SOC, V133, P8146, DOI 10.1021/ja202945g
   Yoo L, 2012, BIOMATERIALS, V33, P6194, DOI 10.1016/j.biomaterials.2012.05.028
   Yu JB, 2012, ADV MATER, V24, P3498, DOI 10.1002/adma.201201245
   Yu JH, 2008, PHOTOCHEM PHOTOBIOL, V84, P1435, DOI 10.1111/j.1751-1097.2008.00434.x
   Zhang LZ, 2012, MACROMOL BIOSCI, V12, P83, DOI 10.1002/mabi.201100197
   Zhang XY, 2014, COLLOID SURFACE B, V113, P435, DOI 10.1016/j.colsurfb.2013.09.031
   Zhang XY, 2012, NANOSCALE, V4, P5581, DOI 10.1039/c2nr31281f
   Zhang XJ, 2012, ACS NANO, V6, P5429, DOI 10.1021/nn301308w
   Zhang Y, 2014, POLYM CHEM-UK, V5, P3824, DOI 10.1039/c4py00075g
   Zhang Y, 2013, CHEM COMMUN, V49, P8256, DOI 10.1039/c3cc44048f
   Zhou SY, 2013, POLYM CHEM-UK, V4, P4103, DOI 10.1039/c3py00522d
   Zhu LL, 2013, J AM CHEM SOC, V135, P5175, DOI 10.1021/ja400456h
   Zupke O, 2010, BIOMATERIALS, V31, P7086, DOI 10.1016/j.biomaterials.2010.05.073
NR 158
TC 128
Z9 130
U1 23
U2 309
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0306-0012
EI 1460-4744
J9 CHEM SOC REV
JI Chem. Soc. Rev.
PY 2015
VL 44
IS 14
BP 4699
EP 4722
DI 10.1039/c4cs00294f
PG 24
WC Chemistry, Multidisciplinary
SC Chemistry
GA CM4YA
UT WOS:000357691200011
PM 25531691
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zorzi, GK
   Parraga, JE
   Seijo, B
   Sanchez, A
AF Zorzi, Giovanni K.
   Parraga, Jenny E.
   Seijo, Begona
   Sanchez, Alejandro
TI On the Biomaterials for Nanostructured Ocular Therapeutics
SO CURRENT ORGANIC CHEMISTRY
LA English
DT Article
DE Eye; nanotechnology; nanoparticles; drug delivery; biomaterial
ID SOLID LIPID NANOPARTICLES; OPHTHALMIC DRUG-DELIVERY; CHONDROITIN SULFATE
   PROTEOGLYCANS; DIFFERENT AMINE COMPOUNDS; PIGMENT EPITHELIAL-CELLS;
   POORLY ABSORBABLE DRUGS; LOADED GELATIN NANOPARTICLES; ENDOTOXIN-INDUCED
   UVEITIS; POLYMER MOLECULAR-WEIGHT; NONVIRAL GENE-TRANSFER
AB Due to its unique anatomy, drug delivery to eye structures has always been problematic. Many efforts have been addressed to enhance ocular bioavailability by lowering non-specific interactions between drug and tissue, increasing drug stability or increasing the residence time in the case of topical drugs. In this context, nanotechnology has been a very helpful tool for developing suitable drug delivery systems. More specifically, different kinds of strategies in this field have been proposed to overcome the problems related to ocular administration. However, the success of a nanoparticulated system relies on the correct choice of the material which it is made of. Based on these statements, the present article offers a review of the most important biomaterials employed in nanostructured systems for ocular drug delivery, especially those designated to delivery to the ocular surface and their impact on the final activity of such systems.
C1 [Zorzi, Giovanni K.] Univ Fed Rio Grande do Sul, Grad Program Pharmaceut Sci, Fac Pharm, BR-90610000 Porto Alegre, RS, Brazil.
   [Parraga, Jenny E.; Seijo, Begona; Sanchez, Alejandro] Univ Santiago de Compostela, Dept Pharm & Pharmaceut Technol, Fac Pharm, Santiago De Compostela 15782, Spain.
   [Seijo, Begona; Sanchez, Alejandro] Univ Clin Hosp Santiago de Compostela IDIS, Hlth Res Inst, Mol Image Grp, Santiago De Compostela 15706, Spain.
RP Sanchez, A (reprint author), Univ Santiago de Compostela, Dept Pharm & Pharmaceut Technol, Fac Pharm, Campus Sur, Santiago De Compostela 15782, Spain.
EM Alejandro.sanchez@usc.es
FU Ministry of Economy and Competitiveness of Spain [MAT2013-47501-C2-2-R];
   Xunta de Galicia (Competitive Reference Groups, FEDER Funds) [2014/043];
   CNPq/CAPES [BJT 028/2012]
FX Posthumous acknowledgement to Begona Seijo, an excellent scientist and
   professor, who was co-author of this work. This work was supported by
   grants of the Ministry of Economy and Competitiveness of Spain
   (MAT2013-47501-C2-2-R), Xunta de Galicia (Competitive Reference Groups,
   FEDER Funds, Ref. 2014/043) and CNPq/CAPES (BJT 028/2012).
CR Abdelbary G, 2011, PHARM DEV TECHNOL, V16, P44, DOI 10.3109/10837450903479988
   Adibkia K, 2007, J DRUG TARGET, V15, P407, DOI 10.1080/10611860701453125
   Almeida H, 2014, J PHARM PHARM SCI, V17, P278, DOI 10.18433/J3DP43
   Alonso MJ, 2003, J PHARM PHARMACOL, V55, P1451, DOI 10.1211/0022357022476
   ALONSO MJ, 1991, INT J PHARM, V68, P69, DOI 10.1016/0378-5173(91)90128-B
   Alonso-Sande M, 2006, MACROMOLECULES, V39, P4152, DOI 10.1021/ma060230j
   Alonso-Sande M, 2009, EUR J PHARM BIOPHARM, V72, P453, DOI 10.1016/j.ejpb.2008.02.005
   Ammar HO, 2009, AAPS PHARMSCITECH, V10, P808, DOI 10.1208/s12249-009-9268-4
   Aoyama T, 2002, J CONTROL RELEASE, V80, P345, DOI 10.1016/S0168-3659(02)00029-9
   Aragona P, 2004, CHEMISTRY AND BIOLOGY OF HYALURONAN, P529
   Aranaz I., 2009, CURR CHEM BIOL, V3, P203, DOI DOI 10.2174/187231309788166415
   Arima H, 1997, J PHARM SCI, V86, P438, DOI 10.1021/js9603865
   Asane GS, 2008, DRUG DEV IND PHARM, V34, P1246, DOI 10.1080/03639040802026012 
   ASARI A, 1992, ARCH HISTOL CYTOL, V55, P503, DOI 10.1679/aohc.55.503
   Attama AA, 2008, INT J PHARM, V355, P307, DOI 10.1016/j.ijpharm.2007.12.007
   Aukunuru JV, 2003, J PHARM PHARMACOL, V55, P1199, DOI 10.1211/0022357021701
   Barbault-Foucher S, 2002, J CONTROL RELEASE, V83, P365, DOI 10.1016/S0168-3659(02)00207-9
   Barbu E, 2006, J MATER CHEM, V16, P3439, DOI 10.1039/b605640g
   Basaran E., 2009, J MICROENCAPSUL, V27, P37
   Bejjani RA, 2005, CHIMIA, V59, P344, DOI 10.2533/000942905777676281
   Bhadra D, 2003, INT J PHARM, V257, P111, DOI 10.1016/S0378-5173(03)00132-7
   Bochot A, 2002, INVEST OPHTH VIS SCI, V43, P253
   Bochot A, 2000, PROG RETIN EYE RES, V19, P131, DOI 10.1016/S1350-9462(99)00014-2
   Borderie V, 2005, EMC OPHTALMOL, V2, P103
   Bourges JL, 2003, INVEST OPHTH VIS SCI, V44, P3562, DOI 10.1167/iovs.02-1068
   BOYLE D, 1991, INVEST OPHTH VIS SCI, V32, P1464
   Bucolo C, 2004, J PHARM PHARMACOL, V56, P841, DOI 10.1211/0022357023835
   Cai X, 2008, VISION RES, V48, P319, DOI 10.1016/j.visres.2007.07.012
   Calvo P, 1997, COLLOID POLYM SCI, V275, P46, DOI 10.1007/s003960050050
   Calvo P, 1996, J PHARM PHARMACOL, V48, P1147, DOI 10.1111/j.2042-7158.1996.tb03911.x
   Calvo P, 1997, INT J PHARM, V153, P41, DOI 10.1016/S0378-5173(97)00083-5
   Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
   Calvo P, 1996, PHARMACEUT RES, V13, P311, DOI 10.1023/A:1016015803611
   Camelo S, 2007, MOL VIS, V13, P2263
   Carvalho ELS, 2009, METHOD ENZYMOL, V465, P289, DOI 10.1016/S0076-6879(09)65015-1
   Cavalli R, 2002, INT J PHARM, V238, P241, DOI 10.1016/S0378-5173(02)00080-7
   Chaplot SP, 2014, J PHARM PHARMACOL, V66, P542, DOI 10.1111/jphp.12104
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Cho YW, 2000, BIOMACROMOLECULES, V1, P609, DOI 10.1021/bm000036j
   Choi MJ, 2005, SKIN PHARMACOL PHYSI, V18, P209, DOI 10.1159/000086666
   Contreras-Ruiz L, 2013, GENE THER, V20, P467, DOI 10.1038/gt.2012.56
   Csaba N, 2009, ADV DRUG DELIVER REV, V61, P140, DOI 10.1016/j.addr.2008.09.005
   Cuna M, 2006, J NANOSCI NANOTECHNO, V6, P2887, DOI 10.1166/jnn.2006.435
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   de Campos AM, 2004, PHARM RES, V21, P803, DOI 10.1023/B:PHAM.0000026432.75781.cb
   De Campos AM, 2003, EUR J PHARM SCI, V20, P73, DOI 10.1016/S0928-0987(03)00178-7
   De Campos AM, 2001, INT J PHARM, V224, P159, DOI 10.1016/S0378-5173(01)00760-8
   de la Fuente M, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/7/075105
   de la Fuente M, 2008, GENE THER, V15, P668, DOI 10.1038/gt.2008.16
   de la Fuente M, 2008, MACROMOL BIOSCI, V8, P441, DOI 10.1002/mabi.200700190
   de la Fuente M, 2008, INVEST OPHTH VIS SCI, V49, P2016, DOI 10.1167/iovs.07-1077
   de la Fuente M, 2010, ADV DRUG DELIVER REV, V62, P100, DOI 10.1016/j.addr.2009.11.026
   del Pozo-Rodriguez A, 2008, INT J PHARM, V360, P177, DOI 10.1016/j.ijpharm.2008.04.023
   del Pozo-Rodriguez A, 2007, INT J PHARM, V339, P261, DOI 10.1016/j.ijpharm.2007.02.015
   del Pozo-Rodriguez A, 2009, EUR J PHARM BIOPHARM, V71, P181, DOI 10.1016/j.ejpb.2008.09.015
   Diebold Y, 2007, BIOMATERIALS, V28, P1553, DOI 10.1016/j.biomaterials.2006.11.028
   DIEPOLD R, 1987, ARCH PHARM, V320, P909
   Dodane V, 1998, PHARM SCI TECHNOL TO, V1, P246, DOI 10.1016/S1461-5347(98)00059-5
   Dodane V, 1999, INT J PHARM, V182, P21, DOI 10.1016/S0378-5173(99)00030-7
   Dufes C, 2005, ADV DRUG DELIVER REV, V57, P2177, DOI 10.1016/j.addr.2005.09.017
   Durairaj C, 2010, INVEST OPHTH VIS SCI, V51, P5804, DOI 10.1167/iovs.10-5388
   El-Gazayerly ON, 1997, INT J PHARM, V158, P121, DOI 10.1016/S0378-5173(97)00186-5
   Elzoghby AO, 2013, J CONTROL RELEASE, V172, P1075, DOI 10.1016/j.jconrel.2013.09.019
   Fagerholm P, 1996, PROG RETIN EYE RES, V15, P281, DOI 10.1016/1350-9462(96)00004-3
   Falkowski M, 2003, HISTOCHEM CELL BIOL, V120, P361, DOI 10.1007/s00418-003-0585-5
   Fattal E, 2006, ADV DRUG DELIVER REV, V58, P1203, DOI 10.1016/j.addr.2006.07.020
   Fenske DB, 2008, TOXICOL PATHOL, V36, P21, DOI 10.1177/0192623307310960
   Fialho Sílvia Ligório, 2007, Arq. Bras. Oftalmol., V70, P173, DOI 10.1590/S0004-27492007000100034
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Fukunaka Y, 2002, J CONTROL RELEASE, V80, P333, DOI 10.1016/S0168-3659(02)00026-3
   Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x
   Gaudana R., 2008, PHARM RES, V26, P1197
   Giannavola C, 2003, PHARMACEUT RES, V20, P584, DOI 10.1023/A:1023290514575
   Goes RM, 2005, CURR EYE RES, V30, P405, DOI 10.1080/02713680590934148
   Graf A, 2009, EXPERT OPIN DRUG DEL, V6, P371, DOI [10.1517/17425240902870413, 10.1517/17425240902870413 ]
   Hao J, 2010, BRAIN RES BULL, V81, P256, DOI 10.1016/j.brainresbull.2009.06.011
   Harris EN, 2004, J BIOL CHEM, V279, P36201, DOI 10.1074/jbc.M405322200
   Hathout RM, 2007, AAPS PHARMSCITECH, V8
   Heredero-Bermejo I, 2015, PARASITOL RES, V114, P473, DOI 10.1007/s00436-014-4205-1
   Holden CA, 2012, NANOMED-NANOTECHNOL, V8, P776, DOI 10.1016/j.nano.2011.08.018
   Hori K, 2007, J CONTROL RELEASE, V118, P169, DOI 10.1016/j.jconrel.2006.12.011
   Hosseinkhani H., 2002, J DRUG TARGET, V10, P197
   Huang M, 2005, J CONTROL RELEASE, V106, P391, DOI 10.1016/j.cornel.2005.05.004
   Iezzi R, 2012, BIOMATERIALS, V33, P979, DOI 10.1016/j.biomaterials.2011.10.010
   Janes KA, 2003, J APPL POLYM SCI, V88, P2769, DOI 10.1002/app.12016
   Janes KA, 2001, ADV DRUG DELIVER REV, V47, P83, DOI 10.1016/S0169-409X(00)00123-X
   JARVINEN K, 1995, ADV DRUG DELIVER REV, V16, P3, DOI 10.1016/0169-409X(95)00010-5
   Jiang X, 2006, J GENE MED, V8, P477, DOI 10.1002/jgm.868
   Juberias JR, 1998, CURR EYE RES, V17, P39, DOI 10.1076/ceyr.17.1.39.5251
   JUBERIAS JR, 1995, INVEST OPHTH VIS SCI, V36, pS1009
   Kalam MA, 2009, J PHARM PHARMACOL, V61, pA75
   Kambhampati SP, 2015, EUR J PHARM BIOPHARM, V95, P239, DOI 10.1016/j.ejpb.2015.02.013
   Kaur A, 2008, ACTA PHARMACEUT, V58, P61, DOI 10.2478/v10007-007-0045-1
   Kaur IP, 2004, INT J PHARM, V269, P1, DOI 10.1016/j.ijpharm.2003.09.016
   Kaur IP, 2002, DRUG DEV IND PHARM, V28, P473
   Kawakami S, 2004, INT J PHARM, V278, P255, DOI 10.1016/j.ijpharm.2004.03.013
   Kawashima H, 1999, INT IMMUNOL, V11, P393, DOI 10.1093/intimm/11.3.393
   Kawashima H, 2000, TRENDS GLYCOSCI GLYC, V12, P283, DOI 10.4052/tigg.12.283
   Kinoshita S, 2001, PROG RETIN EYE RES, V20, P639, DOI 10.1016/S1350-9462(01)00007-6
   Kirker KR, 2004, J BURN CARE REHABIL, V25, P276, DOI 10.1097/01.BCR.0000124790.69026.3D
   Klang S, 2000, PHARM DEV TECHNOL, V5, P521, DOI 10.1081/PDT-100102035
   Klang SH, 1999, J CONTROL RELEASE, V57, P19, DOI 10.1016/S0168-3659(98)00107-2
   Kofuji K, 2005, EUR POLYM J, V41, P2784, DOI 10.1016/j.eurpolymj.2005.04.041
   Kompella UB, 2003, INVEST OPHTH VIS SCI, V44, P1192, DOI 10.1167/iovs.02-0791
   Zorzi GK, 2011, MOL PHARMACEUT, V8, P1783, DOI 10.1021/mp200155t
   Zorzi GK, 2011, MACROMOL BIOSCI, V11, P905, DOI 10.1002/mabi.201100005
   KOZLOV PV, 1983, POLYMER, V24, P651, DOI 10.1016/0032-3861(83)90001-0
   Kushibiki T, 2006, J CONTROL RELEASE, V112, P249, DOI 10.1016/j.jconrel.2006.02.003
   Kushibiki T, 2006, J CONTROL RELEASE, V110, P610, DOI 10.1016/j.jconrel.2005.11.007
   Kushibiki T, 2005, J CONTROL RELEASE, V105, P318, DOI 10.1016/j.jconrel.2005.02.030
   Kushibiki T, 2006, J BIOMAT SCI-POLYM E, V17, P645, DOI 10.1163/156856206777346278
   Kyosseva SV, 2008, J BIOL CHEM, V283, P15047, DOI 10.1074/jbc.M709921200
   Lajavardi L, 2007, INVEST OPHTH VIS SCI, V48, P3230, DOI 10.1167/iovs.06-1305
   Laroui H, 2007, BIOMACROMOLECULES, V8, P3879, DOI 10.1021/bm700836y
   Laude A, 2010, PROG RETIN EYE RES, V29, P466, DOI 10.1016/j.preteyeres.2010.04.003
   Law SL, 2000, J CONTROL RELEASE, V63, P135, DOI 10.1016/S0168-3659(99)00192-3
   Le Bourlais C, 1998, PROG RETIN EYE RES, V17, P33, DOI 10.1016/S1350-9462(97)00002-5
   Lee D, 2007, PHARM RES, V24, P157, DOI 10.1007/s11095-006-9136-9
   Leong KW, 1998, J CONTROL RELEASE, V53, P183, DOI 10.1016/S0168-3659(97)00252-6
   Lerner LE, 1998, EXP EYE RES, V67, P481, DOI 10.1006/exer.1998.0567
   Li N, 2009, INT J PHARMACEUT, V379, P131, DOI 10.1016/j.ijpharm.2009.06.020
   Li V H, 1986, J Microencapsul, V3, P213, DOI 10.3109/02652048609031575
   Li X, 2008, INT J PHARMACEUT, V363, P177, DOI 10.1016/j.ijpharm.2008.07.017
   Lopez AI, 2009, MOL BIOSYST, V5, P1148, DOI 10.1039/b904746h
   LOPEZ MI, 1995, INVEST OPHTH VIS SCI, V36, pS539
   Lopez-Cebral R, 2011, MED CHEM, V7, P145, DOI 1573-4064/11 $58.00+.00
   LOSA C, 1991, J PHARM PHARMACOL, V43, P548, DOI 10.1111/j.2042-7158.1991.tb03534.x
   LOSA C, 1992, J OCUL PHARMACOL, V8, P191, DOI 10.1089/jop.1992.8.191
   LOSA C, 1993, PHARMACEUT RES, V10, P80, DOI 10.1023/A:1018977130559
   Ludwig A, 2005, ADV DRUG DELIVER REV, V57, P1595, DOI 10.1016/j.addr.2005.07.005
   Mainardes RM, 2005, CURR DRUG TARGETS, V6, P363, DOI 10.2174/1389450053765914
   Mannermaa E, 2005, CURR EYE RES, V30, P345, DOI 10.1080/02713680590934058
   Marano RJ, 2004, EXP EYE RES, V79, P525, DOI 10.1016/j.exer.2004.06.023
   MARCHALHEUSSLER L, 1991, J FR OPHTALMOL, V14, P371
   MARCHALHEUSSLER L, 1993, PHARMACEUT RES, V10, P386, DOI 10.1023/A:1018936205485
   Maruyama-Tabata H, 2000, GENE THER, V7, P53, DOI 10.1038/sj.gt.3301044
   Mastorakos P, 2015, NANOSCALE, V7, P3845, DOI 10.1039/c4nr04284k
   Masuda I, 1996, INVEST OPHTH VIS SCI, V37, P1914
   Matsuo T, 1996, BIOCHEM BIOPH RES CO, V219, P947, DOI 10.1006/bbrc.1996.0326
   MEISNER D, 1995, ADV DRUG DELIVER REV, V16, P75, DOI 10.1016/0169-409X(95)00016-Z
   Muchow M, 2008, DRUG DEV IND PHARM, V34, P1394, DOI [10.1080/03639040802130061, 10.1080/03639040802130061 ]
   Nagarwal RC, 2009, J CONTROL RELEASE, V136, P2, DOI 10.1016/j.jconrel.2008.12.018
   Naik R, 2009, DRUG DISCOV TODAY, V14, P306, DOI 10.1016/j.drudis.2008.09.012
   Naveh N, 2000, GRAEF ARCH CLIN EXP, V238, P334, DOI 10.1007/s004170050361
   Olczyk P, 2008, POSTEP HIG MED DOSW, V62, P651
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Ooya T, 2003, J CONTROL RELEASE, V93, P121, DOI 10.1016/j.jconrel.2003.07.001
   PANGBURN SH, 1982, BIOMATERIALS, V3, P105, DOI 10.1016/0142-9612(82)90043-6
   Paolicelli P, 2009, EXPERT OPIN DRUG DEL, V6, P239, DOI 10.1517/17425240902762818
   Pardeike J, 2009, INT J PHARMACEUT, V366, P170, DOI 10.1016/j.ijpharm.2008.10.003
   Park K, 2007, J CONTROL RELEASE, V122, P305, DOI 10.1016/j.jconrel.2007.04.009
   Parraga J. E., 2009, HUM GENE THER, V20, P1417
   Parraga JE, 2014, INT J PHARMACEUT, V477, P12, DOI 10.1016/j.ijpharm.2014.09.049
   Peeters L, 2007, BIOCHEM SOC T, V35, P47, DOI 10.1042/BST0350047
   Peeters L, 2005, INVEST OPHTH VIS SCI, V46, P3553, DOI 10.1167/iovs.05-0165
   Pignatello R, 2006, AAPS PHARMSCITECH, V7, DOI 10.1208/pt070127
   Pignatello R, 2002, J PHARM SCI, V91, P2636, DOI 10.1002/jps.10227
   Pignatello R, 2002, BIOMATERIALS, V23, P3247, DOI 10.1016/S0142-9612(02)00080-7
   Pitkanen LH, 2001, INVEST OPHTH VIS SCI, V42, pS344
   Prego Cecilia, 2005, Expert Opin Drug Deliv, V2, P843, DOI 10.1517/17425247.2.5.843
   Prow TW, 2008, NANOMED-NANOTECHNOL, V4, P340, DOI 10.1016/j.nano.2008.06.003
   Qaddoumi MG, 2004, PHARM RES, V21, P641, DOI 10.1023/B:PHAM.0000022411.47059.76
   Rabinovich-Guilatt L, 2004, J DRUG TARGET, V12, P623, DOI 10.1080/10611860400015910
   Ranney DF, 2000, BIOCHEM PHARMACOL, V59, P105, DOI 10.1016/S0006-2952(99)00316-0
   Ravina M, 2010, MINI-REV MED CHEM, V10, P73, DOI 10.2174/138955710791112569
   Rowe R. C., 2003, HDB PHARM EXCIPIENTS, P462
   Rowe R. C., 2003, HDB PHARM EXCIPIENTS, P19
   Sahoo SK, 2008, DRUG DISCOV TODAY, V13, P144, DOI 10.1016/j.drudis.2007.10.021
   Sakai T, 2006, EXP EYE RES, V82, P657, DOI 10.1016/j.exer.2005.09.003
   Sanchez A., 2011, U.S. Patent, Patent No. 20110256059
   Sandri G, 2006, EUR J PHARM BIOPHARM, V62, P59, DOI 10.1016/j.ejpb.2005.07.002
   Sarker Dipak K., 2005, Current Drug Delivery, V2, P297, DOI 10.2174/156720105774370267
   Schipper NGM, 1999, EUR J PHARM SCI, V8, P335, DOI 10.1016/S0928-0987(99)00032-9
   Schipper NGM, 1996, PHARMACEUT RES, V13, P1686, DOI 10.1023/A:1016444808000
   Schipper NGM, 1997, PHARMACEUT RES, V14, P923, DOI 10.1023/A:1012160102740
   SCOTT JE, 1995, J ANAT, V187, P259
   Seki T, 2006, J PHARM SCI-US, V95, P1393, DOI 10.1002/jps.20616
   Seki T, 2007, INT J PHARM, V338, P213, DOI 10.1016/j.ijpharm.2007.02.004
   Shen J, 2009, J CONTROL RELEASE, V137, P217, DOI 10.1016/j.jconrel.2009.04.021
   Shen Y., 2007, AAPS J, V9, P371
   SHEPHERD VL, 1991, INVEST OPHTH VIS SCI, V32, P1779
   Sintzel MB, 1996, EUR J PHARM BIOPHARM, V42, P358
   Sogias IA, 2008, BIOMACROMOLECULES, V9, P1837, DOI 10.1021/bm800276d
   Souto EB, 2007, J BIOMED NANOTECHNOL, V3, P317, DOI 10.1166/jbn.2007.049
   Souto E. B., 2008, International Journal of Cosmetic Science, V30, P157, DOI 10.1111/j.1468-2494.2008.00433.x
   Spataro G, 2010, EUR J MED CHEM, V45, P326, DOI 10.1016/j.ejmech.2009.10.017
   Stanley R. G., 2008, SMALL ANIMAL CLIN PH, P557
   Sutter M, 2007, J CONTROL RELEASE, V119, P301, DOI 10.1016/j.jconrel.2007.03.003
   Sznitowska M, 1999, INT J PHARM, V184, P115, DOI 10.1016/S0378-5173(99)00106-4
   Sznitowska M, 2000, INT J PHARM, V202, P161, DOI 10.1016/S0378-5173(00)00443-9
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   Tamilvanan S, 2004, PROG LIPID RES, V43, P489, DOI 10.1016/j.plipres.2004.09.001
   Tamilvanan S, 2004, EUR J PHARM BIOPHARM, V58, P357, DOI 10.1016/j.ejpb.2004.03.033
   Thakor D, 2007, MOL THER, V15, P2124, DOI 10.1038/sj.mt.6300256
   Theocharis DA, 2008, CONNECT TISSUE RES, V49, P124, DOI 10.1080/03008200802148496
   Thyagarajapuram N, 2007, J PHARM SCI-US, V96, P3363, DOI 10.1002/jps.21022
   Toropainen E, 2007, J GENE MED, V9, P208, DOI 10.1002/jgm.1011
   TREMBLAY C, 1985, INVEST OPHTH VIS SCI, V26, P711
   Vandamme TF, 2005, J CONTROL RELEASE, V102, P23, DOI 10.1016/j.jconrel.2004.09.015
   Vandervoort J, 2004, EUR J PHARM BIOPHARM, V57, P251, DOI 10.1016/s0939-6411(03)00187-5
   Vandervoort J, 1999, J Pharm Belg, V54, P85
   Vauthier C, 2003, ADV DRUG DELIVER REV, V55, P519, DOI 10.1016/S0169-409X(03)00041-3
   Vega E, 2006, J PHARM SCI-US, V95, P2393, DOI 10.1002/jps.20685
   Vega E, 2008, J PHARM SCI-US, V97, P5306, DOI 10.1002/jps.21383
   Wang WY, 2011, J PHARMACEUT BIOMED, V56, P825, DOI 10.1016/j.jpba.2011.07.017
   Weigel JA, 2003, GLYCOBIOLOGY, V13, P860
   Weigel JA, 2003, J BIOL CHEM, V278, P42802, DOI 10.1074/jbc.M307201200
   Weigel JA, 2002, BIOCHEM BIOPH RES CO, V294, P918, DOI 10.1016/S0006-291X(02)00558-2
   Wong K, 2006, BIOCONJUGATE CHEM, V17, P152, DOI 10.1021/bc0501597
   Yandrapu SK, 2013, NANOMED-NANOTECHNOL, V9, P514, DOI 10.1016/j.nano.2012.10.005
   Yang SC, 2004, PHARM RES, V21, P261, DOI 10.1023/B:PHAM.0000016238.44452.f1
   Yavuz B, 2013, SCI WORLD J, DOI 10.1155/2013/732340
   Yenice I, 2008, EXP EYE RES, V87, P162, DOI 10.1016/j.exer.2008.04.002
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Zhang H, 2001, BIOMATERIALS, V22, P1653, DOI 10.1016/S0142-9612(00)00326-4
   Zhang YQ, 2007, BIOTECHNOL APPL BIOC, V46, P197, DOI 10.1042/BA2060163
   Zhao DD, 1997, ACTA MED OKAYAMA, V51, P149
   Zillies Jan, 2005, J Pharm Pharm Sci, V7, P17
   Zillies JC, 2008, EUR J PHARM BIOPHARM, V70, P514, DOI 10.1016/j.ejpb.2008.04.026
   ZIMMER A, 1994, PHARMACEUT RES, V11, P1435, DOI 10.1023/A:1018995923348
   Zurowska-Pryczkowska K, 1999, EUR J PHARM BIOPHARM, V47, P255, DOI 10.1016/S0939-6411(98)00098-8
NR 221
TC 3
Z9 3
U1 3
U2 6
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1385-2728
EI 1875-5348
J9 CURR ORG CHEM
JI Curr. Org. Chem.
PY 2015
VL 19
IS 15
BP 1443
EP 1459
PG 17
WC Chemistry, Organic
SC Chemistry
GA CM3TL
UT WOS:000357607200001
DA 2018-10-19
ER

PT J
AU Kim, HY
   Miyazaki, S
AF Kim, Hee Young
   Miyazaki, Shuichi
TI Martensitic Transformation and Superelastic Properties of Ti-Nb Base
   Alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE shape memory effect; superelasticity; martensitic transformation;
   titanium alloy; biomaterial; alloy design; microstructure control;
   crystal structure
ID SHAPE-MEMORY BEHAVIOR; ELASTIC-DEFORMATION-BEHAVIOR;
   MECHANICAL-PROPERTIES; TITANIUM-ALLOY; BIOMEDICAL ALLOYS;
   THERMOMECHANICAL TREATMENT; CYCLIC DEFORMATION; SURFACE MODIFICATION;
   ALPHA''-MARTENSITE; HEAT-TREATMENT
AB Ti-Nb base alloys have been proposed as prospective candidates for Ni-free biomedical superelastic alloys due to their excellent mechanical properties with good biocompatibility, and many kinds of Ti-Nb base alloys exhibiting shape memory effect or superelasticity have been developed up to now. However, typical Ti-Nb base superelastic alloys show a small recovery strain which is less than one third of the recovery strain of practical Ti-Ni superelastic alloys. Over the last decade there have been extensive efforts to improve the properties of Ti-Nb base superelastic alloys through microstructure control and alloying. Low temperature annealing and aging are very effective to increase the critical stress for slip due to fine subgrain structure and precipitation hardening. The addition of interstitial alloying elements such as O and N raises the critical stress for slip and improves superelastic properties. In this paper, the roles of alloying elements on the martensitic transformation temperature, crystal structure, microstructure and deformation behavior in the Ti-Nb base alloys are reviewed and the alloy design strategy for biomedical superelastic alloys is proposed.
C1 [Kim, Hee Young; Miyazaki, Shuichi] Univ Tsukuba, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
RP Kim, HY (reprint author), Univ Tsukuba, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
EM heeykim@ims.tsukuba.ac.jp; miyazaki@ims.tsukuba.ac.jp
RI Kim, Hee Young/F-6065-2011; Miyazaki, Shuichi/A-3113-2012
OI Kim, Hee Young/0000-0003-1981-6678; Miyazaki,
   Shuichi/0000-0003-3849-4176
FU JSPS KAKENHI [26249104]; MEXT KAKENHI [25102704]
FX This work was partially supported by JSPS KAKENHI Grant Number 26249104
   and MEXT KAKENHI Grant Number 25102704.
CR Adharapurapu RR, 2007, EXP MECH, V47, P365, DOI 10.1007/s11340-006-9004-x
   Ahmed T, 1996, J MATER SCI, V31, P4267, DOI 10.1007/BF00356449
   Al-Zain Y, 2011, ACTA MATER, V59, P1464, DOI 10.1016/j.actamat.2010.11.008
   Al-Zain Y, 2010, ACTA MATER, V58, P4212, DOI 10.1016/j.actamat.2010.04.013
   Al-Zain Y, 2012, ACTA MATER, V60, P2437, DOI 10.1016/j.actamat.2011.12.033
   Baker C., 1971, Metal Science Journal, V5, P92
   BAKER C, 1969, PHILOS MAG, V19, P1223, DOI 10.1080/14786436908228647
   Barrabes M, 2007, J MATER SCI-MATER M, V18, P2123, DOI 10.1007/s10856-007-3012-y
   Biesiekierski A, 2012, ACTA BIOMATER, V8, P1661, DOI 10.1016/j.actbio.2012.01.018
   BOWLES JS, 1954, ACTA METALL MATER, V2, P129, DOI 10.1016/0001-6160(54)90102-9
   Buenconsejo PJS, 2009, ACTA MATER, V57, P2509, DOI 10.1016/j.actamat.2009.02.007
   Buenconsejo PJS, 2009, ACTA MATER, V57, P1068, DOI 10.1016/j.actamat.2008.10.041
   BYWATER KA, 1972, PHILOS MAG, V25, P1249, DOI 10.1080/14786437208223852
   Chai Y. W., 2008, ACTA MAT, P3088
   Chai Y. W., 2009, ACTA MAT, P4054
   Cheng Y, 2006, J MATER SCI, V41, P4961, DOI 10.1007/s10853-006-0096-6
   Chrzanowski W, 2008, J MATER SCI-MATER M, V19, P1553, DOI 10.1007/s10856-008-3374-9
   Chu CL, 2009, ACTA BIOMATER, V5, P2238, DOI 10.1016/j.actbio.2009.01.046
   Collings E. W., 1994, MAT PROPERTIES HDB T
   Cui Y, 2010, MAT SCI ENG A-STRUCT, V527, P652, DOI 10.1016/j.msea.2009.08.063
   Denkhaus E, 2002, CRIT REV ONCOL HEMAT, V42, P35, DOI 10.1016/S1040-8428(01)00214-1
   DUERIG TW, 1982, ACTA METALL MATER, V30, P2161, DOI 10.1016/0001-6160(82)90137-7
   Elahinia MH, 2012, PROG MATER SCI, V57, P911, DOI 10.1016/j.pmatsci.2011.11.001
   Es-Souni M, 2005, ANAL BIOANAL CHEM, V381, P557, DOI 10.1007/s00216-004-2888-3
   Espinar E, 2011, J MATER SCI-MATER M, V22, P1119, DOI 10.1007/s10856-011-4292-9
   Farooq MU, 2014, MATER LETT, V121, P58, DOI 10.1016/j.matlet.2014.01.148
   Fukui Y, 2004, MATER TRANS, V45, P1077, DOI 10.2320/matertrans.45.1077
   Grosdidier T, 2000, MAT SCI ENG A-STRUCT, V291, P218, DOI 10.1016/S0921-5093(00)00921-7
   Haider W, 2009, J MATER ENG PERFORM, V18, P760, DOI 10.1007/s11665-009-9435-5
   Hao YL, 2006, MAT SCI ENG A-STRUCT, V441, P112, DOI 10.1016/j.msea.2006.09.051
   Horiuchi Y, 2007, MATER TRANS, V48, P407, DOI 10.2320/matertrans.48.407
   Horiuchi Y, 2007, MATER TRANS, V48, P414, DOI 10.2320/matertrans.48.414
   Horiuchi Y, 2006, MATER TRANS, V47, P1209, DOI 10.2320/matertrans.47.1209
   Hosoda H, 2003, MATER SCI FORUM, V426-4, P3121, DOI 10.4028/www.scientific.net/MSF.426-432.3121
   Hosoda H., 2006, MATER SCI FORUM, V638-642, P2046
   Ijaz MF, 2014, SCRIPTA MATER, V72-73, P29, DOI 10.1016/j.scriptamat.2013.10.007
   Inamura T, 2007, PHILOS MAG, V87, P3325, DOI 10.1080/14786430601003874
   Inamura T, 2005, MAT SCI ENG C-BIO S, V25, P426, DOI 10.1016/j.msec.2005.01.025
   Inamura T, 2004, MATER TRANS, V45, P1083, DOI 10.2320/matertrans.45.1083
   Inamura T, 2013, PHILOS MAG, V93, P618, DOI 10.1080/14786435.2012.725955
   Inamura T., 2010, PHILOS MAG, P3475
   Jepson K.S., 1970, SCI TECHNOLOGY APPL, P677
   Kent D, 2010, MAT SCI ENG A-STRUCT, V527, P2246, DOI 10.1016/j.msea.2009.11.059
   Kim H., 2014, MAT JAPAN, V53, P11
   Kim HY, 2006, MAT SCI ENG A-STRUCT, V438, P839, DOI 10.1016/j.msea.2006.02.136
   Kim HY, 2007, MATER TRANS, V48, P400, DOI 10.2320/matertrans.48.400
   Kim HY, 2013, ACTA MATER, V61, P4874, DOI 10.1016/j.actamat.2013.04.060
   Kim HY, 2006, ACTA MATER, V54, P2419, DOI 10.1016/j.actamat.2006.01.019
   Kim HY, 2006, MAT SCI ENG A-STRUCT, V417, P120, DOI 10.1016/j.msea.2005.10.065
   Kim HY, 2006, ACTA MATER, V54, P423, DOI 10.1016/j.actamat.2005.09.014
   Kim HY, 2004, MATER TRANS, V45, P2443, DOI 10.2320/matertrans.45.2443
   Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090
   Kim JI, 2006, MATER TRANS, V47, P505, DOI 10.2320/matertrans.47.505
   Kim JI, 2005, MAT SCI ENG A-STRUCT, V403, P334, DOI 10.1016/j.msea.2005.05.050
   Kim JI, 2005, MATER TRANS, V46, P852, DOI 10.2320/matertrans.46.852
   Kujala S, 2004, BIOMATERIALS, V25, P353, DOI 10.1016/S0142-9612(03)00488-5
   Li Q, 2012, MAT SCI ENG A-STRUCT, V536, P197, DOI 10.1016/j.msea.2011.12.103
   Li QA, 2010, AUSTRALAS PHYS ENG S, V33, P129, DOI 10.1007/s13246-010-0022-8
   Ma LW, 2013, INTERMETALLICS, V32, P44, DOI 10.1016/j.intermet.2012.07.024
   MACKENZIE JK, 1954, ACTA METALL MATER, V2, P138, DOI 10.1016/0001-6160(54)90103-0
   Maeshima T, 2004, MATER TRANS, V45, P1096, DOI 10.2320/matertrans.45.1096
   Michiardi A, 2006, J BIOMED MATER RES B, V77B, P249, DOI 10.1002/jbm.b.30441
   Miyazaki S, 2006, MAT SCI ENG A-STRUCT, V438, P18, DOI 10.1016/j.msea.2006.02.054
   MIYAZAKI S, 1986, METALL TRANS A, V17, P115, DOI 10.1007/BF02644447
   MIYAZAKI S, 1989, ISIJ INT, V29, P353, DOI 10.2355/isijinternational.29.353
   MIYAZAKI S, 1986, METALL TRANS A, V17, P53, DOI 10.1007/BF02644442
   Miyazaki S, 2007, MATER SCI FORUM, V561-565, P5, DOI 10.4028/www.scientific.net/MSF.561-565.5
   MOFFAT DL, 1988, METALL TRANS A, V19, P1677, DOI 10.1007/BF02645135
   Moneim MS, 2002, CLIN ORTHOP RELAT R, P251
   MORNIROLI JP, 1973, MEM ETUD SCI REV MET, V70, P831
   Nii Y, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214104
   Niinomi M, 2008, MAT SCI ENG C-BIO S, V28, P406, DOI 10.1016/j.msec.2007.04.028
   Nozoe F, 2007, MATER TRANS, V48, P3007, DOI 10.2320/matertrans.MER2007182
   Obbard EG, 2011, ACTA MATER, V59, P112, DOI 10.1016/j.actamat.2010.09.015
   Otsuka K., 1998, SHAPE MEMORY MAT
   Pavon LL, 2015, SCRIPTA MATER, V95, P46, DOI 10.1016/j.scriptamat.2014.09.029
   Ping DH, 2005, SCRIPTA MATER, V52, P1287, DOI 10.1016/j.scriptamat.2005.02.029
   Pond RC, 2003, INT MATER REV, V48, P225, DOI 10.1179/095066003225010245
   Ramarolahy A, 2012, J MECH BEHAV BIOMED, V9, P83, DOI 10.1016/j.jmbbm.2012.01.017
   Sakaguchi N, 2005, MAT SCI ENG C-BIO S, V25, P363, DOI 10.1016/j.msec.2004.12.014
   Sasano H., 1985, P 5 INT C TIT, P1667
   Singh R, 2007, J MATER SCI-MATER M, V18, P725, DOI 10.1007/s10856-006-0016-y
   Sun F, 2011, J MECH BEHAV BIOMED, V4, P1864, DOI 10.1016/j.jmbbm.2011.06.003
   Sun F, 2011, MAT SCI ENG A-STRUCT, V528, P7811, DOI 10.1016/j.msea.2011.06.052
   Tada H, 2012, MATER TRANS, V53, P1981, DOI 10.2320/matertrans.M2012184
   Tahara M, 2009, ACTA MATER, V57, P2461, DOI 10.1016/j.actamat.2009.01.037
   Tahara M, 2014, ACTA MATER, V80, P317, DOI 10.1016/j.actamat.2014.07.012
   Tahara M, 2013, J ALLOY COMPD, V577, pS404, DOI 10.1016/j.jallcom.2011.12.113
   Tahara M, 2011, ACTA MATER, V59, P6208, DOI 10.1016/j.actamat.2011.06.015
   Tahara M, 2010, MAT SCI ENG A-STRUCT, V527, P6844, DOI 10.1016/j.msea.2010.07.052
   Tahara M, 2009, MATER TRANS, V50, P2726, DOI 10.2320/matertrans.MA200907
   Tahara M, 2009, FUNCT MATER LETT, V2, P79, DOI 10.1142/S1793604709000600
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
   WECHSLER MS, 1953, T AM I MIN MET ENG, V197, P1503
   Williams J. C., 1973, P 2 INT C TIT, P1433
   Yamauchi K, 2011, SHAPE MEMORY AND SUPERELASTIC ALLOYS: TECHNOLOGIES AND APPLICATIONS, P1, DOI 10.1533/9780857092625
   Yang Y, 2014, J ALLOY COMPD, V591, P85, DOI 10.1016/j.jallcom.2013.12.207
   Yoneyama T, 2008, WOODHEAD PUBL MATER, P1
   Zhang DC, 2013, J MECH BEHAV BIOMED, V20, P29, DOI 10.1016/j.jmbbm.2013.01.015
   Zhang JY, 2013, MAT SCI ENG A-STRUCT, V563, P78, DOI 10.1016/j.msea.2012.11.045
   Zhou T, 2004, SCRIPTA MATER, V50, P343, DOI 10.1016/j.scriptamat.2003.10.012
   Zhu YF, 2012, J MECH BEHAV BIOMED, V12, P151, DOI 10.1016/j.jmbbm.2012.02.010
NR 102
TC 20
Z9 20
U1 2
U2 68
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PY 2015
VL 56
IS 5
BP 625
EP 634
DI 10.2320/matertrans.M2014454
PG 10
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CM4YB
UT WOS:000357691400002
OA Bronze
DA 2018-10-19
ER

PT J
AU Roch, T
   Ma, N
   Kratz, K
   Lendlein, A
AF Roch, Toralf
   Ma, Nan
   Kratz, Karl
   Lendlein, Andreas
TI Cell-based detection of microbial biomaterial contaminations
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Biomaterials; polymers; endotoxins; microbial contaminations;
   immuno-compatibility
ID PATTERN-RECOGNITION RECEPTORS; ENDOTHELIAL-CELLS; INNATE IMMUNITY;
   IN-VIVO; ENDOTOXIN; TOLL; ADHESION; BACTERIAL; LIPOPOLYSACCHARIDE;
   REGULATORS
AB A major challenge in biomaterial synthesis and functionalization is the prevention of microbial contaminations such as endotoxins (lipopolysaccharides (LPS)). In addition to LPS, which are exclusively expressed by Gram negative bacteria, also other microbial products derived from fungi or Gram positive bacteria can be found as contaminations in research laboratories. Typically, the Limulus amebocyte lysate (LAL)-test is used to determine the endotoxin levels of medical devices. However, this test fails to detect material-bound LPS and other microbial contaminations and, as demonstrated in this study, detects LPS from various bacterial species with different sensitivities.
   In this work, a cell-based assay using genetically engineered RAW macrophages, which detect not only soluble but also material-bound microbial contaminations is introduced.
   The sensitivity of this cell-line towards different LPS species and different heat-inactivated microbes was investigated. As proof of principle a soft hydrophobic poly(n-butyl acrylate) network (cPnBA), which may due to adhesive properties strongly bind microbes, was deliberately contaminated with heat-inactivated bacteria. While the LAL-test failed to detect the microbial contamination, the cell-based assay clearly detected material-bound microbial contaminations. Our data demonstrate that a cell-based detection system should routinely be used as supplement to the LAL-test to determine microbial contaminations of biomaterials.
C1 [Roch, Toralf; Ma, Nan; Kratz, Karl; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, D-14513 Teltow, Germany.
   [Roch, Toralf; Ma, Nan; Kratz, Karl; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-14513 Teltow, Germany.
   [Roch, Toralf; Ma, Nan; Kratz, Karl; Lendlein, Andreas] Helmholtz Virtual Inst Multifunct Biomat Med, Teltow, Germany.
   [Roch, Toralf; Ma, Nan; Kratz, Karl; Lendlein, Andreas] Helmholtz Virtual Inst Multifunct Biomat Med, Berlin, Germany.
   [Ma, Nan; Lendlein, Andreas] Free Univ Berlin, Inst Chem & Biochem, Dept Biol, Chem & Pharm, Berlin, Germany.
   [Lendlein, Andreas] Univ Potsdam, Inst Chem, Potsdam, Germany.
RP Roch, T (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
EM toralf.roch@hzg.de
RI Ma, Nan/L-1282-2013; Kratz, Karl/K-7115-2013; Lendlein,
   Andreas/K-9553-2013
OI Ma, Nan/0000-0003-4006-1003; Kratz, Karl/0000-0002-9229-4266; Lendlein,
   Andreas/0000-0003-4126-4670; Roch, Toralf/0000-0003-2948-8700
FU German Federal Ministry of Education and Research (BMBF) [276 0315696A]
FX The authors thank German Federal Ministry of Education and Research
   (BMBF project number 276 0315696A 'Poly4Bio BB') for financial support
   as well as Anja Muller-Heyn, Angelika Ritschel, and Ruth Hesse for their
   technical assistance.
CR [Anonymous], 1987, GUID VAL LIM AM LYS, P1
   Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202
   Bar-Shavit Z, 2008, AUTOIMMUNITY, V41, P195, DOI 10.1080/08916930701694469
   Barbosa JN, 2004, BIOMATERIALS, V25, P2557, DOI [10.1016/j.biomaterials.2003.09.047, 10.1016/j .biomaterials.2003.09.047]
   Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   Brandenburg K, 1996, J ENDOTOXIN RES, V3, P173, DOI 10.1177/096805199600300302
   Braune S., 2013, BIOINTERPHASES, V8, P30, DOI DOI 10.1186/1559-4106-8-33
   COOPER JF, 1990, J PARENT SCI TECHN, V44, P13
   Cui J, 2011, POLYM ADVAN TECHNOL, V22, P126, DOI 10.1002/pat.1816
   English K, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015560
   Furlani D, 2012, J CELL MOL MED, V16, P1094, DOI 10.1111/j.1582-4934.2011.01381.x
   GALANOS C, 1985, EUR J BIOCHEM, V148, P1, DOI 10.1111/j.1432-1033.1985.tb08798.x
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Hiebl B, 2012, J BIOMAT SCI-POLYM E, V23, P901, DOI 10.1163/092050611X566144
   Hirayama C, 2002, J CHROMATOGR B, V781, P419, DOI 10.1016/S1570-0232(02)00430-0
   Hwang Jeong-Min, 2012, BMC Res Notes, V5, P78, DOI 10.1186/1756-0500-5-78
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Lendlein A, 2011, EXPERT REV MED DEVIC, V8, P533, DOI [10.1586/erd.11.39, 10.1586/ERD.11.39]
   Lendlein A, 2011, INT J ARTIF ORGANS, V34, P71, DOI 10.5301/IJAO.2011.6422
   Lewis JS, 2014, MRS BULL, V39, P25, DOI 10.1557/mrs.2013.310
   Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5
   Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156
   Neffe AT, 2013, MACROMOL BIOSCI, V13, P1720, DOI 10.1002/mabi.201300309
   Peter S.L., 2007, DRUGS PHARM SCI, V167, P361
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0
   RIETSCHEL ET, 1994, FASEB J, V8, P217
   Roch T, 2012, CLIN HEMORHEOL MICRO, V50, P131, DOI 10.3233/CH-2010-1449
   Roch T, 2012, CLIN HEMORHEOL MICRO, V52, P375, DOI 10.3233/CH-2012-1612
   Roch T, 2011, MACROMOL SYMP, V309-310, P182, DOI 10.1002/masy.201100048
   ROSLANSKY PF, 1991, J CLIN MICROBIOL, V29, P2477
   Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200
   Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979
   SWEADNER KJ, 1977, APPL ENVIRON MICROB, V34, P382
   Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Tanford C., 1980, HYDROPHOBIC EFFECT F, P233
   Tuladhar E, 2012, APPL ENVIRON MICROB, V78, P7769, DOI 10.1128/AEM.02144-12
   Vijayakumar R., 2012, EUROPEAN J PARENTERA, V17, P4
   Williams K.L., 2007, DRUGS PHARM SCI, V167, P27
   Williams K.L., 2007, DRUGS PHARM SCI, V167, P191
   Wischke C, 2012, J CONTROL RELEASE, V164, P299, DOI 10.1016/j.jconrel.2012.06.034
   Yoshikawa HY, 2012, J PHYS CHEM B, V116, P8024, DOI 10.1021/jp212385p
NR 43
TC 2
Z9 2
U1 0
U2 5
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2015
VL 60
IS 1
BP 51
EP 63
DI 10.3233/CH-151939
PG 13
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA CM3SX
UT WOS:000357605600006
PM 25818158
DA 2018-10-19
ER

PT J
AU van der Stok, J
   Koolen, MKE
   de Maat, MPM
   Yavari, SA
   Alblas, J
   Patka, P
   Verhaar, JAN
   van Lieshout, EMM
   Zadpoor, AA
   Weinans, H
   Jahr, H
AF van der Stok, J.
   Koolen, M. K. E.
   de Maat, M. P. M.
   Yavari, S. Amin
   Alblas, J.
   Patka, P.
   Verhaar, J. A. N.
   van Lieshout, E. M. M.
   Zadpoor, A. A.
   Weinans, H.
   Jahr, H.
TI FULL REGENERATION OF SEGMENTAL BONE DEFECTS USING POROUS TITANIUM
   IMPLANTS LOADED WITH BMP-2 CONTAINING FIBRIN GELS
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE BMP; bone graft; bone regeneration; fibrin; metal surface treatment;
   scaffold; titanium
ID HEPARIN-CONJUGATED FIBRIN; COLLOIDAL GELATIN GELS; MORPHOGENETIC
   PROTEIN-2; IN-VIVO; ORTHOPEDIC APPLICATIONS; MECHANICAL-PROPERTIES;
   TI-6AL-4V STRUCTURES; CONTROLLED DELIVERY; SUSTAINED DELIVERY;
   GROWTH-FACTORS
AB Regeneration of load-bearing segmental bone defects is a major challenge in trauma and orthopaedic surgery. The ideal bone graft substitute is a biomaterial that provides immediate mechanical stability, while stimulating bone regeneration to completely bridge defects over a short period. Therefore, selective laser melted porous titanium, designed and fine-tuned to tolerate full load-bearing, was filled with a physiologically concentrated fibrin gel loaded with bone morphogenetic protein-2 (BMP-2). This biomaterial was used to graft critical-sized segmental femoral bone defects in rats. As a control, porous titanium implants were either left empty or filled with a fibrin gels without BMP-2. We evaluated bone regeneration, bone quality and mechanical strength of grafted femora using in vivo and ex vivo mu CT scanning, histology, and torsion testing. This biomaterial completely regenerated and bridged the critical-sized bone defects within eight weeks. After twelve weeks, femora were anatomically re-shaped and revealed open medullary cavities. More importantly, new bone was formed throughout the entire porous titanium implants and grafted femora regained more than their innate mechanical stability: torsional strength exceeded twice their original strength. In conclusion, combining porous titanium implants with a physiologically concentrated fibrin gels loaded with BMP-2 improved bone regeneration in load-bearing segmental defects. This material combination now awaits its evaluation in larger animal models to show its suitability for grafting load-bearing defects in trauma and orthopaedic surgery.
C1 [van der Stok, J.; Koolen, M. K. E.; Verhaar, J. A. N.] Erasmus Univ, Med Ctr Rotterdam, Dept Orthopaed, Orthopaed Res Lab, Rotterdam, Netherlands.
   [Koolen, M. K. E.; Alblas, J.; Weinans, H.] Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands.
   [de Maat, M. P. M.] Erasmus Univ, Med Ctr Rotterdam, Dept Haematol, Rotterdam, Netherlands.
   [Yavari, S. Amin; Zadpoor, A. A.; Weinans, H.] Delft Univ Technol, Dept Biomed Engn, Delft, Netherlands.
   [Patka, P.] Erasmus Univ, Med Ctr Rotterdam, Dept Orthopaed, Dept Emergency Med, Rotterdam, Netherlands.
   [van Lieshout, E. M. M.] Erasmus Univ, Med Ctr Rotterdam, Dept Surg, Trauma Res Unit, Rotterdam, Netherlands.
   [Weinans, H.] Univ Med Ctr Utrecht, Dept Rheumatol, Utrecht, Netherlands.
   [Jahr, H.] Univ Hosp RWTH Aachen, Dept Orthopaed Surg, Aachen, Germany.
RP van der Stok, J (reprint author), Room Ee1614,Box 2040, NL-3000 CA Rotterdam, Netherlands.
EM j.vanderstok@erasmusmc.nl
RI Zadpoor, Amir A/A-8510-2008; Amin Yavari, Saber/G-9486-2013; Jahr,
   Holger/M-3099-2015; Amin Yavari, Saber/E-5360-2017
OI Amin Yavari, Saber/0000-0003-1677-5751; Jahr,
   Holger/0000-0001-7308-5584; Amin Yavari, Saber/0000-0003-1677-5751;
   Verhaar, Jan/0000-0003-3016-9600; Zadpoor, Amir
   Abbas/0000-0003-3234-2112
FU Dutch Ministry of Economic Affair; Dutch government [FES0908];
   START-Program of the Faculty of Medicine, RWTH Aachen; Osteosynthesis &
   Trauma Care foundation [2011-HWJV]; Project BONE-IP of the research
   program of the BioMedical Materials institute [P2.04]
FX This research forms part of the Project P2.04 BONE-IP of the research
   program of the BioMedical Materials institute, co-funded by the Dutch
   Ministry of Economic Affair and was supported by a grant from the Dutch
   government to The Netherlands Institute for Regenerative Medicine (NIRM,
   grant No. FES0908). This research project was further supported by the
   START-Program of the Faculty of Medicine, RWTH Aachen. Osteosynthesis &
   Trauma Care foundation is acknowledged for financial support
   (2011-HWJV).
CR Alvarez K, 2009, MATERIALS, V2, P790, DOI 10.3390/ma2030790
   An YH, 1999, ANIMAL MODELS ORTHOP
   Angle SR, 2012, J MUSCULOSKEL NEURON, V12, P28
   Bandyopadhyay A, 2010, ACTA BIOMATER, V6, P1640, DOI 10.1016/j.actbio.2009.11.011
   Bandyopadhyay A, 2009, J MATER SCI-MATER M, V20, P29, DOI 10.1007/s10856-008-3478-2
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Bessa PC, 2010, TISSUE ENG PART C-ME, V16, P937, DOI [10.1089/ten.tec.2009.0486, 10.1089/ten.TEC.2009.0486]
   Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513
   Chung YI, 2007, J CONTROL RELEASE, V121, P91, DOI 10.1016/j.jconrel.2007.05.029
   de Wild M, 2013, TISSUE ENG PT A, V19, P2645, DOI [10.1089/ten.tea.2012.0753, 10.1089/ten.TEA.2012.0753]
   Diefenderfer DL, 2003, J BONE JOINT SURG AM, V85A, P19, DOI 10.2106/00004623-200300003-00005
   EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016
   Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435
   GIANNOUDIS PV, 2011, INJURY S2, V42, pS1
   Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009
   Heinl P, 2008, ACTA BIOMATER, V4, P1536, DOI 10.1016/j.actbio.2008.03.013
   Hollander DA, 2006, BIOMATERIALS, V27, P955, DOI 10.1016/j.biomaterials.2005.07.041
   HOLM B, 1985, THROMB RES, V37, P165, DOI 10.1016/0049-3848(85)90043-X
   Hrabe NW, 2011, J BIOMED MATER RES B, V99B, P313, DOI 10.1002/jbm.b.31901
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   Kaijzel EL, 2006, J THROMB HAEMOST, V4, P1975, DOI 10.1111/j.1538-7836.2006.02081.x
   Kaipel M, 2012, J ORTHOP RES, V30, P1563, DOI 10.1002/jor.22132
   Khan SN, 2004, EXPERT OPIN BIOL TH, V4, P741
   Kim SS, 2008, J BIOMED MATER RES A, V87A, P245, DOI 10.1002/jbm.a.31782
   KIRKERHEAD CA, 1995, VET SURG, V24, P408, DOI 10.1111/j.1532-950X.1995.tb01352.x
   Koo KH, 2012, ARTIF ORGANS, V36, P629, DOI 10.1111/j.1525-1594.2012.01444.x
   Koo KH, 2013, ARTIF ORGANS, V37, P487, DOI 10.1111/j.1525-1594.2012.01578.x
   La WG, 2012, ARTIF ORGANS, V36, P642, DOI 10.1111/j.1525-1594.2011.01420.x
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7
   Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110
   Milleret V, 2011, EUR CELLS MATER, V21, P430, DOI 10.22203/eCM.v021a32
   Mullen L, 2009, J BIOMED MATER RES B, V89B, P325, DOI 10.1002/jbm.b.31219
   Murakami N, 2002, J BIOMED MATER RES, V62, P169, DOI 10.1002/jbm.10236
   Murr LE, 2011, J MECH BEHAV BIOMED, V4, P1396, DOI 10.1016/j.jmbbm.2011.05.010
   Murr LE, 2010, PHILOS T R SOC A, V368, P1999, DOI 10.1098/rsta.2010.0010
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Nurnberger S, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P237, DOI 10.1007/978-3-7091-0286-2_16
   Onishi T, 1998, BONE, V22, P605, DOI 10.1016/S8756-3282(98)00056-8
   Pape HC, 2010, J ORTHOP TRAUMA, V24, pS36, DOI 10.1097/BOT.0b013e3181cec4a1
   Peterbauer-Scherb A, 2012, J TISSUE ENG REGEN M, V6, P434, DOI 10.1002/term.446
   Ponader S, 2010, J BIOMED MATER RES A, V92A, P56, DOI 10.1002/jbm.a.32337
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Ryan G, 2009, J BIOMED MATER RES B, V90B, P894, DOI 10.1002/jbm.b.31361
   Schmoekel H, 2004, J ORTHOPAED RES, V22, P376, DOI 10.1016/S0736-0266(03)00188-8
   Schmokel HG, 2004, VET SURG, V33, P112, DOI [10.1111/j.1532-950x.2004.04018.x, 10.1111/j.1532-950X.2004.04018.x]
   Schutzenberger S, 2012, ARCH ORTHOP TRAUM SU, V132, P1363, DOI 10.1007/s00402-012-1551-2
   Seebach E, 2014, ACTA BIOMATER, V10, P4730, DOI 10.1016/j.actbio.2014.07.017
   Senta H, 2009, CYTOKINE GROWTH F R, V20, P213, DOI 10.1016/j.cytogfr.2009.05.006
   Stamp R, 2009, J MATER SCI-MATER M, V20, P1839, DOI 10.1007/s10856-009-3763-8
   Stefan U, 2010, BONE, V47, P1048, DOI 10.1016/j.bone.2010.08.012
   Termaat MF, 2005, J BONE JOINT SURG AM, V87A, P1367, DOI 10.2106/JBJS.D.02585
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   van der Stok J, 2013, TISSUE ENG PT A, V19, P2605, DOI [10.1089/ten.tea.2013.0181, 10.1089/ten.TEA.2013.0181]
   Van der Stok J, 2013, J ORTHOP RES, V31, P792, DOI 10.1002/jor.22293
   Wang HN, 2013, J CONTROL RELEASE, V166, P172, DOI 10.1016/j.jconrel.2012.12.015
   Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028
   Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Woo EJ, 2013, CLIN ORTHOP RELAT R, V471, P1707, DOI 10.1007/s11999-012-2684-x
   Yang HS, 2010, TISSUE ENG PT A, V16, P1225, DOI [10.1089/ten.tea.2009.0390, 10.1089/ten.TEA.2009.0390]
   Yang HS, 2012, EXP MOL MED, V44, P350, DOI 10.3858/emm.2012.44.5.039
   Yavari SA, 2014, J MECH BEHAV BIOMED, V36, P109, DOI 10.1016/j.jmbbm.2014.04.010
   Yavari SA, 2013, MAT SCI ENG C-MATER, V33, P4849, DOI 10.1016/j.msec.2013.08.006
   Yavari SA, 2014, BIOMATERIALS, V35, P6172, DOI 10.1016/j.biomaterials.2014.04.054
   Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.TEA.2010.0555, 10.1089/ten.tea.2010.0555]
NR 69
TC 20
Z9 20
U1 1
U2 16
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2015
VL 29
BP 141
EP 154
DI 10.22203/eCM.v029a11
PG 14
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA CL6TY
UT WOS:000357101500007
PM 25738583
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Kunz, F
   Rebl, H
   Quade, A
   Matschegewski, C
   Finke, B
   Nebe, JB
AF Kunz, F.
   Rebl, H.
   Quade, A.
   Matschegewski, C.
   Finke, B.
   Nebe, J. B.
TI OSTEOBLASTS WITH IMPAIRED SPREADING CAPACITY BENEFIT FROM THE POSITIVE
   CHARGES OF PLASMA POLYMERISED ALLYLAMINE
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Osteoblast function; actin cytoskeleton; vinculin; spreading;
   cytochalasin D; titanium; surface modification; plasma polymerised
   allylamine; surface charge
ID TITANIUM SURFACES; FOCAL ADHESION; CELL-ADHESION; IN-VITRO; SUBCHONDRAL
   BONE; ACTIN; OSTEOARTHRITIS; OSTEOPOROSIS; MG-63; ORGANIZATION
AB Bone diseases such as osteoporosis, osteoarthritis and rheumatoid arthritis, impinge on the performance of orthopaedic implants by impairing bone regeneration. For this reason, the development of effective surface modifications supporting the ingrowth of implants in morbid bone tissue is essential. Our study is designed to elucidate if cells with restricted cell-function limiting adhesion processes benefit from plasma polymer deposition on titanium. We used the actin filament disrupting agent cytochalasin D (CD) as an experimental model for cells with impaired actin cytoskeleton. Indeed, the cell's capacity to adhere and spread was drastically reduced due to shortened actin filaments and vinculin contacts that were smaller. The coating of titanium with a positively charged nanolayer of plasma polymerised allylamine (PPAAm) abrogated these disadvantages in cell adhesion and the CD-treated osteoblasts were able to spread significantly. Interestingly, PPAAm increased spreading by causing enhanced vinculin number and contact length, but without significantly reorganising actin filaments. PPAAm with the monomer allylamine was deposited in a microwave-excited low-pressure plasma-processing reactor. Cell physiology was monitored by flow cytometry and confocal laser scanning microscopy, and the length and number of actin filaments was quantified by mathematical image processing. We showed that biomaterial surface modification with PPAAm could be beneficial even for osteoblasts with impaired cytoskeleton components. These insights into in vitro conditions may be used for the evaluation of future strategies to design implants for morbid bone tissue.
C1 [Kunz, F.; Rebl, H.; Matschegewski, C.; Nebe, J. B.] Univ Med Ctr Rostock, Dept Cell Biol, D-18057 Rostock, Germany.
   [Kunz, F.] Univ Rostock, Fac Interdisciplinary Res, D-18055 Rostock, Germany.
   [Quade, A.; Finke, B.] Leibniz Inst Plasma Sci & Technol eV INP, Greifswald, Germany.
   [Matschegewski, C.] Univ Rostock, Fac Agr & Environm Sci, D-18055 Rostock, Germany.
RP Nebe, JB (reprint author), Univ Med Ctr Rostock, Dept Cell Biol, Schillingallee 69, D-18057 Rostock, Germany.
EM barbara.nebe@med.uni-rostock.de
OI Finke, Birgit/0000-0002-5941-0376
FU European Union; State Ministry of Economic Affairs, Employment and
   Tourism of Mecklenburg-Vorpommern in Germany [EFRE:
   V220-630-08-TFMV-F-009, ESV: V220-630-08-TFMV-S-009]; DFG Research
   Training Group welisa [GRK 1505/1]; project Campus Plasma-Med (BMBF)
   [13N9779, 13N11188/INP, 13N9775, 13N11183/Cell Biol.]
FX The author FK is grateful to the European Union and to the State
   Ministry of Economic Affairs, Employment and Tourism of
   Mecklenburg-Vorpommern in Germany for financial support within the joint
   project Tissue Regeneration (GEREMA) (EFRE: V220-630-08-TFMV-F-009, ESV:
   V220-630-08-TFMV-S-009). We acknowledge the financial support of CM and
   FK by the DFG Research Training Group welisa (GRK 1505/1). BF and HR
   were financially supported by the project Campus Plasma-Med (BMBF,
   13N9779 and 13N11188/INP, 13N9775 and 13N11183/Cell Biol.). We
   acknowledge the excellent technical help of Janine Wetzel (BMBF,
   13N11183) and the valuable scientific input of Dr. Ulrike Bulnheim. We
   wish to confirm that there are no known conflicts of interest associated
   with this publication and there has been no significant financial
   support for this work that could have influenced its outcome.
CR Abbas A, 2009, COLLOID SURFACE B, V73, P315, DOI 10.1016/j.colsurfb.2009.06.007
   Beil FT, 2008, EUR J TRAUMA EMERG S, V34, P527, DOI 10.1007/s00068-008-8201-y
   Birkholz H, 2011, PROC SPIE, V8000, DOI 10.1117/12.895269
   Birkholz H, 2011, J COMPUT APPL MATH, V235, P2502, DOI 10.1016/j.cam.2010.11.003
   Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245
   Bray D, 1992, CELL MOVEMENTS, P75
   CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0
   CLOVER J, 1992, J CELL SCI, V103, P267
   Corrado A, 2005, CLIN RHEUMATOL, V24, P527, DOI 10.1007/s10067-005-1100-2
   Czekanska EM, 2012, EUR CELLS MATER, V24, P1
   DEQUEKER J, 1993, ARTHRITIS RHEUM, V36, P1702, DOI 10.1002/art.1780361209
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   El Miedany YM, 2000, JOINT BONE SPINE, V67, P521, DOI 10.1016/S1297-319X(00)00218-9
   Ezzell RM, 1997, EXP CELL RES, V231, P14, DOI 10.1006/excr.1996.3451
   Finke B, 2011, SURF COAT TECH, V205, pS520, DOI 10.1016/j.surfcoat.2010.12.044
   Finke B, 2011, P INT PLASM CHEM SOC
   Finke B, 2007, BIOMATERIALS, V28, P4521, DOI 10.1016/j.biomaterials.2007.06.028
   Finke B, 2014, LANGMUIR, V30, P13914, DOI 10.1021/la5019778
   Gabler C, 2014, INT J MOL SCI, V15, P2454, DOI 10.3390/ijms15022454
   Gonzalez RC, 2008, DIGITAL IMAGE PROCES
   Hagiwara A, 2011, CYTOSKELETON, V68, P512, DOI 10.1002/cm.20528
   Hamerli P, 2003, BIOMATERIALS, V24, P3989, DOI 10.1016/S0142-9612(03)00312-0
   Hilal G, 1998, ARTHRITIS RHEUM, V41, P891, DOI 10.1002/1529-0131(199805)41:5<891::AID-ART17>3.0.CO;2-X
   Hoene A, 2010, ACTA BIOMATER, V6, P676, DOI 10.1016/j.actbio.2009.09.003
   Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036
   Intranuovo F, 2011, ACTA BIOMATER, V7, P3336, DOI 10.1016/j.actbio.2011.05.020
   Kartsogiannis V, 2004, MOL CELL ENDOCRINOL, V228, P79, DOI 10.1016/j.mce.2003.06.002
   Klein-Nulend J, 2003, ADV SPACE RES, V32, P1551, DOI 10.1016/S0273-1177(03)00488-5
   LAJEUNESSE D, 1990, J BONE MINER RES, V5, P915
   Lajeunesse D, 2003, CURR OPIN RHEUMATOL, V15, P628, DOI 10.1097/00002281-200309000-00018
   Lanniel M, 2011, THIN SOLID FILMS, V519, P2003, DOI 10.1016/j.tsf.2010.10.054
   Lee JW, 2002, ANAL BIOANAL CHEM, V373, P526, DOI 10.1007/s00216-002-1339-2
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   Matschegewski C, 2012, MATERIALS, V5, P1176, DOI 10.3390/ma5071176
   Matschegewski C, 2010, BIOMATERIALS, V31, P5729, DOI 10.1016/j.biomaterials.2010.03.073
   May JA, 1998, PLATELETS, V9, P227, DOI 10.1080/09537109876744
   Myers KA, 2007, BIOCHEM BIOPH RES CO, V364, P214, DOI 10.1016/j.bbrc.2007.09.109
   Nabavi N, 2011, BONE, V49, P965, DOI 10.1016/j.bone.2011.07.036
   Nebe B, 2013, HYG MED, V38, P192
   Nebe B, 2007, BIOMOL ENG, V24, P447, DOI 10.1016/j.bioeng.2007.07.004
   Nebe JB, 2012, MATER SCI FORUM, V706-709, P566, DOI 10.4028/www.scientific.net/MSF.706-709.566
   Nebe JGB, 2007, MACROMOL BIOSCI, V7, P567, DOI 10.1002/mabi.200600293
   Nebe JGB, 2008, METALLIC BIOMATERIAL, P179
   Neve A, 2011, CELL TISSUE RES, V343, P289, DOI 10.1007/s00441-010-1086-1
   Nileback E, 2014, ANALYST, V139, P5350, DOI 10.1039/c4an01393j
   Parreno J, 2008, MOL CELL BIOCHEM, V317, P21, DOI 10.1007/s11010-008-9801-x
   Perrini S, 2008, ENDOCRINOLOGY, V149, P1302, DOI 10.1210/en.2007-1349
   Raisz L G, 2000, Clin Cornerstone, V2, P1, DOI 10.1016/S1098-3597(00)90001-2
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rebl H, 2012, ACTA BIOMATER, V8, P3840, DOI 10.1016/j.actbio.2012.06.015
   Rebl H, 2010, INT J ARTIF ORGANS, V33, P738
   Ruoslahti E, 1996, EXP CELL RES, V227, P1, DOI 10.1006/excr.1996.0243
   Schnabelrauch M, 2014, INT J POLYM SCI, DOI 10.1155/2014/439784
   Schroder K, 2010, J ADHES SCI TECHNOL, V24, P1191, DOI 10.1163/016942409X12619870771501
   Sun YB, 2012, ANNU REV BIOPHYS, V41, P519, DOI 10.1146/annurev-biophys-042910-155306
   Takai E, 2005, ANN BIOMED ENG, V33, P963, DOI 10.1007/s10439-005-3555-3
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Walcott S, 2010, P NATL ACAD SCI USA, V107, P7757, DOI 10.1073/pnas.0912739107
   Walsh NC, 2009, J BONE MINER RES, V24, P1572, DOI [10.1359/JBMR.090320, 10.1359/jbmr.090320]
   Wittmann T, 2001, J CELL SCI, V114, P3795
   Wyrwa R, 2011, ADV ENG MATER, V13, pB165, DOI 10.1002/adem.201080116
   Yang J, 2010, BIOMATERIALS, V31, P8827, DOI 10.1016/j.biomaterials.2010.08.028
   Yang ZL, 2012, BIOMATERIALS, V33, P7959, DOI 10.1016/j.biomaterials.2012.07.050
   Yang ZL, 2011, MACROMOL BIOSCI, V11, P797, DOI 10.1002/mabi.201000474
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
NR 65
TC 3
Z9 3
U1 1
U2 6
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2015
VL 29
BP 177
EP 189
DI 10.22203/eCM.v029a13
PG 13
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA CL6TY
UT WOS:000357101500009
PM 25738585
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Yue, C
   Zhao, B
   Ren, Y
   Kuijer, R
   van der Mei, HC
   Busscher, HJ
   Rochford, ETJ
AF Yue, C.
   Zhao, B.
   Ren, Y.
   Kuijer, R.
   van der Mei, H. C.
   Busscher, H. J.
   Rochford, E. T. J.
TI THE IMPLANT INFECTION PARADOX: WHY DO SOME SUCCEED WHEN OTHERS FAIL?
   OPINION AND DISCUSSION PAPER
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Implant infection; immune responses; host pathogens; infection risk;
   biofilms
ID PROSTHETIC JOINT INFECTION; TOTAL HIP-ARTHROPLASTY; CREVICULAR FLUID;
   ORAL MUCOSAL; COMPLICATION RATES; LANGERHANS CELLS; CUTANEOUS WOUNDS;
   DENDRITIC CELLS; REGISTER; SKIN
AB Biomaterial-implants are frequently used to restore function and form of human anatomy. However, the presence of implanted biomaterials dramatically elevates infection risk. Paradoxically, dental-implants placed in a bacteria-laden milieu experience moderate failure-rates, due to infection (0.0-1.1 %), similar to the ones of joint-arthroplasties placed in a near-sterile environment (0.1-1.3 %). Transcutaneous bone-fixation pins breach the immune-barrier of the epidermis, exposing underlying sterile-tissue to an unsterile external environment. In contrast to dental-implants, also placed in a highly unsterile environment, these pins give rise to relatively high infection-associated failure-rates of up to 23.0 %. Herein, we attempt to identify causes as to why dental-implants so often succeed, where others fail. The major part of all implants considered are metal-made, with similar surface-finishes. Material choice was therefore discarded as underlying the paradox. Antimicrobial activity of saliva has also been suggested as a cause for the success of dental-implants, but was discarded because saliva is the implant-site-fluid from which viable bacteria adhere. Crevicular fluid was discarded as it is largely analogous to serum. Instead, we attribute the relative success of dental-implants to (1) ability of oral tissues to heal rapidly in the continuous presence of commensal bacteria and opportunistic pathogens, and (2) tolerance of the oral immune-system. Inability of local tissue to adhere, spread and grow in presence of bacteria and an intolerant immune-system are identified as the likely main causes explaining the susceptibility of other implants to infection-associated failure. In conclusion, it is the authors' belief that new anti-infection strategies for a wide range of biomaterial-implants may be derived from the relative success of dental-implants.
C1 [Yue, C.; Kuijer, R.; van der Mei, H. C.; Busscher, H. J.; Rochford, E. T. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [Zhao, B.; Ren, Y.] Univ Groningen, Univ Med Ctr Groningen, Dept Orthodont, NL-9700 RB Groningen, Netherlands.
RP Rochford, ETJ (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM e.rochford@umcg.nl
RI Kuijer, Roel/A-6690-2015
OI Kuijer, Roel/0000-0002-7637-4944
FU China Scholarship Council; W. J. Kolff institute
FX CY would like to thank the China Scholarship Council and W. J. Kolff
   institute for financial support.
CR Aboltins C, 2014, INTERN MED J, V44, P834, DOI 10.1111/imj.12510
   Al-Ahmad A, 2013, ARCH ORAL BIOL, V58, P1139, DOI 10.1016/j.archoralbio.2013.04.011
   Antalainen AK, 2013, INT J ORAL MAX IMPL, V28, P1612, DOI 10.11607/jomi.3277
   Benito N, 2014, J ORTHOP RES, V32, P633, DOI 10.1002/jor.22581
   Berezow AB, 2011, PERIODONTOL 2000, V55, P36, DOI 10.1111/j.1600-0757.2010.00350.x
   Buser D, 1997, CLIN ORAL IMPLAN RES, V8, P161, DOI 10.1034/j.1600-0501.1997.080302.x
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Chai WL, 2012, J R SOC INTERFACE, V9, P3528, DOI 10.1098/rsif.2012.0507
   Chehroudi B, 2002, BIOMATERIALS, V23, P229, DOI 10.1016/S0142-9612(01)00100-4
   Dale H, 2012, ACTA ORTHOP, V83, P449, DOI 10.3109/17453674.2012.733918
   De Bruyn H, 2013, CLIN IMPLANT DENT R, V15, P73, DOI 10.1111/j.1708-8208.2011.00359.x
   Derks J, 2015, J DENT RES, V94, p44S, DOI 10.1177/0022034514563077
   Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   Engels-Deutsch M, 2011, ARCH ORAL BIOL, V56, P22, DOI 10.1016/j.archoralbio.2010.08.010
   Gorr SU, 2011, J CLIN PERIODONTOL, V38, P126, DOI 10.1111/j.1600-051X.2010.01664.x
   Hailer NP, 2015, ACTA ORTHOP, V86, P1, DOI 10.3109/17453674.2014.1002183
   Hakkinen L, 2000, PERIODONTOL 2000, V24, P127, DOI 10.1034/j.1600-0757.2000.2240107.x
   Iorio R, 2012, J ARTHROPLASTY, V27, P726, DOI 10.1016/j.arth.2011.09.013
   Isolauri E, 2001, AM J CLIN NUTR, V73, p444S, DOI 10.1093/ajcn/73.2.444s
   Ito H, 1998, ARCH ORAL BIOL, V43, P741, DOI 10.1016/S0003-9969(98)00066-1
   Jakubovics NS, 2008, FEMS MICROBIOL ECOL, V66, P637, DOI 10.1111/j.1574-6941.2008.00585.x
   Kraemer P, 2010, J SPINAL DISORD TECH, V23, pE59, DOI 10.1097/BSD.0b013e3181d1e14c
   Kreth J, 2009, DNA CELL BIOL, V28, P397, DOI 10.1089/dna.2009.0868
   Le DH, 2014, CLIN ORTHOP RELAT R, V472, P2197, DOI 10.1007/s11999-014-3540-y
   Lee JJ, 2000, J ORAL MAXIL SURG, V58, P1372, DOI 10.1053/joms.2000.18269
   Lindgren JV, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-384
   Lukac J, 2003, J ORAL PATHOL MED, V32, P271, DOI 10.1034/j.1600-0714.2003.00127.x
   Mak K, 2009, J DERMATOL SCI, V56, P168, DOI 10.1016/j.jdermsci.2009.09.005
   Makela KT, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7592
   McKeown STW, 2007, J DENT RES, V86, P457, DOI 10.1177/154405910708600513
   Mombelli A, 2011, J CLIN PERIODONTOL, V38, P203, DOI 10.1111/j.1600-051X.2010.01666.x
   Mowat AM, 2005, VACCINE, V23, P1797, DOI 10.1016/j.vaccine.2004.11.008
   Ohara-Nemoto Y, 2008, J MED MICROBIOL, V57, P95, DOI 10.1099/jmm.0.47561-0
   Ostman PO, 2012, CLIN IMPLANT DENT R, V14, P852, DOI 10.1111/j.1708-8208.2012.00453.x
   Patterson MM, 2005, ORTHOP NURS, V24, P349
   Pedersen AB, 2010, ACTA ORTHOP, V81, P542, DOI 10.3109/17453674.2010.519908
   Peel TN, 2012, ANTIMICROB AGENTS CH, V56, P2386, DOI 10.1128/AAC.06246-11
   Petti S, 2001, ARCH ORAL BIOL, V46, P705, DOI 10.1016/S0003-9969(01)00033-4
   Pisano E, 2005, EUR J ORAL SCI, V113, P462, DOI 10.1111/j.1600-0722.2005.00246.x
   Pjetursson BE, 2007, CLIN ORAL IMPLAN RES, V18, P73, DOI 10.1111/j.1600-0501.2007.01467.x
   Prabhakara R, 2011, INFECT IMMUN, V79, P5010, DOI 10.1128/IAI.05571-11
   Santagati M, 2012, FEMS IMMUNOL MED MIC, V65, P23, DOI 10.1111/j.1574-695X.2012.00928.x
   Schalamon J, 2007, J PEDIATR SURG, V42, P1584, DOI 10.1016/j.jpedsurg.2007.04.022
   Schrama JC, 2010, ARTHRIT CARE RES, V62, P473, DOI 10.1002/acr.20036
   Schrementi ME, 2008, WOUND REPAIR REGEN, V16, P80, DOI 10.1111/j.1524-475X.2007.00320.x
   SCIUBBA JJ, 1978, J ORAL PATHOL MED, V7, P214, DOI 10.1111/j.1600-0714.1978.tb01596.x
   Shaik M, 2014, J MAXILLOFAC ORAL SU, V13, P47, DOI 10.1007/s12663-012-0443-x
   SHILLITOE EJ, 1972, ARCH ORAL BIOL, V17, P241, DOI 10.1016/0003-9969(72)90206-3
   SKAPSKI H, 1976, J PERIODONTAL RES, V11, P19, DOI 10.1111/j.1600-0765.1976.tb00046.x
   Stach Renee M, 2003, Implant Dent, V12, P87
   Stoodley P, 2011, FEMS IMMUNOL MED MIC, V62, P66, DOI 10.1111/j.1574-695X.2011.00793.x
   Stumbles PA, 2003, APMIS, V111, P741, DOI 10.1034/j.1600-0463.2003.11107806.x
   Szpaderska AM, 2003, J DENT RES, V82, P621, DOI 10.1177/154405910308200810
   VANLOON LAJ, 1989, J ORAL PATHOL MED, V18, P197
   Veiga-Malta I, 2004, CELL MICROBIOL, V6, P79, DOI 10.1046/j.1462-5822.2003.00344.x
   Villar CC, 2012, ORAL WOUND HEALING C, P287
   Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006
   Wilgus TA, 2008, PHARMACOL RES, V58, P112, DOI 10.1016/j.phrs.2008.07.009
   Williamson E, 2002, J IMMUNOL, V169, P3606, DOI 10.4049/jimmunol.169.7.3606
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Zelles T, 1995, J DENT RES, V74, P1826, DOI 10.1177/00220345950740120301
NR 62
TC 10
Z9 10
U1 0
U2 10
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2015
VL 29
BP 303
EP 313
DI 10.22203/eCM.v029a23
PG 11
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA CL6TY
UT WOS:000357101500019
PM 26044130
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Baniasadi, H
   Ramazani, SAA
   Mashayekhan, S
   Farani, MR
   Ghaderinezhad, F
   Dabaghi, M
AF Baniasadi, Hossein
   Ramazani, Ahmad S. A.
   Mashayekhan, Shohreh
   Farani, Marzieh Ramezani
   Ghaderinezhad, Fariba
   Dabaghi, Mohammadhossein
TI Design, Fabrication, and Characterization of Novel Porous Conductive
   Scaffolds for Nerve Tissue Engineering
SO INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS
LA English
DT Article
DE Biocompatibility; biodegradation; conductivity; polypyrrole; porous
   scaffold
ID IN-VITRO; CHITOSAN; POLYPYRROLE; GELATIN; REGENERATION; COMPOSITES;
   NANOFIBERS
AB Highly conductive polypyrrole/graphene (PYG) nanocomposite was synthesized with chemical oxidation process via emulsion polymerization and used for the preparation of novel porous conductive gelatin/chitosan-based scaffolds. The effect of PYG loading on various properties of scaffolds was investigated. The obtained results indicated that by introducing PYG into the polymeric matrix, the porosity and swelling capacity decreased while electrical conductivity and Young's modulus demonstrated increasing trend. The in vitro biodegradation test revealed that pure gelatin/chitosan matrix lost 80% of its weight after six weeks in the presence of lysozyme whilst the biodegradation rate was significantly lower for the conductive scaffolds. Furthermore, Schwann cell attachment and proliferation were evaluated by MTT assay and SEM image and the results revealed significant cell biocompatibility of the conductive scaffold with low amount of PYG. The results confirmed the potential of gelatin/chitosan/PYG compounding as a suitable biomaterial for using in nerve tissue engineering applications in which electrical stimulation plays a vital role.
C1 [Baniasadi, Hossein; Ramazani, Ahmad S. A.; Mashayekhan, Shohreh; Ghaderinezhad, Fariba; Dabaghi, Mohammadhossein] Sharif Univ Technol, Dept Chem & Petr Engn, POB 11365-8639, Tehran, Iran.
   [Farani, Marzieh Ramezani] Sharif Univ Technol, Kish Isl, Iran.
RP Ramazani, SAA (reprint author), Sharif Univ Technol, Dept Chem & Petr Engn, POB 11365-8639, Tehran, Iran.
EM ramazani@sharif.edu
OI Dabaghi, Mohammadhossein/0000-0002-8860-3775; Ramazani S.A.,
   Ahmad/0000-0002-0095-6104
CR Ai J, 2014, ARCH NEUROSCI, V1, DOI 10.5812/archneurosci.9144
   Alizadeh M, 2013, MAT SCI ENG C-MATER, V33, P3958, DOI 10.1016/j.msec.2013.05.039
   Amoabediny G., 2011, BIOMATERIALS SCI ENG
   Baniasadi H, 2015, INT J BIOL MACROMOL, V74, P360, DOI 10.1016/j.ijbiomac.2014.12.014
   Baniasadi H, 2014, SYNTHETIC MET, V196, P199, DOI 10.1016/j.synthmet.2014.08.007
   Bini TB, 2005, J MATER SCI-MATER M, V16, P367, DOI 10.1007/s10856-005-0637-6
   Brahatheeswaran D., 2011, INT J POLYM SCI
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Cong Y., 2013, NANOMATER
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   Dalton P., 2008, TISSUE ENG
   Dhandayuthapani B., 2011, INT J POLYM SCI, V2011
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Guan S, 2013, J BIOMAT SCI-POLYM E, V24, P999, DOI 10.1080/09205063.2012.731374
   Hajiabbas M, 2015, ARTIF CELL NANOMED B, V43, P124, DOI 10.3109/21691401.2013.852101
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Lee JY, 2009, J R SOC INTERFACE, V6, P801, DOI 10.1098/rsif.2008.0403
   Lee JW, 2014, B KOREAN CHEM SOC, V35, P293, DOI 10.5012/bkcs.2014.35.1.293
   Lu XL, 2010, COMPOS PART A-APPL S, V41, P1516, DOI 10.1016/j.compositesa.2010.06.014
   Lum L. Y., 2003, TOPICS TISSUE ENG
   Peng ZY, 2011, POLYM-PLAST TECHNOL, V50, P1160, DOI 10.1080/03602559.2011.574670
   Qian YF, 2011, J BIOMAT SCI-POLYM E, V22, P1099, DOI 10.1163/092050610X499447
   Sadrolhosseini AR, 2013, INT J POLYM MATER PO, V62, P284, DOI 10.1080/00914037.2012.664209
   Sajesh KM, 2013, INT J BIOL MACROMOL, V62, P465, DOI 10.1016/j.ijbiomac.2013.09.028
   Su N, 2012, EXPRESS POLYM LETT, V6, P697, DOI 10.3144/expresspolymlett.2012.75
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   Wan Y, 2004, MACROMOL BIOSCI, V4, P882, DOI 10.1002/mabi.200400044
   Wan Y, 2004, POLYMER, V45, P71, DOI 10.1016/j.polymer.2003.10.075
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Yan F, 2000, J APPL POLYM SCI, V77, P135, DOI 10.1002/(SICI)1097-4628(20000705)77:1<135::AID-APP18>3.0.CO;2-B
   Yan J, 2010, CARBON, V48, P487, DOI 10.1016/j.carbon.2009.09.066
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zhang K, 2010, CHEM MATER, V22, P1392, DOI 10.1021/cm902876u
NR 36
TC 8
Z9 8
U1 1
U2 30
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 0091-4037
EI 1563-535X
J9 INT J POLYM MATER PO
JI Int. J. Polym. Mater. Polym. Biomat.
PY 2015
VL 64
IS 18
BP 969
EP 977
DI 10.1080/00914037.2015.1038817
PG 9
WC Materials Science, Biomaterials; Polymer Science
SC Materials Science; Polymer Science
GA CL9KX
UT WOS:000357298300004
DA 2018-10-19
ER

PT J
AU Andrade, GF
   Carvalho, JL
   Armando, SC
   Goes, AM
   Sousa, EMB
AF Andrade, Gracielle F.
   Carvalho, Juliana L.
   Armando, S. C. Junior
   Goes, Alfredo M.
   Sousa, Edesia M. B.
TI Osteogenic differentiation of adipose-derived stem cells in mesoporous
   SBA-16 and SBA-16 hydroxyapatite scaffolds
SO RSC ADVANCES
LA English
DT Article
ID BIOACTIVE GLASS DISSOLUTION; TISSUE REGENERATION; IONIC PRODUCTS;
   DRUG-DELIVERY; SILICA; PROLIFERATION; BIOCERAMICS; GROWTH;
   CYTOCOMPATIBILITY; COPOLYMER
AB Adipose-derived stem cells (ASCs) are currently a point of focus for bone tissue engineering applications. In this study, a biomaterial (HA-SBA-16) has been developed based on the growth of calcium phosphate (HA) particles within an organized silica structure (SBA-16) to evaluate their application in the osteogenic differentiation process. Indeed, pure SBA-16 was used to compare the effect of structural characteristics on the biological application. The samples were characterized by N-2 Adsorption, transmission electron microscopy (TEM), energy-dispersive X-ray spectroscopy (EDS) and thermal analysis. In vitro assays were performed to evaluate the viability, cytotoxicity and biological behavior of the ASCs on SBA-16 and HA/SBA-16 nanocomposites to verify their potential as bioactive materials for applications in bone-tissue engineering. The differentiation capacity of the ASCs seeded in SBA-16 and HA/SBA-16 was confirmed by the induction of the increase in AP production/activity of the ASCs, the expression of osteogenic gene markers (type I collagen mRNA, osteopontin and osteocalcin), and functionally, by Von Kossa staining. The results showed that those compositions have beneficial effects in stem cells, maintaining cell viability and allowing/promoting osteogenic differentiation.
C1 [Andrade, Gracielle F.; Sousa, Edesia M. B.] Ctr Desenvolvimento Tecnol Nucl CDTN CNEN, SENAN, BR-30270901 Belo Horizonte, MG, Brazil.
   [Andrade, Gracielle F.; Armando, S. C. Junior] Univ Fed Minas Gerais, Fac Farm, Belo Horizonte, MG, Brazil.
   [Carvalho, Juliana L.; Goes, Alfredo M.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
RP Sousa, EMB (reprint author), Ctr Desenvolvimento Tecnol Nucl CDTN CNEN, SENAN, Av Presidente Antonio Carlos 6627,Campus UFMG, BR-30270901 Belo Horizonte, MG, Brazil.
EM sousaem@cdtn.br
RI Carvalho, Juliana/F-4498-2015; Cunha, Armando/G-1157-2012
OI Carvalho, Juliana/0000-0002-1423-0523; Cunha,
   Armando/0000-0002-1161-8936
FU CAPES; CNPq; FAPEMIG
FX This work was supported by funding from CAPES, CNPq, and FAPEMIG.
   Experiments and analyses involving electron microscopy were performed in
   the Microscopy Center of the Federal University of Minas Gerais, Belo
   Horizonte, Brazil (http://www.microscopia.ufmg.br).
CR Andrade GF, 2014, J MATER SCI-MATER M, V25, P2527, DOI 10.1007/s10856-014-5273-6
   Andrade GF, 2013, MICROPOR MESOPOR MAT, V168, P102, DOI 10.1016/j.micromeso.2012.09.034
   Arcos D, 2013, ACTA MATER, V61, P890, DOI 10.1016/j.actamat.2012.10.039
   Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311
   Best SM, 2008, J EUR CERAM SOC, V28, P1319, DOI 10.1016/j.jeurceramsoc.2007.12.001
   Carvalho J.V.S., 2013, ANTARCT SCI, V56, P1
   Carvalho PH, 2013, ARQ BRAS CARDIOL, V100, P82, DOI 10.1590/S0066-782X2012005000114
   Cheng XL, 2012, CHEMPHYSCHEM, V13, P2392, DOI 10.1002/cphc.201200115
   Martins TMD, 2014, STEM CELL REV REP, V10, P697, DOI 10.1007/s12015-014-9529-9
   de Paula A. C. C., 2012, TISSUE ENG PART A, V19, P277
   Diaz A, 2006, ACTA BIOMATER, V2, P173, DOI 10.1016/j.actbio.2005.12.006
   Dominici K. L.-C. M., 2006, CYTOTHERAPY, V8, P315
   Fisichella H. D.-L.-P. Matthieu, 2009, TOXICOL IN VITRO, V23, P697
   Gobin O. C., 2006, THESIS U LAVAL
   Hench LL, 2000, MATER RES INNOV, V3, P313, DOI 10.1007/s100190000055
   Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hu YC, 2012, MICROPOR MESOPOR MAT, V147, P94, DOI 10.1016/j.micromeso.2011.06.001
   Kimata Y, 2003, MOL BIOL CELL, V14, P2559, DOI 10.1091/mbc.E02-11-0708
   Laaksonen H. S.-P. Timo, 2007, CHEM RES TOXICOL, V20, P1913
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Shi XT, 2008, J MATER SCI-MATER M, V19, P2933, DOI 10.1007/s10856-008-3424-3
   Sousa A, 2008, ACTA BIOMATER, V4, P671, DOI 10.1016/j.actbio.2007.11.003
   St John Thomas A, 2003, Am J Orthop (Belle Mead NJ), V32, P18
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
   Zhao DY, 1998, J AM CHEM SOC, V120, P6024, DOI 10.1021/ja974025i
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 31
TC 1
Z9 1
U1 0
U2 18
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 67
BP 54551
EP 54562
DI 10.1039/c5ra07330h
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA CL3QN
UT WOS:000356865500072
DA 2018-10-19
ER

PT J
AU Alexander, D
   Biller, R
   Rieger, M
   Ardjomandi, N
   Reinert, S
AF Alexander, Dorothea
   Biller, Regina
   Rieger, Melanie
   Ardjomandi, Nina
   Reinert, Siegmar
TI Phenotypic Characterization of a Human Immortalized Cranial Periosteal
   Cell Line
SO CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE Cranial periosteal cells; SV40 immortalization; CD146 expression; TERT
   expression; Mineralization
ID MESENCHYMAL STEM-CELLS; LONG-TERM CULTURE; REPLICATIVE SENESCENCE;
   TELOMERASE ACTIVITY; STROMAL CELLS; IN-VITRO; CANCER; HALLMARKS
AB Background/Aims: Human cell material for basic research work is limited due to restricted patient numbers and occurring cell senescence during prolonged in vitro cell cultivation. In the present study, we established for the first time a human immortalized cranial periosteal cell line and characterized its phenotype in detail in comparison to that of parental cells. Methods: For this purpose, human primary cranial periosteal cells were stably transduced with the large T antigen cDNA from polyomavirus SV40 (TAg cells). Results: The functional activity of the large T antigen was demonstrated by human telomerase gene expression. Whereas TAg cells maintained long-term cell proliferation, immortalization did not compromise their osteogenic differentiation potential. In contrast, TAg cells showed an earlier and stronger mineralization compared to parental cells. Among the analysed stem cell surface markers, CD146 and MSCA-1 (mesenchymal stem cell antigen-1) were shown to be elevated in Tag cells. Gene expression analyses revealed in general higher constitutive m-RNA levels of key factors of osteogenesis than in parental cells. Conclusion: We conclude that the herein generated cell line represents a suitable cell source for basic science research studying bone biology, the osteogenesis process or biomaterial tests for bone regeneration purposes. Copyright (C) 2015 S. Karger AG, Basel
C1 [Alexander, Dorothea; Biller, Regina; Rieger, Melanie; Ardjomandi, Nina; Reinert, Siegmar] Univ Tubingen Hosp, Dept Oral & Maxillofacial Surg, D-72076 Tubingen, Germany.
RP Alexander, D (reprint author), Univ Tubingen Hosp, Dept Oral & Maxillofacial Surg, Osianderstr 2-8, D-72076 Tubingen, Germany.
EM dorothea.alexander@med.uni-tuebingen.de
CR Alexander D, 2010, CELL PHYSIOL BIOCHEM, V26, P1073, DOI 10.1159/000323985
   Allt G, 2001, CELLS TISSUES ORGANS, V169, P1, DOI 10.1159/000047855
   Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y
   Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x
   Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Crisan M, 2012, J CELL MOL MED, V16, P2851, DOI 10.1111/j.1582-4934.2012.01617.x
   Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9
   Dazzi F, 2012, IMMUNOLOGY, V137, P206, DOI 10.1111/j.1365-2567.2012.03621.x
   Greider CW, 1996, SCI AM, V274, P92, DOI 10.1038/scientificamerican0296-92
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   Lee WYW, 2013, CYTOTHERAPY, V15, P1484, DOI 10.1016/j.jcyt.2013.06.010
   Li NF, 2007, CELL PROLIFERAT, V40, P780, DOI 10.1111/j.1365-2184.2007.00462.x
   Low KC, 2013, TRENDS BIOCHEM SCI, V38, P426, DOI 10.1016/j.tibs.2013.07.001
   Nakamura-Ota M, 2014, CELL TISSUE BANK, V15, P373, DOI 10.1007/s10561-013-9394-9
   Razzouk S, 2012, J PERIODONTOL, V83, P547, DOI 10.1902/jop.2011.110384
   Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2
   Sobiesiak M, 2010, STEM CELLS DEV, V19, P669, DOI 10.1089/scd.2009.0290
   Thalmeier K, 2001, ACTA HAEMATOL-BASEL, V105, P159, DOI 10.1159/000046559
   Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213
   Wagner W, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt145
   Wang YH, 2006, BIOTECHNOL PROGR, V22, P1697, DOI 10.1021/bp060274b
   Wu LA, 2011, CELL TISSUE RES, V343, P545, DOI 10.1007/s00441-010-1120-3
   Zeng XM, 2007, STEM CELL REV, V3, P270, DOI 10.1007/s12015-007-9005-x
NR 25
TC 2
Z9 2
U1 0
U2 4
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1015-8987
EI 1421-9778
J9 CELL PHYSIOL BIOCHEM
JI Cell. Physiol. Biochem.
PY 2015
VL 35
IS 6
BP 2244
EP 2254
DI 10.1159/000374029
PG 11
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA CL3FA
UT WOS:000356834600015
PM 25895553
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Swartjes, JJTM
   Sharma, PK
   van Kooten, TG
   van der Mei, HC
   Mahmoudi, M
   Busscher, HJ
   Rochford, ETJ
AF Swartjes, J. J. T. M.
   Sharma, P. K.
   van Kooten, T. G.
   van der Mei, H. C.
   Mahmoudi, M.
   Busscher, H. J.
   Rochford, E. T. J.
TI Current Developments in Antimicrobial Surface Coatings for Biomedical
   Applications
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Article
DE Antibacterial; antibiotics; antimicrobial peptides; bacterial adhesion;
   nanoparticles; quaternary ammonium compounds; surface coating
ID IMPLANT-ASSOCIATED INFECTIONS; HOST-DEFENSE PEPTIDES; ANTIBACTERIAL
   PROPERTIES; BACTERIAL ADHESION; MULTILAYER FILMS; SUPERHYDROPHOBIC
   SURFACES; RESISTANT STAPHYLOCOCCUS; NONSPECIFIC INTERACTIONS;
   IMMOBILIZING LYSOZYME; QUATERNIZED CHITOSAN
AB Bacterial adhesion and subsequent biofilm formation on material surfaces represent a serious problem in society from both an economical and health perspective. Surface coating approaches to prevent bacterial adhesion and biofilm formation are of increased importance due to the increasing prevalence of antibiotic resistant bacterial strains. Effective antimicrobial surface coatings can be based on an anti-adhesive principle that prevents bacteria to adhere, or on bactericidal strategies, killing organisms either before or after contact is made with the surface. Many strategies, however, implement a multifunctional approach that incorporates both of these mechanisms. For anti-adhesive strategies, the use of polymer chains, or hydrogels is preferred, although recently a new class of super-hydrophobic surfaces has been described which demonstrate improved anti-adhesive activity. In addition, bacterial killing can be achieved using antimicrobial peptides, antibiotics, chitosan or enzymes directly bound, tethered through spacer-molecules or encased in biodegradable matrices, nanoparticles and quaternary ammonium compounds. Notwithstanding the ubiquitous nature of the problem of microbial colonization of material surfaces, this review focuses on the recent developments in antimicrobial surface coatings with respect to biomaterial implants and devices. In this biomedical arena, to rank the different coating strategies in order of increasing efficacy is impossible, since this depends on the clinical application aimed for and whether expectations are short- or long term. Considering that the era of antibiotics to control infectious biofilms will eventually come to an end, the future for biofilm control on biomaterial implants and devices is likely with surface-associated modifications that are non-antibiotic related.
C1 [Swartjes, J. J. T. M.; Sharma, P. K.; van Kooten, T. G.; van der Mei, H. C.; Busscher, H. J.; Rochford, E. T. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9700 AD Groningen, Netherlands.
   [Mahmoudi, M.] Univ Tehran Med Sci, Fac Pharm, Dept Nanotechnol, Tehran, Iran.
   [Mahmoudi, M.] Univ Tehran Med Sci, Fac Pharm, Nanotechnol Res Ctr, Tehran, Iran.
RP van Kooten, TG (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, FB40,Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM T.G.van.Kooten@med.umcg.nl
RI Mahmoudi, Morteza/L-5332-2017
OI Mahmoudi, Morteza/0000-0002-2575-9684
FU UMCG, Groningen, The Netherlands
FX This study was funded by the UMCG, Groningen, The Netherlands. H.J.
   Busscher is also director of a consulting company, SASA BV (GN
   Schutterlaan 4, 9797 PC Thesinge, The Netherlands). Opinions and
   assertions contained herein are those of the authors and are not
   construed as necessarily representing views of the funding organization
   or their respective employers.
CR Akhavan O, 2010, SURF COAT TECH, V205, P219, DOI 10.1016/j.surfcoat.2010.06.036
   Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009
   Almodovar J, 2013, BIOTECHNOL BIOENG, V110, P609, DOI 10.1002/bit.24710
   Asri LATW, 2014, ADV FUNCT MATER, V24, P346, DOI 10.1002/adfm.201301686
   Bagheri M, 2012, BIOCONJUGATE CHEM, V23, P66, DOI 10.1021/bc200367f
   Bagheri M, 2009, ANTIMICROB AGENTS CH, V53, P1132, DOI 10.1128/AAC.01254-08
   Bahar AA, 2013, PHARMACEUTICALS, V6, P1543, DOI 10.3390/ph6121543
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Belcarz A, 2013, INT J PHARMACEUT, V454, P285, DOI 10.1016/j.ijpharm.2013.06.076
   Bhattacharyya MS, 2010, J PHYS CHEM C, V114, P19928, DOI 10.1021/jp1078218
   Botequim D, 2012, LANGMUIR, V28, P7646, DOI 10.1021/la300948n
   Bowdish DME, 2005, CURR PROTEIN PEPT SC, V6, P35, DOI 10.2174/1389203053027494
   Buffet-Bataillon S, 2012, INT J ANTIMICROB AG, V39, P381, DOI 10.1016/j.ijantimicag.2012.01.011
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440
   BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1016/0378-1097(87)90062-0
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Charnley M, 2011, REACT FUNCT POLYM, V71, P329, DOI 10.1016/j.reactfunctpolym.2010.10.013
   Chen CP, 2012, ADV FUNCT MATER, V22, P780, DOI 10.1002/adfm.201102333
   Coad BR, 2013, SURF COAT TECH, V233, P169, DOI 10.1016/j.surfcoat.2013.05.019
   Daghighi S, 2013, BIOMATERIALS, V34, P8013, DOI 10.1016/j.biomaterials.2013.07.044
   Darouiche RO, 2003, CLIN INFECT DIS, V36, P1284, DOI 10.1086/374842
   Di Luca M, 2014, PATHOG DIS, V70, P257, DOI 10.1111/2049-632X.12151
   Ding FY, 2013, CARBOHYD POLYM, V98, P1547, DOI 10.1016/j.carbpol.2013.07.042
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Dutta P, 2011, ORG BIOMOL CHEM, V9, P5123, DOI 10.1039/c0ob00798f
   Epstein AK, 2012, P NATL ACAD SCI USA, V109, P13182, DOI 10.1073/pnas.1201973109
   Etayash H, 2014, ACS APPL MATER INTER, V6, P1131, DOI 10.1021/am404729c
   Faure E, 2012, ADV FUNCT MATER, V22, P5271, DOI 10.1002/adfm.201201106
   Fernandez L, 2011, DRUG RESIST UPDATE, V14, P1, DOI 10.1016/j.drup.2011.01.001
   Forsgren J, 2011, BIOTECHNOL LETT, V33, P1265, DOI 10.1007/s10529-011-0542-7
   Gabriel M, 2006, BIOCONJUGATE CHEM, V17, P548, DOI 10.1021/bc050091v
   Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180
   Garcia-Fernandez L, 2013, ADV MATER, V25, P529, DOI 10.1002/adma.201203362
   Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011
   Gottenbos B, 2002, BIOMATERIALS, V23, P1417, DOI 10.1016/S0142-9612(01)00263-0
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Guillaume O, 2012, J CONTROL RELEASE, V162, P492, DOI 10.1016/j.jconrel.2012.08.003
   Hajipour MJ, 2012, TRENDS BIOTECHNOL, V30, P499, DOI 10.1016/j.tibtech.2012.06.004
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   Hickok NJ, 2012, ADV DRUG DELIVER REV, V64, P1165, DOI 10.1016/j.addr.2012.03.015
   Hoiby N, 2011, INT J ORAL SCI, V3, P55, DOI 10.4248/IJOS11026
   HOLMBERG K, 1993, J ADHES SCI TECHNOL, V7, P503, DOI 10.1163/156856193X00826
   Holmberg KV, 2013, ACTA BIOMATER, V9, P8224, DOI 10.1016/j.actbio.2013.06.017
   Hu CM, 2013, ADV HEALTHC MATER, V2, P1314, DOI 10.1002/adhm.201300021
   Huang WJ, 2013, INT J BIOL MACROMOL, V53, P26, DOI 10.1016/j.ijbiomac.2012.10.024
   Huda S, 2010, ACS APPL MATER INTER, V2, P1206, DOI 10.1021/am100045v
   Humblot V, 2009, BIOMATERIALS, V30, P3503, DOI 10.1016/j.biomaterials.2009.03.025
   Hussain R, 2006, INT J PEPT RES THER, V12, P269, DOI 10.1007/s10989-006-9033-4
   Iarikov DD, 2014, BIOMACROMOLECULES, V15, P169, DOI 10.1021/bm401440h
   Jia BQ, 2012, ACS APPL MATER INTER, V4, P2897, DOI 10.1021/am3007609
   Jose B, 2005, CHEM BIOL, V12, P1041, DOI 10.1016/j.chembiol.2005.06.013
   Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004
   Kazemzadeh-Narbat M, 2013, BIOMATERIALS, V34, P5969, DOI 10.1016/j.biomaterials.2013.04.036
   Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V31, P9519, DOI 10.1016/j.biomaterials.2010.08.035
   Kim JA, 2013, ACS NANO, V7, P7483, DOI 10.1021/nn403126e
   Kluin OS, 2009, BIOMATERIALS, V30, P4738, DOI 10.1016/j.biomaterials.2009.05.012
   Kong ZQ, 2013, COLLOID SURFACE B, V111, P536, DOI 10.1016/j.colsurfb.2013.07.006
   Konradi R, 2012, MACROMOL RAPID COMM, V33, P1663, DOI 10.1002/marc.201200422
   Kugler R, 2005, MICROBIOL-SGM, V151, P1341, DOI 10.1099/mic.0.27526-0
   Kumar A, 2008, NAT MATER, V7, P236, DOI 10.1038/nmat2099
   Laverty G, 2012, J BIOMED MATER RES A, V100A, P1803, DOI 10.1002/jbm.a.34132
   Lee HS, 2012, J MATER CHEM, V22, P19605, DOI 10.1039/c2jm34316a
   Lee HS, 2011, LANGMUIR, V27, P12458, DOI 10.1021/la202616u
   Lequeux I, 2014, EUR POLYM J, V51, P182, DOI 10.1016/j.eurpolymj.2013.11.012
   Li JS, 2013, ACS APPL MATER INTER, V5, P6704, DOI 10.1021/am401532z
   Liu Y, 2012, BIOMATERIALS, V33, P8745, DOI 10.1016/j.biomaterials.2012.08.010
   Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105
   Ma ML, 2006, CURR OPIN COLLOID IN, V11, P193, DOI 10.1016/j.cocis.2006.06.002
   Madhusudana Rao K., 2013, J BIOMED MATER RES A, P1
   Meyer B, 2003, INT BIODETER BIODEGR, V51, P249, DOI 10.1016/S0964-8305(03)00047-7
   MILNER ST, 1988, MACROMOLECULES, V21, P2610, DOI 10.1021/ma00186a051
   Mirshafiee V, 2013, CHEM COMMUN, V49, P2557, DOI 10.1039/c3cc37307j
   Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/NNANO.2012.207, 10.1038/nnano.2012.207]
   Murata H, 2007, BIOMATERIALS, V28, P4870, DOI 10.1016/j.biomaterials.2007.06.012
   Muszanska AK, 2011, BIOMATERIALS, V32, P6333, DOI 10.1016/j.biomaterials.2011.05.016
   Nejadnik MR, 2008, BIOMATERIALS, V29, P4117, DOI 10.1016/j.biomaterials.2008.07.014
   Noble ML, 2014, BIOMATER SCI-UK, V2, P893, DOI 10.1039/c3bm60203f
   Okshevsky M, 2013, CRIT REV MICROBIOL, V4, P1
   Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002
   Onaizi SA, 2011, BIOTECHNOL ADV, V29, P67, DOI 10.1016/j.biotechadv.2010.08.012
   Palermo EF, 2009, BIOMACROMOLECULES, V10, P1416, DOI 10.1021/bm900044x
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Pavlukhina S, 2010, BIOMACROMOLECULES, V11, P3448, DOI 10.1021/bm100975w
   Pavlukhina SV, 2012, ACS APPL MATER INTER, V4, P4708, DOI 10.1021/am3010847
   Peng ZX, 2011, ANTIMICROB AGENTS CH, V55, P860, DOI 10.1128/AAC.01005-10
   Peyre J, 2012, J PHYS CHEM B, V116, P13839, DOI 10.1021/jp305597y
   Pinto MS, 2011, COLLOID SURFACE A, V377, P182, DOI 10.1016/j.colsurfa.2010.12.038
   Pop-Georgievski O, 2011, BIOMACROMOLECULES, V12, P3232, DOI 10.1021/bm2007086
   Privett BJ, 2011, LANGMUIR, V27, P9597, DOI 10.1021/la201801e
   Rai A, 2010, J MATER CHEM, V20, P6789, DOI 10.1039/c0jm00817f
   Rapsch K, 2014, BIOCONJUGATE CHEM, V25, P308, DOI 10.1021/bc4004469
   Schaer TP, 2012, BIOMATERIALS, V33, P1245, DOI 10.1016/j.biomaterials.2011.10.038
   Shalev T, 2012, J MATER CHEM, V22, P2026, DOI 10.1039/c1jm13994k
   Shukla A, 2012, J CONTROL RELEASE, V157, P64, DOI 10.1016/j.jconrel.2011.09.062
   Siedenbiedel F, 2013, MACROMOL BIOSCI, V13, P1447, DOI 10.1002/mabi.201300219
   Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046
   Song L, 2011, MATER LETT, V65, P974, DOI 10.1016/j.matlet.2010.12.051
   Spellberg B, 2013, NEW ENGL J MED, V368, P299, DOI 10.1056/NEJMp1215093
   Stevens KNJ, 2011, BIOMATERIALS, V32, P1264, DOI 10.1016/j.biomaterials.2010.10.042
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Strobel C, 2011, J CONTROL RELEASE, V156, P37, DOI 10.1016/j.jconrel.2011.07.006
   Sui Y, 2012, J MEMBRANE SCI, V394, P107, DOI 10.1016/j.memsci.2011.12.038
   Swanson TE, 2011, J BIOMED MATER RES A, V97A, P167, DOI 10.1002/jbm.a.33043
   Swartjes JJTM, 2013, ADV FUNCT MATER, V23, P2843, DOI 10.1002/adfm.201202927
   Takigami I, 2010, ARCH ORTHOP TRAUM SU, V130, P1221, DOI 10.1007/s00402-009-0991-9
   Tan HL, 2013, INT J MOL SCI, V14, P1854, DOI 10.3390/ijms14011854
   Tan HL, 2012, BIOMATERIALS, V33, P365, DOI 10.1016/j.biomaterials.2011.09.084
   Tavares LS, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00412
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Tiller JC, 2011, ADV POLYM SCI, V240, P193, DOI 10.1007/12_2010_101
   Tischer M, 2012, CHEMMEDCHEM, V7, P22, DOI 10.1002/cmdc.201100404
   VANLOOSDRECHT MCM, 1990, AQUAT SCI, V52, P103, DOI 10.1007/BF00878244
   Wang BL, 2013, ACS APPL MATER INTER, V5, P4136, DOI 10.1021/am4000547
   Wang Y, 2012, SURF COAT TECH, V210, P71, DOI 10.1016/j.surfcoat.2012.08.066
   Wang Y, 2011, ADV FUNCT MATER, V21, P3916, DOI 10.1002/adfm.201100659
   Wong LS, 2009, CHEM REV, V109, P4025, DOI 10.1021/cr8004668
   Wong SY, 2010, J AM CHEM SOC, V132, P17840, DOI 10.1021/ja106288c
   Wong SY, 2010, BIOMATERIALS, V31, P4079, DOI 10.1016/j.biomaterials.2010.01.119
   Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447
   Yala JF, 2011, APPL MICROBIOL BIOT, V89, P623, DOI 10.1007/s00253-010-2930-7
   Yang WJ, 2011, LANGMUIR, V27, P7065, DOI 10.1021/la200620s
   Yuan SJ, 2011, LANGMUIR, V27, P2761, DOI 10.1021/la104442f
   Zhao C, 2013, LANGMUIR, V29, P1517, DOI 10.1021/la304511s
   Zhao Y, 2010, MAR DRUGS, V8, P24, DOI 10.3390/md8010024
   Zhou B, 2014, COLLOID SURFACE B, V116, P432, DOI 10.1016/j.colsurfb.2014.01.016
   Zhou CC, 2011, BIOMATERIALS, V32, P2704, DOI 10.1016/j.biomaterials.2010.12.040
NR 127
TC 32
Z9 33
U1 6
U2 152
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8673
EI 1875-533X
J9 CURR MED CHEM
JI Curr. Med. Chem.
PY 2015
VL 22
IS 18
BP 2116
EP 2129
DI 10.2174/0929867321666140916121355
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA CL5ZL
UT WOS:000357044400002
PM 25245508
DA 2018-10-19
ER

PT J
AU Azari, P
   Luan, NS
   Gan, SN
   Yahya, R
   Wong, CS
   Chua, KH
   Pingguan-Murphy, B
AF Azari, Pedram
   Luan, Ng Sook
   Gan, Seng Neon
   Yahya, Rosiyah
   Wong, Chiow San
   Chua, Kien Hui
   Pingguan-Murphy, Belinda
TI Electrospun Biopolyesters as Drug Screening Platforms for Corneal
   Keratocytes
SO INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS
LA English
DT Article
DE Biopolyesters; corneal keratocytes; electrospinning; polycaprolactone;
   polyhydroxybutyrate; polyhydroxybutyrate-co-hydroxyvalerate
ID EXTRACELLULAR-MATRIX; SCAFFOLDS; CELLS; MATS; DIFFERENTIATION;
   REGENERATION; DEGRADATION; LUMICAN; CULTURE; SYSTEM
AB In vitro drug screening techniques provide rapid and easy to analyze data, while saving a lot of animals from being sacrificed. An important part of any in vitro drug screening platform is a biomaterial which promotes cell growth and proliferation. The potential of electrospun scaffolds made of polyhydroxybutyrate (PHB), poly (3-hydroxybutyric acid-co-3-hydroxyvaleric acid) (PHBV), and polycaprolactone (PCL) were studied to serve as drug screening platform for corneal keratocyte tissues. The results showed that the proliferation rate was slightly higher for PCL and PHBV on day 7. Gene expression results showed that PCL was the best in maintaining keratocyte genes.
   [GRAPHICS]
   .
C1 [Azari, Pedram; Gan, Seng Neon; Yahya, Rosiyah] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur 50603, Malaysia.
   [Luan, Ng Sook; Chua, Kien Hui] Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia.
   [Pingguan-Murphy, Belinda] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
   [Wong, Chiow San] Univ Malaya, Fac Sci, Dept Phys, Plasma Technol Res Ctr, Kuala Lumpur 50603, Malaysia.
RP Pingguan-Murphy, B (reprint author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
EM bpingguan@gmail.com
RI Pingguan-Murphy, Belinda/B-8332-2010; yahya, rosiyah/B-9604-2010;
   Engineering, Faculty/I-7935-2015; Wong, C.S./C-1047-2010; CHUA, KEK
   HENG/B-5261-2010; Azari, Pedram/Q-7407-2016
OI Pingguan-Murphy, Belinda/0000-0001-5567-1141; Engineering,
   Faculty/0000-0002-4848-7052; Wong, C.S./0000-0002-7186-2578; Azari,
   Pedram/0000-0002-1918-4247
FU University of Malaya [PV-107-2012A]; Ministry of Education Malaysia
   [UM.C/HIR/MOHE/ENG/44]
FX This study was supported by High Impact Research Grant
   (UM.C/HIR/MOHE/ENG/44) from the Ministry of Education Malaysia and
   Postgraduate Research Grant (PPP) (PV-107-2012A), University of Malaya.
CR Abadi FJH, 2014, INT J POLYM MATER PO, V63, P57, DOI 10.1080/00914037.2013.769248
   Abidin FZ, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-94
   Aghdam RM, 2014, INT J POLYM MATER PO, V63, P229, DOI 10.1080/00914037.2013.800983
   Chen Y, 2013, PROG RETIN EYE RES, V33, P28, DOI 10.1016/j.preteyeres.2012.10.001
   Cui WG, 2008, POLYM DEGRAD STABIL, V93, P731, DOI 10.1016/j.polymdegradstab.2007.12.002
   Cui WG, 2007, J APPL POLYM SCI, V103, P3105, DOI 10.1002/app.25464
   Cui WG, 2006, BIOMACROMOLECULES, V7, P1623, DOI 10.1021/bm060057z
   Ghafar NA, 2007, TISSUE ENG REGEN MED, V4, P557
   Ghasemi-Mobarakeh L, 2014, INT J POLYM MATER PO, V63, P240, DOI 10.1080/00914037.2013.830247
   Guan DH, 2008, APPL SURF SCI, V255, P324, DOI 10.1016/j.apsusc.2008.06.093
   Gunatillake PA, 2003, EUR CELLS MATER, V20, P1
   Ito Y, 2005, J BIOSCI BIOENG, V100, P43, DOI 10.1263/jbb.100.43
   JESTER JV, 1995, INVEST OPHTH VIS SCI, V36, P809
   Jester JV, 2003, EXP EYE RES, V77, P581, DOI 10.1016/S0014-4835(03)00188-X
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   Michelacci YM, 2003, BRAZ J MED BIOL RES, V36, P1037, DOI 10.1590/S0100-879X2003000800009
   Nikitovic D, 2008, IUBMB LIFE, V60, P818, DOI 10.1002/iub.131
   Piersma AH, 2004, TOXICOL LETT, V149, P147, DOI 10.1016/j.toxlet.2003.12.029
   Ritchey ER, 2011, MOL VIS, V17, P2440
   Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607
   Shenoy SL, 2005, POLYMER, V46, P3372, DOI 10.1016/j.polymer.2005.03.011
   Sombatmankhong K, 2007, POLYMER, V48, P1419, DOI 10.1016/j.polymer.2007.01.014
   Tehrani AH, 2010, J MATER SCI-MATER M, V21, P2989, DOI 10.1007/s10856-010-4149-7
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Wang LK, 2007, INT SER DEV HEAT TRA, P27
   West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010
   Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214
   Wilson S. E., 1998, EYE CONTACT LENS, V24, P181
   Wilson SE, 2003, AM J OPHTHALMOL, V136, P530, DOI 10.1016/S0002-9394(02)00085-0
NR 29
TC 3
Z9 3
U1 0
U2 17
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 0091-4037
EI 1563-535X
J9 INT J POLYM MATER PO
JI Int. J. Polym. Mater. Polym. Biomat.
PY 2015
VL 64
IS 15
BP 785
EP 791
DI 10.1080/00914037.2015.1030648
PG 7
WC Materials Science, Biomaterials; Polymer Science
SC Materials Science; Polymer Science
GA CL3TW
UT WOS:000356874500003
DA 2018-10-19
ER

PT J
AU Li, JJ
   Kim, K
   Roohani-Esfahani, SI
   Guo, J
   Kaplan, DL
   Zreiqat, H
AF Li, Jiao Jiao
   Kim, Kyungsook
   Roohani-Esfahani, Seyed-Iman
   Guo, Jin
   Kaplan, David L.
   Zreiqat, Hala
TI A biphasic scaffold based on silk and bioactive ceramic with stratified
   properties for osteochondral tissue regeneration
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE REPAIR; CALCIUM-PHOSPHATE
   CERAMICS; BMP-INDUCED OSTEOGENESIS; IN-VITRO; ENGINEERING SCAFFOLDS;
   SUBCHONDRAL BONE; BIOMATERIAL SCAFFOLDS; MECHANICAL-PROPERTIES;
   COMPOSITE SCAFFOLDS
AB Significant clinical challenges encountered in the effective long-term treatment of osteochondral defects have inspired advancements in scaffold-based tissue engineering techniques to aid repair and regeneration. This study reports the development of a biphasic scaffold produced via a rational combination of silk fibroin and bioactive ceramic with stratified properties to satisfy the complex and diverse regenerative requirements of osteochondral tissue. Structural examination showed that the biphasic scaffold contained two phases with different pore morphologies to match the cartilage and bone segments of osteochondral tissue, which were joined at a continuous interface. Mechanical assessment showed that the two phases of the biphasic scaffold imitated the load-bearing behaviour of native osteochondral tissue and matched its compressive properties. In vitro testing showed that different compositions in the two phases of the biphasic scaffold could direct the preferential differentiation of human mesenchymal stem cells towards the chondrogenic or osteogenic lineage. By featuring simple and reproducible fabrication and a well-integrated interface, the biphasic scaffold strategy established in this study circumvented the common problems experienced with integrated scaffold designs and could provide an effective approach for the regeneration of osteochondral tissue.
C1 [Li, Jiao Jiao; Roohani-Esfahani, Seyed-Iman; Zreiqat, Hala] Univ Sydney, Sch AMME, Biomat & Tissue Engn Res Unit, Sydney, NSW 2006, Australia.
   [Kim, Kyungsook; Guo, Jin; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Zreiqat, H (reprint author), Univ Sydney, Sch AMME, Biomat & Tissue Engn Res Unit, Sydney, NSW 2006, Australia.
EM hala.zreiqat@sydney.edu.au
OI Li, Jiao Jiao/0000-0002-3584-6765; Roohani, Iman/0000-0001-6618-8577
FU Australian National Health and Medical Research Council; U.S. National
   Institutes of Health [P41 EB002520, R01 DE106525]; Rebecca Cooper
   Foundation; Australian Postgraduate Award; Vice-Chancellor's Research
   Scholarship
FX The authors gratefully acknowledge the financial support of the
   Australian National Health and Medical Research Council, the U.S.
   National Institutes of Health (P41 EB002520, R01 DE106525), the Rebecca
   Cooper Foundation, the Australian Postgraduate Award and the
   Vice-Chancellor's Research Scholarship.
CR Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x
   Alford JW, 2005, AM J SPORT MED, V33, P295, DOI 10.1177/0363546504273510
   Alhadlaq A, 2004, ANN BIOMED ENG, V32, P911, DOI 10.1023/B:ABME.0000032454.53116.ee
   Barber FA, 2011, ARTHROSCOPY, V27, P60, DOI 10.1016/j.arthro.2010.06.023
   Bernstein A, 2013, ACTA BIOMATER, V9, P7490, DOI 10.1016/j.actbio.2013.03.021
   Carmont MR, 2009, ARTHROSCOPY, V25, P810, DOI 10.1016/j.arthro.2009.01.023
   Castro NJ, 2012, ANN BIOMED ENG, V40, P1628, DOI 10.1007/s10439-012-0605-5
   Chang CH, 2006, BIOMATERIALS, V27, P1876, DOI 10.1016/j.biomaterials.2005.10.014
   Chen GP, 2006, MAT SCI ENG C-BIO S, V26, P118, DOI 10.1016/j.msec.2005.07.024
   Chen JN, 2011, BIOMATERIALS, V32, P4793, DOI 10.1016/j.biomaterials.2011.03.041
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Coburn JM, 2012, P NATL ACAD SCI USA, V109, P10012, DOI 10.1073/pnas.1121605109
   Cui WD, 2011, J BIOSCI BIOENG, V111, P493, DOI 10.1016/j.jbiosc.2010.11.023
   Da H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054838
   de Vries-van Melle M. L., 2013, TISSUE ENG PART A, V20, P23
   Delcogliano M, 2014, KNEE SURG SPORT TR A, V22, P1260, DOI 10.1007/s00167-013-2717-3
   Deng TZ, 2014, J TISSUE ENG REGEN M, V8, P546, DOI 10.1002/term.1556
   Dhollander AAM, 2012, ARTHROSCOPY, V28, P225, DOI 10.1016/j.arthro.2011.07.017
   Dormer NH, 2012, J BIOMED MATER RES A, V100A, P162, DOI 10.1002/jbm.a.33225
   Duan PG, 2014, J BIOMED MATER RES A, V102, P180, DOI 10.1002/jbm.a.34683
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Erisken C., 2010, TISSUE ENG PART A, V17, P1239
   Filardo G, 2013, AM J SPORT MED, V41, P1786, DOI 10.1177/0363546513490658
   Galperin A, 2013, ADV HEALTHC MATER, V2, P872, DOI 10.1002/adhm.201200345
   Giannoni P., 2012, J TISSUE ENG REGEN M, DOI [10.1002/term.1651., DOI 10.1002/TERM.1651, 10.1002/term.1651]
   Gibson LJ, 2005, J BIOMECH, V38, P377, DOI 10.1016/j.jbiomech.2004.09.027
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   Guilak F, 2014, J BIOMECH, V47, P1933, DOI 10.1016/j.jbiomech.2014.04.019
   Guo XM, 2004, TISSUE ENG, V10, P1818, DOI 10.1089/ten.2004.10.1818
   Guo XM, 2004, TISSUE ENG, V10, P1830, DOI 10.1089/ten.2004.10.1830
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387
   Harris JD, 2011, OSTEOARTHR CARTILAGE, V19, P779, DOI 10.1016/j.joca.2011.02.010
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Jakob RP, 2002, CLIN ORTHOP RELAT R, P170
   Jeon JE, 2014, ANAT REC, V297, P26, DOI 10.1002/ar.22795
   Jiang CC, 2007, J ORTHOP RES, V25, P1277, DOI 10.1002/jor.20442
   Jiang J, 2010, ANN BIOMED ENG, V38, P2183, DOI 10.1007/s10439-010-0038-y
   Jin QM, 2000, J BIOMED MATER RES, V52, P841, DOI 10.1002/1097-4636(20001215)52:4<841::AID-JBM31>3.0.CO;2-3
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Jung MR, 2012, J CONTROL RELEASE, V162, P485, DOI 10.1016/j.jconrel.2012.07.040
   Kandel RA, 2006, BIOMATERIALS, V27, P4120, DOI 10.1016/j.biomaterials.2006.03.005
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kawakami M, 2011, BIO-MED MATER ENG, V21, P53, DOI 10.3233/BME-2011-0656
   Keeney M, 2009, TISSUE ENG PART B-RE, V15, P55, DOI 10.1089/ten.teb.2008.0388
   Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kuboki Y, 2002, CONNECT TISSUE RES, V43, P529, DOI 10.1080/03008200290001104
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Kundu SC, 2012, BIOPOLYMERS, V97, P455, DOI 10.1002/bip.22024
   Laasanen MS, 2003, BIORHEOLOGY, V40, P133
   Lam J, 2014, ACTA BIOMATER, V10, P1112, DOI 10.1016/j.actbio.2013.11.020
   Levingstone TJ, 2014, ACTA BIOMATER, V10, P1996, DOI 10.1016/j.actbio.2014.01.005
   Li JJ, 2014, J MATER CHEM B, V2, P7272, DOI 10.1039/c4tb01073f
   Li JJ, 2013, BIOMACROMOLECULES, V14, P2179, DOI 10.1021/bm400303w
   Lian J B, 1995, Iowa Orthop J, V15, P118
   Lien SM, 2009, MAT SCI ENG C-BIO S, V29, P315, DOI 10.1016/j.msec.2008.07.017
   Magne D, 2005, TRENDS MOL MED, V11, P519, DOI 10.1016/j.molmed.2005.09.002
   Makaya K, 2009, J BIOSCI BIOENG, V108, P68, DOI 10.1016/j.jbiosc.2009.02.015
   Manferdini C, 2016, J TISSUE ENG REGEN M, V10, P374, DOI 10.1002/term.1723
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Marquass B, 2010, J ORTHOP RES, V28, P1586, DOI 10.1002/jor.21173
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Mayr HO, 2013, ACTA BIOMATER, V9, P4845, DOI 10.1016/j.actbio.2012.07.040
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Miot S, 2012, EUR CELLS MATER, V23, P222, DOI 10.22203/eCM.v023a17
   Mithoefer K, 2009, AM J SPORT MED, V37, P2053, DOI 10.1177/0363546508328414
   Mohan N, 2011, TISSUE ENG PT A, V17, P2845, DOI 10.1089/ten.tea.2011.0135
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nooeaid P, 2012, J CELL MOL MED, V16, P2247, DOI 10.1111/j.1582-4934.2012.01571.x
   O'Shea TM, 2008, TISSUE ENG PART B-RE, V14, P447, DOI 10.1089/ten.teb.2008.0327
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Pei M, 2009, OSTEOARTHR CARTILAGE, V17, P714, DOI 10.1016/j.joca.2008.11.017
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   POOLE AR, 2001, CLIN ORTHOP S, V391, P26
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Re'em T, 2012, ACTA BIOMATER, V8, P3283, DOI 10.1016/j.actbio.2012.05.014
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Roohani-Esfahani SI, 2013, ACTA BIOMATER, V9, P7014, DOI 10.1016/j.actbio.2013.02.039
   Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107
   Schaefer D, 2002, ARTHRITIS RHEUM, V46, P2524, DOI 10.1002/art.10493
   Shao XX, 2006, TISSUE ENG, V12, P1539, DOI 10.1089/ten.2006.12.1539
   Sheehy EJ, 2013, ACTA BIOMATER, V9, P5484, DOI 10.1016/j.actbio.2012.11.008
   Shimomura K, 2014, TISSUE ENG PT A, V20, P2291, DOI 10.1089/ten.tea.2013.0414
   Sundelacruz S, 2009, SEMIN CELL DEV BIOL, V20, P646, DOI 10.1016/j.semcdb.2009.03.017
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Tuli R, 2004, TISSUE ENG, V10, P1169, DOI 10.1089/ten.2004.10.1169
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   Wang W, 2010, BIOMATERIALS, V31, P8964, DOI 10.1016/j.biomaterials.2010.08.018
   Wang XH, 2004, BIOMATERIALS, V25, P3681, DOI 10.1016/j.biomaterials.2003.10.102
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Zhang SF, 2013, ACTA BIOMATER, V9, P7236, DOI 10.1016/j.actbio.2013.04.003
NR 103
TC 14
Z9 15
U1 5
U2 31
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 26
BP 5361
EP 5376
DI 10.1039/c5tb00353a
PG 16
WC Materials Science, Biomaterials
SC Materials Science
GA CL4YO
UT WOS:000356964700026
PM 26167284
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Shen, CH
   Han, YM
   Wang, BL
   Tang, JM
   Chen, H
   Lin, QK
AF Shen, Chenghui
   Han, Yuemei
   Wang, Bailiang
   Tang, Junmei
   Chen, Hao
   Lin, Quankui
TI Ocular biocompatibility evaluation of POSS nanomaterials for biomedical
   material applications
SO RSC ADVANCES
LA English
DT Article
ID POLYHEDRAL OLIGOMERIC SILSESQUIOXANE; SILVER NANOPARTICLES; OXIDATIVE
   STRESS; CYTOTOXICITY; SILICA; CELLS; CYTOCOMPATIBILITY; BIOMATERIALS;
   APOPTOSIS; PATHWAYS
AB The tremendous advancement of polyhedral oligomeric silsesquioxanes (POSSs) has been focused on the field of biomaterial applications including tissue engineering, drug delivery, biomedical devices and biosensors. More recently, POSSs have been used in components of ophthalmic biomedical devices, such as contact lenses and intraocular lenses due to their chemical inertness and transparency. A systematic biocompatibility evaluation of POSS nanomaterials is thus essential. Herein, the ocular biocompatibility and cytotoxicity of POSS nanomaterials were investigated both in vitro and in vivo. Three types of commercial POSS nanomaterials with different functional groups were utilized in this research, including aminoethylaminopropylisobutyl-POSS (NH2-POSS), mercaptopropylisobutyl-POSS (SH-POSS) and octahydroxypropyldimethylsilyl-POSS (HO-POSS). The cellular metabolic activity, membrane integrality, cell apoptosis and oxidative damage were tested on human lens epithelial cells (HLECs) under different concentrations of POSS nanomaterial exposure. The ocular irritation on rabbit eyes was measured as well. The results show that the studied POSS nanomaterials do not exhibit any significant toxicity to cell growth and proliferation in most cases, except for the NH2-POSS, which decreases the cellular viability at high concentration. All of the POSS nanomaterials slightly induced oxidative stress as a result of an increase in reactive oxygen species (ROS), however they did not generate cell apoptosis. The animal experiment results also show that no acute ocular irritation can be detected after POSS nanomaterial administration. These results indicate the good ocular biocompatibility of the POSS nanomaterials in most cases, which have great potential in ocular biomedical applications.
C1 [Shen, Chenghui; Han, Yuemei; Wang, Bailiang; Tang, Junmei; Chen, Hao; Lin, Quankui] Wenzhou Med Univ, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou 325027, Peoples R China.
   [Shen, Chenghui] Wenzhou Inst Biomat & Engn, Wenzhou 325000, Peoples R China.
RP Chen, H (reprint author), Wenzhou Med Univ, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou 325027, Peoples R China.
EM Chenhao823@mail.eye.ac.cn; lqk97531@126.com
FU National Natural Science Foundation of China [51203120, 81271703,
   51403158]; Science & Technology Program of Wenzhou [Y20140177]; Medical
   & Health Technology Program of Zhejiang Province [2013KYA133,
   2014KYA149]
FX Financial support from the National Natural Science Foundation of China
   (51203120, 81271703, 51403158), Science & Technology Program of Wenzhou
   (Y20140177) and Medical & Health Technology Program of Zhejiang Province
   (2013KYA133, 2014KYA149) are greatly acknowledged.
CR Ahmed M, 2014, BIOMATERIALS, V35, P9033, DOI 10.1016/j.biomaterials.2014.07.008
   Andon FT, 2013, ACCOUNTS CHEM RES, V46, P733, DOI 10.1021/ar300020b
   Aranda A, 2013, TOXICOL IN VITRO, V27, P954, DOI 10.1016/j.tiv.2013.01.016
   Bhattacharjee S, 2013, NANOSCALE, V5, P4870, DOI 10.1039/c3nr34266b
   Bohmert L, 2012, ARCH TOXICOL, V86, P1107, DOI 10.1007/s00204-012-0840-4
   Bonafini Jr J. A., 2003, U.S. Pat, Patent No. 6586548
   Chen HM, 2015, CHEM RES TOXICOL, V28, P339, DOI 10.1021/tx500487w
   Chowdhury SM, 2013, BIOMATERIALS, V34, P283, DOI 10.1016/j.biomaterials.2012.09.057
   Chrusciel J. J., 2014, PROG POLYM SCI, V41, P67
   Cordes DB, 2010, CHEM REV, V110, P2081, DOI 10.1021/cr900201r
   Ghanbari H, 2011, MACROMOL RAPID COMM, V32, P1032, DOI 10.1002/marc.201100126
   Han XL, 2011, TOXICOLOGY, V287, P99, DOI 10.1016/j.tox.2011.06.011
   Huang YS, 2010, MOL VIS, V16, P341
   Jung Y, 2014, ACS APPL MATER INTER, V6, P6054, DOI 10.1021/am405099r
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Kuo SW, 2011, PROG POLYM SCI, V36, P1649, DOI 10.1016/j.progpolymsci.2011.05.002
   Lee YH, 2014, BIOMATERIALS, V35, P4706, DOI 10.1016/j.biomaterials.2014.02.021
   Lin QK, 2015, J MATER CHEM B, V3, P3695, DOI 10.1039/c5tb00111k
   Lin QK, 2010, BIOMATERIALS, V31, P4017, DOI 10.1016/j.biomaterials.2010.01.092
   Marano F, 2011, ARCH TOXICOL, V85, P733, DOI 10.1007/s00204-010-0546-4
   McCusker C, 2005, CHEM COMMUN, P996, DOI 10.1039/b416266h
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Nowak JS, 2014, TOXICOL LETT, V224, P84, DOI 10.1016/j.toxlet.2013.10.003
   Oh WK, 2010, ACS NANO, V4, P5301, DOI 10.1021/nn100561e
   Phillips SH, 2004, CURR OPIN SOLID ST M, V8, P21, DOI 10.1016/j.cossms.2004.03.002
   Pierscionek BK, 2012, NANOMED-NANOTECHNOL, V8, P383, DOI 10.1016/j.nano.2011.06.016
   SCOTT DW, 1946, J AM CHEM SOC, V68, P356, DOI 10.1021/ja01207a003
   Tanaka K, 2013, POLYM J, V45, P247, DOI 10.1038/pj.2012.154
   Tanaka K, 2012, J MATER CHEM, V22, P1733, DOI 10.1039/c1jm14231c
   Tay CY, 2014, ACS APPL MATER INTER, V6, P6248, DOI 10.1021/am501266a
   Teng CP, 2014, NPG ASIA MATER, V6, DOI 10.1038/am.2014.102
   Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158
   Wang BL, 2014, RSC ADV, V4, P52959, DOI 10.1039/c4ra08060b
   Wang BL, 2014, J COLLOID INTERF SCI, V431, P1, DOI 10.1016/j.jcis.2014.05.056
   Wu J, 2009, POLYM REV, V49, P25, DOI 10.1080/15583720802656237
   Wu J, 2011, ACS NANO, V5, P4476, DOI 10.1021/nn103530b
   Wu MH, 2010, ANAL CHEM, V82, P5447, DOI 10.1021/ac1003147
   Yan L, 2012, CHEM RES TOXICOL, V25, P1265, DOI 10.1021/tx300129f
   Zhang WA, 2013, PROG POLYM SCI, V38, P1121, DOI 10.1016/j.progpolymsci.2013.03.002
NR 39
TC 10
Z9 10
U1 6
U2 35
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 66
BP 53782
EP 53788
DI 10.1039/c5ra08668j
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA CL2UP
UT WOS:000356801300075
DA 2018-10-19
ER

PT J
AU Kandhasamy, S
   Ramanathan, G
   Kamalraja, J
   Balaji, R
   Mathivanan, N
   Sivagnanam, UT
   Perumal, PT
AF Kandhasamy, Subramani
   Ramanathan, Giriprasath
   Kamalraja, Jayabal
   Balaji, Ravichandran
   Mathivanan, Narayanasamy
   Sivagnanam, Uma Tiruchirapalli
   Perumal, Paramasivan Thirumalai
TI Synthesis, characterization and biological evaluation of chromen and
   pyrano chromen-5-one derivatives impregnated into a novel collagen based
   scaffold for tissue engineering applications
SO RSC ADVANCES
LA English
DT Article
ID POLY 3-HYDROXYBUTYRIC ACID; DRUG-DELIVERY; CROSS-LINKING; COUMARIN
   DERIVATIVES; REGENERATION; SKIN; FABRICATION; NANOFIBERS; COMPOSITE;
   POTENT
AB In this article, we describe the synthesis and biological evaluation of a novel 2-(methylamino)-3-nitro-4-(4-oxo- 4H-chromen-3-yl) pyrano[3,2-c]chromen-5(4H)-one (CCN). It is also determined that CCN impregnated into the collagen scaffold has the potential to mimic the function of the extracellular matrix as a biomaterial in the field of tissue engineering. The series of pyrano[3,2-c] chromen-5(4H)-one derivatives (4a-4j), was analyzed by H-1 NMR, C-13 NMR, mass spectra and FTIR analysis. Compound 4c was confirmed by single crystal XRD studies. All the compounds were screened for antimicrobial activity against Gram positive, Gram negative bacteria and yeast. Among all the compounds, compound (4a=CCN) showed activity against Gram positive and Gram negative bacteria, when compared to the synthesized compounds. Further, compound CCN was evaluated for cytotoxicity against MCF-7, Hep-2 and Vero cancer cell lines with IC50 values of 5.4 mu g ml(-1), 5.3 mu g ml(-1) and 68.4 mu g ml(-1) respectively. In addition, the results of flow cytometry and docking (PDBID: 1A27 with the ligand) studies supported the activity of the synthesized compound (4a). FTIR and NMR analysis of the CCN impregnated collagen scaffold were done to reveal the existence of the CCN molecule in the scaffold. The inherent property of the collagen scaffold was not significantly affected by the structure of the CCN molecule. The thermal and mechanical properties of the collagen scaffold impregnated with CCN molecules gives stability as well as supports the swelling. However, the COL-CCN scaffold showed an enhanced cell attachment and proliferation of NIH 3T3 fibroblast cells. Based on the results, the novel CCN molecule impregnated within a collagen scaffold has potential application as a biomaterial in tissue engineering.
C1 [Kandhasamy, Subramani; Kamalraja, Jayabal; Perumal, Paramasivan Thirumalai] CSIR, Cent Leather Res Inst, Div Organ Chem, Madras 600020, Tamil Nadu, India.
   [Ramanathan, Giriprasath; Sivagnanam, Uma Tiruchirapalli] CSIR, Cent Leather Res Inst, Bioprod Lab, Madras 600020, Tamil Nadu, India.
   [Balaji, Ravichandran; Mathivanan, Narayanasamy] Univ Madras, Ctr Adv Studies Bot, Biocontrol & Microbial Metabolites Lab, Madras 600025, Tamil Nadu, India.
RP Perumal, PT (reprint author), CSIR, Cent Leather Res Inst, Div Organ Chem, Madras 600020, Tamil Nadu, India.
EM suma67@gmail.com; ptperumal@gmail.com
RI Tirichurapalli Sivagnanam, uma/E-1325-2017; Ramanathan,
   Giriprasath/E-2019-2017
OI Tirichurapalli Sivagnanam, uma/0000-0002-1401-2569; Ramanathan,
   Giriprasath/0000-0002-2541-6577; , Kandhasamy/0000-0001-9821-7694;
   Perumal, P T/0000-0003-2057-6368
FU TATA-CSIR-OSDD; CSIR, New Delhi, India
FX We thank TATA-CSIR-OSDD and CSIR, New Delhi, India for the financial
   support in the form of Senior Research Fellowship. The authors
   acknowledge the CSIR-CLRI for providing infrastructure to carry out this
   work.
CR Agarwal P., 2011, INT J BIOMED RES, V2, P181
   Al-Rifai AA, 2012, MED CHEM RES, V21, P468, DOI 10.1007/s00044-011-9553-0
   Archana D, 2013, INT J BIOL MACROMOL, V57, P193, DOI 10.1016/j.ijbiomac.2013.03.002
   Azagarsamy MA, 2014, ACS MACRO LETT, V3, P515, DOI 10.1021/mz500230p
   Bhardwaj N., 2013, INTEGR BIOL, V7, P142
   Boccafoschi F, 2005, BIOMATERIALS, V26, P7410, DOI 10.1016/j.biomaterials.2005.05.052
   Chicatun F, 2013, TISSUE ENG PT A, V19, P2553, DOI [10.1089/ten.TEA.2013.0114, 10.1089/ten.tea.2013.0114]
   Chicatun F, 2011, BIOMACROMOLECULES, V12, P2946, DOI 10.1021/bm200528z
   Davidenko N, 2010, ACTA BIOMATER, V6, P3957, DOI 10.1016/j.actbio.2010.05.005
   Duraipandy N, 2015, J MATER CHEM B, V3, P1415, DOI 10.1039/c4tb01791a
   Falini G, 2004, J MATER CHEM, V14, P2297, DOI 10.1039/b401393j
   Fazeli MR, 2007, FOOD CONTROL, V18, P646, DOI 10.1016/j.foodcont.2006.03.002
   Funke M, 2013, J MED CHEM, V56, P5182, DOI 10.1021/jm400587g
   Gaspar A, 2014, CHEM REV, V114, P4960, DOI 10.1021/cr400265z
   GONG JP, 1994, ANAL BIOCHEM, V218, P314, DOI 10.1006/abio.1994.1184
   Horn MM, 2009, CARBOHYD POLYM, V77, P239, DOI 10.1016/j.carbpol.2008.12.039
   Hwang YJ, 2011, ACS APPL MATER INTER, V3, P2579, DOI 10.1021/am200416h
   Jithendra P, 2013, ACS APPL MATER INTER, V5, P7291, DOI 10.1021/am401637c
   Kanungo I, 2015, PHYS CHEM CHEM PHYS, V17, P2778, DOI 10.1039/c4cp04363d
   Kharadi GJ, 2012, J THERM ANAL CALORIM, V107, P651, DOI 10.1007/s10973-011-1671-x
   Kim Y, 2013, J MATER CHEM B, V1, P3185, DOI 10.1039/c3tb20485e
   Kontogiorgis CA, 2005, J MED CHEM, V48, P6400, DOI 10.1021/jm0580149
   Kulkarni MV, 2006, CURR MED CHEM, V13, P2795, DOI 10.2174/092986706778521968
   Kumar B. Dillip, 2013, J MATER CHEM, V1, P3972
   Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060
   Lee HJ, 2012, CHEM MATER, V24, P881, DOI 10.1021/cm200733s
   Lee S, 2014, ACS APPL MATER INTER, V6, P1082, DOI 10.1021/am404627r
   Lin JT, 2012, ACS APPL MATER INTER, V4, P1050, DOI 10.1021/am201669z
   Luo DM, 2011, MATER LETT, V65, P2395, DOI 10.1016/j.matlet.2011.05.011
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Maddipatla MVSN, 2013, MACROMOLECULES, V46, P5133, DOI 10.1021/ma400584y
   Mattanavee W, 2009, ACS APPL MATER INTER, V1, P1076, DOI 10.1021/am900048t
   Melliou E, 2005, J NAT PROD, V68, P78, DOI 10.1021/np0497447
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Muthukumar T, 2013, COLLOID SURFACE B, V102, P694, DOI 10.1016/j.colsurfb.2012.09.041
   Nagai T, 2000, FOOD CHEM, V68, P277, DOI 10.1016/S0308-8146(99)00188-0
   Nagiah N, 2014, INT J POLYM MATER PO, V63, P583, DOI 10.1080/00914037.2013.854230
   Nagiah N, 2013, ADV POLYM TECH, V32, DOI 10.1002/adv.21370
   Nagiah N, 2013, POLYM BULL, V70, P2337, DOI 10.1007/s00289-013-0956-6
   National Committee for Clinical Laboratory Standards, 2000, M7A5 NCCLS, V20, P2
   Nihal K., 2007, PHOTOCHEM PHOTOBIOL, V83, P1237
   Nimmo CM, 2011, BIOCONJUGATE CHEM, V22, P2199, DOI 10.1021/bc200281k
   Novelo B. M., 2014, J MATER CHEM B, V2, P2874
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Perumal S, 2014, EUR J PHARM SCI, V52, P26, DOI 10.1016/j.ejps.2013.10.006
   Peter M, 2010, CARBOHYD POLYM, V80, P687, DOI 10.1016/j.carbpol.2009.11.050
   Pochet L, 2000, BIOORGAN MED CHEM, V8, P1489, DOI 10.1016/S0968-0896(00)00071-7
   Ramanathan G, 2014, J BIOMATER TISS ENG, V4, P203, DOI 10.1166/jbt.2014.1157
   Rameshw J. A., 2009, J MATER SCI-MATER M, V20, P3
   Rappa G, 2000, ONCOL RES, V12, P113
   Reddy BVS, 2010, BIOORG MED CHEM LETT, V20, P7507, DOI 10.1016/j.bmcl.2010.10.003
   Rifai A., 2012, MED CHEM RES, V21, P468
   Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h
   Satieshkumar R., 2014, ACS APPL MATER INTER, V6, P15015
   Shi YA, 2011, BIOORG MED CHEM LETT, V21, P956, DOI 10.1016/j.bmcl.2010.12.059
   Singaravelu S, 2015, MATER LETT, V152, P90, DOI 10.1016/j.matlet.2015.03.088
   Sionkowska A, 2013, INT J BIOL MACROMOL, V52, P250, DOI 10.1016/j.ijbiomac.2012.10.002
   Sionkowska A, 2014, J MOL LIQ, V199, P318, DOI 10.1016/j.molliq.2014.09.028
   Sridhar R, 2015, CHEM SOC REV, V44, P790, DOI 10.1039/c4cs00226a
   Thaisrivongs S, 1996, J MED CHEM, V39, P2400, DOI 10.1021/jm950888f
   Trenor SR, 2004, CHEM REV, V104, P3059, DOI 10.1021/cr030037c
   Tronci G, 2013, J MATER CHEM B, V1, P5478, DOI 10.1039/c3tb20218f
   Tronci G, 2013, J MATER CHEM B, V1, P3705, DOI 10.1039/c3tb20720j
   Tsai RY, 2015, CARBOHYD POLYM, V115, P525, DOI 10.1016/j.carbpol.2014.08.108
   Wang LM, 2010, BIOMATERIALS, V31, P3976, DOI 10.1016/j.biomaterials.2010.01.131
   Yamamoto N, 2012, BIOCONJUGATE CHEM, V23, P1110, DOI 10.1021/bc200561n
   Yang EB, 1999, BIOCHEM BIOPH RES CO, V260, P682, DOI 10.1006/bbrc.1999.0958
   Zhang L, 2011, CARBOHYD POLYM, V84, P118, DOI 10.1016/j.carbpol.2010.11.009
NR 69
TC 11
Z9 11
U1 0
U2 6
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 68
BP 55075
EP 55087
DI 10.1039/c5ra07133j
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA CL6BH
UT WOS:000357051100033
DA 2018-10-19
ER

PT J
AU Chen, J
   Yu, J
   He, Q
   Zhao, X
   Sang, HX
   Lei, W
   Wu, ZX
   Chen, JY
AF Chen, Jun
   Yu, Jin
   He, Qiang
   Zhao, Xiong
   Sang, Hongxun
   Lei, Wei
   Wu, Zixiang
   Chen, Jingyuan
TI A novel injectable porous surface modified bioactive bone cement for
   vertebroplasty: an in vivo biomechanical and osteogenic study in a
   rabbit osteoporosis model
SO AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH
LA English
DT Article
DE Osteoporosis; vertebroplasty; bone cement; bioglass
ID COMPRESSION FRACTURES; CANCELLOUS BONE; TRABECULAR BONE; STRENGTH;
   OVARIECTOMY; PREVALENCE; SHEEP; PMMA
AB Purpose: The aim of this study is to determine the feasibility and effectiveness of a novel injectable Porous Surface Modified Bioactive Bone Cement (PSMBBC) for vertebroplasty of aiding osteoporotic vertebrae in an osteoporosis model. Methods: 72 osteoporosis rabbits were randomly divided into three groups: the Polymethyl Methacrylate (PMMA) group, the PSMBBC group and the control group. PMMA and PSMBBC were administrated to osteoporotic vertebrae in vertebroplasty, respectively. The animals were sacrificed at 1w, 4w, 12w after the procedure. Micro-CT analysis, biomechanical tests and histological analysis were performed at each time point. Results: From 4 to 12 weeks after the implantation of bone cements, the bone volume fraction (BV/TV) of the PSMBBC group increased from 28.27 +/- 1.69% to 38.43 +/- 1.34%. However, the BV/TV of the PMMA group showed no significant difference after the implantation. At 4 weeks, direct contact between the bone and the bone cement was observed in the PSMBBC group. At 12 weeks, it was discovered that new intact bone trabecular was formed in PSMBBC group. Furthermore, the maximum compressive strength values of the PSMBBC group were significantly higher than those of the control group at each time point after implantation. Conclusions: In summary, this study was the first investigation to evaluate the potential application of PSMBBC for vertebroplasty. Results demonstrated its beneficial effects on the trabecular ingrowth of new bone and bone mineral density increase. With further validation, PSMBBC can become a valuable biomaterial for aiding osteoporotic vertebrae and usable bone cement applied in vertebroplasty.
C1 [Chen, Jun; Chen, Jingyuan] Fourth Mil Med Univ, Xijing Hosp, Sch Publ Hlth, Dept Occupat & Environm Hlth, Xian 710032, Shaanxi, Peoples R China.
   [Chen, Jun; Chen, Jingyuan] Fourth Mil Med Univ, Xijing Hosp, Sch Publ Hlth, Minist Educ,Key Lab Hazard Assessment & Control S, Xian 710032, Shaanxi, Peoples R China.
   [Chen, Jun; He, Qiang; Zhao, Xiong; Sang, Hongxun; Lei, Wei; Wu, Zixiang] Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed, Xian 710032, Shaanxi, Peoples R China.
   [Yu, Jin] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Med, Xian 710032, Shaanxi, Peoples R China.
RP Lei, W (reprint author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China.
EM lei-wei@fmmu.edu.cn; wuzixiang@fmmu.edu.cn; jy_chen@fmmu.edu.cn
FU Research Fund for the National Natural Science Foundation of China
   (NSFC) [31170913]; NSFC [81000141]
FX This study work was supported by the Research Fund for the National
   Natural Science Foundation of China (NSFC No. 31170913). Jin Yu is
   supported by NSFC founding No. 81000141.
CR Aho A. J., 2004, Cell and Tissue Banking, V5, P213, DOI 10.1007/s10561-004-0214-0
   Barralet JE, 2002, J BIOMED MATER RES, V63, P1, DOI 10.1002/jbm.1074
   Boger A, 2008, J BIOMAT SCI-POLYM E, V19, P1125, DOI 10.1163/156856208785540154
   Castaneda S, 2006, SKELETAL RADIOL, V35, P34, DOI 10.1007/s00256-005-0022-z
   Cauley JA, 2007, JAMA-J AM MED ASSOC, V298, P2761, DOI 10.1001/jama.298.23.2761
   Chen Lih-Hui, 2011, Chang Gung Med J, V34, P352
   Covey MK, 2008, J NURS MEAS, V16, P155, DOI 10.1891/1061-3749.16.3.155
   Cunin G, 2000, SPINE, V25, P1070, DOI 10.1097/00007632-200005010-00006
   Denaro L, 2009, ORTHOP CLIN N AM, V40, P465, DOI 10.1016/j.ocl.2009.05.004
   Denaro V, 2009, CLIN CASES MINER BON, V6, P125
   Deramond H, 1998, RADIOL CLIN N AM, V36, P533, DOI 10.1016/S0033-8389(05)70042-7
   GRARDEL B, 1994, OSTEOPOROSIS INT, V4, P204, DOI 10.1007/BF01623240
   Hautamaki M, 2010, J MATER SCI-MATER M, V21, P1685, DOI 10.1007/s10856-010-4018-4
   He Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042525
   Ikeda S, 2001, BONE, V28, P625, DOI 10.1016/S8756-3282(01)00462-8
   Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4
   Lau EMC, 1996, J BONE MINER RES, V11, P1364
   Peters KR, 2002, NEUROSURGERY, V51, pS96, DOI 10.1227/01.NEU.0000031000.61275.4C
   Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5
   Schorlemmer S, 2005, BONE, V37, P491, DOI 10.1016/j.bone.2005.05.002
   Tan HL, 2012, ACTA BIOMATER, V8, P2166, DOI 10.1016/j.actbio.2012.03.013
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wu SS, 2003, J WOMEN HEALTH GEN-B, V12, P17, DOI 10.1089/154099903321154103
   Wu ZX, 2008, MED ENG PHYS, V30, P1112, DOI 10.1016/j.medengphy.2008.01.007
   Yang HL, 2011, ARTIF CELL BLOOD SUB, V39, P87, DOI 10.3109/10731199.2010.503319
NR 25
TC 2
Z9 2
U1 2
U2 10
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1943-8141
J9 AM J TRANSL RES
JI Am. J. Transl. Res.
PY 2015
VL 7
IS 3
BP 548
EP 557
PG 10
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA CK8LU
UT WOS:000356490400012
PM 26045894
DA 2018-10-19
ER

PT J
AU Perea-Gil, I
   Uriarte, JJ
   Prat-Vidal, C
   Galvez-Monton, C
   Roura, S
   Llucia-Valldeperas, A
   Soler-Botija, C
   Farre, R
   Navajas, D
   Bayes-Genis, A
AF Perea-Gil, Isaac
   Uriarte, Juan J.
   Prat-Vidal, Cristina
   Galvez-Monton, Carolina
   Roura, Santiago
   Llucia-Valldeperas, Aida
   Soler-Botija, Carolina
   Farre, Ramon
   Navajas, Daniel
   Bayes-Genis, Antoni
TI In vitro comparative study of two decellularization protocols in search
   of an optimal myocardial scaffold for recellularization
SO AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH
LA English
DT Article
DE Myocardial infarction; acellular myocardial scaffold; extracellular
   matrix; decellularization protocols; recellularization; adipose
   tissue-derived progenitor cells
ID MESENCHYMAL STEM-CELLS; CARDIAC EXTRACELLULAR-MATRIX; MARROW
   MONONUCLEAR-CELLS; HUMAN ADIPOSE-TISSUE; PROGENITOR CELLS;
   MICROMECHANICAL PROPERTIES; HEART; INFARCTION; REGENERATION;
   DIFFERENTIATION
AB Introduction. Selection of a biomaterial-based scaffold that mimics native myocardial extracellular matrix (ECM) architecture can facilitate functional cell attachment and differentiation. Although decellularized myocardial ECM accomplishes these premises, decellularization processes may variably distort or degrade ECM structure. Materials and methods. Two decellularization protocols (DP) were tested on porcine heart samples (epicardium, mid myocardium and endocardium). One protocol, DP1, was detergent-based (SDS and Triton X-100), followed by DNase I treatment. The other protocol, DP2, was focused in trypsin and acid with Triton X-100 treatments. Decellularized myocardial scaffolds were reseeded by embedding them in RAD16-I peptidic hydrogel with adipose tissue-derived progenitor cells (ATDPCs). Results. Both protocols yielded acellular myocardial scaffolds (similar to 82% and similar to 94% DNA reduction for DP1 and DP2, respectively). Ultramicroscopic assessment of scaffolds was similar for both protocols and showed filamentous ECM with preserved fiber disposition and structure. DP1 resulted in more biodegradable scaffolds (P = 0.04). Atomic force microscopy revealed no substantial ECM stiffness changes post-decellularization compared to native tissue. The Young's modulus did not differ between heart layers (P = 0.69) or decellularization protocols (P = 0.15). After one week, recellularized DP1 scaffolds contained higher cell density (236 +/- 106 and 98 +/- 56 cells/mm(2) for recellularized DP1 and DP2 scaffolds, respectively; P = 0.04). ATDPCs in both DP1 and DP2 scaffolds expressed the endothelial marker isolectin B4, but only in the DP1 scaffold ATDPCs expressed the cardiac markers GATA4, connexin43 and cardiac troponin T. Conclusions. In our hands, DP1 produced myocardial scaffolds with higher cell repopulation and promotes ATDPCs expression of endothelial and cardiomyogenic markers.
C1 [Perea-Gil, Isaac; Prat-Vidal, Cristina; Galvez-Monton, Carolina; Roura, Santiago; Llucia-Valldeperas, Aida; Soler-Botija, Carolina; Bayes-Genis, Antoni] Hosp Badalona Germans Trias & Pujol, Serv Cardiol, Hlth Sci Res Inst Germans Trias & Pujol IGTP, ICREC Heart Failure & Cardiac Regenerat Res Lab, Barcelona 08916, Spain.
   [Uriarte, Juan J.; Farre, Ramon; Navajas, Daniel] Univ Barcelona, Fac Med, Biophys & Bioengn Unit, Barcelona 7, Spain.
   [Uriarte, Juan J.; Farre, Ramon; Navajas, Daniel] CIBER Enfermedades Resp, Madrid, Spain.
   [Farre, Ramon] Inst Invest Biomed August Pi I Sunyer, Barcelona, Spain.
   [Navajas, Daniel] Inst Bioengn Catalonia, Barcelona, Spain.
   [Bayes-Genis, Antoni] Autonomous Univ Barcelona, Dept Med, Barcelona, Spain.
RP Bayes-Genis, A (reprint author), Hosp Badalona Germans Trias & Pujol, Serv Cardiol, Hlth Sci Res Inst Germans Trias & Pujol IGTP, ICREC Res Lab, Crta Canyet S-N, Barcelona 08916, Spain.
EM abayesgenis@gmail.com
RI Navajas, Daniel/E-4233-2010; Farre, Ramon/L-2664-2017
OI Navajas, Daniel/0000-0001-7150-9363; Farre, Ramon/0000-0002-9084-7824
FU Instituto de Salud Carlos III: Redes Tematicas de Investigacion
   Cooperativa en Salud [Red de Investigacion Cardiovascular (RIC)
   [RD12/0042/0047]; Ministerio de Ciencia e Innovacion
   [SAF-2011-30067-C02-01/02, SAF2011-22576, FIS-P11/00089,
   FIS-PI14/01682]; Fundacio Privada Daniel Bravo Andreu; La Marato de TV3
   [12/2232]; Societat Catalana de Cardiologia; Sociedad Espanola de
   Cardiologia; Instituto de Salud Carlos III: Redes Tematicas de
   Investigacion Cooperativa en Salud (Red de Investigacion en Terapia
   Celular-TerCel) [RD12/0019/0029];  [IF09/3667]
FX The authors want to thank the members of the Jesus Uson Minimally
   Invasive Surgery Centre (Caceres, Spain) for providing mediastinal
   adipose tissue samples from pigs that underwent cardiothoracic surgery.
   This work was supported in part by the Instituto de Salud Carlos III:
   Redes Tematicas de Investigacion Cooperativa en Salud [Red de
   Investigacion Cardiovascular (RIC; RD12/0042/0047) and Red de
   Investigacion en Terapia Celular-TerCel (RD12/0019/0029)] and by
   Infrastructure Grant (IF09/3667). The study also received funding from
   the Ministerio de Ciencia e Innovacion (SAF-2011-30067-C02-01/02 to ABG,
   SAF2011-22576 to RF, FIS-P11/00089 to DN and FIS-PI14/01682); from the
   Fundacio Privada Daniel Bravo Andreu; from La Marato de TV3 (12/2232 to
   SR); and from the Societat Catalana de Cardiologia and the Sociedad
   Espanola de Cardiologia.
CR Akhyari P, 2011, TISSUE ENG PART C-ME, V17, P915, DOI [10.1089/ten.tec.2011.0210, 10.1089/ten.TEC.2011.0210]
   Aleksandrova A, 2012, DEV BIOL, V363, P348, DOI 10.1016/j.ydbio.2011.12.036
   Andreu I, 2014, ACTA BIOMATER, V10, P3235, DOI 10.1016/j.actbio.2014.03.034
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Bayes-Genis A, 2010, J MOL CELL CARDIOL, V49, P771, DOI 10.1016/j.yjmcc.2010.08.010
   Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005
   Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647
   Bissell M J, 1987, Prog Clin Biol Res, V249, P251
   Butt H J, 1995, NANOTECHNOLOGY, V1, P1, DOI DOI 10.1088/0957-4484/6/1/001
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Cui XJ, 2010, TOHOKU J EXP MED, V222, P281, DOI 10.1620/tjem.222.281
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678
   Galvez-Monton C, 2013, REV ESP CARDIOL, V66, P391, DOI 10.1016/j.rec.2012.11.012
   Grauss RW, 2005, EUR J CARDIO-THORAC, V27, P566, DOI 10.1016/j.ejcts.2004.12.052
   Grayson WL, 2009, SEMIN CELL DEV BIOL, V20, P665, DOI 10.1016/j.semcdb.2008.12.008
   Hersch N, 2013, BIOL OPEN, V2, P351, DOI 10.1242/bio.20133830
   Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118
   Jin JY, 2009, EUR J HEART FAIL, V11, P147, DOI 10.1093/eurjhf/hfn017
   Kawamoto A, 2001, CIRCULATION, V103, P634
   Kim BS, 2012, CELL TISSUE RES, V348, P559, DOI 10.1007/s00441-012-1391-y
   Kumar BM, 2007, MOL CELLS, V24, P343
   Liang CH, 2004, BIOMATERIALS, V25, P3541
   Lockhart M, 2011, BIRTH DEFECTS RES A, V91, P535, DOI 10.1002/bdra.20810
   Lu P., 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A005058
   Lu QJ, 2004, BIOMATERIALS, V25, P5227, DOI 10.1016/j.biomaterials.2003.12.019
   Lu TY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3307
   Luque T, 2013, ACTA BIOMATER, V9, P6852, DOI 10.1016/j.actbio.2013.02.044
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Martinez-Estrada OM, 2005, CARDIOVASC RES, V65, P328, DOI 10.1016/j.cardiores.2004.11.015
   Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003
   Miyagi Y, 2010, BIOMATERIALS, V31, P7684, DOI 10.1016/j.biomaterials.2010.06.048
   Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014
   Novakovic GV, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014076
   Ock SA, 2010, TISSUE ENG PART C-ME, V16, P1481, DOI [10.1089/ten.tec.2010.0149, 10.1089/ten.TEC.2010.0149]
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Prat-Vidal C, 2014, INT J CARDIOL, V174, P654, DOI 10.1016/j.ijcard.2014.04.181
   Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914
   Rigol M, 2014, EUR J CLIN INVEST, V44, P83, DOI 10.1111/eci.12195
   Rigol M, 2010, J CARD FAIL, V16, P357, DOI 10.1016/j.cardfail.2009.12.006
   Robinson KA, 2005, CIRCULATION, V112, pI135
   Sarig U, 2012, TISSUE ENG PT A, V18, P2125, DOI [10.1089/ten.tea.2011.0586, 10.1089/ten.TEA.2011.0586]
   Sarig U, 2011, EXPERT OPIN BIOL TH, V11, P1055, DOI 10.1517/14712598.2011.578574
   Sieminski AL, 2008, J BIOMED MATER RES A, V87A, P494, DOI 10.1002/jbm.a.31785
   Siepe M, 2006, J THORAC CARDIOV SUR, V132, P124, DOI 10.1016/j.jtcvs.2006.01.052
   Soler-Botija C, 2014, AM J TRANSL RES, V6, P291
   Soler-Botija C, 2012, ANN NY ACAD SCI, V1254, P57, DOI 10.1111/j.1749-6632.2012.06519.x
   Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005
   Song JJ, 2014, TRENDS MOL MED, V17, P424
   Templin C, 2012, CIRCULATION, V126, P430, DOI 10.1161/CIRCULATIONAHA.111.087684
   Trinh LA, 2004, DEV CELL, V6, P371
   Vunjak-Noyakovic G, 2011, ANNU REV BIOMED ENG, V13, P245, DOI 10.1146/annurev-bioeng-071910-124701
   Wainwright JM, 2010, TISSUE ENG PART C-ME, V16, P525, DOI [10.1089/ten.tec.2009.0392, 10.1089/ten.TEC.2009.0392]
   Wang B, 2010, J BIOMED MATER RES A, V94A, P1100, DOI 10.1002/jbm.a.32781
   Witzenburg C, 2012, J BIOMECH, V45, P842, DOI 10.1016/j.jbiomech.2011.11.025
   Xu YY, 2014, ACTA BIOMATER, V10, P3449, DOI 10.1016/j.actbio.2014.04.018
   Zhang J, 2013, CIRC RES, V111, P1125
   Zhang SN, 2011, J CELL MOL MED, V15, P2245, DOI 10.1111/j.1582-4934.2010.01217.x
   Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170
   Zhou C, 2014, SCI REP, V4, P3733
NR 63
TC 17
Z9 17
U1 7
U2 28
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1943-8141
J9 AM J TRANSL RES
JI Am. J. Transl. Res.
PY 2015
VL 7
IS 3
BP 558
EP +
PG 18
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA CK8LU
UT WOS:000356490400013
PM 26045895
DA 2018-10-19
ER

PT J
AU Pielesz, A
   Machnicka, A
   Gawlowski, A
   Fabia, J
   Sarna, E
   Binias, W
AF Pielesz, Anna
   Machnicka, Alicja
   Gawlowski, Andrzej
   Fabia, Janusz
   Sarna, Ewa
   Binias, Wlodzimierz
TI Inhibitors of thermally induced burn incidents - characterization by
   microbiological procedure, electrophoresis, SEM, DSC and IR spectroscopy
SO ANALYST
LA English
DT Article
ID BOVINE SERUM-ALBUMIN; RAMAN-SPECTROSCOPY; FTIR SPECTROSCOPY;
   STRUCTURAL-CHANGES; GLYCATED ALBUMIN; COLLAGEN; AGGREGATION; SKIN;
   PROTEINS; FUCOIDAN
AB Differential scanning calorimetry (DSC) and thermogravimetric (TGA) investigations, acetate electrophoresis (CAE), Fourier-transform infrared spectrometry (FTIR), scanning electron microscopy (SEM) analysis and microbiological procedures were all carried out after heating the samples to a temperature sufficient for simulating a burn incident. In particular, the purpose of the present study was to analyze the effect of antioxidants, such as fucoidan from brown seaweed and flame-retardant cyclic organophosphates and phosphonates, on an organic chicken skin that gets changed by a burn incident. DSC was considered to be a useful tool in assessing in vitro temperature-mediated cross-linking; an innovative analytical conclusion was obtained from the experimentation described in the paper. FTIR tests revealed that heating a dry organic chicken skin to the boiling point leads to the disappearance of a wide band in the 1650-1550 cm(-1) area or the conversion of a band, which may be attributed to the intermolecular beta-sheet aggregates. Fucoidan from brown seaweed and flame-retardant cyclic organophosphates and phosphonates probably bind with the collagen that is changed by the burn (in addition to the influence of antioxidant solutions on samples of a blank or not boiled organic chicken skin) incident forming a polymer film with the collagen of the chicken skin surface (SEM analysis), decreasing the aggregation process and native collagen recovery. Good bacteriostatic properties were determined for fucoidan samples from brown seaweed and flame-retardant cyclic organophosphates and phosphonates against the pathogenic bacteria Escherichia coli and Staphylococcus aureus. Thus, it was observed that the fucoidan incorporated into collagen films can be used as a therapeutically active biomaterial that speeds up the wound-healing process.
C1 [Pielesz, Anna; Machnicka, Alicja; Gawlowski, Andrzej; Fabia, Janusz; Sarna, Ewa; Binias, Wlodzimierz] Univ Bielsko Biala, Fac Mat Civil & Environm Engn, Bielsko Biala, Poland.
RP Pielesz, A (reprint author), Univ Bielsko Biala, Fac Mat Civil & Environm Engn, Bielsko Biala, Poland.
EM apielesz@ath.bielsko.pl
RI Machnicka, Alicja/T-4332-2017
OI Machnicka, Alicja/0000-0003-0277-5160; Binias,
   Wlodzimierz/0000-0002-7260-7739
CR Alimova A, 2009, J PHOTOCH PHOTOBIO B, V96, P178, DOI 10.1016/j.jphotobiol.2009.06.004
   BAILEY AJ, 1995, BIOCHEM J, V305, P385, DOI 10.1042/bj3050385
   Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004
   Binder RJ, 2004, TISSUE ANTIGENS, V64, P442, DOI 10.1111/j.1399-0039.2004.00299.x
   Chen HI, 2010, INT J BIOL MACROMOL, V46, P535, DOI 10.1016/j.ijbiomac.2010.03.001
   Cohen MP, 2003, ARCH BIOCHEM BIOPHYS, V419, P25, DOI 10.1016/j.abb.2003.08.012
   Crane NJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.010902
   Crane NJ, 2010, WOUND REPAIR REGEN, V18, P409, DOI 10.1111/j.1524-475X.2010.00597.x
   Dong AC, 2000, J BIOL CHEM, V275, P27689
   Evers LH, 2010, EXP DERMATOL, V19, P777, DOI 10.1111/j.1600-0625.2010.01105.x
   Farhan KM, 2011, CLIN CHIM ACTA, V412, P386, DOI 10.1016/j.cca.2010.11.016
   Finot PA, 2005, ANN NY ACAD SCI, V1043, P1, DOI 10.1196/annals.1333.001
   GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0
   Honda C, 2000, CHEM PHARM BULL, V48, P464
   Horrocks AR, 2008, ADVANCES IN FIRE RETARDANT MATERIALS, P1, DOI 10.1533/9781845694701
   JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140
   Janowska G., 2007, PALNOSC POLIMEROW MA
   Meli M, 2003, J PROTEIN CHEM, V22, P521, DOI 10.1023/B:JOPC.0000005501.48719.84
   Mendelsohn R, 2006, BBA-BIOMEMBRANES, V1758, P923, DOI 10.1016/j.bbamem.2006.04.009
   Mentink CJAL, 2002, CLIN CHIM ACTA, V321, P69, DOI 10.1016/S0009-8981(02)00097-9
   Militello V, 2003, BIOPHYS CHEM, V105, P133, DOI 10.1016/S0301-4622(03)00153-4
   Paul RG, 1998, BIOCHEM J, V330, P1241, DOI 10.1042/bj3301241
   Pielesz A, 2011, CARBOHYD RES, V346, P1937, DOI 10.1016/j.carres.2011.05.016
   Pielesz A, 2014, ELECTROPHORESIS, V35, P2237, DOI 10.1002/elps.201400178
   Pielesz A, 2014, SPECTROCHIM ACTA A, V118, P287, DOI 10.1016/j.saa.2013.08.056
   Pouliot R, 1999, BBA-MOL CELL BIOL L, V1439, P341, DOI 10.1016/S1388-1981(99)00086-4
   Rondeau P, 2007, ARCH BIOCHEM BIOPHYS, V460, P141, DOI 10.1016/j.abb.2007.01.014
   Rondeau P, 2011, BIOCHIMIE, V93, P645, DOI 10.1016/j.biochi.2010.12.003
   Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167
   Semenza GL, 2000, J APPL PHYSIOL, V88, P1474
   Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2
   VARGHESE MC, 1986, ARCH DERMATOL, V122, P52, DOI 10.1001/archderm.122.1.52
   Votteler M, 2012, J BIOPHOTONICS, V5, P47, DOI 10.1002/jbio.201100068
   Wiens R, 2007, ANAL BIOANAL CHEM, V387, P1679, DOI 10.1007/s00216-006-1095-9
NR 34
TC 2
Z9 2
U1 2
U2 22
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0003-2654
EI 1364-5528
J9 ANALYST
JI Analyst
PY 2015
VL 140
IS 13
BP 4599
EP 4607
DI 10.1039/c5an00329f
PG 9
WC Chemistry, Analytical
SC Chemistry
GA CK4DO
UT WOS:000356171400033
PM 26029873
DA 2018-10-19
ER

PT J
AU Paul, NE
   Losel, R
   Hemmrich, K
   Goy, D
   Pallua, N
   Klee, D
AF Paul, N. E.
   Loesel, R.
   Hemmrich, K.
   Goy, D.
   Pallua, N.
   Klee, D.
TI L-arginine and arginine ethyl ester enhance proliferation of endothelial
   cells and preadipocytes - How an arginine ethyl ester-releasing
   biomaterial could support endothelial cell growth in tissue engineering
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Arginine; arginine ethyl ester; endothelial cells; preadipocytes;
   angiogenesis
ID HUMAN ADIPOSE-TISSUE; NITRIC-OXIDE; IN-VIVO; STROMAL CELLS;
   ANGIOGENESIS; DIFFERENTIATION; SECRETION; PRECURSOR; INSULIN; LEPTIN
AB Adipose tissue engineering is a promising solution for the reconstruction of soft tissue defects. An insufficient neovascularisation within the scaffolds that leads to necrosis and tissue loss is still a major shortcoming of current tissue engineering attempts. Biomaterials, which release angiogenic factors such as L-arginine, could overcome this challenge by supporting the neovascularisation of the constructs. L-arginine is insoluble in organic solvents and thus cannot be incorporated into commonly used polymers in contrast to its ethyl ester. Here, we compared the effects of arginine and its ethyl ester on endothelial cells and preadipocytes, and generated an arginine ethyl ester-releasing, angiogenic polymer. We cultivated adipose tissue-derived endothelial cells and preadipocytes in arginine-free medium supplemented with L-arginine or L-arginine ethyl ester and assayed the proliferation rate and the degree of adipogenic differentiation, respectively. Additionally, we prepared arginine ethyl ester-releasing poly(D, L-lactide) foils, and investigated their impact on endothelial cell proliferation. We could demonstrate that arginine ethyl ester like arginine significantly increased the proliferation of endothelial cells and preadipocytes without inhibiting an induced adipogenic conversion of the preadipocytes. Further, we could show that the arginine ethyl ester-releasing polymer significantly increased endothelial cell growth. The present data are helpful guidance for generating angiogenic biomaterials that promote endothelial cell growth, and thereby could support neovascularisation within tissue engineering approaches.
C1 [Paul, N. E.; Hemmrich, K.; Goy, D.; Pallua, N.] Rhein Westfal TH Aachen, Univ Hosp, Burn Ctr, Dept Plast Surg & Hand Surg, D-52074 Aachen, Germany.
   [Loesel, R.; Klee, D.] Rhein Westfal TH Aachen, Dept Text & Macromol Chem, D-52074 Aachen, Germany.
RP Paul, NE (reprint author), Rhein Westfal TH Aachen, Univ Hosp, Burn Ctr, Dept Plast Surg & Hand Surg, Pauwelsstr 30, D-52074 Aachen, Germany.
EM npaul@ukaachen.de
FU Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich
   Transregio 37]
FX This work was supported by a grant from the Deutsche
   Forschungsgemeinschaft (DFG), Sonderforschungsbereich Transregio 37.
CR Chin K, 1997, ONCOGENE, V15, P437, DOI 10.1038/sj.onc.1201201
   Cooke JP, 2003, ATHEROSCLEROSIS SUPP, V4, P53, DOI 10.1016/S1567-5688(03)00034-5
   Dulak J, 2000, ARTERIOSCL THROM VAS, V20, P659, DOI 10.1161/01.ATV.20.3.659
   ERSEK RA, 1991, PLAST RECONSTR SURG, V87, P219, DOI 10.1097/00006534-199102000-00001
   FASEHUN OA, 1990, J PHARMACOL EXP THER, V255, P1348
   Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0
   FOLKMAN J, 1982, ANN NY ACAD SCI, V401, P212, DOI 10.1111/j.1749-6632.1982.tb25720.x
   Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA
   Hemmrich K, 2006, EXPERT REV MED DEVIC, V3, P635, DOI 10.1586/17434440.3.5.635
   Holmang A, 1996, DIABETOLOGIA, V39, P206, DOI 10.1007/BF00403964
   Hoss M, 2013, J TISSUE ENG REGEN M, V7, P312, DOI 10.1002/term.526
   Hutley LJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE1037
   Jozkowicz A, 1999, ACTA BIOCHIM POL, V46, P703
   KERN PA, 1989, DIABETES, V38, P710, DOI 10.2337/diabetes.38.6.710
   Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d
   Neels JG, 2004, FASEB J, V18, P983, DOI 10.1096/fj.03-1101fje
   PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0
   Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1
   Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799
   Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683
   SILVERMAN KJ, 1988, BIOCHEM BIOPH RES CO, V153, P347, DOI 10.1016/S0006-291X(88)81229-4
   SPRINGHORN JP, 1995, IN VITRO CELL DEV-AN, V31, P473
   Stoppato M, 2013, BIOMATERIALS, V34, P4573, DOI 10.1016/j.biomaterials.2013.02.009
   VARZANEH FE, 1994, METABOLISM, V43, P906, DOI 10.1016/0026-0495(94)90275-5
   von Heimburg D, 2005, RESP PHYSIOL NEUROBI, V146, P107, DOI 10.1016/j.resp.2004.12.013
   Ziche M, 1997, J CLIN INVEST, V99, P2625, DOI 10.1172/JCI119451
   ZICHE M, 1994, J CLIN INVEST, V94, P2036, DOI 10.1172/JCI117557
   ZICHE M, 1993, BIOCHEM BIOPH RES CO, V192, P1198, DOI 10.1006/bbrc.1993.1543
NR 28
TC 0
Z9 0
U1 0
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2015
VL 25
IS 3
BP 289
EP 297
DI 10.3233/BME-151275
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CK9CP
UT WOS:000356538400007
PM 26407115
DA 2018-10-19
ER

PT J
AU Yamamoto, K
   Yoshizawa, Y
   Yanagiguchi, K
   Ikeda, T
   Yamada, S
   Hayashi, Y
AF Yamamoto, Kohei
   Yoshizawa, Yuu
   Yanagiguchi, Kajiro
   Ikeda, Takeshi
   Yamada, Shizuka
   Hayashi, Yoshihiko
TI The Characterization of Fish (Tilapia) Collagen Sponge as a Biomaterial
SO INTERNATIONAL JOURNAL OF POLYMER SCIENCE
LA English
DT Article
ID I COLLAGEN; SCAFFOLDS; CHITOSAN; MATRICES
AB For scaffold manufacturing, the utility of bioactive natural organic materials derived from marine products is useful and indispensable as an alternative to bovine collagen. The weakest feature of fish collagen for scaffold application is its low degeneration temperature (T-d), indicating poor stability of fish collagen in mammals in vivo. We have focused on the tropical fish tilapia as a candidate for generating a clinical scaffold. The aim of this study was to confirm the T-d of tilapia type I atelocollagen (TAC) for biomedical application. Furthermore, the physical and structural properties were investigated and evaluated as a scaffold on a sponge form. Different concentrations {0.5%, 1.0%, and 2.0% (v/v)} of TAC solution were analyzed. Differential scanning calorimetry showed that the T-d of TAC was 35-36 degrees C. The scanning electron microscopy results indicated that the pore size (90-160 mu m) of TAC sponges is acceptable for cell proliferation. The tensile strength of porous sponges was in the range of 0.01-0.07 MPa. These findings indicate that the TAC sponge prepared from tilapia is one of candidates as a scaffold. The 1.0% (v/v) concentration of TAC solution is especially recommended to be advantageous for preparing and handling the solution and for sponge formation.
C1 [Yamamoto, Kohei; Yoshizawa, Yuu; Yanagiguchi, Kajiro; Ikeda, Takeshi; Yamada, Shizuka; Hayashi, Yoshihiko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cariol, Nagasaki 8528588, Japan.
RP Hayashi, Y (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Cariol, Nagasaki 8528588, Japan.
EM hayashi@nagasaki-u.ac.jp
FU Funds for Integrated Promotion of Social System Reform and Research and
   Development; Ministry of Education, Science, Sports and Culture of Japan
FX This work was supported by Funds for Integrated Promotion of Social
   System Reform and Research and Development, Contract Grant Sponsor:
   Ministry of Education, Science, Sports and Culture of Japan.
CR Chen VJ, 2004, BIOMATERIALS, V25, P2065, DOI 10.1016/j.biomaterials.2003.08.058
   Dawlee S, 2005, BIOMACROMOLECULES, V6, P2040, DOI 10.1021/bm050013a
   Dillow A., 2002, BIOMIMETIC MAT DESIG
   Hayashi Y., 2014, SEAFOOD PROCESSING B, P455
   Hayashi Y, 2012, ADV FOOD NUTR RES, V65, P107, DOI 10.1016/B978-0-12-416003-3.00006-8
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Ikoma T, 2003, INT J BIOL MACROMOL, V32, P199, DOI 10.1016/S0141-8130(03)00054-0
   KIMURA S, 1988, J FOOD SCI, V53, P1315, DOI 10.1111/j.1365-2621.1988.tb09266.x
   Lefler A, 2009, J BIOMAT SCI-POLYM E, V20, P1335, DOI 10.1163/092050609X12457417534295
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MATSUI R, 1991, COMP BIOCHEM PHYS B, V99, P171, DOI 10.1016/0305-0491(91)90025-9
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Winter AD, 2000, MOL CELL BIOL, V20, P4084, DOI 10.1128/MCB.20.11.4084-4093.2000
   Wu JL, 2011, CARBOHYD POLYM, V86, P1048, DOI 10.1016/j.carbpol.2011.05.060
   Yamada S, 2014, BIOMED RES INT, DOI 10.1155/2014/302932
   Yamamoto K, 2014, BIOMED RES INT, DOI 10.1155/2014/630757
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
NR 18
TC 1
Z9 1
U1 0
U2 12
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-9422
EI 1687-9430
J9 INT J POLYM SCI
JI Int. J. Polym. Sci.
PY 2015
AR 957385
DI 10.1155/2015/957385
PG 5
WC Polymer Science
SC Polymer Science
GA CL2OB
UT WOS:000356782800001
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Zhang, WF
   Yu, JX
   Chang, HX
AF Zhang, Wenfeng
   Yu, Jingxue
   Chang, Haixin
TI Two dimensional nanosheets as conductive, flexible elements in
   biomaterials
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID TISSUE-ENGINEERED PERIOSTEUM; MESENCHYMAL STEM-CELLS; GRAPHENE OXIDE;
   COMPOSITE SCAFFOLDS; SUBRETINAL SPACE; DIFFERENTIATION; FILMS;
   STRATEGIES; DELIVERY; BEHAVIOR
AB Since the discovery of graphene in 2004, two-dimensional (2D) nanostructures have been attracting tremendous interest for a variety of applications, including bio-inspired applications, due to their fascinating electronic, mechanical and optical properties. Especially, graphene and other 2D or quasi-2D nanostructures show excellent conductivity and flexibility. Herein, we highlight the recent impressive progress concerning the use of two representative types of 2D and quasi-2D nanostructures, graphenebased nanosheets and ultrathin polymeric nanosheets, as conductive or/and flexible elements to engineer three dimensional (3D) tissues. The results feature the unique potential of these 2D and quasi-2D nanostructures in the biomaterial tissue engineering research field.
C1 [Zhang, Wenfeng; Yu, Jingxue; Chang, Haixin] Huazhong Univ Sci & Technol, Sch Mat Sci & Engn, Ctr Joining & Elect Packaging, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Peoples R China.
RP Chang, HX (reprint author), Huazhong Univ Sci & Technol, Sch Mat Sci & Engn, Ctr Joining & Elect Packaging, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Peoples R China.
EM hxchang@hust.edu.cn
RI zhang, wenfeng/C-5730-2011; Chang, Haixin/A-1753-2012
OI zhang, wenfeng/0000-0001-9487-9375; 
FU National Basic Research Program of China [2015CB258400]; Natural Science
   Foundation of China [51402118]; HUST [0118110089, 0124110361]
FX This study is supported by the National Basic Research Program of China
   (No. 2015CB258400), the Natural Science Foundation of China (No.
   51402118) and the HUST (No. 0118110089 and 0124110361).
CR Ahadian S, 2014, RSC ADV, V4, P9534, DOI 10.1039/c3ra46218h
   Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056
   Binder S, 2007, PROG RETIN EYE RES, V26, P516, DOI 10.1016/j.preteyeres.2007.02.002
   Chang HX, 2013, ENERG ENVIRON SCI, V6, P3483, DOI 10.1039/c3ee42518e
   Chang HX, 2013, ADV FUNCT MATER, V23, P1984, DOI 10.1002/adfm.201202460
   Chang HX, 2010, ANAL CHEM, V82, P2341, DOI 10.1021/ac9025384
   Chen D, 2012, CHEM REV, V112, P6027, DOI 10.1021/cr300115g
   Chen GY, 2012, BIOMATERIALS, V33, P418, DOI 10.1016/j.biomaterials.2011.09.071
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Fan W, 2008, BONE, V42, P81, DOI 10.1016/j.bone.2007.08.048
   Foolen J, 2008, J ORTHOP RES, V26, P1263, DOI 10.1002/jor.20586
   Forrest JA, 2001, ADV COLLOID INTERFAC, V94, P167, DOI 10.1016/S0001-8686(01)00060-4
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Fujie T, 2014, ADV MATER, V26, P1699, DOI 10.1002/adma.201304183
   Fujie T, 2013, NANO LETT, V13, P3185, DOI 10.1021/nl401237s
   Fujie T, 2011, LANGMUIR, V27, P13173, DOI 10.1021/la203140a
   Fujie Y. O. T., 2011, FUNCTIONAL POLYM FIL, P907
   Ge Y, 2012, J MATER CHEM, V22, P17619, DOI 10.1039/c2jm33173j
   Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877
   Guillame-Gentil O, 2010, ADV MATER, V22, P5443, DOI 10.1002/adma.201001747
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Hoffman MD, 2013, BIOMATERIALS, V34, P8887, DOI 10.1016/j.biomaterials.2013.08.005
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Hynes SR, 2010, GRAEF ARCH CLIN EXP, V248, P763, DOI 10.1007/s00417-009-1263-7
   Ku SH, 2013, BIOMATERIALS, V34, P2017, DOI 10.1016/j.biomaterials.2012.11.052
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451
   Liu KP, 2011, J MATER CHEM, V21, P12034, DOI 10.1039/c1jm10749f
   Matsusaki M, 2007, ANGEW CHEM INT EDIT, V46, P4689, DOI 10.1002/anie.20070108
   Matsusaki M, 2012, ADV MATER, V24, P454, DOI 10.1002/adma.201103698
   Nishiguchi A, 2011, ADV MATER, V23, P3506, DOI 10.1002/adma.201101787
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Rao CNR, 2009, ANGEW CHEM INT EDIT, V48, P7752, DOI 10.1002/anie.200901678
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Sanchez VC, 2011, CHEM RES TOXICOL, V25, P15, DOI DOI 10.1021/TX200339H
   Schonmeyr B, 2009, TISSUE ENG PT A, V15, P1833, DOI 10.1089/ten.tea.2008.0446
   Shan CS, 2009, LANGMUIR, V25, P12030, DOI 10.1021/la903265p
   Shi XT, 2014, ADV MATER, V26, P3290, DOI 10.1002/adma.201305804
   Shi XT, 2012, ADV FUNCT MATER, V22, P751, DOI 10.1002/adfm.201102305
   Shin SR, 2014, ADV FUNCT MATER, V24, P6136, DOI 10.1002/adfm.201401300
   Shin SR, 2013, ADV MATER, V25, P6385, DOI 10.1002/adma.201301082
   Stanzel BV, 2012, INVEST OPHTH VIS SCI, V53, P490, DOI 10.1167/iovs.11-8260
   Sun ZH, 2014, ACS NANO, V8, P4133, DOI 10.1021/nn500508c
   Taccola S, 2011, LANGMUIR, V27, P5589, DOI 10.1021/la2004134
   Tang LH, 2011, ACS NANO, V5, P3817, DOI 10.1021/nn200147n
   Tao S, 2007, LAB CHIP, V7, P695, DOI 10.1039/b618583e
   Thumann G, 2009, BIOMATERIALS, V30, P287, DOI 10.1016/j.biomaterials.2008.09.039
   Wang Y, 2013, J MATER CHEM B, V1, P3521, DOI 10.1039/c3tb20524j
   Zhou YF, 2007, BIOMATERIALS, V28, P814, DOI 10.1016/j.biomaterials.2006.09.032
   Zorlutuna P, 2012, ADV MATER, V24, P1782, DOI 10.1002/adma.201104631
NR 51
TC 4
Z9 4
U1 1
U2 36
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 25
BP 4959
EP 4964
DI 10.1039/c5tb00087d
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA CK6YS
UT WOS:000356375800004
DA 2018-10-19
ER

PT J
AU Purcel, G
   Surdu, A
   Stoleriu, S
AF Purcel, Gabriela
   Surdu, Adrian
   Stoleriu, Stefania
TI INFLUENCE OF SPARK PLASMA SINTERING CONDITIONS ON Si3N4 CERAMICS USED
   FOR BONE IMPLANTS
SO REVISTA ROMANA DE MATERIALE-ROMANIAN JOURNAL OF MATERIALS
LA English
DT Article
DE Si3N4; spark plasma sintering; biocompatibility
ID STRUCTURAL ORTHOPEDIC IMPLANTS; SILICON-NITRIDE; MECHANICAL-PROPERTIES;
   ALPHA-SI3N4 CERAMICS; COMPOSITES; ADDITIVES
AB Silicon nitride attracts the attention of many researchers for its use in orthopedic and dental applications, but is not yet established as a biomaterial, the research is ongoing. Present paper deals with the obtaining of Si3N4 ceramics unconventional heat treatment (spark plasma sintering.
   The sintering process was pursued through the variation of four Influencing parameters: sintering temperature, the heating rate, the pressure applied during sintering and soaking time. The obtained ceramics were characterized using X-ray diffraction for the phases determination and scanning electron microscopy for microstructure characterization. Also, were determined ceramic and mechanical properties.
   By testing the biocompatibility of these ceramics in contact with the physiological environment by following the evolution of pH and ionic conductivity on immersion of ceramics in SBF is found that pH values and ionic conductivity samples varies widely In the first days but after stabilizes around SBF values.
   Regarding the antibacterial effect, the tests indicate a triple value of biofilm inhibition area for the Si3N4 samples, as comparing with pure titanium, measured under the same condition. Also, was evaluated the MG-63 cell proliferation (by lactate dehydrogenase method - LDH) and morphology.
C1 [Purcel, Gabriela; Surdu, Adrian; Stoleriu, Stefania] Univ Politehn Bucuresti, Bucharest 011061, Romania.
RP Stoleriu, S (reprint author), Univ Politehn Bucuresti, 1,Sect 1, Bucharest 011061, Romania.
EM stefania.stoleriu@upb.ro
OI STOLERIU, Stefania/0000-0003-3553-2034; Surdu,
   Vasile-Adrian/0000-0002-4207-5380
FU Sectoral Operational Programme Human Resources Development; European
   Social Fund; Romanian Government [POSDRU/156/1.2/G/135764]
FX This research was financially supported by Sectoral Operational
   Programme Human Resources Development, financed from the European Social
   Fund and by the Romanian Government under the contract number
   POSDRU/156/1.2/G/135764 "Improvement and implementation of universitary
   master programs in the field of Applied Chemistry and Materials Science
   - ChimMaster".
CR Albu F, 2012, REV ROM MATER, V42, P164
   Bal BS, 2012, ACTA BIOMATER, V8, P2889, DOI 10.1016/j.actbio.2012.04.031
   Ceja-Cardenas L, 2010, J ALLOY COMPD, V501, P345, DOI 10.1016/j.jallcom.2010.04.102
   Chen F, 2008, MATER CHEM PHYS, V107, P67, DOI 10.1016/j.matchemphys.2007.06.042
   Geibel MA, 2005, EUR J MED RES, V10, P333
   Jorgensen J.H., MANUAL CLIN MICROBIO, P1152
   Mazzocchi M, 2008, J MATER SCI-MATER M, V19, P2881, DOI 10.1007/s10856-008-3417-2
   Mazzocchi M, 2008, J MATER SCI-MATER M, V19, P2889, DOI 10.1007/s10856-008-3437-y
   Miranzo P, 2011, CERAM INT, V37, P159, DOI 10.1016/j.ceramint.2010.08.019
   Siqueira JF, 2001, ORAL SURG ORAL MED O, V92, P451, DOI 10.1067/moe.2001.118620
   Tath Z., 2014, CERAM INT, V40, P1399
   Zhang BR, 1998, J AM CERAM SOC, V81, P1344
NR 12
TC 0
Z9 0
U1 0
U2 2
PU SERBAN SOLACOLU FOUNDATION
PI BUCUREST
PA STR GHEORGHE POLIZU NR 1, COD 011061 SECTOR 1, BUCUREST, 00000, ROMANIA
SN 1583-3186
J9 REV ROM MATER
JI Rev. Rom. Mat.
PY 2015
VL 45
IS 2
BP 160
EP 170
PG 11
WC Construction & Building Technology; Materials Science, Multidisciplinary
SC Construction & Building Technology; Materials Science
GA CL0MP
UT WOS:000356637100008
DA 2018-10-19
ER

PT J
AU Allenstein, U
   Mayr, SG
   Zink, M
AF Allenstein, U.
   Mayr, S. G.
   Zink, M.
TI Contractile cell forces deform macroscopic cantilevers and quantify
   biomaterial performance
SO SOFT MATTER
LA English
DT Article
ID SHAPE-MEMORY ALLOYS; SURFACE STRESS; LIVING CELLS; THIN-FILMS; FE-PD;
   ADHESION; FIBROBLASTS; BIOCOMPATIBILITY; SPECTROSCOPY; LOCOMOTION
AB Cells require adhesion to survive, proliferate and migrate, as well as for wound healing and many other functions. The strength of contractile cell forces on an underlying surface is a highly relevant quantity to measure the affinity of cells to a rigid surface with and without coating. Here we show with experimental and theoretical studies that these forces create surface stresses that are sufficient to induce measurable bending of macroscopic cantilevers. Since contractile forces are linked to the formation of focal contacts, results give information on adhesion promoting qualities and allow a comparison of very diverse materials. In exemplary studies, in vitro fibroblast adhesion on the magnetic shape memory alloy Fe-Pd and on the L-lysine derived plasma-functionalized polymer PPLL was determined. We show that cells on Fe-Pd are able to induce surface stresses three times as high as on pure titanium cantilevers. A further increase was observed for PPLL, where the contractile forces are four times higher than on the titanium reference. In addition, we performed finite element simulations on the beam bending to back up the calculation of contractile forces from cantilever bending under non-homogenous surface stress. Our findings consolidate the role of contractile forces as a meaningful measure of biomaterial performance.
C1 [Allenstein, U.; Mayr, S. G.] Leibniz Inst Surface Modificat IOM eV, D-04318 Leipzig, Germany.
   [Allenstein, U.; Mayr, S. G.; Zink, M.] Univ Leipzig, Fac Phys & Earth Sci, D-04103 Leipzig, Germany.
   [Mayr, S. G.] Univ Leipzig, Translat Ctr Regenerat Med TRM, D-04103 Leipzig, Germany.
RP Allenstein, U (reprint author), Leibniz Inst Surface Modificat IOM eV, Permoserstr 15, D-04318 Leipzig, Germany.
EM uta.allenstein@iom-leipzig.de; zink@physik.uni-leipzig.de
RI Zink, Mareike/D-8454-2016
OI Zink, Mareike/0000-0002-3603-3483
FU European Social Fund (ESF); German Science Foundation (DFG); Project
   "BIOSTRAIN''; Federal Ministry of Education and Research [BMBF 1315883]
FX We thank BSc N. John and Dr M. Ehrhard for help with cantilever
   preparation and laser cutting, respectively, Mr S. Daum at the workshop
   of the Leibniz Institute of Surface Modification for manufacturing the
   setups framework, as well as Prof. Dr J. Kas for general support. This
   work is funded in parts by the European Social Fund (ESF), the German
   Science Foundation (DFG), Project "BIOSTRAIN'' and Federal Ministry of
   Education and Research (BMBF 1315883) and was performed within the
   Leipzig Graduate School of Natural Sciences BuildMoNa, established
   within the German Excellence Initiative by the DFG.
CR Allenstein U, 2014, J MATER CHEM B, V2, P7739, DOI 10.1039/c4tb01061b
   Allenstein U, 2013, ACTA BIOMATER, V9, P5845, DOI 10.1016/j.actbio.2012.10.040
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   Bertoncini P, 2012, J MOL RECOGNIT, V25, P262, DOI 10.1002/jmr.2193
   Dahmen K, 2000, SURF SCI, V446, P161, DOI 10.1016/S0039-6028(99)01174-7
   Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8
   Dong C, 2000, J BIOMECH, V33, P35, DOI 10.1016/S0021-9290(99)00174-8
   HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736
   Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999
   Hu M, 1999, J BIOMED MATER RES, V47, P79, DOI 10.1002/(SICI)1097-4636(199910)47:1<79::AID-JBM11>3.0.CO;2-J
   Humphries MJ, 2001, MOL BIOTECHNOL, V18, P57, DOI 10.1385/MB:18:1:57
   Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7
   James RD, 1998, PHILOS MAG A, V77, P1273, DOI 10.1080/01418619808214252
   Kakeshita T., 2002, Materials Science Forum, V394-395, P531
   KOCH R, 1994, J PHYS-CONDENS MAT, V6, P9519, DOI 10.1088/0953-8984/6/45/005
   Koser J, 2011, EUR CELLS MATER, V21, P479
   Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999
   Mayr SG, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.036105
   Mierke CT, 2008, BIOPHYS J, V94, P661, DOI 10.1529/biophysj.107.108472
   Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018
   Muller DJ, 2009, NAT CHEM BIOL, V5, P383, DOI 10.1038/nchembio.181
   MURAKAMI M, 1979, THIN SOLID FILMS, V60, P1, DOI 10.1016/0040-6090(79)90339-0
   Puech PH, 2005, J CELL SCI, V118, P4199, DOI 10.1242/jcs.02547
   Raiteri R, 2001, SENSOR ACTUAT B-CHEM, V79, P115, DOI 10.1016/S0925-4005(01)00856-5
   Rasband W., 1997, IMAGEJ VERSION 1 49
   Sander D, 2003, CURR OPIN SOLID ST M, V7, P51, DOI 10.1016/S1359-0286(02)00137-7
   Sander D, 2008, SENSORS-BASEL, V8, P4466, DOI 10.3390/s8074466
   Schwarz US, 2002, BIOPHYS J, V83, P1380, DOI 10.1016/S0006-3495(02)73909-X
   Selhuber-Unkel C, 2010, BIOPHYS J, V98, P543, DOI 10.1016/j.bpj.2009.11.001
   Shan CS, 2009, LANGMUIR, V25, P12030, DOI 10.1021/la903265p
   SINGER II, 1982, J CELL BIOL, V92, P398, DOI 10.1083/jcb.92.2.398
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stoney GG, 1909, P R SOC LOND A-CONTA, V82, P172, DOI 10.1098/rspa.1909.0021
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Turner N, 2004, CELL BIOL INT, V28, P541, DOI 10.1016/j.cellbi.2004.04.009
   Wyser Y, 2001, PACKAG TECHNOL SCI, V14, P97, DOI 10.1002/pts.540
   Zhang YJ, 2004, J PHYS CHEM B, V108, P15343, DOI 10.1021/jp0471094
   Zink M, 2014, MATER SCI TECH-LOND, V30, P1579, DOI 10.1179/1743284714Y.0000000592
   Zink M, 2013, ADV FUNCT MATER, V23, P1383, DOI 10.1002/adfm.201201789
NR 39
TC 3
Z9 3
U1 1
U2 9
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2015
VL 11
IS 25
BP 5053
EP 5059
DI 10.1039/c5sm01212k
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA CK7EM
UT WOS:000356394400009
PM 26027952
OA Bronze
DA 2018-10-19
ER

PT J
AU Espinosa-Dzib, A
   Chen, J
   Zavgorodnya, O
   Kozlovskaya, V
   Liang, X
   Kharlampieva, E
AF Espinosa-Dzib, Alejandra
   Chen, Jun
   Zavgorodnya, Oleksandra
   Kozlovskaya, Veronika
   Liang, Xing
   Kharlampieva, Eugenia
TI Tuning assembly and enzymatic degradation of
   silk/poly(N-vinylcaprolactam) multilayers via molecular weight and
   hydrophobicity
SO SOFT MATTER
LA English
DT Article
ID HYDROGEN-BONDED MULTILAYERS; MORI SILK FIBROIN; BLEND FILMS; THIN-FILMS;
   BIOMATERIAL COATINGS; PHYSICAL-PROPERTIES; LENGTH SCALE; TANNIC-ACID;
   LAYER; MICROCAPSULES
AB We report on enzymatically degradable nanothin coatings obtained by layer-by-layer (LbL) assembly of silk fibroin with poly(N-vinylcaprolactam) (PVCL) via hydrogen bonding and hydrophobic interactions. We found that both silk beta-sheet content, controlled through dipping and spin-assisted LbL, and PVCL molecular weight regulate film thickness, microstructure, pH-stability, and biodegradability with a nanoscale precision. Thickness of (silk/PVCL) films increased with increase in PVCL molecular weight and decrease in deposition pH. The impact of assembly pH on film growth was more dramatic for dipped films. These systems show a significant rise in thickness with increase in PVCL molecular weight at pH < 5 but become independent on polymer chain length at pH >= 5. We also found that spin-assisted films exhibited a greater stability at elevated pH and against enzymatic degradation as compared to their dipped counterparts. For both film types, the pH and enzymatic stability was improved with increasing PVCL length and beta-sheet content, indicating enhanced hydrophobic and hydrogen-bonded interactions between PVCL and silk. Finally, we fabricated spherical and cubical (silk/PVCL) LbL capsules of regulated permeability and enzymatic degradation. Our approach gives a unique opportunity to tune thickness, morphology, structure, and biodegradability rate of silk films and capsules by varying silk secondary structure and PVCL length. Accounting for all-aqueous fabrication and the biocompatibility of both polymers these biodegradable materials provide novel platforms for delivery systems and medical devices.
C1 [Espinosa-Dzib, Alejandra; Chen, Jun; Zavgorodnya, Oleksandra; Kozlovskaya, Veronika; Liang, Xing; Kharlampieva, Eugenia] Univ Alabama Birmingham, Dept Chem, Ctr Nanoscale Mat & Biointegrat, Birmingham, AL 35294 USA.
RP Kharlampieva, E (reprint author), Univ Alabama Birmingham, Dept Chem, Ctr Nanoscale Mat & Biointegrat, Birmingham, AL 35294 USA.
EM ekharlam@uab.edu
OI Zavgorodnya, Oleksandra/0000-0001-8296-6340
FU NSF DMR Award [1306110]; Consejo Nacional de Ciencia y Tecnologia
   (CONACYT, Mexico) [203111]
FX This work was supported by NSF DMR Award 1306110 (EK). The Consejo
   Nacional de Ciencia y Tecnologia (CONACYT, Mexico) is acknowledged for
   postdoctoral scholarship 203111 (AED). Mr Will Higgins (UAB) is
   acknowledged for technical assistance. The UAB SEM Lab is also
   acknowledged.
CR Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746
   Basal G, 2011, J APPL POLYM SCI, V121, P1885, DOI 10.1002/app.33651
   Chen X, 1997, J APPL POLYM SCI, V65, P2257, DOI 10.1002/(SICI)1097-4628(19970912)65:11<2257::AID-APP23>3.0.CO;2-Z
   Cheng C, 2014, MACROMOL BIOSCI, V14, P807, DOI 10.1002/mabi.201300497
   Chiarelli PA, 2001, ADV MATER, V13, P1167, DOI 10.1002/1521-4095(200108)13:15<1167::AID-ADMA1167>3.0.CO;2-A
   Cho J, 2001, ADV MATER, V13, P1076, DOI 10.1002/1521-4095(200107)13:14<1076::AID-ADMA1076>3.0.CO;2-M
   de Moraes MA, 2015, BIOMACROMOLECULES, V16, P97, DOI 10.1021/bm5012135
   de Moraes MA, 2014, MAT SCI ENG C-MATER, V40, P85, DOI 10.1016/j.msec.2014.03.047
   DeLongchamp DM, 2004, LANGMUIR, V20, P5403, DOI 10.1021/la049777m
   Dhyani V, 2014, ACS APPL MATER INTER, V6, P5005, DOI 10.1021/am4060595
   Du B, 2014, CHEM COMMUN, V50, P4423, DOI 10.1039/c3cc49489f
   Fleer GJ, 1999, MACROMOLECULES, V32, P845, DOI 10.1021/ma980794q
   Freddi G, 1999, J APPL POLYM SCI, V71, P1563, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1563::AID-APP4>3.0.CO;2-E
   Guan Y, 2006, J PHYS CHEM B, V110, P13484, DOI 10.1021/jp061548g
   Jang Y, 2013, MACROMOLECULES, V46, P4580, DOI 10.1021/ma4007736
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jiang P, 2006, MATER LETT, V60, P919, DOI 10.1016/j.matlet.2005.10.056
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Keten S, 2008, NANO LETT, V8, P743, DOI 10.1021/nl0731670
   Kharlampieva E, 2005, MACROMOLECULES, V38, P10523, DOI 10.1021/ma0516891
   Kharlampieva E, 2003, LANGMUIR, V19, P1235, DOI 10.1021/la026546b
   Kharlampieva E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.128303
   Kharlampieva E, 2010, ACS NANO, V4, P7053, DOI 10.1021/nn102456w
   Kharlampieva E, 2009, ADV MATER, V21, P3053, DOI 10.1002/adma.200803653
   Kozlovskaya V, 2015, ADV HEALTHC MATER, V4, P686, DOI 10.1002/adhm.201400657
   Kozlovskaya V, 2014, J MATER CHEM B, V2, P2494, DOI 10.1039/c4tb00165f
   Kozlovskaya V, 2013, ACS MACRO LETT, V2, P226, DOI 10.1021/mz300661f
   Kozlovskaya V, 2012, ACS MACRO LETT, V1, P384, DOI 10.1021/mz200118f
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Lefaux CJ, 2004, J POLYM SCI POL PHYS, V42, P3654, DOI 10.1002/polb.20209
   Liang X, 2014, J POLYM SCI POL CHEM, V52, P2725, DOI 10.1002/pola.27291
   Liang X, 2012, CHEM MATER, V24, P3707, DOI 10.1021/cm301657q
   Liu F, 2014, SOFT MATTER, V10, P9237, DOI 10.1039/c4sm01813c
   Lutkenhaus JL, 2007, MACROMOLECULES, V40, P8367, DOI 10.1021/ma0713557CCC:$37.00
   Maeda Y, 2002, MACROMOLECULES, V35, P217, DOI 10.1021/ma011034+
   Mandal BB, 2009, EUR J PHARM SCI, V37, P160, DOI 10.1016/j.ejps.2009.02.005
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Nogueira GM, 2010, LANGMUIR, V26, P8953, DOI 10.1021/la904741h
   Padol A. R., 2012, INT J TOXICOL APPL P, V2, P31
   Quinn JF, 2007, CHEM SOC REV, V36, P707, DOI 10.1039/b610778h
   Rajkhowa R, 2012, BIOMACROMOLECULES, V13, P2503, DOI 10.1021/bm300736m
   Rao K.M., 2013, J APPL PHARM SCI, V3, P61
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Sashina ES, 2006, RUSS J APPL CHEM+, V79, P869, DOI 10.1134/S1070427206060012
   Seo J, 2008, LANGMUIR, V24, P7995, DOI 10.1021/la800906x
   Shchepelina O, 2012, CHEM MATER, V24, P1245, DOI 10.1021/cm202820r
   Shchepelina O, 2011, ADV MATER, V23, P4655, DOI 10.1002/adma.201102234
   Shi PJ, 2013, BIOMACROMOLECULES, V14, P4465, DOI 10.1021/bm401381s
   Shu SJ, 2010, BIOMATERIALS, V31, P6039, DOI 10.1016/j.biomaterials.2010.04.016
   Shulha H, 2006, POLYMER, V47, P5821, DOI 10.1016/j.polymer.2006.06.002
   Stockton WB, 1997, MACROMOLECULES, V30, P2717, DOI 10.1021/ma9700486
   Sukhishvili SA, 2002, MACROMOLECULES, V35, P301, DOI 10.1021/ma011346c
   Sun YY, 1997, J POLYM SCI POL PHYS, V35, P1405
   Tanaka T, 1998, POLYM INT, V45, P175, DOI 10.1002/(SICI)1097-0126(199802)45:2<175::AID-PI883>3.0.CO;2-K
   Urinov E, 1989, POLYM SCI USSR, V31, P666
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wallet B, 2012, LANGMUIR, V28, P11481, DOI 10.1021/la300916e
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang Y, 2007, MACROMOLECULES, V40, P7594, DOI 10.1021/ma071125s
   Wang Y, 2013, SOFT MATTER, V9, P9420, DOI 10.1039/c3sm51496j
   Xiang FM, 2015, SOFT MATTER, V11, P1001, DOI 10.1039/c4sm02363c
   Ye CH, 2011, BIOMACROMOLECULES, V12, P4319, DOI 10.1021/bm201246f
   Zelikin AN, 2007, ACS NANO, V1, P63, DOI 10.1021/nn700063w
   Zhang X, 2007, CHEM COMMUN, P1395, DOI 10.1039/b615590a
NR 69
TC 7
Z9 7
U1 1
U2 31
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2015
VL 11
IS 25
BP 5133
EP 5145
DI 10.1039/c5sm00464k
PG 13
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA CK7EM
UT WOS:000356394400018
PM 26041120
DA 2018-10-19
ER

PT J
AU Assuncao-Silva, RC
   Gomes, ED
   Sousa, N
   Silva, NA
   Salgado, AJ
AF Assuncao-Silva, Rita C.
   Gomes, Eduardo D.
   Sousa, Nuno
   Silva, Nuno A.
   Salgado, Antonio J.
TI Hydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration
SO STEM CELLS INTERNATIONAL
LA English
DT Review
ID OLFACTORY ENSHEATHING CELLS; NEURAL STEM-CELLS; MARROW STROMAL CELLS;
   PROMOTES FUNCTIONAL RECOVERY; CENTRAL-NERVOUS-SYSTEM; COLONY-STIMULATING
   FACTOR; TEMPLATED AGAROSE SCAFFOLDS; ADULT-RAT BRAIN; BONE-MARROW;
   SCHWANN-CELL
AB Spinal cord injury (SCI) is a central nervous system- (CNS-) related disorder for which there is yet no successful treatment. Within the past several years, cell-based therapies have been explored for SCI repair, including the use of pluripotent human stem cells, and a number of adult-derived stem and mature cells such as mesenchymal stem cells, olfactory ensheathing cells, and Schwann cells. Although promising, cell transplantation is often overturned by the poor cell survival in the treatment of spinal cord injuries. Alternatively, the therapeutic role of different cells has been used in tissue engineering approaches by engrafting cells with biomaterials. The latter have the advantages of physically mimicking the CNS tissue, while promoting a more permissive environment for cell survival, growth, and differentiation. The roles of both cell- and biomaterial-based therapies as single therapeutic approaches for SCI repair will be discussed in this review. Moreover, as the multifactorial inhibitory environment of a SCI suggests that combinatorial approaches would be more effective, the importance of using biomaterials as cell carriers will be herein highlighted, as well as the recent advances and achievements of these promising tools for neural tissue regeneration.
C1 [Assuncao-Silva, Rita C.; Gomes, Eduardo D.; Sousa, Nuno; Silva, Nuno A.; Salgado, Antonio J.] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, P-4710057 Braga, Portugal.
   [Assuncao-Silva, Rita C.; Gomes, Eduardo D.; Sousa, Nuno; Silva, Nuno A.; Salgado, Antonio J.] PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal.
RP Salgado, AJ (reprint author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Campus Gualtar, P-4710057 Braga, Portugal.
EM asalgado@ecsaude.uminho.pt
RI Sousa, Nuno/N-9137-2017; Silva, Nuno/K-4077-2012
OI Sousa, Nuno/0000-0002-8755-5126; Silva, Nuno/0000-0002-1061-1716; Silva,
   Rita/0000-0002-8526-0279; Gomes, Eduardo/0000-0003-3179-1741
FU Portuguese Foundation for Science and Technology
   [PTDC/SAUBMA/114059/2009]; Programa Operacional Regional do Norte
   (ON.2-O Novo Norte), ao abrigo do Quadro de Referencia Estrategico
   Nacional (QREN), atraves do Fundo Europeu de Desenvolvimento Regional
   (FEDER)
FX The authors would like to acknowledge the Portuguese Foundation for
   Science and Technology (Grant no. PTDC/SAUBMA/114059/2009; IF
   Development Grant to Antonio J. Salgado); Premios Santa Casa
   Neurociencias for funds attributed to Antonio J. Salgado under the scope
   of the Prize Melo e Castro for Spinal Cord Injury Research; cofunded by
   Programa Operacional Regional do Norte (ON.2-O Novo Norte), ao abrigo do
   Quadro de Referencia Estrategico Nacional (QREN), atraves do Fundo
   Europeu de Desenvolvimento Regional (FEDER).
CR Abranches E, 2003, BIOTECHNOL LETT, V25, P725, DOI 10.1023/A:1023462832608
   ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   Alcantar NA, 2000, J BIOMED MATER RES, V51, P343, DOI 10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D
   [Anonymous], 2013, MIAM PROJ CUR PAR DO
   Ansorena E, 2013, INT J PHARMACEUT, V455, P148, DOI 10.1016/j.ijpharm.2013.07.045
   Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807
   Arboleda D, 2011, CELL MOL NEUROBIOL, V31, P1113, DOI 10.1007/s10571-011-9712-3
   Ashton RS, 2007, BIOMATERIALS, V28, P5518, DOI 10.1016/j.biomaterials.2007.08.038
   Bachelin C, 2005, BRAIN, V128, P540, DOI 10.1093/brain/awh406
   BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085
   Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322
   Bamber NI, 2001, EUR J NEUROSCI, V13, P257, DOI 10.1046/j.1460-9568.2001.01387.x
   Barnett SC, 2004, TRENDS NEUROSCI, V27, P54, DOI 10.1016/j.tins.2003.10.011
   Belkas JS, 2005, BIOMATERIALS, V26, P1741, DOI 10.1016/j.biomaterials.2004.05.031
   Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Berns EJ, 2014, BIOMATERIALS, V35, P185, DOI 10.1016/j.biomaterials.2013.09.077
   Blesch A, 2002, BRAIN RES BULL, V57, P833, DOI 10.1016/S0361-9230(01)00774-2
   BLIGHT AR, 1989, J NEUROL SCI, V91, P15, DOI 10.1016/0022-510X(89)90073-7
   Borgens RB, 2001, J NEUROSCI RES, V66, P1179
   Boruch AV, 2001, GLIA, V33, P225, DOI 10.1002/1098-1136(200103)33:3<225::AID-GLIA1021>3.0.CO;2-Y
   Boyd JG, 2005, FASEB J, V19, P694, DOI 10.1096/fj.04-2833rev
   Brack HP, 1997, POLYMER, V38, P2351, DOI 10.1016/S0032-3861(96)00780-X
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Chan RTH, 2014, BIOMACROMOLECULES, V15, P339, DOI 10.1021/bm401572a
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Chvatal SA, 2008, BIOMATERIALS, V29, P1967, DOI 10.1016/j.biomaterials.2008.01.002
   Cizkova D, 2011, J NEUROTRAUM, V28, P1951, DOI 10.1089/neu.2010.1413
   Cizkova D, 2006, CELL MOL NEUROBIOL, V26, P1167, DOI 10.1007/s10571-006-9093-1
   Connolly P. J., 2003, SPINAL CORD MED PRIN
   Coviello T, 2006, EXPERT OPIN DRUG DEL, V3, P395, DOI 10.1517/17425247.3.3.395
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102
   Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   DEVON R, 1992, BRAIN RES, V589, P175
   Dong H, 2007, J AM CHEM SOC, V129, P12468, DOI 10.1021/ja072536r
   DOUCETTE R, 1995, HISTOL HISTOPATHOL, V10, P503
   DOUCETTE R, 1993, MICROSC RES TECHNIQ, V24, P113, DOI 10.1002/jemt.1070240204
   Dubois Severine G., 2008, V449, P69, DOI 10.1007/978-1-60327-169-1_5
   Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P265, DOI 10.1097/00002826-200109000-00003
   Eftekharpour E, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E18
   Fan JA, 2011, J BIOMED MATER RES B, V97B, P271, DOI 10.1002/jbm.b.31810
   Fang DY, 2007, J APPL POLYM SCI, V103, P707, DOI 10.1002/app.24941
   Feron F, 2005, BRAIN, V128, P2951, DOI 10.1093/brain/awh657
   Ferrero-Gutierrez A, 2013, HISTOL HISTOPATHOL, V28, P89, DOI 10.14670/HH-28.89
   Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100
   Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005
   Fraga JS, 2013, BIOCHIMIE, V95, P2297, DOI 10.1016/j.biochi.2013.06.028
   FRANKLIN RJM, 1993, INT J DEV NEUROSCI, V11, P641, DOI 10.1016/0736-5748(93)90052-F
   Franklin RJM, 1996, GLIA, V17, P217, DOI 10.1002/(SICI)1098-1136(199607)17:3<217::AID-GLIA4>3.0.CO;2-Y
   Franklin RJM, 1997, J NEUROSCI RES, V50, P665, DOI 10.1002/(SICI)1097-4547(19971201)50:5<665::AID-JNR4>3.3.CO;2-U
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x
   Fu-Jiang C, 2009, CHINESE MED J-PEKING, V122, P225, DOI 10.3760/cma.j.issn.0366-6999.2009.02.021
   Gao MY, 2013, BIOMATERIALS, V34, P1529, DOI 10.1016/j.biomaterials.2012.10.070
   Gautier SE, 1998, J BIOMED MATER RES, V42, P642, DOI 10.1002/(SICI)1097-4636(19981215)42:4<642::AID-JBM22>3.0.CO;2-K
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   Giannetti S, 2001, NEUROL RES, V23, P405, DOI 10.1179/016164101101198622
   Gong HP, 2000, J BIOMED MATER RES, V52, P285
   Gorgieva S., 2011, BIOMATERIALS APPL NA
   GRASDALEN H, 1987, CARBOHYD POLYM, V7, P371, DOI 10.1016/0144-8617(87)90004-X
   Groll J, 2005, J BIOMED MATER RES A, V74A, P607, DOI 10.1002/jbm.a.30335
   Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035
   Guest JD, 1997, EXP NEUROL, V148, P502, DOI 10.1006/exnr.1997.6693
   Gutierrez-Aranda I, 2010, STEM CELLS, V28, P1568, DOI 10.1002/stem.471
   Haastert-Talini K, 2013, BIOMATERIALS, V34, P9886, DOI 10.1016/j.biomaterials.2013.08.074
   Hadley MN, 2002, NEUROSURGERY, V50, pS63, DOI 10.1097/00006123-200203001-00013
   Hagen Ellen Merete, 2012, Tidsskr Nor Laegeforen, V132, P831, DOI 10.4045/tidsskr.10.0859
   Hamann MCJ, 2005, EXP NEUROL, V194, P106, DOI 10.1016/j.expneurol.2005.01.030
   Hejcl A, 2008, PHYSIOL RES, V57, pS121
   Hejcl A, 2008, J NEUROSURG-SPINE, V8, P67, DOI 10.3171/SPI-08/01/067
   Hejcl A, 2010, STEM CELLS DEV, V19, P1535, DOI 10.1089/scd.2009.0378
   Hoffman JA, 2007, FRONT BIOSCI-LANDMRK, V12, P3321, DOI 10.2741/2315
   Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107
   Hurtado A, 2011, BIOMATERIALS, V32, P6068, DOI 10.1016/j.biomaterials.2011.05.006
   Imaizumi T, 1998, J NEUROSCI, V18, P6176
   Itosaka H, 2009, NEUROPATHOLOGY, V29, P248, DOI 10.1111/j.1440-1789.2008.00971.x
   Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436
   Iwaya K, 1999, NEUROSURGERY, V44, P589, DOI 10.1097/00006123-199903000-00085
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Jain A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016135
   JANSSON PE, 1983, CARBOHYD RES, V124, P135, DOI 10.1016/0008-6215(83)88361-X
   JHON MS, 1973, J BIOMED MATER RES, V7, P509, DOI 10.1002/jbm.820070604
   Johnson PJ, 2010, J BIOMED MATER RES A, V92A, P152, DOI 10.1002/jbm.a.32343
   Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72
   Ju YE, 2007, BIOMATERIALS, V28, P2097, DOI 10.1016/j.biomaterials.2007.01.008
   Kakulas BA, 2004, SPINAL CORD, V42, P549, DOI 10.1038/sj.sc.3101670
   Kamada T, 2005, J NEUROPATH EXP NEUR, V64, P37, DOI 10.1093/jnen/64.1.37
   Kamada T, 2011, NEUROPATHOLOGY, V31, P48, DOI 10.1111/j.1440-1789.2010.01130.x
   Kang KN, 2011, TISSUE ENG PT A, V17, P2143, DOI [10.1089/ten.tea.2011.0122, 10.1089/ten.TEA.2011.0122]
   Katayama Y, 2006, BIOMATERIALS, V27, P505, DOI 10.1016/j.biomaterials.2005.07.016
   Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0
   Kean T., 2009, DESK REFERENCE NATUR, P327
   Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005
   Kim YT, 2009, BIOMATERIALS, V30, P2582, DOI 10.1016/j.biomaterials.2008.12.077
   King VR, 2010, BIOMATERIALS, V31, P4447, DOI 10.1016/j.biomaterials.2010.02.018
   King VR, 2006, BIOMATERIALS, V27, P485, DOI 10.1016/j.biomaterials.2005.06.033
   Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052787
   Koda M, 2007, BRAIN RES, V1149, P223, DOI 10.1016/j.brainres.2007.02.058
   Kubinova S., 2013, J TISSUE ENG REGENER
   Kubinova S, 2010, BIOMATERIALS, V31, P5966, DOI 10.1016/j.biomaterials.2010.04.040
   Kumar AA, 2009, EXP CLIN TRANSPLANT, V7, P241
   Laverty PH, 2004, J NEUROTRAUM, V21, P1767, DOI 10.1089/0897715042664867
   Lavik Erin, 2002, Methods Mol Biol, V198, P89
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106
   Lee KY, 2000, NATURE, V408, P998
   Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536
   Leonard M, 2004, J CONTROL RELEASE, V98, P395, DOI 10.1016/j.jconrel.2004.05.009
   Lima C, 2010, NEUROREHAB NEURAL RE, V24, P10, DOI 10.1177/1545968309347685
   Little L, 2008, CHEM REV, V108, P1787, DOI 10.1021/cr078228t
   Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126
   Liu Y, 2013, ACTA BIOMATER, V9, P8075, DOI 10.1016/j.actbio.2013.06.001
   Lopez-Vales R, 2006, NEUROBIOL DIS, V21, P57, DOI 10.1016/j.nbd.2005.06.011
   Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2
   Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020
   Lu S, 2011, TOXICOLOGY, V279, P189, DOI 10.1016/j.tox.2010.10.011
   Luo J, 2002, J NEUROCHEM, V83, P471, DOI 10.1046/j.1471-4159.2002.01160.x
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Mackay-Sim A, 2008, BRAIN, V131, P2376, DOI 10.1093/brain/awn173
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   McCreedy DA, 2012, NEUROSCI LETT, V519, P115, DOI 10.1016/j.neulet.2012.02.025
   McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1
   Meilander NJ, 2003, J CONTROL RELEASE, V88, P321, DOI 10.1016/S0168-3659(03)00007-5
   Menei P, 1998, EUR J NEUROSCI, V10, P607, DOI 10.1046/j.1460-9568.1998.00071.x
   Meyerrose T, 2010, ADV DRUG DELIVER REV, V62, P1167, DOI 10.1016/j.addr.2010.09.013
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   Mothe AJ, 2012, J CLIN INVEST, V122, P3824, DOI 10.1172/JCI64124
   Nakano N, 2010, NEUROSCI LETT, V483, P57, DOI 10.1016/j.neulet.2010.07.062
   Nehrt A, 2010, J NEUROTRAUM, V27, P151, DOI 10.1089/neu.2009.0993
   Nicaise C, 2011, NEUROPATH APPL NEURO, V37, P179, DOI 10.1111/j.1365-2990.2010.01124.x
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108
   Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6
   Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033
   Novikova LN, 2006, J BIOMED MATER RES A, V77A, P242, DOI 10.1002/jbm.a.30603
   Obermair FJ, 2008, PHYSIOLOGY, V23, P296, DOI 10.1152/physiol.00017.2008
   Ogawa E, 2006, FOOD HYDROCOLLOID, V20, P378, DOI 10.1016/j.foodhyd.2005.03.016
   Oliveira AL, 2012, J MATER SCI-MATER M, V23, P2821, DOI 10.1007/s10856-012-4741-0
   Oliveira JT, 2010, TISSUE ENG PT A, V16, P343, DOI 10.1089/ten.TEA.2009.0117
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Oudega M, 2006, J NEUROTRAUM, V23, P453, DOI 10.1089/neu.2006.23.453
   Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X
   Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101
   Pal R, 2009, CYTOTHERAPY, V11, P897, DOI 10.3109/14653240903253857
   Patel V, 2010, J NEUROTRAUM, V27, P789, DOI 10.1089/neu.2008.0809
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Pego AP, 2012, J CELL MOL MED, V16, P2564, DOI 10.1111/j.1582-4934.2012.01603.x
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Pertici V, 2013, ASN NEURO, V5, P149, DOI 10.1042/AN20120082
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Plant GW, 2002, J NEUROSCI, V22, P6083
   Pollack A., 2011, US NEW YORK TIMES
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Puri MC, 2012, STEM CELLS, V30, P10, DOI 10.1002/stem.788
   Quinn F. X., 1993, Polymer Gels and Networks, V1, P93, DOI 10.1016/0966-7822(93)90014-9
   Rahimi-Movaghar V, 2013, NEUROEPIDEMIOLOGY, V41, P65, DOI 10.1159/000350710
   Ramer LM, 2004, J COMP NEUROL, V473, P1, DOI 10.1002/cne.20049
   RAMONCUETO A, 1994, EXP NEUROL, V127, P232, DOI 10.1006/exnr.1994.1099
   Rauch MF, 2009, EUR J NEUROSCI, V29, P132, DOI 10.1111/j.1460-9568.2008.06567.x
   Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1
   Ribeiro CA, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt109
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Rowe RC, 2009, HDB PHARM EXCIPIENTS
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x
   Saberi H, 2008, NEUROSCI LETT, V443, P46, DOI 10.1016/j.neulet.2008.07.041
   Saberi H, 2011, J NEUROSURG-SPINE, V15, P515, DOI 10.3171/2011.6.SPINE10917
   Saito F, 2008, J TRAUMA, V64, P53, DOI [10.1097/TA.0013e31815b847d, 10.1097/TA.0b013e31815b847d]
   Sakaguchi Y, 2005, ARTHRITIS RHEUM, V52, P2521, DOI 10.1002/art.21212
   Sakiyama-Elbert SE, 2001, FASEB J, V15, P1300
   Salgado AJ, 2008, WOODHEAD PUBL MATER, P570, DOI 10.1533/9781845694814.4.570
   Salgado AJ, 2010, STEM CELLS DEV, V19, P1067, DOI 10.1089/scd.2009.0279
   Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103
   Samadikuchaksaraei A, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-15
   Samdani AF, 2009, SPINE, V34, P2605, DOI 10.1097/BRS.0b013e3181bdca87
   Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389
   Schachtrup C, 2007, P NATL ACAD SCI USA, V104, P11814, DOI 10.1073/pnas.0704045104
   Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Sharp KG, 2012, EXP NEUROL, V235, P345, DOI 10.1016/j.expneurol.2012.02.016
   Sheth RN, 2008, J NEUROSURG-SPINE, V8, P153, DOI 10.3171/SPI/2008/8/2/153
   Shi Q, 2014, SCI CHINA LIFE SCI, V57, P232, DOI 10.1007/s11427-014-4612-7
   Shi R, 1999, J NEUROPHYSIOL, V81, P2406
   Shi RY, 2013, NEUROSCI BULL, V29, P460, DOI 10.1007/s12264-013-1364-5
   Shields SA, 2000, J NEUROSCI RES, V60, P571, DOI 10.1002/(SICI)1097-4547(20000601)60:5<571::AID-JNR1>3.0.CO;2-Q
   Shu XZ, 2002, INT J PHARM, V233, P217, DOI 10.1016/S0378-5173(01)00943-7
   Sieminski AL, 2004, J BIOMAT SCI-POLYM E, V15, P237, DOI 10.1163/156856204322793610
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002
   Silva NA, 2013, BIOCHIMIE, V95, P2314, DOI 10.1016/j.biochi.2013.08.016
   Silva NA, 2010, TISSUE ENG PT A, V16, P45, DOI [10.1089/ten.tea.2008.0559, 10.1089/ten.TEA.2008.0559]
   Silva NA, 2012, BIOMATERIALS, V33, P6345, DOI 10.1016/j.biomaterials.2012.05.050
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   StemCells, 2014, PROV UPD ITS PHAS 1
   Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005
   Steward O, 2014, J NEUROSCI, V34, P14013, DOI 10.1523/JNEUROSCI.3066-14.2014
   Stocum DL, 2006, REGENERATIVE BIOL ME
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Sur S, 2013, BIOMATERIALS, V34, P4749, DOI 10.1016/j.biomaterials.2013.03.025
   Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381
   Sykova E, 2006, CELL MOL NEUROBIOL, V26, P1113, DOI 10.1007/s10571-006-9007-2
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takami T, 2002, J NEUROSCI, V22, P6670
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Teixeira FG, 2013, CELL MOL LIFE SCI, V70, P3871, DOI 10.1007/s00018-013-1290-8
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687
   Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107
   Tysseling VM, 2010, J NEUROSCI RES, V88, P3161, DOI 10.1002/jnr.22472
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Urdzikova L, 2006, J NEUROTRAUM, V23, P1379, DOI 10.1089/neu.2006.23.1379
   Vogel L. C., 2011, HDB PEDIAT NEUROPHYC
   Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001
   Weidner N, 1999, J COMP NEUROL, V413, P495, DOI 10.1002/(SICI)1096-9861(19991101)413:4<495::AID-CNE1>3.0.CO;2-Z
   Weiss S, 1996, J NEUROSCI, V16, P7599
   Willerth SM, 2008, ADV DRUG DELIVER REV, V60, P263, DOI 10.1016/j.addr.2007.08.028
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Woerly S, 2001, INT J DEV NEUROSCI, V19, P63, DOI 10.1016/S0736-5748(00)00064-2
   WOODHALL E, 2001, MOL BRAIN RES, V88, P203
   Wu SF, 2001, NEUROSCI LETT, V312, P173, DOI 10.1016/S0304-3940(01)02219-4
   Xiong Y, 2009, BIOMATERIALS, V30, P3711, DOI 10.1016/j.biomaterials.2009.03.046
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yao L, 2013, GENE THER, V20, P1149, DOI 10.1038/gt.2013.42
   Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780
   Yoon SH, 2007, STEM CELLS, V25, P2066, DOI 10.1634/stemcells.2006-0807
   Yoshii S, 2004, J BIOMED MATER RES A, V70A, P569, DOI 10.1002/jbm.a.30120
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002
   Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135
   Zhu Leyin, 2011, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V28, P774
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 250
TC 29
Z9 30
U1 5
U2 35
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-966X
EI 1687-9678
J9 STEM CELLS INT
JI Stem Cells Int.
PY 2015
AR 948040
DI 10.1155/2015/948040
PG 24
WC Cell & Tissue Engineering
SC Cell Biology
GA CK7CT
UT WOS:000356388900001
PM 26124844
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Dong, RJ
   Pang, Y
   Su, Y
   Zhu, XY
AF Dong, Ruijiao
   Pang, Yan
   Su, Yue
   Zhu, Xinyuan
TI Supramolecular hydrogels: synthesis, properties and their biomedical
   applications
SO BIOMATERIALS SCIENCE
LA English
DT Review
ID HOST-GUEST INTERACTIONS; WALLED CARBON NANOTUBES; DRUG-DELIVERY; GENE
   DELIVERY; FLUORESCENT NANOPARTICLES; BIOLOGICAL SIGNIFICANCE;
   BLOCK-COPOLYMERS; AU NANOPARTICLES; SMALL MOLECULES; CROSS-LINKERS
AB As a novel class of three-dimensional (3D) hydrophilic cross-linked polymers, supramolecular hydrogels not only display unique physicochemical properties (e.g., water-retention ability, drug loading capacity, biodegradability and biocompatibility, biostability) as well as specific functionalities (e.g., optoelectronic properties, bioactivity, self-healing ability, shape memory ability), but also have the capability to undergo reversible gel-sol transition in response to various environmental stimuli inherent to the noncovalent cross-linkages, thereby showing great potential as promising biomaterial scaffolds for diagnosis and therapy. In this Review, we summarized the recent progress in the design and synthesis of supramolecular hydrogels through specific, directional noncovalent interactions, with particular emphasis on the structure-property relationship, as well as their wide-ranging applications in disease diagnosis and therapy including bioimaging, biodetection, therapeutic delivery, and tissue engineering. We believe that these current achievements in supramolecular hydrogels will greatly stimulate new ideas and inspire persistent efforts in this hot topic area in future.
C1 [Dong, Ruijiao; Pang, Yan; Su, Yue; Zhu, Xinyuan] Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, State Key Lab Met Matrix Composites, Shanghai 200240, Peoples R China.
RP Dong, RJ (reprint author), Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, State Key Lab Met Matrix Composites, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.
EM yuesu@sjtu.edu.cn; xyzhu@sjtu.edu.cn
RI Dong, Ruijiao/G-3185-2015
OI Dong, Ruijiao/0000-0002-3091-7712
FU National Basic Research Program [2015CB931801]; National Natural Science
   Foundation of China [21204048, 51473093]; China Postdoctoral Science
   Foundation [2013T60439]
FX This work was financially supported by the National Basic Research
   Program (2015CB931801), National Natural Science Foundation of China
   (21204048, 51473093), and Project funded by China Postdoctoral Science
   Foundation (2013T60439).
CR Adhikari B, 2012, LANGMUIR, V28, P1460, DOI 10.1021/la203498j
   Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962
   Altunbas A, 2012, TOP CURR CHEM, V310, P135, DOI 10.1007/128_2011_206
   Appel EA, 2014, ANGEW CHEM INT EDIT, V53, P10038, DOI 10.1002/anie.201403192
   Appel EA, 2012, CHEM SOC REV, V41, P6195, DOI 10.1039/c2cs35264h
   Appel EA, 2012, J AM CHEM SOC, V134, P11767, DOI 10.1021/ja3044568
   Appel EA, 2010, J AM CHEM SOC, V132, P14251, DOI 10.1021/ja106362w
   Babu SS, 2014, CHEM REV, V114, P1973, DOI 10.1021/cr400195e
   Bai W, 2013, J AM CHEM SOC, V135, P6977, DOI 10.1021/ja400576p
   Bairi P, 2013, ACS APPL MATER INTER, V5, P5478, DOI 10.1021/am4013566
   Bastings MMC, 2014, ADV HEALTHC MATER, V3, P70, DOI 10.1002/adhm.201300076
   Cafferty BJ, 2013, J AM CHEM SOC, V135, P2447, DOI 10.1021/ja312155v
   Cao W, 2013, ANGEW CHEM INT EDIT, V52, P6233, DOI 10.1002/anie.201300662
   Castellano RK, 2000, P NATL ACAD SCI USA, V97, P12418, DOI 10.1073/pnas.97.23.12418
   Chen KJ, 2011, BIOMATERIALS, V32, P2160, DOI 10.1016/j.biomaterials.2010.11.043
   Chen Y, 2010, LANGMUIR, V26, P9011, DOI 10.1021/la9048133
   Chen Y, 2010, ADV FUNCT MATER, V20, P579, DOI 10.1002/adfm.200901400
   Choi M, 2013, NAT PHOTONICS, V7, P987, DOI [10.1038/nphoton.2013.278, 10.1038/NPHOTON.2013.278]
   Cui HT, 2014, MACROMOL BIOSCI, V14, P440, DOI 10.1002/mabi.201300366
   Dankers PYW, 2006, BIOMATERIALS, V27, P5490, DOI 10.1016/j.biomaterials.2006.07.011
   Dankers PYW, 2012, ADV MATER, V24, P2703, DOI 10.1002/adma.201104072
   Dankers PYW, 2005, NAT MATER, V4, P568, DOI 10.1038/nmat1418
   Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576
   Deng W, 2007, ANGEW CHEM INT EDIT, V46, P5144, DOI 10.1002/anie.200701272
   Dong RJ, 2015, ADV MATER, V27, P498, DOI 10.1002/adma.201402975
   Dong RJ, 2014, ACCOUNTS CHEM RES, V47, P2006, DOI 10.1021/ar500057e
   Dong RJ, 2014, NANOSCALE, V6, P4544, DOI 10.1039/c4nr00212a
   Dong RJ, 2013, CHEM COMMUN, V49, P9845, DOI 10.1039/c3cc46123h
   Dong RJ, 2012, ACS MACRO LETT, V1, P1208, DOI 10.1021/mz300375c
   Dong RJ, 2011, CHEM COMMUN, V47, P5473, DOI 10.1039/c1cc10934k
   Dong YX, 2014, ACTA BIOMATER, V10, P2076, DOI 10.1016/j.actbio.2013.12.045
   Du R, 2014, SMALL, V10, P1387, DOI 10.1002/smll.201302649
   Elmalem E, 2014, CHEM COMMUN, V50, P8930, DOI 10.1039/c4cc03167a
   Gao Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2040
   Gao Y, 2009, J AM CHEM SOC, V131, P13576, DOI 10.1021/ja904411z
   Griffith A, 2013, CHEM COMMUN, V49, P731, DOI 10.1039/c2cc37842f
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guo H, 2013, BIOMACROMOLECULES, V14, P2733, DOI 10.1021/bm4005645
   Guo MY, 2014, J AM CHEM SOC, V136, P6969, DOI 10.1021/ja500205v
   Guo WW, 2015, ADV MATER, V27, P73, DOI 10.1002/adma.201403702
   Ha W, 2014, ACS APPL MATER INTER, V6, P10623, DOI 10.1021/am5022864
   Han DL, 2014, ACS SUSTAIN CHEM ENG, V2, P296, DOI 10.1021/sc400352a
   He MT, 2013, J AM CHEM SOC, V135, P18718, DOI 10.1021/ja409000b
   Himmelein S, 2014, CHEM SCI, V5, P1054, DOI 10.1039/c3sc52964a
   HOGG R, 1962, J CHEM SOC, P341, DOI 10.1039/jr9620000341
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Huang P, 2014, J AM CHEM SOC, V136, P11748, DOI 10.1021/ja505212y
   Hwang I, 2007, ANGEW CHEM INT EDIT, V46, P210, DOI 10.1002/anie.200603149
   Ikeda M, 2014, NAT CHEM, V6, P511, DOI [10.1038/nchem.1937, 10.1038/NCHEM.1937]
   Ikeda M, 2011, ADV MATER, V23, P2819, DOI 10.1002/adma.201004658
   Ikeda M, 2011, J AM CHEM SOC, V133, P1670, DOI 10.1021/ja109692z
   Ikeda M, 2010, CHEM SCI, V1, P491, DOI 10.1039/c0sc00278j
   Ikeda M, 2008, CHEM-EUR J, V14, P10808, DOI 10.1002/chem.200801144
   Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30
   Jung H, 2014, BIOMACROMOLECULES, V15, P707, DOI 10.1021/bm401123m
   Jung SH, 2014, J AM CHEM SOC, V136, P6446, DOI 10.1021/ja5018199
   Kakuta T, 2013, ADV MATER, V25, P2849, DOI 10.1002/adma.201205321
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kim JH, 2007, PROG POLYM SCI, V32, P1031, DOI 10.1016/j.progpolymsci.2007.05.016
   Koenigs MME, 2014, MACROMOLECULES, V47, P2712, DOI 10.1021/ma500446g
   Komatsu H, 2009, J AM CHEM SOC, V131, P5580, DOI 10.1021/ja8098239
   Koshi Y, 2006, J AM CHEM SOC, V128, P10413, DOI 10.1021/ja0613963
   Kuang Y, 2014, ANGEW CHEM INT EDIT, V53, P8104, DOI 10.1002/anie.201402216
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 1998, NATURE, V392, P5
   Lee J, 2012, NAT NANOTECHNOL, V7, P816, DOI [10.1038/nnano.2012.211, 10.1038/NNANO.2012.211]
   Li JY, 2013, ADV HEALTHC MATER, V2, P1586, DOI 10.1002/adhm.201300041
   Li JY, 2013, J AM CHEM SOC, V135, P9907, DOI 10.1021/ja404215g
   Li JY, 2013, J AM CHEM SOC, V135, P542, DOI 10.1021/ja310019x
   Li JB, 2014, CHEM COMMUN, V50, P3722, DOI 10.1039/c4cc00156g
   Li J, 2010, NPG ASIA MATER, V2, P112, DOI 10.1038/asiamat.2010.84
   Li XM, 2011, ANGEW CHEM INT EDIT, V50, P9365, DOI 10.1002/anie.201103641
   Li XM, 2010, J AM CHEM SOC, V132, P17707, DOI 10.1021/ja109269v
   Li ZB, 2012, BIOMACROMOLECULES, V13, P3162, DOI 10.1021/bm300936x
   Liao XJ, 2010, ANGEW CHEM INT EDIT, V49, P4409, DOI 10.1002/anie.201000141
   Lin N, 2013, BIOMACROMOLECULES, V14, P871, DOI 10.1021/bm301955k
   Liu JH, 2011, MACROMOLECULES, V44, P7682, DOI 10.1021/ma201620w
   Liu JH, 2010, MACROMOLECULES, V43, P8086, DOI 10.1021/ma101437k
   Liu KL, 2010, SOFT MATTER, V6, P2300, DOI 10.1039/b923472a
   Liu Y, 2011, ANGEW CHEM INT EDIT, V50, P3058, DOI 10.1002/anie.201005740
   Liu ZJ, 2014, POLYM CHEM-UK, V5, P1072, DOI 10.1039/c3py01083j
   Ma CX, 2014, ADV MATER, V26, P5665, DOI 10.1002/adma.201402026
   Ma D, 2011, BIOMACROMOLECULES, V12, P3124, DOI 10.1021/bm101566r
   Ma D, 2009, J POLYM SCI POL PHYS, V47, P740, DOI 10.1002/polb.21677
   Matsusaki M, 2011, ADV MATER, V23, P2957, DOI 10.1002/adma.201101284
   McKee JR, 2014, ADV FUNCT MATER, V24, P2706, DOI 10.1002/adfm.201303699
   Meng LL, 2012, MACROMOL BIOSCI, V12, P1524, DOI 10.1002/mabi.201200137
   Menyo MS, 2013, SOFT MATTER, V9, P10314, DOI [10.1039/c3sm51824h, 10.1039/C3SM51824H]
   Mukherjee S, 2014, CHEM-ASIAN J, V9, P2798, DOI 10.1002/asia.201402358
   Nakahata M, 2013, ANGEW CHEM INT EDIT, V52, P5731, DOI 10.1002/anie.201300862
   Nakahata M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1521
   Nandi S, 2012, ORG LETT, V14, P3826, DOI 10.1021/ol300555a
   O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/nchem.1123, 10.1038/NCHEM.1123]
   Ochi R, 2013, CHEM COMMUN, V49, P2115, DOI 10.1039/c2cc37908b
   Ogoshi T, 2007, J AM CHEM SOC, V129, P4878, DOI 10.1021/ja070457
   Oishi M, 2010, NANOMEDICINE-UK, V5, P451, DOI [10.2217/nnm.10.18, 10.2217/NNM.10.18]
   Park KM, 2012, ACS NANO, V6, P2960, DOI 10.1021/nn204123p
   Patil SP, 2012, CHEM COMMUN, V48, P8901, DOI 10.1039/c2cc34466a
   Pedron S, 2015, ADV MATER, V27, P1567, DOI 10.1002/adma.201404896
   Peng K, 2010, CHEM COMMUN, V46, P4094, DOI 10.1039/c002565h
   Ren CH, 2014, CHEM COMMUN, V50, P3473, DOI 10.1039/c3cc48807a
   Rybtchinski B, 2011, ACS NANO, V5, P6791, DOI 10.1021/nn2025397
   Saeed A, 2015, ADV MATER, V27, P662, DOI 10.1002/adma.201403626
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Shen YQ, 2010, J AM CHEM SOC, V132, P4259, DOI 10.1021/ja909475m
   Siegel RA, 2010, J CONTROL RELEASE, V141, P303, DOI 10.1016/j.jconrel.2009.12.012
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Singh A, 2013, ADV FUNCT MATER, V23, P575, DOI 10.1002/adfm.201201902
   Singh A, 2014, ADV MATER, V26, P6530, DOI 10.1002/adma.201402105
   Stuart MAC, 2005, CURR OPIN COLLOID IN, V10, P30, DOI 10.1016/j.cocis.2005.04.004
   Sun TL, 2013, NAT MATER, V12, P932, DOI [10.1038/nmat3713, 10.1038/NMAT3713]
   Sun ZF, 2013, J AM CHEM SOC, V135, P13379, DOI 10.1021/ja403345p
   Takashima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2280
   Tamesue S, 2013, J AM CHEM SOC, V135, P15650, DOI 10.1021/ja408547g
   Tamesue S, 2010, ANGEW CHEM INT EDIT, V49, P7461, DOI 10.1002/anie.201003567
   Tan ZQ, 2011, ADV MATER, V23, P4053, DOI 10.1002/adma.201102160
   Tran NQ, 2010, BIOMACROMOLECULES, V11, P617, DOI 10.1021/bm100047y
   Wada A, 2009, J AM CHEM SOC, V131, P5321, DOI 10.1021/ja900500j
   Wang DL, 2014, CHEM COMMUN, V50, P11994, DOI 10.1039/c4cc03155e
   Wang H, 2010, ACS NANO, V4, P6235, DOI 10.1021/nn101908e
   Wang H, 2009, ANGEW CHEM INT EDIT, V48, P4344, DOI 10.1002/anie.200900063
   Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Wu YL, 2013, ADV HEALTHC MATER, V2, P297, DOI 10.1002/adhm.201200183
   Wurm F, 2009, J AM CHEM SOC, V131, P7954, DOI 10.1021/ja9019148
   Yallapu MM, 2011, DRUG DISCOV TODAY, V16, P457, DOI 10.1016/j.drudis.2011.03.004
   Yan XZ, 2012, CHEM SOC REV, V41, P6042, DOI 10.1039/c2cs35091b
   Yang CB, 2014, BIOMATER SCI-UK, V2, P651, DOI 10.1039/c3bm60252d
   Yang JA, 2014, PROG POLYM SCI, V39, P1973, DOI 10.1016/j.progpolymsci.2014.07.006
   Yang ZM, 2007, CHEM COMMUN, P843, DOI 10.1039/b616563
   Yang ZM, 2012, CHEM COMMUN, V48, P9257, DOI 10.1039/c2cc34935c
   Yang ZM, 2006, J AM CHEM SOC, V128, P3038, DOI 10.1021/ja057412y
   Yin LC, 2013, ADV MATER, V25, P3063, DOI 10.1002/adma.201205088
   Yoshii T, 2014, ANGEW CHEM INT EDIT, V53, P7264, DOI 10.1002/anie.201404158
   Yu SR, 2012, POLYM CHEM-UK, V3, P3324, DOI 10.1039/c2py20487h
   Zhang H, 2014, J MATER CHEM B, V2, P4067, DOI 10.1039/c4tb00155a
   Zhang JX, 2013, ADV DRUG DELIVER REV, V65, P1215, DOI 10.1016/j.addr.2013.05.001
   Zhang JX, 2010, ACS NANO, V4, P1049, DOI 10.1021/nn901213a
   Zhang QW, 2013, CHEM COMMUN, V49, P9800, DOI 10.1039/c3cc46297h
   Zhang Y, 2013, J AM CHEM SOC, V135, P5008, DOI 10.1021/ja402490j
   Zhang ZX, 2013, ANGEW CHEM INT EDIT, V52, P6180, DOI 10.1002/anie.201301956
   Zhao F, 2009, CHEM SOC REV, V38, P883, DOI 10.1039/b806410p
   Zheng WT, 2013, J AM CHEM SOC, V135, P266, DOI 10.1021/ja308690y
   Zhou J, 2014, J AM CHEM SOC, V136, P2970, DOI 10.1021/ja4127399
   Zhu Q, 2013, RSC ADV, V3, P2071, DOI 10.1039/c2ra22210h
NR 145
TC 47
Z9 48
U1 19
U2 211
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2015
VL 3
IS 7
BP 937
EP 954
DI 10.1039/c4bm00448e
PG 18
WC Materials Science, Biomaterials
SC Materials Science
GA CK6AE
UT WOS:000356309200005
PM 26221932
DA 2018-10-19
ER

PT J
AU Yang, Z
   Gao, D
   Cao, Z
   Zhang, C
   Cheng, D
   Liu, J
   Shuai, XT
AF Yang, Zhe
   Gao, Di
   Cao, Zhong
   Zhang, Chao
   Cheng, Du
   Liu, Jie
   Shuai, Xintao
TI Drug and gene co-delivery systems for cancer treatment
SO BIOMATERIALS SCIENCE
LA English
DT Review
ID MESOPOROUS SILICA NANOPARTICLES; OVERCOME MULTIDRUG-RESISTANCE;
   ANTICANCER DRUG; OVARIAN-CANCER; SHELL NANOPARTICLES; TUMOR-CELLS;
   ANTISENSE OLIGONUCLEOTIDES; POLYAMIDOAMINE DENDRIMER; BIODEGRADABLE
   COPOLYMER; TRANSFECTION EFFICIENCY
AB Cancer remains a major killer and a leading cause of death in the world; thus, a growing number of new treatments have been focused on cancer therapy over the past few decades. Chemotherapy, which is thought to be a powerful strategy for cancer treatment, has been widely used in clinical therapy in recent years. However, due to the complexity of cancer, a single therapeutic approach is insufficient for the suppression of cancer growth and migration. Therefore, increasing attention has been paid to the use of smart multifunctional carriers and combinatorially delivers chemotherapeutic drugs and functional genes in order to maximize therapeutic efficiency. Combination therapy using selected drugs and genes can not only overcome multidrug resistance and inhibit the cellular anti-apoptotic process but also achieve a synergistic therapeutic effect. Because multifunctional nanocarriers are important for achieving these goals, this review will illustrate and discuss some advanced biomaterial nanocarriers for co-delivering therapeutic genes and drugs, including multifunctional micelles, liposomes, polymeric conjugates and inorganic nanoparticles. In addition, the challenges and future perspectives for co-delivery systems, containing therapeutic drugs and genes to achieve better therapeutic effects for cancer treatment will be discussed.
C1 [Yang, Zhe; Gao, Di; Cao, Zhong; Zhang, Chao; Liu, Jie] Sun Yat Sen Univ, Sch Engn, Dept Biomed Engn, Guangzhou 510006, Guangdong, Peoples R China.
   [Cheng, Du; Shuai, Xintao] Sun Yat Sen Univ, Sch Chem & Chem Engn, PCFM Lab, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China.
RP Yang, Z (reprint author), Sun Yat Sen Univ, Sch Engn, Dept Biomed Engn, Guangzhou 510006, Guangdong, Peoples R China.
EM bmeliu@gmail.com; Shuaixt@mail.sysu.edu
RI Zhang, Chao/G-9707-2014
OI Yang, Zhe/0000-0001-9525-035X; Cheng, Du/0000-0001-5105-7777; Shuai,
   Xintao/0000-0003-4271-0310
FU National Natural Science Foundation of China [51225305, 51103183,
   81101142, U1401242]; Doctoral Fund of Ministry of Education of China
   [20110171120004]; Project of Zhu Jiang Science and the Technology New
   Star [2012J2200053]; Science and Technology Planning Project of
   Guangdong Province [2012B091100452, 2013B010404014]; Fundamental
   Research Funds for the Central Universities [12lgpy04]
FX This study was supported by the National Natural Science Foundation of
   China (51225305, 51103183, 81101142 and U1401242), the Doctoral Fund of
   Ministry of Education of China (20110171120004), the Project of Zhu
   Jiang Science and the Technology New Star (2012J2200053), the Science
   and Technology Planning Project of Guangdong Province (2012B091100452
   and 2013B010404014) and the Fundamental Research Funds for the Central
   Universities (12lgpy04).
CR Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004
   Alani AWG, 2010, BIOMATERIALS, V31, P1765, DOI 10.1016/j.biomaterials.2009.11.038
   Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037
   Ashley CE, 2011, NAT MATER, V10, P389, DOI [10.1038/NMAT2992, 10.1038/nmat2992]
   Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544
   Bagalkot V, 2009, MOL PHARMACEUT, V6, P1019, DOI 10.1021/mp800177f
   Beh CW, 2009, BIOMACROMOLECULES, V10, P41, DOI 10.1021/bm801109g
   Cai SS, 2007, PHARM RES, V24, P2099, DOI 10.1007/s11095-007-9335-z
   Cao N, 2011, BIOMATERIALS, V32, P2222, DOI 10.1016/j.biomaterials.2010.11.061
   Chan JM, 2009, BIOMATERIALS, V30, P1627, DOI 10.1016/j.biomaterials.2008.12.013
   Chen AM, 2009, SMALL, V5, P2673, DOI 10.1002/smll.200900621
   Chen WC, 2014, SMALL, V10, P2678, DOI 10.1002/smll.201303951
   Cheng D, 2012, BIOMATERIALS, V33, P1170, DOI 10.1016/j.biomaterials.2011.10.057
   Cheng J, 2007, BIOMATERIALS, V28, P869, DOI 10.1016/j.biomaterials.2006.09.047
   Cho H, 2013, J CONTROL RELEASE, V166, P1, DOI 10.1016/j.jconrel.2012.12.005
   Chung YC, 2010, BIOMATERIALS, V31, P4194, DOI 10.1016/j.biomaterials.2010.01.116
   Creixell M, 2012, NANO TODAY, V7, P367, DOI 10.1016/j.nantod.2012.06.013
   Deng C, 2012, NANO TODAY, V7, P467, DOI 10.1016/j.nantod.2012.08.005
   Dicheva BM, 2013, NANO LETT, V13, P2324, DOI 10.1021/nl3014154
   Ediriwickrema A, 2014, BIOMATERIALS, V35, P9343, DOI 10.1016/j.biomaterials.2014.07.043
   Endres TK, 2011, BIOMATERIALS, V32, P7721, DOI 10.1016/j.biomaterials.2011.06.064
   Feng Q, 2014, BIOMATERIALS, V35, P5028, DOI 10.1016/j.biomaterials.2014.03.012
   Fowers KD, 2012, MACROMOL BIOSCI, V12, P502, DOI 10.1002/mabi.201100350
   Ganta S, 2009, MOL PHARMACEUT, V6, P928, DOI 10.1021/mp800240j
   Ge ZS, 2014, BIOMATERIALS, V35, P3416, DOI 10.1016/j.biomaterials.2013.12.086
   Gullotti E, 2009, MOL PHARMACEUT, V6, P1041, DOI 10.1021/mp900090z
   Guo ST, 2011, J NANOMATER, DOI 10.1155/2011/742895
   Guo ST, 2010, J MATER CHEM, V20, P6935, DOI 10.1039/c0jm00506a
   Han LA, 2011, BIOMATERIALS, V32, P1242, DOI 10.1016/j.biomaterials.2010.09.070
   He CB, 2014, J AM CHEM SOC, V136, P5181, DOI 10.1021/ja4098862
   Hedayati R, 2012, J CHEM TECHNOL BIOT, V87, P1401, DOI 10.1002/jctb.3758
   Holoch PA, 2009, EUR J PHARMACOL, V625, P63, DOI 10.1016/j.ejphar.2009.06.066
   Hu QD, 2011, CHEM COMMUN, V47, P5572, DOI 10.1039/c1cc10721f
   Hu QL, 2012, BIOMATERIALS, V33, P6580, DOI 10.1016/j.biomaterials.2012.05.060
   Hu QY, 2013, BIOMATERIALS, V34, P9496, DOI 10.1016/j.biomaterials.2013.09.001
   Huang HY, 2011, J BIOMED MATER RES A, V97A, P330, DOI 10.1002/jbm.a.33055
   Huang RQ, 2007, FASEB J, V21, P1117, DOI 10.1096/fj.06-7380com
   Itaka K, 2010, BIOMATERIALS, V31, P3707, DOI 10.1016/j.biomaterials.2009.11.072
   Ito T, 2010, BIOMATERIALS, V31, P2912, DOI 10.1016/j.biomaterials.2009.12.032
   Iwamoto T, 2013, BIOL PHARM BULL, V36, P715, DOI 10.1248/bpb.b12-01102
   Jiang TY, 2012, BIOMATERIALS, V33, P9246, DOI 10.1016/j.biomaterials.2012.09.027
   Kaneshiro TL, 2009, BIOMATERIALS, V30, P5660, DOI 10.1016/j.biomaterials.2009.06.026
   Khan M, 2012, ADV HEALTHC MATER, V1, P373, DOI 10.1002/adhm.201200109
   Kibria G, 2014, ARCH PHARM RES, V37, P4, DOI 10.1007/s12272-013-0276-2
   Kim C, 2011, MOL PHARMACEUT, V8, P1955, DOI 10.1021/mp100460h
   Kim HJ, 2014, DRUG DELIV TRANSL RE, V4, P50, DOI 10.1007/s13346-013-0175-6
   Kim HJ, 2010, J CONTROL RELEASE, V145, P141, DOI 10.1016/j.jconrel.2010.03.019
   Kim YH, 2009, J CONTROL RELEASE, V134, P132, DOI 10.1016/j.jconrel.2008.10.020
   Konopleva M, 2000, BLOOD, V95, P3929
   Kurosaki T, 2010, J CONTROL RELEASE, V142, P404, DOI 10.1016/j.jconrel.2009.11.010
   Kusumoto K, 2013, ACS NANO, V7, P7534, DOI 10.1021/nn401317t
   Li P, 2012, INT J NANOMED, V7, P925, DOI 10.2147/IJN.S26955
   Lin S, 2008, BIOMACROMOLECULES, V9, P109, DOI 10.1021/bm7008747
   Liu SH, 2012, BIOMATERIALS, V33, P4907, DOI 10.1016/j.biomaterials.2012.03.031
   Liu T, 2013, CHINESE J POLYM SCI, V31, P924, DOI 10.1007/s10118-013-1281-0
   Liu XJ, 2012, BIOMACROMOLECULES, V13, P1307, DOI 10.1021/bm2018382
   Lo YL, 2014, RSC ADV, V4, P11089, DOI 10.1039/c3ra46914j
   Ma D, 2014, BIOMATERIALS, V35, P4357, DOI 10.1016/j.biomaterials.2014.01.070
   Ma M, 2012, ACTA BIOMATER, V8, P599, DOI 10.1016/j.actbio.2011.11.006
   Meng FH, 2012, MATER TODAY, V15, P436, DOI 10.1016/S1369-7021(12)70195-5
   Meng HA, 2010, ACS NANO, V4, P4539, DOI 10.1021/nn100690m
   Nie Y, 2011, BIOMATERIALS, V32, P858, DOI 10.1016/j.biomaterials.2010.09.032
   Nitta SK, 2013, INT J MOL SCI, V14, P1629, DOI 10.3390/ijms14011629
   Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900
   Oh KT, 2009, INT J PHARMACEUT, V376, P134, DOI 10.1016/j.ijpharm.2009.04.021
   Pakunlu RI, 2004, CANCER RES, V64, P6214, DOI 10.1158/0008-5472.CAN-04-0001
   Pasut G, 2007, PROG POLYM SCI, V32, P933, DOI 10.1016/j.progpolymsci.2007.05.008
   Patil YB, 2010, BIOMATERIALS, V31, P358, DOI 10.1016/j.biomaterials.2009.09.048
   Qian XM, 2014, BIOMATERIALS, V35, P2322, DOI 10.1016/j.biomaterials.2013.11.039
   Qiu LY, 2007, BIOMATERIALS, V28, P4132, DOI 10.1016/j.biomaterials.2007-05.035
   Rebowski G, 2001, ACTA BIOCHIM POL, V48, P1061
   Saad M, 2008, NANOMEDICINE-UK, V3, P761, DOI 10.2217/17435889.3.6.761
   Sato T, 2001, BIOMATERIALS, V22, P2075, DOI 10.1016/S0142-9612(00)00385-9
   Scholz C, 2014, BIOCONJUGATE CHEM, V25, P251, DOI 10.1021/bc400392y
   Shen Y, 2001, ADV CANCER RES, V82, P55, DOI 10.1016/S0065-230X(01)82002-9
   Shim G, 2011, J CONTROL RELEASE, V155, P60, DOI 10.1016/j.jconrel.2010.10.017
   Shin HC, 2012, J CONTROL RELEASE, V163, P93, DOI 10.1016/j.jconrel.2012.04.024
   Sun XY, 2012, BIOMATERIALS, V33, P916, DOI 10.1016/j.biomaterials.2011.10.035
   Taratula O, 2013, J CONTROL RELEASE, V171, P349, DOI 10.1016/j.jconrel.2013.04.018
   Taratula O, 2011, J DRUG TARGET, V19, P900, DOI 10.3109/1061186X.2011.622404
   Torney F, 2007, NAT NANOTECHNOL, V2, P295, DOI 10.1038/nnano.2007.108
   van Veen HW, 1998, BBA-BIOENERGETICS, V1365, P31, DOI 10.1016/S0005-2728(98)00039-5
   Wang HJ, 2010, BIOMATERIALS, V31, P8741, DOI 10.1016/j.biomaterials.2010.07.082
   Wang Y, 2007, BIOMACROMOLECULES, V8, P1028, DOI 10.1021/bm061051c
   Wang Y, 2006, NAT MATER, V5, P791, DOI 10.1038/nmat1737
   Wiradharma N, 2009, BIOMATERIALS, V30, P3100, DOI 10.1016/j.biomaterials.2009.03.006
   Xiong XB, 2011, ACS NANO, V5, P5202, DOI 10.1021/nn2013707
   Xu XH, 2014, SMALL, V10, P1133, DOI 10.1002/smll.201301885
   Xue HY, 2011, BIOMATERIALS, V32, P2662, DOI 10.1016/j.biomaterials.2010.12.029
   Yadav S, 2009, CANCER CHEMOTH PHARM, V63, P711, DOI 10.1007/s00280-008-0790-y
   Yang JY, 2002, WORLD J GASTROENTERO, V8, P644, DOI 10.3748/wjg.v8.i4.644
   Yang Z, 2015, J BIOMED NANOTECHNOL, V11, P1401, DOI 10.1166/jbn.2015.2086
   Yang Z, 2014, NANOSCALE, V6, P10193, DOI 10.1039/c4nr02395a
   Yang Z, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/025012
   Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308
   Yuan YY, 2012, ADV MATER, V24, P5476, DOI 10.1002/adma.201202296
   Yue XY, 2010, BIOMACROMOLECULES, V11, P2306, DOI 10.1021/bm100410m
   Yue YN, 2013, BIOMATER SCI-UK, V1, P152, DOI 10.1039/c2bm00030j
   Zhang CY, 2014, J CONTROL RELEASE, V180, P42, DOI 10.1016/j.jconrel.2014.02.015
   Zhang JX, 2010, ACS NANO, V4, P1049, DOI 10.1021/nn901213a
   Zhang J, 2013, J AM CHEM SOC, V135, P5068, DOI 10.1021/ja312004m
   Zhao D, 2012, MOL PHARMACEUT, V9, P2887, DOI 10.1021/mp3002123
   Zheng CF, 2013, BIOMATERIALS, V34, P3431, DOI 10.1016/j.biomaterials.2013.01.053
   Zhou JB, 2012, NAT MATER, V11, P82, DOI [10.1038/NMAT3187, 10.1038/nmat3187]
   Zhu CH, 2010, BIOMATERIALS, V31, P2408, DOI 10.1016/j.biomaterials.2009.11.077
   Zou SY, 2012, INT J NANOMED, V7, P3823, DOI 10.2147/IJN.S29328
NR 106
TC 30
Z9 32
U1 10
U2 153
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2015
VL 3
IS 7
BP 1035
EP 1049
DI 10.1039/c4bm00369a
PG 15
WC Materials Science, Biomaterials
SC Materials Science
GA CK6AE
UT WOS:000356309200011
PM 26221938
DA 2018-10-19
ER

PT J
AU Lampot, JD
   Liu, B
   Yin, LJ
   Zhang, WW
   Wang, ZL
   Luther, G
   Wagner, E
   Li, RD
   Nan, GX
   Shui, W
   Yan, ZJ
   Rames, R
   Deng, F
   Zhang, HM
   Liao, Z
   Liu, W
   Zhang, JH
   Zhang, ZL
   Zhang, Q
   Ye, JX
   Deng, YL
   Qiao, M
   Haydon, RC
   Luu, HH
   Angeles, J
   Shi, LL
   He, TC
   Ho, SH
AF Lampot, Joseph D.
   Liu, Bo
   Yin, Liangjun
   Zhang, Wenwen
   Wang, Zhongliang
   Luther, Gaurav
   Wagner, Eric
   Li, Ruidong
   Nan, Guoxin
   Shui, Wei
   Yan, Zhengjian
   Rames, Richard
   Deng, Fang
   Zhang, Hongmei
   Liao, Zhan
   Liu, Wei
   Zhang, Junhui
   Zhang, Zhonglin
   Zhang, Qian
   Ye, Jixing
   Deng, Youlin
   Qiao, Min
   Haydon, Rex C.
   Luu, Hue H.
   Angeles, Jovito
   Shi, Lewis L.
   He, Tong-Chuan
   Ho, Sherwin H.
TI Reversibly Immortalized Mouse Articular Chondrocytes Acquire Long-Term
   Proliferative Capability While Retaining Chondrogenic Phenotype
SO CELL TRANSPLANTATION
LA English
DT Article
DE Articular cartilage; Chondrocytes; Chondrogenesis; Tissue engineering;
   Immortalization; Chondrogenic progenitors; Osteoarthritis
ID MESENCHYMAL STEM-CELLS; BONE MORPHOGENETIC PROTEINS; BMP-9-INDUCED
   OSTEOGENIC DIFFERENTIATION; HEPATIC PROGENITOR CELLS; LARGE T-ANTIGEN;
   HUMAN OSTEOSARCOMA; CARTILAGE TISSUE; OSTEOBLAST DIFFERENTIATION;
   RECOMBINANT ADENOVIRUSES; IN-VITRO
AB Cartilage tissue engineering holds great promise for treating cartilaginous pathologies including degenerative disorders and traumatic injuries. Effective cartilage regeneration requires an optimal combination of biomaterial scaffolds, chondrogenic seed cells, and biofactors. Obtaining sufficient chondrocytes remains a major challenge due to the limited proliferative capability of primary chondrocytes. Here we investigate if reversibly immortalized mouse articular chondrocytes (iMACs) acquire long-term proliferative capability while retaining the chondrogenic phenotype. Primary mouse articular chondrocytes (MACs) can be efficiently immortalized with a retroviral vector-expressing SV40 large T antigen flanked with Cre/loxP sites. iMACs exhibit long-term proliferation in culture, although the immortalization phenotype can be reversed by Cre recombinase. iMACs express the chondrocyte markers Col2a1 and aggrecan and produce chondroid matrix in micromass culture. iMACs form subcutaneous cartilaginous masses in athymic mice. Histologic analysis and chondroid matrix staining demonstrate that iMACs can survive, proliferate, and produce chondroid matrix. The chondrogenic growth factor BMP2 promotes iMACs to produce more mature chondroid matrix resembling mature articular cartilage. Taken together, our results demonstrate that iMACs acquire long-term proliferative capability without losing the intrinsic chondrogenic features of MACs. Thus, iMACs provide a valuable cellular platform to optimize biomaterial scaffolds for cartilage regeneration, to identify biofactors that promote the proliferation and differentiation of chondrogenic progenitors, and to elucidate the molecular mechanisms underlying chondrogenesis.
C1 [Lampot, Joseph D.; Liu, Bo; Yin, Liangjun; Zhang, Wenwen; Wang, Zhongliang; Luther, Gaurav; Wagner, Eric; Li, Ruidong; Nan, Guoxin; Shui, Wei; Yan, Zhengjian; Rames, Richard; Deng, Fang; Zhang, Hongmei; Liao, Zhan; Liu, Wei; Zhang, Junhui; Zhang, Zhonglin; Zhang, Qian; Ye, Jixing; Deng, Youlin; Qiao, Min; Haydon, Rex C.; Luu, Hue H.; Angeles, Jovito; Shi, Lewis L.; He, Tong-Chuan; Ho, Sherwin H.] Univ Chicago, Mol Oncol Lab, Med Ctr, Dept Orthopaed Surg & Rehabil Med, Chicago, IL 60637 USA.
   [Liu, Bo; Yin, Liangjun; Wang, Zhongliang; Li, Ruidong; Nan, Guoxin; Shui, Wei; Yan, Zhengjian; Zhang, Hongmei; Liu, Wei; Zhang, Junhui; Zhang, Qian; Deng, Youlin; Qiao, Min; He, Tong-Chuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Chongqing, Peoples R China.
   [Liu, Bo; Yin, Liangjun; Wang, Zhongliang; Li, Ruidong; Nan, Guoxin; Shui, Wei; Yan, Zhengjian; Zhang, Hongmei; Liu, Wei; Zhang, Junhui; Zhang, Qian; Deng, Youlin; Qiao, Min; He, Tong-Chuan] Chongqing Med Univ, Minist Educ, Key Lab Diagnost Med, Chongqing, Peoples R China.
   [Liu, Bo; Yin, Liangjun; Wang, Zhongliang; Li, Ruidong; Nan, Guoxin; Shui, Wei; Yan, Zhengjian; Zhang, Hongmei; Liu, Wei; Zhang, Junhui; Zhang, Qian; Deng, Youlin; Qiao, Min; He, Tong-Chuan] Chongqing Med Univ, Affiliated Hosp, Chongqing, Peoples R China.
   [Zhang, Wenwen] Binzhou Med Univ, Affiliated Hosp, Dept Lab Med, Yantai, Shandong, Peoples R China.
   [Deng, Fang] Third Mil Med Univ, Dept Cell Biol, Chongqing, Peoples R China.
   [Liao, Zhan] Cent S Univ, Xiang Ya Hosp, Dept Orthopaed Surg, Changsha, Hunan, Peoples R China.
   [Zhang, Zhonglin] Wuhan Univ, Zhongnan Hosp, Dept Surg, Wuhan 430072, Peoples R China.
   [Ye, Jixing] Chongqing Univ, Sch Bioengn, Chongqing 630044, Peoples R China.
RP He, TC (reprint author), Univ Chicago, Mol Oncol Lab, Med Ctr, 5841 South Maryland Ave,MC 3079, Chicago, IL 60637 USA.
EM tche@uchicago.edu; sho@bsd.uchicago.edu
FU National Institutes of Health; North American Spine Society; SHOCK Fund;
   Pritzker Research Fellowship from The University of Chicago Pritzker
   School of Medicine; Alpha Omega Alpha Carolyn L. Kuckein Student
   Research Fellowship; University of Chicago Core Facility Subsidy grant
   from the National Center for Advancing Translational Sciences (NCATS) of
   the National Institutes of Health [UL1 TR000430]
FX The authors thank Dr. Philippe Leboulch of Harvard Medical School for
   providing the SSR #69 vector. The reported work was supported in part by
   research grants from the National Institutes of Health (R.C.H., H.H.L.,
   and T.C.H.), North American Spine Society (T.C.H.), and the SHOCK Fund
   (S.H.H.). J.D.L. was the recipient of the Pritzker Research Fellowship
   from The University of Chicago Pritzker School of Medicine and the Alpha
   Omega Alpha Carolyn L. Kuckein Student Research Fellowship. This work
   was also supported in part by The University of Chicago Core Facility
   Subsidy grant from the National Center for Advancing Translational
   Sciences (NCATS) of the National Institutes of Health through Grant
   Number UL1 TR000430. The authors declare no conflicts of interest.
CR AYDELOTTE MB, 1988, CONNECT TISSUE RES, V18, P223, DOI 10.3109/03008208809016809
   Behery OA, 2013, J KNEE SURG, V26, P203, DOI 10.1055/s-0032-1329231
   Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254
   BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170
   BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3
   Cha BH, 2013, CELL TRANSPLANT, V22, P1519, DOI 10.3727/096368912X647261
   Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133
   Chen X., CELL PHYSL BIOCH, V32, P1083
   Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017
   Chiang H, 2013, OSTEOARTHR CARTILAGE, V21, P589, DOI 10.1016/j.joca.2013.01.004
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819
   Egli RJ, 2011, INT REV CEL MOL BIO, V289, P37, DOI 10.1016/B978-0-12-386039-2.00002-X
   Gardner O. F., HISTOL HISTOPATHOL, V28, P23
   GEE CJ, 1979, J CELL SCI, V36, P223
   Glowacki J, 2000, J REHABIL RES DEV, V37, P171
   Goldring MB, 1999, OSTEOARTHR CARTILAGE, V7, P386, DOI 10.1053/joca.1998.0219
   Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95
   Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719
   Haydon RC, 2002, CLIN CANCER RES, V8, P1288
   He B. C., MOL PHARM, V79, P211
   He BC, 2010, CLIN CANCER RES, V16, P2235, DOI 10.1158/1078-0432.CCR-09-2499
   He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509
   He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509
   HOWELL N, 1982, CYTOGENET CELL GENET, V34, P215, DOI 10.1159/000131809
   Hu N., 2012, J CELL SCI, V126, P532
   Huang E., 2011, J BONE MINER RES, V27, P1566
   Huang EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032428
   Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x
   Jeong C. G., J BIOMED MAT RES A, V100, P2088
   KAHN P, 1983, VIROLOGY, V126, P348, DOI 10.1016/0042-6822(83)90484-1
   Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298
   Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130
   Lee CR, 2000, J ORTHOPAED RES, V18, P790, DOI 10.1002/jor.1100180517
   Li RD, 2014, CURR CANCER DRUG TAR, V14, P274, DOI 10.2174/1568009614666140305105805
   Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135
   Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98
   Luther GA, 2013, CANCER LETT, V336, P222, DOI 10.1016/j.canlet.2013.05.002
   Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359
   Neumann AJ, 2013, TISSUE ENG PT A, V19, P1285, DOI [10.1089/ten.tea.2012.0411, 10.1089/ten.TEA.2012.0411]
   Nitta M, 2001, GYNECOL ONCOL, V81, P10, DOI 10.1006/gyno.2000.6084
   O'Sullivan J, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt49
   Oldershaw RA, 2012, INT J EXP PATHOL, V93, P389, DOI 10.1111/j.1365-2613.2012.00837.x
   Pelttari K, 2009, SWISS MED WKLY, V139, P602, DOI smw-12742
   Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200
   Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744
   PRIVES C, 1990, CELL, V61, P735, DOI 10.1016/0092-8674(90)90179-I
   Rastegar F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014182
   Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200
   Shi SL, 2013, J CELL BIOCHEM, V114, P908, DOI 10.1002/jcb.24430
   Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006
   Srinivasan PP, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024109
   Su Y., ONCOGENE, V30, P3907
   Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x
   Tang QO, 2012, EXPERT OPIN BIOL TH, V12, P1361, DOI 10.1517/14712598.2012.707182
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Toh WS, 2011, STEM CELL REV REP, V7, P544, DOI 10.1007/s12015-010-9222-6
   Trinh TQ, 2013, ARTHROSCOPY, V29, P566, DOI 10.1016/j.arthro.2012.10.008
   Varghese S, 2010, STEM CELLS, V28, P765, DOI 10.1002/stem.325
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   Wan Mei, 2005, Biochemical and Biophysical Research Communications, V328, P651, DOI 10.1016/j.bbrc.2004.11.067
   Westerman KA, 1996, P NATL ACAD SCI USA, V93, P8971, DOI 10.1073/pnas.93.17.8971
   Yang K, 2012, J INVEST DERMATOL, V132, P2479, DOI 10.1038/jid.2012.145
   Yoon BS, 2004, J CELL BIOCHEM, V93, P93, DOI 10.1002/jcb.20211
   Zhang YJ, 2005, SPINE, V30, P2601, DOI 10.1097/01.brs.0000187880.39298.f0
   Zhou GD, 2006, TISSUE ENG, V12, P3209, DOI 10.1089/ten.2006.12.3209
   Zhou L, 2002, BIOTECHNIQUES, V33, P1126, DOI 10.2144/02335dd07
   Zhou L, 2002, BIOTECHNIQUES, V33, P1132
   Zhou L, 2002, BIOTECHNIQUES, V33, P1130
   Zhu GH, 2009, DIFFERENTIATION, V78, P195, DOI 10.1016/j.diff.2009.06.001
   ZHU JY, 1991, J VIROL, V65, P6872
NR 71
TC 20
Z9 20
U1 3
U2 9
PU COGNIZANT COMMUNICATION CORP
PI PUTNAM VALLEY
PA 18 PEEKSKILL HOLLOW RD, PO BOX 37, PUTNAM VALLEY, NY 10579 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2015
VL 24
IS 6
BP 1053
EP 1066
DI 10.3727/096368914X681054
PG 14
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA CK4PQ
UT WOS:000356206100008
PM 24800751
DA 2018-10-19
ER

PT J
AU Lee, F
   Lim, J
   Reithofer, MR
   Lee, SS
   Chung, JE
   Hauser, CAE
   Kurisawa, M
AF Lee, Fan
   Lim, Jaehong
   Reithofer, Michael R.
   Lee, Su Seong
   Chung, Joo Eun
   Hauser, Charlotte A. E.
   Kurisawa, Motoichi
TI Synthesis and bioactivity of a conjugate composed of green tea catechins
   and hyaluronic acid
SO POLYMER CHEMISTRY
LA English
DT Article
ID REACTIVE OXYGEN; EPIGALLOCATECHIN-3-GALLATE EGCG; (-)-EPIGALLOCATECHIN
   GALLATE; ANTIOXIDANT PROPERTIES; CONDENSATION PRODUCTS;
   RHEUMATOID-ARTHRITIS; GLYOXYLIC-ACID; IN-VITRO; PERSPECTIVES;
   POLYPHENOLS
AB (-)-Epigallocatechin-3-gallate (EGCG) is a green tea polyphenol that has several biological activities, including anti-cancer activity and anti-inflammation. Hyaluronic acid (HA) is a naturally-occurring polysaccharide that is widely used as a biomaterial for drug delivery and tissue engineering due to its visco-elastic, biocompatible and biodegradable properties. By conjugating HA with EGCG, the resulting HA-EGCG conjugate is expected to exhibit not only the inherent properties of HA but also the bioactivities of EGCG. Toward this end, we report the synthesis of an amine-functionalized EGCG as an intermediate compound for conjugation to HA. EGCG was reacted with 2,2-diethoxyethylamine (DA) under acidic conditions, forming ethylamine-bridged EGCG dimers. The EGCG dimers were composed of four isomers, which were characterized by HPLC, high-resolution mass spectrometry and NMR spectroscopy. The amine-functionalized EGCG dimers were conjugated to hyaluronic acid (HA) through the formation of amide bonds. HA-EGCG conjugates demonstrated several bioactivities which were not present in unmodified HA, including resistance to hyaluronidase-mediated degradation, inhibition of cell growth and scavenging of radicals. The potential applications of HA-EGCG conjugates are discussed.
C1 [Lee, Fan; Lim, Jaehong; Reithofer, Michael R.; Lee, Su Seong; Chung, Joo Eun; Hauser, Charlotte A. E.; Kurisawa, Motoichi] Inst Bioengn & Nanotechnol, Singapore 138669, Singapore.
RP Kurisawa, M (reprint author), Inst Bioengn & Nanotechnol, 31 Biopolis Way,04-01, Singapore 138669, Singapore.
EM mkurisawa@ibn.a-star.edu.sg
RI KURISAWA, MOTOICHI/C-1325-2014; Lee, Su Seong/B-8485-2014
OI KURISAWA, MOTOICHI/0000-0003-2413-6933; Lee, Su
   Seong/0000-0002-2968-5707; Hauser, Charlotte/0000-0001-8251-7246;
   Reithofer, Michael/0000-0002-6328-1896
FU Institute of Bioengineering and Nanotechnology (Biomedical Research
   Council, Agency for Science, Technology and Research, Singapore)
FX This research was funded by the Institute of Bioengineering and
   Nanotechnology (Biomedical Research Council, Agency for Science,
   Technology and Research, Singapore). The authors acknowledge JNC
   Corporation (Japan) for the gift of hyaluronic acid, and Yan Shan Ang
   for assistance in the purification of HA-EGCG conjugates and Yue Wang
   for assistance in the superoxide radical scavenging assay.
CR Ahmed S, 2004, J PHARMACOL EXP THER, V308, P767, DOI 10.1124/jpet.103.059220
   Ahmed S, 2009, ARTHRITIS RHEUM-US, V60, P1282, DOI 10.1002/art.24488
   Asari A, 2004, CHEMISTRY AND BIOLOGY OF HYALURONAN, P457
   Avila LZ, 2008, CARBOHYDRATE CHEMISTRY, BIOLOGY AND MEDICAL APPLICATIONS, P333, DOI 10.1016/B978-0-08-054816-6.00015-X
   Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x
   Chung JE, 2014, NAT NANOTECHNOL, V9, P907, DOI [10.1038/NNANO.2014.208, 10.1038/nnano.2014.208]
   Drinkine J, 2005, J AGR FOOD CHEM, V53, P7552, DOI 10.1021/jf0504723
   El-Safory NS, 2010, CARBOHYD POLYM, V81, P165, DOI 10.1016/j.carbpol.2010.02.047
   Es-Safi NE, 2000, J AGR FOOD CHEM, V48, P4233, DOI 10.1021/jf000283e
   Fernandes E, 2004, FREE RADICAL BIO MED, V37, P1895, DOI 10.1016/j.freeradbiomed.2004.09.001
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   Gross G, 2007, J EUR ACAD DERMATOL, V21, P1404, DOI 10.1111/j.1468-3083.2007.02441.x
   HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3
   He Q, 2007, FOOD CHEM, V101, P1178, DOI 10.1016/j.foodchem.2006.03.020
   Henrotin Y, 2005, OSTEOARTHR CARTILAGE, V13, P643, DOI 10.1016/j.joca.2005.04.002
   Homma A, 2009, BIOORGAN MED CHEM, V17, P4647, DOI 10.1016/j.bmc.2009.04.063
   Kanwar Jyoti, 2012, Front Biosci (Elite Ed), V4, P111
   KUO JW, 1991, BIOCONJUGATE CHEM, V2, P232, DOI 10.1021/bc00010a007
   Lei F, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39732
   Li C, 2008, ADV DRUG DELIVER REV, V60, P886, DOI 10.1016/j.addr.2007.11.009
   Lin JK, 2000, J AGR FOOD CHEM, V48, P2736, DOI 10.1021/jf000066d
   Lo GH, 2003, JAMA-J AM MED ASSOC, V290, P3115, DOI 10.1001/jama.290.23.3115
   Loeser RF, 2002, ARTHRITIS RHEUM, V46, P2349, DOI 10.1002/art.10496
   Moseley R, 2002, BIOMATERIALS, V23, P2255, DOI 10.1016/S0142-9612(01)00360-X
   Nagle DG, 2006, PHYTOCHEMISTRY, V67, P1849, DOI 10.1016/j.phytochem.2006.06.020
   Nakagawa H, 2007, BIOCHEM PHARMACOL, V73, P34, DOI 10.1016/j.bcp.2006.09.002
   Nakagawa T, 2002, FOOD CHEM TOXICOL, V40, P1745, DOI 10.1016/S0278-6915(02)00169-2
   Nanjo F, 1996, FREE RADICAL BIO MED, V21, P895, DOI 10.1016/0891-5849(96)00237-7
   Nonier MF, 2006, ANAL CHIM ACTA, V563, P76, DOI 10.1016/j.aca.2005.09.036
   Oh EJ, 2010, J CONTROL RELEASE, V141, P2, DOI 10.1016/j.jconrel.2009.09.010
   Perron NR, 2010, DALTON T, V39, P9982, DOI 10.1039/c0dt00752h
   Picotti F, 2013, CARBOHYD POLYM, V93, P273, DOI 10.1016/j.carbpol.2012.04.009
   REISSIG JL, 1955, J BIOL CHEM, V217, P959
   Saucier C, 1997, PHYTOCHEMISTRY, V46, P229, DOI 10.1016/S0031-9422(97)00268-9
   Schante CE, 2011, CARBOHYD POLYM, V87, P2211
   Shaw CY, 2003, PHYTOTHER RES, V17, P823, DOI 10.1002/ptr.1170
   Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093
   Soltes L, 2006, BIOMACROMOLECULES, V7, P659, DOI 10.1021/bm050867v
   Sousa F, 2009, PROCESS BIOCHEM, V44, P749, DOI 10.1016/j.procbio.2009.03.009
   Sreejayan, 1997, J PHARM PHARMACOL, V49, P105, DOI 10.1111/j.2042-7158.1997.tb06761.x
   Sutherland BA, 2006, J NUTR BIOCHEM, V17, P291, DOI 10.1016/j.jnutbio.2005.10.005
   Suzuki Y, 2012, P JPN ACAD B-PHYS, V88, P88, DOI 10.2183/pjab.88.88
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Wan SB, 2005, BIOORGAN MED CHEM, V13, P2177, DOI 10.1016/j.bmc.2004.12.056
   Wang XY, 2007, J AGR FOOD CHEM, V55, P4987, DOI 10.1021/jf070590l
   Wheeler DS, 2004, DRUG DEVELOP RES, V61, P45, DOI 10.1002/ddr.10341
   Yang CS, 2011, PHARMACOL RES, V64, P113, DOI 10.1016/j.phrs.2011.03.001
   Zhang YM, 2004, J BIOL CHEM, V279, P30994, DOI 10.1074/jbc.M403697200
NR 48
TC 9
Z9 10
U1 6
U2 45
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1759-9954
EI 1759-9962
J9 POLYM CHEM-UK
JI Polym. Chem.
PY 2015
VL 6
IS 24
BP 4462
EP 4472
DI 10.1039/c5py00495k
PG 11
WC Polymer Science
SC Polymer Science
GA CK2EB
UT WOS:000356022300014
DA 2018-10-19
ER

PT J
AU Gieseler, D
   Jordan, R
AF Gieseler, Dan
   Jordan, Rainer
TI Poly(2-oxazoline) molecular brushes by grafting through of
   poly(2-oxazoline)methacrylates with aqueous ATRP
SO POLYMER CHEMISTRY
LA English
DT Article
ID CRITICAL SOLUTION TEMPERATURE; GROUP-TRANSFER POLYMERIZATION;
   RING-OPENING POLYMERIZATION; RADICAL POLYMERIZATION; DRUG-DELIVERY;
   CYLINDRICAL BRUSHES; LIGAND STRUCTURE; BUILDING-BLOCKS; SIDE-CHAINS;
   COPOLYMERS
AB Molecular brushes of poly(2-oxazoline)s (POx) are an intriguing class of polymers as they combine a unique architecture with the properties of POx as a biomaterial. Here, the synthesis of several POx macromonomers with methacrylate end groups and consecutive grafting through polymerization by aqueous atom transfer radical polymerization (ATRP) at room temperature is reported. H-1-NMR spectroscopy and size exclusion chromatography (SEC) confirmed the synthesis of POx molecular brushes with maximum side chain grafting densities, narrow molar mass distributions (D <= 1.16) and final molar masses corresponding to the initial macromonomer : initiator ratio. Chain extension experiments show high end group fidelity and formation of block copolymer molecular brushes, and kinetic studies revealed a polymerization behavior of oligo(2-methyl-2-oxazoline) methacrylate very similar to the frequently used oligo (ethylene glycol) methacrylate (OEGMA(475)). Aqueous solutions of POx molecular brushes with poly( 2-ethyl- and 2-isopropyl-2-oxazoline) side chains exhibit the typically defined thermoresponsive behavior with a tunable, very narrow and reversible phase transition.
C1 [Gieseler, Dan; Jordan, Rainer] Tech Univ Dresden, Dept Chem, Makromol Chem, D-01069 Dresden, Germany.
RP Jordan, R (reprint author), Tech Univ Dresden, Dept Chem, Makromol Chem, Mommsenstr 4, D-01069 Dresden, Germany.
EM Rainer.Jordan@tu-dresden.de
RI Jordan, Rainer/B-6542-2008
OI Jordan, Rainer/0000-0002-9414-1597
FU Excellence Initiative by the German Federal Government; Excellence
   Initiative by the German State Government
FX Financial support by the "Excellence Initiative by the German Federal
   and State Governments" (Institutional Strategy, measure "support the
   best") is gratefully acknowledged.
CR Aoi K, 1996, PROG POLYM SCI, V21, P151, DOI 10.1016/0079-6700(95)00020-8
   Averick S, 2012, ACS MACRO LETT, V1, P6, DOI 10.1021/mz200020c
   Barz M, 2011, POLYM CHEM-UK, V2, P1900, DOI 10.1039/c0py00406e
   Bauer M, 2013, J POLYM SCI POL CHEM, V51, P1816, DOI 10.1002/pola.26564
   Bergenudd H, 2009, MACROMOLECULES, V42, P3302, DOI 10.1021/ma8028425
   Bloksma MM, 2011, MACROMOLECULES, V44, P4057, DOI 10.1021/ma200514n
   Bonne TB, 2007, MACROMOL CHEM PHYSIC, V208, P1402, DOI 10.1002/macp.200700140
   Buhler J, 2014, CHEM-EUR J, V20, P12405, DOI 10.1002/chem.201403942
   Buhler J, 2013, MACROMOL RAPID COMM, V34, P588, DOI 10.1002/marc.201200784
   Cesana S, 2006, MACROMOL CHEM PHYSIC, V207, P183, DOI 10.1002/macp.200500495
   David G, 2003, EUR POLYM J, V39, P1209, DOI 10.1016/S0014-3057(02)00369-5
   Farrugia BL, 2013, BIOMACROMOLECULES, V14, P2724, DOI 10.1021/bm400518h
   Fijten MWM, 2008, MACROMOL CHEM PHYSIC, V209, P1887, DOI 10.1002/macp.200800226
   Gaertner FC, 2007, J CONTROL RELEASE, V119, P291, DOI 10.1016/j.jconrel.2007.02.015
   Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70
   Grasmuller M, 1998, MACROMOL SYMP, V127, P109, DOI 10.1002/masy.19981270115
   Gross A, 1996, MACROMOL CHEM PHYSIC, V197, P2811, DOI 10.1002/macp.1996.021970919
   Guillerm B, 2012, CHEM COMMUN, V48, P2879, DOI 10.1039/c2cc30191a
   Hoogenboom R, 2008, CHEM COMMUN, P5758, DOI 10.1039/b813140f
   Hoogenboom R, 2007, MACROMOLECULES, V40, P2837, DOI 10.1021/ma062725e
   Huber S, 2008, COLLOID POLYM SCI, V286, P395, DOI 10.1007/s00396-007-1781-y
   Jordan R, 2001, MACROMOLECULES, V34, P8858, DOI 10.1021/ma011573e
   KOBAYASHI S, 1991, POLYM J, V23, P1307, DOI 10.1295/polymj.23.1307
   Kobayashi S, 2002, J POLYM SCI POL CHEM, V40, P192, DOI 10.1002/pola.10090
   KOBAYASHI S, 1985, POLYM BULL, V13, P447, DOI 10.1007/BF01033343
   KOBAYASHI S, 1989, MACROMOLECULES, V22, P2878, DOI 10.1021/ma00197a002
   Konradi R, 2008, LANGMUIR, V24, P613, DOI 10.1021/la702917z
   Lava K, 2015, EUR POLYM J, V65, P98, DOI 10.1016/j.eurpolymj.2015.01.014
   Li CM, 2004, ANGEW CHEM INT EDIT, V43, P1101, DOI 10.1002/anie.200352845
   LIN PY, 1988, J POLYM SCI POL PHYS, V26, P603, DOI 10.1002/polb.1988.090260312
   Ludtke K, 2005, MACROMOL BIOSCI, V5, P384, DOI 10.1002/mabi.200500004
   Luxenhofer R, 2006, MACROMOLECULES, V39, P3509, DOI 10.1021/ma052515m
   Luxenhofer R, 2008, MACROMOL RAPID COMM, V29, P1509, DOI 10.1002/marc.200800293
   Luxenhofer R, 2011, J CONTROL RELEASE, V153, P73, DOI 10.1016/j.jconrel.2011.04.010
   Luxenhofer R, 2010, BIOMATERIALS, V31, P4972, DOI 10.1016/j.biomaterials.2010.02.057
   MIYAMOTO M, 1989, MACROMOLECULES, V22, P1604, DOI 10.1021/ma00194a016
   Mullner M, 2015, ACS NANO, V9, P1294, DOI 10.1021/nn505125f
   Nuyken O, 1997, POLYM BULL, V38, P657, DOI 10.1007/s002890050102
   Nuyken O, 1997, MACROMOL RAPID COMM, V18, P125, DOI 10.1002/marc.1997.030180209
   Park JS, 2006, MACROMOLECULES, V39, P6622, DOI 10.1021/ma0605548
   Rehfeldt F, 2002, LANGMUIR, V18, P4908, DOI 10.1021/la0112559
   Reif M, 2011, MACROMOL CHEM PHYS, V212, P1815, DOI 10.1002/macp.201100276
   Rosen BM, 2009, CHEM REV, V109, P5069, DOI 10.1021/cr900024j
   Rueda J, 2005, MACROMOLECULES, V38, P7330, DOI 10.1021/ma050570p
   Sheiko SS, 2008, PROG POLYM SCI, V33, P759, DOI 10.1016/j.progpolymsci.2008.05.001
   Shimano Y, 1999, POLYM J, V31, P296, DOI 10.1295/polymj.31.296
   Shimano Y, 1999, POLYM J, V31, P219, DOI 10.1295/polymj.31.219
   Shimano Y, 1999, POLYM J, V31, P458, DOI 10.1295/polymj.31.458
   SHODA S, 1992, J POLYM SCI POL CHEM, V30, P1489, DOI 10.1002/pola.1992.080300728
   Tang C, 2007, MACROMOLECULES, V40, P6199, DOI 10.1021/ma070892o
   Tang W, 2006, MACROMOLECULES, V39, P4953, DOI 10.1021/ma0609634
   Taubmann C, 2005, MACROMOL BIOSCI, V5, P603, DOI 10.1002/mabi.200500059
   TRIVEDI PD, 1980, POLYM BULL, V3, P37, DOI 10.1007/BF00263203
   Tsarevsky NV, 2004, MACROMOLECULES, V37, P9768, DOI 10.1021/ma048438x
   UYAMA H, 1993, J POLYM SCI POL CHEM, V31, P123, DOI 10.1002/pola.1993.080310114
   Viegas TX, 2011, BIOCONJUGATE CHEM, V22, P976, DOI 10.1021/bc200049d
   Wang WX, 2014, POLYM CHEM-UK, V5, P3533, DOI 10.1039/c3py01398g
   Wang XS, 2000, MACROMOLECULES, V33, P6640, DOI 10.1021/ma000671h
   Weber C, 2013, MACROMOLECULES, V46, P5107, DOI 10.1021/ma400947r
   Weber C, 2013, J POLYM SCI POL CHEM, V51, P139, DOI 10.1002/pola.26332
   Weber C, 2011, MACROMOL SYMP, V308, P17, DOI 10.1002/masy.201151004
   Weber C, 2012, PROG POLYM SCI, V37, P686, DOI 10.1016/j.progpolymsci.2011.10.002
   Weber C, 2009, DES MONOMERS POLYM, V12, P149, DOI 10.1163/156855509X412090
   Weber C, 2009, MACROMOLECULES, V42, P2965, DOI 10.1021/ma8028437
   Weberskirch R, 1999, MACROMOL CHEM PHYSIC, V200, P863, DOI 10.1002/(SICI)1521-3935(19990401)200:4<863::AID-MACP863>3.0.CO;2-N
   WOODLE MC, 1994, BIOCONJUGATE CHEM, V5, P493, DOI 10.1021/bc00030a001
   Zalipsky S, 1996, J PHARM SCI, V85, P133, DOI 10.1021/js9504043
   Zhang N, 2013, J AM CHEM SOC, V135, P8810, DOI 10.1021/ja4036175
   Zhang N, 2012, MACROMOL CHEM PHYS, V213, P1963, DOI 10.1002/macp.201200261
   Zhang N, 2012, MACROMOL BIOSCI, V12, P926, DOI 10.1002/mabi.201200026
   Zhang N, 2012, MACROMOL CHEM PHYS, V213, P973, DOI 10.1002/macp.201200015
   Zhang N, 2009, MACROMOLECULES, V42, P2215, DOI 10.1021/ma802627y
   Zhang T, 2015, POLYM CHEM-UK, V6, P2726, DOI 10.1039/c5py00093a
   Zhang YZ, 2012, MACROMOLECULES, V45, P78, DOI 10.1021/ma201963c
   Zhao P, 2012, MACROMOL RAPID COMM, V33, P1351, DOI 10.1002/marc.201200172
NR 75
TC 12
Z9 12
U1 2
U2 34
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1759-9954
EI 1759-9962
J9 POLYM CHEM-UK
JI Polym. Chem.
PY 2015
VL 6
IS 25
BP 4678
EP 4689
DI 10.1039/c5py00561b
PG 12
WC Polymer Science
SC Polymer Science
GA CK5WW
UT WOS:000356298900015
OA Bronze
DA 2018-10-19
ER

PT J
AU Karthika, A
   Kavitha, L
   Surendiran, M
   Kannan, S
   Gopi, D
AF Karthika, A.
   Kavitha, L.
   Surendiran, M.
   Kannan, S.
   Gopi, D.
TI Fabrication of divalent ion substituted hydroxyapatite/gelatin
   nanocomposite coating on electron beam treated titanium: mechanical,
   anticorrosive, antibacterial and bioactive evaluations
SO RSC ADVANCES
LA English
DT Article
ID GRADE STAINLESS-STEEL; PULSED ELECTRODEPOSITION METHOD; IN-VITRO;
   ORTHOPEDIC APPLICATIONS; CORROSION-RESISTANCE; NANOPARTICLES SYNTHESIS;
   COMPOSITE MICROSPHERES; ANTIMICROBIAL ACTIVITY; NANO-HYDROXYAPATITE;
   CALCIUM-PHOSPHATE
AB The key property in the fabrication of a biomaterial is to facilitate the replacement and/or regeneration of damaged tissues and organs. To obtain such a biomaterial, we fabricated a triple mineral (strontium, magnesium and zinc) substituted hydroxyapatite/gelatin (M-HAP/Gel) nanocomposite coating on electron beam treated titanium (Ti) metal. The influence of gelatin concentration in M-HAP was studied to investigate its effect on morphological changes, crystallinity, mechanical and anticorrosion properties. The M-HAP/Gel nanocomposite coating (with 3 wt% gelatin) on treated Ti resulted in better mechanical and anticorrosion properties as a consequence of the electron beam treatment of Ti. A reduced number of bacterial colonies were observed for the M-HAP/Gel composite against Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) microbes which evidences a lower chance of implant failure after implantation. Moreover, the cell proliferation assay, live/dead staining of MT3C3-E1 cells and cell viability of fibroblast stem cells on the resultant nanocomposite revealed that the M-HAP/Gel composite will definitely be an effective implant material for better cell growth in orthopedic applications.
C1 [Karthika, A.; Surendiran, M.; Gopi, D.] Periyar Univ, Dept Chem, Salem 636011, India.
   [Kavitha, L.] Cent Univ Tamilnadu, Sch Basic & Appl Sci, Dept Phys, Thiruvarur 610101, India.
   [Kannan, S.] Periyar Univ, Sch Life Sci, Dept Zool, Salem 636011, India.
   [Gopi, D.] Periyar Univ, Ctr Nanosci & Nanotechnol, Salem 636011, India.
RP Gopi, D (reprint author), Periyar Univ, Dept Chem, Salem 636011, India.
EM dhanaraj_gopi@yahoo.com
RI Gopi, Dhanaraj/A-9163-2012; Louis, Kavitha/B-9313-2017
OI Gopi, Dhanaraj/0000-0001-6662-1238; Louis, Kavitha/0000-0002-8893-2050
FU Department of Science and Technology, New Delhi, India (DST-TSD)
   [DST/TSG/NTS/2011/73]; DST-EMEQ [SB/EMEQ-185/2013]; Defence Research and
   Development Organisation, New Delhi, India, (DRDO)
   [ERIP/ER/1103949/M/01/1513]; UGC, New Delhi, India [F.
   30-1/2013(SA-II)/RA-2012-14-NEW-SC-TAM-3240]
FX One of the authors D. Gopi acknowledges major financial support from the
   Department of Science and Technology, New Delhi, India (DST-TSD, Ref.
   no.: DST/TSG/NTS/2011/73), DST-EMEQ, Ref. no.: SB/EMEQ-185/2013) and
   Defence Research and Development Organisation, New Delhi, India, (DRDO,
   no. ERIP/ER/1103949/M/01/1513). D. Gopi also acknowledges UGC, New
   Delhi, India for the Research Award (Ref. no. F.
   30-1/2013(SA-II)/RA-2012-14-NEW-SC-TAM-3240. The authors acknowledge
   Industrial and Medical Accelerator Section, Raja Ramanna Centre for
   Advanced Technology (RRCAT), Indore (MP), India for the support to carry
   out high energy electron beam surface treatment.
CR *ASTM INT, F104405 ASTM INT
   Bigi A, 2004, BIOMATERIALS, V25, P2893, DOI 10.1016/j.biomaterials.2003.09.059
   Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Chen MF, 2008, APPL SURF SCI, V254, P2730, DOI 10.1016/j.apsusc.2007.10.011
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Chiono V., 2008, J MATER SCI-MATER M, V19, P89
   DIGENIS GA, 1994, J PHARM SCI, V83, P915, DOI 10.1002/jps.2600830702
   Dong C, 2003, SURF COAT TECH, V163, P620, DOI 10.1016/S0257-8972(02)00657-6
   Favi PM, 2013, MAT SCI ENG C-MATER, V33, P1935, DOI 10.1016/j.msec.2012.12.100
   Gopi D, 2015, RSC ADV, V5, P27402, DOI 10.1039/c5ra03432a
   Gopi D, 2015, CERAM INT, V41, P5454, DOI 10.1016/j.ceramint.2014.12.114
   Gopi D, 2014, RSC ADV, V4, P34751, DOI 10.1039/c4ra04484c
   Gopi D, 2014, COLLOID SURFACE A, V451, P172, DOI 10.1016/j.colsurfa.2014.03.035
   Gopi D, 2013, APPL SURF SCI, V286, P83, DOI 10.1016/j.apsusc.2013.09.023
   Gopi D, 2013, MATER LETT, V105, P216, DOI 10.1016/j.matlet.2013.04.019
   Gopi D, 2012, SURF COAT TECH, V206, P2859, DOI 10.1016/j.surfcoat.2011.12.011
   Gopi D, 2014, MATER CHEM PHYS, V144, P75, DOI 10.1016/j.matchemphys.2013.12.017
   Haroun AA, 2010, INT J BIOL MACROMOL, V46, P310, DOI 10.1016/j.ijbiomac.2010.01.005
   Hong J., 2004, POLYMER, V45, P6699
   Huang Y, 2014, APPL SURF SCI, V290, P353, DOI 10.1016/j.apsusc.2013.11.082
   Huang Y, 2013, APPL SURF SCI, V282, P456, DOI 10.1016/j.apsusc.2013.05.152
   Huang Y, 2013, APPL SURF SCI, V282, P583, DOI 10.1016/j.apsusc.2013.06.015
   KIM HM, 1995, J AM CERAM SOC, V78, P2405, DOI 10.1111/j.1151-2916.1995.tb08677.x
   Kim HW, 2005, J BIOMED MATER RES A, V72A, P136, DOI 10.1002/jbm.a.30168
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kolanthai E, 2015, RSC ADV, V5, P18301, DOI 10.1039/c4ra14584d
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lee K, 2006, SURF COAT TECH, V201, P1620, DOI 10.1016/j.surfcoat.2006.02.032
   LeGeros R. Z., 1991, CALCIUM PHOSPHATES O
   Li B., 2014, ACS APPL MATER INTER, V4, P18258
   Li XR, 2008, LANGMUIR, V24, P14145, DOI 10.1021/la802984a
   Liong M, 2009, ADV MATER, V21, P1684, DOI 10.1002/adma.200802646
   Liu HY, 2014, NANOSCALE, V6, P5315, DOI 10.1039/c4nr00355a
   Lu Y, 2010, APPL SURF SCI, V256, P7228, DOI 10.1016/j.apsusc.2010.05.056
   Milovac D., 2014, MAT SCI ENG C, V42, P262
   Proskurovsky DI, 1998, J VAC SCI TECHNOL A, V16, P2480, DOI 10.1116/1.581369
   Rajeswari D, 2014, RSC ADV, V4, P61525, DOI 10.1039/c4ra12207k
   Ravi ND, 2012, J AM CERAM SOC, V95, P2700, DOI 10.1111/j.1551-2916.2012.05262.x
   Rose P.I., 1987, ENCY POLYM SCI ENG, P488
   Sivakumar M, 2002, BIOMATERIALS, V23, P3175, DOI 10.1016/S0142-9612(02)00066-2
   Stanic V, 2010, APPL SURF SCI, V256, P6083, DOI 10.1016/j.apsusc.2010.03.124
   Suchanek WL, 2004, BIOMATERIALS, V25, P4647, DOI [10.1016/j.biomaterials.2003.12.008, 10.1016/biomaterials.2003.12.008]
   Sun GF, 2014, MAT SCI ENG C-MATER, V39, P67, DOI 10.1016/j.msec.2014.02.023
   Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P399, DOI 10.1016/S0753-3322(03)00081-7
   Teng SH, 2007, J INORG BIOCHEM, V101, P686, DOI 10.1016/j.jinorgbio.2006.11.018
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Xia W, 2010, ACTA BIOMATER, V6, P1591, DOI 10.1016/j.actbio.2009.10.030
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Zandi M, 2010, J BIOMED MATER RES A, V92A, P1244, DOI 10.1002/jbm.a.32452
NR 50
TC 12
Z9 13
U1 5
U2 41
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 59
BP 47341
EP 47352
DI 10.1039/c5ra05624a
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA CJ7TX
UT WOS:000355703700010
DA 2018-10-19
ER

PT J
AU Firempong, CK
   Cao, X
   Tong, SS
   Yu, JN
   Xu, XM
AF Firempong, Caleb Kesse
   Cao, Xia
   Tong, Shanshan
   Yu, Jiangnan
   Xu, Ximing
TI Prospects for multitarget lipid-raft-coated silica beads: a remarkable
   online biomaterial for discovering multitarget antitumor lead compounds
SO RSC ADVANCES
LA English
DT Review
ID GROWTH-FACTOR RECEPTOR; CELL-MEMBRANE CHROMATOGRAPHY; STATIONARY-PHASE
   CHROMATOGRAPHY; TYROSINE KINASE INHIBITOR; PROSTATE-CANCER CELLS;
   AFFINITY-CHROMATOGRAPHY; IN-VITRO; BREAST-CANCER; DRUG DISCOVERY;
   SIGNALING PATHWAYS
AB A recently discovered receptor-rich lipid raft, which is linked to numerous transmembrane signal transduction pathways, has emerged as a medically significant biomaterial for screening antitumor agents. Compounds that interact with the biomaterial might potentially inhibit cancer cell growth, and thus be valuable as antitumor agents. Two standard anticancer drugs, lestaurtinib and gefitinib, interacted with the tropomyosin-related tyrosine kinase A (TrkA) receptor-rich lipid raft. The fact that they are both well known inhibitors of TrkA receptor strengthened the observed linkage. There is now a considerable interest in developing other related biomaterials to serve a similar purpose, and more importantly, support the concept of multitarget drug discovery. It is expected that new anticancer drugs strategically act on multiple pathways to achieve optimal therapeutic efficacies and decreased stimulation of acquired resistance. However, the current conventional approaches such as chemical screening systems and in silico methods cannot fully satisfy the increasing demand for the therapeutic agents. It has therefore become imperative to explore other alternatives to increase the number of clinically important antitumor agents. Here, we report the prospect of establishing lipid raft biomaterial with well endowed multiple cancer-related receptors for screening antitumor leads that affect multiple pathways. This review also examines receptor-ligand interactions in the hunt for novel antitumor agents and the associated key receptors.
C1 [Firempong, Caleb Kesse; Cao, Xia; Tong, Shanshan; Yu, Jiangnan; Xu, Ximing] Jiangsu Univ, Ctr Nano Drug Gene Delivery & Tissue Engn, Sch Pharm, Dept Pharmaceut, Zhenjiang, Peoples R China.
   [Yu, Jiangnan] China Pharmaceut Univ, Sch Pharm, Nanjing, Jiangsu, Peoples R China.
RP Xu, XM (reprint author), Jiangsu Univ, Ctr Nano Drug Gene Delivery & Tissue Engn, Sch Pharm, Dept Pharmaceut, 301 Xuefu Rd, Zhenjiang, Peoples R China.
EM calebuse@yahoo.com; yjn@ujs.edu.cn; xmxu@ujs.edu.cn
FU National Natural Science Foundation of China [30973677, 81373371];
   Doctoral Fund of Ministry of Education of China [20113227110012];
   Special Funds in Zhenjiang [JHB2012-37, GY2012049, GY2013055,
   GY2011028]; Jiangsu Province
FX We appreciate the support by National Natural Science Foundation of
   China (30973677, 81373371), Doctoral Fund of Ministry of Education of
   China (20113227110012) and Special Funds (JHB2012-37, GY2012049,
   GY2013055, GY2011028) in Zhenjiang, Jiangsu Province for all projects
   related to lipid raft biomaterial.
CR Abulrob A, 2004, ONCOGENE, V23, P6967, DOI 10.1038/sj.onc.1207911
   Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025
   Arai MA, 2009, CHEM-ASIAN J, V4, P1802, DOI 10.1002/asia.200900357
   Araujo RP, 2007, NAT REV DRUG DISCOV, V6, P871, DOI 10.1038/nrd2381
   Aube J, 2012, ACS MED CHEM LETT, V3, P442, DOI 10.1021/ml300114c
   Bates David, 2003, Curr Opin Investig Drugs, V4, P1468
   Beigi F, 1999, J CHROMATOGR A, V852, P313, DOI 10.1016/S0021-9673(99)00025-4
   Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793
   Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815
   BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J
   Carroll FI, 2009, NEUROPSYCHOPHARMACOL, V34, P251, DOI 10.1038/npp.2008.160
   Chen XG, 2011, MOL THER, V19, P93, DOI 10.1038/mt.2010.214
   Chiu SJ, 2006, J CONTROL RELEASE, V112, P199, DOI 10.1016/j.jconrel.2006.02.011
   CHUN MY, 1994, P NATL ACAD SCI USA, V91, P11728, DOI 10.1073/pnas.91.24.11728
   Chung HY, 2008, INT J CANCER, V122, P816, DOI 10.1002/ijc.23182
   Clark IA, 2007, CYTOKINE GROWTH F R, V18, P335, DOI 10.1016/j.cytogfr.2007.04.002
   Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4
   Edidin M, 2001, Sci STKE, V2001, ppe1, DOI 10.1126/stke.2001.67.pe1
   Escriba PV, 2006, TRENDS MOL MED, V12, P34, DOI 10.1016/j.molmed.2005.11.004
   Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027
   Franco-Molina M, 2003, PHYTOTHER RES, V17, P1076, DOI 10.1002/ptr.1313
   Gabizon A, 2010, CANCER CHEMOTH PHARM, V66, P43, DOI 10.1007/s00280-009-1132-4
   Gill AL, 2007, CURR TOP MED CHEM, V7, P1408
   Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016
   GORODINSKY A, 1995, J CELL BIOL, V129, P619, DOI 10.1083/jcb.129.3.619
   Grewal IS, 2009, ADV EXP MED BIOL, V647, P1, DOI 10.1007/978-0-387-89520-8_1
   Habicht KL, 2013, J PHARMACEUT BIOMED, V72, P159, DOI 10.1016/j.jpba.2012.10.001
   Haggerty TJ, 2012, ASSAY DRUG DEV TECHN, V10, P187, DOI 10.1089/adt.2011.0379
   Han HD, 2010, CLIN CANCER RES, V16, P3910, DOI 10.1158/1078-0432.CCR-10-0005
   Han SL, 2014, J SEP SCI, V37, P1525, DOI 10.1002/jssc.201400236
   He LC, 1999, CHINESE SCI BULL, V44, P826, DOI 10.1007/BF02885029
   Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x
   Horrobin DF, 2003, NAT REV DRUG DISCOV, V2, P151, DOI 10.1038/nrd1012
   Hou XF, 2011, J SEP SCI, V34, P508, DOI 10.1002/jssc.201000643
   Hou XF, 2009, J CHROMATOGR A, V1216, P7081, DOI 10.1016/j.chroma.2009.08.062
   Houghten RA, 2006, AAPS J, V8, pE371, DOI 10.1208/aapsj080242
   Hryniewicz-Jankowska A, 2014, BBA-REV CANCER, V1845, P155, DOI 10.1016/j.bbcan.2014.01.006
   Huang YL, 2008, CANCER LETT, V264, P101, DOI 10.1016/j.canlet.2008.01.043
   Jacoby E, 2011, WIRES COMPUT MOL SCI, V1, P57, DOI 10.1002/wcms.11
   Alonso-Castro AJ, 2011, J ETHNOPHARMACOL, V133, P945, DOI 10.1016/j.jep.2010.11.055
   Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596
   Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8
   Kingsmore SF, 2008, NAT REV DRUG DISCOV, V7, P221, DOI 10.1038/nrd2519
   Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389
   Krug M, 2008, MINI-REV MED CHEM, V8, P1312, DOI 10.2174/138955708786369591
   Kubinyi H, 2003, NAT REV DRUG DISCOV, V2, P665, DOI 10.1038/nrd1156
   Kuo HP, 2011, J AGR FOOD CHEM, V59, P8216, DOI 10.1021/jf2012584
   LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804
   Lee CB, 2007, REV RECENT CLIN TRIA, V2, P117, DOI 10.2174/157488707780599401
   Lee LT, 2002, ANTICANCER RES, V22, P1615
   Li J, 2011, MOL CANCER THER, V10, P1346, DOI 10.1158/1535-7163.MCT-10-0985
   Li MA, 2010, J PHARMACEUT BIOMED, V53, P1063, DOI 10.1016/j.jpba.2010.07.011
   Liang MJ, 2005, LIFE SCI, V78, P128, DOI 10.1016/j.lfs.2005.04.038
   Lin CM, 2006, PLANTA MED, V72, P1305, DOI 10.1055/s-2006-951692
   Lipinski C, 2004, NATURE, V432, P855, DOI 10.1038/nature03193
   Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299
   Lu BA, 2010, TOXICOL IN VITRO, V24, P1482, DOI 10.1016/j.tiv.2010.07.017
   Medina-Franco JL, 2013, DRUG DISCOV TODAY, V18, P495, DOI 10.1016/j.drudis.2013.01.008
   Mena-Rejon G, 2009, J ETHNOPHARMACOL, V121, P462, DOI 10.1016/j.jep.2008.11.012
   Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636
   Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930
   Miodini P, 1999, BRIT J CANCER, V80, P1150, DOI 10.1038/sj.bjc.6690479
   Mitchell SH, 1999, CANCER RES, V59, P5892
   Mitri Zahi, 2012, Chemother Res Pract, V2012, P743193, DOI 10.1155/2012/743193
   Moaddel R, 2002, J CHROMATOGR B, V768, P41, DOI 10.1016/S0378-4347(01)00484-4
   Moaddel R, 2010, J PHARMACEUT BIOMED, V52, P416, DOI 10.1016/j.jpba.2009.06.035
   Mollinedo F, 2006, DRUG RESIST UPDATE, V9, P51, DOI 10.1016/j.durp.2006.04.002
   Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044
   Mou HB, 2011, TOXICOL IN VITRO, V25, P1027, DOI 10.1016/j.tiv.2011.03.023
   NOCTOR TAG, 1992, J CHROMATOGR-BIOMED, V577, P305, DOI 10.1016/0378-4347(92)80252-L
   Pan YJ, 2003, CHINESE SCI BULL, V48, P630, DOI 10.1360/03tb9134
   Pang MH, 2012, DRUG DISCOV TODAY, V17, P425, DOI 10.1016/j.drudis.2012.01.003
   Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228
   Partlow KC, 2008, BIOMATERIALS, V29, P3367, DOI 10.1016/j.biomaterials.2008.04.030
   Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002
   Patwardhan CA, 2015, J BIOMOL SCREEN, V20, P223, DOI 10.1177/1087057114549147
   Peng F, 2002, J CANCER RES CLIN, V128, P223, DOI 10.1007/S00432-002-0326-5
   Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200
   Pozo-Guisado E, 2004, INT J CANCER, V109, P167, DOI 10.1002/ijc.11720
   Raghu H, 2007, J VIROL, V81, P7941, DOI 10.1128/JVI.02848-06
   Roepstorff K, 2002, J BIOL CHEM, V277, P18954, DOI 10.1074/jbc.M201422200
   Sadagopan S, 2007, J VIROL, V81, P3949, DOI 10.1128/JVI.02333-06
   SAINSBURY JRC, 1987, LANCET, V1, P1398
   Sanchez I, 2001, PHYTOTHER RES, V15, P290, DOI 10.1002/ptr.954
   SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789
   Sarnataro D, 2006, MOL PHARMACOL, V70, P1298, DOI 10.1124/mol.106.025601
   Sathornsumetee S., 2009, TARGETING MULTILE KI
   Schwartz J, 2009, AM J HEALTH-SYST PH, V66, pS3, DOI 10.2146/ajhp090438
   Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474
   Shankar DB, 2007, BLOOD, V109, P3400, DOI 10.1182/blood-2006-06-029579
   Sharma R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043248
   Sherman SI, 2008, ENDOCRIN METAB CLIN, V37, P511, DOI 10.1016/j.ecl.2008.02.005
   Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4
   Silverman L, 1998, CURR OPIN CHEM BIOL, V2, P397, DOI 10.1016/S1367-5931(98)80015-X
   Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084
   Stockwell BR, 2004, NATURE, V432, P846, DOI 10.1038/nature03196
   Su XY, 2007, J CHROMATOGR A, V1154, P132, DOI 10.1016/j.chroma.2007.03.050
   Sun M, 2011, ACTA PHARM SIN B, V1, P115, DOI 10.1016/j.apsb.2011.06.008
   Sun M, 2012, RAPID COMMUN MASS SP, V26, P2027, DOI 10.1002/rcm.6318
   Sun M, 2010, J CHROMATOGR B, V878, P2712, DOI 10.1016/j.jchromb.2010.08.010
   Sung B, 2010, J BIOL CHEM, V285, P11498, DOI 10.1074/jbc.M109.090209
   Takebayashi M, 2004, SYNAPSE, V53, P90, DOI 10.1002/syn.20041
   Tansey MG, 2009, DRUG DISCOV TODAY, V14, P1082, DOI 10.1016/j.drudis.2009.10.002
   Thomann-Harwood LJ, 2013, J CONTROL RELEASE, V166, P95, DOI 10.1016/j.jconrel.2012.11.015
   Tong SS, 2014, BIOMED CHROMATOGR, V28, P1615, DOI 10.1002/bmc.3189
   Tong SS, 2014, CHROMATOGRAPHIA, V77, P419, DOI 10.1007/s10337-014-2623-y
   Vadlapudi AD, 2012, INT J PHARMACEUT, V434, P315, DOI 10.1016/j.ijpharm.2012.05.033
   van Deurs B, 2003, TRENDS CELL BIOL, V13, P92, DOI 10.1016/S0962-8924(02)00039-9
   Vuignier K, 2013, J PHARMACEUT BIOMED, V74, P205, DOI 10.1016/j.jpba.2012.10.030
   Wang L, 2010, J PHARMACEUT BIOMED, V51, P1032, DOI 10.1016/j.jpba.2009.11.007
   Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920
   Wang SC, 2010, J CHROMATOGR A, V1217, P5246, DOI 10.1016/j.chroma.2010.06.037
   Wong CI, 2009, J CLIN ONCOL, V27, P4718, DOI 10.1200/JCO.2008.21.7125
   Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529
   Yeh CH, 2012, CHIN J INTEGR MED, V18, P676, DOI 10.1007/s11655-012-1206-8
   Yi ZF, 2009, INT J CANCER, V124, P843, DOI 10.1002/ijc.24027
   Yu B, 2010, MOL MEMBR BIOL, V27, P286, DOI 10.3109/09687688.2010.521200
   Yuan BX, 2005, CHROMATOGRAPHIA, V61, P381, DOI 10.1365/s10337-005-0497-8
   Yuan BX, 2005, ACTA PHARMACOL SIN, V26, P113, DOI 10.1117/j.1745-7254.2005.00015.x
   Zhang C, 2012, J CHROMATOGR A, V1233, P78, DOI 10.1016/j.chroma.2012.02.013
   Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559
   Zhang L, 2013, CANCER SCI, V104, P604, DOI 10.1111/cas.12120
   Zhang X, 2008, TRENDS BIOTECHNOL, V26, P295, DOI 10.1016/j.tibtech.2008.02.008
   Zhang XL, 2011, INT J CANCER, V129, P2502, DOI 10.1002/ijc.25909
   Zhen Y, 2007, ONCOGENE, V26, P6372, DOI 10.1038/sj.onc.1210473
   Zheng XH, 2008, CHINESE SCI BULL, V53, P842, DOI 10.1007/s11434-007-0510-8
   Zhuang LY, 2005, J CLIN INVEST, V115, P959
NR 127
TC 2
Z9 2
U1 3
U2 26
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 61
BP 49330
EP 49342
DI 10.1039/c5ra08322b
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA CK1TE
UT WOS:000355989400041
DA 2018-10-19
ER

PT J
AU Zhuo, SM
   Ni, M
   Bi, L
   Xia, L
   Fan, JJ
   Chan, HHN
AF Zhuo, Shuangmu
   Ni, Ming
   Bi, Long
   Xia, Lei
   Fan, Junjun
   Chan, Hugh H. N.
TI Stem Cell-Biomaterial Interactions for Tissue Engineering
SO STEM CELLS INTERNATIONAL
LA English
DT Editorial Material
C1 [Zhuo, Shuangmu] Fujian Normal Univ, Minist Educ, Fujian Prov Key Lab Photon Technol, Fuzhou 350007, Peoples R China.
   [Zhuo, Shuangmu] Fujian Normal Univ, Minist Educ, Key Lab Optoelect Sci & Technol Med, Fuzhou 350007, Peoples R China.
   [Ni, Ming] Inst Bioengn & Nanotechnol, The Nanos 138669, Singapore.
   [Bi, Long; Fan, Junjun] Fourth Mil Med Univ, Xian 710032, Peoples R China.
   [Xia, Lei] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore.
   [Chan, Hugh H. N.] Lerner Res Inst, Cleveland, OH 44195 USA.
RP Zhuo, SM (reprint author), Fujian Normal Univ, Minist Educ, Fujian Prov Key Lab Photon Technol, Fuzhou 350007, Peoples R China.
EM shuangmuzhuo@gmail.com
RI Zhuo, Shuangmu/F-4826-2012
OI Zhuo, Shuangmu/0000-0001-5767-5197
NR 0
TC 0
Z9 0
U1 0
U2 9
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-966X
EI 1687-9678
J9 STEM CELLS INT
JI Stem Cells Int.
PY 2015
AR 126710
DI 10.1155/2015/126710
PG 2
WC Cell & Tissue Engineering
SC Cell Biology
GA CK7BO
UT WOS:000356385200001
PM 26124838
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT S
AU Eom, T
   Shim, BS
AF Eom, Taesik
   Shim, Bong Sub
BE BarCohen, Y
TI Natural Melanin Composites by Layer-by-Layer Assembly
SO ELECTROACTIVE POLYMER ACTUATORS AND DEVICES (EAPAD) 2015
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Electroactive Polymer Actuators and Devices (EAPAD)
CY MAR 09-12, 2015
CL San Diego, CA
SP SPIE, American Soc Mech Engineers, Intelligent Mat Forum, Jet Propuls Lab, Natl Sci Fdn
DE melanin; polyvinyl alcohol (PVA); Layer-by-Layer (LBL) assembly;
   electrical conductive; biocompatible; neural interface; implantable
   device
ID X-RAY CHARACTERIZATION; FILMS; EUMELANINS
AB Melanin is an electrically conductive biomaterial from human skin, eyes, brain, and beyond, because their conjugated backbone structures provide conducting pathways. Thus, there is a potential of using as materials for the neural interfaces and the body implantable devices. Extracted from Sepia officinalis ink, our natural melanin was uniformly dispersed in polar solvents such as water and alcohols. Then, the dispersed melanin was further fabricated to nano-thin layered composites by the layer-by-layer (LBL) assembly technique. Combined with polyvinyl alcohol (PVA), the melanin nanoparticles behave as an LBL component to from finely tuned nanostructured films. The LBL process can adjust the smart performances of the composites by varying the layering conditions and sandwich thickness. We further demonstrated the melanin loading degree of stacked layers, combination nanostructures, and biocompatibility of the resulting composites by UV-vis spectrophotometer, scanning electron microscope (SEM), and in-vitro cell test of PC12, respectively.
C1 [Eom, Taesik; Shim, Bong Sub] Inha Univ, Dept Chem Engn, Inchon, South Korea.
RP Shim, BS (reprint author), Inha Univ, Dept Chem Engn, 100 Inha Ro, Inchon, South Korea.
EM bshim@inha.ac.kr
CR Bettinger CJ, 2009, BIOMATERIALS, V30, P3050, DOI 10.1016/j.biomaterials.2009.02.018
   CHENG J, 1994, PIGM CELL RES, V7, P255, DOI 10.1111/j.1600-0749.1994.tb00060.x
   CHENG J, 1994, PIGM CELL RES, V7, P263, DOI 10.1111/j.1600-0749.1994.tb00061.x
   d'Ischia M, 2013, PIGM CELL MELANOMA R, V26, P616, DOI 10.1111/pcmr.12121
   d'Ischia M, 2009, ANGEW CHEM INT EDIT, V48, P3914, DOI 10.1002/anie.200803786
   Irimia-Vladu M, 2014, CHEM SOC REV, V43, P6470
   Irimia-Vladu M, 2012, MATER TODAY, V15, P340, DOI 10.1016/S1369-7021(12)70139-6
   Kim IG, 2011, ELECTROCHIM ACTA, V56, P2954, DOI 10.1016/j.electacta.2010.12.095
   Ligonzo T, 2009, J NON-CRYST SOLIDS, V355, P1221, DOI 10.1016/j.jnoncrysol.2009.05.014
   Liu Y, 2003, PIGM CELL RES, V16, P606, DOI 10.1046/j.1600-0749.2003.00098.x
   Liu YL, 2014, CHEM REV, V114, P5057, DOI 10.1021/cr400407a
   Mostert AB, 2012, P NATL ACAD SCI USA, V109, P8943, DOI 10.1073/pnas.1119948109
   Oh SH, 2013, TISSUE ENG PART C-ME, V19, P233, DOI [10.1089/ten.tec.2012.0221, 10.1089/ten.TEC.2012.0221]
   Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003
   Srivastava S, 2008, ACCOUNTS CHEM RES, V41, P1831, DOI 10.1021/ar8001377
   Subianto S, 2005, POLYMER, V46, P11505, DOI 10.1016/j.polymer.2005.10.068
NR 16
TC 0
Z9 0
U1 0
U2 11
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-1-62841-533-9
J9 PROC SPIE
PY 2015
VL 9430
AR 94302V
DI 10.1117/12.2085519
PG 7
WC Engineering, Electrical & Electronic; Optics; Physics, Applied; Polymer
   Science
SC Engineering; Optics; Physics; Polymer Science
GA BC8EW
UT WOS:000355580900074
DA 2018-10-19
ER

PT J
AU Asha, S
   Sangappa, Y
   Ganesh, S
AF Asha, S.
   Sangappa, Y.
   Ganesh, Sanjeev
TI Tuning the Refractive Index and Optical Band Gap of Silk Fibroin Films
   by Electron Irradiation
SO JOURNAL OF SPECTROSCOPY
LA English
DT Article
ID PHOTOCHEMICAL BEHAVIOR; BIOMATERIAL COATINGS; NATURAL SILK; DEPOSITION;
   POLYMERS; ROBUST
AB The Bombyx mori silk fibroin (SF) films were prepared by solution casting method and effects of electron beam on the optical properties and optical constants of the films have been studied by using UV-Visible spectrophotometer. Optical properties like optical band gap E-g, refractive index n, extinction coefficient k, optical conductivity sigma(opt), and dielectric constants epsilon* of virgin and electron irradiated films were determined by usingUV-Visible absorption and transmission spectra. It was found that the reduction in optical band gap and increase in refractive index with increasing radiation dosage was observed. It is also observed from results that there is increase in dielectric constants with increasing photon energy. The observed optical changes have been tried to be correlated with the structural changes, revealed through FT-IR spectroscopy. The present study is quite important for tailoring the optical responses of SF films as per specific requirements.
C1 [Asha, S.; Sangappa, Y.; Ganesh, Sanjeev] Mangalore Univ, Dept Studies Phys, Mangalore 574199, India.
   [Sangappa, Y.] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
RP Asha, S (reprint author), Mangalore Univ, Dept Studies Phys, Mangalore 574199, India.
EM a_shinda@yahoo.co.in
FU UGC (New Delhi, India)
FX The first author (S. Asha) thanks UGC (New Delhi, India) for an RGNF
   fellowship.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Asha S., 2013, AIP C P, V1591, P219
   Awatif A. M., 2007, J ENG TECHNOL, V25, P558
   Bakr NA, 2011, PRAMANA-J PHYS, V76, P519, DOI 10.1007/s12043-011-0024-4
   Baltova S, 1998, POLYM DEGRAD STABIL, V60, P53, DOI 10.1016/S0141-3910(97)00016-5
   Baltova S, 1998, POLYM DEGRAD STABIL, V60, P61, DOI 10.1016/S0141-3910(98)80027-X
   CREED D, 1984, PHOTOCHEM PHOTOBIOL, V39, P537
   Demappa T., 2009, NUCL INSTRUMENTS M B, V267, P2385
   FOROUHI AR, 1988, PHYS REV B, V38, P1865, DOI 10.1103/PhysRevB.38.1865
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Giulivi C, 2003, AMINO ACIDS, V25, P227, DOI 10.1007/s00726-003-0013-0
   Guo HL, 2009, SENSOR ACTUAT B-CHEM, V139, P598, DOI 10.1016/j.snb.2009.03.046
   Holland C, 2012, ADV MATER, V24, P105, DOI 10.1002/adma.201103664
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/nmat2745, 10.1038/NMAT2745]
   Kim DH, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3238552
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kojthung A, 2008, INT BIODETER BIODEGR, V62, P487, DOI 10.1016/j.ibiod.2007.12.012
   Kumar SV, 2006, J APPL POLYM SCI, V101, P1591, DOI 10.1002/app.23552
   Kumar V, 2011, RADIAT EFF DEFECT S, V166, P109, DOI 10.1080/10420151003587385
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Metcalfe AD, 2007, BIOMATERIALS, V28, P5100, DOI 10.1016/j.biomaterials.2007.07.031
   Migahed MD, 2006, CURR APPL PHYS, V6, P91, DOI 10.1016/j.cap.2004.12.009
   Mott N., 1979, ELECT PROCESS NONCRY
   Omar M. A., 1993, ELEMENTARY SOLID STA
   Parker ST, 2009, ADV MATER, V21, P2411, DOI 10.1002/adma.200801580
   Perry H, 2008, ADV MATER, V20, P3070, DOI 10.1002/adma.200800011
   Sargunamani D, 2006, POLYM DEGRAD STABIL, V91, P2644, DOI 10.1016/j.polymdegradstab.2006.05.001
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Singh S, 2004, NUCL INSTRUM METH B, V222, P518, DOI 10.1016/j.nimb.2004.03.004
   Sinha D, 2004, RADIAT EFF DEFECT S, V159, P587, DOI 10.1080/10420150412331330539
   Srisa-Ard M., 2008, J APPL SCI, V8, P3518
   Tao H, 2012, ADV MATER, V24, P1067, DOI 10.1002/adma.201103814
   Tauc J., 1972, Optical properties of solids, P277
   Tsuboi Y, 2002, JPN J APPL PHYS 1, V41, P4772, DOI 10.1143/JJAP.41.4772
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   URBACH F, 1953, PHYS REV, V92, P1324, DOI 10.1103/PhysRev.92.1324
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Yakuphanoglu F, 2005, OPT MATER, V27, P1363, DOI [10.1016/j.optmat.2004.09.021, 10.1016/optmat.2004.09.021]
   Zaki MF, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/17/175404
   Zidan HM, 2003, J APPL POLYM SCI, V88, P104, DOI 10.1002/app.11569
NR 43
TC 5
Z9 5
U1 3
U2 20
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-4920
EI 2314-4939
J9 J SPECTROSC
JI J. Spectrosc.
PY 2015
AR 879296
DI 10.1155/2015/879296
PG 7
WC Biochemical Research Methods; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA CJ4LC
UT WOS:000355455500001
OA DOAJ Gold
DA 2018-10-19
ER

PT S
AU Khobragade, P
   Jain, A
   Nagesh, SVS
   Andreana, S
   Dziak, R
   Sunkara, SK
   Sunkara, S
   Bednarek, DR
   Rudin, S
   Ionita, CN
AF Khobragade, P.
   Jain, A.
   Nagesh, S. V. Setlur
   Andreana, S.
   Dziak, R.
   Sunkara, S. K.
   Sunkara, S.
   Bednarek, D. R.
   Rudin, S.
   Ionita, C. N.
BE Gimi, B
   Molthen, RC
TI Micro-Computed tomography (CT) based assessment of dental regenerative
   therapy in the canine mandible model
SO MEDICAL IMAGING 2015: BIOMEDICAL APPLICATIONS IN MOLECULAR, STRUCTURAL,
   AND FUNCTIONAL IMAGING
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Medical Imaging - Biomedical Applications in Molecular,
   Structural, and Functional Imaging
CY FEB 24-26, 2015
CL Orlando, FL
SP SPIE, ALIO Ind, Alpin Med Syst, Modus Med Devices Inc, Bruker
ID BONE-MINERAL DENSITY; TRABECULAR BONE; RAT MODEL; OSTEOPOROSIS;
   BIOMATERIAL; ALGORITHM; CARTILAGE; STRENGTH; SYSTEM
AB High-resolution 3D bone-tissue structure measurements may provide information critical to the understanding of the bone regeneration processes and to the bone strength assessment. Tissue engineering studies rely on such nondestructive measurements to monitor bone graft regeneration area. In this study, we measured bone yield, fractal dimension and trabecular thickness through micro-CT slices for different grafts and controls. Eight canines underwent surgery to remove a bone volume (defect) in the canine's jaw at a total of 44 different locations. We kept 11 defects empty for control and filled the remaining ones with three regenerative materials; NanoGen (NG), a FDA-approved material (n= 11), a novel NanoCalcium Sulfate (NCS) material (n= 11) and NCS alginate (NCS+ alg) material (n= 11). After a minimum of four and eight weeks, the canines were sacrificed and the jaw samples were extracted. We used a custom-built micro-CT system to acquire the data volume and developed software to measure the bone yield, fractal dimension and trabecular thickness. The software used a segmentation algorithm based on histograms derived from volumes of interest indicated by the operator. Using bone yield and fractal dimension as indices we are able to differentiate between the control and regenerative material (p< 0.005). Regenerative material NCS showed an average 63.15% bone yield improvement over the control sample, NCS+ alg showed 55.55% and NanoGen showed 37.5%. The bone regeneration process and quality of bone were dependent upon the position of defect and time period of healing. This study presents one of the first quantitative comparisons using non-destructive Micro-CT analysis for bone regenerative material in a large animal with a critical defect model. Our results indicate that Micro-CT measurement could be used to monitor in-vivo bone regeneration studies for greater regenerative process understanding.
C1 [Khobragade, P.; Rudin, S.; Ionita, C. N.] SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA.
   [Khobragade, P.; Jain, A.; Nagesh, S. V. Setlur; Bednarek, D. R.; Rudin, S.; Ionita, C. N.] SUNY Buffalo, Toshiba Stroke & Vasc Res Ctr, Buffalo, NY 14260 USA.
   [Andreana, S.] SUNY Buffalo, Dept Restorat Dent, Buffalo, NY 14260 USA.
   [Dziak, R.; Sunkara, S. K.; Sunkara, S.] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14260 USA.
RP Khobragade, P (reprint author), SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA.
CR Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141
   Boyd SK, 2006, BONE, V39, P854, DOI 10.1016/j.bone.2006.04.017
   Dziak R., 2014, RECENT PATENTS REGEN, V94-102
   Eckstein F, 2006, NMR BIOMED, V19, P822, DOI 10.1002/nbm.1063
   FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   Genant HK, 2008, RHEUMATOLOGY, V47, P9, DOI 10.1093/rheumatology/ken180
   Geraets WGM, 2008, DENTOMAXILLOFAC RAD, V37, P375, DOI 10.1259/dmfr/29966973
   Guedon J., 2012, SPIE MED IMAGING
   Huh JY, 2005, ORAL SURG ORAL MED O, V100, P296, DOI 10.1016/j.tripleo.2004.12.015
   Ionita CN, 2008, J DIGIT IMAGING, V21, P296, DOI 10.1007/s10278-007-9024-9
   Kallai I, 2011, NAT PROTOC, V6, P105, DOI 10.1038/nprot.2010.180
   Kontogiorgos E, 2011, CALCIFIED TISSUE INT, V89, P43, DOI 10.1007/s00223-011-9492-2
   Laib A, 2000, MED BIOL ENG COMPUT, V38, P326, DOI 10.1007/BF02347054
   LIEBOVITCH LS, 1989, PHYS LETT A, V141, P386, DOI 10.1016/0375-9601(89)90854-2
   Luo GM, 1999, ULTRASOUND MED BIOL, V25, P823, DOI 10.1016/S0301-5629(99)00026-5
   Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4
   Park YB, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055007
   Patel V, 2009, MED PHYS, V36, P48, DOI 10.1118/1.3026615
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Plachokova AS, 2006, CLIN ORAL IMPLAN RES, V17, P305, DOI 10.1111/j.1600-0501.2005.01208.x
   Requicha JF, 2014, J ORTHOP RES, V32, P904, DOI 10.1002/jor.22609
   Rudin S., 2002, SPIE MED IMAGING
   Sanchez U.G., 2011, J DENT, V39, P273
   Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007
   Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077
   Seeman E, 2010, J BONE MINER RES, V25, P1886, DOI 10.1002/jbmr.81
   Sittinger M, 2004, CURR OPIN BIOTECH, V15, P411, DOI 10.1016/j.copbio.2004.08.010
   Swain MV, 2009, INT J ORAL SCI, V1, P177, DOI 10.4248/IJOS09031
   Ulrich D, 1999, BONE, V25, P55, DOI 10.1016/S8756-3282(99)00098-8
   Waarsing JH, 2004, BONE, V34, P163, DOI 10.1016/j.bone.2003.08.012
   Wachter NJ, 2002, BONE, V31, P90, DOI 10.1016/S8756-3282(02)00779-2
NR 32
TC 1
Z9 1
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-1-62841-507-0
J9 PROC SPIE
PY 2015
VL 9417
AR 94171D
DI 10.1117/12.2082173
PG 12
WC Optics; Radiology, Nuclear Medicine & Medical Imaging
SC Optics; Radiology, Nuclear Medicine & Medical Imaging
GA BC8GL
UT WOS:000355665600045
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Anwar, S
   Mubarik, M
   Waheed, A
   Firdous, S
AF Anwar, S.
   Mubarik, M.
   Waheed, A.
   Firdous, S.
TI Polarization Imaging and Characterization of Chitosan for applications
   in tissue engineering
SO OPTIK
LA English
DT Article
DE Biomaterial; Chitosan; Polarization; SEM; XRD; FTIR; Mueller matrix;
   Tissue engineering
ID LIGHT
AB In this study we described the optical properties of Chitosan as a biomaterial using light polarization Mueller analytical model which are not well understood by conventional characterization techniques. Despite the physical, mechanical and chemical properties measured by Scanning Electron Microscope (SEM), X-ray Powder Diffraction (XRD) and FTIR (Fourier Transform Infrared) Spectroscopy, optical properties are very useful to investigate the biodegradable Chitosan based scaffolds in tissue engineering. It has been observed from the SEM, XRD, FTIR and polarimetric results (diattenuation, retardance, depolarization, and degree of polarization) that Chitosan has porosity, amorphous, compactable and anisotropic material. (C) 2015 Elsevier GmbH. All rights reserved.
C1 [Anwar, S.; Waheed, A.; Firdous, S.] Natl Inst Lasers & Optron NILOP, Nilore, Pakistan.
   [Mubarik, M.] FUUAST, Dept Phys, Islamabad, Pakistan.
RP Firdous, S (reprint author), Natl Inst Lasers & Optron NILOP, Nilore, Pakistan.
EM shamaraz@gmail.com
RI Firdous, Shamaraz/I-8028-2015
CR [Anonymous], 2001, P SPIE, V4532
   BICKEL WS, 1985, AM J PHYS, V53, P468, DOI 10.1119/1.14202
   Brosseau C., 1998, FUNDAMENTALS POLARIZ
   Collett E., 1993, POLARIZED LIGHT FUND
   Correlo VM, 2005, MAT SCI ENG A-STRUCT, V403, P57, DOI 10.1016/j.msea.2005.04.055
   Firdous S, 2005, APPL OPTICS, V44, P1171, DOI 10.1364/AO.44.001171
   Firdous S, 2013, OPTIK, V124, P1297, DOI 10.1016/j.ijleo.2012.03.069
   Firdous S, 2011, OPT SPECTROSC+, V110, P438, DOI 10.1134/S0030400X11030064
   Firdous S, 2011, OPTIK, V122, P99, DOI 10.1016/j.ijleo.2009.10.008
   Firdous S, 2010, LASER ENG, V19, P291
   FIRDOUS S, 2005, P SOC PHOTO-OPT INS, V5867, P25
   Firdous S., 2005, TURK J MED SCI, V35, P145
   Firdous S., 2007, P SPIE, V6632
   Kucklick T., 2005, MED DEVICE R D HDB
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kumar S., 2010, J ADV POLYM SCI, V1
   Kumirska J., 2010, MAR DRUGS
   Moore J., 2003, BIOMEDICAL TECHNOLOG
   NESALIN J.A.J., 2012, ASIAN J PHARM SCI, V7, P80
   Ogawa K, 2004, INT J BIOL MACROMOL, V34, P1, DOI 10.1016/j.ijbiomac.2003.11.002
   Ray M, 2010, DES MONOMERS POLYM, V13, P193, DOI 10.1163/138577210X12634696333479
   Rice W., 2008, BIOMATERIALS, V29, P2014
   Struszczyk H., 2005, ADV CHITIN SCI, VVIII
   Sun K, 2011, EXPRESS POLYM LETT, V5, P342, DOI 10.3144/expresspolymlett.2011.34
   Tuchin V.V., 2007, OPTICAL POLARIZATION
   Walters J., 2013, OPT ENG, V52, P27
   Zhang HL, 2010, J NANO MAT, V2010, P1, DOI DOI 10.1155/2010/898910
   Zivanovic S., 2007, BIOMACROMOLECULES, V8, P505
NR 28
TC 3
Z9 3
U1 0
U2 10
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0030-4026
J9 OPTIK
JI Optik
PY 2015
VL 126
IS 7-8
BP 871
EP 876
DI 10.1016/j.ijleo.2015.02.027
PG 6
WC Optics
SC Optics
GA CJ8UB
UT WOS:000355777900040
DA 2018-10-19
ER

PT J
AU Perez-Madrigal, MM
   Cianga, L
   del Valle, LJ
   Cianga, I
   Aleman, C
AF Perez-Madrigal, Maria M.
   Cianga, Luminita
   del Valle, Luis J.
   Cianga, Ioan
   Aleman, Carlos
TI Electroactive and bioactive films of random copolymers containing
   terthiophene, carboxyl and Schiff base functionalities in the main chain
SO POLYMER CHEMISTRY
LA English
DT Article
ID PHASE-TRANSFER CATALYSIS; POLYTHIOPHENE-G-POLY(ETHYLENE GLYCOL);
   ELECTROCHEMICAL PROPERTIES; ELECTROCHROMIC PROPERTIES; SURFACE
   CHARACTERIZATION; ANTITUBERCULAR ACTIVITY; POLYTHIOPHENE FILMS;
   CONJUGATED POLYMERS; POLYAZOMETHINES; NANOMEMBRANES
AB A new bis-thienyl type monomer with preformed azomethine linkages (AzbT) was chemically synthesized and, subsequently, electro-copolymerized with 2,2' : 5', 2 ''-terthiophene (Th-3). AzbT : Th-3 mixtures with different molar ratios (i.e. 50 : 50, 60 : 40 and 80 : 20) were considered, the resulting thin films being made of random insoluble copolymers, P(AzbT-co-Th-3)s. The content of AzbT in P(AzbT-co-Th-3) s was found to increase with the AzbT : Th-3 molar ratio in the electropolymerization medium. Furthermore, characterization of the different copolymers suggests the existence of several concomitant processes in the reaction medium. Thus, depending on the composition of the reaction medium, AzbT worked as a co-monomer and/or as a dopant for the growing polymer chains. The morphology of the films evolved from a porous multi-level surface to a more compact and flat globular structure with increasing AzbT content. On the other hand, the electrochemical and optical properties were also influenced by the AzbT : Th-3 ratio. Cytotoxicity and cell adhesion and proliferation tests, which were performed using human osteosarcoma and monkey kidney epithelial cell lines (MG-63 and Vero, respectively), revealed that P(AzbT-co-Th-3) matrices can be potentially applied as bioactive substrates. This behaviour was especially relevant for the 80 : 20 copolymer, which exhibits optical and electrochemical properties in the range of polythiophene derivatives, suggesting that it is a promising functional biomaterial.
C1 [Perez-Madrigal, Maria M.; del Valle, Luis J.; Aleman, Carlos] Univ Politecn Cataluna, ETSEIB, Dept Engn Quim, E-08028 Barcelona, Spain.
   [Perez-Madrigal, Maria M.; Aleman, Carlos] Univ Politecn Cataluna, Ctr Res Nanoengn, E-08028 Barcelona, Spain.
   [Cianga, Luminita; Cianga, Ioan] Petru Poni Inst Macromol Chem, Iasi 700487, Romania.
RP Aleman, C (reprint author), Univ Politecn Cataluna, ETSEIB, Dept Engn Quim, Avda Diagonal 647, E-08028 Barcelona, Spain.
EM ioanc@icmpp.ro; carlos.aleman@upc.edu
RI del Valle, Luis J./I-1342-2015; Perez-Madrigal, Maria M./I-1052-2015
OI del Valle, Luis J./0000-0001-9916-1741; Perez-Madrigal, Maria
   M./0000-0002-2498-8485; Aleman, Carlos/0000-0003-4462-6075
FU MINECO; FEDER [MAT2012-34498]; FPI-UPC grant
FX Authors are indebted to the support from MINECO and FEDER
   (MAT2012-34498). M.M.P.-M. acknowledges financial support through a
   FPI-UPC grant.
CR ABDOU MSA, 1993, MACROMOLECULES, V26, P2954, DOI 10.1021/ma00063a047
   Ahmad S, 2007, LANGMUIR, V23, P11430, DOI 10.1021/la702442c
   Alam MS, 2012, BIOORGAN MED CHEM, V20, P4103, DOI 10.1016/j.bmc.2012.04.058
   Ali MM, 2009, J SCI RES, V1, P641
   Aradilla D, 2012, POLYM CHEM-UK, V3, P436, DOI 10.1039/c1py00504a
   Aradilla D, 2011, POLYM CHEM-UK, V2, P2548, DOI 10.1039/c1py00291k
   Armelin E, 2012, J MATER CHEM, V22, P585, DOI 10.1039/c1jm14168f
   Avram M., 1966, SPECTROSCOPIA INFRAR
   Barik S, 2012, MACROMOLECULES, V45, P1165, DOI 10.1021/ma2024304
   Barik S, 2011, POLYM CHEM-UK, V2, P1091, DOI 10.1039/c0py00394h
   Bendrea AD, 2013, J MATER CHEM B, V1, P4135, DOI 10.1039/c3tb20679c
   Bendrea AD, 2013, POLYM CHEM-UK, V4, P2709, DOI 10.1039/c3py00029j
   Benoit R., LASURFACE XRAY PHOTO
   Berridge R, 2007, J MATER CHEM, V17, P225, DOI 10.1039/b613879a
   Bertran O, 2010, J PHYS CHEM B, V114, P6281, DOI 10.1021/jp1006796
   Bolduc A, 2014, POLYM CHEM-UK, V5, P1119, DOI 10.1039/c3py01370g
   Chastain J., 1995, HDB XRAY PHOTOELECTR
   Cianga I, 2006, EUR POLYM J, V42, P1922, DOI 10.1016/j.eurpolymj.2006.03.001
   Cianga L, 2005, HIGH PERFORM POLYM, V17, P117, DOI 10.1177/0954008305042758
   Colak D, 2006, J POLYM SCI POL CHEM, V44, P727, DOI 10.1002/pola.21165
   Delpeux S, 1998, EUR POLYM J, V34, P905, DOI 10.1016/S0014-3057(97)00225-5
   Destri S, 1998, MACROMOLECULES, V31, P1079, DOI 10.1021/ma970756r
   Dillingham TR, 1996, J VAC SCI TECHNOL A, V14, P1494, DOI 10.1116/1.579975
   Ezugwu C. I., 2013, CHEM SCI T, V2, P1118
   Fabregat G, 2014, ACS APPL MATER INTER, V6, P11940, DOI 10.1021/am503904h
   Ferreira MD, 2009, CARBOHYD RES, V344, P2042, DOI 10.1016/j.carres.2009.08.006
   Ganguli S, 2012, INT J PHARM PHARM SC, V4, P175
   Giuseppone N, 2006, CHEM-EUR J, V12, P1723, DOI 10.1002/chem.200501037
   Grande CD, 2011, MACROMOLECULES, V44, P966, DOI 10.1021/ma102065u
   Grigoras M, 2000, REV ROUM CHIM, V45, P703
   Hamciuc E, 2014, HIGH PERFORM POLYM, V26, P175, DOI 10.1177/0954008313505626
   Hendrickson DN, 1970, INORG CHEM, V9, P612, DOI 10.1021/ic50085a035
   Hu BL, 2012, J AM CHEM SOC, V134, P17408, DOI 10.1021/ja307933t
   Isik D, 2012, ORG ELECTRON, V13, P3022, DOI 10.1016/j.orgel.2012.08.018
   Iwan A, 2008, PROG POLYM SCI, V33, P289, DOI 10.1016/j.progpolymsci.2007.09.005
   Iwan A, 2013, SYNTHETIC MET, V185, P17, DOI 10.1016/j.synthmet.2013.10.008
   Janeliunas D, 2013, ANGEW CHEM INT EDIT, V52, P1998, DOI 10.1002/anie.201209004
   Jesmin M., 2010, THAI J PHARM SCI, V34, P20
   Kaya I, 2013, J FLUORESC, V23, P115, DOI 10.1007/s10895-012-1124-3
   Khan KM, 2009, BIOORGAN MED CHEM, V17, P7795, DOI 10.1016/j.bmc.2009.09.028
   Kiebooms R., 2001, HDB ADV ELECT PHOTON, V8, P15
   Kiss E, 2002, J COLLOID INTERF SCI, V245, P91, DOI 10.1006/jcis.2001.7954
   Krompiec M, 2011, ELECTROCHIM ACTA, V56, P8108, DOI 10.1016/j.electacta.2011.05.132
   Kumar KS, 2010, EUR J MED CHEM, V45, P5474, DOI 10.1016/j.ejmech.2010.07.058
   Kunz TK, 2011, POLYM CHEM-UK, V2, P640, DOI 10.1039/c0py00308e
   Lehn JM, 2005, PROG POLYM SCI, V30, P814, DOI 10.1016/j.progpolymsci.2005.06.002
   Li GT, 1998, MACROMOL CHEM PHYSIC, V199, P525, DOI 10.1002/macp.1998.021990404
   Li JQ, 1998, J ELECTROANAL CHEM, V458, P155, DOI 10.1016/S0022-0728(98)00355-6
   Li SL, 1999, CORROS SCI, V41, P1273, DOI 10.1016/S0010-938X(98)00183-8
   Li XG, 2009, J PHYS CHEM B, V113, P9718, DOI 10.1021/jp901395u
   Llorens E, 2014, RSC ADV, V4, P15245, DOI 10.1039/c3ra42829j
   Llorens E, 2013, POLYMERS-BASEL, V5, P1115, DOI 10.3390/polym5031115
   Lopez-Perez DE, 2013, J PHYS CHEM C, V117, P6607, DOI 10.1021/jp3123117
   Maeda T, 2009, PROG POLYM SCI, V34, P581, DOI 10.1016/j.progpolymsci.2009.03.001
   Maione S, 2015, J POLYM SCI POL PHYS, V53, P239, DOI 10.1002/polb.23617
   Mallet C, 2013, POLYM CHEM-UK, V4, P250, DOI 10.1039/c2py20703f
   Manceau M, 2009, POLYM DEGRAD STABIL, V94, P898, DOI 10.1016/j.polymdegradstab.2009.03.005
   Marin L, 2009, SOFT MATER, V7, P1, DOI 10.1080/15394450802656214
   Martins F, 2014, EUR J MED CHEM, V81, P119, DOI 10.1016/j.ejmech.2014.04.077
   Maruoka K, 2003, CHEM REV, V103, P3013, DOI 10.1021/cr020020e
   Mishra P, 2005, J GEN APPL MICROBIOL, V51, P133, DOI 10.2323/jgam.51.133
   Mohamed GG, 2005, SPECTROCHIM ACTA A, V62, P1140, DOI 10.1016/j.saa.2005.03.031
   Moulin E, 2012, CHEM SOC REV, V41, P1031, DOI 10.1039/c1cs15185a
   NEFEDOV VI, 1975, ZH NEORG KHIM+, V20, P2307
   Onciu M, 2007, J APPL POLYM SCI, V103, P2013, DOI 10.1002/app.25302
   Ooi T, 2007, ANGEW CHEM INT EDIT, V46, P4222, DOI 10.1002/anie.200601737
   Ozaytekin Y., 2014, POLYM COMPOSITE, V35, P372
   Peng H, 2007, POLYMER, V48, P3413, DOI 10.1016/j.polymer.2007.04.029
   Perez-Madrigal MM, 2014, POLYM CHEM-UK, V5, P1248, DOI 10.1039/c3py01313h
   Perez-Madrigal M. M., 2013, POLYM CHEM, V4, P568
   Perez-Madrigal MM, 2015, ACS APPL MATER INTER, V7, P1632, DOI 10.1021/am507142f
   Perez-Madrigal MM, 2014, ACS APPL MATER INTER, V6, P9719, DOI 10.1021/am502150q
   Perez-Madrigal MM, 2012, POLYM CHEM-UK, V3, P979, DOI 10.1039/c2py00584k
   Planellas M, 2015, POLYM CHEM-UK, V6, P925, DOI 10.1039/c4py01243g
   Purvis KL, 2000, J AM CHEM SOC, V122, P1808, DOI 10.1021/ja992910q
   Revanasiddappa B. C., 2013, UNIVERS J PHARM, V2, P145
   Sari N, 2004, Z NATURFORSCH B, V59, P692
   Sashidhara KV, 2009, EUR J MED CHEM, V44, P1813, DOI 10.1016/j.ejmech.2008.08.004
   Sharma S, 2003, APPL SURF SCI, V206, P218, DOI 10.1016/S0169-4332(02)01220-5
   Simionescu CI, 1999, EUR POLYM J, V35, P1895, DOI 10.1016/S0014-3057(98)00272-9
   Simionescu CI, 1998, EUR POLYM J, V34, P891, DOI 10.1016/S0014-3057(97)00226-7
   Simionescu CI, 1999, EUR POLYM J, V35, P587, DOI 10.1016/S0014-3057(98)00171-2
   Soto-Delgado J, 2015, RSC ADV, V5, P9189, DOI 10.1039/c4ra13812k
   Spanninga SA, 2010, J PHYS CHEM C, V114, P14992, DOI 10.1021/jp104591d
   Stevens JS, 2013, SURF INTERFACE ANAL, V45, P1238, DOI 10.1002/sia.5261
   Tarkuc S, 2006, POLYMER, V47, P2001, DOI 10.1016/j.polymer.2006.01.072
   Tumer M, 2008, J COORD CHEM, V61, P2935, DOI 10.1080/00958970801989902
   VANINI AS, 1994, CORROS SCI, V36, P1825
   Zhang Z, 2013, J INORG BIOCHEM, V123, P1, DOI 10.1016/j.jinorgbio.2013.02.004
   Zhou YJ, 2010, BIOORGAN MED CHEM, V18, P2165, DOI 10.1016/j.bmc.2010.01.075
NR 90
TC 6
Z9 6
U1 2
U2 24
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1759-9954
EI 1759-9962
J9 POLYM CHEM-UK
JI Polym. Chem.
PY 2015
VL 6
IS 23
BP 4319
EP 4335
DI 10.1039/c5py00480b
PG 17
WC Polymer Science
SC Polymer Science
GA CJ8FJ
UT WOS:000355735300015
DA 2018-10-19
ER

PT J
AU Kunert-Keil, C
   Botzenhart, U
   Gedrange, T
   Gredes, T
AF Kunert-Keil, Christiane
   Botzenhart, Ute
   Gedrange, Tomasz
   Gredes, Tomasz
TI Interrelationship between bone substitution materials and skeletal
   muscle tissue
SO ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER
LA English
DT Article
DE In vivo biocompatibility; MyHC expression; Muscle histology; Growth
   factor; Ectopic bone formation
ID MESSENGER-RNA EXPRESSION; IN-VIVO DEGRADATION; GENE-EXPRESSION;
   GROWTH-FACTOR; MYOGENIC DIFFERENTIATION; EXTRACELLULAR-MATRIX;
   LATISSIMUS-DORSI; FIBERS; CELLS; ADAPTATION
AB Bone density and quantity are primary conditions for the insertion and stability of dental implants. In cases of a lack of adequate maxillary or mandibulary bone, bone augmentation will be necessary. The use of synthetic bioactive bone substitution materials is of increasing importance as alternatives to autogenously bone grafts.
   It is well known that bone can influence muscle function and muscle function can influence bone structures. Muscles have a considerable potential of adaptation and muscle tissue surrounding an inserted implant or bone surrogate can integrate changes in mechanical load of the muscle and hereupon induce signaling cascades with protein synthesis and arrangement of the cytoskeleton.
   The Musculus latissimus dorsi is very often used for the analyses of the in vivo biocompatibility of newly designed biomaterials. Beside macroscopically and histologically examination, biocompatibility can be assessed by analyses of the biomaterial influence of gene expression.
   This review discusses changes in the fiber type distribution, myosin heavy chain isoform composition, histological appearance and vascularization of the skeletal muscle after implantation of bone substitution materials. Especially, the effects of bone surrogates should be described at the molecular-biological and cellular level. (C) 2014 Elsevier GmbH. All rights reserved.
C1 [Kunert-Keil, Christiane; Botzenhart, Ute; Gedrange, Tomasz; Gredes, Tomasz] Tech Univ Dresden, Dept Orthodont, D-01307 Dresden, Germany.
RP Kunert-Keil, C (reprint author), Tech Univ Dresden, Dept Orthodont, Carl Gustav Carus Campus,Fetscherstr 74,Haus 28, D-01307 Dresden, Germany.
EM christiane.kunert-keil@uniklinikum-dresden.de
CR ADAMS GR, 1993, J APPL PHYSIOL, V74, P911
   ALAMEDDINE HS, 1989, MUSCLE NERVE, V12, P544, DOI 10.1002/mus.880120705
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   BOOTH FW, 1983, MED SCI SPORT EXER, V15, P415
   Burugapalli K, 2007, BIOMACROMOLECULES, V8, P3439, DOI 10.1021/bm700560k
   Censi R, 2011, J BIOMED MATER RES A, V97A, P219, DOI 10.1002/jbm.a.33048
   Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001
   Deasy BM, 2009, MOL THER, V17, P1788, DOI 10.1038/mt.2009.136
   Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012
   FITTS RH, 1986, J APPL PHYSIOL, V60, P1946
   FLORINI JR, 1991, ANNU REV PHYSIOL, V53, P201, DOI 10.1146/annurev.physiol.53.1.201
   FLORINI JR, 1991, J BIOL CHEM, V266, P15917
   FLORINI JR, 1991, MOL ENDOCRINOL, V5, P718, DOI 10.1210/mend-5-5-718
   Fluck M, 2003, Ther Umsch, V60, P371, DOI 10.1024/0040-5930.60.7.371
   Folland JP, 2007, SPORTS MED, V37, P145, DOI 10.2165/00007256-200737020-00004
   Gedrange T, 2008, J PHYSIOL PHARMACOL, V59, P3
   Giannoudis P.V., 2005, INJURY, V36
   Gotz W, 2010, FOLIA HISTOCHEM CYTO, V48, P589, DOI 10.2478/v10042-010-0096-x
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   GOLDSPINK G, 1992, AM J PHYSIOL, V262, pR356
   Gredes T, 2009, J PHYSIOL PHARMACOL, V60, P77
   Gredes T, 2012, ANN ANAT, V194, P179, DOI 10.1016/j.aanat.2011.10.003
   Gredes T, 2010, BIOMED TECH, V55, P323, DOI 10.1515/BMT.2010.048
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Hulsart-Billstrom G, 2011, ACTA BIOMATER, V7, P3042, DOI 10.1016/j.actbio.2011.04.021
   Jankala H, 1997, J APPL PHYSIOL, V82, P977
   Kaji Hiroshi, 2014, J Bone Metab, V21, P29, DOI 10.11005/jbm.2014.21.1.29
   Kerdoncuff V., 2002, Annales de Readaptation et de Medecine Physique, V45, P198, DOI 10.1016/S0168-6054(02)00203-9
   Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003
   Krutki P, 2008, J PHYSIOL PHARMACOL, V59, P85
   Kunert-Keil C., 2013, ANN ANAT
   LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9
   Lauer G, 2007, ANN ANAT, V189, P412, DOI 10.1016/j.aanat.2007.02.021
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Mack HB, 2008, J PHYSIOL PHARMACOL, V59, P95
   Mai R, 2006, J CRANIO MAXILL SURG, V34, P101, DOI 10.1016/S1010-5182(06)60022-X
   McCroskery S, 2005, J CELL SCI, V118, P3531, DOI 10.1242/jcs.02482
   McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0
   Messina S, 2007, FASEB J, V21, P3737, DOI 10.1096/fj.07-8459com
   Pette D, 2002, CAN J APPL PHYSIOL, V27, P423, DOI 10.1139/h02-023
   Pieper JS, 2000, BIOMATERIALS, V21, P1689, DOI 10.1016/S0142-9612(00)00052-1
   PUZAS JE, 1989, CLIN ORTHOP RELAT R, P269
   Ricotti L, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/3/035010
   Ricotti L, 2011, IEEE ENG MED BIO, P3597, DOI 10.1109/IEMBS.2011.6090602
   SASSOUNI V, 1969, AMER J ORTHODONTICS, V55, P109, DOI 10.1016/0002-9416(69)90122-5
   SAWYER JR, 1991, CALCIFIED TISSUE INT, V49, P208, DOI 10.1007/BF02556120
   Schumacher G H, 1991, Phillip J, V8, P210
   Shishatskaya EI, 2007, B EXP BIOL MED+, V144, P786, DOI 10.1007/s10517-007-0432-0
   Shishatskaya EI, 2004, J MATER SCI-MATER M, V15, P719, DOI 10.1023/B:JMSM.0000030215.49991.0d
   Sondag GR, 2014, J CELL PHYSIOL, V229, P955, DOI 10.1002/jcp.24512
   STARON RS, 1993, COMP BIOCHEM PHYS B, V106, P463, DOI 10.1016/0305-0491(93)90120-T
   STARON RS, 1993, HISTOCHEMISTRY, V100, P149, DOI 10.1007/BF00572901
   Tanaka K, 2012, BONE, V51, P158, DOI 10.1016/j.bone.2012.04.017
   Warnke PH, 2006, BIOMATERIALS, V27, P1081, DOI 10.1016/j.biomaterials.2005.07.042
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Widrick JJ, 2002, AM J PHYSIOL-REG I, V283, pR408, DOI 10.1152/ajpregu.00120.2002
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   WOLF JH, 1995, ORTHOPADE, V24, P378
   Yang W, 2007, J BIOL CHEM, V282, P3799, DOI 10.1074/jbc.M610185200
NR 60
TC 1
Z9 1
U1 0
U2 7
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0940-9602
EI 1618-0402
J9 ANN ANAT
JI Ann. Anat.-Anat. Anz.
PY 2015
VL 199
SI SI
BP 73
EP 78
DI 10.1016/j.aanat.2014.07.008
PG 6
WC Anatomy & Morphology
SC Anatomy & Morphology
GA CJ5AB
UT WOS:000355498700012
PM 25159858
DA 2018-10-19
ER

PT J
AU Liu, XH
   Zhu, C
   Li, YJ
   Yan, YL
   Hou, CY
   Wang, H
   Yang, YL
   Guan, GP
   Feng, QL
AF Liu, Xinhui
   Zhu, Chao
   Li, Yijiong
   Yan, Yueling
   Hou, Chuanyong
   Wang, Hua
   Yang, Yelin
   Guan, Guoping
   Feng, Qingling
TI The Preparation and In Vitro Evaluations of a Nanoscaled Injectable Bone
   Repair Material
SO JOURNAL OF NANOMATERIALS
LA English
DT Article
ID LASER-SCANNING MICROSCOPY; DRUG-DELIVERY; SUBSTITUTE; COMPOSITES;
   HYDROGELS; REGENERATION; SCAFFOLDS; MARROW; MATRIX; CELLS
AB There are usually two forms of bone repair materials, block and granular, for common clinical use. This paper describes a novel injectable material, nano-HA/collagen/alginate (nHAC/Alg) composite biomaterial, including its preparation and evaluations in vitro. Based on the idea of bionics and the study of collagen/calcium phosphate salt composite materials, the injectable bone repair material was developed. Then, human bone marrow stem cells (hBMSCs) were cultured on the nHAC/Alg material. The cell attachment, proliferation, and differentiation were evaluated with inverted microscope, scanning electron microscope, laser scanning confocal microscope, 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) analysis, and alkaline phosphatase (ALP) test. The results showed that nHAC/Alg not only had no negative effect on cellular functions but also promotes cell proliferation and differentiation into osteogenic cells, which suggests that the nanoscaled injectable bone repair material has good clinical application prospects for bone repair.
C1 [Liu, Xinhui; Zhu, Chao; Hou, Chuanyong; Wang, Hua; Yang, Yelin; Guan, Guoping] Nanjing Med Univ, Jiangning Hosp, Orthopaed, Nanjing 211100, Jiangsu, Peoples R China.
   [Li, Yijiong; Yan, Yueling] Hebei Med Univ, Hosp 1, Orthopaed, Shijiazhuang 050031, Peoples R China.
   [Feng, Qingling] Tsinghua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
RP Liu, XH (reprint author), Nanjing Med Univ, Jiangning Hosp, Orthopaed, Nanjing 211100, Jiangsu, Peoples R China.
EM professorlxh2008@163.com
FU Natural Science Foundation of Jiangsu Province of China [BK20141436]
FX The authors acknowledge the financial support from the Natural Science
   Foundation of Jiangsu Province of China (no. BK20141436).
CR Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255
   Chen ZG, 2014, MAT SCI ENG C-MATER, V45, P94, DOI 10.1016/j.msec.2014.08.060
   D'Este M, 2013, ACTA BIOMATER, V9, P5421, DOI 10.1016/j.actbio.2012.11.022
   D'Este M, 2012, CARBOHYD POLYM, V90, P1378, DOI 10.1016/j.carbpol.2012.07.007
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   Gan Shao-lei, 2006, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V28, P710
   Ghanaati S, 2011, ACTA BIOMATER, V7, P4018, DOI 10.1016/j.actbio.2011.07.003
   Ginebra MP, 2012, ADV DRUG DELIVER REV, V64, P1090, DOI 10.1016/j.addr.2012.01.008
   Han Y, 2013, ACTA BIOMATER, V9, P9107, DOI 10.1016/j.actbio.2013.06.022
   Hu NM, 2012, J MECH BEHAV BIOMED, V12, P119, DOI 10.1016/j.jmbbm.2011.12.007
   Huang Z, 2011, MAT SCI ENG C-MATER, V31, P683, DOI 10.1016/j.msec.2010.12.014
   Huang Z, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/5/055005
   KAZAMA JJ, 1993, BONE, V14, P885, DOI 10.1016/8756-3282(93)90319-6
   Khanarian NT, 2012, TISSUE ENG PT A, V18, P533, DOI [10.1089/ten.tea.2011.0279, 10.1089/ten.TEA.2011.0279]
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Li XM, 2014, J BIOMED MATER RES A, V102, P1580, DOI 10.1002/jbm.a.34801
   Li XM, 2014, J BIOMED MATER RES A, V102, P1092, DOI 10.1002/jbm.a.34774
   Li XM, 2012, BIOMATERIALS, V33, P4818, DOI 10.1016/j.biomaterials.2012.03.045
   Li XM, 2011, J BIOMED MATER RES B, V97B, P10, DOI 10.1002/jbm.b.31773
   Li XM, 2009, J BIOMED MATER RES B, V90B, P503, DOI 10.1002/jbm.b.31311
   Lian XJ, 2013, PROG NAT SCI-MATER, V23, P549, DOI 10.1016/j.pnsc.2013.11.003
   Liu H, 2006, ACTA BIOMATER, V2, P557, DOI 10.1016/j.actbio.2006.03.007
   Liu J, 2014, BONE, V67, P81, DOI 10.1016/j.bone.2014.06.040
   Liu XH, 2014, INT J POLYM SCI, DOI 10.1155/2014/238247
   Maggiano C, 2006, MOL CELL PROBE, V20, P154, DOI 10.1016/j.mcp.2005.11.009
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Navarro M, 2004, BIOMATERIALS, V25, P4233, DOI 10.1016/j.biomaterials.2003.11.012
   Pelin IM, 2009, MAT SCI ENG C-MATER, V29, P2188, DOI 10.1016/j.msec.2009.04.021
   Peng C, 2013, J BIOMATER TISS ENG, V3, P534, DOI 10.1166/jbt.2013.1117
   Scherliess R, 2011, INT J PHARMACEUT, V411, P98, DOI 10.1016/j.ijpharm.2011.03.053
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Xu HHK, 2006, BIOMATERIALS, V27, P4279, DOI 10.1016/j.biomaterials.2006.03.001
   Zheng L, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/6/065004
NR 33
TC 0
Z9 1
U1 1
U2 17
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-4110
EI 1687-4129
J9 J NANOMATER
JI J. Nanomater.
PY 2015
AR 858493
DI 10.1155/2015/858493
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CJ4GE
UT WOS:000355442000001
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Hasan, J
   Raj, S
   Yadav, L
   Chatterjee, K
AF Hasan, Jafar
   Raj, Shammy
   Yadav, Lavendra
   Chatterjee, Kaushik
TI Engineering a nanostructured "super surface" with superhydrophobic and
   superkilling properties
SO RSC ADVANCES
LA English
DT Article
ID BLACK SILICON METHOD; BIOFILM FORMATION; CONTACT ANGLES; ARRAYS;
   BIOMATERIAL; RESISTANCE; ADHESION; ETCHER; WINGS
AB We present a nanostructured "super surface" fabricated using a simple recipe based on deep reactive ion etching of a silicon wafer. The topography of the surface is inspired by the surface topographical features of dragonfly wings. The super surface is comprised of nanopillars 4 mm in height and 220 nm in diameter with random inter-pillar spacing. The surface exhibited superhydrophobicity with a static water contact angle of 154.0 degrees and contact angle hysteresis of 8.3 degrees. Bacterial studies revealed the bactericidal property of the surface against both gram negative (Escherichia coli) and gram positive (Staphylococcus aureus) strains through mechanical rupture of the cells by the sharp nanopillars. The cell viability on these nanostructured surfaces was nearly six-fold lower than on the unmodified silicon wafer. The nanostructured surface also killed mammalian cells (mouse osteoblasts) through mechanical rupture of the cell membrane. Thus, such nanostructured super surfaces could find applications for designing selfcleaning and anti-bacterial surfaces in diverse applications such as microfluidics, surgical instruments, pipelines and food packaging.
C1 [Hasan, Jafar; Raj, Shammy; Chatterjee, Kaushik] Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.
   [Yadav, Lavendra] Indian Inst Sci, Ctr Nanosci & Engn, Bangalore 560012, Karnataka, India.
RP Chatterjee, K (reprint author), Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.
EM kchatterjee@materials.iisc.ernet.in
OI Hasan, Jafar/0000-0002-0956-6145; Chatterjee,
   Kaushik/0000-0002-7204-2926
FU Wellcome Trust/DBT India Alliance for the Early Career Fellowship;
   Department of Science and Technology (DST), India; DST
FX Authors thank Mr Sumit Bahl for assistance with mammalian cell studies.
   Authors thank Ms Kriti Gupta and Prof. Sandhya Visweswariah for help
   with the fluorescence imaging of bacterial cells. J.H. acknowledges the
   financial support from the Wellcome Trust/DBT India Alliance for the
   Early Career Fellowship. K.C. acknowledges the Ramanujan fellowship from
   the Department of Science and Technology (DST), India. Financial support
   from DST is acknowledged.
CR Abdolvand R, 2008, SENSOR ACTUAT A-PHYS, V144, P109, DOI 10.1016/j.sna.2007.12.026
   Ayon AA, 1999, J ELECTROCHEM SOC, V146, P339, DOI 10.1149/1.1391611
   Bahl S, 2014, RSC ADV, V4, P38078, DOI 10.1039/c4ra05440g
   Bhushan B, 2011, PROG MATER SCI, V56, P1, DOI 10.1016/j.pmatsci.2010.04.003
   Bridier A, 2011, BIOFOULING, V27, P1017, DOI 10.1080/08927014.2011.626899
   Bucaro MA, 2012, ACS NANO, V6, P6222, DOI 10.1021/nn301654e
   Cavallaro A, 2014, BIOINTERPHASES, V9, DOI 10.1116/1.4866697
   Chatterjee K, 2011, BIOMATERIALS, V32, P1361, DOI 10.1016/j.biomaterials.2010.10.043
   Chu ZL, 2014, CHEM SOC REV, V43, P2784, DOI 10.1039/c3cs60415b
   DETTRE RH, 1965, J PHYS CHEM-US, V69, P1507, DOI 10.1021/j100889a012
   Diu T, 2014, SCI REP-UK, V4, DOI 10.1038/srep07122
   Drelich J, 1996, J COLLOID INTERF SCI, V179, P37, DOI 10.1006/jcis.1996.0186
   Elnathan R, 2014, NANO TODAY, V9, P172, DOI 10.1016/j.nantod.2014.04.001
   Epstein AK, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494007
   Feng L, 2002, ADV MATER, V14, P1857, DOI 10.1002/adma.200290020
   Gant RM, 2009, J BIOMED MATER RES A, V90A, P695, DOI 10.1002/jbm.a.32135
   Ghanbari A, 2014, SURF COAT TECH, V246, P26, DOI 10.1016/j.surfcoat.2014.02.057
   Hasan J, 2013, APPL MICROBIOL BIOT, V97, P9257, DOI 10.1007/s00253-012-4628-5
   Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017
   Hasan J, 2012, LANGMUIR, V28, P17404, DOI 10.1021/la303560w
   Ivanova EP, 2012, SMALL, V8, P2489, DOI 10.1002/smll.201200528
   Ivanova EP, 2011, APPL MICROBIOL BIOT, V91, P1149, DOI 10.1007/s00253-011-3195-5
   JANSEN H, 1995, J MICROMECH MICROENG, V5, P115, DOI 10.1088/0960-1317/5/2/015
   Jansen H, 1996, PROC IEEE MICR ELECT, P250, DOI 10.1109/MEMSYS.1996.493989
   Ji TJ, 2013, ADV MATER, V25, P3508, DOI 10.1002/adma.201300299
   Kumar G, 2011, BIOMATERIALS, V32, P9188, DOI 10.1016/j.biomaterials.2011.08.054
   Kumar S, 2015, ACS APPL MATER INTER, V7, P3237, DOI 10.1021/am5079732
   Li XM, 2007, CHEM SOC REV, V36, P1350, DOI 10.1039/b602486f
   Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098
   Liu KS, 2011, NANO TODAY, V6, P155, DOI 10.1016/j.nantod.2011.02.002
   Liu YF, 2013, IET NANOBIOTECHNOL, V7, P59, DOI 10.1049/iet-nbt.2012.0018
   Madkour AE, 2008, POLYM INT, V57, P6, DOI 10.1002/pi.2399
   Nejadnik MR, 2014, BIOMATERIALS, V35, P6918, DOI 10.1016/j.biomaterials.2014.05.003
   Nishimoto S, 2013, RSC ADV, V3, P671, DOI 10.1039/c2ra21260a
   Oh J, 2012, NAT NANOTECHNOL, V7, P743, DOI [10.1038/nnano.2012.166, 10.1038/NNANO.2012.166]
   Pignalosa P, 2012, OPT LETT, V37, P2808, DOI 10.1364/OL.37.002808
   Qi SJ, 2009, ACS APPL MATER INTER, V1, P30, DOI 10.1021/am800027d
   Shirtcliffe NJ, 2004, ADV MATER, V16, P1929, DOI 10.1002/adma.200400315
   Song Y, 2007, PROC I MECH ENG PART, V221, P41, DOI 10.1243/17403499JNN106
   Song YJ, 2011, ADV MATER, V23, P4215, DOI 10.1002/adma.201101853
   Takenaka S, 2007, APPL ENVIRON MICROB, V73, P1797, DOI 10.1128/AEM.02426-06
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   WAHLIG H, 1980, ACTA ORTHOP SCAND, V51, P49, DOI 10.3109/17453678008990768
   Walter H., 2010, NANOTECHNOLOGY, V21
   Wang ST, 2006, ADV MATER, V18, P767, DOI 10.1002/adma.200501794
   Warnes SL, 2011, APPL ENVIRON MICROB, V77, P6049, DOI 10.1128/AEM.00597-11
   Wisdom KM, 2013, P NATL ACAD SCI USA, V110, P7992, DOI 10.1073/pnas.1210770110
   Xu LC, 2012, ACTA BIOMATER, V8, P72, DOI 10.1016/j.actbio.2011.08.009
   Yan L, 2014, ADV MATER, V26, P5533, DOI 10.1002/adma.201305683
   Yu Q, 2015, ACTA BIOMATER, V16, P1, DOI 10.1016/j.actbio.2015.01.018
NR 52
TC 32
Z9 32
U1 4
U2 61
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 56
BP 44953
EP 44959
DI 10.1039/c5ra05206h
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA CI7SQ
UT WOS:000354965300028
PM 29075481
OA Bronze, Green Accepted
DA 2018-10-19
ER

PT J
AU Huang, CH
   Zhang, WM
   Yan, ZM
   Gao, J
   Liu, W
   Tong, P
   Zhang, L
AF Huang, Chuanhui
   Zhang, Wenmin
   Yan, Zhiming
   Gao, Jia
   Liu, Wei
   Tong, Ping
   Zhang, Lan
TI Protonated mesoporous graphitic carbon nitride for rapid and highly
   efficient removal of microcystins
SO RSC ADVANCES
LA English
DT Article
ID GRAPHENE OXIDE; HYDROGEN EVOLUTION; VISIBLE-LIGHT; LR; ADSORPTION;
   WATER; CYANOBACTERIA; EQUILIBRIUM; NANOSHEETS; NANOTUBES
AB Cyanotoxins have caused worldwide concern due to their diverse occurrence and toxic effects, which has led to an intensive search for cost-effective techniques for their removal from contaminated water. In this study, a novel biomaterial, protonated mesoporous graphitic carbon nitride (mpg-C3N4-H+) which is fabricated by treating mpg-C3N4 with concentrated hydrochloric acid, is applied as a promising bioadsorbent for the uptake of microcystins (MCs). The pH of the reaction media played a significant role in the removal of MCs; maximum adsorption occurred at pH 7. Kinetic studies showed that the adsorption of MC-LR and MC-RR onto the adsorbent was a rapid process. The mpgH(+) exhibited high adsorption capacities of 2360.96 and 2868.78 mu g g(-1) from the Langmuir model for MC-LR/RR, respectively. The high adsorption capacity, good solvent stability, and excellent reusability make mpg-C3N4-H+ promising as a novel adsorbent for the adsorption and removal of MCs from aqueous solution. This information may be useful for further research and practical applications of the novel two-dimensional layered, mesoporous graphitic carbon nitride.
C1 [Huang, Chuanhui; Zhang, Wenmin; Yan, Zhiming; Gao, Jia; Liu, Wei; Tong, Ping; Zhang, Lan] Fuzhou Univ, Coll Chem, Fujian Prov Key Lab Anal & Detect Technol Food Sa, Minist Educ,Key Lab Anal & Detect Food Safety, Fuzhou 350116, Fujian, Peoples R China.
   [Liu, Wei; Tong, Ping; Zhang, Lan] Fuzhou Univ, Testing Ctr, Sport Sci Res Ctr, Fuzhou 350002, Fujian, Peoples R China.
RP Zhang, L (reprint author), Fuzhou Univ, Coll Chem, Fujian Prov Key Lab Anal & Detect Technol Food Sa, Minist Educ,Key Lab Anal & Detect Food Safety, Fuzhou 350116, Fujian, Peoples R China.
EM tping@fzu.edu.cn; zlan@fzu.edu.cn
FU National Nature Sciences Foundation of China [21275029, 201405018];
   National Basic Research Program of China [2010CB732403]; 12th Five-Year
   National Science and Technology Support Program [2012BAD29B06]; Program
   for Changjiang Scholars and Innovative Research Team in University
   [IRT1116]
FX The authors are grateful for the National Nature Sciences Foundation of
   China (21275029 and 201405018), the National Basic Research Program of
   China (No. 2010CB732403), the "12th Five-Year National Science and
   Technology Support Program" (2012BAD29B06), and the Program for
   Changjiang Scholars and Innovative Research Team in University (no.
   IRT1116).
CR Bourne DG, 2006, WATER RES, V40, P1294, DOI 10.1016/j.watres.2006.01.022
   Cheng CM, 2013, ANAL CHEM, V85, P2601, DOI 10.1021/ac303263n
   Crini G, 2007, SEP PURIF TECHNOL, V53, P97, DOI 10.1016/j.seppur.2006.06.018
   De Maagd PGJ, 1999, WATER RES, V33, P677, DOI 10.1016/S0043-1354(98)00258-9
   Falconer IR, 1999, ENVIRON TOXICOL, V14, P5, DOI 10.1002/(SICI)1522-7278(199902)14:1<5::AID-TOX3>3.3.CO;2-S
   Feng LY, 2013, ADV MATER, V25, P168, DOI 10.1002/adma.201203229
   Groenewolt M, 2005, ADV MATER, V17, P1789, DOI 10.1002/adma.200401756
   Jurczak T, 2005, WATER RES, V39, P2394, DOI 10.1016/j.watres.2005.04.031
   Li XF, 2009, APPL PHYS A-MATER, V94, P387, DOI 10.1007/s00339-008-4816-4
   Lin LS, 2014, J MATER CHEM B, V2, P1031, DOI 10.1039/c3tb21479f
   Loh KP, 2010, NAT CHEM, V2, P1015, DOI 10.1038/NCHEM.907
   Merel S, 2009, CHEMOSPHERE, V74, P832, DOI 10.1016/j.chemosphere.2008.10.024
   Morris RJ, 2000, TOXICON, V38, P303, DOI 10.1016/S0041-0101(99)00149-X
   Pavagadhi S, 2013, WATER RES, V47, P4621, DOI 10.1016/j.watres.2013.04.033
   Ramesh S, 2004, J PHYS CHEM B, V108, P8794, DOI 10.1021/jp036971t
   Sathishkumar M, 2010, J HAZARD MATER, V184, P417, DOI 10.1016/j.jhazmat.2010.08.051
   Shen PP, 2003, ENVIRON INT, V29, P641, DOI 10.1016/S0160-4120(03)00047-3
   Su FZ, 2012, CATAL SCI TECHNOL, V2, P1005, DOI 10.1039/c2cy00012a
   Svrcek C, 2004, J ENVIRON ENG SCI, V3, P155, DOI 10.1139/S04-010
   Takanabe K, 2010, PHYS CHEM CHEM PHYS, V12, P13020, DOI 10.1039/c0cp00611d
   Teng W, 2013, ENERG ENVIRON SCI, V6, P2765, DOI 10.1039/c3ee41775a
   Teng W, 2013, ENVIRON SCI TECHNOL, V47, P8633, DOI 10.1021/es400659b
   Vadivelan V, 2005, J COLLOID INTERF SCI, V286, P90, DOI 10.1016/j.jcis.2005.01.007
   Wang L, 2010, DESALINATION, V254, P68, DOI 10.1016/j.desal.2009.12.012
   Wang X., 2008, NAT MATER, V8, P76
   Wang XC, 2009, ADV MATER, V21, P1609, DOI 10.1002/adma.200802627
   Wang XC, 2009, J AM CHEM SOC, V131, P1680, DOI 10.1021/ja809307s
   Wu XQ, 2011, ENVIRON SCI TECHNOL, V45, P2641, DOI 10.1021/es103729m
   Xia W, 2013, RSC ADV, V3, P11007, DOI 10.1039/c3ra40741a
   Yan H, 2006, CHEMOSPHERE, V62, P142, DOI 10.1016/j.chemosphere.2005.03.075
   Yang SB, 2013, ADV MATER, V25, P2452, DOI 10.1002/adma.201204453
   Zhang XD, 2014, ADV MATER, V26, P4438, DOI 10.1002/adma.201400111
   Zhang Y. J., 2008, J AM CHEM SOC, V131, P50
   Zhang YJ, 2010, CHEM-ASIAN J, V5, P1307, DOI 10.1002/asia.200900685
   Zhao YC, 2005, J MATER SCI, V40, P2645, DOI 10.1007/s10853-005-2096-3
NR 35
TC 6
Z9 6
U1 4
U2 40
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 56
BP 45368
EP 45375
DI 10.1039/c5ra01415h
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CI7SQ
UT WOS:000354965300073
DA 2018-10-19
ER

PT J
AU Shikha, D
   Jha, U
   Sinha, SK
   Nair, KGM
   Tyagi, AK
AF Shikha, Deep
   Jha, Usha
   Sinha, S. K.
   Nair, K. G. M.
   Tyagi, A. K.
TI Nitrogen Ion Beam Modification of Alumina for Hard Tissue Implants
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT 3rd International Conference on Science and Engineering (ICSEM)
CY JAN 06-08, 2014
CL Sharda Univ, Noida, INDIA
SP Mat Res Lab
HO Sharda Univ
DE alumina; biomaterial; ion dose; ion implantation; nitrogen
ID FILMS
AB Alumina has wide applications in industry, automobiles, electrical appliances etc. However its application as biomaterial has started recently. We propose to improve the bio- physical, bio- chemical and bio-medical properties of alumina for its application as biomaterial by nitrogen ion implantation. Alumina is implanted with nitrogen ions at different energies (30 keV to 90 keV) and various ion doses (1 x 10(15) ions/cm(2) to 5 x 10(17) ions/cm(2)). The microstructural changes and surface roughness of the specimens are characterized using Optical Microscope, Scanning Electron Microscope (SEM) and Atomic Force Microscope (AFM). Nanolayered compound formation of nitrides & oxynitrides were observed using Glancing angle X- ray Diffraction (GXRD). Mechanical changes like hardness are studied using nanoindentation method. It is observed that corrosion resistance studied using Electrochemical analyzer (ECA) increases at lower energy and at intermediate ion dose. At higher energy and higher ion doses corrosion resistance deteriorates which is in co-ordinance with the micrstructural analysis. Bio-medical characterization of the specimens has been carried out by Wettability and Thrombogenicity tests. Wettability decreases in comparison with unimplanted samples. The thrombogenicity of unimplanted and implanted samples were evaluated using a whole blood kinetic clotting time method. From thrombogenicity test, it is concluded that at lower energy, thrombogenicity increases whereas for higher energy thrombogenicity decreases in comparison with the unimplanted samples. On the basis of all the above studies, best suitable energy and ion-dose is decided for the hard tissue replacement by alumina.
C1 [Shikha, Deep; Jha, Usha] BIT Mesra, Dept Appl Chem, Ranchi 835215, Jharkhand, India.
   [Sinha, S. K.] BIT Mesra, Dept Appl Phys, Ranchi 835215, Jharkhand, India.
   [Nair, K. G. M.; Tyagi, A. K.] Indira Gandhi Ctr Atom Res, Kalpakkam 603102, Tamil Nadu, India.
RP Shikha, D (reprint author), BIT Mesra, Dept Appl Chem, Ranchi 835215, Jharkhand, India.
EM deepshikha1011@gmail.com
CR Azevedo AF, 2005, SURF COAT TECH, V194, P271, DOI 10.1016/j.surfcoat.2004.10.007
   BIERSACK JP, 1980, NUCL INSTRUM METHODS, V174, P257, DOI 10.1016/0029-554X(80)90440-1
   Delgado-Alvarado P. A. Sundaram, 2006, ACTA BIOMATER, V2, P701
   Halitim F, 1997, J PHYS D APPL PHYS, V30, P330, DOI 10.1088/0022-3727/30/3/004
   HEIMKE G, 1989, ANGEW CHEM INT EDIT, V28, P111, DOI 10.1002/anie.198901111
   Heimke G., 1986, HDB BIOMATERIAL EVOL
   Hong J, 2005, BIOMATERIALS, V26, P1397, DOI 10.1016/j.biomaterials.2004.05.036
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   Hulbert S. F., 1993, INTRO BIOCERAMICS
   IMAI Y, 1972, J BIOMED MATER RES, V6, P165, DOI 10.1002/jbm.820060305
   Jagielski J, 2006, SURF COAT TECH, V200, P6355, DOI 10.1016/j.surfcoat.2005.11.005
   Liu ZS, 2006, MATER CHEM PHYS, V99, P75, DOI 10.1016/j.matchemphys.2005.09.088
   Motlagh D., 2006, BIOMATERIALS
   Shikha D, 2008, INT J APPL CERAM TEC, V5, P44, DOI 10.1111/j.1744-7402.2008.02184.x
   Shikha D, 2007, NUCL INSTRUM METH B, V264, P254, DOI 10.1016/j.nimb.2007.08.093
   Sinha SK, 2002, SURF COAT TECH, V158, P214, DOI 10.1016/S0257-8972(02)00210-4
   Vlcak P, 2013, J NANOMATER, DOI 10.1155/2013/475758
   Wang MC, 2001, J MATER SCI, V36, P3283, DOI 10.1023/A:1017907024197
   Zeigler J. F., 2003, SRIM COM
NR 19
TC 0
Z9 1
U1 0
U2 6
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1360
EI 1521-3900
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JAN
PY 2015
VL 347
IS 1
SI SI
BP 39
EP 48
DI 10.1002/masy.201400037
PG 10
WC Polymer Science
SC Polymer Science
GA AZ9WM
UT WOS:000348564800006
DA 2018-10-19
ER

PT J
AU Lewis, KJR
   Tibbitt, MW
   Zhao, Y
   Branchfield, K
   Sun, X
   Balasubramaniam, V
   Anseth, KS
AF Lewis, Katherine J. R.
   Tibbitt, Mark W.
   Zhao, Yi
   Branchfield, Kelsey
   Sun, Xin
   Balasubramaniam, Vivek
   Anseth, Kristi S.
TI In vitro model alveoli from photodegradable microsphere templates
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID EPITHELIAL-CELLS; EXTRACELLULAR-MATRIX; 3-DIMENSIONAL CULTURE; II CELLS;
   MECHANICAL-PROPERTIES; SYNTHETIC MATRIX; LUNG DEVELOPMENT;
   GENE-EXPRESSION; STEM-CELLS; TISSUE
AB Recreating the 3D cyst-like architecture of the alveolar epithelium in vitro has been challenging to achieve in a controlled fashion with primary lung epithelial cells. Here, we demonstrate model alveoli formed within a tunable synthetic biomaterial platform using photodegradable microspheres as templates to create physiologically relevant, cyst structures. Poly(ethylene glycol) (PEG)-based hydrogels were polymerized in suspension to form microspheres on the order of 120 mu m in diameter. The gel chemistry was designed to allow erosion of the microspheres with cytocompatible light doses (<= 15 min exposure to 10 mW cm(-2) of 365 nm light) via cleavage of a photolabile nitrobenzyl ether crosslinker. Epithelial cells were incubated with intact microspheres, modified with adhesive peptide sequences to facilitate cellular attachment to and proliferation on the surface. A tumor-derived alveolar epithelial cell line, A549, completely covered the microspheres after only 24 hours, whereas primary mouse alveolar epithelial type II (ATII) cells took similar to 3 days. The cell-laden microsphere structures were embedded within a second hydrogel formulation at user defined densities; the microsphere templates were subsequently removed with light to render hollow epithelial cysts that were cultured for an additional 6 days. The resulting primary cysts stained positive for cell-cell junction proteins (beta-catenin and ZO-1), indicating the formation of a functional epithelial layer. Typically, primary ATII cells differentiated in culture to the alveolar epithelial type I (ATI) phenotype; however, each cyst contained similar to 1-5 cells that stained positive for an ATII marker (surfactant protein C), which is consistent with ATII cell numbers in native mouse alveoli. This biomaterial-templated alveoli culture system should be useful for future experiments to study lung development and disease progression, and is ideally suited for co-culture experiments where pulmonary fibroblasts or endothelial cells could be presented in the hydrogel surrounding the epithelial cysts.
C1 [Lewis, Katherine J. R.; Tibbitt, Mark W.; Zhao, Yi; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, BioFrontiers Inst, Boulder, CO 80303 USA.
   [Lewis, Katherine J. R.; Tibbitt, Mark W.; Zhao, Yi; Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80303 USA.
   [Branchfield, Kelsey; Sun, Xin] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.
   [Balasubramaniam, Vivek] Univ Colorado, Pediat Heart Lung Ctr Lab, Denver, CO 80202 USA.
RP Lewis, KJR (reprint author), Univ Colorado, Dept Chem & Biol Engn, BioFrontiers Inst, 3415 Colorado Ave,596 UCB, Boulder, CO 80303 USA.
EM kristi.anseth@colorado.edu
OI Tibbitt, Mark/0000-0002-4917-7187
FU National Science Foundation [CTS1236662]; Howard Hughes Medical
   Institute
FX The authors would like to thank Emi Kiyotake for histological
   sectioning, particle tracking, and image analysis and Sharon Ryan for
   mouse cell isolations. This work was supported in part by a grant from
   the National Science Foundation (CTS1236662) and the Howard Hughes
   Medical Institute.
CR Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782
   Bellusci S, 1997, DEVELOPMENT, V124, P4867
   Benton JA, 2009, BIOMATERIALS, V30, P6593, DOI 10.1016/j.biomaterials.2009.08.031
   Bhaskaran M, 2007, J BIOL CHEM, V282, P3968, DOI 10.1074/jbc.M609060200
   Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013
   Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016
   Burri PH, 2006, BIOL NEONATE, V89, P313, DOI 10.1159/000092868
   Carterson AJ, 2005, INFECT IMMUN, V73, P1129, DOI 10.1128/IAI.73.2.1129-1140.2005
   Cavalcante FSA, 2005, J APPL PHYSIOL, V98, P672, DOI 10.1152/japplphysiol.00619.2004
   Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009
   Ernst D, 2013, PHYS CHEM CHEM PHYS, V15, P845, DOI 10.1039/c2cp43433d
   Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172
   Gill BJ, 2012, CANCER RES, V72, P6013, DOI 10.1158/0008-5472.CAN-12-0895
   Gould ST, 2012, ACTA BIOMATER, V8, P3201, DOI 10.1016/j.actbio.2012.05.009
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Guillot L, 2013, INT J BIOCHEM CELL B, V45, P2568, DOI 10.1016/j.biocel.2013.08.009
   Herzog Erica L, 2008, Proc Am Thorac Soc, V5, P778, DOI 10.1513/pats.200803-028HR
   Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012
   Isakson BE, 2001, AM J PHYSIOL-CELL PH, V281, pC1291
   Isakson BE, 2002, IN VITRO CELL DEV-AN, V38, P443, DOI 10.1290/1071-2690(2002)038<0443:HCOPAE>2.0.CO;2
   Kitaoka H, 2007, J PHYSIOL SCI, V57, P175, DOI 10.2170/physiolsci.RP000807
   Kloxin AM, 2012, INTEGR BIOL-UK, V4, P1540, DOI 10.1039/c2ib20212c
   Kloxin AM, 2010, NAT PROTOC, V5, P1867, DOI 10.1038/nprot.2010.139
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kyburz KA, 2013, ACTA BIOMATER, V9, P6381, DOI 10.1016/j.actbio.2013.01.026
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Lewis KJR, 2013, MRS BULL, V38, P260, DOI 10.1557/mrs.2013.54
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076
   Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x
   MATTER ML, 1994, J CELL BIOL, V124, P1083, DOI 10.1083/jcb.124.6.1083
   McKinnon DD, 2013, BIOMATER SCI-UK, V1, P460, DOI 10.1039/c3bm00166k
   Michalet X, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041914
   Mondrinos MJ, 2006, TISSUE ENG, V12, P717, DOI 10.1089/ten.2006.12.717
   Montesano R, 2002, J CELL SCI, V115, P4419, DOI 10.1242/jcs.00164
   O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859
   Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-11070C
   Park WY, 1998, DEV BIOL, V201, P125, DOI 10.1006/dbio.1998.8994
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Perl AKT, 2009, AM J PHYSIOL-LUNG C, V297, pL299, DOI 10.1152/ajplung.00008.2009
   Prasad S, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-7
   Qiao R, 2008, AM J RESP CELL MOL, V38, P239, DOI 10.1165/rcmb.2007-0172OC
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Schumacher KM, 2008, KIDNEY INT, V73, P1187, DOI 10.1038/ki.2008.20
   Sharp JA, 2006, MATRIX BIOL, V25, P430, DOI 10.1016/j.matbio.2006.05.003
   Shenoy R, 2013, CHEM MATER, V25, P761, DOI 10.1021/cm303913f
   Soutiere SE, 2004, RESP PHYSIOL NEUROBI, V140, P283, DOI 10.1016/j.resp.2004.02.003
   Sugahara K, 2006, RESPIROLOGY, V11, pS28, DOI 10.1111/j.1440-1843.2006.00804.x
   SUGIHARA H, 1993, AM J PATHOL, V142, P783
   Tang N, 2011, SCIENCE, V333, P342, DOI 10.1126/science.1204831
   Tibbitt MW, 2013, MACROMOLECULES, V46, P2785, DOI 10.1021/ma302522x
   Tibbitt MW, 2012, J BIOMED MATER RES A, V100A, P1647, DOI 10.1002/jbm.a.34107
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Uhal BD, 1997, AM J PHYSIOL-LUNG C, V272, pL1031
   Umino T, 2000, AM J RESP CELL MOL, V22, P702, DOI 10.1165/ajrcmb.22.6.3806
   Wang JR, 2007, AM J RESP CELL MOL, V36, P661, DOI 10.1165/rcmb.2006-0410OC
   Williams MC, 2003, ANNU REV PHYSIOL, V65, P669, DOI 10.1146/annurev.physiol.65.092101.142446
   Yano T, 2000, AM J PHYSIOL-LUNG C, V279, pL1146
   Yu W, 2007, MOL BIOL CELL, V18, P1693, DOI 10.1091/mbc.E06-11-1052
NR 61
TC 12
Z9 12
U1 4
U2 24
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2015
VL 3
IS 6
BP 821
EP 832
DI 10.1039/c5bm00034c
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA CI5IX
UT WOS:000354790100005
PM 26221842
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Lee, Y
   Bae, JW
   Thi, TTH
   Park, KM
   Park, KD
AF Lee, Yunki
   Bae, Jin Woo
   Thi, Thai Thanh Hoang
   Park, Kyung Min
   Park, Ki Dong
TI Injectable and mechanically robust 4-arm PPO-PEO/graphene oxide
   composite hydrogels for biomedical applications
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID CROSS-LINKABLE GELATIN; GRAPHENE OXIDE; THERMOSENSITIVE HYDROGELS;
   POLY(VINYL ALCOHOL); POLYMER COMPOSITES; HYBRID HYDROGELS; TOUGH
   HYDROGELS; DRUG-DELIVERY; OXIDATION; BIOCOMPATIBILITY
AB Graphene-based nanomaterials with different oxidation degrees were incorporated into Tetronic-tyramine (Tet-TA) hydrogels via enzymatic cross-linking. The molecular oxidation of graphene in combination with amphiphilic Tet-TA significantly improved the water dispersibility of graphene oxide (GO), resulting in a significant reinforcement of Tet-TA/GO composite hydrogels that can be used as an injectable biomaterial platform.
C1 [Lee, Yunki; Bae, Jin Woo; Thi, Thai Thanh Hoang; Park, Ki Dong] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea.
   [Park, Kyung Min] Incheon Natl Univ, Div Bioengn, Inchon 406772, South Korea.
RP Park, KD (reprint author), Ajou Univ, Dept Mol Sci & Technol, San 5, Suwon 443749, South Korea.
EM kdp@ajou.ac.kr
FU National Research Foundation of Korea (NRF) grant - Ministry of Science,
   ICT & Future Planning [NRF-2012R1A2A2A06046885]; Ministry of Education
   [NRF-2009-0093826]
FX This work was supported by Basic Science Research Program through the
   National Research Foundation of Korea (NRF) grant funded by the Ministry
   of Science, ICT & Future Planning (NRF-2012R1A2A2A06046885), and the
   Ministry of Education (NRF-2009-0093826).
CR Bae JW, 2015, J TISSUE ENG REGEN M, V9, P1225, DOI 10.1002/term.1917
   Balazs AC, 2006, SCIENCE, V314, P1107, DOI 10.1126/science.1130557
   Cha CY, 2014, SMALL, V10, P514, DOI 10.1002/smll.201302182
   Chen J, 2012, ADV MATER, V24, P4569, DOI 10.1002/adma.201201978
   Chiu CF, 2013, J AM CHEM SOC, V135, P13356, DOI 10.1021/ja400699y
   Choi I, 2013, LANGMUIR, V29, P9761, DOI 10.1021/la401597p
   Darnell MC, 2013, BIOMATERIALS, V34, P8042, DOI 10.1016/j.biomaterials.2013.06.061
   Fan HL, 2010, BIOMACROMOLECULES, V11, P2345, DOI 10.1021/bm100470q
   Goenka S, 2014, J CONTROL RELEASE, V173, P75, DOI 10.1016/j.jconrel.2013.10.017
   Hu KS, 2014, PROG POLYM SCI, V39, P1934, DOI 10.1016/j.progpolymsci.2014.03.001
   Jun I, 2012, ADV FUNCT MATER, V22, P4060, DOI 10.1002/adfm.201200667
   Kim DW, 2013, BIOMATERIALS, V34, P8258, DOI 10.1016/j.biomaterials.2013.07.071
   Kim J, 2010, J AM CHEM SOC, V132, P8180, DOI 10.1021/ja102777p
   Krishnamoorthy K, 2013, CARBON, V53, P38, DOI 10.1016/j.carbon.2012.10.013
   Kuilla T, 2010, PROG POLYM SCI, V35, P1350, DOI 10.1016/j.progpolymsci.2010.07.005
   Kurisawa M, 2005, CHEM COMMUN, P4312, DOI 10.1039/b506989k
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee SH, 2014, ADV FUNCT MATER, V24, P6771, DOI 10.1002/adfm.201401110
   Li YL, 2012, CHEM SOC REV, V41, P2193, DOI 10.1039/c1cs15203c
   Liang JJ, 2009, ADV FUNCT MATER, V19, P2297, DOI 10.1002/adfm.200801776
   Liu RQ, 2012, J MATER CHEM, V22, P14160, DOI [10.1039/c2jm32541, 10.1039/c2jm32541a]
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Park KM, 2011, SOFT MATTER, V7, P986, DOI 10.1039/c0sm00612b
   Park KM, 2012, BIOMACROMOLECULES, V13, P604, DOI 10.1021/bm201712z
   Qiu Y, 2014, NANOSCALE, V6, P11744, DOI 10.1039/c4nr03275f
   Rourke JP, 2011, ANGEW CHEM INT EDIT, V50, P3173, DOI 10.1002/anie.201007520
   Sahu A, 2012, CHEM COMMUN, V48, P5820, DOI 10.1039/c2cc31862h
   Seabra AB, 2014, CHEM RES TOXICOL, V27, P159, DOI 10.1021/tx400385x
   Sengupta R, 2011, PROG POLYM SCI, V36, P638, DOI 10.1016/j.progpolymsci.2010.11.003
   Seo JWT, 2011, J PHYS CHEM LETT, V2, P1004, DOI 10.1021/jz2003556
   Shin SR, 2013, ADV MATER, V25, P6385, DOI 10.1002/adma.201301082
   Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409
   Zhang L, 2011, J MATER CHEM, V21, P10399, DOI 10.1039/c0jm04043f
   Zhao X, 2010, MACROMOLECULES, V43, P2357, DOI 10.1021/ma902862u
   Zhao XH, 2014, SOFT MATTER, V10, P672, DOI 10.1039/c3sm52272e
NR 35
TC 12
Z9 12
U1 2
U2 58
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PY 2015
VL 51
IS 42
BP 8876
EP 8879
DI 10.1039/c5cc02511g
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA CI1CG
UT WOS:000354477600036
PM 25925723
DA 2018-10-19
ER

PT S
AU Yada, SH
   Terakaw, M
AF Yada, Shuhei
   Terakaw, Mitsuhiro
BE Heisterkamp, A
   Herman, PR
   Meunier, M
   Nolte, S
TI Optical and thermal properties in ultrafast laser surface
   nanostructuring on biodegradable polymer
SO FRONTIERS IN ULTRAFAST OPTICS: BIOMEDICAL, SCIENTIFIC, AND INDUSTRIAL
   APPLICATIONS XV
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Frontiers in Ultrafast Optics - Biomedical, Scientific,
   and Industrial Applications XV
CY FEB 08-10, 2015
CL San Francisco, CA
SP SPIE, Amplitude Syst, APE GmbH, TRUMPF Inc
DE Biodegradable; PLLA; LIPSS; Femtosecond Laser
ID FEMTOSECOND LASER; TOPOGRAPHICAL CONTROL; FILM; FABRICATION; MICRO
AB We investigate the effect of optical and thermal properties in laser-induced periodic surface structures (LIPSS) formation on a poly-L-lactic acid (PLLA), a biodegradable polymer. Surface properties of biomaterials are known to be one of the key factors in tissue engineering. Methods to process biomaterial surfaces have been studied widely to enhance cell adhesive and anisotropic properties. LIPSS formation has advantages in a dry processing which is able to process complex-shaped surfaces without using a toxic chemical component. LIPSS, however, was difficult to be formed on PLLA due to its thermal and optical properties compared to other polymers. To obtain new perspectives in effect of these properties above, LIPSS formation dependences on wavelength, pulse duration and repetition rate have been studied. At 800 nm of incident wavelength, high-spatial frequency LIPSS (HSFL) was formed after applying 10000 femtosecond pulses at 1.0 J/cm(2) in laser fluence. At 400 nm of the wavelength, HSFL was formed at fluences higher than 0.20 J/cm(2) with more than 3000 pulses. Since LIPSS was less formed with lower repetition rate, certain heat accumulation may be required for LIPSS formation. With the pulse duration of 2.0 ps, higher laser fluence as well as number of pulses compared to the case of 120 fs was necessary. This indicates that multiphoton absorption process is essential for LIPSS formation. Study on biodegradation modification was also performed.
C1 [Yada, Shuhei; Terakaw, Mitsuhiro] Keio Univ, Sch Integrated Design Engn, Yokohama, Kanagawa 2238522, Japan.
   [Terakaw, Mitsuhiro] Keio Univ, Dept Elect & Elect Engn, Yokohama, Kanagawa 2238522, Japan.
RP Yada, SH (reprint author), Keio Univ, Sch Integrated Design Engn, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.
CR Aguilar CA, 2005, BIOMATERIALS, V26, P7642, DOI 10.1016/j.biomaterials.2005.04.053
   Altomare L, 2010, ACTA BIOMATER, V6, P1948, DOI 10.1016/j.actbio.2009.12.040
   Baudach S, 1999, APPL PHYS A-MATER, V69, pS395, DOI 10.1007/s003390051424
   Beamson G, 1996, POLYMER, V37, P379, DOI 10.1016/0032-3861(96)82906-5
   Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322
   BOLLE M, 1993, APPL SURF SCI, V69, P31, DOI 10.1016/0169-4332(93)90478-T
   Bonse J, 2012, J LASER APPL, V24, DOI 10.2351/1.4712658
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Eaton SM, 2005, OPT EXPRESS, V13, P4708, DOI 10.1364/OPEX.13.004708
   Forster M, 2011, PHYS CHEM CHEM PHYS, V13, P4155, DOI 10.1039/c0cp01798a
   Kaiser JP, 2006, BIOMATERIALS, V27, P5230, DOI 10.1016/j.biomaterials.2006.06.002
   Kaneko Y., 2011, P IEEE, P1918
   Kuetemeyer K, 2009, APPL PHYS B-LASERS O, V97, P695, DOI 10.1007/s00340-009-3746-y
   Lizundia E, 2012, POLYMER, V53, P2412, DOI 10.1016/j.polymer.2012.03.046
   Lu Y, 2004, ADV DRUG DELIVER REV, V56, P1621, DOI 10.1016/j.addr.2004.05.002
   NIKOGOSYAN DN, 1983, CHEM PHYS, V77, P131, DOI 10.1016/0301-0104(83)85070-8
   Oya K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.125203
   Perez S., 2012, APPL PHYS A, V110, P683
   Rebollar E, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3679103
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shinonaga T, 2014, APPL SURF SCI, V288, P649, DOI 10.1016/j.apsusc.2013.10.090
   Vozzi G, 2003, BIOMATERIALS, V24, P2533, DOI 10.1016/S0142-9612(03)00052-8
NR 24
TC 0
Z9 0
U1 1
U2 10
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-1-62841-445-5
J9 PROC SPIE
PY 2015
VL 9355
AR UNSP 935503
DI 10.1117/12.2080483
PG 7
WC Engineering, Biomedical; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BC6OP
UT WOS:000354259800002
DA 2018-10-19
ER

PT S
AU Widodo
AF Widodo
BE Sandhu, A
   Okada, H
   Boutchich, M
   Maenosono, S
   Wadhwa, R
TI Bioinformatics: Cheap and Robust Method to Explore Biomaterial from
   Indonesia Biodiversity
SO IRAGO CONFERENCE 2014
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT Irago Conference
CY NOV 06-07, 2014
CL Natl Inst Adv Ind Sci & Technol, Tsukuba, JAPAN
SP Tahara Low Carbon Greenhouse Hort Convent, Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst
HO Natl Inst Adv Ind Sci & Technol
DE bioinformatics; Virtual screening; Protein-protein interaction; pathway
   analysis; biomaterial
AB Indonesia has a huge amount of biodiversity, which may contain many biomaterials for pharmaceutical application. These resources potency should be explored to discover new drugs for human wealth. However, the bioactive screening using conventional methods is very expensive and time-consuming. Therefore, we developed a methodology for screening the potential of natural resources based on bioinformatics. The method is developed based on the fact that organisms in the same taxon will have similar genes, metabolism and secondary metabolites product. Then we employ bioinformatics to explore the potency of biomaterial from Indonesia biodiversity by comparing species with the well-known taxon containing the active compound through published paper or chemical database. Then we analyze drug-likeness, bioactivity and the target proteins of the active compound based on their molecular structure. The target protein was examined their interaction with other proteins in the cell to determine action mechanism of the active compounds in the cellular level, as well as to predict its side effects and toxicity. By using this method, we succeeded to screen anti-cancer, immunomodulators and anti-inflammation from Indonesia biodiversity. For example, we found anticancer from marine invertebrate by employing the method. The anti-cancer was explore based on the isolated compounds of marine invertebrate from published article and database, and then identified the protein target, followed by molecular pathway analysis. The data suggested that the active compound of the invertebrate able to kill cancer cell. Further, we collect and extract the active compound from the invertebrate, and then examined the activity on cancer cell (MCF7). The MTT result showed that the methanol extract of marine invertebrate was highly potent in killing MCF7 cells. Therefore, we concluded that bioinformatics is cheap and robust way to explore bioactive from Indonesia biodiversity for source of drug and another pharmaceutical material.
C1 Univ Brawijaya, Fac Math & Nat Sci, Dept Biol, Malang, Indonesia.
RP Widodo (reprint author), Univ Brawijaya, Fac Math & Nat Sci, Dept Biol, Malang, Indonesia.
EM widodo@ub.ac.id
CR Engel S, 2006, ENVIRON RESOUR ECON, V33, P73, DOI 10.1007/s10640-005-1706-5
   Franceschini A. L., 2013, NUCL ACIDS RES, V41
   Henley D, 2008, HUM ECOL, V36, P273, DOI 10.1007/s10745-007-9137-2
   Jensen L. J., 2009, NUCL ACIDS RES, V37
   Liu XP, 2013, BIOINFORMATICS, V29, P1910, DOI 10.1093/bioinformatics/btt303
   Mi H, 2007, NUCL ACIDS RES, V35
   Szklarczyk D, 2011, NUCL ACIDS RES, V39
   von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034
NR 8
TC 0
Z9 0
U1 0
U2 2
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1291-0
J9 AIP CONF PROC
PY 2015
VL 1649
BP 148
EP 151
DI 10.1063/1.4913560
PG 4
WC Physics, Applied
SC Physics
GA BC7HN
UT WOS:000354882800025
DA 2018-10-19
ER

PT J
AU Kim, YS
   Youe, WJ
   Kim, SJ
   Lee, OK
   Lee, SS
AF Kim, Yong Sik
   Youe, Won-Jae
   Kim, Seok Ju
   Lee, Oh-Kyu
   Lee, Sung-Suk
TI Preparation of a Thermoplastic Lignin-Based Biomaterial through Atom
   Transfer Radical Polymerization
SO JOURNAL OF WOOD CHEMISTRY AND TECHNOLOGY
LA English
DT Article
DE Lignin modification; ATRP; biomaterials; polystyrene; thermoplastic
   copolymers
ID GRAFT-COPOLYMERIZATION; N-ISOPROPYLACRYLAMIDE; METHYL-METHACRYLATE;
   CHEMICALS; CELLULOSE
AB Graft copolymerization of styrene onto kraft lignin (KL) was achieved by atom transfer radical polymerization (ATRP) using a fully substituted lignin-based macroinitiator (KLM). The number average of molecular mass (M-n) of polystyrene copolymer graft side-chains was achieved by varying the ratio of the DMF: water solvent system from 5:0 to 1:4. A M-n of up to approximate to 206,000 was obtained using a DMF/water ratio of 3:2 (v/v). However, as the M-n increased, the overall ATRP became less controlled. In addition, the thermal properties of the lignin-g-polystyrene copolymers improved significantly with increasing M-n of polystyrene copolymer side-chains.
C1 [Kim, Yong Sik; Youe, Won-Jae; Kim, Seok Ju; Lee, Oh-Kyu; Lee, Sung-Suk] Korea Forest Res Inst, Div Wood Chem & Microbiol, Seoul 130712, South Korea.
RP Kim, YS (reprint author), Korea Forest Res Inst, Div Wood Chem & Microbiol, 57 Hoegiro, Seoul 130712, South Korea.
EM yskim@forest.go.kr
FU Korea Forest Research Institute
FX The authors thank the Korea Forest Research Institute for financial
   support.
CR Alder E., 1977, WOOD SCI TECHNOL, V11, P169, DOI DOI 10.1007/BF00365615
   Bokias G, 2001, MACROMOLECULES, V34, P4958, DOI 10.1021/ma010154e
   Capanema EA, 2004, J AGR FOOD CHEM, V52, P1850, DOI 10.1021/jf035282b
   CHEN RL, 1986, J APPL POLYM SCI, V32, P4815, DOI 10.1002/app.1986.070320504
   Coessens V, 2001, PROG POLYM SCI, V26, P337, DOI 10.1016/S0079-6700(01)00003-X
   COOK PM, 1989, ACS SYM SER, V397, P324
   de Wild P, 2009, ENVIRON PROG SUSTAIN, V28, P461, DOI 10.1002/ep.10391
   Demirbas A, 2009, ENERG CONVERS MANAGE, V50, P2782, DOI 10.1016/j.enconman.2009.06.035
   FREUDENBERG K, 1965, SCIENCE, V148, P595, DOI 10.1126/science.148.3670.595
   Gao GZ, 2012, BIOMACROMOLECULES, V13, P3602, DOI 10.1021/bm301039f
   GLASSER WG, 1989, ACS SYM SER, V385, P43, DOI 10.1021/bk-1989-0385.ch004
   Gupta KC, 2003, BIOMACROMOLECULES, V4, P758, DOI 10.1021/bm020135s
   HUANG YF, 1992, J APPL POLYM SCI, V45, P71, DOI 10.1002/app.1992.070450108
   Ifuku S, 2008, BIOMACROMOLECULES, V9, P3308, DOI 10.1021/bm800911w
   Kennedy J. F., 1992, LIGNOCELLULOSIC SCI, P613
   Kim YS, 2010, BIOMACROMOLECULES, V11, P981, DOI 10.1021/bm901455p
   Lapierre C, 2000, J AGR FOOD CHEM, V48, P2326, DOI 10.1021/jf991398p
   Mai C, 2000, ENZYME MICROB TECH, V27, P167, DOI 10.1016/S0141-0229(00)00214-3
   Masci G, 2004, MACROMOL RAPID COMM, V25, P559, DOI 10.1002/marc.200300140
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   MEISTER JJ, 1984, J APPL POLYM SCI, V29, P3457, DOI 10.1002/app.1984.070291122
   Prade RA, 1996, BIOTECHNOL GENET ENG, V13, P101, DOI 10.1080/02648725.1996.10647925
   Qin DQ, 2000, POLYMER, V41, P7347, DOI 10.1016/S0032-3861(00)00105-1
   Sarkanen K. V., 1971, LIGNINS OCCURRENCE F, P11
   Shen D, 2006, CELLULOSE, V13, P235, DOI 10.1007/s10570-005-9044-x
   Shen DW, 2004, POLYMER, V45, P7091, DOI 10.1016/j.polymer.2004.08.042
   Tsarevsky NV, 2002, MACROMOLECULES, V35, P6142, DOI 10.1021/ma020560d
   Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u
NR 28
TC 11
Z9 11
U1 4
U2 24
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0277-3813
EI 1532-2319
J9 J WOOD CHEM TECHNOL
JI J. Wood Chem. Technol.
PY 2015
VL 35
IS 4
BP 251
EP 259
DI 10.1080/02773813.2014.937006
PG 9
WC Materials Science, Paper & Wood
SC Materials Science
GA CI7HB
UT WOS:000354932700002
DA 2018-10-19
ER

PT J
AU Pieroni, L
   Mortera, SL
   Greco, V
   Sirolli, V
   Ronci, M
   Felaco, P
   Fucci, G
   De Fulviis, S
   Massoud, R
   Condo, S
   Capria, A
   Di Daniele, N
   Bernardini, S
   Urbani, A
   Bonomini, M
AF Pieroni, Luisa
   Mortera, Stefano Levi
   Greco, Viviana
   Sirolli, Vittorio
   Ronci, Maurizio
   Felaco, Paolo
   Fucci, Giorgio
   De Fulviis, Silvia
   Massoud, Renato
   Condo, Stefano
   Capria, Ambrogio
   Di Daniele, Nicola
   Bernardini, Sergio
   Urbani, Andrea
   Bonomini, Mario
TI Biocompatibility assessment of haemodialysis membrane materials by
   proteomic investigations
SO MOLECULAR BIOSYSTEMS
LA English
DT Article
ID PROTEIN ADSORPTION; COMPLEMENT ACTIVATION; PLASMA-PROTEINS;
   ANTICOAGULATION; COAGULATION; HOMEOSTASIS; RELEVANCE; THERAPY; DISEASE;
   SYSTEM
AB The exposure of blood to an artificial surface such as the haemodialysis membrane results in the nearly instantaneous deposition of a layer of plasma proteins. The composition of the protein layer profoundly influences all subsequent events, and to a large extent determines the biocompatibility of the biomaterial. In the present study, we examine the protein adsorption capacity and coagulation profiles of the polysulfone-based helixone material in comparison to cellulose triacetate. A differential profiling investigation using shotgun proteomics data-independent analysis was applied to eluates obtained with each membrane after a dialysis session, in order to assess the function of desorbed proteins. Functional classification and network analysis performed using bioinformatics tools shed light on the involvement of adsorbed proteins into important molecular processes, such as lipid transport and metabolism, cell growth differentiation and communication, and the coagulation cascade. The collected evidence was further validated by targeted mass spectrometry using selected reaction monitoring on proteotypic transitions of key protein effectors, confirming the different panels of adsorbed protein on each membrane. The coagulation profile during haemodialysis of patients under polysulfone-based helixone filter cartridges was also assessed showing a slightly higher platelet activation profile after the dialysis session. The overall collected evidence highlights a modulation of the coagulation biological pathway during haemodialysis, which is largely influenced by the biomaterial used.
C1 [Pieroni, Luisa; Mortera, Stefano Levi; Greco, Viviana; Fucci, Giorgio; Massoud, Renato; Bernardini, Sergio; Urbani, Andrea] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy.
   [Pieroni, Luisa; Mortera, Stefano Levi; Greco, Viviana; Ronci, Maurizio; Urbani, Andrea] IRCCS, Santa Lucia Fdn, Rome, Italy.
   [Sirolli, Vittorio; Felaco, Paolo; De Fulviis, Silvia; Bonomini, Mario] Univ G DAnnunzio, Dept Med, Nephrol & Dialysis Inst, Pescara, Italy.
   [Ronci, Maurizio] Univ G DAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy.
   [Ronci, Maurizio] Univ S Australia, Mawson Inst, Mawson Lakes, SA 5095, Australia.
   [Condo, Stefano; Capria, Ambrogio; Di Daniele, Nicola] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy.
RP Pieroni, L (reprint author), Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy.
OI Levi Mortera, Stefano/0000-0001-6184-0933; Ronci,
   Maurizio/0000-0002-0797-6087; Pieroni, Luisa/0000-0001-7141-1817
FU Nipro Corporation, Japan
FX The study was partially supported by unconditional grants from Nipro
   Corporation, Japan.
CR Alberio T, 2014, MOL BIOSYST, V10, P1332, DOI 10.1039/c3mb70611g
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   ANDRADE JD, 1984, PURE APPL CHEM, V56, P1345, DOI 10.1351/pac198456101345
   Aoike I, 2007, NEPHROL DIAL TRANSPL, V22, P13, DOI 10.1093/ndt/gfm295
   Bomzin G. A., 1982, J COLLOID INTERF SCI, V86, P539
   Bonomini M, 2006, J PROTEOME RES, V5, P2666, DOI 10.1021/pr060150u
   Bonomini M, 2012, J NEPHROL, V25, P865, DOI 10.5301/jn.5000217
   Chanard J, 2003, NEPHROL DIAL TRANSPL, V18, P252, DOI 10.1093/ndt/18.2.252
   Ciavardelli D, 2013, MOL BIOSYST, V9, P1117, DOI 10.1039/c3mb25594h
   Domon B, 2012, PROTEOM CLIN APPL, V6, P609, DOI 10.1002/prca.201200111
   Frank RD, 2001, KIDNEY INT, V60, P1972, DOI 10.1046/j.1523-1755.2001.00009.x
   Holman SW, 2012, BIOANALYSIS, V4, P1763, DOI 10.4155/BIO.12.126
   Horl W. H., 2002, J AM SOC NEPHROL S2, V13, P562
   Horl WH, 2002, J AM SOC NEPHROL, V13, pS62
   JOHNSON RJ, 1994, NEPHROL DIAL TRANSPL, V9, P36
   JONSSON U, 1982, J COLLOID INTERF SCI, V90, P148, DOI 10.1016/0021-9797(82)90408-8
   Kaysen GA, 2001, J AM SOC NEPHROL, V12, P1549
   Kuragano T, 2003, BLOOD PURIFICAT, V21, P176, DOI 10.1159/000069157
   Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P1272, DOI 10.1093/ndt/gfg074
   Lucchi L, 2006, ARTIF ORGANS, V30, P106, DOI 10.1111/j.1525-1594.2006.00188.x
   Maiolica A, 2012, J PROTEOMICS, V75, P3495, DOI 10.1016/j.jprot.2012.04.048
   Mares J, 2009, KIDNEY INT, V76, P404, DOI 10.1038/ki.2009.138
   Marinelli S, 2014, PAIN, V155, P93, DOI 10.1016/j.pain.2013.09.013
   Marzano V, 2012, J PROTEOMICS, V75, P4632, DOI 10.1016/j.jprot.2012.05.029
   Mason R. G., 1983, THROMBOEMBOLIC DISOR, P533
   Mi H, 2012, NUCLEIC ACIDS RES, V41, P377, DOI DOI 10.1093/NAR/GKS1118
   Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092
   Mulvihill J, 1997, NEPHROL DIAL TRANSPL, V12, P1968, DOI 10.1093/ndt/12.9.1968
   Olafiranye F, 2011, CASE REP MED, V2011
   Ouseph R, 2000, SEMIN DIALYSIS, V13, P181, DOI 10.1046/j.1525-139X.2000.00052.x
   Pavone B, 2010, BLOOD TRANSFUS-ITALY, V8, pS113, DOI 10.2450/2010.018S
   Pesic I, 2013, BBA-PROTEINS PROTEOM, V1834, P754, DOI 10.1016/j.bbapap.2013.01.021
   Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]
   Pieroni L, 2011, MOL BIOSYST, V7, P630, DOI 10.1039/c0mb00135j
   Sagedal S, 2001, NEPHROL DIAL TRANSPL, V16, P987, DOI 10.1093/ndt/16.5.987
   SAGRIPANTI A, 1993, NEPHRON, V63, P273, DOI 10.1159/000187209
   Salame M, 1999, INT J CARDIOL, V69, P231, DOI 10.1016/S0167-5273(99)00046-7
   Sun SD, 2003, J MEMBRANE SCI, V222, P3, DOI 10.1016/S0376-7388(03)00313-2
   Thongboonkerd V, 2010, J PROTEOMICS, V73, P521, DOI 10.1016/j.jprot.2009.06.003
   Urbani A., 2012, J BLOOD TRANSFUS S2, V10, pS97
   Urbani A, 2012, MOL BIOSYST, V8, P1029, DOI 10.1039/c2mb05393d
   Wermer C., 1999, INT J ARTIF ORGANS, V22, P160
NR 42
TC 14
Z9 14
U1 0
U2 8
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1742-206X
EI 1742-2051
J9 MOL BIOSYST
JI Mol. Biosyst.
PY 2015
VL 11
IS 6
BP 1633
EP 1643
DI 10.1039/c5mb00058k
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CI5JU
UT WOS:000354792500017
PM 25845767
OA Bronze
DA 2018-10-19
ER

PT J
AU Nishida, K
   Tamura, A
   Yui, N
AF Nishida, Kei
   Tamura, Atsushi
   Yui, Nobuhiko
TI Acid-labile polyrotaxane exerting endolysosomal pH-sensitive
   supramolecular dissociation for therapeutic applications
SO POLYMER CHEMISTRY
LA English
DT Article
ID HYDROLYZABLE POLYROTAXANE; BIOCLEAVABLE POLYROTAXANE;
   BETA-CYCLODEXTRINS; GENE DELIVERY; C-DISEASE; CHOLESTEROL; DRUG;
   ACIDIFICATION; MECHANISM; COPOLYMER
AB pH-sensitive polymeric materials are rational designs for therapeutics, because they can change their intrinsic properties selectively in response to pH changes in targeted tissues and organelles, such as tumor tissue, skin, inflammation sites, and intracellular endosomes and lysosomes. Herein, we describe a novel acid-labile Pluronic/beta-cyclodextrin (beta-CD)-based polyrotaxane (PRX) showing the dissociation of supramolecular interlocked structures in response to a pH change with a narrow acidic range for biomedical applications. Acid cleavable ketal linkages were introduced into both terminals of the axle polymer of the PRX (ket-PRX) to acquire acid sensitivity. The ket-PRX was sufficiently stable and maintained its supramolecular structure under physiological conditions (pH 7.4), whereas the dissociation of the ket-PRX was observed under weakly acidic pH conditions (pH 5.0) due to the cleavage of the ketal linkages. Concomitant with this supramolecular dissociation it was found that the ket-PRX released beta-CDs to form an inclusion complex with guest molecules specifically under weakly acidic pH conditions. As one of the possible intracellular therapeutic applications, it was confirmed that the ket-PRX showed superior reduction of lysosomal cholesterols in Niemann-Pick type C disease in comparison with beta-CD derivatives, presumably due to the local release of beta-CDs from the ket-PRX in response to the weakly acidic pH in endosomes and/or lysosomes. Altogether with these results, it is concluded that the ket-PRX exerting pH-sensitive dissociation is an attractive candidate as a potential therapeutic biomaterial.
C1 [Nishida, Kei; Tamura, Atsushi; Yui, Nobuhiko] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Organ Biomat, Chiyoda Ku, Tokyo 1010062, Japan.
RP Yui, N (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Organ Biomat, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM yui.org@tmd.ac.jp
OI Tamura, Atsushi/0000-0003-0235-7364
FU Ministry of Education, Culture, Sports, Science, and Technology (MEXT)
   of Japan [23107004]; MEXT of Japan [26750155]; Mochida Memorial
   Foundation for Medical and Pharmaceutical Research; Sasakawa Scientific
   Research Grant from The Japan Science Society
FX This work was financially supported by the Grant-in-Aid for Scientific
   Research (no. 23107004) on Innovative Areas "Nanomedicine Molecular
   Science" (N. Y.) from the Ministry of Education, Culture, Sports,
   Science, and Technology (MEXT) of Japan: Grant-in-Aid for Young
   Scientists (B) (no. 26750155) (A. T.) from the MEXT of Japan: the
   Mochida Memorial Foundation for Medical and Pharmaceutical Research (A.
   T.): the Sasakawa Scientific Research Grant from The Japan Science
   Society (A. T.).
CR Abi-Mosleh L, 2009, P NATL ACAD SCI USA, V106, P19316, DOI 10.1073/pnas.0910916106
   Alarcon CDH, 2005, CHEM SOC REV, V34, P276, DOI 10.1039/b406727d
   Bae Y, 2003, ANGEW CHEM INT EDIT, V42, P4640, DOI 10.1002/anie.200250653
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228
   Chang TY, 2005, J BIOL CHEM, V280, P20917, DOI 10.1074/jbc.R400040200
   CORDES EH, 1974, CHEM REV, V74, P581, DOI 10.1021/cr60291a004
   Dotsikas Y, 2000, J PHARMACEUT BIOMED, V23, P997, DOI 10.1016/S0731-7085(00)00392-7
   Fujita H, 1999, MACROMOLECULES, V32, P2534, DOI 10.1021/ma9814550
   Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017
   Ichi T, 2001, BIOMACROMOLECULES, V2, P204, DOI 10.1021/bm005617n
   Katoono R, 2008, CHEM LETT, V37, P988, DOI 10.1246/cl.2008.988
   Kopecek J, 2000, EUR J PHARM BIOPHARM, V50, P61, DOI 10.1016/S0939-6411(00)00075-8
   Kwon YJ, 2005, MOL PHARMACEUT, V2, P83, DOI 10.1021/mp0498953
   Lee Y, 2007, J AM CHEM SOC, V129, P5362, DOI 10.1021/ja071090b
   Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106
   MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.bi.55.070186.003311
   Mondjinou YA, 2013, BIOMACROMOLECULES, V14, P4189, DOI 10.1021/bm400922a
   MURPHY RF, 1984, J CELL BIOL, V98, P1757, DOI 10.1083/jcb.98.5.1757
   Ooya T, 2006, J AM CHEM SOC, V128, P3852, DOI 10.1021/ja055868+
   Ooya T, 2005, MACROMOL BIOSCI, V5, P379, DOI 10.1002/mabi.200400216
   Ooya T, 1999, J CONTROL RELEASE, V58, P251, DOI 10.1016/S0168-3659(98)00163-1
   Ooya T, 2001, BIOMACROMOLECULES, V2, P200, DOI 10.1021/bm005618f
   STEEN KH, 1995, J NEUROSCI, V15, P3982
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Tamura A, 2014, CHEM COMMUN, V50, P13433, DOI 10.1039/c4cc03709j
   Tamura A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04356
   Tamura A, 2013, J MATER CHEM B, V1, P3535, DOI 10.1039/c3tb20514b
   TANNOCK IF, 1989, CANCER RES, V49, P4373
   Yamashita A, 2006, NAT PROTOC, V1, P2861, DOI 10.1038/nprot.2006.438
   ZLOTOGORSKI A, 1987, ARCH DERMATOL RES, V279, P398, DOI 10.1007/BF00412626
NR 31
TC 5
Z9 5
U1 1
U2 33
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1759-9954
EI 1759-9962
J9 POLYM CHEM-UK
JI Polym. Chem.
PY 2015
VL 6
IS 21
BP 4040
EP 4047
DI 10.1039/c5py00445d
PG 8
WC Polymer Science
SC Polymer Science
GA CI5QA
UT WOS:000354812300016
DA 2018-10-19
ER

PT J
AU Chen, L
   Zhai, D
   Huan, ZG
   Ma, N
   Zhu, HB
   Wu, CT
   Chang, J
AF Chen, Lei
   Zhai, Dong
   Huan, Zhiguang
   Ma, Nan
   Zhu, Haibo
   Wu, Chengtie
   Chang, Jiang
TI Silicate bioceramic/PMMA composite bone cement with distinctive
   physicochemical and bioactive properties
SO RSC ADVANCES
LA English
DT Article
ID MECHANICAL-PROPERTIES; IN-VITRO; OSTEOGENIC DIFFERENTIATION;
   BIOLOGICAL-PROPERTIES; IONIC PRODUCTS; FILLER CONTENT; STEM-CELLS;
   AKERMANITE; PROLIFERATION; GLASS
AB Polymethyl methacrylate (PMMA) bone cement has been widely used for orthopedic application due to its high mechanical strength and proper setting time. However, the major shortcomings of PMMA bone cement are its relatively low osseointegration and strong exothermic reactions. Silicate-based bioceramics, like akermanite (Ca2MgSi2O7, AKT), have been demonstrated to possess excellent osteostimulation ability and controlled biodegradability. The purpose of this study is to harness the advantages of both PMMA and AKT in order to prepare a new kind of composite bone cement (AKT/PMMA) with superior mechanical strength, improved exothermic effect and osteogenic activity. AKT particles were uniformly incorporated into the matrix of PMMA cement. The effect of AKT on the in vitro setting behaviors, and mechanical and biological properties of resultant composite cements was systematically investigated. The results showed that the prepared AKT/PMMA composite bone cements revealed significantly decreased polymerization temperature as compared with pure PMMA, but maintained ideal setting times (12-14 min) and high mechanical strength (similar to 100 MPa for compressive strength). Most interestingly, the incorporation of AKT into PMMA improved its osteogenic activity, as indicated by the significantly enhanced apatite-mineralization ability and stimulatory effect on the proliferation and alkaline phosphate (ALP) activity of osteoblasts. The results suggest that AKT/PMMA composite bone cements possess distinctive physicochemical and bioactive properties, and are a promising injectable biomaterial for orthopedic applications.
C1 [Chen, Lei; Zhai, Dong; Huan, Zhiguang; Wu, Chengtie; Chang, Jiang] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Ma, Nan; Zhu, Haibo] Xuhui Dist Cent Hosp, Shanghai 200031, Peoples R China.
RP Chang, J (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, 1295 Dingxi Rd, Shanghai 200050, Peoples R China.
EM chengtiewu@mail.sic.ac.cn; jchang@mail.sic.ac.cn
FU Natural Science Foundation of China [81190132]; Funds of the Clinical
   Research Center for Biomaterials, Shanghai Institute of Ceramics, CAS
   [BMCRC2010001]; Key Research Program of Chinese Academy of Sciences
   [KGZD-EW-T06]; Innovative Project of SIC, CAS; One Hundred Talent
   Project, SIC-CAS [Y36ZB1110G]
FX This work was supported by grants from the Natural Science Foundation of
   China (grants no. 81190132), the Funds of the Clinical Research Center
   for Biomaterials, Shanghai Institute of Ceramics, CAS (grants no.
   BMCRC2010001), Key Research Program of Chinese Academy of Sciences
   (Grant KGZD-EW-T06), Innovative Project of SIC, CAS, and One Hundred
   Talent Project, SIC-CAS (Y36ZB1110G).
CR Abd Samad H, 2011, BIO-MED MATER ENG, V21, P247, DOI 10.3233/BME-2011-0673
   [Anonymous], 1987, ISO58331
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Chang J., 2015, Invention Patent, CN, Patent No. 104307035A
   CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28
   Chou YF, 2005, BIOMATERIALS, V26, P285, DOI 10.1016/j.biomaterials.2004.02.030
   Cunningham Larry L, 2005, J Long Term Eff Med Implants, V15, P609
   Dalby MJ, 2001, BIOMATERIALS, V22, P1739, DOI 10.1016/S0142-9612(00)00334-3
   ElGhannam A, 1997, BIOMATERIALS, V18, P295, DOI 10.1016/S0142-9612(96)00059-2
   Endogan T, 2009, J APPL POLYM SCI, V113, P4077, DOI 10.1002/app.30488
   Jasso-Gastinel CF, 2009, MACROMOL SYMP, V283-84, P159, DOI 10.1002/masy.200950921
   FREEMAN MAR, 1982, J BONE JOINT SURG BR, V64, P489
   Fukuda C, 2011, ACTA BIOMATER, V7, P3595, DOI 10.1016/j.actbio.2011.06.006
   Fukuda C, 2010, J BIOMED MATER RES B, V95B, P407, DOI 10.1002/jbm.b.31731
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Gu HJ, 2011, BIOMATERIALS, V32, P7023, DOI 10.1016/j.biomaterials.2011.06.003
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   Hong ZK, 2005, BIOMATERIALS, V26, P6296, DOI 10.1016/j.biomaterials.2005.04.018
   Huang Y, 2009, BIOMATERIALS, V30, P5041, DOI 10.1016/j.biomaterials.2009.05.077
   Kaysinger KK, 1998, J CELL BIOCHEM, V68, P83, DOI 10.1002/(SICI)1097-4644(19980101)68:1<83::AID-JCB8>3.0.CO;2-S
   Kim SB, 2004, BIOMATERIALS, V25, P5715, DOI 10.1016/j.biomaterials.2004.01.022
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kuhn K. D., 2000, BONE CEMENTS UP TO D
   Kwon SY, 1997, BIO-MED MATER ENG, V7, P129
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Lewis G, 2008, J BIOMED MATER RES B, V84B, P301, DOI 10.1002/jbm.b.30873
   Liu AX, 2008, ACTA BIOMATER, V4, P1005, DOI 10.1016/j.actbio.2008.02.013
   Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039
   Liu-Snyder P, 2008, CURR NANOSCI, V4, P111, DOI 10.2174/157341308783591799
   Miyazaki T, 2003, J BIOMED MATER RES A, V67A, P1417, DOI 10.1002/jbm.a.20042
   Mousa WF, 2000, BIOMATERIALS, V21, P2137, DOI 10.1016/S0142-9612(00)00097-1
   Olmo N, 2003, BIOMATERIALS, V24, P3383, DOI 10.1016/S0142-9612(03)00200-X
   Razavi M, 2014, CERAM INT, V40, P3865, DOI 10.1016/j.ceramint.2013.08.027
   Serbetci K, 2004, POLYM TEST, V23, P145, DOI 10.1016/S0142-9418(03)00073-4
   Shinzato S, 2001, J BIOMED MATER RES, V54, P491, DOI 10.1002/1097-4636(20010315)54:4<491::AID-JBM40>3.3.CO;2-F
   Silver IA, 2001, BIOMATERIALS, V22, P175, DOI 10.1016/S0142-9612(00)00173-3
   Sun HL, 2006, BIOMATERIALS, V27, P5651, DOI 10.1016/j.biomaterials.2006.07.027
   Wu CT, 2013, J INORG MATER, V28, P29, DOI 10.3724/SP.J.1077.2013.12241
   Wu CT, 2006, J BIOMED MATER RES A, V76A, P73, DOI 10.1002/jbm.a.30496
   Wu CT, 2004, MATER LETT, V58, P2415, DOI 10.1016/j.matlet.2004.02.039
   Xia LG, 2011, EUR CELLS MATER, V22, P68, DOI 10.22203/eCM.v022a06
   Zhai WY, 2013, ACTA BIOMATER, V9, P8004, DOI 10.1016/j.actbio.2013.04.024
   Zhai WY, 2012, ACTA BIOMATER, V8, P341, DOI 10.1016/j.actbio.2011.09.008
   Zhou YH, 2014, J MATER CHEM B, V2, P3907, DOI 10.1039/c4tb00377b
NR 44
TC 8
Z9 8
U1 1
U2 43
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 47
BP 37314
EP 37322
DI 10.1039/c5ra04646g
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA CG9QT
UT WOS:000353653200020
DA 2018-10-19
ER

PT J
AU John, AA
   Subramanian, AP
   Vellayappan, MV
   Balaji, A
   Jaganathan, SK
   Mohandas, H
   Paramalinggam, T
   Supriyanto, E
   Yusof, M
AF John, A. A.
   Subramanian, A. P.
   Vellayappan, M. V.
   Balaji, A.
   Jaganathan, S. K.
   Mohandas, H.
   Paramalinggam, T.
   Supriyanto, E.
   Yusof, M.
TI Review: physico-chemical modification as a versatile strategy for the
   biocompatibility enhancement of biomaterials
SO RSC ADVANCES
LA English
DT Review
ID CALCIUM-PHOSPHATE COATINGS; IN-VITRO BIOCOMPATIBILITY; VAPOR PLASMA
   TREATMENT; MUSCLE-CELL FUNCTION; SURFACE MODIFICATION; WATER-VAPOR;
   BLOOD COMPATIBILITY; STAINLESS-STEEL; BIOMEDICAL APPLICATIONS;
   MECHANICAL-PROPERTIES
AB A biomaterial can be defined as a material intended to interface with biological systems to evaluate, treat, augment or replace any tissue, organ or function of the body. Major problems associated with biomaterials are their properties and biocompatibility, which need to be tackled and resolved before promoting a particular biomaterial to the market or implanting it into a biological system. To enhance the biocompatibility of the biomaterials, several surface modification strategies, such as physico-chemical, mechanical and biological modifications, have been explored. In this review, some recent applications of physico-chemical modification technologies, such as alteration in the structure of a molecule by chemical modification, surface grafting, abrasive blasting and acid etching, surface coatings, heat and steam treatment for medical materials such as polymers, metals, ceramics and nanocomposites are discussed. This article will promote physico-chemical modification as a versatile technology in surface engineering to improve the properties and biocompatibility of medical materials. Furthermore, it will instigate the growth of the biomaterial market with various high quality biomaterials.
C1 [John, A. A.; Subramanian, A. P.; Vellayappan, M. V.; Balaji, A.; Jaganathan, S. K.; Supriyanto, E.; Yusof, M.] Univ Teknol Malaysia, Fac Biosci & Med Engn, IJN UTM Cardiovasc Engn Ctr, Johor Baharu 81310, Malaysia.
   [Paramalinggam, T.] Univ Teknol Malaysia, Fac Sci, Dept Chem, Johor Baharu 81310, Malaysia.
   [Mohandas, H.] Univ Texas Arlington, Dept Biomed Engn, Texas, TX USA.
RP Jaganathan, SK (reprint author), Univ Teknol Malaysia, Fac Biosci & Med Engn, IJN UTM Cardiovasc Engn Ctr, Johor Baharu 81310, Malaysia.
EM jaganathaniitkgp@gmail.com
RI Jaganathan, Saravana Kumar/N-2385-2017
OI Balaji, Arunpandian/0000-0002-6745-9188
FU Ministry of Higher Education Malaysia [R.J130000.7809.4F444]; UPMU, UTM
FX This work was supported partly by the Ministry of Higher Education
   Malaysia with the Grant Vot no: R.J130000.7809.4F444 and also
   acknowledges the support of UPMU, UTM.
CR Abbasi F, 2002, POLYM INT, V51, P882, DOI 10.1002/pi.1069
   Adhikari A. R., 2014, J APPL PHYS, P115
   Akelah A., 2013, TECHNOLOGY ENG, P1, DOI [10.1007/978-1-4614-7061-8, DOI 10.1007/978-1-4614-7061-8]
   Aldenhoff Yvette B. J., 2003, European Cells & Materials, V5, P61
   Alekhin AP, 2010, NANOTECHNOL RUSS, V5, P696, DOI 10.1134/S1995078010090144
   Alves P., 2014, J MATER SCI-MATER M, P2017
   Babiuch K, 2011, MACROMOL BIOSCI, V11, P535, DOI 10.1002/mabi.201000374
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3495, DOI 10.1016/j.biomaterials.2004.09.032
   Barrere F, 2001, J MATER SCI-MATER M, V12, P529, DOI 10.1023/A:1011271713758
   Bertazzo S, 2009, CLIN ORAL IMPLAN RES, V20, P288, DOI 10.1111/j.1600-0501.2008.01642.x
   Bimbo LM, 2010, ACS NANO, V4, P3023, DOI 10.1021/nn901657w
   Bosco R, 2012, COATINGS, V2, P95, DOI 10.3390/coatings2030095
   Bowry SK, 2002, INT J ARTIF ORGANS, V25, P447
   Bronzino D., 2000, BIOMEDICAL ENG HDB, V1
   Butruk-Raszeja B., 2014, J BIOMATER APPL, P801
   Cao Y, 1996, BIOMATERIALS, V17, P419, DOI 10.1016/0142-9612(96)89658-X
   Cao YJ, 2012, BIORESOURCES, V7, P4109
   Chen CH, 2013, NANOMED-NANOTECHNOL, V9, P600, DOI 10.1016/j.nano.2012.12.004
   Cheng ZQ, 2012, ADV MATER RES-SWITZ, V535-537, P1095, DOI 10.4028/www.scientific.net/AMR.535-537.1095
   Citeau A, 2005, BIOMATERIALS, V26, P157, DOI 10.1016/j.biomaterials.2004.02.033
   Cui XY, 2008, J MATER SCI-MATER M, V19, P1767, DOI 10.1007/s10856-007-3314-0
   Danila M. Korotin, 2012, J BIOMATER NANOBIOTE, V3, P87
   de Groot K, 1989, J Biomed Mater Res, V23, P1367, DOI 10.1002/jbm.820231112
   DEGATICA NLH, 1993, APPL SURF SCI, V68, P107, DOI 10.1016/0169-4332(93)90220-6
   Deng C, 2011, INT J POLYM MATER, V60, P969, DOI 10.1080/00914037.2011.553847
   Dong SJ, 2009, CHEM J CHINESE U, V30, P1018
   Duan B, 2010, J R SOC INTERFACE, V7, pS615, DOI 10.1098/rsif.2010.0127.focus
   Ebara M, 2014, SMART BIOMATERIALS, P1, DOI 10.1007/978-4-431-54400-5
   Fedel M, 2009, J BIOMED MATER RES B, V90B, P338, DOI 10.1002/jbm.b.31291
   Feldbauer S. L., STEAM TREATING ENHAN
   Feng YK, 2013, J MATER SCI-MATER M, V24, P61, DOI 10.1007/s10856-012-4685-4
   Ferraris S, 2011, J MATER SCI-MATER M, V22, P1835, DOI 10.1007/s10856-011-4365-9
   Gabo L., 2013, CHEM-EUR J, V19, P10690
   Gentleman E., 2009, MED SCI, VII
   Gong XH, 2004, J MATER SCI-MATER M, V15, P1141, DOI 10.1023/B:JMSM.0000046397.09060.15
   Gottlander M, 1997, CLIN ORAL IMPLAN RES, V8, P345, DOI 10.1034/j.1600-0501.1997.080501.x
   Hansson KM, 2005, BIOMATERIALS, V26, P861, DOI 10.1016/j.biomaterials.2004.03.036
   Hoffman A. S., 1995, CHIN J POLYM SCI, V3, P13
   Hsua S., 2014, 41 INT C MET COAT TH, V572, P91
   Hung HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065738
   Jackson M. J., 2006, Journal of Medical Engineering & Technology, V30, P323, DOI 10.1080/03091900500441287
   Jaganathan S. K., 2014, J MATER SCI, P2007
   Jaganathan S. K., 2014, BIOMED RES INT, V2014, P1
   Jensen C, 2012, J BIOMED MATER RES A, V100A, P3400, DOI 10.1002/jbm.a.34284
   Jovanovic AV, 2006, BIOMACROMOLECULES, V7, P945, DOI 10.1021/bm050820+
   Kang CK, 2012, J IND ENG CHEM, V18, P1670, DOI 10.1016/j.jiec.2012.03.007
   Kashiwazaki H, 2009, BIO-MED MATER ENG, V19, P133, DOI 10.3233/BME-2009-0572
   Kawase T, 2015, J BIOMED MATER RES B, V103, P825, DOI 10.1002/jbm.b.33262
   KHANLOU HM, 2012, AUST J BASIC APPL SC, V6, P125
   Kim HW, 2004, BIOMATERIALS, V25, P4203, DOI 10.1016/j.biomaterials.2003.10.094
   Kim SM, 2014, J BIOMED MATER RES A, V102, P429, DOI 10.1002/jbm.a.34718
   Kim YD, 2010, LASER MED SCI, V25, P25, DOI 10.1007/s10103-008-0585-8
   Kostelijk EH, 2001, TRANSFUSION MED, V11, P199, DOI 10.1046/j.1365-3148.2001.00305.x
   Feng KC, 2007, MATER TRANS, V48, P2978, DOI 10.2320/matertrans.MER2007083
   Kyomoto M, 2009, J BIOMED MATER RES A, V91A, P730, DOI 10.1002/jbm.a.32280
   Lakstein D, 2009, ACTA BIOMATER, V5, P2258, DOI 10.1016/j.actbio.2009.01.033
   Lamolle SF, 2009, BIOMATERIALS, V30, P736, DOI 10.1016/j.biomaterials.2008.10.052
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lee EJ, 2005, BIOMATERIALS, V26, P3843, DOI 10.1016/j.biomaterials.2004.10.019
   Lee HJ, 2007, EUR POLYM J, V43, P1602, DOI 10.1016/j.eurpolymj.2007.02.030
   LEE JH, 1991, BIOMATERIALS, V12, P443
   Lee MH, 2003, MET MATER-INT, V9, P35, DOI 10.1007/BF03027227
   Lee YH, 2010, APPL SURF SCI, V256, P5882, DOI 10.1016/j.apsusc.2010.03.069
   LEMONS J, 1986, DENT CLIN N AM, V30, P3
   Li SB, 2012, J BIOMED MATER RES B, V100B, P1587, DOI 10.1002/jbm.b.32727
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Lim YW, 2011, CLIN ORTHOP RELAT R, V469, P330, DOI 10.1007/s11999-010-1613-0
   Liu PS, 2013, MAT SCI ENG C-MATER, V33, P3865, DOI 10.1016/j.msec.2013.05.025
   Liu YR, 2012, SURF COAT TECH, V208, P51, DOI 10.1016/j.surfcoat.2012.07.084
   Majumdar P, 2012, J MECH BEHAV BIOMED, V10, P1, DOI 10.1016/j.jmbbm.2012.02.014
   Manivasagam G., 2010, RECENT PAT CORROS SC, P40
   McCreery R. L., 2012, NANOFABRICATION, P163, DOI [10.1007/978-3-7091-0424-8_7, DOI 10.1007/978-3-7091-0424-8_7]
   Milinkovi I., 2012, MATER TECHNOL, V3, P251
   Milinkovi I., 2012, MATER TECHNOL, P251
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Minko S., 2008, POLYM SURFACES INTER, P215, DOI DOI 10.1007/978-3-540-73865-7_11
   Mohammadi A, 2013, J MATER SCI, V48, P7493, DOI 10.1007/s10853-013-7563-7
   Mondal D, 2013, J BIOMED MATER RES A, V101, P1489, DOI 10.1002/jbm.a.34455
   MORONI A, 1994, BIOMATERIALS, V15, P926, DOI 10.1016/0142-9612(94)90119-8
   Mu QX, 2010, BIOMATERIALS, V31, P5083, DOI 10.1016/j.biomaterials.2010.03.020
   Nader P., 2012, COMAT RECENT TRENDS, P1
   Nguyen HQ, 2004, BIOMATERIALS, V25, P865, DOI 10.1016/S0142-9612(03)00607-0
   Nie S., 2012, COLLOID SURFACE B, P116
   Niinomi M, 2014, INT J SURF SCI ENG, V8, P138, DOI 10.1504/IJSURFSE.2014.060487
   NISHIZAWA K, 1993, J FERMENT BIOENG, V75, P435, DOI 10.1016/0922-338X(93)90091-L
   Parida P., 2012, INT J ADV APPL SCI, P125
   Parl HD, 2003, J BIOMED MATER RES A, V66A, P596, DOI 10.1002/jbm.a.10505
   Parsapour A, 2012, J MATER SCI TECHNOL, V28, P125, DOI 10.1016/S1005-0302(12)60032-2
   Pascu M. C., 2008, J PHYS D, V41, P12
   Pattanaik Bikash, 2012, Indian J Dent Res, V23, P398, DOI 10.4103/0970-9290.102240
   Prabhakar PK, 2011, COLLOID SURFACE B, V86, P146, DOI 10.1016/j.colsurfb.2011.03.033
   Queffelec C, 2012, CHEM REV, V112, P3777, DOI 10.1021/cr2004212
   Rai R, 2013, MATER LETT, V105, P32, DOI 10.1016/j.matlet.2013.04.024
   Safonov V, 2010, J PHYS CONF SER, V253, DOI 10.1088/1742-6596/253/1/012068
   Schmalz G, 2002, J DENT RES, V81, P660, DOI 10.1177/154405910208101001
   Seivakumar M., 2015, J BIOMED NANOTECHNOL, V11, P291
   Shirzadian T., 2012, J INJ VIOLENCE RES, V4, P39
   Shuchman M, 2006, NEW ENGL J MED, V355, P1949, DOI 10.1056/NEJMp068234
   Singh B, 2012, J MECH BEHAV BIOMED, V9, P9, DOI 10.1016/j.jmbbm.2012.01.021
   Sirolli V, 2000, INT J ARTIF ORGANS, V23, P356
   Stevens K. N. J., 2011, THESIS MAASTRICHT U
   Strnad Z, 2000, INT J ORAL MAX IMPL, V15, P483
   Sultana R, 2006, DENT MATER J, V25, P470, DOI 10.4012/dmj.25.470
   Szabo G, 1999, J LONG-TERM EFF MED, V9, P247
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e
   Wang HJ, 2009, COLLOID SURFACE B, V69, P109, DOI 10.1016/j.colsurfb.2008.11.015
   Wang J, 2004, BIOMATERIALS, V25, P583, DOI 10.1016/S0142-9612(03)00559-3
   Wang J, 2013, ACTA BIOMATER, V9, P8678, DOI 10.1016/j.actbio.2013.02.041
   Wang LS, 2011, ADVANCES IN NANOCOMPOSITES - SYNTHESIS, CHARACTERIZATION AND INDUSTRIAL APPLICATIONS, P289
   Wennerberg A, 1996, Int J Oral Maxillofac Implants, V11, P38
   Williams David, 2003, Med Device Technol, V14, P10
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wu CZ, 2011, J MECH BEHAV BIOMED, V4, P1548, DOI 10.1016/j.jmbbm.2011.02.007
   Xiang T, 2013, COLLOID SURFACE B, V110, P15, DOI 10.1016/j.colsurfb.2013.04.034
   Xu ZK, 2005, BIOMATERIALS, V26, P589, DOI 10.1016/j.biomaterials.2004.03.008
   Xue WC, 2005, BIOMATERIALS, V26, P3029, DOI 10.1016/j.biomaterials.2004.09.003
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
   Ye CH, 2012, APPL SURF SCI, V258, P3420, DOI 10.1016/j.apsusc.2011.11.087
   Ye HJ, 2013, COLLOID SURFACE A, V427, P19, DOI 10.1016/j.colsurfa.2013.02.068
   YOSHINARI M, 1994, BIOMATERIALS, V15, P529, DOI 10.1016/0142-9612(94)90019-1
   Yue Q, 2013, J MATER CHEM B, V1, P6085, DOI 10.1039/c3tb21028f
   Zhang WB, 2012, ADV MATER RES-SWITZ, V391-392, P195, DOI 10.4028/www.scientific.net/AMR.391-392.195
   Zhao Q, 1999, BIOMATERIALS, V20, P595, DOI 10.1016/S0142-9612(98)00218-X
   Zhao XB, 2006, SURF COAT TECH, V200, P5487, DOI 10.1016/j.surfcoat.2005.07.062
   Zhou Y, 2012, J MATER SCI-MATER M, V23, P2101, DOI 10.1007/s10856-012-4699-y
   Zhuang PY, 2012, INT J BIOL MACROMOL, V50, P658, DOI 10.1016/j.ijbiomac.2012.01.026
   Zreiqat H, 1999, J BIOMED MATER RES, V44, P389, DOI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
NR 128
TC 20
Z9 21
U1 5
U2 70
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 49
BP 39232
EP 39244
DI 10.1039/c5ra03018h
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA CH7FQ
UT WOS:000354201500051
DA 2018-10-19
ER

PT J
AU Zhao, CH
   Pan, CJ
   Sandstedt, J
   Fu, YF
   Lindahl, A
   Liu, JH
AF Zhao, Changhong
   Pan, Changjiang
   Sandstedt, Joakim
   Fu, Yifeng
   Lindahl, Anders
   Liu, Johan
TI Combination of positive charges and honeycomb pores to promote MC3T3-E1
   cell behaviour
SO RSC ADVANCES
LA English
DT Article
ID GLYCOL) DIBLOCK COPOLYMER; BREATH-FIGURE METHOD; POLY(ETHYLENE GLYCOL);
   EPSILON-CAPROLACTONE; OSTEOBLAST ADHESION; BANDED SPHERULITES;
   BLOCK-COPOLYMERS; DRUG-DELIVERY; IN-VITRO; POLY(L-LACTIDE)
AB A facile chemistry route to prepare symmetric poly(L-lactide) (PLLA)-based dendritic L-lysine copolymer (PLLA-d), with a PLLA block as the core and lysine dendrons in the two ends to provide certain density of positive charges, through a divergent method is reported. The polymers were characterized by H-1 NMR, GPC and MALDI-TOF to confirm the well-defined chemical architecture. The study on crystallization behaviour demonstrated that the introduction of the lysine dendron favoured the formation of banded spherulites when compared with the PLLA polymer. The differential scanning calorimetry (DSC) results showed that the lysine dendron disrupted PLLA crystalline region and lowered the melting point and crystallinity of PLLA. The PLLA-d was fabricated into honeycomb films (H-PLLA-d) through the breath-figure method for water contact angle test and in vitro study, with flat PLLA, honeycomb PLLA, and flat PLLA-d films (PLLA, H-PLLA, and F-PLLA-d, respectively) as the controls. The water contact angle test indicated that the hydrophilicity of the PLLA-d film was strongly improved after the incorporation of the lysine dendron into PLLA. The incorporation of the lysine dendron increased the surface zeta potential and decreased the mechanical properties of PLLA. Mouse osteoblastic cell (MC3T3-E1) functions including cell attachment, adhesion, proliferation, and differentiation were investigated on PLLA, H-PLLA, F-PLLA-d and H-PLLA-d films. The results indicated that MC3T3-E1 cell functions were significantly enhanced on F-PLLA-d or H-PLLA films and especially H-PLLA-d ones. This study not only demonstrates a facile approach to fabricate a novel copolymer film (H-PLLA-d), which combines positive charges with honeycomb pores, but also provides a potential biomaterial for bone repair by improving osteoblastic cell functions.
C1 [Zhao, Changhong; Liu, Johan] Shanghai Univ, SMIT Ctr, Sch Mechatron Engn & Automat, Shanghai 201800, Peoples R China.
   [Zhao, Changhong; Liu, Johan] Shanghai Univ, Key Lab Adv Display & Syst Applicat, Shanghai 201800, Peoples R China.
   [Pan, Changjiang] Huaiyin Inst Technol, Jiangsu Prov Key Lab Intervent Med Devices, Huaian 223003, Peoples R China.
   [Sandstedt, Joakim; Lindahl, Anders] Sahlgrens Acad, Inst Biomed, Dept Clin Chem & Transfus Med, S-41345 Gothenburg, Sweden.
   [Fu, Yifeng] SHT Smart High Tech AB, SE-41133 Gothenburg, Sweden.
   [Liu, Johan] Chalmers, Bionano Syst Lab, Dept Microtechnol & Nanosci MC2, S-41296 Gothenburg, Sweden.
RP Liu, JH (reprint author), Shanghai Univ, SMIT Ctr, Sch Mechatron Engn & Automat, 20 Chengzhong Rd, Shanghai 201800, Peoples R China.
EM johan.liu@chalmers.se
FU National Science Foundation, China [51272153]; Chongqing Science and
   Technology Key Projects Fund [CSTC2009AB5061]
FX This work was supported by National Science Foundation, China under the
   contract no. 51272153 and Chongqing Science and Technology Key Projects
   Fund under the contract no. CSTC2009AB5061. This work was also carried
   out within the Sustainable Production Initiative and the Production Area
   of Advance at Chalmers. The authors would like to thank Dr Michael
   Edwards, Chalmers University of Technology, for proof reading the
   manuscript.
CR Agrawal P, 2007, BIOMATERIALS, V28, P3349, DOI 10.1016/j.biomaterials.2007.04.004
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Breitenbach A, 2000, POLYMER, V41, P4781, DOI 10.1016/S0032-3861(99)00710-7
   Bunz UHF, 2006, ADV MATER, V18, P973, DOI 10.1002/adma.200501131
   Cai L, 2012, BIOMACROMOLECULES, V13, P342, DOI 10.1021/bm201763n
   Cai L, 2010, BIOMATERIALS, V31, P4457, DOI 10.1016/j.biomaterials.2010.02.020
   Cai Q, 2003, BIOMACROMOLECULES, V4, P828, DOI 10.1021/bm034051a
   Chen HT, 2004, J AM CHEM SOC, V126, P10044, DOI 10.1021/ja048548j
   Dahiya R, 2007, J CHIL CHEM SOC, V52, P1224, DOI 10.4067/S0717-97072007000300006
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Deng C, 2006, BIOMACROMOLECULES, V7, P590, DOI 10.1021/bm050678c
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Fukuhira Y, 2008, COLLOID SURFACE A, V313, P520, DOI 10.1016/j.colsurfa.2007.05.047
   Gong FR, 2009, POLYMER, V50, P2775, DOI 10.1016/j.polymer.2009.04.033
   Heath MD, 2010, LANGMUIR, V26, P5304, DOI 10.1021/la100678n
   Hernandez-Guerrero M, 2012, POLYM CHEM-UK, V3, P563, DOI 10.1039/c1py00219h
   Hynes SR, 2007, J BIOMAT SCI-POLYM E, V18, P1017, DOI 10.1163/156856207781494368
   Jin Y, 2011, APPL SPECTROSC, V65, P454, DOI 10.1366/10-06143
   Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044
   Li SM, 2003, BIOMACROMOLECULES, V4, P372, DOI 10.1021/bm025748j
   Li SM, 2002, BIOMACROMOLECULES, V3, P525, DOI 10.1021/bm010168s
   Li Y, 2006, BIOMACROMOLECULES, V7, P224, DOI 10.1021/bm050602g
   Li Y, 2007, BIOMACROMOLECULES, V8, P1409, DOI 10.1021/bm0701806
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   McMillan JR, 2007, TISSUE ENG, V13, P789, DOI 10.1089/ten.2006.0321
   Nasongkla N, 2004, ANGEW CHEM INT EDIT, V43, P6323, DOI 10.1002/anie.200460800
   Nurkhamidah S, 2011, J APPL POLYM SCI, V122, P1976, DOI 10.1002/app.34021
   Okuda T, 2006, J CONTROL RELEASE, V114, P69, DOI 10.1016/j.jconrel.2006.05.009
   Ouchi T, 2002, BIOMACROMOLECULES, V3, P885, DOI 10.1021/bm0200231
   Rao SS, 2011, J BIOMAT SCI-POLYM E, V22, P611, DOI 10.1163/092050610X488241
   Sista S, 2011, J BIOMED MATER RES A, V97A, P27, DOI 10.1002/jbm.a.33013
   Sun JR, 2004, POLYMER, V45, P5969, DOI 10.1016/j.polymer.2004.06.026
   Sunami H, 2006, COLLOID SURFACE A, V284, P548, DOI 10.1016/j.colsurfa.2005.11.041
   Tanaka M, 2011, BBA-GEN SUBJECTS, V1810, P251, DOI 10.1016/j.bbagen.2010.10.002
   Tsuruma A, 2008, COLLOID SURFACE A, V313, P536, DOI 10.1016/j.colsurfa.2007.05.079
   Wang B, 2010, COLLOID SURFACE B, V76, P38, DOI 10.1016/j.colsurfb.2009.10.006
   Wang JH, 2006, BIOMATERIALS, V27, P3441, DOI 10.1016/j.biomaterials.2006.02.002
   Wang K, 2012, LANGMUIR, V28, P4382, DOI 10.1021/la205162d
   Wei J, 2011, J NANOSCI NANOTECHNO, V11, P10746, DOI 10.1166/jnn.2011.3940
   Wei J, 2009, J AM CERAM SOC, V92, P1017, DOI 10.1111/j.1551-2916.2009.03002.x
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Wu X., 2014, J POSTDOC RES, V1, P17
   Wu XH, 2015, RSC ADV, V5, P6607, DOI 10.1039/c4ra13843k
   Wu XH, 2014, POLYMER, V55, P1756, DOI 10.1016/j.polymer.2014.02.029
   Wu XH, 2013, ADV HEALTHC MATER, V2, P326, DOI 10.1002/adhm.201200205
   Wu XH, 2012, ACS APPL MATER INTER, V4, P4966, DOI 10.1021/am301334s
   Wu XH, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/3/035006
   Wu XH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045008
   Xu J, 2005, POLYMER, V46, P9176, DOI 10.1016/j.polymer.2005.07.010
   Yamamoto S, 2006, SURF SCI, V600, P3785, DOI 10.1016/j.susc.2006.01.085
   Yang Y, 2009, BIOMATERIALS, V30, P1947, DOI 10.1016/j.biomaterials.2008.12.044
   Ye R, 2014, FOOD HYDROCOLLOID, V35, P670, DOI 10.1016/j.foodhyd.2013.08.022
   Yu LMY, 2008, MATER TODAY, V11, P36, DOI 10.1016/S1369-7021(08)70088-9
   Zhao BH, 2006, J MATER CHEM, V16, P509, DOI 10.1039/b512398d
   Zhao YL, 2002, POLYMER, V43, P5819, DOI 10.1016/S0032-3861(02)00529-3
   Zhou HJ, 2011, J MATER SCI-MATER M, V22, P731, DOI 10.1007/s10856-011-4239-1
   Zhou HJ, 2010, J MATER SCI-MATER M, V21, P2175, DOI 10.1007/s10856-010-4083-8
NR 58
TC 3
Z9 3
U1 1
U2 25
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 53
BP 42276
EP 42286
DI 10.1039/c5ra00756a
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA CI0SI
UT WOS:000354447800009
DA 2018-10-19
ER

PT J
AU Pachuau, LS
AF Pachuau, Lalduh Sanga
TI A Mini Review on Plant-based Nanocellulose: Production, Sources,
   Modifications and Its Potential in Drug Delivery Applications
SO MINI-REVIEWS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE Biomaterials; cellulose nanocrystals; cellulose nanofibrils; drug
   delivery; nanocellulose; nanocomposites
ID CELLULOSE MICROCRYSTAL SUSPENSION; NANOCRYSTALLINE CELLULOSE;
   NANOFIBRILLATED CELLULOSE; MICROFIBRILLATED CELLULOSE; NATIVE CELLULOSE;
   FIBERS; NANOWHISKERS; COMPOSITES; NANOFIBERS; HYDROGELS
AB Nanocellulose is an emerging sustainable biomaterial with exceptional physicochemical properties. It can be isolated from inexpensive renewable cellulosic biomass and a number of natural plant fibers have been extensively investigated as a source for such isolation. The geometrical dimensions of the prepared cellulose nanocrystals (CNCs) are however, found to vary widely, depending on the source of the cellulosic material and hydrolysis conditions. CNCs are biocompatible and biodegradable which exhibit very low cytotoxicity thus, offering a wide range of opportunities for biomedical applications. By surface modification of nanocellulose, various functional materials with tunable properties can also be developed. Over the past two decades, CNCs have garnered a significant interest as biobased reinforcing nanofiller material. This mini review will provide an overview into the production methods, sources of cellulosic fibers, surface modification strategies and drug delivery applications of the chemically or mechanically isolated nanocellulose.
C1 Assam Univ, Dept Pharmaceut Sci, Silchar 788011, Assam, India.
RP Pachuau, LS (reprint author), Assam Univ, Dept Pharmaceut Sci, Silchar 788011, Assam, India.
EM aduhapc@gmail.com
RI Pachuau, Lalduhsanga/S-7203-2018
OI Pachuau, Lalduhsanga/0000-0002-3827-9444
CR Abdulkhani A, 2014, POLYM TEST, V35, P73, DOI 10.1016/j.polymertesting.2014.03.002
   Abe K, 2009, CELLULOSE, V16, P1017, DOI 10.1007/s10570-009-9334-9
   Andresen M, 2006, CELLULOSE, V13, P665, DOI 10.1007/s10570-006-9072-1
   Araki J, 1998, COLLOID SURFACE A, V142, P75, DOI 10.1016/S0927-7757(98)00404-X
   Araki J, 1999, J WOOD SCI, V45, P258, DOI 10.1007/BF01177736
   Araki J, 2001, LANGMUIR, V17, P21, DOI 10.1021/la001070m
   Azzam F, 2010, BIOMACROMOLECULES, V11, P3652, DOI 10.1021/bm101106c
   Besbes I, 2011, CARBOHYD POLYM, V86, P1198, DOI 10.1016/j.carbpol.2011.06.015
   Bondeson D, 2006, CELLULOSE, V13, P171, DOI 10.1007/s10570-006-9061-4
   Brinchi L, 2013, CARBOHYD POLYM, V94, P154, DOI 10.1016/j.carbpol.2013.01.033
   Brito BSL, 2012, CELLULOSE, V19, P1527, DOI 10.1007/s10570-012-9738-9
   Cao XW, 2012, CARBOHYD POLYM, V90, P1075, DOI 10.1016/j.carbpol.2012.06.046
   Chen WS, 2011, CELLULOSE, V18, P433, DOI 10.1007/s10570-011-9497-z
   Cherian BM, 2011, CARBOHYD POLYM, V86, P1790, DOI 10.1016/j.carbpol.2011.07.009
   Domingues RMA, 2014, BIOMACROMOLECULES, V15, P2327, DOI 10.1021/bm500524s
   Dong H, 2012, CARBOHYD POLYM, V87, P2488, DOI 10.1016/j.carbpol.2011.11.015
   Dufresne A, 2013, MATER TODAY, V16, P220, DOI 10.1016/j.mattod.2013.06.004
   GARDNER KH, 1974, BIOPOLYMERS, V13, P1975, DOI 10.1002/bip.1974.360131005
   Gousse C, 2004, POLYMER, V45, P1569, DOI 10.1016/j.polymer.2003.12.028
   Gupta KC, 2003, BIOMACROMOLECULES, V4, P758, DOI 10.1021/bm020135s
   Haafiz MKM, 2014, CARBOHYD POLYM, V103, P119, DOI 10.1016/j.carbpol.2013.11.055
   Habibi Y, 2008, J MATER CHEM, V18, P5002, DOI 10.1039/b809212e
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   Jackson JK, 2011, INT J NANOMED, V6, P321, DOI 10.2147/IJN.S16749
   Jiang F, 2010, LANGMUIR, V26, P17919, DOI 10.1021/la1028405
   Khalil HPSA, 2014, CARBOHYD POLYM, V99, P649, DOI 10.1016/j.carbpol.2013.08.069
   Khalil HPSA, 2012, CARBOHYD POLYM, V87, P963, DOI 10.1016/j.carbpol.2011.08.078
   Kloser E, 2010, LANGMUIR, V26, P13450, DOI 10.1021/la101795s
   Kolakovic R, 2012, EUR J PHARM BIOPHARM, V82, P308, DOI 10.1016/j.ejpb.2012.06.011
   Kolakovic R, 2012, INT J PHARMACEUT, V430, P47, DOI 10.1016/j.ijpharm.2012.03.031
   Kolakovic R, 2011, AAPS PHARMSCITECH, V12, P1366, DOI 10.1208/s12249-011-9705-z
   Lam E, 2012, TRENDS BIOTECHNOL, V30, P283, DOI 10.1016/j.tibtech.2012.02.001
   Lavoine N, 2012, CARBOHYD POLYM, V90, P735, DOI 10.1016/j.carbpol.2012.05.026
   Leung ACW, 2011, SMALL, V7, P302, DOI 10.1002/smll.201001715
   Liu HY, 2010, BIORESOURCE TECHNOL, V101, P5685, DOI 10.1016/j.biortech.2010.02.045
   Mandal A, 2011, CARBOHYD POLYM, V86, P1291, DOI 10.1016/j.carbpol.2011.06.030
   Nair SS, 2014, ACS SUSTAIN CHEM ENG, V2, P772, DOI 10.1021/sc400445t
   Nakagaito AN, 2004, APPL PHYS A-MATER, V78, P547, DOI 10.1007/s00339-003-2453-5
   OSullivan AC, 1997, CELLULOSE, V4, P173, DOI 10.1023/A:1018431705579
   Peng BL, 2011, CAN J CHEM ENG, V89, P1191, DOI 10.1002/cjce.20554
   Plackett DV, 2014, NORD PULP PAP RES J, V29, P105
   Rachtanapun P, 2012, LWT-FOOD SCI TECHNOL, V48, P52, DOI 10.1016/j.lwt.2012.02.029
   Rosa MF, 2010, CARBOHYD POLYM, V81, P83, DOI 10.1016/j.carbpol.2010.01.059
   SAKURADA I, 1962, J POLYM SCI, V57, P651, DOI 10.1002/pol.1962.1205716551
   Sanna R, 2013, CELLULOSE, V20, P2393, DOI 10.1007/s10570-013-9988-1
   Morais JPS, 2013, CARBOHYD POLYM, V91, P229, DOI 10.1016/j.carbpol.2012.08.010
   Serge R, 2013, J BIOMATERIALS NANOB, V4, DOI DOI 10.4236/JBNB.2013.42022
   Sheltami RM, 2012, CARBOHYD POLYM, V88, P772, DOI 10.1016/j.carbpol.2012.01.062
   Sundari MT, 2012, CARBOHYD POLYM, V87, P1701, DOI 10.1016/j.carbpol.2011.09.076
   Tingaut P, 2012, J MATER CHEM, V22, P20105, DOI 10.1039/c2jm32956e
   Tonoli GHD, 2012, CARBOHYD POLYM, V89, P80, DOI 10.1016/j.carbpol.2012.02.052
   Wang HZ, 2011, BIOMACROMOLECULES, V12, P1585, DOI 10.1021/bm101584c
   Xiong R, 2012, CELLULOSE, V19, P1189, DOI 10.1007/s10570-012-9730-4
   Yang X, 2013, BIOMACROMOLECULES, V14, P4447, DOI 10.1021/bm401364z
   Zhu HL, 2014, ENERG ENVIRON SCI, V7, P269, DOI 10.1039/c3ee43024c
   Zimmermann T, 2004, ADV ENG MATER, V6, P754, DOI 10.1002/adem.200400097
   Zimmermann T, 2010, CARBOHYD POLYM, V79, P1086, DOI 10.1016/j.carbpol.2009.10.045
NR 57
TC 9
Z9 10
U1 2
U2 82
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-5575
EI 1875-5607
J9 MINI-REV MED CHEM
JI Mini-Rev. Med. Chem.
PY 2015
VL 15
IS 7
BP 543
EP 552
PG 10
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA CH3FQ
UT WOS:000353914400003
PM 25877601
DA 2018-10-19
ER

PT J
AU Novotna, Z
   Reznickova, A
   Rimpelova, S
   Vesely, M
   Kolska, Z
   Svorcik, V
AF Novotna, Zdenka
   Reznickova, Alena
   Rimpelova, Silvie
   Vesely, Martin
   Kolska, Zdenka
   Svorcik, Vaclav
TI Tailoring of PEEK bioactivity for improved cell interaction: plasma
   treatment in action
SO RSC ADVANCES
LA English
DT Article
ID POLYMER SURFACE MODIFICATION; IN-VITRO; TITANIUM-ALLOYS;
   POLYETHERETHERKETONE; ADHESION; POLYETHYLENE; FIBROBLASTS; IMPLANTS;
   DIFFERENTIATION; BIOMATERIALS
AB Despite the extensive use of polyetheretherketone (PEEK) in biomedical applications, information about cell adhesion on this biomaterial is limited. This study focuses on PEEK tuned by argon plasma treatment with the aim to enhance its wettability and cytocompatibility. Changes in surface properties of the plasma treated surface were studied in relation to the adhesion, proliferation and metabolic activity of mouse fibroblasts (L929) and human osteoblast (U-2 OS) in vitro. Moreover, the expression profiles of two proteins (talin 1 and vinculin) responsible for cell adhesion, were determined at 2 time points in dependence on the PEEK treatment. Plasma treatment increased the surface wettability of PEEK and led to changes in its surface morphology and chemistry. The XPS method showed a decrease in carbon content and augmentation of oxygen concentration with increasing effect of the plasma. Plasma treatment of PEEK significantly enhanced cell adhesion, proliferation and metabolic activity of both cell lines when compared to pristine PEEK. Moreover, special attention was devoted to filopodia of L929 cell adhered on PEEK studied by means of scanning electron microscopy. The most abundant filopodia were present on PEEK plasma treated for "longer" times.
C1 [Novotna, Zdenka; Reznickova, Alena; Svorcik, Vaclav] Univ Chem & Technol, Dept Solid State Engn, Prague, Czech Republic.
   [Rimpelova, Silvie] Univ Chem & Technol, Dept Biochem & Microbiol, Prague, Czech Republic.
   [Vesely, Martin] Univ Chem & Technol, Dept Organ Technol, Prague, Czech Republic.
   [Kolska, Zdenka] JE Purkyne Univ Usti Nad Labem, Fac Sci, Usti Nad Labem, Czech Republic.
RP Novotna, Z (reprint author), Univ Chem & Technol, Dept Solid State Engn, Prague, Czech Republic.
EM zdenka1.novotna@vscht.cz
RI Vesely, Martin/V-2711-2017
OI Vesely, Martin/0000-0002-3147-4941; Rimpelova,
   Silvie/0000-0002-9731-8968
FU GACR [14-18149P, 108/12/G108]; specific university research MSMT
   [20/2015]
FX This work was supported by the GACR under projects 14-18149P (A.R.),
   108/12/G108 and by financial support from specific university research
   MSMT no. 20/2015 (Z.N.).
CR ALBIGESRIZO C, 1995, J CELL SCI, V108, P3317
   Althaus J, 2012, EUR J NANOMED, V4, P7, DOI 10.1515/ejnm-2011-0001
   Awaja F, 2012, PLASMA PROCESS POLYM, V9, P355, DOI 10.1002/ppap.201100034
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Briem D, 2005, J MATER SCI-MATER M, V16, P671, DOI 10.1007/s10856-005-2539-z
   Chan CM, 1996, SURF SCI REP, V24, P3
   Choi YH, 2005, SURF COAT TECH, V193, P319, DOI 10.1016/j.surfcoat.2004.08.145
   Hiebl B, 2010, J BIOTECHNOL, V148, P76, DOI 10.1016/j.jbiotec.2010.01.006
   HUSAIN S, 1993, CURR SCI INDIA, V64, P681
   Hwang ML, 2012, NUCL INSTRUM METH B, V281, P45, DOI 10.1016/j.nimb.2012.03.025
   Jiao YP, 2007, BIOMED MATER, V2, pR24, DOI 10.1088/1748-6041/2/4/R02
   Katzer A, 2002, BIOMATERIALS, V23, P1749, DOI 10.1016/S0142-9612(01)00300-3
   Kirby BJ, 2004, ELECTROPHORESIS, V25, P187, DOI 10.1002/elps.200305754
   Kitamura E, 2004, CLIN ORAL IMPLAN RES, V15, P401, DOI 10.1111/j.1600-0501.2004.01022.x
   Kobayashi T, 1998, SOLID STATE IONICS, V106, P219, DOI 10.1016/S0167-2738(97)00512-2
   Kolska Z, 2010, MATER LETT, V64, P1160, DOI 10.1016/j.matlet.2010.02.038
   Kolska Z., 2012, E-POLYMERS, V83, P1
   Kolska Z, 2014, POLYM DEGRAD STABIL, V101, P1, DOI 10.1016/j.polymdegradstab.2014.01.024
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Kuzuya M, 1998, MACROMOLECULES, V31, P3230, DOI 10.1021/ma970937t
   Lee JW, 2011, ANAL SCI, V27, P369, DOI 10.2116/analsci.27.369
   Lossdorfer S, 2004, J BIOMED MATER RES A, V70A, P361, DOI 10.1002/jbm.a.30025
   Ma R, 2014, ACS APPL MATER INTER, V6, P12214, DOI 10.1021/am504409q
   Nieminen T, 2008, J BIOMED MATER RES A, V84A, P377, DOI 10.1002/jbm.a.31310
   Noiset O, 1999, J BIOMAT SCI-POLYM E, V10, P657, DOI 10.1163/156856299X00865
   Olivares-Navarrete R, 2013, SPINE J, V13, P1563, DOI 10.1016/j.spinee.2013.03.047
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Reznickova A, 2011, NUCL INSTRUM METH B, V269, P83, DOI 10.1016/j.nimb.2010.11.018
   Reznickova A., 2014, NANOSCALE RES LETT, V9, P1
   Rimpelova S, 2014, PLASMA PROCESS POLYM, V11, P1057, DOI 10.1002/ppap.201400021
   Rimpelova S, 2013, MAT SCI ENG C-MATER, V33, P1116, DOI 10.1016/j.msec.2012.12.003
   Rivard CH, 2002, J BIOMED MATER RES, V62, P488, DOI 10.1002/jbm.10159
   Sagomonyants KB, 2008, BIOMATERIALS, V29, P1563, DOI 10.1016/j.biomaterials.2007.12.001
   Slepicka P, 2013, EXPRESS POLYM LETT, V7, P535, DOI 10.3144/expresspolymlett.2013.50
   Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9
   Svorcik V, 2006, POLYM DEGRAD STABIL, V91, P1219, DOI 10.1016/j.polymdegradstab.2005.09.007
   Svorcik V, 2006, NUCL INSTRUM METH B, V244, P365, DOI 10.1016/j.nimb.2005.10.003
   Tsou HK, 2009, SURF COAT TECH, V204, P1121, DOI 10.1016/j.surfcoat.2009.06.018
   Wang YY, 2013, WEAR, V303, P255, DOI 10.1016/j.wear.2013.03.036
   Watanabe IS, 2013, MICROSC RES TECHNIQ, V76, P1226, DOI 10.1002/jemt.22289
   Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399
NR 41
TC 11
Z9 11
U1 3
U2 65
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 52
BP 41428
EP 41436
DI 10.1039/c5ra03861h
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA CI0RP
UT WOS:000354445900015
OA Bronze
DA 2018-10-19
ER

PT J
AU Gajdziok, J
   Holesova, S
   Stembirek, J
   Pazdziora, E
   Landova, H
   Dolezel, P
   Vetchy, D
AF Gajdziok, Jan
   Holesova, Sylva
   Stembirek, Jan
   Pazdziora, Erich
   Landova, Hana
   Dolezel, Petr
   Vetchy, David
TI Carmellose Mucoadhesive Oral Films Containing Vermiculite/Chlorhexidine
   Nanocomposites as Innovative Biomaterials for Treatment of Oral
   Infections
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID DRUG-DELIVERY SYSTEMS; NON-CLAY MINERALS; BUCCAL FILMS; IN-VITRO;
   EXCHANGED MONTMORILLONITE; ANTIBACTERIAL ACTIVITY; POLYMERIC PLATFORMS;
   CELLULOSE FIBERS; CARBOXYMETHYLCELLULOSE; CHLORHEXIDINE
AB Infectious stomatitis represents the most common oral cavity ailments. Current therapy is insufficiently effective because of the short residence time of topical liquid or semisolid medical formulations. An innovative application form based on bioadhesive polymers featuring prolonged residence time on the oral mucosa may be a solution to this challenge. This formulation consists of a mucoadhesive oral film with incorporated nanocomposite biomaterial that is able to release the drug directly at the target area. This study describes the unique approach of preparing mucoadhesive oral films from carmellose with incorporating a nanotechnologically modified clay mineral intercalated with chlorhexidine. The multivariate data analysis was employed to evaluate the influence of the formulation and process variables on the properties of the medical preparation. This evaluation was complemented by testing the antimicrobial and antimycotic activity of prepared films with the aim of finding the most suitable composition for clinical application. Generally, the best results were obtained with sample containing 20 mg of chlorhexidine diacetate carried by vermiculite, with carmellose in the form of nonwoven textile in its structure. In addition to its promising physicomechanical, chemical, and mucoadhesive properties, the formulation inhibited the growth of Staphylococcus and Candida; the effect was prolonged for tens of hours.
C1 [Gajdziok, Jan; Landova, Hana; Dolezel, Petr; Vetchy, David] Univ Vet & Pharmaceut Sci, Dept Pharmaceut, Brno 61242, Czech Republic.
   [Holesova, Sylva] Tech Univ Ostrava, Nanotechnol Ctr, Ostrava 70833, Czech Republic.
   [Holesova, Sylva] Tech Univ Ostrava, Ctr Excellence T4Innovat, Ostrava 70800, Czech Republic.
   [Stembirek, Jan] Univ Hosp Ostrava, Dept Maxillofacial Surg, Ostrava 70800, Czech Republic.
   [Pazdziora, Erich] Inst Publ Hlth Ostrava, Ctr Clin Labs, Ostrava 70200, Czech Republic.
RP Vetchy, D (reprint author), Univ Vet & Pharmaceut Sci, Dept Pharmaceut, Palackeho Trida 1-3, Brno 61242, Czech Republic.
EM vetchy@email.cz
RI Stembirek, Jan/G-7169-2014
OI Stembirek, Jan/0000-0002-1974-3096
FU Ministry of Health of the Czech Republic [1 RVO-FNOs/2012, NT14477]; IT4
   Innovations Centre of Excellence [CZ.1.05/1.1.00/02.0070]
FX This work was supported by Ministry of Health of the Czech Republic
   (Project no. 1 RVO-FNOs/2012 and Project no. NT14477) and the IT4
   Innovations Centre of Excellence (Project reg. no.
   CZ.1.05/1.1.00/02.0070). Authors also thank M. Heliova for SEM images
   and L. Pazourkova for particle size analysis.
CR Andrews GP, 2009, EUR J PHARM BIOPHARM, V71, P505, DOI 10.1016/j.ejpb.2008.09.028
   [Anonymous], 2000, AQUALON SODIUM CARBO
   Averineni RK, 2009, PHARM DEV TECHNOL, V14, P199, DOI 10.1080/10837450802498928
   Bali R, 2014, J MAXILLOFAC ORAL SU, V13, P128, DOI 10.1007/s12663-012-0458-3
   Barba C, 2002, CELLULOSE, V9, P319, DOI 10.1023/A:1021184509189
   Bergaya F, 2006, DEV CLAY SCI, V1, P1
   Bernkop-Schnurch A, 2005, ADV DRUG DELIVER REV, V57, P1569, DOI 10.1016/j.addr.2005.07.002
   Bertesteanu S, 2014, INT J PHARMACEUT, V463, P119, DOI [10.1016/j.jpharm.2013.12.012, 10.1016/j.ijpharm.2013.12.012]
   CAWSON RA, 2001, ORAL DIS CLIN PATHOL
   Cho HJ, 2010, INT J PHARMACEUT, V400, P59, DOI 10.1016/j.ijpharm.2010.08.030
   Coronado-Castellote Laura, 2013, J Clin Exp Dent, V5, pe279, DOI 10.4317/jced.51242
   DELACALLE C, 1988, REV MINERAL, V19, P455
   Ding J, 2012, ACTA BIOMATER, V8, P3643, DOI 10.1016/j.actbio.2012.06.027
   Dixit RP, 2009, J CONTROL RELEASE, V139, P94, DOI 10.1016/j.jconrel.2009.06.014
   Dorko E, 2001, FOLIA MICROBIOL, V46, P443, DOI 10.1007/BF02814436
   Dubolazov AV, 2006, BIOMACROMOLECULES, V7, P1637, DOI 10.1021/bm060090l
   Eisen D., 1998, MOUTH DIAGNOSIS TREA
   Esbensen K. H, 2004, MULTIVARIATE DATA AN
   European Directorate for the Quality of Medicines & Health Care, 2013, EUR PHARM 8 0
   Farmer V. C., 1974, INFRARED SPECTRA MIN
   Gajdziok J, 2012, CHEM LISTY, V106, P632
   Gurusamy K, 2013, COCHRANE DB SYST REV, V8
   Herrera P, 2000, VET MICROBIOL, V74, P259, DOI 10.1016/S0378-1135(00)00157-7
   Holesova S, 2014, MAT SCI ENG C-MATER, V42, P466, DOI 10.1016/j.msec.2014.05.054
   Holesova S, 2013, APPL CLAY SCI, V83-84, P17, DOI 10.1016/j.clay.2013.07.013
   Holesova S, 2010, J COLLOID INTERF SCI, V342, P593, DOI 10.1016/j.jcis.2009.10.051
   Hu CH, 2007, AQUACULTURE, V270, P200, DOI 10.1016/j.aquaculture.2007.01.027
   Hu CH, 2006, APPL CLAY SCI, V31, P180, DOI 10.1016/j.clay.2005.10.010
   Carretero MI, 2010, APPL CLAY SCI, V47, P171, DOI 10.1016/j.clay.2009.10.016
   Carretero MI, 2009, APPL CLAY SCI, V46, P73, DOI 10.1016/j.clay.2009.07.017
   Jain D, 2010, ACTA BIOMATER, V6, P1370, DOI 10.1016/j.actbio.2009.11.001
   Kneiflova J, 1988, Cesk Epidemiol Mikrobiol Imunol, V37, P97
   Kube T, 2006, GRAEF ARCH CLIN EXP, V244, P1385, DOI 10.1007/s00417-006-0326-2
   Kulicke WM, 1996, POLYMER, V37, P2723, DOI 10.1016/0032-3861(96)87634-8
   Kumar V., 2011, INT J PHARM BIOL SCI, V1, P89
   Lalla Rajesh V, 2013, J Calif Dent Assoc, V41, P263
   Lee JW, 2000, J PHARM SCI-US, V89, P850, DOI 10.1002/1520-6017(200007)89:7<850::AID-JPS2>3.3.CO;2-7
   Li HY, 2010, EUR J PHARM SCI, V40, P56, DOI 10.1016/j.ejps.2010.02.007
   Ma YL, 2010, APPL CLAY SCI, V50, P348, DOI 10.1016/j.clay.2010.08.025
   Macias JH, 2013, AM J INFECT CONTROL, V41, P634, DOI 10.1016/j.ajic.2012.10.002
   Madejova J, 2003, VIB SPECTROSC, V31, P1, DOI 10.1016/S0924-2031(02)00065-6
   Madhav NVS, 2012, EXPERT OPIN DRUG DEL, V9, P629, DOI 10.1517/17425247.2012.679260
   Magana SM, 2008, J MOL CATAL A-CHEM, V281, P192, DOI 10.1016/j.molcata.2007.10.024
   Malachova K, 2011, APPL CLAY SCI, V53, P642, DOI 10.1016/j.clay.2011.05.016
   Malachova K, 2009, APPL CLAY SCI, V43, P364, DOI 10.1016/j.clay.2008.11.003
   Mcginity J.W., 2002, Patent No. [US 6375963 BI, 6375963]
   Morales JO, 2011, EUR J PHARM BIOPHARM, V77, P187, DOI 10.1016/j.ejpb.2010.11.023
   Nafee NA, 2004, DRUG DEV IND PHARM, V30, P985, DOI 10.1081/DDC-200037245
   Nair AB, 2013, J CONTROL RELEASE, V166, P10, DOI 10.1016/j.jconrel.2012.11.019
   Ozdemir G, 2010, APPL CLAY SCI, V48, P319, DOI 10.1016/j.clay.2010.01.001
   Pasich Ewa, 2013, Medycyna Doswiadczalna i Mikrobiologia, V65, P187
   Perumal VA, 2008, INT J PHARM, V358, P184, DOI 10.1016/j.ijpharm.2008.03.005
   Pinto Andres, 2013, J Calif Dent Assoc, V41, P271
   Prajapati V., 2012, INT J PHARMTECH RES, V4, P582
   Prusov AN, 2007, FIBRE CHEM+, V39, P12, DOI 10.1007/s10692-007-0003-1
   Puratchikody A, 2011, ACTA PHARMACEUT, V61, P157, DOI 10.2478/v10007-011-0011-9
   Racz I, 1997, CELLULOSE, V4, P293, DOI 10.1023/A:1018400226052
   Rivera-Hidalgo F, 1999, PERIODONTOL 2000, V21, P106, DOI 10.1111/j.1600-0757.1999.tb00171.x
   Roy SK, 2010, TROP J PHARM RES, V9, P91
   Russell J. D., 1994, CLAY MINERALOGY SPEC, P11, DOI DOI 10.1007/978-94-011-0727-3_2
   Salamat-Miller N, 2005, ADV DRUG DELIVER REV, V57, P1666, DOI 10.1016/j.addr.2005.07.003
   Shidhaye SS, 2008, AAPS PHARMSCITECH, V9, P909, DOI 10.1208/s12249-008-9125-x
   Shizoru H., 1966, AM MINERAL, P1124
   SILVERSTEIN RM, 1991, SPECTROMETRIC IDENTI
   Slezak R., 2007, PREKLINICKA PARODONT
   SLsirak M., 2010, BOSNIAN J BASIC MED, V10, P32
   Socrates G., 2001, INFRARED RAMAN CHARA
   Sudhakar Y, 2006, J CONTROL RELEASE, V114, P15, DOI 10.1016/j.jconrel.2006.04.012
   Tan SZ, 2008, CHINESE J CHEM, V26, P865, DOI 10.1002/cjoc.200890160
   Tu YY, 2015, J FORMOS MED ASSOC, V114, P17, DOI 10.1016/j.jfma.2012.12.008
   Valaskova M, 2010, GEOCHIM COSMOCHIM AC, V74, P6287, DOI 10.1016/j.gca.2010.08.025
   Vetchy D, 2014, EUR J PHARM BIOPHARM, V86, P498, DOI 10.1016/j.ejpb.2013.12.002
   Walker G. F., 1961, XRAY IDENTIFICATION, P297
   Young H, 2014, J BONE JOINT SURG AM, V96A, P162, DOI 10.2106/JBJS.L.01379
NR 74
TC 3
Z9 3
U1 1
U2 30
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 580146
DI 10.1155/2015/580146
PG 15
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CH8RS
UT WOS:000354304400001
PM 26064926
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Bahl, S
   Shreyas, P
   Trishul, MA
   Suwas, S
   Chatterjee, K
AF Bahl, Sumit
   Shreyas, P.
   Trishul, M. A.
   Suwas, Satyam
   Chatterjee, Kaushik
TI Enhancing the mechanical and biological performance of a metallic
   biomaterial for orthopedic applications through changes in the surface
   oxide layer by nanocrystalline surface modification
SO NANOSCALE
LA English
DT Article
ID FATIGUE LIFE IMPROVEMENT; MESENCHYMAL STEM-CELLS; ATTRITION TREATMENT;
   STAINLESS-STEEL; THIN-FILMS; CRYSTALLOGRAPHIC TEXTURE; CORROSION
   BEHAVIOR; OPTICAL-PROPERTIES; TITANIUM-ALLOYS; GRAIN-SIZE
AB Nanostructured metals are a promising class of biomaterials for application in orthopedics to improve the mechanical performance and biological response for increasing the life of biomedical implants. Surface mechanical attrition treatment (SMAT) is an efficient way of engineering nanocrystalline surfaces on metal substrates. In this work, 316L stainless steel (SS), a widely used orthopedic biomaterial, was subjected to SMAT to generate a nanocrystalline surface. Surface nanocrystallization modified the nature of the oxide layer present on the surface. It increased the corrosion-fatigue strength in saline by 50%. This increase in strength is attributed to a thicker oxide layer, residual compressive stresses, high strength of the surface layer, and lower propensity for intergranular corrosion in the nanocrystalline layer. Nanocrystallization also enhanced osteoblast attachment and proliferation. Intriguingly, wettability and surface roughness, the key parameters widely acknowledged for controlling the cellular response remained unchanged after nanocrystallization. The observed cellular behavior is explained in terms of the changes in electronic properties of the semiconducting passive oxide film present on the surface of 316L SS. Nanocrystallization increased the charge carrier density of the n-type oxide film likely preventing denaturation of the adsorbed cell-adhesive proteins such as fibronectin. In addition, a net positive charge developed on the otherwise neutral oxide layer, which is known to facilitate cellular adhesion. The role of changes in the electronic properties of the oxide films on metal substrates is thus highlighted in this work. This study demonstrates the advantages of nanocrystalline surface modification by SMAT for processing metallic biomaterials used in orthopedic implants.
C1 [Bahl, Sumit; Shreyas, P.; Trishul, M. A.; Suwas, Satyam; Chatterjee, Kaushik] Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.
RP Chatterjee, K (reprint author), Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.
EM kchatterjee@materials.iisc.ernet.in
OI Bahl, Sumit/0000-0002-9471-5001; Chatterjee, Kaushik/0000-0002-7204-2926
FU Department of Science and Technology (DST), India; Department of Atomic
   Energy-Board of Research in Nuclear Sciences (DAE-BRNS), India; DST
FX This work was funded by the Department of Science and Technology (DST),
   India and Department of Atomic Energy-Board of Research in Nuclear
   Sciences (DAE-BRNS), India. K.C. acknowledges the Ramanujan fellowship
   from DST. The authors thank Prof. Praveen C. Ramamurthy for access to
   the electrochemical workstation. The help rendered by Prof. Chandan
   Srivastava and Dr Punith Kumar in impedance measurements is gratefully
   acknowledged.
CR Akl AA, 2004, APPL SURF SCI, V233, P307, DOI 10.1016/j.apsusc.2004.03.263
   Al-Kuhaili MF, 2012, J ALLOY COMPD, V521, P178, DOI 10.1016/j.jallcom.2012.01.115
   Arifvianto B, 2011, MATER CHEM PHYS, V125, P418, DOI 10.1016/j.matchemphys.2010.10.038
   Bahl S, 2014, RSC ADV, V4, P55677, DOI 10.1039/c4ra08484e
   Bahl S, 2014, RSC ADV, V4, P38078, DOI 10.1039/c4ra05440g
   Bain LE, 2013, ACS APPL MATER INTER, V5, P7236, DOI 10.1021/am4015555
   Bigi A, 2007, J BIOMED MATER RES A, V82A, P213, DOI 10.1002/jbm.a.31132
   Chen F, 2007, J BIOMED MATER RES B, V82B, P183, DOI 10.1002/jbm.b.30720
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   Chimmalgi A, 2005, J APPL PHYS, V97, DOI 10.1063/1.1899245
   Cowin S., 1987, HDB BIOENGINEERING
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Di Schino A, 2002, J MATER SCI LETT, V21, P1631, DOI 10.1023/A:1020338103964
   Feng ZC, 2010, CORROS SCI, V52, P3646, DOI 10.1016/j.corsci.2010.07.013
   Gelderman K, 2007, J CHEM EDUC, V84, P685, DOI 10.1021/ed084p685
   Gittens RA, 2012, BIOMATERIALS, V33, P8986, DOI 10.1016/j.biomaterials.2012.08.059
   Guillemot F, 2004, APPL PHYS A-MATER, V79, P811, DOI 10.1007/s00339-004-2688-9
   HOEPPNER DW, 1994, WEAR, V173, P189, DOI 10.1016/0043-1648(94)90272-0
   Huiskes R, 1993, Acta Orthop Belg, V59 Suppl 1, P118
   Khang D, 2012, BIOMATERIALS, V33, P5997, DOI 10.1016/j.biomaterials.2012.05.005
   Kim TN, 2007, BIOMED MATER, V2, pS117, DOI 10.1088/1748-6041/2/3/S06
   Knoner G, 2003, P NATL ACAD SCI USA, V100, P3870, DOI 10.1073/pnas.0730783100
   Liu XD, 2006, CORROS SCI, V48, P3309, DOI 10.1016/j.corsci.2005.12.003
   Lu K, 2004, MAT SCI ENG A-STRUCT, V375, P38, DOI 10.1016/j.msea.2003.10.261
   Ma E, 2003, SCRIPTA MATER, V49, P663, DOI 10.1016/S1359-6462(03)00396-8
   Mathieu JP, 2006, J MATER PROCESS TECH, V173, P29, DOI 10.1016/j.jmatprotec.2005.11.007
   McCafferty E, 2003, CORROS SCI, V45, P1421, DOI 10.1016/S0010-938X(02)00231-7
   Mehranfar M, 2011, MAT SCI ENG A-STRUCT, V528, P3404, DOI 10.1016/j.msea.2011.01.016
   Miyamoto H, 2008, CORROS SCI, V50, P1215, DOI 10.1016/j.corsci.2008.01.024
   Mordyuk BN, 2006, MAT SCI ENG A-STRUCT, V437, P396, DOI 10.1016/j.msea.2006.07.119
   NAVAI F, 1995, J MATER SCI, V30, P1166, DOI 10.1007/BF00356115
   Petersson IU, 2009, BIOMATERIALS, V30, P4471, DOI 10.1016/j.biomaterials.2009.05.042
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   ROFAGHA R, 1991, SCRIPTA METALL MATER, V25, P2867, DOI 10.1016/0956-716X(91)90171-V
   Roland T, 2006, SCRIPTA MATER, V54, P1949, DOI 10.1016/j.scriptamat.2006.01.049
   Sato M, 2004, SCI TECHNOL ADV MAT, V5, P145, DOI 10.1016/j.stam.2003.10.015
   Shaarbaf M, 2008, MAT SCI ENG A-STRUCT, V473, P28, DOI 10.1016/j.msea.2007.03.065
   Shahab F, 2006, BIOMATERIALS, V27, P3532, DOI 10.1016/j.biomaterials.2006.02.027
   Steinemann SG, 1986, BIOL BIOMECHANICAL P
   Takakuwa O, 2012, INT J HYDROGEN ENERG, V37, P5268, DOI 10.1016/j.ijhydene.2011.12.035
   Tao NR, 2002, ACTA MATER, V50, P4603, DOI 10.1016/S1359-6454(02)00310-5
   Tian YS, 2005, APPL SURF SCI, V242, P177, DOI 10.1016/j.apsusc.2004.08.011
   Tsay LW, 2008, CORROS SCI, V50, P2506, DOI 10.1016/j.corsci.2008.06.044
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   Wang TS, 2006, SURF COAT TECH, V200, P4777, DOI 10.1016/j.surfcoat.2005.04.046
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Williams D. F., 1977, P INT S RETR AN ORTH
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
   Xie JH, 2002, MATER CHARACT, V48, P271, DOI 10.1016/S1044-5803(02)00245-0
   Zhang HW, 2003, ACTA MATER, V51, P1871, DOI 10.1016/S1359-6454(02)00594-3
NR 50
TC 18
Z9 18
U1 0
U2 34
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-3364
EI 2040-3372
J9 NANOSCALE
JI Nanoscale
PY 2015
VL 7
IS 17
BP 7704
EP 7716
DI 10.1039/c5nr00574d
PG 13
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CH4DI
UT WOS:000353981700026
PM 25833718
OA Bronze
DA 2018-10-19
ER

PT J
AU Johnson, NR
   Wang, YD
AF Johnson, Noah R.
   Wang, Yadong
TI Drug Delivery Systems for Wound Healing
SO CURRENT PHARMACEUTICAL BIOTECHNOLOGY
LA English
DT Article
DE Biomaterial; coacervate; controlled release; drug delivery; hydrogel;
   microparticle; scaffold; wound healing
ID FIBROBLAST-GROWTH-FACTOR; INCORPORATED COLLAGEN MATRICES; LOCAL
   ANTIBIOTIC DELIVERY; GENETICALLY DIABETIC MICE; INDUCED DECUBITUS ULCER;
   IMPAIRED DB/DB MICE; IN-VITRO EVALUATION; FULL-THICKNESS; FIBRIN
   SCAFFOLD; TISSUE REGENERATION
AB Protein, gene, and small molecule therapies hold great potential for facilitating comprehensive tissue repair and regeneration. However, their clinical value will rely on effective delivery systems which maximize their therapeutic benefit. Significant advances have been made in recent years towards biomaterial delivery systems to satisfy this clinical need. Here we summarize the most outstanding advances in drug delivery technology for cutaneous wound healing.
C1 [Johnson, Noah R.; Wang, Yadong] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Johnson, Noah R.; Wang, Yadong] McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Wang, Yadong] Univ Pittsburgh, Dept Chem & Petr Engn, Pittsburgh, PA 15219 USA.
   [Wang, Yadong] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
   [Wang, Yadong] Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15219 USA.
RP Wang, YD (reprint author), 320 Benedum Hall,3700 OHara St, Pittsburgh, PA 15261 USA.
EM yaw20@pitt.edu
FU National Institutes of Health (NIH) [2T32HL076124]; National Science
   Foundation (NSF) [IIP-1444774]; American Heart Association
   [12EIA9020016]
FX The authors would like to thank Dr. Mantosh Sinha for providing the
   hydrogel image, Dr. Eric Jeffries for providing the electrospun scaffold
   image, and Mr. Andrew Glowacki for providing the microparticles image.
   This work was supported by grants from the National Institutes of Health
   (NIH 2T32HL076124), the National Science Foundation (NSF IIP-1444774),
   and the American Heart Association (12EIA9020016).
CR Adhirajan N, 2009, EUR J PHARM SCI, V36, P235, DOI 10.1016/j.ejps.2008.09.010
   Adhirajan N, 2009, J PHARM PHARMACOL, V61, P1617, DOI 10.1211/jpp/61.12.0005
   [Anonymous], 2012, REVIEW
   Anumolu SS, 2011, BIOMATERIALS, V32, P1204, DOI 10.1016/j.biomaterials.2010.08.117
   Arul V, 2005, J BIOMED MATER RES B, V73B, P383, DOI 10.1002/jbm.b.30246
   Arul V, 2012, J BIOMATER APPL, V26, P917, DOI 10.1177/0885328210390402
   Arul V, 2007, LIFE SCI, V80, P275, DOI 10.1016/j.lfs.2006.09.018
   Balakrishnan B, 2006, BIOMATERIALS, V27, P1355, DOI 10.1016/j.biomaterials.2005.08.021
   Balakrishnan B, 2005, BIOMATERIALS, V26, P6335, DOI 10.1016/j.biomaterials.2005.04.012
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Behm B., 2011, J EUR ACAD DERMATOL
   Bertoncelj V., 2014, EUR J PHARM BIOPHARM
   Blecher K, 2012, NANOMED-NANOTECHNOL, V8, P1364, DOI 10.1016/j.nano.2012.02.014
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Branski LK, 2007, GENE THER, V14, P1, DOI 10.1038/sj.gt.3302837
   Breen A, 2009, TISSUE ENG PART B-RE, V15, P201, DOI [10.1089/ten.teb.2008.0527, 10.1089/ten.TEB.2008.0527]
   Breen A, 2009, J BIOMED MATER RES A, V89A, P876, DOI 10.1002/jbm.a.32039
   Breen AM, 2008, BIOMATERIALS, V29, P3143, DOI 10.1016/j.biomaterials.2008.04.020
   Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Chereddy KK, 2013, J CONTROL RELEASE, V171, P208, DOI 10.1016/j.jconrel.2013.07.015
   Choi JS, 2008, BIOMATERIALS, V29, P587, DOI 10.1016/j.biomaterials.2007.10.012
   Choi JS, 2011, J MATER CHEM, V21, P5258, DOI 10.1039/c0jm03706k
   Choi JK, 2012, BIOMATERIALS, V33, P8579, DOI 10.1016/j.biomaterials.2012.07.061
   Chu HH, 2011, J CONTROL RELEASE, V150, P157, DOI 10.1016/j.jconrel.2010.11.025
   Chu YJ, 2010, WOUND REPAIR REGEN, V18, P499, DOI 10.1111/j.1524-475X.2010.00612.x
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   de Kruif CG, 2004, CURR OPIN COLLOID IN, V9, P340, DOI 10.1016/j.cocis.2004.09.006
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   *FDA, 2008, HLTH HUMAN SERVICES
   Fu SZ, 2014, J BIOMED MATER RES B, V102, P533, DOI 10.1002/jbm.b.33032
   Gainza G, 2014, J CONTROL RELEASE, V185, P51, DOI 10.1016/j.jconrel.2014.04.032
   Geer DJ, 2005, AM J PATHOL, V167, P1575, DOI 10.1016/S0002-9440(10)61242-4
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Gomathi K, 2003, BIOMATERIALS, V24, P2767, DOI 10.1016/S0142-9612(03)00059-0
   Gong CY, 2013, BIOMATERIALS, V34, P6377, DOI 10.1016/j.biomaterials.2013.05.005
   Gopinath D, 2004, BIOMATERIALS, V25, P1911, DOI 10.1016/S0142-9612(03)00625-2
   Guo R, 2011, BIOMATERIALS, V32, P1019, DOI 10.1016/j.biomaterials.2010.08.087
   Guo R, 2010, BIOMATERIALS, V31, P7308, DOI 10.1016/j.biomaterials.2010.06.013
   Han G, 2012, AM J PATHOL, V180, P1465, DOI 10.1016/j.ajpath.2011.12.013
   Hardwicke J, 2008, J CONTROL RELEASE, V130, P275, DOI 10.1016/j.jconrel.2008.07.023
   Hardwicke J, 2010, MOL PHARMACEUT, V7, P699, DOI 10.1021/mp9002656
   Hardwicke JT, 2011, J CONTROL RELEASE, V152, P411, DOI 10.1016/j.jconrel.2011.03.016
   Henderson PW, 2011, WOUND REPAIR REGEN, V19, P420, DOI 10.1111/j.1524-475X.2011.00687.x
   Hirsch T, 2007, FRONT BIOSCI-LANDMRK, V12, P2507, DOI 10.2741/2251
   Hollier B, 2005, EXP CELL RES, V305, P221, DOI 10.1016/j.yexcr.2005.01.004
   Hong JP, 2008, ANN PLAS SURG, V61, P457, DOI 10.1097/SAP.0b013e31815b1feac
   Hong SR, 2001, BIOMATERIALS, V22, P2777, DOI 10.1016/S0142-9612(01)00021-7
   Huang S, 2006, J MICROENCAPSUL, V23, P277, DOI 10.1080/02652040500435170
   Huang X, 2001, J CONTROL RELEASE, V73, P121, DOI 10.1016/S0168-3659(01)00248-6
   Huang ZF, 2011, WOUND REPAIR REGEN, V19, P633, DOI 10.1111/j.1524-475X.2011.00722.x
   Hyde C, 2004, J INVEST DERMATOL, V122, P1198, DOI 10.1111/j.0022-202X.2004.022527.x
   Ishihara Masayuki, 2006, Current Drug Delivery, V3, P351, DOI 10.2174/156720106778559047
   Ito R, 2013, TISSUE ENG PT A, V19, P1398, DOI [10.1089/ten.tea.2012.0375, 10.1089/ten.TEA.2012.0375]
   Jackson SR, 2009, J ORTHOP RES, V27, P903, DOI 10.1002/jor.20828
   Jiang W, 2008, J ALLOY COMPD, V459, P508, DOI 10.1016/j.jallcom.2007.05.020
   Johnson N.R., 2014, EXPERT OPIN DRUG DEL, P1
   Johnson NR, 2014, ACTA BIOMATER, V10, P40, DOI 10.1016/j.actbio.2013.09.012
   Johnson NR, 2013, J CONTROL RELEASE, V166, P124, DOI 10.1016/j.jconrel.2012.11.004
   Kamel RA, 2013, J AM COLL SURGEONS, V217, P533, DOI 10.1016/j.jamcollsurg.2013.03.027
   Kanda N, 2014, J TISSUE ENG REGEN M, V8, P29, DOI 10.1002/term.1492
   Kanda N, 2012, ANN PLAS SURG, V69, P569, DOI 10.1097/SAP.0b013e318222832f
   Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041
   Kawai K, 2005, BRIT J PLAST SURG, V58, P1115, DOI 10.1016/j.bjps.2005.04.010
   Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672
   Kondo S, 2012, J BIOMAT SCI-POLYM E, V23, P629, DOI 10.1163/092050611X555687
   Koria P, 2012, BIODRUGS, V26, P163, DOI 10.2165/11631850-000000000-00000
   Koria P, 2011, P NATL ACAD SCI USA, V108, P1034, DOI 10.1073/pnas.1009881108
   Kulkarni M, 2014, BIOMATERIALS, V35, P2001, DOI 10.1016/j.biomaterials.2013.11.003
   Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001
   Lai H.-J., 2014, ACTA BIOMATER
   Lee JH, 2013, J PHARM SCI-US, V102, P4109, DOI 10.1002/jps.23725
   Lee KW, 2013, BIOMATERIALS, V34, P9877, DOI 10.1016/j.biomaterials.2013.08.082
   Li B, 2009, BIOMATERIALS, V30, P3486, DOI 10.1016/j.biomaterials.2009.03.008
   Li Y, 2010, MOL PHARMACEUT, V7, P254, DOI [10.1021/mp900237f, 10.1021/mp900237t]
   Liu YC, 2007, WOUND REPAIR REGEN, V15, P245, DOI 10.1111/j.1524-475X.2007.00211.x
   Losi P, 2013, ACTA BIOMATER, V9, P7814, DOI 10.1016/j.actbio.2013.04.019
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MacEwan SR, 2010, BIOPOLYMERS, V94, P60, DOI 10.1002/bip.21327
   Martinez LR, 2009, J INVEST DERMATOL, V129, P2463, DOI 10.1038/jid.2009.95
   Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614
   Matsumoto S, 2013, PRS-GLOB OPEN, V1, DOI 10.1097/GOX.0b013e3182a88787
   Matsumoto Y, 2010, J BIOMAT SCI-POLYM E, V21, P715, DOI 10.1163/156856209X435844
   Meng X, 2010, J MATER SCI-MATER M, V21, P1751, DOI 10.1007/s10856-010-3996-6
   Merrell JG, 2009, CLIN EXP PHARMACOL P, V36, P1149, DOI 10.1111/j.1440-1681.2009.05216.x
   Mi FL, 2002, J BIOMED MATER RES, V59, P438, DOI 10.1002/jbm.1260
   Mi FL, 2003, J MEMBRANE SCI, V212, P237, DOI 10.1016/S0376-7388(02)00505-7
   Mizuno K, 2003, J BIOMED MATER RES A, V64A, P177, DOI 10.1002/jbm.a.10396
   Moura LIF, 2014, ACTA BIOMATER, V10, P843, DOI 10.1016/j.actbio.2013.09.040
   Tran NQ, 2011, BIOMACROMOLECULES, V12, P2872, DOI 10.1021/bm200326g
   Noel SP, 2008, CLIN ORTHOP RELAT R, V466, P1377, DOI 10.1007/s11999-008-0228-1
   Obara K, 2003, BIOMATERIALS, V24, P3437, DOI 10.1016/S0142-9612(03)00220-5
   OVERBEEK JAN THEODOOR GERARD, 1957, J CELL AND COMP PHYSIOL, V49, P7, DOI 10.1002/jcp.1030490404
   Pandit AS, 2000, J BIOMATER APPL, V14, P229, DOI 10.1177/088532820001400303
   Pandit AS, 1998, GROWTH FACTORS, V15, P113, DOI 10.3109/08977199809117187
   Park HJ, 2012, BIOMATERIALS, V33, P9148, DOI 10.1016/j.biomaterials.2012.09.005
   Porporato PE, 2012, ANGIOGENESIS, V15, P581, DOI 10.1007/s10456-012-9282-0
   Rabbany SY, 2010, CELL TRANSPLANT, V19, P399, DOI 10.3727/096368909X481782
   Ribeiro MP, 2013, MAT SCI ENG C-MATER, V33, P2958, DOI 10.1016/j.msec.2013.03.025
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Smith JK, 2013, CLIN ORTHOP RELAT R, V471, P3158, DOI 10.1007/s11999-013-2988-5
   Smith JK, 2010, J BIOMED MATER RES B, V94B, P203, DOI 10.1002/jbm.b.31642
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   Stinner DJ, 2010, J ORTHOP TRAUMA, V24, P592, DOI 10.1097/BOT.0b013e3181ed296c
   Sun WJ, 2010, J BIOMED MATER RES A, V92A, P887, DOI 10.1002/jbm.a.32445
   Tan Q, 2014, J TISSUE ENG REGEN M, V8, P195, DOI 10.1002/term.1513
   Tortelli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079610
   Trentin D, 2006, P NATL ACAD SCI USA, V103, P2506, DOI 10.1073/pnas.0505964102
   Uebersax L, 2009, TISSUE ENG PART B-RE, V15, P263, DOI 10.1089/ten.TEB.2008.0668
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   Upton Z, 2008, J INVEST DERMATOL, V128, P1535, DOI 10.1038/sj.jid.5701148
   Upton Z, 2011, INT WOUND J, V8, P522, DOI 10.1111/j.1742-481X.2011.00859.x
   Wang W, 2008, LIFE SCI, V82, P190, DOI 10.1016/j.lfs.2007.11.009
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Xie Y., 2011, J CONTROL RELEASE
   Xie ZW, 2013, ACTA BIOMATER, V9, P9351, DOI 10.1016/j.actbio.2013.07.030
   Yan X, 2010, DIABETES RES CLIN PR, V90, P66, DOI 10.1016/j.diabres.2010.07.001
   Yang HS, 2011, EXP MOL MED, V43, P622, DOI 10.3858/emm.2011.43.11.070
   Yang Y, 2012, MOL PHARMACEUT, V9, P48, DOI 10.1021/mp200246b
   Yang Y, 2011, BIOMATERIALS, V32, P4243, DOI 10.1016/j.biomaterials.2011.02.042
NR 123
TC 5
Z9 5
U1 1
U2 25
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2010
EI 1873-4316
J9 CURR PHARM BIOTECHNO
JI Curr. Pharm. Biotechnol.
PY 2015
VL 16
IS 7
BP 621
EP 629
DI 10.2174/1389201016666150206113720
PG 9
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA CG9QZ
UT WOS:000353654100005
PM 25658378
DA 2018-10-19
ER

PT J
AU Dubey, P
   Nawale, L
   Sarkar, D
   Nisal, A
   Prabhune, A
AF Dubey, Parul
   Nawale, Laxman
   Sarkar, Dhiman
   Nisal, Anuya
   Prabhune, Asmita
TI Sophorolipid assisted tunable and rapid gelation of silk fibroin to form
   porous biomedical scaffolds
SO RSC ADVANCES
LA English
DT Article
ID HYDROGELS; BIOMATERIAL; GROWTH; ASSAY; SOL
AB Three dimensional polymer hydrogels, based on both natural and synthetic polymers, are increasingly being used as scaffolds and drug delivery vehicles for biomedical applications. Fibrous protein, silk fibroin (SF), obtained from the Bombyx mori silkworm is a promising candidate in this area. However, SF has a long gelation time of about a few weeks that can only be reduced by non-physiological treatments (e. g. high temperature, ultrasonication and low pH) or by addition of a chemical and non-biodegradable polymer and/or surfactant. We report here accelerated gelation of SF under physiological conditions using a biosurfactant, sophorolipid (SL) as a gelling agent. SL and SF are completely miscible and form a very clear solution upon mixing. Hence it is interesting to see that this clear solution gels in a time span of just a few hours. The hydrogels so formed have pore architecture, porosities and mechanical stability ideally suited for tissue culture applications. Here we also demonstrate that mouse fibroblast cells not only adhere to but also extensively proliferate on these SF-SL scaffolds.
C1 [Dubey, Parul; Prabhune, Asmita] Natl Chem Lab, Biochem Sci Div, Pune 411008, Maharashtra, India.
   [Nawale, Laxman; Sarkar, Dhiman] Natl Chem Lab, Combichem Bioresource Ctr, OCD, Pune 411008, Maharashtra, India.
   [Nisal, Anuya] Natl Chem Lab, Polymer Sci & Engn Dept, Pune 411008, Maharashtra, India.
RP Nisal, A (reprint author), Natl Chem Lab, Polymer Sci & Engn Dept, Pune 411008, Maharashtra, India.
EM aa.nisal@ncl.res.in; aa.prabhune@ncl.res.in
FU Council of Scientific and Industrial Research, New Delhi, India; 12th
   Five Year Plan project "Molecules to Materials to devices" [CSC00134]
FX This work is financially supported by the Council of Scientific and
   Industrial Research, New Delhi, India and the 12th Five Year Plan
   project CSC00134 titled "Molecules to Materials to devices". Authors
   would like to thank Ms Chaitali Deshpande for her help during
   rheological measurements.
CR Ashby RD, 2008, BIOTECHNOL LETT, V30, P1093, DOI 10.1007/s10529-008-9653-1
   Balakrishnan B, 2011, CHEM REV, V111, P4453, DOI 10.1021/cr100123h
   Borzeix F., 2000, US Patent, Patent No. [6.057.302, 6057302]
   Casas JA, 1999, J BIOSCI BIOENG, V88, P488, DOI 10.1016/S1389-1723(00)87664-1
   Chen J., 2006, ENZYME MICROB TECHNO, V39, P501, DOI DOI 10.1016/J.ENZMICTEC.2005.12.022
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   D'Britto V, 2011, NANOSCALE, V3, P2957, DOI 10.1039/c1nr10154d
   Dengle-Pulate V., 2013, J SURFACTANTS DETERG, V17, P543
   Gil ES, 2011, J BIOMED MATER RES A, V99A, P16, DOI 10.1002/jbm.a.33158
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Joshi-Navare K, 2013, BIOMED RES INT, DOI 10.1155/2013/512495
   Joshi-Navare K, 2011, BIOTECHNOL J, V6, P509, DOI 10.1002/biot.201000345
   Kang GD, 2000, MACROMOL RAPID COMM, V21, P788, DOI 10.1002/1521-3927(20000701)21:11<788::AID-MARC788>3.3.CO;2-O
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kjellin M., 2010, SURFACTANTS RENEWABL, P213
   Kundu B, 2012, BIOMATERIALS, V33, P7456, DOI 10.1016/j.biomaterials.2012.06.091
   Leisk GG, 2010, ADV MATER, V22, P711, DOI 10.1002/adma.200902643
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nagarkar S., 2014, US Pat., Patent No. [8779097 B2, 78779097]
   Nagarkar S, 2009, IND ENG CHEM RES, V48, P8014, DOI 10.1021/ie801723f
   Rammensee S, 2006, APPL PHYS A-MATER, V82, P261, DOI 10.1007/s00339-005-3431-x
   Shah V, 2005, ANTIMICROB AGENTS CH, V49, P4093, DOI 10.1128/AAC.49.10.4093-4100.2005
   Van Bogaert INA, 2007, APPL MICROBIOL BIOT, V76, P23, DOI 10.1007/s00253-007-0988-7
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang L, 2013, J BIOMATER NANOBIOTE, V4, P213, DOI DOI 10.4236/JBNB.2013.43026
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wu XL, 2012, ACTA BIOMATER, V8, P2185, DOI 10.1016/j.actbio.2012.03.007
   Yamamoto M, 2000, J MATER SCI-MATER M, V11, P213, DOI 10.1023/A:1008960024262
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yucel T, 2010, J STRUCT BIOL, V170, P406, DOI 10.1016/j.jsb.2009.12.012
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
NR 32
TC 6
Z9 6
U1 1
U2 12
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 43
BP 33955
EP 33962
DI 10.1039/c5ra04317d
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CG3GR
UT WOS:000353167500032
DA 2018-10-19
ER

PT J
AU Mei, FF
   Peng, Y
   Lu, ST
   Sun, F
   Zhang, Y
   Ge, C
   Zhang, Y
   Gu, HL
   Wang, YD
   Zhao, XW
   Wang, GY
AF Mei, Fangfang
   Peng, Ya
   Lu, Shoutao
   Sun, Fei
   Zhang, Ying
   Ge, Cui
   Zhang, Yong
   Gu, Hualin
   Wang, Yangdan
   Zhao, Xinwei
   Wang, Guoyao
TI Synthesis and Characterization of Biodegradable Poly(lactic-co-glycolic
   acid)
SO Journal of Macromolecular Science Part B-Physics
LA English
DT Article
DE biodegradable; biomaterial; hydrophilicity; poly(lactic-co-glycolic
   acid)
ID DEGRADATION; BLENDS
AB A series of poly(lactic-co-glycolic acid) (PLGA) was synthesized by bulk ring-opening copolymerization with different ratios of L-lactic acid (L-LA) to glycolic acid (GA); stannous octoate [Sn(Oct)2] was used as catalyst. The structures were characterized by FT-IR. The crystallinity and the glass-transition temperature (T-g) were studied by differential scanning calorimeter (DSC). T-g decreased with the increase of GA and the rate of degradation and degree of hydrophilicity increased with the increased content of GA.
C1 [Mei, Fangfang; Peng, Ya; Lu, Shoutao; Sun, Fei] XiHua Univ, Ctr Mat & Energy, Chengdu 610039, Peoples R China.
   [Peng, Ya; Zhang, Ying; Ge, Cui; Zhang, Yong; Gu, Hualin; Wang, Yangdan; Wang, Guoyao] XiHua Univ, Sch Mat Sci & Engn, Chengdu 610039, Peoples R China.
   [Zhao, Xinwei] Tokyo Univ Sci, Dept Phys, Tokyo 162, Japan.
RP Peng, Y (reprint author), XiHua Univ, Sch Mat Sci & Engn, Chengdu 610039, Peoples R China.
EM pengyar@mail.xhu.edu.cn
FU Chinese Ministry of Education [210193]; Science and Technology
   Department of Sichuan Province [2006J13-055]; Educational Commission of
   Sichuan Province of China [12ZA159]; Spring Sunshine Plan of the
   Ministry of Education of China [z20100193]
FX This work was carried out with financial support from the Key Project of
   Chinese Ministry of Education (210193), Applied Fundamental Program from
   Science and Technology Department of Sichuan Province (2006J13-055),
   Educational Commission of Sichuan Province of China (12ZA159), and the
   Spring Sunshine Plan of the Ministry of Education of China (z20100193).
CR Bhardwaj U, 2010, INT J PHARMACEUT, V384, P78, DOI 10.1016/j.ijpharm.2009.09.046
   Chen CC, 2003, BIOMATERIALS, V24, P1167, DOI 10.1016/S0142-9612(02)00466-0
   Claes LE, 1996, BIOMATERIALS, V17, P1621, DOI 10.1016/0142-9612(95)00327-4
   Hosseinabadi M.E., 2011, POLYM DEGRAD STABIL, V27, P1105
   Jahno VD, 2007, J BIOMED MATER RES A, V83A, P209, DOI 10.1002/jbm.a.31210
   Lao LH, 2011, J MATER SCI-MATER M, V22, P1873, DOI 10.1007/s10856-011-4374-8
   Liu LJ, 2001, CHINESE CHEM LETT, V12, P663
   Lu DD, 2008, J POLYM SCI POL CHEM, V46, P3802, DOI 10.1002/pola.22729
   MILLER RA, 1977, J BIOMED MATER RES, V11, P711, DOI 10.1002/jbm.820110507
   Nahar M, 2009, PHARM RES-DORD, V26, P2588, DOI 10.1007/s11095-009-9973-4
   Pandey A, 2008, J MECH BEHAV BIOMED, V1, P227, DOI 10.1016/j.jmbbm.2007.12.001
   Park JK, 2011, ADV FUNCT MATER, V21, P2906, DOI 10.1002/adfm.201100612
   Soares JS, 2010, BIOMATERIALS, V31, P3032, DOI 10.1016/j.biomaterials.2010.01.008
   Steele TWJ, 2011, ACTA BIOMATER, V7, P1973, DOI 10.1016/j.actbio.2011.02.002
   Wang XY, 2008, MACROMOLECULES, V41, P2791, DOI 10.1021/ma702705s
   Zamiri P, 2010, BIOMATERIALS, V31, P7847, DOI 10.1016/j.biomaterials.2010.06.057
NR 16
TC 2
Z9 2
U1 1
U2 23
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0022-2348
EI 1525-609X
J9 J MACROMOL SCI B
JI J. Macromol. Sci. Part B-Phys.
PY 2015
VL 54
IS 5
BP 562
EP 570
DI 10.1080/00222348.2014.1002325
PG 9
WC Polymer Science
SC Polymer Science
GA CG8ON
UT WOS:000353567700006
DA 2018-10-19
ER

PT J
AU Ding, XL
   Wei, X
   Huang, Y
   Guan, CD
   Zou, TQ
   Wang, S
   Liu, HF
   Fan, YB
AF Ding, Xili
   Wei, Xing
   Huang, Yan
   Guan, Changdong
   Zou, Tongqiang
   Wang, Shuo
   Liu, Haifeng
   Fan, Yubo
TI Delivery of demineralized bone matrix powder using a salt-leached silk
   fibroin carrier for bone regeneration
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; IN-VITRO; OSTEOGENIC
   DIFFERENTIATION; BIOMATERIAL SCAFFOLDS; EXTRACELLULAR-MATRIX; VASCULAR
   GRAFTS; COMPOSITE; REPAIR; HYDROXYAPATITE
AB Demineralized bone matrix (DBM) has been widely used for bone regeneration due to its osteoinductivity and osteoconductivity. However, the use of DBM powder is limited due to the difficulties in handling, the tendency to migrate from graft sites and the lack of stability after surgery. In this study, a mechanically stable, salt-leached porous silk fibroin carrier was used to improve the handling properties of DBM powder and to support the attachment, proliferation and osteogenic differentiation of rat bone marrow derived mesenchymal stem cells (rBMSCs). The DBM-silk fibroin (DBM/SF) scaffolds were fabricated with different contents of DBM powder (0%, 10%, 20%, 40% and 80% DBM/SF scaffolds). It was found that the DBM/SF scaffolds could form a stable composite preventing the migration of DBM powder. Moreover, the microarchitecture and mechanical properties of the scaffolds were influenced by the DBM powder. rBMSCs were seeded on the DBM/SF scaffolds and cultured for 14 days. Cell proliferation assays and cell morphology observations indicated that 20% DBM/SF scaffolds exhibited good cell attachment and proliferation. In addition, compared with the other groups, the cellular function was more actively exhibited on 20% DBM/SF scaffolds, as evident by the real-time reverse transcriptase-polymerase chain reaction (RT-PCR) analysis for osteoblast-related gene markers (e.g. COL1A1, ALP and cbfa1), the immunocytochemical evaluations of osteoblast-related extracellular matrix components (e.g. COL1A1, OCN and ONN) and the ALP activities. All the data suggested that DBM powder could be delivered using a silk fibroin carrier with improved handling characteristics and that 20% DBM/SF scaffolds had great potential as osteogenesis promoting scaffolds for successful applications in bone regeneration.
C1 [Ding, Xili; Huang, Yan; Guan, Changdong; Zou, Tongqiang; Liu, Haifeng; Fan, Yubo] Beihang Univ, Key Lab Biomechan & Mechnobiol, Int Res Ctr Implantable & Intervent Med Devices, Minist Educ,Sch Biol Sci & Med Engn, Beijing 100191, Peoples R China.
   [Wei, Xing; Wang, Shuo] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Orthopaed, Beijing 100048, Peoples R China.
RP Liu, HF (reprint author), Beihang Univ, Key Lab Biomechan & Mechnobiol, Int Res Ctr Implantable & Intervent Med Devices, Minist Educ,Sch Biol Sci & Med Engn, Beijing 100191, Peoples R China.
EM haifengliu@buaa.edu.cn; yubofan@buaa.edu.cn
FU National Key Technology RD Program [2012BAI18B06]; National Natural
   Science Foundation of China [31470938, 81171473, 61227902, 11421202,
   11120101001]; International Joint Research Center of Aerospace
   Biotechnology and Medical Engineering from Ministry of Science and
   Technology of China; 111 Project [B13003]; Research Fund for the
   Doctoral Program of Higher Education of China [20131102130004];
   Fundamental Research Funds for the Central Universities
FX This work was supported by the National Key Technology R&D Program
   (2012BAI18B06), the National Natural Science Foundation of China
   (31470938, 81171473, 61227902, 11421202 and 11120101001), the
   International Joint Research Center of Aerospace Biotechnology and
   Medical Engineering from Ministry of Science and Technology of China,
   the 111 Project (B13003), the Research Fund for the Doctoral Program of
   Higher Education of China (20131102130004) and the Fundamental Research
   Funds for the Central Universities.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Anderson HC, 2004, AM J PATHOL, V164, P841, DOI 10.1016/S0002-9440(10)63172-0
   Behnam K, 2006, CONNECT TISSUE RES, V47, P271, DOI 10.1080/03008200600995908
   Dall'Agnol Rosiris, 2003, Acta Cir. Bras., V18, P0, DOI 10.1590/S0102-86502003000300003
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   Duvall CL, 2004, AM J PHYSIOL-HEART C, V287, pH302, DOI 10.1152/ajpheart.00928.2003
   Gertzman Arthur A., 2001, Cell and Tissue Banking, V2, P87, DOI 10.1023/A:1014398514168
   Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008
   Han B, 2003, CONNECT TISSUE RES, V44, P160, DOI 10.1080/03008200390215863
   Han B, 2003, J ORTHOPAED RES, V21, P648, DOI 10.1016/S0736-0266(03)00005-6
   Ho ST, 2006, BIOMATERIALS, V27, P1362, DOI 10.1016/j.biomaterials.2005.08.035
   Holt DJ, 2012, ADV DRUG DELIVER REV, V64, P1123, DOI 10.1016/j.addr.2012.04.002
   Huang Y, 2012, NANOSCALE, V4, P2484, DOI 10.1039/c2nr12072k
   Huang Y, 2010, ARCH MED RES, V41, P497, DOI 10.1016/j.arcmed.2010.10.002
   Huang Y, 2009, BIOMATERIALS, V30, P5041, DOI 10.1016/j.biomaterials.2009.05.077
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kasoju N, 2012, ADV HEALTHC MATER, V1, P393, DOI 10.1002/adhm.201200097
   Kasten P, 2003, BIOMATERIALS, V24, P2593, DOI 10.1016/S0142-9612(03)00062-0
   Kaur G, 2010, BIOMATERIALS, V31, P1732, DOI 10.1016/j.biomaterials.2009.11.041
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lai GJ, 2014, CARBOHYD POLYM, V111, P288, DOI 10.1016/j.carbpol.2014.04.094
   Li XT, 2008, BIOMATERIALS, V29, P3720, DOI 10.1016/j.biomaterials.2008.06.004
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Lin YC, 2011, CURR NANOSCI, V7, P866, DOI 10.2174/157341311798220556
   Liu GP, 2008, CALCIFIED TISSUE INT, V83, P176, DOI 10.1007/s00223-008-9159-9
   Liu HF, 2008, BIOMATERIALS, V29, P1443, DOI 10.1016/j.biomaterials.2007.11.023
   Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035
   Liu HF, 2013, MACROMOL BIOSCI, V13, P755, DOI 10.1002/mabi.201200470
   Liu HF, 2011, BIOMACROMOLECULES, V12, P2914, DOI 10.1021/bm200479f
   Liu HF, 2011, BIOMATERIALS, V32, P3784, DOI 10.1016/j.biomaterials.2011.02.002
   Liu SS, 2013, ACTA BIOMATER, V9, P8991, DOI 10.1016/j.actbio.2013.06.045
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Maddox E, 2000, TISSUE ENG, V6, P441, DOI 10.1089/107632700418146
   Makaya K, 2009, J BIOSCI BIOENG, V108, P68, DOI 10.1016/j.jbiosc.2009.02.015
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Moghadam HG, 2004, J ORAL MAXIL SURG, V62, P202, DOI 10.1016/j.joms.2003.10.002
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Park JS, 2007, FRONT BIOSCI-LANDMRK, V12, P5098, DOI 10.2741/2551
   Qi MC, 2008, INT J ORAL MAX SURG, V37, P453, DOI 10.1016/j.ijom.2007.12.008
   Rajkhowa R, 2010, MACROMOL BIOSCI, V10, P599, DOI 10.1002/mabi.200900358
   Sawkins MJ, 2013, ACTA BIOMATER, V9, P7865, DOI 10.1016/j.actbio.2013.04.029
   Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059
   Thomas CB, 2011, J BIOMAT SCI-POLYM E, V22, P589, DOI 10.1163/092050610X488232
   Tian M, 2012, ACTA BIOMATER, V8, P753, DOI 10.1016/j.actbio.2011.10.030
   Tu JW, 2009, BIOMATERIALS, V30, P4369, DOI 10.1016/j.biomaterials.2009.04.054
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vacanti JP, 1999, LANCET, V354, pSI32
   VANHAASTERT RM, 1994, J MATER SCI-MATER M, V5, P764, DOI 10.1007/BF00120373
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yan Z., 2012, J POROUS MAT, V19, P251
   Yoon SJ, 2008, TISSUE ENG PT A, V14, P539, DOI 10.1089/tea.2007.0129
   Zhang Q, 2012, ACTA BIOMATER, V8, P2628, DOI 10.1016/j.actbio.2012.03.033
NR 59
TC 12
Z9 13
U1 3
U2 41
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 16
BP 3177
EP 3188
DI 10.1039/c5tb00046g
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA CF9FC
UT WOS:000352867800007
DA 2018-10-19
ER

PT J
AU Kim, SI
   Sahu, BB
   Kim, SE
   Ali, A
   Choi, EH
   Han, JG
AF Kim, Sung Il
   Sahu, Bibhuti Bhusan
   Kim, Si Eun
   Ali, Anser
   Choi, Eun Ha
   Han, Jeon Geon
TI Controlling conductivity of carbon film for L-929 cell biocompatibility
   using magnetron sputtering plasmas
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID DIAMOND-LIKE CARBON; AMORPHOUS-CARBON; IN-VITRO; BACTERIAL ADHESION;
   NEURONAL GROWTH; NANOTUBES; MEMBRANES; COATINGS; TITANIUM; LAYERS
AB As a material of current interest compatible with many living organisms, carbon has received considerable attention for applications in medicine. To improve and investigate the performance and applications of diamond-like carbon (DLC) films for implantable bio-organs, it is important to optimize the synthesis process from the original deposition conditions to control the characterization of DLC. Simultaneously, it is necessary to develop new techniques and processes that yield DLC films with stronger adhesion to the substrate and better biocompatibility. This work investigates the suitability of sputtering plasmas for application of carbon film biocompatibility in cell growth. This work also reports an approach to the study of the biomedical response of the well-characterized carbon films deposited by a DC unbalanced magnetron sputtering system (UBMS). Conductive carbon films are prepared at a working pressure of 3 mTorr, and their properties are studied under different operating conditions by varying the target power density. In the present work, we have used L-929 cells as the biomaterial. The influence of L-929 cells on the carbon films fabricated using closed field UBMS is studied. The data reveal that the change in L-929 cell growth with 1-5 day's proliferation is caused by the decreasing electrical resistivity with increasing sp(2) bonding structure.
C1 [Kim, Sung Il; Sahu, Bibhuti Bhusan; Han, Jeon Geon] Sungkyunkwan Univ, Inst Plasma Nano Mat, Ctr Adv Plasma Surface Technol, Suwon 440746, South Korea.
   [Kim, Si Eun; Ali, Anser; Choi, Eun Ha] Kwangwoon Univ, Plasma Biosci Res Ctr Dasanjae 101, Seoul 139701, South Korea.
RP Han, JG (reprint author), Sungkyunkwan Univ, Inst Plasma Nano Mat, Ctr Adv Plasma Surface Technol, 300 ChunChun Dong, Suwon 440746, South Korea.
EM ehchoi@kw.ac.kr; hanjg@skku.edu
FU Leading Foreign Research Institute Recruitment Program through the
   National Research Foundation of Korea (NRF) - Ministry of Science, ICT
   and Future Planning (MSIP) [2011-0031643]; Korea Institute for the
   Advancement of Technology (KIAT) - Ministry of Trade, Industry Energy
   (MOTIE) [N0000590]; National Research Foundation of Korea (NRF) grant -
   Korea government (MSIP) [2010-0027963]
FX The authors sincerely thank the anonymous referees for their valuable
   comments that helped significantly in improving the overall outlook of
   the paper. This work was supported by Leading Foreign Research Institute
   Recruitment Program through the National Research Foundation of Korea
   (NRF) funded by the Ministry of Science, ICT and Future Planning (MSIP)
   (2011-0031643) and Korea Institute for the Advancement of Technology
   (KIAT) funded by the Ministry of Trade, Industry & Energy (MOTIE)
   (N0000590). This work was also supported by the National Research
   Foundation of Korea (NRF) grant funded by the Korea government (MSIP)
   (No. 2010-0027963).
CR Acharya M, 1999, J MEMBRANE SCI, V161, P1, DOI 10.1016/S0376-7388(99)00173-8
   Ajayi OO, 2005, TRIBOL LUBR TECHNOL, V61, P40
   Akyol M, 2013, CUMHURIYET MED J, V35, P33
   Berlind T., 2011, ACTA BIOMATER, V3, P1369
   Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7
   Bhat S, 2012, J BIOSCI BIOENG, V114, P663, DOI 10.1016/j.jbiosc.2012.07.005
   Bobzin K, 2009, SURF COAT TECH, V204, P1097, DOI 10.1016/j.surfcoat.2009.07.045
   Bougherara H, 2011, MED ENG PHYS, V33, P121, DOI 10.1016/j.medengphy.2010.09.011
   Broo J., 2012, WAR 21 CENTURY CELL
   Caminaga R. M. S., 2014, J APPL BIOL BIOTECHN, V2, P1
   Cao B, 2015, CHEM SCI, V6, P782, DOI 10.1039/c4sc02200a
   Carey JD, 2006, J MATER SCI-MATER EL, V17, P405, DOI 10.1007/s10854-006-8087-6
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chai F, 2008, ACTA BIOMATER, V4, P1369, DOI 10.1016/j.actbio.2008.04.011
   Chang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095590
   Che GL, 1998, NATURE, V393, P346, DOI 10.1038/30694
   Cherian R. S., 2014, J NANOMED NANOTECHNO, V5
   Ching HA, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/1/014402
   Clausen CA, 2013, INT BIODETER BIODEGR, V77, P68, DOI 10.1016/j.ibiod.2012.11.005
   Cui FZ, 2005, SURF COAT TECH, V200, P1009, DOI 10.1016/j.surfcoat.2005.02.157
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Das T, 2007, J MATER SCI-MATER M, V18, P493, DOI 10.1007/s10856-007-2009-x
   Endrino JL, 2008, APPL SURF SCI, V254, P5323, DOI 10.1016/j.apsusc.2008.02.065
   Flores AA, 2009, DIAM RELAT MATER, V18, P1179
   Guzman F., 2013, J PHYS D, V46
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Hutchinson I, 1987, PRINCIPLES PLASMA DI
   International Organization for Standardization ISO, 2007, 1099312 ISO, P10993
   JOHANSSON L, 1966, ARK FYS, V31, P201
   Kamata T, 2014, DIAM RELAT MATER, V49, P25, DOI 10.1016/j.diamond.2014.07.007
   Karakecili AG, 2008, COLLOID SURFACE B, V61, P216, DOI 10.1016/j.colsurfb.2007.08.009
   Kim SE, 2010, SURF INTERFACE ANAL, V42, P524, DOI 10.1002/sia.3374
   Kim SI, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.010304
   KLEBER R, 1993, DIAM RELAT MATER, V2, P246, DOI 10.1016/0925-9635(93)90062-7
   Kwok SCH, 2007, DIAM RELAT MATER, V16, P1353, DOI 10.1016/j.diamond.2006.11.001
   Lackner J. M., 2010, BERG HUTTENMANNISCHE, V155, P528
   Li P, 2013, STEM CELLS DEV, V22, P340, DOI 10.1089/scd.2012.0357
   Liao Y, 2011, SCIENCE, V334, P1687, DOI 10.1126/science.1213902
   Lobo AO, 2008, MAT SCI ENG C-BIO S, V28, P532, DOI 10.1016/j.msec.2007.04.016
   Ma SL, 2007, ACTA MATER, V55, P6350, DOI 10.1016/j.actamat.2007.07.046
   Malarkey EB, 2009, NANO LETT, V9, P264, DOI 10.1021/nl802855c
   Mazzatenta A, 2007, J NEUROSCI, V27, P6931, DOI 10.1523/JNEUROSCI.1051-07.2007
   Muller U, 2011, ACTA MATER, V59, P1150, DOI 10.1016/j.actamat.2010.10.048
   Murphy R, 2002, J PHYS CHEM B, V106, P3087, DOI 10.1021/jp0132836
   Musil J, 1998, MATER CHEM PHYS, V54, P116, DOI 10.1016/S0254-0584(98)00020-0
   Oksanen J, 2014, TRIBOL INT, V70, P94, DOI 10.1016/j.triboint.2013.09.005
   Popov AM, 2007, INT J NANOMED, V2, P361
   Rajzer I, 2010, J MATER SCI-MATER M, V21, P2611, DOI 10.1007/s10856-010-4108-3
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   ROBERTSON J, 1992, SURF COAT TECH, V50, P185, DOI 10.1016/0257-8972(92)90001-Q
   Roch T, 2010, DIAM RELAT MATER, V19, P1472, DOI 10.1016/j.diamond.2010.10.003
   Rodil SE, 2003, DIAM RELAT MATER, V12, P931, DOI 10.1016/S0925-9635(02)00217-0
   Sahu BB, 2015, J APPL PHYS, V117, DOI 10.1063/1.4905541
   Sahu BB, 2014, J APPL PHYS, V116, DOI 10.1063/1.4896833
   Schwan J, 1996, J APPL PHYS, V79, P1416, DOI 10.1063/1.360979
   SHERIDAN TE, 1990, J VAC SCI TECHNOL A, V8, P30, DOI 10.1116/1.577093
   Shiflett MB, 2000, J MEMBRANE SCI, V179, P275, DOI 10.1016/S0376-7388(00)00513-5
   Smart SK, 2006, CARBON, V44, P1034, DOI 10.1016/j.carbon.2005.10.011
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   Thorwarth K, 2014, INT J MOL SCI, V15, P10527, DOI 10.3390/ijms150610527
   TSUJI K, 1993, JPN J APPL PHYS 1, V32, P916, DOI 10.1143/JJAP.32.916
   Wachesk CC, 2013, APPL SURF SCI, V266, P176, DOI 10.1016/j.apsusc.2012.11.124
   Wang J, 2004, BIOMATERIALS, V25, P3163, DOI 10.1016/j.biomaterials.2003.10.010
   Wang JJ, 2013, ACS APPL MATER INTER, V5, P5015, DOI 10.1021/am400778p
   Wang MO, 2013, BIOMACROMOLECULES, V14, P1321, DOI 10.1021/bm301962f
   Willems B, 2014, DIAM RELAT MATER, V41, P25, DOI 10.1016/j.diamond.2013.09.010
   Wu ZR, 2007, SURF COAT TECH, V201, P5710, DOI 10.1016/j.surfcoat.2006.11.032
   Xu T, 1999, J MATER SCI-MATER M, V10, P83, DOI 10.1023/A:1008916903171
   YAMAMOTO S, 1991, ASTROPHYS J, V370, pL103, DOI 10.1086/185987
   Yap SS, 2011, DIAM RELAT MATER, V20, P294, DOI 10.1016/j.diamond.2011.01.013
   Zhao Q, 2007, APPL SURF SCI, V253, P7254, DOI 10.1016/j.apsusc.2007.03.011
   Zheng CL, 2005, SURF COAT TECH, V193, P361, DOI 10.1016/j.surfcoat.2004.08.152
   Zhou H, 2008, DIAM RELAT MATER, V17, P1416, DOI 10.1016/j.diamond.2008.01.047
NR 73
TC 15
Z9 15
U1 1
U2 19
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 16
BP 3267
EP 3278
DI 10.1039/c4tb01397b
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA CF9FC
UT WOS:000352867800017
DA 2018-10-19
ER

PT J
AU Liu, YG
   Chen, ZX
   Wang, SB
   Long, RM
   Fan, JQ
   Chen, AZ
   Wu, WG
AF Liu, Yuangang
   Chen, Zongxiang
   Wang, Shibin
   Long, Ruimin
   Fan, Jingqian
   Chen, Aizheng
   Wu, Wenguo
TI Preparation of ALG-g-Lys and its application as a novel drug carrier
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID ALGINATE; MICROCAPSULES; IMMOBILIZATION; MICROSPHERES; POLYCATION;
   STABILITY; BEHAVIOR; ARGININE; GENIPIN; ENZYME
AB In order to improve alginate microbead stability and further broaden the application of alginate in biomaterials, a new biomaterial, ALG-g-Lys, was prepared and its possibility as a novel drug carrier investigated. The carrier exhibited a sustained release property and preserved activity with no initial burst release, and interestingly, GP-crosslinked ALG-g-Lys microspheres showed obvious fluorescence properties, which showed promising potential for the future drug delivery systems.
C1 [Liu, Yuangang; Chen, Zongxiang; Wang, Shibin; Long, Ruimin; Fan, Jingqian; Chen, Aizheng; Wu, Wenguo] Huaqiao Univ, Coll Chem Engn, Xiamen, Peoples R China.
   [Liu, Yuangang; Wang, Shibin; Chen, Aizheng; Wu, Wenguo] Huaqiao Univ, Inst Pharmaceut Engn, Xiamen, Peoples R China.
RP Liu, YG (reprint author), Huaqiao Univ, Coll Chem Engn, Xiamen, Peoples R China.
EM ygliu@hqu.edu.cn; sbwang@hqu.edu.cn
FU NSFC [31000441, 31170939]; China Postdoctoral Science Foundation
   [2014M551833]; Natural Science Foundation of Fujian Province
   [2013J01189]; Program for New Century Excellent Talents in Fujian
   Province University [2014FJ-NCET-ZR01]; Science and Technology Project
   of Fujian Province, China [2013Y2002]; Scientific Research Foundation
   for Returned Overseas Chinese Scholars (State Education Ministry);
   Promotion Program for Young and Middle-aged Teachers in Science and
   Technology Research of Huaqiao University [ZQN-PY108]
FX We gratefully acknowledge financial support from the NSFC (31000441 and
   31170939), the China Postdoctoral Science Foundation (2014M551833), the
   Natural Science Foundation of Fujian Province (2013J01189), the Program
   for New Century Excellent Talents in Fujian Province University
   (2014FJ-NCET-ZR01), the Science and Technology Project of Fujian
   Province, China (2013Y2002), the Scientific Research Foundation for
   Returned Overseas Chinese Scholars (State Education Ministry) and the
   Promotion Program for Young and Middle-aged Teachers in Science and
   Technology Research of Huaqiao University (ZQN-PY108).
CR Agulhon P, 2014, CARBOHYD POLYM, V112, P525, DOI 10.1016/j.carbpol.2014.05.097
   Bekin S, 2014, SENSOR ACTUAT B-CHEM, V202, P878, DOI 10.1016/j.snb.2014.06.051
   Bhujbal SV, 2014, J MECH BEHAV BIOMED, V37, P196, DOI 10.1016/j.jmbbm.2014.05.020
   Chen HM, 2006, APPL BIOCHEM BIOTECH, V134, P207, DOI 10.1385/ABAB:134:3:207
   Commission C.P., 2010, PHARMACOPOEIA PEOPLE
   Gattas-Asfura KM, 2014, J MATER CHEM B, V2, P8208, DOI 10.1039/c4tb01241k
   Gryshkov O, 2014, MAT SCI ENG C-MATER, V36, P77, DOI 10.1016/j.msec.2013.11.048
   Hui PCL, 2013, COLLOID SURFACE A, V434, P95, DOI 10.1016/j.colsurfa.2013.05.043
   Lau TT, 2010, COMPOS SCI TECHNOL, V70, P1909, DOI 10.1016/j.compscitech.2010.05.015
   Liu YG, 2013, J SOL-GEL SCI TECHN, V67, P66, DOI 10.1007/s10971-013-3051-4
   Liu YG, 2013, J MATER SCI-MATER M, V24, P155, DOI 10.1007/s10856-012-4786-0
   Liu YG, 2012, MATER LETT, V75, P48, DOI 10.1016/j.matlet.2012.01.137
   Pannier A, 2014, J MATER CHEM B, V2, P7896, DOI 10.1039/c4tb00944d
   Rokstad A. M., 2012, IMMUNOBIOLOGY, V217, P1211
   Rokstad AM, 2013, BIOMATERIALS, V34, P621, DOI 10.1016/j.biomaterials.2012.10.012
   Rokstad AM, 2011, ACTA BIOMATER, V7, P2566, DOI 10.1016/j.actbio.2011.03.011
   Taqieddin E, 2004, BIOMATERIALS, V25, P1937, DOI 10.1016/j.biomaterials.2003.08.034
   THOMPSON PD, 1991, BIOCHEMISTRY-US, V30, P8124, DOI 10.1021/bi00247a005
   Wang JC, 2014, MATER LETT, V126, P263, DOI 10.1016/j.matlet.2014.03.178
   Wang SB, 2003, MACROMOL BIOSCI, V3, P347, DOI 10.1002/mabi.200350005
   Yang JS, 2012, CARBOHYD POLYM, V87, P1503, DOI 10.1016/j.carbpol.2011.09.046
NR 21
TC 0
Z9 0
U1 2
U2 24
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 17
BP 3420
EP 3424
DI 10.1039/c5tb00410a
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA CG5QU
UT WOS:000353349300002
DA 2018-10-19
ER

PT J
AU Liu, C
   Liu, X
   Xue, Y
   Ding, TT
   Sun, J
AF Liu, Chao
   Liu, Xin
   Xue, Yang
   Ding, Tingting
   Sun, Jiao
TI Hydrolyzed tilapia fish collagen modulates the biological behavior of
   macrophages under inflammatory conditions
SO RSC ADVANCES
LA English
DT Article
ID GATED CHLORIDE CHANNEL; TNF-ALPHA PRODUCTION; NF-KAPPA-B; IN-VITRO;
   PROINFLAMMATORY CYTOKINES; CALCIUM INFLUX; CELLS CONTAIN; KUPFFER CELLS;
   GLYCINE; ACTIVATION
AB Implantation of a biomaterial causes an early and local inflammatory reaction, and regulation of the biological behavior of macrophages under inflammatory conditions caused by biomaterials is imperative for the full realization of their function after being implanted. In recent years, hydrolyzed fish collagen has attracted extensive attention resulting from its biological activity. However, to date, no studies have investigated the anti-inflammatory activity of hydrolyzed fish collagen. The aim of this study is to evaluate the effect of hydrolyzed tilapia fish collagen (HFC) on lipopolysaccharide-induced inflammatory responses in RAW264.7 macrophages at the gene and protein level and to elucidate its potential mechanism. The results show that glycine rich in HFC can activate the glycine receptor (GlyR) of macrophages, leading to decreased calcium concentration in macrophages, this decrease inhibits the activation of NF-kappa B, and then the inhibition of NF-kappa B further attenuates the inflammatory cytokine gene expression and protein secretion. The current study reveals for the first time that by regulating the biological behavior of the macrophages under an inflammatory state, HFC exhibits specific anti-inflammatory effects. More importantly, the presence of GlyR in RAW264.7 cells is verified for the first time. These findings provide a scientific basis for the future application of HFC in anti-inflammatory biomaterials.
C1 [Liu, Chao; Liu, Xin; Xue, Yang; Ding, Tingting; Sun, Jiao] Shanghai Jiao Tong Univ, Shanghai Ninth Peoples Hosp, Shanghai Biomat Res & Testing Ctr, Sch Med, Shanghai 200023, Peoples R China.
RP Sun, J (reprint author), Shanghai Jiao Tong Univ, Shanghai Ninth Peoples Hosp, Shanghai Biomat Res & Testing Ctr, Sch Med, Room 201,2 Bldg,427 Jumen Rd, Shanghai 200023, Peoples R China.
EM Jiaosun59@126.com
FU National Natural Science Foundation of China [31470917]
FX The authors are grateful to Qisheng Gu at the Institute of Shanghai
   Qisheng Biomaterial Technology for technical advice and Nanping Wang at
   the Shanghai Fisheries Research Institute for providing the hydrolyzed
   tilapia fish collagen. This work was supported by grants from the
   National Natural Science Foundation of China (31470917).
CR Amaravani M, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-58
   Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x
   Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287
   Broekema FI, 2013, CLIN ORAL INVEST, V17, P1273, DOI 10.1007/s00784-012-0809-y
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319
   Ding CH, 2003, CLIN EXP IMMUNOL, V132, P416, DOI 10.1046/j.1365-2249.2003.02167.x
   Froh M, 2002, AM J PHYSIOL-GASTR L, V283, pG856, DOI 10.1152/ajpgi.00503.2001
   Garcia-Macedo R, 2008, EUR J PHARMACOL, V587, P317, DOI 10.1016/j.ejphar.2008.03.051
   Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423
   Hasegawa S, 2011, INFLAMM RES, V60, P1013, DOI 10.1007/s00011-011-0362-1
   Ikejima K, 1997, AM J PHYSIOL-GASTR L, V272, pG1581
   Kajahn Jennifer, 2012, Biomatter, V2, P226, DOI 10.4161/biom.22855
   Lappas M, 2002, BIOL REPROD, V67, P668, DOI 10.1095/biolreprod67.2.668
   Lilienbaum A, 2003, MOL CELL BIOL, V23, P2680, DOI 10.1128/MCB.23.8.2680-2698.2003
   Liu C, 2014, BIOMACROMOLECULES, V15, P436, DOI 10.1021/bm401780v
   Lo CJ, 2013, J SURG RES, V181, P287, DOI 10.1016/j.jss.2012.07.002
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   McNally AK, 2011, ADV EXP MED BIOL, V713, P97, DOI 10.1007/978-94-007-0763-4_7
   Meizel S, 2005, MOL REPROD DEV, V72, P250, DOI 10.1002/mrd.20336
   Miura R, 2010, BIOL PHARM BULL, V33, P1148, DOI 10.1248/bpb.33.1148
   Nagai N, 2007, J BIOMED MATER RES A, V82A, P395, DOI 10.1002/jbm.a.31110
   Ohara H, 2010, BIOSCI BIOTECH BIOCH, V74, P2096, DOI 10.1271/bbb.100193
   Perez-Torres I, 2011, CAN J PHYSIOL PHARM, V89, P899, DOI [10.1139/Y11-086, 10.1139/y11-086]
   Qu W, 2002, AM J PHYSIOL-GASTR L, V283, pG1249, DOI 10.1152/ajpgi.00197.2002
   Ryu B, 2010, PEPTIDES, V31, P79, DOI 10.1016/j.peptides.2009.10.019
   Saino E, 2011, BIOMACROMOLECULES, V12, P1900, DOI 10.1021/bm200248h
   Scherer EQ, 2006, CARDIOVASC RES, V70, P79, DOI 10.1016/j.cardiores.2006.01.011
   Sclavons C., 2013, INT J PEPT, V2013
   Seabra V, 1998, J LEUKOCYTE BIOL, V64, P615
   Spittler A, 1999, FASEB J, V13, P563
   Valdes JA, 2007, AM J PHYSIOL-CELL PH, V292, pC1960, DOI 10.1152/ajpcell.00320.2006
   Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421
   Wang HD, 2009, ACTA PHARMACOL SIN, V30, P1107, DOI 10.1038/aps.2009.106
   Wheeler M, 2000, FASEB J, V14, P476
   Wheeler MD, 1999, AM J PHYSIOL-LUNG C, V277, pL952, DOI 10.1152/ajplung.1999.277.5.L952
   Wheeler MD, 1999, CELL MOL LIFE SCI, V56, P843, DOI 10.1007/s000180050030
   Xu YJ, 2011, REGUL PEPTIDES, V172, P58, DOI 10.1016/j.regpep.2011.08.009
   YADID G, 1990, EUR J PHARMACOL, V175, P365, DOI 10.1016/0014-2999(90)90579-U
   Yamashina S, 2001, NUTR CANCER, V40, P197, DOI 10.1207/S15327914NC402_17
   Ye YX, 2012, INT IMMUNOPHARMACOL, V12, P384, DOI 10.1016/j.intimp.2011.12.011
   Zhang JY, 2015, FITOTERAPIA, V100, P35, DOI 10.1016/j.fitote.2014.11.002
   Zhu CF, 2010, APPL PHYSIOL NUTR ME, V35, P797, DOI 10.1139/H10-075
NR 45
TC 4
Z9 4
U1 1
U2 8
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 39
BP 30727
EP 30736
DI 10.1039/c5ra02355f
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA CF8FK
UT WOS:000352791300044
DA 2018-10-19
ER

PT J
AU Jayakumar, GC
   Mehta, A
   Rao, JR
   Fathima, NN
AF Jayakumar, Gladstone Christopher
   Mehta, Ami
   Rao, Jonnalagadda Raghava
   Fathima, Nishter Nishad
TI Ionic liquids: new age materials for eco-friendly leather processing
SO RSC ADVANCES
LA English
DT Article
ID TECHNOLOGY; INDUSTRY
AB The manufacture of leather is a challenging and complicated process, which converts natural biomaterial to various high end applications. There are several stringent regulations in processing this natural biomaterial skin due to the discharge of effluent and impact on environment. In this study, an attempt has been made to use ionic liquids to remove inter-fibrillary materials from the skin. Cleaner leather processing is a new avenue to explore the existing pollution complications during leather manufacture. Herein, an ionic liquid, 1-butyl-3-methylimidazolium chloride, is used as a fiber opening agent. Conventional reliming process was avoided by the treatment of molten salt. Enzymatic unhairing methods have been adopted for the removal of hairs from the skin. After the complete removal of hair, the pelts are treated with various concentrations of molten salts by the drum method. The pelts treated with low concentrations of molten salts showed better appearance and there was no damage to the pelts. After the fiber opening process, the pelts were subjected to conventional chrome tanning and post tanning processes. The shrinkage temperature of the experimental leathers is around 108-116 degrees C. The physical strength characteristics like tensile strength, tear strength and grain crack index of crust leathers meet the standard norms. Morphological studies ascertain that there was no grain damage and coalescence of fibers. These results show a promising venture for the use of ionic liquid for leather manufacture. This study signifies the role of ionic liquid in the tanning industry and gives a new dimensional approach to existing cleaner processing systems.
C1 [Jayakumar, Gladstone Christopher; Mehta, Ami; Rao, Jonnalagadda Raghava; Fathima, Nishter Nishad] CSIR Cent Leather Res Inst, Madras 600020, Tamil Nadu, India.
RP Fathima, NN (reprint author), CSIR Cent Leather Res Inst, Madras 600020, Tamil Nadu, India.
EM nishad@clri.res.in
FU CSIR [RIWT-CSC0202]
FX The authors thank CSIR 12th five-year plan project-Research Initiatives
   for Waterless Tanning (RIWT-CSC0202) for financial support. CSIR-CLRI
   Communication Code-1117.
CR Andrea S., 2014, CHEM SOC REV, V43, P7358
   Avetta P, 2013, ACS SUSTAIN CHEM ENG, V1, P1545, DOI 10.1021/sc400294z
   Christopher JG, 2014, J CLEAN PROD, V83, P428, DOI 10.1016/j.jclepro.2014.07.039
   Chung J, 2013, RESOUR CONSERV RECY, V70, P32, DOI 10.1016/j.resconrec.2012.10.005
   CLESCERI LS, 1989, STANDARD METHODS EXA
   Griffini G, 2014, ADV ENG MATER, V5
   IUP 6, 2000, JSLTC, V84, P317
   IUP 8, 2000, JSLTC, V84, P327
   IUP2, 2000, J SOC LEATHER TECHNO, V84, P303
   Kase S, 2006, BRIT J OPHTHALMOL, V90, P96, DOI 10.1136/bjo.2005.078394
   Kyriakos A. E., 2012, COLLOID SURF A, V413, P65
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Madhan B., 2010, J AM LEATHER CHEM AS, V5, P105
   Mehta A, 2014, COLLOID SURFACE B, V117, P376, DOI 10.1016/j.colsurfb.2014.03.014
   Nancy G., 2014, J CLEAN PROD, V79, P249
   Orhan O., 2011, ADV COLLOID INTERFAC, V163, P1
   Saran S, 2013, J CLEAN PROD, V54, P315, DOI 10.1016/j.jclepro.2013.04.017
   Saravanan P, 2014, J CLEAN PROD, V79, P258, DOI 10.1016/j.jclepro.2014.05.022
   Shakilanishi S., 2011, J BIOSCI BIOENG, V111, P128
   Song J, 2012, J SOC LEATH TECH CH, V96, P250
   Souza F. R., 2012, BRAZ J CHEM ENG, V29, P473
   Swarna V. K., 2009, J CLEAN PROD, V17, P507
   Xia Z., 2014, RSC ADV, V4, P56831
   Yimei J., 2014, SEP PURIF TECHNOL, V132, P577
   Zelimir F. K., 2014, COMPUT AIDED CHEM EN, V33, P127
   Zhuojun M., 2012, INT J BIOL MACROMOL, V51, P440
NR 26
TC 10
Z9 10
U1 0
U2 31
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 40
BP 31998
EP 32005
DI 10.1039/c5ra02167g
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CG3GD
UT WOS:000353165800096
DA 2018-10-19
ER

PT J
AU Wang, YF
   Wang, YM
   Guo, XC
   Xiong, YF
   Guo, MM
   Wang, X
AF Wang, Yifeng
   Wang, Yanmei
   Guo, Xuecheng
   Xiong, Yanfei
   Guo, Mengmeng
   Wang, Xia
TI Microbial Transglutaminase and Tyrosinase Modified Gelatin-Chitosan
   Material
SO SOFT MATERIALS
LA English
DT Article
DE Chitosan; Enzymatic modification; Gelatin; Microbial transglutaminase;
   Tyrosinase
ID CROSS-LINKING; BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES;
   SCAFFOLDS; HYDROGELS; FILMS; BACTERIA; GLUCOSE
AB A dual-enzymatically modified protein-polysaccharide, which is a potential biomaterial especially for biomedical film, is constructed, modified and reinforced entirely by biocompatible and environmentally-friendly biomacromolecules. We use gelatin/chitosan blend as protein-polysaccharide matrix, and then employ microbial transglutaminase and tyrosinase as biological modifiers. The subsequent tests indicated that the stability in aqueous medium, thermal stability, and tensile strength of the modified material have been improved due to the combined effects of two enzymes that microbial transglutaminase can cross-link gelatin and tyrosinase can catalyze gelatin-chitosan conjugation. Furthermore, the modified gelatin-chitosan shows better in vitro antibacterial activity in comparison with unmodified gelatin.
C1 [Wang, Yifeng; Wang, Yanmei; Guo, Xuecheng; Guo, Mengmeng; Wang, Xia] Wuhan Univ Technol, Sch Mat Sci & Engn, Wuhan 430070, Peoples R China.
   [Xiong, Yanfei] Wuhan Univ Technol, Dept Biol Sci & Technol, Wuhan 430070, Peoples R China.
RP Wang, YF (reprint author), Wuhan Univ Technol, Sch Mat Sci & Engn, 122 Luoshi Rd, Wuhan 430070, Peoples R China.
EM yifengwang@whut.edu.cn
FU Fundamental Research Funds for the Central Universities [WUT:
   2012-IV-001, 2013-IV-008]; National Natural Science Foundation of China
   [50703030]; Scientific Research Foundation for the Returned Overseas
   Chinese Scholars from State Education Ministry
FX The work was supported by the Fundamental Research Funds for the Central
   Universities (WUT: 2012-IV-001 and 2013-IV-008), the National Natural
   Science Foundation of China (Grant No. 50703030), and the Scientific
   Research Foundation for the Returned Overseas Chinese Scholars from
   State Education Ministry.
CR Bigi A, 1998, BIOMATERIALS, V19, P2335, DOI 10.1016/S0142-9612(98)00149-5
   Borges MR, 2009, MAT SCI ENG C-BIO S, V29, P519, DOI 10.1016/j.msec.2008.09.013
   Broderick EP, 2005, J BIOMED MATER RES B, V72B, P37, DOI 10.1002/jbm.b.30119
   Chen TH, 2003, BIOMATERIALS, V24, P2831, DOI 10.1016/S0142-9612(03)00096-6
   Chen TH, 2002, BIOPOLYMERS, V64, P292, DOI 10.1002/bip.10196
   Chiono V, 2008, J MATER SCI-MATER M, V19, P889, DOI 10.1007/s10856-007-3212-5
   da Silva MA, 2014, MACROMOL BIOSCI, V14, P817, DOI 10.1002/mabi.201300472
   Dragusin DM, 2012, SOFT MATTER, V8, P9589, DOI 10.1039/c2sm25536g
   Giosafatto CVL, 2014, BIOPOLYMERS, V101, P931, DOI 10.1002/bip.22477
   Helander IM, 2001, INT J FOOD MICROBIOL, V71, P235, DOI 10.1016/S0168-1605(01)00609-2
   Holappa J, 2006, CARBOHYD POLYM, V65, P114, DOI 10.1016/j.carbpol.2005.11.041
   Huang X, 2013, MAT SCI ENG C-MATER, V33, P4816, DOI 10.1016/j.msec.2013.07.044
   Jatariu (Cadinoiu) A. N., 2013, SOFT MATER, V11, P7616
   Jatariu AN, 2011, J BIOMED MATER RES A, V98A, P342, DOI 10.1002/jbm.a.33122
   Jayasuriya AC, 2010, J MATER SCI-MATER M, V21, P393, DOI 10.1007/s10856-009-3874-2
   Koser SA, 1938, J BACTERIOL, V36, P57
   Li X, 2012, SOFT MATTER, V8, P3781, DOI 10.1039/c2sm06994f
   Liu Y, 2012, J AGR FOOD CHEM, V60, P8963, DOI 10.1021/jf301376b
   McDermott MK, 2004, BIOMACROMOLECULES, V5, P1270, DOI 10.1021/bm034529a
   Mishra D, 2011, MAT SCI ENG C-MATER, V31, P1295, DOI 10.1016/j.msec.2011.04.007
   Pal K, 2013, SOFT MATER, V11, P125, DOI 10.1080/1539445X.2011.586082
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Spanneberg R, 2012, SOFT MATTER, V8, P2222, DOI 10.1039/c2sm06659a
   Stancu IC, 2013, SOFT MATER, V11, P384, DOI 10.1080/1539445X.2011.642091
   Thakur G, 2011, J MATER SCI-MATER M, V22, P115, DOI 10.1007/s10856-010-4185-3
   Wang YF, 2012, COLLOID SURFACE B, V100, P77, DOI 10.1016/j.colsurfb.2012.05.030
   Wu HD, 2012, MAT SCI ENG C-MATER, V32, P207, DOI 10.1016/j.msec.2011.10.020
   Xiao B, 2011, CARBOHYD POLYM, V83, P144, DOI 10.1016/j.carbpol.2010.07.032
   Yang XH, 2009, J ADHESION, V85, P576, DOI 10.1080/00218460902996788
NR 29
TC 8
Z9 8
U1 8
U2 33
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1539-445X
EI 1539-4468
J9 SOFT MATER
JI Soft Mater.
PY 2015
VL 13
IS 1
BP 32
EP 38
DI 10.1080/1539445X.2014.1003270
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA CG8PR
UT WOS:000353572000006
DA 2018-10-19
ER

PT J
AU Gao, J
   Ti, CP
   Chen, N
AF Gao, Juan
   Ti, Chaopu
   Chen, Ning
TI Environmental Comparison of Straw Applications Based on a Life Cycle
   Assessment Model and Emergy Evaluation
SO BIORESOURCES
LA English
DT Review
DE Straw application; Life cycle assessment (LCA); Emergy evaluation;
   Bioethanol; Greenhouse gas emission
ID BIOETHANOL PRODUCTION; ETHANOL; RESIDUES; ACCOUNT; CROPS; LCA
AB Straw is considered to be a renewable resource for bioenergy and biomaterial. However, about 70% of straw is burned in fields, which causes serious air pollution in China. In this study, a life cycle assessment (LCA) model, together with emergy evaluation, was built to compare four straw applications after harvest vs. direct burning, including bioethanol (BE), combined heat and power plant (CHP), corrugated base paper (CP), and medium-density fiberboard (MDF). The results showed that BE and MDF would avoid greenhouse gas (GHG) emissions by 82% and 36%, respectively, while CHP and CP would emit 57% and 152% more GHG, respectively, compared with direct straw burning. Bioethanol had the highest renewability indicator (RI) of 47.7%, and MDF obtained the greatest profit of 657 Yuan.bale(-1). The applications CHP and CP had low RI (< 10.3%) and profit (< 180 Yuan.bale(-1)). Due to water recycling and electrical power as a coproduct, BE had the lowest value (3 x 10(11) sej.Yuan(-1)) of EmPM (emergy per unit money profit); the EmPM value of CP was 18.6 times higher than that of BE. The four straw applications would also greatly reduce particles emission (57 to 98%) to air. BE was judged to be the most environmentally friendly application among the four straw applications. Imposing a carbon tax would encourage investment in BE, but discourage the applications CHP and CP.
C1 [Gao, Juan; Chen, Ning] Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing 210008, Jiangsu, Peoples R China.
   [Ti, Chaopu] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.
RP Gao, J (reprint author), Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing 210008, Jiangsu, Peoples R China.
EM juangao@issas.ac.cn
FU National Science Foundation of China (NSFC) [41201575]
FX This research was funded by the National Science Foundation of China
   (NSFC) No. 41201575. We thank Cun Liu for his help with the Monte Carlo
   analysis.
CR 21food, 2013, CORN ETH PRIC
   Baral A, 2012, ENVIRON SCI TECHNOL, V46, P2436, DOI 10.1021/es2025615
   Baral A, 2010, ENVIRON SCI TECHNOL, V44, P800, DOI 10.1021/es902571b
   Brown MT, 2004, ECOL MODEL, V178, P1, DOI 10.1016/j.ecolmodel.2003.12.001
   Cao GL, 2008, J ENVIRON SCI-CHINA, V20, P50, DOI 10.1016/S1001-0742(08)60007-8
   Cherubini F, 2010, APPL ENERG, V87, P47, DOI 10.1016/j.apenergy.2009.08.024
   del Campo I, 2006, IND CROP PROD, V24, P214, DOI 10.1016/j.indcrop.2006.06.014
   European Commission-Joint Research Centre-Institute for Environment and Sustainability, 2010, 24708 EUR EN EUR COM
   Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416
   Forster P, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129
   Frischknecht R., 2011, ECOINVENT VERSION 2
   Frischknocht R., 2007, OVERVIEW METHODOLOGY
   Fronning BE, 2008, AGRON J, V100, P1703, DOI 10.2134/agronj2008.0052
   Gao J, 2011, AGRON J, V103, P844, DOI 10.2134/agronj2010.0445
   Gao X., 2010, ACTA AGR JIANGXI, V22, P130
   Guinee J., 2001, LCA OPERATIONAL GUID
   Hau JL, 2004, ENVIRON SCI TECHNOL, V38, P3768, DOI 10.1021/es034513s
   Hossaini N., 2012, J SUSTAINABLE DEV, V5, P1
   Huang J., 2008, J SHENGYANG I ENG, V4, P7
   IETA, 2012, GREENH GAS MARK 2012
   ISO (International Organization for Standardization, 2006, 140402006 ISO
   ISO (International Organization for Standardization, 2006, 140442006 ISO
   Jiang MM, 2008, COMMUN NONLINEAR SCI, V13, P2337, DOI 10.1016/j.cnsns.2007.04.025
   Kim S, 2004, BIOMASS BIOENERG, V26, P361, DOI 10.1016/j.biombioe.2003.08.002
   Lardon L, 2009, ENVIRON SCI TECHNOL, V43, P6475, DOI 10.1021/es900705j
   Lau MW, 2009, P NATL ACAD SCI USA, V106, P1368, DOI 10.1073/pnas.0812364106
   Li XJ, 2010, BIORESOURCE TECHNOL, V101, P4662, DOI 10.1016/j.biortech.2010.01.053
   Liu Li-hua, 2011, Huanjing Kexue, V32, P1242
   Maung T. A., 2008, EC BIOMASS FUELS ELE
   Naik S, 2010, RENEW ENERG, V35, P1624, DOI 10.1016/j.renene.2009.08.033
   Odum H. T, 1996, ENV ACCOUNTING EMERG
   Raugei M, 2014, ECOL MODEL, V271, P4, DOI 10.1016/j.ecolmodel.2012.11.025
   Rugani B, 2012, ENVIRON SCI TECHNOL, V46, P4701, DOI 10.1021/es203440n
   Steubing B, 2012, ENVIRON SCI TECHNOL, V46, P164, DOI 10.1021/es202154k
   Tabil L, 2011, BIOFUELS ENG PROCESS
   Volz T., 2013, GABI 6 0 SOFTWARE SY
   Wang M., 2001, ANLESDTM163 US DEP E
   Wang M., 2010, GREENHOUSE GASES REG
   Xi YG, 2009, ECOL ENG, V35, P1677, DOI 10.1016/j.ecoleng.2007.11.006
   Xiao C., 2005, BLACK LIQUOR CROP ST
   Yan X., 2010, AGR ECOLOGICAL SERIE
   Ye XP, 2007, BIORESOURCE TECHNOL, V98, P1077, DOI 10.1016/j.biortech.2006.04.022
   Yoon SH, 2001, ADV ENVIRON RES, V5, P91, DOI 10.1016/S1093-0191(00)00045-9
   Zhang HF, 2011, ENVIRON SCI TECHNOL, V45, P5477, DOI 10.1021/es1037904
   [张钦 Zhang Qin], 2010, [中国软科学, China Soft Science], P104
   Zhang W., 2010, STAT YB JIANGSU 2010
   Zhong C, 2009, APPL MICROBIOL BIOT, V84, P667, DOI 10.1007/s00253-009-2001-0
   Zhou D., 2003, Patents of Straw-based Panel Manufacture Technology, Patent No. [ZL 01137361.X, 01137361]
   ZZ91, 2011, WAST PAP
   ZZ91, 2011, CAST IR PRIC NOV 18
NR 50
TC 2
Z9 2
U1 2
U2 21
PU NORTH CAROLINA STATE UNIV DEPT WOOD & PAPER SCI
PI RALEIGH
PA CAMPUS BOX 8005, RALEIGH, NC 27695-8005 USA
SN 1930-2126
J9 BIORESOURCES
JI BioResources
PY 2015
VL 10
IS 1
BP 548
EP 565
PG 18
WC Materials Science, Paper & Wood
SC Materials Science
GA CE6IV
UT WOS:000351941000046
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Zhang, JP
   Wang, ZL
   Du, MH
   Yao, XH
   Hu, LS
AF Zhang, Jinping
   Wang, Zhoulian
   Du, Menghao
   Yao, Xiaohua
   Hu, Lisong
TI Physicochemical Properties of Camellia Nut Shell and its Thermal
   Degradation Characteristics
SO BIORESOURCES
LA English
DT Review
DE Camellia nut shell; Elemental analysis; Chemical composition;
   Crystallinity index; Thermal degradation
ID BAMBOO SHOOT SHELL; DIRECT LIQUEFACTION; PYROLYSIS; LIQUID;
   OPTIMIZATION; CELLULOSE; RESIDUES; BIOMASS; CARBON; GLYCOL
AB Camellia nut shell (CNS) is known as an important bio-resource that has great potential as a biomaterial. The elemental composition, chemical structure, crystallinity, and pyrolysis characteristics were analyzed in this paper for six species of CNS. The concentration of organic carbon, N, K, and Na in CNS ranges from 44.40 to 48.60%, 2.91 to 4.42 mg.g(-1), 7.67 to 13.80 mg.g(-1), and 0.02 to 0.26 mg.g(-1), respectively. The content of lignin, cellulose, hemicellulose, and ash varies between 30.07 and 36.23%, 13.87 and 20.95%, 35.15 and 49.34%, as well as 2.00 and 4.75%, respectively. Camellia nut shell cellulose crystalline structure belongs to typical cellulose type I, and the cellulose crystallinity index for the six species ranges from 37.4 to 62.3%. The CNS pyrolysis process can be divided into three phases, and the substantial degradation occurs within the temperature range of 200 to 430 degrees C, with nearly 60% loss of weight. The temperature could be reduced greatly during pyrolysis under acidic conditions with PEG 400/glycerol as a solvent. The degradation rate was impacted by K concentration. Increasing cellulose crystallinity negatively affected the degradation rate.
C1 [Zhang, Jinping; Wang, Zhoulian; Du, Menghao; Yao, Xiaohua; Hu, Lisong] Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang 311400, Zhejiang, Peoples R China.
RP Zhang, JP (reprint author), Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang 311400, Zhejiang, Peoples R China.
EM jinpingzhang@126.com
FU Provincial Department of Science and Technology of Zhejiang, China
   [2013C32096]
FX The authors are grateful for the financial support from Provincial
   Department of Science and Technology of Zhejiang, China, Grant. No.
   2013C32096.
CR [Anonymous], 1994, 26776 GBT
   [Anonymous], 1993, 26773 GBT CHIN NAT S
   [Anonymous], 1999, 1270 LYT
   [Anonymous], 1994, 26778 GBT
   [Anonymous], 1999, 1269 LYT
   [Anonymous], 1999, 1237 LYT
   Baldinger T., 2000, LENZINGER BERICHTE, V79, P15
   Bensaid S, 2012, FUEL, V94, P324, DOI 10.1016/j.fuel.2011.11.053
   Cao XF, 2014, BIORESOURCE TECHNOL, V155, P21, DOI 10.1016/j.biortech.2013.12.006
   Chen FG, 2009, J APPL POLYM SCI, V111, P508, DOI 10.1002/app.29107
   Dawy M, 2003, POLYM-PLAST TECHNOL, V42, P643, DOI 10.1081/PPT-120023100
   GB/T, 1994, FIBR RAW MAT DET PEN, V9, P2677
   GB/T, 1995, FIBR RAW MAT DET HOL, V10, P2677
   Guo JX, 2012, BIORESOURCE TECHNOL, V120, P19, DOI 10.1016/j.biortech.2012.06.013
   Hassan EBM, 2008, IND CROP PROD, V27, P33, DOI 10.1016/j.indcrop.2007.07.004
   Hu JL, 2012, INT J FOOD SCI TECH, V47, P1676, DOI 10.1111/j.1365-2621.2012.03020.x
   Jiang JianXin, 2008, Journal of Beijing Forestry University, V30, P128
   Kim SS, 2010, BIORESOURCE TECHNOL, V101, P9797, DOI 10.1016/j.biortech.2010.07.094
   Kosikova B, 1995, CELL CHEM TECHNOL, V29, P683
   Kurimoto Y, 1999, HOLZFORSCHUNG, V53, P617, DOI 10.1515/HF.1999.102
   Lemus R, 2005, CRIT REV PLANT SCI, V24, P1, DOI 10.1080/07352680590910393
   Lin Tao, 2013, Journal of Northeast Forestry University, V41, P89
   Lu YD, 2011, WATER SCI TECHNOL, V64, P1566, DOI 10.2166/wst.2011.657
   Lu ZX, 2013, BIORESOURCE TECHNOL, V142, P579, DOI 10.1016/j.biortech.2013.05.091
   Mortazavi SM, 2010, FIBER POLYM, V11, P877, DOI 10.1007/s12221-010-0877-z
   [彭琳 Peng Lin], 2014, [水土保持通报, Bulletin of Soil and Water Conservation], V34, P129
   [邱贺媛 QIU He-yuan], 2009, [食品科学, Food Science], V30, P198
   Roder T., 2006, LENZINGER BERICHTE, V86, P85
   Su Wen-hui, 2013, Forest Research, V26, P252
   Tekin K, 2013, ENVIRON CHEM LETT, V11, P25, DOI 10.1007/s10311-012-0373-3
   Tong Q. Y., 2005, HEBEI CHEM IND, P74
   Ulloa CA, 2009, FUEL PROCESS TECHNOL, V90, P583, DOI 10.1016/j.fuproc.2008.12.015
   Xiao WH, 2011, IND CROP PROD, V34, P1602, DOI 10.1016/j.indcrop.2011.05.024
   Xu Man, 2009, Chemistry and Industry of Forest Products, V29, P187
   Xu Xiwei, 2012, Proceedings of the CSEE, V32, P118
   Xue K. P., 2012, CHEM RES APPL, V24, P1296
   Yang X. M., 2011, J CHINESE AGR MECH, V42, P151
   YAO Y, 1993, MOKUZAI GAKKAISHI, V39, P930
   Ye LY, 2014, BIORESOURCE TECHNOL, V153, P147, DOI 10.1016/j.biortech.2013.11.070
   Ye N. Y., 2005, FUJIAN CHEM IND, P69
   Yin CG, 2012, BIORESOURCE TECHNOL, V120, P273, DOI 10.1016/j.biortech.2012.06.016
   Zhang JT, 2012, J SOLID STATE ELECTR, V16, P2179, DOI 10.1007/s10008-012-1639-1
   Zhou CS, 2013, CHINESE J CHEM ENG, V21, P544, DOI 10.1016/S1004-9541(13)60509-1
   Zhou JianBin, 2008, Chemistry and Industry of Forest Products, V28, P105
   [周俊琴 Zhou Junqin], 2013, [植物遗传资源学报, Journal of Plant Genetic Resources], V14, P512
   Zou X. L., 2009, CHINA EC WEEKLY, V47, P45
NR 46
TC 2
Z9 3
U1 0
U2 7
PU NORTH CAROLINA STATE UNIV DEPT WOOD & PAPER SCI
PI RALEIGH
PA CAMPUS BOX 8005, RALEIGH, NC 27695-8005 USA
SN 1930-2126
J9 BIORESOURCES
JI BioResources
PY 2015
VL 10
IS 1
BP 647
EP 659
PG 13
WC Materials Science, Paper & Wood
SC Materials Science
GA CE6IV
UT WOS:000351941000054
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Shalumon, KT
   Chen, JP
AF Shalumon, K. T.
   Chen, Jyh-Ping
TI Scaffold-based Drug Delivery for Cartilage Tissue Regeneration
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE Regenerative engineering; cartilage tissue engineering; growth factors;
   proteins; nanofibers; gels; microspheres; scaffolds
ID MESENCHYMAL STEM-CELLS; GROWTH-FACTOR DELIVERY; OSTEOGENIC
   DIFFERENTIATION; EXTRACELLULAR-MATRIX; PROGENITOR CELLS; ADIPOSE-TISSUE;
   IN-VITRO; ENGINEERING APPLICATIONS; ELECTROSPUN NANOFIBERS; CHITOSAN
   MICROSPHERES
AB Regenerative engineering is an advanced field comprising the collective benefit of biodegradable polymers with cells and tissue inducing factors. Current method of replacing the defective organ is through transplantation, but is limited due to immune rejection and availability. As a solution, new polymeric biomaterial-based three-dimensional (3D) scaffolds in combination with cells and inducing factors were aroused to fulfil the existing demands. These scaffolds apply material science, biomedical technology and translational medicine to develop functional tissue engineering constructs. Presence of small molecules and growth factors guides the cell phenotypes to specific organ development. The 3D scaffold thus could also be favorably used as carriers for various types of drugs and genes, with the release profile fine-tuned by modulation of the scaffold's morphology, porosity, and composition. An increasing trend was observed in recent years toward the combination of scaffolds and growth factors to fabricate a bioactive system, which not only provide a biomimetic biodegradable physical support for tissue growth but also explores biological signals to modulate tissue regeneration. In this review, along with general aspects of tissue engineering, we also discuss the importance of various scaffold architectures like nanofibers, hydrogels, beads, meshes, microspheres etc. in combination with specific drugs, growth factors and small molecules for cartilage regeneration. Growth factors may be incorporated into scaffolds by direct blending, physical adsorption, drop casting, surface grafting, covalent bonding, chemical immobilization, coaxial electrospinning, microparticle incorporation etc. This offers new possibilities for the development of biomimetic scaffolds that are endowed with a hierarchical architecture and sophisticated release kinetics of the growth factors. This review portrait the fundamentals of tissue engineering with emphasis on the role of inducing factors in scaffold based cartilage tissue regeneration.
C1 [Shalumon, K. T.; Chen, Jyh-Ping] Chang Gung Univ, Dept Chem & Mat Engn, Taoyuan 333, Taiwan.
   [Chen, Jyh-Ping] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan 333, Taiwan.
RP Chen, JP (reprint author), Chang Gung Univ, Dept Chem & Mat Engn, Taoyuan 333, Taiwan.
EM jpchen@mail.cgu.edu.tw
OI Chen, Jyh-Ping/0000-0001-6527-4801
FU Ministry of Science and Technology, Taiwan, ROC; Ministry of Health and
   Welfare, Taiwan, ROC; Chang Gung Memorial Hospital [CRRPD5C0201-3,
   CMRPD3D0201-2]
FX We are thankful for the financial supports from the Ministry of Science
   and Technology, Taiwan, ROC; Ministry of Health and Welfare, Taiwan,
   ROC; Chang Gung Memorial Hospital (CRRPD5C0201-3 and CMRPD3D0201-2).
CR BARCELLOSHOFF MH, 1989, DEVELOPMENT, V105, P223
   Bilousova G, 2011, STEM CELLS, V29, P206, DOI 10.1002/stem.566
   Bose S, 1999, SCRIPTA MATER, V41, P1009, DOI 10.1016/S1359-6462(99)00250-X
   Bose S, 2003, MAT SCI ENG C-BIO S, V23, P479, DOI 10.1016/S0928-4931(02)00129-7
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Chan PS, 2005, OSTEOARTHR CARTILAGE, V13, P387, DOI 10.1016/j.joca.2005.01.003
   Chang KH, 2013, ACTA BIOMATER, V9, P9012, DOI 10.1016/j.actbio.2013.06.046
   Chang KY, 2010, J BIOMED MATER RES A, V92A, P712, DOI 10.1002/jbm.a.32198
   Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686
   Chen FM, 2007, J CONTROL RELEASE, V121, P81, DOI 10.1016/j.jconrel.2007.05.023
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chen JP, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-170
   Chen JP, 2011, ACTA BIOMATER, V7, P234, DOI 10.1016/j.actbio.2010.08.015
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027
   Cheng T, 2006, J ENVIRON MANAGE, V80, P222, DOI 10.1016/j.jenvman.2005.09.007
   Cheung HK, 2014, BIOMATERIALS, V35, P1914, DOI 10.1016/j.biomaterials.2013.11.067
   Dankers PYW, 2011, J CONTROL RELEASE, V152, P177, DOI 10.1016/j.jconrel.2011.01.034
   Dellamary L, 2004, J CONTROL RELEASE, V95, P489, DOI 10.1016/j.jconrel.2003.12.013
   Deng M, 2010, SOFT MATTER, V6, P3119, DOI 10.1039/b926402g
   Diogo GS, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/025001
   DOILLON CJ, 1994, MAT SCI ENG C-BIOMIM, V2, P43, DOI 10.1016/0928-4931(94)90028-0
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Egusa H, 2010, J ORAL BIOSCI, V52, P107, DOI 10.2330/joralbiosci.52.107
   Fan HB, 2006, J BIOMED MATER RES A, V77A, P785, DOI 10.1002/jbm.a.30647
   Gaetani R, 2012, BIOMATERIALS, V33, P1782, DOI 10.1016/j.biomaterials.2011.11.003
   Garrigues NW, 2014, J BIOMED MATER RES A, V102, P3998, DOI 10.1002/jbm.a.35068
   Georgi N, 2017, J TISSUE ENG REGEN M, V11, P724, DOI 10.1002/term.1969
   Ghosh S, 2009, BIOMATERIALS, V30, P6530, DOI 10.1016/j.biomaterials.2009.08.019
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Granja PL, 2001, J MATER SCI, V36, P2163, DOI 10.1023/A:1017587815583
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guven S, 2011, BIOMATERIALS, V32, P5801, DOI 10.1016/j.biomaterials.2011.04.064
   Guler MO, 2006, BIOMACROMOLECULES, V7, P1855, DOI 10.1021/bm060161g
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Hsu SH, 2006, ARTIF ORGANS, V30, P42, DOI 10.1111/j.1525-1594.2006.00179.x
   Huang AH, 2010, J BIOMECH, V43, P128, DOI 10.1016/j.jbiomech.2009.09.018
   Hung KC, 2014, ADV HEALTHC MATER, V3, P1578, DOI 10.1002/adhm.201400018
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Jaklenec A, 2008, BIOMATERIALS, V29, P185, DOI 10.1016/j.biomaterials.2007.09.017
   Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   Kadzik RS, 2012, CELL STEM CELL, V10, P355, DOI 10.1016/j.stem.2012.03.013
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Kanokpanont S, 2012, INT J PHARMACEUT, V436, P141, DOI 10.1016/j.ijpharm.2012.06.046
   Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028
   Kellner K, 2001, J DRUG TARGET, V9, P439, DOI 10.3109/10611860108998778
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Kim H, 2014, MAT SCI ENG C-MATER, V40, P324, DOI 10.1016/j.msec.2014.04.012
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Klock G, 1997, BIOMATERIALS, V18, P707, DOI 10.1016/S0142-9612(96)00204-9
   Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Kuboki Y, 2002, CONNECT TISSUE RES, V43, P529, DOI 10.1080/03008200290001104
   Kwon DY, 2014, J MATER CHEM B, V2, P1689, DOI 10.1039/c3tb21563f
   Lai GJ, 2014, CARBOHYD POLYM, V111, P288, DOI 10.1016/j.carbpol.2014.04.094
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057
   Lee JE, 2004, ARTIF ORGANS, V28, P829, DOI 10.1111/j.1525-1594.2004.00020.x
   Lee JW, 2013, J BIOMED MATER RES A, V101, P1865, DOI 10.1002/jbm.a.34485
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li XD, 2006, BIOMATERIALS, V27, P2426, DOI 10.1016/j.biomaterials.2005.11.040
   Liao HT, 2011, TISSUE ENG PART C-ME, V17, P1139, DOI 10.1089/ten.tec.2011.0140
   Liao HT, 2011, J TRAUMA, V70, P228, DOI 10.1097/TA.0b013e3181e12b56
   Liu X, 2009, BIOMATERIALS, V30, P2252, DOI 10.1016/j.biomaterials.2008.12.068
   Liu YY, 2012, MAT SCI ENG C-MATER, V32, P2361, DOI 10.1016/j.msec.2012.07.008
   Lu BS, 2014, DRUG DISCOV TODAY, V19, P801, DOI 10.1016/j.drudis.2013.11.011
   Lu S, 2014, BIOMATERIALS, V35, P8829, DOI 10.1016/j.biomaterials.2014.07.006
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   Martinez EC, 2011, J MOL CELL CARDIOL, V50, P312, DOI 10.1016/j.yjmcc.2010.08.009
   Merrill JP, 1956, T AM CLIN CLIMAT ASS, V67, P166
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nanda HS, 2014, BIOMED RES INT, V2014, P10
   NEUMAN RE, 1950, J BIOL CHEM, V186, P549
   Nivison-Smith L, 2010, ACTA BIOMATER, V6, P354, DOI 10.1016/j.actbio.2009.08.011
   NOISHIKI Y, 1982, KOBUNSHI RONBUNSHU, V39, P221, DOI 10.1295/koron.39.221
   Nuttelman CR, 2006, J BIOMED MATER RES A, V76A, P183, DOI 10.1002/jbm.a.30537
   Otani Y, 2015, TISSUE ENG PT A, V21, P627, DOI [10.1089/ten.TEA.2013.0655, 10.1089/ten.tea.2013.0655]
   Paramonov SE, 2006, J AM CHEM SOC, V128, P7291, DOI 10.1021/ja060573x
   Pati F, 2015, BIOMATERIALS, V37, P230, DOI 10.1016/j.biomaterials.2014.10.012
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Pouton CW, 1996, ADV DRUG DELIVER REV, V18, P133, DOI 10.1016/0169-409X(95)00092-L
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Qiu QQ, 1999, BIOMATERIALS, V20, P989, DOI 10.1016/S0142-9612(98)00183-5
   Ratner BD, 2013, BIOMATERIALS SCI, pxxi
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Ronziere MC, 2003, BIOMATERIALS, V24, P851, DOI 10.1016/S0142-9612(02)00418-0
   Sahoo S, 2010, J BIOMED MATER RES A, V93A, P1539, DOI 10.1002/jbm.a.32645
   Sahoo S, 2010, BIOMATERIALS, V31, P2990, DOI 10.1016/j.biomaterials.2010.01.004
   Schauss AG, 2007, FOOD CHEM TOXICOL, V45, P315, DOI 10.1016/j.fct.2006.08.011
   Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307
   Selimis A, 2015, MICROELECTRON ENG, V132, P83, DOI 10.1016/j.mee.2014.10.001
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Shaikh FM, 2008, CELLS TISSUES ORGANS, V188, P333, DOI 10.1159/000139772
   Shalumon KT, 2011, J BIOMED NANOTECHNOL, V7, P609, DOI 10.1166/jbn.2011.1337
   Shalumon KT, 2011, INT J BIOL MACROMOL, V48, P571, DOI 10.1016/j.ijbiomac.2011.01.020
   Shalumon K.T., 2010, J MACROMOL SCI PURE, V48, P21
   Sharon N, 2007, HUMAN CELL CULTURE, P129
   Sionkowska A, 2013, J MOL LIQ, V178, P5, DOI 10.1016/j.molliq.2012.10.042
   Skardal A, 2012, BIOMATERIALS, V33, P4565, DOI 10.1016/j.biomaterials.2012.03.034
   Sridhar BV, 2014, J BIOMED MATER RES A, V102, P4464, DOI 10.1002/jbm.a.35115
   Suciati T, 2006, J MATER SCI-MATER M, V17, P1049, DOI 10.1007/s10856-006-0443-9
   Swarnalatha B, 2013, INT J BIOL MACROMOL, V58, P220, DOI 10.1016/j.ijbiomac.2013.03.060
   Tao SL, 2007, NANO LETT, V7, P1463, DOI 10.1021/nl0700346
   Timmons SF, 2002, USA, Patent No. [6,432,435 B, 6432435]
   Trachtenberg JE, 2014, J BIOMED MATER RES A, V102, P4326, DOI 10.1002/jbm.a.35108
   Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200
   Verreck G, 2003, J CONTROL RELEASE, V92, P349, DOI 10.1016/S0168-3659(03)00342-0
   Vogelhuber W, 2003, EUR J PHARM BIOPHARM, V55, P133, DOI 10.1016/S0939-6411(02)00137-6
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Wang J, 2002, J CONTROL RELEASE, V82, P289, DOI 10.1016/S0168-3659(02)00137-2
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Xing XB, 2008, OPT EXPRESS, V16, P10815, DOI 10.1364/OE.16.010815
   Xu CY, 2004, TISSUE ENG, V10, P1160, DOI 10.1089/ten.2004.10.1160
   Ye KY, 2011, J VISUAL EXPT JOVE
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang Weijie, 2014, Biomed Res Int, V2014, P746138, DOI 10.1155/2014/746138
   Zhao L., 2010, TISSUE ENG PART A, V17, P969
NR 130
TC 8
Z9 8
U1 3
U2 60
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2015
VL 21
IS 15
BP 1979
EP 1990
DI 10.2174/1381612821666150302152836
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CF8YQ
UT WOS:000352848500007
PM 25732662
DA 2018-10-19
ER

PT J
AU Hansen, AW
   Fuhr, LT
   Antonini, LM
   Villarinho, DJ
   Marino, CEB
   Malfatti, CD
AF Hansen, Alana Witt
   Fuehr, Luciane Tais
   Antonini, Leonardo Marasca
   Villarinho, Denis Jardim
   Bruno Marino, Claudia Eliana
   Malfatti, Celia de Fraga
TI The Electrochemical Behavior of the NiTi Alloy in Different Simulated
   Body Fluids
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE metallic biomaterial; electrochemical behavior; NiTi; simulated body
   fluids
ID SHAPE-MEMORY ALLOY; IMMERSION ION-IMPLANTATION; NICKEL-TITANIUM ALLOY;
   CORROSION BEHAVIOR; SURFACE; RESISTANCE; OXIDATION; CYTOTOXICITY;
   BIOACTIVITY; TIO2
AB In order to improve the NiTi alloy biocompatibility, surface treatments become very important. Nevertheless, researchers use different solutions to simulate the body fluids in electrochemical assays, and the correlation between the obtained results is difficult and might not even be possible. The present paper evaluated the electrochemical behavior of polished NiTi surfaces exposed to different simulated body fluid solutions: Hanks solution, Hanks' balanced salt (HBSS) solution, saline body fluid (SBF) solution, and Ringer solution. The electrochemical behavior of NiTi was evaluated by open circuit potential (OCP) and cyclic voltammetry tests. The surfaces of the samples were also characterized by scanning electron microscopy, which was performed after the electrochemical tests. The results demonstrated that the NiTi alloy shows the same corrosion mechanism (pitting) in all simulated body fluids that were studied. However, the corrosion potential changes for each electrolyte, being HBSS, SBF and Ringer the most corrosive solutions. Furthermore, the Hanks and HBSS solutions demonstrated good reproducibility of the electochemical results. Considering that the HBSS represents an extreme environment, this solution seems to be the most indicated to study the corrosion behavior of NiTi treated surfaces.
C1 [Hansen, Alana Witt; Antonini, Leonardo Marasca; Malfatti, Celia de Fraga] Fed Univ Rio Grande Sul UFRGS, Corros Res Lab LAPEC, Porto Alegre, RS, Brazil.
   [Fuehr, Luciane Tais; Villarinho, Denis Jardim] Feevale Univ, Exact & Technol Sci Inst ICET, Novo Hamburgo, RS, Brazil.
   [Bruno Marino, Claudia Eliana] Fed Univ Parana UFPR, Mech Engn Dept, Curitiba, PR, Brazil.
RP Hansen, AW (reprint author), Fed Univ Rio Grande Sul UFRGS, Corros Res Lab LAPEC, 9500 Bento Goncalves Ave, Porto Alegre, RS, Brazil.
EM alanawitt@hotmail.com
RI MARINO, CLAUDIA/H-8169-2017; MALFATTI, CELIA/O-4102-2018
OI MARINO, CLAUDIA/0000-0003-2660-4577; MALFATTI, CELIA/0000-0002-0819-479X
CR [Anonymous], 2008, F212908 ASTM
   Bayat N, 2011, APPL SURF SCI, V257, P8493, DOI 10.1016/j.apsusc.2011.05.001
   Bernard SA, 2011, ACTA BIOMATER, V7, P1902, DOI 10.1016/j.actbio.2011.01.004
   Chrzanowski W, 2008, ACTA BIOMATER, V4, P1969, DOI 10.1016/j.actbio.2008.05.010
   Dhage SR, 2004, MATER LETT, V58, P2310, DOI 10.1016/j.matlet.2004.02.021
   Dinca VC, 2006, APPL SURF SCI, V252, P4619, DOI 10.1016/j.apsusc.2005.07.093
   Filip P, 2001, BIOMATERIALS, V22, P2131, DOI 10.1016/S0142-9612(00)00404-X
   Flamini DO, 2014, CORROS SCI, V81, P36, DOI 10.1016/j.corsci.2013.11.063
   Gupta R, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034005
   Han JB, 2011, INT J GREENH GAS CON, V5, P1680, DOI 10.1016/j.ijggc.2011.08.003
   Horiuchi Y, 2007, DENT MATER J, V26, P924, DOI 10.4012/dmj.26.924
   Hu T, 2010, J MATER RES, V25, P350, DOI 10.1557/JMR.2010.0051
   Huan Z, 2012, APPL SURF SCI, V258, P5244, DOI 10.1016/j.apsusc.2012.02.002
   Khalil-Allafi J, 2010, MAT SCI ENG C-MATER, V30, P1112, DOI 10.1016/j.msec.2010.06.007
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Li XJ, 2007, ACTA BIOMATER, V3, P807, DOI 10.1016/j.actbio.2007.02.002
   Liang CH, 2001, T NONFERR METAL SOC, V11, P579
   Lifeng Z, 2011, BIOMED MATER, V6, DOI [10.1088/1748-6041/6/2/025012, DOI 10.1088/1748-6041/6/2/025012]
   Liu XM, 2008, SURF COAT TECH, V202, P2463, DOI 10.1016/j.surfcoat.2007.08.017
   Liu XM, 2007, APPL SURF SCI, V253, P3154, DOI 10.1016/j.apsusc.2006.07.008
   Maho A, 2013, ELECTROCHIM ACTA, V89, P346, DOI 10.1016/j.electacta.2012.11.026
   McMahon RE, 2012, ACTA BIOMATER, V8, P2863, DOI 10.1016/j.actbio.2012.03.034
   MILOSEV I, 1995, SURF INTERFACE ANAL, V23, P529, DOI 10.1002/sia.740230713
   Oshida Y, 1990, MATER SCI FORUM, V56, P705
   Park HH, 2010, ELECTROCHIM ACTA, V55, P6109, DOI 10.1016/j.electacta.2010.05.082
   Qiu DL, 2010, APPL SURF SCI, V257, P1774, DOI 10.1016/j.apsusc.2010.09.014
   Rondelli G, 1996, BIOMATERIALS, V17, P2003, DOI 10.1016/0142-9612(95)00352-5
   Shabalovskaya SA, 2009, BIOMATERIALS, V30, P3662, DOI 10.1016/j.biomaterials.2009.03.034
   Shahrabi T, 2008, MATER LETT, V62, P2791, DOI 10.1016/j.matlet.2008.01.052
   Shen Y, 2009, ACTA BIOMATER, V5, P3593, DOI 10.1016/j.actbio.2009.05.021
   Shi P, 2007, MATER LETT, V61, P2385, DOI 10.1016/j.matlet.2006.09.020
   Siu HT, 2013, APPL SURF SCI, V274, P181, DOI 10.1016/j.apsusc.2013.03.008
   Tomashov ND, 1985, ZASCHYTA MYETALLOV, V5, P682
   Torres-Islas A, 2008, CORROS SCI, V50, P2831, DOI 10.1016/j.corsci.2008.07.007
   Trepanier C, 2005, Medical Device Materials II: Proceedings from the Materials & Processes for Medical Devices Conference 2004, P392
   Vojtech D, 2008, INTERMETALLICS, V16, P424, DOI 10.1016/j.intermet.2007.12.006
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   Zhao TT, 2011, SURF COAT TECH, V205, P4404, DOI 10.1016/j.surfcoat.2011.03.061
NR 38
TC 5
Z9 5
U1 1
U2 18
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
EI 1980-5373
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PD JAN-FEB
PY 2015
VL 18
IS 1
BP 184
EP 190
DI 10.1590/1516-1439.305614
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA CG1UU
UT WOS:000353061100024
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Mitchelson, AJ
   Wilson, CJ
   Mihalko, WM
   Grupp, TM
   Manning, BT
   Dennis, DA
   Goodman, SB
   Tzeng, TH
   Vasdev, S
   Saleh, KJ
AF Mitchelson, Andrew J.
   Wilson, Craig J.
   Mihalko, William M.
   Grupp, Thomas M.
   Manning, Blaine T.
   Dennis, Douglas A.
   Goodman, Stuart B.
   Tzeng, Tony H.
   Vasdev, Sonia
   Saleh, Khaled J.
TI Biomaterial Hypersensitivity: Is It Real? Supportive Evidence and
   Approach Considerations for Metal Allergic Patients following Total Knee
   Arthroplasty
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID TOTAL HIP-ARTHROPLASTY; CONTACT ALLERGY; ORTHOPEDIC IMPLANTS; JOINT
   REPLACEMENT; HUMAN OSTEOCLASTS; BENZOYL PEROXIDE; SENSITIVITY; NICKEL;
   OSTEOLYSIS; COBALT
AB The prospect of biomaterial hypersensitivity developing in response to joint implant materials was first presented more than 30 years ago. Many studies have established probable causation between first-generation metal-on-metal hip implants and hypersensitivity reactions. In a limited patient population, implant failure may ultimately be related to metal hypersensitivity. The examination of hypersensitivity reactions in current-generation metal-on-metal knee implants is comparatively limited. The purpose of this study is to summarize all available literature regarding biomaterial hypersensitivity after total knee arthroplasty, elucidate overall trends about this topic in the current literature, and provide a foundation for clinical approach considerations when biomaterial hypersensitivity is suspected.
C1 [Mitchelson, Andrew J.; Wilson, Craig J.; Manning, Blaine T.; Tzeng, Tony H.; Vasdev, Sonia; Saleh, Khaled J.] So Illinois Univ, Sch Med, Dept Surg, Div Orthopaed & Rehabil, Springfield, IL 62794 USA.
   [Mihalko, William M.] Univ Tennessee, Dept Orthopaed Surg & Biomed Engn, Memphis, TN 38017 USA.
   [Grupp, Thomas M.] Univ Munich, Clin Orthopaed Surg, D-80539 Munich, Germany.
   [Grupp, Thomas M.] Aesculap AG, Res & Dev, D-78532 Tuttlingen, Germany.
   [Dennis, Douglas A.] Colorado Joint Replacement, Denver, CO 80210 USA.
   [Goodman, Stuart B.] Stanford Univ, Sch Med, Dept Orthopaed Surg, Redwood City, CA 94063 USA.
RP Saleh, KJ (reprint author), So Illinois Univ, Sch Med, Dept Surg, Div Orthopaed & Rehabil, POB 19679, Springfield, IL 62794 USA.
EM ksaleh@siumed.edu
CR Ashraf M. W., 2012, SCI WORLD J, V2012, DOI DOI 10.1100/2012/729430
   Basko-Plluska JL, 2011, DERMATITIS, V22, P65, DOI 10.2310/6620.2011.10055
   Beck RT, 2012, J ORTHOP RES, V30, P541, DOI 10.1002/jor.21554
   Beecker Jennifer, 2009, Dermatitis, V20, pE4
   Bergschmidt Philipp, 2011, Open Orthop J, V5, P354, DOI 10.2174/1874325001105010354
   Bergschmidt P, 2012, KNEE, V19, P144, DOI 10.1016/j.knee.2011.01.001
   Borchers A, 2010, CLIN REV ALLERG IMMU, V39, P95, DOI 10.1007/s12016-009-8176-4
   BROWN GC, 1977, J BONE JOINT SURG AM, V59, P164, DOI 10.2106/00004623-197759020-00004
   Burton L, 2013, J ORTHOP RES, V31, P73, DOI 10.1002/jor.22190
   Cadosch D, 2010, J BIOMED MATER RES A, V95A, P1004, DOI 10.1002/jbm.a.32914
   Cadosch D, 2010, J BIOMED MATER RES A, V92A, P475, DOI 10.1002/jbm.a.32390
   Cadosch D, 2009, J BIOMED MATER RES A, V91A, P1252, DOI 10.1002/jbm.a.32625
   Cadosch D, 2009, J ORTHOP RES, V27, P841, DOI 10.1002/jor.20831
   Caicedo MS, 2009, J ORTHOP RES, V27, P847, DOI 10.1002/jor.20826
   Cancilleri F, 1992, Ital J Orthop Traumatol, V18, P407
   CARLSSON AS, 1980, ACTA ORTHOP SCAND, V51, P57, DOI 10.3109/17453678008990769
   Cousen PJ, 2012, CONTACT DERMATITIS, V66, P55, DOI 10.1111/j.1600-0536.2011.01970.x
   Davis Mark D P, 2004, Dermatitis, V15, P210, DOI 10.2310/6620.2004.04030
   DEUTMAN R, 1977, J BONE JOINT SURG AM, V59, P862, DOI 10.2106/00004623-197759070-00004
   Dietrich KA, 2009, J DTSCH DERMATOL GES, V7, P410, DOI 10.1111/j.1610-0387.2008.06987.x
   Eben R, 2010, DEUT MED WOCHENSCHR, V135, P1418, DOI 10.1055/s-0030-1262426
   Edwards SA, 2007, J ARTHROPLASTY, V22, P1226, DOI 10.1016/j.arth.2006.10.019
   ELVES MW, 1975, BRIT MED J, V4, P376, DOI 10.1136/bmj.4.5993.376
   EVANS EM, 1974, J BONE JOINT SURG BR, VB 56, P626
   Frigerio E, 2011, CONTACT DERMATITIS, V64, P273, DOI 10.1111/j.1600-0536.2011.01886.x
   Gao X, 2011, J ARTHROPLASTY, V26, P665, DOI DOI 10.1016/J.ARTH.2010.06.002
   Granchi D, 2006, J BIOMED MATER RES B, V77B, P257, DOI 10.1002/jbm.b.30445
   Granchi D, 2012, J BONE JOINT SURG BR, V94B, P1126, DOI 10.1302/0301-620X.94B8.28135
   Granchi D, 2008, BIOMATERIALS, V29, P1494, DOI 10.1016/j.biomaterials.2007.11.038
   Hallab N, 2001, JCR-J CLIN RHEUMATOL, V7, P215, DOI 10.1097/00124743-200108000-00004
   Hallab NJ, 2009, BULL HOSP JT DIS, V67, P182
   Hallab Nadim James, 2008, J Orthop Surg Res, V3, P6, DOI 10.1186/1749-799X-3-6
   Hallab NJ, 2005, J ORTHOP RES, V23, P384, DOI 10.1016/j.orthres.2004.09.001
   Handa S, 2003, CONTACT DERMATITIS, V49, P259, DOI 10.1111/j.0105-1873.2003.0225b.x
   Holt G, 2007, CLIN ORTHOP RELAT R, P240, DOI 10.1097/BLO.0b013e31804b4147
   KIEFFER M, 1979, CONTACT DERMATITIS, V5, P398, DOI 10.1111/j.1600-0536.1979.tb04913.x
   Krecisz Beata, 2006, International Journal of Occupational Medicine and Environmental Health, V19, P178, DOI 10.2478/v10001-006-0025-6
   Luetzner J, 2007, CLIN ORTHOP RELAT R, P136, DOI 10.1097/BLO.0b013e31806450ef
   Mesinkovska NA, 2012, ARCH DERMATOL, V148, P687, DOI 10.1001/archdermatol.2011.2561
   Nater J P, 1976, Contact Dermatitis, V2, P259, DOI 10.1111/j.1600-0536.1976.tb03044.x
   Ng VY, 2011, CLIN ORTHOP RELAT R, V469, P523, DOI 10.1007/s11999-010-1570-7
   Niki Y, 2005, BIOMATERIALS, V26, P1019, DOI 10.1016/j.biomaterials.2004.03.038
   Oiso N, 2004, CONTACT DERMATITIS, V51, P151, DOI 10.1111/j.0105-1873.2004.0426e.x
   Park YS, 2005, J BONE JOINT SURG AM, V87A, P1515, DOI 10.2106/JBJS.D.02641
   Reed KB, 2008, ARCH DERMATOL, V144, P999, DOI 10.1001/archderm.144.8.999
   ROOKER GD, 1980, J BONE JOINT SURG BR, V62, P502
   Rui F, 2010, CONTACT DERMATITIS, V62, P225, DOI 10.1111/j.1600-0536.2009.01650.x
   Schafer T, 2001, ALLERGY, V56, P1192, DOI 10.1034/j.1398-9995.2001.00086.x
   Schalock PC, 2012, CONTACT DERMATITIS, V66, P4, DOI 10.1111/j.1600-0536.2011.01971.x
   Summer B, 2010, CONTACT DERMATITIS, V63, P15, DOI 10.1111/j.1600-0536.2010.01744.x
   Swiontkowski MF, 2001, J ORTHOP TRAUMA, V15, P86, DOI 10.1097/00005131-200102000-00002
   Teow Y, 2011, CHEM COMMUN, V47, P7025, DOI 10.1039/c0cc05271j
   Thienpont E, 2013, KNEE SURG SPORT TR A, V21, P636, DOI 10.1007/s00167-012-2000-z
   Thomas P, 2000, ALLERGY, V55, P969, DOI 10.1034/j.1398-9995.2000.00619.x
   Thomsen Marc, 2011, Acta Orthop, V82, P386, DOI 10.3109/17453674.2011.579521
   Thyssen JP, 2011, BRIT J DERMATOL, V164, P473, DOI 10.1111/j.1365-2133.2010.10144.x
   Thyssen JP, 2010, CHEM RES TOXICOL, V23, P309, DOI 10.1021/tx9002726
   Thyssen JP, 2007, CONTACT DERMATITIS, V57, P287, DOI 10.1111/j.1600-0536.2007.01220.x
   Treudler R, 2007, CONTACT DERMATITIS, V57, P177, DOI 10.1111/j.1600-0536.2007.01195.x
   Uter W, 2009, CONTACT DERMATITIS, V61, P31, DOI 10.1111/j.1600-0536.2009.01572.x
   Valentine-Thon E, 2006, NEUROENDOCRINOL LETT, V27, P17
   Van Opstal N, 2011, ACTA ORTHOP BELG, V77, P691
   Verma SB, 2006, CONTACT DERMATITIS, V54, P228, DOI 10.1111/j.0105-1873.2006.0775o.x
   WATERMAN AH, 1985, CONTACT DERMATITIS, V13, P294, DOI 10.1111/j.1600-0536.1985.tb02581.x
   Willert HG, 2005, J BONE JOINT SURG AM, V87A, P28, DOI 10.2106/JBJS.A.02039pp
   Zug KA, 2009, DERMATITIS, V20, P149, DOI 10.2310/6620.2009.08097
NR 66
TC 11
Z9 11
U1 0
U2 10
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 137287
DI 10.1155/2015/137287
PG 10
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CF2QA
UT WOS:000352391000001
PM 25883940
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Shao, RX
   Quan, RF
   Zhang, L
   Wei, XC
   Yang, DS
   Xie, SJ
AF Shao, Rongxue
   Quan, Renfu
   Zhang, Liang
   Wei, Xicheng
   Yang, Disheng
   Xie, Shangju
TI Porous hydroxyapatite bioceramics in bone tissue engineering: current
   uses and perspectives
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Review
DE Bone tissue engineering; Hydroxyapatite; Zirconia; Bone morphogenetic
   protein-2; Mesenchymal stem cells
ID PLURIPOTENT STEM-CELLS; BETA-TRICALCIUM PHOSPHATE; BIPHASIC
   CALCIUM-PHOSPHATE; HUMAN SOMATIC-CELLS; MORPHOGENETIC PROTEIN-2;
   IN-VIVO; MECHANICAL-PROPERTIES; GRAFT SUBSTITUTE; DEFINED FACTORS;
   SPINAL-FUSION
AB The goals of bone tissue engineering are to apply biomaterial scaffolds with adhered cells, such as osteoblasts, bone marrow stromal stem cells, or chondrocytes, to repair, regenerate, and restore the functions of damaged bone tissue or to replace those tissues with porous engineered biomaterials. Over recent decades, a diverse class of biomaterials has been applied in bone tissue engineering field. Porous hydroxyapatite bioceramic is currently receiving significant attention as a bone tissue engineering substitute because of its biological characteristics, including biocompatibility, bioactivity, osteoconduction, and vasculogenesis. This biomaterial has a three-dimensional structure with interconnected spherical pores of uniform size, which encourages bone ingrowth and achieves good integration of the material and the host bone over time. However, the compressive strength and elastic modulus of porous hydroxyapatite scaffolds generally weaken as the porosity increases, in both in vitro and in vivo testing. Zirconia can be used to toughen hydroxyapatite materials for bone repair and replacement because of its unique biomechanical properties, including compressive strength and fracture toughness. Additionally, a zirconia chitosan hybrid containing bone morphogenetic protein-2 and mesenchymal stem cells derived from induced pluripotent stem cells has been used as a coating material adhered to surface of scaffolds to promote bone regeneration and repair. Here, we provide a succinct review of zirconia toughened hydroxyapatite biomaterial scaffolds that incorporate bone morphogenetic protein-2 and mesenchymal stem cells for bone tissue engineering and describe the biomaterials that are currently being investigated based on the recent literature and our own data. (C) 2015 The Ceramic Society of Japan. All rights reserved.
C1 [Shao, Rongxue; Zhang, Liang; Xie, Shangju] Zhejiang Chinese Med Univ, Res Inst Orthoped, Hangzhou 310053, Zhengjiang Prov, Peoples R China.
   [Quan, Renfu] Xiaoshan Tradit Chinese Med Hosp, Dept Orthoped, Hangzhou 311200, Zhengjiang Prov, Peoples R China.
   [Wei, Xicheng] Shanghai Univ, Sch Mat Sci & Engn, Shanghai 200444, Peoples R China.
   [Yang, Disheng] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Orthoped, Hangzhou 310009, Zhengjiang Prov, Peoples R China.
RP Quan, RF (reprint author), Xiaoshan Tradit Chinese Med Hosp, Dept Orthoped, Hangzhou 311200, Zhengjiang Prov, Peoples R China.
EM spinequan@yahoo.com
FU Zhejiang Provincial Science and Technology Program [2012C33114];
   Hangzhou City Science and Technology Program [20122513A44]
FX This work was funded through the Zhejiang Provincial Science and
   Technology Program (NO:2012C33114) and Hangzhou City Science and
   Technology Program (NO:20122513A44).
CR Abarrategi A, 2009, ACTA BIOMATER, V5, P2633, DOI 10.1016/j.actbio.2009.02.031
   Alam I, 2001, J Biomed Mater Res, V54, P129
   Alt V, 2009, EUR SPINE J, V18, P800, DOI 10.1007/s00586-009-0935-7
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   Ayers RA, 1998, J ORAL MAXIL SURG, V56, P1297, DOI 10.1016/S0278-2391(98)90613-9
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Benglis D, 2008, NEUROSURGERY, V62, P423, DOI 10.1227/01.neu.0000326030.24220.d8
   BUCHOLZ RW, 1987, ORTHOP CLIN N AM, V18, P323
   BUCHOLZ RW, 1989, CLIN ORTHOP RELAT R, P53
   Burkus JK, 2009, J BONE JOINT SURG AM, V91A, P1181, DOI 10.2106/JBJS.G.01485
   Cavagna R, 1999, J LONG-TERM EFF MED, V9, P403
   Chang E, 1997, J MATER SCI-MATER M, V8, P201, DOI 10.1023/A:1018535606393
   Chen L, 2014, J MATER SCI-MATER M, V25, P1709, DOI 10.1007/s10856-014-5194-4
   Ciacchi FT, 1996, SOLID STATE IONICS, V86-8, P1167, DOI 10.1016/0167-2738(96)00282-2
   Cornell C N, 1991, J Orthop Trauma, V5, P1
   Curran DJ, 2010, J MATER SCI-MATER M, V21, P1109, DOI 10.1007/s10856-009-3974-z
   de Peppo GM, 2013, P NATL ACAD SCI USA, V110, P8680, DOI 10.1073/pnas.1301190110
   Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006
   Fujibayashi S, 2003, BIOMATERIALS, V24, P3445, DOI 10.1016/S0142-9612(03)00221-7
   Garcia-Gareta E, 2014, J MATER SCI-MATER M, V25, P1553, DOI 10.1007/s10856-014-5170-z
   Hannink G, 2013, J MATER SCI-MATER M, V24, P325, DOI 10.1007/s10856-012-4802-4
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HOLMES RE, 1988, J ORAL MAXIL SURG, V46, P661, DOI 10.1016/0278-2391(88)90109-7
   Jones AC, 2007, BIOMATERIALS, V28, P2491, DOI 10.1016/j.biomaterials.2007.01.046
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Jun SH, 2013, J MATER SCI-MATER M, V24, P773, DOI 10.1007/s10856-012-4822-0
   Jun SH, 2011, J MATER SCI-MATER M, V22, P2757, DOI 10.1007/s10856-011-4458-5
   Jun SH, 2010, ACTA BIOMATER, V6, P302, DOI 10.1016/j.actbio.2009.06.024
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436
   Lecomte A, 2008, J BIOMED MATER RES B, V84B, P1, DOI 10.1002/jbm.b.30569
   Lee EJ, 2009, BIOMATERIALS, V30, P743, DOI 10.1016/j.biomaterials.2008.10.025
   Lee JH, 2013, J MATER SCI-MATER M, V24, P2117, DOI 10.1007/s10856-013-4967-5
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   Lim HP, 2013, J MATER SCI-MATER M, V24, P1895, DOI 10.1007/s10856-013-4939-9
   Linhart W, 2004, UNFALLCHIRURG, V107, P154, DOI 10.1007/s00113-003-0707-5
   Liu B, 2008, J MATER SCI-MATER M, V19, P1203, DOI 10.1007/s10856-007-3216-1
   Liu H, 2010, HEPATOLOGY, V51, P1810, DOI 10.1002/hep.23626
   Liu YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033225
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Martinetti R, 2005, ANAL BIOANAL CHEM, V381, P634, DOI 10.1007/s00216-004-2957-7
   Matsumine A, 2004, J BONE JOINT SURG BR, V86B, P719, DOI 10.1302/0301-620X.86B5.14242
   Matsuno T, 2000, J MATER SCI LETT, V19, P573, DOI 10.1023/A:1006722110462
   Namikawa T, 2005, SPINE, V30, P1717, DOI 10.1097/01.brs.0000172155.17239.fa
   Nishio K, 2000, J BIOMED MATER RES, V52, P652, DOI 10.1002/1097-4636(20001215)52:4<652::AID-JBM9>3.3.CO;2-N
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   OHGUSHI H, 1993, J BIOMED MATER RES, V27, P1401, DOI 10.1002/jbm.820271107
   Omae H, 2006, J BIOMED MATER RES A, V79A, P329, DOI 10.1002/jbm.a.30797
   Oreffo ROC, 1998, BIOMATERIALS, V19, P1845, DOI 10.1016/S0142-9612(98)00084-2
   Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   PROLO DJ, 1985, CLIN ORTHOP RELAT R, P322
   Quan RF, 2008, J MATER SCI-MATER M, V19, P183, DOI 10.1007/s10856-006-0025-x
   Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z
   Sensebe L, 2010, VOX SANG, V98, P93, DOI 10.1111/j.1423-0410.2009.01227.x
   Silva VV, 1997, J MATER SCI-MATER M, V8, P907, DOI 10.1023/A:1018566124507
   Strong M, 2009, BIOLOGICALS, V37, P103, DOI 10.1016/j.biologicals.2009.01.003
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sultana R., 2012, J AM CERAM SOC, V4, P1212
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tancred DC, 1998, BIOMATERIALS, V19, P2303, DOI 10.1016/S0142-9612(98)00141-0
   UCHIDA A, 1990, J BONE JOINT SURG BR, V72, P298
   Vaidhyanathan B, 1997, B MATER SCI, V20, P135, DOI 10.1007/BF02753220
   Villa-Diaz LG, 2012, STEM CELLS, V30, P1174, DOI 10.1002/stem.1084
   Yan X, 2010, STEM CELLS DEV, V19, P469, DOI 10.1089/scd.2009.0314
   Yang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100285
   Yoshikawa Hideki, 2005, J Artif Organs, V8, P131, DOI 10.1007/s10047-005-0292-1
   Yoshikawa H, 2009, J R SOC INTERFACE, V6, pS341, DOI 10.1098/rsif.2008.0425.focus
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
NR 70
TC 13
Z9 14
U1 2
U2 71
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD JAN
PY 2015
VL 123
IS 1433
BP 17
EP 20
DI 10.2109/jcersj2.123.17
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA CE9DH
UT WOS:000352143300003
OA Bronze
DA 2018-10-19
ER

PT J
AU Chahal, S
   Hussain, FSJ
   Kumar, A
   Yusoff, MM
   Rasad, MSBA
AF Chahal, Sugandha
   Hussain, Fathima Shahitha Jahir
   Kumar, Anuj
   Yusoff, Mashitah M.
   Rasad, Mohammad Syaiful Bahari Abdull
TI Electrospun hydroxyethyl cellulose nanofibers functionalized with
   calcium phosphate coating for bone tissue engineering
SO RSC ADVANCES
LA English
DT Article
ID POLY(VINYL ALCOHOL) HYDROGELS; MECHANICAL-PROPERTIES; IN-VITRO;
   SCAFFOLDS; HYDROXYAPATITE; MINERALIZATION; FABRICATION; BEHAVIOR; DEVICE
AB The aim of this study is to develop a facile and efficient scaffold from electrospun hydroxyethyl cellulose (HEC) functionalized with bone-like calcium phosphate (CaP). The HEC/PVA nanofibers were fabricated by electrospinning and mineralized by incubating in 10x simulated body fluid (SBF) for different period of times. After 24 h of incubation, the nanofibers were uniformly coated by a thin layer of mineral deposit. SEM, FTIR, and FESEM-EDS analyses confirm the deposition of CaP on the nanofibers. The nanostructured biomaterial maintained its fibrous and porous structure after mineralization. The XRD results suggest that the deposited mineral phase is a mixture of calcium phosphate hydrate and apatite. The mechanical properties of CaP coated scaffolds show similar tensile strength and elastic modulus with that of trabecular and proximal femoral bones. The cytocompatibility of the CaP coated HEC/PVA scaffolds were evaluated using human osteosarcoma cells. The CaP coated HEC/PVA scaffolds support cellular attachment and proliferation of osteosarcoma cells and will be a promising candidate for bone tissue engineering.
C1 [Chahal, Sugandha; Hussain, Fathima Shahitha Jahir; Yusoff, Mashitah M.] Univ Malaysia Pahang, Fac Ind Sci & Technol, Kuantan 26070, Pahang, Malaysia.
   [Kumar, Anuj] Czech Tech Univ, Fac Civil Engn, Dept Bldg Struct, Prague 16629 6, Czech Republic.
   [Rasad, Mohammad Syaiful Bahari Abdull] IIUM, Kulliyyah Allied Hlth Sci, Dept Biomed Sci, Kuantan 25200, Pahang, Malaysia.
RP Chahal, S (reprint author), Univ Malaysia Pahang, Fac Ind Sci & Technol, Kuantan 26070, Pahang, Malaysia.
EM mlt.mony@gmail.com
RI Kumar, Anuj/I-2105-2014
OI Kumar, Anuj/0000-0001-6940-3850; Yusoff, Mashitah/0000-0003-4118-5307
FU Fundamental Research Grant Scheme (FRGS) [RDU100106]; Ministry of Higher
   Education, Malaysia
FX Authors wish to thanks Mr Tomas Vlach and Ms Lenka Laiblova for helping
   in conducting the tensile properties estimation at Czech Technical
   University in Prague, Czech Republic. This work was supported by
   Fundamental Research Grant Scheme (FRGS) RDU100106, by Ministry of
   Higher Education, Malaysia.
CR Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083
   Beskardes IG, 2009, J BIOACT COMPAT POL, V24, P507, DOI 10.1177/0883911509349311
   Camargo N. H. A., 2007, REV MAT, V12, P574
   Chahal S, 2013, PROCEDIA ENGINEER, V53, P683, DOI 10.1016/j.proeng.2013.02.088
   Chalal S, 2014, BIO-MED MATER ENG, V24, P799, DOI 10.3233/BME-130871
   Domingues RMA, 2014, BIOMACROMOLECULES, V15, P2327, DOI 10.1021/bm500524s
   Fantner GE, 2004, BONE, V35, P1013, DOI 10.1016/j.bone.2004.05.027
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Gupta D, 2009, BIOMATERIALS, V30, P2085, DOI 10.1016/j.biomaterials.2008.12.079
   Hellmich C, 2003, BIOMECH MODEL MECHAN, V2, P21, DOI 10.1007/S10237-002-0025-9
   HYON SH, 1994, J BIOMAT SCI-POLYM E, V5, P397, DOI 10.1163/156856294X00103
   Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006
   Juang JH, 1996, TRANSPLANTATION, V61, P1557, DOI 10.1097/00007890-199606150-00001
   Kobayashi M, 2004, ARTIF ORGANS, V28, P734, DOI 10.1111/j.1525-1594.2004.00079.x
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kovacs T, 2010, NANOTOXICOLOGY, V4, P255, DOI 10.3109/17435391003628713
   KROON G, 1993, PROG ORG COAT, V22, P245, DOI 10.1016/0033-0655(93)80027-8
   Krumova M, 2000, POLYMER, V41, P9265, DOI 10.1016/S0032-3861(00)00287-1
   Kummerer K, 2011, CHEMOSPHERE, V82, P1387, DOI 10.1016/j.chemosphere.2010.11.069
   Lee JS, 2004, J APPL POLYM SCI, V93, P1638, DOI 10.1002/app.20602
   LINDE F, 1989, J BIOMECH, V22, P485, DOI 10.1016/0021-9290(89)90209-1
   Madurantakam PA, 2009, BIOMATERIALS, V30, P5456, DOI 10.1016/j.biomaterials.2009.06.043
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   Nho YC, 2005, J IND ENG CHEM, V11, P159
   Poinern GE, 2009, ULTRASON SONOCHEM, V16, P469, DOI 10.1016/j.ultsonch.2009.01.007
   Prabhakaran MP, 2009, ACTA BIOMATER, V5, P2884, DOI 10.1016/j.actbio.2009.05.007
   RADEBAUGH GW, 1988, INT J PHARM, V45, P39, DOI 10.1016/0378-5173(88)90032-4
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   ROHLMANN A, 1980, ARCH ORTHOP TRAUM SU, V97, P95, DOI 10.1007/BF00450930
   Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/ten.2004.10.1376
   Shah D, 2005, ADV MATER, V17, P525, DOI 10.1002/adma.200400984
   She FH, 2008, ROBOT CIM-INT MANUF, V24, P427, DOI 10.1016/j.rcim.2007.02.023
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Sun WB, 2007, J COLLOID INTERF SCI, V311, P228, DOI 10.1016/j.jcis.2007.02.082
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Tas AC, 2004, J MATER RES, V19, P2742, DOI 10.1557/JMR.2004.0349
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Yang F, 2008, CHEM ENG J, V137, P154, DOI 10.1016/j.cej.2007.07.076
   Yang F, 2009, ACTA BIOMATER, V5, P3295, DOI 10.1016/j.actbio.2009.05.023
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
   Zhang W, 2003, J AM CERAM SOC, V86, P1052, DOI 10.1111/j.1151-2916.2003.tb03422.x
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   Zhang YZ, 2006, BIOMACROMOLECULES, V7, P1049, DOI 10.1021/bm050743i
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhao F, 2006, BIOMATERIALS, V27, P1859, DOI 10.1016/j.biomaterials.2005.09.031
   Zheng CY, 2007, MAT SCI ENG C-BIO S, V27, P824, DOI 10.1016/j.msec.2006.09.021
   Zulkii F. H., 2014, J BIOMATER APPL
   Zulkii H., 2014, POLYM DEGRAD STABIL, V110, P473
NR 51
TC 13
Z9 13
U1 6
U2 44
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 37
BP 29497
EP 29504
DI 10.1039/c4ra17087c
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CE8KQ
UT WOS:000352091600086
DA 2018-10-19
ER

PT J
AU Brzeska, J
   Janeczek, H
   Janik, H
   Kowalczuk, M
   Rutkowska, M
AF Brzeska, J.
   Janeczek, H.
   Janik, H.
   Kowalczuk, M.
   Rutkowska, M.
TI Degradability in vitro of polyurethanes based on synthetic atactic
   poly[(R,S)-3-hydroxybutyrate]
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Polyurethane; atactic poly[(R,S)-3-hydroxybutyrate]; biomaterial;
   hydrolytic degradation; oxidative degradation
ID DEGRADATION
AB The aim of the present study was to determine the degradability of aliphatic polyurethanes, based on a different amount of synthetic, atactic poly[(R,S)-3-hydroxybutyrate] (a-PHB), in hydrolytic (phosphate buffer) and oxidative (H2O2/CoCl2) solutions. The soft segments were built with atactic poly[(R, S)-3-hydroxybutyrate] and polycaprolactone or polyoxytetramethylenediols, whereas hard segments were the reaction product of 4,4'-methylenedicyclohexyl diisocyanate and 1,4-butanediol.
   The selected properties - density and morphology of polymer surfaces - which could influence the sensitivity of polymers to degradation processes -were analyzed.
   The analysis of molecular mass (GPC), thermal properties (DSC) and the sample weight changes were undertaken to estimate the degree of degradability of polymer samples after incubation in environments studied.
   Investigated polyurethanes were amorphous with the very low amount of crystalline phases of hard segments.
   The polyurethane synthesized with a poly[(R, S)-3-hydroxybutyrate] and polyoxytetramethylenediol at a molar ratio of NCO : OH = 3.7 : 1 (prepolymer step) appeared as the most sensitive for both degradative solutions. Its weight and molecular mass losses were the highest in comparison to other investigated polyurethanes.
   It could be expected that playing with the amount of poly[(R, S)-3-hydroxybutyrate] in polyurethane synthesis the rate of polyurethane degradation after immersion in living body would be modeled.
C1 [Brzeska, J.; Rutkowska, M.] Gdynia Maritime Univ, Dept Chem & Commod Ind Sci, PL-81225 Gdynia, Poland.
   [Janeczek, H.; Kowalczuk, M.] Polish Acad Sci, Ctr Polymer & Carbon Mat, Zabrze, Poland.
   [Janik, H.] Gdansk Univ Technol, Fac Chem, Dept Polymer Technol, Gdansk, Poland.
RP Brzeska, J (reprint author), Gdynia Maritime Univ, Dept Chem & Commod Ind Sci, 83 Morska St, PL-81225 Gdynia, Poland.
EM j.brzeska@wpit.am.gdynia.pl
OI Brzeska, Joanna/0000-0001-7596-1381
CR [Anonymous], 2012, Pat PL, Patent No. [212 763, 212763, 212763 (B1)]
   Arslan H, 1999, RAPID COMMUN MASS SP, V13, P2433, DOI 10.1002/(SICI)1097-0231(19991230)13:24<2433::AID-RCM808>3.0.CO;2-X
   Brzeska J., 2011, ENG BIOMATER, V106-108, P73
   Brzeska J., 2012, OCHRONA PRZED KOROZJ, V1, P8
   Brzeska J., 2011, ENG BIOMATERIALS, V106-108, P65
   Brzeska J, 2012, J APPL POLYM SCI, V125, P4285, DOI 10.1002/app.36599
   Brzeska J, 2011, POLIMERY-W, V56, P27, DOI 10.14314/polimery.2011.027
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Christenson EM, 2006, BIOMATERIALS, V27, P3920, DOI 10.1016/j.biomaterials.2006.03.012
   Defoirdt T, 2009, BIOTECHNOL ADV, V27, P680, DOI 10.1016/j.biotechadv.2009.04.026
   Feng YK, 2006, POLYM DEGRAD STABIL, V91, P1711, DOI 10.1016/j.polymdegradstab.2005.12.002
   Glarner M, 2007, POLYM DEGRAD STABIL, V92, P310, DOI 10.1016/j.polymdegradstab.2006.10.009
   Gorna K, 2002, POLYM DEGRAD STABIL, V75, P113, DOI 10.1016/S0141-3910(01)00210-5
   Hong JH, 2007, POLYM DEGRAD STABIL, V92, P1186, DOI 10.1016/j.polymdegradstab.2007.04.007
   Mondal S, 2012, POLYM DEGRAD STABIL, V97, P1553, DOI 10.1016/j.polymdegradstab.2012.04.008
   Ryszkowska JL, 2010, COMPOS SCI TECHNOL, V70, P1894, DOI 10.1016/j.compscitech.2010.05.011
NR 16
TC 1
Z9 1
U1 0
U2 25
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2015
VL 25
IS 2
BP 117
EP 125
DI 10.3233/BME-151262
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE3PA
UT WOS:000351738200001
PM 25813950
DA 2018-10-19
ER

PT J
AU Benedetti, E
   Duchemin, N
   Bethge, L
   Vonhoff, S
   Klussmann, S
   Vasseur, JJ
   Cossy, J
   Smietana, M
   Arseniyadis, S
AF Benedetti, Erica
   Duchemin, Nicolas
   Bethge, Lucas
   Vonhoff, Stefan
   Klussmann, Sven
   Vasseur, Jean-Jacques
   Cossy, Janine
   Smietana, Michael
   Arseniyadis, Stellios
TI DNA-cellulose: an economical, fully recyclable and highly effective
   chiral biomaterial for asymmetric catalysis
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID ENANTIOSELECTIVE CATALYSIS; ORGANIC-SYNTHESIS; FLOW CHEMISTRY; WATER;
   TECHNOLOGY
AB The challenge in DNA-based asymmetric catalysis is to perform a reaction in the vicinity of the helix by incorporating a small-molecule catalyst anchored to the DNA in a covalent, dative, or non-covalent yet stable fashion in order to ensure high levels of enantio-discrimination. Here, we report the first generation of a DNA-based catalyst bound to a cellulose matrix. The chiral biomaterial is commercially available, trivial to use, fully recyclable and produces high levels of enantioselectivity in various Cu(II)-catalyzed asymmetric reactions including Friedel-Crafts alkylations and Michael additions. A single-pass, continuous-flow process is also reported affording fast conversions and high enantioselectivities at low catalyst loadings thus offering a new benchmark in the field of DNA-based asymmetric catalysis.
C1 [Benedetti, Erica; Duchemin, Nicolas; Cossy, Janine; Arseniyadis, Stellios] PSL Res Univ, CNRS, ESPCI ParisTech, Inst Chem Biol & Innovat CBI,Lab Chim Organ,UMR82, F-75231 Paris 05, France.
   [Bethge, Lucas; Vonhoff, Stefan; Klussmann, Sven] NOXXON Pharma AG, D-10589 Berlin, Germany.
   [Vasseur, Jean-Jacques; Smietana, Michael] Univ Montpellier I, CNRS, Inst Biomol Max Mousseron, UMR 5247, F-34095 Montpellier, France.
   [Vasseur, Jean-Jacques; Smietana, Michael] Univ Montpellier 2, F-34095 Montpellier, France.
RP Smietana, M (reprint author), Univ Montpellier I, CNRS, Inst Biomol Max Mousseron, UMR 5247, F-34095 Montpellier, France.
EM msmietana@um2.fr; stellios.arseniyadis@espci.fr
RI Smietana, Michael/F-7828-2016
OI Smietana, Michael/0000-0001-8132-7221; Arseniyadis,
   Stellios/0000-0001-6831-2631; Cossy, Janine/0000-0001-8746-9239;
   Vasseur, Jean-Jacques/0000-0002-4379-6139
FU Ministere de l'Enseignement Superieur et de la Recherche; Agence
   Nationale de la Recherche (NCiS) [ANR-2010-JCJC-715-1]
FX This research was supported by the Ministere de l'Enseignement Superieur
   et de la Recherche and the Agence Nationale de la Recherche (NCiS;
   ANR-2010-JCJC-715-1).
CR BIAGIONI S, 1978, ANAL BIOCHEM, V89, P616, DOI 10.1016/0003-2697(78)90390-1
   Boersma AJ, 2008, J AM CHEM SOC, V130, P11783, DOI 10.1021/ja803170m
   Boersma AJ, 2007, ORG LETT, V9, P3647, DOI 10.1021/ol7015274
   Boersma AJ, 2012, CHEM COMMUN, V48, P2394, DOI 10.1039/c2cc17350f
   Boersma AJ, 2010, NAT CHEM, V2, P991, DOI [10.1038/nchem.819, 10.1038/NCHEM.819]
   Boersma AJ, 2010, CHEM SOC REV, V39, P2083, DOI 10.1039/b811349c
   Boersma AJ, 2009, ANGEW CHEM INT EDIT, V48, P3346, DOI 10.1002/anie.200900371
   Bos J, 2014, CURR OPIN CHEM BIOL, V19, P135, DOI 10.1016/j.cbpa.2014.02.002
   Coquiere D, 2007, ANGEW CHEM INT EDIT, V46, P9308, DOI 10.1002/anie.200703459
   DEHASETH PL, 1977, BIOCHEMISTRY-US, V16, P4777, DOI 10.1021/bi00641a003
   Dijk EW, 2010, ORG BIOMOL CHEM, V8, P3868, DOI 10.1039/c005048b
   Dijk EW, 2008, TETRAHEDRON-ASYMMETR, V19, P2374, DOI 10.1016/j.tetasy.2008.10.004
   Frost CG, 2010, GREEN CHEM, V12, P1687, DOI 10.1039/c0gc00133c
   Garcia-Fernandez A, 2012, METAL IONS LIFE SCI, V10, P249, DOI 10.1007/978-94-007-2172-2_9
   Gjonaj L, 2013, CHEMCATCHEM, V5, P1718, DOI 10.1002/cctc.201300082
   Hartwig J, 2014, ORG BIOMOL CHEM, V12, P3611, DOI 10.1039/c4ob00662c
   KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889
   Li YH, 2013, TETRAHEDRON, V69, P6585, DOI 10.1016/j.tet.2013.05.133
   Mason BP, 2007, CHEM REV, V107, P2300, DOI 10.1021/cr050944c
   Megens RP, 2012, CHEM COMMUN, V48, P6366, DOI 10.1039/c2cc31854g
   Megens RP, 2010, ORG BIOMOL CHEM, V8, P1387, DOI 10.1039/b921385f
   Myers R. M., 2012, MODERN TOOLS SYNTHES, P359, DOI DOI 10.1002/9781118342886.CH11
   Nieuwland PJ, 2011, ORG PROCESS RES DEV, V15, P783, DOI 10.1021/op100338z
   Oelerich J, 2013, CHEM SCI, V4, P2013, DOI 10.1039/c3sc00100h
   PARK SJ, 2013, ASIAN WOMEN, V29, P1
   Park S, 2014, ACS CATAL, V4, P4070, DOI 10.1021/cs501086f
   Park S, 2012, CHEM COMMUN, V48, P10398, DOI 10.1039/c2cc35625b
   Pastre J. C., 2013, CHEM SOC REV, V42, P8801
   Petrova GP, 2014, CHEM PHYS LETT, V600, P87, DOI 10.1016/j.cplett.2014.03.060
   Roe S, 2010, CHEM COMMUN, V46, P4309, DOI 10.1039/c0cc00194e
   Roelfes G, 2005, ANGEW CHEM INT EDIT, V44, P3230, DOI 10.1002/anie.200500298
   Rosati F, 2010, CHEM COMMUN, V46, P7804, DOI 10.1039/c0cc02584d
   Rosati F, 2009, CHEM-EUR J, V15, P9596, DOI 10.1002/chem.200900456
   Shibata N, 2007, SYNLETT, P1153, DOI 10.1055/s-2007-977429
   Wang CH, 2012, ANGEW CHEM INT EDIT, V51, P9352, DOI 10.1002/anie.201204850
   Wang CH, 2012, CHEM COMMUN, V48, P6232, DOI 10.1039/c2cc31320k
   Wang J, 2013, ANGEW CHEM INT EDIT, V52, P11546, DOI 10.1002/anie.201306232
   Wegner J, 2012, ADV SYNTH CATAL, V354, P17, DOI 10.1002/adsc.201100584
   Wilking M, 2013, ORG BIOMOL CHEM, V11, P6940, DOI 10.1039/c3ob41366g
   Zhao H, 2014, RSC ADV, V4, P54051, DOI 10.1039/c4ra10749g
NR 40
TC 16
Z9 16
U1 6
U2 66
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PY 2015
VL 51
IS 28
BP 6076
EP 6079
DI 10.1039/c4cc10190a
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA CE4YL
UT WOS:000351836300003
PM 25613918
DA 2018-10-19
ER

PT J
AU Ruangsomboon, S
AF Ruangsomboon, Suneerat
TI Enhanced Production of Polysaccharides and Protein Content in
   Cyanobacterium, Oscillatoria limnetica as a Defense Mechanism Against
   Low pH and Pb2+
SO CHIANG MAI JOURNAL OF SCIENCE
LA English
DT Article
DE adsorption capacity; chlorophyll fluorescence; detoxification; living
   biosorbent; Pb2+ precipitation
ID BIOSORPTION; WATER; REMOVAL; LEAD
AB Living biomass has better ability to remove Pb2+ from wastewaters as compare to dead biomass. But, living biomass also have some practical limitations, such as, they are not efficient at low pH, and at high concentrations of metal ions. In the present study living biomass of Oscillatoria limnetica was assessed for its metal sorption capacity. O. limnetica considerably sorbed a large amount of Pb2+ within pH range 3-7. The maximum Pb2+ sorption capacity of O. limnetica was 434.78 mg/g. As photochemical efficiency data depicted, Pb2+ exerted inhibitory effects on photosynthesis of the test cyanobacterium. However, the test cyanobacterium showed considerable tolerance to Pb2+ exposure as concentration increased from 0 to 5 mg/L. Defense mechanisms of O. limnetica under Pb2+ enriched condition is probably associated with greater accumulation of intracellular polysaccharides (IPS) and protein. Nonetheless, since Pb2+ binding capacity of O. limnetica is significantly high than that of several other biosorbents, it can be considered as a promising biomaterial for removal of Pb2+ from wastewaters.
C1 King Mongkuts Inst Technol Ladkrabang, Fac Agr Technol, Div Anim Prod Technol & Fisheries, Program Fisheries Sci, Bangkok 10520, Thailand.
RP Ruangsomboon, S (reprint author), King Mongkuts Inst Technol Ladkrabang, Fac Agr Technol, Div Anim Prod Technol & Fisheries, Program Fisheries Sci, Bangkok 10520, Thailand.
EM krsuneer@kmitl.ac.th
FU Thailand Research Fund (TRF)
FX The present work was financially supported by The Thailand Research Fund
   (TRF).
CR [Anonymous], 2010, MIN SCI TECHNOL, P566
   Ashraf MA, 2013, CHIANG MAI J SCI, V40, P198
   Becker E. W., 1994, MICROALGAE BIOTECHNO
   Chakraborty N, 2011, BIORESOURCE TECHNOL, V102, P4191, DOI 10.1016/j.biortech.2010.12.028
   DUBININ MM, 1960, CHEM REV, V60, P235, DOI 10.1021/cr60204a006
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   Erten-Unal M, 1999, WATER AIR SOIL POLL, V116, P501, DOI 10.1023/A:1005176322247
   Gaur JP, 2001, ALGAL ADAPTATION TO ENVIRONMENTAL STRESSES, P363
   GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9
   Gupta VK, 2008, COLLOID SURFACE B, V64, P170, DOI 10.1016/j.colsurfb.2008.01.019
   Hirata K, 2001, J BIOSCI BIOENG, V92, P24, DOI 10.1263/jbb.92.24
   Kumar D, 2012, BIORESOURCE TECHNOL, V104, P202, DOI 10.1016/j.biortech.2011.11.002
   Malik A, 2004, ENVIRON INT, V30, P261, DOI 10.1016/j.envint.2003.08.001
   POST AF, 1985, FEMS MICROBIOL ECOL, V31, P97
   Pumpel T, 2001, HYDROMETALLURGY, V59, P383, DOI 10.1016/S0304-386X(00)00168-7
   Rai LC, 1996, ENVIRON EXP BOT, V36, P99, DOI 10.1016/0098-8472(95)00030-5
   Raungsomboon S, 2008, BIORESOURCE TECHNOL, V99, P5650, DOI 10.1016/j.biortech.2007.10.056
   Ruangsomboon S., 2006, Kasetsart Journal, Natural Sciences, V40, P784
   Sandford P A, 1979, Adv Carbohydr Chem Biochem, V36, P265
   SIMON RD, 1973, J BACTERIOL, V114, P1213
   Temkin M, 1940, ACTA PHYSICOCHIM URS, V12, P327
   Terry PA, 2002, CHEMOSPHERE, V47, P249, DOI 10.1016/S0045-6535(01)00303-4
   VINCENT P, 1994, APPL ENVIRON MICROB, V60, P4134
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   Vymazal J., 1995, ALGAE ELEMENT CYCLIN
   Wilkins MR, 1996, BIO-TECHNOL, V14, P61, DOI 10.1038/nbt0196-61
NR 26
TC 0
Z9 0
U1 1
U2 3
PU CHIANG MAI UNIV, FAC SCIENCE
PI CHIANG MAI
PA 239 HUAY KAEW RD, T SUTHEP, CHIANG MAI, 50200, THAILAND
SN 0125-2526
J9 CHIANG MAI J SCI
JI Chiang Mai J. Sci.
PD JAN
PY 2015
VL 42
IS 1
BP 34
EP 43
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CE6YR
UT WOS:000351984600003
DA 2018-10-19
ER

PT J
AU Park, C
   Vo, CLN
   Kang, T
   Oh, E
   Lee, BJ
AF Park, Chulhun
   Chau Le-Ngoc Vo
   Kang, Taehee
   Oh, Euichaul
   Lee, Beom-Jin
TI New method and characterization of self-assembled gelatin-oleic
   nanoparticles using a desolvation method via
   carbodiimide/N-hydroxysuccinimide (EDC/NHS) reaction
SO EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
LA English
DT Article
DE Gelatin-oleic conjugate; Irinotecan; Fattigation; Desolvation method;
   Self-assembled nanoparticles; Crosslinking agents
ID DRUG-DELIVERY; CARRIER SYSTEM; SERUM-ALBUMIN; ACID; NANOPRECIPITATION;
   PACLITAXEL; BINDING
AB In this study, we investigated a new method for the preparation of gelatin-oleic conjugate (GOC) as an amphiphilic biomaterial to load model anti-cancer drugs into self-assembled nanoparticles (NPs). Oleic acid (OA) was covalently bound to gelatin via carbodiimide/N-hydroxysuccinimide (EDC/NHS) reaction in water-ethanol cosolvent to form a GOC. Fourier transform infrared (FT-IR) spectroscopy and proton nuclear magnetic resonance (H-1 NMR) clearly indicated the successful synthesis of GOC. The percentage of gelatin amino groups reacted with OA was up to 50% as determined using the 2,4,6-trinitrobenzene sulfonic acid (TNBS) method. Subsequently, gelatin-oleic nanoparticles (GONs) were prepared using a desolvation method with glutaraldehyde or genipin used as a crosslinker for comparison. Irinotecan hydrochloride (IRT) was used as a model drug to load into GONs using incubation or an in-process adding method for comparison. Dynamic light scattering (DLS) and transmission electron microscopy (TEM) data showed that the sizes of GONs and IRT-loaded GONs (IRT-GONs) were below 250 nm. The zeta potentials of the GONs and irinotecan-loaded IRT-GONs were below -20 mV, which was found to be stable in suspension against the aggregation process. The incubation method was more suitable for drug loading because it did not affect the process of CON formation and thus did not increase their size much compared to the change in size with the in-process adding method. The lipophilic property of the oleic moiety in the GOC increased the affinity between GOC molecules, thus reducing the amount of crosslinking agents needed to stabilize GONs compared to gelatin nanoparticles (GNs). As novel approaches for the synthesis of protein-fatty acid complexes, chemical reaction has been suggested for the synthesis of GOC. The above results show that GOC synthesized via new method is a promising biomaterial based upon preparation of nanoparticles. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Park, Chulhun; Chau Le-Ngoc Vo; Kang, Taehee; Lee, Beom-Jin] Ajou Univ, Coll Pharm, Suwon 443749, South Korea.
   [Oh, Euichaul] Catholic Univ, Coll Pharm, Puchon, South Korea.
RP Lee, BJ (reprint author), Ajou Univ, Coll Pharm, Suwon 443749, South Korea.
EM beomjinlee@gmail.com
FU Bio & Medical Technology Development Program of the National Research
   Foundation - Ministry of Science, ICT & Future Planning, Korea
   [2013M3A9B5075840, 2013M3A9B5075841]
FX This research was supported by the Bio & Medical Technology Development
   Program of the National Research Foundation funded by the Ministry of
   Science, ICT & Future Planning (2013M3A9B5075840 & 2013M3A9B5075841),
   Korea. We would like to thank KBSI and Ajou University-Central
   Laboratory for the use of TEM, NMR and FTIR.
CR Bajpai AK, 2006, J MATER SCI-MATER M, V17, P345, DOI 10.1007/s10856-006-8235-9
   Balthasar S, 2005, BIOMATERIALS, V26, P2723, DOI 10.1016/j.biomaterials.2004.07.047
   Bernkop-Schnurch A, 1998, J CONTROL RELEASE, V50, P215, DOI 10.1016/S0168-3659(97)00136-3
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   Coester CJ, 2000, J MICROENCAPSUL, V17, P187
   DIGENIS GA, 1994, J PHARM SCI, V83, P915, DOI 10.1002/jps.2600830702
   Elzoghby AO, 2012, J CONTROL RELEASE, V161, P38, DOI 10.1016/j.jconrel.2012.04.036
   Gaihre B, 2009, INT J PHARM, V365, P180, DOI 10.1016/j.ijpharm.2008.08.020
   Gregoriadis G, 1995, TRENDS BIOTECHNOL, V13, P527, DOI 10.1016/S0167-7799(00)89017-4
   Gupta AK, 2004, J CONTROL RELEASE, V95, P197, DOI 10.1016/j.jconrel.2003.11.006
   Jahanshahi M., 2008, AFR J BIOTECHNOL, V7
   Kazunori K., 1993, J CONTROL RELEASE, V24, P119, DOI DOI 10.1016/0168-3659(93)90172-2
   Khan SA, 2013, MACROMOL BIOSCI, V13, P455, DOI 10.1002/mabi.201200382
   Landry V, 2008, PROG ORG COAT, V61, P76, DOI 10.1016/j.porgcoat.2007.09.013
   Lee EJ, 2012, BIOPROC BIOSYST ENG, V35, P297, DOI 10.1007/s00449-011-0591-2
   Lee KD, 2014, ARCH PHARM RES, V37, P1546, DOI 10.1007/s12272-014-0489-z
   Liu Z, 2008, CANCER RES, V68, P6652, DOI 10.1158/0008-5472.CAN-08-1468
   Park Eun Ji, 2014, Journal of Pharmaceutical Investigation, V44, P141, DOI 10.1007/s40005-013-0110-3
   Park JH, 2008, PROG POLYM SCI, V33, P113, DOI 10.1016/j.progpolymsci.2007.09.003
   Tran PHL, 2014, J BIOMED NANOTECHNOL, V10, P154, DOI 10.1166/jbn.2014.1660
   Tran PHL, 2013, J BIOMED NANOTECHNOL, V9, P1416, DOI 10.1166/jbn.2013.1621
   Tang YQ, 2008, J CONTROL RELEASE, V127, P70, DOI 10.1016/j.jconrel.2007.12.012
   Tian JN, 2004, BIOMACROMOLECULES, V5, P1956, DOI 10.1021/bm049668m
   Tseng CL, 2007, BIOMATERIALS, V28, P3996, DOI 10.1016/j.biomaterials.2007.05.006
   Ulbrich K, 2011, INT J PHARMACEUT, V406, P128, DOI 10.1016/j.ijpharm.2010.12.023
   Wang YX, 2011, J FLUORINE CHEM, V132, P489, DOI 10.1016/j.jfluchem.2011.05.003
   Won YW, 2008, J CONTROL RELEASE, V127, P154, DOI 10.1016/j.jconrel.2008.01.010
   Yeh TK, 2005, PHARM RES, V22, P867, DOI 10.1007/s11095-005-4581-4
   Zrazhevskiy P, 2010, CHEM SOC REV, V39, P4326, DOI 10.1039/b915139g
NR 29
TC 15
Z9 15
U1 4
U2 63
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0939-6411
EI 1873-3441
J9 EUR J PHARM BIOPHARM
JI Eur. J. Pharm. Biopharm.
PD JAN
PY 2015
VL 89
BP 365
EP 373
DI 10.1016/j.ejpb.2014.12.002
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CE1FO
UT WOS:000351557700039
PM 25536111
DA 2018-10-19
ER

PT J
AU Sobrinho, JHOS
   Rodrigues, SF
   Silva, ES
   Reis, GS
   Sousa, RC
   Leal, VS
   Mercury, JMR
AF Oliveira Santos Sobrinho, Jose Helio
   Rodrigues, Samuel Filgueiras
   Silva, Eden Santos
   Reis, Gedeon Silva
   Sousa, Regina Celia
   Leal, Valdemar Silva
   Rivas Mercury, Jose Manuel
TI Plastic Instability in ISO 5832-9 High-nitrogen Austenitic Stainless
   Steel
SO ISIJ INTERNATIONAL
LA English
DT Article
DE stainless steel; workability; plastic instability; processing maps;
   corrosion
ID HOT-WORKING; RECRYSTALLIZATION; BIOMATERIAL; PREDICTION
AB ISO 5832-9 high-nitrogen austenitic stainless steel has shown promising results in the fabrication of temporary and permanent orthopedic prostheses, exhibiting better mechanical strength and corrosion resistance than the traditional ISO 5832-1 (ASTM F-138) steel. Recent studies have revealed that this alloy possesses unique properties, such as high mechanical strength and corrosion resistance and the presence of second phase particles (Z phase) in the matrix. However, it is not known how the microstructural and mechanical properties and the corrosion rate are correlated in regions of industrial processability of this alloy during hot forming. In this study, continuous and interrupted isothermal hot torsion tests were performed after solubilization heat treatment at 1 473 K for 300 s, with temperature intervals varying from 1 273 to 1 473 K and strain rates ranging from 0.05 to 5 s(-1). The purpose of these tests was to investigate the alloy's workability and stress corrosion rate by means of electrochemical impedance spectroscopy (EIS) and to characterize its microstructure by optical microscopy. The results indicate that the yield stress is sensitive to the strain parameters. The peak stress decreases with increasing temperature and decreasing strain rate, with a high rate of dynamic recovery, with elongated grains generating areas of stress build-up. These regions of plastic instability present a higher degree of corrosion than as-received samples. The regions of high temperature and low strain rate exhibit good workability with a refined final microstructure of dynamically recrystallized grains.
C1 [Oliveira Santos Sobrinho, Jose Helio; Rodrigues, Samuel Filgueiras; Silva, Eden Santos; Reis, Gedeon Silva; Leal, Valdemar Silva; Rivas Mercury, Jose Manuel] Fed Inst Educ Sci & Technol Maranhao, Dept Mat & Mech, BR-65030005 Sao Luis, MA, Brazil.
   [Sousa, Regina Celia] Univ Fed Maranhao, Dept Phys, BR-65080805 Sao Luis, MA, Brazil.
RP Rodrigues, SF (reprint author), Fed Inst Educ Sci & Technol Maranhao, Dept Mat & Mech, Ave Getulio Vargas 04, BR-65030005 Sao Luis, MA, Brazil.
EM samuel.filgueiras@ifma.edu.br
RI Rodrigues, Samuel/I-2873-2017
OI Rodrigues, Samuel/0000-0003-0002-4566
FU FAPEMA; CNPq; CAPES (Brazil)
FX The authors gratefully acknowledge FAPEMA, CNPq and CAPES (Brazil) for
   their financial support of this work.
CR El Wahabi M, 2003, MAT SCI ENG A-STRUCT, V343, P116, DOI 10.1016/S0921-5093(02)00357-X
   Fields D. S., 1957, P AM SOCIETY SOCIETY, V57, P1259
   Giordani E. J., 2006, SCRIPTA MATER, P743
   Giordani EJ, 2004, INT J FATIGUE, V26, P1129, DOI 10.1016/j.ijfatigue.2004.03.002
   Jocobs J. J., 1998, J BONE SURG A, V80A, P268
   Kocks UF, 2003, PROG MATER SCI, V48, P171, DOI 10.1016/S0079-6425(02)00003-8
   LAASRAOUI A, 1991, METALL TRANS A, V22, P1545, DOI 10.1007/BF02667368
   Mataya MC, 2003, METALL MATER TRANS A, V34A, P1683, DOI 10.1007/s11661-003-0313-8
   McQueen H. J., 2003, MAT SCI ENG A-STRUCT, V203, P387
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Ornhagen C, 1996, J BIOMED MATER RES, V31, P97, DOI 10.1002/(SICI)1097-4636(199605)31:1<97::AID-JBM12>3.0.CO;2-J
   Prasad Y. V. R. K., 1997, HOT WORKING GUIDE CO
   Prasad Y. V. R. K., 2003, J MATER ENG PERFORM, V12, P674
   Prasad Y. V. R. K., 2003, J MATER ENG PERFORM, V12, P656
   Rodrigues SF, 2014, MATER RES-IBERO-AM J, V17, P436, DOI [10.1590/S1516-14392014005000001, 10.1590/S1516-14392014000200023]
   SCHRAMM RE, 1975, METALL TRANS A, V6, P1345, DOI 10.1007/BF02641927
   Silva ES, 2012, MAT SCI ENG A-STRUCT, V543, P69, DOI 10.1016/j.msea.2012.02.048
   Souza RC, 2013, MAT SCI ENG A-STRUCT, V582, P96, DOI 10.1016/j.msea.2013.06.037
   Taylor AS, 2011, MAT SCI ENG A-STRUCT, V528, P3310, DOI 10.1016/j.msea.2010.12.093
   Venugopal S., 2003, J MATER ENG PERFORM, P675
   Ziegler H., 1963, PROGR SOLID MECHANIC, V4, P93
NR 21
TC 1
Z9 1
U1 0
U2 9
PU IRON STEEL INST JAPAN KEIDANREN KAIKAN
PI TOKYO
PA TEKKO KAIKAN-5F, 3-2-10, NIHONBASHI-KAYABACHO, TOKYO, CHUO-KU 103-0025,
   JAPAN
SN 0915-1559
EI 1347-5460
J9 ISIJ INT
JI ISIJ Int.
PY 2015
VL 55
IS 3
BP 670
EP 678
DI 10.2355/isijinternational.55.670
PG 9
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA CE1IZ
UT WOS:000351566600027
OA Bronze
DA 2018-10-19
ER

PT J
AU Lu, SZ
   Li, JJ
   Zhang, SS
   Yin, ZP
   Xing, TL
   Kaplan, DL
AF Lu, Shenzhou
   Li, Jiaojiao
   Zhang, Shanshan
   Yin, Zhuping
   Xing, Tieling
   Kaplan, David L.
TI The influence of the hydrophilic-lipophilic environment on the structure
   of silk fibroin protein
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID PHYSICAL-PROPERTIES; BLEND FILMS; CONFORMATION; SPECTROSCOPY;
   BIOMATERIAL; MEMBRANES
AB The present study examines the influence of the hydrophilic-lipophilic environment, mediated by small molecules, on the structural changes in silk protein fibroin. Small molecules mediate the various hydrophilic-lipophilic balances (HLBs) that impact the organisation of silk protein chains. Changes in the silk fibroin structure due to additives are related to the HLB value. At HLB > 10, silk fibroin primarily forms Silk I crystalline structures. Small molecules with HLB < 8.9 primarily induce the formation of Silk II crystalline structures. When 8.9 < HLB < 10, the crystalline structure of silk is related to the content of small molecules. The Silk I structure is primarily formed when the content of small molecules is low, whereas the Silk II structure is formed when the small molecule content is high. The structure of silk fibroin is maintained by regulating the HLB in the fibroin environment. This type of control for the functional design of materials may play a role in fine-tuning the biomaterial properties of silk fibroin protein.
C1 [Lu, Shenzhou; Li, Jiaojiao; Zhang, Shanshan; Yin, Zhuping; Xing, Tieling] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Lu, SZ (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM lushenzhou@suda.edu.cn
RI Lu, Shenzhou/P-6519-2015; Xing, Tieling/C-9891-2018
OI Lu, Shenzhou/0000-0003-4188-2057; Xing, Tieling/0000-0002-4136-3137
FU National Natural Science Foundation of China [51203107, 51373114]; PAPD;
   Nature Science Foundation of Jiangsu, China [BK20131176]
FX The work is supported by the National Natural Science Foundation of
   China (Grant no. 51203107, 51373114), PAPD and the Nature Science
   Foundation of Jiangsu, China (Grant no. BK20131176).
CR Brown J, 2015, ACTA BIOMATER, V11, P212, DOI 10.1016/j.actbio.2014.09.013
   Cao ZB, 2007, SOFT MATTER, V3, P910, DOI 10.1039/b703139d
   Cebe P, 2013, SCI REP, V3, P1
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Davies J. T., 1957, P 2 INT C SURF ACT, V1, P426
   Gil ES, 2006, BIOMACROMOLECULES, V7, P728, DOI 10.1021/bm050622i
   Gil ES, 2013, ADV HEALTHC MATER, V2, P206, DOI 10.1002/adhm.201200192
   IIZUKA E, 1968, BIOCHEMISTRY-US, V7, P2218, DOI 10.1021/bi00846a026
   Jiang T, 2011, ON BIOMIMETICS, P357
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   KRATKY O, 1950, NATURE, V165, P319, DOI 10.1038/165319a0
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   LIANG CX, 1992, J APPL POLYM SCI, V45, P1937, DOI 10.1002/app.1992.070451108
   [卢神州 Lu Shenzhou], 2003, [高分子材料科学与工程, Polymer Materials Science & Engineering], V19, P104
   Lu SZ, 2010, BIOMACROMOLECULES, V11, P143, DOI 10.1021/bm900993n
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Prosa M, 2014, RSC ADV, V4, P44815, DOI 10.1039/c4ra08390c
   Sashina ES, 2006, RUSS J APPL CHEM+, V79, P869, DOI 10.1134/S1070427206060012
   Shulha H, 2006, POLYMER, V47, P5821, DOI 10.1016/j.polymer.2006.06.002
   Steven E, 2014, MATER HORIZONS, V1, P522, DOI 10.1039/c4mh00074a
   Tanaka T, 1998, POLYM INT, V45, P175, DOI 10.1002/(SICI)1097-0126(199802)45:2<175::AID-PI883>3.0.CO;2-K
   Trabbic KA, 1998, MACROMOLECULES, V31, P462, DOI 10.1021/ma9708860
   TSUKADA M, 1995, J POLYM SCI POL PHYS, V33, P1995, DOI 10.1002/polb.1995.090331402
   Valluzzi R, 1996, MACROMOLECULES, V29, P8606, DOI 10.1021/ma9517759
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wang HY, 2013, SOFT MATTER, V9, P138, DOI 10.1039/c2sm26945g
   Wu J, 2014, BIOMATERIALS, V35, P3744, DOI 10.1016/j.biomaterials.2013.12.078
   Wu XL, 2012, ACTA BIOMATER, V8, P2185, DOI 10.1016/j.actbio.2012.03.007
   Yang G, 2000, J MEMBRANE SCI, V177, P153, DOI 10.1016/S0376-7388(00)00467-1
   Yang YH, 2004, BIOMACROMOLECULES, V5, P773, DOI 10.1021/bm0343848
   Zhou J, 2014, ACS APPL MATER INTER, V6, P21813, DOI 10.1021/am502278b
   Zhou W, 2006, PROG CHEM, V18, P1514
NR 36
TC 9
Z9 9
U1 3
U2 37
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 13
BP 2599
EP 2606
DI 10.1039/c4tb01873g
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA CE1UZ
UT WOS:000351599400003
DA 2018-10-19
ER

PT J
AU Azeem, A
   English, A
   Kumar, P
   Satyam, A
   Biggs, M
   Jones, E
   Tripathi, B
   Basu, N
   Henkel, J
   Vaquette, C
   Rooney, N
   Riley, G
   O'Riordan, A
   Cross, G
   Ivanovski, S
   Hutmacher, D
   Pandit, A
   Zeugolis, D
AF Azeem, Ayesha
   English, Andrew
   Kumar, Pramod
   Satyam, Abhigyan
   Biggs, Manus
   Jones, Eleanor
   Tripathi, Bhawana
   Basu, Nandita
   Henkel, Jan
   Vaquette, Cedryck
   Rooney, Niall
   Riley, Graham
   O'Riordan, Alan
   Cross, Graham
   Ivanovski, Saso
   Hutmacher, Dietmar
   Pandit, Abhay
   Zeugolis, Dimitrios
TI The influence of anisotropic nano- to micro-topography on in vitro and
   in vivo osteogenesis
SO NANOMEDICINE
LA English
DT Article
DE anisotropic topography; cell/biomaterial interface; gene analysis;
   osteogenesis
ID MESENCHYMAL STEM-CELLS; TISSUE ENGINEERING APPLICATIONS;
   PERIPHERAL-NERVE REPAIR; FOCAL ADHESION KINASE; REGENERATIVE MEDICINE;
   DRUG-DELIVERY; OSTEOBLAST ALIGNMENT; CONTROLLED-RELEASE;
   SOFT-LITHOGRAPHY; CELLULAR MECHANOTRANSDUCTION
AB Aim: Topographically modified substrates are increasingly used in tissue engineering to enhance biomimicry. The overarching hypothesis is that topographical cues will control cellular response at the cell-substrate interface. Materials & methods: The influence of anisotropically ordered poly(lactic-co-glycolic acid) substrates (constant groove width of similar to 1860 nm; constant line width of similar to 2220 nm; variable groove depth of similar to 35, 306 and 2046 nm) on in vitro and in vivo osteogenesis were assessed. Results & discussion: We demonstrate that substrates with groove depths of approximately 306 and 2046 nm promote osteoblast alignment parallel to underlined topography in vitro. However, none of the topographies assessed promoted directional osteogenesis in vivo. Conclusion: 2D imprinting technologies are useful tools for in vitro cell phenotype maintenance.
C1 [Azeem, Ayesha; English, Andrew; Kumar, Pramod; Satyam, Abhigyan; Biggs, Manus; Pandit, Abhay; Zeugolis, Dimitrios] Natl Univ Ireland Galway NUI Galway, Network Excellence Funct Biomat NFB, Galway, Ireland.
   [Jones, Eleanor; Riley, Graham] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.
   [Tripathi, Bhawana; Basu, Nandita; Cross, Graham] Univ Dublin Trinity Coll, CRANN, Dublin 2, Ireland.
   [Henkel, Jan; Vaquette, Cedryck; Hutmacher, Dietmar] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.
   [Rooney, Niall] Proxy Biomed, Galway, Ireland.
   [O'Riordan, Alan] Tyndall Natl Inst, Cork, Ireland.
   [Ivanovski, Saso] Griffith Univ, Sch Dent & Oral Hlth, Southport, Qld 4215, Australia.
   [Ivanovski, Saso] Griffith Univ, Mol Basis Dis Program, Southport, Qld 4215, Australia.
RP Zeugolis, D (reprint author), Natl Univ Ireland Galway NUI Galway, Network Excellence Funct Biomat NFB, Biosci Bldg, Galway, Ireland.
EM dimitrios.zeugolis@nuigalway.ie
RI Pandit, Abhay/B-6187-2008; Ivanovski, Saso/I-1835-2016
OI Pandit, Abhay/0000-0002-6292-4933; Ivanovski, Saso/0000-0001-5339-0936;
   zeugolis, dimitrios/0000-0002-7599-5191; O'Riordan,
   Alan/0000-0002-7554-1536; SATYAM, ABHIGYAN/0000-0001-9838-4572; Cross,
   Graham/0000-0003-2299-6091; Hutmacher, Dietmar
   Werner/0000-0001-5678-2134; Vaquette, Cedryck/0000-0001-7937-4432;
   Biggs, Manus/0000-0003-4699-1025
FU Enterprise Ireland, Collaborative Centre for Applied Nanotechnology
   under Irish Government [CCIRP-2007-CCAN-0509]; Tyndall National
   Institute, SFI [NAP382]; Science Foundation Ireland, Research Frontiers
   Programme [SFI-09-RFP-ENM2483]; Health Research Board [HRA_POR/2011/84];
   College of Engineering & Informatics, NUI Galway
FX This work was supported by: Enterprise Ireland, Collaborative Centre for
   Applied Nanotechnology (project number CCIRP-2007-CCAN-0509), under the
   Irish Government's National Development Plan 2007-2013 to D Zeugolis;
   Tyndall National Institute, SFI-funded National Access Programme
   (project number NAP382) to D Zeugolis; Science Foundation Ireland,
   Research Frontiers Programme, (project number SFI-09-RFP-ENM2483) to D
   Zeugolis; Health Research Board (project number HRA_POR/2011/84) to D
   Zeugolis; and College of Engineering & Informatics, NUI Galway,
   Postgraduate Scholarship Scheme to P Kumar and D Zeugolis. The authors
   have no other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Abu-Rub MT, 2011, SOFT MATTER, V7, P2770, DOI 10.1039/c0sm01062f
   Ankam S, 2013, ORGANOGENESIS, V9, P128, DOI 10.4161/org.25425
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056
   Baji A, 2010, COMPOS SCI TECHNOL, V70, P703, DOI 10.1016/j.compscitech.2010.01.010
   Berns EJ, 2014, BIOMATERIALS, V35, P185, DOI 10.1016/j.biomaterials.2013.09.077
   Bhardwaj N, 2009, BIOTECHNOL ADV, V28, P325
   Biggs MJP, 2008, J R SOC INTERFACE, V5, P1231, DOI 10.1098/rsif.2008.0035
   Biggs MJP, 2010, P I MECH ENG H, V224, P1441, DOI 10.1243/09544119JEIM775
   Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049
   Binan L, 2014, BIOMATERIALS, V35, P664, DOI 10.1016/j.biomaterials.2013.09.097
   Blattler T, 2006, J NANOSCI NANOTECHNO, V6, P2237, DOI 10.1166/jnn.2006.501
   Braghirolli DI, 2014, DRUG DISCOV TODAY, V19, P743, DOI 10.1016/j.drudis.2014.03.024
   Brown RA, 2007, INT REV CYTOL, V262, P75, DOI 10.1016/S0074-7696(07)62002-6
   Brunner M, 2011, J CELL BIOL, V194, P307, DOI 10.1083/jcb.201007108
   Brydone AS, 2011, BIOMED MATER, V6, P1
   Cabezas MD, 2014, METHOD CELL BIOL, V119, P261, DOI 10.1016/B978-0-12-416742-1.00013-5
   Cassidy JW, 2014, ACTA BIOMATER, V10, P651, DOI 10.1016/j.actbio.2013.11.008
   Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020
   Chen GC, 2005, MOL CELL BIOL, V25, P979, DOI 10.1128/MCB.25.3.979-987.2005
   Chen HL, 2011, INT J BIOL MACROMOL, V48, P13, DOI 10.1016/j.ijbiomac.2010.09.019
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Cheng XG, 2008, BIOMATERIALS, V29, P3278, DOI 10.1016/j.biomaterials.2008.04.028
   Choi ST, 2008, RHEUMATOLOGY, V47, P1775, DOI 10.1093/rheumatology/ken385
   Cigognini D, 2013, DRUG DISCOV TODAY, V18, P1099, DOI 10.1016/j.drudis.2013.06.007
   Cipitria A, 2012, J BONE MINER RES, V27, P1275, DOI 10.1002/jbmr.1589
   Cipriano AF, 2014, J BIOMED NANOTECHNOL, V10, P660, DOI 10.1166/jbn.2014.1760
   Collin EC, 2011, BIOMATERIALS, V32, P2862, DOI 10.1016/j.biomaterials.2011.01.018
   Costa PF, 2014, J CLIN PERIODONTOL, V41, P283, DOI 10.1111/jcpe.12214
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2007, J CELL BIOCHEM, V100, P326, DOI 10.1002/jcb.21058
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   Daly WT, 2012, BIOMATERIALS, V33, P6660, DOI 10.1016/j.biomaterials.2012.06.002
   Dang JM, 2007, ADV MATER, V19, P2775, DOI 10.1002/adma.200602159
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Edalat F, 2012, ANN BIOMED ENG, V40, P1301, DOI 10.1007/s10439-011-0452-9
   Eersels K, 2013, ACS APPL MATER INTER, V5, P7258, DOI 10.1021/am401605d
   Egerbacher M, 2008, CLIN ORTHOP RELAT R, V466, P1562, DOI 10.1007/s11999-008-0274-8
   Ekaputra AK, 2009, TISSUE ENG PT A, V15, P3779, DOI [10.1089/ten.tea.2009.0186, 10.1089/ten.TEA.2009.0186]
   Embrechts A, 2008, LANGMUIR, V24, P8841, DOI 10.1021/la800770y
   Enea D, 2013, KNEE SURG SPORT TR A, V21, P1783, DOI 10.1007/s00167-012-2102-7
   Engel E, 2009, ANN ANAT, V191, P136, DOI 10.1016/j.aanat.2008.07.013
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   English A, 2012, J MATER SCI-MATER M, V23, P137, DOI 10.1007/s10856-011-4471-8
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Flinn HM, 1996, J CELL SCI, V109, P1133
   Fontana G, 2014, ADV HEALTHC MATER, V3, P2012, DOI 10.1002/adhm.201400175
   Fowlkes JL, 2008, ENDOCRINOLOGY, V149, P1697, DOI 10.1210/en.2007-1408
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Fuller K, 2014, PHARM NAN0TECHNOL, V2, P23
   Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w
   Georgiou M, 2013, BIOMATERIALS, V34, P7335, DOI 10.1016/j.biomaterials.2013.06.025
   Guo J, 2012, NANOMEDICINE NERVOUS, P330
   Hu W, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/38/385301
   Hu XL, 2014, J CONTROL RELEASE, V185, P12, DOI 10.1016/j.jconrel.2014.04.018
   Huang Z, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1465
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   Ingber DE, 2010, ANN BIOMED ENG, V38, P1148, DOI 10.1007/s10439-010-9946-0
   Ismail FSM, 2007, J MATER SCI-MATER M, V18, P705, DOI 10.1007/s10856-006-0012-2
   Jackson JK, 2004, INT J PHARM, V283, P97, DOI 10.1016/j.ijpharm.2004.06.025
   Kam KR, 2014, TISSUE ENG PT A, V20, P130, DOI [10.1089/ten.tea.2012.0772, 10.1089/ten.TEA.2012.0772]
   Kasko AM, 2010, FUTURE MED CHEM, V2, P1669, DOI 10.4155/FMC.10.253
   Kenar H, 2008, J BIOMED MATER RES A, V85A, P1001, DOI 10.1002/jbm.a.31638
   Keogh MB, 2010, ACTA BIOMATER, V6, P4305, DOI 10.1016/j.actbio.2010.06.001
   Khan MR, 2012, BONE, V50, P1, DOI 10.1016/j.bone.2011.07.040
   Kim JK, 2014, ARCH PHARM RES, V37, P60, DOI 10.1007/s12272-013-0280-6
   Kim J, 2014, BIOMATERIALS, V35, P9058, DOI 10.1016/j.biomaterials.2014.07.036
   Kim JE, 2014, INT J NANOMED, V9, P141, DOI 10.2147/IJN.S54114
   Kim JY, 2009, J BIOMED MATER RES A, V88A, P419, DOI 10.1002/jbm.a.31799
   Kirmizidis G, 2009, TISSUE ENG PT A, V15, P1427, DOI 10.1089/ten.tea.2008.0137
   Kishore V, 2012, BIOMATERIALS, V33, P2137, DOI 10.1016/j.biomaterials.2011.11.066
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kolind K, 2014, ACTA BIOMATER, V10, P641, DOI 10.1016/j.actbio.2013.11.006
   Kosuge D, 2013, CURR STEM CELL RES T, V8, P185, DOI 10.2174/1574888X11308030002
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Kuo YJ, 2014, J ORTHOP SCI, V19, P313, DOI 10.1007/s00776-013-0510-2
   Kyle S, 2012, ADV HEALTHC MATER, V1, P640, DOI 10.1002/adhm.201200047
   Lamers E, 2012, EUR CELLS MATER, V23, P182, DOI 10.22203/eCM.v023a14
   Lamers E, 2010, EUR CELLS MATER, V20, P329
   Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034
   Lan HB, 2013, J NANOSCI NANOTECHNO, V13, P3145, DOI 10.1166/jnn.2013.7437
   Lenhert S, 2005, BIOMATERIALS, V26, P563, DOI 10.1016/j.biomaterials.2004.02.068
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Liu W, 2006, TISSUE ENG, V12, P775, DOI 10.1089/ten.2006.12.775
   Liu WY, 2012, ADV HEALTHC MATER, V1, P10, DOI 10.1002/adhm.201100021
   Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lopez-Bosque MJ, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/25/255305
   Lu X, 2003, J BIOMED MATER RES A, V66A, P677, DOI 10.1002/jbm.a.10022
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Matsugaki A, 2013, ACTA BIOMATER, V9, P7227, DOI 10.1016/j.actbio.2013.03.015
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3
   McCall JD, 2012, DRUG DELIV TRANSL RE, V2, P305, DOI 10.1007/s13346-012-0090-2
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Mogosanu GD, 2014, INT J PHARMACEUT, V463, P127, DOI 10.1016/j.ijpharm.2013.12.015
   Mujahid A, 2013, BIOTECHNOL ADV, V31, P1435, DOI 10.1016/j.biotechadv.2013.06.008
   Mullen CA, 2013, J MECH BEHAV BIOMED, V28, P183, DOI 10.1016/j.jmbbm.2013.06.013
   Murakami H, 1999, ONCOGENE, V18, P1975, DOI 10.1038/sj.onc.1202514
   Nebe B, 2004, MAT SCI ENG C-BIO S, V24, P619, DOI 10.1016/j.msec.2004.08.034
   Neidlinger-Wilke C, 2001, J ORTHOP RES, V19, P286, DOI 10.1016/S0736-0266(00)00029-2
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   Nguyen MK, 2014, BIOMATERIALS, V35, P6278, DOI 10.1016/j.biomaterials.2014.04.048
   Noble BS, 2003, AM J PHYSIOL-CELL PH, V284, pC934, DOI 10.1152/ajpcell.00234.2002
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   Park H, 2007, TISSUE ENG, V13, P1867, DOI 10.1089/ten.2006.0198
   Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284
   Pei M, 2012, SPINE, V37, P1538, DOI 10.1097/BRS.0b013e31825150bf
   Perez RA, 2013, ADV DRUG DELIVER REV, V65, P471, DOI 10.1016/j.addr.2012.03.009
   Phillips JB, 2011, METHODS MOL BIOL, V695, P183, DOI 10.1007/978-1-60761-984-0_12
   Pierres A., 2002, European Cells & Materials, V3, P31
   Prabhakaran MP, 2009, ACTA BIOMATER, V5, P2884, DOI 10.1016/j.actbio.2009.05.007
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Rahmany MB, 2013, ACTA BIOMATER, V9, P5431, DOI 10.1016/j.actbio.2012.11.019
   Rebl H, 2012, ACTA BIOMATER, V8, P3840, DOI 10.1016/j.actbio.2012.06.015
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Rong JH, 2008, CHEM COMMUN, P5185, DOI 10.1039/b811039e
   Satyam A, 2014, ADV MATER, V26, P3024, DOI 10.1002/adma.201304428
   Scott A, 2005, BRIT J SPORT MED, V39, P1
   Shin H, 2007, BIOMATERIALS, V28, P126, DOI 10.1016/j.biomaterials.2006.08.007
   Singh AV, 2013, J BIOMED MATER RES A, V101, P3019, DOI 10.1002/jbm.a.34586
   Singh L, 2004, BIOMATERIALS, V25, P2611, DOI 10.1016/j.biomaterials.2003.09.040
   Soliman S, 2010, ACTA BIOMATER, V6, P1227, DOI 10.1016/j.actbio.2009.10.051
   Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Szentivanyi A, 2011, ADV DRUG DELIVER REV, V63, P209, DOI 10.1016/j.addr.2010.12.002
   Tawfick S, 2012, ADV MATER, V24, P1628, DOI 10.1002/adma.201103796
   Thomas D, 2014, BIOMATERIALS, V35, P8757, DOI 10.1016/j.biomaterials.2014.06.053
   Tong WY, 2012, BIOMATERIALS, V33, P7686, DOI 10.1016/j.biomaterials.2012.07.002
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Vatankhah E, 2014, J BIOMATER APPL, V28, P909, DOI 10.1177/0885328213486527
   Vozzi G, 2010, BIOTECHNOL BIOENG, V106, P804, DOI 10.1002/bit.22740
   Wang James Hc, 2010, Sports Med Arthrosc Rehabil Ther Technol, V2, P16, DOI 10.1186/1758-2555-2-16
   Wang PY, 2012, J MATER SCI-MATER M, V23, P3015, DOI 10.1007/s10856-012-4748-6
   Wang PY, 2011, ACTA BIOMATER, V7, P3285, DOI 10.1016/j.actbio.2011.05.021
   Wang YC, 2013, INT J NANOMED, V8, P159, DOI 10.2147/IJN.S36408
   Watari S, 2012, BIOMATERIALS, V33, P128, DOI 10.1016/j.biomaterials.2011.09.058
   Weightman A, 2014, NANOMED-NANOTECHNOL, V10, P291, DOI 10.1016/j.nano.2013.09.001
   Wolf M.T., 2014, ADV DRUG DELIV REV, DOI DOI 10.1016/J.ADDR.2014.08.011
   Wood MA, 2007, J R SOC INTERFACE, V4, P1, DOI 10.1098/rsif.2006.0149
   Wu CT, 2011, BIOMATERIALS, V32, P7068, DOI 10.1016/j.biomaterials.2011.06.009
   Wu XH, 2013, ADV HEALTHC MATER, V2, P326, DOI 10.1002/adhm.201200205
   Xu L, 2010, BIOMATERIALS, V31, P3894, DOI 10.1016/j.biomaterials.2010.01.106
   Yang HS, 2014, BIOMATERIALS, V35, P1478, DOI 10.1016/j.biomaterials.2013.10.067
   Yang JY, 2009, J BIOMED MATER RES A, V90A, P629, DOI 10.1002/jbm.a.32130
   Yang Y, 2011, MOL PHARM, V9, P48
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zeugolis DI, 2008, J BIOMED MATER RES A, V86A, P892, DOI 10.1002/jbm.a.31694
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
   Zhang DM, 2008, NANO LETT, V8, P3283, DOI 10.1021/nl801667s
   Zhang LJ, 2013, INT J NANOMED, V8, P1907, DOI 10.2147/IJN.S41570
   Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/nmat2778, 10.1038/NMAT2778]
   Zheng WF, 2013, ADV HEALTHC MATER, V2, P95, DOI 10.1002/adhm.201200104
   Ziv V, 1996, BONE, V18, P417, DOI 10.1016/8756-3282(96)00049-X
NR 163
TC 23
Z9 24
U1 4
U2 30
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
EI 1748-6963
J9 NANOMEDICINE-UK
JI Nanomedicine
PY 2015
VL 10
IS 5
BP 693
EP 711
DI 10.2217/NNM.14.218
PG 19
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA CE6EY
UT WOS:000351930700005
PM 25816874
DA 2018-10-19
ER

PT J
AU Dhowre, HS
   Rajput, S
   Russell, NA
   Zelzer, M
AF Dhowre, Hala S.
   Rajput, Sunil
   Russell, Noah A.
   Zelzer, Mischa
TI Responsive cell-material interfaces
SO NANOMEDICINE
LA English
DT Review
DE biointerfaces; biomimetic surfaces; cell-material interactions; cell
   response; regenerative medicine; stimuli-responsive materials
ID SELF-ASSEMBLED MONOLAYERS; MESENCHYMAL STEM-CELLS; PHOTORESPONSIVE SMART
   TEMPLATE; REGENERATIVE MEDICINE; EXTRACELLULAR-MATRIX;
   SURFACE-CHEMISTRY; FUNCTIONAL-GROUPS; IN-VITRO; BIOMATERIAL
   INTERACTIONS; BIOMEDICAL APPLICATIONS
AB Major design aspects for novel biomaterials are driven by the desire to mimic more varied and complex properties of a natural cellular environment with man-made materials. The development of stimulus responsive materials makes considerable contributions to the effort to incorporate dynamic and reversible elements into a biomaterial. This is particularly challenging for cell-material interactions that occur at an interface (biointerfaces); however, the design of responsive biointerfaces also presents opportunities in a variety of applications in biomedical research and regenerative medicine. This review will identify the requirements imposed on a responsive biointerface and use recent examples to demonstrate how some of these requirements have been met. Finally, the next steps in the development of more complex biomaterial interfaces, including multiple stimuli-responsive surfaces, surfaces of 3D objects and interactive biointerfaces will be discussed.
C1 [Dhowre, Hala S.; Rajput, Sunil; Russell, Noah A.] Univ Nottingham, Neurophoton Lab, Fac Engn, Nottingham NG7 2RD, England.
   [Dhowre, Hala S.; Rajput, Sunil; Zelzer, Mischa] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.
   [Zelzer, Mischa] Univ Nottingham, Interface & Surface Anal Ctr, Nottingham NG7 2RD, England.
   [Zelzer, Mischa] Natl Phys Lab, Teddington TW11 0LW, Middx, England.
RP Zelzer, M (reprint author), Univ Nottingham, Sch Pharm, Boots Sci Bldg,Univ Pk, Nottingham NG7 2RD, England.
EM mischa.zelzer@nottingham.ac.uk
OI Russell, N/0000-0002-0998-6094
FU EPSRC [EP/H022112/1]; University of Nottingham Strategic Fund;
   Engineering and Physical Sciences Research Council [EP/H022112/1]
FX This work was supported by the EPSRC (EP/H022112/1) and the University
   of Nottingham Strategic Fund. The authors have no other relevant
   affiliations or financial involvement with any organization or entity
   with a financial interest in or financial conflict with the subject
   matter or materials discussed in the manuscript apart from those
   disclosed.
CR Almquist BD, 2011, NANO LETT, V11, P2066, DOI 10.1021/nl200542m
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Auernheimer J, 2005, J AM CHEM SOC, V127, P16107, DOI 10.1021/ja053648q
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Barry JJA, 2006, ADV MATER, V18, P1406, DOI 10.1002/adma.200502719
   Barthes J., 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/921905
   Bebarova M, 2012, GEN PHYSIOL BIOPHYS, V31, P131, DOI 10.4149/gpb_2012_016
   Bellis SL, 2011, BIOMATERIALS, V32, P4205, DOI 10.1016/j.biomaterials.2011.02.029
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Blau A, 2013, CURR OPIN COLLOID IN, V18, P481, DOI 10.1016/j.cocis.2013.07.005
   Brown BN, 2013, ACTA BIOMATER, V9, P4948, DOI 10.1016/j.actbio.2012.10.025
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Cai L, 2014, ACTA BIOMATER, V10, P1751, DOI 10.1016/j.actbio.2013.12.028
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Chan A, 2013, ADV DRUG DELIVER REV, V65, P497, DOI 10.1016/j.addr.2012.07.007
   Curran JM, 2005, BIOMATERIALS, V26, P7057, DOI 10.1016/j.biomaterials.2005.05.008
   CURTIS ASG, 1984, J CELL SCI, V71, P17
   Custodio CA, 2014, ADV HEALTHC MATER, V3, P797, DOI 10.1002/adhm.201300603
   Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058
   Dalby MJ, 2008, J R SOC INTERFACE, V5, P1055, DOI 10.1098/rsif.2008.0016
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Davila J, 2012, J AM CHEM SOC, V134, P83, DOI 10.1021/ja208970b
   DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1
   ELUL R, 1967, J PHYSIOL-LONDON, V189, P351, DOI 10.1113/jphysiol.1967.sp008173
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Fuhrer R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081362
   Fukuda J, 2011, BIOMATERIALS, V32, P6663, DOI 10.1016/j.biomaterials.2011.05.068
   Garcia AJ, 2006, ADV POLYM SCI, P171, DOI 10.1007/12_071
   Garcia-Amoros J, 2012, ANGEW CHEM INT EDIT, V51, P12820, DOI 10.1002/anie.201207602
   Garcia-Parra P, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00010
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Gensel J, 2012, ADV MATER, V24, P985, DOI 10.1002/adma.201103786
   Gilmore IS, 2013, J VAC SCI TECHNOL A, V31, DOI 10.1116/1.4816935
   Gong YH, 2013, J MATER CHEM B, V1, P2013, DOI 10.1039/c3tb20073f
   Gong YH, 2011, MACROMOLECULES, V44, P7499, DOI 10.1021/ma201676w
   Hayward AS, 2013, BIOMACROMOLECULES, V14, P4271, DOI 10.1021/bm401145x
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   Higgins MJ, 2011, J PHYS CHEM B, V115, P3371, DOI 10.1021/jp112045k
   Higuchi A, 2014, PROG POLYM SCI, V39, P1585, DOI 10.1016/j.progpolymsci.2014.05.001
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Inaba R, 2009, BIOMATERIALS, V30, P3573, DOI 10.1016/j.biomaterials.2009.03.045
   Ivashenko O, 2013, LANGMUIR, V29, P4290, DOI 10.1021/la400192c
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kielty CM, 2002, J CELL SCI, V115, P2817
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   Kim J, 2012, TRENDS BIOTECHNOL, V30, P426, DOI 10.1016/j.tibtech.2012.04.003
   Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kourouklis AP, 2014, BIOMATERIALS, V35, P4827, DOI 10.1016/j.biomaterials.2014.02.052
   Krupenkin TN, 2004, LANGMUIR, V20, P3824, DOI 10.1021/la036093q
   Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933
   Lam MT, 2008, BIOMATERIALS, V29, P1705, DOI 10.1016/j.biomaterials.2007.12.010
   Lamb BM, 2011, J AM CHEM SOC, V133, P8870, DOI 10.1021/ja203198y
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Le DM, 2011, ADV MATER, V23, P3278, DOI 10.1002/adma.201100821
   Leal-Egana A, 2013, ADV MATER, V25, P4049, DOI 10.1002/adma.201301227
   Liao XL, 2009, CHEM-EUR J, V15, P12303, DOI 10.1002/chem.200901345
   Liu B, 2010, J AM CHEM SOC, V132, P13630, DOI 10.1021/ja1054669
   Liu DB, 2009, ANGEW CHEM INT EDIT, V48, P4406, DOI 10.1002/anie.200901130
   Liu LY, 2005, J BIOMED MATER RES A, V74A, P23, DOI 10.1002/jbm.a.30221
   Liu XL, 2014, CHEM SOC REV, V43, P2385, DOI 10.1039/c3cs60419e
   Lowik DWPM, 2010, CHEM SOC REV, V39, P3394, DOI 10.1039/b914342b
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   MacEwan SR, 2010, BIOPOLYMERS, V94, P60, DOI 10.1002/bip.21327
   Mager MD, 2011, NAT CHEM, V3, P582, DOI [10.1038/NCHEM.1090, 10.1038/nchem.1090]
   Maitre JL, 2013, CURR BIOL, V23, pR626, DOI 10.1016/j.cub.2013.06.019
   Mandal K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037548
   Martino S, 2012, BIOTECHNOL ADV, V30, P338, DOI 10.1016/j.biotechadv.2011.06.015
   Mendes PM, 2008, CHEM SOC REV, V37, P2512, DOI 10.1039/b714635n
   Mendes PM, 2013, CHEM SOC REV, V42, P9199
   Mertz D, 2009, NAT MATER, V8, P731, DOI [10.1038/NMAT2504, 10.1038/nmat2504]
   Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549
   Mrksich M, 2000, CHEM SOC REV, V29, P267, DOI 10.1039/a705397e
   Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]
   Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002
   Nakayama M, 2012, MACROMOL BIOSCI, V12, P751, DOI 10.1002/mabi.201200018
   Ng CCA, 2012, ANGEW CHEM INT EDIT, V51, P7706, DOI 10.1002/anie.201202118
   Pan GQ, 2014, J AM CHEM SOC, V136, P6203, DOI 10.1021/ja501664f
   Paul N, 2013, SOFT MATTER, V9, P1364, DOI 10.1039/c2sm26896e
   Piantek M, 2009, J AM CHEM SOC, V131, P12729, DOI 10.1021/ja901238p
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Piggott M, 2014, CHEM OGGI, V32, P3
   Pranzetti A, 2013, ADV MATER, V25, P2181, DOI 10.1002/adma.201204880
   Qing GY, 2009, SOFT MATTER, V5, P2759, DOI 10.1039/b900504h
   Qing GY, 2009, J AM CHEM SOC, V131, P8370, DOI 10.1021/ja9028632
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Rahane SB, 2008, ADV FUNCT MATER, V18, P1232, DOI 10.1002/adfm.200701411
   Rashidi H, 2014, BIOMATER SCI-UK, V2, P1318, DOI 10.1039/c3bm60330j
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rawson FJ, 2013, NANO LETT, V13, P1, DOI 10.1021/nl203780d
   Rimmer S, 2009, POLYM INT, V58, P273, DOI 10.1002/pi.2537
   Roach P, 2006, J AM CHEM SOC, V17, P617
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Rodrigo-Navarro A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05849
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   Saadeddin A, 2013, ADV HEALTHC MATER, V2, P1213, DOI 10.1002/adhm.201200473
   Santos E, CELL BIOMATERIAL INT
   Santos MI, 2009, J MATER CHEM, V19, P4091, DOI 10.1039/b819089e
   Schattling P, 2014, POLYM CHEM-UK, V5, P25, DOI [10.1039/c3py00880k, 10.1039/c3py00880]
   Seras-Franzoso J, 2013, J CONTROL RELEASE, V171, P63, DOI 10.1016/j.jconrel.2013.06.034
   Shaikh RP, 2010, AAPS PHARMSCITECH, V11, P441, DOI 10.1208/s12249-010-9403-2
   Shekaran A, 2011, BBA-GEN SUBJECTS, V1810, P350, DOI 10.1016/j.bbagen.2010.04.006
   Sidorenko A, 2007, SCIENCE, V315, P487, DOI 10.1126/science.1135516
   Skorb EV, 2013, ADV FUNCT MATER, V23, P4483, DOI 10.1002/adfm.201203884
   Smith JT, 2004, LANGMUIR, V20, P8279, DOI 10.1021/la0489763
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Sun TL, 2011, ADV MATER, V23, pH57, DOI 10.1002/adma.201004326
   Takahashi H, 2010, BIOMACROMOLECULES, V11, P1991, DOI 10.1021/bm100342e
   Tateno H, 2007, GLYCOBIOLOGY, V17, P1138, DOI 10.1093/glyco/cwm084
   Tekin H, 2011, AICHE J, V57, P3249, DOI 10.1002/aic.12801
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Todd SJ, 2009, LANGMUIR, V25, P7533, DOI 10.1021/la900376h
   Uchiyama S, 2004, J AM CHEM SOC, V126, P3032, DOI 10.1021/ja039697p
   Uto K, 2014, INT J MOL SCI, V15, P1511, DOI 10.3390/ijms15011511
   van Dongen SFM, 2013, ADV MATER, V25, P1687, DOI 10.1002/adma.201204474
   VanDersarl JJ, 2012, NANO LETT, V12, P3881, DOI 10.1021/nl204051v
   Ventre M, 2012, J R SOC INTERFACE, V9, P2017, DOI 10.1098/rsif.2012.0308
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   Wandera D, 2010, J MEMBRANE SCI, V357, P6, DOI 10.1016/j.memsci.2010.03.046
   Wang GJ, 2012, J PHOTOCH PHOTOBIO C, V13, P299, DOI 10.1016/j.jphotochemrev.2012.06.002
   Wang XT, 2012, SOFT MATTER, V8, P2812, DOI 10.1039/c2sm06567c
   Ward MA, 2011, POLYMERS-BASEL, V3, P1215, DOI 10.3390/polym3031215
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
   Xia F, 2006, ADV MATER, V18, P432, DOI 10.1002/adma.200501772
   Yamato M, 2007, PROG POLYM SCI, V32, P1123, DOI 10.1016/j.progpolymsci.2007.06.002
   Yeo WS, 2006, LANGMUIR, V22, P10816, DOI 10.1021/la061212y
   Yeo WS, 2003, J AM CHEM SOC, V125, P14994, DOI 10.1021/ja038265b
   Yeung CL, 2010, ADV FUNCT MATER, V20, P2657, DOI 10.1002/adfm.201000411
   Yousaf M.N., 2001, ANGEW CHEM, V113, P1127
   Zarzar L.D., 2011, ANGEW CHEM, V123, P9528
   Zarzar LD, 2014, ACCOUNTS CHEM RES, V47, P530, DOI 10.1021/ar4001923
   Zarzar LD, 2011, ADV MATER, V23, P1442, DOI 10.1002/adma.201004231
   Zelzer M, 2008, BIOMATERIALS, V29, P172, DOI 10.1016/j.biomaterials.2007.09.026
   Zelzer M, 2013, BIOMATER SCI-UK, V1, P11, DOI 10.1039/c2bm00041e
   Zelzer M, 2012, J MATER CHEM, V22, P12229, DOI 10.1039/c2jm31666h
   Zelzer M, 2012, PLASMA PROCESS POLYM, V9, P149, DOI 10.1002/ppap.201100054
   Zelzer M, 2009, J PHYS CHEM B, V113, P8487, DOI 10.1021/jp902137y
NR 148
TC 18
Z9 19
U1 2
U2 97
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
EI 1748-6963
J9 NANOMEDICINE-UK
JI Nanomedicine
PY 2015
VL 10
IS 5
BP 849
EP 871
DI 10.2217/NNM.14.222
PG 23
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA CE6EY
UT WOS:000351930700015
PM 25816884
OA Other Gold
DA 2018-10-19
ER

PT J
AU Hortensius, RA
   Becraft, JR
   Pack, DW
   Harley, BAC
AF Hortensius, Rebecca A.
   Becraft, Jacob R.
   Pack, Daniel W.
   Harley, Brendan A. C.
TI The effect of glycosaminoglycan content on polyethylenimine-based gene
   delivery within three-dimensional collagen-GAG scaffolds
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID GROWTH-FACTOR SUPPLEMENTATION; MESENCHYMAL STEM-CELLS; BONE
   REGENERATION; IN-VIVO; OSTEOGENIC DIFFERENTIATION; BIOPHYSICAL
   PROPERTIES; EXTRACELLULAR-MATRIX; TENOCYTE BIOACTIVITY;
   CONTROLLED-RELEASE; ACTIVATED MATRIX
AB The design of biomaterials for increasingly complex tissue engineering applications often requires exogenous presentation of biomolecular signals. Integration of gene delivery vectors with a biomaterial scaffold offers the potential to bypass the use of expensive and relatively inefficient growth factor supplementation strategies to augment cell behavior. However, integration of cationic polymer based gene delivery vectors within three-dimensional biomaterials, particularly matrices which can carry significant surface charge, remains poorly explored. We examined the potential of polyethylenimine (PEI) as a gene delivery vector for three-dimensional collagen-glycosaminoglycan (CG) scaffolds under development for tendon repair. While acetylated versions of PEI have demonstrated improved transfection efficiency in 2D culture assays, we investigated translation of this effect to a 3D biomaterial that contains significant electrostatic charge. A reporter gene was used to examine the impact of polymer modification, polymer : DNA ratio, and the degree of sulfation of the biomaterial microenvironment on gene delivery in vitro. We observed highest transgene expression in acetylated and unmodified PEI at distinct polymer : DNA ratios; notably, the enhancement often seen in two-dimensional culture for acetylated PEI did not fully translate to three-dimensional scaffolds. We also found highly sulfated heparin-based CG scaffolds showed enhanced initial luciferase expression but not prolonged activity. While PEI constructs significantly reduced tenocyte metabolic health during the period of transfection, heparin-based CG scaffolds showed the greatest recovery in tenocyte metabolic health over the full 2 week culture. These results suggest that the electrostatic environment of three-dimensional biomaterials may be an important design criterion for cationic polymer-based gene delivery.
C1 [Hortensius, Rebecca A.] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
   [Becraft, Jacob R.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
   [Pack, Daniel W.] Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY USA.
   [Pack, Daniel W.] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY USA.
   [Harley, Brendan A. C.] Univ Illinois, Dept Chem & Biol Engn, Urbana, IL 61801 USA.
   [Harley, Brendan A. C.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
RP Hortensius, RA (reprint author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
EM bharley@illinois.edu
OI Harley, Brendan/0000-0001-5458-154X
FU National Science Foundation [1105300]; National Institute of Arthritis
   and Musculoskeletal and Skin Diseases of the National Institutes of
   Health [R03 AR062811]; NSF Graduate Research Fellowship [DGE 11-44245
   FLLW]; Chemical and Biomolecular Engineering Dept.; Institute for
   Genomic Biology (BAH) at the University of Illinois at Urbana-Champaign
FX Author contributions: R.A.H., J.R.B., and B.A.C.H designed the research;
   J.R.B. and R.A.H. performed the research; D.W.P. contributed polyplexes
   and analytical facilities; R.A.H., J.R.B., and B.A.C.H. analyzed the
   data and interpreted the results; R.A.H. and B.A.H. wrote the paper. The
   authors would like to acknowledge Dr Allison Stewart (Veterinary
   Sciences, UIUC) for the equine tenocytes and Dr Sandra McMasters (SCS,
   UIUC) for culture media preparation. The authors would also like to
   acknowledge Dr Nathan Todd (UIUC) for assistance with statistical
   analysis of the data. This material is based upon work supported by the
   National Science Foundation under Grant No. 1105300. Research reported
   in this publication was supported by the National Institute of Arthritis
   and Musculoskeletal and Skin Diseases of the National Institutes of
   Health under Award Numbers R03 AR062811. The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health. We are grateful for
   the funding for this study provided by the NSF Graduate Research
   Fellowship DGE 11-44245 FLLW (RAH). We are grateful for the funding for
   this study by the Chemical and Biomolecular Engineering Dept. (BAH) and
   the Institute for Genomic Biology (BAH) at the University of Illinois at
   Urbana-Champaign.
CR Abdallah B, 1996, HUM GENE THER, V7, P1947, DOI 10.1089/hum.1996.7.16-1947
   Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222
   Amaduzzi F, 2014, COLLOID SURFACE B, V114, P1, DOI 10.1016/j.colsurfb.2013.09.029
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Caliari SR, 2014, TISSUE ENG PT A, V20, P2463, DOI [10.1089/ten.tea.2013.0400, 10.1089/ten.TEA.2013.0400]
   Caliari SR, 2014, ADV HEALTHC MATER, V3, P1086, DOI 10.1002/adhm.201300646
   Caliari SR, 2013, TISSUE ENG PT A, V19, P1100, DOI [10.1089/ten.TEA.2012.0497, 10.1089/ten.tea.2012.0497]
   Caliari SR, 2012, J MECH BEHAV BIOMED, V11, P27, DOI 10.1016/j.jmbbm.2011.12.004
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Caliari SR, 2011, BIOMATERIALS, V32, P5330, DOI 10.1016/j.biomaterials.2011.04.021
   Capito RM, 2007, GENE THER, V14, P721, DOI 10.1038/sj.gt.3302918
   Carrillo C, 2014, BIOMED PHARMACOTHER, V68, P775, DOI 10.1016/j.biopha.2014.07.009
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Curtin CM, 2015, ADV HEALTHC MATER, V4, P223, DOI 10.1002/adhm.201400397
   Curtin CM, 2012, ADV MATER, V24, P749, DOI 10.1002/adma.201103828
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Davis ME, 2002, CURR OPIN BIOTECH, V13, P128, DOI 10.1016/S0958-1669(02)00294-X
   De la Riva B, 2010, J CONTROL RELEASE, V143, P45, DOI 10.1016/j.jconrel.2009.11.026
   Elangovan S, 2014, BIOMATERIALS, V35, P737, DOI 10.1016/j.biomaterials.2013.10.021
   Fang JM, 1996, P NATL ACAD SCI USA, V93, P5753, DOI 10.1073/pnas.93.12.5753
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   Fischer D, 1999, PHARMACEUT RES, V16, P1273, DOI 10.1023/A:1014861900478
   Forrest ML, 2004, PHARM RES, V21, P365, DOI 10.1023/B:PHAM.0000016251.42392.1e
   Forrest ML, 2003, BIOCONJUGATE CHEM, V14, P934, DOI 10.1021/bc034014g
   Gabrielson NP, 2006, BIOMACROMOLECULES, V7, P2427, DOI 10.1021/bm060300u
   Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5
   Gulotta LV, 2009, CLIN SPORT MED, V28, P13, DOI 10.1016/j.csm.2008.09.002
   Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314
   Hanson JA, 2008, NATURE, V455, P85, DOI 10.1038/nature07197
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Hempel U, 2012, ACTA BIOMATER, V8, P659, DOI 10.1016/j.actbio.2011.10.026
   Hortensius RA, 2013, BIOMATERIALS, V34, P7645, DOI 10.1016/j.biomaterials.2013.06.056
   Hosseinkhani H, 2008, J BIOMED MATER RES A, V85A, P47, DOI 10.1002/jbm.a.31327
   Hudalla GA, 2011, ADV MATER, V23, P5415, DOI 10.1002/adma.201103046
   Hudalla GA, 2011, INTEGR BIOL-UK, V3, P832, DOI 10.1039/c1ib00021g
   Kapoor A, 2010, ACTA BIOMATER, V6, P2580, DOI 10.1016/j.actbio.2009.12.047
   Lim JJ, 2013, BIOMATERIALS, V34, P5007, DOI 10.1016/j.biomaterials.2013.03.037
   Liu CF, 2012, TISSUE ENG PT A, V18, P598, DOI [10.1089/ten.tea.2011.0338, 10.1089/ten.TEA.2011.0338]
   Luo D, 2000, NAT BIOTECHNOL, V18, P33
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Martin TA, 2011, BIOMATERIALS, V32, P3949, DOI 10.1016/j.biomaterials.2011.02.018
   Molloy T, 2003, SPORTS MED, V33, P381, DOI 10.2165/00007256-200333050-00004
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498
   Shen WL, 2010, BIOMATERIALS, V31, P7239, DOI 10.1016/j.biomaterials.2010.05.040
   Sohier J, 2006, J CONTROL RELEASE, V111, P95, DOI 10.1016/j.conrel.2005.11.016
   Somia N, 2000, NAT REV GENET, V1, P91, DOI 10.1038/35038533
   Thomopoulos S, 2010, J MUSCULOSKEL NEURON, V10, P35
   Tierney EG, 2013, J CONTROL RELEASE, V165, P173, DOI 10.1016/j.jconrel.2012.11.013
   Tierney EG, 2012, J CONTROL RELEASE, V158, P304, DOI 10.1016/j.jconrel.2011.11.026
   WAGNER E, 1990, P NATL ACAD SCI USA, V87, P3410, DOI 10.1073/pnas.87.9.3410
   Watson SS, 2009, DEV DYNAM, V238, P693, DOI 10.1002/dvdy.21866
   Weisgerber DW, 2013, J MECH BEHAV BIOMED, V28, P26, DOI 10.1016/j.jmbbm.2013.07.016
   WU GY, 1988, J BIOL CHEM, V263, P14621
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Zhang L, 2006, J CONTROL RELEASE, V114, P130, DOI 10.1016/j.jconrel.2006.06.005
NR 63
TC 10
Z9 10
U1 2
U2 26
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2015
VL 3
IS 4
BP 645
EP 654
DI 10.1039/c5bm00033e
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CE0DN
UT WOS:000351474800010
PM 26097698
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Varshosaz, J
   Taymouri, S
   Hassanzadeh, F
   Javanmard, SH
   Rostami, M
AF Varshosaz, Jaleh
   Taymouri, Somayeh
   Hassanzadeh, Farshid
   Javanmard, Shaghayegh Haghjooy
   Rostami, Mahboobeh
TI Folated Synperonic-Cholesteryl Hemisuccinate Polymeric Micelles for the
   Targeted Delivery of Docetaxel in Melanoma
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID IN-VIVO EVALUATION; METHOXY POLY(ETHYLENE GLYCOL); BLOCK COPOLYMERIC
   MICELLE; DRUG-DELIVERY; METASTATIC MELANOMA; SUSTAINED-RELEASE; VITRO
   EVALUATION; MIXED MICELLES; BREAST-CANCER; TUMOR-CELLS
AB The objective of this study was the synthesis of folic acid-(FA-) targeted polymeric micelles of Synperonic PE/F 127-cholesteryl hemisuccinate (PF127-Chol) for specific delivery of docetaxel (DTX). Targeted or nontargeted micelles loaded with DTX were prepared via dialysis method. The effects of processing variables on the physicochemical properties of targeted micelles were evaluated using a full factorial design. After the optimization of the polymer/drug ratio, the organic solvent type used for the preparation of the micelles, and the temperature of dialyzing medium, the in vitro cytotoxicity and cellular uptake of the optimized micelles were studied on B16F10 melanoma cells by flow cytometry and fluorescent microscopy. The anticancer efficacy of DTX-loaded FA-PF127-Chol was evaluated in mice bearing melanoma tumor. Optimized targeted micelles had the particle size of 171.3 nm, zeta potential of -7.8mV, PDI of 0.325, and a high encapsulation efficiency that released the drug within 144 h. The MTT assay indicated that targeted micelles carrying DTX were significantly more cytotoxic, had higher cellular uptake, and reduced the tumor volume significantly more than the nontargeted micelles and the free drug. FA-PF127-Chol could be, therefore, a promising biomaterial for tumors overexpressing folate receptors.
C1 [Varshosaz, Jaleh; Taymouri, Somayeh] Isfahan Univ Med Sci, Sch Pharm, Dept Pharmaceut, Esfahan 8174673461, Iran.
   [Varshosaz, Jaleh; Taymouri, Somayeh] Isfahan Univ Med Sci, Novel Drug Delivery Syst Res Ctr, Esfahan 8174673461, Iran.
   [Hassanzadeh, Farshid; Rostami, Mahboobeh] Isfahan Univ Med Sci, Sch Pharm, Dept Med Chem, Esfahan 8174673461, Iran.
   [Javanmard, Shaghayegh Haghjooy] Isfahan Univ Med Sci, Appl Physiol Res Ctr, Esfahan 8174673461, Iran.
RP Varshosaz, J (reprint author), Isfahan Univ Med Sci, Sch Pharm, Dept Pharmaceut, Esfahan 8174673461, Iran.
EM varshosaz@pharm.mui.ac.ir
RI varshosaz, jaleh/V-6124-2017; Taymouri, Somayeh/W-3347-2017; Javanmard,
   Shaghayegh/W-5060-2017; Javanmard, Haghjoo, Shaghayeg/V-6376-2017;
   Varshosaz, Jaleh/W-2290-2017; hassanzadeh, Farshid/W-1961-2017
OI Javanmard, Shaghayegh/0000-0002-3853-5006; hassanzadeh,
   Farshid/0000-0003-1100-9820; , Jaleh/0000-0001-9333-5798
FU Isfahan University of Medical Sciences; Iran National Science Foundation
FX The authors wish to thank the Vice Chancellery of Isfahan University of
   Medical Sciences and Iran National Science Foundation for supporting
   this work.
CR Bae YH, 2011, J CONTROL RELEASE, V153, P198, DOI 10.1016/j.jconrel.2011.06.001
   Barreiro-Iglesias R, 2004, J CONTROL RELEASE, V97, P537, DOI 10.1016/j.jconrel.2004.04.007
   Bhatia S, 2009, ONCOLOGY-NY, V23, P488
   Chen MM, 2011, CARBOHYD POLYM, V84, P1244, DOI 10.1016/j.carbpol.2011.01.012
   Chen YZ, 2013, INT J PHARMACEUT, V452, P421, DOI 10.1016/j.ijpharm.2013.05.015
   Chiappetta DA, 2007, EUR J PHARM BIOPHARM, V66, P303, DOI 10.1016/j.ejpb.2007.03.022
   Choi H, 2004, ACAD RADIOL, V11, P996, DOI 10.1016/j.acra.2004.04.018
   Dahmani FZ, 2012, EUR J PHARM SCI, V47, P179, DOI 10.1016/j.ejps.2012.05.015
   Emami J, 2012, J NANOMATER, DOI 10.1155/2012/358782
   Erdei E, 2010, EXPERT REV ANTICANC, V10, P1811, DOI 10.1586/ERA.10.170
   Ernsting MJ, 2012, BIOMATERIALS, V33, P1445, DOI 10.1016/j.biomaterials.2011.10.061
   Fattahi A, 2012, CARBOHYD POLYM, V87, P1176, DOI 10.1016/j.carbpol.2011.08.093
   Gao QH, 2011, COLLOID SURFACE B, V88, P741, DOI 10.1016/j.colsurfb.2011.08.010
   Grossman J. H., 2012, PHYS TODAY, V65
   Guo DD, 2007, CANCER LETT, V254, P244, DOI 10.1016/j.canlet.2007.03.007
   Gupta Y, 2007, J DRUG TARGET, V15, P231, DOI 10.1080/10611860701289719
   He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065
   Ho KS, 2012, BIOMATERIALS, V33, P2223, DOI 10.1016/j.biomaterials.2011.11.072
   Ishimaru C, 2008, LIPIDS, V43, P373, DOI 10.1007/s11745-007-3149-y
   Jalalian SH, 2013, EUR J PHARM SCI, V50, P191, DOI 10.1016/j.ejps.2013.06.015
   Jones MC, 1999, EUR J PHARM BIOPHARM, V48, P101, DOI 10.1016/S0939-6411(99)00039-9
   Kabanov AV, 2002, J CONTROL RELEASE, V82, P189, DOI 10.1016/S0168-3659(02)00009-3
   Kim JH, 2006, J CONTROL RELEASE, V111, P228, DOI 10.1016/j.jconrel.2005.12.013
   Kim SY, 1998, J CONTROL RELEASE, V51, P13, DOI 10.1016/S0168-3659(97)00124-7
   Koopaei MN, 2011, INT J NANOMED, V6, P1903, DOI 10.2147/IJN.S23211
   Lee ALZ, 2012, BIOMATERIALS, V33, P1921, DOI 10.1016/j.biomaterials.2011.11.032
   Li L, 2008, J COLLOID INTERF SCI, V317, P326, DOI 10.1016/j.jcis.2007.09.053
   Lin GY, 2013, J MICROENCAPSUL, V30, P538, DOI 10.3109/02652048.2012.758182
   Lin WJ, 2003, PHARMACEUT RES, V20, P668, DOI 10.1023/A:1023215320026
   Liu DH, 2011, COLLOID SURFACE B, V85, P262, DOI 10.1016/j.colsurfb.2011.02.038
   Liu YH, 2011, INT J PHARMACEUT, V421, P160, DOI 10.1016/j.ijpharm.2011.09.006
   Lu Y, 2013, INT J PHARMACEUT, V453, P198, DOI 10.1016/j.ijpharm.2012.08.042
   Lu YJ, 2002, ADV DRUG DELIVER REV, V54, P675, DOI 10.1016/S0169-409X(02)00042-X
   Luk VN, 2008, LANGMUIR, V24, P6382, DOI 10.1021/la7039509
   Moazeni E, 2010, J MICROENCAPSUL, V27, P618, DOI 10.3109/02652048.2010.506579
   Nagavarma B.V.N., 2012, ASIAN J PHARM CLIN R, V5, P16
   Pan J, 2008, BIOMATERIALS, V29, P2663, DOI 10.1016/j.biomaterials.2008.02.020
   Park KM, 2008, COLLOID SURFACE B, V63, P1, DOI 10.1016/j.colsurfb.2007.10.024
   Pretto F, 2013, PHARMACOL THERAPEUT, V139, P405, DOI 10.1016/j.pharmthera.2013.05.006
   Pu X., 2012, ASIAN J PHARM SCI, V7, P1
   SHARMA A, 2013, BIOMED RES INT
   Shin ILG, 1998, J CONTROL RELEASE, V51, P1
   Shiraishi K., 2009, BIOL PHARM BULL, V36, P878
   Sun B, 2008, BIOMATERIALS, V29, P475, DOI 10.1016/j.biomaterials.2007.09.038
   Tran MA, 2009, PIGM CELL MELANOMA R, V22, P388, DOI 10.1111/j.1755-148X.2009.00581.x
   Varshosaz J., IET NANOBIO IN PRESS
   Varshosaz J., 2014, J LIPOSOME RES
   Varshosaz J, 2014, BIOMED RES INT, DOI 10.1155/2014/708593
   Velho Tiago Rodrigues, 2012, Drugs Context, V2012, P212242, DOI 10.7573/dic.212242
   WANG XZ, 2009, STUD FUZZINESS SOFT, V245, P1
   Yang Z, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/025012
   Yinsong W., 2007, CARBOHYD POLYM, V69, P597
   Yu KF, 2013, INT J NANOMED, V8, P2473, DOI 10.2147/IJN.S46962
   Zhang L, 2002, J CONTROL RELEASE, V85, P73, DOI 10.1016/S0168-3659(02)00273-0
   Zhang L, 2012, INT J NANOMED, V7, P151, DOI 10.2147/IJN.S27639
   Zhang LH, 2012, NANOMED-NANOTECHNOL, V8, P925, DOI 10.1016/j.nano.2011.11.005
   Zhang W, 2011, BIOMATERIALS, V32, P5934, DOI 10.1016/j.biomaterials.2011.04.075
   Zhou JH, 2013, CHINESE J CANCER RES, V25, P527, DOI 10.3978/j.issn.1000-9604.2013.09.04
   Zhu XL, 2013, INT J MOL SCI, V14, P15755, DOI 10.3390/ijms140815755
NR 59
TC 3
Z9 3
U1 1
U2 12
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 746093
DI 10.1155/2015/746093
PG 17
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CE1TI
UT WOS:000351594500001
PM 25839040
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Jantova, S
   Bakos, D
   Birosova, L
   Matejov, P
AF Jantova, Sona
   Bakos, Dusan
   Birosova, Lucia
   Matejov, Patrik
TI Biological properties of a novel coladerm-beta glucan membrane. In vitro
   assessment using human fibroblasts
SO BIOMEDICAL PAPERS-OLOMOUC
LA English
DT Article
DE coladerm-beta glucan membrane; human fibroblasts; biocompatibility;
   cytotoxicity; genotoxicity; antimicrobial activity
ID PLEUROTUS-OSTREATUS; DNA-DAMAGE; RAT HEPATOCYTES; STEM-CELLS; CANCER;
   COLLAGEN; TISSUE; CYTOTOXICITY; FUNGAL; MICE
AB Aim. The purpose of this study was to prepare a coladerm-beta glucan membrane (CBGM) and to evaluate its biocompatibility, cytotoxicity, antimicrobial activity, genotoxicity and mutagenicity.
   Methods. The biocompatibility of the membrane was studied on the base of cell adhesion and colonization of human fibroblasts on the biomaterial surface by light microscopy. The MTT test and LDH level determination in the culture medium removed from the control and cells treated on the membrane, were used for viability and cytotoxic evaluations. Flow cytometry and gel electrophoresis were used for analysis of cell cycle and death. The antimicrobial activity of CBGM was tested using the qualitative dilution method. Ames bacteria gene mutation test and Comet assay were used for mutagenic and genotoxic studies.
   Results. MTT and LDH tests confirmed that CBGM is a non-toxic biomaterial. Flow cytometry and gel electrophoresis demonstrated that the membrane did not affect the cell cycle and did not induce either necrotic or apoptotic cell death. CBGM exhibited antibacterial activity against G-bacteria E. sakazakii, S. marcescens, E. coli and agains G(+) sporogenic bacteria B. cereus. No antifungal activity was detected. The membrane did not induce mutagenicity in the bacterial reverse mutation test in Salmonella Typhimurium strains. Similarly, the comet assay showed that the tested fibroblast cells growing with/without the membrane did not show any statistically significant DNA damage.
   Conclusions. The CBGM has good biocompatibility, no cytotoxicity/genotoxicity/mutagenicity and it can be included as a potential scaffold for tissue engineering.
C1 [Jantova, Sona; Birosova, Lucia; Matejov, Patrik] Slovak Univ Technol Bratislava, Fac Chem & Food Technol, Inst Biochem Nutr & Hlth Protect, Bratislava 81237, Slovakia.
   [Bakos, Dusan] Slovak Univ Technol Bratislava, Fac Chem & Food Technol, Inst Polymer Mat, Bratislava 81237, Slovakia.
RP Birosova, L (reprint author), Slovak Univ Technol Bratislava, Fac Chem & Food Technol, Inst Biochem Nutr & Hlth Protect, Radlinskeho 9, Bratislava 81237, Slovakia.
EM lucia.birosova@stuba.sk
CR Akramiene D, 2007, MED LITH, V43, P597
   Akramiene D, 2010, TOHOKU J EXP MED, V220, P299, DOI 10.1620/tjem.220.299
   Akturk O, 2011, J BIOSCI BIOENG, V112, P279, DOI 10.1016/j.jbiosc.2011.05.014
   Ardizzoni A, 2011, J MATER SCI-MATER M, V22, P2329, DOI 10.1007/s10856-011-4408-2
   Behring J, 2008, ODONTOLOGY, V96, P1, DOI 10.1007/s10266-008-0087-y
   Berahim Z, 2011, J PERIODONTOL, V82, P790, DOI 10.1902/jop.2010.100533
   Bergendiova K, 2011, EUR J APPL PHYSIOL, V111, P2033, DOI 10.1007/s00421-011-1837-z
   Bergmeier H. U., 1970, METHODEN ENZYMATISCH
   Bobek P, 2001, BRIT J BIOMED SCI, V58, P164
   BODAJLA M, 1994, CHEM PAP, V48, P432
   Chen J, 2007, VASC HLTH RISK MANAG, V4, P1265
   Chen JZ, 2007, MYCOL RES, V111, P635, DOI 10.1016/j.mycres.2007.02.011
   Esposito A, 2006, J MATER SCI-MATER M, V17, P1365, DOI 10.1007/s10856-006-0612-x
   Gabelova A, 1997, NEOPLASMA, V44, P380
   Harvanova D, 2009, BIOLOGIA, V64, P1032, DOI 10.2478/s11756-009-0171-y
   Horvathova E, 2008, NEUROENDOCRINOL LETT, V29, P644
   Jantova S, 2008, INT TOXICOL, V4, pA36
   KANEKO Y, 1989, INT J IMMUNOTHER, V5, P203
   Kurashige S, 1997, IMMUNOPHARM IMMUNOT, V19, P175, DOI 10.3109/08923979709007657
   Lazarova M, 2006, NUTR CANCER, V56, P113, DOI 10.1207/s15327914nc5601_15
   Lazova M, 2004, NEOPLASMA, V51, P431
   Lim CK, 2010, TOXICOL IN VITRO, V24, P721, DOI 10.1016/j.tiv.2010.01.006
   Magnani M, 2011, GENET MOL BIOL, V34, P131, DOI 10.1590/S1415-47572010005000103
   Majtan J, 2009, Z NATURFORSCH C, V64, P597
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mantovani MS, 2008, MUTAT RES-REV MUTAT, V658, P154, DOI 10.1016/j.mrrev.2007.07.002
   MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9
   Marone PA, 2010, TOXICOL MECH METHOD, V20, P175, DOI 10.3109/15376511003646440
   Miadokova Eva, 2005, Biomedical Papers (Olomouc), V149, P493
   Mossman T., 1989, J IMMUNOL METHODS, V65, P55, DOI DOI 10.1016/0022-1759(83)90303-4
   Muramatsu K, 2004, J BIOMED MATER RES A, V71A, P635, DOI 10.1002/jbm.a.30197
   Nosal'ova V, 2001, PHYSIOL RES, V50, P575
   Poruban D, 2005, CASE REP CLIN PR REV, V6, P62
   Rahar S, 2011, J ADV PHARM TECHNOL, V2, P94, DOI 10.4103/2231-4040.82953
   Ren L., 2012, FOOD FUNCT IN PRESS
   Rop O, 2009, NUTR REV, V67, P624, DOI 10.1111/j.1753-4887.2009.00230.x
   Rovensky J, 2011, RHEUMATOL INT, V31, P507, DOI 10.1007/s00296-009-1258-z
   Ruozi B, 2009, INT J PHARMACEUT, V378, P108, DOI 10.1016/j.ijpharm.2009.05.049
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1595, DOI 10.1016/j.addr.2003.08.003
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Slamenova D, 2003, CANCER LETT, V198, P153, DOI 10.1016/S0304-3835(03)00336-7
   SLAMENOVA D, 1992, MUTAT RES, V279, P109, DOI 10.1016/0165-1218(92)90252-U
   Theiszova M, 2008, NEOPLASMA, V55, P312
   VIZAROVA K, 1995, BIOMATERIALS, V16, P1217, DOI 10.1016/0142-9612(95)98127-Z
   Vojtassak J, 2006, NEUROENDOCRINOL LETT, V27, P134
   Vojtassak Jan, 2001, Cell and Tissue Banking, V2, P225, DOI 10.1023/A:1021146217176
   Vojtassak J, 2006, BIOLOGIA, V61, P713, DOI 10.2478/s11756-006-0146-1
   Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7
   Woo YI, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/044109
   Yang ZY, 2010, SCI CHINA LIFE SCI, V53, P215, DOI 10.1007/s11427-010-0036-1
   Yoon HJ, 2005, ARCH PHARM RES, V28, P1079, DOI 10.1007/BF02977405
NR 51
TC 2
Z9 2
U1 1
U2 10
PU PALACKY UNIV, MEDICAL FAC
PI OLOMOUC
PA CENTRAL LIBRARY, HNEVOTINSKA 3, OLOMOUC, 00000, CZECH REPUBLIC
SN 1213-8118
EI 1804-7521
J9 BIOMED PAP
JI Biomed. Pap-Olomouc
PY 2015
VL 159
IS 1
BP 67
EP 76
DI 10.5507/bp.2012.115
PG 10
WC Engineering, Biomedical; Medicine, Research & Experimental
SC Engineering; Research & Experimental Medicine
GA CE3HE
UT WOS:000351716500011
PM 23446210
OA Bronze
DA 2018-10-19
ER

PT J
AU Dalmonico, GML
   Silva, DF
   Franczak, PF
   Camargo, NHA
   Rodriguez, MA
AF Dalmonico, G. M. L.
   Silva, D. F.
   Franczak, P. F.
   Camargo, N. H. A.
   Rodriguez, M. A.
TI Elaboration biphasic calcium phosphate nanostructured powders
SO BOLETIN DE LA SOCIEDAD ESPANOLA DE CERAMICA Y VIDRIO
LA English
DT Article
DE Synthesis; Calcium Phosphate; Hydroxyapatite; Biphasic; Biomaterial
AB Nanostructured calcium phosphate and biphasic calcium phosphates have been studied and stand out as biomaterials for bone regeneration. This is due to the fact that thesebiomaterials present bioactivity and morphological, chemical and crystallographic similarities to the bone apatite. The aim of the present work has been the synthesis and characterization of two calcium phosphates with Ca/P=1.5 e 1.67 as molar ratio. These were synthesized through the chemical wet process. After synthesis, the hydrated calcium phosphate powders were subsequently calcined at temperatures of 900 degrees C/2 h providing beta-calcium phosphate (beta-TCP) and hydroxyapatite (HA) powders. These powders were used to elaborate the biphasic powders in the wt.% ratios HA/beta-TCP as follows: 80/20, 20/80, 70/30 and 30/70. The method used for the elaboration of the p-tricalcium phosphate nanostructured powder, hydroxyapatite and biphasic compositions was the attrition milling. The nanostructured powders obtained were characterized by the scanning electron microscopy technique, X-ray diffractometry. Infrared spectroscopy and Specific surface using BET model. (C) 2015 Sociedad Espanola de Ceramica y Vidrio. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license
C1 [Dalmonico, G. M. L.; Silva, D. F.; Franczak, P. F.; Camargo, N. H. A.] Santa Catarina State Univ SC, Program Postgrad Sci & Mat Engn, Joinville, Brazil.
   [Rodriguez, M. A.] CSIC, Inst Ceram & Vidrio, Madrid, Spain.
RP Dalmonico, GML (reprint author), Santa Catarina State Univ SC, Program Postgrad Sci & Mat Engn, Joinville, Brazil.
EM gidalmonico@gmail.com
OI Leite Dalmonico, Gisele Maria/0000-0001-6570-6264; Rodriguez, Miguel
   A./0000-0001-5725-9679
FU Higher Education Personnel Training Coordination (CAPES-BRASIL);
   Institute Ceramic and Glass [MAT2013-48426-C2-1R]
FX The financial support of the Higher Education Personnel Training
   Coordination (CAPES-BRASIL) and Institute Ceramic and Glass
   (MAT2013-48426-C2-1R).
CR Berzina-Cimdina L, 2012, MAT SCI ENG TECHNOL, P524
   Borba E.E.G., 2014, 58 C BRAS CER, P1
   Camargo N.H.A., 2014, J BIOSCI MED, V2, P36
   Camargo N.H.A., 2014, ADV MAT RES, V936, P687
   Camargo N. H. A, 2012, AM J BIOMED ENG, V2, P41, DOI DOI 10.1016/J.BSECV.2015.02.006
   Correa Pricyla, 2013, THESIS CCT UDESC JOI, P108
   Dalmonico G.M.L., 2011, THESIS CCT UDESC JOI
   De Delima S. A., 2009, 7 INT LAT AM C POWD, P913
   Dorozhkin SV, 2012, ACTA BIOMATER, V8, P963, DOI 10.1016/j.actbio.2011.09.003
   Franczak Priscila Ferraz, 2014, THESIS CCT UDESC JOI, P120
   Gbureck U, 2003, BIOMATERIALS, V24, P4123, DOI 10.1016/S0142-9612(03)00283-7
   Godinho J.M, 2008, THESIS U SAO CARLOS, P84
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Levandowski-Jr N., 2014, THESIS CCT UDESC JOI, P153
   Mitri L.F.F, 2013, THESIS U FLUMINENSE, P182
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   Rigo E. C. S., 2007, REV DENT PRESS PERIO, V1, P39
   Silva R, 2012, THESIS CURITIBA, P104
   Vieira EFS, 2014, QUIM NOVA, V37, P398, DOI 10.5935/0100-4042.20140074
   Villani Angelina, 2012, Rev. Fac. Ing. UCV, V27, P7
NR 20
TC 2
Z9 2
U1 1
U2 6
PU SOC ESPANOLA CERAMICA VIDRIO
PI MADRID
PA DESPACHO 176, INST CERAMICA VIDRIO, CSIC, C-KELSEN 5, 28049 MADRID,
   SPAIN
SN 0366-3175
EI 2173-0431
J9 BOL SOC ESP CERAM V
JI Bol. Soc. Esp. Ceram. Vidr.
PD JAN-FEB
PY 2015
VL 54
IS 1
BP 37
EP 43
DI 10.1016/j.bsecv.2015.02.006
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA CD4AA
UT WOS:000351023800005
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Kim, KJ
   Joe, YA
   Kim, MK
   Lee, SJ
   Ryu, YH
   Cho, DW
   Rhie, JW
AF Kim, Ki Joo
   Joe, Young Ae
   Kim, Min Kyoung
   Lee, Su Jin
   Ryu, Yeon Hee
   Cho, Dong-Woo
   Rhie, Jong Won
TI Silica nanoparticles increase human adipose tissue-derived stem cell
   proliferation through ERK1/2 activation
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE particle; ceramic; biomaterial; mesenchymal stem cells; ERK
ID IN-VITRO; OSTEOGENIC DIFFERENTIATION; SCAFFOLDS; CERAMICS; CALCIUM; P38;
   RESPONSES; IMPLANTS; TITANIUM; ADHESION
AB Background: Silicon dioxide composites have been found to enhance the mechanical properties of scaffolds and to support growth of human adipose tissue-derived stem cells (hADSCs) both in vitro and in vivo. Silica (silicon dioxide alone) exists as differently sized particles when suspended in culture medium, but it is not clear whether particle size influences the beneficial effect of silicon dioxide on hADSCs. In this study, we examined the effect of different sized particles on growth and mitogen-activated protein kinase signaling in hADSCs.
   Methods: Silica gel was prepared by a chemical reaction using hydrochloric acid and sodium silicate, washed, sterilized, and suspended in serum-free culture medium for 48 hours, and then sequentially filtered through a 0.22 mu m filter (filtrate containing nanoparticles smaller than 220 nm; silica NPs). hADSCs were incubated with silica NPs or 3 mu m silica microparticles (MPs), examined by transmission electron microscopy, and assayed for cell proliferation, apoptosis, and mitogen-activated protein kinase signaling.
   Results: Eighty-nine percent of the silica NPs were around 50-120 nm in size. When hADSCs were treated with the study particles, silica NPs were observed in endocytosed vacuoles in the cytosol of hADSCs, but silica MPs showed no cell entry. Silica NPs increased the proliferation of hADSCs, but silica MPs had no significant effect in this regard. Instead, silica MPs induced slight apoptosis. Silica NPs increased phosphorylation of extracellular signal-related kinase (ERK) 1/2, while silica MPs increased phosphorylation of p38. Silica NPs had no effect on phosphorylation of Janus kinase or p38. Pretreatment with PD98059, a MEK inhibitor, prevented the ERK1/2 phosphorylation and proliferation induced by silica NPs.
   Conclusion: Scaffolds containing silicon dioxide for tissue engineering may enhance cell growth through ERK1/2 activation only when NPs around 50-120 nm in size are included, and single component silica-derived NPs could be useful for bioscaffolds in stem cell therapy.
C1 [Kim, Ki Joo; Kim, Min Kyoung; Lee, Su Jin; Ryu, Yeon Hee; Rhie, Jong Won] Catholic Univ Korea, Coll Med, Dept Plast Surg, Seoul 137701, South Korea.
   [Kim, Ki Joo; Kim, Min Kyoung; Ryu, Yeon Hee; Rhie, Jong Won] Catholic Univ Korea, Coll Med, Dept Mol Biomed, Seoul 137701, South Korea.
   [Joe, Young Ae] Catholic Univ Korea, Coll Med, Inst Canc Res, Seoul 137701, South Korea.
   [Joe, Young Ae] Catholic Univ Korea, Coll Med, Dept Med Lifesci, Seoul 137701, South Korea.
   [Cho, Dong-Woo] Pohang Univ Sci & Technol, Dept Mech Engn, Gyeongbuk, South Korea.
   [Cho, Dong-Woo] Pohang Univ Sci & Technol, Dept Integrat Biosci & Bioengn, Gyeongbuk, South Korea.
RP Rhie, JW (reprint author), Catholic Univ Korea, Coll Med, Dept Plast Surg, 222 Banpo Dearo, Seoul 137701, South Korea.
EM rhie@catholic.ac.kr
RI Rhie, Jong Won/C-4652-2012
OI Rhie, Jong Won/0000-0002-9398-8059
FU Seoul R&BD Program of the Seoul Government of Korea [SS110011C0211601];
   National Research Foundation of Korea grant - Government of Korea
FX This work was supported financially by the Seoul R&BD Program of the
   Seoul Government of Korea (SS110011C0211601) and by a National Research
   Foundation of Korea grant funded by the Government of Korea.
CR Brandao SM, 2012, ORBIT, V31, P143, DOI 10.3109/01676830.2011.648798
   Chan S, 2014, ACTA HAEMATOL-BASEL, V132, P200, DOI 10.1159/000356808
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Dobrowolski R, 2012, NAT REV MOL CELL BIO, V13, P53, DOI 10.1038/nrm3244
   Domanski M, 2012, J MATER SCI-MATER M, V23, P1637, DOI 10.1007/s10856-012-4635-1
   FARMER VC, 1986, CIBA F SYMP, V121, P4
   Ho PJ, 2012, LIFE SCI, V91, P1358, DOI 10.1016/j.lfs.2012.10.007
   Jin Z, 2008, TISSUE ENG REGEN MED, V5, P869
   Kang KS, 2014, TISSUE ENG PT A, V20, P1767, DOI [10.1089/ten.tea.2013.0157, 10.1089/ten.TEA.2013.0157]
   Kim BS, 2011, AGING CELL, V10, P277, DOI 10.1111/j.1474-9726.2011.00670.x
   Kim KJ, 2010, TISSUE ENG REGEN MED, V7, P171
   Lee JH, 2012, ARCH PLAST SURG-APS, V39, P593, DOI 10.5999/aps.2012.39.6.593
   Lee JH, 2008, BIOCHEM BIOPH RES CO, V370, P456, DOI 10.1016/j.bbrc.2008.03.123
   Lu HX, 2010, J BIOMATER APPL, V25, P39, DOI 10.1177/0885328209342469
   Moura J, 2007, J BIOMED MATER RES A, V82A, P545, DOI 10.1002/jbm.a.31165
   Murphy S, 2010, J MATER SCI-MATER M, V21, P2827, DOI 10.1007/s10856-010-4139-9
   Oh N, 2014, INT J NANOMED, V9, P51, DOI 10.2147/IJN.S26592
   Payne KA, 2010, TISSUE ENG PT A, V16, P3647, DOI [10.1089/ten.tea.2009.0738, 10.1089/ten.TEA.2009.0738]
   Puckett S, 2008, INT J NANOMED, V3, P229
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Sarina, 2013, BRAIN RES, V1490, P61, DOI 10.1016/j.brainres.2012.10.059
   Schubert R, 2009, J IMMUNOL METHODS, V350, P200, DOI 10.1016/j.jim.2009.08.015
   Shi XT, 2009, BIOMATERIALS, V30, P3996, DOI 10.1016/j.biomaterials.2009.04.021
   Shie MY, 2012, INT ENDOD J, V45, P337, DOI 10.1111/j.1365-2591.2011.01981.x
   Sommerfeld J, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0055-5
   Sun JY, 2009, BIOMED PHARMACOTHER, V63, P650, DOI 10.1016/j.biopha.2009.01.007
   Tan F, 2011, BIOTECHNOL BIOENG, V108, P454, DOI 10.1002/bit.22955
   Thanyaphoo S, 2012, J PHARM SCI-US, V101, P2870, DOI 10.1002/jps.23230
   Wang C, 2013, BIOMATERIALS, V34, P64, DOI 10.1016/j.biomaterials.2012.09.021
   Webster TJ, 2012, ACTA BIOMATER, V8, P4447, DOI 10.1016/j.actbio.2012.07.038
   Widenmaier SB, 2009, J BIOL CHEM, V284, P30372, DOI 10.1074/jbc.M109.060178
   Wiens M, 2010, CALCIFIED TISSUE INT, V87, P513, DOI 10.1007/s00223-010-9408-6
   Wu CT, 2005, BIOMATERIALS, V26, P2925, DOI 10.1016/j.biomaterials.2004.09.019
   Xia LG, 2014, BIOMATERIALS, V35, P8514, DOI 10.1016/j.biomaterials.2014.06.028
   Xu CX, 2011, BIOMATERIALS, V32, P1051, DOI 10.1016/j.biomaterials.2010.09.068
   Yang JJ, 2012, CELL BIOCHEM FUNCT, V30, P505, DOI 10.1002/cbf.2829
   Yun HS, 2011, INT J NANOMED, V6, P2521, DOI 10.2147/IJN.S25647
   Zhang ML, 2012, J BIOMED MATER RES A, V100A, P2979, DOI 10.1002/jbm.a.34246
   Zhou HJ, 2010, J MATER SCI-MATER M, V21, P2175, DOI 10.1007/s10856-010-4083-8
   Zou S, 2009, J BIOMED MATER RES B, V90B, P123, DOI 10.1002/jbm.b.31262
NR 40
TC 23
Z9 23
U1 1
U2 22
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2015
VL 10
BP 2261
EP 2272
DI 10.2147/IJN.S71925
PG 12
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA CD9RX
UT WOS:000351437000001
PM 25848249
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Sun, BB
   Li, J
   Liu, W
   Aqeel, BM
   El-Hamshary, H
   Al-Deyab, SS
   Mo, XM
AF Sun, Binbin
   Li, Jun
   Liu, Wei
   Aqeel, Bhutto M.
   El-Hamshary, Hany
   Al-Deyab, Salem S.
   Mo, Xiumei
TI Fabrication and characterization of mineralized P(LLA-CL)/SF
   three-dimensional nanoyarn scaffolds
SO IRANIAN POLYMER JOURNAL
LA English
DT Article
DE Nanoyarns; P(LLA-CL)/SF; Dynamic liquid support electrospinning;
   Biomineralization
ID MESENCHYMAL STEM-CELLS; REGENERATED SILK FIBROIN; SIMULATED BODY-FLUID;
   BIOMIMETIC MINERALIZATION; NANOFIBROUS SCAFFOLDS; APATITE FORMATION;
   IN-VITRO; TISSUE; SURFACE; BIOMATERIAL
AB Particular attention has been given to three-dimensional scaffolds for bone tissue regeneration. In this study, poly(L-lactic acid-co-epsilon-caprolactone) (P(LLA-CL) nanoyarn scaffold and poly(L-lactic acid-co-caprolactone)/silk fibroin (P(LLA-CL)/SF) nanoyarn scaffold were fabricated by a dynamic liquid support electrospinning system; and then the three-dimensional (3D) nanoyarn scaffolds were prepared by freeze-drying processes. The results indicated the average diameter of P(LLA-CL) and P(LLA-CL)/SF nanoyarns were 29.44 +/- 3.47 mu m and 11.59 +/- 0.46 mu m, respectively. The yarn in the nanoyarn scaffold was twisted by many nanofibers as evidenced by scanning electron microscope (SEM) result. These nanoyarn scaffolds were biomineralized by alternatively immersing the nanoyarn scaffolds into phosphoric acid and calcium ion solutions. After biomineralization, the existence of hydroxyapatite (HA) particles on the scaffolds was confirmed using fourier transform infrared spectroscopy (FTIR) and X-ray diffraction (XRD) analysis. In vitro study of cell proliferation was found to be higher on P(LLA-CL)/SF scaffold as compared to P(LLA-CL) scaffold after culturing for 14 days. H&E staining results showed that cells not only attached to the surface of 3D scaffold but also infiltrated into the scaffold. This study indicated that the electrospun P(LLA-CL)/SF scaffold with nanostructure morphology could improve cell adhesion and proliferation and electrospun P(LLA-CL)/SF scaffold with biomineralization has a potential application for bone tissue engineering.
C1 [Sun, Binbin; Li, Jun; Liu, Wei; Aqeel, Bhutto M.; Mo, Xiumei] Donghua Univ, Coll Chem Chem Engn & Bioengn, Biomat & Tissue Engn Lab, Shanghai 201620, Peoples R China.
   [El-Hamshary, Hany; Al-Deyab, Salem S.; Mo, Xiumei] King Saud Univ, Coll Sci, Dept Chem, Riyadh 11451, Saudi Arabia.
   [El-Hamshary, Hany] Tanta Univ, Dept Chem, Fac Sci, Tanta 31527, Egypt.
RP Mo, XM (reprint author), Donghua Univ, Coll Chem Chem Engn & Bioengn, Biomat & Tissue Engn Lab, Rm 4088 4 Coll Bldg, Shanghai 201620, Peoples R China.
EM med@dhu.edu.cn
RI mo, xiumei/C-9340-2013; EL-HAMSHARY, HANY/C-1473-2010
OI EL-HAMSHARY, HANY/0000-0001-6805-7255
FU State Key Laboratory of Bioreactor Engineering, Science and Technology
   Commission of Shanghai Municipality Program [11nm0506200]; National
   Nature Science Foundation of China [31470941, 31271035]; Deanship of
   Scientific Research at King Saud University [RGP-201]
FX This research was supported by Open Funding Project of the State Key
   Laboratory of Bioreactor Engineering, Science and Technology Commission
   of Shanghai Municipality Program (11nm0506200), National Nature Science
   Foundation of China (Project No. 31470941, 31271035), Deanship of
   Scientific Research at King Saud University research group project no.
   RGP-201.
CR Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Calvert P, 1996, CHEM MATER, V8, P1715, DOI 10.1021/cm960126o
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Fan HB, 2009, BIOMATERIALS, V30, P4967, DOI 10.1016/j.biomaterials.2009.05.048
   Fang ZD, 2011, APPL SURF SCI, V257, P4133, DOI 10.1016/j.apsusc.2010.12.011
   Helsen J.A., 1998, METALS BIOMATERIALS
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Kawashita M, 2003, BIOMATERIALS, V24, P2477, DOI 10.1016/S0142-9612(03)00050-4
   Kim SI, 2013, APPL SURF SCI, V276, P586, DOI 10.1016/j.apsusc.2013.03.137
   Kuo Catherine K, 2010, Sports Med Arthrosc Rehabil Ther Technol, V2, P20, DOI 10.1186/1758-2555-2-20
   Liu HF, 2008, BIOMATERIALS, V29, P1443, DOI 10.1016/j.biomaterials.2007.11.023
   Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035
   Mavis B, 2009, ACTA BIOMATER, V5, P3098, DOI 10.1016/j.actbio.2009.04.037
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Min BM, 2006, MACROMOL BIOSCI, V6, P285, DOI 10.1002/mabi.200500246
   Muthumanickkam A, 2013, IRAN POLYM J, V22, P143, DOI 10.1007/s13726-012-0113-3
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   Sabir MI, 2009, J MATER SCI, V44, P5713, DOI 10.1007/s10853-009-3770-7
   Sato K, 2000, J BIOMED MATER RES, V50, P16, DOI 10.1002/(SICI)1097-4636(200004)50:1<16::AID-JBM3>3.0.CO;2-G
   Takeuchi A, 2003, J BIOMED MATER RES A, V65A, P283, DOI 10.1002/jbm.a.10456
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Teo WE, 2011, ACTA BIOMATER, V7, P193, DOI 10.1016/j.actbio.2010.07.041
   Teo WE, 2007, POLYMER, V48, P3400, DOI 10.1016/j.polymer.2007.04.044
   Thorvaldsson A, 2008, BIOMACROMOLECULES, V9, P1044, DOI 10.1021/bm701225a
   Tzezana R, 2008, TISSUE ENG PART C-ME, V14, P281, DOI 10.1089/ten.tec.2008.0201
   Vaquette C, 2010, J BIOMED MATER RES A, V94A, P1270, DOI 10.1002/jbm.a.32801
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wu JL, 2012, MATER LETT, V89, P146, DOI 10.1016/j.matlet.2012.08.141
   Xu AW, 2007, J MATER CHEM, V17, P415, DOI 10.1039/b611918m
   Xu Y, 2013, TISSUE ENG PART C-ME, V19, P925, DOI [10.1089/ten.tec.2012.0328, 10.1089/ten.TEC.2012.0328]
   Yin AL, 2013, J BIOMED MATER RES A, V101, P1292, DOI 10.1002/jbm.a.34434
   Zhang KH, 2010, J BIOMED MATER RES A, V95A, P870, DOI 10.1002/jbm.a.32895
   Zhang KH, 2010, J BIOMED MATER RES A, V93A, P984, DOI 10.1002/jbm.a.32504
   Zheng L, 2013, IRAN POLYM J, V22, P833, DOI 10.1007/s13726-013-0182-y
   Zhou P, 2001, J PHYS CHEM B, V105, P12469, DOI 10.1021/jp0125395
NR 41
TC 4
Z9 4
U1 2
U2 72
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1026-1265
EI 1735-5265
J9 IRAN POLYM J
JI Iran. Polym. J.
PD JAN
PY 2015
VL 24
IS 1
BP 29
EP 40
DI 10.1007/s13726-014-0297-9
PG 12
WC Polymer Science
SC Polymer Science
GA CE1IK
UT WOS:000351565100004
DA 2018-10-19
ER

PT J
AU Pawar, AP
   Munde, PL
   Bothiraja, C
   Kuchekar, AB
AF Pawar, A. P.
   Munde, P. L.
   Bothiraja, C.
   Kuchekar, A. B.
TI Development of ranolazine loaded floating biomaterial gellan beads using
   Box-Behnken factorial design
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Ranolazine; Floating gellan beads; Ionotropic gelation; Box-Behnken
   factorial design; Controlled release; Non-everted rat stomach sac model
ID IN-VITRO EVALUATION; DRUG-DELIVERY SYSTEM; CONTROLLED-RELEASE; GELATION
   METHOD; FORMULATION; AMOXICILLIN; OPTIMIZATION; EFFICIENCY; ACID
AB The present work aimed at development of ranolazine loaded floating biomaterial gellan beads to enhance its site specific absorption. The beads obtained by ionotropic gelation method using sodium bicarbonate as gas-forming agent, calcium chloride and chitosan as a crosslinker were evaluated for physicochemical properties and in vitro performance. Yield and entrapment efficiency varied from 90 to 97% and 58 to 81% respectively. Surface topography revealed spherical microparticles with evenly distributed pores. Differential scanning calorimetry and powder X-ray diffraction pointed out amorphous nature of the drug. Effect of formulation variables on floating lag time and time required for 50% drug release was studied using Box-Behnken factorial design. The beads displayed good in vitro floatability in 0.1 N HCl with initial burst release followed by a controlled release up to 10 h whereas slow drug release was observed in phosphate buffer pH 6.8; probably due to decreased drug solubility and accelerated internal gelation through ionic crosslinking of gellan monomers. The beads, when studied in non-everted rat stomach and intestinal sac models, demonstrated twofold decrease in flux and apparent permeability coefficient as compared to pure ranolazine. Floating gellan beads proved advantageous for controlling the release and enhancing therapeutic activity of ranolazine.
C1 [Pawar, A. P.; Munde, P. L.; Bothiraja, C.; Kuchekar, A. B.] Bharati Vidyapeeth Univ, Poona Coll Pharm, Dept Pharmaceut, Pune 411038, Maharashtra, India.
RP Pawar, AP (reprint author), Bharati Vidyapeeth Univ, Poona Coll Pharm, Dept Pharmaceut, Pune 411038, Maharashtra, India.
EM p_atmaram@rediffmail.com
RI Deemed University, Bharati Vidyapeeth/A-6025-2016
CR Agnihotri SA, 2006, EUR J PHARM BIOPHARM, V63, P249, DOI 10.1016/j.ejpb.12.008
   Angadi SC, 2012, INT J BIOL MACROMOL, V51, P45, DOI 10.1016/j.ijbiomac.2012.04.018
   Arora A., 2005, AAPS PHARMSCITECH, V6, P372
   Babu R. Jayachandra, 2010, Current Drug Delivery, V7, P36
   Bhardwaj T, 2000, DRUG DEV IND PHARM, V26, P1025, DOI 10.1081/DDC-100100266
   Bothiraja C, 2012, NANOSCI NANOTECH LET, V4, P445, DOI 10.1166/nnl.2012.1337
   Bothiraja C, 2012, J PHARMACOL TOX MET, V66, P35, DOI 10.1016/j.vascn.2012.05.007
   Choi BY, 2002, INT J PHARM, V239, P81, DOI 10.1016/S0378-5173(02)00054-6
   Depan D, 2011, MAT SCI ENG C-MATER, V31, P1305, DOI 10.1016/j.msec.2011.04.010
   Depan D, 2011, ACTA BIOMATER, V7, P2163, DOI 10.1016/j.actbio.2011.01.029
   Jerling M, 2006, CLIN PHARMACOKINET, V45, P469, DOI 10.2165/00003088-200645050-00003
   Maiti S, 2011, CARBOHYD POLYM, V85, P164, DOI 10.1016/j.carbpol.2011.02.010
   Malakar J, 2012, INT J BIOL MACROMOL, V50, P138, DOI 10.1016/j.ijbiomac.2011.10.001
   Mao R, 2000, CARBOHYD POLYM, V41, P331, DOI 10.1016/S0144-8617(99)00108-3
   Miyazaki S, 2001, INT J PHARM, V220, P161, DOI 10.1016/S0378-5173(01)00669-X
   Munish A., 2010, CARBOHYD POLYM, V80, P161
   Murthy TEGK, 2011, ASIAN J PHARM, V5, P162, DOI 10.4103/0973-8398.91992
   Narkar M, 2010, AAPS PHARMSCITECH, V11, P267, DOI 10.1208/s12249-010-9384-1
   Nayak AK, 2013, INT J BIOL MACROMOL, V54, P144, DOI 10.1016/j.ijbiomac.2012.12.008
   Nayak AK, 2011, INT J BIOL MACROMOL, V49, P784, DOI 10.1016/j.ijbiomac.2011.07.013
   Patil S, 2006, DRUG DEV IND PHARM, V32, P315, DOI 10.1080/03639040500518930
   Pawar AP, 2012, J MICROENCAPSUL, V29, P409, DOI 10.3109/02652048.2012.655330
   Rajinikanth Parauvathanahalli Siddalingam, 2007, Acta Pharmaceutica (Zagreb), V57, P413, DOI 10.2478/v10007-007-0033-5
   Sanju Dhawan, 2004, AAPS PHARMSCITECH, V5, P1
   Sato Y, 2004, EUR J PHARM BIOPHARM, V57, P235, DOI 10.1016/s0939-6411(03)00185-1
   Sharma S, 2006, INT J PHARM, V313, P150, DOI 10.1016/j.ijpharm.2006.02.001
   Shradha S. B., 2007, EUR J PHARM BIOPHARM, V65, P85
   Singh BN, 2000, J CONTROL RELEASE, V63, P235, DOI 10.1016/S0168-3659(99)00204-7
   Sossalla S, 2012, PHARMACOL THERAPEUT, V133, P311, DOI 10.1016/j.pharmthera.2011.11.003
   Tripathi G, 2010, DARU, V18, P247
   Wang Q, 2010, INT J BIOL MACROMOL, V46, P356, DOI 10.1016/j.ijbiomac.2010.01.009
   Whitehead L, 2000, INT J PHARM, V210, P45, DOI 10.1016/S0378-5173(00)00567-6
NR 32
TC 1
Z9 1
U1 0
U2 3
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD JAN
PY 2015
VL 30
IS 1
BP 33
EP 42
DI 10.1179/1753555714Y.0000000199
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA CD5JJ
UT WOS:000351123600007
DA 2018-10-19
ER

PT J
AU Hou, XF
   Chen, Y
   Liu, Y
AF Hou, Xiao-Fang
   Chen, Yong
   Liu, Yu
TI Enzyme-responsive protein/polysaccharide supramolecular nanoparticles
SO SOFT MATTER
LA English
DT Article
ID DRUG-DELIVERY; ORGANIC FRAMEWORK; BUILDING-BLOCKS; WATER; VESICLES;
   POLYMERIZATION; COMPLEXATION; POLYMERS; SYSTEMS; HYDROGELS
AB Biocompatible and enzyme-responsive supramolecular assemblies have attracted more and more interest in biomaterial fields, and find many feasible applications especially in the controlled drug release at specific sites where the target enzyme is located. In this work, novel supramolecular nanoparticles were successfully constructed from two biocompatible materials, i.e. a cyclic polysaccharide named sulfato-beta-cyclodextrin (SCD) and a protein named protamine, through non-covalent association, and fully characterized by means of atomic force microscopy (AFM) and high-resolution transmission electron microscopy (TEM). Significantly, the disassembly of the resulting nanoparticles can respond especially to trypsin over other enzymes. Owing to their trypsin-triggered disassembly behaviors, these nanoparticles can efficiently release the encapsulated model substrate in a controlled manner. That is, the model substrate can be encapsulated inside the nanoparticles with a high stability and released when treated with trypsin.
C1 [Hou, Xiao-Fang; Chen, Yong; Liu, Yu] Nankai Univ, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Dept Chem, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China.
RP Liu, Y (reprint author), Nankai Univ, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Dept Chem, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China.
EM yuliu@nankai.edu.cn
RI LIU, Yu/C-3197-2012
FU 973 Program [2011CB932502]; NSFC [91227107, 21432004, 21272125]
FX We thank the 973 Program (2011CB932502) and NSFC (91227107, 21432004,
   and 21272125) for financial support.
CR Almutairi A, 2008, J AM CHEM SOC, V130, P444, DOI 10.1021/ja078147e
   Appel EA, 2012, J AM CHEM SOC, V134, P11767, DOI 10.1021/ja3044568
   Assaf KI, 2015, CHEM SOC REV, V44, P394, DOI 10.1039/c4cs00273c
   Cao Y, 2014, J AM CHEM SOC, V136, P10762, DOI 10.1021/ja505344t
   Chen Y, 2010, CHEM SOC REV, V39, P495, DOI 10.1039/b816354p
   Chen Y, 2010, CHEM COMMUN, V46, P5622, DOI 10.1039/c0cc00690d
   Du JZ, 2005, J AM CHEM SOC, V127, P17982, DOI 10.1021/ja056514l
   Duan QP, 2013, J AM CHEM SOC, V135, P10542, DOI 10.1021/ja405014r
   Guo DS, 2012, CHEM SOC REV, V41, P5907, DOI 10.1039/c2cs35075k
   Guo DS, 2012, J AM CHEM SOC, V134, P10244, DOI 10.1021/ja303280r
   Harada A, 2009, CHEM SOC REV, V38, P875, DOI 10.1039/b705458k
   Hu JM, 2012, CHEM SOC REV, V41, P5933, DOI 10.1039/c2cs35103j
   Huang ZH, 2014, ANGEW CHEM INT EDIT, V53, P5351, DOI 10.1002/anie.201402817
   Jiao DZ, 2010, J AM CHEM SOC, V132, P15734, DOI 10.1021/ja106716j
   Kamaly N, 2012, CHEM SOC REV, V41, P2971, DOI 10.1039/c2cs15344k
   Kim K, 2007, CHEM SOC REV, V36, P267, DOI 10.1039/b603088m
   Kiser PF, 1998, NATURE, V394, P459
   Kumpfer JR, 2011, J AM CHEM SOC, V133, P12866, DOI 10.1021/ja205332w
   Lee TC, 2013, NAT CHEM, V5, P376, DOI 10.1038/nchem.1618
   Liu YL, 2011, CHEM-EUR J, V17, P9930, DOI 10.1002/chem.201101611
   Peng S, 2015, SOFT MATTER, V11, P290, DOI 10.1039/c4sm02170c
   Qin ZB, 2014, SOFT MATTER, V10, P2253, DOI 10.1039/c3sm52866a
   Randolph LM, 2012, CHEM SCI, V3, P1363, DOI [10.1039/c2sc00857b, 10.1039/C2SC00857B]
   Rekharsky MV, 1998, CHEM REV, V98, P1875, DOI 10.1021/cr970015o
   Reynolds F, 2005, BIOCONJUGATE CHEM, V16, P1240, DOI 10.1021/bc0501451
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   Tan LL, 2014, ADV MATER, V26, P7027, DOI 10.1002/adma.201401672
   Tan XX, 2015, POLYM CHEM-UK, V6, P681, DOI 10.1039/c4py01440e
   Tian J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6574
   Uekama K, 1998, CHEM REV, V98, P2045, DOI 10.1021/cr970025p
   van Hest JCM, 2009, NATURE, V461, P45, DOI 10.1038/461045a
   Vriezema DM, 2005, CHEM REV, V105, P1445, DOI 10.1021/cr0300688
   Wang C, 2012, ACCOUNTS CHEM RES, V45, P608, DOI 10.1021/ar200226d
   Wang K, 2016, CHEM-EUR J, V22, P1475, DOI 10.1002/chem.201303963
   Wang Y, 2009, ADV MATER, V21, P2849, DOI 10.1002/adma.200803276
   Yang YW, 2014, ACCOUNTS CHEM RES, V47, P1950, DOI 10.1021/ar500022f
   Yu GC, 2012, J AM CHEM SOC, V134, P19489, DOI 10.1021/ja3099905
   Zhang KD, 2013, J AM CHEM SOC, V135, P17913, DOI 10.1021/ja4086935
   Zhang X, 2011, CHEM SOC REV, V40, P94, DOI 10.1039/b919678c
   Zhang X, 2009, NAT CHEM, V1, P623, DOI [10.1038/NCHEM.368, 10.1038/nchem.368]
   Zhou CC, 2014, LANGMUIR, V30, P3381, DOI 10.1021/la500010p
   Zhou CC, 2013, LANGMUIR, V29, P13175, DOI 10.1021/la403257v
NR 42
TC 21
Z9 22
U1 5
U2 40
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2015
VL 11
IS 12
BP 2488
EP 2493
DI 10.1039/c4sm02896a
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA CD9DC
UT WOS:000351396500018
PM 25679755
DA 2018-10-19
ER

PT J
AU Munro, NH
   McGrath, KM
AF Munro, Natasha H.
   McGrath, Kathryn M.
TI Advances in techniques and technologies for bone implants
SO BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS
LA English
DT Article
DE biomaterial; bone; tissue engineering
ID TISSUE ENGINEERING SCAFFOLDS; CALCIUM-PHOSPHATE COATINGS;
   MECHANICAL-PROPERTIES; MAGNESIUM ALLOYS; HYDROXYAPATITE; COLLAGEN;
   CHITOSAN; BIOMATERIALS; FABRICATION; DEFECTS
AB Materials which can augment and repair the function of damaged bone are required. Metals, ceramics and plastics have been widely used as artificial bone implants, although their material properties are not optimally matched to those of the native bone tissue. New materials, and methods of production, are being extensively investigated to overcome the limitations of the current implants. In this review, we give an oversight into the current materials used and their limitations followed by an analysis of the new types of materials and techniques which are under development. The groups of materials covered specifically include new metals and metal alloys which are potentially more biocompatible, porous metal foams which mimic the structure of spongy bone and advanced composites which incorporate the properties of multiple materials within one implant. The use of additive manufacturing techniques is also discussed as these techniques allow for the tailoring of the physical properties of the implant and the production of customisable implants.
C1 [Munro, Natasha H.; McGrath, Kathryn M.] Victoria Univ Wellington, Sch Chem & Phys Sci, Wellington, New Zealand.
   [Munro, Natasha H.; McGrath, Kathryn M.] MacDiarmid Inst Adv Mat & Nanotechnol, Wellington, New Zealand.
RP McGrath, KM (reprint author), Victoria Univ Wellington, Sch Chem & Phys Sci, Wellington, New Zealand.
EM kathryn.mcgrath@vuw.ac.nz
OI McGrath, Kathryn/0000-0003-3531-0562
CR Aboudzadeh N, 2010, J BIOMED MATER RES A, V94A, P137, DOI 10.1002/jbm.a.32673
   Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Ang TH, 2002, MAT SCI ENG C-BIO S, V20, P35, DOI 10.1016/S0928-4931(02)00010-3
   Billiet T, 2012, BIOMATERIALS, V33, P6020, DOI 10.1016/j.biomaterials.2012.04.050
   Bobbio A, 1972, Bull Hist Dent, V20, P1
   Bohner M, 2005, BIOMATERIALS, V26, P6099, DOI 10.1016/j.biomaterials.2005.03.026
   Bugbee WD, 1997, J BONE JOINT SURG AM, V79A, P1007, DOI 10.2106/00004623-199707000-00006
   Butscher A, 2011, ACTA BIOMATER, V7, P907, DOI 10.1016/j.actbio.2010.09.039
   Cai X, 2009, ACTA BIOMATER, V5, P2693, DOI 10.1016/j.actbio.2009.03.005
   Chua CK, 2004, J MATER SCI-MATER M, V15, P1113, DOI 10.1023/B:JMSM.0000046393.81449.a5
   Clarke SA, 2011, BIOTECHNOL ADV, V29, P610, DOI 10.1016/j.biotechadv.2011.04.003
   Cypher T J, 1996, J Foot Ankle Surg, V35, P413
   Dalby MJ, 2001, BIOMATERIALS, V22, P1739, DOI 10.1016/S0142-9612(00)00334-3
   DAMIEN CJ, 1994, CALCIFIED TISSUE INT, V55, P151, DOI 10.1007/BF00297191
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   Fielding GA, 2012, DENT MATER, V28, P113, DOI 10.1016/j.dental.2011.09.010
   Fu Q, 2011, MAT SCI ENG C-MATER, V31, P1245, DOI 10.1016/j.msec.2011.04.022
   Gagg G, 2013, MAT SCI ENG C-MATER, V33, P3858, DOI 10.1016/j.msec.2013.05.021
   Gao TJ, 1997, BIOMATERIALS, V18, P219, DOI 10.1016/S0142-9612(96)00133-0
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Goyenvalle E, 2006, BIOMATERIALS, V27, P1119, DOI 10.1016/j.biomaterials.2005.07.039
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Habibovic P, 2008, BIOMATERIALS, V29, P944, DOI 10.1016/j.biomaterials.2007.10.023
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Huang Z, 2011, CARBOHYD POLYM, V85, P261, DOI 10.1016/j.carbpol.2011.02.029
   Huang Z, 2011, MAT SCI ENG C-MATER, V31, P683, DOI 10.1016/j.msec.2010.12.014
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Klammert U, 2010, J CRANIO MAXILL SURG, V38, P565, DOI 10.1016/j.jcms.2010.01.009
   Kretlow JD, 2007, TISSUE ENG, V13, P927, DOI 10.1089/ten.2006.0394
   Lam CXF, 2002, MAT SCI ENG C-BIO S, V20, P49, DOI 10.1016/S0928-4931(02)00012-7
   Li JP, 2006, BIOMATERIALS, V27, P1223, DOI 10.1016/j.biomaterials.2005.08.033
   Li JJ, 2011, CARBOHYD POLYM, V85, P885, DOI 10.1016/j.carbpol.2011.04.015
   Li XM, 2013, J BIOMED MATER RES A, V101, P2424, DOI 10.1002/jbm.a.34539
   Li XM, 2006, BIOMATERIALS, V27, P1917, DOI 10.1016/j.biomaterials.2005.11.013
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   LUCAS LC, 1993, COLLOID SURFACE A, V77, P141, DOI 10.1016/0927-7757(93)80110-Z
   Ma J, 2012, CERAM INT, V38, P6677, DOI 10.1016/j.ceramint.2012.05.056
   Maleksaeedi S, 2013, PROC CIRP, V5, P158, DOI 10.1016/j.procir.2013.01.032
   Mangano F, 2013, IMPLANT DENT, V22, P388, DOI 10.1097/ID.0b013e31829afa9d
   National Cancer Institute, 2013, SEER TRAIN MOD AN PH
   Ni M, 2003, BIOMATERIALS, V24, P4323, DOI 10.1016/S0142-9612(03)00236-9
   Nijhuis AWG, 2010, MACROMOL BIOSCI, V10, P1316, DOI 10.1002/mabi.201000142
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Poukens J., 2010, DIGITAL DENT NEWS, V4, P30
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Rojaee R., 2013, ADV BIOMECHANICAL SY, V40, P25, DOI [10.1007/978-3-319-00479-2_3, DOI 10.1007/978-3-319-00479-2_3]
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Schoof H, 2001, J BIOMED MATER RES, V58, P352, DOI 10.1002/jbm.1028
   Seidi A, 2011, ACTA BIOMATER, V7, P1441, DOI 10.1016/j.actbio.2011.01.011
   SERRE CM, 1993, BIOMATERIALS, V14, P97, DOI 10.1016/0142-9612(93)90217-P
   Seyedraoufi ZS, 2013, J MECH BEHAV BIOMED, V21, P1, DOI 10.1016/j.jmbbm.2013.01.023
   Shadanbaz S, 2012, ACTA BIOMATER, V8, P20, DOI 10.1016/j.actbio.2011.10.016
   Song SJ, 2011, ARTIF ORGANS, V35, P1132, DOI 10.1111/j.1525-1594.2011.01377.x
   Staiger MP, 2010, MATER LETT, V64, P2572, DOI 10.1016/j.matlet.2010.08.049
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Stoodley MA, 1996, J CLIN NEUROSCI, V3, P149, DOI 10.1016/S0967-5868(96)90009-0
   Tan KH, 2003, BIOMATERIALS, V24, P3115, DOI 10.1016/S0142-9612(03)00131-5
   Tarafder S, 2013, J TISSUE ENG REGEN M, V7, P631, DOI 10.1002/term.555
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   WANG RZ, 1995, J MATER SCI LETT, V14, P490, DOI 10.1007/BF00665911
   Waterman J, 2011, MATER SCI ENG B-ADV, V176, P1756, DOI 10.1016/j.mseb.2011.06.021
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Wong KV, 2012, ISRN MECH ENG, V2012, DOI DOI 10.5402/2012/208760
   Yu CC, 2013, MATER LETT, V93, P133, DOI 10.1016/j.matlet.2012.11.040
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
   Zhou WY, 2008, J MATER SCI-MATER M, V19, P2535, DOI 10.1007/s10856-007-3089-3
NR 72
TC 0
Z9 0
U1 3
U2 59
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2045-9858
EI 2045-9866
J9 BIOINSPIR BIOMIM NAN
JI Bioinspired Biomim. Nanobiomat.
PY 2015
VL 4
IS 1
BP 26
EP 36
DI 10.1680/bbn.14.00015
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CD1XI
UT WOS:000350867400004
DA 2018-10-19
ER

PT J
AU Cox, SC
   Walton, RI
   Mallick, KK
AF Cox, Sophie C.
   Walton, Richard I.
   Mallick, Kajal K.
TI Comparison of techniques for the synthesis of hydroxyapatite
SO BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS
LA English
DT Article
DE bioinorganic; biomaterial; bone; material chemistry; material properties
ID BIOCERAMIC CALCIUM PHOSPHATES; HYDROTHERMAL SYNTHESIS; COMBUSTION
   SYNTHESIS; PRECIPITATION; EMULSION; MICROEMULSION; TEMPERATURE;
   MORPHOLOGY; SCAFFOLDS; CHEMISTRY
AB Hydroxyapatite (HA) is a widely researched calcium phosphate biomaterial that is used primarily in bone replacement due to its chemical similarity to bone mineral. Many synthesis methods have been reported for the production of stoichiometric HA; however, processing parameters vary widely for each technique. Herein, the authors present a comparison of nanosized HA produced by aqueous precipitation, solvothermal synthesis and two self-propagating combustion synthesis (SPCS) methods using urea or citric acid combined with nitric acid. Powders were characterised via scanning electron microscopy, transmission electron microscopy and thermogravimetric analysis, which enabled subtle compositional differences identified via powder X-ray diffraction to be clearly distinguished. Phase transformation of ` HA' prepared by aqueous precipitation to beta-tricalcium phosphate and HA above 600 degrees C revealed as-synthesised samples were in fact calcium-deficient HA. Mixed-phase particles formed spontaneously from solution via SPCS were shown to exhibit a larger average particle size (5.8-11.4 mu m) and degree of agglomeration compared with aqueous precipitation (0.6 mu m) and solvothermal (2 mu m) samples. Ultimately, such physicochemical variations could significantly influence key properties such as solubility, bioactivity and potentially also biocompatibility. This paper provides evidence that the selection of a synthesis method and conditions to produce HA cannot be deemed as a trivial process.
C1 [Cox, Sophie C.; Mallick, Kajal K.] Univ Warwick, Warwick Mfg Grp, Coventry CV4 7AL, W Midlands, England.
   [Walton, Richard I.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.
RP Walton, RI (reprint author), Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.
EM R.I.Walton@warwick.ac.uk
RI Walton, Richard/C-2058-2009
OI Walton, Richard/0000-0001-9706-2774
FU Warwick Chancellor's Scholarship; Institute of Advanced Study at the
   University of Warwick
FX The authors would like to acknowledge Reza J. Kashtiban for his
   assistance with TEM imaging. The Warwick Chancellor's Scholarship and
   the Institute of Advanced Study at the University of Warwick are
   gratefully acknowledged for financially supporting this work.
CR [Anonymous], REL 2000 POWD DIFFR
   [Anonymous], EV DIFFRACPLUS BASIC
   Bezzi G, 2003, MATER CHEM PHYS, V78, P816, DOI 10.1016/S0254-0584(02)00392-9
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   Bohner M, 2000, INJURY, V31, pS37
   Bouyer E, 2000, J MATER SCI-MATER M, V11, P523, DOI 10.1023/A:1008918110156
   Cazalbou S, 2004, J MATER CHEM, V14, P2148, DOI 10.1039/b401318b
   Chaudhry AA, 2006, CHEM COMMUN, P2286, DOI 10.1039/b518102j
   Cox S. C., 2013, J MATER SCI-MATER M, V1, P1
   Cox SC, 2014, MAT SCI ENG C-MATER, V35, P106, DOI 10.1016/j.msec.2013.10.015
   Cunniffe GM, 2010, J BIOMED MATER RES A, V95A, P1142, DOI 10.1002/jbm.a.32931
   Drouet C, 2013, BIO MED RES INT, V2013, DOI [10.1155/2013/490946, DOI 10.1155/2013/490946]
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Guo XY, 2007, J BIOMED MATER RES A, V82A, P1022, DOI 10.1002/jbm.a.31200
   Hing KA, 2004, PHILOS T R SOC A, V362, P2821, DOI 10.1098/rsta.2004.1466
   Kothapalli C, 2004, ACTA MATER, V52, P5655, DOI 10.1016/j.actamat.2004.08.027
   Koumoulidis GC, 2003, J COLLOID INTERF SCI, V259, P254, DOI 10.1016/S0021-9797(02)00233-3
   Lester E, 2013, CRYSTENGCOMM, V15, P3256, DOI 10.1039/c3ce26798a
   Leukers B, 2005, J MATER SCI-MATER M, V16, P1121, DOI 10.1007/s10856-005-4716-5
   Liao CJ, 1999, BIOMATERIALS, V20, P1807, DOI 10.1016/S0142-9612(99)00076-9
   Lim GK, 1997, BIOMATERIALS, V18, P1433, DOI 10.1016/S0142-9612(97)00081-1
   Liu CS, 2001, BIOMATERIALS, V22, P301, DOI 10.1016/S0142-9612(00)00166-6
   Liu DM, 2001, BIOMATERIALS, V22, P1721, DOI 10.1016/S0142-9612(00)00332-X
   Ma MG, 2009, EUR J INORG CHEM, P5522, DOI 10.1002/ejic.200900839
   Niu JL, 2007, KEY ENG MAT, V330-332, P247, DOI 10.4028/www.scientific.net/KEM.330-332.247
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   OSAKA A, 1991, J MATER SCI-MATER M, V2, P51, DOI 10.1007/BF00701687
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Pramanik S, 2007, CERAM INT, V33, P419, DOI 10.1016/j.ceramint.2005.10.025
   Rao RR, 2002, MAT SCI ENG C-BIO S, V20, P187
   Sasikumar S, 2008, CERAM INT, V34, P1373, DOI 10.1016/j.ceramint.2007.03.009
   Sasikumar S, 2010, J MATER SCI TECHNOL, V26, P1114, DOI 10.1016/S1005-0302(11)60010-8
   Tas AC, 2000, J EUR CERAM SOC, V20, P2389, DOI 10.1016/S0955-2219(00)00129-1
   Wang PP, 2010, POWDER TECHNOL, V203, P315, DOI 10.1016/j.powtec.2010.05.023
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Weng WJ, 2002, MATER CHEM PHYS, V74, P92, DOI 10.1016/S0254-0584(01)00399-6
   Yang C, 2008, J COLLOID INTERF SCI, V328, P203, DOI 10.1016/j.jcis.2008.09.010
   Yang JH, 2011, J BIOMED MATER RES B, V99B, P150, DOI 10.1002/jbm.b.31882
   Yoshimura M, 2008, J MATER SCI, V43, P2085, DOI 10.1007/s10853-007-1853-x
   Zhang HF, 2005, SOFT MATTER, V1, P107, DOI 10.1039/b502551f
   Zhang SY, 2007, AUST J CHEM, V60, P99, DOI 10.1071/CH06117
   Zhao Y, 2007, J BIOMED MATER RES B, V83B, P121, DOI 10.1002/jbm.b.30774
NR 42
TC 3
Z9 3
U1 1
U2 32
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2045-9858
EI 2045-9866
J9 BIOINSPIR BIOMIM NAN
JI Bioinspired Biomim. Nanobiomat.
PY 2015
VL 4
IS 1
BP 37
EP 47
DI 10.1680/bbn.14.00010
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CD1XI
UT WOS:000350867400005
DA 2018-10-19
ER

PT J
AU Naseri, S
   Hum, J
   Lepry, WC
   Miri, AK
   Nazhat, SN
   Boccaccini, AR
AF Naseri, Shiva
   Hum, Jasmin
   Lepry, William Cole
   Miri, Amir Kamal
   Nazhat, Showan Najdat
   Boccaccini, Aldo Roberto
TI Fabrication and characterization of zein-bioactive glass scaffolds
SO BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS
LA English
DT Article
DE bioactive glass; bioactivity; composite materials; scaffolds; zein
ID X-RAY-DIFFRACTION; MECHANICAL-PROPERTIES; COMPOSITE SCAFFOLDS;
   DELIVERY-SYSTEM; FILMS; BIOCOMPATIBILITY; BIOGLASS; PROTEIN;
   MINERALIZATION; MICROSPHERES
AB Plant proteins show advantages over animal-based proteins for biomaterial applications attributable to their ease of availability and suitable biodegradability. In this study, composite foams based on zein and 45S5 bioactive glass (BG) particles were produced through salt leaching for potential applications in bone tissue engineering (BTE) applications. Different characterization techniques were used including scanning electron microscopy for morphological and microstructural analysis, ATR-FTIR spectroscopy and X-ray diffraction for composition characterization and mechanical tests. Zein-BG composite scaffolds demonstrate enhanced bioactivity with a compressive modulus and strength around 5.7 MPa and 1.9 MPa, respectively. Zein-BG composite scaffolds constitute a new bioactive material with potential applications in BTE.
C1 [Naseri, Shiva; Hum, Jasmin; Boccaccini, Aldo Roberto] Univ Erlangen Nurnberg, Inst Biomat, Erlangen, Germany.
   [Lepry, William Cole; Miri, Amir Kamal; Nazhat, Showan Najdat] McGill Univ, Dept Min & Mat Engn, Montreal, PQ, Canada.
RP Boccaccini, AR (reprint author), Univ Erlangen Nurnberg, Inst Biomat, Erlangen, Germany.
EM aldo.boccaccini@ww.uni-erlangen.de
RI Lepry, William/F-7824-2017; Boccaccini, Aldo/C-7905-2013
OI Lepry, William/0000-0002-3980-209X; 
CR Bai J, 2003, POSTHARVEST BIOL TEC, V28, P259, DOI 10.1016/S0925-5214(02)00182-5
   Birch RG, 1997, ANNU REV PLANT PHYS, V48, P297, DOI 10.1146/annurev.arplant.48.1.297
   Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008
   Forato LA, 2003, BIOPOLYMERS, V72, P421, DOI 10.1002/bip.10481
   Gao ZB, 2007, INT J PHARM, V328, P57, DOI 10.1016/j.ijpharm.2006.07.048
   Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lai HM, 1997, CEREAL CHEM, V74, P771, DOI 10.1094/CCHEM.1997.74.6.771
   Lai HM, 1999, J APPL POLYM SCI, V71, P1267, DOI 10.1002/(SICI)1097-4628(19990222)71:8<1267::AID-APP7>3.0.CO;2-O
   LARKINS BA, 1984, TRENDS BIOCHEM SCI, V9, P306, DOI 10.1016/0968-0004(84)90297-4
   Li YL, 2012, POLYM COMPOSITE, V33, P961, DOI 10.1002/pc.22202
   Liu XM, 2005, BIOMATERIALS, V26, P109, DOI 10.1016/j.biomaterials.2004.02.013
   Marelli B, 2010, BIOMACROMOLECULES, V11, P1470, DOI 10.1021/bm1001087
   Mecitoglu C, 2006, FOOD RES INT, V39, P12, DOI 10.1016/j.foodres.2005.05.007
   OGINO M, 1980, J BIOMED MATER RES, V14, P55, DOI 10.1002/jbm.820140107
   Qu ZH, 2008, ACTA BIOMATER, V4, P1360, DOI 10.1016/j.actbio.2008.03.006
   Reddy N, 2011, TRENDS BIOTECHNOL, V29, P490, DOI 10.1016/j.tibtech.2011.05.003
   Rehman I, 1998, J BIOMED MATER RES, V41, P162, DOI 10.1002/(SICI)1097-4636(199807)41:1<162::AID-JBM19>3.0.CO;2-P
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Stegemann JP, 2007, TISSUE ENG, V13, P2601, DOI 10.1089/ten.2007.0196
   Tu JW, 2009, BIOMATERIALS, V30, P4369, DOI 10.1016/j.biomaterials.2009.04.054
   Wang HJ, 2005, J CONTROL RELEASE, V105, P120, DOI 10.1016/j.jconrel.2005.03.014
   Wang HJ, 2007, BIOMATERIALS, V28, P3952, DOI 10.1016/j.biomaterials.2007.05.017
   Wang YJ, 2006, MACROMOL MATER ENG, V291, P254, DOI 10.1002/mame.200500381
   Wu YR, 2010, PLANT PHYSIOL, V153, P337, DOI 10.1104/pp.110.154690
   Zhou PY, 2013, J MATER CHEM B, V1, P685, DOI 10.1039/c2tb00102k
NR 27
TC 3
Z9 3
U1 2
U2 23
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2045-9858
EI 2045-9866
J9 BIOINSPIR BIOMIM NAN
JI Bioinspired Biomim. Nanobiomat.
PY 2015
VL 4
IS 1
BP 73
EP 78
DI 10.1680/bbn.14.00025
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CD1XI
UT WOS:000350867400009
DA 2018-10-19
ER

PT J
AU Pokrywczynska, M
   Gubanska, I
   Drewa, G
   Drewa, T
AF Pokrywczynska, Marta
   Gubanska, Iga
   Drewa, Gerard
   Drewa, Tomasz
TI Application of Bladder Acellular Matrix in Urinary Bladder Regeneration:
   The State of the Art and Future Directions
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; SMALL-INTESTINAL
   SUBMUCOSA; UMBILICAL-CORD BLOOD; EXTRACELLULAR-MATRIX; BONE-MARROW;
   SMOOTH-MUSCLE; URETHRAL RECONSTRUCTION; BIOMECHANICAL PROPERTIES;
   BASEMENT-MEMBRANES
AB Construction of the urinary bladder de novo using tissue engineering technologies is the "holy grail" of reconstructive urology. The search for the ideal biomaterial for urinary bladder reconstruction has been ongoing for decades. One of the most promising biomaterials for this purpose seems to be bladder acellular matrix (BAM). In this review we determine the most important factors, which may affect biological and physical properties of BAM and its regeneration potential in tissue engineered urinary bladder. We also point out the directions in modification of BAM, which include incorporation of exogenous growth factors into the BAM structure. Finally, we discuss the results of the urinary bladder regeneration with cell seeded BAM.
C1 [Pokrywczynska, Marta; Drewa, Tomasz] Nicolaus Copernicus Univ Torun, Ludwik Rydygier Med Coll Bydgoszcz, Chair Regenerat Med, PL-85092 Bydgoszcz, Poland.
   [Gubanska, Iga] Gdansk Univ Technol, Dept Polymer Technol, PL-80233 Gdansk, Poland.
   [Drewa, Gerard] Univ Bydgoszcz, PL-85059 Bydgoszcz, Poland.
   [Drewa, Tomasz] Nicolaus Copernicus Hosp, Dept Urol, PL-87100 Torun, Poland.
RP Pokrywczynska, M (reprint author), Nicolaus Copernicus Univ Torun, Ludwik Rydygier Med Coll Bydgoszcz, Chair Regenerat Med, Karlowicza 24 St, PL-85092 Bydgoszcz, Poland.
EM marta.pokrywczynska@interia.pl
RI Pokrywczynska, Marta/E-9323-2014
OI Pokrywczynska, Marta/0000-0003-3259-087X
CR Adamowicz J, 2012, TRANSPL P, V44, P1439, DOI 10.1016/j.transproceed.2012.01.128
   Adamowicz J, 2013, CENT EUR J UROL, V66, P202, DOI 10.5173/ceju.2013.02.art23
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Baka-Ostrowska M, 2011, CENT EUR J UROL, V64, P237, DOI 10.5173/ceju.2011.04.art11
   Barnes CA, 2011, BIOMATERIALS, V32, P137, DOI 10.1016/j.biomaterials.2010.09.007
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Brown AL, 2006, BIOMATERIALS, V27, P3825, DOI 10.1016/j.biomaterials.2006.02.040
   Brown AL, 2005, BIOMATERIALS, V26, P529, DOI 10.1016/j.biomaterials.2004.02.055
   Brown AL, 2002, BIOMATERIALS, V23, P2179, DOI 10.1016/S0142-9612(01)00350-7
   Calle EA, 2014, IEEE T BIO-MED ENG, V61, P1482, DOI 10.1109/TBME.2014.2314261
   Cartwright LM, 2006, J BIOMED MATER RES A, V77A, P180, DOI 10.1002/jbm.a.30652
   Cayan S, 2002, J UROLOGY, V168, P798, DOI 10.1016/S0022-5347(05)64746-5
   Chen BS, 2011, INT J ARTIF ORGANS, V34, P1137, DOI 10.5301/ijao.5000069
   Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020
   Consolo F., 2013, J TISSUE ENG REGENER
   Leite MTC, 2014, PEDIATR SURG INT, V30, P361, DOI 10.1007/s00383-014-3465-2
   Dahms SE, 1998, BRIT J UROL, V82, P411
   Davis NF, 2013, INT J ARTIF ORGANS, V36, P251, DOI 10.5301/ijao.5000194
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Drewa T, 2009, TRANSPL P, V41, P4345, DOI 10.1016/j.transproceed.2009.08.059
   Eberli D, 2007, INT J IMPOT RES, V19, P602, DOI 10.1038/sj.ijir.3901587
   Eberli D, 2011, J MATER SCI-MATER M, V22, P741, DOI 10.1007/s10856-011-4242-6
   Eberli D, 2009, METHODS, V47, P109, DOI 10.1016/j.ymeth.2008.10.014
   Farhat W, 2003, J BIOMED MATER RES A, V67A, P970, DOI 10.1002/jbm.a.10171
   Farhat W. A., 2008, BIOMEDICAL MAT, V3
   Feng C, 2010, J BIOMED MATER RES A, V94A, P317, DOI 10.1002/jbm.a.32729
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Freytes DO, 2008, J BIOMED MATER RES B, V84B, P408, DOI 10.1002/jbm.b.30885
   Freytes DO, 2006, J BIOMED MATER RES B, V78B, P327, DOI 10.1002/jbm.b.30491
   FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267
   Fu Q, 2008, ASIAN J ANDROL, V10, P719, DOI 10.1111/j.1745-7262.2008.00419.x
   Fu Q, 2007, BJU INT, V99, P1162, DOI 10.1111/j.1464-410X.2006.06691.x
   Gilbert TW, 2008, BIOMATERIALS, V29, P4775, DOI 10.1016/j.biomaterials.2008.08.022
   Hodde J, 2002, BIOMATERIALS, V23, P1841, DOI 10.1016/S0142-9612(01)00310-6
   Hodde JP, 2002, TISSUE ENG, V8, P225, DOI 10.1089/107632702753724996
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Jiang WC, 2014, BIOMATERIALS, V35, P3607, DOI 10.1016/j.biomaterials.2014.01.024
   Joo KJ, 2006, ASIAN J ANDROL, V8, P543, DOI 10.1111/j.1745-7262.2006.00192.x
   Kanematsu A, 2003, J UROLOGY, V170, P1633, DOI 10.1097/01.ju.0000084021.51099.8a
   Kanematsu A, 2004, BIOMATERIALS, V25, P4513, DOI 10.1016/j.biomaterials.2003.11.035
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kikuno N, 2009, BJU INT, V103, P1424, DOI 10.1111/j.1464-410X.2008.08129.x
   Kurzrock EA, 2005, J UROLOGY, V173, P281, DOI 10.1097/01.ju.0000141585.17953.fa
   Li C, 2008, UROL INT, V81, P290, DOI 10.1159/000151406
   Li QC, 2013, AESTHET PLAST SURG, V37, P822, DOI 10.1007/s00266-013-0173-6
   Liao W, 2013, TRANSPL P, V45, P730, DOI 10.1016/j.transproceed.2012.08.023
   Loai Y, 2010, J BIOMED MATER RES A, V94A, P1205, DOI 10.1002/jbm.a.32777
   Mahara A., 2014, BIOMED RES INT, V2014
   Malinda KM, 1999, FASEB J, V13, P53
   Mareschi K, 2001, HAEMATOLOGICA, V86, P1099
   MEEZAN E, 1975, LIFE SCI, V17, P1721, DOI 10.1016/0024-3205(75)90119-8
   Merguerian PA, 2000, BJU INT, V85, P894, DOI 10.1046/j.1464-410x.2000.00513.x
   Moriya K, 2005, BJU INT, V96, P152, DOI 10.1111/j.1464-410X.2005.05586.x
   Mueller SM, 2001, J CELL BIOCHEM, V82, P583, DOI 10.1002/jcb.1174
   Nishida S, 1999, J BONE MINER METAB, V17, P171, DOI 10.1007/s007740050081
   Nuininga JE, 2010, TISSUE ENG PT A, V16, P3319, DOI 10.1089/ten.tea.2010.0053
   Ozeki M, 2001, J DRUG TARGET, V9, P461, DOI 10.3109/10611860108998780
   Palmer EM, 2003, TISSUE ENG, V9, P307, DOI 10.1089/107632703764664774
   Peters MC, 2002, J BIOMED MATER RES, V60, P668, DOI 10.1002/jbm.10134
   Piechota HJ, 1999, UROL RES, V27, P206, DOI 10.1007/s002400050111
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pokrywczynska M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105295
   Pokrywczynska M, 2014, EXP BIOL MED, V239, P264, DOI 10.1177/1535370213517615
   Pokrywczynska M, 2013, ARCH IMMUNOL THER EX, V61, P483, DOI 10.1007/s00005-013-0249-7
   Pokrywczynska M, 2013, POSTEP HIG MED DOSW, V67, P790
   Probst M, 1997, BRIT J UROL, V79, P505, DOI 10.1046/j.1464-410X.1997.00103.x
   Ram-Liebig G, 2004, BJU INT, V94, P922, DOI 10.1111/j.1464-410X.2004.05061.x
   Robertson MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090406
   Rosario DJ, 2008, REGEN MED, V3, P145, DOI 10.2217/17460751.3.2.145
   Ross EA, 2012, ORGANOGENESIS, V8, P49, DOI 10.4161/org.20209
   RUBINSTEIN P, 1993, BLOOD, V81, P1679
   Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659
   SKRABANJA ATP, 1994, J PHARM SCI TECHNOL, V48, P311
   Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005
   Sutherland RS, 1996, J UROLOGY, V156, P571, DOI 10.1016/S0022-5347(01)65755-0
   Suzuki K, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/951512
   Tabata Y, 1999, TISSUE ENG, V5, P127, DOI 10.1089/ten.1999.5.127
   Urakami S, 2007, WORLD J UROL, V25, P207, DOI 10.1007/s00345-006-0142-7
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x
   Yang SX, 2005, CHINESE MED J-PEKING, V118, P957
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Youssif M, 2005, UROLOGY, V66, P201, DOI 10.1016/j.urology.2005.01.054
   Yuan HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080959
   Zhou LH, 2013, TISSUE ENG PT A, V19, P264, DOI [10.1089/ten.tea.2011.0609, 10.1089/ten.TEA.2011.0609]
   Zhu WD, 2010, WORLD J UROL, V28, P493, DOI 10.1007/s00345-010-0508-8
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 90
TC 5
Z9 5
U1 0
U2 11
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 613439
DI 10.1155/2015/613439
PG 11
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CD5CL
UT WOS:000351105400001
PM 25793199
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Campanha-Rodrigues, AL
   Grazioli, G
   Oliveira, TC
   Campos-Lisboa, ACV
   Mares-Guia, TR
   Sogayar, MC
AF Campanha-Rodrigues, Ana Lucia
   Grazioli, Gisella
   Oliveira, Talita C.
   Campos-Lisboa, Ana Carolina V.
   Mares-Guia, Thiago R.
   Sogayar, Mari C.
TI Therapeutic Potential of Laminin-Biodritin Microcapsules for Type 1
   Diabetes Mellitus
SO CELL TRANSPLANTATION
LA English
DT Article
DE Laminin (LN); Alginate; Type 1 diabetes mellitus; Islet transplantation;
   Microencapsulation; Biomaterials
ID ALGINATE-BASED MICROCAPSULES; BETA-CELL FUNCTION; PANCREATIC-ISLET
   TRANSPLANTATION; MATRIX INTERACTIONS; INSULIN-SECRETION;
   EXTRACELLULAR-MATRIX; IN-VITRO; CHEMOATTRACTANT PROTEIN-1; DIFFERENTIAL
   EXPRESSION; RAT ISLETS
AB Pancreatic islet microencapsulation constitutes an attractive therapy for type 1 diabetes mellitus; however, long-term beta-cell function remains a major problem. Loss of extracellular matrix interactions during islet isolation dramatically affects beta-cell viability. We have previously shown beneficial effects of laminin (LN) in human islet cultures. Herein, we investigated whether LN could improve the outcome of transplantation after islet microencapsulation in Biodritin, an alginate-based material. To test LN-Biodritin stability, microcapsules were subjected to different types of in vitro stress. Focusing on biocompatibility, empty microcapsules were coincubated with the RAW 264.7 macrophage cell line for up to 24 h, and empty beads were implanted IP in mice and retrieved for analyses after 7 and 30 days. Upon culturing for 48 h, mRNA, protein levels, and caspase 3 activity were evaluated in islets microencapsulated with LN-Biodritin. Mice rendered diabetic by streptozotocin injection were transplanted with microencapsulated islets, followed by assessment of body weight, glycemia, and graft function (evaluated by OGTT). Graft efficiency was observed upon microencapsulated islet explantation. The results obtained showed that LN-Biodritin microcapsules were as stable and biocompatible as Biodritin. Modulation of mRNA and protein levels suggested protection against apoptosis and islet stress. Mice transplanted with LN-Biodritin microencapsulated islets presented a better outcome at 198 days postsurgery. Graft explantation led animals to hyperglycemia. In conclusion, LN-Biodritin constitutes a very promising biomaterial for islet transplantation.
C1 [Campanha-Rodrigues, Ana Lucia; Grazioli, Gisella; Oliveira, Talita C.; Campos-Lisboa, Ana Carolina V.; Mares-Guia, Thiago R.; Sogayar, Mari C.] Univ Sao Paulo, Sch Med, Cell & Mol Therapy Ctr NUCEL NETCEM, Inst Chem,Biochem Dept, BR-05508000 Sao Paulo, SP, Brazil.
   [Grazioli, Gisella; Campos-Lisboa, Ana Carolina V.; Mares-Guia, Thiago R.] Cell Protect Biotechnol Ltda, Sao Paulo, SP, Brazil.
RP Sogayar, MC (reprint author), Univ Sao Paulo, Inst Chem, Av Prof Lineu Prestes 748,Bloco 9S, BR-05508000 Sao Paulo, SP, Brazil.
EM mcsoga@iq.usp.br
FU Fundaccio de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FINEP
   (Financiadora de Estudos e Projetos); BNDES (Banco Nacional de
   Desenvolvimento EconOmico e Social); Brazilian Ministries of Science,
   Technology and Innovation (MCTI) and Health (MS-DECIT)
FX The authors acknowledge the excellent technical support of Zizi de
   Mendonca, Marluce da Cunha Mantovani, Debora Cristina da Costa, Ricardo
   Krett de Oliveira, and Sandra Regina de Souza (Chemistry Institute,
   University of Silo Paulo). This work was supported by Fundaccio de Apoio
   a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), FINEP (Financiadora de
   Estudos e Projetos), BNDES (Banco Nacional de Desenvolvimento EconOmico
   e Social), and the Brazilian Ministries of Science, Technology and
   Innovation (MCTI) and Health (MS-DECIT). This work has been published in
   abstract form in the Annals of the International Pancreas and Islet
   Transplant Association (IPITA) and of the Brazilian Society of
   Biochemistry and Molecular Biology (SBBq), in 2011. Ana Lucia
   Campanha-Rodrigues performed most of the experiments, researched data,
   and wrote the manuscript. Gisella Grazioli performed some of the
   experiments, researched data, and contributed to discussion. Talita C.
   Oliveira performed some of the experiments and researched data. Ana
   Carolina V. Campos-Lisboa researched data and contributed to discussion.
   Thiago R. dos Mares-Guia researched data and contributed to discussion.
   Mari Cleide Sogayar reviewed/edited the manuscript and contributed to
   discussion. Mari C. Sogayar is the guarantor of this work and, as such,
   had full access to all the data in the study and takes responsibility
   for the integrity of the data and the accuracy of the data analysis.
   This work was carried out in collaboration with CellProtect
   Biotechnology Ltda. The authors declare no conflict of interest.
CR Armanet M, 2009, FASEB J, V23, P4046, DOI 10.1096/fj.08-127142
   Banerjee M, 2012, MOL CELL ENDOCRINOL, V355, P78, DOI 10.1016/j.mce.2012.01.020
   Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649
   Basta G, 2011, DIABETES CARE, V34, P2406, DOI 10.2337/dc11-0731
   Basta G, 2011, CURR DIABETES REP, V11, P384, DOI 10.1007/s11892-011-0219-6
   Berney T, 2006, DIABETES METAB, V32, P503, DOI 10.1016/S1262-3636(06)72803-8
   Bertuzzi F, 2004, J CLIN ENDOCR METAB, V89, P5724, DOI 10.1210/jc.2004-0659
   Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233
   Campos-Lisboa ACV, 2008, TRANSPL P, V40, P433, DOI 10.1016/j.transproceed.2008.01.057
   Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395
   Chen MC, 2001, DIABETOLOGIA, V44, P325, DOI 10.1007/s001250051622
   Contreras JL, 2001, TRANSPLANTATION, V71, P1015, DOI 10.1097/00007890-200104270-00001
   Daoud J, 2010, BIOMATERIALS, V31, P1676, DOI 10.1016/j.biomaterials.2009.11.057
   de Groot M, 2004, J SURG RES, V121, P141, DOI 10.1016/j.jss.2004.02.018
   De Vos P, 1999, DIABETES, V48, P1381, DOI 10.2337/diabetes.48.7.1381
   de Vos P, 2003, BIOMATERIALS, V24, P305, DOI 10.1016/S0142-9612(02)00319-8
   de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010
   deVos P, 1997, TRANSPLANT P, V29, P756, DOI 10.1016/S0041-1345(96)00456-3
   Dufrane D, 2006, BIOMATERIALS, V27, P3201, DOI 10.1016/j.biomaterials.2006.01.028
   Duvivier-Kali VF, 2001, DIABETES, V50, P1698, DOI 10.2337/diabetes.50.8.1698
   Emamaullee J, 2005, AM J TRANSPLANT, V5, P1297, DOI 10.1111/j.1600-6143.2005.00891.x
   Emamaullee JA, 2006, DIABETES, V55, P1907, DOI 10.2337/db05-1254
   Jang HJ, 2008, TRANSPL P, V40, P2581, DOI 10.1016/j.transproceed.2008.08.075
   JANSSON L, 1995, J CLIN INVEST, V96, P721, DOI 10.1172/JCI118115
   Jiang FX, 1999, DIABETES, V48, P722, DOI 10.2337/diabetes.48.4.722
   Johansson A, 2009, DIABETOLOGIA, V52, P2385, DOI 10.1007/s00125-009-1485-6
   Juste S, 2005, J BIOMED MATER RES A, V72A, P389, DOI 10.1002/jbm.a.30254
   KAKITA K, 1982, P NATL ACAD SCI-BIOL, V79, P2803, DOI 10.1073/pnas.79.9.2803
   King A, 2001, J BIOMED MATER RES, V57, P374, DOI 10.1002/1097-4636(20011205)57:3<374::AID-JBM1180>3.0.CO;2-L
   Klein D, 2004, BIOCHEM BIOPH RES CO, V323, P473, DOI 10.1016/j.bbrc.2004.08.116
   Kobayashi T, 2008, CELL TRANSPLANT, V17, P1243, DOI 10.3727/096368908787236602
   Labriola L, 2007, MOL CELL ENDOCRINOL, V263, P120, DOI 10.1016/j.mce.2006.09.011
   Lai Y, 2009, CLIN EXP IMMUNOL, V157, P1, DOI 10.1111/j.1365-2249.2009.03899.x
   Lee I, 2003, J IMMUNOL, V171, P6929, DOI 10.4049/jimmunol.171.12.6929
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Ling ZD, 1998, ENDOCRINOLOGY, V139, P491, DOI 10.1210/en.139.2.491
   MARGULIS BA, 1991, DIABETES, V40, P1418, DOI 10.2337/diabetes.40.11.1418
   Melzi R, 2010, CELL TRANSPLANT, V19, P1031, DOI 10.3727/096368910X514639
   Mokhtari D, 2009, BIOCHEM BIOPH RES CO, V387, P553, DOI 10.1016/j.bbrc.2009.07.051
   MORGAN CR, 1963, DIABETES, V12, P115, DOI 10.2337/diab.12.2.115
   Nanji SA, 2006, DIABETES OBES METAB, V8, P15, DOI 10.1111/j.1463-1326.2005.00476.x
   Orive G, 2006, BIOMATERIALS, V27, P3691, DOI 10.1016/j.biomaterials.2006.02.048
   Orive G, 2005, BIOMACROMOLECULES, V6, P927, DOI 10.1021/bm049380x
   Papas KK, 1999, BIOTECHNOL BIOENG, V66, P231, DOI 10.1002/(SICI)1097-0290(1999)66:4<231::AID-BIT4>3.3.CO;2-L
   Paraskevas S, 1999, FEBS LETT, V455, P203, DOI 10.1016/S0014-5793(99)00882-0
   Perfetti R, 1996, PANCREAS, V13, P47, DOI 10.1097/00006676-199607000-00006
   Piemonti L, 2002, DIABETES, V51, P55, DOI 10.2337/diabetes.51.1.55
   Ris F, 2002, DIABETOLOGIA, V45, P841, DOI 10.1007/s00125-002-0840-7
   Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1016/S0039-6060(99)70183-2
   Safley Susan A, 2008, J Diabetes Sci Technol, V2, P760
   Saldeen J, 2000, ENDOCRINOLOGY, V141, P2003, DOI 10.1210/en.141.6.2003
   Saluja A, 2008, J GASTROEN HEPATOL, V23, pS42, DOI 10.1111/j.1440-1746.2007.05272.x
   Schneider S, 2005, DIABETES, V54, P687, DOI 10.2337/diabetes.54.3.687
   Shapiro AMJ, 2011, CURR DIABETES REP, V11, P345, DOI 10.1007/s11892-011-0217-8
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195
   Thomas F, 2001, SURGERY, V130, P333, DOI 10.1067/msy.2001.116413
   Thu B, 1996, BIOMATERIALS, V17, P1031, DOI 10.1016/0142-9612(96)84680-1
   Venter S., 2010, TISSUE ENG PART A, V16, P1503
   Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181
   Weber LM, 2007, BIOMATERIALS, V28, P3004, DOI 10.1016/j.biomaterials.2007.03.005
   Weber LM, 2008, MATRIX BIOL, V27, P667, DOI 10.1016/j.matbio.2008.08.001
   Weber LM, 2008, TISSUE ENG PT A, V14, P1959, DOI 10.1089/ten.tea.2007.0238
   Wilson JT, 2008, ADV DRUG DELIVER REV, V60, P124, DOI 10.1016/j.addr.2007.08.034
   Zhang N, 2006, DIABETES, V55, P2429, DOI 10.2337/db06-0173
   Zhou YP, 2000, AM J PHYSIOL-ENDOC M, V278, pE340
   Zimmermann H, 2007, BIOMATERIALS, V28, P1327, DOI 10.1016/j.biomaterials.2006.11.032
   Zimmermann U, 2000, BIOTECHNIQUES, V29, P564, DOI 10.2144/00293rv01
NR 68
TC 3
Z9 3
U1 0
U2 11
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2015
VL 24
IS 2
BP 247
EP 261
DI 10.3727/096368913X675160
PG 15
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA CD7DQ
UT WOS:000351251400010
PM 24256689
OA Bronze
DA 2018-10-19
ER

PT J
AU Zhang, SZ
   Peng, Y
   Wang, B
   Chen, GM
AF Zhang, Shaozhi
   Peng, Yu
   Wang, Bo
   Chen, Guangming
TI VAPOR PRESSURES ABOVE THE VITRIFIED SUCROSE SOLUTION AT LOW TEMPERATURES
SO CRYOLETTERS
LA English
DT Article
DE freeze drying; sucrose solution; vitrification; water vapor pressure
ID AMORPHOUS PHARMACEUTICAL SOLIDS; GLASS-TRANSITION TEMPERATURE;
   AQUEOUS-SOLUTIONS; WATER ACTIVITY; CRYOPROTECTANTS; PARAMETERS;
   DEPENDENCE; ABSORPTION; MODELS; SUGARS
AB BACKGROUND: Vitrified solutions are encountered in food and biomaterial preservation. Data of the equilibrium water vapor pressure above the vitrified solution are scarce at temperatures below 0 degrees C. OBJECTIVE: The study measures the water vapor pressures above vitrified sucrose solutions. MATERIALS AND METHODS: Sucrose solutions with concentration ranging from 75% to 79% (wt) were vitrified by cooling in liquid nitrogen, and placed in a thermostat bath. Vapor pressure was measured with a high precision pressure gauge using static method. The vitrification of sucrose solution was verified with DSC. RESULTS: Experimental data were compared with two models. The empirical Zobrist model fits the experimental data well. The free volume model was improved by fitting the interaction parameter to experimental data. The average discrepancy could be reduced from 5.57% to 2.86%. CONCLUSION: The data have significant implications in the driving force of water removal in secondary drying process.
C1 [Zhang, Shaozhi; Peng, Yu; Chen, Guangming] Zhejiang Univ, Inst Refrigerat & Cryogen, Hangzhou 310003, Zhejiang, Peoples R China.
   [Wang, Bo] 117 Hosp, Hangzhou, Zhejiang, Peoples R China.
RP Chen, GM (reprint author), Zhejiang Univ, Inst Refrigerat & Cryogen, Hangzhou 310003, Zhejiang, Peoples R China.
EM gmchen@zju.edu.cn
FU archaeological artifact protection technology project of Zhejiang
   Province; National Natural Science Foundation of China [51106074];
   Medical Science and Technology Program of Zhejiang Province
FX This work was supported by archaeological artifact protection technology
   project of Zhejiang Province, National Natural Science Foundation of
   China (No. 51106074) and Medical Science and Technology Program of
   Zhejiang Province.
CR Angell CA, 2002, CHEM REV, V102, P2627, DOI 10.1021/cr000689q
   Fernicola V, 2012, INT J THERMOPHYS, V33, P1363, DOI 10.1007/s10765-011-1128-2
   Frank GA, 2007, J PHYS CHEM REF DATA, V36, P1279, DOI 10.1063/1.2779330
   Fuller BJ, 2004, CRYOLETTERS, V25, P375
   GORDON M, 1952, J APPL CHEM, V2, P493
   HANCOCK BC, 1994, PHARMACEUT RES, V11, P471, DOI 10.1023/A:1018941810744
   HANCOCK BC, 1993, PHARMACEUT RES, V10, P1262, DOI 10.1023/A:1018901325842
   He X, 2006, J APPL PHYS, V100
   He Xiaoming, 2011, Open Biomed Eng J, V5, P47, DOI 10.2174/1874120701105010047
   Hyland RW, 1983, ASHRAE T, V89, P500
   Karel M, 1975, PRINCIPLES FOOD SC 2, P237
   Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1
   LABUZA TP, 1976, J FOOD SCI, V41, P910, DOI 10.1111/j.1365-2621.1976.tb00751.x
   LABUZA TP, 1980, FOOD TECHNOL-CHICAGO, V34, P36
   MAXIMOV N. A., 1929, PROTOPLASMA, V7, P259, DOI 10.1007/BF01612809
   Miyawaki O, 1997, BIOSCI BIOTECH BIOCH, V61, P466, DOI 10.1271/bbb.61.466
   Morillon V, 1999, FLUID PHASE EQUILIBR, V155, P297, DOI 10.1016/S0378-3812(99)00009-6
   Murphy DM, 2005, Q J ROY METEOR SOC, V131, P1539, DOI 10.1256/qj.04.94
   Norrish R.S, 1966, J FOOD TECHNOL, V1, P25
   Sadikoglu H, 2005, DRY TECHNOL, V23, P33, DOI 10.1081/DRT-200047915
   Shamblin SL, 1999, PHARMACEUT RES, V16, P1119, DOI 10.1023/A:1018960405504
   Sikora A, 2007, J MACROMOL SCI B, V46, P71, DOI 10.1080/00222340601036819
   SLADE L, 1995, J FOOD ENG, V24, P431, DOI 10.1016/0260-8774(95)90766-5
   SPIELES G, 1995, CHEM ENG PROCESS, V34, P351, DOI 10.1016/0255-2701(94)00503-6
   Starzak M, 2006, FOOD CHEM, V96, P346, DOI 10.1016/j.foodchem.2005.02.052
   SUTTON RL, 1992, CRYOBIOLOGY, V29, P585, DOI 10.1016/0011-2240(92)90063-8
   TAKAISHI T, 1963, T FARADAY SOC, V59, P2503, DOI 10.1039/tf9635902503
   Velezmoro CE, 2000, J CHEM ENG JPN, V33, P645, DOI 10.1252/jcej.33.645
   VRENTAS JS, 1991, MACROMOLECULES, V24, P2404, DOI 10.1021/ma00009a043
   Wright DL, 2004, REPROD BIOMED ONLINE, V9, P179, DOI 10.1016/S1472-6483(10)62127-X
   YASUMOTO I, 1980, J PHYS CHEM-US, V84, P589, DOI 10.1021/j100443a006
   Yue YZ, 2004, NATURE, V427, P717, DOI 10.1038/nature02295
   Zhang J, 2000, J PHARM SCI, V89, P1063
   Zobrist B, 2008, ATMOS CHEM PHYS, V8, P5221, DOI 10.5194/acp-8-5221-2008
NR 34
TC 0
Z9 0
U1 0
U2 4
PU CRYO LETTERS
PI LONDON
PA C/O ROYAL VETERINARY COLLEGE, ROYAL COLLEGE ST, LONDON NW1 0TU, ENGLAND
SN 0143-2044
EI 1742-0644
J9 CRYOLETTERS
JI CryoLetters
PD JAN-FEB
PY 2015
VL 36
IS 1
BP 60
EP 67
PG 8
WC Biology; Physiology
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA CC8KN
UT WOS:000350617400009
PM 26017174
DA 2018-10-19
ER

PT J
AU Kupkova, M
   Hrubovcakova, M
   Kupka, M
   Orinakova, R
   Turonova, AM
AF Kupkova, Miriam
   Hrubovcakova, Monika
   Kupka, Martin
   Orinakova, Renyta
   Turonova, Andrea Morovska
TI Corrosion Behaviour of Powder Metallurgy Biomaterials from Phosphated
   Carbonyl-Iron Powders
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE biodegradable PM materials; phosphated iron powder; corrosion potential;
   fractal dimension; Fe-P biomaterial
ID FE-MN ALLOYS; MORPHOLOGY; STENTS
AB Phosphate coated carbonyl-iron powders were compacted and sintered to investigate the effect of 0.5 and 1.0wt.% of phosphorus supplied through a phosphate coating on the microstructure and corrosion of sintered samples. The resultant materials consisted of spheroidized iron or iron oxide particles surrounded by a solidified liquid phase composed of various ferric phosphate compounds. The addition of phosphorus to carbonyl iron i) raised the fractal dimension of time series generated by the open -circuit potential fluctuations from 1.14 to about 1.5, ii) more than tripled the corrosion rate and iii) made the steady-state corrosion potential more noble (lower phosphorus content) or less noble (higher phosphorus content) than the corrosion potential of carbonyl-iron sample.
C1 [Kupkova, Miriam; Hrubovcakova, Monika] Slovak Acad Sci, Inst Mat Res, SK-04001 Kosice, Slovakia.
   [Kupka, Martin] Slovak Acad Sci, Inst Expt Phys, SK-04001 Kosice, Slovakia.
   [Orinakova, Renyta; Turonova, Andrea Morovska] Safarik Univ, Fac Sci, Inst Chem, Dept Phys Chem, SK-04154 Kosice, Slovakia.
RP Kupkova, M (reprint author), Slovak Acad Sci, Inst Mat Res, Watsonova 47, SK-04001 Kosice, Slovakia.
EM mkupkova@imr.saske.sk
RI Morovska Turonova, Andrea/B-8754-2017
OI Morovska Turonova, Andrea/0000-0002-7775-2679; Orinakova,
   Renata/0000-0001-8103-2634
FU Slovak Research and Development Agency under contract APVV [0677-11];
   Slovak Research and Development Agency under contract VEGA [2/0168/12]
FX The authors thank for financial support of the research by the Slovak
   Research and Development Agency under contract APVV No. 0677-11 and VEGA
   grant 2/0168/12.
CR Addison P., 1997, FRACTALS CHAOS ILLUS
   [Anonymous], 2010, G10289 ASTM INT
   Brunckova H, 2010, SURF INTERFACE ANAL, V42, P13, DOI 10.1002/sia.3132
   DAWSON JL, 1996, ELECTROCHEMICAL NOIS, P3
   DeBruyn H. J., 1996, ELECTROCHEMICAL NOIS, V1277, P214
   Hermawan H., 2009, ACTA MAT, V6, P1693
   Hermawan H, 2010, ACTA BIOMATER, V6, P1852, DOI 10.1016/j.actbio.2009.11.025
   Hermawan H, 2010, J BIOMED MATER RES A, V93A, P1, DOI 10.1002/jbm.a.32224
   HIGUCHI T, 1988, PHYSICA D, V31, P277, DOI 10.1016/0167-2789(88)90081-4
   Kabatova M, 2013, SURF INTERFACE ANAL, V45, P1166, DOI 10.1002/sia.5244
   Landolf D., 2007, CORROSION SURFACE CH
   McCafferty E., 2010, INTRO CORROSION SCI
   Quadbeck P., 2010, P POWD MET WORLD C E, V2, P239
   Simard P, 2000, MECH SYST SIGNAL PR, V14, P459, DOI 10.1006/mssp.1999.1245
   Turcotte D.L., 1997, FRACTALS CHAOS GEOLO
   Wegener B, 2011, MATER SCI ENG B-ADV, V176, P1789, DOI 10.1016/j.mseb.2011.04.017
   Yun YH, 2009, MATER TODAY, V12, P22, DOI 10.1016/S1369-7021(09)70273-1
NR 17
TC 2
Z9 2
U1 0
U2 10
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD JAN
PY 2015
VL 10
IS 1
BP 671
EP 681
PG 11
WC Electrochemistry
SC Electrochemistry
GA CD4UM
UT WOS:000351080000037
DA 2018-10-19
ER

PT J
AU Zhang, Y
   Wu, S
   Chen, QR
   Zhou, XH
   Wei, ZL
AF Zhang, Ya
   Wu, Sen
   Chen, Qiurong
   Zhou, Xuehua
   Wei, Zhongling
TI The Research on Corrosion Properties of Some Magnesium Alloys for
   Biomaterials
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE degradable planting alloy; magnesium alloys; corrosion properties;
   mechanical properties
ID IN-VIVO CORROSION; BONE IMPLANT APPLICATION; PURE MAGNESIUM;
   BIO-CORROSION; VITRO; SCAFFOLDS; DEGRADATION; BEHAVIOR; SURFACE; FLUID
AB Metals which consist of elements existing in the human body are promising candidates for planting materials. Many magnesium alloys are developed as degradable implanting alloys with improved mechanical properties and enhanced corrosion properties. In this paper, the corrosion properties of these tested alloys are studied for biomaterial through the immersion test and electrochemical potentiodynamic polarization test. The microstructure before and after immersion tests was observed by optical Microscopy and fieldemission scanning electron Microscope. The mechanical properties of these alloys were studied by Universal Testing Machine. The influence of different elements in magnesium alloys on the corrosion properties was analyzed in this paper.
C1 [Zhang, Ya; Wu, Sen; Chen, Qiurong; Zhou, Xuehua; Wei, Zhongling] Chinese Acad Sci, Shanghai Inst Microsyst & Informat Technol, Shanghai 200050, Peoples R China.
   [Zhang, Ya; Chen, Qiurong; Zhou, Xuehua] Chinese Acad Sci, Jiaxing Light Alloy Engn Technol Ctr, Jiaxing 314022, Peoples R China.
RP Zhang, Y (reprint author), Chinese Acad Sci, Shanghai Inst Microsyst & Informat Technol, 865 Changning Rd, Shanghai 200050, Peoples R China.
EM yzhang@mail.sim.ac.cn
FU Shanghai Scientific Research Projects [11DJ1400302]
FX At the point of finishing this paper, I'd like to express my sincere
   thanks to all those who have lent me hands in the course of my writing
   this paper. This paper is funded by Shanghai Scientific Research
   Projects (11DJ1400302).
CR Henderson SE, 2014, ACTA BIOMATER, V10, P2323, DOI 10.1016/j.actbio.2013.12.040
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kirkland NT, 2012, ACTA BIOMATER, V8, P925, DOI 10.1016/j.actbio.2011.11.014
   Kuwahara H, 2001, MATER TRANS, V42, P1317, DOI 10.2320/matertrans.42.1317
   Liu CL, 2007, J MATER RES, V22, P1806, DOI 10.1557/JMR.2007.0241
   MEL, 2005, MAGN EL DAT 467 EL W
   Muller W. D., 2007, J MATER RES, V10, P5
   Ren YB, 2005, ACTA METALL SIN, V41, P1228
   Rettig R, 2008, J BIOMED MATER RES A, V85A, P167, DOI 10.1002/jbm.a.31550
   Rousselle AV, 2002, HISTOL HISTOPATHOL, V17, P1025, DOI 10.14670/HH-17.1025
   Shi ZM, 2011, CORROS SCI, V53, P226, DOI 10.1016/j.corsci.2010.09.016
   Shingde M, 2005, MED J AUSTRALIA, V183, P145
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song GL, 2007, ADV ENG MATER, V9, P298, DOI 10.1002/adem.200600252
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Von der Hoeh N, 2006, DEUT TIERARZTL WOCH, V113, P439
   Wang H, 2008, MATER LETT, V62, P2476, DOI 10.1016/j.matlet.2007.12.052
   Wang H., 2010, CORROS SCI, V52, P255
   Wang QD, 2001, J MATER SCI, V36, P3035
   Winston R., 2008, CORROSION CORROSION, P43
   Wintermantel E, 2002, MEDIZINTECHNIK BIOKO
   Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2006, MATERIALWISS WERKST, V37, P504, DOI 10.1002/mawe.200600027
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Xu LP, 2008, J MATER SCI-MATER M, V19, P1017, DOI 10.1007/s10856-007-3219-y
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Zhang GD, 2007, ACTA METALL SIN, V43, P1186
NR 31
TC 2
Z9 2
U1 3
U2 22
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD JAN
PY 2015
VL 10
IS 1
BP 1015
EP 1026
PG 12
WC Electrochemistry
SC Electrochemistry
GA CD4UM
UT WOS:000351080000067
DA 2018-10-19
ER

PT J
AU Gagnon, J
   Clift, MJD
   Vanhecke, D
   Kuhn, DA
   Weber, P
   Petri-Fink, A
   Rothen-Rutishauser, B
   Fromm, KM
AF Gagnon, J.
   Clift, M. J. D.
   Vanhecke, D.
   Kuhn, D. A.
   Weber, P.
   Petri-Fink, A.
   Rothen-Rutishauser, B.
   Fromm, K. M.
TI Integrating silver compounds and nanoparticles into ceria nanocontainers
   for antimicrobial applications
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID OXIDE NANOPARTICLES; AQUEOUS SUSPENSIONS; IMPLANT; ENCAPSULATION;
   INFECTIONS; COATINGS; AGAR; SUSCEPTIBILITY; CYTOTOXICITY; NANOCERIA
AB Silver compounds and nanoparticles (NPs) are gaining increasing interest in medical applications, specifically in the treatment and prevention of biomaterial-related infections. However, the silver release from these materials, resulting in a limited antimicrobial activity, is often difficult to control. In this paper, ceria nanocontainers were synthesized by a template-assisted method and were then used to encapsulate silver nitrate (AgNO3/CeO2 nanocontainers). Over the first 30 days, a significant level of silver was released, as determined using inductively coupled plasma optical emission spectroscopy (ICP-OES). A novel type of ceria container containing silver NPs (AgNP/CeO2 containers) was also developed using two different template removal methods. The presence of AgNPs was confirmed both on the surface and in the interior of the ceria containers by X-ray diffraction (XRD), transmission electron microscopy (TEM) and scanning electron microscopy (SEM). Upon removal of the template by calcination, the silver was released over a period exceeding three months (>90 days). However, when the template was removed by dissolution, the silver release was shortened to <= 14 days. The antimicrobial activity of the silver-containing CeO2 containers was observed and the minimum bactericidal concentration (MBC) was determined using the broth dilution method. Investigation on human cells, using a model epithelial barrier cell type (A549 cells), highlighted that all three samples induced a heightened cytotoxicity leading to cell death when exposed to all containers in their raw form. This was attributed to the surface roughness of the CeO2 nanocontainers and the kinetics of the silver release from the AgNO3/CeO2 and AgNP/CeO2 nanocontainers. In conclusion, despite the need for further emphasis on their biocompatibility, the concept of the AgNP/CeO2 nanocontainers offers a potentially alternative long-term antibactericidal strategy for implant materials.
C1 [Gagnon, J.; Weber, P.; Fromm, K. M.] Univ Fribourg, Dept Chem, CH-1700 Fribourg, Switzerland.
   [Gagnon, J.; Weber, P.; Fromm, K. M.] Univ Fribourg, Fribourg Ctr Nanomat, CH-1700 Fribourg, Switzerland.
   [Clift, M. J. D.; Vanhecke, D.; Kuhn, D. A.; Petri-Fink, A.; Rothen-Rutishauser, B.] Univ Fribourg, Adolphe Merkle Inst, CH-1723 Marly, Switzerland.
   [Clift, M. J. D.; Vanhecke, D.; Kuhn, D. A.; Petri-Fink, A.; Rothen-Rutishauser, B.] Univ Fribourg, Fribourg Ctr Nanomat, CH-1723 Marly, Switzerland.
RP Fromm, KM (reprint author), Univ Fribourg, Dept Chem, Chemin Musee 9, CH-1700 Fribourg, Switzerland.
EM Jacinthe.Gagnon@iaf.inrs.ca; Katharina.Fromm@unifr.ch
OI Merkle Institute, Adolphe/0000-0002-6220-424X; CLIFT,
   MARTIN/0000-0001-6133-3368; Fink, Alke/0000-0003-3952-7849;
   Rothen-Rutishauser, Barbara/0000-0002-7805-9366
FU Swiss National Science Foundation; University of Fribourg; Adolphe
   Merkle Foundation; FriMat; NCCR "Bioinspired Materials"
FX We are grateful to the Swiss National Science Foundation, the University
   of Fribourg, the Adolphe Merkle Foundation, FriMat and the NCCR
   "Bioinspired Materials" for generously supporting this project. We also
   thank Dr N. H. Kwon and Dr P. S. Brunetto for the SEM images and Y.
   Umehara for her help with the eukaryotic cell culture.
CR Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Ashley CE, 2011, NAT MATER, V10, P389, DOI [10.1038/NMAT2992, 10.1038/nmat2992]
   Bonev B, 2008, J ANTIMICROB CHEMOTH, V61, P1295, DOI 10.1093/jac/dkn090
   Brunetto PS, 2008, CHIMIA, V62, P249, DOI 10.2533/chimia.2008.249
   Cassee FR, 2011, CRIT REV TOXICOL, V41, P213, DOI 10.3109/10408444.2010.529105
   Chaudhary YS, 2010, J MATER CHEM, V20, P2381, DOI 10.1039/b922914k
   Chen FJ, 2011, APPL SURF SCI, V257, P9226, DOI 10.1016/j.apsusc.2011.06.009
   Cheng XL, 2013, RSC ADV, V3, P2296, DOI 10.1039/c2ra23131j
   COOPER KE, 1955, NATURE, V176, P510, DOI 10.1038/176510b0
   Damm C, 2007, J MATER SCI, V42, P6067, DOI 10.1007/s10853-006-1158-5
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Eckhardt S, 2013, CHEM REV, V113, P4708, DOI 10.1021/cr300288v
   Emmerson M, 1998, NEW HORIZ-SCI PRACT, V6, pS3
   Evanoff DD, 2004, J PHYS CHEM B, V108, P13948, DOI 10.1021/jp047565s
   GILBERT P, 1990, ANTIMICROB AGENTS CH, V34, P1865, DOI 10.1128/AAC.34.10.1865
   Gordon O, 2010, ANTIMICROB AGENTS CH, V54, P4208, DOI 10.1128/AAC.01830-09
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hackenberg S, 2011, TOXICOL LETT, V201, P27, DOI 10.1016/j.toxlet.2010.12.001
   Hardas SS, 2010, TOXICOL SCI, V116, P562, DOI 10.1093/toxsci/kfq137
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Kalimuthu K, 2008, COLLOID SURFACE B, V65, P150, DOI 10.1016/j.colsurfb.2008.02.018
   Karakoti AS, 2008, JOM-US, V60, P33, DOI 10.1007/s11837-008-0029-8
   Kartsonakis I, 2008, J SOL-GEL SCI TECHN, V48, P24, DOI 10.1007/s10971-008-1810-4
   Kartsonakis IA, 2008, J AM CERAM SOC, V91, P372, DOI 10.1111/j.1551-2916.2007.02088.x
   Kassaee MZ, 2008, J APPL POLYM SCI, V110, P1699, DOI 10.1002/app.28762
   Kumbhar AS, 2009, CHEM MATER, V21, P2835, DOI 10.1021/cm900436n
   Lehmann A, 2010, ARTECH HSE METH BIOE, P239
   Madadlou A, 2010, BBA-GEN SUBJECTS, V1800, P459, DOI 10.1016/j.bbagen.2010.01.004
   McFarland J, 1907, J AMER MED ASSOC, V49, P1176
   Mittal S., 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/891934
   Montali Andrea, 2006, Injury, V37 Suppl 2, pS81, DOI 10.1016/j.injury.2006.04.013
   Mukherjee S, 2014, THERANOSTICS, V4, P316, DOI 10.7150/thno.7819
   Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h
   Pei AH, 2007, MATER LETT, V61, P2757, DOI 10.1016/j.matlet.2006.04.123
   Poelstra KA, 2002, J BIOMED MATER RES, V60, P206, DOI 10.1002/jbm.10069
   Rothen-Rutishauser BM, 2005, AM J RESP CELL MOL, V32, P281, DOI 10.1165/rcmb.2004-0187OC
   Santillan MJ, 2010, SURF COAT TECH, V205, P2562, DOI 10.1016/j.surfcoat.2010.10.001
   Schubert D, 2006, BIOCHEM BIOPH RES CO, V342, P86, DOI 10.1016/j.bbrc.2006.01.129
   Slenters TV, 2008, J MATER CHEM, V18, P5359, DOI 10.1039/b813026d
   Urabe Y, 2007, CHEMBIOCHEM, V8, P668, DOI 10.1002/cbic.200600486
   Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521
   Wong LL, 2014, ADV EXP MED BIOL, V801, P821, DOI 10.1007/978-1-4614-3209-8_103
   Wu J, 2009, BIOMACROMOLECULES, V10, P2686, DOI 10.1021/bm900620w
   Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k
   Yao C, 2005, J BIOMED NANOTECHNOL, V1, P68, DOI 10.1166/jbn.2005.008
   Zampino D, 2011, J MATER SCI, V46, P6734, DOI 10.1007/s10853-011-5629-y
NR 47
TC 14
Z9 14
U1 1
U2 18
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 9
BP 1760
EP 1768
DI 10.1039/c4tb02079k
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CC4SM
UT WOS:000350343700003
OA Bronze
DA 2018-10-19
ER

PT S
AU Arciola, CR
   Campoccia, D
   Ehrlich, GD
   Montanaro, L
AF Arciola, Carla Renata
   Campoccia, Davide
   Ehrlich, Garth D.
   Montanaro, Lucio
BE Donelli, G
TI Biofilm-Based Implant Infections in Orthopaedics
SO BIOFILM-BASED HEALTHCARE-ASSOCIATED INFECTIONS, VOL I
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
ID PROSTHETIC JOINT INFECTION; FIBRONECTIN-BINDING PROTEINS; TOTAL
   HIP-ARTHROPLASTY; HIGH-WATER-CONTENT; STAPHYLOCOCCUS-AUREUS; IN-VITRO;
   DNA RELEASE; ANTIMICROBIAL PEPTIDES; INTERCELLULAR-ADHESION;
   ENTEROCOCCUS-FAECALIS
AB The demand for joint replacement surgery is continuously increasing with rising costs for hospitals and healthcare systems. Staphylococci are the most prevalent etiological agents of orthopedic infections. After an initial adhesin-mediated implant colonization, Staphylococcus aureus and Staphylococcus epidermidis produce biofilm. Biofilm formation proceeds as a four-step process: (1) initial attachment of bacterial cells; (2) cell aggregation and accumulation in multiple cell layers; (3) biofilm maturation and (4) detachment of cells from the biofilm into a planktonic state to initiate a new cycle of biofilm formation elsewhere. The encasing of bacteria in biofilms gives rise to insuperable difficulties not only in the treatment of the infection, but also in assessing the state and the nature of the infection using traditional cultural methods. Therefore, DNA-based molecular methods have been developed to provide rapid identification of all microbial pathogens. To combat biofilm-centered implant infections, new strategies are being developed, among which anti-infective or infective-resistant materials are at the forefront. Infection-resistant materials can be based on different approaches: (i) modifying the biomaterial surface to give anti-adhesive properties, (ii) doping the material with antimicrobial substances, (iii) combining anti-adhesive and antimicrobial effects in the same coating, (iv) designing materials able to oppose biofilm formation and support bone repair.
C1 [Arciola, Carla Renata; Campoccia, Davide; Montanaro, Lucio] Rizzoli Orthopaed Inst, Res Unit Implant Infect, Bologna, Italy.
   [Arciola, Carla Renata; Montanaro, Lucio] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.
   [Ehrlich, Garth D.] Drexel Univ, Coll Med, Ctr Genom Sci, Inst Mol Med & Infect Dis, Philadelphia, PA 19104 USA.
   [Ehrlich, Garth D.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA.
   [Ehrlich, Garth D.] Drexel Univ, Coll Med, Dept Otolaryngol, Philadelphia, PA 19104 USA.
RP Arciola, CR (reprint author), Rizzoli Orthopaed Inst, Res Unit Implant Infect, Bologna, Italy.
EM carlarenata.arciola@ior.it; lucio.montanaro@unibo.it
RI Campoccia, Davide/K-5348-2018
OI Campoccia, Davide/0000-0002-3336-0219; Ehrlich,
   Garth/0000-0003-1140-6594
CR Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x
   Arciola CR, 2008, BIOMATERIALS, V29, P580, DOI 10.1016/j.biomaterials.2007.10.008
   Arciola CR, 2012, INT J ARTIF ORGANS, V35, P713, DOI 10.5301/ijao.5000158
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Arciola CR, 2011, INT J ARTIF ORGANS, V34, P727, DOI 10.5301/IJAO.2011.8784
   Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091
   Arciola CR, 2003, BIOMATERIALS, V24, P3013, DOI 10.1016/S0142-9612(03)00133-9
   ARCIOLA CR, 1995, BIOMATERIALS, V16, P685, DOI 10.1016/0142-9612(95)99695-I
   Arciola CR, 2001, J CLIN MICROBIOL, V39, P2151, DOI 10.1128/JCM.39.6.2151-2156.2001
   Arciola CR, 1998, J BIOMED MATER RES, V42, P1
   Arciola CR, 1999, BIOMATERIALS, V20, P323, DOI 10.1016/S0142-9612(98)00168-9
   ARCIOLA CR, 1993, BIOMATERIALS, V14, P1161, DOI 10.1016/0142-9612(93)90161-T
   ARCIOLA CR, 1994, J CATARACT REFR SURG, V20, P158, DOI 10.1016/S0886-3350(13)80157-5
   Bagheri M, 2012, BIOCONJUGATE CHEM, V23, P66, DOI 10.1021/bc200367f
   Bustanji Y, 2003, P NATL ACAD SCI USA, V100, P13292, DOI 10.1073/pnas.1735343100
   Campoccia D, 2003, BIOMATERIALS, V24, P587, DOI 10.1016/S0142-9612(02)00373-3
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Campoccia D, 2009, BIOMATERIALS, V30, P6621, DOI 10.1016/j.biomaterials.2009.08.032
   Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306
   Corvec S, 2012, INT J ARTIF ORGANS, V35, P923, DOI 10.5301/ijao.5000168
   Costerton JW, 2011, PLAST RECONSTR SURG, V127, p36S, DOI 10.1097/PRS.0b013e3182001845
   Costerton JW, 2011, FEMS IMMUNOL MED MIC, V61, P133, DOI 10.1111/j.1574-695X.2010.00766.x
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   Costerton JW, 2003, J CLIN INVEST, V112, P1466
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001
   Della Valle C, 2012, INT J ARTIF ORGANS, V35, P864, DOI 10.5301/ijao.5000161
   Ehrlich GD, 2013, JAMA INTERN MED, V173, P1405, DOI 10.1001/jamainternmed.2013.7042
   Ehrlich GD, 2012, INT J ARTIF ORGANS, V35, P695, DOI 10.5301/ijao.5000169
   Ehrlich GD, 2010, FEMS IMMUNOL MED MIC, V59, P269, DOI 10.1111/j.1574-695X.2010.00704.x
   Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P20, DOI 10.1097/01.blo.0000175124.52590.c0
   Ehrlich GD, 2014, J APPL BIOMATER FUNC, V12, pe13
   Ehrlich GD, 2012, CULTURE NEGATIVE ORT
   Esteban J, 2014, EXPERT REV MOL DIAGN, V14, P83, DOI 10.1586/14737159.2014.861327
   Fitzgerald RH, 1995, J AM ACAD ORTHOP SUR, V3, P249
   FOSTER SJ, 1995, J BACTERIOL, V177, P5723, DOI 10.1128/jb.177.19.5723-5725.1995
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   Geoghegan JA, 2010, J BACTERIOL, V192, P5663, DOI 10.1128/JB.00628-10
   Grandi S, 2011, INT J ARTIF ORGANS, V34, P920, DOI 10.5301/ijao.5000059
   GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   Hansen EN, 2012, INT J ARTIF ORGANS, V35, P935, DOI 10.5301/ijao.5000145
   Harris LG, 2010, INT J ARTIF ORGANS, V33, P568
   Hauck CR, 2006, CURR OPIN MICROBIOL, V9, P5, DOI 10.1016/j.mib.2005.12.002
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   HERRMANN M, 1993, J INFECT DIS, V167, P312, DOI 10.1093/infdis/167.2.312
   Hirschhausen N, 2010, CELL MICROBIOL, V12, P1746, DOI 10.1111/j.1462-5822.2010.01506.x
   Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10
   Hunt LP, 2013, LANCET, V382, P1097, DOI 10.1016/S0140-6736(13)61749-3
   Jacovides CL, 2012, J BONE JOINT SURG AM, V94A, P2247, DOI 10.2106/JBJS.L.00210
   Kang SJ, 2012, ARCH PHARM RES, V35, P409, DOI 10.1007/s12272-012-0302-9
   Kapadia BH, 2014, J ARTHROPLASTY, V29, P929, DOI 10.1016/j.arth.2013.09.017
   Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017
   Kurtz SM, 2012, J ARTHROPLASTY, V27, P61, DOI 10.1016/j.arth.2012.02.022
   Legeay G, 2006, INT J ARTIF ORGANS, V29, P453
   Leone James M, 2006, Instr Course Lect, V55, P449
   Lindeque B, 2014, ORTHOPEDICS, V37, P257, DOI 10.3928/01477447-20140401-08
   Mack D, 2004, INT J MED MICROBIOL, V294, P203, DOI 10.1016/j.ijmm.2004.06.015
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   Montanaro L, 2011, INT J ARTIF ORGANS, V34, P824, DOI 10.5301/ijao.5000051
   Montanaro L, 2011, INT J ARTIF ORGANS, V34, P781, DOI 10.5301/ijao.5000052
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   Montanaro L, 2010, J BIOMED MATER RES A, V94A, P825, DOI 10.1002/jbm.a.32764
   Nemes S, 2014, ACTA ORTHOP
   Neoh KG, 2011, ACS APPL MATER INTER, V3, P2808, DOI 10.1021/am200646t
   O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x
   Osmon DR, 2013, CLIN INFECT DIS, V56, P1, DOI 10.1093/cid/cis966
   Parvizi J, 2014, J BONE JOINT SURG AM, V96A, P430, DOI 10.2106/JBJS.L.01793
   Parvizi J, 2011, INT J ARTIF ORGANS, V34, P847, DOI 10.5301/ijao.5000054
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   PATTI JM, 1994, INFECT IMMUN, V62, P152
   Potter A, 2009, J MICROBIOL, V47, P319, DOI 10.1007/s12275-009-0008-y
   Puig-Verdie L, 2013, BONE JOINT J, V95B, P244, DOI 10.1302/0301-620X.95B2.30486
   Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0
   Rak M, 2013, FEMS MICROBIOL LETT, V343, P42, DOI 10.1111/1574-6968.12125
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Ryden C, 1997, BIOCHEM J, V327, P825, DOI 10.1042/bj3270825
   Schinsky MF, 2008, J BONE JOINT SURG AM, V90A, P1869, DOI 10.2106/JBJS.G.01255
   Sculco T P, 1993, Instr Course Lect, V42, P349
   Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x
   Sittka A, 2008, CELL HOST MICROBE, V4, P310, DOI 10.1016/j.chom.2008.09.006
   Speziale P, 2009, FUTURE MICROBIOL, V4, P1337, DOI [10.2217/fmb.09.102, 10.2217/FMB.09.102]
   Speziale P, 2008, CURR MED CHEM, V15, P3185, DOI 10.2174/092986708786848442
   Tan HL, 2012, BIOMATERIALS, V33, P365, DOI 10.1016/j.biomaterials.2011.09.084
   Tande AJ, 2014, CLIN MICROBIOL REV, V27, P302, DOI 10.1128/CMR.00111-13
   Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08
   Thomas VC, 2009, INT J ARTIF ORGANS, V32, P537
   Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794
   Tormo MA, 2005, MICROBIOL-SGM, V151, P2465, DOI 10.1099/mic.0.27865-0
   Trampuz A, 2006, J CLIN MICROBIOL, V44, P628, DOI 10.1128/JCM.44.2.628-631.2006
   Tsaras G, 2012, INFECT CONT HOSP EP, V33, P1207, DOI 10.1086/668421
   Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09
   Whitehouse JD, 2002, INFECT CONT HOSP EP, V23, P183, DOI 10.1086/502033
   Wolcott R, 2011, PLAST RECONSTR SURG, V127, p28S, DOI 10.1097/PRS.0b013e3181fca244
   Zhao L, 2014, COLLOIDS SURF B BIOI
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
NR 99
TC 33
Z9 33
U1 1
U2 49
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
BN 978-3-319-11038-7; 978-3-319-11037-0
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2015
VL 830
BP 29
EP 46
DI 10.1007/978-3-319-11038-7_2
D2 10.1007/978-3-319-11038-7
PG 18
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA BC1SD
UT WOS:000350409600003
PM 25366219
DA 2018-10-19
ER

PT J
AU Feller, L
   Jadwat, Y
   Khammissa, RAG
   Meyerov, R
   Schechter, I
   Lemmer, J
AF Feller, Liviu
   Jadwat, Yusuf
   Khammissa, Razia A. G.
   Meyerov, Robin
   Schechter, Israel
   Lemmer, Johan
TI Cellular Responses Evoked by Different Surface Characteristics of
   Intraosseous Titanium Implants
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID DENTAL IMPLANTS; UNDERLYING MECHANISMS; PLATELET INTERACTIONS;
   BIOMATERIAL SURFACES; RELATIVE INFLUENCE; IN-VITRO; PART 1; BONE;
   TOPOGRAPHY; OSSEOINTEGRATION
AB The properties of biomaterials, including their surface microstructural topography and their surface chemistry or surface energy/wettability, affect cellular responses such as cell adhesion, proliferation, and migration. The nanotopography of moderately rough implant surfaces enhances the production of biological mediators in the peri-implant microenvironment with consequent recruitment of differentiating osteogenic cells to the implant surface and stimulates osteogenic maturation. Implant surfaces with moderately rough topography and with high surface energy promote osteogenesis, increase the ratio of bone-to-implant contact, and increase the bonding strength of the bone to the implant at the interface. Certain features of implant surface chemistry are also important in enhancing peri-implant bone wound healing. It is the purpose of this paper to review some of the more important features of titanium implant surfaces which have an impact on osseointegration.
C1 [Feller, Liviu; Jadwat, Yusuf; Khammissa, Razia A. G.; Meyerov, Robin; Lemmer, Johan] Sefako Makgatho Hlth Sci Univ, Dept Periodontol & Oral Med, ZA-0204 Pretoria, South Africa.
   [Schechter, Israel] Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Haifa, Israel.
RP Feller, L (reprint author), Sefako Makgatho Hlth Sci Univ, Dept Periodontol & Oral Med, ZA-0204 Pretoria, South Africa.
EM liviu.feller@smu.ac.za
CR Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   Anselme K, 2010, P I MECH ENG H, V224, P1487, DOI 10.1243/09544119JEIM901
   Bico J, 2002, COLLOID SURFACE A, V206, P41, DOI 10.1016/S0927-7757(02)00061-4
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   BOURDON MA, 1989, J CELL BIOL, V108, P1149, DOI 10.1083/jcb.108.3.1149
   Boyan BD, 1999, BIOMATERIALS, V20, P2305, DOI 10.1016/S0142-9612(99)00159-3
   Bren L., 2004, P 7 WORLD BIOM C SYD, P1121
   Bucci-Sabattini V, 2010, ORAL SURG ORAL MED O, V109, P217, DOI 10.1016/j.tripleo.2009.09.007
   Coelho PG, 2009, J BIOMED MATER RES B, V88B, P579, DOI 10.1002/jbm.b.31264
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Davies John E, 2003, J Dent Educ, V67, P932
   Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049
   de Gennes P.-G., 2002, CAPILLARITY WETTING
   de Oliveira PT, 2007, J BIOMED MATER RES A, V80A, P554, DOI 10.1002/jbm.a.30955
   Decuzzi P, 2010, BIOMATERIALS, V31, P173, DOI 10.1016/j.biomaterials.2009.09.018
   Ehrenfest DMD, 2010, TRENDS BIOTECHNOL, V28, P198, DOI 10.1016/j.tibtech.2009.12.003
   Elias CN, 2010, EXPERT REV MED DEVIC, V7, P241, DOI [10.1586/erd.09.74, 10.1586/ERD.09.74]
   Feller L, 2014, SADJ, V69, P114
   Feller L, 2014, IMPLANT DENT, V23, P745, DOI 10.1097/ID.0000000000000140
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Ivanovski S, 2011, CLIN ORAL IMPLAN RES, V22, P373, DOI 10.1111/j.1600-0501.2010.02112.x
   Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kwok SCH, 2005, DIAM RELAT MATER, V14, P78, DOI 10.1016/j.diamond.2004.07.019
   Lang NP, 2009, CLIN ORAL IMPLAN RES, V20, P228, DOI 10.1111/j.1600-0501.2009.01771.x
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Marmur A., 1992, MODERN APPROACHES WE
   Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Mendonca G, 2009, BIOMATERIALS, V30, P4053, DOI 10.1016/j.biomaterials.2009.04.010
   Nanci A, 2008, 10 CATES ORAL HISTOL, P57
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Park JY, 2000, CLIN ORAL IMPLAN RES, V11, P530, DOI 10.1034/j.1600-0501.2000.011006530.x
   Ponche A, 2010, P I MECH ENG H, V224, P1471, DOI 10.1243/09544119JEIM900
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Qu Z, 2007, J BIOMED MATER RES A, V82A, P658, DOI 10.1002/bjm.a.31023
   Raines AL, 2010, BIOMATERIALS, V31, P4909, DOI 10.1016/j.biomaterials.2010.02.071
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Schrader M. E. L., 1992, MODERN APPROACHES WE
   Schwartz Z, 1997, J PERIODONTAL RES, V32, P166, DOI 10.1111/j.1600-0765.1997.tb01399.x
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Schwarz F, 2007, CLIN ORAL IMPLAN RES, V18, P481, DOI 10.1111/j.1600-0501.2007.01341.x
   Schwarz F, 2009, J BIOMED MATER RES B, V88B, P544, DOI 10.1002/jbm.b.31233
   Tambasco De Oliveira P., 2004, BIOMATERIALS, V25, P403
   Vlacic-Zischke J, 2011, BIOMATERIALS, V32, P665, DOI 10.1016/j.biomaterials.2010.09.025
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wall I, 2009, BONE, V45, P17, DOI 10.1016/j.bone.2009.03.662
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Woodruff D. P., 2002, SURFACE ALLOYS ALLOY, V10
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
NR 53
TC 18
Z9 20
U1 0
U2 10
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 171945
DI 10.1155/2015/171945
PG 8
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CC3GG
UT WOS:000350234000001
PM 25767803
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Wettstein, P
   Priest, C
   Al-Bataineh, SA
   Short, RD
   Bryant, PM
   Bradley, JW
   Low, SP
   Parkinson, L
   Szili, EJ
AF Wettstein, Pascal
   Priest, Craig
   Al-Bataineh, Sameer A.
   Short, Robert D.
   Bryant, Paul M.
   Bradley, James W.
   Low, Suet P.
   Parkinson, Luke
   Szili, Endre J.
TI Surface protein gradients generated in sealed microchannels using
   spatially varying helium microplasma
SO BIOMICROFLUIDICS
LA English
DT Article
ID MICROFLUIDIC SYSTEMS; MORPHOGEN GRADIENT; CHEMICAL GRADIENTS; DENSITY
   GRADIENTS; DESIGN; TECHNOLOGY; DEPOSITION; PRESSURE; ADHESION; DEVICES
AB Spatially varied surface treatment of a fluorescently labeled Bovine Serum Albumin (BSA) protein, on the walls of a closed (sealed) microchannel is achieved via a well-defined gradient in plasma intensity. The microchips comprised a microchannel positioned in-between two microelectrodes (embedded in the chip) with a variable electrode separation along the length of the channel. The channel and electrodes were 50 mu m and 100 mu m wide, respectively, 50 mu m deep, and adjacent to the channel for a length of 18 mm. The electrode separation distance was varied linearly from 50 mu m at one end of the channel to a maximum distance of 150, 300, 500, or 1000 mu m to generate a gradient in helium plasma intensity. Plasma ignition was achieved at a helium flow rate of 2.5 ml/min, 8.5 kV(pk-pk), and 10 kHz. It is shown that the plasma intensity decreases with increasing electrode separation and is directly related to the residual amount of BSA left after the treatment. The plasma intensity and surface protein gradient, for the different electrode gradients studied, collapse onto master curves when plotted against electrode separation. This precise spatial control is expected to enable the surface protein gradient to be tuned for a range of applications, including high-throughput screening and cell-biomolecule-biomaterial interactions. (c) 2015 AIP Publishing LLC.
C1 [Wettstein, Pascal; Al-Bataineh, Sameer A.; Short, Robert D.; Low, Suet P.; Szili, Endre J.] Univ S Australia, Mawson Inst, Mawson Lakes, SA 5095, Australia.
   [Priest, Craig; Parkinson, Luke] Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
   [Bryant, Paul M.; Bradley, James W.] Univ Liverpool, Dept Elect Engn & Elect, Liverpool L69 3GJ, Merseyside, England.
RP Wettstein, P (reprint author), Univ S Australia, Mawson Inst, Mawson Lakes, SA 5095, Australia.
EM endre.szili@unisa.edu.au
RI Bradley, James/M-7577-2018; Priest, Craig/F-4212-2013; Al-Bataineh,
   Sameer/D-4604-2009
OI Bradley, James/0000-0002-8833-0180; Priest, Craig/0000-0002-8861-2161;
   Al-Bataineh, Sameer/0000-0003-1711-8032
FU ANFF-SA start-up award
FX The microfluidic devices were fabricated at the South Australian node of
   the Australian National Fabrication Facility (ANFF-SA). We would like to
   thank the ANFF-SA staff for the use of state-of-the-art facilities and
   their technical assistance. Part of this work was supported by the
   ANFF-SA start-up award. We thank Doug Veale (Cantech) for the design and
   construction of the power supply and the microchip holder.
CR Al-Bataineh SA, 2011, PLASMA PROCESS POLYM, V8, P695, DOI 10.1002/ppap.201000176
   Beebe DJ, 2000, P NATL ACAD SCI USA, V97, P13488, DOI 10.1073/pnas.250273097
   Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523
   Craighead H, 2006, NATURE, V442, P387, DOI 10.1038/nature05061
   deMello AJ, 2006, NATURE, V442, P394, DOI 10.1038/nature05062
   Dertinger SKW, 2001, ANAL CHEM, V73, P1240, DOI 10.1021/ac001132d
   Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Eccles SA, 2005, CURR OPIN GENET DEV, V15, P77, DOI 10.1016/j.gde.2004.12.001
   El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063
   Evju JK, 2004, APPL PHYS LETT, V84, P1668, DOI 10.1063/1.1668327
   Friedrich D, 2012, CHEM ENG J, V193, P296, DOI 10.1016/j.cej.2012.04.041
   Genzer J, 2008, LANGMUIR, V24, P2294, DOI 10.1021/la7033164
   Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500
   Handique K, 2001, ANAL CHEM, V73, P1831, DOI 10.1021/ac000711f
   Jin T, 2008, CYTOKINE, V44, P1, DOI 10.1016/j.cyto.2008.06.017
   Kaji H, 2006, ANAL CHEM, V78, P5469, DOI 10.1021/ac060304p
   Kang CE, 2004, J BIOMED MATER RES A, V71A, P403, DOI 10.1002/jbm.a.30137
   Klages CP, 2007, CONTRIB PLASM PHYS, V47, P49, DOI 10.1002/ctpp.200710008
   Klages CP, 2007, PLASMA PROCESS POLYM, V4, P208, DOI 10.1002/ppap.200600116
   Lecuit T, 2007, NATURE, V450, P189, DOI 10.1038/nature06304
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MANZ A, 1991, TRAC-TREND ANAL CHEM, V10, P144, DOI 10.1016/0165-9936(91)85116-9
   Menzies DJ, 2010, LANGMUIR, V26, P13987, DOI 10.1021/la102033d
   Michelmore A., 2012, J NANOMATER, V2012
   Morgenthaler S, 2008, SOFT MATTER, V4, P419, DOI 10.1039/b715466f
   Noor MO, 2011, ANAL CHIM ACTA, V708, P1, DOI 10.1016/j.aca.2011.10.004
   Plummer ST, 2003, LANGMUIR, V19, P7528, DOI 10.1021/la030075r
   Priest C, 2011, LAB CHIP, V11, P541, DOI 10.1039/c0lc00339e
   Qin D, 1996, ADV MATER, V8, P917, DOI 10.1002/adma.19960081110
   Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030
   Saadi W, 2007, BIOMED MICRODEVICES, V9, P627, DOI 10.1007/s10544-007-9051-9
   Salim M, 2007, LAB CHIP, V7, P523, DOI 10.1039/b615328c
   Salim M, 2009, ELECTROPHORESIS, V30, P1877, DOI 10.1002/elps.200800619
   Sudarsan AP, 2006, LAB CHIP, V6, P74, DOI 10.1039/b511524h
   Szili EJ, 2012, RSC ADV, V2, P12007, DOI 10.1039/c2ra21504g
   Szili EJ, 2011, PROC SPIE, V8204, DOI 10.1117/12.903293
   Thorslund S, 2007, J MICROMECH MICROENG, V17, pN16, DOI 10.1088/0960-1317/17/4/N02
   Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151
   Verma MKS, 2006, LANGMUIR, V22, P10291, DOI 10.1021/la062516n
   Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148
   Wells N, 2009, BIOMATERIALS, V30, P1066, DOI 10.1016/j.biomaterials.2008.10.027
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   Xiao YH, 2012, J IMMUNOL METHODS, V384, P148, DOI 10.1016/j.jim.2012.06.009
   Zelzer M, 2008, BIOMATERIALS, V29, P172, DOI 10.1016/j.biomaterials.2007.09.026
   Zhao B, 2001, SCIENCE, V291, P1023, DOI 10.1126/science.291.5506.1023
   Zhou JW, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3523055
   Zhu AJ, 2004, GENE DEV, V18, P2985, DOI 10.1101/gad.1233104
NR 48
TC 7
Z9 7
U1 3
U2 16
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1932-1058
J9 BIOMICROFLUIDICS
JI Biomicrofluidics
PD JAN
PY 2015
VL 9
IS 1
AR 014124
DI 10.1063/1.4913367
PG 10
WC Biochemical Research Methods; Biophysics; Nanoscience & Nanotechnology;
   Physics, Fluids & Plasmas
SC Biochemistry & Molecular Biology; Biophysics; Science & Technology -
   Other Topics; Physics
GA CC7KS
UT WOS:000350546900024
PM 25759757
OA Green Published
DA 2018-10-19
ER

PT J
AU Kumar, P
   Choonara, YE
   Modi, G
   Naidoo, D
   Pillay, V
AF Kumar, Pradeep
   Choonara, Yahya E.
   Modi, Girish
   Naidoo, Dinesh
   Pillay, Viness
TI Multifunctional Therapeutic Delivery Strategies for Effective
   Neuro-Regeneration Following Traumatic Spinal Cord Injury
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE Spinal cord injury; hydrogels; scaffolds; multiple channel bridges;
   nerve conduits; fibrous architectures; neurotrophic factors; sustained
   release
ID NERVE GROWTH-FACTOR; PROMOTES FUNCTIONAL RECOVERY; SUSTAINED
   LOCAL-DELIVERY; DRUG-DELIVERY; CHONDROITINASE ABC; CONTROLLED-RELEASE;
   INTRATHECAL DELIVERY; NEUROTROPHIC FACTOR; AXONAL REGENERATION;
   BRAIN-INJURY
AB Traumatic Spinal Cord Injuries (TSCI), due to their devastating nature, present several interventional challenges (extensive inflammation, axonal tethering, scar formation, neuronal degeneration and functional loss) that need to be addressed before even a slight neuronal recovery can be achieved. Recent post-TSCI investigational approaches include a combination of "support and therapeutic" strategies capable of providing localized delivery of therapeutic molecules along with specialized architecture to allow axonal growth and conformal repair. This review provides a brief overview of multifunctional therapeutic delivery strategies for effective neuroregeneration post-TSCI with special emphasis on intrathecal hydrogel-based injectable systems, chondroitinase ABC releasing matrices, micro/nano-sized particulate strategies, 3D-scaffold architectures, biopolymeric channeled bridges for directed neuronal growth, functionalized nerve conduits, nano- and micro-fibrous scaffolds and multicomponent combinatorial paradigms for localized delivery to spinal cord. In addition; a comprehensive account of most widely employed macromolecules and the related neuro-pharmacological, -anatomical, and -functionaloutcomes conferred by the abovementioned neural tissue engineering approaches is provided. Furthermore, the performance of individual delivery systems towards the enhancement of effectiveness, efficiency, and stability of therapeutic molecules and neurotrophic factors is discussed. In conclusion, it is suggested that a multifunctional combinatorial device assimilating the biomaterial, cellular, molecular, structural and functional aspects altogether is the best way forward for effective neuroregeneration post-TSCI.
C1 [Kumar, Pradeep; Choonara, Yahya E.; Modi, Girish; Naidoo, Dinesh; Pillay, Viness] Univ Witwatersrand, Wits Adv Drug Delivery Platform Res Unit, Fac Hlth Sci, Sch Therapeut Sci,Dept Pharm & Pharmacol, ZA-2193 Johannesburg, Parktown, South Africa.
RP Pillay, V (reprint author), Univ Witwatersrand, Wits Adv Drug Delivery Platform Res Unit, Fac Hlth Sci, Sch Therapeut Sci,Dept Pharm & Pharmacol, 7 York Rd, ZA-2193 Johannesburg, Park Town, South Africa.
EM viness.pillay@wits.ac.za
RI Pillay, Viness/C-1569-2010; Choonara, Yahya/B-2955-2013; Kumar,
   Pradeep/C-9424-2013
OI Pillay, Viness/0000-0002-8119-3347; Choonara, Yahya/0000-0002-3889-1529;
   Kumar, Pradeep/0000-0002-8640-4350
FU National Research Foundation (NRF) of South Africa
FX This work was funded by the National Research Foundation (NRF) of South
   Africa.
CR Ansorena E, 2013, INT J PHARMACEUT, V455, P148, DOI 10.1016/j.ijpharm.2013.07.045
   Baumann MD, 2010, BIOMATERIALS, V31, P7631, DOI 10.1016/j.biomaterials.2010.07.004
   Baumann MD, 2009, J CONTROL RELEASE, V138, P205, DOI 10.1016/j.jconrel.2009.05.009
   Bawa P, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/022001
   Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a
   Chvatal SA, 2008, BIOMATERIALS, V29, P1967, DOI 10.1016/j.biomaterials.2008.01.002
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   de Boer R, 2011, MICROSURG, V31, P293, DOI 10.1002/micr.20869
   De Laporte L, 2011, J BIOMED MATER RES A, V98A, P372, DOI 10.1002/jbm.a.33112
   De Laporte L, 2009, MOL THER, V17, P318, DOI 10.1038/mt.2008.252
   De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051
   Ding YM, 2005, CURR PHARM DESIGN, V11, P1441, DOI 10.2174/1381612053507855
   Downing TL, 2012, J CONTROL RELEASE, V161, P910, DOI 10.1016/j.jconrel.2012.05.034
   Fan JA, 2011, J BIOMED MATER RES B, V97B, P271, DOI 10.1002/jbm.b.31810
   Fan JA, 2010, J NEUROTRAUM, V27, P1671, DOI 10.1089/neu.2010.1281
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Hamann MCJ, 2005, EXP NEUROL, V194, P106, DOI 10.1016/j.expneurol.2005.01.030
   Hamann MCJ, 2003, EXP NEUROL, V182, P300, DOI 10.1016/S0014-4886(03)00040-2
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Huang YC, 2011, CARBOHYD POLYM, V84, P788, DOI 10.1016/j.carbpol.2010.03.034
   Hulsebosch CE, 2005, CURR PHARM DESIGN, V11, P1411, DOI 10.2174/1381612053507864
   Hyatt AJT, 2010, J CONTROL RELEASE, V147, P24, DOI 10.1016/j.jconrel.2010.06.026
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Jones TB, 2005, CURR PHARM DESIGN, V11, P1223, DOI 10.2174/1381612053507468
   Kang CE, 2010, J CONTROL RELEASE, V144, P25, DOI 10.1016/j.jconrel.2010.01.029
   Kang CE, 2009, TISSUE ENG PT A, V15, P595, DOI 10.1089/ten.tea.2007.0349
   Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284
   Kern H, 2005, CURR PHARM DESIGN, V11, P1429, DOI 10.2174/1381612053507882
   Kim YT, 2009, BIOMATERIALS, V30, P2582, DOI 10.1016/j.biomaterials.2008.12.077
   Kokai LE, 2010, BIOMATERIALS, V31, P2313, DOI 10.1016/j.biomaterials.2009.11.075
   Kumar P, 2014, MED HYPOTHESES, V82, P437, DOI 10.1016/j.mehy.2014.01.019
   Kumar P, 2014, NANOMEDICINE-UK, V9, P331, DOI 10.2217/nnm.13.203
   Kumar Pradeep, 2011, Recent Pat Drug Deliv Formul, V5, P24, DOI 10.2174/187221111794109510
   Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106
   Liu T, 2012, J BIOMED MATER RES A, V100A, P236, DOI 10.1002/jbm.a.33271
   Madduri S, 2010, BIOMATERIALS, V31, P8402, DOI 10.1016/j.biomaterials.2010.07.052
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   Maquet V, 2001, BIOMATERIALS, V22, P1137, DOI 10.1016/S0142-9612(00)00357-4
   Merelli A, 2013, CURR PHARM DESIGN, V19, P6791
   Nakaji-Hirabayashi T, 2009, BIOMATERIALS, V30, P4581, DOI 10.1016/j.biomaterials.2009.05.009
   Pakulska MM, 2013, J CONTROL RELEASE, V171, P11, DOI 10.1016/j.jconrel.2013.06.029
   Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101
   Perale G, 2012, J CONTROL RELEASE, V159, P271, DOI 10.1016/j.jconrel.2011.12.025
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Pillay V, 2012, RECENT ADVANCES IN NOVEL DRUG CARRIER SYSTEMS, P355, DOI 10.5772/51256
   Pritchard CD, 2011, BIOMATERIALS, V32, P587, DOI 10.1016/j.biomaterials.2010.08.106
   Rossi Filippo, 2012, J Funct Biomater, V3, P199, DOI 10.3390/jfb3010199
   Sakiyama-Elbert S, 2012, Handb Clin Neurol, V109, P575, DOI 10.1016/B978-0-444-52137-8.00036-X
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sanchez-Covarrubias L, 2014, CURR PHARM DESIGN, V20, P1422, DOI 10.2174/13816128113199990463
   Sharma HS, 2007, CURR PHARM DESIGN, V13, P1841
   Shoichet MS, 2007, PROG BRAIN RES, V161, P385, DOI 10.1016/S0079-6123(06)61027-3
   Skop NB, 2013, ACTA BIOMATER, V9, P6834, DOI 10.1016/j.actbio.2013.02.043
   Song BB, 2012, BIOMATERIALS, V33, P9105, DOI 10.1016/j.biomaterials.2012.08.060
   Stanwick JC, 2012, J CONTROL RELEASE, V160, P666, DOI 10.1016/j.jconrel.2012.03.024
   Stanwick JC, 2012, INT J PHARMACEUT, V426, P284, DOI 10.1016/j.ijpharm.2012.01.035
   Steuer I, 2013, CURR PHARM DESIGN, V19, P4423, DOI 10.2174/1381612811319240009
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Taylor SJ, 2006, J CONTROL RELEASE, V116, P204, DOI 10.1016/j.jconrel.2006.07.005
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955
   Tobias CA, 2005, J NEUROTRAUM, V22, P138, DOI 10.1089/neu.2005.22.138
   Tsai EC, 2005, CURR PHARM DESIGN, V11, P1211, DOI 10.2174/1381612053507404
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Vijay N, 2014, CURR PHARM DESIGN, V20, P1487, DOI 10.2174/13816128113199990462
   Walmsey AR, 2007, CURR PHARM DESIGN, V13, P2470
   Wang HJ, 2010, BIOMATERIALS, V31, P6589, DOI 10.1016/j.biomaterials.2010.04.057
   Wang YC, 2008, BIOMATERIALS, V29, P4546, DOI 10.1016/j.biomaterials.2008.07.050
   Weaver SM, 2014, CURR PHARM DESIGN, V20, P4275
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Xia TL, 2013, BRAIN RES, V1538, P41, DOI 10.1016/j.brainres.2013.09.027
   Xiang SL, 2005, CURR PHARM DESIGN, V11, P1267, DOI 10.2174/1381612053507431
   Xie J, 2014, ACS NANO, V8, P1878
   Xie JW, 2014, ACS APPL MATER INTER, V6, P9472, DOI 10.1021/am5018557
   Xu XY, 2002, BIOMATERIALS, V23, P3765, DOI 10.1016/S0142-9612(02)00116-3
   Yang Y, 2005, J CONTROL RELEASE, V104, P433, DOI 10.1016/j.jconrel.2005.02.022
   Yao L, 2013, GENE THER, V20, P1149, DOI 10.1038/gt.2013.42
NR 80
TC 6
Z9 7
U1 7
U2 39
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2015
VL 21
IS 12
BP 1517
EP 1528
DI 10.2174/1381612821666150115152323
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CC3WN
UT WOS:000350281800003
PM 25594407
DA 2018-10-19
ER

PT J
AU Liu, LB
   Zhou, XW
   Xu, YF
   Zhang, WM
   Liu, CH
   Wang, XH
AF Liu, Libiao
   Zhou, Xinwei
   Xu, Yufan
   Zhang, Weiming
   Liu, Cheng-Hsien
   Wang, Xiaohong
TI Controlled Release of Growth Factors for Regenerative Medicine
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE Controlled release; growth factors (GFs); regenerative medicine;
   microencapsulation techniques; stem cells
ID EMBRYONIC STEM-CELLS; PLATELET-RICH PLASMA; FACTOR DELIVERY;
   MYOCARDIAL-INFARCTION; BONE REGENERATION; TRANSFORMING
   GROWTH-FACTOR-BETA-1; THERAPEUTIC ANGIOGENESIS; CARDIAC-MUSCLE;
   IN-VITRO; TISSUE
AB How to release growth factors (GFs) scientifically to promote stem cell proliferation and differentiation is one of the most significant research focuses in the field of regenerative medicine. In a controlled release system, growth factors, extracellular matrices or biomaterial carriers, and sometimes stem cells together form a geometric entirety. Biomaterial carriers provide GFs with a support structure to be adhered, immobilized, encapsulated or/and protected. As a unity, the release rate and rhythm of GFs on cells are normally very delicate and precise. Up to now, the best strategy for clinical applications is the combination systems that encapsulate GFs in microspheres, particularly the nano- or micro-encapsulation techniques integrated GFs with biomaterial carriers. In this mini review, we summarize the current progress in GF delivery systems for regenerative medicine and provide an outlook on two main aspects: one is the classes of stem cells and GFs that have been used frequently in regenerative medicine, including their respective application conditions and functions; the other is the controlled GF release systems, in which various GFs are released orderly and continuously without diffusing simply and rapidly, including their respective opportunities and challenges.
C1 [Liu, Libiao; Zhou, Xinwei; Xu, Yufan; Zhang, Weiming; Wang, Xiaohong] Tsinghua Univ, Key Lab Adv Mat Proc Technol, Minist Educ, Beijing 100084, Peoples R China.
   [Liu, Libiao; Zhou, Xinwei; Xu, Yufan; Zhang, Weiming; Wang, Xiaohong] Tsinghua Univ, Ctr Organ Mfg, Dept Mech Engn, Beijing 100084, Peoples R China.
   [Liu, Cheng-Hsien] Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu 30013, Taiwan.
   [Wang, Xiaohong] Huazhong Univ Sci & Technol, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Peoples R China.
RP Wang, XH (reprint author), Tsinghua Univ, Key Lab Adv Mat Proc Technol, Minist Educ, Beijing 100084, Peoples R China.
EM wangxiaohong@tsinghua.edu.cn
OI Liu, Cheng-Hsien/0000-0003-1882-3892
FU Cross-Strait Tsinghua Cooperation Basic Research [2012THZ02-3]; Beijing
   Municipal Natural Science Foundation [3152015]; National Natural Science
   Foundation of China (NSFC) [81271665, 30970748]; International
   Cooperation and Exchanges NSFC; Japanese Society for the Promotion of
   Science (JSPS) [81411140040]; State Key Laboratory of Materials
   Processing and Die & Mold Technology, Huazhong University of Science and
   Technology [2012-P03]; National High Tech 863 Grant [2009AA043801]
FX The work was supported by grants from the Cross-Strait Tsinghua
   Cooperation Basic Research (No. 2012THZ02-3), Beijing Municipal Natural
   Science Foundation (No. 3152015), National Natural Science Foundation of
   China (NSFC) (No. 81271665 & 30970748), International Cooperation and
   Exchanges NSFC and Japanese Society for the Promotion of Science (JSPS)
   (No. 81411140040), State Key Laboratory of Materials Processing and Die
   & Mold Technology, Huazhong University of Science and Technology (No.
   2012-P03), and the National High Tech 863 Grant (No. 2009AA043801).
CR Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549
   Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147
   Atala A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004890
   Attanasio S, 2009, CARDIOL REV, V17, P115, DOI 10.1097/CRD.0b013e318199e9b7
   Bai J, 2006, CN SCI B, V51, P506
   Barthes J, 2014, BIOMED RES INT, V10, P905
   Bessa PC, 2010, TISSUE ENG PART C-ME, V16, P937, DOI [10.1089/ten.tec.2009.0486, 10.1089/ten.TEC.2009.0486]
   Bi L, 2010, BIOMATERIALS, V31, P3201, DOI 10.1016/j.biomaterials.2010.01.038
   Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099
   Bohm F, 2010, EMBO MOL MED, V2, P294, DOI 10.1002/emmm.201000085
   Cao XD, 1999, BIOMATERIALS, V20, P329, DOI 10.1016/S0142-9612(98)00172-0
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Chen PF, 2012, CN J TISSUE ENG RES, V49, P422
   Elisseeff J, 2001, J ORTHOPAED RES, V19, P1098, DOI 10.1016/S0736-0266(01)00054-7
   Fabio RF, 2010, J CONTROLL RELEASE, V147, P30
   Ferrara N, 1999, CURR TOP MICROBIOL, V237, P1
   Formiga FR, 2014, J CONTROL RELEASE, V173, P132, DOI 10.1016/j.jconrel.2013.10.034
   Franz WM, 2003, LANCET, V362, P675, DOI 10.1016/S0140-6736(03)14240-7
   Gaffney MM, 2007, BRIT J PHARMACOL, V152, P175, DOI 10.1038/sj.bjp.0707315
   Gallego L, 2010, TISSUE ENG PT A, V16, P1179, DOI [10.1089/ten.tea.2009.0517, 10.1089/ten.TEA.2009.0517]
   Ginty PJ, 2008, EUR J PHARM BIOPHARM, V68, P82, DOI 10.1016/j.ejpb.2007.05.023
   Golub JS, 2010, AM J PHYSIOL-HEART C, V298, P1959
   He XS, 2014, THEORY PRACTICE SURG, V19, P281
   Holland TA, 2003, J CONTROL RELEASE, V91, P299, DOI 10.1016/S0168-3659(03)00258-X
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Holland TA, 2003, J CONTROL RELEASE, V86, P1, DOI 10.1016/S0168-3659(02)00373-5
   Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150
   Kim JH, 2011, BIOMATERIALS, V32, P6080, DOI 10.1016/j.biomaterials.2011.05.003
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Kimura Y, 2010, TISSUE ENG PT A, V16, P1263, DOI 10.1089/ten.TEA.2009.0322
   Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361
   Lebkowski JS, 2001, CANCER J, V7, pS83
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee KY, 2000, NATURE, V408, P998
   Liao C, 2013, INCORPORRATION CHITO
   Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05
   Lu HH, 2008, J BIOMED MATER RES A, V86A, P1128, DOI 10.1002/jbm.a.31740
   Meier P, 2009, CIRCULATION, V120, P1355, DOI 10.1161/CIRCULATIONAHA.109.866269
   Mimeault M, 2007, CLIN PHARMACOL THER, V82, P252, DOI 10.1038/sj.clpt.6100301
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Mooney DJ, 2003, BIOTECHNOL BIOENG, V50, P9214
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Nguyen LH, 2009, TISSUE ENG PART B-RE, V15, P363
   Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1
   Park YJ, 2000, J CONTROL RELEASE, V67, P385, DOI 10.1016/S0168-3659(00)00232-7
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Phillips Frank M, 2006, Spine J, V6, P500, DOI 10.1016/j.spinee.2006.01.014
   Prabhakaran MP, 2011, MAT SCI ENG C-MATER, V31, P503, DOI 10.1016/j.msec.2010.12.017
   Rich MH, 2014, J CONTROL RELEASE, V196, P363, DOI 10.1016/j.jconrel.2014.10.020
   Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726
   Richardson T. P., 2001, NAT BIOTECHNOL, V19, P2001, DOI DOI 10.1038/NBT1101-1029
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800
   Sha H, 2008, DEV CONTROLLED RELEA
   Shah NJ, 2011, BIOMATERIALS, V32, P61
   Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x
   Spiller KL, 2012, J CONTROL RELEASE, V157, P39, DOI 10.1016/j.jconrel.2011.09.057
   Tabata Y, 2000, J BIOMAT SCI-POLYM E, V11, P915, DOI 10.1163/156856200744101
   Takehara N, 2008, J AM COLL CARDIOL, V52, P1858, DOI 10.1016/j.jacc.2008.06.052
   Tang YD, 2009, AM HEART J, V158, P941, DOI 10.1016/j.ahj.2009.06.032
   Vo TN, 2012, ADV DRUG DELIVER REV, V64, P1292, DOI 10.1016/j.addr.2012.01.016
   Wang SG, 2011, CN J REPA RECONSTRUC, V15, P280
   Wang W, 2010, BIOMATERIALS, V31, P8964, DOI 10.1016/j.biomaterials.2010.08.018
   Wang X, 2014, J STEM CELLS RES REV, V1, P5
   Wang X, 2013, ADV BIOMATERIALS SCI, P437, DOI DOI 10.5772/53114
   Wang XH, 2007, TRENDS BIOTECHNOL, V25, P505, DOI 10.1016/j.tibtech.2007.08.010
   Wang XH, 2010, TISSUE ENG PART B-RE, V16, P189, DOI [10.1089/ten.teb.2009.0576, 10.1089/ten.TEB.2009.0576]
   Wang XH, 2012, ARTIF ORGANS, V36, P951, DOI 10.1111/j.1525-1594.2012.01499.x
   Wang XH, 2011, ARTIF ORGANS, V35, pE191, DOI 10.1111/j.1525-1594.2011.01341.x
   Wang XH, 2010, BIOMEDICAL APPLICATIONS OF HYDROGELS HANDBOOK, P269, DOI 10.1007/978-1-4419-5919-5_14
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wu B, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044111
   Xu MG, 2009, J BIOACT COMPAT POL, V24, P31, DOI 10.1177/0883911509102794
   Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042
   Yang H., 2011, TISSUE ENG, V17, P1
   Zhao X, 2014, J TISSUE ENG REGEN M, DOI [10.1002/term.1863, DOI 10.1002/TERM.1863]
   Zhao XR, 2013, J BIOACT COMPAT POL, V28, P191, DOI 10.1177/0883911513481892
   Zhao XR, 2014, RES CONSTRUCTION 3D
NR 78
TC 14
Z9 15
U1 4
U2 37
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2015
VL 21
IS 12
BP 1627
EP 1632
DI 10.2174/1381612821666150115154602
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CC3WN
UT WOS:000350281800012
PM 25594403
DA 2018-10-19
ER

PT J
AU Tovstonog, GB
   Sych, OE
   Skorokhod, VV
AF Tovstonog, G. B.
   Sych, O. E.
   Skorokhod, V. V.
TI THE STRUCTURE AND PROPERTIES OF BIOGENIC HYDROXYAPATITE CERAMICS:
   MICROWAVE AND CONVENTIONAL SINTERING
SO POWDER METALLURGY AND METAL CERAMICS
LA English
DT Article
DE hydroxyapatite; biomaterial; microwave sintering; porosity; compressive
   strength; solubility
ID MECHANICAL-PROPERTIES; BONE
AB The structure and properties of biogenic hydroxyapatite ceramics for medical applications produced by microwave and conventional sintering at 800, 900, 1000, and 1100 degrees C are studied. It is established that microwave sintering allows a 33 to 50% decrease in the minimum grain size, which can be attributed to the influence of microwaves on the material structure compared to conventional sintering. The bioceramic samples produced by microwave sintering have stable porosity (similar to 40%) and 30-59 MPa compressive strength, being close to that of native bone and 1.6 to 2 times higher than the compressive strength of samples prepared by conventional sintering. In vitro studies have shown that the solubility of bioceramics sintered in a microwave oven in saline is 1.7 to 5.5 times higher than the solubility of samples produced by conventional sintering. Thus, microwave sintering allows obtaining biogenic hydroxyapatite ceramics with improved mechanical and biological properties for filling bone defects in orthopedics and traumatology.
C1 [Tovstonog, G. B.] Natl Tech Univ Ukraine, Kiev Polytech Inst, Kiev, Ukraine.
   [Sych, O. E.; Skorokhod, V. V.] Natl Acad Sci Ukraine, Frantsevich Inst Problems Mat Sci, Kiev, Ukraine.
RP Sych, OE (reprint author), Natl Acad Sci Ukraine, Frantsevich Inst Problems Mat Sci, Kiev, Ukraine.
EM lena_sych@ukr.net
RI Sych, Olena/T-3111-2017
OI Sych, Olena/0000-0001-9902-7833
CR Dasgupta S, 2013, MAT SCI ENG C-MATER, V33, P2846, DOI 10.1016/j.msec.2013.03.004
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Fang Y., 1994, J MATER RES, V9, P147
   Gao Y, 2006, J MATER SCI-MATER M, V17, P815, DOI 10.1007/s10856-006-9840-3
   Gergely G, 2010, CERAM INT, V36, P803, DOI 10.1016/j.ceramint.2009.09.020
   GOLDSTEIN SA, 1987, J BIOMECH, V20, P1055, DOI 10.1016/0021-9290(87)90023-6
   HEISE U, 1990, INT ORTHOP, V14, P329
   Ivashutenko A. S., 2010, THESIS TOMSK, P22
   Kalita SJ, 2010, MAT SCI ENG C-MATER, V30, P295, DOI 10.1016/j.msec.2009.11.007
   Libenson G. A., 2002, POWDER METALLURGY PR, V2, P320
   Nakahira A, 2005, J AM CERAM SOC, V88, P1334, DOI 10.1111/j.1551-2916.2005.00238.x
   Nazir R, 2012, CERAM INT, V38, P457, DOI 10.1016/j.ceramint.2011.07.027
   Oktar FN, 2007, CERAM INT, V33, P1309, DOI 10.1016/j.ceramint.2006.05.022
   Putlyaev V. I., 2004, SOROS OBRAZOVAT ZH, V8, P44
   Raksujarit A, 2010, MATER DESIGN, V31, P1658, DOI 10.1016/j.matdes.2009.06.050
   Seo DS, 2008, ANN BIOMED ENG, V36, P132, DOI 10.1007/s10439-007-9394-7
   Sych O., 2007, PROCESS APPL CERAM, V1, P1
   Vanetsov A. S., MICROWAVE SINTERING
   Yanga Z., 2004, MATER LETT, V58, P3686
   Zhang Y, 2009, CERAM INT, V35, P2151, DOI 10.1016/j.ceramint.2008.11.022
NR 20
TC 1
Z9 1
U1 1
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1068-1302
EI 1573-9066
J9 POWDER METALL MET C+
JI Powder Metall. Met. Ceram.
PD JAN
PY 2015
VL 53
IS 9-10
BP 566
EP 573
DI 10.1007/s11106-015-9651-5
PG 8
WC Materials Science, Ceramics; Metallurgy & Metallurgical Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CC6NT
UT WOS:000350482800009
DA 2018-10-19
ER

EF